PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Okoroma, EA; Purchase, D; Garelick, H; Morris, R; Neale, MH; Windl, O; Abiola, OO				Okoroma, Emeka A.; Purchase, Diane; Garelick, Hemda; Morris, Roger; Neale, Michael H.; Windl, Otto; Abiola, Oduola O.			Enzymatic Formulation Capable of Degrading Scrapie Prion under Mild Digestion Conditions	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; PROTEIN; AGENT; INACTIVATION; BIOSURFACTANTS; DEGRADATION; INFECTIVITY; SOIL; DECONTAMINATION; SHEEP	The prion agent is notoriously resistant to common proteases and conventional sterilisation procedures. The current methods known to destroy prion infectivity such as incineration, alkaline and thermal hydrolysis are harsh, destructive, environmentally polluting and potentially hazardous, thus limit their applications for decontamination of delicate medical and laboratory devices, remediation of prion contaminated environment and for processing animal by-products including specified risk materials and carcases. Therefore, an environmentally friendly, non-destructive enzymatic degradation approach is highly desirable. A feather-degrading Bacillus licheniformis N22 keratinase has been isolated which degraded scrapie prion to undetectable level of PrPSc signals as determined by Western Blot analysis. Prion infectivity was verified by ex vivo cell-based assay. An enzymatic formulation combining N22 keratinase and biosurfactant derived from Pseudomonas aeruginosa degraded PrPSc at 65 degrees C in 10 min to undetectable level -. A time-course degradation analysis carried out at 50 degrees C over 2 h revealed the progressive attenuation of PrPSc intensity. Test of residual infectivity by standard cell culture assay confirmed that the enzymatic formulation reduced PrPSc infectivity to undetectable levels as compared to cells challenged with untreated standard scrapie sheep prion (SSBP/1) (p-value = 0.008 at 95% confidence interval). This novel enzymatic formulation has significant potential application for prion decontamination in various environmentally friendly systems under mild treatment conditions.	[Okoroma, Emeka A.; Purchase, Diane; Garelick, Hemda] Middlesex Univ, Sch Sci & Technol, Dept Nat Sci, London N17 8HR, England; [Morris, Roger] Kings Coll London, Sch Biomed Sci, London, England; [Neale, Michael H.; Windl, Otto] Anim Hlth & Vet Labs Agcy AHVLA, Sutton, Surrey, England; [Abiola, Oduola O.] Univ Brunei Darussalam, PAP Rashidah Saadatul Bolkiah Inst Hlth Sci, Gadong, Brunei	Middlesex University; University of London; King's College London; University Brunei Darussalam	Purchase, D (corresponding author), Middlesex Univ, Sch Sci & Technol, Dept Nat Sci, London N17 8HR, England.	d.purchase@mdx.ac.uk		Garelick, Hemda/0000-0003-4568-2300; Purchase, Diane/0000-0001-8071-4385	Alberta Prion Research Institute, Canada; Middlesex University, London, UK	Alberta Prion Research Institute, Canada; Middlesex University, London, UK	This work was supported by the Alberta Prion Research Institute, Canada and Middlesex University, London, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barron RM, 2007, J BIOL CHEM, V282, P35878, DOI 10.1074/jbc.M704329200; Berardi VA, 2006, TRANSFUSION, V46, P652, DOI 10.1111/j.1537-2995.2006.00763.x; BOLTON DC, 1984, BIOCHEMISTRY-US, V23, P5898, DOI 10.1021/bi00320a002; Brown P, 2004, ENVIRON SCI TECHNOL, V38, P6155, DOI 10.1021/es040301z; BROWN P, 1990, J INFECT DIS, V161, P467, DOI 10.1093/infdis/161.3.467; BROWN P, 1982, NEW ENGL J MED, V306, P1279, DOI 10.1056/NEJM198205273062107; Brown SA, 2005, J BIOMED MATER RES B, V72B, P186, DOI 10.1002/jbm.b.30125; Brzozowski B, 2011, FOOD TECHNOL BIOTECH, V49, P177; Cao XH, 2009, BRAZ J MICROBIOL, V40, P373, DOI 10.1590/S1517-838220090002000030; CHO HJ, 1983, CAN J COMP MED, V47, P494; Coll BA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000245; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Croud VB, 2008, Unites States Patent Application Publication, Patent No. [US2008/0206843A1, 20080206843]; Defra, 2005, BSE PUBL HLTH ISS NO; Desai JD, 1997, MICROBIOL MOL BIOL R, V61, P47, DOI 10.1128/.61.1.47-64.1997; Deziel E, 1996, APPL ENVIRON MICROB, V62, P1908, DOI 10.1128/AEM.62.6.1908-1912.1996; Dickinson J, 2009, J HOSP INFECT, V72, P65, DOI 10.1016/j.jhin.2008.12.007; Edgeworth JA, 2011, J GEN VIROL, V92, P718, DOI 10.1099/vir.0.027201-0; HISATSUKA KI, 1971, AGR BIOL CHEM TOKYO, V35, P686, DOI 10.1080/00021369.1971.10859987; Hommel RK, 1990, BIODEGRADATION, V1, P107, DOI 10.1007/BF00058830; Huang HS, 2007, CAN J VET RES, V71, P34; Jackson GS, 2005, J GEN VIROL, V86, P869, DOI 10.1099/vir.0.80484-0; Jennette JP, 2002, MED WASTE MANAGEMENT; Kalambura S., 2005, Krmiva, V47, P97; Karanth NGK, 1999, CURR SCI INDIA, V77, P116; Kosaric N, 2001, FOOD TECHNOL BIOTECH, V39, P295; Langeveld JPM, 2003, J INFECT DIS, V188, P1782, DOI 10.1086/379664; Lasmezas CI, 1997, SCIENCE, V275, P402, DOI 10.1126/science.275.5298.402; Lawson VA, 2007, J GEN VIROL, V88, P2905, DOI 10.1099/vir.0.82961-0; McDonnell G, 2003, CLIN INFECT DIS, V36, P1152, DOI 10.1086/374668; McLeod AH, 2004, BIOCHEM BIOPH RES CO, V317, P1165, DOI 10.1016/j.bbrc.2004.03.168; Mitsuiki S, 2010, ANN MICROBIOL, V60, P349, DOI 10.1007/s13213-010-0049-9; Muthusamy K, 2008, CURR SCI INDIA, V94, P736; Neale MH, 2010, J VIROL, V84, P2444, DOI 10.1128/JVI.01855-09; Nitschke M, 2007, TRENDS FOOD SCI TECH, V18, P252, DOI 10.1016/j.tifs.2007.01.002; Noordman WH, 2002, APPL ENVIRON MICROB, V68, P4502, DOI 10.1128/AEM.68.9.4502-4508.2002; OESCH B, 1994, BIOCHEMISTRY-US, V33, P5926, DOI 10.1021/bi00185a033; Okoroma EA, 2012, INT BIODETER BIODEGR, V74, P54, DOI 10.1016/j.ibiod.2012.07.013; Piening N, 2006, J BIOL CHEM, V281, P9373, DOI 10.1074/jbc.M512239200; Pilon JL, 2009, J VIROL METHODS, V161, P168, DOI 10.1016/j.jviromet.2009.04.040; Ramnani P, 2005, PROCESS BIOCHEM, V40, P3352, DOI 10.1016/j.procbio.2005.03.056; Rapp D, 2006, ENVIRON SCI TECHNOL, V40, P6324, DOI 10.1021/es060943h; Rodrigues LR, 2006, COLLOID SURFACE B, V53, P105, DOI 10.1016/j.colsurfb.2006.08.009; Rutala WA, 2010, INFECT CONT HOSP EP, V31, P107, DOI 10.1086/650197; Saunders SE, 2011, APPL ENVIRON MICROB, V77, P4313, DOI 10.1128/AEM.00421-11; Saunders SE, 2008, PRION, V2, P162, DOI 10.4161/pri.2.4.7951; Sharma R, 2010, J IND MICROBIOL BIOT, V37, P785, DOI 10.1007/s10295-010-0723-8; Shih JCH, 2002, US Patent Aplication, Patent No. [US 2002/0192731, 20020192731]; Singh A, 2007, BIOTECHNOL ADV, V25, P99, DOI 10.1016/j.biotechadv.2006.10.004; Soberon-Chavez G, 2005, APPL MICROBIOL BIOT, V68, P718, DOI 10.1007/s00253-005-0150-3; Somerville RA, 2002, J BIOL CHEM, V277, P11084, DOI 10.1074/jbc.M111766200; Somerville RA, 2009, PROCESS BIOCHEM, V44, P1060, DOI 10.1016/j.procbio.2009.06.002; Suzuki Y, 2006, J BIOSCI BIOENG, V102, P73, DOI 10.1263/jbb.102.73; TAYLOR DM, 1994, ARCH VIROL, V139, P313, DOI 10.1007/BF01310794; Taylor DM, 1999, J HOSP INFECT, V43, pS69, DOI 10.1016/S0195-6701(99)90067-1; Thacker HL, 2004, ALKALINE HYDROLYSIS; Tork S., 2010, Asian Journal of Biotechnology, V2, P1; Tsiroulnikov K, 2004, J AGR FOOD CHEM, V52, P6353, DOI 10.1021/jf0493324; Vilette D, 2001, P NATL ACAD SCI USA, V98, P4055, DOI 10.1073/pnas.061337998; Wang QH, 2007, BIOTECHNOL BIOENG, V98, P842, DOI 10.1002/bit.21462; WHO, 1999, WHO INF CONTR GUID T; Woodward JB, 2004, GRAND JUNCTION TSE I; Yokoyama T, 2006, SOIL SCI PLANT NUTR, V52, P71, DOI 10.1111/j.1747-0765.2006.00011.x; Zhang Guo-liang, 2005, J Zhejiang Univ Sci B, V6, P725, DOI 10.1631/jzus.2005.B0725	64	15	15	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68099	10.1371/journal.pone.0068099	http://dx.doi.org/10.1371/journal.pone.0068099			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874511	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000322064300016
J	Rudge, GM; Mohammed, MA; Fillingham, SC; Girling, A; Sidhu, K; Stevens, AJ				Rudge, Gavin M.; Mohammed, Mohammed A.; Fillingham, Sally C.; Girling, Alan; Sidhu, Khesh; Stevens, Andrew J.			The Combined Influence of Distance and Neighbourhood Deprivation on Emergency Department Attendance in a Large English Population: A Retrospective Database Study	PLOS ONE			English	Article							PATIENT SATISFACTION; GENERAL-PRACTICE; ACCIDENT; SERVICES; CARE	The frequency of visits to Emergency Departments (ED) varies greatly between populations. This may reflect variation in patient behaviour, need, accessibility, and service configuration as well as the complex interactions between these factors. This study investigates the relationship between distance, socio-economic deprivation, and proximity to an alternative care setting (a Minor Injuries Unit (MIU)), with particular attention to the interaction between distance and deprivation. It is set in a population of approximately 5.4 million living in central England, which is highly heterogeneous in terms of ethnicity, socio-economics, and distance to hospital. The study data set captured 1,413,363 ED visits made by residents of the region to National Health Service (NHS) hospitals during the financial year 2007/8. Our units of analysis were small units of census geography having an average population of 1,545. Separate regression models were made for children and adults. For each additional kilometre of distance from a hospital, predicted child attendances fell by 2.2% (1.7%-2.6% p<0.001) and predicted adult attendances fell by 1.5% (1.2% -1.8%, p<0.001). Compared to the least deprived quintile, attendances in the most deprived quintile more than doubled for children (incident rate ratio (IRR) = 2.19, (1.90-2.54, p<0.001)) and adults (IRR 2.26, (2.01-2.55, p<0.001)). Proximity of an MIU was significant and both adult and child attendances were greater in populations who lived further away from them, suggesting that MIUs may reduce ED demand. The interaction between distance and deprivation was significant. Attendance in deprived neighbourhoods reduces with distance to a greater degree than in less deprived ones for both adults and children. In conclusion, ED use is related to both deprivation and distance, but the effect of distance is modified by deprivation.	[Rudge, Gavin M.; Fillingham, Sally C.; Girling, Alan; Stevens, Andrew J.] Univ Birmingham, Sch Hlth & Populat Sci, Birmingham, W Midlands, England; [Mohammed, Mohammed A.] Univ Bradford, Bradford BD7 1DP, W Yorkshire, England; [Sidhu, Khesh] Welsh Hlth Specialised Serv Team, Caerphilly, Wales	University of Birmingham; University of Bradford	Rudge, GM (corresponding author), Univ Birmingham, Sch Hlth & Populat Sci, Birmingham, W Midlands, England.	g.rudge@bham.ac.uk		Stevens, Andrew/0000-0003-2079-3397; Girling, Alan/0000-0003-2022-045X	National Institute for Health Research (NIHR) through the Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country (CLAHRC-BBC) programm; National Institute for Health Research (NIHR)	National Institute for Health Research (NIHR) through the Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country (CLAHRC-BBC) programm; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR))	The lead author was funded by the National Institute for Health Research (NIHR) through the Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country (CLAHRC-BBC) programm (www.clahrc-bbc.nihr.ac.uk). This paper presents independent research funded by the National Institute for Health Research (NIHR). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashworth Mark, 2006, BMC Fam Pract, V7, P68, DOI 10.1186/1471-2296-7-68; Beland F, 1998, SOC SCI MED, V47, P165, DOI 10.1016/S0277-9536(98)00029-X; Boyle S., 2007, EUROHEALTH, V13, P12; CAMPBELL JL, 1994, FAM PRACT, V11, P438, DOI 10.1093/fampra/11.4.438; Carlisle R, 1998, BRIT MED J, V316, P520, DOI 10.1136/bmj.316.7130.520; *DEP HLTH, 2000, NHS PLAN; Department of Health, 2010, NHS DAT MOD DICT SER; Department of Health, 2010, NHS REF COSTS 2008 2; Department of Health, 2010, ATT ACC EM DEP MINR; Department of Health, 2009, NHS CHOIC YOUR HLTH; Downing A, 2006, EMERG MED J, V23, P391, DOI 10.1136/emj.2005.025411; Henneman PL, 2011, J EMERG MED, V40, P333, DOI 10.1016/j.jemermed.2009.08.058; Hull S, 1990, J HEALTH SERV RES PO, V2, P6; INGRAM DR, 1978, SOC SCI MED-MED GEOG, V12, P55, DOI 10.1016/0160-8002(78)90007-2; Jung Hans Peter, 2003, Health Expect, V6, P160; Leaman AM, 2006, EMERG MED J, V23, P918, DOI 10.1136/emj.2006.035980; Lyons R A, 1995, Inj Prev, V1, P173, DOI 10.1136/ip.1.3.173; Magnusson G, 1980, Sociol Health Illn, V2, P202, DOI 10.1111/1467-9566.ep10487794; MCKEE CM, 1990, BRIT J GEN PRACT, V40, P150; Mercer SW, 2007, ANN FAM MED, V5, P503, DOI 10.1370/afm.778; Mohammed MA, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b780; Nicholl J, 2007, J EPIDEMIOL COMMUN H, V61, P1010, DOI 10.1136/jech.2007.061747; Noble M, 2008, ENGLISH INDICES DEPR; Norredam M, 2004, SCAND J PUBLIC HEALT, V32, P53, DOI 10.1080/14034940310001659; Office for National Statistics, 2010, POP EST UK ENGL WAL; Office of National Statistics, POSTC PROD GUID METH; United States Census Bureau, 2000, GEOGR AR REF MAN; Walsh M, 1990, Nurs Stand, V5, P28; Wensing M, 2002, INT J QUAL HEALTH C, V14, P111, DOI 10.1093/oxfordjournals.intqhc.a002597; Wright J, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b569	30	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e67943	10.1371/journal.pone.0067943	http://dx.doi.org/10.1371/journal.pone.0067943			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	186SF	23874473	Green Published, gold, Green Submitted			2022-12-27	WOS:000322064300012
J	Marin, I				Marin, Ignacio			Evolution of Plant HECT Ubiquitin Ligases	PLOS ONE			English	Article							SKP1 GENE FAMILY; ARABIDOPSIS-THALIANA; COMPARATIVE GENOMICS; PROTEIN LIGASE; RBR FAMILY; BOX; EXPRESSION; CLASSIFICATION; SYSTEM; DESTRUCTION	HECT ubiquitin ligases are key components of the ubiquitin-proteasome system, which is present in all eukaryotes. In this study, the patterns of emergence of HECT genes in plants are described. Phylogenetic and structural data indicate that viridiplantae have six main HECT subfamilies, which arose before the split that separated green algae from the rest of plants. It is estimated that the common ancestor of all plants contained seven HECT genes. Contrary to what happened in animals, the number of HECT genes has been kept quite constant in all lineages, both in chlorophyta and streptophyta, although evolutionary recent duplications are found in some species. Several of the genes found in plants may have originated very early in eukaryotic evolution, given that they have clear similarities, both in sequence and structure, to animal genes. Finally, in Arabidopsis thaliana, we found significant correlations in the expression patterns of HECT genes and some ancient, broadly expressed genes that belong to a different ubiquitin ligase family, called RBR. These results are discussed in the context of the evolution of the gene families required for ubiquitination in plants.	CSIC, Inst Biomed Valencia, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV)	Marin, I (corresponding author), CSIC, Inst Biomed Valencia, Valencia, Spain.	imarin@ibv.csic.es	Marin, Ignacio/A-9524-2009	Marin, Ignacio/0000-0002-1315-8961	Spanish government [BFU2011-30063]	Spanish government(Spanish GovernmentEuropean Commission)	This study was supported by grant BFU2011-30063 (Spanish government). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Hernandez V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023934; Azevedo C, 2001, TRENDS PLANT SCI, V6, P354, DOI 10.1016/S1360-1385(01)01960-4; Behrends C, 2011, NAT STRUCT MOL BIOL, V18, P520, DOI 10.1038/nsmb.2066; Chen C, 2007, CANCER METAST REV, V26, P587, DOI 10.1007/s10555-007-9091-x; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Cheng YT, 2012, CURR OPIN PLANT BIOL, V15, P392, DOI 10.1016/j.pbi.2012.03.014; Craig A, 2009, J EXP BOT, V60, P1123, DOI 10.1093/jxb/erp059; Dastur A, 2006, J BIOL CHEM, V281, P4334, DOI 10.1074/jbc.M512830200; Dielen AS, 2010, MOL PLANT PATHOL, V11, P293, DOI 10.1111/j.1364-3703.2009.00596.x; Downes BP, 2003, PLANT J, V35, P729, DOI 10.1046/j.1365-313X.2003.01844.x; El Refy A., 2003, MGG Molecular Genetics and Genomics, V270, P403, DOI 10.1007/s00438-003-0932-1; Gagne JM, 2002, P NATL ACAD SCI USA, V99, P11519, DOI 10.1073/pnas.162339999; Gingerich DJ, 2007, PLANT CELL, V19, P2329, DOI 10.1105/tpc.107.051300; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Grau-Bove X, 2013, GENOME BIOL EVOL, V5, P833, DOI 10.1093/gbe/evt052; Hua ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016219; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Kong H, 2007, PLANT J, V50, P873, DOI 10.1111/j.1365-313X.2007.03097.x; Kong HZ, 2004, MOL BIOL EVOL, V21, P117, DOI 10.1093/molbev/msh001; Kuroda H, 2002, PLANT CELL PHYSIOL, V43, P1073, DOI 10.1093/pcp/pcf151; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lucas JI, 2006, J MOL BIOL, V357, P9, DOI 10.1016/j.jmb.2005.12.068; Lyzenga WJ, 2012, J EXP BOT, V63, P599, DOI 10.1093/jxb/err310; Marin I, 2004, PHYSIOL GENOMICS, V17, P253, DOI 10.1152/physiolgenomics.00226.2003; Marin I, 2002, MOL BIOL EVOL, V19, P2039, DOI 10.1093/oxfordjournals.molbev.a004029; Marin I, 2012, PLOS ONE IN PRESS; Marin I, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-331; Marin I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011579; Marin I, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-56; Marin I, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-267; Matentzoglu K, 2008, BIOCHEM SOC T, V36, P797, DOI 10.1042/BST0360797; Miao Y, 2010, PLANT J, V63, P179, DOI 10.1111/j.1365-313X.2010.04233.x; Nicholas KB., 1997, GENEDOC TOOL EDITING; Oudshoorn D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029870; Paterson AH, 2006, TRENDS GENET, V22, P597, DOI 10.1016/j.tig.2006.09.003; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Scheffner M, 2007, BMC BIOCH, P8; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Serrano M, 2006, J MOL EVOL, V62, P434, DOI 10.1007/s00239-005-0038-y; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomas JH, 2006, GENOME RES, V16, P1017, DOI 10.1101/gr.5089806; Trujillo M, 2010, CURR OPIN PLANT BIOL, V13, P402, DOI 10.1016/j.pbi.2010.04.002; Wong JJY, 2006, P NATL ACAD SCI USA, V103, P10735, DOI 10.1073/pnas.0600397103; Xu GX, 2009, P NATL ACAD SCI USA, V106, P835, DOI 10.1073/pnas.0812043106; Yang XH, 2008, PLANT PHYSIOL, V148, P1189, DOI 10.1104/pp.108.121921; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zeng LR, 2008, MOL PLANT, V1, P800, DOI 10.1093/mp/ssn044	51	29	30	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2013	8	7							e68536	10.1371/journal.pone.0068536	http://dx.doi.org/10.1371/journal.pone.0068536			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZN	23869223	gold, Green Published, Green Submitted			2022-12-27	WOS:000323110600022
J	Prashant, A; Vishwanath, P; Kulkarni, P; Narayana, PS; Gowdara, V; Nataraj, SM; Nagaraj, R				Prashant, Akila; Vishwanath, Prashant; Kulkarni, Praveen; Narayana, Prashanth Sathya; Gowdara, Vijaykumar; Nataraj, Suma M.; Nagaraj, Rashmi			Comparative Assessment of Cytokines and Other Inflammatory Markers for the Early Diagnosis of Neonatal Sepsis-A Case Control Study	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; C-REACTIVE PROTEIN; HEMOGLOBIN SCAVENGER RECEPTOR; CORD-BLOOD; BACTERIAL-INFECTION; INTERLEUKIN-6; EXPRESSION; CD163; ALPHA	Objective: Cytokines (IL-6, IL-8 and TNF-alpha), sCD163, and C-reactive protein were serially measured in an attempt to identify a set of tests which can reliably confirm or refute the diagnosis of neonatal sepsis at an early stage. Methods: One hundred neonates suspected to have sepsis on clinical grounds and who met the inclusion criteria were enrolled for the study. Based on the positive or negative blood culture reports they were classified as infected (n = 50) and non-infected (n = 50) neonates respectively. Fifty healthy neonates without any signs of sepsis were also included in the study as control group. The initial blood sample was taken on day 0 (at the time of sepsis evaluation) and two further samples were taken on days 1 and 2 for monitoring the clinical progress and response to treatment. In the control group the cord blood and 48 hours venous sample was collected. Plasma CRP (ng/ml), IL-6 (pg/ml), IL-8 (pg/ml), TNF-alpha (ng/ml) and sCD163 (ng/ml) were determined by double antibody method Enzyme Linked Immunosorbent Assay in all the three blood samples. Results: The cut of levels for CRP at >19,689 ng/ml had a sensitivity of 68%, specificity of 92%, for IL-6 at >95.32 pg/ml had a sensitivity of 54%, specificity of 96%, for IL-8 at.70.86 pg/ml had a sensitivity of 78%, specificity of 70%, for sCD163 at >896.78 ng/ml had a sensitivity of 100%, specificity of 88% for the diagnosis of infection before antibiotics. TNF-a levels of >12.6 ng/ml showed 100% sensitivity and 72% specificity for the diagnosis of inflammation. Conclusion: The most powerful predictor to differentiate between the non-infected and infected neonates before antibiotics was sCD163. The most powerful indicator for evaluation of prognosis is IL-6. sCD163 can be used alone to screen for sepsis in neonates before the results of blood culture are received.	[Prashant, Akila; Vishwanath, Prashant; Nataraj, Suma M.] JSS Univ, JSS Med Coll, Dept Biochem, Mysore, Karnataka, India; [Kulkarni, Praveen] JSS Univ, JSS Med Coll, Dept Community Med, Mysore, Karnataka, India; [Narayana, Prashanth Sathya; Nagaraj, Rashmi] JSS Univ, JSS Med Coll, Dept Pediat, Mysore, Karnataka, India; [Gowdara, Vijaykumar] JSS Univ, JSS Med Coll, Dept Microbiol, Mysore, Karnataka, India	JSS Academy of Higher Education & Research; JSS Medical College, Mysuru; JSS Academy of Higher Education & Research; JSS Medical College, Mysuru; JSS Academy of Higher Education & Research; JSS Medical College, Mysuru; JSS Academy of Higher Education & Research; JSS Medical College, Mysuru	Prashant, A (corresponding author), JSS Univ, JSS Med Coll, Dept Biochem, Mysore, Karnataka, India.	akila.prashant@gmail.com	Vishwanath, Prashant/O-6975-2019; Prashant, Akila/AAI-4468-2020; suma M, Nataraj/AAY-7403-2021; Kulkarni, Praveen/ABI-7473-2020	Prashant, Akila/0000-0003-0383-2366; suma M, Nataraj/0000-0002-2614-5377; Kulkarni, Praveen/0000-0003-1134-4442; , Prashant M Vishwanath/0000-0003-1582-8057	Indian Council of Medical Research, adhoc project IRIS [2008-00740]	Indian Council of Medical Research, adhoc project IRIS	This work was supported by the Indian Council of Medical Research, adhoc project IRIS No-2008-00740 (www.icmr.nic.in). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akila P, 2012, CLIN CHIM ACTA, V413, P669, DOI 10.1016/j.cca.2012.01.028; BUCK C, 1994, PEDIATRICS, V93, P54; Clinical and Laboratory Standards Institute (CLSI) (formerly NCCLS), 2007, M47A CLSI NCCLS, V27; Davis BH, 2005, CYTOM PART B-CLIN CY, V63B, P16, DOI 10.1002/cyto.b.20031; Dollner H, 2001, J CLIN EPIDEMIOL, V54, P1251, DOI 10.1016/S0895-4356(01)00400-0; Franz AR, 2001, ACTA PAEDIATR, V90, P1025, DOI 10.1080/080352501316978110; Groselj-Grenc M, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/202646; Hintz KA, 2002, J LEUKOCYTE BIOL, V72, P711; Isaacman DJ, 2002, ARCH PEDIAT ADOL MED, V156, P905, DOI 10.1001/archpedi.156.9.905; Krueger M, 2001, BIOL NEONATE, V80, P118, DOI 10.1159/000047130; Kurt ANC, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/31397; LEHRNBECHER T, 1995, ACTA PAEDIATR, V84, P806, DOI 10.1111/j.1651-2227.1995.tb13761.x; Lopez Sastre Jose B, 2006, BMC Pediatr, V6, P16; Mehr SS, 2001, AM J PERINAT, V18, P313, DOI 10.1055/s-2001-17857; Messer J, 1996, J PEDIATR-US, V129, P574, DOI 10.1016/S0022-3476(96)70123-3; Moller HJ, 2006, CRIT CARE MED, V34, P2561, DOI 10.1097/01.CCM.0000239120.32490.AB; National Collaborating Centre for Women's and Children's Health, 2007, FEV ILLN CHILDR ASS; Ng PC, 2007, PEDIATR RES, V61, P93, DOI 10.1203/01.pdr.0000250207.95723.96; Ng PC, 2006, CURR OPIN PEDIATR, V18, P125, DOI 10.1097/01.mop.0000193293.87022.4c; Ng PC, 1997, ARCH DIS CHILD-FETAL, V77, pF221, DOI 10.1136/fn.77.3.F221; Panero A, 1997, PEDIATR INFECT DIS J, V16, P370, DOI 10.1097/00006454-199704000-00007; Qazi SA, 2009, PEDIATR INFECT DIS J, V28, pS1, DOI 10.1097/INF.0b013e31819587a9; Silveira RC, 1999, ACTA PAEDIATR, V88, P647, DOI 10.1080/08035259950169314; Singh B, 1996, PEDIATR RES, V39, P976, DOI 10.1203/00006450-199606000-00008; TasciA Y, 2006, EUR J OBSTET GYN R B, V128, P34, DOI 10.1016/j.ejogrb.2005.11.049; Zuwala-Jagiello J, 2006, ACTA BIOCHIM POL, V53, P257	26	52	62	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2013	8	7							e68426	10.1371/journal.pone.0068426	http://dx.doi.org/10.1371/journal.pone.0068426			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZN	23869218	Green Published, Green Submitted, gold			2022-12-27	WOS:000323110600017
J	Aldred, N; Hoeg, JT; Maruzzo, D; Clare, AS				Aldred, Nick; Hoeg, Jens T.; Maruzzo, Diego; Clare, Anthony S.			Analysis of the Behaviours Mediating Barnacle Cyprid Reversible Adhesion	PLOS ONE			English	Article							BALANUS-AMPHITRITE-AMPHITRITE; SCANNING-ELECTRON-MICROSCOPY; SURFACE-PLASMON RESONANCE; TEMPORARY ADHESION; SEMIBALANUS-BALANOIDES; ANTENNULAR SECRETION; FOOTPRINT PROTEINS; IN-SITU; SETTLEMENT; LARVAE	When exploring immersed surfaces the cypris larvae of barnacles employ a tenacious and rapidly reversible adhesion mechanism to facilitate their characteristic 'walking' behaviour. Although of direct relevance to the fields of marine biofouling and bio-inspired adhesive development, the mechanism of temporary adhesion in cyprids remains poorly understood. Cyprids secrete deposits of a proteinaceous substance during surface attachment and these are often visible as 'footprints' on previously explored surfaces. The attachment structures, the antennular discs, of cyprids also present a complex morphology reminiscent of both the hairy appendages used by some terrestrial invertebrates for temporary adhesion and a classic 'suction cup'. Despite the numerous analytical approaches so-far employed, it has not been possible to resolve conclusively the respective contributions of viscoelastic adhesion via the proteinaceous 'temporary adhesive', 'dry' adhesion via the cuticular villi present on the disc and the behavioural contribution by the organism. In this study, high-speed photography was used for the first time to capture the behaviour of cyprids at the instant of temporary attachment and detachment. Attachment is facilitated by a constantly sticky disc surface - presumably due to the presence of the proteinaceous temporary adhesive. The tenacity of the resulting bond, however, is mediated behaviourally. For weak attachment the disc is constantly moved on the surface, whereas for a strong attachment the disc is spread out on the surface. Voluntary detachment is by force, requiring twisting or peeling of the bond - seemingly without any more subtle detachment behaviours. Micro-bubbles were observed at the adhesive interface as the cyprid detached, possibly an adaptation for energy dissipation. These observations will allow future work to focus more specifically on the cyprid temporary adhesive proteins, which appear to be fundamental to adhesion, inherently sticky and exquisitely adapted for reversible adhesion underwater.	[Aldred, Nick; Clare, Anthony S.] Newcastle Univ, Sch Marine Sci & Technol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Hoeg, Jens T.] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Maruzzo, Diego] Univ Padua, Dept Biol, Padua, Italy	Newcastle University - UK; University of Copenhagen; University of Padua	Clare, AS (corresponding author), Newcastle Univ, Sch Marine Sci & Technol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	a.s.clare@ncl.ac.uk	Hoeg, Jens Thorvald/D-5784-2015; Aldred, Nick/H-7896-2012	Hoeg, Jens Thorvald/0000-0002-3596-1691; Aldred, Nick/0000-0003-2285-5133; Clare, Anthony S./0000-0002-7692-9583	SYNTHESYS-2 through the European Community - Research Infrastructure Action under the FP7 "Capacities'' Specific Programme [DK-TAF-355]	SYNTHESYS-2 through the European Community - Research Infrastructure Action under the FP7 "Capacities'' Specific Programme	N. Aldred acknowledges the Department of Biology, University of Copenhagen and the financial support of SYNTHESYS-2 through the European Community - Research Infrastructure Action under the FP7 "Capacities'' Specific Programme, by grant DK-TAF-355. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldred N, 2009, FUNCTIONAL SURFACES IN BIOLOGY: ADHESION RELATED PHENOMENA, VOL 2, P43, DOI 10.1007/978-1-4020-6695-5_3; Aldred N, 2008, BIOFOULING, V24, P351, DOI 10.1080/08927010802256117; Aldred N, 2011, ACS APPL MATER INTER, V3, P2085, DOI 10.1021/am2003075; Aldred N, 2010, BIOFOULING, V26, P287, DOI 10.1080/08927010903511626; Andersson O, 2009, BIOINTERPHASES, V4, P65, DOI 10.1116/1.3274060; Bielecki J, 2009, BIOFOULING, V25, P203, DOI 10.1080/08927010802688087; Chen HN, 2013, BIOFOULING, V29, P133, DOI 10.1080/08927014.2012.753061; Chikina I, 2000, PHYS REV LETT, V85, P4546, DOI 10.1103/PhysRevLett.85.4546; Clare AS, 2009, WOODHEAD PUBL MATER, P46, DOI 10.1533/9781845696313.1.46; Clare AS, 2011, CHEMICAL COMMUNICATION IN CRUSTACEANS, P431, DOI 10.1007/978-0-387-77101-4_22; CLARE AS, 1994, J MAR BIOL ASSOC UK, V74, P243, DOI 10.1017/S0025315400035803; CLARE AS, 1994, J MAR BIOL ASSOC UK, V74, P967, DOI 10.1017/S0025315400090202; Crisp D.J., 1984, P103; Crisp D.J., 1976, ADAPTATION ENV ESSAY, P83; Dirks JH, 2010, J R SOC INTERFACE, V7, P587, DOI 10.1098/rsif.2009.0308; Dreanno C, 2006, BIOL LETTERS, V2, P423, DOI 10.1098/rsbl.2006.0503; Federle W, 2002, INTEGR COMP BIOL, V42, P1100, DOI 10.1093/icb/42.6.1100; GLENNER H, 1993, MAR BIOL, V117, P431; Gohad NV, 2012, J EXP MAR BIOL ECOL, V416, P153, DOI 10.1016/j.jembe.2012.02.013; Hoeg JT, 2012, INTEGR COMP BIOL, V52, P337, DOI 10.1093/icb/ics053; Hui CY, 2011, J R SOC INTERFACE, V8, P868, DOI 10.1098/rsif.2010.0567; Imbesi PM, 2012, POLYM CHEM-UK, V3, P3121, DOI 10.1039/c2py20317k; Kovalev AE, 2012, SOFT MATTER, V8, P7560, DOI 10.1039/c2sm25431j; Lagersson NC, 2002, MAR BIOL, V141, P513, DOI 10.1007/s00227-002-0854-1; Lakrout H, 1999, J ADHESION, V69, P307, DOI 10.1080/00218469908017233; Leger L, 2008, PHILOS T R SOC A, V366, P1425, DOI 10.1098/rsta.2007.2166; Lindner E, 1984, PHIL T R SOC B, P183; Maruzzo D, 2011, BIOFOULING, V27, P225, DOI 10.1080/08927014.2011.555534; Matsumura K, 1998, P ROY SOC B-BIOL SCI, V265, P1825, DOI 10.1098/rspb.1998.0508; Moyse J, 1995, NEW FRONTIERS BARNAC, V10, P153; Phang IY, 2008, J R SOC INTERFACE, V5, P397, DOI 10.1098/rsif.2007.1209; Phang IY, 2010, J R SOC INTERFACE, V7, P285, DOI 10.1098/rsif.2009.0127; Phang IY, 2009, J ADHESION, V85, P616, DOI 10.1080/00218460902996952; Sahni V, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1019; Singh S, 2006, NATURE, V442, P526, DOI 10.1038/442526a; WALKER G, 1985, J ZOOL, V205, P297, DOI 10.1111/j.1469-7998.1985.tb03536.x; WALKER G, 1984, J MAR BIOL ASSOC UK, V64, P679, DOI 10.1017/S0025315400030344; YULE AB, 1983, J MAR BIOL ASSOC UK, V63, P261, DOI 10.1017/S002531540007065X; YULE AB, 1985, J MAR BIOL ASSOC UK, V65, P707, DOI 10.1017/S0025315400052541; YULE AB, 1984, J MAR BIOL ASSOC UK, V64, P429, DOI 10.1017/S0025315400030101	40	25	26	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e68085	10.1371/journal.pone.0068085	http://dx.doi.org/10.1371/journal.pone.0068085			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874504	Green Published, Green Submitted, gold			2022-12-27	WOS:000322218800012
J	Laviolette, LA; Wilson, J; Koller, J; Neil, C; Hulick, P; Rejtar, T; Karger, B; Teh, BT; Iliopoulos, O				Laviolette, Laura A.; Wilson, Jonas; Koller, Julia; Neil, Christopher; Hulick, Peter; Rejtar, Tomas; Karger, Barry; Teh, Bin Tean; Iliopoulos, Othon			Human Folliculin Delays Cell Cycle Progression through Late S and G2/M-Phases: Effect of Phosphorylation and Tumor Associated Mutations	PLOS ONE			English	Article							BIRT-HOGG-DUBE; HEREDITARY MULTIPLE FIBROFOLLICULOMAS; GENE-PRODUCT; SPONTANEOUS PNEUMOTHORAX; POLYCYSTIC KIDNEYS; SUPPRESSOR FLCN; MTOR ACTIVATION; PROTEIN; NEOPLASIA; TRICHODISCOMAS	The Birt-Hogg-Dube disease occurs as a result of germline mutations in the human Folliculin gene (FLCN), and is characterized by clinical features including fibrofolliculomas, lung cysts and multifocal renal neoplasia. Clinical and genetic evidence suggest that FLCN acts as a tumor suppressor gene. The human cell line UOK257, derived from the renal cell carcinoma of a patient with a germline mutation in the FLCN gene, harbors a truncated version of the FLCN protein. Reconstitution of the wild type FLCN protein into UOK257 cells delays cell cycle progression, due to a slower progression through the late S and G2/M-phases. Similarly, Flcn(-/-) mouse embryonic fibroblasts progress more rapidly through the cell cycle than wild type controls (Flcn(flox/flox)). The reintroduction of tumor-associated FLCN mutants (FLCN Delta F157, FLCN 1-469 or FLCN K508R) fails to delay cell cycle progression in UOK257 cells. Additionally, FLCN phosphorylation (on Serines 62 and 73) fluctuates throughout the cell cycle and peaks during the G2/M phase in cells treated with nocodazole. In keeping with this observation, the reintroduction of a FLCN phosphomimetic mutant into the UOK257 cell line results in faster progression through the cell cycle compared to those expressing the wild type FLCN protein. These findings suggest that the tumor suppression function of FLCN may be linked to its impact on the cell cycle and that FLCN phosphorylation is important for this activity. Additionally, these observations describe a novel in vitro assay for testing the functional significance of FLCN mutations and/or genetic polymorphisms.	Massachusetts Gen Hosp, Ctr Canc, Ctr Canc Res, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Ctr Canc, Dept Med, Div Hematol Oncol, Boston, MA USA; Harvard Univ, Sch Med, Dept Med, Boston, MA USA; Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA; Northeastern Univ, Barnett Inst, Boston, MA 02115 USA; Van Andel Res Inst, Canc Genet Lab, Grand Rapids, MI USA; [Teh, Bin Tean] Natl Canc Ctr Singapore, NCCS VARI Translat Res Lab, Singapore, Singapore	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Northeastern University; Northeastern University; Van Andel Institute; National Cancer Centre Singapore (NCCS)	Iliopoulos, O (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Ctr Canc Res, Charlestown, MA 02129 USA.	oiliopoulos@partners.org	Koller, Julia/V-5600-2019; Hulick, Peter J/AAC-9444-2020	Hulick, Peter J/0000-0001-8397-4078; Teh, Bin Tean/0000-0003-1514-1124	National Institutes of Health [RO1 CA-208647, RO1 GM15847]; Dana-Farber/Harvard Cancer Center Kidney Cancer SPORE Development Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM015847] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana-Farber/Harvard Cancer Center Kidney Cancer SPORE Development Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health [RO1 CA-208647 to OI, RO1 GM15847 to BK]; and by a Dana-Farber/Harvard Cancer Center Kidney Cancer SPORE Development Award to OI. For the Barnett Institute researchers [BK] this is manuscript contribution No 1022. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], J INVEST DERMATOL, V127, P588; Baba M, 2008, JNCI-J NATL CANCER I, V100, P140, DOI 10.1093/jnci/djm288; Baba M, 2006, P NATL ACAD SCI USA, V103, P15552, DOI 10.1073/pnas.0603781103; BIRT AR, 1977, ARCH DERMATOL, V113, P1674, DOI 10.1001/archderm.113.12.1674; Chen JD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003581; CHEN PL, 1989, CELL, V58, P1193, DOI 10.1016/0092-8674(89)90517-5; Cho MH, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-120; DANOS O, 1988, P NATL ACAD SCI USA, V85, P6460, DOI 10.1073/pnas.85.17.6460; Hartman TR, 2009, ONCOGENE, V28, P1594, DOI 10.1038/onc.2009.14; Hasumi H, 2008, GENE, V415, P60, DOI 10.1016/j.gene.2008.02.022; Hasumi H, 2012, JNCI-J NATL CANCER I, V104, P1750, DOI 10.1093/jnci/djs418; Hong SB, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-160; Khoo SK, 2001, ONCOGENE, V20, P5239, DOI 10.1038/sj.onc.1204703; Menko FH, 2009, LANCET ONCOL, V10, P1199, DOI 10.1016/S1470-2045(09)70188-3; Nahorski MS, 2011, HUM MUTAT, V32, P921, DOI 10.1002/humu.21519; Nickerson ML, 2002, CANCER CELL, V2, P157, DOI 10.1016/S1535-6108(02)00104-6; Piao XH, 2009, BIOCHEM BIOPH RES CO, V389, P16, DOI 10.1016/j.bbrc.2009.08.070; Ren HZ, 2008, CLIN GENET, V74, P178, DOI 10.1111/j.1399-0004.2008.01030.x; ROTH JS, 1993, J AM ACAD DERMATOL, V29, P1055, DOI 10.1016/S0190-9622(08)82049-X; Scalvenzi M, 1998, J EUR ACAD DERMATOL, V11, P45, DOI 10.1016/S0926-9959(98)00018-X; Schmidt LS, 2005, AM J HUM GENET, V76, P1023, DOI 10.1086/430842; Schmidt LS, 2001, AM J HUM GENET, V69, P876, DOI 10.1086/323744; Stewart ZA, 2001, CHEM RES TOXICOL, V14, P243, DOI 10.1021/tx000199t; Takagi Y, 2008, ONCOGENE, V27, P5339, DOI 10.1038/onc.2008.261; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Toro JR, 2008, J MED GENET, V45, P321, DOI 10.1136/jmg.2007.054304; Toro JR, 1999, ARCH DERMATOL, V135, P1195, DOI 10.1001/archderm.135.10.1195; Truong HT, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-142; van Slegtenhorst M, 2007, J BIOL CHEM, V282, P24583, DOI 10.1074/jbc.M700857200; Wang L, 2010, FEBS LETT, V584, P39, DOI 10.1016/j.febslet.2009.11.033; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Woodward ER, 2008, CLIN CANCER RES, V14, P5925, DOI 10.1158/1078-0432.CCR-08-0608; Xu Jianming, 2005, Curr Protoc Mol Biol, VChapter 28, DOI 10.1002/0471142727.mb2801s70; Zimmer M, 2008, MOL CELL, V32, P838, DOI 10.1016/j.molcel.2008.12.004	34	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e66775	10.1371/journal.pone.0066775	http://dx.doi.org/10.1371/journal.pone.0066775			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874397	gold, Green Published, Green Submitted			2022-12-27	WOS:000322218800003
J	Antunes, JLF; Toporcov, TN; Biazevic, MGH; Boing, AF; Scully, C; Petti, S				Ferreira Antunes, Jose Leopoldo; Toporcov, Tatiana Natasha; Haye Biazevic, Maria Gabriela; Boing, Antonio Fernando; Scully, Crispian; Petti, Stefano			Joint and Independent Effects of Alcohol Drinking and Tobacco Smoking on Oral Cancer: A Large Case-Control Study	PLOS ONE			English	Article							POOLED ANALYSIS; RISK; HEAD; EPIDEMIOLOGY; CONSUMPTION; ETIOPATHOGENESIS; ASSOCIATION; INFORMATION; REGRESSION; DIET	Alcohol drinking and tobacco smoking are assumed to have significant independent and joint effects on oral cancer (OC) development. This assumption is based on consistent reports from observational studies, which, however, overestimated the independent effects of smoking and drinking, because they did not account for the interaction effect in multivariable analyses. This case-control study sought to investigate the independent and the joint effects of smoking and drinking on OC in a homogeneous sample of adults. Case patients (N = 1,144) were affected by invasive oral/oropharyngeal squamous cell carcinoma confirmed histologically, diagnosed between 1998 and 2008 in four hospitals of Sao Paulo (Brazil). Control patients (N = 1,661) were not affected by drinking-, smoking-associated diseases, cancers, upper aero-digestive tract diseases. Cumulative tobacco and alcohol consumptions were assessed anamnestically. Patients were categorized into never/ever users and never/level-1/level-2 users, according to the median consumption level in controls. The effects of smoking and drinking on OC adjusted for age, gender, schooling level were assessed using logistic regression analysis; Model-1 did not account for the smoking-drinking interaction; Model-2 accounted for this interaction and included the resultant interaction terms. The models were compared using the likelihood ratio test. According to Model-1, the adjusted odds ratios (ORs) for smoking, drinking, smoking-drinking were 3.50 (95% confidence interval -95CI, 2.76-4.44), 3.60 (95CI, 2.86-4.53), 12.60 (95CI, 7.89-20.13), respectively. According to Model-2 these figures were 1.41 (95CI, 1.02-1.96), 0.78 (95CI, 0.48-1.27), 8.16 (95CI, 2.09-31.78). Analogous results were obtained using three levels of exposure to smoking and drinking. Model-2 showed statistically significant better goodness-of-fit statistics than Model-1. Drinking was not independently associated with OC, while the independent effect of smoking was lower than expected, suggesting that observational studies should be revised adequately accounting for the smoking-drinking interaction. OC control policies should focus on addictive behaviours rather than on single lifestyle risk factors.	[Ferreira Antunes, Jose Leopoldo; Toporcov, Tatiana Natasha] Univ Sao Paulo, Sch Publ Hlth, Sao Paulo, Brazil; [Haye Biazevic, Maria Gabriela] Univ Sao Paulo, Sch Dent, Sao Paulo, Brazil; [Boing, Antonio Fernando] Univ Fed Santa Catarina, Postgrad Program Publ Hlth, Florianopolis, SC, Brazil; [Scully, Crispian] UCL, London, England; [Petti, Stefano] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Rome, Italy	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Santa Catarina (UFSC); University of London; University College London; Sapienza University Rome	Petti, S (corresponding author), Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Rome, Italy.	stefano.petti@uniroma1.it	Boing, Antonio Fernado/G-3010-2012; Antunes, Jose Leopoldo Ferreira/F-6969-2010; Biazevic, Maria GH/B-7169-2013; Toporcov, Tatiana/M-7729-2015; Petti, Stefano/AAY-6116-2021	Boing, Antonio Fernado/0000-0001-9331-1550; Antunes, Jose Leopoldo Ferreira/0000-0003-3972-9723; Biazevic, Maria GH/0000-0001-6326-5805; Petti, Stefano/0000-0001-9996-8860				Anantharaman D, 2011, ORAL ONCOL, V47, P725, DOI 10.1016/j.oraloncology.2011.05.004; [Anonymous], 1988, IARC Monogr Eval Carcinog Risks Hum, V44, P1; Argiris A, 2008, LANCET, V371, P1695, DOI 10.1016/S0140-6736(08)60728-X; Avena Nicole M, 2011, Curr Drug Abuse Rev, V4, P133; Bagley SC, 2001, J CLIN EPIDEMIOL, V54, P979, DOI 10.1016/S0895-4356(01)00372-9; Bekkering GE, 2008, AM J EPIDEMIOL, V167, P1017, DOI 10.1093/aje/kwn005; Bloomfield K, 2003, ALCOHOL RES HEALTH, V27, P95; Boing AF, 2011, J EPIDEMIOL COMMUN H, V65, P709, DOI 10.1136/jech.2009.097691; dos Santos Silva I, 1999, CANC EPIDEMIOLOGY PR; Gorber SC, 2009, NICOTINE TOB RES, V11, P12, DOI 10.1093/ntr/ntn010; Grant JE, 2010, AM J DRUG ALCOHOL AB, V36, P233, DOI 10.3109/00952990.2010.491884; Greenfield TK, 2008, ADDICTION, V103, P1082, DOI 10.1111/j.1360-0443.2008.02197.x; Grosshans M, 2011, ADDICT BIOL, V16, P189, DOI 10.1111/j.1369-1600.2010.00300.x; Hashibe M, 2009, CANCER EPIDEM BIOMAR, V18, P541, DOI 10.1158/1055-9965.EPI-08-0347; Biazevic MGH, 2011, NUTR CANCER, V63, P350, DOI 10.1080/01635581.2011.536065; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2010, IARC Monogr Eval Carcinog Risks Hum, V92, P1; International Agency for Research on Cancer, 2004, IARC MONOGR EVAL CAR, V83, P1; Lubin JH, 2010, AM J EPIDEMIOL, V171, P1250, DOI 10.1093/aje/kwq088; Marill KA, 2004, ACAD EMERG MED, V11, P94, DOI 10.1197/S1069-6563(03)00601-8; Metcalfe C, 2008, SCAND J PUBLIC HEALT, V36, P442, DOI 10.1177/1403494807088451; Petti S, 2013, Ann Ig, V25, P3, DOI 10.7416/ai.2013.1901; Petti S, 2007, ORAL ONCOL, V43, P408, DOI 10.1016/j.oraloncology.2006.04.010; Petti S, 2012, CANCER EPIDEMIOL, V36, pE1, DOI 10.1016/j.canep.2011.09.009; Petti S, 2010, J DENT, V38, P946, DOI 10.1016/j.jdent.2010.09.002; Petti S, 2009, ORAL ONCOL, V45, P340, DOI 10.1016/j.oraloncology.2008.05.018; Purdue MP, 2009, AM J EPIDEMIOL, V169, P132, DOI 10.1093/aje/kwn306; Room R, 2005, LANCET, V365, P519, DOI 10.1016/S0140-6736(05)70276-2; Schlesselman JJ, 1982, CASE CONTROL STUDIES; Schoenbach VJ, 2000, UNDERSTANDING FUNDAM, P381; Schroder H, 2003, EUR J CANCER PREV, V12, P339, DOI [10.1097/00008469-200308000-00016, 10.1097/01.cej.0000082034.69999.88]; Scully C, 2011, MED ORAL PATOL ORAL, V16, pE306, DOI 10.4317/medoral.16.e306; Szklo M, 2007, EPIDEMIOLOGY BASICS, P227; Toporcov TN, 2012, NUTR CANCER, V64, P1182, DOI 10.1080/01635581.2012.721155; Toporcov TN, 2004, ORAL ONCOL, V40, P925, DOI 10.1016/j.oraloncology.2004.04.007; Tramacere I, 2010, ORAL ONCOL, V46, P497, DOI 10.1016/j.oraloncology.2010.03.024; Turati F, 2010, ORAL ONCOL, V46, P720, DOI 10.1016/j.oraloncology.2010.07.010; von der Goltz C, 2009, EUR ARCH PSY CLIN N, V259, P183, DOI 10.1007/s00406-009-0057-6; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Wunsch V, 2006, BRAZ J MED BIOL RES, V39, P545, DOI 10.1590/S0100-879X2006000400016; Zacny J P, 1990, Recent Dev Alcohol, V8, P205	41	45	47	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68132	10.1371/journal.pone.0068132	http://dx.doi.org/10.1371/journal.pone.0068132			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874521	Green Published, gold, Green Submitted			2022-12-27	WOS:000321765300028
J	Sansone, CL; Blumenthal, EM				Sansone, Christine Lynn; Blumenthal, Edward M.			Neurodegeneration in Drop-Dead Mutant Drosophila melanogaster Is Associated with the Respiratory System but Not with Hypoxia	PLOS ONE			English	Article							EXPRESSION; SURVIVAL; BRAIN; GENE	Mutations in the gene drop-dead (drd) cause diverse phenotypes in adult Drosophila melanogaster including early lethality, neurodegeneration, tracheal defects, gut dysfunction, reduced body mass, and female sterility. Despite the identification of the drd gene itself, the causes of early lethality and neurodegeneration in the mutant flies remain unknown. To determine the pattern of drd expression associated with the neurodegenerative phenotype, knockdown of drd with various Gal4 drivers was performed. Early adult lethality and neurodegeneration were observed upon knockdown of drd in the tracheal system with two independent insertions of the breathless-Gal4 driver and upon knockdown in the tracheal system and elsewhere with the DJ717-Gal4 driver. Surprisingly, rescue of drd expression exclusively in the tracheae in otherwise mutant flies rescued the neurodegenerative phenotype but not adult lethality. Gut dysfunction, as measured by defecation rate, was not rescued in these flies, and gut function appeared normal upon tracheal-specific knockdown of drd. Finally, the hypothesis that tracheal dysfunction in drd mutants results in hypoxia was tested. Hypoxia-sensitive reporter transgenes (LDH-Gal4 and LDH-LacZ) were placed on a drd mutant background, but enhanced expression of these reporters was not observed. In addition, manipulation of drd expression in the tracheae did not affect expression of the hypoxia-induced genes LDH, tango, and similar. Overall, these results indicate that there are at least two causes of adult lethality in drd mutants, that gut dysfunction and neurodegeneration are independent phenotypes, and that neurodegeneration is associated with tracheal expression of drd but not with hypoxia.	[Sansone, Christine Lynn; Blumenthal, Edward M.] Marquette Univ, Dept Biol Sci, Milwaukee, WI 53233 USA	Marquette University	Blumenthal, EM (corresponding author), Marquette Univ, Dept Biol Sci, Milwaukee, WI 53233 USA.	edward.blumenthal@mu.edu			National Institutes of Health [1R15 GM080682-01]; Marquette University; GAANN (Graduate Assistance in Areas on National Need) fellowship from the Department of Education; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM080682] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marquette University; GAANN (Graduate Assistance in Areas on National Need) fellowship from the Department of Education; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by National Institutes of Health 1R15 GM080682-01 to EMB and by Marquette University. CLS was supported in part by a GAANN (Graduate Assistance in Areas on National Need) fellowship from the Department of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azad P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005371; BENZER S, 1971, J AMER MED ASSOC, V218, P1015, DOI 10.1001/jama.218.7.1015; Blumenthal EM, 2008, FLY, V2, DOI 10.4161/fly.6546; BUCHANAN RL, 1993, NEURON, V10, P839, DOI 10.1016/0896-6273(93)90200-B; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Choy RKM, 1999, MOL CELL, V4, P143, DOI 10.1016/S1097-2765(00)80362-7; Danjo R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017131; Gleixner E, 2008, FEBS J, V275, P5108, DOI 10.1111/j.1742-4658.2008.06642.x; HOTTA Y, 1972, NATURE, V240, P527, DOI 10.1038/240527a0; Kim JY, 2012, GENES BRAIN BEHAV, V11, P177, DOI 10.1111/j.1601-183X.2011.00743.x; Lavista-Llanos S, 2002, MOL CELL BIOL, V22, P6842, DOI 10.1128/MCB.22.19.6842-6853.2002; Lehmann FO, 2010, COMP BIOCHEM PHYS A, V156, P337, DOI 10.1016/j.cbpa.2009.12.019; Liu GW, 2006, PHYSIOL GENOMICS, V25, P134, DOI 10.1152/physiolgenomics.00262.2005; Morin PJ, 2005, MOL CELL BIOCHEM, V280, P99, DOI 10.1007/s11010-005-8236-x; Peller CR, 2009, J INSECT PHYSIOL, V55, P834, DOI 10.1016/j.jinsphys.2009.05.011; Pereanu W, 2007, DEV BIOL, V302, P169, DOI 10.1016/j.ydbio.2006.09.022; Sansone CL, 2012, INSECT BIOCHEM MOLEC, V42, P690, DOI 10.1016/j.ibmb.2012.06.002; Sato M, 2002, DEV CELL, V3, P195, DOI 10.1016/S1534-5807(02)00202-2; Seroude L, 2002, AGING CELL, V1, P47, DOI 10.1046/j.1474-9728.2002.00007.x; SIMON JA, 1987, NUCLEIC ACIDS RES, V15, P2971, DOI 10.1093/nar/15.7.2971; Sonnenfeld M, 2005, DEV GENES EVOL, V215, P221, DOI 10.1007/s00427-004-0462-9; Tschape JA, 2003, J NEURAL TRANSM-SUPP, P51; van Uden P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001285; Weaver M, 2008, SCIENCE, V321, P1496, DOI 10.1126/science.1158712	24	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68032	10.1371/journal.pone.0068032	http://dx.doi.org/10.1371/journal.pone.0068032			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874488	Green Submitted, gold, Green Published			2022-12-27	WOS:000321765300022
J	Ivanova, EP; Nguyen, SH; Webb, HK; Hasan, J; Truong, VK; Lamb, RN; Duan, XF; Tobin, MJ; Mahon, PJ; Crawford, RJ				Ivanova, Elena P.; Nguyen, Song Ha; Webb, Hayden K.; Hasan, Jafar; Truong, Vi Khanh; Lamb, Robert N.; Duan, Xiaofei; Tobin, Mark J.; Mahon, Peter J.; Crawford, Russell J.			Molecular Organization of the Nanoscale Surface Structures of the Dragonfly Hemianax papuensis Wing Epicuticle	PLOS ONE			English	Article							RAY PHOTOELECTRON-SPECTROSCOPY; CUTICULAR LIPIDS; PLANT-SURFACES; FATTY-ACIDS; CHEMICAL-COMPOSITION; NANOMECHANICAL PROPERTIES; INFRARED-SPECTROSCOPY; ARTHROPOD CUTICLES; FTIR SPECTROSCOPY; EXTERNAL LIPIDS	The molecular organization of the epicuticle (the outermost layer) of insect wings is vital in the formation of the nanoscale surface patterns that are responsible for bestowing remarkable functional properties. Using a combination of spectroscopic and chromatographic techniques, including Synchrotron-sourced Fourier-transform infrared microspectroscopy (FTIR), x-ray photoelectron spectroscopy (XPS) depth profiling and gas chromatography-mass spectrometry (GCMS), we have identified the chemical components that constitute the nanoscale structures on the surface of the wings of the dragonfly, Hemianax papuensis. The major components were identified to be fatty acids, predominantly hexadecanoic acid and octadecanoic acid, and n-alkanes with even numbered carbon chains ranging from C-14 to C-30. The data obtained from XPS depth profiling, in conjunction with that obtained from GCMS analyses, enabled the location of particular classes of compounds to different regions within the epicuticle. Hexadecanoic acid was found to be a major component of the outer region of the epicuticle, which forms the surface nanostructures, and was also detected in deeper layers along with octadecanoic acid. Aliphatic compounds were detected throughout the epicuticle, and these appeared to form a third discrete layer that was separate from both the inner and outer epicuticles, which has never previously been reported.	[Ivanova, Elena P.; Nguyen, Song Ha; Webb, Hayden K.; Hasan, Jafar; Truong, Vi Khanh; Mahon, Peter J.; Crawford, Russell J.] Swinburne Univ Technol, Fac Life & Social Sci, Hawthorn, Vic 3122, Australia; [Lamb, Robert N.; Duan, Xiaofei] Univ Melbourne, Sch Chem, Parkville, Vic 3052, Australia; [Tobin, Mark J.] Australian Synchrotron, Clayton, Vic, Australia	Swinburne University of Technology; University of Melbourne	Ivanova, EP (corresponding author), Swinburne Univ Technol, Fac Life & Social Sci, Hawthorn, Vic 3122, Australia.	eivanova@swin.edu.au	Tobin, Mark J/B-8208-2015; Mahon, Peter J/H-1967-2013; Ivanova, Elena P/B-1255-2019; Duan, Xiaofei/AAJ-6306-2020; Truong, Vi Khanh/AAS-1155-2020; Hasan, Jafar/B-2685-2018	Tobin, Mark J/0000-0003-1862-0649; Mahon, Peter J/0000-0001-8110-2604; Ivanova, Elena P/0000-0002-5509-8071; Duan, Xiaofei/0000-0002-8787-5496; Truong, Vi Khanh/0000-0002-6016-6438; Hasan, Jafar/0000-0002-0956-6145; Crawford, Russell/0000-0003-1054-5285; Nguyen, Song Ha/0000-0002-7450-8814; Webb, Hayden/0000-0003-2858-0177	Advanced Manufacturing Co-operative Research Centre (AMCRC)	Advanced Manufacturing Co-operative Research Centre (AMCRC)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This research was funded in part by the Advanced Manufacturing Co-operative Research Centre (AMCRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ANDERSEN SVEND OLAV, 1964, ADVANCES INSECT PHYSIOL, V2, P1, DOI 10.1016/S0065-2806(08)60071-5; [Anonymous], 1984, SADTL STAND GAS CHRO; Arsene C, 2002, J CHEM ECOL, V28, P2627, DOI 10.1023/A:1021474820601; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; Barthlott W, 1997, PLANTA, V202, P1, DOI 10.1007/s004250050096; Barthlott W, 1998, BOT J LINN SOC, V126, P237, DOI 10.1111/j.1095-8339.1998.tb02529.x; Bhushan B., 2010, SPRINGER HDB NANOTEC, P1437, DOI DOI 10.1007/978-3-642-02525-9_42; Bhushan B., 2008, J PHYS CONDENS MAT, V20; Bhushan B, 2012, LANGMUIR, V28, P1698, DOI 10.1021/la2043729; Bhushan B, 2011, BEILSTEIN J NANOTECH, V2, P66, DOI 10.3762/bjnano.2.9; Bhushan B, 2009, PHILOS T R SOC A, V367, P1631, DOI 10.1098/rsta.2009.0014; Bhushan B, 2009, LANGMUIR, V25, P3240, DOI 10.1021/la803860d; Boeve JL, 2011, ARTHROPOD STRUCT DEV, V40, P186, DOI 10.1016/j.asd.2011.01.005; Bogus MI, 2010, EXP PARASITOL, V125, P400, DOI 10.1016/j.exppara.2010.04.001; Buckner JS, 2003, ARCH INSECT BIOCHEM, V53, P66, DOI 10.1002/arch.10086; Buckner JS, 1999, COMP BIOCHEM PHYS B, V124, P201, DOI 10.1016/S0305-0491(99)00117-0; Buschhaus C, 2007, ANN BOT-LONDON, V100, P1557, DOI 10.1093/aob/mcm255; Buschhaus C, 2011, J EXP BOT, V62, P841, DOI 10.1093/jxb/erq366; Byun D, 2009, J BIONIC ENG, V6, P63, DOI 10.1016/S1672-6529(08)60092-X; Cameron KD, 2006, PLANT PHYSIOL, V140, P176, DOI 10.1104/pp.105.069724; Carballeira NM, 2008, PROG LIPID RES, V47, P50, DOI 10.1016/j.plipres.2007.10.002; Chen YL, 2011, CHINESE SCI BULL, V56, P1658, DOI 10.1007/s11434-011-4491-2; Cheng YT, 2006, NANOTECHNOLOGY, V17, P1359, DOI 10.1088/0957-4484/17/5/032; Choe DH, 2012, J CHEM ECOL, V38, P176, DOI 10.1007/s10886-012-0074-1; Coury C, 2008, ATMOS ENVIRON, V42, P5923, DOI 10.1016/j.atmosenv.2008.03.026; Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199; Ensikat HJ, 2011, BEILSTEIN J NANOTECH, V2, P152, DOI 10.3762/bjnano.2.19; Galindo RE, 2010, ANAL BIOANAL CHEM, V396, P2725, DOI 10.1007/s00216-009-3339-y; Ganim Z, 2008, ACCOUNTS CHEM RES, V41, P432, DOI 10.1021/ar700188n; Gerber R, 1983, HIGH GRADIENT MAGNET; Golebiowski M, 2011, ANAL BIOANAL CHEM, V399, P3177, DOI 10.1007/s00216-010-4439-4; Golebiowski M, 2010, J INSECT PHYSIOL, V56, P391, DOI 10.1016/j.jinsphys.2009.11.009; Gorb SN, 1997, MICROSC RES TECHNIQ, V37, P583, DOI 10.1002/(SICI)1097-0029(19970601)37:5/6<583::AID-JEMT18>3.0.CO;2-M; Gorb SN, 2000, ARTHROPOD STRUCT DEV, V29, P129, DOI 10.1016/S1467-8039(00)00020-7; HACKMAN RH, 1987, J INSECT PHYSIOL, V33, P39, DOI 10.1016/0022-1910(87)90102-8; HEPBURN HR, 1976, J COMP PHYSIOL, V109, P177, DOI 10.1007/BF00689417; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; Hu HMS, 2011, J EXP BIOL, V214, P915, DOI 10.1242/jeb.051128; Ivanova EP, 2012, SMALL, V8, P2489, DOI 10.1002/smll.201200528; JACKSON M, 1995, CRIT REV BIOCHEM MOL, V30, P95, DOI 10.3109/10409239509085140; Jetter R, 2000, PLANT CELL ENVIRON, V23, P619, DOI 10.1046/j.1365-3040.2000.00581.x; Jetter R, 2001, PLANT PHYSIOL, V126, P1725, DOI 10.1104/pp.126.4.1725; Koch K, 2004, J EXP BOT, V55, P711, DOI 10.1093/jxb/erh077; Koch K, 2008, MICRON, V39, P759, DOI 10.1016/j.micron.2007.11.010; Koch K, 2006, CRYST GROWTH DES, V6, P2571, DOI 10.1021/cg060035w; Koch K, 2009, PHILOS T R SOC A, V367, P1673, DOI 10.1098/rsta.2009.0015; Kramer KJ, 1997, INSECT BIOCHEM MOLEC, V27, P887, DOI 10.1016/S0965-1748(97)00078-7; Kreuz P, 2001, ANN BIOMED ENG, V29, P1054, DOI 10.1114/1.1424921; Kucukbay FZ, 2012, NAT PROD RES, V26, P1668, DOI 10.1080/14786419.2011.599808; Lapointe SL, 2004, AGR FOREST ENTOMOL, V6, P251, DOI 10.1111/j.1461-9555.2004.00230.x; Lasch P, 2002, VIB SPECTROSC, V28, P147, DOI 10.1016/S0924-2031(01)00153-9; Lockey HK, 1959, J EXP BIOL, V37, P316; LOCKEY KH, 1988, COMP BIOCHEM PHYS B, V89, P595, DOI 10.1016/0305-0491(88)90305-7; LOCKEY KH, 1980, COMP BIOCHEM PHYS B, V65, P457, DOI 10.1016/0305-0491(80)90297-7; LOCKEY KH, 1985, COMP BIOCHEM PHYS B, V81, P263, DOI 10.1016/0305-0491(85)90311-6; Mariod AA, 2012, FOOD REV INT, V28, P375, DOI 10.1080/87559129.2012.660716; MILLIGAN G, 1995, TRENDS BIOCHEM SCI, V20, P181, DOI 10.1016/S0968-0004(00)89004-0; Murphy RC, 2011, MASS SPECTROM REV, V30, P579, DOI 10.1002/mas.20284; Nelson DR, 2004, COMP BIOCHEM PHYS B, V138, P313, DOI 10.1016/j.cbpc.2004.04.013; Nelson DR, 2003, COMP BIOCHEM PHYS B, V136, P343, DOI 10.1016/S1096-4959(03)00216-1; Nelson DR, 2003, COMP BIOCHEM PHYS B, V135, P273, DOI 10.1016/S1096-4959(03)00080-0; Nelson DR, 1999, COMP BIOCHEM PHYS B, V123, P137, DOI 10.1016/S0305-0491(99)00054-1; NEVILLE AC, 1976, J CELL SCI, V21, P73; Pacakova V., 1992, CHROMATOGRAPHIC RETE; Riedel M, 2003, PLANTA, V218, P87, DOI 10.1007/s00425-003-1075-7; Riederer M., 2006, BIOL PLANT CUTICLE; Dani FR, 2006, ANN ZOOL FENN, V43, P500; Sajomsang W, 2010, MAT SCI ENG C-MATER, V30, P357, DOI 10.1016/j.msec.2009.11.014; Samuels L, 2008, ANNU REV PLANT BIOL, V59, P683, DOI 10.1146/annurev.arplant.59.103006.093219; SMITH S, 1994, FASEB J, V8, P1248, DOI 10.1096/fasebj.8.15.8001737; Song F, 2007, MAT SCI ENG A-STRUCT, V457, P254, DOI 10.1016/j.msea.2007.01.136; Sun MX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046710; van Dooremalen C, 2010, J INSECT PHYSIOL, V56, P178, DOI 10.1016/j.jinsphys.2009.10.002; VANDENDOOL H, 1963, J CHROMATOGR, V11, P463, DOI 10.1016/S0021-9673(01)80947-X; WAGNER CD, 1978, J VAC SCI TECHNOL, V15, P518, DOI 10.1116/1.569459; WAGNER CD, 1979, ANAL CHEM, V51, P466, DOI 10.1021/ac50040a005; Wan YL, 2008, J BIONIC ENG, V5, P40, DOI 10.1016/S1672-6529(08)60070-0; Xiao KW, 2007, ACTA MECH SINICA, V23, P281, DOI 10.1007/s10409-007-0070-9; Yocum GD, 2011, COMP BIOCHEM PHYS B, V159, P163, DOI 10.1016/j.cbpb.2011.03.007	79	44	44	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e67893	10.1371/journal.pone.0067893	http://dx.doi.org/10.1371/journal.pone.0067893			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874463	Green Published, Green Accepted, gold			2022-12-27	WOS:000321736900033
J	Shen, C; Wu, XR; Jiao, WW; Sun, L; Feng, WX; Xiao, J; Miao, Q; Liu, F; Yin, QQ; Zhang, CG; Guo, YJ; Shen, AD				Shen, Chen; Wu, Xi-rong; Jiao, Wei-wei; Sun, Lin; Feng, Wei-xing; Xiao, Jing; Miao, Qing; Liu, Fang; Yin, Qing-qin; Zhang, Chen-guang; Guo, Ya-jie; Shen, A-dong			A Functional Promoter Polymorphism of IFITM3 Is Associated with Susceptibility to Pediatric Tuberculosis in Han Chinese Population	PLOS ONE			English	Article							WEST NILE VIRUS; GENETIC SUSCEPTIBILITY; COLON-CANCER; EXPRESSION; IDENTIFICATION; INFECTION; PROTEINS; CHILDREN; CELLS	A susceptibility locus for tuberculosis, a re-emerging infectious disease throughout the world, was previously discovered to exist on chromosome 11p15. IFITM3 gene encoding for interferon inducible transmembrane protein 3, is located at 11p15. It acts as an effector molecule for interferon-gamma, which is essential for anti-tuberculosis immune response. In order to investigate the association between susceptibility to TB and genetic polymorphisms of the IFITM3 core promoter, a case-control study including 368 TB patients and 794 healthy controls was performed in Han Chinese children in northern China. The rs3888188 polymorphism showed significant association with susceptibility to TB. The rs3888188 G allele, acting recessively, was more frequent in TB patients (95% confidence interval: 1.08-1.56, Bonferroni P-value: 0.039). We further assessed the effect of rs3888188 polymorphism on IFITM3 transcription in vitro. As based on luciferase promoter assays, the promoter activity of haplotypes with rs3888188 G allele was lower than that of haplotypes with rs3888188 T allele. Moreover, peripheral-blood mononuclear cells carrying rs3888188 GG genotype showed a reduced IFITM3 mRNA level compared to cells carrying TT or GT genotype. In conclusion, rs3888188, a functional promoter polymorphism of IFITM3, was identified to influence the risk for pediatric TB in Han Chinese population.	[Shen, Chen; Wu, Xi-rong; Jiao, Wei-wei; Sun, Lin; Feng, Wei-xing; Xiao, Jing; Miao, Qing; Liu, Fang; Yin, Qing-qin; Guo, Ya-jie; Shen, A-dong] Capital Med Univ, Beijing Childrens Hosp, Beijing Pediat Res Inst, Key Lab Major Dis Children,Minist Educ, Beijing, Peoples R China; [Shen, Chen; Wu, Xi-rong; Jiao, Wei-wei; Sun, Lin; Feng, Wei-xing; Xiao, Jing; Miao, Qing; Liu, Fang; Yin, Qing-qin; Guo, Ya-jie; Shen, A-dong] Capital Med Univ, Beijing Childrens Hosp, Beijing Pediat Res Inst, Natl Key Discipline Pediat,Minist Educ, Beijing, Peoples R China; [Zhang, Chen-guang] Capital Med Univ, Dept Cell Biol, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University	Shen, AD (corresponding author), Capital Med Univ, Beijing Childrens Hosp, Beijing Pediat Res Inst, Key Lab Major Dis Children,Minist Educ, Beijing, Peoples R China.	shenad16@hotmail.com	shen, chen/AAC-2458-2020; 孙, 琳/HGE-6966-2022		National Natural Science Foundation of China [81071315]; Beijing Natural Science Foundation [7121007]; Ministry of Science and Technology [2011ZX09302]; Basic-Clinical research cooperation grant from Capital Medical University [11JL53]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Basic-Clinical research cooperation grant from Capital Medical University	This work was supported by grants from National Natural Science Foundation of China (No. 81071315; http://www.nsfc.gov.cn/Portal0/default152.htm), Beijing Natural Science Foundation (No. 7121007, http://www.bjnsf.org/), Ministry of Science and Technology (No. 2011ZX09302, http://www.most.gov.cn/), and Basic-Clinical research cooperation grant from Capital Medical University (No. 11JL53, http://www.ccmu.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcais A, 2005, J EXP MED, V202, P1617, DOI 10.1084/jem.20052302; Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Bellamy R, 2005, CLIN CHEST MED, V26, P233, DOI 10.1016/j.ccm.2005.02.006; Bellamy R, 2003, GENES IMMUN, V4, P4, DOI 10.1038/sj.gene.6363915; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Cuddapah S, 2008, FEBS LETT, V582, P391, DOI 10.1016/j.febslet.2007.12.033; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Fan JW, 2008, CANCER-AM CANCER SOC, V113, P266, DOI 10.1002/cncr.23551; Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337; FRIEDMAN RL, 1984, CELL, V38, P745, DOI 10.1016/0092-8674(84)90270-8; Graham SM, 2012, J INFECT DIS, V205, pS199, DOI 10.1093/infdis/jis008; He J, 2010, SCAND J IMMUNOL, V71, P452, DOI 10.1111/j.1365-3083.2010.02393.x; Hisamatsu T, 1999, CANCER RES, V59, P5927; Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09; Jiang ZF, 2006, PRACTICAL PEDIAT TUB, P431; Lee Jinhee, 2010, J Cell Death, V3, P1; Li DW, 2011, CLIN CANCER RES, V17, P3558, DOI 10.1158/1078-0432.CCR-10-2729; Li XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015831; Li ZQ, 2009, CELL RES, V19, P519, DOI 10.1038/cr.2009.33; Liu H, 2002, MOL CELL BIOL, V22, P6471, DOI 10.1128/MCB.22.18.6471-6479.2002; Moller M, 2010, TUBERCULOSIS, V90, P71, DOI 10.1016/j.tube.2010.02.002; Newton SM, 2008, LANCET INFECT DIS, V8, P498, DOI 10.1016/S1473-3099(08)70182-8; Rigouts L, 2009, EUR J PEDIATR, V168, P1285, DOI 10.1007/s00431-009-0988-y; Schurr E, 2007, J INTERN MED, V261, P106, DOI 10.1111/j.1365-2796.2006.01741.x; Seo GS, 2010, EXP MOL MED, V42, P99, DOI 10.3858/emm.2010.42.2.011; Seyfried NT, 2008, CANCER LETT, V263, P243, DOI 10.1016/j.canlet.2008.01.007; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Stein CM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004094; Subspecialty Group of Respiratory Diseases, 2006, Zhonghua Er Ke Za Zhi, V44, P249; Vallinoto ACR, 2010, HUM IMMUNOL, V71, P692, DOI 10.1016/j.humimm.2010.03.008; Walls T, 2004, J INFECTION, V48, P13, DOI 10.1016/S0163-4453(03)00121-X; Weidner JM, 2010, J VIROL, V84, P12646, DOI 10.1128/JVI.01328-10; Word Health Organization, GLOB TUB REP 2012; Wu XR, 2012, PEDIATRICS, V130, pE1433, DOI 10.1542/peds.2011-3742; Yim JJ, 2010, RESPIROLOGY, V15, P241, DOI 10.1111/j.1440-1843.2009.01690.x	36	20	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e67816	10.1371/journal.pone.0067816	http://dx.doi.org/10.1371/journal.pone.0067816			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874452	Green Submitted, Green Published, gold			2022-12-27	WOS:000321736900028
J	Xie, SQ; Wen, J; Zhang, YM				Xie, Shang-Qian; Wen, Jia; Zhang, Yuan-Ming			Multi-QTL Mapping for Quantitative Traits Using Epistatic Distorted Markers	PLOS ONE			English	Article							HYBRID MALE-STERILITY; SHOWING SEGREGATION DISTORTION; MAXIMUM-LIKELIHOOD MODELS; VIABILITY SELECTION; 2 LOCI; POPULATIONS; RICE; DROSOPHILA; PLANTS	The interaction between segregation distortion loci (SDL) has been often observed in all kinds of mapping populations. However, little has been known about the effect of epistatic SDL on quantitative trait locus (QTL) mapping. Here we proposed a multi-QTL mapping approach using epistatic distorted markers. Using the corrected linkage groups, epistatic SDL was identified. Then, these SDL parameters were used to correct the conditional probabilities of QTL genotypes, and these corrections were further incorporated into the new QTL mapping approach. Finally, a set of simulated datasets and a real data in 304 mouse F-2 individuals were used to validate the new method. As compared with the old method, the new one corrects genetic distance between distorted markers, and considers epistasis between two linked SDL. As a result, the power in the detection of QTL is higher for the new method than for the old one, and significant differences for estimates of QTL parameters between the two methods were observed, except for QTL position. Among two QTL for mouse weight, one significant difference for QTL additive effect between the above two methods was observed, because epistatic SDL between markers C66 and T93 exists (P = 2.94e-4).	[Xie, Shang-Qian; Wen, Jia; Zhang, Yuan-Ming] Nanjing Agr Univ, Stat Genom Grp, State Key Lab Crop Genet & Germplasm Enhancement, Dept Crop Genet & Breeding, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Zhang, YM (corresponding author), Nanjing Agr Univ, Stat Genom Grp, State Key Lab Crop Genet & Germplasm Enhancement, Dept Crop Genet & Breeding, Nanjing, Jiangsu, Peoples R China.	soyzhang@njau.edu.cn	Zhang, Yuan-Ming/AFQ-8637-2022; Xie, Shangqian/GSD-3701-2022; Zhang, Yuan-Ming/AAT-2899-2021	Xie, Shangqian/0000-0002-8821-2344; Zhang, Yuan-Ming/0000-0003-2317-2190	National Basic Research Program of China [2011CB109306]; Fundamental Research Funds for the Central Universities [KYT201002, KYZ201202-9]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Specialized Research Fund for the Doctoral Program of Higher Education [20100097110035, 20120097110023]	National Basic Research Program of China(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Priority Academic Program Development of Jiangsu Higher Education Institutions; Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Basic Research Program of China grant 2011CB109306; the Fundamental Research Funds for the Central Universities grants KYT201002 and KYZ201202-9; a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions and the Specialized Research Fund for the Doctoral Program of Higher Education grants 20100097110035 and 20120097110023. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumbach J, 2012, PLANT SCI, V195, P151, DOI 10.1016/j.plantsci.2012.07.003; Carr DE, 2003, PHILOS T R SOC B, V358, P1071, DOI 10.1098/rstb.2003.1295; Chang AS, 2010, EVOLUTION, V64, P253, DOI 10.1111/j.1558-5646.2009.00823.x; Doerge RW, 2002, NAT REV GENET, V3, P43, DOI 10.1038/nrg703; Falconer D. S., 1996, INTRO QUANTITATIVE G; Jiang CJ, 1997, GENETICA, V101, P47, DOI 10.1023/A:1018394410659; Kao CH, 1999, GENETICS, V152, P1203; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Kubo T, 2011, GENETICS, V189, P1083, DOI 10.1534/genetics.111.132035; Kubo T, 2008, GENES GENET SYST, V83, P443, DOI 10.1266/ggs.83.443; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Li XH, 2011, THEOR APPL GENET, V123, P667, DOI 10.1007/s00122-011-1617-5; LORIEUX M, 1995, THEOR APPL GENET, V90, P81, DOI 10.1007/BF00220999; LORIEUX M, 1995, THEOR APPL GENET, V90, P73, DOI 10.1007/BF00220998; Luo L, 2005, HEREDITY, V94, P347, DOI 10.1038/sj.hdy.6800615; Lynch M., 1998, GENETICS ANAL QUANTI; LYTTLE TW, 1991, ANNU REV GENET, V25, P511, DOI 10.1146/annurev.ge.25.120191.002455; Mackay TFC, 2001, NAT REV GENET, V2, P11, DOI 10.1038/35047544; PATERSON AH, 1991, GENETICS, V127, P181; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Taylor DR, 2003, GENETICA, V117, P27, DOI 10.1023/A:1022308414864; Torjek O, 2006, THEOR APPL GENET, V113, P1551, DOI 10.1007/s00122-006-0402-3; Vogl C, 2000, GENETICS, V155, P1439; Wang S, 2012, WINDOWS QTL CARTOGRA; Wen J, 2013, MOL BREEDING, V31, P395, DOI 10.1007/s11032-012-9797-5; Xie SQ, 2013, THESIS NANJING AGR U; Xu S, 2010, HEREDITY, V105, P483, DOI 10.1038/hdy.2009.180; Xu S., 2009, INT J PLANT GENOM, V410825, P1, DOI [DOI 10.1155/2009/410825, 10.1155/2009/410825]; Xu SZ, 2008, GENETICS, V180, P2201, DOI 10.1534/genetics.108.090688; Xu Y, 2011, THEOR APPL GENET, V122, P581, DOI 10.1007/s00122-010-1471-x; Yang JY, 2012, SCIENCE, V337, P1336, DOI 10.1126/science.1223702; Zhang LY, 2010, THEOR APPL GENET, V121, P1071, DOI 10.1007/s00122-010-1372-z; Zhu CS, 2007, THEOR APPL GENET, V114, P295, DOI 10.1007/s00122-006-0432-x	33	3	5	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68510	10.1371/journal.pone.0068510	http://dx.doi.org/10.1371/journal.pone.0068510			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874647	gold, Green Published, Green Submitted			2022-12-27	WOS:000321736900091
J	Fourtassi, M; Hajjioui, A; Urquizar, C; Rossetti, Y; Rode, G; Pisella, L				Fourtassi, Maryam; Hajjioui, Abderrazak; Urquizar, Christian; Rossetti, Yves; Rode, Gilles; Pisella, Laure			Iterative Fragmentation of Cognitive Maps in a Visual Imagery Task	PLOS ONE			English	Article							LATERAL EYE-MOVEMENTS; PREMOTOR THEORY; MENTAL-IMAGERY; ATTENTION; LOOKING; INFORMATION; PERCEPTION; LANGUAGE; INPUT; WORLD	It remains unclear whether spontaneous eye movements during visual imagery reflect the mental generation of a visual image (i.e. the arrangement of the component parts of a mental representation). To address this specificity, we recorded eye movements in an imagery task and in a phonological fluency (non-imagery) task, both consisting in naming French towns from long-term memory. Only in the condition of visual imagery the spontaneous eye positions reflected the geographic position of the towns evoked by the subjects. This demonstrates that eye positions closely reflect the mapping of mental images. Advanced analysis of gaze positions using the bi-dimensional regression model confirmed the spatial correlation of gaze and towns' locations in every single individual in the visual imagery task and in none of the individuals when no imagery accompanied memory retrieval. In addition, the evolution of the bi-dimensional regression's coefficient of determination revealed, in each individual, a process of generating several iterative series of a limited number of towns mapped with the same spatial distortion, despite different individual order of towns' evocation and different individual mappings. Such consistency across subjects revealed by gaze (the mind's eye) gives empirical support to theories postulating that visual imagery, like visual sampling, is an iterative fragmented processing.	[Fourtassi, Maryam; Urquizar, Christian; Rossetti, Yves; Rode, Gilles; Pisella, Laure] ImpAct Team, Lyon Neurosci Res Ctr, UMR5292, INSERM,U1028,CNRS, Lyon, France; [Fourtassi, Maryam; Urquizar, Christian; Rossetti, Yves; Rode, Gilles; Pisella, Laure] Univ Lyon 1, F-69365 Lyon, France; [Fourtassi, Maryam; Urquizar, Christian; Rossetti, Yves; Rode, Gilles; Pisella, Laure] Hop Henry Gabrielle, Hosp Civils Lyon, St Genis Laval, France; [Fourtassi, Maryam; Urquizar, Christian; Rossetti, Yves; Rode, Gilles; Pisella, Laure] Hop Neurol, Lyon, France; [Fourtassi, Maryam] Univ Mohamed Premier, Fac Med & Pharm, Oujda, Morocco; [Hajjioui, Abderrazak] Univ Mohammed Benabdellah, Fac Med & Pharm, CHU Hassan Fez 2, Fes, Morocco	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; CHU Lyon; Mohammed First University of Oujda; Mohammed VI University Hospital Center of Oujda; Hassan II University Hospital Center of Fez; Mohammed First University of Oujda; Sidi Mohamed Ben Abdellah University of Fez	Pisella, L (corresponding author), ImpAct Team, Lyon Neurosci Res Ctr, UMR5292, INSERM,U1028,CNRS, Lyon, France.	laure.pisella@inserm.fr	Rode, Gilles/J-8933-2017; Rossetti, Yves/H-3693-2017; Pisella, Laure/H-6072-2017	Rossetti, Yves/0000-0001-8867-4496; Pisella, Laure/0000-0001-6550-3774; FOURTASSI, Maryam/0000-0003-4915-5399; Hajjioui, Abderrazak/0000-0002-2311-5543				Altmann GTM, 2009, COGNITION, V111, P55, DOI 10.1016/j.cognition.2008.12.005; Altmann GTM, 2004, COGNITION, V93, pB79, DOI 10.1016/j.cognition.2004.02.005; Blangero A, 2010, CORTEX, V46, P1132, DOI 10.1016/j.cortex.2009.06.014; Borst G, 2006, MEM COGNITION, V34, P475, DOI 10.3758/BF03193572; Bourlon C, 2011, BRAIN RES, V1367, P287, DOI 10.1016/j.brainres.2010.10.039; Brandt SA, 1997, J COGN NEUROSC, V26, P207; Cauvin C, 2009, LOGICIEL COMPARAISON; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; EHRLICHMAN H, 1983, ACTA PSYCHOL, V53, P9, DOI 10.1016/0001-6918(83)90013-6; EHRLICHMAN H, 1978, PSYCHOL BULL, V85, P1080, DOI 10.1037/0033-2909.85.5.1080; Ehrlichman H, 2007, BRAIN COGNITION, V64, P7, DOI 10.1016/j.bandc.2006.10.001; Ferreira F, 2008, TRENDS COGN SCI, V12, P405, DOI 10.1016/j.tics.2008.07.007; Friedman A, 2003, PSYCHOL METHODS, V8, P468, DOI 10.1037/1082-989X.8.4.468; GUREVITCH B, 1959, NATURE, V184, P1219, DOI 10.1038/1841219a0; Hassabis D, 2007, P NATL ACAD SCI USA, V104, P1726, DOI 10.1073/pnas.0610561104; HEBB DO, 1968, PSYCHOL REV, V75, P466, DOI 10.1037/h0026771; Hessler J, 2006, CARTOGRAPHIA, V4, P101; Huijbers W, 2011, NEUROPSYCHOLOGIA, V49, P1730, DOI 10.1016/j.neuropsychologia.2011.02.051; Johansson R, 2006, COGNITIVE SCI, V30, P1053, DOI 10.1207/s15516709cog0000_86; Johansson R, 2012, J EXP PSYCHOL HUMAN, V38, P1289, DOI 10.1037/a0026585; Khan AZ, 2009, CEREB CORTEX, V19, P383, DOI 10.1093/cercor/bhn088; Laeng B, 2002, COGNITIVE SCI, V26, P207, DOI 10.1016/S0364-0213(01)00065-9; LORENS SA, 1962, ELECTROEN CLIN NEURO, V14, P739, DOI 10.1016/0013-4694(62)90088-3; Martarelli CS, 2013, PSYCHOL RES-PSYCH FO, V77, P303, DOI 10.1007/s00426-012-0439-7; Martarelli CS, 2011, BRIT J DEV PSYCHOL, V29, P425, DOI 10.1348/026151010X495844; Mast FW, 2002, TRENDS COGN SCI, V6, P271, DOI 10.1016/S1364-6613(02)01931-9; Neisser U., 1967, COGNITIVE PSYCHOL; O'Regan JK, 2001, BEHAV BRAIN SCI, V24, P939, DOI 10.1017/S0140525X01000115; Pisella L, 2004, NEUROSCI BIOBEHAV R, V28, P181, DOI 10.1016/j.neubiorev.2004.03.003; Pisella L, 2011, PHILOS T R SOC B, V366, P572, DOI 10.1098/rstb.2010.0258; RAINE A, 1991, BRIT J PSYCHOL, V82, P129, DOI 10.1111/j.2044-8295.1991.tb02388.x; Rensink RA, 2000, VIS COGN, V7, P17, DOI 10.1080/135062800394667; Richardson DC, 2009, TRENDS COGN SCI, V13, P235, DOI 10.1016/j.tics.2009.02.006; Richardson DC, 2004, J EXP PSYCHOL GEN, V133, P46, DOI 10.1037/0096-3445.133.1.46; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; Rode G, 2007, NEUROLOGY, V68, P432, DOI 10.1212/01.wnl.0000252936.54063.b0; RODE G, 1995, REV NEUROL, V151, P161; Rode G, 2004, CORTEX, V40, P391, DOI 10.1016/S0010-9452(08)70133-3; ROLL R, 1991, EXP BRAIN RES, V85, P423; Smith DT, 2012, NEUROPSYCHOLOGIA, V50, P1104, DOI 10.1016/j.neuropsychologia.2012.01.025; Spivey MJ, 2001, PSYCHOL RES-PSYCH FO, V65, P235, DOI 10.1007/s004260100059; Thomas LE, 2009, COGNITION, V111, P168, DOI 10.1016/j.cognition.2009.01.005; Tobler W, 1965, PAPERS REGIONAL SCI, V15, P131; van Reekum CM, 2007, NEUROIMAGE, V36, P1041, DOI 10.1016/j.neuroimage.2007.03.052; Wakefield CE, 2006, J VISUAL IMPAIR BLIN, V100, P306; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7	47	10	10	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e68560	10.1371/journal.pone.0068560	http://dx.doi.org/10.1371/journal.pone.0068560			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	185WH	23874672	Green Published, gold, Green Submitted			2022-12-27	WOS:000322000600011
J	Cheng, AC; Holmes, M; Irving, LB; Brown, SGA; Waterer, GW; Korman, TM; Friedman, ND; Senanayake, S; Dwyer, DE; Brady, S; Simpson, G; Wood-Baker, R; Upham, J; Paterson, D; Jenkins, C; Wark, P; Kelly, PM; Kotsimbos, T				Cheng, Allen C.; Holmes, Mark; Irving, Louis B.; Brown, Simon G. A.; Waterer, Grant W.; Korman, Tony M.; Friedman, N. Deborah; Senanayake, Sanjaya; Dwyer, Dominic E.; Brady, Stephen; Simpson, Grahame; Wood-Baker, Richard; Upham, John; Paterson, David; Jenkins, Christine; Wark, Peter; Kelly, Paul M.; Kotsimbos, Tom			Influenza Vaccine Effectiveness against Hospitalisation with Confirmed Influenza in the 2010-11 Seasons: A Test-negative Observational Study	PLOS ONE			English	Article							SENTINEL SURVEILLANCE; AUTUMN 2009; EFFICACY; AUSTRALIA; TRIVALENT; COHORT; VIRUS	Immunisation programs are designed to reduce serious morbidity and mortality from influenza, but most evidence supporting the effectiveness of this intervention has focused on disease in the community or in primary care settings. We aimed to examine the effectiveness of influenza vaccination against hospitalisation with confirmed influenza. We compared influenza vaccination status in patients hospitalised with PCR-confirmed influenza with patients hospitalised with influenza-negative respiratory infections in an Australian sentinel surveillance system. Vaccine effectiveness was estimated from the odds ratio of vaccination in cases and controls. We performed both simple multivariate regression and a stratified analysis based on propensity score of vaccination. Vaccination status was ascertained in 333 of 598 patients with confirmed influenza and 785 of 1384 test-negative patients. Overall estimated crude vaccine effectiveness was 57% (41%, 68%). After adjusting for age, chronic comorbidities and pregnancy status, the estimated vaccine effectiveness was 37% (95% CI: 12%, 55%). In an analysis accounting for a propensity score for vaccination, the estimated vaccine effectiveness was 48.3% (95% CI: 30.0, 61.8%). Influenza vaccination was moderately protective against hospitalisation with influenza in the 2010 and 2011 seasons.	[Cheng, Allen C.] Alfred Hosp, Infect Dis Unit, Melbourne, Vic, Australia; [Cheng, Allen C.; Holmes, Mark] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Holmes, Mark; Irving, Louis B.] Royal Adelaide Hosp, Dept Resp & Sleep Med, Adelaide, SA 5000, Australia; Univ Adelaide, Dept Med, Adelaide, SA 5001, Australia; [Brown, Simon G. A.] Royal Perth Hosp, Dept Emergency Med, Perth, WA, Australia; [Brown, Simon G. A.] Univ Western Australia, Western Australian Inst Med Res, Ctr Clin Res Emergency Med, Perth, WA 6009, Australia; [Waterer, Grant W.] Univ Western Australia, Sch Med & Pharmacol, Royal Perth Hosp, Dept Resp Med, Perth, WA 6009, Australia; [Korman, Tony M.] Monash Med Ctr, Melbourne, Vic, Australia; [Korman, Tony M.] Monash Univ, Melbourne, Vic 3004, Australia; [Friedman, N. Deborah] Barwon Hlth, Geelong Hosp, Geelong, Vic, Australia; [Senanayake, Sanjaya] Canberra Hosp, Infect Dis Unit, Canberra, ACT, Australia; [Senanayake, Sanjaya] Australian Natl Univ, Sch Med, Canberra, ACT, Australia; [Dwyer, Dominic E.] Univ Sydney, Westmead Hosp, Ctr Infect Dis & Microbiol Lab Serv, Sydney, NSW 2006, Australia; [Brady, Stephen] Alice Springs Hosp, Alice Springs, NT, Australia; [Simpson, Grahame] Cairns Base Hosp, Cairns, Qld, Australia; [Wood-Baker, Richard] Univ Tasmania, Menzies Res Inst, Hobart, Tas, Australia; [Upham, John] Univ Queensland, Princess Alexandra Hosp, Brisbane, Qld 4072, Australia; [Paterson, David] Univ Queensland, Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia; [Jenkins, Christine] Univ Sydney, Concord Hosp, Woolcock Inst Med Res, Sydney, NSW 2006, Australia; [Wark, Peter] Univ Newcastle, Newcastle, NSW 2300, Australia; [Wark, Peter] John Hunter Hosp, Newcastle, NSW, Australia; [Kelly, Paul M.] ACT Govt Hlth Directorate, Populat Hlth Div, Canberra, ACT, Australia; [Kelly, Paul M.] Australian Natl Univ, Sch Med, Canberra, ACT, Australia; [Kotsimbos, Tom] Monash Univ, Alfred Hosp, Dept Med, Allergy Immunol & Resp Med Unit, Melbourne, Vic 3181, Australia	Florey Institute of Neuroscience & Mental Health; Monash University; Royal Adelaide Hospital; University of Adelaide; Royal Perth Hospital; University of Western Australia; University of Western Australia; Royal Perth Hospital; University of Western Australia; Monash University; Monash University; Geelong Hospital; Australian National University; Canberra Hospital; Australian National University; University of Sydney; University of Tasmania; Menzies Institute for Medical Research; University of Queensland; Royal Brisbane & Women's Hospital; University of Queensland; Concord Repatriation General Hospital; University of Sydney; Woolcock Institute of Medical Research; University of Newcastle; John Hunter Hospital; Australian National University; Florey Institute of Neuroscience & Mental Health; Monash University	Cheng, AC (corresponding author), Alfred Hosp, Infect Dis Unit, Melbourne, Vic, Australia.	allen.cheng@monash.edu	Korman, Tony M/I-3099-2013; Upham, John/F-4420-2010; Wark, Peter/G-7037-2013; Waterer, Grant/AAG-2385-2021	Korman, Tony M/0000-0002-6155-8353; Upham, John/0000-0002-0017-3433; Wark, Peter/0000-0001-5676-6126; Paterson, David/0000-0003-2079-4437; Cheng, Allen/0000-0003-3152-116X	Australian Government Department of Health and Ageing; NHMRC	Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	The Australian Government Department of Health and Ageing provided funding for this study via an extension to a National Health and Medical Research Council grant. ACC is funded by a NHMRC Career Development Fellowship. The funder had input into the data collection instruments as it is a public health surveillance system but had no role in the analysis, the writing of the article or decision to publish this paper.	ATAGI, 2008, AUSTR IMM HDB; Austin PC, 2007, STAT MED, V26, P734, DOI 10.1002/sim.2580; Australian Institute of Health and Welfare (AIHW), 2009, 2009 AD VACC SURV SU; Belshe RB, 1998, NEW ENGL J MED, V338, P1405, DOI 10.1056/NEJM199805143382002; Cheng AC, 2011, VACCINE, V29, P7320, DOI 10.1016/j.vaccine.2011.07.087; DoHA, 2011, AUSTR INFL SURV SUMM; FEDSON DS, 1993, JAMA-J AM MED ASSOC, V270, P1956, DOI 10.1001/jama.270.16.1956; Fielding JE, 2011, EMERG INFECT DIS, V17, P1181, DOI 10.3201/eid1707.101959; Griffin MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023085; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Hardelid P, 2011, EURO SURVEILL, V16; Jefferson TO, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001269.pub3; Kelly PM, 2011, MED J AUSTRALIA, V194, P169, DOI 10.5694/j.1326-5377.2011.tb03764.x; Kissling E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027622; Mansson R, 2007, AM J EPIDEMIOL, V166, P332, DOI 10.1093/aje/kwm069; Nichol KL, 2007, NEW ENGL J MED, V357, P1373, DOI 10.1056/NEJMoa070844; Osterholm MT, 2011, LANCET INFECT DIS; Petrie JG, 2011, J INFECT DIS, V203, P1309, DOI 10.1093/infdis/jir015; Puig-Barbera J, 2010, VACCINE, V28, P7460, DOI 10.1016/j.vaccine.2010.09.042; Rivetti D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004876.pub2; Skowronski DM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7297; SMITH PG, 1984, INT J EPIDEMIOL, V13, P87, DOI 10.1093/ije/13.1.87; Song JY, 2011, VACCINE, V29, P1395, DOI 10.1016/j.vaccine.2010.12.050; Steens A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-196; Talbot HK, 2011, J INFECT DIS, V203, P500, DOI 10.1093/infdis/jiq076	25	37	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68760	10.1371/journal.pone.0068760	http://dx.doi.org/10.1371/journal.pone.0068760			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874754	Green Published, gold			2022-12-27	WOS:000322064300070
J	Lin, HL; Zhang, YH; Xu, YJ; Liu, T; Xiao, JP; Luo, Y; Xu, XJ; He, YH; Ma, WJ				Lin, Hualiang; Zhang, Yonghui; Xu, Yanjun; Liu, Tao; Xiao, Jianpeng; Luo, Yuan; Xu, Xiaojun; He, Yanhui; Ma, Wenjun			Large Daily Stock Variation Is Associated with Cardiovascular Mortality in Two Cities of Guangdong, China	PLOS ONE			English	Article							AMBIENT AIR-POLLUTION; PSYCHOLOGICAL STRESS; MENTAL STRESS; TIME-SERIES; RISK-FACTOR; DISEASE; TEMPERATURE; GUANGZHOU; EVENTS; DEATH	Objective: The current study aimed to examine the effects of daily change of the Shenzhen Stock Exchange Index on cardiovascular mortality in Guangzhou and Taishan, China. Methods: Daily mortality and stock performance data during 2006-2010 were collected to construct the time series for the two cities. A distributed lag non-linear model was utilized to examine the effect of daily stock index changes on cardiovascular mortality after controlling for potential confounding factors. Results: We observed a delayed non-linear effect of the stock index change on cardiovascular mortality: both rising and declining of the stock index were associated with increased cardiovascular deaths. In Guangzhou, the 15-25 lag days cumulative relative risk of an 800 index drop was 2.08 (95% CI: 1.38-3.14), and 2.38 (95% CI: 1.31-4.31) for an 800 stock index increase on the cardiovascular mortality, respectively. In Taishan, the cumulative relative risk over 15-25 days lag was 1.65 (95% CI: 1.13-2.42) for an 800 index drop and 2.08 (95% CI: 1.26-3.42) for an 800 index rising, respectively. Conclusions: Large ups and downs in daily stock index might be important predictor of cardiovascular mortality.	[Lin, Hualiang; Xu, Yanjun; Liu, Tao; Xiao, Jianpeng; Luo, Yuan; Xu, Xiaojun; He, Yanhui; Ma, Wenjun] Guangdong Prov Inst Publ Hlth, Guangzhou, Guangdong, Peoples R China; [Lin, Hualiang; Zhang, Yonghui; Liu, Tao; Xiao, Jianpeng; Luo, Yuan; He, Yanhui; Ma, Wenjun] Guangdong Prov Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China	Chinese Center for Disease Control & Prevention; Guangdong Provincial Center for Disease Control & Prevention	Ma, WJ (corresponding author), Guangdong Prov Inst Publ Hlth, Guangzhou, Guangdong, Peoples R China.	mwj68@vip.tom.com	Xiao, Jian/GYU-4351-2022; Xiao, Jianpeng/GRY-5231-2022; Zhang, Yonghui/AGY-9072-2022; 马, 文军/GQQ-7852-2022; Lin, Hualiang/E-6622-2010	Lin, Hualiang/0000-0002-2462-5158	National Natural Science Foundation of China [81202176]; National Major Research Program of China [2012CB955500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Major Research Program of China	This study was partly supported by the National Natural Science Foundation of China (No.: 81202176) and National Major Research Program of China (No.: 2012CB955500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adinaro DJ, 2008, J EMERG MED, V34, P311, DOI 10.1016/j.jemermed.2007.05.014; Austin AW, 2011, ANN BEHAV MED, V42, P153, DOI 10.1007/s12160-011-9274-0; Borjesson M, 2011, EUR HEART J, V32, P2119, DOI 10.1093/eurheartj/ehr178; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Chen CC, 2012, SOCIAL SCI MED; Chen R., 2012, ENV RES; Chen RJ, 2012, AM J EPIDEMIOL, V175, P1173, DOI 10.1093/aje/kwr425; Cohen S, 2007, JAMA-J AM MED ASSOC, V298, P1685, DOI 10.1001/jama.298.14.1685; DAKAK N, 1995, AM J CARDIOL, V76, P125, DOI 10.1016/S0002-9149(99)80043-5; Dimsdale JE, 2008, J AM COLL CARDIOL, V51, P1237, DOI 10.1016/j.jacc.2007.12.024; Fan CC, 2001, ENVIRON PLANN A, V33, P479, DOI 10.1068/a33150; Ferketich AK, 2005, EUR HEART J, V26, P1923, DOI 10.1093/eurheartj/ehi329; Fiuzat M, 2010, AM J CARDIOL, V106, P1545, DOI 10.1016/j.amjcard.2010.07.027; Gasparrini A, 2010, STAT MED, V29, P2224, DOI 10.1002/sim.3940; Gasparrini A, 2010, ENVIRON RES, V110, P633, DOI 10.1016/j.envres.2010.06.005; Goldberg MS, 2011, ENVIRON RES, V111, P853, DOI 10.1016/j.envres.2011.05.022; Goldberg MS, 2006, ENVIRON RES, V100, P255, DOI 10.1016/j.envres.2005.04.007; Granados JAT, 2009, P NATL ACAD SCI USA, V106, P17290, DOI 10.1073/pnas.0904491106; Guo F, 2010, INT REV ECON FINANC, V19, P452, DOI 10.1016/j.iref.2009.10.014; Ha J, 2011, SCI TOTAL ENVIRON, V409, P3274, DOI 10.1016/j.scitotenv.2011.05.034; Holman EA, 2008, ARCH GEN PSYCHIAT, V65, P73, DOI 10.1001/archgenpsychiatry.2007.6; Huang KS, 2011, CLIN CARDIOL, V34, P755, DOI 10.1002/clc.20947; Jouven X, 2001, CARDIOVASC RES, V50, P373, DOI 10.1016/S0008-6363(01)00230-9; Kop WJ, 2001, J AM COLL CARDIOL, V37, P1359, DOI 10.1016/S0735-1097(01)01136-6; Leeder S, 2004, RACE TIME CHALLENGE; Lin HL, 2013, ATMOS ENVIRON, V76, P68, DOI 10.1016/j.atmosenv.2012.08.043; Lu L, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-395; Ma WJ, 2011, EUR HEART J, V32, P1006, DOI 10.1093/eurheartj/ehq495; Peng RD, 2006, J R STAT SOC A STAT, V169, P179, DOI 10.1111/j.1467-985X.2006.00410.x; Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0; Rozanski A, 1999, CIRCULATION, V99, P2192, DOI 10.1161/01.CIR.99.16.2192; Schlenger WE, 2002, JAMA-J AM MED ASSOC, V288, P581, DOI 10.1001/jama.288.5.581; Schwartz BG, 2012, AM J CARDIOL, V109, P1445, DOI 10.1016/j.amjcard.2012.01.354; Sofia S, 2012, AM J HYPERTENS, V25, P556, DOI 10.1038/ajh.2012.4; Sosa Liprandi MIRM, 2012, REV ARGENT CARDIOL, V80, P137; Steptoe A, 2009, NEUROSCI BIOBEHAV R, V33, P63, DOI 10.1016/j.neubiorev.2008.04.010; Stuckler D, 2012, J EPIDEMIOL COMMUN H, V66, P410, DOI 10.1136/jech.2010.121376; Tao Y, 2012, ENV HLTH PERSPECT, V120.; Thorin E, 2012, CARDIOVASC RES, V93, P537, DOI 10.1093/cvr/cvs083; Walczewska J, 2011, EUR HEART J, V32, P730, DOI 10.1093/eurheartj/ehq354; Wang LD, 2005, LANCET, V366, P1821, DOI 10.1016/S0140-6736(05)67344-8; Wilbert-Lampen U, 2008, NEW ENGL J MED, V358, P475, DOI 10.1056/NEJMoa0707427; Yu ITS, 2012, ATMOS ENVIRON, V46, P528, DOI 10.1016/j.atmosenv.2011.07.055; Zhang Y, 2013, J CARDIOVASCULAR MED	44	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68417	10.1371/journal.pone.0068417	http://dx.doi.org/10.1371/journal.pone.0068417			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874619	Green Published, gold, Green Submitted			2022-12-27	WOS:000322064300031
J	Mendes, I; Franco-Duarte, R; Umek, L; Fonseca, E; Drumonde-Neves, J; Dequin, S; Zupan, B; Schuller, D				Mendes, Ines; Franco-Duarte, Ricardo; Umek, Lan; Fonseca, Elza; Drumonde-Neves, Joao; Dequin, Sylvie; Zupan, Blaz; Schuller, Dorit			Computational Models for Prediction of Yeast Strain Potential for Winemaking from Phenotypic Profiles	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE WINE; DIVERSITY; FERMENTATION; POPULATION; VALIDATION; REGION	Saccharomyces cerevisiae strains from diverse natural habitats harbour a vast amount of phenotypic diversity, driven by interactions between yeast and the respective environment. In grape juice fermentations, strains are exposed to a wide array of biotic and abiotic stressors, which may lead to strain selection and generate naturally arising strain diversity. Certain phenotypes are of particular interest for the winemaking industry and could be identified by screening of large number of different strains. The objective of the present work was to use data mining approaches to identify those phenotypic tests that are most useful to predict a strain's potential for winemaking. We have constituted a S. cerevisiae collection comprising 172 strains of worldwide geographical origins or technological applications. Their phenotype was screened by considering 30 physiological traits that are important from an oenological point of view. Growth in the presence of potassium bisulphite, growth at 40 degrees C, and resistance to ethanol were mostly contributing to strain variability, as shown by the principal component analysis. In the hierarchical clustering of phenotypic profiles the strains isolated from the same wines and vineyards were scattered throughout all clusters, whereas commercial winemaking strains tended to co-cluster. Mann-Whitney test revealed significant associations between phenotypic results and strain's technological application or origin. Naive Bayesian classifier identified 3 of the 30 phenotypic tests of growth in iprodion (0.05 mg/mL), cycloheximide (0.1 mu g/mL) and potassium bisulphite (150 mg/mL) that provided most information for the assignment of a strain to the group of commercial strains. The probability of a strain to be assigned to this group was 27% using the entire phenotypic profile and increased to 95%, when only results from the three tests were considered. Results show the usefulness of computational approaches to simplify strain selection procedures.	[Mendes, Ines; Franco-Duarte, Ricardo; Fonseca, Elza; Drumonde-Neves, Joao; Schuller, Dorit] Univ Minho, Dept Biol, CBMA Ctr Mol & Environm Biol, Braga, Portugal; [Umek, Lan] Univ Ljubljana, Fac Adm, Ljubljana, Slovenia; [Umek, Lan; Zupan, Blaz] Univ Ljubljana, Fac Comp & Informat Sci, Ljubljana, Slovenia; [Drumonde-Neves, Joao] Univ Azores, Dept Agr Sci, Res Ctr Agr Technol, Sao Miguel, Azores, Portugal; [Dequin, Sylvie] INRA Inst Natl Rech, UMR1083, Montpellier, France	Universidade do Minho; University of Ljubljana; University of Ljubljana; Universidade dos Acores; INRAE; Universite de Montpellier	Schuller, D (corresponding author), Univ Minho, Dept Biol, CBMA Ctr Mol & Environm Biol, Braga, Portugal.	dschuller@bio.uminho.pt	Schuller, Dorit/I-6649-2013; Zupan, Blaz/L-1595-2019; Franco-Duarte, Ricardo/I-6594-2015	Franco-Duarte, Ricardo/0000-0002-2333-6127; Schuller, Dorit/0000-0001-6030-4602; Zupan, Blaz/0000-0002-5864-7056; Fonseca, Elza/0000-0001-8955-2108; Mendes, Ines/0000-0002-9566-4779	Portuguese Science Foundation, FCT [SFRH/BD/74798/2010, SFRH/BD/48591/2008]; Azores government [M3.1.2/F/006/2008 (DRCT)]; FEDER funds through the program COMPETE; national funds through FCT [COMP-01-0124-008775 (PTDC/AGR-ALI/103392/2008), PTDC/AGR-ALI/121062/2010]; Slovene Research Agency [P2-0209]	Portuguese Science Foundation, FCT(Portuguese Foundation for Science and Technology); Azores government; FEDER funds through the program COMPETE; national funds through FCT(Portuguese Foundation for Science and Technology); Slovene Research Agency(Slovenian Research Agency - Slovenia)	Ines Mendes and Ricardo Franco-Duarte are recipients of a fellowship from the Portuguese Science Foundation, FCT (SFRH/BD/74798/2010, SFRH/BD/48591/2008, respectively) and Joao Drumonde-Neves is recipient of a fellowship from the Azores government (M3.1.2/F/006/2008 (DRCT)). Financial support was obtained from FEDER funds through the program COMPETE and by national funds through FCT by the projects FCOMP-01-0124-008775 (PTDC/AGR-ALI/103392/2008) and PTDC/AGR-ALI/121062/2010. Lan Umek and Blaz Zupan acknowledge financial support from Slovene Research Agency (P2-0209). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnolucci M, 2007, LETT APPL MICROBIOL, V45, P657, DOI 10.1111/j.1472-765X.2007.02244.x; Bisson LF, 1999, AM J ENOL VITICULT, V50, P107; Brandolini V, 2002, WORLD J MICROB BIOT, V18, P499, DOI 10.1023/A:1016306813502; Briones A.I., 1995, DEV FOOD SCI, V37, P1597, DOI 10.1016/S0167-4501(06)80253-0; Cadez N, 2010, FEMS YEAST RES, V10, P619, DOI 10.1111/j.1567-1364.2010.00635.x; Camarasa C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025147; Chiai NO, 2002, BIOSCI BIOTECH BIOCH, V66, P2209; Curk T, 2005, BIOINFORMATICS, V21, P396, DOI 10.1093/bioinformatics/bth474; Demsar J, 2004, ORANGE EXPT MACHINE; Dunn B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-53; Fay JC, 2005, PLOS GENET, V1, P66, DOI 10.1371/journal.pgen.0010005; Fleet GH, 1998, FOOD TECHNOL BIOTECH, V36, P285; Franco-Duarte R, 2009, YEAST, V26, P675, DOI 10.1002/yea.1728; FREZIER V, 1992, AM J ENOL VITICULT, V43, P375; Goddard MR, 2010, ENVIRON MICROBIOL, V12, P63, DOI 10.1111/j.1462-2920.2009.02035.x; Greig D, 2009, CURR BIOL, V19, pR886, DOI 10.1016/j.cub.2009.07.037; Grimshaw SD, 1995, TECHNOMETRICS, V37, P341; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; JIRANEK V, 1995, AM J ENOL VITICULT, V46, P269; Kvitek DJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000223; Legras JL, 2007, MOL ECOL, V16, P2091, DOI 10.1111/j.1365-294X.2007.03266.x; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Lopes CA, 2002, J APPL MICROBIOL, V93, P608, DOI 10.1046/j.1365-2672.2002.01738.x; Mannazzu I, 2002, BIODIVERSITY AND BIOTECHNOLOGY OF WINE YEASTS, P19; Mozina M, 2004, LECT NOTES ARTIF INT, V3202, P337; Muller LAH, 2009, MOL ECOL, V18, P2779, DOI 10.1111/j.1365-294X.2009.04234.x; Ramirez M, 1998, APPL ENVIRON MICROB, V64, P5039; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Sabate J, 1998, LETT APPL MICROBIOL, V26, P452, DOI 10.1046/j.1472-765X.1998.00369.x; Salinas F, 2010, J APPL MICROBIOL, V108, P1850, DOI 10.1111/j.1365-2672.2010.04689.x; Schacherer J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000322; Schacherer J, 2009, NATURE, V458, P342, DOI 10.1038/nature07670; Schuller D, 2005, FEMS MICROBIOL ECOL, V51, P167, DOI 10.1016/j.femsec.2004.08.003; Schuller D, 2007, YEAST, V24, P625, DOI 10.1002/yea.1496; Schuller D, 2010, PROGRESS IN MYCOLOGY, P1, DOI 10.1007/978-90-481-3713-8_1; Tan P., 2006, INTRO DATA MINING; Valero E, 2007, FEMS YEAST RES, V7, P317, DOI 10.1111/j.1567-1364.2006.00161.x; Warringer J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002111	38	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e66523	10.1371/journal.pone.0066523	http://dx.doi.org/10.1371/journal.pone.0066523			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874393	Green Published, Green Submitted, gold			2022-12-27	WOS:000322064300005
J	Raucci, U; Rossi, R; Da Cas, R; Rafaniello, C; Mores, N; Bersani, G; Reale, A; Pirozzi, N; Menniti-Ippolito, F; Traversa, G				Raucci, Umberto; Rossi, Rossella; Da Cas, Roberto; Rafaniello, Concita; Mores, Nadia; Bersani, Giulia; Reale, Antonino; Pirozzi, Nicola; Menniti-Ippolito, Francesca; Traversa, Giuseppe		Italian Multictr Study Grp Drug Va	Stevens-Johnson Syndrome Associated with Drugs and Vaccines in Children: A Case-Control Study	PLOS ONE			English	Article							TOXIC EPIDERMAL NECROLYSIS; CUTANEOUS REACTIONS; RISK	Objective: Stevens-Johnson Syndrome (SJS) is one of the most severe muco-cutaneous diseases and its occurrence is often attributed to drug use. The aim of the present study is to quantify the risk of SJS in association with drug and vaccine use in children. Methods: A multicenter surveillance of children hospitalized through the emergency departments for acute conditions of interest is currently ongoing in Italy. Cases with a diagnosis of SJS were retrieved from all admissions. Parents were interviewed on child's use of drugs and vaccines preceding the onset of symptoms that led to the hospitalization. We compared the use of drugs and vaccines in cases with the corresponding use in a control group of children hospitalized for acute neurological conditions. Results: Twenty-nine children with a diagnosis of SJS and 1,362 with neurological disorders were hospitalized between 1st November 1999 and 31st October 2012. Cases were more frequently exposed to drugs (79% vs 58% in the control group; adjusted OR 2.4; 95% CI 1.0-6.1). Anticonvulsants presented the highest adjusted OR: 26.8 (95% CI 8.4-86.0). Significantly elevated risks were also estimated for antibiotics use (adjusted OR 3.3; 95% CI 1.5-7.2), corticosteroids (adjusted OR 4.2; 95% CI 1.8-9.9) and paracetamol (adjusted OR 3.2; 95% CI 1.5-6.9). No increased risk was estimated for vaccines (adjusted OR: 0.9; 95% CI 0.3-2.8). Discussion: Our study provides additional evidence on the etiologic role of drugs and vaccines in the occurrence of SJS in children.	[Raucci, Umberto; Rossi, Rossella; Reale, Antonino; Pirozzi, Nicola] Bambino Gesu Pediat Hosp, IRCCS, Paediat Emergency Dept, Rome, Italy; [Da Cas, Roberto; Menniti-Ippolito, Francesca; Traversa, Giuseppe] Natl Ctr Epidemiol Surveillance & Hlth Promot, Natl Inst Hlth, Rome, Italy; [Rafaniello, Concita] Univ Naples 2, Dept Expt Med, Sect Pharmacol L Donatelli, Naples, Italy; [Mores, Nadia; Bersani, Giulia] Univ Cattolica S Cuore, Rome, Italy	IRCCS Bambino Gesu; Istituto Superiore di Sanita (ISS); Universita della Campania Vanvitelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Traversa, G (corresponding author), Natl Ctr Epidemiol Surveillance & Hlth Promot, Natl Inst Hlth, Rome, Italy.	giuseppe.traversa@iss.it	Chiappini, Elena/D-1118-2012; Bersani, Giulia/AFM-0071-2022; Trotta, Francesco/G-8702-2013; reale, antonino/AAB-8919-2020; Umberto, Raucci/AAH-9205-2019; Bersani, Giulia/AAH-2391-2022	Chiappini, Elena/0000-0002-1476-4752; Trotta, Francesco/0000-0001-6889-8484; Umberto, Raucci/0000-0002-4881-2038; RAFANIELLO, Concetta/0000-0002-7107-4280; Sollai, Sara/0000-0001-5003-993X; reale, antonino/0000-0001-8058-7742; Venturini, Elisabetta/0000-0002-0048-3933; PERILONGO, GIORGIO/0000-0002-3712-0386; Capuano, Annalisa/0000-0002-8653-2408; Tovo, Pier Angelo/0000-0002-0192-3240; Renna, Salvatore/0000-0002-9477-030X; MORES, Nadia/0000-0002-4197-0914	National Institute of Health (ISS); Ministry of Health; Italian Medicines Agency (AIFA)	National Institute of Health (ISS); Ministry of Health; Italian Medicines Agency (AIFA)	During the period 1999-2012, the study received different funding from Italian public institutions: National Institute of Health (ISS), Ministry of Health, Italian Medicines Agency (AIFA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auquier-Dunant A, 2002, ARCH DERMATOL, V138, P1019, DOI 10.1001/archderm.138.8.1019; Becker DS, 1998, LANCET, V351, P1417, DOI 10.1016/S0140-6736(97)11369-1; Bertuola F, 2010, DRUG SAFETY, V33, P65, DOI 10.2165/11530350-000000000-00000; Bianciotto M, 2013, ARCH DIS CHILD, V98, P218, DOI 10.1136/archdischild-2012-302100; Gerull R, 2011, CRIT CARE MED, V39, P1521, DOI 10.1097/CCM.0b013e31821201ed; GUILLAUME JC, 1987, ARCH DERMATOL, V123, P1166, DOI 10.1001/archderm.123.9.1166; Impicciatore P, 2001, BRIT J CLIN PHARMACO, V52, P77, DOI 10.1046/j.0306-5251.2001.01407.x; JOHNSON ML, 1984, J AM ACAD DERMATOL, V11, P930, DOI 10.1016/S0190-9622(84)80017-1; Levi N, 2009, PEDIATRICS, V123, pE297, DOI 10.1542/peds.2008-1923; Menniti-Ippolito F, 2000, LANCET, V355, P1613, DOI 10.1016/S0140-6736(00)02219-4; Mockenhaupt M, 2008, J INVEST DERMATOL, V128, P35, DOI 10.1038/sj.jid.5701033; Phillips EJ, 2011, J ALLERGY CLIN IMMUN, V127, pS60, DOI 10.1016/j.jaci.2010.11.046; REVUZ J, 1987, ARCH DERMATOL, V123, P1160, DOI 10.1001/archderm.123.9.1160; ROUJEAU JC, 1990, ARCH DERMATOL, V126, P37, DOI 10.1001/archderm.126.1.37; ROUJEAU JC, 1994, NEW ENGL J MED, V331, P1272, DOI 10.1056/NEJM199411103311906; ROUJEAU JC, 1995, NEW ENGL J MED, V333, P1600, DOI 10.1056/NEJM199512143332404; Sassolas B, 2010, CLIN PHARMACOL THER, V88, P60, DOI 10.1038/clpt.2009.252; Segal AR, 2007, PEDIATRICS, V120, pE1082, DOI 10.1542/peds.2005-2321; Smith R, 2012, PLOS ONE, V7	19	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68231	10.1371/journal.pone.0068231	http://dx.doi.org/10.1371/journal.pone.0068231			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874553	Green Published, gold, Green Submitted			2022-12-27	WOS:000322064300019
J	Kwak, SJ; Hong, SH; Bajracharya, R; Yang, SY; Lee, KS; Yu, K				Kwak, Su-Jin; Hong, Seung-Hyun; Bajracharya, Rijan; Yang, Se-Yeol; Lee, Kyu-Sun; Yu, Kweon			Drosophila Adiponectin Receptor in Insulin Producing Cells Regulates Glucose and Lipid Metabolism by Controlling Insulin Secretion	PLOS ONE			English	Article							SHORT NEUROPEPTIDE-F; EXTENDS LIFE-SPAN; BODY-SIZE; RESISTANCE; NEURONS; GROWTH; HOMEOSTASIS; ABLATION; DISRUPTION; EXPRESSION	Adipokines secreted from adipose tissue are key regulators of metabolism in animals. Adiponectin, one of the adipokines, modulates pancreatic beta cell function to maintain energy homeostasis. Recently, significant conservation between Drosophila melanogaster and mammalian metabolism has been discovered. Drosophila insulin like peptides (Dilps) regulate energy metabolism similarly to mammalian insulin. However, in Drosophila, the regulatory mechanism of insulin producing cells (IPCs) by adipokine signaling is largely unknown. Here, we describe the discovery of the Drosophila adiponectin receptor and its function in IPCs. Drosophila adiponectin receptor (dAdipoR) has high homology with the human adiponectin receptor 1. The dAdipoR antibody staining revealed that dAdipoR was expressed in IPCs of larval and adult brains. IPC-specific dAdipoR inhibition (Dilp2>dAdipoR-Ri) showed the increased sugar level in the hemolymph and the elevated triglyceride level in whole body. Dilps mRNA levels in the Dilp2>dAdipoR-Ri flies were similar with those of controls. However, in the Dilp2>dAdipoR-Ri flies, Dilp2 protein was accumulated in IPCs, the level of circulating Dilp2 was decreased, and insulin signaling was reduced in the fat body. In ex vivo fly brain culture with the human adiponectin, Dilp2 was secreted from IPCs. These results indicate that adiponectin receptor in insulin producing cells regulates insulin secretion and controls glucose and lipid metabolism in Drosophila melanogaster. This study demonstrates a new adipokine signaling in Drosophila and provides insights for the mammalian adiponectin receptor function in pancreatic beta cells, which could be useful for therapeutic application.	[Kwak, Su-Jin; Hong, Seung-Hyun; Bajracharya, Rijan; Yang, Se-Yeol; Lee, Kyu-Sun; Yu, Kweon] KRIBB, Neurophysiol Res Grp, Bionano Ctr, Taejon, South Korea; [Yang, Se-Yeol; Lee, Kyu-Sun; Yu, Kweon] UST, Dept Funct Genom, Taejon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Science & Technology (UST)	Yu, K (corresponding author), KRIBB, Neurophysiol Res Grp, Bionano Ctr, Taejon, South Korea.	kweonyu@kribb.re.kr		Yu, Kweon/0000-0002-4942-2576	Research Foundation of Korea [2009-0080870, 2011-0030133]; KRIBB Research Initiative Program	Research Foundation of Korea(National Research Foundation of Korea); KRIBB Research Initiative Program	This work was supported by the grants from the Research Foundation of Korea (2009-0080870 and 2011-0030133) and KRIBB Research Initiative Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birse RT, 2011, J EXP BIOL, V214, P4201, DOI 10.1242/jeb.062091; Birse RT, 2010, CELL METAB, V12, P533, DOI 10.1016/j.cmet.2010.09.014; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Broughton S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003721; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Enell LE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015780; Fridell YWC, 2009, AGING-US, V1, P699, DOI 10.18632/aging.100067; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; Gu WQ, 2006, ENDOCRINE, V30, P217, DOI 10.1385/ENDO:30:2:217; Haselton A, 2010, CELL CYCLE, V9, P3063, DOI 10.4161/cc.9.15.12458; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kapan N, 2012, CELL MOL LIFE SCI, V69, P4051, DOI 10.1007/s00018-012-1097-z; Kaplan DD, 2008, GENE DEV, V22, P1877, DOI 10.1101/gad.1670508; Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200; Lee KS, 2004, J BIOL CHEM, V279, P50781, DOI 10.1074/jbc.M407842200; Lee KS, 2008, NAT CELL BIOL, V10, P468, DOI 10.1038/ncb1710; Lee YH, 2011, METABOLISM, V60, P1664, DOI 10.1016/j.metabol.2011.04.008; Luo JN, 2012, CELL MOL LIFE SCI, V69, P471, DOI 10.1007/s00018-011-0789-0; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Matsuzawa Y, 2004, ARTERIOSCL THROM VAS, V24, P29, DOI 10.1161/01.ATV.0000099786.99623.EF; Miele M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016690; Musselman LP, 2011, DIS MODEL MECH, V4, P842, DOI 10.1242/dmm.007948; Narasimhan ML, 2005, MOL CELL, V17, P171, DOI 10.1016/j.molcel.2004.11.050; Nishio SI, 2008, DEV DYNAM, V237, P1682, DOI 10.1002/dvdy.21559; Okamoto M, 2008, DIABETOLOGIA, V51, P827, DOI 10.1007/s00125-008-0944-9; Pasco MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036583; Rajan A, 2012, CELL, V151, P123, DOI 10.1016/j.cell.2012.08.019; Rajan A, 2011, DEV CELL, V21, P29, DOI 10.1016/j.devcel.2011.06.034; Rideout EJ, 2012, P NATL ACAD SCI USA, V109, P1139, DOI 10.1073/pnas.1113311109; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Sekine O, 2010, J BIOL CHEM, V285, P38684, DOI 10.1074/jbc.M110.155192; Svensson E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021343; Varghese J, 2010, GENE DEV, V24, P2748, DOI 10.1101/gad.1995910; Wijesekara N, 2010, J BIOL CHEM, V285, P33623, DOI 10.1074/jbc.M109.085084; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Zhang H, 2009, P NATL ACAD SCI USA, V106, P19617, DOI 10.1073/pnas.0905083106	40	34	39	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e68641	10.1371/journal.pone.0068641	http://dx.doi.org/10.1371/journal.pone.0068641			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	23874700	Green Submitted, Green Published, gold			2022-12-27	WOS:000321718700035
J	Giusti, B; Margheri, F; Rossi, L; Lapini, I; Magi, A; Serrati, S; Chilla, A; Laurenzana, A; Magnelli, L; Calorini, L; Bianchini, F; Fibbi, G; Abbate, R; Del Rosso, M				Giusti, Betti; Margheri, Francesca; Rossi, Luciana; Lapini, Ilaria; Magi, Alberto; Serrati, Simona; Chilla, Anastasia; Laurenzana, Anna; Magnelli, Lucia; Calorini, Lido; Bianchini, Francesca; Fibbi, Gabriella; Abbate, Rosanna; Del Rosso, Mario			Desmoglein-2-Integrin Beta-8 Interaction Regulates Actin Assembly in Endothelial Cells: Deregulation in Systemic Sclerosis	PLOS ONE			English	Article							CYTOPLASMIC DOMAIN; GENE; ANGIOGENESIS; CADHERIN; BIOINFORMATICS; ACTIVATION; DIVERSITY; INTEGRINS; MIGRATION; JUNCTIONS	Background: The inability of endothelial cells of patients affected by the diffuse form of Systemic sclerosis (SSc) to perform angiogenesis is a marker of the disease. We previously demonstrated that desmoglein-2 reduction is a major difference between (SSc)-microvascular endothelial cells (MVECs) and normal (N)-MVECs. Here we investigated the role of desmoglein-2 in human N-MVECs and SSc-MVECs angiogenesis. Methodology/principal findings: Angiogenesis was studied by Matrigel invasion, capillary morphogenesis in vitro and Matrigel plug assay in vivo. Gene profiling was studied by Affymetrix technology and signal transduction by Western blotting. Colocalization was validated by immunoprecipitation and confocal microscopy. SiRNAs were used to validate the roles of specific molecules. We observed that desmoglein-2 co-localizes with integrin-beta8 in N-MVECs. This complex is required to signal through Rac, FAK, SMAD1/5 and MAP-kinases, promoting an angiogenic program. Inhibition of desmoglein-2 by DSG2-siRNA impaired actin stress fibres formation, capillary morphogenesis in vitro and angiogenesis in vivo. Transcriptome profiling after DSG2 inhibition revealed alterations of several genes involved in actin organization. siRNA inhibition of integrin-beta8 and RAC2 also resulted into capillary morphogenesis impairment in N-MVECs, due to reduced expression of the same actin-assembly genes that were down-regulated by DSG2 silencing. SSc-MVECs showed down-regulation of the same genes in DSG2-siRNA treated N-MVECs, suggesting that impairment of desmoglein-2/integrin-beta8 complex contributes to angiogenesis derangement in SSc. Transfection of DSG2 in SSc-MVEC partially restored their angiogenic properties in vitro. Conclusions/significance: We have shown that impairment of actin assembly as a result of desmoglein-2/integrin-beta8 complex formation is a major factor contributing to angiogenesis deregulation in Systemic sclerosis.	[Giusti, Betti; Rossi, Luciana; Lapini, Ilaria; Magi, Alberto; Abbate, Rosanna] Univ Florence, Dept Expt & Clin Med, Florence, Italy; [Margheri, Francesca; Chilla, Anastasia; Laurenzana, Anna; Magnelli, Lucia; Calorini, Lido; Bianchini, Francesca; Fibbi, Gabriella; Del Rosso, Mario] Univ Florence, Dept Expt & Clin Biomed Sci, Florence, Italy; [Margheri, Francesca; Chilla, Anastasia; Laurenzana, Anna; Magnelli, Lucia; Calorini, Lido; Bianchini, Francesca; Fibbi, Gabriella; Del Rosso, Mario] Ist Toscano Tumori, Florence, Italy; [Serrati, Simona] Adv Cellular Therapy Ctr, Natl Canc Res Ctr Giovanni Paolo 2, Dept Clin & Neoplast Expt Oncol, Haematol Unit, Bari, Italy	University of Florence; University of Florence; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica	Fibbi, G (corresponding author), Univ Florence, Dept Expt & Clin Biomed Sci, Florence, Italy.	fibbi@unifi.it; mario.delrosso@unifi.it	Magnelli, Lucia/J-7077-2018; Serrati, Simona/B-2520-2013; Bianchini, Francesca/P-4355-2019; Giusti, Betti/K-6978-2016; Chillà, Anastasia/ABC-7402-2020; Magi, Alberto/M-6773-2015	Magnelli, Lucia/0000-0003-4585-1450; Serrati, Simona/0000-0002-4015-5205; Bianchini, Francesca/0000-0002-5839-4298; Giusti, Betti/0000-0002-8708-9444; Magi, Alberto/0000-0001-7393-4283; Fibbi, gabriella/0000-0002-0629-851X; Calorini, Lido/0000-0002-5508-4200	Ministero Italiano dell'Universita e della Ricerca (MIUR); Ente Cassa di Risparmio di Firenze; Toscana Life Sciences (Siena); Istituto Toscano Tumori	Ministero Italiano dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); Ente Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze); Toscana Life Sciences (Siena); Istituto Toscano Tumori	This work was supported by grants from Ministero Italiano dell'Universita e della Ricerca (MIUR), Ente Cassa di Risparmio di Firenze, Toscana Life Sciences (Siena), Istituto Toscano Tumori. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angst BD, 2001, J CELL SCI, V114, P629; Avraamides CJ, 2008, NAT REV CANCER, V8, P604, DOI 10.1038/nrc2353; Blangiardo M, 2006, BIOINFORMATICS, V22, P50, DOI 10.1093/bioinformatics/bti750; Bokoch GM, 2000, IMMUNOL RES, V21, P139, DOI 10.1385/IR:21:2-3:139; Chen HJ, 2006, GENE DEV, V20, P1933, DOI 10.1101/gad.1411206; Chernyavsky AI, 2007, J BIOL CHEM, V282, P13804, DOI 10.1074/jbc.M611365200; Choe SE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r16; Christofori G, 1999, TRENDS BIOCHEM SCI, V24, P73, DOI 10.1016/S0968-0004(98)01343-7; D'Alessio S, 2004, ARTHRITIS RHEUM-US, V50, P3275, DOI 10.1002/art.20562; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Giusti B, 2005, ARTHRITIS RHEUM-US, V52, P3618, DOI 10.1002/art.21383; Giusti B, 2009, EUR J VASC ENDOVASC, V38, P104, DOI 10.1016/j.ejvs.2009.01.020; Giusti B, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2002; Giusti B, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-342; Gory-Faure S, 1999, DEVELOPMENT, V126, P2093; Goumans MJ, 2009, CELL RES, V19, P116, DOI 10.1038/cr.2008.326; Hatzfeld M, 2000, J CELL BIOL, V149, P209, DOI 10.1083/jcb.149.1.209; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hudson BI, 2008, J BIOL CHEM, V283, P34457, DOI 10.1074/jbc.M801465200; Indraccolo S, 2007, J IMMUNOL, V178, P1122, DOI 10.4049/jimmunol.178.2.1122; Jakowlew SB, 2006, CANCER METAST REV, V25, P435, DOI 10.1007/s10555-006-9006-2; Lakhe-Reddy S, 2006, J BIOL CHEM, V281, P19688, DOI 10.1074/jbc.M601110200; Manconi Frank, 2000, Methods in Cell Science, V22, P89, DOI 10.1023/A:1009895723488; Margheri F, 2006, ARTHRITIS RHEUM-US, V54, P3926, DOI 10.1002/art.22263; Margheri F, 2011, BLOOD, V118, P3743, DOI 10.1182/blood-2011-02-338681; Nakagawa T, 2004, KIDNEY INT, V66, P862; NISHIMURA SL, 1994, J BIOL CHEM, V269, P28708; Pieperhoff S, 2012, J CELL MOL MED, V16, P1709, DOI 10.1111/j.1582-4934.2011.01463.x; Schmitt CJ, 2007, J INVEST DERMATOL, V127, P2191, DOI 10.1038/sj.jid.5700849; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Suda K, 2001, IN VITRO CELL DEV-AN, V37, P505; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Viemann D, 2006, J LEUKOCYTE BIOL, V80, P174, DOI 10.1189/jlb.0905530; Welch MD, 1997, J CELL BIOL, V138, P375, DOI 10.1083/jcb.138.2.375; Wipff PJ, 2008, EUR J CELL BIOL, V87, P601, DOI 10.1016/j.ejcb.2008.01.012; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x	38	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e68117	10.1371/journal.pone.0068117	http://dx.doi.org/10.1371/journal.pone.0068117			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874518	Green Published, Green Submitted, gold			2022-12-27	WOS:000322218800014
J	Peresani, M; Vanhaeren, M; Quaggiotto, E; Queffelec, A; d'Errico, F				Peresani, Marco; Vanhaeren, Marian; Quaggiotto, Ermanno; Queffelec, Alain; d'Errico, Francesco			An Ochered Fossil Marine Shell From the Mousterian of Fumane Cave, Italy	PLOS ONE			English	Article							MIDDLE; AURIGNACIAN; EMERGENCE; OCHRE; EVOLUTION; SYMBOLISM; TAPHONOMY; EUROPE; AGE	A scanty but varied ensemble of finds challenges the idea that Neandertal material culture was essentially static and did not include symbolic items. In this study we report on a fragmentary Miocene-Pliocene fossil marine shell, Aspa marginata, discovered in a Discoid Mousterian layer of the Fumane Cave, northern Italy, dated to at least 47.6-45.0 Cal ky BP. The shell was collected by Neandertals at a fossil exposure probably located more than 100 kms from the site. Microscopic analysis of the shell surface identifies clusters of striations on the inner lip. A dark red substance, trapped inside micropits produced by bioeroders, is interpreted as pigment that was homogeneously smeared on the outer shell surface. Dispersive X-ray and Raman analysis identify the pigment as pure hematite. Of the four hypotheses we considered to explain the presence of this object at the site, two (tool, pigment container) are discarded because in contradiction with observations. Although the other two ("manuport", personal ornament) are both possible, we favor the hypothesis that the object was modified and suspended by a 'thread' for visual display as a pendant. Together with contextual and chronometric data, our results support the hypothesis that deliberate transport and coloring of an exotic object, and perhaps its use as pendant, was a component of Neandertal symbolic culture, well before the earliest appearance of the anatomically modern humans in Europe.	[Peresani, Marco] Univ Ferrara, Dipartimento Studi Umanist, Sez Preistoria & Antropol, I-44100 Ferrara, Italy; [Vanhaeren, Marian; Queffelec, Alain; d'Errico, Francesco] Univ Bordeaux 1, CNRS UMR PACEA PPP 5199, F-33405 Talence, France; [Quaggiotto, Ermanno] Nat Archaeol Museum Vicenza, I-36100 Vicenza, Italy; [d'Errico, Francesco] Univ Bergen, Dept Archaeol Cultural & Religious Studies, N-5020 Bergen, Norway	University of Ferrara; UDICE-French Research Universities; Universite de Bordeaux; University of Bergen	Peresani, M (corresponding author), Univ Ferrara, Dipartimento Studi Umanist, Sez Preistoria & Antropol, Corso Ercole I dEste 32, I-44100 Ferrara, Italy.	marco.peresani@unife.it	Peresani, Marco/X-1343-2019; Queffelec, Alain/AAD-9531-2019	Peresani, Marco/0000-0001-6562-6336; Queffelec, Alain/0000-0002-9763-7600	Italian Ministry of Culture - Veneto Archaeological Superintendence; Lessinia Mountain Community - Regional Natural Park; Fumane Municipality; Veneto Region - Department for Cultural Heritage; Max Planck Institute for Evolutionary Anthropology; National Geographic Society - CRE [9022-11]; Cariverona Foundation; Banca di Credito Cooperativo della Valpolicella; Roberto Gardina C.; Albino Armani Vinegrowers; European Research Council (ERC) under the European Union [249587]	Italian Ministry of Culture - Veneto Archaeological Superintendence; Lessinia Mountain Community - Regional Natural Park; Fumane Municipality; Veneto Region - Department for Cultural Heritage; Max Planck Institute for Evolutionary Anthropology(Max Planck Society); National Geographic Society - CRE(National Geographic Society); Cariverona Foundation(Fondazione Cariverona); Banca di Credito Cooperativo della Valpolicella; Roberto Gardina C.; Albino Armani Vinegrowers; European Research Council (ERC) under the European Union(European Research Council (ERC))	Research at Fumane is coordinated by the Ferrara University in the framework of a project supported by the Italian Ministry of Culture - Veneto Archaeological Superintendence, public institutions (Lessinia Mountain Community - Regional Natural Park, Fumane Municipality, Veneto Region - Department for Cultural Heritage, Max Planck Institute for Evolutionary Anthropology), and private associations and companies (National Geographic Society - CRE Grant 9022-11, Cariverona Foundation, Banca di Credito Cooperativo della Valpolicella, Roberto Gardina & C., Albino Armani Vinegrowers since 1607 and others). Microscopic study of the shell and elemental and mineralogical analysis of the pigment were funded by the European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7/2007-2013/ERC grant agreement no. 249587). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONELLI R, 1990, CARTA GEOLOGICA VENE; Banks WE, 2013, J HUM EVOL, V64, P39, DOI 10.1016/j.jhevol.2012.10.001; Bartolomei G, 1992, PREIST ALP, V28, P131; Bednarik RG, 2011, DEV PRIMATOL-PROG PR, P1, DOI 10.1007/978-1-4419-9353-3; BEDNARIK RG, 1992, CAMB ARCHAEOL J, V2, P27; Benazzi S, 2011, NATURE, V479, P525, DOI 10.1038/nature10617; Beu AG, 2010, B AM PALEONTOL, p[377, 1]; Bicho N, 2009, INT SERIES, V1938, P167; Bingham PM, 2000, EVOL ANTHROPOL, V9, P248, DOI 10.1002/1520-6505(2000)9:6<248::AID-EVAN1003>3.0.CO;2-X; Brambilla G, 1990, NATURA BRESCIANA ANN, V25, P35; Broglio A., 2004, SPIRITUALITE ACTES C, P97; Broglio A, 2005, PRODUCTIONS LAMELLAI, V1, P415; Broglio A, 2009, ANTHROPOLOGIE, V113, P753, DOI 10.1016/j.anthro.2009.09.016; Calvin WH., 2002, BRAIN ALL SEASONS HU; Cannell A, 2002, J ARCHAEOL SCI, V29, P335, DOI 10.1006/jasc.2002.0710; Caprotti E., 1974, Conchiglie, V10, P1; Caprotti E., 1970, Natura, Milano, V61, P121; Carciumaru M, 2002, ANTIQUITY, V76, P681, DOI 10.1017/S0003598X00091122; CHASE PG, 1987, J ANTHROPOL ARCHAEOL, V6, P263, DOI 10.1016/0278-4165(87)90003-1; Chirli C, 2007, MALACOFAUNA PLIOCENI, V6, P1882; CLOT A, 1987, GROTTE GERDE HAUTES; Colombini MP, 2005, PREISTORIA ALPINA, P50; COPPI F, 1881, PALEONTOLOGIA MODENE; Cossmann M., 1909, ACTES SOC LINNEENNE, V75, P193; d'Errico F, 1998, CURR ANTHROPOL, V39, pS1, DOI 10.1086/204689; D'Errico F, 2003, EVOL ANTHROPOL, V12, P188, DOI 10.1002/evan.10113; d'Errico F., 1989, P237; d'Errico F, 2011, PHILOS T R SOC B, V366, P1060, DOI 10.1098/rstb.2010.0340; Dal Piaz G, 1912, ESISTENZA PLIOCENE M, P212; DART RA, 1974, S AFR J SCI, V70, P167; de la Torre I, 2005, J ARCHAEOL SCI, V32, P273, DOI 10.1016/j.jas.2004.09.010; Demars P-Y, 1992, B SOC PREHIST FR, V47; Douka K, 2012, J WORLD PREHIST, V25, P45, DOI 10.1007/s10963-012-9056-z; Downs R. T., 2006, PROGR ABSTR 19 GEN M, V3, P13; EDWARDS SW, 1978, CURR ANTHROPOL, V19, P135, DOI 10.1086/202016; Errico d' F, 2007, MCDONALD I MONOGRAPH; FELIKS J, 1998, ROCK ART RES, V15, P109; Finlayson C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045927; Fiocchi C, 1996, LETT ATT I VEN SCI A, P441; Fiore I, 2004, INT J OSTEOARCHAEOL, V14, P273, DOI 10.1002/oa.761; Fontana F., 2009, PREISTORIA ALP, V44, P51; Gofas S, 1984, CONCHAS MOLUSCOS ANG, P139; Gurioli F, 2006, ATT 4 C NAZ ARCH, P59; Henshilwood CS, 2011, SCIENCE, V334, P219, DOI 10.1126/science.1211535; Hernandez JM, 2011, MOLUSCOS CONCHAS MAR; Higham T, 2009, QUATERNARY SCI REV, V28, P1257, DOI 10.1016/j.quascirev.2008.12.018; Isaac B, 1987, AFR ARCHAEOL REV, V5, P3, DOI [10.1007/BF01117078, DOI 10.1007/BF01117078]; Landau B, 2004, TONNOIDEA FICOIDEA P, V5, P35; Landau Bernard, 2009, Jahrbuch der Geologischen Bundesanstalt, V149, P61; Langley MC, 2008, CAMB ARCHAEOL J, V18, P289, DOI 10.1017/S0959774308000371; Leakey M., 1971, OLDUVAI GORGE, V3, P306; Lemorini C., 2003, BAR INT SER-US, V1120, P257; Leroi-Gourhan Andre, 1967, TREASURES PREHISTORI; Lhomme V, 1993, B SOC PREHIST FR, V90, P303; MALATESTA A, 1974, MEMORIE SERVIRE DESC, V13, pR1; Maureille B., 2008, PREMIERE HUMANITE GE, P66; Maureille B., 2007, NEANDERTALIENS BIOL, P311; Mellars P, 2010, P NATL ACAD SCI USA, V107, P20147, DOI 10.1073/pnas.1014588107; Moncel MH, 2012, ARCHAEOL ETHNOL ANTH, V40, P24, DOI 10.1016/j.aeae.2012.05.004; Montanaro E, 1935, MEMOIRE PALEONTOLOGI, VXXXV, P1; Morin E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032856; Nannini N, QUAT INT IN PRESS; Oakley K.P., 1973, MELANGES PREHISTOIRE, P581; OAKLEY KP, 1981, PHILOS T ROY SOC B, V292, P205, DOI 10.1098/rstb.1981.0029; Pallecchi P, 2005, PITTURE PALEOLITICHE, P54; Parona CF, 1883, RENDICONTI REALE I 2, V16, P624; PEI W. C., 1931, BULL GEOL SOC CHINA, V11, P109; Peresani M, 2011, QUARTAR, V58, P131, DOI DOI 10.7485/QU58_07; Peresani M., PALEO, V10, P123, DOI [10.3406/pal.1998.1133, DOI 10.3406/PAL.1998.1133]; Peresani M., 2008, CURR ANTHROPOL, V49, P725, DOI DOI 10.1086/588540; Peresani M, 2008, J ARCHAEOL SCI, V35, P2986, DOI 10.1016/j.jas.2008.06.013; Peresani M, 2013, CR PALEVOL, V12, P211, DOI 10.1016/j.crpv.2013.02.005; Peresani M, 2011, P NATL ACAD SCI USA, V108, P3888, DOI 10.1073/pnas.1016212108; Peresani M, 2012, QUATERN INT, V247, P125, DOI 10.1016/j.quaint.2011.02.006; Pettitt PB, 2011, PALAEOLITHIC ORIGINS, P308; POTTS R, 1991, J ANTHROPOL RES, V47, P153, DOI 10.1086/jar.47.2.3630323; Roebroeks W, 2012, P NATL ACAD SCI USA, V109, P1889, DOI 10.1073/pnas.1112261109; Rolan E., 2005, MALACOLOGICAL FAUNA; Romandini M, 2012, THESIS U FERRARA, P504; SALOMON H, 2009, THESIS U BORDEAUX; Sandgathe DM, 2011, J HUM EVOL, V61, P243, DOI 10.1016/j.jhevol.2011.04.003; Segers W, 2009, MAR MOLLUSKS MADEIRA, V611; Solsona y Masana M, 2000, B I CATALANA HIST NA, V68, P51; Sordelli F, 1875, ATTI SOC ITALIANA SC, V18, P308; Soressi M, 2007, NEANDERTALIENS BIOL, P297; Tagliacozzo A, VERTEBRATE PALEOBIOL; Tattersall I, 2008, COMP COGN BEHAV REV, V3, P99, DOI 10.3819/ccbr.2008.30006; Vanhaeren M, 2006, J ARCHAEOL SCI, V33, P1105, DOI 10.1016/j.jas.2005.11.017; Venzo S, 1935, MEMORIE PALENTOLOGIA, VXXXV, P201; Venzo S, 1977, MEMORIE I GEOL MINER, VXXX, P62; von Martens E, 1877, JB DTSCH MALAKOZOOLO, V3, P236; Wadley L, 2004, ANTIQUITY, V78, P661, DOI 10.1017/S0003598X00113298; Zilhao J, 1999, J WORLD PREHIST, V13, P1, DOI 10.1023/A:1022348410845; Zilhao J., 2011, HOMOSYMBOLICUS DAWN, P111; Zilhao J, 2012, LIFE DEATH PESTERA C, P452; Zilhao J, 2007, J ARCHAEOL RES, V15, P1, DOI 10.1007/s10814-006-9008-1; Zilhao J, 2010, P NATL ACAD SCI USA, V107, P1023, DOI 10.1073/pnas.0914088107; Zorzin R, 2005, PITTURE PALEOLITICHE, P47	98	77	78	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68572	10.1371/journal.pone.0068572	http://dx.doi.org/10.1371/journal.pone.0068572			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	182SU	23874677	Green Published, gold, Green Submitted			2022-12-27	WOS:000321765300054
J	Adams, AL; Dickinson, KJM; Robertson, BC; van Heezik, Y				Adams, Amy L.; Dickinson, Katharine J. M.; Robertson, Bruce C.; van Heezik, Yolanda			An Evaluation of the Accuracy and Performance of Lightweight GPS Collars in a Suburban Environment	PLOS ONE			English	Article							POSITIONING SYSTEM COLLARS; ANIMAL LOCATION SYSTEM; TELEMETRY COLLARS; DIFFERENTIAL CORRECTION; HABITAT SELECTION; BOREAL FOREST; FIX INTERVAL; URBAN AREAS; NEW-ZEALAND; 3 BRANDS	The recent development of lightweight GPS collars has enabled medium-to-small sized animals to be tracked via GPS telemetry. Evaluation of the performance and accuracy of GPS collars is largely confined to devices designed for large animals for deployment in natural environments. This study aimed to assess the performance of lightweight GPS collars within a suburban environment, which may be different from natural environments in a way that is relevant to satellite signal acquisition. We assessed the effects of vegetation complexity, sky availability (percentage of clear sky not obstructed by natural or artificial features of the environment), proximity to buildings, and satellite geometry on fix success rate (FSR) and location error (LE) for lightweight GPS collars within a suburban environment. Sky availability had the largest affect on FSR, while LE was influenced by sky availability, vegetation complexity, and HDOP (Horizontal Dilution of Precision). Despite the complexity and modified nature of suburban areas, values for FSR ((x) over bar = 90.6%) and LE ((x) over bar = 30.1 m) obtained within the suburban environment are comparable to those from previous evaluations of GPS collars designed for larger animals and within less built-up environments. Due to fine-scale patchiness of habitat within urban environments, it is recommended that resource selection methods that are not reliant on buffer sizes be utilised for selection studies.	[Adams, Amy L.; Robertson, Bruce C.; van Heezik, Yolanda] Univ Otago, Dept Zool, Dunedin, New Zealand; [Dickinson, Katharine J. M.] Univ Otago, Dept Bot, Dunedin, New Zealand	University of Otago; University of Otago	Adams, AL (corresponding author), Univ Otago, Dept Zool, POB 56, Dunedin, New Zealand.	amylouiseadams@hotmail.com	Dickinson, Katharine J.M./M-1728-2017; van Heezik, Yolanda/I-2744-2019	Dickinson, Katharine J.M./0000-0001-6769-552X; van Heezik, Yolanda/0000-0003-0494-5311	University of Otago Zoology Department; University of Otago Postgraduate Scholarship	University of Otago Zoology Department; University of Otago Postgraduate Scholarship	This study was funded by the University of Otago Zoology Department and AA was supported by a University of Otago Postgraduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, INTRO GPS GLOBAL POS; Augustine BC, 2011, ECOL MODEL, V222, P3616, DOI 10.1016/j.ecolmodel.2011.08.026; Bjorneraas K, 2010, J WILDLIFE MANAGE, V74, P1361, DOI 10.2193/2009-405; Blackie HM, 2010, J WILDLIFE MANAGE, V74, P1911, DOI 10.2193/2009-412; Bowman JL, 2000, WILDLIFE SOC B, V28, P141; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cagnacci F, 2010, PHILOS T R SOC B, V365, P2157, DOI 10.1098/rstb.2010.0107; Cain JW, 2005, WILDLIFE SOC B, V33, P926, DOI 10.2193/0091-7648(2005)33[926:IOTAGF]2.0.CO;2; Cargnelutti B, 2007, J WILDLIFE MANAGE, V71, P1380, DOI 10.2193/2006-257; D'Eon RG, 2005, J APPL ECOL, V42, P383, DOI 10.1111/j.1365-2664.2005.01010.x; D'Eon RG, 2003, J WILDLIFE MANAGE, V67, P858, DOI 10.2307/3802693; D'Eon RG, 2002, WILDLIFE SOC B, V30, P430; Dennis T.E., 2010, Wildlife Biology in Practice, V6, P14; Denys P, 2010, SURVEY Q, V62, P20; Di Orio AP, 2003, WILDLIFE SOC B, V31, P372; Dussault C, 1999, WILDLIFE SOC B, V27, P965; Edenius L, 1997, WILDLIFE BIOL, V3, P39, DOI 10.2981/wlb.1997.006; Frair JL, 2010, PHILOS T R SOC B, V365, P2187, DOI 10.1098/rstb.2010.0084; Frair JL, 2004, J APPL ECOL, V41, P201, DOI 10.1111/j.0021-8901.2004.00902.x; Freeman C, 2003, LANDSCAPE URBAN PLAN, V63, P161, DOI 10.1016/S0169-2046(02)00188-3; Gau RJ, 2004, WILDLIFE SOC B, V32, P693, DOI 10.2193/0091-7648(2004)032[0693:UFPOTG]2.0.CO;2; Gelman A., 2007, DATA ANAL USING REGR; Goddard MA, 2010, TRENDS ECOL EVOL, V25, P90, DOI 10.1016/j.tree.2009.07.016; Graves TA, 2006, J WILDLIFE MANAGE, V70, P844, DOI 10.2193/0022-541X(2006)70[844:UTCOMG]2.0.CO;2; Hansen MC, 2008, J WILDLIFE MANAGE, V72, P518, DOI 10.2193/2006-493; Hebblewhite M, 2007, J WILDLIFE MANAGE, V71, P2026, DOI 10.2193/2006-238; Hebblewhite M, 2010, PHILOS T R SOC B, V365, P2303, DOI 10.1098/rstb.2010.0087; Hofmann-Wellenhof B., 2001, GLOBAL POSITIONING S; Hosmer D. W., APPL LOGISTIC REGRES; Hulbert IAR, 2001, J APPL ECOL, V38, P869, DOI 10.1046/j.1365-2664.2001.00624.x; Jiang Z, 2008, ECOL RES, V23, P581, DOI 10.1007/s11284-007-0412-x; Lemon P., 1956, FOREST SCI, V2, P314; Lewis JS, 2007, J APPL ECOL, V44, P663, DOI 10.1111/j.1365-2664.2007.01286.x; Loram A, 2007, LANDSCAPE ECOL, V22, P601, DOI 10.1007/s10980-006-9051-9; Mathieu R, 2007, LANDSCAPE URBAN PLAN, V81, P179, DOI 10.1016/j.landurbplan.2006.11.009; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Moen R, 1997, J WILDLIFE MANAGE, V61, P530, DOI 10.2307/3802612; Moen R, 1996, J WILDLIFE MANAGE, V60, P659, DOI 10.2307/3802085; Pickett STA, 2008, BIOSCIENCE, V58, P139, DOI 10.1641/B580208; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Recio MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028225; REMPEL RS, 1995, J WILDLIFE MANAGE, V59, P543, DOI 10.2307/3802461; Rempel RS, 1997, J WILDLIFE MANAGE, V61, P525, DOI 10.2307/3802611; Rodgers AR, 1996, WILDLIFE SOC B, V24, P559; Rodgers Arthur R., 2001, P1; Rose E, 2005, BIRD STUDY, V52, P145, DOI 10.1080/00063650509461384; RUMBLE MA, 1997, RESOURCE TECHNOLOGY, V4, P492; Sager-Fradkin KA, 2007, J WILDLIFE MANAGE, V71, P1298, DOI 10.2193/2006-367; Samama N., 2008, GLOBAL POSITIONING T, DOI DOI 10.1002/9780470241912; Skrondal A., 2004, GEN LATENT VARIABLE; STOKELY JM, 2005, FEASIBILITY UTILIZIN; van Heezik Y, 2008, LANDSCAPE URBAN PLAN, V87, P223, DOI 10.1016/j.landurbplan.2008.06.004; White CG, 2005, J WILDLIFE MANAGE, V69, P1528, DOI 10.2193/0022-541X(2005)69[1528:EOTLSN]2.0.CO;2; Zweifel-Schielly B, 2007, WILDLIFE BIOL, V13, P299, DOI 10.2981/0909-6396(2007)13[299:POGTCF]2.0.CO;2	54	21	23	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68496	10.1371/journal.pone.0068496	http://dx.doi.org/10.1371/journal.pone.0068496			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874645	Green Submitted, Green Published, gold			2022-12-27	WOS:000321736900089
J	Chen, L; Shen, YC; Liu, L; Li, XO; Wang, T; Wen, FQ				Chen, Lei; Shen, Yongchun; Liu, Lian; Li, Xiaoou; Wang, Tao; Wen, Fuqiang			Interleukin-13-1112 C/T Promoter Polymorphism Confers Risk for COPD: A Meta-Analysis	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; GENE POLYMORPHISMS; LUNG-FUNCTION; ASSOCIATION; IL-13; IL13	Background: Interleukin (IL)-13, a T-helper type 2 cytokine, plays a critical role in the development of chronic obstructive pulmonary disease (COPD). This meta-analysis was performed to assess the association of IL-13 - 1112 C/T promoter polymorphism with COPD susceptibility. Methods: Published case-control studies from Pubmed and China National Knowledge Infrastructure (CNKI) databases were retrieved. Data were extracted and pooled odds ratios (OR) with 95% confidence intervals (CI) were calculated. Results: Eight case-control studies in seven articles were included in this meta-analysis. Pooled effect size showed IL-13 - 1112 C/T was associated with COPD susceptibility in a codominant genetic model (TT vs CT, OR: 1.82, 95% CI: 1.14-2.92 and TT vs CC, OR: 2.02, 95% CI: 1.10-3.72), indicating individuals with TT genotype had an increased risk for COPD compared with those with CT or CC genotype. According to ethnicity, results indicated IL-13 - 1112 C/T was correlated with COPD susceptibility in Arabians (TT vs CT, OR: 2.94, 95% CI: 1.03-8.42 and TT vs CC, OR: 3.05, 95% CI: 1.08-8.59). Moreover, after excluding the study without Hardy-Weinberg equilibrium, the pooled results were robust and no publication bias was found in this study. Conclusions: This meta-analysis suggests IL-13 - 1112 C/T promoter polymorphism is associated with the risk of COPD in Arabians.	[Chen, Lei; Shen, Yongchun; Liu, Lian; Li, Xiaoou; Wang, Tao; Wen, Fuqiang] Sichuan Univ, West China Hosp, West China Sch Med, State Key Lab Biotherapy China,Div Pulm Dis, Chengdu 610064, Sichuan, Peoples R China; [Chen, Lei; Shen, Yongchun; Liu, Lian; Li, Xiaoou; Wang, Tao; Wen, Fuqiang] Sichuan Univ, West China Hosp, West China Sch Med, Dept Resp Med, Chengdu 610064, Sichuan, Peoples R China	Sichuan University; Sichuan University	Wen, FQ (corresponding author), Sichuan Univ, West China Hosp, West China Sch Med, State Key Lab Biotherapy China,Div Pulm Dis, Chengdu 610064, Sichuan, Peoples R China.	wenfuqiang.scu@gmail.com	yongchun, shen/K-2055-2012		National Natural Science Foundation of China [31000513, 31171103, 81200031, 81230001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported in part by grants 31000513, 31171103, 81200031 and 81230001 from the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beghe B, 2010, ALLERGY, V65, P474, DOI 10.1111/j.1398-9995.2009.02167.x; Brightling CE, 2010, CLIN EXP ALLERGY, V40, P42, DOI 10.1111/j.1365-2222.2009.03383.x; Dong SJ, 2010, J CHIN PRACT DIAGN T, V24, P984; Ezzeldin N, 2012, ARCH MED SCI, V8, P286, DOI 10.5114/aoms.2012.28556; Haq I, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-7; He JQ, 2003, AM J RESP CELL MOL, V28, P379, DOI 10.1165/rcmb.4885; Hegab AE, 2004, CHEST, V126, P1832, DOI 10.1378/chest.126.6.1832; Jiang L, 2005, CHINESE MED J-PEKING, V118, P541; Kraan TCTMV, 2002, GENES IMMUN, V3, P436, DOI 10.1038/sj.gene.6363896; Lee JS, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-64; Liu SF, 2009, EXP LUNG RES, V35, P807, DOI 10.3109/01902140902893644; Miotto D, 2003, EUR RESPIR J, V22, P602, DOI 10.1183/09031936.03.00046402; Sadeghnejad A, 2007, AM J RESP CRIT CARE, V176, P748, DOI 10.1164/rccm.200704-543OC; Soler Artigas M, 2012, THORAX, V67, P271, DOI 10.1136/thoraxjnl-2011-200724; Todd JL, 2011, AM J RESP CRIT CARE, V184, P873, DOI 10.1164/rccm.201106-0971PP; Xue HP, 2011, AM J EPIDEMIOL, V173, P363, DOI 10.1093/aje/kwq378; Zheng T, 2000, J CLIN INVEST, V106, P1081, DOI 10.1172/JCI10458	17	13	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68222	10.1371/journal.pone.0068222	http://dx.doi.org/10.1371/journal.pone.0068222			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874547	Green Published, Green Submitted, gold			2022-12-27	WOS:000321736900070
J	Kalet, BT; Anglin, SR; Handschy, A; O'Donoghue, LE; Halsey, C; Chubb, L; Korch, C; Duval, DL				Kalet, Brian T.; Anglin, Sara R.; Handschy, Anne; O'Donoghue, Liza E.; Halsey, Charles; Chubb, Laura; Korch, Christopher; Duval, Dawn L.			Transcription Factor Ets1 Cooperates with Estrogen Receptor alpha to Stimulate Estradiol-Dependent Growth in Breast Cancer Cells and Tumors	PLOS ONE			English	Article							THERAPY RESISTANCE; GENE-EXPRESSION; MURINE ETS-1; IN-VIVO; COACTIVATOR; PROTEIN; LINES; PROGESTERONE; ACTIVATION; DOMAIN	The purpose of this study was to explore the role of transcription factor Ets1 in estrogen receptor alpha (ER alpha)-positive breast cancer progression. We expressed human Ets1 or empty vector in four human ER alpha-positive breast cancer cell lines and observed increased colony formation. Further examination of cellular responses in stable Ets1-expressing MCF7 clones displayed increased proliferation, migration, and invasion. Ets1-expressing MCF7 tumors grown in the mammary fat pads of nude mice exhibited increased rates of tumor growth (7.36 +/- 2.47 mm(3)/day) compared to control MCF7 tumors (2.52 +/- 1.70 mm(3)/day), but maintained their dependence on estradiol for tumor growth. Proliferation marker Ki-67 staining was not different between control and Ets1-expressing tumors, but Ets1-expressing tumors exhibited large necrotic centers and elevated apoptotic staining. Ets1 was shown to cooperate with ERa and the p160 nuclear receptor coactivator (NCOA/SRC) family to increase activation of a consensus estrogen response element luciferase reporter construct. Ets1-expressing MCF7 cells also exhibited elevated expression of the ER alpha target genes, progesterone receptor and trefoil factor 1. Using GST-pulldown assays, Ets1 formed stable complexes containing both ER alpha and p160 nuclear receptor coactivators. Taken together, these data suggest that the Ets1-dependent estradiol sensitization of breast cancer cells and tumors may be partially due to the ability of Ets1 to cooperate with ER alpha and nuclear receptor coactivators to stimulate transcriptional activity of estrogen-dependent genes.	[Kalet, Brian T.; Anglin, Sara R.; Handschy, Anne; O'Donoghue, Liza E.; Halsey, Charles; Chubb, Laura; Duval, Dawn L.] Colorado State Univ, Dept Clin Sci, Flint Anim Canc Ctr, Ft Collins, CO 80523 USA; [Korch, Christopher] Univ Colorado, Sch Med, Dept Med, Aurora, CO USA; [Korch, Christopher; Duval, Dawn L.] Univ Colorado, Ctr Comprehens Canc, Aurora, CO USA	Colorado State University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Duval, DL (corresponding author), Colorado State Univ, Dept Clin Sci, Flint Anim Canc Ctr, Ft Collins, CO 80523 USA.	Dawn.Duval@colostate.edu		HANDSCHY, ANNE/0000-0003-2537-0019	Cancer League of Colorado; National Institutes of Health [R56 DK070952]; NIH [P30CA046934]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK070952] Funding Source: NIH RePORTER	Cancer League of Colorado; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Cancer League of Colorado and National Institutes of Health R56 DK070952 to DLD. The University of Colorado Cancer Center Shared Resources utilized in these studies were supported by NIH P30CA046934. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED SA, 1994, J IMMUNOL METHODS, V170, P211, DOI 10.1016/0022-1759(94)90396-4; Arpino G, 2008, ENDOCR REV, V29, P217, DOI 10.1210/er.2006-0045; Barrett JM, 2002, BREAST CANCER RES TR, V72, P227, DOI 10.1023/A:1014993006190; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; Dittmer J, 2006, BRIT J CANCER, V94, P176, DOI 10.1038/sj.bjc.6602903; Dittmer Jurgen, 2003, Mol Cancer, V2, P29, DOI 10.1186/1476-4598-2-29; DONALDSON LW, 1994, BIOCHEMISTRY-US, V33, P13509, DOI 10.1021/bi00250a001; Donaldson LW, 1996, EMBO J, V15, P125, DOI 10.1002/j.1460-2075.1996.tb00340.x; Duplessis TT, 2011, ENDOCRINOLOGY, V152, P2517, DOI 10.1210/en.2010-1281; Duval DL, 2003, J BIOL CHEM, V278, P39684, DOI 10.1074/jbc.M302433200; Eckel KL, 2003, DNA CELL BIOL, V22, P79, DOI 10.1089/104454903321515896; ENGEL LW, 1978, CANCER RES, V38, P3352; Foulds CE, 2004, MOL CELL BIOL, V24, P10954, DOI 10.1128/MCB.24.24.10954-10964.2004; Giraud S, 2002, J BIOL CHEM, V277, P8004, DOI 10.1074/jbc.M111486200; Goel A, 2004, J BIOL CHEM, V279, P14909, DOI 10.1074/jbc.M400036200; Gong P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054912; He J, 2007, CANCER BIOL THER, V6, P76, DOI 10.4161/cbt.6.1.3551; HORWITZ KB, 1975, STEROIDS, V26, P785, DOI 10.1016/0039-128X(75)90110-5; Hsu T, 2004, J CELL BIOCHEM, V91, P896, DOI 10.1002/jcb.20012; Kalet BT, 2007, J MED CHEM, V50, P4493, DOI 10.1021/jm070569b; Karmakar S, 2009, ENDOCRINOLOGY, V150, P1588, DOI 10.1210/en.2008-1001; Kim HJ, 2006, CLIN CANCER RES, V12, p1013S, DOI 10.1158/1078-0432.CCR-05-2128; KYPRIANOU N, 1991, CANCER RES, V51, P162; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; LAMP SJ, 1981, J BIOL CHEM, V256, P2269; LASFARGUES EY, 1978, J NATL CANCER I, V61, P967; Lin CY, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r66; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long WW, 2012, J CLIN INVEST, V122, P1869, DOI 10.1172/JCI61492; Massie CE, 2007, EMBO REP, V8, P871, DOI 10.1038/sj.embor.7401046; Mastronardi L, 2001, BMC CANCER, V1, DOI 10.1186/1471-2407-1-12; McIntyre A, 2012, CLIN CANCER RES, V18, P3100, DOI 10.1158/1078-0432.CCR-11-1877; Mitas M, 2002, BRIT J CANCER, V86, P899, DOI 10.1038/sj.bjc.6600190; Mullen P, 1996, INT J CANCER, V67, P816, DOI 10.1002/(SICI)1097-0215(19960917)67:6<816::AID-IJC10>3.0.CO;2-#; Myers E, 2005, CLIN CANCER RES, V11, P2111, DOI 10.1158/1078-0432.CCR-04-1192; Neznanov N, 1999, CANCER RES, V59, P4242; Osborne CK, 2005, CLIN CANCER RES, V11, p865S; Prescott JD, 2004, MOL CELL BIOL, V24, P5548, DOI 10.1128/MCB.24.12.5548-5564.2004; Rau KM, 2005, ENDOCR-RELAT CANCER, V12, P511, DOI 10.1677/erc.1.01026; Ritter HD, 2012, MOL CANCER RES, V10, P558, DOI 10.1158/1541-7786.MCR-11-0423-T; Ronneberg JA, 2011, MOL ONCOL, V5, P61, DOI 10.1016/j.molonc.2010.11.004; Salnikow K, 2008, CARCINOGENESIS, V29, P1493, DOI 10.1093/carcin/bgn088; Sartorius CA, 2003, BREAST CANCER RES TR, V79, P287, DOI 10.1023/A:1024031731269; Schedin PJ, 2004, ONCOGENE, V23, P1766, DOI 10.1038/sj.onc.1207391; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Seth A, 2005, EUR J CANCER, V41, P2462, DOI 10.1016/j.ejca.2005.08.013; SOULE HD, 1980, CANCER LETT, V10, P177, DOI 10.1016/0304-3835(80)90042-7; Span PN, 2002, ONCOGENE, V21, P8506, DOI 10.1038/sj.onc.1206040; Sun ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017490; Tolon RM, 2000, MOL CELL BIOL, V20, P8793, DOI 10.1128/MCB.20.23.8793-8802.2000; WASYLYK C, 1992, GENE DEV, V6, P965, DOI 10.1101/gad.6.6.965; WERNERT N, 1992, AM J PATHOL, V140, P119; Xie M, 2006, P NATL ACAD SCI USA, V103, P17378, DOI 10.1073/pnas.0604708103; Xu JM, 2009, NAT REV CANCER, V9, P615, DOI 10.1038/nrc2695; Xu JM, 2003, MOL ENDOCRINOL, V17, P1681, DOI 10.1210/me.2003-0116; YOUNG RK, 1974, IN VITRO CELL DEV B, V9, P239; YUE W, 1993, J STEROID BIOCHEM, V44, P671, DOI 10.1016/0960-0760(93)90278-5; Zhang Y, 2011, CANCER RES, V71, P3552, DOI 10.1158/0008-5472.CAN-10-2435; Zhou Y, 2005, ENDOCR-RELAT CANCER, V12, pS37, DOI 10.1677/erc.1.00977	59	15	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68815	10.1371/journal.pone.0068815	http://dx.doi.org/10.1371/journal.pone.0068815			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874775	Green Published, Green Submitted, gold			2022-12-27	WOS:000321736900115
J	Narasimhan, S; Perez, O; Mootien, S; DePonte, K; Koski, RA; Fikrig, E; Ledizet, M				Narasimhan, Sukanya; Perez, Oriana; Mootien, Sara; DePonte, Kathleen; Koski, Raymond A.; Fikrig, Erol; Ledizet, Michel			Characterization of Ixophilin, A Thrombin Inhibitor from the Gut of Ixodes scapularis	PLOS ONE			English	Article							ANNOTATED CATALOG; SALIVARY-GLAND; HARD TICK; ANTIOXIDANT; TRANSCRIPTS; EVOLUTION; ANTIGENS; TARGETS; FAMILY; HOST	Ixodes scapularis, the black-legged tick, vectors several human pathogens including Borrelia burgdorferi, the agent of Lyme disease in North America. Pathogen transmission to the vertebrate host occurs when infected ticks feed on the mammalian host to obtain a blood meal. Efforts to understand how the tick confronts host hemostatic mechanisms and imbibes a fluid blood meal have largely focused on the anticoagulation strategies of tick saliva. The blood meal that enters the tick gut remains in a fluid state for several days during the process of feeding, and the role of the tick gut in maintaining the blood-meal fluid is not understood. We now demonstrate that the tick gut produces a potent inhibitor of thrombin, a key enzyme in the mammalian coagulation cascade. Chromatographic fractionation of engorged tick gut proteins identified one predominant thrombin inhibitory activity associated with an approximately 18 kDa protein, henceforth referred to as Ixophilin. The ixophilin gene was preferentially transcribed in the guts of feeding nymphs. Expression began after 24 hours of feeding, coincident with the flow of host blood into the tick gut. Immunity against Ixophilin delayed tick feeding, and decreased feeding efficiency significantly. Surprisingly, immunity against Ixophilin resulted in increased Borrelia burgdorferi transmission to the host, possibly due to delayed feeding and increased transmission opportunity. These observations illuminate the potential drawbacks of targeting individual tick proteins in a functional suite. They also underscore the need to identify the "anticoagulome" of the tick gut, and to prioritize a critical subset of anticoagulants that could be targeted to efficiently thwart tick feeding, and block pathogen transmission to the vertebrate host.	[Narasimhan, Sukanya; DePonte, Kathleen; Fikrig, Erol] Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06510 USA; [Perez, Oriana; Mootien, Sara; Koski, Raymond A.; Ledizet, Michel] L2 Diagnost, New Haven, CT USA; [Fikrig, Erol] Howard Hughes Med Inst, Chevy Chase, MD USA	Yale University; Howard Hughes Medical Institute	Ledizet, M (corresponding author), L2 Diagnost, New Haven, CT USA.	michel.ledizet@L2Dx.com			National Institutes of Health/National Institute of Allergy and Infectious Diseases [R41-AI078650]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R41AI078650, R37AI049200] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the National Institutes of Health/National Institute of Allergy and Infectious Diseases to SN (R41-AI078650). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-552; Anderson JF, 2008, INFECT DIS CLIN N AM, V22, P195, DOI 10.1016/j.idc.2007.12.006; Corral-Rodriguez MA, 2009, INSECT BIOCHEM MOLEC, V39, P579, DOI 10.1016/j.ibmb.2009.07.003; Ceraul SM, 2008, INFECT IMMUN, V76, P5429, DOI 10.1128/IAI.00866-08; Chmelar J, 2012, J PROTEOMICS, V75, P3842, DOI 10.1016/j.jprot.2012.04.026; Chmelar J, 2011, BLOOD, V117, P736, DOI 10.1182/blood-2010-06-293241; Dai SX, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-4; Das S, 2001, J INFECT DIS, V184, P1056, DOI 10.1086/323351; Francischetti IMB, 2002, BLOOD, V99, P3602, DOI 10.1182/blood-2001-12-0237; Francischetti IMB, 2009, FRONT BIOSCI-LANDMRK, V14, P2051, DOI 10.2741/3363; Francischetti NMB, 2004, THROMB HAEMOSTASIS, V91, P886, DOI 10.1160/TH03-11-0715; Franta Z, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-119; Hovius JWR, 2008, PLOS MED, V5, P202, DOI 10.1371/journal.pmed.0050043; Kotsyfakis M, 2008, J IMMUNOL, V181, P5209, DOI 10.4049/jimmunol.181.8.5209; Ledizet Michel, 2005, Current Medicinal Chemistry - Cardiovascular & Hematological Agents, V3, P1, DOI 10.2174/1568016052773315; Liao M, 2009, J INSECT PHYSIOL, V55, P164, DOI 10.1016/j.jinsphys.2008.11.004; Macedo-Ribeiro S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001624; Mans BJ, 2004, INSECT BIOCHEM MOLEC, V34, P1, DOI 10.1016/j.ibmb.2003.09.002; Narasimhan S, 2004, P NATL ACAD SCI USA, V101, P1141, DOI 10.1073/pnas.0307669100; Narasimhan S, 2002, INSECT MOL BIOL, V11, P641, DOI 10.1046/j.1365-2583.2002.00375.x; Narasimhan S, 2007, CELL HOST MICROBE, V2, P7, DOI 10.1016/j.chom.2007.06.001; Nuttall PA, 2006, PARASITE IMMUNOL, V28, P155, DOI 10.1111/j.1365-3024.2006.00806.x; Ribeiro JMC, 2006, INSECT BIOCHEM MOLEC, V36, P111, DOI 10.1016/j.ibmb.2005.11.005; RIBEIRO JMC, 1987, ANNU REV ENTOMOL, V32, P463, DOI 10.1146/annurev.en.32.010187.002335; RIBEIRO JMC, 1985, J EXP MED, V161, P332, DOI 10.1084/jem.161.2.332; RIBEIRO JMC, 1995, PARASITOL TODAY, V11, P91, DOI 10.1016/0169-4758(95)80162-6; Ricci CG, 2007, EXP APPL ACAROL, V42, P291, DOI 10.1007/s10493-007-9097-7; Sauer J. R., 1986, MORPHOLOGY PHYSL BEH; Schuijt TJ, 2011, CELL HOST MICROBE, V10, P136, DOI 10.1016/j.chom.2011.06.010; Schuijt TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015926; Sojka D, 2011, ADV EXP MED BIOL, V712, P177, DOI 10.1007/978-1-4419-8414-2_11; Sonenshine DE., 1991, BIOL TICKS; SPIELMAN A, 1984, YALE J BIOL MED, V57, P507; Thomas V, 2001, INFECT IMMUN, V69, P3359, DOI 10.1128/IAI.69.5.3359-3371.2001	35	13	14	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68012	10.1371/journal.pone.0068012	http://dx.doi.org/10.1371/journal.pone.0068012			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874485	Green Published, gold, Green Submitted			2022-12-27	WOS:000321736900044
J	Mu, QM; Hu, T; Yu, JK				Mu, Qimeng; Hu, Tao; Yu, Jingkai			Molecular Insight into the Steric Shielding Effect of PEG on the Conjugated Staphylokinase: Biochemical Characterization and Molecular Dynamics Simulation	PLOS ONE			English	Article							SITE-SPECIFIC PEGYLATION; POLYETHYLENE-GLYCOL; PLASMINOGEN ACTIVATION; CHEMICAL-MODIFICATION; DRUG-DELIVERY; PROTEIN; HEMOGLOBIN; IMMUNOGENICITY; BIOACTIVITY; STABILITY	PEGylation is a successful approach to improve potency of a therapeutic protein. The improved therapeutic potency is mainly due to the steric shielding effect of PEG. However, the underlying mechanism of this effect on the protein is not well understood, especially on the protein interaction with its high molecular weight substrate or receptor. Here, experimental study and molecular dynamics simulation were used to provide molecular insight into the interaction between the PEGylated protein and its receptor. Staphylokinase (Sak), a therapeutic protein for coronary thrombolysis, was used as a model protein. Four PEGylated Saks were prepared by site-specific conjugation of 5 kDa/20 kDa PEG to N-terminus and C-terminus of Sak, respectively. Experimental study suggests that the native conformation of Sak is essentially not altered by PEGylation. In contrast, the bioactivity, the hydrodynamic volume and the molecular symmetric shape of the PEGylated Sak are altered and dependent on the PEG chain length and the PEGylation site. Molecular modeling of the PEGylated Saks suggests that the PEG chain remains highly flexible and can form a distinctive hydrated layer, thereby resulting in the steric shielding effect of PEG. Docking analyses indicate that the binding affinity of Sak to its receptor is dependent on the PEG chain length and the PEGylation site. Computational simulation results explain experimental data well. Our present study clarifies molecular details of PEG chain on protein surface and may be essential to the rational design, fabrication and clinical application of PEGylated proteins.	[Mu, Qimeng; Hu, Tao; Yu, Jingkai] Chinese Acad Sci, Inst Proc Engn, Natl Key Lab Biochem Engn, Beijing, Peoples R China; [Mu, Qimeng] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Process Engineering, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Hu, T (corresponding author), Chinese Acad Sci, Inst Proc Engn, Natl Key Lab Biochem Engn, Beijing, Peoples R China.	thu@home.ipe.ac.cn; jkyu@home.ipe.ac.cn			Natural Science Foundation of China [61179008, 20906095]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by the Natural Science Foundation of China (Grant Nos. 61179008 and 20906095). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailon P, 1998, PHARM SCI TECHNOL TO, V1, P352, DOI 10.1016/S1461-5347(98)00086-8; Cazalis CS, 2004, BIOCONJUGATE CHEM, V15, P1005, DOI 10.1021/bc049903y; Chiu K, 2010, BIOMACROMOLECULES, V11, P3688, DOI 10.1021/bm1006954; COLLEN D, 1993, J BIOL CHEM, V268, P8284; DELLACHERIE E, 1991, J PROTEIN CHEM, V10, P61, DOI 10.1007/BF01024656; Dhalluin C, 2005, BIOCONJUGATE CHEM, V16, P504, DOI 10.1021/bc049781+; Fishburn CS, 2008, J PHARM SCI-US, V97, P4167, DOI 10.1002/jps.21278; Frisch G. W., 2013, GAUSSIAN 09; Greenwald RB, 2003, ADV DRUG DELIVER REV, V55, P217, DOI 10.1016/S0169-409X(02)00180-1; Hu T, 2012, BBA-GEN SUBJECTS, V1820, P2044, DOI 10.1016/j.bbagen.2012.09.013; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jespers L, 1999, THROMB HAEMOSTASIS, V81, P479; KNUSLI C, 1992, BRIT J HAEMATOL, V82, P654, DOI 10.1111/j.1365-2141.1992.tb06940.x; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Lee HJ, 2007, CELL CYCLE, V6, P2604, DOI 10.4161/cc.6.21.4923; Liu RY, 2012, PROCESS BIOCHEM, V47, P41, DOI 10.1016/j.procbio.2011.10.004; Manjula BN, 2003, BIOCONJUGATE CHEM, V14, P464, DOI 10.1021/bc0200733; Milla P, 2012, CURR DRUG METAB, V13, P105, DOI 10.2174/138920012798356934; Ohlenschlager O, 1998, BIOCHEMISTRY-US, V37, P10635, DOI 10.1021/bi980673i; Okada K, 2000, BLOOD COAGUL FIBRIN, V11, P645, DOI 10.1097/00001721-200010000-00009; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Parry MAA, 1998, NAT STRUCT BIOL, V5, P917, DOI 10.1038/2359; Peisach E, 1999, BIOCHEMISTRY-US, V38, P11180, DOI 10.1021/bi991130r; Ritchie DW, 2003, PROTEINS, V52, P98, DOI 10.1002/prot.10379; Thompson M.A., 2004, ARGUSLAB 4 0 1; Tian P, 2006, BIOPHYS J, V90, P2718, DOI 10.1529/biophysj.105.073304; Tsutsumi Y, 2000, P NATL ACAD SCI USA, V97, P8548, DOI 10.1073/pnas.140210597; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang J, 2011, ANAL BIOCHEM, V412, P114, DOI 10.1016/j.ab.2010.12.030; Wattendorf U, 2008, J PHARM SCI-US, V97, P4655, DOI 10.1002/jps.21350; Winger M, 2009, MOL PHYS, V107, P1313, DOI 10.1080/00268970902794826; Yang C, 2011, BIOCHEMISTRY-US, V50, P2585, DOI 10.1021/bi101926u; Zheng JC, 2012, IMMUNOPHARM IMMUNOT, V34, P866, DOI 10.3109/08923973.2012.666979	33	54	56	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e68559	10.1371/journal.pone.0068559	http://dx.doi.org/10.1371/journal.pone.0068559			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874671	Green Submitted, gold, Green Published			2022-12-27	WOS:000324146200020
J	Papadopoulos, P; Rosa-Neto, P; Rochford, J; Hamel, E				Papadopoulos, Panayiota; Rosa-Neto, Pedro; Rochford, Joseph; Hamel, Edith			Pioglitazone Improves Reversal Learning and Exerts Mixed Cerebrovascular Effects in a Mouse Model of Alzheimer's Disease with Combined Amyloid-beta and Cerebrovascular Pathology	PLOS ONE			English	Article							TRANSGENIC MICE; TRANSFORMING GROWTH-FACTOR-BETA-1; GLUCOSE-UTILIZATION; INDUCED DILATATION; PRECURSOR PROTEIN; OXIDATIVE STRESS; GAMMA AGONIST; NITRIC-OXIDE; INFLAMMATION; ASTROCYTES	Animal models of Alzheimer's disease (AD) are invaluable in dissecting the pathogenic mechanisms and assessing the efficacy of potential new therapies. Here, we used the peroxisome proliferator-activated receptor gamma agonist pioglitazone in an attempt to rescue the pathogenic phenotype in adult (12 months) and aged (>18 months) bitransgenic A/T mice that overexpress a mutated human amyloid precursor protein (APPSwe, Ind) and a constitutively active form of transforming growth factor-beta 1 (TGF-beta 1). A/T mice recapitulate the AD-related cognitive deficits, amyloid beta (A beta) and cerebrovascular pathologies, as well as the altered metabolic and vascular coupling responses to increased neuronal activity. Pioglitazone normalized neurometabolic and neurovascular coupling responses to sensory stimulation, and reduced cortical astroglial and hippocampal microglial activation in both age groups. Spatial learning and memory deficits in the Morris water maze were not rescued by pioglitazone, but reversal learning was improved in the adult cohort notwithstanding a progressing A beta pathology. While pioglitazone preserved the constitutive nitric oxide synthesis in the vessel wall, it unexpectedly failed to restore cerebrovascular reactivity in A/T mice and even exacerbated the dilatory deficits. These data demonstrate pioglitazone's efficacy on selective AD hallmarks in a complex AD mouse model of comorbid amyloidosis and cerebrovascular pathology. They further suggest a potential benefit of pioglitazone in managing neuroinflammation, cerebral perfusion and glucose metabolism in AD patients devoid of cerebrovascular pathology.	[Papadopoulos, Panayiota; Hamel, Edith] McGill Univ, Montreal Neurol Inst, Lab Cerebrovasc Res, Montreal, PQ, Canada; [Rosa-Neto, Pedro] McGill Univ, Montreal Neurol Inst, Brain Imaging Ctr, Montreal, PQ, Canada; [Rosa-Neto, Pedro; Rochford, Joseph] McGill Univ, Douglas Hosp, Res Ctr, Montreal, PQ, Canada	McGill University; McGill University; McGill University	Hamel, E (corresponding author), McGill Univ, Montreal Neurol Inst, Lab Cerebrovasc Res, Montreal, PQ, Canada.	edith.hamel@mcgill.ca	ROSA-NETO, PEDRO/F-5077-2015	ROSA-NETO, PEDRO/0000-0001-9116-1376	Canadian Institutes of Health Research (CIHR) [MOP-84275]; Takeda Pharmaceuticals U.S.A., Inc.	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Takeda Pharmaceuticals U.S.A., Inc.	This work was supported by grants from the Canadian Institutes of Health Research (CIHR grant MOP-84275 to EH) and Takeda Pharmaceuticals U.S.A., Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. These funding sources do not alter our adherence to all the PLOS ONE policies on sharing data and materials.	Bell RD, 2009, ACTA NEUROPATHOL, V118, P103, DOI 10.1007/s00401-009-0522-3; Bellelli G, 2009, J AM GERIATR SOC, V57, P178, DOI 10.1111/j.1532-5415.2009.02067.x; Chen GQ, 2000, NATURE, V408, P975, DOI 10.1038/35050103; Chuquet J, 2010, J NEUROSCI, V30, P15298, DOI 10.1523/JNEUROSCI.0762-10.2010; Ciudin A, 2012, CURR TOP MED CHEM, V12, P585, DOI 10.2174/156802612799436632; de la Torre JC, 1999, ACTA NEUROPATHOL, V98, P1, DOI 10.1007/s004010051044; deIpolyi AR, 2008, NEUROBIOL AGING, V29, P253, DOI 10.1016/j.neurobiolaging.2006.10.021; Dello Russo C, 2003, J BIOL CHEM, V278, P5828, DOI 10.1074/jbc.M208132200; Farkas E, 2001, PROG NEUROBIOL, V64, P575, DOI 10.1016/S0301-0082(00)00068-X; Franklin K.B.J, 1997, MOUSE BRAIN STEREOTA, V186; FUKUYAMA H, 1994, J NUCL MED, V35, P1; Gaertner RF, 2005, NEUROBIOL DIS, V19, P38, DOI 10.1016/j.nbd.2004.11.008; Galea E, 2006, DIABETOLOGIA, V49, P2153, DOI 10.1007/s00125-006-0326-0; GALLAGHER M, 1993, BEHAV NEUROSCI, V107, P618, DOI 10.1037/0735-7044.107.4.618; Geldmacher DS, 2011, ARCH NEUROL-CHICAGO, V68, P45, DOI 10.1001/archneurol.2010.229; Grammas P, 2002, AM J PATHOL, V160, P1583, DOI 10.1016/S0002-9440(10)61105-4; Han BH, 2008, J NEUROSCI, V28, P13542, DOI 10.1523/JNEUROSCI.4686-08.2008; Heneka MT, 2005, BRAIN, V128, P1442, DOI 10.1093/brain/awh452; Izawa Y, 2009, BRAIN RES, V1305, P64, DOI 10.1016/j.brainres.2009.09.098; Kaul S, 2010, J AM COLL CARDIOL, V55, P1885, DOI 10.1016/j.jacc.2010.02.014; KITAZONO T, 1993, AM J PHYSIOL, V265, pH581, DOI 10.1152/ajpheart.1993.265.2.H581; Koehler RC, 2009, TRENDS NEUROSCI, V32, P160, DOI 10.1016/j.tins.2008.11.005; LAN TH, 2013, CARDIOVASC PATHOL, P75582; Langbaum JBS, 2009, NEUROIMAGE, V45, P1107, DOI 10.1016/j.neuroimage.2008.12.072; Lecrux C, 2011, ACTA PHYSIOL, V203, P47, DOI 10.1111/j.1748-1716.2011.02256.x; Levy-Gigi E, 2011, NEUROPSYCHOLOGIA, V49, P3320, DOI 10.1016/j.neuropsychologia.2011.08.005; Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180; Lipson KE, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S24; Maei HR, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.004.2009; Maeshiba Y, 1997, ARZNEIMITTEL-FORSCH, V47, P29; MATHIE RT, 1991, BRIT J PHARMACOL, V103, P1602, DOI 10.1111/j.1476-5381.1991.tb09834.x; Melrose RJ, 2009, INT J GERIATR PSYCH, V24, P885, DOI 10.1002/gps.2229; Mosconi L, 2004, NEUROLOGY, V63, P2332, DOI 10.1212/01.WNL.0000147469.18313.3B; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Nicolakakis N, 2008, J NEUROSCI, V28, P9287, DOI 10.1523/JNEUROSCI.3348-08.2008; Nicolakakis N, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00021; Nicolakakis N, 2011, J CEREBR BLOOD F MET, V31, P1354, DOI 10.1038/jcbfm.2011.43; Nicolakakis N, 2011, J CEREBR BLOOD F MET, V31, P200, DOI 10.1038/jcbfm.2010.78; Niwa K, 2002, NEUROBIOL DIS, V9, P61, DOI 10.1006/nbdi.2001.0460; Niwa K, 2001, CIRC RES, V88, P600, DOI 10.1161/01.RES.88.6.600; Niwa K, 2001, AM J PHYSIOL-HEART C, V281, pH2417, DOI 10.1152/ajpheart.2001.281.6.H2417; Nomura R, 2008, J PHARMACOL SCI, V108, P258, DOI 10.1254/jphs.08117FP; Omae T, 2011, INVEST OPHTH VIS SCI, V52, P6749, DOI 10.1167/iovs.10-6826; Ongali B, 2010, AM J PATHOL, V177, P3071, DOI 10.2353/ajpath.2010.100339; Pellerin L, 2003, J PHYSIOL-LONDON, V546, P325, DOI 10.1113/jphysiol.2002.035105; Rivest Serge, 2011, Expert Rev Neurother, V11, P783, DOI 10.1586/ern.11.64; Santello M, 2010, NATURE, V463, P169, DOI 10.1038/463169a; Sastre M, 2003, J NEUROSCI, V23, P9796; Sato T, 2011, NEUROBIOL AGING, V32, P1626, DOI 10.1016/j.neurobiolaging.2009.10.009; Seeger T, 2004, J NEUROSCI, V24, P10117, DOI 10.1523/JNEUROSCI.3581-04.2004; Tesseur Ina, 2006, Current Alzheimer Research, V3, P505, DOI 10.2174/156720506779025297; Toledo EM, 2010, MOL PSYCHIATR, V15, P272, DOI 10.1038/mp.2009.72; Tong XK, 2012, J NEUROSCI, V32, P4705, DOI 10.1523/JNEUROSCI.0169-12.2012; Tong XK, 2009, NEUROBIOL DIS, V35, P406, DOI 10.1016/j.nbd.2009.06.003; Tong XK, 2005, J NEUROSCI, V25, P11165, DOI 10.1523/JNEUROSCI.4031-05.2005; Vedernikov YP, 2002, CURR MED RES OPIN, V18, P465, DOI 10.1185/030079902125001001; Wyss-Coray T, 2000, AM J PATHOL, V156, P139, DOI 10.1016/S0002-9440(10)64713-X; Wyss-Coray T, 2001, NAT MED, V7, P612, DOI 10.1038/87945; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; Yan Q, 2003, J NEUROSCI, V23, P7504; Yu L, 2011, BRIT J PHARMACOL, V164, P2064, DOI 10.1111/j.1476-5381.2011.01539.x; Zlokovic BV, 2010, NAT MED, V16, P1370, DOI 10.1038/nm1210-1370; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	63	64	65	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e68612	10.1371/journal.pone.0068612	http://dx.doi.org/10.1371/journal.pone.0068612			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874687	Green Submitted, Green Published, gold			2022-12-27	WOS:000324146200021
J	Chen, QS; Lang, L; Wu, WZ; Xu, GY; Zhang, X; Li, T; Huang, HL				Chen, Qingsong; Lang, Li; Wu, Wenzhe; Xu, Guoyong; Zhang, Xiao; Li, Tao; Huang, Hanlin			A Meta-Analysis on the Relationship between Exposure to ELF-EMFs and the Risk of Female Breast Cancer	PLOS ONE			English	Article							60-HERTZ MAGNETIC-FIELDS; ELECTRIC BLANKET USE; ELECTROMAGNETIC-FIELDS; OCCUPATIONAL-EXPOSURE; WOMEN; 50-HZ	Objective: To comprehensively analyze the relationship between exposure to extremely low frequency electromagnetic fields (ELF-EMFs) and the development of female breast cancer. Methods: Reports of case-control studies published from 1990 to 2010 were analyzed. The quality effect model was chosen to calculate total odds ratio (OR) depending on the data in studies and quality scores. Subgroup analyses were also performed by the situation of menopause, estrogenic receptor and exposure assessment respectively. Results: For all 23 studies the OR was 1.07, 95% CI = 1.02-1.13, for estrogen receptor positive subgroup, OR = 1.11, 95% CI = 1.03-1.20; for premenopausal subgroup, OR = 1.11, 95% CI = 1.00-1.23. The results of other subgroups showed no significant association between ELF-EMF and female breast cancer. Conclusion: ELF-EMFs might be related to an increased risk for female breast cancer, especially for premenopausal and ER+ females. However, it's necessary to undertake better epidemiologic researches to verify the association between ELF-EMF and female breast cancer due to the limits of current study, especially the one on exposure assessment.	[Chen, Qingsong; Lang, Li; Wu, Wenzhe; Xu, Guoyong; Zhang, Xiao; Huang, Hanlin] Guangdong Prevent & Treatment Ctr Occupat Dis, Guangzhou, Guangdong, Peoples R China; [Li, Tao] Chinese Ctr Dis Control & Prevent, Natl Inst Occupat Hlth & Poison Control, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute of Occupational Health & Poison Control, Chinese Center for Disease Control & Prevention	Li, T (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Occupat Hlth & Poison Control, Beijing, Peoples R China.	tree52013@yahoo.com.cn; huanghl@gdoh.org			Key Project of the National Eleventh-Five Year Research Program of China [2006BAK04A11]; National Health Standard Enacting Program of China [20100309]	Key Project of the National Eleventh-Five Year Research Program of China; National Health Standard Enacting Program of China	This work was supported by grants from the Key Project of the National Eleventh-Five Year Research Program of China(2006BAK04A11) and the National Health Standard Enacting Program of China in 2010 (20100309). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUM A, 1995, CARCINOGENESIS, V16, P119, DOI 10.1093/carcin/16.1.119; Chen CH, 2010, BREAST CANCER RES TR, V123, P569, DOI 10.1007/s10549-010-0782-6; Coogan PF, 1996, EPIDEMIOLOGY, V7, P459, DOI 10.1097/00001648-199609000-00001; Coogan PF, 1998, ARCH ENVIRON HEALTH, V53, P359, DOI 10.1080/00039899809605722; Davis S, 2002, AM J EPIDEMIOL, V155, P446, DOI 10.1093/aje/155.5.446; Doi SAR, 2008, EPIDEMIOLOGY, V21, P278; Doi SAR, 2008, EPIDEMIOLOGY, V19, P94, DOI 10.1097/EDE.0b013e31815c24e7; Doi SAR, 2011, CONTEMP CLIN TRIALS, V32, P288, DOI 10.1016/j.cct.2010.12.006; Erren TC, 2001, BIOELECTROMAGNETICS, pS105, DOI 10.1002/1521-186X(2001)22:5+<::AID-BEM1027>3.0.CO;2-0; Feychting M, 1998, EPIDEMIOLOGY, V9, P392, DOI 10.1097/00001648-199807000-00008; Forssen UM, 2005, AM J EPIDEMIOL, V161, P250, DOI 10.1093/aje/kwi041; Forssen UM, 2000, EPIDEMIOLOGY, V11, P24, DOI 10.1097/00001648-200001000-00007; Gammon MD, 1998, AM J EPIDEMIOL, V148, P556, DOI 10.1093/oxfordjournals.aje.a009681; Girgert R, 2008, BIOELECTROMAGNETICS, V29, P169, DOI 10.1002/bem.20387; Kabat GC, 2003, EPIDEMIOLOGY, V14, P514, DOI 10.1097/01.ede.0000082047.13618.6b; Kleinerman RA, 2005, AM J EPIDEMIOL, V161, P136, DOI 10.1093/aje/kwi013; Kliukiene J, 2004, AM J EPIDEMIOL, V159, P852, DOI 10.1093/aje/kwh116; Kliukiene J, 2003, EUR J CANCER PREV, V12, P301, DOI 10.1097/00008469-200308000-00010; Labreche F, 2003, AM J IND MED, V44, P643, DOI 10.1002/ajim.10264; Li CY, 1997, EPIDEMIOLOGY, V8, P25, DOI 10.1097/00001648-199701000-00004; London SJ, 2003, AM J EPIDEMIOL, V158, P969, DOI 10.1093/aje/kwg254; LOOMIS DP, 1994, J NATL CANCER I, V86, P921, DOI 10.1093/jnci/86.12.921; McElroy JA, 2001, EPIDEMIOLOGY, V12, P613, DOI 10.1097/00001648-200111000-00006; McElroy JA, 2007, J OCCUP ENVIRON MED, V49, P266, DOI 10.1097/JOM.0b013e318032259b; Norman RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001349; Schoenfeld ER, 2003, AM J EPIDEMIOL, V158, P47, DOI 10.1093/aje/kwg106; Schuz J, 2007, AM J EPIDEMIOL, V166, P263, DOI 10.1093/aje/kwm080; STEVENS RG, 1987, AM J EPIDEMIOL, V125, P556, DOI 10.1093/oxfordjournals.aje.a114569; Van Wijngaarden E, 2001, ANN EPIDEMIOL, V11, P297, DOI 10.1016/S1047-2797(01)00209-5; VENA JE, 1994, AM J EPIDEMIOL, V140, P974, DOI 10.1093/oxfordjournals.aje.a117204; VENA JE, 1991, AM J EPIDEMIOL, V134, P180, DOI 10.1093/oxfordjournals.aje.a116070; WERTHEIMER N, 1979, AM J EPIDEMIOL, V109, P273, DOI 10.1093/oxfordjournals.aje.a112681; Wills GSB, 2012, NEWCASTLE OTTAWA SCA; Zheng TZ, 2000, AM J EPIDEMIOL, V151, P1103, DOI 10.1093/oxfordjournals.aje.a010154; Zhu KM, 2003, AM J EPIDEMIOL, V158, P798, DOI 10.1093/aje/kwg220	35	28	29	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2013	8	7							e69272	10.1371/journal.pone.0069272	http://dx.doi.org/10.1371/journal.pone.0069272			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZN	23869239	Green Published, gold, Green Submitted			2022-12-27	WOS:000323110600039
J	Hsu, CY; Huang, PH; Chiang, CH; Leu, HB; Huang, CC; Chen, JW; Lin, SJ				Hsu, Chien-Yi; Huang, Po-Hsun; Chiang, Chia-Hung; Leu, Hsin-Bang; Huang, Chin-Chou; Chen, Jaw-Wen; Lin, Shing-Jong			Increased Circulating Endothelial Apoptotic Microparticle to Endothelial Progenitor Cell Ratio Is Associated with Subsequent Decline in Glomerular Filtration Rate in Hypertensive Patients	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CORONARY-ARTERY-DISEASE; CKD-EPI EQUATION; CARDIOVASCULAR OUTCOMES; RENAL-INSUFFICIENCY; MYOCARDIAL-INFARCTION; DYSFUNCTION; ATHEROSCLEROSIS; RISK; EVENTS	Background: Recent research indicates hypertensive patients with microalbuminuria have decreased endothelial progenitor cells (EPCs) and increased levels of endothelial apoptotic microparticles (EMP). However, whether these changes are related to a subsequent decline in glomerular filtration rate (GFR) remains unclear. Methods and Results: We enrolled totally 100 hypertensive out-patients with eGFR >= 30 mL/min/1.73 m(2). The mean annual rate of GFR decline (Delta GFR/y) was -1.49 +/- 3.26 mL/min/1.73 m(2) per year during the follow-up period (34 +/- 6 months). Flow cytometry was used to assess circulating EPC (CD34(+)/KDR+) and EMP levels (CD31(+)/annexin V+) in peripheral blood. The Delta GFR/y was correlated with the EMP to EPC ratio (r = -0.465, p<0.001), microalbuminuria (r = -0.329, p = 0.001), and the Framingham risk score (r = -0.245, p = 0.013). When we divided the patients into 4 groups according to the EMP to EPC ratio, there was an association between the EMP to EPC ratio and the Delta GFR/y (mean Delta GFR/y: 0.08 +/- 3.04 vs. -0.50 +/- 2.84 vs. -1.25 +/- 2.49 vs. -4.42 +/- 2.82, p<0.001). Multivariate analysis indicated that increased EMP to EPC ratio is an independent predictor of Delta eGFR/y. Conclusions: An increased circulating EMP to EPC ratio is associated with subsequent decline in GFR in hypertensive patients, which suggests endothelial damage with reduced vascular repair capacity may contribute to further deterioration of renal function in patients with hypertension.	[Hsu, Chien-Yi; Huang, Po-Hsun; Chiang, Chia-Hung; Leu, Hsin-Bang; Huang, Chin-Chou; Chen, Jaw-Wen; Lin, Shing-Jong] Taipei Vet Gen Hosp, Dept Med, Div Cardiol, Taipei, Taiwan; [Huang, Chin-Chou; Chen, Jaw-Wen; Lin, Shing-Jong] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Leu, Hsin-Bang] Taipei Vet Gen Hosp, Healthcare & Management Ctr, Taipei, Taiwan; [Huang, Po-Hsun; Chiang, Chia-Hung; Lin, Shing-Jong] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Hsu, Chien-Yi; Huang, Po-Hsun; Chiang, Chia-Hung; Leu, Hsin-Bang; Huang, Chin-Chou; Chen, Jaw-Wen; Lin, Shing-Jong] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei 112, Taiwan; [Huang, Chin-Chou; Chen, Jaw-Wen] Natl Yang Ming Univ, Inst & Dept Pharmacol, Taipei 112, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Huang, PH (corresponding author), Taipei Vet Gen Hosp, Dept Med, Div Cardiol, Taipei, Taiwan.	huangbs@vghtpe.gov.tw		Hsu, Chien-Yi/0000-0002-9493-7325	UST-UCSD International Center of Excellence in Advanced Bio-engineering from the National Science Council [NSC-100-2911-I-009-101]; Taipei Veterans General Hospital [VGH-V98B1-003, VGH-V100E2-002]; Ministry of Education "Aim for the Top University" Plan;  [NSC 97-2314-B-075-039];  [NSC 98-2314-B-075-035]	UST-UCSD International Center of Excellence in Advanced Bio-engineering from the National Science Council; Taipei Veterans General Hospital(Taipei Veterans General Hospital); Ministry of Education "Aim for the Top University" Plan(Ministry of Education, Taiwan); ; 	This study was supported in part by research grants NSC 97-2314-B-075-039, NSC 98-2314-B-075-035, and UST-UCSD International Center of Excellence in Advanced Bio-engineering NSC-100-2911-I-009-101 from the National Science Council; VGH-V98B1-003 and VGH-V100E2-002 from Taipei Veterans General Hospital; and a grant from the Ministry of Education "Aim for the Top University" Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amabile N, 2005, J AM SOC NEPHROL, V16, P3381, DOI 10.1681/ASN.2005050535; Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365; Best PJM, 2002, J AM COLL CARDIOL, V39, P1113, DOI 10.1016/S0735-1097(02)01745-X; Bonetti PO, 2003, ARTERIOSCL THROM VAS, V23, P168, DOI 10.1161/01.ATV.0000051384.43104.FC; Boulanger CM, 2001, CIRCULATION, V104, P2649, DOI 10.1161/hc4701.100516; Camussi G, 2010, KIDNEY INT, V78, P838, DOI 10.1038/ki.2010.278; Cantaluppi V, 2012, KIDNEY INT, V82, P412, DOI 10.1038/ki.2012.105; Chiang CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031799; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Eknoyan G, 2004, KIDNEY INT, V66, P1310, DOI 10.1111/j.1523-1755.2004.00894.x; Franca CN, 2012, CIRC J, V76, P729, DOI 10.1253/circj.CJ-11-1145; Fujita Y, 2011, CIRC J, V75, P2541, DOI 10.1253/circj.CJ-11-1050; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Horstman LL, 2004, FRONT BIOSCI-LANDMRK, V9, P1118, DOI 10.2741/1270; Hristov M, 2004, BLOOD, V104, P2761, DOI 10.1182/blood-2003-10-3614; Huang PH, 2007, HEART, V93, P1064, DOI 10.1136/hrt.2006.107763; Huang PH, 2007, INT J CARDIOL, V114, P152, DOI 10.1016/j.ijcard.2005.12.009; Huang PH, 2007, CLIN CARDIOL, V30, P135, DOI 10.1002/clc.20058; Huang PH, 2010, J HYPERTENS, V28, P1655, DOI 10.1097/HJH.0b013e32833a4d0a; Huang PH, 2010, ARTERIOSCL THROM VAS, V30, P869, DOI 10.1161/ATVBAHA.109.200618; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Liao Y, 2011, J INT MED RES, V39, P2273, DOI 10.1177/147323001103900624; Mallat Z, 2000, CIRCULATION, V101, P841, DOI 10.1161/01.CIR.101.8.841; Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007; Perticone F, 2004, CIRCULATION, V110, P821, DOI 10.1161/01.CIR.0000138745.21879.27; Perticone F, 2010, CIRCULATION, V122, P379, DOI 10.1161/CIRCULATIONAHA.110.940932; Pirro M, 2006, ARTERIOSCL THROM VAS, V26, P2530, DOI 10.1161/01.ATV.0000243941.72375.15; Ruilope LM, 2001, J AM SOC NEPHROL, V12, P218, DOI 10.1681/ASN.V122218; Sabanayagam C, 2009, ANN INTERN MED, V151, P892, DOI 10.7326/0003-4819-151-12-200912150-00014; Sata M, 2003, CIRC J, V67, P983, DOI 10.1253/circj.67.983; Sinning JM, 2011, EUR HEART J, V32, P2034, DOI 10.1093/eurheartj/ehq478; Turan RG, 2011, CIRC J, V75, P2635, DOI 10.1253/circj.CJ-10-1284; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2; Werner N, 2006, ARTERIOSCL THROM VAS, V26, P112, DOI 10.1161/01.ATV.0000191634.13057.15; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Yun CH, 2010, J CLIN NEUROL, V6, P89, DOI 10.3988/jcn.2010.6.2.89; ZEIHER AM, 1991, CIRCULATION, V84, P1984, DOI 10.1161/01.CIR.84.5.1984	39	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e68644	10.1371/journal.pone.0068644	http://dx.doi.org/10.1371/journal.pone.0068644			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	23874701	Green Published, Green Submitted, gold			2022-12-27	WOS:000321718700036
J	Bidkhori, G; Narimani, Z; Ashtiani, SH; Moeini, A; Nowzari-Dalini, A; Masoudi-Nejad, A				Bidkhori, Gholamreza; Narimani, Zahra; Ashtiani, Saman Hosseini; Moeini, Ali; Nowzari-Dalini, Abbas; Masoudi-Nejad, Ali			Reconstruction of an Integrated Genome-Scale Co-Expression Network Reveals Key Modules Involved in Lung Adenocarcinoma	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; NUCLEOTIDE POLYMORPHISM ARRAY; SQUAMOUS-CELL CARCINOMA; GENE COPY NUMBER; INHIBITS PROLIFERATION; TRANSCRIPTION FACTORS; EXPRESSION ANALYSIS; PANCREATIC-CANCER; SOMATIC MUTATIONS; CYCLIN A2	Our goal of this study was to reconstruct a "genome-scale co-expression network" and find important modules in lung adenocarcinoma so that we could identify the genes involved in lung adenocarcinoma. We integrated gene mutation, GWAS, CGH, array-CGH and SNP array data in order to identify important genes and loci in genome-scale. Afterwards, on the basis of the identified genes a co-expression network was reconstructed from the co-expression data. The reconstructed network was named "genome-scale co-expression network". As the next step, 23 key modules were disclosed through clustering. In this study a number of genes have been identified for the first time to be implicated in lung adenocarcinoma by analyzing the modules. The genes EGFR, PIK3CA, TAF15, XIAP, VAPB, Appl1, Rab5a, ARF4, CLPTM1L, SP4, ZNF124, LPP, FOXP1, SOX18, MSX2, NFE2L2, SMARCC1, TRA2B, CBX3, PRPF6, ATP6V1C1, MYBBP1A, MACF1, GRM2, TBXA2R, PRKAR2A, PTK2, PGF and MYO10 are among the genes that belong to modules 1 and 22. All these genes, being implicated in at least one of the phenomena, namely cell survival, proliferation and metastasis, have an over-expression pattern similar to that of EGFR. In few modules, the genes such as CCNA2 (Cyclin A2), CCNB2 (Cyclin B2), CDK1, CDK5, CDC27, CDCA5, CDCA8, ASPM, BUB1, KIF15, KIF2C, NEK2, NUSAP1, PRC1, SMC4, SYCE2, TFDP1, CDC42 and ARHGEF9 are present that play a crucial role in cell cycle progression. In addition to the mentioned genes, there are some other genes (i.e. DLGAP5, BIRC5, PSMD2, Src, TTK, SENP2, PSMD2, DOK2, FUS and etc.) in the modules.	[Bidkhori, Gholamreza; Narimani, Zahra; Ashtiani, Saman Hosseini; Masoudi-Nejad, Ali] Univ Tehran, Inst Biochem & Biophys, Lab Syst Biol & Bioinformat LBB, Tehran, Iran; [Moeini, Ali] Univ Tehran, Coll Engn, Dept Algorithms & Computat, Tehran, Iran; [Nowzari-Dalini, Abbas] Univ Tehran, Sch Math & Comp Sci, Tehran, Iran	University of Tehran; University of Tehran; University of Tehran	Masoudi-Nejad, A (corresponding author), Univ Tehran, Inst Biochem & Biophys, Lab Syst Biol & Bioinformat LBB, Tehran, Iran.	amasoudin@ibb.ut.ac.ir	nowzari-dalini, abbas/X-8074-2019; Masoudi-Nejad, Ali/ABH-2078-2021	Narimani, Zahra/0000-0003-2534-9201				Ahn MJ, 2012, HUM GENET, V131, P365, DOI 10.1007/s00439-011-1080-z; Altay G, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-31; Amann J, 2005, CANCER RES, V65, P226; Andersen CL, 2009, BRIT J CANCER, V100, P511, DOI 10.1038/sj.bjc.6604884; Arcella A, 2005, NEURO-ONCOLOGY, V7, P236, DOI 10.1215/S1152851704000961; Arjonen A, 2011, CELL ADHES MIGR, V5, P421, DOI 10.4161/cam.5.5.17723; Arsic N, 2012, J CELL BIOL, V196, P147, DOI 10.1083/jcb.201102085; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bidkhori G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048004; Blons H, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-25; BRADBURY AW, 1994, BRIT J CANCER, V69, P738, DOI 10.1038/bjc.1994.139; Broet P, 2011, CLIN CANCER RES, V17, P3542, DOI 10.1158/1078-0432.CCR-10-2185; Catalanotti F, 2009, NAT STRUCT MOL BIOL, V16, P294, DOI 10.1038/nsmb.1564; Chaft JE, 2012, MOL CANCER THER, V11, P485, DOI 10.1158/1535-7163.MCT-11-0692; Chen QY, 2012, INT J ONCOL, V40, P1561, DOI 10.3892/ijo.2012.1336; Cho-Chung Yoon S., 1999, Frontiers in Bioscience, V4, pd898, DOI 10.2741/Cho-Chung; Choi YW, 2007, LUNG CANCER, V55, P43, DOI 10.1016/j.lungcan.2006.09.018; Colon J, 2011, INVEST NEW DRUG, V29, P41, DOI 10.1007/s10637-009-9331-8; Dean EJ, 2010, BRIT J CANCER, V102, P97, DOI 10.1038/sj.bjc.6605418; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dong J, 2009, CANCER BIOL THER, V8, P312, DOI 10.4161/cbt.8.4.7522; Emery IF, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-333; Feng J, 2012, AM J CLIN PATHOL, V138, P230, DOI 10.1309/AJCPDHQFNYJZ01YG; Frullanti E, 2011, CLIN CANCER RES, V17, P2410, DOI 10.1158/1078-0432.CCR-10-2394; Gabriel B, 2009, ACTA OBSTET GYN SCAN, V88, P216, DOI 10.1080/00016340802503021; Galvan A, 2008, INT J CANCER, V123, P2327, DOI 10.1002/ijc.23789; Ganti AK, 2010, CANCER INVEST, V28, P515, DOI 10.3109/07357900903476760; Garcia-Garcia A, 2012, BIOTECH HISTOCHEM, V87, P133, DOI 10.3109/10520295.2011.574647; Gholami AM, 2010, BIOINFORMATICS, V26, P1082, DOI 10.1093/bioinformatics/btq096; Gong D, 2010, MOL BIOL CELL, V21, P3149, DOI 10.1091/mbc.E10-05-0393; Gremel G, 2011, BRIT J CANCER, V105, P565, DOI 10.1038/bjc.2011.249; Gupta A, 2009, CELL CYCLE, V8, P2198, DOI 10.4161/cc.8.14.8947; Heeboll S, 2008, HISTOL HISTOPATHOL, V23, P1069, DOI 10.14670/HH-23.1069; Hirsch FR, 2003, J CLIN ONCOL, V21, P3798, DOI 10.1200/JCO.2003.11.069; Hu Y, 2012, MOL BIOL REP, V39, P4743, DOI 10.1007/s11033-011-1266-4; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Ijichi N, 2012, HORM CANCER-US, V3, P147, DOI 10.1007/s12672-012-0111-0; James MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036116; Jang SY, 2012, CANCER LETT, V314, P185, DOI 10.1016/j.canlet.2011.09.028; Janne PA, 2004, ONCOGENE, V23, P2716, DOI 10.1038/sj.onc.1207329; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Ju Z, 2005, MOL GENET GENOMICS, V274, P141, DOI 10.1007/s00438-005-0014-7; Kang JU, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-237; Kao S, 2012, NUCLEIC ACIDS RES, V40, pD972, DOI 10.1093/nar/gkr1183; KATOH M, 2012, CANC LETT; Kuner R, 2009, LUNG CANCER, V63, P32, DOI 10.1016/j.lungcan.2008.03.033; Kuramoto K, 2000, CANCER RES, V60, P425; Li XX, 2012, CANCER CHEMOTH PHARM, V70, P425, DOI 10.1007/s00280-012-1923-x; Liang H, 2011, ASIAN PAC J CANCER P, V12, P3415; Lister A, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-37; Lu TP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024829; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Mertens C, 2007, CELL, V131, DOI 10.1016/j.cell.2007.10.033; Micke P, 2011, J THORAC ONCOL, V6, P1833, DOI 10.1097/JTO.0b013e3182295917; Mo ML, 2010, INT J BIOL MARKER, V25, P236, DOI 10.5301/JBM.2010.6088; Mukohara T, 2003, LUNG CANCER, V41, P123, DOI 10.1016/S0169-5002(03)00225-3; Nepusz T, 2012, NAT METHODS, V9, P471, DOI [10.1038/nmeth.1938, 10.1038/NMETH.1938]; Olsen C, 2009, EURASIP J BIOINFORM, DOI 10.1155/2009/308959; Osthus RC, 2005, CANCER RES, V65, P5620, DOI 10.1158/0008-5472.CAN-05-0536; Ouyang YQ, 2011, INT J CANCER, V128, P2010, DOI 10.1002/ijc.25544; Perez-Sayans M, 2010, CANCER BIOL THER, V9, P1057, DOI 10.4161/cbt.9.12.11880; PORE MM, 2010, CANC LETT; Ramos AH, 2009, CANCER BIOL THER, V8, P2042, DOI 10.4161/cbt.8.21.9764; Rao M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046281; Saini V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041401; Sanhueza GAA, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-72; Sankpal UT, 2012, CURR MED CHEM, V19, P3779; Sasaki H, 2012, MOL MED REP, V6, P391, DOI 10.3892/mmr.2012.921; Shigematsu H, 2006, INT J CANCER, V118, P257, DOI 10.1002/ijc.21496; Siejka A, 2012, PEPTIDES, V37, P63, DOI 10.1016/j.peptides.2012.07.010; Silva A, 2008, J CLIN INVEST, V118, P3762, DOI 10.1172/JCI34616; Skarpen E, 1998, HISTOCHEM CELL BIOL, V109, P203, DOI 10.1007/s004180050219; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Speyer CL, 2012, BREAST CANCER RES TR, V132, P565, DOI 10.1007/s10549-011-1624-x; Spitzer JI, 2011, GENE CHROMOSOME CANC, V50, P338, DOI 10.1002/gcc.20858; Steelman LS, 2011, AGING-US, V3, P192, DOI 10.18632/aging.100296; Su LP, 2008, J HUAZHONG U SCI-MED, V28, P97, DOI 10.1007/s11596-008-0125-6; Takeo K, 2009, AM J PHYSIOL-CELL PH, V297, pC330, DOI 10.1152/ajpcell.00009.2009; Tan YF, 2010, GENESIS, V48, P531, DOI 10.1002/dvg.20657; Tan YF, 2010, J BIOL CHEM, V285, P6377, DOI 10.1074/jbc.M109.068452; Teh Jessica, 2012, Wiley Interdiscip Rev Membr Transp Signal, V1, P211; Tsakiridis T, 2008, J THORAC ONCOL, V3, P716, DOI 10.1097/JTO.0b013e31817c6094; Tyagarajan SK, 2011, J CELL SCI, V124, P2786, DOI 10.1242/jcs.086199; Vicent S, 2004, BRIT J CANCER, V90, P1047, DOI 10.1038/sj.bjc.6601644; Vincent-Dejean C, 2008, EUR J ENDOCRINOL, V158, P829, DOI 10.1530/EJE-07-0819; Wang Z, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-119; Watanabe T, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-2; Watkins Gareth, 2005, Int Semin Surg Oncol, V2, P23, DOI 10.1186/1477-7800-2-23; Whyte L, 2007, CANCER RES, V67, P12007, DOI 10.1158/0008-5472.CAN-07-2464; Wilkerson MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036530; Woo IS, 2004, TUMOR BIOL, V25, P1, DOI 10.1159/000077716; YASUDA H, 2011, LANCET ONCOL; Yoon KA, 2010, HUM MOL GENET, V19, P4948, DOI 10.1093/hmg/ddq421; Young N, 2006, J NATL CANCER I, V98, P1060, DOI 10.1093/jnci/djj299; Yu J, 2004, BIOINFORMATICS, V20, P3594, DOI 10.1093/bioinformatics/bth448; Zhang Lijian, 2005, World J Surg Oncol, V3, P68, DOI 10.1186/1477-7819-3-68; Zhang NG, 2012, CELL CYCLE, V11, P2073, DOI 10.4161/cc.20241; Zhao XJ, 2005, CANCER RES, V65, P5561, DOI 10.1158/0008-5472.CAN-04-4603; Zhao Z, 2010, CANCER SCI, V101, P1454, DOI 10.1111/j.1349-7006.2010.01558.x; ZHU X, 2012, FEBS LETT	101	80	83	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e67552	10.1371/journal.pone.0067552	http://dx.doi.org/10.1371/journal.pone.0067552			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874428	Green Submitted, Green Published, gold			2022-12-27	WOS:000322218800006
J	Buchmaier, BS; Bibi, A; Muller, GA; Dihazi, GH; Eltoweissy, M; Kruegel, J; Dihazi, H				Buchmaier, Bettina S.; Bibi, Asima; Mueller, Gerhard A.; Dihazi, Gry H.; Eltoweissy, Marwa; Kruegel, Jenny; Dihazi, Hassan			Renal Cells Express Different Forms of Vimentin: The Independent Expression Alteration of these Forms is Important in Cell Resistance to Osmotic Stress and Apoptosis	PLOS ONE			English	Article							THICK ASCENDING LIMB; INTERMEDIATE FILAMENT PROTEINS; ORGANIC OSMOLYTES; VOLUME REGULATION; KINASE-C; IN-VITRO; CYTOSKELETON; ACTIN; FIBROBLASTS; LINES	Osmotic stress has been shown to regulate cytoskeletal protein expression. It is generally known that vimentin is rapidly degraded during apoptosis by multiple caspases, resulting in diverse vimentin fragments. Despite the existence of the known apoptotic vimentin fragments, we demonstrated in our study the existence of different forms of vimentin VIM I, II, III, and IV with different molecular weights in various renal cell lines. Using a proteomics approach followed by western blot analyses and immunofluorescence staining, we proved the apoptosis-independent existence and differential regulation of different vimentin forms under varying conditions of osmolarity in renal cells. Similar impacts of osmotic stress were also observed on the expression of other cytoskeleton intermediate filament proteins; e. g., cytokeratin. Interestingly, 2D western blot analysis revealed that the forms of vimentin are regulated independently of each other under glucose and NaCl osmotic stress. Renal cells, adapted to high NaCl osmotic stress, express a high level of VIM IV (the form with the highest molecular weight), besides the three other forms, and exhibit higher resistance to apoptotic induction with TNF-alpha or staurosporin compared to the control. In contrast, renal cells that are adapted to high glucose concentration and express only the lower-molecular-weight forms VIM I and II, were more susceptible to apoptosis. Our data proved the existence of different vimentin forms, which play an important role in cell resistance to osmotic stress and are involved in cell protection against apoptosis.	[Buchmaier, Bettina S.; Bibi, Asima; Mueller, Gerhard A.; Dihazi, Gry H.; Eltoweissy, Marwa; Kruegel, Jenny; Dihazi, Hassan] Univ Gottingen, Dept Nephrol & Rheumatol, D-37073 Gottingen, Germany	University of Gottingen	Dihazi, H (corresponding author), Univ Gottingen, Dept Nephrol & Rheumatol, D-37073 Gottingen, Germany.	dihazi@med.uni-goettingen.de	Eltoweissy, Marwa/K-4848-2018	Eltoweissy, Marwa/0000-0001-7221-6722; Dihazi, Gry Helene/0000-0002-3214-7969	German Research Foundation; Open Access Publication Funds of the Gottingen University	German Research Foundation(German Research Foundation (DFG)); Open Access Publication Funds of the Gottingen University	We acknowledge support by the German Research Foundation and the Open Access Publication Funds of the Gottingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERS K, 1987, J CELL BIOL, V105, P791, DOI 10.1083/jcb.105.2.791; Ando J, 2008, BIOCHEM BIOPH RES CO, V365, P691, DOI 10.1016/j.bbrc.2007.11.053; Bakris GL, 2009, KIDNEY INT, V75, P1272, DOI 10.1038/ki.2009.87; BALL EH, 1981, P NATL ACAD SCI-BIOL, V78, P6986, DOI 10.1073/pnas.78.11.6986; Bibi A, INT J BIOCH CELL BIO, V43, P1187; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bustamante M, 2003, AM J PHYSIOL-RENAL, V285, pF336, DOI 10.1152/ajprenal.00003.2003; Byun Y, 2001, CELL DEATH DIFFER, V8, P443, DOI 10.1038/sj.cdd.4400840; CORNET M, 1993, J MEMBRANE BIOL, V131, P55, DOI 10.1007/BF02258534; Correia I, 1999, J CELL BIOL, V146, P831, DOI 10.1083/jcb.146.4.831; Di Ciano C, 2002, AM J PHYSIOL-CELL PH, V283, pC850, DOI 10.1152/ajpcell.00018.2002; Dihazi H, 2005, MOL CELL PROTEOMICS, V4, P1445, DOI 10.1074/mcp.M400184-MCP200; Ding M, 1998, MOL BRAIN RES, V62, P77, DOI 10.1016/S0169-328X(98)00240-X; Dinsdale D, 2004, AM J PATHOL, V164, P395, DOI 10.1016/S0002-9440(10)63130-6; Eckes B, 1998, J CELL SCI, V111, P1897; Eckes B, 2000, J CELL SCI, V113, P2455; Esue O, 2006, J BIOL CHEM, V281, P30393, DOI 10.1074/jbc.M605452200; GARCIAPEREZ A, 1991, PHYSIOL REV, V71, P1081, DOI 10.1152/physrev.1991.71.4.1081; Grunewald RW, 2001, EXP NEPHROL, V9, P81; HERRMANN H, 1989, DEVELOPMENT, V105, P279; Ivaska J, 2005, EMBO J, V24, P3834, DOI 10.1038/sj.emboj.7600847; Janmey PA, 1998, PHYSIOL REV, V78, P763, DOI 10.1152/physrev.1998.78.3.763; Kelly DJ, 2002, NEPHROL DIAL TRANSPL, V17, P1327, DOI 10.1093/ndt/17.7.1327; Kokkinos MI, 2007, CELLS TISSUES ORGANS, V185, P191, DOI 10.1159/000101320; KRAPIVINSKY GB, 1994, CELL, V76, P439, DOI 10.1016/0092-8674(94)90109-0; Michelotti A, 2007, EUR J ORTHODONT, V29, P622, DOI 10.1093/ejo/cjm071; MULLER GA, 1995, EXP NEPHROL, V3, P127; Rao L, 1996, J CELL BIOL, V135, P1441, DOI 10.1083/jcb.135.6.1441; Roland J, 2008, BIOPHYS J, V94, P2082, DOI 10.1529/biophysj.107.121988; Runembert I, 2002, J CELL SCI, V115, P713; RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6; SARRIA AJ, 1990, J CELL BIOL, V111, P553, DOI 10.1083/jcb.111.2.553; SCOTT DM, 1987, DIFFERENTIATION, V36, P35, DOI 10.1111/j.1432-0436.1987.tb00179.x; SKALLI O, 1991, CELL MOTIL CYTOSKEL, V19, P67, DOI 10.1002/cm.970190202; SOELLNER P, 1985, P NATL ACAD SCI USA, V82, P7929, DOI 10.1073/pnas.82.23.7929; SOLOMON DH, 1985, FEBS LETT, V190, P342, DOI 10.1016/0014-5793(85)81315-6; STAMENKOVIC I, 1986, AM J PATHOL, V125, P465; Takai Y, 1996, J CELL BIOL, V133, P141, DOI 10.1083/jcb.133.1.141; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Wehner F, 2004, REV PHYSIOL BIOCH P, V148, P1, DOI 10.1007/s10254-003-0009-x; WELCH WJ, 1985, ANN NY ACAD SCI, V455, P57, DOI 10.1111/j.1749-6632.1985.tb50403.x; Xia L, 2008, AM J PHYSIOL-RENAL, V295, pF1705, DOI 10.1152/ajprenal.00043.2008; Yang X, 2005, AM J PATHOL, V167, P705, DOI 10.1016/S0002-9440(10)62045-7	43	15	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e68301	10.1371/journal.pone.0068301	http://dx.doi.org/10.1371/journal.pone.0068301			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874579	Green Submitted, gold, Green Published			2022-12-27	WOS:000322218800023
J	Dai, HC; Mao, JQ; Jiang, DG; Wang, LL				Dai, Huichao; Mao, Jingqiao; Jiang, Dingguo; Wang, Lingling			Longitudinal Hydrodynamic Characteristics in Reservoir Tributary Embayments and Effects on Algal Blooms	PLOS ONE			English	Article							MODEL; EUTROPHICATION	Three Gorges Reservoir (TGR) is one of the largest man-made lakes in the world. Since the impoundment in 2003, however, algal blooms have been often observed in the tributary embayments. To control the algal blooms, a thorough understanding of the hydrodynamics (e.g., flow regime, velocity gradient, and velocity magnitude and direction) in the tributary embayments is particularly important. Using a calibrated three-dimensional hydrodynamic model, we carried out a hydrodynamic analysis of a typical tributary embayment (i.e., Xiangxi Bay) with emphasis on the longitudinal patterns. The results show distinct longitudinal gradients of hydrodynamics in the study area, which can be generally characterized as four zones: riverine, intermediate, lacustrine, and mainstream influenced zones. Compared with the typical longitudinal zonation for a pure reservoir, there is an additional mainstream influenced zone near the mouth due to the strong effects of TGR mainstream. The blooms are prone to occur in the intermediate and lacustrine zones; however, the hydrodynamic conditions of riverine and mainstream influence zones are not propitious for the formation of algal blooms. This finding helps to diagnose the sensitive areas for algal bloom occurrence.	[Dai, Huichao; Mao, Jingqiao; Wang, Lingling] Hohai Univ, State Key Lab Hydrol Water Resources & Hydraul En, Nanjing, Jiangsu, Peoples R China; [Jiang, Dingguo] China Three Gorges Univ, Coll Civil & Hydroelect Engn, Yichang, Peoples R China	Hohai University; China Three Gorges University	Mao, JQ (corresponding author), Hohai Univ, State Key Lab Hydrol Water Resources & Hydraul En, Nanjing, Jiangsu, Peoples R China.	maojq@hhu.edu.cn			National Key Basic Research Program of China [2012CB417006]; National Science Fund for Distinguished Young Scholars [50925932]; National Natural Science Foundation of China [41001348, 51279047]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1233]	National Key Basic Research Program of China(National Basic Research Program of China); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This research is funded by the National Key Basic Research Program of China (2012CB417006), the National Science Fund for Distinguished Young Scholars (grant 50925932), the National Natural Science Foundation of China (grant 41001348, 51279047), and the Program for Changjiang Scholars and Innovative Research Team in University (IRT1233). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DM, 2002, ESTUARIES, V25, P704, DOI 10.1007/BF02804901; Cai Qing-Hua, 2006, Acta Hydrobiologica Sinica, V30, P7; Chanudet V, 2012, J GREAT LAKES RES, V38, P260, DOI 10.1016/j.jglr.2012.01.008; Chen CS, 2003, J ATMOS OCEAN TECH, V20, P159, DOI 10.1175/1520-0426(2003)020<0159:AUGFVT>2.0.CO;2; Choi KW, 2007, TECHNICAL NOTE ON VA; Cole RW, 1995, INSTRUCTION REP EL 9; Dai HC, 2006, J CONSTR ENG M, V132, P615, DOI 10.1061/(ASCE)0733-9364(2006)132:6(615); Danish Hydraulic Institute ( DHI), 2007, MIKE ZERO THE COMMON; Delft Hydraulics, 2006, DELFT 3D FLOW USER M; Dong Y., 2011, THESIS; Hamrick JM, 1996, SPECIAL REPORT 331; Huang Y. S., 2007, THESIS; Kimmel B.L., 1984, LAKE RESERV MANAGE, P277, DOI DOI 10.1080/07438148409354524; Lee JHW, 2004, J ENVIRON ENG-ASCE, V130, P535, DOI 10.1061/(ASCE)0733-9372(2004)130:5(535); Lindim C, 2011, ECOL MODEL, V222, P2485, DOI 10.1016/j.ecolmodel.2010.07.019; Mao JQ, 2009, WATER RES, V43, P4214, DOI 10.1016/j.watres.2009.06.012; Mao JQ, 2011, CHINA OCEAN ENG, V25, P625, DOI 10.1007/s13344-011-0050-5; Ministry of Environmental Protection of China ( MEPC), 2010, TECHNICAL GUIDELINE; Rodi W, 1980, IAHR MONOGRAPH; SCHINDLE.DW, 1974, J FISH RES BOARD CAN, V31, P937, DOI 10.1139/f74-110; Shao ML, 2010, J FRESHWATER ECOL, V25, P107, DOI 10.1080/02705060.2010.9664363; Shchepetkin AF, 2005, OCEAN MODEL, V9, P347, DOI 10.1016/j.ocemod.2004.08.002; Sheng YP, 1987, THREE DIMENSIONAL MA, P35; Thornton KW., 1990, RESERVOIR LIMNOLOGY; United States Environmental Protection Agency ( USEPA), 1974, NATIONAL EUTROPHICAT; van Maren DS, 2009, EARTH SURF PROC LAND, V34, P596, DOI 10.1002/esp.1760; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; Vollenweider R.A., 1968, TECHNICAL REPORT; Wang L, 2011, QUATERN INT, V244, P280, DOI 10.1016/j.quaint.2010.09.012; Wang LL, 2009, WATER SCI ENG, V2, P16, DOI 10.3882/j.issn.1674-2370.2009.01.002; Wang SH, 2005, HYDROBIOLOGIA, V541, P29, DOI 10.1007/s10750-004-4665-x; Wong KTM, 2007, ESTUAR COAST SHELF S, V74, P175, DOI 10.1016/j.ecss.2007.04.012; Yang G. S., 2007, YANGTZE CONSERVATION; Yang ZJ, 2010, SCI CHINA TECHNOL SC, V53, P1114, DOI 10.1007/s11431-009-0387-7; Ye L, 2007, ENVIRON MONIT ASSESS, V127, P135, DOI 10.1007/s10661-006-9267-9; Ye L, 2006, THESIS; Yi Z., 2009, J HYDROECOL, V2, P6; Zheng TG, 2011, SCI CHINA TECHNOL SC, V54, P1588, DOI 10.1007/s11431-011-4371-7	38	24	30	3	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e68186	10.1371/journal.pone.0068186	http://dx.doi.org/10.1371/journal.pone.0068186			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874534	Green Submitted, Green Published, gold			2022-12-27	WOS:000322218800016
J	Johnstone, DB; Ikizler, O; Zhang, JD; Holzman, LB				Johnstone, Duncan B.; Ikizler, Omer; Zhang, Jidong; Holzman, Lawrence B.			Background Strain and the Differential Susceptibility of Podocyte-Specific Deletion of Myh9 on Murine Models of Experimental Glomerulosclerosis and HIV Nephropathy	PLOS ONE			English	Article							DECAY-ACCELERATING FACTOR; NEPHROTOXIC NEPHRITIS; AFRICAN-AMERICANS; KIDNEY-DISEASE; MYH9-RELATED DISEASE; EUROPEAN-AMERICANS; BASEMENT-MEMBRANE; LUPUS NEPHRITIS; II-A; MICE	We previously reported that podocyte-specific deletion of Myh9 (conventional myosin heavy chain 2A) in C57BL/6 mice does not cause spontaneous kidney disease but instead results in a predisposition to glomerulosclerosis in response to a second model of glomerular injury. In contrast, other investigators reported that podocyte-specific deletion of Myh9 (Pod Delta Myh9) resulted in spontaneous glomerulosclerosis in mice on a mixed background, suggesting that the glomerulosclerosis is dependent on background strain. In order to elucidate the cause of this strain dependent effect Podocin::Cre and Myh9(flox) alleles were backcrossed to mouse strain FVB/N, which is highly susceptible to glomerulosclerosis, with the aim of intercrossing susceptible FVB/N and resistant C57BL/6 mice in subsequent congenic analyses. However, after backcrossing mice to FVB/N and aging mice to 28 weeks, we found no evidence of glomerular disease in Pod Delta Myh9 mice vs control littermates (urine MAC ratio all p > 0.05). We also tested C57BL/6 Pod Delta Myh9 mice for a predisposition to injury from models other than Adriamycin including HIV nephropathy (HIVAN), puromycin nephropathy, and sheep nephrotoxic serum. In the Tg26 model of HIVAN, we found that podocyte-specific deletion of Myh9 resulted in a modest hypersensitivity in adults compared to Tg26+ control littermates (urine MAC ratio, p < 0.05 or less). In contrast, we found that Pod Delta Myh9 mice were not predisposed to injury in response to other injury models including puromycin nephropathy and sheep nephrotoxic serum. While the mechanism of injury in these models is not fully understood, we conclude that Pod Delta Myh9 results in a variable susceptibility to glomerulosclerosis in response to different models of glomerular injury. In addition, based on the lack of a spontaneous phenotype of glomerulosclerosis in both C57BL/6 and FVB/N mice, we propose that Myh9 is not absolutely required in adult podocytes.	[Johnstone, Duncan B.] Temple Univ, Sch Med, Div Nephrol, Philadelphia, PA 19122 USA; [Ikizler, Omer; Zhang, Jidong; Holzman, Lawrence B.] Univ Penn, Sch Med, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA; [Holzman, Lawrence B.] Philadelphia VA Med Ctr, Philadelphia, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center	Johnstone, DB (corresponding author), Temple Univ, Sch Med, Div Nephrol, Philadelphia, PA 19122 USA.	duncan.johnstone@tuhs.temple.edu		Holzman, Lawrence/0000-0002-8961-234X	VA merit award;  [K08DK082616]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK082616] Funding Source: NIH RePORTER	VA merit award(US Department of Veterans Affairs); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Sources of funding for this study were K08DK082616 (to DBJ) and VA merit award (to LBH). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashley-Koch AE, 2011, BRIT J HAEMATOL, V155, P386, DOI 10.1111/j.1365-2141.2011.08832.x; Baleato RM, 2008, AM J PATHOL, V173, P927, DOI 10.2353/ajpath.2008.071149; Behar DM, 2010, HUM MOL GENET, V19, P1816, DOI 10.1093/hmg/ddq040; Conti MA, 2004, J BIOL CHEM, V279, P41263, DOI 10.1074/jbc.C400352200; Conti MA, 2008, J CELL SCI, V121, P11, DOI 10.1242/jcs.007112; Cooke JN, 2012, NEPHROL DIAL TRANSPL, V27, P1505, DOI 10.1093/ndt/gfr522; Duner F, 2010, NEPHRON EXP NEPHROL, V116, pE42, DOI 10.1159/000317130; Freedman BI, 2010, J AM SOC NEPHROL, V21, P1422, DOI 10.1681/ASN.2010070730; Freedman BI, 2010, AM J NEPHROL, V32, P66, DOI 10.1159/000314688; Genovese G, 2010, SCIENCE; Gharavi AG, 2004, P NATL ACAD SCI USA, V101, P2488, DOI 10.1073/pnas.0308649100; Hartleben B, 2010, J CLIN INVEST, V120, P1084, DOI 10.1172/JCI39492; Higashi AY, 2009, J IMMUNOL, V182, P5633, DOI 10.4049/jimmunol.0802413; Jacobelli J, 2010, NAT IMMUNOL, V11, P953, DOI 10.1038/ni.1936; Johnstone DB, 2011, MOL CELL BIOL, V31, P2162, DOI 10.1128/MCB.05234-11; Kaneko Y, 2006, J EXP MED, V203, P789, DOI 10.1084/jem.20051900; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; Klein J, 2010, J AM SOC NEPHROL, V21, P1157, DOI 10.1681/ASN.2009090887; KOPP JB, 1992, P NATL ACAD SCI USA, V89, P1577, DOI 10.1073/pnas.89.5.1577; Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226; Lee JY, 2006, J BIOL CHEM, V281, P2649, DOI 10.1074/jbc.M512373200; Lin CP, 2012, GENES IMMUN, V13, P232, DOI 10.1038/gene.2011.82; Lin F, 2004, J IMMUNOL, V172, P2636, DOI 10.4049/jimmunol.172.4.2636; Lin F, 2002, LAB INVEST, V82, P563, DOI 10.1038/labinvest.3780451; Machuca E, 2009, HUM MOL GENET, V18, pR185, DOI 10.1093/hmg/ddp328; Matsushita T, 2004, BIOCHEM BIOPH RES CO, V325, P1163, DOI 10.1016/j.bbrc.2004.10.147; Mhatre AN, 2007, NEUROMOL MED, V9, P205, DOI 10.1007/s12017-007-8008-8; Nadershahi A, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-14; Nelson GW, 2010, HUM MOL GENET, V19, P1805, DOI 10.1093/hmg/ddq039; O'Seaghdha CM, 2011, HUM MOL GENET, V20, P2450, DOI 10.1093/hmg/ddr118; Papeta N, 2011, J AM SOC NEPHROL, V22, P1991, DOI 10.1681/ASN.2011040434; Papeta N, 2010, J CLIN INVEST, V120, P4055, DOI 10.1172/JCI43721; Papeta N, 2009, J CLIN INVEST, V119, P1178, DOI 10.1172/JCI37131; Salamov AA, 1998, BIOINFORMATICS, V14, P384, DOI 10.1093/bioinformatics/14.5.384; Seri M, 2003, MEDICINE, V82, P203, DOI 10.1097/00005792-200305000-00006; Shinozaki M, 2002, J CLIN INVEST, V109, P951, DOI 10.1172/JCI200214574; Singh N, 2009, AM J KIDNEY DIS, V54, P732, DOI 10.1053/j.ajkd.2009.06.023; Tzur S, 2010, HUM GENET; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Wang LM, 2005, J AM SOC NEPHROL, V16, P3611, DOI 10.1681/ASN.2005020167; Wyatt CM, 2012, ANNU REV MED, V63, P147, DOI 10.1146/annurev-med-041610-134224; Yanagita M, 2002, J CLIN INVEST, V110, P239, DOI 10.1172/JCI200214861; Zhang YF, 2012, BLOOD, V119, P238, DOI 10.1182/blood-2011-06-358853	43	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e67839	10.1371/journal.pone.0067839	http://dx.doi.org/10.1371/journal.pone.0067839			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874454	Green Submitted, gold, Green Published			2022-12-27	WOS:000321765300014
J	Kubota, T; Koiwai, O; Hori, K; Watanabe, N; Koiwai, K				Kubota, Takashi; Koiwai, Osamu; Hori, Katsutoshi; Watanabe, Nobuhisa; Koiwai, Kotaro			TdIF1 Recognizes a Specific DNA Sequence through Its Helix-Turn-Helix and AT-Hook Motifs to Regulate Gene Transcription	PLOS ONE			English	Article							HISTONE DEACETYLASE; TERMINAL DEOXYNUCLEOTIDYLTRANSFERASE; BINDING SPECIFICITY; TDT ACTIVITY; TREP-132; PROTEIN; EXPRESSION; REVEALS; CANCER; CELLS	TdIF1 was originally identified as a protein that directly binds to DNA polymerase TdT. TdIF1 is also thought to function in transcription regulation, because it binds directly to the transcriptional factor TReP-132, and to histone deacetylases HDAC1 and HDAC2. Here we show that TdIF1 recognizes a specific DNA sequence and regulates gene transcription. By constructing TdIF1 mutants, we identify amino acid residues essential for its interaction with DNA. An in vitro DNA selection assay, SELEX, reveals that TdIF1 preferentially binds to the sequence 5'-GNTGCATG-3' following an AT-tract, through its Helix-Turn-Helix and AT-hook motifs. We show that four repeats of this recognition sequence allow TdIF1 to regulate gene transcription in a plasmid-based luciferase reporter assay. We demonstrate that TdIF1 associates with the RAB20 promoter, and RAB20 gene transcription is reduced in TdIF1-knocked-down cells, suggesting that TdIF1 stimulates RAB20 gene transcription.	[Kubota, Takashi; Koiwai, Osamu; Koiwai, Kotaro] Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, Noda, Chiba 278, Japan; [Hori, Katsutoshi; Koiwai, Kotaro] Nagoya Univ, Grad Sch Engn, Dept Biotechnol, Nagoya, Aichi 4648601, Japan; [Watanabe, Nobuhisa] Nagoya Univ, NUSR, Nagoya, Aichi 4648601, Japan	Tokyo University of Science; Nagoya University; Nagoya University	Koiwai, K (corresponding author), Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, Noda, Chiba 278, Japan.	koiwai@nubio.nagoya-u.ac.jp	Kubota, Takashi/AAO-3339-2021; Hori, Katsutoshi/K-5289-2012	Kubota, Takashi/0000-0001-7316-5381; Hori, Katsutoshi/0000-0003-1994-3124; Koiwai, Kotaro/0000-0002-9684-3699				Aghdassi A, 2012, GUT, V61, P439, DOI 10.1136/gutjnl-2011-300060; Amillet JM, 2006, HUM PATHOL, V37, P256, DOI 10.1016/j.humpath.2005.10.017; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4413, DOI 10.1093/nar/26.19.4413; Bantscheff M, 2011, NAT BIOTECHNOL, V29, P255, DOI 10.1038/nbt.1759; Bayer TS, 2005, RNA, V11, P1848, DOI 10.1261/rna.2167605; Beishline K, 2012, MOL CELL BIOL, V32, P3790, DOI 10.1128/MCB.00049-12; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DEJONG R, 1993, NUCLEIC ACIDS RES, V21, P4711, DOI 10.1093/nar/21.20.4711; Fujisaki S, 2006, GENES CELLS, V11, P47, DOI 10.1111/j.1365-2443.2005.00916.x; GILFILLAN S, 1993, SCIENCE, V261, P1175, DOI 10.1126/science.8356452; Gizard F, 2005, MOL CELL BIOL, V25, P4335, DOI 10.1128/MCB.25.11.4335-4348.2005; Gizard F, 2004, J MOL ENDOCRINOL, V32, P557, DOI 10.1677/jme.0.0320557; Gizard F, 2002, J BIOL CHEM, V277, P39144, DOI 10.1074/jbc.M205786200; Gizard F, 2001, J BIOL CHEM, V276, P33881, DOI 10.1074/jbc.M100113200; Gizard F, 2006, MOL CELL BIOL, V26, P7632, DOI 10.1128/MCB.00326-06; Hackenbeck T, 2011, BBA-MOL CELL RES, V1813, P1, DOI 10.1016/j.bbamcr.2010.10.019; Hao Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002065; HARRISON SC, 1990, ANNU REV BIOCHEM, V59, P933, DOI 10.1146/annurev.bi.59.070190.004441; Hayano T, 2009, GENES CELLS, V14, P1415, DOI 10.1111/j.1365-2443.2009.01358.x; Huang NW, 2005, MOL ENDOCRINOL, V19, P409, DOI 10.1210/me.2004-0086; Huth JR, 1997, NAT STRUCT BIOL, V4, P657, DOI 10.1038/nsb0897-657; Ito K, 2000, MOL CELL BIOL, V20, P6891, DOI 10.1128/MCB.20.18.6891-6903.2000; Kao HY, 2000, GENE DEV, V14, P55; Kim DW, 2003, J BIOL CHEM, V278, P27532, DOI 10.1074/jbc.M301461200; KOMORI T, 1993, SCIENCE, V261, P1171, DOI 10.1126/science.8356451; Kubota T, 2007, GENES CELLS, V12, P941, DOI 10.1111/j.1365-2443.2007.01105.x; Liang YJ, 2012, NEUROSCI LETT, V527, P110, DOI 10.1016/j.neulet.2012.08.039; Lu H, 2012, J BIOL CHEM; LU Q, 1994, MOL CELL BIOL, V14, P3938, DOI 10.1128/MCB.14.6.3938; Macmaster R, 2006, NUCLEIC ACIDS RES, V34, P5577, DOI 10.1093/nar/gkl447; Maezawa S, 2008, GENES CELLS, V13, P439, DOI 10.1111/j.1365-2443.2008.01179.x; Monteiro LJ, 2012, ONCOGENE; Nair AR, 2001, CANCER LETT, V166, P55, DOI 10.1016/S0304-3835(01)00418-9; Oleaga C, 2012, BIOCH PHARM; REEVES R, 1990, J BIOL CHEM, V265, P8573; Robertson G, 2006, NUCLEIC ACIDS RES, V34, pD68, DOI 10.1093/nar/gkj075; Segre CV, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/690848; Sleumer MC, 2009, NUCLEIC ACIDS RES, V37, P1323, DOI 10.1093/nar/gkn1041; SOLOMON MJ, 1986, P NATL ACAD SCI USA, V83, P1276, DOI 10.1073/pnas.83.5.1276; Takahashi K, 2006, J IMMUNOL, V177, P4605, DOI 10.4049/jimmunol.177.7.4605; Taplick J, 2001, J MOL BIOL, V308, P27, DOI 10.1006/jmbi.2001.4569; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Warren AJ, 2002, CURR OPIN STRUC BIOL, V12, P107, DOI 10.1016/S0959-440X(02)00296-8; Yamashita N, 2001, GENES CELLS, V6, P641, DOI 10.1046/j.1365-2443.2001.00449.x; Yamtich J, 2010, BBA-PROTEINS PROTEOM, V1804, P1136, DOI 10.1016/j.bbapap.2009.07.008; Yoshida M, 2001, CANCER CHEMOTH PHARM, V48, pS20, DOI 10.1007/s002800100300	46	4	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e66710	10.1371/journal.pone.0066710	http://dx.doi.org/10.1371/journal.pone.0066710			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874396	gold, Green Published, Green Submitted			2022-12-27	WOS:000321765300004
J	Lin, D; Yin, X; Wang, XL; Zhou, P; Guo, FB				Lin, Dan; Yin, Xin; Wang, Xianlong; Zhou, Peng; Guo, Feng-Biao			Re-Annotation of Protein-Coding Genes in the Genome of Saccharomyces cerevisiae Based on Support Vector Machines	PLOS ONE			English	Article							YEAST GENOME; CODON USAGE; RECOGNITION; SGD	The annotation of the well-studied organism, Saccharomyces cerevisiae, has been improving over the past decade while there are unresolved debates over the amount of biologically significant open reading frames (ORFs) in yeast genome. We revisited the total count of protein-coding genes in S. cerevisiae S288c genome using a theoretical approach by combining the Support Vector Machine (SVM) method with six widely used measurements of sequence statistical features. The accuracy of our method is over 99.5% in 10-fold cross-validation. Based on the annotation data in Saccharomyces Genome Database (SGD), we studied the coding capacity of all 1744 ORFs which lack experimental results and suggested that the overall number of chromosomal ORFs encoding proteins in yeast should be 6091 by removing 488 spurious ORFs. The importance of the present work lies in at least two aspects. First, cross-validation and retrospective examination showed the fidelity of our method in recognizing ORFs that likely encode proteins. Second, we have provided a web service that can be accessed at http://cobi.uestc.edu.cn/services/yeast/, which enables the prediction of protein-coding ORFs of the genus Saccharomyces with a high accuracy.	[Lin, Dan; Yin, Xin; Wang, Xianlong; Zhou, Peng; Guo, Feng-Biao] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Ctr Bioinformat, Chengdu 610054, Peoples R China	University of Electronic Science & Technology of China	Guo, FB (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci & Technol, Ctr Bioinformat, Chengdu 610054, Peoples R China.	fbguo@uestc.edu.cn	Guo, Feng-Biao/C-2761-2015; Wang, Xianlong/P-7722-2014; Wang, Xianlong/AFU-4519-2022	Guo, Feng-Biao/0000-0002-1129-5233; Wang, Xianlong/0000-0001-8195-2027; Wang, Xianlong/0000-0001-8195-2027; Zhou, Peng/0000-0001-5681-9937	program for New Century Excellent Talents in University [NCET-11-0059]; National Natural Science Foundation of China [31071109]; China Postdoctoral Science Foundation [201104687]	program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This study was supported by the program for New Century Excellent Talents in University (NCET-11-0059), National Natural Science Foundation of China (grant 31071109), and the special fund of the China Postdoctoral Science Foundation (Grant 201104687). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIBB MJ, 1984, GENE, V30, P157, DOI 10.1016/0378-1119(84)90116-1; Blandin G, 2000, FEBS LETT, V487, P31, DOI 10.1016/S0014-5793(00)02275-4; Brachat S, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r45; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen LL, 2003, BIOCHEM BIOPH RES CO, V306, P310, DOI 10.1016/S0006-291X(03)00973-2; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Dujon B, 1996, TRENDS GENET, V12, P263, DOI 10.1016/0168-9525(96)10027-5; FICKETT JW, 1992, NUCLEIC ACIDS RES, V20, P6441, DOI 10.1093/nar/20.24.6441; Fisk DG, 2006, YEAST, V23, P857, DOI 10.1002/yea.1400; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Guo FB, 2004, DNA RES, V11, P361, DOI 10.1093/dnares/11.6.361; Hirschman JE, 2006, NUCLEIC ACIDS RES, V34, pD442, DOI 10.1093/nar/gkj117; Jacquier A, 2009, NAT REV GENET, V10, P833, DOI 10.1038/nrg2683; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Li QR, 2008, GENOME RES, V18, P1294, DOI 10.1101/gr.076661.108; Luo LF, 2003, COMP FUNCT GENOM, V4, P318, DOI 10.1002/cfg.292; Mackiewicz P, 2002, YEAST, V19, P619, DOI 10.1002/yea.865; Mewes HW, 1997, NATURE, V387, P7, DOI 10.1038/387s007; Pena-Castillo L, 2007, GENETICS, V176, P7, DOI 10.1534/genetics.107.074468; Piskur J, 2004, MOL MICROBIOL, V53, P381, DOI 10.1111/j.1365-2958.2004.04182.x; SHARP PM, 1991, YEAST, V7, P657, DOI 10.1002/yea.320070702; SHEPHERD JCW, 1981, P NATL ACAD SCI-BIOL, V78, P1596, DOI 10.1073/pnas.78.3.1596; Siew N, 2003, COMP FUNCT GENOM, V4, P432, DOI 10.1002/cfg.311; Wood V, 2001, COMP FUNCT GENOM, V2, P143, DOI 10.1002/cfg.86; Zhang CT, 2000, NUCLEIC ACIDS RES, V28, P2804, DOI 10.1093/nar/28.14.2804	27	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e64477	10.1371/journal.pone.0064477	http://dx.doi.org/10.1371/journal.pone.0064477			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874379	Green Submitted, Green Published, gold			2022-12-27	WOS:000321765300001
J	Polly, PD; Polyakov, AV; Ilyashenko, VB; Onischenko, SS; White, TA; Shchipanov, NA; Bulatova, NS; Pavlova, SV; Borodin, PM; Searle, JB				Polly, P. David; Polyakov, Andrei V.; Ilyashenko, Vadim B.; Onischenko, Sergei S.; White, Thomas A.; Shchipanov, Nikolay A.; Bulatova, Nina S.; Pavlova, Svetlana V.; Borodin, Pavel M.; Searle, Jeremy B.			Phenotypic Variation across Chromosomal Hybrid Zones of the Common Shrew (Sorex araneus) Indicates Reduced Gene Flow	PLOS ONE			English	Article							KARYOTYPIC RACES; ROBERTSONIAN HETEROZYGOTES; MORPHOLOGICAL INTEGRATION; METACENTRIC CHROMOSOMES; MORPHOMETRIC VARIATION; NATURAL HYBRIDIZATION; GEOMETRIC SHAPE; EVOLUTION; INSECTIVORA; SORICIDAE	Sorex araneus, the Common shrew, is a species with more than 70 karyotypic races, many of which form parapatric hybrid zones, making it a model for studying chromosomal speciation. Hybrids between races have reduced fitness, but microsatellite markers have demonstrated considerable gene flow between them, calling into question whether the chromosomal barriers actually do contribute to genetic divergence. We studied phenotypic clines across two hybrid zones with especially complex heterozygotes. Hybrids between the Novosibirsk and Tomsk races produce chains of nine and three chromosomes at meiosis, and hybrids between the Moscow and Seliger races produce chains of eleven. Our goal was to determine whether phenotypes show evidence of reduced gene flow at hybrid zones. We used maximum likelihood to fit tanh cline models to geometric shape data and found that phenotypic clines in skulls and mandibles across these zones had similar centers and widths as chromosomal clines. The amount of phenotypic differentiation across the zones is greater than expected if it were dissipating due to unrestricted gene flow given the amount of time since contact, but it is less than expected to have accumulated from drift during allopatric separation in glacial refugia. Only if heritability is very low, Ne very high, and the time spent in allopatry very short, will the differences we observe be large enough to match the expectation of drift. Our results therefore suggest that phenotypic differentiation has been lost through gene flow since post-glacial secondary contact, but not as quickly as would be expected if there was free gene flow across the hybrid zones. The chromosomal tension zones are confirmed to be partial barriers that prevent differentiated races from becoming phenotypically homogenous.	[Polly, P. David] Indiana Univ, Dept Geol Sci, Bloomington, IN 47405 USA; [Polly, P. David] Indiana Univ, Dept Biol, Bloomington, IN USA; [Polyakov, Andrei V.; Borodin, Pavel M.] Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, Novosibirsk 630090, Russia; [Ilyashenko, Vadim B.; Onischenko, Sergei S.] Kemerovo State Univ, Dept Zool & Ecol, Kemerovo 650043, Russia; [White, Thomas A.; Searle, Jeremy B.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA; [White, Thomas A.] Univ Bern, Inst Ecol & Evolut, Computat & Mol Populat Genet CMPG Lab, Bern, Switzerland; [Shchipanov, Nikolay A.; Bulatova, Nina S.; Pavlova, Svetlana V.] Russian Acad Sci, AN Severtsov Inst Ecol & Evolut, Moscow, Russia; [Searle, Jeremy B.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Kemerovo State University; Cornell University; University of Bern; Russian Academy of Sciences; Saratov Scientific Center of the Russian Academy of Sciences; Severtsov Institute of Ecology & Evolution; University of York - UK	Polly, PD (corresponding author), Indiana Univ, Dept Geol Sci, Bloomington, IN 47405 USA.	pdpolly@indiana.edu	Shchipanov, Nikolay A/A-6109-2017; Borodin, Pavel/E-4852-2011; Pavlova, Svetlana V/ABH-1527-2020; Polly, P. David/ABC-6597-2020	Shchipanov, Nikolay A/0000-0002-8800-8837; Borodin, Pavel/0000-0002-6717-844X; Pavlova, Svetlana V/0000-0001-7823-9618; Polly, P. David/0000-0001-7338-8526; Searle, Jeremy/0000-0001-7710-5204	INTAS Cooperation Project grant; Russian Foundation for Basic Research (RFBR)	INTAS Cooperation Project grant; Russian Foundation for Basic Research (RFBR)(Russian Foundation for Basic Research (RFBR))	The authors are grateful to an INTAS Cooperation Project grant and the Russian Foundation for Basic Research (RFBR) for funding the study of the Novosibirsk-Tomsk and Moscow-Seliger hybrid zones. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson AC, 2005, MOL ECOL, V14, P2703, DOI 10.1111/j.1365-294X.2005.02584.x; Andersson AC, 2004, MOL ECOL, V13, P1205, DOI 10.1111/j.1365-294X.2004.02146.x; ANISKIN VM, 1989, DOKL AKAD NAUK SSSR+, V309, P1260; ANISKIN VM, 1981, GENETIKA+, V17, P1784; Ayala FJ, 2005, P NATL ACAD SCI USA, V102, P6535, DOI 10.1073/pnas.0501847102; Banaszek A, 2000, HEREDITY, V84, P570, DOI 10.1046/j.1365-2540.2000.00701.x; Banaszek A, 2003, MAMMALIA, V67, P217, DOI 10.1515/mamm.2003.67.2.217; BARTON NH, 1979, HEREDITY, V43, P341, DOI 10.1038/hdy.1979.87; Basset P, 2006, EVOLUTION, V60, P1718; BENGTSSON BO, 1990, J EVOLUTION BIOL, V3, P85, DOI 10.1046/j.1420-9101.1990.3010085.x; Borodin Alexander V., 1996, Acta Zoologica Cracoviensia, V39, P75; Borodin PM, 2008, GENETICS, V133, P649; Bulatova N, 2011, J EVOLUTION BIOL, V24, P573, DOI 10.1111/j.1420-9101.2010.02191.x; Bulatova Nina S., 2007, Russian Journal of Theriology, V6, P111; BUTLIN RK, 1991, PHILOS T R SOC B, V334, P297, DOI 10.1098/rstb.1991.0119; CHEVERUD JM, 1988, EVOLUTION, V42, P958, DOI 10.1111/j.1558-5646.1988.tb02514.x; Churchfield S., 1990, NATURAL HIST SHREWS; Dryden IL, 1998, STAT SHAPE ANAL, DOI DOI 10.5555/1046920.1088707; Ehrich TH, 2003, J EXP ZOOL PART B, V296B, P58, DOI 10.1002/jez.b.00009; Endler J.A., 1977, Monographs in Population Biology, pi; Fedyk S, 2010, ACTA THERIOL, V55, P1, DOI 10.4098/j.at.0001-7051.048.2009; FRYKMAN I, 1984, HEREDITAS, V100, P259, DOI 10.1111/j.1601-5223.1984.tb00127.x; Gay L, 2008, EVOLUTION, V62, P2789, DOI 10.1111/j.1558-5646.2008.00491.x; Grigoryeva OO, 2011, BIOL BULL+, V38, P425, DOI 10.1134/S1062359011050062; Grigoryeva OO, 2011, DOKL BIOCHEM BIOPHYS, V436, P41, DOI 10.1134/S1607672911010133; HAUSSER J, 1991, Memoires de la Societe Vaudoise des Sciences Naturelles, V19, P79; HAUSSER J, 1994, FOLIA ZOOL, V43, P1; HAUSSER J, 1974, Mammalia, V38, P324, DOI 10.1515/mamm.1974.38.2.324; Hausser J., 1990, HDB SAUGETIERE EUROP, V3, P237; Holsinger KE, 2009, NAT REV GENET, V10, P639, DOI 10.1038/nrg2611; Horn A, 2012, EVOLUTION, V66, P882, DOI 10.1111/j.1558-5646.2011.01478.x; Jadwiszczak KA, 2006, MAMM BIOL, V71, P257, DOI 10.1016/j.mambio.2006.02.004; Jadwiszczak KA, 2006, BIOL J LINN SOC, V89, P79, DOI 10.1111/j.1095-8312.2006.00659.x; Jones RM, 2003, MAMMALIA, V67, P193, DOI 10.1515/mamm.2003.67.2.193; King M., 1993, SPECIES EVOLUTION; Klingenberg CP, 2004, GENETICS, V166, P1909, DOI 10.1534/genetics.166.4.1909; Klingenberg CP, 2001, EVOLUTION, V55, P2342; Klingenberg CP, 2001, AM NAT, V157, P11, DOI 10.1086/317002; Kral B, 1974, FOLIA ZOOL, V23, P217; LANDE R, 1976, EVOLUTION, V30, P314, DOI 10.1111/j.1558-5646.1976.tb00911.x; Leamy LJ, 2008, HEREDITY, V101, P518, DOI 10.1038/hdy.2008.79; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; LUKACOVA L, 1994, FOLIA ZOOL, V43, P37; Manly BFJ., 2017, RANDOMIZATION MONTE, DOI 10.1201/9781315273075; Mishta Alina V., 2007, Russian Journal of Theriology, V6, P51; Narain Y, 1997, CYTOGENET CELL GENET, V78, P253, DOI 10.1159/000134668; Navarro A, 2003, EVOLUTION, V57, P447, DOI 10.1554/0014-3820(2003)057[0447:APIGIP]2.0.CO;2; Noor MAF, 2001, P NATL ACAD SCI USA, V98, P12084, DOI 10.1073/pnas.221274498; Panithanarak T, 2004, EVOLUTION, V58, P184; Pialek J, 2001, MOL ECOL, V10, P613, DOI 10.1046/j.1365-294x.2001.01209.x; Polly P. D., 2012, GEOMETRIC MORPHOMETR; Polly P. David, 2007, Russian Journal of Theriology, V6, P73; Polly PD, 2001, GENETICA, V112, P339, DOI 10.1023/A:1013395907225; Polyakov AV, 2011, J EVOLUTION BIOL, V24, P1393, DOI 10.1111/j.1420-9101.2011.02266.x; Polyakov AV, 2002, ACTA THERIOL, V47, P381, DOI 10.1007/BF03192464; Polyakov AV, 2001, RUSS J GENET+, V37, P351, DOI 10.1023/A:1016690023394; Polyakov AV, 1996, HEREDITAS, V125, P109, DOI 10.1111/j.1601-5223.1996.00109.x; Ratkiewicz M, 2002, HEREDITY, V88, P235, DOI 10.1038/sj.hdy.6800032; Rieseberg LH, 2001, TRENDS ECOL EVOL, V16, P351, DOI 10.1016/S0169-5347(01)02187-5; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Rzebik-Kowalska B, 1993, EVOLUTION SHREWS, P23; SEABRIGH.M, 1971, LANCET, V2, P971; SEARLE J B, 1991, Memoires de la Societe Vaudoise des Sciences Naturelles, V19, P13; SEARLE JB, 1986, PROC R SOC SER B-BIO, V229, P277, DOI 10.1098/rspb.1986.0086; SEARLE JB, 1984, SYST ZOOL, V33, P184, DOI 10.2307/2413019; SEARLE JB, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P309; SEARLE JB, 1987, J ZOOL, V212, P373, DOI 10.1111/j.1469-7998.1987.tb06003.x; Searle JB, 1998, EVOLUTION SHREWS, P173; Serdyuk NV, 2006, PALEONTOL J+, V40, pS501, DOI 10.1134/S0031030106100108; Shchipanov NA, 2011, RUSS J GENET+, V47, P66, DOI 10.1134/S1022795411010121; Shchipanov NA., 2005, ADV BIOL SHREWS 2, P201; SPITZE K, 1993, GENETICS, V135, P367; Sprito F, 2000, ENDLESS FORMS SPECIE, P320; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; White M.J.D., 1978, MODES SPECIATION; White TA, 2010, SYST BIOL, V59, P262, DOI 10.1093/sysbio/syq004; Wojcik AM, 2006, EVOLUTION, V60, P1925; WOJCIK JM, 1993, ACTA THERIOL, V38, P315, DOI 10.4098/AT.arch.93-27; Wojcik JM, 2003, MAMMALIA, V67, P169, DOI 10.1515/mamm.2003.67.2.169; Wojcik JM, 2002, ACTA THERIOL, V47, P139, DOI 10.1007/BF03192485; Wojcik JM, 2000, ACTA THERIOL, V45, P161, DOI 10.4098/AT.arch.00-71; Wright S, 1931, GENETICS, V16, P0097; Wright S., 1968, EVOLUTION GENETICS P, P373; Wyttenbach A, 1998, CYTOGENET CELL GENET, V83, P199, DOI 10.1159/000015178; Wyttenbach A, 1996, HEREDITAS, V125, P209, DOI 10.1111/j.1601-5223.1996.00209.x; Yannic G, 2009, HEREDITY, V102, P616, DOI 10.1038/hdy.2009.19; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR	87	21	23	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e67455	10.1371/journal.pone.0067455	http://dx.doi.org/10.1371/journal.pone.0067455			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874420	Green Published, Green Submitted, gold			2022-12-27	WOS:000321765300010
J	Demakakos, P; Cooper, R; Hamer, M; de Oliveira, C; Hardy, R; Breeze, E				Demakakos, Panayotes; Cooper, Rachel; Hamer, Mark; de Oliveira, Cesar; Hardy, Rebecca; Breeze, Elizabeth			The Bidirectional Association between Depressive Symptoms and Gait Speed: Evidence from the English Longitudinal Study of Ageing (ELSA)	PLOS ONE			English	Article							PHYSICAL PERFORMANCE; OLDER-ADULTS; LATE-LIFE; FUNCTIONAL LIMITATIONS; CHRONIC ILLNESS; SOCIAL SUPPORT; RISK-FACTORS; DISABILITY; DECLINE; HEALTH	Background: Depressive symptoms and physical performance are inversely associated, but it is unclear whether their association is bidirectional. We examined whether the association between depressive symptoms and physical performance measured using gait speed is bidirectional. Methods: We used a national sample of 4,581 community-dwelling people aged 60 years and older from the English Longitudinal Study of Ageing (from 2002-03 to 2008-09). We fitted Generalized Estimating Equation (GEE) regression models to analyse repeated measurements of gait speed (m/sec) and elevated depressive symptoms (defined as a score of >= 4 on the eight-item Center for Epidemiological Studies-Depression scale). Results: Slower gait speed was associated with elevated depressive symptoms both concurrently and two years later. After adjustment for previous depressive symptoms and sociodemographic, clinical, lifestyle, psychosocial, and cognitive factors the concurrent association was partially explained (Odds Ratio [OR] 0.42, 95% confidence interval [CI], 0.30 to 0.59, per 1m/sec increase in gait speed) and the two-year lagged association fully (OR 0.75, 95% CI, 0.56 to 1.00). Elevated depressive symptoms were associated with slower gait speed. Full adjustment for covariates (including previous gait speed) partially explained both the concurrent (beta regression coefficient [beta] -0.038, 95% CI, -0.050 to -0.026, for participants with elevated depressive symptoms compared with those with no or one symptom) and the two-year lagged associations (beta -0.017, 95% CI, -0.030 to -0.005). Subthreshold depressive symptoms (defined as a score of two or three on the eight-item Center for Epidemiological Studies-Depression scale) were also associated with slower gait speed. Full adjustment for covariates partially explained both the concurrent (beta -0.029, 95% CI, -0.039 to -0.019, for participants with subthreshold symptoms compared with those with no or one symptom) and the two-year lagged associations (beta -0.011, 95% CI, -0.021 to -0.001). Conclusions: The inverse association between gait speed and depressive symptoms appears to be bidirectional.	[Demakakos, Panayotes; Hamer, Mark; de Oliveira, Cesar; Breeze, Elizabeth] UCL, Dept Epidemiol & Publ Hlth, London, England; [Cooper, Rachel; Hardy, Rebecca] UCL, MRC, Unit Lifelong Hlth & Ageing, London, England	University of London; University College London; University of London; University College London	Demakakos, P (corresponding author), UCL, Dept Epidemiol & Publ Hlth, London, England.	p.demakakos@ucl.ac.uk	Hamer, Mark/C-1602-2008; de Oliveira, Cesar/B-5251-2019; Hardy, Rebecca/AFR-1989-2022; Cooper, Rachel/ABE-3768-2021; Breeze, Elizabeth/AAK-4927-2021; Hamer, Mark/AAJ-6814-2021	Hamer, Mark/0000-0002-8726-7992; Cooper, Rachel/0000-0003-3370-5720; Hamer, Mark/0000-0002-8726-7992; Demakakos, Panayotes/0000-0002-7663-2122; De Oliveira, Cesar/0000-0002-4099-4762; Hardy, Rebecca/0000-0001-9949-0799	National Institute on Aging [2RO1AG7644-01A1, 2RO1AG017644]; consortium of the United Kingdom government department (Department for Education and Skills); consortium of the United Kingdom government department (Department for Environment, Food, and Rural Affairs); consortium of the United Kingdom government department (Department of Health); consortium of the United Kingdom government department (Department of Trade and Industry); consortium of the United Kingdom government department (Department for Work and Pensions); consortium of the United Kingdom government department (HM Treasury Inland Revenue); consortium of the United Kingdom government department (Office of the Deputy Prime Minister); consortium of the United Kingdom government department (Office for National Statistics); MRC [MC_U123092724] Funding Source: UKRI; Medical Research Council [MC_U123092724] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [R01AG017644] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); consortium of the United Kingdom government department (Department for Education and Skills); consortium of the United Kingdom government department (Department for Environment, Food, and Rural Affairs); consortium of the United Kingdom government department (Department of Health); consortium of the United Kingdom government department (Department of Trade and Industry); consortium of the United Kingdom government department (Department for Work and Pensions); consortium of the United Kingdom government department (HM Treasury Inland Revenue); consortium of the United Kingdom government department (Office of the Deputy Prime Minister); consortium of the United Kingdom government department (Office for National Statistics); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was not supported by any third party. The English Longitudinal Study of Ageing is supported by the National Institute on Aging (Grants 2RO1AG7644-01A1 and 2RO1AG017644) and a consortium of the United Kingdom government departments (i.e. the Department for Education and Skills; Department for Environment, Food, and Rural Affairs; Department of Health; Department of Trade and Industry; Department for Work and Pensions; the HM Treasury Inland Revenue; the Office of the Deputy Prime Minister; and the Office for National Statistics) coordinated by the Office for National Statistics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbaraly TN, 2009, DIABETES CARE, V32, P499, DOI 10.2337/dc08-1358; Blazer DG, 2003, J GERONTOL A-BIOL, V58, P249; Bromberger JT, 2009, MATURITAS, V64, P145, DOI 10.1016/j.maturitas.2009.09.017; Bruce ML, 2001, AM J GERIAT PSYCHIAT, V9, P102, DOI 10.1176/appi.ajgp.9.2.102; BRUCE ML, 1994, AM J PUBLIC HEALTH, V84, P1796, DOI 10.2105/AJPH.84.11.1796; Carbonare LD, 2009, AM J GERIAT PSYCHIAT, V17, P144, DOI 10.1097/JGP.0b013e31818af817; Cesari M, 2004, J GERONTOL A-BIOL, V59, P242; Chang M, 2009, AGING CLIN EXP RES, V21, P191, DOI 10.1007/BF03325228; Clarke P, 2011, J GERONTOL B-PSYCHOL, V66, P457, DOI 10.1093/geronb/gbr054; Cole MG, 2003, AM J PSYCHIAT, V160, P1147, DOI 10.1176/appi.ajp.160.6.1147; Cooper R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4467; Cooper R, 2011, J GERONTOL B-PSYCHOL, V66, P468, DOI 10.1093/geronb/gbr049; Cronin-Stubbs D, 2000, ARCH INTERN MED, V160, P3074, DOI 10.1001/archinte.160.20.3074; den Ouden MEM, 2011, MATURITAS, V69, P208, DOI 10.1016/j.maturitas.2011.04.008; Dumurgier J, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4460; Everson-Rose SA, 2005, PSYCHOSOM MED, V67, P609, DOI 10.1097/01.psy.0000170334.77508.35; Gayman MD, 2008, J GERONTOL B-PSYCHOL, V63, pS219, DOI 10.1093/geronb/63.4.S219; Geerlings SW, 2001, PSYCHOL MED, V31, P1361, DOI 10.1017/S0033291701004639; Guralnik JM, 2000, J GERONTOL A-BIOL, V55, pM221, DOI 10.1093/gerona/55.4.M221; Guralnik JM, 2003, AM J PREV MED, V25, P112, DOI 10.1016/S0749-3797(03)00174-0; Herring MP, 2012, ARCH INTERN MED, V172, P101, DOI 10.1001/archinternmed.2011.696; Hybels CF, 2009, PSYCHOL MED, V39, P1677, DOI 10.1017/S0033291709005650; Kelley-Moore JA, 2005, J HEALTH SOC BEHAV, V46, P376, DOI 10.1177/002214650504600405; Landi F, 2007, AGE AGEING, V36, P514, DOI 10.1093/ageing/afm105; Lee Y, 2008, INT J GERIATR PSYCH, V23, P249, DOI 10.1002/gps.1870; Lenze EJ, 2005, J AM GERIATR SOC, V53, P569, DOI 10.1111/j.1532-5415.2005.53202.x; Lenze EJ, 2001, AM J GERIAT PSYCHIAT, V9, P113, DOI 10.1176/appi.ajgp.9.2.113; Liang J, 2008, J GERONTOL B-PSYCHOL, V63, pS282, DOI 10.1093/geronb/63.5.S282; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Meeks S, 2000, PSYCHOL AGING, V15, P100, DOI 10.1037//0882-7974.15.1.100; Ormel J, 2002, J GERONTOL B-PSYCHOL, V57, pP338, DOI 10.1093/geronb/57.4.P338; Penninx BWJH, 1998, JAMA-J AM MED ASSOC, V279, P1720, DOI 10.1001/jama.279.21.1720; Penninx BWJH, 2000, J AFFECT DISORDERS, V61, P1, DOI 10.1016/S0165-0327(00)00152-X; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Sanders JB, 2012, J AM GERIATR SOC, V60, P1673, DOI 10.1111/j.1532-5415.2012.04114.x; Schieman S, 2007, J GERONTOL B-PSYCHOL, V62, pS36, DOI 10.1093/geronb/62.1.S36; Schillerstrom JE, 2008, J GERIATR PSYCH NEUR, V21, P183, DOI 10.1177/0891988708320971; Schnittker J, 2005, SOC SCI MED, V60, P13, DOI 10.1016/j.socscimed.2004.04.020; Steffick D. E., 2000, DR005 HRSAHEAD; Stuck AE, 1999, SOC SCI MED, V48, P445, DOI 10.1016/S0277-9536(98)00370-0; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Taylor MG, 2004, J GERONTOL B-PSYCHOL, V59, pS238, DOI 10.1093/geronb/59.4.S238; Tomey K, 2010, SOC SCI MED, V71, P1259, DOI 10.1016/j.socscimed.2010.06.037; VERBRUGGE LM, 1994, SOC SCI MED, V38, P1, DOI 10.1016/0277-9536(94)90294-1; Yang Y, 2005, J AGING HEALTH, V17, P263, DOI 10.1177/0898264305276295; Yang Y, 2006, J HEALTH SOC BEHAV, V47, P355, DOI 10.1177/002214650604700404	46	70	71	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68632	10.1371/journal.pone.0068632	http://dx.doi.org/10.1371/journal.pone.0068632			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	182JD	23874698	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000321736900100
J	Ditiatkovski, M; D'Souza, W; Kesani, R; Chin-Dusting, J; de Haan, JB; Remaley, A; Sviridov, D				Ditiatkovski, Michael; D'Souza, Wilissa; Kesani, Rajitha; Chin-Dusting, Jaye; de Haan, Judy B.; Remaley, Alan; Sviridov, Dmitri			An Apolipoprotein A-I Mimetic Peptide Designed with a Reductionist Approach Stimulates Reverse Cholesterol Transport and Reduces Atherosclerosis in Mice	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; APOE-NULL MICE; LESION FORMATION; HDL; BINDING; EFFLUX; VIVO; 4F; INFLAMMATION; MACROPHAGES	Apolipoprotein A-I (apoA-I) mimetic peptides are considered a promising novel therapeutic approach to prevent and/or treat atherosclerosis. An apoA-I mimetic peptide ELK-2A2K2E was designed with a reductionist approach and has shown exceptional activity in supporting cholesterol efflux but modest anti-inflammatory and anti-oxidant properties in vitro. In this study we compared these in vitro properties with the capacity of this peptide to modify rates of reverse cholesterol transport and development of atherosclerosis in mouse models. The peptide enhanced the rate of reverse cholesterol transport in C57BL/6 mice and reduced atherosclerosis in Apoe(-/-) mice receiving a high fat diet. The peptide modestly reduced the size of the plaques in aortic arch, but was highly active in reducing vascular inflammation and oxidation. Administration of the peptide to Apoe(-/-) mice on a high fat diet reduced the levels of total, high density lipoprotein and non-high density lipoprotein cholesterol and triglycerides. It increased the proportion of smaller HDL particles in plasma at the expense of larger HDL particles, and increased the capacity of the plasma to support cholesterol efflux. Thus, ELK-2A2K2E peptide reduced atherosclerosis in Apoe(-/-) mice, however, the functional activity profile after chronic in vivo administration was different from that found in acute in vitro studies.	[Ditiatkovski, Michael; D'Souza, Wilissa; Kesani, Rajitha; Chin-Dusting, Jaye; de Haan, Judy B.; Sviridov, Dmitri] Baker Heart & Diabet Inst, Melbourne, Vic, Australia; [Remaley, Alan] NHLBI, Lipoprot Sect, NIH, Bethesda, MD 20892 USA	Baker Heart and Diabetes Institute; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Sviridov, D (corresponding author), Baker Heart & Diabet Inst, Melbourne, Vic, Australia.	Dmitri.Sviridov@Bakeridi.edu.au	Sviridov, Dmitri/E-7943-2010	de Haan, Judy B./0000-0002-2749-7833	National Health and Medical Research Council of Australia [GNT1003106]; Victorian Government's OIS Program; Intramural Research Program of the National Institutes of Health; National Heart, Lung and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002058, ZIAHL006095] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's OIS Program; Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Health and Medical Research Council of Australia (GNT1003106) and in part by the Victorian Government's OIS Program. DS is a Fellow of the National Health and Medical Research Council of Australia. This research was supported in part by the Intramural Research Program of the National Institutes of Health, and National Heart, Lung and Blood Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar MJA, 2010, J PHARMACOL EXP THER, V334, P634, DOI 10.1124/jpet.110.167890; Anantharamaiah GM, 2007, J LIPID RES, V48, P1915, DOI 10.1194/jlr.R700010-JLR200; Bielicki JK, 2010, J LIPID RES, V51, P1496, DOI 10.1194/jlr.M003665; Chattopadhyay A, 2013, J LIPID RES, V54, P995, DOI 10.1194/jlr.M033555; Choudhury RP, 2004, ARTERIOSCL THROM VAS, V24, P1904, DOI 10.1161/01.ATV.0000142808.34602.25; D'Souza W, 2010, CIRC RES, V107, P217, DOI 10.1161/CIRCRESAHA.110.216507; FUKUSHIMA D, 1981, P NATL ACAD SCI-BIOL, V78, P2732, DOI 10.1073/pnas.78.5.2732; Garber DW, 2001, J LIPID RES, V42, P545; GAUDRIAULT G, 1992, PEPTIDES, V13, P1187, DOI 10.1016/0196-9781(92)90027-Z; Getz GS, 2009, CURR OPIN LIPIDOL, V20, P171, DOI 10.1097/MOL.0b013e32832ac051; Handattu SP, 2007, J BIOL CHEM, V282, P1980, DOI 10.1074/jbc.M606231200; Handattu SP, 2010, J LIPID RES, V51, P3491, DOI 10.1194/jlr.M006916; Imaizumi S, 2011, CIRC J, V75, P1533, DOI 10.1253/circj.CJ-11-0460; Iwata A, 2011, ATHEROSCLEROSIS, V218, P300, DOI 10.1016/j.atherosclerosis.2011.05.029; Li XJ, 2004, CIRCULATION, V110, P1701, DOI 10.1161/01.CIR.0000142857.79401.69; Low H, 2012, JOVE-J VIS EXP, DOI 10.3791/3810; Meriwether D, 2011, J LIPID RES, V52, P1795, DOI 10.1194/jlr.M016741; Mukhamedova N, 2008, J LIPID RES, V49, P2312, DOI 10.1194/jlr.M800095-JLR200; Murphy AJ, 2010, CURR PHARM DESIGN, V16, P4134; Navab M, 2002, CIRCULATION, V105, P290, DOI 10.1161/hc0302.103711; Navab M, 2012, J LIPID RES, V53, P437, DOI 10.1194/jlr.M023523; Navab M, 2011, J LIPID RES, V52, P1200, DOI 10.1194/jlr.M013144; Nayyar G, 2012, ATHEROSCLEROSIS, V224, P326, DOI 10.1016/j.atherosclerosis.2012.05.040; Nayyar G, 2012, J LIPID RES, V53, P849, DOI 10.1194/jlr.M019844; Osei-Hwedieh DO, 2011, PHARMACOL THERAPEUT, V130, P83, DOI 10.1016/j.pharmthera.2010.12.003; Qin SC, 2012, J CARDIOVASC PHARM T, V17, P334, DOI 10.1177/1074248411434598; Remaley AT, 2003, J LIPID RES, V44, P828, DOI 10.1194/jlr.M200475-JLR200; Sethi AA, 2007, CURR OPIN INVEST DR, V8, P201; Sviridov D, 2006, TRANSPLANTATION, V81, P361, DOI 10.1097/01.tp.0000197556.83675.a6; Sviridov DO, 2011, BIOCHEM BIOPH RES CO, V410, P446, DOI 10.1016/j.bbrc.2011.05.154; Vakili L, 2010, ADV EXP MED BIOL, V660, P167, DOI 10.1007/978-1-60761-350-3_15; WARNICK GR, 1982, CLIN CHEM, V28, P1379; Wool GD, 2009, J LIPID RES, V50, P1889, DOI 10.1194/jlr.M900151-JLR200; Yvan-Charvet L, 2010, SCIENCE, V328, P1689, DOI 10.1126/science.1189731; Zhang YZ, 2003, CIRCULATION, V108, P661, DOI 10.1161/01.CIR.0000086981.09834.E0; Zhao WT, 2011, EXP BIOL MED, V236, P1468, DOI 10.1258/ebm.2011.011169	36	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68802	10.1371/journal.pone.0068802	http://dx.doi.org/10.1371/journal.pone.0068802			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874769	Green Published, Green Submitted, gold			2022-12-27	WOS:000321736900114
J	Eiby, YA; Wright, LL; Kalanjati, VP; Miller, SM; Bjorkman, ST; Keates, HL; Lumbers, ER; Colditz, PB; Lingwood, BE				Eiby, Yvonne A.; Wright, Layne L.; Kalanjati, Viskasari P.; Miller, Stephanie M.; Bjorkman, Stella T.; Keates, Helen L.; Lumbers, Eugenie R.; Colditz, Paul B.; Lingwood, Barbara E.			A Pig Model of the Preterm Neonate: Anthropometric and Physiological Characteristics	PLOS ONE			English	Article							INTRAUTERINE GROWTH RESTRICTION; FETAL SHEEP; NECROTIZING ENTEROCOLITIS; IMMATURE BABOONS; NEWBORN PIGLETS; BIRTH-WEIGHT; BRAIN GROWTH; INFANTS; RETARDATION; MATURATION	Background: Large animal models are an essential tool in the development of rationally-based new clinical therapies for preterm infants. We provide a description of the newborn pig as a model of the preterm neonate in terms of growth parameters, physiology and the requirement for intensive care over a range of gestational ages. Methods: Twenty-nine litters of piglets (n = 298) were delivered by caesarean section at six timepoints during gestation from 91d to 113d (term = 115d). Two groups, at 91 and 97d gestation, also received maternal glucocorticoid treatment. At four of these timepoints, piglets (n = 79) were ventilated, sedated and monitored using standard neonatal intensive care techniques for up to 8 h in various experimental protocols. Results: Body weight increased from mean 697 g (SD 193) at 91d gestation to 1331 g (SD 368) at 113d gestation. Piglets delivered at 97d gestation were able to be resuscitated and kept alive for at least 8 h on respiratory support after surfactant administration. Maternal glucocorticoid treatment 48 h and 24 h hours prior to delivery reduced the requirement for ventilator support and improved cardiovascular stability. Conclusion: The pig provides a relevant model for the study of human preterm physiology and for investigation of novel therapies to improve outcomes.	[Eiby, Yvonne A.; Wright, Layne L.; Kalanjati, Viskasari P.; Miller, Stephanie M.; Bjorkman, Stella T.; Lumbers, Eugenie R.; Colditz, Paul B.; Lingwood, Barbara E.] Univ Queensland, UQ Ctr Clin Res, Brisbane, Qld, Australia; [Keates, Helen L.] Univ Queensland, Sch Vet Sci, Brisbane, Qld, Australia; [Lumbers, Eugenie R.] Univ Newcastle, Sch Biomed Sci & Pharm, Newcastle, NSW 2300, Australia; [Lumbers, Eugenie R.] Univ Newcastle, Hunter Med Res Inst, Newcastle, NSW 2300, Australia	University of Queensland; University of Queensland; University of Newcastle; Hunter Medical Research Institute; University of Newcastle	Eiby, YA (corresponding author), Univ Queensland, UQ Ctr Clin Res, Brisbane, Qld, Australia.	y.eiby@uq.edu.au	Colditz, Paul B/F-6772-2010; Lingwood, Barbara E/F-1398-2010; Lumbers, Eugenie/AAS-4930-2020; Eiby, Yvonne/F-2772-2010; Bjorkman, Stella/C-9589-2011; Kalanjati, Viskasari P./AAJ-5302-2020; Miller, Stephanie/F-9815-2011	Colditz, Paul B/0000-0002-6408-8238; Eiby, Yvonne/0000-0003-0079-7796; Bjorkman, Stella/0000-0002-6545-3962; Kalanjati, Viskasari P./0000-0002-7005-0025; Miller, Stephanie/0000-0002-5565-2001	National Health and Medical Research Council of Australia [569635]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by the National Health and Medical Research Council of Australia [grant number 569635]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarenga ALN, 2013, REPROD FERT DEVELOP, V25, P387, DOI 10.1071/RD12021; American Academy of Pediatrics and American Heart Association, 2011, TXB NEONATAL RESUSCI, V6 th edition; Aylward GP, 2005, J DEV BEHAV PEDIATR, V26, P427, DOI 10.1097/00004703-200512000-00008; Bauer R, 2000, PEDIATR NEPHROL, V14, P735, DOI 10.1007/PL00013427; Bauer R, 1998, EXP TOXICOL PATHOL, V50, P59, DOI 10.1016/S0940-2993(98)80071-7; BAUER R, 1993, 2ND WORLD CONGRESS OF PERINATAL MEDICINE: PROCEEDINGS OF COMMUNICATIONS AND POSTERS, VOLS 1 AND 2, P423; Bjorkman ST, 2010, NEUROSCIENCE, V166, P157, DOI 10.1016/j.neuroscience.2009.11.067; Burrell JH, 2003, ANAT REC PART A, V274A, P952, DOI 10.1002/ar.a.10110; Coalson JJ, 1999, AM J RESP CRIT CARE, V160, P1333, DOI 10.1164/ajrccm.160.4.9810071; COALSON JJ, 1982, EXP MOL PATHOL, V37, P335, DOI 10.1016/0014-4800(82)90046-6; Colditz PB, 1997, OBSTET NEWBORN, P581; Davies M, 2008, POCKET NOTES NEONATO; De Matteo R, 2010, REPROD SCI, V17, P724, DOI 10.1177/1933719110369182; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Estrada J, 2007, CLONING STEM CELLS, V9, P229, DOI 10.1089/clo.2006.0079; French NP, 1999, AM J OBSTET GYNECOL, V180, P114, DOI 10.1016/S0002-9378(99)70160-2; Hasenfuss G, 2011, EUR HEART J, V32, P1838, DOI 10.1093/eurheartj/ehr026; Jobe AH, 2006, NEOREVIEWS, V7, pe259; Jobe AH, 2010, PEDIATR NEONATOL, V51, P7, DOI 10.1016/S1875-9572(10)60003-4; Johnson MJ, 2012, PEDIATRICS, V130, pE640, DOI 10.1542/peds.2011-3379; Laughon M, 2007, PEDIATRICS, V119, P273, DOI 10.1542/peds.2006-1138; LIGGINS GC, 1972, PEDIATRICS, V50, P515; Logan JW, 2011, ARCH DIS CHILD-FETAL, V96, pF321, DOI 10.1136/adc.2010.183335; Miller DR, 2009, J ANIM SCI, V87, P3167, DOI 10.2527/jas.2009-1825; Miller SL, 2012, REPROD FERT DEVELOP, V24, P753, DOI 10.1071/RD11143; Morrison JL, 2008, CLIN EXP PHARMACOL P, V35, P730, DOI 10.1111/j.1440-1681.2008.04975.x; Newnham J P, 2001, Semin Neonatol, V6, P285, DOI 10.1053/siny.2001.0064; Pond WG, 2000, P SOC EXP BIOL MED, V223, P102, DOI 10.1046/j.1525-1373.2000.22314.x; Probyn ME, 2004, PEDIATR RES, V56, P198, DOI 10.1203/01.PDR.0000132752.94155.13; Quaedackers JS, 2005, BJOG-INT J OBSTET GY, V112, P182, DOI 10.1111/j.1471-0528.2004.00344.x; Sangild PT, 2006, GASTROENTEROLOGY, V130, P1776, DOI 10.1053/j.gastro.2006.02.026; SCHMID G, 1985, VIRCHOWS ARCH B, V48, P59, DOI 10.1007/BF02890115; Sengupta P., 2011, BIOMED INT, V2, P81; Stevenson KM, 1996, CLIN EXP PHARMACOL P, V23, P125, DOI 10.1111/j.1440-1681.1996.tb02583.x; Swart EL, 2012, CURR DRUG METAB, V13, P760; Thompson JMD, 2006, PAEDIATR PERINAT EP, V20, P182, DOI 10.1111/j.1365-3016.2006.00711.x; Thomson MA, 2004, AM J RESP CRIT CARE, V169, P1054, DOI 10.1164/rccm.200309-1276OC; Walter B, 1997, BASIC RES CARDIOL, V92, P191, DOI 10.1007/BF00788636; Williams SM, 2005, GLIA, V49, P520, DOI 10.1002/glia.20139; Wu SF, 2012, PEDIATR NEONATOL, V53, P158, DOI 10.1016/j.pedneo.2012.04.001	40	62	63	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68763	10.1371/journal.pone.0068763	http://dx.doi.org/10.1371/journal.pone.0068763			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874755	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000321736900112
J	Feng, YX; Singleton, D; Guo, C; Gardner, A; Pakala, S; Kumar, R; Jensen, E; Zhang, JS; Khan, S				Feng, Yuxin; Singleton, David; Guo, Chun; Gardner, Amanda; Pakala, Suresh; Kumar, Rakesh; Jensen, Elwood; Zhang, Jinsong; Khan, Sohaib			DNA Homologous Recombination Factor SFR1 Physically and Functionally Interacts with Estrogen Receptor Alpha	PLOS ONE			English	Article							NUCLEAR RECEPTOR; MEDIATED TRANSCRIPTION; REGULATED TRANSCRIPTION; COILED COILS; IN-VIVO; COACTIVATOR; COREPRESSOR; ACTIVATION; REPRESSOR; MOTIF	Estrogen receptor alpha (ER alpha), a ligand-dependent transcription factor, mediates the expression of its target genes by interacting with corepressors and coactivators. Since the first cloning of SRC1, more than 280 nuclear receptor cofactors have been identified, which orchestrate target gene transcription. Aberrant activity of ER or its accessory proteins results in a number of diseases including breast cancer. Here we identified SFR1, a protein involved in DNA homologous recombination, as a novel binding partner of ER alpha. Initially isolated in a yeast two-hybrid screen, the interaction of SFR1 and ER alpha was confirmed in vivo by immunoprecipitation and mammalian one-hybrid assays. SFR1 co-localized with ER alpha in the nucleus, potentiated ER's ligand-dependent and ligand-independent transcriptional activity, and occupied the ER binding sites of its target gene promoters. Knockdown of SFR1 diminished ER's transcriptional activity. Manipulating SFR1 expression by knockdown and overexpression revealed a role for SFR1 in ER-dependent and -independent cancer cell proliferation. SFR1 differs from SRC1 by the lack of an intrinsic activation function. Taken together, we propose that SFR1 is a novel transcriptional modulator for ER alpha and a potential target in breast cancer therapy.	[Feng, Yuxin; Singleton, David; Guo, Chun; Gardner, Amanda; Jensen, Elwood; Zhang, Jinsong; Khan, Sohaib] Univ Cincinnati, Coll Med, Dept Canc Biol, Cincinnati, OH 45221 USA; [Pakala, Suresh; Kumar, Rakesh] George Washington Univ, Sch Med, Dept Biochem & Mol Biol, Washington, DC USA; [Feng, Yuxin] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA	University System of Ohio; University of Cincinnati; George Washington University; Cincinnati Children's Hospital Medical Center	Khan, S (corresponding author), Univ Cincinnati, Coll Med, Dept Canc Biol, Cincinnati, OH 45221 USA.	sohaib.khan@uc.edu	Kumar, Rakesh/ABD-1065-2020	Kumar, Rakesh/0000-0001-7664-0803; Zhang, Jinsong/0000-0002-8798-7316; Pakala, Suresh Babu/0000-0002-5679-4837; Khan, Sohaib/0000-0002-0792-9109	National Institutes of Health (NIH) [CA059268]; Marlene Harris Ride Cincinnati Breast Cancer Grant; NIH [R01HL093195, CA109379]; NATIONAL CANCER INSTITUTE [T32CA059268, R01CA109379] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093195] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marlene Harris Ride Cincinnati Breast Cancer Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Institutes of Health (NIH) training grant CA059268 (SK), Marlene Harris Ride Cincinnati Breast Cancer Grant (SK), NIH R01HL093195 grant (JZ), and in part by the NIH grant CA109379 (RK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001160; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Chen YH, 2005, MOL CELL BIOL, V25, P5965, DOI 10.1128/MCB.25.14.5965-5972.2005; Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Fernandes I, 2003, MOL CELL, V11, P139, DOI 10.1016/S1097-2765(03)00014-5; Gruber M, 2003, TRENDS BIOCHEM SCI, V28, P679, DOI 10.1016/j.tibs.2003.10.008; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Hu X, 1999, NATURE, V402, P93, DOI 10.1038/47069; Ju BG, 2006, CELL CYCLE, V5, P2557, DOI 10.4161/cc.5.22.3497; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Kim JH, 2003, MOL CELL, V12, P1537, DOI 10.1016/S1097-2765(03)00450-7; Koehler KF, 2005, ENDOCR REV, V26, P465, DOI 10.1210/er.2004-0027; Kokabu Y, 2011, J BIOL CHEM, V286, P43569, DOI 10.1074/jbc.M111.303339; Kurtev V, 2004, J BIOL CHEM, V279, P24834, DOI 10.1074/jbc.M312300200; Link KA, 2005, MOL CELL BIOL, V25, P2200, DOI 10.1128/MCB.25.6.2200-2215.2005; Martini PGV, 2000, MOL CELL BIOL, V20, P6224, DOI 10.1128/MCB.20.17.6224-6232.2000; McDonnell DP, 2002, SCIENCE, V296, P1642, DOI 10.1126/science.1071884; Montano MM, 1999, P NATL ACAD SCI USA, V96, P6947, DOI 10.1073/pnas.96.12.6947; Mussi P, 2006, P NATL ACAD SCI USA, V103, P16716, DOI 10.1073/pnas.0607768103; Park SE, 2005, MOL CELL BIOL, V25, P1989, DOI 10.1128/MCB.25.5.1989-1999.2005; Peterson TJ, 2007, MOL CELL BIOL, V27, P5933, DOI 10.1128/MCB.00237-07; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Singleton DW, 2003, ENDOCRINOLOGY, V144, P121, DOI 10.1210/en.2002-220625; Stengel KR, 2008, CELL CYCLE, V7, DOI 10.4161/cc.7.8.5737; Takeshita A, 2001, EUR J ENDOCRINOL, V145, P513, DOI 10.1530/eje.0.1450513; Voegel JJ, 1998, EMBO J, V17, P507, DOI 10.1093/emboj/17.2.507; Williamson LM, 2011, CARCINOGENESIS, V32, P279, DOI 10.1093/carcin/bgq255; Xu JM, 2003, MOL ENDOCRINOL, V17, P1681, DOI 10.1210/me.2003-0116; Xu W, 2005, BIOCHEM CELL BIOL, V83, P418, DOI 10.1139/O05-057; Yan C, 1997, J BIOL CHEM, V272, P17327, DOI 10.1074/jbc.272.28.17327; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; Yuan JS, 2011, J BIOL CHEM, V286, P9888, DOI 10.1074/jbc.M110.207290; Zhang XT, 2005, MOL CELL, V19, P89, DOI 10.1016/j.molcel.2005.05.015	36	1	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68075	10.1371/journal.pone.0068075	http://dx.doi.org/10.1371/journal.pone.0068075			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874500	Green Published, gold, Green Submitted			2022-12-27	WOS:000321736900050
J	Richiardi, L; Fiano, V; Grasso, C; Zugna, D; Delsedime, L; Gillio-Tos, A; Merletti, F				Richiardi, Lorenzo; Fiano, Valentina; Grasso, Chiara; Zugna, Daniela; Delsedime, Luisa; Gillio-Tos, Anna; Merletti, Franco			Methylation of APC and GSTP1 in Non-Neoplastic Tissue Adjacent to Prostate Tumour and Mortality from Prostate Cancer	PLOS ONE			English	Article							CPG ISLAND HYPERMETHYLATION; PROMOTER METHYLATION; RADICAL PROSTATECTOMY; GENE-EXPRESSION; ASSOCIATION; PROGRESSION; PROGNOSIS; PATTERNS; SAMPLES; CELLS	Background: Markers that can discriminate between indolent and aggressive prostate tumours are needed. We studied gene methylation in non-neoplastic tissue adjacent to prostate tumour (NTAT) in association with prostate cancer mortality. Methods: From two cohorts of consecutive prostate cancer patients diagnosed at one pathology ward in Turin, Italy, we selected 157 patients with available NTAT and followed them up for more than 14 years. We obtained DNA from NTAT in paraffin-embedded prostate tumour tissues and used probe real-time PCR to analyse methylation of the glutathione S-transferase (GSTP1) and adenomatous polyposis coli (APC) gene promoters. Results: Prevalence of APC and GSTP1 methylation in the NTAT was between 40 and 45%. It was associated with methylation in prostate tumour tissue for the same two genes as well as with a high Gleason score. The hazard ratio (HR) of prostate cancer mortality was 2.38 (95% confidence interval: 1.23-4.61) for APC methylation, and 2.92 (1.49-5.74) for GSTP1 methylation in NTAT. It changed to 1.91 (1.03-3.56) and 1.60 (0.80-3.19) after adjusting for Gleason score and methylation in prostate tumour tissue. Comparison of 2 vs. 0 methylated genes in NTAT revealed a HR of 4.30 (2.00-9.22), which decreased to 2.40 (1.15-5.01) after adjustment. Results were stronger in the first 5 years of follow-up ( adjusted HR: 3.29, 95% Cl: 1.27-8.52). Conclusions: Changes in gene methylation are an early event in prostate carcinogenesis and may play a role in cancer progression. Gene methylation in NTAT is a possible prognostic marker to be evaluated in clinical studies.	[Richiardi, Lorenzo; Fiano, Valentina; Grasso, Chiara; Zugna, Daniela; Gillio-Tos, Anna; Merletti, Franco] Univ Turin, Dept Med Sci, Canc Epidemiol Unit, Turin, Italy; [Richiardi, Lorenzo; Fiano, Valentina; Grasso, Chiara; Zugna, Daniela; Gillio-Tos, Anna; Merletti, Franco] CPO Piemonte, Turin, Italy; [Delsedime, Luisa] Citta Salute & Sci Torino, Unit Pathol, Turin, Italy	University of Turin; Centro di Riferimento per Epidemiologia e la Prevenzione Oncologica in Piemonte; A.O.U. Citta della Salute e della Scienza di Torino	Richiardi, L (corresponding author), Univ Turin, Dept Med Sci, Canc Epidemiol Unit, Turin, Italy.	lorenzo.richiardi@unito.it	; richiardi, lorenzo/J-3480-2018	FIANO, VALENTINA/0000-0001-7978-372X; Gillio-Tos, Anna/0000-0001-6553-5362; richiardi, lorenzo/0000-0003-0316-9402	Italian Association for Cancer Research (AIRC); Piedmont Region	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Piedmont Region(Regione Piemonte)	The study was partially supported by the Italian Association for Cancer Research (AIRC), and the Piedmont Region. The funders had no role in the study design, in the collection, analysis and interpretation of data, in the writing of the manuscript, and in the decision to submit the manuscript for publication.	Banez LL, 2010, J UROLOGY, V184, P149, DOI 10.1016/j.juro.2010.03.012; Bill-Axelson A, 2011, NEW ENGL J MED, V364, P1708, DOI 10.1056/NEJMoa1011967; Chandran UR, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-45; Chou R, 2011, ANN INTERN MED, V155, P762, DOI 10.7326/0003-4819-155-11-201112060-00375; Eads CA, 2001, CANCER RES, V61, P3410; Ellinger J, 2008, UROLOGY, V71, P161, DOI 10.1016/j.urology.2007.09.056; Esteller M., 2005, DNA METHYLATION APPR; Fearnhead NS, 2001, HUM MOL GENET, V10, P721, DOI 10.1093/hmg/10.7.721; Ferlay J, 2010, IARC CANCERBASE; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Florl AL, 2004, BRIT J CANCER, V91, P985, DOI 10.1038/sj.bjc.6602030; Fordyce CA, 2005, J UROLOGY, V173, P610, DOI 10.1097/01.ju.0000143195.49685.ce; Gillio-Tos A, 2007, PATHOLOGY, V39, P345, DOI 10.1080/00313020701329757; Haaland CM, 2009, INT J ONCOL, V35, P537, DOI 10.3892/ijo_00000365; Hanson JA, 2006, JNCI-J NATL CANCER I, V98, P255, DOI 10.1093/jnci/djj051; Hegarty J, 2011, COCHRANE DB SYST REV; Henrique R, 2006, MOL CANCER RES, V4, P1, DOI 10.1158/1541-7786.MCR-05-0113; Henrique R, 2007, CLIN CANCER RES, V13, P6122, DOI 10.1158/1078-0432.CCR-07-1042; Jentzmik F, 2012, WORLD J UROL, V30, P541, DOI 10.1007/s00345-011-0764-2; Jeronimo C, 2011, EUR UROL, V60, P753, DOI 10.1016/j.eururo.2011.06.035; Liu LY, 2011, INT J CANCER, V129, P2454, DOI 10.1002/ijc.25908; Mehrotra J, 2008, PROSTATE, V68, P152, DOI 10.1002/pros.20675; Nakayama M, 2004, J CELL BIOCHEM, V91, P540, DOI 10.1002/jcb.10740; Parr RL, 2006, J MOL DIAGN, V8, P312, DOI 10.2353/jmoldx.2006.050112; Penney KL, 2011, J CLIN ONCOL, V29, P2391, DOI 10.1200/JCO.2010.32.6421; Pizzi C, 2011, J EPIDEMIOL COMMUN H, V65, P407, DOI 10.1136/jech.2009.107185; Richiardi L, 2009, J CLIN ONCOL, V27, P3161, DOI 10.1200/JCO.2008.18.2485; Risk MC, 2010, CLIN CANCER RES, V16, P5414, DOI 10.1158/1078-0432.CCR-10-0272; Rosenbaum E, 2005, CLIN CANCER RES, V11, P8321, DOI 10.1158/1078-0432.CCR-05-1183; Seligson DB, 2005, NATURE, V435, P1262, DOI 10.1038/nature03672; Trevino V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016492; Van Neste L, 2012, PROSTATE, V72, P1248, DOI 10.1002/pros.22459; Weiss G, 2009, J UROLOGY, V181, P1678, DOI 10.1016/j.juro.2008.11.120; Woodson K, 2004, CANCER LETT, V205, P181, DOI 10.1016/j.canlet.2003.11.027; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158	35	31	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68162	10.1371/journal.pone.0068162	http://dx.doi.org/10.1371/journal.pone.0068162			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874531	gold, Green Published, Green Submitted			2022-12-27	WOS:000321736900063
J	Zhang, J; Wei, YJ; Hu, BF; Huang, M; Xie, W; Zhai, YG				Zhang, Jun; Wei, Yijuan; Hu, Bingfang; Huang, Min; Xie, Wen; Zhai, Yonggong			Activation of Human Stearoyl-Coenzyme A Desaturase 1 Contributes to the Lipogenic Effect of PXR in HepG2 Cells	PLOS ONE			English	Article							PREGNANE-X-RECEPTOR; ELEMENT-BINDING PROTEIN-1C; GENE-EXPRESSION; THYROID-HORMONE; LXR-ALPHA; OXYSTEROL RECEPTORS; ADIPOSE-TISSUE; MOUSE-LIVER; PPAR-GAMMA; METABOLISM	The pregnane X receptor (PXR) was previously known as a xenobiotic receptor. Several recent studies suggested that PXR also played an important role in lipid homeostasis but the underlying mechanism remains to be clearly defined. In this study, we found that rifampicin, an agonist of human PXR, induced lipid accumulation in HepG2 cells. Lipid analysis showed the total cholesterol level increased. However, the free cholesterol and triglyceride levels were not changed. Treatment of HepG2 cells with rifampicin induced the expression of the free fatty acid transporter CD36 and ABCG1, as well as several lipogenic enzymes, including stearoyl-CoA desaturase-1 (SCD1), long chain free fatty acid elongase (FAE), and lecithin-cholesterol acyltransferase (LCAT), while the expression of acyl: cholesterol acetyltransferase(ACAT1) was not affected. Moreover, in PXR over-expressing HepG2 cells (HepG2-PXR), the SCD1 expression was significantly higher than in HepG2-Vector cells, even in the absence of rifampicin. Down-regulation of PXR by shRNA abolished the rifampicin-induced SCD1 gene expression in HepG2 cells. Promoter analysis showed that the human SCD1 gene promoter is activated by PXR and a novel DR-7 type PXR response element (PXRE) response element was located at -338 bp of the SCD1 gene promoter. Taken together, these results indicated that PXR activation promoted lipid synthesis in HepG2 cells and SCD1 is a novel PXR target gene.	[Zhang, Jun; Wei, Yijuan; Zhai, Yonggong] Beijing Normal Univ, Coll Life Sci, Beijing Key Lab Gene Resource & Mol Dev, Beijing 100875, Peoples R China; [Hu, Bingfang; Xie, Wen] Univ Pittsburgh, Ctr Pharmacogenet, Pittsburgh, PA USA; [Hu, Bingfang] Sun Yat Sen Univ, Inst Clin Pharmacol, Guangzhou, Guangdong, Peoples R China; [Zhang, Jun; Wei, Yijuan; Zhai, Yonggong] Beijing Normal Univ, Coll Life Sci, Key Lab Cell Proliferat & Regulat Biol, Minist Educ, Beijing 100875, Peoples R China	Beijing Normal University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Sun Yat Sen University; Beijing Normal University	Zhai, YG (corresponding author), Beijing Normal Univ, Coll Life Sci, Beijing Key Lab Gene Resource & Mol Dev, Beijing 100875, Peoples R China.	ygzhai@bnu.edu.cn	Zhang, Jun/W-5146-2019; Xie, Wen/M-1768-2016	Zhang, Jun/0000-0002-8489-3699; 	National Natural Science Foundation of China [31071027, 30870926]; 973 Project [2011CB915504]; China Scholarship Council [201206380045]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083952] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Project(National Basic Research Program of China); China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants (numbers 31071027 and 30870926) from the National Natural Science Foundation of China, and 973 Project (number 2011CB915504). Bingfang Hu is supported by a scholarship from the China Scholarship Council (number 201206380045). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Barish GD, 2004, CELL, V119, P149, DOI 10.1016/j.cell.2004.10.003; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Chu K, 2006, MOL CELL BIOL, V26, P6786, DOI 10.1128/MCB.00077-06; Febbraio M, 2002, MOL CELL BIOCHEM, V239, P193, DOI 10.1023/A:1020515210972; Feng X, 2000, MOL ENDOCRINOL, V14, P947, DOI 10.1210/me.14.7.947; Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200; Georgel P, 2005, INFECT IMMUN, V73, P4512, DOI 10.1128/IAI.73.8.4512-4521.2005; Handschin C, 2003, PHARMACOL REV, V55, P649, DOI 10.1124/pr.55.4.2; Jiang W, 2004, J ENDOCRINOL, V182, P295, DOI 10.1677/joe.0.1820295; Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kim HJ, 2002, J LIPID RES, V43, P1750, DOI 10.1194/jlr.M100433-JLR200; Laffitte BA, 2003, P NATL ACAD SCI USA, V100, P5419, DOI 10.1073/pnas.0830671100; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; Miyazaki M, 2004, J BIOL CHEM, V279, P25164, DOI 10.1074/jbc.M402781200; Moreau A, 2009, HEPATOLOGY, V49, P2068, DOI 10.1002/hep.22907; Nakamura K, 2007, J BIOL CHEM, V282, P9768, DOI 10.1074/jbc.M610072200; Ntambi JM, 2004, LIPIDS, V39, P1061, DOI 10.1007/s11745-004-1331-2; Ntambi JM, 2004, PROG LIPID RES, V43, P91, DOI 10.1016/S0163-7827(03)00039-0; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Peters JM, 2001, BBA-MOL CELL BIOL L, V1533, P233, DOI 10.1016/S1388-1981(01)00155-X; Podrez EA, 2000, J CLIN INVEST, V105, P1095, DOI 10.1172/JCI8574; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Repa JJ, 2002, NAT MED, V8, P1243, DOI 10.1038/nm1102-1243; Saini SPS, 2005, HEPATOLOGY, V41, P497, DOI 10.1002/hep.20570; Samuel W, 2001, J BIOL CHEM, V276, P28744, DOI 10.1074/jbc.M103587200; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Shimano H, 2001, PROG LIPID RES, V40, P439, DOI 10.1016/S0163-7827(01)00010-8; SUGDEN MC, 1981, BIOSCIENCE REP, V1, P757, DOI 10.1007/BF01114797; Tontonoz P, 2003, MOL ENDOCRINOL, V17, P985, DOI 10.1210/me.2003-0061; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Xie W, 2000, NATURE, V406, P435, DOI 10.1038/35019116; Yu ST, 2003, J BIOL CHEM, V278, P498, DOI 10.1074/jbc.M210062200; Zhai YG, 2007, MOL ENDOCRINOL, V21, P138, DOI 10.1210/me.2006-0291; Zhang B, 2010, ENDOCRINOLOGY, V151, P5721, DOI 10.1210/en.2010-0708; Zhang Y, 2001, J BIOL CHEM, V276, P43018, DOI 10.1074/jbc.M107823200; Zhou J, 2008, GASTROENTEROLOGY, V134, P556, DOI 10.1053/j.gastro.2007.11.037; Zhou J, 2006, J BIOL CHEM, V281, P15013, DOI 10.1074/jbc.M511116200	39	12	12	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e67959	10.1371/journal.pone.0067959	http://dx.doi.org/10.1371/journal.pone.0067959			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874477	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000321736900040
J	Koren, L; Elhanani, O; Kehat, I; Hai, T; Aronheim, A				Koren, Lilach; Elhanani, Ofer; Kehat, Izhak; Hai, Tsonwin; Aronheim, Ami			Adult Cardiac Expression of the Activating Transcription Factor 3, ATF3, Promotes Ventricular Hypertrophy	PLOS ONE			English	Article							C-JUN; GENE; INFLAMMATION; REPRESSOR	Cardiac hypertrophy is an adaptive response to various mechanophysical and pathophysiological stresses. However, when chronic stress is sustained, the beneficial response turns into a maladaptive process that eventually leads to heart failure. Although major advances in the treatment of patients have reduced mortality, there is a dire need for novel treatments for cardiac hypertrophy. Accordingly, considerable efforts are being directed towards developing mice models and understanding the processes that lead to cardiac hypertrophy. A case in point is ATF3, an immediate early transcription factor whose expression is induced in various cardiac stress models but has been reported to have conflicting functional significance in hypertrophy. To address this issue, we generated a transgenic mouse line with tetracycline-regulated ATF3 cardiac expression. These mice allowed us to study the consequence of ATF3 expression in the embryo or during the adult period, thus distinguishing the effect of ATF3 on development versus pathogenesis of cardiac dysfunction. Importantly, ATF3 expression in adult mice resulted in rapid ventricles hypertrophy, heart dysfunction, and fibrosis. When combined with a phenylephrine-infusion pressure overload model, the ATF3 expressing mice displayed a severe outcome and heart dysfunction. In a complementary approach, ATF3 KO mice displayed a lower level of heart hypertrophy in the same pressure overload model. In summary, ectopic expression of ATF3 is sufficient to promote cardiac hypertrophy and exacerbates the deleterious effect of chronic pressure overload; conversely, ATF3 deletion protects the heart. Therefore, ATF3 may serve as an important drug target to reduce the detrimental consequences of heart hypertrophy.	[Koren, Lilach; Elhanani, Ofer; Aronheim, Ami] Technion Israel Inst Technol, Rappaport Family Inst Res Med Sci, Dept Mol Genet, IL-31096 Haifa, Israel; [Kehat, Izhak] Technion Israel Inst Technol, Rappaport Family Inst Res Med Sci, Dept Physiol, IL-31096 Haifa, Israel; [Hai, Tsonwin] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University System of Ohio; Ohio State University	Aronheim, A (corresponding author), Technion Israel Inst Technol, Rappaport Family Inst Res Med Sci, Dept Mol Genet, IL-31096 Haifa, Israel.	aronheim@tx.technion.ac.il	Hai, Tsonwin/E-3185-2011; Hai, Tsonwin/H-4480-2011	Hai, Tsonwin/0000-0003-4510-0315; Hai, Tsonwin/0000-0003-4510-0315; Aronheim, Ami/0000-0002-8575-4092; kehat, izhak/0000-0002-4388-1579				Aronheim A, 1997, MOL CELL BIOL, V17, P3094, DOI 10.1128/MCB.17.6.3094; Bernardo BC, 2010, PHARMACOL THERAPEUT, V128, P191, DOI 10.1016/j.pharmthera.2010.04.005; CHEN BPC, 1994, J BIOL CHEM, V269, P15819; Darlyuk-Saadon I, 2012, BBA-GENE REGUL MECH, V1819, P1142, DOI 10.1016/j.bbagrm.2012.09.005; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Giraldo A, 2012, BIOCHEM J, V444, P343, DOI 10.1042/BJ20120125; Hai T, 2006, ATF TRANSCRIPTION FA, P329; Hai T, 2010, GENE EXPRESSION, V15, P1, DOI 10.3727/105221610X12819686555015; Hartman MG, 2004, MOL CELL BIOL, V24, P5721, DOI 10.1128/MCB.24.13.5721-5732.2004; Hasin T, 2011, BASIC RES CARDIOL, V106, P175, DOI 10.1007/s00395-010-0145-9; HSU JC, 1992, MOL CELL BIOL, V12, P4654, DOI 10.1128/MCB.12.10.4654; Huang CQ, 2003, DEVELOPMENT, V130, P6111, DOI 10.1242/dev.00831; Kehat I, 2006, ANN NY ACAD SCI, V1080, P97, DOI 10.1196/annals.1380.009; Kehat I, 2006, CARDIOVASC RES, V70, P543, DOI 10.1016/j.cardiores.2006.02.018; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Levy D, 2002, NEW ENGL J MED, V347, P1397, DOI 10.1056/NEJMoa020265; Melendez GC, 2010, HYPERTENSION, V56, P225, DOI 10.1161/HYPERTENSIONAHA.109.148635; Nahrendorf M, 2010, CIRCULATION, V121, P2437, DOI 10.1161/CIRCULATIONAHA.109.916346; Nobori K, 2002, J MOL CELL CARDIOL, V34, P1387, DOI 10.1006/jmcc.2002.2091; Okamoto Y, 2001, AM J PATHOL, V159, P639, DOI 10.1016/S0002-9440(10)61735-X; PRAVTCHEVA DD, 1994, J EXP ZOOL, V268, P452, DOI 10.1002/jez.1402680606; SUBRAMANIAM A, 1991, J BIOL CHEM, V266, P24613; Takeda N, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/535241; Takii R, 2010, J IMMUNOL, V184, P1041, DOI 10.4049/jimmunol.0902579; van Veen TAB, 2001, CARDIOVASC RES, V51, P217, DOI 10.1016/S0008-6363(01)00324-8; Weidenfeld-Baranboim K, 2008, NUCLEIC ACIDS RES, V36, P3608, DOI 10.1093/nar/gkn268; Zhou H, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0026744, DOI 10.1371/J0URNAL.P0NE.0026744.PUBMED:22053207]; Zmuda EJ, 2010, DIABETOLOGIA, V53, P1438, DOI 10.1007/s00125-010-1696-x	28	36	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68396	10.1371/journal.pone.0068396	http://dx.doi.org/10.1371/journal.pone.0068396			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23874609	gold, Green Published			2022-12-27	WOS:000321733000002
J	Ma, RQ; Wei, Y; Huang, XM; Fu, R; Luo, X; Zhu, XL; Lei, WB; Fang, JG; Li, HB; Wen, WP				Ma, Renqiang; Wei, Yi; Huang, Xiaoming; Fu, Ran; Luo, Xi; Zhu, Xiaolin; Lei, Wenbin; Fang, Jugao; Li, Huabin; Wen, Weiping			Inhibition of GSK 3 beta Activity Is Associated with Excessive EZH2 Expression and Enhanced Tumour Invasion in Nasopharyngeal Carcinoma	PLOS ONE			English	Article							GROUP PROTEIN EZH2; SYNTHASE KINASE 3-BETA; SIGNALING PATHWAYS; E-CADHERIN; TUMORIGENESIS; CANCER; REPRESSION; GSK-3-BETA; MIR-26A; CELLS	Background: Enhancer of zeste homolog 2 (EZH2) has been shown to contribute to tumour development and/or progression. However, the signalling pathway underlying the regulation of EZH2 in nasopharyngeal carcinoma (NPC) remains unclear. Since EZH2 contains the putative Glycogen synthase kinase 3 beta (GSK3 beta) phosphorylation motif ADHWDSKNVSCKNC (591) and may act as a possible substrate of GSK-3 beta, it is possible that inactivation of GSK3 beta may lead to excessive EZH2 expression in NPC. Method: We first examined the expression of EZH2 and phosphorylated GSK3 beta (p-GSK3 beta) by immunohistochemical staining in NPC samples. Then, we evaluated the interaction of GSK3 beta and EZH2 using immunoprecipitation and immune blot. Moreover, we determined the effect of inhibition of GSK3 beta activity on EZH2 expression and tumor invasiveness in NPC cell lines in vitro. Finally, we evaluated the invasive properties of NPC cells after knocking down EZH2 expression with EZH2 siRNA. Results: We found that expression of EZH2 correlated with phosphorylated GSK3 beta (p-GSK3 beta) at Ser 9 (an inactivated form of GSK3 beta) in human nasopharyngeal carcinoma (NPC) samples. We also provided evidence that GSK3 beta is able to interact with EZH2 using immunoprecipitation and immune blot. Furthermore, we found that inhibition of GSK3 beta activity can lead to upregulation of EZH2 in NPC cell lines in vitro, with enhanced local invasiveness. By knocking down EZH2 expression with EZH2 siRNA, we found that these invasive properties were EZH2 dependent. Conclusion: Our findings indicate that GSK3 beta inactivation may account for EZH2 overexpression and subsequent tumour progression, and this mechanism might be a potential target for NPC therapy.	[Ma, Renqiang; Wei, Yi; Fu, Ran; Luo, Xi; Zhu, Xiaolin; Lei, Wenbin; Li, Huabin; Wen, Weiping] Sun Yat Sen Univ, Affiliated Hosp 1, Otorhinolarygol Hosp, Allergy & Canc Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Xiaoming] Sun Yat Sen Univ, Affiliated Hosp 2, Dept Otolaryngol, Guangzhou 510275, Guangdong, Peoples R China; [Fang, Jugao] Capital Med Univ, Beijing Tongren Hosp, Dept Otolaryngol, Beijing, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Capital Medical University	Li, HB (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Otorhinolarygol Hosp, Allergy & Canc Ctr, Guangzhou 510275, Guangdong, Peoples R China.	allergyli@163.com; wwp1901@yahoo.com.cn	温, 家琦/GYV-3177-2022		National Nature and Science Grant of China [81072204, 81072224]; Program for New Century Excellent Talents in University [NCET-10-0851]; Sun Yat-sen University [10ykpy10]	National Nature and Science Grant of China; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Sun Yat-sen University	This study is supported by National Nature and Science Grant of China (No. 81072204, 81072224) and Program for New Century Excellent Talents in University (No. NCET-10-0851), and Young faculty cultivation project of Sun Yat-sen University (10ykpy10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alajez NM, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.64; Bax B, 2001, STRUCTURE, V9, P1143, DOI 10.1016/S0969-2126(01)00679-7; Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Chou J, 2008, HEAD NECK-J SCI SPEC, V30, P946, DOI 10.1002/hed.20833; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Fang JG, 2012, AURIS NASUS LARYNX, V39, P71, DOI 10.1016/j.anl.2011.02.009; Farago M, 2005, CANCER RES, V65, P5792, DOI 10.1158/0008-5472.CAN-05-1021; Forde JE, 2007, CELL MOL LIFE SCI, V64, P1930, DOI 10.1007/s00018-007-7045-7; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Huang XM, 2009, CANCER LETT, V279, P47, DOI 10.1016/j.canlet.2009.01.020; Hwang CF, 2012, INT J RADIAT ONCOL, V82, P597, DOI 10.1016/j.ijrobp.2010.11.062; Le QT, 2003, INT J RADIAT ONCOL, V56, P1046, DOI 10.1016/S0360-3016(03)00117-2; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045910; Lu JA, 2011, CANCER RES, V71, P225, DOI 10.1158/0008-5472.CAN-10-1850; Luo J, 2009, CANCER LETT, V273, P194, DOI 10.1016/j.canlet.2008.05.045; Manoukian AS, 2002, ADV CANCER RES, V84, P203, DOI 10.1016/S0065-230X(02)84007-6; Min J, 2010, NAT MED, V16, P286, DOI 10.1038/nm.2100; Morrison JA, 2004, CANCER RES, V64, P5251, DOI 10.1158/0008-5472.CAN-04-0538; Morrison JA, 2003, J VIROL, V77, P12276, DOI 10.1128/JVI.77.22.12276-12284.2003; Schaffer B, 2003, GENE, V302, P73, DOI 10.1016/S0378-1119(02)01092-2; Sun W, 2012, CARCINOGENESIS, V33, P810, DOI 10.1093/carcin/bgs027; Swart R, 2000, J VIROL, V74, P10838, DOI 10.1128/JVI.74.22.10838-10845.2000; Tao Qian, 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000312; Tong ZT, 2012, ONCOGENE, V31, P583, DOI 10.1038/onc.2011.254; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431	26	20	25	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e68614	10.1371/journal.pone.0068614	http://dx.doi.org/10.1371/journal.pone.0068614			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874688	Green Published, Green Submitted, gold			2022-12-27	WOS:000324146200022
J	Yang, X; Ben, SQ; Sun, YJ; Fan, XL; Tian, CM; Wang, YL				Yang, Xue; Ben, Siqi; Sun, Yingjiao; Fan, Xinlei; Tian, Chengming; Wang, Yonglin			Genome-Wide Identification, Phylogeny and Expression Profile of Vesicle Fusion Components in Verticillium dahliae	PLOS ONE			English	Article							MEMBRANE-FUSION; VESICULAR TRAFFICKING; HYDROPHOBIN GENE; PROTEIN; SNARES; FAMILY; YEAST; RAB; MICROSCLEROTIA; CONSERVATION	Vesicular trafficking plays a crucial role in protein localization and movement, signal transduction, and multiple developmental processes in eukaryotic cells. Vesicle fusion is the final and key step in vesicle-mediated trafficking and mainly relies on SNAREs (soluble N-ethylmaleimide-sensitive factor attachment protein receptors), the regulators including SM (Sec1/Munc18) family proteins, Rab GTPases and exocyst subunits. Verticillium dahliae is a widespread soil fungus that causes disruptive vascular diseases on a wide range of plants. To date, no genes involved in vesicular fusion process have been identified and characterized in V. dahliae. The recent publication of the draft genome sequence of V. dahliae allowed us to conduct a genome-wide identification, phylogeny and expression profile of genes encoding vesicular fusion components. Using compared genomics and phylogenetic methods, we identified 44 genes encoding vesicle fusion components in the V. dahliae genome. According to the structural features of their encoded proteins, the 44 V. dahliae genes were classified into 22 SNAREs (6 Qa-, 4 Qb-, 6 Qc-, 1 Qbc- and 5 R-types), 4 SM family proteins, 10 Rab GTPases and 8 exocyst proteins. Based on phylogeny and motif constitution analysis, orthologs of vesicle fusion component in filamentous fungi were generally clustered together into the same subclasses with well-supported bootstrap values. Analysis of the expression profiles of these genes indicated that many of them are significantly differentially expressed during vegetative growth and microsclerotia formation in V. dahliae. The analysis show that many components of vesicle fusion are well conserved in filamentous fungi and indicate that vesicle fusion plays a critical role in microsclerotia formation of smoke tree wilt fungus V. dahliae. The genome-wide identification and expression analysis of components involved in vesicle fusion should facilitate research in this gene family and give new insights toward elucidating their functions in growth, development and pathogenesis of V. dahliae.	[Yang, Xue; Ben, Siqi; Sun, Yingjiao; Fan, Xinlei; Tian, Chengming; Wang, Yonglin] Beijing Forestry Univ, Key Lab Silviculture & Conservat, Minist Educ, Coll Forestry, Beijing, Peoples R China; [Yang, Xue; Ben, Siqi] Beijing Forestry Univ, Coll Biol Sci & Technol, Beijing, Peoples R China	Beijing Forestry University; Beijing Forestry University	Wang, YL (corresponding author), Beijing Forestry Univ, Key Lab Silviculture & Conservat, Minist Educ, Coll Forestry, Beijing, Peoples R China.	ylwang@bjfu.edu.cn	Wang, Yonglin/AEF-4563-2022; Fan, Xinlei/AAE-1835-2022	Wang, Yonglin/0000-0003-0993-8102; Fan, Xinlei/0000-0002-4946-4442	Fundamental Research Funds for the Central Universities [YX2013-10]; NSFC [31000302]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); NSFC(National Natural Science Foundation of China (NSFC))	The research was supported by the Fundamental Research Funds for the Central Universities (NO. YX2013-10) and NSFC Project (31000302) to YW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal GK, 2010, PROTEOMICS, V10, P799, DOI 10.1002/pmic.200900514; Ayong L, 2007, MOL BIOCHEM PARASIT, V152, P113, DOI 10.1016/j.molbiopara.2006.12.007; Bassham Diane C, 2008, Arabidopsis Book, V6, pe0116, DOI 10.1199/tab.0116; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Burri L, 2004, TRAFFIC, V5, P45, DOI 10.1046/j.1600-0854.2003.00151.x; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; de Jonge R, 2011, CURR OPIN PLANT BIOL, V14, P400, DOI 10.1016/j.pbi.2011.03.005; Dobinson KF, 1997, CAN J MICROBIOL, V43, P227, DOI 10.1139/m97-031; Dou XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016439; Elias M, 2012, J CELL SCI, V125, P2500, DOI 10.1242/jcs.101378; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; FERRONOVICK S, 1994, NATURE, V370, P191, DOI 10.1038/370191a0; Fradin EF, 2006, MOL PLANT PATHOL, V7, P71, DOI [10.1111/j.1364-3703.2006.00323.x, 10.1111/J.1364-3703.2006.00323.X]; FRIEBERTSHAUSER GE, 1982, PHYTOPATHOLOGY, V72, P872, DOI 10.1094/Phyto-72-872; Gao F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015319; Gerst JE, 1999, CELL MOL LIFE SCI, V55, P707, DOI 10.1007/s000180050328; Girard V, 2013, PROTEOMICS, V13, P597, DOI 10.1002/pmic.201200282; GRIFFITHS DA, 1970, ARCH MIKROBIOL, V74, P207, DOI 10.1007/BF00408881; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guo W, 2001, NAT CELL BIOL, V3, P353, DOI 10.1038/35070029; Gupta GD, 2002, FUNGAL GENET BIOL, V36, P1, DOI 10.1016/S1087-1845(02)00017-8; Hong WJ, 2005, BBA-MOL CELL RES, V1744, P120, DOI 10.1016/j.bbamcr.2005.03.014; Hou YY, 2008, J PLANT PATHOL, V90, P117; Johnson DA, 2010, CAN J PLANT PATHOL, V32, P58, DOI 10.1080/07060661003621134; Kienle N, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-19; Klimes A, 2006, FUNGAL GENET BIOL, V43, P283, DOI 10.1016/j.fgb.2005.12.006; Klimes A, 2008, FUNGAL GENET BIOL, V45, P1525, DOI 10.1016/j.fgb.2008.09.014; Kloepper TH, 2007, MOL BIOL CELL, V18, P3463, DOI 10.1091/mbc.E07-03-0193; Klosterman SJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002137; Klosterman SJ, 2009, ANNU REV PHYTOPATHOL, V47, P39, DOI 10.1146/annurev-phyto-080508-081748; KOIKE ST, 1994, PLANT DIS, V78, P1116, DOI 10.1094/PD-78-1116; Koumandou VL, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-29; Kuratsu M, 2007, FUNGAL GENET BIOL, V44, P1310, DOI 10.1016/j.fgb.2007.04.012; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li L, 2003, CELL MOL LIFE SCI, V60, P942, DOI 10.1007/s00018-003-2240-7; Lipka V, 2007, ANNU REV CELL DEV BI, V23, P147, DOI 10.1146/annurev.cellbio.23.090506.123529; Mcnew JA, 2008, CHEM REV, V108, P1669, DOI 10.1021/cr0782325; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Morgera F, 2012, MOL BIOL CELL, V23, P337, DOI 10.1091/mbc.E11-08-0670; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; Oliva R, 2010, CELL MICROBIOL, V12, P705, DOI 10.1111/j.1462-5822.2010.01471.x; Ostrowicz CW, 2008, AUTOPHAGY, V4, P5, DOI 10.4161/auto.5054; Palmer CS, 2005, PHYSIOL MOL PLANT P, V67, P308, DOI 10.1016/j.pmpp.2006.05.003; Pegg GF, 2002, VERTICILLUM WILTS, DOI [DOI 10.1079/9780851995298.0000, 10.1079/9780851995298.0000]; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Pereira-Leal JB, 2008, TRAFFIC, V9, P27, DOI 10.1111/j.1600-0854.2007.00667.x; PERRY JW, 1984, CAN J BOT, V62, P396, DOI 10.1139/b84-060; Rauyaree P, 2005, CURR GENET, V48, P109, DOI 10.1007/s00294-005-0586-0; Samaj J, 2006, TRENDS PLANT SCI, V11, P594, DOI 10.1016/j.tplants.2006.10.002; Sanderfoot A, 2007, PLANT PHYSIOL, V144, P6, DOI 10.1104/pp.106.092973; Shandala T, 2012, MOL MACHINERY REGULA, DOI [10.5772/39110, DOI 10.5772/39110]; Sollner TH, 2003, MOL MEMBR BIOL, V20, P209, DOI 10.1080/0968768031000104953; Song WW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013193; Sorensen JB, 2005, TRENDS NEUROSCI, V28, P453, DOI 10.1016/j.tins.2005.06.007; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; Toonen RFG, 2003, TRENDS CELL BIOL, V13, P177, DOI 10.1016/S0962-8924(03)00031-X; Tzima AK, 2012, FUNGAL GENET BIOL, V49, P271, DOI 10.1016/j.fgb.2012.02.005; Ungar D, 2003, ANNU REV CELL DEV BI, V19, P493, DOI 10.1146/annurev.cellbio.19.110701.155609; Wang J, 2008, FOREST PEST DIS, V10, P30; Wang JY, 2004, APPL ENVIRON MICROB, V70, P4989, DOI 10.1128/AEM.70.8.4989-4995.2004; Wang YL, 2013, AUSTRALAS PLANT PATH, V42, P33, DOI 10.1007/s13313-012-0172-0; Wedlich-Soldner R, 2000, EMBO J, V19, P1974, DOI 10.1093/emboj/19.9.1974; Wickner W, 2002, EMBO J, V21, P1241, DOI 10.1093/emboj/21.6.1241; Wickner W, 2010, ANNU REV CELL DEV BI, V26, P115, DOI 10.1146/annurev-cellbio-100109-104131; Yao HY, 2011, CURR OPIN PLANT BIOL, V14, P571, DOI 10.1016/j.pbi.2011.06.009; Zhou BJ, 2012, MOL PLANT MICROBE IN, V25, P964, DOI 10.1094/MPMI-12-11-0319	67	8	9	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e68681	10.1371/journal.pone.0068681	http://dx.doi.org/10.1371/journal.pone.0068681			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23874720	Green Published, gold, Green Submitted			2022-12-27	WOS:000322000600017
J	Kim, GH; Jeong, HJ; Yoo, YD; Kim, S; Han, JH; Han, JW; Zuccarello, GC				Kim, Gwang Hoon; Jeong, Hae Jin; Yoo, Yeong Du; Kim, Sunju; Han, Ji Hee; Han, Jong Won; Zuccarello, Giuseppe C.			Still Acting Green: Continued Expression of Photosynthetic Genes in the Heterotrophic Dinoflagellate Pfiesteria piscicida (Peridiniales, Alveolata)	PLOS ONE			English	Article							PHYLOGENOMIC EVIDENCE; EVOLUTIONARY ORIGINS; PLASTID GENOME; ALGAL ORIGIN; APICOMPLEXAN; PROTEIN; CRYPTOPHYTES; HAPTOPHYTES; MAINTENANCE; ACQUISITION	The loss of photosynthetic function should lead to the cessation of expression and finally loss of photosynthetic genes in the new heterotroph. Dinoflagellates are known to have lost their photosynthetic ability several times. Dinoflagellates have also acquired photosynthesis from other organisms, either on a long-term basis or as "kleptoplastids'' multiple times. The fate of photosynthetic gene expression in heterotrophs can be informative into evolution of gene expression patterns after functional loss, and the dinoflagellates ability to acquire new photosynthetic function through additional endosymbiosis. To explore this we analyzed a large-scale EST database consisting of 151,091 unique sequences (29,170 contigs, 120,921 singletons) obtained from 454 pyrosequencing of the heterotrophic dinoflagellate Pfiesteria piscicida. About 597 contigs from P. piscicida showed significant homology (E-value <e(-30)) with proteins associated with plastid and photosynthetic function. Most of the genes involved in the Calvin-Benson cycle were found, genes of the light-dependent reaction were also identified. Also genes of associated pathways including the chorismate pathway and genes involved in starch metabolism were discovered. BLAST searches and phylogenetic analysis suggest that these plastid-associated genes originated from several different photosynthetic ancestors. The Calvin-Benson cycle genes are mostly associated with genes derived from the secondary plastids of peridinin-containing dinoflagellates, while the light-harvesting genes are derived from diatoms, or diatoms that are tertiary plastids in other dinoflagellates. The continued expression of many genes involved in photosynthetic pathways indicates that the loss of transcriptional regulation may occur well after plastid loss and could explain the organism's ability to "capture'' new plastids (i.e. different secondary endosymbiosis or tertiary symbioses) to renew photosynthetic function.	[Kim, Gwang Hoon; Kim, Sunju; Han, Ji Hee; Han, Jong Won] Kongju Natl Univ, Dept Biol, Kong Ju 314701, South Korea; [Jeong, Hae Jin; Yoo, Yeong Du] Seoul Natl Univ, Sch Earth & Environm Sci, Seoul, South Korea; [Zuccarello, Giuseppe C.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand	Kongju National University; Seoul National University (SNU); Victoria University Wellington	Kim, GH (corresponding author), Kongju Natl Univ, Dept Biol, Kong Ju 314701, South Korea.	ghkim@kongju.ac.kr; hjjeong@snu.ac.kr	Jeong, hae jin/B-8908-2009; Zuccarello, Giuseppe C./D-8323-2015; Kim, Gwang Hoon/L-2266-2017	Zuccarello, Giuseppe C./0000-0003-0028-7227; Kim, Gwang Hoon/0000-0002-0009-8277; Kim, Gwang Hoon/0000-0001-8177-6107; Jeong, Hae Jin/0000-0003-3310-4335; Yoo, Yeong Du/0000-0003-0682-2112	Ecological Disturbance Program; KIMST/MOF award; Extreme Genomics Program; Ministry of Land, Transport and Maritime Affairs of the Korean Government; National Research Foundation of Korea [NRF 20120006718]	Ecological Disturbance Program; KIMST/MOF award(Korea Institute of Marine Science & Technology Promotion (KIMST)); Extreme Genomics Program; Ministry of Land, Transport and Maritime Affairs of the Korean Government(Ministry of Land, Transport and Maritime Affairs (MLTM), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea)	This research was partially supported by a grant from Ecological Disturbance Program funded by KIMST/MOF award to HJJ and a grant from the Extreme Genomics Program funded by the Ministry of Land, Transport and Maritime Affairs of the Korean Government to GHK. This research was partially supported by the National Research Foundation of Korea (grant NRF 20120006718 to GHK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archibald JM, 2009, CURR BIOL, V19, pR81, DOI 10.1016/j.cub.2008.11.067; Bachvaroff TR, 2004, PROTIST, V155, P65, DOI 10.1078/1434461000165; Baurain D, 2010, MOL BIOL EVOL, V27, P1698, DOI 10.1093/molbev/msq059; Burkholder JM, 2012, HARMFUL ALGAE, V14, P196, DOI 10.1016/j.hal.2011.10.022; Burki F, 2012, P ROY SOC B-BIOL SCI, V279, P2246, DOI 10.1098/rspb.2011.2301; Cai XM, 2003, GENE, V321, P39, DOI 10.1016/j.gene.2003.08.008; Cavalier-Smith T, 1999, J EUKARYOT MICROBIOL, V46, P347, DOI 10.1111/j.1550-7408.1999.tb04614.x; Deschamps P, 2012, GENOME BIOL EVOL, V4, P795, DOI 10.1093/gbe/evs053; Drummond A. J., 2012, GENEIOUS V5 6; Fast NM, 2001, MOL BIOL EVOL, V18, P418, DOI 10.1093/oxfordjournals.molbev.a003818; Feinstein TN, 2002, J PHYCOL, V38, P659, DOI 10.1046/j.1529-8817.2002.01175.x; Foth BJ, 2003, SCIENCE, V299, P705, DOI 10.1126/science.1078599; Gockel G, 2000, PROTIST, V151, P347, DOI 10.1078/S1434-4610(04)70033-4; Gould SB, 2008, ANNU REV PLANT BIOL, V59, P491, DOI 10.1146/annurev.arplant.59.032607.092915; Hackett JD, 2004, CURR BIOL, V14, P213, DOI 10.1016/j.cub.2004.01.032; Hoppenrath M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013220; Horiguchi T, 2006, PHYCOL RES, V54, P193, DOI 10.1111/j.1440-1835.2006.00426.x; Huang JL, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r88; Imanian B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010711; Janouskovec J, 2010, P NATL ACAD SCI USA, V107, P10949, DOI 10.1073/pnas.1003335107; Jeong HJ, 2006, AQUAT MICROB ECOL, V44, P263, DOI 10.3354/ame044263; Jeong Hae Jin, 2010, Ocean Science Journal, V45, P65, DOI 10.1007/s12601-010-0007-2; Jeong HJ, 2005, J EUKARYOT MICROBIOL, V52, P382, DOI 10.1111/j.1550-7408.2005.00051.x; Johnson MD, 2011, PHOTOSYNTH RES, V107, P117, DOI 10.1007/s11120-010-9546-8; Kaiser J, 2002, SCIENCE, V298, P346, DOI 10.1126/science.298.5592.346; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Keeling PJ, 2010, PHILOS T R SOC B, V365, P729, DOI 10.1098/rstb.2009.0103; Keeling PJ, 2009, J EUKARYOT MICROBIOL, V56, P1, DOI 10.1111/j.1550-7408.2008.00371.x; Kim E, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-73; Kleffmann T, 2004, CURR BIOL, V14, P354, DOI 10.1016/j.cub.2004.02.039; Leander BS, 2004, J PHYCOL, V40, P341, DOI 10.1111/j.1529-8817.2004.03129.x; Lewitus AJ, 1999, J PHYCOL, V35, P1430, DOI 10.1046/j.1529-8817.1999.3561430.x; McFadden GI, 2011, PROTOPLASMA, V248, P641, DOI 10.1007/s00709-010-0250-5; Moore RB, 2008, NATURE, V451, P959, DOI 10.1038/nature06635; Murray S, 2005, PROTIST, V156, P269, DOI 10.1016/j.protis.2005.05.003; Patron NJ, 2006, J MOL BIOL, V357, P1373, DOI 10.1016/j.jmb.2006.01.084; RAMBAUT A., 2009, TRACER V 1 5 0; Reyes-Prieto A, 2008, CURR BIOL, V18, P956, DOI 10.1016/j.cub.2008.05.042; Richards TA, 2006, EUKARYOT CELL, V5, P1517, DOI 10.1128/EC.00106-06; Robledo JAF, 2011, INT J PARASITOL, V41, P1217, DOI 10.1016/j.ijpara.2011.07.008; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Saldarriaga JF, 2001, J MOL EVOL, V53, P204, DOI 10.1007/s002390010210; Sanchez-Puerta MV, 2007, PROTIST, V158, P105, DOI 10.1016/j.protis.2006.09.004; Sekiguchi H, 2002, PROTIST, V153, P157, DOI 10.1078/1434-4610-00094; Shalchian-Tabrizi K, 2006, MOL BIOL EVOL, V23, P1504, DOI 10.1093/molbev/msl011; Slamovits CH, 2008, MOL BIOL EVOL, V25, P1297, DOI 10.1093/molbev/msn075; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; Vogelbein WK, 2002, NATURE, V418, P967, DOI 10.1038/nature01008; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Williams BAP, 2004, METH MOL B, V270, P151; Wisecaver JH, 2011, ANNU REV MICROBIOL, V65, P369, DOI 10.1146/annurev-micro-090110-102841; Wisecaver JH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-366; Wolfe AD, 1998, MOL BIOL EVOL, V15, P1243, DOI 10.1093/oxfordjournals.molbev.a025853; Yoon HS, 2002, P NATL ACAD SCI USA, V99, P11724, DOI 10.1073/pnas.172234799	56	4	4	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68232	10.1371/journal.pone.0068232	http://dx.doi.org/10.1371/journal.pone.0068232			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874554	Green Published, gold, Green Submitted			2022-12-27	WOS:000322064300020
J	Song, XM; Lichti, CF; Townsend, RR; Mueckler, M				Song, XiaoMei; Lichti, Cheryl F.; Townsend, R. Reid; Mueckler, Mike			Single Point Mutations Result in the Miss-Sorting of Glut4 to a Novel Membrane Compartment Associated with Stress Granule Proteins	PLOS ONE			English	Article							GLUCOSE-TRANSPORTER GLUT4; GTPASE-ACTIVATING PROTEIN; 3T3-L1 ADIPOCYTES; INSULIN-RESISTANCE; STORAGE-VESICLES; PLASMA-MEMBRANE; SKELETAL-MUSCLE; TARGETING MOTIF; ADIPOSE-TISSUE; GOLGI NETWORK	Insulin increases cellular glucose uptake and metabolism in the postprandial state by acutely stimulating the translocation of the Glut4 glucose transporter from intracellular membrane compartments to the cell surface in muscle and fat cells. The intracellular targeting of Glut4 is dictated by specific structural motifs within cytoplasmic domains of the transporter. We demonstrate that two leucine residues at the extreme C-terminus of Glut4 are critical components of a motif (IRM, insulin responsive motif) involved in the sorting of the transporter to insulin responsive vesicles in 3T3L1 adipocytes. Light microscopy, immunogold electron microscopy, subcellular fractionation, and sedimentation analysis indicate that mutations in the IRM cause the aberrant targeting of Glut4 to large dispersed membrane vesicles that are not insulin responsive. Proteomic characterization of rapidly and slowly sedimenting membrane vesicles (RSVs and SSVs) that were highly enriched by immunoadsorption for either wild-type Glut4 or an IRM mutant revealed that the major vesicle fraction containing the mutant transporter (IRM-RSVs) possessed a relatively small and highly distinct protein population that was enriched for proteins associated with stress granules. We suggest that the IRM is critical for an early step in the sorting of Glut4 to insulin-responsive subcellular membrane compartments and that IRM mutants are miss-targeted to relatively large, amorphous membrane vesicles that may be involved in a degradation pathway for miss-targeted or miss-folded proteins or represent a transitional membrane compartment that Glut4 traverses en route to insulin responsive storage compartments.	[Song, XiaoMei; Mueckler, Mike] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Lichti, Cheryl F.] Univ Texas, Dept Pharmacol & Toxicol, Galveston, TX USA; [Townsend, R. Reid] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	Washington University (WUSTL); University of Texas System; University of Texas Medical Branch Galveston; Washington University (WUSTL)	Mueckler, M (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.	mmueckler@wustl.edu		Lichti, Cheryl/0000-0003-4099-4954	National Institutes of Health [NIH R01 DK085110, NIH P41RR000954, NIH UCIRR024992]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085110] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants NIH R01 DK085110, NIH P41RR000954, and NIH UCIRR024992. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hasani H, 2002, J CELL SCI, V115, P131; Augustin R, 2010, IUBMB LIFE, V62, P315, DOI 10.1002/iub.315; Blot V, 2008, MOL BIOL CELL, V19, P3477, DOI 10.1091/mbc.E08-03-0236; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; CALDERHEAD DM, 1990, J BIOL CHEM, V265, P13800; Cline GW, 1999, NEW ENGL J MED, V341, P240, DOI 10.1056/NEJM199907223410404; Coort SLM, 2004, DIABETES, V53, P1655, DOI 10.2337/diabetes.53.7.1655; CORVERA S, 1994, J CELL BIOL, V126, P979, DOI 10.1083/jcb.126.4.979; Coster ACF, 2004, TRAFFIC, V5, P763, DOI 10.1111/j.1600-0854.2004.00218.x; CUSHMAN SW, 1980, J BIOL CHEM, V255, P4758; Doehner W, 2010, INT J CARDIOL, V138, P19, DOI 10.1016/j.ijcard.2008.07.004; El-Jack AK, 1999, MOL BIOL CELL, V10, P1581, DOI 10.1091/mbc.10.5.1581; Esk C, 2010, J CELL BIOL, V188, P131, DOI 10.1083/jcb.200908057; Fujita H, 2010, MOL BIOL CELL, V21, P2721, DOI 10.1091/mbc.E10-01-0029; Garippa RJ, 1996, J BIOL CHEM, V271, P20660, DOI 10.1074/jbc.271.34.20660; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; Gross DN, 2004, MOL CELL BIOL, V24, P7151, DOI 10.1128/MCB.24.16.7151-7162.2004; Hajri T, 2007, DIABETES, V56, P1872, DOI 10.2337/db06-1699; HANEY PM, 1995, J CELL BIOL, V129, P641, DOI 10.1083/jcb.129.3.641; Hashiramoto M, 2000, MOL CELL BIOL, V20, P416, DOI 10.1128/MCB.20.1.416-427.2000; Irvine K, 2004, INT J DEV BIOL, V48, P1065, DOI 10.1387/ijdb.041893ki; JAMES DE, 1989, NATURE, V338, P83, DOI 10.1038/338083a0; Jedrychowski MP, 2010, J BIOL CHEM, V285, P104, DOI 10.1074/jbc.M109.040428; Jordens I, 2010, MOL BIOL CELL, V21, P2034, DOI 10.1091/mbc.E10-02-0158; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Karpievitch Y, 2009, BIOINFORMATICS, V25, P2028, DOI 10.1093/bioinformatics/btp362; Karylowski O, 2004, MOL BIOL CELL, V15, P870, DOI 10.1091/mbc.E03-07-0517; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Khan AH, 2004, J BIOL CHEM, V279, P37505, DOI 10.1074/jbc.M405694200; Kobayashi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035820; Kolobova E, 2009, EXP CELL RES, V315, P542, DOI 10.1016/j.yexcr.2008.11.011; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; MARSH BJ, 1995, J CELL BIOL, V130, P1081, DOI 10.1083/jcb.130.5.1081; Marsh BJ, 1998, AM J PHYSIOL-ENDOC M, V275, pE412, DOI 10.1152/ajpendo.1998.275.3.E412; Martinez L, 2010, BIOCHEM PHARMACOL, V79, P1300, DOI 10.1016/j.bcp.2009.12.013; Melvin DR, 1999, BIOCHEMISTRY-US, V38, P1456, DOI 10.1021/bi980988y; Palacios S, 2001, J BIOL CHEM, V276, P3371, DOI 10.1074/jbc.M006739200; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Polpitiya AD, 2008, BIOINFORMATICS, V24, P1556, DOI 10.1093/bioinformatics/btn217; Ramm G, 2000, MOL BIOL CELL, V11, P4079, DOI 10.1091/mbc.11.12.4079; Roche SL, 2010, PEDIATR TRANSPLANT, V14, P159, DOI 10.1111/j.1399-3046.2009.01205.x; Sheena A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025747; Shewan AM, 2000, BIOCHEM J, V350, P99, DOI 10.1042/0264-6021:3500099; Shewan AM, 2003, MOL BIOL CELL, V14, P973, DOI 10.1091/mbc.E02-06-0315; Shi J, 2008, J BIOL CHEM, V283, P30311, DOI 10.1074/jbc.M805182200; Shigematsu S, 2003, J BIOL CHEM, V278, P10683, DOI 10.1074/jbc.M208563200; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; Solomon S, 2007, MOL CELL BIOL, V27, P2324, DOI 10.1128/MCB.02300-06; Song XM, 2008, J BIOL CHEM, V283, P12571, DOI 10.1074/jbc.M800838200; SUZUKI K, 1980, P NATL ACAD SCI-BIOL, V77, P2542, DOI 10.1073/pnas.77.5.2542; TANNER LI, 1987, J BIOL CHEM, V262, P8975; Thong FSL, 2007, DIABETES, V56, P414, DOI 10.2337/db06-0900; Uldry M, 2004, EMBO J, V23, P531, DOI 10.1038/sj.emboj.7600072; Vanderweyde T, 2012, J NEUROSCI, V32, P8270, DOI 10.1523/JNEUROSCI.1592-12.2012; Waller AP, 2011, J VET INTERN MED, V25, P315, DOI 10.1111/j.1939-1676.2010.0674.x; YEH JI, 1995, BIOCHEMISTRY-US, V34, P15523, DOI 10.1021/bi00047a018; Yeh TYJ, 2007, BIOCHEM J, V402, P279, DOI 10.1042/BJ20060793; Zierath JR, 1998, MOL CELL BIOCHEM, V182, P153, DOI 10.1023/A:1006861628496	58	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68516	10.1371/journal.pone.0068516	http://dx.doi.org/10.1371/journal.pone.0068516			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874650	gold, Green Submitted, Green Published			2022-12-27	WOS:000322064300040
J	Bernard, C; Dilharreguy, B; Allard, M; Amieva, H; Bonnet, F; Dauchy, F; Greib, C; Dehail, P; Catheline, G				Bernard, Charlotte; Dilharreguy, Bixente; Allard, Michele; Amieva, Helene; Bonnet, Fabrice; Dauchy, Frederic; Greib, Carinne; Dehail, Patrick; Catheline, Gwenaelle		ANRS Co Aquitaine Cohort Study Grp	Muscular Weakness in Individuals with HIV Associated with a Disorganization of the Cortico-Spinal Tract: A Multi-Modal MRI Investigation	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; DIFFUSION-TENSOR MRI; HUMAN CEREBRAL-CORTEX; HUMAN-IMMUNODEFICIENCY-VIRUS; MAGNETIC-RESONANCE IMAGES; TO-STAND PERFORMANCE; RAT SPINAL-CORD; WHITE-MATTER; MULTIPLE-SCLEROSIS; RADIAL DIFFUSIVITY	Motor impairment is highly prevalent in HIV-infected patients. Here, we assess associations between peripheral muscular deficits as evaluated by the 5 sit-to-stand test (5STS) and structural integrity of the motor system at a central level. Eighty-six HIV-infected patients receiving combination antiretroviral therapy and with no major cerebral events, underwent an MRI scan and the 5STS. Out of 86 participants, forty presented a score greater than two standard deviations above mean normative scores calculated for the 5STS and were therefore considered as motor-impaired. MRI-structural cerebral parameters were compared to the unimpaired participants. Fractional Anisotropy (FA), Axial Diffusivity (AD) and Radial Diffusivity (RD), reflecting microstructural integrity, were extracted from Diffusion-Tensor MRI. Global and regional cerebral volumes or thicknesses were extracted from 3D-T1 morphological MRI. Whereas the two groups did not differ for any HIV variables, voxel-wise analysis revealed that motor-impaired participants present low FA values in various cortico-motor tracts and low AD in left cortico-spinal tract. However, they did not present reduced volumes or thicknesses of the precentral cortices compared to unimpaired participants. The absence of alterations in cortical regions holding motor-neurons might argue against neurodegenerative process as an explanation of White Matter (WM) disorganization.	[Bernard, Charlotte; Dilharreguy, Bixente; Allard, Michele; Catheline, Gwenaelle] Univ Bordeaux, INCIA, UMR 5287, Talence, France; [Bernard, Charlotte; Dilharreguy, Bixente; Allard, Michele; Catheline, Gwenaelle] CNRS, INCIA, UMR 5287, Talence, France; [Bernard, Charlotte; Allard, Michele; Catheline, Gwenaelle] EPHE, Bordeaux, France; [Amieva, Helene; Bonnet, Fabrice] ISPED, Bordeaux, France; [Allard, Michele; Bonnet, Fabrice; Dauchy, Frederic; Greib, Carinne; Dehail, Patrick] CHU, Bordeaux, France; [Dehail, Patrick] Univ Bordeaux, EA 4136, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Catheline, G (corresponding author), Univ Bordeaux, INCIA, UMR 5287, Talence, France.	gwenaelle.catheline@u-bordeaux2.fr	Amieva, Helene/T-4170-2019; Dauchy, Frédéric-Antoine/T-4652-2019; Dehail, Patrick/T-5081-2019; Amieva, Helene/E-4850-2014; catheline, gwenaelle/C-8532-2018; Bonnet, Fabrice/T-3254-2019	Amieva, Helene/0000-0002-0119-7242; Bernard, Charlotte/0000-0003-2677-4023; Catheline, Gwenaelle/0000-0003-1949-8913; dilharreguy, bixente/0000-0002-7771-1383	French Agency for AIDS and hepatitis research (ANRS)	French Agency for AIDS and hepatitis research (ANRS)(ANRS)	This study was supported by grants from the French Agency for AIDS and hepatitis research (ANRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins DL, 2006, J APPL PHYSIOL, V101, P1776, DOI 10.1152/japplphysiol.00515.2006; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Authier FJ, 2005, MUSCLE NERVE, V32, P247, DOI 10.1002/mus.20338; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Blain CRV, 2007, AMYOTROPH LATERAL SC, V8, P348, DOI 10.1080/17482960701548139; Bonnet F, 2013, AIDS, V27, P391, DOI 10.1097/QAD.0b013e32835b1019; Bosch B, 2012, NEUROBIOL AGING, V33, P61, DOI 10.1016/j.neurobiolaging.2010.02.004; Buatois S, 2008, J AM GERIATR SOC, V56, P1575, DOI 10.1111/j.1532-5415.2008.01777.x; Budde MD, 2012, NEUROIMAGE, V63, P1, DOI 10.1016/j.neuroimage.2012.06.042; Budde MD, 2009, J NEUROSCI, V29, P2805, DOI 10.1523/JNEUROSCI.4605-08.2009; CAMPBELL AJ, 1989, J GERONTOL, V44, pM112, DOI 10.1093/geronj/44.4.m112; Chen YS, 2009, NEUROIMAGE, V47, P1154, DOI 10.1016/j.neuroimage.2009.04.030; Ciccarelli O, 2009, HUM BRAIN MAPP, V30, P615, DOI 10.1002/hbm.20527; Concha L, 2010, J NEUROSCI, V30, P996, DOI 10.1523/JNEUROSCI.1619-09.2010; Crystal S, 2000, MED CARE, V38, P1210, DOI 10.1097/00005650-200012000-00008; CSUKA M, 1985, AM J MED, V78, P77, DOI 10.1016/0002-9343(85)90465-6; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Deboy CA, 2007, BRAIN, V130, P2199, DOI 10.1093/brain/awm122; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dudgeon WD, 2006, HIV MED, V7, P299, DOI 10.1111/j.1468-1293.2006.00380.x; Ellis CM, 1999, NEUROLOGY, V53, P1051, DOI 10.1212/WNL.53.5.1051; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; Harsan LA, 2006, J NEUROSCI RES, V83, P392, DOI 10.1002/jnr.20742; Harsan LA, 2007, J NEUROSCI RES, V85, P935, DOI 10.1002/jnr.21201; Hugenschmidt CE, 2008, CEREB CORTEX, V18, P433, DOI 10.1093/cercor/bhm080; Irvine KA, 2006, J NEUROIMMUNOL, V175, P69, DOI 10.1016/j.jneuroim.2006.03.002; Iwata NK, 2008, NEUROLOGY, V70, P528, DOI 10.1212/01.wnl.0000299186.72374.19; JANSSEN RS, 1991, NEUROLOGY, V41, P778; Kim JH, 2006, NEUROBIOL DIS, V21, P626, DOI 10.1016/j.nbd.2005.09.009; Klawiter EC, 2011, NEUROIMAGE, V55, P1454, DOI 10.1016/j.neuroimage.2011.01.007; Kunimatsu Akira, 2004, Magn Reson Med Sci, V3, P11, DOI 10.2463/mrms.3.11; Le Bihan D, 2012, NEUROIMAGE, V61, P324, DOI 10.1016/j.neuroimage.2011.11.006; LIPSITZ LA, 1991, J GERONTOL, V46, pM114, DOI 10.1093/geronj/46.4.M114; Lord SR, 2002, J GERONTOL A-BIOL, V57, pM539, DOI 10.1093/gerona/57.8.M539; Madler B, 2008, MAGN RESON IMAGING, V26, P874, DOI 10.1016/j.mri.2008.01.047; Minnerop M, 2011, BRAIN, V134, P3527, DOI 10.1093/brain/awr299; NAVIA BA, 1986, ANN NEUROL, V19, P517, DOI 10.1002/ana.410190602; NEVITT MC, 1989, JAMA-J AM MED ASSOC, V261, P2663, DOI 10.1001/jama.261.18.2663; Pfefferbaum A, 2007, BRAIN, V130, P48, DOI 10.1093/brain/awl242; Reich DS, 2008, AM J NEURORADIOL, V29, P333, DOI 10.3174/ajnr.A0788; Richert L, 2011, AIDS, V25, P797, DOI 10.1097/QAD.0b013e3283455dff; Robinson-Papp J, 2009, MUSCLE NERVE, V40, P1043, DOI 10.1002/mus.21465; Roccatagliata L, 2009, AMYOTROPH LATERAL SC, V10, P47, DOI 10.1080/17482960802267530; Rose S, 2012, NEUROIMAGE, V59, P2661, DOI 10.1016/j.neuroimage.2011.08.054; Rusch Melanie, 2004, Health Qual Life Outcomes, V2, P46, DOI 10.1186/1477-7525-2-46; Sage CA, 2007, NEUROIMAGE, V34, P486, DOI 10.1016/j.neuroimage.2006.09.025; Scott WB, 2007, MUSCLE NERVE, V36, P374, DOI 10.1002/mus.20832; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Stebbins GT, 2007, JAIDS-J ACQ IMM DEF, V46, P564, DOI 10.1097/QAI.0b013e318159d807; Sullivan EV, 2011, BRAIN IMAGING BEHAV, V5, P12, DOI 10.1007/s11682-010-9107-y; Tate DF, 2010, BRAIN IMAGING BEHAV, V4, P68, DOI 10.1007/s11682-009-9086-z; Thiebaut R, 2000, AIDS, V14, P971, DOI 10.1097/00002030-200005260-00008; Toosy AT, 2003, J NEUROL NEUROSUR PS, V74, P1250, DOI 10.1136/jnnp.74.9.1250; Turner MR, 2007, AMYOTROPH LATERAL SC, V8, P343, DOI 10.1080/17482960701538734; Turner MR, 2009, LANCET NEUROL, V8, P94, DOI 10.1016/S1474-4422(08)70293-X; Tyszka JM, 2006, NEUROIMAGE, V29, P1058, DOI 10.1016/j.neuroimage.2005.08.037; Unrath A, 2010, HUM BRAIN MAPP, V31, P1727, DOI 10.1002/hbm.20971; Vernooij MW, 2008, NEUROIMAGE, V43, P470, DOI 10.1016/j.neuroimage.2008.07.052; Verstraete E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013664; Werring DJ, 2000, J NEUROL NEUROSUR PS, V69, P269, DOI 10.1136/jnnp.69.2.269; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Whitney SL, 2005, PHYS THER, V85, P1034, DOI 10.1093/ptj/85.10.1034; Wieshmann UC, 1999, J NEUROL NEUROSUR PS, V66, P797, DOI 10.1136/jnnp.66.6.797; Wilson M, 2003, J NEUROL NEUROSUR PS, V74, P203, DOI 10.1136/jnnp.74.2.203; Wu YC, 2011, NEUROIMAGE, V58, P829, DOI 10.1016/j.neuroimage.2011.06.067; Yarasheski KE, 2011, J GERONTOL A-BIOL, V66, P332, DOI 10.1093/gerona/glq228; Zhang JY, 2009, J NEUROSCI, V29, P3160, DOI 10.1523/JNEUROSCI.3941-08.2009	78	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e66810	10.1371/journal.pone.0066810	http://dx.doi.org/10.1371/journal.pone.0066810			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874398	Green Published, gold, Green Submitted			2022-12-27	WOS:000322218800004
J	Laeyendecker, O; Piwowar-Manning, E; Fiamma, A; Kulich, M; Donnell, D; Bassuk, D; Mullis, CE; Chin, C; Swanson, P; Hackett, J; Clarke, W; Marzinke, M; Szekeres, G; Gray, G; Richter, L; Alexandre, MW; Chariyalertsak, S; Chingono, A; Celentano, DD; Morin, SF; Sweat, M; Coates, T; Eshleman, SH				Laeyendecker, Oliver; Piwowar-Manning, Estelle; Fiamma, Agnes; Kulich, Michal; Donnell, Deborah; Bassuk, Deb; Mullis, Caroline E.; Chin, Craig; Swanson, Priscilla; Hackett, John, Jr.; Clarke, William; Marzinke, Mark; Szekeres, Greg; Gray, Glenda; Richter, Linda; Alexandre, Michel W.; Chariyalertsak, Suwat; Chingono, Alfred; Celentano, David D.; Morin, Stephen F.; Sweat, Michael; Coates, Thomas; Eshleman, Susan H.			Estimation of HIV Incidence in a Large, Community-Based, Randomized Clinical Trial: NIMH Project Accept (HIV Prevention Trials Network 043)	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; UNITED-STATES; INTERVENTION; RISK	Background: National Institute of Mental Health Project Accept (HIV Prevention Trials Network [HPTN] 043) is a large, Phase III, community-randomized, HIV prevention trial conducted in 48 matched communities in Africa and Thailand. The study intervention included enhanced community-based voluntary counseling and testing. The primary endpoint was HIV incidence, assessed in a single, cross-sectional, post-intervention survey of >50,000 participants. Methods: HIV rapid tests were performed in-country. HIV status was confirmed at a central laboratory in the United States. HIV incidence was estimated using a multi-assay algorithm (MAA) that included the BED capture immunoassay, an avidity assay, CD4 cell count, and HIV viral load. Results: Data from Thailand was not used in the endpoint analysis because HIV prevalence was low. Overall, 7,361 HIV infections were identified (4 acute, 3 early, and 7,354 established infections). Samples from established infections were analyzed using the MAA; 467 MAA positive samples were identified; 29 of those samples were excluded because they contained antiretroviral drugs. HIV prevalence was 16.5% (range at study sites: 5.93% to 30.8%). HIV incidence was 1.60% (range at study sites: 0.78% to 3.90%). Conclusions: In this community-randomized trial, a MAA was used to estimate HIV incidence in a single, cross-sectional post-intervention survey. Results from this analysis were subsequently used to compare HIV incidence in the control and intervention communities.	[Laeyendecker, Oliver] NIAID, Immunoregulat Lab, NIH, Baltimore, MD USA; [Laeyendecker, Oliver; Mullis, Caroline E.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Piwowar-Manning, Estelle; Clarke, William; Marzinke, Mark; Eshleman, Susan H.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Fiamma, Agnes; Coates, Thomas] Univ Calif Los Angeles, Program Global Hlth, Los Angeles, CA USA; [Kulich, Michal] Charles Univ Prague, Fac Math & Phys, Dept Probabil & Stat, Prague, Czech Republic; [Donnell, Deborah; Bassuk, Deb; Chin, Craig] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Donnell, Deborah] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Swanson, Priscilla; Hackett, John, Jr.] Abbott Diagnost, Infect Dis Res, Abbott Pk, IL USA; [Gray, Glenda] Univ Witwatersrand, Chris Hani Baragwanath Hosp, Perinatal HIV Res Unit, Johannesburg, South Africa; [Richter, Linda] Human Sci Res Council, Durban, South Africa; [Alexandre, Michel W.] Muhimbili Univ Hlth & Allied Sci, Dept Microbiol & Immunol, Dar Es Salaam, Tanzania; [Chariyalertsak, Suwat] Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai 50000, Thailand; [Chingono, Alfred] Univ Zimbabwe, Sch Med, Dept Psychiat, Harare, Zimbabwe; [Celentano, David D.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Morin, Stephen F.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Sweat, Michael] Med Univ S Carolina, Dept Psychiat & Behav Sci, Charleston, SC 29425 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); NIH National Institute on Aging (NIA); Johns Hopkins University; Johns Hopkins University; University of California System; University of California Los Angeles; Charles University Prague; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Witwatersrand; Human Sciences Research Council-South Africa; Muhimbili University of Health & Allied Sciences; Chiang Mai University; University of Zimbabwe; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of California System; University of California San Francisco; Medical University of South Carolina	Eshleman, SH (corresponding author), NIAID, Immunoregulat Lab, NIH, Baltimore, MD USA.	seshlem@jhmi.edu	Kulich, Michal/B-1483-2013	Kulich, Michal/0000-0002-2812-8968; Donnell, Deborah/0000-0002-0587-7480; Laeyendecker, Oliver/0000-0002-6429-4760	U.S. National Institute of Mental Health (NIMH) as a cooperative agreement [U01MH066687]; Johns Hopkins University [U01-MH066688]; Medical University of South Carolina [U01-MH066701]; University of California, San Francisco - SFM, PI [U01-MH066702]; HPTN Protocol [U01-AI068613/UM1-AI068613, U01-AI068617/UM1-AI068617, U01-AI068619/UM1-AI068619]; Division of AIDS of the U.S. National Institute of Allergy and Infectious Diseases (NIAID); Office of AIDS Research of the U.S. National Institutes of Health (NIH); Division of Intramural Research, NIAID, NIH [R01-AI095068]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068619, UM1AI068613, UM1AI068617, U01AI068613, ZIAAI000361, UM1AI069399, UM1AI068619, U01AI068617, ZIAAI001040, R01AI095068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH066687, U01MH066701, U01MH066688, U01MH066702] Funding Source: NIH RePORTER	U.S. National Institute of Mental Health (NIMH) as a cooperative agreement; Johns Hopkins University(Johns Hopkins University); Medical University of South Carolina; University of California, San Francisco - SFM, PI; HPTN Protocol; Division of AIDS of the U.S. National Institute of Allergy and Infectious Diseases (NIAID); Office of AIDS Research of the U.S. National Institutes of Health (NIH); Division of Intramural Research, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was sponsored by the U.S. National Institute of Mental Health (NIMH) as a cooperative agreement, through contracts U01MH066687 (Johns Hopkins University - DC, PI); U01-MH066688 (Medical University of South Carolina - MS, PI); U01-MH066701 (University of California, Los Angeles - TC, PI); and U01-MH066702 (University of California, San Francisco - SFM, PI). In addition, this work was supported as HPTN Protocol 043 through contracts U01-AI068613/UM1-AI068613 (HPTN Network Laboratory - SHE, PI); U01-AI068617/UM1-AI068617 (SCHARP - DD, PI); and U01-AI068619/UM1-AI068619 (HPTN - Sten Vermund/Wafaa El-Sadr, PIs) of the Division of AIDS of the U.S. National Institute of Allergy and Infectious Diseases (NIAID); and by the Office of AIDS Research of the U.S. National Institutes of Health (NIH). Additional support was provided through R01-AI095068 (SHE/Ron Brookmeyer - PIs), and by the Division of Intramural Research, NIAID, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROOKMEYER R, 1995, AM J EPIDEMIOL, V141, P166, DOI 10.1093/oxfordjournals.aje.a117404; Brookmeyer R, 2013, J ACQUIR IM IN PRESS; Brookmeyer R, 2013, AM J EPIDEMIOL, V177, P264, DOI 10.1093/aje/kws436; Coates T, 2013, 20 C RETR OPP INF MA; Collinson-Streng AN, 2009, AIDS RES HUM RETROV, V25, P1045, DOI 10.1089/aid.2009.0127; Dobbs T, 2004, J CLIN MICROBIOL, V42, P2623, DOI 10.1128/JCM.42.6.2623-2628.2004; Eshleman SH, 2013, J INFECT DIS, V207, P223, DOI 10.1093/infdis/jis658; Genberg BL, 2008, JAIDS-J ACQ IMM DEF, V49, P309, DOI 10.1097/QAI.0b013e3181893ed0; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Khumalo-Sakutukwa G, 2008, JAIDS-J ACQ IMM DEF, V49, P422, DOI 10.1097/QAI.0b013e31818a6cb5; Kulich M, 2013, EVALUATION MUL UNPUB; Laeyendecker O, 2013, 20 C RETR OPP INF MA; Laeyendecker O, 2013, IDENTIFICATION UNPUB; Laeyendecker O, 2012, AIDS RES HUM RETROV, V28, P816, DOI [10.1089/aid.2011.0258, 10.1089/AID.2011.0258]; Laeyendecker O, 2013, J INFECT DIS, V207, P232, DOI 10.1093/infdis/jis659; Marzinke MA, 2012, 47 M AC CLIN LAB PHY; Masciotra S, 2010, 17 C RETR OPP INF FE; Mullis C, 2012, 19 C RETR OPP INF MA; Piwowar-Manning E, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-251; Rehle TM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011094; Sweat M, 2011, LANCET INFECT DIS, V11, P525, DOI 10.1016/S1473-3099(11)70060-3; UNAIDS Reference Group on Estimates Modeling and Projections, 2006, WEEKLY EPIDEMIOL REC, V81, P33; Wendel SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055525	23	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e68349	10.1371/journal.pone.0068349	http://dx.doi.org/10.1371/journal.pone.0068349			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874597	Green Published, Green Submitted, gold			2022-12-27	WOS:000322218800027
J	Meshcheryakov, VA; Barker, CS; Kostyukova, AS; Samatey, FA				Meshcheryakov, Vladimir A.; Barker, Clive S.; Kostyukova, Alla S.; Samatey, Fadel A.			Function of FlhB, a Membrane Protein Implicated in the Bacterial Flagellar Type III Secretion System	PLOS ONE			English	Article							RAY CRYSTALLOGRAPHIC ANALYSIS; TERMINAL CYTOPLASMIC DOMAIN; SUBSTRATE-SPECIFICITY; HOOK-LENGTH; SALMONELLA; EXPORT; FLIK; CRYSTALLIZATION; COMPONENTS; PURIFICATION	The membrane protein FlhB is a highly conserved component of the flagellar secretion system, and it plays an active role in the regulation of protein export. In this study conserved properties of FlhB that are important for its function were investigated. Replacing the flhB gene (or part of the gene) in Salmonella typhimurium with the flhB gene of the distantly related bacterium Aquifex aeolicus greatly reduces motility. However, motility can be restored to some extent by spontaneous mutations in the part of flhB gene coding for the cytoplasmic domain of Aquifex FlhB. Structural analysis suggests that these mutations destabilize the structure. The secondary structure and stability of the mutated cytoplasmic fragments of FlhB have been studied by circular dichroism spectroscopy. The results suggest that conformational flexibility could be important for FlhB function. An extragenic suppressor mutation in the fliS gene, which decreases the affinity of FliS to FliC, partially restores motility of the FlhB substitution mutants.	[Meshcheryakov, Vladimir A.; Barker, Clive S.; Samatey, Fadel A.] Okinawa Inst Sci & Technol, Trans Membrane Trafficking Unit, Okinawa, Japan; [Kostyukova, Alla S.] Washington State Univ, Sch Chem Engn & Bioengn, Pullman, WA 99164 USA	Okinawa Institute of Science & Technology Graduate University; Washington State University	Samatey, FA (corresponding author), Okinawa Inst Sci & Technol, Trans Membrane Trafficking Unit, Okinawa, Japan.	f.a.samatey@oist.jp		Samatey, Fadel/0000-0002-0733-2863	OIST	OIST	This work was supported by direct funding provided by OIST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa S, 2001, FEMS MICROBIOL LETT, V202, P157, DOI 10.1111/j.1574-6968.2001.tb10797.x; Auvray F, 2001, J MOL BIOL, V308, P221, DOI 10.1006/jmbi.2001.4597; Bange G, 2010, P NATL ACAD SCI USA, V107, P11295, DOI 10.1073/pnas.1001383107; Barker CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044030; Blocker A, 2003, P NATL ACAD SCI USA, V100, P3027, DOI 10.1073/pnas.0535335100; Deane JE, 2008, MOL MICROBIOL, V69, P267, DOI 10.1111/j.1365-2958.2008.06293.x; Deckert G, 1998, NATURE, V392, P353, DOI 10.1038/32831; Evans LDB, 2006, P NATL ACAD SCI USA, V103, P17474, DOI 10.1073/pnas.0605197103; Evdokimov AG, 2003, NAT STRUCT BIOL, V10, P789, DOI 10.1038/nsb982; Ferris HU, 2005, J BIOL CHEM, V280, P41236, DOI 10.1074/jbc.M509438200; Fraser GM, 2003, MOL MICROBIOL, V48, P1043, DOI 10.1046/j.1365-2958.2003.03487.x; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hirano T, 2003, J BACTERIOL, V185, P2485, DOI 10.1128/JB.185.8.2485-2492.2003; HIRANO T, 1994, J BACTERIOL, V176, P5439, DOI 10.1128/JB.176.17.5439-5449.1994; JIANG WH, 1995, J BACTERIOL, V177, P6411, DOI 10.1128/jb.177.22.6411-6421.1995; Karlinsey JE, 2007, METHOD ENZYMOL, V421, P199, DOI 10.1016/S0076-6879(06)21016-4; KUTSUKAKE K, 1994, J BACTERIOL, V176, P7625, DOI 10.1128/JB.176.24.7625-7629.1994; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Merz A, 2000, BIOCHEMISTRY-US, V39, P880, DOI 10.1021/bi992333i; Meshcheryakov VA, 2013, ACTA CRYSTALLOGR D, V69, P812, DOI 10.1107/S0907444913002102; Meshcheryakov VA, 2011, ACTA CRYSTALLOGR F, V67, P808, DOI 10.1107/S1744309111018938; Meshcheryakov VA, 2011, ACTA CRYSTALLOGR F, V67, P280, DOI 10.1107/S1744309110052942; Minamino T, 1999, J BACTERIOL, V181, P1388, DOI 10.1128/JB.181.5.1388-1394.1999; Minamino T, 2000, J BACTERIOL, V182, P4906, DOI 10.1128/JB.182.17.4906-4914.2000; MINAMINO T, 1994, J BACTERIOL, V176, P7630, DOI 10.1128/JB.176.24.7630-7637.1994; Minamino T, 2006, J MOL BIOL, V362, P1148, DOI 10.1016/j.jmb.2006.08.004; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Ohnishi K, 1997, J BACTERIOL, V179, P6092, DOI 10.1128/jb.179.19.6092-6099.1997; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; RYU J, 1990, BIOTECHNIQUES, V8, P43; Thomas J, 2004, P NATL ACAD SCI USA, V101, P3945, DOI 10.1073/pnas.0307223101; Toker AS, 1996, J BACTERIOL, V178, P7069, DOI 10.1128/jb.178.24.7069-7079.1996; VARLEY PG, 1991, J MOL BIOL, V220, P531, DOI 10.1016/0022-2836(91)90028-5; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Williams AW, 1996, J BACTERIOL, V178, P2960, DOI 10.1128/jb.178.10.2960-2970.1996; YAMAGUCHI S, 1984, J GEN MICROBIOL, V130, P255; Zarivach R, 2008, NATURE, V453, P124, DOI 10.1038/nature06832; Zavodszky P, 1998, P NATL ACAD SCI USA, V95, P7406, DOI 10.1073/pnas.95.13.7406	40	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e68384	10.1371/journal.pone.0068384	http://dx.doi.org/10.1371/journal.pone.0068384			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874605	Green Published, Green Submitted, gold			2022-12-27	WOS:000322218800029
J	Al Dhaheri, Y; Attoub, S; Arafat, K; AbuQamar, S; Viallet, J; Saleh, A; Al Agha, H; Eid, A; Iratni, R				Al Dhaheri, Yusra; Attoub, Samir; Arafat, Kholoud; AbuQamar, Synan; Viallet, Jean; Saleh, Alaaeldin; Al Agha, Hala; Eid, Ali; Iratni, Rabah			Anti-Metastatic and Anti-Tumor Growth Effects of Origanum majorana on Highly Metastatic Human Breast Cancer Cells: Inhibition of NF kappa B Signaling and Reduction of Nitric Oxide Production	PLOS ONE			English	Article							E-CADHERIN EXPRESSION; MATRIX METALLOPROTEINASES; TUMOR-GROWTH; PHOSPHATIDYLINOSITOL 3-KINASE; INVASIVE GROWTH; E-SELECTIN; IN-VITRO; MDA-MB-231; ANGIOGENESIS; MIGRATION	Background: We have recently reported that Origanum majorana exhibits anticancer activity by promoting cell cycle arrest and apoptosis of the metastatic MDA-MB-231 breast cancer cell line. Here, we extended our study by investigating the effect of O. majorana on the migration, invasion and tumor growth of these cells. Results: We demonstrate that non-cytotoxic concentrations of O. majorana significantly inhibited the migration and invasion of the MDA-MB-231 cells as shown by wound-healing and matrigel invasion assays. We also show that O. majorana induce homotypic aggregation of MDA-MB-231 associated with an upregulation of E-cadherin protein and promoter activity. Furthermore, we show that O. majorana decrease the adhesion of MDA-MB-231 to HUVECs and inhibits transendothelial migration of MDA-MB-231 through TNF-alpha-activated HUVECs. Gelatin zymography assay shows that O. majorana suppresses the activities of matrix metalloproteinase-2 and -9 (MMP-2 and MMP-9). ELISA, RT-PCR and Western blot results revealed that O. majorana decreases the expression of MMP-2, MMP-9, urokinase plasminogen activator receptor (uPAR), ICAM-1 and VEGF. Further investigation revealed that O. majorana suppresses the phosphorylation of I kappa B, downregulates the nuclear level of NF kappa B and reduces Nitric Oxide (NO) production in MDA-MB-231 cells. Most importantly, by using chick embryo tumor growth assay, we also show that O. majorana promotes inhibition of tumor growth and metastasis in vivo. Conclusion: Our findings identify Origanum majorana as a promising chemopreventive and therapeutic candidate that modulate breast cancer growth and metastasis.	[Al Dhaheri, Yusra; AbuQamar, Synan; Iratni, Rabah] United Arab Emirates Univ, Coll Sci, Dept Biol, Alabama, Ain, U Arab Emirates; [Attoub, Samir; Arafat, Kholoud] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Pharmacol & Therapeut, Alabama, Ain, U Arab Emirates; [Viallet, Jean] Univ Grenoble 1, INSERM, U823, Grenoble, France; [Saleh, Alaaeldin; Al Agha, Hala; Eid, Ali] Qatar Univ, Coll Arts & Sci, Dept Biol & Environm Sci, Doha, Qatar	United Arab Emirates University; United Arab Emirates University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Qatar University	Eid, A (corresponding author), Qatar Univ, Coll Arts & Sci, Dept Biol & Environm Sci, Doha, Qatar.	ali.eid@qu.edu.qa; R_iratni@uaeu.ac.ae	Eid, Ali Hussein/ABD-6291-2021; Attoub, Samir/N-6852-2018; AbuQamar, Synan/AAV-1229-2021	Eid, Ali Hussein/0000-0003-3004-5675; AbuQamar, Synan/0000-0002-2129-7689; Viallet, Jean/0000-0003-1137-0093	College of Science (UAEU); Terry Fox research grant	College of Science (UAEU); Terry Fox research grant	This work was supported by the College of Science (UAEU) interdisciplinary research grant to RI and by a Terry Fox research grant to SA. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Adams LS, 2010, CANCER RES, V70, P3594, DOI 10.1158/0008-5472.CAN-09-3565; Al Dhaheri Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056649; Al-Harbi NO, 2011, J MED PLANTS RES, V5, P5479; Ambs S, 1998, NAT MED, V4, P1371, DOI 10.1038/3957; Attoub S, 2011, EUR J PHARMACOL, V651, P18, DOI 10.1016/j.ejphar.2010.10.063; Bachmeier BE, 2001, ANTICANCER RES, V21, P3821; Baranwal S, 2009, BIOCHEM BIOPH RES CO, V384, P6, DOI 10.1016/j.bbrc.2009.04.051; Berx G, 1995, EMBO J, V14, P6107, DOI 10.1002/j.1460-2075.1995.tb00301.x; Bigelow RLH, 2006, ONCOGENE, V25, P1922, DOI 10.1038/sj.onc.1209227; BROWN LF, 1993, CANCER RES, V53, P4727; Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Corn PG, 2000, CLIN CANCER RES, V6, P4243; El-Ashmawy IM, 2005, BASIC CLIN PHARMACOL, V97, P238, DOI 10.1111/j.1742-7843.2005.pto_136.x; Garbett EA, 2000, J CLIN PATHOL-MOL PA, V53, P99, DOI 10.1136/mp.53.2.99; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Glynn SA, 2010, J CLIN INVEST, V120, P3843, DOI 10.1172/JCI42059; Green CE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006713; Gu YH, 2006, ONCOL REP, V15, P417; Jadeski LC, 2000, INT J CANCER, V86, P30, DOI 10.1002/(SICI)1097-0215(20000401)86:1<30::AID-IJC5>3.0.CO;2-I; Jiang JH, 2008, INT J MOL MED, V21, P577; Kerbel R, 2002, NAT REV CANCER, V2, P727, DOI 10.1038/nrc905; Kerbel RS, 2006, SCIENCE, V312, P1171, DOI 10.1126/science.1125950; Kim NH, 2011, BIOCHEM BIOPH RES CO, V404, P915, DOI 10.1016/j.bbrc.2010.12.081; KLEINER DE, 1994, ANAL BIOCHEM, V218, P325, DOI 10.1006/abio.1994.1186; KOCH AE, 1995, NATURE, V376, P517, DOI 10.1038/376517a0; Kowalski PJ, 2003, BREAST CANCER RES, V5, pR217, DOI 10.1186/bcr651; Kuno T., 2012, Journal of Biophysical Chemistry, V3, P156, DOI 10.4236/jbpc.2012.32018; Lee HS, 2008, J NUTR BIOCHEM, V19, P313, DOI 10.1016/j.jnutbio.2007.05.008; Lee WJ, 2008, TOXICOL APPL PHARM, V226, P178, DOI 10.1016/j.taap.2007.09.013; Lee YJ, 2012, EUR J MED CHEM, V56, P361, DOI 10.1016/j.ejmech.2012.07.041; Leeja L, 2007, J ENVIRON BIOL, V28, P145; Lerebours F, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-41; Li CJ, 2013, CELL BIOCHEM FUNCT, V31, P263, DOI 10.1002/cbf.2899; Li FN, 2012, TOXICOL APPL PHARM, V261, P217, DOI 10.1016/j.taap.2012.04.011; Ling H, 2010, BRIT J PHARMACOL, V161, P1763, DOI 10.1111/j.1476-5381.2010.00991.x; LIOTTA LA, 1980, NATURE, V284, P67, DOI 10.1038/284067a0; Liu YN, 2005, ONCOGENE, V24, P8277, DOI 10.1038/sj.onc.1208991; MEROMSKY L, 1986, CANCER RES, V46, P5270; Miron TL, 2011, J CHROMATOGR A, V1218, P4918, DOI 10.1016/j.chroma.2010.11.055; Mohammadizadeh F, 2009, CANCER BIOMARK, V5, P1, DOI 10.3233/CBM-2009-0551; Muntane J, 2010, WORLD J HEPATOL, V2, P337, DOI 10.4254/wjh.v2.i9.337; Nizamutdinova IT, 2008, CARCINOGENESIS, V29, P1885, DOI 10.1093/carcin/bgn151; NOVAK U, 1991, NUCLEIC ACIDS RES, V19, P3389, DOI 10.1093/nar/19.12.3389; Pacheco MM, 1998, CLIN EXP METASTAS, V16, P577, DOI 10.1023/A:1006580415796; Park JS, 2009, ANTICANCER RES, V29, P355; PERKINS ND, 2012, NAT REV CANCER, V12, P21131; Prudent R, 2013, BRIT J PHARMACOL, V168, P673, DOI 10.1111/j.1476-5381.2012.02230.x; Przybylowska K, 2006, BREAST CANCER RES TR, V95, P65, DOI 10.1007/s10549-005-9042-6; Relf M, 1997, CANCER RES, V57, P963; Reuben SC, 2012, MOL NUTR FOOD RES, V56, P14, DOI 10.1002/mnfr.201100619; Rose P, 2005, TOXICOL APPL PHARM, V209, P105, DOI 10.1016/j.taap.2005.04.010; Rosette C, 2005, CARCINOGENESIS, V26, P943, DOI 10.1093/carcin/bgi070; Schroder C, 2011, J CANCER RES CLIN, V137, P1193, DOI 10.1007/s00432-011-0984-2; Sliva D, 2002, BIOCHEM BIOPH RES CO, V298, P603, DOI 10.1016/S0006-291X(02)02496-8; Sliva D, 2002, J BIOL CHEM, V277, P3150, DOI 10.1074/jbc.M109579200; Switzer CH, 2011, TRENDS PHARMACOL SCI, V32, P644, DOI 10.1016/j.tips.2011.07.001; Teiten MH, 2010, GENES NUTR, V5, P61, DOI 10.1007/s12263-009-0152-3; Tsimogiannis D, 2006, INT J FOOD SCI TECH, V41, P39, DOI 10.1111/j.1365-2621.2006.01259.x; Vagi E, 2005, J AGR FOOD CHEM, V53, P17, DOI 10.1021/jf048777p; Vakkala M, 2000, CLIN CANCER RES, V6, P2408; Wang AY, 2000, EUR J BIOCHEM, V267, P3248, DOI 10.1046/j.1432-1327.2000.01350.x; Wang C, 2003, CHEM RES TOXICOL, V16, P1004, DOI 10.1021/tx0340448; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yang HL, 2011, FOOD CHEM TOXICOL, V49, P290, DOI 10.1016/j.fct.2010.10.031; Yodkeeree S, 2010, EUR J PHARMACOL, V627, P8, DOI 10.1016/j.ejphar.2009.09.052; Zen K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001826	66	46	48	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68808	10.1371/journal.pone.0068808	http://dx.doi.org/10.1371/journal.pone.0068808			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874773	Green Submitted, Green Published, gold			2022-12-27	WOS:000321765300067
J	Khan, S; Brougham, CL; Ryan, J; Sahrudin, A; O'Neill, G; Wall, D; Curran, C; Newell, J; Kerin, MJ; Dwyer, RM				Khan, Sonja; Brougham, Cathy L.; Ryan, James; Sahrudin, Arisha; O'Neill, Gregory; Wall, Deirdre; Curran, Catherine; Newell, John; Kerin, Michael J.; Dwyer, Roisin M.			miR-379 Regulates Cyclin B1 Expression and Is Decreased in Breast Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; ENDOGENOUS CONTROL GENES; INHIBITS PROLIFERATION; MESSENGER-RNAS; LUNG-CANCER; MICRORNAS; OVEREXPRESSION; IDENTIFICATION; BIOMARKERS; TARGETS	MicroRNAs are small non-coding RNA molecules that control gene expression post-transcriptionally, and are known to be altered in many diseases including breast cancer. The aim of this study was to determine the relevance of miR-379 in breast cancer. miR-379 expression was quantified in clinical samples including tissues from breast cancer patients (n=103), healthy controls (n=30) and patients with benign breast disease (n=35). The level of miR-379 and its putative target Cyclin B1 were investigated on all breast tissue specimens by RQ-PCR. Potential relationships with gene expression and patient clinicopathological details were also determined. The effect of miR-379 on Cyclin B1 protein expression and function was investigated using western blot, immunohistochemistry and proliferation assays respectively. Finally, the levels of circulating miR-379 were determined in whole blood from patients with breast cancer (n=40) and healthy controls (n=34). The level of miR-379 expression was significantly decreased in breast cancer (Mean(SEM) 1.9 (0.09) Log(10) Relative Quantity (RQ)) compared to normal breast tissues (2.6 (0.16) Log(10) RQ, p<0.01). miR-379 was also found to decrease significantly with increasing tumour stage. A significant negative correlation was determined between miR-379 and Cyclin B1 (r=-0.31, p<0.001). Functional assays revealed reduced proliferation (p<0.05) and decreased Cyclin B1 protein levels following transfection of breast cancer cells with miR-379. Circulating miR-379 was not significantly dysregulated in patients with breast cancer compared to healthy controls (p=0.42). This data presents miR-379 as a novel regulator of Cyclin B1 expression, with significant loss of the miRNA observed in breast tumours.	[Khan, Sonja; Brougham, Cathy L.; Ryan, James; Sahrudin, Arisha; O'Neill, Gregory; Curran, Catherine; Kerin, Michael J.; Dwyer, Roisin M.] Natl Univ Ireland, Sch Med, Discipline Surg, Galway, Ireland; [Wall, Deirdre; Newell, John] Natl Univ Ireland, HRB Clin Res Facil, Galway, Ireland; [Wall, Deirdre; Newell, John] Natl Univ Ireland, Sch Math Stat & Appl Math, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway; Health Research Board - Ireland; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway	Dwyer, RM (corresponding author), Natl Univ Ireland, Sch Med, Discipline Surg, Galway, Ireland.	roisin.dwyer@nuigalway.ie	Kerin, Michael J/D-6748-2013; Dwyer, Roisin M/C-6654-2013	Dwyer, Roisin M/0000-0002-5854-0339; Kerin, Michael/0000-0003-4164-5561; Newell, John/0000-0001-7685-6655; Khan, Sonja/0000-0002-0763-2583; Wall, Deirdre/0000-0001-6510-6082	National Breast Cancer Research Institute (NBCRI); Health Research Board of Ireland (HRB)	National Breast Cancer Research Institute (NBCRI); Health Research Board of Ireland (HRB)	This study was supported by funding from the National Breast Cancer Research Institute (NBCRI) (www.nbcri.ie) and the Health Research Board of Ireland (HRB) (www.hrb.ie). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Aaltonen K, 2009, BREAST CANCER RES TR, V113, P75, DOI 10.1007/s10549-008-9908-5; Agarwal R, 2009, CLIN CANCER RES, V15, P3654, DOI 10.1158/1078-0432.CCR-08-3293; Androic I, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-391; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Davoren PA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-76; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gattolliat CH, 2011, BRIT J CANCER, V105, P1352, DOI 10.1038/bjc.2011.388; Hassan KA, 2002, CANCER RES, V62, P6414; Heneghan HM, 2010, ONCOLOGIST, V15, P673, DOI 10.1634/theoncologist.2010-0103; Heneghan HM, 2010, GUT, V59, P1002, DOI 10.1136/gut.2009.200121; Huang V, 2012, NUCLEIC ACIDS RES, V40, P1695, DOI 10.1093/nar/gkr934; Ikuerowo SO, 2006, INT J CANCER, V119, P867, DOI 10.1002/ijc.21869; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kawamoto H, 1997, AM J PATHOL, V150, P15; Kuhling H, 2003, J PATHOL, V199, P424, DOI 10.1002/path.1322; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; McNeill RE, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-107; Murakami H, 1999, VIRCHOWS ARCH, V434, P153, DOI 10.1007/s004280050319; Nozoe T, 2002, CLIN CANCER RES, V8, P817; PINES J, 1990, NATURE, V346, P760, DOI 10.1038/346760a0; Pollari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037361; Roa W, 2010, CLIN INVEST MED, V33, pE124; Rudolph P, 2003, INT J CANCER, V105, P674, DOI 10.1002/ijc.11132; Ryan J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016023; Sassen S, 2008, VIRCHOWS ARCH, V452, P1, DOI 10.1007/s00428-007-0532-2; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Soria JC, 2000, CANCER RES, V60, P4000; Takeno S, 2002, CANCER, V94, P2874, DOI 10.1002/cncr.10542; Yamanaka S, 2012, CELL CYCLE, V11, P2729, DOI 10.4161/cc.21105; Yoshida T, 2004, ANN ONCOL, V15, P252, DOI 10.1093/annonc/mdh073; Yuan JP, 2004, ONCOGENE, V23, P5843, DOI 10.1038/sj.onc.1207757; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100	34	70	76	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68753	10.1371/journal.pone.0068753	http://dx.doi.org/10.1371/journal.pone.0068753			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874748	Green Published, gold, Green Submitted			2022-12-27	WOS:000321765300064
J	Gao, FS; Feng, L; Zhang, Q; Yan, RQ; Li, YG; Li, XS				Gao, Feng-Shan; Feng, Lei; Zhang, Qiang; Yan, Ruo-qian; Li, Yun-Gang; Li, Xin-sheng			Immunogenicity of Two FMDV Nonameric Peptides Encapsulated in Liposomes in Mice and the Protective Efficacy in Guinea Pigs	PLOS ONE			English	Article							MOUTH-DISEASE VIRUS; CYTOTOXIC T-LYMPHOCYTES; IMMUNE-RESPONSE; BINDING PREDICTION; CELL EPITOPES; CTL EPITOPE; IN-VIVO; IMMUNODOMINANT; COMPLEX; IMMUNIZATION	It has been predicted that nonameric peptides I (VP1(26-34), RRQHTDVSF), II (VP1(157-165), RTLPTSFNY) and III (VP1(45-53), KEQVNVLDL) from the VP1 capsid protein of the foot-and-mouth disease virus ( FMDV) are T cell epitopes. To investigate whether these peptides have immunological activity, BALB/c mice were immunized with peptide I, II or III conjugated with immunostimulating complexes (ISCOMs). A cytotoxic T lymphocyte assay was used to evaluate the cytotoxic activity induced by peptides along with by measuring peptide-specific T-cell proliferation and CD8(+) T lymphocyte numbers in whole blood and interferon (IFN)-gamma production in peripheral blood mononuclear cells induced by peptides. To further identify the protective efficacy of peptides, an FMDV challenge assay was done in guinea pigs. Peptides I and II stimulated significant increases in T-cell proliferation, CD8(+) T lymphocytes, and IFN-gamma secretion and cytotoxic activity compared to controls. The FMDV challenge assay indicated peptides I and II can protect over 60% of animals from virus attack. The results demonstrate that peptides I and II encapsulated in liposomes should be CTL epitopes of FMDV and can protect animals from virus attack to some extent.	[Gao, Feng-Shan; Feng, Lei] Dalian Univ, Coll Life Sci & Technol, Dept Biochem & Mol Biol, Dalian 116012, Liaoning, Peoples R China; [Zhang, Qiang] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Lanzhou, Gansu, Peoples R China; [Yan, Ruo-qian] Anim Husb Bur Henan Prov, Henan Ctr Anim Dis Control & Prevent, Zhengzhou, Henan, Peoples R China; [Li, Yun-Gang] Shandong Ctr Anim Dis Prevent & Control, Jinan, Shandong, Peoples R China; [Li, Xin-sheng] Henan Agr Univ, Coll Anim Husb & Vet Sci, Zhengzhou, Henan, Peoples R China	Dalian University; Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; Henan Agricultural University	Gao, FS (corresponding author), Dalian Univ, Coll Life Sci & Technol, Dept Biochem & Mol Biol, Dalian 116012, Liaoning, Peoples R China.	gfsh0626@126.com	li, xin/HHS-9461-2022		National Natural Science Foundation of China [30972169, 31172304]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (grant nos. 30972169 and 31172304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Barfoed AM, 2006, ANTIVIR RES, V72, P178, DOI 10.1016/j.antiviral.2006.07.002; Becker Y, 1997, VIRUS GENES, V14, P123, DOI 10.1023/A:1007965200932; Bengtsson KL, 2011, EXPERT REV VACCINES, V10, P401, DOI [10.1586/erv.11.25, 10.1586/ERV.11.25]; BITTLE JL, 1982, NATURE, V298, P30, DOI 10.1038/298030a0; Blanco E, 2001, J VIROL, V75, P3164, DOI 10.1128/JVI.75.7.3164-3174.2001; BLUESTONE JA, 1987, EUR J IMMUNOL, V17, P1035, DOI 10.1002/eji.1830170721; Borrego B, 2006, VACCINE, V24, P3889, DOI 10.1016/j.vaccine.2006.02.028; BRUNNER KT, 1968, IMMUNOLOGY, V14, P181; Castellanos MR, 2001, CRIT REV ONCOL HEMAT, V39, P133, DOI 10.1016/S1040-8428(01)00112-3; Choi EY, 2001, J IMMUNOL, V166, P4370, DOI 10.4049/jimmunol.166.7.4370; COLLEN T, 1991, J IMMUNOL, V146, P749; DERES K, 1989, NATURE, V342, P561, DOI 10.1038/342561a0; Ercolini AM, 2007, J NEUROIMMUNOL, V186, P5, DOI 10.1016/j.jneuroim.2007.02.002; FELTKAMP MCW, 1994, MOL IMMUNOL, V31, P1391, DOI 10.1016/0161-5890(94)90155-4; Gao FS, 2006, VET IMMUNOL IMMUNOP, V113, P328, DOI 10.1016/j.vetimm.2006.06.002; Guzman E, 2008, J GEN VIROL, V89, P667, DOI 10.1099/vir.0.83417-0; Harris SJ, 1997, INT IMMUNOL, V9, P273, DOI 10.1093/intimm/9.2.273; HEEG K, 1991, EUR J IMMUNOL, V21, P1523, DOI 10.1002/eji.1830210628; Hoof I, 2009, IMMUNOGENETICS, V61, P1, DOI 10.1007/s00251-008-0341-z; Hsu SC, 1996, VACCINE, V14, P1159, DOI 10.1016/0264-410X(95)00241-R; Juleff N, 2009, J VIROL, V83, P3626, DOI 10.1128/JVI.02613-08; Lawson TM, 2001, INT IMMUNOL, V13, P1383, DOI 10.1093/intimm/13.11.1383; Li WM, 2003, VACCINE, V21, P3319, DOI 10.1016/S0264-410X(03)00172-5; Li YF, 2008, ONCOL REP, V19, P1445; LIPFORD GB, 1994, VACCINE, V12, P73, DOI 10.1016/0264-410X(94)90013-2; Moore DP, 2011, VET PARASITOL, V175, P245, DOI 10.1016/j.vetpar.2010.10.020; O'Connor DH, 2003, J VIROL, V77, P9029, DOI 10.1128/JVI.77.16.9029-9040.2003; PANJEVIC D, 1989, J VET MED B, V36, P119, DOI 10.1111/j.1439-0450.1989.tb00577.x; PFAFF E, 1982, EMBO J, V1, P869, DOI 10.1002/j.1460-2075.1982.tb01262.x; Rodriguez LL, 2011, EXPERT REV VACCINES, V10, P377, DOI [10.1586/erv.11.4, 10.1586/ERV.11.4]; Sheng XL, 2007, WORLD J GASTROENTERO, V13, P5944, DOI 10.3748/wjg.v13.i44.5944; Su CX, 2007, VET MICROBIOL, V124, P256, DOI 10.1016/j.vetmic.2007.04.030; Sullivan JA, 1997, J IMMUNOL, V159, P2318; Summerfield A, 2009, VET IMMUNOL IMMUNOP, V128, P205, DOI 10.1016/j.vetimm.2008.10.296; Uger RA, 1998, J IMMUNOL, V160, P1598; VANBINNENDIJK RS, 1990, J IMMUNOL, V144, P2394; Vithayasai V, 1997, ASIAN PAC J ALLERGY, V15, P141; Zhang DY, 2008, WORLD J GASTROENTERO, V14, P3554, DOI 10.3748/wjg.14.3554; Zhang HY, 2003, VACCINE, V21, P4704, DOI 10.1016/S0264-410X(03)00519-X; Zhao B, 2003, HUM IMMUNOL, V64, P1123, DOI 10.1016/j.humimm.2003.08.343; Zhao GY, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-151	42	38	40	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68658	10.1371/journal.pone.0068658	http://dx.doi.org/10.1371/journal.pone.0068658			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874709	Green Published, gold, Green Submitted			2022-12-27	WOS:000321736900101
J	Kim, MH; Hong, SH; Lee, MK				Kim, Mi-Hyun; Hong, Seung-Hyun; Lee, Moon-Kyu			Insulin Receptor-Overexpressing beta-Cells Ameliorate Hyperglycemia in Diabetic Rats through Wnt Signaling Activation	PLOS ONE			English	Article							GLUCOKINASE GENE; TRANSCRIPTION FACTOR; CROSS-TALK; KINASE-B; EXPRESSION; GROWTH; SECRETION; PATHWAY; PROTEIN; PROLIFERATION	To investigate the therapeutic efficacy and mechanism of beta-cells with insulin receptor (IR) overexpression on diabetes mellitus (DM), rat insulinoma (INS-1) cells were engineered to stably express human insulin receptor (INS-IR cells), and subsequently transplanted into streptozotocin-induced diabetic rats. Compared with INS-1 cells, INS-IR cells showed improved beta-cell function, including the increase in glucose utilization, calcium mobilization, and insulin secretion, and exhibited a higher rate of cell proliferation, and maintained lower levels of blood glucose in diabetic rats. These results were attributed to the increase of beta-catenin/PPARc complex bindings to peroxisome proliferator response elements in rat glucokinase (GK) promoter and the prolongation of S-phase of cell cycle by cyclin D1. These events resulted from more rapid and higher phosphorylation levels of insulin-signaling intermediates, including insulin receptor substrate (IRS)-1/IRS-2/ phosphotylinositol 3 kinase/v-akt murine thymoma viral oncogene homolog (AKT) 1, and the consequent enhancement of b-catenin nuclear translocation and Wnt responsive genes including GK and cyclin D1. Indeed, the higher functionality and proliferation shown in INS-IR cells were offset by b-catenin, cyclin D1, GK, AKT1, and IRS-2 gene depletion. In addition, the promotion of cell proliferation and insulin secretion by Wnt signaling activation was shown by 100 nM insulin treatment, and to a similar degree, was shown in INS-IR cells. In this regard, this study suggests that transferring INS-IR cells into diabetic animals is an effective and feasible DM treatment. Accordingly, the method might be a promising alternative strategy for treatment of DM given the adverse effects of insulin among patients, including the increased risk of modest weight gain and hypoglycemia. Additionally, this study demonstrates that the novel mechanism of cross-talk between insulin and Wnt signaling plays a primary role in the higher therapeutic efficacy of IR-overexpressing b-cells.	[Kim, Mi-Hyun] Samsung Biomed Res Inst, Div Endocrinol & Metab, Seoul, South Korea; [Hong, Seung-Hyun] Korea Res Inst Biosci & Biotechnol, Bionano Res Ctr, Taejon, South Korea; [Lee, Moon-Kyu] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Endocrinol & Metab, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Sungkyunkwan University (SKKU); Samsung Medical Center	Lee, MK (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Endocrinol & Metab, Seoul, South Korea.	leemk@skku.edu			Ministry of Health and Welfare, Republic of Korea [A084065]; Samsung Biomedical Research Institute Grant of Korea [C-A9-228-1]	Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Samsung Biomedical Research Institute Grant of Korea(Samsung)	This study was supported by a grant from the Ministry of Health and Welfare, Republic of Korea (A084065) and the Samsung Biomedical Research Institute Grant (C-A9-228-1) of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiola M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008509; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Anagnostou SH, 2008, BIOCHEM J, V416, P211, DOI 10.1042/BJ20081426; BALI D, 1995, J BIOL CHEM, V270, P21464, DOI 10.1074/jbc.270.37.21464; Berney T, 2006, DIABETES METAB, V32, P503, DOI 10.1016/S1262-3636(06)72803-8; Bommer GT, 2010, J BIOL CHEM, V285, P1928, DOI 10.1074/jbc.M109.060319; Bonner-Weir S, 2005, NAT BIOTECHNOL, V23, P857, DOI 10.1038/nbt1115; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Cozar-Castellano I, 2008, DIABETES, V57, P3056, DOI 10.2337/db08-0393; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Garcia-Ocana A, 2001, J CLIN ENDOCR METAB, V86, P984, DOI 10.1210/jc.86.3.984; GRUPE A, 1995, CELL, V83, P69, DOI 10.1016/0092-8674(95)90235-X; HATTERSLEY AT, 1992, LANCET, V339, P1307, DOI 10.1016/0140-6736(92)91958-B; Hennige AM, 2003, J CLIN INVEST, V112, P1521, DOI 10.1172/JCI200318581; Hie M, 2011, INT J MOL MED, V28, P455, DOI 10.3892/ijmm.2011.697; Jansson EA, 2005, P NATL ACAD SCI USA, V102, P1460, DOI 10.1073/pnas.0405928102; Johnson D, 2007, DIABETES, V56, P1694, DOI 10.2337/db07-0026; Kim HI, 2002, DIABETES, V51, P676, DOI 10.2337/diabetes.51.3.676; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Leibiger IB, 2002, FEBS LETT, V532, P1, DOI 10.1016/S0014-5793(02)03627-X; Luciani DS, 2005, MOL CELL ENDOCRINOL, V241, P88, DOI 10.1016/j.mce.2005.06.006; MATSCHINSKY FM, 1990, DIABETES, V39, P647, DOI 10.2337/diabetes.39.6.647; Ohsugi M, 2005, J BIOL CHEM, V280, P4992, DOI 10.1074/jbc.M411727200; Otani K, 2004, AM J PHYSIOL-ENDOC M, V286, pE41, DOI 10.1152/ajpendo.00533.2001; Palsgaard J, 2012, J BIOL CHEM, V287, P12016, DOI 10.1074/jbc.M111.337048; Papadopoulou S, 2005, DIABETES, V54, P2844, DOI 10.2337/diabetes.54.10.2844; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; Rulifson IC, 2007, P NATL ACAD SCI USA, V104, P6247, DOI 10.1073/pnas.0701509104; Schinner S, 2008, DIABETOLOGIA, V51, P147, DOI 10.1007/s00125-007-0848-0; Schuit FC, 2001, DIABETES, V50, P1, DOI 10.2337/diabetes.50.1.1; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; Shu L, 2008, DIABETES, V57, P645, DOI 10.2337/db07-0847; Singh R, 2013, CELL METAB, V17, P197, DOI 10.1016/j.cmet.2013.01.009; Srivastava S, 2003, DIABETES, V52, P2049, DOI 10.2337/diabetes.52.8.2049; Sun J, 2010, BBA-GEN SUBJECTS, V1800, P344, DOI 10.1016/j.bbagen.2009.12.007; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; Wang XL, 1999, ENDOCRINOLOGY, V140, P4904, DOI 10.1210/en.140.10.4904; Welters HJ, 2008, TRENDS ENDOCRIN MET, V19, P349, DOI 10.1016/j.tem.2008.08.004; Withers DJ, 1999, NAT GENET, V23, P32, DOI 10.1038/12631; Wrede CE, 2002, J BIOL CHEM, V277, P49676, DOI 10.1074/jbc.M208756200; Yi FH, 2008, ENDOCRINOLOGY, V149, P2341, DOI 10.1210/en.2007-1142; Yu J, 2007, MOL ENDOCRINOL, V21, P2775, DOI 10.1210/me.2006-0473	45	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e67802	10.1371/journal.pone.0067802	http://dx.doi.org/10.1371/journal.pone.0067802			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874448	Green Published, gold, Green Submitted			2022-12-27	WOS:000321736900024
J	Petersen, K; Rajcevic, U; Rahim, SAA; Jonassen, I; Kalland, KH; Jimenez, CR; Bjerkvig, R; Niclou, SP				Petersen, Kjell; Rajcevic, Uros; Rahim, Siti Aminah Abdul; Jonassen, Inge; Kalland, Karl-Henning; Jimenez, Connie R.; Bjerkvig, Rolf; Niclou, Simone P.			Gene Set Based Integrated Data Analysis Reveals Phenotypic Differences in a Brain Cancer Model	PLOS ONE			English	Article							MALIGNANT GLIOMA; EXPRESSION DATA; ENRICHMENT; CELLS	A key challenge in the data analysis of biological high-throughput experiments is to handle the often low number of samples in the experiments compared to the number of biomolecules that are simultaneously measured. Combining experimental data using independent technologies to illuminate the same biological trends, as well as complementing each other in a larger perspective, is one natural way to overcome this challenge. In this work we investigated if integrating proteomics and transcriptomics data from a brain cancer animal model using gene set based analysis methodology, could enhance the biological interpretation of the data relative to more traditional analysis of the two datasets individually. The brain cancer model used is based on serial passaging of transplanted human brain tumor material (glioblastoma - GBM) through several generations in rats. These serial transplantations lead over time to genotypic and phenotypic changes in the tumors and represent a medically relevant model with a rare access to samples and where consequent analyses of individual datasets have revealed relatively few significant findings on their own. We found that the integrated analysis both performed better in terms of significance measure of its findings compared to individual analyses, as well as providing independent verification of the individual results. Thus a better context for overall biological interpretation of the data can be achieved.	[Petersen, Kjell; Jonassen, Inge] Uni Res AS, Uni Comp, Computat Biol Unit, Bergen, Norway; [Rajcevic, Uros; Rahim, Siti Aminah Abdul; Bjerkvig, Rolf; Niclou, Simone P.] Ctr Rech Publ Sante, Norlux Neurooncol Lab, Dept Oncol, Luxembourg, Luxembourg; [Rajcevic, Uros] Blood Transfus Ctr Slovenia, Ljubljana, Slovenia; [Jonassen, Inge] Univ Bergen, Dept Informat, N-5008 Bergen, Norway; [Kalland, Karl-Henning] Univ Bergen, Gade Inst, Bergen, Norway; [Kalland, Karl-Henning] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway; [Jimenez, Connie R.] Vrije Univ Amsterdam, Med Canc Ctr, Dept Med Oncol, OncoProte Lab, Amsterdam, Netherlands; [Bjerkvig, Rolf] Univ Bergen, Dept Biomed, N-5020 Bergen, Norway	University of Bergen; Luxembourg Institute of Health; University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital; Vrije Universiteit Amsterdam; University of Bergen	Petersen, K (corresponding author), Uni Res AS, Uni Comp, Computat Biol Unit, Bergen, Norway.	Kjell.Petersen@uni.no	Kalland, Karl-Henning/B-9445-2017; Jimenez, Connie/AAI-3763-2020; Niclou, Simone/P-2304-2018; Jonassen, Inge/AAC-7035-2020	Kalland, Karl-Henning/0000-0003-4486-2334; Niclou, Simone/0000-0002-3417-9534; Jimenez, Connie R/0000-0002-3103-4508; Jonassen, Inge/0000-0003-4110-0748	Norwegian Cancer Society; Norwegian Research Council; Innovest AS; Helse-Vest; Haukeland University Hospital; Bergen Translational Research Program; Centre Recherche de Public Sante Luxembourg; European Commission 6th Framework Program [504743]; Functional Genomics (FUGE) program in Norway	Norwegian Cancer Society(Norwegian Cancer Society); Norwegian Research Council(Research Council of NorwayEuropean Commission); Innovest AS; Helse-Vest; Haukeland University Hospital; Bergen Translational Research Program; Centre Recherche de Public Sante Luxembourg; European Commission 6th Framework Program(European CommissionEuropean Commission Joint Research Centre); Functional Genomics (FUGE) program in Norway(Research Council of Norway)	This work was supported by the Norwegian Cancer Society, the Norwegian Research Council, Innovest AS, Helse-Vest, Haukeland University Hospital, the Bergen Translational Research Program, the Centre Recherche de Public Sante Luxembourg, the European Commission 6th Framework Program Contract 504743 and the Functional Genomics (FUGE) program in Norway funding the national Bioinformatics platform. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Culhane AC, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-59; Fagan A, 2007, PROTEOMICS, V7, P2162, DOI 10.1002/pmic.200600898; Goplen D, 2006, CANCER RES, V66, P9895, DOI 10.1158/0008-5472.CAN-05-4589; Goplen D, 2010, AM J PATHOL, V177, P1618, DOI 10.2353/ajpath.2010.090063; Johannessen TCA, 2009, NEUROPATH APPL NEURO, V35, P380, DOI [10.1111/j.1365-2990.2009.01008.x, 10.1111/j.1365-2990.2008.01008.x]; Le Roch KG, 2004, GENOME RES, V14, P2308, DOI 10.1101/gr.2523904; Liu Q, 2007, COMP EVALUATION GENE, V8, P242; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Rajcevic U, 2009, MOL CELL PROTEOMICS; Rajcevic U, 2011, SLOV VET RES, V48, P5; Sakariassen PO, 2006, P NATL ACAD SCI USA, V103, P16466, DOI 10.1073/pnas.0607668103; Stavrum Anne Kristin, 2008, Curr Protoc Bioinformatics, VChapter 7, DOI 10.1002/0471250953.bi0703s21; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Wang J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-465	20	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68288	10.1371/journal.pone.0068288	http://dx.doi.org/10.1371/journal.pone.0068288			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874576	gold, Green Published, Green Submitted			2022-12-27	WOS:000321736900077
J	Tiainen, AMK; Mannisto, S; Lahti, M; Blomstedt, PA; Lahti, J; Perala, MM; Raikkonen, K; Kajantie, E; Eriksson, JG				Tiainen, Anna-Maija K.; Mannisto, Satu; Lahti, Marius; Blomstedt, Paul A.; Lahti, Jari; Perala, Mia-Maria; Raikkonen, Katri; Kajantie, Eero; Eriksson, Johan G.			Personality and Dietary Intake - Findings in the Helsinki Birth Cohort Study	PLOS ONE			English	Article							FOOD FREQUENCY QUESTIONNAIRE; HEALTH-STATUS; CONSCIENTIOUSNESS; RESILIENCE; NEUROTICISM; PROTOTYPES; STABILITY; MORTALITY; VALIDITY; TRAITS	Background: Personality traits are associated with health outcomes including non-communicable diseases. This could be partly explained by lifestyle related factors including diet. The personality traits neuroticism, extraversion, openness, agreeableness, and conscientiousness are linked with resilience, meaning adaptability in challenging situations. Resilient people usually comply with favorable health behaviors. Objective: Our objective was to explore the associations between food and nutrient intake, personality traits and resilience. Design: A validated semi-quantitative food frequency questionnaire was used to measure diet and the NEO-personality inventory to assess personality in 1681 subjects. Linear regression analysis was used to explore diet-personality associations and cluster analysis to define resilient and non-resilient personality profiles. Results: Adjusting for age, education and energy intake, and applying Bonferroni corrections, openness in men was associated with higher vegetable (14.9 g/d for 1 SD increase in the personality score, P-Bonf <0.01) and lower confectionery and chocolate (-2.8 g/d, P-Bonf <0.01) intakes. In women, neuroticism was associated with lower fish (-4.9 g/d, P-Bonf <0.001) and vegetable (-18.9 g/d, P-Bonf <0.01) and higher soft drink (19.9 g/d, P-Bonf <0.001) intakes. Extraversion, in women, associated with higher meat (5.9 g/d, P-Bonf <0.05) and vegetable (24.8 g/d, P-Bonf <0.001) intakes, openness with higher vegetable (23.4 g/d, P-Bonf <0.001) and fruit (29.5 g/d, P-Bonf <0.01) intakes. Agreeableness was associated with a lower soft drink (-16.2 g/d, P-Bonf <0.01) and conscientiousness with a higher fruit (32.9 g/d, P-Bonf <0.01) intake in women. Comparing resilient and non-resilient subjects, we found resilience in women to be associated with higher intakes of vegetables (52.0 g/d, P<0.001), fruits (58.3 g/d, P<0.01), fish (8.6 g/d, P<0.01) and dietary fiber (1.6 g/d, P<0.01). Conclusion: Personality traits are associated with dietary intake and especially subjects with resilient personality profiles had healthier dietary intakes. These associations were stronger in women than in men.	[Tiainen, Anna-Maija K.; Mannisto, Satu; Blomstedt, Paul A.; Perala, Mia-Maria; Kajantie, Eero; Eriksson, Johan G.] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Tiainen, Anna-Maija K.; Eriksson, Johan G.] Univ Helsinki, Cent Hosp, Unit Gen Practice, Helsinki, Finland; [Lahti, Marius; Lahti, Jari; Raikkonen, Katri] Univ Helsinki, Inst Behav Sci, Dept Psychol, Helsinki, Finland; [Kajantie, Eero] Univ Helsinki, Cent Hosp, Childrens Hosp, Helsinki, Finland; [Kajantie, Eero] Univ Helsinki, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan G.] Vasa Cent Hosp, Vaasa, Finland; [Eriksson, Johan G.] Folkhalsan Res Ctr, Helsinki, Finland	Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Vaasa Central Hospital; Folkhalsan Research Center	Tiainen, AMK (corresponding author), Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland.	anna-maija.tiainen@thl.fi	Lahti, Jari/P-7987-2018; Lahti, Jari/P-2283-2019; Lahti-Pulkkinen, Marius/Q-2472-2017	Lahti, Jari/0000-0002-4310-5297; Lahti, Jari/0000-0002-4310-5297; Perala, Mia-Maria/0000-0002-6349-6301; Mannisto, Satu/0000-0002-8668-3046; Lahti-Pulkkinen, Marius/0000-0002-5244-5525; Eriksson, Johan/0000-0002-2516-2060; Raikkonen, Katri/0000-0003-3124-3470	Academy of Finland [136895, 141005, 129255, 126775]; Paivikki and Sakari Sohlberg Foundation; Finnish Diabetes Research Foundation; Finnish Foundation for Cardiovascular Research; Yrjo Jahnsson Foundation; Signe o. Ane Gyllenberg Foundation; Juho Vainio Foundation; Samfundet Folkhalsan; Finska Lakaresallskapet; National Doctoral Programme of Psychology; Novo Nordisk Fonden [NNF12OC1016374] Funding Source: researchfish	Academy of Finland(Academy of Finland); Paivikki and Sakari Sohlberg Foundation; Finnish Diabetes Research Foundation; Finnish Foundation for Cardiovascular Research; Yrjo Jahnsson Foundation; Signe o. Ane Gyllenberg Foundation; Juho Vainio Foundation; Samfundet Folkhalsan; Finska Lakaresallskapet; National Doctoral Programme of Psychology; Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was supported by the Academy of Finland (SM: grants 136895 and 141005; JGE: grants 129255 and 126775), The Paivikki and Sakari Sohlberg Foundation, The Finnish Diabetes Research Foundation, the Finnish Foundation for Cardiovascular Research, Yrjo Jahnsson Foundation, Signe o. Ane Gyllenberg Foundation, The Juho Vainio Foundation, Samfundet Folkhalsan, Finska Lakaresallskapet, and The National Doctoral Programme of Psychology. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Asendorpf JB, 2001, EUR J PERSONALITY, V15, P169, DOI 10.1002/per.408; Bogg T, 2004, PSYCHOL BULL, V130, P887, DOI 10.1037/0033-2909.130.6.887; BOOTHKEWLEY S, 1994, J PERS, V62, P282; Brummett BH, 2008, BEHAV MED, V34, P5, DOI 10.3200/BMED.34.1.5-10; Campbell-Sills L, 2006, BEHAV RES THER, V44, P585, DOI 10.1016/j.brat.2005.05.001; Caspi A, 2005, ANNU REV PSYCHOL, V56, P453, DOI 10.1146/annurev.psych.55.090902.141913; Chapman Benjamin P, 2011, J Aging Res, V2011, P759170, DOI 10.4061/2011/759170; Chapman BP, 2010, AM J EPIDEMIOL, V171, P83, DOI 10.1093/aje/kwp323; Charles ST, 2008, HEALTH PSYCHOL, V27, P369, DOI 10.1037/0278-6133.27.3.369; Costa P.T., 1985, NEO PERSONALITY INVE; de Bruijn GJ, 2009, PSYCHOL HEALTH, V24, P1051, DOI 10.1080/08870440802428241; de Bruijn GJ, 2005, HEALTH EDUC RES, V20, P635, DOI 10.1093/her/cyh025; GOLDBERG LR, 1993, AM PSYCHOL, V48, P26, DOI 10.1037/0003-066X.48.1.26; Goodwin RD, 2006, J HEALTH PSYCHOL, V11, P643, DOI 10.1177/1359105306066610; Hampson SE, 2007, HEALTH PSYCHOL, V26, P121, DOI 10.1037/0278-6133.26.1.121; Kikuchi Y, 2000, J Epidemiol, V10, P191; Luthar SS, 2000, CHILD DEV, V71, P543, DOI 10.1111/1467-8624.00164; Mannisto S, 1996, J CLIN EPIDEMIOL, V49, P401, DOI 10.1016/0895-4356(95)00551-X; McCrae RR, 1997, AM PSYCHOL, V52, P509, DOI 10.1037/0003-066X.52.5.509; Mistry R, 2009, PREV MED, V48, P291, DOI 10.1016/j.ypmed.2008.12.013; Mottus R, 2012, HEALTH PSYCHOL, V31, P806, DOI 10.1037/a0027041; Mottus R, 2013, HEALTH PSYCHOL, V32, P353, DOI 10.1037/a0025537; O'Connor DB, 2009, ANN BEHAV MED, V37, P184, DOI 10.1007/s12160-009-9087-6; Paalanen L, 2006, J CLIN EPIDEMIOL, V59, P994, DOI 10.1016/j.jclinepi.2006.01.002; Perna L, 2012, INT J PUBLIC HEALTH, V57, P341, DOI 10.1007/s00038-011-0294-0; PULVER A, 1995, EUR J PERSONALITY, V9, P109, DOI 10.1002/per.2410090205; Raikkonen K, 2008, PSYCHOSOM MED, V70, P306, DOI 10.1097/PSY.0b013e3181651638; Rammstedt B, 2004, EUR J PERSONALITY, V18, P1, DOI 10.1002/per.495; Reinivuo H, 2010, PUBLIC HEALTH NUTR, V13, P915, DOI 10.1017/S1368980010001096; Shipley BA, 2007, PSYCHOSOM MED, V69, P923, DOI 10.1097/PSY.0b013e31815abf83; Specht J, 2011, J PERS SOC PSYCHOL, V101, P862, DOI 10.1037/a0024950; Sutin AR, 2011, J PERS SOC PSYCHOL, V101, P579, DOI 10.1037/a0024286; Sutin AR, 2010, AGE, V32, P513, DOI 10.1007/s11357-010-9153-9; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S	34	43	43	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e68284	10.1371/journal.pone.0068284	http://dx.doi.org/10.1371/journal.pone.0068284			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	214PM	23874573	Green Published, gold, Green Submitted			2022-12-27	WOS:000324146200016
J	Peterson, JE; Dischler, C; Longrich, NR				Peterson, Joseph E.; Dischler, Collin; Longrich, Nicholas R.			Distributions of Cranial Pathologies Provide Evidence for Head-Butting in Dome-Headed Dinosaurs (Pachycephalosauridae)	PLOS ONE			English	Article							SEXUAL SELECTION; EVOLUTION; ONTOGENY; COMBAT	Pachycephalosaurids are small, herbivorous dinosaurs with domed skulls formed by massive thickening of the cranial roof. The function of the dome has been a focus of debate: the dome has variously been interpreted as the product of sexual selection, as an adaptation for species recognition, or as a weapon employed in intraspecific combat, where it was used in butting matches as in extant ungulates. This last hypothesis is supported by the recent identification of cranial pathologies in pachycephalosaurids, which appear to represent infections resulting from trauma. However, the frequency and distribution of pathologies have not been studied in a systematic fashion. Here, we show that pachycephalosaurids are characterized by a remarkably high incidence of cranial injury, where 22% of specimens have lesions on the dome. Frequency of injury shows no significant difference between different genera, but flat-headed morphs (here interpreted as juveniles or females) lack lesions. Mapping of injuries onto a digitial pachycephalosaurid skull shows that although lesions are distributed across the dome, they cluster near the apex, which is consistent with the hypothesis that the dome functioned for intraspecific butting matches.	[Peterson, Joseph E.; Dischler, Collin] Univ Wisconsin, Dept Geol, Oshkosh, WI 54901 USA; [Longrich, Nicholas R.] Yale Univ, Dept Geol & Geophys, New Haven, CT USA	University of Wisconsin System; Yale University	Peterson, JE (corresponding author), Univ Wisconsin, Dept Geol, Oshkosh, WI 54901 USA.	petersoj@uwosh.edu		Longrich, Nicholas/0000-0002-9586-8907	Dinosaur Research Institute; University of Wisconsin Oshkosh Faculty Development Program	Dinosaur Research Institute; University of Wisconsin Oshkosh Faculty Development Program	The authors wish to thank the Dinosaur Research Institute and the University of Wisconsin Oshkosh Faculty Development Program for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown B., 1943, B AM MUS NAT HIST, V82, P121; Carpenter Kenneth, 1997, Contributions to Geology University of Wyoming, V32, P19; Colbert E.H., 1955, EVOLUTION VERTEBRATE; Darwin C., 1871, P423; Darwin C, 1859, ORIGIN SPECIES MEANS; Emlen DJ, 2008, ANNU REV ECOL EVOL S, V39, P387, DOI 10.1146/annurev.ecolsys.39.110707.173502; Emlen ST, 2004, AUK, V121, P391, DOI 10.1642/0004-8038(2004)121[0391:SDICAS]2.0.CO;2; Farke AA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004252; FARLOW JO, 1975, EVOLUTION, V29, P353, DOI 10.1111/j.1558-5646.1975.tb00214.x; GALTON P M, 1970, Discovery (New Haven), V6, P23; GEIST V, 1966, BEHAVIOUR, V27, P175, DOI 10.1163/156853966X00155; GEIST V, 1971, MOUNTAIN SHEEP; Geists V., 1964, Journal of Mammalogy, V45, P551, DOI 10.2307/1377327; Goodwin MB, 2004, PALEOBIOLOGY, V30, P253, DOI 10.1666/0094-8373(2004)030<0253:CHOPOM>2.0.CO;2; Hone DWE, 2013, J ZOOL, DOI [10.1111/jzo.12035, DOI 10.1111/JZ0.12035]; Horner JR, 2011, CR PALEVOL, V10, P439, DOI 10.1016/j.crpv.2011.04.006; Horner JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007626; Kalfas IH, 2001, NEUROSURG FOCUS, V10, P7; Knell RJ, 2011, J ZOOL, V283, P18, DOI 10.1111/j.1469-7998.2010.00758.x; Knell RJ, 2013, TRENDS ECOL EVOL, V28, P38, DOI 10.1016/j.tree.2012.07.015; LIVEZEY BC, 1985, CONDOR, V87, P154, DOI 10.2307/1367152; Longrich NR, 2011, P ROY SOC B-BIOL SCI, V278, P2333, DOI 10.1098/rspb.2010.2117; Longrich NR, 2010, CRETACEOUS RES, V31, P274, DOI 10.1016/j.cretres.2009.12.002; Lundrigan B, 1996, J MAMMAL, V77, P462, DOI 10.2307/1382822; Maryanska T, 1974, Palaeontologia Polonica, VNo. 30, P45; McWhinney LA, 2001, LIFE O PAST, P141; Newton A., 1869, PHIL T R SOC LOND, V159, P327, DOI DOI 10.1098/RSTL.1869.0011; Peterson JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036227; Reid R.E.H., 1997, ENCY DINOSAURS, P329; Resnick D., 1981, DIAGNOSIS BONE JOINT, V3, P2058; SCHAFFER WM, 1968, EVOLUTION, V22, P817, DOI 10.1111/j.1558-5646.1968.tb03480.x; Schott RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021092; Sereno Paul C., 2000, P480; SERENO PC, 1986, NATL GEOGR RES, V2, P234; Snively E, 2008, PALAEONTOL ELECTRON, V11; Snively E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021422; Stankowich T, 2009, P ROY SOC B-BIOL SCI, V276, P4329, DOI 10.1098/rspb.2009.1256; Sues H.-D., 1978, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V1978, P459; Tanke Darren H., 2007, P319; VANVALKENBURGH B, 1988, AM NAT, V131, P291, DOI 10.1086/284790; Williamson TE, 2002, J VERTEBR PALEONTOL, V22, P779, DOI 10.1671/0272-4634(2002)022[0779:ANGODP]2.0.CO;2	41	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68620	10.1371/journal.pone.0068620	http://dx.doi.org/10.1371/journal.pone.0068620			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874691	Green Published, Green Submitted, gold			2022-12-27	WOS:000322064300054
J	Foey, AD; Crean, S				Foey, Andrew D.; Crean, StJohn			Macrophage Subset Sensitivity to Endotoxin Tolerisation by Porphyromonas gingivalis	PLOS ONE			English	Article							NF-KAPPA-B; IN-VITRO; PERIODONTAL-DISEASE; INTESTINAL MACROPHAGES; SUBGINGIVAL PLAQUE; TISSUE DESTRUCTION; SIGNALING PATHWAYS; TNF-ALPHA; CELLS; LIPOPOLYSACCHARIDE	Macrophages (M Phi s) determine oral mucosal responses; mediating tolerance to commensal microbes and food whilst maintaining the capacity to activate immune defences to pathogens. MW responses are determined by both differentiation and activation stimuli, giving rise to two distinct subsets; pro-inflammatory M1- and anti-inflammatory/regulatory M2-M Phi s. M2-like subsets predominate tolerance induction whereas M1 M Phi s predominate in inflammatory pathologies, mediating destructive inflammatory mechanisms, such as those in chronic P. gingivalis (PG) periodontal infection. MW responses can be suppressed to benefit either the host or the pathogen. Chronic stimulation by bacterial pathogen associated molecular patterns (PAMPs), such as LPS, is well established to induce tolerance. The aim of this study was to investigate the susceptibility of MW subsets to suppression by P. gingivalis. CD14(hi) and CD14(lo) M1- and M2-like MWs were generated in vitro from the THP-1 monocyte cell line by differentiation with PMA and vitamin D-3, respectively. MW subsets were pre-treated with heat-killed PG (HKPG) and PG-LPS prior to stimulation by bacterial PAMPs. Modulation of inflammation was measured by TNF alpha, IL-1 beta, IL-6, IL-10 ELISA and NF beta B activation by reporter gene assay. HKPG and PG-LPS differentially suppress PAMP-induced TNFa, IL-6 and IL-10 but fail to suppress IL-1b expression in M1 and M2 M Phi s. In addition, P. gingivalis suppressed NF beta B activation in CD14(lo) and CD14(hi) M2 regulatory MWs and CD14(lo) M1 M Phi s whereas CD14(hi) M1 pro-inflammatory M Phi s were refractory to suppression. In conclusion, P. gingivalis selectively tolerises regulatory M2 M Phi s with little effect on proinflammatory CD14(hi) M1 M Phi s; differential suppression facilitating immunopathology at the expense of immunity.	[Foey, Andrew D.] Univ Plymouth, Sch Biomed & Biol Sci, Plymouth PL4 8AA, Devon, England; [Crean, StJohn] Univ Cent Lancashire, Fac Hlth & Social Work, Preston PR1 2HE, Lancs, England	University of Plymouth; University of Central Lancashire	Foey, AD (corresponding author), Univ Plymouth, Sch Biomed & Biol Sci, Plymouth PL4 8AA, Devon, England.	andrew.foey@plymouth.ac.uk		Foey, Andrew/0000-0003-0419-2268	University of Plymouth VC's Research and Innovation Fellowship	University of Plymouth VC's Research and Innovation Fellowship	This study was part funded by the University of Plymouth VC's Research and Innovation Fellowship awarded to AF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Barksby HE, 2009, CLIN EXP IMMUNOL, V156, P479, DOI 10.1111/j.1365-2249.2009.03920.x; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; CUTLER CW, 1993, J IMMUNOL, V151, P7016; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Darveau RP, 2004, INFECT IMMUN, V72, P5041, DOI 10.1128/IAI.72.9.5041-5051.2004; Dobrovolskaia MA, 2003, J IMMUNOL, V170, P508, DOI 10.4049/jimmunol.170.1.508; Duncan L, 2004, MICROB PATHOGENESIS, V36, P319, DOI 10.1016/j.micpath.2004.02.004; Ezzo PJ, 2003, PERIODONTOL 2000, V32, P24, DOI 10.1046/j.0906-6713.2003.03203.x; Fletcher J, 1998, CURR MICROBIOL, V36, P216, DOI 10.1007/s002849900297; Foey A.D., 2012, HDB MACROPHAGES LIFE, P121; Foey AD, 1998, J IMMUNOL, V160, P920; Foster SL, 2009, CLIN IMMUNOL, V130, P7, DOI 10.1016/j.clim.2008.08.015; Garlet GP, 2010, J DENT RES, V89, P1349, DOI 10.1177/0022034510376402; Gemmell E, 1997, PERIODONTOL 2000, V14, P112, DOI 10.1111/j.1600-0757.1997.tb00194.x; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Hagemann T, 2008, J EXP MED, V205, P1261, DOI 10.1084/jem.20080108; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Jotwani R, 2004, INFECT IMMUN, V72, P1725, DOI 10.1128/IAI.72.3.1725-1732.2004; Kim YG, 2008, J IMMUNOL, V181, P4340, DOI 10.4049/jimmunol.181.6.4340; Liu Y, 2008, J IMMUNOL, V180, P6270, DOI 10.4049/jimmunol.180.9.6270; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Merry R, 2012, BRIT J ORAL MAX SURG, V50, P2, DOI 10.1016/j.bjoms.2010.10.020; Muthukuru M, 2005, INFECT IMMUN, V73, P687, DOI 10.1128/IAI.73.2.687-694.2005; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; Okada H, 1998, CRIT REV ORAL BIOL M, V9, P248, DOI 10.1177/10454411980090030101; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; Pulendran B, 2001, J IMMUNOL, V167, P5067, DOI 10.4049/jimmunol.167.9.5067; Robertshaw HJ, 2005, BRIT J ANAESTH, V94, P222, DOI 10.1093/bja/aei021; Sato S, 2000, J IMMUNOL, V165, P7096, DOI 10.4049/jimmunol.165.12.7096; Smith PD, 2005, IMMUNOL REV, V206, P149, DOI 10.1111/j.0105-2896.2005.00288.x; Smythies LE, 2005, J CLIN INVEST, V115, P66, DOI 10.1172/JCI200519229; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Tervonen T, 2007, J CLIN PERIODONTOL, V34, P377, DOI 10.1111/j.1600-051X.2007.01067.x; Tribble GD, 2010, PERIODONTOL 2000, V52, P68, DOI 10.1111/j.1600-0757.2009.00323.x; Wilson HM, 2005, AM J PATHOL, V167, P27, DOI 10.1016/S0002-9440(10)62950-1; Ximenez-Fyvie LA, 2000, J CLIN PERIODONTOL, V27, P722, DOI 10.1034/j.1600-051x.2000.027010722.x; Xing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368; Yilmaz O, 2002, CELL MICROBIOL, V4, P305, DOI 10.1046/j.1462-5822.2002.00192.x; Yilmaz Ozlem, 2008, Microbiology (Reading), V154, P2897, DOI 10.1099/mic.0.2008/021220-0	40	20	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2013	8	7							e67955	10.1371/journal.pone.0067955	http://dx.doi.org/10.1371/journal.pone.0067955			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZN	23869208	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000323110600007
J	Qi, HY; Zhao, K; Xu, F; Zhang, XZ; Zhang, ZY; Yang, L; Li, CL; Liang, X; Guo, WG; Chen, SH; Liu, ZH; Zhang, WY; Yu, XF				Qi, Haiyan; Zhao, Ke; Xu, Fei; Zhang, Xuzhao; Zhang, Zhiyong; Yang, Li; Li, Chunling; Liang, Xu; Guo, Weigui; Chen, Shihai; Liu, Zhihao; Zhang, Wenyan; Yu, Xiao-Fang			HIV-1 Diversity, Drug-Resistant Mutations, and Viral Evolution among High-Risk Individuals in Phase II HIV Vaccine Trial Sites in Southern China	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; MOLECULAR EPIDEMIOLOGY; POL GENE; TYPE-1; USERS; SUBTYPES; INFECTION; CRF01-AE; GUANGXI; TRANSMISSION	HIV-1 prevalence in Guangxi, China, has been growing since 1996, when the first case was reported. Over half of HIV-1 positive patients in Guangxi Province were injecting drug users (IDUs), possibly because of the province's location near drug-trafficking routes. Since a phase II HIV vaccine trial is ongoing there, a current characterization of the subtypes of HIV-1 among IDUs in Guangxi would provide critical information for future HIV vaccine trials, as well as further control and prevention of HIV-1 transmission. Thus, we conducted a molecular epidemiological investigation of HIV-1 samples from 2008-2010 among IDUs in multiple cities in Guangxi Province. Our results, based on the gag/pol fragment, indicated a very high proportion (78.47%) of HIV-1 CRF08_BC recombinants, some CRF01_AE (15.38%) recombinants, and a low proportion of CRF07_BC (6.15%) recombinants among the IDUs. The high proportion of CRF08 HIV-1 strains among recent IDUs matches the vaccine candidate constructs. However, future vaccine development should also incorporate CRF01-targeted vaccine candidates. Distinct Env sequence evolution patterns were observed for CRF08_BC and CRF01_AE, indicating that different local selection pressures have been exerted on these two HIV-1 subtypes. Unique drug-resistant mutations were also detected, and our data indicate that HIV treatment programs should consider pre-existing drug-resistant mutations.	[Qi, Haiyan; Xu, Fei; Zhang, Xuzhao; Yu, Xiao-Fang] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Inst Canc, Hangzhou 310003, Zhejiang, Peoples R China; [Zhao, Ke; Zhang, Wenyan; Yu, Xiao-Fang] First Hosp Jilin Univ, Inst Virol & AIDS Res, Changchun 130023, Jilin, Peoples R China; [Zhang, Zhiyong; Yang, Li; Li, Chunling] Guangxi Med Univ, Sch Publ Hlth, Nanning, Guangxi, Peoples R China; [Liang, Xu; Liu, Zhihao] Ctr Dis Control & Prevent, Baise, Guangxi, Peoples R China; [Guo, Weigui] Ctr Dis Control & Prevent, Beihai, Guangxi, Peoples R China; [Chen, Shihai] Ctr Dis Control & Prevent, Nanning, Guangxi, Peoples R China; [Yu, Xiao-Fang] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA	Zhejiang University; Jilin University; Guangxi Medical University; Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Yu, XF (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Inst Canc, Hangzhou 310003, Zhejiang, Peoples R China.	xfyu@jhpsh.edu			Chinese Ministry of Science and Technology [2012CB911100, 2013ZX0001-005]; Chinese Ministry of Education [IRT1016]; Key Laboratory of Molecular Virology, Jilin Province, China [20102209]; National Institute on Drug Abuse [R01DA026150]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese Ministry of Education(Ministry of Education, China); Key Laboratory of Molecular Virology, Jilin Province, China; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by funding from the Chinese Ministry of Science and Technology (No. 2012CB911100 and No. 2013ZX0001-005) and Chinese Ministry of Education (No. IRT1016); the Key Laboratory of Molecular Virology, Jilin Province (20102209), China; and a grant (R01DA026150) from the National Institute on Drug Abuse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyrer C, 2000, AIDS, V14, P75, DOI 10.1097/00002030-200001070-00009; Bon I, 2007, NEW MICROBIOL, V30, P313; Dettenhofer M, 1999, J VIROL, V73, P4696, DOI 10.1128/JVI.73.6.4696-4704.1999; FU XY, 1995, J GEN VIROL, V76, P3171, DOI 10.1099/0022-1317-76-12-3171; Garten RJ, 2005, CLIN INFECT DIS, V41, pS18, DOI 10.1086/429491; Garten RJ, 2004, INT J EPIDEMIOL, V33, P182, DOI 10.1093/ije/dyh019; GOTTLINGER HG, 1991, P NATL ACAD SCI USA, V88, P3195, DOI 10.1073/pnas.88.8.3195; KROODSMA KL, 1994, J INFECT DIS, V170, P1292, DOI 10.1093/infdis/170.5.1292; Laeyendecker O, 2005, JAIDS-J ACQ IMM DEF, V38, P356; Liu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023347; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; McCutchan FE, 2002, AIDS RES HUM RETROV, V18, P1135, DOI 10.1089/088922202320567879; Meng ZF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-60; Pang W, 2012, AIDS, V26, P1121, DOI 10.1097/QAD.0b013e3283522c97; Piyasirisilp S, 2000, J VIROL, V74, P11286, DOI 10.1128/JVI.74.23.11286-11295.2000; Shang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010631; Skar H, 2011, ANN NY ACAD SCI, V1230, P108, DOI 10.1111/j.1749-6632.2011.06128.x; Song YH, 2007, ARCH VIROL, V152, P1553, DOI 10.1007/s00705-007-0973-6; Su QJ, 2012, AIDS RES HUM RETROV, V28, P725, DOI [10.1089/AID.2011.0246, 10.1089/aid.2011.0246]; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teng T, 2011, Adv Dent Res, V23, P10, DOI 10.1177/0022034511398871; Tripathy S, 1996, AIDS RES HUM RETROV, V12, P1199, DOI 10.1089/aid.1996.12.1199; Yu ESH, 1996, AM J PUBLIC HEALTH, V86, P1116, DOI 10.2105/AJPH.86.8_Pt_1.1116; Yu XF, 1998, J VIROL, V72, P3412, DOI 10.1128/JVI.72.4.3412-3417.1998; Yu XF, 1999, J ACQ IMMUN DEF SYND, V22, P180; Yu XF, 2002, AIDS RES HUM RETROV, V18, P167, DOI 10.1089/08892220252779719; Yu XF, 1998, LANCET, V351, P1250, DOI 10.1016/S0140-6736(05)79316-8; Zeng HY, 2012, AIDS RES HUM RETROV, V28, P1352, DOI 10.1089/aid.2011.0364	28	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2013	8	7							e68656	10.1371/journal.pone.0068656	http://dx.doi.org/10.1371/journal.pone.0068656			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZN	23869225	Green Published, gold, Green Submitted			2022-12-27	WOS:000323110600024
J	Kong, LJ; Tuomela, S; Hahne, L; Ahlfors, H; Yli-Harja, O; Fadeel, B; Lahesmaa, R; Autio, R				Kong, Lingjia; Tuomela, Soile; Hahne, Lauri; Ahlfors, Helena; Yli-Harja, Olli; Fadeel, Bengt; Lahesmaa, Riitta; Autio, Reija			NanoMiner - Integrative Human Transcriptomics Data Resource for Nanoparticle Research	PLOS ONE			English	Article							GENECHIP DATA; EXPRESSION; BIOCONDUCTOR; TOXICITY; CELLS	The potential impact of nanoparticles on the environment and on human health has attracted considerable interest worldwide. The amount of transcriptomics data, in which tissues and cell lines are exposed to nanoparticles, increases year by year. In addition to the importance of the original findings, this data can have value in broader context when combined with other previously acquired and published results. In order to facilitate the efficient usage of the data, we have developed the NanoMiner web resource (http://nanominer.cs.tut.fi/), which contains 404 human transcriptome samples exposed to various types of nanoparticles. All the samples in NanoMiner have been annotated, preprocessed and normalized using standard methods that ensure the quality of the data analyses and enable the users to utilize the database systematically across the different experimental setups and platforms. With NanoMiner it is possible to 1) search and plot the expression profiles of one or several genes of interest, 2) cluster the samples within the datasets, 3) find differentially expressed genes in various nanoparticle studies, 4) detect the nanoparticles causing differential expression of selected genes, 5) analyze enriched Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways and Gene Ontology (GO) terms for the detected genes and 6) search the expression values and differential expressions of the genes belonging to a specific KEGG pathway or Gene Ontology. In sum, NanoMiner database is a valuable collection of microarray data which can be also used as a data repository for future analyses.	[Kong, Lingjia; Hahne, Lauri; Yli-Harja, Olli; Autio, Reija] Tampere Univ Technol, Dept Signal Proc, FIN-33101 Tampere, Finland; [Kong, Lingjia; Tuomela, Soile; Hahne, Lauri; Ahlfors, Helena; Lahesmaa, Riitta; Autio, Reija] Univ Turku, Turku Ctr Biotechnol, Turku, Finland; [Kong, Lingjia; Tuomela, Soile; Hahne, Lauri; Ahlfors, Helena; Lahesmaa, Riitta; Autio, Reija] Abo Akad Univ, Turku, Finland; [Tuomela, Soile] Turku Doctoral Programme Biomed Sci, Turku, Finland; [Fadeel, Bengt] Karolinska Inst, Inst Environm Med, Div Mol Toxicol, S-10401 Stockholm, Sweden	Tampere University; University of Turku; Abo Akademi University; Karolinska Institutet	Autio, R (corresponding author), Tampere Univ Technol, Dept Signal Proc, FIN-33101 Tampere, Finland.	reija.autio@tut.fi	Autio, Reija/D-2037-2014	Autio, Reija/0000-0002-6519-2715; Yli-Harja, Olli/0000-0001-8581-4414; Kong, Lingjia/0000-0003-1016-030X; Ahlfors, Helena/0000-0002-8183-0895	European Commission [214281]; Academy of Finland Finnish Programme for Centres of Excellence in Signal Processing [129657, 134117, 129529, 140019]; Centre of Excellence in Molecular systems Immunology and Physiology Research [250114]	European Commission(European CommissionEuropean Commission Joint Research Centre); Academy of Finland Finnish Programme for Centres of Excellence in Signal Processing; Centre of Excellence in Molecular systems Immunology and Physiology Research	The project is supported by the Seventh Framework Programme of the European Commission FP7-NANOMMUNE, no 214281 (coordinator: BF) and Academy of Finland Finnish Programme for Centres of Excellence in Signal Processing no 129657, no 134117 (to RA), no 129529 (to RL), no 140019 (to RL) and the Centre of Excellence in Molecular systems Immunology and Physiology Research, no 250114 (to RL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balakumaran A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011462; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Benjamini Y, 2001, ANN STAT, V29, P1165; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Busch W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-65; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Fadeel B, 2013, NAT NANOTECHNOL, V8, P71, DOI 10.1038/nnano.2013.2; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Fujita K, 2009, TOXICOL LETT, V191, P109, DOI 10.1016/j.toxlet.2009.08.011; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gras R, 2009, PHARM RES-DORDR, V26, P577, DOI 10.1007/s11095-008-9776-z; Hanagata N, 2011, ACS NANO, V5, P9326, DOI 10.1021/nn202966t; Hofer TPJ, 2008, J MOL MED, V86, P323, DOI 10.1007/s00109-007-0284-0; Huang YCT, 2011, J TOXICOL ENV HEAL A, V74, P296, DOI 10.1080/15287394.2010.516238; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Karoly ED, 2007, ENVIRON HEALTH PERSP, V115, P535, DOI 10.1289/ehp.9556; Kawata K, 2009, ENVIRON SCI TECHNOL, V43, P6046, DOI 10.1021/es900754q; Kim EY, 2012, GENE THER, V19, P347, DOI 10.1038/gt.2011.95; Krug HF, 2011, ANGEW CHEM INT EDIT, V50, P1260, DOI 10.1002/anie.201001037; Lucas A, 2006, R NEWS, V6, P58; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moos PJ, 2011, METALLOMICS, V3, P1199, DOI 10.1039/c1mt00061f; Nel A, 2012, ACC CHEM RES; Parkinson H, 2011, NUCLEIC ACIDS RES, V39, pD1002, DOI 10.1093/nar/gkq1040; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Shvedova AA, 2010, ANNU REV PHARMACOL, V50, P63, DOI 10.1146/annurev.pharmtox.010909.105819; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Tuomela S, 2013, PLOS ONE IN PRESS	35	14	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e68414	10.1371/journal.pone.0068414	http://dx.doi.org/10.1371/journal.pone.0068414			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	23874618	Green Published, gold, Green Submitted			2022-12-27	WOS:000321718700022
J	Miralles, A; Vences, M				Miralles, Aurelien; Vences, Miguel			New Metrics for Comparison of Taxonomies Reveal Striking Discrepancies among Species Delimitation Methods in Madascincus Lizards	PLOS ONE			English	Article							MALAGASY SCINCID LIZARDS; COMPUTER-PROGRAM; SEQUENCE DATA; POPULATION; DNA; MADAGASCAR; COALESCENT; SOFTWARE; BOUNDARIES; INFERENCE	Delimiting and describing species is fundamental to numerous biological disciplines such as evolution, macroecology, and conservation. Delimiting species as independent evolutionary lineages may and often does yield different outcomes depending on the species criteria applied, but methods should be chosen that minimize the inference of objectively erroneous species limits. Several protocols exploit single-gene or multi-gene coalescence statistics, assignment tests or other rationales related to nuclear DNA (nDNA) allele sharing to automatically delimit species. We apply seven different species delimitation protocols to a taxonomically confusing group of Malagasy lizards (Madascincus), and compare the resulting taxonomies with two newly developed metrics: the Taxonomic index of congruence C-tax which quantifies the congruence between two taxonomies, and the Relative taxonomic resolving power index R-tax which quantifies the potential of an approach to capture a high number of species boundaries. The protocols differed in the total number of species proposed, between 9 and 34, and were also highly incongruent in placing species boundaries. The Generalized Mixed Yule-Coalescent approach captured the highest number of potential species boundaries but many of these were clearly contradicted by extensive nDNA admixture between sympatric mitochondrial DNA (mtDNA) haplotype lineages. Delimiting species as phenotypically diagnosable mtDNA clades failed to detect two cryptic species that are unambiguous due to a lack of nDNA gene flow despite sympatry. We also consider the high number of species boundaries and their placement by multi-gene Bayesian species delimitation as poorly reliable whereas the Bayesian assignment test approach provided a species delimitation highly congruent with integrative taxonomic practice. The present study illustrates the trade-off in taxonomy between reliability (favored by conservative approaches) and resolving power (favored by inflationist approaches). Quantifying excessive splitting is more difficult than quantifying excessive lumping, suggesting a priority for conservative taxonomies in which errors are more liable to be detected and corrected by subsequent studies.	[Miralles, Aurelien; Vences, Miguel] Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, Div Evolutionary Biol, Braunschweig, Germany; [Miralles, Aurelien] CNRS, Ctr Ecol Fonct & Evolut, CEFE, UMR5175, F-34033 Montpellier, France	Braunschweig University of Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier	Miralles, A (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, Div Evolutionary Biol, Pockelsstr 10A, Braunschweig, Germany.	miralles.skink@gmail.com	Miralles, Aurélien/AAD-7987-2020	Miralles, Aurélien/0000-0002-2538-7710; Vences, Miguel/0000-0003-0747-0817	postdoctoral Research Fellowship from the Alexander von Humboldt Foundation; SYNTHESYS [FR-TAF-842, GB-TAF-843]	postdoctoral Research Fellowship from the Alexander von Humboldt Foundation; SYNTHESYS	Aurelien Miralles was supported by a postdoctoral Research Fellowship from the Alexander von Humboldt Foundation (http://www.humboldt-foundation.de/web/home.html) and by two SYNTHESYS grants (FR-TAF-842, GB-TAF-843, http://www.synthesys.info). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreone F, 2002, J ZOOL, V258, P139, DOI 10.1017/S0952836902001280; Bartlett John M S, 2003, Methods Mol Biol, V226, P3; Bauer AM, 2011, P ROY SOC B-BIOL SCI, V278, P490, DOI 10.1098/rspb.2010.1330; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bond JE, 2008, SYST BIOL, V57, P628, DOI 10.1080/10635150802302443; Brown JL, 2009, ZOOTAXA, P1; Butcher BA, 2012, ZOOTAXA, P7; Carson H., 1957, SPECIES PROBLEM, P23; Carstens BC, 2010, SYST BIOL, V59, P400, DOI 10.1093/sysbio/syq024; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Corander J, 2006, MOL ECOL, V15, P2833, DOI 10.1111/j.1365-294X.2006.02994.x; Costello MJ, 2013, SCIENCE, V339, P413, DOI 10.1126/science.1230318; Crottini A, 2009, MOL PHYLOGENET EVOL, V53, P345, DOI 10.1016/j.ympev.2009.05.024; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Dejaco T, 2012, ZOOL ANZ, V251, P307, DOI 10.1016/j.jcz.2011.12.005; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; DOYLE JJ, 1995, SYST BOT, V20, P574, DOI 10.2307/2419811; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Earl D.A., 2011, STRUCTURE HARVESTER; Ence DD, 2011, MOL ECOL RESOUR, V11, P473, DOI 10.1111/j.1755-0998.2010.02947.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Flot Jean-Francois, 2011, BMC Ecology, V11, P22, DOI 10.1186/1472-6785-11-22; Flot JF, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-372; Fontaneto D, 2007, PLOS BIOL, V5, P914, DOI 10.1371/journal.pbio.0050087; Fujita MK, 2011, P ROY SOC B-BIOL SCI, V278, P493, DOI 10.1098/rspb.2010.1864; Glaw F, 2007, FIELD GUIDE AMPHIBIA; Goker M, 2010, EVOL BIOINFORM, V6, P97; Goldstein PZ, 2011, BIOESSAYS, V33, P135, DOI 10.1002/bies.201000036; Good D.A., 1992, U CALIFORNIA PUBLICA, V126, P1; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Harrington RC, 2012, SYST BIOL, V61, P63, DOI 10.1093/sysbio/syr077; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Highton R, 2000, BIOLOGY OF PLETHODONTID SALAMANDERS, P215; Kalinowski ST, 2011, HEREDITY, V106, P625, DOI 10.1038/hdy.2010.95; Knowles LL, 2010, ESTIMATING SPECIES T; Kremen C, 2008, SCIENCE, V320, P222, DOI 10.1126/science.1155193; Kumar S, 2005, NAT REV GENET, V6, P654, DOI 10.1038/nrg1659; Latch EK, 2006, CONSERV GENET, V7, P295, DOI 10.1007/s10592-005-9098-1; Leache AD, 2010, P ROY SOC B-BIOL SCI, V277, P3071, DOI 10.1098/rspb.2010.0662; Leache AD, 2009, P NATL ACAD SCI USA, V106, P12418, DOI 10.1073/pnas.0906380106; Li B, 2009, ZOOL SCR, V38, P101, DOI 10.1111/j.1463-6409.2008.00361.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lim GS, 2012, SYST BIOL, V61, P165, DOI 10.1093/sysbio/syr030; Liu L, 2009, MOL PHYLOGENET EVOL, V53, P320, DOI 10.1016/j.ympev.2009.05.033; Marcet-Houben M, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr087; Marshall JC, 2006, EVOLUTION, V60, P1050; Masters BC, 2011, MOL ECOL RESOUR, V11, P154, DOI 10.1111/j.1755-0998.2010.02896.x; Mayden R. L., 1997, V54, P381; Mayden RL, 2002, FISH FISH, V3, P171, DOI 10.1046/j.1467-2979.2002.00086.x; Miralles A, 2011, ZOOTAXA, P47, DOI 10.11646/zootaxa.2918.1.5; Miralles Aurelien, 2011, Zootaxa, V2876, P1; Miralles A, 2011, ORG DIVERS EVOL, V11, P135, DOI 10.1007/s13127-011-0042-6; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Noble DWA, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-197; Nylander J.A.A, 2004, MRMODELTEST V2; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; O'Meara BC, 2010, SYST BIOL, V59, P59, DOI 10.1093/sysbio/syp077; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Philippe H, 2005, ANNU REV ECOL EVOL S, V36, P541, DOI 10.1146/annurev.ecolsys.35.112202.130205; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; PORTER AH, 1990, SYST ZOOL, V39, P131, DOI 10.2307/2992451; Powell JR, 2012, METHODS ECOL EVOL, V3, P1, DOI 10.1111/j.2041-210X.2011.00122.x; Pritchard JK, 2000, GENETICS, V155, P945; Pruett CL, 2008, J AVIAN BIOL, V39, P252, DOI 10.1111/j.2008.0908-8857.04094.x; Puigbo P, 2007, BIOINFORMATICS, V23, P1556, DOI 10.1093/bioinformatics/btm135; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Rambaut A., 2007, TRACER V1 5; Ramey RR, 2005, ANIM CONSERV, V8, P329, DOI 10.1017/S1367943005002313; Rannala B, 2003, GENETICS, V164, P1645; Reeves PA, 2011, SYST BIOL, V60, P45, DOI 10.1093/sysbio/syq056; Riedel A, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-15; Riedel A, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.280.3906; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ross KG, 2010, SYST BIOL, V59, P162, DOI 10.1093/sysbio/syp089; Sasa MM, 1998, EVOLUTION, V52, P1811, DOI 10.1111/j.1558-5646.1998.tb02258.x; Sauer J, 2012, CLADISTICS, V28, P300, DOI 10.1111/j.1096-0031.2011.00382.x; Schmitz A, 2005, MOL PHYLOGENET EVOL, V34, P118, DOI 10.1016/j.ympev.2004.08.016; Shimada T, 2008, ZOOTAXA, P24, DOI 10.11646/zootaxa.1843.1.2; SIMPSON GEORGE GAYLORD, 1961; Sites JW, 2004, ANNU REV ECOL EVOL S, V35, P199, DOI 10.1146/annurev.ecolsys.35.112202.130128; Sites JW, 2003, TRENDS ECOL EVOL, V18, P462, DOI 10.1016/S0169-5347(03)00184-8; Smith VS, 2011, ZOOKEYS, P1, DOI 10.3897/zookeys.150.2458; Steinfartz S, 2007, MOL ECOL, V16, P4550, DOI 10.1111/j.1365-294X.2007.03490.x; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Strutzenberger P, 2011, INSECT SCI, V18, P349, DOI 10.1111/j.1744-7917.2010.01366.x; TEMPLETON AR, 1992, GENETICS, V132, P619; Vences M, 2009, TRENDS ECOL EVOL, V24, P456, DOI 10.1016/j.tree.2009.03.011; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P8267, DOI 10.1073/pnas.0810821106; Wagner CE, 2013, MOL ECOL, V22, P787, DOI 10.1111/mec.12023; Weisrock DW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009883; Wheeler QD, 2012, SYST BIODIVERS, V10, P1, DOI 10.1080/14772000.2012.665095; Whiting Alison S., 2004, African Journal of Herpetology, V53, P135; Wiens JJ, 2000, P ROY SOC B-BIOL SCI, V267, P631, DOI 10.1098/rspb.2000.1049; Wiens JJ, 2002, SYST BIOL, V51, P69, DOI 10.1080/106351502753475880; Wiens JJ, 2007, SYST BIOL, V56, P875, DOI 10.1080/10635150701748506; WILEY EO, 1978, SYST ZOOL, V27, P17, DOI 10.2307/2412809; Wilme L, 2006, SCIENCE, V312, P1063, DOI 10.1126/science.1122806; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107	104	141	142	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e68242	10.1371/journal.pone.0068242	http://dx.doi.org/10.1371/journal.pone.0068242			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	23874561	Green Submitted, Green Published, gold			2022-12-27	WOS:000321718700015
J	Shehzad, SA; Alsaedi, A; Hayat, T				Shehzad, Sabir Ali; Alsaedi, Ahmad; Hayat, Tasawar			Hydromagnetic Steady Flow of Maxwell Fluid over a Bidirectional Stretching Surface with Prescribed Surface Temperature and Prescribed Surface Heat Flux	PLOS ONE			English	Article							HOMOTOPY PERTURBATION METHOD; BOUNDARY-LAYER-FLOW; 3-DIMENSIONAL FLOW; POROUS-MEDIUM; THERMAL-RADIATION; JEFFERY FLUID; SHEET; PLATE	This paper investigates the steady hydromagnetic three-dimensional boundary layer flow of Maxwell fluid over a bidirectional stretching surface. Both cases of prescribed surface temperature (PST) and prescribed surface heat flux (PHF) are considered. Computations are made for the velocities and temperatures. Results are plotted and analyzed for PST and PHF cases. Convergence analysis is presented for the velocities and temperatures. Comparison of PST and PHF cases is given and examined.	[Shehzad, Sabir Ali; Hayat, Tasawar] Quaid I Azam Univ, Dept Math, Islamabad, Pakistan; [Alsaedi, Ahmad; Hayat, Tasawar] King Abdulaziz Univ, Fac Sci, Nonlinear Anal & Appl Math NAAM Res Grp, Jeddah, Saudi Arabia	Quaid I Azam University; King Abdulaziz University	Shehzad, SA (corresponding author), Quaid I Azam Univ, Dept Math, Islamabad, Pakistan.	ali_qau70@yahoo.com	Shehzad, Sabir Ali/J-3885-2014; Hayat, Tasawar/A-3853-2013; Alsaedi, Ahmed/A-2094-2013; Hayat, Tasawar/Y-2524-2019; Hayat, Tasawar/E-9449-2015	Alsaedi, Ahmed/0000-0003-3452-8922; 	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah [10-130/1433HiCi]	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah	This paper was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah under grant no. 10-130/1433HiCi. The authors, therefore, acknowledge with thanks DSR technical and financial support. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad I, 2011, THERM SCI, V15, pS205, DOI 10.2298/TSCI100926006A; Ariel PD, 2007, COMPUT MATH APPL, V54, P920, DOI 10.1016/j.camwa.2006.12.066; CRANE LJ, 1970, Z ANGEW MATH PHYS, V21, P645, DOI 10.1007/BF01587695; Fetecau C, 2011, ARCH APPL MECH, V81, P1153, DOI 10.1007/s00419-011-0536-x; Fetecau C, 2009, COMPUT MATH APPL, V57, P596, DOI 10.1016/j.camwa.2008.09.052; Fisher E., 1976, EXTRUSION PLASTICS; Harris J., 1977, RHEOLOGY NONNEWTONIA; Hayat T, 2008, NONLINEAR ANAL-REAL, V9, P2288, DOI 10.1016/j.nonrwa.2007.08.005; Hayat T, 2012, CHINESE PHYS LETT, V29, DOI 10.1088/0256-307X/29/11/114704; Hayat T, 2012, APPL MATH MECH-ENGL, V33, P1301, DOI 10.1007/s10483-012-1623-6; Hayat T, 2012, J HEAT TRANS-T ASME, V134, DOI 10.1115/1.4006897; Hayat T, 2012, NUCL ENG DES, V243, P15, DOI 10.1016/j.nucengdes.2011.11.005; Hayat T., 2012, INT J PHYS SCI, V7, P761; Hayat T, 2011, Z NATURFORSCH A, V66, P417, DOI 10.1515/zna-2011-6-706; Jamil M, 2010, NONLINEAR ANAL-REAL, V11, P4302, DOI 10.1016/j.nonrwa.2010.05.016; Kazem S, 2011, J FRANKLIN I, V348, P2044, DOI 10.1016/j.jfranklin.2011.05.020; Liao SJ, 2009, COMMUN NONLINEAR SCI, V14, P983, DOI 10.1016/j.cnsns.2008.04.013; Liu IC, 2008, INT J HEAT MASS TRAN, V51, P4018, DOI 10.1016/j.ijheatmasstransfer.2007.10.041; Makinde OD, 2011, INT J THERM SCI, V50, P1326, DOI 10.1016/j.ijthermalsci.2011.02.019; Mukhopadhyay S, 2012, Z NATURFORSCH A, V67, P641, DOI 10.5560/ZNA.2012-0075; Mukhopadhyay S, 2011, INT J HEAT MASS TRAN, V54, P2751, DOI 10.1016/j.ijheatmasstransfer.2011.03.017; Rashidi MM, 2012, INT J NUMER METHOD H, V22, P971, DOI 10.1108/09615531211271817; Rashidi MM, 2011, COMMUN NONLINEAR SCI, V16, P1874, DOI 10.1016/j.cnsns.2010.08.016; SAKIADIS BC, 1961, AICHE J, V7, P26, DOI 10.1002/aic.690070108; Schichting H., 1964, BOUNDARY LAYER THEOR, Vsixth; Shehzad SA, 2012, INT J HEAT MASS TRAN, V55, P3971, DOI 10.1016/j.ijheatmasstransfer.2012.03.027; Tadmor Z., 1970, ENG PRINCIPLES PLAST; Turkyilmazoglu M, 2012, PHYS SCRIPTA, V86, DOI 10.1088/0031-8949/86/05/055004; Turkyilmazoglu M, 2012, COMMUN NONLINEAR SCI, V17, P4097, DOI 10.1016/j.cnsns.2012.01.030; Turkyilmazoglu M, 2011, INT J NONLIN SCI NUM, V12, P9, DOI 10.1515/IJNSNS.2011.020; Turkyilmazoglu M, 2011, INT J THERM SCI, V50, P831, DOI 10.1016/j.ijthermalsci.2010.12.014; Turkyilmazoglu M, 2011, INT J THERM SCI, V50, P88, DOI 10.1016/j.ijthermalsci.2010.08.016; WANG CY, 1984, PHYS FLUIDS, V27, P1915, DOI 10.1063/1.864868; Wang SW, 2011, INT J HEAT FLUID FL, V32, P88, DOI 10.1016/j.ijheatfluidflow.2010.10.005; Zierep J, 2007, INT J ENG SCI, V45, P617, DOI 10.1016/j.ijengsci.2007.04.015	35	47	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e68139	10.1371/journal.pone.0068139	http://dx.doi.org/10.1371/journal.pone.0068139			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	23874523	Green Published, Green Submitted, gold			2022-12-27	WOS:000321718700010
J	Archimbaud, C; Ouchchane, L; Mirand, A; Chambon, M; Demeocq, F; Labbe, A; Laurichesse, H; Schmidt, J; Clavelou, P; Aumaitre, O; Regagnon, C; Bailly, JL; Henquell, C; Peigue-Lafeuille, H				Archimbaud, Christine; Ouchchane, Lemlih; Mirand, Audrey; Chambon, Martine; Demeocq, Francois; Labbe, Andre; Laurichesse, Henri; Schmidt, Jeannot; Clavelou, Pierre; Aumaitre, Olivier; Regagnon, Christel; Bailly, Jean-Luc; Henquell, Cecile; Peigue-Lafeuille, Helene			Improvement of the Management of Infants, Children and Adults with a Molecular Diagnosis of Enterovirus Meningitis during Two Observational Study Periods	PLOS ONE			English	Article							PEDIATRIC-PATIENTS; IMPACT; HOSPITALIZATION	Enteroviruses (EVs) are a major cause of aseptic meningitis, and RNA detection using molecular assay is the gold standard diagnostic test. The aim of this study was to assess the impact of an EV positive diagnosis on the clinical management of patients admitted for meningitis over the course of two observational study periods (2005 and 2008-09) in the same clinical departments. We further investigated in multivariate analysis various factors possibly associated with hospital length of stay (LOS) in all age groups (infants, children, and adults). The results showed an overall improvement in the management of patients (n = 142) between the study periods, resulting in a significantly shorter hospital LOS for adults and children, and a shorter duration of antibiotic use for adults and infants. In multivariate analysis, we observed that the time from molecular test results to discharge of patients and the median duration of antibiotic treatment were associated with an increase in LOS in all age groups. In addition, among adults, the turnaround time of the molecular assay was significantly correlated with LOS. The use of CT scan in children and hospital admission outside the peak of EV prevalence in infants tended to increase LOS. In conclusion, the shorter length of stay of patients with meningitis in this study was due to various factors including the rapidity of the EV molecular test (particularly in adults), greater physician responsiveness after a positive result (in adults and children), and greater experience on the part of physicians in handling EV meningitis, as evidenced by the shorter duration of antibiotic use in adults and infants.	[Archimbaud, Christine; Mirand, Audrey; Chambon, Martine; Bailly, Jean-Luc; Peigue-Lafeuille, Helene] Univ Auvergne, Lab Virol EPIE EA4843, Clermont Ferrand, France; [Archimbaud, Christine; Mirand, Audrey; Chambon, Martine; Regagnon, Christel; Henquell, Cecile; Peigue-Lafeuille, Helene] CHU Clermont Ferrand, Lab Virol, Ctr Natl Reference Enterovirus Parechovirus, Lab Associe, Clermont Ferrand, France; [Ouchchane, Lemlih] Univ Auvergne, Serv Biostat, Clermont Ferrand, France; [Demeocq, Francois; Labbe, Andre] INSERM CIC 501, CHU Clermont Ferrand, Serv Pediat Gen, Clermont Ferrand, France; [Laurichesse, Henri] CHU Clermont Ferrand, Serv Malad infectieuses, Clermont Ferrand, France; [Schmidt, Jeannot] CHU Clermont Ferrand, Serv Accueil Urgences, Clermont Ferrand, France; [Clavelou, Pierre] CHU Clermont Ferrand, Serv Neurol, Clermont Ferrand, France; [Aumaitre, Olivier] CHU Clermont Ferrand, Serv Med Interne, Clermont Ferrand, France	Universite Clermont Auvergne (UCA); CHU Clermont Ferrand; Universite Clermont Auvergne (UCA); CHU Clermont Ferrand; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Clermont Ferrand; CHU Clermont Ferrand; CHU Clermont Ferrand; CHU Clermont Ferrand	Archimbaud, C (corresponding author), Univ Auvergne, Lab Virol EPIE EA4843, Clermont Ferrand, France.	carchimbaud@chu-clermontferrand.fr	Bailly, Jean-Luc/ABE-9210-2020	Clavelou, Pierre/0000-0003-2363-9352; Bailly, Jean-Luc/0000-0002-9770-6450	Universite d'Auvergne [EA4843]	Universite d'Auvergne	The laboratory (EA4843) is supported by grants from "Universite d'Auvergne". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archimbaud C, 2009, J MED VIROL, V81, P42, DOI 10.1002/jmv.21330; Archimbaud C, 2004, J MED VIROL, V74, P604, DOI 10.1002/jmv.20217; Chambon M, 2001, J MED VIROL, V65, P340, DOI 10.1002/jmv.2039; Cohen-Bacrie S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022403; de Crom SCM, 2012, EUR J PEDIATR, V171, P795, DOI 10.1007/s00431-011-1626-z; Dewan M, 2010, ARCH PEDIAT ADOL MED, V164, P824, DOI 10.1001/archpediatrics.2010.153; Henquell C, 2001, J CLIN VIROL, V21, P29, DOI 10.1016/S1386-6532(00)00176-1; Huizing KMN, 2011, PEDIATR INFECT DIS J, V30, P1107, DOI 10.1097/INF.0b013e31822cca1f; Kestenbaum LA, 2010, PEDIATRICS, V125, P257, DOI 10.1542/peds.2009-1181; King RL, 2007, PEDIATRICS, V120, P489, DOI 10.1542/peds.2007-0252; Mechai F, 2010, REV MED INTERNE, V31, P596, DOI 10.1016/j.revmed.2010.04.003; Nolte FS, 2011, J CLIN MICROBIOL, V49, P528, DOI 10.1128/JCM.01570-10; Nowak DA, 2003, EUR J NEUROL, V10, P271, DOI 10.1046/j.1468-1331.2003.00575.x; Peigue-Lafeuille H, 2002, J MED VIROL, V67, P47, DOI 10.1002/jmv.2191; Peigue-Lafeuille H, 2012, MOL DIAGNOSTICS INFE, P155; Ramers C, 2000, JAMA-J AM MED ASSOC, V283, P2680, DOI 10.1001/jama.283.20.2680; Robinson CC, 2002, PEDIATR INFECT DIS J, V21, P283, DOI 10.1097/00006454-200204000-00005	17	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e68571	10.1371/journal.pone.0068571	http://dx.doi.org/10.1371/journal.pone.0068571			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874676	Green Submitted, Green Published, gold			2022-12-27	WOS:000322218800036
J	Tamburini, C; Canals, M; de Madron, XD; Houpert, L; Lefevre, D; Martini, V; D'Ortenzio, F; Robert, A; Testor, P; Aguilar, JA; Al Samarai, I; Albert, A; Andre, M; Anghinolfi, M; Anton, G; Anvar, S; Ardid, M; Jesus, ACA; Astraatmadja, TL; Aubert, JJ; Baret, B; Basa, S; Bertin, V; Biagi, S; Bigi, A; Bigongiari, C; Bogazzi, C; Bou-Cabo, M; Bouhou, B; Bouwhuis, MC; Brunner, J; Busto, J; Camarena, F; Capone, A; Carloganu, C; Carminati, G; Carr, J; Cecchini, S; Charif, Z; Charvis, P; Chiarusi, T; Circella, M; Coniglione, R; Costantini, H; Coyle, P; Curtil, C; Decowski, P; Dekeyser, I; Deschamps, A; Donzaud, C; Dornic, D; Dorosti, HQ; Drouhin, D; Eberl, T; Emanuele, U; Ernenwein, JP; Escoffier, S; Fermani, P; Ferri, M; Flaminio, V; Folger, F; Fritsch, U; Fuda, JL; Galata, S; Gay, P; Giacomelli, G; Giordano, V; Gomez-Gonzalez, JP; Graf, K; Guillard, G; Halladjian, G; Hallewell, G; van Haren, H; Hartman, J; Heijboer, AJ; Hello, Y; Hernandez-Rey, JJ; Herold, B; Hossl, J; Hsu, CC; de Jong, M; Kadler, M; Kalekin, O; Kappes, A; Katz, U; Kavatsyuk, O; Kooijman, P; Kopper, C; Kouchner, A; Kreykenbohm, I; Kulikovskiy, V; Lahmann, R; Lamare, P; Larosa, G; Lattuada, D; Lim, G; Lo Presti, D; Loehner, H; Loucatos, S; Mangano, S; Marcelin, M; Margiotta, A; Martinez-Mora, JA; Meli, A; Montaruli, T; Moscoso, L; Motz, H; Neff, M; Nezri, EN; Palioselitis, D; Pavalas, GE; Payet, K; Payre, P; Petrovic, J; Piattelli, P; Picot-Clemente, N; Popa, V; Pradier, T; Presani, E; Racca, C; Reed, C; Riccobene, G; Richardt, C; Richter, R; Riviere, C; Roensch, K; Rostovtsev, A; Ruiz-Rivas, J; Rujoiu, M; Russo, VG; Salesa, F; Sanchez-Losa, A; Sapienza, P; Schock, F; Schuller, JP; Schussler, F; Shanidze, R; Simeone, F; Spies, A; Spurio, M; Steijger, JJM; Stolarczyk, T; Taiuti, MGF; Toscano, S; Vallage, B; Van Elewyck, V; Vannoni, G; Vecchi, M; Vernin, P; Wijnker, G; Wilms, J; de Wolf, E; Yepes, H; Zaborov, D; Zornoza, JD; Zuniga, J				Tamburini, Christian; Canals, Miquel; de Madron, Xavier Durrieu; Houpert, Loic; Lefevre, Dominique; Martini, Verine; D'Ortenzio, Fabrizio; Robert, Anne; Testor, Pierre; Aguilar, Juan Antonio; Al Samarai, Imen; Albert, Arnaud; Andre, Michel; Anghinolfi, Marco; Anton, Gisela; Anvar, Shebli; Ardid, Miguel; Jesus, Ana Carolina Assis; Astraatmadja, Tri L.; Aubert, Jean-Jacques; Baret, Bruny; Basa, Stephane; Bertin, Vincent; Biagi, Simone; Bigi, Armando; Bigongiari, Ciro; Bogazzi, Claudio; Bou-Cabo, Manuel; Bouhou, Boutayeb; Bouwhuis, Mieke C.; Brunner, Jurgen; Busto, Jose; Camarena, Francisco; Capone, Antonio; Carloganu, Christina; Carminati, Giada; Carr, John; Cecchini, Stefano; Charif, Ziad; Charvis, Philippe; Chiarusi, Tommaso; Circella, Marco; Coniglione, Rosa; Costantini, Heide; Coyle, Paschal; Curtil, Christian; Decowski, Patrick; Dekeyser, Ivan; Deschamps, Anne; Donzaud, Corinne; Dornic, Damien; Dorosti, Hasankiadeh Q.; Drouhin, Doriane; Eberl, Thomas; Emanuele, Umberto; Ernenwein, Jean-Pierre; Escoffier, Stephanie; Fermani, Paolo; Ferri, Marcelino; Flaminio, Vincenzo; Folger, Florian; Fritsch, Ulf; Fuda, Jean-Luc; Galata, Salvatore; Gay, Pascal; Giacomelli, Giorgio; Giordano, Valentina; Gomez-Gonzalez, Juan-Pablo; Graf, Kay; Guillard, Goulven; Halladjian, Garadeb; Hallewell, Gregory; van Haren, Hans; Hartman, Joris; Heijboer, Aart J.; Hello, Yann; Hernandez-Rey, Juan Jose; Herold, Bjoern; Hossl, Jurgen; Hsu, Ching-Cheng; de Jong, Marteen; Kadler, Matthias; Kalekin, Oleg; Kappes, Alexander; Katz, Uli; Kavatsyuk, Oksana; Kooijman, Paul; Kopper, Claudio; Kouchner, Antoine; Kreykenbohm, Ingo; Kulikovskiy, Vladimir; Lahmann, Robert; Lamare, Patrick; Larosa, Giuseppina; Lattuada, Dario; Lim, Gordon; Lo Presti, Domenico; Loehner, Herbert; Loucatos, Sotiris; Mangano, Salvatore; Marcelin, Michel; Margiotta, Annarita; Martinez-Mora, Juan Antonio; Meli, Athina; Montaruli, Teresa; Moscoso, Luciano; Motz, Holger; Neff, Max; Nezri, Emma Nuel; Palioselitis, Dimitris; Pavalas, Gabriela E.; Payet, Kevin; Payre, Patrice; Petrovic, Jelena; Piattelli, Paolo; Picot-Clemente, Nicolas; Popa, Vlad; Pradier, Thierry; Presani, Eleonora; Racca, Chantal; Reed, Corey; Riccobene, Giorgio; Richardt, Carsten; Richter, Roland; Riviere, Colas; Roensch, Kathrin; Rostovtsev, Andrei; Ruiz-Rivas, Joaquin; Rujoiu, Marius; Russo, Valerio G.; Salesa, Francisco; Sanchez-Losa, Augustin; Sapienza, Piera; Schoeck, Friederike; Schuller, Jean-Pierre; Schussler, Fabian; Shanidze, Rezo; Simeone, Francesco; Spies, Andreas; Spurio, Maurizio; Steijger, Jos J. M.; Stolarczyk, Thierry; Taiuti, Mauro G. F.; Toscano, Simona; Vallage, Bertrand; Van Elewyck, Veronique; Vannoni, Giulia; Vecchi, Manuela; Vernin, Pascal; Wijnker, Guus; Wilms, Jorn; de Wolf, Els; Yepes, Harold; Zaborov, Dmitry; Zornoza, Juan De Dios; Zuniga, Juan			Deep-Sea Bioluminescence Blooms after Dense Water Formation at the Ocean Surface	PLOS ONE			English	Article							ANTARES NEUTRINO TELESCOPE; MEDITERRANEAN SEA; INTERANNUAL VARIABILITY; BACKGROUND LIGHT; CLIMATE-CHANGE; CONVECTION; GULF; DYNAMICS; ATLANTIC; IMPACT	The deep ocean is the largest and least known ecosystem on Earth. It hosts numerous pelagic organisms, most of which are able to emit light. Here we present a unique data set consisting of a 2.5-year long record of light emission by deep-sea pelagic organisms, measured from December 2007 to June 2010 at the ANTARES underwater neutrino telescope in the deep NW Mediterranean Sea, jointly with synchronous hydrological records. This is the longest continuous time-series of deep-sea bioluminescence ever recorded. Our record reveals several weeks long, seasonal bioluminescence blooms with light intensity up to two orders of magnitude higher than background values, which correlate to changes in the properties of deep waters. Such changes are triggered by the winter cooling and evaporation experienced by the upper ocean layer in the Gulf of Lion that leads to the formation and subsequent sinking of dense water through a process known as "open-sea convection". It episodically renews the deep water of the study area and conveys fresh organic matter that fuels the deep ecosystems. Luminous bacteria most likely are the main contributors to the observed deep-sea bioluminescence blooms. Our observations demonstrate a consistent and rapid connection between deep open-sea convection and bathypelagic biological activity, as expressed by bioluminescence. In a setting where dense water formation events are likely to decline under global warming scenarios enhancing ocean stratification, in situ observatories become essential as environmental sentinels for the monitoring and understanding of deep-sea ecosystem shifts.	[Tamburini, Christian; Lefevre, Dominique; Martini, Verine; Robert, Anne; Dekeyser, Ivan; Fuda, Jean-Luc] Aix Marseille Univ, CNRS INSU, IRD, MIO,U110, Marseille, France; [Tamburini, Christian; Lefevre, Dominique; Martini, Verine; Robert, Anne; Dekeyser, Ivan; Fuda, Jean-Luc] Univ Toulon & Var, CNRS INSU, IRD, MIO,U110, La Garde, France; [Canals, Miquel] Univ Barcelona, Fac Geol, GRC Geociencies Marines, Dept Estratig Paleontol & Geociencies Marines, Barcelona, Spain; [de Madron, Xavier Durrieu; Houpert, Loic] Univ Perpignan, CNRS INSU, CEFREM UMR5110, F-66025 Perpignan, France; [D'Ortenzio, Fabrizio] Univ Paris 06, CNRS INSU, LOV UMR7093, Villefranche Sur Mer, France; [Testor, Pierre] Univ Paris 06, CNRS INSU, Inst Pierre Simon Laplace, LOCEAN UMR 7159, Paris, France; [Aguilar, Juan Antonio; Bigongiari, Ciro; Dornic, Damien; Emanuele, Umberto; Gomez-Gonzalez, Juan-Pablo; Hernandez-Rey, Juan Jose; Mangano, Salvatore; Ruiz-Rivas, Joaquin; Salesa, Francisco; Sanchez-Losa, Augustin; Toscano, Simona; Yepes, Harold; Zornoza, Juan De Dios; Zuniga, Juan] CSIC Univ Valencia, IFIC Inst Fis Corpuscular, Valencia, Spain; [Al Samarai, Imen; Aubert, Jean-Jacques; Bertin, Vincent; Brunner, Jurgen; Busto, Jose; Carr, John; Charif, Ziad; Costantini, Heide; Coyle, Paschal; Curtil, Christian; Dornic, Damien; Ernenwein, Jean-Pierre; Escoffier, Stephanie; Galata, Salvatore; Halladjian, Garadeb; Hallewell, Gregory; Payre, Patrice; Picot-Clemente, Nicolas; Riviere, Colas; Vecchi, Manuela] CPPM Aix Marseille Univ, CNRS IN2P3, Marseille, France; [Albert, Arnaud; Drouhin, Doriane; Racca, Chantal] GRPHE Inst Univ Technol Colmar, Colmar, France; [Andre, Michel] Tech Univ Catalonia, Lab Appl Bioacoust, Barcelona, Spain; [Anghinolfi, Marco; Costantini, Heide; Kulikovskiy, Vladimir; Taiuti, Mauro G. F.] Ist Nazl Fis Nucl, Sez Genova, I-16146 Genoa, Italy; [Anton, Gisela; Eberl, Thomas; Folger, Florian; Fritsch, Ulf; Graf, Kay; Herold, Bjoern; Hossl, Jurgen; Kalekin, Oleg; Kappes, Alexander; Katz, Uli; Kopper, Claudio; Lahmann, Robert; Meli, Athina; Motz, Holger; Neff, Max; Richardt, Carsten; Richter, Roland; Roensch, Kathrin; Schoeck, Friederike; Shanidze, Rezo; Spies, Andreas] Univ Erlangen Nurnberg, Erlangen Ctr Astroparticle Phys, D-91054 Erlangen, Germany; [Anvar, Shebli; Lamare, Patrick] CEA Saclay, Serv Elect Detecteurs & Informat, Direct Sci Mat, Inst Rech lois Fondamentales Univers, F-91191 Gif Sur Yvette, France; [Ardid, Miguel; Bou-Cabo, Manuel; Camarena, Francisco; Ferri, Marcelino; Larosa, Giuseppina; Martinez-Mora, Juan Antonio] Univ Politecn Valencia, Inst Invest Gestio Integrada Zones Costaneres IGI, Gandia, Spain; [Jesus, Ana Carolina Assis; Astraatmadja, Tri L.; Bogazzi, Claudio; Bouwhuis, Mieke C.; Decowski, Patrick; Hartman, Joris; Heijboer, Aart J.; Hsu, Ching-Cheng; de Jong, Marteen; Kooijman, Paul; Lim, Gordon; Palioselitis, Dimitris; Petrovic, Jelena; Presani, Eleonora; Reed, Corey; Steijger, Jos J. M.; Wijnker, Guus; de Wolf, Els] NIKHEF H, NL-1009 DB Amsterdam, Netherlands; [Baret, Bruny; Bouhou, Boutayeb; Donzaud, Corinne; Kouchner, Antoine; Moscoso, Luciano; Van Elewyck, Veronique] Univ Paris Diderot, APC, CNRS IN2P3, CEA IRFU,Observ Paris,Sorbonne Paris Cite, Paris, France; [Basa, Stephane; Marcelin, Michel; Nezri, Emma Nuel] Aix Marseille Univ, CNRS, LAM, UMR 7326, Marseille, France; [Biagi, Simone; Carminati, Giada; Cecchini, Stefano; Chiarusi, Tommaso; Giacomelli, Giorgio; Margiotta, Annarita; Spurio, Maurizio] Ist Nazl Fis Nucl, Sez Bologna, I-40126 Bologna, Italy; [Biagi, Simone; Carminati, Giada; Giacomelli, Giorgio; Margiotta, Annarita; Spurio, Maurizio] Univ Bologna, Dipartmento Fis, Bologna, Italy; [Bigi, Armando; Flaminio, Vincenzo] Ist Nazl Fis Nucl, Sez Pisa, Pisa, Italy; [Capone, Antonio; Fermani, Paolo; Simeone, Francesco] Ist Nazl Fis Nucl, Sez Roma, Rome, Italy; [Capone, Antonio; Fermani, Paolo; Simeone, Francesco] Univ Roma La Sapienza, Dipartimento Fis, I-00185 Rome, Italy; [Carloganu, Christina; Gay, Pascal; Guillard, Goulven] Univ Blaise Pascal, Clermont Univ, CNRS IN2P3, Lab Phys Corpusculaire,CNRS, Clermont Ferrand, France; [Cecchini, Stefano] INAF IASF, Bologna, Italy; [Charvis, Philippe; Deschamps, Anne; Hello, Yann] Univ Nice Sophia Antipolis, Geoazur, CNRS INSU, IRD,Observ Cote Azur, Villefranche Sur Mer, France; [Charvis, Philippe; Deschamps, Anne; Hello, Yann] Univ Paris 06, Villefranche Sur Mer, France; [Circella, Marco; Montaruli, Teresa] Ist Nazl Fis Nucl, Sez Bari, I-70126 Bari, Italy; [Coniglione, Rosa; Giordano, Valentina; Lattuada, Dario; Piattelli, Paolo; Riccobene, Giorgio; Sapienza, Piera] Ist Nazl Fis Nucl, LNS, I-95129 Catania, Italy; [Donzaud, Corinne] Univ Paris 11, Orsay, France; [Dorosti, Hasankiadeh Q.; Kavatsyuk, Oksana; Loehner, Herbert] Univ Groningen, KVI, Groningen, Netherlands; [Flaminio, Vincenzo] Univ Pisa, Dipartimento Fis, I-56100 Pisa, Italy; [van Haren, Hans] Royal Netherlands Inst Sea Res NIOZ, Texel, Netherlands; [Kadler, Matthias; Kreykenbohm, Ingo; Wilms, Jorn] Dr Remeis Sternwarte & ECAP, Bamberg, Germany; [Kooijman, Paul] Univ Utrecht, Fac Betawetenschappen, Utrecht, Netherlands; [Kooijman, Paul; Lim, Gordon; de Wolf, Els] Univ Amsterdam, Inst Hoge Energie Fys, Amsterdam, Netherlands; [Kulikovskiy, Vladimir] Moscow MV Lomonosov State Univ, Skobeltsyn Inst Nucl Phys, Moscow, Russia; [Lo Presti, Domenico; Russo, Valerio G.] Ist Nazl Fis Nucl, Sez Catania, I-95129 Catania, Italy; [Lo Presti, Domenico; Russo, Valerio G.] Univ Catania, Dipartimento Fis & Astron, Catania, Italy; [Loucatos, Sotiris; Moscoso, Luciano; Payet, Kevin; Schuller, Jean-Pierre; Schussler, Fabian; Stolarczyk, Thierry; Vallage, Bertrand; Vannoni, Giulia; Vernin, Pascal] CEA Saclay, Direct Sci Mat, Inst Rech Lois Fondamentales Univers, Serv Phys Particules, F-91191 Gif Sur Yvette, France; [Montaruli, Teresa] Univ Wisconsin, Madison, WI USA; [Pavalas, Gabriela E.; Popa, Vlad; Rujoiu, Marius] Inst Space Sci, Bucharest, Romania; [Pradier, Thierry] Univ Strasbourg, IPHC, Strasbourg, France; [Pradier, Thierry] CNRS IN2P3, Strasbourg, France; [Rostovtsev, Andrei; Zaborov, Dmitry] ITEP, Moscow, Russia; [Taiuti, Mauro G. F.] Univ Genoa, Dipartimento Fis, Genoa, Italy	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Toulon; University of Barcelona; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite Perpignan Via Domitia; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Fisica Corpuscular (IFIC); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Aix-Marseille Universite; Universites de Strasbourg Etablissements Associes; Universite de Haute-Alsace (UHA); Universitat Politecnica de Catalunya; Istituto Nazionale di Fisica Nucleare (INFN); University of Erlangen Nuremberg; CEA; UDICE-French Research Universities; Universite Paris Saclay; Universitat Politecnica de Valencia; FOM National Institute for Subatomic Physics; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; PSL Research University Paris; Universite Paris Cite; Observatoire de Paris; CEA; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Aix-Marseille Universite; Istituto Nazionale di Fisica Nucleare (INFN); University of Bologna; Istituto Nazionale di Fisica Nucleare (INFN); Istituto Nazionale di Fisica Nucleare (INFN); Sapienza University Rome; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Universite Clermont Auvergne (UCA); Istituto Nazionale Astrofisica (INAF); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur; UDICE-French Research Universities; Sorbonne Universite; Istituto Nazionale di Fisica Nucleare (INFN); Istituto Nazionale di Fisica Nucleare (INFN); UDICE-French Research Universities; Universite Paris Saclay; University of Groningen; University of Pisa; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); University of Erlangen Nuremberg; Utrecht University; University of Amsterdam; Lomonosov Moscow State University; Istituto Nazionale di Fisica Nucleare (INFN); University of Catania; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Wisconsin System; University of Wisconsin Madison; Institute of Space Science; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); National Research Centre - Kurchatov Institute; Alikhanov Institute for Theoretical & Experimental Physics; University of Genoa	Tamburini, C (corresponding author), Aix Marseille Univ, CNRS INSU, IRD, MIO,U110, Marseille, France.	christian.tamburini@univ-amu.fr; escoffier@cppm.in2p3.fr	Greus, Francisco Salesa/P-2820-2017; Tamburini, Christian/AAO-8577-2020; Camarena, Francisco/L-9349-2014; Lahmann, Robert/L-7461-2015; Riccobene, Giorgio/A-4502-2010; Simeone, Francesco/L-1057-2016; Motz, Holger/ABC-6086-2021; Kreykenbohm, Ingo/H-9659-2013; Martínez-Mora, Juan A./P-3552-2015; Zuniga, Juan/P-4385-2014; PRADIER, Thierry/P-6052-2017; Fermani, Paolo/G-3628-2018; Presti, Domenico Lo/G-2709-2013; Lefevre, Dominique/AAN-8201-2021; Canals, Miquel/F-4922-2013; Zaborov, Dmitry/AAD-8694-2019; Biagi, Simone/G-4557-2016; Escoffier, Stephanie/AAW-1061-2020; Presani, Eleonora/AAD-9734-2019; Charvis, Philippe/K-1576-2016; Hernández-Rey, Juan José/N-5955-2014; Wilms, Joern/C-8116-2013; Giordano, Valentina/Y-5113-2018; Schüssler, Fabian/G-5313-2013; Eberl, Thomas/AGX-6072-2022; Kulikovskiy, Vladimir/AGG-7476-2022; Anton, Gisela/C-4840-2013; Spurio, Maurizio/AAM-2262-2020; Brunner, Juergen/G-3540-2015; Charvis, Philippe/AAH-4484-2020; Testor, Pierre/M-4564-2014; BOU-CABO, Manuel/R-8255-2018; Capone, Antonio/F-1098-2010; de Dios Zornoza, Juan/L-1604-2014; Schüssler, Fabian/M-3789-2019; Giordano, Valentina/O-1571-2019; Houpert, Loïc/A-4841-2012; Piattelli, Paolo/AAJ-2835-2020; cabo, bou/N-2076-2014; Kopper, Claudio/N-5824-2019; Löhner, Herbert/B-2397-2014; Vecchi, Manuela/J-9180-2014; Eberl, Thomas/J-4826-2016; Tamburini, Christian/I-7821-2012; Sánchez, Juan Antonio Aguilar/H-4467-2015; sanchez, juan/GSD-8167-2022; Ardid, Miguel/H-9544-2015; Sánchez Losa, Agustín/B-6153-2019; Katz, Uli F/E-1925-2013; Chiarusi, Tommaso/HDN-8739-2022; Kadler, Matthias/R-2099-2016	Greus, Francisco Salesa/0000-0002-8610-8703; Tamburini, Christian/0000-0003-3752-7423; Camarena, Francisco/0000-0002-6713-1414; Riccobene, Giorgio/0000-0002-0600-2774; Motz, Holger/0000-0003-1918-2177; Kreykenbohm, Ingo/0000-0001-7335-1803; Martínez-Mora, Juan A./0000-0001-7956-2847; Zuniga, Juan/0000-0002-1041-6451; PRADIER, Thierry/0000-0001-5501-0060; Fermani, Paolo/0000-0003-1204-4097; Presti, Domenico Lo/0000-0002-4540-2885; Lefevre, Dominique/0000-0003-1694-3807; Canals, Miquel/0000-0001-5267-7601; Zaborov, Dmitry/0000-0002-9335-1410; Biagi, Simone/0000-0001-8598-0017; Escoffier, Stephanie/0000-0002-2847-7498; Charvis, Philippe/0000-0003-4397-7842; Hernández-Rey, Juan José/0000-0002-1527-7200; Wilms, Joern/0000-0003-2065-5410; Giordano, Valentina/0000-0001-8865-5930; Schüssler, Fabian/0000-0003-1500-6571; Eberl, Thomas/0000-0002-5301-9106; Anton, Gisela/0000-0003-2039-4724; Spurio, Maurizio/0000-0002-8698-3655; Brunner, Juergen/0000-0002-5052-7236; BOU-CABO, Manuel/0000-0002-0345-2462; Capone, Antonio/0000-0001-9657-6220; de Dios Zornoza, Juan/0000-0002-1834-0690; Schüssler, Fabian/0000-0003-1500-6571; Giordano, Valentina/0000-0001-8865-5930; Houpert, Loïc/0000-0001-8750-5631; Piattelli, Paolo/0000-0003-4748-6485; Löhner, Herbert/0000-0002-7441-739X; Vecchi, Manuela/0000-0002-5338-6029; Eberl, Thomas/0000-0002-5301-9106; Tamburini, Christian/0000-0003-3752-7423; Sánchez, Juan Antonio Aguilar/0000-0003-2252-9514; Ardid, Miguel/0000-0002-3199-594X; Sánchez Losa, Agustín/0000-0001-9596-7078; Katz, Uli F/0000-0002-7063-4418; DURRIEU DE MADRON, Xavier/0000-0002-4543-6903; Ferri Garcia, Marcelino/0000-0002-2049-3821; Toscano, Simona/0000-0002-1860-2240; Kulikovskiy, Vladimir/0000-0003-4096-5934; Carloganu, Cristina/0000-0002-4824-8895; Van Elewyck, Veronique/0000-0002-8242-5453; Montaruli, Teresa/0000-0001-5014-2152; Kouchner, Antoine/0000-0001-7068-2113; Vannoni, Giulia/0000-0003-4375-8252; Andre, Michel/0000-0002-0091-7279; Presani, Eleonora/0000-0001-6254-9603; Bigongiari, Ciro/0000-0003-3293-8522; Kavatsyuk, Oksana/0000-0002-4609-5012; Lattuada, Dario/0000-0002-1073-1339; Chiarusi, Tommaso/0000-0001-8454-8644; Yepes-Ramirez, Harold/0000-0002-1105-0412; Kadler, Matthias/0000-0001-5606-6154; martini, severine/0000-0001-9471-1708; Hsu, Ching-Cheng/0000-0001-9406-2023	ANR-POTES program [ANR-05-BLAN-0161-01]; ANTARES-Bioluminescence project (INSU-IN2P3); AAMIS project (Univ. Mediterranee); EC2CO Biolux project (CNRS INSU); Excellence Research Groups (Generalitat de Catalunya) [2009-SGR-1305]; EuroSITES project [FP7-ENV-2007-1-202955]; MARINERA-REDECO project [CTM2008-04973-E/MAR]; HERMIONE project [FP7-ENV-2008-1-226354]; KM3NeT-PP project [212525]; ESONET NoE project [FP6-GOCE-036851]; DOS MARES project [CTM2010-21810-C03-01]; CONSOLIDER-INGENIO GRACCIE project [CSD2007-00067]; Ministry of Education, Research and Technology, France; Direction Generale de l'Armement; CNRS; CEA; ANR; FEDER fund; Marie Curie Program; Region Alsace; Region Provence-Alpes-Cote d'Azur; Departement du Var and Ville de La Seyne-sur-Mer, France; BMBF, Germany; INFN, Italy; FOM, the Netherlands; NWO, the Netherlands; Council of the President of the Russian Federation, Russia; ANCS, Romania; MICINN [FPA2009-13983-C02-01]; PROMETEO [2009/026]; MultiDark [CSD2009-00064]	ANR-POTES program(French National Research Agency (ANR)); ANTARES-Bioluminescence project (INSU-IN2P3); AAMIS project (Univ. Mediterranee); EC2CO Biolux project (CNRS INSU); Excellence Research Groups (Generalitat de Catalunya)(Generalitat de Catalunya); EuroSITES project; MARINERA-REDECO project; HERMIONE project; KM3NeT-PP project; ESONET NoE project; DOS MARES project; CONSOLIDER-INGENIO GRACCIE project; Ministry of Education, Research and Technology, France; Direction Generale de l'Armement; CNRS(Centre National de la Recherche Scientifique (CNRS)); CEA(French Atomic Energy Commission); ANR(French National Research Agency (ANR)); FEDER fund; Marie Curie Program(European Commission); Region Alsace(Region Grand-Est); Region Provence-Alpes-Cote d'Azur(Region Provence-Alpes-Cote d'Azur); Departement du Var and Ville de La Seyne-sur-Mer, France(Region Provence-Alpes-Cote d'Azur); BMBF, Germany(Federal Ministry of Education & Research (BMBF)); INFN, Italy(Istituto Nazionale di Fisica Nucleare (INFN)); FOM, the Netherlands(FOM (The Netherlands)Netherlands Government); NWO, the Netherlands(Netherlands Organization for Scientific Research (NWO)Netherlands Government); Council of the President of the Russian Federation, Russia; ANCS, Romania; MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); PROMETEO; MultiDark	This work was partially funded by the ANR-POTES program (ANR-05-BLAN-0161-01), ANTARES-Bioluminescence project (INSU-IN2P3), AAMIS project (Univ. Mediterranee), EC2CO Biolux project (CNRS INSU), Excellence Research Groups (2009-SGR-1305, Generalitat de Catalunya), EuroSITES (FP7-ENV-2007-1-202955), MARINERA-REDECO (CTM2008-04973-E/MAR), HERMIONE (FP7-ENV-2008-1-226354), KM3NeT-PP (212525), ESONET NoE (FP6-GOCE-036851), DOS MARES (CTM2010-21810-C03-01) and CONSOLIDER-INGENIO GRACCIE (CSD2007-00067) projects. SM was granted a MERNT fellowship (Ministry of Education, Research and Technology, France). LH acknowledges the support of the Direction Generale de l'Armement (supervisor: Elisabeth Gibert-Brunet). The authors also acknowledge the financial support of the funding agencies: CNRS, CEA, ANR, FEDER fund and Marie Curie Program, Regions Alsace and Provence-Alpes-Cote d'Azur, Departement du Var and Ville de La Seyne-sur-Mer, France; BMBF, Germany; INFN, Italy; FOM and NWO, the Netherlands; Council of the President of the Russian Federation for young scientists and leading scientific schools supporting grants, Russia; ANCS, Romania; MICINN (FPA2009-13983-C02-01), PROMETEO (2009/026) and MultiDark (CSD2009-00064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ageron M, 2011, NUCL INSTRUM METH A, V656, P11, DOI 10.1016/j.nima.2011.06.103; Aguilar JA, 2007, NUCL INSTRUM METH A, V570, P107, DOI 10.1016/j.nima.2006.09.098; Aguilar JA, 2006, ASTROPART PHYS, V26, P314, DOI 10.1016/j.astropartphys.2006.07.004; Aguilar JA, 2010, ASTROPART PHYS, V33, P86, DOI 10.1016/j.astropartphys.2009.12.002; Aguilar JA, 2005, NUCL INSTRUM METH A, V555, P132, DOI 10.1016/j.nima.2005.09.035; Al Ali B, 2010, CHEM ECOL, V26, P57, DOI 10.1080/02757540903513766; Amram P, 2000, ASTROPART PHYS, V13, P127, DOI 10.1016/S0927-6505(99)00118-8; Amram P, 2002, NUCL INSTRUM METH A, V484, P369, DOI 10.1016/S0168-9002(01)02026-5; ANDREWS CC, 1984, NATURE, V307, P539, DOI 10.1038/307539a0; AOKI T, 1986, NUOVO CIMENTO C, V9, P642, DOI 10.1007/BF02514882; Bethoux JP, 2002, J MARINE SYST, V33, P117, DOI 10.1016/S0924-7963(02)00055-6; BRADNER H, 1987, DEEP-SEA RES, V34, P1831, DOI 10.1016/0198-0149(87)90057-4; Canals M, 2006, NATURE, V444, P354, DOI 10.1038/nature05271; Company JB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001431; de Madron XD, 2013, GEOPHYS RES LETT, V40, P1379, DOI 10.1002/grl.50331; Geistdoerfer P, 1999, OCEANOL ACTA, V22, P137, DOI 10.1016/S0399-1784(99)80041-3; Gentile G, 2009, DEEP-SEA RES PT II, V56, P763, DOI 10.1016/j.dsr2.2008.07.023; Haddock SHD, 2010, ANNU REV MAR SCI, V2, P443, DOI 10.1146/annurev-marine-120308-081028; Herring P.J., 1987, Journal of Bioluminescence and Chemiluminescence, V1, P147, DOI 10.1002/bio.1170010303; Herrmann M, 2008, CONT SHELF RES, V28, P2092, DOI 10.1016/j.csr.2008.03.003; Marshall J, 1999, REV GEOPHYS, V37, P1, DOI 10.1029/98RG02739; Martin J, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043704; Martini S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066580; Mertens C, 1998, J PHYS OCEANOGR, V28, P1410, DOI 10.1175/1520-0485(1998)028<1410:IVODWF>2.0.CO;2; Miller SD, 2005, P NATL ACAD SCI USA, V102, P14181, DOI 10.1073/pnas.0507253102; NEALSON KH, 1979, MICROBIOL REV, V43, P496, DOI 10.1128/MMBR.43.4.496-518.1979; Palanques A, 2012, PROG OCEANOGR, V106, P1, DOI 10.1016/j.pocean.2012.05.002; Priede IG, 2006, DEEP-SEA RES PT I, V53, P1272, DOI 10.1016/j.dsr.2006.05.004; Priede IG, 2008, DEEP-SEA RES PT I, V55, P1474, DOI 10.1016/j.dsr.2008.07.001; Puig P, 2013, PROG OCEANOGR, V111, P1, DOI 10.1016/j.pocean.2012.10.003; Pusceddu A, 2013, BIOGEOSCIENCES, V10, P2659, DOI 10.5194/bg-10-2659-2013; Robison BH, 2004, J EXP MAR BIOL ECOL, V300, P253, DOI 10.1016/j.jembe.2004.01.012; Roether W, 1996, SCIENCE, V271, P333, DOI 10.1126/science.271.5247.333; Santinelli C, 2010, DEEP-SEA RES PT II, V57, P1446, DOI 10.1016/j.dsr2.2010.02.014; Schroder K, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027121; Shulman I, 2005, J ATMOS OCEAN TECH, V22, P1267, DOI 10.1175/JTECH1760.1; Sohrin R, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002731; Somot S, 2006, CLIM DYNAM, V27, P851, DOI 10.1007/s00382-006-0167-z; Stabholz M, 2013, BIOGEOSCIENCES, V10, P1097, DOI 10.5194/bg-10-1097-2013; SWIFT E, 1985, J PLANKTON RES, V7, P831, DOI 10.1093/plankt/7.6.831; Testor P, 2006, DEEP-SEA RES PT I, V53, P869, DOI 10.1016/j.dsr.2006.02.004; van Haren H, 2011, DEEP-SEA RES PT I, V58, P875, DOI 10.1016/j.dsr.2011.06.006; Weikert H, 2001, J MARINE SYST, V30, P221, DOI 10.1016/S0924-7963(01)00060-4; Widder EA, 2010, SCIENCE, V328, P704, DOI 10.1126/science.1174269; Widder EA, 1999, MAR BIOL, V134, P429, DOI 10.1007/s002270050559; WIDDER EA, 1989, MAR BIOL, V100, P541, DOI 10.1007/BF00394831	46	53	53	3	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e67523	10.1371/journal.pone.0067523	http://dx.doi.org/10.1371/journal.pone.0067523			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874425	Green Published, gold, Green Accepted			2022-12-27	WOS:000321765300012
J	Deribe, K; Brooker, SJ; Pullan, RL; Hailu, A; Enquselassie, F; Reithinger, R; Newport, M; Davey, G				Deribe, Kebede; Brooker, Simon J.; Pullan, Rachel L.; Hailu, Asrat; Enquselassie, Fikre; Reithinger, Richard; Newport, Melanie; Davey, Gail			Spatial Distribution of Podoconiosis in Relation to Environmental Factors in Ethiopia: A Historical Review	PLOS ONE			English	Article							NON-FILARIAL ELEPHANTIASIS; NEGLECTED TROPICAL DISEASE; LOWER LEGS; ENDEMIC ELEPHANTIASIS; BANCROFTIAN FILARIASIS; SOUTHERN ETHIOPIA; WESTERN ETHIOPIA; HIGH PREVALENCE; DISTRICT; CAMEROON	Background: An up-to-date and reliable map of podoconiosis is needed to design geographically targeted and cost-effective intervention in Ethiopia. Identifying the ecological correlates of the distribution of podoconiosis is the first step for distribution and risk maps. The objective of this study was to investigate the spatial distribution and ecological correlates of podoconiosis using historical and contemporary survey data. Methods: Data on the observed prevalence of podoconiosis were abstracted from published and unpublished literature into a standardized database, according to strict inclusion and exclusion criteria. In total, 10 studies conducted between 1969 and 2012 were included, and data were available for 401,674 individuals older than 15 years of age from 229 locations. A range of high resolution environmental factors were investigated to determine their association with podoconiosis prevalence, using logistic regression. Results: The prevalence of podoconiosis in Ethiopia was estimated at 3.4% (95% CI 3.3%-3.4%) with marked regional variation. We identified significant associations between mean annual Land Surface Temperature (LST), mean annual precipitation, topography of the land and fine soil texture and high prevalence of podoconiosis. The derived maps indicate both widespread occurrence of podoconiosis and a marked variability in prevalence of podoconiosis, with prevalence typically highest at altitudes >1500 m above sea level (masl), with >1500 mm annual rainfall and mean annual LST of 19-21 degrees C. No (or very little) podoconiosis occurred at altitudes <1225 masl, with annual rainfall <900 mm, and mean annual LST of >24 degrees C. Conclusion: Podoconiosis remains a public health problem in Ethiopia over considerable areas of the country, but exhibits marked geographical variation associated in part with key environmental factors. This is work in progress and the results presented here will be refined in future work.	[Deribe, Kebede; Newport, Melanie; Davey, Gail] Brighton & Sussex Med Sch, Brighton, E Sussex, England; [Deribe, Kebede; Enquselassie, Fikre] Univ Addis Ababa, Sch Publ Hlth, Addis Ababa, Ethiopia; [Brooker, Simon J.] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Nairobi, Kenya; [Brooker, Simon J.; Pullan, Rachel L.; Reithinger, Richard] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England; [Hailu, Asrat] Univ Addis Ababa, Sch Med, Addis Ababa, Ethiopia; [Reithinger, Richard] Res Triangle Inst, Int Dev Grp, Washington, DC USA	University of Brighton; University of Sussex; Addis Ababa University; Kenya Medical Research Institute; University of London; London School of Hygiene & Tropical Medicine; Addis Ababa University; Research Triangle Institute	Deribe, K (corresponding author), Brighton & Sussex Med Sch, Brighton, E Sussex, England.	Kebededeka@yahoo.com	Deribe, Kebede/I-5422-2019; Deribe, Kebede/K-7055-2019; Hailu, Asrat/AAM-6982-2020	Deribe, Kebede/0000-0002-8526-6996; Davey, Gail/0000-0003-2796-7468; Newport, Melanie/0000-0002-8946-7525; Reithinger, Richard/0000-0001-5710-1556; Pullan, Rachel/0000-0001-9844-1362	TOMS Shoes; Wellcome Trust through Research Training Fellowship in Public Health and Tropical Medicine; Bill & Melinda Gates Foundation; Research Career Development Fellowship from the Wellcome Trust [081673]; Wellcome Trust University award	TOMS Shoes; Wellcome Trust through Research Training Fellowship in Public Health and Tropical Medicine(Wellcome Trust); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Research Career Development Fellowship from the Wellcome Trust; Wellcome Trust University award(Wellcome Trust)	The authors would like to acknowledge the work of EW Price in mapping podoconiosis, which is the basis for this work. KD is supported by TOMS Shoes for preparatory work of mapping podoconiosis in Ethiopia during the writing of the manuscript, currently is supported by the Wellcome Trust through Research Training Fellowship in Public Health and Tropical Medicine. RLP is supported by grants from the Bill & Melinda Gates Foundation. SJB is funded by a Research Career Development Fellowship (081673) from the Wellcome Trust. GD is supported by a Wellcome Trust University award to do work in podoconiosis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; KD was supported by TOMS Shoes for preparatory work of mapping podoconiosis in Ethiopia during the writing of the manuscript. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Alemu G, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001184; Birrie HL, 1997, ETHIOPIAN MED J, V35, P245; Brooker S, 2007, T ROY SOC TROP MED H, V101, P1, DOI 10.1016/j.trstmh.2006.08.004; Clements ACA, 2006, TROP MED INT HEALTH, V11, P490, DOI 10.1111/j.1365-3156.2006.01594.x; CRIVELLI PE, 1986, E AFR MED J, V63, P191; Davey G, 2007, T ROY SOC TROP MED H, V101, P1175, DOI 10.1016/j.trstmh.2007.08.013; Davey G, 2007, LANCET, V369, P888, DOI 10.1016/S0140-6736(07)60425-5; Davey G, 2012, LANCET, V379, P1004, DOI 10.1016/S0140-6736(12)60427-9; Davey G, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000424; DELALLA F, 1988, T ROY SOC TROP MED H, V82, P895, DOI 10.1016/0035-9203(88)90032-6; Deribe K, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-240; Destas K, 2003, TROP DOCT, V33, P217, DOI 10.1177/004947550303300410; FROMMEL D, 1993, TROP GEOGR MED, V45, P165; Gyapong JO, 2001, T ROY SOC TROP MED H, V95, P681, DOI 10.1016/S0035-9203(01)90115-4; Gyapong JO, 2002, ANN TROP MED PARASIT, V96, P695, DOI 10.1179/000349802125001735; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; KLOOS H, 1992, TROP DOCT, V22, P109, DOI 10.1177/004947559202200306; Mace JM, 1997, ANN TROP MED PARASIT, V91, P379, DOI 10.1080/00034989761003; MENGISTU G, 1987, ETHIOPIAN MED J, V25, P203; Molla YB, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001744; Molyneux DH, 2012, NEW ENGL J MED, V366, P1169, DOI 10.1056/NEJMp1202011; Molyneux DH, 2009, T ROY SOC TROP MED H, V103, P338, DOI 10.1016/j.trstmh.2008.12.016; Njenga SM, 2007, ANN TROP MED PARASIT, V101, P161, DOI 10.1179/136485907X156933; Oli GG, 2012, TROP MED INT HEALTH, V17, P722, DOI 10.1111/j.1365-3156.2012.02978.x; Onapa AW, 2001, ACTA TROP, V78, P171, DOI 10.1016/S0001-706X(00)00185-6; Oomen AP, 1969, TROP GEOGR MED, V1969, P3; Price E.W., 1974, Ethiopian Med J, V12, P77; PRICE EW, 1990, T ROY SOC TROP MED H, V84, P885, DOI 10.1016/0035-9203(90)90115-U; PRICE EW, 1981, ANN OCCUP HYG, V24, P1, DOI 10.1093/annhyg/24.1.1; PRICE EW, 1981, TROP GEOGR MED, V33, P23; PRICE EW, 1973, TROP GEOGR MED, V25, P23; PRICE EW, 1974, TROP GEOGR MED, V26, P225; PRICE EW, 1976, T ROY SOC TROP MED H, V70, P288, DOI 10.1016/0035-9203(76)90078-X; PRICE EW, 1976, TROP GEOGR MED, V28, P283; PRICE EW, 1984, TROP GEOGR MED, V36, P1; Price EW, 1990, PODOCONIOSIS NONFILA; Pullan RL, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000958; SAUNDERS MK, 1970, ENG GEOL, V4, P289, DOI 10.1016/0013-7952(70)90021-9; Shiferaw W, 2012, T ROY SOC TROP MED H, V106, P117, DOI 10.1016/j.trstmh.2011.10.006; Sikorski C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000902; Tekola F, 2006, TROP MED INT HEALTH, V11, P1136, DOI 10.1111/j.1365-3156.2006.01658.x; Wanji S, 2008, ANN TROP MED PARASIT, V102, P529, DOI 10.1179/136485908X311849; WEINERT H. H., 1965, AGR METEOROL, V2, P27, DOI 10.1016/0002-1571(65)90033-6	43	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68330	10.1371/journal.pone.0068330	http://dx.doi.org/10.1371/journal.pone.0068330			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874587	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000321736900081
J	Gil, H; Escudero, R; Pons, I; Rodriguez-Vargas, M; Garcia-Esteban, C; Rodriguez-Moreno, I; Garcia-Amil, C; Lobo, B; Valcarcel, F; Perez, A; Jimenez, S; Jado, I; Juste, R; Segura, F; Anda, P				Gil, Horacio; Escudero, Raquel; Pons, Inmaculada; Rodriguez-Vargas, Manuela; Garcia-Esteban, Coral; Rodriguez-Moreno, Isabel; Garcia-Amil, Cristina; Lobo, Bruno; Valcarcel, Felix; Perez, Azucena; Jimenez, Santos; Jado, Isabel; Juste, Ramon; Segura, Ferran; Anda, Pedro			Distribution of Bartonella henselae Variants in Patients, Reservoir Hosts and Vectors in Spain	PLOS ONE			English	Article							RNA GENE TYPES; DOMESTIC CATS; NATURAL-POPULATION; SEQUENCE TYPES; RISK-FACTORS; PET CATS; PREVALENCE; DIVERSITY; REVEALS; IDENTIFICATION	We have studied the diversity of B. henselae circulating in patients, reservoir hosts and vectors in Spain. In total, we have fully characterized 53 clinical samples from 46 patients, as well as 78 B. henselae isolates obtained from 35 cats from La Rioja and Catalonia (northeastern Spain), four positive cat blood samples from which no isolates were obtained, and three positive fleas by Multiple Locus Sequence Typing and Multiple Locus Variable Number Tandem Repeats Analysis. This study represents the largest series of human cases characterized with these methods, with 10 different sequence types and 41 MLVA profiles. Two of the sequence types and 35 of the profiles were not described previously. Most of the B. henselae variants belonged to ST5. Also, we have identified a common profile (72) which is well distributed in Spain and was found to persist over time. Indeed, this profile seems to be the origin from which most of the variants identified in this study have been generated. In addition, ST5, ST6 and ST9 were found associated with felines, whereas ST1, ST5 and ST8 were the most frequent sequence types found infecting humans. Interestingly, some of the feline associated variants never found on patients were located in a separate clade, which could represent a group of strains less pathogenic for humans.	[Gil, Horacio; Escudero, Raquel; Rodriguez-Vargas, Manuela; Garcia-Esteban, Coral; Rodriguez-Moreno, Isabel; Garcia-Amil, Cristina; Lobo, Bruno; Jado, Isabel; Anda, Pedro] Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid, Spain; [Pons, Inmaculada; Segura, Ferran] Corp Sanitaria Parc Tauli, Serv Malalties Infeccioses, Barcelona, Spain; [Valcarcel, Felix] Inst Nacl Invest & Tecnol Agr & Alimentaria, Ctr Invest Sanidad Anim, Madrid, Spain; [Perez, Azucena; Jimenez, Santos] Gobierno La Rioja, Consejeria Salud Consumo & Bienestar Social La Ri, Logrono, La Rioja, Spain; [Juste, Ramon] Inst Vasco Invest & Desarrollo Agr, Neiker Tecnalia, Derio, Vizcaya, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA)	Gil, H (corresponding author), Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid, Spain.	hgil@isciii.es	Juste, Ramon A./C-3570-2008; Anda, Pedro/V-8436-2019; JADO, ISABEL/E-9952-2018; Valcarcel, Felix/Y-3386-2019; Escudero, Raquel/I-3353-2017	Juste, Ramon A./0000-0001-6037-5873; Anda, Pedro/0000-0001-9081-8188; JADO, ISABEL/0000-0002-4871-9407; Valcarcel, Felix/0000-0001-5609-0496; Escudero, Raquel/0000-0001-6275-3225; Gil, Horacio/0000-0002-7114-6686	Spanish Fondo de Investigacion Sanitaria [PI10/00051, PI10/00165]	Spanish Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III)	This work was supported by the Spanish Fondo de Investigacion Sanitaria (PI10/00051 and PI10/00165). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelakis E, 2010, EMERG INFECT DIS, V16, P385, DOI [10.3201/eid1603.091685, 10.3201/eid1603.081685]; Arvand M, 2001, J CLIN MICROBIOL, V39, P743, DOI 10.1128/JCM.39.2.743-746.2001; Arvand M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001346; Ayllon T, 2012, VECTOR-BORNE ZOONOT, V12, P143, DOI 10.1089/vbz.2011.0729; Azzag N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043621; Beaucournu J C., 1990, PUCES FRANCE BASIN M; Bergmans AMC, 1996, J CLIN MICROBIOL, V34, P254, DOI 10.1128/JCM.34.2.254-260.1996; Birtles RJ, 2002, VET REC, V151, P225, DOI 10.1136/vr.151.8.225; Blanco JR, 2006, ANN NY ACAD SCI, V1078, P270, DOI 10.1196/annals.1374.050; Bouchouicha R, 2009, CLIN MICROBIOL INFEC; Bouchouicha R, 2009, EMERG INFECT DIS, V15, P813, DOI 10.3201/eid1505.080995; Boulouis HJ, 2005, VET RES, V36, P383, DOI 10.1051/vetres:2005009; Chaloner GL, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001248; Chaloner GL, 2011, J CLIN MICROBIOL, V49, P2132, DOI 10.1128/JCM.00275-11; Chomel BB, 1999, AM J TROP MED HYG, V60, P593, DOI 10.4269/ajtmh.1999.60.593; CHOMEL BB, 1995, J CLIN MICROBIOL, V33, P2445, DOI 10.1128/JCM.33.9.2445-2450.1995; Chomel BB, 1996, J CLIN MICROBIOL, V34, P1952, DOI 10.1128/JCM.34.8.1952-1956.1996; Chomel BB, 2009, VET RES, V40, DOI 10.1051/vetres/2009011; Cotte V, 2008, EMERG INFECT DIS, V14, P1074, DOI 10.3201/eid1407.071110; Dillon B, 2002, J CLIN MICROBIOL, V40, P4691, DOI 10.1128/JCM.40.12.4691-4699.2002; Drancourt M, 1996, LANCET, V347, P441, DOI 10.1016/S0140-6736(96)90012-4; Garcia-Esteban C, 2008, J CLIN MICROBIOL, V46, P776, DOI 10.1128/JCM.01720-07; Gil H, 2010, APPL ENVIRON MICROB, V76, P8062, DOI 10.1128/AEM.01963-10; Guptill L, 2004, J CLIN MICROBIOL, V42, P652, DOI 10.1128/JCM.42.2.652-659.2004; Harms A, 2012, CLIN MICROBIOL REV, V25, P42, DOI 10.1128/CMR.05009-11; Iredell J, 2003, J CLIN MICROBIOL, V41, P5071, DOI 10.1128/JCM.41.11.5071-5079.2003; Jacomo V, 2002, CLIN DIAGN LAB IMMUN, V9, P8, DOI 10.1128/CDLI.9.1.8-18.2002; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; La Scola B, 1999, J CLIN MICROBIOL, V37, P1899, DOI 10.1128/JCM.37.6.1899-1905.1999; Lamps Laura W, 2004, Am J Clin Pathol, V121 Suppl, pS71; Li WJ, 2007, EMERG INFECT DIS, V13, P1178, DOI 10.3201/eid1308.070085; Li WJ, 2006, J CLIN MICROBIOL, V44, P2499, DOI 10.1128/JCM.00498-06; Lindroos H, 2006, J BACTERIOL, V188, P7426, DOI 10.1128/JB.00472-06; Maruyama S, 2001, AM J TROP MED HYG, V65, P783, DOI 10.4269/ajtmh.2001.65.783; Maruyama S, 2000, J VET MED SCI, V62, P273, DOI 10.1292/jvms.62.273; Mietze A, 2011, VET MICROBIOL, V148, P238, DOI 10.1016/j.vetmic.2010.08.012; Monteil M, 2007, MICROBIOL-SGM, V153, P1141, DOI 10.1099/mic.0.2006/001164-0; Pons I, 2005, AM J TROP MED HYG, V72, P453, DOI 10.4269/ajtmh.2005.72.453; Regnery RL, 2000, P 15 M AM SOC RICK, V19; Solano-Gallego L, 2006, VET MICROBIOL, V118, P274, DOI 10.1016/j.vetmic.2006.07.010; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tsai YL, 2011, COMP IMMUNOL MICROB, V34, P299, DOI 10.1016/j.cimid.2011.04.005; Welch D.F., 2005, BERGEYS MANUAL SYSTE, P362; Yanagihara M, 2010, EMERG INFECT DIS, V16, P1983, DOI 10.3201/eid1612.100962; Yanagihara M, 2010, FEMS IMMUNOL MED MIC, V60, P44, DOI 10.1111/j.1574-695X.2010.00711.x; Yuan CL, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001301; Zeaiter Z, 2002, J CLIN MICROBIOL, V40, P1023, DOI 10.1128/JCM.40.3.1023-1030.2002; Zhao F, 2012, CHINESE MED J-PEKING, V125, P2284, DOI 10.3760/cma.j.issn.0366-6999.2012.13.008	48	20	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68248	10.1371/journal.pone.0068248	http://dx.doi.org/10.1371/journal.pone.0068248			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874563	Green Published, gold, Green Submitted			2022-12-27	WOS:000321736900073
J	Kovalchuk, I; Walz, P; Thomas, J; Kovalchuk, O				Kovalchuk, Igor; Walz, Paul; Thomas, James; Kovalchuk, Olga			Genomic Instability in Liver Cells Caused by an LPS-Induced Bystander-Like Effect	PLOS ONE			English	Article							FACTOR-KAPPA-B; ESCHERICHIA-COLI; HISTONE H2AX; DNA-DAMAGE; IN-VIVO; INFECTION; CANCER; LIPOPOLYSACCHARIDE; PHOSPHORYLATION; EXPRESSION	Bacterial infection has been linked to carcinogenesis, however, there is lack of knowledge of molecular mechanisms that associate infection with the development of cancer. We analyzed possible effects of the consumption of heat-killed E. coli O157:H7 cells or its cellular components, DNA, RNA, protein or lipopolysaccharides (LPS) on gene expression in naive liver cells. Four week old mice were provided water supplemented with whole heat-killed bacteria or bacterial components for a two week period. One group of animals was sacrificed immediately, whereas another group was allowed to consume uncontaminated tap water for an additional two weeks, and liver samples were collected, post mortem. Liver cells responded to exposure of whole heat-killed bacteria and LPS with alteration in gamma H2AX levels and levels of proteins involved in proliferation, DNA methylation (MeCP2, DNMT1, DNMT3A and 3B) or DNA repair (APE1 and KU70) as well as with changes in the expression of genes involved in stress response, cell cycle control and bile acid biosynthesis. Other bacterial components analysed in this study did not lead to any significant changes in the tested molecular parameters. This study suggests that lipopolysaccharides are a major component of Gram-negative bacteria that induce molecular changes within naive cells of the host.	[Kovalchuk, Igor; Walz, Paul; Thomas, James; Kovalchuk, Olga] Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 3M4, Canada	University of Lethbridge	Kovalchuk, I (corresponding author), Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 3M4, Canada.	igor.kovalchuk@uleth.ca			NSERC; CIHR Chair in Gender and Health to Olga Kovalchuk	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR Chair in Gender and Health to Olga Kovalchuk(Canadian Institutes of Health Research (CIHR))	The work was sponsored by NSERC and the CIHR Chair in Gender and Health to Olga Kovalchuk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell AN, 2007, J BIOL CHEM, V282, P30476, DOI 10.1074/jbc.M705783200; Abraham SM, 2006, BIOCHEM SOC T, V34, P1018, DOI 10.1042/BST0341018; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Bechard D, 2001, J IMMUNOL, V167, P3099, DOI 10.4049/jimmunol.167.6.3099; Blanco-Rodriguez J, 2012, REPRODUCTION, V144, P699, DOI 10.1530/REP-12-0326; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; DARVEAU RP, 1983, J BACTERIOL, V155, P831, DOI 10.1128/JB.155.2.831-838.1983; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Ferrero RL, 2000, J PATHOL, V191, P333; Gagou ME, 2010, MOL BIOL CELL, V21, P739, DOI 10.1091/mbc.E09-07-0618; Gannon VPJ, 2005, SCI TOTAL ENVIRON, V348, P19, DOI 10.1016/j.scitotenv.2004.12.076; Griener TP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021457; Hammer M, 2006, J EXP MED, V203, P15, DOI 10.1084/jem.20051753; Hervouet E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011333; Holt JA, 2003, GENE DEV, V17, P1581, DOI 10.1101/gad.1083503; Horie H, 1999, EUR J CANCER PREV, V8, P533, DOI 10.1097/00008469-199912000-00009; Huang L, 2006, HUM PATHOL, V37, P1557, DOI 10.1016/j.humpath.2006.05.015; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; JACKSON GD, 1990, NEUROLOGY, V40, P1869, DOI 10.1212/WNL.40.12.1869; Jirillo E, 2002, J ENDOTOXIN RES, V8, P319, DOI 10.1179/096805102125000641; Kocazeybek B, 2003, J MED MICROBIOL, V52, P721, DOI 10.1099/jmm.0.04845-0; Koturbash I, 2006, ONCOGENE, V25, P4267, DOI 10.1038/sj.onc.1209467; Koturbash I, 2006, INT J RADIAT ONCOL, V66, P327, DOI 10.1016/j.ijrobp.2006.06.012; Koturbash I, 2009, CELL CYCLE, V8, P1935, DOI 10.4161/cc.8.12.8797; Kovalchuk I, 2013, ENV MOL MUT IN PRESS; Leonard S, 2011, J VIROL, V85, P9568, DOI 10.1128/JVI.00468-11; Lim JW, 2001, LAB INVEST, V81, P349, DOI 10.1038/labinvest.3780243; Lirussi L, 2012, MOL BIOL CELL, V23, P4079, DOI 10.1091/mbc.E12-04-0299; Luo Juan, 2012, Frontiers in Genetics, V3, P20, DOI 10.3389/fgene.2012.00020; Majumder S, 2002, J BIOL CHEM, V277, P16048, DOI 10.1074/jbc.M111662200; Murata A, 1998, CYTOKINE, V10, P544, DOI 10.1006/cyto.1997.0329; Naryzhny SN, 2005, J BIOL CHEM, V280, P13888, DOI 10.1074/jbc.M500304200; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Paulsen FP, 2008, J BIOL CHEM, V283, P13418, DOI 10.1074/jbc.M800177200; Reymond D, 1996, J CLIN MICROBIOL, V34, P2053, DOI 10.1128/JCM.34.9.2053-2057.1996; RUTEGARD JN, 1988, ANN SURG, V208, P721, DOI 10.1097/00000658-198812000-00008; Sanlioglu S, 2001, J BIOL CHEM, V276, P30188, DOI 10.1074/jbc.M102061200; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Tang BK, 2011, MOL IMMUNOL, V48, P1001, DOI 10.1016/j.molimm.2011.01.003; Um JH, 2001, ONCOGENE, V20, P6048, DOI 10.1038/sj.onc.1204732; Wadleigh DJ, 2000, J BIOL CHEM, V275, P6259, DOI 10.1074/jbc.275.9.6259; YAMAMOTO M, 1992, CANCER RES, V52, P5329; Yana JQ, 2011, BIOCHEM BIOPH RES CO, V408, P99, DOI 10.1016/j.bbrc.2011.03.127; Zubkov MV, 1999, APPL ENVIRON MICROB, V65, P3251	45	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e67342	10.1371/journal.pone.0067342	http://dx.doi.org/10.1371/journal.pone.0067342			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874414	Green Published, gold, Green Submitted			2022-12-27	WOS:000321736900009
J	Qiu, T; Shen, Y; Wang, MZ; Wang, YP; Wang, D; Wang, ZZ; Jin, XF; Wei, YC				Qiu, Tong; Shen, Yi; Wang, Ming-zhao; Wang, Yao-peng; Wang, Dong; Wang, Zi-zong; Jin, Xiang-feng; Wei, Yu-cheng			External Suction versus Water Seal after Selective Pulmonary Resection for Lung Neoplasm: A Systematic Review	PLOS ONE			English	Review							PROSPECTIVE RANDOMIZED-TRIAL; CHEST TUBES; AIR LEAKS; MANAGEMENT; PNEUMOTHORAX; METAANALYSIS; DRAINS; LOBECTOMY	Objective: To evaluate whether external suction is more advantageous than water seal in patients undergoing selective pulmonary resection (SPR) for lung neoplasm. Summary of Background Data: Whether external suction should be routinely applied in postoperative chest drainage is still unclear, particularly for lung neoplasm patients. To most surgeons, the decision is based on their clinical experience. Methods: Randomized control trials were selected. The participants were patients undergoing SPR with lung neoplasm. Lung volume reduction surgery and pneumothorax were excluded. Suction versus non-suction for the intervention. The primary outcome was the incidence of persistent air leak (PAL). The definition of PAL was air leak for more than 3-7 days. The secondary outcomes included air leak duration, time of drainage, postoperative hospital stay and the incidence of postoperative pneumothorax. Studies were identified from literature collections through screening. Bias was analyzed and meta-analysis was used. Results: From the 1824 potentially relevant trials, 6 randomized control trials involving 676 patients were included. There was no difference between external suction and water seal in decreasing the incidence of PAL [95% confidence interval (CI) 0.81-2.16; z = 1.10; P = 0.27]. Regarding secondary outcomes, there were no differences in time of drainage (95% CI-0.36-1.56, P = 0.22), postoperative hospital stay (95% CI -.31 - .54, P = 0.87) or incidence of postoperative pneumothorax (95% CI 0.18 - .02, P = 0.05) between external suction and water seal. Conclusions: For participants, no differences are identified in terms of PAL incidence, drainage time, length of postoperative hospital stay or incidence of postoperative pneumothorax between external suction and water seal. The bias analysis should be emphasized. To the limitations of the bias and methodological differences among the included studies, we have no recommendation on whether external suction should be routinely applied after lung neoplasm SPR. More high-quality randomized controlled trials are needed.	[Qiu, Tong; Shen, Yi; Wang, Ming-zhao; Wang, Yao-peng; Wang, Dong; Wang, Zi-zong; Jin, Xiang-feng; Wei, Yu-cheng] Qingdao Univ, Affiliated Hosp, Coll Med, Dept Thorac Surg, Qingdao 266071, Peoples R China	Qingdao University	Wei, YC (corresponding author), Qingdao Univ, Affiliated Hosp, Coll Med, Dept Thorac Surg, Qingdao 266071, Peoples R China.	qt990552@gmail.com			Department of Thoracic Surgery, Affiliated Hospital of Medical College, Qingdao University	Department of Thoracic Surgery, Affiliated Hospital of Medical College, Qingdao University	Funding from the Department of Thoracic Surgery, Affiliated Hospital of Medical College, Qingdao University, www.qyfy.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alphonso N, 2005, EUR J CARDIO-THORAC, V27, P391, DOI 10.1016/j.ejcts.2004.12.004; Antanavicius G, 2005, AM SURGEON, V71, P416; Ayed AK, 2003, ANN THORAC SURG, V75, P1593, DOI 10.1016/S0003-4975(02)04894-4; Brunelli A, 2004, ANN THORAC SURG, V77, P1932, DOI 10.1016/j.athoracsur.2003.12.022; Brunelli A, 2012, EUR J CARDIO-THORAC, V43, P899; Brunelli A, 2011, EUR J CARDIO-THORAC, V40, P291, DOI 10.1016/j.ejcts.2011.05.020; Cerfolio RJ, 1998, ANN THORAC SURG, V66, P1726, DOI 10.1016/S0003-4975(98)00958-8; Cerfolio RJ, 2001, ANN THORAC SURG, V71, P1613, DOI 10.1016/S0003-4975(01)02474-2; Cerfolio RJ, 2005, CHEST, V128, P816, DOI 10.1378/chest.128.2.816; Coughlin SM, 2012, CAN J SURG, V55, P264, DOI 10.1503/cjs.001411; Deng B, 2010, EUR J CARDIO-THORAC, V38, P210, DOI 10.1016/j.ejcts.2010.01.050; ENERSON DM, 1966, J THORAC CARDIOV SUR, V52, P40, DOI 10.1016/S0022-5223(19)43453-3; Malapert G, 2010, ANN THORAC SURG, V90, P1779, DOI 10.1016/j.athoracsur.2010.07.033; Marshall MB, 2002, CHEST, V121, P831, DOI 10.1378/chest.121.3.831; Parlak M, 2012, RESP MED, V106, P1600, DOI 10.1016/j.rmed.2012.08.005; Prokakis C, 2008, WORLD J SURG, V32, P2336, DOI 10.1007/s00268-008-9741-3; Rice Thomas W, 2002, Chest Surg Clin N Am, V12, P529, DOI 10.1016/S1052-3359(02)00022-4; Sanni Aliu, 2006, Interact Cardiovasc Thorac Surg, V5, P275, DOI 10.1510/icvts.2006.130559	18	18	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68087	10.1371/journal.pone.0068087	http://dx.doi.org/10.1371/journal.pone.0068087			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874505	Green Published, gold, Green Submitted			2022-12-27	WOS:000321736900054
J	Rohrmeier, M; Cross, I				Rohrmeier, Martin; Cross, Ian			Artificial Grammar Learning of Melody Is Constrained by Melodic Inconsistency: Narmour's Principles Affect Melodic Learning	PLOS ONE			English	Article							STRUCTURAL KNOWLEDGE; IMPLICIT; MUSIC; EXPECTATION; LANGUAGE; FORM; SEGMENTATION; INFORMATION; PERCEPTION; SPEECH	Considerable evidence suggests that people acquire artificial grammars incidentally and implicitly, an indispensable capacity for the acquisition of music or language. However, less research has been devoted to exploring constraints affecting incidental learning. Within the domain of music, the extent to which Narmour's (1990) melodic principles affect implicit learning of melodic structure was experimentally explored. Extending previous research (Rohrmeier, Rebuschat & Cross, 2011), the identical finite-state grammar is employed having terminals (the alphabet) manipulated so that melodies generated systematically violated Narmour's principles. Results indicate that Narmour-inconsistent melodic materials impede implicit learning. This further constitutes a case in which artificial grammar learning is affected by prior knowledge or processing constraints.	[Rohrmeier, Martin; Cross, Ian] MIT, Cambridge, MA 02139 USA; [Rohrmeier, Martin] Univ Cambridge, Fac Mus, Ctr Mus & Sci, Cambridge, England	Massachusetts Institute of Technology (MIT); University of Cambridge	Cross, I (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	ic108@cam.ac.uk		Cross, Ian Ralph McKenzie/0000-0002-2404-7765; Rohrmeier, Martin Alois/0000-0002-4323-7257	Microsoft Research through the Microsoft European PhD Scholarship Programme; Arts & Humanities Research Council, UK; MIT Intelligence Initiative	Microsoft Research through the Microsoft European PhD Scholarship Programme(Microsoft); Arts & Humanities Research Council, UK(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); MIT Intelligence Initiative	This research was funded in part by Microsoft Research through the Microsoft European PhD Scholarship Programme and the Arts & Humanities Research Council, UK. The final corrected version of the manuscript was created by MR under the funding of the MIT Intelligence Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann GTM, 2002, COGNITION, V85, pB43, DOI 10.1016/S0010-0277(02)00106-3; Berry D. C., 1993, IMPLICIT LEARNING TH; Bigand E, 2003, ANN NY ACAD SCI, V999, P304, DOI 10.1196/annals.1284.041; Boucher L, 2003, COGNITIVE SCI, V27, P807, DOI 10.1016/j.cogsci.2003.03.001; Bregman A.S., 1990, AUDITORY SCENE ANAL; Brighton H, 2005, PHYS LIFE REV, V2, P177, DOI 10.1016/j.plrev.2005.06.001; Carlsen JC., 1981, PSYCHOMUSICOLOGY J R, V1, P12, DOI [10.1037/h0094276, DOI 10.1037/H0094276]; Chen WW, 2011, CONSCIOUS COGN, V20, P1751, DOI 10.1016/j.concog.2011.03.003; Christiansen M.H., 2003, LANGUAGE EVOLUTION; Christiansen MH, 2008, BEHAV BRAIN SCI, V31, P489, DOI 10.1017/S0140525X08004998; CLEEREMANS A, 1993, PROCEEDINGS OF THE FIFTEENTH ANNUAL CONFERENCE OF THE COGNITIVE SCIENCE SOCIETY, P330; Cleeremans A., 1993, MECH IMPLICIT LEARNI; Cleeremans A, 2008, CAMB HANDB PSYCHOL, P396; Creel SC, 2004, J EXP PSYCHOL LEARN, V30, P1119, DOI 10.1037/0278-7393.30.5.1119; CUDDY LL, 1995, PERCEPT PSYCHOPHYS, V57, P451, DOI 10.3758/BF03213071; Deliege I, 1996, MUSIC PERCEPT, V14, P117; Dienes Z, 2005, PSYCHOL RES-PSYCH FO, V69, P338, DOI 10.1007/s00426-004-0208-3; Dienes Z, 2004, COGNITIVE SCI, V28, P531, DOI 10.1016/j.cogsci.2004.03.003; DIENES Z, 1992, COGNITIVE SCI, V16, P41, DOI 10.1207/s15516709cog1601_2; DIENES Z, 1995, J EXP PSYCHOL LEARN, V21, P848, DOI 10.1037/0278-7393.21.4.848; Dienes Z., 2008, UNDERSTANDING PSYCHO; Eerola T., 2004, MIDI TOOLBOX MATLAB; Eerola T, 2003, THESIS U JYVASKYLA; Eerola T., 2004, P 8 INT C MUS PERC C, P83; Eerola T, 2009, MUSIC SCI, V13, P231, DOI 10.1177/102986490901300203; ELMAN JL, 1990, COGNITIVE SCI, V14, P179, DOI 10.1207/s15516709cog1402_1; Hawkins JA, 1994, PERFORMANCE THEORY O; Heit E, 1997, KNOWLEDGE CONCEPTS C, P7; Huron D.B., 2006, SWEET ANTICIPATION M; Kaplan AS, 2000, J EXP PSYCHOL LEARN, V26, P829, DOI 10.1037//0278-7393.26.4.829; Krumhansl CL, 2000, COGNITION, V76, P13, DOI 10.1016/S0010-0277(00)00068-8; Krumhansl CL, 1999, MUSIC PERCEPT, V17, P151; KRUMHANSL CL, 1995, MUSIC THEOR SPECTRUM, V17, P53, DOI 10.1525/mts.1995.17.1.02a00030; KRUMHANSL CL, 1995, SYSTEMATISCHE MUSIKW, V3, P211; Kuhn G, 2005, J EXP PSYCHOL LEARN, V31, P1417, DOI 10.1037/0278-7393.31.6.1417; Kuhn G, 2006, Q J EXP PSYCHOL, V59, P1725, DOI 10.1080/17470210500438361; Leung JHC, 2012, LANG LEARN, V62, P634, DOI 10.1111/j.1467-9922.2011.00637.x; Loui P., 2012, STAT LEARNING LANGUA, P433, DOI DOI 10.1515/9781934078242.433; Loui P, 2008, MUSIC SCI, V12, P207, DOI 10.1177/102986490801200202; Loui P, 2012, TOP COGN SCI, V4, P554, DOI 10.1111/j.1756-8765.2012.01208.x; Loui P, 2012, ANN NY ACAD SCI, V1252, P354, DOI 10.1111/j.1749-6632.2011.06401.x; Loui P, 2011, NEUROIMAGE, V55, P500, DOI 10.1016/j.neuroimage.2010.12.022; Loui P, 2010, MUSIC PERCEPT, V27, P377, DOI 10.1525/mp.2010.27.5.377; Loui P, 2009, J NEUROSCI, V29, P454, DOI 10.1523/JNEUROSCI.4503-08.2009; Luhmann Niklas, 2000, ART SOCIAL SYSTEM; MANZARA L. C., 1992, LEONARDO, V2, P81, DOI DOI 10.2307/1513213; Marcus GF, 1999, SCIENCE, V283, P77, DOI 10.1126/science.283.5398.77; Meulemans T, 1997, J EXP PSYCHOL LEARN, V23, P1007; Meyer L., 1956, EMOTION MEANING MUSI; Meyer Leonard B, 1973, EXPLAINING MUSIC ESS; Miranda E. R., 2003, CONTEMP MUSIC REV, V22, P91, DOI DOI 10.1080/07494; NARMOUR E, 1991, MUSIC PERCEPT, V9, P1; Narmour E, 1999, PSYCHOL MUSIC, P441; NARMOUR E, 1990, ANAL COGNITION BASIC; Narmour Eugene, 1992, ANAL COGNITION MELOD; Omigie D, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00109; Onnis L, 2005, J MEM LANG, V53, P225, DOI 10.1016/j.jml.2005.02.011; Pearce M. T., 2005, CONSTRUCTION EVALUAT; Pearce MT, 2006, MUSIC PERCEPT, V23, P377, DOI 10.1525/mp.2006.23.5.377; Pearce MT, 2012, TOP COGN SCI, V4, P625, DOI 10.1111/j.1756-8765.2012.01214.x; Peretz I, 2012, ANN NY ACAD SCI, V1252, P361, DOI 10.1111/j.1749-6632.2011.06429.x; Perruchet P, 2004, J NEUROLINGUIST, V17, P97, DOI 10.1016/S0911-6044(03)00059-9; Polth M, 2001, MUSIK ASTHETIK, V18, P12; Pothos EM, 2005, MEM COGNITION, V33, P171, DOI 10.3758/BF03195306; Pothos EM, 2007, PSYCHOL BULL, V133, P227, DOI 10.1037/0033-2909.133.2.227; REBER AS, 1977, COGNITION, V5, P333, DOI 10.1016/0010-0277(77)90020-8; Rebuschat P, 2008, THESIS U CAMBRIDGE; Rohrmeier M., 2010, THESIS U CAMBRIDGE; Rohrmeier M., 2009, P 7 TRIENN C EUR SOC, P443; Rohrmeier M, 2013, LANGUAGE RE IN PRESS; Rohrmeier M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045885; Rohrmeier M, 2012, TOP COGN SCI, V4, P525, DOI 10.1111/j.1756-8765.2012.01223.x; Rohrmeier M, 2011, CONSCIOUS COGN, V20, P214, DOI 10.1016/j.concog.2010.07.004; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Schellenberg EG, 2002, J EXP PSYCHOL GEN, V131, P511, DOI 10.1037//0096-3445.131.4.511; Schellenberg EG, 1997, MUSIC PERCEPT, V14, P295; Schellenberg EG, 1996, COGNITION, V58, P75, DOI 10.1016/0010-0277(95)00665-6; Schon D, 2011, FRONTIERS PSYCHOL, V2; Schon D, 2008, COGNITION, V106, P975, DOI 10.1016/j.cognition.2007.03.005; Scott RB, 2010, CONSCIOUS COGN, V19, P413, DOI 10.1016/j.concog.2009.12.012; SERVANSCHREIBER E, 1990, J EXP PSYCHOL LEARN, V16, P592, DOI 10.1037/0278-7393.16.4.592; Shanks D. R., 2005, HDB COGNITION, P203, DOI [10.4135/9781848608177.n8, DOI 10.4135/9781848608177.N8]; Shukla M, 2007, COGNITIVE PSYCHOL, V54, P1, DOI 10.1016/j.cogpsych.2006.04.002; Stevens C., 2009, OXFORD HDB MUSIC PSY, P14; Sun R, 2001, COGNITIVE SCI, V25, P203, DOI 10.1016/S0364-0213(01)00035-0; Sun R., 2002, DUALITY MIND BOTTOM; Temperley D, 2004, MUSIC PERCEPT, V21, P313, DOI 10.1525/mp.2004.21.3.313; Tillmann B, 2005, ANN NY ACAD SCI, V1060, P100, DOI 10.1196/annals.1360.007; Tillmann B, 2010, Q J EXP PSYCHOL, V63, P1646, DOI 10.1080/17470210903511228; Tunney RJ, 2003, MEM COGNITION, V31, P1060, DOI 10.3758/BF03196127; Verhoeven KJF, 2005, OIKOS, V108, P643, DOI 10.1111/j.0030-1299.2005.13727.x; Williams JN, 2009, NEW HANDBOOK OF SECOND LANGUAGE ACQUISITION, 2ND EDITION, P319; Ziori E, 2008, Q J EXP PSYCHOL, V61, P601, DOI 10.1080/17470210701255374	93	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e66174	10.1371/journal.pone.0066174	http://dx.doi.org/10.1371/journal.pone.0066174			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	182JD	23874388	Green Published, gold, Green Submitted			2022-12-27	WOS:000321736900003
J	Zhang, JX; Zhang, HY; Chen, J; Fan, M; Gong, QY				Zhang, Jiaxing; Zhang, Haiyan; Chen, Ji; Fan, Ming; Gong, Qiyong			Structural Modulation of Brain Development by Oxygen: Evidence on Adolescents Migrating from High Altitude to Sea Level Environment	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; ANDEAN NATIVES; CELL-DEATH; VENTILATORY RESPONSES; NORMOBARIC HYPEROXIA; GROWTH; CHILDHOOD; HYPOXIA; AUTOREGULATION; ACTIVATION	The present study aimed to investigate structural modulation of brain by high level of oxygen during its peak period of development. Voxel-based morphometry analysis of gray matter (GM) and white matter (WM) volumes and Tract-Based Spatial Statistics analysis of WM fractional anisotropy (FA) and mean diffusion (MD) based on MRI images were carried out on 21 Tibetan adolencents (15-18 years), who were born and raised in Qinghai-Tibetan Plateau (2900-4700 m) and have lived at sea level (SL) in the last 4 years. The control group consisted of matched Tibetan adolescents born and raised at high altitude all the time. SL immigrants had increased GM volume in the left insula, left inferior parietal gyrus, and right superior parietal gyrus and decreased GM in the left precentral cortex and multiple sites in cerebellar cortex (left lobule 8, bilateral lobule 6 and crus 1/2). Decreased WM volume was found in the right superior frontal gyrus in SL immigrants. SL immigrants had higher FA and lower MD at multiple sites of WM tracts. Moreover, we detected changes in ventilation and circulation. GM volume in cerebellum lobule 8 positively correlated with diastolic pressure, while GM volume in insula positively correlated vital capacity and hypoxic ventilatory response. Our finding indicate that the structural modulations of GM by high level of oxygen during its peak period of development are related to respiratory and circulatory regulations, while the modulation in WM mainly exhibits an enhancement in myelin maturation.	[Zhang, Jiaxing; Zhang, Haiyan; Chen, Ji] Xiamen Univ, Coll Med, Dept Physiol & Neurobiol, Xiamen, Peoples R China; [Zhang, Haiyan] Weifang Nursing Vocat Coll, Dept Physiol, Weifang, Peoples R China; [Fan, Ming] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Brain Protect & Plast, Beijing 100730, Peoples R China; [Gong, Qiyong] Sichuan Univ, West China Hosp, Huaxi Magnet Resonance Res Ctr, Dept Radiol, Chengdu 610064, Peoples R China	Xiamen University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Sichuan University	Fan, M (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Dept Brain Protect & Plast, Beijing 100730, Peoples R China.	fanmingchina@126.com; qiyonggong@hmrrc.org.cn	Gong, Qiyong/W-3052-2019	Gong, Qiyong/0000-0002-5912-4871; Chen, Ji/0000-0002-9476-1737	National Science Foundation of China [30425008, 60628101, 31071041, 81030027, 81227002, 81220108013]; National Key Project [2012CB518200]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Project	This work was funded by National Science Foundation of China (30425008, 60628101, 31071041, 81030027, 81227002, and 81220108013) and the National Key Project (Grant No. 2012CB518200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHDABBARMADA M, 1986, J NEUROPATH EXP NEUR, V45, P233, DOI 10.1097/00005072-198605000-00005; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; BANCHERO N, 1970, AEROSPACE MED, V41, P849; Bickford PC, 1999, FREE RADICAL BIO MED, V26, P817, DOI 10.1016/S0891-5849(98)00260-3; Blakemore SJ, 2012, NEUROIMAGE, V61, P397, DOI 10.1016/j.neuroimage.2011.11.080; Bloch Y, 2012, J CLIN PSYCHOPHARM, V32, P525, DOI 10.1097/JCP.0b013e31825d70b8; Brand K, 1997, J BIOENERG BIOMEMBR, V29, P355, DOI 10.1023/A:1022498714522; Brutsaert TD, 2007, RESP PHYSIOL NEUROBI, V158, P151, DOI 10.1016/j.resp.2007.03.004; Bulte DP, 2007, J CEREBR BLOOD F MET, V27, P69, DOI 10.1038/sj.jcbfm.9600319; Canessa N, 2011, AM J RESP CRIT CARE, V183, P1419, DOI 10.1164/rccm.201005-0693OC; Chung SC, 2004, BRAIN COGNITION, V56, P279, DOI 10.1016/j.bandc.2004.07.005; Chung SC, 2006, INT J PSYCHOPHYSIOL, V62, P103, DOI 10.1016/j.ijpsycho.2006.02.006; Claydon VE, 2008, STROKE, V39, P336, DOI 10.1161/STROKEAHA.107.491498; CRUZ JC, 1973, RESP PHYSIOL, V17, P146, DOI 10.1016/0034-5687(73)90058-3; Davenport PW, 2009, RESP PHYSIOL NEUROBI, V167, P72, DOI 10.1016/j.resp.2008.10.001; Dean JB, 2004, J APPL PHYSIOL, V96, P784, DOI 10.1152/japplphysiol.00892.2003; Evans KC, 2010, BIOL PSYCHOL, V84, P13, DOI 10.1016/j.biopsycho.2010.02.005; Felderhoff-Mueser U, 2004, NEUROBIOL DIS, V17, P273, DOI 10.1016/j.nbd.2004.07.019; Frisancho AR, 2009, AM J HUM BIOL, V21, P694, DOI 10.1002/ajhb.20891; Gamboa A, 2001, HIGH ALT MED BIOL, V2, P341, DOI 10.1089/15270290152608516; Gerstner B, 2008, J NEUROSCI, V28, P1236, DOI 10.1523/JNEUROSCI.3213-07.2008; Gerstner B, 2006, J NEUROSCI RES, V84, P306, DOI 10.1002/jnr.20880; Giedd JN, 2010, NEURON, V67, P728, DOI 10.1016/j.neuron.2010.08.040; Gogtay N, 2010, BRAIN COGNITION, V72, P6, DOI 10.1016/j.bandc.2009.08.009; GRAVE GD, 1972, J NEUROCHEM, V19, P187, DOI 10.1111/j.1471-4159.1972.tb01268.x; GREKSA LP, 1984, AM J PHYS ANTHROPOL, V65, P315, DOI 10.1002/ajpa.1330650312; Hernandez-Garcia D, 2010, FREE RADICAL BIO MED, V49, P130, DOI 10.1016/j.freeradbiomed.2010.03.020; HOCHACHKA PW, 1994, J CEREBR BLOOD F MET, V14, P671, DOI 10.1038/jcbfm.1994.84; HULTGREN HN, 1968, ANNU REV MED, V19, P119, DOI 10.1146/annurev.me.19.020168.001003; Ikonomidou C, 2011, ANTIOXID REDOX SIGN, V14, P1535, DOI 10.1089/ars.2010.3581; Jansen GFA, 2007, J APPL PHYSIOL, V103, P518, DOI 10.1152/japplphysiol.01429.2006; Kennedy KAM, 2012, CELL MOL LIFE SCI, V69, P215, DOI 10.1007/s00018-011-0807-2; Kolbitsch C, 2002, MAGN RESON IMAGING, V20, P535, DOI 10.1016/S0730-725X(02)00534-9; Lebel C, 2011, J NEUROSCI, V31, P10937, DOI 10.1523/JNEUROSCI.5302-10.2011; Lenroot RK, 2007, NEUROIMAGE, V36, P1065, DOI 10.1016/j.neuroimage.2007.03.053; Macey PM, 2007, PLOS MED, V4, P828, DOI 10.1371/journal.pmed.0040173; Masamoto K, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3184694; MCKENZIE DC, 1991, J APPL PHYSIOL, V70, P2650, DOI 10.1152/jappl.1991.70.6.2650; Milovanova TN, 2009, J APPL PHYSIOL, V106, P711, DOI 10.1152/japplphysiol.91054.2008; O'Reilly JX, 2010, CEREB CORTEX, V20, P953, DOI 10.1093/cercor/bhp157; Ogren JA, 2012, CEREBELLUM, V11, P931, DOI 10.1007/s12311-012-0361-y; Oppenheimer SM, 1996, CLIN AUTON RES, V6, P131, DOI 10.1007/BF02281899; Pefialoza D, 1963, AM J CARDIOL, V11, P150; Ramani M, 2013, NEUROBIOL DIS, V50, P69, DOI 10.1016/j.nbd.2012.10.005; Rockswold SB, 2010, J NEUROSURG, V112, P1080, DOI 10.3171/2009.7.JNS09363; Shoemaker JK, 2012, ANAT REC, V295, P1375, DOI 10.1002/ar.22528; SIME F, 1971, BRIT HEART J, V33, P647; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; STINSON S, 1982, AM J PHYS ANTHROPOL, V59, P61, DOI 10.1002/ajpa.1330590107; Teicher MH, 2006, ANN NY ACAD SCI, V1071, P313, DOI 10.1196/annals.1364.024; Terashvili M, 2006, PEDIATR CLIN N AM, V53, P1029, DOI 10.1016/j.pcl.2006.08.003; Tiemeier H, 2010, NEUROIMAGE, V49, P63, DOI 10.1016/j.neuroimage.2009.08.016; Vargas M, 1998, J APPL PHYSIOL, V84, P1024, DOI 10.1152/jappl.1998.84.3.1024; von Leupoldt A, 2010, RESP PHYSIOL NEUROBI, V170, P198, DOI 10.1016/j.resp.2009.12.006; Vottier G, 2011, DEV NEUROSCI-BASEL, V33, P261, DOI 10.1159/000327245; Watson NA, 2000, EUR J ANAESTH, V17, P152, DOI 10.1046/j.1365-2346.2000.00640.x; Woo MA, 2005, PEDIATR RES, V57, P510, DOI 10.1203/01.PDR.0000155763.93819.46; Wozniak JR, 2006, NEUROSCI BIOBEHAV R, V30, P762, DOI 10.1016/j.neubiorev.2006.06.003; Xu F, 2012, J CEREBR BLOOD F MET, V32, P1909, DOI 10.1038/jcbfm.2012.93; Yan XD, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-94; Yis U, 2008, BRAIN DEV-JPN, V30, P556, DOI 10.1016/j.braindev.2008.01.010; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045; Zhang HY, 2012, HIGH ALT MED BIOL, V13, P118, DOI 10.1089/ham.2011.1073; Zhang JX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011449; Zhang T, 2010, BRAIN INJURY, V24, P1350, DOI 10.3109/02699052.2010.504525; Zhou QQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031097	67	14	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e67803	10.1371/journal.pone.0067803	http://dx.doi.org/10.1371/journal.pone.0067803			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874449	gold, Green Published, Green Submitted			2022-12-27	WOS:000321736900025
J	Zhang, YX; Wang, L				Zhang, Yuxia; Wang, Li			Characterization of the Mitochondrial Localization of the Nuclear Receptor SHP and Regulation of Its Subcellular Distribution by Interaction with Bcl2 and HNF4 alpha	PLOS ONE			English	Article							SMALL HETERODIMER PARTNER; X-RECEPTOR; ENDOPLASMIC-RETICULUM; DIURNAL REGULATION; DNMT1 EXPRESSION; LIVER RECEPTOR; FAMILY; GROWTH; TRIGLYCERIDE; INHIBITION	The nuclear receptor small heterodimer partner SHP was shown recently to translocate to the mitochondria, interact with Bcl2, and induce apoptosis in liver cancer cells. However, the exact mitochondrial localization of SHP remains to be determined. In addition, the detailed interaction domains between SHP and Bcl2 have not been characterized. Using biochemistry and molecular biology approaches, we demonstrate that SHP is localized to the mitochondrial outer membrane. Interestingly, compared with the full-length SHP, the N-terminal deleted protein exhibits increased expression in the mitochondria and decreased expression in the nucleus. GST pull-down assays demonstrate that the interaction domain of SHP shows the strongest interaction with Bcl2. Furthermore, the interaction of Bcl2 with SHP is completely abolished by deletion of the Bcl2 transmembrane domain (TM), whereas deletion of the Bcl2 BH1 domain enhances the interaction. As expected, AHPN, a synthetic SHP ligand, markedly augments the direct protein-protein interaction between Bcl2 and SHP. Ectopic expression of hepatocyte nuclear factor 4 alpha (HNF4 alpha) results in exclusive nuclear translocation of SHP proteins that contain either the full-length or the N-terminal domain, but has a minimal effect on the subcellular distribution of SHP protein containing only the interaction domain or repression domain. These results indicate that the N-terminal domain of SHP is important for itsnuclear translocation via HNF4 alpha. Overall, this study provides novel insights into the domains of SHP that are critical for its shutting between different subcellular compartments.	[Wang, Li] Univ Utah, Sch Med, Huntsman Canc Inst, Dept Med, Salt Lake City, UT 84112 USA; Univ Utah, Sch Med, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Wang, L (corresponding author), Univ Utah, Sch Med, Huntsman Canc Inst, Dept Med, Salt Lake City, UT 84112 USA.	l.wang@hsc.utah.edu			National Institutes of Health grant [DK080440]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080440] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grant DK080440. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Datta S, 2006, J BIOL CHEM, V281, P807, DOI 10.1074/jbc.M511050200; Farhana L, 2007, CANCER RES, V67, P318, DOI 10.1158/0008-5472.CAN-06-2164; Garruti G, 2012, J LIPIDS, V2012, DOI 10.1155/2012/304292; Gotow T, 2000, CELL DEATH DIFFER, V7, P666, DOI 10.1038/sj.cdd.4400694; He N, 2008, GASTROENTEROLOGY, V134, P793, DOI 10.1053/j.gastro.2008.01.006; Hetz C, 2008, TRENDS CELL BIOL, V18, P38, DOI 10.1016/j.tcb.2007.10.003; Horie C, 2002, MOL BIOL CELL, V13, P1615, DOI 10.1091/mbc.01-12-0570; Huang JS, 2007, HEPATOLOGY, V46, P147, DOI 10.1002/hep.21632; Huang JS, 2010, AM J PHYSIOL-GASTR L, V299, pG1211, DOI 10.1152/ajpgi.00322.2010; Kong B, 2012, HEPATOLOGY, V56, P1034, DOI 10.1002/hep.25740; KRAJEWSKI S, 1993, CANCER RES, V53, P4701; Kuroda R, 1998, J BIOL CHEM, V273, P31097, DOI 10.1074/jbc.273.47.31097; Lee YK, 2000, MOL CELL BIOL, V20, P187, DOI 10.1128/MCB.20.1.187-195.2000; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Matsukuma KE, 2007, J BIOL CHEM, V282, P20164, DOI 10.1074/jbc.M702895200; McEwan Iain J., 2009, V505, P3, DOI 10.1007/978-1-60327-575-0_1; Ogata M, 2002, BIOCHEM BIOPH RES CO, V292, P8, DOI 10.1006/bbrc.2002.6593; Pan XY, 2010, CELL METAB, V12, P174, DOI 10.1016/j.cmet.2010.05.014; Strasser A, 2011, EMBO J, V30, P3667, DOI 10.1038/emboj.2011.307; Szegezdi E, 2009, AM J PHYSIOL-CELL PH, V296, pC941, DOI 10.1152/ajpcell.00612.2008; Tabbi-Anneni I, 2010, AM J PHYSIOL-ENDOC M, V298, pE961, DOI 10.1152/ajpendo.00655.2009; Wang L, 2003, J BIOL CHEM, V278, P44475, DOI 10.1074/jbc.M305258200; Wang L, 2002, DEV CELL, V2, P721, DOI 10.1016/S1534-5807(02)00187-9; Wang L, 2005, CELL METAB, V2, P227, DOI 10.1016/j.cmet.2005.08.010; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Yuan XH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005609; Yuk JM, 2011, NAT IMMUNOL, V12, P742, DOI 10.1038/ni.2064; Zhang YX, 2008, HEPATOLOGY, V48, P289, DOI 10.1002/hep.22342; Zhang YX, 2012, NUCLEIC ACIDS RES, V40, P4850, DOI 10.1093/nar/gks159; Zhang YX, 2011, J BIOL CHEM, V286, P29635, DOI 10.1074/jbc.M111.253039; Zhang YX, 2011, BBA-MOL BASIS DIS, V1812, P893, DOI 10.1016/j.bbadis.2010.10.006; Zhang YX, 2011, FEBS LETT, V585, P1269, DOI 10.1016/j.febslet.2011.03.059; Zhang YX, 2010, MOL CELL BIOL, V30, P1341, DOI 10.1128/MCB.01076-09; Zhang ZD, 2004, GENOME RES, V14, P580, DOI 10.1101/gr.2160004; Zhou TF, 2010, J BIOL CHEM, V285, P24871, DOI 10.1074/jbc.M110.133280	35	8	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68491	10.1371/journal.pone.0068491	http://dx.doi.org/10.1371/journal.pone.0068491			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874642	Green Submitted, Green Published, gold			2022-12-27	WOS:000321736900087
J	Alavi, P; Muller, H; Cardinale, M; Zachow, C; Sanchez, MB; Martinez, JL; Berg, G				Alavi, Peyman; Mueller, Henry; Cardinale, Massimiliano; Zachow, Christin; Sanchez, Maria B.; Luis Martinez, Jose; Berg, Gabriele			The DSF Quorum Sensing System Controls the Positive Influence of Stenotrophomonas maltophilia on Plants	PLOS ONE			English	Article							BIOFILM FORMATION; XANTHOMONAS-MALTOPHILIA; GROWTH; RHIZOSPHERE; BACTERIA; SIGNAL; VIRULENCE; GENUS; MICROORGANISMS; PATHOGENICITY	The interaction of the Gram-negative bacterium Stenotrophomonas maltophilia with eukaryotes can improve overall plant growth and health, but can also cause opportunistic infections in humans. While the quorum sensing molecule DSF (diffusible signal factor) is responsible for the regulation of phenotypes in pathogenic Stenotrophomonas, up until now, no beneficial effects were reported to be controlled by it. Our objective was to study the function of DSF in the plant growth promoting model strain S. maltophilia R551-3 using functional and transcriptomic analyses. For this purpose, we compared the wild-type strain with a mutant deficient in the rpfF (regulation of pathogenicity factors) gene that is essential for the synthesis of DSF. Oilseed rape seeds treated with the wild-type strain showed a statistically significant increase in germination rate compared with those treated with the rpfF mutant. Similarly, the wild-type strain exhibited better plant growth promotion and a greater efficiency in colonizing oilseed rape compared to the mutant strain. Moreover, only the wild-type was capable of forming structured cell aggregates both in vitro and in the rhizosphere, a characteristic mediated by DSF. Gene transcription analyses showed that numerous genes known to play a role in plant colonization (e. g. chemotaxis, cell motility, biofilm formation, multidrug efflux pumps) are controlled by the rpf/ DSF system in S. maltophilia. In addition, we detected new potential functions of spermidine, primarily for both growth promotion and stress protection. Overall, our results showed a correspondence between the regulation of DSF and the positive interaction effect with the plant host.	[Alavi, Peyman; Mueller, Henry; Cardinale, Massimiliano; Zachow, Christin; Berg, Gabriele] Graz Univ Technol, Inst Environm Biotechnol, A-8010 Graz, Austria; [Zachow, Christin] Austrian Ctr Ind Biotechnol ACIB GmbH, Graz, Austria; [Sanchez, Maria B.; Luis Martinez, Jose] CSIC, CNB, Madrid, Spain	Graz University of Technology; Austrian Centre of Industrial Biotechnology; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Berg, G (corresponding author), Graz Univ Technol, Inst Environm Biotechnol, A-8010 Graz, Austria.	Gabriele.berg@tugraz.at	Cardinale, Massimiliano/B-8269-2014; Sanchez, Maria Blanca/AAD-8294-2020; Martinez, Jose L/A-4725-2013	Cardinale, Massimiliano/0000-0003-1421-722X; Sanchez, Maria Blanca/0000-0002-5209-4518; Martinez, Jose L/0000-0001-8813-7607; Zachow, Christin/0000-0002-9211-7104; Berg, Gabriele/0000-0001-9423-3101	Austrian Science Foundation [FWF 20542-B16]; Austrian Science Fund (FWF) [P 20542] Funding Source: researchfish	Austrian Science Foundation(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was funded by the Austrian Science Foundation (FWF 20542-B16). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamek M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027615; Al-Whaibi M. H., 2012, Journal of Medicinal Plants Research, V6, P1948; Alavi P, 2013, FRONTIERS F IN PRESS; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Barber CE, 1997, MOL MICROBIOL, V24, P555, DOI 10.1046/j.1365-2958.1997.3721736.x; Berg G, 1999, J CLIN MICROBIOL, V37, P3594, DOI 10.1128/JCM.37.11.3594-3600.1999; Berg G, 1996, MICROBIOL RES, V151, P19, DOI 10.1016/S0944-5013(96)80051-6; Berg G, 2010, CELL ORIG LIFE EXTRE, V17, P447, DOI 10.1007/978-90-481-9449-0_22; Berg G, 2009, APPL MICROBIOL BIOT, V84, P11, DOI 10.1007/s00253-009-2092-7; Boon C, 2008, ISME J, V2, P27, DOI 10.1038/ISMEJ.2007.76; Cardinale M, 2008, FEMS MICROBIOL ECOL, V66, P63, DOI 10.1111/j.1574-6941.2008.00546.x; Turrientes MC, 2010, APPL ENVIRON MICROB, V76, P1746, DOI 10.1128/AEM.02817-09; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; de Weert S, 2002, MOL PLANT MICROBE IN, V15, P1173, DOI 10.1094/MPMI.2002.15.11.1173; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; Denton M, 1998, CLIN MICROBIOL REV, V11, P57, DOI 10.1128/CMR.11.1.57; Dow JM, 2003, P NATL ACAD SCI USA, V100, P10995, DOI 10.1073/pnas.1833360100; ELAD Y, 1987, PLANT SOIL, V98, P325, DOI 10.1007/BF02378353; Fouhy Y, 2007, J BACTERIOL, V189, P4964, DOI 10.1128/JB.00310-07; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Gotz M, 2006, FEMS MICROBIOL ECOL, V56, P207, DOI 10.1111/j.1574-6941.2006.00093.x; Hardoim PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030438; Hauben L, 1999, INT J SYST BACTERIOL, V49, P1749, DOI 10.1099/00207713-49-4-1749; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Jakobi M, 1996, J ANTIBIOT, V49, P1101, DOI 10.7164/antibiotics.49.1101; JUHNKE ME, 1989, APPL ENVIRON MICROB, V55, P747, DOI 10.1128/AEM.55.3.747-750.1989; Kai M, 2007, ARCH MICROBIOL, V187, P351, DOI 10.1007/s00203-006-0199-0; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; McGinnis MW, 2009, FEMS MICROBIOL LETT, V299, P166, DOI 10.1111/j.1574-6968.2009.01744.x; Muller H, 2009, FEMS MICROBIOL ECOL, V67, P468, DOI 10.1111/j.1574-6941.2008.00635.x; Muller H, 2008, BIOCONTROL, V53, P905, DOI 10.1007/s10526-007-9111-3; Nakayama T, 1999, APPL ENVIRON MICROB, V65, P4334; Newman KL, 2004, P NATL ACAD SCI USA, V101, P1737, DOI 10.1073/pnas.0308399100; PALLERONI NJ, 1993, INT J SYST BACTERIOL, V43, P606, DOI 10.1099/00207713-43-3-606; Park M, 2005, MICROBIOL RES, V160, P127, DOI 10.1016/j.micres.2004.10.003; Perkins TT, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000569; Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x; Ribbeck-Busch K, 2005, ENVIRON MICROBIOL, V7, P1853, DOI 10.1111/j.1462-2920.2005.00928.x; Ryan RP, 2008, MOL MICROBIOL, V68, P75, DOI 10.1111/j.1365-2958.2008.06132.x; Ryan RP, 2009, NAT REV MICROBIOL, V7, P514, DOI 10.1038/nrmicro2163; Ryan RP, 2011, TRENDS MICROBIOL, V19, P3; SCHIPPERS B, 1987, ANNU REV PHYTOPATHOL, V25, P339, DOI 10.1146/annurev.py.25.090187.002011; Schmidt CS, 2012, BIOL FERT SOILS, V48, P947, DOI 10.1007/s00374-012-0688-z; Slater H, 2000, MOL MICROBIOL, V38, P986, DOI 10.1046/j.1365-2958.2000.02196.x; Suckstorff I, 2003, J APPL MICROBIOL, V95, P656, DOI 10.1046/j.1365-2672.2003.02021.x; Taghavi S, 2009, APPL ENVIRON MICROB, V75, P748, DOI 10.1128/AEM.02239-08; Torres PS, 2007, ENVIRON MICROBIOL, V9, P2101, DOI 10.1111/j.1462-2920.2007.01332.x	47	39	39	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e67103	10.1371/journal.pone.0067103	http://dx.doi.org/10.1371/journal.pone.0067103			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874407	Green Submitted, Green Published, gold			2022-12-27	WOS:000324146200006
J	Fan, L; Cheng, C; Qiao, YB; Li, F; Li, W; Wu, H; Ren, B				Fan, Li; Cheng, Chong; Qiao, Youbei; Li, Fei; Li, Wei; Wu, Hong; Ren, Bo			GNPs-CS/KGM as Hemostatic First Aid Wound Dressing with Antibiotic Effect: In Vitro and In Vivo Study	PLOS ONE			English	Article							CONDENSED STATE STRUCTURE; CHITOSAN; MICROSPHERES; REGENERATION; TRANSFUSION; ALGINATE; EFFICACY; COMPLEX	Ideal wound dressing materials should create a good healing environment, with immediate hemostatic effects and antimicrobial activity. In this study, chitosan/konjac glucomannan (CS/KGM) films embedded with gentamicin-loaded poly(dex-GMA/AAc) nanoparticles (giving GNP-CS/KGM films) were prepared as novel wound dressings. The results revealed that the modified CS/KGM films could be used as effective wound dressings and had significant hemostatic effects. With their microporous structure, the films could effectively absorb water from blood and trap blood cells. The gentamicinloaded poly(dex-GMA/AAc) nanoparticles (GNPs) also further promoted blood clotting, with their favorable water uptake capacity. Thus, the GNP-CS/KGM films had wound healing and synergistic effects that helped to stop bleeding from injuries, and also showed good antibiotic abilities by addition of gentamicin to the NPs. These GNPCS/KGM films can be considered as promising novel biodegradable and biocompatible wound dressings with hemostatic capabilities and antibiotic effects for treatment of external bleeding injuries.	[Fan, Li; Cheng, Chong; Qiao, Youbei; Li, Fei; Li, Wei; Wu, Hong] Fourth Mil Med Univ, Sch Pharm, Dept Pharmaceut Chem & Anal, Xian 710032, Shaanxi, Peoples R China; [Ren, Bo] 302 Mil Hosp China, Dept Anesthesia, Beijing, Peoples R China	Air Force Military Medical University; Fifth Medical Center of Chinese PLA General Hospital	Wu, H (corresponding author), Fourth Mil Med Univ, Sch Pharm, Dept Pharmaceut Chem & Anal, Xian 710032, Shaanxi, Peoples R China.	hongwuxa@hotmail.com; renbo1971@sina.com			National Natural Science Foundation of China [81201179, 81271687]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was partially funded by grants from the National Natural Science Foundation of China No. 81201179 and No. 81271687. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balakrishnan B, 2006, BIOMATERIALS, V27, P1355, DOI 10.1016/j.biomaterials.2005.08.021; Chen FM, 2006, INT J PHARMACEUT, V307, P23, DOI 10.1016/j.ijpharm.2005.09.024; Connolly RJ, 2004, J TRAUMA, V57, pS26, DOI 10.1097/01.TA.0000136746.97192.B2; CORKHILL PH, 1989, BIOMATERIALS, V10, P3, DOI 10.1016/0142-9612(89)90002-1; Dai CL, 2010, BIOMATERIALS, V31, P7620, DOI 10.1016/j.biomaterials.2010.06.049; Dai TH, 2011, EXPERT REV ANTI-INFE, V9, P857, DOI [10.1586/ERI.11.59, 10.1586/eri.11.59]; DARMADJI P, 1994, MEAT SCI, V38, P243, DOI 10.1016/0309-1740(94)90114-7; de Carvalho VF, 2011, J WOUND OSTOMY CONT, V38, P643, DOI 10.1097/WON.0b013e3182349d2f; Dhanuja G, 2005, SEP PURIF TECHNOL, V44, P130, DOI 10.1016/j.seppur.2005.01.001; Gavriliuk B K, 2011, Biofizika, V56, P1138; Huang LY, 2011, ANTIMICROB AGENTS CH, V55, P3432, DOI 10.1128/AAC.01803-10; Hui Z, 2008, BIOFACTORS, V30, P227; Hui Z, 2008, POLYM COMPOSITE, V30, P1243; Kim IY, 2007, INT J PHARM, V341, P35, DOI 10.1016/j.ijpharm.2007.03.042; Laurens N, 2006, J THROMB HAEMOST, V4, P932, DOI 10.1111/j.1538-7836.2006.01861.x; Laurienzo P, 2006, J BIOMED MATER RES A, V78A, P523, DOI 10.1002/jbm.a.30763; Lenselink E, 2011, J WOUND CARE, V20, P534, DOI 10.12968/jowc.2011.20.11.534; Li B, 2011, CARBOHYD POLYM, V83, P44, DOI 10.1016/j.carbpol.2010.07.017; Lo S F, 2007, J Wound Care, V16, P373; Losee JE, 2005, ANN PLAS SURG, V54, P165, DOI 10.1097/01.sap.0000143798.55846.8d; Nakashima Teruo, 2006, Biocontrol Science, V11, P27; Nie HR, 2011, CARBOHYD POLYM, V85, P681, DOI 10.1016/j.carbpol.2011.03.036; Oberyszyn TM, 2007, FRONT BIOSCI-LANDMRK, V12, P2993, DOI 10.2741/2289; Pasqui D, 2012, POLYMERS-BASEL, V4, P1517, DOI 10.3390/polym4031517; Pereira AL, 2005, REV BRAS ENFERM, V58, P208, DOI 10.1590/S0034-71672005000200016; Perkins JG, 2008, CRIT CARE MED, V36, pS325, DOI 10.1097/CCM.0b013e31817e2ec5; Persin Z, 2011, CARBOHYD POLYM, V84, P22, DOI 10.1016/j.carbpol.2010.11.044; Petrulyte S, 2008, DAN MED BULL, V55, P72; Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P; Scherer SS, 2011, J TRAUMA, V71, pS183, DOI 10.1097/TA.0b013e318225585b; Sugawara J, 2013, CLIN APPL THROMB-HEM, V19, P557, DOI 10.1177/1076029612443305; Sun GM, 2011, P NATL ACAD SCI USA, V108, P20976, DOI 10.1073/pnas.1115973108; Tsao CT, 2011, CARBOHYD POLYM, V84, P812, DOI 10.1016/j.carbpol.2010.04.034; Virto MR, 2007, BIOMATERIALS, V28, P877, DOI 10.1016/j.biomaterials.2006.09.045; Wang T, 2012, CARBOHYD POLYM, V88, P75, DOI 10.1016/j.carbpol.2011.11.069; Wittaya-areekul S, 2006, INT J PHARMACEUT, V313, P123, DOI 10.1016/j.ijpharm.2006.01.027; Ye X, 2006, CARBOHYD POLYM, V64, P532, DOI 10.1016/j.carbpol.2005.11.005; Zhang JL, 2010, MAR DRUGS, V8, P1962, DOI 10.3390/md8071962; Zhang YL, 2011, J BIOMAT SCI-POLYM E, V22, P809, DOI 10.1163/092050610X496242	39	15	17	1	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e66890	10.1371/journal.pone.0066890	http://dx.doi.org/10.1371/journal.pone.0066890			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874402	Green Published, Green Submitted, gold			2022-12-27	WOS:000322064300007
J	Zoughlami, Y; van Stalborgh, AM; van Hennik, PB; Hordijk, PL				Zoughlami, Younes; van Stalborgh, Anne M.; van Hennik, Paula B.; Hordijk, Peter L.			Nucleophosmin1 Is a Negative Regulator of the Small GTPase Rac1	PLOS ONE			English	Article							RHO-GTPASES; NUCLEOLAR PROTEIN; NUCLEAR-LOCALIZATION; POLYBASIC REGION; CELL-MIGRATION; FAMILY; PHOSPHORYLATION; DEGRADATION; ACTIVATION; LEUKEMIA	The Rac1 GTPase is a critical regulator of cytoskeletal dynamics and controls many biological processes, such as cell migration, cell-cell contacts, cellular growth and cell division. These complex processes are controlled by Rac1 signaling through effector proteins. We have previously identified several effector proteins of Rac1 that also act as Rac1 regulatory proteins, including caveolin-1 and PACSIN2. Here, we report that Rac1 interacts through its C-terminus with nucleophosmin1 (NPM1), a multifunctional nucleo-cytoplasmic shuttling protein with oncogenic properties. We show that Rac1 controls NPM1 subcellular localization. In cells expressing active Rac1, NPM1 translocates from the nucleus to the cytoplasm. In addition, Rac1 regulates the localization of the phosphorylated pool of NPM1 as this pool translocated from the nucleus to the cytosol in cells expressing activated Rac1. Conversely, we found that expression of NPM1 limits Rac1 GTP loading and cell spreading. In conclusion, this study identifies NPM1 as a novel, negative regulator of Rac1.	[Zoughlami, Younes; van Stalborgh, Anne M.; van Hennik, Paula B.; Hordijk, Peter L.] Univ Amsterdam, Acad Med Ctr, Dept Mol Cell Biol, Sanquin Res & Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Hordijk, PL (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Mol Cell Biol, Sanquin Res & Landsteiner Lab, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	p.hordijk@sanquin.nl		Hordijk, Peter/0000-0002-3348-078X	Lansteiner Foundation for Blood Transfusion Research (LSBR) [0630]; Sanquin	Lansteiner Foundation for Blood Transfusion Research (LSBR); Sanquin	YZ was funded by the Lansteiner Foundation for Blood Transfusion Research (LSBR) grant no. 0630. AvS, PBvH and PLH were funded by Sanquin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernards A, 2004, TRENDS CELL BIOL, V14, P377, DOI 10.1016/j.tcb.2004.05.003; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; CHANG JH, 1988, J BIOL CHEM, V263, P12824; CHANG JH, 1990, J BIOL CHEM, V265, P18227; Chung CY, 2000, P NATL ACAD SCI USA, V97, P5225, DOI 10.1073/pnas.97.10.5225; Colomba A, 2008, ONCOGENE, V27, P2728, DOI 10.1038/sj.onc.1210921; Colomba A, 2011, BLOOD CANCER J, V1, DOI 10.1038/bcj.2011.19; de Kreu BJ, 2011, J CELL SCI, V124, P2375, DOI 10.1242/jcs.080630; del Pozo MA, 2000, EMBO J, V19, P2008, DOI 10.1093/emboj/19.9.2008; DIDSBURY J, 1989, J BIOL CHEM, V264, P16378; Dovas A, 2005, BIOCHEM J, V390, P1, DOI 10.1042/BJ20050104; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Falini B, 2007, BLOOD, V109, P874, DOI 10.1182/blood-2006-07-012252; Fletcher SJ, 2010, TRENDS CELL BIOL, V20, P71, DOI 10.1016/j.tcb.2009.11.006; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Guo FK, 2004, MOL CELL BIOL, V24, P1426, DOI 10.1128/MCB.24.3.1426-1438.2004; Haferlach C, 2009, BLOOD, V114, P3024, DOI 10.1182/blood-2009-01-197871; Hingorani K, 2000, J BIOL CHEM, V275, P24451, DOI 10.1074/jbc.M003278200; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Lam B Daniel, 2013, Small GTPases, V4, P78, DOI 10.4161/sgtp.23310; Lam BD, 2012, CYTOM PART A, V81A, P81, DOI 10.1002/cyto.a.21153; Lanning CC, 2004, J BIOL CHEM, V279, P44197, DOI 10.1074/jbc.M404977200; MAMRACK MD, 1979, BIOCHEMISTRY-US, V18, P3381, DOI 10.1021/bi00582a026; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Michaelson D, 2008, J CELL BIOL, V181, P485, DOI 10.1083/jcb.200801047; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Nethe M, 2010, J CELL SCI, V123, P1948, DOI 10.1242/jcs.062919; Nishimura Y, 2002, BIOSCI BIOTECH BIOCH, V66, P2239, DOI 10.1271/bbb.66.2239; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Okuwaki M, 2008, J BIOCHEM, V143, P441, DOI 10.1093/jb/mvm222; Olofsson B, 1999, CELL SIGNAL, V11, P545, DOI 10.1016/S0898-6568(98)00063-1; Pop M, 2004, J BIOL CHEM, V279, P35840, DOI 10.1074/jbc.M404346200; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Szebeni A, 2003, J BIOL CHEM, V278, P9107, DOI 10.1074/jbc.M204411200; ten Klooster JP, 2007, BIOL CELL, V99, P1, DOI 10.1042/BC20060071; ten Klooster JP, 2007, EMBO J, V26, P336, DOI 10.1038/sj.emboj.7601518; ten Klooster JP, 2006, J CELL BIOL, V172, P759, DOI 10.1083/jcb.200509096; Tokuyama Y, 2001, J BIOL CHEM, V276, P21529, DOI 10.1074/jbc.M100014200; van Hennik PB, 2003, J BIOL CHEM, V278, P39166, DOI 10.1074/jbc.M307001200; van Rijssel RJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029912, DOI 10.1371/J0URNAL.P0NE.0029912]; vanLeeuwen FN, 1995, ONCOGENE, V11, P2215; VONLINDERN M, 1992, MOL CELL BIOL, V12, P3346, DOI 10.1128/MCB.12.8.3346; VONLINDERN M, 1992, GENE CHROMOSOME CANC, V5, P227, DOI 10.1002/gcc.2870050309; Wang W, 2005, NAT CELL BIOL, V7, P823, DOI 10.1038/ncb1282; Williams CL, 2003, CELL SIGNAL, V15, P1071, DOI 10.1016/S0898-6568(03)00098-6	50	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68477	10.1371/journal.pone.0068477	http://dx.doi.org/10.1371/journal.pone.0068477			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874639	Green Published, gold, Green Submitted			2022-12-27	WOS:000322064300038
J	De Bonis, P; Trevisi, G; de Waure, C; Sferrazza, A; Volpe, M; Pompucci, A; Anile, C; Mangiola, A				De Bonis, Pasquale; Trevisi, Gianluca; de Waure, Chiara; Sferrazza, Antonella; Volpe, Massimo; Pompucci, Angelo; Anile, Carmelo; Mangiola, Annunziato			Antiplatelet/Anticoagulant Agents and Chronic Subdural Hematoma in the Elderly	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; LOW-DOSE ASPIRIN; PRIMARY PREVENTION; COLORECTAL-CANCER; RISK; METAANALYSIS; HEMORRHAGE; DISEASE; EVENTS	Background and Purpose: In the last decade there has been an increasing use of antiplatelet/anticoagulant agents in the elderly. The aim of the study was to evaluate the association between exposure to anticoagulant/antiplatelet therapy and chronic subdural haematoma-CSDH. Methods: Single institution case-control study involving 138786 patients older than 60 years who visited our academic tertiary care Emergency Department from January 1st 2001 to December 31st 2010. 345 patients with CSDH (cases) were identified by review of ICD-9 codes 432.1 and 852.2x. Case and controls were matched with a 1: 3 ratio for gender, age (+/- 5 years), year of admission and recent trauma. A conditional logistic model was built. A stratified analysis was performed with respect to the presence (842 patients) or absence (536 patients) of recent trauma. Results: There were 345 cases and 1035 controls. Both anticoagulant and antiplatelet agents were associated with an increased risk of CSDH with an OR of 2.46 (CI 95% 1.66-3.64) and 1.42 (CI 95% 1.07-1.89), respectively. OR was 2.70 (CI 95% 1.75-4.15), 1.90 (CI 95% 1.13-3.20), and 1.37(CI 95% 0.99-1.90) for patients receiving oral anticoagulants, ADP-antagonists, or Cox-inhibitors, respectively. History of recent trauma was an effect modifier of the association between anticoagulants and CSDH, with an OR 1.71 (CI 95% 0.99-2.96) for patients with history of trauma and 4.30 (CI 95% 2.23-8.32) for patients without history of trauma. Conclusions: Anticoagulant and antiplatelet therapy have a significant association with an increased risk of CSDH. This association, for patients under anticoagulant therapy, appears even stronger in those patients who develop a CSDH in the absence of a recent trauma.	[De Bonis, Pasquale; Trevisi, Gianluca; Pompucci, Angelo; Anile, Carmelo; Mangiola, Annunziato] Univ Cattolica Sacro Cuore, Sch Med, Inst Neurosurg, I-00168 Rome, Italy; [de Waure, Chiara; Sferrazza, Antonella] Univ Cattolica Sacro Cuore, Sch Med, Inst Hyg, I-00168 Rome, Italy; [Volpe, Massimo] Univ Cattolica Sacro Cuore, Sch Med, Dept Hlth, I-00168 Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Trevisi, G (corresponding author), Univ Cattolica Sacro Cuore, Sch Med, Inst Neurosurg, I-00168 Rome, Italy.	trevisi.gianluca@gmail.com	Volpe, Massimo/K-5240-2016; Trevisi, Gianluca/K-9664-2016; Trevisi, Gianluca/ABD-1335-2020; de bonis, pasquale/K-8200-2016; Dewaure, Chiara/K-7192-2016	Volpe, Massimo/0000-0002-9642-8380; Trevisi, Gianluca/0000-0002-2879-8451; Trevisi, Gianluca/0000-0002-2879-8451; de bonis, pasquale/0000-0002-9879-8940; Dewaure, Chiara/0000-0002-4346-1494				Adhiyaman V, 2002, POSTGRAD MED J, V78, P71, DOI 10.1136/pmj.78.916.71; Baechli H, 2004, NEUROSURG REV, V27, P263, DOI 10.1007/s10143-004-0337-6; Benamouzig R, 2005, CURR TOP MED CHEM, V5, P493, DOI 10.2174/1568026054201631; Berger JS, 2006, JAMA-J AM MED ASSOC, V295, P306, DOI 10.1001/jama.295.3.306; Flaherty ML, 2007, NEUROLOGY, V68, P116, DOI 10.1212/01.wnl.0000250340.05202.8b; Flossmann E, 2007, LANCET, V369, P1603, DOI 10.1016/S0140-6736(07)60747-8; Forster MT, 2010, J CLIN NEUROSCI, V17, P975, DOI 10.1016/j.jocn.2009.11.023; HART RG, 1995, STROKE, V26, P1471, DOI 10.1161/01.STR.26.8.1471; Lindvall P, 2009, J CLIN NEUROSCI, V16, P1287, DOI 10.1016/j.jocn.2009.01.001; McQuaid KR, 2006, AM J MED, V119, P624, DOI 10.1016/j.amjmed.2005.10.039; REYMOND MA, 1992, NEUROSURG REV, V15, P21, DOI 10.1007/BF02352062; Rust T, 2006, J CLIN NEUROSCI, V13, P823, DOI 10.1016/j.jocn.2004.12.013; Sanmuganathan PS, 2001, HEART, V85, P265, DOI 10.1136/heart.85.3.265; STROOBANDT G, 1995, ACTA NEUROCHIR, V137, P6, DOI 10.1007/BF02188772; Thun MJ, 2012, NAT REV CLIN ONCOL; Tsai TH, 2010, J TRAUMA, V68, P571, DOI 10.1097/TA.0b013e3181a5f31c; Tsutani K, 2007, INTERNAL MED, V46, P157, DOI 10.2169/internalmedicine.46.1843	17	52	52	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e68732	10.1371/journal.pone.0068732	http://dx.doi.org/10.1371/journal.pone.0068732			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	23874740	Green Published, gold, Green Submitted			2022-12-27	WOS:000321718700039
J	Fernandez-Luna, A; Gallardo, L; Plaza-Carmona, M; Garcia-Unanue, J; Sanchez-Sanchez, J; Felipe, JL; Burillo, P; Ara, I				Fernandez-Luna, Alvaro; Gallardo, Leonor; Plaza-Carmona, Maria; Garcia-Unanue, Jorge; Sanchez-Sanchez, Javier; Luis Felipe, Jose; Burillo, Pablo; Ara, Ignacio			Respiratory Function and Changes in Lung Epithelium Biomarkers after a Short-Training Intervention in Chlorinated vs. Ozone Indoor Pools	PLOS ONE			English	Article							DISINFECTION BY-PRODUCTS; PROTEIN CC16; EXPOSURE; SYMPTOMS; ASTHMA; RISK; PREVALENCE; ATTENDANCE; EXERCISE	Background: Swimming in indoor pools treated with combined chemical treatments (e.g. ozone) may reduce direct exposure to disinfection byproducts and thus have less negative effects on respiratory function compared to chlorinated pools. The aim of this study is to analyze the effects of a short-term training intervention on respiratory function and lung epithelial damage in adults exercising in indoor swimming pool waters treated with different disinfection methods (chlorine vs. ozone with bromine). Methods: Lung permeability biomakers [surfactant protein D (SP-D) and Clara cell secretory protein (CC16) in plasma] and forced expiratory volumes and flow (FEV1, FVC and FEF25-75) were measured in 39 healthy adults. Thirteen participants swam during 20 sessions in a chlorinated pool (CP), 13 performed and equivolumic intervention in an ozone pool (OP) and 13 were included in a control group (CG) without exposition. Results: Median plasma CC16 levels increased in CP swimmers (4.27 +/- 3.29 and 6.62 +/- 5.51 mu g/L, p = 0.01, pre and post intervention respectively) while no significant changes in OP and CG participants were found. No significant changes in median plasma SP-D levels were found in any of the groups after the training period. FVC increased in OP (4.26 +/- 0.86 and 4.43 +/- 0.92 L, p<0.01) and CP swimmers (4.25 +/- 0.86 and 4.35 +/- 0.85 L, p<0.01). FEV1 only increased in OP swimmers (3.50 +/- 0.65 and 3.59 +/- 0.67, p = 0.02) and FEF25-75 decreased in CP swimmers (3.70 +/- 0.87 and 3.37 +/- 0.67, p = 0.02). Conclusion: Despite lung function being similar in both groups, a higher lung permeability in CP compared to OP swimmers was found after a short-term swimming program. Combined chemical treatments for swimming pools such as ozone seem to have less impact on lung epithelial of swimmers compared to chlorinated treated pools.	[Fernandez-Luna, Alvaro; Luis Felipe, Jose] European Univ Madrid, Sch Sports Sci, Madrid, Spain; [Gallardo, Leonor; Plaza-Carmona, Maria; Garcia-Unanue, Jorge; Sanchez-Sanchez, Javier] Univ Castilla La Mancha, IGOID Res Grp, Toledo, Spain; [Burillo, Pablo] Camilo Jose Cela Univ, Sports Sci Inst, Madrid, Spain; [Ara, Ignacio] Univ Castilla La Mancha, GENUD Growth Exercise NUtr & Dev Toledo Res Grp, Toledo, Spain	European University of Madrid; Universidad de Castilla-La Mancha; Camilo Jose Cela University; Universidad de Castilla-La Mancha	Fernandez-Luna, A (corresponding author), European Univ Madrid, Sch Sports Sci, Madrid, Spain.	alvaro.fernandez2@uem.es	Felipe, José Luis/U-1062-2017; Burillo, Pablo/K-6647-2014; Plaza Carmona, Maria/ABD-9868-2021; Garcia-Unanue, Jorge/AAY-6231-2020; Felipe, Jose Luis/M-1442-2015; García-Unanue, Jorge/F-6674-2016; Fernandez-Luna, Alvaro/N-4189-2015	Felipe, José Luis/0000-0002-2029-1277; Burillo, Pablo/0000-0003-4331-1661; Garcia-Unanue, Jorge/0000-0002-1741-5566; García-Unanue, Jorge/0000-0002-1741-5566; Ara Royo, Ignacio/0000-0002-2854-6684; Sanchez-Sanchez, Javier/0000-0003-0017-0184; Fernandez-Luna, Alvaro/0000-0002-8633-7311; Gallardo Guerrero, Leonor/0000-0002-6296-6121; Plaza-Carmona, Maria/0000-0001-6886-7215				Nievas DA, 2008, GAC SANIT, V22, P287, DOI 10.1157/13123976; Basler RSW, 2000, J AM ACAD DERMATOL, V43, P299, DOI 10.1067/mjd.2000.107495; Bernard A, 2003, OCCUP ENVIRON MED, V60, P385, DOI 10.1136/oem.60.6.385; Bernard A, 2007, PEDIATRICS, V119, P1095, DOI 10.1542/peds.2006-3333; Bjerk SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056249; Bonetto G, 2006, AM J RESP CRIT CARE, V174, P545, DOI 10.1164/rccm.200509-1392OC; Broeckaert F, 2000, ANN NY ACAD SCI, V923, P68; Carbonnelle S, 2002, BIOMARKERS, V7, P464, DOI 10.1080/13547500210166612; Carbonnelle S, 2008, MED SCI SPORT EXER, V40, P1472, DOI 10.1249/MSS.0b013e3181733159; Cassan D, 2006, CHEMOSPHERE, V62, P1507, DOI 10.1016/j.chemosphere.2005.06.006; Cheng G, 2000, EUR RESPIR J, V16, P831, DOI 10.1183/09031936.00.16583100; Cheng YJ, 2003, BRIT J SPORT MED, V37, P521, DOI 10.1136/bjsm.37.6.521; Drobnic F, 2009, APUNTS-MED ESPORT, V44, P42, DOI 10.1016/S1886-6581(09)70107-0; Erdfelder E, 1996, BEHAV RES METH INS C, V28, P1, DOI 10.3758/BF03203630; Fernandez-Luna A, 2011, J SPORT HEALTH RES, V3, P203; Ferrari M, 2011, J SCI MED SPORT, V14, P184, DOI 10.1016/j.jsams.2010.12.006; Font-Ribera L, 2009, EUR RESPIR J, V34, P1304, DOI 10.1183/09031936.00180608; Font-Ribera L, 2010, ENVIRON HEALTH PERSP, V118, P1538, DOI 10.1289/ehp.1001961; Jacobs JH, 2007, EUR RESPIR J, V29, P690, DOI 10.1183/09031936.00024706; Kim H, 2002, CHEMOSPHERE, V46, P123, DOI 10.1016/S0045-6535(00)00581-6; Kishore U, 2006, MOL IMMUNOL, V43, P1293, DOI 10.1016/j.molimm.2005.08.004; Kogevinas M, 2010, ENVIRON HEALTH PERSP, V118, P1531, DOI 10.1289/ehp.1001959; Lazarov A, 2005, CONTACT DERMATITIS, V53, P327, DOI 10.1111/j.0105-1873.2005.00699.x; Lee J, 2009, SCI TOTAL ENVIRON, V407, P1990, DOI 10.1016/j.scitotenv.2008.11.021; Levesque B, 2006, INT ARCH OCC ENV HEA, V80, P32, DOI 10.1007/s00420-006-0100-0; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Richardson SD, 2010, ENVIRON HEALTH PERSP, V118, P1523, DOI 10.1289/ehp.1001965; Romberg K, 2011, RESP MED, V105, P31, DOI 10.1016/j.rmed.2010.07.012; Tager IB, 2005, EPIDEMIOLOGY, V16, P751, DOI 10.1097/01.ede.0000183166.68809.b0; Voisin C, 2010, EUR RESPIR J, V36, P41, DOI 10.1183/09031936.00118009; World Health Organization, 2000, GUID SAF RECR WAT EN, V2	32	13	14	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e68447	10.1371/journal.pone.0068447	http://dx.doi.org/10.1371/journal.pone.0068447			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	23874631	gold, Green Submitted, Green Published			2022-12-27	WOS:000321718700027
J	Zhang, Q; Ge, HA; Zhou, JJ; Yuan, CQ; Chen, K; Cheng, B				Zhang, Qiang; Ge, Heng'an; Zhou, Jiaojiao; Yuan, Chaoqun; Chen, Kai; Cheng, Biao			Single-Row or Double-Row Fixation Technique for Full-Thickness Rotator Cuff Tears: A Meta-Analysis	PLOS ONE			English	Article							RANDOMIZED CLINICAL-TRIAL; SUTURE ANCHOR REPAIR; ARTHROSCOPIC REPAIR; OUTCOMES; TENDON; AGE	Background: The single-row and double-row fixation techniques have been widely used for rotator cuff tears. However, whether the double-row technique produces superior clinical or anatomic outcomes is still considered controversial. This study aims to use meta-analysis to compare the clinical and anatomical outcomes between the two techniques. Methods: The Pubmed, Embase, and Cochrane library databases were searched for relevant studies published before November 1, 2012. Studies clearly reporting a comparison of the single-row and double-row techniques were selected. The Constant, ASES, and UCLA scale systems and the rotator cuff integrity rate were evaluated. The weighted mean differences and relative risks were calculated using a fixed-effects or random-effects model. Results: Eight studies were included in this meta-analysis. The weighted mean differences of the ASES (-0.84; P = 0.04; I-2 = 0%) and UCLA (-0.75; P = 0.007; I-2 = 0%) scales were significantly low in the single-row group for full-thickness rotator cuff tears. For tear sizes smaller than 3 cm, no significant difference was found between the groups no matter in Constant (P = 0.95; I-2 = 0%), ASES (P = 0.77; I-2 = 0%), or UCLA (P = 0.24; I-2 = 13%) scales. For tear sizes larger than 3 cm, the ASES (-1.95; P = 0.001; I-2 = 49%) and UCLA (-1.17; P = 0.006; I-2 = 0%) scales were markedly lower in the single-row group. The integrity of the rotator cuff (0.81; P = 0.0004; I-2 = 10%) was greater and the partial thickness retear rate (1.93; P = 0.007; I-2 = 10%) was less in the double-row group. Full-thickness retears showed no difference between the groups (P = 0.15; I-2 = 0%). Conclusion: The meta-analysis suggests that the double-row fixation technique increases post-operative rotator cuff integrity and improves the clinical outcomes, especially for full-thickness rotator cuff tears larger than 3 cm. For tear sizes smaller than 3 cm, there was no difference in the clinical outcomes between the two techniques.	[Zhang, Qiang; Ge, Heng'an; Zhou, Jiaojiao; Yuan, Chaoqun; Chen, Kai; Cheng, Biao] Tongji Univ, Dept Orthoped, Shanghai Peoples Hosp 10, Sch Med, Shanghai 200092, Peoples R China; [Zhang, Qiang; Ge, Heng'an; Zhou, Jiaojiao; Yuan, Chaoqun; Chen, Kai] Nanjing Med Univ, Clin Med Coll 1, Nanjing, Peoples R China	Tongji University; Nanjing Medical University	Cheng, B (corresponding author), Tongji Univ, Dept Orthoped, Shanghai Peoples Hosp 10, Sch Med, Shanghai 200092, Peoples R China.	cbiaob@163.com		Yuan, Chaoqun/0000-0003-4354-422X				Aydin N, 2010, J SHOULDER ELB SURG, V19, P722, DOI 10.1016/j.jse.2009.11.053; Boileau P, 2005, J BONE JOINT SURG AM, V87A, P1229, DOI 10.2106/JBJS.D.02035; Burks RT, 2009, AM J SPORT MED, V37, P674, DOI 10.1177/0363546508328115; Carbonel I, 2012, INT ORTHOP, V36, P1877, DOI 10.1007/s00264-012-1559-9; Charousset C, 2006, REV CHIR ORTHOP, V92, P223; Charousset C, 2007, AM J SPORT MED, V35, P1247, DOI 10.1177/0363546507301661; Franceschi F, 2007, AM J SPORT MED, V35, P1254, DOI 10.1177/0363546507302218; Galatz LM, 2004, J BONE JOINT SURG AM, V86A, P219, DOI 10.2106/00004623-200402000-00002; Gerber C, 2000, J BONE JOINT SURG AM, V82A, P505, DOI 10.2106/00004623-200004000-00006; Gerhardt C, 2012, AM J SPORTS MED; Grasso A, 2009, ARTHROSCOPY, V25, P4, DOI 10.1016/j.arthro.2008.09.018; Koh KH, 2011, ARTHROSCOPY, V27, P453, DOI 10.1016/j.arthro.2010.11.059; Lapner PLC, 2012, J BONE JOINT SURG AM, V94A, P1249, DOI 10.2106/JBJS.K.00999; Lehman Christopher, 1995, Bulletin Hospital for Joint Diseases, V54, P30; Ma HL, 2012, ARTHROSCOPY, V28, P16, DOI 10.1016/j.arthro.2011.07.003; Mihata T, 2011, AM J SPORT MED, V39, P2091, DOI 10.1177/0363546511415660; MILGROM C, 1995, J BONE JOINT SURG BR, V77B, P296, DOI 10.1302/0301-620X.77B2.7706351; Park JY, 2008, AM J SPORT MED, V36, P1310, DOI 10.1177/0363546508315039; Pauly S, 2010, KNEE SURG SPORT TR A, V18, P1718, DOI 10.1007/s00167-010-1245-7; Pennington WT, 2010, ARTHROSCOPY, V26, P1419, DOI 10.1016/j.arthro.2010.03.013; Smith CD, 2006, J BONE JOINT SURG AM, V88A, P2425, DOI 10.2106/JBJS.E.00697; Tempelhof S, 1999, J SHOULDER ELB SURG, V8, P296, DOI 10.1016/S1058-2746(99)90148-9; Toussaint B, 2011, AM J SPORT MED, V39, P1217, DOI 10.1177/0363546510397725	23	32	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e68515	10.1371/journal.pone.0068515	http://dx.doi.org/10.1371/journal.pone.0068515			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874649	Green Published, gold, Green Submitted			2022-12-27	WOS:000322218800034
J	Molleman, L; Pen, I; Weissing, FJ				Molleman, Lucas; Pen, Ido; Weissing, Franz J.			Effects of Conformism on the Cultural Evolution of Social Behaviour	PLOS ONE			English	Article							LEARNING STRATEGIES; ALTRUISTIC PUNISHMENT; FINITE POPULATIONS; TRANSMISSION; COOPERATION; COEVOLUTION; EMERGENCE; SELECTION; NORMS; GAMES	Models of cultural evolution study how the distribution of cultural traits changes over time. The dynamics of cultural evolution strongly depends on the way these traits are transmitted between individuals by social learning. Two prominent forms of social learning are payoff-based learning (imitating others that have higher payoffs) and conformist learning (imitating locally common behaviours). How payoff-based and conformist learning affect the cultural evolution of cooperation is currently a matter of lively debate, but few studies systematically analyse the interplay of these forms of social learning. Here we perform such a study by investigating how the interaction of payoff-based and conformist learning affects the outcome of cultural evolution in three social contexts. First, we develop a simple argument that provides insights into how the outcome of cultural evolution will change when more and more conformist learning is added to payoff-based learning. In a social dilemma (e. g. a Prisoner's Dilemma), conformism can turn cooperation into a stable equilibrium; in an evasion game (e. g. a Hawk-Dove game or a Snowdrift game) conformism tends to destabilize the polymorphic equilibrium; and in a coordination game (e. g. a Stag Hunt game), conformism changes the basin of attraction of the two equilibria. Second, we analyse a stochastic event-based model, revealing that conformism increases the speed of cultural evolution towards pure equilibria. Individual-based simulations as well as the analysis of the diffusion approximation of the stochastic model by and large confirm our findings. Third, we investigate the effect of an increasing degree of conformism on cultural group selection in a group-structured population. We conclude that, in contrast to statements in the literature, conformism hinders rather than promotes the evolution of cooperation.	[Molleman, Lucas; Pen, Ido; Weissing, Franz J.] Univ Groningen, Theoret Biol Grp, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands	University of Groningen	Molleman, L (corresponding author), Univ Groningen, Theoret Biol Grp, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands.	L.S.Molleman@rug.nl		Weissing, Franz J./0000-0003-3281-663X	University of Groningen	University of Groningen	Lucas Molleman was funded by an Ubbo Emmius grant of the University of Groningen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASCH SE, 1956, PSYCHOL MONOGR, V70, P1, DOI 10.1037/h0093718; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; Boyd R, 2002, J THEOR BIOL, V215, P287, DOI 10.1006/jtbi.2001.2515; Boyd R., 1985, CULTURE EVOLUTIONARY; Efferson C, 2008, EVOL HUM BEHAV, V29, P56, DOI 10.1016/j.evolhumbehav.2007.08.003; Gargiulo F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048916; Guzman RA, 2007, EVOL HUM BEHAV, V28, P112, DOI 10.1016/j.evolhumbehav.2006.08.002; Hauert C, 2012, J THEOR BIOL, V299, P106, DOI 10.1016/j.jtbi.2011.06.010; Henrich J, 1998, EVOL HUM BEHAV, V19, P215, DOI 10.1016/S1090-5138(98)00018-X; Henrich J, 2004, J ECON BEHAV ORGAN, V53, P3, DOI 10.1016/S0167-2681(03)00094-5; Henrich J, 2001, EVOL HUM BEHAV, V22, P165, DOI 10.1016/S1090-5138(00)00071-4; Henrich J, 2001, J THEOR BIOL, V208, P79, DOI 10.1006/jtbi.2000.2202; Karlin S., 1975, 1 COURSE STOCHASTIC, V2; Laland KN, 2004, LEARN BEHAV, V32, P4; Lehmann L, 2008, AM NAT, V172, P12, DOI 10.1086/587851; Lehmann L, 2008, THEOR POPUL BIOL, V73, P506, DOI 10.1016/j.tpb.2008.02.004; McElreath R, 2005, EVOL HUM BEHAV, V26, P483, DOI 10.1016/j.evolhumbehav.2005.04.003; McElreath R, 2008, PHILOS T R SOC B, V363, P3515, DOI 10.1098/rstb.2008.0131; Mesoudi A, 2011, EVOL HUM BEHAV, V32, P334, DOI 10.1016/j.evolhumbehav.2010.12.001; Molleman L, EVOL HUM BE IN PRESS; Nowak MA, 2004, NATURE, V428, P646, DOI 10.1038/nature02414; Pena J, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016110; Rendell L, 2011, TRENDS COGN SCI, V15, P68, DOI 10.1016/j.tics.2010.12.002; Skyrms B, 2005, MONIST, V88, P260, DOI 10.5840/monist200588213; Traulsen A, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011909; Traulsen A, 2006, P NATL ACAD SCI USA, V103, P10952, DOI 10.1073/pnas.0602530103; Traulsen A, 2010, P NATL ACAD SCI USA, V107, P2962, DOI 10.1073/pnas.0912515107; Vilone D, 2012, SCI REP-UK, V2, DOI 10.1038/srep00686	29	27	27	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68153	10.1371/journal.pone.0068153	http://dx.doi.org/10.1371/journal.pone.0068153			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	182SU	23874528	Green Submitted, Green Published, gold			2022-12-27	WOS:000321765300031
J	Huser, V; Cimino, JJ				Huser, Vojtech; Cimino, James J.			Linking ClinicalTrials.gov and PubMed to Track Results of Interventional Human Clinical Trials	PLOS ONE			English	Article							PUBLICATION BIAS; REGISTRATION; UPDATE	Objective: In an effort to understand how results of human clinical trials are made public, we analyze a large set of clinical trials registered at ClinicalTrials.gov, the world's largest clinical trial registry. Materials and Methods: We considered two trial result artifacts: (1) existence of a trial result journal article that is formally linked to a registered trial or (2) the deposition of a trial's basic summary results within the registry. Results: The study sample consisted of 8907 completed, interventional, phase 2-or-higher clinical trials that were completed in 2006-2009. The majority of trials (72.2%) had no structured trial-article link present. A total of 2367 trials (26.6%) deposited basic summary results within the registry. Of those, 969 trials (10.9%) were classified as trials with extended results and 1398 trials (15.7%) were classified as trials with only required basic results. The majority of the trials (54.8%) had no evidence of results, based on either linked result articles or basic summary results (silent trials), while a minimal number (9.2%) report results through both registry deposition and publication. Discussion: Our study analyzes the body of linked knowledge around clinical trials (which we refer to as the "trialome"). Our results show that most trials do not report results and, for those that do, there is minimal overlap in the types of reporting. We identify several mechanisms by which the linkages between trials and their published results can be increased. Conclusion: Our study shows that even when combining publications and registry results, and despite availability of several information channels, trial sponsors do not sufficiently meet the mandate to inform the public either via a linked result publication or basic results submission.	[Huser, Vojtech; Cimino, James J.] NIH, Ctr Clin, Lab Informat Dev, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Huser, V (corresponding author), NIH, Ctr Clin, Lab Informat Dev, Bethesda, MD 20892 USA.	vojtech.huser@nih.gov		Cimino, James/0000-0003-4101-1622	Intramural Research Program of the National Institutes of Health Clinical Center; National Library of Medicine; CLINICAL CENTER [ZIACL000907, ZIACL000904] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health Clinical Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); CLINICAL CENTER	This research was supported by the Intramural Research Program of the National Institutes of Health Clinical Center and the National Library of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Huic M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025258; Huser V, 2012, AMIA ANN S P; HUSER V, 2012, AMIA ANN S P, P400; HUSER V, 2013, J AM MED INFORM ASSN, P96544; Huser V, 2013, J AM MED INFORM ASSN, V20, pE169, DOI 10.1136/amiajnl-2012-001501; Kirillova O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037847; Kishore R, 2010, DRUG INF J, V44, P469, DOI 10.1177/009286151004400411; Kunath F, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000430; Liu XM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012676; Marusic A, 2008, CROAT MED J, V49, P582, DOI 10.3325/cmj.2008.5.582; *NAT LIBR MED, 2010, MILESTONES; *NIH, GRANTS POL STAT ADM; Prayle AP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7373; Ross JS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000144; ROSS JS, 2012, BMJ-BRIT MED J, V344, DOI DOI 10.1136/BMJ.D7292; Shamliyan T, 2012, PEDIATRICS, V129, pE1291, DOI 10.1542/peds.2010-2847; SIMES RJ, 1986, J CLIN ONCOL, V4, P1529, DOI 10.1200/JCO.1986.4.10.1529; Tse T, 2009, CHEST, V136, P295, DOI 10.1378/chest.08-3022; Vawdrey DK, 2013, J BIOMED INFORM, V46, P139, DOI 10.1016/j.jbi.2012.08.007; Vedula SS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001378; Viergever RF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014701; Zarin DA, 2011, NEW ENGL J MED, V364, P852, DOI 10.1056/NEJMsa1012065; NLM TECHNICAL B, V374, pEB16	23	49	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68409	10.1371/journal.pone.0068409	http://dx.doi.org/10.1371/journal.pone.0068409			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874614	Green Published, Green Submitted, gold			2022-12-27	WOS:000321736900085
J	Jordan, S; Watkins, A; Storey, M; Allen, SJ; Brooks, CJ; Garaiova, I; Heaven, ML; Jones, R; Plummer, SF; Russell, IT; Thornton, CA; Morgan, G				Jordan, Sue; Watkins, Alan; Storey, Mel; Allen, Steven J.; Brooks, Caroline J.; Garaiova, Iveta; Heaven, Martin L.; Jones, Ruth; Plummer, Sue F.; Russell, Ian T.; Thornton, Catherine A.; Morgan, Gareth			Volunteer Bias in Recruitment, Retention, and Blood Sample Donation in a Randomised Controlled Trial Involving Mothers and Their Children at Six Months and Two Years: A Longitudinal Analysis	PLOS ONE			English	Article							CLINICAL-TRIALS; EXTERNAL VALIDITY; PREVENTION TRIALS; ECZEMA PREVALENCE; COHORT PROFILE; HEALTH-CARE; UK; PARTICIPATION; NONRESPONSE; POPULATIONS	Background: The vulnerability of clinical trials to volunteer bias is under-reported. Volunteer bias is systematic error due to differences between those who choose to participate in studies and those who do not. Methods and Results: This paper extends the applications of the concept of volunteer bias by using data from a trial of probiotic supplementation for childhood atopy in healthy dyads to explore 1) differences between a) trial participants and aggregated data from publicly available databases b) participants and non-participants as the trial progressed 2) impact on trial findings of weighting data according to deprivation (Townsend) fifths in the sample and target populations. 1) a) Recruits (n = 454) were less deprived than the target population, matched for area of residence and delivery dates (n = 6,893) (mean [SD] deprivation scores 0.09[4.21] and 0.79[4.08], t = 3.44, df = 511, p<0.001). b) i)As the trial progressed, representation of the most deprived decreased. These participants and smokers were less likely to be retained at 6 months (n = 430[95%]) (OR 0.29,0.13-0.67 and 0.20,0.09-0.46), and 2 years (n = 380[84%]) (aOR 0.68,0.50-0.93 and 0.55,0.28-1.09), and consent to infant blood sample donation (n = 220[48%]) (aOR 0.72,0.57-0.92 and 0.43,0.22-0.83). ii)Mothers interested in probiotics or research or reporting infants' adverse events or rashes were more likely to attend research clinics and consent to skin-prick testing. Mothers participating to help children were more likely to consent to infant blood sample donation. 2) In one trial outcome, atopic eczema, the intervention had a positive effect only in the over-represented, least deprived group. Here, data weighting attenuated risk reduction from 6.9%(0.9-13.1%) to 4.6%(-1.4-+10.5%), and OR from 0.40(0.18-0.91) to 0.56(0.26-1.21). Other findings were unchanged. Conclusions: Potential for volunteer bias intensified during the trial, due to non-participation of the most deprived and smokers. However, these were not the only predictors of non-participation. Data weighting quantified volunteer bias and modified one important trial outcome.	[Jordan, Sue] Swansea Univ, Coll Human & Hlth Sci, Dept Nursing, Swansea, W Glam, Wales; [Watkins, Alan; Storey, Mel; Allen, Steven J.; Brooks, Caroline J.; Heaven, Martin L.; Jones, Ruth; Russell, Ian T.; Thornton, Catherine A.; Morgan, Gareth] Swansea Univ, Coll Med, Swansea, W Glam, Wales; [Garaiova, Iveta; Plummer, Sue F.] Obsidian Res Ltd, Port Talbot, W Glam, Wales	Swansea University; Swansea University	Jordan, S (corresponding author), Swansea Univ, Coll Human & Hlth Sci, Dept Nursing, Singleton Pk, Swansea, W Glam, Wales.	s.e.jordan@swansea.ac.uk	jordan, sue/O-1297-2019; Jones, Ruth/R-5773-2016	jordan, sue/0000-0002-5691-2987; Jones, Ruth/0000-0001-5811-8827; Allen, Stephen/0000-0001-6675-249X; Brooks, Caroline/0000-0002-4612-5867; Watkins, Alan/0000-0003-3804-1943	Knowledge Exploitation Fund, Collaborative Industrial Research [HE09 COL 1002]; Welsh Development Agency, United Kingdom (UK); Cultech Limited, Unit 3, Christchurch Rd, Baglan Industrial Park, Port Talbot, UK; Cultech Ltd. UK	Knowledge Exploitation Fund, Collaborative Industrial Research; Welsh Development Agency, United Kingdom (UK); Cultech Limited, Unit 3, Christchurch Rd, Baglan Industrial Park, Port Talbot, UK; Cultech Ltd. UK	The project was supported by the Knowledge Exploitation Fund, Collaborative Industrial Research (project number HE09 COL 1002), Welsh Development Agency, United Kingdom (UK) and Cultech Limited, Unit 3, Christchurch Rd, Baglan Industrial Park, Port Talbot, SA12 7BZ, UK. Cultech Ltd. UK part funded the trial and provided the probiotic and matching placebo, and generated the random allocation sequence. Sue Plummer is a Director of Cultech and advised on study design and contributed to the final report. The sponsors were not involved in data collection, analysis or interpretation of the findings. The Knowledge Exploitation Fund had no involvement in the conduct of the trial. The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript. Dr. Sue Plummer proposed the product to be researched and commented on the study design. Dr. Sue Plummer and Dr. Iveta Garaiova commented on the manuscript prepared by Sue Jordan to ensure clarity. No changes to the findings were either suggested or made.	Akl EA, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2809; Allen SJ, 2012, ARCH DIS CHILD, V97, p[S1, A2, P05], DOI [10.1136/archdischild-2012-301885.5, DOI 10.1136/ARCHDISCHILD-2012-301885.5]; Allen SJ, 2010, J NUTR, V140, P483, DOI 10.3945/jn.109.117093; [Anonymous], 1990, PUBMED MESH DATABASE; Bartlett C, 2005, HEALTH TECHNOL ASSES, V9, P1; Bolling K, 2007, INFANT FEEDING SURVE; Britton A, 1999, J Health Serv Res Policy, V4, P112; Caldwell PHY, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000368; Campbell M K, 2007, Health Technol Assess, V11, pix; Chantler TEA, 2007, QUAL HEALTH RES, V17, P311, DOI 10.1177/1049732306298561; Chou R, 2010, J CLIN EPIDEMIOL, V63, P502, DOI 10.1016/j.jclinepi.2008.06.007; Cole SR, 2010, AM J EPIDEMIOL, V172, P107, DOI 10.1093/aje/kwq084; Daniels LA, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-129; Dekkers OM, 2010, INT J EPIDEMIOL, V39, P89, DOI 10.1093/ije/dyp174; Department of Health, 2005, RES GOV FRAM HLTH SO; Dex S, 2004, MILLENNIUM COHORT ST; Dhruva SS, 2008, ARCH INTERN MED, V168, P136, DOI 10.1001/archinternmed.2007.56; Dillman D. A., 2014, INTERNET PHONE MAIL; DiMartino LD, 2009, MED CARE, V47, P916, DOI 10.1097/MLR.0b013e318197b104; Dolman R, 2008, WELSH HLTH SURVEY 20; Duke NN, 2009, J ADOLESCENT HEALTH, V44, P161, DOI 10.1016/j.jadohealth.2008.07.007; Eisner J, 2009, CLIN DISCOVERY, V4, P19; Elliott J, 2006, INT J EPIDEMIOL, V35, P836, DOI 10.1093/ije/dyl174; ELWOOD PC, 1981, ARCH DIS CHILD, V56, P831, DOI 10.1136/adc.56.11.831; European Commission, 2008, OBJ 1 SUPP DEV LESS; Fewtrell MS, 2008, ARCH DIS CHILD, V93, P458, DOI 10.1136/adc.2007.127316; Fisher HR, 2011, J MED ETHICS, V37, P544, DOI 10.1136/jme.2010.040220; Fitzgibbon ML, 1998, PREV MED, V27, P838, DOI 10.1006/pmed.1998.0367; Ford DV, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-157; Fouad MN, 2004, CONTROL CLIN TRIALS, V25, P335, DOI 10.1016/j.cct.2004.03.005; Francis D, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-37; Frangakis C, 2009, CLIN TRIALS, V6, P136, DOI 10.1177/1740774509103868; Godin G, 2005, VOX SANG, V89, P140, DOI 10.1111/j.1423-0410.2005.00674.x; Groves RM, 2000, PUBLIC OPIN QUART, V64, P299, DOI 10.1086/317990; Groves RM, 2006, PUBLIC OPIN QUART, V70, P646, DOI 10.1093/poq/nfl033; Hansen K., 2008, MILLENNIUM COHORT ST; HARTH SC, 1990, BRIT MED J, V300, P1372, DOI 10.1136/bmj.300.6736.1372; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hoehn KS, 2005, ARCH DIS CHILD-FETAL, V90, P267, DOI 10.1136/adc.2004.065078; ICH, 1996, ICH HARM TRIP GUID G; Institute of Medicine (US), 2012, PUBL ENG CLIN TRIALS; Jordan S, 2011, WELSH PAEDIAT J, V35, P36; Jordan S, 2008, J NURS MANAGE, V16, P385, DOI 10.1111/j.1365-2834.2008.00881.x; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Kalliomaki M, 2001, LANCET, V357, P1076, DOI 10.1016/S0140-6736(00)04259-8; Kaur B, 1998, BRIT MED J, V316, P118; Keeter S, 2000, PUBLIC OPIN QUART, V64, P125, DOI 10.1086/317759; Kenyon S, 2006, QUAL SAF HEALTH CARE, V15, P98, DOI 10.1136/qshc.2005.015636; Kho Michelle E, 2009, BMJ, V338, pb866, DOI 10.1136/bmj.b866; Kotaniemi JT, 2001, EUR J EPIDEMIOL, V17, P809, DOI 10.1023/A:1015615130459; Krosnick JA, 1999, ANNU REV PSYCHOL, V50, P537, DOI 10.1146/annurev.psych.50.1.537; Lagakos SW, 2006, NEW ENGL J MED, V354, P1667, DOI 10.1056/NEJMp068070; Lyons RA, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-3; MAJEED FA, 1995, BRIT MED J, V310, P1511, DOI 10.1136/bmj.310.6993.1511; Mapstone J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000013.pub3; Martinson BC, 2010, J PHYS ACT HEALTH, V7, P127, DOI 10.1123/jpah.7.1.127; McColl E, 2001, Health Technol Assess, V5, P1; McDonald AM, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-9; McMahon R, 2008, TRANSFUSION, V48, P321, DOI 10.1111/j.1537-2995.2007.01526.x; McNally NJ, 2000, BRIT J DERMATOL, V142, P712, DOI 10.1046/j.1365-2133.2000.03416.x; Medical Research Council, 2004, CLIN RES LEAFL; Mihrshahi S, 2002, RESPIROLOGY, V7, P147, DOI 10.1046/j.1440-1843.2002.00384.x; NPSA (National Patient Safety Agency), 2007, INF SHEETS CONS FORM; Nystuen P, 2004, J CLIN EPIDEMIOL, V57, P773, DOI 10.1016/j.jclinepi.2003.12.015; O'Neill RT, 2012, CLIN PHARMACOL THER, V91, P550, DOI 10.1038/clpt.2011.340; Office for National Statistics (ONS), 2005, STAND OCC CLASS SOC; Office for National Statistics (ONS), 2005, NAT STAT SOC CLASS U; Office for National Statistics (ONS), 2003, CENS 2001 KEY STAT A; Olson L, 2002, MONASH BIOETHICS REV, V21, P55; Park ER, 2007, PREV MED, V44, P223, DOI 10.1016/j.ypmed.2006.10.008; Perkin MR, 2006, PEDIAT ALLERG IMM-UK, V17, P118, DOI 10.1111/j.1399-3038.2005.00364.x; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Prescott RJ, 1999, HEALTH TECHNOL ASSES, V3, P1, DOI DOI 10.3310/hta3200; Prinz RJ, 2001, AM J PREV MED, V20, P31, DOI 10.1016/S0749-3797(00)00271-3; Propper C, 2007, HEALTH ECON, V16, P1245, DOI 10.1002/hec.1221; REMINGTON RD, 1978, J EPIDEMIOL COMMUN H, V32, P250, DOI 10.1136/jech.32.4.250; Robinson EJ, 2005, HEALTH TECHNOL ASSES, V9, pIII; Rothmier JD, 2003, PEDIATRICS, V111, P1037, DOI 10.1542/peds.111.5.1037; Royston P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b604; SACKETT DL, 1979, J CHRON DIS, V32, P51, DOI 10.1016/0021-9681(79)90012-2; Schmoor C, 2011, BIOMETRICAL J, V53, P369, DOI 10.1002/bimj.201000154; Schoetzau A, 2002, ARCH DIS CHILD, V86, P180, DOI 10.1136/adc.86.3.180; Schram ME, 2010, BRIT J DERMATOL, V162, P964, DOI 10.1111/j.1365-2133.2010.09689.x; Seaman SR, 2012, BIOMETRICS, V68, P129, DOI 10.1111/j.1541-0420.2011.01666.x; Shaw TE, 2011, J INVEST DERMATOL, V131, P67, DOI 10.1038/jid.2010.251; Shilling V, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15150; Shilling V, 2009, BMC MED ETHICS, V10, DOI 10.1186/1472-6939-10-1; Snowdon C, 2006, SOC SCI MED, V62, P2279, DOI 10.1016/j.socscimed.2005.10.008; Southern DA, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-57; Sun X, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1553; Toerien M, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-52; Tooher Rebecca L, 2008, BMC Pregnancy Childbirth, V8, P36, DOI 10.1186/1471-2393-8-36; Townsend PP., 1988, HLTH DEPRIVATION INE; University of Bristol, 2008, ALSPAC AV LONG STUD; UyBico SJ, 2007, J GEN INTERN MED, V22, P852, DOI 10.1007/s11606-007-0126-3; Violato M, 2009, SOC SCI MED, V69, P955, DOI 10.1016/j.socscimed.2009.06.036; Vuchinich S, 2012, PREV SCI, V13, P300, DOI 10.1007/s11121-011-0265-y; Wade J, 2009, SOC SCI MED, V68, P2018, DOI 10.1016/j.socscimed.2009.02.023; Wahlbeck K, 2001, PSYCHOPHARMACOLOGY, V155, P230, DOI 10.1007/s002130100711; Watson Judith M, 2006, BMC Med Res Methodol, V6, P34, DOI 10.1186/1471-2288-6-34; White IR, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d40; Zarin DA, 2005, SOC PSYCH PSYCH EPID, V40, P27, DOI 10.1007/s00127-005-0838-9	102	51	50	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e67912	10.1371/journal.pone.0067912	http://dx.doi.org/10.1371/journal.pone.0067912			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	182JD	23874465	Green Published, gold, Green Submitted			2022-12-27	WOS:000321736900035
J	Li, Q; Dong, Z; Lin, Y; Jia, XY; Li, Q; Jiang, H; Wang, LW; Gao, Y				Li, Qi; Dong, Zhao; Lin, Yun; Jia, Xinyan; Li, Qun; Jiang, Hong; Wang, Liwei; Gao, Yong			The rs2233678 Polymorphism in PIN1 Promoter Region Reduced Cancer Risk: A Meta-Analysis	PLOS ONE			English	Article							PROLYL ISOMERASE PIN1; SQUAMOUS-CELL CARCINOMA; BREAST-CANCER; DECREASED RISK; GENE; -842G-GREATER-THAN-C; ISOMERIZATION	Background: Published evidence suggests that the rs2233678 (-842 G>C) polymorphism in the PIN1 (peptidyl-prolyl cis/trans somerase NIMA-interacting 1) promoter region may be associated with cancer risk; however, the conclusion is still inconclusive. Methods: We conducted a meta-analysis to determine whether -842 G>C polymorphism was associated with cancer risk. Odds ratio (OR) and 95% confidence intervals (95% Cl) were used to assess the strength of association. Genotype distribution data and adjusted ORs were collected to calculate the pooled ORs. Meta-regression was conducted to detect the source of heterogeneity. Publication bias was evaluated by Egger's test and Begg's test. Results: A total of 11 eligible studies, including 9280 participants, were identified and analyzed. Overall, we found that carriers of the -842 C allele were associated with significantly decreased cancer risk (C vs. G, OR = 0.750, 95% Cl: 0.639-0.880, P-heterogeneity = 0.014, estimated by genotype distribution data; CC+GC vs. GG, OR = 0.668, 95% Cl: 0.594-0.751, P-heterogeneity = 0.638, estimated by adjusted ORs). No evidence of publication bias was observed. Meta-regression revealed that ethnicities (p = 0.021) and sample size (p = 0.02) but not sources of control (p = 0.069) were the source of heterogeneity. Conclusion: These results suggest that the PIN1 rs2233678 (-842 G>C) polymorphism significantly reduces cancer risk.	[Li, Qi; Wang, Liwei] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Oncol, Shanghai 200030, Peoples R China; [Dong, Zhao] 85 Hosp Peoples Liberat Army, Dept Radiotherapy, Shanghai, Peoples R China; [Lin, Yun; Jia, Xinyan; Li, Qun; Jiang, Hong; Gao, Yong] Tongji Univ, Shanghai East Hosp, Dept Oncol, Shanghai 200092, Peoples R China	Shanghai Jiao Tong University; Tongji University	Li, Q (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Oncol, Shanghai 200030, Peoples R China.	liqisjt@126.com			Natural Science Foundation of China [81071664, 81272714]; Pudong New Area Health Bureau Fund [PWRd2010-07]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Pudong New Area Health Bureau Fund	This work is supported by Natural Science Foundation of China (81071664 and 81272714) and Pudong New Area Health Bureau Fund (PWRd2010-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayala G, 2003, CANCER RES, V63, P6244; [曹文平 Cao Wenping], 2012, [江苏医药, Jiangsu Medical Journal], V38, P1067; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Galat A, 2003, CURR TOP MED CHEM, V3, P1315, DOI 10.2174/1568026033451862; Han CH, 2010, BREAST CANCER RES TR, V122, P243, DOI 10.1007/s10549-009-0682-9; Lam PB, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-91; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Liu WF, 2001, FEBS LETT, V496, P105, DOI 10.1016/S0014-5793(01)02411-5; Lu JC, 2011, HUM MUTAT, V32, P1299, DOI 10.1002/humu.21574; Lu JC, 2009, CARCINOGENESIS, V30, P1717, DOI 10.1093/carcin/bgp171; Lu KP, 2003, CANCER CELL, V4, P175, DOI 10.1016/S1535-6108(03)00218-6; Lu KP, 2004, TRENDS BIOCHEM SCI, V29, P200, DOI 10.1016/j.tibs.2004.02.002; Lu KP, 1996, NATURE, V380, P544; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu KP, 2006, MOL CARCINOGEN, V45, P397, DOI 10.1002/mc.20216; Lu Y, 2013, MOL BIOL REP, V40, P3777, DOI 10.1007/s11033-012-2454-6; Messenger MM, 2002, J BIOL CHEM, V277, P23054, DOI 10.1074/jbc.M200111200; Miyashita H, 2003, ONCOL REP, V10, P455; Naidu R, 2011, SCAND J CLIN LAB INV, V71, P500, DOI 10.3109/00365513.2011.590223; Pathan N, 2001, NEOPLASIA, V3, P550, DOI 10.1038/sj.neo.7900213; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Segat L, 2007, NEUROBIOL AGING, V28, P69, DOI 10.1016/j.neurobiolaging.2005.11.009; Segat L, 2007, GASTROENTEROLOGY, V132, P2618, DOI 10.1053/j.gastro.2007.04.037; Shen MH, 1998, GENE DEV, V12, P706, DOI 10.1101/gad.12.5.706; WHITEHEAD A, 1991, STAT MED, V10, P1665, DOI 10.1002/sim.4780101105; Wulf G, 2005, NAT CELL BIOL, V7, P435, DOI 10.1038/ncb0505-435; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; You YH, 2013, MOL BIOL REP, V40, P829, DOI 10.1007/s11033-012-2122-x	31	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68148	10.1371/journal.pone.0068148	http://dx.doi.org/10.1371/journal.pone.0068148			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874525	Green Published, gold, Green Submitted			2022-12-27	WOS:000321736900061
J	Pearson, FE; McNeilly, CL; Crichton, ML; Primiero, CA; Yukiko, SR; Fernando, GJP; Chen, XF; Gilbert, SC; Hill, AVS; Kendall, MAF				Pearson, Frances E.; McNeilly, Celia L.; Crichton, Michael L.; Primiero, Clare A.; Yukiko, Sally R.; Fernando, Germain J. P.; Chen, Xianfeng; Gilbert, Sarah C.; Hill, Adrian V. S.; Kendall, Mark A. F.			Dry-Coated Live Viral Vector Vaccines Delivered by Nanopatch Microprojections Retain Long-Term Thermostability and Induce Transgene-Specific T Cell Responses in Mice	PLOS ONE			English	Article							PRIME-BOOST IMMUNIZATION; PROTECTIVE EFFICACY; LANGERHANS CELLS; ARRAY PATCHES; MALARIA; IMMUNOGENICITY; VIRUS; POTENT; STABILIZATION; PENETRATION	The disadvantages of needle-based immunisation motivate the development of simple, low cost, needle-free alternatives. Vaccine delivery to cutaneous environments rich in specialised antigen-presenting cells using microprojection patches has practical and immunological advantages over conventional needle delivery. Additionally, stable coating of vaccine onto microprojections removes logistical obstacles presented by the strict requirement for cold-chain storage and distribution of liquid vaccine, or lyophilised vaccine plus diluent. These attributes make these technologies particularly suitable for delivery of vaccines against diseases such as malaria, which exerts its worst effects in countries with poorly-resourced healthcare systems. Live viral vectors including adenoviruses and poxviruses encoding exogenous antigens have shown significant clinical promise as vaccines, due to their ability to generate high numbers of antigen-specific T cells. Here, the simian adenovirus serotype 63 and the poxvirus modified vaccinia Ankara - two vectors under evaluation for the delivery of malaria antigens to humans - were formulated for coating onto Nanopatch microprojections and applied to murine skin. Co-formulation with the stabilising disaccharides trehalose and sucrose protected virions during the dry-coating process. Transgene-specific CD8(+) T cell responses following Nanopatch delivery of both vectors were similar to intradermal injection controls after a single immunisation (despite a much lower delivered dose), though MVA boosting of pre-primed responses with Nanopatch was found to be less effective than the ID route. Importantly, disaccharide-stabilised ChAd63 could be stored for 10 weeks at 37 degrees C with less than 1 log(10) loss of viability, and retained single-dose immunogenicity after storage. These data support the further development of microprojection patches for the deployment of live vaccines in hot climates.	[Pearson, Frances E.; McNeilly, Celia L.; Crichton, Michael L.; Primiero, Clare A.; Yukiko, Sally R.; Fernando, Germain J. P.; Chen, Xianfeng; Kendall, Mark A. F.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Delivery Drugs & Genes Grp D2G2, Brisbane, Qld, Australia; [Pearson, Frances E.; Gilbert, Sarah C.; Hill, Adrian V. S.] Univ Oxford, Jenner Inst, Oxford, England; [Kendall, Mark A. F.] Univ Queensland, Diamantina Inst, Brisbane, Qld, Australia; [Crichton, Michael L.; Yukiko, Sally R.; Fernando, Germain J. P.; Kendall, Mark A. F.] Vaxxas Pty Ltd, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia	University of Queensland; University of Oxford; Jenner Institute; University of Queensland; University of Queensland	Kendall, MAF (corresponding author), Univ Queensland, Australian Inst Bioengn & Nanotechnol, Delivery Drugs & Genes Grp D2G2, Brisbane, Qld, Australia.	m.kendall@uq.edu.au	Fernando, Germain JP/C-3733-2009; Gilbert, Sarah C./H-2857-2019; Primiero, Clare A/N-6734-2013; Kendall, Mark/M-4122-2017; Chen, Xianfeng/O-3359-2019; Crichton, Michael/B-5970-2014; Pearson, Frances E/K-8928-2018; Chen, Xianfeng/D-1709-2010	Fernando, Germain JP/0000-0003-3260-0548; Gilbert, Sarah C./0000-0002-6823-9750; Primiero, Clare A/0000-0002-2944-0013; Chen, Xianfeng/0000-0002-3189-2756; Crichton, Michael/0000-0002-3683-802X; Chen, Xianfeng/0000-0002-3189-2756; Pearson, Frances/0000-0001-7274-9211	UK Medical Research Council Capacity Building Studentship [G0600311]; Bill and Melinda Gates Foundation [003436]	UK Medical Research Council Capacity Building Studentship; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work has been supported by a UK Medical Research Council Capacity Building Studentship (G0600311, www.mrc.ac.uk) and by the Bill and Melinda Gates Foundation (003436, www.gatesfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; AIDOO M, 1995, LANCET, V345, P1003, DOI 10.1016/S0140-6736(95)90754-8; Alcock R, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000490; Bachy V, 2013, P NATL ACAD SCI USA, V110, P3041, DOI 10.1073/pnas.1214449110; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Berk A, 2006, ADENOVIRIDAE; Bos JD, 2000, EXP DERMATOL, V9, P165, DOI 10.1034/j.1600-0625.2000.009003165.x; Brookes RH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002921; Capone S, 2010, VACCINE, V29, P256, DOI 10.1016/j.vaccine.2010.10.041; Carey JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022442; Chang LQ, 2005, J PHARM SCI-US, V94, P1427, DOI 10.1002/jps.20364; Chen DX, 2009, EXPERT REV VACCINES, V8, P547, DOI [10.1586/erv.09.20, 10.1586/ERV.09.20]; Chen XF, 2011, ADV FUNCT MATER, V21, P464, DOI 10.1002/adfm.201000966; Chen X, 2011, J CONTROL RELEASE, V152, P349, DOI 10.1016/j.jconrel.2011.02.026; Chen XF, 2009, J CONTROL RELEASE, V139, P212, DOI 10.1016/j.jconrel.2009.06.029; Choi HJ, 2013, J CONTROL RELEASE, V166, P159, DOI 10.1016/j.jconrel.2012.12.002; Corbett HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013460; Crichton ML, 2010, BIOMATERIALS, V31, P4562, DOI 10.1016/j.biomaterials.2010.02.022; Draper SJ, 2010, NAT REV MICROBIOL, V8, P62, DOI 10.1038/nrmicro2240; Dudareva M, 2009, VACCINE, V27, P3501, DOI 10.1016/j.vaccine.2009.03.080; Edens C, 2013, VACCINE, V31, P3403, DOI 10.1016/j.vaccine.2012.09.062; Fernando GJP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010266; Gilbert SC, 2002, VACCINE, V20, P1039, DOI 10.1016/S0264-410X(01)00450-9; Gilbert SC, 1997, NAT BIOTECHNOL, V15, P1280, DOI 10.1038/nbt1197-1280; Hill AVS, 2010, HUM VACCINES, V6, P78, DOI 10.4161/hv.6.1.10116; Hiraishi Y, 2011, VACCINE, V29, P2626, DOI 10.1016/j.vaccine.2011.01.042; Jenkins D, 2012, RSC ADV, V2, P3490, DOI 10.1039/c2ra20153d; Kask AS, 2010, VACCINE, V28, P7483, DOI 10.1016/j.vaccine.2010.09.014; Kim YC, 2010, AAPS PHARMSCITECH, V11, P1193, DOI 10.1208/s12249-010-9471-3; Kim YC, 2011, PHARM RES-DORDR, V28, P135, DOI 10.1007/s11095-010-0134-6; Kim YC, 2010, J CONTROL RELEASE, V142, P187, DOI 10.1016/j.jconrel.2009.10.013; Lloyd J., 2000, TECHNOLOGIES VACCINE; Moore AC, 2004, IMMUNOL REV, V199, P126, DOI 10.1111/j.0105-2896.2004.00138.x; Mulholland WJ, 2006, J INVEST DERMATOL, V126, P1541, DOI 10.1038/sj.jid.5700290; Ng HI, 2012, J CONTROL RELEASE, V162, P477, DOI 10.1016/j.jconrel.2012.07.024; O'Hara GA, 2012, J INFECT DIS, V205, P772, DOI 10.1093/infdis/jir850; Prow TW, 2010, SMALL, V6, P1776, DOI 10.1002/smll.201000331; Quan FS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007152; Reyes-Sandoval A, 2008, EUR J IMMUNOL, V38, P732, DOI 10.1002/eji.200737672; Reyes-Sandoval A, 2010, INFECT IMMUN, V78, P145, DOI 10.1128/IAI.00740-09; Reyes-Sandoval A, 2009, CURR OPIN MOL THER, V11, P72; Rheinbaben F v., 2007, POXVIRUSES, P397, DOI [10.1007/978-3-7643-7557-7_19, DOI 10.1007/978-3-7643-7557-7_19]; Ruutu MP, 2011, EXP DERMATOL, V20, P534, DOI 10.1111/j.1600-0625.2010.01234.x; Schneider J, 1998, NAT MED, V4, P397, DOI 10.1038/nm0498-397; Simonsen L, 1999, B WORLD HEALTH ORGAN, V77, P789; Stoitzner P, 2006, P NATL ACAD SCI USA, V103, P7783, DOI 10.1073/pnas.0509307103; Tatsis N, 2004, MOL THER, V10, P616, DOI 10.1016/j.ymthe.2004.07.013; Vrdoljak A, 2012, J CONTROL RELEASE, V159, P34, DOI 10.1016/j.jconrel.2011.12.026; Webster DP, 2006, VACCINE, V24, P3026, DOI 10.1016/j.vaccine.2005.10.058; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2006, TEMP SENS VACC	51	56	56	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e67888	10.1371/journal.pone.0067888	http://dx.doi.org/10.1371/journal.pone.0067888			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874462	Green Published, gold, Green Submitted			2022-12-27	WOS:000321736900032
J	Thomas, CJ; Cross, DE; Bogh, C				Thomas, Christopher J.; Cross, Donall E.; Bogh, Claus			Landscape Movements of Anopheles gambiae Malaria Vector Mosquitoes in Rural Gambia	PLOS ONE			English	Article							SPATIAL-DISTRIBUTION; CULICIDAE DISPERSAL; BREEDING SITES; AEDES-AEGYPTI; WEST-AFRICA; DIPTERA; TRANSMISSION; FUNESTUS; SURVIVAL; LONG	Background: For malaria control in Africa it is crucial to characterise the dispersal of its most efficient vector, Anopheles gambiae, in order to target interventions and assess their impact spatially. Our study is, we believe, the first to present a statistical model of dispersal probability against distance from breeding habitat to human settlements for this important disease vector. Methods/Principal Findings: We undertook post-hoc analyses of mosquito catches made in The Gambia to derive statistical dispersal functions for An. gambiae sensu lato collected in 48 villages at varying distances to alluvial larval habitat along the River Gambia. The proportion dispersing declined exponentially with distance, and we estimated that 90% of movements were within 1.7 km. Although a 'heavy-tailed' distribution is considered biologically more plausible due to active dispersal by mosquitoes seeking blood meals, there was no statistical basis for choosing it over a negative exponential distribution. Using a simple random walk model with daily survival and movements previously recorded in Burkina Faso, we were able to reproduce the dispersal probabilities observed in The Gambia. Conclusions/Significance: Our results provide an important quantification of the probability of An. gambiae s.l. dispersal in a rural African setting typical of many parts of the continent. However, dispersal will be landscape specific and in order to generalise to other spatial configurations of habitat and hosts it will be necessary to produce tractable models of mosquito movements for operational use. We show that simple random walk models have potential. Consequently, there is a pressing need for new empirical studies of An. gambiae survival and movements in different settings to drive this development.	[Thomas, Christopher J.; Cross, Donall E.] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales; [Bogh, Claus] Sumba Fdn, Kuta Poleng, Bali, Indonesia	Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS)	Thomas, CJ (corresponding author), Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales.	cjt@aber.ac.uk		Cross, Donall Eoin/0000-0002-4974-951X; Thomas, Christopher J./0000-0003-4939-9959	Natural Environment Research Council [NE/H022740/1]; NERC [NE/H022740/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by Natural Environment Research Council grant NE/H022740/1 (http://www.nerc.ac.uk) and the original study by DANIDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1993, MOSQUITO ECOLOGY FIE; [Anonymous], 1968, ANOPHELINAE AFR S SA; Baber I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010270; Balls MJ, 2004, T ROY SOC TROP MED H, V98, P400, DOI 10.1016/j.trstmh.2003.11.005; Bartumeus F, 2005, ECOLOGY, V86, P3078, DOI 10.1890/04-1806; Bogh C, 2003, B ENTOMOL RES, V93, P279, DOI 10.1079/BER2003239; Bogh C, 2007, AM J TROP MED HYG, V76, P875; Bomblies A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-223; BRYAN JH, 1991, J AUST ENTOMOL SOC, V30, P119; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Carter R, 2000, B WORLD HEALTH ORGAN, V78, P1401; Charlwood JD, 1998, AFR ENTOMOL, V6, P1; Conrad KF, 1999, ECOGRAPHY, V22, P524, DOI 10.1111/j.1600-0587.1999.tb00541.x; Costantini C, 1996, MED VET ENTOMOL, V10, P203, DOI 10.1111/j.1365-2915.1996.tb00733.x; Cummins B, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002500; De Silva PM, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/819563; Directorate of Overseas Surveys UK, 1975, MAP GAMB; Estep LK, 2010, J MED ENTOMOL, V47, P977, DOI 10.1603/ME10056; Ferguson HM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000303; Fillinger U, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-353; Fillinger U, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-62; GARRETTJONES C, 1950, NATURE, V165, P285, DOI 10.1038/165285a0; GILLIES M. T., 1961, BULL ENT RES, V52, P99, DOI 10.1017/S0007485300055309; GILLIES MT, 1978, B ENTOMOL RES, V68, P401, DOI 10.1017/S000748530000938X; GILLIES MT, 1972, B ENTOMOL RES, V61, P389, DOI 10.1017/S0007485300047295; Gillies MT, 1988, MALARIA PRINCIPLES P; Gu WD, 2006, P NATL ACAD SCI USA, V103, P17560, DOI 10.1073/pnas.0608452103; Hamer GL, 2012, J MED ENTOMOL, V49, P61, DOI 10.1603/ME11076; Honorio NA, 2009, CAD SAUDE PUBLICA, V25, P1203, DOI 10.1590/S0102-311X2009000600003; Kay BH, 2000, J MED ENTOMOL, V37, P797, DOI 10.1603/0022-2585-37.6.797; Killeen GF, 2003, LANCET INFECT DIS, V3, P297, DOI 10.1016/S1473-3099(03)00611-X; Kweka EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052084; Lacroix R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042771; LINDSAY SW, 1995, MED VET ENTOMOL, V9, P50, DOI 10.1111/j.1365-2915.1995.tb00116.x; LINDSAY SW, 1993, T ROY SOC TROP MED H, V87, P19, DOI 10.1016/0035-9203(93)90171-L; Lutambi AM, 2013, MATH BIOSCI, V241, P198, DOI 10.1016/j.mbs.2012.11.013; Machault V, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-138; Majambere S, 2008, AM J TROP MED HYG, V79, P19, DOI 10.4269/ajtmh.2008.79.19; Marks M, 1992, AERIAL PHOTOINTERPRE; Meats A, 2007, J APPL ENTOMOL, V131, P518, DOI 10.1111/j.1439-0418.2007.01168.x; Midega JT, 2007, J MED ENTOMOL, V44, P923, DOI 10.1603/0022-2585(2007)44[923:EDASOA]2.0.CO;2; Midega JT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1672; Paradis E, 2002, ECOL MODEL, V151, P279, DOI 10.1016/S0304-3800(01)00487-2; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Ray N, 2002, BIODIVERS CONSERV, V11, P2143, DOI 10.1023/A:1021390527698; REITER P, 1995, AM J TROP MED HYG, V52, P177, DOI 10.4269/ajtmh.1995.52.177; Russell TL, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-24; Service MW, 1997, J MED ENTOMOL, V34, P579, DOI 10.1093/jmedent/34.6.579; SHAW MW, 1995, P ROY SOC B-BIOL SCI, V259, P243, DOI 10.1098/rspb.1995.0036; Smith MW, 2013, EARTH-SCI REV, V116, P109, DOI 10.1016/j.earscirev.2012.11.004; SMITH T, 1995, ACTA TROP, V59, P1, DOI 10.1016/0001-706X(94)00082-C; Snow WF, 1999, R6434 NRI; Studds CE, 2012, DIVERS DISTRIB, V18, P919, DOI 10.1111/j.1472-4642.2012.00931.x; Tackenberg O, 2003, ECOL MONOGR, V73, P173, DOI 10.1890/0012-9615(2003)073[0173:MLDOPD]2.0.CO;2; Takken W, 1998, B ENTOMOL RES, V88, P561, DOI 10.1017/S0007485300026080; Taylor C, 2001, GENETICS, V157, P743; Thomas CJ, 2000, T ROY SOC TROP MED H, V94, P159, DOI 10.1016/S0035-9203(00)90257-8; THOMSON MC, 1995, MED VET ENTOMOL, V9, P413, DOI 10.1111/j.1365-2915.1995.tb00015.x; TRAPE JF, 1992, AM J TROP MED HYG, V47, P181, DOI 10.4269/ajtmh.1992.47.181; Utzinger J, 2002, NATURE, V419, P431, DOI 10.1038/419431a; Yakob L, 2010, T ROY SOC TROP MED H, V104, P669, DOI 10.1016/j.trstmh.2010.07.014; Zhou GF, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-67	62	40	40	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e68679	10.1371/journal.pone.0068679	http://dx.doi.org/10.1371/journal.pone.0068679			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874719	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000324146200025
J	Honma, Y; Tsukano, H; Horie, M; Ohshima, S; Tohmi, M; Kubota, Y; Takahashi, K; Hishida, R; Takahashi, S; Shibuki, K				Honma, Yuusuke; Tsukano, Hiroaki; Horie, Masao; Ohshima, Shinsuke; Tohmi, Manavu; Kubota, Yamato; Takahashi, Kuniyuki; Hishida, Ryuichi; Takahashi, Sugata; Shibuki, Katsuei			Auditory Cortical Areas Activated by Slow Frequency-Modulated Sounds in Mice	PLOS ONE			English	Article							INFERIOR COLLICULUS; DIRECTION SELECTIVITY; FUNCTIONAL-ORGANIZATION; HEARING-LOSS; CORTEX; MOUSE; RESPONSES; RAT; DISCRIMINATION; PLASTICITY	Species-specific vocalizations in mice have frequency-modulated (FM) components slower than the lower limit of FM direction selectivity in the core region of the mouse auditory cortex. To identify cortical areas selective to slow frequency modulation, we investigated tonal responses in the mouse auditory cortex using transcranial flavoprotein fluorescence imaging. For differentiating responses to frequency modulation from those to stimuli at constant frequencies, we focused on transient fluorescence changes after direction reversal of temporally repeated and superimposed FM sweeps. We found that the ultrasonic field (UF) in the belt cortical region selectively responded to the direction reversal. The dorsoposterior field (DP) also responded weakly to the reversal. Regarding the responses in UF, no apparent tonotopic map was found, and the right UF responses were significantly larger in amplitude than the left UF responses. The half-max latency in responses to FM sweeps was shorter in UF compared with that in the primary auditory cortex (A1) or anterior auditory field (AAF). Tracer injection experiments in the functionally identified UF and DP confirmed that these two areas receive afferent inputs from the dorsal part of the medial geniculate nucleus (MG). Calcium imaging of UF neurons stained with fura-2 were performed using a two-photon microscope, and the presence of UF neurons that were selective to both direction and direction reversal of slow frequency modulation was demonstrated. These results strongly suggest a role for UF, and possibly DP, as cortical areas specialized for processing slow frequency modulation in mice.	[Honma, Yuusuke; Tsukano, Hiroaki; Tohmi, Manavu; Hishida, Ryuichi; Shibuki, Katsuei] Niigata Univ, Brain Res Inst, Dept Neurophysiol, Asahi, Niigata, Japan; [Honma, Yuusuke; Ohshima, Shinsuke; Kubota, Yamato; Takahashi, Kuniyuki; Takahashi, Sugata] Niigata Univ, Fac Med, Dept Otolaryngol, Asahi, Niigata, Japan; [Horie, Masao] Niigata Univ, Fac Med, Dept Anat, Asahi, Niigata, Japan	Niigata University; Niigata University; Niigata University	Shibuki, K (corresponding author), Niigata Univ, Brain Res Inst, Dept Neurophysiol, Asahi, Niigata, Japan.	shibuki@bri.niigata-u.ac.jp	Tsukano, Hiroaki/G-5053-2013	Tsukano, Hiroaki/0000-0001-8511-7256	Core Research for Evolutional Science and Technology program from the Japanese Government;  [22115011];  [22240044]; Grants-in-Aid for Scientific Research [23500383] Funding Source: KAKEN	Core Research for Evolutional Science and Technology program from the Japanese Government; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (Nos. 22115011 and 22240044) and Core Research for Evolutional Science and Technology program from the Japanese Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andoni S, 2007, J NEUROSCI, V27, P4882, DOI 10.1523/JNEUROSCI.4342-06.2007; Atencio CA, 2007, J NEUROPHYSIOL, V98, P2182, DOI 10.1152/jn.00394.2007; Bakin JS, 1996, BEHAV NEUROSCI, V110, P905, DOI 10.1037/0735-7044.110.5.905; Bandyopadhyay S, 2010, NAT NEUROSCI, V13, P361, DOI 10.1038/nn.2490; Bao SW, 2004, NAT NEUROSCI, V7, P974, DOI 10.1038/nn1293; Chabout J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029401; CLOPTON BM, 1974, EXP NEUROL, V42, P532, DOI 10.1016/0014-4886(74)90076-4; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Ehret G, 2002, P NATL ACAD SCI USA, V99, P479, DOI 10.1073/pnas.012361999; Felsheim C, 1996, HEARING RES, V98, P137, DOI 10.1016/0378-5955(96)00078-0; Gaub S, 2010, GENES BRAIN BEHAV, V9, P390, DOI 10.1111/j.1601-183X.2010.00570.x; Guo W, 2012, J NEUROSCI, V32, P9159, DOI 10.1523/JNEUROSCI.0065-12.2012; Hage SR, 2003, EUR J NEUROSCI, V18, P2301, DOI 10.1046/j.1460-9568.2003.02945.x; Hanson JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040782; Hoffmann F, 2012, PHYSIOL BEHAV, V105, P766, DOI 10.1016/j.physbeh.2011.10.011; HOFSTETTER KM, 1992, J COMP NEUROL, V323, P370, DOI 10.1002/cne.903230306; HU B, 1994, J PHYSIOL-LONDON, V479, P217, DOI 10.1113/jphysiol.1994.sp020290; Kubota Y, 2008, NEUROSCI RES, V60, P422, DOI 10.1016/j.neures.2007.12.013; Kuo RI, 2012, NEURON, V73, P1016, DOI 10.1016/j.neuron.2011.11.035; LEDOUX JE, 1987, J COMP NEUROL, V264, P123, DOI 10.1002/cne.902640110; LEDOUX JE, 1985, J COMP NEUROL, V242, P182, DOI 10.1002/cne.902420204; Lee CC, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/neuro.01.014.2010; Lee CC, 2010, P NATL ACAD SCI USA, V107, P372, DOI 10.1073/pnas.0907873107; LI HS, 1991, ACTA OTO-LARYNGOL, V111, P827, DOI 10.3109/00016489109138418; Llano DA, 2009, J NEUROPHYSIOL, V101, P3325, DOI 10.1152/jn.91291.2008; Lui B, 2003, EXP BRAIN RES, V153, P550, DOI 10.1007/s00221-003-1618-y; MIKAELIAN DO, 1974, ACTA OTO-LARYNGOL, V77, P327, DOI 10.3109/00016487409124632; Nishiyama K, 2011, J ACOUST SOC AM, V130, P4148, DOI 10.1121/1.3651815; Ohl FW, 1999, LEARN MEMORY, V6, P347; Ohshima S, 2010, NEUROSCI RES, V67, P51, DOI 10.1016/j.neures.2010.01.005; Pantev C, 1998, NATURE, V392, P811, DOI 10.1038/33918; Paxinos G., 2009, CHEMOARCHITECTONIC A; Paxinos G., 2001, MOUSE BRAIN STEREOTA; RECANZONE GH, 1993, J NEUROSCI, V13, P87; REES A, 1983, HEARING RES, V10, P301, DOI 10.1016/0378-5955(83)90095-3; Ricketts C, 1998, HEARING RES, V123, P27, DOI 10.1016/S0378-5955(98)00086-0; Rothschild G, 2010, NAT NEUROSCI, V13, P353, DOI 10.1038/nn.2484; Rybalko N, 2006, EUR J NEUROSCI, V23, P1614, DOI 10.1111/j.1460-9568.2006.04688.x; SHEPARD RN, 1964, J ACOUST SOC AM, V36, P2346, DOI 10.1121/1.1919362; Shibuki K, 2006, NEUROIMAGE, V30, P735, DOI 10.1016/j.neuroimage.2005.10.004; Shibuki K, 2003, J PHYSIOL-LONDON, V549, P919, DOI 10.1113/jphysiol.2003.040709; SINEX DG, 1981, HEARING RES, V4, P127, DOI 10.1016/0378-5955(81)90001-0; Smith PH, 2012, J COMP NEUROL, V520, P34, DOI 10.1002/cne.22682; Sohya K, 2007, J NEUROSCI, V27, P2145, DOI 10.1523/JNEUROSCI.4641-06.2007; Stiebler I, 1997, J COMP PHYSIOL A, V181, P559, DOI 10.1007/s003590050140; SUGA N, 1976, SCIENCE, V194, P542, DOI 10.1126/science.973140; Takahashi K, 2006, EUR J NEUROSCI, V23, P1365, DOI 10.1111/j.1460-9568.2006.04662.x; Tohmi M, 2006, J NEUROSCI, V26, P11775, DOI 10.1523/JNEUROSCI.1643-06.2006; Tohmi M, 2009, J NEUROCHEM, V109, P3, DOI 10.1111/j.1471-4159.2009.05926.x; Trujillo M, 2011, J NEUROPHYSIOL, V106, P2825, DOI 10.1152/jn.00480.2011; Wetzel W, 2008, P NATL ACAD SCI USA, V105, P6753, DOI 10.1073/pnas.0707844105; WILLOTT JF, 1986, J NEUROPHYSIOL, V56, P391, DOI 10.1152/jn.1986.56.2.391; Ye CQ, 2010, J NEUROSCI, V30, P1861, DOI 10.1523/JNEUROSCI.3088-09.2010; Zeng FG, 2005, P NATL ACAD SCI USA, V102, P2293, DOI 10.1073/pnas.0406460102; Zhang LI, 2003, NATURE, V424, P201, DOI 10.1038/nature01796	55	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e68113	10.1371/journal.pone.0068113	http://dx.doi.org/10.1371/journal.pone.0068113			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23874516	Green Submitted, Green Published, gold			2022-12-27	WOS:000322000600003
J	Xu, W; Banerji, S; Davie, JR; Kassie, F; Yee, D; Kratzke, R				Xu, Wayne; Banerji, Shantanu; Davie, James R.; Kassie, Fekadu; Yee, Douglas; Kratzke, Robert			Yin Yang Gene Expression Ratio Signature for Lung Cancer Prognosis	PLOS ONE			English	Article							SQUAMOUS-CELL; PREDICT SURVIVAL; HUMAN TISSUES; RECURRENCE; ADENOCARCINOMA; RECEPTOR; CARCINOMA; BALANCE; GROWTH; RNA	Many studies have established gene expression-based prognostic signatures for lung cancer. All of these signatures were built from training data sets by learning the correlation of gene expression with the patients' survival time. They require all new sample data to be normalized to the training data, ultimately resulting in common problems of low reproducibility and impracticality. To overcome these problems, we propose a new signature model which does not involve data training. We hypothesize that the imbalance of two opposing effects in lung cancer cells, represented by Yin and Yang genes, determines a patient's prognosis. We selected the Yin and Yang genes by comparing expression data from normal lung and lung cancer tissue samples using both unsupervised clustering and pathways analyses. We calculated the Yin and Yang gene expression mean ratio (YMR) as patient risk scores. Thirty-one Yin and thirty-two Yang genes were identified and selected for the signature development. In normal lung tissues, the YMR is less than 1.0; in lung cancer cases, the YMR is greater than 1.0. The YMR was tested for lung cancer prognosis prediction in four independent data sets and it significantly stratified patients into high-and low-risk survival groups (p = 0.02, HR = 2.72; p = 0.01, HR = 2.70; p = 0.007, HR = 2.73; p = 0.005, HR = 2.63). It also showed prediction of the chemotherapy outcomes for stage II & III. In multivariate analysis, the YMR risk factor was more successful at predicting clinical outcomes than other commonly used clinical factors, with the exception of tumor stage. The YMR can be measured in an individual patient in the clinic independent of gene expression platform. This study provided a novel insight into the biology of lung cancer and shed light on the clinical applicability.	[Xu, Wayne; Banerji, Shantanu; Davie, James R.] Univ Manitoba, Manitoba Inst Cell Biol, Winnipeg, MB, Canada; [Xu, Wayne; Davie, James R.] Univ Manitoba, Manitoba Inst Child Hlth, Winnipeg, MB, Canada; [Xu, Wayne] Univ Manitoba, Fac Pharm, Winnipeg, MB R3T 2N2, Canada; [Banerji, Shantanu] Univ Manitoba, Dept Internal Med, Sect Hematol & Oncol, Winnipeg, MB, Canada; [Davie, James R.] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada; [Banerji, Shantanu] CancerCare Manitoba, Dept Med Oncol & Hematol, Winnipeg, MB, Canada; [Kassie, Fekadu; Yee, Douglas; Kratzke, Robert] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA; [Kratzke, Robert] Univ Minnesota, Dept Med, Div Hematol Oncol & Transplantat, Minneapolis, MN 55455 USA	University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba; CancerCare Manitoba Foundation; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Xu, W (corresponding author), Univ Manitoba, Manitoba Inst Cell Biol, Winnipeg, MB, Canada.	umxuw@cc.umanitoba.ca	xu, wayne/ABA-1961-2020	xu, wayne/0000-0003-0484-7340; Yee, Douglas/0000-0002-3387-4009; Davie, James/0000-0002-0420-6888				April C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008162; Aragaki M, 2011, CLIN CANCER RES, V17, P5889, DOI 10.1158/1078-0432.CCR-11-0240; Arenberg D, 2010, AM J RESP CRIT CARE, V182, P1030, DOI 10.1164/rccm.201001-0120OC; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Boutros R, 2007, NAT REV CANCER, V7, P495, DOI 10.1038/nrc2169; Chen HY, 2007, NEW ENGL J MED, V356, P11, DOI 10.1056/NEJMoa060096; Chen WY, 2001, ONCOGENE, V20, P7686, DOI 10.1038/sj.onc.1204989; Crouser ED, 2009, AM J RESP CRIT CARE, V179, P929, DOI 10.1164/rccm.200803-490OC; Dai MS, 2006, NEOPLASIA, V8, P630, DOI 10.1593/neo.06334; DORGAN J, 2010, ANTIMULLERIAN HORMON; Flanagan JM, 2009, MOL CANCER THER, V8, P249, DOI 10.1158/1535-7163.MCT-08-0636; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Goetz MP, 2006, CLIN CANCER RES, V12, P2080, DOI 10.1158/1078-0432.CCR-05-1263; Gonzalez S, 2006, NATURE, V440, P702, DOI 10.1038/nature04585; Gordon GJ, 2002, CANCER RES, V62, P4963; Guo L, 2006, CLIN CANCER RES, V12, P3344, DOI 10.1158/1078-0432.CCR-05-2336; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kratz JR, 2012, LANCET, V379, P823, DOI 10.1016/S0140-6736(11)61941-7; Kratz JR, 2009, CLIN LUNG CANCER, V10, P151, DOI 10.3816/CLC.2009.n.021; Landi MT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001651; Larsen JE, 2007, CLIN CANCER RES, V13, P2946, DOI 10.1158/1078-0432.CCR-06-2525; Larsen JE, 2007, CARCINOGENESIS, V28, P760, DOI 10.1093/carcin/bgl207; Larsson LG, 2010, EXP CELL RES, V316, P1429, DOI 10.1016/j.yexcr.2010.03.025; Lau SK, 2007, J CLIN ONCOL, V25, P5562, DOI 10.1200/JCO.2007.12.0352; Lu Y, 2006, PLOS MED, V3, P2229, DOI 10.1371/journal.pmed.0030467; Lu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030880; Luksch H, 2011, ANTICANCER RES, V31, P3181; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; Martin NL, 2005, ONCOGENE, V24, P6890, DOI 10.1038/sj.onc.1208840; Nakata H, 1998, GASTROENTEROLOGY, V115, P1144, DOI 10.1016/S0016-5085(98)70085-X; Navab R, 2011, P NATL ACAD SCI USA, V108, P7160, DOI 10.1073/pnas.1014506108; Ohtani Y, 2008, ONCOGENE, V27, P7162, DOI 10.1038/onc.2008.329; OKABE T, 1984, EXP CELL RES, V154, P125, DOI 10.1016/0014-4827(84)90673-6; PARKINDM HT, 1991, CANC REGISTRATION PR; Patel D, 2012, BIOCHEM BIOPH RES CO, V422, P146, DOI 10.1016/j.bbrc.2012.04.126; Petropoulou C, 2008, FRONT BIOSCI, V13, P4485, DOI 10.2741/3018; Raponi M, 2006, CANCER RES, V66, P7466, DOI 10.1158/0008-5472.CAN-06-1191; RIENZO AD, 2011, CLIN CANCER RES, V17, P310; Rinewalt D, 2012, J THORAC CARDIOV SUR, V144, P1344, DOI 10.1016/j.jtcvs.2012.08.033; Roepman P, 2009, CLIN CANCER RES, V15, P284, DOI 10.1158/1078-0432.CCR-08-1258; Sachdeva M, 2009, CELL CYCLE, V8, P1303, DOI 10.4161/cc.8.9.8362; Sasaki H, 2007, ONCOL REP, V18, P623; Schroder MS, 2011, BIOINFORMATICS, V27, P3206, DOI 10.1093/bioinformatics/btr511; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Shyamsundar R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r22; Skrzypski M, 2008, CLIN CANCER RES, V14, P4794, DOI 10.1158/1078-0432.CCR-08-0576; Su YR, 2010, CANCER RES, V70, P9207, DOI 10.1158/0008-5472.CAN-10-1743; Subramanian J, 2010, JNCI-J NATL CANCER I, V102, P464, DOI 10.1093/jnci/djq025; Sun ZF, 2008, J CLIN ONCOL, V26, P877, DOI 10.1200/JCO.2007.13.1516; Taylor DD, 2005, BRIT J CANCER, V92, P305, DOI 10.1038/sj.bjc.6602316; Tomida S, 2004, ONCOGENE, V23, P5360, DOI 10.1038/sj.onc.1207697; Vaishlia N A, 2008, Mol Biol (Mosk), V42, P652; Wan YW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012222; Xie Y, 2011, CLIN CANCER RES, V17, P5705, DOI 10.1158/1078-0432.CCR-11-0196; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042; Zhai HH, 2008, J HISTOCHEM CYTOCHEM, V56, P765, DOI 10.1369/jhc.2008.950519; Zhu CQ, 2010, J CLIN ONCOL, V28, P4417, DOI 10.1200/JCO.2009.26.4325	59	13	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e68742	10.1371/journal.pone.0068742	http://dx.doi.org/10.1371/journal.pone.0068742			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23874744	Green Submitted, gold, Green Published			2022-12-27	WOS:000322000600023
J	Bartlett, TE; Zaikin, A; Olhede, SC; West, J; Teschendorff, AE; Widschwendter, M				Bartlett, Thomas E.; Zaikin, Alexey; Olhede, Sofia C.; West, James; Teschendorff, Andrew E.; Widschwendter, Martin			Corruption of the Intra-Gene DNA Methylation Architecture Is a Hallmark of Cancer	PLOS ONE			English	Article							HYPERMETHYLATION; EXPRESSION; SIGNATURE	Epigenetic processes - including DNA methylation - are increasingly seen as having a fundamental role in chronic diseases like cancer. It is well known that methylation levels at particular genes or loci differ between normal and diseased tissue. Here we investigate whether the intra-gene methylation architecture is corrupted in cancer and whether the variability of levels of methylation of individual CpGs within a defined gene is able to discriminate cancerous from normal tissue, and is associated with heterogeneous tumour phenotype, as defined by gene expression. We analysed 270985 CpGs annotated to 18272 genes, in 3284 cancerous and 681 normal samples, corresponding to 14 different cancer types. In doing so, we found novel differences in intra-gene methylation pattern across phenotypes, particularly in those genes which are crucial for stem cell biology; our measures of intra-gene methylation architecture are a better determinant of phenotype than measures based on mean methylation level alone (K-S test p < 10(-3) in all 14 diseases tested). These per-gene methylation measures also represent a considerable reduction in complexity, compared to conventional per-CpG beta-values. Our findings strongly support the view that intra-gene methylation architecture has great clinical potential for the development of DNA-based cancer biomarkers.	[Bartlett, Thomas E.; Olhede, Sofia C.; West, James] UCL, CoMPLEX, London, England; [Bartlett, Thomas E.; Zaikin, Alexey] UCL, Dept Math, London, England; [Olhede, Sofia C.] UCL, Dept Stat Sci, London, England; [West, James; Teschendorff, Andrew E.] UCL, Stat Genom Grp, Inst Canc, London, England; [Widschwendter, Martin] UCL, Elizabeth Garrett Anderson Inst Womens Hlth, Dept Womens Canc, London, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London	Widschwendter, M (corresponding author), UCL, Elizabeth Garrett Anderson Inst Womens Hlth, Dept Womens Canc, London, England.	M.Widschwendter@ucl.ac.uk	Zaikin, Alexey/K-6581-2017; Zaikin, Alexey/T-7171-2019	Zaikin, Alexey/0000-0001-7540-1130; Zaikin, Alexey/0000-0001-7540-1130; Widschwendter, Martin/0000-0002-7778-8380; Bartlett, Thomas/0000-0003-0831-9713; Olhede, Sofia/0000-0003-0061-227X	Engineering and Physical Sciences Research Council (CoMPLEX/ESPRC); European Commission [305428]; UCLH/UCL Comprehensive Biomedical Research Centre [152]; Department of Health NIHR Biomedical Research Centres (BRC) funding scheme; CR-UK project [PROMISE-2016]; Heller Research Fellowship; EPSRC [EP/I005250/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I005250/1] Funding Source: researchfish; Medical Research Council [1297534] Funding Source: researchfish	Engineering and Physical Sciences Research Council (CoMPLEX/ESPRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); UCLH/UCL Comprehensive Biomedical Research Centre; Department of Health NIHR Biomedical Research Centres (BRC) funding scheme; CR-UK project; Heller Research Fellowship; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by Engineering and Physical Sciences Research Council (CoMPLEX/ESPRC), the European Commission (FP7, EpiFemCare, project number 305428) and a grant from the UCLH/UCL Comprehensive Biomedical Research Centre (project No. 152). The epigenetic analyses were undertaken at UCLH/UCL, which received a proportion of its funding from the Department of Health NIHR Biomedical Research Centres (BRC) funding scheme. AZ acknowledges financial support from the CR-UK project PROMISE-2016. AET is supported by a Heller Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; Collins FS, 2007, SCI AM, V296, P50, DOI 10.1038/scientificamerican0307-50; Cooney CA, 2007, DIS MARKERS, V23, P121, DOI 10.1155/2007/394034; Easwaran H, 2012, GENOME RES, V22, P837, DOI 10.1101/gr.131169.111; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Jaffe AE, 2012, BIOSTATISTICS, V13, P166, DOI 10.1093/biostatistics/kxr013; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li YR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000533; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; R Core Team, 2021, R LANGUAGE ENV STAT; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Teschendorff AE, 2012, GENOME MED, V4, DOI 10.1186/gm323; Teschendorff AE, 2012, BIOINFORMATICS, V28, P1487, DOI 10.1093/bioinformatics/bts170; Triche Jr T, 2012, ILLUMINAHUMANMETHYLA; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Zhuang J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002517	26	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68285	10.1371/journal.pone.0068285	http://dx.doi.org/10.1371/journal.pone.0068285			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874574	Green Published, Green Submitted, gold			2022-12-27	WOS:000322064300022
J	Beig, A; Agbaria, R; Dahan, A				Beig, Avital; Agbaria, Riad; Dahan, Arik			Oral Delivery of Lipophilic Drugs: The Tradeoff between Solubility Increase and Permeability Decrease When Using Cyclodextrin-Based Formulations	PLOS ONE			English	Article							IN-VIVO BIOAVAILABILITY; WATER-SOLUBLE DRUGS; INTESTINAL PERMEABILITY; ENABLING FORMULATIONS; APPARENT SOLUBILITY; EFFLUX TRANSPORT; VITRO LIPOLYSIS; P-GLYCOPROTEIN; ABSORPTION; INTERPLAY	The purpose of this study was to investigate the impact of oral cyclodextrin-based formulation on both the apparent solubility and intestinal permeability of lipophilic drugs. The apparent solubility of the lipophilic drug dexamethasone was measured in the presence of various HP beta CD levels. The drug's permeability was measured in the absence vs. presence of HP beta CD in the rat intestinal perfusion model, and across Caco-2 cell monolayers. The role of the unstirred water layer (UWL) in dexamethasone's absorption was studied, and a simplified mass-transport analysis was developed to describe the solubility-permeability interplay. The PAMPA permeability of dexamethasone was measured in the presence of various HP beta CD levels, and the correlation with the theoretical predictions was evaluated. While the solubility of dexamethasone was greatly enhanced by the presence of HP beta CD (K-1:1 = 2311 M-1), all experimental models showed that the drug's permeability was significantly reduced following the cyclodextrin complexation. The UWL was found to have no impact on the absorption of dexamethasone. A mass transport analysis was employed to describe the solubility-permeability interplay. The model enabled excellent quantitative prediction of dexamethasone's permeability as a function of the HP beta CD level. This work demonstrates that when using cyclodextrins in solubility-enabling formulations, a tradeoff exists between solubility increase and permeability decrease that must not be overlooked. This tradeoff was found to be independent of the unstirred water layer. The transport model presented here can aid in striking the appropriate solubility-permeability balance in order to achieve optimal overall absorption.	[Beig, Avital; Agbaria, Riad; Dahan, Arik] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Pharmacol, Sch Pharm, Beer Sheva, Israel	Ben Gurion University	Dahan, A (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Pharmacol, Sch Pharm, Beer Sheva, Israel.	arikd@bgu.ac.il			AbbVie Incorporation	AbbVie Incorporation(AbbVie)	The work was supported by a research grant from AbbVie Incorporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMIDON GL, 1995, PHARMACEUT RES, V12, P413, DOI 10.1023/A:1016212804288; Beig A, 2012, EUR J PHARM BIOPHARM, V81, P386, DOI 10.1016/j.ejpb.2012.02.012; Brewster ME, 2007, ADV DRUG DELIVER REV, V59, P645, DOI 10.1016/j.addr.2007.05.012; Carrier RL, 2007, J CONTROL RELEASE, V123, P78, DOI 10.1016/j.jconrel.2007.07.018; Dahan A, 2008, J CONTROL RELEASE, V129, P1, DOI 10.1016/j.jconrel.2008.03.021; Dahan A, 2007, EUR J PHARM BIOPHARM, V67, P96, DOI 10.1016/j.ejpb.2007.01.017; Dahan A, 2006, PHARM RES, V23, P2165, DOI 10.1007/s11095-006-9054-x; Dahan A, 2013, AAPS J, V15, P347, DOI 10.1208/s12248-012-9445-3; Dahan A, 2012, MOL PHARMACEUT, V9, P1847, DOI 10.1021/mp300140h; Dahan A, 2012, AAPS J, V14, P244, DOI 10.1208/s12248-012-9337-6; Dahan A, 2010, MOL PHARMACEUT, V7, P1827, DOI 10.1021/mp100175a; Dahan A, 2010, J PHARM SCI-US, V99, P2739, DOI 10.1002/jps.22033; Dahan A, 2010, INT J PHARMACEUT, V386, P216, DOI 10.1016/j.ijpharm.2009.11.021; Dahan A, 2009, AAPS J, V11, P740, DOI 10.1208/s12248-009-9144-x; Dahan A, 2009, DRUG METAB DISPOS, V37, P2028, DOI 10.1124/dmd.109.028282; Dahan A, 2009, AAPS J, V11, P205, DOI 10.1208/s12248-009-9092-5; Dahan A, 2009, AM J PHYSIOL-GASTR L, V297, pG371, DOI 10.1152/ajpgi.00102.2009; Dahan A, 2009, PHARM RES-DORDR, V26, P883, DOI 10.1007/s11095-008-9789-7; Dahan A, 2009, MOL PHARMACEUT, V6, P19, DOI 10.1021/mp800088f; Davis ME, 2004, NAT REV DRUG DISCOV, V3, P1023, DOI 10.1038/nrd1576; Fairstein M, 2013, AAPS J, V15, P589, DOI 10.1208/s12248-013-9462-x; Gamsiz ED, 2010, BIOTECHNOL BIOENG, V105, P421, DOI 10.1002/bit.22524; Gamsiz ED, 2011, ANN BIOMED ENG, V39, P455, DOI 10.1007/s10439-010-0169-1; Gamsiz ED, 2010, BIOTECHNOL BIOENG, V105, P409, DOI 10.1002/bit.22523; HIGUCHI T, 1970, J PHARM SCI-US, V59, P1601, DOI 10.1002/jps.2600591112; Higuchi T., 1965, ADV ANAL CHEM INSTRU, V4, P117; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lobenberg R, 2000, EUR J PHARM BIOPHARM, V50, P3, DOI 10.1016/S0939-6411(00)00091-6; Loftsson T., 2004, AM J DRUG DELIV, V2, P261, DOI [10.2165/00137696-200402040-00006, DOI 10.2165/00137696-200402040-00006]; Loftsson T, 2007, J PHARM SCI-US, V96, P2532, DOI 10.1002/jps.20992; Loftsson Thorsteinn, 2005, Expert Opin Drug Deliv, V2, P335, DOI 10.1517/17425247.2.1.335; Martinez MN, 2002, J CLIN PHARMACOL, V42, P620, DOI 10.1177/00970002042006005; Miller JM, 2012, MOL PHARMACEUT, V9, P2009, DOI 10.1021/mp300104s; Miller JM, 2012, INT J PHARMACEUT, V430, P388, DOI 10.1016/j.ijpharm.2012.03.017; Miller JM, 2012, MOL PHARMACEUT, V9, P581, DOI 10.1021/mp200460u; Miller JM, 2011, MOL PHARMACEUT, V8, P1848, DOI 10.1021/mp200181v; Rao VM, 2003, J PHARM SCI, V92, P927, DOI 10.1002/jps.10341; Stella VJ, 1999, ADV DRUG DELIVER REV, V36, P3, DOI 10.1016/S0169-409X(98)00052-0; Wohnsland F, 2001, J MED CHEM, V44, P923, DOI 10.1021/jm001020e; Yalkowsky SH, 2012, J PHARM SCI-US, V101, P3047, DOI 10.1002/jps.23093	40	89	89	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68237	10.1371/journal.pone.0068237	http://dx.doi.org/10.1371/journal.pone.0068237			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874557	Green Published, gold, Green Submitted			2022-12-27	WOS:000322064300021
J	Lakshminarayana, R; Eble, A; Bhakta, P; Frost, C; Boone, P; Elbourne, D; Mann, V				Lakshminarayana, Rashmi; Eble, Alex; Bhakta, Preetha; Frost, Chris; Boone, Peter; Elbourne, Diana; Mann, Vera			The Support to Rural India's Public Education System (STRIPES) Trial: A Cluster Randomised Controlled Trial of Supplementary Teaching, Learning Material and Material Support	PLOS ONE			English	Article								Background: The aim of the STRIPES trial was to assess the effectiveness of providing supplementary, remedial teaching and learning materials (and an additional 'kit' of materials for girls) on a composite of language and mathematics test scores for children in classes two, three and four in public primary schools in villages in the Nagarkurnool division of Andhra Pradesh, India. Methods: STRIPES was a cluster randomised trial in which 214 villages were allocated either to the supplementary teaching intervention (n = 107) or to serve as controls (n = 107). 54 of the intervention villages were further randomly allocated to receive additional kit for girls. The study was not blinded. Analysis was conducted on the intention to treat principle, allowing for clustering. Results: Composite test scores were significantly higher in the intervention group (107 villages; 2364 children) than in the control group (106 villages; 2014 children) at the end of the trial (mean difference on a percentage scale 15.8; 95% CI 13.1 to 18.6; p < 0.001; 0.75 Standard Deviation (SD) difference). Composite test scores were not significantly different in the 54 villages (614 girls) with the additional kits for girls compared to the 53 villages (636 girls) without these kits at the end of the trial (mean difference on a percentage scale 0.5; 95% CI -4.34 to 5.4; p = 0.84). The cost per 0.1 SD increase in composite test score for intervention without kits is Rs. 382.97 (4.45 pound, $7.13), and Rs. 480.59 (5.58 pound, $8.94) for the intervention with kits. Conclusions: A 18 month programme of supplementary remedial teaching and learning materials had a substantial impact on language and mathematics scores of primary school students in rural Andhra Pradesh, yet providing a 'kit' of materials to girls in these villages did not lead to any measured additional benefit.	[Lakshminarayana, Rashmi; Eble, Alex; Boone, Peter] London Sch Econ, Ctr Econ Performance, London WC2A 2AE, England; [Eble, Alex] Brown Univ, Dept Econ, Providence, RI 02912 USA; [Bhakta, Preetha] Naandi Fdn, Hyderabad, Andhra Pradesh, India; [Frost, Chris; Elbourne, Diana; Mann, Vera] Univ London London Sch Hyg & Trop Med, Dept Med Stat, London WC1E 7HT, England	University of London; London School Economics & Political Science; Brown University; University of London; London School of Hygiene & Tropical Medicine	Boone, P (corresponding author), London Sch Econ, Ctr Econ Performance, London WC2A 2AE, England.	pb@effint.org	Eble, Alex/AAX-9203-2021	Frost, Chris/0000-0003-0098-9915; Eble, Alex/0000-0002-1273-5886	Effective Intervention; Naandi Foundation	Effective Intervention; Naandi Foundation	Effective Intervention, a UK based charity, sponsored the research assessment including external testing. The intervention was co-financed by Effective Intervention and the Naandi Foundation. The funder was represented on the trial steering committee and was therefore involved in discussions about study design, data collection and analysis, and the decision to publish, but was not shown the interim unblinded analyses. After the final analysis, the funder took part in interpreting the data and writing the paper.	Abeberese AB, 2011, IMPROVING READING SK; Banerjee A., 2007, ECON POLIT WEEKLY, P1365; Banerjee AV, 2007, Q J ECON, V122, P1235, DOI 10.1162/qjec.122.3.1235; Banerjee AV, 2010, AM ECON J-ECON POLIC, V2, P1, DOI 10.1257/pol.2.1.1; Behrman JR, 2010, HBK ECON, V5, P4883, DOI 10.1016/B978-0-444-52944-2.00011-2; Boone Peter, 2007, BMC Pediatr, V7, P26, DOI 10.1186/1471-2431-7-26; Burde D, 2012, 18039 NAT BUR EC RES; Campbell MK, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5661; Duflo E, 2001, AM ECON REV, V91, P795, DOI 10.1257/aer.91.4.795; Duflo E, 2006, ED HIV AIDS PREVENTI; Eble A, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-10; Edwards SJL, 1999, BMJ-BRIT MED J, V318, P1407, DOI 10.1136/bmj.318.7195.1407; He F, 2007, HELPING TEACH UNPUB; Hutton JL, 2001, STAT MED, V20, P473, DOI 10.1002/1097-0258(20010215)20:3<473::AID-SIM805>3.0.CO;2-D; Kingdon GG, 2007, OXFORD REV ECON POL, V23, P168, DOI 10.1093/icb/grm015; Kremer M, 2005, J EUR ECON ASSOC, V3, P658, DOI 10.1162/jeea.2005.3.2-3.658; Kremer M, 2009, ANNU REV ECON, V1, P513, DOI 10.1146/annurev.economics.050708.143323; Kremer M, 2009, REV ECON STAT, V91, P437, DOI 10.1162/rest.91.3.437; Ministry of Human Resource Development Department of School Education & Literacy Government of India, SARV SIKSH ABH PROGR; Muralidharan K, 2011, J POLIT ECON, V119, P39, DOI 10.1086/659655; Nussbaum MC, 2001, WOMEN HUMAN DEV CAPA; Pratham, 2010, ANN STAT ED REP RUR; Psacharopoulos G., 2004, EDUC ECON, V12, P111, DOI [DOI 10.1080/0964529042000239140, 10.1080/0964529042000239140]; Sachs JD, 2005, LANCET, V365, P347, DOI 10.1016/S0140-6736(05)70201-4	24	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e65775	10.1371/journal.pone.0065775	http://dx.doi.org/10.1371/journal.pone.0065775			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	186SF	23874383	gold, Green Accepted, Green Published			2022-12-27	WOS:000322064300003
J	Qi, ZY; Shao, C; Zhang, X; Hui, GZ; Wang, Z				Qi, Zhen-Yu; Shao, Chuan; Zhang, Xin; Hui, Guo-Zhen; Wang, Zhong			Exogenous and Endogenous Hormones in Relation to Glioma in Women: A Meta-analysis of 11 Case-Control Studies	PLOS ONE			English	Article							ADULT BRAIN-TUMOR; REPRODUCTIVE FACTORS; REPLACEMENT THERAPY; SEX-HORMONES; CANCER RISK; COHORT; GLIOBLASTOMA; MENINGIOMA; ESTROGEN; PARITY	Background and Objective: Previous investigations of glioma risk in women have focused on oral contraceptive (OC), hormone replacement therapy (HRT), and reproductive factors. However, the results of published studies were inconclusive and inconsistent. Thus, a meta-analysis based on published case-control studies was performed to assess the role of exogenous and endogenous hormones factors in glioma risk. Methods: The PubMed and EMBASE databases were searched without any restrictions on language or publication year. Reference lists from retrieved articles were also reviewed. We included case-control studies reporting relative risks (RRs) with corresponding 95% confidence intervals (CIs) (or data to calculate them) between oral contraceptive (OC) and hormone replacement therapy (HRT) use, reproductive factors and glioma. Random-effects models were used to calculate the summary risk estimates. Results: Finally, 11 eligible studies with 4860 cases and 14,740 controls were identified. A lower risk of glioma was observed among women who were ever users of exogenous hormones (OC RR = 0.707, 95% CI = 0.604-0.828; HRT: RR = 0.683, 95% CI = 0.577-0.808) compared with never users. An increased glioma risk was associated with older age at menarche (RR = 1.401, 95% CI = 1.052-1.865). No association was observed for menopause status, parous status, age at menopause, or age at first birth and glioma risk. Conclusion: The results of our study support the hypothesis female sex hormones play a role in the development of glioma in women. Additional studies are warranted to validate the conclusion from this meta-analysis and clarity the underlying mechanisms.	[Qi, Zhen-Yu; Shao, Chuan; Zhang, Xin; Hui, Guo-Zhen; Wang, Zhong] Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, Suzhou, Jiangsu, Peoples R China	Soochow University - China	Qi, ZY (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, Suzhou, Jiangsu, Peoples R China.	qizhenyu@suda.edu.cn		Shao, Chuan/0000-0001-8260-4761				ADAMI HO, 1989, INT J CANCER, V44, P833, DOI 10.1002/ijc.2910440515; Barone TA, 2009, J NEURO-ONCOL, V95, P37, DOI 10.1007/s11060-009-9904-6; Benson VS, 2008, BRIT J CANCER, V99, P185, DOI 10.1038/sj.bjc.6604445; Benson VS, 2010, INT J CANCER, V127, P1692, DOI 10.1002/ijc.25184; Camargo MC, 2012, CANCER EPIDEM BIOMAR, V21, P20, DOI 10.1158/1055-9965.EPI-11-0834; CANTOR KP, 1993, CANCER CAUSE CONTROL, V4, P505, DOI 10.1007/BF00052425; CARROLL RS, 1995, NEUROSURGERY, V37, P496, DOI 10.1227/00006123-199509000-00019; Chamaon K, 2005, J NEURO-ONCOL, V72, P11, DOI 10.1007/s11060-004-2158-4; Chiu HF, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-857; Cicuttini FM, 1997, INT J CANCER, V71, P203; Cowppli-Bony A, 2011, CANCER CAUSE CONTROL, V22, P697, DOI 10.1007/s10552-011-9742-7; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Felini MJ, 2009, CANCER CAUSE CONTROL, V20, P87, DOI 10.1007/s10552-008-9220-z; Gandini S, 2011, EUR J CANCER, V47, P2607, DOI 10.1016/j.ejca.2011.04.023; Hatch EE, 2005, INT J CANCER, V114, P797, DOI 10.1002/ijc.20776; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; HOCHBERG F, 1990, J NEURO-ONCOL, V8, P55; Huang K, 2004, CANCER EPIDEM BIOMAR, V13, P1583; Kabat GC, 2011, INT J CANCER, V128, P944, DOI 10.1002/ijc.25413; Khalid MH, 2004, J NEUROSURG, V100, P923, DOI 10.3171/jns.2004.100.5.0923; Lambe M, 1997, INT J CANCER, V72, P389; Lis A, 2004, CANCER LETT, V213, P57, DOI 10.1016/j.canlet.2004.04.021; Lonn S, 2004, INT J CANCER, V108, P450, DOI 10.1002/ijc.11578; McKinley BP, 2000, J NEUROSURG, V93, P932, DOI 10.3171/jns.2000.93.6.0932; Michaud DS, 2010, CANCER EPIDEM BIOMAR, V19, P2562, DOI 10.1158/1055-9965.EPI-10-0447; MILLER AB, 1980, J CHRON DIS, V33, P595, DOI 10.1016/0021-9681(80)90002-8; Ohgaki H, 2005, ACTA NEUROPATHOL, V109, P93, DOI 10.1007/s00401-005-0991-y; Persson I, 1996, INT J CANCER, V67, P327, DOI 10.1002/(SICI)1097-0215(19960729)67:3<327::AID-IJC4>3.0.CO;2-T; PLESKO I, 1985, INT J CANCER, V36, P529, DOI 10.1002/ijc.2910360502; Plunkett RJ, 1999, J NEUROSURG, V90, P1072, DOI 10.3171/jns.1999.90.6.1072; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; RYAN P, 1992, INT J CANCER, V51, P20, DOI 10.1002/ijc.2910510105; SCHLEHOFER B, 1992, J NATL CANCER I, V84, P1346, DOI 10.1093/jnci/84.17.1346; Schlehofer B, 1999, INT J CANCER, V82, P155, DOI 10.1002/(SICI)1097-0215(19990719)82:2<155::AID-IJC1>3.0.CO;2-P; Schwartzbaum JA, 2006, NAT CLIN PRACT NEURO, V2, P494, DOI 10.1038/ncpneuro0289; Silvera SAN, 2006, INT J CANCER, V118, P1321, DOI 10.1002/ijc.21467; Sterne J. A. C., 2009, METAANALYSIS STATA U; VERZAT C, 1990, NEUROPATH APPL NEURO, V16, P141, DOI 10.1111/j.1365-2990.1990.tb00943.x; Wang SS, 2011, AM J EPIDEMIOL, V174, P901, DOI 10.1093/aje/kwr184; WHITTLE IR, 1987, EUR J SURG ONCOL, V13, P303; Wigertz A, 2008, CANCER EPIDEM BIOMAR, V17, P2663, DOI 10.1158/1055-9965.EPI-08-0406; Wigertz A, 2006, AM J EPIDEMIOL, V164, P629, DOI 10.1093/aje/kwj254	43	36	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68695	10.1371/journal.pone.0068695	http://dx.doi.org/10.1371/journal.pone.0068695			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874728	Green Published, gold, Green Submitted			2022-12-27	WOS:000322064300065
J	Quast, C; Cuboni, S; Bader, D; Altmann, A; Weber, P; Arloth, J; Roh, S; Bruckl, T; Ising, M; Kopczak, A; Erhardt, A; Hausch, F; Lucae, S; Binder, EB				Quast, Carina; Cuboni, Serena; Bader, Daniel; Altmann, Andre; Weber, Peter; Arloth, Janine; Roeh, Simone; Brueckl, Tanja; Ising, Marcus; Kopczak, Anna; Erhardt, Angelika; Hausch, Felix; Lucae, Susanne; Binder, Elisabeth B.			Functional Coding Variants in SLC6A15, a Possible Risk Gene for Major Depression	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; V7-3 SLC6A15; HUMAN GENOME; DISEASE; RARE; ASSOCIATION; IDENTIFICATION; CONSTRAINT; 1-PERCENT; SCALE	SLC6A15 is a neuron-specific neutral amino acid transporter that belongs to the solute carrier 6 gene family. This gene family is responsible for presynaptic re-uptake of the majority of neurotransmitters. Convergent data from human studies, animal models and pharmacological investigations suggest a possible role of SLC6A15 in major depressive disorder. In this work, we explored potential functional variants in this gene that could influence the activity of the amino acid transporter and thus downstream neuronal function and possibly the risk for stress-related psychiatric disorders. DNA from 400 depressed patients and 400 controls was screened for genetic variants using a pooled targeted re-sequencing approach. Results were verified by individual re-genotyping and validated non-synonymous coding variants were tested in an independent sample (N = 1934). Nine variants altering the amino acid sequence were then assessed for their functional effects by measuring SLC6A15 transporter activity in a cellular uptake assay. In total, we identified 405 genetic variants, including twelve non-synonymous variants. While none of the non-synonymous coding variants showed significant differences in case-control associations, two rare non-synonymous variants were associated with a significantly increased maximal 3 H proline uptake as compared to the wildtype sequence. Our data suggest that genetic variants in the SLC6A15 locus change the activity of the amino acid transporter and might thus influence its neuronal function and the risk for stress-related psychiatric disorders. As statistically significant association for rare variants might only be achieved in extremely large samples (N > 70,000) functional exploration may shed light on putatively disease-relevant variants.	[Quast, Carina; Cuboni, Serena; Bader, Daniel; Altmann, Andre; Weber, Peter; Arloth, Janine; Roeh, Simone; Brueckl, Tanja; Ising, Marcus; Kopczak, Anna; Erhardt, Angelika; Hausch, Felix; Lucae, Susanne; Binder, Elisabeth B.] Max Planck Inst Psychiat, Munich, Germany; [Altmann, Andre] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Palo Alto, CA 94304 USA	Max Planck Society; Stanford University	Quast, C (corresponding author), Max Planck Inst Psychiat, Munich, Germany.	quast@mpipsykl.mpg.de	Binder, Elisabeth B/K-8905-2014; Altmann, Andre/ABF-1675-2020	Altmann, Andre/0000-0002-9265-2393; Bader, Daniel Magnus/0000-0003-1875-6044; Kopczak, Anna/0000-0002-5037-2342; Roeh, Simone/0000-0002-7450-0871	Exzellenz-Stiftung of the Max Planck Society; Ministry of Education and Research (BMBF) in the framework of the National Genome Research Network (NGFN) [FKZ 01GS0481]	Exzellenz-Stiftung of the Max Planck Society; Ministry of Education and Research (BMBF) in the framework of the National Genome Research Network (NGFN)	This work has been supported by a grant of the Exzellenz-Stiftung of the Max Planck Society. This work has also been funded by the Federal Ministry of Education and Research (BMBF) in the framework of the National Genome Research Network (NGFN), FKZ 01GS0481. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Altmann A, 2011, BIOINFORMATICS, V27, pI77, DOI 10.1093/bioinformatics/btr205; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Bansal V, 2010, NAT REV GENET, V11, P773, DOI 10.1038/nrg2867; Bao L, 2005, BIOINFORMATICS, V21, P2185, DOI 10.1093/bioinformatics/bti365; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Broer A, 2006, BIOCHEM J, V393, P421, DOI 10.1042/BJ20051273; Chasman D, 2001, J MOL BIOL, V307, P683, DOI 10.1006/jmbi.2001.4510; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Cooper GM, 2008, GENOME RES, V18, P201, DOI 10.1101/gr.7205808; Cooper GM, 2011, NAT REV GENET, V12, P628, DOI 10.1038/nrg3046; David M, 2011, BIOINFORMATICS, V27, P1011, DOI 10.1093/bioinformatics/btr046; Dobson RJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-217; Drgonova J, 2007, BRAIN RES, V1183, P10, DOI 10.1016/j.brainres.2007.09.001; Erhardt A, 2011, MOL PSYCHIATR, V16, P647, DOI 10.1038/mp.2010.41; Farmer MK, 2000, GENOMICS, V70, P241, DOI 10.1006/geno.2000.6387; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Hagglund MGA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058651; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Hennings JM, 2008, J PSYCHIATR RES, V43, P215, DOI 10.1016/j.jpsychires.2008.05.002; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Ising M, 2009, ARCH GEN PSYCHIAT, V66, P966, DOI 10.1001/archgenpsychiatry.2009.95; Javitt DC, 2004, MOL PSYCHIATR, V9, P984, DOI 10.1038/sj.mp.4001551; Kohli MA, 2011, NEURON, V70, P252, DOI 10.1016/j.neuron.2011.04.005; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lucae S, 2006, HUM MOL GENET, V15, P2438, DOI 10.1093/hmg/ddl166; Margulies EH, 2007, GENOME RES, V17, P760, DOI 10.1101/gr.6034307; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Miller MP, 2001, HUM MOL GENET, V10, P2319, DOI 10.1093/hmg/10.21.2319; Morgenthaler S, 2007, MUTATION RES FUNDAME, V615; Muglia P, 2010, MOL PSYCHIATR, V15, P589, DOI 10.1038/mp.2008.131; Papakostas GI, 2009, J CLIN PSYCHIAT, V70, P18, DOI 10.4088/JCP.8157su1c.04; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quast C, 2012, AM J MED GENET B, V159B, P896, DOI 10.1002/ajmg.b.32096; Raychaudhuri S, 2011, CELL, V147, P57, DOI 10.1016/j.cell.2011.09.011; Schuhmacher A, 2013, INT J NEUROPSYCHOPH, V16, P83, DOI 10.1017/S1461145712000223; Sunyaev S, 2000, TRENDS GENET, V16, P198, DOI 10.1016/S0168-9525(00)01988-0; Tapiero H, 2002, BIOMED PHARMACOTHER, V56, P446, DOI 10.1016/S0753-3322(02)00285-8; Thomas JW, 2003, NATURE, V424, P788, DOI 10.1038/nature01858; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Wang K, 2010, NUCL ACIDS RES, V38; Wyse ATS, 2011, METAB BRAIN DIS, V26, P159, DOI 10.1007/s11011-011-9246-x; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Yudkoff M, 1996, J NEUROCHEM, V66, P378; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zollner S, 2012, EUR J HUM GENET, V20, P1085, DOI 10.1038/ejhg.2012.58	51	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68645	10.1371/journal.pone.0068645	http://dx.doi.org/10.1371/journal.pone.0068645			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874702	Green Published, gold, Green Submitted			2022-12-27	WOS:000322064300058
J	Attridge, N; Inglis, M				Attridge, Nina; Inglis, Matthew			Advanced Mathematical Study and the Development of Conditional Reasoning Skills	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; COGNITIVE REFLECTION; SELECTION TASK; INFERENCE; EDUCATION; THINKING; SCHOOL; LOGIC; BIAS	Since the time of Plato, philosophers and educational policy-makers have assumed that the study of mathematics improves one's general 'thinking skills'. Today, this argument, known as the 'Theory of Formal Discipline' is used in policy debates to prioritize mathematics in school curricula. But there is no strong research evidence which justifies it. We tested the Theory of Formal Discipline by tracking the development of conditional reasoning behavior in students studying post-compulsory mathematics compared to post-compulsory English literature. In line with the Theory of Formal Discipline, the mathematics students did develop their conditional reasoning to a greater extent than the literature students, despite them having received no explicit tuition in conditional logic. However, this development appeared to be towards the so-called defective conditional understanding, rather than the logically normative material conditional understanding. We conclude by arguing that Plato may have been correct to claim that studying advanced mathematics is associated with the development of logical reasoning skills, but that the nature of this development may be more complex than previously thought.	[Attridge, Nina] Univ Bath, Ctr Pain Res, Bath BA2 7AY, Avon, England; [Inglis, Matthew] Univ Loughborough, Math Educ Ctr, Loughborough, Leics, England	University of Bath; Loughborough University	Attridge, N (corresponding author), Univ Bath, Ctr Pain Res, Bath BA2 7AY, Avon, England.	f.attridge@bath.ac.uk	Inglis, Matthew/U-3677-2017	Inglis, Matthew/0000-0001-7617-4689; Attridge, Nina/0000-0001-9586-372X	Royal Society Worshipful Company of Actuaries Research Fellowship	Royal Society Worshipful Company of Actuaries Research Fellowship	M.I. is supported by a Royal Society Worshipful Company of Actuaries Research Fellowship (http://royalsociety.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assessment and Qualifications Alliance, 2011, GEN CERT ED MATH SPE; Braine MDS, 1998, MENTAL LOGIC, P79; Cacioppo JT, 1996, PSYCHOL BULL, V119, P197, DOI 10.1037/0033-2909.119.2.197; CHENG PW, 1986, COGNITIVE PSYCHOL, V18, P293, DOI 10.1016/0010-0285(86)90002-2; Dolton PJ, 2002, ECONOMICA, V69, P113, DOI 10.1111/1468-0335.00273; Epp SS, 2003, AM MATH MON, V110, P886, DOI 10.2307/3647960; Evans JSBT, 2007, MEM COGNITION, V35, P1772, DOI 10.3758/BF03193509; Evans JS, 2003, J EXP PSYCHOL LEARN, V29, P321, DOI 10.1037/0278-7393.29.2.321; EVANS JST, 1995, Q J EXP PSYCHOL-A, V48, P644; Frederick S, 2005, J ECON PERSPECT, V19, P25, DOI 10.1257/089533005775196732; Hodgen J., 2010, IS UK OUTLIER INT CO; Inglis M, 2011, PSYCHON B REV, V18, P1222, DOI 10.3758/s13423-011-0154-1; Inglis M, 2009, EDUC STUD MATH, V72, P185, DOI 10.1007/s10649-009-9187-z; Johnson-Laird PN, 2002, PSYCHOL REV, V109, P646, DOI 10.1037//0033-295X.109.4.646; LEHMAN DR, 1990, DEV PSYCHOL, V26, P952, DOI 10.1037/0012-1649.26.6.952; Leron U., 1985, EDUC STUD MATH, V16, P321; Locke J, 1706, CONDUCT UNDERSTANDIN; National Council of Teachers of Mathematics, 2000, PRINC STAND SCH MATH; National Research Council, 2001, ADDING IT HELPING CH, DOI [DOI 10.17226/9822, 10.17226/9822]; Newstead SE, 2004, Q J EXP PSYCHOL-A, V57, P33, DOI 10.1080/02724980343000116; Oakley CO, 1946, AM MATH MONTHLY, V56, P19; Owen AM, 2010, NATURE, V465, P775, DOI 10.1038/nature09042; Plato, 2003, REPUBLIC; Sa WC, 1999, J EDUC PSYCHOL, V91, P497, DOI 10.1037/0022-0663.91.3.497; Sfard A, 1998, NEW ICMI STUD SER, V4, P445; Smith, 2004, MAKING MATH COUNT; Spencer SJ, 1999, AM PSYCHOL, V52, P613; Sperber D, 2002, COGNITION, V85, P277, DOI 10.1016/S0010-0277(02)00125-7; STANIC GMA, 1986, J RES MATH EDUC, V17, P190, DOI 10.2307/749301; STANOVICH K, 2004, ROBOTS REBELLION; STANOVICH KE, 1992, MEM COGNITION, V20, P51, DOI 10.3758/BF03208254; Thorndike EL, 1924, J EDUC PSYCHOL, V15, P1, DOI 10.1037/h0075386; Thorndike EL, 1901, PSYCHOL REV, V8, P247, DOI 10.1037/h0071363; Toplak ME, 2011, MEM COGNITION, V39, P1275, DOI 10.3758/s13421-011-0104-1; Walport M., 2010, SCI MATH SECONDARY E; Wason P.C., 1966, NEW HORIZONS PSYCHOL, DOI DOI 10.1080/14640746808400161; WASON PC, 1968, Q J EXP PSYCHOL, V20, P273, DOI 10.1080/14640746808400161	38	24	25	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2013	8	7							e69399	10.1371/journal.pone.0069399	http://dx.doi.org/10.1371/journal.pone.0069399			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	200ZN	23869241	Green Published, gold, Green Submitted			2022-12-27	WOS:000323110600041
J	Taubitz, A; Schwarz, M; Eltrich, N; Lindenmeyer, MT; Vielhauer, V				Taubitz, Anela; Schwarz, Martin; Eltrich, Nuru; Lindenmeyer, Maja T.; Vielhauer, Volker			Distinct Contributions of TNF Receptor 1 and 2 to TNF-Induced Glomerular Inflammation in Mice	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; TUBULAR EPITHELIAL-CELLS; EXPERIMENTAL CRESCENTIC GLOMERULONEPHRITIS; RAT MESANGIAL CELLS; LARGE GENE LISTS; MATRIX METALLOPROTEINASES; LEUKOCYTE SUBSETS; LUPUS NEPHRITIS; RENAL-DISEASE; FACTOR-ALPHA	TNF is an important mediator of glomerulonephritis. The two TNF-receptors TNFR1 and TNFR2 contribute differently to glomerular inflammation in vivo, but specific mechanisms of TNFR-mediated inflammatory responses in glomeruli are unknown. We investigated their expression and function in murine kidneys, isolated glomeruli ex vivo, and glomerular cells in vitro. In normal kidney TNFR1 and TNFR2 were preferentially expressed in glomeruli. Expression of both TNFRs and TNF-induced upregulation of TNFR2 mRNA was confirmed in murine glomerular endothelial and mesangial cell lines. In vivo, TNF exposure rapidly induced glomerular accumulation of leukocytes. To examine TNFR-specific inflammatory responses in intrinsic glomerular cells but not infiltrating leukocytes we performed microarray gene expression profiling on intact glomeruli isolated from wildtype and Tnfr-deficient mice following exposure to soluble TNF ex vivo. Most TNF-induced effects were exclusively mediated by TNFR1, including induced glomerular expression of adhesion molecules, chemokines, complement factors and pro-apoptotic molecules. However, TNFR2 contributed to TNFR1-dependent mRNA expression of inflammatory mediators in glomeruli when exposed to low TNF concentrations. Chemokine secretion was absent in TNF-stimulated Tnfr1-deficient glomeruli, but also significantly decreased in glomeruli lacking TNFR2. In vivo, TNF-induced glomerular leukocyte infiltration was abrogated in Tnfr1-deficient mice, whereas Tnfr2-deficiency decreased mononuclear phagocytes infiltrates, but not neutrophils. These data demonstrate that activation of intrinsic glomerular cells by soluble TNF requires TNFR1, whereas TNFR2 is not essential, but augments TNFR1-dependent effects. Previously described TNFR2-dependent glomerular inflammation may therefore require TNFR2 activation by membrane-bound, but not soluble TNF.	[Taubitz, Anela; Schwarz, Martin; Eltrich, Nuru; Vielhauer, Volker] Univ Munich, Nephrolog Zentrum, Med Klin, Klinikum Univ Munchen, Munich, Germany; [Lindenmeyer, Maja T.] Univ Zurich, Inst Physiol, Zurich, Switzerland	University of Munich; University of Zurich	Vielhauer, V (corresponding author), Univ Munich, Nephrolog Zentrum, Med Klin, Klinikum Univ Munchen, Munich, Germany.	Volker.Vielhauer@med.uni-muenchen.de		Lindenmeyer, Maja/0000-0003-4162-9107	Deutsche Forschungsgemeinschaft DFG [VI 231/2-1]; Medical Faculty of the Ludwig-Maximilians-University Munich	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); Medical Faculty of the Ludwig-Maximilians-University Munich	This study was funded by the Deutsche Forschungsgemeinschaft DFG (VI 231/2-1, V.V.) and the Medical Faculty of the Ludwig-Maximilians-University Munich (M.S. and V.V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akis N, 2004, KIDNEY INT, V65, P2223, DOI 10.1111/j.1523-1755.2004.00634.x; Allam R, 2009, J AM SOC NEPHROL, V20, P1986, DOI 10.1681/ASN.2008101067; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aten J, 2000, J AM SOC NEPHROL, V11, P1426, DOI 10.1681/ASN.V1181426; BAUD L, 1989, KIDNEY INT, V35, P1111, DOI 10.1038/ki.1989.98; BERTANI T, 1989, AM J PATHOL, V134, P419; Biragyn A, 2008, J LEUKOCYTE BIOL, V83, P998, DOI 10.1189/jlb.1007700; Bruggeman LA, 2011, LAB INVEST, V91, P413, DOI 10.1038/labinvest.2010.199; Cabal-Hierro L, 2012, CELL SIGNAL, V24, P1297, DOI 10.1016/j.cellsig.2012.02.006; Chan LYY, 2005, KIDNEY INT, V67, P602, DOI 10.1111/j.1523-1755.2005.67116.x; Ernandez T, 2009, KIDNEY INT, V76, P262, DOI 10.1038/ki.2009.142; GOMEZGUERRERO C, 1994, J IMMUNOL, V153, P5247; Grell M, 1998, P NATL ACAD SCI USA, V95, P570, DOI 10.1073/pnas.95.2.570; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; Grigoriev I, 2007, DEV CELL, V13, P305, DOI 10.1016/j.devcel.2007.06.010; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; ISHA N, 1989, J IMMUNOL, V142, P3083; JEVNIKAR AM, 1991, KIDNEY INT, V40, P203, DOI 10.1038/ki.1991.201; Karkar AM, 2001, NEPHROL DIAL TRANSPL, V16, P518, DOI 10.1093/ndt/16.3.518; Khan SB, 2005, KIDNEY INT, V67, P1812, DOI 10.1111/j.1523-1755.2005.00279.x; Lan HY, 1997, MOL MED, V3, P136, DOI 10.1007/BF03401805; Le Hir M, 1998, LAB INVEST, V78, P1625; MULLIGAN MS, 1993, J CLIN INVEST, V91, P577, DOI 10.1172/JCI116237; NEALE TJ, 1995, AM J PATHOL, V146, P1444; NORONHA IL, 1993, KIDNEY INT, V43, P682, DOI 10.1038/ki.1993.98; Pinckard JK, 1997, J BIOL CHEM, V272, P10784; Rodriguez M, 2011, J BIOL CHEM, V286, P22814, DOI 10.1074/jbc.M111.225631; Ronco P, 2008, KIDNEY INT, V74, P873, DOI 10.1038/ki.2008.349; Satriano JA, 1997, J AM SOC NEPHROL, V8, P596; Seelen MA, 2006, AUTOIMMUNITY, V39, P411, DOI 10.1080/08916930600739688; Segerer S, 2007, SEMIN NEPHROL, V27, P260, DOI 10.1016/j.semnephrol.2007.02.003; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; TAKEMURA T, 1994, VIRCHOWS ARCH, V424, P459; TARTAGLIA LA, 1993, J BIOL CHEM, V268, P18542; Timoshanko JR, 2004, AM J PATHOL, V164, P1967, DOI 10.1016/S0002-9440(10)63757-1; Timoshanko JR, 2003, J AM SOC NEPHROL, V14, P1785, DOI 10.1097/01.ASN.0000073902.38428.33; Tipping PG, 2007, SEMIN NEPHROL, V27, P275, DOI 10.1016/j.semnephrol.2007.02.002; TIPPING PG, 1991, LAB INVEST, V65, P272; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Tveita A, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2532; Vielhauer V, 2004, KIDNEY BLOOD PRESS R, V27, P226, DOI 10.1159/000079867; Vielhauer V, 2003, NEPHRON EXP NEPHROL, V93, pE63, DOI 10.1159/000068517; Vielhauer V, 2005, J CLIN INVEST, V115, P1199, DOI 10.1172/JCI200523348; Vielhauer V, 2007, SEMIN NEPHROL, V27, P286, DOI 10.1016/j.semnephrol.2007.02.004; Vieyra MB, 2010, KIDNEY INT, V77, P495, DOI 10.1038/ki.2009.491; Wu CJ, 2005, EMBO J, V24, P1886, DOI 10.1038/sj.emboj.7600649; WUTHRICH RP, 1990, KIDNEY INT, V37, P783, DOI 10.1038/ki.1990.46	51	20	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2013	8	7							e68167	10.1371/journal.pone.0068167	http://dx.doi.org/10.1371/journal.pone.0068167			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZN	23869211	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000323110600010
J	Wang, CC; Tu, CC; Wang, PC; Lin, HC; Wei, PL				Wang, Chien-Che; Tu, Chao-Chiang; Wang, Pi-Chieh; Lin, Herng-Ching; Wei, Po-Li			Outcome Comparison between Laparoscopic and Open Appendectomy: Evidence from a Nationwide Population-Based Study	PLOS ONE			English	Article							HEALTH INSURANCE; APPENDICITIS	Background: Mounting evidence supports the use of laparoscopic techniques for the treatment of simple appendicitis. However, most of the advantages of these techniques are of limited clinical relevance. This study compares the treatment outcomes of laparoscopic appendectomies and open appendectomies performed in Taiwan. Methods: This study uses data from the 2007 to 2009 Taiwan National Health Insurance Research Database. The study sample included 65,339 patients, hospitalized with a discharge diagnosis of acute appendicitis (33.8% underwent laparoscopic appendectomy). A generalized estimated equation (GEE) was performed to explore the relationship between the use of laparoscopy and 30-day re-admission. Hierarchical linear regressions were performed to examine the relationship between the use of laparoscopy, the length of stay (LOS), and the cost per discharge. Results: A significantly lower proportion of patients undergoing laparoscopic appendectomies were re-admitted within 30 days of their index appendectomy, in comparison to patients undergoing open appendectomies (0.66% versus 1.925, p<0.001). Compared with patients undergoing open appendectomies, patients undergoing laparoscopic appendectomies had a shorter LOS (4.01 versus 5.33 days, p<0.001) and a higher cost per discharge (NT$40,554 versus NT$38,509, p<0.001. In 2007, the average exchange rate was US$1 = NT$31.0). GEE revealed that the odds ratio of 30-day readmission for patients undergoing laparoscopic appendectomy was 0.38 (95% CI = 0.33-0.46) that of patients undergoing open appendectomies, after adjusting for surgeon, hospital, and patient characteristics, as well as for the clustering effect of particular surgeons and the propensity score. Conclusion: This study found that laparoscopic appendectomies had a lower 30-day re-admission rate, and a shorter LOS, but a slightly higher cost per discharge than open appendectomies.	[Wang, Chien-Che] PoJen Gen Hosp, Dept Gen Surg, Taipei, Taiwan; [Tu, Chao-Chiang; Wei, Po-Li] Taipei Med Univ Hosp, Dept Surg, Div Gen Surg, Taipei, Taiwan; [Wang, Pi-Chieh] PoJen Gen Hosp, Dept Family Med, Taipei, Taiwan; [Lin, Herng-Ching] Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan; [Wei, Po-Li] Taipei Med Univ, Coll Med, Sch Med, Dept Surg, Taipei, Taiwan	Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University	Wei, PL (corresponding author), Taipei Med Univ Hosp, Dept Surg, Div Gen Surg, Taipei, Taiwan.	poliwei@tmu.edu.tw						Aziz O, 2006, ANN SURG, V243, P17, DOI 10.1097/01.sla.0000193602.74417.14; Chen YC, 2011, SCIENTOMETRICS, V86, P365, DOI 10.1007/s11192-010-0289-2; Chiu CC, 2006, J LAPAROENDOSC ADV S, V16, P113, DOI 10.1089/lap.2006.16.113; Duff SE, 2000, ANN ROY COLL SURG, V82, P388; Gagne JP, 2007, SURG ENDOSC, V21, P1383, DOI 10.1007/s00464-007-9227-7; Guller U, 2004, ANN SURG, V239, P43, DOI 10.1097/01.sla.0000103071.35986.c1; Huang MT, 2001, SURG LAPARO ENDO PER, V11, P306, DOI 10.1097/00019509-200110000-00004; Huang N, 2006, PUBLIC HEALTH, V120, P1055, DOI 10.1016/j.puhe.2006.06.011; Lam CM, 2005, SURG ENDOSC, V19, P774, DOI 10.1007/s00464-004-9158-5; Lin HF, 2006, J GASTROINTEST SURG, V10, P906, DOI 10.1016/j.gassur.2005.12.012; Lintula H, 2001, BRIT J SURG, V88, P510, DOI 10.1046/j.1365-2168.2001.01723.x; Masoomi H, 2011, J GASTROINTEST SURG; Pier A, 1991, Surg Laparosc Endosc, V1, P8; Sauerland S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001546.pub3; SEMM K, 1983, ENDOSCOPY, V15, P59, DOI 10.1055/s-2007-1021466; Swank HA, 2011, WORLD J SURG, V35, P1221, DOI 10.1007/s00268-011-1088-5; Wei PL, 2004, SURG LAPARO ENDO PER, V14, P61, DOI 10.1097/00129689-200404000-00003; Wu SC, 2011, AM SURGEON, V77, P466; Yao CC, 1999, SURG LAPARO ENDO PER, V9, P271, DOI 10.1097/00019509-199908000-00008; Yeh CC, 2011, SURG ENDOSC, V25, P2932, DOI 10.1007/s00464-011-1645-x	20	5	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e68662	10.1371/journal.pone.0068662	http://dx.doi.org/10.1371/journal.pone.0068662			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	23874710	Green Published, gold, Green Submitted			2022-12-27	WOS:000321718700038
J	Wilding, TA; Nickell, TD				Wilding, Thomas A.; Nickell, Thomas D.			Changes in Benthos Associated with Mussel (Mytilus edulis L.) Farms on the West-Coast of Scotland	PLOS ONE			English	Article							MACROFAUNAL COMMUNITIES; SHELLFISH AQUACULTURE; MARLBOROUGH SOUNDS; SALDANHA BAY; CULTURE; IMPACTS; GEOCHEMISTRY; ASSEMBLAGES; DEPLETION; OXYGEN	Aquaculture, as a means of food production, is growing rapidly in response to an increasing demand for protein and the over-exploitation of wild fisheries. This expansion includes mussels (family Mytilidae) where production currently stands at 1.5 million tonnes per annum. Mussel culture is frequently perceived as having little environmental impact yet mussel biodeposits and shell debris accumulate around the production site and are linked to changes in the benthos. To assess the extent and nature of changes in benthos associated with mussel farming grab and video sampling around seven mussel farms was conducted. Grab samples were analysed for macrofauna and shell-hash content whilst starfish were counted and the shell-hash cover estimated from video imaging. Shell-hash was patchily distributed and occasionally dominated sediments (maximum of 2116 g per 0.1 m(2) grab). Mean shell-hash content decreased rapidly at distances >5 m from the line and, over the distance 1-64 m, decreased by three orders of magnitude. The presence of shell-hash and the distance-from-line influenced macrofaunal assemblages but this effect differed between sites. There was no evidence that mussel farming was associated with changes in macrobenthic diversity, species count or feeding strategy. However, total macrofaunal count was estimated to be 2.5 times higher in close proximity to the lines, compared with 64 m distance, and there was evidence that this effect was conditional on the presence of shell-hash. Starfish density varied considerably between sites but, overall, they were approximately 10 times as abundant close to the mussel-lines compared with 64 m distance. There was no evidence that starfish were more abundant in the presence of shell-hash visible on the sediment surface. In terms of farm-scale benthic impacts these data suggest that mussel farming is a relatively benign way of producing food, compared with intensive fish-farming, in similar environments.	[Wilding, Thomas A.; Nickell, Thomas D.] Scottish Marine Inst, Scottish Assoc Marine Sci, Oban, Argyll, Scotland	UHI Millennium Institute	Wilding, TA (corresponding author), Scottish Marine Inst, Scottish Assoc Marine Sci, Oban, Argyll, Scotland.	Tom.wilding@sams.ac.uk	Wilding, Tom/AAN-8904-2020	Wilding, Thomas/0000-0002-4946-4020	Scottish Aquaculture Research Forum [SARF053]	Scottish Aquaculture Research Forum	This research was funded by the Scottish Aquaculture Research Forum (Project SARF053) for which the authors are grateful. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Perez F, 2010, J EXP MAR BIOL ECOL, V382, P96, DOI 10.1016/j.jembe.2009.11.008; Anderson DR, 2000, J WILDLIFE MANAGE, V64, P912, DOI 10.2307/3803199; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], [No title captured]; [Anonymous], 2009, LANG ENV STAT COMP; Asche Frank, 2008, P271, DOI 10.1007/978-1-4020-6810-2_9; Black KD, 1997, ICES J MAR SCI, V54, P276, DOI 10.1006/jmsc.1996.0203; BLACK KD, 1998, BIOL FARMED FISH, P284; Callier MD, 2007, MAR ECOL PROG SER, V348, P103, DOI 10.3354/meps07034; Christensen PB, 2003, AQUACULTURE, V218, P567, DOI 10.1016/S0044-8486(02)00587-2; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; CODLING ID, 1992, 31021 NR; Conlan KE, 2004, MAR POLLUT BULL, V49, P43, DOI 10.1016/j.marpolbul.2004.01.007; Cromey CJ, 2002, AQUACULTURE, V214, P211, DOI 10.1016/S0044-8486(02)00368-X; D'Amours O, 2008, MAR ECOL PROG SER, V371, P73, DOI 10.3354/meps07672; DAHLBACK B, 1981, MAR BIOL, V63, P269, DOI 10.1007/BF00395996; Diaz RJ, 1995, OCEANOGR MAR BIOL, V33, P245; Dumbauld BR, 2009, AQUACULTURE, V290, P196, DOI 10.1016/j.aquaculture.2009.02.033; GRANT J, 1995, ESTUARIES, V18, P124, DOI 10.2307/1352288; Grant J, 2008, J MARINE SYST, V73, P155, DOI 10.1016/j.jmarsys.2007.10.007; Grant J, 2007, CAN J FISH AQUAT SCI, V64, P387, DOI 10.1139/F07-021; Hall-Spencer J, 2006, MAR ECOL PROG SER, V326, P1, DOI 10.3354/meps326001; Hartstein ND, 2005, IEEE J OCEANIC ENG, V30, P85, DOI 10.1109/JOE.2004.841388; Hartstein ND, 2004, MAR ENVIRON RES, V57, P339, DOI 10.1016/j.marenvres.2003.11.003; Inglis GJ, 2003, J APPL ECOL, V40, P1077, DOI 10.1111/j.1365-2664.2003.00860.x; Jiang WM, 2005, AQUACULTURE, V244, P171, DOI 10.1016/j.aquaculture.2004.11.050; Kaiser MJ, 1998, J SHELLFISH RES, V17, P59; Kalantzi I, 2006, MAR POLLUT BULL, V52, P484, DOI 10.1016/j.marpolbul.2005.09.034; KASPAR HF, 1985, MAR BIOL, V85, P127, DOI 10.1007/BF00397431; Keeley N, 2009, 1476 MIN FISH; Lloyd B.D., 2003, POTENTIAL EFFECTS MU; MATTSSON J, 1983, SARSIA, V68, P97, DOI 10.1080/00364827.1983.10420561; Mayor DJ, 2010, ENVIRON SCI TECHNOL, V44, P2079, DOI 10.1021/es903073h; McKindsey CW, 2011, CAN J ZOOL, V89, P622, DOI [10.1139/Z11-037, 10.1139/z11-037]; Naylor R, 2005, ANNU REV ENV RESOUR, V30, P185, DOI 10.1146/annurev.energy.30.081804.121034; Newell RIE, 2004, J SHELLFISH RES, V23, P51; Osenberg C.W., 1996, DETECTING ECOLOGICAL, P3; Otero XL, 2009, ESTUAR COAST SHELF S, V81, P83, DOI 10.1016/j.ecss.2008.10.006; Pearson T.H., 1978, Oceanography and Marine Biology an Annual Review, V16, P229; PEARSON TH, 2001, ENV IMPACTS AQUACULT, P1; Piumsombun S., 2005, Aquaculture Economics and Management, V9, P265, DOI 10.1080/13657300590961582; Safi KA, 2003, NEW ZEAL J MAR FRESH, V37, P267, DOI 10.1080/00288330.2003.9517164; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Sigvaldadottir E, 2003, DEV HYDROBIOLOGY ADV; Smaal AC, 2002, HYDROBIOLOGIA, V484, P89, DOI 10.1023/A:1021352904712; Somerfield PJ, 2000, RAFFLES B ZOOL, V48, P263; Stenton-Dozey J, 2001, CAN J FISH AQUAT SCI, V58, P1021, DOI 10.1139/cjfas-58-5-1021; Stenton-Dozey JME, 1999, MAR POLLUT BULL, V39, P357, DOI 10.1016/S0025-326X(98)00180-5; Tunkijjanukij S., 2007, Aquaculture Asia Magazine, V12, P24; Wilding TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045159; Wilding TA, 2012, AQUACULT ENV INTERAC, V2, P145, DOI 10.3354/aei00038; Wong KLC, 2011, NEW ZEAL J MAR FRESH, V45, P187, DOI 10.1080/00288330.2010.550628; Wood S, 2011, GAMM4 GEN ADDICTIVE; Ysebaert T, 2009, HELGOLAND MAR RES, V63, P59, DOI 10.1007/s10152-008-0136-5; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x; Zuur Alain F., 2009, P1	58	31	32	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e68313	10.1371/journal.pone.0068313	http://dx.doi.org/10.1371/journal.pone.0068313			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	23874583	Green Published, gold, Green Submitted			2022-12-27	WOS:000321718700016
J	Beukes, CW; Venter, SN; Law, IJ; Phalane, FL; Steenkamp, ET				Beukes, Chrizelle W.; Venter, Stephanus N.; Law, Ian J.; Phalane, Francina L.; Steenkamp, Emma T.			South African Papilionoid Legumes Are Nodulated by Diverse Burkholderia with Unique Nodulation and Nitrogen-Fixation Loci	PLOS ONE			English	Article							SP-NOV.; ROOT-NODULES; MIMOSA SPP.; NOD GENES; PLANT; BACTERIA; IDENTIFICATION; SYMBIONTS; PHYMATUM; STRAINS	The root-nodule bacteria of legumes endemic to the Cape Floristic Region are largely understudied, even though recent reports suggest the occurrence of nodulating Burkholderia species unique to the region. In this study, we considered the diversity and evolution of nodulating Burkholderia associated with the endemic papilionoid tribes Hypocalypteae and Podalyrieae. We identified distinct groups from verified rhizobial isolates by phylogenetic analyses of the 16S rRNA and recA housekeeping gene regions. In order to gain insight into the evolution of the nodulation and diazotrophy of these rhizobia we analysed the genes encoding NifH and NodA. The majority of these 69 isolates appeared to be unique, potentially representing novel species. Evidence of horizontal gene transfer determining the symbiotic ability of these Cape Floristic Region isolates indicate evolutionary origins distinct from those of nodulating Burkholderia from elsewhere in the world. Overall, our findings suggest that Burkholderia species associated with fynbos legumes are highly diverse and their symbiotic abilities have unique ancestries. It is therefore possible that the evolution of these bacteria is closely linked to the diversification and establishment of legumes characteristic of the Cape Floristic Region.	[Beukes, Chrizelle W.; Venter, Stephanus N.; Steenkamp, Emma T.] Univ Pretoria, Dept Microbiol & Plant Pathol, FABI, ZA-0002 Pretoria, Gauteng, South Africa; [Law, Ian J.; Phalane, Francina L.] Plant Protect Res Inst, ARC, ZA-0001 Pretoria, Gauteng, South Africa	University of Pretoria; Agricultural Research Council of South Africa	Beukes, CW (corresponding author), Univ Pretoria, Dept Microbiol & Plant Pathol, FABI, ZA-0002 Pretoria, Gauteng, South Africa.	chrizelle.beukes@fabi.up.ac.za	Venter, Stephanus N/A-9987-2008; Beukes, Chrizelle/AAC-1597-2022; Steenkamp, Emma T/B-7958-2009	Venter, Stephanus N/0000-0002-5726-4918; Steenkamp, Emma T/0000-0003-0217-8219; Beukes, Chrizelle/0000-0002-3164-0698	National Research Foundation (NRF); University of Pretoria; Centre of Excellence in Tree Health Biotechnology (CTHB) of the Department of Science and Technology (DST)	National Research Foundation (NRF); University of Pretoria; Centre of Excellence in Tree Health Biotechnology (CTHB) of the Department of Science and Technology (DST)	This study was funded by the National Research Foundation (NRF) (www.nrf.ac.za), the University of Pretoria (web.up.ac.za) and the Centre of Excellence in Tree Health Biotechnology (CTHB) of the Department of Science and Technology (DST) (www.dst.gov.za). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors acknowledge that opinions, findings and conclusions or recommendations expressed in any publication generated by NRF-supported research are that of the authors and that the NRF accepts no liability whatsoever in this regard.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andam CP, 2007, APPL ENVIRON MICROB, V73, P4686, DOI 10.1128/AEM.00160-07; Ardley JK, 2011, ADV LEGUME IN PRESS; Ardley J, 2009, ARCH MICROBIOL, V191, P311, DOI 10.1007/s00203-009-0456-0; Ferreira PAA, 2012, WORLD J MICROB BIOT, V28, P1947, DOI 10.1007/s11274-011-0997-7; Barrett CF, 2006, APPL ENVIRON MICROB, V72, P1198, DOI 10.1128/AEM.72.2.1198-1206.2006; Benson DA, 2004, NUCLEIC ACIDS RES, V32, pD23, DOI 10.1093/nar/gkh045; Bontemps C, 2010, MOL ECOL, V19, P44, DOI 10.1111/j.1365-294X.2009.04458.x; Broughton WJ, 2000, J BACTERIOL, V182, P5641, DOI 10.1128/JB.182.20.5641-5652.2000; Caballero-Mellado J, 2004, INT J SYST EVOL MICR, V54, P1165, DOI 10.1099/ijs.0.02951-0; Caballero-Mellado J, 2007, APPL ENVIRON MICROB, V73, P5308, DOI 10.1128/AEM.00324-07; Castro-Gonzalez R, 2011, PLANT SOIL, V345, P155, DOI 10.1007/s11104-011-0768-0; Chen WM, 2008, INT J SYST EVOL MICR, V58, P2174, DOI 10.1099/ijs.0.65816-0; Chen WM, 2007, INT J SYST EVOL MICR, V57, P1055, DOI 10.1099/ijs.0.64873-0; Chen WM, 2006, INT J SYST EVOL MICR, V56, P1847, DOI 10.1099/ijs.0.64325-0; Chen WM, 2005, NEW PHYTOL, V168, P661, DOI 10.1111/j.1469-8137.2005.01533.x; Chen WM, 2005, APPL ENVIRON MICROB, V71, P7461, DOI 10.1128/AEM.71.11.7461-7471.2005; Chiarini L, 2006, TRENDS MICROBIOL, V14, P277, DOI 10.1016/j.tim.2006.04.006; Cocks MP, 2001, BASIC APPL ECOL, V2, P115, DOI 10.1078/1439-1791-00042; Coenye T, 2001, INT J SYST EVOL MICR, V51, P1099, DOI 10.1099/00207713-51-3-1099; Compant S, 2008, FEMS MICROBIOL REV, V32, P607, DOI 10.1111/j.1574-6976.2008.00113.x; Crossman LC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002567; Doyle JJ, 1998, TRENDS PLANT SCI, V3, P473, DOI 10.1016/S1360-1385(98)01340-5; Elliott GN, 2007, ANN BOT-LONDON, V100, P1403, DOI 10.1093/aob/mcm227; Elliott GN, 2007, NEW PHYTOL, V173, P168, DOI 10.1111/j.1469-8137.2006.01894.x; Elliott GN, 2009, ENVIRON MICROBIOL, V11, P762, DOI 10.1111/j.1462-2920.2008.01799.x; Estrada-de los Santos P, 2013, CURR MICROBIOL, V67, P51, DOI 10.1007/s00284-013-0330-9; Euzeby JP, 1997, INT J SYST BACTERIOL, V47, P590, DOI 10.1099/00207713-47-2-590; Farris JS, 1995, CLADISTICS, V10, P315, DOI [DOI 10.1111/J.1096-0031.1994.TB00181.X, DOI 10.1111/J.1096-0031.1996.TB00196.X]; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Flores M, 2005, J BACTERIOL, V187, P7185, DOI 10.1128/JB.187.21.7185-7192.2005; Fujishige NA, 2008, MOL MICROBIOL, V67, P504, DOI 10.1111/j.1365-2958.2007.06064.x; Garau G, 2009, SOIL BIOL BIOCHEM, V41, P125, DOI 10.1016/j.soilbio.2008.10.011; Gerding M, 2012, PLANT SOIL, V358, P385, DOI 10.1007/s11104-012-1153-3; Giraud E, 2007, SCIENCE, V316, P1307, DOI 10.1126/science.1139548; Gogarten JP, 2002, MOL BIOL EVOL, V19, P2226, DOI 10.1093/oxfordjournals.molbev.a004046; Goldblatt P, 2002, ANN MO BOT GARD, V89, P281, DOI 10.2307/3298566; Goris J, 2002, SYST APPL MICROBIOL, V25, P340, DOI 10.1078/0723-2020-00134; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gyaneshwar P, 2011, MOL PLANT MICROBE IN, V24, P1276, DOI 10.1094/MPMI-06-11-0172; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hauser AR, 2011, CLIN MICROBIOL REV, V24, P29, DOI 10.1128/CMR.00036-10; Hirsch AM, 2001, PLANT PHYSIOL, V127, P1484, DOI 10.1104/pp.010866; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jaftha JB, 2002, THESIS U PRETORIA PR; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kenicer G, 2005, ENDINB J BOT, V62, P195; Kock M. M., 2003, THESIS; Lim JH, 2008, INT J SYST EVOL MICR, V58, P565, DOI 10.1099/ijs.0.65502-0; Lock JM, 1989, LEGUMES AFRICA CHECK; MacLean AM, 2007, PLANT PHYSIOL, V144, P615, DOI 10.1104/pp.107.101634; Martinez-Aguilar L, 2008, APPL ENVIRON MICROB, V74, P4574, DOI 10.1128/AEM.00201-08; Mishra RPN, 2012, FEMS MICROBIOL ECOL, V79, P487, DOI 10.1111/j.1574-6941.2011.01235.x; MOLLER EM, 1992, NUCLEIC ACIDS RES, V20, P6115, DOI 10.1093/nar/20.22.6115; Moulin L, 2004, MOL PHYLOGENET EVOL, V30, P720, DOI 10.1016/S1055-7903(03)00255-0; Moulin L, 2001, NATURE, V411, P948, DOI 10.1038/35082070; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Parker MA, 2007, BIOL INVASIONS, V9, P127, DOI 10.1007/s10530-006-0009-2; Payne GW, 2005, APPL ENVIRON MICROB, V71, P3917, DOI 10.1128/AEM.71.7.3917-3927.2005; Perez-Mendoza D, 2004, J BACTERIOL, V186, P5753, DOI 10.1128/JB.186.17.5753-5761.2004; Perin L, 2006, INT J SYST EVOL MICR, V56, P1931, DOI 10.1099/ijs.0.64362-0; Phalane FL, 2008, CURR PLANT SCI BIOT, V42, P119; Polhill RM, 1981, ADV LEGUME SYSTEMA 1, P396; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Raven P. H., 1981, Advances in legume systematics. Part 1 [Polhill, R.M.; Raven, P.H. (Editors)], P27; Renier A, 2008, SOIL BIOL BIOCHEM, V40, P1404, DOI 10.1016/j.soilbio.2007.12.020; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Santos AV, 2004, FEMS MICROBIOL LETT, V239, P319, DOI 10.1016/j.femsle.2004.09.005; Schutte AL, 1998, NOVON, V8, P178, DOI 10.2307/3391993; Schutte AL, 1998, PLANT SYST EVOL, V209, P1, DOI 10.1007/BF00991521; Sheu SY, 2012, INT J SYST EVOL MICR, V62, P2272, DOI 10.1099/ijs.0.037408-0; Sheu SY, 2013, INT J SYST EVOL MICR, V63, P435, DOI 10.1099/ijs.0.039859-0; Somasegaran P., 1994, HDB RHIZOBIA METHODS; Sprent J.I., 2009, LEGUME NODULATION GL; Steenkamp ET, 2006, MOL BIOL EVOL, V23, P93, DOI 10.1093/molbev/msj011; Suau A, 1999, APPL ENVIRON MICROB, V65, P4799; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Vandamme P, 2002, SYST APPL MICROBIOL, V25, P507, DOI 10.1078/07232020260517634; Vandamme P, 2007, INT J SYST EVOL MICR, V57, P2228, DOI 10.1099/ijs.0.65142-0; VANEECHOUTTE M, 1993, J CLIN MICROBIOL, V31, P2061, DOI 10.1128/JCM.31.8.2061-2065.1993; Wojciechowski MF, 2004, AM J BOT, V91, P1846, DOI 10.3732/ajb.91.11.1846; Wong-Villarreal A, 2010, SYST APPL MICROBIOL, V33, P35, DOI 10.1016/j.syapm.2009.10.004; Yang HC, 2006, INT J SYST EVOL MICR, V56, P453, DOI 10.1099/ijs.0.63968-0; Young JPW, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r34	87	51	52	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e68406	10.1371/journal.pone.0068406	http://dx.doi.org/10.1371/journal.pone.0068406			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874611	gold, Green Published, Green Submitted			2022-12-27	WOS:000322218800031
J	Li, XY; Wang, YG; Liu, LJ; Luo, GP; Li, Y; Chen, X				Li, Xiaoyu; Wang, Yugang; Liu, Lijuan; Luo, Geping; Li, Yan; Chen, Xi			Effect of Land Use History and Pattern on Soil Carbon Storage in Arid Region of Central Asia	PLOS ONE			English	Article							ORGANIC-CARBON; COVER CHANGE; STOCKS; SEQUESTRATION; CULTIVATION; DYNAMICS; XINJIANG; EROSION; VEGETATION; LANDSCAPE	The purpose of this study is to investigate variations in soil organic carbon (SOC) in arid areas due to differences in the cultivation history, land use, and soil salinization. The study area is the lower Sangong River basin on the piedmont of the northern TianShan mountains, which experiences heavy land-use activities. In 1982 and 2005,127(152) and 74 (161) samples in old (new) oasis were collected from each site at the surface soil (i.e., 0-20 cm). The data reveal that the mean value of the surface soil organic carbon content of the old oasis was higher than that of the new oasis by 4.01 g/kg in 1982 and 3.79 g/kg in 2005. Additionally, the soil organic carbon content decreased more rapidly in the newly reclaimed oasis than in the old oasis from 1982 to 2005. The spatial pattern of the SOC content was correlated with the exploitation time in the new oasis, the agricultural land use history, and the SOC content. The decreasing trend is clearer in the high SOC content area than in the low SOC content area. Farmland is the largest carbon pool in both the new and old oases. The carbon density of the old oasis was higher than that of the new oasis by 4.01 and 3.79 g/kg in 1982 and 2005 respectively. The loss of SOC in the agricultural watershed of the arid region in NW China is obvious. Improvements of land management practices, such as no tillage, straw returning to soil, and balanced fertilization techniques, should be adopted to increase the SOC content.	[Li, Xiaoyu; Wang, Yugang; Liu, Lijuan; Luo, Geping; Li, Yan; Chen, Xi] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, State Key Lab Desert & Oasis Ecol, Urumqi, Xinjiang, Peoples R China	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS	Wang, YG (corresponding author), Chinese Acad Sci, Xinjiang Inst Ecol & Geog, State Key Lab Desert & Oasis Ecol, Urumqi, Xinjiang, Peoples R China.	wangyg@ms.xjb.ac.cn; chenxi@ms.xjb.ac.cn			973 Program of China [2009CB825102]; National Natural Science Foundation of China [41271202, 41101179]; Knowledge Innovation Program of the Chinese Academy of Sciences [KZCX2-EW-QN-316]	973 Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences)	This study was financed by 973 Program of China (No. 2009CB825102), National Natural Science Foundation of China (No. 41271202 and 41101179), and the Knowledge Innovation Program of the Chinese Academy of Sciences (No. KZCX2-EW-QN-316). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brye KR, 2002, ECOL APPL, V12, P962, DOI 10.1890/1051-0761(2002)012[0962:CBFAPA]2.0.CO;2; CAMBARDELLA CA, 1994, SOIL SCI SOC AM J, V58, P1501, DOI 10.2136/sssaj1994.03615995005800050033x; Cerri CEP, 2004, ENVIRON MANAGE, V33, pS274, DOI 10.1007/s00267-003-9137-y; Ci L, 2010, DESERTIFICATION AND ITS CONTROL IN CHINA, P1, DOI 10.1007/978-3-642-01869-5; Cruickshank MM, 2000, J ENVIRON MANAGE, V58, P269, DOI 10.1006/jema.2000.0330; DAVIDSON EA, 1993, BIOGEOCHEMISTRY, V20, P161, DOI 10.1007/BF00000786; DeFries RS, 1999, GLOBAL BIOGEOCHEM CY, V13, P803, DOI 10.1029/1999GB900037; Ehleringer JR, 2000, ECOL APPL, V10, P412, DOI 10.1890/1051-0761(2000)010[0412:CIRIBC]2.0.CO;2; Falloon P, 2006, SOIL USE MANAGE, V22, P274, DOI 10.1111/j.1475-2743.2006.00028.x; Feng Q., 2000, GEO J, V51, P181, DOI DOI 10.1023/A:1017557712431; Freibauer A, 2004, GEODERMA, V122, P1, DOI 10.1016/j.geoderma.2004.01.021; Fu BJ, 2006, AGR ECOSYST ENVIRON, V114, P387, DOI 10.1016/j.agee.2005.11.012; Gregorich EG, 1998, SOIL TILL RES, V47, P291, DOI 10.1016/S0167-1987(98)00117-2; GREGORICH EG, 1985, GEODERMA, V36, P343, DOI 10.1016/0016-7061(85)90012-6; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Halvorson AD, 2002, SOIL SCI SOC AM J, V66, P906, DOI 10.2136/sssaj2002.0906; Houghton JT, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P1; Houghton RA, 1999, SCIENCE, V285, P574, DOI 10.1126/science.285.5427.574; HOUGHTON RA, 1985, NATURE, V316, P617, DOI 10.1038/316617a0; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Lal, 2000, ADV AGRON, V71, P145, DOI DOI 10.1016/S0065-2113(01)71014-0; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lal R, 2003, ENVIRON INT, V29, P437, DOI 10.1016/S0160-4120(02)00192-7; Lal R, 2001, CLIMATIC CHANGE, V51, P35, DOI 10.1023/A:1017529816140; Lal R, 1999, SOIL QUALITY SOIL ER; Lal R., 1995, SOILS GLOBAL CHANGE, P131; Lal R, 2008, PHILOS T R SOC B, V363, P815, DOI 10.1098/rstb.2007.2185; Lambin EF, 2001, GLOBAL ENVIRON CHANG, V11, P261, DOI 10.1016/S0959-3780(01)00007-3; Land Resource Administration of Fukang, 1983, LAND US SOIL INV REP; Landi A, 2004, SOIL SCI SOC AM J, V68, P175, DOI 10.2136/sssaj2004.0175; Li CH, 2010, ENVIRON EARTH SCI, V60, P549, DOI 10.1007/s12665-009-0195-1; Li XY, 2007, FRONT ECOL ENVIRON, V5, P139, DOI 10.1890/1540-9295(2007)5[139:FAWFAC]2.0.CO;2; Li YQ, 2012, AGR ECOSYST ENVIRON, V159, P55, DOI 10.1016/j.agee.2012.06.024; Li ZP, 2007, GEODERMA, V138, P119, DOI 10.1016/j.geoderma.2006.11.007; Lillesand T.M., 2000, REMOTE SENSING IMAGE, V4th ed.; Ling HB, 2012, QUATERN INT, V282, P14, DOI 10.1016/j.quaint.2012.01.033; Luo GP, 2008, J ENVIRON MANAGE, V88, P775, DOI 10.1016/j.jenvman.2007.04.003; Marland G, 2000, TRENDS COMPENDIUM DA; Munoz-Rojas M, 2011, SCI TOTAL ENVIRON, V409, P2796, DOI 10.1016/j.scitotenv.2011.04.009; Nosetto MD, 2006, J ARID ENVIRON, V67, P142, DOI 10.1016/j.jaridenv.2005.12.008; Poeplau C, 2013, GEODERMA, V192, P189, DOI 10.1016/j.geoderma.2012.08.003; POST WM, 1982, NATURE, V298, P156, DOI 10.1038/298156a0; Robinson DT, 2009, ECOL MODEL, V220, P1325, DOI 10.1016/j.ecolmodel.2009.02.020; San Jose JJ, 2001, FOREST ECOL MANAG, V150, P293, DOI 10.1016/S0378-1127(00)00588-0; Schulp CJE, 2008, AGR ECOSYST ENVIRON, V127, P251, DOI 10.1016/j.agee.2008.04.010; Setia R, 2013, SCI TOTAL ENVIRON, V465, P267, DOI 10.1016/j.scitotenv.2012.08.028; Singh SK, 2007, J ARID ENVIRON, V68, P408, DOI 10.1016/j.jaridenv.2006.06.005; Singh SK, 2011, CATENA, V87, P78, DOI 10.1016/j.catena.2011.05.008; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Su YZ, 2010, J ENVIRON MANAGE, V91, P2109, DOI 10.1016/j.jenvman.2009.12.014; TIESSEN H, 1994, NATURE, V371, P783, DOI 10.1038/371783a0; Viglizzo EF, 2012, AGR ECOSYST ENVIRON, V154, P78, DOI 10.1016/j.agee.2011.07.007; VORONEY RP, 1981, CAN J SOIL SCI, V61, P211, DOI 10.4141/cjss81-026; Wang YG, 2008, ENVIRON MONIT ASSESS, V140, P291, DOI 10.1007/s10661-007-9867-z; Wang YG, 2013, CATENA, V100, P50, DOI 10.1016/j.catena.2012.08.005; Wang YG, 2010, SCI TOTAL ENVIRON, V408, P1925, DOI 10.1016/j.scitotenv.2010.01.015; Watson RT, 2000, SPEC REP INT PAN CLI; Watson RT, 2000, LAND USE CHANGE FORE; Woomer PL, 2004, J ARID ENVIRON, V59, P499, DOI 10.1016/j.jaridenv.2004.03.027; Xie ZB, 2007, GLOBAL CHANGE BIOL, V13, P1989, DOI 10.1111/j.1365-2486.2007.01409.x; Yang YH, 2007, BIOGEOCHEMISTRY, V84, P131, DOI 10.1007/s10533-007-9109-z; Yoo K, 2006, GEODERMA, V130, P47, DOI 10.1016/j.geoderma.2005.01.008	62	10	11	3	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68372	10.1371/journal.pone.0068372	http://dx.doi.org/10.1371/journal.pone.0068372			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874601	Green Published, gold, Green Submitted			2022-12-27	WOS:000321765300046
J	Milto, K; Botyriute, A; Smirnovas, V				Milto, Katazyna; Botyriute, Akvile; Smirnovas, Vytautas			Amyloid-Like Fibril Elongation Follows Michaelis-Menten Kinetics	PLOS ONE			English	Article							NEURODEGENERATIVE DISEASES; IN-VITRO; PRION; NUCLEATION; PROTEIN; POLYMERIZATION; CONVERSION; MECHANISM	A number of proteins can aggregate into amyloid-like fibrils. It was noted that fibril elongation has similarities to an enzymatic reaction, where monomers or oligomers would play a role of substrate and nuclei/fibrils would play a role of enzyme. The question is how similar these processes really are. We obtained experimental data on insulin amyloid-like fibril elongation at the conditions where other processes which may impact kinetics of fibril formation are minor and fitted it using Michaelis-Menten equation. The correlation of the fit is very good and repeatable. It speaks in favour of enzyme-like model of fibril elongation. In addition, obtained K-M and v(max) values at different conditions may help in better understanding influence of environmental factors on the process of fibril elongation.	[Milto, Katazyna; Botyriute, Akvile; Smirnovas, Vytautas] Vilnius State Univ, Inst Biotechnol, Dept Biothermodynam & Drug Design, Vilnius, Lithuania	Vilnius University	Smirnovas, V (corresponding author), Vilnius State Univ, Inst Biotechnol, Dept Biothermodynam & Drug Design, Vilnius, Lithuania.	vytautas.smirnovas@bti.vu.lt	Smirnovas, Vytautas/O-6270-2018	Smirnovas, Vytautas/0000-0002-1829-5455	Marie Curie Career Integration Grant [293476]; Research Council of Lithuania	Marie Curie Career Integration Grant; Research Council of Lithuania(Research Council of Lithuania (LMTLT))	The work was funded by Marie Curie Career Integration Grant 293476. KM and AB acknowledge support by project "Promotion of Student Scientific Activities'' from the Research Council of Lithuania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; Cannon MJ, 2004, ANAL BIOCHEM, V328, P67, DOI 10.1016/j.ab.2004.01.014; Chatani E, 2010, J MOL BIOL, V400, P1057, DOI 10.1016/j.jmb.2010.05.071; Chatani E, 2009, P NATL ACAD SCI USA, V106, P11119, DOI 10.1073/pnas.0901422106; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cohen SIA, 2011, INT J MOL SCI, V12, P5844, DOI 10.3390/ijms12095844; Dzwolak W, 2004, PROTEIN SCI, V13, P1927, DOI 10.1110/ps.03607204; Eisele YS, 2010, SCIENCE, V330, P980, DOI 10.1126/science.1194516; Esler WP, 1996, BIOCHEMISTRY-US, V35, P749, DOI 10.1021/bi951685w; Fodera V, 2008, J PHYS CHEM B, V112, P3853, DOI 10.1021/jp710131u; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Hortschansky P, 2005, PROTEIN SCI, V14, P1753, DOI 10.1110/ps.041266605; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Lee SJ, 2010, NAT REV NEUROL, V6, P702, DOI 10.1038/nrneurol.2010.145; Naiki H, 1999, METHOD ENZYMOL, V309, P305; Naiki H, 1997, AMYLOID, V4, P223, DOI 10.3109/13506129709003833; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Scheibel T, 2004, P NATL ACAD SCI USA, V101, P2287, DOI 10.1073/pnas.0308754101; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Smirnovas V, 2008, BIOPHYS J, V94, P3241, DOI 10.1529/biophysj.107.123133; Westermark GT, 2010, TRENDS MOL MED, V16, P501, DOI 10.1016/j.molmed.2010.08.004; Xue WF, 2008, P NATL ACAD SCI USA, V105, P8926, DOI 10.1073/pnas.0711664105	23	15	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68684	10.1371/journal.pone.0068684	http://dx.doi.org/10.1371/journal.pone.0068684			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874721	Green Submitted, Green Published, gold			2022-12-27	WOS:000321765300062
J	Meyer, S; Lorenz, C; Baser, B; Wordehoff, M; Jager, V; van den Heuvel, J				Meyer, Steffen; Lorenz, Carmen; Baser, Bahar; Woerdehoff, Mona; Jaeger, Volker; van den Heuvel, Joop			Multi-Host Expression System for Recombinant Production of Challenging Proteins	PLOS ONE			English	Article							TRANSIENT TRANSFECTION; CELLS; GENE; GLYCOSYLATION; GLYCOPROTEINS; VECTOR; DNA	Recombinant production of complex eukaryotic proteins for structural analyses typically requires a profound screening process to identify suitable constructs for the expression of ample amounts of properly folded protein. Furthermore, the evaluation of an optimal expression host has a major impact on protein yield and quality as well as on actual cost of the production process. Here we present a novel fast expression system for multiple hosts based on a single donor vector termed pFlp-Bac-to-Mam. The range of applications of pFlp-Bac-to-Mam comprises highly efficient transient transfection of HEK293-6E in serum-free suspension culture and subsequent large-scale production of challenging proteins expressing in mg per Liter level using either the baculoviral expression vector system or stable CHO production cell lines generated by Flp-mediated cassette exchange. The success of the multi-host expression vector to identify the optimal expression strategy for efficient production of high quality protein is demonstrated in a comparative expression study of three model proteins representing different protein classes: intracellular expression using a fluorescent protein, secretion of a single-chain-Fv-hIgG1Fc fusion construct and production of a large amount of highly homogeneous protein sample of the extracellular domain of a Toll-like receptor. The evaluation of the production efficiency shows that the pFlp-Bac-to-Mam system allows a fast and individual optimization of the expression strategy for each protein class.	[Meyer, Steffen; Lorenz, Carmen; Baser, Bahar; Woerdehoff, Mona; Jaeger, Volker; van den Heuvel, Joop] Helmholtz Ctr Infect Res, Dept Mol Struct Biol, Braunschweig, Germany	Helmholtz Association; Helmholtz-Center for Infection Research	van den Heuvel, J (corresponding author), Helmholtz Ctr Infect Res, Dept Mol Struct Biol, Braunschweig, Germany.	Joop.vandenheuvel@helmholtz-hzi.de		Lorenz, Carmen/0000-0002-7762-8133	European Community [270089]; Helmholtz Association; Instruct, part of the European Strategy Forum on Research Infrastructures (ESFRI)	European Community(European Commission); Helmholtz Association(Helmholtz Association); Instruct, part of the European Strategy Forum on Research Infrastructures (ESFRI)	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement number 270089 (ComplexInc) and the Helmholtz Association funded Protein Sample Production Facility (PSPF). This work was also supported by Instruct, part of the European Strategy Forum on Research Infrastructures (ESFRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1114, DOI 10.1107/S0907444906029805; Backliwal G, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn423; Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Bieniossek Christoph, 2008, Curr Protoc Protein Sci, VChapter 5, DOI 10.1002/0471140864.ps0520s51; BLASEY HD, 1991, ANIMAL CELL CULTURE AND PRODUCTION OF BIOLOGICALS, P61; Bollin F, 2011, PROTEIN EXPRES PURIF, V78, P61, DOI 10.1016/j.pep.2011.02.008; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; DAVIS SJ, 1993, PROTEIN ENG, V6, P229, DOI 10.1093/protein/6.2.229; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; HOEIJMAKERS JHJ, 1987, EXP CELL RES, V169, P111, DOI 10.1016/0014-4827(87)90230-8; Huh SH, 2007, BIOLOGICALS, V35, P165, DOI 10.1016/j.biologicals.2006.08.004; Jin MS, 2008, BMB REP, V41, P353, DOI 10.5483/BMBRep.2008.41.5.353; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Liang MF, 2001, J IMMUNOL METHODS, V247, P119, DOI 10.1016/S0022-1759(00)00322-7; Liang MF, 2010, ANTIBODY ENGINEERING, VOL 1, SECOND EDITION, P453, DOI 10.1007/978-3-642-01144-3_29; LUCKOW VA, 1993, J VIROL, V67, P4566, DOI 10.1128/JVI.67.8.4566-4579.1993; Menzel C, 2008, BLOOD, V111, P3830, DOI 10.1182/blood-2007-04-082768; Novy R, 1999, INNOVATIONS, V10, P5; Rajendra Y, 2012, BIOTECHNOL BIOENG, V109, P2271, DOI 10.1002/bit.24494; Rajendra Y, 2011, J BIOTECHNOL, V153, P22, DOI 10.1016/j.jbiotec.2011.03.001; SCHLAKE T, 1994, BIOCHEMISTRY-US, V33, P12746, DOI 10.1021/bi00209a003; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; STANLEY P, 1989, MOL CELL BIOL, V9, P377, DOI 10.1128/MCB.9.2.377; Trowitzsch S, 2010, J STRUCT BIOL, V172, P45, DOI 10.1016/j.jsb.2010.02.010; Wasilko D., 2006, BIOPROCESS J, V5, P29, DOI [10.12665/J53.WasilkoLee, DOI 10.12665/J53.WASILKOLEE]; Wilke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027829	28	25	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e68674	10.1371/journal.pone.0068674	http://dx.doi.org/10.1371/journal.pone.0068674			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23874717	Green Published, gold, Green Submitted			2022-12-27	WOS:000322000600016
J	Page, AL; de Rekeneire, N; Sayadi, S; Aberrane, S; Janssens, AC; Rieux, C; Djibo, A; Manuguerra, JC; Ducou-le-Pointe, H; Grais, RF; Schaefer, M; Guerin, PJ; Baron, E				Page, Anne-Laure; de Rekeneire, Nathalie; Sayadi, Sani; Aberrane, Said; Janssens, Ann-Carole; Rieux, Claire; Djibo, Ali; Manuguerra, Jean-Claude; Ducou-le-Pointe, Hubert; Grais, Rebecca F.; Schaefer, Myrto; Guerin, Philippe J.; Baron, Emmanuel			Infections in Children Admitted with Complicated Severe Acute Malnutrition in Niger	PLOS ONE			English	Article							MALNOURISHED CHILDREN; DEVELOPING-COUNTRIES; BACTEREMIA; ANTIBIOTICS; MANAGEMENT	Background: Although malnutrition affects thousands of children throughout the Sahel each year and predisposes them to infections, there is little data on the etiology of infections in these populations. We present a clinical and biological characterization of infections in hospitalized children with complicated severe acute malnutrition (SAM) in Maradi, Niger. Methods: Children with complicated SAM hospitalized in the intensive care unit of a therapeutic feeding center, with no antibiotics in the previous 7 days, were included. A clinical examination, blood, urine and stool cultures, and chest radiography were performed systematically on admission. Results: Among the 311 children included in the study, gastroenteritis was the most frequent clinical diagnosis on admission, followed by respiratory tract infections and malaria. Blood or urine culture was positive in 17% and 16% of cases, respectively, and 36% had abnormal chest radiography. Enterobacteria were sensitive to most antibiotics, except amoxicillin and cotrimoxazole. Twenty-nine (9%) children died, most frequently from sepsis. Clinical signs were poor indicators of infection and initial diagnoses correlated poorly with biologically or radiography-confirmed diagnoses. Conclusions: These data confirm the high level of infections and poor correlation with clinical signs in children with complicated SAM, and provide antibiotic resistance profiles from an area with limited microbiological data. These results contribute unique data to the ongoing debate on the use and choice of broad-spectrum antibiotics as first-line treatment in children with complicated SAM and reinforce the call for an update of international guidelines on management of complicated SAM based on more recent data.	[Page, Anne-Laure; de Rekeneire, Nathalie; Janssens, Ann-Carole; Rieux, Claire; Grais, Rebecca F.; Guerin, Philippe J.; Baron, Emmanuel] Epicentre, Paris, France; [Sayadi, Sani] Epicentre, Maradi, Niger; [Aberrane, Said] Ctr Hosp Intercommunal, Microbiol Lab, Creteil, France; [Djibo, Ali] Minist Hlth, Direct Gen Sante, Niamey, Niger; [Djibo, Ali] Niamey Univ, Niamey, Niger; [Manuguerra, Jean-Claude] Inst Pasteur, Lab Urgent Response Biol Threats, Paris, France; [Ducou-le-Pointe, Hubert] Armand Trousseau Hosp, Dept Radiol, Paris, France; [Schaefer, Myrto] Med Sans Frontieres, Dept Med, Sydney, NSW, Australia; [Guerin, Philippe J.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, CCVTM, Oxford, England	Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Oxford	Page, AL (corresponding author), Epicentre, Paris, France.	anne-laure.page@epicentre.msf.org	Guerin, Philippe/AAH-8873-2021	Guerin, Philippe/0000-0002-6008-2963; ducou le pointe, hubert/0000-0002-6667-8629; Freeman Grais, Rebecca/0000-0002-5037-8218	Medecins Sans Frontieres	Medecins Sans Frontieres	The study was funded by Medecins Sans Frontieres. The funders had no role in study design, data collection and analysis, but participated in the preparation of the manuscript and decision to publish.	Ambrus JL, 2004, EXP BIOL MED, V229, P464, DOI 10.1177/153537020422900603; [Anonymous], 2005, HOSP CAR CHILDR GUID; Ashworth A., 2003, GUIDELINES INPATIENT; Bachou H, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-160; Bejon P, 2005, J ANTIMICROB CHEMOTH, V56, P232, DOI 10.1093/jac/dki145; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Blomberg B, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-43; Chisti MJ, 2009, TROP MED INT HEALTH, V14, P1173, DOI 10.1111/j.1365-3156.2009.02364.x; Courvalin P, 2006, ANTIOBIOGRAMME; Fergusson P, 2009, T ROY SOC TROP MED H, V103, P541, DOI 10.1016/j.trstmh.2008.10.029; Florescu D, 2008, PEDIATR INFECT DIS J, V27, P1013, DOI 10.1097/INF.0b013e3181792621; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Cortes RG, 2009, AN PEDIATR, V71, P271, DOI 10.1016/j.anpedi.2009.05.005; Graham SM, 2010, CURR OPIN INFECT DIS, V23, P409, DOI 10.1097/QCO.0b013e32833dd25d; Graham SM, 2009, LANCET, V373, P267, DOI 10.1016/S0140-6736(09)60073-8; Institut National de la Statistique (INS) Macro International Inc., 2007, ENQ DEM SANT IND MUL; Kliegman RM, 2020, NELSON TXB PEDIAT; Maitland K, 2006, PLOS MED, V3, P2431, DOI 10.1371/journal.pmed.0030500; Noorani N, 2005, East Afr Med J, V82, P343; Onipede AO, 2009, J INFECT DEV COUNTR, V3, P429, DOI 10.3855/jidc.413; Picot J, 2012, HEALTH TECHNOL ASSES, V16, pIX, DOI 10.3310/hta16190; Reddy EA, 2010, LANCET INFECT DIS, V10, P417, DOI 10.1016/S1473-3099(10)70072-4; Reed RP, 1996, ANN TROP PAEDIATR, V16, P61, DOI 10.1080/02724936.1996.11747805; Schaible UE, 2007, PLOS MED, V4, P806, DOI 10.1371/journal.pmed.0040115; Societe de pathologie infectieuse de langue francaise, 1991, MED MALADIES INFECT, V21, P55; Trehan I, 2013, NEW ENGL J MED, V368, P425, DOI 10.1056/NEJMoa1202851; UN Inter-agency Group for Child Mortality Estimation, 2012, LEV TRENDS CHILD MOR; WHO, 2005, HDB IMCI INT MAN CHI; Woerther PL, 2011, CLIN INFECT DIS, V53, P677, DOI 10.1093/cid/cir522; World Health Organization, 2011, SER FERR CONC ASS IR; World Health Organization, 1999, MAN SEV MALN MAN PHY; World Health Organization, 2012, WORLD HLTH STAT 2010; World Health Organization, 2012, WHO INF MOL DIAGN IN; World Health Organization United Nations Children's Fund, 2009, WHO CHILD GROWTH STA; World Health Organization World Food Programme UN Standing Committee on Nutrition et al, 2007, COMM BAS MAN SEV AC	36	59	59	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e68699	10.1371/journal.pone.0068699	http://dx.doi.org/10.1371/journal.pone.0068699			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23874731	Green Published, Green Submitted, gold			2022-12-27	WOS:000322000600020
J	Ong, WY; Ng, MPE; Loke, SY; Jin, SL; Wu, YJ; Tanaka, K; Wong, PTH				Ong, Wei-Yi; Ng, Mary Pei-Ern; Loke, Sau-Yeen; Jin, Shalai; Wu, Ya-Jun; Tanaka, Kazuhiro; Wong, Peter Tsun-Hon			Comprehensive Gene Expression Profiling Reveals Synergistic Functional Networks in Cerebral Vessels after Hypertension or Hypercholesterolemia	PLOS ONE			English	Article							FACTOR-KAPPA-B; PROTEIN-KINASE-C; PLASMINOGEN-ACTIVATOR INHIBITOR; UBIQUITIN-PROTEASOME SYSTEM; MUSCLE-CELL PROLIFERATION; RESCUES MEMORY DEFICITS; LOW-DENSITY-LIPOPROTEIN; NUCLEAR FACTOR 4-ALPHA; LARGE ARTERY-DISEASE; ALZHEIMERS-DISEASE	Atherosclerotic stenosis of cerebral arteries or intracranial large artery disease (ICLAD) is a major cause of stroke especially in Asians, Hispanics and Africans, but relatively little is known about gene expression changes in vessels at risk. This study compares comprehensive gene expression profiles in the middle cerebral artery (MCA) of New Zealand White rabbits exposed to two stroke risk factors i.e. hypertension and/or hypercholesterolemia, by the 2-Kidney-1-Clip method, or dietary supplementation with cholesterol. Microarray and Ingenuity Pathway Analyses of the MCA of the hypertensive rabbits showed up-regulated genes in networks containing the node molecules: UBC (ubiquitin), P38 MAPK, ERK, NF kappa B, SERPINB2, MMP1 and APP (amyloid precursor protein); and down-regulated genes related to MAPK, ERK 1/2, Akt, 26 s proteasome, histone H3 and UBC. The MCA of hypercholesterolemic rabbits showed differentially expressed genes that are surprisingly, linked to almost the same node molecules as the hypertensive rabbits, despite a relatively low percentage of 'common genes' (21 and 7%) between the two conditions. Up-regulated common genes were related to: UBC, SERPINB2, TNF, HNF4A (hepatocyte nuclear factor 4A) and APP, and down-regulated genes, related to UBC. Increased HNF4A message and protein were verified in the aorta. Together, these findings reveal similar nodal molecules and gene pathways in cerebral vessels affected by hypertension or hypercholesterolemia, which could be a basis for synergistic action of risk factors in the pathogenesis of ICLAD.	[Ong, Wei-Yi; Ng, Mary Pei-Ern; Loke, Sau-Yeen; Jin, Shalai; Wu, Ya-Jun] Natl Univ Singapore, Dept Anat, Singapore 117548, Singapore; [Tanaka, Kazuhiro] Natl Univ Singapore, Dept Physiol, Singapore 117548, Singapore; [Wong, Peter Tsun-Hon] Natl Univ Singapore, Dept Pharmacol, Singapore 117548, Singapore; [Ong, Wei-Yi; Wong, Peter Tsun-Hon] Natl Univ Singapore, Neurobiol & Ageing Res Program, Inst Life Sci, Singapore 117548, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore	Ong, WY (corresponding author), Natl Univ Singapore, Dept Anat, Singapore 117548, Singapore.	wei_yi_ong@nuhs.edu.sg		Wu, Yajun/0000-0001-9598-4433; Loke, Sau Yeen/0000-0002-3475-3575	National Research Foundation Singapore [NRF-CRP 3-2008-1]	National Research Foundation Singapore(National Research Foundation, Singapore)	This research was supported by the National Research Foundation Singapore under its Competitive Research Programme (CRP Award NRF-CRP 3-2008-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKABANE S, 1985, J HYPERTENS, V3, P469; AKIYAMA H, 1993, NEUROSCI LETT, V164, P233, DOI 10.1016/0304-3940(93)90899-V; ALEXANDER RW, 1995, HYPERTENSION, V25, P155, DOI 10.1161/01.HYP.25.2.155; Altman R, 2010, CLIN SCI, V119, P407, DOI 10.1042/CS20100094; Aoshiba K, 1999, J IMMUNOL, V162, P1692; Arand M, 2001, LANGENBECK ARCH SURG, V386, P241, DOI 10.1007/s004230100204; Arning A, 2012, BLOOD, V120, P5231, DOI 10.1182/blood-2012-07-442038; Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; Barone FC, 2001, MED RES REV, V21, P129, DOI 10.1002/1098-1128(200103)21:2<129::AID-MED1003>3.0.CO;2-H; Barone FC, 2001, J PHARMACOL EXP THER, V296, P312; Bergman D, 2011, J AM ACAD NURSE PRAC, V23, P659, DOI 10.1111/j.1745-7599.2011.00650.x; Bienek R, 2012, ENDOKRYNOL POL, V63, P338; Biscetti F, 2013, HUM GENET, V132, P49, DOI 10.1007/s00439-012-1224-9; Blondeau N, 2001, J NEUROSCI, V21, P4668, DOI 10.1523/JNEUROSCI.21-13-04668.2001; Bolotin E, 2010, HEPATOLOGY, V51, P642, DOI 10.1002/hep.23357; Bonzo JA, 2012, J BIOL CHEM, V287, P7345, DOI 10.1074/jbc.M111.334599; Boyden LM, 2012, NATURE, V482, P98, DOI 10.1038/nature10814; Breuss JM, 2002, CIRCULATION, V105, P633, DOI 10.1161/hc0502.102966; Bright R, 2005, STROKE, V36, P2781, DOI 10.1161/01.STR.0000189996.71237.f7; Bright R, 2004, J NEUROSCI, V24, P6880, DOI 10.1523/JNEUROSCI.4474-03.2004; Brown AT, 2010, J VASC INTERV RADIOL, V21, P903, DOI 10.1016/j.jvir.2010.02.023; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; BURN J, 1994, STROKE, V25, P333, DOI 10.1161/01.STR.25.2.333; Chang XT, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3929; Chen CH, 2003, CIRCULATION, V107, P2102, DOI 10.1161/01.CIR.0000065220.70220.F7; Chou WH, 2005, TRENDS CARDIOVAS MED, V15, P47, DOI 10.1016/j.tcm.2005.01.003; Crawford K, 2003, BLOOD, V102, P1745, DOI 10.1182/blood-2002-07-2206; Csiszar A, 2008, J APPL PHYSIOL, V105, P1333, DOI 10.1152/japplphysiol.90470.2008; De Silva DA, 2009, EUR J NEUROL, V16, P643, DOI 10.1111/j.1468-1331.2009.02551.x; De Silva DA, 2009, J STROKE CEREBROVASC, V18, P424, DOI 10.1016/j.jstrokecerebrovasdis.2009.01.010; DeGraba TJ, 1998, NEUROLOGY, V51, pS62, DOI 10.1212/WNL.51.3_Suppl_3.S62; Dietzmann K, 2000, PATHOL RES PRACT, V196, P15, DOI 10.1016/S0344-0338(00)80017-5; Ding Y, 2008, J NEUROSCI, V28, P11622, DOI 10.1523/JNEUROSCI.3153-08.2008; Du M, 1998, J BIOL CHEM, V273, P24289, DOI 10.1074/jbc.273.38.24289; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Dutta J, 2006, ONCOGENE, V25, P6800, DOI 10.1038/sj.onc.1209938; Enose-Akahata Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000682; Fang HY, 2007, J CLIN NEUROSCI, V14, P435, DOI 10.1016/j.jocn.2005.12.022; Frasch SC, 1998, J BIOL CHEM, V273, P8389, DOI 10.1074/jbc.273.14.8389; Fu YX, 2013, INT J MOL MED; Furukawa M, 2003, NAT CELL BIOL, V5, P1001, DOI 10.1038/ncb1056; Giardina JB, 2001, HYPERTENSION, V37, P561, DOI 10.1161/01.HYP.37.2.561; Gorelick PB, 2008, STROKE, V39, P2396, DOI 10.1161/STROKEAHA.107.505776; Greenberg DA, 2013, CELL MOL LIFE SCI; Gu LJ, 2012, STROKE, V43, P1941, DOI 10.1161/STROKEAHA.112.656611; Hankey GJ, 2010, INT J STROKE, V5, P209, DOI 10.1111/j.1747-4949.2010.00429.x; Hedrick SM, 2002, IMMUNITY, V16, P619, DOI 10.1016/S1074-7613(02)00316-3; Hillen T, 2003, STROKE, V34, P1457, DOI 10.1161/01.STR.0000072985.24967.7F; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; HOLLANDER W, 1993, STROKE, V24, P1218, DOI 10.1161/01.STR.24.8.1218; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Horstmann S, 2003, STROKE, V34, P2165, DOI 10.1161/01.STR.0000088062.86084.F2; Iadecola C, 1999, NAT NEUROSCI, V2, P157, DOI 10.1038/5715; INGALL TJ, 1991, ARCH NEUROL-CHICAGO, V48, P687, DOI 10.1001/archneur.1991.00530190033011; Kaneda Y, 2013, ASIA PAC J PUBLIC HL; King MD, 2013, NEUROSCI LETT; Kovar Heinrich, 2011, Sarcoma, V2011, P1, DOI 10.1155/2011/837474; Langley B, 2009, STROKE, V40, P2899, DOI 10.1161/STROKEAHA.108.540229; Le Goff C, 2011, HUM MOL GENET, V20, pR163, DOI 10.1093/hmg/ddr361; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luchsinger JA, 2001, AM J EPIDEMIOL, V154, P635, DOI 10.1093/aje/154.7.635; Matsuo R, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-32; Mazighi M, 2006, NEUROLOGY, V66, P1187, DOI 10.1212/01.wnl.0000208404.94585.b2; McKellar GE, 2009, NAT REV CARDIOL, V6, P410, DOI 10.1038/nrcardio.2009.57; Medcalf RL, 2005, FEBS J, V272, P4858, DOI 10.1111/j.1742-4658.2005.04879.x; Meienberg J, 2010, EUR J HUM GENET, V18, P1315, DOI 10.1038/ejhg.2010.105; Meller R, 2009, NEUROSCIENTIST, V15, P243, DOI 10.1177/1073858408327809; MERRILL AH, 1990, BIOCHIM BIOPHYS ACTA, V1044, P1, DOI 10.1016/0005-2760(90)90211-F; Meyer JS, 2000, ANN NY ACAD SCI, V903, P411, DOI 10.1111/j.1749-6632.2000.tb06393.x; Mills S, 2007, BRIT J RADIOL, V80, pS128, DOI 10.1259/bjr/79217686; Mok VCT, 2009, J NEUROL, V256, P750, DOI 10.1007/s00415-009-5008-7; Monaco C, 2004, CARDIOVASC RES, V61, P671, DOI 10.1016/j.cardiores.2003.11.038; Morgan AR, 2004, STROKE, V35, P1310, DOI 10.1161/01.STR.0000126822.01756.99; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Negro A, 2001, FASEB J, V15, P210, DOI 10.1096/fj.01-0517fje; Nowell CS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002348; Nurmi A, 2004, STROKE, V35, P987, DOI 10.1161/01.STR.0000120732.45951.26; O'Rourke MF, 2005, HYPERTENSION, V46, P200, DOI 10.1161/01.HYP.0000168052.00426.65; OLSEN TS, 1985, STROKE, V16, P459, DOI 10.1161/01.STR.16.3.459; Park JH, 2008, CLIN NEUROL NEUROSUR, V110, P215, DOI 10.1016/j.clineuro.2007.10.016; Perez-de-Puig I, 2013, NEUROSCIENCE; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Phillips MA, 2013, TOXICOL APPL PHARM; Prosser J, 2007, STROKE, V38, P2295, DOI 10.1161/STROKEAHA.106.471813; Ritman EL, 2007, CARDIOVASC RES, V75, P649, DOI 10.1016/j.cardiores.2007.06.020; Rivard A, 2000, HISTOL HISTOPATHOL, V15, P557, DOI 10.14670/HH-15.557; Ropper AH, 2009, ADAMS VICTORS PRINCI, Vx; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Rundek T, 2010, ARCH NEUROL-CHICAGO, V67, P1195, DOI 10.1001/archneurol.2010.235; Russell JC, 2006, CARDIOVASC PATHOL, V15, P318, DOI 10.1016/j.carpath.2006.09.001; Sada K, 2001, J BIOCHEM-TOKYO, V130, P177, DOI 10.1093/oxfordjournals.jbchem.a002970; Sawe N, 2008, J NEUROSCI RES, V86, P1659, DOI 10.1002/jnr.21604; Schneider A, 1999, NAT MED, V5, P554, DOI 10.1038/8432; Schwarz DA, 1998, IMMUNITY, V9, P657, DOI 10.1016/S1074-7613(00)80663-9; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Skoog I, 2002, ANN NY ACAD SCI, V977, P29, DOI 10.1111/j.1749-6632.2002.tb04796.x; Sodhi RK, 2013, PROG NEURO-PSYCHOPH, V40, P38, DOI 10.1016/j.pnpbp.2012.09.012; Speich HE, 2008, AM J PHYSIOL-CELL PH, V295, pC1045, DOI 10.1152/ajpcell.90644.2007; Speiser DE, 2001, J IMMUNOL, V167, P6165, DOI 10.4049/jimmunol.167.11.6165; Steinberg D, 2009, J LIPID RES, V50, pS376, DOI 10.1194/jlr.R800087-JLR200; Stockinger B, 2006, IMMUNOL REV, V211, P39, DOI 10.1111/j.0105-2896.2006.00381.x; Supuran CT, 2008, CURR PHARM DESIGN, V14, P603, DOI 10.2174/138161208783877884; Tangye SG, 2000, J IMMUNOL, V165, P2932, DOI 10.4049/jimmunol.165.6.2932; Tian YF, 2012, J CEREBR BLOOD F MET, V32, P780, DOI 10.1038/jcbfm.2011.179; Trinchieri G, 1998, ADV IMMUNOL, V70, P83, DOI 10.1016/S0065-2776(08)60387-9; Tuomilehto J, 1996, STROKE, V27, P210, DOI 10.1161/01.STR.27.2.210; Ueland T, 2005, CIRCULATION, V111, P2461, DOI 10.1161/01.CIR.0000165119.62099.14; Van Den Tweel ERW, 2006, PEDIATR RES, V59, P232, DOI 10.1203/01.pdr.0000196807.10122.5f; Veillette A, 2003, CURR OPIN IMMUNOL, V15, P277, DOI 10.1016/S0952-7915(03)00041-4; VIITANEN M, 1988, EUR NEUROL, V28, P227, DOI 10.1159/000116272; Vrhovski-Hebrang D, 2002, CROAT MED J, V43, P696; Wannamethee SG, 1999, STROKE, V30, P1780, DOI 10.1161/01.STR.30.9.1780; WEIS JR, 1991, FASEB J, V5, P2459, DOI 10.1096/fasebj.5.10.2065893; Wojcik C, 2004, STROKE, V35, P1506, DOI 10.1161/01.STR.0000126891.93919.4e; Wong KS, 2003, STROKE, V34, P2361, DOI 10.1161/01.STR.0000089017.90037.7A; Wong LKS, 2006, INT J STROKE, V1, P158, DOI 10.1111/j.1747-4949.2006.00045.x; Wu JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059843; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; XU CP, 1991, HYPERTENSION, V18, P123, DOI 10.1161/01.HYP.18.2.123; Xu L, 2002, BIOCHEM BIOPH RES CO, V299, P14, DOI 10.1016/S0006-291X(02)02573-1; Yanni AE, 2004, LAB ANIM-UK, V38, P246, DOI 10.1258/002367704323133628; Ye S, 2003, EUR HEART J, V24, P1668, DOI 10.1016/S0195-668X(03)00385-3; Yoshimura S, 2001, GENE THER, V8, P1635, DOI 10.1038/sj.gt.3301566; Young JL, 2002, THROMB HAEMOSTASIS, V88, P554, DOI 10.1055/s-0037-1613256; Zaremba J, 2006, FOLIA NEUROPATHOL, V44, P59; Zhang FY, 1997, J NEUROSCI, V17, P7655, DOI 10.1523/jneurosci.17-20-07655.1997; Zhang J, 2011, AM J HYPERTENS, V24, P304, DOI 10.1038/ajh.2010.246; Zhao H, 2005, J NEUROSCI, V25, P9794, DOI 10.1523/JNEUROSCI.3163-05.2005; Zhou R H, 2001, J Atheroscler Thromb, V8, P30; Ziegler S, 2005, ATHEROSCLEROSIS, V182, P175, DOI 10.1016/j.atherosclerosis.2005.01.042; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114; Zuckerbraun BS, 2003, J VASC SURG, V38, P812, DOI 10.1016/S0741-5214(03)00427-0	132	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68335	10.1371/journal.pone.0068335	http://dx.doi.org/10.1371/journal.pone.0068335			58	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874591	Green Submitted, Green Published, gold			2022-12-27	WOS:000322064300024
J	Shen, CC; Hu, YW; Hu, LY; Perng, CL; Su, TP; Teng, CJ; Yen, SH; Tzeng, CH; Chiou, TJ; Yeh, CM; Chen, TJ; Wang, WS; Chen, PM; Liu, CJ				Shen, Cheng-Che; Hu, Yu-Wen; Hu, Li-Yu; Perng, Chin-Lin; Su, Tung-Ping; Teng, Chung-Jen; Yen, Sang-Hue; Tzeng, Cheng-Hwai; Chiou, Tzeon-Jye; Yeh, Chiu-Mei; Chen, Tzeng-Ji; Wang, Wei-Shu; Chen, Pan-Ming; Liu, Chia-Jen			The Risk of Cancer among Taiwanese Female Registered Nurses: A Nationwide Retrospective Study	PLOS ONE			English	Article							ROTATING NIGHT SHIFTS; BREAST-CANCER; IONIZING-RADIATION; BRITISH-COLUMBIA; INCIDENCE TRENDS; DANISH NURSES; EXPOSURE; COHORT; WORK; RACE	Background: To evaluate the risk of cancer among Taiwanese female registered nurses (RNs) using a nationwide population-based dataset. Methods: We recruited female RNs without antecedent cancer from the Taiwan National Health Insurance Research database during 2000-2010. Standardized incidence ratios (SIRs) of cancer were calculated. We also compared rates of Papanicolaou (Pap) smear use between the RNs and the general population matched by age and sex. Results: A total of 2,077 cancers developed among 184,809 female RNs, with a follow-up of 1,371,910 person-years (median follow-up of 7.86 years), leading to an increased SIR of 1.10 [95% confidence interval (CI) 1.05-1.15]. RNs aged between 40-59 years also had a significantly increased SIR (1.14, 95% CI 1.08-1.21). For specific cancer types, RNs had an increased SIR for breast (1.28, 95% CI 1.19-1.37), thyroid (1.26, 95% CI 1.10-1.43), lung and mediastinum (1.36, 95% CI 1.13-1.62), and uterine cancers (1.23, 95% CI 1.01-1.49). A decreased SIR was found for cervix (0.48, 95% CI 0.37-0.61) and liver and biliary tract cancers (0.68, 95% CI 0.50-0.90). Pap smear use averaged 5.80 times per person among female RNs aged 35 years or older and 5.50 times per person in the age-matched control group (p = 0.009). Conclusion: This study found that overall cancer risk was higher among female RNs than general population. For individual cancers, the risks of breast, lung, thyroid and uterine cancer were higher and the risks of cervix and liver cancer were lower than general population. The lower risk of cervical cancer might be partially explained by the increased use of Pap smears in the RNs group. Further large, unbiased population-based prospective studies are needed to investigate the association between nurses and cancer risk and identify the risk factors of cancer in nurses.	[Shen, Cheng-Che] Taichung Vet Gen Hosp, Chiayi Branch, Dept Psychiat, Chiayi, Taiwan; [Hu, Yu-Wen; Perng, Chin-Lin; Su, Tung-Ping; Teng, Chung-Jen; Yen, Sang-Hue; Tzeng, Cheng-Hwai; Chiou, Tzeon-Jye; Chen, Tzeng-Ji; Wang, Wei-Shu; Liu, Chia-Jen] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Hu, Yu-Wen; Yen, Sang-Hue] Taipei Vet Gen Hosp, Ctr Canc, Taipei, Taiwan; [Hu, Yu-Wen] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Hu, Li-Yu] Yuli Vet Hosp, Dept Psychiat, Hualien, Taiwan; [Perng, Chin-Lin] Taipei Vet Gen Hosp, Div Gastroenterol, Dept Med, Taipei, Taiwan; [Su, Tung-Ping] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Teng, Chung-Jen] Far Eastern Mem Hosp, Dept Med, Div Hematol & Oncol, Taipei, Taiwan; [Yen, Sang-Hue] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan; [Tzeng, Cheng-Hwai; Chiou, Tzeon-Jye; Liu, Chia-Jen] Taipei Vet Gen Hosp, Div Hematol & Oncol, Dept Med, Taipei, Taiwan; [Yeh, Chiu-Mei; Chen, Tzeng-Ji] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan; [Wang, Wei-Shu; Liu, Chia-Jen] Natl Yang Ming Univ Hosp, Dept Internal Med, Yilan, Taiwan; [Chen, Pan-Ming] Taipei Vet Gen Hosp, Dept Psychiat, Su Ao Branch, Taipei, Taiwan	Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Far Eastern Memorial Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital	Liu, CJ (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan.	pures1000@yahoo.com.tw	Chen, TJ/AAH-8430-2021	Shen, Cheng-Che/0000-0003-1587-5590; Hu, Yu-Wen/0000-0002-7983-415X	Taipei Veterans General Hospital [V101D-001-2]	Taipei Veterans General Hospital(Taipei Veterans General Hospital)	This study is supported by a grant from Taipei Veterans General Hospital (V101D-001-2). The study is based in part on data from the National Health Insurance Research Database provided by the Bureau of National Health Insurance, Department of Health and managed by National Health Research Institutes. The interpretation and conclusions contained herein do not represent those of Bureau of National Health Insurance, Department of Health or National Health Research Institutes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Band PR, 2000, J OCCUP ENVIRON MED, V42, P284, DOI 10.1097/00043764-200003000-00010; Canavan TP, 2000, AM FAM PHYSICIAN, V61, P1369; Cook MB, 2009, BRIT J CANCER, V101, P855, DOI 10.1038/sj.bjc.6605246; Dickerman B, 2012, WORKPLACE HEALTH SAF, V60, P273, DOI 10.3928/21650799-20120529-06; Dimich-Ward H, 2007, AM J IND MED, V50, P892, DOI 10.1002/ajim.20505; Franzese Ester, 2007, Prof Inferm, V60, P89; Gates MA, 2007, SCAND J WORK ENV HEA, V33, P140, DOI 10.5271/sjweh.1117; Gunnarsdottir, 1997, Int J Occup Environ Health, V3, P254; Hansen J, 2012, EUR J CANCER, V48, P1722, DOI 10.1016/j.ejca.2011.07.005; Hewitt J B, 1993, AWHONNS Clin Issues Perinat Womens Health Nurs, V4, P320; Hulka BS, 2001, MATURITAS, V38, P103, DOI 10.1016/S0378-5122(00)00196-1; Kjaer TK, 2010, INT NURS REV, V57, P211, DOI 10.1111/j.1466-7657.2009.00798.x; Kjaer TK, 2009, SCAND J WORK ENV HEA, V35, P446, DOI 10.5271/sjweh.1358; Knutsson A, 2003, OCCUP MED-OXFORD, V53, P103, DOI 10.1093/occmed/kqg048; Langley AR, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000532; Lee DJ, 2008, CANCER CAUSE CONTROL, V19, P711, DOI 10.1007/s10552-008-9134-9; Lie JAS, 2006, CANCER CAUSE CONTROL, V17, P39, DOI 10.1007/s10552-005-3639-2; Lie JAS, 2003, EUR J CANCER PREV, V12, P517, DOI 10.1097/00008469-200312000-00011; Lie JAS, 2008, EUR J CANCER PREV, V17, P369, DOI 10.1097/CEJ.0b013e3282b6fe0a; Lie JAS, 2007, SCAND J WORK ENV HEA, V33, P66, DOI 10.5271/sjweh.1066; Lie JAS, 2011, AM J EPIDEMIOL, V173, P1272, DOI 10.1093/aje/kwr014; Lin HP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-55; Liu LH, 2012, INT J CANCER, V130, P395, DOI 10.1002/ijc.26004; Morch LS, 2007, EUR J PUBLIC HEALTH, V17, P624, DOI 10.1093/eurpub/ckm036; Murphy G, 2011, INT J CANCER, V128, P1668, DOI 10.1002/ijc.25481; OMENN GS, 1984, AM J IND MED, V6, P129, DOI 10.1002/ajim.4700060207; Ou SM, 2013, NEUROEPIDEMIOLOGY, V40, P42, DOI 10.1159/000341411; Ratner PA, 2010, BMC NURS, V9, DOI 10.1186/1472-6955-9-15; Schernhammer ES, 2004, AM J EPIDEMIOL, V160, P1079, DOI 10.1093/aje/kwh327; Schernhammer ES, 2001, J NATL CANCER I, V93, P1563, DOI 10.1093/jnci/93.20.1563; Schernhammer ES, 2011, J NATL CANCER I, V103, P602, DOI 10.1093/jnci/djr044; Schottenfeld D, 2006, CANC EPIDEMIOLOGY PR; Shen CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057399; SKOV T, 1992, BRIT J IND MED, V49, P855; STEVENS RG, 1987, AM J EPIDEMIOL, V125, P556, DOI 10.1093/oxfordjournals.aje.a114569; Stevens RG, 2011, OCCUP ENVIRON MED, V68, P154, DOI 10.1136/oem.2009.053512; Teschke K, 2008, J OCCUP ENVIRON HYG, V5, P75, DOI 10.1080/15459620701793050; Vyas MV, 2012, BMJ, V345, pe4800; Wang JX, 2002, HEALTH PHYS, V82, P455, DOI 10.1097/00004032-200204000-00004; Wu MT, 2003, ARCH ENVIRON HEALTH, V58, P353	40	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68420	10.1371/journal.pone.0068420	http://dx.doi.org/10.1371/journal.pone.0068420			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874621	gold, Green Published, Green Submitted			2022-12-27	WOS:000322064300032
J	Zhou, B; Song, ZS; Qian, MP; Li, L; Gong, J; Zou, SW				Zhou, Bo; Song, Zhenshun; Qian, Mingping; Li, Liang; Gong, Jian; Zou, Shaowu			Functional Polymorphisms in the CYP2C19 Gene Contribute to Digestive System Cancer Risk: Evidence from 11,042 Subjects	PLOS ONE			English	Article							S-MEPHENYTOIN 4'-HYDROXYLATION; SALMONELLA-TYPHIMURIUM YG7108; HUMAN CYTOCHROME-P450; POOR METABOLIZERS; GENOTYPE ANALYSIS; BREAST-CANCER; SUSCEPTIBILITY; OMEPRAZOLE; FORM; METAANALYSIS	Background: CYP2C19 belongs to the cytochrome P450 superfamily of enzymes involved in activating and detoxifying many carcinogens and endogenous compounds, which has attracted considerable attention as a candidate gene for digestive system cancer. CYP2C19 has two main point mutation sites (CYP2C19*2, CYP2C19*3) leading to poor metabolizer (PM) phenotype. In the past decade, the relationship between CYP2C19 polymorphism and digestive system cancer has been reported in various ethnic groups; however, these studies have yielded contradictory results. Methods: To clarify this inconsistency, we performed this meta-analysis. Databases including Pubmed, EMBASE, Web of Science and China National Knowledge Infrastructure (CNKI) were searched to find relevant studies. Odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the strength of association. Results: In total, 18 studies with 4,414 cases and 6,628 controls were included. Overall, significantly elevated digestive system cancer risk was associated CYP2C19 PM with OR of 1.66 (95% CI: 1.31-2.10, P < 10(-5)) when all studies were pooled into the meta-analysis. There was strong evidence of heterogeneity (P = 0.006), which largely disappeared after stratification by cancer type. In the stratified analyses according to cancer type, ethnicity, control source and sample size, significantly increased risks were found. Conclusions: In summary, our meta-analysis suggested that the PM phenotype caused by the variation on CYP2C19 gene is associated with increased risk of digestive system cancer, especially in East Asians.	[Zhou, Bo; Song, Zhenshun; Qian, Mingping; Li, Liang; Gong, Jian; Zou, Shaowu] Tongji Univ, Dept Gen Surg, Shanghai Peoples Hosp 10, Shanghai 200092, Peoples R China	Tongji University	Zou, SW (corresponding author), Tongji Univ, Dept Gen Surg, Shanghai Peoples Hosp 10, Shanghai 200092, Peoples R China.	shaowuzou@gmail.com						Agundez JAG, 2004, CURR DRUG METAB, V5, P211, DOI 10.2174/1389200043335621; ANDERSSON T, 1991, CLIN PHARMACOKINET, V21, P195, DOI 10.2165/00003088-199121030-00004; BROCKMOLLER J, 1995, PHARMACOGENETICS, V5, P80; Chang FH, 2010, ZHONGGUO YAO LI TONG, V27, P22; Chau TKH, 2000, LIFE SCI, V67, P1719, DOI 10.1016/S0024-3205(00)00757-8; DEMORAIS SMF, 1994, MOL PHARMACOL, V46, P594; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dick DM, 2011, ANNU REV CLIN PSYCHO, V7, P383, DOI 10.1146/annurev-clinpsy-032210-104518; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fujita K, 2001, ENVIRON MOL MUTAGEN, V38, P339, DOI 10.1002/em.10036; Fujita K, 2001, MUTAT RES-FUND MOL M, V483, P35, DOI 10.1016/S0027-5107(01)00223-8; Furuta T, 2004, PHARMACOGENOMICS, V5, P181, DOI 10.1517/phgs.5.2.181.27483; Gao LB, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-117; He N, 2002, EUR J CLIN PHARMACOL, V58, P15, DOI 10.1007/s00228-002-0425-x; Hu XP, 2010, ZHONGHUA ZHONGLIU FA, V17; ISHIZAKI T, 1995, CLIN PHARMACOL THER, V58, P155, DOI 10.1016/0009-9236(95)90193-0; Isomura Y, 2010, J GASTROENTEROL, V45, P1045, DOI 10.1007/s00535-010-0246-0; Jiang W, 2008, WEI CHANG BING XUE, V13, P39; Kappers WA, 2001, TOXICOL APPL PHARM, V177, P68, DOI 10.1006/taap.2001.9294; Kubota T, 1996, CLIN PHARMACOL THER, V60, P661, DOI 10.1016/S0009-9236(96)90214-3; Landi S, 2005, PHARMACOGENET GENOM, V15, P535, DOI 10.1097/01.fpc.0000165904.48994.3d; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Mochizuki J, 2005, J GASTROEN HEPATOL, V20, P1191, DOI 10.1111/j.1440-1746.2005.03808.x; Pirmohamed M, 2001, TRENDS PHARMACOL SCI, V22, P298, DOI 10.1016/S0165-6147(00)01717-X; Rodrigues AD, 2002, CURR DRUG METAB, V3, P289, DOI 10.2174/1389200023337522; Sachse C, 2002, CARCINOGENESIS, V23, P1839, DOI 10.1093/carcin/23.11.1839; Sainz J, 2011, ENDOCR-RELAT CANCER, V18, P265, DOI 10.1530/ERC-10-0264; Shi WX, 2004, WORLD J GASTROENTERO, V10, P1961, DOI 10.3748/wjg.v10.i13.463; Shi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043412; Shirai N, 2001, ALIMENT PHARM THER, V15, P1929, DOI 10.1046/j.1365-2036.2001.01108.x; Shu Y, 2000, ACTA PHARMACOL SIN, V21, P193; Sugimoto M, 2005, ALIMENT PHARM THER, V22, P1033, DOI 10.1111/j.1365-2036.2005.02678.x; Sugimoto M, 2004, CLIN PHARMACOL THER, V76, P290, DOI 10.1016/j.clpt.2004.06.008; Tamer L, 2006, J GASTROINTEST CANC, V37, P1, DOI 10.1385/IJGC:37:1:1; Tapia T, 2008, BREAST CANCER RES TR, V107, P281, DOI 10.1007/s10549-007-9544-5; Tsuneoka Y, 1996, LIFE SCI, V59, P1711, DOI 10.1016/S0024-3205(96)00507-3; Yamazaki Y, 2004, MUTAT RES-GEN TOX EN, V562, P151, DOI 10.1016/j.mrgentox.2004.06.003; Yang ZF, 2008, ZHONGLIU YAN JIU YU, V20, P65; Zaphiropoulos PG, 1999, NUCLEIC ACIDS RES, V27, P2585, DOI 10.1093/nar/27.13.2585; Zhang LiWei, 2009, Journal of Practical Oncology, V24, P232; Zhou YL, 2006, ZHONGGUO ZHONG LIU, V15, P659	43	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e66865	10.1371/journal.pone.0066865	http://dx.doi.org/10.1371/journal.pone.0066865			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874401	Green Published, gold, Green Submitted			2022-12-27	WOS:000322064300006
J	Lv, XX; Wang, XX; Li, K; Wang, ZY; Li, Z; Lv, Q; Fu, XM; Hu, ZW				Lv, Xiao-xi; Wang, Xiao-xing; Li, Ke; Wang, Zi-yan; Li, Zhe; Lv, Qi; Fu, Xiao-ming; Hu, Zhuo-Wei			Rupatadine Protects against Pulmonary Fibrosis by Attenuating PAF-Mediated Senescence in Rodents	PLOS ONE			English	Article							EPITHELIAL-CELL SENESCENCE; INDUCED LUNG FIBROSIS; TH1/TH2 BALANCE; MAST-CELLS; INFLAMMATION; MACROPHAGES; MECHANISMS; AUTOPHAGY; PROMOTES; DISEASE	A similar immune response is implicated in the pathogenesis of pulmonary fibrosis and allergic disorders. We investigated the potential therapeutic efficacy and mechanism of rupatadine, a dual antagonist of histamine and platelet-activation factor (PAF), in bleomycin- (BLM-) and silica-induced pulmonary fibrosis. The indicated dosages of rupatadine were administered in rodents with bleomycin or silica-induced pulmonary fibrosis. The tissue injury, fibrosis, inflammatory cells and cytokines, and lung function were examined to evaluate the therapeutic efficacy of rupatadine. The anti-fibrosis effect of rupatadine was compared with an H1 or PAF receptor antagonist, and efforts were made to reveal rupatadine's anti-fibrotic mechanism. Rupatadine promoted the resolution of pulmonary inflammation and fibrosis in a dose-dependent manner, as indicated by the reductions in inflammation score, collagen deposition and epithelial-mesenchymal transformation, and infiltration or expression of inflammatory cells or cytokines in the fibrotic lung tissue. Thus, rupatadine treatment improved the declined lung function and significantly decreased animal death. Moreover, rupatadine was able not only to attenuate silica-induced silicosis but also to produce a superior therapeutic efficacy compared to pirfenidone, histamine H1 antagonist loratadine, or PAF antagonist CV-3988. The anti-fibrotic action of rupatadine might relate to its attenuation of BLM- or PAF-induced premature senescence because rupatadine treatment protected against the in vivo and in vitro activation of the p53/p21-dependent senescence pathway. Our studies indicate that rupatadine promotes the resolution of pulmonary inflammation and fibrosis by attenuating the PAF-mediated senescence response. Rupatadine holds promise as a novel drug to treat the devastating disease of pulmonary fibrosis.	Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Mol Immunol & Pharmacol Grp, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Hu, ZW (corresponding author), Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Mol Immunol & Pharmacol Grp, Beijing 100730, Peoples R China.	huzhuowei@imm.ac.cn	Wang, Ziyan/HII-8458-2022	Lv, Qi/0000-0001-9076-7042	National Natural Science Foundation [81273529]; Major Program of National Natural Science Foundation [81030056]; Ministry of Science and Technology [2010DFB32900]; program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) [IRT1007]; Creation of Major New Drugs [2009ZX09301-003-13]; Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study [BZ0150]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Major Program of National Natural Science Foundation; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); program for Changjiang Scholars and Innovative Research Team in University (PCSIRT)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Creation of Major New Drugs; Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study	This study was supported by grants from the National Natural Science Foundation (81273529), Major Program of National Natural Science Foundation (81030056), International Corporation Project supported by the Ministry of Science and Technology (2010DFB32900), program for Changjiang Scholars and Innovative Research Team in University (PCSIRT, No.IRT1007), and Creation of Major New Drugs (2009ZX09301-003-13), Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study (NO. BZ0150). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Andrade MRM, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-166; Carter NJ, 2011, DRUGS, V71, P1721, DOI 10.2165/11207710-000000000-00000; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; De Lisle RC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004283; de Mello LM, 2009, IMMUNOL LETT, V124, P88, DOI 10.1016/j.imlet.2009.04.011; Donado E, 2010, BRIT J CLIN PHARMACO, V69, P401, DOI 10.1111/j.1365-2125.2009.03599.x; du Bois RM, 2010, NAT REV DRUG DISCOV, V9, P129, DOI 10.1038/nrd2958; Fernandez IE, 2012, LANCET, V380, P680, DOI 10.1016/S0140-6736(12)61144-1; Fujii S, 2012, ONCOIMMUNOLOGY, V1, P630, DOI 10.4161/onci.20297; Gauldie J, 2007, BIOCHEM SOC T, V35, P661, DOI 10.1042/BST0350661; GIRI S N, 1986, Toxicologic Pathology, V14, P149; GIRI SN, 1995, EXP LUNG RES, V21, P287, DOI 10.3109/01902149509068833; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Holgate Stephen T., 2003, Journal of Allergy and Clinical Immunology, V111, pS18, DOI 10.1067/mai.2003.25; Katiyar Subodh, 2009, Prim Care Respir J, V18, P57, DOI 10.3132/pcrj.2008.00043; Kikuchi N, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-31; Kohyama T, 2010, MOL CELL BIOCHEM, V337, P77, DOI 10.1007/s11010-009-0287-y; Kotsianidis I, 2009, AM J RESP CRIT CARE, V179, P1121, DOI 10.1164/rccm.200812-1936OC; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Lang YD, 2010, TOXICOL LETT, V193, P19, DOI 10.1016/j.toxlet.2009.12.001; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Lim E, 2011, JOVE-J VIS EXP, DOI 10.3791/2775; Linge A, 2007, INT J BIOCHEM CELL B, V39, P1964, DOI 10.1016/j.biocel.2007.05.018; Liu H, 2013, AUTOPHAGY, V9, P730, DOI 10.4161/auto.24039; Malmhall C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040012; McNeil HP, 2008, ARTHRITIS RHEUM-US, V58, P2338, DOI 10.1002/art.23639; Metz M, 2011, EXPERT REV CLIN IMMU, V7, P15, DOI 10.1586/ECI.10.85; Mi S, 2011, J IMMUNOL, V187, P3003, DOI 10.4049/jimmunol.1004081; Noble PW, 2012, J CLIN INVEST, V122, P2756, DOI 10.1172/JCI60323; Okamoto T, 2009, CLIN EXP IMMUNOL, V157, P27, DOI 10.1111/j.1365-2249.2009.03958.x; Orjalo AV, 2009, P NATL ACAD SCI USA, V106, P17031, DOI 10.1073/pnas.0905299106; Phillips JE, 2012, PULM PHARMACOL THER, V25, P281, DOI 10.1016/j.pupt.2011.10.001; Picado C, 2006, EXPERT OPIN PHARMACO, V7, P1989, DOI 10.1517/14656566.7.14.1989; Prokop S, 2011, AM J PATHOL, V178, P1279, DOI 10.1016/j.ajpath.2010.11.065; Reddy GK, 1996, CLIN BIOCHEM, V29, P225, DOI 10.1016/0009-9120(96)00003-6; Redente EF, 2010, J LEUKOCYTE BIOL, V88, P159, DOI 10.1189/jlb.0609378; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Shivshankar P, 2012, AM J RESP CELL MOL, V47, P28, DOI 10.1165/rcmb.2011-0349OC; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Soroosh P, 2009, IMMUNOLOGY, V127, P450, DOI 10.1111/j.1365-2567.2009.03114.x; Summers SA, 2012, KIDNEY INT, V82, P676, DOI 10.1038/ki.2012.211; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tsuji T, 2010, RESPIRATION, V80, P59, DOI 10.1159/000268287; Vasiadi M, 2010, INT ARCH ALLERGY IMM, V151, P38, DOI 10.1159/000232569; Wang YH, 2008, CURR OPIN IMMUNOL, V20, P697, DOI 10.1016/j.coi.2008.09.004; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Yang HZ, 2012, AM J PATHOL, V180, P275, DOI 10.1016/j.ajpath.2011.09.019; Yang HZ, 2009, J IMMUNOL, V182, P692, DOI 10.4049/jimmunol.182.1.692	50	28	34	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2013	8	7							e68631	10.1371/journal.pone.0068631	http://dx.doi.org/10.1371/journal.pone.0068631			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZN	23869224	gold, Green Published, Green Submitted			2022-12-27	WOS:000323110600023
J	Kim, J; Yi, GS				Kim, Jinki; Yi, Gwan-Su			RMOD: A Tool for Regulatory Motif Detection in Signaling Network	PLOS ONE			English	Article							CASPASE ACTIVATION; CYTOSCAPE PLUGIN; ALGORITHM	Regulatory motifs are patterns of activation and inhibition that appear repeatedly in various signaling networks and that show specific regulatory properties. However, the network structures of regulatory motifs are highly diverse and complex, rendering their identification difficult. Here, we present a RMOD, a web-based system for the identification of regulatory motifs and their properties in signaling networks. RMOD finds various network structures of regulatory motifs by compressing the signaling network and detecting the compressed forms of regulatory motifs. To apply it into a large-scale signaling network, it adopts a new subgraph search algorithm using a novel data structure called path-tree, which is a tree structure composed of isomorphic graphs of query regulatory motifs. This algorithm was evaluated using various sizes of signaling networks generated from the integration of various human signaling pathways and it showed that the speed and scalability of this algorithm outperforms those of other algorithms. RMOD includes interactive analysis and auxiliary tools that make it possible to manipulate the whole processes from building signaling network and query regulatory motifs to analyzing regulatory motifs with graphical illustration and summarized descriptions. As a result, RMOD provides an integrated view of the regulatory motifs and mechanism underlying their regulatory motif activities within the signaling network. RMOD is freely accessible online at the following URL: http://pks.kaist.ac.kr/rmod.	[Kim, Jinki; Yi, Gwan-Su] Korea Adv Inst Sci & Technol, Dept Informat & Commun Engn, Taejon 305701, South Korea; [Yi, Gwan-Su] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Yi, GS (corresponding author), Korea Adv Inst Sci & Technol, Dept Informat & Commun Engn, Taejon 305701, South Korea.	gsyi@kaist.ac.kr	Yi, Gwan-Su/A-7896-2011	Yi, Gwan-Su/0000-0003-0012-6546	Ministry of Education, Science and Technology; National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2012R1A1A2008510]; Korean government (MEST) [2012M3A9C4048759]	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the KAIST Future Systems Healthcare Project from the Ministry of Education, Science and Technology. This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A2008510). This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MEST) (2012M3A9C4048759). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cordella LP, 2004, IEEE T PATTERN ANAL; Cui QH, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100200; Eissing T, 2004, J BIOL CHEM, V279, P36892, DOI 10.1074/jbc.M404893200; Ferro A, 2007, BIOINFORMATICS, V23, P910, DOI 10.1093/bioinformatics/btm032; FLOYD RW, 1962, COMMUN ACM, V5, P345, DOI 10.1145/367766.368168; Foggia P., 2001, P 3 IAPR TC 15 WORKS, P188; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kashtan N, 2004, BIOINFORMATICS, V20, P1746, DOI 10.1093/bioinformatics/bth163; Kim JR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001390; Klein T. E., 2001, Pharmacogenomics Journal, V1, P167; Le DH, 2011, BIOINFORMATICS, V27, P2767, DOI 10.1093/bioinformatics/btr466; Legewie S, 2006, PLOS COMPUT BIOL, V2, P1061, DOI 10.1371/journal.pcbi.0020120; Lopes CT, 2010, BIOINFORMATICS, V26, P2347, DOI 10.1093/bioinformatics/btq430; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; Ma'ayan A, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-10; Masoudi-Nejad A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043287; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; Mckay B. D., 1981, C NUMERANTIUM, V30, P45, DOI DOI 10.1016/J.JSC.2013.09.003; Monk NAM, 2003, CURR BIOL, V13, P1409, DOI 10.1016/S0960-9822(03)00494-9; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; Rehm M, 2002, J BIOL CHEM, V277, P24506, DOI 10.1074/jbc.M110789200; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Schreiber F, 2005, BIOINFORMATICS, V21, P3572, DOI 10.1093/bioinformatics/bti556; Serrano MA, 2009, P NATL ACAD SCI USA, V106, P6483, DOI 10.1073/pnas.0808904106; Shah NA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002085; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Wernicke S, 2006, BIOINFORMATICS, V22, P1152, DOI 10.1093/bioinformatics/btl038; Wernicke S, 2005, LECT NOTES COMPUT SC, V3692, P165; Wolf DM, 2003, CURR OPIN MICROBIOL, V6, P125, DOI 10.1016/S1369-5274(03)00033-X	30	0	0	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e68407	10.1371/journal.pone.0068407	http://dx.doi.org/10.1371/journal.pone.0068407			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	23874612	Green Published, Green Submitted, gold			2022-12-27	WOS:000321718700021
J	van Leeuwen, MA; du Pre, MF; van Wanrooij, RL; de Ruiter, LF; Raatgeep, HC; Lindenbergh-Kortleve, DJ; Mulder, CJ; de Ridder, L; Escher, JC; Samsom, JN				van Leeuwen, Marieke A.; du Pre, M. Fleur; van Wanrooij, Roy L.; de Ruiter, Lilian F.; Raatgeep, H. (Rolien) C.; Lindenbergh-Kortleve, Dicky J.; Mulder, Chris J.; de Ridder, Lissy; Escher, Johanna C.; Samsom, Janneke N.			Changes in Natural Foxp3(+)Treg but Not Mucosally-Imprinted CD62L(neg) CD38(+)Foxp3(+)Treg in the Circulation of Celiac Disease Patients	PLOS ONE			English	Article							REGULATORY T-CELLS; SMALL-INTESTINAL MUCOSA; PERIPHERAL-BLOOD; FOXP3 EXPRESSION; DENDRITIC CELLS; ORAL TOLERANCE; RETINOIC-ACID; CHILDREN; INTERLEUKIN-15; INFILTRATION	Background: Celiac disease (CD) is an intestinal inflammation driven by gluten-reactive CD4(+) T cells. Due to lack of selective markers it has not been determined whether defects in inducible regulatory T cell (Treg) differentiation are associated with CD. This is of importance as changes in numbers of induced Treg could be indicative of defects in mucosal tolerance development in CD. Recently, we have shown that, after encounter of retinoic acid during differentiation, circulating gut-imprinted T cells express CD62L(neg)CD38(+). Using this new phenotype, we now determined whether alterations occur in the frequency of natural CD62L(+) Foxp3(+) Treg or mucosally-imprinted CD62L(neg)CD38(+) Foxp3(+) Treg in peripheral blood of CD patients. In particular, we compared pediatric CD, aiming to select for disease at onset, with adult CD. Methods: Cell surface markers, intracellular Foxp3 and Helios were determined by flow cytometry. Foxp3 expression was also detected by immunohistochemistry in duodenal tissue of CD patients. Results: In children, the percentages of peripheral blood CD4(+) Foxp3(+) Treg were comparable between CD patients and healthy age-matched controls. Differentiation between natural and mucosally-imprinted Treg on the basis of CD62L and CD38 did not uncover differences in Foxp3. In adult patients on gluten-free diet and in refractory CD increased percentages of circulating natural CD62L(+) Foxp3(+) Treg, but normal mucosally-imprinted CD62L(neg)CD38+ Foxp3(+) Treg frequencies were observed. Conclusions: Our data exclude that significant numeric deficiency of mucosally-imprinted or natural Foxp3(+) Treg explains exuberant effector responses in CD. Changes in natural Foxp3(+) Treg occur in a subset of adult patients on a gluten-free diet and in refractory CD patients.	[van Leeuwen, Marieke A.; du Pre, M. Fleur; de Ruiter, Lilian F.; Raatgeep, H. (Rolien) C.; Lindenbergh-Kortleve, Dicky J.; Samsom, Janneke N.] Sophia Childrens Univ Hosp, Erasmus Med Center, Div Gastroenterol & Nutr, Pediat Lab, Rotterdam, Netherlands; [du Pre, M. Fleur] Univ Oslo, Inst Immunol, Ctr Immune Regulat, Oslo, Norway; [du Pre, M. Fleur] Univ Oslo, Rikshosp, Oslo Univ Hosp, N-0027 Oslo, Norway; [van Wanrooij, Roy L.; Mulder, Chris J.] Vrije Univ Amsterdam Med Ctr, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands; [de Ridder, Lissy; Escher, Johanna C.] Erasmus MC Sophia Childrens Hosp, Dept Pediat Gastroenterol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; University of Oslo; University of Oslo; National Hospital Norway; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Erasmus University Rotterdam; Erasmus MC	Samsom, JN (corresponding author), Sophia Childrens Univ Hosp, Erasmus Med Center, Div Gastroenterol & Nutr, Pediat Lab, Rotterdam, Netherlands.	j.samsom@erasmusmc.nl		du Pre, M. Fleur/0000-0001-9231-643X	Dutch Sophia Research Foundation [557]; Dutch Celiac Disease Consortium [CDC2]	Dutch Sophia Research Foundation; Dutch Celiac Disease Consortium	This research was funded by the Dutch Sophia Research Foundation grant: 557 and the Dutch Celiac Disease Consortium (CDC2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MB, 2009, J IMMUNOL, V182, P6763, DOI 10.4049/jimmunol.0801792; Badami E, 2011, DIABETES, V60, P2120, DOI 10.2337/db10-1201; Bernardo D, 2008, CLIN IMMUNOL, V126, P172, DOI 10.1016/j.clim.2007.09.005; Brazowski E, 2010, PATHOBIOLOGY, V77, P328, DOI 10.1159/000322049; Broere F, 2009, MUCOSAL IMMUNOL, V2, P254, DOI 10.1038/mi.2009.2; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; de Lafaille MAC, 2008, IMMUNITY, V29, P114, DOI 10.1016/j.immuni.2008.05.010; Di Sabatino A, 2006, GUT, V55, P469, DOI 10.1136/gut.2005.068684; du Pre MF, 2011, AM J GASTROENTEROL, V106, P1147, DOI 10.1038/ajg.2011.24; Frisullo G, 2009, HUM IMMUNOL, V70, P430, DOI 10.1016/j.humimm.2009.04.006; Granzotto M, 2009, DIGEST DIS SCI, V54, P1513, DOI 10.1007/s10620-008-0501-x; Hmida NB, 2011, AM J GASTROENTEROL; Itoh M, 1999, J IMMUNOL, V162, P5317; Kim YC, 2012, BLOOD, V119, P2810, DOI 10.1182/blood-2011-09-377895; Kivling A, 2008, ANN NY ACAD SCI, V1150, P273, DOI 10.1196/annals.1447.018; Lee SK, 2003, GASTROINTEST ENDOSC, V57, P187, DOI 10.1067/mge.2003.54; LERNER A, 1994, CLIN EXP IMMUNOL, V95, P78; Liu L, 2008, NEUROENDOCRINOL LETT, V29, P240; LUNDIN KEA, 1994, HUM IMMUNOL, V41, P285, DOI 10.1016/0198-8859(94)90047-7; LUNDIN KEA, 1993, J EXP MED, V178, P187, DOI 10.1084/jem.178.1.187; Malamut G, 2009, GASTROENTEROLOGY, V136, P81, DOI 10.1053/j.gastro.2008.09.069; Mention JJ, 2003, GASTROENTEROLOGY, V125, P730, DOI 10.1016/S0016-5085(03)01047-3; Mucida D, 2005, J CLIN INVEST, V115, P1923, DOI 10.1172/JCI24487; NILSEN EM, 1995, GUT, V37, P766, DOI 10.1136/gut.37.6.766; Peluso I, 2007, J IMMUNOL, V178, P732, DOI 10.4049/jimmunol.178.2.732; Sakaguchi S, 2003, J CLIN INVEST, V112, P1310, DOI 10.1172/JCI200320274; Sarigul M, 2010, LUPUS, V19, P138, DOI 10.1177/0961203309348234; Shearer WT, 2003, J ALLERGY CLIN IMMUN, V112, P973, DOI 10.1016/j.jaci.2003.07.003; Slobodin G, 2010, CELL IMMUNOL, V261, P77, DOI 10.1016/j.cellimm.2009.12.009; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Sun JB, 2006, J IMMUNOL, V177, P7634, DOI 10.4049/jimmunol.177.11.7634; Tack GJ, 2010, NAT REV GASTRO HEPAT, V7, P204, DOI 10.1038/nrgastro.2010.23; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Tiittanen M, 2008, CLIN EXP IMMUNOL, V152, P498, DOI 10.1111/j.1365-2249.2008.03662.x; Tokuno K, 2009, ANTICANCER RES, V29, P1527; TRIER JS, 1991, NEW ENGL J MED, V325, P1709, DOI 10.1056/NEJM199112123252406; van Dieren JM, 2011, EUR J IMMUNOL, V41, P1047, DOI 10.1002/eji.201040899; Verhagen J, 2010, J IMMUNOL, V185, P7129, DOI 10.4049/jimmunol.1090105; Vorobjova T, 2009, SCAND J GASTROENTERO, V44, P422, DOI 10.1080/00365520802624177; Zabransky DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034547; Zanzi D, 2011, AM J GASTROENTEROL, V106, P1308, DOI 10.1038/ajg.2011.80; Zhang L, 2010, CLIN IMMUNOL, V135, P108, DOI 10.1016/j.clim.2009.11.008	42	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e68432	10.1371/journal.pone.0068432	http://dx.doi.org/10.1371/journal.pone.0068432			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	23874626	gold, Green Published, Green Submitted			2022-12-27	WOS:000321718700025
J	Takahashi, H; Yokota, R; Kanzaki, R				Takahashi, Hirokazu; Yokota, Ryo; Kanzaki, Ryohei			Response Variance in Functional Maps: Neural Darwinism Revisited	PLOS ONE			English	Article							PRIMARY AUDITORY-CORTEX; RECEPTIVE-FIELD PLASTICITY; CEREBRAL-CORTEX; NUCLEUS BASALIS; SENSORY CORTEX; DISCRIMINATION; REPRESENTATION; ORGANIZATION; MEMORY; RAT	The mechanisms by which functional maps and map plasticity contribute to cortical computation remain controversial. Recent studies have revisited the theory of neural Darwinism to interpret the learning-induced map plasticity and neuronal heterogeneity observed in the cortex. Here, we hypothesize that the Darwinian principle provides a substrate to explain the relationship between neuron heterogeneity and cortical functional maps. We demonstrate in the rat auditory cortex that the degree of response variance is closely correlated with the size of its representational area. Further, we show that the response variance within a given population is altered through training. These results suggest that larger representational areas may help to accommodate heterogeneous populations of neurons. Thus, functional maps and map plasticity are likely to play essential roles in Darwinian computation, serving as effective, but not absolutely necessary, structures to generate diverse response properties within a neural population.	[Takahashi, Hirokazu; Yokota, Ryo; Kanzaki, Ryohei] Univ Tokyo, Grad Sch Informat Sci & Technol, Bunkyo Ku, Tokyo, Japan; [Takahashi, Hirokazu; Kanzaki, Ryohei] Univ Tokyo, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo, Japan; [Takahashi, Hirokazu] JST, PRESTO, Kawaguchi, Saitama, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST)	Takahashi, H (corresponding author), Univ Tokyo, Grad Sch Informat Sci & Technol, Bunkyo Ku, Tokyo, Japan.	takahashi@i.u-tokyo.ac.jp			JST (Japan Science and Technology agency) PRESTO program	JST (Japan Science and Technology agency) PRESTO program	This work was supported by JST (Japan Science and Technology agency) PRESTO program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DL, 2003, NAT NEUROSCI, V6, P113, DOI 10.1038/nn1004; Bakin JS, 1996, P NATL ACAD SCI USA, V93, P11219, DOI 10.1073/pnas.93.20.11219; Bandyopadhyay S, 2010, NAT NEUROSCI, V13, P361, DOI 10.1038/nn.2490; Bar-Yosef O, 2002, J NEUROSCI, V22, P8619; BARFIELD RJ, 1972, SCIENCE, V176, P1349, DOI 10.1126/science.176.4041.1349; BEAR MF, 1987, SCIENCE, V237, P42, DOI 10.1126/science.3037696; Bieszczad KM, 2010, P NATL ACAD SCI USA, V107, P3793, DOI 10.1073/pnas.1000159107; BLANCHARD RJ, 1991, PHYSIOL BEHAV, V50, P967, DOI 10.1016/0031-9384(91)90423-L; Brown M, 2004, CEREB CORTEX, V14, P952, DOI 10.1093/cercor/bhh056; DAWKINS R, 1971, NATURE, V229, P118, DOI 10.1038/229118a0; Ecker AS, 2010, SCIENCE, V327, P584, DOI 10.1126/science.1179867; EDELINE JM, 1993, BEHAV NEUROSCI, V107, P82, DOI 10.1037/0735-7044.107.1.82; EDELMAN GM, 1993, NEURON, V10, P115, DOI 10.1016/0896-6273(93)90304-A; Feldman DE, 2009, ANNU REV NEUROSCI, V32, P33, DOI 10.1146/annurev.neuro.051508.135516; FIELD DJ, 1994, NEURAL COMPUT, V6, P559, DOI 10.1162/neco.1994.6.4.559; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Funamizu A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063655; Gdalyahu A, 2012, NEURON, V75, P121, DOI 10.1016/j.neuron.2012.04.035; Ghose GM, 2004, CURR OPIN NEUROBIOL, V14, P513, DOI 10.1016/j.conb.2004.07.003; Han YK, 2007, NAT NEUROSCI, V10, P1191, DOI 10.1038/nn1941; Horton JC, 2005, PHILOS T R SOC B, V360, P837, DOI 10.1098/rstb.2005.1623; Hromadka T, 2008, PLOS BIOL, V6, P124, DOI 10.1371/journal.pbio.0060016; Kilgard MP, 2012, TRENDS NEUROSCI, V35, P715, DOI 10.1016/j.tins.2012.09.002; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Levy WB, 1996, NEURAL COMPUT, V8, P531, DOI 10.1162/neco.1996.8.3.531; Ma LS, 2010, BRAIN RES, V1318, P64, DOI 10.1016/j.brainres.2009.12.073; MERZENICH MM, 1975, J NEUROPHYSIOL, V38, P231, DOI 10.1152/jn.1975.38.2.231; Molina-Luna K, 2008, NEUROIMAGE, V40, P1748, DOI 10.1016/j.neuroimage.2007.11.018; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Nelken I, 2007, HEARING RES, V229, P94, DOI 10.1016/j.heares.2007.01.012; Ohl FW, 2005, CURR OPIN NEUROBIOL, V15, P470, DOI 10.1016/j.conb.2005.07.002; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; Pienkowski M, 2011, NEUROSCI BIOBEHAV R, V35, P2117, DOI 10.1016/j.neubiorev.2011.02.002; Polley DB, 2007, J NEUROPHYSIOL, V97, P3621, DOI 10.1152/jn.01298.2006; Polley DB, 2006, J NEUROSCI, V26, P4970, DOI 10.1523/JNEUROSCI.3771-05.2006; RECANZONE GH, 1993, J NEUROSCI, V13, P87; Reed A, 2011, NEURON, V70, P121, DOI 10.1016/j.neuron.2011.02.038; Renart A, 2010, SCIENCE, V327, P587, DOI 10.1126/science.1179850; Rothschild G, 2010, NAT NEUROSCI, V13, P353, DOI 10.1038/nn.2484; Rutkowski RG, 2005, P NATL ACAD SCI USA, V102, P13664, DOI 10.1073/pnas.0506838102; Takahashi H, 2011, NEUROSCIENCE, V199, P243, DOI 10.1016/j.neuroscience.2011.09.046; Takahashi H, 2010, BIOSYSTEMS, V101, P37, DOI 10.1016/j.biosystems.2010.04.003; Talwar SK, 2001, J NEUROPHYSIOL, V86, P1555, DOI 10.1152/jn.2001.86.4.1555; Tanaka K, 2003, CEREB CORTEX, V13, P90, DOI 10.1093/cercor/13.1.90; Wang XQ, 1995, J NEUROPHYSIOL, V74, P2685, DOI 10.1152/jn.1995.74.6.2685; Weinberger NM, 2007, LEARN MEMORY, V14, P1, DOI 10.1101/lm.421807; Yokota R, 2012, NEUROSCIENCE, V223, P377, DOI 10.1016/j.neuroscience.2012.07.051; Yotsumoto Y, 2008, NEURON, V57, P827, DOI 10.1016/j.neuron.2008.02.034; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	50	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e68705	10.1371/journal.pone.0068705	http://dx.doi.org/10.1371/journal.pone.0068705			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874733	Green Published, gold, Green Submitted			2022-12-27	WOS:000322218800041
J	Hardelid, P; Davey, J; Dattani, N; Gilbert, R				Hardelid, Pia; Davey, Jonathan; Dattani, Nirupa; Gilbert, Ruth		Royal Coll Paediat Child Hlth	Child Deaths Due to Injury in the Four UK Countries: A Time Trends Study from 1980 to 2010	PLOS ONE			English	Article							ADOLESCENT MORTALITY; NORDIC COUNTRIES; SEX-DIFFERENCES	Background: Injuries are an increasingly important cause of death in children worldwide, yet injury mortality is highly preventable. Determining patterns and trends in child injury mortality can identify groups at particularly high risk. We compare trends in child deaths due to injury in four UK countries, between 1980 and 2010. Methods: We obtained information from death certificates on all deaths occurring between 1980 and 2010 in children aged 28 days to 18 years and resident in England, Scotland, Wales or Northern Ireland. Injury deaths were defined by an external cause code recorded as the underlying cause of death. Injury mortality rates were analysed by type of injury, country of residence, age group, sex and time period. Results: Child mortality due to injury has declined in all countries of the UK. England consistently experienced the lowest mortality rate throughout the study period. For children aged 10 to 18 years, differences between countries in mortality rates increased during the study period. Inter-country differences were largest for boys aged 10 to 18 years with mortality rate ratios of 1.38 (95% confidence interval 1.16, 1.64) for Wales, 1.68 (1.48, 1.91) for Scotland and 1.81 (1.50, 2.18) for Northern Ireland compared with England (the baseline) in 2006-10. The decline in mortality due to injury was accounted for by a decline in unintentional injuries. For older children, no declines were observed for deaths caused by self-harm, by assault or from undetermined intent in any UK country. Conclusion: Whilst child deaths from injury have declined in all four UK countries, substantial differences in mortality rates remain between countries, particularly for older boys. This group stands to gain most from policy interventions to reduce deaths from injury in children.	[Hardelid, Pia; Davey, Jonathan; Dattani, Nirupa; Gilbert, Ruth] UCL, Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London, England	University of London; University College London	Gilbert, R (corresponding author), UCL, Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London, England.	r.gilbert@ucl.ac.uk	Hardelid, Pia/K-3353-2013	Hardelid, Pia/0000-0002-0154-1306; Gilbert, Ruth/0000-0001-9347-2709	Department of Health; health department of the Scottish Government; health department of the Welsh Government; States of Jersey; Isle of Man; Department of Health's National Institute of Health Research ('Biomedical Research Centres' [MRC]); Medical Research Council; States of Guernsey; Medical Research Council [MR/K006584/1, G0400546] Funding Source: researchfish; MRC [G0400546] Funding Source: UKRI	Department of Health; health department of the Scottish Government; health department of the Welsh Government; States of Jersey; Isle of Man; Department of Health's National Institute of Health Research ('Biomedical Research Centres' [MRC])(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); States of Guernsey; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Clinical Outcome Review Programme: Child Health Reviews-UK is commissioned by the Healthcare Quality Improvement Partnership (HQIP) on behalf of the funding bodies of the Department of Health, the health department of the Scottish Government, the health department of the Welsh Government, the States of Jersey, States of Guernsey, and the Isle of Man. This work was undertaken at Great Ormond Street Hospital/University College London, Institute of Child Health, which received a proportion of funding from the Department of Health's National Institute of Health Research ('Biomedical Research Centres' [MRC] funding). The Medical Research Council provides funds for the MRC Centre of Epidemiology for Child Health. RG is a member of the CHAPTER e-Health Centre funded by the MRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Administrative Data Taskforce, 2012, UK ADM DAT RES NETW; Armour-Marshall J, 2012, EUR J PUBLIC HEALTH, V22, P61, DOI 10.1093/eurpub/ckr004; Department for Work and Pensions, 2012, HOUS AV INC 1994 95; Gissler M, 2012, J EPIDEMIOL COMMUN H, V66, P57, DOI 10.1136/jech.2009.093153; Gissler M, 2009, SCAND J PUBLIC HEALT, V37, P340, DOI 10.1177/1403494809103905; Hjern A, 2004, J EPIDEMIOL COMMUN H, V58, P412, DOI 10.1136/jech.2003.014282; Jung-Choi K, 2011, J EPIDEMIOL COMMUN H, V65, P124, DOI 10.1136/jech.2008.086884; Moller J, 1997, PROGR CURRENT ISSUES; National Records for Scotland, 2012, WEEKL DAT BIRTHS DEA; Office for National Statistics, 2012, MORT STAT MET; Orton E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035193; R Core Team, 2012, R LANG ENV STAT COMP; ROBERTS I, 1993, BRIT MED J, V306, P1737, DOI 10.1136/bmj.306.6894.1737; Roberts I, 1996, BRIT MED J, V313, P784; Roberts I, 1998, Inj Prev, V4, pS10; Safe Kids USA, 2011, TRENDS UN CHILDH INJ; Shaw Caroline, 2005, N Z Med J, V118, pU1779; The Prince's Trust, 2007, COST EXCL COUNT COST; The Scottish Government, 2012, HIGH LEV SUMM STAT T; Unicef Innocenti Research Centre, 2001, LEAG TABL CHILD DEAT; United Nations Development Programme (UNDP), 2010, HUMAN DEV REPORT 201; Venables WN., 2002, MODERN APPL STAT S 4; Viner RM, 2011, LANCET, V377, P1162, DOI 10.1016/S0140-6736(11)60106-2; Weitoft GR, 2003, LANCET, V361, P289, DOI 10.1016/S0140-6736(03)12324-0; World Health Organisation, 2010, INT CLASS DIS REL HL; World Health Organisation Regional Office for Europe, 2000, HLTH HLTH BEH YOUNG; World Health Organization, 2008, WORLD REPORT CHILD I	27	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68323	10.1371/journal.pone.0068323	http://dx.doi.org/10.1371/journal.pone.0068323			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874585	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000321765300042
J	Pongrakhananon, V; Chunhacha, P; Chanvorachote, P				Pongrakhananon, Varisa; Chunhacha, Preedakorn; Chanvorachote, Pithi			Ouabain Suppresses the Migratory Behavior of Lung Cancer Cells	PLOS ONE			English	Article							FOCAL ADHESION KINASE; INVASION; METASTASIS; MOTILITY; CDC42; LAMELLIPODIA; EXPRESSION; FILOPODIA; ANTISENSE; PATHWAY	The migratory capability of cancer cells is one of the most important hallmarks reflecting metastatic potential. Ouabain, an endogenous cardiac glycoside produced by the adrenal gland, has been previously reported to have anti-tumor activities; however, its role in the regulation of cancer cell migration remains unknown. The present study has revealed that treatment with ouabain at physiological concentrations is able to inhibit the migratory activities of human lung cancer H292 cells. The negative effects of ouabain were found to be mediated through the suppression of migration regulatory proteins, such as focal adhesion kinase (FAK), ATP-dependent tyrosine kinase (Akt), and cell division cycle 42 (Cdc42). We found that the observed actions of ouabain were mediated via a reactive oxygen species (ROS)-dependent mechanism because the addition of ROS scavengers (N-acetylcysteine and glutathione) could reverse the effect of ouabain on cell migration. Furthermore, ouabain was shown to inhibit the spheroidal tumor growth and decrease the cancer cell adhesion to endothelial cells. However, the compound had no significant effect on anoikis of the cells. Together, these findings shed light on the understanding of cancer cell biology by exploring the novel function of this endogenous human substance.	[Chanvorachote, Pithi] Chulalongkorn Univ, Dept Physiol & Pharmacol, Fac Pharmaceut Sci, Bangkok, Thailand; Chulalongkorn Univ, Cell Based Drug & Hlth Prod Dev Res Unit, Bangkok, Thailand	Chulalongkorn University; Chulalongkorn University	Chanvorachote, P (corresponding author), Chulalongkorn Univ, Dept Physiol & Pharmacol, Fac Pharmaceut Sci, Bangkok, Thailand.	pithi_chan@yahoo.com		Chunhacha, Preedakorn/0000-0002-5060-7113; chanvorachote, pithi/0000-0002-3103-3249	Thailand Research Fund; Ratchadaphiseksomphot Endowment Fund	Thailand Research Fund(Thailand Research Fund (TRF)); Ratchadaphiseksomphot Endowment Fund	This research was supported by the Thailand Research Fund and Ratchadaphiseksomphot Endowment Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chanvorachote P, 2013, AM J PHYSIOL-CELL PH, V304, pC263, DOI 10.1152/ajpcell.00225.2012; Chanvorachote P, 2009, J BIOL CHEM, V284, P28476, DOI 10.1074/jbc.M109.050864; Chen JS, 2010, CLIN EXP METASTAS, V27, P71, DOI 10.1007/s10585-010-9306-3; Chen QY, 2012, INT J ONCOL, V40, P1561, DOI 10.3892/ijo.2012.1336; Chunhacha Preedakorn, 2012, Int J Physiol Pathophysiol Pharmacol, V4, P149; GOTTLIEB SS, 1992, CIRCULATION, V86, P420, DOI 10.1161/01.CIR.86.2.420; HAMLYN JM, 1991, P NATL ACAD SCI USA, V88, P6259, DOI 10.1073/pnas.88.14.6259; Hiratsuka S, 2011, P NATL ACAD SCI USA, V108, P3725, DOI 10.1073/pnas.1100446108; Hsia DA, 2003, J CELL BIOL, V160, P753, DOI 10.1083/jcb.200212114; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Huang Q, 2005, CELL MOL LIFE SCI, V62, P1167, DOI 10.1007/s00018-005-5050-2; Itoh K, 1999, NAT MED, V5, P221, DOI 10.1038/5587; Johnson E, 2010, J BIOL CHEM, V285, P29491, DOI 10.1074/jbc.M110.136770; KARIYA K, 1986, CLIN EXP HYPERTENS A, V8, P167, DOI 10.3109/10641968609074770; Kim D, 2001, FASEB J, V15, P1953, DOI 10.1096/fj.01-0198com; Kim JB, 2005, SEMIN CANCER BIOL, V15, P365, DOI 10.1016/j.semcancer.2005.05.002; Lietha D, 2007, CELL, V129, P1177, DOI 10.1016/j.cell.2007.05.041; Liu M, 2011, INT J CANCER, V128, P1269, DOI 10.1002/ijc.25452; Luanpitpong S, 2010, J BIOL CHEM, V285, P38832, DOI 10.1074/jbc.M110.124958; Machesky LM, 2008, FEBS LETT, V582, P2102, DOI 10.1016/j.febslet.2008.03.039; Manunta P, 1999, HYPERTENSION, V34, P450, DOI 10.1161/01.HYP.34.3.450; Manunta P, 2001, HYPERTENSION, V38, P198, DOI 10.1161/01.HYP.38.2.198; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Meng XN, 2009, BRIT J CANCER, V101, P327, DOI 10.1038/sj.bjc.6605154; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Miyazaki T, 2003, BRIT J CANCER, V89, P140, DOI 10.1038/sj.bjc.6601050; Nicholls MG, 2009, J HYPERTENS, V27, P3, DOI 10.1097/HJH.0b013e32831101d1; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Nyga A, 2013, ACTA BIOMATER, V9, P7917, DOI 10.1016/j.actbio.2013.04.028; Nyga A, 2011, J CELL COMMUN SIGNAL, V5, P239, DOI 10.1007/s12079-011-0132-4; Park YM, 2009, J CLIN INVEST, V119, P136, DOI 10.1172/JCI35535; Pu PY, 2006, J NEURO-ONCOL, V76, P1, DOI 10.1007/s11060-005-3029-3; Pu PY, 2004, TUMOR BIOL, V25, P172, DOI 10.1159/000081099; Scaltriti M, 2006, CLIN CANCER RES, V12, P5268, DOI 10.1158/1078-0432.CCR-05-1554; Shen Q, 2008, MOL CANCER RES, V6, P555, DOI 10.1158/1541-7786.MCR-07-2033; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Usatyuk PV, 2005, AM J PHYSIOL-LUNG C, V289, pL999, DOI 10.1152/ajplung.00211.2005; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245	40	39	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68623	10.1371/journal.pone.0068623	http://dx.doi.org/10.1371/journal.pone.0068623			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874694	gold, Green Submitted, Green Published			2022-12-27	WOS:000321765300057
J	Price, H; Dunn, D; Pillay, D; Bani-Sadr, F; de Vries-Sluijs, T; Jain, MK; Kuzushita, N; Mauss, S; Nunez, M; Nuesch, R; Peters, M; Reiberger, T; Stephan, C; Tan, L; Gilson, R				Price, Huw; Dunn, David; Pillay, Deenan; Bani-Sadr, Firouze; de Vries-Sluijs, Theodora; Jain, Mamta K.; Kuzushita, Noriyoshi; Mauss, Stefan; Nunez, Marina; Nueesch, Reto; Peters, Marion; Reiberger, Thomas; Stephan, Christoph; Tan, Lionel; Gilson, Richard			Suppression of HBV by Tenofovir in HBV/HIV Coinfected Patients: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							HEPATITIS-B-VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL-THERAPY; DISOPROXIL FUMARATE; POLYMERASE MUTATIONS; PLUS EMTRICITABINE; SURFACE-ANTIGEN; RESCUE THERAPY; HIV; LAMIVUDINE	Background: Hepatitis B coinfection is common in HIV-positive individuals and as antiretroviral therapy has made death due to AIDS less common, hepatitis has become increasingly important. Several drugs are available to treat hepatitis B. The most potent and the one with the lowest risk of resistance appears to be tenofovir (TDF). However there are several questions that remain unanswered regarding the use of TDF, including the proportion of patients that achieves suppression of HBV viral load and over what time, whether suppression is durable and whether prior treatment with other HBV-active drugs such as lamivudine, compromises the efficacy of TDF due to possible selection of resistant HBV strains. Methods: A systematic review and meta-analysis following PRISMA guidelines and using multilevel mixed effects logistic regression, stratified by prior and/or concomitant use of lamivudine and/or emtricitabine. Results: Data was available from 23 studies including 550 HBV/HIV coinfected patients treated with TDF. Follow up was for up to seven years but to ensure sufficient power the data analyses were limited to three years. The overall proportion achieving suppression of HBV replication was 57.4%, 79.0% and 85.6% at one, two and three years, respectively. No effect of prior or concomitant 3TC/FTC was shown. Virological rebound on TDF treatment was rare. Interpretation: TDF suppresses HBV to undetectable levels in the majority of HBV/HIV coinfected patients with the proportion fully suppressed continuing to increase during continuous treatment. Prior treatment with 3TC/FTC does not compromise efficacy of TDF treatment. The use of combination treatment with 3TC/FTC offers no significant benefit over TDF alone.	[Price, Huw; Gilson, Richard] UCL, Res Dept Infect & Populat Hlth, London, England; [Dunn, David] MRC, Clin Trials Unit, London, England; [Pillay, Deenan] UCL, London, England; [Bani-Sadr, Firouze] Hop Tenon, AP HP, F-75970 Paris, France; [de Vries-Sluijs, Theodora] Erasmus MC, Rotterdam, Netherlands; [Jain, Mamta K.] UT Southwestern Med Ctr, Dallas, TX USA; [Kuzushita, Noriyoshi] Osaka Natl Hosp, Osaka, Japan; [Mauss, Stefan] Ctr HIV & Hepatogastroenterol, Dusseldorf, Germany; [Nunez, Marina] Wake Forest Univ Hlth Sci, Winston Salem, NC USA; [Nueesch, Reto] Univ Basel Hosp, CH-4031 Basel, Switzerland; [Peters, Marion] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Reiberger, Thomas] Med Univ Vienna, Vienna, Austria; [Stephan, Christoph] Goethe Univ Frankfurt, D-60054 Frankfurt, Germany; [Tan, Lionel] Univ London Imperial Coll Sci Technol & Med, London, England	University of London; University College London; Medical Research Council Clinical Trials Unit; University of London; University College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Erasmus University Rotterdam; Erasmus MC; University of Texas System; University of Texas Southwestern Medical Center Dallas; Osaka National Hospital; Wake Forest University; Wake Forest University School of Medicine; University of Basel; University of California System; University of California San Francisco; Medical University of Vienna; Goethe University Frankfurt; Imperial College London	Price, H (corresponding author), UCL, Res Dept Infect & Populat Hlth, London, England.	huw.price@ucl.ac.uk	Jain, Mamta/W-9767-2019; Reiberger, Thomas/H-7613-2019; Stephan, Christoph/D-1305-2014	Jain, Mamta/0000-0003-2292-6544; Reiberger, Thomas/0000-0002-4590-3583; Stephan, Christoph/0000-0003-3777-9006; Dunn, David/0000-0003-1836-4446	Medical Research Council; Medical Research Council [MR/K006584/1] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	HP is funded by a fellowship from the Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Uria G, 2009, HIV MED, V10, P269, DOI 10.1111/j.1468-1293.2008.00683.x; Amini-Bavil-Olyaee S, 2009, HEPATOLOGY, V49, P1158, DOI 10.1002/hep.22790; Ayihingsanon A, 2010, ANTIVIR THER, V15, P917, DOI 10.3851/IMP1645; Bani-Sadr F, 2004, CLIN INFECT DIS, V39, P1062, DOI 10.1086/424012; Benhamou Y, 1999, HEPATOLOGY, V30, P1302, DOI 10.1002/hep.510300525; Berg T, 2010, 61 ANN M AM ASS STUD; Berg T, 2010, GASTROENTEROLOGY, V139, P1207, DOI 10.1053/j.gastro.2010.06.053; Brook G, 2010, HIV MED, V11, P1, DOI 10.1111/j.1468-1293.2009.00781.x; Butt Adeel A, 2006, AIDS Read, V16, P219; de Vries-Sluijs TEMS, 2010, GASTROENTEROLOGY, V139, P1934, DOI 10.1053/j.gastro.2010.08.045; Delaney WE, 2006, ANTIMICROB AGENTS CH, V50, P2471, DOI 10.1128/AAC.00138-06; Dore GJ, 2004, J INFECT DIS, V189, P1185, DOI 10.1086/380398; Engell Christian A, 2011, ISRN Gastroenterol, V2011, P405390, DOI 10.5402/2011/405390; Fung S, 2009, 60 ANN M AM ASS STUD; Gutierrez S, 2008, CLIN INFECT DIS, V46, pE28, DOI 10.1086/525857; Jain MK, 2007, J VIRAL HEPATITIS, V14, P176, DOI 10.1111/j.1365-2893.2006.00797.x; Kosi L, 2012, J VIRAL HEPATITIS, V19, P801, DOI 10.1111/j.1365-2893.2012.01601.x; Kuzushita N, 2010, 61 ANN M AM ASS STUD; Lacombe K, 2008, ANTIVIR THER, V13, P705; Lee T, 2009, HIV CLIN TRIALS, V10, P153, DOI 10.1310/hct1003-153; Marcelin AG, 2003, 10 C RETR OPP INF BO; Marcellin P, 2008, NEW ENGL J MED, V359, P2442, DOI 10.1056/NEJMoa0802878; Martin-Carbonero L, 2011, AIDS, V25, P73, DOI 10.1097/QAD.0b013e328340fde2; Matthews GV, 2008, HEPATOLOGY, V48, P1062, DOI 10.1002/hep.22462; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Nelson M, 2006, 13 C RETR OPP INF DE; Nuesch R, 2008, AIDS, V22, P152, DOI 10.1097/QAD.0b013e3282f303bf; Ong A, 2011, ALIMENT PHARM THER, V34, P972, DOI 10.1111/j.1365-2036.2011.04833.x; Peters MG, 2006, HEPATOLOGY, V44, P1110, DOI 10.1002/hep.21388; Petersen J, 2012, J HEPATOL, V56, P520, DOI 10.1016/j.jhep.2011.09.018; Psevdos G, 2010, WORLD J GASTROENTERO, V16, P1093, DOI 10.3748/wjg.v16.i9.1093; Qi XP, 2007, ANTIVIR THER, V12, P355; Quiros-Roldan E, 2008, ANTIVIR THER, V13, P341; Rodriguez Allan E, 2010, Open AIDS J, V4, P167, DOI [10.2174/1874613601004020062, 10.2174/1874613601004010167]; Santos SA, 2006, EUR J GASTROEN HEPAT, V18, P1247, DOI 10.1097/01.meg.0000243877.17444.5e; Schmutz G, 2006, AIDS, V20, P1951, DOI 10.1097/01.aids.0000247116.89455.5d; Sheldon J, 2005, ANTIVIR THER, V10, P727; Si-Ahmed SN, 2011, ANTIVIR RES, V92, P90, DOI 10.1016/j.antiviral.2011.07.003; Stephan C, 2005, J ANTIMICROB CHEMOTH, V56, P1087, DOI 10.1093/jac/dki396; Sterne JAC, 2004, STATA J, V4, P127, DOI 10.1177/1536867X0400400204; Tan LKK, 2009, J VIRAL HEPATITIS, V16, P471, DOI 10.1111/j.1365-2893.2009.01084.x; Tuma P, 2008, 59 ANN M AM ASS STUD; van Bommel F, 2004, HEPATOLOGY, V40, P1421, DOI 10.1002/hep.20464; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; Woo G, 2010, GASTROENTEROLOGY, V139, P1218, DOI 10.1053/j.gastro.2010.06.042; Zoutendijk R, 2012, J INFECT DIS, V206, P974, DOI 10.1093/infdis/jis439	46	48	48	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68152	10.1371/journal.pone.0068152	http://dx.doi.org/10.1371/journal.pone.0068152			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874527	Green Published, Green Submitted, gold			2022-12-27	WOS:000321765300030
J	Zhou, GQ; Yu, XL; Chen, M; Guo, R; Lei, Y; Sun, Y; Mao, YP; Liu, LZ; Li, L; Lin, AH; Ma, J				Zhou, Guan-Qun; Yu, Xiao-Li; Chen, Mo; Guo, Rui; Lei, Ying; Sun, Ying; Mao, Yan-Ping; Liu, Li-Zhi; Li, Li; Lin, Ai-Hua; Ma, Jun			Radiation-Induced Temporal Lobe Injury for Nasopharyngeal Carcinoma: A Comparison of Intensity-Modulated Radiotherapy and Conventional Two-Dimensional Radiotherapy	PLOS ONE			English	Article							NECROSIS FOLLOWING RADIOTHERAPY; CLINICAL-DIAGNOSIS; THERAPY; FRACTIONATION; FEASIBILITY; PLANS	Background: To compare the radiation-induced temporal lobe injury (TLI) in patients with nasopharyngeal carcinoma (NPC) treated with intensity-modulated radiotherapy (IMRT) or two-dimensional conventional radiotherapy (2D-CRT). Patients and Methods: 1276 cases of NPC treated with IMRT or 2D-CRT were retrospectively reviewed. A diagnosis of TLI was made on follow-up magnetic resonance imaging (MRI). Results: The crude incidence of TLI was 7.5% and 10.8% (P = 0.048), and the actuarial 5-year incidence was 16% and 34.9% (P < 0.001) for the IMRT and 2D-CRT groups, respectively. Multivariate analysis revealed both T stage (P < 0.001) and radiation technique (P, 0.001) as independent predictors. Patients with T1, T2 and T3 disease had a significantly higher risk when treated with 2D-CRT (P = 0.005, 0.016, <0.001, respectively). This trend was not evident for T4 patients (P = 0.680). The 2D-CRT group had a longer latency for the development of TLI (P, 0.001). Those with T4 disease had a shorter median time to TLI (P = 0.006, 0.042, <0.001 when compared with T1, T2 and T3, respectively). Conclusions: IMRT is superior to 2DRT for the management of T1-T3 NPC in terms of sparing the temporal lobe. The high incidence of TLI in T4 disease needs to be addressed.	[Zhou, Guan-Qun; Yu, Xiao-Li; Chen, Mo; Guo, Rui; Lei, Ying; Sun, Ying; Mao, Yan-Ping; Ma, Jun] Sun Yat Sen Univ, State Key Lab Oncol Southern China, Dept Radiat Oncol, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Li-Zhi; Li, Li] Sun Yat Sen Univ, State Key Lab Oncol Southern China, Imaging Diag & Intervent Ctr, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Lin, Ai-Hua] Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University	Ma, J (corresponding author), Sun Yat Sen Univ, State Key Lab Oncol Southern China, Dept Radiat Oncol, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China.	drjunma@hotmail.com			Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme; Science Foundation of Key Hospital Clinical Program of Ministry of Health, P. R. China [2010-178]; National Natural Science Foundation of China [81071836]	Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme; Science Foundation of Key Hospital Clinical Program of Ministry of Health, P. R. China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Project Supported by Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2010), the Science Foundation of Key Hospital Clinical Program of Ministry of Health, P. R. China (No.2010-178); and the National Natural Science Foundation of China (No. 81071836). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Joint Committee on Cancer (AJCC), 2002, AJCC CANC STAG MAN, P157; Bakst RL, 2011, INT J RADIAT ONCOL, V80, P148, DOI 10.1016/j.ijrobp.2010.01.026; Ballivy O, 2006, Curr Oncol, V13, P108; CHATANI M, 1986, CANCER, V57, P2267, DOI 10.1002/1097-0142(19860615)57:12<2267::AID-CNCR2820571205>3.0.CO;2-C; Chen SW, 2005, MED DOSIM, V30, P219, DOI 10.1016/j.meddos.2005.07.001; Cheung MC, 2003, CANCER-AM CANCER SOC, V97, P2019, DOI 10.1002/cncr.11295; Dorr W, 2010, NUKLEARMED-NUCL MED, V49, pS53; Edge SB, 2009, AM JOINT COMMITTEE C; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kam MKM, 2003, INT J RADIAT ONCOL, V56, P145, DOI 10.1016/S0360-3016(03)00075-0; Lai SZ, 2011, INT J RADIAT ONCOL, V80, P661, DOI 10.1016/j.ijrobp.2010.03.024; LEE AWM, 1992, BRIT J RADIOL, V65, P918, DOI 10.1259/0007-1285-65-778-918; Lee AWM, 1999, RADIOTHER ONCOL, V52, P207; LEE AWM, 1990, CLIN RADIOL, V42, P24, DOI 10.1016/S0009-9260(05)81617-4; LEE AWM, 1988, CANCER-AM CANCER SOC, V61, P1535, DOI 10.1002/1097-0142(19880415)61:8<1535::AID-CNCR2820610809>3.0.CO;2-E; Lee AWM, 1998, INT J RADIAT ONCOL, V40, P35, DOI 10.1016/S0360-3016(97)00580-4; Lee AWM, 2002, INT J RADIAT ONCOL, V53, P75, DOI 10.1016/S0360-3016(02)02711-6; Li WF, 2012, CHIN J CANCER, V31, P579, DOI 10.5732/cjc.012.10095; PEREZ CA, 1992, INT J RADIAT ONCOL, V23, P271, DOI 10.1016/0360-3016(92)90741-Y; SHAM J, 1994, INT J RADIAT ONCOL, V29, P699, DOI 10.1016/0360-3016(94)90556-8; Wang J, 2009, RADIOTHER ONCOL, V90, P221, DOI 10.1016/j.radonc.2008.08.017; Wang YXJ, 2010, RADIOLOGY, V254, P210, DOI 10.1148/radiol.09090428; Xia P, 2000, INT J RADIAT ONCOL, V48, P329, DOI 10.1016/S0360-3016(00)00585-X	23	58	61	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e67488	10.1371/journal.pone.0067488	http://dx.doi.org/10.1371/journal.pone.0067488			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874422	Green Published, Green Submitted, gold			2022-12-27	WOS:000321765300011
J	Nishimoto, M; Katano, M; Yamagishi, T; Hishida, T; Kamon, M; Suzuki, A; Hirasaki, M; Nabeshima, Y; Nabeshima, Y; Katsura, Y; Satta, Y; Deakin, JE; Graves, JAM; Kuroki, Y; Ono, R; Ishino, F; Ema, M; Takahashi, S; Kato, H; Okuda, A				Nishimoto, Masazumi; Katano, Miyuki; Yamagishi, Toshiyuki; Hishida, Tomoaki; Kamon, Masayoshi; Suzuki, Ayumu; Hirasaki, Masataka; Nabeshima, Yoko; Nabeshima, Yo-ichi; Katsura, Yukako; Satta, Yoko; Deakin, Janine E.; Graves, Jennifer A. Marshall; Kuroki, Yoko; Ono, Ryuichi; Ishino, Fumitoshi; Ema, Masatsugu; Takahashi, Satoru; Kato, Hidemasa; Okuda, Akihiko			In Vivo Function and Evolution of the Eutherian-Specific Pluripotency Marker UTF1	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; PLACENTAL DEVELOPMENT; SELF-RENEWAL; MOUSE; NANOG; EXPRESSION; SEQUENCE; SOX2; RETROTRANSPOSON; MAINTENANCE	Embryogenesis in placental mammals is sustained by exquisite interplay between the embryo proper and placenta. UTF1 is a developmentally regulated gene expressed in both cell lineages. Here, we analyzed the consequence of loss of the UTF1 gene during mouse development. We found that homozygous UTF1 mutant newborn mice were significantly smaller than wild-type or heterozygous mutant mice, suggesting that placental insufficiency caused by the loss of UTF1 expression in extra-embryonic ectodermal cells at least in part contributed to this phenotype. We also found that the effects of loss of UTF1 expression in embryonic stem cells on their pluripotency were very subtle. Genome structure and sequence comparisons revealed that the UTF1 gene exists only in placental mammals. Our analyses of a family of genes with homology to UTF1 revealed a possible mechanism by which placental mammals have evolved the UTF1 genes.	[Nishimoto, Masazumi] Saitama Med Univ, Res Ctr Genom Med, Radioisotope Expt Lab, Yamane Hidaka, Saitama, Japan; [Katano, Miyuki; Hishida, Tomoaki; Kamon, Masayoshi; Suzuki, Ayumu; Hirasaki, Masataka; Kato, Hidemasa; Okuda, Akihiko] Saitama Med Univ, Res Ctr Genom Med, Div Dev Biol, Yamane Hidaka, Saitama, Japan; [Yamagishi, Toshiyuki] Osaka City Univ, Grad Sch Med, Dept Anat & Cell Biol, Osaka 558, Japan; [Nabeshima, Yoko; Nabeshima, Yo-ichi] Fdn Biomed Res & Innovat, Chuo Ku, Kobe, Hyogo, Japan; [Katsura, Yukako; Satta, Yoko] Grad Univ Adv Studies Sokendai, Dept Evolutionary Studies Biosyst, Hayama, Kanagawa, Japan; [Deakin, Janine E.; Graves, Jennifer A. Marshall] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [Graves, Jennifer A. Marshall] La Trobe Univ, La Trobe Inst Mol Sci, Melbourne, Vic, Australia; [Kuroki, Yoko] RIKEN Res Ctr Allergy & Immunol, Lab Immunogen, Tsurumi Ku, Yokohama, Kanagawa, Japan; [Ono, Ryuichi; Ishino, Fumitoshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Epigenet, Chiyoda Ku, Tokyo, Japan; [Ema, Masatsugu; Takahashi, Satoru] Univ Tsukuba, Inst Basic Med Sci, Grad Sch Comprehens Human Sci, Dept Anat & Embryol, Tsukuba, Ibaraki 305, Japan; [Takahashi, Satoru; Okuda, Akihiko] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol CREST, Kawaguchi, Saitama, Japan	Saitama Medical University; Saitama Medical University; Osaka Metropolitan University; Institute for Biomedical Research & Innovation (IBRI); Graduate University for Advanced Studies - Japan; Australian National University; La Trobe University; RIKEN; Tokyo Medical & Dental University (TMDU); University of Tsukuba; Japan Science & Technology Agency (JST)	Nishimoto, M (corresponding author), Saitama Med Univ, Res Ctr Genom Med, Radioisotope Expt Lab, Yamane Hidaka, Saitama, Japan.	masamasa@saitama-med.ac.jp; akiokuda@saitama-med.ac.jp	Katsura, Yukako/V-1413-2018; Deakin, Janine/A-1941-2008	Deakin, Janine/0000-0002-1259-3531; Ema, Masatsugu/0000-0003-0645-6183; Graves, Jennifer/0000-0001-6480-7856; Satta, Yoko/0000-0002-5305-493X	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); Support Program for the Strategic Research Foundation at Private Universities; Grants-in-Aid for Scientific Research [25293082] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Support Program for the Strategic Research Foundation at Private Universities; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT), and mostly by the Support Program for the Strategic Research Foundation at Private Universities, 2008-2012. This study was performed as a part of the Core Research for Evolutional Science and Technology (CREST) Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], GENOMICS; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bryja V, 2006, STEM CELLS, V24, P844, DOI 10.1634/stemcells.2005-0444; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Cai JJ, 2010, GENOME BIOL EVOL, V2, P393, DOI 10.1093/gbe/evq019; Carter AM, 2007, PLACENTA, V28, pS41, DOI 10.1016/j.placenta.2006.11.002; Carvunis AR, 2012, NATURE, V487, P370, DOI 10.1038/nature11184; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Deakin JE, 2008, CHROMOSOME RES, V16, P1159, DOI 10.1007/s10577-008-1266-y; Edwards CA, 2008, PLOS BIOL, V6, P1292, DOI 10.1371/journal.pbio.0060135; Ekman D, 2010, J MOL BIOL, V396, P396, DOI 10.1016/j.jmb.2009.11.053; Evans M, 2011, NAT REV MOL CELL BIO, V12, P680, DOI 10.1038/nrm3190; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; FLEMING TP, 1987, DEV BIOL, V119, P520, DOI 10.1016/0012-1606(87)90055-8; Fukushima A, 1998, J BIOL CHEM, V273, P25840, DOI 10.1074/jbc.273.40.25840; Jia JL, 2012, CELL, V151, P576, DOI 10.1016/j.cell.2012.09.023; Kaneko-Ishino T, 2010, DEV GROWTH DIFFER, V52, P533, DOI 10.1111/j.1440-169X.2010.01194.x; Kusakabe M, 2011, BLOOD, V118, P1374, DOI 10.1182/blood-2010-08-300400; Lipman DJ, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-20; Mari G, 2007, CLIN OBSTET GYNECOL, V50, P497, DOI 10.1097/GRF.0b013e31804c96a9; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Miyagi S, 2008, FEBS LETT, V582, P2811, DOI 10.1016/j.febslet.2008.07.011; Mototani Y, 2006, GENOMICS, V87, P191, DOI 10.1016/j.ygeno.2005.09.011; Nishimoto M, 2005, MOL CELL BIOL, V25, P5084, DOI 10.1128/MCB.25.12.5084-5094.2005; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okuda A, 1998, EMBO J, V17, P2019, DOI 10.1093/emboj/17.7.2019; Ono R, 2006, NAT GENET, V38, P101, DOI 10.1038/ng1699; Pain B, 1996, DEVELOPMENT, V122, P2339; Pennisi DJ, 2012, PLACENTA, V33, P175, DOI 10.1016/j.placenta.2011.12.014; Petitte JN, 2004, MECH DEVELOP, V121, P1159, DOI 10.1016/j.mod.2004.05.003; Pfannkuche K, 2010, PLOS ONE, V5, pA140, DOI 10.1371/journal.pone.0009580; Rapkins RW, 2006, PLOS GENET, V2, P1666, DOI 10.1371/journal.pgen.0020182; Renfree MB, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r81; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Rossant J, 2009, DEVELOPMENT, V136, P701, DOI 10.1242/dev.017178; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tan SM, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm704; Taranova OV, 2006, GENE DEV, V20, P1187, DOI 10.1101/gad.1407906; Tautz D, 2011, NAT REV GENET, V12, P692, DOI 10.1038/nrg3053; van den Boom V, 2007, J CELL BIOL, V178, P913, DOI 10.1083/jcb.200702058; Wolf YI, 2009, P NATL ACAD SCI USA, V106, P7273, DOI 10.1073/pnas.0901808106; Yang ZZ, 2003, J BIOL CHEM, V278, P32124, DOI 10.1074/jbc.M302847200; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	50	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68119	10.1371/journal.pone.0068119	http://dx.doi.org/10.1371/journal.pone.0068119			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874519	Green Published, gold, Green Submitted			2022-12-27	WOS:000321736900060
J	Udhane, S; Kempna, P; Hofer, G; Mullis, PE; Fluck, CE				Udhane, Sameer; Kempna, Petra; Hofer, Gaby; Mullis, Primus E.; Flueck, Christa E.			Differential Regulation of Human 3 beta-Hydroxysteroid Dehydrogenase Type 2 for Steroid Hormone Biosynthesis by Starvation and Cyclic Amp Stimulation: Studies in the Human Adrenal NCI-H295R Cell Model	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; ORPHAN NUCLEAR RECEPTOR; DEHYDROGENASE/DELTA(5)-DELTA(4) ISOMERASE GENE; PROTEIN-KINASE KINASE; NGFI-B FAMILY; ADRENOCORTICAL-CELLS; ANDROGEN PRODUCTION; SIGNALING PATHWAYS; INSULIN-RESISTANCE; MOLECULAR-BIOLOGY	Human steroid biosynthesis depends on a specifically regulated cascade of enzymes including 3 beta-hydroxysteroid dehydrogenases (HSD3Bs). Type 2 HSD3B catalyzes the conversion of pregnenolone, 17 alpha- hydroxypregnenolone and dehydroepiandrosterone to progesterone, 17 alpha-hydroxyprogesterone and androstenedione in the human adrenal cortex and the gonads but the exact regulation of this enzyme is unknown. Therefore, specific downregulation of HSD3B2 at adrenarche around age 6-8 years and characteristic upregulation of HSD3B2 in the ovaries of women suffering from the polycystic ovary syndrome remain unexplained prompting us to study the regulation of HSD3B2 in adrenal NCI-H295R cells. Our studies confirm that the HSD3B2 promoter is regulated by transcription factors GATA, Nur77 and SF1/LRH1 in concert and that the NBRE/Nur77 site is crucial for hormonal stimulation with cAMP. In fact, these three transcription factors together were able to transactivate the HSD3B2 promoter in placental JEG3 cells which normally do not express HSD3B2. By contrast, epigenetic mechanisms such as methylation and acetylation seem not involved in controlling HSD3B2 expression. Cyclic AMP was found to exert differential effects on HSD3B2 when comparing short (acute) versus long-term (chronic) stimulation. Short cAMP stimulation inhibited HSD3B2 activity directly possibly due to regulation at co-factor or substrate level or posttranslational modification of the protein. Long cAMP stimulation attenuated HSD3B2 inhibition and increased HSD3B2 expression through transcriptional regulation. Although PKA and MAPK pathways are obvious candidates for possibly transmitting the cAMP signal to HSD3B2, our studies using PKA and MEK1/2 inhibitors revealed no such downstream signaling of cAMP. However, both signaling pathways were clearly regulating HSD3B2 expression.	[Udhane, Sameer; Kempna, Petra; Hofer, Gaby; Mullis, Primus E.; Flueck, Christa E.] Univ Childrens Hosp, Dept Pediat, Div Pediat Endocrinol & Diabetol, Bern, Switzerland; [Udhane, Sameer; Kempna, Petra; Hofer, Gaby; Mullis, Primus E.; Flueck, Christa E.] Univ Bern, Dept Clin Res, Bern, Switzerland; [Udhane, Sameer] Univ Bern, Grad Sch Berne Cellular & Biomed Sci, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Bern	Fluck, CE (corresponding author), Univ Childrens Hosp, Dept Pediat, Div Pediat Endocrinol & Diabetol, Bern, Switzerland.	christa.flueck@dkf.unibe.ch	Udhane, Sameer S./I-5165-2019	Udhane, Sameer S./0000-0002-9651-8159; Flueck, Christa/0000-0002-4568-5504	Swiss National Science Foundation [31003A-130710]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by a grant of the Swiss National Science Foundation (31003A-130710) to CEF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal AK, 2005, ENDOCRINOLOGY, V146, P2531, DOI 10.1210/en.2005-0061; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Alos N, 2000, J CLIN ENDOCR METAB, V85, P1968, DOI 10.1210/jc.85.5.1968; Auchus RJ, 2004, CLIN ENDOCRINOL, V60, P288, DOI 10.1046/j.1365-2265.2003.01858.x; Auchus RJ, 1998, TRENDS ENDOCRIN MET, V9, P47, DOI 10.1016/S1043-2760(98)00016-2; Bassett MH, 2004, ENDOCR RES, V30, P567, DOI 10.1081/ERC-200043715; Bassett MH, 2004, J BIOL CHEM, V279, P37622, DOI 10.1074/jbc.M405431200; Boerboom D, 2000, ENDOCRINOLOGY, V141, P4647, DOI 10.1210/en.141.12.4647; Castro DS, 1999, J BIOL CHEM, V274, P37483, DOI 10.1074/jbc.274.52.37483; Dardis A, 1999, PEDIATR RES, V45, P384, DOI 10.1203/00006450-199903000-00016; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dunaif A, 1997, ENDOCR REV, V18, P774, DOI 10.1210/er.18.6.774; Enyeart JJ, 1996, MOL CELL ENDOCRINOL, V124, P97, DOI 10.1016/S0303-7207(96)03938-X; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Feltus FA, 1999, MOL ENDOCRINOL, V13, P1084, DOI 10.1210/me.13.7.1084; FERGUSON JJ, 1963, J BIOL CHEM, V238, P2754; Fluck CE, 2004, MOL ENDOCRINOL, V18, P1144, DOI 10.1210/me.2003-0342; Gallo-Payet N, 2003, MICROSC RES TECHNIQ, V61, P275, DOI 10.1002/jemt.10337; Gingras S, 1999, MOL ENDOCRINOL, V13, P66, DOI 10.1210/me.13.1.66; Gingras S, 1999, ENDOCRINOLOGY, V140, P4573, DOI 10.1210/en.140.10.4573; Goto M, 2006, J CLIN INVEST, V116, P953, DOI 10.1172/JCI25091; Havelock JC, 2005, MOL HUM REPROD, V11, P79, DOI 10.1093/molehr/gah139; Havelock JC, 2004, SEMIN REPROD MED, V22, P337, DOI 10.1055/s-2004-861550; Hirakawa T, 2003, MOL ENDOCRINOL, V17, P2189, DOI 10.1210/me.2003-0205; Hirsch A, 2012, ENDOCRINOLOGY; Hirsch A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030956; Hirsch A, 2011, J CLIN ENDOCR METAB, V96, pE65, DOI 10.1210/jc.2010-1056; Hoivik EA, 2008, ENDOCRINOLOGY, V149, P5599, DOI 10.1210/en.2008-0104; Kelly SN, 2004, J ENDOCRINOL, V181, P355, DOI 10.1677/joe.0.1810355; Kempna P, 2010, MOL CELL ENDOCRINOL, V314, P101, DOI 10.1016/j.mce.2009.08.010; Kempna P, 2008, BEST PRACT RES CL EN, V22, P77, DOI 10.1016/j.beem.2007.07.008; Kempna P, 2010, ENDOCRINOLOGY, V151, P3686, DOI 10.1210/en.2010-0093; LACHANCE Y, 1991, DNA CELL BIOL, V10, P701, DOI 10.1089/dna.1991.10.701; LACHANCE Y, 1990, J BIOL CHEM, V265, P20469; LeersSucheta S, 1997, J BIOL CHEM, V272, P7960, DOI 10.1074/jbc.272.12.7960; Lin CJ, 2001, MOL ENDOCRINOL, V15, P1277, DOI 10.1210/me.15.8.1277; Logie A, 1999, J MOL ENDOCRINOL, V23, P23, DOI 10.1677/jme.0.0230023; LORENCE MC, 1990, MOL ENDOCRINOL, V4, P1850, DOI 10.1210/mend-4-12-1850; Manna PR, 2009, MOL HUM REPROD, V15, P321, DOI 10.1093/molehr/gap025; Martin LJ, 2005, MOL ENDOCRINOL, V19, P2358, DOI 10.1210/me.2004-0257; Martin LJ, 2005, ENDOCRINOLOGY, V146, P861, DOI 10.1210/en.2004-0859; Martinez-Arguelles DB, 2010, STEROIDS, V75, P467, DOI 10.1016/j.steroids.2010.02.004; Mikhaylova IV, 2008, J ENDOCRINOL, V199, P435, DOI 10.1677/JOE-08-0377; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Miller WL, 2009, REV ENDOCR METAB DIS, V10, P3, DOI 10.1007/s11154-008-9102-4; Missaghian E, 2009, J ENDOCRINOL, V202, P99, DOI 10.1677/JOE-08-0353; Moisan AM, 1999, J CLIN ENDOCR METAB, V84, P4410, DOI 10.1210/jc.84.12.4410; Nelson VL, 1999, MOL ENDOCRINOL, V13, P946, DOI 10.1210/me.13.6.946; Nelson VL, 2001, J CLIN ENDOCR METAB, V86, P5925, DOI 10.1210/jc.86.12.5925; Nogueira EF, 2009, J MOL ENDOCRINOL, V42, P319, DOI 10.1677/JME-08-0112; Nomura M, 1998, J BIOCHEM, V124, P217, DOI 10.1093/oxfordjournals.jbchem.a022083; Pawlak KJ, 2011, J BIOL CHEM, V286, P39130, DOI 10.1074/jbc.M111.290031; Peng LH, 2004, MOL ENDOCRINOL, V18, P2049, DOI 10.1210/me.2004-0028; Peng N, 2003, J CLIN ENDOCR METAB, V88, P6020, DOI 10.1210/jc.2003-030880; Rainey WE, 2004, MOL CELL ENDOCRINOL, V228, P23, DOI 10.1016/j.mce.2003.12.020; RHEAUME E, 1991, MOL ENDOCRINOL, V5, P1147, DOI 10.1210/mend-5-8-1147; Richards JS, 2001, MOL ENDOCRINOL, V15, P209, DOI 10.1210/me.15.2.209; Samandari E, 2007, J ENDOCRINOL, V195, P459, DOI 10.1677/JOE-07-0166; Sewer MB, 2002, ENDOCRINOLOGY, V143, P1280, DOI 10.1210/en.143.4.1280; Sewer MB, 2003, MICROSC RES TECHNIQ, V61, P300, DOI 10.1002/jemt.10339; Sewer MB, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290163; Simard J, 2005, ENDOCR REV, V26, P525, DOI 10.1210/er.2002-0050; SIMPSON ER, 1988, ANNU REV PHYSIOL, V50, P427, DOI 10.1146/annurev.ph.50.030188.002235; Stocco DM, 2005, MOL ENDOCRINOL, V19, P2647, DOI 10.1210/me.2004-0532; Tremblay JJ, 1999, MOL ENDOCRINOL, V13, P1388, DOI 10.1210/me.13.8.1388; Welzel M, 2008, J CLIN ENDOCR METAB, V93, P1418, DOI 10.1210/jc.2007-1874	66	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68691	10.1371/journal.pone.0068691	http://dx.doi.org/10.1371/journal.pone.0068691			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874725	Green Submitted, Green Published, gold			2022-12-27	WOS:000321736900104
J	van den Tillaart, SAHM; Corver, WE; Neto, DR; ter Haar, NT; Goeman, JJ; Trimbos, JBMZ; Fleuren, GJ; Oosting, J				van den Tillaart, Sabrina A. H. M.; Corver, Wim E.; Neto, Dina Ruano; ter Haar, Natalja T.; Goeman, Jelle J.; Trimbos, J. Baptist M. Z.; Fleuren, Gertjan J.; Oosting, Jan			Loss of Heterozygosity and Copy Number Alterations in Flow-Sorted Bulky Cervical Cancer	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; SQUAMOUS-CELL CARCINOMA; GYNECOLOGIC-ONCOLOGY-GROUP; STAGE-IB; RADICAL HYSTERECTOMY; SURGICAL-TREATMENT; CHROMOSOMAL-ABERRATIONS; GENETIC ALTERATIONS; GAIN; FREQUENT	Treatment choices for cervical cancer are primarily based on clinical FIGO stage and the post-operative evaluation of prognostic parameters including tumor diameter, parametrial and lymph node involvement, vaso-invasion, infiltration depth, and histological type. The aim of this study was to evaluate genomic changes in bulky cervical tumors and their relation to clinical parameters, using single nucleotide polymorphism (SNP)-analysis. Flow-sorted tumor cells and patient-matched normal cells were extracted from 81 bulky cervical tumors. DNA-index (DI) measurement and whole genome SNP-analysis were performed. Data were analyzed to detect copy number alterations (CNA) and allelic balance state: balanced, imbalanced or pure LOH, and their relation to clinical parameters. The DI varied from 0.92-2.56. Pure LOH was found in >= 40% of samples on chromosome-arms 3p, 4p, 6p, 6q, and 11q, CN gains in >20% on 1q, 3q, 5p, 8q, and 20q, and losses on 2q, 3p, 4p, 11q, and 13q. Over 40% showed gain on 3q. The only significant differences were found between histological types (squamous, adeno and adenosquamous) in the lesser allele intensity ratio (LAIR) (p = 0.035) and in the CNA analysis (p = 0.011). More losses were found on chromosome-arm 2q (FDR = 0.004) in squamous tumors and more gains on 7p, 7q, and 9p in adenosquamous tumors (FDR = 0.006, FDR = 0.004, and FDR = 0.029). Whole genome analysis of bulky cervical cancer shows widespread changes in allelic balance and CN. The overall genetic changes and CNA on specific chromosome-arms differed between histological types. No relation was found with the clinical parameters that currently dictate treatment choice.	[van den Tillaart, Sabrina A. H. M.; Trimbos, J. Baptist M. Z.] Leiden Univ, Dept Gynecol, Med Ctr, Leiden, Netherlands; [Corver, Wim E.; Neto, Dina Ruano; ter Haar, Natalja T.; Fleuren, Gertjan J.; Oosting, Jan] Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands; [Goeman, Jelle J.] Leiden Univ, Dept Med Stat, Med Ctr, NL-2300 RA Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van den Tillaart, SAHM (corresponding author), Leiden Univ, Dept Gynecol, Med Ctr, Leiden, Netherlands.	s.a.h.m.van_den_tillaart@lumc.nl	Goeman, Jelle/AAT-1300-2020	Goeman, Jelle/0000-0003-4283-0259; Corver, Willem/0000-0001-8313-3658	Netherlands Genomic Initiative (NGI) [93518025]	Netherlands Genomic Initiative (NGI)	D. Ruano Neto received funding from grant 93518025 of the Netherlands Genomic Initiative (NGI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DG, 2000, BRIT J CANCER, V83, P1659, DOI 10.1054/bjoc.2000.1509; ALVAREZ RD, 1993, SURG GYNECOL OBSTET, V176, P539; Bancroft J.D., 1977, THEORY PRACTICE HIST; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; BLOSS JD, 1992, GYNECOL ONCOL, V47, P21, DOI 10.1016/0090-8258(92)90069-U; BURGHARDT E, 1992, CANCER, V70, P648, DOI 10.1002/1097-0142(19920801)70:3<648::AID-CNCR2820700318>3.0.CO;2-R; Cibula D, 2011, INT J GYNECOL CANCER, V21, P690, DOI 10.1097/IGC.0b013e318213653d; Corver WE, 2005, J PATHOL, V206, P233, DOI 10.1002/path.1765; Corver WE, 2009, CURR PROTOC CYTOM; Corver WE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038287; Corver WE, 2008, CANCER RES, V68, P10333, DOI 10.1158/0008-5472.CAN-08-2665; Corver WE, 2011, CELL ONCOL, V34, P553, DOI 10.1007/s13402-011-0061-5; DELGADO G, 1990, GYNECOL ONCOL, V38, P352, DOI 10.1016/0090-8258(90)90072-S; Dellas A, 1999, CANCER RES, V59, P3475; dos Reis R, 2007, GYNECOL ONCOL, V107, P458, DOI 10.1016/j.ygyno.2007.07.080; EIFEL PJ, 1994, INT J RADIAT ONCOL, V28, P113, DOI 10.1016/0360-3016(94)90148-1; Farley JH, 2003, CANCER, V97, P2196, DOI 10.1002/cncr.11371; Gien LT, 2010, GYNECOL ONCOL, V116, P140, DOI 10.1016/j.ygyno.2009.09.040; Glogovac JK, 1996, CYTOMETRY, V24, P260, DOI 10.1002/(SICI)1097-0320(19960701)24:3<260::AID-CYTO9>3.3.CO;2-G; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Grigsby PW, 1996, GYNECOL ONCOL, V62, P135, DOI 10.1006/gyno.1996.0204; HACKER NF, 2005, PRACTICAL GYNECOLOGI, P337; Heselmeyer K, 1997, GENE CHROMOSOME CANC, V19, P233, DOI 10.1002/(SICI)1098-2264(199708)19:4<233::AID-GCC5>3.0.CO;2-Y; Hidalgo A, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-77; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Huang KF, 2007, J FORMOS MED ASSOC, V106, P894, DOI 10.1016/S0929-6646(08)60059-5; Lando M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000719; Landoni F, 1997, LANCET, V350, P535, DOI 10.1016/S0140-6736(97)02250-2; Lips EH, 2005, CANCER RES, V65, P10188, DOI 10.1158/0008-5472.CAN-05-2486; Look KY, 1996, GYNECOL ONCOL, V63, P304, DOI 10.1006/gyno.1996.0327; Lyng H, 2004, INT J CANCER, V111, P358, DOI 10.1002/ijc.20258; Moore DH, 2003, CANCER TREAT REV, V29, P401, DOI 10.1016/S0305-7372(03)00075-6; Oosting J, 2007, GENOME RES, V17, P368, DOI 10.1101/gr.5686107; Rao PH, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-5; Rudtanasudjatum K, 2011, INT J GYNECOL OBSTET, V115, P183, DOI 10.1016/j.ijgo.2011.06.011; Samlal RAK, 1997, GYNECOL ONCOL, V64, P463, DOI 10.1006/gyno.1996.4576; Trimbos JB, 2004, GYNECOL ONCOL, V95, P77, DOI 10.1016/j.ygyno.2004.06.025; Umayahara K, 2002, GENE CHROMOSOME CANC, V33, P98, DOI 10.1002/gcc.1215; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Wilting S, 2006, J PATHOL, V209, P220, DOI 10.1002/path.1966; Yang YC, 2001, CANCER GENET CYTOGEN, V131, P48, DOI 10.1016/S0165-4608(01)00510-6	42	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e67414	10.1371/journal.pone.0067414	http://dx.doi.org/10.1371/journal.pone.0067414			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874418	Green Published, Green Submitted, gold			2022-12-27	WOS:000321736900010
J	Shukla, S; Mahata, S; Shishodia, G; Pandey, A; Tyagi, A; Vishnoi, K; Basir, SF; Das, BC; Bharti, AC				Shukla, Shirish; Mahata, Sutapa; Shishodia, Gauri; Pandey, Arvind; Tyagi, Abhishek; Vishnoi, Kanchan; Basir, Seemi F.; Das, Bhudev C.; Bharti, Alok C.			Functional Regulatory Role of STAT3 in HPV16-Mediated Cervical Carcinogenesis	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; SQUAMOUS INTRAEPITHELIAL LESIONS; ACTIVATED SIGNAL TRANSDUCER; POLYMERASE-CHAIN-REACTION; CANCER-CELLS; CARCINOMA CELLS; TRANSCRIPTIONAL REGULATION; RNA INTERFERENCE; GENE-EXPRESSION; IN-VITRO	Signal transducer and activator of transcription 3 (STAT3) is an oncogenic transcription factor constitutively active and aberrantly expressed in cervical cancer. However, the functional role of STAT3 in regulation of HPV's viral oncogene expression and downstream events associated with cervical carcinogenesis is not known. Our present study performed on HPV16-positive cervical cancer cell lines (SiHa and CaSki) and primary tumor tissues revealed a strong positive correlation of constitutively active STAT3 with expression of HPV16 E6 and E7 oncoproteins and a negative association with levels of p53 and pRB. Pharmacologic targeting of STAT3 expression in cervical cancer cell lines either by STAT3-specific siRNA or blocking its tyrosine phosphorylation by AG490 or curcumin led to dose-dependent accumulation of p53 and pRb in cervical cancer cells. Interestingly, the suppression of STAT3 expression or activation was associated with the gradual loss of HPV16 E6 and E7 expression and was accompanied by loss of cell viability. The viability loss was specifically high in HPV16-positive cells as compared to HPV negative C33a cells. These findings substantiate the regulatory role of STAT3 in HPV16-mediated cervical carcinogenesis. Leads obtained from the present study provide a strong rationale for developing novel STAT3-based approaches for therapeutic interventions against HPV infection to control cervical cancer.	[Shukla, Shirish; Mahata, Sutapa; Shishodia, Gauri; Pandey, Arvind; Tyagi, Abhishek; Vishnoi, Kanchan; Bharti, Alok C.] Inst Cytol & Prevent Oncol, Div Mol Oncol, Noida, Uttar Pradesh, India; [Basir, Seemi F.] Jamia Millia Islamia, Dept Biosci, New Delhi 110025, India; [Das, Bhudev C.] Univ Delhi, Dr B R Ambedkar Ctr Biomed Res, New Delhi, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cancer Prevention & Research (NICPR); Jamia Millia Islamia; University of Delhi	Bharti, AC (corresponding author), Inst Cytol & Prevent Oncol, Div Mol Oncol, Noida, Uttar Pradesh, India.	bhartiac@icmr.org.in	Tyagi, Abhishek/AFZ-6213-2022; Bharti, Prof. AC/AGL-5994-2022; Pandey, Arvind/J-9091-2019; Tyagi, Abhishek/CAF-1274-2022; Basir, Seemi Farhat/GOE-4171-2022	Tyagi, Abhishek/0000-0002-0155-2099; Pandey, Arvind/0000-0002-9942-5468; Tyagi, Abhishek/0000-0002-0155-2099; Vishnoi, Kanchan/0000-0002-1111-0163	Department of Biotechnology, Government of India [102/IFD/SAN/PR-1612/2007, BT/PR6198/Med/14/756/2005]; ICMR; Senior Research Fellowship	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); ICMR(Indian Council of Medical Research (ICMR)); Senior Research Fellowship	The study was supported by research grants from Department of Biotechnology, Government of India to ACB (Grant Support 102/IFD/SAN/PR-1612/2007 & BT/PR6198/Med/14/756/2005), Intramural funding from ICMR to ACB and Senior Research Fellowship to SS and SM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2009, ANN NY ACAD SCI, V1171, P59, DOI 10.1111/j.1749-6632.2009.04911.x; Arany I, 2002, ANTIVIR RES, V55, P331, DOI 10.1016/S0166-3542(02)00070-0; Baak JPA, 2005, AM J SURG PATHOL, V29, P1062; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Butz K, 2003, ONCOGENE, V22, P5938, DOI 10.1038/sj.onc.1206894; CRIPE TP, 1987, EMBO J, V6, P3745, DOI 10.1002/j.1460-2075.1987.tb02709.x; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; DAS BC, 1992, J GEN VIROL, V73, P2327, DOI 10.1099/0022-1317-73-9-2327; De Andrea M, 2010, CANCER RES, V70, P7938, DOI 10.1158/0008-5472.CAN-10-1128; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; Feng W, 2007, MODERN PATHOL, V20, P961, DOI 10.1038/modpathol.3800927; Fu XY, 2006, CELL RES, V16, P214, DOI 10.1038/sj.cr.7310029; Ghoreschi K, 2009, IMMUNOL REV, V228, P273, DOI 10.1111/j.1600-065X.2008.00754.x; Giannoudis A, 2000, CANCER, V89, P1300, DOI 10.1002/1097-0142(20000915)89:6<1300::AID-CNCR15>3.0.CO;2-U; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Gu W, 2006, CANCER GENE THER, V13, P1023, DOI 10.1038/sj.cgt.7700971; Hall AHS, 2003, J VIROL, V77, P6066, DOI 10.1128/JVI.77.10.6066-6069.2003; Haura EB, 2005, NAT CLIN PRACT ONCOL, V2, P315, DOI 10.1038/ncponc0195; Jiang M, 2002, ONCOGENE, V21, P6041, DOI 10.1038/sj.onc.1205878; Kortylewski M, 2009, CANCER CELL, V15, P114, DOI 10.1016/j.ccr.2008.12.018; Leslie K, 2006, CANCER RES, V66, P2544, DOI 10.1158/0008-5472.CAN-05-2203; Libermann TA, 2006, CURR GENE THER, V6, P17, DOI 10.2174/156652306775515501; Loffler D, 2007, BLOOD, V110, P1330, DOI 10.1182/blood-2007-03-081133; Mahata S, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-15; Martinez I, 2008, ONCOGENE, V27, P2575, DOI 10.1038/sj.onc.1210919; Munagala R, 2011, CARCINOGENESIS, V32, P1697, DOI 10.1093/carcin/bgr192; MUNGER K, 1989, EMBO J, V8, P4099, DOI 10.1002/j.1460-2075.1989.tb08594.x; MUNGER K, 1989, J VIROL, V63, P4417; NCRP, 2008, ATL CANC IND; Niu GL, 2005, MOL CELL BIOL, V25, P7432, DOI 10.1128/MCB.25.17.7432-7440.2005; O'Connor M, 1995, HUMAN PAPILLOMAVIRUS, pIII21; OFFORD EA, 1990, J VIROL, V64, P4792, DOI 10.1128/JVI.64.10.4792-4798.1990; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Rajkumar T, 1998, EUR J GYNAECOL ONCOL, V19, P556; Rosl F, 1997, J VIROL, V71, P362; Salcedo M, 2002, INT J EXP PATHOL, V83, P275, DOI 10.1046/j.1365-2613.2002.00198.x; Sathish Narayanan, 2004, Mol Diagn, V8, P57; Schmitt M, 2010, CANCER RES, V70, P249, DOI 10.1158/0008-5472.CAN-09-2514; Schroer N, 2011, CANCER RES, V71, P87, DOI 10.1158/0008-5472.CAN-10-2193; Shukla S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-282; Shukla S, 2009, INDIAN J MED RES, V130, P222; Sima N, 2007, GYNECOL ONCOL, V106, P299, DOI 10.1016/j.ygyno.2007.04.039; SLEBOS RJC, 1994, P NATL ACAD SCI USA, V91, P5320, DOI 10.1073/pnas.91.12.5320; SMOTKIN D, 1987, J VIROL, V61, P1686, DOI 10.1128/JVI.61.5.1686-1689.1987; Sobti RC, 2009, MOL CELL BIOCHEM, V330, P193, DOI 10.1007/s11010-009-0133-2; Sun S, 2002, J GEN VIROL, V83, P1651, DOI 10.1099/0022-1317-83-7-1651; Takemoto S, 2009, BRIT J CANCER, V101, P967, DOI 10.1038/sj.bjc.6605212; Thierry F, 2009, VIROLOGY, V384, P375, DOI 10.1016/j.virol.2008.11.014; Vijayalakshmi N, 2007, ONCOL RES, V16, P527, DOI 10.3727/096504007783438367; Vultur A, 2005, MOL BIOL CELL, V16, P3832, DOI 10.1091/mbc.E04-12-1104; Wang-Johanning F, 2002, CANCER-AM CANCER SOC, V94, P2199, DOI 10.1002/cncr.10439; WERNESS BA, 1990, SCIENCE, V248, P76, DOI 10.1126/science.2157286; Yamato K, 2008, CANCER GENE THER, V15, P140, DOI 10.1038/sj.cgt.7701118; Yang J, 2005, CANCER RES, V65, P939; Yang SF, 2005, GYNECOL ONCOL, V98, P446, DOI 10.1016/j.ygyno.2005.05.032; Yang Sheau-Fang, 2006, Kaohsiung Journal of Medical Sciences, V22, P539; Yoshinouchi M, 2003, MOL THER, V8, P762, DOI 10.1016/j.ymthe.2003.08.004; Zhou Y, 2009, J INTERF CYTOK RES, V29, P695, DOI 10.1089/jir.2009.0003; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	61	50	55	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e67849	10.1371/journal.pone.0067849	http://dx.doi.org/10.1371/journal.pone.0067849			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874455	Green Submitted, Green Published, gold			2022-12-27	WOS:000324146200010
J	Wilson, C; Ramai, D; Serjanov, D; Lama, N; Levinger, L; Chang, EJ				Wilson, Christopher; Ramai, Daryl; Serjanov, Dmitri; Lama, Neema; Levinger, Louis; Chang, Emmanuel J.			Tethered Domains and Flexible Regions in tRNase Z(L), the Long Form of tRNase Z	PLOS ONE			English	Article							CANCER SUSCEPTIBILITY GENE; LIMITED PROTEOLYSIS; MASS-SPECTROMETRY; SUBSTRATE RECOGNITION; PROCESSING KINETICS; THERMOTOGA-MARITIMA; SECONDARY STRUCTURE; SEGMENTAL MOBILITY; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI	tRNase Z, a member of the metallo-beta-lactamase family, endonucleolytically removes the pre-tRNA 3' trailer in a step central to tRNA maturation. The short form (tRNase Z(S)) is the only one found in bacteria and archaebacteria and is also present in some eukaryotes. The homologous long form (tRNase Z(L)), exclusively found in eukaryotes, consists of related amino-and carboxy-domains, suggesting that tRNase Z(L) arose from a tandem duplication of tRNase Z(S) followed by interdependent divergence of the domains. X-ray crystallographic structures of tRNase Z(S) reveal a flexible arm (FA) extruded from the body of tRNase Z remote from the active site that binds tRNA far from the scissile bond. No tRNase Z(L) structures have been solved; alternative biophysical studies are therefore needed to illuminate its functional characteristics. Structural analyses of tRNase Z(L) performed by limited proteolysis, two dimensional gel electrophoresis and mass spectrometry establish stability of the amino and carboxy domains and flexibility of the FA and inter-domain tether, with implications for tRNase Z(L) function.	[Wilson, Christopher; Serjanov, Dmitri; Levinger, Louis] CUNY York Coll, Dept Biol, Jamaica, NY 11451 USA; [Ramai, Daryl; Lama, Neema; Chang, Emmanuel J.] CUNY York Coll, Dept Chem, Jamaica, NY 11451 USA	City University of New York (CUNY) System; York College NY (CUNY); City University of New York (CUNY) System; York College NY (CUNY)	Chang, EJ (corresponding author), CUNY York Coll, Dept Chem, Jamaica, NY 11451 USA.	echang@york.cuny.edu		Wilson, Christopher/0000-0002-8012-2440	NIH [SC2GM086343, R15CA120072, SC3GM084764, F33]; NATIONAL CANCER INSTITUTE [R15CA120072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC2GM086343, SC3GM084764, R15GM101620] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NIH grants SC2GM086343 to EC and R15CA120072, SC3GM084764 and F33 to LL. www.nih.go The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind L, 1999, In Silico Biol, V1, P69; Arighi CN, 2003, BIOCHEMISTRY-US, V42, P7539, DOI 10.1021/bi020680d; Baker ES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030534; Brzezniak LK, 2011, RNA BIOL, V8, P616, DOI 10.4161/rna.8.4.15393; Cadene M, 2000, ANAL CHEM, V72, P5655, DOI 10.1021/ac000811l; Chang EJ, 2004, ANAL CHEM, V76, P4472, DOI 10.1021/ac049637h; Cohen SL, 2001, ANNU REV BIOPH BIOM, V30, P67, DOI 10.1146/annurev.biophys.30.1.67; de la Sierra-Gallay IL, 2006, NAT STRUCT MOL BIOL, V13, P376, DOI 10.1038/nsmb1066; de la Sierra-Gallay IL, 2005, NATURE, V433, P657, DOI 10.1038/nature03284; Dominski Z, 2007, CRIT REV BIOCHEM MOL, V42, P67, DOI 10.1080/10409230701279118; Dubrovsky EB, 2004, NUCLEIC ACIDS RES, V32, P255, DOI 10.1093/nar/gkh182; Dubrovsky EB, 2000, DEV BIOL, V224, P486, DOI 10.1006/dbio.2000.9800; Fenyo David, 2007, J Vis Exp, P192, DOI 10.3791/192; Fontana A, 2004, ACTA BIOCHIM POL, V51, P299; FONTANA A, 1986, BIOCHEMISTRY-US, V25, P1847, DOI 10.1021/bi00356a001; Hartmann RK, 2009, PROG MOL BIOL TRANSL, V85, P319, DOI 10.1016/S0079-6603(08)00808-8; HERSCHLAG D, 1988, BIOORG CHEM, V16, P62, DOI 10.1016/0045-2068(88)90038-7; Hopkinson A, 2008, RNA BIOL, V5, P104, DOI 10.4161/rna.5.2.6086; Ishii R, 2005, J BIOL CHEM, V280, P14138, DOI 10.1074/jbc.M500355200; Ishii R, 2007, ACTA CRYSTALLOGR F, V63, P637, DOI 10.1107/S1744309107033623; Kalkum M, 2003, P NATL ACAD SCI USA, V100, P2795, DOI 10.1073/pnas.0436605100; Karkashon S, 2007, BIOCHEMISTRY-US, V46, P9380, DOI 10.1021/bi700578v; Kazanov MD, 2011, J PROTEOME RES, V10, P3642, DOI 10.1021/pr200271w; Kostelecky B, 2006, J BACTERIOL, V188, P1607, DOI 10.1128/JB.188.4.1607-1614.2006; Levinger L, 1998, J BIOL CHEM, V273, P1015, DOI 10.1074/jbc.273.2.1015; Levinger L, 2009, J BIOL CHEM, V284, P15685, DOI 10.1074/jbc.M900745200; Malone JP, 2001, ELECTROPHORESIS, V22, P919, DOI 10.1002/1522-2683()22:5<919::AID-ELPS919>3.0.CO;2-U; MCCLAIN WH, 1987, SCIENCE, V238, P527, DOI 10.1126/science.2443980; Mineri R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005713; NOVOTNY J, 1987, FEBS LETT, V211, P185, DOI 10.1016/0014-5793(87)81433-3; PACKMAN LC, 1987, BIOCHEM J, V242, P531, DOI 10.1042/bj2420531; Pellegrini O, 2012, STRUCTURE, V20, P1769, DOI 10.1016/j.str.2012.08.002; Redko Y, 2007, NAT REV MICROBIOL, V5, P278, DOI 10.1038/nrmicro1622; Rossmanith W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019152; Sajnani G, 2008, J MOL BIOL, V382, P88, DOI 10.1016/j.jmb.2008.06.070; Schiffer S, 2002, EMBO J, V21, P2769, DOI 10.1093/emboj/21.11.2769; Schilling O, 2005, J BIOL CHEM, V280, P17857, DOI 10.1074/jbc.M500591200; Shi PY, 1998, RNA, V4, P276; Takaku H, 2003, NUCLEIC ACIDS RES, V31, P2272, DOI 10.1093/nar/gkg337; Tavtigian SV, 2001, NAT GENET, V27, P172, DOI 10.1038/84808; Villanueva J, 2002, J MASS SPECTROM, V37, P974, DOI 10.1002/jms.356; Wang ZK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044264; Yan H, 2006, J BIOL CHEM, V281, P3926, DOI 10.1074/jbc.M509822200; Zareen N, 2005, J MOL BIOL, V350, P189, DOI 10.1016/j.jmb.2005.04.073	44	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e66942	10.1371/journal.pone.0066942	http://dx.doi.org/10.1371/journal.pone.0066942			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23874404	gold, Green Published, Green Submitted			2022-12-27	WOS:000322000600002
J	Kekre, N; Mallick, R; Allan, D; Tinmouth, A; Tay, J				Kekre, Natasha; Mallick, Ranjeeta; Allan, David; Tinmouth, Alan; Tay, Jason			The Impact of Prolonged Storage of Red Blood Cells on Cancer Survival	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; CRITICALLY-ILL PATIENTS; IN-HOSPITAL MORTALITY; BYPASS GRAFT-SURGERY; DEEP-VEIN THROMBOSIS; TRANSFUSED BLOOD; CARDIAC-SURGERY; COLORECTAL-CANCER; AGE; DURATION	Background: The duration of storage of transfused red blood cells (RBC) has been associated with poor clinical outcomes in some studies. We sought to establish whether prolonged storage of transfused RBC in cancer patients influences overall survival (OS) or cancer recurrence. Methods and Findings: Patients diagnosed with cancer at The Ottawa Regional Cancer Centre between January 01, 2000 and December 31, 2005 were included (n = 27,591) where 1,929 (7.0%) received RBC transfusions within one year from diagnosis. Transfused RBC units were categorized as "new'' if stored for less than 14 days, "intermediate'' if stored between 14 and 28 days and "old'' if stored for more than 28 days. Baseline characteristics between the comparative groups were compared by ANOVA test. Categorical variables and continuous variables were compared using Chi-squared and Wilcoxan rank-sum tests respectively. Overall survival was not associated with duration of storage of transfused RBC with a median survival of 1.2, 1.7, 1.1 years for only new, intermediate and old RBC units respectively (p = 0.36). Cancer recurrence was significantly higher in patients who received a RBC transfusion than those who did not (56.3% vs 33.0% respectively; p<0.0001) but was not affected by the duration of storage of transfused RBC (p = 0.06). In multivariate analysis, lung cancer, advanced stage, chemotherapy, radiation, cancer-related surgery and cancer recurrence were associated with inferior OS (p<0.05), while age, advanced stage, lung cancer, and more than 6 units of blood transfused were associated with cancer recurrence (p,<0.05). The duration of storage of RBC before transfusion was not associated with OS or cancer recurrence in multivariate analysis. Conclusion: In patients diagnosed with cancer, the duration of storage of transfused RBC had no impact on OS or cancer recurrence. This suggests that our current RBC storage policy of providing RBC of variable duration of storage for patients with malignancy is safe.	[Kekre, Natasha] Ottawa Hosp, Dept Med, Div Hematol, Ottawa, ON, Canada; [Mallick, Ranjeeta; Tinmouth, Alan; Tay, Jason] Ottawa Hosp, Ctr Transfus Res, Ottawa, ON, Canada; [Allan, David; Tinmouth, Alan; Tay, Jason] Ottawa Hosp, Clin Epidemiol Program, Ottawa, ON, Canada; [Allan, David; Tinmouth, Alan; Tay, Jason] Ottawa Hosp Res Inst, Regenerat Med Program, Ottawa, ON, Canada; [Allan, David; Tay, Jason] Ottawa Hosp, Blood & Marrow Transplant Program, Div Hematol, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute	Tay, J (corresponding author), Ottawa Hosp, Ctr Transfus Res, Ottawa, ON, Canada.	jtay@ottawahospital.on.ca	Tay, Jason/J-5061-2019	Tay, Jason/0000-0002-5969-9755; Allan, David/0000-0003-3261-8289	ASH trainee research award	ASH trainee research award	NK was supported by an ASH trainee research award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen JJ, 2011, EUR J CARDIO-THORAC, V39, P329, DOI 10.1016/j.ejcts.2010.06.019; Cata JP, 2011, MAYO CLIN PROC, V86, P120, DOI 10.4065/mcp.2010.0313; de Watering LV, 2006, TRANSFUSION, V46, P1712, DOI 10.1111/j.1537-2995.00958.x; Dessertaine G, 2008, TRANSFUS CLIN BIOL, V15, P154, DOI 10.1016/j.tracli.2008.06.001; Dunn LK, 2012, LIVER TRANSPLANT, V18, P475, DOI 10.1002/lt.23379; Edna TH, 1998, EUR J SURG, V164, P449; Eikelboom JW, 2010, AM HEART J, V159, P737, DOI 10.1016/j.ahj.2009.12.045; Estrin J T, 1999, Oncologist, V4, P318; Fergusson D, 2009, TRANSFUS MED REV, V23, P55, DOI 10.1016/j.tmrv.2008.09.005; Hamasaki N, 2000, VOX SANG, V79, P191, DOI 10.1159/000056729; HEATON A, 1984, BRIT J HAEMATOL, V57, P467, DOI 10.1111/j.1365-2141.1984.tb02921.x; Hebert PC, 2005, ANESTH ANALG, V100, P1433, DOI 10.1213/01.ANE.0000148690.48803.27; HOGMAN CF, 1983, VOX SANG, V45, P217; Isbister JP, 2011, TRANSFUS MED REV, V25, P89, DOI 10.1016/j.tmrv.2010.11.001; Katsios C, 2011, CRIT CARE, V15, DOI 10.1186/cc10526; Kekre N, 2011, TRANSFUSION, V51, P2488, DOI 10.1111/j.1537-2995.2011.03166.x; Keller ME, 2002, J TRAUMA, V53, P1023, DOI 10.1097/00005373-200211000-00037; Koch CG, 2008, NEW ENGL J MED, V358, P1229, DOI 10.1056/NEJMoa070403; Lacroix J, 2011, TRANSFUS MED REV, V25, P197, DOI 10.1016/j.tmrv.2011.03.001; Leal-Noval SR, 2003, ANESTHESIOLOGY, V98, P815, DOI 10.1097/00000542-200304000-00005; Lelubre C, 2009, TRANSFUSION, V49, P1384, DOI 10.1111/j.1537-2995.2009.02211.x; MARTIN CM, 1994, CLIN INVEST MED, V17, P124; Murrell Z, 2005, AM SURGEON, V71, P781; Mynster T, 2000, SCAND J GASTROENTERO, V35, P212; Mynster T, 2001, DIS COLON RECTUM, V44, P955, DOI 10.1007/BF02235483; Offner PJ, 2002, ARCH SURG-CHICAGO, V137, P711, DOI 10.1001/archsurg.137.6.711; Panagopoulos ND, 2008, LUNG CANCER, V62, P273, DOI 10.1016/j.lungcan.2008.02.025; Pettila V, 2011, CRIT CARE, V15, DOI 10.1186/cc10142; Purdy FR, 1997, CAN J ANAESTH, V44, P1256, DOI 10.1007/BF03012772; Robinson SD, 2010, AM HEART J, V159, P876, DOI 10.1016/j.ahj.2010.02.018; Sanders J, 2011, TRANSFUSION, V51, P2286, DOI 10.1111/j.1537-2995.2011.03170.x; SIMON TL, 1987, TRANSFUSION, V27, P178, DOI 10.1046/j.1537-2995.1987.27287150195.x; Skillings J R, 1999, Cancer Prev Control, V3, P207; SOHMER PR, 1982, TRANSFUSION, V22, P479, DOI 10.1046/j.1537-2995.1982.22683068607.x; Sparrow RL, 2010, BLOOD TRANSFUS-ITALY, V8, pS26, DOI 10.2450/2010.005S; Spinella PC, 2009, CRIT CARE, V13, DOI 10.1186/cc8050; Stehling LC, 1996, ANESTHESIOLOGY, V84, P732; Taylor RW, 2006, CRIT CARE MED, V34, P2302, DOI 10.1097/01.CCM.0000234034.51040.7F; Tinmouth A, 2006, TRANSFUSION, V46, P2014, DOI 10.1111/j.1537-2995.2006.01026.x; Valeri CR, 2002, VOX SANG, V83, P193, DOI 10.1111/j.1423-0410.2002.tb05299.x; Vamvakas EC, 1999, TRANSFUSION, V39, P701, DOI 10.1046/j.1537-2995.1999.39070701.x; Vamvakas EC, 2001, BLOOD, V97, P1180, DOI 10.1182/blood.V97.5.1180; Vamvakas EC, 2000, TRANSFUSION, V40, P101, DOI 10.1046/j.1537-2995.2000.40010101.x; van Straten AHM, 2011, J THORAC CARDIOV SUR, V141, P231, DOI 10.1016/j.jtcvs.2010.02.059; Weinberg JA, 2008, J TRAUMA, V65, P279, DOI 10.1097/TA.0b013e31817c9687; Wu Y, 2009, CLIN THER, V31, P2416, DOI 10.1016/j.clinthera.2009.11.020; Yap CH, 2008, ANN THORAC SURG, V86, P554, DOI 10.1016/j.athoracsur.2008.04.040; Yeh JJ, 2007, BRIT J SURG, V94, P466, DOI 10.1002/bjs.5488; Zallen G, 1999, AM J SURG, V178, P570, DOI 10.1016/S0002-9610(99)00239-1	49	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68820	10.1371/journal.pone.0068820	http://dx.doi.org/10.1371/journal.pone.0068820			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874777	gold, Green Submitted, Green Published			2022-12-27	WOS:000322064300073
J	Kim, HK; Lee, S; Jo, SM; McCormick, SP; Butchko, RAE; Proctor, RH; Yun, SH				Kim, Hee-Kyoung; Lee, Seunghoon; Jo, Seong-Mi; McCormick, Susan P.; Butchko, Robert A. E.; Proctor, Robert H.; Yun, Sung-Hwan			Functional Roles of FgLaeA in Controlling Secondary Metabolism, Sexual Development, and Virulence in Fusarium graminearum	PLOS ONE			English	Article							NITROGEN REGULATORY GENE; HEAD BLIGHT PATHOGEN; GIBBERELLA-ZEAE; MYCOTOXIN PRODUCTION; POLYKETIDE SYNTHASE; CHEMICAL DIVERSITY; SPECIES COMPLEX; BIOSYNTHESIS; LAEA; AREA	Fusarium graminearum, the causal agent of Fusarium head blight in cereal crops, produces mycotoxins such as trichothecenes and zearalenone in infected plants. Here, we focused on the function of FgLaeA in F. graminearum, a homolog of Aspergillus nidulans LaeA encoding the global regulator for both secondary metabolism and sexual development. Prior to gene analysis, we constructed a novel luciferase reporter system consisting of a transgenic F. graminearum strain expressing a firefly luciferase gene under control of the promoter for either TRI6 or ZEB2 controlling the biosynthesis of these mycotoxins. Targeted deletion of FgLaeA led to a dramatic reduction of luminescence in reporter strains, indicating that FgLaeA controls the expression of these transcription factors in F. graminearum; reduced toxin accumulation was further confirmed by GC-MS analysis. Overexpression of FgLaeA caused the increased production of trichothecenes and additional metabolites. RNA seq-analysis revealed that gene member(s) belonging to similar to 70% of total tentative gene clusters, which were previously proposed, were differentially expressed in the DFgLaeA strain. In addition, Delta FgLaeA strains exhibited an earlier induction of sexual fruiting body (perithecia) formation and drastically reduced disease symptoms in wheat, indicating that FgLaeA seems to negatively control perithecial induction, but positively control virulence toward the host plant. FgLaeA was constitutively expressed under both mycotoxin production and sexual development conditions. Overexpression of a GFP-FgLaeA fusion construct in the DFgLaeA strain restored all phenotypic changes to wild-type levels and led to constitutive expression of GFP in both nuclei and cytoplasm at different developmental stages. A split luciferase assay demonstrated that FgLaeA was able to interact with FgVeA, a homolog of A. nidulans veA. Taken together, these results demonstrate that FgLaeA, a member of putative FgVeA complex, controls secondary metabolism, sexual development, and virulence in F. graminearum, although the specific regulation pattern differs from that of LaeA in A. nidulans.	[Kim, Hee-Kyoung; Lee, Seunghoon; Jo, Seong-Mi; Yun, Sung-Hwan] Soonchunhyang Univ, Dept Med Biotechnol, Asan, South Korea; [McCormick, Susan P.; Butchko, Robert A. E.; Proctor, Robert H.] ARS, Bacterial Foodborne Pathogens & Mycol Res Unit, Natl Ctr Agr Utilizat Res, USDA, Peoria, IL USA	Soonchunhyang University; United States Department of Agriculture (USDA)	Yun, SH (corresponding author), Soonchunhyang Univ, Dept Med Biotechnol, Asan, South Korea.	sy14@sch.ac.kr		McCormick, Susan/0000-0002-7824-6372	R&D Convergence Center Support Program, Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea; Next-Generation Bio Green21 Program, the Rural Development Administration, Republic of Korea [PJ008210]	R&D Convergence Center Support Program, Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea; Next-Generation Bio Green21 Program, the Rural Development Administration, Republic of Korea	This research was supported by the R&D Convergence Center Support Program, Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea, and by a grant from the Next-Generation Bio Green21 Program (no. PJ008210), the Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaike S, 2009, EUKARYOT CELL, V8, P1051, DOI 10.1128/EC.00088-09; [Anonymous], 2006, BLACKWELL PUB PROF; Bayram O, 2008, SCIENCE, V320, P1504, DOI 10.1126/science.1155888; Bayram OS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001226; Bok JW, 2005, EUKARYOT CELL, V4, P1574, DOI 10.1128/EC.4.9.1574-1582.2005; Bok JW, 2004, EUKARYOT CELL, V3, P527, DOI 10.1128/EC.3.2.527-535.2004; Butchko RAE, 2012, FUNGAL GENET BIOL, V49, P602, DOI 10.1016/j.fgb.2012.06.003; CAPPELLINI RA, 1965, MYCOLOGIA, V57, P962, DOI 10.2307/3756895; Catlett N.L., 2003, FUNGAL GENET NEWSL, V50, P9, DOI DOI 10.4148/1941-4765.1150; Chi MH, 2009, PLANT PATHOLOGY J, V25, P108, DOI 10.5423/PPJ.2009.25.1.108; Desjardins A. E., 2006, FUSARIUM MYCOTOXIN C; Flaherty JE, 2003, APPL ENVIRON MICROB, V69, P5222, DOI 10.1128/AEM.69.9.5222-5227.2003; Gardiner DM, 2009, MICROBIOL-SGM, V155, P3149, DOI 10.1099/mic.0.029546-0; Gardiner DM, 2009, FUNGAL GENET BIOL, V46, P604, DOI 10.1016/j.fgb.2009.04.004; Hoff B, 2010, EUKARYOT CELL, V9, P1236, DOI 10.1128/EC.00077-10; Hohn TM, 1999, FUNGAL GENET BIOL, V26, P224, DOI 10.1006/fgbi.1999.1122; Jiang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028291; Jiang JH, 2012, FUNGAL GENET BIOL, V49, P653, DOI 10.1016/j.fgb.2012.06.005; Kale SP, 2008, FUNGAL GENET BIOL, V45, P1422, DOI 10.1016/j.fgb.2008.06.009; Karimi-Aghcheh R, 2013, G3-GENES GENOM GENET, V3, P369, DOI 10.1534/g3.112.005140; Kim HK, 2012, FEMS MICROBIOL LETT, V337, P89, DOI 10.1111/1574-6968.12012; Kim HK, 2012, CURR GENET, V58, P179, DOI 10.1007/s00294-012-0375-5; Kim HK, 2011, PLANT PATHOLOGY J, V27, P301, DOI 10.5423/PPJ.2011.27.4.301; Kim H, 2008, FUNGAL GENET BIOL, V45, P947, DOI 10.1016/j.fgb.2008.03.007; Kim JE, 2005, APPL ENVIRON MICROB, V71, P1701, DOI 10.1128/AEM.71.4.1701-1708.2005; Kim YT, 2005, MOL MICROBIOL, V58, P1102, DOI 10.1111/j.1365-2958.2005.04884.x; Kwon BR, 2009, APPL MICROBIOL BIOT, V83, P339, DOI 10.1007/s00253-009-1906-y; Lee J, 2003, MOL MICROBIOL, V50, P145, DOI 10.1046/j.1365-2958.2003.03694.x; Lee J, 2012, MICROBIOL-SGM, V158, P1723, DOI 10.1099/mic.0.059188-0; Lee J, 2011, PLANT PATHOLOGY J, V27, P349, DOI 10.5423/PPJ.2011.27.4.349; Lee S, 2011, EUKARYOT CELL, V10, P1043, DOI 10.1128/EC.05071-11; Lee SH, 2006, FUNGAL GENET BIOL, V43, P295, DOI 10.1016/j.fgb.2005.12.007; Lee W, 2010, COMPREHENSIVE DISCOV; Lopez-Berges MS, 2013, MOL MICROBIOL, V87, P49, DOI 10.1111/mmi.12082; MARASAS WFO, 1984, TOXIGENIC FUSARIUM S; McCormick SP, 2010, APPL ENVIRON MICROB, V76, P136, DOI 10.1128/AEM.02017-09; McMullen M, 1997, PLANT DIS, V81, P1340, DOI 10.1094/PDIS.1997.81.12.1340; Min K, 2012, FEMS MICROBIOL LETT, V334, P66, DOI 10.1111/j.1574-6968.2012.02620.x; Namiki F, 2001, MOL PLANT MICROBE IN, V14, P580, DOI 10.1094/MPMI.2001.14.4.580; O'Donnell K, 2004, FUNGAL GENET BIOL, V41, P600, DOI 10.1016/j.fgb.2004.03.003; O'Donnell K, 2000, P NATL ACAD SCI USA, V97, P7905, DOI 10.1073/pnas.130193297; O'Donnell K, 2008, FUNGAL GENET BIOL, V45, P1514, DOI 10.1016/j.fgb.2008.09.002; Perrin RM, 2007, PLOS PATHOG, V3, P508, DOI 10.1371/journal.ppat.0030050; PROCTOR RH, 1995, MOL PLANT MICROBE IN, V8, P593, DOI 10.1094/MPMI-8-0593; Sambrook J., 2001, MOL CLONING LAB MANU; Sarver BAJ, 2011, FUNGAL GENET BIOL, V48, P1096, DOI 10.1016/j.fgb.2011.09.002; Seiboth B, 2012, MOL MICROBIOL, V84, P1150, DOI 10.1111/j.1365-2958.2012.08083.x; Seo JA, 1996, MYCOPATHOLOGIA, V134, P31, DOI 10.1007/BF00437050; Shwab EK, 2007, EUKARYOT CELL, V6, P1656, DOI 10.1128/EC.00186-07; Son H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002310; Starkey DE, 2007, FUNGAL GENET BIOL, V44, P1191, DOI 10.1016/j.fgb.2007.03.001; Trail F, 2002, MYCOLOGIA, V94, P181, DOI 10.2307/3761794; Tudzynski B, 1999, MOL GEN GENET, V261, P106, DOI 10.1007/s004380050950; Wiemann P, 2010, MOL MICROBIOL, V29; Wu DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002542; Yli-Mattila T, 2009, MYCOLOGIA, V101, P841, DOI 10.3852/08-217; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001	57	40	47	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68441	10.1371/journal.pone.0068441	http://dx.doi.org/10.1371/journal.pone.0068441			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874628	Green Submitted, Green Published, gold			2022-12-27	WOS:000322064300035
J	Poupin, MJ; Timmermann, T; Vega, A; Zuniga, A; Gonzalez, B				Josefina Poupin, Maria; Timmermann, Tania; Vega, Andrea; Zuniga, Ana; Gonzalez, Bernardo			Effects of the Plant Growth-Promoting Bacterium Burkholderia phytofirmans PsJN throughout the Life Cycle of Arabidopsis thaliana	PLOS ONE			English	Article							VITIS-VINIFERA L.; GENE-EXPRESSION; ACC DEAMINASE; ENDOPHYTIC COLONIZATION; STRAIN PSJN; RHIZOBACTERIA; ENHANCEMENT; RESISTANCE; GRAPEVINE; POTATO	Plant growth-promoting rhizobacteria (PGPR) induce positive effects in plants, such as increased growth or reduced stress susceptibility. The mechanisms behind PGPR/plant interaction are poorly understood, as most studies have described short-term responses on plants and only a few studies have analyzed plant molecular responses under PGPR colonization. Here, we studied the effects of the PGPR bacterial model Burkholderia phytofirmans PsJN on the whole life cycle of Arabidopsis thaliana plants. We reported that at different plant developmental points, strain PsJN can be found in the rhizosphere and also colonizing their internal tissues. In early ontogeny, strain PsJN increased several growth parameters and accelerated growth rate of the plants. Also, an Arabidopsis transcriptome analysis revealed that 408 genes showed differential expression in PsJN-inoculated plants; some of these genes are involved in stress response and hormone pathways. Specifically, genes implicated in auxin and gibberellin pathways were induced. Quantitative transcriptional analyses of selected genes in different developmental stages revealed that the beginning of these changes could be evidenced early in development, especially among the down-regulated genes. The inoculation with heat-killed bacteria provoked a more severe transcriptional response in plants, but was not able to induce plant growth-promotion. Later in ontogeny, the growth rates of inoculated plants decreased with respect to the non-inoculated group and, interestingly, the inoculation accelerated the flowering time and the appearance of senescence signs in plants; these modifications correlate with the early up-regulation of flowering control genes. Then, we show that a single inoculation with a PGPR could affect the whole life cycle of a plant, accelerating its growth rate and shortening its vegetative period, both effects relevant for most crops. Thus, these findings provide novel and interesting aspects of these relevant biological interactions.	[Josefina Poupin, Maria; Timmermann, Tania; Zuniga, Ana; Gonzalez, Bernardo] Univ Adolfo Ibanez, Fac Ingn & Ciencias, Lab Bioingn, Santiago, Chile; [Vega, Andrea] Pontificia Univ Catolica Chile, Fac Agron & Ingn Forestal, Dept Ciencias Vegetales, Santiago, Chile	Universidad Adolfo Ibanez; Pontificia Universidad Catolica de Chile	Poupin, MJ (corresponding author), Univ Adolfo Ibanez, Fac Ingn & Ciencias, Lab Bioingn, Santiago, Chile.	mpoupin@uai.cl	Montenegro, Gloria/D-9830-2013; Vega, Andrea/J-2961-2016; Vega, Andrea/Y-1874-2019; González, Bernardo/AAW-9578-2021	Montenegro, Gloria/0000-0003-3878-5686; Vega, Andrea/0000-0003-0841-5713; Vega, Andrea/0000-0003-0841-5713; Zuniga, Ana/0000-0002-2708-0915; Poupin, Maria Josefina/0000-0002-7355-7120	FONDECYT [3100040, 11110095]; CONICYT PAI/IAC [9090016]; Millennium nucleus on Plant Functional Genomics [P10-062-F]; ceCIBUC	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT PAI/IAC; Millennium nucleus on Plant Functional Genomics; ceCIBUC	This research was funded by grants FONDECYT 3100040 (www.fondecyt.cl), CONICYT PAI/IAC 9090016 (www.conicyt.cl), and Millennium nucleus on Plant Functional Genomics P10-062-F. AV is supported by FONDECYT 11110095 and is part of ceCIBUC. AZ is a CONICYT PhD Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babalola OO, 2010, BIOTECHNOL LETT, V32, P1559, DOI 10.1007/s10529-010-0347-0; Bais HP, 2004, TRENDS PLANT SCI, V9, P26, DOI 10.1016/j.tplants.2003.11.008; Barka EA, 2000, FEMS MICROBIOL LETT, V186, P91, DOI 10.1111/j.1574-6968.2000.tb09087.x; Barka EA, 2002, BIOL CONTROL, V24, P135, DOI 10.1016/S1049-9644(02)00034-8; Barka EA, 2006, APPL ENVIRON MICROB, V72, P7246, DOI 10.1128/AEM.01047-06; Belimov AA, 2007, J EXP BOT, V58, P1485, DOI 10.1093/jxb/erm010; Blazquez MA, 1997, DEVELOPMENT, V124, P3835; Blazquez MA, 2000, J CELL SCI, V113, P3547; Bordiec S, 2011, J EXP BOT, V62, P595, DOI 10.1093/jxb/erq291; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Cartieaux F, 2003, PLANT J, V36, P177, DOI 10.1046/j.1365-313X.2003.01867.x; Cartieaux F, 2008, MOL PLANT MICROBE IN, V21, P244, DOI 10.1094/MPMI-21-2-0244; Catala C, 1997, PLANT J, V12, P417, DOI 10.1046/j.1365-313X.1997.12020417.x; Chapman EJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-210; Chen L, 2013, J EXP BOT, V64, P1565, DOI 10.1093/jxb/ert031; Coenye T, 2003, ENVIRON MICROBIOL, V5, P719, DOI 10.1046/j.1462-2920.2003.00471.x; Compant S, 2005, APPL ENVIRON MICROB, V71, P1685, DOI 10.1128/AEM.71.4.1685-1693.2005; Compant S, 2008, FEMS MICROBIOL REV, V32, P607, DOI 10.1111/j.1574-6976.2008.00113.x; Compant S, 2008, FEMS MICROBIOL ECOL, V63, P84, DOI 10.1111/j.1574-6941.2007.00410.x; Contesto C, 2010, PLANTA, V232, P1455, DOI 10.1007/s00425-010-1264-0; Corbesier L, 2006, J EXP BOT, V57, P3395, DOI 10.1093/jxb/erl095; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Da KD, 2012, PLANT PHYSIOL BIOCH, V50, P24, DOI 10.1016/j.plaphy.2011.09.013; Dauelsberg P, 2011, J PLANT PHYSIOL, V168, P1667, DOI 10.1016/j.jplph.2011.03.006; De Smet I, 2010, P NATL ACAD SCI USA, V107, P2705, DOI 10.1073/pnas.0915001107; Deal RB, 2005, PLANT CELL, V17, P2633, DOI 10.1105/tpc.105.035196; Desbrosses G, 2009, PLANT SIGNAL BEHAV, V4, P321, DOI 10.1016/j.plantsci.2008.01.020; Dimkpa C, 2009, PLANT CELL ENVIRON, V32, P1682, DOI 10.1111/j.1365-3040.2009.02028.x; Dobbelaere S, 2003, CRIT REV PLANT SCI, V22, P107, DOI 10.1080/713610853; DORN E, 1974, ARCH MICROBIOL, V99, P61, DOI 10.1007/BF00696222; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fernandez O, 2012, MOL PLANT MICROBE IN, V25, P496, DOI 10.1094/MPMI-09-11-0245; FROMMEL MI, 1991, PLANT PHYSIOL, V96, P928, DOI 10.1104/pp.96.3.928; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Glick BR, 2005, FEMS MICROBIOL LETT, V251, P1, DOI 10.1016/j.femsle.2005.07.030; Glick BR, 2004, ADV APPL MICROBIOL, V56, P291, DOI 10.1016/S0065-2164(04)56009-4; Hu JH, 2008, PLANT CELL, V20, P320, DOI 10.1105/tpc.107.057752; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Issartel J, 2011, OECOLOGIA, V165, P1, DOI 10.1007/s00442-010-1807-x; Katari MS, 2010, PLANT PHYSIOL, V152, P500, DOI 10.1104/pp.109.147025; Kloepper JW, 2004, ACTA HORTIC, P217; Lartey R, 1997, PLANT J, V12, P537, DOI 10.1046/j.1365-313X.1997.00537.x; Lazarovits G, 1997, HORTSCIENCE, V32, P188, DOI 10.21273/HORTSCI.32.2.188; Lopez-Bucio J, 2007, MOL PLANT MICROBE IN, V20, P207, DOI 10.1094/MPMI-20-2-0207; Lucy M, 2004, ANTON LEEUW INT J G, V86, P1, DOI 10.1023/B:ANTO.0000024903.10757.6e; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Metcalfe NB, 2003, EXP GERONTOL, V38, P935, DOI 10.1016/S0531-5565(03)00159-1; Mitchum MG, 2006, PLANT J, V45, P804, DOI 10.1111/j.1365-313X.2005.02642.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Ng M, 2001, NAT REV GENET, V2, P186, DOI 10.1038/35056041; Nowak J, 2004, ACTA HORTIC, P253, DOI 10.17660/ActaHortic.2004.631.32; Nowak J, 1998, PLANT CELL TISS ORG, V52, P97, DOI 10.1023/A:1005965822698; Nowak J, 2003, IN VITRO CELL DEV-PL, V39, P107, DOI 10.1079/IVP2002403; Ortiz-Castro R, 2008, PLANT CELL ENVIRON, V31, P1497, DOI 10.1111/j.1365-3040.2008.01863.x; Ortiz-Castro R, 2011, P NATL ACAD SCI USA, V108, P7253, DOI 10.1073/pnas.1006740108; Ortiz-Castro R, 2008, PLANT SIGNAL BEHAV, V3, P263, DOI 10.4161/psb.3.4.5204; Overvoorde P, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001537; Pearl R, 1928, Q REV BIOL, V3, P391, DOI 10.1086/394311; Persello-Cartieaux F, 2003, PLANT CELL ENVIRON, V26, P189, DOI 10.1046/j.1365-3040.2003.00956.x; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Poupin MJ, 2007, GENE, V404, P10, DOI 10.1016/j.gene.2007.08.005; Remans T, 2008, PLANTA, V227, P1343, DOI 10.1007/s00425-008-0706-4; Ryu CM, 2003, P NATL ACAD SCI USA, V100, P4927, DOI 10.1073/pnas.0730845100; Schwachtje J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029382; Sessitsch A, 2005, INT J SYST EVOL MICR, V55, P1187, DOI 10.1099/ijs.0.63149-0; Sharma VK, 1998, CAN J MICROBIOL, V44, P806, DOI 10.1139/cjm-44-8-806; Sokal RR, 1997, BIOMETRY PRINCIPLES; Stearns JC, 2012, MOL PLANT MICROBE IN, V25, P668, DOI 10.1094/MPMI-08-11-0213; Sun TP, 2004, ANNU REV PLANT BIOL, V55, P197, DOI 10.1146/annurev.arplant.55.031903.141753; Sun YL, 2009, FEMS MICROBIOL LETT, V296, P131, DOI 10.1111/j.1574-6968.2009.01625.x; Swain SM, 2005, TRENDS PLANT SCI, V10, P123, DOI 10.1016/j.tplants.2005.01.007; Theocharis A, 2012, MOL PLANT MICROBE IN, V25, P496, DOI [10.1094/MPMI-09-11-0245, DOI 10.1094/MPMI-09-11-0245]; Trognitz F., 2008, INTERACTION POTATO E, P63, DOI DOI 10.3389/FPLS.2016.00024; van Loon LC, 2007, EUR J PLANT PATHOL, V119, P243, DOI 10.1007/s10658-007-9165-1; Verhagen BWM, 2004, MOL PLANT MICROBE IN, V17, P895, DOI 10.1094/MPMI.2004.17.8.895; Vessey JK, 2003, PLANT SOIL, V255, P571, DOI 10.1023/A:1026037216893; Wang K, 2006, APPL ENVIRON MICROB, V72, P760, DOI 10.1128/AEM.72.1.760-768.2006; Wang YQ, 2005, MOL PLANT MICROBE IN, V18, P385, DOI 10.1094/MPMI-18-0385; Xie XT, 2009, PLANT SIGNAL BEHAV, V4, P948, DOI 10.4161/psb.4.10.9709; Yang J, 2009, TRENDS PLANT SCI, V14, P1, DOI 10.1016/j.tplants.2008.10.004; Zhang H, 2007, PLANTA, V226, P839, DOI 10.1007/s00425-007-0530-2; Zuniga A, 2013, MOL PLANT MICROBE IN, V26, P546, DOI 10.1094/MPMI-10-12-0241-R	83	109	113	5	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2013	8	7							e69435	10.1371/journal.pone.0069435	http://dx.doi.org/10.1371/journal.pone.0069435			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZN	23869243	Green Published, gold, Green Submitted			2022-12-27	WOS:000323110600043
J	Karimi, G; Star, K; Noren, GN; Hagg, S				Karimi, Ghazaleh; Star, Kristina; Noren, G. Niklas; Hagg, Staffan			The Impact of Duration of Treatment on Reported Time-to-Onset in Spontaneous Reporting Systems for Pharmacovigilance	PLOS ONE			English	Article							INDUCED LIVER-INJURY; DRUG	Within pharmacovigilance, knowledge of time-to-onset (time from start of drug administration to onset of reaction) is important in causality assessment of drugs and suspected adverse drug reactions (ADRs) and may indicate pharmacological mechanisms involved. It has been suggested that time-to-onset from individual case reports can be used for detection of safety signals. However, some ADRs only occur during treatment, while those that do occur later are less likely to be reported. The aim of this study was to investigate the impact of treatment duration on the reported time-to-onset. Case reports from the WHO Global ICSR database, VigiBase, up until February 5th 2010 were the basis of this study. To examine the effect of duration of treatment on reported time-to-onset, angioedema and hepatitis were selected to represent short and long latency ADRs, respectively. The reported time-to-onset for each of these ADRs was contrasted for a set of drugs expected to be used short-or long-term, respectively. The study included 2,980 unique reports for angioedema and 1,159 for hepatitis. Median reported time-to-onset for angioedema in short-term treatments ranged 0-1 days (median 0.5), for angioedema in long-term treatments 0-26 days (median 8), for hepatitis in short-term treatments 4-12 days (median 7.5) and for hepatitis in long term treatments 19-73 days (median 28). Short-term treatments presented significantly shorter reported time-to-onset than long-term treatments. Of note is that reported time-to-onset for angioedema for long-term treatments (median value of medians being 8 days) was very similar to that of hepatitis for short-term treatments (median value of medians equal 7.5 days). The expected duration of treatment needs to be considered in the interpretation of reported time-to-onset and should be accounted for in signal detection method development and case evaluation.	[Karimi, Ghazaleh; Star, Kristina; Noren, G. Niklas] WHO Collaborating Ctr Int Drug Monitoring, Uppsala Monitoring Ctr, Uppsala, Sweden; [Star, Kristina] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden; [Noren, G. Niklas] Stockholm Univ, Dept Math, S-10691 Stockholm, Sweden; [Hagg, Staffan] Linkoping Univ, Dept Drug Res Clin Pharmacol, Linkoping, Sweden	World Health Organization; Uppsala University; Stockholm University; Linkoping University	Karimi, G (corresponding author), WHO Collaborating Ctr Int Drug Monitoring, Uppsala Monitoring Ctr, Uppsala, Sweden.	ghazaleh.karimi@who-umc.org	Hägg, Staffan/G-5612-2013; Norén, G. Niklas/D-4739-2012	Hägg, Staffan/0000-0002-5137-8420; Norén, G. Niklas/0000-0002-4595-230X				Abboud G, 2007, DRUG SAFETY, V30, P277, DOI 10.2165/00002018-200730040-00001; [Anonymous], DRUGDEX SYST INT DAT; Chalasani N, 2008, GASTROENTEROLOGY, V135, P1924, DOI 10.1053/j.gastro.2008.09.011; Chun LJ, 2009, J CLIN GASTROENTEROL, V43, P342, DOI 10.1097/MCG.0b013e31818a3854; Fescharek DR., 2004, INT J PHARM MED, V18, P259, DOI [10.2165/00124363-200418050-00001, DOI 10.2165/00124363-200418050-00001]; Grigoriadou S, 2009, CLIN EXP IMMUNOL, V155, P367, DOI 10.1111/j.1365-2249.2008.03845.x; Gunawan B, 2004, DRUG METAB REV, V36, P301, DOI 10.1081/DMR-120034148; Kaplan AP, 2005, J AM ACAD DERMATOL, V53, P373, DOI 10.1016/j.jaad.2004.09.032; Klepper MJ, 2011, DRUG SAFETY, V34, P299, DOI 10.2165/11588490-000000000-00000; Lammert C, 2008, HEPATOLOGY, V47, P2003, DOI 10.1002/hep.22272; Lindquist M, 2008, DRUG INF J, V42, P409, DOI 10.1177/009286150804200501; Maignen F, 2010, DRUG SAFETY, V33, P417, DOI 10.2165/11532850-000000000-00000; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Med DRA, MED DRA MED DICT REG; Noren GN, 2007, DATA MIN KNOWL DISC, V14, P305, DOI 10.1007/s10618-006-0052-8; R CT, 2013, R LANG ENV STAT COMP; Roth RA, 2010, J PHARMACOL EXP THER, V332, P692, DOI 10.1124/jpet.109.162651; Uetrecht J, 2007, ANNU REV PHARMACOL, V47, P513, DOI 10.1146/annurev.pharmtox.47.120505.105150; Van Holle L, 2012, PHARMACOEPIDEM DR S, V21, P603, DOI 10.1002/pds.3226; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269	20	6	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2013	8	7							e68938	10.1371/journal.pone.0068938	http://dx.doi.org/10.1371/journal.pone.0068938			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZN	23869234	Green Published, Green Submitted, gold			2022-12-27	WOS:000323110600034
J	Liu, P; Qin, W; Wang, JJ; Zeng, F; Zhou, GY; Wen, HX; von Deneen, KM; Liang, FR; Gong, QY; Tian, J				Liu, Peng; Qin, Wei; Wang, Jingjing; Zeng, Fang; Zhou, Guangyu; Wen, Haixia; von Deneen, Karen M.; Liang, Fanrong; Gong, Qiyong; Tian, Jie			Identifying Neural Patterns of Functional Dyspepsia Using Multivariate Pattern Analysis: A Resting-State fMRI Study	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; ANTERIOR CINGULATE CORTEX; GASTRIC DISTENSION; BRAIN RESPONSES; PAIN; ACTIVATION; CONNECTIVITY; DEPRESSION; DISORDERS; ANXIETY	Background: Previous imaging studies on functional dyspepsia (FD) have focused on abnormal brain functions during special tasks, while few studies concentrated on the resting-state abnormalities of FD patients, which might be potentially valuable to provide us with direct information about the neural basis of FD. The main purpose of the current study was thereby to characterize the distinct patterns of resting-state function between FD patients and healthy controls (HCs). Methodology/Principal Findings: Thirty FD patients and thirty HCs were enrolled and experienced 5-mintue resting-state scanning. Based on the support vector machine (SVM), we applied multivariate pattern analysis (MVPA) to investigate the differences of resting-state function mapped by regional homogeneity (ReHo). A classifier was designed by using the principal component analysis and the linear SVM. Permutation test was then employed to identify the significant contribution to the final discrimination. The results displayed that the mean classifier accuracy was 86.67%, and highly discriminative brain regions mainly included the prefrontal cortex (PFC), orbitofrontal cortex (OFC), supplementary motor area (SMA), temporal pole (TP), insula, anterior/middle cingulate cortex (ACC/MCC), thalamus, hippocampus (HIPP)/parahippocamus (ParaHIPP) and cerebellum. Correlation analysis revealed significant correlations between ReHo values in certain regions of interest (ROI) and the FD symptom severity and/or duration, including the positive correlations between the dmPFC, pACC and the symptom severity; whereas, the positive correlations between the MCC, OFC, insula, TP and FD duration. Conclusions: These findings indicated that significantly distinct patterns existed between FD patients and HCs during the resting-state, which could expand our understanding of the neural basis of FD. Meanwhile, our results possibly showed potential feasibility of functional magnetic resonance imaging diagnostic assay for FD.	[Liu, Peng; Qin, Wei; Wang, Jingjing; Zhou, Guangyu; Wen, Haixia; von Deneen, Karen M.; Tian, Jie] Xidian Univ, Sch Life Sci & Technol, Life Sci Res Ctr, Xian, Peoples R China; [Zeng, Fang; Liang, Fanrong] Chengdu Univ Tradit Chinese Med, Acupuncture & Tuina Sch, Chengdu, Peoples R China; [Tian, Jie] Chinese Acad Sci, Inst Automat, Beijing, Peoples R China; [Gong, Qiyong] Sichuan Univ, West China Hosp, Ctr Med Imaging, Huaxi MR Res Ctr,Dept Radiol, Chengdu, Sichuan, Peoples R China	Xidian University; Chengdu University of Traditional Chinese Medicine; Chinese Academy of Sciences; Institute of Automation, CAS; Sichuan University	Qin, W (corresponding author), Xidian Univ, Sch Life Sci & Technol, Life Sci Res Ctr, Xian, Peoples R China.	wqin@ieee.org; tian@ieee.org	秦, 伟/J-9770-2016; zhang, feng/L-7009-2016; Life, PAM/M-9552-2013; Gong, Qiyong/W-3052-2019; Tian, Jie/H-1190-2011; tian, jie/M-6336-2013	秦, 伟/0000-0003-4583-0406; Gong, Qiyong/0000-0002-5912-4871; Tian, Jie/0000-0003-0498-0432; Liang, Fanrong/0000-0003-2210-2027; Zhou, Guangyu/0000-0003-0897-6465	Project for the National Key Basic Research and Development Program (973) [2012CB518501, 2011CB707700]; National Natural Science Foundation of China [81001504, 81227901, 81271644, 30930112, 81000640, 81000641, 81101036, 81101108, 31200837, 81030027, 81271546, 81102662]; Youth Foundation of Sichuan Province [2012JQ0052]; Fundamental Research Funds for the Central Universities	Project for the National Key Basic Research and Development Program (973)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Foundation of Sichuan Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by the Project for the National Key Basic Research and Development Program (973) under Grant Nos. 2012CB518501, 2011CB707700; the National Natural Science Foundation of China under Grant Nos. 81001504, 81227901, 81271644, 30930112, 81000640, 81000641, 81101036, 81101108, 31200837, 81030027, 81271546, 81102662; the Youth Foundation of Sichuan Province under Grant No 2012JQ0052; and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen V, 2005, NEUROGASTROENT MOTIL, V17, P827, DOI 10.1111/j.1365-2982.2005.00720.x; Berman SM, 2008, J NEUROSCI, V28, P349, DOI 10.1523/JNEUROSCI.2500-07.2008; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Chunfang W, 1986, CHIN J NERV MENL DIS, V12, P267; Craddock RC, 2009, MAGN RESON MED, V62, P1619, DOI 10.1002/mrm.22159; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Ecker C, 2010, NEUROIMAGE, V49, P44, DOI 10.1016/j.neuroimage.2009.08.024; Elsenbruch S, 2010, GUT, V59, P489, DOI 10.1136/gut.2008.175000; Fan Y, 2008, NEUROIMAGE, V39, P1731, DOI 10.1016/j.neuroimage.2007.10.031; Hall GBC, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2009.01436.x; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Ladabaum U, 2001, GASTROENTEROLOGY, V120, P369, DOI 10.1053/gast.2001.21201; Larsson MBO, 2012, GASTROENTEROLOGY, V142, P463, DOI 10.1053/j.gastro.2011.11.022; Lee HF, 2012, PAIN, V153, P1301, DOI 10.1016/j.pain.2012.03.018; Liu P, 2013, NEUROGASTROENT MOTIL, DOI [10.1111/nmo.12131, DOI 10.1111/NM0.12131]; Lu CL, 2004, NEUROGASTROENT MOTIL, V16, P575, DOI 10.1111/j.1365-2982.2004.00562.x; Mayer E, 2001, ALIMENT PHARM THER, V13, P65; Mayer EA, 2006, GASTROENTEROLOGY, V131, P1925, DOI 10.1053/j.gastro.2006.10.026; Mayer EA, 2011, NAT REV NEUROSCI, V12, P453, DOI 10.1038/nrn3071; Mayey EA, 2001, J CLIN PSYCHIAT, V62, P28; Mendez M.F., 2010, BRAIN BEHAV INTRO BE; Momennejad I, 2012, NEUROIMAGE, V61, P139, DOI 10.1016/j.neuroimage.2012.02.079; Mouao-Miranda J, 2007, NEUROIMAGE, V36, P88, DOI 10.1016/j.neuroimage.2007.02.020; Mourao-Miranda J, 2005, NEUROIMAGE, V28, P980, DOI 10.1016/j.neuroimage.2005.06.070; Mourao-Miranda J, 2006, NEUROIMAGE, V33, P1055, DOI 10.1016/j.neuroimage.2006.08.016; Olson IR, 2007, BRAIN, V130, P1718, DOI 10.1093/brain/awm052; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Pereira F, 2009, NEUROIMAGE, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Phillips ML, 2003, BRAIN, V126, P669, DOI 10.1093/brain/awg065; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; Ringel Y, 2008, GASTROENTEROLOGY, V134, P396, DOI 10.1053/j.gastro.2007.11.011; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Saper CB, 2002, ANNU REV NEUROSCI, V25, P433, DOI 10.1146/annurev.neuro.25.032502.111311; Song ST, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017191; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Stephan E, 2003, J GASTROINTEST SURG, V7, P740, DOI 10.1016/S1091-255X(03)00071-4; Tack J, 2006, GASTROENTEROLOGY, V130, P1466, DOI 10.1053/j.gastro.2005.11.059; TALAIRAC.J, 1973, ELECTROEN CLIN NEURO, V34, P45, DOI 10.1016/0013-4694(73)90149-1; Talley NI, 1999, ALIMENT PHARM THERAP, V13, P225; Talley NJ, 1999, AM J GASTROENTEROL, V94, P2390; Taylor KS, 2009, HUM BRAIN MAPP, V30, P2731, DOI 10.1002/hbm.20705; Tian XP, 2009, WORLD J GASTROENTERO, V15, P3173, DOI 10.3748/wjg.15.3173; Valet M, 2004, PAIN, V109, P399, DOI 10.1016/j.pain.2004.02.033; Van Oudenhove L, 2010, GASTROENTEROLOGY, V139, P36, DOI 10.1053/j.gastro.2010.04.015; Van Oudenhove L, 2010, AM J GASTROENTEROL, V105, P913, DOI 10.1038/ajg.2010.39; Vandenbergh J, 2005, GASTROENTEROLOGY, V128, P564, DOI 10.1053/j.gastro.2004.11.054; Vandenberghe J, 2007, GASTROENTEROLOGY, V132, P1684, DOI 10.1053/j.gastro.2007.03.037; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Wang LB, 2012, NEUROIMAGE, V61, P931, DOI 10.1016/j.neuroimage.2012.03.080; Weygandt M, 2012, HUM BRAIN MAPP, V33, P2135, DOI 10.1002/hbm.21345; Weygandt M, 2012, NEUROIMAGE, V60, P1186, DOI 10.1016/j.neuroimage.2012.01.064; Wiech K, 2005, NEUROIMAGE, V27, P59, DOI 10.1016/j.neuroimage.2005.03.044; Wilder-Smith CH, 2004, GUT, V53, P1595, DOI 10.1136/gut.2003.028514; Wu WY, 1990, SHANGHAI ARCH PSYC S, V2, P44; You XZ, 2013, HUM BRAIN MAPP, V34, P2330, DOI 10.1002/hbm.22069; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zeng F, 2011, GASTROENTEROLOGY, V141, P499, DOI 10.1053/j.gastro.2011.05.003; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; Zhou GY, 2013, NMR BIOMED, V26, P410, DOI 10.1002/nbm.2878; Zhou GY, 2013, AM J GASTROENTEROL, V108, P260, DOI 10.1038/ajg.2012.405; Zhu CZ, 2008, NEUROIMAGE, V40, P110, DOI 10.1016/j.neuroimage.2007.11.029; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V13, P508, DOI 10.1001/archpsyc.1965.01730060026004	65	31	34	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e68205	10.1371/journal.pone.0068205	http://dx.doi.org/10.1371/journal.pone.0068205			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	23874543	Green Submitted, Green Published, gold			2022-12-27	WOS:000321718700013
J	Xiang, L; Moncivais, K; Jiang, FQ; Willams, B; Alfonta, L; Zhang, ZWJ				Xiang, Liang; Moncivais, Kathryn; Jiang, Faqin; Willams, Blake; Alfonta, Lital; Zhang, Zhiwen J.			Crucial Optimization of Translational Components towards Efficient Incorporation of Unnatural Amino Acids into Proteins in Mammalian Cells	PLOS ONE			English	Article							TRANSFER-RNA SYNTHETASES; GENETIC-CODE; TRANSCRIPTION; RECOGNITION	The ability to site-specifically incorporate unnatural amino acids (UAAs) into proteins is a powerful tool in protein engineering. While dozens of UAAs have been successfully introduced into proteins expressed by Escherichia coli cells, it has been much more challenging to create tRNA and tRNA-Synthetase pairs that enable UAAs incorporation, for use in mammalian systems. By altering the orthogonality properties of existing unnatural pairs, previously evolved pairs for use in E. coli could be used in mammalian cells. This would bypass the cumbersome step of having to evolve mutant synthetases and would allow for the rapid development of new mammalian pairs. A major limitation to the amount of UAA-containing proteins that can be expressed in the cell is the availability of UAA-charged orthogonal suppressor tRNA. By using a natural mammalian tRNA promoter, the amount of functional suppressor tRNA can be greatly increased. Furthermore, increasing recognition of the suppressor tRNA by the mutant synthetase will ultimately lead to the appearance of more UAA-charged tRNA.	[Xiang, Liang; Willams, Blake] Santa Clara Univ, Sch Engn, Dept Bioengn, Santa Clara, CA 95053 USA; [Xiang, Liang; Moncivais, Kathryn] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Jiang, Faqin] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200030, Peoples R China; [Alfonta, Lital] Ben Gurion Univ Negev, Ilse Katz Inst Nanoscale Sci & Technol, Avram & Stella Goldstein Goren Dept Biotechnol En, IL-84105 Beer Sheva, Israel	Santa Clara University; University of Texas System; University of Texas Austin; Shanghai Jiao Tong University; Ben Gurion University	Alfonta, L (corresponding author), Ben Gurion Univ Negev, Ilse Katz Inst Nanoscale Sci & Technol, Avram & Stella Goldstein Goren Dept Biotechnol En, IL-84105 Beer Sheva, Israel.	alfontal@bgu.ac.il; zzhang@scu.edu	Alfonta, Lital/AAB-9689-2022; Alfonta, Lital/B-6101-2012	Alfonta, Lital/0000-0002-3805-8625; Alfonta, Lital/0000-0002-3805-8625	Welch Foundation Research Grant [F1618]; NIH [R01 CA120168]; European Research Commission (ERC) starting Grant [260647]; Edmond J. Safra Center for the Design and Engineering of Functional Biopolymers; NATIONAL CANCER INSTITUTE [R01CA120168] Funding Source: NIH RePORTER	Welch Foundation Research Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Commission (ERC) starting Grant; Edmond J. Safra Center for the Design and Engineering of Functional Biopolymers; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work has been supported by Welch Foundation Research Grant (F1618, http://www.welch1.org/), NIH R01 CA120168 (http://www.nih.gov/), European Research Commission (ERC) starting Grant (260647), and Edmond J. Safra Center for the Design and Engineering of Functional Biopolymers (http://www.edmondjsafra.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir L, 2013, J AM CHEM SOC, V135, P70, DOI 10.1021/ja310556n; Chin JW, 2003, SCIENCE, V301, P964, DOI 10.1126/science.1084772; Kobayashi T, 2003, NAT STRUCT BIOL, V10, P425, DOI 10.1038/nsb934; Myslinski E, 2001, NUCLEIC ACIDS RES, V29, P2502, DOI 10.1093/nar/29.12.2502; SCHIMMEL P, 1987, ANNU REV BIOCHEM, V56, P125, DOI 10.1146/annurev.bi.56.070187.001013; SCHIMMEL P, 1993, P NATL ACAD SCI USA, V90, P8763, DOI 10.1073/pnas.90.19.8763; SHARP S, 1981, P NATL ACAD SCI-BIOL, V78, P6657, DOI 10.1073/pnas.78.11.6657; Steer BA, 1999, J BIOL CHEM, V274, P35601, DOI 10.1074/jbc.274.50.35601; Thibodeaux GN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011263; Umeda A, 2009, CHEMBIOCHEM, V10, P1302, DOI 10.1002/cbic.200900127; Wakasugi K, 1998, EMBO J, V17, P297, DOI 10.1093/emboj/17.1.297; Wang L, 2005, ANGEW CHEM INT EDIT, V44, P34, DOI 10.1002/anie.200460627; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Wang WY, 2007, NAT NEUROSCI, V10, P1063, DOI 10.1038/nn1932; Yaremchuk A, 2002, EMBO J, V21, P3829, DOI 10.1093/emboj/cdf373; Zhang ZW, 2003, BIOCHEMISTRY-US, V42, P6735, DOI 10.1021/bi0300231	16	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e67333	10.1371/journal.pone.0067333	http://dx.doi.org/10.1371/journal.pone.0067333			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	23874413	Green Published, Green Submitted, gold			2022-12-27	WOS:000321718700001
J	Hsiao, FJ; Wang, YJ; Yan, SH; Chen, WT; Lin, YY				Hsiao, Fu-Jung; Wang, Yuh-Jen; Yan, Sui-Hing; Chen, Wei-Ta; Lin, Yung-Yang			Altered Oscillation and Synchronization of Default-Mode Network Activity in Mild Alzheimer's Disease Compared to Mild Cognitive Impairment: An Electrophysiological Study	PLOS ONE			English	Article							STATE FUNCTIONAL CONNECTIVITY; FRONTOTEMPORAL DEMENTIA; EEG SYNCHRONIZATION; CORTICAL RHYTHMS; CINGULATE CORTEX; RESTING BRAIN; MEMORY; ALPHA; TASK; FMRI	Some researchers have suggested that the default mode network (DMN) plays an important role in the pathological mechanisms of Alzheimer's disease (AD). To examine whether the cortical activities in DMN regions show significant difference between mild AD from mild cognitive impairment (MCI), electrophysiological responses were analyzed from 21 mild Alzheimer's disease (AD) and 21 mild cognitive impairment (MCI) patients during an eyes closed, resting-state condition. The spectral power and functional connectivity of the DMN were estimated using a minimum norm estimate (MNE) combined with fast Fourier transform and imaginary coherence analysis. Our results indicated that source-based EEG maps of resting-state activity showed alterations of cortical spectral power in mild AD when compared to MCI. These alterations are characteristic of attenuated alpha or beta activities in the DMN, as are enhanced delta or theta activities in the medial temporal, inferior parietal, posterior cingulate cortex and precuneus. With regard to altered synchronization in AD, altered functional interconnections were observed as specific connectivity patterns of connection hubs in the precuneus, posterior cingulate cortex, anterior cingulate cortex and medial temporal regions. Moreover, posterior theta and alpha power and altered connectivity in the medial temporal lobe correlated significantly with scores obtained on the Mini-Mental State Examination (MMSE). In conclusion, EEG is a useful tool for investigating the DMN in the brain and differentiating early stage AD and MCI patients. This is a promising finding; however, further large-scale studies are needed.	[Hsiao, Fu-Jung] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan; [Hsiao, Fu-Jung; Wang, Yuh-Jen; Yan, Sui-Hing] Taipei City Hosp, Dept Neurol, Taipei, Taiwan; [Hsiao, Fu-Jung; Lin, Yung-Yang] Natl Yang Ming Univ, Sch Med, Inst Brain Sci, Taipei 112, Taiwan; [Hsiao, Fu-Jung; Chen, Wei-Ta; Lin, Yung-Yang] Natl Yang Ming Univ, Sch Med, Dept Neurol, Taipei 112, Taiwan; [Lin, Yung-Yang] Taipei Vet Gen Hosp, Dept Med Res & Educ, Neurophysiol Lab, Taipei, Taiwan; [Chen, Wei-Ta; Lin, Yung-Yang] Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan	Taipei City Hospital; Taipei City Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital	Hsiao, FJ (corresponding author), Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan.	fujunghsiao@gmail.com			Taipei City Hospital [99TPECH04]; Taipei Veterans General Hospital [V101C-023]; National Science Council, Taipei, Taiwan [NSC98-2321-B-010-007, NSC99-2321-B-010-004, NSC 99-2628-B-010 -011-MY3, NSC 100-2218-E-010-002, NSC100-2321-B-010-004, NSC 101-2314-B-010 -068 -MY3]	Taipei City Hospital; Taipei Veterans General Hospital(Taipei Veterans General Hospital); National Science Council, Taipei, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported in part by research grants from Taipei City Hospital (99TPECH04), Taipei Veterans General Hospital (V101C-023), and from the National Science Council (NSC98-2321-B-010-007, NSC99-2321-B-010-004, NSC 99-2628-B-010 -011-MY3, NSC 100-2218-E-010-002, NSC100-2321-B-010-004, NSC 101-2314-B-010 -068 -MY3), Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold SE, 1991, CEREB CORTEX, V1, P103, DOI 10.1093/cercor/1.1.103; Attwell D, 2002, TRENDS NEUROSCI, V25, P621, DOI 10.1016/S0166-2236(02)02264-6; Babiloni C, 2006, BRAIN RES BULL, V69, P63, DOI 10.1016/j.brainresbull.2005.10.013; Babiloni C, 2004, NEUROIMAGE, V22, P57, DOI 10.1016/j.neuroimage.2003.09.028; Babiloni C., 2012, HUM BRAIN MAPP; Babiloni C, 2011, J ALZHEIMERS DIS, V26, P201, DOI 10.3233/JAD-2011-0051; Babiloni C, 2010, J ALZHEIMERS DIS, V22, P1047, DOI 10.3233/JAD-2010-100798; Benjamini Y, 2005, GENETICS, V171, P783, DOI 10.1534/genetics.104.036699; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennys K, 2001, NEUROPHYSIOL CLIN, V31, P153, DOI 10.1016/S0987-7053(01)00254-4; Bluhm RL, 2007, SCHIZOPHRENIA BULL, V33, P1004, DOI 10.1093/schbul/sbm052; Bokde ALW, 2005, DEMENT GERIATR COGN, V20, P352, DOI 10.1159/000088558; BRESSLER SL, 1995, BRAIN RES REV, V20, P288, DOI 10.1016/0165-0173(94)00016-I; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; D'Argembeau A, 2005, NEUROIMAGE, V25, P616, DOI 10.1016/j.neuroimage.2004.11.048; de Haan W, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-101; de Leon M, 2001, NEUROLOGY, V56, P820, DOI 10.1212/WNL.56.6.820; Dehaene S, 1998, P NATL ACAD SCI USA, V95, P14529, DOI 10.1073/pnas.95.24.14529; Delbeuck X, 2003, NEUROPSYCHOL REV, V13, P79, DOI 10.1023/A:1023832305702; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Eichenbaum H, 2001, BEHAV BRAIN RES, V127, P199, DOI 10.1016/S0166-4328(01)00365-5; Firbank MJ, 2007, NEUROIMAGE, V36, P1, DOI 10.1016/j.neuroimage.2007.02.027; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GHATAN PH, 1995, NEUROIMAGE, V2, P112, DOI 10.1006/nimg.1995.1014; Gianotti LRR, 2007, CLIN NEUROPHYSIOL, V118, P186, DOI 10.1016/j.clinph.2006.09.007; Greicius MD, 2004, J COGNITIVE NEUROSCI, V16, P1484, DOI 10.1162/0898929042568532; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Groppe DM, 2011, PSYCHOPHYSIOLOGY, V48, P1711, DOI 10.1111/j.1469-8986.2011.01273.x; Grundman M, 2004, ARCH NEUROL-CHICAGO, V61, P59, DOI 10.1001/archneur.61.1.59; Guggisberg AG, 2008, ANN NEUROL, V63, P193, DOI 10.1002/ana.21224; Hamalainen M. S., 2010, MEG INTRO METHODS, P186, DOI [10.1093/acprof:oso/9780195307238.003., DOI 10.1093/ACPROF:OSO/9780195307238.003, DOI 10.1093/ACPROF:OSO/9780195307238.003.0008]; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; IHL R, 1993, NEUROPSYCHOBIOLOGY, V27, P231, DOI 10.1159/000118986; Jann K, 2009, NEUROIMAGE, V45, P903, DOI 10.1016/j.neuroimage.2009.01.001; Jung TP, 2000, CLIN NEUROPHYSIOL, V111, P1745, DOI 10.1016/S1388-2457(00)00386-2; Kennedy DP, 2008, NEUROIMAGE, V39, P1877, DOI 10.1016/j.neuroimage.2007.10.052; Klimesch W, 1996, INT J PSYCHOPHYSIOL, V24, P61, DOI 10.1016/S0167-8760(96)00057-8; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Laufs H, 2007, HUM BRAIN MAPP, V28, P1023, DOI 10.1002/hbm.20323; Lin FH, 2006, NEUROIMAGE, V31, P160, DOI 10.1016/j.neuroimage.2005.11.054; Lin FH, 2006, HUM BRAIN MAPP, V27, P1, DOI 10.1002/hbm.20155; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Mantini D, 2007, NEUROIMAGE, V34, P598, DOI 10.1016/j.neuroimage.2006.09.037; Martino J, 2011, ANN NEUROL, V69, P521, DOI 10.1002/ana.22167; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; MAURER K, 1992, ACTA NEUROL SCAND, V85, P40, DOI 10.1111/j.1600-0404.1992.tb04453.x; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mevel Katell, 2011, Int J Alzheimers Dis, V2011, P535816, DOI 10.4061/2011/535816; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Petersen RC, 2006, ARCH NEUROL-CHICAGO, V63, P665, DOI 10.1001/archneur.63.5.665; Petrella JR, 2011, NEUROLOGY, V76, P511, DOI 10.1212/WNL.0b013e31820af94e; Qi ZG, 2010, NEUROIMAGE, V50, P48, DOI 10.1016/j.neuroimage.2009.12.025; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rombouts SARB, 2005, HUM BRAIN MAPP, V26, P231, DOI 10.1002/hbm.20160; Sanz-Arigita EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013788; Sekihara K, 2005, NEUROIMAGE, V25, P1056, DOI 10.1016/j.neuroimage.2004.11.051; Simpson JR, 2001, P NATL ACAD SCI USA, V98, P683, DOI 10.1073/pnas.98.2.683; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; Stam CJ, 2006, NEUROIMAGE, V32, P1335, DOI 10.1016/j.neuroimage.2006.05.033; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Stam CJ, 2005, CLIN NEUROPHYSIOL, V116, P708, DOI 10.1016/j.clinph.2004.09.022; Stam CJ, 2003, ACTA NEUROL SCAND, V108, P90, DOI 10.1034/j.1600-0404.2003.02067.x; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Tadel F, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/879716; Tian LX, 2006, NEUROSCI LETT, V400, P39, DOI 10.1016/j.neulet.2006.02.022; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Viard A, 2007, CEREB CORTEX, V17, P2453, DOI 10.1093/cercor/bhl153; Wang L, 2006, NEUROIMAGE, V31, P496, DOI 10.1016/j.neuroimage.2005.12.033; Zhang HY, 2010, RADIOLOGY, V256, P598, DOI 10.1148/radiol.10091701; Zhang HY, 2009, BEHAV BRAIN RES, V197, P103, DOI 10.1016/j.bbr.2008.08.012; Zhou J, 2010, BRAIN, V133, P1352, DOI 10.1093/brain/awq075	78	57	57	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e68792	10.1371/journal.pone.0068792	http://dx.doi.org/10.1371/journal.pone.0068792			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874766	Green Published, Green Submitted, gold			2022-12-27	WOS:000322218800045
J	Radmaneshfar, E; Kaloriti, D; Gustin, MC; Gow, NAR; Brown, AJP; Grebogi, C; Romano, MC; Thiel, M				Radmaneshfar, Elahe; Kaloriti, Despoina; Gustin, Michael C.; Gow, Neil A. R.; Brown, Alistair J. P.; Grebogi, Celso; Romano, M. Carmen; Thiel, Marco			From START to FINISH: The Influence of Osmotic Stress on the Cell Cycle	PLOS ONE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; ANAPHASE-PROMOTING COMPLEX; BUDDING YEAST; MORPHOGENESIS CHECKPOINT; PROTEIN-KINASE; S-PHASE; DNA-REPLICATION; CDC14 PHOSPHATASE; MITOTIC EXIT; MATHEMATICAL-MODEL	The cell cycle is a sequence of biochemical events that are controlled by complex but robust molecular machinery. This enables cells to achieve accurate self-reproduction under a broad range of different conditions. Environmental changes are transmitted by molecular signalling networks, which coordinate their action with the cell cycle. The cell cycle process and its responses to environmental stresses arise from intertwined nonlinear interactions among large numbers of simpler components. Yet, understanding of how these pieces fit together into a coherent whole requires a systems biology approach. Here, we present a novel mathematical model that describes the influence of osmotic stress on the entire cell cycle of S. cerevisiae for the first time. Our model incorporates all recently known and several proposed interactions between the osmotic stress response pathway and the cell cycle. This model unveils the mechanisms that emerge as a consequence of the interaction between the cell cycle and stress response networks. Furthermore, it characterises the role of individual components. Moreover, it predicts different phenotypical responses for cells depending on the phase of cells at the onset of the stress. The key predictions of the model are: (i) exposure of cells to osmotic stress during the late S and the early G2/M phase can induce DNA re-replication before cell division occurs, (ii) cells stressed at the late G2/M phase display accelerated exit from mitosis and arrest in the next cell cycle, (iii) osmotic stress delays the G1-to-S and G2-to-M transitions in a dose dependent manner, whereas it accelerates the M-to-G1 transition independently of the stress dose and (iv) the Hog MAPK network compensates the role of the MEN network during cell division of MEN mutant cells. These model predictions are supported by independent experiments in S. cerevisiae and, moreover, have recently been observed in other eukaryotes.	[Radmaneshfar, Elahe; Grebogi, Celso; Romano, M. Carmen; Thiel, Marco] Univ Aberdeen, SUPA, Inst Complex Syst & Math Biol, Aberdeen, Scotland; [Kaloriti, Despoina; Gow, Neil A. R.; Brown, Alistair J. P.; Romano, M. Carmen] Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland; [Gustin, Michael C.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA	University of Aberdeen; University of Aberdeen; Rice University	Radmaneshfar, E (corresponding author), Univ Aberdeen, SUPA, Inst Complex Syst & Math Biol, Aberdeen, Scotland.	radmaneshfar@gmail.com	Brown, Alistair J.P./B-6627-2014; GOW, Neil/AAS-5323-2021	GOW, Neil/0000-0002-2776-5850; Brown, Alistair JP/0000-0003-1406-4251; Gustin, Michael/0000-0003-0097-9194; Romano, M. Carmen/0000-0002-6261-2147; Grebogi, Celso/0000-0002-9811-4617	College of Physical Sciences, University of Aberdeen; UK Biotechnology and Biological Sciences Research Council (BBSRC) under the SABR Initiative (Systems Approaches to Biological Research) [BB/F00513X/1, BB/G010722]; Scottish Universities Life Science Alliance (SULSA); Wellcome Trust [080088]; European Commission (FINSysB) [PITN-GA-2008-214004]; European Commission (STRIFE) [ERC-2009-AdG-249793]; EC Ariadne Mariu Training Network; NSF [IOS 1052527]; BBSRC [BB/F00513X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F00513X/1] Funding Source: researchfish; Direct For Biological Sciences [1052527] Funding Source: National Science Foundation	College of Physical Sciences, University of Aberdeen; UK Biotechnology and Biological Sciences Research Council (BBSRC) under the SABR Initiative (Systems Approaches to Biological Research)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Scottish Universities Life Science Alliance (SULSA); Wellcome Trust(Wellcome TrustEuropean Commission); European Commission (FINSysB)(European CommissionEuropean Commission Joint Research Centre); European Commission (STRIFE)(European Commission); EC Ariadne Mariu Training Network; NSF(National Science Foundation (NSF)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	ER is fully funded by the College of Physical Sciences, University of Aberdeen. The authors are also grateful to the UK Biotechnology and Biological Sciences Research Council (BBSRC) for funding our CRISP Consortium (Combinatorial Responses in Stress Pathways) under the SABR Initiative (Systems Approaches to Biological Research) (BB/F00513X/1, BB/G010722) and the Scottish Universities Life Science Alliance (SULSA). AJPB and NARG were also supported by the Wellcome Trust (080088), and AJPB was also funded by the European Commission (FINSysB, PITN-GA-2008-214004; STRIFE, ERC-2009-AdG-249793). NARG is also funded by the EC Ariadne Mariu Training Network. MCG was supported by NSF IOS 1052527. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrover MA, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002204; Alexander MR, 2001, MOL BIOL CELL, V12, P53, DOI 10.1091/mbc.12.1.53; AMON A, 1993, CELL, V74, P993, DOI 10.1016/0092-8674(93)90722-3; Barberis M, 2007, PLOS COMPUT BIOL, V3, P649, DOI 10.1371/journal.pcbi.0030064; Barberis M, 2012, BIOTECHNOL ADV, V30, P108, DOI 10.1016/j.biotechadv.2011.09.004; Barberis M, 2011, MOL BIOSYST, V7, P2804, DOI 10.1039/c1mb05073g; Bardin AJ, 2003, MOL CELL BIOL, V23, P5018, DOI 10.1128/MCB.23.14.5018-5030.2003; Belli G, 2001, MOL MICROBIOL, V39, P1022, DOI 10.1046/j.1365-2958.2001.02297.x; BOOHER RN, 1993, EMBO J, V12, P3417, DOI 10.1002/j.1460-2075.1993.tb06016.x; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; Burton JL, 2000, MOL CELL BIOL, V20, P4614, DOI 10.1128/MCB.20.13.4614-4625.2000; Chandrasekaran S, 2011, MOL CELL BIOL, V31, P4405, DOI 10.1128/MCB.06163-11; Chen KC, 2000, MOL BIOL CELL, V11, P369, DOI 10.1091/mbc.11.1.369; Chen KC, 2004, MOL BIOL CELL, V15, P3841, DOI 10.1091/mbc.E03-11-0794; Ciliberto A, 2003, J CELL BIOL, V163, P1243, DOI 10.1083/jcb.200306139; Claeys H, 2012, PLANT PHYSIOL, V159, P739, DOI 10.1104/pp.112.195032; Clotet J, 2006, EMBO J, V25, P2338, DOI 10.1038/sj.emboj.7601095; Cross FR, 2005, MOL BIOL CELL, V16, P2129, DOI 10.1091/mbc.E04-10-0897; Cross FR, 2002, MOL BIOL CELL, V13, P52, DOI 10.1091/mbc.01-05-0265; DAHMANN C, 1995, CURR BIOL, V5, P1257, DOI 10.1016/S0960-9822(95)00252-1; DIRICK L, 1995, EMBO J, V14, P4803, DOI 10.1002/j.1460-2075.1995.tb00162.x; EPSTEIN CB, 1994, MOL CELL BIOL, V14, P2041, DOI 10.1128/MCB.14.3.2041; Escote X, 2004, NAT CELL BIOL, V6, P997, DOI 10.1038/ncb1174; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Grandin N, 1998, MOL GEN GENET, V258, P104, DOI 10.1007/s004380050712; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; Jaspersen SL, 1998, MOL BIOL CELL, V9, P2803, DOI 10.1091/mbc.9.10.2803; Jensen S, 2002, CURR BIOL, V12, pR221, DOI 10.1016/S0960-9822(02)00756-X; Lew DJ, 2003, CURR OPIN CELL BIOL, V15, P648, DOI 10.1016/j.ceb.2003.09.001; Lew DJ, 2000, CURR OPIN GENET DEV, V10, P47, DOI 10.1016/S0959-437X(99)00051-9; LEW DJ, 1993, J CELL BIOL, V120, P1305, DOI 10.1083/jcb.120.6.1305; McCollum D, 2001, TRENDS CELL BIOL, V11, P89, DOI 10.1016/S0962-8924(00)01901-2; McMillan JN, 1999, MOL CELL BIOL, V19, P6929; Mendenhall MD, 1998, MICROBIOL MOL BIOL R, V62, P1191, DOI 10.1128/MMBR.62.4.1191-1243.1998; Morgan DO, 1999, NAT CELL BIOL, V1, pE47, DOI 10.1038/10039; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600; NIGG EA, 1995, BIOESSAYS, V17, P471, DOI 10.1002/bies.950170603; Nurse P, 1997, EUR J CANCER, V33, P1002, DOI 10.1016/S0959-8049(97)00091-9; Piatti S, 1996, GENE DEV, V10, P1516, DOI 10.1101/gad.10.12.1516; Reiser V, 2006, MOL BIOL CELL, V17, P3136, DOI 10.1091/mbc.E05-12-1102; Saito H, 2012, GENETICS, V192, P289, DOI 10.1534/genetics.112.140863; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; SCHWOB E, 1993, GENE DEV, V7, P1160, DOI 10.1101/gad.7.7a.1160; Sia RAL, 1998, EMBO J, V17, P6678, DOI 10.1093/emboj/17.22.6678; Sia RAL, 1996, MOL BIOL CELL, V7, P1657, DOI 10.1091/mbc.7.11.1657; Simpson-Lavy KJ, 2009, CELL CYCLE, V8, P3006; Skirycz A, 2011, PLANT CELL, V23, P1876, DOI 10.1105/tpc.111.084160; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; SU TT, 1995, CELL, V81, P825, DOI 10.1016/0092-8674(95)90000-4; SURANA U, 1991, CELL, V65, P145, DOI 10.1016/0092-8674(91)90416-V; Theesfeld CL, 2003, MOL BIOL CELL, V14, P3280, DOI 10.1091/mbc.e03-03-0154; Traverso EE, 2001, J BIOL CHEM, V276, P21924, DOI 10.1074/jbc.M011689200; TYERS M, 1993, EMBO J, V12, P1955, DOI 10.1002/j.1460-2075.1993.tb05845.x; Venta R, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00459; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; Yaakov G, 2009, MOL BIOL CELL, V20, P3572, DOI 10.1091/mbc.E09-02-0129; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039; Zi ZK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009522	61	23	23	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68067	10.1371/journal.pone.0068067	http://dx.doi.org/10.1371/journal.pone.0068067			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874495	Green Published, gold			2022-12-27	WOS:000321765300024
J	Gritti, ES; Gaucherel, C; Crespo-Perez, MV; Chuine, I				Gritti, Emmanuel Stephan; Gaucherel, Cedric; Crespo-Perez, Maria-Veronica; Chuine, Isabelle			How Can Model Comparison Help Improving Species Distribution Models?	PLOS ONE			English	Article							FAGUS-SYLVATICA L.; CLIMATE-CHANGE IMPACTS; VEGETATION DYNAMICS; RANGE SHIFTS; VULNERABILITY; UNCERTAINTY; ECOSYSTEMS; FUTURE; CARBON; NICHE	Today, more than ever, robust projections of potential species range shifts are needed to anticipate and mitigate the impacts of climate change on biodiversity and ecosystem services. Such projections are so far provided almost exclusively by correlative species distribution models (correlative SDMs). However, concerns regarding the reliability of their predictive power are growing and several authors call for the development of process-based SDMs. Still, each of these methods presents strengths and weakness which have to be estimated if they are to be reliably used by decision makers. In this study we compare projections of three different SDMs (STASH, LPJ and PHENOFIT) that lie in the continuum between correlative models and process-based models for the current distribution of three major European tree species, Fagus sylvatica L., Quercus robur L. and Pinus sylvestris L. We compare the consistency of the model simulations using an innovative comparison map profile method, integrating local and multi-scale comparisons. The three models simulate relatively accurately the current distribution of the three species. The process-based model performs almost as well as the correlative model, although parameters of the former are not fitted to the observed species distributions. According to our simulations, species range limits are triggered, at the European scale, by establishment and survival through processes primarily related to phenology and resistance to abiotic stress rather than to growth efficiency. The accuracy of projections of the hybrid and process-based model could however be improved by integrating a more realistic representation of the species resistance to water stress for instance, advocating for pursuing efforts to understand and formulate explicitly the impact of climatic conditions and variations on these processes.	[Gritti, Emmanuel Stephan; Crespo-Perez, Maria-Veronica; Chuine, Isabelle] Univ Montpellier 2, CNRS, CEFE, UMR 5175, F-34293 Montpellier, France; [Gritti, Emmanuel Stephan] Montpellier SupAgro, UMR Syst, F-34060 Montpellier 1, France; [Gaucherel, Cedric] UMR AMAP INRA, Montpellier, France; [Gaucherel, Cedric] IFP CNRS, French Inst Pondicherry, Pondicherry, India	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Institut Agro; Montpellier SupAgro; INRAE; Universite de Montpellier	Gritti, ES (corresponding author), Univ Montpellier 2, CNRS, CEFE, UMR 5175, 1919 Route Mende, F-34293 Montpellier, France.	emmanuel.gritti@supagro.inra.fr	BITOUN, RACHEL Elisabeth/AAC-9538-2021; Crespo-Pérez, Verónica/AAJ-7499-2020	BITOUN, RACHEL Elisabeth/0000-0002-3614-9910; Crespo-Pérez, Verónica/0000-0002-8811-1965; Gritti, Emmanuel S./0000-0002-0276-953X	Agence Nationale de la Recherche [ANR-05-BDIV-009, ANR-2009 PEXT 001105]	Agence Nationale de la Recherche(French National Research Agency (ANR))	The authors acknowledge with thanks financial support from the Agence Nationale de la Recherche (Projects ANR-05-BDIV-009; ANR-2009 PEXT 001105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2003, INT J PLANT SCI, V164, pS1, DOI 10.1086/374729; Beaumont LJ, 2005, ECOL MODEL, V186, P250, DOI 10.1016/j.ecolmodel.2005.01.030; Bohn U, 2003, MAP NATURAL VEGETATI; Brus DJ, 2012, EUR J FOREST RES, V131, P145, DOI 10.1007/s10342-011-0513-5; Buisson L, 2010, GLOBAL CHANGE BIOL, V16, P1145, DOI 10.1111/j.1365-2486.2009.02000.x; Cheaib A, 2012, ECOL LETT, V15, P533, DOI 10.1111/j.1461-0248.2012.01764.x; Chuine I, 2001, ECOL LETT, V4, P500, DOI 10.1046/j.1461-0248.2001.00261.x; de Noblet-Ducoudre N, 2004, AGRONOMIE, V24, P397, DOI 10.1051/agro:2004038; Dormann CF, 2012, J BIOGEOGR, V39, P2119, DOI 10.1111/j.1365-2699.2011.02659.x; Dufrene E, 2005, ECOL MODEL, V185, P407, DOI 10.1016/j.ecolmodel.2005.01.004; Etterson JR, 2001, SCIENCE, V294, P151, DOI 10.1126/science.1063656; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Garreta V, 2010, CLIM DYNAM, V35, P371, DOI 10.1007/s00382-009-0629-1; Gaston KJ, 2003, STRUCTURE DYNAMICS G; Gaucherel C, 2010, J ZOOL, V280, P185, DOI 10.1111/j.1469-7998.2009.00652.x; Gaucherel C, 2008, IEEE T GEOSCI REMOTE, V46, P2708, DOI 10.1109/TGRS.2008.919379; Grinnell J, 1914, AM NAT, V48, P248, DOI 10.1086/279402; Gritti ES, 2013, METHODS ECOL EVOL, V4, P442, DOI 10.1111/2041-210X.12032; Gritti ES, 2006, J BIOGEOGR, V33, P145, DOI 10.1111/j.1365-2699.2005.01377.x; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Haxeltine A, 1996, GLOBAL BIOGEOCHEM CY, V10, P693, DOI 10.1029/96GB02344; Herbette S, 2010, TREE PHYSIOL, V30, P1448, DOI 10.1093/treephys/tpq079; Hickler T, 2004, ECOLOGY, V85, P519, DOI 10.1890/02-0344; Holt RD, 2009, P NATL ACAD SCI USA, V106, P19659, DOI 10.1073/pnas.0905137106; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Kearney MR, 2010, CONSERV LETT, V3, P203, DOI 10.1111/j.1755-263X.2010.00097.x; Keenan T, 2011, GLOBAL CHANGE BIOL, V17, P565, DOI 10.1111/j.1365-2486.2010.02254.x; Koca D, 2006, CLIMATIC CHANGE, V78, P381, DOI 10.1007/s10584-005-9030-1; Kramer K, 2010, FOREST ECOL MANAG, V259, P2213, DOI 10.1016/j.foreco.2009.12.023; Lamy JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023476; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Laurent JM, 2004, J VEG SCI, V15, P739, DOI 10.1111/j.1654-1103.2004.tb02316.x; Lindner M, 2010, FOREST ECOL MANAG, V259, P698, DOI 10.1016/j.foreco.2009.09.023; Miller PA, 2008, J ECOL, V96, P247, DOI 10.1111/j.1365-2745.2007.01342.x; Mitchell T. D., 2004, 55 TYND CTR; Morin X, 2008, J ECOL, V96, P784, DOI 10.1111/j.1365-2745.2008.01369.x; Morin X, 2007, ECOLOGY, V88, P2280, DOI 10.1890/06-1591.1; Morin X, 2009, ECOLOGY, V90, P1301, DOI 10.1890/08-0134.1; Nicks AD, 1995, 10 NSERL USDAARS; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; PRENTICE IC, 1991, FOREST ECOL MANAG, V42, P79, DOI 10.1016/0378-1127(91)90066-5; Rehfeldt GE, 2002, GLOBAL CHANGE BIOL, V8, P912, DOI 10.1046/j.1365-2486.2002.00516.x; Reich PB, 2008, ECOL LETT, V11, P588, DOI 10.1111/j.1461-0248.2008.01172.x; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Rosenzweig ML, 1987, EVOL ECOL, V1, P1, DOI 10.1007/BF02067263; Segurado P, 2004, J BIOGEOGR, V31, P1555, DOI 10.1111/j.1365-2699.2004.01076.x; Sitch S, 2003, GLOBAL CHANGE BIOL, V9, P161, DOI 10.1046/j.1365-2486.2003.00569.x; Smith B, 2001, GLOBAL ECOL BIOGEOGR, V10, P621, DOI 10.1046/j.1466-822X.2001.00256.x; Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106; Svenning JC, 2004, ECOL LETT, V7, P565, DOI 10.1111/j.1461-0248.2004.00614.x; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Sykes MT, 1996, J BIOGEOGR, V23, P203; TEEB, 2010, EC ECOSYSTEMS BIODIV, P410; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Tutin TG, 1964, FLORA EUROPAEAE; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104; Woodward F.I., 1987, CLIMATE PLANT DISTRI; Wortemann R, 2011, TREE PHYSIOL, V31, P1175, DOI 10.1093/treephys/tpr101	59	23	24	0	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68823	10.1371/journal.pone.0068823	http://dx.doi.org/10.1371/journal.pone.0068823			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874779	Green Published, Green Submitted, gold			2022-12-27	WOS:000321736900116
J	Kojima, KK; Jurka, J				Kojima, Kenji K.; Jurka, Jerzy			A Superfamily of DNA Transposons Targeting Multicopy Small RNA Genes	PLOS ONE			English	Article							NON-LTR RETROTRANSPOSONS; INTEGRATION; ELEMENTS; IDENTIFICATION; DATABASE; REPBASE; R1	Target-specific integration of transposable elements for multicopy genes, such as ribosomal RNA and small nuclear RNA (snRNA) genes, is of great interest because of the relatively harmless nature, stable inheritance and possible application for targeted gene delivery of target-specific transposable elements. To date, such strict target specificity has been observed only among non-LTR retrotransposons. We here report a new superfamily of sequence-specific DNA transposons, designated Dada. Dada encodes a DDE-type transposase that shows a distant similarity to transposases encoded by eukaryotic MuDR, hAT, P and Kolobok transposons, as well as the prokaryotic IS256 insertion element. Dada generates 6-7 bp target site duplications upon insertion. One family of Dada DNA transposons targets a specific site inside the U6 snRNA genes and are found in various fish species, water flea, oyster and polycheate worm. Other target sequences of the Dada transposons are U1 snRNA genes and different tRNA genes. The targets are well conserved in multicopy genes, indicating that copy number and sequence conservation are the primary constraints on the target choice of Dada transposons. Dada also opens a new frontier for target-specific gene delivery application.	[Kojima, Kenji K.; Jurka, Jerzy] Genet Informat Res Inst, Mountain View, CA USA		Jurka, J (corresponding author), Genet Informat Res Inst, Mountain View, CA USA.	jurka@girinst.org	Kojima, Kenji/AAO-2213-2021	Kojima, Kenji/0000-0003-2715-5531	National Library of Medicine [P41LM006252]; NATIONAL LIBRARY OF MEDICINE [P41LM006252] Funding Source: NIH RePORTER	National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The project described was supported by award number P41LM006252 from the National Library of Medicine (http://www.nlm.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bao ZR, 2002, GENOME RES, V12, P1269, DOI 10.1101/gr.88502; Bohne A, 2012, MOL BIOL EVOL, V29, P631, DOI 10.1093/molbev/msr208; Burke WD, 1998, NATURE, V392, P141, DOI 10.1038/32330; Chung T, 2007, MOL CELL BIOL, V27, P8492, DOI 10.1128/MCB.01173-07; FRANZ G, 1981, NATURE, V292, P638, DOI 10.1038/292638a0; Goodwin TJD, 2003, MICROBIOL-SGM, V149, P3099, DOI 10.1099/mic.0.26529-0; Hickman AB, 2010, CRIT REV BIOCHEM MOL, V45, P50, DOI 10.3109/10409230903505596; Huang X, 2010, MOL THER, V18, P1803, DOI 10.1038/mt.2010.141; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kapitonov VV, 2008, NAT REV GENET, V9, DOI 10.1038/nrg2165-c1; Kapitonov VV, 2005, PLOS BIOL, V3, P998, DOI 10.1371/journal.pbio.0030181; Kapitonov VV, 2001, P NATL ACAD SCI USA, V98, P8714, DOI 10.1073/pnas.151269298; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kawashima T, 2007, VIRUS RES, V127, P49, DOI 10.1016/j.virusres.2007.03.014; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Kojima KK, 2006, MOL BIOL EVOL, V23, P1984, DOI 10.1093/molbev/msl067; Kojima KK, 2005, MOL BIOL EVOL, V22, P2157, DOI 10.1093/molbev/msi210; Kojima KK, 2004, MOL BIOL EVOL, V21, P207, DOI 10.1093/molbev/msg235; Kojima KK, 2003, MOL BIOL EVOL, V20, P351, DOI 10.1093/molbev/msg031; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leem YE, 2008, MOL CELL, V30, P98, DOI 10.1016/j.molcel.2008.02.016; Liao GC, 2000, P NATL ACAD SCI USA, V97, P3347, DOI 10.1073/pnas.050017397; Linheiro RS, 2008, NUCLEIC ACIDS RES, V36, P6199, DOI 10.1093/nar/gkn563; Linheiro RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030008; Malik HS, 1999, GENETICS, V151, P653; Melek M, 2000, CELL, V101, P625, DOI 10.1016/S0092-8674(00)80874-0; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; Sullender BW, 1993, PRELIMINARY CHARACTE; Yant SR, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm089; Yuan YW, 2011, P NATL ACAD SCI USA, V108, P7884, DOI 10.1073/pnas.1104208108	31	19	19	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68260	10.1371/journal.pone.0068260	http://dx.doi.org/10.1371/journal.pone.0068260			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874566	Green Published, Green Submitted, gold			2022-12-27	WOS:000321736900074
J	Lambert, AA; Azzi, A; Lin, SX; Allaire, G; St-Gelais, KP; Tremblay, MJ; Gilbert, C				Lambert, Alexandra A.; Azzi, Arezki; Lin, Sheng-Xiang; Allaire, Genevieve; St-Gelais, Karianne P.; Tremblay, Michel J.; Gilbert, Caroline			Dendritic Cell Immunoreceptor Is a New Target for Anti-AIDS Drug Development: Identification of DCIR/HIV-1 Inhibitors	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; LECTIN SURFACE-RECEPTOR; DC-SIGN; T-CELLS; HOMOLOGY MODELS; SWISS-MODEL; HIV-1 INFECTION; TRANS-INFECTION; TYPE-1; PROTEIN	The HIV-1 pandemic continues to expand while no effective vaccine or cure is yet available. Existing therapies have managed to limit mortality and control viral proliferation, but are associated with side effects, do not cure the disease and are subject to development of resistance. Finding new therapeutic targets and drugs is therefore crucial. We have previously shown that the dendritic cell immunoreceptor (DCIR), a C-type lectin receptor expressed on dendritic cells (DCs), acts as an attachment factor for HIV-1 to DCs and contributes to HIV-1 transmission to CD4(+) T lymphocytes (CD4TL). Directly involved in HIV-1 infection, DCIR is expressed in apoptotic or infected CD4TL and promotes trans-infection to bystander cells. Here we report the 3D modelling of the extracellular domain of DCIR. Based on this structure, two surface accessible pockets containing the carbohydrate recognition domain and the EPS binding motif, respectively, were targeted for screening of chemicals that will disrupt normal interaction with HIV-1 particle. Preliminary screening using Raji-CD4-DCIR cells allowed identification of two inhibitors that decreased HIV-1 attachment and propagation. The impact of these inhibitors on infection of DCs and CD4TL was evaluated as well. The results of this study thus identify novel molecules capable of blocking HIV-1 transmission by DCs and CD4TL.	[Lambert, Alexandra A.; Allaire, Genevieve; St-Gelais, Karianne P.; Tremblay, Michel J.; Gilbert, Caroline] Ctr Rech CHU Quebec Infect Dis & Immunol, Quebec City, PQ, Canada; [Azzi, Arezki; Lin, Sheng-Xiang] Univ Laval, Fac Med, Quebec City, PQ G1K 7P4, Canada; [Azzi, Arezki] Al Imam Mohammad Ibn Saud Islam Univ IMSIU, Coll Med, Dept Pharmacol, Riyadh, Saudi Arabia	Laval University; Imam Mohammad Ibn Saud Islamic University (IMSIU)	Azzi, A (corresponding author), Univ Laval, Fac Med, Quebec City, PQ G1K 7P4, Canada.	arezkiazzi@yahoo.ca; michel.j.tremblay@crchul.ulaval.ca; caroline.gilbert@crchul.ulaval.ca		Lin, Sheng-Xiang/0000-0001-9149-375X; Gilbert, Caroline/0000-0003-2722-1180	CRCHUQ; Canadian Institutes of Health Research (CIHR) [MOP-188726, 79542]; Fonds de la Recherche en Sante du Quebec; CIHR/HIV/AIDs initiative	CRCHUQ; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); CIHR/HIV/AIDs initiative	This work was supported by startup funding allotted to C.G. by the CRCHUQ, and by operating grants to C.G., M.J.T, from the Canadian Institutes of Health Research (CIHR) (MOP-188726 HIV/AIDs initiative, 79542 respectively). A.A.L. holds a CIHR Doctoral Award. C.G. is the recipient of a Junior 1 Scholarship Award from the Fonds de la Recherche en Sante du Quebec and of a New Investigator Award from the CIHR/HIV/AIDs initiative. M.J.T. holds the Canada Research Chair in Human Immuno-Retrovirology (Tier 1 level). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderluh M, 2012, CURR MED CHEM; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Azzi A, 2004, PROTEINS, V57, P12, DOI 10.1002/prot.20194; Bates EEM, 1999, J IMMUNOL, V163, P1973; Berzi A, 2012, AIDS, V26, P127, DOI 10.1097/QAD.0b013e32834e1567; Bhattacharya S, 2009, J INFECTION, V59, P377, DOI 10.1016/j.jinf.2009.09.014; Bissantz C, 2003, PROTEINS, V50, P5, DOI 10.1002/prot.10237; Blanchet F, 2011, CURR OPIN HIV AIDS, V6, P391, DOI 10.1097/COH.0b013e328349b0a0; Blanchet FP, 2010, IMMUNITY, V32, P654, DOI 10.1016/j.immuni.2010.04.011; Boggiano C, 2007, J VIROL, V81, P2519, DOI 10.1128/JVI.01661-06; CAMERON PU, 1992, CLIN EXP IMMUNOL, V88, P226, DOI 10.1111/j.1365-2249.1992.tb03066.x; Cavasotto CN, 2007, CURR TOP MED CHEM, V7, P1006, DOI 10.2174/156802607780906753; Celum Connie L, 2011, Top Antivir Med, V19, P181; Dearden JC, 2006, EXPERT OPIN DRUG DIS, V1, P31, DOI 10.1517/17460441.1.1.31; Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172; Diller DJ, 2003, J MED CHEM, V46, P4638, DOI 10.1021/jm020503a; Eldridge MD, 1997, J COMPUT AID MOL DES, V11, P425, DOI 10.1023/A:1007996124545; Evans DT, 2005, J VIROL, V79, P7707, DOI 10.1128/JVI.79.12.7707-7720.2005; Fujikado N, 2008, NAT MED, V14, P176, DOI 10.1038/nm1697; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Gilbert C, 2007, J VIROL, V81, P7672, DOI 10.1128/JVI.02810-06; Gilbert C, 2007, J IMMUNOL, V178, P2862, DOI 10.4049/jimmunol.178.5.2862; Gougeon ML, 1996, J IMMUNOL, V156, P3509; Granelli-Piperno A, 1998, J VIROL, V72, P2733, DOI 10.1128/JVI.72.4.2733-2737.1998; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; Haase AT, 2011, ANNU REV MED, V62, P127, DOI 10.1146/annurev-med-080709-124959; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Haase AT, 2005, NAT REV IMMUNOL, V5, P783, DOI 10.1038/nri1706; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Kairys V, 2006, J CHEM INF MODEL, V46, P365, DOI 10.1021/ci050238c; Kanazawa N, 2004, IMMUNOBIOLOGY, V209, P179, DOI 10.1016/j.imbio.2004.03.004; Klechevsky E, 2010, BLOOD, V116, P1685, DOI 10.1182/blood-2010-01-264960; Lambert AA, 2011, BLOOD; Lambert AA, 2008, BLOOD, V112, P1299, DOI 10.1182/blood-2008-01-136473; Lambert AA, 2011, BLOOD, V117, P6589, DOI 10.1182/blood-2011-01-331363; Lambert AA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001188; Lee RT, 2011, GLYCOBIOLOGY, V21, P512, DOI 10.1093/glycob/cwq193; Lin G, 2003, J VIROL, V77, P1337, DOI 10.1128/JVI.77.2.1337-1346.2003; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Mannhold R, 2009, J PHARM SCI-US, V98, P861, DOI 10.1002/jps.21494; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Meyer-Wentrup F, 2008, BLOOD, V111, P4245, DOI 10.1182/blood-2007-03-081398; Meyer-Wentrup F, 2009, J LEUKOCYTE BIOL, V85, P518, DOI 10.1189/jlb.0608352; Moore JP, 2003, P NATL ACAD SCI USA, V100, P10598, DOI 10.1073/pnas.1932511100; Nikolopoulos G, 2009, MINI-REV MED CHEM, V9, P900, DOI 10.2174/138955709788681609; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Palella FJ, 2011, CURR OPIN HIV AIDS, V6, P266, DOI 10.1097/COH.0b013e328347876c; Poirier D, 2005, J MED CHEM, V48, P8134, DOI 10.1021/jm058235e; Qiu W, 2002, FASEB J, V16, P1829, DOI 10.1096/fj.02-0026fje; Qiu W, 2007, J BIOL CHEM, V282, P8368, DOI 10.1074/jbc.M606784200; Richard M, 2003, BIOCHEM BIOPH RES CO, V310, P767, DOI 10.1016/j.bbrc.2003.09.077; Roche M, 2011, J VIROL, V85, P4330, DOI 10.1128/JVI.00106-11; Schapira M, 2003, P NATL ACAD SCI USA, V100, P7354, DOI 10.1073/pnas.1131854100; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Snyder GA, 2005, J VIROL, V79, P4589, DOI 10.1128/JVI.79.8.4589-4598.2005; Sokal R.R., 2012, BIOMETRY; Sousa AE, 2002, J IMMUNOL, V169, P3400, DOI 10.4049/jimmunol.169.6.3400; Tetko I, 2007, PROPERTY BASED LOGP; Tran Thuong H, 2011, J Antivir Antiretrovir, V3, P49; TREMBLAY M, 1994, EMBO J, V13, P774, DOI 10.1002/j.1460-2075.1994.tb06320.x; Trono D, 2010, SCIENCE, V329, P174, DOI 10.1126/science.1191047; Tsunetsugu-Yokota Y, 1997, VIROLOGY, V239, P259, DOI 10.1006/viro.1997.8895; Turville SG, 2004, BLOOD, V103, P2170, DOI 10.1182/blood-2003-09-3129; Vigerust DJ, 2007, TRENDS MICROBIOL, V15, P211, DOI 10.1016/j.tim.2007.03.003; Wu L, 2004, VIROLOGY, V318, P17, DOI 10.1016/j.virol.2003.09.028; Wu L, 2006, NAT REV IMMUNOL, V6, P859, DOI 10.1038/nri1960; Yuan YZ, 2011, VIROLOGY, V413, P293, DOI 10.1016/j.virol.2011.02.019; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	71	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e67873	10.1371/journal.pone.0067873	http://dx.doi.org/10.1371/journal.pone.0067873			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874461	Green Published, gold, Green Submitted			2022-12-27	WOS:000321736900031
J	Smee, DF; Wong, MH; Hurst, BL; Ennis, J; Turner, JD				Smee, Donald F.; Wong, Min-Hui; Hurst, Brett L.; Ennis, Jane; Turner, Jeffrey D.			Effects of Nasal or Pulmonary Delivered Treatments with an Adenovirus Vectored Interferon (mDEF201) on Respiratory and Systemic Infections in Mice Caused by Cowpox and Vaccinia Viruses	PLOS ONE			English	Article							EQUINE ENCEPHALITIS-VIRUS; PROTECTION	An adenovirus 5 vector encoding for mouse interferon alpha, subtype 5 (mDEF201) was evaluated for efficacy against lethal cowpox (Brighton strain) and vaccinia (WR strain) virus respiratory and systemic infections in mice. Two routes of mDEF201 administration were used, nasal sinus (5-mu l) and pulmonary (50-mu l), to compare differences in efficacy, since the preferred treatment of humans would be in a relatively small volume delivered intranasally. Lower respiratory infections (LRI), upper respiratory infections (URI), and systemic infections were induced by 50-mu l intranasal, 10-mu l intranasal, and 100-mu l intraperitoneal virus challenges, respectively. mDEF201 treatments were given prophylactically either 24 h (short term) or 56d (long-term) prior to virus challenge. Single nasal sinus treatments of 10(6) and 10(7) PFU/mouse of mDEF201 protected all mice from vaccinia-induced LRI mortality (comparable to published studies with pulmonary delivered mDEF201). Systemic vaccinia infections responded significantly better to nasal sinus delivered mDEF201 than to pulmonary treatments. Cowpox LRI infections responded to 10(7) mDEF201 treatments, but a 10(6) dose was only weakly protective. Cowpox URI infections were equally treatable by nasal sinus and pulmonary delivered mDEF201 at 10(7) PFU/mouse. Dose-responsive prophylaxis with mDEF201, given one time only 56 d prior to initiating a vaccinia virus LRI infection, was 100% protective from 10(5) to 10(7) PFU/mouse. Improvements in lung hemorrhage score and lung weight were evident, as were decreases in liver, lung, and spleen virus titers. Thus, mDEF201 was able to treat different vaccinia and cowpox virus infections using both nasal sinus and pulmonary treatment regimens, supporting its development for humans.	[Smee, Donald F.; Wong, Min-Hui; Hurst, Brett L.] Utah State Univ, Inst Antiviral Res, Dept Anim Dairy & Vet Sci, Logan, UT 84322 USA; [Ennis, Jane; Turner, Jeffrey D.] Defyrus Inc, Toronto, ON, Canada	Utah System of Higher Education; Utah State University	Smee, DF (corresponding author), Utah State Univ, Inst Antiviral Res, Dept Anim Dairy & Vet Sci, Logan, UT 84322 USA.	don.smee@usu.edu			Virology Branch, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA [HHSN272201000039I/HHSN27200006/A30]	Virology Branch, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA	This work was supported by contract HHSN272201000039I/HHSN27200006/A30 from the Virology Branch, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Croyle MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003548; Gowen BB, 2012, ANTIMICROB AGENTS CH, V56, P4168, DOI 10.1128/AAC.00376-12; Gowen BB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026072; Julander JG, 2011, ANTIMICROB AGENTS CH, V55, P2067, DOI 10.1128/AAC.01635-10; Knorr CW, 2006, ANTIVIR RES, V72, P125, DOI 10.1016/j.antiviral.2006.05.005; Kumaki Y, 2011, ANTIVIR RES, V89, P75, DOI 10.1016/j.antiviral.2010.11.007; Lederman ER, 2012, J INFECT DIS, V206, P1372, DOI 10.1093/infdis/jis510; National Research Council, 2011, GUIDE CARE USE LAB A; O'Brien L, 2009, J GEN VIROL, V90, P874, DOI 10.1099/vir.0.006833-0; Richardson JS, 2011, J BIOTERROR BIODEF S, VS1; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Smee DF, 2002, ANTIMICROB AGENTS CH, V46, P1329, DOI 10.1128/AAC.46.5.1329-1335.2002; Smee DF, 2008, INT J ANTIMICROB AG, V31, P352, DOI 10.1016/j.ijantimicag.2007.11.013; Smee DF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026330; Southam DS, 2002, AM J PHYSIOL-LUNG C, V282, pL833, DOI 10.1152/ajplung.00173.2001; Wu JQH, 2007, VIROLOGY, V369, P206, DOI 10.1016/j.virol.2007.07.024	16	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68685	10.1371/journal.pone.0068685	http://dx.doi.org/10.1371/journal.pone.0068685			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874722	Green Submitted, Green Published, gold			2022-12-27	WOS:000321736900103
J	Lacayo, CI; Hwang, MS; Ding, SY; Thelen, MP				Lacayo, Catherine I.; Hwang, Mona S.; Ding, Shi-You; Thelen, Michael P.			Lignin Depletion Enhances the Digestibility of Cellulose in Cultured Xylem Cells	PLOS ONE			English	Article							CARBOHYDRATE-BINDING MODULES; TRACHEARY-ELEMENT DIFFERENTIATION; STEAM PRETREATED SOFTWOOD; ENZYMATIC-HYDROLYSIS; CORN STOVER; LIGNOCELLULOSE FRACTIONATION; DOWN-REGULATION; ENZYMES; ACCESSIBILITY; ACID	Plant lignocellulose constitutes an abundant and sustainable source of polysaccharides that can be converted into biofuels. However, the enzymatic digestion of native plant cell walls is inefficient, presenting a considerable barrier to cost-effective biofuel production. In addition to the insolubility of cellulose and hemicellulose, the tight association of lignin with these polysaccharides intensifies the problem of cell wall recalcitrance. To determine the extent to which lignin influences the enzymatic digestion of cellulose, specifically in secondary walls that contain the majority of cellulose and lignin in plants, we used a model system consisting of cultured xylem cells from Zinnia elegans. Rather than using purified cell wall substrates or plant tissue, we have applied this system to study cell wall degradation because it predominantly consists of homogeneous populations of single cells exhibiting large deposits of lignocellulose. We depleted lignin in these cells by treating with an oxidative chemical or by inhibiting lignin biosynthesis, and then examined the resulting cellulose digestibility and accessibility using a fluorescent cellulose-binding probe. Following cellulase digestion, we measured a significant decrease in relative cellulose content in lignin-depleted cells, whereas cells with intact lignin remained essentially unaltered. We also observed a significant increase in probe binding after lignin depletion, indicating that decreased lignin levels improve cellulose accessibility. These results indicate that lignin depletion considerably enhances the digestibility of cellulose in the cell wall by increasing the susceptibility of cellulose to enzymatic attack. Although other wall components are likely to contribute, our quantitative study exploits cultured Zinnia xylem cells to demonstrate the dominant influence of lignin on the enzymatic digestion of the cell wall. This system is simple enough for quantitative image analysis, but realistic enough to capture the natural complexity of lignocellulose in the plant cell wall. Consequently, these cells represent a suitable model for analyzing native lignocellulose degradation.	[Lacayo, Catherine I.; Hwang, Mona S.; Thelen, Michael P.] Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA USA; [Ding, Shi-You] Natl Renewable Energy Lab, Chem & Biosci Ctr, Golden, CO USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA	Thelen, MP (corresponding author), Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA USA.	mthelen@llnl.gov	DING, SHIYOU/ABD-8519-2021; Thelen, Michael P/G-2032-2014; Thelen, Michael/C-6834-2008; Ding, Shi-You/O-1209-2013	DING, SHIYOU/0000-0002-1102-1507; Thelen, Michael P/0000-0002-2479-5480; Thelen, Michael/0000-0002-2479-5480; 	U.S. Department of Energy [DE-AC52-07NA27344, ER65258]	U.S. Department of Energy(United States Department of Energy (DOE))	This work was performed under the auspices of the U.S. Department of Energy under Contracts DE-AC52-07NA27344 (LLNL) and ER65258 (NREL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLGREN PA, 1971, CAN J CHEMISTRY, V49, P1272, DOI 10.1139/v71-207; Barcelo AR, 1998, PLANTA, V207, P207, DOI 10.1007/s004250050474; Blake AW, 2008, PLANTA, V228, P1, DOI 10.1007/s00425-008-0713-5; Blanchette C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042116; Boraston AB, 2002, J MOL BIOL, V319, P1143, DOI 10.1016/S0022-2836(02)00374-1; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Bura R, 2009, BIOTECHNOL PROGR, V25, P315, DOI 10.1002/btpr.98; Burton RA, 2010, NAT CHEM BIOL, V6, P724, DOI [10.1038/NCHEMBIO.439, 10.1038/nchembio.439]; Clarke ND, 2010, CURR OPIN STRUC BIOL, V20, P527, DOI 10.1016/j.sbi.2010.06.001; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Ding SY, 2006, BIOTECHNIQUES, V41, P435, DOI 10.2144/000112244; Ding SY, 2012, SCIENCE, V338, P1055, DOI 10.1126/science.1227491; Ding SY, 2006, J AGR FOOD CHEM, V54, P597, DOI 10.1021/jf051851z; Eudes A, 2012, PLANT BIOTECHNOL J, V10, P609, DOI 10.1111/j.1467-7652.2012.00692.x; FALCONER MM, 1985, PROTOPLASMA, V125, P190, DOI 10.1007/BF01281237; Fu CX, 2011, P NATL ACAD SCI USA, V108, P3803, DOI 10.1073/pnas.1100310108; Fukuda H, 1996, ANNU REV PLANT PHYS, V47, P299, DOI 10.1146/annurev.arplant.47.1.299; FUKUDA H, 1982, PLANTA, V155, P423, DOI 10.1007/BF00394471; Grabber JH, 2005, CROP SCI, V45, P820, DOI 10.2135/cropsci2004.0191; Grabber JH, 1998, J AGR FOOD CHEM, V46, P2609, DOI 10.1021/jf9800099; GRETHLEIN HE, 1984, BIOTECHNOL BIOENG, V26, P1498, DOI 10.1002/bit.260261215; Hendriks ATWM, 2009, BIORESOURCE TECHNOL, V100, P10, DOI 10.1016/j.biortech.2008.05.027; Henmi K, 2005, PLANT CELL PHYSIOL, V46, P1757, DOI 10.1093/pcp/pci198; Hong J, 2007, LANGMUIR, V23, P12535, DOI 10.1021/la7025686; Hubbell CA, 2010, BIORESOURCE TECHNOL, V101, P7410, DOI 10.1016/j.biortech.2010.04.029; Ishizawa CI, 2009, CELLULOSE, V16, P677, DOI 10.1007/s10570-009-9313-1; Jeoh T, 2007, BIOTECHNOL BIOENG, V98, P112, DOI 10.1002/bit.21408; Jung HJG, 2000, J SCI FOOD AGR, V80, P419, DOI 10.1002/1097-0010(200002)80:3&lt;419::AID-JSFA544&gt;3.0.CO;2-I; Karlsson M, 2005, J EXP BOT, V56, P2085, DOI 10.1093/jxb/eri207; Klein-Marcuschamer D, 2011, BIOFUEL BIOPROD BIOR, V5, P562, DOI 10.1002/bbb.303; Knox JP, 2008, CURR OPIN PLANT BIOL, V11, P308, DOI 10.1016/j.pbi.2008.03.001; Kumar L, 2012, BIORESOURCE TECHNOL, V103, P201, DOI 10.1016/j.biortech.2011.09.091; Kumar L, 2011, BIOTECHNOL BIOENG, V108, P2300, DOI 10.1002/bit.23185; Lacayo CI, 2010, PLANT PHYSIOL, V154, P121, DOI 10.1104/pp.110.155242; LEAVITT SW, 1993, ANAL CHEM, V65, P87, DOI 10.1021/ac00049a017; Linder M, 2002, APPL ENVIRON MICROB, V68, P2503, DOI 10.1128/AEM.68.5.2503-2508.2002; Mansfield SD, 1999, BIOTECHNOL PROGR, V15, P804, DOI 10.1021/bp9900864; McCartney L, 2004, ANAL BIOCHEM, V326, P49, DOI 10.1016/j.ab.2003.11.011; Medie FM, 2012, NAT REV MICROBIOL, V10, P227, DOI 10.1038/nrmicro2729; Mellerowicz EJ, 2001, PLANT MOL BIOL, V47, P239, DOI 10.1023/A:1010699919325; Mooney CA, 1998, BIORESOURCE TECHNOL, V64, P113, DOI 10.1016/S0960-8524(97)00181-8; Palonen H, 2004, J BIOTECHNOL, V107, P65, DOI 10.1016/j.jbiotec.2003.09.011; Pattathil S, 2010, PLANT PHYSIOL, V153, P514, DOI 10.1104/pp.109.151985; Perez J., 2002, International Microbiology, V5, P53, DOI 10.1007/s10123-002-0062-3; Piquemal J, 1998, PLANT J, V13, P71, DOI 10.1046/j.1365-313X.1998.00014.x; Porter SE, 2007, BIOTECHNOL BIOENG, V98, P123, DOI 10.1002/bit.21409; PURI VP, 1984, BIOTECHNOL BIOENG, V26, P1219, DOI 10.1002/bit.260261010; Ralph J, 1998, P NATL ACAD SCI USA, V95, P12803, DOI 10.1073/pnas.95.22.12803; Reddy MSS, 2005, P NATL ACAD SCI USA, V102, P16573, DOI 10.1073/pnas.0505749102; ROBERTS AW, 1992, PLANT CELL TISS ORG, V28, P27, DOI 10.1007/BF00039912; Rollin JA, 2011, BIOTECHNOL BIOENG, V108, P22, DOI 10.1002/bit.22919; Turner S, 2007, ANNU REV PLANT BIOL, V58, P407, DOI 10.1146/annurev.arplant.57.032905.105236; Van Dyk JS, 2012, BIOTECHNOL ADV, V30, P1458, DOI 10.1016/j.biotechadv.2012.03.002; Wei H, 2009, CURR OPIN BIOTECH, V20, P330, DOI 10.1016/j.copbio.2009.05.008; WOOD PJ, 1983, J CEREAL SCI, V1, P95, DOI 10.1016/S0733-5210(83)80027-7; Yang B, 2004, BIOTECHNOL BIOENG, V86, P88, DOI 10.1002/bit.20043; Yoshida M, 2008, BIOSCI BIOTECH BIOCH, V72, P805, DOI 10.1271/bbb.70689; Zhu ZG, 2009, BIOTECHNOL BIOENG, V103, P715, DOI 10.1002/bit.22307	58	19	19	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e68266	10.1371/journal.pone.0068266	http://dx.doi.org/10.1371/journal.pone.0068266			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874568	Green Submitted, Green Published, gold			2022-12-27	WOS:000324146200015
J	Zhou, J; Zheng, XX; Yang, Q; Liang, ZY; Li, DH; Yang, XB; Xu, J				Zhou, Jing; Zheng, Xiaoxue; Yang, Qi; Liang, Zhenyi; Li, Donghai; Yang, Xiaobo; Xu, Jing			Optimization of Ultrasonic-Assisted Extraction and Radical-Scavenging Capacity of Phenols and Flavonoids from Clerodendrum cyrtophyllum Turcz Leaves	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; TEMPERATURE; TIME	Ultrasonic-assisted extraction (UAE) was developed to extract phenolic and flavonoid antioxidants from Clerodendrum cyrtophyllum Turcz leaves. The optimal experimental parameters for antioxidant extraction from C. cyrtophyllum leaves were measured using single-factor experimentation combined with response surface methodology (RSM). Total phenolic content (TPC) and total flavonoid content (TFC) assays were used to quantify antioxidant compounds. Next, antioxidant radical scavenging capacity was measured using 2,2'-diphenyl-1-picrylhydrazyl (DPPH) and 2,2' -azino-bis(3-ethylbenzothiazoline-6-sulphonicacid) (ABTS) radicals. Optimized extraction conditions for UAE from C. cyrtophyllum leaves were as follows: 60.9% ethanol, 85.4 min, and 63.3 degrees C for maximal TPC extraction (16.8 +/- 0.2 mg GAE/g DW); 67.7% ethanol, 82.9 min, and 63.0 degrees C for maximal TFC extraction (49.3 +/- 0.4 mg RT/g DW); 48.8% ethanol, 85.1 min, and 63.9 degrees C for maximal DPPH radical-scavenging capacity (86.8 +/- 0.2%); and 50.6% ethanol, 81.3 min, and 63.4 degrees C for maximal ABTS radical-scavenging capacity (92.9 +/- 0.5%). Ethanol concentration was the most important factor in the extraction process. Our work offers optimal extraction conditions for C. cyrtophyllum as a potential source of natural antioxidants.	[Zhou, Jing; Zheng, Xiaoxue; Yang, Qi; Liang, Zhenyi; Li, Donghai; Yang, Xiaobo; Xu, Jing] Hainan Univ, Coll Mat & Chem Engn, Minist Educ, Key Lab Protect & Dev Utilizat Trop Crop Germplas, Haikou, Peoples R China; [Xu, Jing] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Inst Funct Biomol, Nanjing 210008, Jiangsu, Peoples R China	Hainan University; Nanjing University	Yang, XB (corresponding author), Hainan Univ, Coll Mat & Chem Engn, Minist Educ, Key Lab Protect & Dev Utilizat Trop Crop Germplas, Haikou, Peoples R China.	yanfengxb@163.com; happyjing3@163.com			National Natural Science Foundation of China [81202456]; State key subject of Botany at Hainan University [071001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State key subject of Botany at Hainan University	Co-Financed by grants of National Natural Science Foundation of China for Young Scholar (number 81202456) and the State key subject of Botany at Hainan University (071001) are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Bakar MF, 2009, FOOD CHEM, V113, P479, DOI 10.1016/j.foodchem.2008.07.081; Chan EWC, 2009, FOOD CHEM, V113, P166, DOI 10.1016/j.foodchem.2008.07.090; Cheng HH, 2001, J NAT PROD, V64, P915, DOI 10.1021/np000595b; Donghai Li, 2012, Advanced Materials Research, V524-527, P1723, DOI 10.4028/www.scientific.net/AMR.524-527.1723; Fearon IM, 2009, J MOL CELL CARDIOL, V47, P372, DOI 10.1016/j.yjmcc.2009.05.013; Gonzalez-Montelongo R, 2010, SEP PURIF TECHNOL, V71, P347, DOI 10.1016/j.seppur.2009.12.022; Halliwell B, 2011, TRENDS PHARMACOL SCI, V32, P125, DOI 10.1016/j.tips.2010.12.002; Hemwimol S, 2006, ULTRASON SONOCHEM, V13, P543, DOI 10.1016/j.ultsonch.2005.09.009; Huang W, 2009, FOOD CHEM, V114, P1147, DOI 10.1016/j.foodchem.2008.10.079; Li DH, 2012, HITCHC AFR J BIOTECH, V11, P4513; Liu H, 2011, HORTIC ENVIRON BIOTE, V52, P309, DOI 10.1007/s13580-011-0204-7; Liyana-Pathirana C, 2005, FOOD CHEM, V93, P47, DOI 10.1016/j.foodchem.2004.08.050; MUNIR A A, 1989, Journal of the Adelaide Botanic Gardens, V11, P101; Patricia I., 2005, CLIN DEV IMMUNOL, V12, P23; Pietta P, 1998, J AGR FOOD CHEM, V46, P4487, DOI 10.1021/jf980310p; Sharififar F, 2009, FOOD CHEM, V112, P885, DOI 10.1016/j.foodchem.2008.06.064; Silva EM, 2007, SEP PURIF TECHNOL, V55, P381, DOI 10.1016/j.seppur.2007.01.008; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Sokmen M, 2004, J AGR FOOD CHEM, V52, P3309, DOI 10.1021/jf049859g; Spigno G, 2007, J FOOD ENG, V81, P200, DOI 10.1016/j.jfoodeng.2006.10.021; Thoo YY, 2010, FOOD CHEM, V120, P290, DOI 10.1016/j.foodchem.2009.09.064; TIAN XD, 1993, CHEM PHARM BULL, V41, P1415, DOI 10.1248/cpb.41.1415; Vinatoru M, 2001, ULTRASON SONOCHEM, V8, P303, DOI 10.1016/S1350-4177(01)00071-2; Wang J, 2008, FOOD CHEM, V106, P804, DOI 10.1016/j.foodchem.2007.06.062; Wang MF, 1998, J AGR FOOD CHEM, V46, P4869, DOI 10.1021/jf980614b; Wu ZY, 2004, FLORA REPUBULICAE PO; Xu BJ, 2007, J FOOD SCI, V72, pS159, DOI 10.1111/j.1750-3841.2006.00260.x; Zhang ZS, 2007, SEP PURIF TECHNOL, V57, P17, DOI 10.1016/j.seppur.2007.03.006	28	33	34	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68392	10.1371/journal.pone.0068392	http://dx.doi.org/10.1371/journal.pone.0068392			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874607	Green Published, Green Submitted, gold			2022-12-27	WOS:000322064300027
J	Vellakkal, S; Subramanian, SV; Millett, C; Basu, S; Stuckler, D; Ebrahim, S				Vellakkal, Sukumar; Subramanian, S. V.; Millett, Christopher; Basu, Sanjay; Stuckler, David; Ebrahim, Shah			Socioeconomic Inequalities in Non-Communicable Diseases Prevalence in India: Disparities between Self-Reported Diagnoses and Standardized Measures	PLOS ONE			English	Article							ROSE ANGINA QUESTIONNAIRE; RISK-FACTORS; GLOBAL BURDEN; HEALTH; PERFORMANCE; MORTALITY; REGIONS; PROFILE; INDEX; PAIN	Background: Whether non-communicable diseases (NCDs) are diseases of poverty or affluence in low-and-middle income countries has been vigorously debated. Most analyses of NCDs have used self-reported data, which is biased by differential access to healthcare services between groups of different socioeconomic status (SES). We sought to compare self-reported diagnoses versus standardised measures of NCD prevalence across SES groups in India. Methods: We calculated age-adjusted prevalence rates of common NCDs from the Study on Global Ageing and Adult Health, a nationally representative cross-sectional survey. We compared self-reported diagnoses to standardized measures of disease for five NCDs. We calculated wealth-related and education-related disparities in NCD prevalence by calculating concentration index (C), which ranges from -1 to +1 (concentration of disease among lower and higher SES groups, respectively). Findings: NCD prevalence was higher (range 5.2 to 19.1%) for standardised measures than self-reported diagnoses (range 3.1 to 9.4%). Several NCDs were particularly concentrated among higher SES groups according to self-reported diagnoses (C-srd) but were concentrated either among lower SES groups or showed no strong socioeconomic gradient using standardized measures (C-sm): age-standardised wealth-related C: angina C-srd 0.02 vs. C-sm -0.17; asthma and lung diseases C-srd -0.05 vs. C-sm -0.04 (age-standardised education-related C-srd 0.04 vs. C-sm -0.05); vision problems C-srd 0.07 vs. C-sm -0.05; depression C-srd 0.07 vs. C-sm -0.13. Indicating similar trends of standardized measures detecting more cases among low SES, concentration of hypertension declined among higher SES (C-srd 0.19 vs. C-sm 0.03). Conclusions: The socio-economic patterning of NCD prevalence differs markedly when assessed by standardized criteria versus self-reported diagnoses. NCDs in India are not necessarily diseases of affluence but also of poverty, indicating likely under-diagnosis and under-reporting of diseases among the poor. Standardized measures should be used, wherever feasible, to estimate the true prevalence of NCDs.	[Vellakkal, Sukumar; Millett, Christopher; Ebrahim, Shah] Publ Hlth Fdn India, South Asia Network Chron Dis, New Delhi, India; [Subramanian, S. V.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA; [Millett, Christopher] Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, London, England; [Basu, Sanjay] Stanford Univ, Prevent Res Ctr, Stanford, CA 94305 USA; [Basu, Sanjay; Stuckler, David] Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England; [Stuckler, David] Univ Oxford, Dept Sociol, Oxford, England; [Ebrahim, Shah] Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1E 7HT, England	Public Health Foundation of India; Harvard University; Harvard T.H. Chan School of Public Health; Imperial College London; Stanford University; University of London; London School of Hygiene & Tropical Medicine; University of Oxford; University of London; London School of Hygiene & Tropical Medicine	Vellakkal, S (corresponding author), Publ Hlth Fdn India, South Asia Network Chron Dis, New Delhi, India.	sukumar.vellakkal@phfi.org	Vellakkal, Sukumar/AAD-4893-2020	Vellakkal, Sukumar/0000-0003-2635-1944; Stuckler, David/0000-0002-1288-8401; Millett, Christopher/0000-0002-0793-9884; Vellakkal, Sukumar/0000-0002-0594-1454	Wellcome Trust [084674/Z/08/Z]; Leverhulme Trust	Wellcome Trust(Wellcome TrustEuropean Commission); Leverhulme Trust(Leverhulme Trust)	specific funding has been received for this study, however, SE and SV are supported by a Wellcome Trust strategic award 084674/Z/08/Z, and CM with fellowship award from Leverhulme Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyi O, 2007, DIR DEV, P1, DOI 10.1596/978-0-8213-7044-5; [Anonymous], 2008, CLOS GAP GEN HLTH EQ; [Anonymous], 2010, HLTH NUTR POPUL SER; [Anonymous], 2005, PREV CHRON DIS VIT I; [Anonymous], 2007, INT J EQUITY HEALTH, DOI DOI 10.1186/1475-9276-6-23; Balarajan Y, 2011, LANCET, V377, P505, DOI 10.1016/S0140-6736(10)61894-6; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bhan N, 2012, BMJ OPEN, P2; Chalmers J, 1999, J HYPERTENS, V17, P151; Corsi DJ, 2012, BMJ OPEN, P2; CORTINOVIS I, 1993, SOC SCI MED, V36, P1087, DOI 10.1016/0277-9536(93)90127-P; Deaton Angus, 2002, ECON POLIT WEEKLY, V9, P3729, DOI DOI 10.2307/4412578; Deepa Mohan, 2011, J Diabetes Sci Technol, V5, P918; DIMDI, 2005, INT CLASS FUNCT DIS; Disease GIfCOL, 2011, GLOB STRAT DIAGN MAN; Ferguson B., 2003, HLTH SYSTEMS PERFORM, P747; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Filmer D, 2012, DEMOGRAPHY, V49, P359, DOI 10.1007/s13524-011-0077-5; Fischbacher CM, 2001, INT J EPIDEMIOL, V30, P1009, DOI 10.1093/ije/30.5.1009; GoI, 2008, SUMM STAT CAUS DEATH; Gol, 2010, NAT PROGR PREV CONTR; Gulliford Martin, 2002, J Health Serv Res Policy, V7, P186, DOI 10.1258/135581902760082517; Gupta R, 2003, J Assoc Physicians India, V51, P470; Gupta R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044098; Gupta R, 2010, PREV MED, V51, P408, DOI 10.1016/j.ypmed.2010.08.014; HLEG, 2011, HIGH LEV EXP GROUP R; Hosseinpoor AR, 2006, INT J EPIDEMIOL, V35, P1211, DOI 10.1093/ije/dyl164; Jha P, 2008, NEW ENGL J MED, V358, P1137, DOI 10.1056/NEJMsa0707719; Joint National Committee on Prevention D Evaluation and Treatment of High Blood Pressure, 2004, NIH PUBL; Kakwani N, 1997, J ECONOMETRICS, V77, P87, DOI 10.1016/S0304-4076(96)01807-6; KEHOE R, 1994, AM J EPIDEMIOL, V139, P813, DOI 10.1093/oxfordjournals.aje.a117078; Kmra S, 2012, BMJ-BRIT MED J, V341, pc4974; Kowal P, 2012, INT J EPIDEMIOL, V41, P1639, DOI 10.1093/ije/dys210; Kurian NJ, 2007, INDIAN J MED RES, V126, P374; Lambert P.J., 2001, DISTRIBUTION REDISTR, Vthird; Lampe FC, 1998, EUR HEART J, V19, P63, DOI 10.1053/euhj.1997.0729; Lawlor DA, 2003, J EPIDEMIOL COMMUN H, V57, P538, DOI 10.1136/jech.57.7.538; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mackenbach JP, 1996, AM J PUBLIC HEALTH, V86, P706, DOI 10.2105/AJPH.86.5.706; Mackenbach JP, 1997, SOC SCI MED, V44, P757, DOI 10.1016/S0277-9536(96)00073-1; Majra JP, 2009, J HEALTH POPUL NUTR, V27, P316; MARMOT MG, 1978, BMJ-BRIT MED J, V2, P1109, DOI 10.1136/bmj.2.6145.1109; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; Montgomery MR, 2000, DEMOGRAPHY, V37, P155, DOI 10.2307/2648118; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Nedjat S, 2012, J EPIDEMIOL COMMUN H, V66, P495, DOI 10.1136/jech.2010.108977; Patel V, 2011, LANCET, V377, P413, DOI 10.1016/S0140-6736(10)61188-9; Raban MZ, 2012, B WORLD HEALTH ORGAN, V90, P20, DOI 10.2471/BLT.11.091041; Rahman MA, 2012, INDIAN HEART J, V65, P30; Reddy KS, 2007, P NATL ACAD SCI USA, V104, P16263, DOI 10.1073/pnas.0700933104; Reddy KS, 1998, CIRCULATION, V97, P596; Reddy KS, 2002, PUBLIC HEALTH NUTR, V5, P231, DOI 10.1079/PHN2001298; Reddy KS, 2004, REPORT TOBACCO CONTR; ROSE GA, 1962, B WORLD HEALTH ORGAN, V27, P645; Sen A, 2002, BRIT MED J, V324, P860, DOI 10.1136/bmj.324.7342.860; Singh VP, 2010, AM J TROP MED HYG, V82, P9, DOI 10.4269/ajtmh.2010.09-0235; Smith GD, 1997, LIFE COURSE APPROACH TO CHRONIC DISEASE EPIDEMIOLOGY, P242; StataCorp, 2010, INT STAT 10 WIND; Subramanian S, 2013, INT J EPIDEMIOL; van Doorslaer E, 2004, HEALTH ECON, V13, P609, DOI 10.1002/hec.918; van Doorslaer E, 2000, J HEALTH ECON, V19, P553, DOI 10.1016/S0167-6296(00)00050-3; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; WAGSTAFF A, 1991, SOC SCI MED, V33, P545, DOI 10.1016/0277-9536(91)90212-U; Wagstaff A, 2005, HEALTH ECON, V14, P429, DOI 10.1002/hec.953; Wagstaff A, 2002, J HEALTH ECON, V21, P627, DOI 10.1016/S0167-6296(02)00006-1; Wagstaff A, 2000, ANNU REV PUBL HEALTH, V21, P543, DOI 10.1146/annurev.publhealth.21.1.543; Wagstaff A, 2011, HLTH EQUITY FINANCIA; WHO, 2011, WORLD HLTH SURV HLTH; WHO, 2011, SAMPL GUID PART COUN; WHO, 2012, ICD 10 CLASS MENT BE; WHO, 2004, 20 INT STAT CLASS DI; World Health Organization, 2011, WHO STUD GLOB AGEING; Zaman MJ, 2012, INT J EPIDEMIOL, V41, P1302, DOI 10.1093/ije/dyr226	74	127	128	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2013	8	7							e68219	10.1371/journal.pone.0068219	http://dx.doi.org/10.1371/journal.pone.0068219			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	200ZN	23869213	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000323110600012
J	Stajner, N; Cregeen, S; Javornik, B				Stajner, Natasa; Cregeen, Sara; Javornik, Branka			Evaluation of Reference Genes for RT-qPCR Expression Studies in Hop (Humulus lupulus L.) during Infection with Vascular Pathogen Verticillium albo-atrum	PLOS ONE			English	Article							BOX RNA HELICASES; PCR DATA; ARABIDOPSIS-THALIANA; HOUSEKEEPING GENES; INTERNAL CONTROL; NORMALIZATION; VALIDATION; IDENTIFICATION; SELECTION; RICE	Hop plant (Humulus lupulus L.), cultivated primarily for its use in the brewing industry, is faced with a variety of diseases, including severe vascular diseases, such as Verticillium wilt, against which no effective protection is available. The understanding of disease resistance with tools such as differentially expressed gene studies is an important objective of plant defense mechanisms. In this study, we evaluated twenty-three reference genes for RT-qPCR expression studies on hop under biotic stress conditions. The candidate genes were validated on susceptible and resistant hop cultivars sampled at three different time points after infection with Verticillium albo-atrum. The stability of expression and the number of genes required for accurate normalization were assessed by three different Excel-based approaches (geNorm v.3.5 software, NormFinder, and RefFinder). High consistency was found among them, identifying the same six best reference genes (YLS8, DRH1, TIP41, CAC, POAC and SAND) and five least stably expressed genes (CYCL, UBQ11, POACT, GAPDH and NADH). The candidate genes in different experimental subsets/conditions resulted in different rankings. A combination of the two best reference genes, YLS8 and DRH1, was used for normalization of RT-qPCR data of the gene of interest (PR-1) implicated in biotic stress of hop. We outlined the differences between normalized and non-normalized values and the importance of RT-qPCR data normalization. The high correlation obtained among data standardized with different sets of reference genes confirms the suitability of the reference genes selected for normalization. Lower correlations between normalized and non-normalized data may reflect different quantity and/or quality of RNA samples used in RT-qPCR analyses.	[Stajner, Natasa; Cregeen, Sara; Javornik, Branka] Univ Ljubljana, Dept Agron, Biotech Fac, Ljubljana, Slovenia	University of Ljubljana	Javornik, B (corresponding author), Univ Ljubljana, Dept Agron, Biotech Fac, Ljubljana, Slovenia.	branka.javornik@bf.uni-lj.si			Slovenian Research Agency [P4-0077]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	The authors acknowledge funding by the Slovenian Research Agency (http://www.arrs.gov.si/en/dobrodoslica.asp), research program grant no. P4-0077. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Ascencio-Ibanez JT, 2008, PLANT PHYSIOL, V148, P436, DOI 10.1104/pp.108.121038; Aubourg S, 1999, NUCLEIC ACIDS RES, V27, P628, DOI 10.1093/nar/27.2.628; Barsalobres-Cavallari CF, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-1; Brand Yael, 2010, Peanut Science, V37, P12, DOI 10.3146/PS09-014.1; Brunner Amy M., 2004, BMC Plant Biology, V4, P14, DOI 10.1186/1471-2229-4-14; Castro CB, 2008, ANN BOT-LONDON, V102, P265, DOI 10.1093/aob/mcn089; Chaouachi M, 2007, J AGR FOOD CHEM, V55, P8003, DOI 10.1021/jf071429d; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; de Boer GJ, 1998, PLANT PHYSIOL BIOCH, V36, P473, DOI 10.1016/S0981-9428(98)80172-1; Ding JY, 2004, J AGR FOOD CHEM, V52, P3372, DOI 10.1021/jf049915d; Dong QF, 2004, NUCLEIC ACIDS RES, V32, pD354, DOI 10.1093/nar/gkh046; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Iskandar HM, 2004, PLANT MOL BIOL REP, V22, P325, DOI 10.1007/BF02772676; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Kant P, 2007, PLANT PHYSIOL, V145, P814, DOI 10.1104/pp.107.099895; Li HP, 2011, PLANT SCI, V181, P132, DOI 10.1016/j.plantsci.2011.04.014; Libault M, 2008, PLANT GENOME-US, V1, P44, DOI 10.3835/plantgenome2008.02.0091; Lilly ST, 2011, MOL PLANT MICROBE IN, V24, P294, DOI 10.1094/MPMI-10-10-0236; Maloukh L, 2009, J PLANT BIOCHEM BIOT, V18, P53, DOI 10.1007/BF03263295; Matousek J, 2007, J AGR FOOD CHEM, V55, P7767, DOI 10.1021/jf071153+; Migocka M, 2011, MOL BREEDING, V28, P343, DOI 10.1007/s11032-010-9487-0; Mingam A, 2004, PLANT BIOTECHNOL J, V2, P401, DOI 10.1111/j.1467-7652.2004.00084.x; Morgante Carolina V, 2011, BMC Res Notes, V4, P339, DOI 10.1186/1756-0500-4-339; Nagel J, 2008, PLANT CELL, V20, P186, DOI 10.1105/tpc.107.055178; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Radisek S, 2003, PLANT DIS, V87, P633, DOI 10.1094/PDIS.2003.87.6.633; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Remans T, 2008, PLANTA, V227, P1343, DOI 10.1007/s00425-008-0706-4; Robb J, 2012, PLANTA, V236, P623, DOI 10.1007/s00425-012-1637-7; Seefelder S., 2009, CICH IHB IHGC INT HO, P67; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Sturzenbaum SR, 2001, COMP BIOCHEM PHYS B, V130, P281, DOI 10.1016/S1096-4959(01)00440-7; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Walker NJ, 2002, SCIENCE, V296, P557, DOI 10.1126/science.296.5567.557	40	32	32	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e68228	10.1371/journal.pone.0068228	http://dx.doi.org/10.1371/journal.pone.0068228			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	23874551	Green Published, Green Submitted, gold			2022-12-27	WOS:000321718700014
J	Hackerott, S; Valdivia, A; Green, SJ; Cote, IM; Cox, CE; Akins, L; Layman, CA; Precht, WF; Bruno, JF				Hackerott, Serena; Valdivia, Abel; Green, Stephanie J.; Cote, Isabelle M.; Cox, Courtney E.; Akins, Lad; Layman, Craig A.; Precht, William F.; Bruno, John F.			Native Predators Do Not Influence Invasion Success of Pacific Lionfish on Caribbean Reefs	PLOS ONE			English	Article							REGION-WIDE DECLINES; PTEROIS-VOLITANS; RED LIONFISH; CORAL-REEFS; COMMUNITIES; RECRUITMENT; ATLANTIC	Biotic resistance, the process by which new colonists are excluded from a community by predation from and/or competition with resident species, can prevent or limit species invasions. We examined whether biotic resistance by native predators on Caribbean coral reefs has influenced the invasion success of red lionfishes (Pterois volitans and Pterois miles), piscivores from the Indo-Pacific. Specifically, we surveyed the abundance (density and biomass) of lionfish and native predatory fishes that could interact with lionfish (either through predation or competition) on 71 reefs in three biogeographic regions of the Caribbean. We recorded protection status of the reefs, and abiotic variables including depth, habitat type, and wind/wave exposure at each site. We found no relationship between the density or biomass of lionfish and that of native predators. However, lionfish densities were significantly lower on windward sites, potentially because of habitat preferences, and in marine protected areas, most likely because of ongoing removal efforts by reserve managers. Our results suggest that interactions with native predators do not influence the colonization or post-establishment population density of invasive lionfish on Caribbean reefs.	[Hackerott, Serena; Valdivia, Abel; Cox, Courtney E.; Bruno, John F.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Green, Stephanie J.; Cote, Isabelle M.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Akins, Lad] REEF, Key Largo, FL USA; [Layman, Craig A.] Florida Int Univ, Marine Sci Program, North Miami, FL USA; [Precht, William F.] NOAA Florida Keys Natl Marine Sanctuary, Key Largo, FL USA	University of North Carolina; University of North Carolina Chapel Hill; Simon Fraser University; State University System of Florida; Florida International University; National Oceanic Atmospheric Admin (NOAA) - USA	Hackerott, S (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA.	snhackerott@gmail.com	Green, Stephanie/AGE-1160-2022; Cote, Isabelle/ABD-5898-2021	Green, Stephanie/0000-0003-4705-7859; Cox, Courtney/0000-0002-4344-001X	National Science Foundation [OCE-0746164, OCE-0940019]; National Geographic Society Committee for Research and Exploration [8514-08]; Natural Science and Engineering Research Council (NSERC) of Canada; NSERC Canada Graduate Scholarship; Rufford Small Grants Foundation; University of North Carolina at Chapel Hill	National Science Foundation(National Science Foundation (NSF)); National Geographic Society Committee for Research and Exploration(National Geographic Society); Natural Science and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Canada Graduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Rufford Small Grants Foundation; University of North Carolina at Chapel Hill	This work was funded in part by the National Science Foundation (OCE-0746164 to CAL and OCE-0940019 to JFB), the National Geographic Society Committee for Research and Exploration (grant 8514-08 to JFB), a Discovery Grant from the Natural Science and Engineering Research Council (NSERC) of Canada (to IMC), an NSERC Canada Graduate Scholarship (to SJG), the Rufford Small Grants Foundation, and the University of North Carolina at Chapel Hill. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akins JL, 2012, EDUCATION AND OUTREA, P113; Albins MA, 2008, MAR ECOL PROG SER, V367, P233, DOI 10.3354/meps07620; Albins MA, 2013, BIOL INVASIONS, V15, P29, DOI 10.1007/s10530-012-0266-1; Albins MA, 2013, ENVIRON BIOL FISH, V96, P1151, DOI 10.1007/s10641-011-9795-1; Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; Barbour AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019666; Bjornstad O. N., 2012, SPATIAL NONPARAMETRI, V1, P1; Bjornstad ON, 2001, ENVIRON ECOL STAT, V8, P53, DOI 10.1023/A:1009601932481; Bolker B, 2012, GETTING STARTED WITH; Darling ES, 2011, BIOL INVASIONS, V13, P2045, DOI 10.1007/s10530-011-0020-0; Elton C S., 1958, THE ECOLOGY OF INVAS; Frazer TK, 2012, REV FISH SCI, V20, P185, DOI 10.1080/10641262.2012.700655; Green SJ, 2009, CORAL REEFS, V28, P107, DOI 10.1007/s00338-008-0446-8; Green SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032596; Handwerk B, 2011, SHARKS LIONFISH LUNC; Hixon MA, 2011, B MAR SCI, V87, P727, DOI 10.5343/bms.2010.1055; Johnston MA, 2012, LONG TERM MONITORING; Jud ZR, 2011, AQUAT BIOL, V13, P21, DOI 10.3354/ab00351; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Lang JC, 2010, AGRRA PROTOCOLS VERS; Lesser MP, 2011, BIOL INVASIONS, V13, P1855, DOI 10.1007/s10530-011-0005-z; Levine JM, 2004, ECOL LETT, V7, P975, DOI 10.1111/j.1461-0248.2004.00657.x; Levine JM, 1999, OIKOS, V87, P15, DOI 10.2307/3546992; Lichstein JW, 2002, ECOL MONOGR, V72, P445, DOI 10.1890/0012-9615(2002)072[0445:SAAAMI]2.0.CO;2; Maljkovic A, 2008, CORAL REEFS, V27, P501, DOI 10.1007/s00338-008-0372-9; MANTEL N, 1967, CANCER RES, V27, P209; McCulloch C. E., 2001, GENERALIZED LINEAR A; Morris J, 2009, MONOGRAPH OR SERIAL; Mumby PJ, 2007, P NATL ACAD SCI USA, V104, P8362, DOI 10.1073/pnas.0702602104; Mumby PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021510; Mumby PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008657; Newman MJH, 2006, ECOL LETT, V9, P1216, DOI 10.1111/j.1461-0248.2006.00976.x; Paddack MJ, 2009, CURR BIOL, V19, P590, DOI 10.1016/j.cub.2009.02.041; Pinheiro J, 2001, MIXED EFFECTS MODELS; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Schofield Pamela J., 2009, Aquatic Invasions, V4, P473; Stallings CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005333; Whitfield PE, 2007, BIOL INVASIONS, V9, P53, DOI 10.1007/s10530-006-9005-9; Williams ID, 2011, JOURNAL OF MARINE BI, V2011	39	103	109	1	166	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e68259	10.1371/journal.pone.0068259	http://dx.doi.org/10.1371/journal.pone.0068259			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874565	gold, Green Published, Green Submitted			2022-12-27	WOS:000322218800020
J	Liang, X; Wang, RS; Wang, F; Liu, S; Guo, F; Sun, L; Wang, YJ; Sun, YX; Chen, XL				Liang, Xun; Wang, Ren-Su; Wang, Fei; Liu, Sheng; Guo, Feng; Sun, Li; Wang, Yong-Jie; Sun, Ye-Xiang; Chen, Xu-Lin			Sodium Butyrate Protects against Severe Burn-Induced Remote Acute Lung Injury in Rats	PLOS ONE			English	Article							MOBILITY GROUP BOX-1; INFLAMMATORY RESPONSE; OXIDATIVE STRESS; HMGB1; CELLS; APOPTOSIS; MODEL; MICE; PANCREATITIS; ASSOCIATION	High-mobility group box 1 protein (HMGB1), a ubiquitous nuclear protein, drives proinflammatory responses when released extracellularly. It plays a key role as a distal mediator in the development of acute lung injury (ALI). Sodium butyrate, an inhibitor of histone deacetylase, has been demonstrated to inhibit HMGB1 expression. This study investigates the effect of sodium butyrate on burn-induced lung injury. Sprague-Dawley rats were divided into three groups: 1) sham group, sham burn treatment; 2) burn group, third-degree burns over 30% total body surface area (TBSA) with lactated Ringer's solution for resuscitation; 3) burn plus sodium butyrate group, third-degree burns over 30% TBSA with lactated Ringer's solution containing sodium butyrate for resuscitation. The burned animals were sacrificed at 12, 24, and 48 h after burn injury. Lung injury was assessed in terms of histologic changes and wet weight to dry weight (W/D) ratio. Tumor necrosis factor (TNF)-alpha and interleukin (IL)-8 protein concentrations in bronchoalveolar lavage fluid (BALF) and serum were measured by enzyme-linked immunosorbent assay, and HMGB1 expression in the lung was determined by Western blot analysis. Pulmonary myeloperoxidase (MPO) activity and malondialdehyde (MDA) concentration were measured to reflect neutrophil infiltration and oxidative stress in the lung, respectively. As a result, sodium butyrate significantly inhibited the HMGB1 expressions in the lungs, reduced the lung W/D ratio, and improved the pulmonary histologic changes induced by burn trauma. Furthermore, sodium butyrate administration decreased the TNF-alpha and IL-8 concentrations in BALF and serum, suppressed MPO activity, and reduced the MDA content in the lungs after severe burn. These results suggest that sodium butyrate attenuates inflammatory responses, neutrophil infiltration, and oxidative stress in the lungs, and protects against remote ALI induced by severe burn, which is associated with inhibiting HMGB1 expression.	[Liang, Xun; Wang, Ren-Su; Wang, Fei; Liu, Sheng; Guo, Feng; Sun, Li; Wang, Yong-Jie; Sun, Ye-Xiang; Chen, Xu-Lin] Anhui Med Univ, Affiliated Hosp 1, Dept Burns, Hefei, Anhui, Peoples R China	Anhui Medical University	Chen, XL (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Burns, Hefei, Anhui, Peoples R China.	okcxl@126.com			National Natural Science Foundation of China [30872687, 81000836]; Natural Science Foundation of Anhui Province [1208085MH135]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Anhui Province(Natural Science Foundation of Anhui Province)	This study was supported by the National Natural Science Foundation of China (Grant nos. 30872687 and 81000836) and the Natural Science Foundation of Anhui Province (Grant no. 1208085MH135). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2000, J IMMUNOL, V165, P2950, DOI 10.4049/jimmunol.165.6.2950; Bitto A, 2010, PHARMACOL RES, V61, P116, DOI 10.1016/j.phrs.2009.07.014; Chow CW, 2003, AM J RESP CELL MOL, V29, P427, DOI 10.1165/rcmb.F278; Costantini TW, 2009, SHOCK, V31, P416, DOI 10.1097/SHK.0b013e3181863080; Dong Ning, 2010, Zhonghua Shao Shang Za Zhi, V26, P109; Fang Y, 2011, J TRAUMA, V71, P1297, DOI 10.1097/TA.0b013e3182127d48; Fang Y, 2011, J BURN CARE RES, V32, pE82, DOI 10.1097/BCR.0b013e318217f84f; Feng YK, 2008, EXP MOL PATHOL, V85, P214, DOI 10.1016/j.yexmp.2008.09.002; Fudala R, 2008, CLIN SCI, V114, P403, DOI 10.1042/CS20070272; Galani V, 2010, PATHOL RES PRACT, V206, P145, DOI 10.1016/j.prp.2009.12.002; Gloor B, 2000, PANCREAS, V21, P414, DOI 10.1097/00006676-200011000-00013; Gong Q, 2009, SCAND J IMMUNOL, V69, P29, DOI 10.1111/j.1365-3083.2008.02194.x; Gong QA, 2010, J MOL MED, V88, P1289, DOI 10.1007/s00109-010-0681-7; Guo F, 2009, BURNS, V35, P210, DOI 10.1016/j.burns.2008.05.021; Hu X, 2010, BIOMED PHARMACOTHER; Jiang WJ, 2012, MOL BIOL REP, V39, P6235, DOI 10.1007/s11033-011-1443-5; Jin SW, 2007, ANESTH ANALG, V104, P369, DOI 10.1213/01.ane.0000252414.00363.c4; Kato K, 2011, MOL CANCER THER, V10, P1430, DOI 10.1158/1535-7163.MCT-10-1062; Kim HJ, 2007, J PHARMACOL EXP THER, V321, P892, DOI 10.1124/jpet.107.120188; Kitamura Y, 2010, NEUROL MED-CHIR, V50, P456, DOI 10.2176/nmc.50.456; Kong XQ, 2011, BIOFACTORS, V37, P323, DOI 10.1002/biof.177; Krzyzaniak M, 2011, SHOCK, V36, P24, DOI 10.1097/SHK.0b013e318212276b; Kumar K, 2008, PARASITOL INT, V57, P150, DOI 10.1016/j.parint.2007.11.005; Lee JS, 2012, BIOTECHNOL PROGR, V28, P349, DOI 10.1002/btpr.1512; Lutz Waldemar, 2004, Int J Occup Med Environ Health, V17, P245; Magnotti LJ, 1999, ARCH SURG-CHICAGO, V134, P1333, DOI 10.1001/archsurg.134.12.1333; Maybauer MO, 2009, ANAESTHESIST, V58, P805, DOI 10.1007/s00101-009-1560-x; Naglova H, 2012, BRATISL MED J, V113, P163, DOI 10.4149/BLL_2012_039; Romero R, 2011, J MATERN-FETAL NEO M, V24, P1444, DOI 10.3109/14767058.2011.591460; Ronchi CF, 2012, J APPL PHYSIOL, V112, P1184, DOI 10.1152/japplphysiol.01334.2011; Ryan CM, 1998, NEW ENGL J MED, V338, P362, DOI 10.1056/NEJM199802053380604; Schmid E, 1997, SHOCK, V8, P119, DOI 10.1097/00024382-199708000-00010; Shin H, 2012, ONCOL REP, V27, P1111, DOI 10.3892/or.2011.1585; Sio SWS, 2010, J IMMUNOL, V185, P6265, DOI 10.4049/jimmunol.1001739; Sun LD, 2011, NAT GENET, V43, P690, DOI 10.1038/ng.851; Turnage RH, 2002, WORLD J SURG, V26, P848, DOI 10.1007/s00268-002-4063-3; Ueno H, 2004, AM J RESP CRIT CARE, V170, P1310, DOI 10.1164/rccm.200402-188OC; Ulloa L, 2006, CYTOKINE GROWTH F R, V17, P189, DOI 10.1016/j.cytogfr.2006.01.003; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100; Yang HA, 2010, P NATL ACAD SCI USA, V107, P11942, DOI 10.1073/pnas.1003893107; Yang QW, 2010, J CEREBR BLOOD F MET, V30, P243, DOI 10.1038/jcbfm.2009.202; Yuan GJ, 2005, WORLD J GASTROENTERO, V11, P1825; Zhang LT, 2007, SHOCK, V27, P672, DOI 10.1097/SHK.0b013e31802e3f4c	43	29	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e68786	10.1371/journal.pone.0068786	http://dx.doi.org/10.1371/journal.pone.0068786			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874764	Green Submitted, gold, Green Published			2022-12-27	WOS:000322218800044
J	Hebert, PDN; deWaard, JR; Zakharov, EV; Prosser, SWJ; Sones, JE; McKeown, JTA; Mantle, B; La Salle, J				Hebert, Paul D. N.; deWaard, Jeremy R.; Zakharov, Evgeny V.; Prosser, Sean W. J.; Sones, Jayme E.; McKeown, Jaclyn T. A.; Mantle, Beth; La Salle, John			A DNA 'Barcode Blitz': Rapid Digitization and Sequencing of a Natural History Collection	PLOS ONE			English	Article							QUALITY	DNA barcoding protocols require the linkage of each sequence record to a voucher specimen that has, whenever possible, been authoritatively identified. Natural history collections would seem an ideal resource for barcode library construction, but they have never seen large-scale analysis because of concerns linked to DNA degradation. The present study examines the strength of this barrier, carrying out a comprehensive analysis of moth and butterfly (Lepidoptera) species in the Australian National Insect Collection. Protocols were developed that enabled tissue samples, specimen data, and images to be assembled rapidly. Using these methods, a five-person team processed 41,650 specimens representing 12,699 species in 14 weeks. Subsequent molecular analysis took about six months, reflecting the need for multiple rounds of PCR as sequence recovery was impacted by age, body size, and collection protocols. Despite these variables and the fact that specimens averaged 30.4 years old, barcode records were obtained from 86% of the species. In fact, one or more barcode compliant sequences (> 487 bp) were recovered from virtually all species represented by five or more individuals, even when the youngest was 50 years old. By assembling specimen images, distributional data, and DNA barcode sequences on a web-accessible informatics platform, this study has greatly advanced accessibility to information on thousands of species. Moreover, much of the specimen data became publically accessible within days of its acquisition, while most sequence results saw release within three months. As such, this study reveals the speed with which DNA barcode workflows can mobilize biodiversity data, often providing the first web-accessible information for a species. These results further suggest that existing collections can enable the rapid development of a comprehensive DNA barcode library for the most diverse compartment of terrestrial biodiversity - insects.	[Hebert, Paul D. N.; deWaard, Jeremy R.; Zakharov, Evgeny V.; Prosser, Sean W. J.; Sones, Jayme E.; McKeown, Jaclyn T. A.] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada; [Mantle, Beth; La Salle, John] CSIRO Ecosyst Sci, Canberra, ACT, Australia; [La Salle, John] CSIRO Ecosyst Sci, Atlas Living Australia, Canberra, ACT, Australia	University of Guelph; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Hebert, PDN (corresponding author), Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada.	phebert@uoguelph.ca	Hebert, Paul DN/C-4161-2013; La Salle, John/B-9544-2008; Zakharov, Evgeny/G-9587-2014; deWaard, Jeremy R/G-8112-2014; Mantle, Beth/B-2524-2009	Hebert, Paul DN/0000-0002-3081-6700; La Salle, John/0000-0002-8816-9569; Mantle, Beth/0000-0001-5413-0159	government of Canada through Genome Canada; Ontario Genomics Institute; Ontario Ministry of Research and Innovation	government of Canada through Genome Canada(Genome Canada); Ontario Genomics Institute; Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario)	The authors thank NSERC and CSIRO for the support that allowed the processing of specimens at ANIC. Sequence analysis was enabled by funding from the government of Canada through Genome Canada and the Ontario Genomics Institute in support of the International Barcode of Life project. This work was heavily dependent upon BOLD; the authors thank the Ontario Ministry of Research and Innovation for funding its development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allentoft ME, 2010, QUATERNARY SCI REV, V29, P753, DOI 10.1016/j.quascirev.2009.11.022; Andersen JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045549; [Anonymous], 2012, ZOOTAXA; Arino AH, 2010, BIODIVERS INFORM, V7, P81, DOI [10.17161/bi.v7i2.3991, DOI 10.17161/BI.V7I2.3991]; Borisenko AV, 2009, MOL ECOL RESOUR, V9, P27, DOI 10.1111/j.1755-0998.2009.02629.x; Dean MD, 2001, ENTOMOL EXP APPL, V98, P279, DOI 10.1023/A:1018963131302; Espeland M, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-2; Fontaine B, 2007, CURR BIOL, V22, pR943; Godfray HCJ, 2007, SYST BIOL, V56, P943, DOI 10.1080/10635150701777521; Hajibabaei M, 2005, PHILOS T R SOC B, V360, P1959, DOI 10.1098/rstb.2005.1727; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hausmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017134; Hebert PDN, 2010, BIOL LETTERS, V6, P359, DOI 10.1098/rsbl.2009.0848; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Nielsen ES, 1996, CHECKLIST AUSTR LEPI; Ratnasingham S, 2013, PLOS ONE IN PRESS; Riedel A, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.280.3906; Rohland N, 2007, BIOTECHNIQUES, V42, P343, DOI 10.2144/000112383; Thomsen PF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005048; Wandeler P, 2007, TRENDS ECOL EVOL, V22, P634, DOI 10.1016/j.tree.2007.08.017; Whitten M, 2003, INVERTEBR SYST, V17, P5, DOI 10.1071/IS02031	23	145	154	0	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68535	10.1371/journal.pone.0068535	http://dx.doi.org/10.1371/journal.pone.0068535			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874660	Green Published, gold			2022-12-27	WOS:000321765300053
J	Gabor, KA; Stevens, CR; Pietraszewski, MJ; Gould, TJ; Shim, J; Yoder, JA; Lam, SH; Gong, ZY; Hess, ST; Kim, CH				Gabor, Kristin A.; Stevens, Chad R.; Pietraszewski, Matthew J.; Gould, Travis J.; Shim, Juyoung; Yoder, Jeffrey A.; Lam, Siew Hong; Gong, Zhiyuan; Hess, Samuel T.; Kim, Carol H.			Super Resolution Microscopy Reveals that Caveolin-1 Is Required for Spatial Organization of CRFB1 and Subsequent Antiviral Signaling in Zebrafish	PLOS ONE			English	Article							LIPID RAFTS; MEMBRANE DOMAINS; JAK/STAT PATHWAY; RECEPTOR; RECOGNITION; ALPHA/BETA; MODEL; ENDOCYTOSIS; INHIBITION; ROLES	Understanding spatial distribution and dynamics of receptors within unperturbed membranes is essential for elucidating their role in antiviral signaling, but conventional studies of detergent-resistant membrane fractions cannot provide this information. Caveolae are integral to numerous signaling pathways and these membrane domains have been previously implicated in viral entry but not antiviral defense. This study shows, for the first time, the importance of spatio-temporal regulation of signaling receptors and the importance of the regulation of clustering for downstream signaling. A novel mechanism for virus evasion of host cell defenses is demonstrated through disruption of clusters of signaling molecules organized within caveolin-rich domains. Viral infection leads to a downregulation in Caveolin-1b (Cav-1b), disrupting clusters of CRFB1, a zebrafish type I interferon receptor (-R) subunit. Super-resolution microscopy has enabled the first single-molecule imaging of CRFB1 association with cav-1b-containing membrane domains. Strikingly, downregulation of Cav-1b, the major protein component of caveolae, caused CRFB1 clusters to disperse. Dispersal of CRFB1 clusters led to a suppressed antiviral immune response both in vitro and in vivo, through abrogation of downstream signaling. This response strongly suggests that CRFB1 organization within cav-1b-containing membrane domains is critical for IFN-mediated antiviral defense and presents a previously undescribed antiviral evasion strategy to alter IFN signaling and the antiviral immune response.	[Gabor, Kristin A.; Hess, Samuel T.; Kim, Carol H.] Univ Maine, Grad Sch Biomed Sci, Orono, ME USA; [Gabor, Kristin A.; Stevens, Chad R.; Pietraszewski, Matthew J.; Shim, Juyoung; Kim, Carol H.] Univ Maine, Dept Mol & Biomed Sci, Orono, ME USA; [Gabor, Kristin A.; Gould, Travis J.; Hess, Samuel T.] Univ Maine, Dept Phys & Astron, Orono, ME 04469 USA; [Lam, Siew Hong; Gong, Zhiyuan] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Yoder, Jeffrey A.] N Carolina State Univ, Dept Mol & Biomed Sci, Raleigh, NC 27695 USA	University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono; National University of Singapore; University of North Carolina; North Carolina State University	Hess, ST (corresponding author), Univ Maine, Grad Sch Biomed Sci, Orono, ME USA.	sam.hess@umit.maine.edu; carolkim@maine.edu	Lam, Siew Hong/H-8483-2012; Yoder, Jeffrey A./I-5329-2019; Gong, Zhiyuan/H-8794-2012	Yoder, Jeffrey A./0000-0002-6083-1311; Gong, Zhiyuan/0000-0002-9660-5260; Kim, Carol/0000-0002-0465-4496	National Institutes of Health (NIH) [RO1 GM087308, R15A1065509, K25-AI65459]; NSF [IGERT-0221625]; Maine Agricultural and Forest Experiment Station [3327]; NSF MRI [CHE-0722759]; Maine Technology Institute MTAF [1106, 2061]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K25AI065459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087308, P20GM103534, R15GM094713] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Maine Agricultural and Forest Experiment Station; NSF MRI(National Science Foundation (NSF)NSF - Office of the Director (OD)); Maine Technology Institute MTAF; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the following grants: National Institutes of Health (NIH) RO1 GM087308 and R15A1065509 (KAG, CRS, MJP, CHK), NIH Career Award K25-AI65459 (TJG and STH), NSF IGERT-0221625 (KAG), Maine Agricultural and Forest Experiment Station Publication Number 3327 (CHK), NSF MRI CHE-0722759 (TJG and STH), and Maine Technology Institute MTAF #1106 and 2061 (TJG and STH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abulrob A, 2009, J BIOL CHEM; Aggad D, 2009, J IMMUNOL, V183, P3924, DOI 10.4049/jimmunol.0901495; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Altmann SM, 2004, DEV COMP IMMUNOL, V28, P295, DOI 10.1016/j.dci.2003.09.001; Altmann SM, 2003, J VIROL, V77, P1992, DOI 10.1128/JVI.77.3.1992-2002.2003; Balbis A, 2004, J BIOL CHEM, V279, P39348, DOI 10.1074/jbc.M404280200; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; Claudinon J, 2007, BIOCHIMIE, V89, P735, DOI 10.1016/j.biochi.2007.03.014; Couet J, 1997, J BIOL CHEM, V272, P30429, DOI 10.1074/jbc.272.48.30429; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; de Weerd NA, 2007, J BIOL CHEM, V282, P20053, DOI 10.1074/jbc.R700006200; Ewers H, 2010, NAT CELL BIOL, V12, P11, DOI 10.1038/ncb1999; Fang PK, 2006, AM J PATHOL, V169, P2209, DOI 10.2353/ajpath.2006.060562; FIJAN N, 1983, ANN INST PASTEUR VIR, V134, P207, DOI 10.1016/S0769-2617(83)80060-4; Folling J, 2007, ANGEW CHEM INT EDIT, V46, P6266, DOI 10.1002/anie.200702167; Galbiati F, 2001, CELL, V106, P403, DOI 10.1016/S0092-8674(01)00472-X; Garcia-Sastre A, 2002, MICROBES INFECT, V4, P647, DOI 10.1016/S1286-4579(02)01583-6; Garcia-Sastre A, 2001, VIROLOGY, V279, P375, DOI 10.1006/viro.2000.0756; GHOSH C, 1994, CELL BIOL TOXICOL, V10, P167, DOI 10.1007/BF00757560; Gough DJ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000361; Gould TJ, 2009, NAT PROTOC, V4, P291, DOI 10.1038/nprot.2008.246; Gould TJ, 2008, NAT METHODS, V5, P1027, DOI 10.1038/nmeth.1271; Gunewardene MS, 2011, BIOPHYS J, V101, P1522, DOI 10.1016/j.bpj.2011.07.049; Hess ST, 2007, P NATL ACAD SCI USA, V104, P17370, DOI 10.1073/pnas.0708066104; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Honda K, 2005, INT IMMUNOL, V17, P1367, DOI 10.1093/intimm/dxh318; Hou SX, 2002, DEV CELL, V3, P765, DOI 10.1016/S1534-5807(02)00376-3; Juette MF, 2008, NAT METHODS, V5, P527, DOI 10.1038/nmeth.1211; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Kwok W, 2009, AM J PHYSIOL-GASTR L, V297, pG930, DOI 10.1152/ajpgi.00106.2009; Lam SH, 2004, DEV COMP IMMUNOL, V28, P9, DOI 10.1016/S0145-305X(03)00103-4; Levraud JP, 2007, J IMMUNOL, V178, P4385, DOI 10.4049/jimmunol.178.7.4385; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Lisanti Michael P., 1994, Trends in Cell Biology, V4, P231, DOI 10.1016/0962-8924(94)90114-7; Marjomaki V, 2002, J VIROL, V76, P1856, DOI 10.1128/JVI.76.4.1856-1865.2002; Martin CSS, 2004, J VIROL, V78, P2310, DOI 10.1128/JVI.78.5.2310-2318.2004; McCurley AT, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-102; Medina FA, 2006, INFECT IMMUN, V74, P6665, DOI 10.1128/IAI.00949-06; Meeker ND, 2008, DEV COMP IMMUNOL, V32, P745, DOI 10.1016/j.dci.2007.11.011; Nixon SJ, 2007, J CELL SCI, V120, P2151, DOI 10.1242/jcs.003830; Ogi Mariko, 2003, Medical Electron Microscopy, V36, P33, DOI 10.1007/s007950300004; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Pelkmans L, 2002, TRAFFIC, V3, P311, DOI 10.1034/j.1600-0854.2002.30501.x; Phelan PE, 2005, J VIROL, V79, P1842, DOI 10.1128/JVI.79.3.1842-1852.2005; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Picker Alexander, 2009, V546, P153, DOI 10.1007/978-1-60327-977-2_11; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rust MJ, 2004, NAT STRUCT MOL BIOL, V11, P567, DOI 10.1038/nsmb769; Schlegel A, 1998, CELL SIGNAL, V10, P457, DOI 10.1016/S0898-6568(98)00007-2; Shogomori H, 2003, BIOL CHEM, V384, P1259, DOI 10.1515/BC.2003.139; Simmons G, 2003, J VIROL, V77, P13433, DOI 10.1128/JVI.77.24.13433-13438.2003; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; STEINHOFF U, 1995, J VIROL, V69, P2153, DOI 10.1128/JVI.69.4.2153-2158.1995; Subach FV, 2009, NAT METHODS, V6, P153, DOI [10.1038/nmeth.1298, 10.1038/NMETH.1298]; Sullivan C, 2008, FISH SHELLFISH IMMUN, V25, P341, DOI 10.1016/j.fsi.2008.05.005; Sullivan C, 2007, J IMMUNOL, V178, P4517, DOI 10.4049/jimmunol.178.7.4517; Swaim LE, 2006, INFECT IMMUN, V74, P6108, DOI 10.1128/IAI.00887-06; Takaoka A, 2000, SCIENCE, V288, P2357, DOI 10.1126/science.288.5475.2357; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Traver D, 2003, ADV IMMUNOL, V81, P253; Uematsu S, 2007, J BIOL CHEM, V282, P15319, DOI 10.1074/jbc.R700009200; VANDENBROEK MF, 1995, J VIROL, V69, P4792, DOI 10.1128/JVI.69.8.4792-4796.1995; Wang HL, 2008, CELL RES, V18, P290, DOI 10.1038/cr.2008.15; Werling D, 1999, J LEUKOCYTE BIOL, V66, P50, DOI 10.1002/jlb.66.1.50; Williams TM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-214; Yeomans J.M., 2002, STAT MECH PHASE TRAN; Yoder JA, 2007, GENE, V401, P154, DOI 10.1016/j.gene.2007.07.014; Yoder JA, 2010, IMMUNOGENETICS, V62, P117, DOI 10.1007/s00251-009-0416-5	74	25	25	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68759	10.1371/journal.pone.0068759	http://dx.doi.org/10.1371/journal.pone.0068759			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874753	gold, Green Published, Green Submitted			2022-12-27	WOS:000321736900111
J	Hwang, WY; Fu, YF; Reyon, D; Maeder, ML; Kaini, P; Sander, JD; Joung, JK; Peterson, RT; Yeh, JRJ				Hwang, Woong Y.; Fu, Yanfang; Reyon, Deepak; Maeder, Morgan L.; Kaini, Prakriti; Sander, Jeffry D.; Joung, J. Keith; Peterson, Randall T.; Yeh, Jing-Ruey Joanna			Heritable and Precise Zebrafish Genome Editing Using a CRISPR-Cas System	PLOS ONE			English	Article							ZINC-FINGER NUCLEASES; TARGETED GENE DISRUPTION; TALENS; ENDONUCLEASE; MUTAGENESIS; BACTERIA; ARCHAEA; CELLS	We have previously reported a simple and customizable CRISPR (clustered regularly interspaced short palindromic repeats) RNA-guided Cas9 nuclease (RGN) system that can be used to efficiently and robustly introduce somatic indel mutations in endogenous zebrafish genes. Here we demonstrate that RGN-induced mutations are heritable, with efficiencies of germline transmission reaching as high as 100%. In addition, we extend the power of the RGN system by showing that these nucleases can be used with single-stranded oligodeoxynucleotides (ssODNs) to create precise intended sequence modifications, including single nucleotide substitutions. Finally, we describe and validate simple strategies that improve the targeting range of RGNs from 1 in every 128 basepairs (bps) of random DNA sequence to 1 in every 8 bps. Together, these advances expand the utility of the CRISPR-Cas system in the zebrafish beyond somatic indel formation to heritable and precise genome modifications.	[Hwang, Woong Y.; Kaini, Prakriti; Peterson, Randall T.; Yeh, Jing-Ruey Joanna] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA 02129 USA; [Hwang, Woong Y.; Kaini, Prakriti; Peterson, Randall T.; Yeh, Jing-Ruey Joanna] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Fu, Yanfang; Reyon, Deepak; Maeder, Morgan L.; Sander, Jeffry D.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Canc Res, Mol Pathol Unit, Charlestown, MA USA; [Fu, Yanfang; Reyon, Deepak; Maeder, Morgan L.; Sander, Jeffry D.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Charlestown, MA USA; [Fu, Yanfang; Reyon, Deepak; Sander, Jeffry D.; Joung, J. Keith] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Peterson, Randall T.] Broad Inst, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Peterson, RT (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA 02129 USA.	peterson@cvrc.mgh.harvard.edu; jyeh1@partners.org	Reyon, Deepak/HCH-3183-2022	Yeh, Jing-Ruey Joanna/0000-0002-7768-4901; Peterson, Randall/0000-0003-0727-3469; Hwang, Woong/0000-0002-0575-0033	National Institutes of Health [R01 GM088040]; NIH Director's Pioneer Award [DP1 OD006862, K01 AG031300, R01 CA140188]; Defense Advanced Research Projects Agency (DARPA) [W911NF-11-2-0056]; Jim and Ann Orr MGH Research Scholar award; Charles and Ann Sanders MGH Research Scholar award; MGH Claflin Distinguished Scholar Award; NATIONAL CANCER INSTITUTE [R01CA140188] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088040, DP1GM105378] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG031300] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Jim and Ann Orr MGH Research Scholar award; Charles and Ann Sanders MGH Research Scholar award; MGH Claflin Distinguished Scholar Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health [R01 GM088040 to JKJ and RTP, NIH Director's Pioneer Award DP1 OD006862 to JKJ, K01 AG031300 to JRJY, R01 CA140188 to JRJY]; Defense Advanced Research Projects Agency (DARPA) [W911NF-11-2-0056 to JKJ]; the Jim and Ann Orr MGH Research Scholar award (JKJ); the Charles and Ann Sanders MGH Research Scholar award (RTP); and the MGH Claflin Distinguished Scholar Award (JRJY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Blackburn PR, 2013, ZEBRAFISH, V10, P116, DOI 10.1089/zeb.2013.9999; Cade L, 2012, NUCLEIC ACIDS RES, V40, P8001, DOI 10.1093/nar/gks518; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dahlem TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002861; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Foley JE, 2009, NAT PROTOC, V4, P1855, DOI 10.1038/nprot.2009.209; Foley JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004348; Gupta A, 2013, GENOME RES; Gupta A, 2012, NAT METHODS, V9, P588, DOI [10.1038/NMETH.1994, 10.1038/nmeth.1994]; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Sander JD, NUCL ACIDS RES, V38, pW462; Sander JD, BMC BIOINFORMATICS, V11, P543; Sander JD, 2011, METHOD CELL BIOL, V104, P51, DOI 10.1016/B978-0-12-374814-0.00003-3; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Sander JD, 2011, NAT METHODS, V8, P67, DOI 10.1038/NMETH.1542; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Valton J, 2012, J BIOL CHEM, V287, P38427, DOI 10.1074/jbc.C112.408864; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Zhu C, 2011, DEVELOPMENT, V138, P4555, DOI 10.1242/dev.066779; Zu Y, 2013, NAT METHODS, V10, P329, DOI 10.1038/NMETH.2374	35	257	307	0	113	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68708	10.1371/journal.pone.0068708	http://dx.doi.org/10.1371/journal.pone.0068708			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874735	Green Published, Green Submitted, gold			2022-12-27	WOS:000321736900106
J	Lai, Z; Moravcova, S; Canitrot, Y; Andrzejewski, LP; Walshe, DM; Rea, S				Lai, Zheng; Moravcova, Simona; Canitrot, Yvan; Andrzejewski, Lukasz P.; Walshe, Dervla M.; Rea, Stephen			Msl2 Is a Novel Component of the Vertebrate DNA Damage Response	PLOS ONE			English	Article							STRAND BREAK REPAIR; HISTONE H4 ACETYLATION; DOSAGE COMPENSATION; LYSINE 16; RING FINGER; PROTEIN; 53BP1; MOF; COMPLEX; ACETYLTRANSFERASE	hMSL2 (male-specific lethal 2, human) is a RING finger protein with ubiquitin ligase activity. Although it has been shown to target histone H2B at lysine 34 and p53 at lysine 351, suggesting roles in transcription regulation and apoptosis, its function in these and other processes remains poorly defined. To further characterize this protein, we have disrupted the Msl2 gene in chicken DT40 cells. Msl2(-/-) cells are viable, with minor growth defects. Biochemical analysis of the chromatin in these cells revealed aberrations in the levels of several histone modifications involved in DNA damage response pathways. DNA repair assays show that both Msl2(-/-) chicken cells and hMSL2-depleted human cells have defects in non-homologous end joining (NHEJ) repair. DNA damage assays also demonstrate that both Msl2 and hMSL2 proteins are modified and stabilized shortly after induction of DNA damage. Moreover, hMSL2 mediates modification, presumably ubiquitylation, of a key DNA repair mediator 53BP1 at lysine 1690. Similarly, hMSL1 and hMOF (males absent on the first) are modified in the presence of hMSL2 shortly after DNA damage. These data identify a novel role for Msl2/hMSL2 in the cellular response to DNA damage. The kinetics of its stabilization suggests a function early in the NHEJ repair pathway. Moreover, Msl2 plays a role in maintaining normal histone modification profiles, which may also contribute to the DNA damage response.	[Lai, Zheng; Moravcova, Simona; Andrzejewski, Lukasz P.; Walshe, Dervla M.; Rea, Stephen] Natl Univ Ireland, Sch Nat Sci, Ctr Chromosome Biol, Galway, Ireland; [Moravcova, Simona] Universite Toulouse, UPS, CNRS, Toulouse, France	Ollscoil na Gaillimhe-University of Galway; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Rea, S (corresponding author), Natl Univ Ireland, Sch Nat Sci, Ctr Chromosome Biol, Galway, Ireland.	stephen.rea@nuigalway.ie	Moravcova, Simona/G-6192-2014	Rea, Stephen/0000-0001-5797-5157	IRCSET; Thomas Crawford Hayes Fund; Beckman fund award; Breast Cancer Campaign PhD studentship- grant [2011NovPhD03]; Science Foundation Ireland PIYRA award [07/YI4/B1054]	IRCSET(Irish Research Council for Science, Engineering and Technology); Thomas Crawford Hayes Fund; Beckman fund award; Breast Cancer Campaign PhD studentship- grant; Science Foundation Ireland PIYRA award(Science Foundation Ireland)	SM was supported by an IRCSET studentship and by the Thomas Crawford Hayes Fund (http://www.irchss.ie/). ZL was supported by the Beckman fund award. LPA was supported by a Breast Cancer Campaign PhD studentship- grant 2011NovPhD03 (http://www.breastcancercampaign.org/). This work was supported by Science Foundation Ireland PIYRA award 07/YI4/B1054(http://www.sfi.ie/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar A, 2000, MOL CELL, V5, P367, DOI 10.1016/S1097-2765(00)80431-1; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Brandsma Inger, 2012, Genome Integr, V3, P9, DOI 10.1186/2041-9414-3-9; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Capp JP, 2006, NUCLEIC ACIDS RES, V34, P2998, DOI 10.1093/nar/gkl380; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Copps K, 1998, EMBO J, V17, P5409, DOI 10.1093/emboj/17.18.5409; Dobbs TA, 2010, DNA REPAIR, V9, P1307, DOI 10.1016/j.dnarep.2010.09.019; Eliezer Y, 2009, J BIOL CHEM, V284, P426, DOI 10.1074/jbc.M807375200; Faucher D, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001082; FitzGerald JE, 2009, BIOCHEM SOC T, V37, P897, DOI 10.1042/BST0370897; Fukushima T, 2001, J BIOL CHEM, V276, P44413, DOI 10.1074/jbc.M106295200; Georgiev P, 2011, FLY, V5, P147, DOI 10.4161/fly.5.2.14934; Gironella M, 2009, J CELL PHYSIOL, V221, P594, DOI 10.1002/jcp.21889; Greeson NT, 2008, J BIOL CHEM, V283, P33168, DOI 10.1074/jbc.M806857200; Gupta A, 2005, MOL CELL BIOL, V25, P5292, DOI 10.1128/MCB.25.12.5292-5305.2005; Gupta A, 2008, MOL CELL BIOL, V28, P397, DOI 10.1128/MCB.01045-07; Hallacli E, 2012, MOL CELL, V48, P587, DOI 10.1016/j.molcel.2012.09.014; Huen MSY, 2010, MOL CELL, V37, P854, DOI 10.1016/j.molcel.2009.12.040; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Kapoor-Vazirani P, 2011, MOL CELL BIOL, V31, P1594, DOI 10.1128/MCB.00524-10; KELLEY RL, 1995, CELL, V81, P867, DOI 10.1016/0092-8674(95)90007-1; Krishnan V, 2011, P NATL ACAD SCI USA, V108, P12325, DOI 10.1073/pnas.1102789108; Kruse JP, 2009, J BIOL CHEM, V284, P3250, DOI 10.1074/jbc.M805658200; Li XZ, 2010, MOL CELL BIOL, V30, P5335, DOI 10.1128/MCB.00350-10; Li XZ, 2009, MOL CELL, V36, P290, DOI 10.1016/j.molcel.2009.07.031; Mendjan S, 2006, MOL CELL, V21, P811, DOI 10.1016/j.molcel.2006.02.007; Mendjan S, 2007, CHROMOSOMA, V116, P95, DOI 10.1007/s00412-006-0089-x; Mok MTS, 2012, INT J BIOCHEM CELL B, V44, P1398, DOI 10.1016/j.biocel.2012.05.025; Morey C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002212; Moudry P, 2012, CELL DEATH DIFFER, V19, P798, DOI 10.1038/cdd.2011.150; Muscolini M, 2011, J BIOL CHEM, V286, P39693, DOI 10.1074/jbc.M111.279539; Noon AT, 2011, DNA REPAIR, V10, P1071, DOI 10.1016/j.dnarep.2011.07.012; Pei HD, 2011, NATURE, V470, P124, DOI 10.1038/nature09658; Pfister S, 2008, INT J CANCER, V122, P1207, DOI 10.1002/ijc.23283; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Rass E, 2009, NAT STRUCT MOL BIOL, V16, P819, DOI 10.1038/nsmb.1641; Rea S, 2007, ONCOGENE, V26, P5385, DOI 10.1038/sj.onc.1210607; Rooney S, 2004, IMMUNOL REV, V200, P115, DOI 10.1111/j.0105-2896.2004.00165.x; Sharma GG, 2010, MOL CELL BIOL, V30, P3582, DOI 10.1128/MCB.01476-09; Smith ER, 2005, MOL CELL BIOL, V25, P9175, DOI 10.1128/MCB.25.21.9175-9188.2005; Stephan AK, 2011, MOL CELL BIOL, V31, P1369, DOI 10.1128/MCB.00786-10; Straub T, 2012, GENOME RES; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Sugrue T, 2013, STEM CELLS, V31, P137, DOI 10.1002/stem.1222; SUKEGAWA J, 1993, CELL, V72, P29, DOI 10.1016/0092-8674(93)90047-T; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Taipale M, 2005, MOL CELL BIOL, V25, P6798, DOI 10.1128/MCB.25.15.6798-6810.2005; Villa R, 2012, MOL CELL; Villa R, 2012, MOL CELL, V48, P647, DOI 10.1016/j.molcel.2012.09.012; Wakeman TP, 2012, EMBO J, V31, P2169, DOI 10.1038/emboj.2012.50; Wang Yan-Dong, 2006, Subcell Biochem, V40, P439; Watanabe K, 2009, NUCLEIC ACIDS RES, V37, P2176, DOI 10.1093/nar/gkp082; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Wu LP, 2011, MOL CELL, V43, P132, DOI 10.1016/j.molcel.2011.05.015; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Zgheib O, 2009, MOL CELL BIOL, V29, P1050, DOI 10.1128/MCB.01011-08	57	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68549	10.1371/journal.pone.0068549	http://dx.doi.org/10.1371/journal.pone.0068549			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874665	Green Published, Green Submitted, gold			2022-12-27	WOS:000321736900094
J	Smyser, CD; Snyder, AZ; Shimony, JS; Blazey, TM; Inder, TE; Neil, JJ				Smyser, Christopher D.; Snyder, Abraham Z.; Shimony, Joshua S.; Blazey, Tyler M.; Inder, Terrie E.; Neil, Jeffrey J.			Effects of White Matter Injury on Resting State fMRI Measures in Prematurely Born Infants	PLOS ONE			English	Article							INTRINSIC FUNCTIONAL CONNECTIVITY; BRAINS DEFAULT NETWORK; PERIVENTRICULAR LEUKOMALACIA; CHILDREN BORN; SPASTIC DIPLEGIA; PRETERM INFANTS; CEREBRAL-PALSY; MOTOR CORTEX; MRI; FLUCTUATIONS	The cerebral white matter is vulnerable to injury in very preterm infants (born prior to 30 weeks gestation), resulting in a spectrum of lesions. These range from severe forms, including cystic periventricular leukomalacia and periventricular hemorrhagic infarction, to minor focal punctate lesions. Moderate to severe white matter injury in preterm infants has been shown to predict later neurodevelopmental disability, although outcomes can vary widely in infants with qualitatively comparable lesions. Resting state functional connectivity magnetic resonance imaging has been increasingly utilized in neurodevelopmental investigations and may provide complementary information regarding the impact of white matter injury on the developing brain. We performed resting state functional connectivity magnetic resonance imaging at term equivalent postmenstrual age in fourteen preterm infants with moderate to severe white matter injury secondary to periventricular hemorrhagic infarction. In these subjects, resting state networks were identifiable throughout the brain. Patterns of aberrant functional connectivity were observed and depended upon injury severity. Comparisons were performed against data obtained from prematurely-born infants with mild white matter injury and healthy, term-born infants and demonstrated group differences. These results reveal structural-functional correlates of preterm white matter injury and carry implications for future investigations of neurodevelopmental disability.	[Smyser, Christopher D.; Snyder, Abraham Z.; Inder, Terrie E.; Neil, Jeffrey J.] Washington Univ, Dept Neurol, St Louis, MO 63130 USA; [Smyser, Christopher D.; Inder, Terrie E.; Neil, Jeffrey J.] Washington Univ, Dept Pediat, St Louis, MO 63130 USA; [Snyder, Abraham Z.; Shimony, Joshua S.; Blazey, Tyler M.; Inder, Terrie E.; Neil, Jeffrey J.] Washington Univ, Mallinckrodt Inst Radiol, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Smyser, CD (corresponding author), Washington Univ, Dept Neurol, St Louis, MO 63130 USA.	smyserc@neuro.wustl.edu			Child Neurology Foundation; National Institutes of Health [K12 NS001690, UL1 TR000448, R01 HD05709801, P30 HD062171, P30 NS048056]; Doris Duke Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD062171] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS048056, K12NS001690] Funding Source: NIH RePORTER	Child Neurology Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Foundation(Doris Duke Charitable Foundation (DDCF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Child Neurology Foundation [to C.D.S.]; National Institutes of Health [grant numbers K12 NS001690 to C.D.S., UL1 TR000448 to C.D.S, R01 HD05709801 to T.E.I. and J.J.N., P30 HD062171 to T.E.I and J.J.N. and P30 NS048056 to A.Z.S.]; and the Doris Duke Foundation [to T.E.I.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Chapman I, 2008, PEDIATRICS, V121, pE1167, DOI 10.1542/peds.2007-0423; Allen G, 2005, NEUROIMAGE, V28, P39, DOI 10.1016/j.neuroimage.2005.06.013; Andiman SE, 2010, BRAIN PATHOL, V20, P803, DOI 10.1111/j.1750-3639.2010.00380.x; Back SA, 2001, J NEUROSCI, V21, P1302; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Bing X, 2012, BRAIN RES, V1490, P225, DOI DOI 10.1016/J.BRAINRES.2012.10.048; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Boardman JP, 2010, NEUROIMAGE, V52, P409, DOI 10.1016/j.neuroimage.2010.04.261; Brier MR, 2012, J NEUROSCI, V32, P8890, DOI 10.1523/JNEUROSCI.5698-11.2012; Buckner RL, 2011, J NEUROPHYSIOL, V106, P2322, DOI 10.1152/jn.00339.2011; Burton H, 2009, SOMATOSENS MOT RES, V26, P90, DOI 10.3109/08990220903335742; Carter AR, 2012, NEUROREHAB NEURAL RE, V26, P7, DOI 10.1177/1545968311411054; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; Counsell SJ, 2007, NEUROIMAGE, V34, P896, DOI 10.1016/j.neuroimage.2006.09.036; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Damoiseaux JS, 2009, BRAIN STRUCT FUNCT, V213, P525, DOI 10.1007/s00429-009-0208-6; Doria V, 2010, P NATL ACAD SCI USA, V107, P20015, DOI 10.1073/pnas.1007921107; Drobyshevsky A, 2007, DEV NEUROSCI-BASEL, V29, P289, DOI 10.1159/000105470; Edgin JO, 2008, J INT NEUROPSYCH SOC, V14, P90, DOI 10.1017/S1355617708080053; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fair DA, 2007, P NATL ACAD SCI USA, V104, P13507, DOI 10.1073/pnas.0705843104; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Fox K, 2005, NEURON, V48, P465, DOI 10.1016/j.neuron.2005.10.013; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2010, FRONT SYST NEUROSCI, V4, DOI [10.3389/fnsys.2010.00019, 10.3389/fnsys.2010.0001]; Fransson P, 2007, P NATL ACAD SCI USA, V104, P15531, DOI 10.1073/pnas.0704380104; Fransson P, 2009, PEDIATR RES, V66, P301, DOI 10.1203/PDR.0b013e3181b1bd84; Gao W, 2009, P NATL ACAD SCI USA, V106, P6790, DOI 10.1073/pnas.0811221106; Gholipour A, 2008, IEEE ENG MED BIO, P94, DOI 10.1109/IEMBS.2008.4649099; Glass HC, 2008, PEDIATR NEUROL, V38, P10, DOI 10.1016/j.pediatrneurol.2007.08.019; Habas C, 2009, J NEUROSCI, V29, P8586, DOI 10.1523/JNEUROSCI.1868-09.2009; Haynes RL, 2003, J NEUROPATH EXP NEUR, V62, P441, DOI 10.1093/jnen/62.5.441; Hoon AH, 2009, DEV MED CHILD NEUROL, V51, P697, DOI 10.1111/j.1469-8749.2009.03306.x; Huppi PS, 2001, PEDIATRICS, V107, P455, DOI 10.1542/peds.107.3.455; Iida K, 1995, PEDIATR NEUROL, V13, P296, DOI 10.1016/0887-8994(95)00192-1; Inder TE, 2003, J PEDIATR-US, V143, P171, DOI 10.1067/S0022-3476(03)00357-3; Jenkins G., 1968, SPECTRAL ANAL ITS AP; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kelly AMC, 2009, CEREB CORTEX, V19, P640, DOI 10.1093/cercor/bhn117; Khwaja O, 2008, ARCH DIS CHILD-FETAL, V93, pF153, DOI 10.1136/adc.2006.108837; Kidokoro H, 2013, AJNR AM J N IN PRESS; Kinney HC, 2012, ANN NEUROL, V71, P397, DOI 10.1002/ana.22612; KOSTOVIC I, 1990, J COMP NEUROL, V297, P441, DOI 10.1002/cne.902970309; Lee JD, 2011, BRAIN, V134, P1199, DOI 10.1093/brain/awr021; Limperopoulos C, 2012, CEREB CORTE IN PRESS; Limperopoulos C, 2010, PEDIATR RES, V68, P145, DOI 10.1203/00006450-201011001-00282; Lin W, 2008, AM J NEURORADIOL, V29, P1883, DOI 10.3174/ajnr.A1256; Liu WC, 2008, BRAIN RES, V1223, P42, DOI 10.1016/j.brainres.2008.05.054; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Lubsen J, 2011, SEMIN PERINATOL, V35, P34, DOI 10.1053/j.semperi.2010.10.006; MarinPadilla M, 1997, J NEUROPATH EXP NEUR, V56, P219, DOI 10.1097/00005072-199703000-00001; Marrelec G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014788; Mathur AM, 2008, PEDIATR RADIOL, V38, P260, DOI 10.1007/s00247-007-0705-9; McCrea HL, 2008, CLIN PERINATOL, V35, P777, DOI 10.1016/j.clp.2008.07.014; Miller SP, 2005, J PEDIATR-US, V147, P609, DOI 10.1016/j.jpeds.2005.06.033; Miller SP, 2002, J MAGN RESON IMAGING, V16, P621, DOI 10.1002/jmri.10205; Mink Jonathan W., 2003, Curr Treat Options Neurol, V5, P279, DOI 10.1007/s11940-003-0033-9; Murakami A, 2008, PEDIATRICS, V122, P500, DOI 10.1542/peds.2007-2816; Nagae LM, 2007, AM J NEURORADIOL, V28, P1213, DOI 10.3174/ajnr.A0534; O'Reilly JX, 2010, CEREB CORTEX, V20, P953, DOI 10.1093/cercor/bhp157; Okoshi Y, 2001, PEDIATR NEUROL, V25, P221, DOI 10.1016/S0887-8994(01)00309-5; Ovadia-Caro S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037238; Pierson CR, 2007, ACTA NEUROPATHOL, V114, P619, DOI 10.1007/s00401-007-0295-5; Pizoli CE, 2011, P NATL ACAD SCI USA, V108, P11638, DOI 10.1073/pnas.1109144108; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Qi RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046681; Roze E, 2012, NEURORADIOLOGY, V54, P507, DOI 10.1007/s00234-011-0969-5; Rutherford MA, 2010, NEURORADIOLOGY, V52, P505, DOI 10.1007/s00234-010-0700-y; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Smyser CD, 2010, CEREB CORTEX, V20, P2852, DOI 10.1093/cercor/bhq035; Tam EWY, 2011, J PEDIATR-US, V158, P366, DOI 10.1016/j.jpeds.2010.09.005; Tam EWY, 2009, PEDIATR RES, V66, P102, DOI 10.1203/PDR.0b013e3181a1fb3d; Thomason ME, 2008, NEUROIMAGE, V41, P1493, DOI 10.1016/j.neuroimage.2008.03.029; Turner JA, 2012, PSYCHIAT RES-NEUROIM, V201, P253, DOI 10.1016/j.pscychresns.2011.09.012; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Wang DH, 2013, J NEUROPHYSIOL, V109, P46, DOI 10.1152/jn.00598.2012; Wingert JR, 2010, HUM BRAIN MAPP, V31, P1772, DOI 10.1002/hbm.20977; Woodward LJ, 2006, NEW ENGL J MED, V355, P685, DOI 10.1056/NEJMoa053792; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198	81	75	76	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68098	10.1371/journal.pone.0068098	http://dx.doi.org/10.1371/journal.pone.0068098			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874510	Green Published, Green Submitted, gold			2022-12-27	WOS:000321736900056
J	Wang, H; Stier, G; Lin, J; Liu, G; Zhang, Z; Chang, YH; Reid, MS; Jiang, CZ				Wang, Hong; Stier, Genevieve; Lin, Jing; Liu, Gang; Zhang, Zhen; Chang, Youhong; Reid, Michael S.; Jiang, Cai-Zhong			Transcriptome Changes Associated with Delayed Flower Senescence on Transgenic Petunia by Inducing Expression of etr1-1, a Mutant Ethylene Receptor	PLOS ONE			English	Article							DOMAIN FACTOR AGL15; GENE-EXPRESSION; PERIANTH SENESCENCE; PLANT SENESCENCE; LEAF SENESCENCE; UP-REGULATION; INSENSITIVITY; MODEL; INVOLVEMENT; INHIBITION	Flowers of ethylene-sensitive ornamental plants transformed with ethylene-insensitive 1-1(etr1-1), a mutant ethylene receptor first isolated from Arabidopsis, are known to have longer shelf lives. We have generated petunia plants in which the etr1-1 gene was over-expressed under the control of a chemically-inducible promoter, which would allow expression of etr1-1 to be initiated at the desired time and stage of development. Here, we showed that transgenic plants grew and developed normally without a chemical inducer. Semi-quantitative RT-PCR demonstrated that the abundance of transcripts of Arabidopsis etr1-1 gene was substantially induced in flowers with 30 mu M dexamethasone (DEX). Consequently, t he life of the flowers was almost doubled and the peak of ethylene production was delayed. We compared gene expression changes of petals with DEX to those without DEX at 24 h and 48 h by microarray. Our results indicated that transcripts of many putative genes encoding transcription factors were down-regulated by etr1-1 induced expression at the early stage. In addition, putative genes involved in gibberellin biosynthesis, response to jasmonic acid/gibberellins stimulus, cell wall modification, ethylene biosynthesis, and cell death were down-regulated associating with etr1-1 induced expression. We investigated time-course gene expression profiles and found two profiles which displayed totally opposite expression patterns under these two treatments. In these profiles, 'the regulation of transcription' was predominant in GO categories. Taking all results together, we concluded those transcription factors down-regulated at early stage might exert a major role in regulating the senescence process which were consequently characterized by cell wall modification and cell death.	[Wang, Hong; Lin, Jing; Chang, Youhong] Jiangsu Acad Agr Sci, Inst Hort, Nanjing, Jiangsu, Peoples R China; [Wang, Hong; Stier, Genevieve; Reid, Michael S.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Liu, Gang; Zhang, Zhen] Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China; [Jiang, Cai-Zhong] ARS, Crops Pathol & Genet Res Unit, USDA, Davis, CA USA	Jiangsu Academy of Agricultural Sciences; University of California System; University of California Davis; Nanjing Agricultural University; United States Department of Agriculture (USDA)	Chang, YH (corresponding author), Jiangsu Acad Agr Sci, Inst Hort, Nanjing, Jiangsu, Peoples R China.	cyh@jaas.ac.cn; msreid@ucdavis.edu; cjiang@ucdavis.edu	Reid, Michael/ABI-1128-2020	Jiang, Cai-Zhong/0000-0002-5972-7963	USDA CRIS project [5306-21000-019-00D]; USDA Floriculture Initiative [5306-13210-001-02S]; National System for PEAR Industry Technology of China [CARS-29-18]	USDA CRIS project; USDA Floriculture Initiative; National System for PEAR Industry Technology of China	This work was partially supported by USDA CRIS project 5306-21000-019-00D, USDA Floriculture Initiative (5306-13210-001-02S) and the National System for PEAR Industry Technology of China (No. CARS-29-18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander L, 2002, J EXP BOT, V53, P2039, DOI 10.1093/jxb/erf072; Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; Balaji V, 2008, PLANT PHYSIOL, V146, P1797, DOI 10.1104/pp.107.115188; Balazadeh S, 2008, PLANT BIOLOGY, V10, P63, DOI 10.1111/j.1438-8677.2008.00088.x; Balazadeh S, 2010, PLANT J, V62, P250, DOI 10.1111/j.1365-313X.2010.04151.x; Benlloch-Gonzalez M, 2010, J EXP BOT, V61, P1139, DOI 10.1093/jxb/erp379; Bleecker AB, 2000, ANNU REV CELL DEV BI, V16, P1, DOI 10.1146/annurev.cellbio.16.1.1; BLEECKER AB, 1988, SCIENCE, V241, P1086, DOI 10.1126/science.241.4869.1086; Breeze E, 2004, PLANT BIOTECHNOL J, V2, P155, DOI 10.1111/j.1467-7652.2004.00059.x; CHANG C, 1993, SCIENCE, V262, P539, DOI 10.1126/science.8211181; Clark DG, 1999, PLANT PHYSIOL, V121, P53, DOI 10.1104/pp.121.1.53; Clevenger DJ, 2004, J AM SOC HORTIC SCI, V129, P401, DOI 10.21273/JASHS.129.3.0401; Craft J, 2005, PLANT J, V41, P899, DOI 10.1111/j.1365-313X.2005.02342.x; Dupuy D, 2007, NAT BIOTECHNOL, V25, P663, DOI 10.1038/nbt1305; Fang SC, 2002, PLANT PHYSIOL, V130, P78, DOI 10.1104/pp.004721; Fernandez DE, 2000, PLANT CELL, V12, P183, DOI 10.1105/tpc.12.2.183; Gallie DR, 2010, PLANT PHYSIOL, V152, P1928, DOI 10.1104/pp.109.151688; Ge HY, 2010, NUCLEIC ACIDS RES, V38, P143, DOI 10.1093/nar/gkp849; Gerats T, 2005, TRENDS PLANT SCI, V10, P251, DOI 10.1016/j.tplants.2005.03.005; GRBIC V, 1995, PLANT J, V8, P595, DOI 10.1046/j.1365-313X.1995.8040595.x; Gubrium EK, 2000, J AM SOC HORTIC SCI, V125, P277, DOI 10.21273/JASHS.125.3.277; Guo Y, 2004, PLANT CELL ENVIRON, V27, P521, DOI 10.1111/j.1365-3040.2003.01158.x; Guo YF, 2006, PLANT J, V46, P601, DOI 10.1111/j.1365-313X.2006.02723.x; Hatsugai N, 2006, APOPTOSIS, V11, P905, DOI 10.1007/s10495-006-6601-1; Hoeberichts FA, 2007, J EXP BOT, V58, P2873, DOI 10.1093/jxb/erm076; Hoffman T, 1999, PLANT PHYSIOL, V119, P935, DOI 10.1104/pp.119.3.935; Hunter DA, 2004, PHYSIOL PLANTARUM, V121, P313, DOI 10.1111/j.0031-9317.2004.0311.x; Hunter DA, 2002, PLANT SCI, V163, P13, DOI 10.1016/S0168-9452(02)00068-7; KENDE H, 1993, ANNU REV PLANT PHYS, V44, P283, DOI 10.1146/annurev.pp.44.060193.001435; Kim JH, 2009, SCIENCE, V323, P1053, DOI 10.1126/science.1166386; Knoester M, 1998, P NATL ACAD SCI USA, V95, P1933, DOI 10.1073/pnas.95.4.1933; Langston BJ, 2005, J EXP BOT, V56, P15, DOI 10.1093/jxb/eri002; Li JS, 2006, PLANT PHYSIOL, V140, P899, DOI 10.1104/pp.105.070987; Lin ZF, 2009, J EXP BOT, V60, P3311, DOI 10.1093/jxb/erp204; Mahmood T, 2008, ELECTRON J BIOTECHN, P1115; Miller LD, 2002, CANCER CELL, V2, P353, DOI 10.1016/S1535-6108(02)00181-2; Moore I, 2006, PLANT J, V45, P651, DOI 10.1111/j.1365-313X.2006.02660.x; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nishiyama K, 2007, J EXP BOT, V58, P1281, DOI 10.1093/jxb/erl283; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PORAT R, 1995, PHYSIOL PLANTARUM, V94, P205, DOI 10.1111/j.1399-3054.1995.tb05302.x; PORAT R, 1993, PLANT GROWTH REGUL, V13, P297, DOI 10.1007/BF00024851; Ramoni MF, 2002, P NATL ACAD SCI USA, V99, P9121, DOI 10.1073/pnas.132656399; Robatzek S, 2002, GENE DEV, V16, P1139, DOI 10.1101/gad.222702; SAKS Y, 1993, PLANT GROWTH REGUL, V12, P105, DOI 10.1007/BF00144590; Salman A, 2009, EUR FOOD RES TECHNOL, V228, P651, DOI 10.1007/s00217-008-0974-z; Sanikhani M, 2008, PLANT CELL REP, V27, P729, DOI 10.1007/s00299-007-0493-6; SCHALLER GE, 1995, SCIENCE, V270, P1809, DOI 10.1126/science.270.5243.1809; Schlitt T, 2003, GENOME RES, V13, P2568, DOI 10.1101/gr.1111403; Seo PJ, 2011, PLANTA, V233, P189, DOI 10.1007/s00425-010-1293-8; Serek M, 2006, BIOTECHNOL ADV, V24, P368, DOI 10.1016/j.biotechadv.2006.01.007; Sriskandarajah S, 2007, PLANT CELL REP, V26, P805, DOI 10.1007/s00299-006-0291-6; Sugawara H, 2002, J EXP BOT, V53, P407, DOI 10.1093/jexbot/53.368.407; Ulker B, 2007, PLANTA, V226, P125, DOI 10.1007/s00425-006-0474-y; Van der Graaff E, 2006, PLANT PHYSIOL, V141, P776, DOI 10.1104/pp.106.079293; van Doorn WG, 2003, PLANT MOL BIOL, V53, P845, DOI 10.1023/B:PLAN.0000023670.61059.1d; van Doorn WG, 2008, J EXP BOT, V59, P453, DOI 10.1093/jxb/erm356; Wagstaff C, 2009, PLANT J, V57, P690, DOI 10.1111/j.1365-313X.2008.03722.x; Wang H, 2013, MOL PLANT PATHOL; Wilkinson JQ, 1997, NAT BIOTECHNOL, V15, P444, DOI 10.1038/nbt0597-444; Xu XJ, 2007, J EXP BOT, V58, P2193, DOI 10.1093/jxb/erm058; Xu Y, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-8; Zentgraf U, 2010, EUR J CELL BIOL, V89, P133, DOI 10.1016/j.ejcb.2009.10.014; Zhou X, 2011, MOL CELLS, V31, P303, DOI 10.1007/s10059-011-0047-1	64	24	24	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e65800	10.1371/journal.pone.0065800	http://dx.doi.org/10.1371/journal.pone.0065800			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874385	Green Published, gold, Green Submitted			2022-12-27	WOS:000321736900002
J	Zhou, P; Xu, WY; Peng, XL; Luo, ZH; Xing, QH; Chen, XL; Hou, CQ; Liang, WH; Zhou, JW; Wu, XY; Songyang, Z; Jiang, SS				Zhou, Peng; Xu, Weiyi; Peng, Xueling; Luo, Zhenhua; Xing, Qinghe; Chen, Xulin; Hou, Chengqian; Liang, Weihong; Zhou, Jianwen; Wu, Xiaoyan; Songyang, Zhou; Jiang, Songshan			Large-Scale Screens of miRNA-mRNA Interactions Unveiled That the 3 ' UTR of a Gene Is Targeted by Multiple miRNAs	PLOS ONE			English	Article							MICRORNA BIOGENESIS; PROTEIN; PREDICTION; IDENTIFICATION; ACCESSIBILITY; EXPRESSION; FAMILY	Animal microRNA (miRNA) target prediction is still a challenge, although many prediction programs have been exploited. MiRNAs exert their function through partially binding the messenger RNAs (mRNAs; likely at 3' untranslated regions [3'UTRs]), which makes it possible to detect the miRNA-mRNA interactions in vitro by co-transfection of miRNA and a luciferase reporter gene containing the target mRNA fragment into mammalian cells under a dual-luciferase assay system. Here, we constructed a human miRNA expression library and used a dual-luciferase assay system to perform large-scale screens of interactions between miRNAs and the 3'UTRs of seven genes, which included more than 3,000 interactions with triplicate experiments for each interaction. The screening results showed that the 3'UTRs of one gene can be targeted by multiple miRNAs. Among the prediction algorithms, a Bayesian phylogenetic miRNA target identification algorithm and a support vector machine (SVM) presented a relatively better performance (27% for EIMMo and 24.7% for miRDB) against the average precision (17.3%) of the nine prediction programs used here. Additionally, we noticed that a relatively high conservation level was shown at the miRNA 3' end targeted regions, as well as the 5' end (seed region) binding sites.	[Zhou, Peng; Xu, Weiyi; Peng, Xueling; Luo, Zhenhua; Zhou, Jianwen; Wu, Xiaoyan; Songyang, Zhou; Jiang, Songshan] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Zhou, Peng; Zhou, Jianwen; Jiang, Songshan] Sun Yat Sen Univ, Sch Life Sci, Minist Educ, Key Lab Gene Engn, Guangzhou 510275, Guangdong, Peoples R China; [Xing, Qinghe] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Chen, Xulin] Gene Sci & Hlth Co, Shenzhen, Peoples R China; [Hou, Chengqian; Liang, Weihong] Henan Normal Univ, Coll Life Sci, Xinxiang, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Fudan University; Henan Normal University	Jiang, SS (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.	jiangssh@mail.sysu.edu.cn			National Natural Science Foundation of China [81272773, 81101960]; Scientific and Technological Planning of Guangzhou [2012J4100082]; Fundamental Re- search Funds for the Central Universities [10lgpy23]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific and Technological Planning of Guangzhou; Fundamental Re- search Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants from the National Natural Science Foundation of China (Grant number 81272773 and 81101960); the Scientific and Technological Planning of Guangzhou (Grant number 2012J4100082); and the Fundamental Re- search Funds for the Central Universities (Grant number 10lgpy23). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexiou P, 2009, BIOINFORMATICS, V25, P3049, DOI 10.1093/bioinformatics/btp565; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Didiano D, 2008, RNA, V14, P1297, DOI 10.1261/rna.1082708; Didiano D, 2006, NAT STRUCT MOL BIOL, V13, P849, DOI 10.1038/nsmb1138; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Enright AJ, 2004, GENOME BIOL, V5; Gaidatzis D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-69; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Jiang Q, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-194; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kusenda Branislav, 2006, Biomedical Papers (Olomouc), V150, P205; Lall S, 2006, CURR BIOL, V16, P460, DOI 10.1016/j.cub.2006.01.050; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; Marin RM, 2011, NUCLEIC ACIDS RES, V39, P19, DOI 10.1093/nar/gkq768; Nelson PT, 2010, BRAIN RES, V1338, P122, DOI 10.1016/j.brainres.2010.03.108; Patraquim P, 2011, MOL BIOL EVOL, V28, P2453, DOI 10.1093/molbev/msr073; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shen XK, 2011, J BIOL CHEM, V286, P26616, DOI 10.1074/jbc.M111.224212; Shirdel EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017429; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Vo NK, 2010, P NATL ACAD SCI USA, V107, P19231, DOI 10.1073/pnas.1013162107; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Vosa U, 2011, GENE CHROMOSOME CANC, V50, P812, DOI 10.1002/gcc.20902; Wang Q, 2011, ONCOGENE, V30, P3875, DOI 10.1038/onc.2011.103; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Wu S, 2010, ONCOGENE, V29, P2302, DOI 10.1038/onc.2010.34; Wu TT, 2012, J BIOL CHEM, V287, P7503, DOI 10.1074/jbc.M111.292722; Yousef M, 2007, BIOINFORMATICS, V23, P2987, DOI 10.1093/bioinformatics/btm484; Zhang XHD, 2011, J BIOMOL SCREEN, V16, P775, DOI 10.1177/1087057111405851	52	49	55	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68204	10.1371/journal.pone.0068204	http://dx.doi.org/10.1371/journal.pone.0068204			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874542	Green Published, Green Submitted, gold			2022-12-27	WOS:000321736900067
J	De Pitta, C; Biscontin, A; Albiero, A; Sales, G; Millino, C; Mazzotta, GM; Bertolucci, C; Costa, R				De Pitta, Cristiano; Biscontin, Alberto; Albiero, Alessandro; Sales, Gabriele; Millino, Caterina; Mazzotta, Gabriella M.; Bertolucci, Cristiano; Costa, Rodolfo			The Antarctic Krill Euphausia superba Shows Diurnal Cycles of Transcription under Natural Conditions	PLOS ONE			English	Article							GENE-EXPRESSION; CIRCADIAN CLOCK; MESSENGER-RNA; CLIMATE-CHANGE; METABOLISM; MOUSE; CRUSTACEANS; HORMONE	Background: Polar environments are characterized by extreme seasonal changes in day length, light intensity and spectrum, the extent of sea ice during the winter, and food availability. A key species of the Southern Ocean ecosystem, the Antarctic krill (Euphausia superba) has evolved rhythmic physiological and behavioral mechanisms to adapt to daily and seasonal changes. The molecular organization of the clockwork underlying these biological rhythms is, nevertheless, still only partially understood. Methodology/Principal Findings: The genome sequence of the Antarctic krill is not yet available. A normalized cDNA library was produced and pyrosequenced in the attempt to identify large numbers of transcripts. All available E. superba sequences were then assembled to create the most complete existing oligonucleotide microarray platform with a total of 32,217 probes. Gene expression signatures of specimens collected in the Ross Sea at five different time points over a 24-hour cycle were defined, and 1,308 genes differentially expressed were identified. Of the corresponding transcripts, 609 showed a significant sinusoidal expression pattern; about 40% of these exibithed a 24-hour periodicity while the other 60% was characterized by a shorter (about 12-hour) rhythm. We assigned the differentially expressed genes to functional categories and noticed that those concerning translation, proteolysis, energy and metabolic process, redox regulation, visual transduction and stress response, which are most likely related to daily environmental changes, were significantly enriched. Two transcripts of peroxiredoxin, thought to represent the ancestral timekeeping system that evolved about 2.5 billion years ago, were also identified as were two isoforms of the EsRh1 opsin and two novel arrestin1 sequences involved in the visual transduction cascade. Conclusions: Our work represents the first characterization of the krill diurnal transcriptome under natural conditions and provides a first insight into the genetic regulation of physiological changes, which occur around the clock during an Antarctic summer day.	[De Pitta, Cristiano; Biscontin, Alberto; Sales, Gabriele; Mazzotta, Gabriella M.; Costa, Rodolfo] Univ Padua, Dipartimento Biol, Padua, Italy; [Albiero, Alessandro; Millino, Caterina] Univ Padua, CRIBI, Padua, Italy; [Albiero, Alessandro] BMR Genom, Padua, Italy; [Bertolucci, Cristiano] Univ Ferrara, Dipartimento Sci Vita & Biotecnol, I-44100 Ferrara, Italy	University of Padua; University of Padua; University of Ferrara	Costa, R (corresponding author), Univ Padua, Dipartimento Biol, Padua, Italy.	rodolfo.costa@unipd.it	De Pitta, Cristiano/AAY-7302-2020; Bertolucci, Cristiano/H-1916-2015; Sales, Gabriele/K-5065-2016	De Pitta, Cristiano/0000-0001-8013-8162; Bertolucci, Cristiano/0000-0003-0252-3107; Biscontin, Alberto/0000-0003-1492-7715; Sales, Gabriele/0000-0003-2078-5661; MAZZOTTA, GABRIELLA MARGHERITA/0000-0001-5461-6837	Italian Programma Nazionale di Ricerche in Antartide - PNRA [2003/1.3, 2005/1.04]; Helmholtz Virtual Institute "PolarTime" [VH-VI-500]; European Community [01874]; University of Ferrara	Italian Programma Nazionale di Ricerche in Antartide - PNRA; Helmholtz Virtual Institute "PolarTime"; European Community(European Commission); University of Ferrara	This work was supported by the Italian Programma Nazionale di Ricerche in Antartide - PNRA (grant 2003/1.3 and grant 2005/1.04 to RC and CB) and the Helmholtz Virtual Institute "PolarTime" (VH-VI-500: Biological timing in a changing marine environment - clocks and rhythms in polar pelagic organisms). RC also thanks the European Community (6th Framework Project EUCLOCK number 01874) research grant. CB acknowledges research grants from the University of Ferrara. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi J, 2010, ADV MAR BIOL, V58, P155, DOI 10.1016/S0065.2881(10)58003.9; Atkinson A, 2008, MAR ECOL PROG SER, V362, P1, DOI 10.3354/meps07498; Atkinson A, 2004, NATURE, V432, P100, DOI 10.1038/nature02996; Atkinson A, 2009, DEEP-SEA RES PT I, V56, P727, DOI 10.1016/j.dsr.2008.12.007; Battelle BA, 2000, VISUAL NEUROSCI, V17, P217, DOI 10.1017/S0952523800172049; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Ceriani MF, 2002, J NEUROSCI, V22, P9305, DOI 10.1523/jneurosci.22-21-09305.2002; Chudova D, 2009, BIOINFORMATICS, V25, P3114, DOI 10.1093/bioinformatics/btp547; Claridge-Chang A, 2001, NEURON, V32, P657, DOI 10.1016/S0896-6273(01)00515-3; Clark MS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-362; Clark MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015919; Clarke A, 2008, CURR BIOL, V18, P282, DOI 10.1016/j.cub.2008.01.059; CRAFT CM, 1990, J NEUROCHEM, V55, P1461, DOI 10.1111/j.1471-4159.1990.tb04927.x; Craft JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008875; De Pitta C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-45; Doherty CJ, 2010, ANNU REV GENET, V44, P419, DOI 10.1146/annurev-genet-102209-163432; Doi M, 2004, CURR BIOL, V14, P975, DOI 10.1016/j.cub.2004.05.043; Edgar RS, 2012, NATURE, V485, P459, DOI 10.1038/nature11088; Flores H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031775; Forcada J, 2005, ECOLOGY, V86, P2408, DOI 10.1890/04-1153; Fukuyama T, 2008, BIOMED RES-TOKYO, V29, P93, DOI 10.2220/biomedres.29.93; Gaten E, 2008, J GENET, V87, P473, DOI 10.1007/s12041-008-0070-y; Gigliotti JC, 2008, FOOD CHEM, V111, P209, DOI 10.1016/j.foodchem.2008.03.030; Godlewska Malgorzata, 1996, Polskie Archiwum Hydrobiologii, V43, P9; Golombek DA, 2004, NEUROCHEM INT, V45, P929, DOI 10.1016/j.neuint.2004.03.023; Golombek DA, 2010, PHYSIOL REV, V90, P1063, DOI 10.1152/physrev.00009.2009; Gotow T, 2008, BRAIN RES, V1225, P3, DOI 10.1016/j.brainres.2008.04.059; Henriques R, 2009, CURR OPIN PLANT BIOL, V12, P49, DOI 10.1016/j.pbi.2008.10.009; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Im SH, 2010, J COMP NEUROL, V518, P1925, DOI 10.1002/cne.22311; Jeffery NW, 2012, POLAR BIOL, V35, P959, DOI 10.1007/s00300-011-1137-4; Jung H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027938; Kawaguchi S, 2009, FISHERIES MANAG ECOL, V16, P424, DOI 10.1111/j.1365-2400.2009.00686.x; Lin JD, 2008, CELL CYCLE, V7, P453, DOI 10.4161/cc.7.4.5442; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Fanjul-Moles ML, 2010, CHRONOBIOL INT, V27, P34, DOI 10.3109/07420520903398526; Ma KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039727; Mandilaras K, 2012, METALLOMICS, V4, P928, DOI 10.1039/c2mt20065a; Masri S, 2012, ANN NY ACAD SCI, V1264, P103, DOI 10.1111/j.1749-6632.2012.06649.x; Mazzotta GM, 2010, CHRONOBIOL INT, V27, P425, DOI 10.3109/07420521003697494; MCGINNIS JF, 1992, J NEUROSCI RES, V31, P584, DOI 10.1002/jnr.490310325; Meyer B, 2010, MAR ECOL PROG SER, V398, P1, DOI 10.3354/meps08371; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Milan M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-234; Mundry M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031410; Naylor E, 2006, MAR FRESHW BEHAV PHY, V39, P13, DOI 10.1080/10236240600593344; Nieoullon A, 2006, J NEUROCHEM, V98, P1007, DOI 10.1111/j.1471-4159.2006.03978.x; Oster H, 2006, J BIOL RHYTHM, V21, P350, DOI 10.1177/0748730406293053; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Rajkumar P, 2010, J EXP BIOL, V213, P4240, DOI 10.1242/jeb.051011; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sasagawa H, 2003, EUR J NEUROSCI, V17, P963, DOI 10.1046/j.1460-9568.2003.02528.x; Seear PJ, 2012, MAR ECOL PROG SER, V467, P61, DOI 10.3354/meps09947; Seear PJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-582; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Strauss J, 2010, FRONT BIOSCI-LANDMRK, V15, P1040, DOI 10.2741/3661; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tarling GA, 2006, CURR BIOL, V16, pR83, DOI 10.1016/j.cub.2006.01.044; Teschke M, 2007, LIMNOL OCEANOGR, V52, P1046, DOI 10.4319/lo.2007.52.3.1046; Teschke M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026090; Tessmar-Raible K, 2011, BIOESSAYS, V33, P165, DOI 10.1002/bies.201000096; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trathan PN, 2007, PHILOS T R SOC B, V362, P2351, DOI 10.1098/rstb.2006.1953; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Ward B, 2010, J BIOMOLECULAR TECHN, V21, pS30; Weger BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017080; Yang R, 2010, BIOINFORMATICS, V26, pi168, DOI 10.1093/bioinformatics/btq189; Zhulidov PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh031; Zhulidov PA, 2005, RUSS J BIOORG CHEM+, V31, P170, DOI 10.1007/s11171-005-0023-7	69	27	27	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e68652	10.1371/journal.pone.0068652	http://dx.doi.org/10.1371/journal.pone.0068652			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23874706	Green Published, gold, Green Submitted			2022-12-27	WOS:000322000600013
J	New, LF; Moretti, DJ; Hooker, SK; Costa, DP; Simmons, SE				New, Leslie F.; Moretti, David J.; Hooker, Sascha K.; Costa, Daniel P.; Simmons, Samantha E.			Using Energetic Models to Investigate the Survival and Reproduction of Beaked Whales (family Ziphiidae)	PLOS ONE			English	Article							BOTTLE-NOSED WHALES; CUVIERS ZIPHIUS-CAVIROSTRIS; HYPEROODON-AMPULLATUS; STOMACH CONTENTS; BIOLOGICAL OBSERVATIONS; MESOPLODON-STEJNEGERI; INDOPACETUS-PACIFICUS; DIVING BEHAVIOR; M-MIRUS; CETACEA	Mass stranding of several species of beaked whales (family Ziphiidae) associated with exposure to anthropogenic sounds has raised concern for the conservation of these species. However, little is known about the species' life histories, prey or habitat requirements. Without this knowledge, it becomes difficult to assess the effects of anthropogenic sound, since there is no way to determine whether the disturbance is impacting the species' physical or environmental requirements. Here we take a bioenergetics approach to address this gap in our knowledge, as the elusive, deep-diving nature of beaked whales has made it hard to study these effects directly. We develop a model for Ziphiidae linking feeding energetics to the species' requirements for survival and reproduction, since these life history traits would be the most likely to be impacted by non-lethal disturbances. Our models suggest that beaked whale reproduction requires energy dense prey, and that poor resource availability would lead to an extension of the inter-calving interval. Further, given current information, it seems that some beaked whale species require relatively high quality habitat in order to meet their requirements for survival and reproduction. As a result, even a small non-lethal disturbance that results in displacement of whales from preferred habitats could potentially impact a population if a significant proportion of that population was affected. We explored the impact of varying ecological parameters and model assumptions on survival and reproduction, and find that calf and fetus survival appear more readily affected than the survival of adult females.	[New, Leslie F.; Simmons, Samantha E.] US Marine Mammal Commiss, Bethesda, MD USA; [Moretti, David J.] Naval Undersea Warfare Ctr, Newport, RI USA; [Hooker, Sascha K.] Univ St Andrews, St Andrews, Fife, Scotland; [Costa, Daniel P.] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA	United States Department of Defense; United States Navy; US Navy Naval Sea Systems Command; University of St Andrews; University of California System; University of California Santa Cruz	New, LF (corresponding author), US Marine Mammal Commiss, Bethesda, MD USA.	lnew@usgs.gov	Hooker, Sascha K/J-3267-2013; New, Leslie/C-8796-2018; Costa, Daniel/E-2616-2013	Simmons, Samantha/0000-0003-0326-6990; Costa, Daniel/0000-0002-0233-5782; Hooker, Sascha/0000-0002-7518-3548	National Research Council; Office of Naval Research [N0014-09-0896]; Natural Environment Research Council [smru10001] Funding Source: researchfish	National Research Council; Office of Naval Research(Office of Naval Research); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported in part by a grant from the National Research Council to LN, as well as being informed by the Working Group on the Population Consequences of Disturbance supported by grant N0014-09-0896 from the Office of Naval Research to University of California, Santa Barbara. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson R. Charles, 2006, Aquatic Mammals, V32, P223, DOI 10.1578/AM.32.2.2006.223; Arai Kazumi, 2004, Mammal Study, V29, P125, DOI 10.3106/mammalstudy.29.125; Baird RW, 2006, CAN J ZOOL, V84, P1120, DOI 10.1139/Z06-095; BAIRD RW, 2004, AB133F03SE0986 SW FI; Baker AN, 2001, MAR MAMMAL SCI, V17, P473, DOI 10.1111/j.1748-7692.2001.tb00999.x; Balcomb K. C. III, 2001, BAHAMAS J SCI, V5, P1; BENJAMINSEN T, 1972, Norwegian Journal of Zoology, V20, P233; Bloch D, 1996, J ZOOL, V239, P123, DOI 10.1111/j.1469-7998.1996.tb05441.x; BONDE RK, 1989, J MAMMAL, V70, P447, DOI 10.2307/1381540; Brody S., 1968, BIOENERGETICS GROWTH; CHRISTENSEN I, 1973, Norwegian Journal of Zoology, V21, P331; Claridge DE, 2001, 14 BIENN C MAR MAMM; Costa D., 2011, EFFECTS NOISE AQUATI, P423; Costa DP, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P383; Cox T. M., 2005, Journal of Cetacean Research and Management, V7, P177; Crocker DE, 2001, ECOLOGY, V82, P3541, DOI 10.2307/2680171; Dalebout ML, 2004, J ROY SOC NEW ZEAL, V34, P347, DOI 10.1080/03014223.2004.9517771; Dalebout ML, 2003, MAR MAMMAL SCI, V19, P421, DOI 10.1111/j.1748-7692.2003.tb01314.x; Dalebout ML, 2002, MAR MAMMAL SCI, V18, P577, DOI 10.1111/j.1748-7692.2002.tb01061.x; Dixon J.M., 1994, AUST MAMMAL, V17, P85; DRENT RH, 1980, ARDEA, V68, P225; Fernandez A, 2011, J WILDLIFE DIS, V47, P1043, DOI 10.7589/0090-3558-47.4.1043; Gillespie D, 2009, J ACOUST SOC AM, V125, P3428, DOI 10.1121/1.3110832; Gomercic H, 2006, EUR J WILDLIFE RES, V52, P182, DOI 10.1007/s10344-006-0032-8; Goodman-Lowe GD, 1999, CAN J ZOOL, V77, P653, DOI 10.1139/cjz-77-4-653; Gowans S, 2001, ANIM BEHAV, V62, P369, DOI 10.1006/anbe.2001.1756; Grandi M. Florencia, 2005, Latin American Journal of Aquatic Mammals, V4, P97; Hobson RP, 1996, CAN J ZOOL, V74, P388, DOI 10.1139/z96-045; Hooker SK, 2012, P ROY SOC B-BIOL SCI, V279, P1041, DOI 10.1098/rspb.2011.2088; Hooker SK, 1999, P ROY SOC B-BIOL SCI, V266, P671, DOI 10.1098/rspb.1999.0688; Hooker SK, 2002, BIOL CONSERV, V104, P51, DOI 10.1016/S0006-3207(01)00153-7; Huang SL, 2011, MAR MAMMAL SCI, V27, P182, DOI 10.1111/j.1748-7692.2010.00392.x; INNES S, 1987, J ANIM ECOL, V56, P115, DOI 10.2307/4803; Jepson PD, 2003, NATURE, V425, P575, DOI 10.1038/425575a; Johnson M, 2004, P ROY SOC B-BIOL SCI, V271, pS383, DOI 10.1098/rsbl.2004.0208; Kasuya T., 1977, Scientific Rep. Whales Res. Inst., Tokyo, VNo. 29, P1; Kasuya T, 2002, ENCY MARINE MAMMALS, P519; Kasuya Toshio, 1997, Report of the International Whaling Commission, V47, P969; Kenney Robert D., 1997, Journal of Northwest Atlantic Fishery Science, V22, P155; Kleiber M., 1975, FIRE LIFE INTRO ANIM; Kriete B., 1995, THESIS U BRIT COLUMB; Lee K, 2005, ENV STUDIES RES FUND; Lockyer C, 1981, FAO FISH SER, V3, P498; Lockyer C, 2007, J MAR BIOL ASSOC UK, V87, P1035, DOI 10.1017/S0025315407054720; Lockyer Christina, 1993, Reports of the International Whaling Commission Special Issue, V14, P325; LOUGHLIN TR, 1982, J MAMMAL, V63, P697, DOI 10.2307/1380289; MacLeod CD, 2003, J MAR BIOL ASSOC UK, V83, P651, DOI 10.1017/S0025315403007616h; MacLeod CD, 2005, MAR BIOL, V147, P1, DOI 10.1007/s00227-004-1546-9; MacLeod Colin D., 2005, Journal of Cetacean Research and Management, V7, P301; Marsh H., 1991, P281; McCarthy E, 2011, MAR MAMMAL SCI, V27, pE206, DOI 10.1111/j.1748-7692.2010.00457.x; McSweeney DJ, 2007, MAR MAMMAL SCI, V23, P666, DOI 10.1111/j.1748-7692.2007.00135.x; Mead J.G., 1982, Smithsonian Contributions to Zoology, V344, P1; Mead J.G., 1984, Reports of the International Whaling Commission Special Issue, P91; Mead JG, 1981, HDB MARINE MAMMALS, V4, P309; Mead JG, 1987, J R SOC NZ, V17, P321; Moretti D, 2010, APPL ACOUST, V71, P1036, DOI 10.1016/j.apacoust.2010.04.011; Noren SR, 2012, MAR ECOL PROG SER, V460, P261, DOI 10.3354/meps09706; Oftedal OT, 1997, J MAMMARY GLAND BIOL, V2, P205, DOI 10.1023/A:1026328203526; Ohizumi H, 2003, FISHERIES SCI, V69, P11, DOI 10.1046/j.1444-2906.2003.00582.x; Omura H., 1955, Scientific Reports of the Whales Research Institute Tokyo No 10, P89; Pereira JN, 2011, DEEP-SEA RES PT I, V58, P1084, DOI 10.1016/j.dsr.2011.08.004; PEREZ MA, 1986, FISH B-NOAA, V84, P371; Perez MA, 1994, NOAA TECHNICAL MEMOI, P32; Pitman R. L., 2002, ENCY MARINE MAMMALS, P738; Pitman RL, 2006, MAR MAMMAL SCI, V22, P744, DOI 10.1111/j.1748-7692.2006.00066.x; Pitman RL, 2001, MAR MAMMAL SCI, V17, P648, DOI 10.1111/j.1748-7692.2001.tb01010.x; PONGANIS PJ, 1995, MAR MAMMAL SCI, V11, P247, DOI 10.1111/j.1748-7692.1995.tb00523.x; R Core Team, 2012, R LANG ENV STAT COMP; RECCHIA CA, 1989, CAN J ZOOL, V67, P2140, DOI 10.1139/z89-304; REYES JC, 1991, MAR MAMMAL SCI, V7, P1, DOI 10.1111/j.1748-7692.1991.tb00546.x; Riek A, 2008, J ZOOL, V274, P160, DOI 10.1111/j.1469-7998.2007.00369.x; SAKAMOTO W, 1989, NIPPON SUISAN GAKK, V55, P2057; Scheidat M, 2011, POLAR BIOL, V34, P1513, DOI 10.1007/s00300-011-1010-5; Sekiguchi K, 1996, J ZOOL, V239, P453, DOI 10.1111/j.1469-7998.1996.tb05935.x; Shindo Junji, 2008, Okajimas Folia Anatomica Japonica, V84, P121, DOI 10.2535/ofaj.84.121; SLIP DJ, 1995, MAR MAMMAL SCI, V11, P575, DOI 10.1111/j.1748-7692.1995.tb00681.x; Stephens PA, 2009, ECOLOGY, V90, P2057, DOI 10.1890/08-1369.1; SUBRAMANIAN A, 1988, MAR POLLUT BULL, V19, P284, DOI 10.1016/0025-326X(88)90600-5; TOVE M, 1995, MAR MAMMAL SCI, V11, P80, DOI 10.1111/j.1748-7692.1995.tb00276.x; Tyack PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017009; URBANRAMIREZ J, 1992, MAR MAMMAL SCI, V8, P420, DOI 10.1111/j.1748-7692.1992.tb00058.x; Vollenweider JJ, 2011, MAR BIOL, V158, P413, DOI 10.1007/s00227-010-1569-3; Walker WA, 1999, MAR MAMMAL SCI, V15, P1314, DOI 10.1111/j.1748-7692.1999.tb00893.x; Webber MA., 1993, FAO SPECIES IDENTIFI; WEINER J, 1992, TRENDS ECOL EVOL, V7, P384, DOI 10.1016/0169-5347(92)90009-Z; Weir CR, 2004, J MAR BIOL ASSOC UK, V84, P1095, DOI 10.1017/S0025315404010525h; Whitehead H, 1997, MAR MAMMAL SCI, V13, P173, DOI 10.1111/j.1748-7692.1997.tb00625.x; Yatabe A, 2010, AQUAT MAMM, V36, P172, DOI 10.1578/AM.36.2.2010.172; [No title captured]	90	63	66	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e68725	10.1371/journal.pone.0068725	http://dx.doi.org/10.1371/journal.pone.0068725			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23874737	Green Submitted, Green Published, gold			2022-12-27	WOS:000322000600021
J	Aguero-Chapin, G; Molina-Ruiz, R; Maldonado, E; de la Riva, G; Sanchez-Rodriguez, A; Vasconcelos, V; Antunes, A				Agueero-Chapin, Guillermin; Molina-Ruiz, Reinaldo; Maldonado, Emanuel; de la Riva, Gustavo; Sanchez-Rodriguez, Aminael; Vasconcelos, Vitor; Antunes, Agostinho			Exploring the Adenylation Domain Repertoire of Nonribosomal Peptide Synthetases Using an Ensemble of Sequence-Search Methods	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; NEURAL-NETWORK MODEL; IN-SILICO; TOPOLOGICAL INDEXES; GRAPHICAL REPRESENTATION; ADJACENCY MATRIX; EFFICIENT SEARCH; PREDICTION; ALIGNMENT; DNA	The introduction of two-dimension (2D) graphs and their numerical characterization for comparative analyses of DNA/RNA and protein sequences without the need of sequence alignments is an active yet recent research topic in bioinformatics. Here, we used a 2D artificial representation (four-color maps) with a simple numerical characterization through topological indices (TIs) to aid the discovering of remote homologous of Adenylation domains (A-domains) from the Nonribosomal Peptide Synthetases (NRPS) class in the proteome of the cyanobacteria Microcystis aeruginosa. Cyanobacteria are a rich source of structurally diverse oligopeptides that are predominantly synthesized by NPRS. Several A-domains share amino acid identities lower than 20 % being a possible source of remote homologous. Therefore, A-domains cannot be easily retrieved by BLASTp searches using a single template. To cope with the sequence diversity of the A-domains we have combined homology-search methods with an alignment-free tool that uses protein four-color-maps. TI2BioP (Topological Indices to BioPolymers) version 2.0, available at http://ti2biop.sourceforge.net/ allowed the calculation of simple TIs from the protein sequences (four-color maps). Such TIs were used as input predictors for the statistical estimations required to build the alignment-free models. We concluded that the use of graphical/numerical approaches in cooperation with other sequence search methods, like multi-templates BLASTp and profile HMM, can give the most complete exploration of the repertoire of highly diverse protein families.	[Agueero-Chapin, Guillermin; Maldonado, Emanuel; Vasconcelos, Vitor; Antunes, Agostinho] Univ Porto, CIMAR CIIMAR, Ctr Interdisciplinar Invest Marinha & Ambiental, P-4100 Porto, Portugal; [Agueero-Chapin, Guillermin; Molina-Ruiz, Reinaldo] Univ Cent Marta Abreu Las Villas UCLV, Mol Simulat & Drug Design CBQ, Santa Clara, Cuba; [Agueero-Chapin, Guillermin; Vasconcelos, Vitor; Antunes, Agostinho] Univ Porto, Dept Biol, Fac Ciencias, P-4100 Porto, Portugal; [de la Riva, Gustavo] Inst Tecnol Super Irapuato ITESI, Dept Biol, Guanajuato, Mexico; [Sanchez-Rodriguez, Aminael] Katholieke Univ Leuven, Dept Microbial & Mol Syst, CMPG, Louvain, Belgium	Universidade do Porto; Universidad Central "Marta Abreu" de Las Villas; Universidade do Porto; KU Leuven	Antunes, A (corresponding author), Univ Porto, CIMAR CIIMAR, Ctr Interdisciplinar Invest Marinha & Ambiental, Rua Campo Alegre 823, P-4100 Porto, Portugal.	aantunes@ciimar.up.pt	Maldonado, Emanuel/X-1620-2019; Vasconcelos, Vitor/A-8933-2008; Agüero-Chapin, Guillermin/C-8067-2019	Maldonado, Emanuel/0000-0002-0084-6116; Vasconcelos, Vitor/0000-0003-3585-2417; Agüero-Chapin, Guillermin/0000-0002-9908-2418; Sanchez-Rodriguez, Aminael/0000-0002-9269-0621; Antunes, Agostinho/0000-0002-1328-1732; Molina-Ruiz, Reinaldo/0000-0001-5098-5432	Portuguese Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BD/47256/2008];  [PTDC/AAC-AMB/104983/2008 (FCOMP-01-0124-FEDER-008610)];  [PTDC/AAC-CLI/116122/2009 (FCOMP-01-0124-FEDER-014029)];  [PesT-C/MAR/LA0015/2011]	Portuguese Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and Technology); ; ; 	The authors acknowledge the Portuguese Fundacao para a Ciencia e a Tecnologia (FCT) for financial support to GACH (SFRH/BD/47256/2008), and the projects PTDC/AAC-AMB/104983/2008 (FCOMP-01-0124-FEDER-008610), PTDC/AAC-CLI/116122/2009 (FCOMP-01-0124-FEDER-014029), and PesT-C/MAR/LA0015/2011 to AA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguero-Chapin G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026638; Agueero-Chapin G, 2011, J THEOR BIOL, V273, P167, DOI 10.1016/j.jtbi.2010.12.019; Aguero-Chapin G, 2011, AMINO ACIDS, V40, P431, DOI 10.1007/s00726-010-0653-9; Aguero-Chapin G, 2009, J PROTEOME RES, V8, P2122, DOI 10.1021/pr800867y; Aguero-Chapin GA, 2006, FEBS LETT, V580, P723, DOI 10.1016/j.febslet.2005.12.072; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ansari MZ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-454; Ansari MZ, 2004, NUCLEIC ACIDS RES, V32, pW405, DOI 10.1093/nar/gkh359; Boekhorst J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-356; Cai YD, 2003, J COMPUT CHEM, V24, P727, DOI 10.1002/jcc.10222; Cai YD, 2002, COMPUT CHEM, V26, P179, DOI 10.1016/S0097-8485(01)00106-1; Cai YD, 2001, J BIOMOL STRUCT DYN, V18, P607, DOI 10.1080/07391102.2001.10506692; Chou KC, 2005, BIOINFORMATICS, V21, P10, DOI 10.1093/bioinformatics/bth466; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Concu R, 2010, CURR PHARM DESIGN, V16, P2710, DOI 10.2174/138161210792389207; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Cruz-Monteagudo M, 2008, CHEM RES TOXICOL, V21, P619, DOI 10.1021/tx700296t; de Jong A, 2006, NUCLEIC ACIDS RES, V34, pW273, DOI 10.1093/nar/gkl237; Ding YS, 2007, PROTEIN PEPTIDE LETT, V14, P811; Eddy Sean R, 2009, Genome Inform, V23, P205; Estrada E, 1996, J CHEM INF COMP SCI, V36, P844, DOI 10.1021/ci950187r; Estrada E, 2001, CURR MED CHEM, V8, P1573, DOI 10.2174/0929867013371923; Gonzalez-Diaz H, 2009, J THEOR BIOL, V261, P136, DOI 10.1016/j.jtbi.2009.07.029; HOBOHM U, 1995, J MOL BIOL, V251, P390, DOI 10.1006/jmbi.1995.0442; Jenke-Kodama H, 2009, NAT PROD REP, V26, P874, DOI 10.1039/b810283j; KOETSCHAN C, 2009, NUCL ACIDS RES; Kumar Manish, 2008, In Silico Biology, V8, P121; KUTNER MH, 2005, STANDARDIZED MULTIPL, P271; Marrero Ponce Yovani, 2004, Bioorganic & Medicinal Chemistry, V12, P5331, DOI 10.1016/j.bmc.2004.07.051; Marrero-Ponce Y, 2005, BIOORGAN MED CHEM, V13, P1005, DOI 10.1016/j.bmc.2004.11.040; *MATHWORKS I, 2004, NEUR NETW TOOLB US G; Molina R., 2011, TI2BIOP TOPOLOGICAL; NANDY A, 1994, INDIAN J BIOCHEM BIO, V31, P149; Ponce YM, 2004, BIOORGAN MED CHEM, V12, P5331, DOI 10.1016/j.bmc.2004.07.051; Randic M, 2012, J COMPUT CHEM, V33, P702, DOI 10.1002/jcc.22903; Randic M, 2005, CHEM PHYS LETT, V407, P205, DOI 10.1016/j.cplett.2005.03.086; Randic M, 2001, J CHEM INF COMP SCI, V41, P550, DOI 10.1021/ci000095o; Randic M, 2004, CHEM PHYS LETT, V386, P468, DOI 10.1016/j.cplett.2004.01.088; Randic M, 2004, SAR QSAR ENVIRON RES, V15, P191, DOI 10.1080/10629360410001697753; Randic M, 2007, J MOL GRAPH MODEL, V26, P290, DOI 10.1016/j.jmgm.2006.12.006; Randic M, 2013, J COMPUT CHEM, V34, P77, DOI 10.1002/jcc.23105; Randic M, 2011, CHEM REV, V111, P790, DOI 10.1021/cr800198j; Randic M, 2009, J MOL GRAPH MODEL, V27, P637, DOI 10.1016/j.jmgm.2008.10.004; Rivals I, 1999, NEURAL COMPUT, V11, P863, DOI 10.1162/089976699300016476; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Santana L, 2006, J MED CHEM, V49, P1149, DOI 10.1021/jm0509849; Shen HB, 2008, ANAL BIOCHEM, V373, P386, DOI 10.1016/j.ab.2007.10.012; Statsoft, 2008, STATISTICA 8 0 DAT A; Strope PK, 2007, GENOMICS, V89, P602, DOI 10.1016/j.ygeno.2007.01.008; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vilar S, 2005, J CHEM INF MODEL, V45, P502, DOI 10.1021/ci049662o; Wass MN, 2008, BIOINFORMATICS, V24, P798, DOI 10.1093/bioinformatics/btn037; Welker M, 2006, FEMS MICROBIOL REV, V30, P530, DOI 10.1111/j.1574-6976.2006.00022.x	55	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e65926	10.1371/journal.pone.0065926	http://dx.doi.org/10.1371/journal.pone.0065926			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874386	Green Published, gold, Green Submitted			2022-12-27	WOS:000322064300004
J	Aires, T; Serrao, EA; Kendrick, G; Duarte, CM; Arnaud-Haond, S				Aires, Tania; Serrao, Ester A.; Kendrick, Gary; Duarte, Carlos M.; Arnaud-Haond, Sophie			Invasion Is a Community Affair: Clandestine Followers in the Bacterial Community Associated to Green Algae, Caulerpa racemosa, Track the Invasion Source	PLOS ONE			English	Article							POSIDONIA-OCEANICA DECLINE; TAXIFOLIA CHLOROPHYTA; NITROGEN-FIXATION; MARINE MACROALGAE; DIVERSITY; GROWTH; DNA; POLYMORPHISM; COLONIZATION; BRYOPSIDALES	Biological invasions rank amongst the most deleterious components of global change inducing alterations from genes to ecosystems. The genetic characteristics of introduced pools of individuals greatly influence the capacity of introduced species to establish and expand. The recently demonstrated heritability of microbial communities associated to individual genotypes of primary producers makes them a potentially essential element of the evolution and adaptability of their hosts. Here, we characterized the bacterial communities associated to native and non-native populations of the marine green macroalga Caulerpa racemosa through pyrosequencing, and explored their potential role on the strikingly invasive trajectory of their host in the Mediterranean. The similarity of endophytic bacterial communities from the native Australian range and several Mediterranean locations confirmed the origin of invasion and revealed distinct communities associated to a second Mediterranean variety of C. racemosa long reported in the Mediterranean. Comparative analysis of these two groups demonstrated the stability of the composition of bacterial communities through the successive steps of introduction and invasion and suggested the vertical transmission of some major bacterial OTUs. Indirect inferences on the taxonomic identity and associated metabolism of bacterial lineages showed a striking consistency with sediment upheaval conditions associated to the expansion of their invasive host and to the decline of native species. These results demonstrate that bacterial communities can be an effective tracer of the origin of invasion and support their potential role in their eukaryotic host's adaptation to new environments. They put forward the critical need to consider the 'meta-organism' encompassing both the host and associated micro-organisms, to unravel the origins, causes and mechanisms underlying biological invasions.	[Aires, Tania; Serrao, Ester A.] Univ Algarve, Ctr Marine Sci, Faro, Portugal; [Kendrick, Gary; Duarte, Carlos M.] Univ Western Australia, Sch Plant Biol, Crawley, Australia; [Duarte, Carlos M.] Inst Mediterrani Estudis Avancats, Dept Global Change Res, Esporles, Mallorca, Spain; [Arnaud-Haond, Sophie] IFREMER, Ctr Bretagne, F-29280 Plouzane, France	Universidade do Algarve; University of Western Australia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Ifremer; Universite de Bretagne Occidentale	Arnaud-Haond, S (corresponding author), IFREMER, Technopole Brest Iroise, Plouzane, France.	sarnaud@ifremer.fr	Serrao, Ester A/C-6686-2012; Duarte Quesada, Carlos Manuel/ABD-6208-2021; Duarte, Carlos M/A-7670-2013; Kendrick, Gary Andrew/B-3460-2011; Arnaud-Haond, Sophie/B-2479-2008; Aires, Tania/M-8306-2013	Serrao, Ester A/0000-0003-1316-658X; Duarte, Carlos M/0000-0002-1213-1361; Kendrick, Gary Andrew/0000-0002-0276-6064; Arnaud-Haond, Sophie/0000-0001-5814-8452; Aires, Tania/0000-0002-1964-6819	IBISA [PTDC / MAR / 64749 / 2006]; Portuguese Foundation for Science and Technology (FCT - Fundacao para a Cincia e Tecnologia); FEDER (Fundo Europeu de Desenvolvimento Regional); FSE (Fundo Social Europeu)	IBISA; Portuguese Foundation for Science and Technology (FCT - Fundacao para a Cincia e Tecnologia); FEDER (Fundo Europeu de Desenvolvimento Regional)(European Commission); FSE (Fundo Social Europeu)(European Social Fund (ESF))	This research was supported by the project IBISA (PTDC / MAR / 64749 / 2006) funded by the Portuguese Foundation for Science and Technology (FCT - Fundacao para a Cincia e Tecnologia) and FEDER (Fundo Europeu de Desenvolvimento Regional) and a PhD fellowship (TA) from FCT and FSE (Fundo Social Europeu) [http://www.fct.pt/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, PLANT SOIL, V240, P181, DOI 10.1023/A:1015840224564; Aires T, 2012, J PHYCOL, V48, P483, DOI 10.1111/j.1529-8817.2012.01124.x; Barott KL, 2011, ENVIRON MICROBIOL, V13, P1192, DOI 10.1111/j.1462-2920.2010.02419.x; Burke C, 2011, ISME J, V5, P590, DOI 10.1038/ismej.2010.164; Byers JE, 2010, ECOLOGY, V91, P1787, DOI 10.1890/09-0712.1; Calleja ML, 2007, ESTUAR COAST SHELF S, V73, P583, DOI 10.1016/j.ecss.2007.02.016; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Chisholm JRM, 2003, LIMNOL OCEANOGR, V48, P787, DOI 10.4319/lo.2003.48.2.0787; Chisholm JRM, 1996, NATURE, V381, P382, DOI 10.1038/381382a0; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; Coenye T, 2003, ENVIRON MICROBIOL, V5, P719, DOI 10.1046/j.1462-2920.2003.00471.x; Coombs JT, 2003, APPL ENVIRON MICROB, V69, P5603, DOI 10.1128/AEM.69.9.5603-5608.2003; Croft MT, 2005, NATURE, V438, P90, DOI 10.1038/nature04056; DRUMMOND AJ, 2011, ENEIOUS V 5 4; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Egan S, 2000, ENVIRON MICROBIOL, V2, P343, DOI 10.1046/j.1462-2920.2000.00107.x; Elbeltagy A, 2001, APPL ENVIRON MICROB, V67, P5285, DOI 10.1128/AEM.67.11.5285-5293.2001; Erwin PM, 2008, MOL ECOL, V17, P2937, DOI 10.1111/j.1365-294X.2008.03808.x; Facon B, 2008, CURR BIOL, V18, P363, DOI 10.1016/j.cub.2008.01.063; Forster P, 2001, MOL BIOL EVOL, V18, P1864, DOI 10.1093/oxfordjournals.molbev.a003728; Gihring TM, 2011, APPL ENVIRON MICROB, V77, P5955, DOI 10.1128/AEM.00220-11; Goecke F, 2013, PHYCOLOGIA, V52, P14, DOI 10.2216/12-24.1; Goecke F, 2010, MAR ECOL PROG SER, V409, P267, DOI 10.3354/meps08607; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gyaneshwar P, 2011, MOL PLANT MICROBE IN, V24, P1276, DOI 10.1094/MPMI-06-11-0172; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hollants J, 2013, MOL PHYLOGENET EVOL, V67, P608, DOI 10.1016/j.ympev.2013.02.025; Hollants J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2659; Hollants J, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-255; Holmer M, 2009, ESTUAR COAST, V32, P456, DOI 10.1007/s12237-009-9133-4; Joint I, 2007, PHILOS T R SOC B, V362, P1223, DOI 10.1098/rstb.2007.2047; KESHTACHERLIEBSON E, 1995, APPL ENVIRON MICROB, V61, P2439, DOI 10.1128/AEM.61.6.2439-2441.1995; Klein J, 2008, MAR POLLUT BULL, V56, P205, DOI 10.1016/j.marpolbul.2007.09.043; Lachnit T, 2011, ENVIRON MICROBIOL, V13, P655, DOI 10.1111/j.1462-2920.2010.02371.x; Lachnit T, 2009, AQUAT BIOL, V5, P181, DOI 10.3354/ab00149; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Marba N, 2007, ECOSYSTEMS, V10, P745, DOI 10.1007/s10021-007-9053-8; Marshall K, 2006, MICROB ECOL, V52, P302, DOI 10.1007/s00248-006-9060-x; Masson-Boivin C, 2009, TRENDS MICROBIOL, V17, P458, DOI 10.1016/j.tim.2009.07.004; Matsuo Y, 2003, ENVIRON MICROBIOL, V5, P25, DOI 10.1046/j.1462-2920.2003.00382.x; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; Meusnier I, 2004, EUR J PHYCOL, V39, P83, DOI 10.1080/09670260310001646531; Meusnier I, 2002, MOL ECOL, V11, P2317, DOI 10.1046/j.1365-294X.2002.01627.x; Meusnier I, 2001, MOL ECOL, V10, P931, DOI 10.1046/j.1365-294X.2001.01245.x; Nakanishi K, 1996, J PHYCOL, V32, P479, DOI 10.1111/j.0022-3646.1996.00479.x; Oliveros J.C., 2007, VENNY INTERACTIVE TO; OROSSICHLER M, 2006, MODERN SOIL MICROBIO, P355; Pini F, 2011, GENES-BASEL, V2, P1017, DOI 10.3390/genes2041017; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; PROVASOLI L, 1980, J PHYCOL, V16, P196, DOI 10.1111/j.1529-8817.1980.tb03019.x; Sauvage T, 2013, PHYCOLOGIA, V52, P6, DOI 10.2216/11-116.1; Stachowicz JJ, 2002, P NATL ACAD SCI USA, V99, P15497, DOI 10.1073/pnas.242437499; STRATIL SB, 2013, MICROBIOL OPEN SN, V2, P2045; Terrados J, 1999, AQUAT BOT, V65, P175, DOI 10.1016/S0304-3770(99)00039-X; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tujula NA, 2010, ISME J, V4, P301, DOI 10.1038/ismej.2009.107; Verlaque M, 2003, EUR J PHYCOL, V38, P325, DOI 10.1080/09670260310001612592; Wallentinus I, 2007, MAR POLLUT BULL, V55, P323, DOI 10.1016/j.marpolbul.2006.11.010; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weinberger F, 2007, J PHYCOL, V43, P235, DOI 10.1111/j.1529-8817.2007.00329.x; Zhao GY, 2012, ECOL ENG, V42, P107, DOI 10.1016/j.ecoleng.2012.02.007	65	48	48	5	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68429	10.1371/journal.pone.0068429	http://dx.doi.org/10.1371/journal.pone.0068429			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874625	Green Published, gold			2022-12-27	WOS:000322064300034
J	Hsu, TW; Lu, HJ; Wei, CK; Yin, WY; Chang, CM; Chiou, WY; Lee, MS; Lin, HY; Su, YC; Hung, SK				Hsu, Ta-Wen; Lu, Hsin-Ju; Wei, Chang-Kuo; Yin, Wen-Yao; Chang, Chun-Ming; Chiou, Wen-Yen; Lee, Moon-Sing; Lin, Hon-Yi; Su, Yu-Chieh; Hung, Shih-Kai			Clinical and Pathologic Factors Affecting Lymph Node Yields in Colorectal Cancer	PLOS ONE			English	Article							COLON-CANCER; PROGNOSTIC-SIGNIFICANCE; RESECTION SPECIMENS; RETRIEVAL; NUMBER; SURVIVAL; TUMOR	Objective: Lymph node yield is recommended as a benchmark of quality care in colorectal cancer. The objective of this study was to evaluate the impact of various factors upon lymph node yield and to identify independent factors associated with lymph node harvest. Materials and Methods: The records of 162 patients with Stage I to Stage III colorectal cancers seen in one institution were reviewed. These patients underwent radical surgery as definitive therapy; high-risk patients then received adjuvant treatment. Pathologic and demographic data were recorded and analyzed. The subgroup analysis of lymph node yields was determined using a t-test and analysis of variants. Linear regression model and multivariable analysis were used to perform potential confounding and predicting variables. Results: Five variables had significant association with lymph node yield after adjustment for other factors in a multiple linear regression model. These variables were: tumor size, surgical method, specimen length, and individual surgeon and pathologist. The model with these five significant variables interpreted 44.4% of the variation. Conclusions: Patients, tumor characteristics and surgical variables all influence the number of lymph nodes retrieved. Physicians are the main gatekeepers. Adequate training and optimized guidelines could greatly improve the quality of lymph node yields.	[Hsu, Ta-Wen; Wei, Chang-Kuo; Yin, Wen-Yao; Chang, Chun-Ming] Buddhist Dalin Tzu Chi Gen Hosp, Dept Gen Surg, Chiayi, Taiwan; [Lu, Hsin-Ju] Buddhist Dalin Tzu Chi Gen Hosp, Teaching Div, Chiayi, Taiwan; [Chiou, Wen-Yen; Lee, Moon-Sing; Lin, Hon-Yi; Hung, Shih-Kai] Buddhist Dalin Tzu Chi Gen Hosp, Dept Radiat Oncol, Chiayi, Taiwan; [Lee, Moon-Sing; Lin, Hon-Yi; Su, Yu-Chieh; Hung, Shih-Kai] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Su, Yu-Chieh] Buddhist Dalin Tzu Chi Gen Hosp, Dept Hematol Oncol, Chiayi, Taiwan	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital	Hung, SK (corresponding author), Buddhist Dalin Tzu Chi Gen Hosp, Dept Radiat Oncol, Chiayi, Taiwan.	oncology158@yahoo.com.tw	Su, Yu-Chieh/M-7867-2013	Su, Yu-Chieh/0000-0002-1771-9017; Hung, Shih-Kai/0000-0002-4945-528X; Chiou, Wen-Yen/0000-0002-5541-6834	Buddhist Dalin Tzu Chi General Hospital [DTCRD101(2)-I-20]	Buddhist Dalin Tzu Chi General Hospital	This work was supported by the Buddhist Dalin Tzu Chi General Hospital (DTCRD101(2)-I-20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbas A, 2011, J SURG RES, V170, pE41, DOI 10.1016/j.jss.2011.03.055; Baxter NN, 2005, J NATL CANCER I, V97, P219, DOI 10.1093/jnci/dji020; Berberoglu U, 2004, HEPATO-GASTROENTEROL, V51, P1689; Bilimoria KY, 2008, J NATL CANCER I, V100, P1310, DOI 10.1093/jnci/djn293; Chang YJ, 2012, SURG ONCOL, V21, pE75, DOI 10.1016/j.suronc.2011.12.003; Chen Li-Tzong, 2004, Clin Colorectal Cancer, V4, P196, DOI 10.3816/CCC.2004.n.020; Chou JF, 2010, CANCER-AM CANCER SOC, V116, P2560, DOI 10.1002/cncr.25032; Chung KP, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-27; Huang CW, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-76; Le Voyer TE, 2003, J CLIN ONCOL, V21, P2912, DOI 10.1200/JCO.2003.05.062; Leung AM, 2011, J SURG RES, V168, P224, DOI 10.1016/j.jss.2009.09.001; Mekenkamp LJM, 2009, AM J SURG PATHOL, V33, P1547, DOI 10.1097/PAS.0b013e3181b2e01f; Nash GM, 2011, ANN SURG, V253, P318, DOI 10.1097/SLA.0b013e318204e637; Nicholl MB, 2009, AM SURGEON, V75, P887; Norwood MGA, 2010, COLORECTAL DIS, V12, P304, DOI 10.1111/j.1463-1318.2009.01788.x; Sarli L, 2005, EUR J CANCER, V41, P272, DOI 10.1016/j.ejca.2004.10.010; Storli K, 2011, APMIS, V119, P127, DOI 10.1111/j.1600-0463.2010.02702.x; Svec A, 2006, EJSO-EUR J SURG ONC, V32, P426, DOI 10.1016/j.ejso.2006.02.002; Thorn C C, 2004, Colorectal Dis, V6, P356, DOI 10.1111/j.1463-1318.2004.00670.x; Wright FC, 2003, ANN SURG ONCOL, V10, P903, DOI 10.1245/ASO.2003.01.012	20	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68526	10.1371/journal.pone.0068526	http://dx.doi.org/10.1371/journal.pone.0068526			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874656	Green Published, gold, Green Submitted			2022-12-27	WOS:000322064300043
J	Wang, KW; Shu, ZK; Cai, L; Wu, JQ; Wei, W				Wang, Ke-wei; Shu, Zhan-kun; Cai, Le; Wu, Jun-Qing; Wei, Wei			Assessment of the Magnitude of Contextual and Individual Demographic Effects on Diabetes Mellitus and Glucose Intolerance in Rural Southwest China: A Multilevel Analysis	PLOS ONE			English	Article							BODY-MASS INDEX; RISK-FACTORS; SOCIOECONOMIC-STATUS; CARDIOVASCULAR-DISEASE; ALCOHOL-CONSUMPTION; CIGARETTE-SMOKING; PHYSICAL-ACTIVITY; PREVALENCE; POPULATION; HEALTH	Objective: This study aimed to determine the contribution of individual and contextual socioeconomic status (SES) to the prevalence of diabetes mellitus and glucose intolerance in the adult population in rural southwest China. Methods: A population-based cross-sectional study of diabetes was performed in 4801(2152 men) Chinese adults (>= 25 years old). Multilevel logistic regression model was used to examine the association between individuals' and townships' variables and the prevalence of diabetes mellitus and glucose intolerance. Results: The age-and gender-standardized prevalence of diabetes mellitus and glucose intolerance were 7.1% (3.6% for undiagnosed) and 8.8% in adults aged >= 25 years, respectively, and increasing with age. Females were more likely to develop diabetes than males. The probability of developing diabetes increased with BMI. Both contextual and individual educational level and yearly household income were found to be negatively associated with the prevalence of diabetes. Residence in communities with a higher percentage of ethnic minorities was associated with higher prevalence of diabetes. Smoking had a protective effect for diabetes, drinking had a positive association with diabetes mellitus and glucose intolerance. Conclusions: Diabetes mellitus and glucose intolerance are common in rural adults of southwest China by international standards. These results indicate that diabetes mellitus has become a major public health problem in rural areas in southwest China, and strategies aimed at the prevention and treatment of diabetes mellitus and glucose intolerance are needed.	[Wang, Ke-wei; Wu, Jun-Qing; Wei, Wei] Fudan Univ, Sch Publ Hlth, Shanghai 200433, Peoples R China; [Wang, Ke-wei; Wu, Jun-Qing] WHO Collaborating Ctr Res Human Reprod Unit Epide, Shanghai Inst Planned Parenthood Res, Dept Epidemiol & Social Sci RH, Shanghai, Peoples R China; [Shu, Zhan-kun] Luo Ping Cty Hosp, Yunan, Peoples R China; [Cai, Le] Kunming Med Univ, Sch Publ Hlth, Kunming, Peoples R China	Fudan University; Kunming Medical University	Cai, L (corresponding author), Kunming Med Univ, Sch Publ Hlth, Kunming, Peoples R China.	caile002@hotmail.com; wkwllj168@gmail.com			National Natural Science Funds of China [30960335]; Yunnan Provincial Natural Science Funds [2008CD115]	National Natural Science Funds of China(National Natural Science Foundation of China (NSFC)); Yunnan Provincial Natural Science Funds	This study was supported by the National Natural Science Funds of China (grant number 30960335) and Yunnan Provincial Natural Science Funds (grant number 2008CD115), and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajani UA, 2000, ARCH INTERN MED, V160, P1025, DOI 10.1001/archinte.160.7.1025; Alwan A, 1992, World Health Stat Q, V45, P355; [Anonymous], 1981, Zhonghua Nei Ke Za Zhi, V20, P678; BARKER DJP, 1982, DIABETOLOGIA, V22, P421, DOI 10.1007/BF00282583; Borrell LN, 2006, AM J PUBLIC HEALTH, V96, P1637, DOI 10.2105/AJPH.2005.072884; CHEAH J S, 1990, Annals Academy of Medicine Singapore, V19, P501; Cockram C. S., 2000, Hong Kong Medical Journal, V6, P43; Connolly V, 2000, J EPIDEMIOL COMMUN H, V54, P173, DOI 10.1136/jech.54.3.173; Cowie CC, 2006, DIABETES CARE, V29, P1263, DOI 10.2337/dc06-0062; Cutter J, 2001, B WORLD HEALTH ORGAN, V79, P908; Dijkstra S, 2003, Ned Tijdschr Geneeskd, V147, P2146; Dong Y, 2005, DIABETIC MED, V22, P1427, DOI 10.1111/j.1464-5491.2005.01658.x; Dowse Gary K., 1992, World Health Statistics Quarterly, V45, P360; Ehrenberg HM, 2004, AM J OBSTET GYNECOL, V191, P964, DOI 10.1016/j.ajog.2004.05.052; Green C, 2003, SOC SCI MED, V57, P551, DOI 10.1016/S0277-9536(02)00380-5; Guize L, 2008, B ACAD NAT MED PARIS, V192, P1707, DOI 10.1016/S0001-4079(19)32638-X; Gulliford MC, 2003, BMC HEALTH SERV RES, V3, DOI 10.1186/1472-6963-3-4; HOLBROOK TL, 1990, AM J EPIDEMIOL, V132, P902, DOI 10.1093/oxfordjournals.aje.a115733; Janus ED, 2000, DIABETIC MED, V17, P741, DOI 10.1046/j.1464-5491.2000.00376.x; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; KING H, 1993, DIABETES CARE, V16, P157, DOI 10.2337/diacare.16.1.157; Ko GTC, 2001, EUR J EPIDEMIOL, V17, P289, DOI 10.1023/A:1017935707807; Krakoff J, 2003, DIABETES CARE, V26, P76, DOI 10.2337/diacare.26.1.76; Kraut A, 2001, DIABETES CARE, V24, P64, DOI 10.2337/diacare.24.1.64; Kroenke C, 2008, SOC SCI MED, V66, P31, DOI 10.1016/j.socscimed.2007.07.018; Larsson D, 1999, SCAND J PUBLIC HEALT, V27, P101, DOI 10.1177/14034948990270020901; Li GW, 1996, CHINESE MED J-PEKING, V109, P599; Li Li-ming, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P478; Li Y, 2006, AM J HYPERTENS, V19, P448, DOI 10.1016/j.amjhyper.2005.08.014; Lu FH, 1998, DIABETIC MED, V15, P564, DOI 10.1002/(SICI)1096-9136(199807)15:7<564::AID-DIA615>3.0.CO;2-H; McCance DR, 1997, DIABETOLOGIA, V40, P247, DOI 10.1007/s001250050671; Muntner P, 2005, AM J PUBLIC HEALTH, V95, P1631, DOI 10.2105/AJPH.2004.044743; Nakagami T, 2003, DIABETOLOGIA, V46, P1063, DOI 10.1007/s00125-003-1158-9; Pan X, 1997, Zhonghua Nei Ke Za Zhi, V36, P384; Pan XR, 1997, DIABETES CARE, V20, P1664, DOI 10.2337/diacare.20.11.1664; Plotnikoff RC, 2006, MED SCI SPORT EXER, V38, P1526, DOI 10.1249/01.mss.0000228937.86539.95; Rathmann W, 2004, DIABETES CARE, V27, P2568, DOI 10.2337/diacare.27.10.2568; Reynolds K, 2007, OBESITY, V15, P10, DOI 10.1038/oby.2007.527; RIMM EB, 1995, BRIT MED J, V310, P555, DOI 10.1136/bmj.310.6979.555; Satman I, 2002, DIABETES CARE, V25, P1551, DOI 10.2337/diacare.25.9.1551; Schlundt DG, 2006, J AMBUL CARE MANAG, V29, P125, DOI 10.1097/00004479-200604000-00005; SCRAGG R, 1991, NEW ZEAL MED J, V104, P395; Tang XL, 2005, SUBST USE MISUSE, V40, P687, DOI 10.1081/JA-200055382; Tsumura K, 1999, DIABETES CARE, V22, P1432, DOI 10.2337/diacare.22.9.1432; Ujcic-Voortman JK, 2009, EUR J PUBLIC HEALTH, V19, P511, DOI 10.1093/eurpub/ckp096; Wei M, 2000, DIABETES CARE, V23, P18, DOI 10.2337/diacare.23.1.18; World Health Organization, 1999, GEN DIAB NONC DIS RI; Xiang HD, 1998, CHINESE J DIABETES, P131; Yang GH, 2008, LANCET, V372, P1697, DOI 10.1016/S0140-6736(08)61366-5; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292	50	3	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68553	10.1371/journal.pone.0068553	http://dx.doi.org/10.1371/journal.pone.0068553			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	186SF	23874667	Green Published, gold, Green Submitted			2022-12-27	WOS:000322064300048
J	Cilfone, NA; Perry, CR; Kirschner, DE; Linderman, JJ				Cilfone, Nicholas A.; Perry, Cory R.; Kirschner, Denise E.; Linderman, Jennifer J.			Multi-Scale Modeling Predicts a Balance of Tumor Necrosis Factor-alpha and Interleukin-10 Controls the Granuloma Environment during Mycobacterium tuberculosis Infection	PLOS ONE			English	Article							NF-KAPPA-B; T-CELL; TNF-ALPHA; IN-VIVO; IL-10 PRODUCTION; GENE-EXPRESSION; INTRACELLULAR PATHOGENS; PULMONARY TUBERCULOSIS; MACROPHAGE ACTIVATION; RECEPTOR EXPRESSION	Interleukin-10 (IL-10) and tumor necrosis factor-alpha (TNF-alpha) are key anti-and pro-inflammatory mediators elicited during the host immune response to Mycobacterium tuberculosis (Mtb). Understanding the opposing effects of these mediators is difficult due to the complexity of processes acting across different spatial (molecular, cellular, and tissue) and temporal (seconds to years) scales. We take an in silico approach and use multi-scale agent based modeling of the immune response to Mtb, including molecular scale details for both TNF-alpha and IL-10. Our model predicts that IL-10 is necessary to modulate macrophage activation levels and to prevent host-induced tissue damage in a granuloma, an aggregate of cells that forms in response to Mtb. We show that TNF-alpha and IL-10 parameters related to synthesis, signaling, and spatial distribution processes control concentrations of TNF-alpha and IL-10 in a granuloma and determine infection outcome in the long-term. We devise an overall measure of granuloma function based on three metrics - total bacterial load, macrophage activation levels, and apoptosis of resting macrophages - and use this metric to demonstrate a balance of TNF-alpha and IL-10 concentrations is essential to Mtb infection control, within a single granuloma, with minimal host-induced tissue damage. Our findings suggest that a balance of TNF-alpha and IL-10 defines a granuloma environment that may be beneficial for both host and pathogen, but perturbing the balance could be used as a novel therapeutic strategy to modulate infection outcomes.	[Cilfone, Nicholas A.; Linderman, Jennifer J.] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA; [Perry, Cory R.; Kirschner, Denise E.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Kirschner, DE (corresponding author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.	kirschne@umich.edu; linderma@umich.edu			National Institutes of Health [R01 EB012579, R01 HL110811]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB012579] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by National Institutes of Health (nih.gov) Grants R01 EB012579 and R01 HL110811 (JJL and DEK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbanoma G, 2012, J IMMUNOL, V188, P1307, DOI 10.4049/jimmunol.1100625; Algood HMS, 2004, J IMMUNOL, V173, P3287; Algood HMS, 2004, J IMMUNOL, V172, P6846, DOI 10.4049/jimmunol.172.11.6846; Balcewicz-Sablinska MK, 1999, J INFECT DIS, V180, P1230, DOI 10.1086/315011; BARAKAT HZ, 1966, J HEAT TRANSF, V88, P421, DOI 10.1115/1.3691590; Beamer GL, 2008, J IMMUNOL, V181, P5545, DOI 10.4049/jimmunol.181.8.5545; Bird R.B., 1994, TRANSPORT PHENOMENA; Bogdan C, 1991, J EXP MED, P174; Bouabe H, 2011, J IMMUNOL, V187, P3165, DOI 10.4049/jimmunol.1101477; Brennan FM, 2008, EUR J IMMUNOL, V38, P1106, DOI 10.1002/eji.200737821; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Chabot V, 2006, J LEUKOCYTE BIOL, V79, P767, DOI 10.1189/jlb.0804464; Chakravarty SD, 2008, INFECT IMMUN, V76, P916, DOI 10.1128/IAI.01011-07; Cheeran MCJ, 2003, J VIROL, V77, P4502, DOI 10.1128/JVI.77.8.4502-4515.2003; Comas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000600; Cyktor JC, 2011, INFECT IMMUN, V79, P2964, DOI 10.1128/IAI.00047-11; Dagvadorj J, 2008, INNATE IMMUN-LONDON, V14, P109, DOI 10.1177/1753425908089618; Daley CL, 2010, AM J RESP CRIT CARE, V181, P550, DOI 10.1164/rccm.201001-0140UP; DANNENBERG AM, 1989, REV INFECT DIS, V11, pS369; Davis JM, 2008, IMMUNITY, V28, P146, DOI 10.1016/j.immuni.2008.01.002; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Denys A, 2002, J IMMUNOL, V168, P4837, DOI 10.4049/jimmunol.168.10.4837; Duell BL, 2012, FEMS IMMUNOL MED MIC, V64, P295, DOI 10.1111/j.1574-695X.2012.00931.x; Egen JG, 2008, IMMUNITY, V28, P271, DOI 10.1016/j.immuni.2007.12.010; Fallahi-Sichani M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00170; Fallahi-Sichani M, 2012, J IMMUNOL, V188, P3169, DOI 10.4049/jimmunol.1103298; Fallahi-Sichani M, 2011, J IMMUNOL, V186, P3472, DOI 10.4049/jimmunol.1003299; Fallahi-Sichani M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000778; Fickenscher H, 2002, TRENDS IMMUNOL, V23, P89, DOI 10.1016/S1471-4906(01)02149-4; Figueiredo AS, 2009, FEBS J, V276, P3454, DOI 10.1111/j.1742-4658.2009.07068.x; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Flynn JL, 2011, MUCOSAL IMMUNOL, V4, P271, DOI 10.1038/mi.2011.14; Flynn JL, 2004, TUBERCULOSIS, V84, P93, DOI 10.1016/j.tube.2003.08.010; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Flynn JL, 2006, MICROBES INFECT, V8, P1179, DOI 10.1016/j.micinf.2005.10.033; Ford CB, 2011, NAT GENET, V43, P482, DOI 10.1038/ng.811; Giacomini E, 2001, J IMMUNOL, V166, P7033, DOI 10.4049/jimmunol.166.12.7033; Gideon HP, 2011, IMMUNOL RES, V50, P202, DOI 10.1007/s12026-011-8229-7; Grosset J, 2003, ANTIMICROB AGENTS CH, V47, P833, DOI 10.1128/AAC.47.3.833-836.2003; Guo ZY, 2008, J THEOR BIOL, V255, P163, DOI 10.1016/j.jtbi.2008.08.008; Gutierrez MG, 2008, J IMMUNOL, V181, P2651, DOI 10.4049/jimmunol.181.4.2651; Harris J, 2008, J INFECT DIS, V198, P1842, DOI 10.1086/593174; Hart PH, 1996, J IMMUNOL, V157, P3672; Higgins DM, 2009, TUBERCULOSIS, V89, P149, DOI 10.1016/j.tube.2009.01.001; Hosokawa Y, 2009, J PERIODONTAL RES, V44, P225, DOI 10.1111/j.1600-0765.2008.01124.x; Ikeda T, 2002, J LEUKOCYTE BIOL, V72, P1198; JOYCE DA, 1994, EUR J IMMUNOL, V24, P2699, DOI 10.1002/eji.1830241119; Jung YJ, 2003, IMMUNOLOGY, V109, P295, DOI 10.1046/j.1365-2567.2003.01645.x; Junqueira-Kipnis AP, 2005, IMMUNOLOGY, V115, P246, DOI 10.1111/j.1365-2567.2005.02136.x; Keane J, 2002, TUBERCULOSIS, V82, P55, DOI 10.1054/tube.2002.0322; Lang R, 2002, J IMMUNOL, V169, P2253, DOI 10.4049/jimmunol.169.5.2253; Lauffenburger D. A., 1993, RECEPTORS MODELS BIN; Lin PL, 2006, INFECT IMMUN, V74, P3790, DOI 10.1128/IAI.00064-06; Lin PL, 2010, J IMMUNOL, V185, P15, DOI 10.4049/jimmunol.0903856; Lin PL, 2010, ARTHRITIS RHEUM-US, V62, P340, DOI 10.1002/art.27271; Lucas TA, 2008, SIAM J NUMER ANAL, V46, P3113, DOI 10.1137/070701595; Ma J, 2003, CELL MOL LIFE SCI, V60, P2334, DOI 10.1007/s00018-003-3020-0; MarfaingKoka A, 1996, INT IMMUNOL, V8, P1587, DOI 10.1093/intimm/8.10.1587; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Marino S, 2011, J THEOR BIOL, V280, P50, DOI 10.1016/j.jtbi.2011.03.022; Marino S, 2010, J THEOR BIOL, V265, P586, DOI 10.1016/j.jtbi.2010.05.012; Mege JL, 2006, LANCET INFECT DIS, V6, P557, DOI 10.1016/S1473-3099(06)70577-1; Meyaard L, 1996, J IMMUNOL, V156, P2776; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Moya C, 2011, IET SYST BIOL, V5, P15, DOI 10.1049/iet-syb.2009.0060; Murray PJ, 2005, P NATL ACAD SCI USA, V102, P8686, DOI 10.1073/pnas.0500419102; Newton SM, 2006, P NATL ACAD SCI USA, V103, P15594, DOI 10.1073/pnas.0604283103; North RJ, 1998, CLIN EXP IMMUNOL, V113, P55, DOI 10.1046/j.1365-2249.1998.00636.x; O'Garra A, 2004, J CLIN INVEST, V114, P1, DOI [10.1172/JCI200423215.1372, DOI 10.1172/JCI200423215.1372]; O'Garra A, 2008, IMMUNOL REV, V223, P114, DOI 10.1111/j.1600-065X.2008.00635.x; ORME IM, 1993, J IMMUNOL, V151, P518; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Pitt JM, 2012, J IMMUNOL, V189, P4079, DOI 10.4049/jimmunol.1201061; PLATZER C, 1995, INT IMMUNOL, V7, P517, DOI 10.1093/intimm/7.4.517; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; Ray JCJ, 2009, J IMMUNOL, V182, P3706, DOI 10.4049/jimmunol.0802297; Redford PS, 2011, MUCOSAL IMMUNOL, V4, P261, DOI 10.1038/mi.2011.7; Redford PS, 2010, EUR J IMMUNOL, V40, P2200, DOI 10.1002/eji.201040433; Redpath S, 2001, TRENDS MICROBIOL, V9, P86, DOI 10.1016/S0966-842X(00)01919-3; Riley JK, 1999, J BIOL CHEM, V274, P16513, DOI 10.1074/jbc.274.23.16513; Roach DR, 2001, SCAND J IMMUNOL, V54, P163, DOI 10.1046/j.1365-3083.2001.00952.x; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Russell DG, 2010, SCIENCE, V328, P852, DOI 10.1126/science.1184784; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Saunders BM, 2004, CLIN EXP IMMUNOL, V137, P279, DOI 10.1111/j.1365-2249.2004.02518.x; Schreiber T, 2009, J IMMUNOL, V183, P1301, DOI 10.4049/jimmunol.0803567; Shaler CR, 2011, AM J PATHOL, V178, P1622, DOI 10.1016/j.ajpath.2010.12.022; Shaw TC, 2000, CYTOKINE, V12, P483, DOI 10.1006/cyto.1999.0586; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Smallie T, 2010, J EXP MED, V207, P2081, DOI 10.1084/jem.20100414; TAN JC, 1993, J BIOL CHEM, V268, P21053; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Theus SA, 2005, J INFECT DIS, V191, P453, DOI 10.1086/425936; Tsai MC, 2006, CELL MICROBIOL, V8, P218, DOI 10.1111/j.1462-5822.2005.00612.x; Turner J, 2002, J IMMUNOL, V169, P6343, DOI 10.4049/jimmunol.169.11.6343; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Vesosky B, 2010, J LEUKOCYTE BIOL, V87, P1153, DOI 10.1189/jlb.1109742; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wallis RS, 2009, CURR OPIN INFECT DIS, V22, P403, DOI 10.1097/QCO.0b013e32832dda55; Walls RS, 2008, LANCET INFECT DIS, V8, P601, DOI 10.1016/S1473-3099(08)70227-5; WANIDWORANUN C, 1993, J IMMUNOL, V151, P6853; WEBERNORDT RM, 1994, J IMMUNOL, V153, P3734; Wei SHY, 2006, J INTERF CYTOK RES, V26, P281, DOI 10.1089/jir.2006.26.281; Wigginton JE, 2001, J IMMUNOL, V166, P1951, DOI 10.4049/jimmunol.166.3.1951; Wu KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030512; YSSEL H, 1992, J IMMUNOL, V149, P2378; Zhou ZG, 2007, CELL SIGNAL, V19, P1238, DOI 10.1016/j.cellsig.2006.12.013	112	82	83	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2013	8	7							e68680	10.1371/journal.pone.0068680	http://dx.doi.org/10.1371/journal.pone.0068680			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZN	23869227	Green Published, Green Submitted, gold			2022-12-27	WOS:000323110600026
J	Markova, S; Dufresne, F; Manca, M; Kotlik, P				Markova, Silvia; Dufresne, France; Manca, Marina; Kotlik, Petr			Mitochondrial Capture Misleads about Ecological Speciation in the Daphnia pulex Complex	PLOS ONE			English	Article							ASEXUAL SPECIES COMPLEX; HOLARCTIC PHYLOGEOGRAPHY; SYMPATRIC SPECIATION; CLONAL STRUCTURE; GLACIAL REFUGIA; DNA VARIATION; RECOMBINATION; INTROGRESSION; HYBRIDIZATION; POLYMORPHISM	The North American ecological species Daphnia pulicaria and Daphnia pulex are thought to have diverged from a common ancestor by adaptation to sympatric but ecologically distinct lake and pond habitats respectively. Based on mtDNA relationships, European D. pulicaria is considered a different species only distantly related to its North American counterpart, but both species share a lactate dehydrogenase (Ldh) allele F supposedly involved in lake adaptation in North America, and the same allele is also carried by the related Holarctic Daphnia tenebrosa. The correct inference of the species' ancestral relationships is therefore critical for understanding the origin of their adaptive divergence. Our species tree inferred from unlinked nuclear loci for D. pulicaria and D. pulex resolved the European and North American D. pulicaria as sister clades, and we argue that the discordant mtDNA gene tree is best explained by capture of D. pulex mtDNA by D. pulicaria in North America. The Ldh gene tree shows that F-class alleles in D. pulicaria and D. tenebrosa are due to common descent (as opposed to introgression), with D. tenebrosa alleles paraphyletic with respect to D. pulicaria alleles. That D. tenebrosa still segregates the ancestral and derived amino acids at the two sites distinguishing the pond and lake alleles suggests that D. pulicaria inherited the derived states from the D. tenebrosa ancestry. Our results suggest that some adaptations restricting the gene flow between D. pulicaria and D. pulex might have evolved in response to selection in ancestral environments rather than in the species' current sympatric habitats. The Arctic (D. tenebrosa) populations are likely to provide important clues about these issues.	[Markova, Silvia; Kotlik, Petr] Acad Sci Czech Republ, Lab Mol Ecol, Inst Anim Physiol & Genet, Libechov, Czech Republic; [Dufresne, France] Univ Quebec Rimouski, Dept Biol, Ctr Etud Nord, Quebec City, PQ, Canada; [Manca, Marina] CNR Ist Studio Ecosistemi, Verbania, Italy	Czech Academy of Sciences; Institute of Animal Physiology & Genetics of the Czech Academy of Sciences; University of Quebec; Universite du Quebec a Rimouski; Consiglio Nazionale delle Ricerche (CNR); Istituto per lo Studio degli Ecosistemi (ISE-CNR)	Kotlik, P (corresponding author), Acad Sci Czech Republ, Lab Mol Ecol, Inst Anim Physiol & Genet, Libechov, Czech Republic.	kotlik@iapg.cas.cz	Kotlík, Petr/AAP-1342-2021; Markova, Silvia/G-3875-2014; Kotlik, Petr/B-4633-2009	Kotlík, Petr/0000-0001-9429-0667; Kotlik, Petr/0000-0001-9429-0667	Academy of Sciences of the Czech Republic [KJB600450901, RVO: 67985904]; Natural Sciences and Engineering Research Council of Canada	Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The study was supported by grants from the Academy of Sciences of the Czech Republic to SM and PK (grant numbers KJB600450901, RVO: 67985904). Additional support to FD was provided by the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilee R, 2011, J EVOLUTION BIOL, V24, P2663, DOI 10.1111/j.1420-9101.2011.02392.x; BENZIE JAH, 2005, CLADOCERA GENUS DAPH, P376; Bolnick DI, 2007, ANNU REV ECOL EVOL S, V38, P459, DOI 10.1146/annurev.ecolsys.38.091206.095804; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; Cerny M, 1999, LIMNOL OCEANOGR, V44, P1381, DOI 10.4319/lo.1999.44.6.1381; CERNY M, 1995, THESIS CHARLES U PRA, P88542; Clarke B, 1996, PHILOS T R SOC B, V351, P773, DOI 10.1098/rstb.1996.0072; Colbourne JK, 1998, BIOL J LINN SOC, V65, P347, DOI 10.1006/bijl.1998.0251; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Coyne J.A., 2004, SPECIATION; Crease TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046620; Crease TJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-212; Cristescu ME, 2012, MOL ECOL, V21, P1411, DOI 10.1111/j.1365-294X.2011.05465.x; Cristescu ME, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-268; Cronn R, 2002, THEOR APPL GENET, V104, P482, DOI 10.1007/s001220100741; Dudycha JL, 2004, FRESHWATER BIOL, V49, P505, DOI 10.1111/j.1365-2427.2004.01201.x; Dudycha JL, 2003, OECOLOGIA, V135, P555, DOI 10.1007/s00442-003-1230-7; Dudycha JL, 1999, EVOLUTION, V53, P1744, DOI 10.1111/j.1558-5646.1999.tb04559.x; Dufresne F, 1997, P ROY SOC B-BIOL SCI, V264, P201, DOI 10.1098/rspb.1997.0028; DUFRESNE F, 1994, P ROY SOC B-BIOL SCI, V258, P141, DOI 10.1098/rspb.1994.0154; DUFRESNE F, 1995, HEREDITY, V75, P45, DOI 10.1038/hdy.1995.102; Dufresne F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020049; Gavrilets S, 2003, EVOLUTION, V57, P2197; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Glemet H, 1998, MOL ECOL, V7, P1655, DOI 10.1046/j.1365-294x.1998.00494.x; Good JM, 2008, MOL ECOL, V17, P1313, DOI 10.1111/j.1365-294X.2007.03640.x; Haag CR, 2009, GENETICS, V182, P313, DOI 10.1534/genetics.109.101147; HEBERT PDN, 1993, HEREDITY, V70, P148, DOI 10.1038/hdy.1993.24; Heier CR, 2009, LIMNOL OCEANOGR, V54, P492, DOI 10.4319/lo.2009.54.2.0492; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hey J, 1997, GENETICS, V145, P833; HILTON H, 1994, EVOLUTION, V48, P1900, DOI 10.1111/j.1558-5646.1994.tb02222.x; Holmes EC, 1999, MOL BIOL EVOL, V16, P405, DOI 10.1093/oxfordjournals.molbev.a026121; HRBACKOVAESSLOV.M, 1966, INT REV GESAMTEN HYD, V48, P325; Hrbaek J, 1977, AQUATIC MICROBIAL CO, P305; Jordal BH, 2006, MOL ECOL, V15, P2935, DOI 10.1111/j.1365-294X.2006.02993.x; Llopart A, 2005, GENETICS, V171, P197, DOI 10.1534/genetics.104.033597; MADDISON DR, 2003, MACCLADE ANAL PHYLOG; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Maddison WP, 2011, MESQUITE MODULAR SYS; Markova S, 2007, MOL PHYLOGENET EVOL, V44, P42, DOI 10.1016/j.ympev.2006.12.025; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2011, MOL ECOL RESOUR, V11, P943, DOI 10.1111/j.1755-0998.2011.03026.x; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; Mergeay J, 2008, MOL ECOL, V17, P1789, DOI 10.1111/j.1365-294X.2007.03679.x; Meyers SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036480; Omilian AR, 2008, MOL BIOL EVOL, V25, P2129, DOI 10.1093/molbev/msn164; Omilian AR, 2009, GENETICS, V182, P325, DOI 10.1534/genetics.108.099549; Pfrender ME, 2000, MOL ECOL, V9, P1717, DOI 10.1046/j.1365-294x.2000.01062.x; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; RICE WR, 1993, EVOLUTION, V47, P1637, DOI [10.2307/2410209, 10.1111/j.1558-5646.1993.tb01257.x]; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Rundle Howard D., 2004, P192; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; SMITH JM, 1992, J MOL EVOL, V34, P126; Toews DPL, 2012, MOL ECOL, V21, P3907, DOI 10.1111/j.1365-294X.2012.05664.x; Vergilino R, 2011, MOL ECOL, V20, P1191, DOI 10.1111/j.1365-294X.2011.05004.x; Weider LJ, 1999, MOL ECOL, V8, P1, DOI 10.1046/j.1365-294X.1999.00522.x; Weider LJ, 2003, MOL ECOL, V12, P463, DOI 10.1046/j.1365-294X.2003.01746.x; Weider LJ, 1997, HEREDITY, V78, P363; Weider LJ, 1999, EVOLUTION, V53, P777, DOI 10.1111/j.1558-5646.1999.tb05372.x; Xu S, 2012, MOL BIOL EVOL, V29, P763, DOI 10.1093/molbev/msr243; Zwickl DJ., 2006, THESIS	66	33	34	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2013	8	7							e69497	10.1371/journal.pone.0069497	http://dx.doi.org/10.1371/journal.pone.0069497			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZN	23869244	Green Published, gold			2022-12-27	WOS:000323110600044
J	Shen, LJ; Chen, C; Li, BF; Gao, J; Xia, YF				Shen, Lu-Jun; Chen, Chen; Li, Bo-Fei; Gao, Jin; Xia, Yun-Fei			High Weight Loss during Radiation Treatment Changes the Prognosis in Under-/Normal Weight Nasopharyngeal Carcinoma Patients for the Worse: A Retrospective Analysis of 2433 Cases	PLOS ONE			English	Article							LOCALLY ADVANCED HEAD; BODY-MASS INDEX; QUALITY-OF-LIFE; NECK-CANCER; RADIOTHERAPY; IMPACT; PREDICTORS; SURVIVAL; CHEMOTHERAPY; DIAGNOSIS	Background: Although weight loss is common in nasopharyngeal carcinoma (NPC) patients receiving radiotherapy, the prognostic influence of weight loss and its impact modified by body mass index (BMI) are still unclear. Methods: 2433 NPC patients receiving radical radiotherapy at Sun Yat-sen University Cancer Center from November, 2000 to December, 2004 were enrolled. Weight change during radiation treatment was categorized into high weight loss (HWL) and low weight loss (LWL). The associations of HWL with overall survival (OS) and disease-specific survival (DSS) were analyzed by Cox regression. Results: Among underweight patients, HWL was independently associated with poor OS (hazard ratio [HR], 2.06; 95% CI 1.36-3.11) and DSS (HR, 2.27; 95% CI 1.38-3.73), as compared with LWL, after adjusting for covariates. In normal weight patients, the impact of HWL on OS (HR, 1.47; 95% CI 1.19-1.80) and DSS (HR, 1.59; 95% CI 1.24-2.03) was moderate. Among overweight/obese patients, no significant association between HWL and OS (HR, 1.22; 95% CI 0.95-1.55), or DSS (HR, 1.23; 95% CI 0.93-1.64) was found. Conclusion: Except for overweight/obese patients, high weight loss during radiation treatment was independently associated with poor survival in NPC. This impact was more prominent in the underweight patient group.	[Shen, Lu-Jun; Chen, Chen; Li, Bo-Fei; Gao, Jin; Xia, Yun-Fei] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol Southern China, Guangzhou 510275, Guangdong, Peoples R China; [Gao, Jin; Xia, Yun-Fei] Sun Yat Sen Univ, Ctr Canc, Dept Radiat Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Shen, Lu-Jun; Chen, Chen; Li, Bo-Fei] Sun Yat Sen Univ, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Xia, YF (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol Southern China, Guangzhou 510275, Guangdong, Peoples R China.	xiayf@sysucc.org.cn	Shen, Lujun/GQQ-3457-2022		Hi-Tech Research and Development Program of China [2006AA02Z4B4]; National Natural Science Foundation of China [30770641, 31170805]	Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Hi-Tech Research and Development Program of China (No. 2006AA02Z4B4), and National Natural Science Foundation of China (No. 30770641; No. 31170805). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Beaver ME, 2001, OTOLARYNG HEAD NECK, V125, P645, DOI 10.1067/mhn.2001.120428; Canada Todd, 2002, Nutr Clin Pract, V17, P246, DOI 10.1177/0115426502017004246; Capuano G, 2008, HEAD NECK-J SCI SPEC, V30, P503, DOI 10.1002/hed.20737; Chan ATC, 2002, ANN ONCOL, V13, P1007, DOI 10.1093/annonc/mdf179; Cheng SH, 2001, INT J RADIAT ONCOL, V50, P717, DOI 10.1016/S0360-3016(01)01509-7; Couch M, 2007, HEAD NECK-J SCI SPEC, V29, P401, DOI 10.1002/hed.20447; Datema FR, 2011, ORAL ONCOL, V47, P910, DOI 10.1016/j.oraloncology.2011.06.510; Fang FM, 2010, J CLIN ONCOL, V28, P4384, DOI 10.1200/JCO.2010.28.8324; Ghadjar P, 2012, RADIOTHER ONCOL, V104, P213, DOI 10.1016/j.radonc.2012.05.004; He JR, 2012, HEAD NECK; Hu Jing-Ye, 2009, Ai Zheng, V28, P1043; Huang PY, 2013, EUR J CANCER, V49, P1923, DOI 10.1016/j.ejca.2013.01.027; Isenring EA, 2004, BRIT J CANCER, V91, P447, DOI 10.1038/sj.bjc.6601962; Kubrak C, 2012, HEAD NECK; Kwong DLW, 1997, INT J RADIAT ONCOL, V39, P703, DOI 10.1016/S0360-3016(97)00339-8; Larsson M, 2005, CANCER NURS, V28, P425, DOI 10.1097/00002820-200511000-00004; LEE AWM, 1992, INT J RADIAT ONCOL, V23, P261, DOI 10.1016/0360-3016(92)90740-9; Lee N, 2009, J CLIN ONCOL, V27, P3684, DOI 10.1200/JCO.2008.19.9109; Li G, 2013, HEAD NECK; Mao YP, 2009, INT J RADIAT ONCOL, V73, P1326, DOI 10.1016/j.ijrobp.2008.07.062; Meyer F, 2012, INT J RADIAT ONCOL, V82, P1454, DOI 10.1016/j.ijrobp.2011.04.022; Ng K, 2004, NUTR CANCER, V49, P156, DOI 10.1207/s15327914nc4902_6; Nourissat A, 2010, CANCER-AM CANCER SOC, V116, P2275, DOI 10.1002/cncr.25041; O'Shea D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008660; Pai PC, 2012, INT J RADIAT ONCOL, V83, pE93, DOI 10.1016/j.ijrobp.2011.11.071; Qiu C, 2011, NUTR CANCER, V63, P873, DOI 10.1080/01635581.2011.582223; Rabinovitch R, 2006, HEAD NECK-J SCI SPEC, V28, P287, DOI 10.1002/hed.20335; Ramakrishnan Y, 2007, CLIN OTOLARYNGOL, V32, P484, DOI 10.1111/j.1749-4486.2007.01543.x; Ravasco P, 2003, CLIN ONCOL-UK, V15, P443, DOI 10.1016/S0936-6555(03)00155-9; Salas S, 2008, RADIOTHER ONCOL, V87, P195, DOI 10.1016/j.radonc.2008.02.011; SHAM JST, 1990, BRIT J RADIOL, V63, P51, DOI 10.1259/0007-1285-63-745-51; Shen GP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036515; Sze HCK, 2012, ORAL ONCOL, V48, P162, DOI 10.1016/j.oraloncology.2011.08.019; Teitelbaum Daniel, 2005, Nutr Clin Pract, V20, P281, DOI 10.1177/0115426505020002281; van der Schueren MAEV, 1999, CANCER-AM CANCER SOC, V86, P519; Yu MC, 2002, SEMIN CANCER BIOL, V12, P421, DOI 10.1016/S1044579X02000858	37	44	54	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2013	8	7							e68660	10.1371/journal.pone.0068660	http://dx.doi.org/10.1371/journal.pone.0068660			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZN	23869226	Green Published, Green Submitted, gold			2022-12-27	WOS:000323110600025
J	Wright, DF; Stigall, AL				Wright, David F.; Stigall, Alycia L.			Geologic Drivers of Late Ordovician Faunal Change in Laurentia: Investigating Links between Tectonics, Speciation, and Biotic Invasions	PLOS ONE			English	Article							NORTH-AMERICA; RICHMONDIAN INVASION; MIDDLE ORDOVICIAN; EVOLUTION; EASTERN; STRATIGRAPHY; BIOGEOGRAPHY; BRACHIOPODS; EXTINCTION; TRILOBITES	Geologic process, including tectonics and global climate change, profoundly impact the evolution of life because they have the propensity to facilitate episodes of biogeographic differentiation and influence patterns of speciation. We investigate causal links between a dramatic faunal turnover and two dominant geologic processes operating within Laurentia during the Late Ordovician: the Taconian Orogeny and GICE related global cooling. We utilize a novel approach for elucidating the relationship between biotic and geologic changes using a time-stratigraphic, species-level evolutionary framework for articulated brachiopods from North America. Phylogenetic biogeographic analyses indicate a fundamental shift in speciation mode-from a vicariance to dispersal dominated macroevolutionary regime -across the boundary between the Sandbian to Katian Stages. This boundary also corresponds to the onset of renewed intensification of tectonic activity and mountain building, the development of an upwelling zone that introduced cool, nutrient-rich waters into the epieric seas of eastern Laurentia, and the GICE isotopic excursion. The synchronicity of these dramatic geologic, oceanographic, and macroevolutionary changes supports the influence of geologic events on biological evolution. Together, the renewed tectonic activity and oceanographic changes facilitated fundamental changes in habitat structure in eastern North America that reduced opportunities for isolation and vicariance. They also facilitated regional biotic dispersal of taxa that led to the subsequent establishment of extrabasinal (=invasive) species and may have led to a suppression of speciation within Laurentian faunas. Phylogenetic biogeographic analysis further indicates that the Richmondian Invasion was a multidirectional regional invasion event that involved taxa immigrating into the Cincinnati region from basins located near the continental margins and within the continental interior.	[Wright, David F.] Ohio State Univ, Sch Earth Sci, Columbus, OH 43210 USA; [Stigall, Alycia L.] Ohio Univ, Dept Geol Sci, Athens, OH 45701 USA; [Stigall, Alycia L.] Ohio Univ, OHIO Ctr Ecol & Evolutionary Studies, Athens, OH 45701 USA	Ohio State University; Ohio University; Ohio University	Stigall, AL (corresponding author), Ohio Univ, Dept Geol Sci, Athens, OH 45701 USA.	stigall@ohio.edu	Stigall, Alycia/C-7989-2013	Stigall, Alycia/0000-0002-4722-3303	NSF [EAR-0922067]; Yale Peabody Museum; Dry Dredgers Paul Sanders Award; Ohio University Geological Sciences Alumni Grant; OHIO Center for Ecology and Evolutionary Studies Fellowship; Division Of Earth Sciences [0922067] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Yale Peabody Museum; Dry Dredgers Paul Sanders Award; Ohio University Geological Sciences Alumni Grant; OHIO Center for Ecology and Evolutionary Studies Fellowship; Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was supported by NSF EAR-0922067 to ALS and the Schuchert and Dunbar Grants-in-Aid Award from the Yale Peabody Museum, the Dry Dredgers Paul Sanders Award, the Ohio University Geological Sciences Alumni Grant, and the OHIO Center for Ecology and Evolutionary Studies Fellowship to DFW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe FR, 2009, EVOL BIOL, V36, P225, DOI 10.1007/s11692-009-9060-0; [Anonymous], [No title captured]; ANSTEY RL, 1986, LETHAIA, V19, P33, DOI 10.1111/j.1502-3931.1986.tb01898.x; Congreve CR, 2010, J PALEONTOL, V84, P128, DOI 10.1666/09-026.1; Elias RJ, 1983, US GEOL SURV PAP; ELIAS RJ, 1991, ADV ORDOVICIAN GEOLO, P205; ETTENSOHN F.R., 1994, CONCEPTS SEDIMENTOLO, V4, P217; Ettensohn FR, 2010, GEOL SOC AM SPEC PAP, V466, P163, DOI 10.1130/2010.2466(11); Foerste Aug. F., 1914, Bulletin of the Scientific Laboratories of Denison University Granville Ohio, V17; Fortey RA, 2005, GEOLOGY, V33, P405, DOI 10.1130/G21180.1; Goldman D, 2010, GEOL SOC AM SPEC PAP, V466, P149, DOI 10.1130/2010.2466(10); Hall J., 1892, INTRO STUDY GENERA P, V8; Hall J., 1847, DESCRIPTIONS ORGANIC, V1; Holland S.M., 1996, GEOLOGICAL SOC AM SP, P117, DOI [DOI 10.1130/0-8137-2306-X.117, 10.1130/0-8137-2306-X.117]; Holland SM, 2009, PALAIOS, V24, P303, DOI 10.2110/palo.2008.p08-095r; HOWE HERBERT J., 1966, J PALEONTOL, V40, P241; Jin J., 2001, LATE ORDOVICIAN ARTI; Jin JS, 2001, CAN J EARTH SCI, V38, P143, DOI 10.1139/e00-049; Kidwell SM, 1996, ANNU REV EARTH PL SC, V24, P433, DOI 10.1146/annurev.earth.24.1.433; Kolata DR, 2001, GEOL SOC AM BULL, V113, P1067, DOI 10.1130/0016-7606(2001)113<1067:TOSTAO>2.0.CO;2; Lieberman, 2000, PALEOBIOGEOGRAPHY US; Lieberman BS, 1997, GEOLOGY, V25, P1039, DOI 10.1130/0091-7613(1997)025<1039:ECPATH>2.3.CO;2; Lieberman BS, 1996, PALEOBIOLOGY, V22, P66, DOI 10.1017/S009483730001602X; Malizia RW, 2011, PALAEOGEOGR PALAEOCL, V311, P154, DOI 10.1016/j.palaeo.2011.08.017; MILLER AI, 1995, GEOLOGY, V23, P305, DOI 10.1130/0091-7613(1995)023<0305:AOOAWT>2.3.CO;2; Neslon SJ, 1959, J ALBERTA SOC PETROL, V7, P45; PATZKOWSKY ME, 1993, GEOLOGY, V21, P619, DOI 10.1130/0091-7613(1993)021<0619:BRTAMO>2.3.CO;2; Pope MC, 1997, SEPM SPEC P, P411; Rasmussen CMO, 2013, PALAEONTOLOGY, V56, P359, DOI 10.1111/j.1475-4983.2012.01205.x; Rode ALS, 2005, PALAEOGEOGR PALAEOCL, V222, P272, DOI 10.1016/j.palaeo.2005.03.018; Saltzman MR, 2005, GEOLOGY, V33, P109, DOI 10.1130/G21219.1; SHANMUGAM G, 1982, GEOLOGY, V10, P562, DOI 10.1130/0091-7613(1982)10<562:ATEOTO>2.0.CO;2; Shaw FC, 1991, J PALEONTOL, V63, P919; Stigall AL, 2012, GEOLOGICAL SOC AM TO, V22, P4, DOI DOI 10.1130/G128A.1; Stigall AL, 2013, PALAEONTOL IN PRESS, P56; Stigall AL, 2006, J BIOGEOGR, V33, P2051, DOI 10.1111/j.1365-2699.2006.01585.x; Stigall AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015584; Stigall AL, 2010, PALAEONTOL ELECTRON, V13; Upchurch P, 2002, P ROY SOC B-BIOL SCI, V269, P613, DOI 10.1098/rspb.2001.1921; Webby BD, 2004, CRIT MOM PERSP EARTH, P124; Wiley EO, 2011, PHYLOGENETICS THEORY; Witzke BJ, 1980, PALEOZOIC PALEOGEOGR, V1, P1; Wright DF, 2013, J PALEONTOL IN PRESS, P87; Wright DF, 2013, J SYST PALA IN PRESS, V11; Young SA, 2005, PALAEOGEOGR PALAEOCL, V222, P53, DOI 10.1016/j.palaeo.2005.03.008	45	32	32	0	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2013	8	7							e68353	10.1371/journal.pone.0068353	http://dx.doi.org/10.1371/journal.pone.0068353			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZN	23869215	Green Submitted, Green Published, gold			2022-12-27	WOS:000323110600014
J	Li, Q; Iqbal, A; Perc, M; Chen, MY; Abbott, D				Li, Qiang; Iqbal, Azhar; Perc, Matjaz; Chen, Minyou; Abbott, Derek			Coevolution of Quantum and Classical Strategies on Evolving Random Networks	PLOS ONE			English	Article							EVOLUTIONARY PRISONERS-DILEMMA; SOCIAL DILEMMAS; COOPERATION; GAME; DIVERSITY; EMERGENCE; SELECTION; DYNAMICS; PROMOTES; RULES	We study the coevolution of quantum and classical strategies on weighted and directed random networks in the realm of the prisoner's dilemma game. During the evolution, agents can break and rewire their links with the aim of maximizing payoffs, and they can also adjust the weights to indicate preferences, either positive or negative, towards their neighbors. The network structure itself is thus also subject to evolution. Importantly, the directionality of links does not affect the accumulation of payoffs nor the strategy transfers, but serves only to designate the owner of each particular link and with it the right to adjust the link as needed. We show that quantum strategies outperform classical strategies, and that the critical temptation to defect at which cooperative behavior can be maintained rises, if the network structure is updated frequently. Punishing neighbors by reducing the weights of their links also plays an important role in maintaining cooperation under adverse conditions. We find that the self-organization of the initially random network structure, driven by the evolutionary competition between quantum and classical strategies, leads to the spontaneous emergence of small average path length and a large clustering coefficient.	[Li, Qiang; Chen, Minyou] Chongqing Univ, Coll Elect Engn, State Key Lab Power Transmiss Equipment & Syst Se, Chongqing 630044, Peoples R China; [Li, Qiang; Iqbal, Azhar; Abbott, Derek] Univ Adelaide, Sch Elect & Elect Engn, Adelaide, SA, Australia; [Perc, Matjaz] Univ Maribor, Fac Nat Sci & Math, Dept Phys, SLO-2000 Maribor, Slovenia; [Iqbal, Azhar] King Fahd Univ Petr & Minerals, Dept Math & Stat, Dhahran 31261, Saudi Arabia	Chongqing University; University of Adelaide; University of Maribor; King Fahd University of Petroleum & Minerals	Li, Q (corresponding author), Chongqing Univ, Coll Elect Engn, State Key Lab Power Transmiss Equipment & Syst Se, Chongqing 630044, Peoples R China.	anjuh@cqu.edu.cn; minyouchen@cqu.edu.cn	Perc, Matjaz/A-5148-2009; Li, Qiang/AAF-3315-2019; Abbott, Derek/E-8352-2011; Iqbal, Azhar/E-8749-2011	Perc, Matjaz/0000-0002-3087-541X; Li, Qiang/0000-0002-1899-2808; Abbott, Derek/0000-0002-0945-2674; Iqbal, Azhar/0000-0002-5221-9384	National Natural Science Foundation of China [61105125, 51177177]; China Postdoctoral Science Foundation [2011M501385]; Australian Research Council [DP0771453]; Slovenian Research Agency [J1-4055]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Australian Research Council(Australian Research Council); Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by the National Natural Science Foundation of China (Grants 61105125 and 51177177), by the China Postdoctoral Science Foundation (Grant 2011M501385) and by the Australian Research Council (Grant DP0771453). MP acknowledges support from the Slovenian Research Agency (Grant J1-4055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson G, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.030901; Aharon N, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.052310; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Ben-Jacob E, 2000, ADV PHYS, V49, P395, DOI 10.1080/000187300405228; BENJACOB E, 1994, NATURE, V368, P46, DOI 10.1038/368046a0; Benjamin SC, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.030301; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Brede M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056016; Cao L, 2011, J THEOR BIOL, V272, P8, DOI 10.1016/j.jtbi.2010.12.008; Chappell JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036404; Chappell JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029015; Chappell JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021623; Dorogovtsev SN, 2003, EVOLUTION NETWORKS B; Du J, 2001, QUANTPH0111138 ARXIV; Du JF, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.137902; Ebel H, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.056118; Eisert J, 1999, PHYS REV LETT, V83, P3077, DOI 10.1103/PhysRevLett.83.3077; Flitney AP, 2002, FLUCT NOISE LETT, V2, pR175, DOI 10.1142/S0219477502000981; Floria LM, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.026106; Fu F, 2011, P ROY SOC B-BIOL SCI, V278, P42, DOI 10.1098/rspb.2010.1107; Fu F, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.016104; Fu F, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.036101; Gomez-Gardenes J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108103; Gomez-Gardenes J, 2008, J THEOR BIOL, V253, P296, DOI 10.1016/j.jtbi.2008.03.007; Guo H, 2008, DECIS SUPPORT SYST, V46, P318, DOI 10.1016/j.dss.2008.07.001; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Holme P, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.030901; Iqbal A, 2002, PHYS LETT A, V300, P541, DOI 10.1016/S0375-9601(02)00893-9; Iqbal A, 2002, PHYS LETT A, V293, P103, DOI 10.1016/S0375-9601(02)00003-8; Iqbal A, 2001, PHYS LETT A, V280, P249, DOI 10.1016/S0375-9601(01)00082-2; Iqbal A, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.061122; Kay R, 2001, J PHYS A-MATH GEN, V34, pL547, DOI 10.1088/0305-4470/34/41/101; Kim BJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.021907; Kolenderski P, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.012321; Li J, 2012, PHYSICA A, V391, P3924, DOI 10.1016/j.physa.2012.03.016; Li Q, 2012, EUR PHYS J B, V85, DOI 10.1140/epjb/e2012-30398-1; Li Q, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/10/103034; Li Q, 2012, PHYSICA A, V391, P3316, DOI 10.1016/j.physa.2012.01.048; Luthi L, 2008, PHYSICA A, V387, P955, DOI 10.1016/j.physa.2007.09.046; Marinatto L, 2000, PHYS LETT A, V272, P291, DOI 10.1016/S0375-9601(00)00441-2; Meyer DA, 1999, PHYS REV LETT, V82, P1052, DOI 10.1103/PhysRevLett.82.1052; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Pacheco JM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.258103; Perc M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011904; Perc M, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/9/183; Perc M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0997; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Poncela J, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/184; Poncela J, 2009, EPL-EUROPHYS LETT, V88, DOI 10.1209/0295-5075/88/38003; Poncela J, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/8/083031; Poncela J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002449; Prevedel R, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/205; Ren J, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.045101; Roca CP, 2009, PHYS LIFE REV, V6, P208, DOI 10.1016/j.plrev.2009.08.001; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Santos FC, 2006, J EVOLUTION BIOL, V19, P726, DOI 10.1111/j.1420-9101.2005.01063.x; Santos FC, 2006, P NATL ACAD SCI USA, V103, P3490, DOI 10.1073/pnas.0508201103; Santos FC, 2008, NATURE, V454, P213, DOI 10.1038/nature06940; Santos FC, 2012, J THEOR BIOL, V299, P88, DOI 10.1016/j.jtbi.2011.09.003; Schmid C, 2009, ARXIV09010063V1; Shigaki K, 2012, EPL-EUROPHYS LETT, V98, DOI 10.1209/0295-5075/98/40008; Sicardi EA, 2009, J THEOR BIOL, V256, P240, DOI 10.1016/j.jtbi.2008.09.022; Sigmund K, 2010, PRINC SER THEOR COMP, P1; Szabo G, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/18007; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/30004; Szolnoki A, 2008, EPL-EUROPHYS LETT, V84, DOI 10.1209/0295-5075/84/50007; Szolnoki A, 2008, PHYSICA A, V387, P2075, DOI 10.1016/j.physa.2007.11.021; Szolnoki A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056112; Szolnoki A, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/30007; Szolnoki A, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/4/043036; Tanimoto J, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.032101; Tanimoto J, 2010, PHYSICA A, V389, P2284, DOI 10.1016/j.physa.2010.01.033; Tanimoto J, 2009, PHYSICA A, V388, P953, DOI 10.1016/j.physa.2008.11.023; Tanimoto J, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.021126; Tirole J., 1983, GAME THEORY, P18; Tomassini M, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.016132; Van Segbroeck S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.058105; Van Segbroeck S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-287; Vukov J, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.026109; Wardil L, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.036115; Wardil L, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/38001; Wu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011187; Wu Z.-X., 2009, PHYS REV E, V80; Wu ZX, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.021107; Wu ZX, 2007, PHYSICA A, V379, P672, DOI 10.1016/j.physa.2007.02.085; Wu ZX, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.037103; Wu ZX, 2006, CHINESE PHYS LETT, V23, P531, DOI 10.1088/0256-307X/23/3/002; Zimmermann MG, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.056118; Zimmermann MG, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.065102	94	22	22	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e68423	10.1371/journal.pone.0068423	http://dx.doi.org/10.1371/journal.pone.0068423			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	23874622	Green Published, gold, Green Submitted			2022-12-27	WOS:000321718700024
J	Brandmeyer, A; Farquhar, JDR; McQueen, JM; Desain, PWM				Brandmeyer, Alex; Farquhar, Jason D. R.; McQueen, James M.; Desain, Peter W. M.			Decoding Speech Perception by Native and Non-Native Speakers Using Single-Trial Electrophysiological Data	PLOS ONE			English	Article							CATEGORICAL PERCEPTION; MISMATCH NEGATIVITY; LANGUAGE; REORGANIZATION; NEUROFEEDBACK; COMPONENTS; STIMULI; VOICE; P300; FMRI	Brain-computer interfaces (BCIs) are systems that use real-time analysis of neuroimaging data to determine the mental state of their user for purposes such as providing neurofeedback. Here, we investigate the feasibility of a BCI based on speech perception. Multivariate pattern classification methods were applied to single-trial EEG data collected during speech perception by native and non-native speakers. Two principal questions were asked: 1) Can differences in the perceived categories of pairs of phonemes be decoded at the single-trial level? 2) Can these same categorical differences be decoded across participants, within or between native-language groups? Results indicated that classification performance progressively increased with respect to the categorical status (within, boundary or across) of the stimulus contrast, and was also influenced by the native language of individual participants. Classifier performance showed strong relationships with traditional event-related potential measures and behavioral responses. The results of the cross-participant analysis indicated an overall increase in average classifier performance when trained on data from all participants (native and non-native). A second cross-participant classifier trained only on data from native speakers led to an overall improvement in performance for native speakers, but a reduction in performance for non-native speakers. We also found that the native language of a given participant could be decoded on the basis of EEG data with accuracy above 80%. These results indicate that electrophysiological responses underlying speech perception can be decoded at the single-trial level, and that decoding performance systematically reflects graded changes in the responses related to the phonological status of the stimuli. This approach could be used in extensions of the BCI paradigm to support perceptual learning during second language acquisition.	[Brandmeyer, Alex; Farquhar, Jason D. R.; McQueen, James M.; Desain, Peter W. M.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [McQueen, James M.] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands; [McQueen, James M.] Max Planck Inst Psycholinguist, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Max Planck Society	Brandmeyer, A (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	a.brandmeyer@donders.ru.nl	Desain, Peter/D-1267-2012; McQueen, James M./B-2212-2010	McQueen, James M./0000-0003-3734-6286	Donders Centre for Cogntion; BrainGain Smart Mix Programme of the Netherlands Ministry of Economic Affairs; Netherlands Ministry of Education, Culture and Science; Technology Foundation STW	Donders Centre for Cogntion; BrainGain Smart Mix Programme of the Netherlands Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Netherlands Ministry of Education, Culture and Science; Technology Foundation STW(Technologiestichting STW)	This research has been supported by the Donders Centre for Cogntion, the BrainGain Smart Mix Programme of the Netherlands Ministry of Economic Affairs and the Netherlands Ministry of Education, Culture and Science, and the Technology Foundation STW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	1966, 1966, SIGNAL DETECTION THE, V1974; Belitski A, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025022; Best C, 1993, DEV NEUROCOGNITION S, P167; BEST CT, 1988, J EXP PSYCHOL HUMAN, V14, P345, DOI 10.1037/0096-1523.14.3.345; Bishop C. M., 2006, SPRINGER; Bishop D, 2010, PSYCHOPHYSIOLOGY, P1; Blankertz B, 2011, NEUROIMAGE, V56, P814, DOI 10.1016/j.neuroimage.2010.06.048; Brandmeyer A, 2012, NEUROREPORT, V23, P653, DOI 10.1097/WNR.0b013e32835542cd; Brunner Clemens, 2008, INT J BIOELEKTROMAGN, V10, P52, DOI DOI 10.1.1.330.3349; Collins B, 1996, THE PHONETICS OF ENG; DehaeneLambertz G, 1997, NEUROREPORT, V8, P919, DOI 10.1097/00001756-199703030-00021; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Farquhar JRD, 2012, NEUROINFORMATICS, P1; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Formisano E, 2008, SCIENCE, V322, P970, DOI 10.1126/science.1164318; Gonsalvez CJ, 2002, PSYCHOPHYSIOLOGY, V39, P388, DOI 10.1017/S0048577201393137; Grimm S, 2011, PSYCHOPHYSIOLOGY, V48, P377, DOI 10.1111/j.1469-8986.2010.01073.x; Handy T.C., 2004, EVENT RELATED POTENT; Haynes JD, 2005, NAT NEUROSCI, V8, P686, DOI 10.1038/nn1445; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Hohne J, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/045003; Hohne J, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00099; Johnston SJ, 2010, NEUROIMAGE, V49, P1066, DOI 10.1016/j.neuroimage.2009.07.056; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kasai K, 2001, NEUROREPORT, V12, P2467, DOI 10.1097/00001756-200108080-00036; Kay KN, 2008, NATURE, V452, P352, DOI 10.1038/nature06713; Korpilahti P, 2001, BRAIN LANG, V76, P332, DOI 10.1006/brln.2000.2426; Korpilahti P., 1995, ELECTROENCEPHALOGRAP, V95, p96P; KUHL PK, 1992, SCIENCE, V255, P606, DOI 10.1126/science.1736364; Kuhl PK, 2004, NAT REV NEUROSCI, V5, P831, DOI 10.1038/nrn1533; Kujala T, 2007, BIOL PSYCHOL, V74, P1, DOI 10.1016/j.biopsycho.2006.06.001; MAISTE AC, 1995, EAR HEARING, V16, P68, DOI 10.1097/00003446-199502000-00006; Munka L, 2006, NEUROSCI LETT, V396, P177, DOI 10.1016/j.neulet.2005.11.035; Naatanen R, 1997, NATURE, V385, P432, DOI 10.1038/385432a0; Naatanen R, 2007, CLINICAL NEUROPHYSIO, V118, P2544; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Phillips C, 2000, J COGNITIVE NEUROSCI, V12, P1038, DOI 10.1162/08989290051137567; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Rivera-Gaxiola M, 2000, BEHAV BRAIN RES, V111, P13, DOI 10.1016/S0166-4328(00)00139-X; Rueschemeyer SA, 2006, NEUROIMAGE, V31, P354, DOI 10.1016/j.neuroimage.2005.11.047; Schaefer RS, 2011, NEUROIMAGE, V56, P843, DOI 10.1016/j.neuroimage.2010.05.084; Schreuder M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009813; Schroger E, 1998, NEUROREPORT, V9, P3355, DOI 10.1097/00001756-199810260-00003; Sharma A, 1999, J ACOUST SOC AM, V106, P1078, DOI 10.1121/1.428048; Sharma A, 2000, J ACOUST SOC AM, V107, P2697, DOI 10.1121/1.428655; Shibata K, 2011, SCIENCE, V334, P1413, DOI 10.1126/science.1212003; Tremblay K, 1998, NEUROREPORT, V9, P3557, DOI 10.1097/00001756-199811160-00003; van Alphen PM, 2004, J PHONETICS, V32, P455, DOI 10.1016/j.wocn.2004.05.001; van der Waal M, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/045002; van Gerven M, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/041001; Vidaurre C, 2010, BRAIN TOPOGR, V23, P194, DOI 10.1007/s10548-009-0121-6; Vlek RJ, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036002; Weiskopf N, 2012, NEUROIMAGE, V62, P682, DOI 10.1016/j.neuroimage.2011.10.009; WERKER JF, 1984, INFANT BEHAV DEV, V7, P49, DOI 10.1016/S0163-6383(84)80022-3; WERKER JF, 1988, DEV PSYCHOL, V24, P672, DOI 10.1037/0012-1649.24.5.672; Winkler I, 1999, PSYCHOPHYSIOLOGY, P1; Yoo SS, 2006, NEUROREPORT, V17, P1273, DOI 10.1097/01.wnr.0000227996.53540.22; Zander TO, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025005; Zoefel B, 2011, NEUROIMAGE, V54, P1427, DOI 10.1016/j.neuroimage.2010.08.078; Zotev V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024522	64	12	12	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e68261	10.1371/journal.pone.0068261	http://dx.doi.org/10.1371/journal.pone.0068261			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874567	Green Published, gold			2022-12-27	WOS:000322218800021
J	Huang, B; Huang, YJ; Yao, ZJ; Chen, X; Guo, SJ; Mao, XP; Wang, DH; Chen, JX; Qiu, SP				Huang, Bin; Huang, Yi Jun; Yao, Zhi Jun; Chen, Xu; Guo, Sheng Jie; Mao, Xiao Peng; Wang, Dao Hu; Chen, Jun Xing; Qiu, Shao Peng			Cancer Stem Cell-Like Side Population Cells in Clear Cell Renal Cell Carcinoma Cell Line 769P	PLOS ONE			English	Article							IDENTIFICATION; EXPANSION; BIOLOGY	Although cancers are widely considered to be maintained by stem cells, the existence of stem cells in renal cell carcinoma (RCC) has seldom been reported, in part due to the lack of unique surface markers. We here identified cancer stem cell-like cells with side population (SP) phenotype in five human RCC cell lines. Flow cytometry analysis revealed that 769P, a human clear cell RCC cell line, contained the largest amount of SP cells as compared with other four cell lines. These 769P SP cells possessed characteristics of proliferation, self-renewal, and differentiation, as well as strong resistance to chemotherapy and radiotherapy that were possibly related to the ABCB1 transporter. In vivo experiments with serial tumor transplantation in mice also showed that 769P SP cells formed tumors in NOD/SCID mice. Taken together, these results indicate that 769P SP cells have the properties of cancer stem cells, which may play important roles in tumorigenesis and therapy-resistance of RCC.	[Huang, Bin; Yao, Zhi Jun; Chen, Xu; Mao, Xiao Peng; Wang, Dao Hu; Chen, Jun Xing; Qiu, Shao Peng] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Urol, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Yi Jun] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Pharmacol, Guangzhou 510275, Guangdong, Peoples R China; [Guo, Sheng Jie] Sun Yat Sen Univ, Ctr Canc, Dept Urol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Chen, JX (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Urol, Guangzhou 510275, Guangdong, Peoples R China.	junxingchen@hotmail.com; qiusp2009@live.cn		Huang, Bin/0000-0002-6429-4023	National Natural Science Foundation [81272809, 80202011, 81202013, 30872584]; Guangdong Natural Science Foundation [8251008901000018, S2012040007557]; Sun Yat-sen Innovative Talents Cultivation Program for Excellent Tutors [80000-3126205]; Science and Technology Planning Project of Guangdong Province, China [2011B050400021, 2012B090600021, 445323198311050317]; Guangdong Key Laboratory of Urology, the first affiliated Hospital of Guangzhou Medical University [2010A060801016]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Sun Yat-sen Innovative Talents Cultivation Program for Excellent Tutors; Science and Technology Planning Project of Guangdong Province, China; Guangdong Key Laboratory of Urology, the first affiliated Hospital of Guangzhou Medical University	This work was supported by grants from the National Natural Science Foundation (No. 81272809, No. 80202011, No. 81202013, No. 30872584); Guangdong Natural Science Foundation (No. 8251008901000018, No. S2012040007557); Sun Yat-sen Innovative Talents Cultivation Program for Excellent Tutors (No. 80000-3126205); Science and Technology Planning Project of Guangdong Province, China (No. 2011B050400021, No. 2012B090600021, No. 445323198311050317); and Guangdong Key Laboratory of Urology, the first affiliated Hospital of Guangzhou Medical University (No. 2010A060801016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addla SK, 2008, AM J PHYSIOL-RENAL, V295, pF680, DOI 10.1152/ajprenal.90286.2008; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Bapat SA, 2005, CANCER RES, V65, P3025, DOI 10.1158/0008-5472.CAN-04-3931; Britton KM, 2012, CANC LETT, V323, P3; Bunting KD, 2000, BLOOD, V96, P902, DOI 10.1182/blood.V96.3.902.015k40_902_909; Bunting KD, 2002, STEM CELLS, V20, P11, DOI 10.1002/stem.200011; Cabarcas SM, 2011, INT J CANCER, V129, P2315, DOI 10.1002/ijc.26312; Chiba T, 2006, HEPATOLOGY, V44, P240, DOI 10.1002/hep.21227; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Coppin C, 2011, BJU INT, V108, P1556, DOI 10.1111/j.1464-410X.2011.10629.x; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dean M, 2011, NAT REV CANCER, V5, P275; Finley DS, 2011, ONCOLOGIST, V16, P4, DOI 10.1634/theoncologist.2011-S2-04; Golebiewska A, 2011, CELL STEM CELL, V8, P136, DOI 10.1016/j.stem.2011.01.007; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Haraguchi Naotsugu, 2006, Hum Cell, V19, P24, DOI 10.1111/j.1749-0774.2005.00004.x; Hubbard SA, 2009, CANCER RES, V69, P8241, DOI 10.1158/0008-5472.CAN-08-4808; Hui ZG, 2009, INT J RADIAT ONCOL, V73, P288, DOI 10.1016/j.ijrobp.2008.08.043; Klatte Tobias, 2007, Rev Urol, V9, P47; Komuro H, 2007, J PEDIATR SURG, V42, P2040, DOI 10.1016/j.jpedsurg.2007.08.026; Li JJ, 2011, ONCOL REP, V25, P979, DOI 10.3892/or.2011.1158; Liang Y, 2010, J BIOL CHEM, V285, P4931, DOI 10.1074/jbc.M109.048397; Ning ZF, 2009, J INT MED RES, V37, P621, DOI 10.1177/147323000903700304; Nishizawa S, 2012, CANCER RES, V72, P2844, DOI 10.1158/0008-5472.CAN-11-3062; Oates JE, 2009, STEM CELLS DEV, V18, P1515, DOI 10.1089/scd.2008.0302; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rizzo S, 2011, MOL CANCER THER, V10, P325, DOI 10.1158/1535-7163.MCT-10-0788; Salcido CD, 2010, BRIT J CANCER, V102, P1636, DOI 10.1038/sj.bjc.6605668; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Singh SK, 2003, CANCER RES, V63, P5821; Wang J, 2007, CANCER RES, V67, P3716, DOI 10.1158/0008-5472.CAN-06-4343; Watts KL, 2011, CYTOTHERAPY, V13, P1164, DOI 10.3109/14653249.2011.620748; Wu C, 2011, CANCER RES, V67, P8216; Zhi Y, 2012, INT J MOL SCI, V13, P6009, DOI 10.3390/ijms13056009; Zhong Y, 2010, CANCER LETT, V299, P150, DOI 10.1016/j.canlet.2010.08.013; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	39	44	44	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e68293	10.1371/journal.pone.0068293	http://dx.doi.org/10.1371/journal.pone.0068293			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874578	Green Published, gold, Green Submitted			2022-12-27	WOS:000322218800022
J	Flores, DEFL; Tomotani, BM; Tachinardi, P; Oda, GA; Valentinuzzi, VS				Flores, Danilo E. F. L.; Tomotani, Barbara M.; Tachinardi, Patricia; Oda, Gisele A.; Valentinuzzi, Veronica S.			Modeling Natural Photic Entrainment in a Subterranean Rodent (Ctenomys aff. knighti), the Tuco-Tuco	PLOS ONE			English	Article							CIRCADIAN PACEMAKERS; FUNCTIONAL-ANALYSIS; NOCTURNAL RODENTS; ACTIVITY RHYTHMS; SUPRACHIASMATIC NUCLEUS; LIGHT; PHASE; PHOTOENTRAINMENT; TEMPERATURE; EXPRESSION	Subterranean rodents spend most of the day inside underground tunnels, where there is little daily change in environmental variables. Our observations of tuco-tucos (Ctenomys aff. knighti) in a field enclosure indicated that these animals perceive the aboveground light-dark cycle by several bouts of light-exposure at irregular times during the light hours of the day. To assess whether such light-dark pattern acts as an entraining agent of the circadian clock, we first constructed in laboratory the Phase Response Curve for 1 h light-pulses (1000lux). Its shape is qualitatively similar to other curves reported in the literature and to our knowledge it is the first Phase Response Curve of a subterranean rodent. Computer simulations were performed with a non-linear limit-cycle oscillator subjected to a simple model of the light regimen experienced by tuco-tucos. Results showed that synchronization is achieved even by a simple regimen of a single daily light pulse scattered uniformly along the light hours of the day. Natural entrainment studies benefit from integrated laboratory, field and computational approaches.	[Flores, Danilo E. F. L.; Tomotani, Barbara M.; Tachinardi, Patricia; Oda, Gisele A.] Univ Sao Paulo, Inst Biociencias, Dept Fisiol, Sao Paulo, Brazil; [Valentinuzzi, Veronica S.] Ctr Reg Invest Cient & Transferencia Tecnol CRILA, RA-5301 Anillaco, La Rioja, Argentina	Universidade de Sao Paulo	Oda, GA (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Fisiol, Sao Paulo, Brazil.	gaoda@ib.usp.br; vvalentinuzzi@crilar-conicet.gob.ar	Mizumo Tomotani, Barbara/A-5600-2013; oda, gisele a/F-4283-2012	Mizumo Tomotani, Barbara/0000-0002-8855-4803; oda, gisele a/0000-0001-7776-5368; Eugenio de Franca Laurindo Flores, Danilo/0000-0003-1770-3581	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas) [PIP-11420090100252]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2011/1979]; CRILAR (Centro Regional de investigaciones Cientificas y Transferencia Tecnologica); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2008/55035-5, 2010/50222-1]; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [130021/2009-1]	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); CRILAR (Centro Regional de investigaciones Cientificas y Transferencia Tecnologica); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas, grant PIP-11420090100252), Agencia Nacional de Promocion Cientifica y Tecnologica, grant PICT 2011/1979, CRILAR (Centro Regional de investigaciones Cientificas y Transferencia Tecnologica), FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, grants 2008/55035-5, 2010/50222-1), CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, 130021/2009-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham U, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.92; Aschoff, 1965, CIRCADIAN CLOCKS, P95; Beersma DGM, 1999, J BIOL RHYTHM, V14, P320, DOI 10.1177/074873099129000740; Beersma DGM, 1999, J BIOL RHYTHM, V14, P524, DOI 10.1177/074873099129000858; Boulos Z, 2002, J BIOL RHYTHM, V17, P353, DOI 10.1177/074873002129002654; Boulos Z, 1996, J BIOL RHYTHM, V11, P216, DOI 10.1177/074873049601100304; Buffenstein R, 2000, LIFE UNDERGROUND, P62; Casiraghi LP, 2012, J BIOL RHYTHM, V27, P59, DOI 10.1177/0748730411429447; CHANDRASHEKARAN MK, 1973, J COMP PHYSIOL, V82, P347, DOI 10.1007/BF00696804; DAAN S, 1976, J COMP PHYSIOL, V106, P253, DOI 10.1007/BF01417857; David-Gray ZK, 1998, NAT NEUROSCI, V1, P655, DOI 10.1038/3656; DECOURSEY G, 1964, BIOL BULL, V126, P14, DOI 10.2307/1539413; DECOURSEY PJ, 1986, J COMP PHYSIOL A, V159, P161, DOI 10.1007/BF00612299; DECOURSEY PJ, 1960, SCIENCE, V131, P33, DOI 10.1126/science.131.3392.33; DeCoursey PJ, 1989, CIRCADIAN CLOCKS ECO, P187; ELLIOTT JA, 1976, FED PROC, V35, P2339; Entright J. T., 1970, A Rev Ecol Syst, V1, P221; Fleissner G, 1998, INT CONGR SER, V1152, P171; Flores DEF, 2011, THESIS U SAO PAULO; Friesen WO, 2001, NEUROCOMPUTING, V38, P607, DOI 10.1016/S0925-2312(01)00449-0; Friesen WO, 2009, NEURODYNAMIX 2 CONCE; Granada AE, 2011, INTERFACE FOCUS, V1, P153, DOI 10.1098/rsfs.2010.0002; Hut RA, 1999, J BIOL RHYTHM, V14, P290, DOI 10.1177/074873099129000704; Johnson CH, 1999, CHRONOBIOL INT, V16, P711, DOI 10.3109/07420529909016940; KAVANAU JL, 1976, SCIENCE, V191, P83, DOI 10.1126/science.813298; Moore-Ede M., 1984, CLOCKS TIME US PHYSL; Oda GA, 2000, J BIOL RHYTHM, V15, P246, DOI 10.1177/074873040001500306; OKUDAIRA N, 1983, AM J PHYSIOL, V245, pR613, DOI 10.1152/ajpregu.1983.245.4.R613; Oosthuizen MK, 2005, NEUROSCIENCE, V133, P555, DOI 10.1016/j.neuroscience.2005.01.017; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P223, DOI 10.1007/BF01417856; PITTENDRIGH CS, 1991, J BIOL RHYTHM, V6, P299, DOI 10.1177/074873049100600402; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P291, DOI 10.1007/BF01417859; PRATT BL, 1986, PHYSIOL BEHAV, V36, P91, DOI 10.1016/0031-9384(86)90079-X; PRATT BL, 1986, PHYSIOL BEHAV, V36, P83, DOI 10.1016/0031-9384(86)90078-8; R Development Core Team, 2010, R LANG ENV STAT COMP; Refinetti R, 2004, PHYSIOL BEHAV, V82, P285, DOI 10.1016/j.physbeh.2004.03.015; Roenneberg T, 1997, PHOTOCHEM PHOTOBIOL, V66, P549, DOI 10.1111/j.1751-1097.1997.tb03188.x; Valentinuzzi VS, 2009, CHRONOBIOL INT, V26, P14, DOI 10.1080/07420520802686331; Schwartz WJ, 2011, P NATL ACAD SCI USA, V108, P17219, DOI 10.1073/pnas.1107848108; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; TERMAN M, 1991, J BIOL RHYTHM, V6, P31, DOI 10.1177/074873049100600105; Tomotani BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037918; Tomotani BM MSc Dissertation, 2011, THESIS U SAO PAULO; TWENTE JW, 1955, ECOLOGY, V36, P706, DOI 10.2307/1931308; Wever R., 1965, CIRCADIAN CLOCKS, P47; Williams CT, 2012, PHYSIOL BIOCHEM ZOOL, V85, P397, DOI 10.1086/666509	47	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68243	10.1371/journal.pone.0068243	http://dx.doi.org/10.1371/journal.pone.0068243			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874562	Green Published, Green Submitted, gold			2022-12-27	WOS:000321765300038
J	Kumaran, R; Yang, SY; Leu, JY				Kumaran, Rajaraman; Yang, Shi-Yow; Leu, Jun-Yi			Characterization of Chromosome Stability in Diploid, Polyploid and Hybrid Yeast Cells	PLOS ONE			English	Article							SPINDLE ASSEMBLY CHECKPOINT; SISTER-CHROMATID COHESION; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; MATING-TYPE; MITOTIC RECOMBINATION; FLUCTUATION ANALYSIS; REPLICATION ORIGINS; CANDIDA-ALBICANS; SEX-CHROMOSOMES	Chromosome instability is a key component of cancer progression and many heritable diseases. Understanding why some chromosomes are more unstable than others could provide insight into understanding genome integrity. Here we systematically investigate the spontaneous chromosome loss for all sixteen chromosomes in Saccharomyces cerevisiae in order to elucidate the mechanisms underlying chromosome instability. We observed that the stability of different chromosomes varied more than 100-fold. Consistent with previous studies on artificial chromosomes, chromosome loss frequency was negatively correlated to chromosome length in S. cerevisiae diploids, triploids and S. cerevisiae-S. bayanus hybrids. Chromosome III, an equivalent of sex chromosomes in budding yeast, was found to be the most unstable chromosome among all cases examined. Moreover, similar instability was observed in chromosome III of S. bayanus, a species that diverged from S. cerevisiae about 20 million years ago, suggesting that the instability is caused by a conserved mechanism. Chromosome III was found to have a highly relaxed spindle checkpoint response in the genome. Using a plasmid stability assay, we found that differences in the centromeric sequence may explain certain aspects of chromosome instability. Our results reveal that even under normal conditions, individual chromosomes in a genome are subject to different levels of pressure in chromosome loss (or gain).	[Kumaran, Rajaraman; Leu, Jun-Yi] Acad Sinica, Inst Mol Biol, Taiwan Int Grad Program, Taipei, Taiwan; [Kumaran, Rajaraman; Leu, Jun-Yi] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Kumaran, Rajaraman; Yang, Shi-Yow; Leu, Jun-Yi] Acad Sinica, Inst Mol Biol, Taipei, Taiwan	Academia Sinica - Taiwan; National Defense Medical Center; Academia Sinica - Taiwan	Leu, JY (corresponding author), Acad Sinica, Inst Mol Biol, Taiwan Int Grad Program, Taipei, Taiwan.	jleu@imb.sinica.edu.tw	Leu, Jun-Yi/A-7364-2009	Leu, Jun-Yi/0000-0001-5445-2799	Academia Sinica of Taiwan [100-CDA-L04]; National Science Council of Taiwan [NSC100-2321-B-001-021]	Academia Sinica of Taiwan(Academia Sinica - Taiwan); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Academia Sinica of Taiwan (grant 100-CDA-L04) and the National Science Council of Taiwan (grant NSC100-2321-B-001-021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachtrog D, 2011, TRENDS GENET, V27, P350, DOI 10.1016/j.tig.2011.05.005; Barber TD, 2008, P NATL ACAD SCI USA, V105, P3443, DOI 10.1073/pnas.0712384105; Bensasson D, 2008, GENETICS, V178, P2161, DOI 10.1534/genetics.107.083980; Bharadwaj R, 2004, ONCOGENE, V23, P2016, DOI 10.1038/sj.onc.1207374; Biggins S, 1998, CURR OPIN CELL BIOL, V10, P769, DOI 10.1016/S0955-0674(98)80120-8; CAMPBELL DA, 1977, GENETICS, V85, P573; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; Delneri D, 2008, NAT GENET, V40, P113, DOI 10.1038/ng.2007.49; DERSHOWITZ A, 1993, MOL CELL BIOL, V13, P391, DOI 10.1128/MCB.13.1.391; Ellegren H, 2009, TRENDS GENET, V25, P278, DOI 10.1016/j.tig.2009.04.005; Fang X, 2011, SEMIN CELL DEV BIOL, V22, P595, DOI 10.1016/j.semcdb.2011.03.002; Feng WY, 2009, GENETICS, V183, P1249, DOI 10.1534/genetics.109.107508; FITZGERALDHAYES M, 1982, CELL, V29, P235, DOI 10.1016/0092-8674(82)90108-8; FUTCHER B, 1986, MOL CELL BIOL, V6, P2213, DOI 10.1128/MCB.6.6.2213; Gordon JL, 2011, P NATL ACAD SCI USA, V108, P20024, DOI 10.1073/pnas.1112808108; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; GUTHRIE C, 2004, GUIDE YEAST GENETICS; Hall BM, 2009, BIOINFORMATICS, V25, P1564, DOI 10.1093/bioinformatics/btp253; Hartwell LW, 1982, RECENT ADV YEAST MOL, V1, P28; HAWTHORNE DC, 1963, GENETICS, V48, P1721; HEGEMANN JH, 1988, MOL CELL BIOL, V8, P2523, DOI 10.1128/MCB.8.6.2523; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Henry IM, 2005, GENETICS, V170, P1979, DOI 10.1534/genetics.104.037788; Herrera LA, 2008, CURR GENOMICS, V9, P43, DOI 10.2174/138920208783884883; HIETER P, 1985, CELL, V40, P381, DOI 10.1016/0092-8674(85)90152-7; HILL A, 1987, MOL CELL BIOL, V7, P2397, DOI 10.1128/MCB.7.7.2397; Hiraoka M, 2000, GENETICS, V156, P1531; Ide S, 2010, SCIENCE, V327, P693, DOI 10.1126/science.1179044; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JONES C, 1994, HUM MOL GENET, V3, P2123, DOI 10.1093/hmg/3.12.2123; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kim YH, 2006, NUCLEIC ACIDS RES, V34, P2914, DOI 10.1093/nar/gkl293; Knop M, 2006, BIOESSAYS, V28, P696, DOI 10.1002/bies.20435; KOHLI J, 1977, GENETICS, V87, P471; Kolodner RD, 2002, SCIENCE, V297, P552, DOI 10.1126/science.1075277; Lang GI, 2008, GENETICS, V178, P67, DOI 10.1534/genetics.107.071506; LAVANIA UC, 1987, GENETICA, V72, P211, DOI 10.1007/BF00116225; Lee HY, 2008, CELL, V135, P1065, DOI 10.1016/j.cell.2008.10.047; Lemoine FJ, 2005, CELL, V120, P587, DOI 10.1016/j.cell.2004.12.039; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; Lockhart SR, 2002, GENETICS, V162, P737; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; Marinoni G, 1999, J BACTERIOL, V181, P6488, DOI 10.1128/JB.181.20.6488-6496.1999; MAYER VW, 1989, MUTAT RES, V224, P471, DOI 10.1016/0165-1218(89)90072-4; MAYER VW, 1990, MUTAT RES, V231, P177, DOI 10.1016/0027-5107(90)90024-X; MCGREW J, 1986, MOL CELL BIOL, V6, P530, DOI 10.1128/MCB.6.2.530; Mieczkowski PA, 2006, DNA REPAIR, V5, P1010, DOI 10.1016/j.dnarep.2006.05.027; MURRAY AW, 1986, CELL, V45, P529, DOI 10.1016/0092-8674(86)90284-9; Nemec AA, 2010, SEMIN CANCER BIOL, V20, P320, DOI 10.1016/j.semcancer.2010.10.010; Newlon CS, 2002, BIOESSAYS, V24, P300, DOI 10.1002/bies.10075; Niwa O, 2006, YEAST, V23, P937, DOI 10.1002/yea.1411; Paek AL, 2009, GENE DEV, V23, P2861, DOI 10.1101/gad.1862709; Pangilinan F, 1996, MOL BIOL CELL, V7, P1195, DOI 10.1091/mbc.7.8.1195; RAD MR, 1992, MOL GEN GENET, V236, P145; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; Reshmi SC, 2005, J DENT RES, V84, P107, DOI 10.1177/154405910508400203; RESNICK MA, 1986, MUTAT RES, V167, P47, DOI 10.1016/0165-1110(86)90008-4; Rodriguez-Arnaiz R, 2004, MUTAGENESIS, V19, P121, DOI 10.1093/mutage/geh013; SARKAR S, 1992, GENETICA, V85, P173, DOI 10.1007/BF00120324; Scannell DR, 2011, G3-GENES GENOM GENET, V1, P11, DOI 10.1534/g3.111.000273; Shonn MA, 2000, SCIENCE, V289, P300, DOI 10.1126/science.289.5477.300; Silva P, 2011, CELL PROLIFERAT, V44, P391, DOI 10.1111/j.1365-2184.2011.00767.x; Singh N. D., 2007, V3, P101, DOI 10.1159/000107606; Spence JM, 2006, CHROMOSOMA, V115, P60, DOI 10.1007/s00412-005-0032-6; Storchova Z, 2006, NATURE, V443, P541, DOI 10.1038/nature05178; Szilard RK, 2010, NAT STRUCT MOL BIOL, V17, P299, DOI 10.1038/nsmb.1754; Thompson SL, 2010, CURR BIOL, V20, pR285, DOI 10.1016/j.cub.2010.01.034; Torres EM, 2008, GENETICS, V179, P737, DOI 10.1534/genetics.108.090878; Umezu K, 2002, GENETICS, V160, P97; Velicescu M, 2003, CANCER RES, V63, P5813; Watanabe Y, 2005, TRENDS GENET, V21, P405, DOI 10.1016/j.tig.2005.05.009; WHITTAKER SG, 1990, MUTAT RES, V241, P225, DOI 10.1016/0165-1218(90)90020-3; Wu W, 2005, GENETICS, V169, P1311, DOI 10.1534/genetics.104.033167; Wyrick JJ, 2001, SCIENCE, V294, P2357, DOI 10.1126/science.1066101; ZIMMERMANN FK, 1984, MUTAT RES, V141, P15, DOI 10.1016/0165-7992(84)90030-7; ZIMMERMANN FK, 1984, MUTAT RES, V139, P21, DOI 10.1016/0165-7992(84)90116-7	76	39	40	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68094	10.1371/journal.pone.0068094	http://dx.doi.org/10.1371/journal.pone.0068094			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874507	Green Published, Green Submitted, gold			2022-12-27	WOS:000321765300026
J	Mandak, B; Hadincova, V; Mahelka, V; Wildova, R				Mandak, Bohumil; Hadincova, Veroslava; Mahelka, Vaclav; Wildova, Radka			European Invasion of North American Pinus strobus at Large and Fine Scales: High Genetic Diversity and Fine-Scale Genetic Clustering over Time in the Adventive Range	PLOS ONE			English	Article							EASTERN WHITE-PINE; POPULATION-STRUCTURE; MULTIPLE SOURCES; TROPICAL TREE; AMBROSIA-ARTEMISIIFOLIA; BIOLOGICAL INVASION; MICROSATELLITE DNA; REYNOUTRIA TAXA; PLANT INVASIONS; SEED DISPERSAL	Background: North American Pinus strobus is a highly invasive tree species in Central Europe. Using ten polymorphic microsatellite loci we compared various aspects of the large-scale genetic diversity of individuals from 30 sites in the native distribution range with those from 30 sites in the European adventive distribution range. To investigate the ascertained pattern of genetic diversity of this intercontinental comparison further, we surveyed fine-scale genetic diversity patterns and changes over time within four highly invasive populations in the adventive range. Results: Our data show that at the large scale the genetic diversity found within the relatively small adventive range in Central Europe, surprisingly, equals the diversity found within the sampled area in the native range, which is about thirty times larger. Bayesian assignment grouped individuals into two genetic clusters separating North American native populations from the European, non-native populations, without any strong genetic structure shown over either range. In the case of the fine scale, our comparison of genetic diversity parameters among the localities and age classes yielded no evidence of genetic diversity increase over time. We found that SGS differed across age classes within the populations under study. Old trees in general completely lacked any SGS, which increased over time and reached its maximum in the sapling stage. Conclusions: Based on (1) the absence of difference in genetic diversity between the native and adventive ranges, together with the lack of structure in the native range, and (2) the lack of any evidence of any temporal increase in genetic diversity at four highly invasive populations in the adventive range, we conclude that population amalgamation probably first happened in the native range, prior to introduction. In such case, there would have been no need for multiple introductions from previously isolated populations, but only several introductions from genetically diverse populations.	[Mandak, Bohumil; Hadincova, Veroslava; Mahelka, Vaclav; Wildova, Radka] Acad Sci Czech Republ, Inst Bot, CS-25243 Pruhonice, Czech Republic; [Mandak, Bohumil] Czech Univ Life Sci Prague, Fac Environm Sci, Prague, Czech Republic; [Wildova, Radka] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA	Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; Czech University of Life Sciences Prague; University of Michigan System; University of Michigan	Mandak, B (corresponding author), Acad Sci Czech Republ, Inst Bot, CS-25243 Pruhonice, Czech Republic.	mandak@ibot.cas.cz	Hadincova, Veroslava/D-4572-2013; Mahelka, Václav/H-1608-2014; Mandak, Bohumil/A-3348-2009	Hadincova, Veroslava/0000-0002-3825-1919; Mahelka, Václav/0000-0003-1922-0540; Mandak, Bohumil/0000-0002-9545-7497	Grant Agency of the Academy of Sciences of the Czech Republic [IAA600050711]; Grant Agency of the Czech Republic [P504/11/0402];  [RVO 67985939]	Grant Agency of the Academy of Sciences of the Czech Republic(Czech Academy of SciencesGrant Agency of the Czech Republic); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); 	This study was supported by grant no. IAA600050711 from the Grant Agency of the Academy of Sciences of the Czech Republic, partly supported by grant no. P504/11/0402 from the Grant Agency of the Czech Republic and realized in the frame of the long-term research development project no. RVO 67985939. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUGSPURGER CK, 1984, OECOLOGIA, V61, P211, DOI 10.1007/BF00396763; AUGSPURGER CK, 1983, J ECOL, V71, P759, DOI 10.2307/2259591; Austerlitz F, 2000, GENETICS, V154, P1309; BEAULIEU J, 1994, CAN J FOREST RES, V24, P1726, DOI 10.1139/x94-223; BERG EE, 1995, EVOLUTION, V49, P110, DOI 10.1111/j.1558-5646.1995.tb05963.x; Buchert GP, 1997, CONSERV BIOL, V11, P747, DOI 10.1046/j.1523-1739.1997.96074.x; Chun YJ, 2010, NEW PHYTOL, V185, P1100, DOI 10.1111/j.1469-8137.2009.03129.x; Chung MY, 2003, HEREDITY, V90, P98, DOI 10.1038/sj.hdy.6800187; COCKERHAM CC, 1969, EVOLUTION, V23, P72, DOI 10.1111/j.1558-5646.1969.tb03496.x; Cornuet JM, 1996, GENETICS, V144, P2001; Crawley MJ, 1978, COLONIZATION SUCCESS, P429; Crooks Jeffrey A., 1999, Population and Community Biology Series, V24, P103; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; Davis MB, 1993, OLD GROWTH E SURVEY; Dlugosch KM, 2008, ECOL LETT, V11, P701, DOI 10.1111/j.1461-0248.2008.01181.x; Dovciak M, 2005, ECOL MONOGR, V75, P363, DOI 10.1890/03-0802; Echt CS, 1997, GENOME, V40, P9, DOI 10.1139/g97-002; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; Epperson B. K., 1992, New Forests, V6, P257, DOI 10.1007/BF00120648; Epperson BK, 2005, HEREDITY, V95, P7, DOI 10.1038/sj.hdy.6800680; Epperson BK, 2001, AM J BOT, V88, P1006, DOI 10.2307/2657081; EPPERSON BK, 1989, GENETICS, V121, P369; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Foster D. R., 2000, NEW ENGLAND FORESTS; FOSTER DR, 1992, J ECOL, V80, P753, DOI 10.2307/2260864; Gaggiotti OE, 1999, MOL ECOL, V8, P1513, DOI 10.1046/j.1365-294x.1999.00730.x; Gapare WJ, 2005, MOL ECOL, V14, P2659, DOI 10.1111/j.1365-294X.2005.02633.x; Gaskin JF, 2002, P NATL ACAD SCI USA, V99, P11256, DOI 10.1073/pnas.132403299; Genton BJ, 2005, MOL ECOL, V14, P4275, DOI 10.1111/j.1365-294X.2005.02750.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hadincova V., 2008, Plant invasions: human perception, ecological impacts and management, P117; Hadincova V, 2007, SANDSTONES LANDSCAPE, P219; HAMRICK JL, 1993, VEGETATIO, V108, P281; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Herben T, 2004, ECOLOGY, V85, P3223, DOI 10.1890/03-0648; HOBBS RJ, 1992, CONSERV BIOL, V6, P324, DOI 10.1046/j.1523-1739.1992.06030324.x; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jones FA, 2006, MOL ECOL, V15, P851, DOI 10.1111/j.1365-294X.2005.02830.x; Jorgensen S, 2002, AM J BOT, V89, P792, DOI 10.3732/ajb.89.5.792; Robledo-Arnuncio JJ, 2011, NEW PHYTOL, V190, P222, DOI 10.1111/j.1469-8137.2010.03588.x; Kalisz S, 2001, EVOLUTION, V55, P1560, DOI 10.1111/j.0014-3820.2001.tb00675.x; Keller SR, 2010, J EVOLUTION BIOL, V23, P1720, DOI 10.1111/j.1420-9101.2010.02037.x; Kolbe JJ, 2008, BIOL LETTERS, V4, P434, DOI 10.1098/rsbl.2008.0205; Kolbe JJ, 2007, CONSERV BIOL, V21, P1612, DOI 10.1111/j.1523-1739.2007.00826.x; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; KOWARIK I, 1995, PLANT INVASIONS, P15; Lambrinos JG, 2004, ECOLOGY, V85, P2061, DOI 10.1890/03-8013; Latta RG, 1998, EVOLUTION, V52, P61, DOI [10.2307/2410920, 10.1111/j.1558-5646.1998.tb05138.x]; Latta RG, 1999, EVOLUTION, V53, P769, DOI 10.2307/2640717; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; Levine JM, 2000, SCIENCE, V288, P852, DOI 10.1126/science.288.5467.852; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Lonsdale WM, 1999, ECOLOGY, V80, P1522, DOI 10.2307/176544; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; Mandak B, 2006, MOL ECOL, V15, P2653, DOI 10.1111/j.1365-294X.2006.02953.x; Mandak B, 2005, PLANT SYST EVOL, V253, P219, DOI 10.1007/s00606-005-0316-6; Mandak B, 2004, PRESLIA, V76, P15; Mandak B, 2003, PLANT INVASIONS: ECOLOGICAL THREATS AND MANAGEMENT SOLUTIONS, P313; Mandak B, 2003, ANN BOT-LONDON, V92, P265, DOI 10.1093/aob/mcg141; Mandak B, 2003, FLORA, V198, P45, DOI 10.1078/0367-2530-00075; Mandak B, 1998, PLANT INVASIONS: ECOLOGICAL MECHANISMS AND HUMAN RESPONSES, P209; Marquardt PE, 2004, MOL ECOL, V13, P3305, DOI 10.1111/j.1365-294X.2004.02341.x; Marrs RA, 2008, MOL ECOL, V17, P4197, DOI 10.1111/j.1365-294X.2008.03903.x; Mehes MS, 2007, PLANT SYST EVOL, V267, P47, DOI 10.1007/s00606-007-0534-1; Mehes M, 2009, J PLANT ECOL-UK, V2, P143, DOI 10.1093/jpe/rtp016; Munzbergova Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056953; Munzbergova Z, 2010, BIOL INVASIONS, V12, P2471, DOI 10.1007/s10530-009-9656-4; Musil I, 1971, ACTA MUSEI SILESIAE, P129; Musil I, 1971, ACTA MUSEI SILESIAE, P97; Myers ER, 2007, PLANT SYST EVOL, V264, P15, DOI 10.1007/s00606-006-0498-6; NEI M, 1978, GENETICS, V89, P583; NOZICKA J, 1965, PRACE VYZKUMNEHO UST, V31, P41; Parchman TL, 2011, AM J BOT, V98, P669, DOI 10.3732/ajb.1000378; Pardini EA, 2008, MOL ECOL, V17, P2865, DOI 10.1111/j.1365-294X.2008.03807.x; Parker KC, 2001, HEREDITY, V87, P99, DOI 10.1046/j.1365-2540.2001.00914.x; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Premoli AC, 2005, MOL ECOL, V14, P2319, DOI 10.1111/j.1365-294X.2005.02629.x; Pritchard JK, 2000, GENETICS, V155, P945; Prus-Glowacki W, 2012, FLORA, V207, P150, DOI 10.1016/j.flora.2011.11.006; Pysek Petr, 2002, Preslia (Prague), V74, P97; Rajora OP, 2000, MOL ECOL, V9, P339, DOI 10.1046/j.1365-294x.2000.00886.x; Rajora OP, 1998, CAN J BOT, V76, P500, DOI 10.1139/cjb-76-3-500; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; Reichard SH, 1997, CONSERV BIOL, V11, P193, DOI 10.1046/j.1523-1739.1997.95473.x; Rejmanek M, 1996, ECOLOGY, V77, P1655, DOI 10.2307/2265768; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Richardson BA, 2002, MOL ECOL, V11, P215, DOI 10.1046/j.1365-294X.2002.01435.x; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Richardson DM, 2000, BIOL REV, V75, P65, DOI 10.1017/S0006323199005435; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rosenthal DM, 2008, MOL ECOL, V17, P4657, DOI 10.1111/j.1365-294X.2008.03844.x; Rousset F, 1996, GENETICS, V142, P1357; Simberloff D, 2009, ANNU REV ECOL EVOL S, V40, P81, DOI 10.1146/annurev.ecolsys.110308.120304; SLATKIN M, 1995, GENETICS, V139, P457; Sokal R.R., 2012, BIOMETRY; Storchova H, 2000, TAXON, V49, P79, DOI 10.2307/1223934; Taylor DR, 2007, EVOLUTION, V61, P334, DOI 10.1111/j.1558-5646.2007.00037.x; Tilman D, 1997, ECOLOGY, V78, P81, DOI 10.1890/0012-9658(1997)078[0081:CIRLAG]2.0.CO;2; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Tolasz R, 1997, CLIMATE ATLAS CZECHI; Troupin D, 2006, MOL ECOL, V15, P3617, DOI 10.1111/j.1365-294X.2006.03047.x; van Kleunen M, 2010, ECOL LETT, V13, P947, DOI 10.1111/j.1461-0248.2010.01503.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vekemans X, 2004, MOL ECOL, V13, P921, DOI 10.1046/j.1365-294X.2004.02076.x; Walter R, 2004, AM J BOT, V91, P549, DOI 10.3732/ajb.91.4.549; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wendel G.W., 1990, SILVICS N AM, V654, P476; Williams CG, 2010, AM J BOT, V97, P846, DOI 10.3732/ajb.0900255; Williamson M., 1996, BIOL INVASIONS; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; YOUNG AG, 1994, HEREDITY, V72, P201, DOI 10.1038/hdy.1994.27; YOUNG RA, 2003, INTRO FOREST ECOSYST; Zayed A, 2008, P NATL ACAD SCI USA, V105, P3421, DOI 10.1073/pnas.0800107105; Zenger KR, 2003, MOL ECOL, V12, P789, DOI 10.1046/j.1365-294X.2003.01759.x; Zhang YY, 2010, MOL ECOL, V19, P1774, DOI 10.1111/j.1365-294X.2010.04609.x	120	13	16	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68514	10.1371/journal.pone.0068514	http://dx.doi.org/10.1371/journal.pone.0068514			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874648	Green Published, Green Submitted, gold			2022-12-27	WOS:000321765300051
J	Thogerson, CM; Brady, CM; Howard, RD; Mason, GJ; Pajor, EA; Vicino, GA; Garner, JP				Thogerson, Collette M.; Brady, Colleen M.; Howard, Richard D.; Mason, Georgia J.; Pajor, Edmond A.; Vicino, Greg A.; Garner, Joseph P.			Winning the Genetic Lottery: Biasing Birth Sex Ratio Results in More Grandchildren	PLOS ONE			English	Article							LOCAL RESOURCE COMPETITION; WHITE-TAILED DEER; FACULTATIVE ADJUSTMENT; MATERNAL DOMINANCE	Population dynamics predicts that on average parents should invest equally in male and female offspring; similarly, the physiology of mammalian sex determination is supposedly stochastic, producing equal numbers of sons and daughters. However, a high quality parent can maximize fitness by biasing their birth sex ratio (SR) to the sex with the greatest potential to disproportionately outperform peers. All SR manipulation theories share a fundamental prediction: grandparents who bias birth SR should produce more grandoffspring via the favored sex. The celebrated examples of biased birth SRs in nature consistent with SR manipulation theories provide compelling circumstantial evidence. However, this prediction has never been directly tested in mammals, primarily because the complete three-generation pedigrees needed to test whether individual favored offspring produce more grandoffspring for the biasing grandparent are essentially impossible to obtain in nature. Three-generation pedigrees were constructed using 90 years of captive breeding records from 198 mammalian species. Male and female grandparents consistently biased their birth SR toward the sex that maximized second-generation success. The most strongly male-biased granddams and grandsires produced respectively 29% and 25% more grandoffspring than non-skewing conspecifics. The sons of the most male-biasing granddams were 2.7 times as fecund as those of granddams with a 50:50 bias (similar results are seen in grandsires). Daughters of the strongest female-biasing granddams were 1.2 times as fecund as those of non-biasing females (this effect is not seen in grandsires). To our knowledge, these results are the first formal test of the hypothesis that birth SR manipulation is adaptive in mammals in terms of grandchildren produced, showing that SR manipulation can explain biased birth SR in general across mammalian species. These findings also have practical implications: parental control of birth SR has the potential to accelerate genetic loss and risk of extinction within captive populations of endangered species.	[Thogerson, Collette M.] US Fish & Wildlife Serv, Ecol Serv, Arlington, VA USA; [Brady, Colleen M.] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA; [Howard, Richard D.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Mason, Georgia J.] Univ Guelph, Dept Anim & Poultry Sci, Guelph, ON N1G 2W1, Canada; [Pajor, Edmond A.] Univ Calgary, Calgary, AB T2N 1N4, Canada; [Vicino, Greg A.] San Diego Zoo Global, Collect Husb Sci, San Diego, CA USA; [Garner, Joseph P.] Stanford Univ, Dept Comparat Med, Stanford, CA 94305 USA; [Garner, Joseph P.] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	United States Department of the Interior; US Fish & Wildlife Service; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Guelph; University of Calgary; Stanford University; Stanford University	Garner, JP (corresponding author), Stanford Univ, Dept Comparat Med, Stanford, CA 94305 USA.	jgarner@stanford.edu	Garner, Joseph P/C-8422-2009	Brady, Colleen/0000-0002-3828-9917	Purdue University	Purdue University	The project was supported by a graduate stipend to CMT from Purdue University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BURKE RL, 1995, ECOL RES, V10, P351, DOI 10.1007/BF02347861; Cameron EZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004195; Cameron EZ, 1999, BEHAV ECOL, V10, P472, DOI 10.1093/beheco/10.5.472; Cameron EZ, 2004, P ROY SOC B-BIOL SCI, V271, P1723, DOI 10.1098/rspb.2004.2773; Catalano R, 2005, INT J EPIDEMIOL, V34, P944, DOI 10.1093/ije/dyi081; CLUTTONBROCK TH, 1986, Q REV BIOL, V61, P339, DOI 10.1086/415033; CLUTTONBROCK TH, 1984, NATURE, V308, P358, DOI 10.1038/308358a0; Cockburn A, 2002, SEX RATIOS: CONCEPTS AND RESEARCH METHODS, P266, DOI 10.1017/CBO9780511542053.014; Faust LJ, 2000, ZOO BIOL, V19, P11, DOI 10.1002/(SICI)1098-2361(2000)19:1<11::AID-ZOO2>3.0.CO;2-V; Fisher RA, 1930, GENETICAL THEORY NAT; Glatston AR, 1997, APPL ANIM BEHAV SCI, V51, P209, DOI 10.1016/S0168-1591(96)01105-7; Gomendio M, 2006, SCIENCE, V314, P1445, DOI 10.1126/science.1133064; Grafen A, 2002, MODERN STAT LIFE SCI, Vxv; Grant VJ, 2007, J THEOR BIOL, V246, P708, DOI 10.1016/j.jtbi.2007.02.005; Grant VJ, 1996, HUM REPROD, V11, P2371; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; Sheldon BC, 2004, AM NAT, V163, P40, DOI 10.1086/381003; SILK JB, 1983, AM NAT, V121, P56, DOI 10.1086/284039; Silk JB, 2008, P ROY SOC B-BIOL SCI, V275, P1761, DOI 10.1098/rspb.2008.0340; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; VERME LJ, 1981, J WILDLIFE MANAGE, V45, P710, DOI 10.2307/3808704; WEATHERHEAD PJ, 1979, AM NAT, V113, P201, DOI 10.1086/283379; West SA, 2009, MONOGR POPUL BIOL, V44, P162; Woodward M., 2014, EPIDEMIOLOGY STUDY D	24	14	14	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e67867	10.1371/journal.pone.0067867	http://dx.doi.org/10.1371/journal.pone.0067867			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874458	Green Published, gold, Green Submitted			2022-12-27	WOS:000321765300015
J	Adachi, T; Takahara, K; Taneo, J; Uchiyama, Y; Inaba, K				Adachi, Takumi; Takahara, Kazuhiko; Taneo, Jun; Uchiyama, Yasuo; Inaba, Kayo			Particle Size of Latex Beads Dictates IL-1 beta Production Mechanism	PLOS ONE			English	Article							NALP3 INFLAMMASOME; NLRP3 INFLAMMASOME; AMYLOID-BETA; ACTIVATION; CRYSTALS; RECEPTOR; SILICA; CELLS; NANOPARTICLES; THIOREDOXIN	Macrophages (M phi) are well documented to produce IL-1 beta through various signaling pathways in response to small particles such as silica, asbestos and urea crystals, in the presence of lipopolysaccharide (LPS). However, it has not been clear to what extent particle size affects the response. To investigate this point, we stimulated bone marrow-derived macrophages (BMDM) with size-defined latex beads (LxB). Although both nano-sized (20 nm) and micro-sized (1,000 nm) LxB induced IL-1 beta production, only the nano-sized particles formed large intracellular vacuoles. In contrast, 100 nm LxB did not induce either of the responses. The same cellular responses were also observed in primary microglia cells. Although K+ efflux and NLRP3 activation in BMDM were crucial in response to both 20 and 1,000 nm LxB, only IL-1 beta production by 20 nm LxB was sensitive to cathepsin B and P2X(7), a receptor for ATP. The response by 1,000 nm LxB relied on a robust production of reactive oxygen species (ROS), since IL-1 beta production was remarkably reduced by ROS inhibitors such as diphenylene iodonium (DPI) and N-acetylcysteine (NAC). In contrast, IL-1 beta production by 20 nm LxB was augmented by NAC and in BMDM deficient in thioredoxin-binding protein-2 (TBP-2), a negative regulator of the ROS scavenger thioredoxin. These results suggest that the cells responded differently in their secretion of IL-1 beta depending on particle size, and that there is a range within which neither pathway works.	[Adachi, Takumi; Takahara, Kazuhiko; Taneo, Jun; Inaba, Kayo] Kyoto Univ, Grad Sch Biostudies, Dept Anim Dev & Physiol, Sakyo Ku, Kyoto, Japan; [Takahara, Kazuhiko; Inaba, Kayo] Core Res Evolut Sci & Technol, Japan Sci & Technol Agcy, Tokyo, Japan; [Uchiyama, Yasuo] Juntendo Univ, Grad Sch Med, Dept Cell Biol & Neurosci, Bunkyo Ku, Tokyo, Japan	Kyoto University; Japan Science & Technology Agency (JST); Juntendo University	Inaba, K (corresponding author), Kyoto Univ, Grad Sch Biostudies, Dept Anim Dev & Physiol, Sakyo Ku, Kyoto, Japan.	kayo@lif.kyoto-u.ac.jp			Japan Science and Technology Agency [20659036, 21590417, 100111500004]	Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by the Grant-in-Aid for Challenging Exploratory Research (20659036 to KI), Grant-in-Aid for Scientific Research (21590417 to KT) and Technology of Japan and Core Research for Evolutional Science and Technology, Japan Science and Technology Agency (100111500004 to KI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; Bruchard M, 2013, NAT MED, V19, P57, DOI 10.1038/nm.2999; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Deussing J, 1998, P NATL ACAD SCI USA, V95, P4516, DOI 10.1073/pnas.95.8.4516; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Dostert C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006510; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hernandez-Cuellar E, 2012, J IMMUNOL, V189, P5113, DOI 10.4049/jimmunol.1202479; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Jiang W, 2008, NAT NANOTECHNOL, V3, P145, DOI 10.1038/nnano.2008.30; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kitao Y, 2007, HUM MOL GENET, V16, P50, DOI 10.1093/hmg/ddl439; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Lee J, 2011, NAT CHEM BIOL, V7, P602, DOI [10.1038/nchembio.624, 10.1038/NCHEMBIO.624]; Lunov O, 2011, ACS NANO, V5, P9648, DOI 10.1021/nn203596e; Lupfer C, 2013, NAT IMMUNOL, V14, P480, DOI 10.1038/ni.2563; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Marks PA, 2006, SEMIN CANCER BIOL, V16, P436, DOI 10.1016/j.semcancer.2006.09.005; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Morishige T, 2010, BIOMATERIALS, V31, P6833, DOI 10.1016/j.biomaterials.2010.05.036; NAKAJIMA K, 1992, BRAIN RES, V577, P285, DOI 10.1016/0006-8993(92)90285-H; Niemi K, 2011, J IMMUNOL, V186, P6119, DOI 10.4049/jimmunol.1002843; Oka S, 2006, FASEB J, V20, pA45, DOI 10.1096/fj.05-4439fje; Palomaki J, 2011, ACS NANO, V5, P6861, DOI 10.1021/nn200595c; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Riteau N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.144; SAFTIG P, 1995, EMBO J, V14, P3599, DOI 10.1002/j.1460-2075.1995.tb00029.x; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Takahara K, 2011, EUR J IMMUNOL, V41, P1435, DOI 10.1002/eji.200940188; van de Veerdonk FL, 2010, P NATL ACAD SCI USA, V107, P3030, DOI 10.1073/pnas.0914795107; Verma A, 2008, NAT MATER, V7, P588, DOI 10.1038/nmat2202; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	42	10	11	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68499	10.1371/journal.pone.0068499	http://dx.doi.org/10.1371/journal.pone.0068499			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874646	Green Submitted, Green Published, gold			2022-12-27	WOS:000321736900090
J	Finan, A; Sopko, N; Dong, F; Turturice, B; Kiedrowski, M; Penn, MS				Finan, Amanda; Sopko, Nikolai; Dong, Feng; Turturice, Ben; Kiedrowski, Matthew; Penn, Marc S.			Bone Marrow SSEA1+Cells Support the Myocardium in Cardiac Pressure Overload	PLOS ONE			English	Article							ISCHEMIC-HEART FAILURE; STEM-CELLS; PROGENITOR CELLS; CORD BLOOD; INFARCTION; TRANSPLANTATION; REGENERATION; MULTIPOTENT; POPULATION; MOUSE	Rationale: Stage specific embryonic antigen 1+ (SSEA1+) cells have been described as the most primitive mesenchymal progenitor cell in the bone marrow. Cardiac injury mobilizes SSEA1+ cells into the peripheral blood but their in vivo function has not been characterized. Objective: We generated animals with chimeric bone marrow to determine the fate and function of bone marrow SSEA1+ cells in response to acute cardiac pressure overload. Methods and Results: Lethally irradiated mice were transplanted with normal bone marrow where the wild-type SSEA1+ cells were replaced with green fluorescent protein (GFP) SSEA1+ cells. Cardiac injury was induced by trans-aortic constriction (TAC). We identified significant GFP+ cell engraftment into the myocardium after TAC. Bone marrow GFP+ SSEA1 derived cells acquired markers of endothelial lineage, but did not express markers of c-kit+ cardiac progenitor cells. The function of bone marrow SSEA1+ cells after TAC was determined by transplanting lethally irradiated mice with bone marrow depleted of SSEA1+ cells (SSEA1-BM). The cardiac function of SSEA1-BM mice declined at a greater rate after TAC compared to their complete bone marrow transplant counterparts and was associated with decreased bone marrow cell engraftment and greater vessel rarefication in the myocardium. Conclusions: These results provide evidence for the recruitment of endogenous bone marrow SSEA1+ cells to the myocardium after TAC. We demonstrate that, in vivo, bone marrow SSEA1+ cells have the differentiation potential to acquire endothelial lineage markers. We also show that bone marrow SSEA1+ deficiency is associated with a reduced compensatory capacity to cardiac pressure overload, suggesting their importance in cardiac homeostasis. These data demonstrate that bone marrow SSEA1+ cells are critical for sustaining vascular density and cardiac repair to pressure overload.	[Penn, Marc S.] Summa Hlth Syst, Summa Cardiovas Inst, Akron, OH USA; [Finan, Amanda; Sopko, Nikolai; Dong, Feng; Turturice, Ben; Kiedrowski, Matthew; Penn, Marc S.] Northeast Ohio Med Univ, Dept Integrat Med Sci, Rootstown, OH USA	Summa Health System; Northeast Ohio Medical University (NEOMED)	Penn, MS (corresponding author), Summa Hlth Syst, Summa Cardiovas Inst, Akron, OH USA.	mpenn2@neomed.edu	Turturice, Benjamin/AAF-6819-2019; Sopko, Nikolai/AAL-2036-2020	Turturice, Benjamin/0000-0001-9382-4612; Sopko, Nikolai/0000-0003-4913-0570	Skirball Foundation; American Heart Association; Corbin Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	Skirball Foundation; American Heart Association(American Heart Association); Corbin Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Skirball Foundation, American Heart Association, and Corbin Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal U, 2011, J MOL CELL CARDIOL, V50, P426, DOI 10.1016/j.yjmcc.2010.08.024; Anjos-Afonso F, 2007, BLOOD, V109, P1298, DOI 10.1182/blood-2006-06-030551; Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Blin G, 2010, J CLIN INVEST, V120, P1125, DOI 10.1172/JCI40120; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Dawn B, 2008, STEM CELLS, V26, P1646, DOI 10.1634/stemcells.2007-0715; de Weger RA, 2008, BONE MARROW TRANSPL, V41, P563, DOI 10.1038/sj.bmt.1705939; Dong F, 2012, CIRCULATION, V126, P314, DOI 10.1161/CIRCULATIONAHA.111.082453; Dong F, 2010, CIRC RES, V106, P601, DOI 10.1161/CIRCRESAHA.109.208967; Dor FJMF, 2006, EXP HEMATOL, V34, P1573, DOI 10.1016/j.exphem.2006.06.016; Dutta P, 2012, NATURE, V487, P325, DOI 10.1038/nature11260; FAULK WP, 1989, SEMIN THROMB HEMOST, V15, P88, DOI 10.1055/s-2007-1002691; Fazel S, 2006, J CLIN INVEST, V116, P1865, DOI 10.1172/JCI27019; Finan Amanda, 2013, Front Biosci (Elite Ed), V5, P232; Finan A, 2012, CYTOTHERAPY, V14, P983, DOI 10.3109/14653249.2012.684380; Fransioli J, 2008, STEM CELLS, V26, P1315, DOI 10.1634/stemcells.2007-0751; He JQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027719; Hilfiker-Klemer D, 2006, J AM COLL CARDIOL, V48, pA56, DOI 10.1016/j.jacc.2006.07.007; Kucia M, 2007, LEUKEMIA, V21, P297, DOI 10.1038/sj.leu.2404470; Kucia M, 2006, LEUKEMIA, V20, P857, DOI 10.1038/sj.leu.2404171; Kucia MJ, 2008, STEM CELLS, V26, P2083, DOI 10.1634/stemcells.2007-0922; LaRocca TJ, 2012, J MOL CELL CARDIOL, V53, P223, DOI 10.1016/j.yjmcc.2012.05.016; Lawal RA, 2011, TISSUE ENG PART B-RE, V17, P415, DOI [10.1089/ten.teb.2011.0197, 10.1089/ten.TEB.2011.0197]; Li SH, 2013, EUR HEART J, V34, P1157, DOI 10.1093/eurheartj/ehs072; Masuda H, 2011, CIRC RES, V109, P20, DOI 10.1161/CIRCRESAHA.110.231837; Mouquet F, 2005, CIRC RES, V97, P1090, DOI 10.1161/01.RES.0000194330.66545.f5; Mueller P, 2008, CARDIOVASC RES, V77, P151, DOI 10.1093/cvr/cvm037; Muller P, 2009, CARDIOVASC RES, V83, P106, DOI 10.1093/cvr/cvp123; Ott Harald C, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS27, DOI 10.1038/ncpcardio0771; Pelosi E, 2002, BLOOD, V100, P3203, DOI 10.1182/blood-2002-05-1511; Penn MS, 2013, CIRC RES, V112, P816, DOI 10.1161/CIRCRESAHA.111.300440; Quaini F, 2002, NEW ENGL J MED, V346, P5, DOI 10.1056/NEJMoa012081; Ratajczak J, 2011, EXP HEMATOL, V39, P225, DOI 10.1016/j.exphem.2010.10.007; Schenk S, 2007, STEM CELLS, V25, P245, DOI 10.1634/stemcells.2006-0293; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; Son BR, 2006, STEM CELLS, V24, P1254, DOI 10.1634/stemcells.2005-0271; Sopko NA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015187; Spruill LS, 2008, J MOL CELL CARDIOL, V44, P69, DOI 10.1016/j.yjmcc.2007.10.011; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Urbanek K, 2005, P NATL ACAD SCI USA, V102, P8692, DOI 10.1073/pnas.0500169102; Urbanek K, 2003, P NATL ACAD SCI USA, V100, P10440, DOI 10.1073/pnas.1832855100; Wojakowski W, 2010, INT J ONCOL, V37, P237, DOI 10.3892/ijo_00000671; Wojakowski W, 2009, J AM COLL CARDIOL, V53, P1, DOI 10.1016/j.jacc.2008.09.029; Zuba-Surma EK, 2011, J CELL MOL MED, V15, P1319, DOI 10.1111/j.1582-4934.2010.01126.x; Zuba-Surma EK, 2008, CYTOM PART A, V73A, P1116, DOI 10.1002/cyto.a.20667	47	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68528	10.1371/journal.pone.0068528	http://dx.doi.org/10.1371/journal.pone.0068528			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874657	Green Published, Green Submitted, gold			2022-12-27	WOS:000321736900092
J	Okumura, N; Tsujihata, M; Momohara, C; Yoshioka, I; Suto, K; Nonomura, N; Okuyama, A; Takao, T				Okumura, Nobuaki; Tsujihata, Masao; Momohara, Chikahiro; Yoshioka, Iwao; Suto, Kouzou; Nonomura, Norio; Okuyama, Akihiko; Takao, Toshifumi			Diversity in Protein Profiles of Individual Calcium Oxalate Kidney Stones	PLOS ONE			English	Article							CRYSTAL MATRIX PROTEIN; F1 ACTIVATION PEPTIDE; PROTEOMIC ANALYSIS; POTENT INHIBITOR; URINARY STONE; MESSENGER-RNA; FIBRONECTIN; PROTHROMBIN; GROWTH; CRYSTALLIZATION	Calcium oxalate kidney stones contain low amounts of proteins, some of which have been implicated in progression or prevention of kidney stone formation. To gain insights into the pathophysiology of urolithiasis, we have characterized protein components of calcium oxalate kidney stones by proteomic approaches. Proteins extracted from kidney stones showed highly heterogeneous migration patterns in gel electrophoresis as reported. This was likely to be mainly due to proteolytic degradation and protein-protein crosslinking of Tamm-Horsfall protein and prothrombin. Protein profiles of calcium oxalate kidney stones were obtained by in-solution protease digestion followed by nanoLC-MALDI- tandem mass spectrometry, which resulted in identification of a total of 92 proteins in stones from 9 urolithiasis patients. Further analysis showed that protein species and their relative amounts were highly variable among individual stones. Although proteins such as prothrombin, osteopontin, calgranulin A and calgranulin B were found in most stones tested, some samples had high contents of prothrombin and osteopontin, while others had high contents of calgranulins. In addition, calgranulin-rich stones had various neutrophil-enriched proteins such as myeloperoxidase and lactotransferrin. These proteomic profiles of individual kidney stones suggest that multiple systems composed of different groups of proteins including leucocyte-derived ones are differently involved in pathogenesis of individual kidney stones depending on situations.	[Okumura, Nobuaki] Osaka Univ, Inst Prot Res, Lab Homeostat Integrat, Div Integrated Prot Funct, Suita, Osaka 565, Japan; [Suto, Kouzou; Takao, Toshifumi] Osaka Univ, Inst Prot Res, Lab Prot Profiling & Funct Prote, Res Ctr Struct & Funct Prote, Suita, Osaka 565, Japan; [Tsujihata, Masao; Momohara, Chikahiro; Yoshioka, Iwao; Nonomura, Norio; Okuyama, Akihiko] Osaka Univ, Grad Sch Med, Dept Urol, Suita, Osaka 565, Japan	Osaka University; Osaka University; Osaka University	Okumura, N (corresponding author), Osaka Univ, Inst Prot Res, Lab Homeostat Integrat, Div Integrated Prot Funct, Suita, Osaka 565, Japan.	nokumura@protein.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology-Japan; Grants-in-Aid for Scientific Research [23570164] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology-Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by funds from the Ministry of Education, Culture, Sports, Science and Technology-Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Berggren KN, 2002, PROTEOMICS, V2, P486, DOI 10.1002/1615-9861(200205)2:5<486::AID-PROT486>3.0.CO;2-X; Bergsland KJ, 2006, AM J PHYSIOL-RENAL, V291, pF530, DOI 10.1152/ajprenal.00370.2005; Borregaard N, 2007, TRENDS IMMUNOL, V28, P340, DOI 10.1016/j.it.2007.06.002; BOYCE WH, 1968, AM J MED, V45, P673, DOI 10.1016/0002-9343(68)90203-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Canales BK, 2010, UROLOGY, V76, DOI 10.1016/j.urology.2010.05.005; Chen WC, 2008, J CLIN LAB ANAL, V22, P77, DOI 10.1002/jcla.20214; Grover PK, 2006, J PATHOL, V210, P273, DOI 10.1002/path.2061; Grover PK, 2002, CLIN SCI, V102, P425, DOI 10.1042/CS20010223; HESS B, 1992, UROL RES, V20, P83, DOI 10.1007/BF00294343; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Kaneko K, 2005, UROL RES, V33, P415, DOI 10.1007/s00240-005-0480-8; Kaneko K, 2004, ANAL BIOCHEM, V324, P191, DOI 10.1016/j.ab.2003.09.018; Kaneko K, 2012, INT J UROL, V19, P765, DOI 10.1111/j.1442-2042.2012.03005.x; KOHRI K, 1993, J BIOL CHEM, V268, P15180; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lominadze G, 2005, MOL CELL PROTEOMICS, V4, P1503, DOI 10.1074/mcp.M500143-MCP200; MAXFIELD M, 1963, ANNU REV MED, V14, P99, DOI 10.1146/annurev.me.14.020163.000531; Merchant ML, 2008, AM J PHYSIOL-RENAL, V295, pF1254, DOI 10.1152/ajprenal.00134.2008; Mo L, 2004, KIDNEY INT, V66, P1159, DOI 10.1111/j.1523-1755.2004.00867.x; Mo L, 2007, AM J PHYSIOL-RENAL, V293, pF1935, DOI 10.1152/ajprenal.00383.2007; Mushtaq S, 2007, CLIN CHIM ACTA, V384, P41, DOI 10.1016/j.cca.2007.05.015; NAKAGAWA Y, 1983, J BIOL CHEM, V258, P2594; Okumura N, 2005, PROTEOMICS, V5, P2896, DOI 10.1002/pmic.200401181; Pillay SN, 1998, AM J PHYSIOL-RENAL, V275, pF255, DOI 10.1152/ajprenal.1998.275.2.F255; ROBERTSON WG, 1968, CLIN SCI, V34, P579; RYALL RL, 1995, CLIN SCI, V89, P533, DOI 10.1042/cs0890533; RYALL RL, 2004, NEPHRON PHYSIOL, V98, P37, DOI DOI 10.1159/000080262; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; STAPLETON AMF, 1995, BRIT J UROL, V75, P712, DOI 10.1111/j.1464-410X.1995.tb07377.x; STAPLETON AMF, 1993, BIOCHEM BIOPH RES CO, V195, P1199, DOI 10.1006/bbrc.1993.2171; Tsujihata M, 2003, UROL RES, V31, P368, DOI 10.1007/s00240-003-0349-7; Tsujihata M, 2000, J UROLOGY, V164, P1718, DOI 10.1016/S0022-5347(05)67095-4; Tsujihata M, 2008, INT J UROL, V15, P115, DOI 10.1111/j.1442-2042.2007.01953.x; Tsujihata M, 2006, INT J UROL, V13, P743, DOI 10.1111/j.1442-2042.2006.01396.x; Vervaet BA, 2009, KIDNEY INT, V75, P41, DOI 10.1038/ki.2008.450; WORCESTER EM, 1992, J BONE MINER RES, V7, P1029; WORCESTER EM, 1995, ANN NY ACAD SCI, V760, P375, DOI 10.1111/j.1749-6632.1995.tb44661.x	38	23	23	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68624	10.1371/journal.pone.0068624	http://dx.doi.org/10.1371/journal.pone.0068624			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874695	Green Published, Green Submitted, gold			2022-12-27	WOS:000321736900099
J	Dowling, NM; Gleason, CE; Manson, JE; Hodis, HN; Miller, VM; Brinton, EA; Neal-Perry, G; Santoro, MN; Cedars, M; Lobo, R; Merriam, GR; Wharton, W; Naftolin, F; Taylor, H; Harman, SM; Asthana, S				Dowling, N. Maritza; Gleason, Carey E.; Manson, JoAnn E.; Hodis, Howard N.; Miller, Virginia M.; Brinton, Eliot A.; Neal-Perry, Genevieve; Santoro, M. Nanette; Cedars, Marcelle; Lobo, Rogerio; Merriam, George R.; Wharton, Whitney; Naftolin, Frederick; Taylor, Hugh; Harman, S. Mitchell; Asthana, Sanjay			Characterization of Vascular Disease Risk in Postmenopausal Women and Its Association with Cognitive Performance	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; APOLIPOPROTEIN-E GENOTYPE; NON-HISPANIC WHITES; BODY-MASS INDEX; CARDIOVASCULAR RISK; ALZHEIMERS-DISEASE; SOCIOECONOMIC-STATUS; DENSITY-LIPOPROTEIN; MAXIMUM-LIKELIHOOD; HEALTH	Objectives: While global measures of cardiovascular (CV) risk are used to guide prevention and treatment decisions, these estimates fail to account for the considerable interindividual variability in pre-clinical risk status. This study investigated heterogeneity in CV risk factor profiles and its association with demographic, genetic, and cognitive variables. Methods: A latent profile analysis was applied to data from 727 recently postmenopausal women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS). Women were cognitively healthy, within three years of their last menstrual period, and free of current or past CV disease. Education level, apolipoprotein E epsilon 4 allele (APOE4), ethnicity, and age were modeled as predictors of latent class membership. The association between class membership, characterizing CV risk profiles, and performance on five cognitive factors was examined. A supervised random forest algorithm with a 10-fold cross-validation estimator was used to test accuracy of CV risk classification. Results: The best-fitting model generated two distinct phenotypic classes of CV risk 62% of women were "low-risk" and 38% "high-risk". Women classified as low-risk outperformed high-risk women on language and mental flexibility tasks (p = 0.008) and a global measure of cognition (p = 0.029). Women with a college degree or above were more likely to be in the low-risk class (OR = 1.595, p = 0.044). Older age and a Hispanic ethnicity increased the probability of being at high-risk (OR = 1.140, p = 0.002; OR = 2.622, p = 0.012; respectively). The prevalence rate of APOE-epsilon 4 was higher in the high-risk class compared with rates in the low-risk class. Conclusion: Among recently menopausal women, significant heterogeneity in CV risk is associated with education level, age, ethnicity, and genetic indicators. The model-based latent classes were also associated with cognitive function. These differences may point to phenotypes for CV disease risk. Evaluating the evolution of phenotypes could in turn clarify preclinical disease, and screening and preventive strategies. ClinicalTrials.gov NCT00154180	[Dowling, N. Maritza] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biostat & Med Informat, Madison, WI 53706 USA; [Dowling, N. Maritza; Gleason, Carey E.; Asthana, Sanjay] Wisconsin Alzheimers Dis Res Ctr, Madison, WI USA; [Gleason, Carey E.; Wharton, Whitney; Asthana, Sanjay] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI USA; [Gleason, Carey E.; Wharton, Whitney; Asthana, Sanjay] William S Middleton Mem Vet Adm Med Ctr, Geriatr Res Educ & Clin Ctr, Madison, WI USA; [Manson, JoAnn E.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA; [Hodis, Howard N.] Univ So Calif, Atherosclerosis Res Unit, Los Angeles, CA USA; [Miller, Virginia M.] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN USA; [Miller, Virginia M.] Mayo Clin, Dept Surg, Rochester, MN USA; [Brinton, Eliot A.] Univ Utah, Dept Cardiovasc Genet, Salt Lake City, UT USA; [Neal-Perry, Genevieve] Albert Einstein Coll Med, Dept Obstet & Gynecol & Womens Hlth, Bronx, NY 10467 USA; [Neal-Perry, Genevieve] Albert Einstein Coll Med, Dominick Purpura Dept Neurosci, Bronx, NY 10467 USA; [Santoro, M. Nanette] Univ Colorado, Sch Med, Dept Obstet & Gynecol, Aurora, CO USA; [Cedars, Marcelle] Univ Calif San Francisco, Dept Obstet & Gynecol, San Francisco, CA 94143 USA; [Lobo, Rogerio] Columbia Univ Coll Phys & Surg, Dept Obstet & Gynecol, New York, NY 10032 USA; [Merriam, George R.] VA Puget Sound Hlth Care Syst, Seattle, WA USA; [Merriam, George R.] Univ Washington, Div Metab Endocrinol & Nutr, Seattle, WA 98195 USA; [Naftolin, Frederick] NYU, Dept Obstet & Gynecol, New York, NY 10016 USA; [Taylor, Hugh] Yale Univ, Sch Med, Dept Obstet & Gynecol, New Haven, CT 06510 USA; [Harman, S. Mitchell] Kronos Longev Res Inst, Phoenix, AZ USA; [Harman, S. Mitchell] Phoenix VA Med Ctr, Phoenix, AZ USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Southern California; Mayo Clinic; Mayo Clinic; Utah System of Higher Education; University of Utah; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California San Francisco; Columbia University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; New York University; Yale University	Dowling, NM (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Biostat & Med Informat, Madison, WI 53706 USA.	nmdowlin@biostat.wisc.edu	Dowling, N. Maritza/AAW-1928-2021	Dowling, N. Maritza/0000-0001-8642-7299	National Institutes of Health (NIH) [R01 AG029624, P50AG033514, R01AG031790]; Aurora Foundation; NIH [HL90639]; Mayo [CTSA1 UL1 RR024150]; Einstein College of Medicine CTSA [UL1 RR025750, KL2 RR025749, TL1 RR025748]; Mayo Foundation; United States Department of Veterans Affairs Puget Sound Health Care System; Brigham and Women's Hospital/Harvard Medical School CTSA; CTSA [UL1 RR024139]; UCSF CTSA from the National Center for Advancing Translational Sciences (NCATS), a component of the NIH [UL1 RR024131]; NIH Roadmap for Medical Research; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025750, TL1RR025748, UL1RR024139, KL2RR025749, UL1RR024150, UL1RR024131] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029624, R01AG031790, P50AG033514] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Aurora Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo; Einstein College of Medicine CTSA; Mayo Foundation; United States Department of Veterans Affairs Puget Sound Health Care System; Brigham and Women's Hospital/Harvard Medical School CTSA; CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); UCSF CTSA from the National Center for Advancing Translational Sciences (NCATS), a component of the NIH; NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The KEEPS-cog project was supported by grants from the National Institutes of Health (NIH) R01 AG029624, P50AG033514, and R01AG031790. The parent KEEPS trial is funded by grants from the Aurora Foundation to the Kronos Longevity Research Institute, NIH HL90639 to VMM, Mayo CTSA1 UL1 RR024150, the Einstein College of Medicine CTSA UL1 RR025750, KL2 RR025749 and TL1 RR025748, the Mayo Foundation, the United States Department of Veterans Affairs Puget Sound Health Care System, Brigham and Women's Hospital/Harvard Medical School CTSA, CTSA UL1 RR024139 and UCSF CTSA UL1 RR024131 from the National Center for Advancing Translational Sciences (NCATS), a component of the NIH and NIH Roadmap for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Bandeen-Roche K, 1997, J AM STAT ASSOC, V92, P1375, DOI 10.2307/2965407; Biegelsen ES, 1999, CORONARY ARTERY DIS, V10, P241; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2012, BREIMAN CUTLERS RAND; BURCHFIEL CM, 1990, AM J EPIDEMIOL, V131, P57, DOI 10.1093/oxfordjournals.aje.a115485; Carew TG, 1997, NEUROPSYCHOLOGY, V11, P400, DOI 10.1037/0894-4105.11.3.400; Chan NN, 2001, J AM COLL CARDIOL, V38, P1814, DOI 10.1016/S0735-1097(01)01669-2; Christian AH, 2005, MAYO CLIN PROC, V80, P1593, DOI 10.4065/80.12.1593; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DANNENBERG AL, 1988, AM J PUBLIC HEALTH, V78, P676, DOI 10.2105/AJPH.78.6.676; Deary IJ, 2002, NATURE, V418, P932, DOI 10.1038/418932a; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Derby CA, 2010, ETHNIC DIS, V20, P396; Dupuy AM, 2001, GERONTOLOGY, V47, P213, DOI 10.1159/000052801; EAKER ED, 1989, PSYCHIAT CLIN N AM, V12, P167; Erdine S, 2006, HERZ, V31, P331, DOI 10.1007/s00059-006-2829-3; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Ferre R, 2011, ATHEROSCLEROSIS, V216, P115, DOI 10.1016/j.atherosclerosis.2011.01.039; Giovannetti T, 2001, ARCH CLIN NEUROPSYCH, V16, P547, DOI 10.1016/S0887-6177(00)00066-4; Grundy SM, 1999, J AM COLL CARDIOL, V34, P1348, DOI 10.1016/S0735-1097(99)00387-3; Harman SM, 2005, CLIMACTERIC, V8, P3, DOI 10.1080/13697130500042417; HARMAN SM, 2009, MENOPAUSAL MED, V17, pS1; Harris TB, 1997, AM J CLIN NUTR, V66, P837, DOI 10.1093/ajcn/66.4.837; HATYROLER, 1989, HYPERTENSION, V13, P194; HIRATA K, 1995, CIRC RES, V76, P958, DOI 10.1161/01.RES.76.6.958; Hodis HN, 2001, ANN INTERN MED, V135, P939, DOI 10.7326/0003-4819-135-11-200112040-00005; Howard Barbara V, 2002, Circulation, V105, pe132, DOI 10.1161/01.CIR.0000013953.41667.09; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; JENSEN J, 1990, MATURITAS, V12, P321, DOI 10.1016/0378-5122(90)90012-U; Kahn R, 2005, DIABETES CARE, V28, P2289, DOI 10.2337/diacare.28.9.2289; Kerwin DR, 2011, J AM GERIATR SOC, V59, P107, DOI 10.1111/j.1532-5415.2010.03219.x; Kerwin DR, 2010, J AM GERIATR SOC, V58, P1427, DOI 10.1111/j.1532-5415.2010.02969.x; Kivipelto M, 2001, BMJ-BRIT MED J, V322, P1447, DOI 10.1136/bmj.322.7300.1447; Kivipelto M, 2002, ANN INTERN MED, V137, P149, DOI 10.7326/0003-4819-137-3-200208060-00006; Knopman D, 2001, NEUROLOGY, V56, P42, DOI 10.1212/WNL.56.1.42; Kofler BM, 2012, ATHEROSCLEROSIS, V221, P467, DOI 10.1016/j.atherosclerosis.2012.01.042; KRAUS JF, 1980, AM J EPIDEMIOL, V111, P407, DOI 10.1093/oxfordjournals.aje.a112915; Kuvin JT, 2003, AM J CARDIOL, V92, P275, DOI 10.1016/S0002-9149(03)00623-4; LAAKSO M, 1990, ARTERIOSCLEROSIS, V10, P223, DOI 10.1161/01.ATV.10.2.223; Lazarsfeld P.F., 1968, LATENT STRUCTURE ANA; Liu J, 2004, JAMA-J AM MED ASSOC, V291, P2591, DOI 10.1001/jama.291.21.2591; Lo YT, 2001, BIOMETRIKA, V88, P767, DOI 10.1093/biomet/88.3.767; LUEPKER RV, 1993, CIRCULATION, V88, P2172, DOI 10.1161/01.CIR.88.5.2172; Magidson J, 2001, SOCIOL METHODOL, V31, P223, DOI 10.1111/0081-1750.00096; McLachlan G., 2000, WILEY SER PROB STAT; McSweeney JC, 2003, CIRCULATION, V108, P2619, DOI 10.1161/01.CIR.0000097116.29625.7C; Mickanin J, 1994, NEUROPSYCHOLOGY, V8, P385, DOI DOI 10.1037/0894-4105.8.3.385; Miller VM, 2009, J CARDIOVASC TRANSL, V2, P228, DOI 10.1007/s12265-009-9104-y; MITCHELL BD, 1990, AM J EPIDEMIOL, V131, P423, DOI 10.1093/oxfordjournals.aje.a115517; Mosca, 2011, CIRCULATION, V123, pE624, DOI 10.1161/CIR.0b013e318222b330; Mosca L, 2010, CIRC-CARDIOVASC QUAL, V3, P120, DOI 10.1161/CIRCOUTCOMES.109.915538; Muthen B., 2010, MPLUS USERS GUIDE; Naqvi TZ, 2010, J AM SOC ECHOCARDIOG, V23, P809, DOI 10.1016/j.echo.2010.05.005; *NIH, 1998, OBES RES S2, V6, pS51, DOI DOI 10.1001/JAMA.2012.39; NYBOE J, 1989, EUR HEART J, V10, P910, DOI 10.1093/oxfordjournals.eurheartj.a059401; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; O'Keefe JH, 2009, MAYO CLIN PROC, V84, P741, DOI 10.1016/S0025-6196(11)60525-9; Pappolla MA, 2003, NEUROLOGY, V61, P199, DOI 10.1212/01.WNL.0000070182.02537.84; Reilly M, 2006, PLOS MED, V3, P736, DOI 10.1371/journal.pmed.0030258; Rodondi N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034287; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; Schachinger V, 2000, CIRCULATION, V101, P1899, DOI 10.1161/01.CIR.101.16.1899; SCHAEFER EJ, 1994, J LIPID RES, V35, P779; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sherwin BB, 2003, ENDOCR REV, V24, P133, DOI 10.1210/er.2001-0016; SHETTERLY SM, 1994, J HYPERTENS, V12, P1095; Small BJ, 2004, PSYCHOL AGING, V19, P592, DOI 10.1037/0882-7974.19.4.592; STEIGER JH, 1990, MULTIVAR BEHAV RES, V25, P173, DOI 10.1207/s15327906mbr2502_4; Taddei S, 1996, HYPERTENSION, V28, P576, DOI 10.1161/01.HYP.28.4.576; WEINGARTNER HJ, 1993, GERONTOLOGIST, V33, P637, DOI 10.1093/geront/33.5.637; Wilson PWF, 1996, ARTERIOSCL THROM VAS, V16, P1250, DOI 10.1161/01.ATV.16.10.1250; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Yaffe K, 2002, ARCH NEUROL-CHICAGO, V59, P378, DOI 10.1001/archneur.59.3.378; Yaffe K, 1997, ARCH NEUROL-CHICAGO, V54, P1110, DOI 10.1001/archneur.1997.00550210044011	78	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e68741	10.1371/journal.pone.0068741	http://dx.doi.org/10.1371/journal.pone.0068741			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23874743	Green Published, Green Submitted, gold			2022-12-27	WOS:000322000600022
J	Lucas, GM; Mullen, BA; Galai, N; Moore, RD; Cook, K; McCaul, ME; Glass, S; Oursler, KK; Rand, C				Lucas, Gregory M.; Mullen, Bernadette Anna; Galai, Noya; Moore, Richard D.; Cook, Katie; McCaul, Mary E.; Glass, Sheldon; Oursler, Krisann K.; Rand, Cynthia			Directly Administered Antiretroviral Therapy for HIV-Infected Individuals in Opioid Treatment Programs: Results from a Randomized Clinical Trial	PLOS ONE			English	Article							DRUG-USERS; ADHERENCE; INTERVENTION; OUTCOMES; METAANALYSIS	Background: Data regarding the efficacy of directly administered antiretroviral therapy (DAART) are mixed. Opioid treatment programs (OTPs) provide a convenient framework for DAART. In a randomized controlled trial, we compared DAART and self-administered therapy (SAT) among HIV-infected subjects attending five OTPs in Baltimore, MD. Methods: HIV-infected individuals attending OTPs were eligible if they were not taking antiretroviral therapy (ART) or were virologically failing ART at last clinical assessment. In subjects assigned to DAART, we observed one ART dose per weekday at the OTP for up to 12 months. SAT subjects administered ART at home. The primary efficacy comparison was the between-arm difference in the average proportions with HIV RNA <50 copies/mL during the intervention phase (3-, 6-, and 12-month study visits), using a logistic regression model accounting for intra-person correlation due to repeated observations. Adherence was measured with electronic monitors in both arms. Results: We randomized 55 and 52 subjects from five Baltimore OTPs to DAART and SAT, respectively. The average proportions with HIV RNA <50 copies/mL during the intervention phase were 0.51 in DAART and 0.40 in SAT (difference 0.11, 95% CI: -0.020 to 0.24). There were no significant differences between arms in electronically-measured adherence, average CD4 cell increase from baseline, average change in log(10) HIV RNA from baseline, opportunistic conditions, hospitalizations, mortality, or the development of new drug resistance mutations. Conclusions: In this randomized trial, we found little evidence that DAART provided clinical benefits compared to SAT among HIV-infected subjects attending OTPs.	[Lucas, Gregory M.; Mullen, Bernadette Anna; Cook, Katie] Johns Hopkins Univ, Sch Med, Div Infect Dis, Dept Med, Baltimore, MD 21205 USA; [Galai, Noya] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Galai, Noya] Univ Haifa, Dept Stat, IL-31999 Haifa, Israel; [Moore, Richard D.] Johns Hopkins Univ, Sch Med, Div Gen Internal Med, Dept Med, Baltimore, MD 21205 USA; [Rand, Cynthia] Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care, Dept Med, Baltimore, MD 21205 USA; [McCaul, Mary E.; Glass, Sheldon] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Oursler, Krisann K.] Univ Maryland, Sch Med, Dept Med, Div Gerontol & Geriatr Med, Baltimore, MD 21201 USA; [Oursler, Krisann K.] Dept Vet Affairs Med Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Haifa; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore	Lucas, GM (corresponding author), Johns Hopkins Univ, Sch Med, Div Infect Dis, Dept Med, Baltimore, MD 21205 USA.	glucas@jhmi.edu	Galai, Noya/HII-8086-2022		National Institutes of Health [R01 DA018577, K23 DA15616, R01 DA11602, R01 AA16893, K24 DA00432]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA016893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011602, R01DA018577, K24DA000432, K23DA015616] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This project was supported by the National Institutes of Health [R01 DA018577 and K23 DA15616 to G.M.L., and R01 DA11602, R01 AA16893, and K24 DA00432 to R.D.M.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute on Drug Abuse or the National Institutes of Health.	Altice FL, 2007, CLIN INFECT DIS, V45, P770, DOI 10.1086/521166; ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; Berg KM, 2011, CLIN INFECT DIS, V53, P936, DOI 10.1093/cid/cir537; Berg KM, 2011, DRUG ALCOHOL DEPEN, V113, P192, DOI 10.1016/j.drugalcdep.2010.07.025; Berg KM, 2009, CONTEMP CLIN TRIALS, V30, P481, DOI 10.1016/j.cct.2009.05.003; CDC (Centers for Disease Control and Prevention), 1993, MMWR RECOMM REP, V41, P1; Ford N, 2009, LANCET, V374, P2064, DOI 10.1016/S0140-6736(09)61671-8; Goldie SJ, 2003, AM J MED, V115, P632, DOI 10.1016/j.amjmed.2003.07.007; Gross R, 2009, ARCH INTERN MED, V169, P1224, DOI 10.1001/archinternmed.2009.172; Hart JE, 2010, JAIDS-J ACQ IMM DEF, V54, P167, DOI 10.1097/QAI.0b013e3181d9a330; Johnson Victoria A, 2009, Top HIV Med, V17, P138; Lucas GM, 2006, CLIN INFECT DIS, V42, P1628, DOI 10.1086/503905; Macalino GE, 2007, AIDS, V21, P1473, DOI 10.1097/QAD.0b013e32811ebf68; Maru DSR, 2009, JAIDS-J ACQ IMM DEF, V50, P176, DOI 10.1097/QAI.0b013e3181938e7e; Mullen BA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-45; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Wohl AR, 2006, CLIN INFECT DIS, V42, P1619, DOI 10.1086/503906; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	18	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68286	10.1371/journal.pone.0068286	http://dx.doi.org/10.1371/journal.pone.0068286			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874575	Green Published, Green Submitted, gold			2022-12-27	WOS:000322064300023
J	Milani, C; Hevia, A; Foroni, E; Duranti, S; Turroni, F; Lugli, GA; Sanchez, B; Martin, R; Gueimonde, M; van Sinderen, D; Margolles, A; Ventura, M				Milani, Christian; Hevia, Arancha; Foroni, Elena; Duranti, Sabrina; Turroni, Francesca; Lugli, Gabriele Andrea; Sanchez, Borja; Martin, Rebeca; Gueimonde, Miguel; van Sinderen, Douwe; Margolles, Abelardo; Ventura, Marco			Assessing the Fecal Microbiota: An Optimized Ion Torrent 16S rRNA Gene-Based Analysis Protocol	PLOS ONE			English	Article							GUT MICROBIOTA; PHYLOGENETIC MICROARRAY; INTESTINAL MICROBIOTA; BACTERIAL; DIVERSITY; COMMUNITIES; SEQUENCE; SUCCESSION; HEALTH; IMPACT	Assessing the distribution of 16S rRNA gene sequences within a biological sample represents the current state-of-the-art for determination of human gut microbiota composition. Advances in dissecting the microbial biodiversity of this ecosystem have very much been dependent on the development of novel high-throughput DNA sequencing technologies, like the Ion Torrent. However, the precise representation of this bacterial community may be affected by the protocols used for DNA extraction as well as by the PCR primers employed in the amplification reaction. Here, we describe an optimized protocol for 16S rRNA gene-based profiling of the fecal microbiota.	[Milani, Christian; Foroni, Elena; Duranti, Sabrina; Lugli, Gabriele Andrea; Ventura, Marco] Univ Parma, Lab Probiogen, Dept Life Sci, I-43100 Parma, Italy; [Hevia, Arancha; Sanchez, Borja; Gueimonde, Miguel; Margolles, Abelardo] IPLA CSIC, Dept Microbiol & Bioquim Prod Lacteos, Villaviciosa, Asturias, Spain; [Turroni, Francesca; van Sinderen, Douwe] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Biosci Inst, Cork, Ireland; [Turroni, Francesca; van Sinderen, Douwe] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Biosci Inst, Cork, Ireland; [Martin, Rebeca] MICALIS Microbiol Lalimentat Serv Sante humaine, INRA, UMR 1319, F-78352 Jouy En Josas, France	University of Parma; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Productos Lacteos de Asturias (IPLA); University College Cork; University College Cork; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Margolles, A (corresponding author), IPLA CSIC, Dept Microbiol & Bioquim Prod Lacteos, Villaviciosa, Asturias, Spain.	amargolles@ipla.csic.es; marco.ventura@unipr.it	Van Sinderen, Douwe/A-6778-2015; ventura, marco/M-8230-2015; Gueimonde, Miguel/A-2106-2008; Lugli, Gabriele Andrea/AAV-5150-2021; Margolles, Abelardo/H-3871-2012; Milani, Christian/ABA-8160-2020; Turroni, Francesca/K-9660-2016; Lugli, Gabriele Andrea/GRX-2617-2022; Martin, Rebeca/F-3785-2015; Duranti, Sabrina/AAI-7916-2020; Sanchez, Borja/B-7770-2009; Hevia-Gonzalez, Arancha/Q-9758-2017	Van Sinderen, Douwe/0000-0003-1823-7957; Gueimonde, Miguel/0000-0002-0192-901X; Lugli, Gabriele Andrea/0000-0002-3024-0537; Margolles, Abelardo/0000-0003-2278-1816; Turroni, Francesca/0000-0001-5363-0231; Lugli, Gabriele Andrea/0000-0002-3024-0537; Martin, Rebeca/0000-0002-5980-4113; Duranti, Sabrina/0000-0002-7724-5669; Ventura, Marco/0000-0002-4875-4560; Sanchez, Borja/0000-0003-1408-8018; Hevia-Gonzalez, Arancha/0000-0001-8446-7203; Milani, Christian/0000-0002-5062-3164	GenProbio srl; Fondazione Cariparma; FEMS Advanced Fellowship; IRCSET Embark postdoctoral fellowship; Regione Emilia Romagna; Science Foundation Ireland (SFI), through the Irish Government's National Development Plan [02/CE/B124, 07/CE/B1368]; Spanish Plan Nacional de I+D [AGL2010-14952]; FPI grant; Juan de la Cierva postdoctoral contract	GenProbio srl; Fondazione Cariparma(Fondazione Cariparma); FEMS Advanced Fellowship; IRCSET Embark postdoctoral fellowship; Regione Emilia Romagna(Regione Emilia Romagna); Science Foundation Ireland (SFI), through the Irish Government's National Development Plan(Science Foundation Ireland); Spanish Plan Nacional de I+D; FPI grant; Juan de la Cierva postdoctoral contract	The authors thank GenProbio srl for the financial support of the Laboratory of Probiogenomics. This work was financially supported by Fondazione Cariparma to MV and by a FEMS Advanced Fellowship 2011 and an IRCSET Embark postdoctoral fellowship to FT. This work was also financially supported by a Ph.D. fellowship (Spinner 2013, Regione Emilia Romagna) to S. D. DvS is a member of The Alimentary Pharmabiotic Centre, which is a Centre for Science and Technology (CSET) funded by the Science Foundation Ireland (SFI), through the Irish Government's National Development Plan (Grant no. 02/CE/B124 and 07/CE/B1368). The authors also acknowledge the support of the Spanish Plan Nacional de I+D (grant AGL2010-14952). Arancha Hevia was the recipient of an FPI grant, and Borja Sanchez was the recipient of a Juan de la Cierva postdoctoral contract. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers SV, 2011, NAT REV MICROBIOL, V9, P414, DOI 10.1038/nrmicro2576; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Ariefdjohan MW, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-23; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; De la Cochetiere MF, 2004, PEDIATR RES, V56, P366, DOI 10.1203/01.PDR.0000134251.45878.D5; Delzenne NM, 2011, NAT REV ENDOCRINOL, V7, P639, DOI 10.1038/nrendo.2011.126; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fanaro S, 2003, ACTA PAEDIATR, V92, P48; Fanning S, 2012, P NATL ACAD SCI USA, V109, P2108, DOI 10.1073/pnas.1115621109; Favier CF, 2002, APPL ENVIRON MICROB, V68, P219, DOI 10.1128/AEM.68.1.219-226.2002; Field D, 2008, NAT BIOTECHNOL, V26, P541, DOI 10.1038/nbt1360; Junemann S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041606; Kassinen A, 2007, GASTROENTEROLOGY, V133, P24, DOI 10.1053/j.gastro.2007.04.005; Kembel SW, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002743; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Kullen MJ, 2000, J APPL MICROBIOL, V89, P511, DOI 10.1046/j.1365-2672.2000.01146.x; Liu L, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/251364; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Samuel BS, 2007, P NATL ACAD SCI USA, V104, P10643, DOI 10.1073/pnas.0704189104; Sim K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032543; Smith Birgitte, 2011, Open Microbiol J, V5, P14, DOI 10.2174/1874285801105010014; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Tamboli CP, 2004, GUT, V53, P1, DOI 10.1136/gut.53.1.1; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turroni F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036957; Turroni F, 2009, APPL ENVIRON MICROB, V75, P1534, DOI 10.1128/AEM.02216-08; Ventura M, 2007, MICROBIOL MOL BIOL R, V71, P495, DOI 10.1128/MMBR.00005-07; Wang M, 2005, FEMS MICROBIOL ECOL, V54, P219, DOI 10.1016/j.femsec.2005.03.012; Werner JJ, 2012, ISME J, V6, P94, DOI 10.1038/ismej.2011.82; Whiteley AS, 2012, J MICROBIOL METH, V91, P80, DOI 10.1016/j.mimet.2012.07.008; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yergeau E, 2012, APPL ENVIRON MICROB, V78, P7626, DOI 10.1128/AEM.02036-12; Young VB, 2012, CURR OPIN GASTROEN, V28, P63, DOI 10.1097/MOG.0b013e32834d61e9; Zhang CH, 2010, ISME J, V4, P232, DOI 10.1038/ismej.2009.112	45	206	210	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2013	8	7							e68739	10.1371/journal.pone.0068739	http://dx.doi.org/10.1371/journal.pone.0068739			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZN	23869230	Green Published, Green Submitted, gold			2022-12-27	WOS:000323110600029
J	Grove, ML; Yu, B; Cochran, BJ; Haritunians, T; Bis, JC; Taylor, KD; Hansen, M; Borecki, IB; Cupples, LA; Fornage, M; Gudnason, V; Harris, TB; Kathiresan, S; Kraaij, R; Launer, LJ; Levy, D; Liu, YM; Mosley, T; Peloso, GM; Psaty, BM; Rich, SS; Rivadeneira, F; Siscovick, DS; Smith, AV; Uitterlinden, A; van Duijn, CM; Wilson, JG; O'Donnell, CJ; Rotter, JI; Boerwinkle, E				Grove, Megan L.; Yu, Bing; Cochran, Barbara J.; Haritunians, Talin; Bis, Joshua C.; Taylor, Kent D.; Hansen, Mark; Borecki, Ingrid B.; Cupples, L. Adrienne; Fornage, Myriam; Gudnason, Vilmundur; Harris, Tamara B.; Kathiresan, Sekar; Kraaij, Robert; Launer, Lenore J.; Levy, Daniel; Liu, Yongmei; Mosley, Thomas; Peloso, Gina M.; Psaty, Bruce M.; Rich, Stephen S.; Rivadeneira, Fernando; Siscovick, David S.; Smith, Albert V.; Uitterlinden, Andre; van Duijn, Cornelia M.; Wilson, James G.; O'Donnell, Christopher J.; Rotter, Jerome I.; Boerwinkle, Eric			Best Practices and Joint Calling of the HumanExome BeadChip: The CHARGE Consortium	PLOS ONE			English	Article							STUDY OBJECTIVES; DESIGN; ASSOCIATION; POPULATION; MUTATION; HEART	Genotyping arrays are a cost effective approach when typing previously-identified genetic polymorphisms in large numbers of samples. One limitation of genotyping arrays with rare variants (e.g., minor allele frequency [MAF] < 0.01) is the difficulty that automated clustering algorithms have to accurately detect and assign genotype calls. Combining intensity data from large numbers of samples may increase the ability to accurately call the genotypes of rare variants. Approximately 62,000 ethnically diverse samples from eleven Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium cohorts were genotyped with the Illumina HumanExome BeadChip across seven genotyping centers. The raw data files for the samples were assembled into a single project for joint calling. To assess the quality of the joint calling, concordance of genotypes in a subset of individuals having both exome chip and exome sequence data was analyzed. After exclusion of low performing SNPs on the exome chip and non-overlap of SNPs derived from sequence data, genotypes of 185,119 variants (11,356 were monomorphic) were compared in 530 individuals that had whole exome sequence data. A total of 98,113,070 pairs of genotypes were tested and 99.77% were concordant, 0.14% had missing data, and 0.09% were discordant. We report that joint calling allows the ability to accurately genotype rare variation using array technology when large sample sizes are available and best practices are followed. The cluster file from this experiment is available at www.chargeconsortium.com/main/exomechip.	[Grove, Megan L.; Yu, Bing; Cochran, Barbara J.; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Sch Publ Hlth, Houston, TX 77030 USA; [Haritunians, Talin; Taylor, Kent D.; Rotter, Jerome I.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Bis, Joshua C.; Psaty, Bruce M.; Siscovick, David S.] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Hansen, Mark] Illumina Inc, San Diego, CA USA; [Borecki, Ingrid B.] Washington Univ, Sch Med, Dept Genet, Div Stat Gen, St Louis, MO USA; [Cupples, L. Adrienne] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Cupples, L. Adrienne; Levy, Daniel] NHLBI, Framingham Heart Study, Framingham, MA USA; [Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Inst Mol Med, Houston, TX 77030 USA; [Gudnason, Vilmundur; Smith, Albert V.] Iceland Heart Assoc, Res Inst, Kopavogur, Iceland; [Gudnason, Vilmundur; Smith, Albert V.] Univ Iceland, Fac Med, Reykjavik, Iceland; [Harris, Tamara B.; Launer, Lenore J.] NIA, Lab Populat Sci, Bethesda, MD 20892 USA; [Peloso, Gina M.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Kathiresan, Sekar] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Kathiresan, Sekar] Harvard Univ, Sch Med, Boston, MA USA; [Kathiresan, Sekar] Broad Inst Harvard, Cambridge, MA USA; [Kathiresan, Sekar] MIT, Cambridge, MA 02139 USA; [Kraaij, Robert; Rivadeneira, Fernando] Erasmus Univ, Med Ctr, Dept Internal Med, Rotterdam, Netherlands; [Liu, Yongmei] Wake Forest Univ, Sch Med, Dept Epidemiol & Prevent, Winston Salem, NC 27109 USA; [Mosley, Thomas] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA; [Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Med, Seattle, WA USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Psaty, Bruce M.] Grp Hlth Res Inst, Seattle, WA USA; [Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Gen, Charlottesville, VA USA; [Rivadeneira, Fernando; van Duijn, Cornelia M.] Erasmus Univ, Med Ctr, ErasmusAGE, Rotterdam, Netherlands; [Rivadeneira, Fernando; Uitterlinden, Andre; van Duijn, Cornelia M.] Erasmus Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [Rivadeneira, Fernando; Uitterlinden, Andre; van Duijn, Cornelia M.] Netherlands Genom Initiat, Netherlands Consortium Hlth Aging, Leiden, Netherlands; [Wilson, James G.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA; [O'Donnell, Christopher J.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Boerwinkle, Eric] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Cedars Sinai Medical Center; University of Washington; University of Washington Seattle; Illumina; Washington University (WUSTL); Boston University; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Texas System; University of Texas Health Science Center Houston; Icelandic Heart Association; University of Iceland; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Erasmus University Rotterdam; Erasmus MC; Wake Forest University; University of Mississippi; University of Mississippi Medical Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Virginia; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Mississippi; University of Mississippi Medical Center; Harvard University; Massachusetts General Hospital; Baylor College of Medicine	Grove, ML (corresponding author), Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Sch Publ Hlth, Houston, TX 77030 USA.	Megan.L.Grove@uth.tmc.edu	Smith, Albert Vernon/K-5150-2015; Rotter, Jerome/AAY-6598-2021; Gudnason, Vilmundur/AAE-7126-2019; Rivadeneira, Fernando/O-5385-2015; Levy, Daniel/ABF-6873-2021; Gudnason, Vilmundur/K-6885-2015; Levy, Daniel/ABB-2752-2021	Smith, Albert Vernon/0000-0003-1942-5845; Gudnason, Vilmundur/0000-0001-5696-0084; Rivadeneira, Fernando/0000-0001-9435-9441; Levy, Daniel/0000-0003-1843-8724; Gudnason, Vilmundur/0000-0001-5696-0084; Van Duijn, Cornelia/0000-0002-2374-9204; Cupples, L. Adrienne/0000-0003-0273-7965; Rich, Stephen/0000-0003-3872-7793	Building on GWAS for NHLBI-diseases; U.S. CHARGE consortium through the National Institutes of Health (NIH) American Recovery and Reinvestment Act (ARRA) [5RC2HL102419]; NIH [N01-AG-12100]; NIA Intramural Research Program; Icelandic Heart Association; Icelandic Parliament; National Heart, Lung, and Blood Institute (NHLBI) [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN2682011000010C, HHSN2682011000011C, HHSN2682011000012C]; National Heart, Lung, and Blood Institute [HL41993, HL091244, N01-HC-95095, N01-HC-48047, N01-HC-48048, N01-HC-48049, N01-HC-48050, N01-HC-45134, N01-HC-05187, N01-HC-45205, N01-HC-45204, U01 HL56563, U01 HL56564, U01 HL56565]; University of Washington Clinical Nutrition Research Unit [DK-35816]; Medic One Foundation, Seattle, WA; NHLBI [N01-HC-85239, N01-HC-85079, N01-HC-85080, N01-HC-85081, N01-HC-85082, N01-HC-85083, N01-HC-85084, N01-HC-85085]; NIA [AG-023629, AG-15928, AG-20098, AG-027058, N01AG62101, N01AG62103, N01AG62106, 1R01AG032098-01A1]; National Center of Advancing Translational Technologies CTSI [UL1TR000124]; National Institute of Diabetes and Digestive and Kidney Diseases [DK063491]; Cedars-Sinai Board of Governors' Chair in Medical Genetics (JIR); Erasmus Medical Center and Erasmus University, Rotterdam; Netherlands Organization for the Health Research and Development (ZonMw); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; European Commission (DG XII); Municipality of Rotterdam; Illumina, Inc.; Intramural Research Program of the NIH, National Institute on Aging; National Center on Minority Health and Health Disparities;  [U01-HG-004729];  [R01-HL-084099];  [N01-HC-25195];  [N01-HC-95159];  [N01-HC-95160];  [N01-HC-95161];  [N01-HC-95162];  [N01-HC-95163];  [N01-HC-95164];  [N01-HC-95165]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC048050, N01HC045133, N01HC075150, N01HC095170, N01HC095171, N01HC035129, N01HC095172, N01HC048048, N01HC085086, N01HC048047, N01HC095164, N01HC055222, N01HC095163, N01HC095160, N01HC095166, N01HC095167, N01HC015103, N01HC045134, N01HC005187, N01HC025195, N01HC095165, N01HC095095, N01HC095168, N01HC085079, N01HC095162, N01HC095161, N01HC048049, N01HC095159, N01HC095169] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005, UL1RR024156] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071251, U01HL056567, R01HL041993, R01HL091244, R01HL071258, R01HL071051, R01HL071205, U01HL056565, R01HL105756, R01HL071252, U01HL056569, R01HL087652, U01HL056568, U01HL056563, RC2HL102419, R01HL071259, U01HL056564, R01HL071250, R01HL080295, U01HL056566, R01HL084099, U01HL080295, K01HL070444, ZIAHL006001] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK035816, P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023629, R01AG015928, R56AG023629, N01AG062101, ZIAAG007380, N01AG062106, R01AG027058, N01AG012100, ZIAAG006000, N01AG062103, R01AG032098] Funding Source: NIH RePORTER	Building on GWAS for NHLBI-diseases; U.S. CHARGE consortium through the National Institutes of Health (NIH) American Recovery and Reinvestment Act (ARRA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Icelandic Heart Association; Icelandic Parliament; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of Washington Clinical Nutrition Research Unit; Medic One Foundation, Seattle, WA; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Center of Advancing Translational Technologies CTSI; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Cedars-Sinai Board of Governors' Chair in Medical Genetics (JIR); Erasmus Medical Center and Erasmus University, Rotterdam; Netherlands Organization for the Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; European Commission (DG XII)(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; Illumina, Inc.; Intramural Research Program of the NIH, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Center on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); ; ; ; ; ; ; ; ; ; ; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Support for the centralized work was provided by Building on GWAS for NHLBI-diseases: the U.S. CHARGE consortium through the National Institutes of Health (NIH) American Recovery and Reinvestment Act of 2009 (ARRA) (5RC2HL102419) (PI: E. Boerwinkle). Funding support of the individual cohorts is detailed below. The Age, Gene/Environment, Susceptibility-Reykjavik (AGES) study is funded by NIH contract N01-AG-12100, the NIA Intramural Research Program, the Icelandic Heart Association, and the Icelandic Parliament. The Atherosclerosis Risk in Communities (ARIC) Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute (NHLBI) contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN2682011000010C, HHSN2682011000011C, and HHSN2682011000012C). The authors thank the staff and participants of the ARIC study for their important contributions. The research reported in this manuscript on behalf of the Cardiac Arrest Blood Study (CABS) was supported by grants from the National Heart, Lung, and Blood Institute (HL41993 and HL091244); the University of Washington Clinical Nutrition Research Unit (DK-35816); and the Medic One Foundation, Seattle, WA. The authors gratefully acknowledge the Coronary Artery Risk Development in Young Adults (CARDIA) study participants and staff for their valuable contributions. The CARDIA study is funded by contracts N01-HC-95095, N01-HC-48047, N01-HC-48048, N01-HC-48049, N01-HC-48050, N01-HC-45134, N01-HC-05187, N01-HC-45205, and N01-HC-45204 from the National Heart, Lung, and Blood Institute to the CARDIA investigators. Genotyping of the CARDIA participants was supported by grants U01-HG-004729 and R01-HL-084099. This manuscript has been reviewed by CARDIA for scientific content and consistency of data interpretation with previous CARDIA publications. This CHS research was supported by NHLBI contracts N01-HC-85239, N01-HC-85079 through N01-HC-85086; N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, HHSN268201200036C and NHLBI grants HL080295, HL087652, HL105756 with additional contribution from NINDS. Additional support was provided through AG-023629, AG-15928, AG-20098, and AG-027058 from the NIA. See also http://www.chs-nhlbi.org/pi. DNA handling and genotyping was supported in part by National Center of Advancing Translational Technologies CTSI grant UL1TR000124, the National Institute of Diabetes and Digestive and Kidney Diseases grant DK063491 to the Southern California Diabetes Endocrinology Research Center, and Cedars-Sinai Board of Governors' Chair in Medical Genetics (JIR). The Rotterdam Study is supported by Erasmus Medical Center and Erasmus University, Rotterdam, Netherlands Organization for the Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the European Commission (DG XII), and the Municipality of Rotterdam. The authors are grateful to the study participants, the staff from the Rotterdam Study and the participating general practitioners and pharmacists. The NHLBI's Framingham Heart Study is a joint project of the National Institutes of Health and Boston University School of Medicine and was supported by contract N01-HC-25195 and its contract with Illumina, Inc. for genotyping services.; The Family Heart Study (FamHS) was supported by grants from the National Heart, Lung, & Blood Institute (U01 HL56563, U01 HL56564, U01 HL56565, U01 HL56566, U01 HL56567, U01 HL56568, U01 HL56569, and K01-HL70444). The Health, Aging, and Body Composition (HABC) Study is supported by NIA contracts N01AG62101, N01AG62103, and N01AG62106. The genome-wide association study was funded by NIA grant 1R01AG032098-01A1 to Wake Forest University Health Sciences. This research was supported in part by the Intramural Research Program of the NIH, National Institute on Aging. The Jackson Heart Study (JHS) is supported by the National Heart, Lung, and Blood Institute (N01 HC-95170, N01 HC-95171 and N01 HC-95172) and the National Center on Minority Health and Health Disparities. The authors thank the staff, interns and participants in JHS for their long-term commitment and important contributions to the study. MESA is supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with MESA investigators. Support for MESA is provided by contracts N01-HC-95159 through N01-HC-95169 and UL1-RR-024156. Funding for MESA Family is provided by grants R01- HL-071051, R01-HL-071205, R01-HL-071250, R01-HL-071251, R01-HL-071252, R01-HL-071258, R01-HL-071259, UL1-RR-025005. The authors thank the other investigators, the staff, and the participants of the MESA study for their valuable contributions. A full list of participating MESA investigators and institutions can be found at http://www.mesa-nhlbi.org. Gina Peloso was supported by Award Number T32HL007208 from the National Heart, Lung, And Blood Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung, and Blood Institute or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; CUTTER G R, 1991, Controlled Clinical Trials, V12, p1S; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Goldstein JI, 2012, BIOINFORMATICS, V28, P2543, DOI 10.1093/bioinformatics/bts479; Gudnason V, 1997, HUM MUTAT, V10, P36, DOI 10.1002/(SICI)1098-1004(1997)10:1<36::AID-HUMU5>3.0.CO;2-K; Harris TB, 2007, AM J EPIDEMIOL, V165, P1076, DOI 10.1093/aje/kwk115; Higgins M, 1996, AM J EPIDEMIOL, V143, P1219, DOI 10.1093/oxfordjournals.aje.a008709; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; Hofman A, 2007, EUR J EPIDEMIOL, V22, P819, DOI 10.1007/s10654-007-9199-x; Hofman A, 2011, EUR J EPIDEMIOL, V26, P657, DOI 10.1007/s10654-011-9610-5; Hofman A, 2009, EUR J EPIDEMIOL, V24, P553, DOI 10.1007/s10654-009-9386-z; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; Mills P, 2011, INT J REMOTE SENS, V32, P6109, DOI 10.1080/01431161.2010.507795; Park SW, 2006, DIABETES, V55, P1813, DOI 10.2337/db05-1183; Press W.H., 1992, NUMERICAL RECIPES AR, V2nd; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ritchie ME, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-68; SISCOVICK DS, 1995, JAMA-J AM MED ASSOC, V274, P1363, DOI 10.1001/jama.274.17.1363; Taylor Jr HA, 2005, ETHNIC DIS, V15; Tell G S, 1993, Ann Epidemiol, V3, P358, DOI 10.1016/1047-2797(93)90062-9; Thomas MC, 2006, ELEMENTS INFORM THEO; Thorlacius S, 1996, NAT GENET, V13, P117, DOI 10.1038/ng0596-117; 1989, AM J EPIDEMIOL, V4, P687	27	193	195	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e68095	10.1371/journal.pone.0068095	http://dx.doi.org/10.1371/journal.pone.0068095			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	23874508	Green Submitted, Green Published, gold			2022-12-27	WOS:000321718700009
J	de Bie, MK; Buiten, MS; Gaasbeek, A; Boogers, MJ; Roos, CJ; Schuijf, JD; Krol, MJ; Rabelink, TJ; Bax, JJ; Schalij, MJ; Jukema, JW				de Bie, Mihaly K.; Buiten, Maurits S.; Gaasbeek, Andre; Boogers, Mark J.; Roos, Cornelis J.; Schuijf, Joanne D.; Krol, M. Jacqueline; Rabelink, Ton J.; Bax, Jeroen J.; Schalij, Martin J.; Jukema, J. Wouter			CT Coronary Angiography Is Feasible for the Assessment of Coronary Artery Disease in Chronic Dialysis Patients, Despite High Average Calcium Scores	PLOS ONE			English	Article							64-SLICE COMPUTED-TOMOGRAPHY; STAGE RENAL-DISEASE; HEMODIALYSIS-PATIENTS; DIAGNOSTIC-ACCURACY; KIDNEY-DISEASE; STENOSIS; CALCIFICATIONS; METAANALYSIS; INITIATION; THERAPY	Purpose: Significant obstructive coronary artery disease (CAD) is common in asymptomatic dialysis patients. Identifying these high risk patients is warranted and may improve the prognosis of this vulnerable patient group. Routine catheterization of incident dialysis patients has been proposed, but is considered too invasive. CT-angiography may therefore be more appropriate. However, extensive coronary calcification, often present in this patient group, might hamper adequate lumen evaluation. The objective of this study was to assess the feasibility of CT-angiography in this patient group. Methods: For this analysis all patients currently participating in the ICD2 trial (ISRCTN20479861), with no history of PCI or CABG were included. The major epicardial vessels were evaluated on a segment basis (segment 1-3, 5-8, 11 and 13) by a team consisting of an interventional and an imaging specialist. Segments were scored as not significant, significant and not interpretable. Results: A total of 70 dialysis patients, with a mean age of 66 +/- 8 yrs and predominantly male (70%) were included. The median calcium score was 623 [79, 1619]. Over 90% of the analyzed segments were considered interpretable. The incidence of significant CAD on CT was 43% and was associated with cardiovascular events during follow-up. The incidence of cardiovascular events after 2-years follow-up: 36% vs. 0% in patients with no significant CAD (p < 0.01). Conclusion: Despite the high calcium scores CT-angiography is feasible for the evaluation of the extent of CAD in dialysis patients. Moreover the presence of significant CAD on CT was associated with events during follow-up.	[de Bie, Mihaly K.; Buiten, Maurits S.; Boogers, Mark J.; Roos, Cornelis J.; Schuijf, Joanne D.; Bax, Jeroen J.; Schalij, Martin J.; Jukema, J. Wouter] Leiden Univ, Dept Cardiol, Med Ctr, Leiden, Netherlands; [Gaasbeek, Andre; Rabelink, Ton J.] Leiden Univ, Dept Nephrol, Med Ctr, Leiden, Netherlands; [Krol, M. Jacqueline] Haga Hosp, Dept Nephrol, The Hague, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Haga Hospital	Jukema, JW (corresponding author), Leiden Univ, Dept Cardiol, Med Ctr, Leiden, Netherlands.	j.w.jukema@lumc.nl	Jukema, J. Wouter/ABD-6503-2021; Rabelink, Ton J./A-5316-2008	Jukema, J. Wouter/0000-0002-3246-8359; Rabelink, Ton J./0000-0001-6780-5186; Schuijf, Joanne/0000-0002-7612-4865	Biotronik	Biotronik	This study was supported by an unrestricted research grant of Biotronik. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braun J, 1996, AM J KIDNEY DIS, V27, P394, DOI 10.1016/S0272-6386(96)90363-7; Cannata-Andia JB, 2006, J AM SOC NEPHROL, V17, pS267, DOI 10.1681/ASN.2006080925; Carrigan TP, 2009, EUR HEART J, V30, P362, DOI 10.1093/eurheartj/ehn605; Charytan D, 2007, AM J KIDNEY DIS, V49, P409, DOI 10.1053/j.ajkd.2006.11.042; Cheung AK, 2004, KIDNEY INT, V65, P2380, DOI 10.1111/j.1523-1755.2004.00657.x; de Bie MK, 2008, CURR MED RES OPIN, V24, P2151, DOI 10.1185/03007990802237343; de Graaf FR, 2010, EUR HEART J, V31, P1908, DOI 10.1093/eurheartj/ehp571; den Dekker MAM, 2012, EUR RADIOL, V22, P2688, DOI 10.1007/s00330-012-2551-x; DeVriese AS, 2011, KIDNEY INT; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Ghostine S, 2006, J AM COLL CARDIOL, V48, P1929, DOI 10.1016/j.jacc.2006.04.103; Goldsmith D, 2004, KIDNEY INT, V66, P1315, DOI 10.1111/j.1523-1755.2004.00895.x; Hemmelgarn BR, 2004, CIRCULATION, V110, P1890, DOI 10.1161/01.CIR.0000143629.55725.D9; Iio K, 2008, NEPHRON CLIN PRACT, V109, pC72, DOI 10.1159/000139992; Joki N, 1997, NEPHROL DIAL TRANSPL, V12, P718, DOI 10.1093/ndt/12.4.718; Joki Nobuhiko, 2003, International Urology and Nephrology, V35, P289, DOI 10.1023/B:UROL.0000020356.82724.37; Mowatt G, 2008, HEART, V94, P1386, DOI 10.1136/hrt.2008.145292; Ohtake T, 2005, J AM SOC NEPHROL, V16, P1141, DOI 10.1681/ASN.2004090765; Raff GL, 2005, J AM COLL CARDIOL, V46, P552, DOI 10.1016/j.jacc.2005.05.056; Rocco MV, 2002, AM J KIDNEY DIS, V39, P146, DOI 10.1053/ajkd.2002.29905; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; U.S. Renal Data System, 2006, ANN DAT REP ATL CHRO; Yasuda K, 2006, J AM SOC NEPHROL, V17, P2322, DOI 10.1681/ASN.2005090958	23	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e67936	10.1371/journal.pone.0067936	http://dx.doi.org/10.1371/journal.pone.0067936			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874471	Green Submitted, gold, Green Published			2022-12-27	WOS:000321765300019
J	Birgand, G; Lepelletier, D; Baron, G; Barrett, S; Breier, AC; Buke, C; Markovic-Denic, L; Gastmeier, P; Kluytmans, J; Lyytikainen, O; Sheridan, E; Szilagyi, E; Tacconelli, E; Troillet, N; Ravaud, P; Lucet, JC				Birgand, Gabriel; Lepelletier, Didier; Baron, Gabriel; Barrett, Steve; Breier, Ann-Christin; Buke, Cagri; Markovic-Denic, Ljiljana; Gastmeier, Petra; Kluytmans, Jan; Lyytikainen, Outi; Sheridan, Elizabeth; Szilagyi, Emese; Tacconelli, Evelina; Troillet, Nicolas; Ravaud, Philippe; Lucet, Jean-Christophe			Agreement among Healthcare Professionals in Ten European Countries in Diagnosing Case-Vignettes of Surgical-Site Infections	PLOS ONE			English	Article							NOSOCOMIAL INFECTIONS; WOUND-INFECTION; HOSPITALS; SURVEILLANCE; PERFORMANCE; RATES; REQUIREMENTS; PREVENTION; PREVALENCE; QUALITY	Objective: Although surgical-site infection (SSI) rates are advocated as a major evaluation criterion, the reproducibility of SSI diagnosis is unknown. We assessed agreement in diagnosing SSI among specialists involved in SSI surveillance in Europe. Methods: Twelve case-vignettes based on suspected SSI were submitted to 100 infection-control physicians (ICPs) and 86 surgeons in 10 European countries. Each participant scored eight randomly-assigned case-vignettes on a secure online relational database. The intra-class correlation coefficient (ICC) was used to assess agreement for SSI diagnosis on a 7-point Likert scale and the kappa coefficient to assess agreement for SSI depth on a three-point scale. Results: Intra-specialty agreement for SSI diagnosis ranged across countries and specialties from 0.00 (95% CI, 0.00-0.35) to 0.65 (0.45-0.82). Inter-specialty agreement varied from 0.04 (0.00-0.62) in to 0.55 (0.37-0.74) in Germany. For all countries pooled, intra-specialty agreement was poor for surgeons (0.24, 0.14-0.42) and good for ICPs (0.41, 0.28-0.61). Reading SSI definitions improved agreement among ICPs (0.57) but not surgeons (0.09). Intra-specialty agreement for SSI depth ranged across countries and specialties from 0.05 (0.00-0.10) to 0.50 (0.45-0.55) and was not improved by reading SSI definition. Conclusion: Among ICPs and surgeons evaluating case-vignettes of suspected SSI, considerable disagreement occurred regarding the diagnosis, with variations across specialties and countries.	[Birgand, Gabriel; Lucet, Jean-Christophe] Bichat Claude Bernard Hosp, Infect Control Unit, Paris, France; [Lepelletier, Didier] Nantes Univ Hosp, Bacteriol & Hyg Dept, Nantes, France; [Baron, Gabriel; Ravaud, Philippe] Hop Hotel Dieu, Ctr Epidemiol Clin, F-75181 Paris, France; [Breier, Ann-Christin; Gastmeier, Petra] Charite, Inst Hyg & Environm Med, D-13353 Berlin, Germany; [Buke, Cagri] Ege Univ, Fac Med, Dept Infect Dis & Clin Microbiol, Izmir, Turkey; [Markovic-Denic, Ljiljana] Sch Med, Inst Epidemiol, Belgrade, Serbia; [Kluytmans, Jan] Amphia Hosp Breda, Lab Microbiol & Infect Control, Breda, Netherlands; [Lyytikainen, Outi] Natl Publ Hlth Inst, Dept Infect Dis, Helsinki, Finland; [Sheridan, Elizabeth] HPA Ctr Infect, Dept Healthcare Associated Infect & Antimicrobial, London, England; [Szilagyi, Emese] Off Chief Med Officer, Dept Epidemiol, Gyali, Hungary; [Tacconelli, Evelina] Univ Cattolica Sacro Cuore, Dept Infect Dis, Rome, Italy; [Troillet, Nicolas] Cent Inst Valais Hosp, Div Infect Dis, Sion, Switzerland	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Nantes Universite; CHU de Nantes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ege University; University of Belgrade; Amphia Hospital; Finland National Institute for Health & Welfare; Health Protection Agency; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Birgand, G (corresponding author), Bichat Claude Bernard Hosp, Infect Control Unit, Paris, France.	gbirgand@gmail.com	Tacconelli, Evelina/AAC-8200-2019; ravaud, philippe/C-1694-2009	Sheridan, Elizabeth/0000-0002-7804-3217; Gastmeier, Petra/0000-0001-5520-4287; Ravaud, Philippe/0000-0001-8264-9206	French Ministry of Health [PREQHOS 0901]	French Ministry of Health	This study was supported by the French Ministry of Health (national grant PREQHOS 0901). This grant was used to finance a part of the salary of the first author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaujean D, 2002, EUR J CLIN MICROBIOL, V21, P444, DOI 10.1007/s10096-002-0745-x; Bonett DG, 2002, STAT MED, V21, P1331, DOI 10.1002/sim.1108; CULVER DH, 1991, AM J MED, V91, pS152, DOI 10.1016/0002-9343(91)90361-Z; Emmerson AM, 1996, J HOSP INFECT, V32, P175, DOI 10.1016/S0195-6701(96)90144-9; Eriksen HM, 2005, J HOSP INFECT, V60, P40, DOI 10.1016/j.jhin.2004.09.038; Fung CH, 2008, ANN INTERN MED, V148, P111, DOI 10.7326/0003-4819-148-2-200801150-00006; Gastmeier P, 2005, ARCH ORTHOP TRAUM SU, V125, P526, DOI 10.1007/s00402-005-0036-y; Gastmeier P, 2008, J HOSP INFECT, V70, P11, DOI 10.1016/S0195-6701(08)60005-5; Geubbels ELPE, 2004, AM J INFECT CONTROL, V32, P424, DOI 10.1016/j.ajic.2004.07.001; HALEY RW, 1985, AM J EPIDEMIOL, V121, P182, DOI 10.1093/oxfordjournals.aje.a113990; Haustein T, 2011, LANCET INFECT DIS, V11, P471, DOI 10.1016/S1473-3099(10)70315-7; Hejblum G, 2008, CHEST, V133, P1107, DOI 10.1378/chest.06-3014; Hospital in Europe Link for Infection Control through Surveillance (HELICS), 2004, SURV SURG SIT INF; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lepelletier D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035131; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; McKibben L, 2005, AM J INFECT CONTROL, V33, P217, DOI 10.1016/j.ajic.2005.04.001; Mertens R, 1996, Euro Surveill, V1, P28; Nunnaly JC, 1994, PSYCHOMETRIC THEORY; Perla RJ, 2009, AM J INFECT CONTROL, V37, P615, DOI 10.1016/j.ajic.2009.03.003; Pittet D, 2004, ANN INTERN MED, V141, P1, DOI 10.7326/0003-4819-141-1-200407060-00008; Rosenthal R, 2010, J HOSP INFECT, V75, P178, DOI 10.1016/j.jhin.2009.10.028; TAYLOR G, 1990, AM J INFECT CONTROL, V18, P295, DOI 10.1016/0196-6553(90)90228-K; Thibon P, 2002, INFECT CONT HOSP EP, V23, P368, DOI 10.1086/502067; Wachter RM, 2008, ANN INTERN MED, V149, P29, DOI 10.7326/0003-4819-149-1-200807010-00007; Wilson APR, 2004, BRIT MED J, V329, P720, DOI 10.1136/bmj.38232.646227.DE; Wilson J, 2007, J HOSP INFECT, V65, P165, DOI 10.1016/S0195-6701(07)60037-1	27	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68618	10.1371/journal.pone.0068618	http://dx.doi.org/10.1371/journal.pone.0068618			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874690	Green Published, gold, Green Submitted			2022-12-27	WOS:000321736900097
J	Tso, VK; Sydora, BC; Foshaug, RR; Churchill, TA; Doyle, J; Slupsky, CM; Fedorak, RN				Tso, Victor K.; Sydora, Beate C.; Foshaug, Rae R.; Churchill, Thomas A.; Doyle, Jason; Slupsky, Carolyn M.; Fedorak, Richard N.			Metabolomic Profiles Are Gender, Disease and Time Specific in the Interleukin-10 Gene-Deficient Mouse Model of Inflammatory Bowel Disease	PLOS ONE			English	Article							INTESTINAL INFLAMMATION; ULCERATIVE-COLITIS; SEXUAL-DIMORPHISM; MICE; METABONOMICS; WOMEN	Metabolomic profiling can be used to study disease-induced changes in inflammatory bowel diseases (IBD). The aim of this study was to investigate the difference in the metabolomic profile of males and females as they developed IBD. Using the IL10 gene-deficient mouse model of IBD and wild-type mice, urine at age 4, 6, 8, 12, 16, and 20 weeks was collected and analyzed by nuclear magnetic resonance (NMR) spectroscopy. Multivariate data analysis was employed to assess differences in metabolomic profiles that occurred as a consequence of IBD development and severity (at week 20). These changes were contrasted to those that occurred as a consequence of gender. Our results demonstrate that both IL-10 gene-deficient and wild-type mice exhibit gender-related changes in urinary metabolomic profile over time. Some male-female separating metabolites are common to both IL-10 gene-deficient and control wild-type mice and, therefore, appear to be related predominantly to gender maturation. In addition, we were able to identify gender-separating metabolites that are unique for IL-10 gene-deficient and wild-type mice and, therefore, may be indicative of a gender-specific involvement in the development and severity of the intestinal inflammation. The comparison of the gender-separating metabolomic profile from IL-10 gene-deficient mice and wild-type mice during the development of IBD allowed us to identify changes in profile patterns that appear to be imperative in the development of intestinal inflammation, but yet central to gender-related differences in IBD development. The knowledge of metabolomic profile differences by gender and by disease severity has potential clinical implications in the design of both biomarkers of disease as well as the development of optimal therapies.	[Tso, Victor K.; Sydora, Beate C.; Foshaug, Rae R.; Fedorak, Richard N.] Univ Alberta, Dept Med, Div Gastroenterol, Ctr Excellence Gastrointestinal Inflammat & Immun, Edmonton, AB, Canada; [Churchill, Thomas A.] Univ Alberta, Dept Surg, Edmonton, AB, Canada; [Doyle, Jason] Vernon Jubilee Hosp, Dept Lab Med & Pathol, Vernon, BC, Canada; [Slupsky, Carolyn M.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA	University of Alberta; University of Alberta; University of California System; University of California Davis	Fedorak, RN (corresponding author), Univ Alberta, Dept Med, Div Gastroenterol, Ctr Excellence Gastrointestinal Inflammat & Immun, Edmonton, AB, Canada.	richard.fedorak@ualberta.ca		Tso, Victor/0000-0002-9980-8995; Fedorak, Richard/0000-0002-7382-0080	Crohn's and Colitis Foundation of Canada	Crohn's and Colitis Foundation of Canada	This study was funded by the Crohn's and Colitis Foundation of Canada. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado CM, 2011, THROMB RES, V127, P478, DOI 10.1016/j.thromres.2011.01.004; Bamias G, 2007, CURR OPIN GASTROEN, V23, P365, DOI 10.1097/MOG.0b013e3281c55eb2; Bjerrum JT, 2010, J PROTEOME RES, V9, P954, DOI 10.1021/pr9008223; Blaak E, 2001, CURR OPIN CLIN NUTR, V4, P499, DOI 10.1097/00075197-200111000-00006; Blumenstein I, 2011, J CROHNS COLITIS, V5, P203, DOI 10.1016/j.crohns.2010.12.012; Bollard ME, 2005, NMR BIOMED, V18, P143, DOI 10.1002/nbm.935; Chen C, 2008, CELL METAB, V7, P135, DOI 10.1016/j.cmet.2007.12.003; Chichlowski M, 2008, AM J PHYSIOL-GASTR L, V295, pG1139, DOI 10.1152/ajpgi.90516.2008; Chrousos GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3143pe36; Duma D, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001077; Fernandes MTB, 2010, ACTA PAEDIATR, V99, P1218, DOI 10.1111/j.1651-2227.2010.01774.x; Ghazeeri G, 2011, AM J REPROD IMMUNOL, V66, P163, DOI 10.1111/j.1600-0897.2011.01052.x; Gleicher N, 2007, J AUTOIMMUN, V28, P1, DOI 10.1016/j.jaut.2006.12.004; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lee GJ, 2012, J PEDIATR GASTR NUTR, V55, P701, DOI 10.1097/MPG.0b013e318266241b; Lindon JC, 2004, BIOMARKERS, V9, P1, DOI 10.1080/13547500410001668379; Looijer-van Langen M, 2011, AM J PHYSIOL-GASTR L, V300, pG621, DOI 10.1152/ajpgi.00274.2010; Malickova K, 2011, AUTOIMMUN DIS, V2011, DOI 10.4061/2011/945861; Marchesi JR, 2007, J PROTEOME RES, V6, P546, DOI 10.1021/pr060470d; Martin FPJ, 2009, J PROTEOME RES, V8, P2376, DOI 10.1021/pr801006e; McCombe PA, 2009, CURR MOL MED, V9, P1058, DOI 10.2174/156652409789839116; Mittelstrass K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002215; Mittendorfer B, 2002, AM J PHYSIOL-ENDOC M, V283, pE58, DOI 10.1152/ajpendo.00504.2001; Moleski SM, 2011, GASTROENTEROL CLIN N, V40, P387, DOI 10.1016/j.gtc.2011.03.003; Morris ME, 2003, PHARMACOL REV, V55, P229, DOI 10.1124/pr.55.2.1; Murdoch TB, 2008, ANAL CHEM, V80, P5524, DOI 10.1021/ac8005236; Otter D, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/974701; Peyrin-Biroulet L, INFLAMM BOWEL DIS; Qiao Q, 2011, TALANTA, V85, P718, DOI 10.1016/j.talanta.2011.04.060; Sartor RB, 1997, ALIMENT PHARM THERAP, V11, P17; Schicho R, 2010, J PROTEOME RES, V9, P6265, DOI 10.1021/pr100547y; Sherman MA, 2004, IMMUNOL RES, V29, P241, DOI 10.1385/IR:29:1-3:241; Sridhar ARM, 2011, J CROHNS COLITIS, V5, P287, DOI 10.1016/j.crohns.2011.01.011; Stanley EG, 2005, ANAL BIOCHEM, V343, P195, DOI 10.1016/j.ab.2005.01.024; Sydora BC, 2003, INFLAMM BOWEL DIS, V9, P87, DOI 10.1097/00054725-200303000-00002; Tarnopolsky M A, 2000, J Sci Med Sport, V3, P287; Tarnopolsky MA, 2001, CURR OPIN CLIN NUTR, V4, P521, DOI 10.1097/00075197-200111000-00010; Turner MW, 1996, IMMUNOL TODAY, V17, P532, DOI 10.1016/0167-5699(96)10062-1; Williams HRT, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-108; Williams HRT, 2009, AM J GASTROENTEROL, V104, P1435, DOI 10.1038/ajg.2009.175; Wu BN, 2011, J NUTR METAB, V2011, DOI 10.1155/2011/391809; Zandman-Goddard G, 2007, AUTOIMMUN REV, V6, P366, DOI 10.1016/j.autrev.2006.10.001; Zelinkova Z, 2012, WORLD J GASTROENTERO, V18, P6967, DOI 10.3748/wjg.v18.i47.6967	43	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e67654	10.1371/journal.pone.0067654	http://dx.doi.org/10.1371/journal.pone.0067654			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874435	Green Submitted, Green Published, gold			2022-12-27	WOS:000321736900015
J	Li, XZ; Buckton, AJ; Wilkinson, SL; John, S; Walsh, R; Novotny, T; Valaskova, I; Gupta, M; Game, L; Barton, PJR; Cook, SA; Ware, JS				Li, Xinzhong; Buckton, Andrew J.; Wilkinson, Samuel L.; John, Shibu; Walsh, Roddy; Novotny, Tomas; Valaskova, Iveta; Gupta, Manu; Game, Laurence; Barton, Paul J. R.; Cook, Stuart A.; Ware, James S.			Towards Clinical Molecular Diagnosis of Inherited Cardiac Conditions: A Comparison of Bench-Top Genome DNA Sequencers	PLOS ONE			English	Article							ION TORRENT; HIGH-THROUGHPUT; MUTATIONS; PREVALENCE; FIDELITY	Background: Molecular genetic testing is recommended for diagnosis of inherited cardiac disease, to guide prognosis and treatment, but access is often limited by cost and availability. Recently introduced high-throughput bench-top DNA sequencing platforms have the potential to overcome these limitations. Methodology/Principal Findings: We evaluated two next-generation sequencing (NGS) platforms for molecular diagnostics. The protein-coding regions of six genes associated with inherited arrhythmia syndromes were amplified from 15 human samples using parallelised multiplex PCR (Access Array, Fluidigm), and sequenced on the MiSeq (Illumina) and Ion Torrent PGM (Life Technologies). Overall, 97.9% of the target was sequenced adequately for variant calling on the MiSeq, and 96.8% on the Ion Torrent PGM. Regions missed tended to be of high GC-content, and most were problematic for both platforms. Variant calling was assessed using 107 variants detected using Sanger sequencing: within adequately sequenced regions, variant calling on both platforms was highly accurate (Sensitivity: MiSeq 100%, PGM 99.1%. Positive predictive value: MiSeq 95.9%, PGM 95.5%). At the time of the study the Ion Torrent PGM had a lower capital cost and individual runs were cheaper and faster. The MiSeq had a higher capacity (requiring fewer runs), with reduced hands-on time and simpler laboratory workflows. Both provide significant cost and time savings over conventional methods, even allowing for adjunct Sanger sequencing to validate findings and sequence exons missed by NGS. Conclusions/Significance: MiSeq and Ion Torrent PGM both provide accurate variant detection as part of a PCR-based molecular diagnostic workflow, and provide alternative platforms for molecular diagnosis of inherited cardiac conditions. Though there were performance differences at this throughput, platforms differed primarily in terms of cost, scalability, protocol stability and ease of use. Compared with current molecular genetic diagnostic tests for inherited cardiac arrhythmias, these NGS approaches are faster, less expensive, and yet more comprehensive.	[Li, Xinzhong; John, Shibu; Barton, Paul J. R.; Cook, Stuart A.; Ware, James S.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Buckton, Andrew J.; Wilkinson, Samuel L.; Walsh, Roddy; Gupta, Manu; Barton, Paul J. R.; Ware, James S.] Royal Brompton & Harefield NHS Fdn Trust, NIHR Biomed Res Unit Cardiovasc Dis, London, England; [Buckton, Andrew J.; Wilkinson, Samuel L.; Walsh, Roddy; Gupta, Manu; Barton, Paul J. R.; Ware, James S.] Univ London Imperial Coll Sci Technol & Med, London, England; [Novotny, Tomas; Valaskova, Iveta] Univ Hosp, Dept Internal Med & Cardiol, Brno, Czech Republic; [Novotny, Tomas; Valaskova, Iveta] Masaryk Univ, Fac Med, Brno, Czech Republic; [Game, Laurence] Univ London Imperial Coll Sci Technol & Med, Genom Lab, MRC Clin Sci Ctr, London, England; [Cook, Stuart A.] Natl Heart Ctr Singapore, Singapore, Singapore	Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Imperial College London; University Hospital Brno; Masaryk University Brno; Imperial College London; National Heart Centre Singapore	Cook, SA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England.	stuart.cook@duke-nus.edu.sg; j.ware@imperial.ac.uk	li, xin/HHS-9461-2022; Valaskova, Iveta/U-9718-2017; Walsh, Roddy/H-8462-2019; Ware, James S/G-5139-2012; Valaskova, Iveta/F-5734-2014; Novotny, Tomas/ABD-5968-2020	Walsh, Roddy/0000-0001-5092-8825; Ware, James S/0000-0002-6110-5880; 	British Heart Foundation; Wellcome Trust; Czech Republic Ministry of Health project for conceptual development of research organization (University Hospital Brno, Brno, Czech Republic) [65269705]; NIHR Royal Brompton Cardiovascular Biomedical Research Unit; British Heart Foundation [SP/10/10/28431] Funding Source: researchfish; Medical Research Council [MC_U120085815] Funding Source: researchfish; National Institute for Health Research [ACF-2007-21-004] Funding Source: researchfish; MRC [MC_U120085815] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Czech Republic Ministry of Health project for conceptual development of research organization (University Hospital Brno, Brno, Czech Republic); NIHR Royal Brompton Cardiovascular Biomedical Research Unit; British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the British Heart Foundation, the Wellcome Trust, the Czech Republic Ministry of Health project for conceptual development of research organization 65269705 (University Hospital Brno, Brno, Czech Republic) and the NIHR Royal Brompton Cardiovascular Biomedical Research Unit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman MJ, 2012, EUROPACE, V13, P1077; Burton H, 2010, PUBLIC HEALTH GENOM, V13, P235, DOI 10.1159/000279625; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Chan M, 2012, J MOL DIAGN, V14, P602, DOI 10.1016/j.jmoldx.2012.06.003; Commission HG, 2007, INF GATH SESS STRAT; Daum LT, 2012, J CLIN MICROBIOL, V50, P3831, DOI 10.1128/JCM.01893-12; Department of Health (2009cc), 2009, COR HEART DIS NAT SE; Descamps OS, 2011, ATHEROSCLEROSIS, V218, P272, DOI 10.1016/j.atherosclerosis.2011.06.016; Elliott Aaron M, 2012, J Biomol Tech, V23, P24, DOI 10.7171/jbt.12-2301-003; Eyre DW, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001124; Garratt CJ, 2008, HEART, V94, P502, DOI 10.1136/hrt.2007.127761; Harismendy O, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r124; Hedges DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018595; Junemann S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041606; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LifeTechnologies, 2011, ION PGM SEQ EXH SUP; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meder B, 2011, CIRC-CARDIOVASC GENE, V4, P110, DOI 10.1161/CIRCGENETICS.110.958322; Mokry M, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq072; Novotny T, 2011, PACE, V34, P742, DOI 10.1111/j.1540-8159.2011.03045.x; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rozen S, 2000, Methods Mol Biol, V132, P365; Sulonen AM, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r94; Tester DJ, 2005, HEART RHYTHM, V2, P1099, DOI 10.1016/j.hrthm.2005.07.012; Tewhey R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r116; TINDALL KR, 1988, BIOCHEMISTRY-US, V27, P6008, DOI 10.1021/bi00416a027; Vogel U, 2012, J CLIN MICROBIOL, V50, P1889, DOI 10.1128/JCM.00038-12; Wang CL, 2012, P NATL ACAD SCI USA, V109, P8676, DOI 10.1073/pnas.1206614109; Ware JS, 2012, HUM MUTAT, V33, P1188, DOI 10.1002/humu.22114; Ware JS, 2012, HEART, V98, P276, DOI 10.1136/heartjnl-2011-300742; Whiteley AS, 2012, J MICROBIOL METH, V91, P80, DOI 10.1016/j.mimet.2012.07.008; Yeo ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045798	35	106	109	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67744	10.1371/journal.pone.0067744	http://dx.doi.org/10.1371/journal.pone.0067744			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23874512	Green Submitted, Green Published, gold			2022-12-27	WOS:000323350700031
J	Mostafavi, S; Battle, A; Zhu, XW; Urban, AE; Levinson, D; Montgomery, SB; Koller, D				Mostafavi, Sara; Battle, Alexis; Zhu, Xiaowei; Urban, Alexander E.; Levinson, Douglas; Montgomery, Stephen B.; Koller, Daphne			Normalizing RNA-Sequencing Data by Modeling Hidden Covariates with Prior Knowledge	PLOS ONE			English	Article							PREDICTION; ALGORITHM	Transcriptomic assays that measure expression levels are widely used to study the manifestation of environmental or genetic variations in cellular processes. RNA-sequencing in particular has the potential to considerably improve such understanding because of its capacity to assay the entire transcriptome, including novel transcriptional events. However, as with earlier expression assays, analysis of RNA-sequencing data requires carefully accounting for factors that may introduce systematic, confounding variability in the expression measurements, resulting in spurious correlations. Here, we consider the problem of modeling and removing the effects of known and hidden confounding factors from RNA-sequencing data. We describe a unified residual framework that encapsulates existing approaches, and using this framework, present a novel method, HCP (Hidden Covariates with Prior). HCP uses a more informed assumption about the confounding factors, and performs as well or better than existing approaches while having a much lower computational cost. Our experiments demonstrate that accounting for known and hidden factors with appropriate models improves the quality of RNA-sequencing data in two very different tasks: detecting genetic variations that are associated with nearby expression variations (cis-eQTLs), and constructing accurate co-expression networks.	[Mostafavi, Sara; Battle, Alexis; Koller, Daphne] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Zhu, Xiaowei; Urban, Alexander E.; Levinson, Douglas] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Montgomery, Stephen B.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Koller, D (corresponding author), Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA.	koller@cs.stanford.edu		Mostafavi, Sara/0000-0003-4698-1177; Montgomery, Stephen/0000-0002-5200-3903; Zhu, Xiaowei/0000-0002-5731-3177	National Institute of Mental Health [RC2MH089916]; National Institute of Health [ED-8767-69-ST2, 152016.5057381.0008]; NATIONAL INSTITUTE OF MENTAL HEALTH [RC2MH089916] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Support for this work was provided by National Institute of Mental Health (grant RC2MH089916 to D. F. L) and National Institute of Health (grant ED-8767-69-ST2 and 152016.5057381.0008 to D. K). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres S, 1999, GENOME BIOL, V11; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Benjamini Y, 1995, J ROYAL STAT SOC B, V1; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Cloonan N, 2008, NATURE METHODS, V5; Engelhardt BE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001117; Fehrmann RSN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002197; Furlotte N, 2011, BIOINFORMATICS, V27; Fusi N, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002330; Gagnon-Bartsch J, 2011, BIOSTATISTICS; Hansen KD, 2011, NAT BIOTECHNOL, V29, P572, DOI 10.1038/nbt.1910; Johnson W, 2007, BIOSTATISTICS, V8; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kang HM, 2008, GENETICS, V180, P1909, DOI 10.1534/genetics.108.094201; Langmead B, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r83; Leek J.T., 2007, PLOS GENETICS, V3; Listgarten J, 2010, P NATL ACAD SCI USA, V107; Lonsdale J., 2013, NATURE GENETICS, V45; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Montgomery SB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002144; Montgomery SB, 2011, NAT REV GENET, V12, P277, DOI 10.1038/nrg2969; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Mortazavi A, 2008, NATURE METHODS, V5; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Parts L, 2011, PLOS GENET, V7; Pena-Castillo L, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s2; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Stegle O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000770; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; Toung J, 2011, GENOME RES; Xu QH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026905; Zheng W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-290; Zhou DY, 2004, ADV NEUR IN, V16, P321	34	42	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e68141	10.1371/journal.pone.0068141	http://dx.doi.org/10.1371/journal.pone.0068141			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874524	Green Published, Green Submitted, gold			2022-12-27	WOS:000324146200013
J	Loverdo, C; Lloyd-Smith, JO				Loverdo, Claude; Lloyd-Smith, James O.			Evolutionary Invasion and Escape in the Presence of Deleterious Mutations	PLOS ONE			English	Article							ASEXUAL POPULATIONS; LETHAL MUTAGENESIS; EMERGENCE; ADAPTATION; PATHOGENS; VIRUSES; RATES; RNA; CONSEQUENCES; EPIDEMIOLOGY	Replicators such as parasites invading a new host species, species invading a new ecological niche, or cancer cells invading a new tissue often must mutate to adapt to a new environment. It is often argued that a higher mutation rate will favor evolutionary invasion and escape from extinction. However, most mutations are deleterious, and even lethal. We study the probability that the lineage will survive and invade successfully as a function of the mutation rate when both the initial strain and an adaptive mutant strain are threatened by lethal mutations. We show that mutations are beneficial, i.e. a non-zero mutation rate increases survival compared to the limit of no mutations, if in the no-mutation limit the survival probability of the initial strain is smaller than the average survival probability of the strains which are one mutation away. The mutation rate that maximizes survival depends on the characteristics of both the initial strain and the adaptive mutant, but if one strain is closer to the threshold governing survival then its properties will have greater influence. These conclusions are robust for more realistic or mechanistic depictions of the fitness landscapes such as a more detailed viral life history, or non-lethal deleterious mutations.	[Loverdo, Claude; Lloyd-Smith, James O.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90024 USA; [Lloyd-Smith, James O.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Loverdo, C (corresponding author), Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90024 USA.	loverdo@ucla.edu	/K-4080-2012; Lloyd-Smith, James/AAG-4463-2021	/0000-0001-7941-502X; Loverdo, Claude/0000-0002-0888-1717	NSF [EF-0928690]; De Logi Chair in Biological Sciences; RAPIDD program of the Science & Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health	NSF(National Science Foundation (NSF)); De Logi Chair in Biological Sciences(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); RAPIDD program of the Science & Technology Directorate, Department of Homeland Security(United States Department of Homeland Security (DHS)); Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Both authors are supported by the NSF grant EF-0928690. JLS is grateful for the support of the De Logi Chair in Biological Sciences, and the RAPIDD program of the Science & Technology Directorate, Department of Homeland Security, and the Fogarty International Center, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander HK, 2010, J R SOC INTERFACE, V7, P1455, DOI 10.1098/rsif.2010.0123; Anderson JP, 2004, ANNU REV MICROBIOL, V58, P183, DOI 10.1146/annurev.micro.58.030603.123649; Andre JB, 2006, GENETICS, V172, P611, DOI 10.1534/genetics.105.046680; Andre JB, 2005, P ROY SOC B-BIOL SCI, V272, P1949, DOI 10.1098/rspb.2005.3170; Antia R, 2003, NATURE, V426, P658, DOI 10.1038/nature02104; Baer CF, 2007, NAT REV GENET, V8, P619, DOI 10.1038/nrg2158; Borderia A, 2011, CURR OPIN VIROL, V1, P1; Bull JJ, 2008, J THEOR BIOL, V254, P667, DOI 10.1016/j.jtbi.2008.06.006; Bull JJ, 2007, J VIROL, V81, P2930, DOI 10.1128/JVI.01624-06; Campos PRA, 2010, EVOLUTION, V64, P1973, DOI 10.1111/j.1558-5646.2010.00981.x; Chen HY, 2007, P NATL ACAD SCI USA, V104, P19079, DOI 10.1073/pnas.0707449104; Cleaveland S, 2007, CURR TOP MICROBIOL, V315, P85; Denamur E, 2006, MOL MICROBIOL, V60, P820, DOI 10.1111/j.1365-2958.2006.05150.x; ESHEL I, 1973, J APPL PROBAB, V10, P728, DOI 10.2307/3212376; Eyre-Walker A, 2007, NAT REV GENET, V8, P610, DOI 10.1038/nrg2146; Furio V, 2005, P NATL ACAD SCI USA, V102, P10233, DOI 10.1073/pnas.0501062102; Gavrilets S, 1997, TRENDS ECOL EVOL, V12, P307, DOI 10.1016/S0169-5347(97)01098-7; GILLESPIE JH, 1981, EVOLUTION, V35, P468, DOI [10.2307/2408195, 10.1111/j.1558-5646.1981.tb04910.x]; Harris T. E., 1963, THEORY BRANCHING PRO; Holmes EC, 2007, CURR TOP MICROBIOL, V315, P51; Iranzo J, 2011, P NATL ACAD SCI USA, V108, P16008, DOI 10.1073/pnas.1110489108; Iwasa Y, 2004, J THEOR BIOL, V226, P205, DOI 10.1016/j.jtbi.2003.08.014; Johnson T, 2002, GENETICS, V162, P395; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kimura M, 1967, GENET RES, V16, P39; Leigh GLJ, 1970, AM NAT, V104, P301; Loverdo C, 2012, EVOLUTION, V66, P3462, DOI 10.1111/j.1558-5646.2012.01687.x; Lozovsky ER, 2009, P NATL ACAD SCI USA, V106, P12025, DOI 10.1073/pnas.0905922106; Lynch M, 1999, EVOLUTION, V53, P645, DOI 10.1111/j.1558-5646.1999.tb05361.x; Lynch M, 2010, TRENDS GENET, V26, P345, DOI 10.1016/j.tig.2010.05.003; Manrubia SC, 2010, PHILOS T R SOC B, V365, P1943, DOI 10.1098/rstb.2010.0076; Martin G, 2010, PHILOS T R SOC B, V365, P1953, DOI 10.1098/rstb.2010.0058; Orr HA, 2008, AM NAT, V172, P160, DOI 10.1086/589460; Orr HA, 2000, GENETICS, V155, P961; Pearson JE, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001058; Regoes RR, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2047; Sanjuan R, 2010, PHILOS T R SOC B, V365, P1975, DOI 10.1098/rstb.2010.0063; Shackelton LA, 2005, P NATL ACAD SCI USA, V102, P379, DOI 10.1073/pnas.0406765102; Shih ACC, 2007, P NATL ACAD SCI USA, V104, P6283, DOI 10.1073/pnas.0701396104; Sniegowski PD, 2000, BIOESSAYS, V22, P1057, DOI 10.1002/1521-1878(200012)22:12&lt;1057::AID-BIES3&gt;3.0.CO;2-W; Sturtevant AH, 1937, Q REV BIOL, V12, P464, DOI 10.1086/394543; Thebaud G, 2010, P ROY SOC B-BIOL SCI, V277, P809, DOI 10.1098/rspb.2009.1247; Wang GP, 2010, J VIROL, V84, P6218, DOI 10.1128/JVI.02271-09; Woolhouse MEJ, 2005, TRENDS ECOL EVOL, V20, P238, DOI 10.1016/j.tree.2005.02.009; Wylie CS, 2011, P NATL ACAD SCI USA, V108, P9916, DOI 10.1073/pnas.1017572108	45	8	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e68179	10.1371/journal.pone.0068179	http://dx.doi.org/10.1371/journal.pone.0068179			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23874532	Green Submitted, gold, Green Published			2022-12-27	WOS:000322000600004
J	Loots, GG; Bergmann, A; Hum, NR; Oldenburg, CE; Wills, AE; Hu, N; Ovcharenko, I; Harland, RM				Loots, Gabriela G.; Bergmann, Anne; Hum, Nicholas R.; Oldenburg, Catherine E.; Wills, Andrea E.; Hu, Na; Ovcharenko, Ivan; Harland, Richard M.			Interrogating Transcriptional Regulatory Sequences in Tol2-Mediated Xenopus Transgenics	PLOS ONE			English	Article							CONSERVED NONCODING SEQUENCES; TISSUE-SPECIFIC ENHANCERS; RED FLUORESCENT PROTEIN; SKELETAL-MUSCLE; GENE-EXPRESSION; HUMAN GENOME; IN-VIVO; TROPICALIS; ZEBRAFISH; PROMOTER	Identifying gene regulatory elements and their target genes in vertebrates remains a significant challenge. It is now recognized that transcriptional regulatory sequences are critical in orchestrating dynamic controls of tissue-specific gene expression during vertebrate development and in adult tissues, and that these elements can be positioned at great distances in relation to the promoters of the genes they control. While significant progress has been made in mapping DNA binding regions by combining chromatin immunoprecipitation and next generation sequencing, functional validation remains a limiting step in improving our ability to correlate in silico predictions with biological function. We recently developed a computational method that synergistically combines genome-wide gene-expression profiling, vertebrate genome comparisons, and transcription factor binding-site analysis to predict tissue-specific enhancers in the human genome. We applied this method to 270 genes highly expressed in skeletal muscle and predicted 190 putative cis-regulatory modules. Furthermore, we optimized Tol2 transgenic constructs in Xenopus laevis to interrogate 20 of these elements for their ability to function as skeletal muscle-specific transcriptional enhancers during embryonic development. We found 45% of these elements expressed only in the fast muscle fibers that are oriented in highly organized chevrons in the Xenopus laevis tadpole. Transcription factor binding site analysis identified >2 Mef2/MyoD sites within similar to 200 bp regions in 6 of the validated enhancers, and systematic mutagenesis of these sites revealed that they are critical for the enhancer function. The data described herein introduces a new reporter system suitable for interrogating tissue-specific cis-regulatory elements which allows monitoring of enhancer activity in real time, throughout early stages of embryonic development, in Xenopus.	[Loots, Gabriela G.; Bergmann, Anne; Hum, Nicholas R.] Lawrence Livermore Natl Lab, Biol & Biotechnol Div, Livermore, CA 94550 USA; [Loots, Gabriela G.] Univ Calif Merced, Sch Nat Sci, Merced, CA USA; [Ovcharenko, Ivan] Natl Lib Med, Computat Biol Branch, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD USA; [Oldenburg, Catherine E.; Wills, Andrea E.; Hu, Na; Harland, Richard M.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Merced; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); University of California System; University of California Berkeley	Loots, GG (corresponding author), Lawrence Livermore Natl Lab, Biol & Biotechnol Div, Livermore, CA 94550 USA.	loots1@llnl.gov	Loots, Gabriela G/AGA-4868-2022	Loots, Gabriela G/0000-0001-9546-5561; Hum, Nicholas/0000-0003-1605-3193	National Institutes of Health (NIH) [HG003963]; Intramural Research Program of the NIH, National Library of Medicine; United States Department of Energy by Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003963] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM200881] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the NIH, National Library of Medicine; United States Department of Energy by Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	GGL, NH, and AB were supported by National Institutes of Health (NIH) grant HG003963. This research was supported in part by the Intramural Research Program of the NIH, National Library of Medicine to I.O. This work performed under the auspices of the United States Department of Energy by Lawrence Livermore National Laboratory under contract DE-AC52-07NA27344. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allende ML, 2006, METHODS, V39, P212, DOI 10.1016/j.ymeth.2005.12.005; Amaya E., 2010, JOVE-J VIS EXP, DOI [DOI 10.3791/2010, 10.3791/2010]; Balciunas D, 2006, PLOS GENET, V2, P1715, DOI 10.1371/journal.pgen.0020169; Belay E, 2011, CURR GENE THER, V11, P406; Birnbaum RY, 2012, GENOME RES, V22, P1059, DOI 10.1101/gr.133546.111; Brancaccio M, 2003, NAT MED, V9, P68, DOI 10.1038/nm805; Clark KJ, 2011, METHOD CELL BIOL, V104, P137, DOI 10.1016/B978-0-12-374814-0.00008-2; Collette NM, 2012, P NATL ACAD SCI US; Conte C, 2002, EMBO J, V21, P3908, DOI 10.1093/emboj/cdf367; de la Calle-Mustienes E, 2005, GENOME RES, V15, P1061, DOI 10.1101/gr.4004805; De Repentigny Y, 2004, HUM MOL GENET, V13, P2853, DOI 10.1093/hmg/ddh305; DONOGHUE M, 1988, GENE DEV, V2, P1779, DOI 10.1101/gad.2.12b.1779; Donoviel DB, 1996, MOL CELL BIOL, V16, P1649; Gong ZY, 2002, DEV DYNAM, V223, P204, DOI 10.1002/dvdy.10051; Grimaldi A, 2004, DEVELOPMENT, V131, P3249, DOI 10.1242/dev.01194; Haeri Mohammad, 2012, Methods Mol Biol, V884, P17, DOI 10.1007/978-1-61779-848-1_2; Hamlet MRJ, 2006, GENESIS, V44, P438, DOI 10.1002/dvg.20234; Harada H, 2007, BIOCHEM BIOPH RES CO, V360, P791, DOI 10.1016/j.bbrc.2007.06.149; Hirsch N, 2002, DEV DYNAM, V225, P522, DOI 10.1002/dvdy.10188; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Kawakami K, 2004, GENE, V338, P93, DOI 10.1016/j.gene.2004.05.013; Kroll KL, 1996, DEVELOPMENT, V122, P3173; Kuo TY, 2012, P NATL ACAD SCI USA, V109, P11160, DOI 10.1073/pnas.1111334109; Loots GG, 2005, GENOME RES, V15, P928, DOI 10.1101/gr.3437105; Momken I, 2005, J PHYSIOL-LONDON, V565, P951, DOI 10.1113/jphysiol.2005.086397; Murakami K, 2005, J MOL BIOL, V352, P178, DOI 10.1016/j.jmb.2005.06.067; Nanda V, 2012, J BIOL CHEM, V287, P2459, DOI 10.1074/jbc.M111.302224; Narlikar L, 2010, GENOME RES, V20, P381, DOI 10.1101/gr.098657.109; Natarajan A, 2012, GENOME RES, V22, P1711, DOI 10.1101/gr.135129.111; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Ogino H, 2006, MECH DEVELOP, V123, P103, DOI 10.1016/j.mod.2005.11.006; Ohtsuki S, 1998, GENE DEV, V12, P547, DOI 10.1101/gad.12.4.547; Parinov S, 2004, DEV DYNAM, V231, P449, DOI 10.1002/dvdy.20157; Pennacchio LA, 2007, GENOME RES, V17, P201, DOI 10.1101/gr.5972507; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Pletnev S, 2008, J BIOL CHEM, V283, P28980, DOI 10.1074/jbc.M800599200; Qiu HF, 2008, J GENET GENOMICS, V35, P257, DOI 10.1016/S1673-8527(08)60036-3; Shcherbo D, 2007, NAT METHODS, V4, P741, DOI 10.1038/NMETH1083; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Sun HY, 2005, MOL CELL BIOCHEM, V269, P85, DOI 10.1007/s11010-005-2539-9; Suster Maximiliano L, 2009, Methods Mol Biol, V561, P41, DOI 10.1007/978-1-60327-019-9_3; Takada F, 2001, P NATL ACAD SCI USA, V98, P1595, DOI 10.1073/pnas.041609698; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Wasserman WW, 1998, J MOL BIOL, V278, P167, DOI 10.1006/jmbi.1998.1700; Yergeau DA, 2009, DEV DYNAM, V238, P1727, DOI 10.1002/dvdy.21994	46	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68548	10.1371/journal.pone.0068548	http://dx.doi.org/10.1371/journal.pone.0068548			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874664	gold, Green Published, Green Submitted			2022-12-27	WOS:000322064300046
J	Souza, PSL; Santana, RHC; Santana, MJ; Zaluska, E; Faical, BS; Estrella, JC				Souza, Paulo S. L.; Santana, Regina H. C.; Santana, Marcos J.; Zaluska, Ed; Faical, Bruno S.; Estrella, Julio C.			Load Index Metrics for an Optimized Management of Web Services: A Systematic Evaluation	PLOS ONE			English	Article								The lack of precision to predict service performance through load indices may lead to wrong decisions regarding the use of web services, compromising service performance and raising platform cost unnecessarily. This paper presents experimental studies to qualify the behaviour of load indices in the web service context. The experiments consider three services that generate controlled and significant server demands, four levels of workload for each service and six distinct execution scenarios. The evaluation considers three relevant perspectives: the capability for representing recent workloads, the capability for predicting near-future performance and finally stability. Eight different load indices were analysed, including the JMX Average Time index (proposed in this paper) specifically designed to address the limitations of the other indices. A systematic approach is applied to evaluate the different load indices, considering a multiple linear regression model based on the stepwise-AIC method. The results show that the load indices studied represent the workload to some extent; however, in contrast to expectations, most of them do not exhibit a coherent correlation with service performance and this can result in stability problems. The JMX Average Time index is an exception, showing a stable behaviour which is tightly-coupled to the service runtime for all executions. Load indices are used to predict the service runtime and therefore their inappropriate use can lead to decisions that will impact negatively on both service performance and execution cost.	[Souza, Paulo S. L.; Santana, Regina H. C.; Santana, Marcos J.; Faical, Bruno S.; Estrella, Julio C.] Univ Sao Paulo, Comp Syst Dept, Sao Paulo, Brazil; [Zaluska, Ed] Univ Southampton, Southampton, Hants, England	Universidade de Sao Paulo; University of Southampton	Souza, PSL (corresponding author), Univ Sao Paulo, Comp Syst Dept, Sao Paulo, Brazil.	pssouza@icmc.usp.br	Estrella, Julio Cezar/AAP-4484-2020; Souza, Paulo S. L./F-5487-2011; Faiçal, Bruno S./G-7359-2018	Estrella, Julio Cezar/0000-0003-0524-3274; Souza, Paulo S. L./0000-0002-1560-2704; S. Faical, Bruno/0000-0002-9866-3712	FAPESP; INCT/SEC; CNPq [2008/57870-9, 573963/2008-8, 2009/03605-5, 2010/02839-0]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); INCT/SEC; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work is sponsored by FAPESP, INCT/SEC and CNPq; contract/grant numbers: 2008/57870-9, 573963/2008-8, 2009/03605-5 and 2010/02839-0. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Al-Masri E, 2007, P 16 INT C WORLD WID, P1257, DOI DOI 10.1145/1242572.1242795; [Anonymous], 2012, ACTION STAT SOFTWARE; Apache Software Foundation, 2009, WEBSERVICES AX; Ardagna D, 2006, LECT NOTES COMPUT SC, V3812, P32; Bichler M, 2006, COMPUTER, V39, P99, DOI 10.1109/MC.2006.102; Chen Gong, 2008, P 5 USENIX S NETW SY, V5, P337; de Souza P. S. L., 2011, 2011 Proceedings of IEEE International Conference on Services Computing (SCC 2011), P520, DOI 10.1109/SCC.2011.90; Dyachuk D, 2007, 21ST INTERNATIONAL CONFERENCE ON ADVANCED NETWORKING AND APPLICATIONS, PROCEEDINGS, P46, DOI 10.1109/AINA.2007.107; El Saddik A, 2006, IEEE T INSTRUM MEAS, V55, P1599, DOI 10.1109/TIM.2006.880288; Ferrari D., 1987, P PERF 87 12 INT S C, P515; Grundy J., 2006, P INT WORKSH SERV OR, P26; Huhns MN, 2005, IEEE INTERNET COMPUT, V9, P75, DOI 10.1109/MIC.2005.21; Josuttis N. M., 2007, SOA PRACTICE ART DIS; Kalepu S, 2004, FOURTH INTERNATIONAL CONFERENCE ON WEB INFORMATION SYSTEMS ENGINEERING WORKSHOPS, PROCEEDINGS, P131; Li Z, 2006, 2006 AUSTRALIAN SOFTWARE ENGINEERING CONFERENCE, PROCEEDINGS, P70; Liu Y, 2007, P INT COMP SOFTW APP, P327; Mahmoud QH, 2004, GETTING STARTED JAVA; Mani A, 2002, UNDERSTANDING QUALIT; Marchioni F, 2010, JBOSS AS 5 DEV; Marzolla M, 2007, LECT NOTES COMPUT SC, V4880, P127; Massie ML, 2004, PARALLEL COMPUT, V30, P817, DOI 10.1016/j.parco.2004.04.001; Montgomery D.C., 2012, INTRO LINEAR REGRESS, Vfifith; Muszala SP, 2006, J ATMOS OCEAN TECH, V23, P525, DOI 10.1175/JTECH1865.1; Pacifici G, 2005, IEEE J SEL AREA COMM, V23, P2333, DOI 10.1109/JSAC.2005.857208; Papazoglou MP, 2007, COMPUTER, V40, P38, DOI 10.1109/MC.2007.400; Papazoglou MR, 2005, IEEE INTERNET COMPUT, V9, P58, DOI 10.1109/MIC.2005.137; Porter G, 2006, COMMUN ACM, V49, P49; Qin X, 2008, J NETW COMPUT APPL, V31, P32, DOI 10.1016/j.jnca.2006.07.001; Raimondi F, 2008, P 16 ACM SIGSOFT INT, P170, DOI DOI 10.1145/1453101.1453125; Red Hat, 2005, JBOSS APPL SERV DOC; Rosenberg F, 2006, ICWS 2006: IEEE INTERNATIONAL CONFERENCE ON WEB SERVICES, PROCEEDINGS, P205; Rud D, 2006, SCW 2006: IEEE SERVICES COMPUTING WORKSHOPS, PROCEEDINGS, P140; Sabetta A, 2008, LECT NOTES COMPUT SC, V4909, P226, DOI 10.1007/978-3-540-68947-8_21; Schaefer J, 2006, LECT NOTES COMPUT SC, V4025, P169; Schopfl JM, 2006, ANLMCSP12480405, P1; Schultheiss SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024914; Sherchan W, 2005, P 5 INT C QUAL SOFTW, P493; Song HG, 2005, LECT NOTES COMPUT SC, V3733, P392; The Apache Software Foundation, 1999, AP TOMC; Tsouloupas G, P 2 IEEE INT C E SCI; Tu S, 2004, ITCC 2004: INTERNATIONAL CONFERENCE ON INFORMATION TECHNOLOGY: CODING AND COMPUTING, VOL 2, PROCEEDINGS, P444, DOI 10.1109/ITCC.2004.1286692; Xiong PC, 2007, FOURTH INTERNATIONAL CONFERENCE ON FUZZY SYSTEMS AND KNOWLEDGE DISCOVERY, VOL 3, PROCEEDINGS, P632, DOI 10.1109/FSKD.2007.462; Yamashita T, 2007, COMMUN STAT-THEOR M, V36, P2395, DOI 10.1080/03610920701215639; Yu T, 2007, ACM T WEB, V1, DOI 10.1145/1232722.1232728; ZHOU SN, 1993, SOFTWARE PRACT EXPER, V23, P1305, DOI 10.1002/spe.4380231203	45	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68819	10.1371/journal.pone.0068819	http://dx.doi.org/10.1371/journal.pone.0068819			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874776	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000322064300072
J	van Leeuwen, M; Kemna, MJ; de Winther, MPJ; Boon, L; Duijvestijn, AM; Henatsch, D; Bos, NA; Gijbels, MJJ; Tervaert, JWC				van Leeuwen, Marcella; Kemna, Michael J.; de Winther, Menno P. J.; Boon, Louis; Duijvestijn, Adriaan M.; Henatsch, Darius; Bos, Nico A.; Gijbels, Marion J. J.; Tervaert, Jan Willem Cohen			Passive Immunization with Hypochlorite-oxLDL Specific Antibodies Reduces Plaque Volume in LDL Receptor-Deficient Mice	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; CORONARY-ARTERY-DISEASE; OXIDIZED LDL; ATHEROSCLEROTIC LESIONS; NATURAL ANTIBODIES; IMMUNE-RESPONSE; MYELOPEROXIDASE; IGM; IMMUNOGLOBULIN; PHOSPHORYLCHOLINE	Aims: New strategies to overcome complications of cardiovascular diseases are needed. Since it has been demonstrated that atherosclerosis is an inflammatory disease, modulation of the immune system may be a promising approach. Previously, it was suggested that antibodies may confer protective effects on the development of atherosclerosis. In this study, we hypothesised that passive immunization with anti-oxLDL IgM antibodies specific for hypochlorite (HOCl) may be athero-protective in mice. Methods and Results: Monoclonal mouse IgM antibodies were produced and the antibody with specificity for hypochlorite-oxLDL (HOCl-oxLDL) (Moab A7S8) was selected. VH sequence determination revealed that Moab A7S8 is a natural IgM antibody. Atherosclerosis in LDLr-/- mice was induced by a perivascular collar placement around the right carotid artery in combination with feeding a high-fat diet. Subsequently, the mice were treated every six days with 500 mu g Moab A7S8, non-relevant IgM or with PBS and the carotid arteries and aortic roots were studied for atherosclerosis. Passive immunization with this Moab A7S8 resulted in a significant reduced plaque volume formation in LDLr-/- mice when compared with PBS treatment (P = 0.002 and P = 0.035). Cholesterol levels decreased by 20% when mice were treated with Moab A7S8 compared to PBS. Furthermore, anti-oxLDL specific IgM and IgG antibody production increased significantly in the Moab A7S8 treated mice in comparison with PBS treated mice. Conclusion: Our data show that passive immunization with a natural IgM antibody, directed to HOCl-oxLDL, can reduce atherosclerotic plaque development. We postulate that specific antibody therapy may be developed for use in human cardiovascular diseases.	[van Leeuwen, Marcella; Kemna, Michael J.; de Winther, Menno P. J.; Duijvestijn, Adriaan M.; Henatsch, Darius; Gijbels, Marion J. J.; Tervaert, Jan Willem Cohen] Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [de Winther, Menno P. J.; Gijbels, Marion J. J.] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands; [Boon, Louis] Bioceros BV, Utrecht, Netherlands; [Bos, Nico A.] Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, NL-9700 AB Groningen, Netherlands; [Tervaert, Jan Willem Cohen] Maastricht Univ, Med Ctr, Immunol Lab, Maastricht, Netherlands	Maastricht University; University of Amsterdam; Academic Medical Center Amsterdam; Bioceros B.V.; University of Groningen; Maastricht University	Tervaert, JWC (corresponding author), Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands.	jw.cohentervaert@maastrichtuniversity.nl	Bos, Nicolaas/C-1503-2015; Boon, Laurence/HCI-3629-2022; tervaert, jan willem cohen/AAB-1111-2019	Bos, Nicolaas/0000-0002-8649-0455; de Winther, Menno/0000-0002-4038-6636; Boon, Louis/0000-0002-0937-9171	transnational University Limburg (tUL)	transnational University Limburg (tUL)	This research was funded by the transnational University Limburg (tUL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselbergs FW, 2004, AM J MED, V116, P429, DOI 10.1016/j.amjmed.2003.10.025; Binder CJ, 2008, CURR DRUG TARGETS, V9, P190; Binder CJ, 2005, J LIPID RES, V46, P1353, DOI 10.1194/jlr.R500005-JLR200; Binder CJ, 2004, J CLIN INVEST, V114, P427, DOI 10.1172/jci200420479; Binder CJ, 2003, NAT MED, V9, P736, DOI 10.1038/nm876; Brennan M, 2003, NEW ENGL J MED, V349, P1595, DOI 10.1056/NEJMoa035003; Caidahl K, 2012, INT J CARDIOL; Caligiuri G, 2007, J AM COLL CARDIOL, V50, P540, DOI 10.1016/j.jacc.2006.11.054; Cesena FHY, 2012, ATHEROSCLEROSIS, V220, P59, DOI 10.1016/j.atherosclerosis.2011.10.002; Charo IF, 2011, NAT REV DRUG DISCOV, V10, P365, DOI 10.1038/nrd3444; Chou MY, 2009, J CLIN INVEST, V119, P1335, DOI 10.1172/JCI36800; Chyu KY, 2007, CURR OPIN MOL THER, V9, P176; DAUGHERTY A, 1994, J CLIN INVEST, V94, P437, DOI 10.1172/JCI117342; de Faire U, 2010, J AUTOIMMUN, V34, P73, DOI 10.1016/j.jaut.2009.05.003; Ehrenstein MR, 1998, P NATL ACAD SCI USA, V95, P10089, DOI 10.1073/pnas.95.17.10089; Faria-Neto JR, 2006, ATHEROSCLEROSIS, V189, P83, DOI 10.1016/j.atherosclerosis.2005.11.033; Frostegard J, 2010, CLIN IMMUNOL, V134, P47, DOI 10.1016/j.clim.2009.08.013; Giudicelli V, 2004, NUCLEIC ACIDS RES, V32, pW435, DOI 10.1093/nar/gkh412; Goossens P, 2010, CELL METAB, V12, P142, DOI 10.1016/j.cmet.2010.06.008; Habets KLL, 2010, CARDIOVASC RES, V85, P622, DOI 10.1093/cvr/cvp338; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Horie K, 1997, J CLIN INVEST, V100, P2995, DOI 10.1172/JCI119853; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Kanters E, 2003, J CLIN INVEST, V112, P1176, DOI 10.1172/JCI18580; Karvonen J, 2003, CIRCULATION, V108, P2107, DOI 10.1161/01.CIR.0000092891.55157.A7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Meuwese MC, 2007, J AM COLL CARDIOL, V50, P159, DOI 10.1016/j.jacc.2007.03.033; Nicholls SJ, 2005, ARTERIOSCL THROM VAS, V25, P1102, DOI 10.1161/01.ATV.0000163262.83456.6d; ORLANDI R, 1989, P NATL ACAD SCI USA, V86, P3833, DOI 10.1073/pnas.86.10.3833; Podrez EA, 1999, J CLIN INVEST, V103, P1547, DOI 10.1172/JCI5549; Rouhl RPW, 2010, STROKE, V41, P2687, DOI 10.1161/STROKEAHA.110.592725; Shaw PX, 2001, ARTERIOSCL THROM VAS, V21, P1333, DOI 10.1161/hq0801.093587; Slot MC, 2007, CLIN EXP IMMUNOL, V149, P257, DOI 10.1111/j.1365-2249.2007.03420.x; Smook MLF, 2008, CLIN EXP IMMUNOL, V154, P264, DOI 10.1111/j.1365-2249.2008.03746.x; Stoel M, 2005, J IMMUNOL, V174, P1046, DOI 10.4049/jimmunol.174.2.1046; Su J, 2006, ATHEROSCLEROSIS, V188, P160, DOI 10.1016/j.atherosclerosis.2005.10.017; van Leeuwen M, 2009, AUTOIMMUN REV, V9, P53, DOI 10.1016/j.autrev.2009.03.001; van Leeuwen M, 2008, ARTERIOSCL THROM VAS, V28, P84, DOI 10.1161/ATVBAHA.107.154807; van Leeuwen M, 2009, ANN NY ACAD SCI, V1173, P274, DOI 10.1111/j.1749-6632.2009.04657.x; von der Thusen JH, 2001, CIRCULATION, V103, P1164, DOI 10.1161/01.CIR.103.8.1164; Zhang ZL, 2001, JAMA-J AM MED ASSOC, V286, P2136, DOI 10.1001/jama.286.17.2136	41	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68039	10.1371/journal.pone.0068039	http://dx.doi.org/10.1371/journal.pone.0068039			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874490	Green Published, Green Submitted, gold			2022-12-27	WOS:000322064300013
J	Arredondo, A; Reyes, G				Arredondo, Armando; Reyes, Gabriela			Health Disparities from Economic Burden of Diabetes in Middle-income Countries: Evidence from Mexico	PLOS ONE			English	Article							COST; COMPLICATIONS	The rapid growth of diabetes in middle-income countries is generating disparities in global health. In this context we conducted a study to quantify the health disparities from the economic burden of diabetes in Mexico. Evaluative research based on a longitudinal design, using cost methodology by instrumentation. For the estimation of epidemiological changes during the 2010-2012 period, several probabilistic models were developed using the Box-Jenkins technique. The financial requirements were obtained from expected case management costs by disease and the application of an econometric adjustment factor to control the effects of inflation. Comparing the economic impact in 2010 versus 2012 (p<0.05), there was a 33% increase in financial requirements. The total amount for diabetes in 2011 (US dollars) was $7.7 billion. It includes $3.4 billion in direct costs and $4.3 in indirect costs. The total direct costs were $.4 billion to the Ministry of Health (SSA), serving the uninsured population; $1.2 to the institutions serving the insured population (Mexican Institute for Social Security-IMSS-, and Institute for Social Security and Services for State Workers-ISSSTE-); $1.8 to users; and $.1 to Private Health Insurance (PHI). If the risk factors and the different health care models remain as they currently are in the analyzed institutions, health disparities in terms of financial implications will have the greatest impact on users' pockets. In middle-income countries, health disparities generated by the economic burden of diabetes is one of the main reasons for catastrophic health expenditure. Health disparities generated by the economic burden of diabetes suggests the need to design and review the current organization of health systems and the relevance of moving from biomedical models and curative health care to preventive and socio-medical models to meet expected challenges from diseases like diabetes in middle-income countries.	[Arredondo, Armando; Reyes, Gabriela] Natl Inst Publ Hlth, Res Ctr Hlth Syst, Cuernavaca, Morelos, Mexico	Instituto Nacional de Salud Publica	Arredondo, A (corresponding author), Natl Inst Publ Hlth, Res Ctr Hlth Syst, Cuernavaca, Morelos, Mexico.	armando.arredondo@insp.mx						Arredondo A, 2007, DIABETOLOGIA, V50, P2408, DOI 10.1007/s00125-007-0828-4; Arredondo A, 2004, DIABETES CARE, V27, P104, DOI 10.2337/diacare.27.1.104; Arredondo A, 2009, DIABETOLOGIA, V52, P1693, DOI 10.1007/s00125-009-1417-5; Banco de Mexico, 2012, IND NAC PREC SERV ME, P46; Barcelo A, 2001, Rev Panam Salud Publica, V10, P318; Barcelo A, 2003, B WORLD HEALTH ORGAN, V81, P19; Brown JB, 1999, ARCH INTERN MED, V159, P1873, DOI 10.1001/archinte.159.16.1873; Caro JJ, 2002, DIABETES CARE, V25, P476, DOI 10.2337/diacare.25.3.476; Caspersen CJ, 2012, AM J PUBLIC HEALTH, V102, P1482, DOI 10.2105/AJPH.2011.300616; Dawson KG, 2002, DIABETES CARE, V25, P1303, DOI 10.2337/diacare.25.8.1303; Frenk J, 2012, DEMANDA OFERTA SERVI, P23; Instituto Nacional de Estadistica, 2012, PROD INT BRUT NAC PE; Instituto Nacional de Salud Publica, 2012, INF MEM MET, P63; Instituto Nacional de Salud Publica, 2012, ENC NAC SAL NUTR 201; International Diabetes Federation, 2010, DECL INT LAW PRINC R, P29; International Diabetes Federation, 2010, DIR COST HLTH CAR SE, P13; Murray A, 2005, OXFORD SCI PUBLICATI, P112; Panamerican Health Organization, 2012, HLTH AN INF SYST REG; Petersen M, 2008, DIABETES CARE, V31, P1271, DOI 10.2337/dc08-9017; Ray NF, 1998, DIABETES CARE, V21, P296; Secretaria de Salud, 2012, INFORM TECNICO, P68; Snowdon A., 2012, MEASURING WHAT MATTE, P12; SSA, 2004, SALUD PUBLICA MEXICO, V42, P68; SSA, 2010, MED MAT DES SOL EQ, P38; SSA IMSS ISSSTE, 2011, B INF EST CAS MORT G, P7; SSA IMSS ISSSTE, 2008, PROGR NACL SAL 2001, P15; SSA IMSS ISSSTE, 2012, B INF EST CAS MORB H, P12; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Zhang P, 2010, DIABETES RES CLIN PR, V87, P293, DOI 10.1016/j.diabres.2010.01.026	29	30	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e68443	10.1371/journal.pone.0068443	http://dx.doi.org/10.1371/journal.pone.0068443			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	23874629	Green Published, Green Submitted, gold			2022-12-27	WOS:000321718700026
J	Barman, M; Johansson, S; Hesselmar, B; Wold, AE; Sandberg, AS; Sandin, A				Barman, Malin; Johansson, Sara; Hesselmar, Bill; Wold, Agnes E.; Sandberg, Ann-Sofie; Sandin, Anna			High Levels of Both n-3 and n-6 Long-Chain Polyunsaturated Fatty Acids in Cord Serum Phospholipids Predict Allergy Development	PLOS ONE			English	Article							FISH-OIL SUPPLEMENTATION; LYMPHOCYTE-PROLIFERATION; CYTOKINE PRODUCTION; ATOPIC-DERMATITIS; IMMUNE-RESPONSES; CONTROLLED-TRIAL; EARLY-CHILDHOOD; BIRTH COHORT; EARLY-LIFE; HIGH-RISK	Background: Long-chain polyunsaturated fatty acids (LCPUFAs) reduce T-cell activation and dampen inflammation. They might thereby counteract the neonatal immune activation and hamper normal tolerance development to harmless environmental antigens. We investigated whether fatty acid composition of cord serum phospholipids affects allergy development up to age 13 years. Methods: From a population-based birth-cohort born in 1996/7 and followed until 13 years of age (n = 794), we selected cases with atopic eczema (n = 37) or respiratory allergy (n = 44), as well as non-allergic non-sensitized controls (n = 48) based on diagnosis at 13 years of age. Cord and maternal sera obtained at delivery from cases and controls were analysed for proportions of saturated, monounsaturated and polyunsaturated fatty acids among serum phospholipids. Results: The cord serum phospholipids from subject who later developed either respiratory allergy or atopic eczema had significantly higher proportions of 5/8 LCPUFA species, as well as total n-3 LCPUFA, total n-6 LCPUFA and total LCPUFA compared to cord serum phospholipids from controls who did not develop allergy (P < 0.001 for all comparisons). Conversely, individuals later developing allergy had lower proportion of the monounsaturated fatty acid 18:1n-9 as well as total MUFA (p < 0.001) among cord serum phospholipids. The risk of respiratory allergy at age 13 increased linearly with the proportion of n-3 LCPUFA (P-trend < 0.001), n-6 LCPUFA (P-trend = 0.001), and total LCPUFA (P-trend < 0.001) and decreased linearly with the proportions of total MUFA (P-trend = 0.025) in cord serum phospholipids. Furthermore, Kaplan-Meier estimates of allergy development demonstrated that total LCPUFA proportion in cord serum phospholipids was significantly associated with respiratory allergy (P = 0.008) and sensitization (P = 0.002), after control for sex and parental allergy. Conclusion: A high proportion of long-chain PUFAs among cord serum phospholipids may predispose to allergy development. The mechanism is unknown, but may involve dampening of the physiologic immune activation in infancy needed for proper maturation of the infant's immune system.	[Barman, Malin; Johansson, Sara; Sandberg, Ann-Sofie] Chalmers Univ Technol, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden; [Hesselmar, Bill] Univ Gothenburg, Inst Clin Sci, Dept Paediat, Gothenburg, Sweden; [Wold, Agnes E.] Univ Gothenburg, Dept Infect Dis, Inst Biomed, Gothenburg, Sweden; [Sandin, Anna] Umea Univ, Dept Clin Sci, Umea, Sweden	Chalmers University of Technology; University of Gothenburg; University of Gothenburg; Umea University	Barman, M (corresponding author), Chalmers Univ Technol, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden.	malin.barman@chalmers.se	sandberg, ann-sofie/B-6857-2016; barman, malin/AAF-7933-2019	sandberg, ann-sofie/0000-0002-9681-3342; barman, malin/0000-0002-5317-2768; Wold, Agnes/0000-0001-9196-5040	Swedish Research Council for Environmental, Agricultural Sciences and Spatial Planning (FORMAS), Stockholm, Sweden [216-2009-752]; Vastra Gotaland Region, Sweden; Centre for Environment and Sustainability, GMV, Gothenburg, Sweden; Research and Development Department of the Jamtland County Council, Sweden; Research and Development Department of the Norrbotten County Council, Sweden; Th. C. Bergh Foundation	Swedish Research Council for Environmental, Agricultural Sciences and Spatial Planning (FORMAS), Stockholm, Sweden; Vastra Gotaland Region, Sweden; Centre for Environment and Sustainability, GMV, Gothenburg, Sweden; Research and Development Department of the Jamtland County Council, Sweden; Research and Development Department of the Norrbotten County Council, Sweden; Th. C. Bergh Foundation	The work was supported by grants from the Swedish Research Council for Environmental, Agricultural Sciences and Spatial Planning (FORMAS), Stockholm, Sweden, project number 216-2009-752; the Vastra Gotaland Region, Sweden; the Centre for Environment and Sustainability, GMV, Gothenburg, Sweden; the Research and Development Departments of the Jamtland and Norrbotten County Councils, Sweden; and the Th. C. Bergh Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers R, 2002, BRIT J NUTR, V88, P291, DOI 10.1079/BJN2002614; Alm B, 2009, ARCH DIS CHILD, V94, P11, DOI 10.1136/adc.2008.140418; Arrington JL, 2001, CLIN EXP IMMUNOL, V125, P499, DOI 10.1046/j.1365-2249.2001.01627.x; Bolte G, 2005, ANN EPIDEMIOL, V15, P207, DOI 10.1016/j.annepidem.2004.04.004; Brix S, 2010, IMMUNOLOGY, V129, P338, DOI 10.1111/j.1365-2567.2009.03163.x; Byberg K, 2008, PROSTAG LEUKOTR ESS, V78, P61, DOI 10.1016/j.plefa.2007.10.008; CALDER PC, 1992, CLIN SCI, V82, P695, DOI 10.1042/cs0820695; CALDER PC, 1991, INT J BIOCHEM, V23, P579; Calvani M, 2006, PEDIAT ALLERG IMM-UK, V17, P94, DOI 10.1111/j.1399-3038.2005.00367.x; Chang HH, 2009, FOOD CHEM TOXICOL, V47, P848, DOI 10.1016/j.fct.2009.01.017; Cunningham P, 2009, J NUTR, V139, P636, DOI 10.3945/jn.108.098608; Duchen K, 2000, PEDIAT ALLERG IMM-UK, V11, P29, DOI 10.1034/j.1399-3038.2000.00052.x; Dunder T, 2001, ALLERGY, V56, P425, DOI 10.1034/j.1398-9995.2001.056005425.x; Dunstan JA, 2003, J ALLERGY CLIN IMMUN, V112, P1178, DOI 10.1016/j.jaci.2003.09.009; Fogg MI, 2003, J ALLERGY CLIN IMMUN, V112, P796, DOI 10.1016/S0091-6749(03)01715-9; Fritsche KL, 1999, IMMUNOL LETT, V65, P167, DOI 10.1016/S0165-2478(98)00109-6; Furuhjelm C, 2011, PEDIAT ALLERG IMM-UK, V22, P505, DOI 10.1111/j.1399-3038.2010.01096.x; Furuhjelm C, 2009, ACTA PAEDIATR, V98, P1461, DOI 10.1111/j.1651-2227.2009.01355.x; Galli C, 2009, ANN NUTR METAB, V55, P123, DOI 10.1159/000228999; Gold DR, 2006, J ALLERGY CLIN IMMUN, V117, P931, DOI 10.1016/j.jaci.2005.12.1322; GREWE M, 1995, J INVEST DERMATOL, V105, P407, DOI 10.1111/1523-1747.ep12321078; HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44; Hesselmar B, 2010, ACTA PAEDIATR, V99, P1861, DOI 10.1111/j.1651-2227.2010.01939.x; Hesselmar B, 1999, CLIN EXP ALLERGY, V29, P611; Hesselmar B, 2013, PEDIATRICS IN PRESS; Hjern A, 1999, PEDIATR ALLERGY IMMU, V10, P101, DOI 10.1034/j.1399-3038.1999.00023.x; Holt PG, 2003, VACCINE, V21, P3432, DOI 10.1016/S0264-410X(03)00345-1; Ismail IH, 2012, PEDIAT ALLERG IMM-UK, V23, P674, DOI 10.1111/j.1399-3038.2012.01328.x; Johansson S, 2011, CLIN EXP ALLERGY, V41, P505, DOI 10.1111/j.1365-2222.2010.03678.x; Johansson S, 2010, CLIN EXP IMMUNOL, V160, P411, DOI 10.1111/j.1365-2249.2010.04107.x; KALUZNY MA, 1985, J LIPID RES, V26, P135; Kamp F, 2003, J BIOL CHEM, V278, P7988, DOI 10.1074/jbc.M206648200; Khalfoun B, 1996, SCAND J IMMUNOL, V43, P248, DOI 10.1046/j.1365-3083.1996.d01-42.x; Knight SC, 2008, IMMUNITY, V28, P135, DOI 10.1016/j.immuni.2008.01.003; Kramer U, 1999, LANCET, V353, P450, DOI 10.1016/S0140-6736(98)06329-6; Kull I, 2006, ALLERGY, V61, P1009, DOI 10.1111/j.1398-9995.2006.01115.x; Lee CM, 1996, J AOAC INT, V79, P487; LEPAGE G, 1984, J LIPID RES, V25, P1391; Matricardi PM, 2001, CURR OPIN ALLERGY CL, V1, P413, DOI 10.1097/00130832-200110000-00006; MEYDANI SN, 1991, J NUTR, V121, P547, DOI 10.1093/jn/121.4.547; Nafstad P, 2003, J ASTHMA, V40, P343, DOI 10.1081/JAS-120018633; Olsen SF, 2008, AM J CLIN NUTR, V88, P167, DOI 10.1093/ajcn/88.1.167; Palmer DJ, 2012, BMJ, V344; Pelosi U, 2005, ALLERGY, V60, P626, DOI 10.1111/j.1398-9995.2005.00747.x; Purasiri P, 1997, IMMUNOLOGY, V92, P166, DOI 10.1046/j.1365-2567.1997.d01-2308.x; Riedler J, 2001, LANCET, V358, P1129, DOI 10.1016/S0140-6736(01)06252-3; Sandin A, 2004, PEDIATR ALLERGY IMMU, V15, P316, DOI 10.1111/j.1399-3038.2004.00166.x; SANTOLI D, 1990, J CLIN INVEST, V85, P424, DOI 10.1172/JCI114455; Sausenthaler S, 2006, PEDIAT ALLERG IMM-UK, V17, P85, DOI 10.1111/j.1399-3038.2005.00366.x; Strachan David P., 2000, Thorax, V55, pS2, DOI 10.1136/thorax.55.suppl_1.S2; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; The ISAAC Steering Committee, 1998, PHAS 2 MOD INT STUD; Wallace FA, 2001, J LEUKOCYTE BIOL, V69, P449; Wang M, 2008, J ALLERGY CLIN IMMUN, V121, P129, DOI 10.1016/j.jaci.2007.09.011; WEYMAN C, 1975, LANCET, V2, P33; WILLIAMS HC, 1994, BRIT MED J, V308, P1132, DOI 10.1136/bmj.308.6937.1132; Yaqoob P, 2002, EUR J CLIN NUTR, V56, pS9, DOI 10.1038/sj.ejcn.1601477; Yu G, 1998, EUR J PEDIATR, V157, P298, DOI 10.1007/s004310050815; Zhang P, 2005, J NUTR, V135, P1745, DOI 10.1093/jn/135.7.1745; Zurier RB, 1999, PROSTAG LEUKOTR ESS, V60, P371, DOI 10.1016/S0952-3278(99)80015-5	60	23	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e67920	10.1371/journal.pone.0067920	http://dx.doi.org/10.1371/journal.pone.0067920			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874467	Green Published, Green Submitted, gold			2022-12-27	WOS:000321765300016
J	Fekih, R; Takagi, H; Tamiru, M; Abe, A; Natsume, S; Yaegashi, H; Sharma, S; Sharma, S; Kanzaki, H; Matsumura, H; Saitoh, H; Mitsuoka, C; Utsushi, H; Uemura, A; Kanzaki, E; Kosugi, S; Yoshida, K; Cano, L; Kamoun, S; Terauchi, R				Fekih, Rym; Takagi, Hiroki; Tamiru, Muluneh; Abe, Akira; Natsume, Satoshi; Yaegashi, Hiroki; Sharma, Shailendra; Sharma, Shiveta; Kanzaki, Hiroyuki; Matsumura, Hideo; Saitoh, Hiromasa; Mitsuoka, Chikako; Utsushi, Hiroe; Uemura, Aiko; Kanzaki, Eiko; Kosugi, Shunichi; Yoshida, Kentaro; Cano, Liliana; Kamoun, Sophien; Terauchi, Ryohei			MutMap plus : Genetic Mapping and Mutant Identification without Crossing in Rice	PLOS ONE			English	Article							GENOME; MECHANISMS; MUTATIONS; ALLELES; LOCI; DAG	Advances in genome sequencing technologies have enabled researchers and breeders to rapidly associate phenotypic variation to genome sequence differences. We recently took advantage of next-generation sequencing technology to develop MutMap, a method that allows rapid identification of causal nucleotide changes of rice mutants by whole genome resequencing of pooled DNA of mutant F2 progeny derived from crosses made between candidate mutants and the parental line. Here we describe MutMap+, a versatile extension of MutMap, that identifies causal mutations by comparing SNP frequencies of bulked DNA of mutant and wild-type progeny of M3 generation derived from selfing of an M2 heterozygous individual. Notably, MutMap+ does not necessitate artificial crossing between mutants and the wild-type parental line. This method is therefore suitable for identifying mutations that cause early development lethality, sterility, or generally hamper crossing. Furthermore, MutMap+ is potentially useful for gene isolation in crops that are recalcitrant to artificial crosses.	[Fekih, Rym; Takagi, Hiroki; Tamiru, Muluneh; Abe, Akira; Natsume, Satoshi; Yaegashi, Hiroki; Sharma, Shailendra; Sharma, Shiveta; Kanzaki, Hiroyuki; Matsumura, Hideo; Saitoh, Hiromasa; Mitsuoka, Chikako; Utsushi, Hiroe; Uemura, Aiko; Kanzaki, Eiko; Kosugi, Shunichi; Yoshida, Kentaro; Terauchi, Ryohei] Iwate Biotechnol Res Ctr, Kitakami, Iwate, Japan; [Takagi, Hiroki; Natsume, Satoshi] Iwate Univ, United Grad Sch, Morioka, Iwate 020, Japan; [Cano, Liliana; Kamoun, Sophien] Sainsbury Lab, Norwich, Norfolk, England	Iwate Biotechnology Research Center; Iwate University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Terauchi, R (corresponding author), Iwate Biotechnol Res Ctr, Kitakami, Iwate, Japan.	terauchi@ibrc.or.jp	Terauchi, Ryohei/Y-2992-2019; FEKIH, Rym/GRO-6301-2022; Cano, Liliana M/O-7041-2016; Kamoun, Sophien/B-3529-2009	Terauchi, Ryohei/0000-0002-0095-4651; Cano, Liliana M/0000-0002-7996-4181; Kamoun, Sophien/0000-0002-0290-0315; Yoshida, Kentaro/0000-0002-3614-1759; SHARMA, Shiveta/0000-0002-6744-3231; Sharma, Shailendra/0000-0002-0803-5203; Kosugi, Shunichi/0000-0002-5882-9255; Matsumura, Hideo/0000-0003-4849-1016	Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN); Ministry of Agriculture, Forestry, and Fisheries of Japan [PMI-0010]; Ministry of Education, Cultures, Sports and Technology, Japan [23113009]; JSPS KAKENHI [24248004]; Gatsby Charitable Foundation; Grants-in-Aid for Scientific Research [12F02212, 22510217, 23580065] Funding Source: KAKEN	Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN); Ministry of Agriculture, Forestry, and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); Ministry of Education, Cultures, Sports and Technology, Japan; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Gatsby Charitable Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN), the Ministry of Agriculture, Forestry, and Fisheries of Japan (Genomics for Agricultural Innovation PMI-0010) and Grant-in-aid for Scientific Research from the Ministry of Education, Cultures, Sports and Technology, Japan, to HS and RT (Grant-in-Aid for Scientific Research on Innovative Areas 23113009) and JSPS KAKENHI to RT (Grant No. 24248004). RF is a postdoctoral fellow of the Japanese Society for the Promotion of Sciences (JSPS). LC and S. Kamoun are supported by the Gatsby Charitable Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 2012, NAT BIOTECHNOL, V30, P174, DOI 10.1038/nbt.2095; Arnold CN, 2011, GENETICS, V187, P633, DOI 10.1534/genetics.110.124586; Austin RS, 2011, PLANT J, V67, P715, DOI 10.1111/j.1365-313X.2011.04619.x; Birkeland SR, 2010, GENETICS, V186, P1127, DOI 10.1534/genetics.110.123232; Chatterjee M, 1996, EMBO J, V15, P4194, DOI 10.1002/j.1460-2075.1996.tb00794.x; Chatterjee M, 1997, PLANT J, V11, P759, DOI 10.1046/j.1365-313X.1997.11040759.x; Fisher RA, 1935, J R STAT SOC, V98, P39, DOI 10.2307/2342435; Fontecave M, 2005, J BIOL INORG CHEM, V10, P713, DOI 10.1007/s00775-005-0025-1; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Gonzaga-Jauregui C, 2012, ANNU REV MED, V63, P35, DOI 10.1146/annurev-med-051010-162644; Hjorth E, 2005, FEBS LETT, V579, P1129, DOI 10.1016/j.febslet.2004.12.084; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lindner H, 2012, GENETICS, V191, P1381, DOI 10.1534/genetics.112.141341; Miki D, 2004, PLANT CELL PHYSIOL, V45, P490, DOI 10.1093/pcp/pch048; Schneeberger K, 2009, NAT METHODS, V6, P550, DOI 10.1038/nmeth0809-550; Sujay Rakshit, 2010, The handbook of plant mutation screening: mining of natural and induced alleles, P187; Takagi H, 2013, PLANT J, V74, P174, DOI 10.1111/tpj.12105; Toki S, 2006, PLANT J, V47, P969, DOI 10.1111/j.1365-313X.2006.02836.x; Wollers S, 2010, J BIOL CHEM, V285, P23329, DOI 10.1074/jbc.M110.127449; Xu XM, 2004, P NATL ACAD SCI USA, V101, P9143, DOI 10.1073/pnas.0400799101; Yu F, 2007, PLANT CELL ENVIRON, V30, P350, DOI 10.1111/j.1365-3040.2006.01630.x; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	22	168	189	14	119	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68529	10.1371/journal.pone.0068529	http://dx.doi.org/10.1371/journal.pone.0068529			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874658	Green Published, Green Submitted, gold			2022-12-27	WOS:000321765300052
J	Kundel, Y; Nasser, NJ; Purim, O; Yerushalmi, R; Fenig, E; Pfeffer, RM; Stemmer, SM; Rizel, S; Symon, Z; Kaufman, B; Sulkes, A; Brenner, B				Kundel, Yulia; Nasser, Nicola J.; Purim, Ofer; Yerushalmi, Rinat; Fenig, Eyal; Pfeffer, Raphael M.; Stemmer, Salomon M.; Rizel, Shulamith; Symon, Zvi; Kaufman, Bella; Sulkes, Aaron; Brenner, Baruch			Phase II Study of Concurrent Capecitabine and External Beam Radiotherapy for Pain Control of Bone Metastases of Breast Cancer Origin	PLOS ONE			English	Article							RECTAL-CANCER; RADIATION-THERAPY; PREOPERATIVE CHEMORADIATION; MULTIFRACTION RADIOTHERAPY; OSSEOUS METASTASES; RANDOMIZED-TRIAL; SINGLE FRACTION; PALLIATION; 5-FLUOROURACIL; OXALIPLATIN	Background: Pain from bone metastases of breast cancer origin is treated with localized radiation. Modulating doses and schedules has shown little efficacy in improving results. Given the synergistic therapeutic effect reported for combined systemic chemotherapy with local radiation in anal, rectal, and head and neck malignancies, we sought to evaluate the tolerability and efficacy of combined capecitabine and radiation for palliation of pain due to bone metastases from breast cancer. Methodology/Principal Findings: Twenty-nine women with painful bone metastases from breast cancer were treated with external beam radiation in 10 fractions of 3 Gy, 5 fractions a week for 2 consecutive weeks. Oral capecitabine 700 mg/m(2) twice daily was administered throughout radiation therapy. Rates of complete response, defined as a score of 0 on a 10-point pain scale and no increase in analgesic consumption, were 14% at 1 week, 38% at 2 weeks, 52% at 4 weeks, 52% at 8 weeks, and 48% at 12 weeks. Corresponding rates of partial response, defined as a reduction of at least 2 points in pain score without an increase in analgesics consumption, were 31%, 38%, 28%, 34% and 38%. The overall response rate (complete and partial) at 12 weeks was 86%. Side effects were of mild intensity (grade I or II) and included nausea (38% of patients), weakness (24%), diarrhea (24%), mucositis (10%), and hand and foot syndrome (7%). Conclusions/Significance: External beam radiation with concurrent capecitabine is safe and tolerable for the treatment of pain from bone metastases of breast cancer origin. The overall and complete response rates in our study are unusually high compared to those reported for radiation alone. Further evaluation of this approach, in a randomized study, is warranted.	[Kundel, Yulia; Nasser, Nicola J.; Purim, Ofer; Yerushalmi, Rinat; Fenig, Eyal; Stemmer, Salomon M.; Rizel, Shulamith; Sulkes, Aaron; Brenner, Baruch] Rabin Med Ctr, Davidoff Canc Ctr, Inst Oncol, Petah Tiqwa, Israel; [Pfeffer, Raphael M.; Symon, Zvi; Kaufman, Bella] Chaim Sheba Med Ctr, Inst Oncol, IL-52621 Tel Hashomer, Israel; [Kundel, Yulia; Purim, Ofer; Yerushalmi, Rinat; Fenig, Eyal; Pfeffer, Raphael M.; Stemmer, Salomon M.; Symon, Zvi; Kaufman, Bella; Sulkes, Aaron; Brenner, Baruch] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	Rabin Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Brenner, B (corresponding author), Rabin Med Ctr, Davidoff Canc Ctr, Inst Oncol, Beilinson Campus, Petah Tiqwa, Israel.	brennerb@clalit.org.il	Symon, Zvi/GNH-3482-2022					AlSarraf M, 1997, J CLIN ONCOL, V15, P277, DOI 10.1200/JCO.1997.15.1.277; [Anonymous], 2006, NCI COMMON TERMINOLO; Ben-Josef E, 1999, INT J RADIAT ONCOL, V45, P715, DOI 10.1016/S0360-3016(99)00231-X; BLITZER PH, 1985, CANCER-AM CANCER SOC, V55, P1468, DOI 10.1002/1097-0142(19850401)55:7<1468::AID-CNCR2820550708>3.0.CO;2-M; BYFIELD JE, 1982, INT J RADIAT ONCOL, V8, P1923, DOI 10.1016/0360-3016(82)90451-5; Carlomagno C, 2009, ANN ONCOL, V20, P906, DOI 10.1093/annonc/mdn719; Chow E, 2002, RADIOTHER ONCOL, V64, P275, DOI 10.1016/S0167-8140(02)00170-6; Chow E, 2007, J CLIN ONCOL, V25, P1423, DOI 10.1200/JCO.2006.09.5281; Crane CH, 2010, INT J RADIAT ONCOL, V76, P824, DOI 10.1016/j.ijrobp.2009.02.037; De Paoli A, 2006, ANN ONCOL, V17, P246, DOI 10.1093/annonc/mdj041; DOUGLASS HO, 1987, CANCER, V59, P2006; Arnalot PF, 2008, RADIOTHER ONCOL, V89, P150, DOI 10.1016/j.radonc.2008.05.018; Gerard JP, 2006, J CLIN ONCOL, V24, P4620, DOI 10.1200/JCO.2006.06.7629; Hartsell WF, 2005, JNCI-J NATL CANCER I, V97, P798, DOI 10.1093/jnci/dji139; Hofheinz R, 2011, J CLIN ONCOL S, V29; Hong YS, 2011, INT J RADIAT ONCOL, V79, P1171, DOI 10.1016/j.ijrobp.2009.12.073; HOSKIN PJ, 1988, CANCER SURV, V7, P69; KALSER MH, 1985, ARCH SURG-CHICAGO, V120, P899; Kim JC, 2005, INT J RADIAT ONCOL, V63, P346, DOI 10.1016/j.ijrobp.2005.02.046; Kim JS, 2002, INT J RADIAT ONCOL, V54, P403, DOI 10.1016/S0360-3016(02)02856-0; Klautke G, 2006, BRIT J CANCER, V94, P976, DOI 10.1038/sj.bjc.6603053; LAWRENCE TS, 1994, INT J RADIAT ONCOL, V29, P519, DOI 10.1016/0360-3016(94)90448-0; Morris M, 1999, NEW ENGL J MED, V340, P1137, DOI 10.1056/NEJM199904153401501; NAKAJIMA Y, 1979, CANCER RES, V39, P3763; Ofner D, 2011, STRAHLENTHER ONKOL, V187, P100, DOI 10.1007/s00066-010-2182-6; PRICE P, 1986, RADIOTHER ONCOL, V6, P247, DOI 10.1016/S0167-8140(86)80191-8; Ryan DP, 2000, NEW ENGL J MED, V342, P792, DOI 10.1056/NEJM200003163421107; SERLIN RC, 1995, PAIN, V61, P277, DOI 10.1016/0304-3959(94)00178-H; Sze WM, 2003, CLIN ONCOL-UK, V15, P345, DOI 10.1016/S0936-6555(03)00113-4; TONG D, 1982, CANCER, V50, P893, DOI 10.1002/1097-0142(19820901)50:5<893::AID-CNCR2820500515>3.0.CO;2-Y; Vaishampayan UN, 2002, INT J RADIAT ONCOL, V53, P675, DOI 10.1016/S0360-3016(02)02772-4; van der Linden YM, 2004, INT J RADIAT ONCOL, V59, P528, DOI 10.1016/j.ijrobp.2003.10.006; WEINBERG MJ, 1987, INT J RADIAT ONCOL, V13, P1691; Wendt TG, 1998, J CLIN ONCOL, V16, P1318, DOI 10.1200/JCO.1998.16.4.1318; Wu JSY, 2003, INT J RADIAT ONCOL, V55, P594, DOI 10.1016/S0360-3016(02)04147-0	35	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68327	10.1371/journal.pone.0068327	http://dx.doi.org/10.1371/journal.pone.0068327			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874586	Green Published, gold			2022-12-27	WOS:000321765300043
J	Laeng, B; Vermeer, O; Sulutvedt, U				Laeng, Bruno; Vermeer, Oddrun; Sulutvedt, Unni			Is Beauty in the Face of the Beholder?	PLOS ONE			English	Article							MATE-CHOICE; PHYSICAL ATTRACTIVENESS; SELF-RECOGNITION; PATERNAL RESEMBLANCE; GENETIC SIMILARITY; PARENTAL INFLUENCE; KIN RECOGNITION; MERE-EXPOSURE; PERCEPTION; EVOLUTION	Opposing forces influence assortative mating so that one seeks a similar mate while at the same time avoiding inbreeding with close relatives. Thus, mate choice may be a balancing of phenotypic similarity and dissimilarity between partners. In the present study, we assessed the role of resemblance to Self's facial traits in judgments of physical attractiveness. Participants chose the most attractive face image of their romantic partner among several variants, where the faces were morphed so as to include only 22% of another face. Participants distinctly preferred a "Self-based morph" (i.e., their partner's face with a small amount of Self's face blended into it) to other morphed images. The Self-based morph was also preferred to the morph of their partner's face blended with the partner's same-sex "prototype", although the latter face was ("objectively") judged more attractive by other individuals. When ranking morphs differing in level of amalgamation (i.e., 11% vs. 22% vs. 33%) of another face, the 22% was chosen consistently as the preferred morph and, in particular, when Self was blended in the partner's face. A forced-choice signal-detection paradigm showed that the effect of self-resemblance operated at an unconscious level, since the same participants were unable to detect the presence of their own faces in the above morphs. We concluded that individuals, if given the opportunity, seek to promote "positive assortment" for Self's phenotype, especially when the level of similarity approaches an optimal point that is similar to Self without causing a conscious acknowledgment of the similarity.	[Laeng, Bruno; Sulutvedt, Unni] Univ Oslo, Dept Psychol, Oslo, Norway; [Vermeer, Oddrun] Univ Tromso, Dept Psychol, Tromso, Norway	University of Oslo; UiT The Arctic University of Tromso	Laeng, B (corresponding author), Univ Oslo, Dept Psychol, Oslo, Norway.	bruno.laeng@psykologi.uio.no						Alexander R. D., 1979, DARWINISM HUMAN AFFA; ALEXANDER RD, 1990, ETHOL SOCIOBIOL, V11, P241, DOI 10.1016/0162-3095(90)90012-U; Alvarez L, 2004, EVOLUTIONARY PSYCHOL, V2, P177, DOI DOI 10.1177/1474704904002001223; AMSTERDAM B, 1972, DEV PSYCHOBIOL, V5, P297, DOI 10.1002/dev.420050403; Apicella CL, 2004, EVOL HUM BEHAV, V25, P371, DOI 10.1016/j.evolhumbehav.2004.06.003; BANDURA A, 1982, AM PSYCHOL, V37, P747, DOI 10.1037/0003-066X.37.7.747; Bateson P., 1983, P257; Becker Gary S., 1991, TREATISE FAMILY, DOI DOI 10.4159/9780674020665; BENTLER PM, 1978, J CONSULT CLIN PSYCH, V46, P1053, DOI 10.1037/0022-006X.46.5.1053; Bereczkei T, 2004, P ROY SOC B-BIOL SCI, V271, P1129, DOI 10.1098/rspb.2003.2672; Bereczkei T, 2002, PERS INDIV DIFFER, V33, P677, DOI 10.1016/S0191-8869(01)00182-9; Bereczkei T, 2007, OXFORD HDB EVOLUTION; Berridge KC, 2003, COGNITION EMOTION, V17, P181, DOI 10.1080/02699930302289; BERSCHEID E, 1971, J EXP SOC PSYCHOL, V7, P173, DOI 10.1016/0022-1031(71)90065-5; Blomqvist D, 2002, NATURE, V419, P613, DOI 10.1038/nature01104; Bovet J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049791; BURLEY N, 1983, ETHOL SOCIOBIOL, V4, P191, DOI 10.1016/0162-3095(83)90009-2; BUSS DM, 1985, AM SCI, V73, P47; Buston PM, 2003, P NATL ACAD SCI USA, V100, P8805, DOI 10.1073/pnas.1533220100; CHEESMAN J, 1984, PERCEPT PSYCHOPHYS, V36, P387, DOI 10.3758/BF03202793; Cohen LB, 2004, ANIM BEHAV, V68, P1229, DOI 10.1016/j.anbehav.2003.12.021; COSMIDES L, 1994, COGNITION, V50, P41, DOI 10.1016/0010-0277(94)90020-5; CUNNINGHAM MR, 1995, J PERS SOC PSYCHOL, V68, P261, DOI 10.1037/0022-3514.68.2.261; Currie TE, 2009, EVOL HUM BEHAV, V30, P409, DOI 10.1016/j.evolhumbehav.2009.06.005; Dimberg U, 2000, PSYCHOL SCI, V11, P86, DOI 10.1111/1467-9280.00221; Edmands S, 2007, MOL ECOL, V16, P463, DOI 10.1111/j.1365-294X.2006.03148.x; EPSTEIN E, 1984, SOC BIOL, V31, P243; FEINGOLD A, 1988, PSYCHOL BULL, V104, P226, DOI 10.1037/0033-2909.104.2.226; Ferguson MJ, 2009, CURR DIR PSYCHOL SCI, V18, P362, DOI 10.1111/j.1467-8721.2009.01668.x; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; FOLKES VS, 1982, PERS SOC PSYCHOL B, V8, P631, DOI 10.1177/0146167282084005; Fraley RC, 2010, PERS SOC PSYCHOL B, V36, P1202, DOI 10.1177/0146167210377180; Freyre Gilberto, 1986, MASTERS SLAVES STUDY; Frost P, 2008, J SOCIAL EVOLUTIONAR, V2, P169; GALLUP GG, 1970, SCIENCE, V167, P86, DOI 10.1126/science.167.3914.86; Garcia LT, 2007, J SEX RES, V44, P250, DOI 10.1080/00224490701443817; Godoy R, 2008, EVOL HUM BEHAV, V29, P201, DOI 10.1016/j.evolhumbehav.2007.12.003; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hassin RR, 2013, PERSPECT PSYCHOL SCI, V8, P195, DOI 10.1177/1745691612460684; Helgason A, 2008, SCIENCE, V319, P813, DOI 10.1126/science.1150232; HINSZ VB, 1989, J SOC PERS RELAT, V6, P223, DOI 10.1177/026540758900600205; HUSTON TL, 1973, J EXP SOC PSYCHOL, V9, P32, DOI 10.1016/0022-1031(73)90060-7; JEDLICKA D, 1984, J MARRIAGE FAM, V46, P65, DOI 10.2307/351864; JEDLICKA D, 1980, J SOC PSYCHOL, V112, P295, DOI 10.1080/00224545.1980.9924331; Jiang Y, 2006, P NATL ACAD SCI USA, V103, P17048, DOI 10.1073/pnas.0605678103; JONES D, 1993, HUM NATURE-INT BIOS, V4, P271, DOI 10.1007/BF02692202; KALICK SM, 1986, J PERS SOC PSYCHOL, V51, P673, DOI 10.1037/0022-3514.51.4.673; Kaminski G, 2009, P ROY SOC B-BIOL SCI, V276, P3193, DOI 10.1098/rspb.2009.0677; Keenan J. P., 2003, FACE MIRROR SEARCH O; Kleven O, 2005, BIOL LETT-UK, V1, P389, DOI 10.1098/rsbl.2005.0376; Laeng B, 2007, BEHAV ECOL SOCIOBIOL, V61, P371, DOI 10.1007/s00265-006-0266-1; Laeng B, 2010, EMOTION, V10, P573, DOI 10.1037/a0018689; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; Li NP, 2002, J PERS SOC PSYCHOL, V82, P947, DOI 10.1037//0022-3514.82.6.947; Lie HC, 2010, EVOL HUM BEHAV, V31, P48, DOI 10.1016/j.evolhumbehav.2009.07.001; Lieberman D, 2007, NATURE, V445, P727, DOI 10.1038/nature05510; Lihoreau M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003365; Liljedal S, 2008, BEHAV ECOL SOCIOBIOL, V62, P1805, DOI 10.1007/s00265-008-0609-1; Macmillan N. A., 2004, DETECTION THEORY USE; MANGAN B, 1993, CONSCIOUS COGN, V2, P89, DOI 10.1006/ccog.1993.1008; Mateo JM, 2003, ANIM COGN, V6, P73, DOI 10.1007/s10071-003-0165-z; McDonald PR, 2008, PERCEPTION, V37, P1054, DOI 10.1068/p5774; McGraw KJ, 2002, ETHOLOGY, V108, P303, DOI 10.1046/j.1439-0310.2002.00757.x; MCKILLIP J, 1983, J APPL SOC PSYCHOL, V13, P328, DOI 10.1111/j.1559-1816.1983.tb01743.x; Merikle PM, 2001, COGNITION, V79, P115, DOI 10.1016/S0010-0277(00)00126-8; Miller GF, 1998, TRENDS COGN SCI, V2, P190, DOI 10.1016/S1364-6613(98)01169-3; MITA TH, 1977, J PERS SOC PSYCHOL, V35, P597, DOI 10.1037/0022-3514.35.8.597; Monahan JL, 2000, PSYCHOL SCI, V11, P462, DOI 10.1111/1467-9280.00289; MORELAND RL, 1982, J EXP SOC PSYCHOL, V18, P395, DOI 10.1016/0022-1031(82)90062-2; MORTON J, 1991, PSYCHOL REV, V98, P164, DOI 10.1037/0033-295X.98.2.164; MURSTEIN BI, 1972, J PERS SOC PSYCHOL, V22, P8, DOI 10.1037/h0032394; Noe R, 1995, TREE PERSPECTIVES, V10, P338; Nojo S, 2012, HUM NATURE-INT BIOS, V23, P323, DOI 10.1007/s12110-012-9146-8; Ortigue S, 2007, J COGNITIVE NEUROSCI, V19, P1218, DOI 10.1162/jocn.2007.19.7.1218; Parr LA, 1999, NATURE, V399, P647, DOI 10.1038/21345; Pascalis O, 2002, SCIENCE, V296, P1321, DOI 10.1126/science.1070223; Penn DJ, 1999, AM NAT, V153, P145, DOI 10.1086/303166; Penton-Voak IS, 1999, CURR PSYCHOL, V18, P104; Peters M, 2007, ANIM BEHAV, V73, P937, DOI 10.1016/j.anbehav.2006.07.012; Platek SM, 2004, EVOL HUM BEHAV, V25, P394, DOI 10.1016/j.evolhumbehav.2004.08.007; Platek SM, 2003, EVOL HUM BEHAV, V24, P81, DOI 10.1016/S1090-5138(02)00117-4; Platek SM, 2007, EVOLUTIONARY PSYCHOL, V5, P223; PLATEK SM, 2002, EVOLUTION COGNITION, V8, P207; Platek SM, 2009, NEUROPSYCHOLOGIA, V47, P849, DOI 10.1016/j.neuropsychologia.2008.12.027; Plotnik JM, 2006, P NATL ACAD SCI USA, V103, P17053, DOI 10.1073/pnas.0608062103; PRICE RA, 1980, BEHAV GENET, V10, P59, DOI 10.1007/BF01067319; Rantala MJ, 2011, BEHAV ECOL SOCIOBIOL, V65, P859, DOI 10.1007/s00265-011-1145-y; RATTI O, 1995, BEHAV ECOL SOCIOBIOL, V37, P419, DOI 10.1007/BF00170590; Reiss D, 2001, P NATL ACAD SCI USA, V98, P5937, DOI 10.1073/pnas.101086398; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Rhodes G, 2002, FACIAL ATTRACTIVENES; Salter F, 1996, ETHOL SOCIOBIOL, V17, P211, DOI 10.1016/0162-3095(96)00036-2; Savoye I, 1998, ANGLE ORTHOD, V68, P467; Saxton TK, 2009, PERS INDIV DIFFER, V47, P864, DOI 10.1016/j.paid.2009.07.005; Schyns PG, 2002, PSYCHOL SCI, V13, P402, DOI 10.1111/1467-9280.00472; Scott LS, 2009, PSYCHOL SCI, V20, P676, DOI 10.1111/j.1467-9280.2009.02348.x; Seth AK, 2008, TRENDS COGN SCI, V12, P314, DOI 10.1016/j.tics.2008.04.008; Shimojo S, 2003, NAT NEUROSCI, V6, P1317, DOI 10.1038/nn1150; SPUHLER JN, 1968, EUGEN QUART, V15, P128, DOI 10.1080/19485565.1968.9987763; Sugyama L, 2005, HDB EVOLUTIONARY PSY; THIESSEN D, 1980, ETHOL SOCIOBIOL, V1, P111, DOI 10.1016/0162-3095(80)90003-5; Todd PM, 2007, P NATL ACAD SCI USA, V104, P15011, DOI 10.1073/pnas.0705290104; Tramm NA, 2008, EVOLUTION, V62, P1991, DOI 10.1111/j.1558-5646.2008.00419.x; Tregenza T, 2000, MOL ECOL, V9, P1013, DOI 10.1046/j.1365-294x.2000.00964.x; Turk DJ, 2002, NAT NEUROSCI, V5, P841, DOI 10.1038/nn907; Tyler CW, 2006, J VISION, V6, P1117, DOI 10.1167/6.10.11; VANDENBERGHE PL, 1983, BEHAV BRAIN SCI, V6, P91, DOI 10.1017/S0140525X00014850; Verosky SC, 2010, PSYCHOL SCI, V21, P779, DOI 10.1177/0956797610371965; Watkins CD, 2012, EVOL HUM BEHAV, V32, P70; ZAJONC RB, 1987, MOTIV EMOTION, V11, P335, DOI 10.1007/BF00992848; Zhu Q, 2010, CURR BIOL, V20, P137, DOI 10.1016/j.cub.2009.11.067	111	19	19	2	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68395	10.1371/journal.pone.0068395	http://dx.doi.org/10.1371/journal.pone.0068395			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	182SU	23874608	Green Published, Green Submitted, gold			2022-12-27	WOS:000321765300047
J	Winn, KM; Bourne, DG; Mitchell, JG				Winn, Karina M.; Bourne, David G.; Mitchell, James G.			Vibrio coralliilyticus Search Patterns across an Oxygen Gradient	PLOS ONE			English	Article							MARINE-BACTERIA; COMMUNITIES; STRATEGIES; DIVERSITY	The coral pathogen, Vibrio coralliilyticus shows specific chemotactic search pattern preference for oxic and anoxic conditions, with the newly identified 3-step flick search pattern dominating the patterns used in oxic conditions. We analyzed motile V. coralliilyticus cells for behavioral changes with varying oxygen concentrations to mimic the natural coral environment exhibited during light and dark conditions. Results showed that 3-step flicks were 1.4 x (P = 0.006) more likely to occur in oxic conditions than anoxic conditions with mean values of 18 flicks (95% CI = 0.4, n = 53) identified in oxic regions compared to 13 (95% CI = 0.5, n = 38) at anoxic areas. In contrast, run and reverse search patterns were more frequent in anoxic regions with a mean value of 15 (95% CI = 0.7, n = 46), compared to a mean value of 10 (95% CI = 0.8, n = 29) at oxic regions. Straight swimming search patterns remained similar across oxic and anoxic regions with a mean value of 13 (95% CI = 0.7, n = oxic: 13, anoxic: 14). V. coralliilyticus remained motile in oxic and anoxic conditions, however, the 3-step flick search pattern occurred in oxic conditions. This result provides an approach to further investigate the 3-step flick.	[Winn, Karina M.; Mitchell, James G.] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Winn, Karina M.; Bourne, David G.] Australian Inst Marine Sci, Ctr Marine Microbiol & Genet, Townsville, Qld 4810, Australia	Flinders University South Australia; Australian Institute of Marine Science	Winn, KM (corresponding author), Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia.	karina.winn@flinders.edu.au	Bourne, David G/B-5073-2008	Bourne, David G/0000-0002-1492-8710; Mitchell, Jim/0000-0002-8445-0935	ARC [DP1096658]; Australian Institute of Marine Science	ARC(Australian Research Council); Australian Institute of Marine Science	This study was funded by an ARC Discovery Grant to JG Mitchell. The associated grant number is DP1096658 with URL www.arc.gov.au. Work at the Cape Ferguson laboratories was supported by the Australian Institute of Marine Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altindal T, 2011, BIOPHYS J, V100, P32, DOI 10.1016/j.bpj.2010.11.029; Alves N, 2010, ENV MICROBIOL REP, V2, P90, DOI 10.1111/j.1758-2229.2009.00101.x; Armitage JP, 1999, ADV MICROB PHYSIOL, V41, P229, DOI 10.1016/S0065-2911(08)60168-X; Armitage JP, 1997, ARCH MICROBIOL, V168, P249, DOI 10.1007/s002030050496; Barbara GM, 2003, FEMS MICROBIOL ECOL, V44, P79, DOI 10.1111/j.1574-6941.2003.tb01092.x; Barbara GM, 1996, APPL ENVIRON MICROB, V62, P3985, DOI 10.1128/AEM.62.11.3985-3990.1996; Ben-Haim Y, 2003, INT J SYST EVOL MICR, V53, P309, DOI 10.1099/ijs.0.02402-0; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; Bourne D, 2008, ISME J, V2, P350, DOI 10.1038/ismej.2007.112; Bourne DG, 2005, ENVIRON MICROBIOL, V7, P1162, DOI 10.1111/j.1462-2920.2005.00793.x; Cardenas MB, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035343; Chimetto LA, 2008, SYST APPL MICROBIOL, V31, P312, DOI 10.1016/j.syapm.2008.06.001; Guerin TF, 2001, LETT APPL MICROBIOL, V32, P340, DOI 10.1046/j.1472-765X.2001.00916.x; Guerin TF, 1999, ENVIRON POLLUT, V106, P13, DOI 10.1016/S0269-7491(99)00067-6; Hoj L, 2005, FEMS MICROBIOL ECOL, V53, P89, DOI 10.1016/j.femsec.2005.01.004; Karakashev D, 2003, WORLD J MICROB BIOT, V19, P233, DOI 10.1023/A:1023674315047; KUHL M, 1995, MAR ECOL PROG SER, V117, P159, DOI 10.3354/meps117159; Luchsinger RH, 1999, BIOPHYS J, V77, P2377, DOI 10.1016/S0006-3495(99)77075-X; Magariyama Y, 2005, BIOPHYS J, V88, P3648, DOI [10.1529/biophysj.104.054049, 10.1529/biophsj.104.054049]; Meron D, 2009, APPL ENVIRON MICROB, V75, P5704, DOI 10.1128/AEM.00198-09; Mitchell JG, 2002, AM NAT, V160, P727, DOI 10.1086/343874; MITCHELL JG, 1995, APPL ENVIRON MICROB, V61, P877, DOI 10.1128/AEM.61.3.877-882.1995; Morrow KM, 2011, CORAL REEFS, V30, P309, DOI 10.1007/s00338-011-0747-1; Musielak MM, 2009, J FLUID MECH, V638, P401, DOI 10.1017/S0022112009991108; Nilsson GE, 2004, J EXP BIOL, V207, P33, DOI 10.1242/jeb.00713; Schneider IC, 2005, BIOPHYS J, V89, P1420, DOI 10.1529/biophysj.105.061218; SHIOI J, 1987, J BACTERIOL, V169, P3118, DOI 10.1128/jb.169.7.3118-3123.1987; Stocker R, 2008, P NATL ACAD SCI USA, V105, P4209, DOI 10.1073/pnas.0709765105; Stocker R, 2011, P NATL ACAD SCI USA, V108, P2635, DOI 10.1073/pnas.1019199108; Thurber RV, 2009, ENVIRON MICROBIOL, V11, P2148, DOI 10.1111/j.1462-2920.2009.01935.x; Wijgerde T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052702; Xie L, 2011, P NATL ACAD SCI USA, V108, P2246, DOI 10.1073/pnas.1011953108	32	8	8	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e67975	10.1371/journal.pone.0067975	http://dx.doi.org/10.1371/journal.pone.0067975			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874480	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000321765300020
J	Par, G; Szereday, L; Berki, T; Palinkas, L; Halasz, M; Miseta, A; Hegedus, G; Szekeres-Bartho, J; Vincze, A; Hunyady, B; Par, A				Par, Gabriella; Szereday, Laszlo; Berki, Timea; Palinkas, Laszlo; Halasz, Melinda; Miseta, Attila; Hegedus, Geza; Szekeres-Bartho, Julia; Vincze, Aron; Hunyady, Bela; Par, Alajos			Increased Baseline Proinflammatory Cytokine Production in Chronic Hepatitis C Patients with Rapid Virological Response to Peginterferon Plus Ribavirin	PLOS ONE			English	Article							RECEPTOR EXPRESSION; GENE-EXPRESSION; VIRUS; INTERFERON; IL28B; OUTCOMES; THERAPY; PROTEIN; INNATE; RNA	Background: Chronic hepatitis C (CHC) patients achieving rapid virological response (RVR) on PEG-IFN/ribavirin (P/R) therapy have high chance of sustained virological response (SVR). To analyze host immunological factors associated with RVR, viral kinetics, phenotype distribution and Th1/Th2 cytokine production by peripheral blood mononuclear cells (PBMC) were studied prior to and during P/R therapy. Methods: TNF-alpha, IFN-gamma, IL-2, IL-6, IL-4 and IL-10 production by PBMC were measured after Toll-like receptor 4 (TLR-4) or phorbol myristate acetate/Ionomycin stimulation in 20 healthy controls and in 50 CHC patients before receiving and during P/R therapy. RVR was achieved by 14, complete early virological response (cEVR) by 19 patients and 17 patients were nullresponders (NR). Results: Patients with RVR showed an increased baseline TNF-alpha and IL-6 production by TLR-gamma activated monocytes and increased IFN-gamma, decreased IL-4 and IL-10 production by lymphocytes compared to non-RVR patients. SVR was also associated with increased baseline TNF-alpha production and decreased IL-10 levels compared to patients who did not achieve SVR. Baseline IL-2 production was higher in cEVR compared to NR patients. Antiviral treatment increased TNF-alpha, IL-6 production by monocytes and IFN-gamma secretion by lymphocytes and decreased IL-4 and IL-10 production by lymphocytes in cEVR compared to NR patients. Conclusion: RVR was associated with increased baseline proinflammatory cytokine production by TLR-4 stimulated monocytes and by activated lymphocytes. In null-responders and in patients who did not achieve SVR both TLR-4 sensing function and proinflammatory cytokine production were impaired, suggesting that modulation of TLR activity and controlled induction of inflammatory cytokine production may provide further therapeutic strategy for CHC patients non-responding to P/R treatment.	[Par, Gabriella; Vincze, Aron; Hunyady, Bela; Par, Alajos] Univ Pecs, Ctr Clin, Dept Med 1, Pecs, Hungary; [Szereday, Laszlo; Halasz, Melinda; Szekeres-Bartho, Julia] Univ Pecs, Ctr Clin, Dept Med Microbiol & Immunol, Pecs, Hungary; [Berki, Timea; Palinkas, Laszlo] Univ Pecs, Ctr Clin, Dept Immunol & Biotechnol, Pecs, Hungary; [Miseta, Attila] Univ Pecs, Sch Med, Ctr Clin, Dept Lab Med, Pecs, Hungary; [Hegedus, Geza] Baranya Cty Hosp, Dept Pathol, Pecs, Hungary; [Szereday, Laszlo; Halasz, Melinda] Janos Szentagothai Res Ctr, Pecs, Hungary	University of Pecs; University of Pecs; University of Pecs; University of Pecs; University of Pecs	Szereday, L (corresponding author), Univ Pecs, Ctr Clin, Dept Med Microbiol & Immunol, Pecs, Hungary.	szereday.laszlo@pte.hu	Halasz, Melinda/AAM-9423-2021; Szereday, Laszlo/AAR-5741-2021; Vincze, Aron/J-6724-2019; Vincze, Aron/A-7048-2011	Szereday, Laszlo/0000-0002-1208-2969; Vincze, Aron/0000-0003-2217-7686; Vincze, Aron/0000-0003-2217-7686; Miseta, Attila/0000-0002-7984-3347; Berki, Timea/0000-0002-0134-8127; Halasz, Melinda/0000-0002-6175-9630	National Scientific Research Fund [OTKA K81454, K104960]; Pecs University Research Fund [34039/KA-OTKA/11-19, KA-PostDoc12-03]; Liver Research Foundation (Pecs), United European Gastroenterology Federation (UEGF)	National Scientific Research Fund; Pecs University Research Fund; Liver Research Foundation (Pecs), United European Gastroenterology Federation (UEGF)	This work was supported by grants from National Scientific Research Fund (OTKA K81454 and K104960), Pecs University Research Fund (34039/KA-OTKA/11-19 and KA-PostDoc12-03) and Liver Research Foundation (Pecs), United European Gastroenterology Federation (UEGF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2007, J VIROL, V81, P8953, DOI 10.1128/JVI.00649-07; Agaugue S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000330; Askarieh G, 2010, HEPATOLOGY, V51, P1523, DOI 10.1002/hep.23509; Atsukawa M, 2012, J GASTROEN HEPATOL, V27, P823, DOI 10.1111/j.1440-1746.2011.06882.x; Binder M, 2007, HEPATOLOGY, V46, P1365, DOI 10.1002/hep.21829; Blackburn SD, 2007, TRENDS MICROBIOL, V15, P143, DOI 10.1016/j.tim.2007.02.006; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Burke KP, 2010, IMMUNOL RES, V47, P216, DOI 10.1007/s12026-009-8152-3; Ciuffreda D, 2011, CURR OPIN HIV AIDS, V6, P559, DOI 10.1097/COH.0b013e32834b879e; Clark V, 2012, LIVER INT, V32, P103, DOI 10.1111/j.1478-3231.2011.02711.x; Dolganiuc A, 2006, WORLD J GASTROENTERO, V12, P1198, DOI 10.3748/wjg.v12.i8.1198; Falasca K, 2006, ANN CLIN LAB SCI, V36, P144; Fattovich G, 2011, ALIMENT PHARM THER, V33, P1162, DOI 10.1111/j.1365-2036.2011.04635.x; Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082; Fidock MD, 2011, CLIN PHARMACOL THER, V89, P821, DOI 10.1038/clpt.2011.60; Foy E, 2005, P NATL ACAD SCI USA, V102, P2986, DOI 10.1073/pnas.0408707102; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Hammond T, 2011, J VIRAL HEPATITIS, V18, P482, DOI 10.1111/j.1365-2893.2010.01331.x; Hammond T, 2010, CELL IMMUNOL, V264, P150, DOI 10.1016/j.cellimm.2010.06.001; He Q, 2006, LIVER INT, V26, P1100, DOI 10.1111/j.1478-3231.2006.01357.x; Hedayat M, 2011, LANCET INFECT DIS, V11, P702, DOI 10.1016/S1473-3099(11)70099-8; Innes HA, 2011, HEPATOLOGY, V54, P2281, DOI [10.1002/hep.24776, 10.1002/hep.24561]; Jensen DM, 2006, HEPATOLOGY, V43, P954, DOI 10.1002/hep.21159; Kaukinen P, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-66; Kondo Y, 2011, HEPATOL RES, V41, P1153, DOI 10.1111/j.1872-034X.2011.00878.x; Lau DTY, 2008, HEPATOLOGY, V47, P799, DOI 10.1002/hep.22076; Li K, 2012, HEPATOLOGY, V55, P666, DOI 10.1002/hep.24763; Lloyd AR, 2007, IMMUNOL CELL BIOL, V85, P24, DOI 10.1038/sj.icb.7100010; Malaguarnera M, 1997, J GASTROENTEROL, V32, P211, DOI 10.1007/BF02936370; Marchetti G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032028; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Neumann-Haefelin C, 2011, DIGEST DIS, V29, P416, DOI 10.1159/000329807; Ng V, 2011, CLIN GASTROENTEROL H, V9, P923, DOI 10.1016/j.cgh.2011.05.028; Par G, 2002, J HEPATOL, V37, P514, DOI 10.1016/S0168-8278(02)00218-0; Rehermann B, 2009, J CLIN INVEST, V119, P1745, DOI 10.1172/JCI39133; Riordan SM, 2006, INFLAMM RES, V55, P279, DOI 10.1007/s00011-006-0082-0; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Sarikonda G, 2011, METHODS MOL BIOL, V677, P431, DOI 10.1007/978-1-60761-869-0_27; Schwabe RF, 2006, GASTROENTEROLOGY, V130, P1886, DOI 10.1053/j.gastro.2006.01.038; Siren J, 2005, J IMMUNOL, V174, P1932, DOI 10.4049/jimmunol.174.4.1932; Spengler U, 2007, CLIN SCI, V112, P141, DOI 10.1042/CS20060171; Stevenson NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027866; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tang KH, 2005, J HEPATOL, V43, P776, DOI 10.1016/j.jhep.2005.05.024; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013; Tillmann HL, 2010, GASTROENTEROLOGY, V139, P1586, DOI 10.1053/j.gastro.2010.07.005; Tox U, HEPATOGASTROENTEROLO, V55, P1666; Umemura T, 2011, ANTIVIR THER, V16, P1073, DOI 10.3851/IMP1869; Woitas RP, 2002, WORLD J GASTROENTERO, V8, P562, DOI 10.3748/wjg.v8.i3.562; Yoneda S, 2011, J INFECT DIS, V203, P1087, DOI 10.1093/infdis/jiq165	51	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e67770	10.1371/journal.pone.0067770	http://dx.doi.org/10.1371/journal.pone.0067770			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874444	Green Published, Green Submitted, gold			2022-12-27	WOS:000321736900021
J	Takacs, M; Petoukhov, MV; Atkinson, RA; Roblin, P; Ogi, FX; Demeler, B; Potier, N; Chebaro, Y; Dejaegere, A; Svergun, DI; Moras, D; Billas, IML				Takacs, Maria; Petoukhov, Maxim V.; Atkinson, R. Andrew; Roblin, Pierre; Ogi, Francois-Xavier; Demeler, Borries; Potier, Noelle; Chebaro, Yassmine; Dejaegere, Annick; Svergun, Dmitri I.; Moras, Dino; Billas, Isabelle M. L.			The Asymmetric Binding of PGC-1 alpha to the ERR alpha and ERR gamma Nuclear Receptor Homodimers Involves a Similar Recognition Mechanism	PLOS ONE			English	Article							SMALL-ANGLE SCATTERING; TRANSCRIPTIONAL COACTIVATOR; BIOLOGICAL MACROMOLECULES; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; LIGAND-BINDING; EXPRESSION; PROGRAM; COMPLEX; CASCADE	Background: PGC-1 alpha is a crucial regulator of cellular metabolism and energy homeostasis that functionally acts together with the estrogen-related receptors (ERR alpha and ERR gamma) in the regulation of mitochondrial and metabolic gene networks. Dimerization of the ERRs is a pre-requisite for interactions with PGC-1 alpha and other coactivators, eventually leading to transactivation. It was suggested recently (Devarakonda et al) that PGC-1 alpha binds in a strikingly different manner to ERR gamma ligand-binding domains (LBDs) compared to its mode of binding to ERR alpha and other nuclear receptors (NRs), where it interacts directly with the two ERR gamma homodimer subunits. Methods/Principal Findings: Here, we show that PGC-1 alpha receptor interacting domain (RID) binds in an almost identical manner to ERR alpha and ERR gamma homodimers. Microscale thermophoresis demonstrated that the interactions between PGC-1 alpha RID and ERR LBDs involve a single receptor subunit through high-affinity, ERR-specific L3 and low-affinity L2 interactions. NMR studies further defined the limits of PGC-1 alpha RID that interacts with ERRs. Consistent with these findings, the solution structures of PGC-1 alpha/ERRa LBDs and PGC-1 alpha/ERRc LBDs complexes share an identical architecture with an asymmetric binding of PGC-1 alpha to homodimeric ERR. Conclusions/Significance: These studies provide the molecular determinants for the specificity of interactions between PGC-1 alpha and the ERRs, whereby negative cooperativity prevails in the binding of the coactivators to these receptors. Our work indicates that allosteric regulation may be a general mechanism controlling the binding of the coactivators to homodimers.	[Takacs, Maria; Chebaro, Yassmine; Dejaegere, Annick; Moras, Dino; Billas, Isabelle M. L.] Univ Strasbourg UdS, Dept Integrat Struct Biol, Inst Genet & Mol & Cellular Biol IGBMC, CNRS,UMR 7104,INSERM U964, Illkirch Graffenstaden, France; [Petoukhov, Maxim V.; Svergun, Dmitri I.] EMBL DESY, Hamburg Outstn, European Mol Biol Lab, Hamburg, Germany; [Atkinson, R. Andrew] Kings Coll London, Ctr Biomol Spect, London WC2R 2LS, England; [Atkinson, R. Andrew] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England; [Roblin, Pierre] Orme Merisiers St Aubin, SOLEIL Synchrotron, Gif Sur Yvette, France; [Ogi, Francois-Xavier] NanoTemper Technol GmbH, Munich, Germany; [Demeler, Borries] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Potier, Noelle] Univ Strasbourg, Inst Chim LC3, CNRS, UMR 7177, Strasbourg, France; [Roblin, Pierre] INRA URBIA, Nantes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of London; King's College London; University of London; King's College London; SOLEIL Synchrotron; University of Texas System; University of Texas Health San Antonio; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; INRAE	Billas, IML (corresponding author), Univ Strasbourg UdS, Dept Integrat Struct Biol, Inst Genet & Mol & Cellular Biol IGBMC, CNRS,UMR 7104,INSERM U964, Illkirch Graffenstaden, France.	billas@igbmc.fr	Billas, Isabelle M.L./I-2790-2016; Atkinson, Robert Andrew/ABE-8068-2020; Noelle, POTIER/AAX-7633-2021; Petoukhov, Maxim V/R-7371-2016; Chebaro, Yassmine/M-2174-2019	Billas, Isabelle M.L./0000-0003-2323-4208; Atkinson, Robert Andrew/0000-0002-3645-9492; Petoukhov, Maxim V/0000-0001-6760-4595; Chebaro, Yassmine/0000-0002-5970-2117; Demeler, Borries/0000-0002-2414-9518; POTIER, Noelle/0000-0002-6381-4365; Svergun, Dmitri/0000-0003-0830-5696	CNRS, INSERM, the Association pour la Recherche sur le Cancer (ARC); Karo Bio Research Foundation; French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05-01]; Instruct as part of the European Strategy Forum on Research Infrastructures (ESFRI); WeNMR project [261572]; BMBF research grant SYNC-LIFE [05K10YEA]	CNRS, INSERM, the Association pour la Recherche sur le Cancer (ARC); Karo Bio Research Foundation; French Infrastructure for Integrated Structural Biology (FRISBI); Instruct as part of the European Strategy Forum on Research Infrastructures (ESFRI); WeNMR project; BMBF research grant SYNC-LIFE	This work was supported by CNRS, INSERM, the Association pour la Recherche sur le Cancer (ARC), the Karo Bio Research Foundation, the French Infrastructure for Integrated Structural Biology (FRISBI) ANR-10-INSB-05-01, Instruct as part of the European Strategy Forum on Research Infrastructures (ESFRI), the WeNMR project (European FP7 e-Infrastructure grant, contract no. 261572, www.wenmr.eu) and the BMBF research grant SYNC-LIFE ( Contract no: 05K10YEA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Bich C, 2009, CURR OPIN STRUC BIOL, V19, P632, DOI 10.1016/j.sbi.2009.08.004; Bourdoncle A, 2005, J MOL BIOL, V347, P921, DOI 10.1016/j.jmb.2005.01.048; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Delerive P, 2002, J BIOL CHEM, V277, P3913, DOI 10.1074/jbc.M109409200; Delfosse V, 2012, P NATL ACAD SCI USA, V109, P14930, DOI 10.1073/pnas.1203574109; Devarakonda S, 2011, P NATL ACAD SCI USA, V108, P18678, DOI 10.1073/pnas.1113813108; ECCLES C, 1991, Journal of Biomolecular NMR, V1, P111, DOI 10.1007/BF01877224; Finck BN, 2007, CIRCULATION, V115, P2540, DOI 10.1161/CIRCULATIONAHA.107.670588; Gaillard S, 2006, MOL CELL, V24, P797, DOI 10.1016/j.molcel.2006.10.012; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Greschik H, 2002, MOL CELL, V9, P303, DOI 10.1016/S1097-2765(02)00444-6; Greschik H, 2008, J BIOL CHEM, V283, P20220, DOI 10.1074/jbc.M801920200; Handschin C, 2009, TRENDS PHARMACOL SCI, V30, P322, DOI 10.1016/j.tips.2009.03.006; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; Kallen J, 2004, J BIOL CHEM, V279, P49330, DOI 10.1074/jbc.M407999200; Kallen J, 2007, J BIOL CHEM, V282, P23231, DOI 10.1074/jbc.M703337200; Kamei Y, 2003, P NATL ACAD SCI USA, V100, P12378, DOI 10.1073/pnas.2135217100; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Koch MHJ, 2003, Q REV BIOPHYS, V36, P147, DOI 10.1017/S0033583503003871; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Laganiere J, 2004, J BIOL CHEM, V279, P18504, DOI 10.1074/jbc.M313543200; Li Y, 2008, J BIOL CHEM, V283, P19132, DOI 10.1074/jbc.M802040200; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Liu D, 2005, J MOL ENDOCRINOL, V34, P473, DOI 10.1677/jme.1.01586; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Osz J, 2012, P NATL ACAD SCI USA, V109, pE588, DOI 10.1073/pnas.1118192109; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Potier N, 2005, METHOD ENZYMOL, V402, P361, DOI 10.1016/S0076-6879(05)02011-2; Puigserver P, 2005, INT J OBESITY, V29, pS5, DOI 10.1038/sj.ijo.0802905; Rha GB, 2009, J BIOL CHEM, V284, P35165, DOI 10.1074/jbc.M109.052506; Rochel N, 2011, NAT STRUCT MOL BIOL, V18, P564, DOI 10.1038/nsmb.2054; Rowe GC, 2010, CIRC RES, V107, P825, DOI 10.1161/CIRCRESAHA.110.223818; Schilling J, 2011, J MOL CELL CARDIOL, V51, P578, DOI 10.1016/j.yjmcc.2010.09.021; Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200; Sheng BY, 2012, J NEUROCHEM, V120, P419, DOI 10.1111/j.1471-4159.2011.07581.x; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tcherepanova I, 2000, J BIOL CHEM, V275, P16302, DOI 10.1074/jbc.M001364200; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000	44	29	31	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e67810	10.1371/journal.pone.0067810	http://dx.doi.org/10.1371/journal.pone.0067810			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874451	Green Published, Green Submitted, gold			2022-12-27	WOS:000321736900027
J	Feng, J; Wu, J; Dai, N; Lin, SJ; Xu, HH; Deng, ZX; He, XY				Feng, Jun; Wu, Jun; Dai, Nan; Lin, Shuangjun; Xu, H. Howard; Deng, Zixin; He, Xinyi			Discovery and Characterization of BlsE, a Radical S-AdenosylL-methionine Decarboxylase Involved in the Blasticidin S Biosynthetic Pathway	PLOS ONE			English	Article							PYRUVATE FORMATE-LYASE; BIOTIN SYNTHASE; ADENOSYLMETHIONINE-ENZYME; ESCHERICHIA-COLI; DEAMINASE GENE; FUNCTIONAL-CHARACTERIZATION; MILDIOMYCIN BIOSYNTHESIS; RIBONUCLEOTIDE REDUCTASE; PROTEIN SYNTHESIS; CRYSTAL-STRUCTURE	BlsE, a predicted radical S-adenosyl-L-methionine (SAM) protein, was anaerobically purified and reconstituted in vitro to study its function in the blasticidin S biosynthetic pathway. The putative role of BlsE was elucidated based on bioinformatics analysis, genetic inactivation and biochemical characterization. Biochemical results showed that BlsE is a SAM-dependent radical enzyme that utilizes cytosylglucuronic acid, the accumulated intermediate metabolite in blsE mutant, as substrate and catalyzes decarboxylation at the C5 position of the glucoside residue to yield cytosylarabinopyranose. Additionally, we report the purification and reconstitution of BlsE, characterization of its [4Fe-4S] cluster using UV-vis and electron paramagnetic resonance (EPR) spectroscopic analysis, and investigation of the ability of flavodoxin (Fld), flavodoxin reductase (Fpr) and NADPH to reduce the [4Fe-4S](2+) cluster. Mutagenesis studies demonstrated that Cys(31), Cys(35), Cys(38) in the CxxxCxMC motif and Gly(73), Gly(74), Glu(75), Pro(76) in the GGEP motif were crucial amino acids for BlsE activity while mutation of Met37 had little effect on its function. Our results indicate that BlsE represents a typical [4Fe-4S]-containing radical SAM enzyme and it catalyzes decarboxylation in blasticidin S biosynthesis.	[Feng, Jun; Wu, Jun; Lin, Shuangjun; Deng, Zixin; He, Xinyi] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Feng, Jun; Wu, Jun; Lin, Shuangjun; Deng, Zixin; He, Xinyi] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China; [Dai, Nan] New England Biolabs Inc, Res Dept, Ipswich, MA USA; [Xu, H. Howard] Calif State Univ Los Angeles, Dept Biol Sci, Los Angeles, CA 90032 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; New England Biolabs; California State University System; California State University Los Angeles	He, XY (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China.	xyhe@sjtu.edu.cn	Dai, Nan/I-5950-2013	Xu, Howard/0000-0003-4540-8539	Ministry of Science and Technology of China [2012CB721004, 2009CB118901]; National Natural Science Foundation of China [31121064]; Ministry of Education of China [20110073130011]; State Key Laboratory of Bio-organic and Natural Products Chemistry; Shanghai Jiao Tong University; California State University; U.S. Army Research Laboratory; U.S. Army Research Office [W911NF-12-1-0059]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); State Key Laboratory of Bio-organic and Natural Products Chemistry(Chinese Academy of Sciences); Shanghai Jiao Tong University; California State University; U.S. Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); U.S. Army Research Office	This study was supported in part by grants from the Ministry of Science and Technology of China (2012CB721004, 2009CB118901); the National Natural Science Foundation of China (31121064); Ministry of Education of China (20110073130011); Open Fund of State Key Laboratory of Bio-organic and Natural Products Chemistry; the Chen Xing Young Scholars Program, Shanghai Jiao Tong University; Dr Xu acknowledge Wang Family Faculty Fellowship from California State University, and U.S. Army Research Laboratory and the U.S. Army Research Office (W911NF-12-1-0059). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bali S, 2011, P NATL ACAD SCI USA, V108, P18260, DOI 10.1073/pnas.1108228108; BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; Ben Mamoun C, 1999, P NATL ACAD SCI USA, V96, P8716, DOI 10.1073/pnas.96.15.8716; Berkovitch F, 2004, SCIENCE, V303, P76, DOI 10.1126/science.1088493; Chatterjee A, 2008, NAT CHEM BIOL, V4, P758, DOI 10.1038/nchembio.121; Chatterjee A, 2010, ANGEW CHEM INT EDIT, V49, P8653, DOI 10.1002/anie.201003419; Cicchillo RM, 2005, J AM CHEM SOC, V127, P2860, DOI 10.1021/ja042428u; Cone MC, 2003, CHEMBIOCHEM, V4, P821, DOI 10.1002/cbic.200300583; Dowling DP, 2012, BBA-PROTEINS PROTEOM, V1824, P1178, DOI 10.1016/j.bbapap.2012.04.006; Frey PA, 2001, ADV PROTEIN CHEM, V58, P1; Frey PA, 2003, CHEM REV, V103, P2129, DOI 10.1021/cr020422m; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Gambarelli S, 2010, BIOL MAGN RESON, V29, P53, DOI 10.1007/978-1-4419-1139-1_4; Grove TL, 2010, BIOCHEMISTRY-US, V49, P3783, DOI 10.1021/bi9022126; Haldar S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031797; Hernandez HL, 2007, BIOCHEMISTRY-US, V46, P5140, DOI 10.1021/bi7000449; HUANG KT, 1964, J ANTIBIOT, V17, P65; KAMAKURA T, 1990, MOL GEN GENET, V223, P332, DOI 10.1007/BF00265072; KENNEDY MC, 1984, J BIOL CHEM, V259, P4463; KIMURA M, 1994, BBA-GENE STRUCT EXPR, V1219, P653, DOI 10.1016/0167-4781(94)90224-0; Krebs C, 2002, J AM CHEM SOC, V124, P912, DOI 10.1021/ja017562i; Layer G, 2005, J BIOL CHEM, V280, P29038, DOI 10.1074/jbc.M501275200; Layer G, 2003, EMBO J, V22, P6214, DOI 10.1093/emboj/cdg598; Li L, 2008, CHEMBIOCHEM, V9, P1286, DOI 10.1002/cbic.200800008; Liu A, 2000, J BIOL CHEM, V275, P12367, DOI 10.1074/jbc.275.17.12367; Lobo SAL, 2009, BIOCHEM J, V420, P317, DOI 10.1042/BJ20090151; Lotierzo M, 2005, BIOCHEM SOC T, V33, P820, DOI 10.1042/BST0330820; Nicolet Y, 2004, NUCLEIC ACIDS RES, V32, P4015, DOI 10.1093/nar/gkh728; Nicolet Y, 2009, P NATL ACAD SCI USA, V106, P14867, DOI 10.1073/pnas.0904385106; Sancho J, 2006, CELL MOL LIFE SCI, V63, P855, DOI 10.1007/s00018-005-5514-4; SANYAL I, 1994, BIOCHEMISTRY-US, V33, P3625, DOI 10.1021/bi00178a020; Shaw NM, 1998, BIOCHEM J, V330, P1079; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Szu PH, 2009, J AM CHEM SOC, V131, P14030, DOI 10.1021/ja903354k; Tamura K, 1995, BIOSCI BIOTECH BIOCH, V59, P2336, DOI 10.1271/bbb.59.2336; Torrents E, 2000, J BIOL CHEM, V275, P2463, DOI 10.1074/jbc.275.4.2463; Vey JL, 2011, CHEM REV, V111, P2487, DOI 10.1021/cr9002616; WAGNER AFV, 1992, P NATL ACAD SCI USA, V89, P996, DOI 10.1073/pnas.89.3.996; Wecksler SR, 2010, CHEM COMMUN, V46, P7031, DOI 10.1039/c0cc00968g; Wecksler SR, 2009, BIOCHEMISTRY-US, V48, P10151, DOI 10.1021/bi900918b; Wu J, 2012, CHEMBIOCHEM, V13, P1613, DOI 10.1002/cbic.201200173; YAMAGUCHI H, 1965, J BIOCHEM, V57, P667; Yokoyama K, 2007, J AM CHEM SOC, V129, P15147, DOI 10.1021/ja072481t; Zhang Q, 2011, J BIOL CHEM, V286, P21287, DOI 10.1074/jbc.M111.224832; Zhang Q, 2011, NAT CHEM BIOL, V7, P154, DOI [10.1038/nchembio.512, 10.1038/NCHEMBIO.512]	45	14	16	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e68545	10.1371/journal.pone.0068545	http://dx.doi.org/10.1371/journal.pone.0068545			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874663	Green Published, gold, Green Submitted			2022-12-27	WOS:000324146200018
J	Niu, SQ; Luo, M; Tang, J; Zhou, H; Zhang, YL; Min, X; Cai, XF; Zhang, WL; Xu, WC; Li, DF; Ding, JJ; Hu, YL; Wang, DC; Huang, AL; Yin, YB; Wang, DQ				Niu, Siqiang; Luo, Miao; Tang, Jian; Zhou, Hua; Zhang, Yangli; Min, Xun; Cai, Xuefei; Zhang, Wenlu; Xu, Wenchu; Li, Defeng; Ding, Jingjin; Hu, Yonglin; Wang, Dacheng; Huang, Ailong; Yin, Yibin; Wang, Deqiang			Structural Basis of the Novel S. pneumoniae Virulence Factor, GHIP, a Glycosyl Hydrolase 25 Participating in Host-Cell Invasion	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; LISTERIA-MONOCYTOGENES; CRYSTAL-STRUCTURE; EUKARYOTIC CELLS; X-RAY; AUTOLYSIN; WALL; ADHERENCE; NEURAMINIDASE; RECOGNITION	Pathogenic bacteria produce a wide variety of virulence factors that are considered to be potential antibiotic targets. In this study, we report the crystal structure of a novel S. pneumoniae virulence factor, GHIP, which is a streptococcus-specific glycosyl hydrolase. This novel structure exhibits an alpha/beta-barrel fold that slightly differs from other characterized hydrolases. The GHIP active site, located at the negatively charged groove in the barrel, is very similar to the active site in known peptidoglycan hydrolases. Functionally, GHIP exhibited weak enzymatic activity to hydrolyze the PNP-(GlcNAc)(5) peptidoglycan by the general acid/base catalytic mechanism. Animal experiments demonstrated a marked attenuation of S. pneumoniae-mediated virulence in mice infected by Delta GHIP-deficient strains, suggesting that GHIP functions as a novel S. pneumoniae virulence factor. Furthermore, GHIP participates in allowing S. pneumoniae to colonize the nasopharynx and invade host epithelial cells. Taken together, these findings suggest that GHIP can potentially serve as an antibiotic target to effectively treat streptococcus-mediated infection.	[Niu, Siqiang; Luo, Miao; Tang, Jian; Zhou, Hua; Zhang, Yangli; Min, Xun; Xu, Wenchu; Yin, Yibin; Wang, Deqiang] Chongqing Med Univ, Dept Lab Med, Chongqing, Peoples R China; [Niu, Siqiang; Luo, Miao; Tang, Jian; Zhou, Hua; Zhang, Yangli; Min, Xun; Cai, Xuefei; Zhang, Wenlu; Huang, Ailong; Wang, Deqiang] Chongqing Med Univ, Key Lab Mol Biol Infect Dis, Chongqing, Peoples R China; [Li, Defeng; Ding, Jingjin; Hu, Yonglin; Wang, Dacheng] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Niu, Siqiang] Chongqing Med Univ, Affiliated Hosp 1, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chongqing Medical University	Yin, YB (corresponding author), Chongqing Med Univ, Dept Lab Med, Chongqing, Peoples R China.	yibingyin@21cn.com; wangd@ustc.edu		Ding, Jingjin/0000-0001-9941-7997	Chinese National Natural Science Foundation [31240082, 30970563, 81101304]; National Science and Technology Major Projects [2013ZX10002002]; Natural Science Foundation of Chongqing [2009BB5413]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Projects; Natural Science Foundation of Chongqing(Natural Science Foundation of Chongqing)	Financial support for this project was provided by research grants from the Chinese National Natural Science Foundation (grant Nos. 31240082 and 30970563), the National Science and Technology Major Projects (2013ZX10002002), Natural Science Foundation of Chongqing (grant Nos. 2009BB5413) to Deqiang Wang, and the Chinese National Natural Science Foundation (grant Nos. 81101304) to Siqiang Niu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal V, 2010, J BIOL CHEM, V285, P23484, DOI 10.1074/jbc.M110.142703; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bergmann S, 2006, MICROBIOL-SGM, V152, P295, DOI 10.1099/mic.0.28610-0; Bergmann S, 2009, J CELL SCI, V122, P256, DOI 10.1242/jcs.035600; Blue CE, 2003, INFECT IMMUN, V71, P4405, DOI 10.1128/IAI.71.8.4405-4413.2003; Cabanes D, 2004, MOL MICROBIOL, V51, P1601, DOI 10.1111/j.1365-2958.2003.03945.x; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Coutinho PM, 1999, ROY SOC CH, P3; DeLano WL, 2004, PYMOL USERS MANUAL; Eberhardt A, 2009, MOL MICROBIOL, V74, P395, DOI 10.1111/j.1365-2958.2009.06872.x; Feldman C, 2007, INT J INFECT DIS, V11, P11, DOI 10.1016/j.ijid.2005.09.002; Frias MJ, 2009, J BACTERIOL, V191, P5428, DOI 10.1128/JB.00477-09; Frolet C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-190; Gamez G, 2012, CURR DRUG TARGETS, V13, P323, DOI 10.2174/138945012799424697; Gut H, 2008, FEBS LETT, V582, P3348, DOI 10.1016/j.febslet.2008.08.026; Hammerschmidt S, 2006, CURR OPIN MICROBIOL, V9, P12, DOI 10.1016/j.mib.2005.11.001; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.03106.x; Hermoso JA, 2003, STRUCTURE, V11, P1239, DOI 10.1016/j.str.2003.09.005; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kafka D, 2008, INT IMMUNOL, V20, P1139, DOI 10.1093/intimm/dxn071; Kim YG, 2009, J BACTERIOL, V191, P6550, DOI 10.1128/JB.00641-09; Klug D, 2003, J CLIN MICROBIOL, V41, P3348, DOI 10.1128/JCM.41.7.3348-3350.2003; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 1992, JOINT CCP4 ESF EACMB; Martinez-Fleites C, 2009, CARBOHYD RES, V344, P1753, DOI 10.1016/j.carres.2009.06.001; Mellroth P, 2012, J BIOL CHEM; Milohanic E, 2001, MOL MICROBIOL, V39, P1212, DOI 10.1046/j.1365-2958.2001.02208.x; Mook-Kanamori BB, 2011, CLIN MICROBIOL REV, V24, P557, DOI 10.1128/CMR.00008-11; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nagano N, 1999, PROTEIN SCI, V8, P2072, DOI 10.1110/ps.8.10.2072; NANJO F, 1988, J BIOCHEM-TOKYO, V104, P255, DOI 10.1093/oxfordjournals.jbchem.a122453; Niu SQ, 2010, ACTA CRYSTALLOGR F, V66, P286, DOI 10.1107/S1744309110000163; Obita T, 2003, CELL MOL LIFE SCI, V60, P176, DOI 10.1007/s000180300012; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parker D, 2009, INFECT IMMUN, V77, P3722, DOI 10.1128/IAI.00228-09; Perez-Dorado I, 2012, NAT STRUCT MOL BIOL, V17, P576; Perez-Dorado I, 2007, J BIOL CHEM, V282, P24990, DOI 10.1074/jbc.M704317200; Porter CJ, 2007, J MOL BIOL, V366, P540, DOI 10.1016/j.jmb.2006.11.056; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Pracht D, 2005, INFECT IMMUN, V73, P2680, DOI 10.1128/IAI.73.5.2680-2689.2005; Ramasubbu N, 2005, J MOL BIOL, V349, P475, DOI 10.1016/j.jmb.2005.03.082; Ramos-Sevillano E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023626; Rau A, 2001, J BIOL; Song LB, 2006, CANCER RES, V66, P6225, DOI 10.1158/0008-5472.CAN-06-0094; Stenberg K, 1997, PROTEIN SCI, V6, P1009, DOI 10.1002/pro.5560060506; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V53, P571; Uchiyama S, 2009, J EXP MED, V206, P1845, DOI 10.1084/jem.20090386; Velanker SS, 1997, STRUCTURE, V5, P751, DOI 10.1016/S0969-2126(97)00230-X; Vijayabaskar MS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002505; Wang LR, 2008, MICROBIOL-SGM, V154, P1900, DOI 10.1099/mic.0.2007/015172-0; Wohlkonig A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015388; Wu KF, 2010, INFECT IMMUN, V78, P1276, DOI 10.1128/IAI.00473-09; Zoll S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000807	56	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68647	10.1371/journal.pone.0068647	http://dx.doi.org/10.1371/journal.pone.0068647			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874703	Green Submitted, Green Published, gold			2022-12-27	WOS:000322064300059
J	Ramadugu, C; Pfeil, BE; Keremane, ML; Lee, RF; Maureira-Butler, IJ; Roose, ML				Ramadugu, Chandrika; Pfeil, Bernard E.; Keremane, Manjunath L.; Lee, Richard F.; Maureira-Butler, Ivan J.; Roose, Mikeal L.			A Six Nuclear Gene Phylogeny of Citrus (Rutaceae) Taking into Account Hybridization and Lineage Sorting	PLOS ONE			English	Article							POPULATION-STRUCTURE; RESISTANCE GENES; MOSAIC STRUCTURE; RFLP ANALYSIS; RECOMBINATION; INCONGRUENCE; DIVERSITY; SEQUENCES; GENOME; RECONSTRUCTION	Background: Genus Citrus (Rutaceae) comprises many important cultivated species that generally hybridize easily. Phylogenetic study of a group showing extensive hybridization is challenging. Since the genus Citrus has diverged recently (4-12 Ma), incomplete lineage sorting of ancestral polymorphisms is also likely to cause discrepancies among genes in phylogenetic inferences. Incongruence of gene trees is observed and it is essential to unravel the processes that cause inconsistencies in order to understand the phylogenetic relationships among the species. Methodology and Principal Findings: (1) We generated phylogenetic trees using haplotype sequences of six low copy nuclear genes. (2) Published simple sequence repeat data were re-analyzed to study population structure and the results were compared with the phylogenetic trees constructed using sequence data and coalescence simulations. (3) To distinguish between hybridization and incomplete lineage sorting, we developed and utilized a coalescence simulation approach. In other studies, species trees have been inferred despite the possibility of hybridization having occurred and used to generate null distributions of the effect of lineage sorting alone (by coalescent simulation). Since this is problematic, we instead generate these distributions directly from observed gene trees. Of the six trees generated, we used the most resolved three to detect hybrids. We found that 11 of 33 samples appear to be affected by historical hybridization. Analysis of the remaining three genes supported the conclusions from the hybrid detection test. Conclusions: We have identified or confirmed probable hybrid origins for several Citrus cultivars using three different approaches-gene phylogenies, population structure analysis and coalescence simulation. Hybridization and incomplete lineage sorting were identified primarily based on differences among gene phylogenies with reference to null expectations via coalescence simulations. We conclude that identifying hybridization as a frequent cause of incongruence among gene trees is critical to correctly infer the phylogeny among species of Citrus.	[Ramadugu, Chandrika; Roose, Mikeal L.] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Pfeil, Bernard E.] Commonwealth Sci & Ind Res Org Plant Ind, Canberra, ACT, Australia; [Pfeil, Bernard E.] Gothenburg Univ, DBES, Gothenburg, Sweden; [Keremane, Manjunath L.; Lee, Richard F.] ARS, USDA, Natl Clonal Germplasm Repository Citrus & Dates, Riverside, CA USA; [Maureira-Butler, Ivan J.] Agriaquaculture Nutr Genom Ctr, Genom & Bioinformat Unit, Temuco, Chile	University of California System; University of California Riverside; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Gothenburg; United States Department of Agriculture (USDA)	Pfeil, BE (corresponding author), Commonwealth Sci & Ind Res Org Plant Ind, Canberra, ACT, Australia.	bernard.pfeil@bioenv.gu.se	Maureira-Butler, Ivan J/U-3130-2017; Pfeil, Bernard E/C-1108-2008	Maureira-Butler, Ivan J/0000-0001-7360-3580; Pfeil, Bernard E/0000-0001-8179-2270	Citrus Research Board and Citrus Research and Development Fund	Citrus Research Board and Citrus Research and Development Fund	Funding from the Citrus Research Board and Citrus Research and Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abkenar AA, 2004, SCI HORTIC-AMSTERDAM, V102, P233, DOI 10.1016/j.scienta.2004.01.003; Abkenar AA, 2003, J HORTIC SCI BIOTECH, V78, P108, DOI 10.1080/14620316.2003.11511574; Barkley NA, 2006, THEOR APPL GENET, V112, P1519, DOI 10.1007/s00122-006-0255-9; Barrett H. C., 1976, Systematic Botany, V1, P105, DOI 10.2307/2418763; Baumgarten A, 2003, GENETICS, V165, P309; Bayer RJ, 2009, AM J BOT, V96, P668, DOI 10.3732/ajb.0800341; Bernet GP, 2010, MOL BREEDING, V25, P659, DOI 10.1007/s11032-009-9363-y; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; Buckley TR, 2006, SYST BIOL, V55, P411, DOI 10.1080/10635150600697283; de Araujo EF, 2003, ORG DIVERS EVOL, V3, P55, DOI 10.1078/1439-6092-00058; Doyle J. J., 1987, PHYTOCHEM B, P11; DOYLE JJ, 1992, SYST BOT, V17, P144, DOI 10.2307/2419070; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Farris JS, 1995, CLADISTICS, V10, P315, DOI [DOI 10.1111/J.1096-0031.1994.TB00181.X, DOI 10.1111/J.1096-0031.1996.TB00196.X]; Federici CT, 1998, THEOR APPL GENET, V96, P812, DOI 10.1007/s001220050807; Froelicher Y, 2011, TREE GENET GENOMES, V7, P49, DOI 10.1007/s11295-010-0314-x; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gulsen O, 2001, J AM SOC HORTIC SCI, V126, P309, DOI 10.21273/JASHS.126.3.309; HIRAI M, 1986, JPN J BREED, V36, P377; Innes RW, 2008, PLANT PHYSIOL, V148, P1740, DOI 10.1104/pp.108.127902; Iwamasa M., 1988, Citriculture. Sixth international citrus congress, Middle-East, Tel Aviv, Israel, 6-11 March 1988. Volume 1., P123; Joly S, 2009, AM NAT, V174, pE54, DOI 10.1086/600082; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kato M, 2004, PLANT PHYSIOL, V134, P824, DOI 10.1104/pp.103.031104; Kubatko LS, 2007, SYSTEMATIC BIOL, V56, P17, DOI 10.1080/10635150601146041; Kubatko LS, 2009, SYST BIOL, V58, P478, DOI 10.1093/sysbio/syp055; Blanco-Pastor JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039089; Mabberley D. J., 1997, Telopea, V7, P167; Mabberley D. J., 1998, Telopea, V7, P333; Maddison WP, 2006, SYST BIOL, V55, P21, DOI 10.1080/10635150500354928; Marshall DC, 2010, SYST BIOL, V59, P108, DOI 10.1093/sysbio/syp080; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; Maureira-Butler IJ, 2008, SYST BIOL, V57, P466, DOI 10.1080/10635150802172168; Meng C, 2009, THEOR POPUL BIOL, V75, P35, DOI 10.1016/j.tpb.2008.10.004; Nicolosi E, 2000, THEOR APPL GENET, V100, P1155, DOI 10.1007/s001220051419; Novelli VM, 2004, EUPHYTICA, V138, P227, DOI 10.1023/B:EUPH.0000047086.47988.82; Penjor T, 2010, TREE GENET GENOMES, V6, P931, DOI 10.1007/s11295-010-0302-1; Peters JL, 2007, EVOLUTION, V61, P1992, DOI 10.1111/j.1558-5646.2007.00149.x; Pfeil BE, 2008, AM J BOT, V95, P1621, DOI 10.3732/ajb.0800214; Pfeil BE, 2009, TAXON, V58, P511, DOI 10.1002/tax.582015; Poke FS, 2006, MOL PHYLOGENET EVOL, V39, P160, DOI 10.1016/j.ympev.2005.11.016; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Pritchard JK, 2000, GENETICS, V155, P945; Reid N, 2012, SYST BIOL, V61, P44, DOI 10.1093/sysbio/syr094; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Salminen MO, 1995, AIDS RES HUMAN RETRO, V11; Schwartz T, 2012, SYSTEMATIC BOT UNPUB; SCORA RW, 1975, B TORREY BOT CLUB, V102, P369, DOI 10.2307/2484763; SCORA RW, 1988, P 6 INT CITR C, P277; SMITH JM, 1992, J MOL EVOL, V34, P126; Stefanovic S, 2009, SYST BOT, V34, P115, DOI 10.1600/036364409787602221; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; STONE B C, 1973, Biotropica, V5, P102, DOI 10.2307/2989659; Swingle W.T., 1915, J WASHINGTON ACAD SC, V5, P569; Swingle W T, 1967, CITRUS IND, P190; Swingle W.T., 1915, J WASH ACAD SCI, V5, P165; Swingle WT, 1914, J AGRIC RES, V2, P85; SWINGLE WALTER T., 1939, JOUR ARNOLD ARBORETUM, V20, P250; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Syring J, 2007, SYST BIOL, V56, P163, DOI 10.1080/10635150701258787; Tanaka T., 1977, STUD CITROG, V14, P1; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ting N, 2008, MOL PHYLOGENET EVOL, V46, P466, DOI 10.1016/j.ympev.2007.11.008; van der Niet T, 2008, MOL PHYLOGENET EVOL, V47, P154, DOI 10.1016/j.ympev.2007.12.008; Wendel J.F., 1998, MOL SYSTEMATICS PLAN, P265, DOI 10.1007/978-1-4615-5419-6_10; Xu Q, 2013, NAT GENET, V45, P59, DOI 10.1038/ng.2472; YAMAMOTO M, 1993, JPN J BREED, V43, P355	70	31	33	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68410	10.1371/journal.pone.0068410	http://dx.doi.org/10.1371/journal.pone.0068410			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874615	gold, Green Published, Green Submitted			2022-12-27	WOS:000322064300030
J	Cho, KH; Kang, SO				Cho, Kyu Hong; Kang, Song Ok			Streptococcus pyogenes c-di-AMP Phosphodiesterase, GdpP, Influences SpeB Processing and Virulence	PLOS ONE			English	Article							EXTRACELLULAR CYSTEINE PROTEASE; GROUP-A STREPTOCOCCUS; PEROXIDE RESISTANCE; BACILLUS-SUBTILIS; ESSENTIAL GENES; TRIGGER FACTOR; PROTEINASE; IDENTIFICATION; FIBRONECTIN; MUTAGENESIS	Small cyclic nucleotide derivatives are employed as second messengers by both prokaryotes and eukaryotes to regulate diverse cellular processes responding to various signals. In bacteria, c-di-AMP has been discovered most recently, and some Gram-positive pathogens including S. pyogenes use this cyclic nucleotide derivative as a second messenger instead of c-di-GMP, a well-studied important bacterial second messenger. GdpP, c-di-AMP phosphodiesterase, is responsible for degrading c-di-AMP inside cells, and the cellular role of GdpP in S. pyogenes has not been examined yet. To test the cellular role of GdpP, we created a strain with a nonpolar inframe deletion of the gdpP gene, and examined the properties of the strain including virulence. From this study, we demonstrated that GdpP influences the biogenesis of SpeB, the major secreted cysteine protease, at a post-translational level, susceptibility to the beta lactam antibiotic ampicillin, and is necessary for full virulence in a murine subcutaneous infection model.	[Cho, Kyu Hong] So Illinois Univ, Dept Microbiol, Carbondale, IL 62901 USA; [Kang, Song Ok] So Illinois Univ, Sch Med, Dept Physiol, Carbondale, IL 62901 USA	Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University	Cho, KH (corresponding author), So Illinois Univ, Dept Microbiol, Carbondale, IL 62901 USA.	kyuhongcho@gmail.com			American Heart Association [11SDG7440083]; National Institutes of Health [R15GM101603-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM101603] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported in part by American Heart Association Grant 11SDG7440083 and National Institutes of Health Grant R15GM101603-01 to KHC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Bai Y., 2012, PLOS ONE, V7, DOI DOI 10.1371/J0URNAL.P0NE; Brenot A, 2005, MOL MICROBIOL, V55, P221, DOI 10.1111/j.1365-2958.2004.04370.x; Brenot A, 2004, INFECT IMMUN, V72, P408, DOI 10.1128/IAI.72.1.408-413.2004; Burns EH, 1996, INFECT IMMUN, V64, P4744, DOI 10.1128/IAI.64.11.4744-4750.1996; BUSTIN M, 1970, J BIOL CHEM, V245, P846; CAPARON MG, 1991, METHOD ENZYMOL, V204, P556; Cho KH, 2008, INFECT IMMUN, V76, P3176, DOI 10.1128/IAI.01721-07; Cole JN, 2007, PROTEOMICS, V7, P4488, DOI 10.1002/pmic.200700626; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; Doran JD, 1999, EUR J BIOCHEM, V263, P145, DOI 10.1046/j.1432-1327.1999.00473.x; French CT, 2008, MOL MICROBIOL, V69, P67, DOI 10.1111/j.1365-2958.2008.06262.x; Ghosh J, 2006, MOL MICROBIOL, V62, P1203, DOI 10.1111/j.1365-2958.2006.05430.x; Glantz S.A., 2002, PRIMER BIOSTATISTICS; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Granok AB, 2000, J BACTERIOL, V182, P1529, DOI 10.1128/JB.182.6.1529-1540.2000; HANSKI E, 1992, P NATL ACAD SCI USA, V89, P6172, DOI 10.1073/pnas.89.13.6172; HAUSER AR, 1990, J BACTERIOL, V172, P4536, DOI 10.1128/jb.172.8.4536-4542.1990; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Herr AJ, 2001, J MOL BIOL, V309, P1029, DOI 10.1006/jmbi.2001.4717; Herwald H, 1996, J EXP MED, V184, P665, DOI 10.1084/jem.184.2.665; Hoffman DW, 1996, J MOL BIOL, V264, P1058, DOI 10.1006/jmbi.1996.0696; Holland LM, 2008, J BACTERIOL, V190, P5178, DOI 10.1128/JB.00375-08; Kamegaya T, 2011, NAGOYA J MED SCI, V73, P49; KAPUR V, 1993, P NATL ACAD SCI USA, V90, P7676, DOI 10.1073/pnas.90.16.7676; KAPUR V, 1993, MICROB PATHOGENESIS, V15, P327, DOI 10.1006/mpat.1993.1083; KIEFHABER T, 1990, BIOCHEMISTRY-US, V29, P3061, DOI 10.1021/bi00464a024; King KY, 2000, J BACTERIOL, V182, P5290, DOI 10.1128/JB.182.19.5290-5299.2000; Kulesekara H, 2006, P NATL ACAD SCI USA, V103, P2839, DOI 10.1073/pnas.0511090103; Luo Y, 2012, MOL MICROBIOL, V83, P623, DOI 10.1111/j.1365-2958.2011.07953.x; Lyon WR, 1998, EMBO J, V17, P6263, DOI 10.1093/emboj/17.21.6263; Lyon WR, 2004, INFECT IMMUN, V72, P1618, DOI 10.1128/IAI.72.3.1618-1625.2004; Lyon WR, 2003, J BACTERIOL, V185, P3661, DOI 10.1128/JB.185.12.3661-3667.2003; Ma YS, 2006, J BACTERIOL, V188, P7626, DOI 10.1128/JB.01059-06; Meehl MA, 2005, PLOS PATHOG, V1, P362, DOI 10.1371/journal.ppat.0010035; Olsen RJ, 2010, ANNU REV PATHOL-MECH, V5, P1, DOI 10.1146/annurev-pathol-121808-102135; Oppenheimer-Shaanan Y, 2011, EMBO REP, V12, P594, DOI 10.1038/embor.2011.77; Podbielski A, 1999, MED MICROBIOL IMMUN, V188, P99, DOI 10.1007/s004300050111; Rao F, 2010, J BIOL CHEM, V285, P473, DOI 10.1074/jbc.M109.040238; Rasmussen M, 2002, MOL MICROBIOL, V43, P537, DOI 10.1046/j.1365-2958.2002.02766.x; Rosch J, 2004, SCIENCE, V304, P1513, DOI 10.1126/science.1097404; Rosch JW, 2007, J BACTERIOL, V189, P801, DOI 10.1128/JB.01549-06; SCOTT JR, 1974, VIROLOGY, V62, P344, DOI 10.1016/0042-6822(74)90397-3; Song JH, 2005, MOL CELLS, V19, P365; Song MS, 2001, J BIOL CHEM, V276, P35165, DOI 10.1074/jbc.M100389200; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Yonath A, 2002, CURR PROTEIN PEPT SC, V3, P67, DOI 10.2174/1389203023380828	46	44	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2013	8	7							e69425	10.1371/journal.pone.0069425	http://dx.doi.org/10.1371/journal.pone.0069425			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZN	23869242	Green Submitted, Green Published, gold			2022-12-27	WOS:000323110600042
J	Fang, WD; Lv, FJ; Luo, TY; Cheng, OM; Liao, W; Sheng, K; Wang, XF; Wu, F; Hu, YD; Luo, J; Yang, QX; Zhang, H				Fang, Weidong; Lv, Fajin; Luo, Tianyou; Cheng, Oumei; Liao, Wei; Sheng, Ke; Wang, Xuefeng; Wu, Fei; Hu, Yida; Luo, Jing; Yang, Qing X.; Zhang, Han			Abnormal Regional Homogeneity in Patients with Essential Tremor Revealed by Resting-State Functional MRI	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; CEREBELLAR GRAY-MATTER; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; MOTOR CORTEX; CONNECTIVITY; FMRI; NETWORKS; STIMULATION; INVOLVEMENT	Essential tremor (ET) is one of the most common movement disorders in human adults. It can be characterized as a progressive neurological disorder of which the most recognizable feature is a tremor of the arms or hands that is apparent during voluntary movements such as eating and writing. The pathology of ET remains unclear. Resting-state fMRI (RS-fMRI), as a non-invasive imaging technique, was employed to investigate abnormalities of functional connectivity in ET in the brain. Regional homogeneity (ReHo) was used as a metric of RS-fMRI to assess the local functional connectivity abnormality in ET with 20 ET patients and 20 age-and gender-matched healthy controls (HC). The ET group showed decreased ReHo in the anterior and posterior bilateral cerebellar lobes, the bilateral thalamus and the insular lobe, and increased ReHo in the bilateral prefrontal and parietal cortices, the left primary motor cortex and left supplementary motor area. The abnormal ReHo value of ET patients in the bilateral anterior cerebellar lobes and the right posterior cerebellar lobe were negatively correlated with the tremor severity score, while positively correlated with that in the left primary motor cortex. These findings suggest that the abnormality in cerebello-thalamo-cortical motor pathway is involved in tremor generation and propagation, which may be related to motor-related symptoms in ET patients. Meanwhile, the abnormality in the prefrontal and parietal regions may be associated with non-motor symptoms in ET. These findings suggest that the ReHo could be utilized for investigations of functional-pathological mechanism of ET.	[Fang, Weidong; Lv, Fajin; Luo, Tianyou; Wu, Fei] Chongqing Med Univ, Affiliated Hosp 1, Dept Radiol, Chongqing, Peoples R China; [Cheng, Oumei; Sheng, Ke; Wang, Xuefeng; Hu, Yida; Luo, Jing] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China; [Liao, Wei; Zhang, Han] Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China; [Liao, Wei; Zhang, Han] Zhejiang Key Lab Res Assessment Cognit Impairment, Hangzhou, Zhejiang, Peoples R China; [Yang, Qing X.] Penn State Coll Med, Dept Radiol, Ctr NMR Res, Hershey, PA USA	Chongqing Medical University; Chongqing Medical University; Hangzhou Normal University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Luo, TY (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Radiol, Chongqing, Peoples R China.	ltychy@sina.com; hanzhang@hznu.edu.cn	Yang, Heroine/GRY-2630-2022	Zhang, Han/0000-0002-6645-8810	Medicine Scientific Key Research Project of Chongqing Health Bureau [2010-2-030]; National Natural Science Foundation of China [81201156]	Medicine Scientific Key Research Project of Chongqing Health Bureau; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research is supported by the Medicine Scientific Key Research Project of Chongqing Health Bureau (Project NO. 2010-2-030), the National Natural Science Foundation of China (Project NO. 81201156). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avanzino L, 2009, EUR J NEUROSCI, V30, P1971, DOI 10.1111/j.1460-9568.2009.06984.x; Bagepally BS, 2012, J NEUROIMAGING, V22, P275, DOI 10.1111/j.1552-6569.2011.00598.x; Barut BO, 2013, ACTA NEUROL BELG, V113, P117, DOI 10.1007/s13760-012-0124-z; Baudrexel S, 2011, NEUROIMAGE, V55, P1728, DOI 10.1016/j.neuroimage.2011.01.017; Benito-Leon J, 2009, J NEUROL SCI, V287, P138, DOI 10.1016/j.jns.2009.08.037; Bermejo-Pareja F, 2007, MOVEMENT DISORD, V22, P1573, DOI 10.1002/mds.21553; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2012, NEUROIMAGE, V62, P938, DOI 10.1016/j.neuroimage.2012.01.090; Boecker H, 1998, MOVEMENT DISORD, V13, P64; Boecker H, 2010, J NUCL MED, V51, P1030, DOI 10.2967/jnumed.109.074120; Breit S, 2006, J NEURAL TRANSM, V113, P187, DOI 10.1007/s00702-005-0311-7; Bucher SF, 1997, ANN NEUROL, V41, P32, DOI 10.1002/ana.410410108; Buijink AWG, 2013, CEREBELLUM, V12, P199, DOI 10.1007/s12311-012-0414-2; Cerasa A, 2009, AM J NEURORADIOL, V30, P1240, DOI 10.3174/ajnr.A1544; Cerasa A, 2010, NEUROREPORT, V21, P148, DOI 10.1097/WNR.0b013e328335b42c; Chandran V, 2012, PARKINSONISM RELAT D, V18, P407, DOI 10.1016/j.parkreldis.2011.12.003; Coste CP, 2011, CEREB CORTEX, V21, P2612, DOI 10.1093/cercor/bhr050; Daniels C, 2006, NEUROLOGY, V67, P1452, DOI 10.1212/01.wnl.0000240130.94408.99; Douaud G, 2011, BRAIN, V134, P3467, DOI 10.1093/brain/awr279; Fasano A, 2010, BRAIN, V133, P3635, DOI 10.1093/brain/awq267; Fox MD, 2010, FRONT SYST NEUROSCI, V4, DOI [10.3389/fnsys.2010.00019, 10.3389/fnsys.2010.0001]; Galvin JE, 2011, NEUROLOGY, V76, P1797, DOI 10.1212/WNL.0b013e31821ccc83; Hacker CD, 2012, BRAIN, V135, P3699, DOI 10.1093/brain/aws281; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Hellwig B, 2003, CLIN NEUROPHYSIOL, V114, P1462, DOI 10.1016/S1388-2457(03)00116-0; Hellwig B, 2001, LANCET, V357, P519, DOI 10.1016/S0140-6736(00)04044-7; Helmich RC, 2011, ANN NEUROL, V69, P269, DOI 10.1002/ana.22361; Hoskovcova M, 2013, CEREBELLUM, V12, P27, DOI 10.1007/s12311-012-0384-4; Klein JC, 2011, HUM BRAIN MAPP, V32, P896, DOI 10.1002/hbm.21077; Koster B, 2002, J NEUROL NEUROSUR PS, V73, P400, DOI 10.1136/jnnp.73.4.400; Kronenbuerger M, 2007, BRAIN, V130, P1538, DOI 10.1093/brain/awm081; Lenglet C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029153; Liang H, 2012, PARKINSONISM RELAT D, V18, P303, DOI 10.1016/j.parkreldis.2011.10.017; Louis ED, 1998, ARCH NEUROL-CHICAGO, V55, P823, DOI 10.1001/archneur.55.6.823; Louis ED, 2005, LANCET NEUROL, V4, P100, DOI 10.1016/S1474-4422(05)00991-9; Louis ED, 2004, MOVEMENT DISORD, V19, P672, DOI 10.1002/mds.20019; Louis ED, 2008, MOVEMENT DISORD, V23, P174, DOI 10.1002/mds.21731; Louis ED, 2011, PARKINSONISM RELAT D, V17, P406, DOI 10.1016/j.parkreldis.2011.05.004; Louis ED, 2010, LANCET NEUROL, V9, P613, DOI 10.1016/S1474-4422(10)70090-9; Louis ED, 2009, ARCH NEUROL-CHICAGO, V66, P1202, DOI 10.1001/archneurol.2009.217; Louis ED, 2009, MOVEMENT DISORD, V24, P1606, DOI 10.1002/mds.22570; Molnar GF, 2005, J NEUROPHYSIOL, V93, P3094, DOI 10.1152/jn.00881.2004; Muthuraman M, 2012, NEUROIMAGE, V60, P1331, DOI 10.1016/j.neuroimage.2012.01.088; Nicoletti G, 2010, NEUROLOGY, V74, P988, DOI 10.1212/WNL.0b013e3181d5a460; Passamonti L, 2011, BRAIN, V134, P2274, DOI 10.1093/brain/awr164; Perlmutter JS, 2002, NEUROLOGY, V58, P1388, DOI 10.1212/WNL.58.9.1388; Popa T, 2013, BRAIN STIMUL, V6, P175, DOI 10.1016/j.brs.2012.04.009; Power JD, 2013, NEUROIMAGE, V76, P439, DOI 10.1016/j.neuroimage.2012.03.017; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Quattrone A, 2008, AM J NEURORADIOL, V29, P1692, DOI 10.3174/ajnr.A1190; Raethjen J, 2012, CLIN NEUROPHYSIOL, V123, P61, DOI 10.1016/j.clinph.2011.09.024; Rajput AH, 2012, PARKINSONISM RELAT D, V18, P626, DOI 10.1016/j.parkreldis.2012.01.013; Rajput AH, 2011, PARKINSONISM RELAT D, V17, P16, DOI 10.1016/j.parkreldis.2010.08.009; Rajput AH, 2012, NEURODEGENER DIS MAN, V2, P259, DOI 10.2217/nmt.12.23; Saini J, 2012, PARKINSONISM RELAT D, V18, P477, DOI 10.1016/j.parkreldis.2012.01.006; Santangelo G, 2013, J NEUROL, V260, P513, DOI 10.1007/s00415-012-6668-2; Satterthwaite TD, 2013, NEUROIMAGE, V64, P240, DOI 10.1016/j.neuroimage.2012.08.052; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Sheline YI, 2013, BIOL PSYCHIAT, DOI [10.1016/j.biopsych.2012.11.028, DOI 10.1016/J.BI0P-SYCH.2012.11.028]; Sheline YI, 2010, P NATL ACAD SCI USA, V107, P11020, DOI 10.1073/pnas.1000446107; Shibasaki H, 2012, CLIN NEUROPHYSIOL, V123, P229, DOI 10.1016/j.clinph.2011.07.042; Shill Holly A, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS135, DOI 10.1016/S1353-8020(11)70042-6; Shukla DK, 2010, NEUROSCI LETT, V476, P46, DOI 10.1016/j.neulet.2010.03.080; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Stolze H, 2001, BRAIN, V124, P2278, DOI 10.1093/brain/124.11.2278; Stoodley CJ, 2012, NEUROIMAGE, V59, P1560, DOI 10.1016/j.neuroimage.2011.08.065; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Teive Helio A G, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS140, DOI 10.1016/S1353-8020(11)70044-X; Tessitore A, 2012, NEUROLOGY, V79, P2226, DOI 10.1212/WNL.0b013e31827689d6; Tian LX, 2012, NEUROIMAGE, V60, P539, DOI 10.1016/j.neuroimage.2011.11.098; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Wang L, 2006, NEUROIMAGE, V31, P496, DOI 10.1016/j.neuroimage.2005.12.033; Wu T, 2009, HUM BRAIN MAPP, V30, P1502, DOI 10.1002/hbm.20622; Xie CM, 2012, NEUROIMAGE, V63, P320, DOI 10.1016/j.neuroimage.2012.06.062; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yang Z, 2012, NEUROIMAGE, V63, P403, DOI 10.1016/j.neuroimage.2012.06.060; You H, 2011, NEUROSCI LETT, V502, P18, DOI 10.1016/j.neulet.2011.07.015; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zarei M, 2013, NEUROIMAGE, V66, P28, DOI 10.1016/j.neuroimage.2012.10.071; Zhang ZQ, 2012, NEUROIMAGE, V59, P1429, DOI 10.1016/j.neuroimage.2011.08.049; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	82	63	64	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2013	8	7							e69199	10.1371/journal.pone.0069199	http://dx.doi.org/10.1371/journal.pone.0069199			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZN	23869236	Green Published, gold, Green Submitted			2022-12-27	WOS:000323110600036
J	Hu, Y; Ellis, BL; Yiu, YY; Miller, MM; Urban, JF; Shi, LZ; Aroian, RV				Hu, Yan; Ellis, Brian L.; Yiu, Ying Y.; Miller, Melanie M.; Urban, Joseph F.; Shi, Linda Z.; Aroian, Raffi V.			An Extensive Comparison of the Effect of Anthelmintic Classes on Diverse Nematodes	PLOS ONE			English	Article							TRANSMITTED HELMINTH INFECTIONS; IN-VIVO EFFICACY; HELIGMOSOMOIDES-POLYGYRUS; TRICHURIS-MURIS; GASTROINTESTINAL NEMATODE; ASCARIS-SUUM; VITRO; DRUGS; RESISTANCE; ALBENDAZOLE	Soil-transmitted helminths are parasitic nematodes that inhabit the human intestine. These parasites, which include two hookworm species, Ancylostoma duodenale and Necator americanus, the whipworm Trichuris trichiura, and the large roundworm Ascaris lumbricoides, infect upwards of two billion people and are a major cause of disease burden in children and pregnant women. The challenge with treating these diseases is that poverty, safety, and inefficient public health policy have marginalized drug development and distribution to control infection in humans. Anthelmintics (anti-worm drugs) have historically been developed and tested for treatment of non-human parasitic nematodes that infect livestock and companion animals. Here we systematically compare the in vitro efficacy of all major anthelmintic classes currently used in human therapy (benzimidazoles, nicotinic acetylcholine receptor agonists, macrocyclic lactones, nitazoxanide) against species closely related to human parasitic nematodes-Ancylostoma ceylanicum, Trichuris muris, and Ascaris suum- as well as a rodent parasitic nematode used in veterinary drug discovery, Heligmosomoides bakeri, and the free-living nematode Caenorhabditis elegans. Extensive in vitro data is complemented with single-dose in vivo data in three rodent models of parasitic diseases. We find that the effects of the drugs in vitro and in vivo can vary greatly among these nematode species, e. g., the efficacy of albendazole is strong on A. ceylanicum but weak on H. bakeri. Nonetheless, certain commonalities of the in vitro effects of the drugs can be seen, e. g., nitazoxanide consistently shows an all-or-nothing response. Our in vitro data suggest that further optimization of the clinical efficacy of some of these anthelmintics could be achieved by altering the treatment routine and/or dosing. Most importantly, our in vitro and in vivo data indicate that the hookworm A. ceylanicum is a particularly sensitive and useful model for anthelmintic studies and should be incorporated early on in drug screens for broad-spectrum human soil-transmitted helminth therapies.	[Hu, Yan; Ellis, Brian L.; Yiu, Ying Y.; Miller, Melanie M.; Aroian, Raffi V.] Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Urban, Joseph F.] USDA ARS, Beltsville Human Nutr Res Ctr, Diet Genom & Immunol Lab, Beltsville, MD USA; [Shi, Linda Z.] Univ Calif San Diego, Inst Engn Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; United States Department of Agriculture (USDA); University of California System; University of California San Diego	Aroian, RV (corresponding author), Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.	raroian@ucsd.edu	Ellis, Brian L./AAC-6105-2021	Ellis, Brian L./0000-0002-5878-3461; Urban, Joseph/0000-0002-1590-8869	National Institutes of Health/National Institute of Allergy and Infectious [2R01AI056189]; Institute of One World Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056189] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious; Institute of One World Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by National Institutes of Health/National Institute of Allergy and Infectious grant 2R01AI056189 to RVA. and by grant from the Institute of One World Health to RVA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANSEMIR AD, 1994, J PARASITOL, V80, P24, DOI 10.2307/3283340; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Cliffe LJ, 2004, ADV PARASIT, V57, P255, DOI 10.1016/S0065-308X(04)57004-5; Conlan JV, 2012, AM J TROP MED HYG, V86, P624, DOI 10.4269/ajtmh.2012.11-0413; de Bellocq JG, 2001, MOL PHYLOGENET EVOL, V19, P430, DOI 10.1006/mpev.2001.0925; Ducray P, 2008, BIOORG MED CHEM LETT, V18, P2935, DOI 10.1016/j.bmcl.2008.03.071; Epe C, 2013, TRENDS PARASITOL, V29, P129, DOI 10.1016/j.pt.2013.01.001; Fallon PG, 1996, INT J PARASITOL, V26, P557, DOI 10.1016/0020-7519(96)89383-0; Fox LM, 2005, CLIN INFECT DIS, V40, P1173, DOI 10.1086/428839; Geary TG, 2001, VET PARASITOL, V101, P371, DOI 10.1016/S0304-4017(01)00562-3; Geary TG, 2010, INT J PARASITOL, V40, P1, DOI 10.1016/j.ijpara.2009.11.001; Githiori JB, 2003, VET PARASITOL, V118, P215, DOI 10.1016/j.vetpar.2003.10.006; Hall A, 2008, MATERN CHILD NUTR, V4, P118, DOI 10.1111/j.1740-8709.2007.00127.x; Holden-Dye Lindy, 2007, WormBook, P1, DOI 10.1895/wormbook.1.143.1; Hu Y, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001900; Hu Y, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000614; Hu Y, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000499; Humphries D, 2011, AM J TROP MED HYG, V84, P792, DOI 10.4269/ajtmh.2011.11-0003; Keiser J, 2008, JAMA-J AM MED ASSOC, V299, P1937, DOI 10.1001/jama.299.16.1937; Keiser J, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-292; Keiser J, 2010, ADV PARASIT, V73, P197, DOI 10.1016/S0065-308X(10)73008-6; Knopp S, 2012, INFECT DIS CLIN N AM, V26, P341, DOI 10.1016/j.idc.2012.02.006; Kopp SR, 2008, VET PARASITOL, V152, P284, DOI 10.1016/j.vetpar.2007.12.020; Kotze AC, 2006, VET PARASITOL, V137, P294, DOI 10.1016/j.vetpar.2006.01.017; Kotze AC, 2004, AM J TROP MED HYG, V71, P608, DOI 10.4269/ajtmh.2004.71.608; Kotze AC, 2009, AM J TROP MED HYG, V81, P163, DOI 10.4269/ajtmh.2009.81.163; Leles D, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-42; McKellar QA, 2004, TRENDS PARASITOL, V20, P456, DOI 10.1016/j.pt.2004.08.002; Morimoto M, 2003, EXP PARASITOL, V104, P113, DOI 10.1016/S0014-4894(03)00139-5; Omura S, 2008, INT J ANTIMICROB AG, V31, P91, DOI 10.1016/j.ijantimicag.2007.08.023; Paveley RA, 2013, PARASITE IMMUNOL, V35, P302, DOI 10.1111/pim.12037; RAJASEKARIAH GR, 1991, INT J PARASITOL, V21, P697, DOI 10.1016/0020-7519(91)90081-H; REW RS, 1986, AM J VET RES, V47, P869; Ruiz-Lancheros E, 2011, INT J PARASITOL, V41, P455, DOI 10.1016/j.ijpara.2010.11.009; SAYLES PC, 1983, J PARASITOL, V69, P1079, DOI 10.2307/3280868; Shea JL, 2013, CLIN CHEM LAB MED, V51, P205, DOI 10.1515/cclm-2012-0519; SHOOP WL, 1990, J PARASITOL, V76, P349, DOI 10.2307/3282664; Silbereisen A, 2011, J MICROBIOL METH, V87, P169, DOI 10.1016/j.mimet.2011.08.009; Smout MJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000885; Soukhathammavong PA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001417; Speich B, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001685; Stepek G, 2005, PARASITOLOGY, V130, P203, DOI 10.1017/S0031182004006225; Stepek G, 2006, INT J EXP PATHOL, V87, P325, DOI 10.1111/j.1365-2613.2006.00495.x; Stothard JR, 2009, ANN TROP MED PARASIT, V103, P357, DOI 10.1179/136485909X398320; Tchuente LAT, 2011, ACTA TROP, V120, pS4, DOI 10.1016/j.actatropica.2010.07.001; Tritten L, 2012, ACTA TROP, V122, P101, DOI 10.1016/j.actatropica.2011.12.008; Tritten L, 2012, PARASITOLOGY, V139, P348, DOI 10.1017/S0031182011001934; Tritten L, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001457; Williamson SM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000517	49	53	54	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2013	8	7							e70702	10.1371/journal.pone.0070702	http://dx.doi.org/10.1371/journal.pone.0070702			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZN	23869246	gold, Green Published, Green Submitted			2022-12-27	WOS:000323110600046
J	Schuetz, CA; Alperin, P; Guda, S; van Herick, A; Cariou, B; Eddy, D; Gumprecht, J; Nicolucci, A; Schwarz, P; Wareham, NJ; Witte, DR; Smith, U				Schuetz, C. Andy; Alperin, Peter; Guda, Swathi; van Herick, Andrew; Cariou, Bertrand; Eddy, David; Gumprecht, Janusz; Nicolucci, Antonio; Schwarz, Peter; Wareham, Nick J.; Witte, Daniel R.; Smith, Ulf			A Standardized Vascular Disease Health Check in Europe: A Cost-Effectiveness Analysis	PLOS ONE			English	Article							INDIVIDUAL DATA; BLOOD-PRESSURE; HIGH-RISK; TYPE-2; PREVENTION; AGE; METAANALYSIS; CHOLESTEROL; STRATEGIES; ARCHIMEDES	Background: No clinical trials have assessed the effects or cost-effectiveness of health check strategies to detect and manage vascular disease. We used a mathematical model to estimate the cost-effectiveness of several health check strategies in six European countries. Methods: We used country-specific data from Denmark, France, Germany, Italy, Poland, and the United Kingdom to generate simulated populations of individuals aged 40-75 eligible for health checks in those countries (e. g. individuals without a previous diagnosis of diabetes, myocardial infarction, stroke, or serious chronic kidney disease). For each country, we used the Archimedes model to compare seven health check strategies consisting of assessments for diabetes, hypertension, lipids, and smoking. For patients diagnosed with vascular disease, treatment was simulated in a standard manner. We calculated the effects of each strategy on the incidence of type 2 diabetes, major adverse cardiovascular events (MACE), and microvascular complications in addition to quality of life, costs, and cost per quality-adjusted life-year (QALY). Results: Compared with current care, health checks reduced the incidence of MACE (6-17 events prevented per 1000 people screened) and diabetes related microvasular complications (5-11 events prevented per 1000 people screened), and increased QALYs (31-59 discounted QALYs) over 30 years, in all countries. The cost per QALY of offering a health check to all individuals in the study cohort ranged from is an element of 14903 (France) to cost saving (Poland). Pre-screening the population and offering health checks only to higher risk individuals lowered the cost per QALY. Pre-screening on the basis of obesity had a cost per QALY of is an element of 10200 (France) or less, and pre-screening with a non-invasive risk score was similar. Conclusions: A vascular disease health check would likely be cost effective at 30 years in Denmark, France, Germany, Italy, Poland, and the United Kingdom.	[Schuetz, C. Andy; Alperin, Peter; Guda, Swathi; van Herick, Andrew; Eddy, David] Archimedes Inc, San Francisco, CA USA; [Cariou, Bertrand] CHU Nantes, Clin Endocrinol, Inst Thorax, F-44035 Nantes 01, France; [Gumprecht, Janusz] Med Univ Silesia, Dept Internal Dis Diabetol & Nephrol, Zabrze, Poland; [Nicolucci, Antonio] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Dept Clin Pharmacol & Epidemiol, I-66030 Santa Maria Imbaro, Italy; [Schwarz, Peter] Univ Dresden, Dept Med Prevent & Care Diabet 3, Dresden, Germany; [Wareham, Nick J.] Addenbrookes Hosp, Inst Metab Sci, Med Res Council, Epidemiol Unit, Cambridge, England; [Witte, Daniel R.] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Smith, Ulf] Sahlgrens Univ Hosp, Gothenburg, Sweden	Nantes Universite; CHU de Nantes; Medical University Silesia; Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Technische Universitat Dresden; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; Steno Diabetes Center; Sahlgrenska University Hospital	Schuetz, CA (corresponding author), Archimedes Inc, San Francisco, CA USA.	andy.schuetz@archimedesmodel.com	Schwarz, Peter/AAF-1558-2020; Witte, Daniel R/C-1722-2008; H, V/M-5550-2014; Witte, Daniel/AAF-9535-2019	Witte, Daniel R/0000-0002-0769-2922; Witte, Daniel/0000-0002-0769-2922; Schwarz, Peter/0000-0002-0483-8594; Cariou, Bertrand/0000-0002-1580-8040	Novo Nordisk; Medical Research Council [MC_U106179471, MC_UU_12015/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10135] Funding Source: researchfish; MRC [MC_UU_12015/1] Funding Source: UKRI	Novo Nordisk(Novo Nordisk); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Novo Nordisk sponsored this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Anand SS, 2011, LANCET, V377, P529, DOI 10.1016/S0140-6736(10)62346-X; CDC/NCHS, NAT HLTH NUTR EX SUR; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Coffey JT, 2002, DIABETES CARE, V25, P2238, DOI 10.2337/diacare.25.12.2238; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Davies M, 2008, HDB VASCULAR RISK AS; Department of Health, 2008, EC MOD VASC CHECKS; Eddy DM, 2003, DIABETES CARE, V26, P3102, DOI 10.2337/diacare.26.11.3102; Eddy DM, 2003, DIABETES CARE, V26, P3093, DOI 10.2337/diacare.26.11.3093; Eddy DM, 2005, ANN INTERN MED, V143, P251, DOI 10.7326/0003-4819-143-4-200508160-00006; Ferguson J, 2005, ADDICTION, V100, P59, DOI 10.1111/j.1360-0443.2005.01028.x; Gillies CL, 2008, BMJ-BRIT MED J, V336, P1180, DOI 10.1136/bmj.39545.585289.25; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Jebb SA, 2011, LANCET, V378, P1485, DOI 10.1016/S0140-6736(11)61344-5; [Joint National Committee on Prevention D Evaluation and Treatment of High Blood Pressure National Institutes of Health N], 2003, NIH PUBLICATION; Kahn R, 2010, LANCET, V375, P1365, DOI 10.1016/S0140-6736(09)62162-0; Kanavos P, 2012, DIABETES EXPENDITURE; Lader D, 2007, 32 OFF NAT STAT; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; NHS Health Check Programme, 2009, PUTT PREV 1 NHS HLTH; Palmer AJ, 2007, DIABETES CARE, V30, P1638, DOI 10.2337/dc07-9919; Rahman M, 2008, FAM PRACT, V25, P191, DOI 10.1093/fampra/cmn024; SCHWARZ PE, 2012, NAT REV ENDOCRINOL, V8, P363, DOI [DOI 10.1038/NRENDO.2011.232, DOI 10.1038/nrendo.2011.232]; Spijkerman AMW, 2003, DIABETES CARE, V26, P2604, DOI 10.2337/diacare.26.9.2604; Sullivan PW, 2006, MED DECIS MAKING, V26, P401, DOI 10.1177/0272989X06290496; Tsai AG, 2005, ANN INTERN MED, V142, P56, DOI 10.7326/0003-4819-142-1-200501040-00012; World Health Organization, 2004, ATLAS HEART DIS STRO	33	33	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2013	8	7							e66454	10.1371/journal.pone.0066454	http://dx.doi.org/10.1371/journal.pone.0066454			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZN	23869204	gold, Green Published, Green Submitted			2022-12-27	WOS:000323110600003
J	Skinner, MK; Haque, CGBM; Nilsson, E; Bhandari, R; McCarrey, JR				Skinner, Michael K.; Haque, Carlos Guerrero-Bosagna M.; Nilsson, Eric; Bhandari, Ramji; McCarrey, John R.			Environmentally Induced Transgenerational Epigenetic Reprogramming of Primordial Germ Cells and the Subsequent Germ Line	PLOS ONE			English	Article							ENDOCRINE DISRUPTOR VINCLOZOLIN; DNA METHYLATION; INHERITANCE; DISEASE; RECEPTOR; SPERM; SPERMATOGENESIS; TRANSCRIPTOME; MECHANISMS; INHIBITION	A number of environmental factors (e.g. toxicants) have been shown to promote the epigenetic transgenerational inheritance of disease and phenotypic variation. Transgenerational inheritance requires the germline transmission of altered epigenetic information between generations in the absence of direct environmental exposures. The primary periods for epigenetic programming of the germ line are those associated with primordial germ cell development and subsequent fetal germline development. The current study examined the actions of an agricultural fungicide vinclozolin on gestating female (F0 generation) progeny in regards to the primordial germ cell (PGC) epigenetic reprogramming of the F3 generation (i.e. great-grandchildren). The F3 generation germline transcriptome and epigenome (DNA methylation) were altered transgenerationally. Interestingly, disruptions in DNA methylation patterns and altered transcriptomes were distinct between germ cells at the onset of gonadal sex determination at embryonic day 13 (E13) and after cord formation in the testis at embryonic day 16 (E16). A larger number of DNA methylation abnormalities (epimutations) and transcriptional alterations were observed in the E13 germ cells than in the E16 germ cells. These observations indicate that altered transgenerational epigenetic reprogramming and function of the male germline is a component of vinclozolin induced epigenetic transgenerational inheritance of disease. Insights into the molecular control of germline transmitted epigenetic inheritance are provided.	[Skinner, Michael K.; Haque, Carlos Guerrero-Bosagna M.; Nilsson, Eric; Bhandari, Ramji] Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA 99164 USA; [McCarrey, John R.] Univ Texas San Antonio, Dept Biol, San Antonio, TX USA	Washington State University; University of Texas System; University of Texas at San Antonio (UTSA)	Skinner, MK (corresponding author), Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA 99164 USA.	skinner@wsu.edu	Nilsson, Eric/AAR-5021-2020	Guerrero-Bosagna, Carlos/0000-0003-1935-5875	NIH NIEHS	NIH NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by a NIH NIEHS grant to MKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anway MD, 2008, PROSTATE, V68, P517, DOI 10.1002/pros.20724; Anway MD, 2006, J ANDROL, V27, P868, DOI 10.2164/jandrol.106.000349; Anway MD, 2006, ENDOCRINOLOGY, V147, P5515, DOI 10.1210/en.2006-0640; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Bruner-Tran KL, 2011, REPROD TOXICOL, V31, P344, DOI 10.1016/j.reprotox.2010.10.003; Burdge GC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028282; Burns JG, 2010, J EVOLUTION BIOL, V23, P678, DOI 10.1111/j.1420-9101.2010.01932.x; Champagne FA, 2008, FRONT NEUROENDOCRIN, V29, P386, DOI 10.1016/j.yfrne.2008.03.003; CLERMONT Y, 1972, PHYSIOL REV, V52, P198, DOI 10.1152/physrev.1972.52.1.198; Clowney EJ, 2011, GENOME RES, V21, P1249, DOI 10.1101/gr.120162.110; Cornwall GA, 2009, HUM REPROD UPDATE, V15, P213, DOI 10.1093/humupd/dmn055; Crews D, 2007, P NATL ACAD SCI USA, V104, P5942, DOI 10.1073/pnas.0610410104; Crews D, 2012, P NATL ACAD SCI USA, V109, P9143, DOI 10.1073/pnas.1118514109; de Assis S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2058; Doyle TJ, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.106104; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; EISENHART C, 1947, BIOMETRICS, V3, P1, DOI 10.2307/3001534; Filipponi D, 2009, EPIGENETICS-US, V4, P27, DOI 10.4161/epi.4.1.7311; Frith MC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000071; Greer EL, 2011, NATURE, V479, P365, DOI 10.1038/nature10572; Guerrero-Bosagna C, 2012, REPROD TOXICOL, V34, P694, DOI 10.1016/j.reprotox.2012.09.005; Guerrero-Bosagna C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013100; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hajkova P, 2011, PHILOS T R SOC B, V366, P2266, DOI 10.1098/rstb.2011.0042; Hammoud SS, 2011, HUM REPROD, V26, P2558, DOI 10.1093/humrep/der192; Hauser MT, 2011, BBA-GENE REGUL MECH, V1809, P459, DOI 10.1016/j.bbagrm.2011.03.007; Hemberger M, 2009, NAT REV MOL CELL BIO, V10, P526, DOI 10.1038/nrm2727; Hwang Gi-Wook, 2007, Journal of Toxicological Sciences, V32, P581, DOI 10.2131/jts.32.581; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; Kalivoda EJ, 2010, RES MICROBIOL, V161, P158, DOI 10.1016/j.resmic.2009.12.004; Kavlock R, 2005, CRIT REV TOXICOL, V35, P721, DOI 10.1080/10408440591007377; Levine E, 2000, BIOL REPROD, V62, P477, DOI 10.1095/biolreprod62.3.477; Magnusdottir E, 2012, CURR OPIN GENET DEV, V22, P466, DOI 10.1016/j.gde.2012.06.002; Manikkam M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055387; Manikkam M, 2012, REPROD TOXICOL, V34, P708, DOI 10.1016/j.reprotox.2012.08.010; Manikkam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046249; Manikkam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031901; MCCARREY JR, 1992, DEV BIOL, V154, P160, DOI 10.1016/0012-1606(92)90056-M; McClintock TS, 2010, CHEM SENSES, V35, P447, DOI 10.1093/chemse/bjq041; McLaren A, 1998, INT J DEV BIOL, V42, P855; Mochizuki K, 2010, DEV GROWTH DIFFER, V52, P517, DOI 10.1111/j.1440-169X.2010.01190.x; Murakami Y, 2012, J BIOL CHEM, V287, P6318, DOI 10.1074/jbc.M111.331090; Nilsson E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036129; Nilsson EE, 2008, REPRODUCTION, V135, P713, DOI 10.1530/REP-07-0542; Painter RC, 2008, BJOG-INT J OBSTET GY, V115, P1243, DOI 10.1111/j.1471-0528.2008.01822.x; Pancetti A, 2001, FEMS MICROBIOL LETT, V197, P203, DOI 10.1016/S0378-1097(01)00106-9; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Pepling ME, 2006, GENESIS, V44, P622, DOI 10.1002/dvg.20258; Poole A, 2001, NAT REV MOL CELL BIO, V2, P147, DOI 10.1038/35052091; Rechavi O, 2011, CELL, V147, P1248, DOI 10.1016/j.cell.2011.10.042; Reeves R, 2000, ENVIRON HEALTH PERSP, V108, P803, DOI 10.2307/3454310; RUSSELL LD, 1985, INT REV CYTOL, V94, P177, DOI 10.1016/S0074-7696(08)60397-6; Salian S, 2009, LIFE SCI, V85, P11, DOI 10.1016/j.lfs.2009.04.005; Seisenberger S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0330; Sharma A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005763; Skinner MK, 2008, REPROD TOXICOL, V25, P2, DOI 10.1016/j.reprotox.2007.09.001; Skinner MK, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R91, 10.1186/gb-2012-13-10-r91]; Skinner MK, 2011, EPIGENETICS-US, V6, P838, DOI 10.4161/epi.6.7.16537; Skinner MK, 2010, TRENDS ENDOCRIN MET, V21, P214, DOI 10.1016/j.tem.2009.12.007; Skinner MK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003745; Spehr M, 2006, MOL CELL ENDOCRINOL, V250, P128, DOI 10.1016/j.mce.2005.12.035; Surani MA, 2010, COLD SH Q B, V75, P211, DOI 10.1101/sqb.2010.75.010; Takahashi M, 1996, EMBO J, V15, P4254, DOI 10.1002/j.1460-2075.1996.tb00800.x; Takeda S, 2006, CHROMOSOMA, V115, P27, DOI 10.1007/s00412-005-0031-7; Tracey R, 2013, REPROD TOXICOL, V36, P104, DOI 10.1016/j.reprotox.2012.11.011; Uzumcu M, 2004, REPROD TOXICOL, V18, P765, DOI 10.1016/j.reprotox.2004.05.008; Wilhelm D, 2007, PHYSIOL REV, V87, P1, DOI 10.1152/physrev.00009.2006; Williamson NR, 2006, J IND MICROBIOL BIOT, V33, P151, DOI 10.1007/s10295-005-0040-9; Yamazaki Y, 2005, P NATL ACAD SCI USA, V102, P11361, DOI 10.1073/pnas.0504943102	70	149	153	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2013	8	7							e66318	10.1371/journal.pone.0066318	http://dx.doi.org/10.1371/journal.pone.0066318			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZN	23869203	gold, Green Published, Green Submitted			2022-12-27	WOS:000323110600002
J	el Barzouhi, A; Vleggeert-Lankamp, CLAM; Nijeholt, GJLA; Van der Kallen, BF; Van den Hout, WB; Verwoerd, AJH; Koes, BW; Peul, WC				el Barzouhi, Abdelilah; Vleggeert-Lankamp, Carmen L. A. M.; Nijeholt, Geert J. Lycklama A.; Van der Kallen, Bas F.; Van den Hout, Wilbert B.; Verwoerd, Annemieke J. H.; Koes, Bart W.; Peul, Wilco C.		Leiden-The Hague Spine Interventio	Magnetic Resonance Imaging Interpretation in Patients with Sciatica Who Are Potential Candidates for Lumbar Disc Surgery	PLOS ONE			English	Article							PROLONGED CONSERVATIVE TREATMENT; OBSERVER VARIABILITY; BACK-PAIN; SPINE; RELIABILITY; HERNIATION; AGREEMENT; DISEASE; CLASSIFICATION; DIAGNOSIS	Background: Magnetic Resonance Imaging (MRI) is considered the mainstay imaging investigation in patients suspected of lumbar disc herniations. Both imaging and clinical findings determine the final decision of surgery. The objective of this study was to assess MRI observer variation in patients with sciatica who are potential candidates for lumbar disc surgery. Methods: Patients for this study were potential candidates (n = 395) for lumbar disc surgery who underwent MRI to assess eligibility for a randomized trial. Two neuroradiologists and one neurosurgeon independently evaluated all MRIs. A four point scale was used for both probability of disc herniation and root compression, ranging from definitely present to definitely absent. Multiple characteristics of the degenerated disc herniation were scored. For inter-agreement analysis absolute agreements and kappa coefficients were used. Kappa coefficients were categorized as poor (<0.00), slight (0.00-0.20), fair (0.21-0.40), moderate (0.41-0.60), substantial (0.61-0.80) and excellent (0.81-1.00) agreement. Results: Excellent agreement was found on the affected disc level (kappa range 0.81-0.86) and the nerve root that most likely caused the sciatic symptoms (kappa range 0.86-0.89). Interobserver agreement was moderate to substantial for the probability of disc herniation (kappa range 0.57-0.77) and the probability of nerve root compression (kappa range 0.42-0.69). Absolute pairwise agreement among the readers ranged from 90-94% regarding the question whether the probability of disc herniation on MRI was above or below 50%. Generally, moderate agreement was observed regarding the characteristics of the symptomatic disc level and of the herniated disc. Conclusion: The observer variation of MRI interpretation in potential candidates for lumbar disc surgery is satisfactory regarding characteristics most important in decision for surgery. However, there is considerable variation between observers in specific characteristics of the symptomatic disc level and herniated disc.	[el Barzouhi, Abdelilah; Vleggeert-Lankamp, Carmen L. A. M.; Peul, Wilco C.] Leiden Univ Med Ctr, Dept Neurosurg, Leiden, Netherlands; [Nijeholt, Geert J. Lycklama A.; Van der Kallen, Bas F.] Med Ctr Haaglanden, Dept Radiol, The Hague, Netherlands; [Van den Hout, Wilbert B.] Leiden Univ Med Ctr, Dept Med Decis Making, Leiden, Netherlands; [Verwoerd, Annemieke J. H.; Koes, Bart W.] Univ Med Ctr, ErasmusMC, Dept Gen Practice, Rotterdam, Netherlands; [Peul, Wilco C.] Med Ctr Haaglanden, Dept Neurosurg, The Hague, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Haaglanden Medical Center; Leiden University; Leiden University Medical Center (LUMC); Erasmus University Rotterdam; Erasmus MC; Haaglanden Medical Center	el Barzouhi, A (corresponding author), Leiden Univ Med Ctr, Dept Neurosurg, Leiden, Netherlands.	A.el_barzouhi@lumc.nl	Vleggeert-Lankamp, Carmen/AGX-9660-2022; Koes, Bart w/K-4614-2016	Vleggeert-Lankamp, Carmen/0000-0001-9597-7225; Koes, Bart w/0000-0002-0450-9969; van den Hout, Wilbert B./0000-0002-6425-0135	Netherlands Organisation for Health Research and Development (ZonMW); Hoelen Foundation, The Hague	Netherlands Organisation for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); Hoelen Foundation, The Hague	Sponsors of the study: a grant from the Netherlands Organisation for Health Research and Development (ZonMW) and the Hoelen Foundation, The Hague. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, NEUROLOGY, V44, P767; Arana E, 2010, RADIOLOGY, V254, P809, DOI 10.1148/radiol.09090706; Bejia I, 2004, JOINT BONE SPINE, V71, P567, DOI 10.1016/j.jbspin.2004.01.008; BODEN SD, 1990, J BONE JOINT SURG AM, V72A, P403, DOI 10.2106/00004623-199072030-00013; Boos N, 1995, SPINE, V20, P2613, DOI 10.1097/00007632-199512150-00002; BRENNAN P, 1992, BMJ-BRIT MED J, V304, P1491, DOI 10.1136/bmj.304.6840.1491; Brouwer S, 2003, J OCCUP REHABIL, V13, P207, DOI 10.1023/A:1026264519996; Carlisle Elliot, 2005, Spine J, V5, P608, DOI 10.1016/j.spinee.2005.05.384; Carragee EJ, 1997, SPINE, V22, P1650, DOI 10.1097/00007632-199707150-00025; Carrino JA, 2009, RADIOLOGY, V250, P161, DOI 10.1148/radiol.2493071999; Cheng F, 2010, CAN FAM PHYSICIAN, V56, pE323; Cihangiroglu M, 2004, EUR J RADIOL, V51, P202, DOI 10.1016/j.ejrad.2003.08.004; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Fardon D F, 2001, Spine (Phila Pa 1976), V26, pE93, DOI 10.1097/00007632-200103010-00006; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L; Findlay GF, 1998, SPINE, V23, P1168, DOI 10.1097/00007632-199805150-00019; Fleiss J, 2003, STAT METHODS RATES P; GJORUP T, 1988, METHOD INFORM MED, V27, P184; Jarvik JG, 2009, RADIOLOGY, V250, P15, DOI 10.1148/radiol.2493081458; Jarvik JG, 1996, ACAD RADIOL, V3, P537, DOI 10.1016/S1076-6332(96)80214-5; Jarvik JJ, 2001, SPINE, V26, P1158, DOI 10.1097/00007632-200105150-00014; JENSEN MC, 1994, NEW ENGL J MED, V331, P69, DOI 10.1056/NEJM199407143310201; Kim SW, 2009, CLIN ORTHOP SURG, V1, P34, DOI 10.4055/cios.2009.1.1.34; Koes BW, 2007, BMJ-BRIT MED J, V334, P1313, DOI 10.1136/bmj.39223.428495.BE; Korres D S, 1992, Eur Spine J, V1, P20, DOI 10.1007/BF00302137; Kovacs FM, 2009, ACTA RADIOL, V50, P497, DOI 10.1080/02841850902838074; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lurie JD, 2008, SPINE, V33, P991, DOI 10.1097/BRS.0b013e31816c8379; Lurie JD, 2009, SPINE, V34, P701, DOI 10.1097/BRS.0b013e31819b390e; LYNN MR, 1986, NURS RES, V35, P382; Milette PC, 2001, AM J NEURORADIOL, V22, P428; MODIC MT, 1988, RADIOLOGY, V168, P177, DOI 10.1148/radiology.168.1.3289089; MODIC MT, 1988, RADIOLOGY, V166, P193, DOI 10.1148/radiology.166.1.3336678; Mulconrey Daniel S, 2006, Spine J, V6, P177, DOI 10.1016/j.spinee.2005.08.011; Peul WC, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-8; Peul WC, 2008, BRIT MED J, V336, P1355, DOI 10.1136/bmj.a143; Peul WC, 2007, NEW ENGL J MED, V356, P2245, DOI 10.1056/NEJMoa064039; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Ross JS, 2010, RADIOLOGY, V254, P640, DOI 10.1148/radiol.09092250; Sorensen JS, 2006, ACTA RADIOL, V47, P947, DOI 10.1080/02841850600965062; van Rijn JC, 2006, BRIT J RADIOL, V79, P372, DOI 10.1259/bjr/26216335; van Rijn JC, 2005, AM J ROENTGENOL, V184, P299, DOI 10.2214/ajr.184.1.01840299; Vucetic N, 1999, CLIN ORTHOP RELAT R, P116	44	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68411	10.1371/journal.pone.0068411	http://dx.doi.org/10.1371/journal.pone.0068411			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874616	Green Published, gold, Green Submitted			2022-12-27	WOS:000321765300048
J	Leman, M; Moelants, D; Varewyck, M; Styns, F; van Noorden, L; Martens, JP				Leman, Marc; Moelants, Dirk; Varewyck, Matthias; Styns, Frederik; van Noorden, Leon; Martens, Jean-Pierre			Activating and Relaxing Music Entrains the Speed of Beat Synchronized Walking	PLOS ONE			English	Article							NOT-EQUAL-TEMPO; NEURONAL ENTRAINMENT; ATTENTIONAL FOCUS; MOTOR BEHAVIOR; PERCEPTION; METER; DISSOCIATIONS; PATTERNS; STRENGTH; PREMOTOR	Inspired by a theory of embodied music cognition, we investigate whether music can entrain the speed of beat synchronized walking. If human walking is in synchrony with the beat and all musical stimuli have the same duration and the same tempo, then differences in walking speed can only be the result of music-induced differences in stride length, thus reflecting the vigor or physical strength of the movement. Participants walked in an open field in synchrony with the beat of 52 different musical stimuli all having a tempo of 130 beats per minute and a meter of 4 beats. The walking speed was measured as the walked distance during a time interval of 30 seconds. The results reveal that some music is 'activating' in the sense that it increases the speed, and some music is 'relaxing' in the sense that it decreases the speed, compared to the spontaneous walked speed in response to metronome stimuli. Participants are consistent in their observation of qualitative differences between the relaxing and activating musical stimuli. Using regression analysis, it was possible to set up a predictive model using only four sonic features that explain 60% of the variance. The sonic features capture variation in loudness and pitch patterns at periods of three, four and six beats, suggesting that expressive patterns in music are responsible for the effect. The mechanism may be attributed to an attentional shift, a subliminal audio-motor entrainment mechanism, or an arousal effect, but further study is needed to figure this out. Overall, the study supports the hypothesis that recurrent patterns of fluctuation affecting the binary meter strength of the music may entrain the vigor of the movement. The study opens up new perspectives for understanding the relationship between entrainment and expressiveness, with the possibility to develop applications that can be used in domains such as sports and physical rehabilitation.	[Leman, Marc; Moelants, Dirk; Styns, Frederik; van Noorden, Leon] Univ Ghent, Inst Psychoacoust & Elect Mus, Dept Musicol, B-9000 Ghent, Belgium; [Varewyck, Matthias; Martens, Jean-Pierre] Univ Ghent, Dept Elect & Informat Syst, B-9000 Ghent, Belgium	Ghent University; Ghent University	Leman, M (corresponding author), Univ Ghent, Inst Psychoacoust & Elect Mus, Dept Musicol, B-9000 Ghent, Belgium.	marc.leman@ugent.be			Flemish Government, Belgium; Ghent University	Flemish Government, Belgium; Ghent University(Ghent University)	Funding by a Methusalem grant from the Flemish Government, Belgium, and a BOF grant from Ghent University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauldoff GS, 2002, CHEST, V122, P948, DOI 10.1378/chest.122.3.948; Baumann S, 2007, BRAIN RES, V1161, P65, DOI 10.1016/j.brainres.2007.05.045; Bengtsson SL, 2009, CORTEX, V45, P62, DOI 10.1016/j.cortex.2008.07.002; Bieber G, 2006, MST NEWS, V3, P31; BROWNLEY KA, 1995, INT J PSYCHOPHYSIOL, V19, P193, DOI 10.1016/0167-8760(95)00007-F; Chen JL, 2008, CEREB CORTEX, V18, P2844, DOI 10.1093/cercor/bhn042; Edworthy J, 2006, ERGONOMICS, V49, P1597, DOI 10.1080/00140130600899104; Grahn JA, 2009, J NEUROSCI, V29, P7540, DOI 10.1523/JNEUROSCI.2018-08.2009; James CE, 2012, HUM BRAIN MAPP, V33, P2751, DOI 10.1002/hbm.21397; Karageorghis C, 2008, INT J SPORTS MED, V29, P613, DOI 10.1055/s-2007-989266; Karageorghis CI, 2010, PSYCHOL SPORT EXERC, V11, P551, DOI 10.1016/j.psychsport.2010.06.004; Karageorghis CI, 2009, J SPORT EXERCISE PSY, V31, P18, DOI 10.1123/jsep.31.1.18; Large EW, 2009, ANN NY ACAD SCI, V1169, P46, DOI 10.1111/j.1749-6632.2009.04550.x; Large EW, 1999, PSYCHOL REV, V106, P119, DOI 10.1037/0033-295X.106.1.119; LEMAN M, 2008, EMBODIED MUSIC COGNI; Leman M, 2012, EMPIR MUSICOL REV, V7, P64; Leman M, 2010, MUSIC PERCEPT, V28, P71, DOI 10.1525/MP.2010.28.1.71; Lesaffre M, 2008, J AM SOC INF SCI TEC, V59, P695, DOI 10.1002/asi.20731; Lim I, 2005, CLIN REHABIL, V19, P695, DOI 10.1191/0269215505cr906oa; London J, 2011, EMPIR MUSICOL REV, V6, P43, DOI 10.18061/1811/49761; MacDougall HG, 2005, J APPL PHYSIOL, V99, P1164, DOI 10.1152/japplphysiol.00138.2005; Maes PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054682; McKinney MF, 2007, J NEW MUSIC RES, V36, P1, DOI 10.1080/09298210701653252; McKinney MF, 2006, MUSIC PERCEPT, V24, P155, DOI 10.1525/mp.2006.24.2.155; McNeill W. H., 1995, KEEPING TOGETHER TIM; Moens B, 2010, P 7 SOUND MUS COMP C, P451; MURRAY MP, 1964, J BONE JOINT SURG AM, V46, P335, DOI 10.2106/00004623-196446020-00009; Naveda L, 2010, MUSIC PERCEPT, V28, P93, DOI 10.1525/MP.2010.28.1.93; Nozaradan S, 2012, J NEUROSCI, V32, P17572, DOI 10.1523/JNEUROSCI.3203-12.2012; Nozaradan S, 2011, J NEUROSCI, V31, P10234, DOI 10.1523/JNEUROSCI.0411-11.2011; Ranganathan VK, 2004, NEUROPSYCHOLOGIA, V42, P944, DOI 10.1016/j.neuropsychologia.2003.11.018; Reiser M, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00194; Repp B. H., 2013, PSYCHONOMIC B REV; Repp BH, 2011, EMPIR MUSICOL REV, V6, P56, DOI 10.18061/1811/49762; Roerdink M, 2009, NEUROREHAB NEURAL RE, V23, P668, DOI 10.1177/1545968309332879; Sevdalis V, 2011, BRAIN COGNITION, V77, P231, DOI 10.1016/j.bandc.2011.08.005; Simpson SD, 2006, J SPORT SCI, V24, P1095, DOI 10.1080/02640410500432789; Styns F, 2007, HUM MOVEMENT SCI, V26, P769, DOI 10.1016/j.humov.2007.07.007; Tenenbaum G, 2004, PSYCHOL SPORT EXERC, V5, P89, DOI 10.1016/S1469-0292(02)00041-9; Thaut MH, 1997, J NEUROL SCI, V151, P207, DOI 10.1016/S0022-510X(97)00146-9; Toiviainen P, 2010, MUSIC PERCEPT, V28, P59, DOI 10.1525/MP.2010.28.1.59; Van Dyck E, 2013, MUSIC PERCEPTION, V30; van Noorden L, 1999, J NEW MUSIC RES, V28, P43, DOI 10.1076/jnmr.28.1.43.3122; Varewyck M, J NEW MUSIC IN PRESS; Varma S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-91; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152	46	86	86	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e67932	10.1371/journal.pone.0067932	http://dx.doi.org/10.1371/journal.pone.0067932			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	182SU	23874469	gold, Green Submitted, Green Published			2022-12-27	WOS:000321765300018
J	Howard, LR; Kumaran, D; Olafsdottir, HF; Spiers, HJ				Howard, Lorelei R.; Kumaran, Dharshan; Olafsdottir, H. Freyja; Spiers, Hugo J.			Dissociation between Dorsal and Ventral Posterior Parietal Cortical Responses to Incidental Changes in Natural Scenes	PLOS ONE			English	Article							EPISODIC MEMORY RETRIEVAL; SHORT-TERM-MEMORY; HUMAN BRAIN; INDIVIDUAL-DIFFERENCES; ATTENTIVE TRACKING; NEURAL MECHANISMS; LOBE CONTRIBUTION; CHANGE BLINDNESS; OBJECT IDENTITY; MOVING TARGETS	Background: The posterior parietal cortex (PPC) is thought to interact with the medial temporal lobe (MTL) to support spatial cognition and topographical memory. While the response of medial temporal lobe regions to topographical stimuli has been intensively studied, much less research has focused on the role of PPC and its functional connectivity with the medial temporal lobe. Methodology/Principle Findings: Here we report a dissociation between dorsal and ventral regions of PPC in response to different types of change in natural scenes using an fMRI adaptation paradigm. During scanning subjects performed an incidental target detection task whilst viewing trial unique sequentially presented pairs of natural scenes, each containing a single prominent object. We observed a dissociation between the superior parietal gyrus and the angular gyrus, with the former showing greater sensitivity to spatial change, and the latter showing greater sensitivity to scene novelty. In addition, we observed that the parahippocampal cortex has increased functional connectivity with the angular gyrus, but not superior parietal gyrus, when subjects view change to the scene content. Conclusions/Significance: Our findings provide support for proposed dissociations between dorsal and ventral regions of PPC and suggest that the dorsal PPC may support the spatial coding of the visual environment even when this information is incidental to the task at hand. Further, through revealing the differential functional interactions of the SPG and AG with the MTL our results help advance our understanding of how the MTL and PPC cooperate to update representations of the world around us.	[Howard, Lorelei R.; Olafsdottir, H. Freyja; Spiers, Hugo J.] UCL, Div Psychol & Language Sci, Res Dept Cognit Perceptual & Brain Sci, Inst Behav Neurosci, London, England; [Kumaran, Dharshan] UCL, Inst Cognit Neurosci, London, England	University of London; University College London; University of London; University College London	Spiers, HJ (corresponding author), UCL, Div Psychol & Language Sci, Res Dept Cognit Perceptual & Brain Sci, Inst Behav Neurosci, London, England.	h.spiers@ucl.ac.uk	Spiers, Hugo J/E-4448-2014	Spiers, Hugo J/0000-0002-6792-6356; Olafsdottir, Freyja/0000-0003-2416-0589	BBSRC, UK studentship; Wellcome Trust Advanced Training Fellowship; James S. McDonnell Foundation Scholar Award	BBSRC, UK studentship; Wellcome Trust Advanced Training Fellowship(Wellcome Trust); James S. McDonnell Foundation Scholar Award	This research was supported by a BBSRC, UK studentship to LRH and a Wellcome Trust Advanced Training Fellowship and a James S. McDonnell Foundation Scholar Award to H.J.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre GK, 1999, BRAIN, V122, P1613, DOI 10.1093/brain/122.9.1613; Ally BA, 2008, NEUROPSYCHOLOGIA, V46, P1800, DOI 10.1016/j.neuropsychologia.2008.02.026; Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Beck DM, 2006, CEREB CORTEX, V16, P712, DOI 10.1093/cercor/bhj017; Beck DM, 2001, NAT NEUROSCI, V4, P645, DOI 10.1038/88477; Behrmann M, 2004, CURR OPIN NEUROBIOL, V14, P212, DOI 10.1016/j.conb.2004.03.012; Bergstrom ZM, 2013, NEUROIMAGE, V68, P141, DOI 10.1016/j.neuroimage.2012.11.030; Braddick OJ, 2001, PERCEPTION, V30, P61, DOI 10.1068/p3048; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Brown TI, 2010, J NEUROSCI, V30, P7414, DOI 10.1523/JNEUROSCI.6021-09.2010; Buchel C, 1998, BRAIN, V121, P1281, DOI 10.1093/brain/121.7.1281; Burgess N, 2001, NEUROIMAGE, V14, P439, DOI 10.1006/nimg.2001.0806; Byrne P, 2007, PSYCHOL REV, V114, P340, DOI 10.1037/0033-295X.114.2.340; Cabeza R, 2008, NAT REV NEUROSCI, V9, P613, DOI 10.1038/nrn2459; Castelhano MS, 2008, CAN J EXP PSYCHOL, V62, P1, DOI 10.1037/1196-1961.62.1.1; Constantinidis C, 2001, CEREB CORTEX, V11, P592, DOI 10.1093/cercor/11.7.592; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Culham JC, 1998, J NEUROPHYSIOL, V80, P2657, DOI 10.1152/jn.1998.80.5.2657; Dobbins IG, 2012, NEUROPSYCHOLOGIA, V50, P2992, DOI 10.1016/j.neuropsychologia.2012.07.037; Epstein R, 2003, NEURON, V37, P865, DOI 10.1016/S0896-6273(03)00117-X; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Epstein RA, 2005, J COGNITIVE NEUROSCI, V17, P73, DOI 10.1162/0898929052879987; Epstein RA, 2008, TRENDS COGN SCI, V12, P388, DOI 10.1016/j.tics.2008.07.004; Friston KJ, 2004, NEUROIMAGE, V23, P21, DOI 10.1016/j.neuroimage.2004.04.021; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Goh JOS, 2004, J NEUROSCI, V24, P10223, DOI 10.1523/JNEUROSCI.3373-04.2004; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Grosbras MN, 2005, HUM BRAIN MAPP, V25, P140, DOI 10.1002/hbm.20145; Harrison A, 2010, CEREB CORTEX, V20, P2478, DOI 10.1093/cercor/bhp314; Hartley T, 2003, NEURON, V37, P877, DOI 10.1016/S0896-6273(03)00095-3; Henderson JM, 2007, EXP BRAIN RES, V179, P75, DOI 10.1007/s00221-006-0766-2; Howard LR, 2011, J NEUROSCI, V31, P5253, DOI 10.1523/JNEUROSCI.6055-10.2011; Husain M, 2007, TRENDS COGN SCI, V11, P30, DOI 10.1016/j.tics.2006.10.011; Hutchinson JB, 2009, LEARN MEMORY, V16, P343, DOI 10.1101/lm.919109; Jahn G, 2012, BRAIN COGNITION, V78, P105, DOI 10.1016/j.bandc.2011.12.001; King JA, 2005, NEUROIMAGE, V28, P256, DOI 10.1016/j.neuroimage.2005.05.057; Konen CS, 2008, NAT NEUROSCI, V11, P224, DOI 10.1038/nn2036; Kumaran D, 2005, J NEUROSCI, V25, P7254, DOI 10.1523/JNEUROSCI.1103-05.2005; Kumaran D, 2007, NEUROPSYCHOLOGIA, V45, P2699, DOI 10.1016/j.neuropsychologia.2007.04.007; Kumaran D, 2007, J NEUROSCI, V27, P8517, DOI 10.1523/JNEUROSCI.1677-07.2007; Kumaran D, 2007, HIPPOCAMPUS, V17, P735, DOI 10.1002/hipo.20326; Kumaran D, 2006, PLOS BIOL, V4, P2372, DOI 10.1371/journal.pbio.0040424; Kumaran D, 2009, TRENDS COGN SCI, V13, P47, DOI 10.1016/j.tics.2008.11.004; Lambrey S, 2012, CEREB CORTEX, V22, P166, DOI 10.1093/cercor/bhr101; Lancaster JL, 2007, HUM BRAIN MAPP, V28, P1194, DOI 10.1002/hbm.20345; Mantini D, 2011, J NEUROSCI, V31, P12954, DOI 10.1523/JNEUROSCI.2318-11.2011; Marois R, 2000, NEURON, V25, P717, DOI 10.1016/S0896-6273(00)81073-9; Moscovitch M, 2005, J ANAT, V207, P35, DOI 10.1111/j.1469-7580.2005.00421.x; Nelson SM, 2010, NEURON, V67, P156, DOI 10.1016/j.neuron.2010.05.025; Pihlajamaki M, 2004, EUR J NEUROSCI, V19, P1939, DOI 10.1111/j.1460-9568.2004.03282.x; Ranganath C, 2003, NAT REV NEUROSCI, V4, P193, DOI 10.1038/nrn1052; Ranganath C, 2012, NAT REV NEUROSCI, V13, P713, DOI 10.1038/nrn3338; Rauchs G, 2008, HIPPOCAMPUS, V18, P503, DOI 10.1002/hipo.20411; Rosenbaum RS, 2004, HIPPOCAMPUS, V14, P826, DOI 10.1002/hipo.10218; Rushworth MFS, 2006, CEREB CORTEX, V16, P1418, DOI 10.1093/cercor/bhj079; Schacter DL, 1999, HIPPOCAMPUS, V9, P7, DOI 10.1002/(SICI)1098-1063(1999)9:1<7::AID-HIPO2>3.0.CO;2-K; Sestieri C, 2011, J NEUROSCI, V31, P4407, DOI 10.1523/JNEUROSCI.3335-10.2011; Simons JS, 2008, NEUROPSYCHOLOGIA, V46, P1739, DOI 10.1016/j.neuropsychologia.2008.05.001; Simons JS, 2008, NEUROPSYCHOLOGIA, V46, P1185, DOI 10.1016/j.neuropsychologia.2007.07.024; Simons JS, 2010, CEREB CORTEX, V20, P479, DOI 10.1093/cercor/bhp116; Spiers HJ, 2007, TRENDS COGN SCI, V11, P356, DOI 10.1016/j.tics.2007.06.002; Spiers HJ, 2006, NEUROIMAGE, V31, P1826, DOI 10.1016/j.neuroimage.2006.01.037; STEINMETZ MA, 1995, CEREB CORTEX, V5, P448, DOI 10.1093/cercor/5.5.448; Stern CE, 1996, P NATL ACAD SCI USA, V93, P8660, DOI 10.1073/pnas.93.16.8660; Uncapher MR, 2009, NEUROBIOL LEARN MEM, V91, P139, DOI 10.1016/j.nlm.2008.10.011; Vann SD, 2009, NAT REV NEUROSCI, V10, P792, DOI 10.1038/nrn2733; Vilberg KL, 2008, NEUROPSYCHOLOGIA, V46, P1787, DOI 10.1016/j.neuropsychologia.2008.01.004; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Vinogradova OS, 2001, HIPPOCAMPUS, V11, P578, DOI 10.1002/hipo.1073; Vogel EK, 2005, NATURE, V438, P500, DOI 10.1038/nature04171; Vuilleumier P, 2002, NAT NEUROSCI, V5, P491, DOI 10.1038/nn839; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001; Wolbers T, 2004, COGNITIVE BRAIN RES, V21, P401, DOI 10.1016/j.cogbrainres.2004.06.013; Wolbers T, 2005, J NEUROSCI, V25, P3333, DOI 10.1523/JNEUROSCI.4705-04.2005; Xu YD, 2006, NATURE, V440, P91, DOI 10.1038/nature04262; Yazar Y, 2012, CORTEX, V48, P1381, DOI 10.1016/j.cortex.2012.05.011; Zhang H., 2012, HUM BRAIN MAPP; Zhang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044886	81	13	13	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e67988	10.1371/journal.pone.0067988	http://dx.doi.org/10.1371/journal.pone.0067988			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874482	Green Published, Green Submitted, gold			2022-12-27	WOS:000321736900042
J	Zakharkina, T; Heinzel, E; Koczulla, RA; Greulich, T; Rentz, K; Pauling, JK; Baumbach, J; Herrmann, M; Grunewald, C; Dienemann, H; von Muller, L; Bals, R				Zakharkina, Tetyana; Heinzel, Elke; Koczulla, Rembert A.; Greulich, Timm; Rentz, Katharina; Pauling, Josch K.; Baumbach, Jan; Herrmann, Mathias; Gruenewald, Christiane; Dienemann, Hendrik; von Mueller, Lutz; Bals, Robert			Analysis of the Airway Microbiota of Healthy Individuals and Patients with Chronic Obstructive Pulmonary Disease by T-RFLP and Clone Sequencing	PLOS ONE			English	Article							POLYMICROBIAL NATURE; EXACERBATIONS; MANAGEMENT; INFECTION	Chronic obstructive pulmonary disease (COPD) is a progressive, inflammatory lung disease that affects a large number of patients and has significant impact. One hallmark of the disease is the presence of bacteria in the lower airways. Objective: The aim of this study was to analyze the detailed structure of microbial communities found in the lungs of healthy individuals and patients with COPD. Nine COPD patients as compared and 9 healthy individuals underwent flexible bronchoscopy and BAL was performed. Bacterial nucleic acids were subjected to terminal restriction fragment (TRF) length polymorphism and clone library analysis. Overall, we identified 326 T-RFLP band, 159 in patients and 167 in healthy controls. The results of the TRF analysis correlated partly with the data obtained from clone sequencing. Although the results of the sequencing showed high diversity, the genera Prevotella, Sphingomonas, Pseudomonas, Acinetobacter, Fusobacterium, Megasphaera, Veillonella, Staphylococcus, and Streptococcus constituted the major part of the core microbiome found in both groups. A TRF band possibly representing Pseudomonas sp. monoinfection was associated with a reduction of the microbial diversity. Non-cultural methods reveal the complexity of the pulmonary microbiome in healthy individuals and in patients with COPD. Alterations of the microbiome in pulmonary diseases are correlated with disease.	[Zakharkina, Tetyana; Rentz, Katharina; Bals, Robert] Saarland Univ Hosp, Dept Internal Med Pulmonol Allergol Resp Intens C, Homburg, Germany; [Heinzel, Elke; Herrmann, Mathias; von Mueller, Lutz] Univ Saarland, Inst Med Microbiol & Hyg, Homburg, Germany; [Koczulla, Rembert A.; Greulich, Timm] Univ Marburg, Clin Pneumol, Univ Hosp Giessen & Marburg, Marburg, Germany; [Pauling, Josch K.; Baumbach, Jan] Max Planck Inst Informat, Dept Computat Syst Biol, D-66123 Saarbrucken, Germany; [Gruenewald, Christiane; Dienemann, Hendrik] Univ Heidelberg Hosp, Dept Thorac Surg, Thoraxklinik, Heidelberg, Germany	Universitatsklinikum des Saarlandes; Saarland University; Philipps University Marburg; University Hospital of Giessen & Marburg; Max Planck Society; Ruprecht Karls University Heidelberg	Bals, R (corresponding author), Saarland Univ Hosp, Dept Internal Med Pulmonol Allergol Resp Intens C, Homburg, Germany.	robert.bals@uks.eu	Herrmann, Mathias/B-6475-2013	Herrmann, Mathias/0000-0003-2638-2257; Baumbach, Jan/0000-0002-0282-0462; von Muller, Lutz/0000-0001-9013-4245	Federal Ministry of Education and Research [FKZ 01GI0881-0888]	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This study was supported by grants from the Federal Ministry of Education and Research (FKZ 01GI0881-0888) to RB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen B, 2009, AM NAT, V174, P236, DOI 10.1086/600101; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bahrani-Mougeot FK, 2007, J CLIN MICROBIOL, V45, P1588, DOI 10.1128/JCM.01963-06; Brown CJ, 2007, J MED MICROBIOL, V56, P271, DOI 10.1099/jmm.0.46607-0; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Collins MD, 1991, PHYLOGENETIC ANAL GE; Diederen BMW, 2007, EUR RESPIR J, V30, P240, DOI 10.1183/09031936.00012707; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; GABRIEL KR, 1990, STAT MED, V9, P469, DOI 10.1002/sim.4780090502; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Han MK, 2012, THORAX, V67, P456, DOI 10.1136/thoraxjnl-2011-201183; Heijink IH, 2012, EUR RESPIR J, V39, P419, DOI 10.1183/09031936.00193810; Herr C, 2009, THORAX, V64, P144, DOI 10.1136/thx.2008.102681; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Huang YJ, 2011, J ALLERGY CLIN IMMUN, V127, P372, DOI 10.1016/j.jaci.2010.10.048; Huang YJ, 2010, OMICS, V14, P9, DOI 10.1089/omi.2009.0100; Joliffe I T, 1992, Stat Methods Med Res, V1, P69, DOI 10.1177/096228029200100105; Lee ZMP, 2009, NUCLEIC ACIDS RES, V37, pD489, DOI 10.1093/nar/gkn689; Lemon KP, 2010, MBIO, V1, DOI 10.1128/mBio.00129-10; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Liu ZQ, 2012, J CLIN PERIODONTOL, V39, P45, DOI 10.1111/j.1600-051X.2011.01808.x; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD123, DOI 10.1093/nar/gkr975; O'Toole PW, 2012, CLIN MICROBIOL INFEC, V18, P44, DOI 10.1111/j.1469-0691.2012.03867.x; Pauly JL, 2011, J ONCOL, V2011, DOI 10.1155/2011/819129; Proctor LM, 2011, CELL HOST MICROBE, V10, P287, DOI 10.1016/j.chom.2011.10.001; R Development Core Team, 2021, R PROJECT STAT COMPU; Rogers GB, 2010, J CLIN MICROBIOL, V48, P78, DOI 10.1128/JCM.01324-09; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Sethi S, 2010, EUR RESPIR J, V35, P1209, DOI 10.1183/09031936.00081409; Sibley CD, 2011, CAN J MICROBIOL, V57, P69, DOI [10.1139/W10-105, 10.1139/w10-105]; Sibley CD, 2009, CURR OPIN INVEST DR, V10, P787; Stressmann FA, 2011, J CLIN MICROBIOL, V49, P281, DOI 10.1128/JCM.01650-10; Sze MA, 2012, AM J RESP CRIT CARE, V185, P1073, DOI 10.1164/rccm.201111-2075OC; Veeramachaneni Sateesh B, 2006, COPD, V3, P109; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zakharkina T, 2011, RESPIROLOGY, V16, P932, DOI 10.1111/j.1440-1843.2011.01977.x	37	69	76	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68302	10.1371/journal.pone.0068302	http://dx.doi.org/10.1371/journal.pone.0068302			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874580	Green Published, Green Submitted, gold			2022-12-27	WOS:000321736900079
J	Pinel, S; Mriouah, J; Vandamme, M; Chateau, A; Plenat, F; Guerin, E; Taillandier, L; Bernier-Chastagner, V; Merlin, JL; Chastagner, P				Pinel, Sophie; Mriouah, Jihane; Vandamme, Marc; Chateau, Alicia; Plenat, Francois; Guerin, Eric; Taillandier, Luc; Bernier-Chastagner, Valerie; Merlin, Jean-Louis; Chastagner, Pascal			Synergistic Antitumor Effect between Gefitinib and Fractionated Irradiation in Anaplastic Oligodendrogliomas Cannot Be Predicted by the Egfr Signaling Activity	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; PHASE-II TRIAL; DIAGNOSED GLIOBLASTOMA-MULTIFORME; FACTOR RECEPTOR INHIBITION; BRAIN-STEM GLIOMAS; MALIGNANT GLIOMAS; RECURRENT GLIOBLASTOMA; ONCOGENE ADDICTION; RADIATION-THERAPY; KINASE INHIBITION	In high-grade gliomas, the identification of patients that could benefit from EGFR inhibitors remains a challenge, hindering the use of these agents. Using xenografts models, we evaluated the antitumor effect of the combined treatment "gefitinib + radiotherapy" and aimed to identify the profile of responsive tumors. Expression of phosphorylated proteins involved in the EGFR-dependent signaling pathways was analyzed in 10 glioma models. We focused on three models of anaplastic oligodendrogliomas (TCG2, TCG3 and TCG4) harboring high levels of phospho-EGFR, phospho-AKT and phospho-MEK1. They were treated with gefitinib (GEF 75 mg/kg/day x 5 days/week, for 2 weeks) and/or fractionated radiotherapy (RT: 5x2Gy/week for 2 weeks). Our results showed that GEF and/or RT induced significant tumor growth delays. However, only the TCG3 xenografts were highly responsive to the combination GEF+RT, with similar to 50% of tumor cure. Phosphoproteins analysis five days after treatment onset demonstrated in TCG3 xenografts, but not in TCG2 model, that the EGFR-dependent pathways were inhibited after GEF treatment. Moreover, TCG3-bearing mice receiving GEF monotherapy exhibited a transient beneficial therapeutic response, rapidly followed by tumor regrowth, along with a major vascular remodeling. Taken together, our data evoked an "EGFR-addictive" behavior for TCG3 tumors. This study confirms that combination of gefitinib with fractionated irradiation could be a potent therapeutic strategy for anaplastic oligodendrogliomas harboring EGFR abnormalities but this treatment seems mainly beneficial for "EGFR-addictive" tumors. Unfortunately, neither the usual molecular markers (EGFR amplification, PTEN loss) nor the basal overexpression of phosphoproteins were useful to distinguish this responsive tumor. Evaluating the impact of TKIs on the EGFR-dependent pathways during the treatment might be more relevant, and requires further validation.	[Pinel, Sophie; Mriouah, Jihane; Vandamme, Marc; Chateau, Alicia; Plenat, Francois; Taillandier, Luc; Merlin, Jean-Louis; Chastagner, Pascal] Univ Lorraine, CRAN, UMR 7039, Vandoeuvre Les Nancy, France; [Pinel, Sophie; Mriouah, Jihane; Vandamme, Marc; Chateau, Alicia; Plenat, Francois; Taillandier, Luc; Merlin, Jean-Louis; Chastagner, Pascal] CNRS, CRAN, UMR 7039, Vandoeuvre Les Nancy, France; [Plenat, Francois] Hop Brabois CHRU Nancy, Serv Anat & Cytol Pathol, Vandoeuvre Les Nancy, France; [Guerin, Eric] Univ Strasbourg, EA 4438, Strasbourg, France; [Taillandier, Luc] Hop Cent CHRU Nancy, Serv Neurol, Nancy, France; [Bernier-Chastagner, Valerie; Merlin, Jean-Louis] Inst Cancerol Lorraine, Vandoeuvre Les Nancy, France; [Chastagner, Pascal] Hop Enfants CHRU Nancy, Serv Onco Hematol Pediat, Vandoeuvre Les Nancy, France	Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; CHU de Nancy; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU de Nancy; UNICANCER; Institut de cancerologie de Lorraine (ICL); CHU de Nancy	Pinel, S (corresponding author), Univ Lorraine, CRAN, UMR 7039, Campus Sci, Vandoeuvre Les Nancy, France.	sophie.pinel@univ-lorraine.fr	Guerin, Eric/R-3426-2016	GUERIN, ERIC/0000-0003-1388-2834	French "Ligue Contre le Cancer, Comites Lorrains"; "Association pour la Recherche et les Etudes sur les Maladies Infantiles Graves"	French "Ligue Contre le Cancer, Comites Lorrains"; "Association pour la Recherche et les Etudes sur les Maladies Infantiles Graves"	Financial support for this work was obtained from the French "Ligue Contre le Cancer, Comites Lorrains" and the "Association pour la Recherche et les Etudes sur les Maladies Infantiles Graves." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arko L, 2010, PHARMACOL THERAPEUT, V128, P1, DOI 10.1016/j.pharmthera.2010.04.015; Brandes AA, 2008, CLIN CANCER RES, V14, P957, DOI 10.1158/1078-0432.CCR-07-1810; Bredel M, 1999, CLIN CANCER RES, V5, P1786; Brown PD, 2008, J CLIN ONCOL, V26, P5603, DOI 10.1200/JCO.2008.18.0612; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Cancer Genome Atlas Research Network, 2008, NATURE, V455, P1061; Cerniglia GJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006539; Chakravarti A, 2002, CANCER RES, V62, P4307; Chergui F, 2009, CLIN CHEM, V55, P1327, DOI 10.1373/clinchem.2008.116632; Cooper LAD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012548; de Groot JF, 2008, J NEURO-ONCOL, V90, P89, DOI 10.1007/s11060-008-9637-y; Geoerger B, 2008, INT J CANCER, V123, P209, DOI 10.1002/ijc.23488; Geyer JR, 2010, EUR J CANCER, V46, P3287, DOI 10.1016/j.ejca.2010.07.005; Gorovets D, 2012, CLIN CANCER RES, V18, P2490, DOI 10.1158/1078-0432.CCR-11-2977; Guillamo JS, 2009, CLIN CANCER RES, V15, P3697, DOI 10.1158/1078-0432.CCR-08-2042; Haas-Kogan DA, 2005, JNCI-J NATL CANCER I, V97, P880, DOI 10.1093/jnci/dji161; Hatanpaa KJ, 2010, NEOPLASIA, V12, P675, DOI 10.1593/neo.10688; Hegi ME, 2011, MOL CANCER THER, V10, P1102, DOI 10.1158/1535-7163.MCT-11-0048; Huang JZ, 2004, MOL CANCER RES, V2, P36; Idbaih A, 2008, INT J CANCER, V122, P1778, DOI 10.1002/ijc.23270; Idbaih A, 2011, J NEURO-ONCOL, V103, P221, DOI 10.1007/s11060-010-0380-9; Labussiere M, 2008, ANTI-CANCER DRUG, V19, P991, DOI 10.1097/CAD.0b013e328313e172; Labussiere M, 2011, INT J RADIAT ONCOL, V79, P892, DOI 10.1016/j.ijrobp.2010.09.051; Lassman AB, 2005, CLIN CANCER RES, V11, P7841, DOI 10.1158/1078-0432.CCR-05-0421; LUNDJOHANSEN M, 1990, CANCER RES, V50, P6039; McNamara MG, 2013, CURR TREAT OPTION NE, V24, P24; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Miqueli AD, 2009, BRIT J CANCER, V100, P950, DOI 10.1038/sj.bjc.6604943; Mukherjee B, 2009, CANCER RES, V69, P4252, DOI 10.1158/0008-5472.CAN-08-4853; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Park SY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-222; Peereboom DM, 2010, J NEURO-ONCOL, V98, P93, DOI 10.1007/s11060-009-0067-2; Perkins G, 2010, INT J CANCER, V127, P1321, DOI 10.1002/ijc.25152; Pinel S, 2004, INT J RADIAT ONCOL, V59, P250, DOI 10.1016/j.ijrobp.2003.12.022; Pollack IF, 2011, NEURO-ONCOLOGY, V13, P290, DOI 10.1093/neuonc/noq199; Prados MD, 2009, J CLIN ONCOL, V27, P579, DOI 10.1200/JCO.2008.18.9639; Qayum N, 2009, CANCER RES, V69, P6347, DOI 10.1158/0008-5472.CAN-09-0657; Raizer JJ, 2010, NEURO-ONCOLOGY, V12, P95, DOI 10.1093/neuonc/nop015; Raizer RJ, 2005, J NEURO-ONCOL, V74, P77, DOI 10.1007/s11060-005-0603-7; Rich JN, 2004, J CLIN ONCOL, V22, P133, DOI 10.1200/JCO.2004.08.110; Sambade MJ, 2010, INT J RADIAT ONCOL, V77, P575, DOI 10.1016/j.ijrobp.2009.12.063; Sarkaria JN, 2007, MOL CANCER THER, V6, P1167, DOI 10.1158/1535-7163.MCT-06-0691; Sharma SV, 2006, CLIN CANCER RES, V12, p4392S, DOI 10.1158/1078-0432.CCR-06-0096; Stea B, 2003, CANCER LETT, V202, P43, DOI 10.1016/j.canlet.2003.07.006; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Westphal M, 2011, NAT REV NEUROSCI, V12, P495, DOI 10.1038/nrn3060; Zhuang HQ, 2009, CANCER SCI, V100, P1520, DOI 10.1111/j.1349-7006.2009.01190.x	50	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e68333	10.1371/journal.pone.0068333	http://dx.doi.org/10.1371/journal.pone.0068333			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874590	Green Published, gold, Green Submitted			2022-12-27	WOS:000324146200017
J	Forsgren, J; Frykstrand, S; Grandfield, K; Mihranyan, A; Stromme, M				Forsgren, Johan; Frykstrand, Sara; Grandfield, Kathryn; Mihranyan, Albert; Stromme, Maria			A Template-Free, Ultra-Adsorbing, High Surface Area Carbonate Nanostructure	PLOS ONE			English	Article							THERMAL-DECOMPOSITION; MAGNESIUM; XPS; ADSORPTION; SPECTROSCOPY; SPECTRA	We report the template-free, low-temperature synthesis of a stable, amorphous, and anhydrous magnesium carbonate nanostructure with pore sizes below 6 nm and a specific surface area of similar to 800 m(2) g(-1), substantially surpassing the surface area of all previously described alkali earth metal carbonates. The moisture sorption of the novel nanostructure is featured by a unique set of properties including an adsorption capacity similar to 50% larger than that of the hygroscopic zeolite-Y at low relative humidities and with the ability to retain more than 75% of the adsorbed water when the humidity is decreased from 95% to 5% at room temperature. These properties can be regenerated by heat treatment at temperatures below 100 degrees C. The structure is foreseen to become useful in applications such as humidity control, as industrial adsorbents and filters, in drug delivery and catalysis.	[Forsgren, Johan; Frykstrand, Sara; Mihranyan, Albert; Stromme, Maria] Uppsala Univ, Angstrom Lab, Dept Engn Sci, Div Nanotechnol & Funct Mat, Uppsala, Sweden; [Grandfield, Kathryn] Uppsala Univ, Angstrom Lab, Dept Engn Sci, Div Appl Mat Sci, Uppsala, Sweden	Uppsala University; Uppsala University	Forsgren, J (corresponding author), Uppsala Univ, Angstrom Lab, Dept Engn Sci, Div Nanotechnol & Funct Mat, Uppsala, Sweden.	johan.frosgren@angstrom.uu.se; albert.mihranyan@angstrom.uu.se; maria.stromme@angstrom.uu.se		Mihranyan, Albert/0000-0002-8105-2317; Grandfield, Kathryn/0000-0002-0188-9580	Carl Trygger Foundation; Swedish Research Council	Carl Trygger Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	The Carl Trygger Foundation (www.carltryggersstiftelse.se) and the Swedish Research Council (www.vr.se) are acknowledged for financing our work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardizzone S, 1997, APPL SURF SCI, V119, P253, DOI 10.1016/S0169-4332(97)00180-3; Botha A, 2003, J THERM ANAL CALORIM, V71, P987, DOI 10.1023/A:1023355016208; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; Buzagh A, 1926, KOLLOID Z, V38, P222, DOI 10.1007/BF01460833; CHOUDHARY VR, 1994, THERMOCHIM ACTA, V232, P95, DOI 10.1016/0040-6031(94)80049-9; CLARK CB, 1946, J AM CERAM SOC, V29, P25, DOI 10.1111/j.1151-2916.1946.tb11544.x; Dastgheib SA, 2005, J COLLOID INTERF SCI, V292, P312, DOI 10.1016/j.jcis.2005.06.017; Deelman J. C., 2011, LOW TEMPERATURE FORM; DELL RM, 1959, T FARADAY SOC, V55, P2203, DOI 10.1039/tf9595502203; DUBININ MM, 1971, ADV CHEM SER, P69; European Commission, 2012, COM341; Fadeel B, 2010, J INTERN MED, V267, P2, DOI 10.1111/j.1365-2796.2009.02186.x; GARDNER SD, 1995, CARBON, V33, P587, DOI 10.1016/0008-6223(94)00144-O; Gouadec G, 2007, PROG CRYST GROWTH CH, V53, P1, DOI 10.1016/j.pcrysgrow.2007.01.001; Hashimoto H, 1968, KOGYO KAGAKU ZASSHI, V71, P480; Khan N, 2001, THERMOCHIM ACTA, V367, P321, DOI 10.1016/S0040-6031(00)00669-9; Kurov VI, 1961, RUSS J GEN CHEM+, V31, P9; Mihranyan A, 2012, PROG MATER SCI, V57, P875, DOI 10.1016/j.pmatsci.2011.10.001; Neuberg C., 1908, COLLOID POLYM SCI, V2, P354; Pires J, 2003, ADSORPTION, V9, P303, DOI 10.1023/A:1026219813234; POHL W, 1990, GEOL RUNDSCH, V79, P291, DOI 10.1007/BF01830626; RAADE G, 1970, AM MINERAL, V55, P1457; RUTT HN, 1974, J PHYS C SOLID STATE, V7, P4522, DOI 10.1088/0022-3719/7/24/015; Santamaria M, 2007, ELECTROCHIM ACTA, V53, P1314, DOI 10.1016/j.electacta.2007.03.019; SAWADA Y, 1978, THERMOCHIM ACTA, V27, P45, DOI 10.1016/0040-6031(78)85020-5; Siegbahn K., 1969, ESCA APPL FREE MOL; SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603; SPLINTER SJ, 1993, SURF SCI, V292, P130, DOI 10.1016/0039-6028(93)90396-2; Truitt B, 2009, HDB PHARM EXCIPIENTS, P397; Varshney HM, 2012, INT J THER APPL, V6, P14; Verhoeven L, 2001, AM CARBON SOC C P; XIE YM, 1990, CHEM MATER, V2, P293, DOI 10.1021/cm00009a020	32	51	55	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e68486	10.1371/journal.pone.0068486	http://dx.doi.org/10.1371/journal.pone.0068486			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23874640	Green Submitted, Green Published, gold			2022-12-27	WOS:000322000600009
J	Li, W; Jia, ZW; Zhang, SX; Lin, XS; Yang, RJ; He, Q; Ruan, DK				Li, Wei; Jia, Zhiwei; Zhang, Shunxin; Lin, Xingshi; Yang, Ruojia; He, Qing; Ruan, Dike			The Cellular Immune Mechanism after Transfer of Chemically Extracted Acellular Nerve Xenografts	PLOS ONE			English	Article							CD8(+) T-CELLS; SCHWANN-CELLS; INTRACELLULAR CYTOKINES; SCIATIC-NERVE; REGENERATION; ALLOGRAFT; RAT; TRANSPLANTATION; PRETREATMENT; REJECTION	Severe peripheral nerve defect by injuries causing functional loss require nerve grafting. Autograft has limitations for clinical use because it results in the creation of a new nerve injury and the generation of donor site morbidity. Based on these limitations, nerve allografts and xenografts provide a readily accessible alternative strategy. The aim of the present study was to observe the immune mechanism underlying the rejection of chemically extracted acellular nerve xenografts, and further evaluate immunogenicity of chemically treated acellular nerve grafts for clinical applications. A total of 160 BALB/c mice were randomly divided into a negative contrast group (NC, 40 mice), a fresh autograft group (AG, 40 mice), a fresh xenogeneic nerve group (FXN, 40 mice) and a chemically extracted acellular xenogeneic nerve group (CEXN, 40 mice). Various types of nerve grafts were implanted into the thigh muscle of BALB/C mice in the corresponding groups. At 3, 7, 14 and 28 days post-operation, the mice (10 mice from each group) were sacrificed and their spleens were extracted. The spleens were ground into paste. The erythrocytes and other cells were lysed using distilled water and the T lymphocytes were collected. Fluorescein isothiocyanate (FITC) -labeled monoclonal antibodies (CD3, CD4, CD8, CD25, IL-2, IFN-gamma and TNF-alpha) were then added to the solution. The Fluorescence Activated Cell Sorting (FACS) was used to determine the positivity rate of the cells combined with the monoclonal antibodies above. No significant statistical differences were observed between the CEXN, NC and AG groups, so that no obvious immune rejections were observed among the chemically extracted acellular nerve xenografts.	[Li, Wei; Jia, Zhiwei; He, Qing; Ruan, Dike] Navy Gen Hosp, Dept Orthopaed, Beijing, Peoples R China; [Zhang, Shunxin] Peoples Liberat Army Gen Hosp, South Clin Dept, Beijing, Peoples R China; [Lin, Xingshi; Yang, Ruojia] Peoples Liberat Army Gen Hosp, Dept Immun, Beijing, Peoples R China	Sixth Medical Center of Chinese PLA General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Li, W (corresponding author), Navy Gen Hosp, Dept Orthopaed, Beijing, Peoples R China.	weilichn@126.com			Natural Innovation Foundation of Navy General Hospital of China [2010018]	Natural Innovation Foundation of Navy General Hospital of China	This study was supported by the research grants from Natural Innovation Foundation of Navy General Hospital of China (2010018. www.hjzyy.com.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguayo A J, 1979, Ann N Y Acad Sci, V317, P512, DOI 10.1111/j.1749-6632.1979.tb56571.x; AGUAYO AJ, 1978, NEUROLOGY, V28, P356; AGUAYO AJ, 1977, J NEUROPATH EXP NEUR, V36, P595, DOI 10.1097/00005072-197705000-00031; BERGSTEINSDOTTIR K, 1992, J NEUROCYTOL, V21, P382, DOI 10.1007/BF01191706; Chaikovskii Iu B, 1988, Arkh Anat Gistol Embriol, V95, P17; Cho MS, 2012, J HAND SURG-AM, V37A, P2340, DOI 10.1016/j.jhsa.2012.08.028; Davila E, 2006, XENOTRANSPLANTATION, V13, P31, DOI 10.1111/j.1399-3089.2005.00258.x; ESIRI MM, 1989, J NEUROIMMUNOL, V23, P187, DOI 10.1016/0165-5728(89)90050-7; EVANS PJ, 1994, PROG NEUROBIOL, V43, P187, DOI 10.1016/0301-0082(94)90001-9; Fox IK, 2005, MUSCLE NERVE, V31, P59, DOI 10.1002/mus.20231; Galeano M, 2009, MICROSURG, V29, P568, DOI 10.1002/micr.20652; GULATI AK, 1990, J NEUROSURG, V72, P114, DOI 10.3171/jns.1990.72.1.0114; Huang Xijun, 2012, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V26, P993; Ijpma FFA, 2006, ANN PLAS SURG, V57, P391, DOI 10.1097/01.sap.0000221963.66229.b6; Johnson EO, 2005, INJURY, V36, pS24, DOI 10.1016/j.injury.2005.10.012; Jones ND, 2006, J IMMUNOL, V176, P2316, DOI 10.4049/jimmunol.176.4.2316; JUNG T, 1993, J IMMUNOL METHODS, V159, P197, DOI 10.1016/0022-1759(93)90158-4; KINGSTON AE, 1989, EUR J IMMUNOL, V19, P177, DOI 10.1002/eji.1830190128; Kreisel D, 2002, NAT MED, V8, P233, DOI 10.1038/nm0302-233; LASSNER F, 1989, TRANSPLANTATION, V48, P386, DOI 10.1097/00007890-198909000-00006; Li CY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044712, 10.1371/journal.pone.0042813]; Li W, 2012, MOL MED REP, V5, P1080, DOI 10.3892/mmr.2012.747; Lu LJ, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/412598; Lundborg G., 2005, NERVE INJURY REPAIR; MACKINNON SE, 1984, NEUROSURGERY, V14, P167, DOI 10.1227/00006123-198402000-00008; Rovak JM, 2005, J RECONSTR MICROSURG, V21, P207, DOI 10.1055/s-2005-869828; SKETELJ J, 1989, J NEUROSCI RES, V24, P153, DOI 10.1002/jnr.490240205; Sondell M, 1998, BRAIN RES, V795, P44, DOI 10.1016/S0006-8993(98)00251-0; TANIGUCHI M, 1990, Shikwa Gakuho, V90, P1057; Yu L T, 1988, Ann N Y Acad Sci, V540, P472, DOI 10.1111/j.1749-6632.1988.tb27139.x	30	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e68806	10.1371/journal.pone.0068806	http://dx.doi.org/10.1371/journal.pone.0068806			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23874771	Green Published, Green Submitted, gold			2022-12-27	WOS:000322000600028
J	Lee, SW; Triandafilou, K; Lock, BA; Kamper, DG				Lee, Sang Wook; Triandafilou, Kristen; Lock, Blair A.; Kamper, Derek G.			Impairment in Task-Specific Modulation of Muscle Coordination Correlates with the Severity of Hand Impairment following Stroke	PLOS ONE			English	Article							MOTOR UNIT DISCHARGE; HEMIPARETIC STROKE; RETICULOSPINAL TRACT; ANTICIPATORY CONTROL; ACTIVATION PATTERNS; SYNERGY PATTERNS; FINGERTIP FORCES; MOVEMENTS; SHOULDER; ELBOW	Significant functional impairment of the hand is commonly observed in stroke survivors. Our previous studies suggested that the inability to modulate muscle coordination patterns according to task requirements may be substantial after stroke, but these limitations have not been examined directly. In this study, we aimed to characterize post-stroke impairment in the ability to modulate muscle coordination patterns across tasks and its correlation with hand impairment. Fourteen stroke survivors, divided into a group with severe hand impairment (8 subjects) and a group with moderate hand impairment (6 subjects) according to their clinical functionality score, participated in the experiment. Another four neurologically intact subjects participated in the experiment to serve as a point of comparison. Activation patterns of nine hand and wrist muscles were recorded using surface electromyography while the subjects performed six isometric tasks. Patterns of covariation in muscle activations across tasks, i.e., muscle modules, were extracted from the muscle activation data. Our results showed that the degree of reduction in the inter-task separation of the multi-muscle activation patterns was indicative of the clinical functionality score of the subjects (mean value = 26.2 for severely impaired subjects, 38.1 for moderately impaired subjects). The values for moderately impaired subjects were much closer to those of the impaired subjects (mean value = 46.1). The number of muscle modules extracted from the muscle activation patterns of a subject across six tasks, which represents the degree of motor complexity, was found to be correlated with the clinical functionality score (R = 0.68). Greater impairment was also associated with a change in the muscle module patterns themselves, with greater muscle coactivation. A substantial reduction in the degrees-of-freedom of the multi-muscle coordination post-stroke was apparent, and the extent of the reduction, assessed by the stated metrics, was strongly associated with the level of clinical impairment.	[Lee, Sang Wook] Catholic Univ Amer, Dept Biomed Engn, Washington, DC 20064 USA; [Lee, Sang Wook] MedStar Natl Rehabil Hosp, Ctr Appl Biomech & Rehabil Res, Washington, DC USA; [Triandafilou, Kristen; Kamper, Derek G.] Rehabil Inst Chicago, Sensory Motor Performance Program, Chicago, IL 60611 USA; [Lock, Blair A.] Rehabil Inst Chicago, Ctr Bion Med, Chicago, IL 60611 USA; [Kamper, Derek G.] IIT, Dept Biomed Engn, Chicago, IL 60616 USA	Catholic University of America; Shirley Ryan AbilityLab; Shirley Ryan AbilityLab; Illinois Institute of Technology	Lee, SW (corresponding author), Catholic Univ Amer, Dept Biomed Engn, Washington, DC 20064 USA.	leeb@cua.edu		Lee, Sang Wook/0000-0002-9732-0427	National Institute on Disability and Rehabilitation Research [H133F090018]; National Institutes of Health (NINDS) [1R01NS052369-01A1]; Coleman Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052369] Funding Source: NIH RePORTER	National Institute on Disability and Rehabilitation Research; National Institutes of Health (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Coleman Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by the National Institute on Disability and Rehabilitation Research (H133F090018), the National Institutes of Health (NINDS; 1R01NS052369-01A1), and the Coleman Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AN KN, 1985, J ORTHOP RES, V3, P202, DOI 10.1002/jor.1100030210; Baker SN, 2011, J PHYSIOL-LONDON, V589, P5603, DOI 10.1113/jphysiol.2011.215160; Beebe JA, 2009, STROKE, V40, P1772, DOI 10.1161/STROKEAHA.108.536763; Beer RF, 2004, EXP BRAIN RES, V156, P458, DOI 10.1007/s00221-003-1807-8; Beer RF, 1999, ARCH PHYS MED REHAB, V80, P766, DOI 10.1016/S0003-9993(99)90225-3; BOHANNON RW, 1987, PHYS THER, V67, P522, DOI 10.1093/ptj/67.4.522; BOURBONNAIS D, 1989, BRAIN, V112, P85, DOI 10.1093/brain/112.1.85; Bowden MG, 2010, NEUROREHAB NEURAL RE, V24, P328, DOI 10.1177/1545968309343215; Brunnstrom S., 1970, MOVEMENT THERAPY HEM; Burnett RA, 2000, J APPL PHYSIOL, V89, P61, DOI 10.1152/jappl.2000.89.1.61; Canning CG, 2000, J NEUROL SCI, V176, P45, DOI 10.1016/S0022-510X(00)00305-1; Cheung VCK, 2012, P NATL ACAD SCI USA, V109, P14652, DOI 10.1073/pnas.1212056109; Cheung VCK, 2009, P NATL ACAD SCI USA, V106, P19563, DOI 10.1073/pnas.0910114106; Cirstea MC, 2000, BRAIN, V123, P940, DOI 10.1093/brain/123.5.940; Clark DJ, 2010, J NEUROPHYSIOL, V103, P844, DOI 10.1152/jn.00825.2009; COLE KJ, 1986, J NEUROPHYSIOL, V55, P1407, DOI 10.1152/jn.1986.55.6.1407; Conrad MO, 2011, SOC NEUR ANN M WASH; Cruz EG, 2005, BRAIN, V128, P1112, DOI 10.1093/brain/awh432; d'Avella A, 2005, P NATL ACAD SCI USA, V102, P3076, DOI 10.1073/pnas.0500199102; DATTOLA R, 1993, EUR NEUROL, V33, P109, DOI 10.1159/000116915; Davidson AG, 2006, EXP BRAIN RES, V173, P25, DOI 10.1007/s00221-006-0374-1; Dennerlein JT, 1998, J BIOMECH, V31, P295, DOI 10.1016/S0021-9290(98)00006-2; Dewald J P, 2001, Top Stroke Rehabil, V8, P1; DEWALD JPA, 1995, BRAIN, V118, P495, DOI 10.1093/brain/118.2.495; Dipietro L, 2007, J NEUROPHYSIOL, V98, P757, DOI 10.1152/jn.01295.2006; ELLIOTT JM, 1984, DEV MED CHILD NEUROL, V26, P283, DOI 10.1111/j.1469-8749.1984.tb04445.x; Ellis MD, 2005, MUSCLE NERVE, V32, P170, DOI 10.1002/mus.20343; Ellis MD, 2007, EXP BRAIN RES, V176, P594, DOI 10.1007/s00221-006-0637-x; Feldmann RG, 1980, SPASTICITY DISORDERE, P485; Frere J, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00099; GALGANSKI ME, 1993, J NEUROPHYSIOL, V69, P2108, DOI 10.1152/jn.1993.69.6.2108; GEMPERLINE JJ, 1995, MUSCLE NERVE, V18, P1101, DOI 10.1002/mus.880181006; GIVEN JD, 1995, J NEUROL NEUROSUR PS, V59, P271, DOI 10.1136/jnnp.59.3.271; GOWLAND C, 1992, PHYS THER, V72, P624, DOI 10.1093/ptj/72.9.624; GOWLAND CA, 1990, STROKE, V21, P19; Hoffmann G, 2009, J NEUROPHYSIOL, V102, P1420, DOI 10.1152/jn.90950.2008; Holdefer RN, 2002, EXP BRAIN RES, V146, P233, DOI 10.1007/s00221-002-1166-x; Iwamuro BT, 2008, ARCH PHYS MED REHAB, V89, P2121, DOI 10.1016/j.apmr.2008.04.022; Jesunathadas M, 2010, J APPL PHYSIOL, V108, P1659, DOI 10.1152/japplphysiol.00807.2009; Johnston JA, 2010, NEUROSCI LETT, V474, P104, DOI 10.1016/j.neulet.2010.03.017; Kamper DG, 2000, MUSCLE NERVE, V23, P954, DOI 10.1002/(SICI)1097-4598(200006)23:6<954::AID-MUS17>3.0.CO;2-0; Kamper DG, 2001, MUSCLE NERVE, V24, P673, DOI 10.1002/mus.1054; Kamper DG, 2003, J NEUROPHYSIOL, V90, P3702, DOI 10.1152/jn.00546.2003; Klein CS, 2010, J APPL PHYSIOL, V109, P1337, DOI 10.1152/japplphysiol.00804.2009; Kutch JJ, 2008, J NEUROPHYSIOL, V100, P2455, DOI 10.1152/jn.90274.2008; Laidlaw DH, 2000, MUSCLE NERVE, V23, P600, DOI 10.1002/(SICI)1097-4598(200004)23:4<600::AID-MUS20>3.3.CO;2-4; Lang CE, 2004, J NEUROPHYSIOL, V91, P1722, DOI 10.1152/jn.00805.2003; LAWRENCE DG, 1968, BRAIN, V91, P15, DOI 10.1093/brain/91.1.15; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Lee SW, 2008, J BIOMECH, V41, P1567, DOI 10.1016/j.jbiomech.2008.02.008; Lee SW, 2011, IEEE T NEUR SYS REH, V19, P558, DOI 10.1109/TNSRE.2010.2079334; Lindeman RH, 1979, INTRO BIVARIATE MULT; Lum PS, 2003, MUSCLE NERVE, V27, P211, DOI 10.1002/mus.10305; MAIER MA, 1995, EXP BRAIN RES, V103, P108, DOI 10.1007/BF00241969; McPherson JG, 2008, J NEUROPHYSIOL, V100, P3236, DOI 10.1152/jn.90563.2008; NAPIER JR, 1956, J BONE JOINT SURG BR, V38, P902, DOI 10.1302/0301-620X.38B4.902; ODwyer NJ, 1996, BRAIN, V119, P1737, DOI 10.1093/brain/119.5.1737; Patten C, 2004, J REHABIL RES DEV, V41, P293, DOI 10.1682/JRRD.2004.03.0293; Patten C, 2002, P INT SOC MAGN RES M; Raghavan P, 2006, BRAIN, V129, P1415, DOI 10.1093/brain/awl070; Raghavan P, 2010, J NEUROPHYSIOL, V103, P3034, DOI 10.1152/jn.00936.2009; Ranganathan VK, 2001, J AM GERIATR SOC, V49, P1478, DOI 10.1046/j.1532-5415.2001.4911240.x; Rearick MP, 2003, J NEUROPHYSIOL, V89, P1317, DOI 10.1152/jn.00581.2002; Reinkensmeyer DJ, 2002, EXP BRAIN RES, V143, P525, DOI 10.1007/s00221-002-1055-3; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Roh J, 2013, J NEUROPHYSIOL, V109, P768, DOI 10.1152/jn.00670.2012; Roh J, 2012, J NEUROPHYSIOL, V107, P2123, DOI 10.1152/jn.00173.2011; Schieber MH, 2004, J APPL PHYSIOL, V96, P2293, DOI 10.1152/japplphysiol.01063.2003; Schmit BD, 2000, ARCH PHYS MED REHAB, V81, P269; Scholz JP, 1999, EXP BRAIN RES, V126, P289, DOI 10.1007/s002210050738; Schwerin S, 2008, EXP BRAIN RES, V185, P509, DOI 10.1007/s00221-007-1169-8; Seo NJ, 2011, ARCH PHYS MED REHAB, V92, P24, DOI 10.1016/j.apmr.2010.08.016; Seo NJ, 2010, EXP BRAIN RES, V202, P891, DOI 10.1007/s00221-010-2193-7; Seo NJ, 2009, J NEUROPHYSIOL, V101, P3108, DOI 10.1152/jn.91108.2008; Shah Prithvi K, 2012, Eur J Neurosci, V36, P2054, DOI 10.1111/j.1460-9568.2012.08106.x; Sommerfeld DK, 2004, STROKE, V35, P134, DOI 10.1161/01.STR.0000105386.05173.5E; Spiegel KM, 1996, EXP PHYSIOL, V81, P805, DOI 10.1113/expphysiol.1996.sp003978; Sukal TM, 2007, EXP BRAIN RES, V183, P215, DOI 10.1007/s00221-007-1029-6; Takahashi CD, 2003, EXP BRAIN RES, V149, P131, DOI 10.1007/s00221-002-1340-1; Ting LH, 2005, J NEUROPHYSIOL, V93, P609, DOI 10.1152/jn.00681.2004; Torres-Oviedo G, 2007, J NEUROPHYSIOL, V98, P2144, DOI 10.1152/jn.01360.2006; Traversa R, 1997, STROKE, V28, P110, DOI 10.1161/01.STR.28.1.110; Tresch MC, 1999, NAT NEUROSCI, V2, P162, DOI 10.1038/5721; Triandafilou KM, 2011, J NEUROPHYSIOL, V106, P1644, DOI 10.1152/jn.00936.2010; Trombly C. A., 1989, OCCUPATIONAL THERAPY, P454; Valero-Cuevas FJ, 1998, J BIOMECH, V31, P693, DOI 10.1016/S0021-9290(98)00082-7; Valero-Cuevas FJ, 2000, J NEUROPHYSIOL, V83, P1469, DOI 10.1152/jn.2000.83.3.1469; Valero-Cuevas FJ, 2009, J NEUROPHYSIOL, V102, P59, DOI 10.1152/jn.90324.2008; Weiss EJ, 2004, J NEUROPHYSIOL, V92, P523, DOI 10.1152/jn.01265.2003; Welmer AK, 2006, AM J PHYS MED REHAB, V85, P112, DOI 10.1097/01.phm.0000197587.78140.17; Zajac FE, 2002, GAIT POSTURE, V16, P215, DOI 10.1016/S0966-6362(02)00068-1; Zhou P, 2007, ANN BIOMED ENG, V35, P1521, DOI 10.1007/s10439-007-9329-3	92	20	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68745	10.1371/journal.pone.0068745	http://dx.doi.org/10.1371/journal.pone.0068745			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874745	gold, Green Published, Green Submitted			2022-12-27	WOS:000322064300067
J	Drew, K; Renfrew, PD; Craven, TW; Butterfoss, GL; Chou, FC; Lyskov, S; Bullock, BN; Watkins, A; Labonte, JW; Pacella, M; Kilambi, KP; Leaver-Fay, A; Kuhlman, B; Gray, JJ; Bradley, P; Kirshenbaum, K; Arora, PS; Das, R; Bonneau, R				Drew, Kevin; Renfrew, P. Douglas; Craven, Timothy W.; Butterfoss, Glenn L.; Chou, Fang-Chieh; Lyskov, Sergey; Bullock, Brooke N.; Watkins, Andrew; Labonte, Jason W.; Pacella, Michael; Kilambi, Krishna Praneeth; Leaver-Fay, Andrew; Kuhlman, Brian; Gray, Jeffrey J.; Bradley, Philip; Kirshenbaum, Kent; Arora, Paramjit S.; Das, Rhiju; Bonneau, Richard			Adding Diverse Noncanonical Backbones to Rosetta: Enabling Peptidomimetic Design	PLOS ONE			English	Article							ALPHA/BETA-PEPTIDE FOLDAMERS; PROTEIN-PROTEIN INTERACTIONS; SMALL-MOLECULE INHIBITORS; COMPUTATIONAL DESIGN; BETA-PEPTIDE; TRANSMEMBRANE HELICES; CANCER-THERAPY; P53 PATHWAY; SIDE-CHAINS; PEPTOIDS	Peptidomimetics are classes of molecules that mimic structural and functional attributes of polypeptides. Peptidomimetic oligomers can frequently be synthesized using efficient solid phase synthesis procedures similar to peptide synthesis. Conformationally ordered peptidomimetic oligomers are finding broad applications for molecular recognition and for inhibiting protein-protein interactions. One critical limitation is the limited set of design tools for identifying oligomer sequences that can adopt desired conformations. Here, we present expansions to the ROSETTA platform that enable structure prediction and design of five non-peptidic oligomer scaffolds (noncanonical backbones), oligooxopiperazines, oligo-peptoids, beta-peptides, hydrogen bond surrogate helices and oligosaccharides. This work is complementary to prior additions to model noncanonical protein side chains in ROSETTA. The main purpose of our manuscript is to give a detailed description to current and future developers of how each of these noncanonical backbones was implemented. Furthermore, we provide a general outline for implementation of new backbone types not discussed here. To illustrate the utility of this approach, we describe the first tests of the ROSETTA molecular mechanics energy function in the context of oligooxopiperazines, using quantum mechanical calculations as comparison points, scanning through backbone and side chain torsion angles for a model peptidomimetic. Finally, as an example of a novel design application, we describe the automated design of an oligooxopiperazine that inhibits the p53-MDM2 protein-protein interaction. For the general biological and bioengineering community, several noncanonical backbones have been incorporated into web applications that allow users to freely and rapidly test the presented protocols (http://rosie.rosettacommons.org). This work helps address the peptidomimetic community's need for an automated and expandable modeling tool for noncanonical backbones.	[Drew, Kevin; Renfrew, P. Douglas; Craven, Timothy W.; Butterfoss, Glenn L.] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Chou, Fang-Chieh; Das, Rhiju] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; [Lyskov, Sergey; Labonte, Jason W.; Gray, Jeffrey J.] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD USA; [Bullock, Brooke N.; Watkins, Andrew; Kirshenbaum, Kent; Arora, Paramjit S.] NYU, Dept Chem, New York, NY 10003 USA; [Pacella, Michael] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA; [Leaver-Fay, Andrew; Kuhlman, Brian] Univ N Carolina, Dept Biochem, Chapel Hill, NC 27599 USA; [Gray, Jeffrey J.] Johns Hopkins Univ, Program Mol Biophys, Baltimore, MD USA; [Bradley, Philip] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Bonneau, Richard] NYU, Courant Inst Math Sci, Dept Comp Sci, New York, NY 10012 USA	New York University; Stanford University; Johns Hopkins University; New York University; Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; Fred Hutchinson Cancer Center; New York University	Bonneau, R (corresponding author), NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA.	bonneau@nyu.edu	Arora, Paramjit/AAR-3086-2020; Gray, Jeffrey J./B-5682-2008; Bonneau, Richard/ABD-6737-2021; Bonneau, Richard/GZL-2900-2022	Gray, Jeffrey J./0000-0001-6380-2324; Watkins, Andrew/0000-0003-1617-1720; Drew, Kevin/0000-0002-1260-4413; Kilambi, Krishna Praneeth/0000-0003-4848-2611; Das, Rhiju/0000-0001-7497-0972	NSF [CHE-1151554, IOS-1126971, CHE-1152317, CHE-0848410]; NIH [U54CA143907-01, PN2 EY016586-06, T32 GM 88118-2, R01GM073943, RO1GM073151, RO1GM073960]; Burroughs Wellcome Foundation; HHMI International Student Fellowship; NATIONAL CANCER INSTITUTE [U54CA143907] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY016586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM088118, R01GM073151, R01GM073960, R01GM073943] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1151554] Funding Source: National Science Foundation; Division Of Chemistry [1152317] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); HHMI International Student Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The authors acknowledge support from NSF CHE-1151554, NSF IOS-1126971, NSF CHE-1152317, NSF CHE-0848410, NIH U54CA143907-01, NIH PN2 EY016586-06, NIH T32 GM 88118-2, NIH R01GM073943, NIH RO1GM073151 (SL, JG, BK and AL), NIH RO1GM073960 (BK and AL), the Burroughs Wellcome Foundation (Career Award to RD), and an HHMI International Student Fellowship (FC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Armand P, 1998, P NATL ACAD SCI USA, V95, P4309, DOI 10.1073/pnas.95.8.4309; Baral PK, 2012, ACTA CRYSTALLOGR D, V68, P1501, DOI 10.1107/S0907444912037328; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boersma MD, 2012, J AM CHEM SOC, V134, P315, DOI 10.1021/ja207148m; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bullock BN, 2011, J AM CHEM SOC, V133, P14220, DOI 10.1021/ja206074j; Butterfoss GL, 2009, J AM CHEM SOC, V131, P16798, DOI 10.1021/ja905267k; Culf AS, 2010, MOLECULES, V15, P5282, DOI 10.3390/molecules15085282; Cummings CG, 2010, CURR OPIN CHEM BIOL, V14, P341, DOI 10.1016/j.cbpa.2010.04.001; Daniels DS, 2007, J AM CHEM SOC, V129, P1532, DOI 10.1021/ja068678n; Dohm MT, 2011, CURR PHARM DESIGN, V17, P2732; Edwards TA, 2011, AMINO ACIDS, V41, P743, DOI 10.1007/s00726-011-0880-8; Ermonval M, 2003, BIOCHIMIE, V85, P33, DOI 10.1016/S0300-9084(03)00040-3; Fowler SA, 2009, ORG BIOMOL CHEM, V7, P1508, DOI 10.1039/b817980h; Frisch G. W., 2013, GAUSSIAN 09; Gellman SH, 1998, ACCOUNTS CHEM RES, V31, P173, DOI 10.1021/ar960298r; Goodman CM, 2007, NAT CHEM BIOL, V3, P252, DOI 10.1038/nchembio876; Hart GT, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-120; Hauri HP, 2000, FEBS LETT, V476, P32, DOI 10.1016/S0014-5793(00)01665-3; HELENIUS A, 1994, MOL BIOL CELL, V5, P253, DOI 10.1091/mbc.5.3.253; Henchey LK, 2010, CHEMBIOCHEM, V11, P2104, DOI 10.1002/cbic.201000378; Henchey LK, 2010, J AM CHEM SOC, V132, P941, DOI 10.1021/ja9082864; Henchey LK, 2008, CURR OPIN CHEM BIOL, V12, P692, DOI 10.1016/j.cbpa.2008.08.019; Horne WS, 2008, ACCOUNTS CHEM RES, V41, P1399, DOI 10.1021/ar800009n; Horne WS, 2008, ANGEW CHEM INT EDIT, V47, P2853, DOI 10.1002/anie.200705315; Horne WS, 2009, P NATL ACAD SCI USA, V106, P14751, DOI 10.1073/pnas.0902663106; Jochim AL, 2010, ACS CHEM BIOL, V5, P919, DOI 10.1021/cb1001747; Kirshenbaum K, 1998, P NATL ACAD SCI USA, V95, P4303, DOI 10.1073/pnas.95.8.4303; Ko E, 2013, J AM CHEM SOC, V135, P167, DOI 10.1021/ja3067258; Korendovych IV, 2010, ORG LETT, V12, P5142, DOI 10.1021/ol102092r; KORNFELD S, 1990, BIOCHEM SOC T, V18, P367, DOI 10.1042/bst0180367; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lemmon G, 2012, METHODS MOL BIOL, V819, P143, DOI 10.1007/978-1-61779-465-0_10; Levine PM, 2012, ACS CHEM BIOL, V7, P1693, DOI 10.1021/cb300332w; Michelsen K, 2012, J AM CHEM SOC, V134, P17059, DOI 10.1021/ja305839b; MILLER SM, 1995, DRUG DEVELOP RES, V35, P20, DOI 10.1002/ddr.430350105; Molski MA, 2013, CHEM SCI, V4, P319, DOI 10.1039/c2sc21117c; Pang PC, 2011, SCIENCE, V333, P1761, DOI 10.1126/science.1207438; Patgiri A, 2008, ACCOUNTS CHEM RES, V41, P1289, DOI 10.1021/ar700264k; Patgiri A, 2011, NAT CHEM BIOL, V7, P585, DOI [10.1038/NCHEMBIO.612, 10.1038/nchembio.612]; Renfrew PD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032637; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Seebach D, 2008, ACCOUNTS CHEM RES, V41, P1366, DOI 10.1021/ar700263g; Shah NH, 2008, J AM CHEM SOC, V130, P16622, DOI 10.1021/ja804580n; Shandler SJ, 2011, J AM CHEM SOC, V133, P12378, DOI 10.1021/ja204215f; Shandler SJ, 2010, J AM CHEM SOC, V132, P7312, DOI 10.1021/ja906700x; SIMON RJ, 1992, P NATL ACAD SCI USA, V89, P9367, DOI 10.1073/pnas.89.20.9367; Stewart ML, 2010, NAT CHEM BIOL, V6, P595, DOI [10.1038/NCHEMBIO.391, 10.1038/nchembio.391]; Stigers KD, 1999, CURR OPIN CHEM BIOL, V3, P714, DOI 10.1016/S1367-5931(99)00030-7; Stockwin LH, 2003, EXPERT OPIN BIOL TH, V3, P1133, DOI 10.1517/14712598.3.7.1133; Stringer JR, 2011, J AM CHEM SOC, V133, P15559, DOI 10.1021/ja204755p; Tosovska P, 2010, ORG LETT, V12, P1588, DOI 10.1021/ol1003143; Tran H, 2011, JOVE-J VIS EXP, DOI 10.3791/3373; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vassilev LT, 2007, TRENDS MOL MED, V13, P23, DOI 10.1016/j.molmed.2006.11.002; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Yin H, 2007, SCIENCE, V315, P1817, DOI 10.1126/science.1136782; Yoo B, 2005, J AM CHEM SOC, V127, P17132, DOI 10.1021/ja055105m	63	43	43	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2013	8	7							e67051	10.1371/journal.pone.0067051	http://dx.doi.org/10.1371/journal.pone.0067051			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZN	23869206	Green Submitted, Green Published, gold			2022-12-27	WOS:000323110600005
J	Genius, J; Geiger, J; Dolzer, AL; Benninghoff, J; Giegling, I; Hartmann, AM; Moller, HJ; Rujescu, D				Genius, Just; Geiger, Johanna; Doelzer, Anna-Lena; Benninghoff, Jens; Giegling, Ina; Hartmann, Annette M.; Moeller, Hans-Juergen; Rujescu, Dan			Glutamatergic Dysbalance and Oxidative Stress in In Vivo and In Vitro Models of Psychosis Based on Chronic NMDA Receptor Antagonism	PLOS ONE			English	Article							D-ASPARTATE RECEPTORS; POSSIBLE ANIMAL-MODEL; ANTIPSYCHOTIC-DRUGS; SCHIZOPHRENIC-PATIENTS; CEREBROSPINAL-FLUID; CHRONIC HALOPERIDOL; PROTON MRS; KETAMINE; RATS; DOPAMINE	Background: The psychotomimetic effects of N-methyl-D-aspartate (NMDA) receptor antagonists in healthy humans and their tendency to aggravate psychotic symptoms in schizophrenic patients have promoted the notion of altered glutamatergic neurotransmission in the pathogenesis of schizophrenia. Methods: The NMDA-receptor antagonist MK-801 was chronically administered to rats (0.02 mg/kg intraperitoneally for 14 days). In one subgroup the antipsychotic haloperidol (1 mg/kg) was employed as a rescue therapy. Glutamate distribution and 3-NT (3-nitrotyrosine) as a marker of oxidative stress were assessed by immunohistochemistry in tissue sections. In parallel, the effects of MK-801 and haloperidol were investigated in primary embryonal hippocampal cell cultures from rats. Results: Chronic NMDA-R antagonism led to a marked increase of intracellular glutamate in the hippocampus (126.1 +/- 10.4% S.E.M of control; p = 0.037), while 3-NT staining intensity remained unaltered. No differences were observed in extrahippocampal brain regions. Essentially these findings could be reproduced in vitro. Conclusion: The combined in vivo and in vitro strategy allowed us to assess the implications of disturbed glutamate metabolism for the occurrence of oxidative stress and to investigate the effects of antipsychotics. Our data suggest that oxidative stress plays a minor role in this model than previously suggested. The same applies to apoptosis. Moreover, the effect of haloperidol seems to be mediated through yet unidentified mechanisms, unrelated to D2-antagonism. These convergent lines of evidence indicate that further research should be focused on the glutamatergic system and that our animal model may provide a tool to explore the biology of schizophrenia.	[Genius, Just; Geiger, Johanna; Doelzer, Anna-Lena; Benninghoff, Jens; Giegling, Ina; Hartmann, Annette M.; Moeller, Hans-Juergen; Rujescu, Dan] Univ Munich, Dept Psychiat, D-80539 Munich, Germany; [Genius, Just; Benninghoff, Jens] Univ Essen Gesamthsch, Dept Psychiat, Essen, Germany; [Giegling, Ina; Rujescu, Dan] Univ Halle Wittenberg, Dept Psychiat, D-06108 Halle, Germany	University of Munich; University of Duisburg Essen; Martin Luther University Halle Wittenberg	Rujescu, D (corresponding author), Univ Munich, Dept Psychiat, D-80539 Munich, Germany.	Dan.Rujescu@med.uni-muenchen.de	Giegling, Ina/ABA-3677-2021; Hartmann, Annette/AAS-6331-2021; Rujescu, Dan/GRS-3875-2022	Genius, Just/0000-0003-3270-3491				Abel KM, 2003, NEUROPHARMACOLOGY, V44, P729, DOI 10.1016/S0028-3908(03)00073-X; AIZENMAN E, 1995, NEUROSCI LETT, V189, P57, DOI 10.1016/0304-3940(95)11442-Y; Akyol O, 2002, PROG NEURO-PSYCHOPH, V26, P995, DOI 10.1016/S0278-5846(02)00220-8; Al-Amin HA, 2001, BIOL PSYCHIAT, V49, P528, DOI 10.1016/S0006-3223(00)00968-9; Becker A, 2003, PROG NEURO-PSYCHOPH, V27, P687, DOI 10.1016/S0278-5846(03)00080-0; Behrens MM, 2007, SCIENCE, V318, P1645, DOI 10.1126/science.1148045; Braun I, 2007, SCHIZOPHR RES, V97, P254, DOI 10.1016/j.schres.2007.05.005; Brimecombe JC, 1999, J PHARMACOL EXP THER, V291, P785; Cabungcal JH, 2006, NEUROBIOL DIS; CHOI DW, 1988, J NEUROSCI, V8, P185; Coyle JT, 2002, CNS NEUROL DISORD-DR, V1, P183, DOI 10.2174/1568007024606212; Dakhale G, 2004, NEUROPSYCHOBIOLOGY, V49, P205, DOI 10.1159/000077368; de Bartolomeis A, 2005, CURR PHARM DESIGN, V11, P3561, DOI 10.2174/138161205774414538; Ellison GD, 1996, PSYCHOPHARMACOLOGY, V126, P271, DOI 10.1007/BF02246457; Eyjolfsson EM, 2006, NEUROCHEM INT, V48, P541, DOI 10.1016/j.neuint.2005.11.019; Eyjolfsson EM, 2006, NEUROCHEM INT; Faustman WO, 1999, BIOL PSYCHIAT, V45, P68, DOI 10.1016/S0006-3223(98)00207-8; Feifel D, 1999, PSYCHOPHARMACOLOGY, V146, P175, DOI 10.1007/s002130051103; Feinberg I, 1998, NEUROREPORT, V9, P2189, DOI 10.1097/00001756-199807130-00008; Genius J, 2012, CURR PHARM BIOTECHNO; Goff DC, 2005, HARVARD REV PSYCHIAT, V13, P352, DOI 10.1080/10673220500433262; Grunze HCR, 1996, J NEUROSCI, V16, P2034; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; Hashimoto K, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-6; Herin GA, 2001, J NEUROCHEM, V78, P1307, DOI 10.1046/j.1471-4159.2001.00517.x; Keilhoff G, 2004, NEUROSCIENCE, V126, P591, DOI 10.1016/j.neuroscience.2004.03.039; KONDZIELLA D, 2005, NEUROPSYCHOPHARMACOL; Kotecha SA, 2002, NEURON, V35, P1111, DOI 10.1016/S0896-6273(02)00859-0; KREBS MO, 1991, J NEUROCHEM, V56, P81, DOI 10.1111/j.1471-4159.1991.tb02565.x; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; Lahti AC, 2001, NEUROPSYCHOPHARMACOL, V25, P455, DOI 10.1016/S0893-133X(01)00243-3; LAHTI AC, 1995, NEUROPSYCHOPHARMACOL, V13, P9, DOI 10.1016/0893-133X(94)00131-I; Laruelle M, 2005, CLIN THER, V27, pS16, DOI 10.1016/j.clinthera.2005.07.017; Leveque JC, 2000, J NEUROSCI, V20, P4011; Lipska BK, 2003, EUR J NEUROSCI, V18, P391, DOI 10.1046/j.1460-9568.2003.02738.x; Mahadik SP, 1996, PROSTAG LEUKOTR ESS, V55, P45, DOI 10.1016/S0952-3278(96)90144-1; Malhotra AK, 1997, NEUROPSYCHOPHARMACOL, V17, P141; Moghaddam B, 1997, J NEUROSCI, V17, P2921; Morita T, 2000, PSYCHOPHARMACOLOGY, V148, P281, DOI 10.1007/s002130050052; NIEOULLON A, 1983, NEUROSCI LETT, V43, P191, DOI 10.1016/0304-3940(83)90186-6; Nishioka N, 2004, AM J GERIAT PSYCHIAT, V12, P167, DOI 10.1176/appi.ajgp.12.2.167; OLNEY JW, 1991, SCIENCE, V254, P1515, DOI 10.1126/science.1835799; Ossowska K, 1999, N-S ARCH PHARMACOL, V359, P280, DOI 10.1007/PL00005353; PAXINOS G, 1980, J NEUROSCI METH, V3, P129, DOI 10.1016/0165-0270(80)90021-7; Pietraszek M, 2002, N-S ARCH PHARMACOL, V366, P417, DOI 10.1007/s00210-002-0619-x; Rowland LM, 2005, AM J PSYCHIAT, V162, P394, DOI 10.1176/appi.ajp.162.2.394; Rujescu D, 2006, BIOL PSYCHIAT, V59, P721, DOI 10.1016/j.biopsych.2005.08.029; SamsDodd F, 1996, BEHAV PHARMACOL, V7, P3; Scarr E, 2005, NEUROPSYCHOPHARMACOL, V30, P1521, DOI 10.1038/sj.npp.1300758; Smythies J, 1999, NEUROTOX RES, V1, P27, DOI 10.1007/BF03033337; Smythies JR, 1997, SCHIZOPHR RES, V24, P357, DOI 10.1016/S0920-9964(97)00005-4; Steullet P, 2006, NEUROSCIENCE, V137, P807, DOI 10.1016/j.neuroscience.2005.10.014; Tibbo P, 2004, AM J PSYCHIAT, V161, P1116, DOI 10.1176/appi.ajp.161.6.1116; Torrey EF, 2005, BIOL PSYCHIAT, V57, P252, DOI 10.1016/j.biopsych.2004.10.019; TSAI GC, 1995, ARCH GEN PSYCHIAT, V52, P829; Tsai GC, 1998, AM J PSYCHIAT, V155, P1207, DOI 10.1176/ajp.155.9.1207; van Elst LT, 2005, BIOL PSYCHIAT, V58, P724, DOI 10.1016/j.biopsych.2005.04.041; VANDENBE.CJ, 1971, BIOCHEM J, V123, P211, DOI 10.1042/bj1230211; Velardo MJ, 1998, ALCOHOL CLIN EXP RES, V22, P1509; Zhang ZJ, 2002, SCHIZOPHR RES, V55, P1, DOI 10.1016/S0920-9964(01)00188-8	60	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2013	8	7							e59395	10.1371/journal.pone.0059395	http://dx.doi.org/10.1371/journal.pone.0059395			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZN	23869202	Green Submitted, Green Published, gold			2022-12-27	WOS:000323110600001
J	Judice, PB; Matias, CN; Santos, DA; Magalhaes, JP; Hamilton, MT; Sardinha, LB; Silva, AM				Judice, Pedro B.; Matias, Catarina N.; Santos, Diana A.; Magalhaes, Joao P.; Hamilton, Marc T.; Sardinha, Luis B.; Silva, Analiza M.			Caffeine Intake, Short Bouts of Physical Activity, and Energy Expenditure: A Double-Blind Randomized Crossover Trial	PLOS ONE			English	Article							FAT OXIDATION; SEDENTARY BEHAVIORS; GREEN TEA; TIME; ASSOCIATIONS; CONSUMPTION; METABOLISM; INGESTION; MORTALITY; VALIDITY	PA energy expenditure (PAEE) is the most variable component of Total Energy Expenditure (TEE) and largely due to the balance of sedentary time (SedT) and low intensity physical activity (LIPA). There has been an emergence for seeking an understanding of factors which determine variations in SedT, LIPA, and PAEE. Sedentary behavior and physical activity are relatively resistant to change by experimental dietary treatments and significant body weight changes. Although caffeine (Caf) is by far the most heavily used nutritional agent ingested to promote a sense of vigor/alertness, it is still unknown if Caf is effective in increasing PAEE and physical activity. The aim of the study was to test the hypothesis that 2 daily doses of Caf (as a capsule to blind the treatment and divided equally during breakfast and lunch) increase PAEE and TEE, and it would do so through increasing the frequent and brief bouts of physical activity (similar to 1-5 min long) through the day as measured by accelerometry. In 21 low Caf users (<100 mg day(-1)), we used a double-blind crossover trial (ClinicalTrials.govID;NCT01477294) with two conditions (4-day each with a 3-day washout period) randomly ordered as 5 mg kg(-1) day(-1) of Caf and maltodextrin as placebo (Plc). Resting energy expenditure (REE) by indirect calorimetry, total energy expenditure (TEE) from doubly labeled water, PAEE calculated as TEE-(REE+0.1TEE), and accelerometry measurements of both LIPA and MVPA were not different between conditions. However, regardless of caffeine or placebo, there were several significant relationships between brief bouts of LIPA and MVPA with PAEE. In conclusion, this double-blind study found that low and moderate-vigorous activity as well as the total volume of PAEE in free-living conditions is resistant to dietary caffeine intake that was equivalent to 5 cups of espresso or 7 cups of tea.	[Judice, Pedro B.; Matias, Catarina N.; Santos, Diana A.; Magalhaes, Joao P.; Sardinha, Luis B.; Silva, Analiza M.] Univ Tecn Lisboa, Fac Human Kinet, Interdisciplinary Ctr Study Human Performance, Exercise & Hlth Lab, Cruz Quebrada, Portugal; [Hamilton, Marc T.] Pennington Biomed Res Ctr, Inact Physiol Lab, Baton Rouge, LA USA	Universidade de Lisboa; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Silva, AM (corresponding author), Univ Tecn Lisboa, Fac Human Kinet, Interdisciplinary Ctr Study Human Performance, Exercise & Hlth Lab, Cruz Quebrada, Portugal.	analiza@fmh.utl.pt	Santos, Diana A/H-9086-2013; Sardinha, Luís B./ABG-5389-2020; Santos, Vanessa/AAP-4130-2020; Magalhães, João/ABH-2119-2021; Sardinha, Luís Bettencourt/F-2641-2013; Matias, Catarina N/I-7957-2014; Silva, Analiza M/C-9858-2010	Santos, Diana A/0000-0003-0429-3093; Sardinha, Luís B./0000-0002-6230-6027; Magalhães, João/0000-0003-1073-8650; Sardinha, Luís Bettencourt/0000-0002-6230-6027; Silva, Analiza M/0000-0002-8984-8600; Judice, Pedro/0000-0003-2791-258X	Portuguese Institute of Hydration and Health	Portuguese Institute of Hydration and Health	This work was supported by the Portuguese Institute of Hydration and Health (http://www.ihs.pt/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Andrews KW, 2007, ANAL BIOANAL CHEM, V389, P231, DOI 10.1007/s00216-007-1437-2; ARCIERO PJ, 1995, AM J PHYSIOL-ENDOC M, V268, pE1192, DOI 10.1152/ajpendo.1995.268.6.E1192; ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759; Baptista F, 2012, MED SCI SPORT EXER, V44, P466, DOI 10.1249/MSS.0b013e318230e441; Barone JJ, 1996, FOOD CHEM TOXICOL, V34, P119, DOI 10.1016/0278-6915(95)00093-3; Berube-Parent S, 2005, BRIT J NUTR, V94, P432, DOI 10.1079/BJN20051502; Bird ET, 2005, NEUROUROL URODYNAM, V24, P611, DOI 10.1002/nau.20179; Boreham CAG, 2005, BRIT J SPORT MED, V39, P590, DOI 10.1136/bjsm.2002.001131; BRACCO D, 1995, AM J PHYSIOL-ENDOC M, V269, pE671, DOI 10.1152/ajpendo.1995.269.4.E671; Burke LM, 2008, APPL PHYSIOL NUTR ME, V33, P1319, DOI 10.1139/H08-130; Church TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019657; COLLINS LC, 1994, INT J OBESITY, V18, P551; Compher C, 2006, J AM DIET ASSOC, V106, P881, DOI 10.1016/j.jada.2006.02.009; CURRIE SR, 1995, CLIN J PAIN, V11, P214; Drescher AA, 2011, J CLIN SLEEP MED, V7, P337, DOI 10.5664/JCSM.1182; DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44; Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040; DULLOO AG, 1992, METABOLISM, V41, P1233, DOI 10.1016/0026-0495(92)90015-3; Dunstan D, 2012, DIABETES RES CLIN PR, DOI 10.10; Dunstan DW, 2012, DIABETES CARE, V35, P976, DOI 10.2337/dc11-1931; Greenberg JA, 2005, INT J OBESITY, V29, P1121, DOI 10.1038/sj.ijo.0802999; Gregersen NT, 2009, BRIT J NUTR, V102, P1187, DOI 10.1017/S0007114509371779; Hamada T, 2008, TOHOKU J EXP MED, V214, P365, DOI 10.1620/tjem.214.365; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046; Heckman MA, 2010, J FOOD SCI, V75, pR77, DOI 10.1111/j.1750-3841.2010.01561.x; Hursel R, 2011, OBES REV, V12, pE573, DOI 10.1111/j.1467-789X.2011.00862.x; Hursel R, 2010, INT J OBESITY, V34, P659, DOI 10.1038/ijo.2009.299; John D, 2010, MED SCI SPORT EXER, V42, P368, DOI 10.1249/MSS.0b013e3181b3af49; Katzmarzyk PT, 2009, MED SCI SPORT EXER, V41, P998, DOI 10.1249/MSS.0b013e3181930355; KOOT P, 1995, ANN NUTR METAB, V39, P135, DOI 10.1159/000177854; Kozey-Keadle S, 2012, J OBES, V2012, DOI 10.1155/2012/282303; Kozey-Keadle S, 2011, MED SCI SPORT EXER, V43, P1561, DOI 10.1249/MSS.0b013e31820ce174; Lohman TG, 1988, ANTHROPOMETRIC STAND, P177, DOI DOI 10.1002/AJHB.1310040323; Lyden K, 2012, MED SCI SPORT EXER, V44, P2243, DOI 10.1249/MSS.0b013e318260c477; Macfarlane DJ, 2006, PREV MED, V43, P332, DOI 10.1016/j.ypmed.2006.06.002; Martin CK, 2012, OBESITY, V20, P891, DOI 10.1038/oby.2011.344; Matthews CE, 2012, AM J CLIN NUTR, V95, P437, DOI 10.3945/ajcn.111.019620; Miyashita M, 2008, AM J CLIN NUTR, V88, P1225, DOI 10.3945/ajcn.2008.26493; Owen N, 2010, EXERC SPORT SCI REV, V38, P105, DOI 10.1097/JES.0b013e3181e373a2; Roberts AT, 2005, ALTERN MED REV, V10, P321; ROBERTSON D, 1981, J CLIN INVEST, V67, P1111, DOI 10.1172/JCI110124; Santos DA, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-22; SCHOELLER DA, 1987, HUM NUTR-CLIN NUTR, V41C, P215; SCHOELLER DA, 1982, J APPL PHYSIOL, V53, P955, DOI 10.1152/jappl.1982.53.4.955; Sedentary Behaviour Research Network, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/h2012-024, DOI 10.1139/H2012-024]; Swartz AM, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-69; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98; Vandelanotte C, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1084; Ward DS, 2005, MED SCI SPORT EXER, V37, pS582, DOI 10.1249/01.mss.0000185292.71933.91; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; WHO, 2007, SPIN, P32; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053	55	10	10	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2013	8	7							e68936	10.1371/journal.pone.0068936	http://dx.doi.org/10.1371/journal.pone.0068936			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZN	23869233	Green Published, gold			2022-12-27	WOS:000323110600033
J	Belot, MP; Fradin, D; Mai, N; Le Fur, S; Zelenika, D; Kerr-Conte, J; Pattou, F; Lucas, B; Bougneres, P				Belot, Marie-Pierre; Fradin, Delphine; Mai, Nga; Le Fur, Sophie; Zelenika, Diana; Kerr-Conte, Julie; Pattou, Francois; Lucas, Bruno; Bougneres, Pierre			CpG Methylation Changes within the IL2RA Promoter in Type 1 Diabetes of Childhood Onset	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; TROPHOBLAST STEM-CELLS; NATURAL-KILLER-CELLS; HUMAN B-CELLS; DNA METHYLATION; GENE-EXPRESSION; T-CELLS; EPIGENETIC CONTROL; DENDRITIC CELLS; EMBRYONIC STEM	None of the polymorphic variants of the IL2RA gene found associated with Type 1 Diabetes (T1D) was shown to have a functional effect. To test if the epigenetic variation could play a role at this locus, we studied the methylation of 6 CpGs located within the proximal promoter of IL2RA gene in 252 T1D patients compared with 286 age-matched controls. We found that DNA methylation at CpGs -373 and -456 was slightly but significantly higher in patients than in controls (40.4 +/- 4.6 vs 38.3 +/- 5.4, p = 1.4E4; 91.4 +/- 2.8 vs 89.5 +/- 5.3, p = 1.8E-6), while other CpG showed a strictly comparable methylation. Among 106 single nucleotide polymorphisms (SNPs) located in the neighboring 180kb region, we found that 28 SNPs were associated with DNA methylation at CpG -373. Sixteen of these SNPs were known to be associated with T1D. Our findings suggest that the effect of IL2RA risk alleles on T1D may be partially mediated through epigenetic changes.	[Belot, Marie-Pierre; Fradin, Delphine; Mai, Nga; Le Fur, Sophie; Bougneres, Pierre] Univ Paris Sud, Bicetre Hosp, Pole I3E, INSERM U986, Paris, France; [Belot, Marie-Pierre; Fradin, Delphine; Mai, Nga; Le Fur, Sophie; Bougneres, Pierre] Univ Paris Sud, Bicetre Hosp, Pole I3E, Dept Pediat Endocrinol, Paris, France; [Zelenika, Diana] Ctr Natl Genotypage, Evry, France; [Kerr-Conte, Julie; Pattou, Francois] Univ Lille Nord France, INSERM U859, Lille, France; [Kerr-Conte, Julie; Pattou, Francois] Ctr Hosp Reg Univ Lille, Lille, France; [Lucas, Bruno] Cochin Hosp, CNRS Unite Mixte Rech 8104, INSERM U1016, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Bougneres, P (corresponding author), Univ Paris Sud, Bicetre Hosp, Pole I3E, INSERM U986, Paris, France.	Pierre.bougneres@inserm.fr	Pattou, Francois/O-6151-2017; Fradin, Delphine/K-7181-2015	Pattou, Francois/0000-0001-8388-3766; Fradin, Delphine/0000-0001-6231-2649; LUCAS, Bruno/0000-0002-0322-3977; BELOT, Marie-Pierre/0000-0001-7502-0549	"Alliance Diabete de Type 1 NovoNordisk-INSERM'' program; Centre National de Genotypage (Evry); Association pour la Recherche sur le Diabete; Association pour la Recherche sur le Diabete (ARD); NovoNordisk France ("Alliance''); Programme Hospitalier de Recherche Clinique	"Alliance Diabete de Type 1 NovoNordisk-INSERM'' program; Centre National de Genotypage (Evry); Association pour la Recherche sur le Diabete(Fondation ARC pour la Recherche sur le Cancer); Association pour la Recherche sur le Diabete (ARD); NovoNordisk France ("Alliance''); Programme Hospitalier de Recherche Clinique	This study was supported by "Alliance Diabete de Type 1 NovoNordisk-INSERM'' program, Centre National de Genotypage (Evry), Association pour la Recherche sur le Diabete, Programme Hospitalier de Recherche Clinique; by a grant from Association pour la Recherche sur le Diabete (ARD grant 2012 to DF), and NovoNordisk France ("Alliance'' 2010-2013 to PB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bell CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014040; Bosco MC, 1997, J IMMUNOL, V159, P2922; Bradfield JP, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002293; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Byun HM, 2009, HUM MOL GENET, V18, P4808, DOI 10.1093/hmg/ddp445; CALIGIURI MA, 1993, J CLIN INVEST, V91, P123, DOI 10.1172/JCI116161; CALIGIURI MA, 1990, J EXP MED, V171, P1509, DOI 10.1084/jem.171.5.1509; CASTANO L, 1990, ANNU REV IMMUNOL, V8, P647, DOI 10.1146/annurev.iy.08.040190.003243; Cho JH, 2001, ENDOCRINOLOGY, V142, P3389, DOI 10.1210/en.142.8.3389; Cui HM, 2003, SCIENCE, V299, P1753, DOI 10.1126/science.1080902; Fehniger TA, 2003, BLOOD, V101, P3052, DOI 10.1182/blood-2002-09-2876; Fradin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036278; Furtado GC, 2002, J EXP MED, V196, P851, DOI 10.1084/jem.20020190; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hattori N, 2004, J BIOL CHEM, V279, P17063, DOI 10.1074/jbc.M309002200; Hattori N, 2007, GENES CELLS, V12, P387, DOI 10.1111/j.1365-2443.2007.01058.x; Imamura T, 2001, GENOMICS, V76, P117, DOI 10.1006/geno.2001.6607; JUNG LKL, 1984, J EXP MED, V160, P1597, DOI 10.1084/jem.160.5.1597; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Kim HP, 2006, CYTOKINE GROWTH F R, V17, P349, DOI 10.1016/j.cytogfr.2006.07.003; KNIEP EM, 1992, IMMUNOLOGY, V75, P299; Kronin V, 1998, INT IMMUNOL, V10, P237, DOI 10.1093/intimm/10.2.237; Kuniyasu Y, 2000, INT IMMUNOL, V12, P1145, DOI 10.1093/intimm/12.8.1145; Lee GR, 2006, IMMUNITY, V24, P369, DOI 10.1016/j.immuni.2006.03.007; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Lowe CE, 2007, NAT GENET, V39, P1074, DOI 10.1038/ng2102; Nishino K, 2004, J BIOL CHEM, V279, P22306, DOI 10.1074/jbc.M309513200; Qu HQ, 2007, DIABETES, V56, P1174, DOI 10.2337/db06-1555; Rakyan VK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002300; Roep BO, 2003, DIABETOLOGIA, V46, P305, DOI 10.1007/s00125-003-1089-5; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Shen SM, 2008, NAT NEUROSCI, V11, P1024, DOI 10.1038/nn.2172; Shoemaker R, 2010, GENOME RES, V20, P883, DOI 10.1101/gr.104695.109; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Talens RP, 2010, FASEB J, V24, P3135, DOI 10.1096/fj.09-150490; Tisch R, 1996, CELL, V85, P291, DOI 10.1016/S0092-8674(00)81106-X; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Vella A, 2005, AM J HUM GENET, V76, P773, DOI 10.1086/429843; Velten FW, 2007, MOL IMMUNOL, V44, P1544, DOI 10.1016/j.molimm.2006.08.020; WALDMANN TA, 1984, J EXP MED, V160, P1450, DOI 10.1084/jem.160.5.1450; Yagi S, 2008, GENOME RES, V18, P1969, DOI 10.1101/gr.074070.107; Zhang DD, 2010, AM J HUM GENET, V86, P411, DOI 10.1016/j.ajhg.2010.02.005	44	32	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e68093	10.1371/journal.pone.0068093	http://dx.doi.org/10.1371/journal.pone.0068093			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	23874506	Green Published, gold, Green Submitted			2022-12-27	WOS:000321718700008
J	Farrell, M; Sebeny, P; Klena, JD; DeMattos, C; Pimentel, G; Turner, M; Joseph, A; Espiritu, J; Zumwalt, J; Dueger, E				Farrell, Margaret; Sebeny, Peter; Klena, John D.; DeMattos, Cecilia; Pimentel, Guillermo; Turner, Mark; Joseph, Antony; Espiritu, Jennifer; Zumwalt, John; Dueger, Erica			Influenza Risk Management: Lessons Learned from an A(H1N1) pdm09 Outbreak Investigation in an Operational Military Setting	PLOS ONE			English	Article							VIRUSES	Background: At the onset of an influenza pandemic, when the severity of a novel strain is still undetermined and there is a threat of introduction into a new environment, e. g., via the deployment of military troops, sensitive screening criteria and conservative isolation practices are generally recommended. Objectives: In response to elevated rates of influenza-like illness among U. S. military base camps in Kuwait, U. S. Naval Medical Research Unit No. 3 partnered with local U. S. Army medical units to conduct an A(H1N1) pdm09 outbreak investigation. Patients/Methods: Initial clinical data and nasal specimens were collected via the existent passive surveillance system and active surveillance was conducted using a modified version of the World Health Organization/U.S. Centers for Disease Control and Prevention influenza-like illness case definition [fever (T > 100.5 degrees F/38 degrees C) in addition to cough and/or sore throat in the previous 72 hours] as the screening criteria. Samples were tested via real-time reverse-transcription PCR and sequenced for comparison to global A(H1N1) pdm09 viruses from the same time period. Results: The screening criteria used in Kuwait proved insensitive, capturing only 16% of A(H1N1) pdm09-positive individuals. While still not ideal, using cough as the sole screening criteria would have increased sensitivity to 73%. Conclusions: The results of and lessons learned from this outbreak investigation suggest that pandemic influenza risk management should be a dynamic process (as information becomes available regarding true attack rates and associated mortality, screening and isolation criteria should be re-evaluated and revised as appropriate), and that military operational environments present unique challenges to influenza surveillance.	[Farrell, Margaret; Dueger, Erica] US Amer Naval Med Res Unit, Global Dis Detect & Response Program, Cairo, Egypt; [Sebeny, Peter; Klena, John D.] US Naval Med Res Unit 3, Clin Trials & Mil Studies Dept, Cairo, Egypt; [DeMattos, Cecilia] Naval Hlth Res Ctr, San Diego, CA USA; [DeMattos, Cecilia; Pimentel, Guillermo] US Naval Med Res Unit 3, Viral & Zoonot Dis Res Program, Cairo, Egypt; [Turner, Mark] Naval Hosp Bremerton, Bremerton, WA USA; [Joseph, Antony] Naval Med Ctr San Diego, Navy Environm & Preventat Med Unit, San Diego, CA USA; [Espiritu, Jennifer] US Ctr Dis Control & Prevent, Epidem Intelligence Serv Program, Atlanta, GA USA; [Zumwalt, John] Navy Hosp Jacksonville, Naval Air Stn Jacksonville, Jacksonville, FL USA; [Dueger, Erica] US Ctr Dis Control & Prevent, Global Dis Detect Branch, Atlanta, GA USA	Naval Medical Research Center (NMRC); Naval Medical Research Unit - No. 3 (NAMRU-3); United States Department of Defense; United States Navy; Naval Medical Research Center (NMRC); Naval Health Research Center (NHRC); Naval Medical Research Center (NMRC); Naval Medical Research Unit - No. 3 (NAMRU-3); United States Department of Defense; United States Navy; Naval Medical Center San Diego; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Farrell, M (corresponding author), US Amer Naval Med Res Unit, Global Dis Detect & Response Program, Cairo, Egypt.	marleefar@gmail.com		Pimentel, Guillermo/0000-0003-2464-1526	Global Emerging Infections Surveillance and Response System (GEIS); CDC Global Disease Detection and Response Program (GDDRP)	Global Emerging Infections Surveillance and Response System (GEIS); CDC Global Disease Detection and Response Program (GDDRP)	This work was supported by the Global Emerging Infections Surveillance and Response System (GEIS, http://www.afhsc.mil/geis) and the CDC Global Disease Detection and Response Program (GDDRP, http://www.cdc.gov/globalhealth/gdder/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balicer RD, 2005, EMERG INFECT DIS, V11, P579, DOI 10.3201/eid1104.040845; Committee for the Assessment of Dod-GEIS Influenza Surveillance and Response Programs, 2007, REV DOD GEIS INFL PR; Faix DJ, 2009, NEW ENGL J MED, V361, P728, DOI 10.1056/NEJMc0904264; Hanada K, 2004, MOL BIOL EVOL, V21, P1074, DOI 10.1093/molbev/msh109; Kapp L., 2009, ROLE DEP DEFENSE FLU, V18; Kilic Selim, 2007, Turk Silahli Kuvvetleri Koruyucu Hekim Bul, V6, P285; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Montero EM, 2010, REV ESP SALUD PUBLIC, V84, P597, DOI 10.1590/s1135-57272010000500011; Nelson M, 2009, PLOS CURR, V1; Potdar VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009693; Shiino T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011057; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Stone WJ, 1919, J AMER MED ASSOC, V72, P487, DOI 10.1001/jama.1919.02610070025014; Balish Amanda L, 2013, Curr Protoc Microbiol, VChapter 15, DOI [10.1002/0471729256.mc15g01s3, 10.1002/9780471729259.mc15g01s29]; Tamura K, 2011, MOL EVOL GENET ANAL, V5; Valli MB, 2010, PLOS CURR, V2; WHO, 2009, SEQ PRIM PROT; World Health Organization, 2002, WHO MAN AN INFL DIAG; World Health Organization, 2011, IR SIT REP INFL H1N1	20	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68639	10.1371/journal.pone.0068639	http://dx.doi.org/10.1371/journal.pone.0068639			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874699	Green Published, gold			2022-12-27	WOS:000321765300058
J	Hu, J; Qiu, S; Yang, F; Cao, ZJ; Li, WX; Wu, YL				Hu, Jun; Qiu, Su; Yang, Fan; Cao, Zhijian; Li, Wenxin; Wu, Yingliang			Unique Mechanism of the Interaction between Honey Bee Toxin TPNQ and rKir1.1 Potassium Channel Explored by Computational Simulations: Insights into the Relative Insensitivity of Channel towards Animal Toxins	PLOS ONE			English	Article							SEA-ANEMONE TOXIN; K+ CHANNEL; KV1.3 CHANNEL; MOLECULAR-MECHANISM; CRYSTAL-STRUCTURE; HIGH-AFFINITY; PEPTIDE; INHIBITOR; TERTIAPIN; DOCKING	Background: The 21-residue compact tertiapin-Q (TPNQ) toxin, a derivative of honey bee toxin tertiapin (TPN), is a potent blocker of inward-rectifier K+ channel subtype, rat Kir1.1 (rKir1.1) channel, and their interaction mechanism remains unclear. Principal Findings: Based on the flexible feature of potassium channel turrets, a good starting rKir1.1 channel structure was modeled for the accessibility of rKir1.1 channel turrets to TPNQ toxin. In combination with experimental alanine scanning mutagenesis data, computational approaches were further used to obtain a reasonable TPNQ toxin-rKir1.1 channel complex structure, which was completely different from the known binding modes between animal toxins and potassium channels. TPNQ toxin mainly adopted its helical domain as the channel-interacting surface together with His12 as the pore-blocking residue. The important Gln13 residue mainly contacted channel residues near the selectivity filter, and Lys20 residue was surrounded by a polar "groove" formed by Arg118, Thr119, Glu123, and Asn124 in the channel turret. On the other hand, four turrets of rKir1.1 channel gathered to form a narrow pore entryway for TPNQ toxin recognition. The Phe146 and Phe148 residues in the channel pore region formed strong hydrophobic protrusions, and produced dominant nonpolar interactions with toxin residues. These specific structure features of rKir1.1 channel vestibule well matched the binding of potent TPNQ toxin, and likely restricted the binding of the classical animal toxins. Conclusions/Significance: The TPNQ toxin-rKir1.1 channel complex structure not only revealed their unique interaction mechanism, but also would highlight the diverse animal toxin-potassium channel interactions, and elucidate the relative insensitivity of rKir1.1 channel towards animal toxins.	[Hu, Jun; Qiu, Su; Yang, Fan; Cao, Zhijian; Li, Wenxin; Wu, Yingliang] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China	Wuhan University	Wu, YL (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	ylwu@whu.edu.cn			National Basic Research Program of China [2010CB529800]; National High Technology Research and Development Program of China [2012AA020304]; National Natural Sciences Foundation of China [31170789]; New Century Excellent Talents in Wuhan University by the Ministry of Education of China [NCET-10-0651]; Wuhan City Science and Technology Foundation of China [2013070204020046]	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents in Wuhan University by the Ministry of Education of China; Wuhan City Science and Technology Foundation of China	This work was supported by grants from the National Basic Research Program of China (2010CB529800), National High Technology Research and Development Program of China (2012AA020304), and National Natural Sciences Foundation of China (number 31170789). New Century Excellent Talents in Wuhan University by the Ministry of Education of China (No. NCET-10-0651), and Wuhan City Science and Technology Foundation of China (No. 2013070204020046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashcroft FM, 2006, NATURE, V440, P440, DOI 10.1038/nature04707; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Case D.A., 2022, AMBER 2020; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Chen R, 2012, BIOCHEMISTRY-US, V51, P1976, DOI 10.1021/bi201811j; Chen ZY, 2012, J BIOL CHEM, V287, P13813, DOI 10.1074/jbc.M112.343996; Chi V, 2012, TOXICON, V59, P529, DOI 10.1016/j.toxicon.2011.07.016; Eriksson MAL, 2002, BIOPHYS J, V83, P2595, DOI 10.1016/S0006-3495(02)75270-3; Gilquin B, 2005, J BIOL CHEM, V280, P27093, DOI 10.1074/jbc.M413626200; Han S, 2008, J BIOL CHEM, V283, P19058, DOI 10.1074/jbc.M802054200; Han S, 2010, J PROTEOME RES, V9, P3118, DOI 10.1021/pr100027k; Hilder TA, 2013, BIOCHEMISTRY-US, V52, P967, DOI 10.1021/bi301498x; Huang XQ, 2005, J AM CHEM SOC, V127, P6836, DOI 10.1021/ja042641q; Jin L, 2007, J CHEM INF MODEL, V47, P1967, DOI 10.1021/ci700178w; Jin L, 2011, J MOL RECOGNIT, V24, P101, DOI 10.1002/jmr.1031; Jin WL, 1999, BIOCHEMISTRY-US, V38, P14286, DOI 10.1021/bi991205r; Jin WL, 1999, BIOCHEMISTRY-US, V38, P14294, DOI 10.1021/bi991206j; Li Z, 2012, J BIOL CHEM, V287, P29479, DOI 10.1074/jbc.M112.379594; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Mouhat S, 2005, J PEPT SCI, V11, P65, DOI 10.1002/psc.630; Mouhat S, 2008, CURR PHARM DESIGN, V14, P2503, DOI 10.2174/138161208785777441; Qiu S, 2009, J CHEM INF MODEL, V49, P1831, DOI 10.1021/ci900025n; Ramu Y, 2001, BIOCHEMISTRY-US, V40, P3601, DOI 10.1021/bi002584n; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wu YL, 2004, BIOPHYS J, V87, P105, DOI 10.1529/biophysj.103.039156; Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983; XU XB, 1993, PROTEINS, V17, P124, DOI 10.1002/prot.340170203; Yi H, 2008, PROTEINS, V70, P844, DOI 10.1002/prot.21706; Yi H, 2007, J PROTEOME RES, V6, P611, DOI 10.1021/pr060368g; Yi H, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11; Yin SJ, 2008, J PROTEOME RES, V7, P4890, DOI 10.1021/pr800494a	33	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e67213	10.1371/journal.pone.0067213	http://dx.doi.org/10.1371/journal.pone.0067213			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874410	Green Submitted, gold, Green Published			2022-12-27	WOS:000321765300007
J	Kerkhoff, AD; Wood, R; Lowe, DM; Vogt, M; Lawn, SD				Kerkhoff, Andrew D.; Wood, Robin; Lowe, David M.; Vogt, Monica; Lawn, Stephen D.			Blood Neutrophil Counts in HIV-Infected Patients with Pulmonary Tuberculosis: Association with Sputum Mycobacterial Load	PLOS ONE			English	Article							OUTCOMES; PROGRAM; SERVICE; AFRICA; IMPACT; CELLS	Background: Increasing evidence suggests that neutrophils play a role in the host response to Mycobacterium tuberculosis. We determined whether neutrophil counts in peripheral blood are associated with tuberculosis (TB) and with mycobacterial load in sputum in HIV-infected patients. Methodology/Principal Findings: Adults enrolling in an antiretroviral treatment (ART) clinic in a Cape Town township were screened for TB regardless of symptoms. Paired sputum samples were examined using liquid culture, fluorescence microscopy, and the Xpert MTB/RIF assay. Absolute neutrophil counts (ANC) were measured in blood samples. Of 602 HIV-infected patients screened, 523 produced one or more sputum samples and had complete results available for analysis. Among these 523 patients, the median CD4 count was 169 x 10(9)/L (IQR, 96-232) and median ANC was 2.6 x 10(9)/L (IQR, 1.9-3.6). Culture-positive pulmonary tuberculosis was diagnosed in 89 patients. Patients with TB had a median ANC of 3.4 x 10(9)/L (IQR, 2.4-5.1) compared to 2.5 x 10(9)/L (IQR, 1.8-3.4) among those who were culture negative (p<0.0001). In multivariable analyses, having pulmonary TB was associated with an adjusted risk ratio (aRR) of 2.6 (95%CI, 1.5-4.5) for having an ANC level that exceeded the median value (ANC >= 2.6 x 10(9)/L; p = 0.0006) and an aRR of 6.8 (95%CI, 2.3-20.4) for having neutrophilia defined by a neutrophil count exceeding the upper limit of the normal range (ANC >7.5 x 10(9)/L; p = 0.0005). Patients were then classified into four mutually exclusive groups with increasing sputum mycobacterial load as defined by the results of culture, Xpert MTB/RIF and sputum smear microscopy. Multivariable analyses demonstrated that increasing sputum mycobacterial load was positively associated with blood ANC >= 2.6 x 10(9)/L and with neutrophilia. Conclusions/Significance: Increased blood neutrophil counts were independently associated with pulmonary TB and sputum mycobacterial burden in this HIV-infected patient group. This observation supports the growing body of literature regarding the potential role for neutrophils in the host response to TB.	[Kerkhoff, Andrew D.] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA; [Kerkhoff, Andrew D.; Wood, Robin; Vogt, Monica; Lawn, Stephen D.] Univ Cape Town, Fac Hlth Sci, Desmond Tutu HIV Ctr, Inst Infect Dis & Mol Med, Cape Town, South Africa; [Lowe, David M.] Univ Cape Town, Inst Infect Dis & Mol Med, Clin Infect Dis Res Initiat, Cape Town, South Africa; [Lowe, David M.] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Lawn, Stephen D.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, London WC1, England	George Washington University; University of Cape Town; University of Cape Town; Imperial College London; University of London; London School of Hygiene & Tropical Medicine	Kerkhoff, AD (corresponding author), George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA.	Kerkhoff@gwu.edu			International Epidemiologic Database to Evaluate Aids; Cost-Effectiveness of Preventing AIDS Complications (CEPAC); National Institutes of Health (NIH) [5 R01AI058736-02]; USAID Right to Care [CA 674 A 00 08 0000 700]; South African Centre for Epidemiological Modeling and Analysis (SACEMA); Wellcome Trust, London, UK; National Institute of Allergy and Infectious Diseases (NIAID) [5U01AI069924-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058736, U01AI069924] Funding Source: NIH RePORTER	International Epidemiologic Database to Evaluate Aids; Cost-Effectiveness of Preventing AIDS Complications (CEPAC); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USAID Right to Care(United States Agency for International Development (USAID)); South African Centre for Epidemiological Modeling and Analysis (SACEMA); Wellcome Trust, London, UK(Wellcome Trust); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	RW is funded in part by the International Epidemiologic Database to Evaluate Aids with a grant from the National Institute of Allergy and Infectious Diseases (NIAID: 5U01AI069924-02); Cost-Effectiveness of Preventing AIDS Complications (CEPAC) funded by the National Institutes of Health (NIH, 5 R01AI058736-02); USAID Right to Care (CA 674 A 00 08 0000 700), and the South African Centre for Epidemiological Modeling and Analysis (SACEMA). DL and SDL are funded by the Wellcome Trust, London, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anbarasu D, 2013, CYTOKINE, V61, P747, DOI 10.1016/j.cyto.2012.12.031; Ashitani J, 2002, CHEST, V121, P519, DOI 10.1378/chest.121.2.519; Bandara A, 2008, THORAX, V63, pA114; BARNES PF, 1988, J INFECT DIS, V158, P366, DOI 10.1093/infdis/158.2.366; Condos R, 1998, AM J RESP CRIT CARE, V157, P729, DOI 10.1164/ajrccm.157.3.9705044; Eum SY, 2010, CHEST, V137, P122, DOI 10.1378/chest.09-0903; Fiorenza G, 2003, FEMS IMMUNOL MED MIC, V35, P159, DOI 10.1016/S0928-8244(03)00004-X; Fiorenza G, 2007, ARCH MED RES, V38, P526, DOI 10.1016/j.arcmed.2007.01.011; Furze RC, 2008, IMMUNOLOGY, V125, P281, DOI 10.1111/j.1365-2567.2008.02950.x; Getahun H, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000391; Gupta A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055824; Lawn SD, 2013, INT J TUBERC LUNG D, V17, P636, DOI 10.5588/ijtld.12.0811; Lawn SD, 2012, INT J TUBERC LUNG D, V16, P1354, DOI 10.5588/ijtld.12.0174; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Lawn SD, 2007, AIDS, V21, P335, DOI 10.1097/QAD.0b013e328011efac; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; Lawn SD, 2013, LANCET INFECT DIS, V13, P349, DOI 10.1016/S1473-3099(13)70008-2; Lawn SD, 2012, AIDS, V26, P1635, DOI 10.1097/QAD.0b013e3283553685; Lawn SD, 2012, JAIDS-J ACQ IMM DEF, V60, P289, DOI 10.1097/QAI.0b013e318258c6af; Lawn SD, 2012, CLIN INFECT DIS, V54, P1071, DOI 10.1093/cid/cir1039; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Liu FL, 1997, BLOOD, V90, P2583, DOI 10.1182/blood.V90.7.2583.2583_2583_2590; Lowe DM, 2012, TRENDS IMMUNOL, V33, P14, DOI 10.1016/j.it.2011.10.003; Martineau AR, 2007, J CLIN INVEST, V117, P1988, DOI 10.1172/JCI31097; Martineau AR, 2011, LANCET, V377, P242, DOI 10.1016/S0140-6736(10)61889-2; Nandi B, 2011, J EXP MED, V208, P2251, DOI 10.1084/jem.20110919; Shalekoff S, 1998, CLIN DIAGN LAB IMMUN, V5, P41, DOI 10.1128/CDLI.5.1.41-44.1998	27	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e67956	10.1371/journal.pone.0067956	http://dx.doi.org/10.1371/journal.pone.0067956			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874476	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000321736900039
J	Iovino, F; Orihuela, CJ; Moorlag, HE; Molema, G; Bijlsma, JJE				Iovino, Federico; Orihuela, Carlos J.; Moorlag, Henk E.; Molema, Grietje; Bijlsma, Jetta J. E.			Interactions between Blood-Borne Streptococcus pneumoniae and the Blood-Brain Barrier Preceding Meningitis	PLOS ONE			English	Article							MICROVASCULAR ENDOTHELIAL-CELLS; NECROSIS-FACTOR-ALPHA; BACTERIAL-MENINGITIS; PNEUMOCOCCAL MENINGITIS; EPITHELIAL-CELLS; NERVOUS-SYSTEM; IN-VITRO; INVASION; ACTIVATION; MICROGLIA	Streptococcus pneumoniae (the pneumococcus) is a Gram-positive bacterium and the predominant cause of bacterial meningitis. Meningitis is thought to occur as the result of pneumococci crossing the blood-brain barrier to invade the Central Nervous System (CNS); yet little is known about the steps preceding immediate disease development. To study the interactions between pneumococci and the vascular endothelium of the blood-brain barrier prior to meningitis we used an established bacteremia-derived meningitis model in combination with immunofluorescent imaging. Brain tissue of mice infected with S. pneumoniae strain TIGR4, a clinical meningitis isolate, was investigated for the location of the bacteria in relation to the brain vasculature in various compartments. We observed that S. pneumoniae adhered preferentially to the subarachnoid vessels, and subsequently, over time, reached the more internal cerebral areas including the cerebral cortex, septum, and choroid plexus. Interestingly, pneumococci were not detected in the choroid plexus till 8 hours-post infection. In contrast to the lungs, little to no leukocyte recruitment to the brain was observed over time, though Iba-1 and GFAP staining showed that microglia and astrocytes were activated as soon as 1 hour post-infection. Our results imply that i) the local immune system of the brain is activated immediately upon entry of bacteria into the bloodstream and that ii) adhesion to the blood brain barrier is spatiotemporally controlled at different sites throughout the brain. These results provide new information on these two important steps towards the development of pneumococcal meningitis.	[Iovino, Federico; Bijlsma, Jetta J. E.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands; [Orihuela, Carlos J.] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA; [Moorlag, Henk E.; Molema, Grietje] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Med Biol Sect, Groningen, Netherlands	University of Groningen; University of Texas System; University of Texas Health San Antonio; University of Groningen	Bijlsma, JJE (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands.	j.j.e.bijlsma@umcg.nl	Iovino, Federico/AGW-9968-2022; Iovino, Federico/R-2721-2017	Iovino, Federico/0000-0001-5249-9120; Iovino, Federico/0000-0001-5249-9120; Molema, Grietje/0000-0002-4147-6676	National Institutes of Health (NIH) [AI078972]; Netherlands Organisation for Scientific Research (NWO) [40-00506-98-9021, 175-010-2009-023]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078972] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Parts of this work were funded by the National Institutes of Health (NIH) AI078972 (CJO). Part of the imaging analysis has been performed at the UMCG Microscopy and Imaging center (UMIC), which is sponsored by grants 40-00506-98-9021, and 175-010-2009-023 of the Netherlands Organisation for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Altin JG, 1997, IMMUNOL CELL BIOL, V75, P430, DOI 10.1038/icb.1997.68; Attali C, 2008, INFECT IMMUN, V76, P5350, DOI 10.1128/IAI.00184-08; Barichello T, 2012, BRAIN RES, V1471, P162, DOI 10.1016/j.brainres.2012.06.054; Barichello T, 2009, NEUROSCI LETT, V467, P217, DOI 10.1016/j.neulet.2009.10.039; Bramanti Vincenzo, 2010, Front Biosci (Schol Ed), V2, P558; Brouwer MC, 2010, CLIN MICROBIOL REV, V23, P467, DOI 10.1128/CMR.00070-09; CLEMENT LT, 1992, J CLIN IMMUNOL, V12, P1, DOI 10.1007/BF00918266; Corada M, 1999, P NATL ACAD SCI USA, V96, P9815, DOI 10.1073/pnas.96.17.9815; Coureuil M, 2009, SCIENCE, V325, P83, DOI 10.1126/science.1173196; Debbage PL, 2001, HISTOCHEM CELL BIOL, V116, P349, DOI 10.1007/s004180100328; Elm C, 2004, J BIOL CHEM, V279, P6296, DOI 10.1074/jbc.M310528200; Fassbender K, 1996, J NEUROL NEUROSUR PS, V61, P57, DOI 10.1136/jnnp.61.1.57; Gerber J, 2010, CURR OPIN NEUROL, V23, P312, DOI 10.1097/WCO.0b013e32833950dd; Hammerschmidt S, 2005, INFECT IMMUN, V73, P4653, DOI 10.1128/IAI.73.8.4653-4667.2005; Hashizume H, 2000, AM J PATHOL, V156, P1363, DOI 10.1016/S0002-9440(10)65006-7; Hoffman Olaf, 2009, Ther Adv Neurol Disord, V2, P1, DOI 10.1177/1756285609337975; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Koedel U, 2002, LANCET INFECT DIS, V2, P721, DOI 10.1016/S1473-3099(02)00450-4; KREUTZBERG GW, 1995, ARZNEIMITTEL-FORSCH, V45-1, P357; Liu W, 2011, LIFE SCI, V89, P141, DOI 10.1016/j.lfs.2011.05.011; Marriott HM, 2008, CURR MOL MED, V8, P497, DOI 10.2174/156652408785747924; Minogue AM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-126; Mook-Kanamori B, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-71; Newman PJ, 2003, ARTERIOSCL THROM VAS, V23, P953, DOI 10.1161/01.ATV.0000071347.69358.D9; OHGA S, 1994, ARCH DIS CHILD, V70, P123, DOI 10.1136/adc.70.2.123; Orihuela CJ, 2006, INFECT IMMUN, V74, P3783, DOI 10.1128/IAI.00022-06; Orihuela CJ, 2009, J CLIN INVEST, V119, P1638, DOI 10.1172/JCI36759; Orihuela CJ, 2004, J INFECT DIS, V190, P1661, DOI 10.1086/424596; Ostergaard C, 2004, J INFECT DIS, V190, P1212, DOI 10.1086/423852; Pancholi V, 2003, MICROB PATHOGENESIS, V35, P293, DOI 10.1016/j.micpath.2003.08.004; Paul R, 2005, J INFECT DIS, V191, P776, DOI 10.1086/427829; Paul R, 2004, J NEUROIMMUNOL, V152, P78, DOI 10.1016/j.jneuroim.2004.04.004; Paul R, 1998, ANN NEUROL, V44, P592, DOI 10.1002/ana.410440404; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Purves D., 2001, NEUROSCIENCE; Radin JN, 2006, INFECT IMMUN, V74, P3078, DOI 10.1128/IAI.74.5.3078.2006; Ring A, 1998, J CLIN INVEST, V102, P347, DOI 10.1172/JCI2406; Schiff L, 2012, MOL DIAGN THER, V16, P79, DOI 10.2165/11631580-000000000-00000; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwerk C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030069; SHARIEF MK, 1992, J INFECT DIS, V166, P350, DOI 10.1093/infdis/166.2.350; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Stins MF, 2001, MICROB PATHOGENESIS, V30, P19, DOI 10.1006/mpat.2000.0406; Tam SJ, 2010, ANNU REV NEUROSCI, V33, P379, DOI 10.1146/annurev-neuro-060909-152829; Tenenbaum T, 2009, CELL MICROBIOL, V11, P323, DOI 10.1111/j.1462-5822.2008.01255.x; Tenenbaum T, 2006, BRAIN RES, V1100, P1, DOI 10.1016/j.brainres.2006.05.041; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wen YR, 2011, J FORMOS MED ASSOC, V110, P487, DOI 10.1016/S0929-6646(11)60074-0; Woehrl B, 2011, EXPERT REV ANTI-INFE, V9, P1053, DOI [10.1586/ERI.11.129, 10.1586/eri.11.129]; Zhang D, 2010, MOL NEUROBIOL, V41, P232, DOI 10.1007/s12035-010-8098-4; Zysk G, 2001, INFECT IMMUN, V69, P845, DOI 10.1128/IAI.69.2.845-852.2001	54	53	53	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68408	10.1371/journal.pone.0068408	http://dx.doi.org/10.1371/journal.pone.0068408			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874613	Green Submitted, gold, Green Published			2022-12-27	WOS:000322064300029
J	Biondo, AE; Pluchino, A; Rapisarda, A; Helbing, D				Biondo, Alessio Emanuele; Pluchino, Alessandro; Rapisarda, Andrea; Helbing, Dirk			Are Random Trading Strategies More Successful than Technical Ones?	PLOS ONE			English	Article							RATIONAL-EXPECTATIONS; MARKETS; OPTIONS; POWER	In this paper we explore the specific role of randomness in financial markets, inspired by the beneficial role of noise in many physical systems and in previous applications to complex socio-economic systems. After a short introduction, we study the performance of some of the most used trading strategies in predicting the dynamics of financial markets for different international stock exchange indexes, with the goal of comparing them to the performance of a completely random strategy. In this respect, historical data for FTSE-UK, FTSE-MIB, DAX, and S & P500 indexes are taken into account for a period of about 15-20 years (since their creation until today).	[Biondo, Alessio Emanuele] Univ Catania, Dipartimento Econ & Impresa, Catania, Italy; [Pluchino, Alessandro; Rapisarda, Andrea] Univ Catania, Dipartimento Fis & Astron, Catania, Italy; [Pluchino, Alessandro; Rapisarda, Andrea] INFN Sez Catania, Catania, Italy; [Helbing, Dirk] Swiss Fed Inst Technol, Zurich, Switzerland	University of Catania; University of Catania; Istituto Nazionale di Fisica Nucleare (INFN); Swiss Federal Institutes of Technology Domain; ETH Zurich	Biondo, AE (corresponding author), Univ Catania, Dipartimento Econ & Impresa, Catania, Italy.	ae.biondo@unict.it	Rapisarda, Andrea/S-2758-2019; Pluchino, Alessandro/D-7407-2014; Rapisarda, Andrea/D-2453-2014; Biondo, Alessio Emanuele/C-3951-2015	Rapisarda, Andrea/0000-0001-8290-8183; Pluchino, Alessandro/0000-0001-9368-5800; Rapisarda, Andrea/0000-0001-8290-8183; Biondo, Alessio Emanuele/0000-0002-1421-3707; Zogala, Paul/0000-0002-0730-677X				ARROW KJ, 1958, ECONOMETRICA, V26, P297, DOI 10.2307/1907591; BENZI R, 1982, TELLUS, V34, P10, DOI 10.1111/j.2153-3490.1982.tb01787.x; Biondo AE, 2013, J STAT PHYS, V151, P607, DOI 10.1007/s10955-013-0691-2; BLACK F, 1973, J POLIT ECON, V81, P637, DOI 10.1086/260062; Brock W.A., 1993, ESTUDIOS EC, V8, P3; Brock WA, 1997, ECONOMETRICA, V65, P1059, DOI 10.2307/2171879; Brock WA, 1993, INTRO ECONOPHYSICS C, V8, P3; Cagan P., 1956, STUDIES QUANTITY THE; Campbell JY, 1988, REV FINANC STUD, V1, P195, DOI 10.1093/rfs/1.3.195; Carbone A, 2004, PHYSICA A, V344, P267, DOI 10.1016/j.physa.2004.06.130; Caruso F, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.190501; Chiarella C., 1992, Annals of Operations Research, V37, P101, DOI 10.1007/BF02071051; Chiarella C, 1992, EC EVOLVING COMPLEX, V37, P101; Chiarella C., 2002, COMPUT ECON, V19, P95, DOI DOI 10.1023/A:1014957310778; COX JC, 1985, ECONOMETRICA, V53, P385, DOI 10.2307/1911242; CUTLER DM, 1989, J PORTFOLIO MANAGE, V15, P4, DOI 10.3905/jpm.1989.409212; ENGLE RF, 1982, ECONOMETRICA, V50, P987, DOI 10.2307/1912773; FAMA EF, 1970, J FINANC, V25, P383, DOI 10.2307/2325486; Farmer JD, 2005, P NATL ACAD SCI USA, V102, P2254, DOI 10.1073/pnas.0409157102; FRIEDMAN M, 1968, AM ECON REV, V58, P1; Friedman M, 1956, J APPL FINANCE; Friedman M., 1956, THEORY CONSUMPTION F; Gabaix X, 2003, NATURE, V423, P267, DOI 10.1038/nature01624; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; Helbing D, 2011, PHYS FINANCIAL MARKE; HULL J, 1987, J FINANC, V42, P281, DOI 10.1111/j.1540-6261.1987.tb02568.x; JENSEN MC, 1978, J FINANC ECON, V6, P95, DOI 10.1016/0304-405X(78)90025-9; Keynes John Maynard, 1936, GEN THEORY UNEMPLOYM; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Krawiecki A, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.158701; Livan G, 2012, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2012/07/P07025; LUCAS RE, 1972, J ECON THEORY, V4, P103, DOI 10.1016/0022-0531(72)90142-1; LUX T, 1995, ECON J, V105, P881, DOI 10.2307/2235156; Lux T., 1996, APPL FINANCIAL EC, V6, P463, DOI DOI 10.1080/096031096333917; Malkiel B., 1992, EFFICIENT MARKET HYP; MANDELBROT B, 1963, J BUS, V36, P394, DOI 10.1086/294632; Mandelbrot B, 1997, FRACTALS SCALING FIN; Mantegna RN, 1996, PHYS REV LETT, V76, P563, DOI 10.1103/PhysRevLett.76.563; MERTON RC, 1973, BELL J ECON, V4, P141, DOI 10.2307/3003143; Murphy J. J., 1999, TECHNICAL ANAL FINAN; MUTH JF, 1961, ECONOMETRICA, V29, P315, DOI 10.2307/1909635; Peel D.A., 1993, ECONOMICA, V61, P402, DOI [10.2307/2554626, DOI 10.2307/2554626]; Peter L.J., 1969, PETER PRINCIPLE WHY; PHELPS ES, 1967, ECONOMICA, V34, P254, DOI 10.2307/2552025; Pluchino A, 2011, PHYSICA A, V390, P3944, DOI 10.1016/j.physa.2011.06.028; Pluchino A, 2011, PHYSICA A, V390, P3496, DOI 10.1016/j.physa.2011.05.021; Pluchino A, 2010, PHYSICA A, V389, P467, DOI 10.1016/j.physa.2009.09.045; SARGENT TJ, 1975, J POLIT ECON, V83, P241, DOI 10.1086/260321; Satinover JB, 2007, EUR PHYS J B, V60, P369, DOI 10.1140/epjb/e2007-00353-6; Satinover JB, 2009, EUR PHYS J B, V67, P357, DOI 10.1140/epjb/e2009-00037-3; Simon H. A., 1957, MODELS MAN; Taleb N. N., 2010, BLACK SWAN, DOI DOI 10.1176/PS.2009.60.11.1564; Taleb NN, 2005, J PORTFOLIO MANAGE; Taleb NN, 2005, FOOLED RANDOMNESS HI; Tedeschi G, 2012, J ECON BEHAV ORGAN, V81, P82, DOI 10.1016/j.jebo.2011.09.006; VANDENBROECK C, 1994, PHYS REV LETT, V73, P3395, DOI 10.1103/PhysRevLett.73.3395; WANG J, 1994, J POLIT ECON, V102, P127, DOI 10.1086/261924; Wang J, 1994, GREEK EC REV, V102, P127; Wiseman R., 2007, QUIRKOLOGY; Zeeman EC., 1974, J MATH ECON, V1, P39, DOI DOI 10.1016/0304-4068(74)90034-2	60	37	37	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e68344	10.1371/journal.pone.0068344	http://dx.doi.org/10.1371/journal.pone.0068344			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	188UA	23874594	Green Submitted, Green Published, gold			2022-12-27	WOS:000322218800026
J	Dai, XJ; Okazaki, H; Hanakawa, Y; Murakami, M; Tohyama, M; Shirakata, Y; Sayama, K				Dai, Xiuju; Okazaki, Hidenori; Hanakawa, Yasushi; Murakami, Masamoto; Tohyama, Mikiko; Shirakata, Yuji; Sayama, Koji			Eccrine Sweat Contains IL-1 alpha, IL-1 beta and IL-31 and Activates Epidermal Keratinocytes as a Danger Signal	PLOS ONE			English	Article							ATOPIC-DERMATITIS; SCRATCHING BEHAVIOR; NC/NGA MICE; SKIN; EXPRESSION; GLAND; PUSTULOSIS; RESPONSES	Eccrine sweat is secreted onto the skin's surface and is not harmful to normal skin, but can exacerbate eczematous lesions in atopic dermatitis. Although eccrine sweat contains a number of minerals, proteins, and proteolytic enzymes, how it causes skin inflammation is not clear. We hypothesized that it stimulates keratinocytes directly, as a danger signal. Eccrine sweat was collected from the arms of healthy volunteers after exercise, and levels of proinflammatory cytokines in the sweat were quantified by ELISA. We detected the presence of IL-1 alpha, IL-1 beta, and high levels of IL-31 in sweat samples. To investigate whether sweat activates keratinocytes, normal human keratinocytes were stimulated with concentrated sweat. Western blot analysis demonstrated the activation of NF-kappa B, ERK, and JNK signaling in sweat-stimulated keratinocytes. Real-time PCR using total RNA and ELISA analysis of supernatants showed the upregulation of IL-8 and IL-1 beta by sweat. Furthermore, pretreatment with IL-1R antagonist blocked sweat-stimulated cytokine production and signal activation, indicating that bioactive IL-1 is a major factor in the activation of keratinocytes by sweat. Moreover, IL-31 seems to be another sweat stimulator that activates keratinocytes to produce inflammatory cytokine, CCL2. Sweat is secreted onto the skin's surface and does not come into contact with keratinocytes in normal skin. However, in skin with a defective cutaneous barrier, such as atopic dermatitis-affected skin, sweat cytokines can directly act on epidermal keratinocytes, resulting in their activation. In conclusion, eccrine sweat contains proinflammatory cytokines, IL-1 and IL-31, and activates epidermal keratinocytes as a danger signal.	[Dai, Xiuju; Okazaki, Hidenori; Hanakawa, Yasushi; Murakami, Masamoto; Tohyama, Mikiko; Shirakata, Yuji; Sayama, Koji] Ehime Univ, Grad Sch Med, Dept Dermatol, Toon, Ehime, Japan	Ehime University	Dai, XJ (corresponding author), Ehime Univ, Grad Sch Med, Dept Dermatol, Toon, Ehime, Japan.	daixiuju@m.ehime-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan; Health and Labour Sciences Research Grants (Research on Intractable Diseases) from the Ministry of Health, Labour and Welfare of Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health and Labour Sciences Research Grants (Research on Intractable Diseases) from the Ministry of Health, Labour and Welfare of Japan	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and by Health and Labour Sciences Research Grants (Research on Intractable Diseases) from the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A A, 1996, Exp Dermatol, V5, P230, DOI 10.1111/j.1600-0625.1996.tb00122.x; BOEHM KD, 1994, LYMPHOKINE CYTOK RES, V13, P9; Cornelissen C, 2012, EUR J CELL BIOL, V91, P552, DOI 10.1016/j.ejcb.2011.07.006; Cornelissen C, 2012, J ALLERGY CLIN IMMUN, V129, P426, DOI 10.1016/j.jaci.2011.10.042; Dai X, 2008, INT IMMUNOL, V20, P901, DOI 10.1093/intimm/dxn048; Dai XJ, 2006, J INVEST DERMATOL, V126, P1574, DOI 10.1038/sj.jid.5700294; Dai XJ, 2011, J ALLERGY CLIN IMMUN, V127, P806, DOI 10.1016/j.jaci.2010.12.006; Dambacher J, 2007, GUT, V56, P1257, DOI 10.1136/gut.2006.118679; DIDIERJEAN L, 1990, Cytokine, V2, P438, DOI 10.1016/1043-4666(90)90053-V; DINARELLO CA, 1984, REV INFECT DIS, V6, P51, DOI 10.1016/S1359-6101(97)00023-3; Eishi K, 2002, BRIT J DERMATOL, V147, P683, DOI 10.1046/j.1365-2133.2002.04765.x; Grimstad O, 2009, EXP DERMATOL, V18, P35, DOI 10.1111/j.1600-0625.2008.00766.x; JONES AP, 1995, J LEUKOCYTE BIOL, V57, P434, DOI 10.1002/jlb.57.3.434; Kameyoshi Yoshikazu, 2008, Arerugi, V57, P130; Kasraie S, 2011, ALLERGY, V66, P845, DOI 10.1111/j.1398-9995.2011.02545.x; Kim S, 2011, ANN DERMATOL, V23, P468, DOI 10.5021/ad.2011.23.4.468; Marques-Deak A, 2006, J IMMUNOL METHODS, V315, P99, DOI 10.1016/j.jim.2006.07.011; Murakami M, 2002, J INVEST DERMATOL, V119, P1090, DOI 10.1046/j.1523-1747.2002.19507.x; Murakami M, 2010, J INVEST DERMATOL, V130, P2010, DOI 10.1038/jid.2010.87; Niyonsaba F, 2009, BRIT J DERMATOL, V160, P243, DOI 10.1111/j.1365-2133.2008.08925.x; Ozawa M, 2005, DERMATOLOGY, V211, P249, DOI 10.1159/000087019; REITAMO S, 1990, BRIT J DERMATOL, V122, P315, DOI 10.1111/j.1365-2133.1990.tb08279.x; SATO K, 1994, AM J PHYSIOL, V266, pR950, DOI 10.1152/ajpregu.1994.266.3.R950; Shiohara T, 2011, CURR PROBL DERMATOL, V41, P68, DOI 10.1159/000323297; Takaoka A, 2006, EXP DERMATOL, V15, P161, DOI 10.1111/j.1600-0625.2006.00405.x; Wenzel FG, 1998, J AM ACAD DERMATOL, V38, P1, DOI 10.1016/S0190-9622(98)70532-8	26	45	50	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e67666	10.1371/journal.pone.0067666	http://dx.doi.org/10.1371/journal.pone.0067666			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874436	Green Published, gold, Green Submitted			2022-12-27	WOS:000322218800009
J	Dong, R; Deng, PM; Huang, YL; Shen, C; Xue, P; Zheng, S				Dong, Rui; Deng, Panmo; Huang, Yanlei; Shen, Chun; Xue, Ping; Zheng, Shan			Identification of HSP90 as Potential Biomarker of Biliary Atresia Using Two-Dimensional Electrophoresis and Mass Spectrometry	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; MESENCHYMAL TRANSITION; GEL-ELECTROPHORESIS; SECRETORY FUNCTION; PROTEOMICS; CHOLANGIOCYTES; EXPRESSION; PHYSIOLOGY; DISCOVERY; INJURY	Biliary atresia (BA) is a devastating cholestatic liver disease targeting infants. Current diagnosis depends on surgical exploration of the biliary tree. The aim of the present study was to identify potential biomarkers for the diagnosis of biliary atresia (BA). Two-dimensional electrophoresis was utilized for the identification of proteins that were differentially expressed in liver biopsies of 20 BA patients and 12 infants with non-BA neonatal cholestasis (NC) as controls. Using mass spectrometry, we identified 15 proteins with expressions significantly altered. Out of the 15 proteins identified, heat shock protein (HSP) 90 was the most significantly altered and was down-regulated in BA samples compared to NC samples using immunoblotting analysis. Our findings suggest that HSP90 might be a potential biomarker for the diagnosis of BA and may be used for monitoring further development and therapy for BA. This study demonstrated that a comprehensive strategy of proteomic identification combined with further validation should be adopted in biomarker discovery.	[Zheng, Shan] Fudan Univ, Dept Pediat Surg, Childrens Hosp, Shanghai 200433, Peoples R China; Minist Hlth, Key Lab Neonatal Dis, Shanghai, Peoples R China	Fudan University	Zheng, S (corresponding author), Fudan Univ, Dept Pediat Surg, Childrens Hosp, Shanghai 200433, Peoples R China.	szheng@shmu.edu.cn		Zheng, Shan/0000-0002-9712-4573	National Natural Science Foundation of China [30973139]; The Science Foundation of Shanghai [09JC1402800, 11JC1401300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); The Science Foundation of Shanghai	This study received financial support from the National Natural Science Foundation of China (no. 30973139), and The Science Foundation of Shanghai (no. 09JC1402800 and no. 11JC1401300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abane R, 2010, FEBS J, V277, P4150, DOI 10.1111/j.1742-4658.2010.07830.x; ALPINI G, 1989, AM J PHYSIOL, V257, pG124, DOI 10.1152/ajpgi.1989.257.1.G124; ALPINI G, 1988, J CLIN INVEST, V81, P569, DOI 10.1172/JCI113355; Bando Y, 2003, EUR J NEUROSCI, V18, P829, DOI 10.1046/j.1460-9568.2003.02818.x; Barnes BH, 2009, LIVER INT, V29, P1253, DOI 10.1111/j.1478-3231.2008.01921.x; Blonder J, 2011, ELECTROPHORESIS, V32, P1541, DOI 10.1002/elps.201000585; Chitsaz E, 2009, CAN J PUBLIC HEALTH, V100, P475, DOI 10.1007/BF03404348; Chow SN, 2010, EUR J GYNAECOL ONCOL, V31, P55; De Maio A, 1999, SHOCK, V11, P1, DOI 10.1097/00024382-199901000-00001; Deng YH, 2011, DIGEST DIS SCI, V56, P731, DOI 10.1007/s10620-010-1347-6; Diaz R, 2008, HUM PATHOL, V39, P102, DOI 10.1016/j.humpath.2007.05.021; Gemoll T, 2011, MOL MED REP, V4, P1045, DOI 10.3892/mmr.2011.566; Glaser, 2010, J CELL DEATH, V3, P13, DOI DOI 10.4137/JCD.S2785; Glushkova OV, 2010, BIOCHEMISTRY-MOSCOW+, V75, P702, DOI 10.1134/S0006297910060040; Gonzalez L, 2006, ELECTROPHORESIS, V27, P2016, DOI 10.1002/elps.200500634; Ha GH, 2002, ELECTROPHORESIS, V23, P2513, DOI 10.1002/1522-2683(200208)23:15<2513::AID-ELPS2513>3.0.CO;2-W; Hartley JL, 2009, LANCET, V374, P1704, DOI 10.1016/S0140-6736(09)60946-6; JAKOB U, 1995, J BIOL CHEM, V270, P7288, DOI 10.1074/jbc.270.13.7288; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Lee M, 2001, ARIEL-REV INT ENGL, V32, P90; Li W, 2008, WORLD J GASTROENTERO, V14, P5657, DOI 10.3748/wjg.14.5657; Luo Y, 2008, WORLD J PEDIATR, V4, P14, DOI 10.1007/s12519-008-0003-0; Mack CL, 2012, SEMIN LIVER DIS, V32, P307, DOI 10.1055/s-0032-1329899; Martyniuk CJ, 2012, ECOTOX ENVIRON SAFE, V76, P3, DOI 10.1016/j.ecoenv.2011.09.020; Marzioni M, 2005, GASTROENTEROLOGY, V128, P121, DOI 10.1053/j.gastro.2004.10.002; Minter RM, 2009, AM J PHYSIOL-GASTR L, V296, pG45, DOI 10.1152/ajpgi.00041.2008; MIYATA Y, 1992, J BIOL CHEM, V267, P7042; Onori P, 2001, MARC MALPIG SYMP SER, V7, P371; Pandey A, 2000, NATURE, V405, P837, DOI 10.1038/35015709; Petricoin EF, 2002, NAT REV DRUG DISCOV, V1, P683, DOI 10.1038/nrd891; Rabilloud T, 2002, PROTEOMICS, V2, P3, DOI 10.1002/1615-9861(200201)2:1<3::AID-PROT3>3.3.CO;2-I; Ren XS, 2011, AM J PATHOL, V179, P2845, DOI 10.1016/j.ajpath.2011.08.028; Sa-Correia I, 2010, EXPERT REV PROTEOMIC, V7, P943, DOI 10.1586/EPR.10.76; Santos JL, 2010, BRAZ J MED BIOL RES, V43, P522, DOI 10.1590/S0100-879X2010000600001; Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167; Serra DO, 2008, PROTEOMICS, V8, P4995, DOI 10.1002/pmic.200800218; TIETZ PS, 1995, AM J PHYSIOL-GASTR L, V269, pG110, DOI 10.1152/ajpgi.1995.269.1.G110; Wadhwani SI, 2008, PEDIATRICS, V121, pE1438, DOI 10.1542/peds.2007-2709; Whitington PF, 2005, PEDIATR RES, V57, P837, DOI 10.1203/01.PDR.0000161414.99181.61; WIECH H, 1992, NATURE, V358, P169, DOI 10.1038/358169a0; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Zimny-Arndt Ursula, 2009, V492, P65, DOI 10.1007/978-1-59745-493-3_4	42	10	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e68602	10.1371/journal.pone.0068602	http://dx.doi.org/10.1371/journal.pone.0068602			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874684	Green Published, Green Submitted, gold			2022-12-27	WOS:000322218800039
J	Reuveni, I; Saar, D; Barkai, E				Reuveni, Iris; Saar, Drorit; Barkai, Edi			A Novel Whole-Cell Mechanism for Long-Term Memory Enhancement	PLOS ONE			English	Article							RECEPTOR UNITARY CONDUCTANCE; LEARNING-INDUCED ENHANCEMENT; PYRAMIDAL NEURONS; PIRIFORM CORTEX; POTENTIATION; FACILITATION; MODULATION; DENDRITES; STRENGTH	Olfactory-discrimination learning was shown to induce a profound long-lasting enhancement in the strength of excitatory and inhibitory synapses of pyramidal neurons in the piriform cortex. Notably, such enhancement was mostly pronounced in a sub-group of neurons, entailing about a quarter of the cell population. Here we first show that the prominent enhancement in the subset of cells is due to a process in which all excitatory synapses doubled their strength and that this increase was mediated by a single process in which the AMPA channel conductance was doubled. Moreover, using a neuronal-network model, we show how such a multiplicative whole-cell synaptic strengthening in a sub-group of cells that form a memory pattern, sub-serves a profound selective enhancement of this memory. Network modeling further predicts that synaptic inhibition should be modified by complex learning in a manner that much resembles synaptic excitation. Indeed, in a subset of neurons all GABA(A)-receptors mediated inhibitory synapses also doubled their strength after learning. Like synaptic excitation, Synaptic inhibition is also enhanced by two-fold increase of the single channel conductance. These findings suggest that crucial learning induces a multiplicative increase in strength of all excitatory and inhibitory synapses in a subset of cells, and that such an increase can serve as a long-term whole-cell mechanism to profoundly enhance an existing Hebbian-type memory. This mechanism does not act as synaptic plasticity mechanism that underlies memory formation but rather enhances the response of already existing memory. This mechanism is cell-specific rather than synapse-specific; it modifies the channel conductance rather than the number of channels and thus has the potential to be readily induced and un-induced by whole-cell transduction mechanisms.	[Barkai, Edi] Univ Haifa, Dept Neurobiol, IL-31999 Haifa, Israel; Univ Haifa, Dept Biol, IL-31999 Haifa, Israel	University of Haifa; University of Haifa	Barkai, E (corresponding author), Univ Haifa, Dept Neurobiol, IL-31999 Haifa, Israel.	ebarkai@research.haifa.ac.il			Israel Science Foundation [47013]	Israel Science Foundation(Israel Science Foundation)	This study was funded by "Israel Science Foundation'', grant number 47013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bathellier B, 2009, J NEUROSCI, V29, P12641, DOI 10.1523/JNEUROSCI.1124-09.2009; Bear MF, 1996, P NATL ACAD SCI USA, V93, P13453, DOI 10.1073/pnas.93.24.13453; Benke TA, 2001, J PHYSIOL-LONDON, V537, P407, DOI 10.1111/j.1469-7793.2001.00407.x; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Cohen Y, 2008, J NEUROSCI, V28, P6664, DOI 10.1523/JNEUROSCI.0178-08.2008; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Derkach VA, 2003, BIOPHYS J, V84, P1701, DOI 10.1016/S0006-3495(03)74978-9; Eisenberg M, 2003, SCIENCE, V301, P1102, DOI 10.1126/science.1086881; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; Gutig R, 2003, J NEUROSCI, V23, P3697; Han JH, 2008, LEARN MEMORY, V15, P443, DOI 10.1101/lm.993608; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Han JH, 2009, SCIENCE, V323, P1492, DOI 10.1126/science.1164139; Hartveit E, 2006, J PHYSIOL-LONDON, V574, P751, DOI 10.1113/jphysiol.2006.111856; Hines ML, 2001, NEUROSCIENTIST, V7, P123, DOI 10.1177/107385840100700207; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Knafo S, 2005, EUR J NEUROSCI, V21, P927, DOI 10.1111/j.1460-9568.2005.03936.x; Kristensen AS, 2011, NAT NEUROSCI, V14, P727, DOI 10.1038/nn.2804; Luthi A, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-44; Malinow R, 2005, SCIENCE, V310, P234; Massey PV, 2007, TRENDS NEUROSCI, V30, P176, DOI 10.1016/j.tins.2007.02.005; Matsuo N, 2008, SCIENCE, V319, P1104, DOI 10.1126/science.1149967; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; Okuda T, 2007, P NATL ACAD SCI USA, V104, P13479, DOI 10.1073/pnas.0702334104; Quinlan EM, 2004, NEURON, V41, P185, DOI 10.1016/S0896-6273(03)00874-2; Saar D, 2002, J NEUROPHYSIOL, V87, P2358, DOI 10.1152/jn.2002.87.5.2358; Saar D, 1999, J NEUROSCI, V19, P8616; Saar D, 1998, EUR J NEUROSCI, V10, P1518, DOI 10.1046/j.1460-9568.1998.00149.x; Saar D, 2012, J NEUROPHYSIOL, V107, P1222, DOI 10.1152/jn.00356.2011; Sacchetti B, 2004, NEURON, V42, P973, DOI 10.1016/j.neuron.2004.05.012; Sacchetti B, 2001, EUR J NEUROSCI, V13, P2291, DOI 10.1046/j.0953-816x.2001.01609.x; Schroeder BW, 2005, EUR J NEUROSCI, V22, P1775, DOI 10.1111/j.1460-9568.2005.04343.x; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Tye KM, 2008, NATURE, V453, P1253, DOI 10.1038/nature06963; Wessa P, 2008, HIERARCHICAL CLUSTER; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Yin HH, 2009, NAT NEUROSCI, V12, P333, DOI 10.1038/nn.2261	39	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e68131	10.1371/journal.pone.0068131	http://dx.doi.org/10.1371/journal.pone.0068131			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874520	Green Published, Green Submitted, gold			2022-12-27	WOS:000322218800015
J	Capece, D; Zazzeroni, F; Mancarelli, MM; Verzella, D; Fischietti, M; Di Tommaso, A; Maccarone, R; Plebani, S; Di Ianni, M; Gulino, A; Alesse, E				Capece, Daria; Zazzeroni, Francesca; Mancarelli, Maria Michela; Verzella, Daniela; Fischietti, Mariafausta; Di Tommaso, Ambra; Maccarone, Rita; Plebani, Sara; Di Ianni, Mauro; Gulino, Alberto; Alesse, Edoardo			A Novel, Non-canonical Splice Variant of the Ikaros Gene Is Aberrantly Expressed in B-cell Lymphoproliferative Disorders	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; DOMINANT-NEGATIVE ISOFORM; BCL-XL; MECHANISM; APOPTOSIS; CHILDREN; DELETION; ABILITY; FAMILY	The Ikaros gene encodes a Kruppel-like zinc-finger transcription factor involved in hematopoiesis regulation. Ikaros has been established as one of the most clinically relevant tumor suppressors in several hematological malignancies. In fact, expression of dominant negative Ikaros isoforms is associated with adult B-cell acute lymphoblastic leukemia, myelodysplastic syndrome, acute myeloid leukemia and adult and juvenile chronic myeloid leukemia. Here, we report the isolation of a novel, non-canonical Ikaros splice variant, called Ikaros 11 (Ik11). Ik11 is structurally related to known dominant negative Ikaros isoforms, due to the lack of a functional DNA-binding domain. Interestingly, Ik11 is the first Ikaros splice variant missing the transcriptional activation domain. Indeed, we demonstrated that Ik11 works as a dominant negative protein, being able to dimerize with Ikaros DNA-binding isoforms and inhibit their functions, at least in part by retaining them in the cytoplasm. Notably, we demonstrated that Ik11 is the first dominant negative Ikaros isoform to be aberrantly expressed in B-cell lymphoproliferative disorders, such as chronic lymphocytic leukemia. Aberrant expression of Ik11 interferes with both proliferation and apoptotic pathways, providing a mechanism for Ik11 involvement in tumor pathogenesis. Thus, Ik11 could represent a novel marker for B-cell lymphoproliferative disorders.	[Capece, Daria; Zazzeroni, Francesca; Mancarelli, Maria Michela; Verzella, Daniela; Fischietti, Mariafausta; Maccarone, Rita; Alesse, Edoardo] Univ Aquila, Dept Biotechnol & Appl Clin Sci, I-67100 Laquila, Italy; [Di Tommaso, Ambra; Plebani, Sara; Di Ianni, Mauro] Univ Aquila, Dept Life Hlth & Environm Sci, I-67100 Laquila, Italy; [Gulino, Alberto] Univ Roma La Sapienza, Dept Mol Med, I-00185 Rome, Italy	University of L'Aquila; University of L'Aquila; Sapienza University Rome	Alesse, E (corresponding author), Univ Aquila, Dept Biotechnol & Appl Clin Sci, I-67100 Laquila, Italy.	edoardo.alesse@univaq.it	Di Tommaso, Paolo/N-1662-2015; Capece, Daria/AFR-1769-2022; Fischietti, Mariafausta/Y-6449-2019	Di Tommaso, Paolo/0000-0003-3220-0253; Capece, Daria/0000-0003-3126-2014; Zazzeroni, Francesca/0000-0002-4474-3274; MACCARONE, Rita/0000-0003-0648-3771	The Italian Ministry of Education; University and Research Fund for Investments in Basic Research MIUR-FIRB grant [RBAP10A9H9]; MIUR-PRIN grant [2009EWAW4M_003]; Ph.D. program in Experimental Medicine; Ph.D program in Biotechnology	The Italian Ministry of Education; University and Research Fund for Investments in Basic Research MIUR-FIRB grant; MIUR-PRIN grant(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Ph.D. program in Experimental Medicine; Ph.D program in Biotechnology	This work was supported by The Italian Ministry of Education, University and Research Fund for Investments in Basic Research MIUR-FIRB grant No. RBAP10A9H9 to E.A. and to A.G. (http://firb.miur.it/) and by MIUR-PRIN grant No. 2009EWAW4M_003 to F.Z. (http://prin.miur.it/). D.V. was supported by the Ph.D. program in Experimental Medicine, and M.F. was supported by the Ph.D program in Biotechnology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avitahl N, 1999, IMMUNITY, V10, P333, DOI 10.1016/S1074-7613(00)80033-3; Beverly LJ, 2003, CANCER CELL, V3, P551, DOI 10.1016/S1535-6108(03)00137-5; Billot K, 2011, BLOOD, V117, P1917, DOI 10.1182/blood-2010-09-307140; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; Crescenzi B, 2004, HAEMATOLOGICA, V89, P281; Erlanson M, 2001, LEUKEMIA LYMPHOMA, V40, P461, DOI 10.3109/10428190109097645; Ezzat S, 2006, MOL ENDOCRINOL, V20, P2976, DOI 10.1210/me.2006-0265; Francis Olivia L, 2011, World J Biol Chem, V2, P119, DOI 10.4331/wjbc.v2.i6.119; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Gomez-del Arco P, 2004, MOL CELL BIOL, V24, P2797, DOI 10.1128/MCB.24.7.2797-2807.2004; He LC, 2011, BIOCHEM BIOPH RES CO, V406, P430, DOI 10.1016/j.bbrc.2011.02.062; Iacobucci I, 2008, BLOOD, V112, P3847, DOI 10.1182/blood-2007-09-112631; Iacobucci I, 2008, HAEMATOL-HEMATOL J, V93, P1814, DOI 10.3324/haematol.13260; John LB, 2011, MOL IMMUNOL, V48, P1272, DOI 10.1016/j.molimm.2011.03.006; Kano G, 2008, LEUKEMIA LYMPHOMA, V49, P965, DOI 10.1080/10428190801993462; Kathrein KL, 2005, MOL CELL BIOL, V25, P1645, DOI 10.1128/MCB.25.5.1645-1654.2005; Klug CA, 1998, P NATL ACAD SCI USA, V95, P657, DOI 10.1073/pnas.95.2.657; Li Zhanjun, 2011, World J Biol Chem, V2, P140, DOI 10.4331/wjbc.v2.i6.140; Liu P, 2012, ANN HEMATOL, V91, P1039, DOI 10.1007/s00277-012-1415-4; Ma SB, 2010, MOL CELL BIOL, V30, P4149, DOI 10.1128/MCB.00224-10; Mancarelli MM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-172; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Nakase K, 2000, CANCER RES, V60, P4062; Nakayama H, 1999, CANCER RES, V59, P3931; Nishii K, 2002, LEUKEMIA, V16, P1285, DOI 10.1038/sj.leu.2402533; Oestreich KJ, 2012, NAT IMMUNOL, V13, P16, DOI 10.1038/ni.2191; Olivero S, 2000, BRIT J HAEMATOL, V110, P826, DOI 10.1046/j.1365-2141.2000.02297.x; Payne Kimberly J., 2011, Critical Reviews in Oncogenesis, V16, P3; Payne KJ, 2003, J IMMUNOL, V170, P3091, DOI 10.4049/jimmunol.170.6.3091; Payne KJ, 2001, J IMMUNOL, V167, P1867, DOI 10.4049/jimmunol.167.4.1867; Pulte D, 2006, AM J HEMATOL, V81, P12, DOI 10.1002/ajh.20507; Ruiz A, 2004, BRIT J HAEMATOL, V125, P31, DOI 10.1111/j.1365-2141.2004.04854.x; Ruiz A, 2008, INT J CANCER, V123, P1240, DOI 10.1002/ijc.23706; Sezaki N, 2003, BRIT J HAEMATOL, V121, P165, DOI 10.1046/j.1365-2141.2003.04263.x; Sun L, 1999, CLIN CANCER RES, V5, P2112; Sun L, 1999, P NATL ACAD SCI USA, V96, P680, DOI 10.1073/pnas.96.2.680; Sun L, 1999, J CLIN ONCOL, V17, P3753, DOI 10.1200/JCO.1999.17.12.3753; Takanashi M, 2002, BRIT J HAEMATOL, V117, P525, DOI 10.1046/j.1365-2141.2002.03487.x; Tonnelle C, 2001, BLOOD, V98, P2673, DOI 10.1182/blood.V98.9.2673; Tonnelle Cecile, 2003, Hematol J, V4, P104, DOI 10.1038/sj.thj.6200235; Trageser D, 2009, J EXP MED, V206, P1739, DOI 10.1084/jem.20090004; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; WINANDY S, 1995, CELL, V83, P289, DOI 10.1016/0092-8674(95)90170-1; Yagi T, 2002, BLOOD, V99, P1350, DOI 10.1182/blood.V99.4.1350; Zazzeroni F, 2003, BLOOD, V102, P3270, DOI 10.1182/blood-2003-03-0689; Zhou F, 2011, J PEDIAT HEMATOL ONC, V33, P429, DOI 10.1097/MPH.0b013e318217f5f2	48	9	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68080	10.1371/journal.pone.0068080	http://dx.doi.org/10.1371/journal.pone.0068080			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874502	gold, Green Published, Green Submitted			2022-12-27	WOS:000321736900052
J	Hur, KY; Moon, JY; Kim, SH; Yoo, JY				Hur, Kye-Yeon; Moon, Joon-Young; Kim, Seung-Hwan; Yoo, Joo-Yeon			Model-Based Simulation and Prediction of an Antiviral Strategy against Influenza A Infection	PLOS ONE			English	Article							OSELTAMIVIR-RESISTANT; VIRUS-INFECTION; CELL-CULTURE; NEURAMINIDASE INHIBITORS; ENCEPHALITIS-VIRUS; RECEPTOR-BINDING; DENDRITIC CELLS; HOST-DEFENSE; MDCK CELLS; MICE	There is a strong need to develop novel strategies in using antiviral agents to efficiently treat influenza infections. Thus, we constructed a rule-based mathematical model that reflects the complicated interactions of the host immunity and viral life cycle and analyzed the key controlling steps of influenza infections. The main characteristics of the pandemic and seasonal influenza strains were estimated using parameter values derived from cells infected with Influenza A/California/04/2009 and Influenza A/NewCaledonia/20/99, respectively. The quantitative dynamics of the infected host cells revealed a more aggressive progression of the pandemic strain than the seasonal strain. The perturbation of each parameter in the model was then tested for its effects on viral production. In both the seasonal and pandemic strains, the inhibition of the viral release (k(C)), the reinforcement of viral attachment (k(V)), and an increased transition rate of infected cells into activated cells (k(I)) exhibited significant suppression effects on the viral production; however, these inhibitory effects were only observed when the numerical perturbations were performed at the early stages of the infection. In contrast, combinatorial perturbations of both the inhibition of viral release and either the reinforcement of the activation of infected cells or the viral attachment exhibited a significant reduction in the viral production even at a later stage of infection. These results suggest that, in addition to blocking the viral release, a combination therapy that also enhances either the viral attachment or the transition of the infected cells might provide an alternative for effectively controlling progressed influenza infection.	[Hur, Kye-Yeon; Kim, Seung-Hwan; Yoo, Joo-Yeon] Pohang Univ Sci & Technol POSTECH, Sch Interdisciplinary Biosci & Bioengn, Pohang, South Korea; [Kim, Seung-Hwan] Pohang Univ Sci & Technol POSTECH, Dept Phys, Pohang, South Korea; [Yoo, Joo-Yeon] Pohang Univ Sci & Technol POSTECH, Dept Life Sci, Pohang, South Korea; [Moon, Joon-Young] Univ Michigan, Sch Med, Dept Anesthesiol, Ann Arbor, MI USA	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); University of Michigan System; University of Michigan	Kim, SH (corresponding author), Pohang Univ Sci & Technol POSTECH, Sch Interdisciplinary Biosci & Bioengn, Pohang, South Korea.	swan@postech.ac.kr; jyoo@postech.ac.kr	Moon, Joon-Young/ABA-6712-2021	Moon, Joon-Young/0000-0002-7842-5864; KIM, Seunghwan/0000-0002-0563-3902	National Research Foundation of Korea (NRF); Korea government (MEST) [2012028200]; TEPIK, which is part of Korea Healthcare technology R&D Project by the Ministry of Health & Welfare, Republic of Korea [A103001]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); TEPIK, which is part of Korea Healthcare technology R&D Project by the Ministry of Health & Welfare, Republic of Korea	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 2012028200) awarded to JYY and a grant of the TEPIK, which is part of Korea Healthcare technology R&D Project by the Ministry of Health & Welfare, Republic of Korea (No. A103001) awarded to JYY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolou E, 2008, CELL, V134, P85, DOI 10.1016/j.cell.2008.05.052; Beauchemin CAA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S1-S7; Beigel JH, 2010, DRUG FUTURE, V35, P385, DOI 10.1358/dof.2010.035.05.1487081; Bernard KA, 2000, VIROLOGY, V276, P93, DOI 10.1006/viro.2000.0546; Burke J D, 2009, Curr Mol Pharmacol, V2, P32; Calatayud L, 2011, EMERG INFECT DIS, V17, P1807, DOI 10.3201/eid1710.110117; Chairat K, 2012, J CLIN PHARM; Chakrabarti A, 2011, J INTERF CYTOK RES, V31, P49, DOI 10.1089/jir.2010.0120; Dharan NJ, 2009, JAMA-J AM MED ASSOC, V301, P1034, DOI 10.1001/jama.2009.294; Englund JA, 1998, CLIN INFECT DIS, V26, P1418, DOI 10.1086/516358; ENOCH T, 1986, MOL CELL BIOL, V6, P801, DOI 10.1128/MCB.6.3.801; Furuta Y, 2005, ANTIMICROB AGENTS CH, V49, P981, DOI 10.1128/AAC.49.3.981-986.2005; Garcia-Sastre A, 2006, EMERG INFECT DIS, V12, P44, DOI 10.3201/eid1201.051186; Gaur P, 2011, MED SCI MONITOR, V17, pRA148, DOI 10.12659/MSM.881801; Genzel Y, 2006, VACCINE, V24, P6074, DOI 10.1016/j.vaccine.2006.05.023; Govorkova EA, 2004, ANTIMICROB AGENTS CH, V48, P4855, DOI 10.1128/AAC.48.12.4855-4863.2004; Gubareva LV, 2000, LANCET, V355, P827, DOI 10.1016/S0140-6736(99)11433-8; Haller O, 2007, BIOCHIMIE, V89, P812, DOI 10.1016/j.biochi.2007.04.015; Hay AJ, 2001, PHILOS T R SOC B, V356, P1861, DOI 10.1098/rstb.2001.0999; Hayden F, 2009, CLIN INFECT DIS, V48, pS3, DOI 10.1086/591851; Hedlund M, 2010, VIRUSES-BASEL, V2, P1766, DOI 10.3390/v2081766; Hu JZ, 2007, NUCLEIC ACIDS RES, V35, P5232, DOI 10.1093/nar/gkm557; Hurt AC, 2012, J INFECT DIS, V206, P148, DOI 10.1093/infdis/jis337; Hwang SY, 2013, J IMMUNOL, V190, P1192, DOI 10.4049/jimmunol.1202326; Hwang SY, 2012, NUCLEIC ACIDS RES, V40, P2724, DOI 10.1093/nar/gkr1098; Ilyushina NA, 2008, ANTIMICROB AGENTS CH, V52, P3889, DOI 10.1128/AAC.01579-07; Lee E, 2002, J VIROL, V76, P4901, DOI 10.1128/JVI.76.10.4901-4911.2002; Mata MA, 2011, NAT CHEM BIOL, V7, P712, DOI [10.1038/NCHEMBIO.645, 10.1038/nchembio.645]; Mayburd Anatoly L, 2010, Recent Pat Antiinfect Drug Discov, V5, P64; Meijer A, 2012, EUROSURVEILLANCE, V17, P2; Meijer A, 2011, ANTIVIR RES, V92, P81, DOI 10.1016/j.antiviral.2011.07.004; Mitchell H, 2011, J VIROL, V85, P1125, DOI 10.1128/JVI.01722-10; Mohler L, 2005, BIOTECHNOL BIOENG, V90, P46, DOI 10.1002/bit.20363; Morimoto K, 2008, DRUG METAB DISPOS, V36, P6, DOI 10.1124/dmd.107.017699; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Nguyen JT, 2009, ANTIMICROB AGENTS CH, V53, P4115, DOI 10.1128/AAC.00476-09; Qiao L, 2010, BIOPHYS J, V98, P505, DOI 10.1016/j.bpj.2009.10.049; Reece PA, 2007, J MED VIROL, V79, P1577, DOI 10.1002/jmv.20951; Salomon R, 2009, CELL, V136, P402, DOI 10.1016/j.cell.2009.01.029; Schulze-Horsel J, 2009, VACCINE, V27, P2712, DOI 10.1016/j.vaccine.2009.02.027; Senger K, 2000, MOL CELL, V6, P931, DOI 10.1016/S1097-2765(05)00081-X; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Smee DF, 2009, ANTIMICROB AGENTS CH, V53, P2120, DOI 10.1128/AAC.01012-08; Smith AM, 2011, WIRES SYST BIOL MED, V3, P429, DOI 10.1002/wsbm.129; Tamura SI, 2004, JPN J INFECT DIS, V57, P236; Wilks S, 2012, VACCINE, V30, P4369, DOI 10.1016/j.vaccine.2012.02.076; WONG JP, 1995, ANTIMICROB AGENTS CH, V39, P2574, DOI 10.1128/AAC.39.11.2574; Yan N, 2012, NAT IMMUNOL, V13, P214, DOI 10.1038/ni.2229; Yang JR, 2013, J MED VIROL, V85, P379, DOI 10.1002/jmv.23482; Zhao MW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001249	50	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68235	10.1371/journal.pone.0068235	http://dx.doi.org/10.1371/journal.pone.0068235			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874556	Green Submitted, Green Published, gold			2022-12-27	WOS:000321736900072
J	McGuire, KL; Allison, SD; Fierer, N; Treseder, KK				McGuire, Krista L.; Allison, Steven D.; Fierer, Noah; Treseder, Kathleen K.			Ectomycorrhizal-Dominated Boreal and Tropical Forests Have Distinct Fungal Communities, but Analogous Spatial Patterns across Soil Horizons	PLOS ONE			English	Article							DIVERSITY; DECOMPOSITION; NITROGEN; TREE; IDENTIFICATION; MONODOMINANCE; MYCORRHIZAS; BACTERIAL; RESOURCE; DYNAMICS	Fungi regulate key nutrient cycling processes in many forest ecosystems, but their diversity and distribution within and across ecosystems are poorly understood. Here, we examine the spatial distribution of fungi across a boreal and tropical ecosystem, focusing on ectomycorrhizal fungi. We analyzed fungal community composition across litter (organic horizons) and underlying soil horizons (0-20 cm) using 454 pyrosequencing and clone library sequencing. In both forests, we found significant clustering of fungal communities by site and soil horizons with analogous patterns detected by both sequencing technologies. Free-living saprotrophic fungi dominated the recently-shed leaf litter and ectomycorrhizal fungi dominated the underlying soil horizons. This vertical pattern of fungal segregation has also been found in temperate and European boreal forests, suggesting that these results apply broadly to ectomycorrhizal-dominated systems, including tropical rain forests. Since ectomycorrhizal and free-living saprotrophic fungi have different influences on soil carbon and nitrogen dynamics, information on the spatial distribution of these functional groups will improve our understanding of forest nutrient cycling.	[McGuire, Krista L.] Columbia Univ, Barnard Coll, Dept Biol, New York, NY 10027 USA; [Allison, Steven D.; Treseder, Kathleen K.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA; [Allison, Steven D.] Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA USA; [Fierer, Noah] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Fierer, Noah] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA	Columbia University; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	McGuire, KL (corresponding author), Columbia Univ, Barnard Coll, Dept Biol, New York, NY 10027 USA.	kmcguire@barnard.columbia.edu	Treseder, Kathleen K/E-5148-2011; Allison, Steven D./E-2978-2010	Treseder, Kathleen K/0000-0003-2847-6935; Allison, Steven D./0000-0003-4629-7842; FIERER, NOAH/0000-0002-6432-4261; McGuire Meliora, Krista/0000-0002-8970-8827	National Science Foundation; NOAA Climate and Global Change Postdoctoral Fellowship; Doctoral Dissertation Improvement Grant	National Science Foundation(National Science Foundation (NSF)); NOAA Climate and Global Change Postdoctoral Fellowship(National Oceanic Atmospheric Admin (NOAA) - USA); Doctoral Dissertation Improvement Grant	Funding for this work came from the National Science Foundation grant to KKT, a NOAA Climate and Global Change Postdoctoral Fellowship to SDA, and Doctoral Dissertation Improvement Grant to KLM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER IJ, 1986, NEW PHYTOL, V102, P541, DOI 10.1111/j.1469-8137.1986.tb00830.x; Allison SD, 2008, GLOBAL CHANGE BIOL, V14, P1156, DOI 10.1111/j.1365-2486.2008.01549.x; Allison SD, 2007, SOIL BIOL BIOCHEM, V39, P1878, DOI 10.1016/j.soilbio.2007.02.001; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ba AM, 2012, MYCORRHIZA, V22, P1, DOI 10.1007/s00572-011-0415-x; Bending GD, 2006, ADV APPL MICROBIOL, V60, P97, DOI 10.1016/S0065-2164(06)60004-X; Brundrett MC, 2009, PLANT SOIL, V320, P37, DOI 10.1007/s11104-008-9877-9; Cairney JWG, 2002, CAN J BOT, V80, P803, DOI [10.1139/b02-072, 10.1139/B02-072]; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Clarke K. R., 2001, CHANGES MARINE COMMU; Colpaert JV, 1996, NEW PHYTOL, V134, P123, DOI 10.1111/j.1469-8137.1996.tb01152.x; CONNELL JH, 1989, AM NAT, V134, P88, DOI 10.1086/284967; Dickie IA, 2002, NEW PHYTOL, V156, P527, DOI 10.1046/j.1469-8137.2002.00535.x; Feinstein LM, 2009, APPL ENVIRON MICROB, V75, P5428, DOI 10.1128/AEM.00120-09; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; GADGIL RL, 1971, NATURE, V233, P133, DOI 10.1038/233133a0; Gadgil RL, 1975, NZ J FORESTRY SCI, V5, P35; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gihring TM, 2012, ENVIRON MICROBIOL, V14, P285, DOI 10.1111/j.1462-2920.2011.02550.x; Henkel TW, 2012, BIODIVERS CONSERV, V21, P2195, DOI 10.1007/s10531-011-0166-1; Henkel TW, 2003, J TROP ECOL, V19, P417, DOI 10.1017/S0266467403003468; Henkel TW, 2002, MYCOL RES, V106, P515, DOI 10.1017/S0953756202005919; Hibbett David S., 2011, Fungal Biology Reviews, V25, P38, DOI 10.1016/j.fbr.2011.01.001; Hobbie SE, 2006, ECOLOGY, V87, P2288, DOI 10.1890/0012-9658(2006)87[2288:TSEODA]2.0.CO;2; Kennedy PG, 2012, MOL ECOL, V21, P4151, DOI 10.1111/j.1365-294X.2012.05703.x; Koljalg U, 2005, NEW PHYTOL, V166, P1063, DOI 10.1111/j.1469-8137.2005.01376.x; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lilleskov EA, 2002, NEW PHYTOL, V154, P219, DOI 10.1046/j.1469-8137.2002.00367.x; Lindahl B, 1999, NEW PHYTOL, V144, P183, DOI 10.1046/j.1469-8137.1999.00502.x; Lindahl BD, 2007, NEW PHYTOL, V173, P611, DOI 10.1111/j.1469-8137.2006.01936.x; Mack MC, 2008, ECOSYSTEMS, V11, P209, DOI 10.1007/s10021-007-9117-9; Matheny PB, 2003, MYCOL RES, V107, P495, DOI 10.1017/S0953756203007627; McGuire KL, 2008, MYCORRHIZA, V18, P217, DOI 10.1007/s00572-008-0170-9; McGuire KL, 2010, OECOLOGIA, V164, P785, DOI 10.1007/s00442-010-1686-1; McGuire KL, 2010, ECOLOGY, V91, P2324, DOI 10.1890/09-0654.1; Mcguire Krista L., 2008, P287, DOI 10.1007/978-1-4020-8770-7_12; Miller O. K. Jr., 1983, Canadian Journal of Botany, V61, P909, DOI 10.1139/b83-103; Nilsson RH, 2008, EVOL BIOINFORM, V4, P193; O'Brien HE, 2005, APPL ENVIRON MICROB, V71, P5544, DOI 10.1128/AEM.71.9.5544-5550.2005; Osono T, 2002, MYCOLOGIA, V94, P421, DOI 10.2307/3761776; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3624; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Read DJ, 2003, NEW PHYTOL, V157, P475, DOI 10.1046/j.1469-8137.2003.00704.x; READ DJ, 1991, EXPERIENTIA, V47, P376, DOI 10.1007/BF01972080; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Smith ME, 2011, NEW PHYTOL, V192, P699, DOI 10.1111/j.1469-8137.2011.03844.x; Smith SE, 2008, MYCORRHIZAL SYMBIOSIS, 3RD EDITION, P1; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Taylor DL, 1999, MOL ECOL, V8, P1837, DOI 10.1046/j.1365-294x.1999.00773.x; Tedersoo L, 2012, MOL ECOL, V21, P4160, DOI 10.1111/j.1365-294X.2012.05602.x; Tedersoo L, 2010, NEW PHYTOL, V188, P291, DOI 10.1111/j.1469-8137.2010.03373.x; Tedersoo L, 2010, MYCORRHIZA, V20, P217, DOI 10.1007/s00572-009-0274-x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Torti SD, 2001, AM NAT, V157, P141, DOI 10.1086/318629; Treseder KK, 2004, ECOL APPL, V14, P1826, DOI 10.1890/03-5133; VISSER S, 1995, NEW PHYTOL, V129, P389, DOI 10.1111/j.1469-8137.1995.tb04309.x; Watling R, 2001, MYCOL RES, V105, P1440, DOI 10.1017/S0953756201004877; WATLING R, 1995, NOVA HEDWIGIA, V61, P417; Wolfe BE, 2012, MYCOLOGIA, V104, P22, DOI 10.3852/11-056; Zimov SA, 2006, SCIENCE, V312, P1612, DOI 10.1126/science.1128908	64	57	60	1	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68278	10.1371/journal.pone.0068278	http://dx.doi.org/10.1371/journal.pone.0068278			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874569	Green Published, gold			2022-12-27	WOS:000321736900075
J	Rosinski, AA; Narine, S; Yamey, G				Rosinski, Alexander Anthony; Narine, Steven; Yamey, Gavin			Developing a Scorecard to Assess Global Progress in Scaling Up Diarrhea Control Tools: A Qualitative Study of Academic Leaders and Implementers	PLOS ONE			English	Article							CHILDHOOD DIARRHEA; HEALTH	Background: In 2010, diarrhea caused 0.75 million child deaths, accounting for nearly 12% of all under-five mortality worldwide. Many evidence-based interventions can reduce diarrhea mortality, including oral rehydration solution (ORS), zinc, and improved sanitation. Yet global coverage levels of such interventions remain low. A new scorecard of diarrhea control, showing how different countries are performing in their control efforts, could draw greater attention to the low coverage levels of proven interventions. Methods: We conducted in-depth qualitative interviews with 21 experts, purposively sampled for their relevant academic or implementation expertise, to explore their views on (a) the value of a scorecard of global diarrhea control and (b) which indicators should be included in such a scorecard. We then conducted a ranking exercise in which we compiled a list of all 49 indicators suggested by the experts, sent the list to the 21 experts, and asked them to choose 10 indicators that they would include and 10 that they would exclude from such a scorecard. Finally, we created a "prototype" scorecard based on the 9 highest-ranked indicators. Results: Key themes that emerged from coding the interview transcripts were: a scorecard could facilitate country comparisons; it could help to identify best practices, set priorities, and spur donor action; and it could help with goal-setting and accountability in diarrhea control. The nine highest ranking indicators, in descending order, were ORS coverage, rotavirus vaccine coverage, zinc coverage, diarrhea-specific mortality rate, diarrhea prevalence, proportion of population with access to improved sanitation, proportion with access to improved drinking water, exclusive breastfeeding coverage, and measles vaccine coverage. Conclusion: A new scorecard of global diarrhea control could help track progress, focus prevention and treatment efforts on the most effective interventions, establish transparency and accountability, and alert donors and ministries of health to inadequacies in diarrhea control efforts.	[Rosinski, Alexander Anthony; Narine, Steven] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Yamey, Gavin] Univ Calif San Francisco, Global Hlth Grp, Evidence Policy Initiat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Rosinski, AA (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	aarosinski11@gmail.com						Access to Medicine Foundation, 2008, ACC MED IND; [Anonymous], 2012, UNICEF PROGR REPORT; [Anonymous], 2012, EXP PAN FIND; Bump J, 2012, HLTH POLICY PLANNING, P1; Davis K.E., 2011, INDICATORS INTERVENT; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI DOI 10.1007/s00134-012-2769-8; Enserink M, 2009, SCIENCE, V323, P700, DOI 10.1126/science.323.5915.700; Glassman A, 2012, COMMITMENT VACCINATI; Hudacek DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020438; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Kikwete JM, 2011, GUARDIAN; Kingdon J., 2003, AGENDAS ALTERNATIVES, V2nd; Kosek M, 2009, J HEALTH POPUL NUTR, V27, P319; Larson CP, 2012, HEALTH POLICY PLANN, V27, P102, DOI 10.1093/heapol/czr015; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Luby SP, 2004, JAMA-J AM MED ASSOC, V291, P2547, DOI 10.1001/jama.291.21.2547; Luby SP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001052; Measure DHS, 2012, DEM HLTH SURV COUNTR; PATH, 2008, DIARRH DIS ADV FIND; PATH, 2013, ROT VACC ACC DEL GLO; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Peters DH, 2007, B WORLD HEALTH ORGAN, V85, P146, DOI 10.2471/BLT.06.033746; Ploeg J., 1999, EVID BASED NURS, V2, P36, DOI [10.1136/ebn.2.2.36, DOI 10.1136/EBN.2.2.36]; Publish What You Fund, 2012, AID TRANSP IND EX SU; Sabot O, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e940; Santosham M, 2010, LANCET, V376, P63, DOI 10.1016/S0140-6736(10)60356-X; Save the Children, 2012, STAT WORLDS MOTH 201; Strauss A., 1990, BASICS QUALITATIVE R; Streeton Rosemarie, 2004, Nurse Res, V12, P35; The Mo Ibrahim Foundation, 2012, IBR IND AFR GOV SUMM; The Uniting to Combat NTDs coalition of private and public sector organizations, 2013, PROM PROGR 1 ANN REP; The World Bank Water and Sanitation Program (WSP), 2013, GLOB SCAL HANDW PROJ; Trotta A, 2013, INT J HEALTH PLAN M, V28, P181, DOI 10.1002/hpm.2132; UNICEF WHO, 2012, PNEUM DIARRH TACKL D; UNICEF/WHO, 2009, DIARRH WHY CHILDR AR; UNICEF WHO, 2012, COUNTD 2015 BUILD FU; United Nations, 2012, COMM LIF SAV COMM CO; Walker CLF, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000428; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2012, COMM CHILD SURV PROM; WHO, 2013, GLOB STRAT WOM CHILD; WHO/UNICEF, 2004, JOINT STAT CLIN MAN; WHO UNICEF, 2012, PROGR DRINK WAT SAN; World Health Organization, 2012, WORLD HLTH STAT 2012; Yamey G, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-11	45	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e67320	10.1371/journal.pone.0067320	http://dx.doi.org/10.1371/journal.pone.0067320			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874412	Green Published, gold, Green Submitted			2022-12-27	WOS:000321736900008
J	Surdo, M; Balestra, E; Saccomandi, P; Di Santo, F; Montano, M; Di Carlo, D; Sarmati, L; Aquaro, S; Andreoni, M; Svicher, V; Perno, CF; Ceccherini-Silberstein, F				Surdo, Matteo; Balestra, Emanuela; Saccomandi, Patrizia; Di Santo, Fabiola; Montano, Marco; Di Carlo, Domenico; Sarmati, Loredana; Aquaro, Stefano; Andreoni, Massimo; Svicher, Valentina; Perno, Carlo Federico; Ceccherini-Silberstein, Francesca			Inhibition of Dual/Mixed Tropic HIV-1 Isolates by CCR5-Inhibitors in Primary Lymphocytes and Macrophages	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TREATMENT-EXPERIENCED PATIENTS; MONOCYTE-DERIVED MACROPHAGES; TREATMENT-NAIVE PATIENTS; CD4 CELL COUNT; CORECEPTOR USAGE; ANTIRETROVIRAL THERAPY; INFECTED MACROPHAGES; CHEMOKINE RECEPTORS; TYPE-1 HIV-1	Background: Dual/mixed-tropic HIV-1 strains are predominant in a significant proportion of patients, though little information is available regarding their replication-capacity and susceptibility against CCR5-antagonists in-vitro. The aim of the study was to analyze the replication-capacity and susceptibility to maraviroc of HIV-1 clinical isolates with different tropism characteristics in primary monocyte-derived-macrophages (MDM), peripheral-blood-mononuclear-cells (PBMC), and CD4(+)T-lymphocytes. Methods: Twenty-three HIV-1 isolates were phenotipically and genotipically characterized as R5, X4 or dual (discriminated as R5(+)/X4, R5/X4, R5/X4(+)). Phenotypic-tropism was evaluated by multiple-cycles-assay on U87MG-CD4(+)-CCR5(+)-/CXCR4(+)-expressing cells. Genotypic-tropism prediction was obtained using Geno2Pheno-algorithm (false-positive-rate [FPR] = 10%). Replication-capacity and susceptibility to maraviroc were investigated in human-primary MDM, PBMC and CD4(+)T-cells. AMD3100 was used as CXCR4-inhibitor. Infectivity of R5/Dual/X4-viruses in presence/absence of maraviroc was assessed also by total HIV-DNA, quantified by real-time polymerase-chain-reaction. Results: Among 23 HIV-1 clinical isolates, phenotypic-tropism-assay distinguished 4, 17 and 2 viruses with R5-tropic, dual/mixed-, and X4-tropic characteristics, respectively. Overall, viruses defined as R5(+)/X4-tropic were found with the highest prevalence (10/23, 43.5%). The majority of isolates efficiently replicated in both PBMC and CD4(+)T-cells, regardless of their tropism, while MDM mainly sustained replication of R5- or R5(+)/X4-tropic isolates; strong correlation between viral-replication and genotypic-FPR-values was observed in MDM (rho = 0.710; p-value = 1.4e-4). In all primary cells, maraviroc inhibited viral-replication of isolates not only with pure R5- but also with dual/mixed tropism (mainly R5(+)/X4 and, to a lesser extent R5/X4 and R5/X4(+)). Finally, no main differences by comparing the total HIV-DNA with the p24-production in presence/absence of maraviroc were found. Conclusions: Maraviroc is effective in-vitro against viruses with dual-characteristics in both MDM and lymphocytes, despite the potential X4-mediated escape. This suggests that the concept of HIV-entry through one of the two coreceptors "separately" may require revision, and that the use of CCR5-antagonists in patients with dual/mixed-tropic viruses may be a therapeutic-option that deserves further investigations in different clinical settings.	[Surdo, Matteo; Balestra, Emanuela; Saccomandi, Patrizia; Di Santo, Fabiola; Di Carlo, Domenico; Svicher, Valentina; Perno, Carlo Federico; Ceccherini-Silberstein, Francesca] Univ Roma Tor Vergata, Dept Expt Med & Surg, Rome, Italy; [Montano, Marco; Sarmati, Loredana; Andreoni, Massimo] Tor Vergata Univ PTV, Rome, Italy; [Aquaro, Stefano] Univ Calabria, Dept Pharmacobiol, I-87036 Arcavacata Di Rende, CS, Italy; [Aquaro, Stefano] 4INMI L Spallanzani, Rome, Italy	University of Rome Tor Vergata; University of Calabria	Perno, CF (corresponding author), Univ Roma Tor Vergata, Dept Expt Med & Surg, Rome, Italy.	Cf.perno@uniroma2.it	Aquaro, Stefano/GQY-7881-2022; Surdo, Matteo/D-1612-2014; Ceccherini-Silberstein, Francesca/K-4762-2016; Andreoni, Masimo/AAL-2214-2020; perno, carlo federico/O-1544-2016; Di Maio, Velia Chiara/AGH-2628-2022	Aquaro, Stefano/0000-0002-8417-2103; Surdo, Matteo/0000-0001-7244-1540; sarmati, loredana/0000-0003-1452-0333; Andreoni, Massimo/0000-0002-3205-9758; SVICHER, VALENTINA/0000-0002-2377-504X; Di Carlo, Domenico/0000-0002-8324-4873; PERNO, CARLO FEDERICO/0000-0002-0825-5388; CECCHERINI SILBERSTEIN, FRANCESCA/0000-0002-6024-5101	European Commission Framework 7 Program [223131]; Aviralia Foundation; National Institute of Health [40H41]; Ministry of University and Scientific Research [prot. 2008MRLSNZ_003]; Abbott; Boehringer Ingelheim; Bristol Myers Squibb; Gilead; Merck Sharp Dohme; Janssen Cilag; Pfizer; Tibotec; Roche; ViiV	European Commission Framework 7 Program; Aviralia Foundation; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); Abbott(Abbott Laboratories); Boehringer Ingelheim(Boehringer Ingelheim); Bristol Myers Squibb(Bristol-Myers Squibb); Gilead(Gilead Sciences); Merck Sharp Dohme(Merck & Company); Janssen Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Pfizer(Pfizer); Tibotec; Roche(Roche Holding); ViiV	This work was financially supported by the European Commission Framework 7 Program (CHAIN, collaborative HIV and anti-HIV drugs Resistance Network, Integrated Project number 223131), Aviralia Foundation, National Institute of Health conv. number 40H41 and Ministry of University and Scientific Research prot. 2008MRLSNZ_003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; CF Perno have received funds for attending symposia, speaking, organizing educational activities, grant research support, consultancy and advisory board membership, from Abbott, Boehringer Ingelheim, Bristol Myers Squibb, Gilead, Merck Sharp & Dohme, Janssen Cilag, Pfizer, Tibotec, Roche, and ViiV. F Ceccherini-Silberstein has received funds for attending symposia, speaking and organizing educational activities from Abbott, Merck Sharp & Dohme, Janssen Cilag, and ViiV. V Svicher has received funds for attending symposia, speaking and organizing educational activities from ViiV. The other authors declare that no competing interests exist. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Andreoni A, 2000, AIDS, V14, P23, DOI 10.1097/00002030-200001070-00003; Aquaro S, 2002, J MED VIROL, V68, P479, DOI 10.1002/jmv.10245; Balestra E, 2001, J BIOL REG HOMEOS AG, V15, P272; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Bjorndal A, 1997, J VIROL, V71, P7478; Brumme ZL, 2005, J INFECT DIS, V192, P466, DOI 10.1086/431519; Cammack N, 1999, ANTIVIR CHEM CHEMOTH, V10, P53, DOI 10.1177/095632029901000201; Cassol E, 2006, J LEUKOCYTE BIOL, V80, P1018, DOI 10.1189/jlb.0306150; Chueca N, 2009, J MED VIROL, V81, P763, DOI 10.1002/jmv.21425; Church JD, 2008, J INFECT DIS, V197, P1382, DOI 10.1086/587492; Coiras M, 2010, DISCOV MED, V9, P185; Coiras M, 2009, NAT REV MICROBIOL, V7, P798, DOI 10.1038/nrmicro2223; Cooper DA, 2010, J INFECT DIS, V201, P803, DOI 10.1086/650697; De CE, 1994, ANTIMICROB AGENTS CH, V38, P668; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Duncan CJA, 2011, VIRUSES-BASEL, V3, P2255, DOI 10.3390/v3112255; Fatkenheuer G, 2008, NEW ENGL J MED, V359, P1442, DOI 10.1056/NEJMoa0803154; Fatkenheuer G, 2005, NAT MED, V11, P1170, DOI 10.1038/nm1319; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; FOLKS TM, 1986, J EXP MED, V164, P280, DOI 10.1084/jem.164.1.280; Fransen S, 2008, ANTIMICROB AGENTS CH, V52, P2608, DOI 10.1128/AAC.01226-07; Goodenow MM, 2006, J LEUKOCYTE BIOL, V80, P965, DOI 10.1189/jlb.0306148; Gorry PR, 2001, J VIROL, V75, P10073, DOI 10.1128/JVI.75.21.10073-10089.2001; Gorry PR, 2005, CURR HIV RES, V3, P53, DOI 10.2174/1570162052772951; Gulick RM, 2008, NEW ENGL J MED, V359, P1429, DOI 10.1056/NEJMoa0803152; HART C, 1990, NUCLEIC ACIDS RES, V18, P4029, DOI 10.1093/nar/18.13.4029; Kamp C, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-274; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Koppensteiner H, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-82; Lewin SR, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-4; Li S, 1999, J VIROL, V73, P9741, DOI 10.1128/JVI.73.12.9741-9755.1999; Loftin LM, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S3; MAMMANO F, 1995, J VIROL, V69, P82, DOI 10.1128/JVI.69.1.82-92.1995; McGovern RA, 2012, JAIDS-J ACQ IMM DEF, V61, P279, DOI 10.1097/QAI.0b013e31826249cf; Melby T, 2006, J INFECT DIS, V194, P238, DOI 10.1086/504693; Moore JP, 2009, CURR OPIN HIV AIDS, V4, P118, DOI 10.1097/COH.0b013e3283223d46; Moore JP, 1997, CURR OPIN IMMUNOL, V9, P551, DOI 10.1016/S0952-7915(97)80110-0; Moyle GJ, 2005, J INFECT DIS, V191, P866, DOI 10.1086/428096; Naif HM, 2002, J VIROL, V76, P3114, DOI 10.1128/JVI.76.7.3114-3124.2002; Nicastri E, 2004, J VIROL METHODS, V115, P199, DOI 10.1016/j.jviromet.2003.09.032; Orenstein JM, 1997, SCIENCE, V276, P1857, DOI 10.1126/science.276.5320.1857; PERNO CF, 1988, J EXP MED, V168, P1111, DOI 10.1084/jem.168.3.1111; PERNO CF, 1994, J LEUKOCYTE BIOL, V56, P381, DOI 10.1002/jlb.56.3.381; PONTEN J, 1968, ACTA PATHOL MIC SC, V74, P465; Poveda E, 2009, J ANTIMICROB CHEMOTH, V63, P1006, DOI 10.1093/jac/dkp063; Prosperi MCF, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-56; R Foundation for Statistical Computing VA, 2012, R COR TEAM R LANG EN; Rozera Gabriella, 2012, J Med Virol, V84, P839, DOI 10.1002/jmv.23292; Saag M, 2009, J INFECT DIS, V199, P1638, DOI 10.1086/598965; Santoro MM, 2012, CLIN MICROBIOL INFEC, V18, pE289, DOI 10.1111/j.1469-0691.2012.03905.x; Saracino A, 2009, J MED VIROL, V81, P2036, DOI 10.1002/jmv.21598; Scarlatti G, 1997, NAT MED, V3, P1259, DOI 10.1038/nm1197-1259; Schweighardt B, 2004, J VIROL, V78, P9164, DOI 10.1128/JVI.78.17.9164-9173.2004; Shen R, 2009, J VIROL, V83, P3258, DOI 10.1128/JVI.01796-08; Simon B, 2010, AIDS, V24, P2051, DOI 10.1097/QAD.0b013e32833c93e6; Skrabal K, 2007, J CLIN MICROBIOL, V45, P279, DOI 10.1128/JCM.01118-06; Sohy D, 2009, J BIOL CHEM, V284, P31270, DOI 10.1074/jbc.M109.054809; Svicher V, 2011, ANTIVIR RES, V90, P42, DOI 10.1016/j.antiviral.2011.02.005; Svicher V, 2010, NEW MICROBIOL, V33, P195; Swenson LC, 2012, CURR OPIN HIV AIDS, DOI [10.1097/COH.0-b013e328356e9da, DOI 10.1097/C0H.0-B013E328356E9DA]; Swenson LC, 2011, CLIN INFECT DIS, V53, P732, DOI 10.1093/cid/cir493; Swingler S, 1999, NAT MED, V5, P997, DOI 10.1038/12433; Symons J, 2011, J ANTIMICROB CHEMOTH, V66, P890, DOI 10.1093/jac/dkq535; Toma J, 2010, AIDS, V24, P2181, DOI 10.1097/QAD.0b013e32833c543f; Trouplin V, 2001, J VIROL, V75, P251, DOI 10.1128/JVI.75.1.251-259.2001; Tuttle DL, 2002, AIDS RES HUM RETROV, V18, P353, DOI 10.1089/088922202753519133; URYU T, 1992, BIOCHEM PHARMACOL, V43, P2385, DOI 10.1016/0006-2952(92)90317-C; Vandekerckhove LPR, 2011, LANCET INFECT DIS, V11, P394, DOI 10.1016/S1473-3099(10)70319-4; Viard JP, 2004, AIDS, V18, P45, DOI 10.1097/00002030-200401020-00005; Waters L, 2008, CLIN INFECT DIS, V46, P1617, DOI 10.1086/587660; Weinberger AD, 2011, MATH BIOSCI ENG, V8, P605, DOI 10.3934/mbe.2011.8.605; Wilkin TJ, 2007, CLIN INFECT DIS, V44, P591, DOI 10.1086/511035; Yilmaz Aylin, 2009, AIDS, V23, P2537, DOI 10.1097/QAD.0b013e328333ae0e; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L	75	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68076	10.1371/journal.pone.0068076	http://dx.doi.org/10.1371/journal.pone.0068076			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874501	Green Submitted, Green Published, gold			2022-12-27	WOS:000321736900051
J	Argov-Argaman, N; Mida, K; Cohen, BC; Visker, M; Hettinga, K				Argov-Argaman, Nurit; Mida, Kfir; Cohen, Bat-Chen; Visker, Marleen; Hettinga, Kasper			Milk Fat Content and DGAT1 Genotype Determine Lipid Composition of the Milk Fat Globule Membrane	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; MAMMARY-GLAND; RAW-MILK; SIZE; ACIDS; PARAMETERS; SECRETION; CANCER; YIELD	During secretion of milk fat globules, triacylglycerol (TAG) droplets are enveloped by a phospholipid (PL) trilayer. Globule size has been found to be related to polar lipid composition and fat content, and milk fat content and fatty acid composition have been associated with the diacylglycerol acyltransferase 1 (DGAT1) K232A polymorphism; however, the association between the DGAT1 polymorphism and fat globule size and polar lipid composition has not been studied. The ratio between polar and neutral lipids as well as the composition of the polar lipids in milk has industrial as well as nutritional and health implications. Understanding phenotypic and genotypic factors influencing these parameters could contribute to improving milk lipid composition for dairy products. The focus of the present study was to determine the effect of both fat content and DGAT1 polymorphism on PL/TAG ratio, as a marker for milk fat globule size, and detailed PL composition. Milk samples were selected from 200 cows such that there were equal numbers of samples for the different fat contents as well as per DGAT1 genotype. Samples were analyzed for neutral and polar lipid concentration and composition. PL/TAG ratio was significantly associated with both fat content and DGAT1 genotype. Phosphatidylinositol and phosphatidylserine concentrations were associated with fat content*DGAT1 genotype with a stronger association for the AA than the KK genotype. Sphingomyelin concentration tended to interact with fat content*DGAT1 genotype. Phosphatidylethanolamine (PE) concentration showed a biphasic response to fat content, suggesting that multiple biological processes influence its concentration. These results provide a new direction for controlling polar lipid concentration and composition in milk through selective breeding of cows.	[Argov-Argaman, Nurit; Mida, Kfir; Cohen, Bat-Chen] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Dept Anim Sci, Jerusalem, Israel; [Visker, Marleen] Wageningen Univ, Anim Breeding & Genom Ctr, NL-6700 AP Wageningen, Netherlands; [Hettinga, Kasper] Wageningen Univ, Prod Design & Qual Management Grp, NL-6700 AP Wageningen, Netherlands	Hebrew University of Jerusalem; Wageningen University & Research; Wageningen University & Research	Argov-Argaman, N (corresponding author), Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Dept Anim Sci, Jerusalem, Israel.	argov@agri.huji.ac.il	Visker, Marleen/E-1394-2012; argovArgaman, Nurit/AAB-1846-2020		Wageningen University (Wageningen, the Netherlands); Dutch Dairy Association (NZO, Zoetermeer, the Netherlands); Cooperative Cattle Improvement Organization CRV (Arnhem, the Netherlands); Dutch Technology Foundation (STW, Utrecht, the Netherlands)	Wageningen University (Wageningen, the Netherlands)(Netherlands Government); Dutch Dairy Association (NZO, Zoetermeer, the Netherlands)(Netherlands Government); Cooperative Cattle Improvement Organization CRV (Arnhem, the Netherlands)(Netherlands Government); Dutch Technology Foundation (STW, Utrecht, the Netherlands)(Technologiestichting STWNetherlands Government)	This study is part of the Dutch Milk Genomics Initiative, funded by Wageningen University (Wageningen, the Netherlands), the Dutch Dairy Association (NZO, Zoetermeer, the Netherlands), the Cooperative Cattle Improvement Organization CRV (Arnhem, the Netherlands) and the Dutch Technology Foundation (STW, Utrecht, the Netherlands). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. None of the authors works for/is paid directly by/sells products for CRV and therefore this does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Argov N, 2008, TRENDS FOOD SCI TECH, V19, P617, DOI 10.1016/j.tifs.2008.07.006; Argov-Argaman N, 2012, J DAIRY SCI, V95, P5776, DOI 10.3168/jds.2012-5569; Bagnato C, 2003, J BIOL CHEM, V278, P52203, DOI 10.1074/jbc.M305760200; BITMAN J, 1990, J DAIRY SCI, V73, P1208, DOI 10.3168/jds.S0022-0302(90)78784-X; Burgess JW, 2005, J LIPID RES, V46, P350, DOI 10.1194/jlr.M400438-JLR200; Cases S, 1980, P NATL ACAD SCI USA, V27, P13018; COHEN FS, 1984, J CELL BIOL, V98, P1054, DOI 10.1083/jcb.98.3.1054; Couvreur S, 2007, J DAIRY SCI, V90, P392, DOI 10.3168/jds.S0022-0302(07)72640-1; Dewettinck K, 2008, INT DAIRY J, V18, P436, DOI 10.1016/j.idairyj.2007.10.014; DILLEHAY DL, 1994, J NUTR, V124, P615, DOI 10.1093/jn/124.5.615; FOLCH J, 1957, J BIOL CHEM, V226, P497; German JB, 2004, AM J CLIN NUTR, V80, P550; GHOSAL D, 1994, BBA-GEN SUBJECTS, V1200, P175, DOI 10.1016/0304-4165(94)90133-3; Gilmour A., 2006, ASREML USER GUIDE RE; GOLOVASTOV VV, 2002, BIOKHIMIYA, V67, P1182; Grisart B, 2004, P NATL ACAD SCI USA, V101, P2398, DOI 10.1073/pnas.0308518100; HAMILTON RL, 1989, BIOCHEM BIOPH RES CO, V160, P162, DOI 10.1016/0006-291X(89)91635-5; Heck JML, 2009, J DAIRY SCI, V92, P4745, DOI 10.3168/jds.2009-2146; Huth PJ, 2012, ADV NUTR, V3, P266, DOI 10.3945/an.112.002030; Jackowski S, 2000, BBA-MOL CELL BIOL L, V1483, P301, DOI 10.1016/S1388-1981(99)00203-6; Jensen RG, 2002, J DAIRY SCI, V85, P295, DOI 10.3168/jds.S0022-0302(02)74079-4; KEENAN TW, 1972, J DAIRY SCI, V55, P1586, DOI 10.3168/jds.S0022-0302(72)85725-4; Lopez C, 2008, J AGR FOOD CHEM, V56, P5226, DOI 10.1021/jf7036104; Lopez C, 2011, FOOD CHEM, V125, P355, DOI 10.1016/j.foodchem.2010.09.005; Mather IH, 1998, J MAMMARY GLAND BIOL, V3, P259, DOI 10.1023/A:1018711410270; Menard O, 2010, FOOD CHEM, V120, P544, DOI 10.1016/j.foodchem.2009.10.053; Mesilati-Stahy R, 2012, J DAIRY SCI, V95, P1767, DOI 10.3168/jds.2011-4583; Mesilati-Stahy R, 2011, J AGR FOOD CHEM, V59, P7427, DOI 10.1021/jf201373j; Michalski MC, 2004, CHEM PHYS LIPIDS, V132, P247, DOI 10.1016/j.chemphyslip.2004.08.007; Michalski MC, 2003, LAIT, V83, P131, DOI 10.1051/lait:2003003; Mikhaleva NI, 2001, FEBS LETT, V493, P85, DOI 10.1016/S0014-5793(01)02288-8; Mozaffarian D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000252; Ocke MC, 2009, EUR J CLIN NUTR, V63, pS3, DOI 10.1038/ejcn.2009.72; Schennink A, 2007, ANIM GENET, V38, P467, DOI 10.1111/j.1365-2052.2007.01635.x; STALS HK, 1994, FEBS LETT, V343, P99, DOI 10.1016/0014-5793(94)80615-2; Stoop WM, 2007, J DAIRY SCI, V90, P1981, DOI 10.3168/jds.2006-434; Wiking L, 2006, J DAIRY SCI, V89, P1004, DOI 10.3168/jds.S0022-0302(06)72166-X; WILMINK JBM, 1987, LIVEST PROD SCI, V16, P335, DOI 10.1016/0301-6226(87)90003-0	38	37	39	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e68707	10.1371/journal.pone.0068707	http://dx.doi.org/10.1371/journal.pone.0068707			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874734	gold, Green Published, Green Submitted			2022-12-27	WOS:000324146200028
J	Cui, WG; Cheng, LY; Hu, CM; Li, HY; Zhang, YG; Chang, J				Cui, Wenguo; Cheng, Liying; Hu, Changmin; Li, Haiyan; Zhang, Yuguang; Chang, Jiang			Electrospun Poly(L-Lactide) Fiber with Ginsenoside Rg3 for Inhibiting Scar Hyperplasia of Skin	PLOS ONE			English	Article							IN-VIVO DEGRADATION; HYPERTROPHIC SCAR; POLYMER NANOFIBERS; DRUG-DELIVERY; SILICONE GEL; RABBIT EAR; FIBROBLASTS; TISSUE; RELEASE; POLY(DL-LACTIDE)	Hypertrophic scarring (HS) has been considered as a great concern for patients and a challenging problem for clinicians as it can be cosmetically disfiguring and functionally debilitating. In this study, Ginsenoside Rg3/Poly(l-lactide) (G-Rg3/PLLA) electrospun fibrous scaffolds covering on the full-thickness skin excisions location was designed to suppress the hypertrophic scar formation in vivo. SEM and XRD results indicated that the crystal G-Rg3 carried in PLLA electrospun fibers was in amorphous state, which facilitates the solubility of G-Rg3 in the PLLA electrospun fibrous scaffolds, and solubility of G-Rg3 in PBS is increased from 3.2 mu g/ml for pure G-Rg3 powders to 19.4 mu g/ml for incorporated in PLLA-10% fibers. The released G-Rg3 content in the physiological medium could be further altered from 324 to 3445 mu g in a 40-day release period by adjusting the G-Rg3 incorporation amount in PLLA electrospun fibers. In vitro results demonstrated that electrospun GRg3/PLLA fibrous scaffold could significantly inhibit fibroblast cell growth and proliferation. In vivo results confirmed that the G-Rg3/PLLA electrospun fibrous scaffold showed significant improvements in terms of dermis layer thickness, fibroblast proliferation, collagen fibers and microvessels, revealing that the incorporation of the G-Rg3 in the fibers prevented the HS formation. The above results demonstrate the potential use of G-Rg3/PLLA electrospun fibrous scaffolds to rapidly minimize fibroblast growth and restore the structural and functional properties of wounded skin for patients with deep trauma, severe burn injury, and surgical incision.	[Cui, Wenguo; Hu, Changmin; Li, Haiyan; Chang, Jiang] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China; [Cui, Wenguo; Hu, Changmin; Li, Haiyan; Chang, Jiang] Shanghai Jiao Tong Univ, Med Res Inst X, Shanghai 200030, Peoples R China; [Cheng, Liying; Zhang, Yuguang] Shanghai Jiao Tong Univ, Peoples Hosp 9, Sch Med, Dept Plast & Reconstruct Surg, Shanghai 200030, Peoples R China; [Chang, Jiang] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institute of Ceramics, CAS	Zhang, YG (corresponding author), Shanghai Jiao Tong Univ, Peoples Hosp 9, Sch Med, Dept Plast & Reconstruct Surg, Shanghai 200030, Peoples R China.	zhangyg18@126.com; jchang@mail.sic.ac.cn	Hu, Changmin/N-3508-2017	Hu, Changmin/0000-0002-1472-9981; Li, Haiyan/0000-0002-7423-2715	National Natural Science Foundation of China [51003058]; Program for SMC-Young Scholar in Shanghai Jiao Tong University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for SMC-Young Scholar in Shanghai Jiao Tong University	This work was supported by National Natural Science Foundation of China (51003058) (http://www.nsfc.gov.cn/Portal0/default152.htm) and Program for SMC-Young Scholar in Shanghai Jiao Tong University (http://www.sjtu.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa M, 1996, BRIT J DERMATOL, V134, P863; Attele AS, 1999, BIOCHEM PHARMACOL, V58, P1685, DOI 10.1016/S0006-2952(99)00212-9; Bie L, 2010, CHEM RES CHINESE U, V26, P780; Bolgen N, 2005, J BIOMAT SCI-POLYM E, V16, P1537, DOI 10.1163/156856205774576655; Brown RJ, 2008, PLAST RECONSTR SURG, V121, P1165, DOI 10.1097/01.prs.0000302512.17904.2a; Cui WG, 2008, INT J PHARMACEUT, V361, P47, DOI 10.1016/j.ijpharm.2008.05.005; Cui WG, 2007, J APPL POLYM SCI, V103, P3105, DOI 10.1002/app.25464; Cui WG, 2010, SCI TECHNOL ADV MAT, V11, DOI 10.1088/1468-6996/11/1/014108; Cui WG, 2009, MAT SCI ENG C-MATER, V29, P1869, DOI 10.1016/j.msec.2009.02.013; Cui WG, 2006, BIOMACROMOLECULES, V7, P1623, DOI 10.1021/bm060057z; Fumagalli M, 2007, EXP DERMATOL, V16, P600, DOI 10.1111/j.1600-0625.2007.00571.x; He BC, 2011, INT J ONCOL, V38, P437, DOI 10.3892/ijo.2010.858; Jing Z, 2003, J CONTROL RELEASE, V92, P227, DOI 10.1016/S0168-3659(03)00372-9; Joo EJ, 2009, BIOL PHARM BULL, V32, P548, DOI 10.1248/bpb.32.548; Kang KS, 2007, BIOL PHARM BULL, V30, P917, DOI 10.1248/bpb.30.917; Karagoz H, 2009, BURNS, V35, P1097, DOI 10.1016/j.burns.2009.06.206; Kenawy ER, 2009, MATER CHEM PHYS, V113, P296, DOI 10.1016/j.matchemphys.2008.07.081; Kim JS, 2012, MOL CELL BIOCHEM, V365, P181, DOI 10.1007/s11010-012-1258-2; Kloeters O, 2007, WOUND REPAIR REGEN, V15, pS40, DOI 10.1111/j.1524-475X.2007.00224.x; Kurokawa N, 2010, J PLAST SURG HAND SU, V44, P272, DOI 10.3109/2000656X.2010.532923; Lau KKS, 2007, MACROMOL BIOSCI, V7, P429, DOI 10.1002/mabi.200700017; Li H, 2011, AFR J BIOTECHNOL, V10, P10040; Li L, 2006, POLYMER, V47, P6208, DOI 10.1016/j.polymer.2006.06.049; Liu TG, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-250; Lu L, 2000, BIOMATERIALS, V21, P1837, DOI 10.1016/S0142-9612(00)00047-8; Morris DE, 1997, PLAST RECONSTR SURG, V100, P674, DOI 10.1097/00006534-199709000-00021; Popovich DG, 2005, J FOOD SCI, V70, pS355, DOI 10.1111/j.1365-2621.2005.tb11455.x; Qiu XP, 2001, LANGMUIR, V17, P5375, DOI 10.1021/la010201w; She Z, 2010, BIOMACROMOLECULES, V11, P1241, DOI 10.1021/bm901450r; Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011; Sun S, 2010, FOOD CHEM, V118, P307, DOI 10.1016/j.foodchem.2009.04.122; Tan ST, 2005, CHEMPHYSCHEM, V6, P1461, DOI 10.1002/cphc.200500167; Tandara AA, 2008, J PLAST RECONSTR AES, V61, P1219, DOI 10.1016/j.bjps.2008.03.022; Toncheva A, 2011, MACROMOL RES, V19, P1310, DOI 10.1007/s13233-011-1206-0; Usov D, 2010, LANGMUIR, V26, P12575, DOI 10.1021/la1018949; Varkey M, 2011, BIOMATERIALS, V32, P7581, DOI 10.1016/j.biomaterials.2011.06.070; Verreck G, 2003, J CONTROL RELEASE, V92, P349, DOI 10.1016/S0168-3659(03)00342-0; Wischke C, 2008, INT J PHARMACEUT, V364, P298, DOI 10.1016/j.ijpharm.2008.04.042; Yoo HH, 2006, AM J CHINESE MED, V34, P137, DOI 10.1142/S0192415X06003709; Yoo HS, 2009, ADV DRUG DELIVER REV, V61, P1033, DOI 10.1016/j.addr.2009.07.007; Yu DG, 2010, PHARM RES-DORDR, V27, P2466, DOI 10.1007/s11095-010-0239-y; Yue PYK, 2006, BIOCHEM PHARMACOL, V72, P437, DOI 10.1016/j.bcp.2006.04.034; Zhang QY, 2008, CANCER BIOTHER RADIO, V23, P647, DOI 10.1089/cbr.2008.0532; Zhao QA, 2010, J CHROMATOGR B, V878, P2266, DOI 10.1016/j.jchromb.2010.06.019	44	33	35	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e68771	10.1371/journal.pone.0068771	http://dx.doi.org/10.1371/journal.pone.0068771			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874757	Green Submitted, Green Published, gold			2022-12-27	WOS:000324146200031
J	Herrero, R; Quint, W; Hildesheim, A; Gonzalez, P; Struijk, L; Katki, HA; Porras, C; Schiffman, M; Rodriguez, AC; Solomon, D; Jimenez, S; Schiller, JT; Lowy, DR; van Doorn, LJ; Wacholder, S; Kreimer, AR				Herrero, Rolando; Quint, Wim; Hildesheim, Allan; Gonzalez, Paula; Struijk, Linda; Katki, Hormuzd A.; Porras, Carolina; Schiffman, Mark; Cecilia Rodriguez, Ana; Solomon, Diane; Jimenez, Silvia; Schiller, John T.; Lowy, Douglas R.; van Doorn, Leen-Jan; Wacholder, Sholom; Kreimer, Aimee R.		CVT Vaccine Grp	Reduced Prevalence of Oral Human Papillomavirus (HPV) 4 Years after Bivalent HPV Vaccination in a Randomized Clinical Trial in Costa Rica	PLOS ONE			English	Article							CANCER INCIDENCE; BROAD-SPECTRUM; GENOMIC DNA; YOUNG-WOMEN; NECK-CANCER; INFECTION; EFFICACY; ASSAY; HUMAN-PAPILLOMAVIRUS-16; TRENDS	Background: Human papillomavirus (HPV) infection, particularly with type 16, causes a growing fraction of oropharyngeal cancers, whose incidence is increasing, mainly in developed countries. In a double-blind controlled trial conducted to investigate vaccine efficacy (VE) of the bivalent HPV 16/18 vaccine against cervical infections and lesions, we estimated VE against prevalent oral HPV infections 4 years after vaccination. Methods and Findings: A total of 7,466 women 18-25 years old were randomized (1: 1) to receive the HPV16/18 vaccine or hepatitis A vaccine as control. At the final blinded 4-year study visit, 5,840 participants provided oral specimens (91.9% of eligible women) to evaluate VE against oral infections. Our primary analysis evaluated prevalent oral HPV infection among all vaccinated women with oral and cervical HPV results. Corresponding VE against prevalent cervical HPV16/18 infection was calculated for comparison. Oral prevalence of identifiable mucosal HPV was relatively low (1.7%). Approximately four years after vaccination, there were 15 prevalent HPV16/18 infections in the control group and one in the vaccine group, for an estimated VE of 93.3% (95% CI = 63% to 100%). Corresponding efficacy against prevalent cervical HPV16/18 infection for the same cohort at the same visit was 72.0% (95% CI = 63% to 79%) (p versus oral VE = 0.04). There was no statistically significant protection against other oral HPV infections, though power was limited for these analyses. Conclusions: HPV prevalence four years after vaccination with the ASO4-adjuvanted HPV16/18 vaccine was much lower among women in the vaccine arm compared to the control arm, suggesting that the vaccine affords strong protection against oral HPV16/18 infection, with potentially important implications for prevention of increasingly common HPV-associated oropharyngeal cancer.	[Herrero, Rolando] Int Agcy Res Canc, Prevent & Implementat Grp, F-69372 Lyon, France; [Quint, Wim; Struijk, Linda; van Doorn, Leen-Jan] DDL Diagnost Lab, Rijswijk, Netherlands; [Hildesheim, Allan; Katki, Hormuzd A.; Schiffman, Mark; Wacholder, Sholom; Kreimer, Aimee R.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Gonzalez, Paula; Porras, Carolina; Cecilia Rodriguez, Ana; Jimenez, Silvia] Fdn INCIENSA, Proyecto Epidemiol Guanacaste, Guanacaste, Costa Rica; [Solomon, Diane] NCI, Canc Prevent Div, Bethesda, MD 20892 USA; [Schiller, John T.; Lowy, Douglas R.] NCI, Cellular Oncol Lab, Bethesda, MD 20892 USA	World Health Organization; International Agency for Research on Cancer (IARC); DDL Diagnostic Laboratory; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Herrero, R (corresponding author), Int Agcy Res Canc, Prevent & Implementat Grp, 150 Cours Albert Thomas, F-69372 Lyon, France.	herreror@iarc.fr	Hildesheim, Allan/B-9760-2015; Schiffman, Mark/B-9766-2015; Kreimer, Aimee ARK/H-1687-2015; Schiller, John/ABK-8287-2022; Katki, Hormuzd A/B-4003-2015; Rodríguez, Ana/GQR-0554-2022	Hildesheim, Allan/0000-0003-0257-2363; 	NCI [N01-CP-11005]; National Institutes of Health Office of Research on Women's Health; GSK [FDA BB-IND 7920]; NATIONAL CANCER INSTITUTE [ZIACP010209, ZIABC009052] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health Office of Research on Women's Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH Office of Research on Women's Health (ORWH)); GSK(GlaxoSmithKline); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The Costa Rica HPV Vaccine Trial is a long-standing collaboration between investigators in Costa Rica and the National Cancer Institute (NCI). The trial is sponsored and funded by the NCI (contract N01-CP-11005), with funding support from the National Institutes of Health Office of Research on Women's Health. Vaccine was provided for our trial by GlaxoSmithKline Biologicals (GSK), under a Clinical Trials Agreement with the NCI. GSK also provided support for aspects of the trial associated with regulatory submission needs of the company under FDA BB-IND 7920. NCI and Costa Rica investigators were responsible for the study design, data collection, data management, data analysis, interpretation, and preparation of the report. The corresponding author had access to all summary-level data. The NCI and Costa Rica investigators had final responsibility for the decision to submit for publication. GSK had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. GSK had the right to review and comment on the report.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; Blomberg M, 2011, INT J CANCER, V129, P733, DOI 10.1002/ijc.25699; Brown LM, 2011, CANCER CAUSE CONTROL, V22, P753, DOI 10.1007/s10552-011-9748-1; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; Cogliano V, 2005, LANCET ONCOL, V6, P204, DOI 10.1016/S1470-2045(05)70086-3; de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7; Dessy FJ, 2008, HUM VACCINES, V4, P425, DOI 10.4161/hv.4.6.6912; Garcia-Closas M, 2001, CANCER EPIDEM BIOMAR, V10, P687; Gillison ML, 2008, CANCER-AM CANCER SOC, V113, P3036, DOI 10.1002/cncr.23764; Gillison ML, 2012, JAMA-J AM MED ASSOC, V307, P693, DOI 10.1001/jama.2012.101; Giuliano AR, 2011, NEW ENGL J MED, V364, P401, DOI 10.1056/NEJMoa0909537; Herrero R, 2003, JNCI-J NATL CANCER I, V95, P1772, DOI [10.1093/jnci/djg/107, 10.1093/jnci/djg107]; Herrero R, 2008, VACCINE, V26, P4795, DOI 10.1016/j.vaccine.2008.07.002; Herrero R, 2011, CANCER DISCOV, V1, P408, DOI 10.1158/2159-8290.CD-11-0131; Hildesheim A, 2007, JAMA-J AM MED ASSOC, V298, P743, DOI 10.1001/jama.298.7.743; Hocking JS, 2011, BRIT J CANCER, V104, P886, DOI 10.1038/sj.bjc.6606091; Kleter B, 1998, AM J PATHOL, V153, P1731, DOI 10.1016/S0002-9440(10)65688-X; Kleter B, 1999, J CLIN MICROBIOL, V37, P2508, DOI 10.1128/JCM.37.8.2508-2517.1999; Kreimer AR, 2011, LANCET ONCOL, V12, P862, DOI 10.1016/S1470-2045(11)70213-3; Kreimer AR, 2010, SEX TRANSM DIS, V37, P386, DOI 10.1097/OLQ.0b013e3181c94a3b; Lang Kuhs KA, J INFECT DI IN PRESS; Lehtinen M, 2012, LANCET ONCOL, V13, P89, DOI 10.1016/S1470-2045(11)70286-8; Ligier K, 2011, ORAL ONCOL, V47, P302, DOI 10.1016/j.oraloncology.2011.02.013; Lum A, 1998, CANCER EPIDEM BIOMAR, V7, P719; Munoz N, 2010, JNCI-J NATL CANCER I, V102, P325, DOI 10.1093/jnci/djp534; Nardelli-Haefliger D, 2003, JNCI-J NATL CANCER I, V95, P1128, DOI 10.1093/jnci/djg018; Nasman A, 2009, INT J CANCER, V125, P362, DOI 10.1002/ijc.24339; Palefsky JM, 2011, NEW ENGL J MED, V365, P1576, DOI 10.1056/NEJMoa1010971; Reddy VM, 2010, ANN ROY COLL SURG, V92, P655, DOI 10.1308/003588410X12699663904871; Rothman KJ., 1982, EPIDEMIOLOGIC ANAL P; Rowhani-Rahbar A, 2009, J INFECT DIS, V200, P1452, DOI 10.1086/606026; van Doorn LJ, 2006, J CLIN MICROBIOL, V44, P3292, DOI 10.1128/JCM.00539-06; WALSH DJ, 1992, J FORENSIC SCI, V37, P387; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	34	302	310	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e68329	10.1371/journal.pone.0068329	http://dx.doi.org/10.1371/journal.pone.0068329			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23873171	gold, Green Submitted, Green Published			2022-12-27	WOS:000322000600008
J	Sattler, S; Sauer, C; Mehlkop, G; Graeff, P				Sattler, Sebastian; Sauer, Carsten; Mehlkop, Guido; Graeff, Peter			The Rationale for Consuming Cognitive Enhancement Drugs in University Students and Teachers	PLOS ONE			English	Article							COLLEGE-STUDENTS; PRESCRIPTION STIMULANTS; NONMEDICAL USE; CHOICE THEORY; NORMS; MEMORY; INDIVIDUALS; PERFORMANCE; PREDICTS; CRIME	Cognitive enhancement (CE) is the pharmaceutical augmentation of mental abilities (e. g., learning or memory) without medical necessity. This topic has recently attracted widespread attention in scientific and social circles. However, knowledge regarding the mechanisms that underlie the decision to use CE medication is limited. To analyze these decisions, we used data from two online surveys of randomly sampled university teachers (N = 1,406) and students (N = 3,486). Each respondent evaluated one randomly selected vignette with regard to a hypothetical CE drug. We experimentally varied the characteristics of the drugs among vignettes and distributed them among respondents. In addition, the respondent's internalization of social norms with respect to CE drug use was measured. Our results revealed that students were more willing to enhance cognitive performance via drugs than university teachers, although the overall willingness was low. The probability of side effects and their strength reduced the willingness to use CE drugs among students and university teachers, whereas higher likelihoods and magnitudes of CE increased this propensity. In addition, the internalized norm against CE drug use influenced decision making: Higher internalization decreased the willingness to use such medications. Students' internalized norms more strongly affected CE abstinence compared with those of university teachers. Furthermore, internalized norms negatively interacted with the instrumental incentives for taking CE medication. This internalization limited the influence of and deliberation on instrumental incentives. This study is the first to provide empirical evidence regarding the importance of social norms and their influence on rational decision making with regard to CE. We identified previously undiscovered decision-making patterns concerning CE. Thus, this study provides insight into the motivators and inhibitors of CE drug use. These findings have implications for contending with CE behavior by highlighting the magnitude of potential side effects and by informing the debate regarding the ethics of CE use.	[Sattler, Sebastian] Univ Bielefeld, Fac Sociol, D-33615 Bielefeld, Germany; [Sattler, Sebastian] Univ Freiburg, Inst Psychol, D-79106 Freiburg, Germany; [Sauer, Carsten] Univ Bielefeld, Collaborat Res Ctr 882, D-33615 Bielefeld, Germany; [Mehlkop, Guido] Univ Erfurt, Fac Econ Law & Social Sci, Erfurt, Germany; [Graeff, Peter] Univ Munich, Fac Humanities, Munich, Germany	University of Bielefeld; University of Freiburg; University of Bielefeld; University of Erfurt; University of Munich	Sattler, S (corresponding author), Univ Bielefeld, Fac Sociol, D-33615 Bielefeld, Germany.	sebastian.sattler@uni-bielefeld.de	Sattler, Sebastian/Y-3590-2018; Graeff, Peter/AAI-5667-2021	Sattler, Sebastian/0000-0002-6491-0754; Sauer, Carsten/0000-0002-8090-6886	Federal Ministry of Education and Research (FMER) [01PH08024]; Bielefeld Graduate School in History and Sociology (BGHS); Bielefeld University [3521.01]; Deutsche Forschungsgemeinschaft; Open Access Publication Funds of Bielefeld University Library	Federal Ministry of Education and Research (FMER); Bielefeld Graduate School in History and Sociology (BGHS); Bielefeld University; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publication Funds of Bielefeld University Library	This research was funded by the Federal Ministry of Education and Research (FMER; grant number 01PH08024, headed by Sebastian Sattler and Martin Diewald; http://www.bmbf.de/en/index.php). Carsten Sauer gratefully acknowledges a grant from the Bielefeld Graduate School in History and Sociology (BGHS; http://www.uni-bielefeld.de/(en)/bghs/), and Sebastian Sattler acknowledges a Rectorate Fellowship of the Bielefeld University (grant number 3521.01; http://www.uni-bielefeld.de/(en)/nachwuchs/finanzierung_und_foerderung/promovierende/rektoratsstipendien.html). We acknowledge support for the Article Processing Charge by the Deutsche Forschungsgemeinschaft and the Open Access Publication Funds of Bielefeld University Library. The funding agencies had no role with regard to study design, data collection and analysis, the decision to publish, or the preparation of the manuscript.	Anderson MS, 2007, SCI ENG ETHICS, V13, P387, DOI 10.1007/s11948-007-9047-0; [Anonymous], 2005, WONGS ESSENTIALS PED; Arria AM, 2008, PREV SCI, V9, P191, DOI 10.1007/s11121-008-0095-8; Banjo OC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014322; Barrett SP, 2005, CAN J PSYCHIAT, V50, P457, DOI 10.1177/070674370505000805; BECK L, 1991, J RES PERS, V25, P285, DOI 10.1016/0092-6566(91)90021-H; BECKER GS, 1968, J POLIT ECON, V76, P169, DOI 10.1086/259394; Becker R, 2006, RATION SOC, V18, P193, DOI 10.1177/1043463106063323; Beddington J, 2008, NATURE, V455, P1057, DOI 10.1038/4551057a; Bennett T, 1986, REASONING CRIMINAL R, P83; Bergstrom LS, 2008, SCAND J PUBLIC HEALT, V36, P532, DOI 10.1177/1403494807087558; BLIX AG, 1994, EDUC RES, V36, P157, DOI 10.1080/0013188940360205; Bostrom N, 2009, SCI ENG ETHICS, V15, P311, DOI 10.1007/s11948-009-9142-5; Chatterjee A, 2006, J MED ETHICS, V32, P110, DOI 10.1136/jme.2005.013599; Chatterjee A, 2007, CAMB Q HEALTHC ETHIC, V16, P129, DOI 10.1017/S0963180107070156; Choong P., 2002, INT J MANAGEMENT, V19, P3; Chuah LYM, 2009, SLEEP, V32, P999, DOI 10.1093/sleep/32.8.999; Clatworthy PL, 2009, J NEUROSCI, V29, P4690, DOI 10.1523/JNEUROSCI.3266-08.2009; Cochran JK, 1999, SOCIOL INQ, V69, P91, DOI 10.1111/j.1475-682X.1999.tb00491.x; Coleman J., 1990, FDN SOCIAL THEORY; Cools R, 2007, J NEUROSCI, V27, P5506, DOI 10.1523/JNEUROSCI.0601-07.2007; Dahlback O., 2003, ANAL RATIONAL CRIME; DANIELS K, 1992, WORK STRESS, V6, P347, DOI 10.1080/02678379208259965; Dockery CA, 2009, J NEUROSCI, V29, P7271, DOI 10.1523/JNEUROSCI.0065-09.2009; Elster J., 1989, CEMENT SOC STUDY SOC; ETZIONI A, 1986, ECON PHILOS, V2, P159, DOI 10.1017/S1478061500002619; Etzioni A, 2000, LAW SOC REV, V34, P157, DOI 10.2307/3115119; Farah MJ, 2004, NAT REV NEUROSCI, V5, P421, DOI 10.1038/nrn1390; Fishbein M., 2010, PREDICTING CHANGING, DOI 10.4324/9780203838020; Frank MJ, 2006, BEHAV NEUROSCI, V120, P497, DOI 10.1037/0735-7044.120.3.497; Franke AG, 2011, PHARMACOPSYCHIATRY, V44, P60, DOI 10.1055/s-0030-1268417; Garra G, 2010, ACAD EMERG MED, V17, P50, DOI 10.1111/j.1553-2712.2009.00620.x; Gibbs SEB, 2005, COGN AFFECT BEHAV NE, V5, P212, DOI 10.3758/CABN.5.2.212; Glannon W, 2008, NEUROETHICS-NETH, V1, P45, DOI 10.1007/s12152-008-9005-9; Goritz AS, 2006, INT J INTERNET SCI, V1, P58; GRASMICK HG, 1990, LAW SOC REV, V24, P837, DOI 10.2307/3053861; Greely H, 2008, NATURE, V456, P702, DOI 10.1038/456702a; Guerette RT, 2005, J CRIM JUST, V33, P77, DOI 10.1016/j.jcrimjus.2004.10.005; Hastie R., 2010, RATIONAL CHOICE UNCE; Hechter M., 2001, SOCIAL NORMS; Hotze TD, 2011, AM J BIOETHICS, V11, P3, DOI 10.1080/15265161.2011.534957; Husain M, 2011, TRENDS COGN SCI, V15, P28, DOI 10.1016/j.tics.2010.11.002; Jasso G, 2006, SOCIOL METHOD RES, V34, P334, DOI 10.1177/0049124105283121; Keck J F, 1996, J Pediatr Nurs, V11, P368, DOI 10.1016/S0882-5963(96)80081-9; Khantzian EJ, 1997, HARVARD REV PSYCHIAT, V4, P231, DOI 10.3109/10673229709030550; Kroneberg C, 2010, CRIMINOLOGY, V48, P259, DOI 10.1111/j.1745-9125.2010.00187.x; Kroneberg C, 2010, RATION SOC, V22, P3, DOI 10.1177/1043463109355494; Kroutil LA, 2006, DRUG ALCOHOL DEPEN, V84, P135, DOI 10.1016/j.drugalcdep.2005.12.011; Low KG., 2002, PSYCHOL HEALTH MED, V7, P283, DOI [10.1080/13548500220139386, DOI 10.1080/13548500220139386, 10.1177/1087054719855691, DOI 10.1177/1087054719855691]; Maher B, 2008, NATURE, V452, P674, DOI 10.1038/452674a; March J.G., 1989, REDISCOVERING I ORG; MCCABE DL, 1993, J HIGH EDUC, V64, P522, DOI 10.2307/2959991; McCabe DL, 2002, RES HIGH EDUC, V43, P357, DOI 10.1023/A:1014893102151; McCabe DL, 2001, ETHICS BEHAV, V11, P219, DOI 10.1207/S15327019EB1103_2; McCabe SE, 2005, ADDICTION, V100, P96, DOI 10.1111/j.1360-0443.2005.00944.x; McCabe SE, 2008, ARCH PEDIAT ADOL MED, V162, P225, DOI 10.1001/archpediatrics.2007.41; Mehlkop G, 2010, RATION SOC, V22, P189, DOI 10.1177/1043463110364730; Middendorff E., 2012, HOCHSCHUL INF SYST E, P11; Muller CP, 2011, BEHAV BRAIN SCI, V34, P328, DOI 10.1017/S0140525X1100135X; Normann C, 2008, EUR ARCH PSY CLIN N, V258, P110, DOI 10.1007/s00406-008-5022-2; Novak SP, 2007, SUBST ABUSE TREAT PR, V2, DOI 10.1186/1747-597X-2-32; Opp KD, 2013, THEOR DECIS, V74, P383, DOI 10.1007/s11238-012-9315-6; Opp KD, 1999, J THEOR POLIT, V11, P171, DOI 10.1177/0951692899011002002; Posner RA, 1999, INT REV LAW ECON, V19, P369, DOI 10.1016/S0144-8188(99)00013-7; Rabiner DL, 2009, J ATTEN DISORD, V13, P259, DOI 10.1177/1087054708320399; Racine E, 2010, NEUROETHICS-NETH, V3, P1, DOI 10.1007/s12152-008-9023-7; Repantis D, 2010, PHARMACOL RES, V61, P473, DOI 10.1016/j.phrs.2010.02.009; Rose SPR, 2002, NAT REV NEUROSCI, V3, P975, DOI 10.1038/nrn984; Sabini J, 2005, ETHICS BEHAV, V15, P81, DOI 10.1207/s15327019eb1501_6; Sahakian B, 2007, NATURE, V450, P1157, DOI 10.1038/4501157a; Sampson RJ, 2005, ANN AM ACAD POLIT SS, V602, P12, DOI 10.1177/0002716205280075; Sattler S, 2013, DEVIANT BEHAV, V34, P444, DOI 10.1080/01639625.2012.735909; Sattler S, 2013, SUBST USE MISUSE, V48, P220, DOI 10.3109/10826084.2012.751426; Scott J. F, 1971, INTERNALIZATION NORM; Teter CJ, 2006, PHARMACOTHERAPY, V26, P1501, DOI 10.1592/phco.26.10.1501; Tibbetts S. G., 1999, AM J CRIM JUSTICE, V23, P179, DOI DOI 10.1007/BF02887271; Tittle CR, 2010, SOC SCI RES, V39, P1029, DOI 10.1016/j.ssresearch.2010.08.007; Tully T, 2003, NAT REV DRUG DISCOV, V2, P267, DOI 10.1038/nrd1061; Wallander L, 2009, SOC SCI RES, V38, P505, DOI 10.1016/j.ssresearch.2009.03.004; Wason K. D., 2002, AUSTRALASIAN MARKETI, V10, P41, DOI DOI 10.1016/S1441-3582(02)70157-2; West R., 2006, THEORY ADDICTION; Weyandt LL, 2009, J ATTEN DISORD, V13, P284, DOI 10.1177/1087054709342212; Wezenberg E, 2007, NEUROPSYCHOPHARMACOL, V32, P1272, DOI 10.1038/sj.npp.1301257; Wikstrom POH, 2006, PATHWAY CRIME, P61, DOI 10.1017/CBO9780511489341.004; Winder-Rhodes SE, 2010, J PSYCHOPHARMACOL, V24, P1649, DOI 10.1177/0269881109105899; Yee AS, 1997, J POLIT, V59, P1001, DOI 10.2307/2998589	86	38	38	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e68821	10.1371/journal.pone.0068821	http://dx.doi.org/10.1371/journal.pone.0068821			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	185WH	23874778	gold, Green Submitted, Green Published			2022-12-27	WOS:000322000600030
J	Huang, YX; Wan, P; Zhang, HN; Huang, MS; Li, ZH; Gould, F				Huang, Yunxin; Wan, Peng; Zhang, Huannan; Huang, Minsong; Li, Zhaohua; Gould, Fred			Diminishing Returns from Increased Percent Bt Cotton: The Case of Pink Bollworm	PLOS ONE			English	Article							FIELD-EVOLVED RESISTANCE; BACILLUS-THURINGIENSIS; INSECT RESISTANCE; SUPPRESSION; LEPIDOPTERA; CROPS; EVOLUTION; CHINA	Regional suppression of pests by transgenic crops producing insecticidal proteins from Bacillus thuringiensis (Bt) has been reported in several cropping systems, but little is known about the functional relationship between the ultimate pest population density and the pervasiveness of Bt crops. Here we address this issue by analyzing 16 years of field data on pink bollworm (Pectinophora gossypiella) population density and percentage of Bt cotton in the Yangtze River Valley of China. In this region, the percentage of cotton hectares planted with Bt cotton increased from 9% in 2000 to 94% in 2009 and 2010. We find that as the percent Bt cotton increased over the years, the cross-year growth rate of pink bollworm from the last generation of one year to the first generation of the next year decreased. However, as the percent Bt cotton increased, the within-year growth rate of pink bollworm from the first to last generation of the same year increased, with a slope approximately opposite to that of the cross-year rates. As a result, we did not find a statistically significant decline in the annual growth rate of pink bollworm as the percent Bt cotton increased over time. Consistent with the data, our modeling analyses predict that the regional average density of pink bollworm declines as the percent Bt cotton increases, but the higher the percent Bt cotton, the slower the decline in pest density. Specifically, we find that 95% Bt cotton is predicted to cause only 3% more reduction in larval density than 80% Bt cotton. The results here suggest that density dependence can act against the decline in pest density and diminish the net effects of Bt cotton on suppression of pink bollworm in the study region. The findings call for more studies of the interactions between pest density-dependence and Bt crops.	[Huang, Yunxin; Zhang, Huannan; Li, Zhaohua] Hubei Univ, Sch Resource & Environm Sci, Wuhan, Peoples R China; [Wan, Peng; Huang, Minsong] Hubei Acad Agr Sci, Inst Plant Protect & Soil Sci, Wuhan, Peoples R China; [Gould, Fred] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA	Hubei University; Hubei Academy of Agricultural Sciences; University of North Carolina; North Carolina State University	Huang, YX (corresponding author), Hubei Univ, Sch Resource & Environm Sci, Wuhan, Peoples R China.	yunxin.huang@gmail.com	li, zh/HII-5698-2022		Key Project for Breeding Genetically Modified Organisms [2013ZX08012-004]	Key Project for Breeding Genetically Modified Organisms	This work was funded by the Key Project for Breeding Genetically Modified Organisms (2013ZX08012-004). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alstad DN, 1996, AGBIOTECH NEWS INFOR, V8, P177; Bagla P, 2010, SCIENCE, V327, P1439, DOI 10.1126/science.327.5972.1439; Bell JR, 2012, ECOL LETT, V15, P310, DOI 10.1111/j.1461-0248.2011.01739.x; Carriere Y, 2003, P NATL ACAD SCI USA, V100, P1519, DOI 10.1073/pnas.0436708100; Dhurua S, 2011, PEST MANAG SCI, V67, P898, DOI 10.1002/ps.2127; Draper N.R, 1998, WILEY SERIES PROBABI, Vthird; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; Henneberry T. J., 1998, Integrated Pest Management Reviews, V3, P31, DOI 10.1023/A:1009673622862; Hutchison WD, 2010, SCIENCE, V330, P222, DOI 10.1126/science.1190242; Liu YB, 2002, J ECON ENTOMOL, V95, P143, DOI 10.1603/0022-0493-95.1.143; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; National Agro-Technical Extension and Service Center (NATESC), 2005, HANDBOOK FOR CROP PE; National Research Council (NRC), 2010, THE IMPACT OF GENETI; RigginBucci TM, 1997, J ECON ENTOMOL, V90, P241, DOI 10.1093/jee/90.2.241; Royama T., 1992, ANAL POPULATION ECOL; Sanahuja G, 2011, PLANT BIOTECHNOL J, V9, P283, DOI 10.1111/j.1467-7652.2011.00595.x; Storer Nicholas P., 2008, V5, P273, DOI 10.1007/978-1-4020-8373-0_10; TABASHNIK BE, 1994, ANNU REV ENTOMOL, V39, P47, DOI 10.1146/annurev.en.39.010194.000403; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2012, J INVERTEBR PATHOL, V110, P301, DOI 10.1016/j.jip.2012.04.008; Tabashnik BE, 2010, SCIENCE, V330, P189, DOI 10.1126/science.1196864; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; Wan P, 2004, CROP PROT, V23, P463, DOI 10.1016/j.cropro.2003.09.017; Wan P, 2012, PLOS ONE; Wan P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029975; Wu KM, 2005, ANNU REV ENTOMOL, V50, P31, DOI 10.1146/annurev.ento.50.071803.130349; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Zhang HN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022874	29	2	3	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68573	10.1371/journal.pone.0068573	http://dx.doi.org/10.1371/journal.pone.0068573			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874678	Green Submitted, Green Published, gold			2022-12-27	WOS:000322064300052
J	Steffen, A; Sorensen, TIA; Knuppel, S; Travier, N; Sanchez, MJ; Huerta, JM; Quiros, JR; Ardanaz, E; Dorronsoro, M; Teucher, B; Li, KR; Bueno-de-Mesquita, HB; van der A, D; Mattiello, A; Palli, D; Tumino, R; Krogh, V; Vineis, P; Trichopoulou, A; Orfanos, P; Trichopoulos, D; Hedblad, B; Wallstrom, P; Overvad, K; Halkjaer, J; Tjonneland, A; Fagherazzi, G; Dartois, L; Crowe, F; Khaw, KT; Wareham, N; Middleton, L; May, AM; Peeters, PHM; Boeing, H				Steffen, Annika; Sorensen, Thorkild I. A.; Knueppel, Sven; Travier, Noemie; Sanchez, Maria-Jose; Maria Huerta, Jose; Ramon Quiros, J.; Ardanaz, Eva; Dorronsoro, Miren; Teucher, Birgit; Li, Kuanrong; Bueno-de-Mesquita, H. Bas; van der A, Daphne; Mattiello, Amalia; Palli, Domenico; Tumino, Rosario; Krogh, Vittorio; Vineis, Paolo; Trichopoulou, Antonia; Orfanos, Philippos; Trichopoulos, Dimitrios; Hedblad, Bo; Wallstrom, Peter; Overvad, Kim; Halkjaer, Jytte; Tjonneland, Anne; Fagherazzi, Guy; Dartois, Laureen; Crowe, Francesca; Khaw, Kay-Tee; Wareham, Nick; Middleton, Lefkos; May, Anne M.; Peeters, Petra H. M.; Boeing, Heiner			Development and Validation of a Risk Score Predicting Substantial Weight Gain over 5 Years in Middle-Aged European Men and Women	PLOS ONE			English	Article							BODY-WEIGHT; BREAST-CANCER; SUBSEQUENT CHANGES; SURVIVAL ANALYSIS; EPIC PROJECT; OBESITY; PARTICIPANTS; MODELS; DISCRIMINATION; POPULATIONS	Background: Identifying individuals at high risk of excess weight gain may help targeting prevention efforts at those at risk of various metabolic diseases associated with weight gain. Our aim was to develop a risk score to identify these individuals and validate it in an external population. Methods: We used lifestyle and nutritional data from 53 degrees 758 individuals followed for a median of 5.4 years from six centers of the European Prospective Investigation into Cancer and Nutrition (EPIC) to develop a risk score to predict substantial weight gain (SWG) for the next 5 years (derivation sample). Assuming linear weight gain, SWG was defined as gaining >= 10% of baseline weight during follow-up. Proportional hazards models were used to identify significant predictors of SWG separately by EPIC center. Regression coefficients of predictors were pooled using random-effects meta-analysis. Pooled coefficients were used to assign weights to each predictor. The risk score was calculated as a linear combination of the predictors. External validity of the score was evaluated in nine other centers of the EPIC study (validation sample). Results: Our final model included age, sex, baseline weight, level of education, baseline smoking, sports activity, alcohol use, and intake of six food groups. The model's discriminatory ability measured by the area under a receiver operating characteristic curve was 0.64 (95% CI = 0.63-0.65) in the derivation sample and 0.57 (95% CI = 0.56-0.58) in the validation sample, with variation between centers. Positive and negative predictive values for the optimal cut-off value of >= 200 points were 9% and 96%, respectively. Conclusion: The present risk score confidently excluded a large proportion of individuals from being at any appreciable risk to develop SWG within the next 5 years. Future studies, however, may attempt to further refine the positive prediction of the score.	[Steffen, Annika; Knueppel, Sven; Boeing, Heiner] German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany; [Sorensen, Thorkild I. A.] Bispebjerg Hosp, Inst Prevent Med, Capital Region, Denmark; [Sorensen, Thorkild I. A.] Frederiksberg Univ Hosp, Inst Prevent Med, Capital Region, Denmark; [Travier, Noemie] Catalan Inst Oncol, Unit Nutr Environm & Canc, Barcelona, Spain; [Sanchez, Maria-Jose] Andalusian Sch Publ Hlth, Granada, Spain; [Maria Huerta, Jose] Murcia Reg Hlth Council, Dept Epidemiol, Murcia, Spain; [Sanchez, Maria-Jose; Maria Huerta, Jose; Ardanaz, Eva] CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain; [Ramon Quiros, J.] Publ Hlth Directorate, Asturias, Spain; [Ardanaz, Eva] Navarre Publ Hlth Inst, Pamplona, Spain; [Dorronsoro, Miren] Basque Reg Hlth Dept, San Sebastian, Spain; [Dorronsoro, Miren] Ciberesp Biodonostia, San Sebastian, Spain; [Teucher, Birgit; Li, Kuanrong] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Bueno-de-Mesquita, H. Bas; van der A, Daphne] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Bueno-de-Mesquita, H. Bas] Univ Med Ctr, Dept Gastroenterol & Hepatol, Utrecht, Netherlands; [Mattiello, Amalia] Univ Naples Federico II, Dipartimento Med Clin & Chirurg, Naples, Italy; [Palli, Domenico] Canc Res & Prevent Inst, Mol & Nutr Epidemiol Unit, Florence, Italy; [Tumino, Rosario] Civile MP Arezzo Hosp, Canc Registry, Ragusa, Italy; [Tumino, Rosario] Civile MP Arezzo Hosp, Histopathol Unit, Ragusa, Italy; [Krogh, Vittorio] Fdn IRCCS Ist Nazl Tumori, Nutr Epidemiol Unit, Milan, Italy; [Vineis, Paolo] HuGeF Fdn Torino, Turin, Italy; [Trichopoulou, Antonia; Orfanos, Philippos; Trichopoulos, Dimitrios] Hellen Hlth Fdn, Athens, Greece; [Trichopoulou, Antonia; Orfanos, Philippos] Univ Athens, Sch Med, WHO Collaborating Ctr Food & Nutr Policies, Dept Hyg Epidemiol & Med Stat, GR-11527 Athens, Greece; [Trichopoulos, Dimitrios] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Trichopoulos, Dimitrios] Acad Athens, Bur Epidemiol Res, Athens, Greece; [Hedblad, Bo] Skane Univ Hosp, Clin Res Ctr, Dept Clin Sci Malmo, Malmo, Sweden; [Wallstrom, Peter] Lund Univ, Dept Clin Sci, Nutr Epidemiol Res Grp, Malmo, Sweden; [Overvad, Kim] Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark; [Halkjaer, Jytte; Tjonneland, Anne] Danish Canc Soc Res Ctr, Copenhagen, Denmark; [Fagherazzi, Guy; Dartois, Laureen] Inst Gustave Roussy, INSERM, Ctr Res Epidemiol & Populat Hlth, F-94805 Villejuif, France; [Fagherazzi, Guy; Dartois, Laureen] Paris South Univ, Villejuif, France; [Crowe, Francesca] Univ Oxford, Nuffield Dept Clin Med, Canc Epidemiol Unit, Oxford, England; [Khaw, Kay-Tee] Univ Cambridge, Clin Gerontol Unit, Cambridge, England; [Wareham, Nick] Univ Cambridge, MRC, Epidemiol Unit, Inst Metab Sci, Cambridge, England; [Middleton, Lefkos] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, London, England; [Vineis, Paolo; May, Anne M.; Peeters, Petra H. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Peeters, Petra H. M.] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London, England	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); University of Copenhagen; Bispebjerg Hospital; Catalan Institute of Oncology; Escuela Andaluza de Salud Publica; Murcia Regional Health Council; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Public Health Institute of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Helmholtz Association; German Cancer Research Center (DKFZ); Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; University of Naples Federico II; Civile M.P. Arezzo Hospital; Civile M.P. Arezzo Hospital; Fondazione IRCCS Istituto Nazionale Tumori Milan; Athens Medical School; National & Kapodistrian University of Athens; World Health Organization; Harvard University; Harvard T.H. Chan School of Public Health; Academy of Athens; Lund University; Skane University Hospital; Lund University; Aarhus University; Danish Cancer Society; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; University of Oxford; University of Cambridge; University of Cambridge; Imperial College London; Utrecht University; Utrecht University Medical Center; Imperial College London	Steffen, A (corresponding author), German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany.	annika.steffen@dife.de	May, Anne M/G-9183-2011; Steffen, Annika/H-7709-2018; Khaw, Kay-Tee/AAZ-3209-2021; Orfanos, Philippos/AAL-2606-2021; Steffen, Annika/E-8540-2016; Krogh, Vittorio/AAA-9171-2019; TRICHOPOULOU, ANTONIA/ABF-8727-2021; Mattiello, Amalia AM/K-5112-2016; Krogh, Vittorio/K-2628-2016; Knüppel, Sven/AAI-7195-2020; Sánchez, Maria-José/D-1087-2011; Huerta, José María/N-8654-2015; Fagherazzi, Guy/ABB-2555-2020; Teucher, Birgit/J-6380-2015; Fagherazzi, Guy/P-3534-2017; Dartois, Laureen/C-4745-2013	Steffen, Annika/0000-0003-4072-9245; Steffen, Annika/0000-0003-4072-9245; Krogh, Vittorio/0000-0003-0122-8624; TRICHOPOULOU, ANTONIA/0000-0002-7204-6396; Mattiello, Amalia AM/0000-0003-3676-7353; Krogh, Vittorio/0000-0003-0122-8624; Knüppel, Sven/0000-0001-9006-9906; Sánchez, Maria-José/0000-0003-4817-0757; Huerta, José María/0000-0002-9637-3869; Fagherazzi, Guy/0000-0001-5033-5966; Fagherazzi, Guy/0000-0001-5033-5966; Tjonneland, Anne/0000-0003-4385-2097; Travier, Noemie/0000-0001-5228-7769; Crowe, Francesca/0000-0003-4026-1726; tumino, rosario/0000-0003-2666-414X; PALLI, Domenico/0000-0002-5558-2437; Orfanos, Philippos/0000-0002-9949-3137; Overvad, Kim/0000-0001-6429-7921	EU [2005328]; European Commission: Public Health and Consumer Protection Directorate; Research Directorate-General; Ligue contre le Cancer; Societe 3M; Mutuelle Generale de l'Education Nationale; Institut National de la Sante et de la Recherche Medicale; German Cancer Aid (Germany); German Cancer Research Center (Germany); Federal Ministry of Education and Research (Germany); Danish Cancer Society (Denmark); Health Research Fund (FIS) of the Spanish Ministry of Health RTICC 'Red Tematica de Investigacion Cooperativa en Cancer [C03/10, R06/0020]; Cancer Research United Kingdom (United Kingdom); Medical Research Council (United Kingdom); Stroke Association (United Kingdom); British Heart Foundation (United Kingdom); Department of Health (United Kingdom); Food Standards Agency (United Kingdom); Wellcome Trust (United Kingdom); Italian Association for Research on Cancer (Italy); National Research Council (Italy); Dutch Ministry of Public Health, Welfare and Sports (Netherlands); Dutch Ministry of Health (Netherlands); Dutch Prevention Funds (Netherlands); LK Research Funds (Netherlands); Dutch Zorg Onderzoek Nederland (Netherlands); World Cancer Research Fund (Netherlands); Swedish Cancer Society; Swedish Scientific Council; Regional Government of Skane; Cancer Research UK [14136] Funding Source: researchfish; Medical Research Council [G0401527, G1000143] Funding Source: researchfish; Direct For Biological Sciences [1300426] Funding Source: National Science Foundation	EU(European Commission); European Commission: Public Health and Consumer Protection Directorate(European CommissionEuropean Commission Joint Research Centre); Research Directorate-General; Ligue contre le Cancer(Ligue nationale contre le cancer); Societe 3M(3M); Mutuelle Generale de l'Education Nationale; Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); German Cancer Aid (Germany)(Deutsche Krebshilfe); German Cancer Research Center (Germany); Federal Ministry of Education and Research (Germany)(Federal Ministry of Education & Research (BMBF)); Danish Cancer Society (Denmark)(Danish Cancer Society); Health Research Fund (FIS) of the Spanish Ministry of Health RTICC 'Red Tematica de Investigacion Cooperativa en Cancer; Cancer Research United Kingdom (United Kingdom); Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Stroke Association (United Kingdom); British Heart Foundation (United Kingdom)(British Heart Foundation); Department of Health (United Kingdom); Food Standards Agency (United Kingdom); Wellcome Trust (United Kingdom)(Wellcome Trust); Italian Association for Research on Cancer (Italy)(Fondazione AIRC per la ricerca sul cancro); National Research Council (Italy)(Consiglio Nazionale delle Ricerche (CNR)); Dutch Ministry of Public Health, Welfare and Sports (Netherlands); Dutch Ministry of Health (Netherlands); Dutch Prevention Funds (Netherlands)(Netherlands Government); LK Research Funds (Netherlands)(Netherlands Government); Dutch Zorg Onderzoek Nederland (Netherlands); World Cancer Research Fund (Netherlands)(Netherlands Government); Swedish Cancer Society(Swedish Cancer Society); Swedish Scientific Council; Regional Government of Skane; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This publication arises from a collaboration of two EU projects, the Diet, Obesity and Genes (DiOGenes) project and the Physical Activity, Nutrition, Alcohol, Cessation of Smoking, Eating out of Home and Obesity (PANACEA) project. DiOGenes is a pan-European study within the EU Sixth Framework Programme for Research and Technological Development (2005-2009) (FOOD-CT-2005-513946, http://www.diogenes.eu.org). PANACEA received funding from the EU in the framework of the Public Health Programme (project 2005328). This work was further supported by the European Commission: Public Health and Consumer Protection Directorate 1993-2004, the Research Directorate-General 2005, the Ligue contre le Cancer, the Societe 3M, the Mutuelle Generale de l'Education Nationale, and the Institut National de la Sante et de la Recherche Medicale; German Cancer Aid, the German Cancer Research Center, and the Federal Ministry of Education and Research (Germany); the Danish Cancer Society (Denmark); Health Research Fund (FIS) of the Spanish Ministry of Health RTICC 'Red Tematica de Investigacion Cooperativa en Cancer (grant number C03/10, R06/0020); the participating regional governments and institutions of Spain; Cancer Research United Kingdom, the Medical Research Council, the Stroke Association, the British Heart Foundation, the Department of Health, the Food Standards Agency, and the Wellcome Trust (United Kingdom); the Italian Association for Research on Cancer and the National Research Council (Italy); the Dutch Ministry of Public Health, Welfare and Sports, the Dutch Ministry of Health, Dutch Prevention Funds, LK Research Funds, the Dutch Zorg Onderzoek Nederland, and the World Cancer Research Fund (Netherlands); the Swedish Cancer Society, the Swedish Scientific Council, and the Regional Government of Skane. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berghofer A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-200; Bergmann M. M., 2011, European Journal of Clinical Nutrition, V65, P1079; Bewick V, 2004, CRIT CARE, V8, P508, DOI 10.1186/cc3000; Black E, 2005, DIABETIC MED, V22, P1199, DOI 10.1111/j.1464-5491.2005.01615.x; Branca F., 2007, CHALLENGE OBESITY WH; Buijsse B, 2011, EPIDEMIOL REV, V33, P46, DOI 10.1093/epirev/mxq019; Buijsse B, 2009, AM J CLIN NUTR, V90, P202, DOI 10.3945/ajcn.2008.27394; COLDITZ GA, 1990, AM J CLIN NUTR, V51, P1100, DOI 10.1093/ajcn/51.6.1100; Cui JS, 2009, ANN EPIDEMIOL, V19, P711, DOI 10.1016/j.annepidem.2009.05.005; D'Agostino RB, 2004, HANDB STAT, V23, P1; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Driver JA, 2007, AM J MED, V120, P257, DOI 10.1016/j.amjmed.2006.05.055; Du HD, 2010, AM J CLIN NUTR, V91, P329, DOI 10.3945/ajcn.2009.28191; Field AE, 2001, INT J OBESITY, V25, P1113, DOI 10.1038/sj.ijo.0801643; Fogarty AW, 2008, AM J CLIN NUTR, V87, P30, DOI 10.1093/ajcn/87.1.30; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; Gail MH, 2008, J NATL CANCER I, V100, P1037, DOI 10.1093/jnci/djn180; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Haftenberger M, 2002, PUBLIC HEALTH NUTR, V5, P1147, DOI 10.1079/PHN2002396; Hu FB, 2004, NEW ENGL J MED, V351, P2694, DOI 10.1056/NEJMoa042135; Juntunen M, 2003, J HUM HYPERTENS, V17, P775, DOI 10.1038/sj.jhh.1001611; Kaaks R, 1997, INT J EPIDEMIOL, V26, pS26, DOI 10.1093/ije/26.suppl_1.S26; Korkeila M, 1999, AM J CLIN NUTR, V70, P965; Kroke A, 2002, INT J OBESITY, V26, P403, DOI 10.1038/sj.ijo.0801920; Lahti-Koski M, 2005, OBES RES, V13, P333, DOI 10.1038/oby.2005.45; Li SX, 2010, AM J CLIN NUTR, V91, P184, DOI 10.3945/ajcn.2009.28403; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Margetts BM, 1997, INT J EPIDEMIOL, V26, pS1, DOI 10.1093/ije/26.suppl_1.S1; Moons KGM, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b606; Norman JE, 2003, INT J OBESITY, V27, P369, DOI 10.1038/sj.ijo.0802243; Pala V, 2009, AM J CLIN NUTR, V90, P602, DOI 10.3945/ajcn.2008.27173; PARMAR M, 1995, SURVIVAL ANAL PRACTI; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Riboli E, 1997, INT J EPIDEMIOL, V26, pS6, DOI 10.1093/ije/26.suppl_1.S6; Romaguera D, 2010, AM J CLIN NUTR, V92, P912, DOI 10.3945/ajcn.2010.29482; Saris WHM, 2005, NUTR BULL, V30, P188, DOI 10.1111/j.1467-3010.2005.00496.x; Schulze MB, 2009, DIABETES CARE, V32, P2116, DOI 10.2337/dc09-0197; Snijder MB, 2006, INT J EPIDEMIOL, V35, P83, DOI 10.1093/ije/dyi253; Spitz MR, 2007, JNCI-J NATL CANCER I, V99, P715, DOI 10.1093/jnci/djk153; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Steyerberg EW, 2019, CLIN PREDICTION MODE, V2nd, DOI 10.1007/978-0-387-77244-8; Vergnaud AC, 2008, INT J OBESITY, V32, P315, DOI 10.1038/sj.ijo.0803739; Vergnaud AC, 2010, AM J CLIN NUTR, V92, P398, DOI 10.3945/ajcn.2009.28713; Vergouwe Y, 2010, J CLIN EPIDEMIOL, V63, P205, DOI 10.1016/j.jclinepi.2009.03.017; Vimaleswaran KS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001389; von Ruesten A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027455; Von Rusten A, 2012, THESIS TU BERLIN; World Health Organization, 2000, WHO TECHN REP SER, V894, DOI DOI 10.1007/978-0-387-71799-9_454; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	50	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e67429	10.1371/journal.pone.0067429	http://dx.doi.org/10.1371/journal.pone.0067429			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874419	Green Published, Green Submitted, gold			2022-12-27	WOS:000322064300009
J	Wang, GQ; Wada, K; Hoshi, K; Sasaki, N; Ezoe, S; Satoh, T				Wang, Guoqin; Wada, Koji; Hoshi, Keika; Sasaki, Nanae; Ezoe, Satoshi; Satoh, Toshihiko			Association of Knowledge of HIV and Other Factors with Individuals' Attitudes toward HIV Infection: A National Cross-Sectional Survey among the Japanese Non-Medical Working Population	PLOS ONE			English	Article							5 AFRICAN COUNTRIES; PSYCHOMETRIC ASSESSMENT; PUBLIC UNIVERSITY; RISK BEHAVIOR; HIV/AIDS; STIGMA; AIDS; STUDENTS; PEOPLE; UNEMPLOYMENT	Background: The stigma of and discrimination because of HIV has been described as the most important obstacle to prevention and treatment efforts. The purpose of this study was to investigate negative attitudes and prejudice toward HIV among the Japanese non-medical working population and to explore contributing factors. Methods: An online anonymous nationwide survey involving approximately 3,000 individuals was conducted in Japan. Questions ranged from background information and HIV knowledge to individuals' attitudes towards HIV infection in the workplace. Descriptive statistics and logistic regression were applied for analysis. Results: Thirty-three percent of participants feared transmission of HIV from infected colleagues, 34% tended to avoid contact with them and 40% had prejudiced opinions about HIV infection. Despite a relatively high level of knowledge of HIV/AIDS overall (11.9 +/- 3.3 from 15 points), only 50% of individuals were aware of some issues. Greater knowledge was associated with less negative attitudes towards HIV infection (OR 0.39, 95% CI 0.31-0.48 for prejudiced opinion, high compared with low level of knowledge), whereas greater health consciousness was inversely related to attitude (OR 1.97, 95% CI 1.50-2.58 for prejudiced opinion, high compared with low health consciousness). Conclusion: Knowledge neutralizes peoples' negative attitudes towards HIV infection, whereas greater health consciousness may worsen them. Educational programs should balance knowledge with health consciousness to improve the efficacy of HIV interventions.	[Wang, Guoqin; Satoh, Toshihiko] Kitasato Univ, Sch Med, Kitasato Clin Res Ctr, Sagamihara, Kanagawa 228, Japan; [Wada, Koji] Kitasato Univ, Sch Med, Dept Publ Hlth, Sagamihara, Kanagawa 228, Japan; [Hoshi, Keika] Kitasato Univ, Sch Med, Dept Prevent Med, Sagamihara, Kanagawa 228, Japan; [Sasaki, Nanae] Komatsu Ltd, Hlth Promot Ctr, Shonan Area, Hiratsuka, Kanagawa, Japan; [Ezoe, Satoshi] Joint United Nations Programme HIV & AIDS UNAIDS, Geneva, Switzerland	Kitasato University; Kitasato University; Kitasato University; Komatsu Ltd; UNAIDS	Wang, GQ (corresponding author), Kitasato Univ, Sch Med, Kitasato Clin Res Ctr, Sagamihara, Kanagawa 228, Japan.	wangguoqin@med.kitasato-u.ac.jp			Health Labour Sciences Research Grant of the Ministry of Health, Labour, and Welfare [H23-Hepatitis-general-001]	Health Labour Sciences Research Grant of the Ministry of Health, Labour, and Welfare	This study was funded by a Health Labour Sciences Research Grant of the Ministry of Health, Labour, and Welfare (H23-Hepatitis-general-001, http://www.mhlw.go.jp/english/). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerson LK, 2012, AIDS BEHAV, V16, P2072, DOI 10.1007/s10461-011-0031-y; Adebamowo Clement A, 2002, BMC Surg, V2, P7, DOI 10.1186/1471-2482-2-7; Agrawal HK, 1999, ANN TROP PAEDIATR, V19, P143, DOI 10.1080/02724939992464; Ahmed SI, 2009, AM J PHARM EDUC, V73, DOI 10.5688/aj730115; AIDS Action, 1992, AIDS ACTION, P4; Al-Rabeei N. A., 2012, Eastern Mediterranean Health Journal, V18, P221; Arigbede A O, 2011, Niger J Med, V20, P90; Askarian M, 2006, INFECT CONT HOSP EP, V27, P48, DOI 10.1086/500002; Berger BE, 2001, RES NURS HEALTH, V24, P518, DOI 10.1002/nur.10011; Boer H, 2004, AIDS CARE, V16, P167, DOI 10.1080/09540120410001641011; Carr RL, 2004, J ASSOC NURSE AIDS C, V15, P30, DOI 10.1177/1055329003261981; Chen J Q, 2004, Asia Pac J Public Health, V16, P9, DOI 10.1177/101053950401600103; Cherutich P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036797; Delpierre C, 2008, SEX TRANSM INFECT, V84, P183, DOI 10.1136/sti.2007.027961; Dray-Spira R, 2006, EUR J PUBLIC HEALTH, V16, P89, DOI 10.1093/eurpub/cki153; Earnshaw VA, 2009, AIDS BEHAV, V13, P1160, DOI 10.1007/s10461-009-9593-3; Gao XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044881; Genberg BL, 2009, SOC SCI MED, V68, P2279, DOI 10.1016/j.socscimed.2009.04.005; Gilmour S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043473; Ha TH, 2012, AIDS CARE, V24, P39, DOI 10.1080/09540121.2011.592820; Hassan Zeinab M, 2011, Issues Ment Health Nurs, V32, P774, DOI 10.3109/01612840.2011.610562; Holzemer WL, 2009, SAHARA J-J SOC ASP H, V6, P76, DOI 10.1080/17290376.2009.9724933; Ibrahim N, 2012, PREV MED, V55, P505, DOI 10.1016/j.ypmed.2012.09.003; Korhonen T, 2012, J BIOSOC SCI, V44, P661, DOI 10.1017/S0021932012000338; KRASNIK A, 1990, DAN MED BULL, V37, P275; Kushimo O T, 2007, Niger Postgrad Med J, V14, P261; Kuwahara T, 2008, J MED INVESTIG, V55, P156, DOI 10.2152/jmi.55.156; Leclerc PM, 2008, INT J STD AIDS, V19, P660, DOI 10.1258/ijsa.2008.008099; Lieber E, 2006, AIDS BEHAV, V10, P463, DOI 10.1007/s10461-005-9047-5; Lifson AR, 2012, BMC INT HEALTH HUM R, V12, DOI 10.1186/1472-698X-12-6; Liu Y, 2012, AIDS CARE, V24, P129, DOI 10.1080/09540121.2011.596512; Nagelkerke NJD, 2002, B WORLD HEALTH ORGAN, V80, P89; Nur N, 2012, CROAT MED J, V53, P271, DOI 10.3325/cmj.2012.53.271; Nyblade Laura C, 2006, Psychol Health Med, V11, P335, DOI 10.1080/13548500600595178; Qu B, 2010, AIDS PATIENT CARE ST, V24, P59, DOI 10.1089/apc.2009.0190; Reynolds G L, 2000, Am Indian Alsk Native Ment Health Res, V9, P17; Ryalat Soukaina T, 2011, BMC Res Notes, V4, P191, DOI 10.1186/1756-0500-4-191; Stein JA, 2008, AIDS BEHAV, V12, P789, DOI 10.1007/s10461-007-9339-z; Tee Y, 2009, SAHARA J-J SOC ASP H, V6, P179, DOI 10.1080/17290376.2009.9724946; Tung WC, 2012, J IMMIGR MINOR HLTH; *UNAIDS, 2003, PROGR REP GLOB RESP; United Nations Agency for AIDS (UNAIDS), 2012, PROGR REP SUBM COUNT; Woods SP, 2011, REHABIL PSYCHOL, V56, P77, DOI 10.1037/a0022753	43	10	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68495	10.1371/journal.pone.0068495	http://dx.doi.org/10.1371/journal.pone.0068495			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	186SF	23874644	Green Submitted, Green Published, gold			2022-12-27	WOS:000322064300039
J	Chen, YG				Chen, Yanguang			New Approaches for Calculating Moran's Index of Spatial Autocorrelation	PLOS ONE			English	Article							ASSOCIATION	Spatial autocorrelation plays an important role in geographical analysis; however, there is still room for improvement of this method. The formula for Moran's index is complicated, and several basic problems remain to be solved. Therefore, I will reconstruct its mathematical framework using mathematical derivation based on linear algebra and present four simple approaches to calculating Moran's index. Moran's scatterplot will be ameliorated, and new test methods will be proposed. The relationship between the global Moran's index and Geary's coefficient will be discussed from two different vantage points: spatial population and spatial sample. The sphere of applications for both Moran's index and Geary's coefficient will be clarified and defined. One of theoretical findings is that Moran's index is a characteristic parameter of spatial weight matrices, so the selection of weight functions is very significant for autocorrelation analysis of geographical systems. A case study of 29 Chinese cities in 2000 will be employed to validate the innovatory models and methods. This work is a methodological study, which will simplify the process of autocorrelation analysis. The results of this study will lay the foundation for the scaling analysis of spatial autocorrelation.	Peking Univ, Dept Geog, Coll Urban & Environm Sci, Beijing 100871, Peoples R China	Peking University	Chen, YG (corresponding author), Peking Univ, Dept Geog, Coll Urban & Environm Sci, Beijing 100871, Peoples R China.	chenyg@pku.edu.cn			National Natural Science Foundation of China [41171129]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was sponsored by the National Natural Science Foundation of China (grant 41171129; http://www.nsfc.gov.cn/Portal0/default166.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Anselin L., 1996, SPATIAL ANAL PERSPEC, P111, DOI [10.1201/9780203739051-8, DOI 10.1201/9780203739051-8]; Beck J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010416; Benedetti-Cecchi L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012946; Bivand R, 2009, COMPUT STAT DATA AN, V53, P2859, DOI 10.1016/j.csda.2008.07.021; Bonnot N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014436; Braun A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042046; Chen YG, 2012, LETT SPAT RESOUR SCI, V5, P65, DOI 10.1007/s12076-011-0076-6; Chen YG, 2013, CHAOS SOLITON FRACT, V49, P47, DOI 10.1016/j.chaos.2013.02.006; Chen YG, 2008, DISCRETE DYN NAT SOC, V2008, DOI 10.1155/2008/728420; Chen YG, 2009, CHAOS SOLITON FRACT, V41, P603, DOI 10.1016/j.chaos.2008.02.030; Chen YT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017876, 10.1371/journal.pone.0021428, 10.1371/journal.pone.0017844, 10.1371/journal.pone.0024144, 10.1371/journal.pone.0027163, 10.1371/journal.pone.0027333]; Cliff A, 1973, SPATIAL AUTOCORRELAT; Cliff A. D., 1981, SPATIAL PROCESSES MO; Cliff A. D., 1969, LONDON PAPERS REGION, V1, P25; Deblauwe V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048766; Geary R.C., 1954, INC STAT, V5, P115, DOI [DOI 10.2307/2986645, 10.2307/2986645]; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; Getis A, 2009, GEOGR ANAL, V41, P404, DOI 10.1111/j.1538-4632.2009.00768.x; GRIFFITH DA, 2003, ADV SPAT SCI, pR7, DOI 10.1007/978-3-540-24806-4; Haggett P., 1977, LOCATIONAL ANAL HUMA; Haining RP, 2009, GEOGR ANAL, V41, P364, DOI 10.1111/j.1538-4632.2009.00763.x; Impoinvil DE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022192; Kumar C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037515; Li HF, 2007, GEOGR ANAL, V39, P357, DOI 10.1111/j.1538-4632.2007.00708.x; Mateo-Tomas P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012374; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; MORAN PAP, 1948, J ROY STAT SOC B, V10, P243; Odland John, 1988, SPATIAL AUTOCORRELAT; SOKAL RR, 1978, BIOL J LINN SOC, V10, P199, DOI 10.1111/j.1095-8312.1978.tb00013.x; Stark JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034245; Thomson J.D, 1987, DEV NUMER ECOL, V14, P431; Tiefelsdorf M, 2002, GEOGR ANAL, V34, P187, DOI 10.1111/j.1538-4632.2002.tb01084.x; Weeks JR, 2004, ANN ASSOC AM GEOGR, V94, P74, DOI 10.1111/j.1467-8306.2004.09401005.x; Wilson A. G., 1970, ENTROPY URBAN REGION; Yanguang Chen, 2010, International Journal of Artificial Life Research, V1, P12, DOI 10.4018/jalr.2010102102	36	96	101	17	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e68336	10.1371/journal.pone.0068336	http://dx.doi.org/10.1371/journal.pone.0068336			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	23874592	Green Published, Green Submitted, gold			2022-12-27	WOS:000321718700018
J	Sun, FY; Liu, SK; Gao, XY; Jiang, YL; Perera, D; Wang, XL; Li, C; Sun, LY; Zhang, JR; Kaltenboeck, L; Dunham, R; Liu, ZJ				Sun, Fanyue; Liu, Shikai; Gao, Xiaoyu; Jiang, Yanliang; Perera, Dayan; Wang, Xiuli; Li, Chao; Sun, Luyang; Zhang, Jiaren; Kaltenboeck, Ludmilla; Dunham, Rex; Liu, Zhanjiang			Male-Biased Genes in Catfish as Revealed by RNA-Seq Analysis of the Testis Transcriptome	PLOS ONE			English	Article							CHANNEL CATFISH; ICTALURUS-PUNCTATUS; DIMORPHIC EXPRESSION; GONADAL DEVELOPMENT; INITIAL ANALYSIS; RAINBOW-TROUT; X-CHROMOSOME; LINKAGE MAP; SOX9; DIFFERENTIATION	Background: Catfish has a male-heterogametic (XY) sex determination system, but genes involved in gonadogenesis, spermatogenesis, testicular determination, and sex determination are poorly understood. As a first step of understanding the transcriptome of the testis, here, we conducted RNA-Seq analysis using high throughput Illumina sequencing. Methodology/Principal Findings: A total of 269.6 million high quality reads were assembled into 193,462 contigs with a N50 length of 806 bp. Of these contigs, 67,923 contigs had hits to a set of 25,307 unigenes, including 167 unique genes that had not been previously identified in catfish. A meta-analysis of expressed genes in the testis and in the gynogen (double haploid female) allowed the identification of 5,450 genes that are preferentially expressed in the testis, providing a pool of putative male-biased genes. Gene ontology and annotation analysis suggested that many of these male-biased genes were involved in gonadogenesis, spermatogenesis, testicular determination, gametogenesis, gonad differentiation, and possibly sex determination. Conclusion/Significance: We provide the first transcriptome-level analysis of the catfish testis. Our analysis would lay the basis for sequential follow-up studies of genes involved in sex determination and differentiation in catfish.	[Liu, Zhanjiang] Auburn Univ, Dept Fisheries & Allied Aquacultures, Fish Mol Genet & Biotechnol Lab, Auburn, AL 36849 USA; Auburn Univ, Program Cell & Mol Biosci, Aquat Genom Unit, Auburn, AL 36849 USA	Auburn University System; Auburn University; Auburn University System; Auburn University	Liu, ZJ (corresponding author), Auburn Univ, Dept Fisheries & Allied Aquacultures, Fish Mol Genet & Biotechnol Lab, Auburn, AL 36849 USA.	liuzhan@auburn.edu	Li, Chao/GSM-8117-2022; Liu, Shikai/AAO-2247-2021; Liu, Zhanjiang/R-9633-2019; Liu, Shikai/D-4664-2013	Li, Chao/0000-0001-6110-6210; Liu, Shikai/0000-0001-5777-489X; Liu, Shikai/0000-0001-5777-489X; Li, Chao/0000-0002-1950-0190	Agriculture and Food Research Initiative (AFRI) Competitive Grants from the USDA National Institute of Food and Agriculture (NIFA) [2009-35205-05101, 2010-65205-20356, 2012-67015-19410]	Agriculture and Food Research Initiative (AFRI) Competitive Grants from the USDA National Institute of Food and Agriculture (NIFA)	This project was supported by Agriculture and Food Research Initiative (AFRI) Competitive Grants no. 2009-35205-05101, 2010-65205-20356 and 2012-67015-19410 from the USDA National Institute of Food and Agriculture (NIFA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affara NA, 2000, J ENDOCRINOL INVEST, V23, P630, DOI 10.1007/BF03343787; Assis R, 2012, GENOME BIOL EVOL, V4, P1189, DOI 10.1093/gbe/evs093; Bagheri-Fam S, 2010, INT J BIOCHEM CELL B, V42, P472, DOI 10.1016/j.biocel.2009.07.001; Bak Chong Won, 2011, Clin Exp Reprod Med, V38, P61, DOI 10.5653/cerm.2011.38.2.61; Barrionuevo F, 2006, BIOL REPROD, V74, P195, DOI 10.1095/biolreprod.105.045930; Berbejillo J, 2012, MOL REPROD DEV, V79, P504, DOI 10.1002/mrd.22053; Bradley KM, 2011, G3-GENES GENOM GENET, V1, P3, DOI 10.1534/g3.111.000190; Cao D, 2001, ANIM GENET, V32, P169, DOI 10.1046/j.1365-2052.2001.00753.x; Castrillon DH, 2000, P NATL ACAD SCI USA, V97, P9585, DOI 10.1073/pnas.160274797; Chaboissier MC, 2004, DEVELOPMENT, V131, P1891, DOI 10.1242/dev.01087; Chen F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011546; Clemente EJ, 2006, MAMM GENOME, V17, P956, DOI 10.1007/s00335-006-0029-3; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cota CD, 2012, DEV DYNAM, V241, P1249, DOI 10.1002/dvdy.23810; Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1; El Jamil A, 2008, DEV DYNAM, V237, P2996, DOI 10.1002/dvdy.21692; Ellegren H, 2007, NAT REV GENET, V8, P689, DOI 10.1038/nrg2167; Gallarate M, 2011, INT J CHEM ENG, V2011, DOI [10.1155/2011/132435, 10.4061/2011/989438]; GODBOUT R, 1993, P NATL ACAD SCI USA, V90, P7578, DOI 10.1073/pnas.90.16.7578; Green CC, 2009, FISH PHYSIOL BIOCHEM, V35, P377, DOI 10.1007/s10695-008-9260-z; Guo YQ, 2005, BIOCHEM BIOPH RES CO, V330, P950, DOI 10.1016/j.bbrc.2005.03.066; Hale MC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-404; Hattori RS, 2012, P NATL ACAD SCI USA, V109, P2955, DOI 10.1073/pnas.1018392109; Herpin A, 2011, FEBS J, V278, P1010, DOI 10.1111/j.1742-4658.2011.08030.x; Hosokawa M, 2007, DEV BIOL, V301, P38, DOI 10.1016/j.ydbio.2006.10.046; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jiang T, 2012, MOL BIOL REP; Ju ZL, 2000, GENE, V261, P373, DOI 10.1016/S0378-1119(00)00491-1; Kamiya T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002798; Karsi A, 2002, GENE, V285, P157, DOI 10.1016/S0378-1119(02)00414-6; Kent J, 1996, DEVELOPMENT, V122, P2813; Kikuchi K, 2007, GENETICS, V175, P2039, DOI 10.1534/genetics.106.069278; Kobayashi Y, 2013, SEX DEV, V7, P115, DOI 10.1159/000342009; Kocabas AM, 2002, MAR BIOTECHNOL, V4, P526, DOI 10.1007/s10126-002-0067-0; Kojima K, 2009, GENES CELLS, V14, P1155, DOI 10.1111/j.1365-2443.2009.01342.x; Koopman P, 1999, CELL MOL LIFE SCI, V55, P839; Kopp A, 2012, TRENDS GENET, V28, P175, DOI 10.1016/j.tig.2012.02.002; Leder EH, 2010, MOL BIOL EVOL, V27, P1495, DOI 10.1093/molbev/msq031; Li C, 2012, FISH SHELLFISH IMMUN, V32, P816, DOI 10.1016/j.fsi.2012.02.004; Li P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-177; Liu SK, 2013, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-595; Liu SK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-53; Liu ZH, 2010, FISH PHYSIOL BIOCHEM, V36, P223, DOI 10.1007/s10695-008-9281-7; Liu ZJ, 2003, COMP FUNCT GENOM, V4, P259, DOI 10.1002/cfg.265; Marchand O, 2000, BBA-GENE STRUCT EXPR, V1493, P180, DOI 10.1016/S0167-4781(00)00186-X; Martinez P, 2009, GENETICS, V183, P1443, DOI 10.1534/genetics.109.107979; Matsuda M, 2002, NATURE, V417, P559, DOI 10.1038/nature751; Myosho T, 2012, GENETICS, V191, P163, DOI 10.1534/genetics.111.137497; Nakamoto M, 2005, BIOCHEM BIOPH RES CO, V333, P729, DOI 10.1016/j.bbrc.2005.05.158; Ninwichian P, 2012, ANIM GENET, V43, P476, DOI 10.1111/j.1365-2052.2011.02276.x; Ninwichian P, 2012, G3-GENES GENOM GENET, V2, P1233, DOI 10.1534/g3.112.003962; Parisi M, 2003, SCIENCE, V299, P697, DOI 10.1126/science.1079190; Patino R, 1996, J EXP ZOOL, V276, P209, DOI 10.1002/(SICI)1097-010X(19961015)276:3&lt;209::AID-JEZ5&gt;3.0.CO;2-R; Peichel CL, 2004, CURR BIOL, V14, P1416, DOI 10.1016/j.cub.2004.08.030; Piferrer F, 2008, REV FISH SCI, V16, P35, DOI 10.1080/10641260802324644; Puri P, 2008, FASEB J, V22; Raghuveer K, 2011, SEX DEV, V5, P213, DOI 10.1159/000328823; Raghuveer K, 2009, J MOL ENDOCRINOL, V42, P437, DOI 10.1677/JME-09-0011; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Rolland AD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-546; de Mitcheson YS, 2008, FISH FISH, V9, P1, DOI 10.1111/j.1467-2979.2007.00266.x; Saffman EE, 1999, CELL MOL LIFE SCI, V55, P1141, DOI 10.1007/s000180050363; Sarre SD, 2011, ANNU REV GENOM HUM G, V12, P391, DOI 10.1146/annurev-genom-082410-101518; Shao CW, 2010, MAR BIOTECHNOL, V12, P558, DOI 10.1007/s10126-009-9242-x; Shirak A, 2006, GENETICS, V174, P1573, DOI 10.1534/genetics.106.059030; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Small CM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-579; Sun FY, 2012, DEV COMP IMMUNOL, V38, P169, DOI 10.1016/j.dci.2012.05.006; Takase M, 2000, FEBS LETT, V466, P249, DOI 10.1016/S0014-5793(00)01078-4; Tanaka T, 2011, P NATL ACAD SCI USA, V108, P10579, DOI 10.1073/pnas.1015447108; TIERSCH TR, 1990, AQUACULTURE, V87, P15, DOI 10.1016/0044-8486(90)90207-4; Tripathi N, 2009, GENETICS, V182, P365, DOI 10.1534/genetics.108.098541; Vidal VPI, 2001, NAT GENET, V28, P216, DOI 10.1038/90046; Vinas A, 2012, MAR BIOTECHNOL, V14, P655, DOI 10.1007/s10126-012-9451-6; Waldbieser GC, 2010, MAR BIOTECHNOL, V12, P380, DOI 10.1007/s10126-009-9221-2; Wang F, 2012, J BIOMOL STRUCT DYN, V30, P191, DOI 10.1080/07391102.2012.677770; Wang SL, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r8; Wilhelm D, 2007, PHYSIOL REV, V87, P1, DOI 10.1152/physrev.00009.2006; Yano A, 2012, CURR BIOL, V22, P1423, DOI 10.1016/j.cub.2012.05.045	80	53	59	4	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e68452	10.1371/journal.pone.0068452	http://dx.doi.org/10.1371/journal.pone.0068452			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	23874634	gold, Green Published, Green Submitted			2022-12-27	WOS:000321718700030
J	Etemire, E; Krull, M; Hasenberg, M; Reichardt, P; Gunzer, M				Etemire, Eloho; Krull, Marco; Hasenberg, Mike; Reichardt, Peter; Gunzer, Matthias			Transiently Reduced PI3K/Akt Activity Drives the Development of Regulatory Function in Antigen-Stimulated Naive T-Cells	PLOS ONE			English	Article							FOXO TRANSCRIPTION FACTORS; ALPHA-CONVERTING ENZYME; DENDRITIC CELLS; POTENTIAL ROLE; L-SELECTIN; DIFFERENTIATION; COMMITMENT; MECHANISMS; KINASE; GENERATION	Regulatory T-cells (T-regs) are central for immune homeostasis and divided in thymus-derived natural T-regs and peripherally induced iT(reg). However, while phenotype and function of iT(regs) are well known, a remarkable lack exists in knowledge about signaling mechanisms leading to their generation from naive precursors in peripheral tissues. Using antigen specific naive T-cells from mice, we investigated CD4+ CD25+ FoxP3-iT(reg) induction during antigen-specific T-cell receptor (TCR) stimulation with weak antigen presenting cells (APC). We show that early signaling pathways such as ADAM-17-activation appeared similar in developing iT(reg) and effector cells (T-eff) and both initially shedded CD62-L. But iT(reg) started reexpressing CD62-L after 24 h while T-eff permanently downmodulated it. Furthermore, between 24 and 72 hours iT(reg) presented with significantly lower phosphorylation levels of Akt-S473 suggesting lower activity of the PI3K/Akt-axis. This was associated with a higher expression of the Akt hydrophobic motif-specific phosphatase PHLPP1 in iT(reg). Importantly, the lack of costimulatory signals via CD28 from weak APC was central for the development of regulatory function in iT(reg) but not for the reappearance of CD62-L. Thus, T-cells display a window of sensitivity after onset of TCR triggering within which the intensity of the PI3K/Akt signal controls entry into either effector or regulatory pathways.	[Etemire, Eloho; Hasenberg, Mike; Gunzer, Matthias] Univ Duisburg Essen, Univ Hosp, Inst Expt Immunol & Imaging, Essen, Germany; [Krull, Marco; Reichardt, Peter] Otto von Guericke Univ, Inst Mol & Clin Immunol, Magdeburg, Germany	University of Duisburg Essen; Otto von Guericke University	Reichardt, P (corresponding author), Otto von Guericke Univ, Inst Mol & Clin Immunol, Magdeburg, Germany.	peter.reichardt@med.ovgu.de; Matthias.gunzer@uni-due.de	Gunzer, Matthias/AAW-7026-2021	Gunzer, Matthias/0000-0002-5534-6055	German Research Foundation (DFG) [SFB854]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG, SFB854 to M.G. and P.R.). http://www.dfg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Battaglia M, 2012, METHODS MOL BIOL, V821, P279, DOI 10.1007/978-1-61779-430-8_17; Bilate AM, 2012, ANNU REV IMMUNOL, V30, P733, DOI 10.1146/annurev-immunol-020711-075043; Chen JF, 2010, CHINESE MED J-PEKING, V123, P942, DOI 10.3760/cma.j.issn.0366-6999.2010.07.032; Crellin NK, 2007, BLOOD, V109, P2014, DOI 10.1182/blood-2006-07-035279; Dang XT, 2009, BBA-GENE REGUL MECH, V1789, P146, DOI 10.1016/j.bbagrm.2008.10.004; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Fabre S, 2008, J IMMUNOL, V181, P2980, DOI 10.4049/jimmunol.181.5.2980; Garcon F, 2008, BLOOD, V111, P1464, DOI 10.1182/blood-2007-08-108050; Gerner MY, 2012, IMMUNITY, V37, P364, DOI 10.1016/j.immuni.2012.07.011; Guenin-Mace L, 2011, P NATL ACAD SCI USA, V108, P12833, DOI 10.1073/pnas.1016496108; Gunzer M, 2000, IMMUNITY, V13, P323, DOI 10.1016/S1074-7613(00)00032-7; Harada Y, 2010, J EXP MED; Hedrick SM, 2012, NAT REV IMMUNOL, V12, P649, DOI 10.1038/nri3278; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kanno Y, 2012, ANNU REV IMMUNOL, V30, P707, DOI 10.1146/annurev-immunol-020711-075058; Kerdiles YM, 2010, IMMUNITY, V33, P890, DOI 10.1016/j.immuni.2010.12.002; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Labeur MS, 1999, J IMMUNOL, V162, P168; Levings MK, 2005, BLOOD, V105, P1162, DOI 10.1182/blood-2004-03-1211; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Moreau HD, 2012, IMMUNITY, V37, P351, DOI 10.1016/j.immuni.2012.05.014; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Oestreich KJ, 2012, NAT REV IMMUNOL, V12, P799, DOI 10.1038/nri3321; Ohnmacht C, 2009, J EXP MED, V206, P549, DOI 10.1084/jem.20082394; Ouyang WM, 2012, NATURE, V491, P554, DOI 10.1038/nature11581; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Passerini L, 2011, EUR J IMMUNOL, V41, P1120, DOI 10.1002/eji.201040909; Patterson SJ, 2011, J IMMUNOL, V186, P5533, DOI 10.4049/jimmunol.1002126; Pletinckx K, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00039; Powell JD, 2012, ANNU REV IMMUNOL, V30, P39, DOI 10.1146/annurev-immunol-020711-075024; Procaccini C, 2010, IMMUNITY, V33, P929, DOI 10.1016/j.immuni.2010.11.024; Reichardt P, 2007, BLOOD, V110, P1519, DOI 10.1182/blood-2006-10-053793; Reichardt P, 2007, IMMUNOL REV, V218, P165, DOI 10.1111/j.1600-065X.2007.00526.x; Riha Pavel, 2010, Self Nonself, V1, P231, DOI 10.4161/self.1.3.12968; Roberts AD, 2005, J EXP MED, V202, P123, DOI 10.1084/jem.20050137; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Semple K, 2011, BLOOD, V117, P3096, DOI 10.1182/blood-2010-08-301275; Sinclair LV, 2008, NAT IMMUNOL, V9, P513, DOI 10.1038/ni.1603; Soond DR, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00244; Soond SM, 2005, J CELL SCI, V118, P2371, DOI 10.1242/jcs.02357; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Vieira PL, 2004, J IMMUNOL, V172, P5986, DOI 10.4049/jimmunol.172.10.5986; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Wood KJ, 2012, NAT REV IMMUNOL, V12, P417, DOI 10.1038/nri3227; Yang SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022560; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	52	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e68378	10.1371/journal.pone.0068378	http://dx.doi.org/10.1371/journal.pone.0068378			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874604	Green Published, Green Submitted, gold			2022-12-27	WOS:000322218800028
J	Chan, AS; Sze, SL; Siu, NY; Lau, EM; Cheung, MC				Chan, Agnes S.; Sze, Sophia L.; Siu, Nicolson Y.; Lau, Eliza M.; Cheung, Mei-chun			A Chinese Mind-Body Exercise Improves Self-Control of Children with Autism: A Randomized Controlled Trial	PLOS ONE			English	Article							PROGRESSIVE MUSCLE-RELAXATION; ANTERIOR CINGULATE CORTEX; YOUNG-CHILDREN; SPECTRUM DISORDERS; PREFRONTAL CORTEX; INTERVENTIONS; ADOLESCENTS; AGGRESSION; ACTIVATION; THERAPIES	Self-control problems commonly manifest as temper outbursts and repetitive/rigid/impulsive behaviors, in children with autism spectrum disorders (ASD), which often contributes to learning difficulties and caregiver burden. The present study aims to compare the effect of a traditional Chinese Chan-based mind-body exercise, Nei Yang Gong, with that of the conventional Progressive Muscle Relaxation (PMR) technique in enhancing the self-control of children with ASD. Forty-six age-and IQ-matched ASD children were randomly assigned to receive group training in Nei Yang Gong (experimental group) or PMR (control group) twice per week for four weeks. The participants' self-control was measured by three neuropsychological tests and parental rating on standardized questionnaires, and the underlying neural mechanism was assessed by the participants' brain EEG activity during an inhibitory-control task before and after intervention. The results show that the experimental group demonstrated significantly greater improvement in self-control than the control group, which concurs with the parental reports of reduced autistic symptoms and increased control of temper and behaviors. In addition, the experimental group showed enhanced EEG activity in the anterior cingulate cortex, a region that mediates self-control, whereas the PMR group did not. The present findings support the potential application of Chinese Chan-based mind-body exercises as a form of neuropsychological rehabilitation for patients with self-control problems. Chinese Clinical Trial Registry; Registration No.: ChiCTR-TRC-12002561; URL: www.chictr.org.	[Chan, Agnes S.; Sze, Sophia L.; Siu, Nicolson Y.; Lau, Eliza M.] Chinese Univ Hong Kong, Dept Psychol, Neuropsychol Lab, Shatin, Hong Kong, Peoples R China; [Chan, Agnes S.; Sze, Sophia L.] Chinese Univ Hong Kong, Integrat Neuropsychol Rehabil Ctr, Shatin, Hong Kong, Peoples R China; [Chan, Agnes S.] Henan Songshan Res Inst Chanwuyi, Chanwuyi, Henan, Peoples R China; [Cheung, Mei-chun] Hong Kong Polytech Univ, Inst Text & Clothing, Kowloon, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Hong Kong Polytechnic University	Chan, AS (corresponding author), Chinese Univ Hong Kong, Dept Psychol, Neuropsychol Lab, Shatin, Hong Kong, Peoples R China.	aschan@psy.cuhk.edu.hk	Cheung, Mei-chun/A-1261-2014	Cheung, Mei-chun/0000-0002-0210-0772; Siu, Yat Fan/0000-0001-9465-8310	Hong Kong Polytechnic University [A-PK67, 4-ZZD1]	Hong Kong Polytechnic University(Hong Kong Polytechnic University)	This study was partly supported by a donation from Mr. Sau Hung Li to The Chinese University of Hong Kong and partly by the research fund from The Hong Kong Polytechnic University (A-PK67 and 4-ZZD1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JB, 2004, J ALTERN COMPLEM MED, V10, P1033, DOI 10.1089/acm.2004.10.1033; Agam Y, 2010, NEUROIMAGE, V52, P336, DOI 10.1016/j.neuroimage.2010.04.010; Allam H, 2008, J ALTERN COMPLEM MED, V14, P109, DOI 10.1089/acm.2007.0508; American Psychiatric Association, 2000, DIAGNOSTIC STAT MANU; Asada H, 1999, NEUROSCI LETT, V274, P29, DOI 10.1016/S0304-3940(99)00679-5; Autism Treatment Evaluation Checklist, 2000, REL SCOR DISTR; Bahrami F, 2012, RES DEV DISABIL, V33, P1183, DOI 10.1016/j.ridd.2012.01.018; Beider S, 2007, EVID-BASED COMPL ALT, V4, P23, DOI 10.1093/ecam/nel068; Benson H., 2000, J RES DEV EDUC, V33, P156; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Chan A. S., 2008, J PSYCHOL CHINESE SO, V9, P225; Chan A. S, 2013, CONT APPL SHAOLIN ME; Chan A. S., 2010, SHAOLIN CHANWUYI CHI; Chan A. S., 2008, MIND BODY RELAXATION, P165; Chan AS, 2012, J AFFECT DISORDERS, V142, P283, DOI 10.1016/j.jad.2012.05.018; Chan AS, 2012, SCI WORLD J, DOI 10.1100/2012/235206; Chan AS, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/262136; Chan AS, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1155/2011/180704; Chan AS, 2011, RES AUTISM SPECT DIS, V5, P254, DOI 10.1016/j.rasd.2010.04.007; Chan Agnes S, 2009, Cases J, V2, P9080, DOI 10.1186/1757-1626-2-9080; CHAN AS, 2011, EVID-BASED COMPL ALT, P1, DOI DOI 10.1093/ECAM/NEP043; Chan AS, 2013, COMPREHENSI IN PRESS; CHAN AS, 2011, EVID-BASED COMPL ALT, P1, DOI DOI 10.1155/2011/549254; Chen KW, 2012, DEPRESS ANXIETY, V29, P545, DOI 10.1002/da.21964; Cheuk DKL, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007849.pub2; Chiang LC, 2009, INT J NURS STUD, V46, P1061, DOI 10.1016/j.ijnurstu.2009.01.013; Culbertson WC, 2005, TOWER LONDON DX MANU; Cullen-Powell Lesley A, 2005, J Child Health Care, V9, P245, DOI 10.1177/1367493505056479; Diamond A, 2011, SCIENCE, V333, P959, DOI 10.1126/science.1204529; Elliott R, 1998, NEUROIMAGE, V8, P17, DOI 10.1006/nimg.1998.0344; Goin-Kochel RP, 2007, RES AUTISM SPECT DIS, V1, P195, DOI 10.1016/j.rasd.2006.08.006; Gold C, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004381.pub2; Goldbeck L, 2003, J AM ACAD CHILD PSY, V42, P1046, DOI 10.1097/01.CHI.0000070244.24125.F; Granpeesheh D, 2010, RES AUTISM SPECT DIS, V4, P268, DOI 10.1016/j.rasd.2009.09.014; Haznedar MM, 2006, AM J PSYCHIAT, V163, P1252, DOI 10.1176/appi.ajp.163.7.1252; Hyman SL, 2011, EVIDENCE-BASED PRACTICES AND TREATMENTS FOR CHILDREN WITH AUTISM, P275, DOI 10.1007/978-1-4419-6975-0_10; Ishii R, 1999, NEUROREPORT, V10, P675, DOI 10.1097/00001756-199903170-00003; Jacobson E., 1962, YOU MUST RELAX; JARUSIEWICZ B, 2002, J NEUROTHERAPY, V6, P39, DOI [10.1300/J184v06n04_05, DOI 10.1300/J184V06N04_05]; Kenworthy L, 2008, NEUROPSYCHOL REV, V18, P320, DOI 10.1007/s11065-008-9077-7; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Lakes KD, 2004, J APPL DEV PSYCHOL, V25, P283, DOI 10.1016/j.appdev.2004.04.002; Langen M, 2012, CORTEX, V48, P183, DOI 10.1016/j.cortex.2011.05.018; Lohaus A, 2003, PSYCHOL HEALTH, V18, P237, DOI 10.1080/0887044021000057257; Lonsdale D, 2002, NEUROENDOCRINOL LETT, V23, P303; Lopata C, 2003, BEHAV DISORDERS, V28, P162; Lopata C, 2006, TEACH EXCEPT CHILD, V38, P20, DOI 10.1177/004005990603800403; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Magiati I, 2011, J INTELL DISABIL RES, V55, P302, DOI 10.1111/j.1365-2788.2010.01359.x; Malloy-Diniz Leandro Fernandes, 2008, Dement. neuropsychol., V2, P26, DOI [10.1590/S1980-57642009DN20100006, 10.1590/s1980-57642009dn20100006]; Matson JL, 2008, RES AUTISM SPECT DIS, V2, P60, DOI 10.1016/j.rasd.2007.03.003; Mullins JL, 2001, RES DEV DISABIL, V22, P449; Mulloy A, 2010, RES AUTISM SPECT DIS, V4, P328, DOI 10.1016/j.rasd.2009.10.008; National Research Council, 2001, ED CHILDR AUT; Naylor KT, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/464759; OMIZO MM, 1982, ACAD THER, V17, P603, DOI 10.1177/105345128201700514; Ospina MB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003755; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Pizzagalli D, 2001, AM J PSYCHIAT, V158, P405, DOI 10.1176/appi.ajp.158.3.405; Reaven JA, 2009, FOCUS AUTISM DEV DIS, V24, P27, DOI 10.1177/1088357608327666; REGARD M, 1982, PERCEPT MOTOR SKILL, V55, P839, DOI 10.2466/pms.1982.55.3.839; Robinson S, 2009, BRAIN COGNITION, V71, P362, DOI 10.1016/j.bandc.2009.06.007; Rosenblatt LE, 2011, J ALTERN COMPLEM MED, V17, P1029, DOI 10.1089/acm.2010.0834; Russell AJ, 2013, DEPRESS ANXIETY, V30, P697, DOI 10.1002/da.22053; Sarris J, 2011, SLEEP MED REV, V15, P99, DOI 10.1016/j.smrv.2010.04.001; Sattler, 1986, STANFORD BINET INTEL; Silva LMT, 2007, AM J CHINESE MED, V35, P393, DOI 10.1142/S0192415X07004916; Singh Vijay Pratap, 2009, Chron Respir Dis, V6, P209, DOI 10.1177/1479972309346754; Srinivasan P, 2009, ANN CLIN PSYCHIATRY, V21, P237; Strauss E, 2006, COMPENDIUM NEUROPSYC; Suhr J, 1999, NEUROPSYCHOL REHABIL, V9, P31, DOI 10.1080/713755590; TRULSON ME, 1986, HUM RELAT, V39, P1131, DOI 10.1177/001872678603901204; Vismara LA, 2010, ANNU REV CLIN PSYCHO, V6, P447, DOI 10.1146/annurev.clinpsy.121208.131151; Wahbeh H, 2008, NEUROLOGY, V70, P2321, DOI 10.1212/01.wnl.0000314667.16386.5e; Wechsler D, 2010, WISC 4 WECHSLER INTE; Whipple J, 2004, J MUSIC THER, V41, P90, DOI 10.1093/jmt/41.2.90; WILLIAMS J, 1995, ARCH CLIN NEUROPSYCH, V10, P211, DOI 10.1016/0887-6177(94)00041-N; Wisner BL, 2010, CHILD SCH, V32, P150, DOI 10.1093/cs/32.3.150; Xiao T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046569; Yeh GY, 2009, J CARDIOPULM REHABIL, V29, P152, DOI 10.1097/HCR.0b013e3181a33379; ZIPKIN D, 1985, J SPEC EDUC, V19, P283, DOI 10.1177/002246698501900305	81	31	34	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68184	10.1371/journal.pone.0068184	http://dx.doi.org/10.1371/journal.pone.0068184			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	182SU	23874533	Green Published, gold, Green Submitted			2022-12-27	WOS:000321765300032
J	Jin, ZN; Smith, LK; Rajwanshi, VK; Kim, B; Deval, J				Jin, Zhinan; Smith, Lucas K.; Rajwanshi, Vivek K.; Kim, Baek; Deval, Jerome			The Ambiguous Base-Pairing and High Substrate Efficiency of T-705 (Favipiravir) Ribofuranosyl 5 '-Triphosphate towards Influenza A Virus Polymerase	PLOS ONE			English	Article							IN-VIVO ACTIVITIES; RNA-POLYMERASE; ANTIVIRAL ACTIVITY; HEMORRHAGIC-FEVER; INFECTED-CELLS; RIBAVIRIN; REPLICATION; MODEL; VITRO; RESISTANCE	T-705 (Favipiravir) is a broad-spectrum antiviral molecule currently in late stage clinical development for the treatment of influenza virus infection. Although it is believed that T-705 potency is mediated by its ribofuranosyl triphosphate (T-705 RTP) metabolite that could be mutagenic, the exact molecular interaction with the polymerase of influenza A virus (IAVpol) has not been elucidated. Here, we developed a biochemical assay to measure the kinetics of nucleotide incorporation by IAVpol in the elongation mode. In this assay, T-705 RTP was recognized by IAVpol as an efficient substrate for incorporation to the RNA both as a guanosine and an adenosine analog. Compared to natural GTP and ATP, the discrimination of T-705 RTP was about 19- and 30-fold, respectively. Although the single incorporation of the ribonucleotide monophosphate form of T-705 did not efficiently block RNA synthesis, two consecutive incorporation events prevented further primer extension. In comparison, 39-deoxy GTP caused immediate chain termination but was incorporated less efficiently by the enzyme, with a discrimination of 4,900-fold relative to natural GTP. Collectively, these results provide the first detailed biochemical characterization to evaluate the substrate efficiency and the inhibition potency of nucleotide analogs against influenza virus polymerase. The combination of ambiguous base-pairing with low discrimination of T-705 RTP provides a mechanistic basis for the in vitro mutagenic effect of T-705 towards influenza virus.	[Jin, Zhinan; Smith, Lucas K.; Rajwanshi, Vivek K.; Deval, Jerome] Alios BioPharma Inc, San Francisco, CA USA; [Kim, Baek] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA	University of Rochester	Jin, ZN (corresponding author), Alios BioPharma Inc, San Francisco, CA USA.	zjin@aliosbiopharma.com; jdeval@aliosbiopharma.com			Alios BioPharma Inc.	Alios BioPharma Inc.	This research is supported by Alios BioPharma Inc. (www.aliosbiopharma.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010372; Arnold JJ, 2004, BIOCHEMISTRY-US, V43, P5126, DOI 10.1021/bi035212y; Baranovich T, 2013, J VIROL; Bradel-Tretheway BG, 2008, J GEN VIROL, V89, P2923, DOI 10.1099/vir.0.2008/006254-0; Brownlee GG, 2002, J VIROL, V76, P7103, DOI 10.1128/JVI.76.14.7103-7113.2002; Crotty S, 2000, NAT MED, V6, P1375, DOI 10.1038/82191; Crotty S, 2001, P NATL ACAD SCI USA, V98, P6895, DOI 10.1073/pnas.111085598; Day CW, 2005, ANTIVIR RES, V67, P38, DOI 10.1016/j.antiviral.2005.04.002; De Clercq E, 2012, CURR OPIN VIROL, V2, P572, DOI 10.1016/j.coviro.2012.07.004; DESSELBERGER U, 1980, GENE, V8, P315, DOI 10.1016/0378-1119(80)90007-4; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; FODOR E, 1995, J VIROL, V69, P4012, DOI 10.1128/JVI.69.7.4012-4019.1995; Furuta Y, 2005, ANTIMICROB AGENTS CH, V49, P981, DOI 10.1128/AAC.49.3.981-986.2005; Furuta Y, 2002, ANTIMICROB AGENTS CH, V46, P977, DOI 10.1128/AAC.46.4.977-981.2002; Furuta Y, 2009, ANTIVIR RES, V82, P95, DOI 10.1016/j.antiviral.2009.02.198; Gerritz SW, 2011, P NATL ACAD SCI USA, V108, P15366, DOI 10.1073/pnas.1107906108; Gowen BB, 2007, ANTIMICROB AGENTS CH, V51, P3168, DOI 10.1128/AAC.00356-07; Gowen BB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003725; Graci JD, 2006, REV MED VIROL, V16, P37, DOI 10.1002/rmv.483; Hatakeyama S, 2007, JAMA-J AM MED ASSOC, V297, P1435, DOI 10.1001/jama.297.13.1435; Hauge SH, 2009, EMERG INFECT DIS, V15, P155, DOI 10.3201/eid1502.081031; He GM, 2008, ANTIVIR RES, V77, P72, DOI 10.1016/j.antiviral.2007.08.007; Heck JA, 2008, ANTIMICROB AGENTS CH, V52, P1901, DOI 10.1128/AAC.01496-07; HONDA A, 1987, J BIOCHEM-TOKYO, V102, P1241, DOI 10.1093/oxfordjournals.jbchem.a122163; HSU MT, 1987, P NATL ACAD SCI USA, V84, P8140, DOI 10.1073/pnas.84.22.8140; Hwang JS, 2000, J VIROL, V74, P4074, DOI 10.1128/JVI.74.9.4074-4084.2000; Jin ZN, 2011, J BIOL CHEM, V286, P2067, DOI 10.1074/jbc.M110.162685; Julander JG, 2009, ANTIVIR RES, V82, P169, DOI 10.1016/j.antiviral.2009.02.201; Julander JG, 2009, ANTIMICROB AGENTS CH, V53, P202, DOI 10.1128/AAC.01074-08; Kao RY, 2010, NAT BIOTECHNOL, V28, P600, DOI 10.1038/nbt.1638; Maag D, 2001, J BIOL CHEM, V276, P46094, DOI 10.1074/jbc.C100349200; Mendenhall M, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001342; Mendenhall M, 2011, ANTIMICROB AGENTS CH, V55, P782, DOI 10.1128/AAC.01219-10; Moreno H, 2011, J VIROL, V85, P7246, DOI 10.1128/JVI.00614-11; Noble E, 2011, J BIOL CHEM, V286, P22965, DOI 10.1074/jbc.M111.239509; Olson AC, 2010, BIOCHEMISTRY-US, V49, P10208, DOI 10.1021/bi101011j; Parker WB, 2005, VIRUS RES, V107, P165, DOI 10.1016/j.virusres.2004.11.006; Powdrill MH, 2011, P NATL ACAD SCI USA, V108, P20509, DOI 10.1073/pnas.1105797108; ROBERTSON JS, 1979, NUCLEIC ACIDS RES, V6, P3745, DOI 10.1093/nar/6.12.3745; Rocha-Pereira J, 2012, BIOCHEM BIOPH RES CO, V424, P777, DOI 10.1016/j.bbrc.2012.07.034; Sidwell RW, 2007, ANTIMICROB AGENTS CH, V51, P845, DOI 10.1128/AAC.01051-06; Sleeman K, 2010, ANTIMICROB AGENTS CH, V54, P2517, DOI 10.1128/AAC.01739-09; Smee DF, 2009, J ANTIMICROB CHEMOTH, V64, P741, DOI 10.1093/jac/dkp274; Vignuzzi M, 2005, VIRUS RES, V107, P173, DOI 10.1016/j.virusres.2004.11.007; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720; Zhang SJ, 2010, BIOCHEM BIOPH RES CO, V391, P570, DOI 10.1016/j.bbrc.2009.11.100	46	169	174	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68347	10.1371/journal.pone.0068347	http://dx.doi.org/10.1371/journal.pone.0068347			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874596	Green Submitted, Green Published, gold			2022-12-27	WOS:000321765300044
J	Shrestha, N; Boucher, J; Bahnan, W; Clark, ES; Rosqvist, R; Fields, KA; Khan, WN; Schesser, K				Shrestha, Niraj; Boucher, Justin; Bahnan, Wael; Clark, Emily S.; Rosqvist, Roland; Fields, Kenneth A.; Khan, Wasif N.; Schesser, Kurt			The Host-Encoded Heme Regulated Inhibitor (HRI) Facilitates Virulence-Associated Activities of Bacterial Pathogens	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITOR; INITIATION-FACTOR 2; EIF2-ALPHA KINASE; III SECRETION; YERSINIA-PSEUDOTUBERCULOSIS; CHLAMYDIA-TRACHOMATIS; PROTEIN-SYNTHESIS; CELLS; PHOSPHORYLATION; TRANSLOCATION	Here we show that cells lacking the heme-regulated inhibitor (HRI) are highly resistant to infection by bacterial pathogens. By examining the infection process in wild-type and HRI null cells, we found that HRI is required for pathogens to execute their virulence-associated cellular activities. Specifically, unlike wild-type cells, HRI null cells infected with the gram-negative bacterial pathogen Yersinia are essentially impervious to the cytoskeleton-damaging effects of the Yop virulence factors. This effect is due to reduced functioning of the Yersinia type 3 secretion (T3S) system which injects virulence factors directly into the host cell cytosol. Reduced T3S activity is also observed in HRI null cells infected with the bacterial pathogen Chlamydia which results in a dramatic reduction in its intracellular proliferation. We go on to show that a HRI-mediated process plays a central role in the cellular infection cycle of the Gram-positive pathogen Listeria. For this pathogen, HRI is required for the post-invasion trafficking of the bacterium to the infected host cytosol. Thus by depriving Listeria of its intracellular niche, there is a highly reduced proliferation of Listeria in HRI null cells. We provide evidence that these infection-associated functions of HRI (an eIF2 alpha kinase) are independent of its activity as a regulator of protein synthesis. This is the first report of a host factor whose absence interferes with the function of T3S secretion and cytosolic access by pathogens and makes HRI an excellent target for inhibitors due to its broad virulence-associated activities.	[Shrestha, Niraj; Boucher, Justin; Bahnan, Wael; Clark, Emily S.; Fields, Kenneth A.; Khan, Wasif N.; Schesser, Kurt] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA; [Rosqvist, Roland] Umea Univ, Dept Mol Biol, Umea, Sweden	University of Miami; Umea University	Schesser, K (corresponding author), Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA.	kschesser@med.miami.edu	Clark, Emily/GVR-7159-2022		Public Health Service from the National Institute of Allergy and Infectious Diseases [AI53459]	Public Health Service from the National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by Public Health Service grant AI53459 (KS) from the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ALEXANDE.JJ, 1968, J BACTERIOL, V95, P327, DOI 10.1128/JB.95.2.327-332.1968; Betts HJ, 2009, CURR OPIN MICROBIOL, V12, P81, DOI 10.1016/j.mib.2008.11.009; BOLIN I, 1982, INFECT IMMUN, V37, P506; Chen JJ, 2007, BLOOD, V109, P2693, DOI 10.1182/blood-2006-08-041830; Cossart P, 2011, P NATL ACAD SCI USA, V108, P19484, DOI 10.1073/pnas.1112371108; Davenport J, 2011, J NAT PROD, V74, P1085, DOI 10.1021/np200029q; Day JB, 2003, MOL MICROBIOL, V47, P807, DOI 10.1046/j.1365-2958.2003.03343.x; Hackstadt T, 1999, CELL MICROBIOL, V1, P119, DOI 10.1046/j.1462-5822.1999.00012.x; Hakansson S, 1996, MOL MICROBIOL, V20, P593, DOI 10.1046/j.1365-2958.1996.5251051.x; Hakansson S, 1996, EMBO J, V15, P5812, DOI 10.1002/j.1460-2075.1996.tb00968.x; Han AP, 2001, EMBO J, V20, P6909, DOI 10.1093/emboj/20.23.6909; Kauppi AM, 2003, CHEM BIOL, V10, P241, DOI 10.1016/S1074-5521(03)00046-2; Keyser P, 2008, J INTERN MED, V264, P17, DOI 10.1111/j.1365-2796.2008.01941.x; Liu SJ, 2007, J CLIN INVEST, V117, P3296, DOI 10.1172/JCI32084; McEwen E, 2005, J BIOL CHEM, V280, P16925, DOI 10.1074/jbc.M412882200; Mejia E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040003; Muschiol S, 2006, P NATL ACAD SCI USA, V103, P14566, DOI 10.1073/pnas.0606412103; Muschiol S, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-75; Okan Nihal A., 2006, PLoS Pathogens, V2, P50; Rosen MD, 2009, BIOORG MED CHEM LETT, V19, P6548, DOI 10.1016/j.bmcl.2009.10.033; ROSQVIST R, 1991, INFECT IMMUN, V59, P4562, DOI 10.1128/IAI.59.12.4562-4569.1991; Schnupf P, 2007, MICROBES INFECT, V9, P1176, DOI 10.1016/j.micinf.2007.05.005; Shrestha N, 2012, J BIOL CHEM, V287, P28738, DOI 10.1074/jbc.M112.375915; Singh R, 2008, NATURE, V455, P1244, DOI 10.1038/nature07344; Suragani RNVS, 2012, BLOOD, V119, P5276, DOI 10.1182/blood-2011-10-388132; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Wiley DJ, 2009, J BIOL CHEM, V284, P24744, DOI 10.1074/jbc.M109.010140; Wolf K, 2006, MOL MICROBIOL, V61, P1543, DOI 10.1111/j.1365-2958.2006.05347.x; Zhan K, 2002, MOL CELL BIOL, V22, P7134, DOI 10.1128/MCB.22.20.7134-7146.2002; Zhao HP, 2011, BIOORG MED CHEM LETT, V21, P2659, DOI 10.1016/j.bmcl.2010.12.088	30	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68754	10.1371/journal.pone.0068754	http://dx.doi.org/10.1371/journal.pone.0068754			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874749	Green Submitted, Green Published, gold			2022-12-27	WOS:000321765300065
J	Higdon, CW; Mitra, RD; Johnson, SL				Higdon, Charles W.; Mitra, Robi D.; Johnson, Stephen L.			Gene Expression Analysis of Zebrafish Melanocytes, Iridophores, and Retinal Pigmented Epithelium Reveals Indicators of Biological Function and Developmental Origin	PLOS ONE			English	Article							DIAMOND-BLACKFAN ANEMIA; TUMOR-SUPPRESSOR GENE; VITAMIN-A METABOLISM; NEURAL CREST; OCULOCUTANEOUS ALBINISM; EMBRYONIC EXPRESSION; OSSIFICATION DEFECTS; CELL DEVELOPMENT; BINDING-PROTEIN; HOMEOBOX GENE	In order to facilitate understanding of pigment cell biology, we developed a method to concomitantly purify melanocytes, iridophores, and retinal pigmented epithelium from zebrafish, and analyzed their transcriptomes. Comparing expression data from these cell types and whole embryos allowed us to reveal gene expression co-enrichment in melanocytes and retinal pigmented epithelium, as well as in melanocytes and iridophores. We found 214 genes co-enriched in melanocytes and retinal pigmented epithelium, indicating the shared functions of melanin-producing cells. We found 62 genes significantly co-enriched in melanocytes and iridophores, illustrative of their shared developmental origins from the neural crest. This is also the first analysis of the iridophore transcriptome. Gene expression analysis for iridophores revealed extensive enrichment of specific enzymes to coordinate production of their guanine-based reflective pigment. We speculate the coordinated upregulation of specific enzymes from several metabolic pathways recycles the rate-limiting substrate for purine synthesis, phosphoribosyl pyrophosphate, thus constituting a guanine cycle. The purification procedure and expression analysis described here, along with the accompanying transcriptome- wide expression data, provide the first mRNA sequencing data for multiple purified zebrafish pigment cell types, and will be a useful resource for further studies of pigment cell biology.	[Higdon, Charles W.; Mitra, Robi D.; Johnson, Stephen L.] Washington Univ, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL)	Higdon, CW (corresponding author), Washington Univ, Dept Genet, St Louis, MO 63110 USA.	cwhigdon@wustl.edu; sjohnson@genetics.wustl.edu		Mitra, Robi/0000-0002-2680-4264	National Institutes of Health (NIH) [RO1-GM56988]; W.M. Keck Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076993] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W.M. Keck Foundation(W.M. Keck Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was made possible by grants from the National Institutes of Health (NIH) (RO1-GM56988) the W.M. Keck Foundation (http://www.wmkeck.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albajar M, 2011, MOL CANCER RES, V9, P564, DOI 10.1158/1541-7786.MCR-10-0356; Amann PM, 2012, J CELL PHYSIOL, V227, P718, DOI 10.1002/jcp.22779; An JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016516; Bahadoran P, 2001, J CELL BIOL, V152, P843, DOI 10.1083/jcb.152.4.843; Bertrand KC, 2011, CHILD NERV SYST, V27, P1243, DOI 10.1007/s00381-011-1486-x; Beverdam A, 2001, DEVELOPMENT, V128, P3975; Bharti K, 2006, PIGM CELL RES, V19, P380, DOI 10.1111/j.1600-0749.2006.00318.x; Botchkareva NV, 2001, FASEB J, V15, P645, DOI 10.1096/fj.00-0368com; Carreira S, 2005, NATURE, V433, P764, DOI 10.1038/nature03269; Ceol CJ, 2011, NATURE, V471, P513, DOI 10.1038/nature09806; Chen YR, 2002, J INVEST DERMATOL, V118, P933, DOI 10.1046/j.1523-1747.2002.01754.x; Choudhry P, 2011, DEV BIOL, V349, P483, DOI 10.1016/j.ydbio.2010.11.006; Chung MC, 2001, BIOCHEMISTRY-US, V40, P8887, DOI 10.1021/bi002847d; CLARK CR, 1987, IN VITRO CELL DEV B, V23, P417, DOI 10.1007/BF02623857; Cmejla R, 2007, HUM MUTAT, V28, P1178, DOI 10.1002/humu.20608; Coghill ID, 2003, J BIOL CHEM, V278, P24139, DOI 10.1074/jbc.M213259200; Collins JE, 2012, GENOME RES, V22, P2067, DOI 10.1101/gr.137901.112; Curran K, 2010, DEV BIOL, V344, P107, DOI 10.1016/j.ydbio.2010.04.023; Curran K, 2009, DEV BIOL, V332, P408, DOI 10.1016/j.ydbio.2009.06.010; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; Depaz IM, 2006, BRAIN RES, V1081, P59, DOI 10.1016/j.brainres.2006.01.126; Donaldson JG, 2005, BIOCHEM SOC T, V33, P639, DOI 10.1042/BST0330639; Dooley CM, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12053; Draptchinskaia N, 1999, NAT GENET, V21, P169, DOI 10.1038/5951; Dridi S, 2012, P NATL ACAD SCI USA, V109, P13781, DOI 10.1073/pnas.1206494109; Ettensohn CA, 2003, DEVELOPMENT, V130, P2917, DOI 10.1242/dev.00511; Fashena D, 1999, J COMP NEUROL, V406, P415, DOI 10.1002/(SICI)1096-9861(19990412)406:3<415::AID-CNE9>3.0.CO;2-2; Flockhart RJ, 2012, GENOME RES, V22, P1006, DOI 10.1101/gr.140061.112; Fujita Andre, 2009, Journal of Bioinformatics and Computational Biology, V7, P663, DOI 10.1142/S0219720009004230; Fujita H, 2002, J BIOL CHEM, V277, P45428, DOI 10.1074/jbc.M208090200; Fumoto S, 2009, CANCER LETT, V274, P25, DOI 10.1016/j.canlet.2008.08.021; Gronskov K, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-43; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Gu YX, 2011, MOL CELL BIOCHEM, V357, P107, DOI 10.1007/s11010-011-0880-8; He CY, 2009, COMP BIOCHEM PHYS B, V154, P221, DOI 10.1016/j.cbpb.2009.06.006; Henion PD, 1997, DEVELOPMENT, V124, P4351; Herrling T, 2008, SPECTROCHIM ACTA A, V69, P1429, DOI 10.1016/j.saa.2007.09.030; Hinterhuber G, 2004, J INVEST DERMATOL, V122, P406, DOI 10.1046/j.0022-202X.2004.22216.x; Hitchings GH, 1944, P NATL ACAD SCI USA, V30, P294, DOI 10.1073/pnas.30.10.294; Huang QJ, 2011, J BIOL CHEM, V286, P42211, DOI 10.1074/jbc.M111.296905; Jin EJ, 2001, DEV BIOL, V233, P22, DOI 10.1006/dbio.2001.0222; Johnson SL, 2011, DEV BIOL, V350, P405, DOI 10.1016/j.ydbio.2010.12.004; Kelsh RN, 1996, DEVELOPMENT, V123, P369; Kennedy BN, 2004, DEV BIOL, V270, P336, DOI 10.1016/j.ydbio.2004.02.026; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kitajiri S, 2010, CELL, V141, P786, DOI 10.1016/j.cell.2010.03.049; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Lane BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049357; Lang MR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000744; Larson TA, 2010, DEV BIOL, V346, P296, DOI 10.1016/j.ydbio.2010.07.035; LASKIN JD, 1982, J CELL PHYSIOL, V113, P481, DOI 10.1002/jcp.1041130318; Lee HO, 2003, DEV BIOL, V259, P162, DOI 10.1016/S0012-1606(03)00160-X; Leung YF, 2007, INVEST OPHTH VIS SCI, V48, P881, DOI 10.1167/iovs.06-0723; Levin MD, 2009, J CLIN INVEST, V119, P3420, DOI 10.1172/JCI39109; Li B, 2009, DEVELOPMENT, V136, P3267, DOI 10.1242/dev.036954; Li ZS, 2011, CELL BIOL INT, V35, P671, DOI 10.1042/CBI20100568; Linos E, 2009, J INVEST DERMATOL, V129, P1666, DOI 10.1038/jid.2008.423; Lister JA, 2011, DEV DYNAM, V240, P2529, DOI 10.1002/dvdy.22743; Liu YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002722; Lopes SS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000026; Ma L, 2006, CELL DEATH DIFFER, V13, P2079, DOI 10.1038/sj.cdd.4401959; Mansky KC, 2002, J LEUKOCYTE BIOL, V71, P304; Matz M, 1999, NUCLEIC ACIDS RES, V27, P1558, DOI 10.1093/nar/27.6.1558; Mavrogiannis LA, 2001, NAT GENET, V27, P17, DOI 10.1038/83703; MAYER TC, 1970, DEV BIOL, V23, P297, DOI 10.1016/0012-1606(70)90100-4; MCNIVEN MA, 1984, CELL, V37, P753, DOI 10.1016/0092-8674(84)90411-2; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Na GY, 2006, BRIT J DERMATOL, V155, P902, DOI 10.1111/j.1365-2133.2006.07502.x; Netter S, 1998, GENETICS, V149, P257; Ng A, 2009, DEVELOPMENT, V136, P2601, DOI 10.1242/dev.038315; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; Oliver ER, 2004, DEVELOPMENT, V131, P3907, DOI 10.1242/dev.01268; Parichy DM, 2000, DEV BIOL, V227, P294, DOI 10.1006/dbio.2000.9899; Patton EE, 2005, CURR BIOL, V15, P249, DOI 10.1016/j.cub.2005.01.031; Plonka PM, 2009, EXP DERMATOL, V18, P799, DOI 10.1111/j.1600-0625.2009.00912.x; Rausch MP, 2010, J IMMUNOL, V185, P2828, DOI 10.4049/jimmunol.1000945; Rawls JF, 2003, DEV BIOL, V262, P152, DOI 10.1016/S0012-1606(03)00386-5; Rawls JF, 2001, DEVELOPMENT CAMBRIDG, V128, P1; Rehli M, 1999, J IMMUNOL, V162, P1559; RINCHIK EM, 1993, NATURE, V361, P72, DOI 10.1038/361072a0; Rizzolo LJ, 2007, MOL VIS, V13, P1259; ROHRLICH ST, 1975, J CELL BIOL, V66, P635, DOI 10.1083/jcb.66.3.635; Rubinstein AL, 2000, GENESIS, V26, P86, DOI 10.1002/(SICI)1526-968X(200001)26:1<86::AID-GENE11>3.0.CO;2-Q; Runkle EA, 2011, METHODS MOL BIOL, V686, P133, DOI 10.1007/978-1-60761-938-3_5; Saldana-Caboverde A, 2010, PIGM CELL MELANOMA R, V23, P160, DOI 10.1111/j.1755-148X.2010.00678.x; Scholler M, 2012, J CLIN ENDOCR METAB, V97, P2466, DOI 10.1210/jc.2011-2969; Schonthaler HB, 2005, DEV BIOL, V284, P421, DOI 10.1016/j.ydbio.2005.06.001; Searle A.G., 1968, COMP GENETICS COAT C; Serra-Pages C, 1998, J BIOL CHEM, V273, P15611, DOI 10.1074/jbc.273.25.15611; Sheets L, 2007, CURR BIOL, V17, P1721, DOI 10.1016/j.cub.2007.09.028; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Sprague J, 2001, NUCLEIC ACIDS RES, V29, P87, DOI 10.1093/nar/29.1.87; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Tallafuss A, 2006, GENE EXPR PATTERNS, V6, P556, DOI 10.1016/j.modgep.2005.10.005; Tam WY, 2011, NEUROSCIENCE, V172, P562, DOI 10.1016/j.neuroscience.2010.10.023; Thisse B, 2004, ZFIN DIRECT DATA SUB; Thisse C., 2005, ZFIN DIRECT DATA SUB; Thomas DDH, 2010, AM J PHYSIOL-CELL PH, V298, pC725, DOI 10.1152/ajpcell.00455.2009; Thompson DA, 2003, DEV OPHTHALMOL, V37, P141; Tisdale EJ, 2004, J BIOL CHEM, V279, P54046, DOI 10.1074/jbc.M409472200; Tomihari M, 2009, EXP DERMATOL, V18, P586, DOI 10.1111/j.1600-0625.2008.00830.x; TREVARROW B, 1990, NEURON, V4, P669, DOI 10.1016/0896-6273(90)90194-K; Tsetskhladze ZR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047398; Verschoor ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013565; Waxman JS, 2007, DEV DYNAM, V236, P587, DOI 10.1002/dvdy.21049; Wistow G, 2002, MOL VIS, V8, P205; Wu SM, 2012, COMP BIOCHEM PHYS C, V156, P1, DOI 10.1016/j.cbpc.2012.02.001; Wuyts W, 2000, J MED GENET, V37, P916, DOI 10.1136/jmg.37.12.916; Yamamoto S, 2010, J BIOL CHEM, V285, P6522, DOI 10.1074/jbc.M109.032961; Yeung SJ, 2008, CELL MOL LIFE SCI, V65, P3981, DOI 10.1007/s00018-008-8224-x; Zhong X, 2013, J CANCER RES CLIN, V139, P485, DOI 10.1007/s00432-012-1353-5; Zhu YY, 2001, BIOTECHNIQUES, V30, P892, DOI 10.2144/01304pf02	112	64	69	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e67801	10.1371/journal.pone.0067801	http://dx.doi.org/10.1371/journal.pone.0067801			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874447	gold, Green Published, Green Submitted			2022-12-27	WOS:000321736900023
J	Lu, YH; Yuan, M; Gao, XW; Kang, TH; Zhan, S; Wan, H; Li, JH				Lu, Yanhui; Yuan, Miao; Gao, Xiwu; Kang, Tinghao; Zhan, Sha; Wan, Hu; Li, Jianhong			Identification and Validation of Reference Genes for Gene Expression Analysis Using Quantitative PCR in Spodoptera litura (Lepidoptera: Noctuidae)	PLOS ONE			English	Article							RHODNIUS-PROLIXUS HEMIPTERA; POLYMERASE-CHAIN-REACTION; REAL-TIME; HOUSEKEEPING GENES; DIAMONDBACK MOTH; SELECTION; NORMALIZATION; RESISTANCE; TISSUES	Reverse transcription quantitative polymerase chain reaction (qRT-PCR) has rapidly become the most sensitive and accurate method for the quantification of gene expression. To facilitate gene expression studies and obtain more accurate qRT-PCR data, normalization relative to stable housekeeping genes is required. These housekeeping genes need to show stable expression under the given experimental conditions for the qRT-PCR results to be accurate. Unfortunately, there are no studies on the stability of housekeeping genes used in Spodoptera litura. In this study, eight candidate reference genes, elongation factor 1 alpha (EF1), glyceraldehyde-3-phosphate dehydrogenase (GAPDH), ribosomal protein L10 (RPL10), ribosomal protein S3 (RPS3), beta actin (ACTB), beta FTZ-F1 (FTZF1), ubiquinol-cytochrome c reductase (UCCR), and arginine kinase (AK), were evaluated for their suitability as normalization genes under different experimental conditions using the statistical software programs, BestKeeper, geNorm and Normfinder, and the comparative Delta Ct method. We determined the expression levels of the candidate reference genes for three biotic factors (developmental stage, tissue and population), and four abiotic treatments (temperature, insecticide, food and starvation). The results indicated that the best sets of candidates as reference genes were as follows: GAPDH and UCCR for developmental stages; RPL10, AK and EF1 for different tissues; RPL10 and EF1 for different populations in China; GAPDH and EF1 for temperature-stressed larvae; AK and ACTB for larvae treated with different insecticides; RPL10, GAPDH and UCCR for larvae fed different diets; RPS3 and ACTB for starved larvae. We believe that these results make an important contribution to gene analysis studies in S. litura and form the basis of further research on stable reference genes in S. litura and other organisms.	[Lu, Yanhui; Yuan, Miao; Kang, Tinghao; Zhan, Sha; Wan, Hu; Li, Jianhong] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China; [Gao, Xiwu] China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China	Huazhong Agricultural University; China Agricultural University	Li, JH (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China.	jianhl@mail.hzau.edu.cn	Wan, Hu/W-8453-2019; Lu, gls19581211!/L-6918-2019	Wan, Hu/0000-0002-8123-3759	National Natural Science Foundation of China [31201544]; National Science and Technology Support Program [2012BAD27B00]; Hubei Research and Development Project [2011BBB043]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Support Program; Hubei Research and Development Project	This work was supported by grants from the National Natural Science Foundation of China (No. 31201544), the National Science and Technology Support Program (No. 2012BAD27B00), and Hubei Research and Development Project (No. 2011BBB043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bear A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011563; Chapuis MP, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-7; Chen H, 2012, COMP BIOCHEM PHYS B, V163, P203, DOI 10.1016/j.cbpb.2012.05.018; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; HOLLOWAY J D, 1989, Malayan Nature Journal, V42, P57; Hornakova D, 2010, ANAL BIOCHEM, V397, P118, DOI 10.1016/j.ab.2009.09.019; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Lee PD, 2002, GENOME RES, V12, P292, DOI 10.1101/gr.217802; Liang P, 2003, PEST MANAG SCI, V59, P1232, DOI 10.1002/ps.760; Lu YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032288; Majerowicz D, 2011, INSECT MOL BIOL, V20, P713, DOI 10.1111/j.1365-2583.2011.01101.x; Mamidala P, 2011, J MED ENTOMOL, V48, P947, DOI 10.1603/ME10262; Paim Rafaela M., 2012, BMC Research Notes, V5, DOI 10.1186/1756-0500-5-128; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Ponton F, 2011, J INSECT PHYSIOL, V57, P840, DOI 10.1016/j.jinsphys.2011.03.014; [秦厚国 Qin Houguo], 2004, [中国生态农业学报, Chinese journal of eco-agriculture], V12, P40; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Scharlaken B, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3301; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; SHELTON AM, 1993, J ECON ENTOMOL, V86, P697, DOI 10.1093/jee/86.3.697; Shen GM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-76; Sree KS, 2010, PESTIC BIOCHEM PHYS, V97, P168, DOI 10.1016/j.pestbp.2010.01.002; Sun W, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.20801; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Toutges MJ, 2010, J AGR FOOD CHEM, V58, P8948, DOI 10.1021/jf101603j; Van Hiel MB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-56; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Walker NJ, 2002, SCIENCE, V296, P557, DOI 10.1126/science.296.5567.557; Zeng J. H., 2010, ACTA AGR JIANGXI, V22, P87	30	130	152	2	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68059	10.1371/journal.pone.0068059	http://dx.doi.org/10.1371/journal.pone.0068059			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874494	Green Published, gold, Green Submitted			2022-12-27	WOS:000321736900048
J	Mao, JX; Lv, J; Miao, Y; Sun, CS; Hu, LP; Zhang, R; Fu, XT; Zhang, LL; Hu, XL; Wang, S; Bao, ZM				Mao, Junxia; Lv, Jia; Miao, Yan; Sun, Changsen; Hu, Liping; Zhang, Ru; Fu, Xiaoteng; Zhang, Lingling; Hu, Xiaoli; Wang, Shi; Bao, Zhenmin			Development of a Rapid and Efficient Method for Non-Lethal DNA Sampling and Genotyping in Scallops	PLOS ONE			English	Article							EXTRACTION; BIVALVIA; CONSERVATION	Non-lethal DNA sampling has long appealed to researchers studying population and conservation genetics, as it does not necessitate removing individuals permanently from their natural environment or destroying valuable samples. However, such an approach has not yet been well established in bivalves. In this study, we demonstrate that the gill represents a good source of tissue for non-lethal sampling in scallops. Removal of a few gill filaments caused no noticeable behavioral abnormalities or increased mortality rates in Zhikong scallop (Chlamys farreri) during a three-month period of observation. To facilitate rapid gill-based DNA extraction, six methods (MA-MF) were designed and evaluated, each requiring less than one hour of processing time. The optimal method was identified as MF, in terms of maintaining DNA integrity and genotyping accuracy. Further optimization of MF method by orthogonal experimental design suggested that the utilization of gills could be limited to 2 mg of sample, which is sufficient for performing up to 20,000 PCR reactions. We also demonstrate the excellent cross-species utility of MF in two additional scallop species, Yesso scallop (Patinopecten yessoensis) and bay scallop (Argopecten irradians). Taken together, our study provides a rapid and efficient approach for applying non-lethal DNA sampling in bivalve species, which would serve as a valuable tool for maintaining bivalve populations and conservation genetics, as well as in breeding studies.	[Mao, Junxia; Lv, Jia; Miao, Yan; Hu, Liping; Zhang, Ru; Fu, Xiaoteng; Zhang, Lingling; Hu, Xiaoli; Wang, Shi; Bao, Zhenmin] Ocean Univ China, Coll Marine Life Sci, Key Lab Marine Genet & Breeding, Qingdao, Peoples R China; [Sun, Changsen] Taizhou Univ, Sch Life Sci, Taizhou, Peoples R China	Ocean University of China; Taizhou University	Wang, S (corresponding author), Ocean Univ China, Coll Marine Life Sci, Key Lab Marine Genet & Breeding, Qingdao, Peoples R China.	swang@ouc.edu.cn; zmbao@ouc.edu.cn	zhang, lingling/HDM-2189-2022		National Natural Science Foundation of China [31130054, 31272656]; National High Technology Research and Development Program of China [2012AA10A402, 2012AA10A405, 2012AA092204]; Program for New Century Excellent Talents in University [NCET-10-0761]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	Financial support for this work was provided by National Natural Science Foundation of China (31130054, 31272656), National High Technology Research and Development Program of China (2012AA10A402, 2012AA10A405 & 2012AA092204), and Program for New Century Excellent Talents in University (NCET-10-0761). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg DJ, 1995, J N AM BENTHOL SOC, V14, P577, DOI 10.2307/1467542; Brand Andrew R., 2006, Developments in Aquaculture and Fisheries Science, V35, P651; Buhay JE, 2002, J MOLLUS STUD, V68, P385, DOI 10.1093/mollus/68.4.385; Chen M, 2010, CONSERV GENET, V11, P1139, DOI 10.1007/s10592-009-9900-6; Gelfand D. H., 1989, PCR TECHNOLOGY PRINC, P17, DOI 10.1007/978-1-349-20235-5_2; Grobler PJ, 2006, J MOLLUS STUD, V72, P65, DOI 10.1093/mollus/eyi055; Henley WF, 2006, J SHELLFISH RES, V25, P975, DOI 10.2983/0730-8000(2006)25[975:NMTODF]2.0.CO;2; Huang R.H., 2005, EXPT DESIGN DATA PRO; Jones JW, 2004, MOL ECOL NOTES, V4, P649, DOI 10.1111/j.1471-8286.2004.00762.x; Pearse DE, 2001, MOL ECOL, V10, P2711, DOI 10.1046/j.0962-1083.2001.01391.x; Popa Oana Paula, 2007, Travaux du Museum National d'Histoire Naturelle Grigore Antipa, V50, P527; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Singer-Sam J, 1989, AMPLIFICATIONS, V3, P11; Sokolov EP, 2000, J MOLLUS STUD, V66, P573, DOI 10.1093/mollus/66.4.573; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wang S, 2013, PLOS ONE IN PRESS; WINNEPENNINCKX B, 1993, TRENDS GENET, V9, P407; Zhan AB, 2005, FISHERIES SCI, V71, P1341, DOI 10.1111/j.1444-2906.2005.01100.x; Zhan AB, 2006, J MOLLUS STUD, V72, P436, DOI 10.1093/mollus/eyl018	19	5	6	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68096	10.1371/journal.pone.0068096	http://dx.doi.org/10.1371/journal.pone.0068096			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874509	Green Published, gold, Green Submitted			2022-12-27	WOS:000321736900055
J	Taguchi, YH; Murakami, Y				Taguchi, Y-h.; Murakami, Yoshiki			Principal Component Analysis Based Feature Extraction Approach to Identify Circulating microRNA Biomarkers	PLOS ONE			English	Article							UNSUPERVISED FEATURE-SELECTION; GENE SELECTION; LUNG-CANCER; BLOOD; EXPRESSION	The discovery and characterization of blood-based disease biomarkers are clinically important because blood collection is easy and involves relatively little stress for the patient. However, blood generally reflects not only targeted diseases, but also the whole body status of patients. Thus, the selection of biomarkers may be difficult. In this study, we considered miRNAs as biomarker candidates for several reasons. First, since miRNAs were discovered relatively recently, they have not yet been tested extensively. Second, since the number of miRNAs is relatively limited, selection is expected to be easy. Third, since they are known to play critical roles in a wide range of biological processes, their expression may be disease specific. We applied a newly proposed method to select combinations of miRNAs that discriminate between healthy controls and each of 14 diseases that include 5 cancers. A new feature selection method is based on principal component analysis. Namely this method does not require knowledge of whether each sample was derived from a disease patient or a healthy control. Using this method, we found that hsa-miR-425, hsa-miR-15b, hsa-miR-185, hsa-miR-92a, hsa-miR-140-3p, hsa-miR-320a, hsa-miR486-5p, hsa-miR-16, hsa-miR-191, hsa-miR-106b, hsa-miR-19b, and hsa-miR-30d were potential biomarkers; combinations of 10 of these miRNAs allowed us to discriminate each disease included in this study from healthy controls. These 12 miRNAs are significantly up-or downregulated in most cancers and other diseases, albeit in a cancer- or disease-specific combinatory manner. Therefore, these 12 miRNAs were also previously reported to be cancer- and disease-related miRNAs. Many disease-specific KEGG pathways were also significantly enriched by target genes of up-/downregulated miRNAs within several combinations of 10 miRNAs among these 12 miRNAs. We also selected miRNAs that could discriminate one disease from another or from healthy controls. These miRNAs were found to be largely overlapped with miRNAs that discriminate each disease from healthy controls.	[Taguchi, Y-h.] Chuo Univ, Dept Phys, Tokyo 112, Japan; [Murakami, Yoshiki] Osaka City Univ, Sch Med, Dept Hepatol, Osaka 545, Japan	Chuo University; Osaka Metropolitan University	Taguchi, YH (corresponding author), Chuo Univ, Dept Phys, Tokyo 112, Japan.	tag@granular.com	Taguchi, Y-h./E-1474-2011	Taguchi, Y-h./0000-0003-0867-8986	KAKENHI [23300357]; Grants-in-Aid for Scientific Research [23300357] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by KAKENHI (23300357) (http://www.jsps.go.jp/english/e-grants/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeel T, 2010, BIOINFORMATICS, V26, P392, DOI 10.1093/bioinformatics/btp630; Bandyopadhyay Sanghamitra, 2010, Silence, V1, P6, DOI 10.1186/1758-907X-1-6; Brase JC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-306; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Chaussabel D, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-84; d'Aspremont A, 2007, SIAM REV, V49, P434, DOI 10.1137/050645506; Debey-Pascher Svenja, 2012, Methods Mol Biol, V822, P307, DOI 10.1007/978-1-61779-427-8_22; Dy J.-G., 2000, 17 INT C MACHINE LEA, P247; Dy JG, 2004, J MACH LEARN RES, V5, P845; Dy JG, 2003, IEEE T PATTERN ANAL, V25, P373, DOI 10.1109/TPAMI.2003.1182100; Everitt B.S., 2010, APPL MULTIVARIATE DA, V2nd ed.; Guan Y., 2009, J MACHINE LEARNING R, V5, P185; Hant FN, 2011, CURR RHEUMATOL REP, V13, P44, DOI 10.1007/s11926-010-0143-9; Journee M, 2010, J MACH LEARN RES, V11, P517; Keller A, 2011, MOL BIOSYST, V7, P3187, DOI 10.1039/c1mb05353a; Keller A, 2011, NAT METHODS, V8, P841, DOI [10.1038/nmeth.1682, 10.1038/NMETH.1682]; Kurashige J, 2012, J SURG ONCOL, V106, P188, DOI 10.1002/jso.23064; Lee YM, 2011, TUBERC RESPIR DIS, V71, P8, DOI 10.4046/trd.2011.71.1.8; Liu B, 2004, IEEE IJCNN, P1681; Liu B, 2006, IEEE T NANOBIOSCI, V5, P110, DOI 10.1109/TNB.2006.875040; Modha DS, 2003, MACH LEARN, V52, P217, DOI 10.1023/A:1024016609528; Moghaddam B., 2005, NIPS; Nair VS, 2009, J THORAC ONCOL, V4, P1473, DOI 10.1097/JTO.0b013e3181bccbc6; Papadopoulos GL, 2009, BIOINFORMATICS, V25, P1991, DOI 10.1093/bioinformatics/btp299; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Qiu W, 2008, INT J BIOSTAT, V4; R Development Core Team, 2010, R LANG ENV STAT COMP; Ruepp A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r6; Sauter E, 2011, J NUCL ACIDS INV, V2, pe1; Scholer N, 2011, GENOME MED, V3, DOI 10.1186/gm288; Shigoka M, 2010, PATHOL INT, V60, P351, DOI 10.1111/j.1440-1827.2010.02526.x; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van't Westeinde SC, 2011, CANCER J, V17, P3, DOI 10.1097/PPO.0b013e3182099319; Varshavsky R, 2007, BIOINFORMATICS, V23, P3343, DOI 10.1093/bioinformatics/btm528; Wang LG, 2012, CANCER EPIDEMIOL, V36, pE61, DOI 10.1016/j.canep.2011.05.002; Wu Q, 2012, CLIN CHIM ACTA, V413, P1058, DOI 10.1016/j.cca.2012.02.016; Wulfken LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025787; Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056; Yu DC, 2011, INT J MOL SCI, V12, P2055, DOI 10.3390/ijms12032055; Zen K, 2012, MED RES REV, V32, P326, DOI 10.1002/med.20215; Zou H, 2006, J COMPUT GRAPH STAT, V15, P265, DOI 10.1198/106186006X113430	41	48	49	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66714	10.1371/journal.pone.0066714	http://dx.doi.org/10.1371/journal.pone.0066714			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23874370	Green Published, gold			2022-12-27	WOS:000321738400035
J	Piersma, S; Denham, EL; Drulhe, S; Tonk, RHJ; Schwikowski, B; van Dijl, JM				Piersma, Sjouke; Denham, Emma L.; Drulhe, Samuel; Tonk, Rudi H. J.; Schwikowski, Benno; van Dijl, Jan Maarten			TLM-Quant: An Open-Source Pipeline for Visualization and Quantification of Gene Expression Heterogeneity in Growing Microbial Cells	PLOS ONE			English	Article							BACILLUS-SUBTILIS	Gene expression heterogeneity is a key driver for microbial adaptation to fluctuating environmental conditions, cell differentiation and the evolution of species. This phenomenon has therefore enormous implications, not only for life in general, but also for biotechnological applications where unwanted subpopulations of non-producing cells can emerge in large-scale fermentations. Only time-lapse fluorescence microscopy allows real-time measurements of gene expression heterogeneity. A major limitation in the analysis of time-lapse microscopy data is the lack of fast, cost-effective, open, simple and adaptable protocols. Here we describe TLM-Quant, a semi-automatic pipeline for the analysis of time-lapse fluorescence microscopy data that enables the user to visualize and quantify gene expression heterogeneity. Importantly, our pipeline builds on the open-source packages ImageJ and R. To validate TLM-Quant, we selected three possible scenarios, namely homogeneous expression, highly 'noisy' heterogeneous expression, and bistable heterogeneous expression in the Gram-positive bacterium Bacillus subtilis. This bacterium is both a paradigm for systems-level studies on gene expression and a highly appreciated biotechnological 'cell factory'. We conclude that the temporal resolution of such analyses with TLM-Quant is only limited by the numbers of recorded images.	[Piersma, Sjouke; Denham, Emma L.; Tonk, Rudi H. J.; van Dijl, Jan Maarten] Univ Groningen, Dept Med Microbiol, Groningen, Netherlands; [Piersma, Sjouke; Denham, Emma L.; Tonk, Rudi H. J.; van Dijl, Jan Maarten] Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands; [Drulhe, Samuel; Schwikowski, Benno] Inst Pasteur, Dept Genomes & Genet, Syst Biol Lab, Paris, France	University of Groningen; University of Groningen; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	van Dijl, JM (corresponding author), Univ Groningen, Dept Med Microbiol, Groningen, Netherlands.	j.m.van.dijl01@umcg.nl	; Denham, Emma/P-3979-2014	Schwikowski, Benno/0000-0001-5127-5619; Denham, Emma/0000-0002-5123-4099	CEU (Commission of the European Union) [LSHG-CT-2006-037469, PITN-GA-2008-215524, 244093]; Research Council for Earth and Life Sciences of the Netherlands Organization for Scientific Research	CEU (Commission of the European Union); Research Council for Earth and Life Sciences of the Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	S.P., E. L. D., S. D., R.H.J.T, B. S. and J.M.v.D. were in parts supported through the CEU (Commission of the European Union) projects LSHG-CT-2006-037469, PITN-GA-2008-215524 and 244093, and the transnational SysMO projects BACELL SysMO 1 and 2 through the Research Council for Earth and Life Sciences of the Netherlands Organization for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichaoui L, 2012, BIOINFORMATICS, V28, P2705, DOI 10.1093/bioinformatics/bts422; Botella E, 2010, MICROBIOL-SGM, V156, P1600, DOI 10.1099/mic.0.035758-0; Buescher JM, 2012, SCIENCE, V335, P1099, DOI 10.1126/science.1206871; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; de Jong IG, 2011, JOVE-J VIS EXP, DOI 10.3791/3145; Furrer R., 2010, FIELDS TOOLS SPATIAL; Kearns DB, 2005, GENE DEV, V19, P3083, DOI 10.1101/gad.1373905; Klein J, 2012, BIOINFORMATICS, V28, P2276, DOI 10.1093/bioinformatics/bts424; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; R Development Core Team, 2011, R LANG ENV STAT COMP; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Stoter Martin, 2013, Methods Mol Biol, V986, P105, DOI 10.1007/978-1-62703-311-4_8; Veening JW, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.18; Veening JW, 2008, P NATL ACAD SCI USA, V105, P4393, DOI 10.1073/pnas.0700463105; Young JW, 2012, NAT PROTOC, V7, P80, DOI 10.1038/nprot.2011.432	15	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e68696	10.1371/journal.pone.0068696	http://dx.doi.org/10.1371/journal.pone.0068696			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23874729	Green Submitted, gold, Green Published			2022-12-27	WOS:000322000600018
J	Burt, T; Dhillon, S; Sharma, P; Khan, D; Deepa, MV; Alam, S; Jain, S; Alapati, B; Mittal, S; Singh, P				Burt, Tal; Dhillon, Savita; Sharma, Pooja; Khan, Danish; Deepa, M., V; Alam, Sazid; Jain, Sarika; Alapati, Bhavana; Mittal, Sanjay; Singh, Padam			PARTAKE Survey of Public Knowledge and Perceptions of Clinical Research in India	PLOS ONE			English	Article							TRIALS; PARTICIPATION; PATIENT; CANCER; RACE; DISTRUST; PREVENTION; ADVOCACY; BARRIERS	Background: A public that is an informed partner in clinical research is important for ethical, methodological, and operational reasons. There are indications that the public is unaware or misinformed, and not sufficiently engaged in clinical research but studies on the topic are lacking. PARTAKE - Public Awareness of Research for Therapeutic Advancements through Knowledge and Empowerment is a program aimed at increasing public awareness and partnership in clinical research. The PARTAKE Survey is a component of the program. Objective: To study public knowledge and perceptions of clinical research. Methods: A 40-item questionnaire combining multiple-choice and open-ended questions was administered to 175 English- or Hindi-speaking individuals in 8 public locations representing various socioeconomic strata in New Delhi, India. Results: Interviewees were 18-84 old (mean: 39.6, SD +/- 16.6), 23.6% female, 68.6% employed, 7.3% illiterate, 26.3% had heard of research, 2.9% had participated and 58.9% expressed willingness to participate in clinical research. The following perceptions were reported (% true/% false/% not aware): 'research benefits society' (94.1%/3.5%/2.3%), 'the government protects against unethical clinical research' (56.7%/26.3%/16.9%), 'research hospitals provide better care' (67.2%/8.7%/23.9%), 'confidentiality is adequately protected' (54.1%/12.3%/33.5%), 'participation in research is voluntary' (85.3%/5.8%/8.7%); 'participants treated like 'guinea pigs'' (20.7%/53.2%/26.0%), and 'compensation for participation is adequate' (24.7%/12.9%/62.3%). Conclusions: Results suggest the Indian public is aware of some key features of clinical research (e.g., purpose, value, voluntary nature of participation), and supports clinical research in general but is unaware of other key features (e.g., compensation, confidentiality, protection of human participants) and exhibits some distrust in the conduct and reporting of clinical trials. Larger, cross-cultural surveys are required to inform educational programs addressing these issues.	[Burt, Tal] Duke Univ, Duke Global Proof Of Concept POC Res Network, DCRU, Durham, NC 27710 USA; [Burt, Tal] Duke Univ, DCRI, Durham, NC USA; [Burt, Tal] Duke Univ, Dept Psychiat & Behav Sci, Durham, NC USA; [Dhillon, Savita; Khan, Danish; Deepa, M., V; Alam, Sazid; Jain, Sarika] MDRI, Gurgaon, India; [Sharma, Pooja] MIER, Medanta Medicity, Gurgaon, India; [Alapati, Bhavana; Singh, Padam] MIER, Gurgaon, India; [Mittal, Sanjay] Medanta Medicity Hosp, Gurgaon, India	Duke University; Duke University; Duke University	Burt, T (corresponding author), Duke Univ, Duke Global Proof Of Concept POC Res Network, DCRU, Durham, NC 27710 USA.	tal.burt@duke.edu	Burt, Tal/AAE-5073-2019; Burt, Tal/O-1951-2013	Burt, Tal/0000-0002-5853-6110; Sharma, Pooja/0000-0002-6004-457X	NCATS NIH HHS [UL1 TR001117] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001117] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		[Anonymous], 2012, OXFORDDICTIONARY; Bhatt Arun, 2012, Perspect Clin Res, V3, P87, DOI 10.4103/2229-3485.100643; Braunstein JB, 2008, MEDICINE, V87, P1, DOI 10.1097/MD.0b013e3181625d78; Catania C, 2008, ONCOLOGY-BASEL, V74, P177, DOI 10.1159/000151365; Corbie-Smith G, 2002, ARCH INTERN MED, V162, P2458, DOI 10.1001/archinte.162.21.2458; Cottler LB, 2013, AM J PUBLIC HLTH; Doshi MS, 2013, J MED ETHICS; Durant RW, 2011, J NATL MED ASSOC, V103, P123, DOI 10.1016/S0027-9684(15)30261-3; Getz KA, 2008, PUBLIC CONFIDENCE TR; Gordon Elisa J, 2006, IRB, V28, P12; Gorelick PB, 1998, J NATL MED ASSOC, V90, P141; Gupta YK, 2011, TRENDS PHARMACOL SCI, V32, P327, DOI 10.1016/j.tips.2011.02.017; HarrisInteractive, 2005, HEALTHCARE NEWS, P5; HarrisInteractive, 2007, HEALTHCARE NEWS, P7; Inc SI, 2011, SAS 9 3; IndiaGovernment, 2011, CENS IND 2011; Jones JM, 2006, J CANCER EDUC, V21, P237; KaiserFamilyFoundation, 2008, VIEWS PRESCR DRUGS P; Kass NE, 2007, CLIN PHARMACOL THER, V82, P219, DOI 10.1038/sj.clpt.6100192; Krishnan V, 2010, INDIAN EXPRESS; Landy DC, 2012, GENET MED, V14, P223, DOI [10.1038/GIM.0b013e3182310ba0, 10.1038/gim.0b013e3182310ba0]; Mackenzie IS, 2010, BRIT J CLIN PHARMACO, V69, P128, DOI 10.1111/j.1365-2125.2009.03561.x; Mahaluxmivala Narges, 2010, Perspect Clin Res, V1, P15; Markman M, 2008, J CANCER RES CLIN, V134, P115, DOI 10.1007/s00432-007-0263-4; Michaels M, 2012, J CANCER EDUC, V27, P67, DOI 10.1007/s13187-011-0271-6; Mills EJ, 2006, LANCET ONCOL, V7, P141, DOI 10.1016/S1470-2045(06)70576-9; Mudd J, 2007, APPL CLIN TRIALS ONL; Murthy VH, 2004, JAMA-J AM MED ASSOC, V291, P2720, DOI 10.1001/jama.291.22.2720; Nundy S, 2005, NEW ENGL J MED, V352, P1633, DOI 10.1056/NEJMp048361; Parliament of India Rajya Sabha, 2012, 59 PARL IND RAJ SABH; Raghavan VV, 2003, PERCEPTION CLIN TRIA; Ramamurthy N V, 2012, Perspect Clin Res, V3, P47, DOI 10.4103/2229-3485.96442; Research!America, 2005, AM SPEAKS; Rosenbaum JR, 2005, J CLIN EPIDEMIOL, V58, P1109, DOI 10.1016/j.jclinepi.2005.03.014; Sengupta S, 2000, J ACQ IMMUN DEF SYND, V24, P275; Shah JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010730; Shah Kunal, 2011, Perspect Clin Res, V2, P4, DOI 10.4103/2229-3485.76283; Shetty P, 2011, NATURE, V474, P427, DOI 10.1038/474427a; SINGH MADHUR, 2008, TIME; Srinivasan S, 2009, ETHICAL CLIN TRIALS; Srinivasan Sandhya, 2010, Perspect Clin Res, V1, P101; Terry SF, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001857; Tinetti ME, 2013, JAMA-J AM MED ASSOC, P1; US-CensusBureau, 2002, GLOB POP PROF; Woolley M, 2005, JAMA-J AM MED ASSOC, V294, P1380, DOI 10.1001/jama.294.11.1380	45	17	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68666	10.1371/journal.pone.0068666	http://dx.doi.org/10.1371/journal.pone.0068666			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874712	Green Submitted, Green Published, gold			2022-12-27	WOS:000322064300061
J	Guo, S; Liu, Y; Ma, YN; Zhao, Q; Zhu, LP; Shao, YH; Gao, FY; Wu, FQ; Gao, RT; Zhang, W				Guo, Sha; Liu, Ying; Ma, Younan; Zhao, Qing; Zhu, Liping; Shao, Yuehu; Gao, Fengying; Wu, Fengqi; Gao, Ruitong; Zhang, Wei			Systemic Lupus Erythematosus Patients Contain Significantly Less IgM against Mono-Methylated Lysine than Healthy Subjects	PLOS ONE			English	Article							B-CELL; MONOCLONAL-ANTIBODIES; HISTONE MODIFICATIONS; T-CELL; AUTOANTIBODIES; CHROMATIN; DISEASE; NUCLEOSOME; SLE; ANTIGENS	Post-translational modifications on proteins are important in biological processes but may create neo-epitopes that induce autoimmune responses. In this study, we measured the serum IgG and IgM response to a set of non-modified or acetyl- and methyl-modified peptides corresponding to residues 1-19 of the histone 3 N-terminal tail in systemic lupus erythematosus (SLE) patients and healthy subjects. Our results indicated that the SLE patients and healthy subjects produced antibodies (Abs) to the peptides, but the two groups had different Ab isotype and epitope preferences. Abs to the non-modified form, H3(1-19), were of the IgG isotype and produced by SLE patients. They could not recognize the scrambled H3(1-19), which contained the same amino acid composition but a different sequence as H3(1-19). In comparison, healthy subjects in general did not produce IgG against H3(1-19). However, about 70% of the healthy subjects produced IgM Abs against mono-methylated K9 of H3(1-19) (H3(1-19)K9me). Our further studies revealed that epsilon-amine mono-methylated lysine could completely inhibit the IgM binding to H3(1-19)K9me, but lysine had no inhibitory effect. In addition, the IgM Abs could bind peptides containing a mono-methylated lysine residue but with totally different sequences. Thus, mono-methylated lysine was the sole epitope for the IgM. Interestingly, SLE patients had much lower levels of this type of IgM. There was no obvious correlation between the IgM levels and disease activity and the decreased IgM was unlikely caused by medical treatments. We also found that the IgM Abs were not polyreactive to dsDNA, ssDNA, lipopolysaccharide (LPS) or insulin and they did not exist in umbilical cord serum, implying that they were not natural Abs. The IgM Abs against mono-methylated lysine are present in healthy subjects but are significantly lower in SLE patients, suggesting a distinct origin of production and special physiological functions.	[Guo, Sha; Liu, Ying; Ma, Younan; Zhao, Qing; Zhu, Liping; Zhang, Wei] Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Dept Immunol,Sch Basic Med, Beijing 100730, Peoples R China; [Shao, Yuehu] Absea Biotechnol Ltd, Dept Res & Dev, Beijing, Peoples R China; [Gao, Fengying] Pediat Hosp Sanhe, Dept Internal Med, Langfang City, Hebei Province, Peoples R China; [Wu, Fengqi] Capital Inst Pediat, Dept Pediat Rheumatol, Beijing, Peoples R China; [Gao, Ruitong] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Nephrol, Peking Union Med Coll, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Capital Institute of Pediatrics (CIP); Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital	Wu, FQ (corresponding author), Capital Inst Pediat, Dept Pediat Rheumatol, Beijing, Peoples R China.	fengqiwu112@2008.sina.com; gaoruitong@gmail.com; wzhang@pumc.edu.cn	Zhu, Li/GXH-9801-2022		National Natural Science Foundation of China [30972717]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant (no. 30972717) from the National Natural Science Foundation of China (http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderton SM, 2004, CURR OPIN IMMUNOL, V16, P753, DOI 10.1016/j.coi.2004.09.001; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Boes M, 2000, P NATL ACAD SCI USA, V97, P1184, DOI 10.1073/pnas.97.3.1184; Datta SK, 2003, ANN NY ACAD SCI, V987, P79, DOI 10.1111/j.1749-6632.2003.tb06035.x; Diamond B, 2008, FUNDAMENTAL IMMUNOLO, P1292; Dieker J, 2010, CLIN REV ALLERG IMMU, V39, P78, DOI 10.1007/s12016-009-8173-7; Dieker JW, 2007, ARTHRITIS RHEUM-US, V56, P1921, DOI 10.1002/art.22646; Ehrenstein MR, 2010, NAT REV IMMUNOL, V10, P778, DOI 10.1038/nri2849; Ehrenstein MR, 2000, J EXP MED, V191, P1253, DOI 10.1084/jem.191.7.1253; Gronwall C, 2012, CLIN IMMUNOL, V142, P390, DOI 10.1016/j.clim.2012.01.002; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jiang CC, 2007, J IMMUNOL, V178, P7422, DOI 10.4049/jimmunol.178.11.7422; Kaliyaperumal A, 2002, J IMMUNOL, V168, P2530, DOI 10.4049/jimmunol.168.5.2530; Khorasanizadeh S, 2004, CELL, V116, P259, DOI 10.1016/S0092-8674(04)00044-3; Kohm AP, 2003, TRENDS MICROBIOL, V11, P101, DOI 10.1016/S0966-842X(03)00006-4; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Lutz HU, 2009, TRENDS IMMUNOL, V30, P43, DOI 10.1016/j.it.2008.10.002; Mannoor K, 2012, J IMMUNOL, V188, P3628, DOI 10.4049/jimmunol.1102859; Mietzner B, 2008, P NATL ACAD SCI USA, V105, P9727, DOI 10.1073/pnas.0803644105; Monestier M, 2000, J BIOL CHEM, V275, P13558, DOI 10.1074/jbc.275.18.13558; MULLER S, 1989, INT ARCH ALLER A IMM, V89, P288, DOI 10.1159/000234962; PLAUE S, 1989, J EXP MED, V169, P1607, DOI 10.1084/jem.169.5.1607; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Rayzman Veronika M., 2006, Human Antibodies, V15, P71; Schett G, 2002, LUPUS, V11, P704, DOI 10.1191/0961203302lu247oa; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Sherer Y, 2004, SEMIN ARTHRITIS RHEU, V34, P501, DOI 10.1016/j.semarthrit.2004.07.002; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Stummvoll GH, 2009, ANN RHEUM DIS, V68, P110, DOI 10.1136/ard.2007.082032; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Tiller T, 2007, IMMUNITY, V26, P205, DOI 10.1016/j.immuni.2007.01.009; van Bavel CC, 2011, ANN RHEUM DIS, V70, P201, DOI 10.1136/ard.2010.129320; van Bavel CC, 2009, MOL IMMUNOL, V47, P511, DOI 10.1016/j.molimm.2009.08.009; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Wellmann U, 2005, P NATL ACAD SCI USA, V102, P9258, DOI 10.1073/pnas.0500132102; Werwitzke S, 2005, ARTHRITIS RHEUM-US, V52, P3629, DOI 10.1002/art.21379; Witte T, 2008, CLIN REV ALLERG IMMU, V34, P345, DOI 10.1007/s12016-007-8046-x; Yurasov S, 2005, J EXP MED, V201, P703, DOI 10.1084/jem.20042251; Zhang J, 2009, J AUTOIMMUN, V33, P270, DOI 10.1016/j.jaut.2009.03.011; Zhang X, 2012, ACTA BIOCH BIOPH SIN, V44, P14, DOI 10.1093/abbs/gmr100; Zhen QL, 2005, J CLIN INVEST, V115, P3428, DOI 10.1172/JCI23587	47	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68520	10.1371/journal.pone.0068520	http://dx.doi.org/10.1371/journal.pone.0068520			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874652	gold, Green Submitted, Green Published			2022-12-27	WOS:000322064300042
J	Sengupta, S; Mitra, S; Bhakat, KK				Sengupta, Shiladitya; Mitra, Sankar; Bhakat, Kishor K.			Dual Regulatory Roles of Human AP-Endonuclease (APE1/Ref-1) in CDKN1A/p21 Expression	PLOS ONE			English	Article							BASE EXCISION-REPAIR; RESISTANCE GENE MDR1; APURINIC/APYRIMIDINIC-ENDONUCLEASE; DNA-REPAIR; PROTEIN APE1/REF-1; CANCER CELL; ALTERED EXPRESSION; TUMOR SUPPRESSION; OXIDATIVE STRESS; RENIN GENE	The human AP-endonuclease (APE1/Ref-1), an essential multifunctional protein involved in repair of oxidative DNA damage as well as in transcriptional regulation, is often overexpressed in tumor cells. APE1 was earlier shown to stimulate p53's DNA binding and its transactivation function in the expression of cyclin-dependent kinase inhibitor p21 (CDKN1A) gene. Here, we show APE1's stable binding to p53 cis elements which are required for p53-mediated activation of p21 in p53-expressing wild type HCT116 cells. However, surprisingly, we observed APE1-dependent repression of p21 in isogenic p53-null HCT116 cells. Ectopic expression of p53 in the p53-null cells abrogated this repression suggesting that APE1's negative regulatory role in p21 expression is dependent on the p53 status. We then identified APE1's another binding site in p21's proximal promoter region containing cis elements for AP4, a repressor of p21. Interestingly, APE1 and AP4 showed mutual dependence for p21 repression. Moreover, ectopic p53 in p53-null cells inhibited AP4's association with APE1, their binding to the promoter and p21 repression. These results together establish APE1's role as a co-activator or co-repressor of p21 gene, dependent on p53 status. It is thus likely that APE1 overexpression and inactivation of p53, often observed in tumor cells, promote tumor cell proliferation by constitutively downregulating p21 expression.	[Sengupta, Shiladitya; Mitra, Sankar; Bhakat, Kishor K.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Mitra, Sankar; Bhakat, Kishor K.] Univ Texas Med Branch, Sealy Ctr Mol Med, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Bhakat, KK (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.	kkbhakat@utmb.edu	Sengupta, Shiladitya/L-5951-2015	Sengupta, Shiladitya/0000-0001-9558-2741	National Institute of Health (NIH) [R01 CA148941, RO1 ES08457, R01 CA53791]; Keck Center for Quantitative Biomedical Sciences of the Gulf Coast Consortia, on the Computational Cancer Biology Training Program from the Cancer Prevention & Research Institute of Texas (CPRIT) [RP101489]; Sealy Center for Molecular Medicine Pilot Project; NATIONAL CANCER INSTITUTE [R01CA148941, R01CA053791] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008457] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Keck Center for Quantitative Biomedical Sciences of the Gulf Coast Consortia, on the Computational Cancer Biology Training Program from the Cancer Prevention & Research Institute of Texas (CPRIT); Sealy Center for Molecular Medicine Pilot Project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was funded by National Institute of Health (NIH) grants R01 CA148941 (to KKB), RO1 ES08457 and R01 CA53791 (to SM); a training fellowship (to SS) from the Keck Center for Quantitative Biomedical Sciences of the Gulf Coast Consortia, on the Computational Cancer Biology Training Program from the Cancer Prevention & Research Institute of Texas (CPRIT No. RP101489), and Sealy Center for Molecular Medicine Pilot Project grant to KKB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Abukhdeir AM, 2008, P NATL ACAD SCI USA, V105, P288, DOI 10.1073/pnas.0710887105; Abukhdeir Abde M., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000744; AGARWAL ML, 1995, P NATL ACAD SCI USA, V92, P8493, DOI 10.1073/pnas.92.18.8493; Bapat A, 2009, ANTIOXID REDOX SIGN, V11, P651, DOI [10.1089/ars.2008.2218, 10.1089/ARS.2008.2218]; Bhakat KK, 2009, ANTIOXID REDOX SIGN, V11, P621, DOI [10.1089/ars.2008.2198, 10.1089/ARS.2008.2198]; Bhakat KK, 2004, NUCLEIC ACIDS RES, V32, P3033, DOI 10.1093/nar/gkh632; Bhakat KK, 2003, EMBO J, V22, P6299, DOI 10.1093/emboj/cdg595; Bhattacharyya A, 2009, GASTROENTEROLOGY, V136, P2258, DOI 10.1053/j.gastro.2009.02.014; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Busso CS, 2009, ONCOGENE, V28, P1616, DOI 10.1038/onc.2009.5; Busso CS, 2011, NUCLEIC ACIDS RES, V39, P8017, DOI 10.1093/nar/gkr401; Cao J, 2009, INT J SURG PATHOL, V17, P16, DOI 10.1177/1066896908315813; Chattopadhyay R, 2008, MOL CELL BIOL, V28, P7066, DOI 10.1128/MCB.00244-08; CHEN JJ, 1995, NATURE, V374, P386, DOI 10.1038/374386a0; Das S, 2007, J BIOL CHEM, V282, P28474, DOI 10.1074/jbc.M704672200; Daviet S, 2007, DNA REPAIR, V6, P8, DOI 10.1016/j.dnarep.2006.08.001; Demple B, 1997, ENVIRON HEALTH PERSP, V105, P931, DOI 10.2307/3433306; DOETSCH PW, 1990, MUTAT RES, V236, P173, DOI 10.1016/0921-8777(90)90004-O; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; ELDEIRY WS, 1995, CANCER RES, V55, P2910; Evans AR, 2000, MUTAT RES-DNA REPAIR, V461, P83, DOI 10.1016/S0921-8777(00)00046-X; Fantini D, 2008, FREE RADICAL RES, V42, P20, DOI 10.1080/10715760701765616; Fishel ML, 2008, DNA REPAIR, V7, P177, DOI 10.1016/j.dnarep.2007.09.008; Fishel ML, 2007, MOL ASPECTS MED, V28, P375, DOI 10.1016/j.mam.2007.04.005; Fuchs S, 2003, J HYPERTENS, V21, P327, DOI 10.1097/00004872-200302000-00024; Gaiddon C, 1999, EMBO J, V18, P5609, DOI 10.1093/emboj/18.20.5609; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Gros L, 2004, NUCLEIC ACIDS RES, V32, P73, DOI 10.1093/nar/gkh165; Huang E, 2010, NAT CELL BIOL, V12, P563, DOI 10.1038/ncb2058; Izumi T, 2005, P NATL ACAD SCI USA, V102, P5739, DOI 10.1073/pnas.0500986102; Izumi T, 2003, TOXICOLOGY, V193, P43, DOI 10.1016/S0300-483X(03)00289-0; Jayaraman L, 1997, GENE DEV, V11, P558, DOI 10.1101/gad.11.5.558; Jiang Lingyan, 2010, Mol Cell Pharmacol, V2, P69; Jiang YL, 2008, CANCER RES, V68, P6425, DOI 10.1158/0008-5472.CAN-08-1173; Jiang YL, 2010, CANCER INVEST, V28, P885, DOI 10.3109/07357907.2010.512816; Jiang YL, 2009, DNA REPAIR, V8, P1273, DOI 10.1016/j.dnarep.2009.08.003; Jung P, 2009, CELL CYCLE, V8, P982, DOI 10.4161/cc.8.7.7949; Jung P, 2008, P NATL ACAD SCI USA, V105, P15046, DOI 10.1073/pnas.0801773105; Kelley MR, 2001, CLIN CANCER RES, V7, P824; Ku WC, 2009, MOL CELL PROTEOMICS, V8, P2034, DOI 10.1074/mcp.M900013-MCP200; Liu XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037096; Liu XH, 2012, MED ONCOL, V29, P871, DOI 10.1007/s12032-011-9845-8; McNeill DR, 2009, MOL CANCER RES, V7, P897, DOI 10.1158/1541-7786.MCR-08-0519; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; Meira LB, 2001, CANCER RES, V61, P5552; Mohiuddin M, 2002, ANTICANCER RES, V22, P825; Niculescu AB, 1998, MOL CELL BIOL, V18, P629, DOI 10.1128/MCB.18.1.629; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; OKAZAKI T, 1994, J BIOL CHEM, V269, P27855; Ramana CV, 1998, P NATL ACAD SCI USA, V95, P5061, DOI 10.1073/pnas.95.9.5061; Ray S, 2010, MOL ENDOCRINOL, V24, P391, DOI 10.1210/me.2009-0319; Robertson KA, 1997, CELL GROWTH DIFFER, V8, P443; Robertson KA, 2001, CANCER RES, V61, P2220; Schonn I, 2010, APOPTOSIS, V15, P162, DOI 10.1007/s10495-009-0440-9; Sengupta S, 2011, ONCOGENE, V30, P482, DOI 10.1038/onc.2010.435; Sengupta S, 2012, J HYPERTENS, V30, P917, DOI 10.1097/HJH.0b013e3283525124; Strauss PR, 1998, J BIOL CHEM, V273, P14435, DOI 10.1074/jbc.273.23.14435; Tell G, 2009, ANTIOXID REDOX SIGN, V11, P601, DOI 10.1089/ars.2008.2194; Vascotto C, 2009, PROTEOMICS, V9, P1058, DOI 10.1002/pmic.200800638; Vascotto C, 2009, MOL CELL BIOL, V29, P1834, DOI 10.1128/MCB.01337-08; Vidal AE, 2001, EMBO J, V20, P6530, DOI 10.1093/emboj/20.22.6530; Wang D, 2004, MOL CANCER THER, V3, P679; Xanthoudakis S, 1996, P NATL ACAD SCI USA, V93, P8919, DOI 10.1073/pnas.93.17.8919; Xu Y, 1997, ANTICANCER RES, V17, P3713; Yamamori T, 2010, NUCLEIC ACIDS RES, V38, P832, DOI 10.1093/nar/gkp1039; Zaky A, 2008, NUCL ACIDS RES; Zou GM, 2008, MOL CANCER THER, V7, P2012, DOI 10.1158/1535-7163.MCT-08-0113; Zou GM, 2009, J CELL PHYSIOL, V219, P209, DOI 10.1002/jcp.21666	69	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68467	10.1371/journal.pone.0068467	http://dx.doi.org/10.1371/journal.pone.0068467			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874636	gold, Green Published, Green Submitted			2022-12-27	WOS:000322064300037
J	Su, YW; Chen, YP; Chen, MY; Reth, M; Tan, TH				Su, Yu-wen; Chen, Ya-ping; Chen, Ming-yu; Reth, Michael; Tan, Tse-Hua			The Serine/Threonine Phosphatase PP4 Is Required for Pro-B Cell Development through Its Promotion of Immunoglobulin VDJ Recombination	PLOS ONE			English	Article							DNA-DAMAGE CHECKPOINT; V(D)J RECOMBINATION; PROTEIN PHOSPHATASE-4; CATALYTIC SUBUNIT; BONE-MARROW; IN-VIVO; MICE; COMPLEX; REPAIR; DIFFERENTIATION	PP4 phosphatase regulates a number of crucial processes but the role of PP4 in B cells has never been reported. We generated B cell-specific pp4 knockout mice and have identified an essential role for PP4 in B cell development. Deficiency of PP4 in B lineage cells leads to a strong reduction in pre-B cell numbers, an absence in immature B cells, and a complete loss of mature B cells. In PP4-deficient pro-B cells, immunoglobulin (Ig) DJ(H) recombination is impaired and Ig m heavy chain expression is greatly decreased. In addition, PP4-deficient pro-B cells show an increase of DNA double-strand breaks at Ig loci. Consistent with their reduced numbers, residual PP4-deficient pre-B cells accumulate in the G1 phase, exhibit excessive DNA damage, and undergo increased apoptosis. Overexpression of transgenic Ig in PP4-deficient mice rescues the defect in B cell development such that the animals have normal numbers of IgM(+) B cells. Our study therefore reveals a novel function for PP4 in pro-B cell development through its promotion of V(H)DJ(H) recombination.	[Su, Yu-wen; Chen, Ya-ping; Chen, Ming-yu; Tan, Tse-Hua] Natl Hlth Res Inst, Immunol Res Ctr, Zhunan, Miaoli County, Taiwan; [Reth, Michael] Univ Freiburg, Ctr Biol Signalling Studies BIOSS, Max Planck Inst Immunobiol & Epigenet, D-79106 Freiburg, Germany; [Reth, Michael] Univ Freiburg, Fac Biol, Max Planck Inst Immunobiol & Epigenet, D-79106 Freiburg, Germany; [Tan, Tse-Hua] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA	National Health Research Institutes - Taiwan; Max Planck Society; University of Freiburg; Max Planck Society; University of Freiburg; Baylor College of Medicine	Su, YW (corresponding author), Natl Hlth Res Inst, Immunol Res Ctr, Zhunan, Miaoli County, Taiwan.	yuwensu@nhri.org.tw	Tan, Tse-Hua/E-3983-2010; Su, Yu-Wen/E-8804-2010; Tan, Tse-Hua/ABD-7080-2021	Tan, Tse-Hua/0000-0003-4969-3170; Tan, Tse-Hua/0000-0003-4969-3170	National Health Research Institutes [IM-102-PP-04]; National Science Council,Taiwan [NSC100-2320-B-400-003-MY3]	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council,Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants IM-102-PP-04 from the National Health Research Institutes (http://english.nhri.org.tw/NHRI_WEB/nhriw001Action. do) and NSC100-2320-B-400-003-MY3 from the National Science Council (http://web1.nsc.gov.tw/mp.aspx?mp=7), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALT FW, 1984, EMBO J, V3, P1209, DOI 10.1002/j.1460-2075.1984.tb01955.x; Arenzana TL, 2009, BLOOD, V113, P5857, DOI 10.1182/blood-2008-11-188888; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Bertocci B, 2003, IMMUNITY, V19, P203, DOI 10.1016/S1074-7613(03)00203-6; Brechmann M, 2012, IMMUNITY, V37, P697, DOI 10.1016/j.immuni.2012.07.014; CHANG Y, 1995, IMMUNITY, V2, P607, DOI 10.1016/1074-7613(95)90005-5; Chen GI, 2008, J BIOL CHEM, V283, P29273, DOI 10.1074/jbc.M803443200; Chen J, 1998, BIOCHEM BIOPH RES CO, V247, P827, DOI 10.1006/bbrc.1998.8792; Chen L, 2008, FEBS LETT, V582, P2843, DOI 10.1016/j.febslet.2008.07.014; Chowdhury D, 2008, MOL CELL, V31, P33, DOI 10.1016/j.molcel.2008.05.016; Dudley DD, 2005, ADV IMMUNOL, V86, P43, DOI 10.1016/S0065-2776(04)86002-4; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Gingras AC, 2005, MOL CELL PROTEOMICS, V4, P1725, DOI 10.1074/mcp.M500231-MCP200; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Gu YS, 1997, IMMUNITY, V7, P653, DOI 10.1016/S1074-7613(00)80386-6; Guidos CJ, 1996, GENE DEV, V10, P2038, DOI 10.1101/gad.10.16.2038; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Helps NR, 1998, J CELL SCI, V111, P1331; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Hu MCT, 1998, J BIOL CHEM, V273, P33561, DOI 10.1074/jbc.273.50.33561; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; Keogh MC, 2006, NATURE, V439, P497, DOI 10.1038/nature04384; Kloeker S, 1999, J BIOL CHEM, V274, P5339, DOI 10.1074/jbc.274.9.5339; Kong M, 2009, MOL CELL, V36, P51, DOI 10.1016/j.molcel.2009.09.025; Lee DH, 2010, NAT STRUCT MOL BIOL, V17, P365, DOI 10.1038/nsmb.1769; LI YS, 1993, J EXP MED, V178, P951, DOI 10.1084/jem.178.3.951; Liu JP, 2012, CELL CYCLE, V11, P2643, DOI 10.4161/cc.20957; Lyu J, 2011, CELL RES, V21, P911, DOI 10.1038/cr.2011.47; Mansilla-Soto J, 2003, J EXP MED, V197, P543, DOI 10.1084/jem.20022210; McConnell JL, 2007, ONCOGENE, V26, P6021, DOI 10.1038/sj.onc.1210406; Mihindukulasuriya KA, 2004, J BIOL CHEM, V279, P46588, DOI 10.1074/jbc.M408067200; Nakada S, 2008, EMBO REP, V9, P1019, DOI 10.1038/embor.2008.162; Ouyang H, 1997, J EXP MED, V186, P921, DOI 10.1084/jem.186.6.921; Pike KA, 2002, SEMIN IMMUNOL, V14, P351, DOI 10.1016/S1044-5323(02)00068-4; Puebla-Osorio N, 2008, IMMUNOL RES, V41, P103, DOI 10.1007/s12026-008-8015-3; RETH MG, 1986, EMBO J, V5, P2131, DOI 10.1002/j.1460-2075.1986.tb04476.x; ROTH DB, 1993, P NATL ACAD SCI USA, V90, P10788, DOI 10.1073/pnas.90.22.10788; SCHLISSEL M, 1993, GENE DEV, V7, P2520, DOI 10.1101/gad.7.12b.2520; Shui JW, 2007, MOL CELL BIOL, V27, P79, DOI 10.1128/MCB.00799-06; Smetana JHC, 2007, FEBS J, V274, P5891, DOI 10.1111/j.1742-4658.2007.06112.x; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; Sumiyoshi E, 2002, J CELL SCI, V115, P1403; Toyo-oka K, 2008, J CELL BIOL, V180, P1133, DOI 10.1083/jcb.200705148; Venkitaramani DV, 2006, BBA-MOL CELL RES, V1763, P322, DOI 10.1016/j.bbamcr.2006.02.013; Wada T, 2001, J AM SOC NEPHROL, V12, P2601, DOI 10.1681/ASN.V12122601; Zhou GS, 2002, J BIOL CHEM, V277, P6391, DOI 10.1074/jbc.M107014200	46	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68804	10.1371/journal.pone.0068804	http://dx.doi.org/10.1371/journal.pone.0068804			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874770	Green Published, Green Submitted, gold			2022-12-27	WOS:000322064300071
J	Shim, JH; Park, JY; Lee, MG; Kang, HH; Lee, TR; Shin, DW				Shim, Joong Hyun; Park, Ju-Yearl; Lee, Mi-Gi; Kang, Hak Hee; Lee, Tae Ryong; Shin, Dong Wook			Human Dermal Stem/Progenitor Cell-Derived Conditioned Medium Ameliorates Ultraviolet A-Induced Damage of Normal Human Dermal Fibroblasts	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; HUMAN ADIPOSE-TISSUE; STROMAL CELLS; GROWTH-FACTOR; MULTILINEAGE DIFFERENTIATION; OXIDATIVE STRESS; PROGENITOR CELLS; SKIN; MARROW; PRECURSORS	Adult skin stem cells are considered an attractive cell resource for therapeutic potential in aged skin. We previously reported that multipotent human dermal stem/progenitor cells (hDSPCs) can be enriched from (normal human dermal fibroblasts (NHDFs) using collagen type IV. However, the beneficial effects of hDSPCs on aged skin remain to be elucidated. In the present study, we analyzed the growth factors secreted from hDSPCs in conditioned medium (CM) derived from hDSPCs (hDSPC-CM) and found that hDSPCs secreted higher levels of bFGF, IGFBP-1, IGFBP-2, HGF, VEGF and IGF-1 compared with non-hDSPCs. We then investigated whether hDSPC-CM has an effect on ultraviolet A (UVA)-irradiated NHDFs. Real-time RT-PCR analysis revealed that the treatment of UVA-irradiated NHDFs with hDSPC-CM significantly antagonized the UVA-induced up-regulation of the MMP1 and the UVA-induced down-regulation of the collagen types I, IV and V and TIMP1 mRNA expressions. Furthermore, a scratch wound healing assay showed that hDSPC-CM enhanced the migratory properties of UVA-irradiated NHDFs. hDSPC-CM also significantly reduced the number of the early and late apoptotic cell population in UVA-irradiated NHDFs. Taken together, these data suggest that hDSPC-CM can exert some beneficial effects on aged skin and may be used as a therapeutic agent to improve skin regeneration and wound healing.	[Shim, Joong Hyun; Park, Ju-Yearl; Kang, Hak Hee; Lee, Tae Ryong; Shin, Dong Wook] Amorepacific Corp R&D Ctr, Biosci Res Inst, Yongin, Gyeonggi Do, South Korea; [Lee, Mi-Gi] GyeongGi Inst Sci & Technol Promot, Hi Tech Anal Team, GyeongGi Bioctr, Suwon, Gyeonggi Do, South Korea		Lee, TR (corresponding author), Amorepacific Corp R&D Ctr, Biosci Res Inst, Yongin, Gyeonggi Do, South Korea.	TRLee@amorepacific.com; biopang@amorepacific.com		Lee, Tae Ryong/0000-0002-6914-1237	Korea Healthcare technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A103017]	Korea Healthcare technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was partly supported by a grant of the Korea Healthcare technology R&D Project, Ministry of Health & Welfare, Republic of Korea (Grant No.: A103017). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartsch G, 2005, STEM CELLS DEV, V14, P337, DOI 10.1089/scd.2005.14.337; Bell DR, 2004, ONCOGENE, V23, P7290, DOI 10.1038/sj.onc.1207949; Biernaskie J, 2009, CELL STEM CELL, V5, P610, DOI 10.1016/j.stem.2009.10.019; Burdzinska A, 2006, COMPARATIVE MED, V56, P493; Burlacu A, 2012, STEM CELLS DEV; Chen FG, 2007, J CELL SCI, V120, P2875, DOI 10.1242/jcs.03478; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Crigler L, 2007, FASEB J, V21, P2050, DOI 10.1096/fj.06-5880com; Dorshkind K, 2009, CURR OPIN IMMUNOL, V21, P404, DOI 10.1016/j.coi.2009.07.001; Dorshkind K, 2009, NAT REV IMMUNOL, V9, P57, DOI 10.1038/nri2471; Driskell RR, 2009, DEVELOPMENT, V136, P2815, DOI 10.1242/dev.038620; Edmondson SR, 2003, ENDOCR REV, V24, P737, DOI 10.1210/er.2002-0021; Erices A, 2000, BRIT J HAEMATOL, V109, P235, DOI 10.1046/j.1365-2141.2000.01986.x; Falanga V, 2007, TISSUE ENG, V13, P1299, DOI 10.1089/ten.2006.0278; Gilchrest BA, 1996, BRIT J DERMATOL, V135, P867, DOI 10.1046/j.1365-2133.1996.d01-1088.x; Hazane-Puch F, 2010, EUR J DERMATOL, V20, P308, DOI 10.1684/ejd.2010.0934; Ionescu L, 2012, AM J PHYSIOL-LUNG C, V303, pL967, DOI 10.1152/ajplung.00144.2011; Iso Y, 2007, BIOCHEM BIOPH RES CO, V354, P700, DOI 10.1016/j.bbrc.2007.01.045; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Jones DL, 2011, NAT CELL BIOL, V13, P506, DOI 10.1038/ncb0511-506; Kirkwood TBL, 2005, EMBO REP, V6, pS4, DOI 10.1038/sj.embor.7400419; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Lorenz K, 2008, EXP DERMATOL, V17, P925, DOI 10.1111/j.1600-0625.2008.00724.x; Manini I, 2011, CELL TISSUE RES, V344, P85, DOI 10.1007/s00441-011-1139-0; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; McKenzie IA, 2006, J NEUROSCI, V26, P6651, DOI 10.1523/JNEUROSCI.1007-06.2006; Mezey E, 2003, P NATL ACAD SCI USA, V100, P1364, DOI 10.1073/pnas.0336479100; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Rahman Z. A., 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P279, DOI 10.2174/187153006778250037; Rando TA, 2006, NATURE, V441, P1080, DOI 10.1038/nature04958; Sasaki M, 2008, J IMMUNOL, V180, P2581, DOI 10.4049/jimmunol.180.4.2581; Scharffetter-Kochanek K, 2000, EXP GERONTOL, V35, P307, DOI 10.1016/S0531-5565(00)00098-X; Shibuki H, 2002, INVEST OPHTH VIS SCI, V43, P528; Shim JH, STEM CELLS IN PRESS; Shim JH, 2012, J DERMATOL SCI, V67, P202, DOI 10.1016/j.jdermsci.2012.06.007; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Toma JG, 2005, STEM CELLS, V23, P727, DOI 10.1634/stemcells.2004-0134; van Koppen Arianne, 2012, PLoS One, V7, pe38746, DOI 10.1371/journal.pone.0038746; VOJTASSA KJ, 2006, NEUROENDOCRINOL L S2, V2, P134; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; WEISSMAN IL, 2011, ANNU REV CELL DEV BI, V17, P387; Yaar M, 2007, BRIT J DERMATOL, V157, P874, DOI 10.1111/j.1365-2133.2007.08108.x; Zhang XS, 1997, FREE RADICAL BIO MED, V23, P980, DOI 10.1016/S0891-5849(97)00126-3; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	48	20	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e67604	10.1371/journal.pone.0067604	http://dx.doi.org/10.1371/journal.pone.0067604			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874431	Green Published, gold, Green Submitted			2022-12-27	WOS:000322218800007
J	Josson, S; Matsuoka, Y; Gururajan, M; Nomura, T; Huang, WC; Yang, XJ; Lin, JT; Bridgman, R; Chu, CY; Johnstone, PA; Zayzafoon, M; Hu, PZ; Zhau, HY; Berel, D; Rogatko, A; Chung, LWK				Josson, Sajni; Matsuoka, Yasuhiro; Gururajan, Murali; Nomura, Takeo; Huang, Wen-Chin; Yang, Xiaojian; Lin, Jin-tai; Bridgman, Roger; Chu, Chia-Yi; Johnstone, Peter A.; Zayzafoon, Majd; Hu, Peizhen; Zhau, Haiyen; Berel, Dror; Rogatko, Andre; Chung, Leland W. K.			Inhibition of beta 2-Microglobulin/Hemochromatosis Enhances Radiation Sensitivity by Induction of Iron Overload in Prostate Cancer Cells	PLOS ONE			English	Article							BONE METASTASIS; TRANSFERRIN RECEPTOR; CLASS-I; PROTEIN; GROWTH; APOPTOSIS; SERUM; BETA(2)-MICROGLOBULIN; EXPRESSION; CARCINOMA	Background: Bone metastasis is the most lethal form of several cancers. The beta 2-microglobulin (beta 2-M)/hemochromatosis (HFE) complex plays an important role in cancer development and bone metastasis. We demonstrated previously that overexpression of beta 2-M in prostate, breast, lung and renal cancer leads to increased bone metastasis in mouse models. Therefore, we hypothesized that beta 2-M is a rational target to treat prostate cancer bone metastasis. Results: In this study, we demonstrate the role of beta 2-M and its binding partner, HFE, in modulating radiation sensitivity and chemo-sensitivity of prostate cancer. By genetic deletion of beta 2-M or HFE or using an anti-beta 2-M antibody (Ab), we demonstrate that prostate cancer cells are sensitive to radiation in vitro and in vivo. Inhibition of beta 2-M or HFE sensitized prostate cancer cells to radiation by increasing iron and reactive oxygen species and decreasing DNA repair and stress response proteins. Using xenograft mouse model, we demonstrate that anti-beta 2-M Ab sensitizes prostate cancer cells to radiation treatment. Additionally, anti-beta 2-M Ab was able to prevent tumor growth in an immunocompetent spontaneous prostate cancer mouse model. Since bone metastasis is lethal, we used a bone xenograft model to test the ability of anti-beta 2-M Ab and radiation to block tumor growth in the bone. Combination treatment significantly prevented tumor growth in the bone xenograft model by inhibiting beta 2-M and inducing iron overload. In addition to radiation sensitive effects, inhibition of beta 2-M sensitized prostate cancer cells to chemotherapeutic agents. Conclusion: Since prostate cancer bone metastatic patients have high beta 2-M in the tumor tissue and in the secreted form, targeting beta 2-M with anti-beta 2-M Ab is a promising therapeutic agent. Additionally, inhibition of beta 2-M sensitizes cancer cells to clinically used therapies such as radiation by inducing iron overload and decreasing DNA repair enzymes.	[Josson, Sajni; Matsuoka, Yasuhiro; Gururajan, Murali; Huang, Wen-Chin; Yang, Xiaojian; Lin, Jin-tai; Chu, Chia-Yi; Hu, Peizhen; Zhau, Haiyen; Chung, Leland W. K.] Cedars Sinai Med Ctr, Dept Med, Samuel Oschin Comprehens Canc Inst, Urooncol Res Program, Los Angeles, CA 90048 USA; [Nomura, Takeo] Emory Univ, Sch Med, Atlanta, GA USA; [Bridgman, Roger] Auburn Univ, Hybridoma Facil, Auburn, AL 36849 USA; [Johnstone, Peter A.] Indiana Univ Sch Med, Bloomington, IN USA; [Zayzafoon, Majd] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Berel, Dror; Rogatko, Andre] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; Emory University; Auburn University System; Auburn University; Indiana University System; Indiana University Bloomington; University of Alabama System; University of Alabama Birmingham; Cedars Sinai Medical Center	Josson, S (corresponding author), Cedars Sinai Med Ctr, Dept Med, Samuel Oschin Comprehens Canc Inst, Urooncol Res Program, Los Angeles, CA 90048 USA.	Sajni.Josson@cshs.org; Leland.Chung@cshs.org	Huang, Wen-Chin/X-5879-2019	Huang, Wen-Chin/0000-0003-2342-9099	National Institutes of Health/National Cancer Institute [PO1CA098912, RO1CA122602]; NATIONAL CANCER INSTITUTE [P01CA098912, R01CA122602] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported in part by research grants PO1CA098912 and RO1CA122602 from the National Institutes of Health/National Cancer Institute (LWK Chung). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari S, 2008, ANTI-CANCER AGENT ME, V8, P351, DOI 10.2174/187152008784220366; Feder JN, 1998, P NATL ACAD SCI USA, V95, P1472, DOI 10.1073/pnas.95.4.1472; Feder JN, 1997, J BIOL CHEM, V272, P14025, DOI 10.1074/jbc.272.22.14025; Foster BA, 1997, CANCER RES, V57, P3325; Garre P, 2011, CLIN CANCER RES, V17, P1701, DOI 10.1158/1078-0432.CCR-10-2491; Gross M, 2007, CLIN CANCER RES, V13, P1979, DOI 10.1158/1078-0432.CCR-06-1156; Gururajan M, 2008, J IMMUNOL, V181, P4590, DOI 10.4049/jimmunol.181.7.4590; HEMMINGSEN L, 1977, SCAND J UROL NEPHROL, V11, P41, DOI 10.3109/00365597709179690; Huang WC, 2005, CANCER RES, V65, P2303, DOI 10.1158/0008-5472.CAN-04-3448; Huang WC, 2008, CLIN CANCER RES, V14, P5341, DOI 10.1158/1078-0432.CCR-08-0793; Huang WC, 2006, CANCER RES, V66, P9108, DOI 10.1158/0008-5472.CAN-06-1996; Huang WC, 2010, J BIOL CHEM, V285, P7947, DOI 10.1074/jbc.M109.092759; Josson S, 2006, ONCOGENE, V25, P1554, DOI 10.1038/sj.onc.1209186; Josson S, 2008, PROSTATE, V68, P1599, DOI 10.1002/pros.20827; Josson S, 2011, CANCER RES, V71, P2600, DOI 10.1158/0008-5472.CAN-10-3382; Kuvibidila S, 2004, J LAB CLIN MED, V144, P176, DOI 10.1016/j.lab.2004.03.017; Muckenthaler MU, 2004, BLOOD CELL MOL DIS, V33, P125, DOI 10.1016/j.bcmd.2004.05.003; Nomura T, 2007, J UROLOGY, V178, P292, DOI 10.1016/j.juro.2007.03.007; Rothenberg BE, 1996, P NATL ACAD SCI USA, V93, P1529, DOI 10.1073/pnas.93.4.1529; Shiota M, 2013, CANC RES; SHUSTER J, 1976, CLIN CHIM ACTA, V67, P307, DOI 10.1016/0009-8981(76)90339-9; Stevens RG, 2000, RADIAT RES, V154, P725; TEASDALE C, 1977, CLIN CHIM ACTA, V78, P135, DOI 10.1016/0009-8981(77)90346-1; Teng Y, 2012, J BIOL CHEM, V287, P10051, DOI 10.1074/jbc.M111.335000; THALMANN GN, 1994, CANCER RES, V54, P2577; Ward DG, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-19; Wu D, 2007, ONCOGENE, V26, P5070, DOI 10.1038/sj.onc.1210316; Yang J, 2007, BLOOD, V110, P3028, DOI 10.1182/blood-2007-06-094417; Yang J, 2006, CANCER CELL, V10, P295, DOI 10.1016/j.ccr.2006.08.025; Yang XJ, 2010, CLIN CANCER RES, V16, P2833, DOI 10.1158/1078-0432.CCR-10-0059; Zhau Haiyen E., 2000, Cancer, V88, P2995, DOI 10.1002/1097-0142(20000615)88:12+<2995::AID-CNCR15>3.0.CO;2-Y	31	12	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68366	10.1371/journal.pone.0068366	http://dx.doi.org/10.1371/journal.pone.0068366			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874600	gold, Green Published, Green Submitted			2022-12-27	WOS:000321765300045
J	Koumandou, VL; Scorilas, A				Koumandou, Vassiliki Lila; Scorilas, Andreas			Evolution of the Plasma and Tissue Kallikreins, and Their Alternative Splicing Isoforms	PLOS ONE			English	Article							PROSTATE-SPECIFIC ANTIGEN; MULTIPLE SEQUENCE ALIGNMENT; KININ SYSTEM; PROTEIN ISOFORMS; SERINE PROTEASES; GENE FAMILY; IDENTIFICATION; PEPTIDASES; EXPRESSION; HORMONE	Kallikreins are secreted serine proteases with important roles in human physiology. Human plasma kallikrein, encoded by the KLKB1 gene on locus 4q34-35, functions in the blood coagulation pathway, and in regulating blood pressure. The human tissue kallikrein and kallikrein-related peptidases (KLKs) have diverse expression patterns and physiological roles, including cancer-related processes such as cell growth regulation, angiogenesis, invasion, and metastasis. Prostate-specific antigen (PSA), the product of the KLK3 gene, is the most widely used biomarker in clinical practice today. A total of 15 KLKs are encoded by the largest contiguous cluster of protease genes in the human genome (19q13.3-13.4), which makes them ideal for evolutionary analysis of gene duplication events. Previous studies on the evolution of KLKs have traced mammalian homologs as well as a probable early origin of the family in aves, amphibia and reptilia. The aim of this study was to address the evolutionary and functional relationships between tissue KLKs and plasma kallikrein, and to examine the evolution of alternative splicing isoforms. Sequences of plasma and tissue kallikreins and their alternative transcripts were collected from the NCBI and Ensembl databases, and comprehensive phylogenetic analysis was performed by Bayesian as well as maximum likelihood methods. Plasma and tissue kallikreins exhibit high sequence similarity in the trypsin domain (>50%). Phylogenetic analysis indicates an early divergence of KLKB1, which groups closely with plasminogen, chymotrypsin, and complement factor D (CFD), in a monophyletic group distinct from trypsin and the tissue KLKs. Reconstruction of the earliest events leading to the diversification of the tissue KLKs is not well resolved, indicating rapid expansion in mammals. Alternative transcripts of each KLK gene show species-specific divergence, while examination of sequence conservation indicates that many annotated human KLK isoforms are missing the catalytic triad that is crucial for protease activity.	[Koumandou, Vassiliki Lila; Scorilas, Andreas] Univ Athens, Dept Biochem & Mol Biol, Athens, Greece	National & Kapodistrian University of Athens	Scorilas, A (corresponding author), Univ Athens, Dept Biochem & Mol Biol, Athens, Greece.	ascorilas@biol.uoa.gr	Koumandou, V. Lila/AAP-4224-2021	Koumandou, V. Lila/0000-0002-0624-0190; Scorilas, Andreas/0000-0003-2427-4949	Commission of the European Community through the INsPiRE project [EU-FP7-REGPOT-2011-1, 284460]	Commission of the European Community through the INsPiRE project	This work was financially supported by the Commission of the European Community through the INsPiRE project (EU-FP7-REGPOT-2011-1, proposal 284460) (http://ec.europa.eu/research/index.cfm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Angelopoulou K, 2009, MAMM GENOME, V20, P758, DOI 10.1007/s00335-009-9237-y; Angelopoulou K, 2009, GENE, V446, P68, DOI 10.1016/j.gene.2009.07.007; Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; Borgono CA, 2004, MOL CANCER RES, V2, P257; Clark NL, 2005, PLOS GENET, V1, P335, DOI 10.1371/journal.pgen.0010035; Clements JA, 2004, CRIT REV CL LAB SCI, V41, P265, DOI 10.1080/10408360490471931; CLEMENTS JA, 1989, ENDOCR REV, V10, P393, DOI 10.1210/edrv-10-4-393; Debela M, 2008, BIOL CHEM, V389, P623, DOI 10.1515/BC.2008.075; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elliott MB, 2006, GENOMICS, V88, P591, DOI 10.1016/j.ygeno.2006.06.001; Ezkurdia I, 2012, MOL BIOL EVOL, V29, P2265, DOI 10.1093/molbev/mss100; Gharib WH, 2011, BRIEF BIOINFORM, V12, P436, DOI 10.1093/bib/bbr031; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Herwald H, 1996, J BIOL CHEM, V271, P13061, DOI 10.1074/jbc.271.22.13061; Irimia M, 2009, BIOESSAYS, V31, P40, DOI 10.1002/bies.080092; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Kim E, 2008, BIOESSAYS, V30, P38, DOI 10.1002/bies.20692; Kraut H, 1930, H-S Z PHYSIOL CHEM, V189, P97, DOI 10.1515/bchm2.1930.189.3-4.97; Krem MM, 2001, EMBO J, V20, P3036, DOI 10.1093/emboj/20.12.3036; Kurlender L, 2005, BBA-REV CANCER, V1755, P1, DOI 10.1016/j.bbcan.2005.02.001; Lawrence MG, 2010, ENDOCR REV, V31, P407, DOI 10.1210/er.2009-0034; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; Lundwall A, 2006, BIOL CHEM, V387, P637, DOI 10.1515/BC.2006.082; LUNDWALL A, 1987, FEBS LETT, V214, P317, DOI 10.1016/0014-5793(87)80078-9; Luo LY, 2006, TUMOR BIOL, V27, P227, DOI 10.1159/000094693; MADDISON WP, 1989, FOLIA PRIMATOL, V53, P190, DOI 10.1159/000156416; Madeddu P, 2007, NAT CLIN PRACT NEPHR, V3, P208, DOI 10.1038/ncpneph0444; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Marques PI, 2012, GENOME BIOL EVOL, V4, P1331, DOI 10.1093/gbe/evs111; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; Modrek B, 2003, NAT GENET, V34, P177, DOI 10.1038/ng1159; Mudge JM, 2011, MOL BIOL EVOL, V28, P2949, DOI 10.1093/molbev/msr127; Page MJ, 2008, CELL MOL LIFE SCI, V65, P1220, DOI 10.1007/s00018-008-7565-9; Pampalakis G, 2008, COMPUT BIOL CHEM, V32, P111, DOI 10.1016/j.compbiolchem.2007.11.002; Pavlopoulou A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013781; Pepin D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026075; Prensner JR, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003180; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sainz IM, 2007, THROMB HAEMOSTASIS, V98, P77, DOI 10.1160/Th07-04-0250; SCHEDLICH LJ, 1987, DNA-J MOLEC CELL BIO, V6, P429, DOI 10.1089/dna.1987.6.429; Schmaier AH, 2007, J THROMB HAEMOST, V5, P2323, DOI 10.1111/j.1538-7836.2007.02770.x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sun XY, 2001, CARCINOGENESIS, V22, P1775, DOI 10.1093/carcin/22.11.1775; Tan OL, 2006, BIOL CHEM, V387, P697, DOI 10.1515/BC.2006.088; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WATT KWK, 1986, P NATL ACAD SCI USA, V83, P3166, DOI 10.1073/pnas.83.10.3166; Williams SA, 2007, PROSTATE, V67, P312, DOI 10.1002/pros.20531; Williams SA, 2011, PROSTATE, V71, P1595, DOI 10.1002/pros.21375; Xu Q, 2003, NUCLEIC ACIDS RES, V31, P5635, DOI 10.1093/nar/gkg786; Yousef GM, 2000, BIOCHEM BIOPH RES CO, V276, P125, DOI 10.1006/bbrc.2000.3448; Yousef GM, 2003, BIOCHEM BIOPH RES CO, V305, P28, DOI 10.1016/S0006-291X(03)00638-7; Yousef GM, 2001, ENDOCR REV, V22, P184, DOI 10.1210/er.22.2.184; Zambelli F, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-534	58	32	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68074	10.1371/journal.pone.0068074	http://dx.doi.org/10.1371/journal.pone.0068074			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874499	gold, Green Published, Green Submitted			2022-12-27	WOS:000321765300025
J	Lopman, B; Vicuna, Y; Salazar, F; Broncano, N; Esona, MD; Sandoval, C; Gregoricus, N; Bowen, MD; Payne, D; Vaca, M; Chico, M; Parashar, U; Cooper, PJ				Lopman, Ben; Vicuna, Yosselin; Salazar, Fabian; Broncano, Nely; Esona, Matthew D.; Sandoval, Carlos; Gregoricus, Nicole; Bowen, Michael D.; Payne, Daniel; Vaca, Martiza; Chico, Martha; Parashar, Umesh; Cooper, Philip J.			Household Transmission of Rotavirus in a Community with Rotavirus Vaccination in Quininde, Ecuador	PLOS ONE			English	Article							TIME RT-PCR; GASTROENTERITIS; CHILDREN; DISEASE; REDUCTION; INFECTION; EFFICACY; SAMPLES; SAFETY; STATES	Background: We studied the transmission of rotavirus infection in households in peri-urban Ecuador in the vaccination era. Methods: Stool samples were collected from household contacts of child rotavirus cases, diarrhea controls and healthy controls following presentation of the index child to health facilities. Rotavirus infection status of contacts was determined by RT-qPCR. We examined factors associated with transmissibility (index-case characteristics) and susceptibility (householdcontact characteristics). Results: Amongst cases, diarrhea controls and healthy control household contacts, infection attack rates (iAR) were 55%, 8% and 2%, (n = 137, 130, 137) respectively. iARs were higher from index cases with vomiting, and amongst siblings. Disease ARs were higher when the index child was,18 months and had vomiting, with household contact,10 years and those sharing a room with the index case being more susceptible. We found no evidence of asymptomatic infections leading to disease transmission. Conclusion: Transmission rates of rotavirus are high in households with an infected child, while background infections are rare. We have identified factors associated with transmission (vomiting/young age of index case) and susceptibility (young age/sharing a room/being a sibling of the index case). Vaccination may lead to indirect benefits by averting episodes or reducing symptoms in vaccinees.	[Lopman, Ben; Esona, Matthew D.; Gregoricus, Nicole; Bowen, Michael D.; Payne, Daniel; Parashar, Umesh] Ctr Dis Control & Prevent, Div Viral Dis, Atlanta, GA 30329 USA; [Vicuna, Yosselin; Cooper, Philip J.] Fdn Ecuatoriana Invest Salud, Quininde, Esmeraldas Prov, Ecuador; [Vicuna, Yosselin; Salazar, Fabian; Broncano, Nely; Sandoval, Carlos; Vaca, Martiza; Chico, Martha; Cooper, Philip J.] Univ San Francisco Quito, Quito, Ecuador; [Cooper, Philip J.] Univ Liverpool, Liverpool Sch Trop Med, Dept Parasitol, Liverpool L3 5QA, Merseyside, England	Centers for Disease Control & Prevention - USA; Liverpool School of Tropical Medicine; University of Liverpool	Lopman, B (corresponding author), Ctr Dis Control & Prevent, Div Viral Dis, Atlanta, GA 30329 USA.	blopman@cdc.gov	Garcés, Luis Fabian Salazar/AAT-5083-2020	Garcés, Luis Fabian Salazar/0000-0002-5128-7211	Centers for Disease Control and Prevention	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funding was provided by Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar CFL, 2005, DIAGN MOL PATHOL, V14, P90, DOI 10.1097/01.pas.0000162752.61155.d1; Buttery JP, 2011, PEDIATR INFECT DIS J, V30, pS25, DOI 10.1097/INF.0b013e3181fefdee; Cooper PJ, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-184; Curns AT, 2010, J INFECT DIS, V201, P1617, DOI 10.1086/652403; Das BK, 1994, J CLIN MICROBIOL, V32, P1820; Esona MD, 2009, J MED VIROL, V81, P937, DOI 10.1002/jmv.21468; ESTES MK, 1989, MICROBIOL REV, V53, P410, DOI 10.1128/MMBR.53.4.410-449.1989; Freeman MM, 2008, J MED VIROL, V80, P1489, DOI 10.1002/jmv.21228; GENTSCH JR, 1992, J CLIN MICROBIOL, V30, P1365, DOI 10.1128/JCM.30.6.1365-1373.1992; Nelson EAS, 2010, LANCET, V376, P568, DOI 10.1016/S0140-6736(10)60896-3; Parashar UD, 2003, EMERG INFECT DIS, V9, P565, DOI 10.3201/eid0905.020562; Phillips G, 2009, J CLIN VIROL, V44, P242, DOI 10.1016/j.jcv.2008.12.001; Rohayem J, 2004, J VIROL METHODS, V118, P49, DOI 10.1016/j.jviromet.2004.01.016; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; SACK DA, 1980, J CLIN MICROBIOL, V11, P530, DOI 10.1128/JCM.11.5.530-532.1980; Staat A. M., 2008, Morbidity and Mortality Weekly Report, V57, P697; Velazquez FR, 2000, J INFECT DIS, V182, P1602, DOI 10.1086/317619; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664	18	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e67763	10.1371/journal.pone.0067763	http://dx.doi.org/10.1371/journal.pone.0067763			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874443	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000321736900020
J	Verma, RK; Slotboom, J; Heldner, MR; Kellner-Weldon, F; Kottke, R; Ozdoba, C; Weisstanner, C; Kamm, CP; Wiest, R				Verma, Rajeev Kumar; Slotboom, Johannes; Heldner, Mirjam Rahel; Kellner-Weldon, Frauke; Kottke, Raimund; Ozdoba, Christoph; Weisstanner, Christian; Kamm, Christian Philipp; Wiest, Roland			Characterization of Microcirculation in Multiple Sclerosis Lesions by Dynamic Texture Parameter Analysis (DTPA)	PLOS ONE			English	Article							MAGNETIC-RESONANCE; WHITE-MATTER; HEMODYNAMIC IMPAIRMENT; IMAGES; HETEROGENEITY; PATHOLOGY; MRI	Objective: Texture analysis is an alternative method to quantitatively assess MR-images. In this study, we introduce dynamic texture parameter analysis (DTPA), a novel technique to investigate the temporal evolution of texture parameters using dynamic susceptibility contrast enhanced (DSCE) imaging. Here, we aim to introduce the method and its application on enhancing lesions (EL), non-enhancing lesions (NEL) and normal appearing white matter (NAWM) in multiple sclerosis (MS). Methods: We investigated 18 patients with MS and clinical isolated syndrome (CIS), according to the 2010 McDonald's criteria using DSCE imaging at different field strengths (1.5 and 3 Tesla). Tissues of interest (TOIs) were defined within 27 EL, 29 NEL and 37 NAWM areas after normalization and eight histogram-based texture parameter maps (TPMs) were computed. TPMs quantify the heterogeneity of the TOI. For every TOI, the average, variance, skewness, kurtosis and variance-of-the-variance statistical parameters were calculated. These TOI parameters were further analyzed using one-way ANOVA followed by multiple Wilcoxon sum rank testing corrected for multiple comparisons. Results: Tissue-and time-dependent differences were observed in the dynamics of computed texture parameters. Sixteen parameters discriminated between EL, NEL and NAWM (pAVG = 0.0005). Significant differences in the DTPA texture maps were found during inflow (52 parameters), outflow (40 parameters) and reperfusion (62 parameters). The strongest discriminators among the TPMs were observed in the variance-related parameters, while skewness and kurtosis TPMs were in general less sensitive to detect differences between the tissues. Conclusion: DTPA of DSCE image time series revealed characteristic time responses for ELs, NELs and NAWM. This may be further used for a refined quantitative grading of MS lesions during their evolution from acute to chronic state. DTPA discriminates lesions beyond features of enhancement or T2-hypersignal, on a numeric scale allowing for a more subtle grading of MS-lesions.	[Verma, Rajeev Kumar; Slotboom, Johannes; Kellner-Weldon, Frauke; Kottke, Raimund; Ozdoba, Christoph; Weisstanner, Christian; Wiest, Roland] Univ Bern, Inselspital, Support Ctr Adv Neuroimaging, Univ Inst Diagnost & Intervent Neuroradiol, CH-3010 Bern, Switzerland; [Heldner, Mirjam Rahel; Kamm, Christian Philipp] Univ Hosp Bern, Inselspital, Dept Neurol, CH-3010 Bern, Switzerland; [Heldner, Mirjam Rahel; Kamm, Christian Philipp] Univ Bern, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern	Slotboom, J (corresponding author), Univ Bern, Inselspital, Support Ctr Adv Neuroimaging, Univ Inst Diagnost & Intervent Neuroradiol, CH-3010 Bern, Switzerland.	johannes.slotboom@insel.ch		Kellner-Weldon, Frauke/0000-0002-6019-0147; Kottke, Raimund/0000-0003-0166-2770; Ozdoba, Christoph/0000-0002-9382-9621; Weisstanner, Christian/0000-0003-2830-1000; Heldner, Mirjam R/0000-0002-3594-2159	Swiss Multiple Sclerosis Society; Swiss National Science Foundation	Swiss Multiple Sclerosis Society; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The funders (Swiss Multiple Sclerosis Society, and Swiss National Science Foundation) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhya S, 2006, NEUROIMAGE, V33, P1029, DOI 10.1016/j.neuroimage.2006.08.008; Alonso A, 2008, NEUROLOGY, V71, P129, DOI 10.1212/01.wnl.0000316802.35974.34; Barnett MH, 2004, ANN NEUROL, V55, P458, DOI 10.1002/ana.20016; Bernasconi A, 2001, ANN NEUROL, V49, P770, DOI 10.1002/ana.1013; Dani KA, 2012, STROKE, V43, P563, DOI 10.1161/STROKEAHA.111.629923; De Keyser J, 2008, J CEREBR BLOOD F MET, V28, P1645, DOI 10.1038/jcbfm.2008.72; Dhermain FG, 2010, LANCET NEUROL, V9, P906, DOI 10.1016/S1474-4422(10)70181-2; Eliat PA, 2001, ANTICANCER RES, V21, P3857; Engelhardt B, 2009, SEMIN IMMUNOPATHOL, V31, P497, DOI 10.1007/s00281-009-0177-0; Gay F, 2007, J NEUROL SCI, V262, P105, DOI 10.1016/j.jns.2007.07.002; Ge YL, 2005, AM J NEURORADIOL, V26, P1539; Ge YL, 2009, J MAGN RESON IMAGING, V29, P1190, DOI 10.1002/jmri.21758; Gibbs P, 2003, MAGN RESON MED, V50, P92, DOI 10.1002/mrm.10496; Haselhorst R, 2000, JMRI-J MAGN RESON IM, V11, P495, DOI 10.1002/(SICI)1522-2586(200005)11:5<495::AID-JMRI5>3.0.CO;2-S; Jirak D, 2002, J MAGN RESON IMAGING, V15, P68, DOI 10.1002/jmri.10042; Kassner A, 2010, AM J NEURORADIOL, V31, P809, DOI 10.3174/ajnr.A2061; Kutzelnigg A, 2005, BRAIN, V128, P2705, DOI 10.1093/brain/awh641; Lassmann H, 2001, TRENDS MOL MED, V7, P115, DOI 10.1016/S1471-4914(00)01909-2; Law M, 2004, RADIOLOGY, V231, P645, DOI 10.1148/radiol.2313030996; Materka Andrzej, 2004, Dialogues Clin Neurosci, V6, P243; Mathias JM, 1999, MAGN RESON MED, V42, P929, DOI 10.1002/(SICI)1522-2594(199911)42:5<929::AID-MRM13>3.0.CO;2-2; MEIER P, 1954, J APPL PHYSIOL, V6, P731, DOI 10.1152/jappl.1954.6.12.731; Ostergaard L, 1996, MAGNET RESON MED, V36, P726, DOI 10.1002/mrm.1910360511; Parry A, 2002, J NEUROL, V249, P1279, DOI 10.1007/s00415-002-0837-7; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Simka M, 2009, CURR NEUROVASC RES, V6, P132, DOI 10.2174/156720209788185605; Slotboom J, 2008, INVEST RADIOL, V43, P843, DOI 10.1097/RLI.0b013e3181893605; Szczypinski PM, 2009, MED IMAGE ANAL, V13, P312, DOI 10.1016/j.media.2008.12.002; Szczypinski PM, 2009, COMPUT METH PROG BIO, V94, P66, DOI 10.1016/j.cmpb.2008.08.005; Wiest R, 2006, EPILEPSY RES, V72, P102, DOI 10.1016/j.eplepsyres.2006.07.017; Wuerfel J, 2004, BRAIN, V127, P111, DOI 10.1093/brain/awh007; Yu O, 2004, MAGN RESON IMAGING, V22, P1139, DOI 10.1016/j.mri.2004.08.017; Yu O, 1999, MAGN RESON IMAGING, V17, P1261, DOI 10.1016/S0730-725X(99)00062-4; Zhang YY, 2012, INT J BIOMED IMAGING, V2012, DOI 10.1155/2012/762804; Zhang YY, 2011, MULT SCLER J, V17, P532, DOI 10.1177/1352458510395981; Zhang YY, 2009, NEUROIMAGE, V47, P107, DOI 10.1016/j.neuroimage.2009.03.075	36	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e67610	10.1371/journal.pone.0067610	http://dx.doi.org/10.1371/journal.pone.0067610			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874432	Green Published, Green Submitted, gold			2022-12-27	WOS:000322064300010
J	Xu, YM; Wang, H; Bao, SS; Tabassam, F; Cai, W; Xiang, XG; Zhao, GD; Wu, HQ; Gao, T; Li, H; Xie, Q				Xu, Yumin; Wang, Hui; Bao, Shishan; Tabassam, Fazal; Cai, Wei; Xiang, Xiaogang; Zhao, Gangde; Wu, Haiqing; Gao, Ting; Li, Hai; Xie, Qing			Amelioration of Liver Injury by Continuously Targeted Intervention against TNFRp55 in Rats with Acute-on-Chronic Liver Failure	PLOS ONE			English	Article							FULMINANT HEPATIC-FAILURE; NECROSIS-FACTOR-ALPHA; HEPATOCYTE APOPTOSIS; INTERLEUKIN-22; MICE; EXPRESSION; ROLES; IL-22; MODEL	Background: Acute-on-chronic liver failure (ACLF) is an acute deterioration of established liver disease. Blocking the TNF (tumor necrosis factor)/TNFR (tumor necrosis factor receptor) 1 pathway may reduce hepatocyte apoptosis/necrosis, and subsequently decrease mortality during development of ACLF. We demonstrated that a long-acting TNF antagonist (soluble TNF receptor:IgG Fc [sTNFR:IgG-Fc]) prevented/reduced development of acute liver failure by blocking the TNF/TNFR1 (TNFRp55) pathway. However, it is still unclear if sTNFR:IgG-Fc can inhibit hepatocyte damage during development of ACLF. Methodology: Chronic liver disease (liver fibrosis/cirrhosis) was induced in Wistar rats by repeatedly challenging with human serum albumin (HSA), and confirmed by histopathology. ACLF was induced with D-galactosamine (D-GalN)/lipopolysaccharide (LPS) i.p. in the rats with chronic liver disease. Serum and liver were collected for biochemical, pathological and molecular biological examinations. Principal Findings: Reduced mortality was observed in sTNFR:IgG-Fc treated ACLF rats, consistent with reduced interleukin (IL)-6 levels in serum and liver, as well as reduced hepatic caspase-3 activity, compared to that of mock treated group. Reduced hepatic damage was confirmed with histopathology in the sTNFR:IgG-Fc treated group, which is consistent with reduced Bcl-2 and Bax, at mRNA and protein levels, but increased hepatocyte proliferation (PCNA). This is also supported by the findings that caspase-3 production was up-regulated significantly in ACLF group compared to the mock treated group. Moreover, up-regulated caspase-3 was inhibited following sTNFR:IgG-Fc treatment. Finally, there was up-regulation of hepatic IL-22R in sTNFR:IgG-Fc treated ACLF rats. Conclusions: sTNFR:IgG-Fc improved survival rate during development of ACLF via ameliorating liver injury with a potential therapeutic value.	[Xu, Yumin; Wang, Hui; Cai, Wei; Xiang, Xiaogang; Zhao, Gangde; Wu, Haiqing; Xie, Qing] Shanghai Jiao Tong Univ, Dept Infect Dis, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China; [Bao, Shishan] Univ Sydney, Discipline Pathol, Bosch Inst, Sydney, NSW 2006, Australia; [Bao, Shishan] Univ Sydney, Sch Med Sci, Sydney, NSW 2006, Australia; [Tabassam, Fazal] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Gao, Ting; Li, Hai] Shanghai Jiao Tong Univ, Dept Gastroenterol, Renji Hosp,Sch Med,Shanghai Insst Digest Dis, Key Lab Gastroenterol & Hepatol,Minist Hlth, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; University of Sydney; University of Sydney; Baylor College of Medicine; Shanghai Jiao Tong University	Li, H (corresponding author), Shanghai Jiao Tong Univ, Dept Gastroenterol, Renji Hosp,Sch Med,Shanghai Insst Digest Dis, Key Lab Gastroenterol & Hepatol,Minist Hlth, Shanghai 200030, Peoples R China.	haili_17@yahoo.com; xieqingrj@gmail.com	xiaogang, xiang/GXN-4124-2022; Bao, Shisan/C-6072-2014; Bao, Shisan/AAF-6464-2020	Bao, Shisan/0000-0002-6687-3846	National Science and Technology Major Project [2008ZX10002-005, 2008ZX10002-007, 2008ZX09312-007]; New drugs R&D funds of Chinese 11th Five-Year Plan [2009ZX09103-660]; Shanghai Sanitation Bureau Project [2010076]; PhD Innovation Project [BXJ201110]; Outstanding Doctoral Dissertation Incubation Program of Shanghai Jiaotong University School of Medicine	National Science and Technology Major Project; New drugs R&D funds of Chinese 11th Five-Year Plan; Shanghai Sanitation Bureau Project; PhD Innovation Project; Outstanding Doctoral Dissertation Incubation Program of Shanghai Jiaotong University School of Medicine	This work was supported by the National Science and Technology Major Project [Grants 2008ZX10002-005, 2008ZX10002-007, 2008ZX09312-007]; the New drugs R&D funds of Chinese 11th Five-Year Plan [Grant 2009ZX09103-660]; Shanghai Sanitation Bureau Project [Grant 2010076]; the PhD Innovation Project [Grant BXJ201110] and the Outstanding Doctoral Dissertation Incubation Program of Shanghai Jiaotong University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2001, J INTERF CYTOK RES, V21, P1047, DOI 10.1089/107999001317205178; An FM, 2012, APOPTOSIS, V17, P702, DOI 10.1007/s10495-012-0704-7; Cazzaniga M, 2009, J HEPATOL, V51, P475, DOI 10.1016/j.jhep.2009.04.017; Cheng EHY, 1997, P NATL ACAD SCI USA, V94, P690, DOI 10.1073/pnas.94.2.690; Deng CY, 2012, J PHARMACOL EXP THER, V341, P146, DOI 10.1124/jpet.111.189498; Fujii T, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-79; Gao T, 2012, J HEPATOL, V56, pS101, DOI 10.1016/S0168-8278(12)60254-2; Hatano E, 2007, J GASTROEN HEPATOL, V22, pS43, DOI 10.1111/j.1440-1746.2006.04645.x; James LP, 2003, DRUG METAB DISPOS, V31, P1499, DOI 10.1124/dmd.31.12.1499; Ki SH, 2010, HEPATOLOGY, V52, P1291, DOI 10.1002/hep.23837; LEIST M, 1995, J IMMUNOL, V154, P1307; Liu Q, 2009, BLOOD PURIFICAT, V28, P331, DOI 10.1159/000232940; Ni HM, 2008, AM J PATHOL, V173, P962, DOI 10.2353/ajpath.2008.080358; Park JS, 2011, NEUROIMAGE, V56, P174, DOI 10.1016/j.neuroimage.2011.01.065; Patel S, 2010, INT J CARDIOL, V145, P183, DOI 10.1016/j.ijcard.2009.05.024; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Salama SM, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-56; Sarin SK, 2009, HEPATOL INT, V3, P269, DOI 10.1007/s12072-008-9106-x; Streetz K, 2000, GASTROENTEROLOGY, V119, P446, DOI 10.1053/gast.2000.9364; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Xiang XG, 2012, IMMUNOL CELL BIOL, V90, P611, DOI 10.1038/icb.2011.79; Xing WW, 2011, CYTOKINE, V56, P174, DOI 10.1016/j.cyto.2011.07.022; Yang L, 2010, J HEPATOL, V53, P339, DOI 10.1016/j.jhep.2010.03.004; Zhan J, 2012, BIOTECHNOL LETT, V34, P417, DOI 10.1007/s10529-011-0793-3	24	14	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68757	10.1371/journal.pone.0068757	http://dx.doi.org/10.1371/journal.pone.0068757			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874752	Green Published, gold, Green Submitted			2022-12-27	WOS:000322064300069
J	Cebula, M; Ochel, A; Hillebrand, U; Pils, MC; Schirmbeck, R; Hauser, H; Wirth, D				Cebula, Marcin; Ochel, Aaron; Hillebrand, Upneet; Pils, Marina C.; Schirmbeck, Reinhold; Hauser, Hansjoerg; Wirth, Dagmar			An Inducible Transgenic Mouse Model for Immune Mediated Hepatitis Showing Clearance of Antigen Expressing Hepatocytes by CD8+T Cells	PLOS ONE			English	Article							CD8(+) T-CELLS; B VIRUS-INFECTION; AUTOIMMUNE HEPATITIS; CRE RECOMBINASE; HBV INFECTION; LIVER; ACTIVATION; DISEASE; MICE; DYSFUNCTION	The liver has the ability to prime immune responses against neo antigens provided upon infections. However, T cell immunity in liver is uniquely modulated by the complex tolerogenic property of this organ that has to also cope with foreign agents such as endotoxins or food antigens. In this respect, the nature of intrahepatic T cell responses remains to be fully characterized. To gain deeper insight into the mechanisms that regulate the CD8+ T cell responses in the liver, we established a novel OVA_X_CreER(T2) mouse model. Upon tamoxifen administration OVA antigen expression is observed in a fraction of hepatocytes, resulting in a mosaic expression pattern. To elucidate the cross-talk of CD8+ T cells with antigen-expressing hepatocytes, we adoptively transferred K-b/OVA257-264-specific OT-I T cells to OVA_X_CreER(T2) mice or generated triple transgenic OVA_X CreER(T2)_X_OT-I mice. OT-I T cells become activated in OVA_X_CreER(T2) mice and induce an acute and transient hepatitis accompanied by liver damage. In OVA_X_CreER(T2)_X_OT-I mice, OVA induction triggers an OT-I T cell mediated, fulminant hepatitis resulting in 50% mortality. Surviving mice manifest a long lasting hepatitis, and recover after 9 weeks. In these experimental settings, recovery from hepatitis correlates with a complete loss of OVA expression indicating efficient clearance of the antigen-expressing hepatocytes. Moreover, a relapse of hepatitis can be induced upon re-induction of cured OVA_X_CreER(T2)_X_OT-I mice indicating absence of tolerogenic mechanisms. This pathogen-free, conditional mouse model has the advantage of tamoxifen inducible tissue specific antigen expression that reflects the heterogeneity of viral antigen expression and enables the study of intrahepatic immune responses to both de novo and persistent antigen. It allows following the course of intrahepatic immune responses: initiation, the acute phase and antigen clearance.	[Cebula, Marcin; Ochel, Aaron; Hillebrand, Upneet; Pils, Marina C.; Hauser, Hansjoerg; Wirth, Dagmar] Helmholtz Ctr Infect Res, Braunschweig, Germany; [Hauser, Hansjoerg] Univ Hosp Ulm, Ulm, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Ulm University	Wirth, D (corresponding author), Helmholtz Ctr Infect Res, Braunschweig, Germany.	Dagmar.wirth@helmholtz-hzi.de	Cebula, Marcin/ABF-8802-2021	Cebula, Marcin/0000-0003-2649-1269	Centre for Infection Biology Programme (ZIB) in the Hannover Medical University (HBRS); HZI GradSchool; EU [FlpFlex MEST-CT-2004-504990]; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) for the Cluster of Excellence REBIRTH (From Regenerative Biology to Reconstructive Therapy); German Ministry of Education and Research BMBF [FKZ 0313940]; Helmholtz Society through the SBCancer programme;  [Wi2648]	Centre for Infection Biology Programme (ZIB) in the Hannover Medical University (HBRS); HZI GradSchool(Helmholtz Association); EU(European Commission); Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) for the Cluster of Excellence REBIRTH (From Regenerative Biology to Reconstructive Therapy)(German Research Foundation (DFG)); German Ministry of Education and Research BMBF(Federal Ministry of Education & Research (BMBF)); Helmholtz Society through the SBCancer programme; 	MC was supported by the Centre for Infection Biology Programme (ZIB) in the Hannover Medical University (HBRS) and AO by the HZI GradSchool. The research was supported by funding from EU (FlpFlex MEST-CT-2004-504990), the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) for the Cluster of Excellence REBIRTH (From Regenerative Biology to Reconstructive Therapy) and Wi2648, the German Ministry of Education and Research BMBF (FKZ 0313940) and the Helmholtz Society through the SBCancer programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertolino P, 2001, J IMMUNOL, V166, P5430, DOI 10.4049/jimmunol.166.9.5430; Boni C, 2007, J VIROL, V81, P4215, DOI 10.1128/JVI.02844-06; Chisari FV, 2010, PATHOL BIOL, V58, P258, DOI 10.1016/j.patbio.2009.11.001; Crispe IN, 2003, NAT REV IMMUNOL, V3, P51, DOI 10.1038/nri981; Derkow K, 2007, HEPATOLOGY, V46, P1155, DOI 10.1002/HEP.21796; Ernst E, 2007, J MED VIROL, V79, P1103, DOI 10.1002/jmv.20911; Golden-Mason L, 2007, J VIROL, V81, P9249, DOI 10.1128/JVI.00409-07; Hartman ZC, 2007, J VIROL, V81, P1796, DOI 10.1128/JVI.01936-06; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Holz LE, 2008, GASTROENTEROLOGY, V135, P989, DOI 10.1053/j.gastro.2008.05.078; Imayoshi I, 2006, GENESIS, V44, P233, DOI 10.1002/dvg.20212; Lopes AR, 2008, J CLIN INVEST, V118, P1835, DOI 10.1172/JCI33402; Maier H, 2007, J IMMUNOL, V178, P2714, DOI 10.4049/jimmunol.178.5.2714; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Racz Z, 2011, NUCLEIC ACID THER, V21, P215, DOI 10.1089/nat.2010.0248; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Sandhu U, 2011, NUCLEIC ACIDS RES, V39, P1, DOI DOI 10.1093/NAR/GKQ742.PUBMED:20935052; Schuler M, 2004, GENESIS, V39, P167, DOI 10.1002/gene.20039; Stabenow D, 2010, HEPATOLOGY, V51, P1430, DOI 10.1002/hep.23575; Stiffler JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006661; Thimme R, 2003, J VIROL, V77, P68, DOI 10.1128/JVI.77.1.68-76.2003; Thimme R, 2002, P NATL ACAD SCI USA, V99, P15661, DOI 10.1073/pnas.202608299; Thomson AW, 2010, NAT REV IMMUNOL, V10, P753, DOI 10.1038/nri2858; Valitutti S, 1997, J EXP MED, V185, P1859, DOI 10.1084/jem.185.10.1859; Voehringer D, 2000, J IMMUNOL, V165, P2415, DOI 10.4049/jimmunol.165.5.2415; Wahl C, 2007, J IMMUNOL, V178, P2083, DOI 10.4049/jimmunol.178.4.2083; Wakita T, 2000, J MED VIROL, V62, P308, DOI 10.1002/1096-9071(200011)62:3<308::AID-JMV2>3.0.CO;2-6; Wieland SF, 2005, J VIROL, V79, P9369, DOI 10.1128/JVI.79.15.9369-9380.2005; WIRTH S, 1995, J IMMUNOL, V154, P2504; Wuensch SA, 2006, J IMMUNOL, V177, P1689, DOI 10.4049/jimmunol.177.3.1689; Yang PL, 2002, P NATL ACAD SCI USA, V99, P13825, DOI 10.1073/pnas.202398599; Zierden M, 2010, GASTROENTEROLOGY, V139, P975, DOI 10.1053/j.gastro.2010.05.075	32	8	8	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2013	8	7							e68720	10.1371/journal.pone.0068720	http://dx.doi.org/10.1371/journal.pone.0068720			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZN	23869228	Green Published, Green Submitted, gold			2022-12-27	WOS:000323110600027
J	Hagman, A; Sall, T; Compagno, C; Piskur, J				Hagman, Arne; Sall, Torbjorn; Compagno, Concetta; Piskur, Jure			Yeast "Make-Accumulate-Consume" Life Strategy Evolved as a Multi-Step Process That Predates the Whole Genome Duplication	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; KLUYVEROMYCES-LACTIS; ANAEROBIC CONDITIONS; METABOLIC FLUXES; EVOLUTION; GLUCOSE; RESPIRATION; ABILITY; GENES; MIG1	When fruits ripen, microbial communities start a fierce competition for the freely available fruit sugars. Three yeast lineages, including baker's yeast Saccharomyces cerevisiae, have independently developed the metabolic activity to convert simple sugars into ethanol even under fully aerobic conditions. This fermentation capacity, named Crabtree effect, reduces the cell-biomass production but provides in nature a tool to out-compete other microorganisms. Here, we analyzed over forty Saccharomycetaceae yeasts, covering over 200 million years of the evolutionary history, for their carbon metabolism. The experiments were done under strictly controlled and uniform conditions, which has not been done before. We show that the origin of Crabtree effect in Saccharomycetaceae predates the whole genome duplication and became a settled metabolic trait after the split of the S. cerevisiae and Kluyveromyces lineages, and coincided with the origin of modern fruit bearing plants. Our results suggest that ethanol fermentation evolved progressively, involving several successive molecular events that have gradually remodeled the yeast carbon metabolism. While some of the final evolutionary events, like gene duplications of glucose transporters and glycolytic enzymes, have been deduced, the earliest molecular events initiating Crabtree effect are still to be determined.	[Hagman, Arne; Sall, Torbjorn; Piskur, Jure] Lund Univ, Dept Biol Mol Cell Biol, Lund, Sweden; [Compagno, Concetta] Univ Milan, Dept Food Environm & Nutrit Sci, Milan, Italy	Lund University; University of Milan	Hagman, A (corresponding author), Lund Univ, Dept Biol Mol Cell Biol, Lund, Sweden.	arne.hagman@biol.lu.se			Swedish Research Council; Italian Research Ministry; Crafoord Foundation; Sorensen Foundation; Lindstrom Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Italian Research Ministry(Ministry of Education, Universities and Research (MIUR)); Crafoord Foundation; Sorensen Foundation; Lindstrom Foundation	This study was financed by the Swedish Research Council and Italian Research Ministry, Crafoord Foundation, Sorensen Foundation and Lindstrom Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cassart JP, 1997, MOL GEN GENET, V255, P9, DOI 10.1007/s004380050469; Conant GC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100170; deJongGubbels P, 1996, MICROBIOL-UK, V142, P1399, DOI 10.1099/13500872-142-6-1399; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Dujon B, 2010, NAT REV GENET, V11, P512, DOI 10.1038/nrg2811; Fang ZA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007561; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Gojkovic Z, 2004, MOL GENET GENOMICS, V271, P387, DOI 10.1007/s00438-004-0995-7; Ihmels J, 2005, SCIENCE, V309, P938, DOI 10.1126/science.1113833; Jeffroy O, 2006, TRENDS GENET, V22, P225, DOI 10.1016/j.tig.2006.02.003; Jiang HF, 2008, GENOME RES, V18, P1466, DOI 10.1101/gr.074674.107; Klein CJL, 1998, MICROBIOL-SGM, V144, P13, DOI 10.1099/00221287-144-1-13; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P805, DOI 10.1016/B978-0-444-52149-1.00070-7; Kurtzman CP, 2003, FEMS YEAST RES, V3, P417, DOI 10.1016/S1567-1356(03)00012-6; Lin YP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011752; Lin ZG, 2011, MOL BIOL EVOL, V28, P131, DOI 10.1093/molbev/msq184; MacLean R, 2008, HEREDITY, V100, P471, DOI 10.1038/sj.hdy.6801073x; Merico A, 2007, FEBS J, V274, P976, DOI 10.1111/j.1742-4658.2007.05645.x; Moller K, 2001, J BACTERIOL, V183, P2485, DOI 10.1128/JB.183.8.2485-2489.2001; NAGY M, 1992, P NATL ACAD SCI USA, V89, P8966, DOI 10.1073/pnas.89.19.8966; Piskur J, 2006, TRENDS GENET, V22, P183, DOI 10.1016/j.tig.2006.02.002; Pronk JT, 1996, YEAST, V12, P1607, DOI 10.1002/(SICI)1097-0061(199612)12:16<1607::AID-YEA70>3.0.CO;2-4; Rhind N, 2011, SCIENCE, V332, P930, DOI 10.1126/science.1203357; Rozpedowska E, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1305; Snoek ISI, 2006, FEMS YEAST RES, V6, P393, DOI 10.1111/j.1567-1364.2005.00007.x; SousaDias S, 1996, MICROBIOL-UK, V142, P1733, DOI 10.1099/13500872-142-7-1733; Sun G, 2011, NATURE, V471, P625, DOI 10.1038/nature09811; Thomson JM, 2005, NAT GENET, V37, P630, DOI 10.1038/ng1553; Veiga A, 2000, FEMS MICROBIOL LETT, V190, P93, DOI 10.1111/j.1574-6968.2000.tb09268.x; VERDUYN C, 1992, YEAST, V8, P501, DOI 10.1002/yea.320080703; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711	31	121	123	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2013	8	7							e68734	10.1371/journal.pone.0068734	http://dx.doi.org/10.1371/journal.pone.0068734			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZN	23869229	gold, Green Submitted, Green Published			2022-12-27	WOS:000323110600028
J	Proverbio, MC; Mangano, E; Gessi, A; Bordoni, R; Spinelli, R; Asselta, R; Valin, PS; Di Candia, S; Zamproni, I; Diceglie, C; Mora, S; Caruso-Nicoletti, M; Salvatoni, A; De Bellis, G; Battaglia, C				Proverbio, Maria Carla; Mangano, Eleonora; Gessi, Alessandra; Bordoni, Roberta; Spinelli, Roberta; Asselta, Rosanna; Valin, Paola Sogno; Di Candia, Stefania; Zamproni, Ilaria; Diceglie, Cecilia; Mora, Stefano; Caruso-Nicoletti, Manuela; Salvatoni, Alessandro; De Bellis, Gianluca; Battaglia, Cristina			Whole Genome SNP Genotyping and Exome Sequencing Reveal Novel Genetic Variants and Putative Causative Genes in Congenital Hyperinsulinism	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; INSULIN-SECRETION; ALPHA-GENE; PROTEIN; MUTATIONS; ASSOCIATION; EXPRESSION; HYPOGLYCEMIA; CARBOXYLASE; THRESHOLDS	Congenital hyperinsulinism of infancy (CHI) is a rare disorder characterized by severe hypoglycemia due to inappropriate insulin secretion. The genetic causes of CHI have been found in genes regulating insulin secretion from pancreatic beta-cells; recessive inactivating mutations in the ABCC8 and KCNJ11 genes represent the most common events. Despite the advances in understanding the molecular pathogenesis of CHI, specific genetic determinants in about 50 % of the CHI patients remain unknown, suggesting additional locus heterogeneity. In order to search for novel loci contributing to the pathogenesis of CHI, we combined a family-based association study, using the transmission disequilibrium test on 17 CHI patients lacking mutations in ABCC8/KCNJ11, with a whole-exome sequencing analysis performed on 10 probands. This strategy allowed the identification of the potential causative mutations in genes implicated in the regulation of insulin secretion such as transmembrane proteins (CACNA1A, KCNH6, KCNJ10, NOTCH2, RYR3, SCN8A, TRPV3, TRPC5), cytosolic (ACACB, CAMK2D, CDKAL1, GNAS, NOS2, PDE4C, PIK3R3) and mitochondrial enzymes (PC, SLC24A6), and in four genes (CSMD1, SLC37A3, SULF1, TLL1) suggested by TDT family-based association study. Moreover, the exome-sequencing approach resulted to be an efficient diagnostic tool for CHI, allowing the identification of mutations in three causative CHI genes (ABCC8, GLUD1, and HNF1A) in four out of 10 patients. Overall, the present study should be considered as a starting point to design further investigations: our results might indeed contribute to meta-analysis studies, aimed at the identification/confirmation of novel causative or modifier genes.	[Proverbio, Maria Carla] Univ Milan, Dipartimento Fisiopatol & Trapianti DePT, Milan, Italy; [Mangano, Eleonora; Bordoni, Roberta; Spinelli, Roberta; De Bellis, Gianluca; Battaglia, Cristina] CNR, Inst Biomed Technol ITB, I-20133 Milan, Italy; [Gessi, Alessandra] Univ Milan, Scuola Dottorato Med Mol, Milan, Italy; [Asselta, Rosanna; Battaglia, Cristina] Univ Milan, Dipartimento Biotecnol Med & Med Traslazio BIOMET, Milan, Italy; [Valin, Paola Sogno; Di Candia, Stefania] Ist Sci San Raffaele, Dept Pediat, I-20132 Milan, Italy; [Zamproni, Ilaria; Diceglie, Cecilia; Mora, Stefano] Ist Sci San Raffaele, Lab Pediat Endocrinol, Div Metab & Cardiovasc Sci, I-20132 Milan, Italy; [Caruso-Nicoletti, Manuela] Univ Catania, Dipartimento Sci Med & Pediat, Catania, Italy; [Salvatoni, Alessandro] Insubria Univ, Dept Clin & Expt Med, Pediat Unit, Varese, Italy	University of Milan; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Milan; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Catania; University of Insubria	Battaglia, C (corresponding author), CNR, Inst Biomed Technol ITB, I-20133 Milan, Italy.	cristina.battaglia@unimi.it	Battaglia, Cristina/E-5166-2017; Mangano, Eleonora/P-7028-2018; Asselta, Rosanna/AAC-2367-2019; Mora, Sefano/B-2143-2013; De Bellis, Gianluca/H-9725-2013	Battaglia, Cristina/0000-0003-3025-9657; Mangano, Eleonora/0000-0002-4040-4654; Asselta, Rosanna/0000-0001-5351-0619; De Bellis, Gianluca/0000-0002-1622-4477; Salvatoni, Alessandro/0000-0002-9604-810X	MIUR [PRIN2008WY2TY9]	MIUR(Ministry of Education, Universities and Research (MIUR))	The present study was supported by grants of MIUR PRIN2008WY2TY9. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Arnoux JB, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-63; Bailey-Wilson JE, 2011, HUM HERED, V72, P228, DOI 10.1159/000334381; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Bartoloni L, 2004, PFLUG ARCH EUR J PHY, V447, P780, DOI 10.1007/s00424-003-1105-0; Bastepe M, 2007, CURR GENOMICS, V8, P398, DOI 10.2174/138920207783406488; Biagiotti L, 2007, EXP MOL PATHOL, V83, P59, DOI 10.1016/j.yexmp.2006.11.006; Bonnefond A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037423; Brambillasca S, 2012, J BIOL CHEM, V287, P41808, DOI 10.1074/jbc.M112.376558; Braun M, 2008, DIABETES, V57, P1618, DOI 10.2337/db07-0991; Cazzaniga G, 2009, LEUKEMIA, V23, P199, DOI 10.1038/leu.2008.170; Chao LC, 2008, MOL ENDOCRINOL, V22, P2596, DOI 10.1210/me.2008-0161; Chevre JC, 1998, DIABETOLOGIA, V41, P1017, DOI 10.1007/s001250051025; Colsoul B, 2011, REV PHYSIOL BIOCH P, V161, P87, DOI 10.1007/112_2011_2; Corbett BJA, 1995, J EXP MED, P181; Dipple KM, 2000, AM J HUM GENET, V66, P1729, DOI 10.1086/302938; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; Dunne MJ, 2000, J MOL ENDOCRINOL, V24, P313, DOI 10.1677/jme.0.0240313; Flanagan SE, 2011, SEMIN PEDIATR SURG, V20, P13, DOI 10.1053/j.sempedsurg.2010.10.004; Heimann E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014191; Hirsch E, 2007, J ENDOCRINOL, V194, P243, DOI 10.1677/JOE-07-0097; Hojlund K, 2004, DIABETES, V53, P1592, DOI 10.2337/diabetes.53.6.1592; Hussain K, 2008, HORM RES, V69, P2, DOI 10.1159/000111789; Jitrapakdee S, 2010, DIABETOLOGIA, V53, P1019, DOI 10.1007/s00125-010-1685-0; Johansson S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038050; Johnson JD, 2004, FASEB J, V18, P878, DOI 10.1096/fj.03-1280fje; Kim W, 2010, BIOCHEM BIOPH RES CO, V392, P247, DOI 10.1016/j.bbrc.2009.12.115; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lammert E, 2000, MECH DEVELOP, V94, P199, DOI 10.1016/S0925-4773(00)00317-8; Lehne B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020133; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JS, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-14; Nestorowicz A, 1998, HUM MOL GENET, V7, P1119, DOI 10.1093/hmg/7.7.1119; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ohara-Imaizumi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015553; Osterhoff M, 2003, CELL CALCIUM, V33, P175, DOI 10.1016/S0143-4160(02)00227-0; Ott J, 2011, NAT REV GENET, V12, P465, DOI 10.1038/nrg2989; Palty R, 2004, J BIOL CHEM, V279, P25234, DOI 10.1074/jbc.M401229200; Parappil H, 2009, INT J ENDOCRINOL MET, V7, P95; PINEDA M, 1995, BRAIN DEV-JPN, V17, P276, DOI 10.1016/0387-7604(95)00057-I; PRENTKI M, 1992, J BIOL CHEM, V267, P5802; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rochlitz H, 2000, DIABETOLOGIA, V43, P465, DOI 10.1007/s001250051330; Rorsman P, 2012, ANNU REV PHYSIOL, P1; Rorsman P, 2012, CELL CALCIUM, V51, P300, DOI 10.1016/j.ceca.2011.11.006; Rosati B, 2000, FASEB J, V14, P2601, DOI 10.1096/fj.00-0077com; Scholl UI, 2009, P NATL ACAD SCI USA, V106, P5842, DOI 10.1073/pnas.0901749106; Senniappan S, 2012, J INHERIT METAB DIS, V35, P589, DOI 10.1007/s10545-011-9441-2; Snider KE, 2013, J CLIN ENDOCR METAB, V98, pE355, DOI 10.1210/jc.2012-2169; Stanescu DE, 2012, J CLIN ENDOCRINOLOGY, V97, P1; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tanioka T, 2011, J BIOL CHEM, V286, P29388, DOI 10.1074/jbc.M110.192732; Twigger SN, 2007, NUCLEIC ACIDS RES, V35, pD658, DOI 10.1093/nar/gkl988; VIONNET N, 1992, NATURE, V356, P721, DOI 10.1038/356721a0; Waddleton D, 2008, BIOCHEM PHARMACOL, V76, P884, DOI 10.1016/j.bcp.2008.07.025; Xie T, 2007, P NATL ACAD SCI USA, V104, P19601, DOI 10.1073/pnas.0704796104; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0; Yamagata K, 1996, NATURE, V384, P455, DOI 10.1038/384455a0; ZHANG S, 1995, J ENDOCRINOL, V147, P33, DOI 10.1677/joe.0.1470033	59	19	20	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2013	8	7							e68740	10.1371/journal.pone.0068740	http://dx.doi.org/10.1371/journal.pone.0068740			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZN	23869231	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000323110600030
J	Palaiokostas, C; Bekaert, M; Khan, MGQ; Taggart, JB; Gharbi, K; McAndrew, BJ; Penman, DJ				Palaiokostas, Christos; Bekaert, Michael; Khan, Mohd G. Q.; Taggart, John B.; Gharbi, Karim; McAndrew, Brendan J.; Penman, David J.			Mapping and Validation of the Major Sex-Determining Region in Nile Tilapia (Oreochromis niloticus L.) Using RAD Sequencing	PLOS ONE			English	Article							DETERMINING GENE; SNP DISCOVERY; DE-NOVO; TEMPERATURE; LINKAGE; RATIOS; MEDAKA; FISH; REVERSAL; MALES	Sex in Oreochromis niloticus (Nile tilapia) is principally determined by an XX/XY locus but other genetic and environmental factors also influence sex ratio. Restriction Associated DNA (RAD) sequencing was used in two families derived from crossing XY males with females from an isogenic clonal line, in order to identify Single Nucleotide Polymorphisms (SNPs) and map the sex-determining region(s). We constructed a linkage map with 3,802 SNPs, which corresponded to 3,280 informative markers, and identified a major sex-determining region on linkage group 1, explaining nearly 96% of the phenotypic variance. This sex-determining region was mapped in a 2 cM interval, corresponding to approximately 1.2 Mb in the O. niloticus draft genome. In order to validate this, a diverse family (4 families; 96 individuals in total) and population (40 broodstock individuals) test panel were genotyped for five of the SNPs showing the highest association with phenotypic sex. From the expanded data set, SNPs Oni23063 and Oni28137 showed the highest association, which persisted both in the case of family and population data. Across the entire dataset all females were found to be homozygous for these two SNPs. Males were heterozygous, with the exception of five individuals in the population and two in the family dataset. These fish possessed the homozygous genotype expected of females. Progeny sex ratios (over 95% females) from two of the males with the "female'' genotype indicated that they were neomales (XX males). Sex reversal induced by elevated temperature during sexual differentiation also resulted in phenotypic males with the "female'' genotype. This study narrows down the region containing the main sex-determining locus, and provides genetic markers tightly linked to this locus, with an association that persisted across the population. These markers will be of use in refining the production of genetically male O. niloticus for aquaculture.	[Palaiokostas, Christos; Bekaert, Michael; Khan, Mohd G. Q.; Taggart, John B.; McAndrew, Brendan J.; Penman, David J.] Univ Stirling, Inst Aquaculture, Sch Nat Sci, Stirling FK9 4LA, Scotland; [Khan, Mohd G. Q.] Bangladesh Agr Univ, Dept Fisheries Biol & Genet, Mymensingh, Bangladesh; [Gharbi, Karim] Univ Edinburgh, Sch Biol Sci, Edinburgh, Midlothian, Scotland	University of Stirling; Bangladesh Agricultural University (BAU); University of Edinburgh	Penman, DJ (corresponding author), Univ Stirling, Inst Aquaculture, Sch Nat Sci, Stirling FK9 4LA, Scotland.	d.j.penman@stir.ac.uk	Palaiokostas, Christos/E-9347-2015; palaiokostas, christos/AAE-3628-2021; Gharbi, Karim/C-5771-2012	Palaiokostas, Christos/0000-0002-7609-861X; Gharbi, Karim/0000-0003-1092-4488; Khan, MGQ/0000-0002-9421-5269; Taggart, John/0000-0002-3843-9663; Bekaert, Michael/0000-0002-1206-7654; Palaiokostas, Christos/0000-0002-4480-4612	Marine Alliance for Science and Technology for Scotland; Commonwealth PhD scholarship [BDCS-2007-28]; University of Stirling PhD scholarship	Marine Alliance for Science and Technology for Scotland; Commonwealth PhD scholarship; University of Stirling PhD scholarship	The authors are grateful for support from the Marine Alliance for Science and Technology for Scotland, a Commonwealth PhD scholarship to MGQK (CSC reference BDCS-2007-28), and University of Stirling PhD scholarship to CP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Baroiller JF, 2009, COMP BIOCHEM PHYS A, V153, P30, DOI 10.1016/j.cbpa.2008.11.018; BAROILLER JF, 1995, J EXP ZOOL, V273, P216, DOI 10.1002/jez.1402730306; Baroiller JF, 2001, COMP BIOCHEM PHYS C, V130, P399, DOI 10.1016/S1532-0456(01)00267-8; Baxter SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019315; Beardmore JA, 2001, AQUACULTURE, V197, P283, DOI 10.1016/S0044-8486(01)00590-7; Bekaert M, 2012, GENETIC MAPPER; Broman KW, 2009, STAT BIOL HEALTH, P1, DOI 10.1007/978-0-387-92125-9_1; Cartwright DA, 2007, GENETICS, V176, P2521, DOI 10.1534/genetics.106.063982; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Cnaani A, 2008, SEX DEV, V2, P43, DOI 10.1159/000117718; Cnaani Avner, 2008, V2, P101, DOI 10.1007/978-3-540-73837-4_4; Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1; Eshel O, 2012, G3-GENES GENOM GENET, V2, P35, DOI 10.1534/g3.111.001545; Eshel O, 2011, ANIM GENET, V42, P222, DOI 10.1111/j.1365-2052.2010.02128.x; Etter PD, 2011, METHODS MOL BIOL, V772, P157, DOI 10.1007/978-1-61779-228-1_9; FAO Fisheries and Aquaculture Department, 2012, FISHSTAT DAT; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; GUERRERO RD, 1974, PROG FISH CULT, V36, P56, DOI 10.1577/1548-8659(1974)36[56:AASMFS]2.0.CO;2; Hattori RS, 2012, P NATL ACAD SCI USA, V109, P2955, DOI 10.1073/pnas.1018392109; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Houston RD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-244; Kamiya T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002798; Karayucel I, 2004, AQUACULTURE, V234, P51, DOI 10.1016/j.aquaculture.2003.12.016; Kwon JY, 2002, J FISH BIOL, V60, P625, DOI [10.1006/jfbi.2002.1880, 10.1111/j.1095-8649.2002.tb01689.x]; Lee BY, 2007, ANIM GENET, V38, P85, DOI 10.1111/j.1365-2052.2007.01563.x; Lee BY, 2011, MAR BIOTECHNOL, V13, P557, DOI 10.1007/s10126-010-9326-7; Lee BY, 2005, GENETICS, V170, P237, DOI 10.1534/genetics.104.035022; Lee BY, 2003, ANIM GENET, V34, P379, DOI 10.1046/j.1365-2052.2003.01035.x; Luhmann LM, 2012, SEX DEV, V6, P247, DOI 10.1159/000339705; Mair GC, 1997, CAN J FISH AQUAT SCI, V54, P396, DOI 10.1139/cjfas-54-2-396; MAJUMDAR KC, 1986, GENETICA, V68, P175, DOI 10.1007/BF02424441; Margarido GRA, 2007, HEREDITAS, V144, P78, DOI 10.1111/j.2007.0018-0661.02000.x; Matsuda M, 2002, NATURE, V417, P559, DOI 10.1038/nature751; Myosho T, 2012, GENETICS, V191, P163, DOI 10.1534/genetics.111.137497; Nanda I, 2003, GENETICS, V163, P245; Penman DJ, 2008, REV FISH SCI, V16, P16, DOI 10.1080/10641260802324610; Tessema M, 2006, AQUACULTURE, V258, P270, DOI 10.1016/j.aquaculture.2006.04.041; Wessels S, 2007, AQUACULTURE, V272, pS80, DOI 10.1016/j.aquaculture.2007.08.009; Wessels S, 2011, AQUACULTURE, V318, P79, DOI 10.1016/j.aquaculture.2011.04.039; Wu RL, 2002, GENET RES, V79, P85, DOI 10.1017/S0016672301005389; Yano A, 2012, CURR BIOL, V22, P1423, DOI 10.1016/j.cub.2012.05.045; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	43	136	141	1	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e68389	10.1371/journal.pone.0068389	http://dx.doi.org/10.1371/journal.pone.0068389			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874606	Green Published, gold, Green Submitted			2022-12-27	WOS:000322218800030
J	Escobedo-Lucea, C; Bellver, C; Gandia, C; Sanz-Garcia, A; Esteban, FJ; Mirabet, V; Forte, G; Moreno, I; Lezameta, M; Ayuso-Sacido, A; Garcia-Verdugo, JM				Escobedo-Lucea, Carmen; Bellver, Carmen; Gandia, Carolina; Sanz-Garcia, Andres; Esteban, Francisco J.; Mirabet, Vicente; Forte, Giancarlo; Moreno, Isabel; Lezameta, Melissa; Ayuso-Sacido, Angel; Garcia-Verdugo, Jose M.			A Xenogeneic-Free Protocol for Isolation and Expansion of Human Adipose Stem Cells for Clinical Uses	PLOS ONE			English	Article							MESENCHYMAL STROMAL CELLS; FETAL CALF SERUM; UMBILICAL-CORD BLOOD; VERSUS-HOST-DISEASE; BONE-MARROW; IMMUNOSUPPRESSIVE PROPERTIES; OSTEOGENESIS IMPERFECTA; ASSISTED LIPOTRANSFER; SUPPORTIVE USE; BOVINE SERUM	Human adipose stem cells (hASCs) play a crucial role in the fields of regenerative medicine and tissue engineering for different reasons: the abundance of adipose tissue, their easy harvesting, the ability to multipotent differentiation and the fact that they do not trigger allogeneic blood response or secrete cytokines that act as immunosuppressants. The vast majority of protocols use animal origin reagents, with the underlying risk of transmitting infections by non-human pathogens. We have designed a protocol to isolate and maintain the properties of hASCs avoiding xenogeneic reagents. These changes not only preserve hASCs morphology, but also increase cell proliferation and maintain their stem cell marker profile. On the other hand, human serum albumin (HSA), Tryple (R) and human Serum (HS), do not affect hASCs multipotent differentiation ability. The amendments introduced do not trigger modifications in the transcriptional profile of hASCs, alterations in key biochemical pathways or malignization. Thus, we have proven that it is possible to isolate and maintain hASCs avoiding animal reagents and, at the same time, preserving crucial culture parameters during long term culture. Thereby we have revealed a novel and effective tool for the improvement of clinical, cell-based therapies.	[Escobedo-Lucea, Carmen; Bellver, Carmen; Lezameta, Melissa; Garcia-Verdugo, Jose M.] Univ Valencia, Comparat Neurobiol Unit, Inst Cavanilles, RETICS, Valencia, Spain; [Escobedo-Lucea, Carmen; Gandia, Carolina; Sanz-Garcia, Andres; Ayuso-Sacido, Angel] Univ Helsinki, Fac Pharm, Div Biopharmaceut & Pharmacokinet, Helsinki, Finland; [Esteban, Francisco J.] Univ Jaen, Dept Expt Biol, Syst Biol Unit, Jaen, Spain; [Mirabet, Vicente] Reg Transfus Ctr, Cell & Tissue Bank, Valencia, Spain; [Forte, Giancarlo] Natl Inst Mat Sci, Smart Mat Grp, Tsukuba, Ibaraki, Japan; [Forte, Giancarlo] St Annes Univ Hosp, Int Clin Res Ctr, Brno, Czech Republic; [Moreno, Isabel] Univ Valencia, Fac Med, Dept Anat & Histol, Valencia, Spain; [Ayuso-Sacido, Angel] Hosp Madrid Fdn, Integral Oncol Ctr Clara Campal, Madrid, Spain; [Ayuso-Sacido, Angel] Hosp Madrid Fdn, Mol Appl Med Inst, Madrid, Spain	University of Valencia; University of Helsinki; Universidad de Jaen; National Institute for Materials Science; St Anne's University Hospital Brno (FNUSA-ICRC); University of Valencia	Garcia-Verdugo, JM (corresponding author), Univ Valencia, Comparat Neurobiol Unit, Inst Cavanilles, RETICS, Valencia, Spain.	esluma@uv.es; j.manuel.garcia@uv.es	Mirabet, Vicente/ABH-8363-2020; Escobedo-Lucea, Carmen/J-2846-2013; Lucea, Carmen Escobedo/X-8015-2019; Esteban, Francisco J./H-5504-2015; Gandia, Carolina/ABH-3127-2020; García-Verdugo, José Manuel/L-8421-2017; Forte, Giancarlo/M-1447-2017; Sacido, Angel Ayuso/AAV-9331-2021; Mirabet, Vicente/ABH-8673-2020; Sanz-Garcia, Andres/F-7981-2012	Mirabet, Vicente/0000-0003-1469-4210; Escobedo-Lucea, Carmen/0000-0002-5642-0536; Esteban, Francisco J./0000-0002-7135-2973; Gandia, Carolina/0000-0002-4239-4189; García-Verdugo, José Manuel/0000-0001-9872-6499; Forte, Giancarlo/0000-0002-1341-1023; Sacido, Angel Ayuso/0000-0003-3919-5880; Sanz-Garcia, Andres/0000-0003-0413-4965	Institute of Health Carlos III, Ministry of Health, Spain; Regenerative Medicine Program of the Valencian Community and Ministry of Health, Spain;  [rometeo2009/011]	Institute of Health Carlos III, Ministry of Health, Spain; Regenerative Medicine Program of the Valencian Community and Ministry of Health, Spain; 	Dr. Carmen Escobedo-Lucea is financed by post-doctoral program Sara Borrell from Institute of Health Carlos III, Ministry of Health, Spain. Dr. Angel Ayuso-Sacido is financed by program Miguel Servet from Institute of Health Carlos III, Ministry of Health, Spain. This study was supported with financial support from Prometeo2009/011, TerCel and the Regenerative Medicine Program of the Valencian Community and Ministry of Health, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 1997, B WORLD HEALTH ORGAN, V75, P505; Alvarez PDA, 2008, THORAX, V63, P374, DOI 10.1136/thx.2007.083857; Bensidhoum Morad, 2005, Journal de la Societe de Biologie, V199, P337, DOI 10.1051/jbio:2005035; Bieback K, 2008, BIO-MED MATER ENG, V18, pS71; Bieback K, 2010, TISSUE ENG PT A, V16, P3467, DOI [10.1089/ten.tea.2009.0727, 10.1089/ten.TEA.2009.0727]; Bieback K, 2009, STEM CELLS, V27, P2331, DOI 10.1002/stem.139; Bihl F, 2010, J ANTIMICROB CHEMOTH, V65, P817, DOI 10.1093/jac/dkq085; Dromard C, 2011, EXP CELL RES, V317, P770, DOI 10.1016/j.yexcr.2011.01.001; ERICKSON GA, 1991, DEV BIOLOGICALS, V75, P173; Fang B, 2007, TRANSPL P, V39, P1710, DOI 10.1016/j.transproceed.2007.02.091; Fang BJ, 2009, ANN HEMATOL, V88, P261, DOI 10.1007/s00277-008-0599-0; Fraser John K., 2008, V449, P59, DOI 10.1007/978-1-60327-169-1_4; FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267; Garcia-Olmo D, 2003, INT J COLORECTAL DIS, V18, P451, DOI 10.1007/s00384-003-0490-3; Garcia-Olmo D, 2010, CASE REPORT MED, V617-658; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Knight R, 2010, TRANSFUS APHER SCI, V43, P387, DOI 10.1016/j.transci.2010.09.003; Kocaoemer A, 2007, STEM CELLS, V25, P1270, DOI 10.1634/stemcells.2006-0627; Kuhbier JW, 2010, ADV BIOCHEM ENG BIOT, V123, P55, DOI 10.1007/10_2009_24; Le Blanc K, 2005, TRANSPLANTATION, V79, P1607, DOI 10.1097/01.TP.0000159029.48678.93; Lindroos B, 2010, TISSUE ENG PT A, V16, P2281, DOI [10.1089/ten.tea.2009.0621, 10.1089/ten.TEA.2009.0621]; Mackensen A, 2000, CANCER IMMUNOL IMMUN, V49, P152, DOI 10.1007/s002620050614; Mannello F, 2007, STEM CELLS, V25, P1603, DOI 10.1634/stemcells.2007-0127; Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181; Matsumoto D, 2006, TISSUE ENG, V12, P3375, DOI 10.1089/ten.2006.12.3375; Muller I, 2006, CYTOTHERAPY, V8, P437, DOI 10.1080/14653240600920782; Nie CL, 2011, CELL TRANSPLANT, V20, P205, DOI 10.3727/096368910X520065; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Planat-Benard V, 2004, CIRC RES, V94, P223, DOI 10.1161/01.RES.0000109792.43271.47; Puissant N, 2005, BRIT J HAEMATOL, V129, P118, DOI 10.1111/j.1365-2141.2005.05409.x; Sanz-Ruiz R, 2009, CELL TRANSPLANT, V18, P245, DOI 10.3727/096368909788534889; Selvaggi TA, 1997, BLOOD, V89, P776, DOI 10.1182/blood.V89.3.776; Shahdadfar A, 2005, STEM CELLS, V23, P1357, DOI 10.1634/stemcells.2005-0094; Sherman BT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-426; Spees JL, 2004, MOL THER, V9, P747, DOI 10.1016/j.ymthe.2004.02.012; Stute N, 2004, EXP HEMATOL, V32, P1212, DOI 10.1016/j.exphem.2004.09.003; Sundin M, 2007, HAEMATOLOGICA, V92, P1208, DOI 10.3324/haematol.11446; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Willkommen H, 1999, Dev Biol Stand, V99, P131; Yanez R, 2006, STEM CELLS, V24, P2582, DOI 10.1634/stemcells.2006-0228; Yanez R, 2010, EXP CELL RES, V316, P3109, DOI 10.1016/j.yexcr.2010.08.008; Yen BL, 2005, STEM CELLS, V23, P3, DOI 10.1634/stemcells.2004-0098; Yoshimura K, 2008, AESTHET PLAST SURG, V32, P48, DOI 10.1007/s00266-007-9019-4; Young HE, 2001, ANAT RECORD, V264, P51, DOI 10.1002/ar.1128; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	49	23	23	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e67870	10.1371/journal.pone.0067870	http://dx.doi.org/10.1371/journal.pone.0067870			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874459	Green Published, Green Submitted, gold			2022-12-27	WOS:000321736900030
J	Hollenbach, M; Stoll, SJ; Jorgens, K; Seufferlein, T; Kroll, J				Hollenbach, Marcus; Stoll, Sandra Jasmin; Joergens, Kristina; Seufferlein, Thomas; Kroll, Jens			Different Regulation of Physiological and Tumor Angiogenesis in Zebrafish by Protein Kinase D1 (PKD1)	PLOS ONE			English	Article							VASCULAR MORPHOGENESIS; TRANSGENIC ZEBRAFISH; IN-VIVO; CELLS; CANCER; PHOSPHORYLATION; ACTIVATION; MEMBRANE; GROWTH; EXPRESSION	Protein kinase D isoenzymes (PKDs, Prkds) are serine threonine kinases that belong to the CAMK superfamily. PKD1 is expressed in endothelial cells and is a major mediator of biological responses downstream of the VEGFRs that are relevant for angiogenesis such as endothelial cell migration, proliferation and tubulogenesis in vitro. PKDs also play a critical role in tumor development and progression, including tumor angiogenesis. However, given the plethora of signaling modules that drive angiogenesis, the precise role of PKD1 in both physiological and tumor angiogenesis in vivo has not been worked out so far. This study aimed at dissecting the contribution of PKD1 to physiological blood vessel formation, PKD1 was found to be widely expressed during zebrafish development. As far as physiological angiogenesis was concerned, morpholino-based silencing of PKD1 expression moderately reduced the formation of the intersomitic vessels and the dorsal longitudinal anastomotic vessel in tg(fli1:EGFP) zebrafish. In addition, silencing of PKD1 resulted in reduced formation of the parachordal lymphangioblasts that serves as a precursor for the developing thoracic duct. Interestingly, tumor angiogenesis was completely abolished in PKD1 morphants using the zebrafish/tumor xenograft angiogenesis assay. Our data in zebrafish demonstrate that PKD1 contributes to the regulation of physiological angiogenesis and lymphangiogenesis during zebrafish development and is essential for tumor angiogenesis.	[Hollenbach, Marcus; Stoll, Sandra Jasmin; Joergens, Kristina; Kroll, Jens] Heidelberg Univ, Med Fac Mannheim, Ctr Biomed & Med Technol Mannheim, Dept Vasc Biol & Tumorangiogenesis, Heidelberg, Germany; [Hollenbach, Marcus] Univ Halle Wittenberg, Dept Internal Med 1, D-06108 Halle, Germany; [Stoll, Sandra Jasmin; Joergens, Kristina; Kroll, Jens] German Canc Res Ctr DKFZ ZMBH Alliance, Div Vasc Oncol & Metastasis, Heidelberg, Germany; [Seufferlein, Thomas] Univ Ulm, Dept Internal Med 1, D-89069 Ulm, Germany	Ruprecht Karls University Heidelberg; Martin Luther University Halle Wittenberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ulm University	Seufferlein, T (corresponding author), Univ Ulm, Dept Internal Med 1, D-89069 Ulm, Germany.	thomas.seufferlein@uniklinik-ulm.de	Seufferlein, Thomas TW/P-7147-2018; Hollenbach, Marcus/ABF-7452-2021		Deutsche Forschungsgemeinschaft [SFB/TR23, Z5, INST 91027/10-1 FUGG]; German Federal Ministry of Education and Research (BMBF) [NGFN plus/PKB-01GS08209-4]; Deutsche Krebshilfe; Wilhelm-Roux-program from the Martin-Luther-University Halle (Saale); German Cardiac Society	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Krebshilfe(Deutsche Krebshilfe); Wilhelm-Roux-program from the Martin-Luther-University Halle (Saale); German Cardiac Society	This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB/TR23, project Z5 to J.K. and INST 91027/10-1 FUGG) by the German Federal Ministry of Education and Research (BMBF) grant no. NGFN plus/PKB-01GS08209-4 (to T.S.), and the Deutsche Krebshilfe to T.S., by the Wilhelm-Roux-program from the Martin-Luther-University Halle (Saale) (to M.H.) and by the German Cardiac Society (to S.J.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azoitei N, 2010, GUT, V59, P1316, DOI 10.1136/gut.2009.206813; Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; Brandlin I, 2002, J BIOL CHEM, V277, P6490, DOI 10.1074/jbc.M106083200; Du HS, 2011, ONCOL REP, V26, P495, DOI 10.3892/or.2011.1297; Eiseler T, 2009, NAT CELL BIOL, V11, P545, DOI 10.1038/ncb1861; Epting D, 2010, CIRC RES, V107, P45, DOI 10.1161/CIRCRESAHA.109.213983; Evans IM, 2008, CELL SIGNAL, V20, P1375, DOI 10.1016/j.cellsig.2008.03.002; Evans IM, 2011, IUBMB LIFE, V63, P258, DOI 10.1002/iub.456; Feitsma H, 2008, MOL CANCER RES, V6, P685, DOI 10.1158/1541-7786.MCR-07-2167; Goessling W, 2007, J CLIN ONCOL, V25, P2473, DOI 10.1200/JCO.2006.08.9821; Ha CH, 2008, J BIOL CHEM, V283, P14590, DOI 10.1074/jbc.M800264200; Haldi Maryann, 2006, Angiogenesis, V9, P139, DOI 10.1007/s10456-006-9040-2; Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995; Jaggi M, 2007, FRONT BIOSCI-LANDMRK, V12, P3757, DOI 10.2741/2349; Jorgens K, 2011, DEUT MED WOCHENSCHR, V136, P1865, DOI 10.1055/s-0031-1286357; Kersey PJ, 2012, NUCLEIC ACIDS RES, V40, pD91, DOI 10.1093/nar/gkr895; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Langenau DM, 2003, SCIENCE, V299, P887, DOI 10.1126/science.1080280; LaValle CR, 2010, BBA-REV CANCER, V1806, P183, DOI 10.1016/j.bbcan.2010.05.003; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lee LMJ, 2005, DEV DYNAM, V233, P1560, DOI 10.1002/dvdy.20471; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Matthews SA, 2010, BIOCHEM J, V432, P153, DOI 10.1042/BJ20101188; Nicoli S, 2007, NAT PROTOC, V2, P2918, DOI 10.1038/nprot.2007.412; Nicoli S, 2007, CANCER RES, V67, P2927, DOI 10.1158/0008-5472.CAN-06-4268; Prigozhina NL, 2004, CURR BIOL, V14, P88, DOI 10.1016/j.cub.2004.01.003; Qin LL, 2006, J BIOL CHEM, V281, P32550, DOI 10.1074/jbc.M604853200; Rubinstein AL, 2003, CURR OPIN DRUG DI DE, V6, P218; Rykx A, 2003, FEBS LETT, V546, P81, DOI 10.1016/S0014-5793(03)00487-3; Stoletov K, 2007, P NATL ACAD SCI USA, V104, P17406, DOI 10.1073/pnas.0703446104; Stoll SJ, 2011, CIRC RES, V108, P1367, DOI 10.1161/CIRCRESAHA.111.244095; Storz P, 2005, MOL CELL BIOL, V25, P8520, DOI 10.1128/MCB.25.19.8520-8530.2005; von BJ, 2007, EMBO J, V26, P4619; von WG, 2008, CELL SIGNAL, V20, P925; Waldron RT, 2001, J BIOL CHEM, V276, P32606, DOI 10.1074/jbc.M101648200; Wang QMJ, 2006, TRENDS PHARMACOL SCI, V27, P317, DOI 10.1016/j.tips.2006.04.003; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Wood JM, 2000, CANCER RES, V60, P2178; Yaniv K, 2006, NAT MED, V12, P711, DOI 10.1038/nm1427; Yeaman C, 2004, NAT CELL BIOL, V6, P106, DOI 10.1038/ncb1090; Zugaza JL, 1996, EMBO J, V15, P6220, DOI 10.1002/j.1460-2075.1996.tb01012.x	41	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68033	10.1371/journal.pone.0068033	http://dx.doi.org/10.1371/journal.pone.0068033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874489	gold, Green Submitted, Green Published			2022-12-27	WOS:000321736900047
J	Lee, JY; Huo, TI; Wang, SS; Huang, HC; Lee, FY; Lin, HC; Chuang, CL; Lee, SD				Lee, Jing-Yi; Huo, Teh-Ia; Wang, Sun-Sang; Huang, Hui-Chun; Lee, Fa-Yauh; Lin, Han-Chieh; Chuang, Chiao-Lin; Lee, Shou-Dong			Diabetes Diminishes the Portal-Systemic Collateral Vascular Response to Vasopressin via Vasopressin Receptor and G(alpha) Proteins Regulations in Cirrhotic Rats	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; ANGIOTENSIN-II; HYPERTENSIVE-RATS; DOWN-REGULATION; NITRIC-OXIDE; MELLITUS; VASODILATION; ARTERIOLES; REACTIVITY; PATHOPHYSIOLOGY	Liver cirrhosis may lead to portal-systemic collateral formation and bleeding. The hemostatic effect is influenced by the response of collateral vessels to vasoconstrictors. Diabetes and glucose also influence vasoresponsiveness, but their net effect on collaterals remains unexplored. This study investigated the impact of diabetes or glucose application on portalsystemic collateral vasoresponsiveness to arginine vasopressin (AVP) in cirrhosis. Spraque-Dawley rats with bile duct ligation (BDL)-induced cirrhosis received vehicle (citrate buffer) or streptozotocin (diabetic, BDL/STZ). The in situ collateral perfusion was done after hemodynamic measurements: Both were perfused with Krebs solution, D-glucose, or D-glucose and NaF, with additional OPC-31260 for the BDL/STZ group. Splenorenal shunt vasopressin receptors and Ga proteins mRNA expressions were evaluated. The survival rate of cirrhotic rats was decreased by STZ injection. The collateral perfusion pressure changes to AVP were lower in STZ-injected groups, which were reversed by OPC-31260 (a V2R antagonist) and overcome by NaF (a G protein activator). The splenorenal shunt V2R mRNA expression was increased while Ga proteins mRNA expressions were decreased in BDL/STZ rats compared to BDL rats. The Gaq and Ga11 mRNA expressions also correlated with the maximal perfusion pressure changes to AVP. Diabetes diminished the portal-systemic collateral vascular response to AVP in rats with BDL-induced cirrhosis, probably via V2 receptor up-regulation and Ga proteins downregulation.	[Lee, Jing-Yi; Huo, Teh-Ia] Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan; [Wang, Sun-Sang; Huang, Hui-Chun; Lee, Fa-Yauh; Lin, Han-Chieh; Chuang, Chiao-Lin; Lee, Shou-Dong] Natl Yang Ming Univ, Fac Med, Taipei 112, Taiwan; [Chuang, Chiao-Lin] Taipei Vet Gen Hosp, Div Gen Med, Taipei, Taiwan; [Huo, Teh-Ia; Huang, Hui-Chun; Lee, Fa-Yauh; Lin, Han-Chieh] Taipei Vet Gen Hosp, Dept Med, Taipei, Taiwan; [Wang, Sun-Sang] Taipei Vet Gen Hosp, Dept Med Affair & Planning, Taipei, Taiwan; [Lee, Shou-Dong] Cheng Hsin Gen Hosp, Dept Med, Div Gastroenterol, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Cheng Hsin General Hospital	Huang, HC (corresponding author), Natl Yang Ming Univ, Fac Med, Taipei 112, Taiwan.	hchuang2@vgtpe.gov.tw; fylee@vghtpe.gov.tw			National Science Council, Taiwan [96-2314-B-075-047-]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the grants from National Science Council (96-2314-B-075-047-), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babal P, 2006, PHYSIOL RES, V55, P245, DOI 10.33549/physiolres.930808; Baluchnejadmojarad T, 2003, LIFE SCI, V73, P2281, DOI 10.1016/S0024-3205(03)00604-0; Chan CC, 2005, SCAND J GASTROENTERO, V40, P83, DOI 10.1080/00365520410009528; Chan CC, 1999, HEPATOLOGY, V30, P630, DOI 10.1002/hep.510300317; Chan CC, 2004, EUR J CLIN INVEST, V34, P290, DOI 10.1111/j.1365-2362.2004.01336.x; Chang CC, 2013, CLIN SCI, V124, P457, DOI 10.1042/CS20120052; FRANCO D, 1979, ARCH SURG-CHICAGO, V114, P1064; Garcia-Compean D, 2012, ANN HEPATOL, V11, P240, DOI 10.1016/S1665-2681(19)31030-0; Garcia-Compean D, 2009, WORLD J GASTROENTERO, V15, P280, DOI 10.3748/wjg.15.280; Garcia-Pagan JC, 2012, J HEPATOL, V57, P458, DOI 10.1016/j.jhep.2012.03.007; Garcia-Tsao G, 2010, NEW ENGL J MED, V362, P823, DOI 10.1056/NEJMra0901512; Garcia-Tsao G, 2008, HEPATOLOGY, V48, P2064, DOI 10.1002/hep.22605; Garcia-Villalon AL, 2003, EUR J PHARMACOL, V459, P247, DOI 10.1016/S0014-2999(02)02826-1; Heinemann A, 2009, PHARMACOLOGY, V83, P26, DOI 10.1159/000167877; Hennenberg M, 2006, GASTROENTEROLOGY, V130, P838, DOI 10.1053/j.gastro.2005.11.029; HOLLINGER MA, 1982, J PHARMACOL EXP THER, V222, P641; HOSTETTER TH, 1981, KIDNEY INT, V19, P410, DOI 10.1038/ki.1981.33; Huang HC, 2012, J CELL MOL MED, V16, P1125, DOI 10.1111/j.1582-4934.2011.01399.x; Huang HC, 2012, J VASC RES, V49, P160, DOI 10.1159/000332347; Khan ZA, 2003, CAN J PHYSIOL PHARM, V81, P622, DOI 10.1139/Y03-053; KRUSZYNSKA YT, 1991, HEPATOLOGY, V14, P103, DOI 10.1002/hep.1840140117; MAYHAN WG, 1991, AM J PHYSIOL, V260, pH319, DOI 10.1152/ajpheart.1991.260.2.H319; McNeill AM, 2002, STROKE, V33, P1685, DOI 10.1161/01.STR.0000016325.54374.93; Medina P, 1999, AM J HYPERTENS, V12, P188, DOI 10.1016/S0895-7061(98)00230-1; Minano C, 2010, GASTROENTEROL CLIN N, V39, P681, DOI 10.1016/j.gtc.2010.08.015; Mori A, 2010, J PHARMACOL SCI, V112, P336, DOI 10.1254/jphs.09312FP; Nelson LR, 2001, J AM ACAD DERMATOL, V45, pS116, DOI 10.1067/mjd.2001.117432; PETRIDES AS, 1994, HEPATOLOGY, V19, P616, DOI 10.1002/hep.1840190312; PHILLIPS PA, 1995, CLIN SCI, V88, P671, DOI 10.1042/cs0880671; Raimondi L, 2004, DIABETES, V53, P1927, DOI 10.2337/diabetes.53.7.1927; Roden M, 2006, NAT CLIN PRACT ENDOC, V2, P335, DOI 10.1038/ncpendmet0190; ROSENBLUM WI, 1985, MICROCIRC ENDOTH LYM, V2, P195; Sanz E, 2003, EUR J PHARMACOL, V471, P35, DOI 10.1016/S0014-2999(03)01815-6; SARUBBI D, 1989, AM J PHYSIOL, V257, pF762, DOI 10.1152/ajprenal.1989.257.5.F762; Sharma K, 2003, AM J PHYSIOL-RENAL, V285, pF1258, DOI 10.1152/ajprenal.00145.2003; TAGAWA T, 1995, J CARDIOVASC PHARM, V25, P387, DOI 10.1097/00005344-199503000-00006; Tamaki T, 1996, KIDNEY INT, V49, P722, DOI 10.1038/ki.1996.101; TAYLOR PD, 1994, BRIT J PHARMACOL, V113, P801, DOI 10.1111/j.1476-5381.1994.tb17064.x; TRINDER D, 1994, AM J PHYSIOL, V266, pE217, DOI 10.1152/ajpendo.1994.266.2.E217; TURLAPATY PDMV, 1980, AM J PHYSIOL, V239, pE412, DOI 10.1152/ajpendo.1980.239.6.E412; WILLIAMS B, 1992, J CLIN INVEST, V90, P1992, DOI 10.1172/JCI116079; Yin ZH, 2005, WORLD J GASTROENTERO, V11, P1232, DOI 10.3748/wjg.v11.i8.1232	42	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e67703	10.1371/journal.pone.0067703	http://dx.doi.org/10.1371/journal.pone.0067703			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874439	gold, Green Published, Green Submitted			2022-12-27	WOS:000321736900017
J	Verdier, C; Ruidavets, JB; Bongard, V; Taraszkiewicz, D; Martinez, LO; Elbaz, M; Ferrieres, J; Perret, B				Verdier, Celine; Ruidavets, Jean-Bernard; Bongard, Vanina; Taraszkiewicz, Dorota; Martinez, Laurent O.; Elbaz, Meyer; Ferrieres, Jean; Perret, Bertrand			Association of Hepatic Lipase-514T Allele with Coronary Artery Disease and Ankle-Brachial Index, Dependence on the Lipoprotein Phenotype: The GENES Study	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; HEART-DISEASE; INCREASED RISK; ARM INDEX; CHOLESTEROL; POLYMORPHISM; PROMOTER; LIPIDS; LOCI; MEN	Objectives: Relationship between hepatic lipase (LIPC) polymorphism and coronary artery disease (CAD) has often led to contradictory results. We studied this relation by genotyping rs1800588 in the LIPC promoter in a case-control study on CAD (the GENES study). We also investigated the relationship between this polymorphism and the ankle-brachial index (ABI), which is predictive of atherosclerosis progression and complications in patients at high cardiovascular risk. Methods: 557 men aged 45-74 with stable coronary artery disease and 560 paired controls were genotyped for rs1800588. Medical data, clinical examination including determination of ABI and biological measurements related to cardiovascular risk factors enabled multivariate analyses and multiple adjustments. Results: CAD cases showed a higher T-allele frequency than controls (0.246 vs 0.192, p = 0.003). An interaction has been found between LIPC polymorphism and triglycerides (TG) levels regarding risk of CAD: TT-homozigosity was associated with an Odds ratio (OR) of 6.4 (CI: 1.8-22.3) when TG were below 1.5 g/L, but no association was found at higher TG levels (OR = 1.34, CI: 0.3-5.9). The distribution of LIPC genotypes was compared between CAD patients with normal or abnormal ABI and impact of LIPC polymorphism on ABI was determined. Following multiple adjustments, association of the T-allele with pejorative ABI (<0.90) was significant for heterozygotes and for all T-carriers (OR = 1.55, CI: 1.07-2.25). Conclusion: The -514T LIPC allele is associated with CAD under normotriglyceridemic conditions and constitutes an independent determinant of pejorative ABI in coronary patients.	[Verdier, Celine; Perret, Bertrand] CHU Toulouse, Dept Biochem, Toulouse, France; [Verdier, Celine; Martinez, Laurent O.; Elbaz, Meyer; Perret, Bertrand] Univ Toulouse 3, INSERM, UMR 1048, Inst Malad Metab & Cardiovasc Toulouse, F-31062 Toulouse, France; [Ruidavets, Jean-Bernard; Bongard, Vanina] CHU Toulouse, Dept Epidemiol, Toulouse, France; [Ruidavets, Jean-Bernard; Bongard, Vanina; Ferrieres, Jean] Univ Toulouse 3, INSERM UMR 1027, F-31062 Toulouse, France; [Taraszkiewicz, Dorota; Elbaz, Meyer; Ferrieres, Jean] CHU Toulouse, Dept Cardiol, Toulouse, France	CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse	Perret, B (corresponding author), CHU Toulouse, Dept Biochem, Toulouse, France.	perret.b@chu-toulouse.fr	Martinez, Laurent O/B-8343-2015; Martinez, Laurent O./ABD-6880-2020; PERRET, Bertrand/Y-2326-2019; Ferrieres, Jean/S-7993-2016	Martinez, Laurent O/0000-0002-0985-3152; Martinez, Laurent O./0000-0002-0985-3152; Bertrand, PERRET/0000-0001-7568-445X; Verdier, Celine/0000-0002-9920-0947; Bongard, Vanina/0000-0001-5789-0815; ELBAZ, Meyer/0000-0002-3520-7883; Ferrieres, Jean/0000-0001-6144-1297	INSERM (French National Institute of Health and Medical Research); Toulouse University Hospital	INSERM (French National Institute of Health and Medical Research)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Toulouse University Hospital	This study was realized with the financial support of INSERM (French National Institute of Health and Medical Research) and of the Toulouse University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen RV, 2003, J AM COLL CARDIOL, V41, P1972, DOI 10.1016/S0735-1097(03)00407-8; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Bataille V, 2006, DIABETES METAB, V32, P475, DOI 10.1016/S1262-3636(07)70306-3; Bouisset F, 2012, AM J CARDIOL, V110, P197, DOI 10.1016/j.amjcard.2012.03.013; Brunzell JD, 2012, BBA-MOL CELL BIOL L, V1821, P365, DOI 10.1016/j.bbalip.2011.09.008; Dugi KA, 2001, CIRCULATION, V104, P3057, DOI 10.1161/hc5001.100795; Eller P, 2005, J INTERN MED, V258, P344, DOI 10.1111/j.1365-2796.2005.01549.x; Fan YM, 2009, CLIN GENET, V76, P46, DOI 10.1111/j.1399-0004.2009.01180.x; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; HODIS HN, 1994, CIRCULATION, V90, P42, DOI 10.1161/01.CIR.90.1.42; Isaacs A, 2004, J CLIN ENDOCR METAB, V89, P3858, DOI 10.1210/jc.2004-0188; Jansen H, 2002, J LIPID RES, V43, P1352, DOI 10.1194/jlr.R200008-JLR200; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Klein S, 2006, ANN VASC SURG, V20, P282, DOI 10.1007/s10016-006-9019-x; Knoblauch H, 2004, HUM MOL GENET, V13, P993, DOI 10.1093/hmg/ddh119; Morillas P, 2009, AM J CARDIOL, V104, P1494, DOI 10.1016/j.amjcard.2009.07.014; Newman AB, 1999, ARTERIOSCL THROM VAS, V19, P538, DOI 10.1161/01.ATV.19.3.538; RUBINS HB, 1995, AM J CARDIOL, V75, P1196, DOI 10.1016/S0002-9149(99)80761-9; Soyal SM, 2011, ATHEROSCLEROSIS, V216, P374, DOI 10.1016/j.atherosclerosis.2011.01.052; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Valdivielso P, 2008, J DIABETES COMPLICAT, V22, P273, DOI 10.1016/j.jdiacomp.2007.06.011; van Acker BAC, 2008, ATHEROSCLEROSIS, V200, P161, DOI 10.1016/j.atherosclerosis.2007.11.019; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Wang HR, 2010, ARCH MED RES, V41, P383, DOI 10.1016/j.arcmed.2010.08.004; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Zambon A, 1998, ARTERIOSCL THROM VAS, V18, P1723, DOI 10.1161/01.ATV.18.11.1723; Zambon A, 2001, CIRCULATION, V103, P792, DOI 10.1161/01.CIR.103.6.792	28	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e67805	10.1371/journal.pone.0067805	http://dx.doi.org/10.1371/journal.pone.0067805			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874450	Green Submitted, gold, Green Published			2022-12-27	WOS:000321736900026
J	Desai, M; Phillips-Howard, PA; Odhiambo, FO; Katana, A; Ouma, P; Hamel, MJ; Omoto, J; Macharia, S; van Eijk, A; Ogwang, S; Slutsker, L; Laserson, KF				Desai, Meghna; Phillips-Howard, Penelope A.; Odhiambo, Frank O.; Katana, Abraham; Ouma, Peter; Hamel, Mary J.; Omoto, Jackton; Macharia, Sheila; van Eijk, Annemieke; Ogwang, Sheila; Slutsker, Laurence; Laserson, Kayla F.			An Analysis of Pregnancy-Related Mortality in the KEMRI/CDC Health and Demographic Surveillance System in Western Kenya	PLOS ONE			English	Article							INTERMITTENT PREVENTIVE TREATMENT; TREATED BED NETS; MATERNAL MORTALITY; VERBAL AUTOPSY; INDUCED-ABORTION; MALARIA; DEATHS; CARE; RISK; TOO	Background: Pregnancy-related (PR) deaths are often a result of direct obstetric complications occurring at childbirth. Methods and Findings: To estimate the burden of and characterize risk factors for PR mortality, we evaluated deaths that occurred between 2003 and 2008 among women of childbearing age (15 to 49 years) using Health and Demographic Surveillance System data in rural western Kenya. WHO ICD definition of PR mortality was used: "the death of a woman while pregnant or within 42 days of termination of pregnancy, irrespective of the cause of death''. In addition, symptoms and events at the time of death were examined using the WHO verbal autopsy methodology. Deaths were categorized as either (i) directly PR: main cause of death was ascribed as obstetric, or (ii) indirectly PR: main cause of death was non-obstetric. Of 3,223 deaths in women 15 to 49 years, 249 (7.7%) were PR. One-third (34%) of these were due to direct obstetric causes, predominantly postpartum hemorrhage, abortion complications and puerperal sepsis. Two-thirds were indirect; three-quarters were attributable to human immunodeficiency virus (HIV/AIDS), malaria and tuberculosis. Significantly more women who died in lower socio-economic groups sought care from traditional birth attendants (p = 0.034), while less impoverished women were more likely to seek hospital care (p = 0.001). The PR mortality ratio over the six years was 740 (95% CI 651-838) per 100,000 live births, with no evidence of reduction over time (chi(2) linear trend = 1.07; p = 0.3). Conclusions: These data supplement current scanty information on the relationship between infectious diseases and poor maternal outcomes in Africa. They indicate low uptake of maternal health interventions in women dying during pregnancy and postpartum, suggesting improved access to and increased uptake of skilled obstetric care, as well as preventive measures against HIV/AIDS, malaria and tuberculosis among all women of childbearing age may help to reduce pregnancy-related mortality.	[Desai, Meghna; Katana, Abraham; Ouma, Peter] KEMRI CDC Res & Publ Hlth Collaborat, Malaria Branch, Kisumu, Kenya; [Desai, Meghna; Hamel, Mary J.; Slutsker, Laurence; Laserson, Kayla F.] Ctr Dis Control & Prevent, Ctr Global Hlth, Atlanta, GA USA; [Phillips-Howard, Penelope A.; van Eijk, Annemieke] Univ Liverpool, Liverpool Sch Trop Med, Dept Clin Sci, Liverpool L3 5QA, Merseyside, England; [Odhiambo, Frank O.; Ogwang, Sheila; Laserson, Kayla F.] KEMRI CDC Res & Publ Hlth Collaborat, Hlth & Demog Surveillance Syst Branch, Kisumu, Kenya; [Omoto, Jackton] Minist Hlth, Siaya Dist Hosp, Dept Obstet & Gynaecol, Siaya, Kenya; [Macharia, Sheila] US Agcy Int Dev, Off Populat & Hlth, Nairobi, Kenya	Centers for Disease Control & Prevention - USA; Liverpool School of Tropical Medicine; University of Liverpool; United States Agency for International Development (USAID)	Desai, M (corresponding author), KEMRI CDC Res & Publ Hlth Collaborat, Malaria Branch, Kisumu, Kenya.	mdesai@ke.cdc.gov	van Eijk, Anna Maria/AAQ-9894-2021	van Eijk, Anna Maria/0000-0003-1635-1289; Phillips-Howard, Penelope A/0000-0003-1018-116X	US Presidents Malaria Initiative (PMI); The President's Emergency Plan For AIDS Relief (PEPFAR); The Gates Foundation; European and Developing Countries Clinical Trials Partnership (EDCTP); UK Department for International Development; US Agency for International Development, US government collaboration on the Global Health Initiative; MRC [G1100677] Funding Source: UKRI; Medical Research Council [G1100677] Funding Source: researchfish	US Presidents Malaria Initiative (PMI)(United States Agency for International Development (USAID)President's Malaria Initiative (PMI)); The President's Emergency Plan For AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); The Gates Foundation(Bill & Melinda Gates Foundation); European and Developing Countries Clinical Trials Partnership (EDCTP); UK Department for International Development; US Agency for International Development, US government collaboration on the Global Health Initiative(United States Agency for International Development (USAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	HDSS and field staff funding support is acknowledged through individual grants, mainly through The US Presidents Malaria Initiative (PMI), The President's Emergency Plan For AIDS Relief (PEPFAR), The Gates Foundation, The European and Developing Countries Clinical Trials Partnership (EDCTP), and the UK Department for International Development, and through base support from the US Centers for Disease Control and Prevention. Partial funding for this analysis came from the US Agency for International Development as part of the US government collaboration on the Global Health Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adazu K, 2005, AM J TROP MED HYG, V73, P1151, DOI 10.4269/ajtmh.2005.73.1151; Adegoke AA, 2009, BJOG-INT J OBSTET GY, V116, P33, DOI 10.1111/j.1471-0528.2009.02336.x; Amornkul PN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006470; [Anonymous], 2010 KEN MAL IND SUR; Bauni E, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-49; Brabin B, 2002, MATERNAL MORBIDITY M, P65; Byass P, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.19281; Central Bureau of Statistics, 2010, KEN DEM HLTH SURV 20; Chandramohan D, 1998, TROP MED INT HEALTH, V3, P436, DOI 10.1046/j.1365-3156.1998.00255.x; Cotter K, 2006, J HEALTH POPUL NUTR, V24, P467; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Division of Leprosy TaLDMoPHaS, 2010, ANN REP 2010; FAUVEAU V, 1989, SOC SCI MED, V29, P1121, DOI 10.1016/0277-9536(89)90025-7; Ganatra BR, 1998, B WORLD HEALTH ORGAN, V76, P591; Gargano JW, 2012, AIDS, V26, P1545, DOI 10.1097/QAD.0b013e328353b7b9; Godia PM, 2012, SEXUAL REPROD HLTH S; Grange J, 2010, INT J GYNECOL OBSTET, V108, P181, DOI 10.1016/j.ijgo.2009.12.005; Hamel MJ, 2011, AM J TROP MED HYG, V85, P597, DOI 10.4269/ajtmh.2011.10-0678; Hill K, 2006, B WORLD HEALTH ORGAN, V84, P173, DOI 10.2471/BLT.05.027714; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Hubacher D, 2008, CONTRACEPTION, V78, P73, DOI 10.1016/j.contraception.2008.03.002; Kenya National AIDS/STI Control Programme (NASCOP), 2009, 2007 KEN AIDS IND SU; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Kinney MV, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000294; Kwambai TK, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-134; Macro O, 2004, KEN DEM HLTH SURV 20; McKenzie DJ, 2005, J POPUL ECON, V18, P229, DOI 10.1007/s00148-005-0224-7; Meltzer MI, 2003, AM J TROP MED HYG, V68, P149, DOI 10.4269/ajtmh.2003.68.149; Menendez C, 2008, PLOS MED, V5, P220, DOI 10.1371/journal.pmed.0050044; Ministry of Public Health and Sanitation and Ministry of Medical Services, 2009, REP KEN NAT REPR HLT, P2009; Nosten F, 2004, TRENDS PARASITOL, V20, P425, DOI 10.1016/j.pt.2004.06.007; Nyang'au IN, 2012, UNINTENDED PREGNANCI; Odhiambo FO, 2012, INT J EPIDEMIOL, V41, P977, DOI 10.1093/ije/dys108; Ouma PO, 2007, TROP MED INT HEALTH, V12, P953, DOI 10.1111/j.1365-3156.2007.01876.x; Ouma PO, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-1; Ronsmans C, 1999, LANCET, V354, P1448, DOI 10.1016/S0140-6736(99)03222-5; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Sedgh G, 2012, LANCET, V379, P625, DOI 10.1016/S0140-6736(11)61786-8; ter Kuile FO, 2003, AM J TROP MED HYG, V68, P50, DOI 10.4269/ajtmh.2003.68.50; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; van Eijk AM, 2008, TROP MED INT HEALTH, V13, P1314, DOI 10.1111/j.1365-3156.2008.02136.x; van Eijk AM, 2004, TROP MED INT HEALTH, V9, P630, DOI 10.1111/j.1365-3156.2004.01242.x; van Eijk Anna M, 2006, Reprod Health, V3, P2, DOI 10.1186/1742-4755-3-2; van Eijk AM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000370; van Roosmalen J, 2005, TROP MED INT HEALTH, V10, P393, DOI 10.1111/j.1365-3156.2005.01411.x; van't Hoog AH, 2011, AM J RESP CRIT CARE, V183, P1245, DOI 10.1164/rccm.201008-1269OC; WHO, 1999, WHOCDSCSRISR994; Ziraba Abdhalah Kasiira, 2009, Reprod Health, V6, P6, DOI 10.1186/1742-4755-6-6	48	34	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68733	10.1371/journal.pone.0068733	http://dx.doi.org/10.1371/journal.pone.0068733			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	186SF	23874741	Green Accepted, Green Published, gold			2022-12-27	WOS:000322064300066
J	Suzuki, T; Kasuya, Y; Itoh, Y; Ota, Y; Zhan, P; Asamitsu, K; Nakagawa, H; Okamoto, T; Miyata, N				Suzuki, Takayoshi; Kasuya, Yuki; Itoh, Yukihiro; Ota, Yosuke; Zhan, Peng; Asamitsu, Kaori; Nakagawa, Hidehiko; Okamoto, Takashi; Miyata, Naoki			Identification of Highly Selective and Potent Histone Deacetylase 3 Inhibitors Using Click Chemistry-Based Combinatorial Fragment Assembly	PLOS ONE			English	Article							MATRIX METALLOPROTEASE INHIBITORS; TRANSFORMED-CELL DIFFERENTIATION; NF-KAPPA-B; TERMINAL ALKYNES; GENE-EXPRESSION; CANCER-CELLS; ACETYLATION; DESIGN; HDAC3; AZIDES	To find histone deacetylase 3 (HDAC3)-selective inhibitors, a series of 504 candidates was assembled using "click chemistry'', by reacting nine alkynes bearing a zinc-binding group with 56 azide building blocks in the presence of Cu(I) catalyst. Screening of the 504-member triazole library against HDAC3 and other HDAC isozymes led to the identification of potent and selective HDAC3 inhibitors T247 and T326. These compounds showed potent HDAC3 inhibition with submicromolar IC(50)s, whereas they did not strongly inhibit other isozymes. Compounds T247 and T326 also induced a dose-dependent selective increase of NF-kappa B acetylation in human colon cancer HCT116 cells, indicating selective inhibition of HDAC3 in the cells. In addition, these HDAC3-selective inhibitors induced growth inhibition of cancer cells, and activated HIV gene expression in latent HIV-infected cells. These findings indicate that HDAC3-selective inhibitors are promising candidates for anticancer drugs and antiviral agents. This work also suggests the usefulness of the click chemistry approach to find isozyme-selective HDAC inhibitors.	[Suzuki, Takayoshi; Itoh, Yukihiro; Ota, Yosuke; Zhan, Peng] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Kyoto, Japan; [Suzuki, Takayoshi] Japan Sci & Technol Agcy JST, PRESTO, Saitama, Japan; [Kasuya, Yuki; Nakagawa, Hidehiko; Miyata, Naoki] Nagoya City Univ, Grad Sch Pharmaceut Sci, Nagoya, Aichi, Japan; [Asamitsu, Kaori; Okamoto, Takashi] Nagoya City Univ, Grad Sch Med Sci, Nagoya, Aichi, Japan	Kyoto Prefectural University of Medicine; Japan Science & Technology Agency (JST); Nagoya City University; Nagoya City University	Suzuki, T (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Kyoto, Japan.	suzukit@koto.kpu-m.ac.jp; miyata-n@phar.nagoya-cu.ac.jp	Itoh, Yukihiro/S-4159-2019	Itoh, Yukihiro/0000-0002-3410-2924; Asamitsu, Kaori/0000-0001-5333-8011	JST PRESTO program; Japan Society for the Promotion of Science; Foundation NAGASE Science Technology Development; Shorai Foundation for Science and Technology; Grants-in-Aid for Scientific Research [24659050] Funding Source: KAKEN	JST PRESTO program; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Foundation NAGASE Science Technology Development; Shorai Foundation for Science and Technology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by JST PRESTO program (TS), a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (TS), and grants from Foundation NAGASE Science Technology Development (TS) and the Shorai Foundation for Science and Technology (TS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Bhaskara S, 2010, CANCER CELL, V18, P436, DOI 10.1016/j.ccr.2010.10.022; Biel M, 2005, ANGEW CHEM INT EDIT, V44, P3186, DOI 10.1002/anie.200461346; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen XF, 2012, P NATL ACAD SCI USA, V109, pE2865, DOI 10.1073/pnas.1121131109; Chen Y, 2011, NAT NEUROSCI, V14, P437, DOI 10.1038/nn.2780; Chen YF, 2009, CHEMMEDCHEM, V4, P842, DOI 10.1002/cmdc.200800461; Frater J, 2011, CURR OPIN INFECT DIS, V24, P593, DOI 10.1097/QCO.0b013e32834cfb2d; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Gregoire S, 2007, MOL CELL BIOL, V27, P1280, DOI 10.1128/MCB.00882-06; Hassig CA, 1998, P NATL ACAD SCI USA, V95, P3519, DOI 10.1073/pnas.95.7.3519; Hoberg JE, 2006, MOL CELL BIOL, V26, P457, DOI 10.1128/MCB.26.2.457-471.2006; Hu F, 2009, BIOORG MED CHEM LETT, V19, P3928, DOI 10.1016/j.bmcl.2009.03.085; Hu MY, 2008, ORG LETT, V10, P5529, DOI 10.1021/ol802286g; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Huber K, 2011, J BIOL CHEM, V286, P22211, DOI 10.1074/jbc.M110.180224; Itoh Y, 2008, CURR PHARM DESIGN, V14, P529; Itoh Y, 2007, J MED CHEM, V50, P5425, DOI 10.1021/jm7009217; Jia HQ, 2012, NEUROBIOL DIS, V46, P351, DOI 10.1016/j.nbd.2012.01.016; Karagianni P, 2007, ONCOGENE, V26, P5439, DOI 10.1038/sj.onc.1210612; Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.3.CO;2-X; Lee LV, 2003, J AM CHEM SOC, V125, P9588, DOI 10.1021/ja0302836; Longworth MS, 2006, ONCOGENE, V25, P4495, DOI 10.1038/sj.onc.1209473; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Mai A, 2005, MED RES REV, V25, P261, DOI 10.1002/med.20024; Malvaez M, 2013, P NATL ACAD SCI USA, V110, P2647, DOI 10.1073/pnas.1213364110; Mariadason JM, 2008, CANCER BIOL THER, V7, P1581, DOI 10.4161/cbt.7.10.6863; Miller TA, 2003, J MED CHEM, V46, P5097, DOI 10.1021/jm0303094; Paris M, 2008, J MED CHEM, V51, P1505, DOI 10.1021/jm7011408; Richon VM, 1996, P NATL ACAD SCI USA, V93, P5705, DOI 10.1073/pnas.93.12.5705; Richon VM, 1998, P NATL ACAD SCI USA, V95, P3003, DOI 10.1073/pnas.95.6.3003; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Schafer S, 2005, ARCH PHARM, V338, P347, DOI 10.1002/ardp.200500984; Srinivasan R, 2006, ORG LETT, V8, P713, DOI 10.1021/ol052895w; Srinivasan R, 2007, NAT PROTOC, V2, P2655, DOI 10.1038/nprot.2007.323; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Suzuki N, 2009, J MED CHEM, V52, P2909, DOI 10.1021/jm900125m; Suzuki T, 2006, CURR MED CHEM, V13, P935, DOI 10.2174/092986706776361067; Suzuki T, 2005, J MED CHEM, V48, P1019, DOI 10.1021/jm049207j; Suzuki T, 2006, J MED CHEM, V49, P4809, DOI 10.1021/jm060554y; Suzuki T, 2012, J MED CHEM, V55, P9562, DOI 10.1021/jm300837y; Suzuki T, 2010, ANGEW CHEM INT EDIT, V49, P6817, DOI 10.1002/anie.201002205; Takami Y, 2000, J BIOL CHEM, V275, P16191, DOI 10.1074/jbc.M908066199; Tan LP, 2009, ORG LETT, V11, P5102, DOI 10.1021/ol9023419; Thangaraju M, 2009, BIOCHEM J, V417, P379, DOI 10.1042/BJ20081132; Tornoe CW, 2002, J ORG CHEM, V67, P3057, DOI 10.1021/jo011148j; Victoriano AFB, 2011, FEBS LETT, V585, P1103, DOI 10.1016/j.febslet.2011.03.017; Wang J, 2006, ORG LETT, V8, P3821, DOI 10.1021/ol061431a; Watson PJ, 2012, NATURE, V481, P335, DOI 10.1038/nature10728; Weichert W, 2008, BRIT J CANCER, V98, P604, DOI 10.1038/sj.bjc.6604199; Wen YD, 2000, P NATL ACAD SCI USA, V97, P7202, DOI 10.1073/pnas.97.13.7202; Xu CP, 2009, CHEM BIOL, V16, P980, DOI 10.1016/j.chembiol.2009.07.010; Yoshida Minoru, 2003, Prog Cell Cycle Res, V5, P269; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9; Zhu W, 2004, CHEM COMMUN, P888, DOI 10.1039/b400878b	55	62	63	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68669	10.1371/journal.pone.0068669	http://dx.doi.org/10.1371/journal.pone.0068669			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874714	gold, Green Submitted, Green Published			2022-12-27	WOS:000322064300063
J	Tikole, S; Jaravine, V; Orekhov, VY; Guntert, P				Tikole, Suhas; Jaravine, Victor; Orekhov, Vladislav Yu.; Guentert, Peter			Effects of NMR Spectral Resolution on Protein Structure Calculation	PLOS ONE			English	Article							TORSION ANGLE DYNAMICS; MULTIDIMENSIONAL NMR; CHEMICAL-SHIFTS; GLOBAL FOLD; SPECTROSCOPY; ASSIGNMENTS; DECOMPOSITION; SENSITIVITY; NOESY; TROSY	Adequate digital resolution and signal sensitivity are two critical factors for protein structure determinations by solution NMR spectroscopy. The prime objective for obtaining high digital resolution is to resolve peak overlap, especially in NOESY spectra with thousands of signals where the signal analysis needs to be performed on a large scale. Achieving maximum digital resolution is usually limited by the practically available measurement time. We developed a method utilizing non-uniform sampling for balancing digital resolution and signal sensitivity, and performed a large-scale analysis of the effect of the digital resolution on the accuracy of the resulting protein structures. Structure calculations were performed as a function of digital resolution for about 400 proteins with molecular sizes ranging between 5 and 33 kDa. The structural accuracy was assessed by atomic coordinate RMSD values from the reference structures of the proteins. In addition, we monitored also the number of assigned NOESY cross peaks, the average signal sensitivity, and the chemical shift spectral overlap. We show that high resolution is equally important for proteins of every molecular size. The chemical shift spectral overlap depends strongly on the corresponding spectral digital resolution. Thus, knowing the extent of overlap can be a predictor of the resulting structural accuracy. Our results show that for every molecular size a minimal digital resolution, corresponding to the natural linewidth, needs to be achieved for obtaining the highest accuracy possible for the given protein size using state-of-the-art automated NOESY assignment and structure calculation methods.	[Tikole, Suhas; Jaravine, Victor; Guentert, Peter] Goethe Univ Frankfurt, Inst Biophys Chem, Ctr Biomol Magnet Resonance, D-60054 Frankfurt, Germany; [Tikole, Suhas; Jaravine, Victor; Guentert, Peter] Goethe Univ Frankfurt, Frankfurt Inst Adv Studies, D-60054 Frankfurt, Germany; [Orekhov, Vladislav Yu.] Gothenburg Univ, Swedish NMR Ctr, Gothenburg, Sweden; [Guentert, Peter] Tokyo Metropolitan Univ, Grad Sch Sci, Hachioji, Tokyo, Japan	Goethe University Frankfurt; Goethe University Frankfurt; University of Gothenburg; Tokyo Metropolitan University	Guntert, P (corresponding author), Goethe Univ Frankfurt, Inst Biophys Chem, Ctr Biomol Magnet Resonance, D-60054 Frankfurt, Germany.	guentert@em.uni-frankfurt.de	Orekhov, Vladislav/AAD-8464-2019; Güntert, Peter/L-5577-2013; Orekhov, Vladislav/AAC-8357-2022	Orekhov, Vladislav/0000-0002-7892-6896; Güntert, Peter/0000-0002-2911-7574; 	Deutsche Forschungsgemeinschaft [DFG JA1952/1-1]; Lichtenberg program of the Volkswagen Foundation; Japan Society for the Promotion of Science (JSPS); Swedish Research Council [621-2011-5994]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Lichtenberg program of the Volkswagen Foundation; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Deutsche Forschungsgemeinschaft (grant DFG JA1952/1-1), the Lichtenberg program of the Volkswagen Foundation, the Japan Society for the Promotion of Science (JSPS), and the Swedish Research Council (621-2011-5994). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abragam A., 1961, PRINCIPLES NUCL MAGN; BARNA JCJ, 1987, J MAGN RESON, V73, P69, DOI 10.1016/0022-2364(87)90225-3; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Billeter M, 2012, TOP CURR CHEM, V316, pIX; Cavanagh J., 2010, PROTEIN NMR SPECTROS; Coggins BE, 2012, J AM CHEM SOC, V134, P18619, DOI 10.1021/ja307445y; Frueh DP, 2006, J AM CHEM SOC, V128, P5757, DOI 10.1021/ja0584222; Gardner KH, 1998, ANNU REV BIOPH BIOM, V27, P357, DOI 10.1146/annurev.biophys.27.1.357; Guntert P, 2009, EUR BIOPHYS J BIOPHY, V38, P129, DOI 10.1007/s00249-008-0367-z; Guntert P, 2003, PROG NUCL MAG RES SP, V43, P105, DOI 10.1016/S0079-6565(03)00021-9; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Hiller S, 2009, J AM CHEM SOC, V131, P12970, DOI 10.1021/ja902012x; Hoch JC, 1996, NMR DATA PROCESSING; Hyberts SG, 2013, J BIOMOL NMR, V55, P167, DOI 10.1007/s10858-012-9698-2; Ikeya T, 2011, J BIOMOL NMR, V50, P137, DOI 10.1007/s10858-011-9502-8; Jaravine VA, 2008, J AM CHEM SOC, V130, P3927, DOI 10.1021/ja077282o; Jaravine VA, 2006, J AM CHEM SOC, V128, P13421, DOI 10.1021/ja062146p; Jee JunGoo, 2003, Journal of Structural and Functional Genomics, V4, P179, DOI 10.1023/A:1026122726574; Kainosho M, 2006, NATURE, V440, P52, DOI 10.1038/nature04525; Kainosho M, 2009, Q REV BIOPHYS, V42, P247, DOI 10.1017/S0033583510000016; Kirchner DK, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-170; Lemak A, 2011, J BIOMOL NMR, V49, P27, DOI 10.1007/s10858-010-9458-0; Liu GH, 2005, P NATL ACAD SCI USA, V102, P10487, DOI 10.1073/pnas.0504338102; Lopez-Mendez B, 2006, J AM CHEM SOC, V128, P13112, DOI 10.1021/ja061136l; Luan T, 2005, J BIOMOL NMR, V33, P1, DOI 10.1007/s10858-005-1363-6; Maciejewski M. W, 2006, NONUNIFORM SAMPLING, V2, P1305; Montelione GT, 2000, NAT STRUCT BIOL, V7, P982, DOI 10.1038/80768; Orekhov VY, 2011, PROG NUCL MAG RES SP, V59, P271, DOI 10.1016/j.pnmrs.2011.02.002; Rogov VV, 2012, CHEMBIOCHEM, V13, P959, DOI 10.1002/cbic.201200045; Rovnyak D, 2004, J BIOMOL NMR, V30, P1, DOI 10.1023/B:JNMR.0000042946.04002.19; Rule GS, 2006, FUNDAMENTALS PROTEIN; Salzmann M, 1999, J AM CHEM SOC, V121, P844, DOI 10.1021/ja9834226; Schuyler AD, 2011, J BIOMOL NMR, V50, P247, DOI 10.1007/s10858-011-9512-6; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sun ZYJ, 2005, J BIOMOL NMR, V32, P55, DOI 10.1007/s10858-005-3339-y; Tikole S, 2012, CHEMBIOCHEM, V13, P964, DOI 10.1002/cbic.201200044; Tugarinov V, 2005, J AM CHEM SOC, V127, P2767, DOI 10.1021/ja044032o; Tugarinov V, 2005, P NATL ACAD SCI USA, V102, P622, DOI 10.1073/pnas.0407792102; Tugarinov V, 2002, J AM CHEM SOC, V124, P10025, DOI 10.1021/ja0205636; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yee A, 2002, P NATL ACAD SCI USA, V99, P1825, DOI 10.1073/pnas.042684599; Zhang HY, 2003, J BIOMOL NMR, V25, P173, DOI 10.1023/A:1022836027055; Zheng DY, 2003, PROTEIN SCI, V12, P1232, DOI 10.1110/ps.0300203	47	9	9	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68567	10.1371/journal.pone.0068567	http://dx.doi.org/10.1371/journal.pone.0068567			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874675	Green Published, Green Submitted, gold			2022-12-27	WOS:000322064300051
J	Marquand, AF; Filippone, M; Ashburner, J; Girolami, M; Mourao-Miranda, J; Barker, GJ; Williams, SCR; Leigh, PN; Blain, CRV				Marquand, Andre F.; Filippone, Maurizio; Ashburner, John; Girolami, Mark; Mourao-Miranda, Janaina; Barker, Gareth J.; Williams, Steven C. R.; Leigh, P. Nigel; Blain, Camilla R. V.			Automated, High Accuracy Classification of Parkinsonian Disorders: A Pattern Recognition Approach	PLOS ONE			English	Article							PROGRESSIVE SUPRANUCLEAR PALSY; MULTIPLE SYSTEM ATROPHY; VOXEL-BASED MORPHOMETRY; DEEP-BRAIN-STIMULATION; CEREBELLAR PEDUNCLE; CONSENSUS STATEMENT; DIAGNOSTIC-CRITERIA; CEREBRAL ATROPHY; WORKING-MEMORY; DISEASE	Progressive supranuclear palsy (PSP), multiple system atrophy (MSA) and idiopathic Parkinson's disease (IPD) can be clinically indistinguishable, especially in the early stages, despite distinct patterns of molecular pathology. Structural neuroimaging holds promise for providing objective biomarkers for discriminating these diseases at the single subject level but all studies to date have reported incomplete separation of disease groups. In this study, we employed multi-class pattern recognition to assess the value of anatomical patterns derived from a widely available structural neuroimaging sequence for automated classification of these disorders. To achieve this, 17 patients with PSP, 14 with IPD and 19 with MSA were scanned using structural MRI along with 19 healthy controls (HCs). An advanced probabilistic pattern recognition approach was employed to evaluate the diagnostic value of several pre-defined anatomical patterns for discriminating the disorders, including: (i) a subcortical motor network; (ii) each of its component regions and (iii) the whole brain. All disease groups could be discriminated simultaneously with high accuracy using the subcortical motor network. The region providing the most accurate predictions overall was the midbrain/brainstem, which discriminated all disease groups from one another and from HCs. The subcortical network also produced more accurate predictions than the whole brain and all of its constituent regions. PSP was accurately predicted from the midbrain/brainstem, cerebellum and all basal ganglia compartments; MSA from the midbrain/brainstem and cerebellum and IPD from the midbrain/brainstem only. This study demonstrates that automated analysis of structural MRI can accurately predict diagnosis in individual patients with Parkinsonian disorders, and identifies distinct patterns of regional atrophy particularly useful for this process.	[Marquand, Andre F.; Mourao-Miranda, Janaina; Barker, Gareth J.; Williams, Steven C. R.; Blain, Camilla R. V.] Kings Coll London, Inst Psychiat, Dept Neuroimaging, Ctr Neuroimaging Sci, London, England; [Filippone, Maurizio] Univ Glasgow, Sch Comp Sci, Glasgow, Lanark, Scotland; [Ashburner, John] UCL, Wellcome Trust Ctr Neuroimaging, London, England; [Girolami, Mark; Mourao-Miranda, Janaina] UCL, Ctr Computat Stat & Machine Learning, London, England; [Leigh, P. Nigel] Univ Sussex, Trafford Ctr Biomed Res, Brighton & Sussex Med Sch, Falmer, E Sussex, England	University of London; King's College London; University of Glasgow; University of London; University College London; University of London; University College London; University of Brighton; University of Sussex	Marquand, AF (corresponding author), Kings Coll London, Inst Psychiat, Dept Neuroimaging, Ctr Neuroimaging Sci, London, England.	andre.marquand@kcl.ac.uk	Leigh, Peter/AAD-5638-2019; Mourao-Miranda, Janaina/AAS-2072-2021; Marquand, Andre F/B-6050-2012; Barker, Gareth J/C-9616-2009; Mourao-Miranda, Janaina/AAT-2985-2021; Williams, Steve C/D-6979-2011; Ashburner, John/I-3757-2013	Mourao-Miranda, Janaina/0000-0002-3309-8441; Marquand, Andre F/0000-0001-5903-203X; Barker, Gareth J/0000-0002-5214-7421; Williams, Steve C/0000-0003-4299-1941; Ashburner, John/0000-0001-7605-2518; opoku, anita/0000-0001-7243-8157; Filippone, Maurizio/0000-0001-7294-472X; Girolami, Mark/0000-0003-3008-253X	Wellcome Trust [WT025555, WT088641/Z/09/Z, WT086565/Z/08/Z]; King's College London Centre of Excellence in Medical Engineering; Wellcome Trust; Engineering and Physical Sciences Research Council; EPSRC [EP/H024875/2] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H024875/2] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); King's College London Centre of Excellence in Medical Engineering; Wellcome Trust(Wellcome TrustEuropean Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The authors gratefully acknowledge support from the Wellcome Trust (grant nos: WT025555, WT088641/Z/09/Z and WT086565/Z/08/Z). AFM gratefully acknowledges support from King's College London Centre of Excellence in Medical Engineering, funded by the Wellcome Trust and Engineering and Physical Sciences Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bensimon G, 2009, BRAIN, V132, P156, DOI 10.1093/brain/awn291; Blain CRV, 2006, NEUROLOGY, V67, P2199, DOI 10.1212/01.wnl.0000249307.59950.f8; Braak H, 2000, J NEUROL, V247, P3; Brenneis C, 2003, MOVEMENT DISORD, V18, P1132, DOI 10.1002/mds.10502; Brodersen KH, 2010, P 20 INT C PATT REC; Bronte-Stewart HM, 2002, BRAIN, V125, P2100, DOI 10.1093/brain/awf207; Burton EJ, 2004, BRAIN, V127, P791, DOI 10.1093/brain/awh088; Chu C, 2012, NEUROIMAGE, V60, P59, DOI 10.1016/j.neuroimage.2011.11.066; Cordato NJ, 2005, BRAIN, V128, P1259, DOI 10.1093/brain/awh508; Deuschl G, 2006, NEW ENGL J MED, V355, P896, DOI 10.1056/NEJMoa060281; Duchesne S, 2009, ACAD RADIOL, V16, P61, DOI 10.1016/j.acra.2008.05.024; Filippone M, 2012, ANN APPL STAT, V6, P1883, DOI 10.1214/12-AOAS562; Focke NK, 2011, HUM BRAIN MAPP, V32, P1905, DOI 10.1002/hbm.21161; Gilman S, 2008, NEUROLOGY, V71, P670, DOI 10.1212/01.wnl.0000324625.00404.15; Gilman S, 1999, J NEUROL SCI, V163, P94, DOI 10.1016/S0022-510X(98)00304-9; HAUW JJ, 1994, NEUROLOGY, V44, P2015, DOI 10.1212/WNL.44.11.2015; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Hughes AJ, 2002, BRAIN, V125, P861, DOI 10.1093/brain/awf080; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Hughes Andrew J., 2001, Neurology, V57, P1142; Josephs KA, 2008, NEUROBIOL AGING, V29, P280, DOI 10.1016/j.neurobiolaging.2006.09.019; Jubault T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008247; Kloppel S, 2009, NEUROLOGY, V72, P426, DOI 10.1212/01.wnl.0000341768.28646.b6; Kloppel S, 2008, BRAIN, V131, P681, DOI 10.1093/brain/awm319; Kloppel S, 2012, NEUROIMAGE, V61, P457, DOI 10.1016/j.neuroimage.2011.11.002; Litvan I, 2003, MOVEMENT DISORD, V18, P467, DOI 10.1002/mds.10459; Litvan I, 1996, NEUROLOGY, V47, P1, DOI 10.1212/WNL.47.1.1; Mahlknecht P, 2010, NEURODEGENER DIS, V7, P300, DOI 10.1159/000314495; Marquand AF, 2008, NEUROREPORT, V19, P1507, DOI 10.1097/WNR.0b013e328310425e; Marquand AF, 2012, NEUROIMAGE, V60, P1015, DOI 10.1016/j.neuroimage.2012.01.058; Marquand AF, 2011, NEUROPSYCHOPHARMACOL, V36, P1237, DOI 10.1038/npp.2011.9; Minnerop M, 2007, NEUROIMAGE, V36, P1086, DOI 10.1016/j.neuroimage.2007.04.028; Mourao-Miranda J, 2012, BIPOLAR DISORD, V14, P451, DOI 10.1111/j.1399-5618.2012.01019.x; Mourao-Miranda J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029482; Nicoletti G, 2006, RADIOLOGY, V239, P825, DOI 10.1148/radiol.2393050459; Orru G, 2012, NEUROSCI BIOBEHAV R, V36, P1140, DOI 10.1016/j.neubiorev.2012.01.004; Ozawa T, 2004, BRAIN, V127, P2657, DOI 10.1093/brain/awh303; PAPP MI, 1994, BRAIN, V117, P235, DOI 10.1093/brain/117.2.235; Paviour DC, 2005, NEUROLOGY, V64, P675, DOI 10.1212/01.WNL.0000151854.85743.C7; Payan CAM, 2002, MOVEMENT DISORD, V17, pS256; Price S, 2004, NEUROIMAGE, V23, P663, DOI 10.1016/j.neuroimage.2004.06.013; Quattrone A, 2008, RADIOLOGY, V246, P214, DOI 10.1148/radiol.2453061703; Rolland Y, 2011, J NEUROL NEUROSUR PS, V82, P1025, DOI 10.1136/jnnp.2010.214890; Schwab R.S., 1968, P 3 S PARK DIS ED UK, P152; Shih LC, 2007, MOVEMENT DISORD, V22, P2149, DOI 10.1002/mds.21648; Singh N, 2010, LECT NOTES COMPUT SC, V6363, P529; Williams DR, 2005, BRAIN, V128, P1247, DOI 10.1093/brain/awh488	47	29	29	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2013	8	7							e69237	10.1371/journal.pone.0069237	http://dx.doi.org/10.1371/journal.pone.0069237			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZN	23869237	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000323110600037
J	Mellander, PE; Gebrehiwot, SG; Gardenas, AI; Bewket, W; Bishop, K				Mellander, Per-Erik; Gebrehiwot, Solomon G.; Gardenas, Annemieke I.; Bewket, Woldeamlak; Bishop, Kevin			Summer Rains and Dry Seasons in the Upper Blue Nile Basin: The Predictability of Half a Century of Past and Future Spatiotemporal Patterns	PLOS ONE			English	Article							CLIMATE-CHANGE; RIVER-BASIN; STREAM-FLOW; EL-NINO; RAINFALL; VARIABILITY; ETHIOPIA; HIGHLANDS; DYNAMICS; IMPACT	During the last 100 years the Ethiopian upper Blue Nile Basin (BNB) has undergone major changes in land use, and is now potentially facing changes in climate. Rainfall over BNB supplies over two-thirds of the water to the Nile and supports a large local population living mainly on subsistence agriculture. Regional food security is sensitive to both the amount and timing of rain and is already an important political challenge that will be further complicated if scenarios of climate change are realized. In this study a simple spatial model of the timing and duration of summer rains (Kiremt) and dry season (Bega), and annual rain over the upper BNB was established from observed data between 1952 and 2004. The model was used to explore potential impacts of climate change on these rains, using a down-scaled ECHAM5/MP1-OM scenario between 2050 and 2100. Over the observed period the amount, onset and duration of Kiremt rains and rain-free Bega days have exhibited a consistent spatial pattern. The spatially averaged annual rainfall was 1490 mm of which 93% was Kiremt rain. The average Kiremt rain and number of rainy days was higher in the southwest (322 days) and decreased towards the north (136 days). Under the 2050-2100 scenario, the annual mean rainfall is predicted to increase by 6% and maintain the same spatial pattern as in the past. A larger change in annual rainfall is expected in the southwest (ca. +130 mm) with a gradually smaller change towards the north (ca. +70 mm). Results highlight the need to account for the characteristic spatiotemporal zonation when planning water management and climate adaptation within the upper BNB. The presented simple spatial resolved models of the presence of Kiremt and annual total rainfall could be used as a baseline for such long-term planning.	[Mellander, Per-Erik] Johnstown Castle Environm Res Ctr, TEAGASC, Agr Catchments Programme, Wexford, County Wexford, Ireland; [Gebrehiwot, Solomon G.; Bishop, Kevin] Swedish Univ Agr Sci, Dept Aquat Sci & Assessment, Uppsala, Sweden; [Gardenas, Annemieke I.] Swedish Univ Agr Sci, Dept Soil & Environm, Uppsala, Sweden; [Bewket, Woldeamlak] Univ Addis Ababa, Dept Geog & Environm Studies, Addis Ababa, Ethiopia; [Gebrehiwot, Solomon G.] Univ Addis Ababa, Ethiopian Inst Water Resources, Addis Ababa, Ethiopia; [Bishop, Kevin] Uppsala Univ, Dept Earth Sci, Uppsala, Sweden	Teagasc; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Addis Ababa University; Addis Ababa University; Uppsala University	Mellander, PE (corresponding author), Johnstown Castle Environm Res Ctr, TEAGASC, Agr Catchments Programme, Wexford, County Wexford, Ireland.	Per-Erik.Mellander@teagasc.ie	Gärdenäs, Annemieke/AAE-9564-2019; Gärdenäs, Annemieke/HGV-1512-2022; Bishop, Kevin H/C-7816-2012	Bishop, Kevin H/0000-0002-8057-1051; Reurslag Gardenas, Annemarie/0000-0001-8390-220X	Swedish International Development Cooperation Agency	Swedish International Development Cooperation Agency	This study was funded by the Swedish International Development Cooperation Agency, http://www.sida.se/English/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abtew W, 2009, HYDROL PROCESS, V23, P3653, DOI 10.1002/hyp.7367; Bewket W, 2005, HYDROL PROCESS, V19, P445, DOI 10.1002/hyp.5542; Bewket W., 2007, ETHIOP J DEV RES, V29, P1, DOI DOI 10.4314/EJDR.V29I1.38642; Bewket W, 2009, RAINWATER HARVESTING, P168; Bitew MM, 2009, HYDROL PROCESS, V23, P3670, DOI 10.1002/hyp.7468; Block P, 2012, REV DEV ECON, V16, P476, DOI 10.1111/j.1467-9361.2012.00675.x; Bossio D., 2012, Water Alternatives, V5, P223; Bryan E, 2009, ENVIRON SCI POLICY, V12, P413, DOI 10.1016/j.envsci.2008.11.002; Camberlin P, 1997, J CLIMATE, V10, P1380, DOI 10.1175/1520-0442(1997)010<1380:RAITSR>2.0.CO;2; Camberlin P, 2009, MONOGR BIOL, V89, P307; Conway D, 2000, GEOGR J, V166, P49, DOI 10.1111/j.1475-4959.2000.tb00006.x; de Boer B, 2007, KNMI PUBLICATION, P46; Deressa TT, 2011, J AGR SCI-CAMBRIDGE, V149, P23, DOI 10.1017/S0021859610000687; Endalew GJ, 2007, 200702 KNMI WR; Engida AN, 2011, J HYDROL, V399, P226, DOI 10.1016/j.jhydrol.2011.01.001; Gebrehiwot SG, 2012, THESIS SWEDISH U AGR, P13; Gebrehiwot SG, 2010, AMBIO, V39, P284, DOI 10.1007/s13280-010-0047-y; Haile AT, 2009, J APPL METEOROL CLIM, V48, P1696, DOI 10.1175/2009JAMC2092.1; Hulme M., 2005, Climate change and Africa, P29, DOI 10.1017/CBO9780511535864.013; Jury MR, 2010, THEOR APPL CLIMATOL, V101, P29, DOI 10.1007/s00704-009-0200-3; Kim U, 2008, J AM WATER RESOUR AS, V44, P1231, DOI 10.1111/j.1752-1688.2008.00220.x; Kim U, 2009, J AM WATER RESOUR AS, V45, P1361, DOI 10.1111/j.1752-1688.2009.00369.x; Lopez-Moreno JI, 2009, J HYDROL, V374, P384, DOI 10.1016/j.jhydrol.2009.06.049; Lopez-Moreno JI, 2009, THEOR APPL CLIMATOL, V95, P375, DOI 10.1007/s00704-008-0015-7; Mellander PE, 2007, CLIMATIC CHANGE, V85, P179, DOI 10.1007/s10584-007-9254-3; Ministry of Water Resources, 1999, ABB RIV BAS INT DEV; Ministry of Water Resources, 1998, ABB RIV BAS INT DEV; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Mohamed YA, 2005, HYDROL EARTH SYST SC, V9, P693; Mohammed UM, 2005, CLIMATE CHANGE AFRIC, P23; Nicol A, 2011, REV AFR POLIT ECON, V38, P317, DOI 10.1080/03056244.2011.582767; Openshaw K., 2005, Climate change and Africa, P113, DOI 10.1017/CBO9780511535864.021; Rosell S, 2011, APPL GEOGR, V31, P329, DOI 10.1016/j.apgeog.2010.07.005; Segele ZT, 2005, METEOROL ATMOS PHYS, V89, P153, DOI 10.1007/s00703-005-0127-x; Seleshi Y, 2004, INT J CLIMATOL, V24, P973, DOI 10.1002/joc.1052; Tadege A., 2007, CLIMATE CHANGE NATL; Taye MT, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR011466; Tesemma ZK, 2010, HYDROL PROCESS, V24, P3747, DOI 10.1002/hyp.7893; Walker W.E., 2003, INTEGR ASSESS, V4, P5; Weibull W., 1961, FATIGUE TESTING ANAL; World Bank, 2006, ETH MAN WAT RES MAX; Zaitchik BF, 2012, INT J ENV RES PUB HE, V9, P435, DOI 10.3390/ijerph9020435; Zelle H, 2005, J CLIMATE, V18, P4669, DOI 10.1175/JCLI3574.1	43	31	31	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2013	8	7							e68461	10.1371/journal.pone.0068461	http://dx.doi.org/10.1371/journal.pone.0068461			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZN	23869219	Green Published, Green Submitted, gold			2022-12-27	WOS:000323110600018
J	Almenara, CCP; Broseghini, GB; Vescovi, MVA; Angeli, JK; Faria, TD; Stefanon, I; Vassallo, DV; Padilha, AS				Almenara, Camila C. P.; Broseghini-Filho, Gilson B.; Vescovi, Marcus V. A.; Angeli, Jhuli K.; Faria, Thais de O.; Stefanon, Ivanita; Vassallo, Dalton V.; Padilha, Alessandra S.			Chronic Cadmium Treatment Promotes Oxidative Stress and Endothelial Damage in Isolated Rat Aorta	PLOS ONE			English	Article							NITRIC-OXIDE; ANTIOXIDANT; EXPRESSION; EXPOSURE; LEAD; ATHEROSCLEROSIS; DYSFUNCTION; MODULATION; MORTALITY; MERCURY	Cadmium is a highly toxic metal that is present in phosphate fertilizers, and the incidence of cadmium poisoning in the general population has increased, mainly due to cigarette smoking. Once absorbed, cadmium accumulates in the tissues, causing harmful effects including high blood pressure, endothelial damage and oxidative stress. Oxidative stress is known to efficiently produce oxidized low-density lipoprotein and consequently atherosclerosis, mainly in the aorta. However, the mechanisms through which endothelial damage is induced by cadmium have not been elucidated. Thus, the aim of this study was to investigate the effects of this metal in the isolated aorta and the possible role of oxidative stress. Rats received 100 mg. L-1 cadmium chloride (CdCl2) in the drinking water or distilled water alone for four weeks. The pressor effect of cadmium was followed throughout the exposure period by tail plethysmography. At the end of the fourth week, the blood cadmium content was established, and the vascular reactivity of the isolated aorta to phenylephrine, acetylcholine and sodium nitroprusside was analyzed in the context of endothelium denudation and incubation with L-NAME, apocynin, losartan, enalapril, superoxide dismutase (SOD) or catalase. We observed an increased response to phenylephrine in cadmium-treated rats. This increase was abolished by catalase and SOD incubation. Apocynin treatment reduced the phenylephrine response in both treatment groups, but its effect was greater in cadmium-treated rats, and NOX2 expression was greater in the cadmium group. These results suggested that cadmium in blood concentrations similar to those found in occupationally exposed populations is able to stimulate NOX2 expression, contributing to oxidative stress and reducing NO bioavailability, despite enhanced eNOS expression. These findings suggest that cadmium exposure promotes endothelial damage that might contribute to inflammation, vascular injury and the development of atherosclerosis.	[Almenara, Camila C. P.; Broseghini-Filho, Gilson B.; Angeli, Jhuli K.; Faria, Thais de O.; Stefanon, Ivanita; Vassallo, Dalton V.; Padilha, Alessandra S.] Univ Fed Espirito Santo, Dept Physiol Sci, Vitoria, ES, Brazil; [Vassallo, Dalton V.] Hlth Sci Ctr Vitoria EMESCAM, Vitoria, ES, Brazil; [Vescovi, Marcus V. A.] Univ Fed Espirito Santo, Dept Chem, Vitoria, ES, Brazil	Universidade Federal do Espirito Santo; Escola Superior de Ciencias da Santa Casa de Misericordia de Vitoria; Universidade Federal do Espirito Santo	Almenara, CCP (corresponding author), Univ Fed Espirito Santo, Dept Physiol Sci, Vitoria, ES, Brazil.	camilaalmenaracp@gmail.com	Stefanon, Ivanita/J-4729-2014; Vassallo, Dalton/K-8289-2016	Vassallo, Dalton/0000-0002-4463-4174; Stefanon, Ivanita/0000-0003-2638-5183	CAPES (Coordenacao de Aperfeicooamento de Pessoal de Nivel Superior); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)/FAPES (Fundacao de Amparo a Pesquisa do Espirito Santo) [54668662/2011]	CAPES (Coordenacao de Aperfeicooamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)/FAPES (Fundacao de Amparo a Pesquisa do Espirito Santo)	This work was supported by CAPES (Coordenacao de Aperfeicooamento de Pessoal de Nivel Superior) and CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)/FAPES (Fundacao de Amparo a Pesquisa do Espirito Santo) (54668662/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afridi HI, 2010, J HUM HYPERTENS, V24, P34, DOI 10.1038/jhh.2009.39; ATSDR (Agency for Toxic Substances and Disease Registry), 2008, TOX PROF CA IN PRESS; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Bertin G, 2006, BIOCHIMIE, V88, P1549, DOI 10.1016/j.biochi.2006.10.001; Carageorgiou H, 2005, BASIC CLIN PHARMACOL, V97, P320, DOI 10.1111/j.1742-7843.2005.pto_174.x; Donpunha W, 2011, BIOMETALS, V24, P105, DOI 10.1007/s10534-010-9379-0; Drummond GR, 2000, CIRC RES, V86, P347, DOI 10.1161/01.RES.86.3.347; Gaubin Y, 2000, BBA-MOL CELL RES, V1495, P4, DOI 10.1016/S0167-4889(99)00149-4; Gokalp O, 2009, TOXICOL IND HEALTH, V25, P447, DOI 10.1177/0748233709106822; Grizzo LT, 2008, TOXICOL SCI, V103, P207, DOI 10.1093/toxsci/kfn018; Hare JM, 2005, J CLIN INVEST, V115, P509, DOI 10.1172/JCI200524459; Harja E, 2008, J CLIN INVEST, V118, P183, DOI 10.1172/JCI32703; Lemos NB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049005; Ferramola ML, 2011, ENVIRON TOXICOL PHAR, V32, P17, DOI 10.1016/j.etap.2011.03.002; MANCA D, 1991, TOXICOLOGY, V67, P303, DOI 10.1016/0300-483X(91)90030-5; Martin MD, 2005, NITRIC OXIDE-BIOL CH, V12, P163, DOI 10.1016/j.niox.2005.02.003; Menke A, 2009, ENVIRON HEALTH PERSP, V117, P190, DOI 10.1289/ehp.11236; Messner B, 2010, BIOMETALS, V23, P811, DOI 10.1007/s10534-010-9314-4; Mitra S, 2011, AM J MED SCI, V342, P135, DOI 10.1097/MAJ.0b013e318224a147; Navas-Acien A, 2004, CIRCULATION, V109, P3196, DOI 10.1161/01.CIR.0000130848.18636.B2; Nawrot TS, 2008, ENVIRON HEALTH PERSP, V116, P1620, DOI 10.1289/ehp.11667; Nishijo M, 2006, OCCUP ENVIRON MED, V63, P545, DOI 10.1136/oem.2006.026591; Ozturk IM, 2009, TOXICOL MECH METHOD, V19, P308, DOI 10.1080/15376510802662751; Pinheiro MCN, 2008, ENVIRON RES, V107, P53, DOI 10.1016/j.envres.2007.08.007; Prozialeck WC, 2008, TOXICOL SCI, V102, P207, DOI 10.1093/toxsci/kfm263; Puri VN, 1999, CLIN EXP HYPERTENS, V21, P79, DOI 10.3109/10641969909068651; Satarug S, 2005, TOXICOL LETT, V157, P57, DOI 10.1016/j.toxlet.2005.01.004; Sato M, 2002, TOHOKU J EXP MED, V196, P9, DOI 10.1620/tjem.196.9; Takahashi Yuji, 2004, Environ Health Prev Med, V9, P251, DOI 10.1007/BF02898138; Tandon SK, 2003, TOXICOL LETT, V145, P211, DOI 10.1016/S0378-4274(03)00265-0; Tzotzes V, 2007, BIOMETALS, V20, P83, DOI 10.1007/s10534-006-9017-z; Vanhoutte PM, 2009, ACTA PHYSIOL, V196, P193, DOI 10.1111/j.1748-1716.2009.01964.x; Vassallo DV, 2011, BRAZ J MED BIOL RES, V44, P939, DOI 10.1590/S0100-879X2011000900016; White SJ, 2011, J CELL PHYSIOL, V226, P2841, DOI 10.1002/jcp.22629; *WHO, 1992, CADM ENV HLTH CRIT 1, V134; Yoopan N, 2008, TOXICOL LETT, V176, P157, DOI 10.1016/j.toxlet.2007.11.002; Zhang WH, 2010, EUR J PHARMACOL, V628, P171, DOI 10.1016/j.ejphar.2009.11.015	37	69	75	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e68418	10.1371/journal.pone.0068418	http://dx.doi.org/10.1371/journal.pone.0068418			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	23874620	Green Published, Green Submitted, gold			2022-12-27	WOS:000321718700023
J	Peng, D; Xu, BC; Wang, Y; Guo, H; Jiang, YF				Peng, Di; Xu, Bingchuan; Wang, Ye; Guo, Hui; Jiang, Yanfang			A High Frequency of Circulating Th22 and Th17 Cells in Patients with New Onset Graves' Disease	PLOS ONE			English	Article							T-CELLS; INTERLEUKIN 22; DISTINCT; INFLAMMATION; EXPRESSION; PROPORTION; CYTOKINES; LINEAGE; IL-22; GENE	T-helper (Th) 22 and Th17 cells are involved in the pathogenesis of autoimmune diseases. However, their roles in the pathogenesis of Graves'disease (GD) are unclear. This study is aimed at examining the frequency of peripheral blood Th22, Th17, and Th1 cells and the levels of plasma IL-22, IL-17, and IFN-gamma in patients with GD. A total of 27 patients with new onset GD and 27 gender- and age-matched healthy controls (HC) were examined for the frequency of peripheral blood Th22, Th17, and IFN-gamma cells by flow cytometry. The concentrations of plasma IL-22, IL-17, and IFN-gamma were examined by enzyme-linked immunosorbent assay. The levels of serum TSHR antibodies (A-TSHR), free triiodothyronine (FT3), free thyroxine (FT4), and thyroid stimulating hormone (TSH) were examined by radioimmunoassay and chemiluminescent assay, respectively. The levels of serum TSAb were examined by enzyme-linked immunosorbent assay. In comparison with those in the HC, significantly elevated percentages of Th22 and Th17 cells, but not Th1 cells, and increased levels of plasma IL-22 and IL-17, but not IFN-gamma, were detected in GD patients (P<0.0001, for both). The percentages of both Th22 and Th17 cells and the levels of plasma IL-22 and IL-17 were correlated positively with the levels of serum TSAb in GD patients (r = 0.7944, P<0.0001; r = 0.8110, P<0.0001; r = 0.7101, p<0.0001; r = 0.7407, p<0.0001, respectively). Th22 and Th17 cells may contribute to the pathogenesis of GD.	[Peng, Di; Xu, Bingchuan; Wang, Ye; Guo, Hui; Jiang, Yanfang] Jilin Univ, Hosp 1, Dept Cent Lab, Changchun 130023, Peoples R China; [Jiang, Yanfang] Jilin Univ, Key Lab Zoonosis Res, Minist Educ, Inst Zoonosis, Changchun 130023, Peoples R China	Jilin University; Jilin University	Guo, H (corresponding author), Jilin Univ, Hosp 1, Dept Cent Lab, Changchun 130023, Peoples R China.	nfmguohui@126.com; yanfangjiang@hotmail.com	Wang, Ye/GWQ-7482-2022					Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Cheng F, 2009, ANN RHEUM DIS, V68, P604, DOI 10.1136/ard.2008.097089; Colin EM, 2010, ARTHRITIS RHEUM-US, V62, P132, DOI 10.1002/art.25043; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; Figueroa-Vega N, 2010, J CLIN ENDOCR METAB, V95, P953, DOI 10.1210/jc.2009-1719; Gianoukakis AG, 2008, THYROID, V18, P953, DOI 10.1089/thy.2007.0405; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hayashi F, 2009, CLIN EXP IMMUNOL, V158, P281, DOI 10.1111/j.1365-2249.2009.04034.x; Horie I, 2011, AUTOIMMUNITY, V44, P159, DOI 10.3109/08916931003777247; Kagami S, 2010, J INVEST DERMATOL, V130, P1373, DOI 10.1038/jid.2009.399; Kim SE, 2012, GRAEF ARCH CLIN EXP, V250, P1521, DOI 10.1007/s00417-012-2092-7; Lo YH, 2010, J DERMATOL SCI, V58, P225, DOI 10.1016/j.jdermsci.2010.03.018; Lubberts E, 2001, J IMMUNOL, V167, P1004, DOI 10.4049/jimmunol.167.2.1004; Mao CM, 2011, J IMMUNOL, V186, P4734, DOI 10.4049/jimmunol.0904135; McLachlan SM, 2005, ENDOCR REV, V26, P800, DOI 10.1210/er.2004-0023; McLachlan SM, 2003, J ENDOCRINOL METAB, V26, P800; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Murphy KM, 2010, NAT IMMUNOL, V11, P674, DOI 10.1038/ni.1899; Nanba T, 2009, THYROID, V19, P495, DOI 10.1089/thy.2008.0423; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Qin WZ, 2011, CLIN EXP MED, V11, P245, DOI 10.1007/s10238-011-0134-9; Rapoport B, 1998, ENDOCR REV, V19, P673, DOI 10.1210/er.19.6.673; Shen H, 2009, ARTHRITIS RHEUM-US, V60, P1647, DOI 10.1002/art.24568; Shi Y, 2010, SCAND J IMMUNOL, V72, P250, DOI 10.1111/j.1365-3083.2010.02425.x; SMITH BR, 1988, ENDOCR REV, V9, P106, DOI 10.1210/edrv-9-1-106; Spaulding SW, 2011, CURR OPIN ENDOCRINOL, V18, P315, DOI 10.1097/MED.0b013e32834a8764; Takasu N, 2012, J THROID RES, V2012, DOI 10.1155/2012/182176; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Zhang L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031000, 10.1371/journal.pone.0037865]; Zhang L, 2011, J CLIN IMMUNOL, V31, P606, DOI 10.1007/s10875-011-9540-8	31	59	66	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e68446	10.1371/journal.pone.0068446	http://dx.doi.org/10.1371/journal.pone.0068446			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874630	Green Submitted, gold, Green Published			2022-12-27	WOS:000322218800033
J	Gafter-Gvili, A; Zingerman, B; Rozen-Zvi, B; Ori, Y; Green, H; Lubin, I; Malachi, T; Gafter, U; Herman-Edelstein, M				Gafter-Gvili, Anat; Zingerman, Boris; Rozen-Zvi, Benaya; Ori, Yaacov; Green, Hefziba; Lubin, Ido; Malachi, Tsipora; Gafter, Uzi; Herman-Edelstein, Michal			Oxidative Stress-Induced DNA Damage and Repair in Human Peripheral Blood Mononuclear Cells: Protective Role of Hemoglobin	PLOS ONE			English	Article							IRON-DEFICIENCY ANEMIA; STRAND BREAKS; IN-VITRO; IMMUNOSUPPRESSIVE DRUGS; FLUOROMETRIC ANALYSIS; CULTURED LYMPHOCYTES; MAMMALIAN-CELLS; ASSOCIATION; FADU	Background: DNA repair is a cellular defence mechanism responding to DNA damage caused in large part by oxidative stress. There is a controversy with regard to the effect of red blood cells on DNA damage and cellular response. Aim: To investigate the effect of red blood cells on H2O2-induced DNA damage and repair in human peripheral blood mononuclear cells. Methods: DNA breaks were induced in peripheral blood mononuclear cells by H2O2 in the absence or presence of red blood cells, red blood cells hemolysate or hemoglobin. DNA repair was measured by H-3-thymidine uptake, % double-stranded DNA was measured by fluorometric assay of DNA unwinding. DNA damage was measured by the comet assay and by the detection of histone H2AX phosphorylation. Results: Red blood cells and red blood cells hemolysate reduced DNA repair in a dose-dependent manner. Red blood cells hemolysate reduced % double-stranded DNA, DNA damage and phosphorylation of histone H2AX. Hemoglobin had the same effect as red blood cells hemolysate on % double-stranded DNA. Conclusion: Red blood cells, via red blood cells hemolysate and hemoglobin, reduced the effect of oxidative stress on peripheral blood mononuclear cell DNA damage and phosphorylation of histone H2AX. Consequently, recruitment of DNA repair proteins diminished with reduction of DNA repair. This suggests that anemia predisposes to increased oxidative stress induced DNA damage, while a higher hemoglobin level provides protection against oxidative-stress-induced DNA damage.	[Zingerman, Boris; Rozen-Zvi, Benaya; Ori, Yaacov; Green, Hefziba; Malachi, Tsipora; Gafter, Uzi; Herman-Edelstein, Michal] Rabin Med Ctr, Dept Hypertens & Nephrol, Petah Tiqwa, Israel; [Gafter-Gvili, Anat] Rabin Med Ctr, Dept Med E, Petah Tiqwa, Israel; [Lubin, Ido; Gafter, Uzi; Herman-Edelstein, Michal] Rabin Med Ctr, Felsenstein Med Res Inst, Petah Tiqwa, Israel; [Gafter-Gvili, Anat; Zingerman, Boris; Ori, Yaacov; Lubin, Ido; Gafter, Uzi; Herman-Edelstein, Michal] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel	Rabin Medical Center; Rabin Medical Center; Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Gafter, U (corresponding author), Rabin Med Ctr, Dept Hypertens & Nephrol, Petah Tiqwa, Israel.	uzig@clalit.org.il	rozen-zvi, benaya/AAR-4812-2021					Aksu BY, 2010, EUR J PEDIATR, V169, P951, DOI 10.1007/s00431-010-1147-1; Aslan M, 2006, MUTAT RES-FUND MOL M, V601, P144, DOI 10.1016/j.mrfmmm.2006.06.013; Baumstark-Khan C, 2000, PHOTOCHEM PHOTOBIOL, V72, P477, DOI 10.1562/0031-8655(2000)072<0477:FAODUF>2.0.CO;2; BIRNBOIM HC, 1990, METHOD ENZYMOL, V186, P550; Campise M, 2003, TRANSPLANTATION, V76, P1474, DOI 10.1097/01.TP.0000090344.61975.F0; Debiak M, 2011, TOXICOLOGY, V280, P53, DOI 10.1016/j.tox.2010.11.007; Gafter-Gvili A, 2010, LEUKEMIA RES, V35, P219; Halicka HD, 2012, AGING-US, V4, P270, DOI 10.18632/aging.100450; Herman M, 2001, J LAB CLIN MED, V137, P14, DOI 10.1067/mlc.2001.111469; Herman M, 2008, NEPHRON CLIN PRACT, V108, pC188, DOI 10.1159/000118941; Herman-Edelstein M, 2012, BIOMED PHARMACOTHER, V66, P111, DOI 10.1016/j.biopha.2011.11.008; Korzets A, 1999, J LAB CLIN MED, V133, P362, DOI 10.1016/S0022-2143(99)90067-7; KOVACS E, 1991, ONCOLOGY, V48, P312; Kuo LJ, 2008, IN VIVO, V22, P305; Moreno-Villanueva M, 2011, ALTEX-ALTERN ANIM EX, V28, P295, DOI 10.14573/altex.2011.4.295; Moreno-Villanueva M, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-39; Ori Y, 2012, BIOMED PHARMACOTHER, V66, P409, DOI 10.1016/j.biopha.2012.06.001; Park JH, 2011, MUTAT RES-GEN TOX EN, V718, P56, DOI 10.1016/j.mrgentox.2010.10.005; Porto B, 2006, MUTAT RES-GEN TOX EN, V603, P41, DOI 10.1016/j.mrgentox.2005.10.012; Porto B, 2003, MUTAT RES-GEN TOX EN, V536, P61, DOI 10.1016/S1383-5718(03)00032-9; Tanaka T, 2006, CELL CYCLE, V5, P1940, DOI 10.4161/cc.5.17.3191; Thorlaksdottir AY, 2007, NUTR CANCER, V59, P21, DOI 10.1080/01635580701365092; Tronov VA, 2002, CELL BIOL TOXICOL, V18, P359, DOI 10.1023/A:1020859405262	23	19	19	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68341	10.1371/journal.pone.0068341	http://dx.doi.org/10.1371/journal.pone.0068341			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874593	Green Published, gold, Green Submitted			2022-12-27	WOS:000321736900082
J	Galateanu, G; Hildebrandt, TB; Maillot, A; Etienne, P; Potier, R; Mulot, B; Saragusty, J; Hermes, R				Galateanu, Gabriela; Hildebrandt, Thomas B.; Maillot, Alexis; Etienne, Pascal; Potier, Romain; Mulot, Baptiste; Saragusty, Joseph; Hermes, Robert			One Small Step for Rhinos, One Giant Leap for Wildlife Management- Imaging Diagnosis of Bone Pathology in Distal Limb	PLOS ONE			English	Article							COMPUTED TOMOGRAPHIC EVALUATION; RADIOGRAPHIC DIAGNOSIS; NAVICULAR BONE; PHALANX; OSTEOMYELITIS; FRACTURES	Chronic foot disease poses a threat to the general health, represents a tremendous clinical challenge, and often is a reason for euthanasia in captive megaherbivores, among them the elephant and rhinoceros. Nevertheless, apart from the elephant, foot pathology is handled as being confined only to soft tissues whereas bone pathology is often overlooked. As a case in point, the authors selected the second largest mammal on land, the rhinoceros. We performed a computed tomographic (CT) study using the highest resolution available in veterinary world, followed by digital radiography of eight distal limbs from two white and one Indian rhinoceroses. Our study demonstrated that bone pathology in rhinoceroses' foot is present and in large numbers, yet none of these were diagnosed ante mortem. Even when the animals were euthanized due to foot problems, the decision was based on soft tissue pathology rather than orthopedic reasons. Even more worrying is the fact that the largest number of osteopathologies was present in one of the white rhinoceroses that showed no discernable related clinical signs. This study describes for the first time the existence of bone pathology in white rhinoceros foot, in addition to the two previously described rhinoceros species - Indian and black rhinoceroses. Furthermore, the chronic foot disease reported for the Indian rhinoceros in our study was not restricted to soft tissue structures as was presumed ante mortem but included severe bone pathology. New evidence suggesting that osteopathology in rhinoceroses' distal limb is more widespread than it was thought before could force us to rethink of radiographic diagnosis in captive megaherbivores as routine examination incorporated into their health management. The anticipated improvements in radiologic examinations in megaherbivores will increase the effectiveness of their management and husbandry and open the way for improved animal welfare and better wildlife conservation.	[Galateanu, Gabriela; Hildebrandt, Thomas B.; Saragusty, Joseph; Hermes, Robert] Leibniz Inst Zoo & Wildlife Res, Dept Reprod Management, Berlin, Germany; [Maillot, Alexis] Parc Zool Amneville, Amneville, France; [Etienne, Pascal] Parc Zool La Barben Pelissane, La Barben, France; [Potier, Romain; Mulot, Baptiste] ZooParc Beauval, St Aignan, France	Leibniz Institut fur Zoo und Wildtierforschung	Galateanu, G (corresponding author), Leibniz Inst Zoo & Wildlife Res, Dept Reprod Management, Berlin, Germany.	galateanu@izw-berlin.de	Saragusty, Joseph/M-5030-2016	Saragusty, Joseph/0000-0002-9274-7800				Adelman JS, 2009, INTEGR COMP BIOL, V49, P202, DOI 10.1093/icb/icp028; [Anonymous], 1998, RHINOCEROS CAPTIVITY; Atkinson M, 2002, HUSBANDRY MANUAL GRE; Benz A, 2005, ELEPHANTS HOOF MACRO; Bergman H. J., 2011, Veterinary computed tomography, P457; Biddle R, 2012, EUROPEAN STUDBOOK 20; Dennis R, 2001, HDB SMALL ANIMAL RAD, P1; Ebedes Hym, 1999, P575; Emslie R., 2012, IUCN 2012 IUCN RED L; Farrow CS, 2009, VET DIAGNOSTIC IMAGI, P346; Flach E., 2003, VERH 41 INT S ERKR Z, V41, P1; Fowler ME, 2010, RESTRAINT HANDLING W, P343; Fowler Murray E., 2006, P271, DOI 10.1002/9780470344484.ch20; Fowler Murray E., 2006, P75, DOI 10.1002/9780470344484.ch8; Gage Laurie, 2006, P192; Gage Laurie J., 1999, P517; Galateanu G, 2013, INT C DIS ZOO WILD A; Galateanu G, 2012, INT C DIS ZOO WILD A; Galateanu G, 2012, 16 INT VET RAD ASS M; Gelatt KJ, 1996, VET RADIOL ULTRASOUN, V37, P275, DOI 10.1111/j.1740-8261.1996.tb01230.x; Greer M, 1977, Proceedings of the Oklahoma Academy of Science, V57, P39; Harrison TM, 2011, J ZOO WILDLIFE MED, V42, P317, DOI 10.1638/2010-0149.1; Hart BL, 2011, PHILOS T R SOC B, V366, P3406, DOI 10.1098/rstb.2011.0092; Hittmair KM, 2000, VET RADIOL ULTRASOUN, V41, P511, DOI 10.1111/j.1740-8261.2000.tb01879.x; HONNAS CM, 1988, VET RADIOLOGY, V29, P98, DOI 10.1111/j.1740-8261.1988.tb01758.x; Hutchins M., 2006, International Zoo Yearbook, V40, P150, DOI 10.1111/j.1748-1090.2006.00150.x; Hutchinson JR, 2008, ANATOMICAL IMAGING: TOWARDS A NEW MORPHOLOGY, P23, DOI 10.1007/978-4-431-76933-0_3; Hutchinson JR, 2011, SCIENCE, V334, P1699, DOI 10.1126/science.1211437; KANEPS AJ, 1995, VET RADIOL ULTRASOUN, V36, P179, DOI 10.1111/j.1740-8261.1995.tb00244.x; Kaulfers C, 2010, J ZOO WILDLIFE MED, V41, P697, DOI 10.1638/2009-0168.1; KLAITS B G, 1972, Mammalia, V36, P126, DOI 10.1515/mamm.1972.36.1.126; KOCK RA, 1993, RHINOCEROS BIOLOGY AND CONSERVATION, P325; Liem KF, 2001, FUNCTIONAL ANATOMY V, p[299, 311, 375]; Miller R.E., 2003, FOWLERS ZOO WILD ANI, P559; PETERSON PR, 1988, VET RADIOLOGY, V29, P147, DOI 10.1111/j.1740-8261.1988.tb01767.x; POULOS PW, 1988, VET RADIOLOGY, V29, P60, DOI 10.1111/j.1740-8261.1988.tb01749.x; Raath J.P., 1999, P556; Roocroft A, 2001, ELEPHANT'S FOOT, P21; Rose PL, 1997, VET RADIOL ULTRASOUN, V38, P424, DOI 10.1111/j.1740-8261.1997.tb00865.x; Ruohoniemi M, 1998, VET RADIOL ULTRASOUN, V39, P125, DOI 10.1111/j.1740-8261.1998.tb01978.x; Ruohoniemi M, 1999, VET RADIOL ULTRASOUN, V40, P275, DOI 10.1111/j.1740-8261.1999.tb00362.x; Schmitt D.L., 2003, ZOO WILD ANIMAL MED, P541; Sedrish S, 1996, VET RADIOL ULTRASOUN, V37, P417, DOI 10.1111/j.1740-8261.1996.tb01252.x; Seeram E, 2009, CLIN APPL QUALITY CO, P536; SHIVELY MJ, 1988, VET RADIOLOGY, V29, P282; Siegal-Willott Jessica L., 2012, P515; SMALLWOOD JE, 1985, VET RADIOLOGY, V26, P2, DOI 10.1111/j.1740-8261.1985.tb01105.x; Strauss G, 1982, SERIES PODODERMATIS, V24, p[19, 177]; Talukdar BK, 2008, IUCN 2012 IUCN RED L; Troisieme T, 1819, ENCY METHODIQUE SYST, P203; van Strien NJ, 2008, IUCN 2012 IUCN RED L; Versteege L, 2012, 2011 EUROPEAN STUDBO; von Houwald F, 2012, GREATER ONE HORNED I; von Houwald FF, 2001, FOOT PROBLEMS INDIAN; WALLACH JD, 1967, J AM VET MED ASSOC, V151, P887; West Gary, 2006, P263, DOI 10.1002/9780470344484.ch19; Wilson DE, 2011, HDB MAMMALS WORLD, P144; Wobeser G.A., 1994, INVESTIGATION MANAGE; Zuba Jeffery R., 2012, P619	59	15	15	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68493	10.1371/journal.pone.0068493	http://dx.doi.org/10.1371/journal.pone.0068493			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874643	gold, Green Published			2022-12-27	WOS:000321736900088
J	Wang, LX; Nomura, Y; Du, YZ; Dong, K				Wang, Lingxin; Nomura, Yoshiko; Du, Yuzhe; Dong, Ke			Differential Effects of TipE and a TipE-Homologous Protein on Modulation of Gating Properties of Sodium Channels from Drosophila melanogaster	PLOS ONE			English	Article							SLOW INACTIVATION; MOLECULAR-MECHANISMS; MEMBRANE-PROTEIN; BETA-1 SUBUNIT; ION CHANNELS; MUTATIONS; SENSITIVITY; ACTIVATION; EXPRESSION; CURRENTS	beta subunits of mammalian sodium channels play important roles in modulating the expression and gating of mammalian sodium channels. However, there are no orthologs of beta subunits in insects. Instead, an unrelated protein, TipE in Drosophila melanogaster and its orthologs in other insects, is thought to be a sodium channel auxiliary subunit. In addition, there are four TipE-homologous genes (TEH1-4) in D. melanogaster and three to four orthologs in other insect species. TipE and TEH1-3 have been shown to enhance the peak current of various insect sodium channels expressed in Xenopus oocytes. However, limited information is available on how these proteins modulate the gating of sodium channels, particularly sodium channel variants generated by alternative splicing and RNA editing. In this study, we compared the effects of TEH1 and TipE on the function of three Drosophila sodium channel splice variants, DmNa(v)9-1, DmNa(v)22, and DmNa(v)26, in Xenopus oocytes. Both TipE and TEH1 enhanced the amplitude of sodium current and accelerated current decay of all three sodium channels tested. Strikingly, TEH1 caused hyperpolarizing shifts in the voltage-dependence of activation, fast inactivation and slow inactivation of all three variants. In contrast, TipE did not alter these gating properties except for a hyperpolarizing shift in the voltage-dependence of fast inactivation of DmNa(v)26. Further analysis of the gating kinetics of DmNa(v)9-1 revealed that TEH1 accelerated the entry of sodium channels into the fast inactivated state and slowed the recovery from both fast-and slow-inactivated states, thereby, enhancing both fast and slow inactivation. These results highlight the differential effects of TipE and TEH1 on the gating of insect sodium channels and suggest that TEH1 may play a broader role than TipE in regulating sodium channel function and neuronal excitability in vivo.	[Wang, Lingxin; Nomura, Yoshiko; Du, Yuzhe; Dong, Ke] Michigan State Univ, Dept Entomol, Genet & Neurosci Programs, E Lansing, MI 48824 USA	Michigan State University	Dong, K (corresponding author), Michigan State Univ, Dept Entomol, Genet & Neurosci Programs, E Lansing, MI 48824 USA.	dongk@cns.msu.edu	Wang, Lingxin/ABC-7603-2020		National Institutes of Health [GM057440]; China Scholarship Council via Northwest A & F University, China [2008630022]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council via Northwest A & F University, China(China Scholarship Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by a grant to KD from National Institutes of Health (GM057440). LW was partially supported by a China Scholarship Council fellowship, #2008630022, via Northwest A & F University, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balser JR, 1996, J PHYSIOL-LONDON, V494, P431, DOI 10.1113/jphysiol.1996.sp021503; Brackenbury WJ, 2013, P NATL ACAD SCI USA, V110, P1089, DOI 10.1073/pnas.1208767110; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Catterall WA, 2002, NOVART FDN SYMP, V241, P206; Chahine M, 2005, TRENDS PHARMACOL SCI, V26, P496, DOI 10.1016/j.tips.2005.08.002; Chahine M, 2008, CNS NEUROL DISORD-DR, V7, P144, DOI 10.2174/187152708784083830; Chen CF, 1995, PFLUG ARCH EUR J PHY, V431, P186, DOI 10.1007/BF00410190; Derst C, 2006, BIOCHEM BIOPH RES CO, V339, P939, DOI 10.1016/j.bbrc.2005.11.096; Dong K., 2010, INSECT PHARM CHANNEL, P25; Dong Ke, 2007, Invertebrate Neuroscience, V7, P17, DOI 10.1007/s10158-006-0036-9; FENG GP, 1995, CELL, V82, P1001, DOI 10.1016/0092-8674(95)90279-1; Goldin AL, 2003, CURR OPIN NEUROBIOL, V13, P284, DOI 10.1016/S0959-4388(03)00065-5; GOLDIN AL, 1992, METHOD ENZYMOL, V207, P266; Goldin AL, 2000, NEURON, V28, P365, DOI 10.1016/S0896-6273(00)00116-1; Hodges DD, 2002, MOL CELL NEUROSCI, V19, P402, DOI 10.1006/mcne.2001.1088; HONG CS, 1994, J NEUROSCI, V14, P5160; Isom LL, 2002, FRONT BIOSCI, V7, P12; JACKSON FR, 1986, J NEUROGENET, V3, P1, DOI 10.3109/01677068609106891; KULKARNI SJ, 1982, GENET RES, V40, P191, DOI 10.1017/S0016672300019054; Lin WH, 2009, J NEUROPHYSIOL, V102, P1994, DOI 10.1152/jn.00613.2009; Littleton JT, 2000, NEURON, V26, P35, DOI 10.1016/S0896-6273(00)81135-6; LOUGHNEY K, 1989, CELL, V58, P1143, DOI 10.1016/0092-8674(89)90512-6; McCormick KA, 1999, J BIOL CHEM, V274, P32638, DOI 10.1074/jbc.274.46.32638; Meadows LS, 2002, NEUROSCIENCE, V114, P745, DOI 10.1016/S0306-4522(02)00242-7; Narahashi T, 2000, J PHARMACOL EXP THER, V294, P1; ODOWD DK, 1988, J NEUROSCI, V8, P3633; Olson RO, 2008, INSECT BIOCHEM MOLEC, V38, P604, DOI 10.1016/j.ibmb.2008.01.003; Qu Y, 2001, MOL CELL NEUROSCI, V18, P570, DOI 10.1006/mcne.2001.1039; Soderlund D.M., 2005, P1; SODERLUND DM, 1989, ANNU REV ENTOMOL, V34, P77, DOI 10.1146/annurev.en.34.010189.000453; Song WZ, 2006, NEUROTOXICOLOGY, V27, P237, DOI 10.1016/j.neuro.2005.10.004; Song WZ, 2004, J BIOL CHEM, V279, P32554, DOI 10.1074/jbc.M402392200; SUZUKI DT, 1971, P NATL ACAD SCI USA, V68, P890, DOI 10.1073/pnas.68.5.890; Tan J, 2002, INSECT BIOCHEM MOLEC, V32, P445, DOI 10.1016/S0965-1748(01)00122-9; Tan JG, 2005, MOL PHARMACOL, V67, P513, DOI 10.1124/mol.104.006205; TATEBAYASHI H, 1994, J PHARMACOL EXP THER, V270, P595; Vais H, 2000, J GEN PHYSIOL, V115, P305, DOI 10.1085/jgp.115.3.305; Vijayaragavan K, 2004, BIOCHEM BIOPH RES CO, V319, P531, DOI 10.1016/j.bbrc.2004.05.026; Vijayaragavan K, 2001, J NEUROSCI, V21, P7909, DOI 10.1523/JNEUROSCI.21-20-07909.2001; Vilin YY, 2001, CELL BIOCHEM BIOPHYS, V35, P171, DOI 10.1385/CBB:35:2:171; Vilin YY, 1999, BIOPHYS J, V77, P1384, DOI 10.1016/S0006-3495(99)76987-0; Warmke JW, 1997, J GEN PHYSIOL, V110, P119, DOI 10.1085/jgp.110.2.119; Webb J, 2009, PFLUG ARCH EUR J PHY, V457, P1253, DOI 10.1007/s00424-008-0600-8; Xu R, 2007, NEUROSCIENCE, V148, P164, DOI 10.1016/j.neuroscience.2007.05.038; Yu FH, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-207; Zhao J, 2011, J NEUROPHYSIOL, V106, P608, DOI 10.1152/jn.00107.2011	46	11	12	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e67551	10.1371/journal.pone.0067551	http://dx.doi.org/10.1371/journal.pone.0067551			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874427	gold, Green Submitted, Green Published			2022-12-27	WOS:000324146200008
J	Lovett, DH; Mahimkar, R; Raffai, RL; Cape, L; Zhu, BQ; Jin, ZQ; Baker, AJ; Karliner, JS				Lovett, David H.; Mahimkar, Rajeev; Raffai, Robert L.; Cape, Leslie; Zhu, Bo-Qing; Jin, Zhu-Qiu; Baker, Anthony J.; Karliner, Joel S.			N-Terminal Truncated Intracellular Matrix Metalloproteinase-2 Induces Cardiomyocyte Hypertrophy, Inflammation and Systolic Heart Failure	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; GREEN FLUORESCENT PROTEIN; CARDIAC-HYPERTROPHY; INNATE IMMUNITY; KAPPA-B; EXPRESSION; ABNORMALITIES; ACTIVATION; APOPTOSIS; FOSB	Matrix metalloproteinase-2 (MMP-2) is increasingly recognized as a major contributor to progressive cardiac injury within the setting of ischemia-reperfusion injury and ischemic ventricular remodeling. A common feature of these conditions is an increase in oxidative stress, a process that engages multiple pro-inflammatory and innate immunity cascades. We recently reported on the identification and characterization of an intracellular isoform of MMP-2 generated by oxidative stress-mediated activation of an alternative promoter located within the first intron of the MMP-2 gene. Transcription from this site generates an N-terminal truncated 65 kDa isoform of MMP-2 (NTT-MMP-2) that lacks the secretory sequence and the inhibitory prodomain region. The NTT-MMP-2 isoform is intracellular, enzymatically active and localizes in part to mitochondria. Expression of the NTT-MMP-2 isoform triggers Nuclear Factor of Activated T-cell (NFAT) and NF-kappa B signaling with the expression of a highly defined innate immunity transcriptome, including Interleukin-6, MCP-1, IRF-7 and pro-apoptotic transcripts. To determine the functional significance of the NTT-MMP-2 isoform in vivo we generated cardiac-specific NTT-MMP-2 transgenic mice. These mice developed progressive cardiomyocyte and ventricular hypertrophy associated with systolic heart failure. Further, there was evidence for cardiomyocyte apoptosis and myocardial infiltration with mononuclear cells. The NTT-MMP-2 transgenic hearts also demonstrated more severe injury following ex vivo ischemia-reperfusion injury. We conclude that a novel intracellular MMP-2 isoform induced by oxidant stress directly contributes, in the absence of superimposed injury, to cardiomyocyte hypertrophy. inflammation, systolic heart failure and enhanced susceptibility to ischemia-reperfusion injury.	[Lovett, David H.; Mahimkar, Rajeev; Cape, Leslie; Zhu, Bo-Qing; Jin, Zhu-Qiu; Baker, Anthony J.; Karliner, Joel S.] Univ Calif San Francisco, Dept Med, San Francisco Dept Vet Affairs Med Ctr, San Francisco, CA 94143 USA; [Raffai, Robert L.] Univ Calif San Francisco, Dept Surg, San Francisco Dept Vet Affairs Med Ctr, San Francisco, CA USA; [Karliner, Joel S.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lovett, DH (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco Dept Vet Affairs Med Ctr, San Francisco, CA 94143 USA.	david.lovett@va.gov	Jin, Zhuqiu/ABB-1444-2020	Jin, Zhuqiu/0000-0001-9856-7790	National Heart, Lung and Blood Institute Grant [PO1-HL-68738, RO1-HL089871]; Department of Veterans Affairs Merit Review [1101BX000593, IO1 BX000740]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL068738, R01HL089871] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000593] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Department of Veterans Affairs Merit Review(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Heart, Lung and Blood Institute Grant PO1-HL-68738 (JSK and DHL), a Department of Veterans Affairs Merit Review Awards 1101BX000593 (DHL), and IO1 BX000740 (AJB), and a National Heart, Lung and Blood Institute Grant RO1-HL089871 (RLR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate A, 2007, INT J CARDIOL, V114, P118, DOI 10.1016/j.ijcard.2005.11.025; Alfonso-Jaume MA, 2006, AM J PHYSIOL-HEART C, V291, pH1838, DOI 10.1152/ajpheart.00026.2006; Ali MAM, 2012, J CELL PHYSIOL, V227, P3397, DOI 10.1002/jcp.24040; Arbustini E, 2008, HEART FAIL REV, V13, P121, DOI 10.1007/s10741-007-9072-8; ARNOLD G, 1985, PATHOL RES PRACT, V180, P405; Arslan F, 2011, NAT REV CARDIOL, V8, P292, DOI 10.1038/nrcardio.2011.38; Bergman MR, 2007, AM J PHYSIOL-HEART C, V292, pH1847, DOI 10.1152/ajpheart.00434.2006; Bergman MR, 2003, BIOCHEM J, V369, P485, DOI 10.1042/BJ20020707; BERGMANN U, 1995, BIOCHEMISTRY-US, V34, P2819, DOI 10.1021/bi00009a011; Caron KM, 2001, P NATL ACAD SCI USA, V98, P615, DOI 10.1073/pnas.021548898; Castro MM, 2013, CURR DRUG TARGETS, V14, P335; Dahi S, 2011, INT J EXP PATHOL, V92, P50, DOI 10.1111/j.1365-2613.2010.00744.x; Fleischmann M, 1998, FEBS LETT, V440, P370, DOI 10.1016/S0014-5793(98)01476-8; Gordon JW, 2011, CIRC RES, V108, P1122, DOI 10.1161/CIRCRESAHA.110.226928; Gupta S, 2008, J MOL BIOL, V375, P637, DOI 10.1016/j.jmb.2007.10.006; Hayashidani S, 2003, AM J PHYSIOL-HEART C, V285, pH1229, DOI 10.1152/ajpheart.00207.2003; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Hori Y, 2012, AM J PHYSL IN PRESS; Li J, 2007, EUR J PHARMACOL, V554, P60, DOI 10.1016/j.ejphar.2006.08.024; Liu QH, 2012, CIRC RES, V110, P1077, DOI 10.1161/CIRCRESAHA.111.260729; Liu Y, 2008, CLONING STEM CELLS, V10, P421, DOI 10.1089/clo.2008.0015; Lovett DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034177; Mahimkar R, 2009, CARDIOVASC PATHOL, V18, P253, DOI 10.1016/j.carpath.2008.08.001; Mann DL, 2011, CIRC RES, V108, P1133, DOI 10.1161/CIRCRESAHA.110.226936; McMillan JI, 1996, J CLIN INVEST, V97, P1094, DOI 10.1172/JCI118502; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Morgunova E, 1999, SCIENCE, V284, P1667, DOI 10.1126/science.284.5420.1667; Rex Tonia S, 2005, Mol Vis, V11, P1236; Rizzi E, 2013, INT J CARDIOL, V165, P165, DOI 10.1016/j.ijcard.2011.08.060; Sawicki G, 2005, CIRCULATION, V112, P544, DOI 10.1161/CIRCULATIONAHA.104.531616; Schulz R, 2007, ANNU REV PHARMACOL, V47, P211, DOI 10.1146/annurev.pharmtox.47.120505.105230; Shirakabe A, 2010, INT HEART J, V51, P404, DOI 10.1536/ihj.51.404; Spinale FG, 2007, PHYSIOL REV, V87, P1285, DOI 10.1152/physrev.00012.2007; Valen G, 2011, HEART FAIL REV, V16, P71, DOI 10.1007/s10741-010-9187-1; Wang GY, 2006, CARDIOVASC RES, V69, P688, DOI 10.1016/j.cardiores.2005.08.023; Wang WJ, 2002, CIRCULATION, V106, P1543, DOI 10.1161/01.CIR.0000028818.33488.7B; Wilkins BJ, 2004, CIRC RES, V94, P110, DOI 10.1161/01.RES.0000109415.17511.18; Will H, 1996, J BIOL CHEM, V271, P17119, DOI 10.1074/jbc.271.29.17119; Xian MW, 1999, J MOL CELL CARDIOL, V31, P2155, DOI 10.1006/jmcc.1999.1046; Yamazaki T, 2004, EUR J HEART FAIL, V6, P41, DOI 10.1016/j.ejheart.2003.05.002; Zhang SW, 2005, CIRCULATION, V111, P3457, DOI 10.1161/CIRCULATIONAHA.104.523563; Zhou HZ, 2007, BIOCHEM BIOPH RES CO, V358, P189, DOI 10.1016/j.bbrc.2007.04.094	42	42	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68154	10.1371/journal.pone.0068154	http://dx.doi.org/10.1371/journal.pone.0068154			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874529	Green Published, gold, Green Submitted			2022-12-27	WOS:000322064300018
J	Mijiti, P; Yahepu, D; Zhong, XN; Sun, Y; Zhao, T; Zhao, Z; Abuduaili, Z; Zhou, HF; Meng, FL; Dai, JH; Huang, AL				Mijiti, Peierdun; Yahepu, Dilixiati; Zhong, Xiaoni; Sun, Yong; Zhao, Ting; Zhao, Zhen; Abuduaili, Zaiyinuer; Zhou, Hongfang; Meng, Fanliang; Dai, Jianghong; Huang, Ailong			Awareness of and Willingness to Use Oral Pre-Exposure Prophylaxis for HIV Prevention among HIV-Serodiscordant Heterosexual Couples: A Cross-Sectional Survey in Xinjiang, China	PLOS ONE			English	Article							ANTIRETROVIRAL PROPHYLAXIS; LIMITED KNOWLEDGE; MEN; SEX; INFECTION; CARE	Objectives: We aimed to investigate the awareness of and willingness to use oral pre-exposure prophylaxis (PrEP) for HIV prevention among HIV-negative partners in HIV-serodiscordant heterosexual couples in Xinjiang, China and determine factors that predict willingness to use oral PrEP. Methods: Between November 2009 and December 2010, a cross-sectional survey was carried out among 351 HIV-negative partners in HIV-serodiscordant heterosexual couples from three cities in Xinjiang, China. Participants completed a self-administered questionnaire to assess their awareness of and willingness to use oral PrEP. Additionally, blood samples were collected to test for HIV infection. Univariate and multivariate logistic regression analyses were performed to identify predictors of willingness to use oral PrEP. Results: Only 10 participants (2.8%) reported having heard of PrEP, and only two reported ever using PrEP. However, 297 (84.6%) reported that they were willing to use oral PrEP if it was proven to be both safe and effective. Results of multivariate analysis revealed the following independent predictors of willingness to use oral PrEP: monthly household income (adjusted odds ratio = 2.78, < 1000 RMB vs. >= 1000 RMB, 95% confidence interval: 1.36-5.69), perceived likelihood of contracting HIV from HIV-positive partner (adjusted odds ratio = 2.63, likely vs. unlikely, 95% confidence interval: 1.12-6.19), and worrying about being discriminated against by others due to oral PrEP use (adjusted odds ratio = 9.43, No vs. Yes, 95% confidence interval: 3.78-23.50). Conclusions: Our results showed HIV-negative partners in HIV-serodiscordant heterosexual couples in China had low awareness of oral PrEP but high willingness to use oral PrEP for HIV prevention. Cost of oral PrEP should be taken into consideration in future PrEP prevention strategy. In addition, efforts should be made to reduce stigma attached to oral PrEP use, which may increase its acceptability among potential users.	[Mijiti, Peierdun; Sun, Yong; Zhao, Ting; Zhao, Zhen; Abuduaili, Zaiyinuer; Zhou, Hongfang; Meng, Fanliang; Dai, Jianghong] Xinjiang Med Univ, Sch Publ Hlth, Urumqi, Xinjiang Uyghur, Peoples R China; [Yahepu, Dilixiati] Bur Hlth, Dept Dis Control & Prevent, Urumqi, Xinjiang Uyghur, Peoples R China; [Zhong, Xiaoni] Chongqing Med Univ, Sch Publ Hlth, Chongqing, Peoples R China; [Huang, Ailong] Chongqing Med Univ, Virus Hepatitis Res Inst, Chongqing, Peoples R China	Xinjiang Medical University; Chongqing Medical University; Chongqing Medical University	Dai, JH (corresponding author), Xinjiang Med Univ, Sch Publ Hlth, Urumqi, Xinjiang Uyghur, Peoples R China.	epi102@sina.com; ahuang1964@yahoo.com.cn			National Eleven Fifth Science and Technology Major Project of the Ministry of Science and Technology of China [2008ZX10001-016]	National Eleven Fifth Science and Technology Major Project of the Ministry of Science and Technology of China	This study was supported by National Eleven Fifth Science and Technology Major Project of the Ministry of Science and Technology of China (2008ZX10001-016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Celum C, 2012, CURR OPIN INFECT DIS, V25, P51, DOI 10.1097/QCO.0b013e32834ef5ef; Cohen MS, 2012, NEW ENGL J MED, V367, P459, DOI 10.1056/NEJMe1207438; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Golub SA, 2010, JAIDS-J ACQ IMM DEF, V54, P548, DOI 10.1097/QAI.0b013e3181e19a54; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Guthrie BL, 2007, CURR HIV RES, V5, P416, DOI 10.2174/157016207781023992; Health Department of PRC, 2012, CHIN J AIDS STD, V18, P1; Heffron R, 2012, JAIDS-J ACQ IMM DEF, V61, P116, DOI 10.1097/QAI.0b013e31825da73f; Heneine W, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007419; Jackson T, 2012, AIDS BEHAV, V16, P1853, DOI 10.1007/s10461-012-0188-z; Jia ZW, 2013, LANCET, V382, P1195, DOI 10.1016/S0140-6736(12)61898-4; Liu AY, 2008, JAIDS-J ACQ IMM DEF, V47, P241, DOI 10.1097/QAI.0b013e31815e4041; Mao Yu-rong, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P322; Marrazzo J, 2013, C RETR OPP INF UNPUB; Martin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025127; Matthews LT, 2010, AIDS, V24, P1975, DOI 10.1097/QAD.0b013e32833bedeb; Mimiaga MJ, 2009, JAIDS-J ACQ IMM DEF, V50, P77, DOI 10.1097/QAI.0b013e31818d5a27; Moon S, 2008, AIDS CARE, V20, P984, DOI 10.1080/09540120701768446; Newman PA, 2010, AIDS, V24, P1749, DOI 10.1097/QAD.0b013e32833adbe8; Ni MingJian, 2012, Endemic Diseases Bulletin / Di Fang Bing Tong Bao, V27, P1; Padian NS, 2008, LANCET, V372, P585, DOI 10.1016/S0140-6736(08)60885-5; Peng B, 2012, HIV AIDS-RES PALLIAT, V4, P149, DOI 10.2147/HIV.S33445; Sheeran P, 1999, J APPL SOC PSYCHOL, V29, P1624, DOI 10.1111/j.1559-1816.1999.tb02045.x; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; UNAIDS, 2012, GLOB FACT SHEET TOG; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; Vermund SH, 2013, CURR HIV-AIDS REP, DOI [10.1007/s11904-013-0155-y, DOI 10.1007/S11904-013-0155-Y.[]; Veronese F, 2011, AIDS RES HUM RETROV, V27, P81, DOI [10.1089/aid.2010.0226, 10.1089/AID.2010.0226]; Woolf SH, 2005, ANN INTERN MED, V143, P293, DOI 10.7326/0003-4819-143-4-200508160-00010; Xue QY, 2011, DRUG DISCOV THER, V5, P159, DOI 10.5582/ddt.2011.v5.4.159; Zhou F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032329	32	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e67392	10.1371/journal.pone.0067392	http://dx.doi.org/10.1371/journal.pone.0067392			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	186SF	23874417	Green Published, gold, Green Submitted			2022-12-27	WOS:000322064300008
J	Weltz, K; Kock, AA; Winker, H; Attwood, C; Sikweyiya, M				Weltz, Kay; Kock, Alison A.; Winker, Henning; Attwood, Colin; Sikweyiya, Monwabisi			The Influence of Environmental Variables on the Presence of White Sharks, Carcharodon carcharias at Two Popular Cape Town Bathing Beaches: A Generalized Additive Mixed Model	PLOS ONE			English	Article							FALSE BAY; SOUTH-AFRICA; CONSERVATION	Shark attacks on humans are high profile events which can significantly influence policies related to the coastal zone. A shark warning system in South Africa, Shark Spotters, recorded 378 white shark (Carcharodon carcharias) sightings at two popular beaches, Fish Hoek and Muizenberg, during 3690 six-hour long spotting shifts, during the months September to May 2006 to 2011. The probabilities of shark sightings were related to environmental variables using Binomial Generalized Additive Mixed Models (GAMMs). Sea surface temperature was significant, with the probability of shark sightings increasing rapidly as SST exceeded 14 degrees C and approached a maximum at 18 degrees C, whereafter it remains high. An 8 times (Muizenberg) and 5 times (Fish Hoek) greater likelihood of sighting a shark was predicted at 18 degrees C than at 14 degrees C. Lunar phase was also significant with a prediction of 1.5 times (Muizenberg) and 4 times (Fish Hoek) greater likelihood of a shark sighting at new moon than at full moon. At Fish Hoek, the probability of sighting a shark was 1.6 times higher during the afternoon shift compared to the morning shift, but no diel effect was found at Muizenberg. A significant increase in the number of shark sightings was identified over the last three years, highlighting the need for ongoing research into shark attack mitigation. These patterns will be incorporated into shark awareness and bather safety campaigns in Cape Town.	[Weltz, Kay; Kock, Alison A.; Winker, Henning; Attwood, Colin] Univ Cape Town, Marine Res Inst, ZA-7925 Cape Town, South Africa; [Weltz, Kay; Kock, Alison A.; Winker, Henning; Attwood, Colin] Univ Cape Town, Dept Zool, ZA-7925 Cape Town, South Africa; [Kock, Alison A.; Sikweyiya, Monwabisi] Shark Spotters, Cape Town, South Africa	University of Cape Town; University of Cape Town	Weltz, K (corresponding author), Univ Cape Town, Marine Res Inst, ZA-7925 Cape Town, South Africa.	k.weltz@iafrica.com	; Weltz, Kay/J-4645-2013	Kock, Alison/0000-0001-9981-1652; Weltz, Kay/0000-0003-3866-8148; Attwood, Colin/0000-0002-1045-3439	City of Cape Town; Save Our Seas Foundation	City of Cape Town; Save Our Seas Foundation	Thank you to the City of Cape Town and the Save Our Seas Foundation for funding the Shark Spotters programme which allowed for the collection of shark sighting records used in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal FJ, 2011, MAR BIOL, V158, P1175, DOI 10.1007/s00227-011-1639-1; ATKINS GR, 1970, T ROY SOC S AFR, V39, P139, DOI 10.1080/00359197009519109; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Bruce B., 2008, SHARKS OPEN OCEAN BI, P69, DOI DOI 10.1002/9781444302516; Burgess G H, 1996, GREAT WHITE SHARKS B; City of Cape Town, 2013, CITY CONSIDER PROPOS; Clark BM, 1996, MAR ECOL PROG SER, V131, P35, DOI 10.3354/meps131035; CLIFF G, 1989, S AFR J MARINE SCI, V8, P131, DOI 10.2989/02577618909504556; Cliff G, 2006, WWF S AFRICA REPORT; Cliff G, 2011, MAR FRESHWATER RES, V62, P700, DOI 10.1071/MF10182; COMPAGNO LJV, 1991, S AFR J SCI, V87, P284; Curtis T, 2012, GLOBAL PERSPECTIVES, VFirst, P477; Dewar H, 2004, ENVIRON BIOL FISH, V70, P133, DOI 10.1023/B:EBFI.0000029343.54027.6a; Fergusson IL, 2012, IUCN RED LIST THREAT; Goldman KJ, 1997, J COMP PHYSIOL B, V167, P423, DOI 10.1007/s003600050092; Guttridge T, 2009, SOCIAL ORG BEHAV JUV, P1; Hopkins TE, 2003, ENVIRON BIOL FISH, V66, P279, DOI 10.1023/A:1023907121605; Knip DM, 2010, MAR ECOL PROG SER, V402, P1, DOI 10.3354/meps08498; Kock A, 2013, RESIDENCY HABITAT US; Kock AA, 2012, GLOBAL PERSPECTIVES, P447; Lamberth SJ, 2006, AFR J MAR SCI, V28, P723, DOI 10.2989/18142320609504222; LAMBERTH SJ, 1995, S AFR J MARINE SCI, V15, P157; Lamberth SJ, 1994, THESIS U CAPE TOWN S, P122; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Naylor E, 2001, EARTH MOON PLANETS, V85-6, P291, DOI 10.1023/A:1017088504226; Neff C, 2012, COAST MANAGE, V40, P88, DOI 10.1080/08920753.2011.639867; Nel DC, 2006, WWF S AFRICA REPORT, V1; Oelofse G, 2006, WWF S AFRICA REPORT; Pyle P, 1996, GREAT WHITE SHARKS, P281, DOI 10.1016/B978-012415031-7/50027-6; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Simpfendorfer CA, 2011, MAR FRESHWATER RES, V62, P518, DOI 10.1071/MF11086; TRICAS T C, 1984, Proceedings of the California Academy of Sciences, V43, P221; Vogler R, 2008, FISH RES, V91, P212, DOI 10.1016/j.fishres.2007.11.028; Wallett T., 1978, SHARK ATTACK TREATME; Werry Jonathan M., 2012, P271; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zuur Alain F., 2009, P1	37	28	28	0	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68554	10.1371/journal.pone.0068554	http://dx.doi.org/10.1371/journal.pone.0068554			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874668	Green Published, gold, Green Submitted			2022-12-27	WOS:000322064300049
J	Barrero, CA; Datta, PK; Sen, S; Deshmane, S; Amini, S; Khalili, K; Merali, S				Barrero, Carlos A.; Datta, Prasun K.; Sen, Satarupa; Deshmane, Satish; Amini, Shohreh; Khalili, Kamel; Merali, Salim			HIV-1 Vpr Modulates Macrophage Metabolic Pathways: A SILAC-Based Quantitative Analysis	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; OXYGEN-REGULATED PROTEIN; PYRUVATE-KINASE M2; GENE-TRANSCRIPTION; PROTEOMIC ANALYSIS; T-CELLS; REPLICATION; EXPRESSION; INFECTION; APOPTOSIS	Human immunodeficiency virus type 1 encoded viral protein Vpr is essential for infection of macrophages by HIV-1. Furthermore, these macrophages are resistant to cell death and are viral reservoir. However, the impact of Vpr on the macrophage proteome is yet to be comprehended. The goal of the present study was to use a stable-isotope labeling by amino acids in cell culture (SILAC) coupled with mass spectrometry-based proteomics approach to characterize the Vpr response in macrophages. Cultured human monocytic cells, U937, were differentiated into macrophages and transduced with adenovirus construct harboring the Vpr gene. More than 600 proteins were quantified in SILAC coupled with LC-MS/MS approach, among which 136 were significantly altered upon Vpr overexpression in macrophages. Quantified proteins were selected and clustered by biological functions, pathway and network analysis using Ingenuity computational pathway analysis. The proteomic data illustrating increase in abundance of enzymes in the glycolytic pathway (pentose phosphate and pyruvate metabolism) was further validated by western blot analysis. In addition, the proteomic data demonstrate down regulation of some key mitochondrial enzymes such as glutamate dehydrogenase 2 (GLUD2), adenylate kinase 2 (AK2) and transketolase (TKT). Based on these observations we postulate that HIV-1 hijacks the macrophage glucose metabolism pathway via the Vpr-hypoxia inducible factor 1 alpha (HIF-1 alpha) axis to induce expression of hexokinase (HK), glucose-6-phosphate dehyrogenase (G6PD) and pyruvate kinase muscle type 2 (PKM2) that facilitates viral replication and biogenesis, and long-term survival of macrophages. Furthermore, dysregulation of mitochondrial glutamate metabolism in macrophages can contribute to neurodegeneration via neuroexcitotoxic mechanisms in the context of NeuroAIDS.	[Barrero, Carlos A.; Merali, Salim] Temple Univ, Sch Med, Fels Inst, Dept Biochem, Philadelphia, PA 19122 USA; [Datta, Prasun K.; Sen, Satarupa; Deshmane, Satish; Amini, Shohreh; Khalili, Kamel] Temple Univ, Sch Med, Dept Neurosci, Philadelphia, PA 19122 USA; [Barrero, Carlos A.; Datta, Prasun K.; Deshmane, Satish; Amini, Shohreh; Khalili, Kamel; Merali, Salim] Temple Univ, Sch Med, Ctr Neurovirol, Philadelphia, PA 19122 USA; [Sen, Satarupa; Amini, Shohreh] Temple Univ, Dept Biol, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Datta, PK (corresponding author), Temple Univ, Sch Med, Dept Neurosci, Philadelphia, PA 19122 USA.	dattapk@temple.edu		Barrero, Carlos/0000-0001-5779-6642; Datta, Prasun/0000-0001-5133-253X	National Institutes of Health (NIH) [NIH/NIDA 5 R01 DA033213-02, P01NS4390, P30MH092177, RO1MH092371, RO1MH086358]; Comprehensive NeuroAIDS Center (CNAC, NIMH) at Temple University School of Medicine [P30MH092177]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH092177, R01MH086358, R01MH093271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033213] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Comprehensive NeuroAIDS Center (CNAC, NIMH) at Temple University School of Medicine; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work is supported in part by funding from the National Institutes of Health (NIH) (PKD: NIH/NIDA 5 R01 DA033213-02; SA: P01NS4390; KK: P30MH092177; RO1MH092371 and RO1MH086358). This study utilized services offered by core facilities of the Comprehensive NeuroAIDS Center (CNAC, NIMH grant number P30MH092177) at Temple University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amini S, 2004, DNA CELL BIOL, V23, P249, DOI 10.1089/104454904773819833; Arokium H, 2009, J VIROL, V83, P11283, DOI 10.1128/JVI.00756-09; Azoulay-Zohar H, 2004, BIOCHEM J, V377, P347, DOI 10.1042/BJ20031465; Burdo TH, 2004, DNA CELL BIOL, V23, P261, DOI 10.1089/104454904773819842; Busca A, 2012, J BIOL CHEM, V287, P15118, DOI 10.1074/jbc.M111.312660; Cechowska-Pasko M, 2006, CELL PHYSIOL BIOCHEM, V17, P89, DOI 10.1159/000091467; Chen X, 2011, CURR HIV RES, V9, P295, DOI 10.2174/157016211797635937; COLLMAN R, 1992, J VIROL, V66, P7517, DOI 10.1128/JVI.66.12.7517-7521.1992; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Cosentino C, 2011, EMBO J, V30, P546, DOI 10.1038/emboj.2010.330; Deshmane SL, 2009, J BIOL CHEM, V284, P11364, DOI 10.1074/jbc.M809266200; Duan XB, 2010, PROTEOMICS, V10, P2165, DOI 10.1002/pmic.201000020; Dyrlund TF, 2012, PROTEOMICS, V12, P2792, DOI 10.1002/pmic.201200109; Eckstein DA, 2001, J EXP MED, V194, P1407, DOI 10.1084/jem.194.10.1407; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; Godet AN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013760; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; Hollenbaugh JA, 2011, VIROLOGY, V415, P153, DOI 10.1016/j.virol.2011.04.007; Huber K, 2011, J BIOL CHEM, V286, P22211, DOI 10.1074/jbc.M110.180224; Jacquot G, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-84; Jager S, 2012, NATURE, V481, P365, DOI 10.1038/nature10719; Kogan M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-25; Le Rouzic E, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-11; Lee HJ, 2007, NAT CELL BIOL, V9, P1303, DOI 10.1038/ncb1650; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Marin-Hernandez A, 2011, BBA-BIOENERGETICS, V1807, P755, DOI 10.1016/j.bbabio.2010.11.006; Melendez LM, 2011, J NEUROIMMUNE PHARM, V6, P89, DOI 10.1007/s11481-010-9253-4; Merk M, 2009, J IMMUNOL, V182, P6896, DOI 10.4049/jimmunol.0803710; Mukerjee R, 2011, J BIOL CHEM, V286, P34976, DOI 10.1074/jbc.M111.241547; Muthumani K, 2002, J BIOL CHEM, V277, P37820, DOI 10.1074/jbc.M205313200; Navare AT, 2012, VIROLOGY, V429, P37, DOI 10.1016/j.virol.2012.03.026; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Noma T, 2005, J MED INVESTIG, V52, P127, DOI 10.2152/jmi.52.127; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Patel CA, 2000, J VIROL, V74, P9717, DOI 10.1128/JVI.74.20.9717-9726.2000; Pendyala G, 2009, J PROTEOME RES, V8, P2253, DOI 10.1021/pr800854t; Plaitakis A, 2011, NEUROCHEM INT, V59, P495, DOI 10.1016/j.neuint.2011.03.015; Planelles V, 2009, CURR TOP MICROBIOL, V339, P177, DOI 10.1007/978-3-642-02175-6_9; Raimundo N, 2011, TRENDS MOL MED, V17, P641, DOI 10.1016/j.molmed.2011.06.001; Reynolds JL, 2006, BRAIN RES, V1123, P226, DOI 10.1016/j.brainres.2006.09.034; Ricardo-Dukelow M, 2007, J NEUROIMMUNOL, V185, P37, DOI 10.1016/j.jneuroim.2007.01.004; Ringrose J, 2008, J VIROL, V82, P4320, DOI 10.1128/JVI.01819-07; Rivera-Rivera L, 2012, J NEUROVIROL, V18, P20, DOI 10.1007/s13365-011-0061-2; Sargent PJ, 2005, CURR MED CHEM, V12, P2683, DOI 10.2174/092986705774462969; Sawaya BE, 1998, J BIOL CHEM, V273, P20052, DOI 10.1074/jbc.273.32.20052; Saxena M, 2011, J IMMUNOL, V187, P5865, DOI 10.4049/jimmunol.1100115; Sharifi HJ, 2012, CURR OPIN HIV AIDS, V7, P187, DOI 10.1097/COH.0b013e32835049e0; Smolka MB, 2001, ANAL BIOCHEM, V297, P25, DOI 10.1006/abio.2001.5318; Stanton RC, 2012, IUBMB LIFE, V64, P362, DOI 10.1002/iub.1017; Subbramanian RA, 1998, J EXP MED, V187, P1103, DOI 10.1084/jem.187.7.1103; Tacchini L, 2008, J BIOL CHEM, V283, P20674, DOI 10.1074/jbc.M800365200; Takeuchi S, 2006, PROTEIN J, V25, P517, DOI 10.1007/s10930-006-9038-z; Tjernlund A, 2007, AIDS RES HUM RETROV, V23, P398, DOI 10.1089/aid.2006.0100; Toro-Nieves DM, 2009, J NEUROVIROL, V15, P36, DOI 10.1080/13550280802385505; WANG LL, 1995, J BIOL CHEM, V270, P25564, DOI 10.1074/jbc.270.43.25564; Wang T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002507; Wiederin J, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-8; Wu JQ, 2008, VIROLOGY, V380, P124, DOI 10.1016/j.virol.2008.06.039; Wu JQ, 2013, VIROLOGY, V435, P308, DOI 10.1016/j.virol.2012.10.026; Wu JQ, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-18; Wu JQ, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-24; Yang WW, 2012, CELL, V150, P685, DOI 10.1016/j.cell.2012.07.018; Yedavalli VSRK, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-61; Yin ZM, 2000, CANCER RES, V60, P4053; Yogev O, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000328; Zhao J, 2009, NEUROSCI BULL, V25, P94, DOI 10.1007/s12264-009-1113-y; Zhao RY, 2011, J NEUROIMMUNE PHARM, V6, P216, DOI 10.1007/s11481-011-9261-z; Zhou L, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-677; Zieske LR, 2006, J EXP BOT, V57, P1501, DOI 10.1093/jxb/erj168	69	63	65	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e68376	10.1371/journal.pone.0068376	http://dx.doi.org/10.1371/journal.pone.0068376			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	23874603	Green Submitted, Green Published, gold			2022-12-27	WOS:000321718700020
J	Del Toro, I				Del Toro, Israel			Diversity of Eastern North American Ant Communities along Environmental Gradients	PLOS ONE			English	Article							BETA-DIVERSITY; CLIMATE-CHANGE; BIOGEOGRAPHY; SCALE	Studies of species diversity patterns across regional environmental gradients seldom consider the impact of habitat type on within-site (alpha) and between-site (beta) diversity. This study is designed to identify the influence of habitat type across geographic and environmental space, on local patterns of species richness and regional turnover patterns of ant diversity in the northeastern United States. Specifically, I aim to 1) compare local species richness in paired open and forested transects and identify the environmental variables that best correlate with richness; and 2) document patterns of beta diversity throughout the region in both open and forested habitat. I systematically sampled ants at 67 sites from May to August 2010, spanning 10 degrees of latitude, and 1000 meters of elevation. Patterns of alpha and beta diversity across the region and along environmental gradients differed between forested and open habitats. Local species richness was higher in the low elevation and warmest sites and was always higher in open habitat than in forest habitat transects. Richness decreased as temperature decreased or elevation increased. Forested transects show strong patterns of decreasing dissimilarity in species composition between sites along the temperature gradient but open habitat transects did not. Maximum temperature of the warmest month better predicted species richness than either latitude or elevation. I find that using environmental variables as key predictors of richness yields more biologically relevant results, and produces simpler macroecological models than commonly used models which use only latitude and elevation as predictors of richness and diversity patterns. This study contributes to the understanding of mechanisms that structure the communities of important terrestrial arthropods which are likely to be influenced by climatic change.	[Del Toro, Israel] Univ Massachusetts, Amherst, MA 01003 USA; [Del Toro, Israel] Harvard Univ, Petersham, MA USA	University of Massachusetts System; University of Massachusetts Amherst; Harvard University	Del Toro, I (corresponding author), Univ Massachusetts, Amherst, MA 01003 USA.	ideltoro@cns.umass.edu		Del Toro, Israel/0000-0002-3901-8713	National Geographic Young Explorer's; American Philosophical Society Lewis and Clark; UMass Amherst Natural History Collections Grant; United States Department of Energy Program for Ecosystem Research award [DE-FG02-08ER64510]	National Geographic Young Explorer's(National Geographic Society); American Philosophical Society Lewis and Clark; UMass Amherst Natural History Collections Grant; United States Department of Energy Program for Ecosystem Research award	Funding for this study was provided by The National Geographic Young Explorer's grant- for financial support of field research (http://www.nationalgeographic.com/explorers/grants-programs/young-explorers/); The American Philosophical Society Lewis and Clark fund for exploration and field research, for financial support of field research (http://www.amphilsoc.org/grants/lewisandclark); The UMass Amherst Natural History Collections Grant, for financial support of field research and sample processing materials (http://bcrc.bio.umass.edu/ummnh/about.htm). Also, funding for publication was provided by a United States Department of Energy Program for Ecosystem Research award (DE-FG02-08ER64510). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABLE KP, 1976, OECOLOGIA, V26, P275, DOI 10.1007/BF00345296; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Andrew ME, 2012, GLOBAL ECOL BIOGEOGR, V21, P352, DOI 10.1111/j.1466-8238.2011.00676.x; Baselga A, 2012, BETAPART PACKAGE R 1; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Chao A, 2012, ECOLOGY, V93, P2533, DOI 10.1890/11-1952.1; Colwell R.K, 1997, ESTIMATES STAT ESTIM; Cooperation CfE, 2006, EC REG N AM COMM PER; De Frenne P, 2013, J ECOLOGY; Del Toro I, NE NATURALI IN PRESS; Del Toro I, 2012, MYRMECOL NEWS, V17, P133; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Ellison AM., 2012, FIELD GUIDE ANTS NEW; Francis MP, 2011, MAR FRESHWATER RES, V62, P1327, DOI 10.1071/MF11067; Fry JA, 2011, PHOTOGRAMM ENG REM S, V77, P859; Gotelli NJ, 2011, MYRMECOL NEWS, V15, P13; Gotelli NJ, 2002, ECOLOGY, V83, P1604, DOI 10.1890/0012-9658(2002)083[1604:BAARSD]2.0.CO;2; Gotelli NJ, 2002, OIKOS, V99, P591, DOI 10.1034/j.1600-0706.2002.11734.x; Gotelli NJ, 2000, ECOL LETT, V3, P257, DOI 10.1046/j.1461-0248.2000.00138.x; Hawkins BA, 2007, ECOLOGY, V88, P1877, DOI 10.1890/06-1444.1; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Lepetz V, 2009, BIODIVERS CONSERV, V18, P3185, DOI 10.1007/s10531-009-9636-0; Motzkin G, 1996, ECOL MONOGR, V66, P345, DOI 10.2307/2963522; Oberg EW, 2012, INSECT SOC, V59, P167, DOI 10.1007/s00040-011-0201-y; Paknia O, 2011, DIVERS DISTRIB, V17, P122, DOI 10.1111/j.1472-4642.2010.00719.x; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; RICKLEFS RE, 1987, SCIENCE, V235, P167, DOI 10.1126/science.235.4785.167; Ridgeway G., 2013, GEN BOOSTED REGRESSI; Ripley B, 2012, MASS PACK R 7 3; Rodenhouse NL, 2009, CAN J FOREST RES, V39, P249, DOI 10.1139/X08-160; Service NRC, 2012, USDA WEB SOIL SURV; Soininen J, 2007, ECOLOGY, V88, P2830, DOI 10.1890/06-1730.1; Team RDC, 2012, COMP RFFS; Tylianakis JM, 2006, J BIOGEOGR, V33, P1295, DOI 10.1111/j.1365-2699.2006.01493.x; USGS, 2012, US GEOL SURV DAT POO; Veech JA, 2007, GLOBAL ECOL BIOGEOGR, V16, P650, DOI 10.1111/j.1466-8238.2007.00315.x; Whittaker RJ, 2011, ROOTS CONSERVATION B, P1; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Wiken E., 2011, N AM TERRESTRIAL ECO; Yates ML, 2011, AUST J ZOOL, V59, P332, DOI 10.1071/ZO11096	42	7	8	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e67973	10.1371/journal.pone.0067973	http://dx.doi.org/10.1371/journal.pone.0067973			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	23874479	gold, Green Published			2022-12-27	WOS:000321718700005
J	Tortoriello, G; Rhodes, BP; Takacs, SM; Stuart, JM; Basnet, A; Raboune, S; Widlanski, TS; Doherty, P; Harkany, T; Bradshaw, HB				Tortoriello, Giuseppe; Rhodes, Brandon P.; Takacs, Sara M.; Stuart, Jordyn M.; Basnet, Arjun; Raboune, Siham; Widlanski, Theodore S.; Doherty, Patrick; Harkany, Tibor; Bradshaw, Heather B.			Targeted Lipidomics in Drosophila melanogaster Identifies Novel 2-Monoacylglycerols and N-acyl Amides	PLOS ONE			English	Article							MONOACYLGLYCEROL LIPASE; FATTY-ACIDS; METABOLISM; RECEPTORS; STORAGE; TRP; ENDOCANNABINOIDS; INHIBITION; GLYCEROL; CHANNELS	Lipid metabolism is critical to coordinate organ development and physiology in response to tissue-autonomous signals and environmental cues. Changes to the availability and signaling of lipid mediators can limit competitiveness, adaptation to environmental stressors, and augment pathological processes. Two classes of lipids, the N-acyl amides and the 2-acyl glycerols, have emerged as important signaling molecules in a wide range of species with important signaling properties, though most of what is known about their cellular functions is from mammalian models. Therefore, expanding available knowledge on the repertoire of these lipids in invertebrates will provide additional avenues of research aimed at elucidating biosynthetic, metabolic, and signaling properties of these molecules. Drosophila melanogaster is a commonly used organism to study intercellular communication, including the functions of bioactive lipids. However, limited information is available on the molecular identity of lipids with putative biological activities in Drosophila. Here, we used a targeted lipidomics approach to identify putative signaling lipids in third instar Drosophila larvae, possessing particularly large lipid mass in their fat body. We identified 2-linoleoyl glycerol, 2-oleoyl glycerol, and 45 N-acyl amides in larval tissues, and validated our findings by the comparative analysis of Oregon-RS, Canton-S and w1118 strains. Data here suggest that Drosophila represent another model system to use for the study of 2-acyl glycerol and N-acyl amide signaling.	[Rhodes, Brandon P.; Takacs, Sara M.; Stuart, Jordyn M.; Raboune, Siham; Bradshaw, Heather B.] Indiana Univ, Bloomington, IN 47405 USA; [Tortoriello, Giuseppe; Harkany, Tibor] Karolinska Inst, Div Mol Neurobiol, Dept Med Biochem & Biophys, Stockholm, Sweden; [Basnet, Arjun; Widlanski, Theodore S.] Indiana Univ, Dept Chem, Bloomington, IN USA; [Doherty, Patrick] Kings Coll London, Wolfson Ctr Ageing Related Dis, London, England; [Harkany, Tibor] Univ Aberdeen, European Neurosci Inst, Aberdeen, Scotland	Indiana University System; Indiana University Bloomington; Karolinska Institutet; Indiana University System; Indiana University Bloomington; University of London; King's College London; University of Aberdeen	Bradshaw, HB (corresponding author), Indiana Univ, Bloomington, IN 47405 USA.	hbbradshaw@gmail.com		stuart, Jordyn/0000-0003-3474-2662; Doherty, Patrick/0000-0002-0407-5689	National Institutes of Health [DA032150, DA023214]; Swedish Research Council [K2011-X-21837-01-6]; Swedish Brain Foundation [Hjarnfonden F2012-0278]; Novo Nordisk Foundation [R195-A16447]; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA032150, R01DA023214] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institutes of Health (DA032150, HBB; DA023214, TH), the Swedish Research Council (K2011-X-21837-01-6, TH), Swedish Brain Foundation (Hjarnfonden F2012-0278, TH), and the Novo Nordisk Foundation (R195-A16447, TH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Baker KD, 2007, CELL METAB, V6, P257, DOI 10.1016/j.cmet.2007.09.002; Ben-Shabat S, 1998, EUR J PHARMACOL, V353, P23, DOI 10.1016/S0014-2999(98)00392-6; Bradshaw HB, 2005, BRIT J PHARMACOL, V144, P459, DOI 10.1038/sj.bjp.0706093; Bradshaw HB, 2006, AM J PHYSIOL-REG I, V291, pR349, DOI 10.1152/ajpregu.00933.2005; Bradshaw HB, 2009, VITAM HORM, V81, P191, DOI 10.1016/S0083-6729(09)81008-X; BURGOYNE RD, 1990, TRENDS BIOCHEM SCI, V15, P365, DOI 10.1016/0968-0004(90)90227-3; CARVALHO M, 2012, MOL SYSTEMS BIOL, P8; Cermelli S, 2006, CURR BIOL, V16, P1783, DOI 10.1016/j.cub.2006.07.062; Chyb S, 1999, NATURE, V397, P255, DOI 10.1038/16703; Daly CJ, 2010, BRIT J PHARMACOL, V159, P787, DOI 10.1111/j.1476-5381.2009.00608.x; Delgado R, 2009, J NEUROPHYSIOL, V101, P2372, DOI 10.1152/jn.90578.2008; Di Marzo V, 2008, DIABETOLOGIA, V51, P1356, DOI 10.1007/s00125-008-1048-2; Di Marzo V, 2011, NAT NEUROSCI, V14, P9, DOI 10.1038/nn.2720; Fauny JD, 2005, DEV DYNAM, V232, P725, DOI 10.1002/dvdy.20277; Ghafouri N, 2004, BRIT J PHARMACOL, V143, P774, DOI 10.1038/sj.bjp.0705948; GRIFFIN JL, 2011, NATURE REV CARDIOLOG; Gutierrez E, 2007, NATURE, V445, P275, DOI 10.1038/nature05382; Hader T, 2003, EMBO REP, V4, P511, DOI 10.1038/sj.embor.embor837; Hansen KB, 2011, J CLIN ENDOCR METAB, V96, pE1409, DOI 10.1210/jc.2011-0647; Hardie RC, 2012, SCIENCE, V338, P260, DOI 10.1126/science.1222376; Harkewicz R, 2011, ANNU REV BIOCHEM, V80, P301, DOI 10.1146/annurev-biochem-060409-092612; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; KANG J, 2012, ENDOCRINE REV; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Kinsey SG, 2011, J PHARMACOL EXP THER, V338, P795, DOI 10.1124/jpet.110.175778; Lee SH, 2010, INT J MOL SCI, V11, P3965, DOI 10.3390/ijms11103965; Leung HT, 2008, NEURON, V58, P884, DOI 10.1016/j.neuron.2008.05.001; Lo Verme J, 2005, MOL PHARMACOL, V67, P15, DOI 10.1124/mol.104.006353; Matias I, 2006, J Endocrinol Invest, V29, P15; Matias I, 2007, TRENDS ENDOCRIN MET, V18, P27, DOI 10.1016/j.tem.2006.11.006; McPartland JM, 2004, BRAIN RES REV, V45, P18, DOI 10.1016/j.brainresrev.2003.11.005; McPartland JM, 2007, GENE, V397, P126, DOI 10.1016/j.gene.2007.04.017; Niwa R, 2011, CHOLESTEROL, DOI 10.1155/2011/176802; Nomura DK, 2011, SCIENCE, V334, P809, DOI 10.1126/science.1209200; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Piper MDW, 2005, EXP GERONTOL, V40, P857, DOI 10.1016/j.exger.2005.06.013; Richardson D, 2007, ANAL BIOCHEM, V360, P216, DOI 10.1016/j.ab.2006.10.039; Rimmerman N, 2008, MOL PHARMACOL, V74, P213, DOI 10.1124/mol.108.045997; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Schroeder F, 2008, LIPIDS, V43, P1, DOI 10.1007/s11745-007-3111-z; Shen LR, 2010, J LIPID RES, V51, P2985, DOI 10.1194/jlr.M008524; Smoum R, 2010, P NATL ACAD SCI USA, V107, P17710, DOI 10.1073/pnas.0912479107; Tan B, 2006, AAPS J, V8, pE461, DOI 10.1208/aapsj080354; Tan B, 2010, J LIPID RES, V51, P112, DOI 10.1194/jlr.M900198-JLR200; Tan B, 2009, J CHROMATOGR B, V877, P2890, DOI 10.1016/j.jchromb.2009.01.002; Teleman AA, 2005, DEV CELL, V9, P271, DOI 10.1016/j.devcel.2005.07.004; Ugrankar R, 2011, MOL CELL BIOL, V31, P1646, DOI 10.1128/MCB.01335-10	48	57	58	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e67865	10.1371/journal.pone.0067865	http://dx.doi.org/10.1371/journal.pone.0067865			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874457	Green Submitted, Green Published, gold			2022-12-27	WOS:000322218800011
J	Sanchez-Sutil, MC; Perez, JP; Gomez-Santos, N; Shimkets, LJ; Moraleda-Munoz, A; Munoz-Dorado, J				Celestina Sanchez-Sutil, Maria; Perez, Juana; Gomez-Santos, Nuria; Shimkets, Lawrence J.; Moraleda-Munoz, Aurelio; Munoz-Dorado, Jose			The Myxococcus xanthus Two-Component System CorSR Regulates Expression of a Gene Cluster Involved in Maintaining Copper Tolerance during Growth and Development	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; CAROTENOID SYNTHESIS; FRUA; HOMEOSTASIS; ACTIVATION; INDUCTION; MUTANTS; LOCUS	Myxococcus xanthus is a soil-dwelling member of the delta-Proteobacteria that exhibits a complex developmental cycle upon starvation. Development comprises aggregation and differentiation into environmentally resistant myxospores in an environment that includes fluctuations in metal ion concentrations. While copper is essential for M. xanthus cells because several housekeeping enzymes use it as a cofactor, high copper concentrations are toxic. These opposing effects force cells to maintain a tight copper homeostasis. A plethora of paralogous genes involved in copper detoxification, all of which are differentially regulated, have been reported in M. xanthus. The use of in-frame deletion mutants and fusions with the reporter gene lacZ has allowed the identification of a two-component system, CorSR, that modulates the expression of an operon termed curA consisting of nine genes whose expression slowly increases after metal addition, reaching a plateau. Transcriptional regulation of this operon is complex because transcription can be initiated at different promoters and by different types of regulators. These genes confer copper tolerance during growth and development. Copper induces carotenoid production in a Delta corSR mutant at lower concentrations than with the wild-type strain due to lack of expression of a gene product resembling subunit III of cbb3-type cytochrome c oxidase. This data may explain why copper induces carotenoid biosynthesis at suboptimal rather than optimal growth conditions in wild-type strains.	[Celestina Sanchez-Sutil, Maria; Perez, Juana; Gomez-Santos, Nuria; Moraleda-Munoz, Aurelio; Munoz-Dorado, Jose] Univ Granada, Fac Ciencias, Dept Microbiol, E-18071 Granada, Spain; [Shimkets, Lawrence J.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA	University of Granada; University System of Georgia; University of Georgia	Munoz-Dorado, J (corresponding author), Univ Granada, Fac Ciencias, Dept Microbiol, E-18071 Granada, Spain.	jdorado@ugr.es	Moraleda-Munoz, Aurelio/AAA-1599-2019; Munoz-Dorado, Jose/N-6840-2016; Torres, Juana Pérez/H-2480-2015	Munoz-Dorado, Jose/0000-0001-7765-5687; Torres, Juana Pérez/0000-0001-8073-9398; Moraleda-Munoz, Aurelio/0000-0002-3330-5535; Gomez Santos, Nuria/0000-0002-1161-250X	Spanish Government [CSD2009-00006, BFU2012-33248]; FEDER; National Institute of General Medical Science of the National Institutes of Health [R01GM095826]; National Science Foundation [MCB0742976]; Junta de Andalucia	Spanish Government(Spanish GovernmentEuropean Commission); FEDER(European Commission); National Institute of General Medical Science of the National Institutes of Health; National Science Foundation(National Science Foundation (NSF)); Junta de Andalucia(Junta de Andalucia)	This work has been funded by the Spanish Government (grants CSD2009-00006 and BFU2012-33248, 70% funded by FEDER). This work was also supported by the National Institute of General Medical Science of the National Institutes of Health under award number R01GM095826 to LJS, and by the National Science Foundation under award number MCB0742976 to LJS. JMD and JP received a fellowship from Junta de Andalucia to do some work at University of Georgia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bleackley MR, 2011, BIOMETALS, V24, P785, DOI 10.1007/s10534-011-9451-4; Cho KY, 1999, MOL MICROBIOL, V34, P268, DOI 10.1046/j.1365-2958.1999.01594.x; Ekici S, 2012, MBIO, V3, DOI 10.1128/mBio.00293-11; Ekici S, 2013, J BACTERIOL, V195, P261, DOI 10.1128/JB.01415-12; Ellehauge E, 1998, MOL MICROBIOL, V30, P807, DOI 10.1046/j.1365-2958.1998.01113.x; FONTES M, 1993, EMBO J, V12, P1265, DOI 10.1002/j.1460-2075.1993.tb05771.x; Gaggelli E, 2006, CHEM REV, V106, P1995, DOI 10.1021/cr040410w; GARCIAHORSMAN JA, 1994, J BACTERIOL, V176, P5587, DOI 10.1128/JB.176.18.5587-5600.1994; Gomez-Santos N, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002106; Gupta SD, 1997, J BACTERIOL, V179, P4977, DOI 10.1128/jb.179.16.4977-4984.1997; HAGEN DC, 1978, DEV BIOL, V64, P284, DOI 10.1016/0012-1606(78)90079-9; Julien B, 2000, P NATL ACAD SCI USA, V97, P9098, DOI 10.1073/pnas.97.16.9098; Kaiser D, 2008, ANNU REV GENET, V42, P109, DOI 10.1146/annurev.genet.42.110807.091615; KASHEFI K, 1995, MOL MICROBIOL, V15, P483, DOI 10.1111/j.1365-2958.1995.tb02262.x; Kroos L, 2007, MYXOBACTERIA: MULTICELLULARITY AND DIFFERENTIATION, P149; Moraleda-Munoz A, 2005, MOL MICROBIOL, V56, P1159, DOI 10.1111/j.1365-2958.2005.04613.x; Moraleda-Munoz A, 2010, APPL ENVIRON MICROB, V76, P6077, DOI 10.1128/AEM.00755-10; Moraleda-Munoz A, 2010, APPL ENVIRON MICROB, V76, P6069, DOI 10.1128/AEM.00753-10; Nariya H, 2006, MOL MICROBIOL, V60, P1205, DOI 10.1111/j.1365-2958.2006.05178.x; Ogawa M, 1996, MOL MICROBIOL, V22, P757, DOI 10.1046/j.1365-2958.1996.d01-1725.x; Outten FW, 2001, J BIOL CHEM, V276, P30670, DOI 10.1074/jbc.M104122200; Sambrook J., 2001, MOL CLONING LAB MANU; Sanchez-Sutil MC, 2007, J BACTERIOL, V189, P4887, DOI 10.1128/JB.00309-07; Solioz M, 2010, J BIOL INORG CHEM, V15, P3, DOI 10.1007/s00775-009-0588-3; Teichmann SA, 2004, NAT GENET, V36, P492, DOI 10.1038/ng1340; Ueki T, 2005, J BACTERIOL, V187, P8504, DOI 10.1128/JB.187.24.8504-8506.2005; Ueki T, 2003, P NATL ACAD SCI USA, V100, P8782, DOI 10.1073/pnas.1533026100; Yang CH, 1996, P NATL ACAD SCI USA, V93, P7315, DOI 10.1073/pnas.93.14.7315; Zufferey R, 1996, J BIOL CHEM, V271, P9114, DOI 10.1074/jbc.271.15.9114	30	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68240	10.1371/journal.pone.0068240	http://dx.doi.org/10.1371/journal.pone.0068240			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874560	Green Published, Green Submitted, gold			2022-12-27	WOS:000321765300037
J	Oliver, SP; Turner, JR; Gann, K; Silvosa, M; Jackson, TD				Oliver, Simon P.; Turner, John R.; Gann, Klemens; Silvosa, Medel; Jackson, Tim D'Urban			Thresher Sharks Use Tail-Slaps as a Hunting Strategy	PLOS ONE			English	Article							WHALES ORCINUS-ORCA; ALOPIAS-SUPERCILIOSUS; KILLER WHALES; CARCHARODON-CARCHARIAS; FEEDING ECOLOGY; PECTORAL FINS; WHITE SHARKS; SOUTH-AFRICA; SARDINE RUN; CAUDAL FIN	The hunting strategies of pelagic thresher sharks (Alopias pelagicus) were investigated at Pescador Island in the Philippines. It has long been suspected that thresher sharks hunt with their scythe-like tails but the kinematics associated with the behaviour in the wild are poorly understood. From 61 observations recorded by handheld underwater video camera between June and October 2010, 25 thresher shark shunting events were analysed. Thresher sharks employed tail-slaps to debilitate sardines at all times of day. Hunting events comprised preparation, strike, wind-down recovery and prey item collection phases, which occurred sequentially. Preparation phases were significantly longer than the others, presumably to enable a shark to windup a tail-slap. Tail-slaps were initiated by an adduction of the pectoral fins, a manoeuvre that changed a thresher shark's pitch promoting its posterior region to lift rapidly, and stall its approach. Tail-slaps occurred with such force that they may have caused dissolved gas to diffuse out of the water column forming bubbles. Thresher sharks were able to consume more than one sardine at a time, suggesting that tail-slapping is an effective foraging strategy for hunting schooling prey. Pelagic thresher sharks appear to pursue sardines opportunistically by day and night, which may make them vulnerable to fisheries. Alopiids possess specialist pectoral and caudal fins that are likely to have evolved, at least in part, for tail-slapping. The evidence is now clear; thresher sharks really do hunt with their tails.	[Oliver, Simon P.; Gann, Klemens; Silvosa, Medel] Thresher Shark Res & Conservat Project, Malapascua Island, Cebu, Philippines; [Oliver, Simon P.; Turner, John R.; Jackson, Tim D'Urban] Bangor Univ, Sch Ocean Sci, Menai Bridge, Anglesey, Wales	Bangor University	Oliver, SP (corresponding author), Thresher Shark Res & Conservat Project, Malapascua Island, Cebu, Philippines.	s.p.oliver@liverpool.ac.uk	Jackson, Tim D'Urban/AAJ-6787-2021; Oliver, Simon/AAK-1712-2020	Jackson, Tim D'Urban/0000-0001-7077-2186; Oliver, Simon/0000-0002-2975-1233	NERC [Blue Skies RES22709]; Thresher Shark Research and Conservation Project	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Thresher Shark Research and Conservation Project	This work was supported by a NERC PhD algorithm studentship awarded to SPO, [Blue Skies RES22709]. This study would not have been possible without financial support from the Thresher Shark Research and Conservation Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalbers SA, 2010, J FISH BIOL, V76, P1863, DOI 10.1111/j.1095-8649.2010.02616.x; Allen WB, 1923, SCIENCE, V58, P31, DOI 10.1126/science.58.1489.31-a; Batchelor GK, 1990, INTRO FLUID DYNAMICS, P481; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; BREDER C. M., 1929, AMER MUS NOVITATES, V382, P1; BRES M, 1993, REV FISH BIOL FISHER, V3, P133, DOI 10.1007/BF00045229; Clua E, 2001, AQUAT LIVING RESOUR, V14, P11, DOI 10.1016/S0990-7440(00)01097-4; Compagno LJV., 1984, FAO FISH SYNOP, P20; Cross R, 2004, AM J PHYS, V72, P305, DOI 10.1119/1.1634964; Deecke VB, 2011, AQUAT BIOL, V13, P79, DOI 10.3354/ab00353; Domenici P, 1997, J EXP BIOL, V200, P1165; Domenici P, 2000, J EXP BIOL, V203, P283; Dudley SFJ, 2010, AFR J MAR SCI, V32, P383, DOI 10.2989/1814232X.2010.502641; Dudley SFJ, 2005, AFR J MAR SCI, V27, P107, DOI 10.2989/18142320509504072; FEDAK MA, 1982, J EXP BIOL, V97, P23; Guerra A, 2007, J MAR BIOL ASSOC UK, V87, P1255, DOI 10.1017/S0025315407058225; HAIN JHW, 1982, FISH B-NOAA, V80, P259; Heithaus MR, 2004, BIOL SHARKS THEIR RE, P524; Herbert E, 2006, CR PHYS, V7, P1000; Iosilevskii G, 2008, J R SOC INTERFACE, V5, P329, DOI 10.1098/rsif.2007.1073; Klimley AP, 1996, GREAT WHITE SHARKS, P175, DOI 10.1016/B978-012415031-7/50017-3; Klimley AP, 1996, GREAT WHITE SHARKS, P241, DOI 10.1016/B978-012415031-7/50023-9; Klimley AP, 2001, MAR BIOL, V138, P617, DOI 10.1007/s002270000489; Lema SC, 2002, J COMP PSYCHOL, V116, P145, DOI 10.1037//0735-7036.116.2.145; Lingham-Soliar T, 2005, NATURWISSENSCHAFTEN, V92, P231, DOI 10.1007/s00114-005-0614-4; Liu KM, 1999, COPEIA, P68; Lowry D, 2008, J R SOC INTERFACE, V5, P641, DOI 10.1098/rsif.2007.1189; Martin RA, 2005, J MAR BIOL ASSOC UK, V85, P1121, DOI 10.1017/S002531540501218X; Mollet HF, 1996, GREAT WHITE SHARKS, P91, DOI 10.1016/B978-012415031-7/50011-2; Motta PJ, 2004, CRC MAR BIOL SER, P165; Motta PJ, 2001, ENVIRON BIOL FISH, V60, P131, DOI 10.1023/A:1007649900712; Nakano H, 2003, MAR ECOL PROG SER, V265, P255, DOI 10.3354/meps265255; O'Donoghue SH, 2010, AFR J MAR SCI, V32, P293, DOI 10.2989/1814232X.2010.501587; Oliver SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014755; Patek SN, 2005, J EXP BIOL, V208, P3655, DOI 10.1242/jeb.01831; SAILA SB, 1993, MAR ECOL PROG SER, V94, P51, DOI 10.3354/meps094051; Sarraf C, 2010, J FLUID STRUCT, V26, P559, DOI 10.1016/j.jfluidstructs.2010.02.004; Shepard ELC, 2006, MAR ECOL PROG SER, V328, P205, DOI 10.3354/meps328205; SIMILA T, 1993, CAN J ZOOL, V71, P1494, DOI 10.1139/z93-210; Simon M, 2005, J EXP BIOL, V208, P2459, DOI 10.1242/jeb.01619; Slater PJB, 1978, QUANTITATIVE ETHOLOG, P15; Sperone E, 2012, MAR BIOL RES, V8, P982, DOI 10.1080/17451000.2012.708043; Sperone E, 2010, MAR BIOL RES, V6, P408, DOI 10.1080/17451000903078648; Stevens JD, 2010, MAR BIOL, V157, P575, DOI 10.1007/s00227-009-1343-6; STILLWELL CE, 1976, FISH B-NOAA, V74, P221; Strasburg D. W., 1958, Fishery Bulletin United States, V58, P335; Versluis M, 2000, SCIENCE, V289, P2114, DOI 10.1126/science.289.5487.2114; WATERS S, 1990, CAN J ZOOL, V68, P2076, DOI 10.1139/z90-289; WEBB PW, 1990, T AM FISH SOC, V119, P629, DOI 10.1577/1548-8659(1990)119<0629:LITBOL>2.3.CO;2; Weng KC, 2004, FISH B-NOAA, V102, P221; Whitehead H, 1985, WHY WHALES LEAP SCI, V25, P84; Wilga CAD, 2004, CRC MAR BIOL SER, P139; Wilga CD, 2001, J MORPHOL, V249, P195, DOI 10.1002/jmor.1049; Wilga CD, 2000, J EXP BIOL, V203, P2261	54	28	28	4	138	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e67380	10.1371/journal.pone.0067380	http://dx.doi.org/10.1371/journal.pone.0067380			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874415	Green Published, gold, Green Submitted			2022-12-27	WOS:000321765300008
J	Sikkeland, J; Saatcioglu, F				Sikkeland, Jorgen; Saatcioglu, Fahri			Differential Expression and Function of Stamp Family Proteins in Adipocyte Differentiation	PLOS ONE			English	Article							MITOTIC CLONAL EXPANSION; ADIPOSE-TISSUE; OXIDATIVE STRESS; PROSTATE-CANCER; MOLECULAR-CLONING; ADIPOGENESIS; GENE; FAT; OBESITY; STEAP4	Six transmembrane protein of prostate (Stamp) proteins play an important role in prostate cancer cell growth. Recently, we found that Stamp2 has a critical role in the integration of inflammatory and metabolic signals in adipose tissue where it is highly expressed and regulated by nutritional and metabolic cues. In this study, we show that all Stamp family members are differentially regulated during adipogenesis: whereas Stamp1 expression is significantly decreased upon differentiation, Stamp2 expression is increased. In contrast, Stamp3 expression is modestly changed in adipocytes compared to preadipocytes, and has a biphasic expression pattern during the course of differentiation. Suppression of Stamp1 or Stamp2 expression both led to inhibition of 3T3-L1 differentiation in concert with diminished expression of the key regulators of adipogenesis - CCAAT/enhancer binding protein alpha (C/ebp alpha) and peroxisome proliferator-activated receptor gamma (Ppar gamma). Upon Stamp1 knockdown, mitotic clonal expansion was also inhibited. In contrast, Stamp2 knockdown did not affect mitotic clonal expansion, but resulted in a marked decrease in superoxide production that is known to affect adipogenesis. These results suggest that Stamp1 and Stamp2 play critical roles in adipogenesis, but through different mechanisms.	[Sikkeland, Jorgen; Saatcioglu, Fahri] Univ Oslo, Dept Biosci, Oslo, Norway	University of Oslo	Saatcioglu, F (corresponding author), Univ Oslo, Dept Biosci, Oslo, Norway.	fahris@ibv.uio.no			Norwegian Research Council; Norwegian Cancer Society; University of Oslo	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society); University of Oslo	This work was supported by funds from the Norwegian Research Council (www.forskningsradet.no), Norwegian Cancer Society (www.kreftforeningen.no), and University of Oslo (www.uio.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arner P, 2008, J CLIN ENDOCR METAB, V93, P2249, DOI 10.1210/jc.2008-0206; Carriere A, 2004, J BIOL CHEM, V279, P40462, DOI 10.1074/jbc.M407258200; Chen XH, 2010, INT J MOL MED, V25, P361, DOI 10.3892/ijmm_00000353; Cheng R, 2011, MOL MED REP, V4, P519, DOI 10.3892/mmr.2011.443; Choi HS, 2006, J IMMUNOASS IMMUNOCH, V27, P31, DOI 10.1080/15321810500403722; Elbein SC, 2011, DIABETES, V60, P1019, DOI 10.2337/db10-1270; Findeisen HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018532; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Gummersbach C, 2009, DIFFERENTIATION, V77, P115, DOI 10.1016/j.diff.2008.09.009; Hausman G J, 2008, J Anim Sci, V86, pE236; Higuchi M, 2013, STEM CELLS DEV, V22, P878, DOI 10.1089/scd.2012.0306; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Joo JI, 2010, J PROTEOME RES, V9, P2977, DOI 10.1021/pr901175w; KLETZIEN RF, 1992, MOL PHARMACOL, V41, P393; Korkmaz CG, 2005, ONCOGENE, V24, P4934, DOI 10.1038/sj.onc.1208677; Korkmaz KS, 2002, J BIOL CHEM, V277, P36689, DOI 10.1074/jbc.M202414200; Lafontan M, 2012, AM J PHYSIOL-CELL PH, V302, pC327, DOI 10.1152/ajpcell.00168.2011; Lambe T, 2009, BLOOD, V113, P1805, DOI 10.1182/blood-2007-11-120402; Lee H, 2009, J BIOL CHEM, V284, P10601, DOI 10.1074/jbc.M808742200; Liu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034315; Lowe CE, 2011, J CELL SCI, V124, P2681, DOI 10.1242/jcs.079699; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; Moreno-Navarrete JM, 2011, J CLIN ENDOCR METAB, V96, pE1816, DOI 10.1210/jc.2011-0310; Moldes M, 2001, J BIOL CHEM, V276, P33938, DOI 10.1074/jbc.M105726200; Ohgami RS, 2006, BLOOD, V108, P1388, DOI 10.1182/blood-2006-02-003681; Ohgami RS, 2005, NAT GENET, V37, P1264, DOI 10.1038/ng1658; Otto TC, 2005, CRIT REV BIOCHEM MOL, V40, P229, DOI 10.1080/10409230591008189; Park KW, 2008, CELL METAB, V8, P454, DOI 10.1016/j.cmet.2008.11.001; Pessler-Cohen Dorit, 2006, Archives of Physiology and Biochemistry, V112, P3, DOI 10.1080/13813450500500399; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Qin DN, 2011, J BIOENERG BIOMEMBR, V43, P247, DOI 10.1007/s10863-011-9360-9; Qin DN, 2010, INT J MOL MED, V26, P803, DOI 10.3892/ijmm_00000528; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; ten Freyhaus H, 2012, CELL METAB, V16, P81, DOI 10.1016/j.cmet.2012.05.009; Tormos KV, 2011, CELL METAB, V14, P537, DOI 10.1016/j.cmet.2011.08.007; Wang L, 2010, CANCER RES, V70, P5818, DOI 10.1158/0008-5472.CAN-09-4697; Wellen KE, 2007, CELL, V129, P537, DOI 10.1016/j.cell.2007.02.049; World Health Organization, 2022, OB OV; Ye F, 2011, J CELL BIOCHEM, V112, P3002, DOI 10.1002/jcb.23223; Zhang CM, 2008, ACTA PHARMACOL SIN, V29, P587, DOI 10.1111/j.1745-7254.2008.00793.x	44	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68249	10.1371/journal.pone.0068249	http://dx.doi.org/10.1371/journal.pone.0068249			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874564	Green Submitted, gold, Green Published			2022-12-27	WOS:000321765300039
J	Al-Juboori, SI; Dondzillo, A; Stubblefield, EA; Felsen, G; Lei, TC; Klug, A				Al-Juboori, Saif I.; Dondzillo, Anna; Stubblefield, Elizabeth A.; Felsen, Gidon; Lei, Tim C.; Klug, Achim			Light Scattering Properties Vary across Different Regions of the Adult Mouse Brain	PLOS ONE			English	Article							TECHNOLOGIES; OPTOGENETICS; CELLS	Recently developed optogenetic tools provide powerful approaches to optically excite or inhibit neural activity. In a typical in-vivo experiment, light is delivered to deep nuclei via an implanted optical fiber. Light intensity attenuates with increasing distance from the fiber tip, determining the volume of tissue in which optogenetic proteins can successfully be activated. However, whether and how this volume of effective light intensity varies as a function of brain region or wavelength has not been systematically studied. The goal of this study was to measure and compare how light scatters in different areas of the mouse brain. We delivered different wavelengths of light via optical fibers to acute slices of mouse brainstem, midbrain and forebrain tissue. We measured light intensity as a function of distance from the fiber tip, and used the data to model the spread of light in specific regions of the mouse brain. We found substantial differences in effective attenuation coefficients among different brain areas, which lead to substantial differences in light intensity demands for optogenetic experiments. The use of light of different wavelengths additionally changes how light illuminates a given brain area. We created a brain atlas of effective attenuation coefficients of the adult mouse brain, and integrated our data into an application that can be used to estimate light scattering as well as required light intensity for optogenetic manipulation within a given volume of tissue.	[Al-Juboori, Saif I.; Lei, Tim C.] Univ Colorado, Dept Elect Engn, Denver, CO 80202 USA; [Dondzillo, Anna; Stubblefield, Elizabeth A.; Felsen, Gidon; Klug, Achim] Univ Colorado, Sch Med, Dept Physiol & Biophys, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus	Klug, A (corresponding author), Univ Colorado, Sch Med, Dept Physiol & Biophys, Aurora, CO 80045 USA.	Achim.klug@ucdenver.edu	Klug, Achim/N-6956-2014	Klug, Achim/0000-0002-3383-850X	NIH [R01 DC011582, R01 NS079518, K25 DK095232, T32 NS007083]; UC Center of NeuroScience; Boettcher Foundation; Higher Committee for Education Development in Iraq (HDED); Optogenetics Core (Academic Enrichment Fund, University of Colorado School of Medicine); Rocky Mountain Neurological Disorders Core Center [NIH P30NS048154]; NIH/NCRR Colorado CTSI Grant [UL1 RR025780]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K25DK095232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079518, P30NS048154, T32NS007083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011582] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UC Center of NeuroScience; Boettcher Foundation; Higher Committee for Education Development in Iraq (HDED); Optogenetics Core (Academic Enrichment Fund, University of Colorado School of Medicine); Rocky Mountain Neurological Disorders Core Center; NIH/NCRR Colorado CTSI Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by NIH grant R01 DC011582 and a grant from the UC Center of NeuroScience to A. K.; NIH grant R01 NS079518 and a grant from the Boettcher Foundation to G.F.; NIH grant K25 DK095232 to T.C.L. E.A.S was supported by a fellowship from NIH training grant T32 NS007083; S.I.A.-J. was supported by a fellowship from the Higher Committee for Education Development in Iraq (HDED). This work was supported in part by Optogenetics Core (Academic Enrichment Fund, University of Colorado School of Medicine) the Rocky Mountain Neurological Disorders Core Center Grant NIH P30NS048154. Imaging experiments were performed in the University of Colorado Anschutz Medical Campus Advanced Light Microscopy Core supported in part by NIH/NCRR Colorado CTSI Grant Number UL1 RR025780. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Bernstein JG, 2012, CURR OPIN NEUROBIOL, V22, P61, DOI 10.1016/j.conb.2011.10.023; Boas DA, 2002, OPT EXPRESS, V10, P159, DOI 10.1364/OE.10.000159; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; CHEONG WF, 1990, IEEE J QUANTUM ELECT, V26, P2166, DOI 10.1109/3.64354; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Henderson JM, 2009, NEUROSURGERY, V64, P796, DOI 10.1227/01.NEU.0000339171.87593.6A; Henyey LG, 1941, ASTROPHYS J, V93, P70, DOI 10.1086/144246; Lagali PS, 2008, NAT NEUROSCI, V11, P667, DOI 10.1038/nn.2117; Nowak VA, 2010, BRIT J NEUROSURG, V24, P618, DOI 10.3109/02688697.2010.520764; SARDAR DK, 1993, LASER MED SCI, V8, P205, DOI 10.1007/BF02547877; Stark E, 2012, J NEUROPHYSIOL, V108, P349, DOI 10.1152/jn.00153.2012; Wang L.V., 2012, BIOMEDICAL OPTICS PR; Wilson RH, 2011, TECHNOL CANCER RES T, V10, P121, DOI 10.7785/tcrt.2012.500187; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	18	76	76	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e67626	10.1371/journal.pone.0067626	http://dx.doi.org/10.1371/journal.pone.0067626			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874433	gold, Green Published, Green Submitted			2022-12-27	WOS:000321736900014
J	Collie, D; Govan, J; Wright, S; Thornton, E; Tennant, P; Smith, S; Doherty, C; McLachlan, G				Collie, David; Govan, John; Wright, Steven; Thornton, Elisabeth; Tennant, Peter; Smith, Sionagh; Doherty, Catherine; McLachlan, Gerry			A Lung Segmental Model of Chronic Pseudomonas Infection in Sheep	PLOS ONE			English	Article							NAKED PLASMID DNA; CYSTIC-FIBROSIS; OVINE LUNG; AERUGINOSA PNEUMONIA; PULMONARY INFECTION; RAT MODEL; AIRWAY INFLAMMATION; SCORING SYSTEM; RHESUS-MONKEYS; GENE-TRANSFER	Background: Chronic lung infection with Pseudomonas aeruginosa is a major contributor to morbidity, mortality and premature death in cystic fibrosis. A new paradigm for managing such infections is needed, as are relevant and translatable animal models to identify and test concepts. We sought to improve on limitations associated with existing models of infection in small animals through developing a lung segmental model of chronic Pseudomonas infection in sheep. Methodology/Principal Findings: Using local lung instillation of P. aeruginosa suspended in agar beads we were able to demonstrate that such infection led to the development of a suppurative, necrotising and pyogranulomatous pneumonia centred on the instilled beads. No overt evidence of organ or systemic compromise was apparent in any animal during the course of infection. Infection persisted in the lungs of individual animals for as long as 66 days after initial instillation. Quantitative microbiology applied to bronchoalveolar lavage fluid derived from infected segments proved an insensitive index of the presence of significant infection in lung tissue (>10(4) cfu/g). Conclusions/Significance: The agar bead model of chronic P. aeruginosa lung infection in sheep is a relevant platform to investigate both the pathobiology of such infections as well as novel approaches to their diagnosis and therapy. Particular ethical benefits relate to the model in terms of refining existing approaches by compromising a smaller proportion of the lung with infection and facilitating longitudinal assessment by bronchoscopy, and also potentially reducing animal numbers through facilitating within-animal comparisons of differential therapeutic approaches.	[Collie, David; Wright, Steven; Thornton, Elisabeth; Tennant, Peter; Smith, Sionagh; McLachlan, Gerry] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; [Collie, David; Wright, Steven; Thornton, Elisabeth; Tennant, Peter; Smith, Sionagh; McLachlan, Gerry] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH9 1QH, Midlothian, Scotland; [Govan, John; Doherty, Catherine] Univ Edinburgh, Sch Med, Edinburgh, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of Edinburgh	Collie, D (corresponding author), Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland.	david.collie@ed.ac.uk		Collie, David/0000-0001-9313-8137; McLachlan, Gerry/0000-0001-5362-9804	Biological and Biotechnological Science Research Council (BBSRC)	Biological and Biotechnological Science Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Biological and Biotechnological Science Research Council (BBSRC; www.bbsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhariri M, 2013, ANTIMICROB AGENTS CH, V57, P569, DOI 10.1128/AAC.01634-12; Ballmann M, 2011, RESP MED, V105, pS2, DOI 10.1016/S0954-6111(11)70021-X; BALTIMORE RS, 1989, AM REV RESPIR DIS, V140, P1650, DOI 10.1164/ajrccm/140.6.1650; Brogden KA, 2001, ANTIMICROB AGENTS CH, V45, P331, DOI 10.1128/AAC.45.1.331-334.2001; Burns JL, 2001, J INFECT DIS, V183, P444, DOI 10.1086/318075; Capuano SV, 2003, INFECT IMMUN, V71, P5831, DOI 10.1128/IAI.71.10.5831-5844.2003; CASH HA, 1979, AM REV RESPIR DIS, V119, P453; Chang AB, 2006, PEDIATR PULM, V41, P887, DOI 10.1002/ppul.20478; CHASTRE J, 1995, AM J RESP CRIT CARE, V152, P231, DOI 10.1164/ajrccm.152.1.7599829; CHASTRE J, 1984, AM REV RESPIR DIS, V130, P924; CHEUNG ATW, 1992, J MED PRIMATOL, V21, P357; CHEUNG ATW, 1993, J MED PRIMATOL, V22, P257; Dagenais A, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-2; Davis SD, 2007, AM J RESP CRIT CARE, V175, P943, DOI 10.1164/rccm.200603-343OC; Ding FM, 2012, RESPIROLOGY, V17, P727, DOI 10.1111/j.1440-1843.2012.02166.x; Emerson M, 2003, MOL THER, V8, P646, DOI 10.1016/S1525-0016(03)00233-8; FITZSIMMONS SC, 1993, J PEDIATR-US, V122, P1, DOI 10.1016/S0022-3476(05)83478-X; Geller DE, 2011, AM J RESP CRIT CARE, V183, P1510, DOI 10.1164/rccm.201008-1293OC; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; GOVAN JRW, 1978, J ANTIMICROB CHEMOTH, V4, P233, DOI 10.1093/jac/4.3.233; Growcott EJ, 2011, J CYST FIBROS, V10, P166, DOI 10.1016/j.jcf.2010.12.007; Grubor B, 2004, VET IMMUNOL IMMUNOP, V101, P235, DOI 10.1016/j.vetimm.2004.05.004; Hraiech S, 2012, J ANTIMICROB CHEMOTH, V67, P2452, DOI 10.1093/jac/dks230; Hubeau C, 2001, CLIN EXP IMMUNOL, V124, P69, DOI 10.1046/j.1365-2249.2001.01456.x; Hurley MN, 2012, EUR RESPIR J, V40, P1014, DOI 10.1183/09031936.00042012; Jassal MS, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-49; Kukavica-Ibrulj I, 2008, J BACTERIOL, V190, P2804, DOI 10.1128/JB.01572-07; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Lin PL, 2009, INFECT IMMUN, V77, P4631, DOI 10.1128/IAI.00592-09; Mccoy KS, 2008, AM J RESP CRIT CARE, V178, P921, DOI 10.1164/rccm.200712-1804OC; McLachlan G, 2011, GENE THER, V18, P996, DOI 10.1038/gt.2011.55; McLachlan G, 2007, MOL THER, V15, P348, DOI 10.1038/sj.mt.6300058; Meers P, 2008, J ANTIMICROB CHEMOTH, V61, P859, DOI 10.1093/jac/dkn059; Meyer KC, 1997, AM J RESP CRIT CARE, V156, P1536, DOI 10.1164/ajrccm.156.5.9701098; Nam SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021387; Olsen RJ, 2010, MICROB PATHOGENESIS, V49, P336, DOI 10.1016/j.micpath.2010.06.012; PATTERSON GA, 1982, J SURG RES, V33, P214, DOI 10.1016/0022-4804(82)90032-4; Polosukhin VV, 2011, AM J RESP CRIT CARE, V184, P317, DOI 10.1164/rccm.201010-1629OC; Pringle IA, 2007, J GENE MED, V9, P369, DOI 10.1002/jgm.1026; Regamey N, 2012, THORAX, V67, P170, DOI 10.1136/thoraxjnl-2011-200585; Reinhold P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030125; Rejman J, 2010, HUM GENE THER, V21, P351, DOI 10.1089/hum.2009.085; Rogers CS, 2008, JCLININVEST; Sibila O, 2007, EUR RESPIR J, V30, P1167, DOI 10.1183/09031936.00053607; Simon BA, 2006, AM J PHYSIOL-LUNG C, V291, pL851, DOI 10.1152/ajplung.00463.2005; Sun X, 2008, JCLININVEST; THOMASSEN MJ, 1984, INFECT IMMUN, V45, P741, DOI 10.1128/IAI.45.3.741-747.1984; Tomashefski JT, 2008, DAIL HUMMARS PULMONA; van Heeckeren A, 1998, GENE THER, V5, P345, DOI 10.1038/sj.gt.3300593; van Heeckeren AM, 2002, LAB ANIM-UK, V36, P291, DOI 10.1258/002367702320162405; WIENERKRONISH JP, 1993, ANNU REV PHYSIOL, V55, P209, DOI 10.1146/annurev.ph.55.030193.001233; WINNIE GB, 1982, INFECT IMMUN, V38, P1088, DOI 10.1128/IAI.38.3.1088-1093.1982	52	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e67677	10.1371/journal.pone.0067677	http://dx.doi.org/10.1371/journal.pone.0067677			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874438	Green Published, Green Submitted, gold			2022-12-27	WOS:000321736900016
J	Jeong, SJ; Luo, R; Singer, K; Giera, S; Kreidberg, J; Kiyozumi, D; Shimono, C; Sekiguchi, K; Piao, XH				Jeong, Sung-Jin; Luo, Rong; Singer, Kathleen; Giera, Stefanie; Kreidberg, Jordan; Kiyozumi, Daiji; Shimono, Chisei; Sekiguchi, Kiyotoshi; Piao, Xianhua			GPR56 Functions Together with alpha 3 beta 1 Integrin in Regulating Cerebral Cortical Development	PLOS ONE			English	Article							BILATERAL FRONTOPARIETAL POLYMICROGYRIA; ALPHA 3 BETA-1-INTEGRIN; PIAL BASEMENT-MEMBRANE; COUPLED RECEPTOR 56; NEURONAL MIGRATION; CELL-ADHESION; LIGAND; DYSTROGLYCAN; COLLAGEN; BINDING	Loss of function mutations in GPR56, which encodes a G protein-coupled receptor, cause a specific human brain malformation called bilateral frontoparietal polymicrogyria (BFPP). Studies from BFPP postmortem brain tissue and Gpr56 knockout mice have previously showed that GPR56 deletion leads to breaches in the pial basement membrane (BM) and neuronal ectopias during cerebral cortical development. Since alpha 3 beta 1 integrin also plays a role in pial BM assembly and maintenance, we evaluated whether it functions together with GPR56 in regulating the same developmental process. We reveal that loss of alpha 3 integrin enhances the cortical phenotype associated with Gpr56 deletion, and that neuronal overmigration through a breached pial BM occurs earlier in double knockout than in Gpr56 single knockout mice. These observations provide compelling evidence of the synergism of GPR56 and alpha 3 beta 1 integrin in regulating the development of cerebral cortex.	[Jeong, Sung-Jin; Luo, Rong; Singer, Kathleen; Giera, Stefanie; Piao, Xianhua] Boston Childrens Hosp, Dept Med, Div Newborn Med, Boston, MA USA; [Jeong, Sung-Jin; Luo, Rong; Singer, Kathleen; Giera, Stefanie; Kreidberg, Jordan; Piao, Xianhua] Harvard Univ, Sch Med, Boston, MA USA; [Jeong, Sung-Jin] Korea Brain Res Inst KBRI, Convergence Brain Res Dept, Taegu, South Korea; [Kreidberg, Jordan] Boston Childrens Hosp, Dept Med, Boston, MA USA; [Kiyozumi, Daiji; Shimono, Chisei; Sekiguchi, Kiyotoshi] Osaka Univ, Inst Prot Res, Lab Extracellular Matrix Biochem, Suita, Osaka 565, Japan	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Korea Brain Research Institute (KBRI); Harvard University; Boston Children's Hospital; Osaka University	Piao, XH (corresponding author), Boston Childrens Hosp, Dept Med, Div Newborn Med, Boston, MA USA.	xianhua.piao@childrens.harvard.edu	Kiyozumi, Daiji/A-2112-2015	Piao, Xianhua/0000-0001-7540-6767; Kiyozumi, Daiji/0000-0003-3289-227X	National Institute of Neurological Disorders and Stroke (NINDS) [R01 NS057536]; William Randolph Hearst Fund Award; Leonard and Isabelle Goldenson Research Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057536] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); William Randolph Hearst Fund Award; Leonard and Isabelle Goldenson Research Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	National Institute of Neurological Disorders and Stroke (NINDS) grant R01 NS057536; William Randolph Hearst Fund Award (Harvard internal grant); Leonard and Isabelle Goldenson Research Fellowship (Harvard internal grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton ES, 1999, NEURON, V22, P277, DOI 10.1016/S0896-6273(00)81089-2; Bahi-Buisson N, 2010, BRAIN, V133, P3194, DOI 10.1093/brain/awq259; Beggs HE, 2003, NEURON, V40, P501, DOI 10.1016/S0896-6273(03)00666-4; Bjarnadottir TK, 2004, GENOMICS, V84, P23, DOI 10.1016/j.ygeno.2003.12.004; CARTER WG, 1991, CELL, V65, P599, DOI 10.1016/0092-8674(91)90092-D; Chang BS, 2003, ANN NEUROL, V53, P596, DOI 10.1002/ana.10520; De Arcangelis A, 1999, DEVELOPMENT, V126, P3957; DiPersio CM, 1997, J CELL BIOL, V137, P729, DOI 10.1083/jcb.137.3.729; DIPERSIO CM, 1995, J CELL SCI, V108, P2321; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; FISHMAN RB, 1993, J NEUROSCI, V13, P3485; Georges-Labouesse E, 1998, CURR BIOL, V8, P983, DOI 10.1016/S0960-9822(98)70402-6; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Halfter W, 2002, J NEUROSCI, V22, P6029; Haubst N, 2006, DEVELOPMENT, V133, P3245, DOI 10.1242/dev.02486; Hayashi Y, 2002, BIOCHEM BIOPH RES CO, V299, P498, DOI 10.1016/S0006-291X(02)02642-6; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ido H, 2004, J BIOL CHEM, V279, P10946, DOI 10.1074/jbc.M313626200; Jaglin XH, 2009, NAT GENET, V41, P746, DOI 10.1038/ng.380; Jeong SJ, 2012, J COMP NEUROL, V520, P2930, DOI 10.1002/cne.23076; Kim JK, 2005, J BIOL CHEM, V280, P32512, DOI 10.1074/jbc.M502431200; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; Koirala S, 2009, J NEUROSCI, V29, P7439, DOI 10.1523/JNEUROSCI.1182-09.2009; Kreidberg JA, 1996, DEVELOPMENT, V122, P3537; Kreidberg JA, 2000, CURR OPIN CELL BIOL, V12, P548, DOI 10.1016/S0955-0674(00)00130-7; Li SH, 2008, J NEUROSCI, V28, P5817, DOI 10.1523/JNEUROSCI.0853-08.2008; Luo R, 2011, P NATL ACAD SCI USA, V108, P12925, DOI 10.1073/pnas.1104821108; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Molyneaux BJ, 2005, NEURON, V47, P817, DOI 10.1016/j.neuron.2005.08.030; Montanaro F, 2003, NEURON, V37, P193, DOI 10.1016/S0896-6273(03)00032-1; Nieto M, 2004, J COMP NEUROL, V479, P168, DOI 10.1002/cne.20322; Niewmierzycka A, 2005, J NEUROSCI, V25, P7022, DOI 10.1523/JNEUROSCI.1695-05.2005; Nishiuchi R, 2006, MATRIX BIOL, V25, P189, DOI 10.1016/j.matbio.2005.12.001; Nykvist P, 2000, J BIOL CHEM, V275, P8255, DOI 10.1074/jbc.275.11.8255; Olson EC, 2002, CURR OPIN GENET DEV, V12, P320, DOI 10.1016/S0959-437X(02)00305-2; Piao XH, 2005, ANN NEUROL, V58, P680, DOI 10.1002/ana.20616; Piao XH, 2004, SCIENCE, V303, P2033, DOI 10.1126/science.1092780; Piao XH, 2002, AM J HUM GENET, V70, P1028, DOI 10.1086/339552; Schmid RS, 2004, DEVELOPMENT, V131, P6023, DOI 10.1242/dev.01532; Schmid RS, 2003, CEREB CORTEX, V13, P219, DOI 10.1093/cercor/13.3.219; Singer K, 2013, MOL NEUROBIOL, V47, P186, DOI 10.1007/s12035-012-8343-0; Stacey M, 2000, TRENDS BIOCHEM SCI, V25, P284, DOI 10.1016/S0968-0004(00)01583-8; Strokes N, 2010, ADV EXP MED BIOL, V706, P87; Takagi J, 2001, NAT STRUCT BIOL, V8, P412, DOI 10.1038/87569; Voss AK, 2008, DEVELOPMENT, V135, P2139, DOI 10.1242/dev.016725; Waite A, 2012, TRENDS NEUROSCI, V35, P487, DOI 10.1016/j.tins.2012.04.004; Yamamoto Tomoko, 2004, Medical Electron Microscopy, V37, P200, DOI 10.1007/s00795-004-0260-5; Yona S, 2008, TRENDS BIOCHEM SCI, V33, P491, DOI 10.1016/j.tibs.2008.07.005; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3	49	31	31	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68781	10.1371/journal.pone.0068781	http://dx.doi.org/10.1371/journal.pone.0068781			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874761	Green Published, Green Submitted, gold			2022-12-27	WOS:000321736900113
J	Shen, LZ; Chen, PZ; Xu, ZH; Deng, JY; Harris, MK; Wanna, R; Wang, FM; Zhou, GX; Yao, ZL				Shen, Li-Ze; Chen, Peng-Zhou; Xu, Zhi-Hong; Deng, Jian-Yu; Harris, Marvin-K; Wanna, Ruchuon; Wang, Fu-Min; Zhou, Guo-Xin; Yao, Zhang-Liang			Effect of Larvae Treated with Mixed Biopesticide Bacillus thuringiensis - Abamectin on Sex Pheromone Communication System in Cotton Bollworm, Helicoverpa armigera	PLOS ONE			English	Article							INSECT GROWTH-REGULATORS; ASIAN CORN-BORER; CHEMICAL COMMUNICATION; MICROPLITIS-MEDIATOR; INDIVIDUAL VARIATION; RESPONSE THRESHOLDS; MOTH LEPIDOPTERA; GCSC-BTA; SUBLETHAL; RESISTANCE	Third instar larvae of the cotton bollworm (Helicoverpa armigera) were reared with artificial diet containing a Bacillus thuringiensis - abamectin (BtA) biopesticide mixture that resulted in 20% mortality (LD20). The adult male survivors from larvae treated with BtA exhibited a higher percentage of "orientation" than control males but lower percentages of "approaching" and "landing" in wind tunnel bioassays. Adult female survivors from larvae treated with BtA produced higher sex pheromone titers and displayed a lower calling percentage than control females. The ratio of Z-11-hexadecenal (Z11-16:Ald) and Z-9-hexadecenal (Z9-16:Ald) in BtA-treated females changed and coefficients of variation (CV) of Z11-16:Ald and Z9-16:Ald were expanded compared to control females. The peak circadian calling time of BtA-treated females occurred later than that of control females. In mating choice experiment, both control males and BtA-treated males preferred to mate with control females and a portion of the Bt-A-treated males did not mate whereas all control males did. Our Data support that treatment of larvae with BtA had an effect on the sex pheromone communication system in surviving H. armigera moths that may contribute to assortative mating.	[Shen, Li-Ze; Chen, Peng-Zhou; Xu, Zhi-Hong; Deng, Jian-Yu; Wang, Fu-Min; Zhou, Guo-Xin; Yao, Zhang-Liang] Zhejiang Agr & Forestry Univ, Sch Agr & Food Sci, Dept Plant Protect, Linan, Zhejiang, Peoples R China; [Harris, Marvin-K] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Wanna, Ruchuon] Mahasarakham Univ, Dept Agr Technol, Kantarawichai District, Maha Sarakham, Thailand	Zhejiang A&F University; Texas A&M University System; Texas A&M University College Station; Mahasarakham University	Xu, ZH (corresponding author), Zhejiang Agr & Forestry Univ, Sch Agr & Food Sci, Dept Plant Protect, Linan, Zhejiang, Peoples R China.	zhhxu@zju.edu.cn		Wang, Fumin/0000-0002-2755-1369; Wanna, Ruchuon/0000-0002-9344-0069	National Natural Science Foundation of China [31101451]; Zhejiang Provincial Key Project of Agriculture [2009C12074]; Zhejiang Provincial Natural Foundation [Y3100384]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Key Project of Agriculture; Zhejiang Provincial Natural Foundation	This research was supported by the National Natural Science Foundation of China (31101451), Zhejiang Provincial Key Project of Agriculture (2009C12074), and Zhejiang Provincial Natural Foundation (Y3100384). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson CI, 2004, ENVIRON ENTOMOL, V33, P378, DOI 10.1603/0046-225X-33.2.378; Adan A, 2011, J ECON ENTOMOL, V104, P1541, DOI 10.1603/EC11019; Baker TC, 2008, J CHEM ECOL, V34, P971, DOI 10.1007/s10886-008-9468-5; Baur ME, 2003, BIOL CONTROL, V26, P325, DOI 10.1016/S1049-9644(02)00160-3; Biddinger DJ, 1999, J ECON ENTOMOL, V92, P314, DOI 10.1093/jee/92.2.314; CHARLTON RE, 1982, J INSECT PHYSIOL, V28, P423, DOI 10.1016/0022-1910(82)90069-5; CLARK DC, 1992, ARCH INSECT BIOCHEM, V19, P105, DOI 10.1002/arch.940190204; CLARK DC, 1992, J ECON ENTOMOL, V85, P1771, DOI 10.1093/jee/85.5.1771; CLARK JM, 1995, ANNU REV ENTOMOL, V40, P1, DOI 10.1146/annurev.en.40.010195.000245; CUSSON M, 1989, SCIENCE, V243, P210, DOI 10.1126/science.243.4888.210; Delpuech JM, 2001, CHEMOSPHERE, V42, P985, DOI 10.1016/S0045-6535(00)00110-7; Deng JY, 2004, J CHEM ECOL, V30, P2037, DOI 10.1023/B:JOEC.0000045593.62422.73; DENHOLM I, 1992, ANNU REV ENTOMOL, V37, P91, DOI 10.1146/annurev.en.37.010192.000515; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; FLOYD JP, 1981, J ECON ENTOMOL, V74, P634, DOI 10.1093/jee/74.5.634; GILL SS, 1992, ANNU REV ENTOMOL, V37, P615, DOI 10.1146/annurev.en.37.010192.003151; HAYNES KF, 1988, J CHEM ECOL, V14, P1547, DOI 10.1007/BF01012521; HAYNES KF, 1985, ARCH INSECT BIOCHEM, V2, P283, DOI 10.1002/arch.940020306; HUNT DWA, 1988, J CHEM ECOL, V14, P529, DOI 10.1007/BF01013904; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Lee Jae Min, 2012, Front Endocrinol (Lausanne), V3, P6, DOI 10.3389/fendo.2012.00006; Li KE, 2006, J ZHEJIANG FORESTRY, V4; LINN C, 1985, PESTIC SCI, V16, P445; LINN CE, 1984, ARCH INSECT BIOCHEM, V1, P331, DOI 10.1002/arch.940010405; Liu B, 2003, ANZ SCHADL-J PEST SC, V76, P44, DOI 10.1046/j.1439-0280.2003.03010.x; Liu JJ, 2004, MODERN AGROCHEMICALS, V3, P28; Liu JJ, 2004, WORLD BAMBOO RATTAN, V2, P39; Liu XX, 2005, ENTOMOL EXP APPL, V114, P205, DOI 10.1111/j.1570-7458.2005.00248.x; LOFSTEDT C, 1985, J CHEM ECOL, V11, P1181, DOI 10.1007/BF01024107; MILLER JR, 1980, ENVIRON ENTOMOL, V9, P359, DOI 10.1093/ee/9.3.359; Mu Lan-Fang, 2005, Acta Entomologica Sinica, V48, P450; Mu LF, 2005, EFFECTS BT TOXIN SEX, P34; PANNELL DJ, 1991, AGR ECON-BLACKWELL, V5, P361, DOI 10.1016/0169-5150(91)90028-J; Phelan PL, 1992, EVOLUTION SEX PHEROM, P265; Qian L, 2008, PESTIC BIOCHEM PHYS, V91, P175, DOI 10.1016/j.pestbp.2008.03.011; Rafaeli A, 2003, INSECT BIOCHEM MOLEC, V33, P371, DOI 10.1016/S0965-1748(02)00264-3; RAINA AK, 1984, SCIENCE, V225, P531, DOI 10.1126/science.225.4661.531; REED JR, 1994, P NATL ACAD SCI USA, V91, P10000, DOI 10.1073/pnas.91.21.10000; ROELOFS WL, 1995, P NATL ACAD SCI USA, V92, P44, DOI 10.1073/pnas.92.1.44; ROELOFS WL, 1971, SCIENCE, V171, P684, DOI 10.1126/science.171.3972.684; Saber M, 2005, J ECON ENTOMOL, V98, P35, DOI 10.1603/0022-0493-98.1.35; SCHAL C, 1987, J CHEM ECOL, V13, P1115, DOI 10.1007/BF01020542; Schneider MI, 2003, J ECON ENTOMOL, V96, P1054, DOI 10.1603/0022-0493-96.4.1054; Sengonca C, 2006, J PEST SCI, V79, P3, DOI 10.1007/s10340-005-0117-2; SOROKER V, 1995, INSECT BIOCHEM MOLEC, V25, P1, DOI 10.1016/0965-1748(94)00049-N; TANG JD, 1987, J INSECT PHYSIOL, V33, P469, DOI 10.1016/0022-1910(87)90110-7; Tang QY, 2013, INSECT SCI, V20, P254, DOI 10.1111/j.1744-7917.2012.01519.x; Umoru PA, 1996, B ENTOMOL RES, V86, P193, DOI 10.1017/S0007485300052445; Wang GL, 2011, PESTIC BIOCHEM PHYS, V101, P227, DOI 10.1016/j.pestbp.2011.09.010; Wanna RC, 2010, ENTOMOL EXP APPL, V137, P111, DOI 10.1111/j.1570-7458.2010.01055.x; Waterfield GM, 2012, ANNU REV ENTOMOL, V37, P14; Wei H, 2004, PESTIC BIOCHEM PHYS, V80, P12, DOI 10.1016/j.pestbp.2004.05.001; Wei HY, 2004, J CHEM ECOL, V30, P1457, DOI 10.1023/B:JOEC.0000037751.86203.10; Xu PX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041653; Xu Z, 2010, J CHEM ECOL, V36, P526, DOI 10.1007/s10886-010-9785-3; Yang ZH, 2003, J CHEM ECOL, V29, P1611, DOI 10.1023/A:1024222830332; Yorulmaz S, 2009, TURK J AGRIC FOR, V33, P393, DOI 10.3906/tar-0809-15; Zhang TY, 2004, J INSECT PHYSIOL, V50, P547, DOI 10.1016/j.jinsphys.2004.03.011; Zhang TY, 2004, J INSECT PHYSIOL, V50, P25, DOI 10.1016/j.jinsphys.2003.09.006; Zhu YJ, 2005, EFFICIENCY BACILLUS; Zhu Yujing, 2006, Mitteilungen der Deutschen Gesellschaft fuer Allgemeine und Angewandte Entomologie, V15, P309; ZHUO YS, 1981, ACTA ENTOMOL SINICA, V24, P108	62	28	32	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68756	10.1371/journal.pone.0068756	http://dx.doi.org/10.1371/journal.pone.0068756			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874751	Green Submitted, Green Published, gold			2022-12-27	WOS:000321736900110
J	Simon, A; Karbach, S; Habermeier, A; Closs, EI				Simon, Alexandra; Karbach, Susanne; Habermeier, Alice; Closs, Ellen I.			Decoding the Substrate Supply to Human Neuronal Nitric Oxide Synthase	PLOS ONE			English	Article							AMINO-ACID TRANSPORTERS; L-ARGININE TRANSPORT; ENDOTHELIAL-CELLS; PEPTIDE/HISTIDINE TRANSPORTER; GUANYLYL CYCLASE; XENOPUS-LAEVIS; EXPRESSION; DISEASE; MACROPHAGES; BRAIN	Nitric oxide, produced by the neuronal nitric oxide synthase (nNOS) from L-arginine is an important second messenger molecule in the central nervous system: It influences the synthesis and release of neurotransmitters and plays an important role in long-term potentiation, long-term depression and neuroendocrine secretion. However, under certain pathological conditions such as Alzheimer's or Parkinson's disease, stroke and multiple sclerosis, excessive NO production can lead to tissue damage. It is thus desirable to control NO production in these situations. So far, little is known about the substrate supply to human nNOS as a determinant of its activity. Measuring bioactive NO via cGMP formation in reporter cells, we demonstrate here that nNOS in both, human A673 neuroepithelioma and TGW-nu-I neuroblastoma cells can be fast and efficiently nourished by extracellular arginine that enters the cells via membrane transporters (pool I that is freely exchangeable with the extracellular space). When this pool was depleted, NO synthesis was partially sustained by intracellular arginine sources not freely exchangeable with the extracellular space (pool II). Protein breakdown made up by far the largest part of pool II in both cell types. In contrast, citrulline to arginine conversion maintained NO synthesis only in TGW-nu-I neuroblastoma, but not A673 neuroepithelioma cells. Histidine mimicked the effect of protease inhibitors causing an almost complete nNOS inhibition in cells incubated additionally in lysine that depletes the exchangeable arginine pool. Our results identify new ways to modulate nNOS activity by modifying its substrate supply.	[Simon, Alexandra; Karbach, Susanne; Habermeier, Alice; Closs, Ellen I.] Johannes Gutenberg Univ Mainz, Dept Pharmacol, Univ Med Ctr, Mainz, Germany	Johannes Gutenberg University of Mainz	Closs, EI (corresponding author), Johannes Gutenberg Univ Mainz, Dept Pharmacol, Univ Med Ctr, Mainz, Germany.	Closs@uni-mainz.de	Karbach, Susanne/X-8136-2019; Karbach, Susanne/GPC-8804-2022; Closs, Ellen/ABD-5217-2020	Closs, Ellen/0000-0002-9505-2289	Deutsche Forschungsgemeinschaft, Bonn, Germany [Cl 100/3-4]	Deutsche Forschungsgemeinschaft, Bonn, Germany(German Research Foundation (DFG))	This work was supported by Grant Cl 100/3-4 from the Deutsche Forschungsgemeinschaft, Bonn, Germany (URL: www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae SY, 2005, BBA-MOL CELL RES, V1745, P65, DOI 10.1016/j.bbamcr.2004.12.006; Baydoun AR, 2006, AMINO ACIDS, V31, P101, DOI 10.1007/s00726-005-0311-9; BERSON SA, 1968, CLIN CHIM ACTA, V22, P51, DOI 10.1016/0009-8981(68)90247-7; BOGLE RG, 1992, BIOCHEM J, V284, P15, DOI 10.1042/bj2840015; Boissel JP, 2004, BIOCHEMISTRY-US, V43, P7197, DOI 10.1021/bi0302191; Braissant O, 1999, MOL BRAIN RES, V70, P231, DOI 10.1016/S0169-328X(99)00151-5; Calabresi P, 2012, MOVEMENT DISORDERS O; Christopherson KS, 1997, J CLIN INVEST, V100, P2424, DOI 10.1172/JCI119783; Closs EI, 2006, J MEMBRANE BIOL, V213, P67, DOI 10.1007/s00232-006-0875-7; Closs EI, 2000, MOL PHARMACOL, V57, P68; Colombo E, 2012, J EXP MED, V209, P521, DOI 10.1084/jem.20110698; Cross AH, 1996, J NEUROIMMUNOL, V71, P145, DOI 10.1016/S0165-5728(96)00147-6; Dawson VL, 1996, J CHEM NEUROANAT, V10, P179, DOI 10.1016/0891-0618(96)00148-2; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; FORSTERMANN U, 1990, MOL PHARMACOL, V38, P7; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; FUJISAWA H, 1994, J NEUROCHEM, V63, P140; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Haider L, 2011, BRAIN, V134, P1914, DOI 10.1093/brain/awr128; HIBBS JB, 1987, J IMMUNOL, V138, P550; Hunot S, 1996, NEUROSCIENCE, V72, P355, DOI 10.1016/0306-4522(95)00578-1; Jezegou A, 2012, P NATL ACAD SCI USA, V109, pE3434, DOI 10.1073/pnas.1211198109; Karbach S, 2011, J MOL CELL CARDIOL, V51, P855, DOI 10.1016/j.yjmcc.2011.07.024; KAVANAUGH MP, 1994, J BIOL CHEM, V269, P15445; Kraft PJ, 2004, INT J BIOCHEM CELL B, V36, P2086, DOI 10.1016/j.biocel.2004.04.006; Leiper J, 1999, CARDIOVASC RES, V43, P542, DOI 10.1016/S0008-6363(99)00162-5; LERMA J, 1986, BRAIN RES, V384, P145, DOI 10.1016/0006-8993(86)91230-8; Li L, 2011, IEEE DATE, P1; Liu B, 2012, SCIENCE, V337, P351, DOI 10.1126/science.1220281; Malinski T, 2007, J ALZHEIMERS DIS, V11, P207; Marques C, 2004, FASEB J, V18, P1424, DOI 10.1096/fj.04-1743fje; Nawrath H, 2000, AM J PHYSIOL-CELL PH, V279, pC1336, DOI 10.1152/ajpcell.2000.279.5.C1336; Nicholson B, 2001, J BIOL CHEM, V276, P15881, DOI 10.1074/jbc.M010030200; Ogura T, 1996, NEUROSCI LETT, V204, P89, DOI 10.1016/0304-3940(96)12324-7; Orlando GF, 2008, AMINO ACIDS, V35, P17, DOI 10.1007/s00726-007-0630-0; Orlando GF, 2008, STRESS, V11, P42, DOI 10.1080/10253890701449867; Pou S, 1999, J BIOL CHEM, V274, P9573, DOI 10.1074/jbc.274.14.9573; Prast H, 2001, PROG NEUROBIOL, V64, P51, DOI 10.1016/S0301-0082(00)00044-7; Rotmann A, 2004, BBA-BIOMEMBRANES, V1660, P138, DOI 10.1016/j.bbamem.2003.11.009; Rotmann A, 2007, AM J PHYSIOL-CELL PH, V292, pC2259, DOI 10.1152/ajpcell.00323.2006; Sakata K, 2001, BIOCHEM J, V356, P53, DOI 10.1042/0264-6021:3560053; SCHMIDT HHHW, 1991, P NATL ACAD SCI USA, V88, P365, DOI 10.1073/pnas.88.2.365; Schulz JB, 1997, MOL CELL BIOCHEM, V174, P193, DOI 10.1023/A:1006852306789; Silverman RB, 2009, ACCOUNTS CHEM RES, V42, P439, DOI 10.1021/ar800201v; Simon A, 2003, CIRC RES, V93, P813, DOI 10.1161/01.RES.0000097761.19223.0D; Verrey F, 2004, PFLUG ARCH EUR J PHY, V447, P532, DOI 10.1007/s00424-003-1086-z; Wyatt AW, 2004, BIOCHEM SOC SYMP, V71, P143; Xu WM, 2002, CELL RES, V12, P311, DOI 10.1038/sj.cr.7290133; Yamashita T, 1997, J BIOL CHEM, V272, P10205; Zhao CG, 2006, N-S ARCH PHARMACOL, V372, P444, DOI 10.1007/s00210-005-0028-z; Zhou L, 2009, NITRIC OXIDE-BIOL CH, V20, P223, DOI 10.1016/j.niox.2009.03.001	51	7	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e67707	10.1371/journal.pone.0067707	http://dx.doi.org/10.1371/journal.pone.0067707			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874440	Green Submitted, Green Published, gold			2022-12-27	WOS:000321736900018
J	Irish, S; Aiemjoy, K; Torondel, B; Abdelahi, F; Ensink, JHJ				Irish, Seth; Aiemjoy, Kristen; Torondel, Belen; Abdelahi, Faraji; Ensink, Jeroen H. J.			Characteristics of Latrines in Central Tanzania and Their Relation to Fly Catches	PLOS ONE			English	Article							DIARRHEA; DISEASES; GAMBIA; FLIES	The disposal of human excreta in latrines is an important step in reducing the transmission of diarrhoeal diseases. However, in latrines, flies can access the latrine contents and serve as a mechanical transmitter of diarrhoeal pathogens. Furthermore, the latrine contents can be used as a breeding site for flies, which may further contribute to disease transmission. Latrines do not all produce flies, and there are some which produce only a few, while others can produce thousands. In order to understand the role of the latrine in determining this productivity, a pilot study was conducted, in which fifty latrines were observed in and around Ifakara, Tanzania. The characteristics of the latrine superstructure, use of the latrine, and chemical characteristics of pit latrine contents were compared to the numbers of flies collected in an exit trap placed over the drop hole in the latrine. Absence of a roof was found to have a significant positive association (t=3.17, p=0.003) with the total number of flies collected, and temporary superstructures, particularly as opposed to brick superstructures (z=4.26, p<0.001), and increased total solids in pit latrines (z=2.57, p=0.01) were significantly associated with increased numbers of blowflies leaving the latrine. The number of larvae per gram was significantly associated with the village from which samples were taken, with the largest difference between two villages outside Ifakara (z=2.12, p=0.03). The effect of latrine superstructure (roof, walls) on fly production may indicate that improvements in latrine construction could result in decreases in fly populations in areas where they transmit diarrhoeal pathogens.	[Irish, Seth; Aiemjoy, Kristen; Torondel, Belen; Ensink, Jeroen H. J.] London Sch Hyg & Trop Med, Fac Infect Dis, Environm Hlth Grp, London WC1, England; [Aiemjoy, Kristen] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Abdelahi, Faraji] Ifakara Hlth Inst, Ifakara, Tanzania	University of London; London School of Hygiene & Tropical Medicine; University of California System; University of California San Francisco; Ifakara Health Institute	Ensink, JHJ (corresponding author), London Sch Hyg & Trop Med, Fac Infect Dis, Environm Hlth Grp, London WC1, England.	jeroen.ensink@lshtm.ac.uk		Aiemjoy, Kristen/0000-0003-1886-2699	Bill and Melinda Gates foundation [OPP52641]; Sanitation and Hygiene Applied Research for Equity (SHARE) consortium; UK Department for International Development [P04990]	Bill and Melinda Gates foundation(Bill & Melinda Gates Foundation); Sanitation and Hygiene Applied Research for Equity (SHARE) consortium; UK Department for International Development	This research received financial support from the Bill and Melinda Gates foundation (grant number OPP52641) and the Sanitation and Hygiene Applied Research for Equity (SHARE) consortium funded by the UK Department for International Development (grant number P04990). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APHA- American Public Health Association, 2005, AM PUBL HLTH ASS STA, V21; Boschi-Pinto C, 2008, B WORLD HEALTH ORGAN, V86, P710, DOI 10.2471/BLT.07.050054; Carlberg G, 1985, WORLD J APPL MICROB, V1, P33, DOI [10.1007/BF01748152, DOI 10.1007/BF01748152]; Chavasse DC, 1999, LANCET, V353, P22, DOI 10.1016/S0140-6736(98)03366-2; Clasen TF, 2009, COCHRANE DB SYST REV, V16; COHEN D, 1991, LANCET, V337, P993, DOI 10.1016/0140-6736(91)92657-N; CURTIS CF, 1982, T ROY SOC TROP MED H, V76, P99, DOI 10.1016/0035-9203(82)90031-1; Emerson PM, 2005, TROP MED INT HEALTH, V10, P706, DOI 10.1111/j.1365-3156.2005.01432.x; Emerson PM, 1999, LANCET, V353, P1401, DOI 10.1016/S0140-6736(98)09158-2; GILLET J., 1946, Annales de la Societe Belge de Medecine Tropicale, V26, P55; Graczyk TK, 2003, AM J TROP MED HYG, V68, P228, DOI 10.4269/ajtmh.2003.68.228; Graczyk TK, 2001, MICROBES INFECT, V3, P231, DOI 10.1016/S1286-4579(01)01371-5; GREENBERG B., 1973, FLIES DIS, V2; Hach, 1997, HACH WATER ANAL HDB; Hewitt C. G., 1914, HOUSE FLY MUSCA DOME; Jenkins MW, 2005, SOC SCI MED, V61, P2446, DOI 10.1016/j.socscimed.2005.04.036; Khan A R, 1978, Bangladesh Med Res Counc Bull, V4, P86; Kigadye E., 2011, TANZAN J HLTH RES, V13, P1; KILPATRICK JW, 1957, AM J TROP MED HYG, V6, P171, DOI 10.4269/ajtmh.1957.6.171; KILPATRICK JW, 1956, AM J TROP MED HYG, V5, P331, DOI 10.4269/ajtmh.1956.5.331; Lindsay SW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001895; Lindsay TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050505; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Masuko T, 2005, ANAL BIOCHEM, V339, P69, DOI 10.1016/j.ab.2004.12.001; Morgan P R, 1977, Cent Afr J Med, V23, P1; Oosterbroek P., 1998, FAMILIES DIPTERA MAL; ORDMAN D, 1946, S Afr Med J, V20, P32; SCHOOF HF, 1954, AM J TROP MED HYG, V3, P930, DOI 10.4269/ajtmh.1954.3.930; Simms VM, 2005, T ROY SOC TROP MED H, V99, P631, DOI 10.1016/j.trstmh.2004.10.004; Taylan-Ozkan A, 2004, INT J DERMATOL, V43, P904, DOI 10.1111/j.1365-4632.2004.02051.x; United Republic Of Tanzania - National Bureau of Statistics (NBS), 2010, TANZ DEM HLTH SURV T; USEPA, 2003, EPA625R92013 EPA US; Vinogradova E.B., 2000, CULEX PIPIENS PIPIEN; Zumpt F., 1965, MYIASIS MAN ANIMALS	34	14	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e67951	10.1371/journal.pone.0067951	http://dx.doi.org/10.1371/journal.pone.0067951			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874475	Green Accepted, Green Published, gold			2022-12-27	WOS:000324146200011
J	Soulen, BK; Cammen, K; Schultz, TF; Johnston, DW				Soulen, Brianne K.; Cammen, Kristina; Schultz, Thomas F.; Johnston, David W.			Factors Affecting Harp Seal (Pagophilus groenlandicus) Strandings in the Northwest Atlantic	PLOS ONE			English	Article							MICROSATELLITE MARKERS; PARENTAL RELATEDNESS; GENETIC-VARIATION; CLIMATE-CHANGE; ICE CONDITIONS; LOCI; POPULATIONS; DIVERSITY; SOFTWARE; SURVIVAL	The effects of climate change on high latitude regions are becoming increasingly evident, particularly in the rapid decline of sea ice cover in the Arctic. Many high latitude species dependent on sea ice are being forced to adapt to changing habitats. Harp seals (Pagophilus groenlandicus) are an indicator species for changing high-latitude ecosystems. This study analyzed multiple factors including ice cover, demographics, and genetic diversity, which could affect harp seal stranding rates along the eastern coast of the United States. Ice cover assessments were conducted for the month of February in the Gulf of St. Lawrence whelping region from 1991-2010 using remote sensing data, and harp seal stranding data were collected over the same time period. Genetic diversity, which may affect how quickly species can adapt to changing climates, was assessed using ten microsatellite markers to determine mean d(2) in a subset of stranded and by-caught (presumably healthy) seals sampled along the northeast U. S. coast. Our study found a strong negative correlation (R-2 = 0.49) between ice cover in the Gulf of St. Lawrence and yearling harp seal strandings, but found no relationship between sea ice conditions and adult strandings. Our analysis revealed that male seals stranded more frequently than females during the study period and that this relationship was strongest during light ice years. In contrast, we found no significant difference in mean d(2) between stranded and by-caught harp seals. The results demonstrate that sea ice cover and demographic factors have a greater influence on harp seal stranding rates than genetic diversity, with only a little of the variance in mean d(2) among stranded seals explained by ice cover. Any changes in these factors could have major implications for harp seals, and these findings should be considered in the development of future management plans for the Arctic that incorporate climate variability.	[Soulen, Brianne K.; Cammen, Kristina; Johnston, David W.] Duke Univ, Marine Lab, Nicholas Sch Environm, Div Marine Sci & Conservat, Beaufort, NC 28516 USA; [Schultz, Thomas F.] Duke Univ, Marine Lab, Div Marine Sci & Conservat, Nicholas Sch Environm,Marine Conservat Mol Facil, Beaufort, NC 28516 USA	Duke University; Duke University	Soulen, BK (corresponding author), Duke Univ, Marine Lab, Nicholas Sch Environm, Div Marine Sci & Conservat, Beaufort, NC 28516 USA.	bksoulen22@gmail.com	Johnston, David/AAJ-5013-2020	Johnston, David/0000-0003-2424-036X; Schultz, Thomas/0000-0001-9694-9920; Cammen, Kristina/0000-0002-3923-6438	International Fund for Animal Welfare; Duke University Marine Laboratory	International Fund for Animal Welfare; Duke University Marine Laboratory	This work was supported by the International Fund for Animal Welfare and the Duke University Marine Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Whitehouse K, 2003, NATURE, V422, P35, DOI 10.1038/422035a; Amos W, 2001, P ROY SOC B-BIOL SCI, V268, P2021, DOI 10.1098/rspb.2001.1751; [Anonymous], GEOPHYS RES LETT, DOI [10.1029/2007/GL029703, DOI 10.1029/2007GL029703]; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Bajzak CE, 2011, CAN J ZOOL, V89, P1050, DOI 10.1139/Z11-081; Bean K, 2004, MOL ECOL, V13, P2365, DOI 10.1111/j.1365-294X.2004.02199.x; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Cammen K, 2011, MOL ECOL, V20, P740, DOI 10.1111/j.1365-294X.2010.04975.x; Canfield C, 2011, HARP SEALS CANADA TA; Coltman DW, 1996, MOL ECOL, V5, P161, DOI 10.1111/j.1365-294X.1996.tb00303.x; Coltman DW, 1998, P ROY SOC B-BIOL SCI, V265, P803, DOI 10.1098/rspb.1998.0363; Coulson TN, 1998, P ROY SOC B-BIOL SCI, V265, P489, DOI 10.1098/rspb.1998.0321; Davis CS, 2002, MOL ECOL NOTES, V2, P203, DOI 10.1046/j.1471-8286.2002.00187.x; DFO, 2007, REV ICE CONDITIONS P; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Friedlaender AS, 2010, PROG OCEANOGR, V86, P261, DOI 10.1016/j.pocean.2010.04.002; Gemmell NJ, 1997, MOL ECOL, V6, P661, DOI 10.1046/j.1365-294X.1997.00235.x; Hammill MO, 2007, ICES J MAR SCI, V64, P702, DOI 10.1093/icesjms/fsm037; Hoffman JI, 2005, MOL ECOL, V14, P599, DOI 10.1111/j.1365-294X.2004.02419.x; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Jepson PD, 2005, ENVIRON TOXICOL CHEM, V24, P238, DOI 10.1897/03-663.1; Johnston DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029158; Johnston DW, 2005, CLIM RES, V29, P209, DOI 10.3354/cr029209; Kovacs Kit M., 2011, Marine Biodiversity, V41, P181, DOI 10.1007/s12526-010-0061-0; Kretzmann M, 2006, J HERED, V97, P555, DOI 10.1093/jhered/esl043; Lavigne DM, 1988, HARPS HOODS ICEBREED; Meisfjord J, 1996, ICES J MAR SCI, V53, P89, DOI 10.1006/jmsc.1996.0008; Moore SE, 2008, ECOL APPL, V18, pS157, DOI 10.1890/06-0571.1; Perry EA, 2000, MAR BIOL, V137, P53, DOI 10.1007/s002279900248; Pichler FB, 2000, P ROY SOC B-BIOL SCI, V267, P97, DOI 10.1098/rspb.2000.0972; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; RIEDMAN M, 1990, PINNIPEDS SEALS SEA; Rosing-Asvid A, 2008, MAR MAMMAL SCI, V24, P730, DOI 10.1111/j.1748-7692.2008.00216.x; Simmonds MP, 2007, ORYX, V41, P19, DOI 10.1017/S0030605307001524; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vinnikov KY, 1999, SCIENCE, V286, P1934, DOI 10.1126/science.286.5446.1934; Wang MY, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037820; Waring GT, 2011, 219 NOAA NMFS NE, V219; Wright S, 1943, GENETICS, V28, P114	41	6	6	2	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e68779	10.1371/journal.pone.0068779	http://dx.doi.org/10.1371/journal.pone.0068779			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23874759	gold, Green Published, Green Submitted			2022-12-27	WOS:000322000600024
J	Daftuar, L; Zhu, Y; Jacq, X; Prives, C				Daftuar, Lilyn; Zhu, Yan; Jacq, Xavier; Prives, Carol			Ribosomal Proteins RPL37, RPS15 and RPS20 Regulate the Mdm2-p53-MdmX Network	PLOS ONE			English	Article							DNA-DAMAGE; P53 ACTIVATION; CYCLIN-G; MDM2; DEGRADATION; TRANSLATION; MUTATIONS; STRESS; HDM2; L11	Changes to the nucleolus, the site of ribosome production, have long been linked to cancer, and mutations in several ribosomal proteins (RPs) have been associated with an increased risk for cancer in human diseases. Relevantly, a number of RPs have been shown to bind to MDM2 and inhibit MDM2 E3 ligase activity, leading to p53 stabilization and cell cycle arrest, thus revealing a RP-Mdm2-p53 signaling pathway that is critical for ribosome biogenesis surveillance. Here, we have identified RPL37, RPS15, and RPS20 as RPs that can also bind Mdm2 and activate p53. We found that each of the aforementioned RPs, when ectopically expressed, can stabilize both co-expressed Flag-tagged Mdm2 and HA-tagged p53 in p53-null cells as well as endogenous p53 in a p53-containing cell line. For each RP, the mechanism of Mdm2 and p53 stabilization appears to be through inhibiting the E3 ubiquitin ligase activity of Mdm2. Interestingly, although they are each capable of inducing cell death and cell cycle arrest, these RPs differ in the p53 target genes that are regulated upon their respective introduction into cells. Furthermore, each RP can downregulate MdmX levels but in distinct ways. Thus, RPL37, RPS15 and RPS20 regulate the Mdm2-p53-MdmX network but employ different mechanisms to do so.	[Daftuar, Lilyn; Zhu, Yan; Prives, Carol] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Jacq, Xavier] Hybrigenics, Paris, France	Columbia University	Prives, C (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	clp3@columbia.edu			National Cancer Institute [CA58316]; NATIONAL CANCER INSTITUTE [R01CA058316, R37CA058316] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grant CA58316 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsterdam A, 2004, PLOS BIOL, V2, P690, DOI 10.1371/journal.pbio.0020139; Barkic M, 2009, MOL CELL BIOL, V29, P2489, DOI 10.1128/MCB.01588-08; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Biderman L, 2012, MOL CELL BIOL, V32, P1214, DOI 10.1128/MCB.06150-11; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Bursac S, 2012, P NATL ACAD SCI USA, V109, P20467, DOI 10.1073/pnas.1218535109; Chen D, 2007, ONCOGENE, V26, P5029, DOI 10.1038/sj.onc.1210327; Chen J, 2010, GENE DEV, V24, P2146, DOI 10.1101/gad.1968910; Daftuar L, 2010, CELL CYCLE, V9, P4259, DOI 10.4161/cc.9.21.13527; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Derenzini M, 2009, HISTOPATHOLOGY, V54, P753, DOI 10.1111/j.1365-2559.2008.03168.x; Fumagalli S, 2012, GENE DEV, V26, P1028, DOI 10.1101/gad.189951.112; Fumagalli S, 2009, NAT CELL BIOL, V11, P501, DOI 10.1038/ncb1858; Gazda HT, 2008, AM J HUM GENET, V83, P769, DOI 10.1016/j.ajhg.2008.11.004; Gilkes DM, 2006, EMBO J, V25, P5614, DOI 10.1038/sj.emboj.7601424; Gu JJ, 2002, J BIOL CHEM, V277, P19251, DOI 10.1074/jbc.C200150200; Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Kawai H, 2003, J BIOL CHEM, V278, P45946, DOI 10.1074/jbc.M308295200; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Lindstrom MS, 2007, MOL CELL BIOL, V27, P1056, DOI 10.1128/MCB.01307-06; Lindstrom MS, 2010, PLOS ONE, V5, pA116, DOI 10.1371/journal.pone.0009578; Linke K, 2008, CELL DEATH DIFFER, V15, P841, DOI 10.1038/sj.cdd.4402309; Llanos S, 2010, CELL CYCLE, V9, P4005, DOI 10.4161/cc.9.19.13299; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Macias E, 2010, CANCER CELL, V18, P231, DOI 10.1016/j.ccr.2010.08.007; Mahata B, 2012, ONCOGENE, V31, P3060, DOI 10.1038/onc.2011.482; MARECHAL V, 1994, MOL CELL BIOL, V14, P7414, DOI 10.1128/MCB.14.11.7414; McGowan KA, 2008, NAT GENET, V40, P963, DOI 10.1038/ng.188; Momand J, 1998, NUCLEIC ACIDS RES, V26, P3453, DOI 10.1093/nar/26.15.3453; Morgado-Palacin L, 2012, CELL CYCLE, V11, P503, DOI 10.4161/cc.11.3.19002; Ofir-Rosenfeld Y, 2008, MOL CELL, V32, P180, DOI 10.1016/j.molcel.2008.08.031; Ohtsuka T, 2004, ONCOGENE, V23, P5405, DOI 10.1038/sj.onc.1207693; Okamoto K, 2002, MOL CELL, V9, P761, DOI 10.1016/S1097-2765(02)00504-X; Peart MJ, 2010, CELL CYCLE, V9, P3956, DOI 10.4161/cc.9.19.13162; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Sun XX, 2011, J BIOL CHEM, V286, P22730, DOI 10.1074/jbc.M111.223651; Sun XX, 2010, J BIOL CHEM, V285, P25812, DOI 10.1074/jbc.M109.098442; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Tanimura S, 1999, FEBS LETT, V447, P5, DOI 10.1016/S0014-5793(99)00254-9; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Tollini Laura A, 2012, Genes Cancer, V3, P219, DOI 10.1177/1947601912454732; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wade M, 2013, NAT REV CANCER, V13, P83, DOI 10.1038/nrc3430; Xiong X, 2011, ONCOGENE, V30, P1798, DOI 10.1038/onc.2010.569; Yadavilli S, 2009, DNA REPAIR, V8, P1215, DOI 10.1016/j.dnarep.2009.07.003; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Zhang X, 2013, ONCOGENE, V32, P2782, DOI 10.1038/onc.2012.289; Zhang Y, 2010, NUCLEIC ACIDS RES, V38, P6544, DOI 10.1093/nar/gkq536; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003; Zhou X, 2013, ONCOGENE, V32, P388, DOI 10.1038/onc.2012.63; Zhu Y, 2009, MOL CELL, V35, P316, DOI 10.1016/j.molcel.2009.07.014	54	99	104	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68667	10.1371/journal.pone.0068667	http://dx.doi.org/10.1371/journal.pone.0068667			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874713	Green Published, gold, Green Submitted			2022-12-27	WOS:000322064300062
J	Hillenbrand, P; Fritz, G; Gerland, U				Hillenbrand, Patrick; Fritz, Georg; Gerland, Ulrich			Biological Signal Processing with a Genetic Toggle Switch	PLOS ONE			English	Article							TRANSCRIPTIONAL REGULATION; MEMORY; LOGIC; CONSTRUCTION; EXPRESSION; STRATEGIES; MECHANISM; NUMBERS; DESIGN; PHASE	Complex gene regulation requires responses that depend not only on the current levels of input signals but also on signals received in the past. In digital electronics, logic circuits with this property are referred to as sequential logic, in contrast to the simpler combinatorial logic without such internal memory. In molecular biology, memory is implemented in various forms such as biochemical modification of proteins or multistable gene circuits, but the design of the regulatory interface, which processes the input signals and the memory content, is often not well understood. Here, we explore design constraints for such regulatory interfaces using coarse-grained nonlinear models and stochastic simulations of detailed biochemical reaction networks. We test different designs for biological analogs of the most versatile memory element in digital electronics, the JK-latch. Our analysis shows that simple protein-protein interactions and protein-DNA binding are sufficient, in principle, to implement genetic circuits with the capabilities of a JK-latch. However, it also exposes fundamental limitations to its reliability, due to the fact that biological signal processing is asynchronous, in contrast to most digital electronics systems that feature a central clock to orchestrate the timing of all operations. We describe a seemingly natural way to improve the reliability by invoking the master-slave concept from digital electronics design. This concept could be useful to interpret the design of natural regulatory circuits, and for the design of synthetic biological systems.	[Hillenbrand, Patrick; Fritz, Georg; Gerland, Ulrich] Univ Munich, Arnold Sommerfeld Ctr Theoret Phys, Munich, Germany; [Hillenbrand, Patrick; Fritz, Georg; Gerland, Ulrich] Univ Munich, Ctr NanoSci, Munich, Germany; [Fritz, Georg] Univ Munich, Dept Biol 1, Planegg Martinsried, Germany	University of Munich; University of Munich; University of Munich	Gerland, U (corresponding author), Univ Munich, Arnold Sommerfeld Ctr Theoret Phys, Munich, Germany.	gerland@lmu.de	Gerland, Ulrich/I-9902-2016; Fritz, Georg/F-3910-2010	Gerland, Ulrich/0000-0002-0859-6422; Fritz, Georg/0000-0002-1503-9165	German Research Foundation (DFG) via the Excellence Cluster "Nano Initiative Munich''; German Research Foundation (DFG) [GE 1098/4-1]	German Research Foundation (DFG) via the Excellence Cluster "Nano Initiative Munich''; German Research Foundation (DFG)(German Research Foundation (DFG))	This study was funded by the German Research Foundation (DFG) via the Excellence Cluster "Nano Initiative Munich'' and via the DFG grant GE 1098/4-1 to UG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100173; Bayliss CD, 2009, FEMS MICROBIOL REV, V33, P504, DOI 10.1111/j.1574-6976.2009.00162.x; Bintu L, 2005, CURR OPIN GENET DEV, V15, P125, DOI 10.1016/j.gde.2005.02.006; Bintu L, 2005, CURR OPIN GENET DEV, V15, P116, DOI 10.1016/j.gde.2005.02.007; Bratsun D, 2005, P NATL ACAD SCI USA, V102, P14593, DOI 10.1073/pnas.0503858102; Bruinsma RF, 2002, PHYSICA A, V313, P211, DOI 10.1016/S0378-4371(02)01038-5; Buchler NE, 2005, P NATL ACAD SCI USA, V102, P9559, DOI 10.1073/pnas.0409553102; Buchler NE, 2003, P NATL ACAD SCI USA, V100, P5136, DOI 10.1073/pnas.0930314100; Celani A, 2010, P NATL ACAD SCI USA, V107, P1391, DOI 10.1073/pnas.0909673107; Chen D, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.52; Cherry JL, 2000, J THEOR BIOL, V203, P117, DOI 10.1006/jtbi.2000.1068; Cox RS, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100187; Dodd IB, 2007, CELL, V129, P813, DOI 10.1016/j.cell.2007.02.053; Fritz Georg, 2007, Syst Synth Biol, V1, P89, DOI 10.1007/s11693-007-9006-8; Gardiner C., 2002, HDB STOCHASTIC METHO; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gilbert SF, 2006, DEV BIOL; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Ham TS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002815; Ham TS, 2006, BIOTECHNOL BIOENG, V94, P1, DOI 10.1002/bit.20916; HOLLIS M, 1988, P NATL ACAD SCI USA, V85, P5834, DOI 10.1073/pnas.85.16.5834; Huffman DA., 1954, J FRANKLIN I, V257, P161, DOI DOI 10.1016/0016-0032(54)90574-8; Katz R. H., 1994, CONT LOGIC DESIGN; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Lewis J, 2003, CURR BIOL, V13, P1398, DOI 10.1016/S0960-9822(03)00534-7; LISMAN JE, 1985, P NATL ACAD SCI USA, V82, P3055, DOI 10.1073/pnas.82.9.3055; Lopez D, 2010, FEMS MICROBIOL REV, V34, P134, DOI 10.1111/j.1574-6976.2009.00199.x; Lou CB, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.2; Lu TK, 2009, NAT BIOTECHNOL, V27, P1139, DOI 10.1038/nbt.1591; MacDonald N., 1989, BIOL DELAY SYSTEMS L; Mitchell A, 2009, NATURE, V460, P220, DOI 10.1038/nature08112; Moon TS, 2011, J MOL BIOL, V406, P215, DOI 10.1016/j.jmb.2010.12.019; Padirac A, 2012, P NATL ACAD SCI US; Papatsenko D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021145; Perkins TJ, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.83; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Regot S, 2011, NATURE, V469, P207, DOI 10.1038/nature09679; Rodrigo Guillermo, 2007, Syst Synth Biol, V1, P183, DOI 10.1007/s11693-008-9017-0; Siuti P, 2013, NAT BIOTECHNOL, V31, P448, DOI 10.1038/nbt.2510; Sourjik V, 2012, CURR OPIN CELL BIOL, V24, P262, DOI 10.1016/j.ceb.2011.11.008; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; Strogatz S.H., 1994, NONLINEAR DYNAMICS S; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565; van der Woude MW, 2004, CLIN MICROBIOL REV, V17, P581, DOI 10.1128/CMR.17.3.581-611.2004; Veening JW, 2008, P NATL ACAD SCI USA, V105, P4393, DOI 10.1073/pnas.0700463105; VERSHON AK, 1987, J MOL BIOL, V195, P311, DOI 10.1016/0022-2836(87)90652-8; Warren PB, 2005, J PHYS CHEM B, V109, P6812, DOI 10.1021/jp045523y; Warren PB, 2004, J MOL BIOL, V342, P1379, DOI 10.1016/j.jmb.2004.07.074; Wiggins S., 2003, INTRO APPL NONLINEAR, DOI 10.1007/b97481; Wolf DM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001700; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Zhan JA, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.42	54	23	23	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68345	10.1371/journal.pone.0068345	http://dx.doi.org/10.1371/journal.pone.0068345			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874595	Green Submitted, Green Published, gold			2022-12-27	WOS:000322064300025
J	Liao, YL; Wang, PS; Lu, CF; Hung, CI; Li, CT; Lin, CP; Hsieh, JC; Su, TP; Wu, YT				Liao, Yuan-Lin; Wang, Po-Shan; Lu, Chia-Feng; Hung, Chih-I; Li, Cheng-Ta; Lin, Ching-Po; Hsieh, Jen-Chuen; Su, Tung-Ping; Wu, Yu-Te			Cortical Shape and Curvedness Analysis of Structural Deficits in Remitting and Non-Remitting Depression	PLOS ONE			English	Article							SELECTIVE SEROTONIN REUPTAKE; UNIPOLAR DEPRESSION; BIPOLAR DISORDER; MAJOR DEPRESSION; MRI; METAANALYSIS; BRAIN; REMISSION; BINDING; SCALE	In morphometric neuroimaging studies, the relationship between brain structural changes and the antidepressant treatment response in patients with major depressive disorder has been explored to search depression-trait biomarkers. Although patients were treated with serotonin-related drugs, whether the same treatment resulted in remission and non-remission in depressed patients is currently under investigation. We recruited 25 depressed patients and 25 healthy controls and acquired volumetric magnetic resonance imaging of each participant. We used the shape index and curvedness to classify cortical shapes and quantify shape complexities, respectively, in studying the pharmacological effect on brain morphology. The results showed that different regions of structural abnormalities emerged between remitting and non-remitting patients when contrasted with healthy controls. In addition to comparing structural metrics in each cortical parcellation, similar to the traditional voxel-based morphometric method, we highlighted the importance of structural integrity along the serotonin pathway in response to medication treatment. We discovered that disrupted serotonin-related cortical regions might cause non-remission to antidepressant treatment from a pharmacological perspective. The anomalous areas manifested in non-remitting patients were mainly in the frontolimbic areas, which can be used to differentiate remitting from non-remitting participants before medication treatment. Because non-remission is the failure to respond to treatment with serotonin-related drugs, our method may help clinicians choose appropriate medications for non-remitting patients.	[Liao, Yuan-Lin; Lu, Chia-Feng; Hung, Chih-I; Lin, Ching-Po; Wu, Yu-Te] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan; [Liao, Yuan-Lin; Wang, Po-Shan; Lu, Chia-Feng; Hung, Chih-I; Li, Cheng-Ta; Lin, Ching-Po; Hsieh, Jen-Chuen; Su, Tung-Ping; Wu, Yu-Te] Natl Yang Ming Univ, Brain Res Ctr, Taipei 112, Taiwan; [Wang, Po-Shan; Li, Cheng-Ta; Lin, Ching-Po; Hsieh, Jen-Chuen; Su, Tung-Ping] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan; [Wang, Po-Shan] Taipei Municipal Gan Dau Hosp, Neurol Inst, Taipei, Taiwan; [Wang, Po-Shan] Natl Yang Ming Univ, Sch Med, Dept Neurol, Taipei 112, Taiwan; [Wang, Po-Shan] Taipei Vet Gen Hosp, Neurol Inst, Dept Neurol, Taipei, Taiwan; [Lu, Chia-Feng] Natl Yang Ming Univ, Dept Phys Therapy & Assist Technol, Taipei 112, Taiwan; [Lu, Chia-Feng] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan; [Li, Cheng-Ta; Su, Tung-Ping] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Li, Cheng-Ta; Su, Tung-Ping] Natl Yang Ming Univ, Fac Med, Taipei 112, Taiwan; [Lin, Ching-Po] Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan; [Hsieh, Jen-Chuen] Taipei Vet Gen Hosp, Integrated Brain Res Lab, Dept Med Res & Educ, Taipei, Taiwan; [Hsieh, Jen-Chuen] Natl Hlth & Res Inst, Ctr Neuropsychiat Res, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei City Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Health Research Institutes - Taiwan	Su, TP (corresponding author), Natl Yang Ming Univ, Brain Res Ctr, Taipei 112, Taiwan.	tomsu0402@gmail.com; ytwu@ym.edu.tw	Li, Cheng-Ta/AAI-5759-2021	Li, Cheng-Ta/0000-0002-0670-1153	National Science Council [NSC95-2752-B-075-001-PAE, NSC96-2752-B-075-001-PAE, NSC97-2752-B-075-001-PAE, NSC98-2752-B-075-001-PAE, NSC101-2221-E-010-004-MY2]; National Science Council supported for the Center for Dynamical Biomarkers and Translational Medicine, National Central University, Jhongli City, Taoyuan County, Taiwan, Republic of China [NSC 101-2911-I-008-001]; Ministry of Education, Aim for the Top University Plan [101AC-B902, 102AC-B902]; Brain Research Center, National Yang-Ming University	National Science Council(Ministry of Science and Technology, Taiwan); National Science Council supported for the Center for Dynamical Biomarkers and Translational Medicine, National Central University, Jhongli City, Taoyuan County, Taiwan, Republic of China; Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan); Brain Research Center, National Yang-Ming University	This work is funded by the National Science Council (NSC95-2752-B-075-001-PAE, NSC96-2752-B-075-001-PAE, NSC97-2752-B-075-001-PAE, NSC98-2752-B-075-001-PAE, NSC101-2221-E-010-004-MY2), the National Science Council supported for the Center for Dynamical Biomarkers and Translational Medicine, National Central University, Jhongli City, Taoyuan County, Taiwan, Republic of China (NSC 101-2911-I-008-001), and Brain Research Center, National Yang-Ming University and a grant from Ministry of Education, Aim for the Top University Plan 101AC-B902, 102AC-B902). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman-Gomez Y., 2006, 12 ANN M ORG HUM BRA; Ardekani BA, 2009, NEUROIMAGE, V46, P677, DOI 10.1016/j.neuroimage.2009.02.030; Arnone D, 2012, MOL PSYCHIAT; Awate SP, 2010, NEUROIMAGE, V53, P450, DOI 10.1016/j.neuroimage.2010.06.072; Bora E, 2012, PSYCHOL MED, V42, P671, DOI 10.1017/S0033291711001668; Caetano SC, 2004, PSYCHIAT RES-NEUROIM, V132, P141, DOI 10.1016/j.psychresns.2004.08.002; Chen CH, 2007, BIOL PSYCHIAT, V62, P407, DOI 10.1016/j.biopsych.2006.09.018; Crespo-Facorro B, 2011, PROG NEURO-PSYCHOPH, V35, P616, DOI 10.1016/j.pnpbp.2011.01.005; Diener C, 2012, NEUROIMAGE, V61, P677, DOI 10.1016/j.neuroimage.2012.04.005; Du MY, 2012, PROG NEURO-PSYCHOPH, V36, P11, DOI 10.1016/j.pnpbp.2011.09.014; Dunner DL, 2008, MED BASIS PSYCHIAT, P73; FRANK E, 1991, ARCH GEN PSYCHIAT, V48, P851, DOI 10.1001/archpsyc.1991.01810330075011; Gaynes BN, 2009, PSYCHIAT SERV, V60, P1439, DOI 10.1176/ps.2009.60.11.1439; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Herrera-Guzman I, 2010, PSYCHIAT RES, V177, P323, DOI 10.1016/j.psychres.2010.03.006; Hoflich A, 2012, REV NEUROSCIENCE, V23, P227, DOI 10.1515/revneuro-2012-0038; Hu H-H, 2012, BRAIN STRUC IN PRESS; Janssen J, 2009, BIOL PSYCHIAT, V66, P1047, DOI 10.1016/j.biopsych.2009.07.021; Li CT, 2012, BRIT J PSYCHIAT, V200, P45, DOI 10.1192/bjp.bp.110.086983; Li CT, 2010, NEUROIMAGE, V50, P347, DOI 10.1016/j.neuroimage.2009.11.021; Lim HK, 2012, NEUROPSYCHOPHARMACOL, V37, P838, DOI 10.1038/npp.2011.264; Liu F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040968; Maalouf FT, 2011, DEPRESS ANXIETY, V28, P946, DOI 10.1002/da.20884; Malykhin NV, 2012, J AFFECT DISORDERS, V136, P1104, DOI 10.1016/j.jad.2011.10.038; Miller JM, 2008, J PSYCHIATR RES, V42, P1137, DOI 10.1016/j.jpsychires.2008.01.012; Miller JM, 2009, NEUROPSYCHOPHARMACOL, V34, P2275, DOI 10.1038/npp.2009.54; Murrough JW, 2011, NEUROBIOL LEARN MEM, V96, P553, DOI 10.1016/j.nlm.2011.06.006; OWENS MJ, 1994, CLIN CHEM, V40, P288; Papakostas GI, 2007, BIOL PSYCHIAT, V62, P1217, DOI 10.1016/j.biopsych.2007.03.027; Parsey RV, 2006, NEUROPSYCHOPHARMACOL, V31, P1745, DOI 10.1038/sj.npp.1300992; Penttila J, 2009, BIPOLAR DISORD, V11, P361, DOI 10.1111/j.1399-5618.2009.00683.x; Phillips JL, 2012, J CLIN PSYCHIAT, V73, P625, DOI 10.4088/JCP.11m06865; Prasad KM, 2010, SCHIZOPHR RES, V116, P143, DOI 10.1016/j.schres.2009.11.003; Ronan L, 2011, INT J NEURAL SYST, V21, P351, DOI 10.1142/S0129065711002948; Salvadore G, 2011, NEUROIMAGE, V54, P2643, DOI 10.1016/j.neuroimage.2010.11.011; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Sheline YI, 2012, AM J PSYCHIAT; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; THIRION JP, 1995, COMPUT VIS IMAGE UND, V61, P190, DOI 10.1006/cviu.1995.1015; Tu PC, 2012, PSYCHIAT RES-NEUROIM, V202, P206, DOI 10.1016/j.pscychresns.2011.07.011; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wagner G, 2008, J PSYCHIATR NEUROSCI, V33, P199; Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018; Wu YT, 2012, NEUROIMAGE, V61, P1, DOI 10.1016/j.neuroimage.2012.02.057; Wu YT, 2010, NEUROIMAGE, V49, P539, DOI 10.1016/j.neuroimage.2009.07.042; Zhang YC, 2009, NEUROREPORT, V20, P378, DOI 10.1097/WNR.0b013e3283249b34	46	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68625	10.1371/journal.pone.0068625	http://dx.doi.org/10.1371/journal.pone.0068625			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874696	gold, Green Published, Green Submitted			2022-12-27	WOS:000322064300056
J	Chatterjee, S; Santos, N; Holgate, J; Haass-Koffler, CL; Hopf, FW; Kharazia, V; Lester, H; Bonci, A; Bartlett, SE				Chatterjee, Susmita; Santos, Nathan; Holgate, Joan; Haass-Koffler, Carolina L.; Hopf, F. Woodward; Kharazia, Viktor; Lester, Henry; Bonci, Antonello; Bartlett, Selena E.			The alpha 5 Subunit Regulates the Expression and Function of alpha 4*-Containing Neuronal Nicotinic Acetylcholine Receptors in the Ventral-Tegmental Area	PLOS ONE			English	Article							CA2+ PERMEABILITY; PHYSIOLOGICAL DIVERSITY; CHOLINERGIC-RECEPTOR; UP-REGULATION; RAT-BRAIN; ETHANOL; MODULATION; MIDBRAIN; ALPHA-4-BETA-2; ACTIVATION	Human genetic association studies have shown gene variants in the alpha 5 subunit of the neuronal nicotinic receptor (nAChR) influence both ethanol and nicotine dependence. The alpha 5 subunit is an accessory subunit that facilitates alpha 4* nAChRs assembly in vitro. However, it is unknown whether this occurs in the brain, as there are few research tools to adequately address this question. As the alpha 4*-containing nAChRs are highly expressed in the ventral tegmental area (VTA) we assessed the molecular, functional and pharmacological roles of alpha 5 in alpha 4*-containing nAChRs in the VTA. We utilized transgenic mice alpha 5+/+(alpha 4YFP) and alpha 5-/-(alpha alpha 4YFP) that allow the direct visualization and measurement of alpha 4-YFP expression and the effect of the presence (alpha 5+/+) and absence of alpha 5 (-/-) subunit, as the antibodies for detecting the alpha 4* subunits of the nAChR are not specific. We performed voltage clamp electrophysiological experiments to study baseline nicotinic currents in VTA dopaminergic neurons. We show that in the presence of the alpha 5 subunit, the overall expression of alpha 4 subunit is increased significantly by 60% in the VTA. Furthermore, the alpha 5 subunit strengthens baseline nAChR currents, suggesting the increased expression of alpha 4* nAChRs to be likely on the cell surface. While the presence of the alpha 5 subunit blunts the desensitization of nAChRs following nicotine exposure, it does not alter the amount of ethanol potentiation of VTA dopaminergic neurons. Our data demonstrates a major regulatory role for the alpha 5 subunit in both the maintenance of alpha 4*-containing nAChRs expression and in modulating nicotinic currents in VTA dopaminergic neurons. Additionally, the alpha 5 alpha 4* nAChR in VTA dopaminergic neurons regulates the effect of nicotine but not ethanol on currents. Together, the data suggest that the alpha 5 subunit is critical for controlling the expression and functional role of a population of alpha 4*-containing nAChRs in the VTA.	[Holgate, Joan; Bartlett, Selena E.] Queensland Univ Technol, Sch Clin Sci, Fac Hlth, Translat Res Inst,Inst Hlth & Biomed Sci, Brisbane, Qld 4001, Australia; [Chatterjee, Susmita; Santos, Nathan; Haass-Koffler, Carolina L.; Hopf, F. Woodward; Kharazia, Viktor] Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Emeryville, CA USA; [Haass-Koffler, Carolina L.] Univ Calif San Francisco, Sch Med, San Francisco, CA USA; [Lester, Henry] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Bonci, Antonello] NIDA, Intramural Res Program, Baltimore, MD USA; [Hopf, F. Woodward; Bonci, Antonello] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Bonci, Antonello] Johns Hopkins Univ, Solomon Snyder Dept Neurosci, Baltimore, MD USA	Queensland University of Technology (QUT); University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco; California Institute of Technology; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); University of California System; University of California San Francisco; Johns Hopkins University	Bartlett, SE (corresponding author), Queensland Univ Technol, Sch Clin Sci, Fac Hlth, Translat Res Inst,Inst Hlth & Biomed Sci, Brisbane, Qld 4001, Australia.	selena.bartlett@qut.edu.au	Haass-Koffler, Carolina L/O-2785-2017; Bartlett, Selena/J-1345-2012	Haass-Koffler, Carolina L/0000-0002-5634-5679; Bartlett, Selena/0000-0002-1741-3958; Kharazia, Viktor/0000-0003-0642-6080	National Institutes of Health (NIH) [1RC2AA019429-01, 1R01AA017924-01, 1R01DA17279]; State of California for Medical Research on Alcohol and Substance Abuse through the University of California San Francisco; California Tobacco-Related Disease Research Program; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [RC2AA019429, R01AA017924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017279] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of California for Medical Research on Alcohol and Substance Abuse through the University of California San Francisco(University of California System); California Tobacco-Related Disease Research Program(University of California System); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by funding from the National Institutes of Health (NIH) 1RC2AA019429-01 (to SEB), NIH 1R01AA017924-01 (to SEB), NIH 1R01DA17279 (to HL), and the State of California for Medical Research on Alcohol and Substance Abuse through the University of California San Francisco (to SEB), and the California Tobacco-Related Disease Research Program (to HL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aistrup GL, 1999, MOL PHARMACOL, V55, P39, DOI 10.1124/mol.55.1.39; Azam L, 2007, NEUROSCIENCE, V144, P1347, DOI 10.1016/j.neuroscience.2006.11.011; Bailey CDC, 2012, BIOL PSYCHIAT, V71, P120, DOI 10.1016/j.biopsych.2011.09.011; Bailey CDC, 2010, J NEUROSCI, V30, P9241, DOI 10.1523/JNEUROSCI.2258-10.2010; Baker TB, 2009, NICOTINE TOB RES, V11, P785, DOI 10.1093/ntr/ntp064; BENOWITZ NL, 1982, CLIN PHARMACOL THER, V32, P758, DOI 10.1038/clpt.1982.233; Bierut LJ, 2008, AM J PSYCHIAT, V165, P1163, DOI 10.1176/appi.ajp.2008.07111711; Bierut LJ, 2000, ALCOHOL RES HEALTH, V24, P233; BLOMQVIST O, 1992, BRAIN RES BULL, V29, P173, DOI 10.1016/0361-9230(92)90023-Q; Bonci A, 1999, J NEUROSCI, V19, P3723; Brodie MS, 1999, ALCOHOL CLIN EXP RES, V23, P1848, DOI 10.1111/j.1530-0277.1999.tb04082.x; Brown RWB, 2007, J NEUROCHEM, V103, P204, DOI 10.1111/j.1471-4159.2007.04700.x; Cardoso RA, 1999, J PHARMACOL EXP THER, V289, P774; Champtiaux N, 2002, J NEUROSCI, V22, P1208, DOI 10.1523/JNEUROSCI.22-04-01208.2002; Chatterjee S, 2011, NEUROPSYCHOPHARMACOL, V36, P603, DOI [10.1038/npp.2010.191, 10.1038/npp.2011.268]; CORRIGALL WA, 1992, PSYCHOPHARMACOLOGY, V107, P285, DOI 10.1007/BF02245149; Covernton PJO, 1997, BRIT J PHARMACOL, V122, P1661, DOI 10.1038/sj.bjp.0701568; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Ericson M, 1998, EUR J PHARMACOL, V358, P189, DOI 10.1016/S0014-2999(98)00602-5; Ericson M, 2003, EUR J PHARMACOL, V467, P85, DOI 10.1016/S0014-2999(03)01564-4; FLORES CM, 1992, MOL PHARMACOL, V41, P31; FORMAN SA, 1989, BIOCHIM BIOPHYS ACTA, V987, P95, DOI 10.1016/0005-2736(89)90459-8; Fowler CD, 2011, NATURE, V471, P597, DOI 10.1038/nature09797; Frahm S, 2011, NEURON, V70, P522, DOI 10.1016/j.neuron.2011.04.013; Freathy RM, 2009, HUM MOL GENET, V18, P2922, DOI 10.1093/hmg/ddp216; Fucile S, 2004, CELL CALCIUM, V35, P1, DOI 10.1016/j.ceca.2003.08.006; Gaimarri A, 2007, BRAIN RES REV, V55, P134, DOI 10.1016/j.brainresrev.2007.02.005; Gangitano D, 2009, GENES BRAIN BEHAV, V8, P398, DOI 10.1111/j.1601-183X.2009.00476.x; Gerzanich V, 1998, J PHARMACOL EXP THER, V286, P311; Gotti C, 1997, PROG NEUROBIOL, V53, P199, DOI 10.1016/S0301-0082(97)00034-8; Gotti C, 2007, BIOCHEM PHARMACOL, V74, P1102, DOI 10.1016/j.bcp.2007.05.023; Gotti C, 2006, TRENDS PHARMACOL SCI, V27, P482, DOI 10.1016/j.tips.2006.07.004; Gotti C, 2009, BIOCHEM PHARMACOL, V78, P703, DOI 10.1016/j.bcp.2009.05.024; Guo JZ, 1998, J NEUROSCI, V18, P1963; Hendrickson LM, 2010, J NEUROSCI, V30, P10169, DOI 10.1523/JNEUROSCI.2601-10.2010; Hendrickson LM, 2009, PSYCHOPHARMACOLOGY, V204, P563, DOI 10.1007/s00213-009-1488-5; Joslyn G, 2008, P NATL ACAD SCI USA, V105, P20368, DOI 10.1073/pnas.0810970105; Kamens HM, 2010, PSYCHOPHARMACOLOGY, V208, P613, DOI 10.1007/s00213-009-1759-1; Klink R, 2001, J NEUROSCI, V21, P1452, DOI 10.1523/JNEUROSCI.21-05-01452.2001; Kuryatov A, 1997, J NEUROSCI, V17, P9035; Kuryatov A, 2008, MOL PHARMACOL, V74, P132, DOI 10.1124/mol.108.046789; Li SG, 2010, GENESIS, V48, P667, DOI 10.1002/dvg.20669; LINDSTROM J, 1990, CIBA F SYMP, V152, P23; Livingstone PD, 2009, BIOCHEM PHARMACOL, V78, P744, DOI 10.1016/j.bcp.2009.06.004; Madhavan A, 2010, J NEUROSCI, V30, P14029, DOI 10.1523/JNEUROSCI.3366-10.2010; Mao D, 2008, J NEUROCHEM, V104, P446, DOI 10.1111/j.1471-4159.2007.05011.x; Mao DY, 2011, J NEUROSCI, V31, P6710, DOI 10.1523/JNEUROSCI.5671-10.2011; Margolis EB, 2006, J PHYSIOL-LONDON, V577, P907, DOI 10.1113/jphysiol.2006.117069; Marszalec W, 1999, ALCOHOL CLIN EXP RES, V23, P439, DOI 10.1111/j.1530-0277.1999.tb04135.x; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; McGranahan TM, 2011, J NEUROSCI, V31, P10891, DOI 10.1523/JNEUROSCI.0937-11.2011; Moroni M, 2006, J MOL NEUROSCI, V30, P95, DOI 10.1385/JMN:30:1:95; Moroni M, 2006, MOL PHARMACOL, V70, P755, DOI 10.1124/mol.106.023044; Nashmi R, 2003, J NEUROSCI, V23, P11554; Nashmi R, 2007, J NEUROSCI, V27, P8202, DOI 10.1523/JNEUROSCI.2199-07.2007; NISELL M, 1994, PHARMACOL TOXICOL, V75, P348, DOI 10.1111/j.1600-0773.1994.tb00373.x; Paterson D, 2000, PROG NEUROBIOL, V61, P75, DOI 10.1016/S0301-0082(99)00045-3; Perry DC, 2002, J NEUROCHEM, V82, P468, DOI 10.1046/j.1471-4159.2002.00951.x; Picciotto MR, 1998, NATURE, V391, P173, DOI 10.1038/34413; Pidoplichko VI, 1997, NATURE, V390, P401, DOI 10.1038/37120; Quick MW, 1999, NEUROPHARMACOLOGY, V38, P769, DOI 10.1016/S0028-3908(99)00024-6; RamirezLatorre J, 1996, NATURE, V380, P347, DOI 10.1038/380347a0; Rice ME, 2004, NAT NEUROSCI, V7, P583, DOI 10.1038/nn1244; Saccone NL, 2009, CANCER RES, V69, P6848, DOI 10.1158/0008-5472.CAN-09-0786; Salas R, 2003, MOL PHARMACOL, V63, P1059, DOI 10.1124/mol.63.5.1059; Santos N, 2012, ALCOHOL CLIN EXP RES; Schlaelpfer IR, 2008, BIOL PSYCHIAT, V63, P1039, DOI 10.1016/j.biopsych.2007.10.024; Tapia L, 2007, MOL PHARMACOL, V71, P769, DOI 10.1124/mol.106.030445; Tapper AR, 2004, SCIENCE, V306, P1029, DOI 10.1126/science.1099420; Wanat MJ, 2008, J PHYSIOL-LONDON, V586, P2157, DOI 10.1113/jphysiol.2007.150078; Wang JC, 2009, MOL PSYCHIATR, V14, P501, DOI 10.1038/mp.2008.42; Wooltorton JRA, 2003, J NEUROSCI, V23, P3176; Yang KC, 2011, J NEUROSCI, V31, P2537, DOI 10.1523/JNEUROSCI.3003-10.2011; Youssef KK, 2010, NAT CELL BIOL, V12, P299, DOI 10.1038/ncb2031; Yu DH, 1996, MOL PHARMACOL, V50, P1010; Zhou FM, 2001, NAT NEUROSCI, V4, P1224, DOI 10.1038/nn769; Zoli M, 1998, J NEUROSCI, V18, P4461	77	29	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2013	8	7							e68300	10.1371/journal.pone.0068300	http://dx.doi.org/10.1371/journal.pone.0068300			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZN	23869214	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000323110600013
J	Fu, LY; Chen, WB; Guo, W; Wang, JS; Tian, Y; Shi, DB; Zhang, XH; Qiu, HJ; Xiao, XS; Kang, TB; Huang, WL; Wang, SS; Deng, WG				Fu, Lingyi; Chen, Wangbing; Guo, Wei; Wang, Jingshu; Tian, Yun; Shi, Dingbo; Zhang, Xiaohong; Qiu, Huijuan; Xiao, Xiangsheng; Kang, Tiebang; Huang, Wenlin; Wang, Shusen; Deng, Wuguo			Berberine Targets AP-2/hTERT, NF-kappa B/COX-2, HIF-1 alpha/VEGF and Cytochrome-c/Caspase Signaling to Suppress Human Cancer Cell Growth	PLOS ONE			English	Article							LUNG-CANCER; PROMOTER ACTIVITY; PROSTATE-CANCER; COX2 EXPRESSION; AMPK ACTIVATION; DOWN-REGULATION; MELANOMA-CELLS; KAPPA-B; INHIBITION; APOPTOSIS	Berberine (BBR), an isoquinoline derivative alkaloid isolated from Chinese herbs, has a long history of uses for the treatment of multiple diseases, including cancers. However, the precise mechanisms of actions of BBR in human lung cancer cells remain unclear. In this study, we investigated the molecular mechanisms by which BBR inhibits cell growth in human non-small-cell lung cancer (NSCLC) cells. Treatment with BBR promoted cell morphology change, inhibited cell migration, proliferation and colony formation, and induced cell apoptosis. Further molecular mechanism study showed that BBR simultaneously targeted multiple cell signaling pathways to inhibit NSCLC cell growth. Treatment with BBR inhibited AP-2 alpha and AP-2 beta expression and abrogated their binding on hTERT promoters, thereby inhibiting hTERT expression. Knockdown of AP-2 alpha and AP-2 beta by siRNA considerably augmented the BBR-mediated inhibition of cell growth. BBR also suppressed the nuclear translocation of p50/p65 NF-kappa B proteins and their binding to COX-2 promoter, causing inhibition of COX-2. BBR also downregulated HIF-1 alpha and VEGF expression and inhibited Akt and ERK phosphorylation. Knockdown of HIF-1 alpha by siRNA considerably augmented the BBR-mediated inhibition of cell growth. Moreover, BBR treatment triggered cytochrome-c release from mitochondrial intermembrane space into cytosol, promoted cleavage of caspase and PARP, and affected expression of BAX and Bcl-2, thereby activating apoptotic pathway. Taken together, these results demonstrated that BBR inhibited NSCLC cell growth by simultaneously targeting AP-2/hTERT, NF-kappa B/COX-2, HIF-1 alpha/VEGF, PI3K/AKT, Raf/MEK/ERK and cytochrome-c/caspase signaling pathways. Our findings provide new insights into understanding the anticancer mechanisms of BBR in human lung cancer therapy.	[Fu, Lingyi; Chen, Wangbing; Wang, Jingshu; Tian, Yun; Shi, Dingbo; Qiu, Huijuan; Xiao, Xiangsheng; Kang, Tiebang; Huang, Wenlin; Wang, Shusen; Deng, Wuguo] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Guo, Wei; Zhang, Xiaohong; Deng, Wuguo] Dalian Med Univ, Ctr Canc, Inst Canc Stem Cell, Dalian, Peoples R China; [Huang, Wenlin; Deng, Wuguo] Guangzhou Double Bioprod Inc, State Key Lab Targeted Drug Tumors Guangdong Prov, Guangzhou, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Dalian Medical University	Wang, SS (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China.	wangshs@sysucc.org.cn; dengwg@sysucc.org.cn	xiao, xiang/GWU-6035-2022		National Natural Science Foundation of China [81071687, 81272195]; State"863 Program"of China [SS2012AA020403]; Doctoral Programs Foundation of Ministry of Education of China [20110171110077]; State Key Laboratory of Oncology in Southern China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State"863 Program"of China(National High Technology Research and Development Program of China); Doctoral Programs Foundation of Ministry of Education of China(Ministry of Education, China); State Key Laboratory of Oncology in Southern China	This work was supported by the funds from the National Natural Science Foundation of China (81071687, 81272195), the State"863 Program"of China (SS2012AA020403), the Doctoral Programs Foundation of Ministry of Education of China20110171110077 and the State Key Laboratory of Oncology in Southern China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah M, 2010, AM J GASTROENTEROL, V105, pS551, DOI 10.14309/00000434-201010001-01484; Briand F, 2013, ARTERIOSCL THROM VAS, V33, P13, DOI 10.1161/ATVBAHA.112.252932; Chen S, 2010, LUNG CANCER, V68, P137, DOI 10.1016/j.lungcan.2009.11.008; de Wilde J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-271; Deng WG, 2007, J BIOL CHEM, P282; Deng WG, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M610579200; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Edwards J, 2004, EUR J CANCER, V40, P50, DOI 10.1016/j.ejca.2003.08.010; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Eom KS, 2010, BIOL PHARM BULL, V33, P1644, DOI 10.1248/bpb.33.1644; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fiamegos YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018127; Ge HX, 2013, BIOORGAN MED CHEM, V21, P62, DOI 10.1016/j.bmc.2012.11.002; Giatromanolaki A, 2001, BRIT J CANCER, V85, P881, DOI 10.1054/bjoc.2001.2018; Gollob JA, 2006, SEMIN ONCOL, V33, P392, DOI 10.1053/j.seminoncol.2006.04.002; Goto H, 2012, CANCER SCI, V103, P775, DOI 10.1111/j.1349-7006.2012.02212.x; Hagen T, 2003, SCIENCE, V302, P1975, DOI 10.1126/science.1088805; Hamsa TP, 2012, PHYTOTHER RES, V26, P568, DOI 10.1002/ptr.3586; Hollingshead HE, 2008, CARCINOGENESIS, V29, P169, DOI 10.1093/carcin/bgm209; IKRAM M, 1975, PLANTA MED, V28, P353, DOI 10.1055/s-0028-1097869; Jeong HW, 2009, AM J PHYSIOL-ENDOC M, V296, pE955, DOI 10.1152/ajpendo.90599.2008; Joshi PV, 2011, PHARM BIOL, V49, P94, DOI 10.3109/13880209.2010.500295; Katiyar SK, 2009, MOL CARCINOGEN, V48, P24, DOI 10.1002/mc.20453; Kim HS, 2012, BIOCHEM PHARMACOL, V83, P385, DOI 10.1016/j.bcp.2011.11.008; Klastersky J, 2012, CRIT REV ONCOL HEMAT, V81, P49, DOI 10.1016/j.critrevonc.2011.02.002; Kyo S, 2008, CANCER SCI, V99, P1528, DOI 10.1111/j.1349-7006.2008.00878.x; Li J, 2011, MOL CANCER THER, V10, P1346, DOI 10.1158/1535-7163.MCT-10-0985; Lim JH, 2004, ONCOGENE, V23, P9427, DOI 10.1038/sj.onc.1208003; Liu YF, 2008, EUR J CANCER, V44, P2425, DOI 10.1016/j.ejca.2008.07.040; May BH, 2012, BIOGERONTOLOGY, V13, P299, DOI 10.1007/s10522-012-9375-6; Park JJ, 2012, BIOCHEM BIOPH RES CO, V426, P461, DOI 10.1016/j.bbrc.2012.08.091; Patil JB, 2010, EUR J PHARMACOL, V645, P70, DOI 10.1016/j.ejphar.2010.07.037; Peng PL, 2008, INT J RADIAT ONCOL, V70, P529, DOI 10.1016/j.ijrobp.2007.08.034; Peng PL, 2006, TOXICOL APPL PHARM, V214, P8, DOI 10.1016/j.taap.2005.11.010; Riechmann JL, 1998, BIOL CHEM, V379, P633; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Rodrigues S, 2004, B CANCER, V91, pS61; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Shi DB, 2012, PLOS ONE, P7; Shi DB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043898; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Stewart SA, 2002, P NATL ACAD SCI USA, V99, P12606, DOI 10.1073/pnas.182407599; Suh Y, 2009, CARCINOGENESIS, V30, P300, DOI 10.1093/carcin/bgn269; Sundin T, 2013, MOL CELL BIOCHEM, V375, P97, DOI 10.1007/s11010-012-1532-3; Sung JH, 2012, J KOREAN SOC APPL BI, V55, P491, DOI 10.1007/s13765-012-2119-0; Takenaka K, 2005, LIFE SCI, V77, P3231, DOI 10.1016/j.lfs.2005.05.048; Van den Berg RM, 2010, INT J ONCOL, V37, P455, DOI 10.3892/ijo_00000694; Wang J, 2012, INT J MOL MED, V30, P1166, DOI 10.3892/ijmm.2012.1095; Zhang YG, 2012, FITOTERAPIA, V83, P1014, DOI 10.1016/j.fitote.2012.05.015; Zhao Hai-ping, 2007, Yaoxue Xuebao, V42, P336	50	71	77	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2013	8	7							e69240	10.1371/journal.pone.0069240	http://dx.doi.org/10.1371/journal.pone.0069240			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZN	23869238	gold, Green Published, Green Submitted			2022-12-27	WOS:000323110600038
J	Shantha, GPS; Kumar, AA; Kahan, S; Irukulla, PK; Cheskin, LJ				Shantha, Ghanshyam Palamaner Subash; Kumar, Anita Ashok; Kahan, Scott; Irukulla, Pavan Kumar; Cheskin, Lawrence Jay			Triglyceride/HDL Ratio as a Screening Tool for Predicting Success at Reducing Anti-Diabetic Medications Following Weight Loss	PLOS ONE			English	Article							DENSITY LIPOPROTEIN CHOLESTEROL; OBESITY; PREVALENCE	Background and Objectives: Intentional weight loss, by reducing insulin resistance, results in both better glycemic control and decreased need for anti-diabetic medications. However, not everyone who is successful with weight loss is able to reduce anti-diabetic medication use. In this retrospective cohort study, we assessed the predictive accuracy of baseline triglyceride (TGL)/HDL ratio, a marker of insulin resistance, to screen patients for success in reducing anti-diabetic medication use with weight loss. Methods: Case records of 121 overweight and obese attendees at two outpatient weight management centers were analyzed. The weight loss intervention consisted of a calorie-restricted diet (similar to 1000Kcal/day deficit), a behavior modification plan, and a plan for increasing physical activity. Results: Mean period of follow-up was 12.5 +/- 3.5 months. By study exit, mean weight loss and mean HbA1c% reduction were 15.4 +/- 5.5 kgs and 0.5 +/- 0.2% respectively. 81 (67%) in the study cohort achieved at least 1 dose reduction of any anti-diabetic medication. Tests for predictive accuracy of baseline TGL/HDL ratio <= 3 to determine success with dose reductions of anti-diabetic medications showed a sensitivity, specificity, positive predictive value, negative predictive value, area under the curve, likelihood ratio (LR) + and LR-of 81, 83, 90, 70, 78, 4.8 and 0.2, respectively. Reproducibility of TGL/HDL ratio was acceptable. Conclusion: TGL/HDL ratio shows promise as an effective screening tool to determine success with dose reductions of anti-diabetic medications. The results of our study may inform the conduct of a systematic review using data from prior weight loss trials.	[Shantha, Ghanshyam Palamaner Subash; Kumar, Anita Ashok] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Shantha, Ghanshyam Palamaner Subash; Irukulla, Pavan Kumar] Wright Ctr Grad Med Educ, Dept Internal Med, Scranton, PA USA; [Kahan, Scott] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy, Baltimore, MD USA; [Cheskin, Lawrence Jay] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD USA; [Kahan, Scott] George Washington Univ, Sch Publ Hlth & Hlth Serv, Dept Hlth Policy, Washington, DC USA; [Kahan, Scott; Cheskin, Lawrence Jay] Johns Hopkins Univ, Johns Hopkins Weight Management Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; George Washington University; Johns Hopkins University	Cheskin, LJ (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD USA.	lcheskin@jhsph.edu	Cheskin, Lawrence/AAM-1094-2021	Cheskin, Lawrence/0000-0003-0262-1030; Kahan, Scott/0000-0002-3080-0661				Appel LJ, 2011, NEW ENGL J MED, V365, P1959, DOI 10.1056/NEJMoa1108660; CHAVEZ AG, 2011, CIR CIR, V79, P126; Colditz GA, 1999, MED SCI SPORT EXER, V31, pS663, DOI 10.1097/00005768-199911001-00026; Espeland M, 2007, DIABETES CARE, V30, P1374; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; GREENBERG RS, 2005, MED EPIDEMIOLOGY, P112; GREENBERG RS, 2005, MED EPIDEMIOLOGY, P227; Grundy SM, 2011, AM J CARDIOL, V108, P40, DOI 10.1016/j.amjcard.2011.03.003; Hatmi Zinat Nadia, 2011, Acta Med Iran, V49, P730; Jeffrey SF, 2005, HARRISONS PRINCIPLES, V1, P422; Kumar AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032395; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Nicholls SJ, 2011, J AM COLL CARDIOL, V57, P153, DOI 10.1016/j.jacc.2010.06.055; RONDANELLI M, 2012, ENDOCRINE, P88542; Shantha GPS, 2012, DIABETES EDUCATOR, V38, P417, DOI 10.1177/0145721712443293; Soska V, 2012, CLIN BIOCHEM, V45, P96, DOI 10.1016/j.clinbiochem.2011.11.001; StataCorp, 2021, STATA STAT SOFTWARE; TOVAR JR, 2012, AM SURGEON, V78, P969; WEISS ICS, 2012, CLIN CHIM ACTA, P88542; Whelton PK, 1997, ARCH INTERN MED, V157, P657, DOI 10.1001/archinte.157.6.657	20	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2013	8	7							e69285	10.1371/journal.pone.0069285	http://dx.doi.org/10.1371/journal.pone.0069285			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZN	23869240	gold, Green Submitted, Green Published			2022-12-27	WOS:000323110600040
J	Zhou, JX; Xu, T; Yan, Y; Qin, R; Wang, HX; Zhang, XP; Huang, Y; Wang, YH; Lu, YC; Fu, D; Chen, JX				Zhou, Jingxu; Xu, Tao; Yan, Yong; Qin, Rong; Wang, Hongxiang; Zhang, Xiaoping; Huang, Yan; Wang, Yuhai; Lu, Yicheng; Fu, Da; Chen, Juxiang			MicroRNA-326 Functions as a Tumor Suppressor in Glioma by Targeting the Nin One Binding Protein (NOB1)	PLOS ONE			English	Article							HUMAN GLIOBLASTOMA; MALIGNANT GLIOMA; CELL-LINES; EXPRESSION; PATHWAYS; GENES; BIOGENESIS; ACTIVATION; PROTEASOME; APOPTOSIS	Malignant glioma is the most common type of primary brain tumor in adults, characterized by rapid tumor growth and infiltration of tumor cells throughout the brain. Alterations in the activity of the 26S proteasome have been associated with malignant glioma cells, although the specific defects have not been identified. Recently, microRNA-326 (miR-326) was shown to play an important role in glioblastoma and breast cancer, but the underlying molecular mechanisms remain unclear. In the present study, the human Nin one binding protein (NOB1) was identified as a direct target of miR-326 and a potential oncogene in human glioma. Similar to NOB1 silencing by shRNA, overexpression of miR-326 in human glioma cell lines (A172 and U373) caused cell cycle arrest at the G1 phase, delayed cell proliferation and enhanced apoptosis. MiR-326 inhibited colony formation in soft agar and decreased growth of a xenograft tumor model, suggesting that miR-326 and NOB1 are required for tumorigenesis in vitro and in vivo. Furthermore, these processes were shown to involve the MAPK pathway. NOB1 overexpression in human glioma samples was detected by Affymetrix array analysis, and NOB1 mRNA and protein levels were shown to be increased in high-grade glioma compared to low-grade glioma and normal brain tissue. Furthermore, high levels of NOB1 were associated with unfavorable prognosis of glioma patients. Taken together, these results indicate that miR-326 and NOB1 may play an important role in the development of glioma.	[Zhou, Jingxu; Xu, Tao; Yan, Yong; Qin, Rong; Wang, Hongxiang; Lu, Yicheng; Chen, Juxiang] Second Mil Med Univ, Changzheng Hosp, Shanghai Inst Neurosurg, Dept Neurosurg, Shanghai, Peoples R China; [Zhou, Jingxu; Wang, Yuhai] PLA Hosp 101, Dept Neurosurg, Wuxi, Jiangsu, Peoples R China; [Zhang, Xiaoping] Tongji Univ, Peoples Hosp 10, Dept Nucl Med, Shanghai 200092, Peoples R China; [Huang, Yan] Fudan Univ, Sch Life Sci, Inst Genet, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Fu, Da] Shanghai Jiao Tong Univ, Sch Med, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai 200030, Peoples R China; [Fu, Da] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China	Naval Medical University; Tongji University; Fudan University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Chen, JX (corresponding author), Second Mil Med Univ, Changzheng Hosp, Shanghai Inst Neurosurg, Dept Neurosurg, Shanghai, Peoples R China.	juxianchen.cz@gmail.com	Fu, Da/GXF-2656-2022		National "863" High Technique Project [2007AA02Z483]; National Natural Science Foundation of China [81272781, 30973076]; Program for academic leaders in health sciences [XBR2011030]; "Shu Guang" project in Shanghai [11SG37]	National "863" High Technique Project(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for academic leaders in health sciences; "Shu Guang" project in Shanghai	This work was supported by the National "863" High Technique Project (2007AA02Z483), National Natural Science Foundation of China (81272781, 30973076), and Program for academic leaders in health sciences (No. XBR2011030) and "Shu Guang" project (No. 11SG37) in Shanghai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Choi BK, 2004, NEUROTOXICOLOGY, V25, P915, DOI 10.1016/j.neuro.2004.06.002; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Davis-Dusenbery Brandi N, 2010, Genes Cancer, V1, P1100, DOI 10.1177/1947601910396213; Ferretti E, 2008, EMBO J, V27, P2616, DOI 10.1038/emboj.2008.172; Gregory RI, 2005, CANCER RES, V65, P3509, DOI 10.1158/0008-5472.CAN-05-0298; Jiang JM, 2005, NUCLEIC ACIDS RES, V33, P5394, DOI 10.1093/nar/gki863; Kefas B, 2009, J NEUROSCI, V29, P15161, DOI 10.1523/JNEUROSCI.4966-09.2009; Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Nakada M, 2007, CELL MOL LIFE SCI, V64, P458, DOI 10.1007/s00018-007-6342-5; Rosenzweig R, 2008, BIOCHEM SOC T, V36, P807, DOI 10.1042/BST0360807; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041; Thatcher EJ, 2007, DEV DYNAM, V236, P2172, DOI 10.1002/dvdy.21211; Tone Y, 2000, GENE, V243, P37, DOI 10.1016/S0378-1119(99)00566-1; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Xu T, 2011, CANCER SCI, V102, P959, DOI 10.1111/j.1349-7006.2011.01888.x; Xu T, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-252; Yacoub A, 2003, CANCER BIOL THER, V2, P347, DOI 10.4161/cbt.2.4.422; Yao YQ, 2008, CANCER LETT, V264, P127, DOI 10.1016/j.canlet.2008.01.049; Zhang Y, 2005, MOL BIOL REP, V32, P185, DOI 10.1007/s11033-005-3141-7; Zhao ZY, 2011, BRAIN RES BULL, V86, P189, DOI 10.1016/j.brainresbull.2011.07.010	26	96	97	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2013	8	7							e68469	10.1371/journal.pone.0068469	http://dx.doi.org/10.1371/journal.pone.0068469			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZN	23869222	Green Published, gold, Green Submitted			2022-12-27	WOS:000323110600021
J	Guz, J; Gackowski, D; Foksinski, M; Rozalski, R; Zarakowska, E; Siomek, A; Szpila, A; Kotzbach, M; Kotzbach, R; Olinski, R				Guz, Jolanta; Gackowski, Daniel; Foksinski, Marek; Rozalski, Rafal; Zarakowska, Ewelina; Siomek, Agnieszka; Szpila, Anna; Kotzbach, Marcin; Kotzbach, Roman; Olinski, Ryszard			Comparison of Oxidative Stress/DNA Damage in Semen and Blood of Fertile and Infertile Men	PLOS ONE			English	Article							TOTAL ANTIOXIDANT CAPACITY; DNA-DAMAGE; HUMAN SPERM; SEMINAL PLASMA; ASCORBIC-ACID; HUMAN-SPERMATOZOA; ASSOCIATION; REPAIR; INCREASE; IMPACTS	Abnormal spermatozoa frequently display typical features of oxidative stress, i.e. excessive level of reactive oxygen species (ROS) and depleted antioxidant capacity. Moreover, it has been found that a high level of oxidatively damaged DNA is associated with abnormal spermatozoa and male infertility. Therefore, the aim of our study was the comparison of oxidative stress/DNA damage in semen and blood of fertile and infertile men. The broad range of parameters which describe oxidative stress and oxidatively damaged DNA and repair were analyzed in the blood plasma and seminal plasma of groups of fertile and infertile subjects. These parameters include: (i) 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodG) and 8-oxo-7,8-dihydroguanine (8-oxoGua) levels in urine; (ii) 8-oxodG level in DNA isolated from leukocytes and spermatozoa; (iii) antioxidant vitamins (A, C and E) and uric acid. Urinary excretion of 8-oxodG and 8-oxoGua and the level of oxidatively damaged DNA in leukocytes as well as the level of antioxidant vitamins were analyzed using HPLC and HPLC/GC/MS methods. The results of our study demonstrate that 8-oxodG level significantly correlated with every parameter which describe sperm quality: sperm count, motility and morphology. Moreover, the data indicate a higher level of 8-oxodG in sperm DNA compared with DNA of surrogate tissue (leukocytes) in infertile men as well as in healthy control group. For the whole study population the median values of 8-oxodG/10(6) dG were respectively 7.85 and 5.87 (p = 0.000000002). Since 8-oxodG level in sperm DNA is inversely correlated with urinary excretion rate of 8-oxoGua, which is the product of OGG1 activity, we hypothesize that integrity of spermatozoa DNA may be highly dependent on OGG1 activity. No relationship between the whole body oxidative stress and that of sperm plasma was found, which suggests that the redox status of semen may be rather independent on this characteristic for other tissues.	[Guz, Jolanta; Gackowski, Daniel; Foksinski, Marek; Rozalski, Rafal; Zarakowska, Ewelina; Siomek, Agnieszka; Szpila, Anna; Olinski, Ryszard] Nicolaus Copernicus Univ, Coll Med, Dept Clin Biochem, Bydgoszcz, Poland; [Kotzbach, Roman] Nicolaus Copernicus Univ, Coll Med, Dept Obstet Nursing, Bydgoszcz, Poland	Nicolaus Copernicus University; Nicolaus Copernicus University	Olinski, R (corresponding author), Nicolaus Copernicus Univ, Coll Med, Dept Clin Biochem, Bydgoszcz, Poland.	ryszardo@cm.umk.pl	Zarakowska, Ewelina/G-7912-2014; Foksinski, Marek/D-4942-2014; Gackowski, Daniel/G-5693-2012; Rozalski, Rafal/E-3397-2014; Guz, Jolanta/E-5302-2014; Szpila, Anna/G-8402-2014; Siomek-Górecka, Agnieszka/C-6384-2015; Olinski, Ryszard/E-9607-2014	Zarakowska, Ewelina/0000-0003-0508-7777; Foksinski, Marek/0000-0002-1338-8230; Gackowski, Daniel/0000-0002-7259-1511; Guz, Jolanta/0000-0003-4173-2729; Siomek-Górecka, Agnieszka/0000-0002-2323-610X; Rozalski, Rafal/0000-0003-2067-9981; Olinski, Ryszard/0000-0001-9927-8755; Szpila, Anna/0000-0002-1139-6157	Polish state funds [N N407 171439]	Polish state funds	This study was supported by Polish state funds for science for years 2010-2013, grant N N407 171439. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken RJ, 2011, ASIAN J ANDROL, V13, P36, DOI 10.1038/aja.2010.68; Aitken R John, 2010, Handb Exp Pharmacol, P99, DOI 10.1007/978-3-642-02062-9_7; Aitken RJ, 2009, INT J ANDROL, V32, P46, DOI 10.1111/j.1365-2605.2008.00943.x; AITKEN RJ, 1987, J REPROD FERTIL, V81, P459; ALVAREZ JG, 1987, J ANDROL, V8, P338; Amente S, 2010, ONCOGENE, V29, P3691, DOI 10.1038/onc.2010.120; Amente S, 2010, CELL CYCLE, V9, P3002, DOI 10.4161/cc.9.15.12499; Ball BA, 2008, ANIM REPROD SCI, V107, P257, DOI 10.1016/j.anireprosci.2008.04.014; Benchaib M, 2007, FERTIL STERIL, V87, P93, DOI 10.1016/j.fertnstert.2006.05.057; Collins AR, 1998, FASEB J, V12, P1397, DOI 10.1096/fasebj.12.13.1397; Collins AR, 2002, FREE RADICAL RES, V36, P239, DOI 10.1080/10715760290019246; Cooke MS, 2008, CANCER EPIDEM BIOMAR, V17, P3, DOI 10.1158/1055-9965.EPI-07-0751; Evans MD, 2010, FASEB J, V24, P1249, DOI 10.1096/fj.09-147124; Foksinski M, 2000, FREE RADICAL BIO MED, V29, P597, DOI 10.1016/S0891-5849(00)00358-0; Foksinski M, 2007, EUR J NUTR, V46, P174, DOI 10.1007/s00394-006-0642-7; Fraga CG, 1996, MUTAT RES-FUND MOL M, V351, P199, DOI 10.1016/0027-5107(95)00251-0; FRAGA CG, 1991, P NATL ACAD SCI USA, V88, P11003, DOI 10.1073/pnas.88.24.11003; Gedik CM, 2005, FASEB J, V19, P82, DOI 10.1096/fj.04-1767fje; Gillespie MN, 2009, ANN NY ACAD SCI, V1177, P140, DOI 10.1111/j.1749-6632.2009.05036.x; Hill JW, 2001, NUCLEIC ACIDS RES, V29, P430, DOI 10.1093/nar/29.2.430; JONES R, 1979, FERTIL STERIL, V31, P531; Kao SH, 2008, FERTIL STERIL, V89, P1183, DOI 10.1016/j.fertnstert.2007.05.029; KNIGHT RD, 1993, INT J CANCER, V54, P589, DOI 10.1002/ijc.2910540412; Kodama H, 1997, FERTIL STERIL, V68, P519, DOI 10.1016/S0015-0282(97)00236-7; KYRTOPOULOS SA, 1995, CLIN CHEM, V41, P1848; Lenton KJ, 1999, CARCINOGENESIS, V20, P607, DOI 10.1093/carcin/20.4.607; Lewis SEM, 2005, CELL TISSUE RES, V322, P33, DOI 10.1007/s00441-005-1097-5; LEWIS SEM, 1995, FERTIL STERIL, V64, P868, DOI 10.1016/S0015-0282(16)57870-4; Lewis SEM, 1997, FERTIL STERIL, V67, P142, DOI 10.1016/S0015-0282(97)81871-7; Loft S, 2003, HUM REPROD, V18, P1265, DOI 10.1093/humrep/deg202; McLachlan RI, 2001, MED J AUSTRALIA, V174, P116, DOI 10.5694/j.1326-5377.2001.tb143180.x; Mostafa T, 2006, ANDROLOGIA, V38, P221, DOI 10.1111/j.1439-0272.2006.00744.x; Ni ZY, 1997, MUTAT RES-FUND MOL M, V381, P77, DOI 10.1016/S0027-5107(97)00151-6; Obtulowicz T, 2010, MUTAGENESIS, V25, P463, DOI 10.1093/mutage/geq028; Oger I, 2003, ZYGOTE, V11, P367, DOI 10.1017/S0967199403002442; Olinski R, 2007, ACTA BIOCHIM POL, V54, P11, DOI 10.18388/abp.2007_3265; PERO RW, 1989, CARCINOGENESIS, V10, P693, DOI 10.1093/carcin/10.4.693; Potts RJ, 1999, HUM REPROD, V14, P2513, DOI 10.1093/humrep/14.10.2513; Rozalski R, 2004, FREE RADICAL RES, V38, P1201, DOI 10.1080/10715760400017350; Saleh RA, 2003, FERTIL STERIL, V79, P1597, DOI 10.1016/S0015-0282(03)00337-6; Seli E, 2004, FERTIL STERIL, V82, P378, DOI 10.1016/j.fertnstert.2003.12.039; Shen HM, 1999, J ANDROL, V20, P718; Shen HM, 2000, FREE RADICAL BIO MED, V28, P529, DOI 10.1016/S0891-5849(99)00234-8; Siomek A, 2007, ANTIOXID REDOX SIGN, V9, P143, DOI 10.1089/ars.2007.9.143; Smith R, 1996, HUM REPROD, V11, P1655; Smith TB, 2013, J CELL SCI; STRAUSS B, 1994, CANCER RES, V54, P5493; THIELE JJ, 1995, HUM REPROD, V10, P110, DOI 10.1093/humrep/10.1.110; Velando A, 2008, BIOESSAYS, V30, P1212, DOI 10.1002/bies.20838; World Health Organization, 2010, WHO LAB MAN EX PROS	51	53	57	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e68490	10.1371/journal.pone.0068490	http://dx.doi.org/10.1371/journal.pone.0068490			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	23874641	Green Published, gold, Green Submitted			2022-12-27	WOS:000321718700032
J	Sahraeian, SME; Yoon, BJ				Sahraeian, Sayed Mohammad Ebrahim; Yoon, Byung-Jun			SMETANA: Accurate and Scalable Algorithm for Probabilistic Alignment of Large-Scale Biological Networks	PLOS ONE			English	Article							PROTEIN-INTERACTION NETWORKS; GLOBAL ALIGNMENT; SYSTEMATIC IDENTIFICATION; CONSERVED PATHWAYS; SIMILARITY; DATABASE; YEAST	In this paper we introduce an efficient algorithm for alignment of multiple large-scale biological networks. In this scheme, we first compute a probabilistic similarity measure between nodes that belong to different networks using a semi-Markov random walk model. The estimated probabilities are further enhanced by incorporating the local and the cross-species network similarity information through the use of two different types of probabilistic consistency transformations. The transformed alignment probabilities are used to predict the alignment of multiple networks based on a greedy approach. We demonstrate that the proposed algorithm, called SMETANA, outperforms many state-of-the-art network alignment techniques, in terms of computational efficiency, alignment accuracy, and scalability. Our experiments show that SMETANA can easily align tens of genome-scale networks with thousands of nodes on a personal computer without any difficulty. The source code of SMETANA is available upon request. The source code of SMETANA can be downloaded from http://www.ece.tamu.edu/similar to bjyoon/SMETANA/.	[Sahraeian, Sayed Mohammad Ebrahim] Univ Calif, Dept Plant & Microbial Biol, Berkeley, CA USA; [Yoon, Byung-Jun] Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX 77843 USA	University of California System; University of California Berkeley; Texas A&M University System; Texas A&M University College Station	Yoon, BJ (corresponding author), Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX 77843 USA.	bjyoon@ece.tamu.edu	Yoon, Byung-Jun/B-1466-2008	Yoon, Byung-Jun/0000-0001-9328-1101	National Science Foundation (NSF) through the NSF Award [CCF-1149544]; Direct For Computer & Info Scie & Enginr [1149544] Funding Source: National Science Foundation	National Science Foundation (NSF) through the NSF Award(National Science Foundation (NSF)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported in part by the National Science Foundation (NSF) through the NSF Award CCF-1149544. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali W, 2009, BIOINFORMATICS, V25, P3166, DOI 10.1093/bioinformatics/btp569; Ay F, 2011, J COMPUT BIOL, V18, P219, DOI 10.1089/cmb.2010.0280; Bandyopadhyay S, 2006, GENOME RES, V16, P428, DOI 10.1101/gr.4526006; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bayati M, 2009, IEEE DATA MINING, P705, DOI 10.1109/ICDM.2009.135; Berg J, 2006, P NATL ACAD SCI USA, V103, P10967, DOI 10.1073/pnas.0602294103; Bradde S, 2010, EPL-EUROPHYS LETT, V89, DOI 10.1209/0295-5075/89/37009; Chindelevitch L, 2010, BIOCOMPUT-PAC SYM, P123; Cinello G, 2012, PLOS ONE, V7; Csermely P, 2013, PHARMACOL THERAPEUT, V138, P333, DOI 10.1016/j.pharmthera.2013.01.016; Cusick ME, 2005, HUM MOL GENET, V14, pR171, DOI 10.1093/hmg/ddi335; Denilou YP, 2009, LECT NOTES COMPUTER, V5577, P263; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Dutkowski J, 2007, BIOINFORMATICS, V23, pI149, DOI 10.1093/bioinformatics/btm194; Flannick J, 2006, GENOME RES, V16, P1169, DOI 10.1101/gr.5235706; Flannick J, 2009, J COMPUT BIOL, V16, P1001, DOI 10.1089/cmb.2009.0099; Ge H, 2000, Nucleic Acids Res, V28, pe3, DOI 10.1093/nar/28.2.e3; Guo X, 2009, BIOINFORMATICS, V25, pI240, DOI 10.1093/bioinformatics/btp202; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Huang ML, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-S2-S12; Kalaev M, 2008, BIOINFORMATICS, V24, P594, DOI 10.1093/bioinformatics/btm630; Kelley BP, 2003, P NATL ACAD SCI USA, V100, P11394, DOI 10.1073/pnas.1534710100; Kim WK, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000232; Klau GW, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S59; Koyuturk M, 2006, J COMPUT BIOL, V13, P182, DOI 10.1089/cmb.2006.13.182; Kuchaiev O, 2011, BIOINFORMATICS, V27, P1390, DOI 10.1093/bioinformatics/btr127; Liao CS, 2009, BIOINFORMATICS, V25, pI253, DOI 10.1093/bioinformatics/btp203; Memisevic V, 2012, INTEGR BIOL-UK, V4, P734, DOI 10.1039/c2ib00140c; Park D, 2011, NUCLEIC ACIDS RES, V39, pD295, DOI 10.1093/nar/gkq1234; Pastor-Satorras R, 2003, J THEOR BIOL, V222, P199, DOI 10.1016/S0022-5193(03)00028-6; Phan HTT, 2012, BIOINFORMATICS, V28, P1239, DOI 10.1093/bioinformatics/bts119; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Qian XN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008070; Sahraeian SME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041474; Sahraeian SME, 2012, BIOINFORMATICS, V28, P2129, DOI 10.1093/bioinformatics/bts341; Sahraeian SME, 2011, IEEE SIGNAL PROC LET, V18, P87, DOI 10.1109/LSP.2010.2096417; Sahraeian SME, 2010, NUCLEIC ACIDS RES, V38, P4917, DOI 10.1093/nar/gkq255; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Sharan R, 2005, P NATL ACAD SCI USA, V102, P1974, DOI 10.1073/pnas.0409522102; Sharan R, 2006, NAT BIOTECHNOL, V24, P427, DOI 10.1038/nbt1196; Singh R, 2008, P NATL ACAD SCI USA, V105, P12763, DOI 10.1073/pnas.0806627105; Skusa A, 2005, BRIEF BIOINFORM, V6, P263, DOI 10.1093/bib/6.3.263; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Vazquez Alexei, 2003, ComPlexUs, V1, P38, DOI 10.1159/000067642; Vishwanathan SVN, 2010, J MACH LEARN RES, V11, P1201; Yoon BJ, 2012, IEEE SIGNAL PROC MAG, V29, P22, DOI 10.1109/MSP.2011.942819; Zaslavskiy M, 2009, BIOINFORMATICS, V25, pI259, DOI 10.1093/bioinformatics/btp196; Zhang A., 2009, PROT INT NETW COMP; Zhenping L, 2007, BIOINFORMATICS, V23, P1631, DOI 10.1093/bioinformatics/btm156	51	63	63	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e67995	10.1371/journal.pone.0067995	http://dx.doi.org/10.1371/journal.pone.0067995			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	23874484	Green Published, gold, Green Submitted			2022-12-27	WOS:000321718700006
J	Wyss, C; Hitz, K; Hengartner, MP; Theodoridou, A; Obermann, C; Uhl, I; Roser, P; Grunblatt, E; Seifritz, E; Juckel, G; Kawohl, W				Wyss, Christine; Hitz, Konrad; Hengartner, Michael P.; Theodoridou, Anastasia; Obermann, Caitriona; Uhl, Idun; Roser, Patrik; Gruenblatt, Edna; Seifritz, Erich; Juckel, Georg; Kawohl, Wolfram			The Loudness Dependence of Auditory Evoked Potentials (LDAEP) as an Indicator of Serotonergic Dysfunction in Patients with Predominant Schizophrenic Negative Symptoms	PLOS ONE			English	Article							INTENSITY DEPENDENCE; SOURCE LOCALIZATION; STIMULUS-INTENSITY; CLINICAL-RESPONSE; RATING-SCALE; DOPAMINE; NEUROTRANSMISSION; ANTIDEPRESSANTS; RELIABILITY; DEPRESSION	Besides the influence of dopaminergic neurotransmission on negative symptoms in schizophrenia, there is evidence that alterations of serotonin (5-HT) system functioning also play a crucial role in the pathophysiology of these disabling symptoms. From post mortem and genetic studies on patients with negative symptoms a 5-HT dysfunction is documented. In addition atypical neuroleptics and some antidepressants improve negative symptoms via serotonergic action. So far no research has been done to directly clarify the association between the serotonergic functioning and the extent of negative symptoms. Therefore, we examined the status of brain 5-HT level in negative symptoms in schizophrenia by means of the loudness dependence of auditory evoked potentials (LDAEP). The LDAEP provides a well established and non-invasive in vivo marker of the central 5-HT activity. We investigated 13 patients with schizophrenia with predominant negative symptoms treated with atypical neuroleptics and 13 healthy age and gender matched controls with a 32-channel EEG. The LDAEP of the N1/P2 component was evaluated by dipole source analysis and single electrode estimation at Cz. Psychopathological parameters, nicotine use and medication were assessed to control for additional influencing factors. Schizophrenic patients showed significantly higher LDAEP in both hemispheres than controls. Furthermore, the LDAEP in the right hemisphere in patients was related to higher scores in scales assessing negative symptoms. A relationship with positive symptoms was not found. These data might suggest a diminished central serotonergic neurotransmission in patients with predominant negative symptoms.	[Wyss, Christine; Hitz, Konrad; Hengartner, Michael P.; Theodoridou, Anastasia; Obermann, Caitriona; Seifritz, Erich; Kawohl, Wolfram] Psychiat Univ Hosp Zurich, Dept Psychiat Psychotherapy & Psychosomat, Zurich, Switzerland; [Uhl, Idun; Roser, Patrik; Juckel, Georg] Ruhr Univ Bochum, Dept Psychiat, LWL Univ Hosp, Bochum, Germany; [Gruenblatt, Edna] Univ Zurich, Dept Child & Adolescent Psychiat, Zurich, Switzerland	University of Zurich; Ruhr University Bochum; University of Zurich	Kawohl, W (corresponding author), Psychiat Univ Hosp Zurich, Dept Psychiat Psychotherapy & Psychosomat, Zurich, Switzerland.	wolfram.kawohl@puk.zh.ch	Grünblatt, Edna/A-6762-2016; Hengartner, Michael Pascal/X-2508-2019; Grünblatt, Edna/AAG-4521-2020	Grünblatt, Edna/0000-0001-8505-7265; Hengartner, Michael Pascal/0000-0002-2956-2969; Grünblatt, Edna/0000-0001-8505-7265; Wyss, Christine/0000-0003-2088-9794; Theodoridou, Anastasia/0000-0003-4792-385X				Abi-Dargham A, 2007, INT REV NEUROBIOL, V78, P133, DOI 10.1016/S0074-7742(06)78005-9; ADDINGTON D, 1990, SCHIZOPHR RES, V3, P247, DOI 10.1016/0920-9964(90)90005-R; ANDREASEN NC, 1989, BRITISH JOURNAL OF PSYCHIATRY, VOL 155, SUPP NO. 7, P49; ANDREASEN NC, 1982, ARCH GEN PSYCHIAT, V39, P784; [Anonymous], 2000, DIAGN STAT MAN MENT, P299; Baribeau J C, 1987, Electroencephalogr Clin Neurophysiol Suppl, V40, P68; Beauducel A, 2000, J PSYCHOPHYSIOL, V14, P226, DOI 10.1027//0269-8803.14.4.226; BECH P, 1980, ACTA PSYCHIAT SCAND, V62, P128, DOI 10.1111/j.1600-0447.1980.tb07683.x; Bozikas VP, 2004, COMPR PSYCHIAT, V45, P392, DOI 10.1016/j.comppsych.2004.03.006; BREIER A, 1995, SCHIZOPHR RES, V14, P187, DOI 10.1016/0920-9964(94)00043-8; BRUNEAU N, 1985, ELECTROEN CLIN NEURO, V62, P364, DOI 10.1016/0168-5597(85)90045-0; Cook IA, 2008, PRIM PSYCHIAT, V15, P54; Davis JM, 2003, ARCH GEN PSYCHIAT, V60, P553, DOI 10.1001/archpsyc.60.6.553; DAVIS KL, 1991, AM J PSYCHIAT, V148, P1474; FLAUM M, 1995, COMPR PSYCHIAT, V36, P421, DOI 10.1016/S0010-440X(95)90249-X; Goff DC, 1998, HARVARD REV PSYCHIAT, V6, P59, DOI 10.3109/10673229809000313; GRACE AA, 1991, NEUROSCIENCE, V41, P1, DOI 10.1016/0306-4522(91)90196-U; Gudlowski Y, 2009, SCHIZOPHR RES, V109, P141, DOI 10.1016/j.schres.2009.02.008; Hafner H, 1999, ACTA PSYCHIAT SCAND, V100, P105, DOI 10.1111/j.1600-0447.1999.tb10831.x; Hagenmuller F, 2011, HUM PSYCHOPHARM CLIN, V26, P147, DOI 10.1002/hup.1186; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HASHIMOTO T, 1993, PSYCHOPHARMACOLOGY, V112, pS35, DOI 10.1007/BF02245005; Hegerl U, 2000, World J Biol Psychiatry, V1, P112, DOI 10.3109/15622970009150574; HEGERL U, 1994, INT J PSYCHOPHYSIOL, V17, P1, DOI 10.1016/0167-8760(94)90050-7; HEGERL U, 1993, BIOL PSYCHIAT, V33, P173, DOI 10.1016/0006-3223(93)90137-3; HEGERL U, 1988, PHARMACOPSYCHIATRY, V21, P336, DOI 10.1055/s-2007-1017000; Hegerl U, 2001, J AFFECT DISORDERS, V62, P93, DOI 10.1016/S0165-0327(00)00353-0; HEGERL U, 1994, PHARMACOPSYCHIATRY, V27, P75, DOI 10.1055/s-2007-1014283; Hensch T, 2008, CLIN NEUROPHYSIOL, V119, P224, DOI 10.1016/j.clinph.2007.09.127; Hitz K, 2012, PSYCHOPHARMACOLOGY, V221, P389, DOI 10.1007/s00213-011-2586-8; Hoffman JP, 2004, GEN LINEAR MODELS AP, P1; Jasper HH, 1958, ELECTROENCEPHALOGR C, V10, P380; Jaworska N, 2012, CLIN NEUROPHYSIOL, V123, P1769, DOI 10.1016/j.clinph.2012.02.076; Juckel G, 2003, SCHIZOPHR RES, V64, P115, DOI 10.1016/S0920-9964(03)00016-1; Juckel G, 2005, SEROTONIN AKUSTISCH, P1; Juckel G, 2008, HUM PSYCHOPHARM CLIN, V23, P115, DOI 10.1002/hup.906; Juckel G, 2008, PSYCHIAT RES, V158, P79, DOI 10.1016/j.psychres.2007.08.013; Juckel G, 2007, J CLIN PSYCHIAT, V68, P1206, DOI 10.4088/JCP.v68n0806; Kapur S, 1996, AM J PSYCHIAT, V153, P466; Kawohl W, 2008, NEUROPSYCHIATRIE, V22, P23; Kawohl W, 2007, J CLIN NEUROPHYSIOL, V24, P257, DOI 10.1097/WNP.0b013e3180555e49; Kawohl W, 2008, INT J NEUROPSYCHOPH, V11, P477, DOI 10.1017/S1461145708008420; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kirkpatrick B, 2006, SCHIZOPHRENIA BULL, V32, P214, DOI 10.1093/schbul/sbj053; Knable MB, 1997, J PSYCHOPHARMACOL, V11, P123, DOI 10.1177/026988119701100205; Lee IH, 2011, PSYCHOPHARMACOLOGY, V214, P617, DOI 10.1007/s00213-010-2064-8; Leucht S, 2011, INT J NEUROPSYCHOPH, V14, P269, DOI 10.1017/S1461145710001380; Lindenmayer JP, 2007, PSYCHIAT CLIN N AM, V30, P339, DOI 10.1016/j.psc.2007.04.005; Linka T, 2004, NEUROSCI LETT, V367, P375, DOI 10.1016/j.neulet.2004.06.038; Meltzer HY, 1999, NEUROPSYCHOPHARMACOL, V21, pS106, DOI 10.1038/sj.npp.1395370; MELTZER HY, 1989, PSYCHOPHARMACOLOGY, V99, pS18, DOI 10.1007/BF00442554; Miyamoto S, 2005, MOL PSYCHIATR, V10, P79, DOI 10.1038/sj.mp.4001556; Moller H-J, 2001, NEUROLEPTIKA PHARMAK, P243; O'Neill BV, 2008, HUM PSYCHOPHARM CLIN, V23, P355, DOI 10.1002/hup.940; O'Neill BV, 2007, PSYCHOPHARMACOLOGY, V195, P85, DOI 10.1007/s00213-007-0870-4; Okubo Y, 2000, LIFE SCI, V66, P2455, DOI 10.1016/S0024-3205(00)80005-3; Oliva JL, 2011, HUM PSYCHOPHARM CLIN, V26, P172, DOI 10.1002/hup.1187; Park YM, 2010, PROG NEURO-PSYCHOPH, V34, P313, DOI 10.1016/j.pnpbp.2009.12.004; Quednow BB, 2012, NEUROIMAGE, V59, P3922, DOI 10.1016/j.neuroimage.2011.09.045; Reynolds GP, 2005, EUR NEUROPSYCHOPHARM, V15, P143, DOI 10.1016/j.euroneuro.2004.07.001; Rossler W, 2005, EUR NEUROPSYCHOPHARM, V15, P399, DOI 10.1016/j.euroneuro.2005.04.009; Roth B, 2000, PSYCHOPHARMACOLOGY 4, P575; Rummel C, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005581.pub2; Salisbury DF, 2007, ARCH GEN PSYCHIAT, V64, P521, DOI 10.1001/archpsyc.64.5.521; SCHECHTER G, 1973, PSYCHOPHYSIOLOGY, V10, P392, DOI 10.1111/j.1469-8986.1973.tb00797.x; Scherg M, 1989, J Cogn Neurosci, V1, P336, DOI 10.1162/jocn.1989.1.4.336; Shenton ME, 2001, SCHIZOPHR RES, V49, P1, DOI 10.1016/S0920-9964(01)00163-3; Silver H, 2004, EXPERT OPIN PHARMACO, V5, P2053, DOI 10.1517/14656566.5.10.2053; Simmons JG, 2011, PSYCHOPHARMACOLOGY, V217, P101, DOI 10.1007/s00213-011-2265-9; Singh SP, 2010, BRIT J PSYCHIAT, V197, P174, DOI 10.1192/bjp.bp.109.067710; Waberski TD, 2003, NEUROSCI LETT, V347, P151, DOI 10.1016/S0304-3940(03)00650-5; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; Winograd-Gurvich C, 2006, BRAIN RES BULL, V70, P312, DOI 10.1016/j.brainresbull.2006.06.007; World Health Organization, 1993, ICD 10 CLASS MENT BE, p[28, 78]; YAMAGUCHI S, 1990, BRAIN RES, V521, P281, DOI 10.1016/0006-8993(90)91553-S; Yasuno F, 2004, BIOL PSYCHIAT, V55, P439, DOI 10.1016/j.biopsych.2003.11.016	76	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e68650	10.1371/journal.pone.0068650	http://dx.doi.org/10.1371/journal.pone.0068650			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	23874705	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000321718700037
J	Guo, HR; Wei, W; Wei, ZH; Liu, XJ; Evans, SL; Yang, WM; Wang, H; Guo, Y; Zhao, K; Zhou, JY; Yu, XF				Guo, Haoran; Wei, Wei; Wei, Zhenhong; Liu, Xianjun; Evans, Sean L.; Yang, Weiming; Wang, Hong; Guo, Ying; Zhao, Ke; Zhou, Jian-Ying; Yu, Xiao-Fang			Identification of Critical Regions in Human SAMHD1 Required for Nuclear Localization and Vpx-Mediated Degradation	PLOS ONE			English	Article							RESTRICTION FACTOR SAMHD1; IMMUNODEFICIENCY-VIRUS TYPE-1; HIV-1 INFECTION; REVERSE TRANSCRIPTION; DENDRITIC CELLS; PROTEIN; GENE; GAG; SIV; REPLICATION	The sterile alpha motif (SAM) and HD domain-containing protein-1 (SAMHD1) inhibits the infection of resting CD4+ T cells and myeloid cells by human and related simian immunodeficiency viruses (HIV and SIV). Vpx inactivates SAMHD1 by promoting its proteasome-dependent degradation through an interaction with CRL4 (DCAF1) E3 ubiquitin ligase and the C-terminal region of SAMHD1. However, the determinants in SAMHD1 that are required for Vpx-mediated degradation have not been well characterized. SAMHD1 contains a classical nuclear localization signal (NLS), and NLS point mutants are cytoplasmic and resistant to Vpx-mediated degradation. Here, we demonstrate that NLS-mutant SAMHD1 K11A can be rescued by wild-type SAMHD1, restoring its nuclear localization; consequently, SAMHD1 K11A became sensitive to Vpx-mediated degradation in the presence of wild-type SAMHD1. Surprisingly, deletion of N-terminal regions of SAMHD1, including the classical NLS, generated mutant SAMHD1 proteins that were again sensitive to Vpx-mediated degradation. Unlike SAMHD1 K11A, these deletion mutants could be detected in the nucleus. Interestingly, NLS-defective SAMHD1 could still bind to karyopherin-beta 1 and other nuclear proteins. We also determined that the linker region between the SAM and HD domain and the HD domain itself is important for Vpx-mediated degradation but not Vpx interaction. Thus, SAMHD1 contains an additional nuclear targeting mechanism in addition to the classical NLS. Our data indicate that multiple regions in SAMHD1 are critical for Vpx-mediated nuclear degradation and that association with Vpx is not sufficient for Vpx-mediated degradation of SAMHD1. Since the linker region and HD domain may be involved in SAMHD1 multimerization, our results suggest that SAMHD1 multimerization may be required for Vpx-mediation degradation.	[Guo, Haoran; Wei, Wei; Wei, Zhenhong; Liu, Xianjun; Wang, Hong; Guo, Ying; Zhao, Ke; Yu, Xiao-Fang] Jilin Univ, Hosp 1, Inst Virol & AIDS Res, Changchun, Jilin Province, Peoples R China; [Guo, Haoran; Wei, Wei; Evans, Sean L.; Yu, Xiao-Fang] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Yang, Weiming; Zhou, Jian-Ying] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD USA	Jilin University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Yu, XF (corresponding author), Jilin Univ, Hosp 1, Inst Virol & AIDS Res, Changchun, Jilin Province, Peoples R China.	xfyu@jhsph.edu	Wei, Wei/ABG-9776-2021	Wei, Wei/0000-0003-4456-840X	Chinese Ministry of Science and Technology [2012CB911100]; Chinese Ministry of Education [IRT1016]; Key Laboratory of Molecular Virology, Jilin Province, China [20102209]; China Scholarship Council	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese Ministry of Education(Ministry of Education, China); Key Laboratory of Molecular Virology, Jilin Province, China; China Scholarship Council(China Scholarship Council)	This work was supported in part by funding from the Chinese Ministry of Science and Technology (No 2012CB911100), the Chinese Ministry of Education (No IRT1016), and the Key Laboratory of Molecular Virology, Jilin Province (20102209), China. The authors also gratefully acknowledge scholarship support from China Scholarship Council for Wei Wei. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accola MA, 1999, J VIROL, V73, P9992, DOI 10.1128/JVI.73.12.9992-9999.1999; Ahn J, 2012, J BIOL CHEM, V287, P12550, DOI 10.1074/jbc.M112.340711; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Ayinde D, 2012, NAT REV MICROBIOL, V10, P675, DOI 10.1038/nrmicro2862; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Berger A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002425; Berger G, 2012, J BIOL CHEM, V287, P41210, DOI 10.1074/jbc.M112.403816; Bi Y, 2011, BIOL REPROD, V84, P756, DOI 10.1095/biolreprod.110.084343; Brandariz-Nunez A, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-49; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Descours B, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-87; Freitas N, 2009, CURR GENOMICS, V10, P550, DOI 10.2174/138920209789503941; Fujita M, 2008, J VIROL, V82, P7752, DOI 10.1128/JVI.01003-07; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Goujon C, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-2; Gramberg T, 2010, J VIROL, V84, P1387, DOI 10.1128/JVI.01437-09; GUYADER M, 1989, EMBO J, V8, P1169, DOI 10.1002/j.1460-2075.1989.tb03488.x; HARRIS CA, 1995, GENOMICS, V28, P198, DOI 10.1006/geno.1995.1131; HENDERSON LE, 1988, SCIENCE, V241, P199, DOI 10.1126/science.3388031; Hofmann H, 2012, J VIROL, V86, P12552, DOI 10.1128/JVI.01657-12; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; KAPPES JC, 1993, VIROLOGY, V193, P222, DOI 10.1006/viro.1993.1118; Kim B, 2012, J BIOL CHEM, V287, P21570, DOI 10.1074/jbc.C112.374843; Laguette N, 2012, CELL HOST MICROBE, V11, P205, DOI 10.1016/j.chom.2012.01.007; Laguette N, 2012, TRENDS IMMUNOL, V33, P26, DOI 10.1016/j.it.2011.11.002; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Mangeot PE, 2002, MOL THER, V5, P283, DOI 10.1006/mthe.2002.0541; MARCON L, 1991, J VIROL, V65, P3938, DOI 10.1128/JVI.65.7.3938-3942.1991; Patenaude AM, 2009, NAT STRUCT MOL BIOL, V16, P517, DOI 10.1038/nsmb.1598; PAXTON W, 1993, J VIROL, V67, P7229, DOI 10.1128/JVI.67.12.7229-7237.1993; Powell RD, 2011, J BIOL CHEM, V286, P43596, DOI 10.1074/jbc.C111.317628; Selig L, 1999, J VIROL, V73, P592, DOI 10.1128/JVI.73.1.592-600.1999; Sharova N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000057; Srivastava S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000059; St Gelais C, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-105; Wei W, 2012, CELL MICROBIOL, V14, P1745, DOI 10.1111/j.1462-5822.2012.01835.x; White TE, 2013, VIROLOGY, V436, P81, DOI 10.1016/j.virol.2012.10.029; WU XY, 1994, J VIROL, V68, P6161, DOI 10.1128/JVI.68.10.6161-6169.1994; Yan JP, 2013, J BIOL CHEM, V288, P10406, DOI 10.1074/jbc.M112.443796; Yan N, 2012, NAT MED, V18, P1611, DOI 10.1038/nm.2980; YU XF, 1988, NATURE, V335, P262, DOI 10.1038/335262a0; YU XF, 1991, J VIROL, V65, P5088, DOI 10.1128/JVI.65.9.5088-5091.1991; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zhang L, 2008, VIROLOGY, V370, P113, DOI 10.1016/j.virol.2007.08.027; Zhang WY, 2012, NATURE, V481, P376, DOI 10.1038/nature10718	49	22	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e66201	10.1371/journal.pone.0066201	http://dx.doi.org/10.1371/journal.pone.0066201			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874389	Green Published, gold, Green Submitted			2022-12-27	WOS:000322218800002
J	Bogdanov, E; Dominova, I; Shusharina, N; Botman, S; Kasymov, V; Patrushev, M				Bogdanov, Evgeny; Dominova, Irina; Shusharina, Natalia; Botman, Stepan; Kasymov, Vitaliy; Patrushev, Maksim			Silicon Dioxide Thin Film Mediated Single Cell Nucleic Acid Isolation	PLOS ONE			English	Article							EXTRACTION METHOD; DNA; ADSORPTION; PURIFICATION; BINDING	A limited amount of DNA extracted from single cells, and the development of single cell diagnostics make it necessary to create a new highly effective method for the single cells nucleic acids isolation. In this paper, we propose the DNA isolation method from biomaterials with limited DNA quantity in sample, and from samples with degradable DNA based on the use of solid-phase adsorbent silicon dioxide nanofilm deposited on the inner surface of PCR tube.	[Bogdanov, Evgeny; Dominova, Irina; Shusharina, Natalia; Botman, Stepan; Patrushev, Maksim] Immanuel Kant Baltic Fed Univ, Kaliningrad, Russia; [Kasymov, Vitaliy] UCL, London, England	Immanuel Kant Baltic Federal University; University of London; University College London	Bogdanov, E (corresponding author), Immanuel Kant Baltic Fed Univ, Kaliningrad, Russia.	eubogdanov@gmail.com	Botman, Stepan/CAF-3206-2022; Shusharina, Natalia/A-6801-2014; Dominova, Irina N/O-2540-2013; Botman, Stepan/A-6852-2014	Botman, Stepan/0000-0002-0141-8877; Dominova, Irina N/0000-0001-5570-058X; Botman, Stepan/0000-0002-0141-8877; Natalia, Shusharina/0000-0002-8848-6134; Bogdanov, Evgeny/0000-0001-6087-2722	Ministry of Education and Science of the Russian Federation [16.552.12.2006, 14.512.11.0036, 14.132.21.1771]; Russian Federation	Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); Russian Federation(Russian Federation)	This work was supported by The Ministry of Education and Science of the Russian Federation (grants: 16.552.12.2006, 14.512.11.0036 and 14.132.21.1771); the President of Russian Federation Scholarship for Young Researchers and Graduate Students (to E. B. and M. P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beld M, 1996, NUCLEIC ACIDS RES, V24, P2618, DOI 10.1093/nar/24.13.2618; Benitez JJ, 2012, LAB CHIP, V12, P4848, DOI 10.1039/c2lc40955k; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Cai P, 2008, COLLOID SURFACE B, V62, P299, DOI 10.1016/j.colsurfb.2007.10.016; CHOI JK, 2013, PLOS ONE, V8, DOI DOI 10.1371/J0URNAL.P0NE.0056158; FRASER GV, 1973, SPECTROCHIM ACTA A, VA 29, P1525, DOI 10.1016/0584-8539(73)80216-8; GOIKHMAN A, 2011, NOVEL MAT COATS NANO, V674, P195; Gribanov OG, 1997, BIOORG KHIM+, V23, P763; Hamdi M, 2003, SURF COAT TECH, V163, P362, DOI 10.1016/S0257-8972(02)00625-4; Luo ZS, 2000, SURF COAT TECH, V131, P192, DOI 10.1016/S0257-8972(00)00824-0; MARKO MA, 1982, ANAL BIOCHEM, V121, P382, DOI 10.1016/0003-2697(82)90497-3; Melzak KA, 1996, J COLLOID INTERF SCI, V181, P635, DOI 10.1006/jcis.1996.0421; Ohtsu N, 2006, SURF COAT TECH, V200, P5455, DOI 10.1016/j.surfcoat.2005.07.003; Ostroumov S.A., 2006, BIOL EFFECTS SURFACT; Parida SK, 2006, ADV COLLOID INTERFAC, V121, P77, DOI 10.1016/j.cis.2006.05.028; Poeckh T, 2008, ANAL BIOCHEM, V373, P253, DOI 10.1016/j.ab.2007.10.026; QUINN P, 1982, J REPROD FERTIL, V66, P161; Suckow MA, 2006, AM COLL LAB, P1; Tan SC, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/574398; THORNHILL A, 2007, SINGLE CELL DIAGNOST; Tian HJ, 2000, ANAL BIOCHEM, V283, P175, DOI 10.1006/abio.2000.4577; Tsuchiya S, 2005, J ASSIST REPROD GEN, V22, P407, DOI 10.1007/s10815-005-7482-x; Wang CX, 2001, NUCL INSTRUM METH B, V179, P364, DOI 10.1016/S0168-583X(01)00585-7; Wang XH, 2004, SURF COAT TECH, V185, P12, DOI 10.1016/j.surfcoat.2003.12.002; Wolfe KA, 2002, ELECTROPHORESIS, V23, P727, DOI 10.1002/1522-2683(200203)23:5<727::AID-ELPS727>3.0.CO;2-O	25	2	3	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68280	10.1371/journal.pone.0068280	http://dx.doi.org/10.1371/journal.pone.0068280			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874571	gold, Green Published, Green Submitted			2022-12-27	WOS:000321765300040
J	Lee, SS; Tsai, CH; Yu, CC; Chang, YC				Lee, Shiuan-Shinn; Tsai, Chung-Hung; Yu, Cheng-Chia; Chang, Yu-Chao			Elevated Snail Expression Mediates Tumor Progression in Areca Quid Chewing-Associated Oral Squamous Cell Carcinoma via Reactive Oxygen Species	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; E-CADHERIN; OXIDATIVE STRESS; UP-REGULATION; CANCER; PHENOTYPE; ARECOLINE; REPRESSOR; SURVIVAL; KINASE	Background: Snail is an important transcription factor implicated in several tumor progression and can be induced by reactive oxygen species (ROS). Areca quid chewing is a major risk factor of oral squamous cell carcinoma (OSCC). Therefore, we hypothesize that the major areca nut alkaloid arecoline may induce Snail via ROS and involve in the pathogenesis of areca quid chewing-associated OSCC. Methodology/Principal Finding: Thirty-six OSCC and ten normal oral epithelium specimens were examined by immunohistochemistry and analyzed by the clinico-pathological profiles. Cytotoxicity, 2',7'-dichlorofluorescein diacetate assay, and western blot were used to investigate the effects of arecoline in human oral keratinocytes (HOKs) and oral epithelial cell line OECM-1 cells. In addition, antioxidants N-acetyl-L-cysteine (NAC), curcumin, and epigallocatechin-3 gallate (EGCG) were added to find the possible regulatory mechanisms. Initially, Snail expression was significantly higher in OSCC specimens (p < 0.05). Elevated Snail expression was associated with lymph node metastasis (p = 0.031) and poor differentiation (p = 0.017). Arecoline enhanced the generation of intracellular ROS at the concentration higher than 40 mu g/ml (p < 0.05). Arecoline was also found to induced Snail expression in a dose- and time-dependent manner (p < 0.05). Treatment with NAC, curcumin, and EGCG markedly inhibited arecoline induced Snail expression (p < 0.05). Conclusion/Significance:: Our results suggest that Snail overexpression in areca quid chewing-associated OSCC is associated with tumors differentiation and lymph node metastasis. Arecoline-upregulated Snail expression may be mediated by ROS generation. In addition, arecoline induced Snail expression was downregulated by NAC, curcumin, and EGCG.	[Lee, Shiuan-Shinn] Chung Shan Med Univ, Sch Publ Hlth, Taichung, Taiwan; [Tsai, Chung-Hung] Chung Shan Med Univ Hosp, Dept Pathol, Taichung, Taiwan; [Yu, Cheng-Chia] Chung Shan Med Univ, Sch Dent, Taichung, Taiwan; [Chang, Yu-Chao] Chung Shan Med Univ Hosp, Dept Dent, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Chang, YC (corresponding author), Chung Shan Med Univ Hosp, Dept Dent, Taichung, Taiwan.	cyc@csmu.edu.tw	Liaw, Yung Po/AAV-6746-2021		Taiwan National Science Council [NSC100-2632-B-040-001-MY3]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by research grants from a Taiwan National Science Council Research Grant (NSC100-2632-B-040-001-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosone CB, 2000, ANTIOXID REDOX SIGN, V2, P903, DOI 10.1089/ars.2000.2.4-903; ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Blechschmidt K, 2008, BRIT J CANCER, V98, P489, DOI 10.1038/sj.bjc.6604115; Chang Y C, 2001, Clin Oral Investig, V5, P51, DOI 10.1007/s007840000085; Chang YC, 1998, J ORAL PATHOL MED, V27, P68; Chen CL, 2002, J TOXICOL ENV HEAL A, V65, P327, DOI 10.1080/15287390252800909; Department of Health Executive Yuan Taiwan ROC, 2012, CANC REG ANN REP TAI; Fan F, 2012, CANCER MED-US, V1, P5, DOI 10.1002/cam4.4; Franz M, 2009, HISTOCHEM CELL BIOL, V131, P651, DOI 10.1007/s00418-009-0559-3; Gotzmann J, 2004, MUTAT RES-REV MUTAT, V566, P9, DOI 10.1016/S1383-5742(03)00033-4; Halliwell B, 2004, BRIT J PHARMACOL, V142, P231, DOI 10.1038/sj.bjp.0705776; He HY, 2012, CANCER SCI, V103, P1296, DOI 10.1111/j.1349-7006.2012.02295.x; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Klaunig JE, 1998, ENVIRON HEALTH PERSP, V106, P289, DOI 10.2307/3433929; KO YC, 1995, J ORAL PATHOL MED, V24, P450, DOI 10.1111/j.1600-0714.1995.tb01132.x; Korde SD, 2011, ONCOLOGY-BASEL, V80, P382, DOI 10.1159/000329811; Lee SS, 2012, ORAL DIS, V18, P713, DOI 10.1111/j.1601-0825.2012.01933.x; Lee SS, 2008, ORAL ONCOL, V44, P884, DOI 10.1016/j.oraloncology.2007.11.004; Lee SS, 2008, ORAL ONCOL, V44, P180, DOI 10.1016/j.oraloncology.2007.01.019; Lee SS, 2012, J ORAL PATHO MED, DOI [10.1111/jop. 12037, DOI 10.1111/J0P.12037]; Lee SS, 2012, J PERIODONTOL, DOI [10.1902/jop.2012.120554, DOI 10.1902/J0P.2012.120554]; Lin JK, 1999, BIOCHEM PHARMACOL, V58, P911, DOI 10.1016/S0006-2952(99)00112-4; Lundgren K, 2009, BRIT J CANCER, V101, P1769, DOI 10.1038/sj.bjc.6605369; Mendelsohn AH, 2012, AM J OTOLARYNG, V33, P6, DOI 10.1016/j.amjoto.2010.11.018; NAIR UJ, 1992, ENVIRON HEALTH PERSP, V98, P203, DOI 10.2307/3431271; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sreejayan, 1997, J PHARM PHARMACOL, V49, P105, DOI 10.1111/j.2042-7158.1997.tb06761.x; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Wu CL, 2012, AUST DENT J, V57, P207, DOI 10.1111/j.1834-7819.2012.01686.x; Wu WS, 2006, CANCER METAST REV, V25, P695, DOI 10.1007/s10555-006-9037-8; Yen CY, 2011, ORAL ONCOL, V47, P345, DOI 10.1016/j.oraloncology.2011.02.014; Zhao D, 2012, CLIN EXP METASTAS, V29, P957, DOI 10.1007/s10585-012-9485-1; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	35	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e67985	10.1371/journal.pone.0067985	http://dx.doi.org/10.1371/journal.pone.0067985			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874481	gold, Green Published, Green Submitted			2022-12-27	WOS:000321765300021
J	Hanlon, CA; Canterberry, M; Taylor, JJ; DeVries, W; Li, XB; Brown, TR; George, MS				Hanlon, Colleen A.; Canterberry, Melanie; Taylor, Joseph J.; DeVries, William; Li, Xingbao; Brown, Truman R.; George, Mark S.			Probing the Frontostriatal Loops Involved in Executive and Limbic Processing via Interleaved TMS and Functional MRI at Two Prefrontal Locations: A Pilot Study	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; BOLD-FMRI; CORTEX; ACTIVATION; SYSTEM; NETWORKS; COIL; ORGANIZATION; MECHANISMS; RESPONSES	Background: The prefrontal cortex (PFC) is an anatomically and functionally heterogeneous area which influences cognitive and limbic processing through connectivity to subcortical targets. As proposed by Alexander et al. (1986) the lateral and medial aspects of the PFC project to distinct areas of the striatum in parallel but functionally distinct circuits. The purpose of this preliminary study was to determine if we could differentially and consistently activate these lateral and medial cortical-subcortical circuits involved in executive and limbic processing though interleaved transcranial magnetic stimulation (TMS) in the MR environment. Methods: Seventeen healthy individuals received interleaved TMS-BOLD imaging with the coil positioned over the dorsolateral (EEG: F3) and ventromedial PFC (EEG: FP1). BOLD signal change was calculated in the areas directly stimulated by the coil and in subcortical regions with afferent and efferent connectivity to the TMS target areas. Additionally, five individuals were tested on two occasions to determine test-retest reliability. Results: Region of interest analysis revealed that TMS at both prefrontal sites led to significant BOLD signal increases in the cortex under the coil, in the striatum, and the thalamus, but not in the visual cortex (negative control region). There was a significantly larger BOLD signal change in the caudate following medial PFC TMS, relative to lateral TMS. The hippocampus in contrast was significantly more activated by lateral TMS. Post-hoc voxel-based analysis revealed that within the caudate the location of peak activity was in the ventral caudate following medial TMS and the dorsal caudate following lateral TMS. Test-retest reliability data revealed consistent BOLD responses to TMS within each individual but a large variation between individuals. Conclusion: These data demonstrate that, through an optimized TMS/BOLD sequence over two unique prefrontal targets, it is possible to selectively interrogate the patency of these established cortical-subcortical networks in healthy individuals, and potentially patient populations.	[Hanlon, Colleen A.; Canterberry, Melanie; Taylor, Joseph J.; DeVries, William; Li, Xingbao; George, Mark S.] Med Univ S Carolina, Dept Psychiat, Charleston, SC 29425 USA; [Hanlon, Colleen A.; Brown, Truman R.; George, Mark S.] Med Univ S Carolina, Ctr Biomed Imaging, Charleston, SC 29425 USA; [Brown, Truman R.] Med Univ S Carolina, Dept Radiol, Charleston, SC 29425 USA; [George, Mark S.] Ralph H Johnson Dept Vet Affairs Med Ctr, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Hanlon, CA (corresponding author), Med Univ S Carolina, Dept Psychiat, Charleston, SC 29425 USA.	hanlon@musc.edu	Hanlon, Colleen/AAV-4334-2020; Taylor, Joseph J/K-8166-2015; Hanlon, Colleen A/K-8405-2014	Hanlon, Colleen/0000-0002-3151-0279; Taylor, Joseph J/0000-0001-7392-7956; Hanlon, Colleen A/0000-0002-3151-0279; Taylor, Joseph/0000-0002-9185-0427; George, Mark/0000-0003-1767-1815	National Institutes of Health [K01DA027756, 1F30DA033748-01, T32DA007288]; NATIONAL CANCER INSTITUTE [T32CA009138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007288, F30DA033748, K01DA027756] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institutes of Health (grant numbers, K01DA027756 (CAH), 1F30DA033748-01 (JJT), T32DA007288). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock RA, 2006, NEURON, V50, P507, DOI 10.1016/j.neuron.2006.03.036; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Barbas H, 1995, HIPPOCAMPUS, V5, P511, DOI 10.1002/hipo.450050604; Baudewig J, 2001, NEUROREPORT, V12, P3543, DOI 10.1097/00001756-200111160-00034; Beam W, 2009, BRAIN STIMUL, V2, P50, DOI 10.1016/j.brs.2008.09.006; Berns GS, 2004, TRENDS COGN SCI, V8, P193, DOI 10.1016/j.tics.2004.03.007; Bestmann S, 2005, NEUROIMAGE, V28, P22, DOI 10.1016/j.neuroimage.2005.05.027; Bestmann S, 2003, J MAGN RESON IMAGING, V17, P309, DOI 10.1002/jmri.10260; Bestmann S, 2004, EUR J NEUROSCI, V19, P1950, DOI 10.1111/j.1460-9568.2004.03277.x; Bjork JM, 2012, BIOL PSYCHOL, V89, P408, DOI 10.1016/j.biopsycho.2011.12.003; Blumenfeld RS, 2006, J NEUROSCI, V26, P916, DOI 10.1523/JNEUROSCI.2353-05.2006; Bohning DE, 1999, BIOL PSYCHIAT, V45, P385, DOI 10.1016/S0006-3223(98)00368-0; Bohning DE, 2003, CLIN NEUROPHYSIOL, V114, P2210, DOI 10.1016/S1388-2457(03)00232-3; Bohning DE, 1998, INVEST RADIOL, V33, P336, DOI 10.1097/00004424-199806000-00004; Bohning DE, 2000, J MAGN RESON IMAGING, V11, P569, DOI 10.1002/1522-2586(200006)11:6<569::AID-JMRI1>3.0.CO;2-3; Bohning DE, 2000, INVEST RADIOL, V35, P676, DOI 10.1097/00004424-200011000-00005; Bozkurt A, 2002, NEUROCOMPUTING, V44, P753, DOI 10.1016/S0925-2312(02)00468-X; Buckholtz JW, 2010, NAT NEUROSCI, V13, P419, DOI 10.1038/nn.2510; Cabeza R, 2002, NEUROIMAGE, V16, P317, DOI 10.1006/nimg.2002.1063; Dolan RJ, 1997, NATURE, V388, P582, DOI 10.1038/41561; Druzgal TJ, 2001, NEURON, V32, P947, DOI 10.1016/S0896-6273(01)00519-0; Fladung AK, 2010, AM J PSYCHIAT, V167, P206, DOI 10.1176/appi.ajp.2009.09010071; Franklin TR, 2007, NEUROPSYCHOPHARMACOL, V32, P2301, DOI 10.1038/sj.npp.1301371; George MS, 2003, CNS SPECTRUMS, V8, P496, DOI 10.1017/S1092852900018976; GOLDMANRAKIC PS, 1984, NEUROSCIENCE, V12, P719, DOI 10.1016/0306-4522(84)90166-0; GOLDMANRAKIC PS, 1988, ANNU REV NEUROSCI, V11, P137, DOI 10.1146/annurev.neuro.11.1.137; Grusser SM, 2004, PSYCHOPHARMACOLOGY, V175, P296, DOI 10.1007/s00213-004-1828-4; HABER SN, 1995, J NEUROSCI, V15, P4851; Hanlon CA, 2011, DRUG ALCOHOL DEPEN, V115, P240, DOI 10.1016/j.drugalcdep.2010.11.008; Hanlon CA, 2010, PSYCHIAT RES-NEUROIM, V181, P15, DOI 10.1016/j.pscychresns.2009.07.009; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Koechlin E, 2000, P NATL ACAD SCI USA, V97, P7651, DOI 10.1073/pnas.130177397; Kufahl PR, 2005, NEUROIMAGE, V28, P904, DOI 10.1016/j.neuroimage.2005.06.039; Li X, 2010, PSYCHIAT RES, V194, P141; Li XB, 2004, NEUROPSYCHOPHARMACOL, V29, P1395, DOI 10.1038/sj.npp.1300452; McConnell KA, 2001, BIOL PSYCHIAT, V49, P454, DOI 10.1016/S0006-3223(00)01039-8; Mobbs D, 2003, NEURON, V40, P1041, DOI 10.1016/S0896-6273(03)00751-7; Morris R, 1999, J COMP NEUROL, V407, P183, DOI 10.1002/(SICI)1096-9861(19990503)407:2<183::AID-CNE3>3.0.CO;2-N; MUFSON EJ, 1984, J COMP NEUROL, V225, P31, DOI 10.1002/cne.902250105; Nahas Z, 2001, BIOL PSYCHIAT, V50, P712, DOI 10.1016/S0006-3223(01)01199-4; Ochsner KN, 2009, J COGNITIVE NEUROSCI, V21, P1841, DOI 10.1162/jocn.2009.21129; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Price JL, 1999, ANN NY ACAD SCI, V877, P383, DOI 10.1111/j.1749-6632.1999.tb09278.x; Rusjan PM, 2010, HUM BRAIN MAPP, V31, P1643, DOI 10.1002/hbm.20964; Shastri A, 1999, EEG CL N SU, P55; Shitara H, 2011, NEUROIMAGE, V56, P1469, DOI 10.1016/j.neuroimage.2011.03.011; Strafella AP, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-15-j0003.2001; Strafella AP, 2005, EUR J NEUROSCI, V22, P2946, DOI 10.1111/j.1460-9568.2005.04476.x; Zanolie K, 2008, NEUROPSYCHOLOGIA, V46, P117, DOI 10.1016/j.neuropsychologia.2007.08.009	49	40	42	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e67917	10.1371/journal.pone.0067917	http://dx.doi.org/10.1371/journal.pone.0067917			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874466	Green Submitted, Green Published, gold			2022-12-27	WOS:000321736900036
J	Kuribayashi, S; Sakoda, Y; Kawasaki, T; Tanaka, T; Yamamoto, N; Okamatsu, M; Isoda, N; Tsuda, Y; Sunden, Y; Umemura, T; Nakajima, N; Hasegawa, H; Kida, H				Kuribayashi, Saya; Sakoda, Yoshihiro; Kawasaki, Takeshi; Tanaka, Tomohisa; Yamamoto, Naoki; Okamatsu, Masatoshi; Isoda, Norikazu; Tsuda, Yoshimi; Sunden, Yuji; Umemura, Takashi; Nakajima, Noriko; Hasegawa, Hideki; Kida, Hiroshi			Excessive Cytokine Response to Rapid Proliferation of Highly Pathogenic Avian Influenza Viruses Leads to Fatal Systemic Capillary Leakage in Chickens	PLOS ONE			English	Article							ANTI-INTERLEUKIN-6 RECEPTOR ANTIBODY; A VIRUS; INFLAMMATORY CYTOKINES; HEMAGGLUTININ SUBTYPE; INTERFERON-GAMMA; IL-6 AMPLIFIER; H5N1 VIRUS; MICE; INFECTION; DISEASE	Highly pathogenic avian influenza viruses (HPAIVs) cause lethal infection in chickens. Severe cases of HPAIV infections have been also reported in mammals, including humans. In both mammals and birds, the relationship between host cytokine response to the infection with HPAIVs and lethal outcome has not been well understood. In the present study, the highly pathogenic avian influenza viruses A/turkey/Italy/4580/1999 (H7N1) (Ty/Italy) and A/chicken/Netherlands/2586/2003 (H7N7) (Ck/NL) and the low pathogenic avian influenza virus (LPAIV) A/chicken/Ibaraki/1/2005 (H5N2) (Ck/Ibaraki) were intranasally inoculated into chickens. Ty/Italy replicated more extensively than Ck/NL in systemic tissues of the chickens, especially in the brain, and induced excessive mRNA expression of inflammatory and antiviral cytokines (IFN-gamma, IL-1 beta, IL-6, and IFN-alpha) in proportion to its proliferation. Using in situ hybridization, IL-6 mRNA was detected mainly in microglial nodules in the brain of the chickens infected with Ty/Italy. Capillary leakage assessed by Evans blue staining was observed in multiple organs, especially in the brains of the chickens infected with Ty/Italy, and was not observed in those infected with Ck/NL. In contrast, LPAIV caused only local infection in the chickens, with neither apparent cytokine expression nor capillary leakage in any tissue of the chickens. The present results indicate that an excessive cytokine response is induced by rapid and extensive proliferation of HPAIV and causes fatal multiple organ failure in chickens.	[Kuribayashi, Saya; Sakoda, Yoshihiro; Yamamoto, Naoki; Okamatsu, Masatoshi; Isoda, Norikazu; Tsuda, Yoshimi; Kida, Hiroshi] Hokkaido Univ, Grad Sch Vet Med, Dept Dis Control, Microbiol Lab, Sapporo, Hokkaido, Japan; [Kawasaki, Takeshi] Res Off Hlth Human & Birds, Abashiri, Japan; [Tanaka, Tomohisa; Sunden, Yuji; Umemura, Takashi] Hokkaido Univ, Grad Sch Vet Med, Dept Vet Clin Sci, Lab Comparat Pathol, Sapporo, Hokkaido, Japan; [Nakajima, Noriko; Hasegawa, Hideki] Natl Inst Infect Dis, Dept Pathol, Tokyo, Japan; [Kida, Hiroshi] Hokkaido Univ, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; National Institute of Infectious Diseases (NIID); Hokkaido University	Kida, H (corresponding author), Hokkaido Univ, Grad Sch Vet Med, Dept Dis Control, Microbiol Lab, Sapporo, Hokkaido, Japan.	kida@vetmed.hokudai.ac.jp	Hasegawa, Hideki/C-7978-2014; Isoda, Norikazu/C-7859-2012	Kawasaki, Takeshi/0000-0002-2173-1801	Programs of Founding Research Centers for Emerging and Re-Emerging Infectious Diseases; Global Centers of Excellence Program by the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Program of Strategic Fund for Promotion of Science and Technology of the Japan Science and Technology Agency	Programs of Founding Research Centers for Emerging and Re-Emerging Infectious Diseases; Global Centers of Excellence Program by the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Program of Strategic Fund for Promotion of Science and Technology of the Japan Science and Technology Agency	This work was supported by the Programs of Founding Research Centers for Emerging and Re-Emerging Infectious Diseases, and Global Centers of Excellence Program by the Ministry of Education, Culture, Sports, Science, and Technology, Japan, and partially by the Program of Strategic Fund for Promotion of Science and Technology of the Japan Science and Technology Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnard DL, 2009, ANTIVIR RES, V82, pA110, DOI 10.1016/j.antiviral.2008.12.014; Baskin CR, 2009, P NATL ACAD SCI USA, V106, P3455, DOI 10.1073/pnas.0813234106; Boe A, 1999, CYTOKINE, V11, P1057, DOI 10.1006/cyto.1999.0502; CAMPBELL IL, 1991, J CLIN INVEST, V87, P739, DOI 10.1172/JCI115055; Capua I, 2002, ACTA TROP, V83, P7, DOI 10.1016/S0001-706X(02)00057-8; Curnow SJ, 2006, CURR OPIN OPHTHALMOL, V17, P532, DOI 10.1097/ICU.0b013e32801094b5; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Grignani G, 2000, HAEMATOLOGICA, V85, P967; Harkness KA, 2000, BRAIN, V123, P698, DOI 10.1093/brain/123.4.698; Hasegawa S, 2011, CYTOKINE, V54, P167, DOI 10.1016/j.cyto.2011.01.006; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; HINSHAW VS, 1982, J VIROL, V42, P865, DOI 10.1128/JVI.42.3.865-872.1982; HORIMOTO T, 1994, J VIROL, V68, P6074, DOI 10.1128/JVI.68.9.6074-6078.1994; JEURISSEN SHM, 1991, RES IMMUNOL, V142, P352, DOI 10.1016/0923-2494(91)90090-6; Kano R, 2009, MICROBIOL IMMUNOL, V53, P224, DOI 10.1111/j.1348-0421.2009.00109.x; Karpala AJ, 2011, J INTERF CYTOK RES, V31, P393, DOI 10.1089/jir.2010.0069; Kawada J, 2003, J INFECT DIS, V188, P690, DOI 10.1086/377101; Koopmans M, 2004, LANCET, V363, P587, DOI 10.1016/S0140-6736(04)15589-X; Kronfol Z, 2000, AM J PSYCHIAT, V157, P683, DOI 10.1176/appi.ajp.157.5.683; Le Goffic R, 2006, PLOS PATHOG, V2, P526, DOI 10.1371/journal.ppat.0020053; Lee J, 2012, J IMMUNOL, V189, P1928, DOI 10.4049/jimmunol.1103613; Li YP, 2007, ARCH VIROL, V152, P463, DOI 10.1007/s00705-006-0878-9; Liang BL, 2006, IMMUNOLOGY, V119, P296, DOI 10.1111/j.1365-2567.2006.02433.x; Liang BL, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-10; Magor KE, 2013, DEV COMP IMMUNOL, V03; Maines TR, 2008, IMMUNOL REV, V225, P68, DOI 10.1111/j.1600-065X.2008.00690.x; Margetic S, 2012, BIOCHEM MEDICA, V22, P49; Mihara M, 2012, CLIN SCI, V122, P143, DOI 10.1042/CS20110340; Moulin HR, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-6; Murakami M, 2012, INT J BIOL SCI, V8, P1267, DOI 10.7150/ijbs.4828; Muramoto Y, 2006, MICROBIOL IMMUNOL, V50, P73, DOI 10.1111/j.1348-0421.2006.tb03764.x; Nakajima N, 2003, AM J PATHOL, V162, P381, DOI 10.1016/S0002-9440(10)63833-3; Nakatani H, 2005, AVIAN DIS, V49, P436, DOI 10.1637/7304-110504R1.1; Nang NT, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-64; Nishimoto N, 2004, ARTHRITIS RHEUM-US, V50, P1761, DOI 10.1002/art.20303; Nishimoto N, 2005, BLOOD, V106, P2627, DOI 10.1182/blood-2004-12-4602; Okamatsu M, 2007, AVIAN DIS, V51, P474, DOI 10.1637/7573-033106R1.1; Okamatsu M, 2007, VET MICROBIOL, V124, P35, DOI 10.1016/j.vetmic.2007.04.025; Okuda Y, 1998, INT IMMUNOL, V10, P703, DOI 10.1093/intimm/10.5.703; Ousman SS, 2012, NAT NEUROSCI, V15, P1096, DOI 10.1038/nn.3161; Pan HY, 2011, CARDIOVASC RES, V89, P595, DOI 10.1093/cvr/cvq358; Paul MS, 2012, VACCINE, V30, P4524, DOI 10.1016/j.vaccine.2012.04.033; Penski N, 2011, J VIROL, V85, P7730, DOI 10.1128/JVI.00063-11; Perrone LA, 2010, J INFECT DIS, V202, P1161, DOI 10.1086/656365; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rohm C, 1996, VIROLOGY, V217, P508, DOI 10.1006/viro.1996.0145; Salomon R, 2007, P NATL ACAD SCI USA, V104, P12479, DOI 10.1073/pnas.0705289104; SEVER JL, 1962, J IMMUNOL, V88, P320; Sprague AH, 2009, BIOCHEM PHARMACOL, V78, P539, DOI 10.1016/j.bcp.2009.04.029; STIENEKEGROBER A, 1992, EMBO J, V11, P2407, DOI 10.1002/j.1460-2075.1992.tb05305.x; Suzuki K, 2009, J VIROL, V83, P7475, DOI 10.1128/JVI.01434-08; Swayne D.E., 2008, DIS POULTRY, P153; Swayne DE, 2007, AVIAN DIS, V51, P242, DOI 10.1637/7763-110706-REGR.1; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tan ACL, 2012, MOL PHARMACEUT, V9, P2710, DOI 10.1021/mp300257x; Tanaka T, 2010, J NEUROVIROL, V16, P125, DOI 10.3109/13550281003682521; Wang SY, 2010, J INFECT DIS, V202, P991, DOI 10.1086/656044; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; World Health Organization, 2002, WHO MAN AN INFL DIAG; Xu T, 2006, AM J RESP CRIT CARE, V174, P1011, DOI 10.1164/rccm.200511-1751OC; Zheng BJ, 2008, P NATL ACAD SCI USA, V105, P8091, DOI 10.1073/pnas.0711942105	62	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68375	10.1371/journal.pone.0068375	http://dx.doi.org/10.1371/journal.pone.0068375			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874602	Green Submitted, gold, Green Published			2022-12-27	WOS:000321736900083
J	Peng, W; Hua, RX; Jiang, R; Ren, C; Jia, YN; Li, J; Guo, WJ				Peng, Wei; Hua, Rui-Xi; Jiang, Rong; Ren, Chao; Jia, Yong-Nin; Li, Jin; Guo, Wei-Jian			Surgical Treatment for Patients with Krukenberg Tumor of Stomach Origin: Clinical Outcome and Prognostic Factors Analysis	PLOS ONE			English	Article							CANCER STEM-CELLS; OVARIAN METASTASES; GASTRIC-CANCER; CD133 EXPRESSION; PHASE-III; RESECTION; IDENTIFICATION; FLUOROURACIL; MANAGEMENT; MEL-18	Krukenberg tumor originated from stomach in female patients is common in clinical practice, but it is still uncertain whether surgical resection of ovarian metastases could improve the outcome. Some studies suggested that a certain group of patients could benefit from the resection of ovarian metastases. However, conclusions were different between studies and there was no data to illustrate if certain molecular markers were associated with patients' survival. In this study, we analyzed the effects of resection of ovarian metastases, and investigated prognostic factors in 133 patients with ovarian metastases originated from stomach. Furthermore, we examined the expression of some cancer stem cells (CSCs) markers or related molecules in 64 ovarian metastases specimens and analyzed the correlation between these molecules and patients' survival. We found that the median overall survival (mOS) of all 133 patients was 16 months, and "gastrectomy" and "without ascites" were two independent prognostic factors associated with longer survival. The mOS of the patients with gastrectomy was longer than that of patients had not undergone gastrectomy (19 vs. 9 months, p = 0.048). Patients without ascites survived longer than those with ascites (mOS: 21 vs. 13 months, p = 0.008). We also found that Sox2, CD44 or CD133 positive expression in ovarian metastases were risk factors correlated with poor survival, and Sox2 expression was an independent prognostic indicator. These results suggested that ovarian metastasectomy might help to prolong the survivor of some patients with Krukenberg tumor originated from stomach. Patients without ascites, and with resected or resectable primary gastric cancer lesion could get benefit from and be potential candidate for surgical treatment. The expression of Sox2 might serve as a prognostic indicator for predicting patients' survival and be helpful for selecting patients in future.	[Peng, Wei; Hua, Rui-Xi; Li, Jin; Guo, Wei-Jian] Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai 200433, Peoples R China; [Jiang, Rong] Fudan Univ, Shanghai Canc Ctr, Ovarian Canc Program, Dept Gynecol, Shanghai 200433, Peoples R China; [Ren, Chao] Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Jia, Yong-Nin] Peking Univ, Sch Oncol, Beijing Canc Hosp & Inst, Dept Gastrointestinal Surg, Beijing 100871, Peoples R China; [Hua, Rui-Xi] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Peng, Wei; Hua, Rui-Xi; Jiang, Rong; Li, Jin; Guo, Wei-Jian] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Sun Yat Sen University; Peking University; Sun Yat Sen University; Fudan University	Li, J (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai 200433, Peoples R China.	fudanlijin@163.com; guoweijian1@sohu.com		Hua, Rui-Xi/0000-0001-5319-656X				Ajani JA, 2010, J CLIN ONCOL, V28, P1547, DOI 10.1200/JCO.2009.25.4706; Al-Agha OM, 2006, ARCH PATHOL LAB MED, V130, P1725; Alvero AB, 2009, CELL CYCLE, V8, P158, DOI 10.4161/cc.8.1.7533; Ayhan A, 2005, GYNECOL ONCOL, V98, P235, DOI 10.1016/j.ygyno.2005.05.028; Bang YJ, 2010, LANCET, V376, P1302; Chen YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002637; Cheong JH, 2004, J SURG ONCOL, V87, P39, DOI 10.1002/jso.20072; CHIAVELLATI L, 1992, ITAL J GASTROENTEROL, V24, P412; Cinti C, 2008, VIRCHOWS ARCH, V453, P449, DOI 10.1007/s00428-008-0676-8; Cunningham D, 2008, NEW ENGL J MED, V358, P36, DOI 10.1056/NEJMoa073149; Curley MD, 2009, STEM CELLS, V27, P2875, DOI 10.1002/stem.236; EKBOM GA, 1980, SURGERY, V88, P476; Forzati F, 2012, CELL CYCLE, V11, P1888, DOI 10.4161/cc.20022; Ishigami S, 2010, ANTICANCER RES, V30, P2453; Jun SY, 2011, J GASTRIC CANCER, V11, P31, DOI 10.5230/jgc.2011.11.1.31; Kataoka Y, 2012, GASTRIC CANC; Kim HK, 2001, GYNECOL ONCOL, V82, P105, DOI 10.1006/gyno.2001.6210; Li J, 2007, DIFFERENTIATION, V75, P299, DOI 10.1111/j.1432-0436.2006.00143.x; Li WH, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-278; Louderbough JMV, 2011, MOL CANCER RES, V9, P1573, DOI 10.1158/1541-7786.MCR-11-0156; Lu YW, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-143; Lukacs RU, 2010, CELL STEM CELL, V7, P682, DOI 10.1016/j.stem.2010.11.013; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; McGill, 1998, Prim Care Update Ob Gyns, V5, P157, DOI 10.1016/S1068-607X(98)00047-X; McGill FM, 1999, GYNECOL OBSTET INVES, V48, P61, DOI 10.1159/000010136; Monk M, 2001, ONCOGENE, V20, P8085, DOI 10.1038/sj.onc.1205088; Pevny LH, 1997, CURR OPIN GENET DEV, V7, P338, DOI 10.1016/S0959-437X(97)80147-5; Sales KM, 2007, STEM CELL REV, V3, P249, DOI 10.1007/s12015-007-9002-0; Smith LM, 2008, BRIT J CANCER, V99, P100, DOI 10.1038/sj.bjc.6604437; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takaishi S, 2009, STEM CELLS, V27, P1006, DOI 10.1002/stem.30; Tazzari PL, 2007, LEUKEMIA, V21, P427, DOI 10.1038/sj.leu.2404523; Van Cutsem E, 2006, J CLIN ONCOL, V24, P4991, DOI 10.1200/JCO.2006.06.8429; Wang J, 2008, INT J GYNECOL CANCER, V18, P825, DOI 10.1111/j.1525-1438.2007.01078.x; Wang Q, 2009, ANTICANCER RES, V29, P1233; Xue ZF, 2012, J CELL BIOCHEM, V113, P302, DOI 10.1002/jcb.23356; Yonemura Yutaka, 2003, Surg Oncol Clin N Am, V12, P635, DOI 10.1016/S1055-3207(03)00035-8; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang XW, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-114; Zhang XW, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-40	40	25	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68227	10.1371/journal.pone.0068227	http://dx.doi.org/10.1371/journal.pone.0068227			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874550	Green Published, gold, Green Submitted			2022-12-27	WOS:000321736900071
J	Zhong, JH; Xiang, BD; Gong, WF; Ke, Y; Mo, QG; Ma, L; Liu, X; Li, LQ				Zhong, Jian-Hong; Xiang, Bang-De; Gong, Wen-Feng; Ke, Yang; Mo, Qin-Guo; Ma, Liang; Liu, Xing; Li, Le-Qun			Comparison of Long-Term Survival of Patients with BCLC Stage B Hepatocellular Carcinoma after Liver Resection or Transarterial Chemoembolization	PLOS ONE			English	Article							GAMMA-CARBOXY PROTHROMBIN; HEPATIC RESECTION; ALPHA-FETOPROTEIN; RADIOFREQUENCY ABLATION; SURGICAL RESECTION; PROGNOSTIC SYSTEM; MILAN CRITERIA; VEIN INVASION; HEPATECTOMY; OUTCOMES	Background and Aims: Treatment of patients with Barcelona Clinic Liver Cancer Stage B hepatocellular carcinoma (BCLC-B HCC) is controversial. This study compared the long-term survival of patients with BCLC-B HCC who received liver resection (LR) or transarterial chemoembolization (TACE). Methods: A total of 257 and 135 BCLC-B HCC patients undergoing LR and TACE, respectively, were retrospectively evaluated. Kaplan-Meier method was used for long-term survival analysis. Independent prognostic predictors were determined by the Cox proportional hazards model. Results: The hospital mortality rate was similar between groups (3.1% vs. 3.7%; P = 0.76). However, the LR group showed a significantly higher postoperative complication rate than the TACE group (28 vs. 18.5%; P = 0.04). At the same time, the LR group showed significantly higher overall survival rates (1 year, 84 vs. 69%; 3 years, 59 vs. 29%; 5 years, 37 vs. 14%; P, 0.001). Moreover, similar results were observed in the propensity score model. Three independent prognostic factors were associated with worse overall survival: serum AFP level (>= 400 ng/ml), serum ALT level, and TACE. Conclusions: LR appears to be as safe as TACE for patients with BCLC-B HCC, and it provides better long-term overall survival. However, prospective studies are needed to disclose if LR may be regarded as the preferred treatment for these patients as long as liver function is preserved.	[Zhong, Jian-Hong; Xiang, Bang-De; Gong, Wen-Feng; Ke, Yang; Mo, Qin-Guo; Ma, Liang; Liu, Xing; Li, Le-Qun] Guangxi Med Univ, Hepatobiliary Surg Dept, Tumor Hosp, Nanning, Peoples R China; [Liu, Xing] Peoples Hosp Liuzhou, Gastrointestinal Surg Dept, Liuzhou, Peoples R China	Guangxi Medical University	Zhong, JH (corresponding author), Guangxi Med Univ, Hepatobiliary Surg Dept, Tumor Hosp, Nanning, Peoples R China.	zhongjianhong66@163.com; xitongpingjia@163.com	Li, Li/AEM-3636-2022; li, li/HII-4157-2022; Zhong, Jian-Hong/D-6641-2018; LI, LI QING/GRR-8855-2022; LI, LI/GVS-5344-2022	Zhong, Jian-Hong/0000-0002-1494-6396; 	National Natural Science Foundation of China [81160262/H1602]; Guangxi Natural Science Foundation [2011GXNSFD018032]; Self-raised Scientific Research Fund of the Ministry of Health of Guangxi Province [Z2012345]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province); Self-raised Scientific Research Fund of the Ministry of Health of Guangxi Province	This work was supported by the grants from the National Natural Science Foundation of China (Project No: 81160262/H1602) and Guangxi Natural Science Foundation (Project No: 2011GXNSFD018032) to LQL, and the Self-raised Scientific Research Fund of the Ministry of Health of Guangxi Province (Project No: Z2012345) to JHZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla EK, 2008, ANN SURG ONCOL, V15, P979, DOI 10.1245/s10434-007-9727-7; Bertino G, 2011, MINERVA MED, V102, P363; Bosetti C, 2008, HEPATOLOGY, V48, P137, DOI 10.1002/hep.22312; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Chang WT, 2012, SURGERY, V152, P809, DOI 10.1016/j.surg.2012.03.024; Chen CF, 2011, GASTROENTEROLOGY, V141, P1240, DOI 10.1053/j.gastro.2011.06.036; Cheng Chih-Hsien, 2012, Chang Gung Med J, V35, P178; Chevret S, 1999, J HEPATOL, V31, P133, DOI 10.1016/S0168-8278(99)80173-1; Cho YB, 2007, WORLD J SURG, V31, P795, DOI 10.1007/s00268-006-0359-z; Cillo U, 2006, J HEPATOL, V44, P723, DOI 10.1016/j.jhep.2005.12.015; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Delis SG, 2010, SURG ONCOL, V19, P200, DOI 10.1016/j.suronc.2009.05.003; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Forner A, 2010, SEMIN LIVER DIS, V30, P61, DOI 10.1055/s-0030-1247133; Giannini EG, 2012, HEPATOLOGY, V56, P1371, DOI 10.1002/hep.25814; Ho MC, 2009, ANN SURG ONCOL, V16, P848, DOI 10.1245/s10434-008-0282-7; Hsieh CB, 2006, EJSO-EUR J SURG ONC, V32, P72, DOI 10.1016/j.ejso.2005.09.003; Hsu CY, 2012, ANN SURG ONCOL, V19, P842, DOI 10.1245/s10434-011-2060-1; Huang JF, 2012, J SURG ONCOL, V106, P959, DOI 10.1002/jso.23172; Hung HH, 2011, CLIN GASTROENTEROL H, V9, P79, DOI 10.1016/j.cgh.2010.08.018; Ishizawa T, 2008, GASTROENTEROLOGY, V134, P1908, DOI 10.1053/j.gastro.2008.02.091; Kaibori M, 2007, AM J SURG, V193, P431, DOI 10.1016/j.amjsurg.2006.06.041; Kao WY, 2012, CLIN RADIOL, V67, P429, DOI 10.1016/j.crad.2011.10.009; Kim Sung Eun, 2011, Korean J Hepatol, V17, P113, DOI 10.3350/kjhep.2011.17.2.113; Kuzuya T, 2011, ONCOLOGY-BASEL, V81, P251, DOI 10.1159/000334454; Le Treut YP, 2006, J GASTROINTEST SURG, V10, P855, DOI 10.1016/j.gassur.2005.12.011; Lencioni R, 2010, ONCOLOGIST, V15, P42, DOI 10.1634/theoncologist.2010-S4-42; Liau KH, 2005, CANCER-AM CANCER SOC, V104, P1948, DOI 10.1002/cncr.21415; Lin CT, 2010, WORLD J SURG, V34, P2155, DOI 10.1007/s00268-010-0598-x; Llovet JM, 2003, HEPATOLOGY, V37, P429, DOI 10.1053/jhep.2003.50047; Llovet JM, 2008, JNCI-J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Maeda T, 2008, HEPATO-GASTROENTEROL, V55, P1428; Manghisi G, 1998, HEPATOLOGY, V28, P751; Ng KK, 2005, ANN SURG ONCOL, V12, P364, DOI 10.1245/ASO.2005.06.004; OKUDA K, 1985, CANCER, V56, P918, DOI 10.1002/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E; Pawlik TM, 2005, SURGERY, V137, P403, DOI 10.1016/j.surg.2004.12.012; Pawlik TM, 2005, ARCH SURG-CHICAGO, V140, P450, DOI 10.1001/archsurg.140.5.450; Rahbari NN, 2011, ANN SURG, V253, P453, DOI 10.1097/SLA.0b013e31820d944f; Raoul JL, 2011, CANCER TREAT REV, V37, P212, DOI 10.1016/j.ctrv.2010.07.006; Rhim H, 2010, WORLD J GASTRO SURG, V2, P128, DOI 10.4240/wjgs.v2.i4.128; Ruzzenente A, 2009, J GASTROINTEST SURG, V13, P1313, DOI 10.1007/s11605-009-0903-x; Shah SA, 2007, SURGERY, V141, P330, DOI 10.1016/j.surg.2006.06.028; Shim JH, 2012, ANN SURG ONCOL, V19, P3687, DOI 10.1245/s10434-012-2416-1; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Toro A, 2012, SURG ONCOL, V21, pE23, DOI 10.1016/j.suronc.2011.10.005; Torzilli G, 2013, ANN SURG, V257, P929, DOI 10.1097/SLA.0b013e31828329b8; Torzilli G, 2008, ARCH SURG-CHICAGO, V143, P1082, DOI 10.1001/archsurg.143.11.1082; Tyson GL, 2011, CLIN GASTROENTEROL H, V9, P989, DOI 10.1016/j.cgh.2011.07.026; Vitale A, 2009, TRANSPL P, V41, P1260, DOI 10.1016/j.transproceed.2009.03.054; Wang JH, 2008, EUR J CANCER, V44, P1000, DOI 10.1016/j.ejca.2008.02.018; Yamashita YI, 2011, J SURG ONCOL, V104, P292, DOI 10.1002/jso.21931; Yang T, 2012, J CANCER RES CLIN, V138, P1121, DOI 10.1007/s00432-012-1188-0; Zhou XD, 2001, CANCER-AM CANCER SOC, V91, P1479, DOI 10.1002/1097-0142(20010415)91:8<1479::AID-CNCR1155>3.0.CO;2-0	54	117	127	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68193	10.1371/journal.pone.0068193	http://dx.doi.org/10.1371/journal.pone.0068193			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874536	Green Published, Green Submitted, gold			2022-12-27	WOS:000321736900065
J	Chen, YS; Li, XQ; Li, HR; Miao, Y; Lian, SQ; Lu, FF; Yu, XL; Lin, YH; Liu, T				Chen, Yu-Sheng; Li, Xiao-Qin; Li, Hong-Ru; Miao, Yan; Lian, Shuang-Qing; Lu, Feng-Feng; Yu, Xiao-Li; Lin, Yun-Hua; Liu, Ting			Risk Factors for Small Airway Obstruction among Chinese Island Residents: A Case-Control Study	PLOS ONE			English	Article							LUNG-FUNCTION; PULMONARY-DISEASE; ABDOMINAL OBESITY; COPD; INTERLEUKIN-6; PREVALENCE; EXERCISE; SMOKING; PROTEIN; BURDEN	Background: We investigated the prevalence of and risk factors for small airway obstruction (SAO) among Chinese island residents to establish means to prevent and treat SAO. Methods: From October 17, 2011 to November 1, 2011, a total of 2,873 residents aged >20 years who lived on the Huangqi Peninsula of Fujian were recruited by random cluster sampling. They were asked to complete a Burden of Obstructive Lung Disease (BOLD) questionnaire and underwent physical examinations and lung function evaluations. SAO was defined as a forced expiratory flow at 50% of vital capacity, Vmax50%, of less than 70% of predicted. Risk factors for SAO were assessed from among demographic and anthropometric variables, blood chemistry results, and questionnaire response items. Results: A total of 216 (7.52%) Chinese island residents were identified as having SAO (95 males; 121 females). Their survey and test results were compared with 432 age and sex-matched healthy controls (192 males; 240 females) for SAO risk factors. Among numerous factors investigated, only diabetes mellitus (p = 0.039), smoking index (SI, p<0.001 for SI>600), second hand smoke (p = 0.002), and lack of regular exercise (p<0.001) were significant risk factors for SAO. Conclusions: The risk factors for SAO among Chinese island residents appeared to be similar to those among people who live in high-density urban environments and impoverished rural areas. Public health policies and medical practices directed toward improving respiratory health for island residents should be comparable to those used for urban and rural dwellers.	[Chen, Yu-Sheng; Li, Xiao-Qin; Li, Hong-Ru; Lu, Feng-Feng; Yu, Xiao-Li; Lin, Yun-Hua; Liu, Ting] Fujian Med Univ, Fujian Prov Hosp, Prov Clin Coll, Dept Resp Med, Fuzhou, Fujian Province, Peoples R China; [Miao, Yan] Fujian Med Univ, Fujian Prov Hosp, Prov Clin Coll, Dept Gen Med,Med Clin, Fuzhou, Fujian Province, Peoples R China; [Lian, Shuang-Qing] Fujian Prov Hosp, Dept Infect Dis, Fuzhou, Fujian Province, Peoples R China	Fujian Medical University; Fujian Provincial Hospital; Fujian Medical University; Fujian Provincial Hospital; Fujian Provincial Hospital	Chen, YS (corresponding author), Fujian Med Univ, Fujian Prov Hosp, Prov Clin Coll, Dept Resp Med, Fuzhou, Fujian Province, Peoples R China.	slyyywb@126.com						ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Bar-Yishay E, 2003, CHEST, V123, P731, DOI 10.1378/chest.123.3.731; Beasley MB, 2010, ADV ANAT PATHOL, V17, P270, DOI 10.1097/PAP.0b013e3181e3bf97; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; Dekker MJ, 2007, METABOLISM, V56, P332, DOI 10.1016/j.metabol.2006.10.015; Eustace A, 2011, CHEST, V139, P1089, DOI 10.1378/chest.10-0779; Fang XC, 2011, CHEST, V139, P920, DOI 10.1378/chest.10-1393; Fischer CP, 2007, SCAND J MED SCI SPOR, V17, P580, DOI 10.1111/j.1600-0838.2006.00602.x; Flouris AD, 2009, AM J RESP CRIT CARE, V179, P1029, DOI 10.1164/rccm.200812-1920OC; Leone N, 2009, AM J RESP CRIT CARE, V179, P509, DOI 10.1164/rccm.200807-1195OC; Lin HH, 2008, LANCET, V372, P1473, DOI 10.1016/S0140-6736(08)61345-8; Liu SM, 2007, THORAX, V62, P889, DOI 10.1136/thx.2006.061457; Lou PA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-287; McClean KM, 2008, THORAX, V63, P649, DOI 10.1136/thx.2007.086801; National Institute for HealthandClinical Excellence, 2006, OB PREV ID ASS MAN O; Olson TP, 2007, INT J OBESITY, V31, P996, DOI 10.1038/sj.ijo.0803534; Pekkarinen E, 2012, CLIN PHYSIOL FUNCT I, V32, P83, DOI 10.1111/j.1475-097X.2011.01064.x; Ren CL, 2003, CHEST, V123, P667, DOI 10.1378/chest.123.3.667; Salome CM, 2010, J APPL PHYSIOL, V108, P206, DOI 10.1152/japplphysiol.00694.2009; SheRn M, 2009, ENVIRON HEALTH PERSP, V117, P261; Shirtcliffe P, 2012, INTERN MED J, V42, P83, DOI 10.1111/j.1445-5994.2010.02238.x; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; van den Berge M, 2011, CHEST, V139, P412, DOI 10.1378/chest.10-1210; Verbanck S, 2004, AM J RESP CRIT CARE, V170, P414, DOI 10.1164/rccm.200401-037OC; Vogiatzis I, 2007, THORAX, V62, P950, DOI 10.1136/thx.2006.069310; Wallace AM, 2012, TOXICOL SCI, V126, P589, DOI 10.1093/toxsci/kfr351; Wang Dan-yang, 2010, Zhonghua Yu Fang Yi Xue Za Zhi, V44, P706; Yin P, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-586	28	3	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e68556	10.1371/journal.pone.0068556	http://dx.doi.org/10.1371/journal.pone.0068556			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874670	Green Published, Green Submitted, gold			2022-12-27	WOS:000324146200019
J	Ueda, R; Sugiura, T; Kume, S; Ichikawa, A; Larsen, S; Miyoshi, H; Hiramatsu, H; Nagatsuka, Y; Arai, F; Suzuki, Y; Hirabayashi, Y; Fukuda, T; Honda, A				Ueda, Ryuta; Sugiura, Tadao; Kume, Shinichiro; Ichikawa, Akihiko; Larsen, Steven; Miyoshi, Hideaki; Hiramatsu, Hiroaki; Nagatsuka, Yasuko; Arai, Fumihito; Suzuki, Yasuo; Hirabayashi, Yoshio; Fukuda, Toshio; Honda, Ayae			A Novel Single Virus Infection System Reveals That Influenza Virus Preferentially Infects Cells in G1 Phase	PLOS ONE			English	Article							PROTEIN EBP1; RECEPTOR SPECIFICITY; BINDING-PROTEIN; A VIRUSES; HEMAGGLUTININ; TRANSCRIPTION; REPLICATION; DNA; ERBB-3; ENTRY	Background: Influenza virus attaches to sialic acid residues on the surface of host cells via the hemagglutinin (HA), a glycoprotein expressed on the viral envelope, and enters into the cytoplasm by receptor-mediated endocytosis. The viral genome is released and transported in to the nucleus, where transcription and replication take place. However, cellular factors affecting the influenza virus infection such as the cell cycle remain uncharacterized. Methods/Results: To resolve the influence of cell cycle on influenza virus infection, we performed a single-virus infection analysis using optical tweezers. Using this newly developed single-virus infection system, the fluorescence-labeled influenza virus was trapped on a microchip using a laser (1064 nm) at 0.6 W, transported, and released onto individual H292 human lung epithelial cells. Interestingly, the influenza virus attached selectively to cells in the G1-phase. To clarify the molecular differences between cells in G1- and S/G2/M-phase, we performed several physical and chemical assays. Results indicated that: 1) the membranes of cells in G1-phase contained greater amounts of sialic acids (glycoproteins) than the membranes of cells in S/G2/M-phase; 2) the membrane stiffness of cells in S/G2/M-phase is more rigid than those in G1-phase by measurement using optical tweezers; and 3) S/G2/M-phase cells contained higher content of Gb3, Gb4 and GlcCer than G1-phase cells by an assay for lipid composition. Conclusions: A novel single-virus infection system was developed to characterize the difference in influenza virus susceptibility between G1- and S/G2/M-phase cells. Differences in virus binding specificity were associated with alterations in the lipid composition, sialic acid content, and membrane stiffness. This single-virus infection system will be useful for studying the infection mechanisms of other viruses.	[Ueda, Ryuta; Kume, Shinichiro; Larsen, Steven; Honda, Ayae] Hosei Univ, Dept Frontier Biosci, Koganei, Tokyo 184, Japan; [Sugiura, Tadao; Miyoshi, Hideaki] Nara Inst Sci & Technol, Dept Informat Sci, Ikoma, Nara, Japan; [Ichikawa, Akihiko; Arai, Fumihito] Nagoya Univ, Dept Micronano Syst Engn, Nagoya, Aichi 4648601, Japan; [Hiramatsu, Hiroaki; Suzuki, Yasuo] Chubu Univ, Dept Biomed Sci, Kasugai, Aichi 487, Japan; [Nagatsuka, Yasuko; Hirabayashi, Yoshio] RIKEN, Lab Mol Membrane Neurosci, Wako, Saitama, Japan; [Fukuda, Toshio] Nagoya Univ, Dept Engn, Nagoya, Aichi 4648601, Japan	Hosei University; Nara Institute of Science & Technology; Nagoya University; Chubu University; RIKEN; Nagoya University	Honda, A (corresponding author), Hosei Univ, Dept Frontier Biosci, Koganei, Tokyo 184, Japan.	ayhonda@hosei.ac.jp		Yasuo, Suzuki/0000-0003-3518-5642; Hirabayashi, Yoshio/0000-0002-5774-7354	Ministry of Education, Culture, Sports, Science, and Technology of Japan [17076017]; CREST from Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CREST from Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST))	This work was supported by grant 17076017 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and CREST from Japan Science and Technology Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Bosanac L, 2008, NANO LETT, V8, P1486, DOI 10.1021/nl080490+; Case RB, 2004, SCIENCE, V305, P222, DOI 10.1126/science.1098225; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; Cureton DK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000394; Ewers H, 2012, METHOD ENZYMOL, V506, P63, DOI 10.1016/B978-0-12-391856-7.00028-7; Guo CT, 2007, GLYCOBIOLOGY, V17, P713, DOI 10.1093/glycob/cwm038; Chen HD, 2007, CELL MOL IMMUNOL, V4, P221; He YA, 2010, J VIROL, V84, P12832, DOI 10.1128/JVI.01216-10; Honda A, 2002, P NATL ACAD SCI USA, V99, P13166, DOI 10.1073/pnas.152456799; Honda A, 2008, J BIOTECHNOL, V133, P208, DOI 10.1016/j.jbiotec.2007.08.019; Honda A, 2007, GENES CELLS, V12, P133, DOI 10.1111/j.1365-2443.2007.01047.x; Ichikawa A, 2007, J ROBOT MECHATRON, V19, P569, DOI 10.20965/jrm.2007.p0569; Ingber DE, 1995, J BIOMECH, V28, P1471, DOI 10.1016/0021-9290(95)00095-X; Lakadamyali M, 2004, MICROBES INFECT, V6, P929, DOI 10.1016/j.micinf.2004.05.002; Matrosovich M, 2007, VIROLOGY, V361, P384, DOI 10.1016/j.virol.2006.11.030; Melikyan GB, 2000, MOL BIOL CELL, V11, P3765, DOI 10.1091/mbc.11.11.3765; Melikyan GB, 2010, P NATL ACAD SCI USA, V107, P17069, DOI 10.1073/pnas.1012748107; Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626; Miyoshi H, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.120223; Nieminen TA, 2007, METHOD CELL BIOL, V82, P207, DOI 10.1016/S0091-679X(06)82006-6; RADOMSKI N, 1995, EXP CELL RES, V220, P434, DOI 10.1006/excr.1995.1335; Rao P, 2003, EMBO J, V22, P1188, DOI 10.1093/emboj/cdg109; Rust MJ, 2004, NAT STRUCT MOL BIOL, V11, P567, DOI 10.1038/nsmb769; Suzuki N, 1996, BIOPHYS J, V70, P401, DOI 10.1016/S0006-3495(96)79583-8; Wang MD, 1997, BIOPHYS J, V72, P1335, DOI 10.1016/S0006-3495(97)78780-0; WARD CW, 1981, CURR TOP MICROBIOL, V94-5, P1; Xia XM, 2001, J CELL PHYSIOL, V187, P209, DOI 10.1002/jcp.1075; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; YONAHA M, 1995, NUCLEIC ACIDS RES, V23, P4050, DOI 10.1093/nar/23.20.4050; Yoo JY, 2000, BRIT J CANCER, V82, P683; [张镱锂 Zhang Yili], 2002, [地理研究, Geographical Research], V21, P1; Zhang YX, 2005, P NATL ACAD SCI USA, V102, P9890, DOI 10.1073/pnas.0503829102; Zhang YX, 2003, NUCLEIC ACIDS RES, V31, P2168, DOI 10.1093/nar/gkg318	34	11	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e67011	10.1371/journal.pone.0067011	http://dx.doi.org/10.1371/journal.pone.0067011			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874406	Green Submitted, gold, Green Published			2022-12-27	WOS:000324146200005
J	Vannini, C; Domingo, G; Onelli, E; Prinsi, B; Marsoni, M; Espen, L; Bracale, M				Vannini, Candida; Domingo, Guido; Onelli, Elisabetta; Prinsi, Bhakti; Marsoni, Milena; Espen, Luca; Bracale, Marcella			Morphological and Proteomic Responses of Eruca sativa Exposed to Silver Nanoparticles or Silver Nitrate	PLOS ONE			English	Article							TOXICITY; PHYTOTOXICITY; PROTEINS; GROWTH; PLANTS	Silver nanoparticles (AgNPs) are widely used in commercial products, and there are growing concerns about their impact on the environment. Information about the molecular interaction of AgNPs with plants is lacking. To increase our understanding of the mechanisms involved in plant responses to AgNPs and to differentiate between particle specific and ionic silver effects we determined the morphological and proteomic changes induced in Eruca sativa (commonly called rocket) in response to AgNPs or AgNO3. Seedlings were treated for 5 days with different concentrations of AgNPs or AgNO3. A similar increase in root elongation was observed when seedlings were exposed to 10 mg Ag L-1 of either PVP-AgNPs or AgNO3. At this concentration we performed electron microscopy investigations and 2-dimensional electrophoresis (2DE) proteomic profiling. The low level of overlap of differentially expressed proteins indicates that AgNPs and AgNO3 cause different plant responses. Both Ag treatments cause changes in proteins involved in the redox regulation and in the sulfur metabolism. These responses could play an important role to maintain cellular homeostasis. Only the AgNP exposure cause the alteration of some proteins related to the endoplasmic reticulum and vacuole indicating these two organelles as targets of the AgNPs action. These data add further evidences that the effects of AgNPs are not simply due to the release of Ag ions.	[Vannini, Candida; Domingo, Guido; Marsoni, Milena; Bracale, Marcella] Univ Insubria, Dipartimento Biotecnol & Sci Vita, Varese, Italy; [Onelli, Elisabetta] Univ Milan, Dipartimento Biosci, Milan, Italy; [Prinsi, Bhakti; Espen, Luca] Univ Milan, Dipartimento Sci Agr & Ambientali Prod, Milan, Italy	University of Insubria; University of Milan; University of Milan	Vannini, C (corresponding author), Univ Insubria, Dipartimento Biotecnol & Sci Vita, Varese, Italy.	candida.vannini@uninsubria.it	vannini, candida/B-3705-2010; Prinsi, Bhakti/L-3482-2017; Espen, Luca/Q-9653-2017; Domingo, Guido/AAR-6621-2021; ONELLI, ELISABETTA/B-1164-2017	vannini, candida/0000-0002-5196-6142; Prinsi, Bhakti/0000-0002-6641-1537; Espen, Luca/0000-0002-0231-8747; Domingo, Guido/0000-0002-2617-8873; ONELLI, ELISABETTA/0000-0003-3724-4116; Marsoni, Milena/0000-0003-0613-1581	Fondazione Banca del Monte di Lombardia	Fondazione Banca del Monte di Lombardia	This work was partially supported by the Fondazione Banca del Monte di Lombardia (grant 2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Asharani PV, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/25/255102; Barrena R, 2009, CHEMOSPHERE, V75, P850, DOI 10.1016/j.chemosphere.2009.01.078; Bouwmeester H, 2011, ACS NANO, V5, P4091, DOI 10.1021/nn2007145; Christen V, 2012, CHEMOSPHERE, V87, P423, DOI 10.1016/j.chemosphere.2011.12.046; Domingos RF, 2011, ENVIRON SCI TECHNOL, V45, P7664, DOI 10.1021/es201193s; Duressa Dechassa, 2011, Int J Plant Genomics, V2011, P282531, DOI 10.1155/2011/282531; El-Temsah YS, 2012, ENVIRON TOXICOL, V27, P42, DOI 10.1002/tox.20610; Fabrega J, 2011, ENVIRON INT, V37, P517, DOI 10.1016/j.envint.2010.10.012; Gao Y, 2011, J PROTEOMICS, V74, P2745, DOI 10.1016/j.jprot.2011.08.009; Gondikas AP, 2012, ENVIRON SCI TECHNOL, V46, P7037, DOI 10.1021/es3001757; Griffitt RJ, 2009, TOXICOL SCI, V107, P404, DOI 10.1093/toxsci/kfn256; Hossein Z, 2013, FRONT PLANT SCI, V3, P112; Jeon YM, 2011, J KOREAN SOC APPL BI, V54, P852, DOI 10.3839/jksabc.2011.130; Kim S, 2012, WATER AIR SOIL POLL, V223, P2799, DOI 10.1007/s11270-011-1067-3; Kissen R, 2009, J BIOL CHEM, V284, P12057, DOI 10.1074/jbc.M807500200; Lim D, 2012, ENVIRON TOXICOL CHEM, V31, P585, DOI 10.1002/etc.1706; Lin DH, 2007, ENVIRON POLLUT, V150, P243, DOI 10.1016/j.envpol.2007.01.016; Lok CN, 2006, J PROTEOME RES, V5, P916, DOI 10.1021/pr0504079; Ma XM, 2010, SCI TOTAL ENVIRON, V408, P3053, DOI 10.1016/j.scitotenv.2010.03.031; Mackey AJ, 2002, MOL CELL PROTEOMICS, V1, P139, DOI 10.1074/mcp.M100004-MCP200; Marsoni M, 2008, PLANT CELL REP, V27, P347, DOI 10.1007/s00299-007-0438-0; Marsoni M, 2010, PLANT CELL ENVIRON, V33, P1161, DOI 10.1111/j.1365-3040.2010.02137.x; Mithen RF, 2001, ADV BOT RES, V35, P213, DOI 10.1016/S0065-2296(01)35008-5; Mueller NC, 2008, ENVIRON SCI TECHNOL, V42, P4447, DOI 10.1021/es7029637; Navarro E, 2008, ENVIRON SCI TECHNOL, V42, P8959, DOI 10.1021/es801785m; Nikiforova V, 2003, PLANT J, V33, P633, DOI 10.1046/j.1365-313X.2003.01657.x; Oukarroum A, 2013, ENVIRON TOXICOL CHEM, V32, P902, DOI 10.1002/etc.2131; Poynton HC, 2012, ENVIRON SCI TECHNOL, V46, P6288, DOI 10.1021/es3001618; Rico CM, 2011, J AGR FOOD CHEM, V59, P3485, DOI 10.1021/jf104517j; Salama H. M. H., 2012, International Research Journal of Biotechnology, V3, P190; Sanjaya, 2008, PLANT CELL ENVIRON, V31, P1074, DOI 10.1111/j.1365-3040.2008.01819.x; Sharma P, 2012, APPL BIOCHEM BIOTECH, V167, P2225, DOI 10.1007/s12010-012-9759-8; Steinitz B, 2011, PLANT CELL TISS ORG, V107, P355, DOI 10.1007/s11240-011-9987-6; Watanabe N, 2011, PLANT J, V66, P969, DOI 10.1111/j.1365-313X.2011.04554.x; Xu XM, 2010, J CELL SCI, V123, P1644, DOI 10.1242/jcs.063222; Yang XF, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-1; Yin LY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047674; Yin LY, 2011, ENVIRON SCI TECHNOL, V45, P2360, DOI 10.1021/es103995x; Zhang R, 2012, INT J BIOCHEM CELL B, V44, P224, DOI 10.1016/j.biocel.2011.10.019	39	132	138	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e68752	10.1371/journal.pone.0068752	http://dx.doi.org/10.1371/journal.pone.0068752			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874747	Green Published, Green Submitted, gold			2022-12-27	WOS:000324146200029
J	Fagerberg, T; Zoete, V; Viatte, S; Baumgaertner, P; Alves, PM; Romero, P; Speiser, DE; Michielin, O				Fagerberg, Theres; Zoete, Vincent; Viatte, Sebastien; Baumgaertner, Petra; Alves, Pedro M.; Romero, Pedro; Speiser, Daniel E.; Michielin, Olivier			Prediction of Cross-Recognition of Peptide-HLA A2 by Melan-A-Specific Cytotoxic T Lymphocytes Using Three-Dimensional Quantitative Structure-Activity Relationships	PLOS ONE			English	Article							GENETIC NEURAL-NETWORKS; MOLECULAR SIMILARITY-MATRICES; MHC CLASS-I; LIGANDS; IDENTIFICATION; LIBRARIES; CTL; TCR; REACTIVITY; SELECTION	The cross-recognition of peptides by cytotoxic T lymphocytes is a key element in immunology and in particular in peptide based immunotherapy. Here we develop three-dimensional (3D) quantitative structure-activity relationships (QSARs) to predict cross-recognition by Melan-A-specific cytotoxic T lymphocytes of peptides bound to HLA A*0201 (hereafter referred to as HLA A2). First, we predict the structure of a set of self-and pathogen-derived peptides bound to HLA A2 using a previously developed ab initio structure prediction approach [Fagerberg et al., J. Mol. Biol., 521-46 (2006)]. Second, shape and electrostatic energy calculations are performed on a 3D grid to produce similarity matrices which are combined with a genetic neural network method [So et al., J. Med. Chem., 4347-59 (1997)] to generate 3D-QSAR models. The models are extensively validated using several different approaches. During the model generation, the leave-one-out cross-validated correlation coefficient (q(2)) is used as the fitness criterion and all obtained models are evaluated based on their q(2) values. Moreover, the best model obtained for a partitioned data set is evaluated by its correlation coefficient (r = 0.92 for the external test set). The physical relevance of all models is tested using a functional dependence analysis and the robustness of the models obtained for the entire data set is confirmed using y-randomization. Finally, the validated models are tested for their utility in the setting of rational peptide design: their ability to discriminate between peptides that only contain side chain substitutions in a single secondary anchor position is evaluated. In addition, the predicted cross-recognition of the mono-substituted peptides is confirmed experimentally in chromium-release assays. These results underline the utility of 3D-QSARs in peptide mimetic design and suggest that the properties of the unbound epitope are sufficient to capture most of the information to determine the cross-recognition.	[Fagerberg, Theres; Viatte, Sebastien; Baumgaertner, Petra; Alves, Pedro M.; Romero, Pedro; Speiser, Daniel E.; Michielin, Olivier] Univ Lausanne, Dept Oncol, Lausanne, Switzerland; [Fagerberg, Theres; Viatte, Sebastien; Baumgaertner, Petra; Alves, Pedro M.; Romero, Pedro; Speiser, Daniel E.; Michielin, Olivier] Univ Lausanne, Ludwig Ctr Canc Res, Lausanne, Switzerland; [Fagerberg, Theres; Zoete, Vincent; Michielin, Olivier] Swiss Inst Bioinformat, Lausanne, Switzerland; [Viatte, Sebastien; Alves, Pedro M.; Michielin, Olivier] Natl Ctr Competence Res NCCR Mol Oncol, Epalinges, Switzerland; [Michielin, Olivier] Lausanne Univ Hosp CHUV, Multidisciplinary Oncol Ctr, Lausanne, Switzerland	University of Lausanne; University of Lausanne; Swiss Institute of Bioinformatics; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Michielin, O (corresponding author), Univ Lausanne, Dept Oncol, Lausanne, Switzerland.	Olivier.Michielin@isb-sib.ch	Viatte, Sebastien/B-4253-2015; Speiser, Daniel E./F-2173-2013; Michielin, Olivier/ABE-7924-2020; Romero, Pedro/S-6015-2017	Viatte, Sebastien/0000-0001-6471-3358; Romero, Pedro/0000-0002-9688-2882	SCORE funds from the Swiss National Science Foundation, OncoSuisse [3232B0-103172, 3200B0-103173, OCS-01381-08-2003]; Novartis	SCORE funds from the Swiss National Science Foundation, OncoSuisse; Novartis(Novartis)	This work was supported by SCORE funds (3232B0-103172 and 3200B0-103173) from the Swiss National Science Foundation, OncoSuisse (OCS-01381-08-2003), Emma Muschamp and Novartis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Baker BM, 2000, IMMUNITY, V13, P475, DOI 10.1016/S1074-7613(00)00047-9; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; CARBO R, 1980, INT J QUANTUM CHEM, V17, P1185, DOI 10.1002/qua.560170612; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; Fagerberg T, 2006, J MOL BIOL, V356, P521, DOI 10.1016/j.jmb.2005.11.059; Golbraikh A, 2003, J COMPUT AID MOL DES, V17, P241, DOI 10.1023/A:1025386326946; Golbraikh A, 2002, J MOL GRAPH MODEL, V20, P269, DOI 10.1016/S1093-3263(01)00123-1; HODGKIN EE, 1987, INT J QUANTUM CHEM, V14, P105; Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N; LJUNGGREN HG, 1990, NATURE, V346, P476, DOI 10.1038/346476a0; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; MEYER AY, 1991, J COMPUT AID MOL DES, V5, P427, DOI 10.1007/BF00125663; Michielin O, 2005, CANC TREAT, V123, P267; Michielin O, 2000, J MOL BIOL, V300, P1205, DOI 10.1006/jmbi.2000.3788; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinilla C, 2001, CANCER RES, V61, P5153; Romero P, 1998, J EXP MED, V188, P1641, DOI 10.1084/jem.188.9.1641; Roux B, 1999, BIOPHYS CHEM, V78, P1, DOI 10.1016/S0301-4622(98)00226-9; Rubio-Godoy V, 2002, EUR J IMMUNOL, V32, P2292, DOI 10.1002/1521-4141(200208)32:8<2292::AID-IMMU2292>3.0.CO;2-K; Rubio-Godoy V, 2002, J IMMUNOL, V169, P5696, DOI 10.4049/jimmunol.169.10.5696; Rubio-Godoy V, 2002, CANCER RES, V62, P2058; Selzer P, 2006, J CHEM INF MODEL, V46, P2319, DOI 10.1021/ci0600657; So SS, 1997, J MED CHEM, V40, P4360, DOI 10.1021/jm970488n; So SS, 1996, J MED CHEM, V39, P5246, DOI 10.1021/jm960536o; So SS, 1996, J MED CHEM, V39, P1521, DOI 10.1021/jm9507035; So SS, 1997, J MED CHEM, V40, P4347, DOI 10.1021/jm970487v; Valmori D, 1999, CANCER RES, V59, P2167; Valmori D, 1998, J IMMUNOL, V160, P1750; Wilson CS, 1999, J IMMUNOL, V162, P3933; Zhao YD, 2001, J IMMUNOL, V167, P2130, DOI 10.4049/jimmunol.167.4.2130; Zippelius A, 2004, CANCER RES, V64, P2865, DOI 10.1158/0008-5472.CAN-03-3066	33	3	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e65590	10.1371/journal.pone.0065590	http://dx.doi.org/10.1371/journal.pone.0065590			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874382	Green Published, gold			2022-12-27	WOS:000322064300002
J	Navabi, N; McGuckin, MA; Linden, SK				Navabi, Nazanin; McGuckin, Michael A.; Linden, Sara K.			Gastrointestinal Cell Lines Form Polarized Epithelia with an Adherent Mucus Layer when Cultured in Semi-Wet Interfaces with Mechanical Stimulation	PLOS ONE			English	Article							HELICOBACTER-PYLORI BINDING; MUCIN GENE-EXPRESSION; COLON-CARCINOMA CELLS; GASTRIC-CANCER; ENTEROCYTIC DIFFERENTIATION; ADENOCARCINOMA CELLS; SODIUM-BUTYRATE; MUCOSAL BARRIER; DRUG TRANSPORT; SURFACE MUCIN	Mucin glycoproteins are secreted in large quantities by mucosal epithelia and cell surface mucins are a prominent feature of the glycocalyx of all mucosal epithelia. Currently, studies investigating the gastrointestinal mucosal barrier use either animal experiments or non-in vivo like cell cultures. Many pathogens cause different pathology in mice compared to humans and the in vitro cell cultures used are suboptimal because they are very different from an in vivo mucosal surface, are often not polarized, lack important components of the glycocalyx, and often lack the mucus layer. Although gastrointestinal cell lines exist that produce mucins or polarize, human cell line models that reproducibly create the combination of a polarized epithelial cell layer, functional tight junctions and an adherent mucus layer have been missing until now. We trialed a range of treatments to induce polarization, 3D-organization, tight junctions, mucin production, mucus secretion, and formation of an adherent mucus layer that can be carried out using standard equipment. These treatments were tested on cell lines of intestinal (Caco-2, LS513, HT29, T84, LS174T, HT29 MTX-P8 and HT29 MTX-E12) and gastric (MKN7, MKN45, AGS, NCI-N87 and its hTERT Clone5 and Clone6) origins using Ussing chamber methodology and (immuno) histology. Semi-wet interface culture in combination with mechanical stimulation and DAPT caused HT29 MTX-P8, HT29 MTX-E12 and LS513 cells to polarize, form functional tight junctions, a three-dimensional architecture resembling colonic crypts, and produce an adherent mucus layer. Caco-2 and T84 cells also polarized, formed functional tight junctions and produced a thin adherent mucus layer after this treatment, but with less consistency. In conclusion, culture methods affect cell lines differently, and testing a matrix of methods vs. cell lines may be important to develop better in vitro models. The methods developed herein create in vitro mucosal surfaces suitable for studies of host-pathogen interactions at the mucosal surface.	[Navabi, Nazanin; Linden, Sara K.] Univ Gothenburg, Dept Med Biochem & Cell Biol, Inst Biomed, Gothenburg, Sweden; [McGuckin, Michael A.] Mater Med Res Inst, Immun Infect & Inflammat Program, Woolloongabba, Qld, Australia; [McGuckin, Michael A.] Univ Queensland, Sch Biomed Sci, Translat Res Inst, Woolloongabba, Qld, Australia	University of Gothenburg; Mater Research; University of Queensland	Linden, SK (corresponding author), Univ Gothenburg, Dept Med Biochem & Cell Biol, Inst Biomed, Gothenburg, Sweden.	sara.linden@gu.se	Lindén, Sara K/A-3271-2011; McGuckin, Michael/G-2310-2010	Lindén, Sara K/0000-0002-7751-9586; McGuckin, Michael/0000-0002-8375-2675	Swedish Research Council [Vetenskapsradet K2010-79X-21372-01-3]; Forska utan Djurforsok; Ragnar Soderbergs Foundation; Animal Free Research	Swedish Research Council(Swedish Research CouncilEuropean Commission); Forska utan Djurforsok; Ragnar Soderbergs Foundation; Animal Free Research	The work was supported by the Swedish Research Council (Vetenskapsradet K2010-79X-21372-01-3), Forska utan Djurforsok, Ragnar Soderbergs Foundation and Animal Free Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemka A, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00015; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Ambort D, 2012, COLD SPRING HARB PER, V2; Atuma C, 2001, AM J PHYSIOL-GASTR L, V280, pG922, DOI 10.1152/ajpgi.2001.280.5.G922; AUGERON C, 1984, CANCER RES, V44, P3961; Bagnoli F, 2005, P NATL ACAD SCI USA, V102, P16339, DOI 10.1073/pnas.0502598102; Bai ZG, 2010, CELL BIOL INT, V34, P1141, DOI 10.1042/CBI20090481; BARRANCO SC, 1983, CANCER RES, V43, P1703; Behrens I, 2001, PHARM RES-DORDR, V18, P1138, DOI 10.1023/A:1010974909998; Biemer-Huttmann AE, 2000, CLIN CANCER RES, V6, P1909; CAPON C, 1992, J BIOL CHEM, V267, P19248; Carvalho F, 1999, VIRCHOWS ARCH, V435, P479, DOI 10.1007/s004280050431; Chailler P, 2005, J CELL PHYSIOL, V202, P263, DOI 10.1002/jcp.20124; Cornberg M, 1999, EUR J CELL BIOL, V78, P832, DOI 10.1016/S0171-9335(99)80034-X; DAHIYA R, 1992, CANCER RES, V52, P4655; Danahay H, 2006, AM J PHYSIOL-LUNG C, V290, pL558, DOI 10.1152/ajplung.00351.2005; Gottke MU, 1998, J EUKARYOT MICROBIOL, V45, p17S, DOI 10.1111/j.1550-7408.1998.tb04519.x; Gouyer V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018761; Grohmann GPM, 2003, CYTOKINE, V23, P86, DOI 10.1016/S1043-4666(03)00202-3; Halm DR, 2000, AM J PHYSIOL-CELL PH, V278, pC212, DOI 10.1152/ajpcell.2000.278.1.C212; Hansson GC, 2010, GUT MICROBES, V1, P51, DOI 10.4161/gmic.1.1.10470; Hershberg RM, 1998, J CLIN INVEST, V102, P792, DOI 10.1172/JCI3201; Ho SB, 2004, DIGEST DIS SCI, V49, P1598, DOI 10.1023/B:DDAS.0000043371.12671.98; Hong DH, 1999, AM J PHYSIOL-GASTR L, V277, pG1041, DOI 10.1152/ajpgi.1999.277.5.G1041; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; JUMARIE C, 1991, J CELL PHYSIOL, V149, P24, DOI 10.1002/jcp.1041490105; Kim DH, 2003, ALIMENT PHARM THER, V18, P14, DOI 10.1046/j.1365-2036.18.s1.4.x; Kim KC, 2003, INFLAMM RES, V52, P258, DOI 10.1007/s00011-003-1171-y; Lee MK, 2005, DRUG DELIV, V12, P305, DOI 10.1080/10717540500177009; LESUFFLEUR T, 1990, CANCER RES, V50, P6334; LESUFFLEUR T, 1993, J CELL SCI, V106, P771; Linden S, 2004, BIOCHEM J, V379, P765, DOI 10.1042/BJ20031557; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; Linden SK, 2008, HELICOBACTER, V13, P81, DOI 10.1111/j.1523-5378.2008.00587.x; Linden SK, 2007, HELICOBACTER, V12, P341, DOI 10.1111/j.1523-5378.2007.00509.x; Linden SK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000617; Linden SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003952; MACK DR, 1994, BIOCHEM BIOPH RES CO, V199, P1012, DOI 10.1006/bbrc.1994.1330; McAuley JL, 2007, J CLIN INVEST, V117, P2313, DOI 10.1172/JCI26705; Mcguckin MA, 2007, GASTROENTEROLOGY, V133, P1210, DOI 10.1053/j.gastro.2007.07.003; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Milano J, 2004, TOXICOL SCI, V82, P341, DOI 10.1093/toxsci/kfh254; PARK JG, 1990, CANCER RES, V50, P2773; Patsos G, 2009, BIOL CHEM, V390, P581, DOI 10.1515/BC.2009.052; Price MR, 1998, TUMOR BIOL, V19, P1, DOI 10.1159/000056500; ROUMAGNAC I, 1987, BIOL CELL, V61, P65, DOI 10.1111/j.1768-322X.1987.tb00570.x; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Singh PK, 2006, TRENDS CELL BIOL, V16, P467, DOI 10.1016/j.tcb.2006.07.006; Sjunnesson H, 2001, FEMS IMMUNOL MED MIC, V30, P167, DOI 10.1111/j.1574-695X.2001.tb01566.x; Skoog EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036378; Skoog EC, 2011, HELICOBACTER, V16, P9, DOI 10.1111/j.1523-5378.2010.00810.x; Smirnova MG, 2003, CELL IMMUNOL, V221, P42, DOI 10.1016/S0008-8749(03)00059-5; Sturegard E, 1998, J MED MICROBIOL, V47, P1123, DOI 10.1099/00222615-47-12-1123; TOM BH, 1976, IN VITRO CELL DEV B, V12, P180; Tu QV, 2008, J MED MICROBIOL, V57, P795, DOI 10.1099/jmm.0.47752-0; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; VanKlinken BJW, 1996, GLYCOCONJUGATE J, V13, P757, DOI 10.1007/BF00702340; VELCICH A, 1995, CELL GROWTH DIFFER, V6, P749; WIKMAN A, 1993, PHARMACEUT RES, V10, P843, DOI 10.1023/A:1018905109971; WIKMANLARHED A, 1995, EUR J PHARM SCI, V3, P171, DOI 10.1016/0928-0987(95)00007-Z; Williams SJ, 2001, J BIOL CHEM, V276, P18327, DOI 10.1074/jbc.M008850200; Yang JJ, 2000, J CONTROL RELEASE, V65, P1, DOI 10.1016/S0168-3659(99)00226-6; ZWEIBAUM A, 1985, J CELL PHYSIOL, V122, P21, DOI 10.1002/jcp.1041220105	64	78	79	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2013	8	7							e68761	10.1371/journal.pone.0068761	http://dx.doi.org/10.1371/journal.pone.0068761			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZN	23869232	gold, Green Published			2022-12-27	WOS:000323110600031
J	Royo, F; Schlangen, K; Palomo, L; Gonzalez, E; Conde-Vancells, J; Berisa, A; Aransay, AM; Falcon-Perez, JM				Royo, Felix; Schlangen, Karin; Palomo, Laura; Gonzalez, Esperanza; Conde-Vancells, Javier; Berisa, Agustin; Aransay, Ana M.; Falcon-Perez, Juan M.			Transcriptome of Extracellular Vesicles Released by Hepatocytes	PLOS ONE			English	Article							MESSENGER-RNAS; HORIZONTAL TRANSFER; PROGENITOR CELLS; EXOSOMES; MICROVESICLES; MICROPARTICLES; MICRORNAS; MECHANISM; PHENOTYPE; ACTIVATE	The discovery that the cells communicate through emission of vesicles has opened new opportunities for better understanding of physiological and pathological mechanisms. This discovery also provides a novel source for non-invasive disease biomarker research. Our group has previously reported that hepatocytes release extracellular vesicles with protein content reflecting the cell-type of origin. Here, we show that the extracellular vesicles released by hepatocytes also carry RNA. We report the messenger RNA composition of extracellular vesicles released in two non-tumoral hepatic models: primary culture of rat hepatocytes and a progenitor cell line obtained from a mouse foetal liver. We describe different subpopulations of extracellular vesicles with different densities and protein and RNA content. We also show that the RNA cargo of extracellular vesicles released by primary hepatocytes can be transferred to rat liver stellate-like cells and promote their activation. Finally, we provide in vitro and in vivo evidence that liver-damaging drugs galactosamine, acetaminophen, and diclofenac modify the RNA content of these vesicles. To summarize, we show that the extracellular vesicles secreted by hepatocytes contain various RNAs. These vesicles, likely to be involved in the activation of stellate cells, might become a new source for non-invasive identification of the liver toxicity markers.	[Royo, Felix; Palomo, Laura; Gonzalez, Esperanza; Conde-Vancells, Javier] CIBERehd, CIC BioGUNE, Metabol Unit, Derio, Spain; [Schlangen, Karin; Aransay, Ana M.] CIBERehd, CIC BioGUNE, Genome Anal Platform, Derio, Spain; [Berisa, Agustin] FARMA SA, FAES, R&D & Innovat Dept, Leioa, Spain; IKERBASQUE, Basque Fdn Sci, Bilbao, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; CIC bioGUNE; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; CIC bioGUNE; Basque Foundation for Science	Royo, F (corresponding author), CIBERehd, CIC BioGUNE, Metabol Unit, Derio, Spain.	jfalcon@cicbiogune.es	Royo, Felix/ABE-8064-2021; Aransay, Ana M./F-8086-2011; González, Esperanza/AAK-4097-2020; Royo, Felix/A-7198-2015; González, Esperanza/H-5450-2015; Falcon-Perez, Juan M/F-5920-2011	Royo, Felix/0000-0001-9769-4165; Aransay, Ana M./0000-0002-8271-612X; González, Esperanza/0000-0002-3831-4596; Royo, Felix/0000-0001-9769-4165; González, Esperanza/0000-0002-3831-4596; Conde Vancells, Javier/0000-0003-2791-2678; Falcon-Perez, Juan M/0000-0003-3133-0670	Fondo de Investigaciones Sanitarias (Institute of Health Carlos III) [PS09/00526]; Program "Ramon y Cajal'' of Spanish Ministry; Centro de Investigacion Biomedica en Red en el Area tematica de Enfermedades Hepaticas y Digestivas (CIBERehd); Institute of Health Carlos III; Department of Industry, Tourism and Trade of the Government of the Autonomous Community of the Basque Country (Etortek Research Programs); Innovation Technology Department of the Bizkaia County	Fondo de Investigaciones Sanitarias (Institute of Health Carlos III)(Instituto de Salud Carlos III); Program "Ramon y Cajal'' of Spanish Ministry; Centro de Investigacion Biomedica en Red en el Area tematica de Enfermedades Hepaticas y Digestivas (CIBERehd); Institute of Health Carlos III(Instituto de Salud Carlos III); Department of Industry, Tourism and Trade of the Government of the Autonomous Community of the Basque Country (Etortek Research Programs); Innovation Technology Department of the Bizkaia County	This work was supported by grants from the Fondo de Investigaciones Sanitarias (Institute of Health Carlos III PS09/00526 and to JMF); Program "Ramon y Cajal'' of Spanish Ministry (to JMF); Centro de Investigacion Biomedica en Red en el Area tematica de Enfermedades Hepaticas y Digestivas (CIBERehd) is funded by the Institute of Health Carlos III. Research infrastructure was supported by the Department of Industry, Tourism and Trade of the Government of the Autonomous Community of the Basque Country (Etortek Research Programs 2010/2013) and the Innovation Technology Department of the Bizkaia County. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bobrie A, 2011, TRAFFIC, V12, P1659, DOI 10.1111/j.1600-0854.2011.01225.x; Brodsky SV, 2008, J GASTROINTEST LIVER, V17, P261; Castell JV, 1997, CELL BIOL TOXICOL, V13, P331, DOI 10.1023/A:1007443610025; Chiba M, 2012, ONCOL REP, V28, P1551, DOI 10.3892/or.2012.1967; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Conde-Vancells J, 2010, EXPERT OPIN DRUG MET, V6, P543, DOI 10.1517/17425251003614766; Conde-Vancells J, 2008, J PROTEOME RES, V7, P5157, DOI 10.1021/pr8004887; de Jong OG, 2012, J EXTRACELL VESICLES, V1, DOI 10.3402/jev.v1i0.18396; DeLeve LD, 2004, AM J PHYSIOL-GASTR L, V287, pG757, DOI 10.1152/ajpgi.00017.2004; Deregibus MC, 2007, BLOOD, V110, P2440, DOI 10.1182/blood-2007-03-078709; Dragovic RA, 2011, NANOMED-NANOTECHNOL, V7, P780, DOI 10.1016/j.nano.2011.04.003; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Duijvesz D, 2011, EUR UROL, V59, P823, DOI 10.1016/j.eururo.2010.12.031; El-Andaloussi S, 2012, NAT PROTOC, V7, P2112, DOI 10.1038/nprot.2012.131; Eldh M, 2012, MOL IMMUNOL, V50, P278, DOI 10.1016/j.molimm.2012.02.001; Eldh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015353; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Garcia-Trevijano ER, 2002, GASTROENTEROLOGY, V122, P1355, DOI 10.1053/gast.2002.33020; GREENWEL P, 1991, LAB INVEST, V65, P644; Gutierrez-Vazquez C, 2013, IMMUNOL REV, V251, P125, DOI 10.1111/imr.12013; Hellerbrand C, 2013, PFLUGERS ARCH; Herrera MB, 2010, J CELL MOL MED, V14, P1605, DOI 10.1111/j.1582-4934.2009.00860.x; Hessvik NP, 2012, BBA-GENE REGUL MECH, V1819, P1154, DOI 10.1016/j.bbagrm.2012.08.016; Huan J, 2012, CANCER RES, V2012, P13; James LP, 2003, DRUG METAB DISPOS, V31, P1499, DOI 10.1124/dmd.31.12.1499; Kalra H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001450; KEPPLER D, 1968, EXP MOL PATHOL, V9, P279, DOI 10.1016/0014-4800(68)90042-7; Kogure T, 2011, HEPATOLOGY, V54, P1237, DOI 10.1002/hep.24504; Kornek M, 2011, HEPATOLOGY, V53, P230, DOI 10.1002/hep.23999; Lamparski HG, 2002, J IMMUNOL METHODS, V270, P211, DOI 10.1016/S0022-1759(02)00330-7; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Medico E, 1996, MOL BIOL CELL, V7, P495, DOI 10.1091/mbc.7.4.495; Mittelbrunn M, 2012, NAT REV MOL CELL BIO, V13, P328, DOI 10.1038/nrm3335; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; O'Loughlin AJ, 2012, CURR GENE THER, V12, P262, DOI 10.2174/156652312802083594; Ohno SI, 2012, ADV DRUG DELIV REV, V2012, P00249; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Ratajczak J, 2006, LEUKEMIA, V20, P847, DOI 10.1038/sj.leu.2404132; Rockey DC, 1997, AM J PHYSIOL-GASTR L, V273, pG124, DOI 10.1152/ajpgi.1997.273.1.G124; Royo F, 2012, J EXTRACELL VESICLES, V1, DOI 10.3402/jev.v1i0.18825; Rozen S, 2000, Methods Mol Biol, V132, P365; Schmelzle M, 2013, TRANSPLANTATION, V95, P63, DOI 10.1097/TP.0b013e318278d3cd; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Simpson RJ, 2008, PROTEOMICS, V8, P4083, DOI 10.1002/pmic.200800109; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Thery C, 1999, J CELL BIOL, V147, P599, DOI 10.1083/jcb.147.3.599; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Waldenstrom A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034653; Wetmore BA, 2010, HEPATOLOGY, V51, P2127, DOI 10.1002/hep.23574; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Witek RP, 2009, GASTROENTEROLOGY, V136, P320, DOI 10.1053/j.gastro.2008.09.066	56	46	50	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e68693	10.1371/journal.pone.0068693	http://dx.doi.org/10.1371/journal.pone.0068693			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874726	Green Published, gold, Green Submitted			2022-12-27	WOS:000322218800040
J	Ali, F; Pan, QC; Chen, GS; Zahid, KR; Yan, JB				Ali, Farhan; Pan, Qingchun; Chen, Genshen; Zahid, Kashif Rafiq; Yan, Jianbing			Evidence of Multiple Disease Resistance (MDR) and Implication of Meta-Analysis in Marker Assisted Selection	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; SOUTHERN LEAF-BLIGHT; DNA-BINDING PROTEINS; SETOSPHAERIA-TURCICA; BROAD-SPECTRUM; MAIZE; GENES; QTL; IDENTIFICATION; SPOT	Meta-analysis was performed for three major foliar diseases with the aim to find out the total number of QTL responsible for these diseases and depict some real QTL for molecular breeding and marker assisted selection (MAS) in maize. Furthermore, we confirmed our results with some major known disease resistance genes and most well-known gene family of nucleotide binding site (NBS) encoding genes. Our analysis revealed that disease resistance QTL were randomly distributed in maize genome, but were clustered at different regions of the chromosomes. Totally 389 QTL were observed for these three major diseases in diverse maize germplasm, out of which 63 QTL were controlling more than one disease revealing the presence of multiple disease resistance (MDR). 44 real-QTLs were observed based on 4 QTL as standard in a specific region of genome. We also confirmed the Ht1 and Ht2 genes within the region of real QTL and 14 NBS-encoding genes. On chromosome 8 two NBS genes in one QTL were observed and on chromosome 3, several cluster and maximum MDR QTL were observed indicating that the apparent clustering could be due to genes exhibiting pleiotropic effect. Significant relationship was observed between the number of disease QTL and total genes per chromosome based on the reference genome B73. Therefore, we concluded that disease resistance genes are abundant in maize genome and these results can unleash the phenomenon of MDR. Furthermore, these results could be very handy to focus on hot spot on different chromosome for fine mapping of disease resistance genes and MAS.	[Ali, Farhan; Chen, Genshen; Zahid, Kashif Rafiq; Yan, Jianbing] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Ali, Farhan] Cereal Crops Res Inst CCRI Pirsabak Nowshera, Khyber Pakhtunkhwa, Pakistan; [Pan, Qingchun] China Agr Univ, Natl Maize Improvement Ctr China, Beijing 100094, Peoples R China	Huazhong Agricultural University; China Agricultural University	Yan, JB (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.	yjianbing@mail.hzau.edu.cn	Ali, Farhan/AAA-6193-2019	Ali, Farhan/0000-0003-4519-7903	National Natural Science Foundation of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali F, 2012, J INTEGR PLANT BIOL, V54, P134, DOI 10.1111/j.1744-7909.2012.01105.x; Alpert KB, 1996, P NATL ACAD SCI USA, V93, P15503, DOI 10.1073/pnas.93.26.15503; Arcade A, 2004, BIOINFORMATICS, V20, P2324, DOI 10.1093/bioinformatics/bth230; Ayliffe M, 2008, CURR OPIN PLANT BIOL, V11, P187, DOI 10.1016/j.pbi.2008.02.001; Balint-Kurti PJ, 2008, PHYTOPATHOLOGY, V98, P315, DOI 10.1094/PHYTO-98-3-0315; Balint-Kurti PJ, 2007, GENETICS, V176, P645, DOI 10.1534/genetics.106.067892; Balint-Kurti PJ, 2006, PHYTOPATHOLOGY, V96, P1067, DOI 10.1094/PHYTO-96-1067; Balint-Kurti PJ, 2010, CROP SCI, V50, P458, DOI 10.2135/cropsci2009.02.0066; Balint-Kurti PJ, 2005, PHYTOPATHOLOGY, V96, P221; BENTOLILA S, 1991, THEOR APPL GENET, V82, P393, DOI 10.1007/BF00588588; Brown AF, 2001, PHYTOPATHOLOGY, V91, P293, DOI 10.1094/PHYTO.2001.91.3.293; BUBECK DM, 1993, CROP SCI, V33, P838, DOI 10.2135/cropsci1993.0011183X003300040041x; BUBECK DM, 1992, THESIS N CAROLINA ST; Cao H, 1998, P NATL ACAD SCI USA, V95, P6531, DOI 10.1073/pnas.95.11.6531; Carson ML, 2004, PHYTOPATHOLOGY, V94, P862, DOI 10.1094/PHYTO.2004.94.8.862; Chen CH, 2000, PLANT MOL BIOL, V42, P387, DOI 10.1023/A:1006399311615; Cheng Y, 2012, FEBS J, V279, P2431, DOI 10.1111/j.1742-4658.2012.08621.x; Chung CL, 2010, THEOR APPL GENET, V121, P205, DOI 10.1007/s00122-010-1303-z; Clements MJ, 2000, PHYTOPATHOLOGY, V90, P1018, DOI 10.1094/PHYTO.2000.90.9.1018; Darvasi A, 1997, BEHAV GENET, V27, P125, DOI 10.1023/A:1025685324830; DeYoung BJ, 2006, NAT IMMUNOL, V7, P1243, DOI 10.1038/ni1410; Dingerdissen AL, 1996, MOL BREEDING, V2, P143, DOI 10.1007/BF00441429; FREYMARK PJ, 1993, THEOR APPL GENET, V87, P537, DOI 10.1007/BF00221876; Glazier AM, 2002, SCIENCE, V298, P2345, DOI 10.1126/science.1076641; Gordon SG, 2004, CROP SCI, V44, P628, DOI 10.2135/cropsci2004.0628; HOOKER A L, 1972, Journal of Environmental Quality, V1, P244, DOI 10.2134/jeq1972.00472425000100030008x; Huang Lie-Jian, 2002, Acta Genetica Sinica, V29, P1100; Jiang C, 1999, THEOR APPL GENET, V99, P1106, DOI 10.1007/s001220051315; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kim CY, 2000, MOL PLANT MICROBE IN, V13, P470, DOI 10.1094/MPMI.2000.13.4.470; Kump KL, 2011, NAT GENET, V43, P163, DOI 10.1038/ng.747; Lehmensiek A, 2001, THEOR APPL GENET, V103, P797, DOI 10.1007/s001220100599; Liu PF, 2011, AFR J AGR RES, V6, P6197, DOI 10.5897/AJAR11.1387; Lobo I., 2008, NATURE ED, V1, P1; Maroof MAS, 1996, THEOR APPL GENET, V93, P539, DOI 10.1007/BF00417945; McMullen MD, 1995, MOL PLANT MICROBE IN, V8, P811, DOI 10.1094/MPMI-8-0811; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Michelmore RW, 1998, GENOME RES, V8, P1113, DOI 10.1101/gr.8.11.1113; Negeri AT, 2011, CROP SCI, V51, P1571, DOI 10.2135/cropsci2010.12.0672; Paul D, 2000, NATURE, V405, P515, DOI 10.1038/35014676; Poland JA, 2011, P NATL ACAD SCI USA, V108, P6893, DOI 10.1073/pnas.1010894108; Schechert AW, 1999, CROP SCI, V39, P514, DOI 10.2135/cropsci1999.0011183X003900020036x; SIMCOX KD, 1993, PHYTOPATHOLOGY, V83, P1326, DOI 10.1094/Phyto-83-1326; Van Inghelandt D, 2010, THEOR APPL GENET, V120, P1289, DOI 10.1007/s00122-009-1256-2; van Ooijen G, 2007, ANNU REV PHYTOPATHOL, V45, P43, DOI 10.1146/annurev.phyto.45.062806.094430; Veiga AD, 2012, CIENC AGROTEC, V36, P31, DOI 10.1590/S1413-70542012000100004; Veyrieras JB, 2005, METAQTL VERSION 1 0; Ward JMJ, 1999, PLANT DIS, V83, P884, DOI 10.1094/PDIS.1999.83.10.884; Welz HG, 1999, THEOR APPL GENET, V98, P1036, DOI 10.1007/s001220051165; Welz HG, 1999, THEOR APPL GENET, V99, P649, DOI 10.1007/s001220051280; Wisser RJ, 2011, P NATL ACAD SCI USA, V108, P7339, DOI 10.1073/pnas.1011739108; Wisser RJ, 2006, PHYTOPATHOLOGY, V96, P120, DOI 10.1094/PHYTO-96-0120; Wisser RJ, 2005, GENETICS, V169, P2277, DOI 10.1534/genetics.104.036327; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yu DQ, 2001, PLANT CELL, V13, P1527, DOI 10.1105/tpc.13.7.1527; Yu HH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017595; Zaitlin D., 1992, Maize Genetics Cooperation Newsletter, P69; Zwonitzer JC, 2010, PHYTOPATHOLOGY, V100, P72, DOI 10.1094/PHYTO-100-1-0072; Zwonitzer JC, 2009, THEOR APPL GENET, V118, P911, DOI 10.1007/s00122-008-0949-2	60	17	18	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68150	10.1371/journal.pone.0068150	http://dx.doi.org/10.1371/journal.pone.0068150			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874526	Green Published, Green Submitted, gold			2022-12-27	WOS:000321765300029
J	Anthony, SJ; St Leger, JA; Navarrete-Macias, I; Nilson, E; Sanchez-Leon, M; Liang, E; Seimon, T; Jain, K; Karesh, W; Daszak, P; Briese, T; Lipkin, WI				Anthony, Simon J.; St. Leger, Judy A.; Navarrete-Macias, Isamara; Nilson, Erica; Sanchez-Leon, Maria; Liang, Eliza; Seimon, Tracie; Jain, Komal; Karesh, William; Daszak, Peter; Briese, Thomas; Lipkin, W. Ian			Identification of a Novel Cetacean Polyomavirus from a Common Dolphin (Delphinus delphis) with Tracheobronchitis	PLOS ONE			English	Article							INFECTION; RANGE	A female short-beaked common dolphin calf was found stranded in San Diego, California in October 2010, presenting with multifocal ulcerative lesions in the trachea and bronchi. Viral particles suggestive of polyomavirus were detected by EM, and subsequently confirmed by PCR and sequencing. Full genome sequencing (Ion Torrent) revealed a circular dsDNA genome of 5,159 bp that was shown to form a distinct lineage within the genus Polyomavirus based on phylogenetic analysis of the early and late transcriptomes. Viral infection and distribution in laryngeal mucosa was characterised using in-situ hybridisation, and apoptosis observed in the virus-infected region. These results demonstrate that polyomaviruses can be associated with respiratory disease in cetaceans, and expand our knowledge of their diversity and clinical significance in marine mammals.	[Anthony, Simon J.; Navarrete-Macias, Isamara; Sanchez-Leon, Maria; Liang, Eliza; Seimon, Tracie; Jain, Komal; Briese, Thomas; Lipkin, W. Ian] Columbia Univ, Ctr Infect & Immun, Mailman Sch Publ Hlth, New York, NY 10027 USA; [Anthony, Simon J.; Liang, Eliza; Karesh, William; Daszak, Peter] EcoHlth Alliance, New York, NY USA; [St. Leger, Judy A.; Nilson, Erica] SeaWorld Pk, Dept Pathol Res, San Diego, CA USA; [Seimon, Tracie] Bronz Zoo, Wildlife Conservat Soc, New York, NY USA	Columbia University; EcoHealth Alliance; Wildlife Conservation Society	Anthony, SJ (corresponding author), Columbia Univ, Ctr Infect & Immun, Mailman Sch Publ Hlth, New York, NY 10027 USA.	sja2127@columbia.edu; judy.st.leger@seaworld.com	Karesh, William/AAU-9084-2020; St. Leger, Judy/AAD-3565-2019; Lipkin, W. Ian/ABE-6216-2020; daszak, peter/U-4588-2017	Karesh, William/0000-0001-6042-2860; St. Leger, Judy/0000-0002-6213-3429; Lipkin, W. Ian/0000-0002-8768-9386; daszak, peter/0000-0002-2046-5695	USAID PREDICT	USAID PREDICT(United States Agency for International Development (USAID))	USAID PREDICT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja D, 2005, ONCOGENE, V24, P7729, DOI 10.1038/sj.onc.1209046; Andrabi S, 2007, P NATL ACAD SCI USA, V104, P19011, DOI 10.1073/pnas.0706696104; Anthony SJ, 2012, MBIO, V3, DOI 10.1128/mBio.00166-12; Bracht AJ, 2006, ARCH VIROL, V151, P423, DOI 10.1007/s00705-005-0679-6; Cimbaluk D, 2009, DIAGN CYTOPATHOL, V37, P773, DOI 10.1002/dc.21147; Colegrove KM, 2010, J VET DIAGN INVEST, V22, P628, DOI 10.1177/104063871002200422; Ferenczy MW, 2012, CLIN MICROBIOL REV, V25, P471, DOI 10.1128/CMR.05031-11; Forslund O, 1999, J GEN VIROL, V80, P2437, DOI 10.1099/0022-1317-80-9-2437; Gerits N, 2012, VIROLOGY, V432, P316, DOI 10.1016/j.virol.2012.05.024; Johne R, 2005, J VIROL, V79, P3883, DOI 10.1128/JVI.79.6.3883-3887.2005; Johne R, 2011, ARCH VIROL, V156, P1627, DOI 10.1007/s00705-011-1008-x; King AMQ, 2012, 9 ICTV; Krumbholz A, 2009, INFECT GENET EVOL, V9, P784, DOI 10.1016/j.meegid.2009.04.008; Mourez T, 2009, EMERG INFECT DIS, V15, P107, DOI [10.3201/eid1501.080758, 10.3201/1501.080758]; Reid SM, 1999, J VIROL METHODS, V82, P99, DOI 10.1016/S0166-0934(99)00088-9; Tong S, 2008, J CLIN MICROBIOL, V46, P2652, DOI 10.1128/JCM.00192-08; van der Meijden E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001024; van Gorder MA, 1999, AM J PATHOL, V154, P1273, DOI 10.1016/S0002-9440(10)65379-5; VanDevanter DR, 1996, J CLIN MICROBIOL, V34, P1666, DOI 10.1128/JCM.34.7.1666-1671.1996; Wellehan JFX, 2011, INFECT GENET EVOL, V11, P987, DOI 10.1016/j.meegid.2011.03.010; Wellehan JFX, 2004, J VIROL, V78, P13366, DOI 10.1128/JVI.78.23.13366-13369.2004	21	14	14	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68239	10.1371/journal.pone.0068239	http://dx.doi.org/10.1371/journal.pone.0068239			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874559	Green Published, Green Submitted, gold			2022-12-27	WOS:000321765300036
J	Caldwell, JT; Edwards, H; Dombkowski, AA; Buck, SA; Matherly, LH; Ge, YB; Taub, JW				Caldwell, John Timothy; Edwards, Holly; Dombkowski, Alan A.; Buck, Steven A.; Matherly, Larry H.; Ge, Yubin; Taub, Jeffrey W.			Overexpression of GATA1 Confers Resistance to Chemotherapy in Acute Megakaryocytic Leukemia	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; ACUTE MEGAKARYOBLASTIC LEUKEMIA; LARGE GENE LISTS; DOWN-SYNDROME; HEMATOPOIETIC DIFFERENTIATION; CLINICAL-SIGNIFICANCE; CYTOSINE-ARABINOSIDE; CYTIDINE DEAMINASE; OBATOCLAX MESYLATE; VALPROIC ACID	It has been previously shown that acute myeloid leukemia (AML) patients with higher levels of GATA1 expression have poorer outcomes. Furthermore, pediatric Down syndrome (DS) patients with acute megakaryocytic leukemia (AMKL), whose blast cells almost universally harbor somatic mutations in exon 2 of the transcription factor gene GATA1, demonstrate increased overall survival relative to non-DS pediatric patients, suggesting a potential role for GATA1 in chemotherapy response. In this study, we confirmed that amongst non-DS patients, GATA1 transcripts were significantly higher in AMKL blasts compared to blasts from other AML subgroups. Further, GATA1 transcript levels significantly correlated with transcript levels for the anti-apoptotic protein Bcl-xL in our patient cohort. ShRNA knockdown of GATA1 in the megakaryocytic cell line Meg-01 resulted in significantly increased cytarabine (ara-C) and daunorubicin anti-proliferative sensitivities and decreased Bcl-xL transcript and protein levels. Chromatin immunoprecipitation (ChIP) and reporter gene assays demonstrated that the Bcl-x gene (which transcribes the Bcl-xL transcripts) is a bona fide GATA1 target gene in AMKL cells. Treatment of the Meg-01 cells with the histone deacetylase inhibitor valproic acid resulted in down-regulation of both GATA1 and Bcl-xL and significantly enhanced ara-C sensitivity. Furthermore, additional GATA1 target genes were identified by oligonucleotide microarray and ChIP-on-Chip analyses. Our findings demonstrate a role for GATA1 in chemotherapy resistance in non-DS AMKL cells, and identified additional GATA1 target genes for future studies.	[Caldwell, John Timothy] Wayne State Univ, Sch Med, MD PhD Program, Detroit, MI USA; [Caldwell, John Timothy; Matherly, Larry H.] Wayne State Univ, Sch Med, Canc Biol Program, Detroit, MI USA; [Edwards, Holly; Matherly, Larry H.; Ge, Yubin] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI USA; [Edwards, Holly; Ge, Yubin; Taub, Jeffrey W.] Wayne State Univ, Sch Med, Barbara Ann Karmanos Canc Inst, Mol Therapeut Program, Detroit, MI 48202 USA; [Dombkowski, Alan A.] Childrens Hosp Michigan, Div Pharmacol & Toxicol, Detroit, MI 48201 USA; [Dombkowski, Alan A.; Buck, Steven A.; Taub, Jeffrey W.] Wayne State Univ, Sch Med, Dept Pediat, Detroit, MI 48201 USA; [Buck, Steven A.; Taub, Jeffrey W.] Childrens Hosp Michigan, Div Pediat Hematol Oncol, Detroit, MI 48201 USA; [Matherly, Larry H.] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA	Wayne State University; Wayne State University; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Children's Hospital of Michigan; Wayne State University; Children's Hospital of Michigan; Wayne State University	Taub, JW (corresponding author), Wayne State Univ, Sch Med, Barbara Ann Karmanos Canc Inst, Mol Therapeut Program, Detroit, MI 48202 USA.	jtaub@med.wayne.edu		Ge, Yubin/0000-0002-8748-716X; Dombkowski, Alan/0000-0002-0312-8750	Karmanos Cancer Institute; Children's Research Center of Michigan; Leukemia Research Life; Children's Leukemia Foundation of Michigan; National Cancer Institute [R01 CA120772, T32 CA009531]; Elana Fund; Herrick Foundation; Justin's Gift Charity; Buric Family; Leukemia and Lymphoma Society; Sehn Family Foundation; Dale Meyer Memorial Endowment for Leukemia Research; Ring Screw Textron Endowed Chair for Pediatric Cancer Research	Karmanos Cancer Institute; Children's Research Center of Michigan; Leukemia Research Life; Children's Leukemia Foundation of Michigan; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Elana Fund; Herrick Foundation; Justin's Gift Charity; Buric Family; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Sehn Family Foundation; Dale Meyer Memorial Endowment for Leukemia Research; Ring Screw Textron Endowed Chair for Pediatric Cancer Research	This study was supported by grants from the Karmanos Cancer Institute, Children's Research Center of Michigan, Leukemia Research Life, Children's Leukemia Foundation of Michigan, National Cancer Institute (R01 CA120772), Elana Fund, the Herrick Foundation, Justin's Gift Charity, The Buric Family, Leukemia and Lymphoma Society, Sehn Family Foundation, Dale Meyer Memorial Endowment for Leukemia Research, and the Ring Screw Textron Endowed Chair for Pediatric Cancer Research. Mr. JTC is a predoctoral trainee supported by T32 CA009531 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athale UH, 2001, BLOOD, V97, P3727, DOI 10.1182/blood.V97.12.3727; Ayala RM, 2009, AM J HEMATOL, V84, P79, DOI 10.1002/ajh.21332; Chateauvieux S, 2011, BIOCHEM PHARMACOL, V81, P498, DOI 10.1016/j.bcp.2010.11.011; Crispino JD, 2005, SEMIN CELL DEV BIOL, V16, P137, DOI 10.1016/j.semcdb.2004.11.002; Edwards H, 2009, BLOOD, V114, P2744, DOI 10.1182/blood-2008-09-179812; Gamis AS, 2003, J CLIN ONCOL, V21, P3415, DOI 10.1200/JCO.2003.08.060; GASSMANN W, 1995, LEUKEMIA LYMPHOMA, V18, P69, DOI 10.3109/10428199509075307; Ge Y, 2008, LEUKEMIA, V22, P521, DOI 10.1038/sj.leu.2405066; Ge YB, 2006, BLOOD, V107, P1570, DOI 10.1182/blood-2005-06-2219; Ge YB, 2005, JNCI-J NATL CANCER I, V97, P226, DOI 10.1093/jnci/dji026; Ge YB, 2004, CANCER RES, V64, P728, DOI 10.1158/0008-5472.CAN-03-2456; Ge YB, 2003, BLOOD, V101, P1551, DOI 10.1182/blood-2002-07-2337; Gregory T, 1999, BLOOD, V94, P87, DOI 10.1182/blood.V94.1.87.413k41_87_96; Guo B, 2012, LEUK LYMPHOMA; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kanda Y, 2000, CANCER, V88, P2529; Kodama T, 2012, CELL DEATH DIFFER, V19, P1856, DOI 10.1038/cdd.2012.88; Kuo YY, 2007, MOL CELL BIOL, V27, P4261, DOI 10.1128/MCB.02212-06; Lange BJ, 1998, BLOOD, V91, P608; Lo Nigro L, 2008, BRIT J HAEMATOL, V141, P94; Madlambayan GJ, 2010, BLOOD, V116, P1539, DOI 10.1182/blood-2009-06-230474; Malinge S, 2012, J CLIN INVEST, V122, P948, DOI 10.1172/JCI60455; Mogal A, 2006, MOL CELL PROBE, V20, P81, DOI 10.1016/j.mcp.2005.09.008; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; O'Brien MM, 2012, PROGNOSTIC FEATURES, P9421; O'Brien SM, 2009, BLOOD, V113, P299, DOI 10.1182/blood-2008-02-137943; Opferman JT, 2007, CURR OPIN IMMUNOL, V19, P497, DOI 10.1016/j.coi.2007.06.002; Pfirrmann M, 2012, LANCET ONCOL, V13, P207, DOI 10.1016/S1470-2045(11)70326-6; Quintas-Cardama A, 2011, LEUKEMIA, V25, P226, DOI 10.1038/leu.2010.276; Rajagopalan D, 2003, BIOINFORMATICS, V19, P1469, DOI 10.1093/bioinformatics/btg202; Raspadori D, 2001, LEUKEMIA, V15, P1161, DOI 10.1038/sj.leu.2402174; RAVINDRANATH Y, 1992, BLOOD, V80, P2210; RIBEIRO RC, 1993, LEUKEMIA LYMPHOMA, V10, P299, DOI 10.3109/10428199309148552; Ross ME, 2004, BLOOD, V104, P3679, DOI 10.1182/blood-2004-03-1154; Schimmer AD, 2008, CLIN CANCER RES, V14, P8295, DOI 10.1158/1078-0432.CCR-08-0999; SHIMAMOTO T, 1995, BLOOD, V86, P3173; Taub JW, 1999, BLOOD, V94, P1393; Vazquez I, 2011, HAEMATOL-HEMATOL J, V96, P1448, DOI 10.3324/haematol.2011.040535; Wechsler J, 2002, NAT GENET, V32, P148, DOI 10.1038/ng955; Xie CZ, 2010, CLIN CANCER RES, V16, P5499, DOI 10.1158/1078-0432.CCR-10-1707; Xu XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017138; Zhu HH, 2013, LEUK RES; ZIPURSKY A, 1994, LEUKEMIA RES, V18, P163, DOI 10.1016/0145-2126(94)90111-2	44	16	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68601	10.1371/journal.pone.0068601	http://dx.doi.org/10.1371/journal.pone.0068601			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874683	Green Published, gold, Green Submitted			2022-12-27	WOS:000321765300056
J	Heimann, D; Lotsch, J; Hummel, T; Doehring, A; Oertel, BG				Heimann, Dirk; Loetsch, Joern; Hummel, Thomas; Doehring, Alexandra; Oertel, Bruno G.			Linkage between Increased Nociception and Olfaction via a SCN9A Haplotype	PLOS ONE			English	Article							GATED SODIUM-CHANNELS; HUMAN PROSTATE-CANCER; OF-FUNCTION MUTATIONS; ODOR DISCRIMINATION; IN-VITRO; PAIN; NA(V)1.7; IDENTIFICATION; EXPRESSION; ERYTHROMELALGIA	Background and Aims: Mutations reducing the function of Na(v)1.7 sodium channels entail diminished pain perception and olfactory acuity, suggesting a link between nociception and olfaction at ion channel level. We hypothesized that if such link exists, it should work in both directions and gain-of-function Na(v)1.7 mutations known to be associated with increased pain perception should also increase olfactory acuity. Methods: SCN9A variants were assessed known to enhance pain perception and found more frequently in the average population. Specifically, carriers of SCN9A variants rs41268673C>A (P610T; n = 14) or rs6746030C>T (R1150W; n = 21) were compared with non-carriers (n = 40). Olfactory function was quantified by assessing odor threshold, odor discrimination and odor identification using an established olfactory test. Nociception was assessed by measuring pain thresholds to experimental nociceptive stimuli (punctate and blunt mechanical pressure, heat and electrical stimuli). Results: The number of carried alleles of the non-mutated SCN9A haplotype rs41268673C/rs6746030C was significantly associated with the comparatively highest olfactory threshold (0 alleles: threshold at phenylethylethanol dilution step 12 of 16 (n = 1), 1 allele: 10.6+/-2.6 (n = 34), 2 alleles: 9.5+/-2.1 (n = 40)). The same SCN9A haplotype determined the pain threshold to blunt pressure stimuli (0 alleles: 21.1 N/m(2), 1 allele: 29.8+/-10.4 N/m(2), 2 alleles: 33.5+/-10.2 N/m(2)). Conclusions: The findings established a working link between nociception and olfaction via Na(v)1.7 in the gain-of-function direction. Hence, together with the known reduced olfaction and pain in loss-of-function mutations, a bidirectional genetic functional association between nociception and olfaction exists at Na(v)1.7 level.	[Heimann, Dirk; Loetsch, Joern; Doehring, Alexandra; Oertel, Bruno G.] Goethe Univ Frankfurt, Inst Clin Pharmacol, D-60054 Frankfurt, Germany; [Loetsch, Joern; Oertel, Bruno G.] Fraunhofer Inst Mol Biol & Appl Ecol Project Grp, Frankfurt, Germany; [Hummel, Thomas] Univ Dresden, Sch Med, Dept Otorhinolaryngol, Smell & Taste Clin, Dresden, Germany	Goethe University Frankfurt; Fraunhofer Gesellschaft; Technische Universitat Dresden	Lotsch, J (corresponding author), Goethe Univ Frankfurt, Inst Clin Pharmacol, D-60054 Frankfurt, Germany.	j.loetsch@em.uni-frankfurt.de		Lotsch, Jorn/0000-0002-5818-6958	Dr. Paul und Cilli Weill Foundation, Frankfurt am Main, Ger-many; "Landesoffensive zur Entwicklung wissenschaftlich-okonomischer Exzellenz'': "LOEWE-Schwerpunkt: Anwendungsorientierte Arzneimittelforschung"	Dr. Paul und Cilli Weill Foundation, Frankfurt am Main, Ger-many; "Landesoffensive zur Entwicklung wissenschaftlich-okonomischer Exzellenz'': "LOEWE-Schwerpunkt: Anwendungsorientierte Arzneimittelforschung"	Financial support was provided by the Dr. Paul und Cilli Weill Foundation, Frankfurt am Main, Ger-many (BGO). The project is embedded in a comprehensive initiative of drug research and development funded by the "Landesoffensive zur Entwicklung wissenschaftlich-okonomischer Exzellenz'': "LOEWE-Schwerpunkt: Anwendungsorientierte Arzneimittelforschung'' (JL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal N, 2007, NAT NEUROSCI, V10, P870, DOI 10.1038/nn1916; Ahn HS, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-32; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Benton R, 2009, ANN NY ACAD SCI, V1170, P478, DOI 10.1111/j.1749-6632.2009.03880.x; Black JA, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-82; Breunig E, 2010, J NEUROSCI, V30, P8965, DOI 10.1523/JNEUROSCI.4030-09.2010; Clare JJ, 2010, EXPERT OPIN INV DRUG, V19, P45, DOI 10.1517/13543780903435340; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Cregg R, 2013, NEUROMOLECULAR MED; Cregg R, 2010, J PHYSIOL-LONDON, V588, P1897, DOI 10.1113/jphysiol.2010.187807; Cummins TR, 2004, J NEUROSCI, V24, P8232, DOI 10.1523/JNEUROSCI.2695-04.2004; Dib-Hajj SD, 2013, NAT REV NEUROSCI, V14, P49, DOI 10.1038/nrn3404; Diss JKJ, 2008, PROSTATE CANCER P D, V11, P325, DOI 10.1038/sj.pcan.4501012; Diss JKJ, 2005, PROSTATE CANCER P D, V8, P266, DOI 10.1038/sj.pcan.4500796; Doehring A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017724; Doehring A, 2009, PSYCHIAT GENET, V19, P259, DOI 10.1097/YPG.0b013e32832d0941; Drenth JPH, 2007, J CLIN INVEST, V117, P3603, DOI 10.1172/JCI33297; Estacion M, 2008, J NEUROSCI, V28, P11079, DOI 10.1523/JNEUROSCI.3443-08.2008; Estacion M, 2009, ANN NEUROL, V66, P862, DOI 10.1002/ana.21895; Faber CG, 2012, ANN NEUROL, V71, P26, DOI 10.1002/ana.22485; Gao N, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-20; Gaut BS, 2003, PLANT CELL, V15, P1502, DOI 10.1105/tpc.150730; Goldberg YP, 2007, CLIN GENET, V71, P311, DOI 10.1111/j.1399-0004.2007.00790.x; Gudziol V, 2006, LARYNGOSCOPE, V116, P1858, DOI 10.1097/01.mlg.0000234915.51189.cb; Guerrini R, 2010, EPILEPSIA, V51, P2474, DOI 10.1111/j.1528-1167.2010.02790.x; Han C, 2012, NEUROLOGY, V78, P1635, DOI 10.1212/WNL.0b013e3182574f12; Han CY, 2006, ANN NEUROL, V59, P553, DOI 10.1002/ana.20776; Hedner M, 2010, J CLIN EXP NEUROPSYC, V32, P1062, DOI 10.1080/13803391003683070; Henkin RI, 2011, AM J MED SCI, V341, P17, DOI 10.1097/MAJ.0b013e3181f1fdc8; Hisama FM, 1993, SCN9A RELATED INHERI; Hoeijmakers JGJ, 2012, CLIN GENET, V82, P351, DOI 10.1111/j.1399-0004.2012.01937.x; Hummel T, 2005, ACTA OTO-LARYNGOL, V125, P116, DOI 10.1080/00016480410022787; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Hummel T, 1998, EUR J CLIN PHARMACOL, V54, P521, DOI 10.1007/s002280050507; Kang K, 2010, NATURE, V464, P597, DOI 10.1038/nature08848; Klein CJ, 2013, J NEUROL NEUROSUR PS, V84, P386, DOI 10.1136/jnnp-2012-303719; KLUGBAUER N, 1995, EMBO J, V14, P1084, DOI 10.1002/j.1460-2075.1995.tb07091.x; Lampert A, 2010, PFLUG ARCH EUR J PHY, V460, P249, DOI 10.1007/s00424-009-0779-3; LEWONTIN RC, 1964, GENETICS, V49, P49; Lotsch J, 2012, TRENDS PHARMACOL SCI, V33, P193, DOI 10.1016/j.tips.2012.01.004; Meguro K, 2009, AM J PHYSIOL-HEART C, V296, pH211, DOI 10.1152/ajpheart.00960.2008; Minett MS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1795; Neddermeyer TJ, 2008, PAIN, V138, P286, DOI 10.1016/j.pain.2007.12.015; Nilsen KB, 2009, PAIN, V143, P155, DOI 10.1016/j.pain.2009.02.016; Priest BT, 2009, CURR OPIN DRUG DISC, V12, P682; Quint C, 2002, ACTA OTO-LARYNGOL, V122, P877, DOI 10.1080/003655402/000028054; Raviv JR, 2004, OTOLARYNG CLIN N AM, V37, P1143, DOI 10.1016/j.otc.2004.06.003; Reimann F, 2010, P NATL ACAD SCI USA, V107, P5148, DOI 10.1073/pnas.0913181107; Samuels ME, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-21; Sangameswaran L, 1997, J BIOL CHEM, V272, P14805, DOI 10.1074/jbc.272.23.14805; Sheets PL, 2007, J PHYSIOL-LONDON, V581, P1019, DOI 10.1113/jphysiol.2006.127027; Singh NA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000649; Staud R, 2010, EUR J PAIN; Steenland HW, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-34; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Theile JW, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00054; ToledoAral JJ, 1997, P NATL ACAD SCI USA, V94, P1527, DOI 10.1073/pnas.94.4.1527; Toth A, 2005, MOL BRAIN RES, V135, P162, DOI 10.1016/j.molbrainres.2004.12.003; Toth J, 2004, LARYNGO RHINO OTOL, V83, P124, DOI 10.1055/s-2004-814246; Uysal-Onganer P, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-76; Weiss J, 2011, NATURE, V472, P186, DOI 10.1038/nature09975; Williams BS, 2007, BIOCHEMISTRY-US, V46, P14693, DOI 10.1021/bi7018207; Wolfensberger M, 2000, ACTA OTO-LARYNGOL, V120, P303, DOI 10.1080/000164800750001134; Wu MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055212; YAMAGISHI M, 1994, ANN OTO RHINOL LARYN, V103, P279, DOI 10.1177/000348949410300404; Yamagishi Masuo, 1994, Rhinology (Utrecht), V32, P113; Yang Y, 2004, J MED GENET, V41, P171, DOI 10.1136/jmg.2003.012153; Young EE, 2012, J MED GENET, V49, P1, DOI 10.1136/jmedgenet-2011-100386; Yuan J, 2013, NEUROLOGY; Zufall F, 2012, ARCH NEUROL-CHICAGO, P1	71	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68654	10.1371/journal.pone.0068654	http://dx.doi.org/10.1371/journal.pone.0068654			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874707	Green Published, gold, Green Submitted			2022-12-27	WOS:000321765300060
J	Mallon, JC; Anderson, JS				Mallon, Jordan C.; Anderson, Jason S.			Skull Ecomorphology of Megaherbivorous Dinosaurs from the Dinosaur Park Formation (Upper Campanian) of Alberta, Canada	PLOS ONE			English	Article							JUDITH RIVER FORMATION; FEEDING-BEHAVIOR; BITE PERFORMANCE; PROVINCIAL-PARK; STRATIGRAPHIC DISTRIBUTION; ORNITHISCHIA ANKYLOSAURIA; FUNCTIONAL-MORPHOLOGY; SANTA-ROSALIA; MISSING DATA; EVOLUTION	Megaherbivorous dinosaur coexistence on the Late Cretaceous island continent of Laramidia has long puzzled researchers, owing to the mystery of how so many large herbivores (6-8 sympatric species, in many instances) could coexist on such a small (4-7 million km(2)) landmass. Various explanations have been put forth, one of which-dietary niche partitioning-forms the focus of this study. Here, we apply traditional morphometric methods to the skulls of megaherbivorous dinosaurs from the Dinosaur Park Formation (upper Campanian) of Alberta to infer the ecomorphology of these animals and to test the niche partitioning hypothesis. We find evidence for niche partitioning not only among contemporaneous ankylosaurs, ceratopsids, and hadrosaurids, but also within these clades at the family and subfamily levels. Consubfamilial ceratopsids and hadrosaurids differ insignificantly in their inferred ecomorphologies, which may explain why they rarely overlap stratigraphically: interspecific competition prevented their coexistence.	[Mallon, Jordan C.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Anderson, Jason S.] Univ Calgary, Dept Comparat Biol & Expt Med, Calgary, AB, Canada	University of Calgary; University of Calgary	Mallon, JC (corresponding author), Canadian Museum Nat, POB 3443 Stn D, Ottawa, ON K1P 6P4, Canada.	jmallon@mus-nature.ca		Mallon, Jordan/0000-0002-8209-8827	Natural Sciences and Engineering Research Council Alexander Graham Bell Canada Graduate Scholarship; Alberta Innovates Technology Futures graduate student scholarship; Jurassic Foundation; Queen Elizabeth II Graduate Scholarship	Natural Sciences and Engineering Research Council Alexander Graham Bell Canada Graduate Scholarship; Alberta Innovates Technology Futures graduate student scholarship; Jurassic Foundation; Queen Elizabeth II Graduate Scholarship	Funding to JCM was provided by a Natural Sciences and Engineering Research Council Alexander Graham Bell Canada Graduate Scholarship, Alberta Innovates Technology Futures graduate student scholarship, Jurassic Foundation grant and a Queen Elizabeth II Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel O., 1922, PALAEONTOL Z, V4, P87; ANAPOL F, 1994, AM J PHYS ANTHROPOL, V94, P239, DOI 10.1002/ajpa.1330940208; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Arbour VM, 2009, J VERTEBR PALEONTOL, V29, P1117, DOI 10.1671/039.029.0405; Archibald J.D., 1996, DINOSAUR EXTINCTION; Bakker R. T., 1986, DINOSAUR HERESIES NE, P481; BAKKER RT, 1978, NATURE, V274, P661, DOI 10.1038/274661a0; Barrett PM, 2006, TRENDS ECOL EVOL, V21, P217, DOI 10.1016/j.tree.2006.01.002; Behrensmeyer Anna K., 1992, P15; BELAND P, 1978, CAN J EARTH SCI, V15, P1012, DOI 10.1139/e78-109; BOCK WJ, 1965, EVOLUTION, V19, P269, DOI 10.2307/2406439; Bock WJ, 1977, VOGELWARTE, V29, P127; BOUVIER M, 1981, J MORPHOL, V167, P1, DOI 10.1002/jmor.1051670102; BOWMAN ROBERT I., 1961, UNIV CALIFORNIA PUBL ZOOL, V58, P1; Braman DR, 2005, LIFE O PAST, P101; Brinkman DB, 1998, PALAIOS, V13, P160, DOI 10.2307/3515487; BRINKMAN DB, 1990, PALAEOGEOGR PALAEOCL, V78, P37, DOI 10.1016/0031-0182(90)90203-J; Brown CM, 2013, PALAEOGEOGR PALAEOCL, V372, P108, DOI 10.1016/j.palaeo.2012.06.027; Brown CM, 2012, SYST BIOL, V61, P941, DOI 10.1093/sysbio/sys047; Butler RJ, 2008, J SYST PALAEONTOL, V6, P1, DOI 10.1017/S1477201907002271; Calvo Jorge O., 1994, Gaia, V10, P183; CARPENTER K, 1982, CAN J EARTH SCI, V19, P689, DOI 10.1139/e82-058; Carpenter K, 2004, CAN J EARTH SCI, V41, P961, DOI 10.1139/E04-043; Carpenter K., 1990, P281, DOI 10.1017/CBO9780511608377.024; Carpenter K., 1997, ENCY DINOSAURS, P16; Carpenter Kenneth, 1997, P307; Carrano MT, 1999, ACTA PALAEONTOL POL, V44, P237; Chapman R.E., 1990, P163, DOI 10.1017/CBO9780511608377.015; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Chin K, 1996, PALAIOS, V11, P280, DOI 10.2307/3515235; Chin K, 2007, PALAIOS, V22, P554, DOI 10.2110/palo.2006.p06-087r; Coe M.J., 1987, P225; Crane P. R., 1987, ORIGINS ANGIOSPERMS, P107; Currie PJ, 2005, LIFE O PAST, P537; Currie Philip J., 2008, P1; Currie Philip J., 1995, P111; Diamond J.M., 1975, P342; DiMichele WA, 2004, ANNU REV ECOL EVOL S, V35, P285, DOI 10.1146/annurev.ecolsys.35.120202.110110; Dodson P., 1990, P231, DOI 10.1017/CBO9780511608377.020; Dodson P., 1983, Mosasaur, V1, P89; DODSON P, 1993, AM J SCI, V293A, P200, DOI 10.2475/ajs.293.A.200; DODSON P, 1975, SYST ZOOL, V24, P37, DOI 10.2307/2412696; Dodson P., 1996, HORNED DINOSAURS NAT; Dodson P, 1997, ENCY DINOSAURS, P473; Dompierre H, 1996, J VERTEBR PALEONTOL, V16, P141, DOI 10.1080/02724634.1996.10011292; Doornik JA, 2008, OXFORD B ECON STAT, V70, P927, DOI 10.1111/j.1468-0084.2008.00537.x; EBERTH DA, 1993, CAN J EARTH SCI, V30, P174, DOI 10.1139/e93-016; Eberth DA, 2005, LIFE O PAST, P54; Erickson GM, 2012, SCIENCE, V338, P98, DOI 10.1126/science.1224495; Erickson GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031781; Evans DC, 2007, THESIS U TORONTO TOR; Farke AA., 2006, HORNS BEAKS CERATOPS, P235; Farke AA, 2011, ACTA PALAEONTOL POL, V56, P691, DOI 10.4202/app.2010.0121; FARLOW JO, 1995, ANNU REV ECOL SYST, V26, P445, DOI 10.1146/annurev.es.26.110195.002305; Fiorillo A. R, 1991, 5 S MES TERR ECOS BI, P23; Fiorillo Anthony R., 2008, P104; Fiorillo Anthony R., 1998, Historical Biology, V13, P1; Forster CA, 1996, J VERTEBR PALEONTOL, V16, P259, DOI 10.1080/02724634.1996.10011313; Fraser D, 2011, J VERTEBR PALEONTOL, V31, P1366, DOI 10.1080/02724634.2011.605404; Fraser D, 2011, J MORPHOL, V272, P1513, DOI 10.1002/jmor.11001; Galton P.M., 1986, P203; Gates TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042135; Godfrey SJ, 1995, J VERTEBR PALEONTOL, V15, P726, DOI 10.1080/02724634.1995.10011258; Gordon IJ, 1988, FUNCT ECOL, V2, P15, DOI 10.2307/2389455; GRANT P R, 1972, Biological Journal of the Linnean Society, V4, P39, DOI 10.1111/j.1095-8312.1972.tb00690.x; GRANT PR, 1980, EVOLUTION, V34, P332, DOI 10.1111/j.1558-5646.1980.tb04822.x; GREAVES W S, 1974, Forma et Functio, V7, P363; GREAVES WS, 1991, ZOOL J LINN SOC-LOND, V102, P367, DOI 10.1111/j.1096-3642.1991.tb00006.x; GREAVES WS, 1978, J ZOOL, V184, P271, DOI 10.1111/j.1469-7998.1978.tb03282.x; Haas G., 1969, American Museum Novitates, VNo. 2399, P1; Hammer O, 2006, PALEONTOLOGICAL DATA ANALYSIS, P1; HAMMER O., 2013, PALAEONTOL ELECTRON, V4, P9; Hatcher J. B., 1907, MONOGRAPHS US GEOLOG, VXLIX, DOI DOI 10.5962/BHL.TITLE.60500; Henderson Donald M., 2010, P293; Herrel A, 2001, J EXP ZOOL, V290, P101, DOI 10.1002/jez.1039; Herrel A, 2001, CAN J ZOOL, V79, P662, DOI 10.1139/cjz-79-4-662; Herrel A, 2002, J EVOLUTION BIOL, V15, P1083, DOI 10.1046/j.1420-9101.2002.00459.x; Herrel A, 2005, J EVOLUTION BIOL, V18, P669, DOI 10.1111/j.1420-9101.2004.00857.x; HOPSON J A, 1975, Paleobiology, V1, P21; HORN HS, 1977, NATURE, V270, P660, DOI 10.1038/270660a0; Horner JR, 2004, DINOSAURIA, 2ND EDITION, P438; Hubbell Stephen P., 2001, V32, pi; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; HYLANDER WL, 1979, J MORPHOL, V160, P223, DOI 10.1002/jmor.1051600208; JANIS C M, 1990, Memoirs of the Queensland Museum, V28, P349; JANIS CM, 1988, ZOOL J LINN SOC-LOND, V92, P267, DOI 10.1111/j.1096-3642.1988.tb01513.x; JANIS CM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P76; KILTIE RA, 1982, BIOTROPICA, V14, P188, DOI 10.2307/2388025; King G.M., 1996, REPTILES HERBIVORY; Koppelhus, 2005, DINOSAUR PROVINCIAL; Koppelhus EB, 2005, LIFE O PAST, P131; Kraeusel R., 1922, Palaeontologische Zeitschrift, V4, P80; KRASSILOV VA, 1981, PALAEOGEOGR PALAEOCL, V34, P207, DOI 10.1016/0031-0182(81)90065-1; LAUDER GV, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P1; Lehman T.M., 1990, P211, DOI 10.1017/CBO9780511608377.019; Lehman Thomas M., 2001, P310; Lehman Thomas M., 1997, P223; LEWIN R, 1983, SCIENCE, V221, P636, DOI 10.1126/science.221.4611.636; Losos Jonathan B., 1994, P60; Lucas P., 2004, DENT FUNCTIONAL MORP; Lull R. S., 1942, Geological Society of America Special Paper, V40, P1; LULL RICHARD SWANN, 1933, MEM PEABODY MUS NAT HIST, V3, P1; Lull RS, 1908, AM J SCI, V25, P387; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Mahalanobis P.C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302; Mallon JC, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-14; Mallon JC, 2012, PALAEOGEOGR PALAEOCL, V350, P124, DOI 10.1016/j.palaeo.2012.06.024; Mallon JC, 2011, J VERTEBR PALEONTOL, V31, P1047, DOI 10.1080/02724634.2011.601484; Marshall CD, 2003, J ZOOL, V259, P245, DOI 10.1017/S0952836902003205; Maryaska T., 1977, PALAEONTOLOGIA POLON, V37, P85; Meers Mason B., 2002, Historical Biology, V16, P1; Mendoza M, 2002, J ZOOL, V258, P223, DOI 10.1017/S0952836902001346; Metzger KA, 2005, BIOL J LINN SOC, V86, P433, DOI 10.1111/j.1095-8312.2005.00546.x; Molnar RE, 2001, LIFE O PAST, P399; Mustoe G, 2007, CYCAD NEWSLETTER, V65, P6; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Nogueira MR, 2005, J ZOOL, V266, P355, DOI 10.1017/S0952836905007053; Nopcsa F., 1928, GEOLOGICA HUNGARIA S, V1, P3; OLSON EC, 1952, EVOLUTION, V6, P181, DOI 10.2307/2405622; Ostrom J.H., 1986, Zitteliana, V14, P111; Ostrom J.H., 1990, P245, DOI 10.1017/CBO9780511608377.021; OSTROM JH, 1966, EVOLUTION, V20, P290, DOI 10.1111/j.1558-5646.1966.tb03367.x; OSTROM JH, 1964, AM J SCI, V262, P975, DOI 10.2475/ajs.262.8.975; Ostrom JH., 1961, B AM MUS NAT HIST, V122, P39; OSTROM JOHN H., 1964, POSTILLA [YALE PEABODY MUS], V88, P1; Owen-Smith R.N., 1988, MEGAHERBIVORES INFLU, DOI [10.1017/CBO9780511565441, DOI 10.1017/CBO9780511565441]; Parks W. A., 1924, University of Toronto Studies Geological Series, V18, P1; Penkalski P, 2013, CAN J EARTH SCI, V50, P171, DOI 10.1139/cjes-2012-0098; PIANKA ER, 1994, AUST J ECOL, V19, P395, DOI 10.1111/j.1442-9993.1994.tb00505.x; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Prasad V, 2005, SCIENCE, V310, P1177, DOI 10.1126/science.1118806; Prieto-Marquez A, 2010, ZOOL J LINN SOC-LOND, V159, P435, DOI 10.1111/j.1096-3642.2009.00617.x; RADINSKY LB, 1987, EVOLUTION VERTEBRATE; RETALLACK G J, 1986, Cretaceous Research, V7, P227, DOI 10.1016/0195-6671(86)90027-3; Ricklefs Robert E., 1994, P13; RUDWICK MJS, 1964, BRIT J PHILOS SCI, V15, P27; Russell L. S., 1940, University of Toronto Studies Geological Series, V43, P1; Ryan M.J., 2003, THESIS U CALGARY CAL; Ryan MJ, 2005, LIFE O PAST, P312; Rybczynski N, 2001, LIFE O PAST, P299; Sampson, 2009, DINOSAUR ODYSSEY FOS; Sampson SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012292; Sander PM., 2010, PLANTS MESOZOIC TIME, P331; SANSON GD, 1989, KANGAROOS, WALLABIES AND RAT-KANGAROOS, VOLS 1 AND 2, P151; Schoener T.W., 1984, P254; Shockey BJ, 2007, PALEOBIOLOGY, V33, P227, DOI 10.1666/05052.1; Sokal RR, 1995, BIOMETRY; SOLOUNIAS N, 1993, J MAMMAL, V74, P1059, DOI 10.2307/1382445; SOLOUNIAS N, 1988, PALAEOGEOGR PALAEOCL, V65, P149, DOI 10.1016/0031-0182(88)90021-1; SPENCER LM, 1995, J MAMMAL, V76, P448, DOI 10.2307/1382355; Stayton CT, 2005, J MORPHOL, V263, P47, DOI 10.1002/jmor.10288; STERNBERG C. M., 1940, JOUR PALEONTOL, V14, P468; Sternberg C. M., 1950, GEOLOGICAL SURVEY CA; Stevens KA, 1999, SCIENCE, V284, P798, DOI 10.1126/science.284.5415.798; Stevens KA, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P178; Strauss RE, 2003, J VERTEBR PALEONTOL, V23, P284, DOI 10.1671/0272-4634(2003)023[0284:EOTPAE]2.0.CO;2; Strauss RE, 2010, MORPHOMETRICS NONMOR, P73, DOI [10.1007/978-3-540-95853-6_4, DOI 10.1007/978-3-540-95853-6_4]; Taggart Ralph E., 1997, P403; TAIT JOHN, 1928, TRANS ROY SOC CANADA SECT V, V22, P13; Tanoue K, 2009, ANAT REC, V292, P1352, DOI 10.1002/ar.20979; Thompson RS, 2012, J SYST PALAEONTOL, V10, P301, DOI 10.1080/14772019.2011.569091; Tiffney Bruce H., 1992, Palaeobotanist (Lucknow), V41, P87; Tweet JS, 2008, PALAIOS, V23, P624, DOI 10.2110/palo.2007.p07-044r; Upchurch Jr G.R., 1993, EVOLUTION W INTERIOR, P243; Upchurch Paul, 2000, P79, DOI 10.1017/CBO9780511549717.005; Varriale FJ, 2011, THESIS J HOPKINS U B; Verwaijen D, 2002, FUNCT ECOL, V16, P842, DOI 10.1046/j.1365-2435.2002.00696.x; Vickaryous MK, 2006, J VERTEBR PALEONTOL, V26, P1011, DOI 10.1671/0272-4634(2006)26[1011:NIOTCA]2.0.CO;2; Vickaryous MK, 2004, DINOSAURIA, 2ND EDITION, P363; Wainwright P.C., 1994, ECOLOGICAL MORPHOLOG; Weishampel D.B., 1984, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V167, P224; WEISHAMPEL DB, 1984, ADV ANAT EMBRYOL CEL, V87, P1; Weishampel DB, 1989, GEOL SOC AM SPEC PAP, V238, P87, DOI DOI 10.1130/SPE238-P87; Whitlock JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018304; WING SL, 1987, REV PALAEOBOT PALYNO, V50, P179, DOI 10.1016/0034-6667(87)90045-5; WOLFE JA, 1987, PALAEOGEOGR PALAEOCL, V61, P33, DOI 10.1016/0031-0182(87)90040-X	176	46	45	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e67182	10.1371/journal.pone.0067182	http://dx.doi.org/10.1371/journal.pone.0067182			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874409	Green Published, gold			2022-12-27	WOS:000321765300006
J	Lin, CY; Chen, HJ; Li, TM; Fong, YC; Liu, SC; Chen, PC; Tang, CH				Lin, Chih-Yang; Chen, Hui-Jye; Li, Te-Mao; Fong, Yi-Chin; Liu, Shan-Chi; Chen, Po-Chun; Tang, Chih-Hsin			beta 5 Integrin Up-Regulation in Brain-Derived Neurotrophic Factor Promotes Cell Motility in Human Chondrosarcoma	PLOS ONE			English	Article							KAPPA-B; SIGNALING PATHWAY; ALPHA-V-BETA-3 INTEGRIN; INCREASES MIGRATION; NEUROBLASTOMA-CELLS; CARCINOMA-CELLS; EXPRESSION; ACTIVATION; CANCER; TRKB	Chondrosarcoma is a primary malignant bone cancer, with a potent capacity to invade locally and cause distant metastasis; it has a poor prognosis and shows a predilection for metastasis to the lungs. Brain derived neurotrophic factor (BDNF) is a small-molecule protein from the neurotrophin family of growth factors that is associated with the disease status and outcomes of cancers. However, the effect of BDNF on migration activity in human chondrosarcoma cells is mostly unknown. Here, we found that human chondrosarcoma tissues showed significant expression of BDNF, which was higher than that in normal cartilage and primary chondrocytes. We also found that BDNF increased the migration and expression of beta 5 integrin in human chondrosarcoma cells. In addition, knockdown of BDNF expression markedly inhibited migratory activity. BDNF-mediated migration and beta 5 integrin up-regulation were attenuated by antibody, inhibitor, or siRNA against the TrkB receptor. Pretreatment of chondrosarcoma cells with PI3K, Akt, and NF-kappa B inhibitors or mutants also abolished BDNF-promoted migration and integrin expression. The PI3K, Akt, and NF-kappa B signaling pathway was activated after BDNF treatment. Taken together, our results indicate that BDNF enhances the migration of chondrosarcoma by increasing beta 5 integrin expression through a signal transduction pathway that involves the TrkB receptor, PI3K, Akt, and NF-kappa B. BDNF thus represents a promising new target for treating chondrosarcoma metastasis.	[Lin, Chih-Yang; Chen, Hui-Jye; Tang, Chih-Hsin] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Chen, Hui-Jye] China Med Univ, Grad Inst Mol Syst Biomed, Taichung, Taiwan; [Li, Te-Mao; Fong, Yi-Chin] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Fong, Yi-Chin] China Med Univ Hosp, Dept Orthopaed, Taichung, Taiwan; [Liu, Shan-Chi] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan; [Chen, Po-Chun] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Tang, Chih-Hsin] China Med Univ, Sch Med, Dept Pharmacol, Taichung, Taiwan; [Tang, Chih-Hsin] Asia Univ, Dept Biotechnol, Coll Hlth Sci, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Chung Hsing University; National Chung Hsing University; China Medical University Taiwan; Asia University Taiwan	Tang, CH (corresponding author), China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan.	chtang@mail.cmu.edu.tw	Tang, Chih Hsin/O-5212-2015	Tang, Chih Hsin/0000-0002-7113-8352	National Science Council of Taiwan [NSC99-2320-B-039-003-MY3, 100-2320-B-039-028-MY3, 101-2314-B-039-002-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Science Council of Taiwan (NSC99-2320-B-039-003-MY3; 100-2320-B-039-028-MY3; 101-2314-B-039-002-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akil H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025097; Au CWH, 2009, CANCER LETT, V281, P151, DOI 10.1016/j.canlet.2009.02.025; BARNES R, 1966, Journal of Bone and Joint Surgery British Volume, V48, P729; Bianchi-Smiraglia A, 2012, ONCOGENE; BLOCK JA, 1991, J BONE JOINT SURG AM, V73A, P647, DOI 10.2106/00004623-199173050-00002; Chang MS, 2004, MOL PHARMACOL, V66, P561; Chen PS, 2007, J CELL SCI, V120, P2053, DOI 10.1242/jcs.03460; Chen YJ, 2009, J CELL PHYSIOL, V221, P98, DOI 10.1002/jcp.21835; DORFMAN HD, 1995, CANCER, V75, P203, DOI 10.1002/1097-0142(19950101)75:1+<203::AID-CNCR2820751308>3.0.CO;2-V; Fong YC, 2007, J ORTHOP RES, V25, P1106, DOI 10.1002/jor.20364; Fong YC, 2012, J CELL PHYSIOL, V227, P223, DOI 10.1002/jcp.22720; Giancotti FG, 2003, ANNU REV CELL DEV BI, V19, P173, DOI 10.1146/annurev.cellbio.19.031103.133334; Heyder C, 2005, CLIN EXP METASTAS, V22, P99, DOI 10.1007/s10585-005-4335-z; Huang CY, 2012, ARTHRITIS RHEUM-US, V64, P3344, DOI 10.1002/art.34557; Huang CY, 2011, BIOCHEM PHARMACOL, V81, P577, DOI 10.1016/j.bcp.2010.12.005; Huang YT, 2010, INT J ONCOL, V37, P943, DOI 10.3892/ijo_00000745; Lai TH, 2009, J CELL PHYSIOL, V218, P334, DOI 10.1002/jcp.21601; Liu SS, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-58; Matsuda S, 2012, J CELL PHYSIOL, V227, P2123, DOI 10.1002/jcp.22942; Nakamura K, 2006, CANCER RES, V66, P4249, DOI 10.1158/0008-5472.CAN-05-2789; Nosrat CA, 1997, CELL TISSUE RES, V290, P569, DOI 10.1007/s004410050962; Numakawa T, 2010, HISTOL HISTOPATHOL, V25, P237, DOI 10.14670/HH-25.237; Okamura K, 2012, LUNG CANCER, V78, P100, DOI 10.1016/j.lungcan.2012.07.011; Okugawa Y, 2012, BRIT J CANC; Pescador D, 2012, INT J SURG CASE REP, V3, P134, DOI 10.1016/j.ijscr.2011.11.009; Qiao M, 2008, CELL CYCLE, V7, P2991, DOI 10.4161/cc.7.19.6784; Scala S, 1996, CANCER RES, V56, P3737; Seales EC, 2005, CANCER RES, V65, P4645, DOI 10.1158/0008-5472.CAN-04-3117; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Su CM, 2009, J CELL PHYSIOL, V220, P499, DOI 10.1002/jcp.21802; Sun CY, 2012, INT J CANCER, V130, P827, DOI 10.1002/ijc.26059; Sun CY, 2010, TUMOR BIOL, V31, P121, DOI 10.1007/s13277-010-0016-x; Takenaka K, 2000, INT J ONCOL, V17, P1187; Tang CH, 2012, CANCER LETT, V322, P98, DOI 10.1016/j.canlet.2012.02.014; Tang CH, 2012, BIOCHEM PHARMACOL, V83, P335, DOI 10.1016/j.bcp.2011.11.013; Tang CH, 2010, ARTHRITIS RHEUM-US, V62, P3615, DOI 10.1002/art.27755; Taverna D, 2005, CANCER RES, V65, P10324, DOI 10.1158/0008-5472.CAN-04-4098; Tong KM, 2011, J CELL BIOCHEM, V112, P1431, DOI 10.1002/jcb.23059; Wang YF, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-84; Wang ZP, 2010, J BIOL CHEM, V285, P20806, DOI 10.1074/jbc.M110.118521; Weis SM, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006478; Wu MH, 2012, J CELL PHYSIOL, V227, P3016, DOI 10.1002/jcp.23043; Yamashiro T, 2001, BONE, V28, P404, DOI 10.1016/S8756-3282(01)00405-7; Yan YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035709; Yao RQ, 2012, NEUROCHEM RES, V37, P2777, DOI 10.1007/s11064-012-0871-5; Yuan J, 2005, J ORTHOP RES, V23, P1467, DOI 10.1016/j.orthres.2005.04.004	46	16	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e67990	10.1371/journal.pone.0067990	http://dx.doi.org/10.1371/journal.pone.0067990			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874483	Green Published, gold, Green Submitted			2022-12-27	WOS:000321736900043
J	Resende, LPF; Boyle, M; Tran, D; Fellner, T; Jones, DL				Resende, Luis Pedro F.; Boyle, Monica; Tran, Darrell; Fellner, Thomas; Jones, D. Leanne			Headcase Promotes Cell Survival and Niche Maintenance in the Drosophila Testis	PLOS ONE			English	Article							STEM-CELL; SELF-RENEWAL; PATHWAY; SPERMATOGENESIS; PROLIFERATION; TRANSCRIPTION; ACTIVATION; SCREEN; OVARY	At the apical tip of the Drosophila testis, germline and somatic stem cells surround a cluster of somatic cells called the hub. Hub cells produce a self-renewal factor, Unpaired (Upd), that activates the JAK-STAT pathway in adjacent stem cells to regulate stem cell behavior. Therefore, apical hub cells are a critical component of the stem cell niche in the testis. In the course of a screen to identify factors involved in regulating hub maintenance, we identified headcase (hdc). Hub cells depleted for hdc undergo programmed cell death, suggesting that anti-apoptotic pathways play an important role in maintenance of the niche. Using hdc as paradigm, we describe here the first comprehensive analysis on the effects of a progressive niche reduction on the testis stem cell pool. Surprisingly, single hub cells remain capable of supporting numerous stem cells, indicating that although the size and number of niche support cells influence stem cell maintenance, the testis stem cell niche appears to be remarkably robust in the its ability to support stem cells after severe damage.	[Resende, Luis Pedro F.; Boyle, Monica; Tran, Darrell; Fellner, Thomas; Jones, D. Leanne] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Resende, Luis Pedro F.] Univ Porto, Inst Ciencias Biomed Abel Salazar, Grad Program Areas Basic & Appl Biol, P-4100 Oporto, Portugal; [Jones, D. Leanne] Univ Calif Los Angeles, Los Angeles, CA USA	Salk Institute; Universidade do Porto; University of California System; University of California Los Angeles	Jones, DL (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	leannejones@ucla.edu		Fernandes Resende, Luis Pedro/0000-0001-7365-904X	California Institute for Regenerative Medicine [RN1-00544-1]; National Institutes of Health [R01 AG028092]; NATIONAL INSTITUTE ON AGING [R01AG028092] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding provided by California Institute for Regenerative Medicine RN1-00544-1 and National Institutes of Health R01 AG028092. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoyel M, 2013, DEVELOPMENT, V140, P56, DOI 10.1242/dev.086413; Bach EA, 2003, GENETICS, V165, P1149; BOYLE M, 1995, DEVELOPMENT, V121, P1815; Boyle M, 2007, CELL STEM CELL, V1, P470, DOI 10.1016/j.stem.2007.08.002; de Cuevas M, 2011, DEVELOPMENT, V138, P2861, DOI 10.1242/dev.056242; Evans CJ, 2009, NAT METHODS, V6, P603, DOI 10.1038/nmeth.1356; Gambis A, 2011, DEV BIOL, V351, P128, DOI 10.1016/j.ydbio.2010.12.040; HARDY RW, 1979, J ULTRA MOL STRUCT R, V69, P180, DOI 10.1016/S0022-5320(79)90108-4; Harrison DA, 1998, GENE DEV, V12, P3252, DOI 10.1101/gad.12.20.3252; HAY BA, 1994, DEVELOPMENT, V120, P2121; Johnson K, 2002, CURR BIOL, V12, P1675, DOI 10.1016/S0960-9822(02)01180-6; Jones DL, 2008, NAT REV MOL CELL BIO, V9, P11, DOI 10.1038/nrm2319; Kawase E, 2004, DEVELOPMENT, V131, P1365, DOI 10.1242/dev.01025; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Le Bras S, 2006, DEV BIOL, V294, P92, DOI 10.1016/j.ydbio.2006.02.030; Leatherman JL, 2008, CELL STEM CELL, V3, P44, DOI 10.1016/j.stem.2008.05.001; Loncle N, 2012, J NEUROSCI, V32, P17086, DOI 10.1523/JNEUROSCI.1391-12.2012; Losick VP, 2011, DEV CELL, V21, P159, DOI 10.1016/j.devcel.2011.06.018; Michel M, 2012, DEVELOPMENT, V139, P2663, DOI 10.1242/dev.075242; Michel M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1426; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Resende LPF, 2012, CURR OPIN CELL BIOL, V24, P225, DOI 10.1016/j.ceb.2012.01.004; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Sheng XR, 2009, DEV BIOL, V334, P335, DOI 10.1016/j.ydbio.2009.07.031; Shivdasani AA, 2003, CURR BIOL, V13, P2065, DOI 10.1016/j.cub.2003.10.063; Song XQ, 2007, DEVELOPMENT, V134, P1071, DOI 10.1242/dev.003392; Steneberg P, 1998, GENE DEV, V12, P956, DOI 10.1101/gad.12.7.956; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Voog J, 2010, CELL STEM CELL, V6, P103, DOI 10.1016/j.stem.2010.01.011; Wawersik M, 2005, NATURE, V436, P563, DOI 10.1038/nature03849; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Zhang Z, 2013, CELL RES, V23, P573, DOI 10.1038/cr.2013.29; Zheng Q, 2011, DEV BIOL, V357, P202, DOI 10.1016/j.ydbio.2011.06.022	34	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68026	10.1371/journal.pone.0068026	http://dx.doi.org/10.1371/journal.pone.0068026			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874487	Green Published, Green Submitted, gold			2022-12-27	WOS:000321736900046
J	Ubeda, B; Di Giacomo, AS; Neiff, JJ; Loiselle, SA; Poi, ASG; Galvez, JA; Casco, S; Cozar, A				Ubeda, Barbara; Di Giacomo, Adrian S.; Jose Neiff, Juan; Loiselle, Steven A.; Guadalupe Poi, Alicia S.; Angel Galvez, Jose; Casco, Silvina; Cozar, Andres			Potential Effects of Climate Change on the Water Level, Flora and Macro-fauna of a Large Neotropical Wetland	PLOS ONE			English	Article							DEER BLASTOCERUS-DICHOTOMUS; CYANOBACTERIUM CYLINDROSPERMOPSIS-RACIBORSKII; SPECIES-AREA CURVES; ESTEROS-DEL-IBERA; MARSH DEER; PANTANAL WETLAND; VEGETATION DIVERSITY; FRESH-WATER; BRAZIL; CONSERVATION	Possible consequences of climate change in one of the world's largest wetlands (Ibera, Argentina) were analysed using a multi-scale approach. Climate projections coupled to hydrological models were used to analyse variability in wetland water level throughout the current century. Two potential scenarios of greenhouse gas emissions were explored, both resulting in an increase in the inter-annual fluctuations of the water level. In the scenario with higher emissions, projections also showed a long-term negative trend in water-level. To explore the possible response of biota to such water-level changes, species-area relationships of flora and aerial censuses of macro-fauna were analysed during an extraordinary dry period. Plant species richness at the basin scale was found to be highly resistant to hydrological changes, as the large dimension of the wetland acts to buffer against the water-level variations. However, local diversity decreased significantly with low water levels, leading to the loss of ecosystem resilience to additional stressors. The analysis of macro-fauna populations suggested that wetland provides refuge, in low water periods, for the animals with high dispersal ability (aquatic and migratory birds). On the contrary, the abundance of animals with low dispersal ability (mainly herbivorous species) was negatively impacted in low water periods, probably because they are required to search for alternative resources beyond the wetland borders. This period of resource scarcity was also related to increased mortality of large mammals (e. g. marsh deer) around water bodies with high anthropogenic enrichment and cyanobacteria dominance. The synergy between recurrent climatic fluctuations and additional stressors (i.e. biological invasions, eutrophication) presents an important challenge to the conservation of neotropical wetlands in the coming decades.	[Ubeda, Barbara; Angel Galvez, Jose; Cozar, Andres] Univ Cadiz, Fac Marine & Environm Sci, Dept Biol, Puerto Real, Spain; [Di Giacomo, Adrian S.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Inst Ecol Genet & Evoluc Buenos Aires CONICET UBA, Buenos Aires, DF, Argentina; [Di Giacomo, Adrian S.; Jose Neiff, Juan; Guadalupe Poi, Alicia S.; Casco, Silvina] Consejo Nacl Invest Cient & Tecn, Consejo Nacl Invest Cient & Tecn, CECOAL, Ctr Ecol Aplicada Litoral, Corrientes, Argentina; [Loiselle, Steven A.] Univ Siena, I-53100 Siena, Italy	Universidad de Cadiz; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Siena	Ubeda, B (corresponding author), Univ Cadiz, Fac Marine & Environm Sci, Dept Biol, Campus CEI MAR, Puerto Real, Spain.	barbara.ubeda@uca.es	Ubeda, Barbara/AAT-6839-2020; Galvez, Jose Angel/AAN-4367-2020; Úbeda Sánchez, Bárbara/AAZ-8930-2021; Loiselle, Steven/ABA-3324-2020; Cozar, Andres/G-2141-2016	Galvez, Jose Angel/0000-0001-6203-5186; Úbeda Sánchez, Bárbara/0000-0001-8165-2091; Loiselle, Steven/0000-0001-7414-0389; Cozar, Andres/0000-0003-1370-9935	BBVA Foundation [BIOCON 04-100/05]	BBVA Foundation	The present study is conducted under BBVA Foundation sponsored research project entitled "Impacto de los cambios del nivel de agua sobre la biodiversidad de los humedales del Ibera (Argentina)'' (BIOCON 04-100/05). The authors would like to thank the Subsecretaria de Recursos Hidricos (Argentina Government) and the Center for Water Research (University of Western Australia) for making hydro-meteorological data and DYRESM freely accessible for research. Request of raw data derived from the present study must be addressed to andres.cozar@uca.es. The authors also thank Ibera park rangers and Conservation Land Trust Foundation for their valuable support during the surveys, and two reviewers for their constructive comments that improved the paper, and are especially grateful to Dr. Vincent Hull for his huge support in the study of Ibera. Permission for field work in Ibera Reserve was granted by Corrientes government, and by Conservation Land Trust Foundation in private land. This research did not involve capture or handling of animals, therefore did not require approval of animal care and use procedures. Field studies did not create effects on endangered or protected species. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez B.B., 2003, FAUNA IBERA; Arbo M. M., 2002, FLORA IBERA; Beccaceci Marcelo D., 1994, Oryx, V28, P131; Beever EA, 2011, BIOL CONSERV, V144, P1255, DOI 10.1016/j.biocon.2011.04.001; Bourke A. T. C., 1983, TOXICON, V21, P45, DOI DOI 10.1016/0041-0101(83)90151-4; Brooks ML, 2004, BIOSCIENCE, V54, P677, DOI 10.1641/0006-3568(2004)054[0677:EOIAPO]2.0.CO;2; Campos ZMS, 2002, COMPORTAMENTO TERMOR; Carbonell M, 1997, WETLANDS BIODIVERSIT, P1; Castro D, 2004, TOXICON, V44, P483, DOI 10.1016/j.toxicon.2004.06.005; Chambers PA, 2008, HYDROBIOLOGIA, V595, P9, DOI 10.1007/s10750-007-9154-6; Cirignoli S, 2010, B ESTEROS, V8, P8; Colwell R.K., 2006, ESTIMATES STAT ESTIM; Cozar A, 2005, ECOL MODEL, V186, P63, DOI 10.1016/j.ecolmodel.2005.01.020; Cozar A, 2005, ECOL MODEL, V186, P29, DOI 10.1016/j.ecolmodel.2005.01.029; Cozar A, 2003, CAN J FISH AQUAT SCI, V60, P411, DOI 10.1139/F03-037; Cozar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029962; Cuadrado Graciela A., 1993, Revista Brasileira de Biologia, V53, P443; Figueira J. E. C., 2006, Braz. J. Biol., V66, P393, DOI 10.1590/S1519-69842006000300003; Gantes P., 2005, LIMNETICA, V24, P203; Giraudo AR, 2003, FAUNA IBERA CORRIENT, P179; Godbold JA, 2011, P ROY SOC B-BIOL SCI, V278, P2510, DOI 10.1098/rspb.2010.2414; Griffiths DJ, 2003, ENVIRON TOXICOL, V18, P78, DOI 10.1002/tox.10103; HAYMAN J, 1992, MED J AUSTRALIA, V157, P794; INCYTH, 1981, EST MACR IB CTR REG, VII; IPCC, 2007, PHYS SCI BAS; Iriondo M., 1994, COMUNICACIONES MUSEO, V4; Iriondo Martin H., 1981, ECOLOGIA, V6, P5; IUCN (International Union for Conservation of Nature), 2012, RED LIST THREAT SPEC; KUSHLAN JA, 1974, COPEIA, P993; Law BS, 1998, BIODIVERS CONSERV, V7, P323, DOI 10.1023/A:1008877611726; MARGALEF R, 1963, AM NAT, V97, P357, DOI 10.1086/282286; Mourao G, 2000, BIOL CONSERV, V92, P175, DOI 10.1016/S0006-3207(99)00051-8; Neiff JJ, 2011, BIODIVERS CONSERV, V20, P2007, DOI 10.1007/s10531-011-0071-7; Neiff JJ, 2001, BIODIVERSITY IN WETLANDS: ASSESSMENT, FUNCTION AND CONSERVATION, VOL 2, P157; Neiff JJ, 2009, IMPACT WATER LEVEL V; Neiff JJ, 1981, ESTUDIO MACROSISTEMA, P14; Olson DD., 1998, FRESHWATER BIODIVERS; Orozco MM, 2007, INFORME PRELIMINAR M, P1; Pinder L, 1996, BIOL CONSERV, V75, P87, DOI 10.1016/0006-3207(95)00033-X; PRANCE GT, 1995, BIODIVERS CONSERV, V4, P490, DOI 10.1007/BF00056339; Reynolds JH, 2011, BIOL CONSERV, V144, P1278, DOI 10.1016/j.biocon.2010.12.002; Riis T, 2002, AQUAT BOT, V74, P133, DOI 10.1016/S0304-3770(02)00074-8; Rossi C, 2002, I18CT980262 EC INCO; Saker ML, 1999, ENVIRON TOXICOL, V14, P179, DOI 10.1002/(SICI)1522-7278(199902)14:1<179::AID-TOX23>3.0.CO;2-G; Scheffer M., 2004, ECOLOGY SHALLOW LAKE; Schladow SG, 1997, ECOL MODEL, V96, P111, DOI 10.1016/S0304-3800(96)00063-4; Sivonen K, 1999, TOXIC CYANOBACTERIA, P41, DOI DOI 10.4324/9780203478073; Soria A, 2003, FAUNA IBERA, P349; Tjorve E, 2003, J BIOGEOGR, V30, P827, DOI 10.1046/j.1365-2699.2003.00877.x; Tjorve E, 2009, J BIOGEOGR, V36, P1435, DOI 10.1111/j.1365-2699.2009.02101.x; Tockner K, 2002, ENVIRON CONSERV, V29, P308, DOI 10.1017/S037689290200022X; Tomas WM, 2000, STUD NEOTROP FAUNA E, V35, P165, DOI 10.1076/snfe.35.3.165.8861; Tomas WM, 2001, STUD NEOTROP FAUNA E, V36, P9, DOI 10.1076/snfe.36.1.9.8877; Tranvik LJ, 2009, LIMNOL OCEANOGR, V54, P2298, DOI 10.4319/lo.2009.54.6_part_2.2298; Triantis KA, 2003, J BIOGEOGR, V30, P19, DOI 10.1046/j.1365-2699.2003.00805.x; Turner MA, 2005, CAN J FISH AQUAT SCI, V62, P991, DOI 10.1139/F05-003; Wagner T, 2002, LAKE RESERV MANAGE, V18, P52, DOI 10.1080/07438140209353929; Woodward G, 2010, PHILOS T R SOC B, V365, P2093, DOI 10.1098/rstb.2010.0055; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4; Zalba SM, 2010, B ESTEROS, V8, P37; Zalocar Y., 2003, LIMNOLOGIA IBERA, P85	61	9	10	1	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e67787	10.1371/journal.pone.0067787	http://dx.doi.org/10.1371/journal.pone.0067787			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874446	gold, Green Published, Green Submitted			2022-12-27	WOS:000321736900022
J	Viding, E; Price, TS; Jaffee, SR; Trzaskowski, M; Davis, OSP; Meaburn, EL; Haworth, CMA; Plomin, R				Viding, Essi; Price, Thomas S.; Jaffee, Sara R.; Trzaskowski, Maciej; Davis, Oliver S. P.; Meaburn, Emma L.; Haworth, Claire M. A.; Plomin, Robert			Genetics of Callous-Unemotional Behavior in Children	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COMMON SNPS EXPLAIN; CONDUCT PROBLEMS; COMPLEX TRAITS; PSYCHOPATHIC PERSONALITY; ANTISOCIAL-BEHAVIOR; CHILDHOOD; HERITABILITY; ADOLESCENCE; RISK	Callous-unemotional behavior (CU) is currently under consideration as a subtyping index for conduct disorder diagnosis. Twin studies routinely estimate the heritability of CU as greater than 50%. It is now possible to estimate genetic influence using DNA alone from samples of unrelated individuals, not relying on the assumptions of the twin method. Here we use this new DNA method (implemented in a software package called Genome-wide Complex Trait Analysis, GCTA) for the first time to estimate genetic influence on CU. We also report the first genome-wide association (GWA) study of CU as a quantitative trait. We compare these DNA results to those from twin analyses using the same measure and the same community sample of 2,930 children rated by their teachers at ages 7, 9 and 12. GCTA estimates of heritability were near zero, even though twin analysis of CU in this sample confirmed the high heritability of CU reported in the literature, and even though GCTA estimates of heritability were substantial for cognitive and anthropological traits in this sample. No significant associations were found in GWA analysis, which, like GCTA, only detects additive effects of common DNA variants. The phrase 'missing heritability' was coined to refer to the gap between variance associated with DNA variants identified in GWA studies versus twin study heritability. However, GCTA heritability, not twin study heritability, is the ceiling for GWA studies because both GCTA and GWA are limited to the overall additive effects of common DNA variants, whereas twin studies are not. This GCTA ceiling is very low for CU in our study, despite its high twin study heritability estimate. The gap between GCTA and twin study heritabilities will make it challenging to identify genes responsible for the heritability of CU.	[Viding, Essi; Price, Thomas S.; Jaffee, Sara R.; Trzaskowski, Maciej; Davis, Oliver S. P.; Haworth, Claire M. A.; Plomin, Robert] Kings Coll London, MRC, Genet & Dev Psychiat Ctr, Inst Psychiat, London WC2R 2LS, England; [Viding, Essi] UCL, Div Psychol & Language Sci, London, England; [Price, Thomas S.] Univ Penn, Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA; [Jaffee, Sara R.] Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA; [Meaburn, Emma L.] Univ London, Birkbeck, Dept Psychol Sci, London, England	University of London; King's College London; University of London; University College London; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of London; Birkbeck University London	Viding, E (corresponding author), Kings Coll London, MRC, Genet & Dev Psychiat Ctr, Inst Psychiat, De Crespigny Pk, London WC2R 2LS, England.	e.viding@ucl.ac.uk	Price, Thomas S./B-7372-2008; Haworth, Claire M.A./C-7073-2009; Davis, Oliver SP/B-9653-2008	Price, Thomas S./0000-0001-7356-2109; Haworth, Claire M.A./0000-0002-8608-289X; Davis, Oliver SP/0000-0002-6448-3684; Trzaskowski, Maciej/0000-0001-8559-6525; Plomin, Robert/0000-0002-0756-3629; Meaburn, Emma/0000-0001-8096-9089; Viding, Essi/0000-0001-8468-8874	U.K. Medical Research Council (MRC) [G0500079]; US National Institutes of Health [HD044454, HD046167]; Medical Research Council Research Professorship award [G19/2]; European Advanced Investigator award [295366]; Wellcome Trust [WT088984]; British Academy; Wellcome Trust Case Control Consortium 2 project [085475/B/08/Z, 085475/Z/08/Z]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059215, R01HD044454] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD046167] Funding Source: NIH RePORTER; Medical Research Council [G9817803B, G0500079, G19/2, G0901245] Funding Source: researchfish; MRC [G0500079, G0901245, G19/2] Funding Source: UKRI	U.K. Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council Research Professorship award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Advanced Investigator award; Wellcome Trust(Wellcome TrustEuropean Commission); British Academy; Wellcome Trust Case Control Consortium 2 project; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	TEDS is supported by a program grant (G0500079) from the U.K. Medical Research Council (MRC), with additional support from the US National Institutes of Health (HD044454; HD046167). R.P. is supported by a Medical Research Council Research Professorship award (G19/2) and a European Advanced Investigator award (295366); O.S.P.D. is supported by a Sir Henry Wellcome Fellowship from the Wellcome Trust (WT088984); C.M.A.H. is supported by a research fellowship from the British Academy. Genome-wide genotyping was made possible by grants from the Wellcome Trust Case Control Consortium 2 project (085475/B/08/Z; 085475/Z/08/Z). Funders websites include: http://www.mrc.ac.uk; http://www.nih.gov/; http://erc.europa.eu/; http://www.wellcome.ac.uk/; http://www.britac.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker ED, 2011, J CHILD PSYCHOL PSYC, V52, P878, DOI 10.1111/j.1469-7610.2011.02397.x; Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; Beitchman JH, 2012, EUR CHILD ADOLES PSY, V21, P125, DOI 10.1007/s00787-012-0240-6; Bezdjian S, 2011, CHILD DEV, V82, P1267, DOI 10.1111/j.1467-8624.2011.01598.x; Boker S, 2011, PSYCHOMETRIKA, V76, P306, DOI 10.1007/s11336-010-9200-6; Browning SR, 2011, AM J HUM GENET, V89, P191, DOI 10.1016/j.ajhg.2011.05.025; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chabris CF, 2012, PSYCHOL SCI, V23, P1314, DOI 10.1177/0956797611435528; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Flint J, 2004, MAMM GENOME, V15, P77, DOI 10.1007/s00335-003-3033-x; Fontaine NMG, 2011, J ABNORM PSYCHOL, V120, P730, DOI 10.1037/a0022620; Fontaine NMG, 2010, J AM ACAD CHILD PSY, V49, P656, DOI 10.1016/j.jaac.2010.03.014; Forsman M, 2008, J ABNORM PSYCHOL, V117, P606, DOI 10.1037/0021-843X.117.3.606; Forsman M, 2007, BRIT J DEV PSYCHOL, V25, P383, DOI 10.1348/026151006X158799; Fowler T, 2009, PSYCHIAT GENET, V19, P312, DOI 10.1097/YPG.0b013e3283328df4; Frick PJ, 2009, DEV PSYCHOPATHOL, V21, P1111, DOI 10.1017/S0954579409990071; Frick PJ, 2003, DEV PSYCHOL, V39, P246, DOI 10.1037/0012-1649.39.2.246; Frick PJ., 2001, ANTISOCIAL PROCESS S; Frick PJ, 2010, PROPOSAL DSM 5 CHILD; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Gomez R, 1999, J CHILD PSYCHOL PSYC, V40, P265, DOI 10.1111/1469-7610.00440; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Hart, 1997, HDB ANTISOCIAL BEHAV; Hill WG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000008; Hindorff LA, CATALOG PUBLISHED GE; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Jones AP, 2009, AM J PSYCHIAT, V166, P95, DOI 10.1176/appi.ajp.2008.07071050; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kovas Y, 2007, MONOGR SOC RES CHILD, V72, P1; Kumsta R, 2012, BRIT J PSYCHIAT, V200, P197, DOI 10.1192/bjp.bp.110.089441; Larsson H, 2008, CRIM JUSTICE BEHAV, V35, P197, DOI 10.1177/0093854807310225; Lee SH, 2012, NAT GENET, V44, P247, DOI 10.1038/ng.1108; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Little R.J.A., 2002, STAT ANAL MISSING DA; Lubke GH, 2012, BIOL PSYCHIAT, V72, P707, DOI 10.1016/j.biopsych.2012.03.011; Lynam DR, 2007, J ABNORM PSYCHOL, V116, P155, DOI 10.1037/0021-843X.116.1.155; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Malik AI, 2012, GENES BRAIN BEHAV, V11, P545, DOI 10.1111/j.1601-183X.2012.00776.x; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marsh AA, 2008, AM J PSYCHIAT, V165, P712, DOI 10.1176/appi.ajp.2007.07071145; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Meyer-Lindenberg A, 2006, P NATL ACAD SCI USA, V103, P6269, DOI 10.1073/pnas.0511311103; Munafo MR, 2008, BIOL PSYCHIAT, V63, P852, DOI 10.1016/j.biopsych.2007.08.016; Nadder TS, 2001, J CHILD PSYCHOL PSYC, V42, P475, DOI 10.1111/1469-7610.00741; Oliver BR, 2007, TWIN RES HUM GENET, V10, P96, DOI 10.1375/twin.10.1.96; Park JH, 2011, P NATL ACAD SCI USA, V108, P18026, DOI 10.1073/pnas.1114759108; Plomin R., 2013, BEHAV GENET; Plomin R, 2013, PSYCHOL SCI, V24, P562, DOI 10.1177/0956797612457952; Plomin R, 2013, CHILD DEV, V84, P104, DOI 10.1111/j.1467-8624.2012.01757.x; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; R Development Core Team, 2011, R LANG ENV STAT COMP; Rowe R, 2010, J CHILD PSYCHOL PSYC, V51, P688, DOI 10.1111/j.1469-7610.2009.02199.x; Sadeh N, 2010, J ABNORM PSYCHOL, V119, P604, DOI 10.1037/a0019709; Sebastian CL, 2012, ARCH GEN PSYCHIAT, V69, P814, DOI 10.1001/archgenpsychiatry.2011.2070; Siontis KCM, 2010, EUR J HUM GENET, V18, P832, DOI 10.1038/ejhg.2010.26; van der Waerden B., 1952, INDAGATIONES MATHEMA, V14, P453, DOI [10.1016/S1385-7258(53)50012-5, DOI 10.1016/S1385-7258(52)50063-5]; Viding E, 2005, J CHILD PSYCHOL PSYC, V46, P592, DOI 10.1111/j.1469-7610.2004.00393.x; Viding E, 2007, BRIT J PSYCHIAT, V190, pS33, DOI 10.1192/bjp.190.5.s33; Viding E, 2012, DEV PSYCHOPATHOL, V24, P969, DOI 10.1017/S095457941200048X; Viding E, 2010, J CHILD PSYCHOL PSYC, V51, P780, DOI 10.1111/j.1469-7610.2010.02236.x; Vinkhuyzen AAE, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.27; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zaitlen N, 2012, HUM GENET, V131, P1655, DOI 10.1007/s00439-012-1199-6	71	33	33	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e65789	10.1371/journal.pone.0065789	http://dx.doi.org/10.1371/journal.pone.0065789			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874384	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000321736900001
J	Matus, S; Lopez, E; Valenzuela, V; Nassif, M; Hetz, C				Matus, Soledad; Lopez, Estefania; Valenzuela, Vicente; Nassif, Melissa; Hetz, Claudio			Functional Contribution of the Transcription Factor ATF4 to the Pathogenesis of Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; FRONTOTEMPORAL LOBAR DEGENERATION; ER-STRESS; NEURODEGENERATIVE DISEASES; DISULFIDE-ISOMERASE; MOTONEURON LOSS; MOTOR-NEURONS; APOPTOSIS; ALS	Endoplasmic reticulum (ER) stress represents an early pathological event in amyotrophic lateral sclerosis (ALS). ATF4 is a key ER stress transcription factor that plays a role in both adaptation to stress and the activation of apoptosis. Here we investigated the contribution of ATF4 to ALS. ATF4 deficiency reduced the rate of birth of SOD1(G86R) transgenic mice. The fraction of ATF4(-/-)-SOD1(G85R) transgenic mice that were born are more resistant to develop ALS, leading to delayed disease onset and prolonged life span. ATF4 deficiency completely attenuated the induction of pro-apoptotic genes, including BIM and CHOP, and also led to quantitative changes in the ER protein homeostasis network. Unexpectedly, ATF4 deficiency enhanced mutant SOD1 aggregation at the end stage of the disease. Studies in the motoneuron cell line NSC34 demonstrated that knocking down ATF4 enhances mutant SOD1 aggregation possibly due to alteration in the redox status of the cell. Our results support a functional role of ATF4 in ALS, offering a novel target for disease intervention.	[Matus, Soledad; Hetz, Claudio] Neurounion Biomed Fdn, Santiago, Chile; [Lopez, Estefania; Valenzuela, Vicente; Nassif, Melissa; Hetz, Claudio] Univ Chile, Fac Med, Biomed Neurosci Inst, Santiago 7, Chile; [Lopez, Estefania; Valenzuela, Vicente; Nassif, Melissa; Hetz, Claudio] Univ Chile, Ctr Mol Studies Cell, Program Cellular & Mol Biol, Inst Biomed Sci, Santiago, Chile; [Hetz, Claudio] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Universidad de Chile; Universidad de Chile; Harvard University; Harvard T.H. Chan School of Public Health	Matus, S (corresponding author), Neurounion Biomed Fdn, Santiago, Chile.	soledad.matus@neurounion.com; chetz@med.uchile.cl	Nassif, Melissa/ABE-6932-2020; Matus, Soledad/AAA-3857-2020; Hetz, Claudio/I-1900-2013; Hetz, Claudio/ABD-7514-2021	Nassif, Melissa/0000-0002-5039-5245; Hetz, Claudio/0000-0001-7724-1767; 	Muscular Dystrophy Association; ALS Therapy Alliance; Millennium Institute [P09-015-F, ACT1109, FONDEF D11I1007]; FONDECYT [1100176, 11121524]; AD Association; ALSA [1829]; Insercion Capital Humano en la Academia [79100007]; CONICYT	Muscular Dystrophy Association(Muscular Dystrophy Association); ALS Therapy Alliance; Millennium Institute(Takeda Pharmaceutical Company Ltd); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); AD Association; ALSA; Insercion Capital Humano en la Academia; CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was funded by The Muscular Dystrophy Association and ALS Therapy Alliance; Millennium Institute no. P09-015-F, ACT1109 and FONDEF D11I1007; FONDECYT no. 1100176; AD Association (CH), FONDECYT 11121524 (SM), ALSA 1829 The Milton-Safenowitz Post-Doctoral Fellowship (SM), Insercion Capital Humano en la Academia 79100007. VV and MC received a CONICYT PhD fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen PM, 2011, NAT REV NEUROL, V7, P603, DOI 10.1038/nrneurol.2011.150; Andreu CI, 2012, FEBS LETT, V586, P2826, DOI 10.1016/j.febslet.2012.07.023; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Atkin JD, 2006, J BIOL CHEM, V281, P30152, DOI 10.1074/jbc.M603393200; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Brotherton TE, 2013, NEUROBIOL DIS, V49, P49, DOI 10.1016/j.nbd.2012.08.010; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Deng HX, 2010, ANN NEUROL, V67, P739, DOI 10.1002/ana.22051; Enyedi B, 2010, ANTIOXID REDOX SIGN, V13, P721, DOI 10.1089/ars.2009.2880; Fecto F, 2011, ARCH NEUROL-CHICAGO, V68, P1440, DOI 10.1001/archneurol.2011.250; Galehdar Z, 2010, J NEUROSCI, V30, P16938, DOI 10.1523/JNEUROSCI.1598-10.2010; Gupta S, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.74; Halterman MW, 2010, J BIOL CHEM, V285, P21329, DOI 10.1074/jbc.M109.095299; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hetz C, 2007, CELL DEATH DIFFER, V14, P1386, DOI 10.1038/sj.cdd.4402166; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hetz C, 2011, PHYSIOL REV, V91, P1219, DOI 10.1152/physrev.00001.2011; Hetz C, 2009, GENE DEV, V23, P2294, DOI 10.1101/gad.1830709; Hoffstrom BG, 2010, NAT CHEM BIOL, V6, P900, DOI [10.1038/nchembio.467, 10.1038/NCHEMBIO.467]; Kieran D, 2007, P NATL ACAD SCI USA, V104, P20606, DOI 10.1073/pnas.0707906105; Kwok CT, 2013, FREE RADICAL BIO MED, V58, P81, DOI 10.1016/j.freeradbiomed.2013.01.001; Lange PS, 2008, J EXP MED, V205, P1227, DOI 10.1084/jem.20071460; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Masuoka HC, 2002, BLOOD, V99, P736, DOI 10.1182/blood.V99.3.736; Matus S, 2012, AUTOPHAGY, V8, P997, DOI 10.4161/auto.20748; Matus S, 2011, CURR OPIN CELL BIOL, V23, P239, DOI 10.1016/j.ceb.2011.01.003; Nassif M, 2010, ANTIOXID REDOX SIGN, V13, P1955, DOI 10.1089/ars.2009.2991; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nishitoh H, 2008, GENE DEV, V22, P1451, DOI 10.1101/gad.1640108; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; RIPPS ME, 1995, P NATL ACAD SCI USA, V92, P689, DOI 10.1073/pnas.92.3.689; Rojas-Rivera D, 2012, CELL DEATH DIFFER; Sasaki S, 2010, J NEUROPATH EXP NEUR, V69, P346, DOI 10.1097/NEN.0b013e3181d44992; Saxena S, 2011, NEURON, V71, P35, DOI 10.1016/j.neuron.2011.06.031; Saxena S, 2009, NAT NEUROSCI, V12, P627, DOI 10.1038/nn.2297; Solda T, 2006, J BIOL CHEM, V281, P6219, DOI 10.1074/jbc.M513595200; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Turner BJ, 2005, J NEUROSCI, V25, P108, DOI 10.1523/JNEUROSCI.4253-04.2005; Valenzuela V, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.8; Verfaillie T, 2012, CELL DEATH DIFFER, V19, P1880, DOI 10.1038/cdd.2012.74; Vidal RL, 2012, HUM MOL GENET, V21, P2245, DOI 10.1093/hmg/dds040; Walker AK, 2011, IUBMB LIFE; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang LJ, 2011, HUM MOL GENET, V20, P1008, DOI 10.1093/hmg/ddq546; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	54	62	63	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e66672	10.1371/journal.pone.0066672	http://dx.doi.org/10.1371/journal.pone.0066672			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874395	Green Published, gold, Green Submitted			2022-12-27	WOS:000324146200002
J	Chen, BD; Ye, B; Zhang, J; Ying, LX; Chen, Y				Chen, Baode; Ye, Bo; Zhang, Jian; Ying, Lixiong; Chen, Yu			RDW to Platelet Ratio: A Novel Noninvasive Index for Predicting Hepatic Fibrosis and Cirrhosis in Chronic Hepatitis B	PLOS ONE			English	Article							CELL DISTRIBUTION WIDTH; LIVER-DISEASE; C VIRUS; POSITIVE PATIENTS; HEART-FAILURE; INFECTION; MARKER; MANAGEMENT; ANEMIA; MODEL	Objective: To develop a simple predictive model for significant fibrosis and cirrhosis in chronic hepatitis B (CHB) using the routine hematological parameters of a complete blood count. Methods: A total of 458 eligible CHB patients who had undergone a liver biopsy were randomly divided into two cohorts: an estimation group (n = 310) and a validation group (n = 148). Liver histology was assessed according to the Metavir scoring scheme. All common demographics, hematological parameters, HBeAg status, HBV DNA, and liver biochemistry were analyzed. Results: Based on routinely available clinical parameters (age, sex, HBeAg status, HBV DNA, common hematological parameters of a complete blood cell count), a model for predicting significant fibrosis (Metavir score >= 2) in the estimation group was derived using platelets and red cell distribution width (RDW), and another model for predicting cirrhosis (Metavir score = 4) was derived using platelets, RDW and hemoglobin. A novel index, the RDW to platelet ratio (RPR), was developed to amplify the opposing effects of liver fibrosis on the RDW and platelets. The AUCs of the RPR for predicting significant fibrosis and cirrhosis were 0.825 and 0.884, respectively, which is superior to the AAR, FIB-4 and APRI in the estimation group. Compared with the two derived models, the RPR has a comparable predictive power for significant fibrosis and cirrhosis. Using optimized cutoffs (0.10 and 0.16), the RPR accurately predicted 63.1% of cases with significant fibrosis and 73.7% of cases with cirrhosis and accurately excluded 85.5% of the cases with mild fibrosis and 93.0% of the cases with no cirrhosis. Conclusion: The RPR, a routinely available, inexpensive and easily calculated index, can predict significant fibrosis and cirrhosis in CHB patients with relatively high accuracy. The application of this index may reduce the need for liver biopsy in CHB patients.	[Chen, Baode; Ye, Bo; Chen, Yu] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Lab Med, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Jian] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Anesthesiol, Hangzhou 310003, Zhejiang, Peoples R China; [Ying, Lixiong] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Pathol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Chen, Y (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Lab Med, Hangzhou 310003, Zhejiang, Peoples R China.	chenyyu@hotmail.com		chen, baode/0000-0003-1362-4296	Health Department of Zhejiang Province [2012RCB011]; Education Department of Zhejiang Province [Y201016866]	Health Department of Zhejiang Province; Education Department of Zhejiang Province	This study was supported by grants from Health Department of Zhejiang Province (2012RCB011; http://www.zjwst.gov.cn), and partly from Education Department of Zhejiang Province (Y201016866; http://www.zjkysz.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhouri N, 2012, LIVER INT, V32, P297, DOI 10.1111/j.1478-3231.2011.02639.x; Allen LA, 2010, J CARD FAIL, V16, P230, DOI 10.1016/j.cardfail.2009.11.003; Anand I, 2004, CIRCULATION, V110, P149, DOI 10.1161/01.CIR.0000134279.79571.73; [Anonymous], J HEPATOLOGY, V50, P227; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bojakowski K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036482; Castera L, 2012, GASTROENTEROLOGY, V142, P1293, DOI 10.1053/j.gastro.2012.02.017; Chan HLY, 2003, J CLIN MICROBIOL, V41, P1277, DOI 10.1128/JCM.41.3.1277-1279.2003; Chen PC, 2010, AM J EPIDEMIOL, V171, P214, DOI 10.1093/aje/kwp360; Dabbah S, 2010, AM J CARDIOL, V105, P312, DOI 10.1016/j.amjcard.2009.09.027; DUCLOS B, 1983, ANN MED INTERNE, V134, P643; Ekiz F, 2011, J CLIN LAB ANAL, V25, P162, DOI 10.1002/jcla.20450; European Association For The Study Of The Liver, 2012, J HEPATOLOGY, V57, P167; Giannini E, 2003, ARCH INTERN MED, V163, P218, DOI 10.1001/archinte.163.2.218; Horne BD, 2012, CARDIOLOGY, V122, P213, DOI 10.1159/000341244; Hui AY, 2005, AM J GASTROENTEROL, V100, P616, DOI 10.1111/j.1572-0241.2005.41289.x; Imbert-Bismut F, 2001, LANCET, V357, P1069, DOI 10.1016/S0140-6736(00)04258-6; Jin WW, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-14; Kim BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035825; Knight V, 2012, HEPATOLOGY, V55, P879, DOI 10.1002/hep.24784; Koda M, 2007, HEPATOLOGY, V45, P297, DOI 10.1002/hep.21520; Liaw YF, 2008, HEPATOL INT, V2, P263, DOI 10.1007/s12072-008-9080-3; Lou YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037644; Mallet V, 2009, ALIMENT PHARM THER, V29, P409, DOI 10.1111/j.1365-2036.2008.03895.x; McHutchison JG, 2006, LIVER INT, V26, P389, DOI 10.1111/j.1478-3231.2006.01228.x; Patel KV, 2009, ARCH INTERN MED, V169, P515, DOI 10.1001/archinternmed.2009.11; Poynard T, 2005, AM J GASTROENTEROL, V100, P1970, DOI 10.1111/j.1572-0241.2005.41957.x; Pradella P, 2011, J HEPATOL, V54, P894, DOI 10.1016/j.jhep.2010.08.018; Purnak T, 2012, CLIN RES HEPATOLOGY; Ramm GA, 2010, SEMIN LIVER DIS, V30, P271, DOI 10.1055/s-0030-1255356; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Ripoche J, 2011, CLIN RES HEPATOL GAS, V35, P353, DOI 10.1016/j.clinre.2011.02.012; Ruddell RG, 2009, HEPATOLOGY, V49, P887, DOI 10.1002/hep.22716; Seto WK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023077; Sitia G, 2012, P NATL ACAD SCI USA, V109, pE2165, DOI 10.1073/pnas.1209182109; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Uyarel H, 2011, CORONARY ARTERY DIS, V22, P138, DOI 10.1097/MCA.0b013e328342c77b; Vallet-Pichard A, 2006, HEPATOLOGY, V44, P769, DOI 10.1002/hep.21334; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Watanabe M, 2009, J GASTROEN HEPATOL, V24, P78, DOI 10.1111/j.1440-1746.2008.05497.x; Wong GLH, 2008, CLIN GASTROENTEROL H, V6, P1027, DOI 10.1016/j.cgh.2008.02.038; Zeng MD, 2005, HEPATOLOGY, V42, P1437, DOI 10.1002/hep.20960; 2000, ZHONGHUA GAN ZANG BI, V6, P324	43	88	88	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e68780	10.1371/journal.pone.0068780	http://dx.doi.org/10.1371/journal.pone.0068780			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23874760	gold, Green Published, Green Submitted			2022-12-27	WOS:000322000600025
J	Edgar, R; Mazor, Y; Rinon, A; Blumenthal, J; Golan, Y; Buzhor, E; Livnat, I; Ben-Ari, S; Lieder, I; Shitrit, A; Gilboa, Y; Ben-Yehudah, A; Edri, O; Shraga, N; Bogoch, Y; Leshansky, L; Aharoni, S; West, MD; Warshawsky, D; Shtrichman, R				Edgar, Ron; Mazor, Yaron; Rinon, Ariel; Blumenthal, Jacob; Golan, Yaron; Buzhor, Ella; Livnat, Idit; Ben-Ari, Shani; Lieder, Iris; Shitrit, Alina; Gilboa, Yaron; Ben-Yehudah, Ahmi; Edri, Osnat; Shraga, Netta; Bogoch, Yoel; Leshansky, Lucy; Aharoni, Shlomi; West, Michael D.; Warshawsky, David; Shtrichman, Ronit			LifeMap Discovery (TM) : The Embryonic Development, Stem Cells, and Regenerative Medicine Research Portal	PLOS ONE			English	Article							GENE-EXPRESSION; DATABASE; MUSCLE	LifeMap Discovery (TM) provides investigators with an integrated database of embryonic development, stem cell biology and regenerative medicine. The hand-curated reconstruction of cell ontology with stem cell biology; including molecular, cellular, anatomical and disease-related information, provides efficient and easy-to-use, searchable research tools. The database collates in vivo and in vitro gene expression and guides translation from in vitro data to the clinical utility, and thus can be utilized as a powerful tool for research and discovery in stem cell biology, developmental biology, disease mechanisms and therapeutic discovery. LifeMap Discovery is freely available to academic nonprofit institutions at http://discovery.lifemapsc.com	[Edgar, Ron; Mazor, Yaron; Rinon, Ariel; Blumenthal, Jacob; Buzhor, Ella; Livnat, Idit; Ben-Ari, Shani; Lieder, Iris; Shitrit, Alina; Gilboa, Yaron; Ben-Yehudah, Ahmi; Edri, Osnat; Shraga, Netta; Bogoch, Yoel; Leshansky, Lucy; Aharoni, Shlomi; Warshawsky, David; Shtrichman, Ronit] LifeMap Sci LTD, Tel Aviv, Israel; [Golan, Yaron; West, Michael D.; Warshawsky, David] LifeMap Sci Inc, Alameda, CA USA; [West, Michael D.] BioTime Inc, Alameda, CA USA		Edgar, R (corresponding author), LifeMap Sci LTD, Tel Aviv, Israel.	re@lifemapsc.com	Edgar, Ron/N-8693-2014	, Netta/0000-0002-6072-5623; Edgar, Ron/0000-0002-0088-1392; West, Michael/0000-0002-4842-5468				Bonfanti P, 2012, EMBO MOL MED, V4, P353, DOI 10.1002/emmm.201200220; Brent AE, 2002, CURR OPIN GENET DEV, V12, P548, DOI 10.1016/S0959-437X(02)00339-8; Bryson-Richardson RJ, 2008, NAT REV GENET, V9, P632, DOI 10.1038/nrg2369; Darabi R, 2012, CELL STEM CELL, V10, P610, DOI 10.1016/j.stem.2012.02.015; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Edgar R, 2006, NAT BIOTECHNOL, V24, P1471, DOI 10.1038/nbt1206-1471; Finger JH, 2011, NUCLEIC ACIDS RES, V39, pD835, DOI 10.1093/nar/gkq1132; Geffers L, 2012, MAMM GENOME, V23, P525, DOI 10.1007/s00335-012-9413-3; Grifone R, 2007, TRENDS GENET, V23, P365, DOI 10.1016/j.tig.2007.05.002; Hackney JA, 2004, METH MOLEC MED, V105, P439; Harding SD, 2011, DEVELOPMENT, V138, P2845, DOI 10.1242/dev.063594; Hatano A, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar046; Helms JA, 2003, NATURE, V423, P326, DOI 10.1038/nature01656; Liu X, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-271; McCall MN, 2011, NUCLEIC ACIDS RES, V39, pD1011, DOI 10.1093/nar/gkq1259; Noden DM, 2006, DEV DYNAM, V235, P1194, DOI 10.1002/dvdy.20697; Richardson L, 2010, NUCLEIC ACIDS RES, V38, pD703, DOI 10.1093/nar/gkp763; Slonim DK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000543; Sternberg H, 2012, REGEN MED; Sternberg H, 2012, REGEN MED, V7, P481, DOI [10.2217/RME.12.29, 10.2217/rme.12.29]; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sunkin SM, 2013, NUCLEIC ACIDS RES, V41, pD996, DOI 10.1093/nar/gks1042; Trainor PA, 2005, BRAIN BEHAV EVOLUT, V66, P266, DOI 10.1159/000088130; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; West MD, 2008, REGEN MED, V3, P287, DOI 10.2217/17460751.3.3.287; West MD, 2007, REGEN MED, V2, P329, DOI 10.2217/17460751.2.4.329; Wong F, 2013, GENESIS; Zhang F, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S10-S4	28	65	67	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e66629	10.1371/journal.pone.0066629	http://dx.doi.org/10.1371/journal.pone.0066629			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23874394	Green Submitted, Green Published, gold			2022-12-27	WOS:000322000600001
J	van der Helm, JJ; Bom, RJM; Grunberg, AW; Bruisten, SM; van der Loeff, MFS; Sabajo, LOA; de Vries, HJC				van der Helm, Jannie J.; Bom, Reinier J. M.; Gruenberg, Antoon W.; Bruisten, Sylvia M.; van der Loeff, Maarten F. Schim; Sabajo, Leslie O. A.; de Vries, Henry J. C.			Urogenital Chlamydia trachomatis Infections among Ethnic Groups in Paramaribo, Suriname; Determinants and Ethnic Sexual Mixing Patterns	PLOS ONE			English	Article							CONCURRENT PARTNERSHIPS; TRANSMITTED-DISEASES; MIGRANT POPULATIONS; RISK BEHAVIOR; PREVALENCE; STRAINS; EPIDEMIOLOGY; NETHERLANDS; AMSTERDAM; GENOTYPES	Background: Little is known about the epidemiology of urogenital Chlamydia trachomatis infection (chlamydia) in Suriname. Suriname is a society composed of many ethnic groups, such as Creoles, Maroons, Hindustani, Javanese, Chinese, Caucasians, and indigenous Amerindians. We estimated determinants for chlamydia, including the role of ethnicity, and identified transmission patterns and ethnic sexual networks among clients of two clinics in Paramaribo, Suriname. Methods: Participants were recruited at two sites a sexually transmitted infections (STI) clinic and a family planning (FP) clinic in Paramaribo. Urine samples from men and nurse-collected vaginal swabs were obtained for nucleic acid amplification testing. Logistic regression analysis was used to identify determinants of chlamydia. Multilocus sequence typing (MLST) was performed to genotype C. trachomatis. To identify transmission patterns and sexual networks, a minimum spanning tree was created, using full MLST profiles. Clusters in the minimum spanning tree were compared for ethnic composition. Results: Between March 2008 and July 2010, 415 men and 274 women were included at the STI clinic and 819 women at the FP clinic. Overall chlamydia prevalence was 15% (224/1508). Age, ethnicity, and recruitment site were significantly associated with chlamydia in multivariable analysis. Participants of Creole and Javanese ethnicity were more frequently infected with urogenital chlamydia. Although sexual mixing with other ethnic groups did differ significantly per ethnicity, this mixing was not independently significantly associated with chlamydia. We typed 170 C. trachomatis-positive samples (76%) and identified three large C. trachomatis clusters. Although the proportion from various ethnic groups differed significantly between the clusters (P = 0.003), all five major ethnic groups were represented in all three clusters. Conclusion: Chlamydia prevalence in Suriname is high and targeted prevention measures are required. Although ethnic sexual mixing differed between ethnic groups, differences in prevalence between ethnic groups could not be explained by sexual mixing.	[van der Helm, Jannie J.; de Vries, Henry J. C.] Publ Hlth Serv Amsterdam, STI Outpatient Clin, Amsterdam, Netherlands; [van der Helm, Jannie J.; van der Loeff, Maarten F. Schim] Publ Hlth Serv Amsterdam, Dept Res, Amsterdam, Netherlands; [Bom, Reinier J. M.; Bruisten, Sylvia M.] Publ Hlth Serv Amsterdam, Publ Hlth Lab, Amsterdam, Netherlands; [Gruenberg, Antoon W.] Lobi Fdn, Paramaribo, Suriname; [Bruisten, Sylvia M.] Univ Amsterdam, Acad Med Ctr, Dept Expt Virol, NL-1105 AZ Amsterdam, Netherlands; [Bruisten, Sylvia M.; van der Loeff, Maarten F. Schim; de Vries, Henry J. C.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [Sabajo, Leslie O. A.] Minist Hlth, Dermatol Serv, Paramaribo, Suriname; [de Vries, Henry J. C.] Univ Amsterdam, Acad Med Ctr, Dept Dermatol, NL-1105 AZ Amsterdam, Netherlands; [de Vries, Henry J. C.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands	Public Health Service Amsterdam; Public Health Service Amsterdam; Public Health Service Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Netherlands National Institute for Public Health & the Environment	van der Helm, JJ (corresponding author), Publ Hlth Serv Amsterdam, STI Outpatient Clin, Amsterdam, Netherlands.	jvdhelm@ggd.amsterdam.nl	de Vries, Henry/K-5963-2012	de Vries, Henry/0000-0001-9784-547X; van der Helm, Jannie/0000-0002-4288-9544	Research and Development fund of the Public Health Service of Amsterdam [2369, 2371]; AGIS healthcare insurance (RVVZ) [1417000]	Research and Development fund of the Public Health Service of Amsterdam; AGIS healthcare insurance (RVVZ)	This work was supported by the Research and Development fund of the Public Health Service of Amsterdam (project no 2369 and 2371) and AGIS healthcare insurance (RVVZ no 1417000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams OP, 2008, SEX TRANSM INFECT, V84, P192, DOI 10.1136/sti.2007.028126; Aral SO, 1999, AM J PUBLIC HEALTH, V89, P825, DOI 10.2105/AJPH.89.6.825; Bom RJM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053869; Bom RJM, 2011, J CLIN MICROBIOL, V49, P2844, DOI 10.1128/JCM.00128-11; Botman M, 2008, OSO J SURINAMISTICS, V27 1; Choudhury B, 2006, LANCET, V368, P139, DOI 10.1016/S0140-6736(06)69003-X; Christerson L, 2012, J CLIN MICROBIOL, V50, P3548, DOI 10.1128/JCM.01713-12; Christerson L, 2011, SEX TRANSM DIS, V38, P490, DOI 10.1097/OLQ.0b013e31820b8be0; Dicker LW, 1998, SEX TRANSM DIS, V25, P251, DOI 10.1097/00007435-199805000-00006; Doerner R, 2012, AIDS BEHAV, V16, P2033, DOI 10.1007/s10461-012-0265-3; Dowe G, 1999, SEX TRANSM INFECT, V75, P412, DOI 10.1136/sti.75.6.412; Farley TA, 2003, PREV MED, V36, P502, DOI 10.1016/S0091-7435(02)00058-0; Geisler WM, 2006, SEX TRANSM DIS, V33, P621, DOI 10.1097/01.olq.0000216027.71144.74; Gras MJ, 1999, AIDS, V13, P1953, DOI 10.1097/00002030-199910010-00019; Gravningen K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034452; Harris SR, 2012, NAT GENET, V44, P413, DOI 10.1038/ng.2214; Klint M, 2007, J CLIN MICROBIOL, V45, P1410, DOI 10.1128/JCM.02301-06; Land JA, 2010, HUM REPROD UPDATE, V16, P189, DOI 10.1093/humupd/dmp035; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; Norman J, 2002, BEST PRACT RES CL OB, V16, P775, DOI 10.1053/beog.2002.0325; Quint KD, 2010, MOL CELL PROBE, V24, P266, DOI 10.1016/j.mcp.2010.04.007; Quint KD, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-63; Rampersad J, 2007, REV PANAM SALUD PUBL, V22, P317, DOI 10.1590/S1020-49892007001000004; Terborg JRH, 2001, SEXUAL BEHAV SEXUALL, P28; van der Helm JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032122; van Veen MG, 2011, INT J STD AIDS, V22, P245, DOI 10.1258/ijsa.2009.008511; van Veen MG, 2009, AIDS CARE, V21, P683, DOI 10.1080/09540120802511984; Weill FX, 2010, SEX TRANSM INFECT, V86, P101, DOI 10.1136/sti.2009.037036; Wekker G, 2008, OSO J SURINAMISTICS, V27.1; WHO World Health Organisation STD Statistics, 2001, GLOB PREV INC SEL CU	30	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e68698	10.1371/journal.pone.0068698	http://dx.doi.org/10.1371/journal.pone.0068698			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23874730	Green Submitted, Green Published, gold			2022-12-27	WOS:000322000600019
J	Borghi, F; Vyas, V; Podesta, A; Milani, P				Borghi, Francesca; Vyas, Varun; Podesta, Alessandro; Milani, Paolo			Nanoscale Roughness and Morphology Affect the IsoElectric Point of Titania Surfaces	PLOS ONE			English	Article							AMPHIFUNCTIONALLY ELECTRIFIED INTERFACES; AQUEOUS-ELECTROLYTE SOLUTION; DOUBLE-LAYER CAPACITANCE; ATOMIC-FORCE MICROSCOPY; CLUSTER BEAM DEPOSITION; NANOSTRUCTURED TIO2; ELECTROSTATIC INTERACTIONS; ELECTROPHORETIC MOBILITY; INTERACTION ENERGY; DLVO INTERACTION	We report on the systematic investigation of the role of surface nanoscale roughness and morphology on the charging behaviour of nanostructured titania (TiO2) surfaces in aqueous solutions. IsoElectric Points (IEPs) of surfaces have been characterized by direct measurement of the electrostatic double layer interactions between titania surfaces and the micrometer-sized spherical silica probe of an atomic force microscope in NaCl aqueous electrolyte. The use of a colloidal probe provides well-defined interaction geometry and allows effectively probing the overall effect of nanoscale morphology. By using supersonic cluster beam deposition to fabricate nanostructured titania films, we achieved a quantitative control over the surface morphological parameters. We performed a systematical exploration of the electrical double layer properties in different interaction regimes characterized by different ratios of characteristic nanometric lengths of the system: the surface rms roughness Rq, the correlation length xi and the Debye length lambda(D). We observed a remarkable reduction by several pH units of IEP on rough nanostructured surfaces, with respect to flat crystalline rutile TiO2. In order to explain the observed behavior of IEP, we consider the roughness-induced self-overlap of the electrical double layers as a potential source of deviation from the trend expected for flat surfaces.	[Borghi, Francesca; Vyas, Varun; Podesta, Alessandro; Milani, Paolo] Univ Milan, Interdisciplinary Ctr Nanostruct Mat & Interfaces, Milan, Italy; [Borghi, Francesca; Vyas, Varun; Podesta, Alessandro; Milani, Paolo] Univ Milan, Dept Phys, Milan, Italy; [Vyas, Varun] SEMM, Milan, Italy	University of Milan; University of Milan	Podesta, A (corresponding author), Univ Milan, Interdisciplinary Ctr Nanostruct Mat & Interfaces, Milan, Italy.	alessandro.podesta@mi.infn.it	borghi, francesca/GSN-3089-2022; Borghi, Francesca/AAY-6302-2021; Milani, Paolo/AAN-5069-2021; Podestà, Alessandro/E-6568-2010; Vyas, Varun/AAA-7983-2021	Podestà, Alessandro/0000-0002-4169-6679; Vyas, Varun/0000-0001-7008-7349; BORGHI, FRANCESCA/0000-0001-6980-4910				Barborini E, 1999, J PHYS D APPL PHYS, V32, pL105, DOI 10.1088/0022-3727/32/21/102; Barborini E, 2003, EUR PHYS J D, V24, P277, DOI 10.1140/epjd/e2003-00189-2; Barten D, 2003, LANGMUIR, V19, P1133, DOI 10.1021/la0117092; Bergstrom L, 1997, ADV COLLOID INTERFAC, V70, P125, DOI 10.1016/S0001-8686(97)00003-1; Bhattacharjee S, 1998, LANGMUIR, V14, P3365, DOI 10.1021/la971360b; Bogdanova NF, 2010, COLLOID J+, V72, P749, DOI 10.1134/S1061933X10060049; Bonnell DA, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/4/044501; Brookes IM, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.266103; Brown GE, 1999, CHEM REV, V99, P77, DOI 10.1021/cr980011z; Bullard JW, 2006, LANGMUIR, V22, P10264, DOI 10.1021/la061900h; Butt H.-J., 1992, Nanotechnology, V3, P60, DOI 10.1088/0957-4484/3/2/003; Butt HJ, 2005, SURF SCI REP, V59, P1, DOI 10.1016/j.surfrep.2005.08.003; BUTT HJ, 1995, BIOELECTROCH BIOENER, V38, P191, DOI 10.1016/0302-4598(95)01800-T; BUTT HJ, 1991, BIOPHYS J, V60, P1438, DOI 10.1016/S0006-3495(91)82180-4; BUTT HJ, 1995, NANOTECHNOLOGY, V6, P1, DOI 10.1088/0957-4484/6/1/001; Cappella B, 1999, SURF SCI REP, V34, P1, DOI 10.1016/S0167-5729(99)00003-5; Carbone R, 2006, BIOMATERIALS, V27, P3221, DOI 10.1016/j.biomaterials.2006.01.056; Carbone R, 2007, BIOMATERIALS, V28, P2244, DOI 10.1016/j.biomaterials.2006.12.026; Caruso T, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2832321; Caruso T, 2007, SURF SCI, V601, P2688, DOI 10.1016/j.susc.2006.12.025; Castellano J.A., 1992, HDB DISPLAY TECHNOLO; Chiappini Ciro, 2006, THESIS U STUDI MILAN; Considine RF, 2001, LANGMUIR, V17, P7777, DOI 10.1021/la0017227; Cremer PS, 1999, J PHYS CHEM B, V103, P2554, DOI 10.1021/jp983996x; Daikhin LI, 1996, PHYS REV E, V53, P6192, DOI 10.1103/PhysRevE.53.6192; Daikhin LI, 1997, ELECTROCHIM ACTA, V42, P2853, DOI 10.1016/S0013-4686(97)00106-0; Daikhin LI, 1998, J CHEM PHYS, V108, P1715, DOI 10.1063/1.475543; Debye P, 1923, PHYS Z, V24, P185; Delgado AV, 2005, PURE APPL CHEM, V77, P1753, DOI 10.1351/pac200577101753; DRUMMOND CJ, 1994, COLLOID SURFACE A, V87, P217, DOI 10.1016/0927-7757(94)80070-7; DUCKER WA, 1992, LANGMUIR, V8, P1831, DOI 10.1021/la00043a024; Duval J, 2002, J ELECTROANAL CHEM, V532, P337, DOI 10.1016/S0022-0728(02)00718-0; Duval J, 2001, LANGMUIR, V17, P7573, DOI 10.1021/la010833i; Duval JFL, 2011, PHYS CHEM CHEM PHYS, V13, P1037, DOI 10.1039/c004243a; Duval JFL, 2004, LANGMUIR, V20, P5052, DOI 10.1021/la030404f; ELIMELECH M, 1994, DESALINATION, V95, P269, DOI 10.1016/0011-9164(94)00064-6; Franks GV, 2002, J COLLOID INTERF SCI, V249, P44, DOI 10.1006/jcis.2002.8250; Giorgetti L, 2008, LANGMUIR, V24, P11637, DOI 10.1021/la801910p; GRAHAME DC, 1947, CHEM REV, V41, P441, DOI 10.1021/cr60130a002; Hartley PG, 1997, LANGMUIR, V13, P2207, DOI 10.1021/la960997c; Hiemstra T, 1996, J COLLOID INTERF SCI, V179, P488, DOI 10.1006/jcis.1996.0242; Hiemstra T, 1996, J COLLOID INTERF SCI, V184, P680, DOI 10.1006/jcis.1996.0666; Hoek EMV, 2006, J COLLOID INTERF SCI, V298, P50, DOI 10.1016/j.jcis.2005.12.031; Hoek EMV, 2003, LANGMUIR, V19, P4836, DOI 10.1021/la027083c; Hsu JP, 2004, J COLLOID INTERF SCI, V272, P352, DOI 10.1016/j.jcis.2003.10.007; Huang XF, 2010, LANGMUIR, V26, P2528, DOI 10.1021/la9028113; Indrieri M, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3553499; JOHNSON SB, 1995, LANGMUIR, V11, P2367, DOI 10.1021/la00007a009; JOHNSON SB, 1995, COLLOID SURFACE A, V103, P195, DOI 10.1016/0927-7757(95)03257-E; Kallay N, 2004, LANGMUIR, V20, P2986, DOI 10.1021/la036185f; Kallay N, 2010, CROAT CHEM ACTA, V83, P357; Khin MM, 2012, ENERG ENVIRON SCI, V5, P8075, DOI 10.1039/c2ee21818f; Kholmanov IN, 2003, NANOTECHNOLOGY, V14, P1168, DOI 10.1088/0957-4484/14/11/002; Kosmulski M, 2004, ADV COLLOID INTERFAC, V112, P93, DOI 10.1016/j.cis.2004.09.005; Kosmulski M, 2003, J COLLOID INTERF SCI, V263, P152, DOI 10.1016/S0021-9797(03)00328-X; Kosmulski M, 2011, J COLLOID INTERF SCI, V353, P1, DOI 10.1016/j.jcis.2010.08.023; Langlet J, 2008, BIOPHYS J, V94, P3293, DOI 10.1529/biophysj.107.115477; LARSON I, 1993, J AM CHEM SOC, V115, P11885, DOI 10.1021/ja00078a029; Leckband D, 2001, Q REV BIOPHYS, V34, P105, DOI 10.1017/S0033583501003687; Leonard KC, 2012, LANGMUIR, V28, P6476, DOI 10.1021/la204173w; LIDE DR, 1997, HDB CHEM PHYS; LIN XY, 1993, J PHYS CHEM-US, V97, P7272, DOI 10.1021/j100130a025; Lokar WJ, 2004, LANGMUIR, V20, P378, DOI 10.1021/la035288v; Lyklema J, 2005, ADV COLLOID INTERFAC, V114, P27, DOI 10.1016/j.cis.2004.05.002; Lyklema J, 1995, FUNDAMENTALS INTERFA, VII; Martines E, 2008, COLLOID SURFACE A, V318, P45, DOI 10.1016/j.colsurfa.2007.11.035; Mazza T, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2035874; MORIMOTO T, 1969, J PHYS CHEM-US, V73, P243, DOI 10.1021/j100721a039; Oldham KB, 2008, J ELECTROANAL CHEM, V613, P131, DOI 10.1016/j.jelechem.2007.10.017; Oleson TA, 2008, LANGMUIR, V24, P4865, DOI 10.1021/la703599g; Oleson TA, 2012, J COLLOID INTERF SCI, V370, P192, DOI 10.1016/j.jcis.2011.12.031; PARKS GA, 1965, CHEM REV, V65, P177, DOI 10.1021/cr60234a002; PARSEGIAN VA, 1972, BIOPHYS J, V12, P1192, DOI 10.1016/S0006-3495(72)86155-1; Piseri P, 2001, REV SCI INSTRUM, V72, P2261, DOI 10.1063/1.1361082; Podesta A, 2009, J PHYS CHEM C, V113, P18264, DOI 10.1021/jp905930r; Preocanin T, 2006, CROAT CHEM ACTA, V79, P95; Raiteri R, 1996, BIOSENS BIOELECTRON, V11, P1009, DOI 10.1016/0956-5663(96)87660-3; Rudzinski W, 1998, COLLOID SURFACE A, V137, P57, DOI 10.1016/S0927-7757(97)00369-5; Schaub R, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.266104; Scopelliti PE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011862; SENDEN TJ, 1995, COLLOID SURFACE A, V94, P29, DOI 10.1016/0927-7757(94)02954-Q; Sokolov I, 2006, J COLLOID INTERF SCI, V300, P475, DOI 10.1016/j.jcis.2006.04.023; Suresh L, 1996, J COLLOID INTERF SCI, V183, P199, DOI 10.1006/jcis.1996.0535; Suttiponparnit K, 2011, NANOSCALE RES LETT, V6, DOI 10.1007/s11671-010-9772-1; Tafreshi HV, 2006, J NANOSCI NANOTECHNO, V6, P1140, DOI 10.1166/jnn.2006.139; Tsao HK, 1999, J COLLOID INTERF SCI, V216, P370, DOI 10.1006/jcis.1999.6328; Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7; Wegner K, 2006, J PHYS D APPL PHYS, V39, pR439, DOI 10.1088/0022-3727/39/22/R02; WHITE LR, 1983, J COLLOID INTERF SCI, V95, P286, DOI 10.1016/0021-9797(83)90103-0; Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1; Yang KL, 2002, J CHEM PHYS, V117, P8499, DOI 10.1063/1.1511726	91	39	39	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68655	10.1371/journal.pone.0068655	http://dx.doi.org/10.1371/journal.pone.0068655			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874708	Green Published, Green Submitted, gold			2022-12-27	WOS:000322064300060
J	Wong, M; Barqasho, B; Ohrmalm, L; Tolfvenstam, T; Nowak, P				Wong, Michelle; Barqasho, Babilonia; Ohrmalm, Lars; Tolfvenstam, Thomas; Nowak, Piotr			Microbial Translocation Contribute to Febrile Episodes in Adults with Chemotherapy-Induced Neutropenia	PLOS ONE			English	Article							REAL-TIME PCR; GRAM-NEGATIVE BACTEREMIA; HEMATOLOGICAL MALIGNANCIES; IMMUNOSUPPRESSED PATIENTS; HIV-INFECTION; ENDOTOXEMIA; FEVER; DISEASE; CANCER	In this study we sought to determine the contribution of microbial translocation to febrile episodes with no attributable microbiological cause (Fever of Unknown Origin, FUO) in an adult febrile neutropaenic cohort. Endotoxin concentrations were measured with the chromogenic Limulus Amoebocyte Assay and used as a direct measure of bacterial products whilst soluble CD14 (sCD14), measured with ELISA was selected as an indicator of the early host response to endotoxins. Endotoxin concentrations in this cohort were generally elevated but did not differ with the presentation of fever. Further stratification of the febrile episodes based on the microbiological findings revealed significantly (p = 0.0077) elevated endotoxin concentrations in FUO episodes compared with episodes with documented bacterial and viral findings. sCD14 concentrations were however, elevated in febrile episodes (p = 0.0066) and no association was observed between sCD14 concentration and microbiological findings. However, FUO episodes and episodes with Gram-negative bacteraemia were associated with higher median sCD14 concentrations than episodes with Gram-positive bacteraemia (p = 0.030). In conclusion, our findings suggest that in the absence of microbiological findings, microbial translocation could contribute to febrile episodes in an adult neutropaenic cohort. We further observed an association between prophylactic antibiotic use and increased plasma endotoxin concentrations (p = 0.0212).	[Wong, Michelle; Ohrmalm, Lars; Tolfvenstam, Thomas] Dept Med, Solna, Sweden; [Wong, Michelle; Ohrmalm, Lars; Tolfvenstam, Thomas] Karolinska Univ Hosp, Ctr Mol Med, Infect Dis Unit, Stockholm, Sweden; [Barqasho, Babilonia; Nowak, Piotr] Karolinska Inst, Dept Lab Med, Div Microbiol, Huddinge, Sweden; [Nowak, Piotr] Dept Med, Huddinge, Sweden; [Nowak, Piotr] Karolinska Univ Hosp, Karolinska Inst, Infect Dis Unit, Huddinge, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Wong, M (corresponding author), Dept Med, Solna, Sweden.	michwsy@gmail.com		Tolfvenstam, Thomas/0000-0003-3549-8083; Nowak, Piotr/0000-0003-2747-0734	Swedish society of Medicine; Swedish Society for Medical Research; Stockholm City Council-Karolinska Institutet; Karolinska Infection Network; Paediatric Cancer Foundation; Groschinsky foundation	Swedish society of Medicine; Swedish Society for Medical Research; Stockholm City Council-Karolinska Institutet; Karolinska Infection Network; Paediatric Cancer Foundation; Groschinsky foundation	This work was supported by grants from the Swedish society of Medicine (TT), Swedish Society for Medical Research (PN), Stockholm City Council-Karolinska Institutet (PN), Karolinska Infection Network (TT), the Paediatric Cancer Foundation (TT) and the Groschinsky foundation (TT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bodey GP, 2000, INT J ANTIMICROB AG, V16, P93, DOI 10.1016/S0924-8579(00)00241-7; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brittain-Long R, 2008, J CLIN VIROL, V41, P53, DOI 10.1016/j.jcv.2007.10.029; Durack D T, 1991, Curr Clin Top Infect Dis, V11, P35; GUNTHER G, 1995, J INTERN MED, V237, P27; Gustafsson I, MULTIPLEX REAL UNPUB; HARRIS RI, 1984, J CLIN PATHOL, V37, P467, DOI 10.1136/jcp.37.4.467; Hurley JC, 2010, EUR J CLIN MICROBIOL, V29, P207, DOI 10.1007/s10096-009-0841-2; Jernberg C, 2010, MICROBIOL-SGM, V156, P3216, DOI 10.1099/mic.0.040618-0; Kitchens RL, 2001, J CLIN INVEST, V108, P485, DOI 10.1172/JCI200113139; Klastersky J, 2007, INT J ANTIMICROB AG, V30, pS51, DOI 10.1016/j.ijantimicag.2007.06.012; Knockaert DC, 2003, J INTERN MED, V253, P263, DOI 10.1046/j.1365-2796.2003.01120.x; Lofmark S, 2010, CLIN INFECT DIS, V50, pS16, DOI 10.1086/647939; Lu XY, 2008, J CLIN MICROBIOL, V46, P533, DOI 10.1128/JCM.01739-07; Mancini N, 2008, J MED MICROBIOL, V57, P601, DOI 10.1099/jmm.0.47732-0; MCCARTNEY AC, 1987, J INFECTION, V15, P201, DOI 10.1016/S0163-4453(87)92528-X; Nijhuis M, 2002, J CLIN MICROBIOL, V40, P3666, DOI 10.1128/JCM.40.10.3666-3670.2002; Novitsky T, 1998, DIAZOCOUPLING OPTION, V16; Ohrmalm L, VIRUS ASS FEVE UNPUB; Ohrmalm L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036543; Pizzo PA, 1999, NEW ENGL J MED, V341, P893, DOI 10.1056/NEJM199909163411207; Redd AD, 2009, P NATL ACAD SCI USA, V106, P6718, DOI 10.1073/pnas.0901983106; RIETSCHEL ET, 1990, ADV EXP MED BIOL, V256, P81; Rolston KVI, 2004, CLIN INFECT DIS, V39, pS44, DOI 10.1086/383053; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Sontakke S, 2009, J MICROBIOL METH, V76, P217, DOI 10.1016/j.mimet.2008.11.002; TANCREDE CH, 1985, J INFECT DIS, V152, P99, DOI 10.1093/infdis/152.1.99; Terlizzi ME, 2009, J VIROL METHODS, V160, P172, DOI 10.1016/j.jviromet.2009.04.039; Tivejung-Lindell A, 2009, J MED VIROL, V81, P167, DOI 10.1002/jmv.21368; Viscoli C, 2005, CLIN INFECT DIS, V40, pS240, DOI 10.1086/427329; WHIMBEY E, 1987, AM J MED, V82, P723, DOI 10.1016/0002-9343(87)90007-6; World Health Organization, 2009, CDC PROT REALT RTPCR	32	63	64	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68056	10.1371/journal.pone.0068056	http://dx.doi.org/10.1371/journal.pone.0068056			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874493	Green Published, Green Submitted, gold			2022-12-27	WOS:000322064300015
J	Paterson, GK; Harrison, EM; Craven, EF; Petersen, A; Larsen, AR; Ellington, MJ; Torok, ME; Peacock, SJ; Parkhill, J; Zadoks, RN; Holmes, MA				Paterson, Gavin K.; Harrison, Ewan M.; Craven, Emily F.; Petersen, Andreas; Larsen, Anders Rhod; Ellington, Matthew J.; Toeroek, M. Estee; Peacock, Sharon J.; Parkhill, Julian; Zadoks, Ruth N.; Holmes, Mark A.			Incidence and Characterisation of Methicillin-Resistant Staphylococcus aureus (MRSA) from Nasal Colonisation in Participants Attending a Cattle Veterinary Conference in the UK	PLOS ONE			English	Article							CASSETTE CHROMOSOME MEC; ANTIMICROBIAL RESISTANCE; GENETIC HOMOLOG; PREVALENCE; PERSONNEL; TRANSMISSION; CARRIAGE; MASTITIS; ANIMALS; STRAINS	We sought to determine the prevalence of nasal colonisation with methicillin-resistant Staphylococcus aureus among cattle veterinarians in the UK. There was particular interest in examining the frequency of colonisation with MRSA harbouring mecC, as strains with this mecA homologue were originally identified in bovine milk and may represent a zoonotic risk to those in contact with dairy livestock. Three hundred and seven delegates at the British Cattle Veterinarian Association (BCVA) Congress 2011 in Southport, UK were screening for nasal colonisation with MRSA. Isolates were characterised by whole genome sequencing and antimicrobial susceptibility testing. Eight out of three hundred and seven delegates (2.6%) were positive for nasal colonisation with MRSA. All strains were positive for mecA and none possessed mecC. The time since a delegate's last visit to a farm was significantly shorter in the MRSA-positive group than in MRSA-negative counterparts. BCVA delegates have an increased risk of MRSA colonisation compared to the general population but their frequency of colonisation is lower than that reported from other types of veterinarian conference, and from that seen in human healthcare workers. The results indicate that recent visitation to a farm is a risk factor for MRSA colonisation and that mecC-MRSA are rare among BCVA delegates (<1% based on sample size). Contact with livestock, including dairy cattle, may still be a risk factor for human colonisation with mecC-MRSA but occurs at a rate below the lower limit of detection available in this study.	[Paterson, Gavin K.; Harrison, Ewan M.; Craven, Emily F.; Holmes, Mark A.] Univ Cambridge, Dept Vet Med, Cambridge, England; [Petersen, Andreas; Larsen, Anders Rhod] Statens Serum Inst, Dept Microbiol Surveillance & Res, DK-2300 Copenhagen, Denmark; [Ellington, Matthew J.; Toeroek, M. Estee] Level 6 Addenbrookes Hosp, Microbiol Serv Div, Hlth Protect Agcy, Cambridge, England; [Toeroek, M. Estee; Peacock, Sharon J.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England; [Toeroek, M. Estee; Peacock, Sharon J.] Cambridge Univ Hosp, Natl Hlth Serv Fdn Trust, Cambridge, England; [Peacock, Sharon J.; Parkhill, Julian] Wellcome Trust Res Labs, Wellcome Trust Sanger Inst, Cambridge, England; [Zadoks, Ruth N.; Holmes, Mark A.] Moredun Res Inst, Penicuik, Midlothian, Scotland	University of Cambridge; Statens Serum Institut; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; Health Protection Agency; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; Wellcome Trust Sanger Institute; Moredun Research Institute	Holmes, MA (corresponding author), Univ Cambridge, Dept Vet Med, Madingley Rd, Cambridge, England.	mah1@cam.ac.uk	Ellington, Matthew/ABH-7978-2020; Harrison, Ewan M/I-5003-2013; Peacock, Sharon J/ABE-6331-2020; Parkhill, Julian/G-4703-2011; Paterson, Gavin/V-6725-2019	Harrison, Ewan M/0000-0003-2720-0507; Parkhill, Julian/0000-0002-7069-5958; Paterson, Gavin/0000-0002-1880-0095; Peacock, Sharon/0000-0002-1718-2782; Petersen, Andreas/0000-0002-6864-0624; Torok, Mili Estee/0000-0001-9098-8590; Larsen, Anders Rhod/0000-0002-1713-8765; Holmes, Mark/0000-0002-5454-1625; Zadoks, Ruth/0000-0002-1164-8000	Medical Research Council [G1001787/1]; School of Clinical Medicine, University of Cambridge; Moredun Research Institute; Wellcome Trust Sanger Institute; MRC [G1001787] Funding Source: UKRI; Medical Research Council [G1001787] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); School of Clinical Medicine, University of Cambridge(University of Cambridge); Moredun Research Institute; Wellcome Trust Sanger Institute(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Medical Research Council Partnership Grant (G1001787/1) held between the Department of Veterinary Medicine, University of Cambridge (M.A.H), the School of Clinical Medicine, University of Cambridge (S.J.P), the Moredun Research Institute (R.N.Z) and the Wellcome Trust Sanger Institute (J.P and S.J.P). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aklilu E, 2010, TROP BIOMED, V27, P483; Albrich WC, 2008, LANCET INFECT DIS, V8, P289, DOI 10.1016/S1473-3099(08)70097-5; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson MEC, 2008, VET MICROBIOL, V129, P410, DOI 10.1016/j.vetmic.2007.11.031; Barros EM, 2012, J CLIN MICROBIOL, V50, P166, DOI 10.1128/JCM.05563-11; Basset P, 2013, J HOSP INFECT, V2, P00426; Bonnstetter KK, 2007, J CLIN MICROBIOL, V45, P141, DOI 10.1128/JCM.01228-06; Bradley AJ, 2007, VET REC, V160, P253, DOI 10.1136/vr.160.8.253; Burstiner LC, 2010, VET SURG, V39, P150, DOI 10.1111/j.1532-950X.2009.00638.x; Concepcion Porrero M, 2011, VET MICROBIOL; Cuny C, 2010, INT J MED MICROBIOL, V300, P109, DOI 10.1016/j.ijmm.2009.11.002; Ellington MJ, 2010, J ANTIMICROB CHEMOTH, V65, P446, DOI 10.1093/jac/dkp448; FROGGATT JW, 1989, ANTIMICROB AGENTS CH, V33, P460, DOI 10.1128/AAC.33.4.460; Garcia-Alvarez L, 2011, LANCET INFECT DIS; Garcia-Alvarez L, 2011, LANCET INFECT DIS, V11, P595, DOI 10.1016/S1473-3099(11)70126-8; Graveland H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010990; Gullberg E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002158; Hanselman BA, 2006, EMERG INFECT DIS, V12, P1933; Harrison EM, 2013, EMBO MOL MED, V5, P509, DOI 10.1002/emmm.201202413; Harrison EM, 2013, ANTIMICROB AGENTS CH, V57, P1524, DOI 10.1128/AAC.01882-12; Hata E, 2010, J CLIN MICROBIOL; Hellman J, 2012, REPORT SWEDISH ANTIB; Holden MT, 2013, GENOME RES, V8, P8; Hsieh JM, 2008, VET MICROBIOL, V126, P234, DOI 10.1016/j.vetmic.2007.07.013; Hung WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046987; Ito T, 2012, ANTIMICROB AGENTS CH, V6, P6; Jordan D, 2011, AUST VET J, V89, P152, DOI 10.1111/j.1751-0813.2011.00710.x; Katayama Y, 2000, ANTIMICROB AGENTS CH, V44, P1549, DOI 10.1128/AAC.44.6.1549-1555.2000; Koser CU, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002824; Koser CU, 2012, NEW ENGL J MED, V366, P2267, DOI 10.1056/NEJMoa1109910; Kriegeskorte A, 2012, EMERG INFECT DIS, V18, P1016, DOI 10.3201/eid1806.110910; Laurent F, 2012, EMERG INFECT DIS, V18, P1465, DOI 10.3201/eid1809.111920; Loeffler A, 2005, J ANTIMICROB CHEMOTH, V56, P692, DOI 10.1093/jac/dki312; Loeffler A, 2009, J HOSP INFECT, V72, P269, DOI 10.1016/j.jhin.2009.04.002; Malik S, 2009, EPIDEMIOL INFECT, V137, P1237, DOI 10.1017/S0950268809002222; Maudsley J, 2004, J HOSP INFECT, V57, P258, DOI 10.1016/j.jhin.2004.03.023; Medhus A, 2012, J ANTIMICROB CHEMOTH, V4, P4; Monecke S, 2007, VET MICROBIOL, V125, P128, DOI 10.1016/j.vetmic.2007.05.016; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Moodley A, 2008, SCAND J WORK ENV HEA, V34, P151, DOI 10.5271/sjweh.1219; Nemati M, 2008, ANTIMICROB AGENTS CH, V52, P3817, DOI 10.1128/AAC.00613-08; Otter JA, 2009, EUR J CLIN MICROBIOL, V28, P835, DOI 10.1007/s10096-008-0698-9; Paterson GK, 2012, EUROSURVEILLANCE, V17, P5; Paterson GK, 2012, J ANTIMICROB CHEMOTH, V67, P2809, DOI 10.1093/jac/dks329; Paterson GK, 2012, J ANTIMICROBIAL CHEM; Paul NC, 2011, ZOONOSES PUBLIC HLTH, V58, P533, DOI 10.1111/j.1863-2378.2011.01398.x; Petersen A, 2012, CLIN MICROBIOLOGY IN; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Rim JY, 2007, INFECT CONT HOSP EP, V28, P1044, DOI 10.1086/519934; Sabat AJ, 2012, J CLIN MICROBIOL, V50, P3374, DOI 10.1128/JCM.01121-12; Sakwinska O, 2011, APPL ENVIRON MICROB, V77, P5908, DOI 10.1128/AEM.00238-11; Sergio DMB, 2007, J MED MICROBIOL, V56, P1107, DOI 10.1099/jmm.0.47283-0; Sharma N, 2012, ASIAN J ANIM VET ADV, V7, P454, DOI 10.3923/ajava.2012.454.476; Shore AC, 2011, ANTIMICROB AGENTS CH, V55, P3765, DOI 10.1128/AAC.00187-11; Strommenger B, 2006, J ANTIMICROB CHEMOTH, V57, P461, DOI 10.1093/jac/dki471; Turkyilmaz S, 2010, ZOONOSES PUBLIC HLTH, V57, P197, DOI 10.1111/j.1863-2378.2009.01257.x; Uhlemann AC, 2012, MBIO, V3, DOI 10.1128/mBio.00027-12; UTSUI Y, 1985, ANTIMICROB AGENTS CH, V28, P397, DOI 10.1128/AAC.28.3.397; Van den Eede A, 2009, VET MICROBIOL, V133, P138, DOI 10.1016/j.vetmic.2008.06.021; Vanderhaeghen W, 2010, VET MICROBIOL; Walther B, 2008, VET MICROBIOL, V127, P171, DOI 10.1016/j.vetmic.2007.07.018; Walther B, 2012, EMERG INFECT DIS, V18, P2017, DOI 10.3201/eid1812.120238; Wan MT, 2012, J APPL MICROBIOL, V112, P205, DOI 10.1111/j.1365-2672.2011.05179.x; Weese JS, 2005, EMERG INFECT DIS, V11, P430, DOI 10.3201/eid1103.040481; Weese JS, 2006, VET MICROBIOL, V114, P160, DOI 10.1016/j.vetmic.2005.11.054; Wulf MWH, 2008, CLIN MICROBIOL INFEC, V14, P29, DOI 10.1111/j.1469-0691.2007.01873.x; Wulf M, 2006, EMERG INFECT DIS, V12, P1939	67	23	24	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2013	8	7							e68463	10.1371/journal.pone.0068463	http://dx.doi.org/10.1371/journal.pone.0068463			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZN	23869220	Green Published, Green Submitted, gold			2022-12-27	WOS:000323110600019
J	Jung, M; Arya, M; Viswanath, K				Jung, Minsoo; Arya, Monisha; Viswanath, Kasisomayajula			Effect of Media Use on HIV/AIDS-Related Knowledge and Condom Use in Sub-Saharan Africa: A Cross-Sectional Study	PLOS ONE			English	Article							MASS-MEDIA; CAMPAIGNS; HEALTH	It is known that the level of HIV/AIDS-related knowledge and the degree of condom use varies by socioeconomic status (SES). However, there is limited research on the effect of mass media use on HIV/AIDS-related cognitive and behavioral outcomes in low-income countries and how it might influence the association between SES and HIV-related outcomes. We investigated the moderating effect of media use on the relationship between SES and HIV/AIDS-related knowledge and condom use in sub-Saharan Africa in terms of communication inequalities. Cross-sectional data from the Demographic Health Surveys from 13 sub-Saharan countries (2004-10) were pooled. Gender-stratified multivariable poisson regression of 151,209 women and 68,890 men were used to calculate adjusted relative ratios and 95% confidence intervals for the associations between SES, media use, HIV-related outcomes, and condom use. We found significant disparities in mass media use among people from different SES groups as well as among countries. Education and wealth are strongly and positively associated with awareness of HIV/AIDS and knowledge about transmission and prevention of HIV/AIDS and are significantly associated with condom use. These associations are attenuated when the use of various types of mass media is added to the models, with newspapers showing the strongest effect. The findings of this study suggest that media use has the potential to blunt the impact of socioeconomic status though not completely eliminate it. Thus, we need to pay attention to reducing communication inequalities among social groups and countries to moderate the effect of wealth and SES on HIV/AIDS.	[Jung, Minsoo; Viswanath, Kasisomayajula] Dana Farber Canc Inst, Ctr Community Based Res, Boston, MA 02115 USA; [Jung, Minsoo] Dongduk Womens Univ, Dept Hlth Sci, Seoul, South Korea; [Arya, Monisha] Baylor Coll Med, Dept Med, Infect Dis Sect, Houston, TX 77030 USA; [Viswanath, Kasisomayajula] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Dongduk Women's University; Baylor College of Medicine; Harvard University; Harvard T.H. Chan School of Public Health	Jung, M (corresponding author), Dana Farber Canc Inst, Ctr Community Based Res, Boston, MA 02115 USA.	minsoo_jung@dfci.harvard.edu		Jung, Minsoo/0000-0003-3317-6507	NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH094235] Funding Source: NIH RePORTER; NIMH NIH HHS [K23 MH094235] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ackerson LK, 2012, AIDS BEHAV, V16, P2072, DOI 10.1007/s10461-011-0031-y; [Anonymous], 2006, DHS METHODOLOGICAL R; Bertrand JT, 2006, HEALTH EDUC RES, V21, P567, DOI 10.1093/her/cyl036; Burgoyne Amy D, 2008, Afr J Reprod Health, V12, P14; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Cresswell JA, 2012, LANCET, V380, P1325, DOI 10.1016/S0140-6736(12)60869-1; Cynthia E, 2008, RADIO CHIEF MEDIUM N; de Walque D, 2011, STUD FAMILY PLANN, V42, P1, DOI 10.1111/j.1728-4465.2011.00259.x; Fishbein M, 2006, J COMMUN, V56, pS1, DOI 10.1111/j.1460-2466.2006.00280.x; Fortson JG, 2008, DEMOGRAPHY, V45, P303, DOI 10.1353/dem.0.0006; Greener R., 2002, IAEN, P49; Gwatkin D R, 2007, Niger J Clin Pract, V10, P272; Hansson Marit, 2008, BMC Int Health Hum Rights, V8, P14, DOI 10.1186/1472-698X-8-14; Lanouette NM, 2003, AM J PUBLIC HEALTH, V93, P917, DOI 10.2105/AJPH.93.6.917; Li L, 2009, J HEALTH COMMUN, V14, P424, DOI 10.1080/10810730903032994; Noar SM, 2009, J HEALTH COMMUN, V14, P15, DOI 10.1080/10810730802592239; Pfanner E., 2007, NY TIMES; Randolph W, 2004, ANNU REV PUBL HEALTH, V25, P419, DOI 10.1146/annurev.publhealth.25.101802.123046; Sheeran P, 1999, PSYCHOL BULL, V125, P90, DOI 10.1037/0033-2909.125.1.90; Singh Madhu B., 1997, Journal of Communicable Diseases, V29, P139; TICHENOR PJ, 1970, PUBLIC OPIN QUART, V34, P159, DOI 10.1086/267786; UNAIDS, 2011, GLOB REP UNAIDS REP; UNAIDS, 2000, NATL AIDS PROGRAMMES; Viswanath K, 2006, EXAMINING HLTH DISPA, P215; Viswanath K., 2007, MACROSOCIAL DETERMIN, P275, DOI DOI 10.1007/978-0-387-70812-6_13; Viswanath K, 2002, PUBLIC HLTH COMMUNIC, P289; WHO UNICEF & UNAIDS., 2011, UN ACC, P1; Zeleza PT, 2009, MEDIA IDENTITY AFRIC, P19; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	29	24	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e68359	10.1371/journal.pone.0068359	http://dx.doi.org/10.1371/journal.pone.0068359			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	182CS	23874598	Green Published, gold, Green Submitted			2022-12-27	WOS:000321718700019
J	Meng, S; Cao, JT; Zhang, XP; Fan, YQ; Fang, L; Wang, CQ; Lv, ZW; Fu, D; Li, YG				Meng, Shu; Cao, Jiatian; Zhang, Xiaoping; Fan, Yuqi; Fang, Lu; Wang, Changqian; Lv, Zhongwei; Fu, Da; Li, Yigang			Downregulation of MicroRNA-130a Contributes to Endothelial Progenitor Cell Dysfunction in Diabetic Patients via Its Target Runx3	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; SMOOTH-MUSCLE-CELLS; VASCULAR-DISEASES; MESSENGER-RNA; GROWTH-FACTOR; ANGIOGENESIS; EXPRESSION; IMPAIRS; CANCER; NEOVASCULARIZATION	Dysfunction of endothelial progenitor cells (EPCs) contributes to diabetic vascular disease. MicroRNAs (miRs) have emerged as key regulators of diverse cellular processes including angiogenesis. We recently reported that miR-126, miR-130a, miR-21, miR-27a, and miR-27b were downregulated in EPCs from type II diabetes mellitus (DM) patients, and downregulation of miR-126 impairs EPC function. The present study further explored whether dysregulated miR-130a were also related to EPC dysfunction. EPCs were cultured from peripheral blood mononuclear cells of diabetic patients and healthy controls. Assays on EPC function (proliferation, migration, differentiation, apoptosis, and colony and tubule formation) were performed. Bioinformatics analyses were used to identify the potential targets of miR-130a in EPCs. Gene expression of miR-103a and Runx3 was measured by real-time PCR, and protein expression of Runx3, extracellular signal-regulated kinase (ERK), vascular endothelial growth factor (VEGF) and Akt was measured by Western blotting. Runx3 promoter activity was measured by luciferase reporter assay. A miR-130a inhibitor or mimic and lentiviral vectors expressing miR-130a, or Runx3, or a short hairpin RNA targeting Runx3 were transfected into EPCs to manipulate miR-130a and Runx3 levels. MiR-130a was decreased in EPCs from DM patients. Anti-miR-130a inhibited whereas miR-130a overexpression promoted EPC function. miR-130a negatively regulated Runx3 (mRNA, protein and promoter activity) in EPCs. Knockdown of Runx3 expression enhanced EPC function. MiR-130a also upregulated protein expression of ERK/VEGF and Akt in EPCs. In conclusion, miR-130a plays an important role in maintaining normal EPC function, and decreased miR-130a in EPCs from DM contributes to impaired EPC function, likely via its target Runx3 and through ERK/VEGF and Akt pathways.	[Meng, Shu; Li, Yigang] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Cardiol, Shanghai 200030, Peoples R China; [Cao, Jiatian; Fan, Yuqi; Wang, Changqian] Shanghai Jiao Tong Univ, Dept Cardiol, Sch Med, Peoples Hosp Affiliated 9, Shanghai 200030, Peoples R China; [Zhang, Xiaoping; Lv, Zhongwei] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Nucl Med, Shanghai 200092, Peoples R China; [Zhang, Xiaoping; Fu, Da] Shanghai Jiao Tong Univ, Sch Med, Chinese Acad Sci, Key Lab Stem Cell Biol,Inst Hlth Sci,Shanghai Ins, Shanghai 200030, Peoples R China; [Fang, Lu] Baker IDI Heart & Diabet Inst, Vasc Pharmacol Lab, Melbourne, Vic, Australia	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Tongji University; Chinese Academy of Sciences; Shanghai Jiao Tong University; Baker Heart and Diabetes Institute	Li, YG (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Cardiol, Shanghai 200030, Peoples R China.	drliyigang@yahoo.com.cn			Shanghai Committee of Science and Technology of China [12ZR1419500, 10JC1412700]; Shanghai's health bureau funding [ZYSNXD-CC-ZDYJ029]; Doctoral students innovation fund of Shanghai Jiaotong University School of Medicine [BXJ201229]	Shanghai Committee of Science and Technology of China; Shanghai's health bureau funding; Doctoral students innovation fund of Shanghai Jiaotong University School of Medicine	Project supported by the Shanghai Committee of Science and Technology of China (Grant No. 12ZR1419500, 10JC1412700), Shanghai's health bureau funding (Grant No ZYSNXD-CC-ZDYJ029), Doctoral students innovation fund of Shanghai Jiaotong University School of Medicine (BXJ201229). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acunzo M, 2012, ONCOGENE, V31, P634, DOI 10.1038/onc.2011.260; Ahn GO, 2009, ANGIOGENESIS, V12, P159, DOI 10.1007/s10456-009-9135-7; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Chen T, 2009, CARDIOVASC RES, V83, P131, DOI 10.1093/cvr/cvp121; Chen XQ, 2010, CANCER RES, V70, P2728, DOI 10.1158/0008-5472.CAN-09-3718; Chen Y, 2008, BLOOD, V111, P1217, DOI 10.1182/blood-2007-07-104133; Fadini GP, 2006, ARTERIOSCL THROM VAS, V26, P2140, DOI 10.1161/01.ATV.0000237750.44469.88; Fleissner F, 2010, CIRC RES, V107, P138, DOI 10.1161/CIRCRESAHA.110.216770; Hager M, 2011, BLOOD, V118, P6649, DOI 10.1182/blood-2011-03-339978; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; He TR, 2004, STROKE, V35, P2378, DOI 10.1161/01.STR.0000141893.33677.5d; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Ii M, 2001, CARDIOVASC RES, V52, P500, DOI 10.1016/S0008-6363(01)00411-4; Jarajapu YPR, 2010, CIRC RES, V106, P854, DOI 10.1161/CIRCRESAHA.109.213140; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Karp X, 2005, SCIENCE, V310, P1288, DOI 10.1126/science.1121566; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Loomans CJM, 2004, DIABETES, V53, P195, DOI 10.2337/diabetes.53.1.195; Ma FX, 2006, J LIPID RES, V47, P1227, DOI 10.1194/jlr.M500507-JLR200; Matkovich SJ, 2009, CIRCULATION, V119, P1263, DOI 10.1161/CIRCULATIONAHA.108.813576; Meng S, 2012, J MOL CELL CARDIOL, V53, P64, DOI 10.1016/j.yjmcc.2012.04.003; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Peng ZH, 2006, CLIN CANCER RES, V12, P6386, DOI 10.1158/1078-0432.CCR-05-2359; Poliseno L, 2006, BLOOD, V108, P3068, DOI 10.1182/blood-2006-01-012369; Sata M, 2003, CIRC J, V67, P983, DOI 10.1253/circj.67.983; Sevinsky JR, 2004, MOL CELL BIOL, V24, P4534, DOI 10.1128/MCB.24.10.4534-4545.2004; Shimada T, 2004, CIRCULATION, V110, P1148, DOI 10.1161/01.CIR.0000139854.74847.99; Shiraha H, 2011, J CELL BIOCHEM, V112, P745, DOI 10.1002/jcb.22973; Suarez Y, 2009, CIRC RES, V104, P442, DOI 10.1161/CIRCRESAHA.108.191270; Tamarat R, 2004, AM J PATHOL, V164, P457, DOI 10.1016/S0002-9440(10)63136-7; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; Tracey WD, 2000, SEMIN CELL DEV BIOL, V11, P337, DOI 10.1006/scdb.2000.0186; Urbich C, 2002, CIRC RES, V90, P737, DOI 10.1161/01.RES.0000014081.30867.F8; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; van den Oever IAM, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/792393; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Wassmann S, 2006, CIRC RES, V99, pE74, DOI 10.1161/01.RES.0000246095.90247.d4; Wu WH, 2011, AM J HYPERTENS, V24, P1087, DOI 10.1038/ajh.2011.116; Xu PZ, 2004, TRENDS GENET, V20, P617, DOI 10.1016/j.tig.2004.09.010; Yang SY, 2003, J BONE MINER RES, V18, P705, DOI 10.1359/jbmr.2003.18.4.705	43	71	74	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e68611	10.1371/journal.pone.0068611	http://dx.doi.org/10.1371/journal.pone.0068611			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	23874686	gold, Green Published, Green Submitted			2022-12-27	WOS:000321718700034
J	Villen-Perez, S; Carrascal, LM; Seoane, J				Villen-Perez, Sara; Carrascal, Luis M.; Seoane, Javier			Foraging Patch Selection in Winter: A Balance between Predation Risk and Thermoregulation Benefit	PLOS ONE			English	Article							TRADE-OFF; PROTECTIVE COVER; SOLAR-RADIATION; LIGHT-INTENSITY; SITE SELECTION; BEHAVIOR; BIRDS; TITS; VIGILANCE; SPARROWS	In winter, foraging activity is intended to optimize food search while minimizing both thermoregulation costs and predation risk. Here we quantify the relative importance of thermoregulation and predation in foraging patch selection of woodland birds wintering in a Mediterranean montane forest. Specifically, we account for thermoregulation benefits related to temperature, and predation risk associated with both illumination of the feeding patch and distance to the nearest refuge provided by vegetation. We measured the amount of time that 38 marked individual birds belonging to five small passerine species spent foraging at artificial feeders. Feeders were located in forest patches that vary in distance to protective cover and exposure to sun radiation; temperature and illumination were registered locally by data loggers. Our results support the influence of both thermoregulation benefits and predation costs on feeding patch choice. The influence of distance to refuge (negative relationship) was nearly three times higher than that of temperature (positive relationship) in determining total foraging time spent at a patch. Light intensity had a negligible and no significant effect. This pattern was generalizable among species and individuals within species, and highlights the preponderance of latent predation risk over thermoregulation benefits on foraging decisions of birds wintering in temperate Mediterranean forests.	[Villen-Perez, Sara; Carrascal, Luis M.] Museo Nacl Ciencias Nat, Dept Biogeog & Global Change, Madrid, Spain; [Seoane, Javier] Univ Autonoma Madrid, Dept Ecol, Terr Ecol Grp, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Autonomous University of Madrid	Villen-Perez, S (corresponding author), Museo Nacl Ciencias Nat, Dept Biogeog & Global Change, Madrid, Spain.	sara.villen@mncn.csic.es	Carrascal, Luis M./Q-2190-2016; Villén-Pérez, Sara/J-8945-2016; Seoane, Javier/B-6833-2008; Carrascal, Luis M./B-8381-2008	Carrascal, Luis M./0000-0003-1288-5531; Villén-Pérez, Sara/0000-0003-1832-1817; Seoane, Javier/0000-0001-9975-4846; Carrascal, Luis M./0000-0003-1288-5531	Spanish Ministry of Educacion y Ciencia [CGL2008-02211/BOS]	Spanish Ministry of Educacion y Ciencia(Spanish Government)	This paper was funded by project CGL2008-02211/BOS of the Spanish Ministry of Educacion y Ciencia. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bicudo J.E.P., 2010, ECOLOGICAL ENV PHYSL; Brana F, 2010, ANN ZOOL FENN, V47, P206, DOI 10.5735/086.047.0305; Breckle S.W, 2002, WALTERS VEGETATION E; BROWN JS, 1988, BEHAV ECOL SOCIOBIOL, V22, P37, DOI 10.1007/BF00395696; Brown JS, 2004, ECOL LETT, V7, P999, DOI 10.1111/j.1461-0248.2004.00661.x; Calder W.A., 1974, AVIAN BIOL, V4, P259; Carr JM, 2012, BEHAV ECOL, V23, P434, DOI 10.1093/beheco/arr208; Carrascal LM, 2006, OIKOS, V112, P51, DOI 10.1111/j.0030-1299.2006.13787.x; Carrascal LM, 2001, ECOLOGY, V82, P1642, DOI 10.1890/0012-9658(2001)082[1642:BTBTTO]2.0.CO;2; CARRASCAL LM, 1987, HOLARCTIC ECOL, V10, P185; Cresswell W, 2008, IBIS, V150, P3, DOI 10.1111/j.1474-919X.2007.00793.x; DEJONG AA, 1976, CONDOR, V78, P174; Fernandez-Juricic E, 2007, ANIM BEHAV, V74, P1381, DOI 10.1016/j.anbehav.2007.01.005; Fernandez-Juricic E, 2012, ETHOLOGY, V118, P341, DOI 10.1111/j.1439-0310.2012.02020.x; Griesser M, 2009, BEHAV ECOL, V20, P709, DOI 10.1093/beheco/arp045; GRUBB TC, 1982, ANIM BEHAV, V30, P637, DOI 10.1016/S0003-3472(82)80133-4; HINSLEY SA, 1995, IBIS, V137, P418, DOI 10.1111/j.1474-919X.1995.tb08042.x; Honek A, 1997, EUR J ENTOMOL, V94, P97; Huertas DL, 2001, CAN J ZOOL, V79, P279, DOI 10.1139/cjz-79-2-279; Kendeigh S.C., 1977, GRANIVOROUS BIRDS EC, P127; Kilpatrick AM, 2003, EVOL ECOL RES, V5, P781; Krams IA, 1996, J AVIAN BIOL, V27, P153, DOI 10.2307/3677144; Kullberg C, 1998, ANIM BEHAV, V56, P227, DOI 10.1006/anbe.1998.0765; Lerman SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043497; LIMA SL, 1990, OIKOS, V58, P151, DOI 10.2307/3545422; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Molokwu MN, 2010, OECOLOGIA, V164, P637, DOI 10.1007/s00442-010-1781-3; Mozetich Ingrid M., 1995, Ardeola, V42, P49; Perrins, 1998, COMPLETE BIRDS W PAL; REPASKY RR, 1994, J ANIM ECOL, V63, P569, DOI 10.2307/5223; Repasky RR, 1996, ECOLOGY, V77, P1880, DOI 10.2307/2265791; Senar J.C., 1997, Butlleti del Grup Catala d'Anellament, V14, P17; Telleria JL, 2001, OIKOS, V95, P253, DOI 10.1034/j.1600-0706.2001.950207.x; Tucker VA, 2000, J EXP BIOL, V203, P3755; Wachob DG, 1996, CONDOR, V98, P114, DOI 10.2307/1369514; Walther BA, 2001, OECOLOGIA, V129, P312, DOI 10.1007/s004420100713; Wolf BO, 1996, ECOLOGY, V77, P2228, DOI 10.2307/2265716; Yasue M, 2003, FUNCT ECOL, V17, P727, DOI 10.1111/j.1365-2435.2003.00783.x	38	19	19	1	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e68448	10.1371/journal.pone.0068448	http://dx.doi.org/10.1371/journal.pone.0068448			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	23874632	Green Published, gold, Green Submitted			2022-12-27	WOS:000321718700028
J	Manzoli, DE; Antoniazzi, LR; Saravia, MJ; Silvestri, L; Rorhmann, D; Beldomenico, PM				Ezequiel Manzoli, Dario; Raul Antoniazzi, Leandro; Jose Saravia, Maria; Silvestri, Leonardo; Rorhmann, David; Martin Beldomenico, Pablo			Multi-Level Determinants of Parasitic Fly Infection in Forest Passerines	PLOS ONE			English	Article							PEARLY-EYED THRASHERS; PHILORNIS ECTOPARASITISM; ECOLOGY; DIPTERA; EPIDEMIOLOGY; BIODIVERSITY; NESTLINGS; DISEASES; CLIMATE; IMPACT	The study of myiasis is important because they may cause problems to the livestock industry, public health, or wildlife conservation. The ecology of parasitic dipterans that cause myiasis is singular, as they actively seek their hosts over relatively long distances. However, studies that address the determinants of myiasis dynamics are very scarce. The genus Philornis include species that may be excellent models to study myiasis ecology, as they exclusively parasitize bird nestlings, which stay in their nests until they are fully fledged, and larvae remain at the point of entry until the parasitic stage is over, thus allowing the collection of sequential individual-level infection data from virtually all the hosts present at a particular area. Here we offer a stratified multi-level analysis of longitudinal data of Philornis torquans parasitism in replicated forest bird communities of central Argentina. Using Generalized Linear Models and Generalized Linear Mixed Models and an information theory approach for model selection, we conducted four groups of analyses, each with a different study unit, the individual, the brood, the community at a given week, and the community at a given year. The response variable was larval abundance per nestling or mean abundance per nestling. At each level, models included the variables of interest of that particular level, and also potential confounders and effect modifiers of higher levels. We found associations of large magnitude at all levels, but only few variables truly governed the dynamics of this parasite. At the individual level, the infection was determined by the species and the age of the host. The main driver of parasite abundance at the microhabitat level was the average height of the forest, and at the community level, the density of hosts and prior rainfall. This multi-level approach contributed to a better understanding of the ecology of myiasis.	[Ezequiel Manzoli, Dario; Raul Antoniazzi, Leandro; Jose Saravia, Maria; Silvestri, Leonardo; Rorhmann, David; Martin Beldomenico, Pablo] Univ Nacl Litoral, Consejo Investigac Cientif & Tecn UNL CONICET, Inst Ciencias Vet Litoral, Lab Ecol Enfermedades, Esperanza, Santa Fe, Argentina	National University of the Littoral	Manzoli, DE (corresponding author), Univ Nacl Litoral, Consejo Investigac Cientif & Tecn UNL CONICET, Inst Ciencias Vet Litoral, Lab Ecol Enfermedades, Esperanza, Santa Fe, Argentina.	dmanzoli@fcv.unl.edu.ar		BELDOMENICO, Pablo/0000-0001-5039-8975; Manzoli, Dario/0000-0001-9653-9729	Wildlife Conservation Society (Wildlife Health Fund); Morris Animal Foundation [D08ZO-304]; CONICET [PIP11220100100261]	Wildlife Conservation Society (Wildlife Health Fund); Morris Animal Foundation; CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This study was funded by Wildlife Conservation Society (Wildlife Health Fund, www.wcs.org), Morris Animal Foundation (www.morrisanimalfoundation.org, Grant No. D08ZO-304), and CONICET (www.conicet.gob.ar, Grant No. PIP11220100100261). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniazzi LR, 2011, J ZOOL, V283, P126, DOI 10.1111/j.1469-7998.2010.00753.x; ARENDT WJ, 1985, AUK, V102, P281, DOI 10.2307/4086770; ARENDT WJ, 1985, AUK, V102, P270, DOI 10.2307/4086769; BENNETT GF, 1992, CAN J ZOOL, V70, P51, DOI 10.1139/z92-008; Broughan JM, 2007, MED VET ENTOMOL, V21, P231, DOI 10.1111/j.1365-2915.2007.00689.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Bush AO, 1997, J PARASITOL, V83, P575, DOI 10.2307/3284227; Calero-Torralbo MA, 2008, PARASITOLOGY, V135, P1343, DOI 10.1017/S0031182008004885; Couri M.S., 1999, MYIASIS CAUSED OBL A, P44; De la Pena MR, 2005, REPRODUCCION AVES AR; Diez-Roux AV, 1998, AM J PUBLIC HEALTH, V88, P216, DOI 10.2105/AJPH.88.2.216; Dudaniec RY, 2007, BIOL CONSERV, V139, P325, DOI 10.1016/j.biocon.2007.07.006; Dudaniec RY, 2006, EMU, V106, P13, DOI 10.1071/MU04040; Eisen RJ, 2012, ANNU REV ENTOMOL, V57, P61, DOI 10.1146/annurev-ento-120710-100717; Gelman A., 2007, DATA ANAL USING REGR; Greene CS, 1975, COASTAL WATER RES PR, P79; GREENLAND S, 1994, AM J EPIDEMIOL, V139, P747, DOI 10.1093/oxfordjournals.aje.a117069; Guimaraes J. H., 1999, BIBLIOGRAPHIC DATABA; Hudson P., 2002, ECOLOGY WILDLIFE DIS; Kleindorfer S, 2009, BEHAV ECOL SOCIOBIOL, V63, P731, DOI 10.1007/s00265-008-0706-1; Le Gros A, 2011, WILSON J ORNITHOL, V123, P788, DOI 10.1676/10-049.1; Lucas A. M., 1961, ATLAS AVIAN HEMATOLO; Manzoli Darío E., 2011, Hornero, V26, P45; Marengo J.A., 2009, INT J CLIMATOL, V29, P2241, DOI [DOI 10.1002/joc.1863, 10.1002/joc.1863]; Norris AR, 2010, J TROP ECOL, V26, P619, DOI 10.1017/S026646741000043X; Ostfeld R, 2000, CAN J ZOOL, V78, P2061, DOI 10.1139/cjz-78-12-2061; Papadopoulos E, 2010, SMALL RUMINANT RES, V89, P51, DOI 10.1016/j.smallrumres.2009.12.004; Pavel V, 2008, J ORNITHOL, V149, P193, DOI 10.1007/s10336-007-0259-5; Pfeffer M, 2010, PARASIT VECTORS, V3; Richards SA, 2008, J APPL ECOL, V45, P218, DOI 10.1111/j.1365-2664.2007.01377.x; Roulin A, 2007, BIOL J LINN SOC, V90, P703, DOI 10.1111/j.1095-8312.2007.00759.x; Roux AVD, 2008, J EPIDEMIOL COMMUN H, V62, P957, DOI 10.1136/jech.2007.064311; Schlacher TA, 2013, MAR FRESHWATER RES, V64, P119, DOI 10.1071/MF12172; Schmidt KA, 2001, ECOLOGY, V82, P609, DOI 10.1890/0012-9658(2001)082[0609:BATDEI]2.0.CO;2; Segura LN, 2011, WILSON J ORNITHOL, V123, P107, DOI 10.1676/10-053.1; Suzan G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005461; Tompkins DM, 2011, J ANIM ECOL, V80, P19, DOI 10.1111/j.1365-2656.2010.01742.x; Wall R, 2012, VET PARASITOL, V189, P44, DOI 10.1016/j.vetpar.2012.03.031; Wiedenfeld David A., 2008, Cotinga, V29, P22; YOUNG BE, 1993, OECOLOGIA, V93, P256, DOI 10.1007/BF00317679	41	20	23	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e67104	10.1371/journal.pone.0067104	http://dx.doi.org/10.1371/journal.pone.0067104			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874408	Green Submitted, gold, Green Published			2022-12-27	WOS:000321765300005
J	Sharifian, F; Nurminen, L; Vanni, S				Sharifian, Fariba; Nurminen, Lauri; Vanni, Simo			Visual Interactions Conform to Pattern Decorrelation in Multiple Cortical Areas	PLOS ONE			English	Article							CLASSICAL RECEPTIVE-FIELD; SURFACE-BASED ANALYSIS; CONTEXTUAL MODULATION; OXYGEN-METABOLISM; NEURONAL-ACTIVITY; FUNCTIONAL MRI; NATURAL IMAGES; BRAIN ACTIVITY; BOLD RESPONSE; SUPPRESSION	Neural responses to visual stimuli are strongest in the classical receptive field, but they are also modulated by stimuli in a much wider region. In the primary visual cortex, physiological data and models suggest that such contextual modulation is mediated by recurrent interactions between cortical areas. Outside the primary visual cortex, imaging data has shown qualitatively similar interactions. However, whether the mechanisms underlying these effects are similar in different areas has remained unclear. Here, we found that the blood oxygenation level dependent (BOLD) signal spreads over considerable cortical distances in the primary visual cortex, further than the classical receptive field. This indicates that the synaptic activity induced by a given stimulus occurs in a surprisingly extensive network. Correspondingly, we found suppressive and facilitative interactions far from the maximum retinotopic response. Next, we characterized the relationship between contextual modulation and correlation between two spatial activation patterns. Regardless of the functional area or retinotopic eccentricity, higher correlation between the center and surround response patterns was associated with stronger suppressive interaction. In individual voxels, suppressive interaction was predominant when the center and surround stimuli produced BOLD signals with the same sign. Facilitative interaction dominated in the voxels with opposite BOLD signal signs. Our data was in unison with recently published cortical decorrelation model, and was validated against alternative models, separately in different eccentricities and functional areas. Our study provides evidence that spatial interactions among neural populations involve decorrelation of macroscopic neural activation patterns, and suggests that the basic design of the cerebral cortex houses a robust decorrelation mechanism for afferent synaptic input.	[Sharifian, Fariba; Nurminen, Lauri; Vanni, Simo] Aalto Univ, Brain Res Unit, Sch Sci, OV Lounasmaa Lab, Espoo, Finland; [Vanni, Simo] Aalto Univ, Adv Magnet Imaging Ctr, Aalto Neuroimaging, OV Lounasmaa Lab,Sch Sci, Espoo, Finland	Aalto University; Aalto University	Sharifian, F (corresponding author), Aalto Univ, Brain Res Unit, Sch Sci, OV Lounasmaa Lab, Espoo, Finland.	fariba@neuro.hut.fi	Vanni, Simo/B-9590-2013	Vanni, Simo/0000-0002-6101-4129; Nurminen, Lauri/0000-0001-7480-7059; Sharifian, Professor Farzad/0000-0002-8420-2667	Academy of Finland [210347, 124698, 111817, 140726]; Finnish Graduate School of Neuroscience	Academy of Finland(Academy of Finland); Finnish Graduate School of Neuroscience	This study has been supported by the Academy of Finland grant numbers 210347, 124698, 111817, 140726 and Finnish Graduate School of Neuroscience. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelucci A, 2002, J NEUROSCI, V22, P8633; Aticky JJ, 2011, NETWORK-COMP NEURAL, V22, P4, DOI [10.1088/0954-898X/3/2/009, 10.3109/0954898X.2011.638888]; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Barlow HB, 1989, COMPUTING NEURON, P54; Boorman L, 2010, J NEUROSCI, V30, P4285, DOI 10.1523/JNEUROSCI.6063-09.2010; Bullier J, 2001, BRAIN RES REV, V36, P96, DOI 10.1016/S0165-0173(01)00085-6; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CANNON MW, 1993, VISION RES, V33, P1685, DOI 10.1016/0042-6989(93)90034-T; Carandini M, 2012, NAT REV NEUROSCI, V13, P51, DOI 10.1038/nrn3136; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2530, DOI 10.1152/jn.00692.2001; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Devor A, 2005, P NATL ACAD SCI USA, V102, P3822, DOI 10.1073/pnas.0407789102; Devor A, 2007, J NEUROSCI, V27, P4452, DOI 10.1523/JNEUROSCI.0134-07.2007; Dunn AK, 2005, NEUROIMAGE, V27, P279, DOI 10.1016/j.neuroimage.2005.04.024; Felsen G, 2005, NETWORK-COMP NEURAL, V16, P139, DOI 10.1080/09548980500463347; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; FOLEY JM, 1994, J OPT SOC AM A, V11, P1710, DOI 10.1364/JOSAA.11.001710; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Fukuda M, 2006, J NEUROSCI, V26, P11821, DOI 10.1523/JNEUROSCI.3098-06.2006; GRINVALD A, 1994, J NEUROSCI, V14, P2545; GULYAS B, 1987, J NEUROPHYSIOL, V57, P1767, DOI 10.1152/jn.1987.57.6.1767; Haak KV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037686; Harrison LM, 2007, NEUROIMAGE, V34, P1199, DOI 10.1016/j.neuroimage.2006.10.017; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P427, DOI 10.1017/S095252380001124X; Henriksson L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036859; Huk AC, 2001, NEURON, V32, P161, DOI 10.1016/S0896-6273(01)00452-4; Ichida JM, 2007, J NEUROPHYSIOL, V98, P2168, DOI 10.1152/jn.00298.2007; Kay KN, 2008, NATURE, V452, P352, DOI 10.1038/nature06713; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; Kriegeskorte N, 2011, NEUROIMAGE, V56, P411, DOI 10.1016/j.neuroimage.2011.01.061; Kriegeskorte N, 2010, NEUROIMAGE, V49, P1965, DOI 10.1016/j.neuroimage.2009.09.059; Larsson J, 2006, J NEUROPHYSIOL, V95, P862, DOI 10.1152/jn.00668.2005; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; Levitt JB, 1997, NATURE, V387, P73, DOI 10.1038/387073a0; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; MAFFEI L, 1976, VISION RES, V16, P1131, DOI 10.1016/0042-6989(76)90253-4; McDonald JS, 2009, VISION RES, V49, P1397, DOI 10.1016/j.visres.2008.12.014; Miller KD, 2002, J NEUROPHYSIOL, V87, P653, DOI 10.1152/jn.00425.2001; Mitchell TM, 2008, SCIENCE, V320, P1191, DOI 10.1126/science.1152876; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; Nurminen L, 2010, J VISION, V10, DOI 10.1167/10.13.9; Nurminen L, 2009, J NEUROPHYSIOL, V102, P2900, DOI 10.1152/jn.00201.2009; Parkes LM, 2005, MAGN RESON MED, V54, P1465, DOI 10.1002/mrm.20712; Pasley BN, 2007, NEUROIMAGE, V36, P269, DOI 10.1016/j.neuroimage.2006.09.015; Pihlaja M, 2008, HUM BRAIN MAPP, V29, P1001, DOI 10.1002/hbm.20442; Polat U, 1998, VISION RES, V38, P3735, DOI 10.1016/S0042-6989(97)00426-4; Putnam NM, 2005, J VISION, V5, P632, DOI 10.1167/5.7.3; Renart A, 2010, SCIENCE, V327, P587, DOI 10.1126/science.1179850; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Sceniak MP, 1999, NAT NEUROSCI, V2, P733, DOI 10.1038/11197; Sceniak MP, 2001, J NEUROPHYSIOL, V85, P1873, DOI 10.1152/jn.2001.85.5.1873; SCHWABE L, 2010, NEUROIMAGE; Schwabe L, 2006, J NEUROSCI, V26, P9117, DOI 10.1523/JNEUROSCI.1253-06.2006; Schwartz Eric L., 1994, Cerebral Cortex, V10, P359; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Somers DC, 1998, CEREB CORTEX, V8, P204, DOI 10.1093/cercor/8.3.204; Swisher JD, 2010, J NEUROSCI, V30, P325, DOI 10.1523/JNEUROSCI.4811-09.2010; Tajima S, 2010, J NEUROSCI, V30, P3264, DOI 10.1523/JNEUROSCI.4473-09.2010; Vanni S, 2004, NEUROIMAGE, V21, P818, DOI 10.1016/j.neuroimage.2003.10.035; Vanni S, 2005, NEUROIMAGE, V27, P95, DOI 10.1016/j.neuroimage.2005.01.046; Vanni S, 2011, J COMPUTATIONAL NEUR; Vanni S, 2012, NEURAL NETWORKS, V25, P30, DOI 10.1016/j.neunet.2011.08.001; Vinje WE, 2002, J NEUROSCI, V22, P2904, DOI 10.1523/JNEUROSCI.22-07-02904.2002; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Wade AR, 2010, J NEUROSCI, V30, P5008, DOI 10.1523/JNEUROSCI.6260-09.2010; Wiechert MT, 2010, NAT NEUROSCI, V13, P1003, DOI 10.1038/nn.2591; Williams AL, 2003, J NEUROPHYSIOL, V89, P525, DOI 10.1152/jn.00048.2002; Xing J, 2001, VISION RES, V41, P571, DOI 10.1016/S0042-6989(00)00270-4; Zenger-Landolt B, 2003, J NEUROSCI, V23, P6884; Zoccolan D, 2005, J NEUROSCI, V25, P8150, DOI 10.1523/JNEUROSCI.2058-05.2005; Zuiderbaan W, 2012, J VISION, V12, DOI 10.1167/12.3.10	75	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68046	10.1371/journal.pone.0068046	http://dx.doi.org/10.1371/journal.pone.0068046			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874491	Green Published, gold, Green Submitted			2022-12-27	WOS:000321765300023
J	Akiyama, Y; Kikuchi, K; Saigusa, D; Suzuki, T; Takeuchi, Y; Mishima, E; Yamamoto, Y; Ishida, A; Sugawara, D; Jinno, D; Shima, H; Toyohara, T; Suzuki, C; Souma, T; Moriguchi, T; Tomioka, Y; Ito, S; Abe, T				Akiyama, Yasutoshi; Kikuchi, Koichi; Saigusa, Daisuke; Suzuki, Takehiro; Takeuchi, Yoichi; Mishima, Eikan; Yamamoto, Yasuaki; Ishida, Ayako; Sugawara, Daiki; Jinno, Daisuke; Shima, Hisato; Toyohara, Takafumi; Suzuki, Chitose; Souma, Tomokazu; Moriguchi, Takashi; Tomioka, Yoshihisa; Ito, Sadayoshi; Abe, Takaaki			Indoxyl Sulfate Down-Regulates SLCO4C1 Transporter through Up-Regulation of GATA3	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CHRONIC-RENAL-FAILURE; ERYTHROPOIETIN GENE-EXPRESSION; UREMIC TOXINS; GUANIDINO COMPOUNDS; DRUG TRANSPORTERS; OXIDATIVE STRESS; TUBULAR CELLS; IN-VITRO; METABOLISM	The accumulated uremic toxins inhibit the expression of various renal transporters and this inhibition may further reduce renal function and subsequently cause the accumulation of uremic toxins. However, the precise mechanism of the nephrotoxicity of uremic toxins on renal transport has been poorly understood. Here we report that indoxyl sulfate, one of the potent uremic toxins, directly suppresses the renal-specific organic anion transporter SLCO4C1 expression through a transcription factor GATA3. The promoter region of SLCO4C1 gene has several GATA motifs, and indoxyl sulfate up-regulated GATA3 mRNA and subsequently down-regulated SLCO4C1 mRNA. Overexpression of GATA3 significantly reduced SLCO4C1 expression, and silencing of GATA3 increased SLCO4C1 expression vice versa. Administration of indoxyl sulfate in rats reduced renal expression of slco4c1 and under this condition, plasma level of guanidinosuccinate, one of the preferable substrates of slco4c1, was significantly increased without changing plasma creatinine. Furthermore, in 5/6 nephrectomized rats, treatment with oral adsorbent AST-120 significantly decreased plasma indoxyl sulfate level and conversely increased the expression of slco4c1, following the reduction of plasma level of guanidinosuccinate. These data suggest that the removal of indoxyl sulfate and blocking its signal pathway may help to restore the SLCO4C1-mediated renal excretion of uremic toxins in CKD.	[Akiyama, Yasutoshi; Ito, Sadayoshi; Abe, Takaaki] Tohoku Univ, Grad Sch Med, Dept Community Hlth Promot, Sendai, Miyagi 980, Japan; [Kikuchi, Koichi; Suzuki, Takehiro; Takeuchi, Yoichi; Mishima, Eikan; Yamamoto, Yasuaki; Shima, Hisato; Toyohara, Takafumi; Suzuki, Chitose; Souma, Tomokazu] Tohoku Univ, Grad Sch Med, Div Nephrol Endocrinol & Vasc Med, Sendai, Miyagi 980, Japan; [Saigusa, Daisuke; Ishida, Ayako; Sugawara, Daiki; Jinno, Daisuke; Tomioka, Yoshihisa] Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Oncol Pharm Practice & Sci, Sendai, Miyagi 980, Japan; [Souma, Tomokazu; Moriguchi, Takashi] Tohoku Univ, Grad Sch Med, Dept Med Chem, Sendai, Miyagi 980, Japan; [Abe, Takaaki] Tohoku Univ, Grad Sch Biomed Engn, Div Med Sci, Sendai, Miyagi 980, Japan; [Abe, Takaaki] Tohoku Univ, Grad Sch Med, Dept Clin Biol & Hormonal Regulat, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University	Abe, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Community Hlth Promot, Sendai, Miyagi 980, Japan.	takaabe@med.tohoku.ac.jp	Ito, Sadayoshi/A-3933-2015; Souma, Tomokazu/K-6439-2019; Souma, Tomokazu/A-5547-2011; Suzuki, Takehiro/AAE-2210-2019	Souma, Tomokazu/0000-0002-3285-8613; Ito, Sadayoshi/0000-0002-5092-3626; Akiyama, Yasutoshi/0000-0002-0211-7793; Saigusa, Daisuke/0000-0001-9484-9870; Mishima, Eikan/0000-0002-3706-2745	Ministry of Education, Culture, Sports, Science, and Technology of Japan [23390033]; Japan Kidney Foundation; Novartis Foundation; Grants-in-Aid for Scientific Research [25430135, 12J07924] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Kidney Foundation; Novartis Foundation(Novartis); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This project was supported by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (23390033), Japan Kidney Foundation, the Novartis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama I, 2003, AM J KIDNEY DIS, V41, pS8, DOI 10.1053/ajkd.2003.50075; Burch JBE, 2005, SEMIN CELL DEV BIOL, V16, P71, DOI 10.1016/j.semcdb.2004.10.002; Cressman AM, 2012, EXPERT REV CLIN PHAR, V5, P69, DOI [10.1586/ecp.11.66, 10.1586/ECP.11.66]; De Deyn PP, 2009, SEMIN DIALYSIS, V22, P340, DOI 10.1111/j.1525-139X.2009.00577.x; Duranton F, 2012, J AM SOC NEPHROL, V23, P1258, DOI 10.1681/ASN.2011121175; Enomoto A, 2007, THER APHER DIAL, V11, pS27, DOI 10.1111/j.1744-9987.2007.00515.x; GEDDES R, 1979, BIOCHEM PHARMACOL, V28, P2285, DOI 10.1016/0006-2952(79)90691-9; GIOVANNETTI S, 1968, CLIN SCI, V34, P141; Glorieux GL, 2004, KIDNEY INT, V65, P2184, DOI 10.1111/j.1523-1755.2004.00631.x; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Imagawa S, 2003, FASEB J, V17, P1742, DOI 10.1096/fj.02-1134fje; Ji L, 2002, KIDNEY INT, V62, P514, DOI 10.1046/j.1523-1755.2002.00464.x; Kakyo M, 1999, FEBS LETT, V445, P343, DOI 10.1016/S0014-5793(99)00152-0; Lim KC, 2000, NAT GENET, V25, P209, DOI 10.1038/76080; Mikkaichi T, 2004, P NATL ACAD SCI USA, V101, P3569, DOI 10.1073/pnas.0304987101; Mikkaichi Tsuyoshi, 2004, Drug Metab Pharmacokinet, V19, P171, DOI 10.2133/dmpk.19.171; Miyazaki T, 1997, KIDNEY INT S, V62, pS15; Muntane J, 2009, CURR DRUG METAB, V10, P932, DOI 10.2174/138920009790274595; Mutsaers HAM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018438; Naud J, 2012, J CLIN PHARMACOL, V52, p10S, DOI 10.1177/0091270011413588; Naud J, 2012, DRUG METAB DISPOS, V40, P39, DOI 10.1124/dmd.111.041145; Naud J, 2011, DRUG METAB DISPOS, V39, P1363, DOI 10.1124/dmd.111.039115; Nii-Kono T, 2007, KIDNEY INT, V71, P738, DOI 10.1038/sj.ki.5002097; NIWA T, 1994, J LAB CLIN MED, V124, P96; Niwa T, 2011, THER APHER DIAL, V15, P120, DOI 10.1111/j.1744-9987.2010.00882.x; Nolin TD, 2008, CLIN PHARMACOL THER, V83, P898, DOI 10.1038/clpt.2008.59; Obara N, 2008, BLOOD, V111, P5223, DOI 10.1182/blood-2007-10-115857; Patient RK, 2002, CURR OPIN GENET DEV, V12, P416, DOI 10.1016/S0959-437X(02)00319-2; Raff AC, 2008, CURR OPIN NEPHROL HY, V17, P560, DOI 10.1097/MNH.0b013e32830f45b6; Saigusa D, 2010, ANAL CHIM ACTA, V677, P169, DOI 10.1016/j.aca.2010.08.005; Schepers E, 2010, BLOOD PURIFICAT, V30, P277, DOI 10.1159/000320765; Shimizu H, 2011, AM J PHYSIOL-CELL PH, V301, pC1201, DOI 10.1152/ajpcell.00471.2010; Sun H, 2006, PHARMACOL THERAPEUT, V109, P1, DOI 10.1016/j.pharmthera.2005.05.010; Suzuki T, 2011, J PHARM SCI-US, V100, P3696, DOI 10.1002/jps.22641; Taki K, 2006, J RENAL NUTR, V16, P199, DOI 10.1053/j.jrn.2006.04.020; Tarumoto T, 2000, BLOOD, V96, P1716, DOI 10.1182/blood.V96.5.1716.h8001716_1716_1722; Torremans A, 2003, AMINO ACIDS, V24, P375, DOI 10.1007/s00726-002-0346-0; Toyohara T, 2010, HYPERTENS RES, V33, P944, DOI 10.1038/hr.2010.113; Toyohara T, 2009, J AM SOC NEPHROL, V20, P2546, DOI 10.1681/ASN.2009070696; Tran M, 2011, J CLIN INVEST, V121, P4003, DOI 10.1172/JCI58662; Tumur Z, 2010, AM J NEPHROL, V31, P435, DOI 10.1159/000299798; Vanholder R, 2008, J AM SOC NEPHROL, V19, P863, DOI 10.1681/ASN.2007121377; Vanholder R, 2012, J RENAL NUTR, V22, P90, DOI 10.1053/j.jrn.2011.10.026; Watanabe H, 2011, J PHARM SCI-US, V100, P3682, DOI 10.1002/jps.22592; Yamamoto S, 2011, AM J NEPHROL, V33, P485, DOI 10.1159/000327820; Yu M, 2011, CLIN J AM SOC NEPHRO, V6, P30, DOI 10.2215/CJN.05340610; Zhou YH, 1998, EMBO J, V17, P6689, DOI 10.1093/emboj/17.22.6689	47	24	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e66518	10.1371/journal.pone.0066518	http://dx.doi.org/10.1371/journal.pone.0066518			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874392	Green Published, Green Submitted, gold			2022-12-27	WOS:000321736900005
J	Cosottini, M; Cecchi, P; Piazza, S; Pesaresi, I; Fabbri, S; Diciotti, S; Mascalchi, M; Siciliano, G; Bonuccelli, U				Cosottini, Mirco; Cecchi, Paolo; Piazza, Selina; Pesaresi, Ilaria; Fabbri, Serena; Diciotti, Stefano; Mascalchi, Mario; Siciliano, Gabriele; Bonuccelli, Ubaldo			Mapping Cortical Degeneration in ALS with Magnetization Transfer Ratio and Voxel-Based Morphometry	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; DIFFUSION TENSOR MRI; MOTOR-NEURON DISEASE; MILD COGNITIVE IMPAIRMENT; CORTICOSPINAL TRACT; FRONTOTEMPORAL DEMENTIA; ALZHEIMERS-DISEASE; INTRANEURONAL INCLUSIONS; CLINICAL-APPLICATIONS; PRECENTRAL GYRUS	Pathological and imaging data indicate that amyotrophic lateral sclerosis (ALS) is a multisystem disease involving several cerebral cortical areas. Advanced quantitative magnetic resonance imaging (MRI) techniques enable to explore in vivo the volume and microstructure of the cerebral cortex in ALS. We studied with a combined voxel-based morphometry (VBM) and magnetization transfer (MT) imaging approach the capability of MRI to identify the cortical areas affected by neurodegeneration in ALS patients. Eighteen ALS patients and 18 age-matched healthy controls were examined on a 1.5T scanner using a high-resolution 3D T1 weighted spoiled gradient recalled sequence with and without MT saturation pulse. A voxel-based analysis (VBA) was adopted in order to automatically compute the regional atrophy and MT ratio (MTr) changes of the entire cerebral cortex. By using a multimodal image analysis MTr was adjusted for local gray matter (GM) atrophy to investigate if MTr changes can be independent of atrophy of the cerebral cortex. VBA revealed several clusters of combined GM atrophy and MTr decrease in motor-related areas and extra-motor frontotemporal cortex. The multimodal image analysis identified areas of isolated MTr decrease in premotor and extra-motor frontotemporal areas. VBM and MTr are capable to detect the distribution of neurodegenerative alterations in the cortical GM of ALS patients, supporting the hypothesis of a multi-systemic involvement in ALS. MT imaging changes exist beyond volume loss in frontotemporal cortices.	[Cosottini, Mirco; Cecchi, Paolo; Piazza, Selina; Fabbri, Serena; Siciliano, Gabriele; Bonuccelli, Ubaldo] Univ Pisa, Dept Neurosci, Pisa, Italy; [Cosottini, Mirco; Cecchi, Paolo; Pesaresi, Ilaria] Santa Chiara Hosp, Unit Neuroradiol, Pisa, Italy; [Diciotti, Stefano; Mascalchi, Mario] Univ Florence, Dept Biomed Expt & Clin Sci, Quantitat & Funct Neuroradiol Res Unit, Florence, Italy	University of Pisa; Santa Chiara Hospital; University of Florence	Cosottini, M (corresponding author), Univ Pisa, Dept Neurosci, Pisa, Italy.	mircocosottini@libero.it	Cosottini, Mirco/K-7991-2016; Cecchi, Paolo/K-6607-2016; Bonuccelli, Ubaldo/K-8681-2016; fabbri, serena/J-5409-2016; Diciotti, Stefano/C-4167-2008	Cosottini, Mirco/0000-0001-9400-6574; Cecchi, Paolo/0000-0003-2725-2657; Bonuccelli, Ubaldo/0000-0001-6218-6312; fabbri, serena/0000-0001-7051-251X; Diciotti, Stefano/0000-0001-8778-7819				Abe K, 1997, J NEUROIMAGING, V7, P208, DOI 10.1111/jon199774208; Abrahams S, 2005, J NEUROL, V252, P321, DOI 10.1007/s00415-005-0646-x; Agosta F, 2007, HUM BRAIN MAPP, V28, P1430, DOI 10.1002/hbm.20364; Agosta F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042816; Andersson J.L.R., 2007, TR07JA1 FMRIB; Andersson J.L.R, 2007, TR07JA2 FMRIB; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Audoin B, 2006, BRAIN, V129, P1031, DOI 10.1093/brain/awl039; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Chan S, 2003, NEUROIMAG CLIN N AM, V13, P307, DOI 10.1016/S1052-5149(03)00018-2; Charil A, 2009, AMYOTROPH LATERAL SC, V10, P269, DOI 10.3109/17482960902777339; CHEUNG G, 1995, RADIOLOGY, V194, P263, DOI 10.1148/radiology.194.1.7997565; Cosottini M, 2005, RADIOLOGY, V237, P258, DOI 10.1148/radiol.2371041506; Cosottini M, 2011, AM J NEURORADIOL, V32, P704, DOI 10.3174/ajnr.A2356; Cosottini M, 2012, EXP NEUROL, V234, P169, DOI 10.1016/j.expneurol.2011.12.024; Cosottini M, 2010, J COMPUT ASSIST TOMO, V34, P746, DOI 10.1097/RCT.0b013e3181e35129; Draganski B, 2011, NEUROIMAGE, V55, P1423, DOI 10.1016/j.neuroimage.2011.01.052; Eisen A, 2001, MUSCLE NERVE, V24, P564, DOI 10.1002/mus.1042; Ellis CM, 2001, NEUROLOGY, V57, P1571, DOI 10.1212/WNL.57.9.1571; Ellis CM, 1999, NEUROLOGY, V53, P1051, DOI 10.1212/WNL.53.5.1051; FLORENCE JM, 1992, PHYS THER, V72, P115, DOI 10.1093/ptj/72.2.115; Geser F, 2008, ARCH NEUROL-CHICAGO, V65, P636, DOI 10.1001/archneur.65.5.636; Ginestroni A, 2010, AM J NEURORADIOL, V31, P1807, DOI 10.3174/ajnr.A2225; Ginestroni A, 2009, J NEUROL, V256, P925, DOI 10.1007/s00415-009-5044-3; Giulietti G, 2012, NEUROIMAGE, V59, P1114, DOI 10.1016/j.neuroimage.2011.09.043; GOODIN DS, 1988, ANN NEUROL, V23, P418, DOI 10.1002/ana.410230424; Grosskreutz J, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-17; Grossman M, 2008, NEUROLOGY, V71, P1396, DOI 10.1212/01.wnl.0000319701.50168.8c; GROSSMAN RI, 1994, RADIOGRAPHICS, V14, P279, DOI 10.1148/radiographics.14.2.8190954; Hecht MJ, 2002, J NEUROL SCI, V199, P59, DOI 10.1016/S0022-510X(02)00104-1; Hong YH, 2004, J NEUROL SCI, V227, P73, DOI 10.1016/j.jns.2004.08.014; ISHIKAWA K, 1993, ANN NEUROL, V33, P218, DOI 10.1002/ana.410330214; Iwata NK, 2008, NEUROLOGY, V70, P528, DOI 10.1212/01.wnl.0000299186.72374.19; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jost G, 2002, MAGN RESON IMAGING, V20, P593, DOI 10.1016/S0730-725X(02)00590-8; Kiefer C, 2009, NEUROIMAGE, V48, P657, DOI 10.1016/j.neuroimage.2009.07.005; Lillo P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043993; Lomen-Hoerth C, 2002, NEUROLOGY, V59, P1077, DOI 10.1212/WNL.59.7.1077; LUDOLPH AC, 1992, ACTA NEUROL SCAND, V85, P81, DOI 10.1111/j.1600-0404.1992.tb04003.x; Mackenzie IRA, 2003, ACTA NEUROPATHOL, V105, P543, DOI 10.1007/s00401-003-0678-1; MAZZIOTTA JC, 1995, NEUROIMAGE, V2, P89, DOI 10.1006/nimg.1995.1012; Mezzapesa DM, 2007, AM J NEURORADIOL, V28, P255; Mohammadi B, 2011, HUM BRAIN MAPP, V32, P750, DOI 10.1002/hbm.21064; Nakano I, 2000, NEUROPATHOLOGY, V20, P68, DOI 10.1046/j.1440-1789.2000.00272.x; Nakano I., 1993, NEUROPATHOLOGY, V13, P215, DOI DOI 10.1111/J.1440-1789.1993.TB00200.X; Neumann M, 2009, INT J MOL SCI, V10, P232, DOI 10.3390/ijms10010232; Ngai S, 2007, AM J NEURORADIOL, V28, P250; NIHEI K, 1993, ACTA NEUROPATHOL, V86, P55, DOI 10.1007/BF00454899; Oakes TR, 2007, NEUROIMAGE, V34, P500, DOI 10.1016/j.neuroimage.2006.10.007; OBA H, 1993, RADIOLOGY, V189, P843, DOI 10.1148/radiology.189.3.8234713; OKAMOTO K, 1991, NEUROSCI LETT, V129, P233, DOI 10.1016/0304-3940(91)90469-A; Ota S, 2005, NEUROPATHOLOGY, V25, P326, DOI 10.1111/j.1440-1789.2005.00646.x; Phukan J, 2007, LANCET NEUROL, V6, P994, DOI 10.1016/S1474-4422(07)70265-X; Piao YS, 2003, BRAIN PATHOL, V13, P10; Ranjeva JP, 2005, AM J NEURORADIOL, V26, P119; Ridha BH, 2007, AM J NEURORADIOL, V28, P965; Roccatagliata L, 2009, AMYOTROPH LATERAL SC, V10, P47, DOI 10.1080/17482960802267530; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; TALBOT PR, 1995, J NEUROL NEUROSUR PS, V58, P541, DOI 10.1136/jnnp.58.5.541; Thorpe JW, 1996, J NEUROL NEUROSUR PS, V61, P314, DOI 10.1136/jnnp.61.3.314; Tsermentseli S, 2012, CORTEX, V48, P166, DOI 10.1016/j.cortex.2011.02.004; Tsnchiya K, 2002, NEUROPATHOLOGY, V22, P308; Tsujimoto M, 2011, J NEUROL SCI, V307, P34, DOI 10.1016/j.jns.2011.05.025; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van der Flier WM, 2002, ANN NEUROL, V52, P62, DOI 10.1002/ana.10244; Wijesekera LC, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-3; WOLFF SD, 1989, MAGNET RESON MED, V10, P135, DOI 10.1002/mrm.1910100113; WOLFF SD, 1994, RADIOLOGY, V192, P593, DOI 10.1148/radiology.192.3.8058919; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	73	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68279	10.1371/journal.pone.0068279	http://dx.doi.org/10.1371/journal.pone.0068279			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874570	Green Published, gold, Green Submitted			2022-12-27	WOS:000321736900076
J	Fang, CP; Li, ZC; Yang, CH; Cheng, JC; Yeh, YJ; Sun, TH; Li, HC; Juang, YL; Lo, SY				Fang, Chiu-Ping; Li, Zhi-Cheng; Yang, Chee-Hing; Cheng, Ju-Chien; Yeh, Yung-Ju; Sun, Tsai-Hsia; Li, Hui-Chun; Juang, Yue-Li; Lo, Shih-Yen			Hepatitis C Virus Non-Structural Protein 3 Interacts with Cytosolic 5 '(3 ')-Deoxyribonucleotidase and Partially Inhibits Its Activity	PLOS ONE			English	Article							NS3 PROTEIN; CELLS; 5'-NUCLEOTIDASES; DEOXYRIBONUCLEOTIDASES; REPLICATION; POLYPROTEIN; NUCLEOTIDE; INFECTION; CLEAVAGE; DISEASE	Infection with hepatitis C virus (HCV) is etiologically involved in liver cirrhosis, hepatocellular carcinoma and B-cell lymphomas. It has been demonstrated previously that HCV non-structural protein 3 (NS3) is involved in cell transformation. In this study, a yeast two-hybrid screening experiment was conducted to identify cellular proteins interacting with HCV NS3 protein. Cytosolic 5'(3')-deoxyribonucleotidase (cdN, dNT-1) was found to interact with HCV NS3 protein. Binding domains of HCV NS3 and cellular cdN proteins were also determined using the yeast two-hybrid system. Interactions between HCV NS3 and cdN proteins were further demonstrated by co-immunoprecipitation and confocal analysis in cultured cells. The cellular cdN activity was partially repressed by NS3 protein in both the transiently-transfected and the stably-transfected systems. Furthermore, HCV partially repressed the cdN activity while had no effect on its protein expression in the systems of HCV sub-genomic replicons and infectious HCV virions. Deoxyribonucleotidases are present in most mammalian cells and involve in the regulation of intracellular deoxyribonucleotides pools by substrate cycles. Control of DNA precursor concentration is essential for the maintenance of genetic stability. Reduction of cdN activity would result in the imbalance of DNA precursor concentrations. Thus, our results suggested that HCV partially reduced the cdN activity via its NS3 protein and this may in turn cause diseases.	[Fang, Chiu-Ping; Li, Zhi-Cheng; Yang, Chee-Hing; Sun, Tsai-Hsia; Lo, Shih-Yen] Tzu Chi Univ, Dept Lab Med & Biotechnol, Hualien, Taiwan; [Cheng, Ju-Chien; Yeh, Yung-Ju] China Med Univ, Dept Med Lab Sci & Biotechnol, Taichung, Taiwan; [Li, Hui-Chun] Tzu Chi Univ, Dept Biochem, Hualien, Taiwan; [Juang, Yue-Li] Tzu Chi Univ, Dept Microbiol, Hualien, Taiwan; [Lo, Shih-Yen] Buddhist Tzu Chi Gen Hosp, Dept Lab Med, Hualien, Taiwan	Tzu Chi University; China Medical University Taiwan; Tzu Chi University; Tzu Chi University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital	Lo, SY (corresponding author), Tzu Chi Univ, Dept Lab Med & Biotechnol, Hualien, Taiwan.	losylo@mail.tcu.edu.tw		Yang, Chee-Hing/0000-0001-6129-272X	National Science Council of Taiwan [NSC 97-3112-B-320-001]; Tzu Chi University [TCIRP96004-05]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Tzu Chi University	This work was supported by grants from the National Science Council of Taiwan (NSC 97-3112-B-320-001) and from the Tzu Chi University (TCIRP96004-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianchi V, 2003, J BIOL CHEM, V278, P46195, DOI 10.1074/jbc.R300032200; Chan SC, 2011, BIOCHEM BIOPH RES CO, V404, P574, DOI 10.1016/j.bbrc.2010.12.037; Cheng JC, 2012, CELL MOL LIFE SCI, V69, P2621, DOI 10.1007/s00018-012-0940-6; CHIEN DY, 1992, P NATL ACAD SCI USA, V89, P10011, DOI 10.1073/pnas.89.21.10011; Choi JN, 2004, HEPATOLOGY, V39, P81, DOI 10.1002/hep.20001; CHRISTENSEN LD, 1988, APMIS, V96, P882, DOI 10.1111/j.1699-0463.1988.tb00955.x; Gallinaro L, 2002, J BIOL CHEM, V277, P35080, DOI 10.1074/jbc.M203755200; Hidajat R, 2005, J GEN VIROL, V86, P2197, DOI 10.1099/vir.0.80862-0; HOGLUND L, 1990, J BIOL CHEM, V265, P6589; HOGLUND L, 1988, CANCER RES, V48, P3681; Hunsucker SA, 2005, PHARMACOL THERAPEUT, V107, P1, DOI 10.1016/j.pharmthera.2005.01.003; Kou YH, 2007, J VIROL, V81, P7999, DOI 10.1128/JVI.00348-07; KUNZ BA, 1988, MUTAT RES, V200, P133, DOI 10.1016/0027-5107(88)90076-0; KUNZ BA, 1994, MUTAT RES-REV GENET, V318, P1, DOI 10.1016/0165-1110(94)90006-X; LEMON SM, 2007, FIELDS VIROLOGY, P1253; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Ma HC, 2008, J BIOMED SCI, V15, P417, DOI 10.1007/s11373-008-9248-9; Ma HC, 2007, J BIOMED SCI, V14, P31, DOI 10.1007/s11373-006-9127-1; Mazzon C, 2003, BIOCHEM PHARMACOL, V66, P471, DOI 10.1016/S0006-2952(03)00290-9; Negri E, 2004, INT J CANCER, V111, P1, DOI 10.1002/ijc.20205; Rampazzo C, 2000, J BIOL CHEM, V275, P5409, DOI 10.1074/jbc.275.8.5409; Rampazzo C, 2002, BIOCHEM BIOPH RES CO, V293, P258, DOI 10.1016/S0006-291X(02)00206-1; Rampazzo C, 2000, P NATL ACAD SCI USA, V97, P8239, DOI 10.1073/pnas.97.15.8239; REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025; SAKAMURO D, 1995, J VIROL, V69, P3893, DOI 10.1128/JVI.69.6.3893-3896.1995; Shoji I, 1999, VIROLOGY, V254, P315, DOI 10.1006/viro.1998.9540; Skapek SX, 2000, J BIOL CHEM, V275, P7212, DOI 10.1074/jbc.275.10.7212; Wallden K, 2007, BIOCHEMISTRY-US, V46, P13809, DOI 10.1021/bi7014794; Wang SY, 2009, BIOCHEM BIOPH RES CO, V385, P230, DOI 10.1016/j.bbrc.2009.05.043; Wei WY, 2012, ARCH VIROL, V157, P635, DOI 10.1007/s00705-011-1221-7; Yang CH, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-65; Zemel R, 2001, J VIRAL HEPATITIS, V8, P96, DOI 10.1046/j.1365-2893.2001.00283.x	32	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68736	10.1371/journal.pone.0068736	http://dx.doi.org/10.1371/journal.pone.0068736			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874742	Green Published, gold, Green Submitted			2022-12-27	WOS:000321736900108
J	Xu, DS; Staedman, A; Zhang, LW				Xu, Dongsheng; Staedman, Andrew; Zhang, Luwen			CD20 Antibody Primes B Lymphocytes for Type I Interferon Production	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; SARCOMA-ASSOCIATED HERPESVIRUS; BARR-VIRUS-DNA; NF-KAPPA-B; KAPOSIS SARCOMA; LIPID RAFTS; LYTIC REPLICATION; INDUCED ARTHRITIS; GENE-EXPRESSION; CELL-LINE	CD20 is a B cell surface marker that is expressed in various stages in B lymphocytes and certain lymphomas. Clinical administration of CD20 antibody, such as rituximab, is used widely to treat human B-cell lymphomas and other diseases. However, CD20 antibody failed to treat systemic lupus erythematosus (SLE or lupus). The reason for the failure is currently unknown. Type I interferons (IFN) are a major component for the host innate immunity, and a key pathogenic factor in lupus. We found that CD20 antibody potentiated human B cells for its production of IFNs in vitro. This function was specific to CD20-expressing cells and the potentiation function seems to be instant. In addition, ectopic expression of CD20 in non-B-lymphocytes increased the IFN promoter reporter activities. Because IFNs are a key pathogenic factor in lupus, our data suggest that, in the presence of virus infection, the CD20-antibody-mediated enhancement of IFN production might be related to its failure in lupus treatments. This work may provide new insights for CD20-Ab therapeutic applications.	[Xu, Dongsheng; Zhang, Luwen] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; [Staedman, Andrew; Zhang, Luwen] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Zhang, LW (corresponding author), Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA.	lzhang2@unlnotes.unl.edu			National Institute of Health [CA138213, RR15635]; Department of Defense-Army Medical Research [W81XWH-12-1-0225]; NATIONAL CANCER INSTITUTE [R01CA138213] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015635] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense-Army Medical Research(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by grants from National Institute of Health CA138213, RR15635, and grant from Department of Defense-Army Medical Research W81XWH-12-1-0225 (LZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Baechler EC, 2004, CURR OPIN IMMUNOL, V16, P801, DOI 10.1016/j.coi.2004.09.014; Banchereau J, 2004, IMMUNITY, V20, P539, DOI 10.1016/S1074-7613(04)00108-6; Bengtsson AA, 2000, LUPUS, V9, P664, DOI 10.1191/096120300674499064; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; BUBIEN JK, 1993, J CELL BIOL, V121, P1121, DOI 10.1083/jcb.121.5.1121; Cahir-McFarland ED, 2000, P NATL ACAD SCI USA, V97, P6055, DOI 10.1073/pnas.100119497; Carter KL, 2002, J VIROL, V76, P10427, DOI 10.1128/JVI.76.20.10427-10436.2002; Chan HTC, 2003, CANCER RES, V63, P5480; Cragg Mark S., 2005, V8, P140; Crow MK, 2003, ARTHRITIS RHEUM, V48, P2396, DOI 10.1002/art.11226; Davis TA, 2000, CLIN CANCER RES, V6, P2644; de Hooge ASK, 2004, ARTHRITIS RHEUM-US, V50, P2014, DOI 10.1002/art.20302; Deans JP, 2002, IMMUNOLOGY, V107, P176, DOI 10.1046/j.1365-2567.2002.01495.x; DESTEFANO E, 1982, J INFECT DIS, V146, P451, DOI 10.1093/infdis/146.4.451; Frost V, 2001, J GEN VIROL, V82, P3057, DOI 10.1099/0022-1317-82-12-3057; Grillo-Lopez AJ, 2000, SEMIN ONCOL, V27, P9, DOI 10.1053/sonc.2000.20444; HENDERSON A, 1983, P NATL ACAD SCI-BIOL, V80, P1987, DOI 10.1073/pnas.80.7.1987; HURLEY EA, 1991, J VIROL, V65, P3958, DOI 10.1128/JVI.65.7.3958-3963.1991; Janas E, 2005, BIOCHEM SOC SYMP, V72, P165, DOI 10.1042/bss0720165; Janas E, 2005, CLIN EXP IMMUNOL, V139, P439, DOI 10.1111/j.1365-2249.2005.02720.x; Jiang YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001569; Kalkner KM, 1998, QJM-MON J ASSOC PHYS, V91, P393, DOI 10.1093/qjmed/91.6.393; Kimby E, 2008, LEUKEMIA LYMPHOMA, V49, P102, DOI 10.1080/10428190701704647; Kirou KA, 2012, ARTHRITIS RHEUM-US, V64, P3486, DOI 10.1002/art.34617; Kono DH, 2003, AUTOIMMUNITY, V36, P503, DOI 10.1080/08916930310001624665; Kuijpers TW, 2010, J CLIN INVEST, V120, P214, DOI 10.1172/JCI40231; Lambotte O, 2005, CLIN NEPHROL, V64, P73; Lau CM, 2005, J EXP MED, V202, P1171, DOI 10.1084/jem.20050630; Lightstone L, 2012, ARTHRITIS RHEUM-US, V64, P962, DOI 10.1002/art.34362; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Mathas S, 2000, CANCER RES, V60, P7170; McFarland EDC, 1999, ONCOGENE, V18, P6959, DOI 10.1038/sj.onc.1203217; Merrill JT, 2010, ARTHRITIS RHEUM-US, V62, P222, DOI 10.1002/art.27233; Moon UY, 2004, ARTHRITIS RES THER, V6, pR295, DOI 10.1186/ar1181; Nanda Shreeya, 2011, Nat Rev Rheumatol, V7, P253, DOI 10.1038/nrrheum.2011.46; Pascual V, 2003, CURR OPIN RHEUMATOL, V15, P548, DOI 10.1097/00002281-200309000-00005; Pescovitz MD, 2006, AM J TRANSPLANT, V6, P859, DOI 10.1111/j.1600-6143.2006.01288.x; Riley LK, 2000, SEMIN ONCOL, V27, P17, DOI 10.1053/sonc.2000.20424; Roberts RM, 1998, J INTERF CYTOK RES, V18, P805, DOI 10.1089/jir.1998.18.805; Ronnblom L, 2001, TRENDS IMMUNOL, V22, P427, DOI 10.1016/S1471-4906(01)01955-X; RONNBLOM LE, 1991, ACTA ONCOL, V30, P537; Rovin BH, 2012, ARTHRITIS RHEUM-US, V64, P1215, DOI 10.1002/art.34359; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Shishkin P, 2008, WALL STREET J, P30; Treschow AP, 2005, ARTHRITIS RHEUM-US, V52, P3739, DOI 10.1002/art.21496; Uchida J, 2004, INT IMMUNOL, V16, P119, DOI 10.1093/intimm/dxh009; Valente RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043317; Verweij CL, 2011, DISCOV MED, V12, P229; Vosslamber S, 2011, ANN RHEUM DIS, V70, P1153, DOI 10.1136/ard.2010.147199; Xu DS, 2007, J VIROL, V81, P6068, DOI 10.1128/JVI.02743-06; Xu YY, 2005, J VIROL, V79, P3479, DOI 10.1128/JVI.79.6.3479-3487.2005; Xuan CY, 2010, BLOOD, V115, P2864, DOI 10.1182/blood-2009-10-250555; Yu SF, 2005, MED MICROBIOL IMMUN, V194, P115, DOI 10.1007/s00430-004-0230-5; Zhang LW, 2000, MOL BIOTECHNOL, V14, P73, DOI 10.1385/MB:14:1:73	56	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e67900	10.1371/journal.pone.0067900	http://dx.doi.org/10.1371/journal.pone.0067900			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23874371	Green Published, gold			2022-12-27	WOS:000320576400193
J	Wang, XF; Li, AM; Li, J; Lin, SY; Chen, CD; Zhou, YL; Wang, X; Chen, CL; Liu, SD; Chen, Y				Wang, Xian-fei; Li, Ai-ming; Li, Jing; Lin, Shi-yong; Chen, Chu-di; Zhou, You-lian; Wang, Xia; Chen, Cun-long; Liu, Si-de; Chen, Ye			Low Molecular Weight Heparin Relieves Experimental Colitis in Mice by Downregulating IL-1 beta and Inhibiting Syndecan-1 Shedding in the Intestinal Mucosa	PLOS ONE			English	Article							PROTEIN-LOSING ENTEROPATHY; INFLAMMATORY-BOWEL-DISEASE; NECROSIS-FACTOR-ALPHA; IN-VITRO MODEL; CROHNS-DISEASE; UNFRACTIONATED HEPARIN; SULFATE PROTEOGLYCANS; EPITHELIAL-CELLS; GENE-EXPRESSION; CYTOKINES	Low molecular weight heparin (LMWH) exhibits anti-inflammatory properties, but its effect on inflammation in colitis remains unclear. This study aimed to evaluate the therapeutic effects of LMWH on dextran sulfate sodium (DSS)-induced colitis in mice, in which acute colitis progresses to chronic colitis, and to explore the potential mechanism involved in this process. C57BL/6 mice were randomly divided into control, DSS, and DSS plus LMWH groups (n = 18). Disease activity was scored by a disease activity index (DAI). Histological changes were evaluated by hematoxylin and eosin (HE) staining. The mRNA levels of syndecan-1, interleukin (IL)-1 beta, and IL-10 were determined by quantitative reverse transcription polymerase chain reaction. Protein expression of syndecan-1 was detected by immunohistochemistry. The serum syndecan-1 level was examined by a dot immunobinding assay. LMWH ameliorated the disease activity of colitis induced by DSS administration in mice. Colon destruction with the appearance of crypt damage, goblet cell loss, and a larger ulcer was found on day 12 after DSS administration, which was greatly relieved by the treatment of LMWH. LMWH upregulated syndecan-1 expression in the intestinal mucosa and reduced the serum syndecan-1 level on days 12 and 20 after DSS administration (P < 0.05 vs. DSS group). In addition, LMWH significantly decreased the expression of both IL-1 beta and IL-10 mRNA on days 12 and 20 (P < 0.05 vs. DSS group). LMWH has therapeutic effects on colitis by downregulating inflammatory cytokines and inhibiting syndecan-1 shedding in the intestinal mucosa.	[Wang, Xian-fei; Li, Ai-ming; Li, Jing; Lin, Shi-yong; Chen, Chu-di; Zhou, You-lian; Wang, Xia; Chen, Cun-long; Liu, Si-de; Chen, Ye] Southern Med Univ, Nanfang Hosp, Dept Gastroenterol, Guangdong Prov Key Lab Gastroenterol, Guangzhou, Guangdong, Peoples R China; [Wang, Xian-fei] North Sichuan Med Coll, Affiliated Hosp, Dept Gastroenterol, Nanchong, Peoples R China	Southern Medical University - China; North Sichuan Medical University	Liu, SD (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Gastroenterol, Guangdong Prov Key Lab Gastroenterol, Guangzhou, Guangdong, Peoples R China.	liuside2011@163.com; chenye2001@hotmail.com			National Natural Science Foundation of China [81070291]; Program for New Century Excellent Talents in University, China [NCET-10-0091]; Medical Research Fund of Guangdong Province [A2010364]; Ministry of Education [2011B090400018]; Guangdong province University-industry cooperation projects [2011B090400018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University, China(Program for New Century Excellent Talents in University (NCET)); Medical Research Fund of Guangdong Province; Ministry of Education; Guangdong province University-industry cooperation projects	Supported by the National Natural Science Foundation of China (YC, 81070291), the Program for New Century Excellent Talents in University (YC, China, NCET-10-0091), the Medical Research Fund of Guangdong Province (XJ, A2010364), and the Ministry of Education and Guangdong province University-industry cooperation projects (SDL 2011B090400018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou AN, 2007, INT J BIOCHEM CELL B, V39, P505, DOI 10.1016/j.biocel.2006.10.014; Andrian E, 2006, ORAL MICROBIOL IMMUN, V21, P123, DOI 10.1111/j.1399-302X.2006.00248.x; Baram D, 1997, CLIN EXP IMMUNOL, V110, P485, DOI 10.1046/j.1365-2249.1997.4541471.x; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Bode L, 2006, J BIOL CHEM, V281, P7809, DOI 10.1074/jbc.M510722200; Bode L, 2005, AM J PHYSIOL-GASTR L, V288, pG1015, DOI 10.1152/ajpgi.00461.2004; Chande N, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006774.pub2; Chande N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006774.pub3; Chowers Y, 2001, GASTROENTEROLOGY, V120, P449, DOI 10.1053/gast.2001.21202; COOPER HS, 1993, LAB INVEST, V69, P238; Day R, 1999, LANCET, V354, P62, DOI 10.1016/S0140-6736(98)09267-8; Day RM, 2003, CYTOKINE, V21, P224, DOI 10.1016/S1043-4666(03)00091-7; Fitzgerald ML, 2000, J CELL BIOL, V148, P811, DOI 10.1083/jcb.148.4.811; Floer M, 2010, AM J PATHOL, V176, P146, DOI 10.2353/ajpath.2010.080639; Gaudio E, 1999, DIGEST DIS SCI, V44, P1458, DOI 10.1023/A:1026620322859; Gotte M, 2003, FASEB J, V17, P575, DOI 10.1096/fj.02-0739rev; Hayashida K, 2009, BLOOD, V114, P3033, DOI 10.1182/blood-2009-02-204966; Hershkoviz R, 1999, J HEPATOL, V31, P834, DOI 10.1016/S0168-8278(99)80284-0; Klein RD, 1997, J BIOL CHEM, V272, P14188, DOI 10.1074/jbc.272.22.14188; Koller M, 2001, INFLAMMATION, V25, P331, DOI 10.1023/A:1012883916991; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo JY, 2011, BIOMED PHARMACOTHER, V65, P111, DOI 10.1016/j.biopha.2010.12.013; Maitra A, 2002, AM J CLIN PATHOL, V118, P194, DOI 10.1309/TPG4-CK1C-9V8V-8AWC; McBride WT, 1996, ANAESTHESIA, V51, P634, DOI 10.1111/j.1365-2044.1996.tb04644.x; Melgar S, 2005, AM J PHYSIOL-GASTR L, V288, pG1328, DOI 10.1152/ajpgi.00467.2004; Meresse B, 2002, GUT, V50, P25, DOI 10.1136/gut.50.1.25; Murano M, 2000, CLIN EXP IMMUNOL, V120, P51, DOI 10.1046/j.1365-2249.2000.01183.x; Nikolova V, 2009, CARCINOGENESIS, V30, P397, DOI 10.1093/carcin/bgp001; Pellequer Y, 2007, J PHARMACOL EXP THER, V321, P726, DOI 10.1124/jpet.106.117226; Prajapati DN, 2002, INFLAMM BOWEL DIS, V8, P192, DOI 10.1097/00054725-200205000-00006; Principi M, 2006, IMMUNOPHARM IMMUNOT, V28, P185, DOI 10.1080/08923970600815048; Pruessmeyer J, 2010, J BIOL CHEM, V285, P555, DOI 10.1074/jbc.M109.059394; REINECKER HC, 1993, CLIN EXP IMMUNOL, V94, P174; Stepp MA, 2002, J CELL SCI, V115, P4517, DOI 10.1242/jcs.00128; Wang X, 2011, DIGEST DIS SCI, V56, P1047, DOI 10.1007/s10620-010-1398-8; Waterman M, 2007, MODERN PATHOL, V20, P8, DOI 10.1038/modpathol.3800710; Watson AJM, 2005, GASTROENTEROLOGY, V129, P902, DOI 10.1053/j.gastro.2005.06.015; Wehkamp J, 2008, MUCOSAL IMMUNOL, V1, pS67, DOI 10.1038/mi.2008.48; WOLF H, 1994, MED CLIN N AM, V78, P733, DOI 10.1016/S0025-7125(16)30155-9; Yip GW, 2006, MOL CANCER THER, V5, P2139, DOI 10.1158/1535-7163.MCT-06-0082; YOUNGMAN KR, 1993, GASTROENTEROLOGY, V104, P749, DOI 10.1016/0016-5085(93)91010-F	43	36	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e66397	10.1371/journal.pone.0066397	http://dx.doi.org/10.1371/journal.pone.0066397			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874391	Green Submitted, Green Published, gold			2022-12-27	WOS:000324146200001
J	Cierniak, P; Jubner, M; Muller, S; Bender, K				Cierniak, Peter; Juebner, Martin; Mueller, Stefan; Bender, Katja			Insights into Mechanisms and Proteomic Characterisation of Pseudomonas aeruginosa Adaptation to a Novel Antimicrobial Substance	PLOS ONE			English	Article							ALKYL HYDROPEROXIDE REDUCTASE; OXIDATIVE STRESS-RESPONSE; LATEX URINARY CATHETERS; OUTER-MEMBRANE; SALMONELLA-TYPHIMURIUM; RESISTANCE; THIOREDOXIN; PORIN; OPRD; PURIFICATION	Antibiotic resistance has been reported since the introduction of synthetic antibiotics. Bacteria, such as one of the most common nosocomial pathogens P. aeruginosa, adapt quickly to changing environmental conditions, due to their short generation time. Thus microevolutional changes can be monitored in situ. In this study, the microevolutional process of Pseudomonas aeruginosa PAO1 resistance against a recently developed novel antibacterial zinc Schiff-base (ZSB) was investigated at the proteome level. After extended exposure to ZSB the passaged strain differed in tolerance against ZSB, with the adapted P. aeruginosa PAO1 exhibiting 1.6 times higher minimal inhibitory concentration. Using Two-dimensional Difference Gel Electrophoresis, the changes in the proteome of ZSB adapted P. aeruginosa PAO1 were examined by comparison with the non-adapted P. aeruginosa PAO1. The proteome of the adapted P. aeruginosa PAO1 strain differed significantly from the non-adapted in the abundance of two proteins when both strains were grown under stressing conditions. One protein could be identified as the outer membrane protein D that plays a role in uptake of basic amino acids as well as in carbapeneme resistance. The second protein has been identified as alkyl peroxide reductase subunit F. Our data indicated a slight increase in abundance of alkyl peroxide reductase F (AhpF) in the case of ZSB passaged P. aeruginosa PAO1. Higher abundance of Ahp has been discussed in the literature as a promoter of accelerated detoxification of benzene derivatives. The observed up-regulated AhpF thus appears to be connected to an increased tolerance against ZSB. Changes in the abundance of proteins connected to oxidative stress were also found after short-time exposure of P. aeruginosa PAO1 to the ZSB. Furthermore, adapted P. aeruginosa PAO1 showed increased tolerance against hydrogen peroxide and, in addition, showed accelerated degradation of ZSB, as determined by HPLC measurements.	[Cierniak, Peter; Juebner, Martin; Bender, Katja] Univ Cologne, Inst Legal Med, Fac Med, D-50931 Cologne, Germany; [Mueller, Stefan] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany	University of Cologne; University of Cologne	Bender, K (corresponding author), Univ Cologne, Inst Legal Med, Fac Med, D-50931 Cologne, Germany.	katja.bender@uk-koeln.de	Mercer-Chalmers-Bender, Katja/ABC-6281-2021	Mercer-Chalmers-Bender, Katja/0000-0002-3843-9065	European Commission, (EMBEK1) [211436]	European Commission, (EMBEK1)	The authors kindly acknowledge funding of this work through the European Commission, (EMBEK1) grant 211436 (http://www.mpip-mainz.mpg.de/eu-projekte/embek1/index.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderegg TR, 2005, INT J ANTIMICROB AG, V26, P13, DOI 10.1016/j.ijantimicag.2005.02.019; [Anonymous], 2008, DECYDER 2D 7 0 US MA; [Anonymous], [No title captured]; [Anonymous], 2004, 2 D EL PRINC METH; Bertani G, 2004, J BACTERIOL, V186, P595, DOI 10.1128/JB.186.3.595-600.2004; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Branski LK, 2009, SURG INFECT, V10, P389, DOI 10.1089/sur.2009.024; BSAC, 2011, BSAC METH ANT SUSC T; Chohan ZH, 2012, J ENZYM INHIB MED CH, V27, P187, DOI 10.3109/14756366.2011.582686; Conejo MC, 2003, ANTIMICROB AGENTS CH, V47, P2313, DOI 10.1128/AAC.47.7.2313-2315.2003; Darwin C, 1859, ORIGIN SPECIES MEANS; Das KC, 2000, BIOCHEM BIOPH RES CO, V277, P443, DOI 10.1006/bbrc.2000.3689; Dastjerdi R, 2010, COLLOID SURFACE B, V79, P5, DOI 10.1016/j.colsurfb.2010.03.029; Doring G, 2000, EUR RESPIR J, V16, P749, DOI 10.1034/j.1399-3003.2000.16d30.x; ECDC/EMEA, 2009, JOINT TECHN REP BACT; Fukumori F, 2001, J GEN APPL MICROBIOL, V47, P269, DOI 10.2323/jgam.47.269; HANCOCK REW, 1988, REV INFECT DIS, V10, P770; HUANG HJ, 1993, J BACTERIOL, V175, P7793, DOI 10.1128/JB.175.24.7793-7800.1993; JACOBSON FS, 1989, J BIOL CHEM, V264, P1488; Kang YS, 2007, MICROBIOL-SGM, V153, P3246, DOI 10.1099/mic.0.2007/008896-0; Karatepe M, 2006, CELL BIOCHEM FUNCT, V24, P547, DOI 10.1002/cbf.1266; Kojima K, 2007, MOL MICROBIOL, V65, P936, DOI 10.1111/j.1365-2958.2007.05836.x; Kumar JK, 2004, P NATL ACAD SCI USA, V101, P3759, DOI 10.1073/pnas.0308701101; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; Martinez-Martinez L, 1999, ANTIMICROB AGENTS CH, V43, P397, DOI 10.1128/AAC.43.2.397; Ochs MM, 1999, ANTIMICROB AGENTS CH, V43, P1085, DOI 10.1128/AAC.43.5.1085; Palumbi SR, 2001, SCIENCE, V293, P1786, DOI 10.1126/science.293.5536.1786; Perron GG, 2006, P ROY SOC B-BIOL SCI, V273, P251, DOI 10.1098/rspb.2005.3301; Poole K, 2002, J APPL MICROBIOL, V92, p55S, DOI 10.1046/j.1365-2672.92.5s1.8.x; Poole K, 2001, J MOL MICROB BIOTECH, V3, P255; Poole LB, 1996, BIOCHEMISTRY-US, V35, P56, DOI 10.1021/bi951887s; Poulter N, 2011, NEW J CHEM, V35, P1477, DOI 10.1039/c1nj20091g; Pournaras S, 2009, SEMIN HEMATOL, V46, P198, DOI 10.1053/j.seminhematol.2009.03.007; Powell SR, 2000, J NUTR, V130, p1447S, DOI 10.1093/jn/130.5.1447S; Reznick DN, 2009, NATURE, V457, P837, DOI 10.1038/nature07894; Ritz D, 2000, J BIOL CHEM, V275, P2505, DOI 10.1074/jbc.275.4.2505; Salunkhe P, 2005, J BACTERIOL, V187, P2565, DOI 10.1128/JB.187.8.2565-2572.2005; Seaver LC, 2001, J BACTERIOL, V183, P7173, DOI 10.1128/JB.183.24.7173-7181.2001; Shim JW, 2002, COLLOID SURFACE A, V207, P105, DOI 10.1016/S0927-7757(02)00044-4; Singh K, 2011, BIOINORG CHEM APPL, V2011, P4; SODERBERG TA, 1990, SCAND J PLAST RECONS, V24, P193; Spiegel PC, 2007, RNA, V13, P1473, DOI 10.1261/rna.601507; Spiers AJ, 2000, MICROBIOL-SGM, V146, P2345, DOI 10.1099/00221287-146-10-2345; Tamarit J, 1998, J BIOL CHEM, V273, P3027, DOI 10.1074/jbc.273.5.3027; Tang Y, 1999, MICROBIOL-SGM, V145, P3069, DOI 10.1099/00221287-145-11-3069; Thomson KS, 2000, MICROBES INFECT, V2, P1225, DOI 10.1016/S1286-4579(00)01276-4; Toprak E, 2012, NAT GENET, V44, P101, DOI 10.1038/ng.1034; TRIAS J, 1990, J BIOL CHEM, V265, P15680; Vasilev K, 2009, EXPERT REV MED DEVIC, V6, P553, DOI [10.1586/erd.09.36, 10.1586/ERD.09.36]; Vincent JL, 2000, INTENS CARE MED, V26, pS3, DOI 10.1007/s001340051111; Wallace A. R., 1858, J P LINNAEAN SOC ZOO, V3, P53; Weidenhaupt M, 1996, ARCH MICROBIOL, V165, P169, DOI 10.1007/s002030050312; Winter J, 2005, MOL CELL, V17, P381, DOI 10.1016/j.molcel.2004.12.027; Zeller T, 2006, NATURWISSENSCHAFTEN, V93, P259, DOI 10.1007/s00114-006-0106-1	54	6	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2013	8	7							e66862	10.1371/journal.pone.0066862	http://dx.doi.org/10.1371/journal.pone.0066862			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZN	23869205	Green Published, gold, Green Submitted			2022-12-27	WOS:000323110600004
J	Zimmerman, ZF; Kulikauskas, RM; Bomsztyk, K; Moon, RT; Chien, AJ				Zimmerman, Zachary F.; Kulikauskas, Rima M.; Bomsztyk, Karol; Moon, Randall T.; Chien, Andy J.			Activation of Wnt/beta-Catenin Signaling Increases Apoptosis in Melanoma Cells Treated with Trail	PLOS ONE			English	Article							NEGATIVE REGULATOR; WNT; INHIBITION; EXPRESSION; AXIN	While the TRAIL pathway represents a promising therapeutic target in melanoma, resistance to TRAIL-mediated apoptosis remains a barrier to its successful adoption. Since the Wnt/beta-catenin pathway has been implicated in facilitating melanoma cell apoptosis, we investigated the effect of Wnt/beta-catenin signaling on regulating the responses of melanoma cells to TRAIL. Co-treatment of melanoma cell lines with WNT3A-conditioned media and recombinant TRAIL significantly enhanced apoptosis compared to treatment with TRAIL alone. This apoptosis correlates with increased abundance of the pro-apoptotic proteins BCL2L11 and BBC3, and with decreased abundance of the anti-apoptotic regulator Mcl1. We then confirmed the involvement of the Wnt/beta-catenin signaling pathway by demonstrating that siRNA-mediated knockdown of an intracellular beta-catenin antagonist, AXIN1, or treating cells with an inhibitor of GSK-3 also enhanced melanoma cell sensitivity to TRAIL. These studies describe a novel regulation of TRAIL sensitivity in melanoma by Wnt/beta-catenin signaling, and suggest that strategies to enhance Wnt/beta-catenin signaling in combination with TRAIL agonists warrant further investigation.	[Zimmerman, Zachary F.; Kulikauskas, Rima M.; Bomsztyk, Karol; Moon, Randall T.; Chien, Andy J.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Moon, Randall T.] Howard Hughes Med Inst, Chevy Chase, MD USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute	Moon, RT (corresponding author), Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA.	rtmoon@uw.edu; andchien@uw.edu	Moon, Randall/M-5605-2019; Moon, Randall T/B-1743-2014	Moon, Randall/0000-0002-9352-1408; Moon, Randall T/0000-0002-9352-1408	Bridge Funding through the University of Washington Provost's Office; National Institutes of Health; National Institutes of Health [T32-CA009515, R37-DK45978, R01-DK083310]; University of Washington's Office of the Provost; University Of Washington Division Of Dermatology; NATIONAL CANCER INSTITUTE [T32CA009515] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK045978, R01DK083310] Funding Source: NIH RePORTER	Bridge Funding through the University of Washington Provost's Office; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington's Office of the Provost; University Of Washington Division Of Dermatology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	RTM is an Investigator of the Howard Hughes Medical Institute. AJC is supported by Bridge Funding through the University of Washington Provost's Office. ZFZ is supported by a T32 training grant in hematology from the National Institutes of Health. ZFZ has received support through a T32 grant from the National Institutes of Health (T32-CA009515). RMK is supported through bridge funding from the University of Washington's Office of the Provost. KB is supported by the National Institutes of Health through grants R37-DK45978 and R01-DK083310. AJC is supported by research endowment funds through the University Of Washington Division Of Dermatology. RTM is an Investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aza-Blanc P, 2003, MOL CELL, V12, P627, DOI 10.1016/S1097-2765(03)00348-4; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Biechele TL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002274; Cha B, 2011, ONCOGENE, V30, P2379, DOI 10.1038/onc.2010.610; Chien AJ, 2009, J INVEST DERMATOL, V129, P1614, DOI 10.1038/jid.2008.445; Chien AJ, 2009, P NATL ACAD SCI USA, V106, P1193, DOI 10.1073/pnas.0811902106; Coureuil M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012134; Delmas V, 2007, GENE DEV, V21, P2923, DOI 10.1101/gad.450107; Dorsky RI, 1998, NATURE, V396, P370, DOI 10.1038/24620; Dorsky RI, 2000, GENE DEV, V14, P158; Flaherty KT, 2012, NAT REV CANCER, V12, P349, DOI 10.1038/nrc3218; Gallagher SJ, 2013, ONCOGENE, V32, P2230, DOI 10.1038/onc.2012.229; Gillespie S, 2006, APOPTOSIS, V11, P2251, DOI 10.1007/s10495-006-0283-6; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Ivanov VN, 2003, ONCOGENE, V22, P3152, DOI 10.1038/sj.onc.1206456; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; John JK, 2012, J INVEST DERMATOL, V132, P2818, DOI 10.1038/jid.2012.237; Kageshita T, 2001, BRIT J DERMATOL, V145, P210, DOI 10.1046/j.1365-2133.2001.04336.x; Lucero OM, 2010, CURR ONCOL REP, V12, P314, DOI 10.1007/s11912-010-0114-3; Maelandsmo GM, 2003, CLIN CANCER RES, V9, P3383; Mamaghani S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041102; Meyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038222; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nelson J, 2009, METHODS MOL BIOL, V567, P45, DOI 10.1007/978-1-60327-414-2_3; Nguyen T, 2000, Forum (Genova), V10, P243; Nguyen T, 2001, CLIN CANCER RES, V7, p966S; Pinon JD, 2008, ONCOGENE, V27, pS41, DOI 10.1038/onc.2009.42; Pollock PM, 2002, CANCER CELL, V2, P5, DOI 10.1016/S1535-6108(02)00089-2; Smalley KSM, 2007, CANCER RES, V67, P209, DOI 10.1158/0008-5472.CAN-06-1538; Thomas WD, 1998, J IMMUNOL, V161, P2195; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Yamamoto H, 1999, J BIOL CHEM, V274, P10681, DOI 10.1074/jbc.274.16.10681; Yu J, 2008, ONCOGENE, V27, pS71, DOI 10.1038/onc.2009.45; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Zhang L, 2010, NATURE, V464, P1058, DOI 10.1038/nature08871; Zhang XD, 2003, BIOCHEM PHARMACOL, V66, P1537, DOI 10.1016/S0006-2952(03)00509-4	37	62	66	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2013	8	7							e69593	10.1371/journal.pone.0069593	http://dx.doi.org/10.1371/journal.pone.0069593			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZN	23869245	Green Published, Green Submitted, gold			2022-12-27	WOS:000323110600045
J	Allantaz-Frager, F; Turrel-Davin, F; Venet, F; Monnin, C; Saint Jean, AD; Barbalat, V; Cerrato, E; Pachot, A; Lepape, A; Monneret, G				Allantaz-Frager, Florence; Turrel-Davin, Fanny; Venet, Fabienne; Monnin, Cecile; Saint Jean, Amelie De; Barbalat, Veronique; Cerrato, Elisabeth; Pachot, Alexandre; Lepape, Alain; Monneret, Guillaume			Identification of Biomarkers of Response to IFNg during Endotoxin Tolerance: Application to Septic Shock	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; GAMMA-INTERFERON; DOWN-REGULATION; DR EXPRESSION; SEVERE SEPSIS; EPIDEMIOLOGY; RESTORATION; NEUTROPHILS; CXCR2	The rapid development in septic patients of features of marked immunosuppression associated with increased risk of nosocomial infections and mortality represents the rational for the initiation of immune targeted treatments in sepsis. However, as there is no clinical sign of immune dysfunctions, the current challenge is to develop biomarkers that will help clinicians identify the patients that would benefit from immunotherapy and monitor its efficacy. Using an in vitro model of endotoxin tolerance (ET), a pivotal feature of sepsis-induced immunosuppression in monocytes, we identified using gene expression profiling by microarray a panel of transcripts associated with the development of ET which expression was restored after immunostimulation with interferon-gamma (IFN-gamma). These results were confirmed by qRT-PCR. Importantly, this short-list of markers was further evaluated in patients. Of these transcripts, six (TNFAIP6, FCN1, CXCL10, GBP1, CXCL5 and PID1) were differentially expressed in septic patients' blood compared to healthy blood upon ex vivo LPS stimulation and were restored by IFN-gamma. In this study, by combining a microarray approach in an in vitro model and a validation in clinical samples, we identified a panel of six new transcripts that could be used for the identification of septic patients eligible for IFNg therapy. Along with the previously identified markers TNFa, IL10 and HLA-DRA, the potential value of these markers should now be evaluated in a larger cohort of patients. Upon favorable results, they could serve as stratification tools prior to immunostimulatory treatment and to monitor drug efficacy.	[Allantaz-Frager, Florence; Turrel-Davin, Fanny; Monnin, Cecile] Hop Edouard Herriot, Joint Unit Hosp Civils Lyon Biomerieux Sepsis, Lyon, France; [Venet, Fabienne; Monneret, Guillaume] Hop Edouard Herriot, Cellular Immunol Lab, Lyon, France; [Barbalat, Veronique; Pachot, Alexandre] BioMerieux Sa, Marcy Letoile, France; [Lepape, Alain] Ctr Hosp Lyon Sud, Intens Care Unit, F-69310 Pierre Benite, France	CHU Lyon; CHU Lyon; bioMerieux; CHU Lyon	Allantaz-Frager, F (corresponding author), Hop Edouard Herriot, Joint Unit Hosp Civils Lyon Biomerieux Sepsis, Lyon, France.	florence.frager@biomerieux.com		Venet, Fabienne/0000-0003-0462-4235; LEPAPE, Alain/0000-0001-5950-7533; Amelie, DE SAINT JEAN/0000-0001-8111-6598	Hospices civils de Lyon; bioMerieux	Hospices civils de Lyon; bioMerieux	GM, FV and AL were supported by the Hospices civils de Lyon. FAF, FTD, CM, ADSJ, VB, EC and AP were supported by bioMerieux. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adib-Conquy M, 2002, J BIOL CHEM, V277, P27927, DOI 10.1074/jbc.M200705200; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Angus Derek C., 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P207; Bundschuh DS, 1997, J IMMUNOL, V158, P2862; Cavaillon JM, 2006, CRIT CARE, V10, DOI 10.1186/cc5055; Chen J, 2010, P NATL ACAD SCI USA, V107, P19438, DOI 10.1073/pnas.1007816107; del Fresno C, 2009, J IMMUNOL, V182, P6494, DOI 10.4049/jimmunol.0803350; Docke WD, 1997, NAT MED, V3, P678, DOI 10.1038/nm0697-678; Goodman R, 1999, CHEST, V116, p111S, DOI 10.1378/chest.116.suppl_1.111S-a; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Leentjens J, 2012, AM J RESP CRIT CARE; Lukaszewicz AC, 2009, CRIT CARE MED, V37, P2746, DOI 10.1097/CCM.0b013e3181ab858a; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; Monneret G, 2008, MOL MED, V14, P64, DOI 10.2119/2007-00102.Monneret; Monneret G, 2006, INTENS CARE MED, V32, P1175, DOI 10.1007/s00134-006-0204-8; Monneret G, 2010, CRIT CARE, V14, DOI [10.1186/cc9357, 10.1186/cc9184]; Munthe-Fog L, 2012, GENES IMMUN; Nakos G, 2002, CRIT CARE MED, V30, P1488, DOI 10.1097/00003246-200207000-00015; Nalos M, 2012, AM J RESP CRIT CARE, V185, P110, DOI 10.1164/ajrccm.185.1.110; Pachot A, 2005, CRIT CARE MED, V33, P31, DOI 10.1097/01.CCM.0000150958.20209.A3; Pachot A, 2004, J BIOTECHNOL, V114, P121, DOI 10.1016/j.jbiotec.2004.07.001; Pachot A, 2006, IMMUNOL LETT, V106, P63, DOI 10.1016/j.imlet.2006.04.010; Pena OM, 2011, J IMMUNOL, V186, P7243, DOI 10.4049/jimmunol.1001952; POLK HC, 1992, AM J SURG, V163, P191, DOI 10.1016/0002-9610(92)90099-D; Pugin Jerome, 2007, Novartis Found Symp, V280, P21; Rios-Santos F, 2007, AM J RESP CRIT CARE, V175, P490, DOI 10.1164/rccm.200601-103OC; Tissieres P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032863; Turrel-Davin F, 2011, CRIT CARE, V15, DOI 10.1186/cc10513; Wong HR, 2007, PHYSIOL GENOMICS, V30, P146, DOI 10.1152/physiolgenomics.00024.2007; Wong HR, 2009, CRIT CARE MED, V37, P1558, DOI 10.1097/CCM.0b013e31819fcc08	32	24	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e68218	10.1371/journal.pone.0068218	http://dx.doi.org/10.1371/journal.pone.0068218			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874546	Green Submitted, gold, Green Published			2022-12-27	WOS:000322218800017
J	Grisham, BA; Boal, CW; Haukos, DA; Davis, DM; Boydston, KK; Dixon, C; Heck, WR				Grisham, Blake A.; Boal, Clint W.; Haukos, David A.; Davis, Dawn M.; Boydston, Kathy K.; Dixon, Charles; Heck, Willard R.			The Predicted Influence of Climate Change on Lesser Prairie-Chicken Reproductive Parameters	PLOS ONE			English	Article							UNITED-STATES; NESTING ECOLOGY; SHINNERY OAK; POPULATIONS; SURVIVAL; DROUGHT; TERM; FRAGMENTATION; VEGETATION; WEATHER	The Southern High Plains is anticipated to experience significant changes in temperature and precipitation due to climate change. These changes may influence the lesser prairie-chicken (Tympanuchus pallidicinctus) in positive or negative ways. We assessed the potential changes in clutch size, incubation start date, and nest survival for lesser prairie-chickens for the years 2050 and 2080 based on modeled predictions of climate change and reproductive data for lesser prairie-chickens from 2001-2011 on the Southern High Plains of Texas and New Mexico. We developed 9 a priori models to assess the relationship between reproductive parameters and biologically relevant weather conditions. We selected weather variable(s) with the most model support and then obtained future predicted values from climatewizard.org. We conducted 1,000 simulations using each reproductive parameter's linear equation obtained from regression calculations, and the future predicted value for each weather variable to predict future reproductive parameter values for lesser prairie-chickens. There was a high degree of model uncertainty for each reproductive value. Winter temperature had the greatest effect size for all three parameters, suggesting a negative relationship between above-average winter temperature and reproductive output. The above-average winter temperatures are correlated to La Nina events, which negatively affect lesser prairie-chickens through resulting drought conditions. By 2050 and 2080, nest survival was predicted to be below levels considered viable for population persistence; however, our assessment did not consider annual survival of adults, chick survival, or the positive benefit of habitat management and conservation, which may ultimately offset the potentially negative effect of drought on nest survival.	[Grisham, Blake A.] Texas Tech Univ, Dept Nat Resources Management, Lubbock, TX 79409 USA; [Boal, Clint W.] Texas Tech Univ, US Geol Survey, Texas Cooperat Fish & Wildlife Res Unit, Lubbock, TX 79409 USA; [Haukos, David A.] Kansas State Univ, US Geol Survey, Kansas Cooperat Fish & Wildlife Res Unit, Manhattan, KS 66506 USA; [Davis, Dawn M.] Univ Idaho, Dept Fish & Wildlife Resources, Moscow, ID USA; [Boydston, Kathy K.] Texas Parks & Wildlife Dept, Austin, TX 78744 USA; [Dixon, Charles] Wildlife Plus Consulting, Alto, NM USA; [Heck, Willard R.] Grasslans Charitable Fdn, Causey, NM USA	Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University; United States Department of the Interior; United States Geological Survey; Kansas State University; United States Department of the Interior; United States Geological Survey; Idaho; University of Idaho	Grisham, BA (corresponding author), Texas Tech Univ, Dept Nat Resources Management, Lubbock, TX 79409 USA.	blake.grisham@ttu.edu			Texas Parks and Wildlife [179795]; Great Plains Landscape Conservation Cooperative [G11AC20304]	Texas Parks and Wildlife; Great Plains Landscape Conservation Cooperative	Texas Parks and Wildlife: (http://www.tpwd.state.tx.us/) Contract # 179795; Great Plains Landscape Conservation Cooperative: (http://www.greatplainslcc.org/) Contract # G11AC20304. The funders had no role in study design, data collection and analysis, or decision to publish; however, one funding agency person is an author (Kathy Boydston) on the publication due to contractual obligations between Texas Tech University and Texas Parks and Wildlife. Mrs. Boydston meets all criteria listed in the PLOS ONE author guidelines.	Akaike H., 1973, SECOND INTERNATIONAL, P267; Anderson DR, 2000, J WILDLIFE MANAGE, V64, P912, DOI 10.2307/3803199; [Anonymous], 2009, CLIMATE CHANGE IMPAC, DOI DOI 10.1111/j.1365-2664.2010.01827.x; ATLAS R, 1993, J CLIMATE, V6, P2034, DOI 10.1175/1520-0442(1993)006<2034:TEOSAS>2.0.CO;2; Brown JL, 1999, P NATL ACAD SCI USA, V96, P5565, DOI 10.1073/pnas.96.10.5565; Chen P, 1998, J CLIMATE, V11, P2491, DOI 10.1175/1520-0442(1998)011<2491:RWPATR>2.0.CO;2; Coe SJ, 2003, ECOLOGY, V84, P3240, DOI 10.1890/02-0789; Conservation Effects Assessment Project, 2012, USDA CONSERVATION PR; Cook ER, 2004, SCIENCE, V306, P1015, DOI 10.1126/science.1102586; Copelin FF, 1963, OKLAHOMA DEPARTMENT, V6; Crawford J.A., 1975, Auk, V92, P808; CRAWFORD JA, 1980, P PRAIR GROUS S OKL, P1; Crick HQP, 2004, IBIS, V146, P48, DOI 10.1111/j.1474-919X.2004.00327.x; Crick HQP, 1999, NATURE, V399, P423, DOI 10.1038/20839; Davis C. A., 1979, FINAL REPORT HABITAT; Davis DM, 2009, WILSON J ORNITHOL, V121, P322, DOI 10.1676/08-090.1; Dinsmore SJ, 2002, ECOLOGY, V83, P3476, DOI 10.1890/0012-9658(2002)083[3476:ATFMAN]2.0.CO;2; Fields TL, 2006, J WILDLIFE MANAGE, V70, P931, DOI 10.2193/0022-541X(2006)70[931:NABSOL]2.0.CO;2; Flanders-Wanner BL, 2004, WILDLIFE SOC B, V32, P22, DOI 10.2193/0091-7648(2004)32[22:WAPGDW]2.0.CO;2; Fuhlendorf SD, 2002, LANDSCAPE ECOL, V17, P617, DOI 10.1023/A:1021592817039; Gershunov A, 1998, J CLIMATE, V11, P1575, DOI 10.1175/1520-0442(1998)011<1575:EIOIER>2.0.CO;2; Hagen C. A., 2005, LESSER PRAIRIE CHICK; Hagen CA, 2009, J WILDLIFE MANAGE, V73, P1325, DOI 10.2193/2008-225; Hamerstrom F., 1961, Wilson Bulletin, V73, P284; Haukos D. A., 1988, THESIS; HAUKOS DA, 1990, J FIELD ORNITHOL, V61, P20; HAUKOS DA, 1989, GREAT BASIN NAT, V49, P624; Intergovernmental Panel on Climate Change, 2007, CONTRIBUTION OF WORK; Li ZT, 2000, REMOTE SENS ENVIRON, V71, P239, DOI 10.1016/S0034-4257(99)00034-6; Ludwig GX, 2006, P ROY SOC B-BIOL SCI, V273, P2009, DOI 10.1098/rspb.2006.3538; Merchant S. S., 1982, THESIS; Nakicenovic N, 2000, EMISSION SCENARIOS I; Patten MA, 2005, EVOL ECOL RES, V7, P235; PETERSON MJ, 1994, J WILDLIFE MANAGE, V58, P222, DOI 10.2307/3809384; Peterson RS, 1998, GEN TECH REP RMRS GT; Pitman JC, 2006, WILSON J ORNITHOL, V118, P23, DOI 10.1676/1559-4491(2006)118[0023:NEOLPI]2.0.CO;2; ROTENBERRY JT, 1991, ECOLOGY, V72, P1325, DOI 10.2307/1941105; SNYDER W. A., 1967, NEW MEXICO WILDLIFE, P121; TRENBERTH KE, 1988, SCIENCE, V242, P1640, DOI 10.1126/science.242.4886.1640; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; WEBB DR, 1987, CONDOR, V89, P874, DOI 10.2307/1368537; Westemeier R. L., 1979, P PRAIRIE GROUSE TEC, V13, P9; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Woodward AJW, 2001, AM MIDL NAT, V145, P261, DOI 10.1674/0003-0031(2001)145[0261:IOLCAC]2.0.CO;2; ZAVALETA J. C., 2012, THESIS	45	28	29	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e68225	10.1371/journal.pone.0068225	http://dx.doi.org/10.1371/journal.pone.0068225			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874549	Green Published, Green Submitted, gold			2022-12-27	WOS:000322218800019
J	Basille, M; Van Moorter, B; Herfindal, I; Martin, J; Linnell, JDC; Odden, J; Andersen, R; Gaillard, JM				Basille, Mathieu; Van Moorter, Bram; Herfindal, Ivar; Martin, Jodie; Linnell, John D. C.; Odden, John; Andersen, Reidar; Gaillard, Jean-Michel			Selecting Habitat to Survive: The Impact of Road Density on Survival in a Large Carnivore	PLOS ONE			English	Article							EURASIAN LYNX POPULATIONS; HOME-RANGE SIZE; ROE DEER; BEHAVIORAL-RESPONSES; RESOURCE SELECTION; ENVIRONMENTAL PRODUCTIVITY; SOUTHEASTERN NORWAY; ECOLOGICAL TRAPS; LARGE HERBIVORE; SPATIAL SCALES	Habitat selection studies generally assume that animals select habitat and food resources at multiple scales to maximise their fitness. However, animals sometimes prefer habitats of apparently low quality, especially when considering the costs associated with spatially heterogeneous human disturbance. We used spatial variation in human disturbance, and its consequences on lynx survival, a direct fitness component, to test the Hierarchical Habitat Selection hypothesis from a population of Eurasian lynx Lynx lynx in southern Norway. Data from 46 lynx monitored with telemetry indicated that a high proportion of forest strongly reduced the risk of mortality from legal hunting at the home range scale, while increasing road density strongly increased such risk at the finer scale within the home range. We found hierarchical effects of the impact of human disturbance, with a higher road density at a large scale reinforcing its negative impact at a fine scale. Conversely, we demonstrated that lynx shifted their habitat selection to avoid areas with the highest road densities within their home ranges, thus supporting a compensatory mechanism at fine scale enabling lynx to mitigate the impact of large-scale disturbance. Human impact, positively associated with high road accessibility, was thus a stronger driver of lynx space use at a finer scale, with home range characteristics nevertheless constraining habitat selection. Our study demonstrates the truly hierarchical nature of habitat selection, which aims at maximising fitness by selecting against limiting factors at multiple spatial scales, and indicates that scale-specific heterogeneity of the environment is driving individual spatial behaviour, by means of trade-offs across spatial scales.	[Basille, Mathieu] Univ Florida, Ft Lauderdale Res & Educ Ctr, Ft Lauderdale, FL 33314 USA; [Basille, Mathieu] Univ Laval, CRSNG Univ Laval sylviculture & Faune, Dept Biol, Chaire Rech Ind, Quebec City, PQ, Canada; [Van Moorter, Bram; Martin, Jodie; Gaillard, Jean-Michel] Univ Lyon 1, Univ Lyon, CNRS, UMR 5558,Lab Biometrie & Biol Evolut, Villeurbanne, France; [Van Moorter, Bram; Linnell, John D. C.; Odden, John; Andersen, Reidar] Norwegian Inst Nat Res NINA, Trondheim, Norway; [Herfindal, Ivar] Norwegian Univ Sci & Technol, Ctr Biodivers Dynam, Dept Biol, N-7034 Trondheim, Norway; [Martin, Jodie] Univ Witwatersrand, Sch Anim Plant & Environm Sci, Ctr African Ecol, ZA-2050 Johannesburg, South Africa; [Andersen, Reidar] Norwegian Univ Sci & Technol, Vitenskapsmuseet, N-7034 Trondheim, Norway	State University System of Florida; University of Florida; Laval University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Norwegian Institute Nature Research; Norwegian University of Science & Technology (NTNU); University of Witwatersrand; Norwegian University of Science & Technology (NTNU)	Basille, M (corresponding author), Univ Florida, Ft Lauderdale Res & Educ Ctr, Ft Lauderdale, FL 33314 USA.	basille@ase-research.org	Basille, Mathieu/A-6133-2017; Odden, John/F-6088-2019; Linnell, John/V-4177-2019; Herfindal, Ivar/A-4609-2015	Basille, Mathieu/0000-0001-9366-7127; Odden, John/0000-0002-6275-8648; Linnell, John/0000-0002-8370-5633; Herfindal, Ivar/0000-0002-5860-9252; Van Moorter, Bram/0000-0002-3196-1993	Norwegian Ministry of Defence; Norwegian Directorate for Nature Management; Research Council of Norway; county governors' office of Hedmark; county governors' office of Akershus Ostfold; county governors' office of Buskerud; Large Carnivore Management Board for region 2; Large Carnivore Management Board for region 3; Norwegian Institute for Nature Research; French Ministry of Research	Norwegian Ministry of Defence; Norwegian Directorate for Nature Management; Research Council of Norway(Research Council of Norway); county governors' office of Hedmark; county governors' office of Akershus Ostfold; county governors' office of Buskerud; Large Carnivore Management Board for region 2; Large Carnivore Management Board for region 3; Norwegian Institute for Nature Research(Bioforsk); French Ministry of Research(Ministry of Research, FranceEuropean Commission)	At various stages of the study, funding was provided by the Norwegian Ministry of Defence (www.regjeringen.no/nb/dep/fd.html), the Norwegian Directorate for Nature Management (www.dirnat.no), the Research Council of Norway (www.forskningsradet.no), the county governors' offices of Hedmark (www.fylkesmannen.no/Hedmark/), Akershus & Ostfold (www.fylkesmannen.no/Oslo-og-Akershus/) and Buskerud (www.fylkesmannen.no/Buskerud/) counties as well as the Large Carnivore Management Boards for regions 2 and 3 and the Norwegian Institute for Nature Research (www.nina.no). Mathieu Basille was funded by a PhD grant from the French Ministry of Research. All funding was provided based on detailed project descriptions submitted by the authors to the various funding mechanisms. Beyond this approval of the proposed study design and methodology, the funders had no input into the data collection, data analysis, interpretation of results, decision to publish, or preparation of this manuscript, with the exception of the occasional contribution to field work from game wardens of the State Nature Inspectorate (http://www.naturoppsyn.no/om-sno/), who are technically a unit of the Directorate for Nature Management.	Aberg J, 2000, WILDLIFE BIOL, V6, P89, DOI 10.2981/wlb.2000.004; Abrams PA, 2012, ECOLOGY, V93, P281, DOI 10.1890/11-0011.1; Aldridge CL, 2008, ISR J ECOL EVOL, V54, P389, DOI 10.1560/IJEE.54.3-4.389; Andren H, 2006, BIOL CONSERV, V131, P23, DOI 10.1016/j.biocon.2006.01.025; [Anonymous], TECHNICAL REPORT; Barber JR, 2010, TRENDS ECOL EVOL, V25, P180, DOI 10.1016/j.tree.2009.08.002; Barton K., 2013, MUMIN MULTIMODEL INF; Basille M, 2008, ECOL MODEL, V211, P233, DOI 10.1016/j.ecolmodel.2007.09.006; Basille M, 2013, ECOGRAPHY, V36, P220, DOI 10.1111/j.1600-0587.2011.07367.x; Basille M, 2009, ECOGRAPHY, V32, P683, DOI 10.1111/j.1600-0587.2009.05712.x; Battin J, 2004, CONSERV BIOL, V18, P1482, DOI 10.1111/j.1523-1739.2004.00417.x; Blanco JC, 2005, CAN J ZOOL, V83, P312, DOI 10.1139/Z05-016; Boyce MS, 2003, ECOSCIENCE, V10, P421, DOI 10.1080/11956860.2003.11682790; Bunnefeld N, 2006, J ZOOL, V270, P31, DOI 10.1111/j.1469-7998.2006.00107.x; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Carroll C, 2007, CONSERV BIOL, V21, P1092, DOI 10.1111/j.1523-1739.2007.00719.x; Crampton LH, 2011, CONDOR, V113, P209, DOI 10.1525/cond.2011.090206; DeCesare NJ, 2010, ANIM CONSERV, V13, P353, DOI 10.1111/j.1469-1795.2009.00328.x; Delibes M, 2001, AM NAT, V158, P277, DOI 10.1086/321319; Doledec S, 2000, ECOLOGY, V81, P2914, DOI 10.1890/0012-9658(2000)081[2914:NSICAA]2.0.CO;2; Donovan TM, 2001, ECOL APPL, V11, P871; Dussault C, 2005, ECOGRAPHY, V28, P619, DOI 10.1111/j.2005.0906-7590.04263.x; Falcucci A, 2009, J APPL ECOL, V46, P600, DOI 10.1111/j.1365-2664.2009.01634.x; Fieberg J, 2009, ECOLOGY, V90, P1687, DOI 10.1890/08-0724.1; Gaillard JM, 2010, PHILOS T R SOC B, V365, P2255, DOI 10.1098/rstb.2010.0085; Gorini L, 2012, MAMMAL REV, V42, P55, DOI 10.1111/j.1365-2907.2011.00189.x; Hall LS, 1997, WILDLIFE SOC B, V25, P173; Harvey DS, 2006, BIOL CONSERV, V130, P206, DOI 10.1016/j.biocon.2005.12.015; Hebblewhite M, 2008, J APPL ECOL, V45, P834, DOI 10.1111/j.1365-2664.2008.01466.x; Hebblewhite M, 2009, ECOLOGY, V90, P3445, DOI 10.1890/08-2090.1; Herfindal I, 2005, J ZOOL, V265, P63, DOI 10.1017/S0952836904006053; Indermaur L, 2009, ECOLOGY, V90, P3430, DOI 10.1890/08-0886.1; James ARC, 2000, J WILDLIFE MANAGE, V64, P154, DOI 10.2307/3802985; Jenkins DA, 2007, J MAMMAL, V88, P614, DOI 10.1644/06-MAMM-A-010R1.1; Johnson CJ, 2002, J ANIM ECOL, V71, P225, DOI 10.1046/j.1365-2656.2002.00595.x; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Kaczensky P, 2003, BIOL CONSERV, V111, P191, DOI 10.1016/S0006-3207(02)00273-2; Kerley LL, 2002, CONSERV BIOL, V16, P97, DOI 10.1046/j.1523-1739.2002.99290.x; Kristan WB, 2003, OIKOS, V103, P457; Kusak J, 2009, EUR J WILDLIFE RES, V55, P7, DOI 10.1007/s10344-008-0208-5; Lande R, 1998, RES POPUL ECOL, V40, P259, DOI 10.1007/BF02763457; Laurian C, 2012, ECOSCIENCE, V19, P69, DOI 10.2980/19-1-3461; Linnell JDC, 2001, ANIM CONSERV, V4, P345, DOI 10.1017/S1367943001001408; Linnell JDC, 2001, ENVIRON MANAGE, V27, P869; Linnell JDC, 2010, ENVIRON MANAGE, V45, P1142, DOI 10.1007/s00267-010-9455-9; Litvaitis John A., 1996, Journal of Wildlife Research, V1, P292; Manly BFJ., 2002, RESOURCE SELECTION A, P240; Matthiopoulos J, 2011, ECOLOGY, V92, P583, DOI 10.1890/10-0751.1; Mayor SJ, 2009, ECOSCIENCE, V16, P238, DOI 10.2980/16-2-3238; Mcloughlin PD, 2007, ECOLOGY, V88, P3192, DOI 10.1890/06-1974.1; McLoughlin PD, 2011, BASIC APPL ECOL, V12, P654, DOI 10.1016/j.baae.2011.09.001; Melis C, 2010, ECOSCIENCE, V17, P166, DOI 10.2980/17-2-3314; MOHR CO, 1947, AM MIDL NAT, V37, P223, DOI 10.2307/2421652; Morin P, 2005, CAN J ZOOL, V83, P1333, DOI 10.1139/Z05-129; Mosser A, 2009, ECOL LETT, V12, P1050, DOI 10.1111/j.1461-0248.2009.01359.x; Moyer MA, 2008, SOUTHEAST NAT, V7, P111, DOI 10.1656/1528-7092(2008)7[111:SHSBFF]2.0.CO;2; Mysterud A, 1998, ECOLOGY, V79, P1435, DOI 10.1890/0012-9658(1998)079[1435:FRIHUA]2.0.CO;2; Nilsen EB, 2009, J ANIM ECOL, V78, P585, DOI 10.1111/j.1365-2656.2009.01523.x; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Odden J, 2008, J WILDLIFE MANAGE, V72, P276, DOI 10.2193/2005-537; Odden J, 2006, EUR J WILDLIFE RES, V52, P237, DOI 10.1007/s10344-006-0052-4; Palazy L, 2012, ANIM CONSERV, V15, P4, DOI 10.1111/j.1469-1795.2011.00476.x; Panzacchi M, 2010, BEHAV ECOL SOCIOBIOL, V64, P1267, DOI 10.1007/s00265-010-0941-0; PICKETT STA, 1995, SCIENCE, V269, P331, DOI 10.1126/science.269.5222.331; R Core Team, 2012, R LANG ENV STAT COMP; Rettie WJ, 2000, ECOGRAPHY, V23, P466, DOI 10.1034/j.1600-0587.2000.230409.x; Roever CL, 2010, ECOGRAPHY, V33, P1113, DOI 10.1111/j.1600-0587.2010.06077.x; Saether BE, 2010, BIOL CONSERV, V143, P1970, DOI 10.1016/j.biocon.2010.04.048; Schwab AC, 2011, APPL GEOGR, V31, P859, DOI 10.1016/j.apgeog.2010.10.015; Sih A, 2011, EVOL APPL, V4, P367, DOI 10.1111/j.1752-4571.2010.00166.x; Singh NJ, 2010, CAN J ZOOL, V88, P436, DOI 10.1139/Z10-015; Stephens D.W., 1986, pi; Takle M, 2002, 200222 NOT STAT NORW, P34; Thomas DL, 2006, J WILDLIFE MANAGE, V70, P324, DOI 10.2193/0022-541X(2006)70[324:SDATFC]2.0.CO;2; Tigas LA, 2002, BIOL CONSERV, V108, P299, DOI 10.1016/S0006-3207(02)00120-9; Tolon V, 2009, CAN J ZOOL, V87, P1129, DOI 10.1139/Z09-101; Torres RT, 2011, ECOL RES, V26, P781, DOI 10.1007/s11284-011-0837-0; Treves A, 2009, J APPL ECOL, V46, P1350, DOI 10.1111/j.1365-2664.2009.01729.x; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; Tuomainen U, 2011, BIOL REV, V86, P640, DOI 10.1111/j.1469-185X.2010.00164.x; Van Moorter B, 2009, OECOLOGIA, V159, P669, DOI 10.1007/s00442-008-1245-1; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Zweifel-Schielly B, 2009, ECOGRAPHY, V32, P103, DOI 10.1111/j.1600-0587.2008.05178.x	84	57	59	0	133	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e65493	10.1371/journal.pone.0065493	http://dx.doi.org/10.1371/journal.pone.0065493			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874381	Green Published, gold, Green Submitted			2022-12-27	WOS:000321765300002
J	Fraisier, C; Camoin, L; Lim, S; Bakli, M; Belghazi, M; Fourquet, P; Granjeaud, S; Osterhaus, ADME; Koraka, P; Martina, B; Almeras, L				Fraisier, Christophe; Camoin, Luc; Lim, Stephanie; Bakli, Mahfoud; Belghazi, Maya; Fourquet, Patrick; Granjeaud, Samuel; Osterhaus, Ab D. M. E.; Koraka, Penelope; Martina, Byron; Almeras, Lionel			Altered Protein Networks and Cellular Pathways in Severe West Nile Disease in Mice	PLOS ONE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; TRAUMATIC BRAIN-INJURY; JAPANESE ENCEPHALITIS-VIRUS; CENTRAL-NERVOUS-SYSTEM; RNA PROFILING REVEALS; PLASMODIUM-FALCIPARUM; CEREBROSPINAL-FLUID; ARP2/3 COMPLEX; DENGUE-VIRUS; IN-VIVO	Background: The recent West Nile virus (WNV) outbreaks in developed countries, including Europe and the United States, have been associated with significantly higher neuropathology incidence and mortality rate than previously documented. The changing epidemiology, the constant risk of (re-)emergence of more virulent WNV strains, and the lack of effective human antiviral therapy or vaccines makes understanding the pathogenesis of severe disease a priority. Thus, to gain insight into the pathophysiological processes in severe WNV infection, a kinetic analysis of protein expression profiles in the brain of WNV-infected mice was conducted using samples prior to and after the onset of clinical symptoms. Methodology/Principal Findings: To this end, 2D-DIGE and gel-free iTRAQ labeling approaches were combined, followed by protein identification by mass spectrometry. Using these quantitative proteomic approaches, a set of 148 proteins with modified abundance was identified. The bioinformatics analysis (Ingenuity Pathway Analysis) of each protein dataset originating from the different time-point comparisons revealed that four major functions were altered during the course of WNV-infection in mouse brain tissue: i) modification of cytoskeleton maintenance associated with virus circulation; ii) deregulation of the protein ubiquitination pathway; iii) modulation of the inflammatory response; and iv) alteration of neurological development and neuronal cell death. The differential regulation of selected host protein candidates as being representative of these biological processes were validated by western blotting using an original fluorescence-based method. Conclusion/Significance: This study provides novel insights into the in vivo kinetic host reactions against WNV infection and the pathophysiologic processes involved, according to clinical symptoms. This work offers useful clues for anti-viral research and further evaluation of early biomarkers for the diagnosis and prevention of severe neurological disease caused by WNV.	[Fraisier, Christophe; Bakli, Mahfoud; Almeras, Lionel] IRBA, Armed Forces Biomed Res Inst, Inst Rech Biomed Armees, Unite Parasitol,URMITE UM 63, Marseille, France; [Camoin, Luc; Fourquet, Patrick; Granjeaud, Samuel] Aix Marseille Univ, Inserm,CNRS,CRCM, U1068,UMR7258, UM 105, Marseille, France; [Camoin, Luc; Fourquet, Patrick; Granjeaud, Samuel] Inst J Paoli I Calmettes, Marseille Prote, F-13009 Marseille, France; [Lim, Stephanie; Osterhaus, Ab D. M. E.; Koraka, Penelope; Martina, Byron] Erasmus MC, Dept Virol, Rotterdam, Netherlands; [Belghazi, Maya] Aix Marseille Univ, CNRS, UMR 7286, Marseille, France; [Almeras, Lionel] Aix Marseille Univ, Fac Med, WHO Collaborat Ctr Rickettsioses & Other Arthropo, URMITE,UM 63,CNRS 7278,IRD 198,Inserm 1095, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UNICANCER; Institut Paoli-Calmette (IPC); Erasmus University Rotterdam; Erasmus MC; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD)	Almeras, L (corresponding author), IRBA, Armed Forces Biomed Res Inst, Inst Rech Biomed Armees, Unite Parasitol,URMITE UM 63, Marseille, France.	almeras.lionel@gmail.com	Granjeaud, Samuel/AAE-6488-2022; Camoin, Luc/AAB-3856-2019	Granjeaud, Samuel/0000-0001-9245-1535; Camoin, Luc/0000-0002-1230-4787; BAKLI, Mahfoud/0000-0002-1427-2985; ALMERAS, Lionel/0000-0003-0490-5774; Martina, Byron/0000-0003-4980-4619	European Community [261466]; Delegation Generale pour l'Armement (DGA) [ArthroSer 10Ca 401]	European Community(European Commission); Delegation Generale pour l'Armement (DGA)	The research leading to these results has received funding from the European Community's Seventh Framework Program (FP7/2007-2013) under the project "VECTORIE", EC grant agreement number 261466. This study was also supported by Delegation Generale pour l'Armement (DGA, ArthroSer 10Ca 401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhoot MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034060; Alhoot MA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001410; Allonso D, 2012, J CLIN VIROL, V55, P214, DOI 10.1016/j.jcv.2012.07.010; Almeras L, 2004, PROTEOMICS, V4, P2184, DOI 10.1002/pmic.200300732; Almeras L, 2010, VECTOR-BORNE ZOONOT, V10, P391, DOI 10.1089/vbz.2009.0042; Ang F, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-24; Auer J, 2010, J PROTEOMICS, V73, P1004, DOI 10.1016/j.jprot.2009.12.014; Beasley DWC, 2001, ANN NY ACAD SCI, V951, P332; Berthet FX, 1997, J GEN VIROL, V78, P2293, DOI 10.1099/0022-1317-78-9-2293; Bhattacharyya S, 2010, VIROLOGY, V401, P18, DOI 10.1016/j.virol.2010.02.015; Bin H, 2001, ANN NY ACAD SCI, V951, P127; Blitvich Bradley J., 2008, Animal Health Research Reviews, V9, P71, DOI 10.1017/S1466252307001430; Boja ES, 2012, PROTEOMICS, V12, P1093, DOI 10.1002/pmic.201100387; Bok J, 2007, MOL CELL NEUROSCI, V36, P13, DOI 10.1016/j.mcn.2007.05.008; Bourgeois MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024371; Bretin S, 2005, J COMP NEUROL, V486, P1, DOI 10.1002/cne.20465; Briolant S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-141; Campbell GL, 2002, LANCET INFECT DIS, V2, P519, DOI 10.1016/S1473-3099(02)00368-7; Cepeda V, 2011, CELL MICROBIOL, V13, P846, DOI 10.1111/j.1462-5822.2011.01583.x; Chen LC, 2008, J INFECTION, V56, P143, DOI 10.1016/j.jinf.2007.10.008; Cheng HJ, 2009, EXP BIOL MED, V234, P63, DOI 10.3181/0805-RM-147; Cheung ZH, 2008, J NEUROSCI, V28, P4872, DOI 10.1523/JNEUROSCI.0689-08.2008; Chu JJH, 2004, J VIROL, V78, P10543, DOI 10.1128/JVI.78.19.10543-10555.2004; Chu JJH, 2003, J GEN VIROL, V84, P3305, DOI 10.1099/vir.0.19447-0; Colombo G, 2009, J MOL NEUROSCI, V37, P111, DOI 10.1007/s12031-008-9114-2; Colpitts TM, 2011, VIROLOGY, V417, P179, DOI 10.1016/j.virol.2011.06.002; Cureton DK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000394; De Filette M, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-16; Del Giudice P, 2004, EMERG INFECT DIS, V10, P1885, DOI 10.3201/eid1010.031021; Dhingra V, 2005, J BIOMED BIOTECHNOL, P271, DOI 10.1155/JBB.2005.271; Diamond MS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000452; Diamond MS, 2003, J EXP MED, V198, P1853, DOI 10.1084/jem.20031223; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Feart C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029480; Fontaine A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-276; Fredericksen BL, 2004, J VIROL, V78, P7737, DOI 10.1128/JVI.78.14.7737-7747.2004; Gao G, 2006, CAN J PHYSIOL PHARM, V84, P5, DOI 10.1139/y05-144; Giacoppo S, 2012, NEUROCRIT CARE, V16, P470, DOI 10.1007/s12028-012-9707-z; Gnanapavan S, 2010, J NEUROIMMUNOL, V225, P118, DOI 10.1016/j.jneuroim.2010.04.020; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Goodbourn S, 2000, J GEN VIROL, V81, P2341, DOI 10.1099/0022-1317-81-10-2341; Grummer B, 2004, J VET MED B, V51, P427, DOI 10.1111/j.1439-0450.2004.00798.x; Guo JT, 2005, J VIROL, V79, P1343, DOI 10.1128/JVI.79.3.1343-1350.2005; He XL, 2010, INT J CLIN EXP PATHO, V3, P156; Helfand BT, 2003, ANNU REV CELL DEV BI, V19, P445, DOI 10.1146/annurev.cellbio.19.111401.092306; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Hoe HS, 2012, CNS NEUROSCI THER, V18, P47, DOI 10.1111/j.1755-5949.2010.00221.x; Hollidge BS, 2012, J VIROL, V86, P7988, DOI 10.1128/JVI.00140-12; Huang HC, 2012, J VIROL, V86, P9443, DOI 10.1128/JVI.00873-12; Hussain KM, 2011, J BIOL CHEM, V286, P309, DOI 10.1074/jbc.M110.168468; Imada K, 2000, MOL IMMUNOL, V37, P1, DOI 10.1016/S0161-5890(00)00018-3; Jauch EC, 2006, STROKE, V37, P2508, DOI 10.1161/01.STR.0000242290.01174.9e; Jordan I, 2000, J INFECT DIS, V182, P1214, DOI 10.1086/315847; Kanlaya R, 2010, MOL BIOSYST, V6, P795, DOI 10.1039/b923864f; Keller BC, 2006, J VIROL, V80, P9424, DOI 10.1128/JVI.00768-06; Kleinschmidt MC, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-49; Kobayashi S, 2012, NEUROPATHOLOGY, V32, P398, DOI 10.1111/j.1440-1789.2011.01275.x; Koh WL, 2005, EMERG INFECT DIS, V11, P629, DOI 10.3201/eid1104.041076; Kolokoltsov AA, 2007, J VIROL, V81, P7786, DOI 10.1128/JVI.02780-06; Kong KF, 2008, VIRAL IMMUNOL, V21, P78, DOI 10.1089/vim.2007.0072; Kowara R, 2005, J NEUROCHEM, V95, P466, DOI 10.1111/j.1471-4159.2005.03383.x; Kramer LD, 2008, ANNU REV ENTOMOL, V53, P61, DOI 10.1146/annurev.ento.53.103106.093258; Kumar M, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-73; LANFORD RE, 1994, VIROLOGY, V202, P606, DOI 10.1006/viro.1994.1381; Laurent-Rolle M, 2010, J VIROL, V84, P3503, DOI 10.1128/JVI.01161-09; Li S, 2010, BBA-PROTEINS PROTEOM, V1804, P1882, DOI 10.1016/j.bbapap.2010.05.011; Lim SM, 2011, VIRUSES-BASEL, V3, P811, DOI 10.3390/v3060811; Liu WJ, 2005, J VIROL, V79, P1934, DOI 10.1128/JVI.79.3.1934-1942.2005; Lundstrom JO, 1999, J VECTOR ECOL, V24, P1; Maxwell KL, 2007, MICROBIOL MOL BIOL R, V71, P398, DOI 10.1128/MMBR.00042-06; McCarthy Derrick P, 2012, Methods Mol Biol, V900, P381, DOI 10.1007/978-1-60761-720-4_19; McGinnis KM, 1998, J BIOL CHEM, V273, P19993, DOI 10.1074/jbc.273.32.19993; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Miyake Y, 2012, ADV EXP MED BIOL, V738, P144, DOI 10.1007/978-1-4614-1680-7_9; Mooren OL, 2012, ANNU REV BIOCHEM, V81, P661, DOI 10.1146/annurev-biochem-060910-094416; Murgue B, 2001, ANN NY ACAD SCI, V951, P117; Murray KO, 2010, VET RES, V41, DOI 10.1051/vetres/2010039; Najjar I, 2010, BIOCHIMIE, V92, P425, DOI 10.1016/j.biochi.2010.02.009; Nandi D, 2006, J BIOSCIENCES, V31, P137, DOI 10.1007/BF02705243; Nawa M, 2003, J GEN VIROL, V84, P1737, DOI 10.1099/vir.0.18883-0; Okuma Y, 2012, ANN NEUROL; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Papa A, 2010, EURO SURVEILL, V15; Parquet MD, 2001, FEBS LETT, V500, P17, DOI 10.1016/S0014-5793(01)02573-X; Passali D, 2012, ACTA OTORHINOLARYNGO, V32, P46; Pastorino B, 2009, MOL CELL PROTEOMICS, V8, P1623, DOI 10.1074/mcp.M800565-MCP200; Petzold A, 2010, MUSCLE NERVE, V41, P42, DOI 10.1002/mus.21448; Platonov AE, 2001, EMERG INFECT DIS, V7, P128, DOI 10.3201/eid0701.010118; Quetglas JI, 2012, J VIROL, V86, P1758, DOI 10.1128/JVI.05666-11; Rossi SL, 2010, CLIN LAB MED, V30, P47, DOI 10.1016/j.cll.2009.10.006; Rossman JS, 2012, J VIROL, V86, P10950, DOI 10.1128/JVI.05992-11; Samuel MA, 2005, J VIROL, V79, P13350, DOI 10.1128/JVI.79.21.13350-13361.2005; Schiff L, 2012, MOL DIAGN THER, V16, P79, DOI 10.2165/11631580-000000000-00000; Schmidt EF, 2007, ADV EXP MED BIOL, V600, P1; See V, 2001, FASEB J, V15, P134, DOI 10.1096/fj.00-0106com; Shichita T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00132; Shichita T, 2012, NAT MED, V18, P911, DOI 10.1038/nm.2749; Shrestha B, 2004, J VIROL, V78, P8312, DOI [10.1128/JVI.78.15.8312-8321.2004, 10.1128/jvi.78.15.8312-8321.2004]; Shrestha B, 2003, J VIROL, V77, P13203, DOI 10.1128/JVI.77.24.13203-13213.2003; Sitati EM, 2006, J VIROL, V80, P12060, DOI 10.1128/JVI.01650-06; Skruzny M, 2012, P NATL ACAD SCI USA, V109, pE2533, DOI 10.1073/pnas.1207011109; Smithburn KC., 1940, AM J TROP MED HYG, V1, P471, DOI 10.4269/ajtmh.1940.s1-20.471; Spearman C, 1908, BRIT J PSYCHOL, V2, P227, DOI 10.1111/j.2044-8295.1908.tb00176.x; Stohlman SA, 2001, BRAIN PATHOL, V11, P92; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Su SC, 2011, ANNU REV CELL DEV BI, V27, P465, DOI 10.1146/annurev-cellbio-092910-154023; Taylor MP, 2011, NAT REV MICROBIOL, V9, P427, DOI 10.1038/nrmicro2574; Thompson SN, 2006, EXP NEUROL, V201, P253, DOI 10.1016/j.expneurol.2006.04.013; Tian Zuo-jun, 2009, Nan Fang Yi Ke Da Xue Xue Bao, V29, P250; Togashi H, 2009, CELL ADHES MIGR, V3, P29, DOI 10.4161/cam.3.1.6773; Torrentino-Madamet M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-4; Tsai TF, 1998, LANCET, V352, P767, DOI 10.1016/S0140-6736(98)03538-7; Tseng YF, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-20; Ulane CM, 2002, VIROLOGY, V304, P160, DOI 10.1006/viro.2002.1773; Van den Broeke C, 2011, VIRUSES-BASEL, V3, P278, DOI 10.3390/v3040278; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Venter M, 2005, VIROLOGY, V342, P119, DOI 10.1016/j.virol.2005.07.013; Wang KY, 2012, CLIN CHIM ACTA, V413, P1737, DOI 10.1016/j.cca.2012.07.002; Wang P, 2005, J NEUROSCI, V25, P1219, DOI 10.1523/JNEUROSCI.4660-04.2005; Wang W, 2012, NEUROCHEM RES, V37, P819, DOI 10.1007/s11064-011-0677-x; Watabe-Uchida M, 2006, J NEUROSCI, V26, P10633, DOI 10.1523/JNEUROSCI.4084-06.2006; Weaver AM, 2003, CURR OPIN CELL BIOL, V15, P23, DOI 10.1016/S0955-0674(02)00015-7; Whitaker JN, 1998, MULT SCLER J, V4, P16, DOI 10.1191/135245898678909123; Yang JS, 2002, EMERG INFECT DIS, V8, P1379, DOI 10.3201/eid0812.020224; Zakharov VV, 2001, NEUROSCI RES, V39, P447, DOI 10.1016/S0168-0102(01)00201-2; Zhang JY, 2011, STROKE, V42, P1420, DOI 10.1161/STROKEAHA.110.598334; Zhang ZQ, 2007, J NEUROTRAUM, V24, P460, DOI 10.1089/neu.2006.0078; Zheng J, 2011, ANAL CHIM ACTA, V702, P149, DOI 10.1016/j.aca.2011.06.045	130	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68318	10.1371/journal.pone.0068318	http://dx.doi.org/10.1371/journal.pone.0068318			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874584	gold, Green Published, Green Submitted			2022-12-27	WOS:000321765300041
J	Kuhla, A; Lange, S; Holzmann, C; Maass, F; Petersen, J; Vollmar, B; Wree, A				Kuhla, Angela; Lange, Sophie; Holzmann, Carsten; Maass, Fabian; Petersen, Jana; Vollmar, Brigitte; Wree, Andreas			Lifelong Caloric Restriction Increases Working Memory in Mice	PLOS ONE			English	Article							CHRONIC FOOD RESTRICTION; ANXIETY-LIKE BEHAVIORS; OPEN-FIELD BEHAVIOR; AGE-RELATED DECLINE; KETOGENIC DIET; PLUS-MAZE; EXPRESSION; BRAIN; RATS; PERFORMANCE	Caloric restriction (CR) is argued to positively affect general health, longevity and the normally occurring age-related reduction of cognition. This issue is well examined, but most studies investigated the effect of short-term periods of CR. Herein, 4 weeks old female mice were fed caloric restricted for 4, 20 and especially for 74 weeks. CR mice received 60% of food eaten by their ad libitum (AL) fed littermates, and all age-matched groups were behaviorally analyzed. The motor coordination, which was tested by rotarod/accelerod, decreased age-related, but was not influenced by the different periods of CR. In contrast, the age-related impairment of spontaneous locomotor activity and anxiety, both being evaluated by open field and by elevated plus maze test, was found aggravated by a lifelong CR. Measurement of cognitive performance with morris water maze showed that the working memory decreased age-related in AL mice, while a lifelong CR caused a better cognitive performance and resulted in a significantly better spatial memory upon 74 weeks CR feeding. However, a late-onset CR feeding in 66 weeks old mice did not ameliorate the working memory. Therefore, a lifelong CR seems to be necessary to improve working memory.	[Kuhla, Angela; Vollmar, Brigitte] Univ Rostock, Inst Expt Surg, D-18055 Rostock, Germany; [Lange, Sophie; Maass, Fabian; Petersen, Jana; Wree, Andreas] Univ Rostock, Inst Anat, D-18055 Rostock, Germany; [Holzmann, Carsten] Univ Rostock, Inst Med Genet, D-18055 Rostock, Germany	University of Rostock; University of Rostock; University of Rostock	Kuhla, A (corresponding author), Univ Rostock, Inst Expt Surg, D-18055 Rostock, Germany.	angela.kuhla@uni-rostock.de	Holzmann, Carsten/B-9254-2008	Holzmann, Carsten/0000-0001-7977-9093; Maass, Fabian/0000-0002-4077-2852	University of Rostock	University of Rostock	This work was supported by an intramural grant of the FORUN program of the University of Rostock to AW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MM, 2008, EXP NEUROL, V211, P141, DOI 10.1016/j.expneurol.2008.01.016; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Bellush LL, 1996, PHYSIOL BEHAV, V60, P541, DOI 10.1016/S0031-9384(96)80029-1; Bergado Jorge A., 2002, Neural Plasticity, V9, P217, DOI 10.1155/NP.2002.217; BOGO V, 1981, NEUROTOXICOLOGY, V2, P765; Carter CS, 2009, J GERONTOL A-BIOL, V64, P850, DOI 10.1093/gerona/glp060; Churchill JD, 2002, NEUROBIOL AGING, V23, P941, DOI 10.1016/S0197-4580(02)00028-3; DAWSON GR, 1995, TRENDS PHARMACOL SCI, V16, P33, DOI 10.1016/S0165-6147(00)88973-7; DENENBERG VH, 1969, ANN NY ACAD SCI, V159, P852, DOI 10.1111/j.1749-6632.1969.tb12983.x; Deng L, 2009, INT J NEUROSCI, V119, P291, DOI 10.1080/00207450802328250; Dhahbi JM, 2004, P NATL ACAD SCI USA, V101, P5524, DOI 10.1073/pnas.0305300101; Eikelis N, 2000, Stress, V3, P319, DOI 10.3109/10253890009001137; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Fahlstrom A, 2011, NEUROBIOL AGING, V32, P1868, DOI 10.1016/j.neurobiolaging.2009.11.003; Forster MJ, 1996, P NATL ACAD SCI USA, V93, P4765, DOI 10.1073/pnas.93.10.4765; Forster MJ, 2003, FASEB J, V17, P690, DOI 10.1096/fj.02-0533fje; GAGE FH, 1984, J NEUROSCI, V4, P2856; GALLAGHER M, 1989, NEUROBIOL AGING, V10, P691, DOI 10.1016/0197-4580(89)90006-7; Geng YQ, 2007, P ANN INT IEEE EMBS, P2393, DOI 10.1109/IEMBS.2007.4352809; Geng YQ, 2011, J CELL BIOCHEM, V112, P3755, DOI 10.1002/jcb.23315; Gillette-Guyonnet S, 2008, CURR OPIN CLIN NUTR, V11, P686, DOI 10.1097/MCO.0b013e328313968f; Hashimoto T, 2005, NEUROREPORT, V16, P1129, DOI 10.1097/00001756-200507130-00019; Hof PR, 2004, TRENDS NEUROSCI, V27, P607, DOI 10.1016/j.tins.2004.07.013; Holzmann C, 2012, BEHAV BRAIN RES, V234, P107, DOI 10.1016/j.bbr.2012.06.008; INGRAM DK, 1988, NEUROBIOL AGING, V9, P475, DOI 10.1016/S0197-4580(88)80101-5; Jahng JW, 2007, BRAIN RES, V1150, P100, DOI 10.1016/j.brainres.2007.02.080; JONES BJ, 1968, J PHARM PHARMACOL, V20, P302, DOI 10.1111/j.2042-7158.1968.tb09743.x; Karl T, 2003, EXP TOXICOL PATHOL, V55, P69, DOI 10.1078/0940-2993-00301; Krikorian R, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.10.006; Kwon YS, 2008, EPILEPSY RES, V78, P186, DOI 10.1016/j.eplepsyres.2007.11.010; Levay EA, 2007, PHYSIOL BEHAV, V92, P889, DOI 10.1016/j.physbeh.2007.06.018; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Maalouf M, 2009, BRAIN RES REV, V59, P293, DOI 10.1016/j.brainresrev.2008.09.002; Masoro EJ, 2006, BIOGERONTOLOGY, V7, P153, DOI 10.1007/s10522-006-9015-0; Matochik JA, 2004, NEUROBIOL AGING, V25, P193, DOI 10.1016/S0197-4580(03)00092-7; MEANS LW, 1993, PHYSIOL BEHAV, V54, P503, DOI 10.1016/0031-9384(93)90243-9; Minor RK, 2008, BEHAV BRAIN RES, V189, P202, DOI 10.1016/j.bbr.2007.12.030; Mouton PR, 2009, NEUROSCI LETT, V464, P184, DOI 10.1016/j.neulet.2009.08.038; Noh HS, 2008, EPILEPSIA, V49, P120, DOI 10.1111/j.1528-1167.2008.01855.x; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Pugh TD, 1999, CANCER RES, V59, P1642; Rodgers RJ, 1997, NEUROSCI BIOBEHAV R, V21, P801, DOI 10.1016/S0149-7634(96)00058-9; Smith LK, 2005, PHYSIOL BEHAV, V85, P581, DOI 10.1016/j.physbeh.2005.06.013; Terry RD, 2001, NEUROBIOL AGING, V22, P347, DOI 10.1016/S0197-4580(00)00250-5; Tomiyama AJ, 2010, PSYCHOSOM MED, V72, P357, DOI 10.1097/PSY.0b013e3181d9523c; WADDEN TA, 1986, J CONSULT CLIN PSYCH, V54, P482, DOI 10.1037/0022-006X.54.4.482; WOOLEY SC, 1991, J AM DIET ASSOC, V91, P1248; Yamamoto Y, 2009, PHYSIOL GENOMICS, V39, P227, DOI 10.1152/physiolgenomics.00082.2009	49	69	70	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68778	10.1371/journal.pone.0068778	http://dx.doi.org/10.1371/journal.pone.0068778			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874758	Green Published, Green Submitted, gold			2022-12-27	WOS:000321765300066
J	Wilson, JP; Kanaya, AM; Fan, B; Shepherd, JA				Wilson, Joseph P.; Kanaya, Alka M.; Fan, Bo; Shepherd, John A.			Ratio of Trunk to Leg Volume as a New Body Shape Metric for Diabetes and Mortality	PLOS ONE			English	Article							X-RAY ABSORPTIOMETRY; CORONARY-HEART-DISEASE; MASS INDEX; WAIST CIRCUMFERENCE; MYOCARDIAL-INFARCTION; ABDOMINAL OBESITY; DXA MEASUREMENTS; VISCERAL FAT; HEALTH-RISK; FOLLOW-UP	Background: Body shape is a known risk factor for diabetes and mortality, but the methods estimating body shape, BMI and waist circumference are crude. We determined whether a novel body shape measure, trunk to leg volume ratio, was independently associated with diabetes and mortality. Methods: Data from the National Health and Nutritional Examination Survey 1999-2004, a study representative of the US population, were used to generate dual-energy X-ray absorptiometry-derived trunk to leg volume ratio and determine its associations to diabetes, metabolic covariates, and mortality by BMI category, gender, and race/ethnicity group. Results: The prevalence of pre-diabetes and diabetes increased with age, BMI, triglycerides, blood pressure, and decreased HDL level. After adjusting for covariates, the corresponding fourth to first quartile trunk to leg volume ratio odds ratios (OR) were 6.8 (95% confidence interval [CI], 4.9-9.6) for diabetes, 3.9 (95% CI, 3.0-5.2) for high triglycerides, 1.8 (95% CI, 1.6-2.1) for high blood pressure, 3.0 (95% CI, 2.4-3.8) for low HDL, 3.6 (95% CI, 2.8-4.7) for metabolic syndrome, and 1.76 (95% CI, 1.20-2.60) for mortality. Additionally, trunk to leg volume ratio was the strongest independent measure associated with diabetes (P<0.001), even after adjusting for BMI and waist circumference. Even among those with normal BMI, those in the highest quartile of trunk to leg volume ratio had a higher likelihood of death (5.5%) than those in the lowest quartile (0.2%). Overall, trunk to leg volume ratio is driven by competing mechanisms of changing adiposity and lean mass. Conclusions: A high ratio of trunk to leg volume showed a strong association to diabetes and mortality that was independent of total and regional fat distributions. This novel body shape measure provides additional information regarding central adiposity and appendicular wasting to better stratify individuals at risk for diabetes and mortality, even among those with normal BMI.	[Wilson, Joseph P.; Shepherd, John A.] Univ Calif San Francisco, Grad Program Bioengn, Univ Calif Berkeley, San Francisco, CA 94143 USA; [Wilson, Joseph P.; Fan, Bo; Shepherd, John A.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Kanaya, Alka M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Shepherd, JA (corresponding author), Univ Calif San Francisco, Grad Program Bioengn, Univ Calif Berkeley, San Francisco, CA 94143 USA.	john.shepherd@ucsf.edu	Shepherd, John/S-3146-2018	Shepherd, John/0000-0003-2280-2541; Wilson, Joseph Patrick/0000-0001-9758-8469	National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The National Science Foundation Graduate Research Fellowship provided the stipend for the lead author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behnke AR, 1942, J AMER MED ASSOC, V118, P495, DOI 10.1001/jama.1942.02830070001001; Blake GM, 2006, BONE, V38, P935, DOI 10.1016/j.bone.2005.11.007; BROZEK J, 1963, ANN NY ACAD SCI, V110, P113, DOI 10.1111/j.1749-6632.1963.tb17079.x; Carey VJ, 1997, AM J EPIDEMIOL, V145, P614, DOI 10.1093/oxfordjournals.aje.a009158; Carnethon MR, 2012, JAMA-J AM MED ASSOC, V308, P581, DOI 10.1001/jama.2012.9282; Coutinho T, 2011, J AM COLL CARDIOL, V57, P1877, DOI 10.1016/j.jacc.2010.11.058; Daniels SR, 1997, PEDIATRICS, V99, P804, DOI 10.1542/peds.99.6.804; de Koning L, 2007, EUR HEART J, V28, P850, DOI 10.1093/eurheartj/ehm026; DEURENBERG P, 1991, BRIT J NUTR, V65, P105, DOI 10.1079/BJN19910073; Ellis KJ, 2004, J CLIN DENSITOM, V7, P413, DOI 10.1385/JCD:7:4:413; Flegal KM, 2010, AM J CLIN NUTR, V91, P1020, DOI 10.3945/ajcn.2009.28589; Flegal KM, 2009, AM J CLIN NUTR, V89, P500, DOI 10.3945/ajcn.2008.26847; Fujimoto WY, 1999, DIABETES CARE, V22, P1808, DOI 10.2337/diacare.22.11.1808; Goldman RF, 1959, BODY VOLUME MEASUREM; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; HAGIWARA S, 1993, BONE MINER, V22, P57, DOI 10.1016/S0169-6009(08)80081-5; Janssen I, 2004, AM J CLIN NUTR, V79, P379; Kaul S, 2012, OBESITY, V20, P1313, DOI 10.1038/oby.2011.393; Kelly TL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007038; Krakauer NY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039504; Leonard CM, 2009, PEDIATR RADIOL, V39, P148, DOI 10.1007/s00247-008-1067-7; Micklesfield LK, 2012, OBESITY, V20, P1109, DOI 10.1038/oby.2011.367; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Moyer VA., 2012, ANN INTERN MED; Nicklas BJ, 2006, J AM GERIATR SOC, V54, P413, DOI 10.1111/j.1532-5415.2005.00624.x; Nicklas BJ, 2004, AM J EPIDEMIOL, V160, P741, DOI 10.1093/aje/kwh281; Novotny R, 2006, J NUTR, V136, P642, DOI 10.1093/jn/136.3.642; Novotny R, 2007, OBESITY, V15, P1565, DOI 10.1038/oby.2007.185; Petersen M, 2003, DIABETES CARE, V26, P917; Petrescu L, 2012, P ROMANIAN ACAD S B, V1, P3; Pietrobelli A, 1998, J PEDIATR-US, V132, P204, DOI 10.1016/S0022-3476(98)70433-0; Schoeller DA, 2005, AM J CLIN NUTR, V81, P1018; SIRI W E, 1956, Adv Biol Med Phys, V4, P239; Wang J, 2006, AM J CLIN NUTR, V83, P809; Wang YF, 2005, AM J CLIN NUTR, V81, P555; Wilson JP, 2012, AM J CLIN NUTR, V95, P25, DOI 10.3945/ajcn.111.019273; Wilson JP, 2013, J CLIN DENSITOM; Wilson JP, 2013, AM J CLIN NUTR; Withers RT, 1998, J APPL PHYSIOL, V85, P238, DOI 10.1152/jappl.1998.85.1.238; Zhang C, 2008, CIRCULATION, V117, P1658, DOI 10.1161/CIRCULATIONAHA.107.739714	41	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68716	10.1371/journal.pone.0068716	http://dx.doi.org/10.1371/journal.pone.0068716			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874736	Green Published, gold, Green Submitted			2022-12-27	WOS:000321765300063
J	Barcaui, HS; Tavares, GC; May, SB; Brandao-Mello, CE; Pires, MMA; Barroso, PF				Barcaui, Halime Silva; Tavares, Gerson Carreiro; May, Silvia Beatriz; Brandao-Mello, Carlos Eduardo; Amendola Pires, Marcia Maria; Barroso, Paulo Feijo			Low Rates of Sustained Virologic Response with Peginterferon Plus Ribavirin for Chronic Hepatitis C Virus Infection in HIV Infected Patients in Rio de Janeiro, Brazil	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RANDOMIZED CONTROLLED-TRIAL; WEIGHT-BASED RIBAVIRIN; STAGE LIVER-DISEASE; COINFECTED PATIENTS; EPOETIN-ALPHA; PEGYLATED-INTERFERON; IMPROVES ANEMIA; THERAPY; HCV	Background: The standard treatment for chronic hepatitis C virus (HCV) infection in HIV-infected subjects is the combination of alfapeginterferon (PEG-IFN) plus ribavirin. We designed this study to evaluate the rate of SVR and predictors of SVR in a public health setting in Rio de Janeiro, Brazil. Methods: Retrospective cohort study of HCV/HIV co-infected patients treated with PEG-IFN plus ribavirin from 2004 to 2011 in 3 outpatient units in Rio de Janeiro. Exposure variables included age, sex, CD4+ cell count, HCV genotype, HCV and HIV viral loads, liver histology (METAVIR fibrosis scoring system) and previous treatment. The main outcome measurement was SVR. Results: 100 patients were included in this analysis. Median age was 47 years and 68% were male. 80%, 4%, 14% and 2% were infected with HCV genotypes 1, 2, 3 and 4, respectively. At baseline, 77% had HCV viral load greater than 800,000 IU/ml, 99% had CD4+ greater than 200 cells/mm(3) and 10% had a diagnosis of cirrhosis. The treatment was withdrawn in 9% of the subjects (5% with adverse effects and 4% dropped out). SVR was observed in 27 (27%) of the 100 patients included. 13 (13%) subjects were classified as null-responders, 33(33%) as non-responders, 9 (9%) as breakthrough and 9(9%) as relapsers. In the multivariate model only being infected with genotype 2 or 3 (p<0.01) and having low levels of gamma glutamyl transferase (GGT) at baseline (p = 0.04), were predictive of SVR. Conclusion: SVR in HCV/HIV co-infected subjects in a public health setting is similar to that observed in clinical trials, albeit very low. A delay in therapy initiation should be considered until new therapies as direct acting antiviral drugs (DAA) become widely available and tested in coinfected subjects.	[Barcaui, Halime Silva; Barroso, Paulo Feijo] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Sch Med, Infect Dis Serv,Dept Prevent Med, Rio De Janeiro, Brazil; [Tavares, Gerson Carreiro; May, Silvia Beatriz] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Sch Med, Rio De Janeiro, Brazil; [Brandao-Mello, Carlos Eduardo; Amendola Pires, Marcia Maria] Univ Fed Estado Rio de Janeiro, Hosp Gafree & Guinle, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Estado do Rio de Janeiro	Barcaui, HS (corresponding author), Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Sch Med, Infect Dis Serv,Dept Prevent Med, Rio De Janeiro, Brazil.	halimebarcaui@gmail.com			NIH; FAPERJ; Abbott Laboratories; GlaxoSmithKline; Bristol Myers Squibb	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Abbott Laboratories(Abbott Laboratories); GlaxoSmithKline(GlaxoSmithKline); Bristol Myers Squibb(Bristol-Myers Squibb)	Dr. Barroso has received research grants from NIH, FAPERJ, Abbott Laboratories and GlaxoSmithKline. He received lecture and travel fees from Bristol Myers Squibb and GlaxoSmithKline. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afdhal NH, 2004, GASTROENTEROLOGY, V126, P1302, DOI 10.1053/j.gastro.2004.01.027; Alavian SM, 2012, J VIRAL HEPATITIS, V19, P88, DOI 10.1111/j.1365-2893.2011.01532.x; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bica I, 2001, CLIN INFECT DIS, V32, P492, DOI 10.1086/318501; Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude, 2011, PROT CLIN DIR TER A; Bura M, 2012, POSTEP HIG MED DOSW, V66, P339, DOI 10.5604/17322693.1000332; Carrat F, 2004, JAMA-J AM MED ASSOC, V292, P2839, DOI 10.1001/jama.292.23.2839; Chung HJ, 2013, INTERVIROLO IN PRESS; Chung RT, 2012, HIV CLIN TRIALS, V13, P70, DOI 10.1310/hct1302-70; Chung RT, 2004, NEW ENGL J MED, V351, P451, DOI 10.1056/NEJMoa032653; Coban S, 2011, HEPATO-GASTROENTEROL, V58, P1301, DOI 10.5754/hge10625; Daar ES, 2001, J ACQ IMMUN DEF SYND, V26, P466, DOI 10.1097/00126334-200104150-00011; Dieterich DT, 2003, AM J GASTROENTEROL, V98, P2491, DOI 10.1016/j.amjgastroenterol.2003.08.006; Dieterich DT, 2011, 19 C RETR OPP INF MA; Gane EJ, 2013, NEW ENGL J MED, V368, P34, DOI 10.1056/NEJMoa1208953; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Graham CS, 2001, CLIN INFECT DIS, V33, P562, DOI 10.1086/321909; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; de Almeida PRL, 2010, ANN HEPATOL, V9, P150, DOI 10.1016/S1665-2681(19)31653-9; Martin-Carbonero L, 2008, AIDS, V22, P15, DOI 10.1097/QAD.0b013e3282f1da99; Mauss S, 2011, J VIRAL HEPATITIS, V18, pe81, DOI 10.1111/j.1365-2893.2010.01372.x; Monga HK, 2001, CLIN INFECT DIS, V33, P240, DOI 10.1086/321819; Nunez M, 2007, AIDS RES HUM RETROV, V23, P972, DOI 10.1089/aid.2007.0011; Vanegas NO, 2011, REV ESP QUIM, V24, P198; Poordad F, 2013, NEW ENGL J MED, V368, P45, DOI 10.1056/NEJMoa1208809; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Ragni MV, 2001, J INFECT DIS, V183, P1112, DOI 10.1086/319273; Ramachandran P, 2012, ALIMENT PHARM THER, V35, P647, DOI 10.1111/j.1365-2036.2012.04992.x; Seden K, 2010, J ANTIMICROB CHEMOTH, V65, P1079, DOI 10.1093/jac/dkq086; Sharvadze L, 2009, GEORGIAN MED NEWS, V175, P32; Sherman KE, 2002, CLIN INFECT DIS, V34, P831, DOI 10.1086/339042; Soriano V, 1999, EUR J EPIDEMIOL, V15, P1, DOI 10.1023/A:1007506617734; Soto B, 1997, J HEPATOL, V26, P1, DOI 10.1016/S0168-8278(97)80001-3; Sulkowski M, 2011, 19 C RETR OPP INF MA; Sulkowski MS, 2005, JAIDS-J ACQ IMM DEF, V39, P504, DOI 10.1097/01.qai.0000167158.90722.73; Talal AH, 2011, JAIDS-J ACQ IMM DEF, V58, P261, DOI 10.1097/QAI.0b013e3182324af9; Torriani FJ, 2004, NEW ENGL J MED, V351, P438, DOI 10.1056/NEJMoa040842; Van den Eynde E, 2010, AIDS, V24, P975, DOI 10.1097/QAD.0b013e3283350f7c; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; Yee HS, 2012, AM J GASTROENTEROL, V107, P669, DOI 10.1038/ajg.2012.48; Yu JW, 2012, HEPATOB PANCREAT DIS, V11, P185, DOI 10.1016/S1499-3872(12)60146-5	41	4	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e67734	10.1371/journal.pone.0067734	http://dx.doi.org/10.1371/journal.pone.0067734			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874441	Green Published, gold, Green Submitted			2022-12-27	WOS:000321736900019
J	Blaimer, BB; Fisher, BL				Blaimer, Bonnie B.; Fisher, Brian L.			How Much Variation Can One Ant Species Hold? Species Delimitation in the Crematogaster kelleri-Group in Madagascar	PLOS ONE			English	Article							HYMENOPTERA; EVOLUTION; BIOGEOGRAPHY; PHYLOGENY; DNA; NUMBER; TAXA	We investigated the species-level taxonomy of the Malagasy Crematogaster (Crematogaster) kelleri-group and an additional more distantly related species of the same subgenus. Morphological data from worker, queen and male ants, as well as genetic data from three nuclear genes (long wavelength rhodopsin, arginine kinase and carbomoylphosphate synthase) and one mitochondrial marker (cytochrome oxidase I) led to the recognition of six species. Within the C. kelleri-group, three new species are described: C. hazolava Blaimer sp. n., C. hafahafa Blaimer sp. n. and C. tavaratra Blaimer sp. n. The previously described taxa C. kelleri Forel and C. madagascariensis Andre are validated by our analysis. Conversely, our data suggests synonymy of C. adrepens Forel (with C. kelleri) and C. gibba Emery (with C. madagascariensis). A more distantly related and phylogenetically isolated species, C. tsisitsilo Blaimer sp. n., is further described. We report high levels of morphological and molecular variation in C. kelleri and illustrate that this variation can be explained partly by geography. Species descriptions, images, distribution maps and identification keys based on worker ants, as well as on queen and male ants where available, are presented for all six species. Our work highlights the elevated species richness of Crematogaster ants throughout Madagascar's humid forests, especially in the far northern tip of the island, and the need to use multiple data sources to ensure clear demarcation of this diversity.	[Blaimer, Bonnie B.] Smithsonian Inst, Dept Entomol, Washington, DC 20560 USA; [Blaimer, Bonnie B.; Fisher, Brian L.] Calif Acad Sci, Dept Entomol, San Francisco, CA 94118 USA; [Blaimer, Bonnie B.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA	Smithsonian Institution; Smithsonian National Museum of Natural History; California Academy of Sciences; University of California System; University of California Davis	Blaimer, BB (corresponding author), Smithsonian Inst, Dept Entomol, NHB 169, Washington, DC 20560 USA.	bonnieblaimer@gmail.com	Fisher, Brian L./S-9374-2019	Fisher, Brian/0000-0002-4653-3270	National Science Foundation [DEB-0072713, DEB-0344731, DEB-0842395, DEB-0842204, DEB-1107515]; Entomology Department at UC Davis; National Geographic Society [W173-11]; American Philosophical Society; Direct For Biological Sciences [0842204, 0842395] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Entomology Department at UC Davis; National Geographic Society(National Geographic Society); American Philosophical Society; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was funded by the National Science Foundation (www.nsf.gov; grants DEB-0072713, DEB-0344731, DEB-0842395 to B.L.F., DEB-0842204 to P.S. Ward and DEB-1107515 to B.B.B. and P.S. Ward), the Entomology Department at UC Davis (entomology.ucdavis.edu; B.B.B.), the National Geographic Society (www.nationalgeographic.com; W173-11 to B.B.B.) and the American Philosophical Society (www.amphilsoc.org; Lewis & Clark grant to B.B.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre Ernest, 1887, Revue d'Entomologie, Vvi, P280; Blaimer BB, 2010, ZOOTAXA, P1; Blaimer BB, 2012, ZOOTAXA, P47; Blaimer BB, 2012, MOL PHYLOGENET EVOL, V65, P421, DOI 10.1016/j.ympev.2012.06.028; Blaimer BB, 2012, ZOOKEYS, P23, DOI 10.3897/zookeys.199.2631; Blaimer BB, 2012, SYST ENTOMOL, V37, P240, DOI 10.1111/j.1365-3113.2011.00609.x; BOLTON B, 2012, BOLTONS CATALOGUE SY; Bolton Barry, 1995, P1; Brady SG, 2006, P NATL ACAD SCI USA, V103, P18172, DOI 10.1073/pnas.0605858103; Buhay JE, 2009, J CRUSTACEAN BIOL, V29, P96, DOI 10.1651/08-3020.1; Drescher J, 2007, MOL ECOL, V16, P1453, DOI 10.1111/j.1365-294X.2007.03260.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emery C., 1922, Genera Insectorum Fasc Bruxelles, V174, P95; Emery C., 1894, ANN SOC ENTOMOLOGIQU, V63, P67, DOI DOI 10.5281/ZENODO.25444; Fisher B., 2003, NATURAL HIST MADAGAS, P811; FISHER BL, 2008, PAYSAGE NATURELS BIO, P183; Fisher BL, 2008, PAYSAGE NATURELS BIO, P249; Fisher Brian L., 2005, Proceedings of the California Academy of Sciences, V56, P86; Forel A, 1891, HIST PHYS NATURELLE, pv +237; Gautier L., 2003, NATURAL HIST MADAGAS, P229; International Commission on Zoological Nomenclature, 1999, INT COD ZOOL NOM VER; Kremen C, 2008, SCIENCE, V320, P222, DOI 10.1126/science.1155193; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lucky A, 2011, MOL PHYLOGENET EVOL, V59, P281, DOI 10.1016/j.ympev.2011.03.004; Maddison WP, 2009, MESQUITE MODULAR SYS; Miller M.A., 2010, P GAT COMP ENV WORKS; R Core Team, 2018, R LANG ENV STAT COMP; Rambaut A., 2007, TRACER V1 4; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schatz GE, 2012, GAZETTEER MALAGASY B; Smith MA, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-31; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Suarez AV, 2008, MOL ECOL, V17, P351, DOI 10.1111/j.1365-294X.2007.03456.x; Suhr EL, 2011, EVOL APPL, V4, P471, DOI 10.1111/j.1752-4571.2010.00161.x; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tsutsui ND, 2003, CONSERV BIOL, V17, P48, DOI 10.1046/j.1523-1739.2003.02018.x; Ward PS, 2010, ANT ECOLOGY, P3; Ward PS, 2010, SYST BIOL, V59, P342, DOI 10.1093/sysbio/syq012; Ward PS, 2005, SYST ENTOMOL, V30, P310, DOI 10.1111/j.1365-3113.2004.00281.x; Wheeler W. M., 1922, Bulletin of the American Museum of Natural History, V45, P1005; WILGENBUSCH JC, 2004, AWTY SYSTEM GRAPHICA; Zwickl DJ., 2006, THESIS; [No title captured]	44	12	13	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68082	10.1371/journal.pone.0068082	http://dx.doi.org/10.1371/journal.pone.0068082			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874503	gold, Green Submitted, Green Published			2022-12-27	WOS:000321736900053
J	Li, ZS; Song, Y; Xing, R; Yu, HY; Zhang, YY; Li, ZJ; Gao, W				Li, Zongshi; Song, Yao; Xing, Rui; Yu, Haiyi; Zhang, Youyi; Li, Zijian; Gao, Wei			Heat Shock Protein 70 Acts as a Potential Biomarker for Early Diagnosis of Heart Failure	PLOS ONE			English	Article							VENTRICULAR DYSFUNCTION; TRANSGENIC MICE; SHOCK PROTEINS; RAT; EXPRESSION; MANAGEMENT; SEVERITY; RELEASE; CELLS	Early identification for heart failure (HF) may be useful for disease modifying treatment in order to reduce heart disease progression or even to reverse it. In our previous studies, we have revealed a group of heat shock proteins (HSPs) which might be related to neonatal rat cardiomyocyte hypertrophy by proteomic approach. Here, we confirm that HSPs, including HSP27 and HSP70, altered in the early stage of cardiac remodeling in vivo animal model. Furthermore, plasma concentrations of those HSPs and their potential screening value were evaluated at different stages in 222 patient subjects. Plasma HSP27, HSP70 and HSP90 were measured using enzyme-linked immunosorbent assay. Results indicate that HSP70 was positively correlated to the severity (progression) of HF (r = 0.456, p<0.001). The area under the rate of change (ROC) curve was 0.601 (p = 0.017) in patients with stage B HF and 0.835 (p<0.001) in those with stage C HF. However, HSP27 and HSP90 did not display significant changes in any stage of HF in this study. Taken together, plasma concentrations of HSP70 elevated with the progression of HF and might act as a potential screening biomarker for early diagnosis of HF.	[Li, Zijian] Peking Univ, Dept Cardiol, Hosp 3, Beijing, Peoples R China	Peking University	Li, ZJ (corresponding author), Peking Univ, Dept Cardiol, Hosp 3, Beijing, Peoples R China.	lizijian@bjmu.edu.cn; dr_gaowei@medmail.com.cn			National Natural Science Foundation of China [81270157, 81070078]; Major State Basic Research Development Program of China (973 Program) [2007CB512107, 2011CB503903]; Beijing Municipal Natural Science Foundation [7102158]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by grants from the National Natural Science Foundation of China (81270157 and 81070078), Major State Basic Research Development Program of China (973 Program, 2007CB512107 and 2011CB503903) and Beijing Municipal Natural Science Foundation (7102158). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CORNELUSSEN R, 1994, AM J PHYSIOL-HEART C, V267, pH1941, DOI 10.1152/ajpheart.1994.267.5.H1941; CURRIE RW, 1988, CIRC RES, V63, P543, DOI 10.1161/01.RES.63.3.543; Dybdahl B, 2002, CIRCULATION, V105, P685, DOI 10.1161/hc0602.103617; Fox K, 2006, EUR HEART J, V27, P1341, DOI 10.1093/eurheartj/ehl001; Genth-Zotz S, 2004, INT J CARDIOL, V96, P397, DOI 10.1016/j.ijcard.2003.08.008; Giannessi D, 2007, CELL STRESS CHAPERON, V12, P265, DOI 10.1379/CSC-272.1; HIGHTOWER LE, 1989, J CELL PHYSIOL, V138, P257, DOI 10.1002/jcp.1041380206; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; KNOWLTON AA, 1991, J CLIN INVEST, V88, P2018, DOI 10.1172/JCI115529; Latchman DS, 2001, CARDIOVASC RES, V51, P637, DOI 10.1016/S0008-6363(01)00354-6; Li ZJ, 2006, CHEM RES CHINESE U, V22, P319, DOI 10.1016/S1005-9040(06)60107-4; Li ZJ, 2009, PROTEOM CLIN APPL, V3, P1407, DOI 10.1002/prca.200900029; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; Meng XZ, 1996, CARDIOVASC RES, V32, P374, DOI 10.1016/0008-6363(96)00078-8; MOALIC JM, 1989, J HYPERTENS, V7, P195; Niizeki T, 2008, AM J CARDIOL, V102, P606, DOI 10.1016/j.amjcard.2008.04.030; Rauchhaus M, 2000, CIRCULATION, V102, P3060; Sivasubramanian N, 2001, CIRCULATION, V104, P826, DOI 10.1161/hc3401.093154; St Rammos K, 2002, CARDIOVASC SURG, V10, P228; Stuhlmeier KM, 2000, EUR J BIOCHEM, V267, P1161, DOI 10.1046/j.1432-1327.2000.01112.x; Tanonaka Kouichi, 2004, Nihon Yakurigaku Zasshi, V123, P71; Tanwar V, 2010, J CARDIOVASC PHARM, V55, P377, DOI 10.1097/FJC.0b013e3181d3da01; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Trost SU, 1998, J CLIN INVEST, V101, P855, DOI 10.1172/JCI265; Tsutsui H, 2001, CARDIOVASC RES, V49, P103, DOI 10.1016/S0008-6363(00)00197-8; WELCH WJ, 1993, SCI AM, V268, P56, DOI 10.1038/scientificamerican0593-56; Zhang LY, 2011, CARDIOVASC RES, V89, P148, DOI 10.1093/cvr/cvq266	27	31	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e67964	10.1371/journal.pone.0067964	http://dx.doi.org/10.1371/journal.pone.0067964			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874478	Green Published, gold, Green Submitted			2022-12-27	WOS:000321736900041
J	Sobenin, IA; Sazonova, MA; Postnov, AY; Salonen, JT; Bobryshev, YV; Orekhov, AN				Sobenin, Igor A.; Sazonova, Margarita A.; Postnov, Anton Y.; Salonen, Jukka T.; Bobryshev, Yuri V.; Orekhov, Alexander N.			Association of Mitochondrial Genetic Variation with Carotid Atherosclerosis	PLOS ONE			English	Article							HEREDITARY OPTIC NEUROPATHY; DNA G13513A MUTATION; CYTOCHROME-B GENE; EXERCISE INTOLERANCE; SPORADIC PATIENT; POINT MUTATIONS; LEIGH-SYNDROME; RIBOSOMAL-RNA; COMPLEX-I; POPULATION	In human pathology, several diseases are associated with somatic mutations in the mitochondrial genome (mtDNA). Even though mitochondrial dysfunction leads to increased oxidative stress, the role of mitochondrial mutations in atherosclerosis has not received much attention so far. In this study we analyzed the association of mitochondrial genetic variation with the severity of carotid atherosclerosis, as assessed by carotid intima-media thickness (cIMT) and the presence of coronary heart disease (CHD) in 190 subjects from Moscow, Russia, a population with high CHD occurrence. cIMT was measured by high-resolution B-mode ultrasonography and mtDNA heteroplasmies by a pyrosequencing-based method. We found that heteroplasmies for several mutations in the mtDNA in leukocytes, including C3256T, T3336C, G12315A, G13513A, G14459A, G14846A, and G15059A mutations, were significantly (p<0.001) associated with both the severity of carotid atherosclerosis and the presence of CHD. These findings indicate that somatic mitochondrial mutations have a role in the development of atherosclerosis.	[Sobenin, Igor A.; Postnov, Anton Y.] Russian Cardiol Res & Prod Complex, Moscow, Russia; [Sobenin, Igor A.; Sazonova, Margarita A.; Orekhov, Alexander N.] Inst Gen Pathol & Pathophysiol, Moscow, Russia; [Salonen, Jukka T.] MAS Metab Analyt Serv Oy, Helsinki, Finland; [Salonen, Jukka T.] Univ Helsinki, Hjelt Inst, Helsinki, Finland; [Bobryshev, Yuri V.; Orekhov, Alexander N.] Skolkovo Innovat Ctr, Atherosclerosis Res Inst, Moscow, Russia; [Bobryshev, Yuri V.] Univ New S Wales, Fac Med, Kensington, NSW 2033, Australia; [Bobryshev, Yuri V.] St Vincents Hosp Sydney, Kensington, NSW, Australia	National Medical Research Center of Cardiology; Russian Academy of Medical Sciences; Institute of General Pathology & Pathophysiology, RAMS; University of Helsinki; University of New South Wales Sydney	Bobryshev, YV (corresponding author), Skolkovo Innovat Ctr, Atherosclerosis Res Inst, Moscow, Russia.	y.bobryshev@unsw.edu.au	Orekhov, Alexander N/J-4838-2013; Sobenin, Igor A/J-4282-2013; Bobryshev, Yuri/J-2838-2013; Sazonova, Margarita/O-9685-2017	Orekhov, Alexander N/0000-0002-6495-1628; Sobenin, Igor A/0000-0003-0978-6444; Postnov, Anton/0000-0002-2501-7269; Sazonova, Margarita/0000-0002-8610-4593	Russian Ministry of Education and Science; TEKES, Finland	Russian Ministry of Education and Science(Ministry of Education and Science, Russian Federation); TEKES, Finland(Finnish Funding Agency for Technology & Innovation (TEKES))	The authors thank the Russian Ministry of Education and Science, and TEKES, Finland, for support of our study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Alderborn A, 2000, GENOME RES, V10, P1249, DOI 10.1101/gr.10.8.1249; Andreu AL, 1999, ANN NEUROL, V45, P127, DOI 10.1002/1531-8249(199901)45:1<127::AID-ART20>3.0.CO;2-Y; Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404; Baldassarre D, 2010, EUR HEART J, V31, P614, DOI 10.1093/eurheartj/ehp496; Baracca A, 2000, J BIOL CHEM, V275, P4177, DOI 10.1074/jbc.275.6.4177; Chen DC, 2003, J MOL DIAGN, V5, P243, DOI 10.1016/S1525-1578(10)60481-3; Chol M, 2003, J MED GENET, V40, P188, DOI 10.1136/jmg.40.3.188; Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004; Filosto M, 2003, ANN NEUROL, V54, P524, DOI 10.1002/ana.10709; Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835; Funalot B, 2002, ANN NEUROL, V52, P374, DOI 10.1002/ana.10299; Galkina E, 2007, CURR DRUG TARGETS, V8, P1239, DOI 10.2174/138945007783220650; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Gropman A, 2004, AM J MED GENET A, V124A, P377, DOI 10.1002/ajmg.a.20456; Han CB, 2005, WORLD J GASTROENTERO, V11, P31, DOI 10.3748/wjg.v11.i1.31; Horvath R, 2002, J MED GENET, V39, P812, DOI 10.1136/jmg.39.11.812; Jeppesen TD, 2003, J NEUROL SCI, V214, P17, DOI 10.1016/S0022-510X(03)00168-0; Karadimas CL, 2002, NEUROMUSCULAR DISORD, V12, P865, DOI 10.1016/S0960-8966(02)00072-X; Kim DS, 2002, J KOREAN MED SCI, V17, P103, DOI 10.3346/jkms.2002.17.1.103; Kirby DM, 2003, ANN NEUROL, V54, P473, DOI 10.1002/ana.10687; Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478; Levinger L, 2004, NUCLEIC ACIDS RES, V32, P5430, DOI 10.1093/nar/gkh884; Lim BC, 2009, J CHILD NEUROL, V24, P828, DOI 10.1177/0883073808331085; Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015; Matsunaga H, 2001, DIABETES CARE, V24, P500, DOI 10.2337/diacare.24.3.500; Meierhofer D, 2005, MITOCHONDRION, V5, P282, DOI 10.1016/j.mito.2005.06.001; MORAES CT, 1993, J CLIN INVEST, V92, P2906, DOI 10.1172/JCI116913; Nishigaki Y, 2003, J CLIN INVEST, V111, P1913, DOI 10.1172/JCI200317828; Rossmanith W, 1998, FEBS LETT, V433, P269, DOI 10.1016/S0014-5793(98)00928-4; SALONEN R, 1995, CIRCULATION, V92, P1758, DOI 10.1161/01.CIR.92.7.1758; Sazonova M, 2009, ATHEROSCLEROSIS, V204, P184, DOI 10.1016/j.atherosclerosis.2008.09.001; Shanske S, 2008, ARCH NEUROL-CHICAGO, V65, P368, DOI 10.1001/archneurol.2007.67; Sinclair A, 2003, ANTIMICROB AGENTS CH, V47, P3620, DOI 10.1128/AAC.47.11.3620-3622.2003; Sobenin IA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046573; Sobenin IA, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/832464; Solano A, 2003, ANN NEUROL, V54, P527, DOI 10.1002/ana.10682; Sudo A, 2004, J HUM GENET, V49, P92, DOI 10.1007/s10038-003-0116-1; Tanimoto H, 2004, ACTA OTO-LARYNGOL, V124, P258, DOI 10.1080/00016480310015740; Tarnopolsky MA, 2004, AM J MED GENET A, V124A, P372, DOI 10.1002/ajmg.a.20449; Valente L, 2009, BBA-BIOENERGETICS, V1787, P491, DOI 10.1016/j.bbabio.2008.10.001; Varlamov DA, 2002, HUM MOL GENET, V11, P1797, DOI 10.1093/hmg/11.16.1797; Wong LJC, 2004, ELECTROPHORESIS, V25, P2602, DOI 10.1002/elps.200406016; Yamagata K, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000019772.17954.F8	43	33	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68070	10.1371/journal.pone.0068070	http://dx.doi.org/10.1371/journal.pone.0068070			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874496	gold, Green Published, Green Submitted			2022-12-27	WOS:000321736900049
J	Pontiroli, A; Khera, TT; Oakley, BB; Mason, S; Dowd, SE; Travis, ER; Erenso, G; Aseffa, A; Courtenay, O; Wellington, EMH				Pontiroli, Alessandra; Khera, Tanya T.; Oakley, Brian B.; Mason, Sam; Dowd, Scot E.; Travis, Emma R.; Erenso, Girum; Aseffa, Abraham; Courtenay, Orin; Wellington, Elizabeth M. H.			Prospecting Environmental Mycobacteria: Combined Molecular Approaches Reveal Unprecedented Diversity	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; WATER DISTRIBUTION-SYSTEMS; NONTUBERCULOUS MYCOBACTERIA; MICROBIAL COMMUNITIES; GENUS MYCOBACTERIUM; RARE BIOSPHERE; SEQUENCE DATA; FOREST SOIL; AVIUM; IDENTIFICATION	Background: Environmental mycobacteria (EM) include species commonly found in various terrestrial and aquatic environments, encompassing animal and human pathogens in addition to saprophytes. Approximately 150 EM species can be separated into fast and slow growers based on sequence and copy number differences of their 16S rRNA genes. Cultivation methods are not appropriate for diversity studies; few studies have investigated EM diversity in soil despite their importance as potential reservoirs of pathogens and their hypothesized role in masking or blocking M. bovis BCG vaccine. Methods: We report here the development, optimization and validation of molecular assays targeting the 16S rRNA gene to assess diversity and prevalence of fast and slow growing EM in representative soils from semi tropical and temperate areas. New primer sets were designed also to target uniquely slow growing mycobacteria and used with PCR-DGGE, tag-encoded Titanium amplicon pyrosequencing and quantitative PCR. Results: PCR-DGGE and pyrosequencing provided a consensus of EM diversity; for example, a high abundance of pyrosequencing reads and DGGE bands corresponded to M. moriokaense, M. colombiense and M. riyadhense. As expected pyrosequencing provided more comprehensive information; additional prevalent species included M. chlorophenolicum, M. neglectum, M. gordonae, M. aemonae. Prevalence of the total Mycobacterium genus in the soil samples ranged from 2.3x10(7) to 2.7x10(8) gene targets g(-1); slow growers prevalence from 2.9x10(5) to 1.2x10(7) cells g(-1). Conclusions: This combined molecular approach enabled an unprecedented qualitative and quantitative assessment of EM across soil samples. Good concordance was found between methods and the bioinformatics analysis was validated by random resampling. Sequences from most pathogenic groups associated with slow growth were identified in extenso in all soils tested with a specific assay, allowing to unmask them from the Mycobacterium whole genus, in which, as minority members, they would have remained undetected.	[Pontiroli, Alessandra; Khera, Tanya T.; Mason, Sam; Travis, Emma R.; Courtenay, Orin; Wellington, Elizabeth M. H.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Oakley, Brian B.] USDA ARS, RBRRC, Athens, GA 30613 USA; [Dowd, Scot E.] Mol Res LP MR DNA, Shallowater, TX USA; [Erenso, Girum; Aseffa, Abraham] Armauer Hansen Res Inst, Addis Ababa, Ethiopia	University of Warwick; United States Department of Agriculture (USDA)	Pontiroli, A (corresponding author), Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England.	alessandra.pontiroli@gmail.com	Oakley, Brian Oakley B/AAG-4015-2019; Aseffa, Abraham/J-3248-2016; Dowd, Scot E/M-5386-2017	Aseffa, Abraham/0000-0002-8028-1150; Dowd, Scot E/0000-0002-6296-1427; Oakley, Brian/0000-0003-2098-6439; Wellington, ELizabeth/0000-0002-4329-0699	Biotechnology and Biological Sciences Research Council [BBSRCBB/E020925/]; BBSRC [BB/E020925/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E020925/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by Biotechnology and Biological Sciences Research Council BBSRCBB/E020925/ grant to OC and EMHW. The authors wish to thank Catriona Munro for her technical help. A Material Transfer Agreement was made with the Institute of Biodiversity and Conservation, Ethiopia, for export of soils. A DEFRA License to import, move and keep prohibited soil (License No. PHL 208/6138) was issued. The funders had no role in study design, data collection or preparation of the manuscript.	Alexander K, 2010, EMERG INFECT DIS; Amend AS, 2010, MOL ECOL, V19, P5555, DOI 10.1111/j.1365-294X.2010.04898.x; Bailey MT, 2010, BRAIN BEHAV IMMUN, V24, P577, DOI 10.1016/j.bbi.2009.12.010; Calvo-Bado LA, 2011, ISME J; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Conlan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047075; Cook JL, 2010, BRIT MED BULL, V96, P45, DOI 10.1093/bmb/ldq035; Covert TC, 1999, APPL ENVIRON MICROB, V65, P2492; Devulder G, 2005, INT J SYST EVOL MICR, V55, P293, DOI 10.1099/ijs.0.63222-0; Dowd SE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-43; Drewe JA, 2009, FEMS MICROBIOL ECOL, V67, P320, DOI 10.1111/j.1574-6941.2008.00618.x; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; Falkinham JO, 2009, J APPL MICROBIOL, V107, P356, DOI 10.1111/j.1365-2672.2009.04161.x; Falkinham JO, 1996, CLIN MICROBIOL REV, V9, P177, DOI 10.1128/CMR.9.2.177; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Ghaemi E., 2006, Eastern Mediterranean Health Journal, V12, P280; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Heller LC, 2008, J CLIN MICROBIOL, V46, P2092, DOI 10.1128/JCM.02001-07; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Iivanainen E, 1999, J APPL MICROBIOL, V86, P673, DOI 10.1046/j.1365-2672.1999.00711.x; IIVANAINEN E, 1995, J APPL BACTERIOL, V78, P663, DOI 10.1111/j.1365-2672.1995.tb03113.x; Jacobs J, 2009, APPL ENV MICROBIOLOG, V75; Jordao CM, 2009, FOOD MICROBIOL, V26, P658, DOI 10.1016/j.fm.2009.04.005; KAMALA T, 1994, APPL ENVIRON MICROB, V60, P2180, DOI 10.1128/AEM.60.6.2180-2183.1994; Kirschner RA, 1999, FEMS MICROBIOL ECOL, V30, P327, DOI 10.1111/j.1574-6941.1999.tb00660.x; Kopecky J, 2011, SOIL BIOL BIOCHEM, V43, P697, DOI 10.1016/j.soilbio.2010.11.033; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Le Dantec C, 2002, APPL ENVIRON MICROB, V68, P5318, DOI 10.1128/AEM.68.11.5318-5325.2002; Leclerc MC, 2003, ANTON LEEUW INT J G, V83, P265, DOI 10.1023/A:1023327929535; Leys NM, 2005, FEMS MICROBIOL ECOL, V51, P375, DOI 10.1016/j.femsec.2004.09.015; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Marsollier L, 2002, APPL ENVIRON MICROB, V68, P4623, DOI 10.1128/AEM.68.9.4623-4628.2002; Mignard S, 2008, INT J SYST EVOL MICR, V58, P1432, DOI 10.1099/ijs.0.65658-0; Murcia MI, 2006, INT J SYST EVOL MICR, V56, P2049, DOI 10.1099/ijs.0.64190-0; Muyzer G, 1998, ANTON LEEUW INT J G, V73, P127, DOI 10.1023/A:1000669317571; Niva M, 2006, BOREAL ENVIRON RES, V11, P45; Pontiroli A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017916; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; ROGALL T, 1990, INT J SYST BACTERIOL, V40, P323, DOI 10.1099/00207713-40-4-323; Salah IB, 2009, CLIN MICROBIOL INFEC, V15, P894, DOI 10.1111/j.1469-0691.2009.03011.x; Schloss PD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008230; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; September SM, 2004, APPL ENVIRON MICROB, V70, P7571, DOI 10.1128/AEM.70.12.7571-7573.2004; Stackebrandt E, 2002, INT J SYST EVOL MICR, V52, P1043, DOI [10.1099/ijs.0.02360-0, 10.1099/00207713-52-3-1043]; STAHL DA, 1990, J BACTERIOL, V172, P116, DOI 10.1128/JB.172.1.116-124.1990; STALEY JT, 1985, ANNU REV MICROBIOL, V39, P321, DOI 10.1146/annurev.mi.39.100185.001541; Thorel MF, 2004, FEMS MICROBIOL ECOL, V49, P343, DOI 10.1016/j.femsec.2004.04.016; Tortoli E, 2003, CLIN MICROBIOL REV, V16, P319, DOI 10.1128/CMR.16.2.319-354.2003; Tortoli E, 2010, J CLIN MICROBIOL, V48, P307, DOI 10.1128/JCM.01536-09; Torvinen E, 2010, J MICROBIOL METH, V82, P78, DOI 10.1016/j.mimet.2010.04.007; Uyttebroek M, 2006, ENVIRON MICROBIOL, V8, P836, DOI 10.1111/j.1462-2920.2005.00970.x; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Wagner D, 2004, INFECTION, V32, P257, DOI 10.1007/s15010-004-4001-4; Young JS, 2005, APPL ENVIRON MICROB, V71, P1946, DOI 10.1128/AEM.71.4.1946-1952.2005	62	25	25	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e68648	10.1371/journal.pone.0068648	http://dx.doi.org/10.1371/journal.pone.0068648			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874704	Green Published, gold, Green Submitted			2022-12-27	WOS:000324146200024
J	Toomey, P; Kodumudi, K; Weber, A; Kuhn, L; Moore, E; Sarnaik, AA; Pilon-Thomas, S				Toomey, Paul; Kodumudi, Krithika; Weber, Amy; Kuhn, Lisa; Moore, Ellen; Sarnaik, Amod A.; Pilon-Thomas, Shari			Intralesional Injection of Rose Bengal Induces a Systemic Tumor-Specific Immune Response in Murine Models of Melanoma and Breast Cancer	PLOS ONE			English	Article							IN-TRANSIT MELANOMA; METASTATIC MELANOMA; MALIGNANT-MELANOMA; INTRATUMORAL INJECTION; DENDRITIC CELLS; BCG; IMMUNOTHERAPY; THERAPY; INTERLEUKIN-2; EXPERIENCE	Intralesional (IL) injection of PV-10 has shown to induce regression of both injected and non-injected lesions in patients with melanoma. To determine an underlying immune mechanism, the murine B16 melanoma model and the MT-901 breast cancer model were utilized. In BALB/c mice bearing MT-901 breast cancer, injection of PV-10 led to regression of injected and untreated contralateral subcutaneous lesions. In a murine model of melanoma, B16 cells were injected into C57BL/6 mice to establish one subcutaneous tumor and multiple lung lesions. Treatment of the subcutaneous lesion with a single injection of IL PV-10 led to regression of the injected lesion as well as the distant B16 melanoma lung metastases. Antitumor immune responses were measured in splenocytes collected from mice treated with IL PBS or PV-10. Splenocytes isolated from tumor bearing mice treated with IL PV-10 demonstrated enhanced tumor-specific IFN-gamma production compared to splenocytes from PBS-treated mice in both models. In addition, a significant increase in lysis of B16 cells by T cells isolated after PV-10 treatment was observed. Transfer of T cells isolated from tumor-bearing mice treated with IL PV10 led to tumor regression in mice bearing B16 melanoma. These studies establish that IL PV-10 therapy induces tumor-specific T cell-mediated immunity in multiple histologic subtypes and support the concept of combining IL PV10 with immunotherapy for advanced malignancies.	[Toomey, Paul; Kodumudi, Krithika; Weber, Amy; Kuhn, Lisa; Moore, Ellen; Sarnaik, Amod A.; Pilon-Thomas, Shari] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Program Immunol, Tampa, FL 33612 USA; [Sarnaik, Amod A.; Pilon-Thomas, Shari] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Cutaneous Oncol Program, Tampa, FL 33612 USA; [Toomey, Paul] Univ S Florida, Coll Med, Tampa, FL USA; [Sarnaik, Amod A.; Pilon-Thomas, Shari] Univ S Florida, Dept Oncol Sci, Tampa, FL USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Pilon-Thomas, S (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Program Immunol, Tampa, FL 33612 USA.	shari.pilon-thomas@moffitt.org	Sarnaik, Amod/W-5536-2019		Provectus Inc.; NATIONAL CANCER INSTITUTE [P30CA076292] Funding Source: NIH RePORTER	Provectus Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a sponsored research agreement from Provectus Inc. to the H Lee Moffitt Cancer Center and Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bornstein R S, 1973, Natl Cancer Inst Monogr, V39, P213; Boyd KU, 2011, J SURG ONCOL, V104, P711, DOI 10.1002/jso.21968; COHEN MH, 1991, CANCER IMMUNOL IMMUN, V32, P315, DOI 10.1007/BF01789050; den Brok MHMGM, 2004, CANCER RES, V64, P4024, DOI 10.1158/0008-5472.CAN-03-3949; FELIX EL, 1978, ARCH SURG-CHICAGO, V113, P893; Foote MC, 2010, MELANOMA RES, V20, P48, DOI 10.1097/CMR.0b013e328331caa2; Guo J, 2007, INT J CANCER, V120, P2418, DOI 10.1002/ijc.22551; HARPER JR, 1982, LANCET, V1, P403; Hofmann MA, 2008, J IMMUNOTHER, V31, P520, DOI 10.1097/CJI.0b013e318174a4df; Kaufman HL, 2010, ANN SURG ONCOL, V17, P718, DOI 10.1245/s10434-009-0809-6; Kidner TB, 2012, J IMMUNOTHER, V35, P716, DOI 10.1097/CJI.0b013e31827457bd; Kodumudi KN, 2012, J IMMUNOL, V189, P5147, DOI 10.4049/jimmunol.1200274; Machado LM, 2009, CORNEA, V28, P732, DOI 10.1097/ICO.0b013e3181930c03; MASTRANGELO MJ, 1976, CANCER, V37, P684, DOI 10.1002/1097-0142(197602)37:2<684::AID-CNCR2820370212>3.0.CO;2-Y; MCKHANN CF, 1975, CANCER-AM CANCER SOC, V35, P514, DOI 10.1002/1097-0142(197502)35:2<514::AID-CNCR2820350233>3.0.CO;2-F; MORTON DL, 1974, ANN SURG, V180, P635, DOI 10.1097/00000658-197410000-00029; Mousavi H, 2006, MELANOMA RES; NORN MS, 1970, ACTA OPHTHALMOL, V48, P546; Pilon-Thomas S, 2006, J IMMUNOTHER, V29, P381, DOI 10.1097/01.cji.0000199199.20717.67; Pilon-Thomas S, 2012, J IMMUNOTHER, V35, P615, DOI 10.1097/CJI.0b013e31826e8f5f; Pilon-Thomas S, 2010, J IMMUNOL, V184, P3442, DOI 10.4049/jimmunol.0904114; PORTELANCE V, 1976, CANCER IMMUNOL IMMUN, V1, P63; ROBINSON JC, 1977, J SURG ONCOL, V9, P587, DOI 10.1002/jso.2930090609; ROSENBERG SA, 1976, MED CLIN N AM, V60, P419, DOI 10.1016/S0025-7125(16)31889-2; SOPKOVA B, 1976, NEOPLASMA, V23, P421; Thompson JF, 2008, MELANOMA RES, V18, P405, DOI 10.1097/CMR.0b013e32831328c7; Triozzi PL, 2000, CANCER-AM CANCER SOC, V89, P2646, DOI 10.1002/1097-0142(20001215)89:12<2646::AID-CNCR18>3.0.CO;2-A; Weide B, 2010, CANCER-AM CANCER SOC, V116, P4139, DOI 10.1002/cncr.25156	28	51	56	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e68561	10.1371/journal.pone.0068561	http://dx.doi.org/10.1371/journal.pone.0068561			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23874673	Green Published, Green Submitted, gold			2022-12-27	WOS:000322000600012
J	Cao, JR; Wang, SL; Wang, J; Cui, WY; Nesil, T; Vigorito, M; Chang, SL; Li, MD				Cao, Junran; Wang, Shaolin; Wang, Ju; Cui, Wenyan; Nesil, Tanseli; Vigorito, Michael; Chang, Sulie L.; Li, Ming D.			RNA Deep Sequencing Analysis Reveals That Nicotine Restores Impaired Gene Expression by Viral Proteins in the Brains of HIV-1 Transgenic Rats	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; ACETYLCHOLINE-RECEPTOR; MODULATION; NEUROPROTECTION; INVOLVEMENT; GLUTATHIONE; ALPHA-7; REQUIREMENT; DYSFUNCTION; ACTIVATION	Persons infected with HIV-1 often develop neurologic disorders despite receiving highly active anti-retroviral therapy. Although the underlying mechanism is largely undetermined, our previous RNA-seq-based study showed that the expression of many genes was altered in the central nervous system (CNS) of HIV-1 transgenic (HIV-1Tg) rats. Because nicotine, a natural agonist of nicotinic acetylcholine receptors, exhibits a neuroprotective effect, we presently tested the hypothesis that nicotine restores the expression of altered genes in the CNS of HIV-1Tg rats. Adult male HIV-1Tg and F344 control strain rats were injected with either nicotine (0.25 mg/kg) or saline subcutaneously twice a day for 17 days. Gene expression in the prefrontal cortex (PFC), dorsal hippocampus (HIP), and dorsal striatum (STR) was evaluated using the RNA deep sequencing technique. We found that about 20% of the altered genes in the HIV-1Tg rat were affected by nicotine in each brain region, with the expression of most restored. Analysis of the restored genes showed distinct pathways corrected by nicotine in different brain regions of HIV-1Tg rats. Specifically, the two most significantly restored pathways were Wnt/beta-catenin signaling and ephrin B signaling in the PFC, cAMP-responsive element-binding protein (CREB) signaling and glutathione metabolism pathway in the HIP, and tricarboxylic acid (TCA) cycle and calcium signaling in the STR. Together, our findings indicate that cholinergic modulators such as nicotine have beneficial effects on HIV-1-induced neurologic deficits.	[Cao, Junran; Wang, Shaolin; Wang, Ju; Cui, Wenyan; Nesil, Tanseli; Li, Ming D.] Univ Virginia, Dept Psychiat & Neurobehav Sci, Charlottesville, VA 22903 USA; [Wang, Ju] Tianjin Med Univ, Sch Biomed Engn, Tianjin, Peoples R China; [Cui, Wenyan] Zhejiang Univ, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China; [Vigorito, Michael; Chang, Sulie L.] Seton Hall Univ, Inst NeuroImmune Pharmacol, S Orange, NJ 07079 USA; [Vigorito, Michael] Seton Hall Univ, Dept Psychol, S Orange, NJ 07079 USA; [Chang, Sulie L.] Seton Hall Univ, Dept Biol Sci, S Orange, NJ 07079 USA	University of Virginia; Tianjin Medical University; Zhejiang University; Seton Hall University; Seton Hall University; Seton Hall University	Li, MD (corresponding author), Univ Virginia, Dept Psychiat & Neurobehav Sci, Charlottesville, VA 22903 USA.	ml2km@virginia.edu	Wang, Shaolin/M-2282-2013; Nesil, Tanseli/Q-4103-2019; Wang, Shaolin/FDL-8163-2022; Cao, Junran/E-7354-2013	Wang, Shaolin/0000-0003-0866-4584; Nesil, Tanseli/0000-0001-9952-8136; Wang, Shaolin/0000-0003-0866-4584; 	US National Institutes of Health [DA-013783, DA-016149, DA-026356]; NATIONAL CANCER INSTITUTE [P30CA044579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013783, K02DA016149, R01DA026356] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The project was supported, in part, by US National Institutes of Health grants DA-013783 to MDL, DA-016149 to SLC, and DA-026356 to SLC and MDL. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBUD RA, 1995, J INFECT DIS, V172, P859, DOI 10.1093/infdis/172.3.859; Agbottah E, 2006, VIROLOGY, V345, P373, DOI 10.1016/j.virol.2005.09.062; Ballester LY, 2012, J BIOL CHEM, V287, P3079, DOI 10.1074/jbc.M111.262543; Barbaro G, 2005, CURR PHARM DESIGN, V11, P1805, DOI 10.2174/1381612053764869; Bartus RT, 2000, EXP NEUROL, V163, P495, DOI 10.1006/exnr.2000.7397; BERGER JR, 1992, ANN NEUROL, V31, P34, DOI 10.1002/ana.410310107; Bito H, 2003, CELL CALCIUM, V34, P425, DOI 10.1016/S0143-4160(03)00140-4; BRACCI L, 1992, FEBS LETT, V311, P115, DOI 10.1016/0014-5793(92)81380-5; Cao JR, 2011, INT J NEUROPSYCHOPH, V14, P157, DOI 10.1017/S1461145710000179; Cataldo JK, 2010, J ALZHEIMERS DIS, V19, P465, DOI 10.3233/JAD-2010-1240; CIARDO A, 1993, EUR J NEUROSCI, V5, P1711, DOI 10.1111/j.1460-9568.1993.tb00238.x; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cui WY, 2012, AMINO ACIDS, V43, P1157, DOI 10.1007/s00726-011-1171-0; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; De Simone R, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-4; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; Del Valle L, 2006, FRONT BIOSCI-LANDMRK, V11, P718, DOI 10.2741/1830; Dieterich DC, 2008, PLOS BIOL, V6, P286, DOI 10.1371/journal.pbio.0060034; Farias GG, 2009, J BIOL CHEM, V284, P15857, DOI 10.1074/jbc.M808986200; Farr SA, 2002, AIDS RES HUM RETROV, V18, P1189, DOI 10.1089/08892220260387931; Feligioni M, 2003, J NEUROSCI, V23, P6810; Furey ML, 2011, CURR OPIN NEUROL, V24, P364, DOI 10.1097/WCO.0b013e328348bda5; Gianotti N, 2005, NEW MICROBIOL, V28, P281; Gilmartin MR, 2010, LEARN MEMORY, V17, P289, DOI 10.1101/lm.1597410; Giunta B, 2004, BRAIN RES BULL, V64, P165, DOI 10.1016/j.brainresbull.2004.06.008; Gonzalez-Lira B, 2006, NEUROSCI LETT, V394, P136, DOI 10.1016/j.neulet.2005.10.021; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Hernandez CM, 2012, CURR DRUG TARGETS, V13, P613, DOI 10.2174/138945012800398973; HERVE D, 1993, J NEUROSCI, V13, P2237, DOI 10.1523/jneurosci.13-05-02237.1993; Homji NF, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-3; Huang JY, 2009, J NEUROCHEM, V109, P1400, DOI 10.1111/j.1471-4159.2009.06061.x; Inestrosa NC, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-9; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; JONES DT, 1990, J BIOL CHEM, V265, P2671; Jones LE, 2005, B MATH BIOL, V67, P1227, DOI 10.1016/j.bulm.2005.01.006; Kennedy NJ, 2007, GENE DEV, V21, P2336, DOI 10.1101/gad.1563107; Krebs F C, 2000, Adv Pharmacol, V49, P315; Lashomb AL, 2009, J NEUROVIROL, V15, P14, DOI 10.1080/13550280802232996; LEE PN, 1994, NEUROEPIDEMIOLOGY, V13, P131, DOI 10.1159/000110372; Leslie FM, 2013, MOL PHARMACOL, V83, P753, DOI 10.1124/mol.112.083659; Li MD, 2004, MOL BRAIN RES, V132, P168, DOI 10.1016/j.molbrainres.2004.09.009; Li M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058745, 10.1371/journal.pone.0078500, 10.1371/journal.pone.0059582, 10.1371/journal.pone.0079955]; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Loram LC, 2010, BRAIN BEHAV IMMUN, V24, P959, DOI 10.1016/j.bbi.2010.03.008; Lucas S, 2001, Intensive Crit Care Nurs, V17, P155, DOI 10.1054/iccn.2000.1541; Martin HL, 2009, FASEB J, V23, P3263, DOI 10.1096/fj.08-125443; McArthur JC, 2003, J NEUROVIROL, V9, P205, DOI 10.1080/13550280390194109; MEISTER A, 1988, J BIOL CHEM, V263, P17205; Midde NM, 2011, PHARMACOL BIOCHEM BE, V98, P587, DOI 10.1016/j.pbb.2011.03.013; Mihailescu S, 2000, ARCH MED RES, V31, P131, DOI 10.1016/S0188-4409(99)00087-9; Montcouquiol M, 2006, ANNU REV NEUROSCI, V29, P363, DOI 10.1146/annurev.neuro.29.051605.112933; Nave KA, 2008, ANNU REV NEUROSCI, V31, P535, DOI 10.1146/annurev.neuro.30.051606.094309; Ohira K, 2009, CURR NEUROPHARMACOL, V7, P276, DOI 10.2174/157015909790031210; Pauly JR, 2004, ANN NY ACAD SCI, V1035, P316, DOI 10.1196/annals.1332.019; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pepeu G, 2010, CHEM-BIOL INTERACT, V187, P403, DOI 10.1016/j.cbi.2009.11.018; Phillis JW, 2004, BRAIN RES REV, V44, P13, DOI 10.1016/j.brainresrev.2003.10.002; Picciotto MR, 2002, J NEUROBIOL, V53, P641, DOI 10.1002/neu.10102; Pocernich CB, 2012, BBA-MOL BASIS DIS, V1822, P625, DOI 10.1016/j.bbadis.2011.10.003; Reid W, 2001, P NATL ACAD SCI USA, V98, P9271, DOI 10.1073/pnas.161290298; Riljak V, 2005, Prague Med Rep, V106, P329; Rock RB, 2008, J NEUROIMMUNE PHARM, V3, P143, DOI 10.1007/s11481-007-9098-7; Sarkar S, 2012, ALCOHOL CLIN EXP RES; SCHMIDBAUER M, 1992, NEUROPATH APPL NEURO, V18, P489, DOI 10.1111/j.1365-2990.1992.tb00816.x; Schulz JB, 2000, EUR J BIOCHEM, V267, P4904, DOI 10.1046/j.1432-1327.2000.01595.x; Sellin AK, 2008, CNS SPECTRUMS, V13, P985, DOI 10.1017/S1092852900014048; Sharifzadeh M, 2005, J NEUROCHEM, V95, P1078, DOI 10.1111/j.1471-4159.2005.03454.x; Sleasman John W., 2003, J ALLERGY CLIN IMM S, VIII, P582; Sopori M, 2002, NAT REV IMMUNOL, V2, P372, DOI 10.1038/nri803; Sopori ML, 1998, J NEUROIMMUNOL, V83, P148, DOI 10.1016/S0165-5728(97)00231-2; Swan GE, 2007, NEUROPSYCHOL REV, V17, P259, DOI 10.1007/s11065-007-9035-9; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Tawk M, 2011, J NEUROSCI, V31, P3729, DOI 10.1523/JNEUROSCI.4270-10.2011; Toledo EM, 2008, PROG NEUROBIOL, V86, P281, DOI 10.1016/j.pneurobio.2008.08.001; Tuesta LM, 2011, BIOCHEM PHARMACOL, V82, P984, DOI 10.1016/j.bcp.2011.06.026; Varela-Nallar L, 2010, P NATL ACAD SCI USA, V107, P21164, DOI 10.1073/pnas.1010011107; Vigano A, 2006, J PEDIATR-US, V148, P389, DOI 10.1016/j.jpeds.2005.11.037; Vigorito M, 2013, J NEUROVIRO IN PRESS; Vigorito M, 2007, J NEUROIMMUNE PHARM, V2, P319, DOI 10.1007/s11481-007-9078-y; Wei JX, 2011, INT J NEUROPSYCHOPH, V14, P91, DOI 10.1017/S1461145710000416; Wiley CA, 1998, BRAIN PATHOL, V8, P277; Xu JQ, 2009, J NEUROIMMUNE PHARM, V4, P200, DOI 10.1007/s11481-008-9136-0; Yu JW, 2008, ONCOGENE, V27, P6216, DOI 10.1038/onc.2008.299	85	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68517	10.1371/journal.pone.0068517	http://dx.doi.org/10.1371/journal.pone.0068517			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874651	Green Submitted, Green Published, gold			2022-12-27	WOS:000322064300041
J	Hoffman, JI; Thorne, MAS; McEwing, R; Forcada, J; Ogden, R				Hoffman, Joseph I.; Thorne, Michael A. S.; McEwing, Rob; Forcada, Jaume; Ogden, Rob			Cross-Amplification and Validation of SNPs Conserved over 44 Million Years between Seals and Dogs	PLOS ONE			English	Article							ANTARCTIC FUR SEALS; SINGLE-NUCLEOTIDE POLYMORPHISMS; GENOME; DISCOVERY; SELECTION; SUCCESS; MARKERS; LONG; WILD; NO	High-density SNP arrays developed for humans and their companion species provide a rapid and convenient tool for generating SNP data in closely-related non-model organisms, but have not yet been widely applied to phylogenetically divergent taxa. Consequently, we used the CanineHD BeadChip to genotype 24 Antarctic fur seal (Arctocephalus gazella) individuals. Despite seals and dogs having diverged around 44 million years ago, 33,324 out of 173,662 loci (19.2%) could be genotyped, of which 173 were polymorphic and clearly interpretable. Two SNPs were validated using KASP genotyping assays, with the resulting genotypes being 100% concordant with those obtained from the high-density array. Two loci were also confirmed through in silico visualisation after mapping them to the fur seal transcriptome. Polymorphic SNPs were distributed broadly throughout the dog genome and did not differ significantly in proximity to genes from either monomorphic SNPs or those that failed to cross-amplify in seals. However, the nearest genes to polymorphic SNPs were significantly enriched for functional annotations relating to energy metabolism, suggesting a possible bias towards conserved regions of the genome.	[Hoffman, Joseph I.] Univ Bielefeld, Dept Anim Behav, D-33615 Bielefeld, North Rhine Wes, Germany; [Thorne, Michael A. S.; Forcada, Jaume] British Antarctic Survey, Nat Environm Res Council, Cambridge CB3 0ET, England; [McEwing, Rob; Ogden, Rob] Royal Zool Soc Scotland, Wildgenes Lab, Edinburgh, Midlothian, Scotland	University of Bielefeld; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Hoffman, JI (corresponding author), Univ Bielefeld, Dept Anim Behav, D-33615 Bielefeld, North Rhine Wes, Germany.	joseph.hoffman@uni-bielefeld.de	Hoffman, Joseph i/K-7725-2012; Forcada, Jaume/GYU-0677-2022	Hoffman, Joseph i/0000-0001-5895-8949; Thorne, Michael/0000-0001-7759-612X	Marie Curie Career Integration Grant [PCIG-GA-2011-303618]; NERC [bas0100025] Funding Source: UKRI; Natural Environment Research Council [bas0100025] Funding Source: researchfish	Marie Curie Career Integration Grant; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by a Marie Curie Career Integration Grant (PCIG-GA-2011-303618) awarded to JH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar A, 2004, P NATL ACAD SCI USA, V101, P3490, DOI 10.1073/pnas.0306582101; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andres AM, 2009, MOL BIOL EVOL, V26, P2755, DOI 10.1093/molbev/msp190; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Asthana S, 2005, TRENDS GENET, V21, P30, DOI 10.1016/j.tig.2004.11.001; BAIROCH A, 1991, NUCLEIC ACIDS RES, V19, P2247, DOI 10.1093/nar/19.suppl.2247; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bubb KL, 2006, GENETICS, V173, P2165, DOI 10.1534/genetics.106.055715; CanineHD BeadChip, ILL DAT SHEET DNA GE; Charlesworth D, 2006, PLOS GENET, V2, P379, DOI 10.1371/journal.pgen.0020064; Davey JL, 2010, BRIEF FUNCT GENOMICS, V9, P416, DOI 10.1093/bfgp/elq031; Fan B, 2010, ASIAN AUSTRAL J ANIM, V23, P833, DOI 10.5713/ajas.2010.r.03; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Haynes GD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036536; Hoffman JI, 2007, NATURE, V445, P912, DOI 10.1038/nature05558; Hoffman JI, 2006, MOL ECOL, V15, P1995, DOI 10.1111/j.1365-294X.2006.02894.x; Hoffman JI, 2012, MOL ECOL RESOUR, V12, P861, DOI 10.1111/j.1755-0998.2012.03158.x; Hoffman JI, 2005, P ROY SOC B-BIOL SCI, V272, P2017, DOI 10.1098/rspb.2005.3176; Hoffman JI, 2003, EVOLUTION, V57, P1917; Hoffman JI, 2004, EVOLUTION, V58, P2087; Hoffman JI, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-52; Hoffman JI, 2011, MOL ECOL RESOUR, V11, P703, DOI 10.1111/j.1755-0998.2011.02999.x; Hoffman JI, 2010, J HERED, V101, P527, DOI 10.1093/jhered/esq045; Hudson ME, 2008, MOL ECOL RESOUR, V8, P3, DOI 10.1111/j.1471-8286.2007.02019.x; Lepoittevin C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011034; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mesnick SL, 2011, MOL ECOL RESOUR, V11, P278, DOI 10.1111/j.1755-0998.2010.02973.x; Miller JM, 2012, MOL ECOL RESOUR, V12, P1145, DOI 10.1111/1755-0998.12017; Miller JM, 2011, MOL ECOL RESOUR, V11, P314, DOI 10.1111/j.1755-0998.2010.02918.x; Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666; Minoche AE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r112; Morin PA, 2007, MOL ECOL NOTES, V7, P937, DOI 10.1111/j.1471-8286.2007.01804.x; Morin PA, 2007, MOL ECOL NOTES, V7, P626, DOI 10.1111/j.1471-8286.2006.01654.x; Morin PA, 2010, MAR MAMMAL SCI, V26, P716, DOI 10.1111/j.1748-7692.2009.00362.x; Namroud MC, 2008, MOL ECOL, V17, P3599, DOI 10.1111/j.1365-294X.2008.03840.x; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Nowell RW, 2011, GENET RES, V93, P255, DOI 10.1017/S0016672311000206; Ogden R, 2012, CONSERV GENET RESOUR, V4, P471, DOI 10.1007/s12686-011-9577-2; Olsen MT, 2011, MOL ECOL RESOUR, V11, P9, DOI 10.1111/j.1755-0998.2010.02941.x; Peregrin-Alvarez JM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r63; Pertoldi C, 2010, CONSERV GENET, V11, P627, DOI 10.1007/s10592-009-9977-y; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sanchez CC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-559; Seeb JE, 2011, MOL ECOL RESOUR, V11, P1, DOI 10.1111/j.1755-0998.2010.02979.x; Slate J, 2009, GENETICA, V136, P97, DOI 10.1007/s10709-008-9317-z; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Trask JAS, 2011, PRIMATES, V52, P129, DOI 10.1007/s10329-010-0232-4; vonHoldt BM, 2012, GENOME BIOL, V21, P1294; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wang GD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055469; Wheat CW, 2010, GENETICA, V138, P433, DOI 10.1007/s10709-008-9326-y	53	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68365	10.1371/journal.pone.0068365	http://dx.doi.org/10.1371/journal.pone.0068365			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874599	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000322064300026
J	Adur, J; DSouza-Li, L; Pedroni, MV; Steiner, CE; Pelegati, VB; de Thomaz, AA; Carvalho, HF; Cesar, CL				Adur, Javier; DSouza-Li, Lilia; Pedroni, Marcus Vinicius; Steiner, Carlos E.; Pelegati, Vitor B.; de Thomaz, Andre A.; Carvalho, Hernandes F.; Cesar, Carlos L.			The Severity of Osteogenesis Imperfecta and Type I Collagen Pattern in Human Skin as Determined by Nonlinear Microscopy: Proof of Principle of a Diagnostic Method	PLOS ONE			English	Article							MULTIPHOTON LASER TOMOGRAPHY; 2ND-HARMONIC GENERATION; FLUORESCENCE; VIVO	Background: The confirmatory diagnosis of Osteogenesis Imperfecta (OI) requires invasive, commonly bone biopsy, time consuming and destructive methods. This paper proposes an alternative method using a combination of two-photon excitation fluorescence (TPEF) and second-harmonic generation (SHG) microscopies from easily obtained human skin biopsies. We show that this method can distinguish subtypes of human OI. Methodology/Principal Findings: Different aspects of collagen microstructure of skin fresh biopsies and standard H&E-stained sections of normal and OI patients (mild and severe forms) were distinguished by TPEF and SHG images. Moreover, important differences between subtypes of OI were identified using different methods of quantification such as collagen density, ratio between collagen and elastic tissue, and gray-level co-occurrence matrix (GLCM) image-pattern analysis. Collagen density was lower in OI dermis, while the SHG/autofluorescence index of the dermis was significantly higher in OI as compared to that of the normal skin. We also showed that the energy value of GLCM texture analysis is useful to discriminate mild from severe OI and from normal skin. Conclusions/Significance: This work demonstrated that nonlinear microscopy techniques in combination with image-analysis approaches represent a powerful tool to investigate the collagen organization in skin dermis in patients with OI and has the potential to distinguish the different types of OI. The procedure outlined in this paper requires a skin biopsy, which is almost painless as compared to the bone biopsy commonly used in conventional methods. The data presented here complement existing clinical diagnostic techniques and can be used as a diagnostic procedure to confirm the disease, evaluate its severity and treatment efficacy.	[Adur, Javier; de Thomaz, Andre A.; Cesar, Carlos L.] State Univ Campinas UNICAMP, Inst Phys Gleb Wataghin, Opt & Photon Res Ctr CEPOF, Biophoton Grp, Campinas, SP, Brazil; [Adur, Javier] Natl Univ Entre Rios, Sch Bioengn, Microscopy Lab Appl Mol & Cellular Studies, Oro Verde, Entre Rios, Argentina; [DSouza-Li, Lilia; Pedroni, Marcus Vinicius] State Univ Campinas UNICAMP, CIPED, Pediat Endocrinol Lab, Campinas, SP, Brazil; [Steiner, Carlos E.] State Univ Campinas UNICAMP, Fac Med Sci, Dept Med Genet, Campinas, SP, Brazil; [Pelegati, Vitor B.; Carvalho, Hernandes F.; Cesar, Carlos L.] INFABiC Natl Inst Sci & Technol Photon Appl Cell, Campinas, SP, Brazil; [Carvalho, Hernandes F.] State Univ Campinas UNICAMP, Inst Biol, Dept Struct & Funct Biol, Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas	Adur, J (corresponding author), State Univ Campinas UNICAMP, Inst Phys Gleb Wataghin, Opt & Photon Res Ctr CEPOF, Biophoton Grp, Campinas, SP, Brazil.	jadur@bioingenieria.edu.ar	Carvalho, Hernandes/C-2046-2012; Cesar, Carlos/O-1470-2013; Li, Lilia/ABC-4466-2021; de Thomaz, Andre/G-7505-2014; Steiner, Carlos E/B-9319-2014; D'Souza-Li, Lilia/A-6973-2013; Lenz Cesar, Carlos/F-2442-2018; Adur, Javier/AAC-9601-2019	de Thomaz, Andre/0000-0002-8318-4428; Steiner, Carlos E/0000-0001-5148-3063; D'Souza-Li, Lilia/0000-0002-8574-7140; Lenz Cesar, Carlos/0000-0001-5573-9636; 	Fundacao do Amparo a Pesquisa do Estado de Sao Paulo - FAPESP; FAPESP [2011/51591-3]; FAPESP-INCT-INFABIC [2008/57906-3]	Fundacao do Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP-INCT-INFABIC	This study was supported by the Fundacao do Amparo a Pesquisa do Estado de Sao Paulo - FAPESP (www.fapesp.br), FAPESP Process No 2011/51591-3, FAPESP-INCT-INFABIC Process No 2008/57906-3. The funding institution had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adur J, 2012, J BIOPHOTONICS, DOI [10.1002/jbio.201200108, DOI 10.1002/JBI0.201200108]; Adur J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047007; Adur J, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.8.081407; Cicchi R, 2007, OPT EXPRESS, V15, P10135, DOI 10.1364/OE.15.010135; Cicchi R, 2010, J BIOPHOTONICS, V3, P34, DOI 10.1002/jbio.200910062; Cox G, 2003, J STRUCT BIOL, V141, P53, DOI 10.1016/S1047-8477(02)00576-2; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Dimitrow E, 2009, EXP DERMATOL, V18, P509, DOI 10.1111/j.1600-0625.2008.00815.x; Dimitrow E, 2009, J INVEST DERMATOL, V129, P1752, DOI 10.1038/jid.2008.439; Dunn AK, 2000, APPL OPTICS, V39, P1194, DOI 10.1364/AO.39.001194; English RS, 1999, DERMATOL SURG, V25, P631, DOI 10.1046/j.1524-4725.1999.98257.x; Gripp K.W., 1993, GENEREVIEWS; Koehler MJ, 2006, OPT LETT, V31, P2879, DOI 10.1364/OL.31.002879; Konig K, 2005, BIOMATERIALS, V26, P495, DOI 10.1016/j.biomaterials.2004.02.059; Konig K, 2003, J BIOMED OPT, V8, P432, DOI 10.1117/1.1577349; LaComb R, 2008, BIOPHYS J, V94, P4504, DOI 10.1529/biophysj.107.114405; Lin SJ, 2005, OPT LETT, V30, P2275, DOI 10.1364/OL.30.002275; Malone JC, 2002, J CUTAN PATHOL, V29, P453, DOI 10.1034/j.1600-0560.2002.290802.x; Masters BR, 2001, OPT EXPRESS, V8, P2, DOI 10.1364/OE.8.000002; Nadiarnykh O, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2799538; Paoli J, 2008, J INVEST DERMATOL, V128, P1248, DOI 10.1038/sj.jid.5701139; Provenzano PP, 2008, MICROSC MICROANAL, V14, P532, DOI 10.1017/S1431927608080884; Rauch F, 2004, LANCET, V363, P1377, DOI 10.1016/S0140-6736(04)16051-0; Sharma A, 2001, OBSTET GYNECOL SURV, V56, P563, DOI 10.1097/00006254-200109000-00022; SILLENCE DO, 1979, J MED GENET, V16, P101, DOI 10.1136/jmg.16.2.101; Torkian Behrooz A, 2004, Arch Facial Plast Surg, V6, P180, DOI 10.1001/archfaci.6.3.180; van Dijk FS, 2011, MOL SYNDROMOL, V2, P1, DOI 10.1159/000332228; Walker RF, 2003, INT J PATTERN RECOGN, V17, P17, DOI 10.1142/S0218001403002228; Watson JM, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.7.076002; Williams RM, 2005, BIOPHYS J, V88, P1377, DOI 10.1529/biophysj.104.047308; Zhuo S, 2011, J BIOMED OPT, V16; Zipfel WR, 2003, P NATL ACAD SCI USA, V100, P7075, DOI 10.1073/pnas.0832308100; Zoumi A, 2002, P NATL ACAD SCI USA, V99, P11014, DOI 10.1073/pnas.172368799	33	12	12	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2013	8	7							e69186	10.1371/journal.pone.0069186	http://dx.doi.org/10.1371/journal.pone.0069186			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZN	23869235	Green Published, gold, Green Submitted			2022-12-27	WOS:000323110600035
J	Bertin, C; Pau-Roblot, C; Courtois, J; Manso-Silvan, L; Thiaucourt, F; Tardy, F; Le Grand, D; Poumarat, F; Gaurivaud, P				Bertin, Clothilde; Pau-Roblot, Corinne; Courtois, Josiane; Manso-Silvan, Lucia; Thiaucourt, Francois; Tardy, Florence; Le Grand, Dominique; Poumarat, Francois; Gaurivaud, Patrice			Characterization of Free Exopolysaccharides Secreted by Mycoplasma mycoides Subsp mycoides	PLOS ONE			English	Article							CONTAGIOUS BOVINE PLEUROPNEUMONIA; SMALL COLONY TYPE; CAPSULAR POLYSACCHARIDE; PHOSPHOTRANSFERASE SYSTEM; EXPERIMENTAL INFECTION; STRUCTURE PREDICTION; CAUSATIVE AGENT; PNEUMONIAE; IDENTIFICATION; GALACTAN	Contagious bovine pleuropneumonia is a severe respiratory disease of cattle that is caused by a bacterium of the Mycoplasma genus, namely Mycoplasma mycoides subsp. mycoides (Mmm). In the absence of classical virulence determinants, the pathogenicity of Mmm is thought to rely on intrinsic metabolic functions and specific components of the outer cell surface. One of these latter, the capsular polysaccharide galactan has been notably demonstrated to play a role in Mmm persistence and dissemination. The free exopolysaccharides (EPS), also produced by Mmm and shown to circulate in the blood stream of infected cattle, have received little attention so far. Indeed, their characterization has been hindered by the presence of polysaccharide contaminants in the complex mycoplasma culture medium. In this study, we developed a method to produce large quantities of EPS by transfer of mycoplasma cells from their complex broth to a chemically defined medium and subsequent purification. NMR analyses revealed that the purified, free EPS had an identical beta(1->6)-galactofuranosyl structure to that of capsular galactan. We then analyzed intraclonal Mmm variants that produce opaque/translucent colonies on agar. First, we demonstrated that colony opacity was related to the production of a capsule, as observed by electron microscopy. We then compared the EPS extracts and showed that the non-capsulated, translucent colony variants produced higher amounts of free EPS than the capsulated, opaque colony variants. This phenotypic variation was associated with an antigenic variation of a specific glucose phosphotransferase permease. Finally, we conducted in silico analyses of candidate polysaccharide biosynthetic pathways in order to decipher the potential link between glucose phosphotransferase permease activity and attachment/release of galactan. The co-existence of variants producing alternative forms of galactan (capsular versus free extracellular galactan) and associated with an antigenic switch constitutes a finely tuned mechanism that may be involved in virulence.	[Bertin, Clothilde; Tardy, Florence; Le Grand, Dominique; Poumarat, Francois; Gaurivaud, Patrice] Agence Natl Securite Sanit, Lab Lyon, UMR Mycoplasmoses Ruminants, Lyon, France; [Bertin, Clothilde; Tardy, Florence; Le Grand, Dominique; Poumarat, Francois; Gaurivaud, Patrice] Univ Lyon, VetAgro Sup, UMR Mycoplasmoses Ruminants, Marcy Letoile, France; [Pau-Roblot, Corinne; Courtois, Josiane] Univ Picardie Jules Verne, EA 3900, Unite Biol Plantes & Innovat, Amiens, France; [Manso-Silvan, Lucia; Thiaucourt, Francois] UMR CMAEE, Ctr Int Rech Agronom Dev, Montpellier, France; [Manso-Silvan, Lucia; Thiaucourt, Francois] CMAEE, UMR1309, Inst Natl Rech Agron, Montpellier, France	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de Lyon; VetAgro Sup; VetAgro Sup; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CIRAD; INRAE	Gaurivaud, P (corresponding author), Agence Natl Securite Sanit, Lab Lyon, UMR Mycoplasmoses Ruminants, Lyon, France.	patrice.gaurivaud@anses.fr		Pau-Roblot, Corinne/0000-0001-8479-6007; TARDY, Florence/0000-0003-3968-4801; Gaurivaud, patrice/0000-0002-8390-8123; Manso-Silvan, Lucia/0000-0002-5539-3804; LE GRAND, Dominique/0000-0001-8881-0160				Abdo EM, 1998, VET MICROBIOL, V59, P109, DOI 10.1016/S0378-1135(97)00184-3; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andres E, 2012, BIOCATAL BIOTRANSFOR, V30, P274, DOI 10.3109/10242422.2012.674733; Andres E, 2011, J BIOL CHEM, V286, P35367, DOI 10.1074/jbc.M110.214148; Barre A, 2004, NUCLEIC ACIDS RES, V32, pD307, DOI 10.1093/nar/gkh114; Beynon LM, 1997, EUR J BIOCHEM, V250, P163, DOI 10.1111/j.1432-1033.1997.00163.x; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Brocchi E, 1993, Rev Sci Tech, V12, P559; Buttery J, 2002, BRIT MED BULL, V61, P63, DOI 10.1093/bmb/61.1.63; BUTTERY SH, 1960, J GEN MICROBIOL, V23, P357, DOI 10.1099/00221287-23-2-357; BUTTERY SH, 1976, J MED MICROBIOL, V9, P379, DOI 10.1099/00222615-9-4-379; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; COCHRAN WG, 1950, BIOMETRICS, V6, P105, DOI 10.2307/3001491; Cordeiro LMC, 2012, CARBOHYD POLYM, V90, P1779, DOI 10.1016/j.carbpol.2012.07.069; de Rezende CE, 2005, APPL ENVIRON MICROB, V71, P7345, DOI 10.1128/AEM.71.11.7345-7351.2005; De Vuyst L, 1998, J APPL MICROBIOL, V84, P1059; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Enos-Berlage JL, 2000, J BACTERIOL, V182, P5513, DOI 10.1128/JB.182.19.5513-5520.2000; Freund EA, 1983, METHODS MYCOPLASMOLO, P127, DOI DOI 10.1016/B978-0-12-583801-6.50029-9; Gaurivaud P, 2004, MICROBIOL-SGM, V150, P4009, DOI 10.1099/mic.0.27247-0; Goncalves VM, 2006, J APPL MICROBIOL, V101, P1009, DOI 10.1111/j.1365-2672.2006.03012.x; GOURLAY RN, 1962, NATURE, V195, P99, DOI 10.1038/195099a0; Hava DL, 2003, MOL MICROBIOL, V50, P1103, DOI 10.1046/j.1365-2958.2003.03764.x; Holden HM, 2003, J BIOL CHEM, V278, P43885, DOI 10.1074/jbc.R300025200; Houot L, 2010, J BACTERIOL, V192, P3055, DOI 10.1128/JB.00213-10; HUDSON JR, 1967, J PATHOL BACTERIOL, V94, P257, DOI 10.1002/path.1700940204; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Klement MLR, 2007, MOL MICROBIOL, V65, P1444, DOI 10.1111/j.1365-2958.2007.05865.x; Koplin R, 1997, J BIOL CHEM, V272, P4121, DOI 10.1074/jbc.272.7.4121; Kremer L, 2001, J BIOL CHEM, V276, P26430, DOI 10.1074/jbc.M102022200; LISS A, 1983, INFECT IMMUN, V41, P1245, DOI 10.1128/IAI.41.3.1245-1251.1983; LLOYD LC, 1971, J MED MICROBIOL, V4, P425, DOI 10.1099/00222615-4-4-425; March JB, 2000, VET REC, V147, P20, DOI 10.1136/vr.147.1.20; March JB, 1999, ANAL CAPSULAR POLYSA, P69; McAuliffe L, 2008, VET MICROBIOL, V129, P315, DOI 10.1016/j.vetmic.2007.11.024; Minga UM, 1981, VET B, V3, P53; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Morgan JLW, 2013, NATURE, V493, P181, DOI 10.1038/nature11744; Nicholas RAJ, 2011, VET REC, V168, P459, DOI 10.1136/vr.d2468; OIE, 2008, MANUAL DIAGNOSTIC TE; Pilo P, 2005, J BACTERIOL, V187, P6824, DOI 10.1128/JB.187.19.6824-6831.2005; Pilo P, 2007, VET J, V174, P513, DOI 10.1016/j.tvjl.2006.10.016; Plackett P, 1963, RECENT PROGRESS MICR, P535; Plackett P, 1963, BIOCHEM J, V90, P201; POUMARAT F, 1991, VET MICROBIOL, V29, P329, DOI 10.1016/0378-1135(91)90140-B; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; RODWELL AW, 1961, J GEN MICROBIOL, V25, P201, DOI 10.1099/00221287-25-2-201; ROSENGARTEN R, 1991, J BACTERIOL, V173, P4782, DOI 10.1128/jb.173.15.4782-4793.1991; SAIER MH, 1992, J BACTERIOL, V174, P1433, DOI 10.1128/jb.174.5.1433-1438.1992; SAXENA IM, 1995, J BACTERIOL, V177, P1419, DOI 10.1128/jb.177.6.1419-1424.1995; Shi F, 2012, INFECT IMMUN, V80, P3993, DOI 10.1128/IAI.00635-12; SHIFRINE M, 1965, NATURE, V208, P498, DOI 10.1038/208498a0; SMITH GR, 1982, J HYG-CAMBRIDGE, V89, P521, DOI 10.1017/S0022172400071096; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sutherland I W, 1972, Adv Microb Physiol, V8, P143, DOI 10.1016/S0065-2911(08)60190-3; SWANSON J, 1978, INFECT IMMUN, V19, P320, DOI 10.1128/IAI.19.1.320-331.1978; Turner AW, 1962, VET J, V38, P401; Westberg J, 2004, GENOME RES, V14, P221, DOI 10.1101/gr.1673304; Wheatley RW, 2012, J BIOL CHEM, V287, P28132, DOI 10.1074/jbc.M112.347484; Whitney JC, 2013, TRENDS MICROBIOL, V21, P63, DOI 10.1016/j.tim.2012.10.001; Wise KS, 2012, J BACTERIOL, V194, P4448, DOI 10.1128/JB.00761-12; Yildiz FH, 1999, P NATL ACAD SCI USA, V96, P4028, DOI 10.1073/pnas.96.7.4028; Yus E, 2009, SCIENCE, V326, P1263, DOI 10.1126/science.1177263	63	24	24	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2013	8	7							e68373	10.1371/journal.pone.0068373	http://dx.doi.org/10.1371/journal.pone.0068373			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZN	23869216	Green Submitted, Green Published, gold			2022-12-27	WOS:000323110600015
J	Brunner, FS; Schmid-Hempel, P; Barribeau, SM				Brunner, Franziska S.; Schmid-Hempel, Paul; Barribeau, Seth M.			Immune Gene Expression in Bombus terrestris: Signatures of Infection Despite Strong Variation among Populations, Colonies, and Sister Workers	PLOS ONE			English	Article							TIME PCR DATA; CRITHIDIA-BOMBI; TRYPANOSOME PARASITE; INSECT IMMUNITY; BUMBLE-BEE; HOST; DROSOPHILA; TRANSMISSION; PROTECTION; RESPONSES	Ecological immunology relies on variation in resistance to parasites. Colonies of the bumblebee Bombus terrestris vary in their susceptibility to the trypanosome gut parasite Crithidia bombi, which reduces colony fitness. To understand the possible origin of this variation in resistance we assayed the expression of 28 immunologically important genes in foraging workers. We deliberately included natural variation of the host "environment" by using bees from colonies collected in two locations and sampling active foraging workers that were not age controlled. Immune gene expression patterns in response to C. bombi showed remarkable variability even among genetically similar sisters. Nevertheless, expression varied with parasite exposure, among colonies and, perhaps surprisingly, strongly among populations (collection sites). While only the antimicrobial peptide abaecin is universally up regulated upon exposure, linear discriminant analysis suggests that the overall exposure effect is driven by a combination of several immune pathways and further immune functions such as ROS regulation. Also, the differences among colonies in their immune gene expression profiles provide clues to the mechanistic basis of well-known inter-colony variation in susceptibility to this parasite. Our results show that transcriptional responses to parasite exposure can be detected in ecologically heterogeneous groups despite strong background noise.	[Brunner, Franziska S.; Schmid-Hempel, Paul; Barribeau, Seth M.] Swiss Fed Inst Technol, Inst Integrat Biol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Barribeau, SM (corresponding author), Swiss Fed Inst Technol, Inst Integrat Biol, Zurich, Switzerland.	seth@env.ethz.ch	Brunner, Franziska/G-5239-2014; Brunner, Franziska/AAF-4430-2020	Brunner, Franziska/0000-0002-6571-6945; Brunner, Franziska/0000-0002-6571-6945; Barribeau, Seth/0000-0001-6643-0562	Swiss SNF [31003A-116057]; ERC [268853 RESIST]	Swiss SNF(Swiss National Science Foundation (SNSF)); ERC(European Research Council (ERC)European Commission)	This work was supported by the Swiss SNF (grant no. 31003A-116057) and an ERC Advanced Grant (no. 268853 RESIST) to PSH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar R, 2005, INSECT BIOCHEM MOLEC, V35, P709, DOI 10.1016/j.ibmb.2005.02.019; [Anonymous], 2010, R LANG ENV STAT COMP; Arvidsson S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-465; Baer B, 1999, NATURE, V397, P151, DOI 10.1038/16451; BRAY JH, 1982, REV EDUC RES, V52, P340, DOI 10.3102/00346543052003340; Brown MJF, 2000, OIKOS, V91, P421, DOI 10.1034/j.1600-0706.2000.910302.x; De Gregorio E, 2002, DEV CELL, V3, P581, DOI 10.1016/S1534-5807(02)00267-8; Dong Y, 2006, PLOS BIOL, P4; Erler S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018126; Garamszegi LZ, 2011, J EVOLUTION BIOL, V24, P184, DOI 10.1111/j.1420-9101.2010.02156.x; Gillespie JP, 1997, ANNU REV ENTOMOL, V42, P611, DOI 10.1146/annurev.ento.42.1.611; Ha EM, 2005, DEV CELL, V8, P125, DOI 10.1016/j.devcel.2004.11.007; Koch H, 2012, ECOLOGY LET IN PRESS; Korner P, 2004, J INVERTEBR PATHOL, V87, P59, DOI 10.1016/j.jip.2004.07.004; Kurtz J, 2004, P ROY SOC B-BIOL SCI, V271, P197, DOI 10.1098/rspb.2003.2567; Lazzaro BP, 2009, PHILOS T R SOC B, V364, P15, DOI 10.1098/rstb.2008.0141; Li JL, 2010, J COMP PHYSIOL B, V180, P161, DOI 10.1007/s00360-009-0434-5; LIPA JJ, 1988, ACTA PROTOZOOL, V27, P287; Moret Y, 2009, OIKOS, V118, P371, DOI 10.1111/j.1600-0706.2008.17187.x; Park J, 2011, INSECT MOL BIOL BIOC; Radyuk SN, 2010, BBA-GEN SUBJECTS, V1800, P1153, DOI 10.1016/j.bbagen.2010.06.010; Richter J, 2012, BEHAV ECOL SOCIOBIOL, V66, P791, DOI 10.1007/s00265-012-1327-2; Riddell C, 2009, PLOS ONE, P4; Riddell CE, 2011, INSECT MOL BIOL, V20, P529, DOI 10.1111/j.1365-2583.2011.01084.x; Rottschaefer SM, 2011, PLOS BIOL, P9; Rozen S, 2000, Methods Mol Biol, V132, P365; Rudenko N, 2005, J MED ENTOMOL, V42, P36, DOI 10.1603/0022-2585(2005)042[0036:DEOIRT]2.0.CO;2; Sadd BM, 2006, CURR BIOL, V16, P1206, DOI 10.1016/j.cub.2006.04.047; Sadd BM, 2011, EVOLUTION, V65, P2995, DOI 10.1111/j.1558-5646.2011.01345.x; Sadd BM, 2005, BIOL LETTERS, V1, P386, DOI 10.1098/rsbl.2005.0369; Salathe R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049046; Schluns H, 2010, DEV COMP IMMUNOL, V34, P705, DOI 10.1016/j.dci.2010.02.002; Schmid-Hempel P, 1999, EVOLUTION, V53, P426, DOI 10.1111/j.1558-5646.1999.tb03778.x; Schmid-Hempel P, 2001, NATURWISSENSCHAFTEN, V88, P147, DOI 10.1007/s001140100222; Schmid-Hempel P, 2004, PARASITOLOGY, V129, P147, DOI 10.1017/S0031182004005542; SCHMIDHEMPEL P, 1993, BEHAV ECOL SOCIOBIOL, V33, P319, DOI 10.1007/BF00172930; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SHYKOFF JA, 1991, APIDOLOGIE, V22, P117, DOI 10.1051/apido:19910204; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; Stathakis DG, 1999, GENETICS, V153, P361; Venables WN., 2002, MODERN APPL STAT S 4; Vogel H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-308; Wang D, 2009, COMP BIOCHEM PHYS B, V152, P20, DOI 10.1016/j.cbpb.2008.09.082; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85	44	31	31	3	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2013	8	7							e68181	10.1371/journal.pone.0068181	http://dx.doi.org/10.1371/journal.pone.0068181			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZN	23869212	gold, Green Published, Green Accepted			2022-12-27	WOS:000323110600011
J	Le, DTV; Eckert, T; Woehlke, G				Doan Tuong-Van Le; Eckert, Thomas; Woehlke, Guenther			Computer Simulation of Assembly and Co-operativity of Hexameric AAA ATPases	PLOS ONE			English	Article							PROTEIN; KINESIN; SPASTIN; BINDING; COMMUNICATION; TRANSITIONS; HEMOGLOBIN; MUTATIONS; KINETICS	AAA ATPases form a functionally diverse superfamily of proteins. Most members form homo-hexameric ring complexes, are catalytically active only in the fully assembled state, and show co-operativity among the six subunits. The mutual dependence among the subunits is clearly evidenced by the fact that incorporation of mutated, inactive subunits can decrease the activity of the remaining wild type subunits. For the first time, we develop here models to describe this form of allostery, evaluate them in a simulation study, and test them on experimental data. We show that it is important to consider the assembly reactions in the kinetic model, and to define a formal inhibition scheme. We simulate three inhibition scenarios explicitly, and demonstrate that they result in differing outcomes. Finally, we deduce fitting formulas, and test them on real and simulated data. A non-competitive inhibition formula fitted experimental and simulated data best. To our knowledge, our study is the first one that derives and tests formal allosteric schemes to explain the inhibitory effects of mutant subunits on oligomeric enzymes.	[Doan Tuong-Van Le; Eckert, Thomas; Woehlke, Guenther] Tech Univ Munich, Dept Phys Biophys E22, Garching, Germany	Technical University of Munich	Woehlke, G (corresponding author), Tech Univ Munich, Dept Phys Biophys E22, Garching, Germany.	guenther.woehlke@mytum.de		Woehlke, Gunther/0000-0001-8462-9962	Deutsche Forschungsgemeinschaft, DFG [WO614/4-1, SFB863, B7]	Deutsche Forschungsgemeinschaft, DFG(German Research Foundation (DFG))	Supported by Deutsche Forschungsgemeinschaft, DFG, WO614/4-1 and SFB863, B7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbondanzieri EA, 2009, NATURE, V457, P392, DOI 10.1038/457392a; Adair GS, 1925, J BIOL CHEM, V63, P529; Ammelburg M, 2006, J STRUCT BIOL, V156, P2, DOI 10.1016/j.jsb.2006.05.002; Aubin-Tam ME, 2011, CELL, V145, P257, DOI 10.1016/j.cell.2011.03.036; Chakraborty M, 2012, BIOPHYS J, V103, P949, DOI 10.1016/j.bpj.2012.07.034; CONFALONIERI F, 1995, BIOESSAYS, V17, P639, DOI 10.1002/bies.950170710; Crimella C, 2011, CLIN GENETICS; D'Orsogna MR, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3688231; Ebbing B, 2008, HUM MOL GENET, V17, P1245, DOI 10.1093/hmg/ddn014; Eckert T, 2012, J BIOL CHEM; Eckert T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050161; Evans KJ, 2005, J CELL BIOL, V168, P599, DOI 10.1083/jcb.200409058; Fersht A., 1984, ENZYME STRUCTURE MEC; Franzmann TM, 2011, J BIOL CHEM, V286, P17992, DOI 10.1074/jbc.M110.216176; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Gutfreund H, 1995, KINETICS LIFE SCI, P45; HACKNEY DD, 1994, P NATL ACAD SCI USA, V91, P6865, DOI 10.1073/pnas.91.15.6865; HAMMES GG, 1974, ANNU REV BIOPHYS BIO, V3, P1, DOI 10.1146/annurev.bb.03.060174.000245; Hattendorf DA, 2002, EMBO J, V21, P12, DOI 10.1093/emboj/21.1.12; HILL TL, 1952, J AM CHEM SOC, V74, P4710, DOI 10.1021/ja01138a512; Hodson S, 2012, J STRUCT BIOL, V179, P161, DOI 10.1016/j.jsb.2012.05.015; Horwitz AA, 2007, J BIOL CHEM, V282, P22921, DOI 10.1074/jbc.M702846200; Hoskins JR, 2009, P NATL ACAD SCI USA, V106, P22233, DOI 10.1073/pnas.0911937106; Jiang W, 1997, J BIOL CHEM, V272, P7626, DOI 10.1074/jbc.272.12.7626; Joshi SA, 2004, NAT STRUCT MOL BIOL, V11, P404, DOI 10.1038/nsmb752; Karle KN, 2012, NEUROGENETICS, V13, P169, DOI 10.1007/s10048-012-0324-y; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Lee JW, 2009, J BIOL CHEM, V284, P33475, DOI 10.1074/jbc.M109.045807; Maillard RA, 2011, CELL, V145, P459, DOI 10.1016/j.cell.2011.04.010; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MONOD J, 1963, J MOL BIOL, V6, P306, DOI 10.1016/S0022-2836(63)80091-1; Nishikori S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201400; Ogura T, 2004, J STRUCT BIOL, V146, P106, DOI 10.1016/j.jsb.2003.11.008; Pastinen T, 2010, NAT REV GENET, V11, P533, DOI 10.1038/nrg2815; Pauling L, 1935, P NATL ACAD SCI USA, V21, P186, DOI 10.1073/pnas.21.4.186; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Roll-Mecak A, 2008, NATURE, V451, P363, DOI 10.1038/nature06482; Saibil HR, 2013, J MOL BIOL, V425, P1476, DOI 10.1016/j.jmb.2012.11.028; Smith DM, 2011, CELL, V144, P526, DOI 10.1016/j.cell.2011.02.005; Stotz M, 2011, NAT STRUCT MOL BIOL, V18, P1366, DOI 10.1038/nsmb.2171; Svenson IK, 2001, AM J HUM GENET, V68, P1077, DOI 10.1086/320111; Wendler P, 2012, BBA-MOL CELL RES, V1823, P2, DOI 10.1016/j.bbamcr.2011.06.014; Werbeck ND, 2008, J MOL BIOL, V378, P178, DOI 10.1016/j.jmb.2008.02.026; Werbeck ND, 2009, BIOCHEMISTRY-US, V48, P7240, DOI 10.1021/bi900880c; White SR, 2007, J CELL BIOL, V176, P995, DOI 10.1083/jcb.200610072; Yamasaki T, 2011, FEBS J; Zhang XD, 2008, NAT STRUCT MOL BIOL, V15, P1223, DOI 10.1038/nsmb.1501	50	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2013	8	7							e67815	10.1371/journal.pone.0067815	http://dx.doi.org/10.1371/journal.pone.0067815			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZN	23869207	Green Published, Green Submitted, gold			2022-12-27	WOS:000323110600006
J	Banerjee, I; Yamauchi, Y; Helenius, A; Horvath, P				Banerjee, Indranil; Yamauchi, Yohei; Helenius, Ari; Horvath, Peter			High-Content Analysis of Sequential Events during the Early Phase of Influenza A Virus Infection	PLOS ONE			English	Article							MEMBRANE-FUSION ACTIVITY; HEMAGGLUTININ	Influenza A virus (IAV) represents a worldwide threat to public health by causing severe morbidity and mortality every year. Due to high mutation rate, new strains of IAV emerge frequently. These IAVs are often drug-resistant and require vaccine reformulation. A promising approach to circumvent this problem is to target host cell determinants crucial for IAV infection, but dispensable for the cell. Several RNAi-based screens have identified about one thousand cellular factors that promote IAV infection. However, systematic analyses to determine their specific functions are lacking. To address this issue, we developed quantitative, imaging-based assays to dissect seven consecutive steps in the early phases of IAV infection in tissue culture cells. The entry steps for which we developed the assays were: virus binding to the cell membrane, endocytosis, exposure to low pH in endocytic vacuoles, acid-activated fusion of viral envelope with the vacuolar membrane, nucleocapsid uncoating in the cytosol, nuclear import of viral ribonucleoproteins, and expression of the viral nucleoprotein. We adapted the assays to automated microscopy and optimized them for high-content screening. To quantify the image data, we performed both single and multi-parametric analyses, in combination with machine learning. By time-course experiments, we determined the optimal time points for each assay. Our quality control experiments showed that the assays were sufficiently robust for high-content analysis. The methods we describe in this study provide a powerful high-throughput platform to understand the host cell processes, which can eventually lead to the discovery of novel anti-pathogen strategies.	[Banerjee, Indranil; Yamauchi, Yohei; Helenius, Ari] Swiss Fed Inst Technol, Inst Biochem, Zurich, Switzerland; [Horvath, Peter] Swiss Fed Inst Technol, Light Microscopy & Screening Ctr, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Helenius, A (corresponding author), Swiss Fed Inst Technol, Inst Biochem, Zurich, Switzerland.	ari.helenius@bc.biol.ethz.ch; peter.horvath@bc.biol.ethz.ch		Yamauchi, Yohei/0000-0002-8233-9133	European Research Council; National Institutes of Health	European Research Council(European Research Council (ERC)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	AH was funded by a European Research Council advanced investigator grant, and by a grant from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; DANIELS RS, 1987, EMBO J, V6, P1459, DOI 10.1002/j.1460-2075.1987.tb02387.x; de Vries E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001329; DOMS RW, 1985, J BIOL CHEM, V260, P2973; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Hao LH, 2008, NATURE, V454, P890, DOI 10.1038/nature07151; Horvath P, 2011, J BIOMOL SCREEN, V16, P1059, DOI 10.1177/1087057111414878; Huotari J, 2012, P NATL ACAD SCI USA, V109, P823, DOI 10.1073/pnas.1118744109; Jones TR, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-482; Karlas A, 2010, NATURE, V463, P818, DOI 10.1038/nature08760; Lakadamyali M, 2004, MICROBES INFECT, V6, P929, DOI 10.1016/j.micinf.2004.05.002; MARTIN K, 1991, J VIROL, V65, P232, DOI 10.1128/JVI.65.1.232-244.1991; MATLIN KS, 1981, J CELL BIOL, V91, P601, DOI 10.1083/jcb.91.3.601; Olivo-Marin JC, 2002, PATTERN RECOGN, V35, P1989, DOI 10.1016/S0031-3203(01)00127-3; Sakai T, 2006, J VIROL, V80, P2013, DOI 10.1128/JVI.80.4.2013-2018.2006; Stertz S, 2011, MICROBES INFECT, V13, P516, DOI 10.1016/j.micinf.2011.01.012; WEBSTER RG, 1983, VIROLOGY, V126, P587, DOI 10.1016/S0042-6822(83)80015-4; WHITE J, 1982, EMBO J, V1, P217, DOI 10.1002/j.1460-2075.1982.tb01150.x; Witten I. H., 2005, DATA MINING PRACTICA; Yamauchi Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002316; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	22	52	53	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e68450	10.1371/journal.pone.0068450	http://dx.doi.org/10.1371/journal.pone.0068450			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	23874633	Green Published, Green Submitted, gold			2022-12-27	WOS:000321718700029
J	Gerloff, NA; Jones, J; Simpson, N; Balish, A; ElBadry, MA; Baghat, V; Rusev, I; de Mattos, CC; de Mattos, CA; Zonkle, LEA; Kis, Z; Davis, CT; Yingst, S; Cornelius, C; Soliman, A; Mohareb, E; Klimov, A; Donis, RO				Gerloff, Nancy A.; Jones, Joyce; Simpson, Natosha; Balish, Amanda; ElBadry, Maha Adel; Baghat, Verina; Rusev, Ivan; de Mattos, Cecilia C.; de Mattos, Carlos A.; Zonkle, Luay Elsayed Ahmed; Kis, Zoltan; Davis, C. Todd; Yingst, Sam; Cornelius, Claire; Soliman, Atef; Mohareb, Emad; Klimov, Alexander; Donis, Ruben O.			A High Diversity of Eurasian Lineage Low Pathogenicity Avian Influenza A Viruses Circulate among Wild Birds Sampled in Egypt	PLOS ONE			English	Article							HEMAGGLUTININ SUBTYPE; MOLECULAR-BASIS; AQUATIC BIRDS; H5N1; PROTEIN; EPIDEMIOLOGY; TRANSMISSION; RESISTANCE; EVOLUTION; CHICKENS	Surveillance for influenza A viruses in wild birds has increased substantially as part of efforts to control the global movement of highly pathogenic avian influenza A (H5N1) virus. Studies conducted in Egypt from 2003 to 2007 to monitor birds for H5N1 identified multiple subtypes of low pathogenicity avian influenza A viruses isolated primarily from migratory waterfowl collected in the Nile Delta. Phylogenetic analysis of 28 viral genomes was performed to estimate their nearest ancestors and identify possible reassortants. Migratory flyway patterns were included in the analysis to assess gene flow between overlapping flyways. Overall, the viruses were most closely related to Eurasian, African and/or Central Asian lineage low pathogenicity viruses and belonged to 15 different subtypes. A subset of the internal genes seemed to originate from specific flyways (Black Sea-Mediterranean, East African-West Asian). The remaining genes were derived from a mixture of viruses broadly distributed across as many as 4 different flyways suggesting the importance of the Nile Delta for virus dispersal. Molecular clock date estimates suggested that the time to the nearest common ancestor of all viruses analyzed ranged from 5 to 10 years, indicating frequent genetic exchange with viruses sampled elsewhere. The intersection of multiple migratory bird flyways and the resulting diversity of influenza virus gene lineages in the Nile Delta create conditions favoring reassortment, as evident from the gene constellations identified by this study. In conclusion, we present for the first time a comprehensive phylogenetic analysis of full genome sequences from low pathogenic avian influenza viruses circulating in Egypt, underscoring the significance of the region for viral reassortment and the potential emergence of novel avian influenza A viruses, as well as representing a highly diverse influenza A virus gene pool that merits continued monitoring.	[Gerloff, Nancy A.; Jones, Joyce; Simpson, Natosha; Balish, Amanda; Kis, Zoltan; Davis, C. Todd; Klimov, Alexander; Donis, Ruben O.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA; [Kis, Zoltan] Natl Ctr Epidemiol, Budapest, Hungary; [ElBadry, Maha Adel; Baghat, Verina; de Mattos, Cecilia C.; de Mattos, Carlos A.; Yingst, Sam; Cornelius, Claire; Soliman, Atef; Mohareb, Emad] US Naval Med Res Unit 3, Viral & Zoonot Dis Res Program, Cairo, Egypt; [Rusev, Ivan] Antiplague Inst, Odessa, Ukraine; [Zonkle, Luay Elsayed Ahmed] Minist Environm, Cairo, Egypt	Centers for Disease Control & Prevention - USA; Naval Medical Research Center (NMRC); Naval Medical Research Unit - No. 3 (NAMRU-3); I. I. Mechnikov Ukrainian Anti-Plague Research Institute Ministry of Health of Ukraine; Ministry of Environment - Egypt	Donis, RO (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA.	rvd6@cdc.gov	Gerloff, Nancy/C-8955-2015; Elbadry, Maha Adel/AAH-4444-2020	Gerloff, Nancy/0000-0001-5696-8318; Elbadry, Maha Adel/0000-0002-6089-4523	Oak Ridge Institute for Science and Education	Oak Ridge Institute for Science and Education(General Electric)	This research was supported in part by an appointment to the Research Participation Program at the Centers for Disease Control and Prevention administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and CDC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; Arzey GG, 2012, EMERG INFECT DIS, V18, P814, DOI 10.3201/eid1805.111852; Beauchamp G, 2011, BIOL LETTERS, V7, P692, DOI 10.1098/rsbl.2011.0243; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Conenello GM, 2007, PLOS PATHOG, V3, P1414, DOI 10.1371/journal.ppat.0030141; Crescenzo-Chaigne B, 2002, VIROLOGY, V303, P240, DOI 10.1006/viro.2002.1637; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; deJong JC, 1997, NATURE, V389, P554, DOI 10.1038/39218; Denny P., 1991, P115; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duan L, 2008, VIROLOGY, V380, P243, DOI 10.1016/j.virol.2008.07.038; Dugan VG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000076; Easterday BC, 1975, INFLUENZA VIRUSES IN; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Finkelstein DB, 2007, J VIROL, V81, P10292, DOI 10.1128/JVI.00921-07; Fouchier RAM, 2009, REV SCI TECH OIE, V28, P49, DOI 10.20506/rst.28.1.1863; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Gaidet N, 2012, P ROY SOC B-BIOL SCI, V279, P1131, DOI 10.1098/rspb.2011.1417; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; HAY AJ, 1985, EMBO J, V4, P3021, DOI 10.1002/j.1460-2075.1985.tb04038.x; Hayman A, 2007, J VIROL, V81, P2318, DOI 10.1128/JVI.01856-06; HINSHAW VS, 1982, J VIROL, V42, P865, DOI 10.1128/JVI.42.3.865-872.1982; HUGHES R.H., 1992, DIRECTORY AFRICAN WE; International Centre for Diarrhoeal Disease Research Bangladesh/Government of The People's Republic of Bangladesh, 2011, HSB (Health Science Bulletin), V9, P5; Iverson SA, 2011, IBIS, V153, P279, DOI 10.1111/j.1474-919X.2010.01095.x; Kochs G, 2007, J VIROL, V81, P7011, DOI 10.1128/JVI.02581-06; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Matrosovich M, 1999, J VIROL, V73, P1146, DOI 10.1128/JVI.73.2.1146-1155.1999; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; OIE, 2012, SUMM IMM NOT FOLL UP; OIE, 2012, UPD HIGHL PATH AV IN; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Rambaut A, 2009, TREE FIGURE DRAWING; Rambaut A, 2009, TRACER; Saad MD, 2007, EMERG INFECT DIS, V13, P1120, DOI 10.3201/eid1307.061222; Salzberg SL, 2007, EMERG INFECT DIS, V13, P713, DOI 10.3201/eid1305.070013; Scholtissek C, 1998, ANTIVIR RES, V37, P83, DOI 10.1016/S0166-3542(97)00061-2; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; Shaw M, 2002, J MED VIROL, V66, P107, DOI 10.1002/jmv.2118; Shinya K, 2004, VIROLOGY, V320, P258, DOI 10.1016/j.virol.2003.11.030; Si YL, 2009, GEOSPATIAL HEALTH, V4, P65, DOI 10.4081/gh.2009.211; Sims LD, 2005, VET REC, V157, P159, DOI 10.1136/vr.157.6.159; Smith GJD, 2012, INFLUENZA OTHER RESP, V6, P1, DOI 10.1111/j.1750-2659.2011.00298.x; Soliman A, 2012, J WILDLIFE DIS, V48, P669, DOI 10.7589/0090-3558-48.3.669; Spackman Erica, 2008, V436, P19, DOI 10.1007/978-1-59745-279-3_4; Steinhauer DA, 1999, VIROLOGY, V258, P1, DOI 10.1006/viro.1999.9716; Stroud DA, 2004, STATUS MIGRATORY WAD, P1; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Twu KY, 2006, J VIROL, V80, P3957, DOI 10.1128/JVI.80.8.3957-3965.2006; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WHO, 2012, FLUNET DAT; WHO/GIP, 2012, CUMM NUMB CONF HUM C; World Health Organization (WHO), 2011, PAND INFL PREP FRAM; Yamnikova SS, 2003, AVIAN DIS, V47, P1164, DOI 10.1637/0005-2086-47.s3.1164; Younan M, 2013, EMERG INFECT DIS, V19, P43, DOI 10.3201/eid1901.121080; Zell R, 2007, J GEN VIROL, V88, P536, DOI 10.1099/vir.0.82378-0	60	13	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e68522	10.1371/journal.pone.0068522	http://dx.doi.org/10.1371/journal.pone.0068522			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	23874653	Green Submitted, Green Published, gold			2022-12-27	WOS:000321718700033
J	Hajirahimkhan, A; Simmler, C; Yuan, Y; Anderson, JR; Chen, SN; Nikolic, D; Dietz, BM; Pauli, GF; van Breemen, RB; Bolton, JL				Hajirahimkhan, Atieh; Simmler, Charlotte; Yuan, Yang; Anderson, Jeffrey R.; Chen, Shao-Nong; Nikolic, Dejan; Dietz, Birgit M.; Pauli, Guido F.; van Breemen, Richard B.; Bolton, Judy L.			Evaluation of Estrogenic Activity of Licorice Species in Comparison with Hops Used in Botanicals for Menopausal Symptoms	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; HUMULUS-LUPULUS L.; IN-VITRO; POSTMENOPAUSAL WOMEN; PLUS PROGESTIN; RECEPTOR-BETA; ANTIPROLIFERATIVE ACTIVITIES; DIETARY-SUPPLEMENTS; TRIFOLIUM-PRATENSE; GLYCYRRHIZA-GLABRA	The increased cancer risk associated with hormone therapies has encouraged many women to seek non-hormonal alternatives including botanical supplements such as hops (Humulus lupulus) and licorice (Glycyrrhiza spec.) to manage menopausal symptoms. Previous studies have shown estrogenic properties for hops, likely due to the presence of 8-prenylnarigenin, and chemopreventive effects mainly attributed to xanthohumol. Similarly, a combination of estrogenic and chemopreventive properties has been reported for various Glycyrrhiza species. The major goal of the current study was to evaluate the potential estrogenic effects of three licorice species (Glycyrrhiza glabra, G. uralensis, and G. inflata) in comparison with hops. Extracts of Glycyrrhiza species and spent hops induced estrogen responsive alkaline phosphatase activity in endometrial cancer cells, estrogen responsive element (ERE)-luciferase in MCF-7 cells, and Tff1 mRNA in T47D cells. The estrogenic activity decreased in the order H. lupulus > G. uralensis > G. inflata > G. glabra. Liquiritigenin was found to be the principle phytoestrogen of the licorice extracts; however, it exhibited lower estrogenic effects compared to 8-prenylnaringenin in functional assays. Isoliquiritigenin, the precursor chalcone of liquiritigenin, demonstrated significant estrogenic activities while xanthohumol, a metabolic precursor of 8-prenylnaringenin, was not estrogenic. Liquiritigenin showed ER beta selectivity in competitive binding assay and isoliquiritigenin was equipotent for ER subtypes. The estrogenic activity of isoliquiritigenin could be the result of its cyclization to liquiritigenin under physiological conditions. 8-Prenylnaringenin had nanomolar estrogenic potency without ER beta selectivity while xanthohumol did not bind ERs. These data demonstrated that Glycyrrhiza species with different contents of liquiritigenin have various levels of estrogenic activities, suggesting the importance of precise labeling of botanical supplements. Although hops shows strong estrogenic properties via ER alpha, licorice might have different estrogenic activities due to its ER beta selectivity, partial estrogen agonist activity, and non-enzymatic conversion of isoliquiritigenin to liquiritigenin.	[Hajirahimkhan, Atieh; Simmler, Charlotte; Yuan, Yang; Anderson, Jeffrey R.; Chen, Shao-Nong; Nikolic, Dejan; Dietz, Birgit M.; Pauli, Guido F.; van Breemen, Richard B.; Bolton, Judy L.] Univ Illinois, Coll Pharm, Dept Med Chem & Pharmacognosy, Natl Inst Hlth Ctr Bot Dietary Supplements, Chicago, IL 60607 USA	National Institutes of Health (NIH) - USA; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Bolton, JL (corresponding author), Univ Illinois, Coll Pharm, Dept Med Chem & Pharmacognosy, Natl Inst Hlth Ctr Bot Dietary Supplements, Chicago, IL 60607 USA.	judy.bolton@uic.edu	Pauli, Guido F/C-1159-2009; Chen, Shao-Nong/G-5405-2010; van Breemen, Richard/AAO-2875-2020	Chen, Shao-Nong/0000-0003-0748-0863; Simmler, Charlotte/0000-0002-6923-2630; Pauli, Guido/0000-0003-1022-4326; Hajirahimkhan, Atieh/0000-0003-0585-5668; van Breemen, Richard/0000-0003-2016-0063	University of Illinois at Chicago/National Institutes of Health Center for Botanical Dietary Supplements Research by the Office of Dietary Supplements [P50 AT00155]; National Center for Complementary and Alternative Medicine [P50 AT00155]; National Center for Complementary & Integrative Health [P50AT000155] Funding Source: NIH RePORTER	University of Illinois at Chicago/National Institutes of Health Center for Botanical Dietary Supplements Research by the Office of Dietary Supplements; National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Support for this work was provided by P50 AT00155 jointly provided to the University of Illinois at Chicago/National Institutes of Health Center for Botanical Dietary Supplements Research by the Office of Dietary Supplements (ods.od.nih.gov/) and the National Center for Complementary and Alternative Medicine (nccam.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andujar SA, 2003, J MOL STRUC-THEOCHEM, V636, P157, DOI 10.1016/S0166-1280(03)00474-3; Barlow DH, 1997, BRIT J OBSTET GYNAEC, V104, P879, DOI 10.1111/j.1471-0528.1997.tb14344.x; Basly JP, 2005, PLANTA MED, V71, P287, DOI 10.1055/s-2005-864092; Blumenthal M, 2000, HERBAL MED EXPANDED; Bolca S, 2010, MOL NUTR FOOD RES, V54, pS284, DOI 10.1002/mnfr.200900519; Calliste CA, 2001, ANTICANCER RES, V21, P3949; CATHERINO WH, 1995, CANCER LETT, V92, P39, DOI 10.1016/0304-3835(95)03755-L; Chadwick LR, 2004, J NAT PROD, V67, P2024, DOI 10.1021/np049783i; Choi SY, 2008, PLANTA MED, V74, P25, DOI 10.1055/s-2007-993760; CISAK A, 1992, J CHEM SOC PERK T 2, P1603, DOI 10.1039/p29920001603; COSTELLO CH, 1950, J AM PHARM ASSOC SCI, V39, P177, DOI 10.1002/jps.3030390316; Cuendet M, 2006, J NAT PROD, V69, P460, DOI 10.1021/np050362q; Cuendet M, 2010, CANCER PREV RES, V3, P221, DOI 10.1158/1940-6207.CAPR-09-0049; Diel P, 2004, PLANTA MED, V70, P39, DOI 10.1055/s-2004-815453; Dietz BM, 2011, CHEM-BIOL INTERACT, V192, P72, DOI 10.1016/j.cbi.2010.10.007; Dietz BM, 2005, CHEM RES TOXICOL, V18, P1296, DOI 10.1021/tx050058x; Dong SJ, 2007, FOOD CHEM TOXICOL, V45, P2470, DOI 10.1016/j.fct.2007.05.031; Eggler AL, 2005, P NATL ACAD SCI USA, V102, P10070, DOI 10.1073/pnas.0502402102; Geller SE, 2005, J WOMENS HEALTH, V14, P634, DOI 10.1089/jwh.2005.14.634; Gherezghiher TB, 2012, CHEM-BIOL INTERACT, V196, P1, DOI 10.1016/j.cbi.2012.01.004; Gustafsson JA, 1999, J ENDOCRINOL, V163, P379, DOI 10.1677/joe.0.1630379; Hajirahimkhan A, 2013, PLANTA MED IN PRESS; HATA H, 1987, J STEROID BIOCHEM, V26, P699, DOI 10.1016/0022-4731(87)91042-9; Johnson BM, 2002, MASS SPECTROM REV, V21, P76, DOI 10.1002/mas.10020; Ju YH, 2008, FOOD CHEM TOXICOL, V46, P310, DOI 10.1016/j.fct.2007.08.006; Kang HE, 2011, J PHARM PHARMACOL, V63, P49, DOI 10.1111/j.2042-7158.2010.01175.x; Kensler TW, 2010, CARCINOGENESIS, V31, P90, DOI 10.1093/carcin/bgp231; Kondo K, 2007, BIOL PHARM BULL, V30, P1271, DOI 10.1248/bpb.30.1271; KRONENBERG F, 1994, EXP GERONTOL, V29, P319, DOI 10.1016/0531-5565(94)90012-4; Kupfer R, 2008, DRUG METAB DISPOS, V36, P2261, DOI 10.1124/dmd.108.021402; LITTLEFIELD BA, 1990, ENDOCRINOLOGY, V127, P2757, DOI 10.1210/endo-127-6-2757; Liu JH, 2001, J AGR FOOD CHEM, V49, P2472, DOI 10.1021/jf0014157; Lutomski J, 1983, Pharm Unserer Zeit, V12, P49, DOI 10.1002/pauz.19830120202; MacGregor JI, 1998, PHARMACOL REV, V50, P151; Madhubhani LP, 2012, CANCER PREV RES, V5, P73, DOI 10.1158/1940-6207.CAPR-11-0348; Maggiolini M, 2002, J STEROID BIOCHEM, V82, P315, DOI 10.1016/S0960-0760(02)00230-3; Mersereau JE, 2008, MOL CELL ENDOCRINOL, V283, P49, DOI 10.1016/j.mce.2007.11.020; Minino Arialdi M, 2011, NCHS Data Brief, P1; NUDELMAN NS, 1991, J PHYS ORG CHEM, V4, P263, DOI 10.1002/poc.610040502; OBOURN JD, 1993, BIOCHEMISTRY-US, V32, P6229, DOI 10.1021/bi00075a016; Overk CR, 2008, CHEM-BIOL INTERACT, V176, P30, DOI 10.1016/j.cbi.2008.06.005; Overk CR, 2005, J AGR FOOD CHEM, V53, P6246, DOI 10.1021/jf050448p; Pauli GF, 2007, J NAT PROD, V70, P589, DOI 10.1021/np060535r; Pisha Emily, 1997, Methods in Cell Science, V19, P37, DOI 10.1023/A:1009746605060; Possemiers S, 2005, J AGR FOOD CHEM, V53, P6281, DOI 10.1021/jf0509714; Possemiers S, 2006, J NUTR, V136, P1862, DOI 10.1093/jn/136.7.1862; Roelens F, 2006, J MED CHEM, V49, P7357, DOI 10.1021/jm060692n; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Salter S, 2010, AUST FAM PHYSICIAN, V39, P433; SHAVER JLF, 1991, SLEEP, V14, P18, DOI 10.1093/sleep/14.1.18; Shumaker SA, 2003, JAMA-J AM MED ASSOC, V289, P2651, DOI 10.1001/jama.289.20.2651; Simmler C, 2013, J AGR FOOD IN PRESS; Simons R, 2011, ANAL BIOANAL CHEM, V401, P305, DOI 10.1007/s00216-011-5061-9; Sun YK, 2005, J AM SOC MASS SPECTR, V16, P271, DOI 10.1016/j.jasms.2004.11.002; Taylor M., 2012, MENOPAUSAL MED, V20, pS1; Wang ZY, 2001, NUTR CANCER, V39, P1, DOI 10.1207/S15327914nc391_1; Wassertheil-Smoller S, 2003, JAMA-J AM MED ASSOC, V289, P2673, DOI 10.1001/jama.289.20.2673; Yamin LJ, 1997, J MOL STRUC-THEOCHEM, V390, P209, DOI 10.1016/S0166-1280(96)04776-8; Yuan X, 2012, J ASIAN NAT PROD RES, V14, P789, DOI 10.1080/10286020.2012.694873; Zhou GS, 2013, MOL MED REP, V7, P531, DOI 10.3892/mmr.2012.1218	60	56	56	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e67947	10.1371/journal.pone.0067947	http://dx.doi.org/10.1371/journal.pone.0067947			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	23874474	Green Submitted, Green Published, gold			2022-12-27	WOS:000321718700004
J	Hamilton-Reeves, JM; Banerjee, S; Banerjee, SK; Holzbeierlein, JM; Thrasher, JB; Kambhampati, S; Keighley, J; van Veldhuizen, P				Hamilton-Reeves, Jill M.; Banerjee, Snigdha; Banerjee, Sushanta K.; Holzbeierlein, Jeffrey M.; Thrasher, J. Brantley; Kambhampati, Suman; Keighley, John; van Veldhuizen, Peter			Short-Term Soy Isoflavone Intervention in Patients with Localized Prostate Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial	PLOS ONE			English	Article							JAPANESE MEN; PURIFIED ISOFLAVONES; CLINICAL-TRIAL; HIGH-RISK; SERUM; ANTIGEN; CONSUMPTION; PROTEIN; METAANALYSIS; PROGRESSION	Purpose: We describe the effects of soy isoflavone consumption on prostate specific antigen (PSA), hormone levels, total cholesterol, and apoptosis in men with localized prostate cancer. Methodology/Principal Findings: We conducted a double-blinded, randomized, placebo-controlled trial to examine the effect of soy isoflavone capsules (80 mg/d of total isoflavones, 51 mg/d aglucon units) on serum and tissue biomarkers in patients with localized prostate cancer. Eighty-six men were randomized to treatment with isoflavones (n = 42) or placebo (n = 44) for up to six weeks prior to scheduled prostatectomy. We performed microarray analysis using a targeted cell cycle regulation and apoptosis gene chip (GEArrayTM). Changes in serum total testosterone, free testosterone, total estrogen, estradiol, PSA, and total cholesterol were analyzed at baseline, mid-point, and at the time of radical prostatectomy. In this preliminary analysis, 12 genes involved in cell cycle control and 9 genes involved in apoptosis were down-regulated in the treatment tumor tissues versus the placebo control. Changes in serum total testosterone, free testosterone, total estrogen, estradiol, PSA, and total cholesterol in the isoflavone-treated group compared to men receiving placebo were not statistically significant. Conclusions/Significance: These data suggest that short-term intake of soy isoflavones did not affect serum hormone levels, total cholesterol, or PSA.	[Hamilton-Reeves, Jill M.] Univ Kansas, Med Ctr, Dept Nutr & Dietet, Kansas City, KS 66103 USA; [Hamilton-Reeves, Jill M.; Banerjee, Snigdha; Banerjee, Sushanta K.; Kambhampati, Suman; van Veldhuizen, Peter] Univ Kansas, Med Ctr, Dept Med, Div Hematol & Oncol, Kansas City, KS 66103 USA; [Banerjee, Sushanta K.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA; [Hamilton-Reeves, Jill M.; Holzbeierlein, Jeffrey M.; Thrasher, J. Brantley] Univ Kansas, Med Ctr, Dept Urol, Kansas City, KS 66103 USA; [Keighley, John] Univ Kansas, Med Ctr, Dept Biostat, Kansas City, KS 66103 USA; [Banerjee, Snigdha; Banerjee, Sushanta K.; Kambhampati, Suman; van Veldhuizen, Peter] VA Med Ctr, Canc Res Unit, Kansas City, MO USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Hamilton-Reeves, JM (corresponding author), Univ Kansas, Med Ctr, Dept Nutr & Dietet, Kansas City, KS 66103 USA.	jhamilton-reeves@kumc.edu; pvanveldhuizen@kumc.edu		Hamilton-Reeves, Jill/0000-0002-0973-1542; Banerjee, Sushanta/0000-0002-7698-0717	VA Merit Review grants; University of Kansas Cancer Center Pilot Grant program	VA Merit Review grants(US Department of Veterans Affairs); University of Kansas Cancer Center Pilot Grant program	The "Soy Isoflavones in Prostate Cancer Study" was supported by VA Merit Review grants (PV, SB, SKB) and the University of Kansas Cancer Center Pilot Grant program (JHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLERCREUTZ H, 1993, LANCET, V342, P1209, DOI 10.1016/0140-6736(93)92188-Y; Banerjee S, 2008, CANCER RES, V68, P7606, DOI 10.1158/0008-5472.CAN-08-1461; Dalais FS, 2004, UROLOGY, V64, P510, DOI 10.1016/j.urology.2004.04.009; Franke AA, 2002, J CHROMATOGR B, V777, P45, DOI 10.1016/S1570-0232(02)00216-7; Frankenfeld CL, 2003, AM J CLIN NUTR, V77, P674, DOI 10.1093/ajcn/77.3.674; Gardner CD, 2009, PROSTATE, V69, P719, DOI 10.1002/pros.20922; Grainger EM, 2008, NUTR CANCER, V60, P145, DOI 10.1080/01635580701621338; Hamilton-Reeves JM, 2008, NUTR CANCER, V60, P7, DOI 10.1080/01635580701586770; Hamilton-Reeves JM, 2007, J NUTR, V137, P2258, DOI 10.1093/jn/137.10.2258; Hamilton-Reeves JM, 2007, J NUTR, V137, P1769, DOI 10.1093/jn/137.7.1769; Hamilton-Reeves JM, 2010, FERTIL STERIL, V94, P997, DOI 10.1016/j.fertnstert.2009.04.038; Handayani R, 2006, J NUTR, V136, P75, DOI 10.1093/jn/136.1.75; Hwang YW, 2009, NUTR CANCER, V61, P598, DOI 10.1080/01635580902825639; Jarred RA, 2002, CANCER EPIDEM BIOMAR, V11, P1689; Kranse R, 2005, INT J CANCER, V113, P835, DOI 10.1002/ijc.20653; Kumar NB, 2007, NUTR CANCER, V59, P163, DOI 10.1080/01635580701432678; Kumar Nagi B, 2010, J Soc Integr Oncol, V8, P3; Kumar NB, 2004, PROSTATE, V59, P141, DOI 10.1002/pros.10362; Kwan W, 2010, NUTR CANCER, V62, P198, DOI 10.1080/01635580903305318; Lazarevic B, 2011, NUTR CANCER, V63, P889, DOI 10.1080/01635581.2011.582221; Li Y, 2008, J BIOL CHEM, V283, P27707, DOI 10.1074/jbc.M802759200; Marks LS, 2004, UROLOGY, V64, P765, DOI 10.1016/j.urology.2004.05.047; Maskarinec G, 2006, EUR J CLIN NUTR, V60, P1423, DOI 10.1038/sj.ejcn.1602473; Messina M, 2006, NUTR CANCER, V55, P1, DOI 10.1207/s15327914nc5501_1; Miyanaga N, 2012, CANCER SCI, V103, P125, DOI 10.1111/j.1349-7006.2011.02120.x; Morton MS, 2002, J NUTR, V132, P3168, DOI 10.1093/jn/131.10.3168; Nagata C, 2001, CANCER EPIDEM BIOMAR, V10, P179; Ornish D, 2005, J UROLOGY, V174, P1065, DOI 10.1097/01.ju.0000169487.49018.73; Setchell KDR, 2006, J NUTR, V136, P2188, DOI 10.1093/jn/136.8.2188; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Taku K, 2007, AM J CLIN NUTR, V85, P1148, DOI 10.1093/ajcn/85.4.1148; Tanaka M, 2009, PROSTATE CANCER P D, V12, P247, DOI 10.1038/pcan.2009.10; Travis RC, 2012, CANCER CAUSE CONTROL, V23, P1163, DOI 10.1007/s10552-012-9985-y; Van Veldhuizen PJ, 2006, ONCOL REP, V16, P1221; White RWD, 2010, NUTR CANCER, V62, P1036, DOI 10.1080/01635581.2010.492085; WHITTEMORE AS, 1995, AM J EPIDEMIOL, V141, P732, DOI 10.1093/oxfordjournals.aje.a117495; Yan L, 2009, AM J CLIN NUTR, V89, P1155, DOI 10.3945/ajcn.2008.27029	37	46	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e68331	10.1371/journal.pone.0068331	http://dx.doi.org/10.1371/journal.pone.0068331			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	23874588	Green Submitted, gold, Green Published			2022-12-27	WOS:000321718700017
J	Krueger, WH; Tanasijevic, B; Barber, V; Flamier, A; Gu, XS; Manautou, J; Rasmussen, TP				Krueger, Winfried H.; Tanasijevic, Borko; Barber, Vanessa; Flamier, Anthony; Gu, Xinsheng; Manautou, Jose; Rasmussen, Theodore P.			Cholesterol-Secreting and Statin-Responsive Hepatocytes from Human ES and iPS Cells to Model Hepatic Involvement in Cardiovascular Health	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; HIGH-DENSITY LIPOPROTEINS; APOLIPOPROTEIN-A-IV; GENE-EXPRESSION; LIVER DEVELOPMENT; METABOLISM; DIFFERENTIATION; GENERATION; CYTOCHROME-P450; MECHANISMS	Hepatocytes play a central and crucial role in cholesterol and lipid homeostasis, and their proper function is of key importance for cardiovascular health. In particular, hepatocytes (especially periportal hepatocytes) endogenously synthesize large amounts of cholesterol and secrete it into circulating blood via apolipoprotein particles. Cholesterol-secreting hepatocytes are also the clinically-relevant cells targeted by statin treatment in vivo. The study of cholesterol homeostasis is largely restricted to the use of animal models and immortalized cell lines that do not recapitulate those key aspects of normal human hepatocyte function that result from genetic variation of individuals within a population. Hepatocyte-like cells (HLCs) derived from human embryonic and induced pluripotent stem cells can provide a cell culture model for the study of cholesterol homeostasis, dyslipidemias, the action of statins and other pharmaceuticals important for cardiovascular health. We have analyzed expression of core components for cholesterol homeostasis in untreated human iPS cells and in response to pravastatin. Here we show the production of differentiated cells resembling periportal hepatocytes from human pluripotent stem cells. These cells express a broad range of apolipoproteins required for secretion and elimination of serum cholesterol, actively secrete cholesterol into the medium, and respond functionally to statin treatment by reduced cholesterol secretion. Our research shows that HLCs derived from human pluripotent cells provide a robust cell culture system for the investigation of the hepatic contribution to human cholesterol homeostasis at both cellular and molecular levels. Importantly, it permits for the first time to also functionally assess the impact of genetic polymorphisms on cholesterol homeostasis. Finally, the system will also be useful for mechanistic studies of heritable dyslipidemias, drug discovery, and investigation of modes of action of cholesterol-modulatory drugs.	[Krueger, Winfried H.; Tanasijevic, Borko; Barber, Vanessa; Flamier, Anthony; Gu, Xinsheng; Manautou, Jose; Rasmussen, Theodore P.] Univ Connecticut, Dept Pharmaceut Sci, Storrs, CT USA; [Krueger, Winfried H.; Tanasijevic, Borko; Rasmussen, Theodore P.] Univ Connecticut, Stem Cell Inst, Farmington, CT USA; [Rasmussen, Theodore P.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT USA	University of Connecticut; University of Connecticut; University of Connecticut	Krueger, WH (corresponding author), Univ Connecticut, Dept Pharmaceut Sci, Storrs, CT USA.	winfried.krueger@uconn.edu		Rasmussen, Theodore/0000-0001-9450-3394	Connecticut Stem Cell Research Grants Program [09-SCB-UCON-18]	Connecticut Stem Cell Research Grants Program	Financial support was obtained through the Connecticut Stem Cell Research Grants Program (grant 09-SCB-UCON-18, http://www.ct.gov/dph/stemcell). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baharvand H, 2008, DIFFERENTIATION, V76, P465, DOI 10.1111/j.1432-0436.2007.00252.x; Boue S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012664; Braeuning A, 2006, FEBS J, V273, P5051, DOI 10.1111/j.1742-4658.2006.05503.x; Cai J, 2007, HEPATOLOGY, V45, P1229, DOI 10.1002/hep.21582; Chen YF, 2012, HEPATOLOGY, V55, P1193, DOI 10.1002/hep.24790; Dergunov AD, 2008, VASC PHARMACOL, V48, P70, DOI 10.1016/j.vph.2007.12.001; Elaut G, 2006, CURR DRUG METAB, V7, P629, DOI 10.2174/138920006778017759; Feidt DM, 2010, DRUG METAB DISPOS, V38, P1589, DOI 10.1124/dmd.110.033886; FEINGOLD KR, 1982, J LAB CLIN MED, V100, P405; Ge XJ, 2005, GENOMICS, V86, P127, DOI 10.1016/j.ygeno.2005.04.008; GEBHARDT R, 1992, PHARMACOL THERAPEUT, V53, P275, DOI 10.1016/0163-7258(92)90055-5; Goedeke L, 2012, CELL MOL LIFE SCI, V69, P915, DOI 10.1007/s00018-011-0857-5; GREEN PHR, 1980, J CLIN INVEST, V65, P911, DOI 10.1172/JCI109745; Guengerich FP, 2008, CHEM RES TOXICOL, V21, P70, DOI 10.1021/tx700079z; Guengerich FP, 2006, P NATL ACAD SCI USA, V103, P13565, DOI 10.1073/pnas.0606333103; GUERIN M, 2012, CURR OPIN LIPIDOL; Hannan NRF, 2013, NAT PROTOC, V8, P430, DOI 10.1038/nprot.2012.153; Hay DC, 2008, STEM CELLS, V26, P894, DOI 10.1634/stemcells.2007-0718; Hovingh GK, 2005, CURR OPIN LIPIDOL, V16, P139, DOI 10.1097/01.mol.0000162318.47172.ef; Jochheim A, 2004, INT J DEV BIOL, V48, P23, DOI 10.1387/ijdb.15005571; Kawabata K, 2012, METHODS MOL BIOL, V826, P115, DOI 10.1007/978-1-61779-468-1_10; Koba S, 2002, CORONARY ARTERY DIS, V13, P255, DOI 10.1097/00019501-200208000-00002; Kung JWC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/984248; LADIAS JAA, 1992, J BIOL CHEM, V267, P15849; LAGROST L, 1989, J LIPID RES, V30, P1525; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Mascaro C, 2000, ARCH BIOCHEM BIOPHYS, V374, P286, DOI 10.1006/abbi.1999.1600; Massimi M, 1999, HEPATOLOGY, V29, P1549, DOI 10.1002/hep.510290504; Mattout A, 2010, CURR OPIN CELL BIOL, V22, P334, DOI 10.1016/j.ceb.2010.02.001; North TE, 2011, METHOD CELL BIOL, V101, P205, DOI 10.1016/B978-0-12-387036-0.00010-4; Pullingr CR, 2002, J CLIN INVEST, V110, P109, DOI 10.1172/JCI200215387; Qin XF, 1998, AM J PHYSIOL-HEART C, V274, pH1836, DOI 10.1152/ajpheart.1998.274.5.H1836; Mello APQ, 2011, ATHEROSCLEROSIS, V215, P257, DOI 10.1016/j.atherosclerosis.2010.12.028; Redondo S, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-175; REUE K, 1988, J BIOL CHEM, V263, P6857; Ribalta J, 2003, CURR OPIN CLIN NUTR, V6, P177, DOI 10.1097/00075197-200303000-00006; ROBINS SJ, 1985, J LIPID RES, V26, P1230; Romero JR, 1999, LIPIDS, V34, P907, DOI 10.1007/s11745-999-0439-8; ROSSENEU M, 1995, FASEB J, V9, P768, DOI 10.1096/fasebj.9.9.7601341; Sanguino E, 2005, BRIT J PHARMACOL, V145, P853, DOI 10.1038/sj.bjp.0706260; SCHNEIDER WJ, 1990, Z KARDIOL, V79, P3; SCHUMAKER VN, 1994, ADV PROTEIN CHEM, V45, P205; Si-Tayeb K, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-81; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Soutar AK, 2007, NAT CLIN PRACT CARD, V4, P214, DOI 10.1038/ncpcardio0836; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takata A., 2011, HEPATOL INT; Takayama K, 2012, MOL THER, V20, P127, DOI 10.1038/mt.2011.234; TALL AR, 1990, J CLIN INVEST, V86, P379, DOI 10.1172/JCI114722; van der Leij FR, 2007, GENOMICS, V90, P680, DOI 10.1016/j.ygeno.2007.08.004; Vrablik M, 2001, PHYSIOL RES, V50, P337	52	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e67296	10.1371/journal.pone.0067296	http://dx.doi.org/10.1371/journal.pone.0067296			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874411	gold, Green Submitted, Green Published			2022-12-27	WOS:000322218800005
J	Pan, D; Zhang, D; Wu, JS; Chen, CH; Xu, ZX; Yang, HJ; Zhou, P				Pan, Deng; Zhang, Dang; Wu, Jiasheng; Chen, Congheng; Xu, Zhixue; Yang, Hongjie; Zhou, Ping			Antidiabetic, Antihyperlipidemic and Antioxidant Activities of a Novel Proteoglycan from Ganoderma Lucidum Fruiting Bodies on db/db Mice and the Possible Mechanism	PLOS ONE			English	Article							TYROSINE-PHOSPHATASE 1B; GENE-TRANSCRIPTION; MESSENGER-RNA; INSULIN; PROTEIN; LIVER; GLUCOKINASE; RESISTANCE; EXTRACTS; CELLS	Previously, we screened a proteoglycan for anti-hyperglycemic, named FYGL, from Ganoderma Lucidum. For further research of the antidiabetic mechanisms of FYGL in vivo, the glucose homeostasis, activities of insulin-sensitive enzymes, glucose transporter expression and pancreatic function were analyzed using db/db mice as diabetic models in the present work. FYGL not only lead to a reduction in glycated hemoglobin level, but also an increase in insulin and C-peptide level, whereas a decrease in glucagons level and showed a potential for the remediation of pancreatic islets. FYGL also increased the glucokinase activities, and simultaneously lowered the phosphoenol pyruvate carboxykinase activities, accompanied by a reduction in the expression of hepatic glucose transporter protein 2, while the expression of adipose and skeletal glucose transporter protein 4 was increased. Moreover, the antioxidant enzyme activities were also increased by FYGL treatment. Thus, FYGL was an effective antidiabetic agent by enhancing insulin secretion and decreasing hepatic glucose output along with increase of adipose and skeletal muscle glucose disposal in the late stage of diabetes. Furthermore, FYGL is beneficial against oxidative stress, thereby being helpful in preventing the diabetic complications.	[Pan, Deng; Chen, Congheng; Xu, Zhixue; Zhou, Ping] Fudan Univ, Dept Macromol Sci, State Key Lab Mol Engn Polymers, Shanghai 200433, Peoples R China; [Zhang, Dang; Yang, Hongjie] Shanghai Univ Tradit Chinese Med, Yueyang Hosp Integrated Tradit Chinese & Western, Shanghai, Peoples R China; [Wu, Jiasheng] Shanghai Univ Tradit Chinese Med, Coll Pharm, Shanghai, Peoples R China	Fudan University; Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine	Yang, HJ (corresponding author), Shanghai Univ Tradit Chinese Med, Yueyang Hosp Integrated Tradit Chinese & Western, Shanghai, Peoples R China.	yanghongjie1964@yahoo.com.cn; pingzhou@fudan.edu.cn		Hongjie, Yang/0000-0002-8054-9313	Natural Science Foundation of China [20673022, 21074025]; Soft Science Program of Jing-An district in Shanghai [2008RZ002]; Scientific Program of Shanghai Municipal Public Health Bureau [2008220, 2010231]; Science and technology innovation program of Science and Technology Commission of Shanghai Municipality (STCSM) [11DZ1971802]; Innovation Program of Shanghai Municipal Education Commission [12ZZ009]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Soft Science Program of Jing-An district in Shanghai; Scientific Program of Shanghai Municipal Public Health Bureau; Science and technology innovation program of Science and Technology Commission of Shanghai Municipality (STCSM); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission)	This work was supported by the Natural Science Foundation of China (20673022, 21074025), the Soft Science Program of Jing-An district in Shanghai (2008RZ002), Scientific Program of Shanghai Municipal Public Health Bureau (2008220, 2010231). Science and technology innovation program of Science and Technology Commission of Shanghai Municipality (STCSM) (11DZ1971802), Innovation Program of Shanghai Municipal Education Commission (12ZZ009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1974, CATALASE METHOD ENZY; Arulselvan P, 2007, CHEM-BIOL INTERACT, V165, P155, DOI 10.1016/j.cbi.2006.10.014; Bettaieb A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034412; Day C, 1998, BRIT J NUTR, V80, P5, DOI 10.1017/S0007114598001718; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; FOLCH J, 1957, J BIOL CHEM, V226, P497; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Friedman JE, 1997, J BIOL CHEM, V272, P31475, DOI 10.1074/jbc.272.50.31475; Gomez-Valades AG, 2006, MOL THER, V13, P401, DOI 10.1016/j.ymthe.2005.08.026; Gupta S, 2005, EUR B DRUG RES, V13, P51; Huang CY, 2010, J AGR FOOD CHEM, V58, P8798, DOI 10.1021/jf1020158; IYNEDJIAN PB, 1988, J BIOL CHEM, V263, P740; Jung UJ, 2007, FOOD CHEM TOXICOL, V45, P2022, DOI 10.1016/j.fct.2007.04.021; KAHN CR, 1994, DIABETES, V43, P1066, DOI 10.2337/diab.43.8.1066; Kamalakkannan N, 2006, BASIC CLIN PHARMACOL, V98, P97, DOI 10.1111/j.1742-7843.2006.pto_241.x; Kenner KA, 1996, J BIOL CHEM, V271, P19810, DOI 10.1074/jbc.271.33.19810; Kitahara Y, 2002, METABOLISM, V51, P1452, DOI 10.1053/meta.2002.35195; Ko SH, 2004, BIOCHEM BIOPH RES CO, V316, P114, DOI 10.1016/j.bbrc.2004.02.023; Lelli SM, 2005, TOXICOLOGY, V216, P49, DOI 10.1016/j.tox.2005.07.016; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; Liu Z, 2008, CHEM-BIOL INTERACT, V173, P68, DOI 10.1016/j.cbi.2007.11.012; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Marnett LJ, 2000, CARCINOGENESIS, V21, P361, DOI 10.1093/carcin/21.3.361; Mollah ML, 2009, PHYTOTHER RES, V23, P220, DOI 10.1002/ptr.2593; National Institutes of Health, 2010, DIAB PRED STAT FACTS; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; OKA Y, 1990, DIABETES, V39, P441, DOI 10.2337/diabetes.39.4.441; ORLAND MJ, 1987, DIABETES, V36, P341, DOI 10.2337/diabetes.36.3.341; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Pei-Hwei W, 2008, FOOD CHEM TOXICOL, V46, P2554, DOI 10.1016/j.fct.2008.04.011; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Rahimi R, 2005, BIOMED PHARMACOTHER, V59, P365, DOI 10.1016/j.biopha.2005.07.002; Reddy SV, 2005, PHYTOTHER RES, V19, P277, DOI 10.1002/ptr.1491; SEIFTER S, 1950, ARCH BIOCHEM, V25, P191; Styskal J, 2012, FREE RADICAL BIO MED, V52, P46, DOI 10.1016/j.freeradbiomed.2011.10.441; Tahrani AA, 2010, PHARMACOL THERAPEUT, V125, P328, DOI 10.1016/j.pharmthera.2009.11.001; Teng BS, 2012, EUR REV MED PHARMACO, V16, P166; Teng BS, 2011, J AGR FOOD CHEM, V59, P6492, DOI 10.1021/jf200527y; Trajkovic LMH, 2009, NUTR CANCER, V61, P696, DOI 10.1080/01635580902898743; Wang CD, 2012, BRIT J NUTR, V108, P2014, DOI 10.1017/S0007114512000153; Weng CJ, 2009, J AGR FOOD CHEM, V57, P5049, DOI 10.1021/jf900828k; WOLFF SP, 1994, METHOD ENZYMOL, V233, P182; Yeh CH, 2010, J AGR FOOD CHEM, V58, P8535, DOI 10.1021/jf100914m; Young Ian S, 2005, J Psychopharmacol, V19, P66, DOI 10.1177/0269881105058374; Yu GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044031; Zhang L, 2010, J ETHNOPHARMACOL, V132, P518, DOI 10.1016/j.jep.2010.08.053	46	40	45	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e68332	10.1371/journal.pone.0068332	http://dx.doi.org/10.1371/journal.pone.0068332			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874589	gold, Green Published, Green Submitted			2022-12-27	WOS:000322218800025
J	Tobin, DM; Roca, FJ; Ray, JP; Ko, DC; Ramakrishnan, L				Tobin, David M.; Roca, Francisco J.; Ray, John P.; Ko, Dennis C.; Ramakrishnan, Lalita			An Enzyme That Inactivates the Inflammatory Mediator Leukotriene B-4 Restricts Mycobacterial Infection	PLOS ONE			English	Article							HUMAN POLYMORPHONUCLEAR LEUKOCYTES; TUBERCULOSIS; 12-HYDROXYDEHYDROGENASE; SUSCEPTIBILITY; EXPRESSION; ZEBRAFISH; RECEPTORS; PATHWAYS; CELLS	While tuberculosis susceptibility has historically been ascribed to failed inflammation, it is now known that an excess of leukotriene A(4) hydrolase (LTA4H), which catalyzes the final step in leukotriene B-4 (LTB4) synthesis, produces a hyperinflammatory state and tuberculosis susceptibility. Here we show that the LTB4-inactivating enzyme leukotriene B-4 dehydrogenase/prostaglandin reductase 1 (LTB4DH/PTGR1) restricts inflammation and independently confers resistance to tuberculous infection. LTB4DH overexpression counters the susceptibility resulting from LTA4H excess while ltb4dh-deficient animals can be rescued pharmacologically by LTB4 receptor antagonists. These data place LTB4DH as a key modulator of TB susceptibility and suggest new tuberculosis therapeutic strategies.	[Tobin, David M.; Ko, Dennis C.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27708 USA; [Tobin, David M.; Ko, Dennis C.] Duke Univ, Med Ctr, Ctr Microbial Pathogenesis, Durham, NC USA; [Ko, Dennis C.] Duke Univ, Med Ctr, Ctr AIDS Res, Durham, NC USA; [Ramakrishnan, Lalita] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Ramakrishnan, Lalita] Univ Washington, Dept Med, Seattle, WA USA; [Ramakrishnan, Lalita] Univ Washington, Dept Immunol, Seattle, WA 98195 USA	Duke University; Duke University; Duke University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Tobin, DM (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27708 USA.	david.tobin@duke.edu; lalitar@uw.edu	Ray, John/F-3187-2015	Ray, John/0000-0001-7294-4260; Tobin, David/0000-0003-3465-5518; Ramakrishnan, Lalita/0000-0003-0692-5533	NIH; Mallinckrodt Scholar Award; educational ministry of Spain; NWRCE for Biodefense and Emerging Infectious Diseases; NIH Director's New Innovator Award; NIH Director's Pioneer Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036396, R37AI054503, R01AI054503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH099901] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008614] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mallinckrodt Scholar Award; educational ministry of Spain; NWRCE for Biodefense and Emerging Infectious Diseases; NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funded by grants from the NIH (L.R.), a Mallinckrodt Scholar Award (D.M.T.), a postdoctoral fellowship from the educational ministry of Spain (F.J.R.), the NWRCE for Biodefense and Emerging Infectious Diseases (L.R. and D.C.K.). D.M.T. is a recipient of the NIH Director's New Innovator Award and L.R. is a recipient of the NIH Director's Pioneer Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KN, 2011, CELL, V145, P39, DOI 10.1016/j.cell.2011.02.022; Agarwal N, 2009, NATURE, V460, P98, DOI 10.1038/nature08123; Back M, 2006, ANN MED, V38, P493, DOI 10.1080/07853890600982737; Bafica A, 2005, J CLIN INVEST, V115, P1601, DOI 10.1172/JCI23949; Chen XX, 2003, J NATL CANCER I, V95, P1053, DOI 10.1093/jnci/95.14.1053; Cosma CL, 2006, INFECT IMMUN, V74, P3125, DOI 10.1128/IAI.02061-05; Cosma CL, CURRENT PROTOCOLS MI, pChapter; Davis JM, 2002, IMMUNITY, V17, P693, DOI 10.1016/S1074-7613(02)00475-2; ElAhmady O, 1997, ANN CLIN BIOCHEM, V34, P160, DOI 10.1177/000456329703400205; Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d; Hallstrand TS, 2010, CURR OPIN ALLERGY CL, V10, P60, DOI 10.1097/ACI.0b013e32833489c3; Hori T, 2004, J BIOL CHEM, V279, P22615, DOI 10.1074/jbc.M312655200; Maddox JE, 1996, J EXP MED, V183, P137, DOI 10.1084/jem.183.1.137; Mancuso P, 2010, INFECT IMMUN, V78, P2264, DOI 10.1128/IAI.01323-09; Mathis S, 2007, AUTOIMMUN REV, V7, P12, DOI 10.1016/j.autrev.2007.03.005; Nicolete R, 2009, INT J ANTIMICROB AG, V34, P365, DOI 10.1016/j.ijantimicag.2009.06.009; RAE SA, 1982, LANCET, V2, P1122; Roca FJ, 2013, CELL IN PRESS; Roca FJ, 2008, J IMMUNOL, V181, P5071, DOI 10.4049/jimmunol.181.7.5071; Serezani CH, 2006, J IMMUNOL, V177, P3201, DOI 10.4049/jimmunol.177.5.3201; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; SHAK S, 1984, J BIOL CHEM, V259, P181; SOBERMAN RJ, 1985, P NATL ACAD SCI USA, V82, P2292, DOI 10.1073/pnas.82.8.2292; Spite M, 2011, J IMMUNOL, V187, P1942, DOI 10.4049/jimmunol.1100196; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Tobin DM, 2012, CELL, V148, P434, DOI 10.1016/j.cell.2011.12.023; Tobin DM, 2010, CELL, V140, P717, DOI 10.1016/j.cell.2010.02.013; Wei L, 2011, INT J ONCOL, V39, P735, DOI 10.3892/ijo.2011.1082; YOKOMIZO T, 1993, J BIOL CHEM, V268, P18128; Yokomizo T, 1996, J BIOL CHEM, V271, P2844, DOI 10.1074/jbc.271.5.2844; Yokomizo T, 2000, J EXP MED, V192, P421, DOI 10.1084/jem.192.3.421; Zhao YH, 2010, LUNG CANCER, V68, P161, DOI 10.1016/j.lungcan.2009.06.011	32	34	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e67828	10.1371/journal.pone.0067828	http://dx.doi.org/10.1371/journal.pone.0067828			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874453	gold, Green Published, Green Submitted			2022-12-27	WOS:000322218800010
J	Deshpande, R; VanderSluis, B; Myers, CL				Deshpande, Raamesh; VanderSluis, Benjamin; Myers, Chad L.			Comparison of Profile Similarity Measures for Genetic Interaction Networks	PLOS ONE			English	Article							CORRELATION-COEFFICIENT; SALTONS COSINE; YEAST; MAP; CONSERVATION; EPISTASIS; PATHWAYS; BIOLOGY; SCALE	Analysis of genetic interaction networks often involves identifying genes with similar profiles, which is typically indicative of a common function. While several profile similarity measures have been applied in this context, they have never been systematically benchmarked. We compared a diverse set of correlation measures, including measures commonly used by the genetic interaction community as well as several other candidate measures, by assessing their utility in extracting functional information from genetic interaction data. We find that the dot product, one of the simplest vector operations, outperforms most other measures over a large range of gene pairs. More generally, linear similarity measures such as the dot product, Pearson correlation or cosine similarity perform better than set overlap measures such as Jaccard coefficient. Similarity measures that involve L-2-normalization of the profiles tend to perform better for the top-most similar pairs but perform less favorably when a larger set of gene pairs is considered or when the genetic interaction data is thresholded. Such measures are also less robust to the presence of noise and batch effects in the genetic interaction data. Overall, the dot product measure performs consistently among the best measures under a variety of different conditions and genetic interaction datasets.	[Deshpande, Raamesh; VanderSluis, Benjamin; Myers, Chad L.] Univ Minnesota Twin Cities, Dept Comp Sci & Engn, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities	Myers, CL (corresponding author), Univ Minnesota Twin Cities, Dept Comp Sci & Engn, Minneapolis, MN USA.	cmyers@cs.umn.edu			Biomedical Informatics and Computational Biology (BICB) traineeship; Doctoral Dissertation Fellowship (DDF), University of Minnesota; National Institutes of Health [1R01HG005084-01A1, 1R01HG005853-01]; National Science Foundation [DBI 0953881]; CIFAR Genetic Networks Program; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005853, R01HG005084] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [0953881] Funding Source: National Science Foundation	Biomedical Informatics and Computational Biology (BICB) traineeship; Doctoral Dissertation Fellowship (DDF), University of Minnesota; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); CIFAR Genetic Networks Program; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	RD was partially funded by a Biomedical Informatics and Computational Biology (BICB) traineeship, and RD and BV are currently funded by Doctoral Dissertation Fellowship (DDF), University of Minnesota. CLM, BV and RD are also partially supported by grants from the National Institutes of Health (1R01HG005084-01A1, 1R01HG005853-01) and a grant from the National Science Foundation (DBI 0953881). CLM is also supported by the CIFAR Genetic Networks Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler J, 2010, CYTOM PART A, V77A, P733, DOI 10.1002/cyto.a.20896; [Anonymous], 1901, B SOC VANDOISE SCI N, V37; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; AVERY L, 1992, TRENDS GENET, V8, P312, DOI 10.1016/0168-9525(92)90263-4; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Baryshnikova A, 2010, NAT METHODS, V7, P1017, DOI 10.1038/NMETH.1534; Bellay J, 2011, GENOME RES, V21, P1375, DOI 10.1101/gr.117176.110; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Collins SR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r63; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Dalirsefat SB, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.7101; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dixon SJ, 2008, P NATL ACAD SCI USA, V105, P16653, DOI 10.1073/pnas.0806261105; Egghe L, 2009, J AM SOC INF SCI TEC, V60, P1027, DOI 10.1002/asi.21009; Falkowski BJ, 1998, J AM SOC INFORM SCI, V49, P854, DOI 10.1002/(SICI)1097-4571(199807)49:9<854::AID-ASI11>3.0.CO;2-N; Gillis J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017258; Haranczyk M, 2008, J CHEM INF MODEL, V48, P498, DOI 10.1021/ci700413a; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; Leiserson MDM, 2011, J COMPUT BIOL, V18, P1399, DOI 10.1089/cmb.2011.0191; Leydesdorff L, 2008, J AM SOC INF SCI TEC, V59, P77, DOI 10.1002/asi.20732; Mani R, 2008, P NATL ACAD SCI USA, V105, P3461, DOI 10.1073/pnas.0712255105; Myers CL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-187; Obayashi T, 2009, DNA RES, V16, P249, DOI 10.1093/dnares/dsp016; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; Pearson K, 1920, BIOMETRIKA, V13, P25, DOI 10.1093/biomet/13.1.25; Reshef DN, 2011, SCIENCE, V334, P1518, DOI 10.1126/science.1205438; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609; Russell PF, 1940, J MALAR I INDIA, V3, P25; Ryan CJ, 2012, MOL CELL, V46, P691, DOI 10.1016/j.molcel.2012.05.028; Schechtman E, 1999, ECON LETT, V63, P133, DOI 10.1016/S0165-1765(99)00033-6; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; Typas A, 2008, NAT METHODS, V5, P781, DOI 10.1038/NMETH.1240; Wang ZW, 1992, P SIGIR 92 P 15 ANN; Yona G, 2006, BIOINFORMATICS, V22, P1616, DOI 10.1093/bioinformatics/btl127	36	20	20	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68664	10.1371/journal.pone.0068664	http://dx.doi.org/10.1371/journal.pone.0068664			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874711	Green Published, Green Submitted, gold			2022-12-27	WOS:000321765300061
J	Guariglia, C; Palermo, L; Piccardi, L; Iaria, G; Incoccia, C				Guariglia, Cecilia; Palermo, Liana; Piccardi, Laura; Iaria, Giuseppe; Incoccia, Chiara			Neglecting the Left Side of a City Square but Not the Left Side of Its Clock: Prevalence and Characteristics of Representational Neglect	PLOS ONE			English	Article							UNILATERAL NEGLECT; WORKING-MEMORY; MENTAL-IMAGERY; VISUAL-IMAGERY; SPACE; DISSOCIATION; HEMINEGLECT; TRANSFORMATIONS; REHABILITATION; STIMULATION	Representational neglect, which is characterized by the failure to report left-sided details of a mental image from memory, can occur after a right hemisphere lesion. In this study, we set out to verify the hypothesis that two distinct forms of representational neglect exist, one involving object representation and the other environmental representation. As representational neglect is considered rare, we also evaluated the prevalence and frequency of its association with perceptual neglect. We submitted a group of 96 unselected, consecutive, chronic, right brain-damaged patients to an extensive neuropsychological evaluation that included two representational neglect tests: the Familiar Square Description Test and the O'Clock Test. Representational neglect, as well as perceptual neglect, was present in about one-third of the sample. Most patients neglected the left side of imagined familiar squares but not the left side of imagined clocks. The present data show that representational neglect is not a rare disorder and also support the hypothesis that two different types of mental representations (i.e. topological and non-topological images) may be selectively damaged in representational neglect.	[Guariglia, Cecilia; Palermo, Liana] Univ Roma La Sapienza, Dipartimento Psicol, I-00185 Rome, Italy; [Guariglia, Cecilia; Palermo, Liana; Piccardi, Laura; Incoccia, Chiara] IRCCS Fdn Santa Lucia, Lab DiViNa, Rome, Italy; [Piccardi, Laura] Univ Aquila, Dipartimento Med Clin Sanita Publ Sci Vita & Ambi, Coppito, AQ, Italy; [Iaria, Giuseppe] Univ Calgary, Dept Psychol, NeuroLab, Calgary, AB T2N 1N4, Canada; [Iaria, Giuseppe] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Iaria, Giuseppe] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada	Sapienza University Rome; IRCCS Santa Lucia; University of L'Aquila; University of Calgary; University of Calgary; University of Calgary	Guariglia, C (corresponding author), Univ Roma La Sapienza, Dipartimento Psicol, I-00185 Rome, Italy.	cecilia.guariglia@uniroma1.it	guariglia, cecilia/J-9898-2018; Palermo, Liana/ABG-2726-2021; Piccardi, laura/AAC-7587-2022	Palermo, Liana/0000-0001-8047-7201; Piccardi, Laura/0000-0002-1322-5538; Incoccia, Chiara/0000-0003-4068-6548; guariglia, cecilia/0000-0001-7474-6030; Iaria, Giuseppe/0000-0002-5987-6491	Ministero della Salute	Ministero della Salute(Ministry of Health, Italy)	Prof. C. Guariglia was supported by grants from the Ministero della Salute (RC 2011-2012). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT ML, 1973, NEUROLOGY, V23, P658, DOI 10.1212/WNL.23.6.658; ANDERSON B, 1993, NEUROLOGY, V43, P213, DOI 10.1212/WNL.43.1_Part_1.213; [Anonymous], 1989, PSYCHOL ASSESSMENT; Arduino LS, 2012, J NEUROPSYCHOL, V6, P43, DOI 10.1111/j.1748-6653.2011.02003.x; Bartolomeo P, 2005, NEUROPSYCHOLOGIA, V43, P1249, DOI 10.1016/j.neuropsychologia.2004.12.013; BARTOLOMEO P, 1994, NEUROLOGY, V44, P1710, DOI 10.1212/WNL.44.9.1710; Beschin N, 1997, CORTEX, V33, P3, DOI 10.1016/S0010-9452(97)80002-0; Beschin N, 2000, CORTEX, V36, P401, DOI 10.1016/S0010-9452(08)70849-9; BISIACH E, 1986, NEUROPSYCHOLOGIA, V24, P759, DOI 10.1016/0028-3932(86)90075-8; BISIACH E, 1979, BRAIN, V102, P609, DOI 10.1093/brain/102.3.609; BISIACH E, 1993, Q J EXP PSYCHOL-A, V46, P435, DOI 10.1080/14640749308401056; Bisiach E., 2000, HDB NEUROPSYCHOLOGY, P459; Bisiach E, 1978, UNILATERAL NEGLECT R; Ciurli P., 1996, ESAME LINGUAGGIO; Corsi PM, 1972, HUMAN MEMORY MEDIAL, DOI DOI 10.1111/DESC.12126; Coslett HB, 1997, BRAIN, V120, P1163, DOI 10.1093/brain/120.7.1163; Crawford JR, 2005, NEUROPSYCHOLOGY, V19, P664, DOI 10.1037/0894-4105.19.5.664; Crawford JR, 1998, CLIN NEUROPSYCHOL, V12, P482, DOI 10.1076/clin.12.4.482.7241; Cristinzio C, 2009, CORTEX, V45, P313, DOI 10.1016/j.cortex.2008.03.013; Della Sala S, 2004, NEUROPSYCHOLOGIA, V42, P1358, DOI 10.1016/j.neuropsychologia.2004.02.011; Diller L, 1977, Adv Neurol, V18, P63; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GROSSI D, 1989, BRAIN COGNITION, V10, P18, DOI 10.1016/0278-2626(89)90072-9; Guariglia C, 2005, NEUROPSYCHOLOGIA, V43, P1138, DOI 10.1016/j.neuropsychologia.2004.11.021; GUARIGLIA C, 1992, NEUROPSYCHOLOGIA, V30, P1001, DOI 10.1016/0028-3932(92)90051-M; GUARIGLIA C, 1993, NATURE, V364, P235, DOI 10.1038/364235a0; Guariglia C, 2006, ADV CONSC RES, V66, P283; Heilman KM, 2000, SEMIN NEUROL, V20, P463, DOI 10.1055/s-2000-13179; Kerkhoff G, 2001, PROG NEUROBIOL, V63, P1, DOI 10.1016/S0301-0082(00)00028-9; Kosslyn S. M., 1980, IMAGE MIND; Logie RH, 2005, MEMORY, V13, P430, DOI 10.1080/09658210344000431; MASSIRONI M, 1988, NEUROPSYCHOLOGIA, V26, P161, DOI 10.1016/0028-3932(88)90039-5; Morgan LK, 2011, J NEUROSCI, V31, P1238, DOI 10.1523/JNEUROSCI.4667-10.2011; OGDEN JA, 1985, NEUROPSYCHOLOGIA, V23, P273, DOI 10.1016/0028-3932(85)90112-5; Ortigue S, 2003, NEUROLOGY, V60, P2000, DOI 10.1212/01.WNL.0000068028.63291.B6; PAIVIO A, 1978, J EXP PSYCHOL HUMAN, V4, P61, DOI 10.1037/0096-1523.4.1.61; Palermo L, 2012, NEUROPSYCHOLOGIA, V50, P904, DOI 10.1016/j.neuropsychologia.2012.01.030; Palermo L, 2010, COGN NEUROPSYCHOL, V27, P115, DOI 10.1080/02643294.2010.503478; Palermo L, 2010, J INT NEUROPSYCH SOC, V16, P921, DOI 10.1017/S1355617710000305; Piccardi L, 2008, NEUROCASE, V14, P329, DOI 10.1080/13554790802366012; Pizzamiglio L, 2004, CORTEX, V40, P441, DOI 10.1016/S0010-9452(08)70138-2; Pizzamiglio L, 1996, ADV PSYCHOLINGUIST, P157; Raven J.C., 1938, RAVENS PROGRESSIVE M; Rode G, 2010, NEUROPSYCHOLOGIA, V48, P2903, DOI 10.1016/j.neuropsychologia.2010.05.032; Spinnler H., 1987, ITAL J NEUROL SCI, V6, P1; Street RF, 1931, TEACH COLL REC, V33, P280; TROJANO L, 1994, BRAIN COGNITION, V24, P213, DOI 10.1006/brcg.1994.1012; Trojano L, 2000, CEREB CORTEX, V10, P473, DOI 10.1093/cercor/10.5.473; Vallar G, 2001, NEUROIMAGE, V14, pS52, DOI 10.1006/nimg.2001.0822; Vallar Giuseppe, 2003, Adv Neurol, V93, P293; WEINTRAUB S, 1988, J NEUROL NEUROSUR PS, V51, P1481, DOI 10.1136/jnnp.51.12.1481; Wojciulik E, 2001, NEUROPSYCHOLOGIA, V39, P390, DOI 10.1016/S0028-3932(00)00131-7	52	39	39	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e67390	10.1371/journal.pone.0067390	http://dx.doi.org/10.1371/journal.pone.0067390			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	182SU	23874416	Green Published, gold, Green Submitted			2022-12-27	WOS:000321765300009
J	Potluri, V; Noothi, SK; Vallabhapurapu, SD; Yoon, SO; Driscoll, JJ; Lawrie, CH; Vallabhapurapu, S				Potluri, Veena; Noothi, Sunil K.; Vallabhapurapu, Subrahmanya D.; Yoon, Sang-Oh; Driscoll, James J.; Lawrie, Charles H.; Vallabhapurapu, Sivakumar			Transcriptional Repression of Bim by a Novel YY1-RelA Complex Is Essential for the Survival and Growth of Multiple Myeloma	PLOS ONE			English	Article							NF-KAPPA-B; CELL-LINES; MOLECULAR CLASSIFICATION; XENOPUS OOCYTES; GENETIC EVENTS; CANCER; YY1; PROLIFERATION; LOCALIZATION; PATHOGENESIS	Multiple Myeloma (MM) is an incurable plasma cell cancer that is caused by several chromosomal translocations and gene deletions. Although deregulation of several signaling pathways including the Nuclear Factor-Kappa B (NF-kappa B) pathway has been reported in MM, the molecular requirement and the crosstalk between NF-kappa B and its target genes in MM cell survival has been largely unclear. Here, we report that Yin Yang1 (YY1), a target gene for NF-kappa B, is hyperexpressed in most MM tumor cells obtained from human patients, exhibits constitutive nuclear localization, and is essential for survival of MM cells. Mechanistically, we report a novel YY1-RelA complex formation, which is essential to transcriptionally repress a proapoptotic gene Bim. In line with this, depletion of YY1 or RelA resulted in elevated levels of Bim and apoptosis. Moreover, both YY1 and RelA are recruited to the Bim promoter and are required to repress the Bim promoter. Importantly, depletion of YY1 or RelA almost completely impaired the colony forming ability of MM progenitor cells suggesting that both RelA and YY1 are essential for the survival and growth of MM progenitor cells. Moreover, depletion of either YY1 or RelA completely inhibited MM tumor growth in xenograft models for human myeloma. Thus, a novel RelA-YY1 transcriptional repression complex is an attractive drug target in MM.	[Potluri, Veena; Noothi, Sunil K.; Vallabhapurapu, Subrahmanya D.; Yoon, Sang-Oh; Vallabhapurapu, Sivakumar] Univ Cincinnati, Coll Med, Dept Canc & Cell Biol, Cincinnati, OH 45221 USA; [Driscoll, James J.] Univ Cincinnati, Coll Med, Div Hematol & Oncol, Cincinnati, OH USA; [Lawrie, Charles H.] Univ Oxford, Biodonostia Res Inst, Spain & Nuffield Dept, Clin Sci Lab, Oxford, England	University of Cincinnati; University of Cincinnati; University of Oxford	Vallabhapurapu, S (corresponding author), Univ Cincinnati, Coll Med, Dept Canc & Cell Biol, Cincinnati, OH 45221 USA.	vallabsr@ucmail.uc.edu	Nooti, Sunil K./H-7740-2017	Nooti, Sunil K./0000-0002-0381-0864; Lawrie, Charles/0000-0002-8882-1131; Driscoll, James/0000-0001-8364-0617	Department of Cancer and Cell Biology, University of Cincinnati; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER	Department of Cancer and Cell Biology, University of Cincinnati; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This project received Start Up funds from the Department of Cancer and Cell Biology, University of Cincinnati. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Bergsagel PL, 1996, P NATL ACAD SCI USA, V93, P13931, DOI 10.1073/pnas.93.24.13931; Castellano G, 2009, CELL CYCLE, V8, P1367, DOI 10.4161/cc.8.9.8314; Chng W J, 2008, Leukemia, V22, P459, DOI 10.1038/sj.leu.2404934; Chng WJ, 2007, BEST PRACT RES CL HA, V20, P571, DOI 10.1016/j.beha.2007.08.004; Cook G, 1999, J LEUKOCYTE BIOL, V66, P981, DOI 10.1002/jlb.66.6.981; Ficzycz A, 2002, J BIOL CHEM, V277, P8382, DOI 10.1074/jbc.M110304200; Ficzycz A, 2001, J BIOL CHEM, V276, P22819, DOI 10.1074/jbc.M011188200; Fonseca R, 2009, LEUKEMIA, V23, P2210, DOI 10.1038/leu.2009.174; Galvin KM, 1997, MOL CELL BIOL, V17, P3723, DOI 10.1128/MCB.17.7.3723; Gillings AS, 2009, FEBS J, V276, P6050, DOI 10.1111/j.1742-4658.2009.07329.x; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; HITZLER JK, 1991, BLOOD, V78, P1996, DOI 10.1182/blood.V78.8.1996.1996; Inta I, 2006, J NEUROSCI, V26, P12896, DOI 10.1523/JNEUROSCI.3670-06.2006; JACKSON N, 1989, CLIN EXP IMMUNOL, V75, P93; Jakubikova J, 2011, BLOOD, V117, P4409, DOI 10.1182/blood-2010-02-267344; Jensen Mette Munk, 2008, BMC Med Imaging, V8, P16, DOI 10.1186/1471-2342-8-16; Jiang CC, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.48; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Kuehl W Michael, 2005, Hematology Am Soc Hematol Educ Program, P346; Kuehl WM, 2012, J CLIN INVEST, V122, P3456, DOI 10.1172/JCI61188; Kuehl WM, 2002, NAT REV CANCER, V2, P175, DOI 10.1038/nrc746; Laubach JP, 2009, LEUKEMIA LYMPHOMA, V50, P694, DOI 10.1080/10428190902866732; Ley R, 2005, CELL DEATH DIFFER, V12, P1008, DOI 10.1038/sj.cdd.4401688; Lopez-Royuela N, 2010, BBA-MOL CELL RES, V1803, P311, DOI 10.1016/j.bbamcr.2009.11.004; Matsui W, 2004, BLOOD, V103, P2332, DOI 10.1182/blood-2003-09-3064; Matsui W, 2008, CANCER RES, V68, P190, DOI 10.1158/0008-5472.CAN-07-3096; Mertins SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057099; NAMBA M, 1989, IN VITRO CELL DEV B, V25, P723; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; Palko L, 2004, J CELL SCI, V117, P465, DOI 10.1242/jcs.00870; Rizkallah R, 2009, MOL BIOL CELL, V20, P4766, DOI 10.1091/mbc.E09-04-0264; Romagnoli M, 2009, BRIT J HAEMATOL, V145, P180, DOI 10.1111/j.1365-2141.2009.07608.x; Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3; Sivakumar V, 2003, J EXP MED, V197, P1613, DOI 10.1084/jem.20022234; Strasser A, 2000, ANN NY ACAD SCI, V917, P541; Takebe N, 2011, NAT REV CLIN ONCOL, V8, P97, DOI 10.1038/nrclinonc.2010.196; Tan BT, 2006, LAB INVEST, V86, P1203, DOI 10.1038/labinvest.3700488; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wang HT, 2007, MOL CELL BIOL, V27, P4374, DOI 10.1128/MCB.02020-06; Yang H, 2011, CANCER RES, V71, P5040, DOI 10.1158/0008-5472.CAN-11-0842; Zhan F, 2006, BLOOD, V108, P2020, DOI 10.1182/blood-2005-11-013458	45	17	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e66121	10.1371/journal.pone.0066121	http://dx.doi.org/10.1371/journal.pone.0066121			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874387	Green Submitted, Green Published, gold			2022-12-27	WOS:000321765300003
J	Iikura, M; Yi, SY; Ichimura, Y; Hori, A; Izumi, S; Sugiyama, H; Kudo, K; Mizoue, T; Kobayashi, N				Iikura, Motoyasu; Yi, Siyan; Ichimura, Yasunori; Hori, Ai; Izumi, Shinyu; Sugiyama, Haruhito; Kudo, Koichiro; Mizoue, Tetsuya; Kobayashi, Nobuyuki			Effect of Lifestyle on Asthma Control in Japanese Patients: Importance of Periodical Exercise and Raw Vegetable Diet	PLOS ONE			English	Article							PASSIVE SMOKING; POPULATION; PATTERNS; OBESITY; RISK	Background: The avoidance of inhaled allergens or tobacco smoke has been known to have favorable effects on asthma control. However, it remains unclear whether other lifestyle-related factors are also related to asthma control. Therefore, a comprehensive study to examine the associations between various lifestyle factors and asthma control was conducted in Japanese asthmatic patients. Methods: The study subjects included 437 stable asthmatic patients recruited from our outpatient clinic over a one-year period. A written, informed consent was obtained from each participant. Asthma control was assessed using the asthma control test (ACT), and a structured questionnaire was administered to obtain information regarding lifestyle factors, including tobacco smoking, alcohol drinking, physical exercise, and diet. Both bivariate and multivariate analyses were conducted. Results: The proportions of total control (ACT = 25), well controlled (ACT = 20-24), and poorly controlled (ACT < 20) were 27.5%, 48.1%, and 24.5%, respectively. The proportions of patients in the asthma treatment steps as measured by Global Initiative for Asthma 2007 in step 1, step 2, step 3, step 4, and step 5 were 5.5%, 17.4%, 7.6%, 60.2%, and 9.4%, respectively. Body mass index, direct tobacco smoking status and alcohol drinking were not associated with asthma control. On the other hand, younger age (< 65 years old), passive smoking, periodical exercise (> 3 metabolic equivalents-h/week), and raw vegetable intake (> 5 units/week) were significantly associated with good asthma control by bivariate analysis. Younger age, periodical exercise, and raw vegetable intake were significantly associated with good asthma control by multiple linear regression analysis. Conclusions: Periodical exercise and raw vegetable intake are associated with good asthma control in Japanese patients.	[Iikura, Motoyasu; Ichimura, Yasunori; Izumi, Shinyu; Sugiyama, Haruhito; Kudo, Koichiro; Kobayashi, Nobuyuki] Natl Ctr Global Hlth & Med, Dept Resp Med, Tokyo, Japan; [Yi, Siyan; Hori, Ai; Mizoue, Tetsuya] Natl Ctr Global Hlth & Med, Dept Epidemiol & Int Hlth, Tokyo, Japan	National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan	Iikura, M (corresponding author), Natl Ctr Global Hlth & Med, Dept Resp Med, Tokyo, Japan.	iikura-tky@umin.ac.jp	Hori, Ai/G-5277-2019	Hori, Ai/0000-0002-0191-5996	Ministry of Health and Welfare of Japan	Ministry of Health and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by grants-in-aid from the Ministry of Health and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakirtas Arzu, 2009, Inflammation & Allergy Drug Targets, V8, P353; Bakolis I, 2010, ALLERGY, V65, P606, DOI 10.1111/j.1398-9995.2009.02215.x; Barros R, 2011, BRIT J NUTR, V106, P441, DOI 10.1017/S0007114511000328; Diez JD, 2008, J ASTHMA, V45, P740, DOI 10.1080/02770900802216783; Forastiere F, 2000, THORAX, V55, P283, DOI 10.1136/thorax.55.4.283; Barcala FJG, 2010, ARCH BRONCONEUMOL, V46, P358, DOI 10.1016/j.arbres.2010.01.007; Gonzalez R, 2011, CRIT REV FOOD SCI, V51, P331, DOI 10.1080/10408390903584094; Hartert TV, 2001, CURR OPIN ALLERGY CL, V1, P421, DOI 10.1097/00130832-200110000-00007; Hirota R, 2010, J FOOD SCI, V75, pH87, DOI 10.1111/j.1750-3841.2010.01541.x; Lucas SR, 2005, J ALLERGY CLIN IMMUN, V115, P928, DOI 10.1016/j.jaci.2005.01.033; Mougey EB, 2011, J CLIN PHARMACOL, V51, P751, DOI 10.1177/0091270010374472; Nagel G, 2010, THORAX, V65, P516, DOI 10.1136/thx.2009.128256; Nja F, 2005, ACTA PAEDIATR, V94, P147, DOI 10.1080/08035250410023638; Patel BD, 2006, THORAX, V61, P388, DOI 10.1136/thx.2004.024935; Radon K, 2002, CHEST, V122, P1086, DOI 10.1378/chest.122.3.1086; Rodriguez-Rodriguez E, 2010, EUR J CLIN NUTR, V64, P1065, DOI 10.1038/ejcn.2010.127; Ronmark E, 2005, EUR RESPIR J, V25, P282, DOI 10.1183/09031936.05.00054304; Varraso R, 2009, EUR RESPIR J, V33, P33, DOI 10.1183/09031936.00130807; Westermann H, 2008, ANN ALLERG ASTHMA IM, V101, P488, DOI 10.1016/S1081-1206(10)60287-6; Wood LG, 2012, AM J CLIN NUTR, V96, P534, DOI 10.3945/ajcn.111.032623; Young SYN, 2001, ARCH INTERN MED, V161, P1605, DOI 10.1001/archinte.161.13.1605	21	17	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68290	10.1371/journal.pone.0068290	http://dx.doi.org/10.1371/journal.pone.0068290			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874577	gold, Green Submitted, Green Published			2022-12-27	WOS:000321736900078
J	Muratsu, D; Yoshiga, D; Taketomi, T; Onimura, T; Seki, Y; Matsumoto, A; Nakamura, S				Muratsu, Daichi; Yoshiga, Daigo; Taketomi, Takaharu; Onimura, Tomohiro; Seki, Yoshihiro; Matsumoto, Akinobu; Nakamura, Seiji			Zoledronic Acid Enhances Lipopolysaccharide-Stimulated Proinflammatory Reactions through Controlled Expression of SOCS1 in Macrophages	PLOS ONE			English	Article							IN-VITRO; BISPHOSPHONATES; BONE; PATHWAY; IMMUNE; VIVO; OSTEONECROSIS; MECHANISMS; NECROSIS; JAWS	Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a serious side effect of nitrogen-containing bisphosphonate (NBP) use. Many studies have shown that BRONJ is limited to the jawbone and does not occur in the other bones. We hypothesized that BRONJ is related to local bacterial iections and involves the innate immune system. To examine the relationship between BRONJ and innate immunity, we examined the effects of NBPs on macrophages, one of the important cell types in innate immunity. The expression of toll-like receptor-4 (TLR4) in cells after pretreatment with zoledronic acid (ZOL) did not considerably differ from that in untreated control cells. However, cytokine levels and nitric oxide (NO) production increased after pretreatment with ZOL. Furthermore, ZOL induced NF-kappa B activation by enhancing I kappa B-alpha degradation. Lipopolysaccharide (LPS)-induced apoptosis also increased after pretreatment with ZOL. This effect was mediated by a reduction of suppressor of cytokine signaling-1 (SOCS1), which is a negative regulator of myeloid differentiation primary response gene 88 (MyD 88)-dependent signaling. These results suggest that ZOL induced excessive innate immune response and proinflammatory cytokine production and that these processes may be involved in the bone destruction observed in BRONJ.	[Muratsu, Daichi; Taketomi, Takaharu; Onimura, Tomohiro; Nakamura, Seiji] Kyushu Univ, Fac Dent Sci, Div Maxillofacial Diagnost & Surg Sci, Sect Oral & Maxillofacial Oncol, Fukuoka 812, Japan; [Yoshiga, Daigo] Kyushu Dent Coll, Dept Oral & Maxillofacial Surg, Div Oral & Maxillofacial Reconstruct Surg, Fukuoka, Japan; [Seki, Yoshihiro] Kyushu Univ, Grad Sch Med Sci, Dept Neuropsychiat, Fukuoka 812, Japan; [Matsumoto, Akinobu] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Fukuoka 812, Japan; [Matsumoto, Akinobu] Harvard Univ, Sch Med, Beth Israel Deaconess Canc Ctr, Boston, MA USA; [Matsumoto, Akinobu] Harvard Univ, Sch Med, Canc Genet Program, Boston, MA USA; [Matsumoto, Akinobu] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Div Genet, Boston, MA 02215 USA; [Matsumoto, Akinobu] Harvard Univ, Sch Med, Dept Pathol & Med, Boston, MA USA	Kyushu University; Kyushu Dental University; Kyushu University; Kyushu University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School	Yoshiga, D (corresponding author), Kyushu Dent Coll, Dept Oral & Maxillofacial Surg, Div Oral & Maxillofacial Reconstruct Surg, Fukuoka, Japan.	r11yoshiga@fa.kyu-dent.ac.jp	Matsumoto, Akinobu/GPF-4945-2022; YOSHIGA, Daigo/GZM-9352-2022	YOSHIGA, Daigo/0000-0001-9603-3138; Matsumoto, Akinobu/0000-0002-4077-3935	 [21890185]		Grant number: 21890185; URL:http://www.jsps.go.jp/j-grantsinaid/03_keikaku/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliprantis AO, 2000, EMBO J, V19, P3325, DOI 10.1093/emboj/19.13.3325; ANDERSON KV, 1985, CELL, V42, P791, DOI 10.1016/0092-8674(85)90275-2; Berenson JR, 1999, ANNU REV MED, V50, P237; Chinen T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1181; Favia G, 2009, BONE, V45, P406, DOI 10.1016/j.bone.2009.05.008; Greenberger S, 2010, NEW ENGL J MED, V362, P1005, DOI 10.1056/NEJMoa0903036; Herrington CS, 2008, J PATHOL, V214, P123, DOI 10.1002/path.2303; Hoekman K, 1997, Ned Tijdschr Geneeskd, V141, P2217; Hubbard LL, 2010, INFECT DIS REPORTS, V2; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Kobayashi Y, 2010, J BONE MINER METAB, V28, P165, DOI 10.1007/s00774-009-0128-9; Lee SH, 2002, J BIOL CHEM, V277, P23358, DOI 10.1074/jbc.M111559200; Licata AA, 2005, ANN PHARMACOTHER, V39, P668, DOI 10.1345/aph.1E357; Lipton A, 2008, CANCER TREAT REV, V34, pS25, DOI 10.1016/j.ctrv.2008.03.008; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Marx RE, 2003, J ORAL MAXIL SURG, V61, P1115, DOI 10.1016/S0278-2391(03)00720-1; Migliorati CA, 2005, CANCER, V104, P83, DOI 10.1002/cncr.21130; Naik NH, 2009, CLIN INFECT DIS, V49, P1729, DOI 10.1086/648075; Norton JT, 2011, P NATL ACAD SCI USA, V108, P11163, DOI 10.1073/pnas.1107899108; Patschan D, 2001, BONE, V29, P498, DOI 10.1016/S8756-3282(01)00610-X; Ramaswamy Bhuvaneswari, 2003, Oncology (Williston Park), V17, P1261; Reuben JS, 2011, ORAL SURG ORAL MED O, V111, P196, DOI 10.1016/j.tripleo.2010.09.068; Ribatti D, 2008, ONCOL REP, V19, P1109; Rogers MJ, 1997, CANCER, V80, P1652, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1652::AID-CNCR15>3.0.CO;2-Z; Ruggiero Salvatore L, 2008, Dent Clin North Am, V52, P111, DOI 10.1016/j.cden.2007.09.002; Saito K, 2003, J BIOL CHEM, V278, P38571, DOI 10.1074/jbc.M304948200; Salesi N, 2006, ANTICANCER RES, V26, P3111; SATO M, 1991, J CLIN INVEST, V88, P2095, DOI 10.1172/JCI115539; Thiebaud D, 1997, CALCIFIED TISSUE INT, V61, P386, DOI 10.1007/s002239900353; Usui T, 1997, XENOBIOTICA, V27, P479, DOI 10.1080/004982597240442; van Beek ER, 2003, BONE, V33, P805, DOI 10.1016/j.bone.2003.07.007; Weinberg J Brice, 2007, Subcell Biochem, V42, P31; Wesche-Soldato DE, 2007, CURR DRUG TARGETS, V8, P493, DOI 10.2174/138945007780362764; Wilde F, 2009, ORAL SURG ORAL MED O, V107, P412, DOI 10.1016/j.tripleo.2008.09.019	35	38	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e67906	10.1371/journal.pone.0067906	http://dx.doi.org/10.1371/journal.pone.0067906			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874464	gold, Green Published, Green Submitted			2022-12-27	WOS:000321736900034
J	Ye, CH; Lu, XL; Zheng, MY; Zhen, J; Li, ZP; Shi, L; Liu, ZY; Feng, LY; Pei, Z; Yao, XL				Ye, Cheng-hui; Lu, Xi-lin; Zheng, Min-ying; Zhen, Jun; Li, Zhi-Ping; Shi, Lei; Liu, Zhi-yong; Feng, Lu-yang; Pei, Zhong; Yao, Xiao-li			Absence of Mutations in Exon 6 of the TARDBP Gene in 207 Chinese Patients with Sporadic Amyotrohic Lateral Sclerosis	PLOS ONE			English	Article							TDP-43	Mutations in the TARDBP gene, which encodes the Tar DNA binding protein, have been shown to causes of both familial amyotrophic lateral sclerosis (FALS) and sporadic ALS (SALS). Recently, several novel TARDBP exon 6 mutants have been reported in patients with ALS in Europe and America but not in Asia. To further examine the spectrum and frequency of TARDBP exon 6 mutations, we investigated their frequency in ethnic Chinese patients with sporadic ALS. TARDBP exon 6 was screened by direct sequencing in 207 non-SOD1 SALS patients and 230 unrelated healthy controls but no mutations were identified. Our data indicate that exon 6 mutations in TARDBP are not a common cause of SALS in Han Chinese population from Southern Mainland China.	[Ye, Cheng-hui; Lu, Xi-lin; Zheng, Min-ying; Liu, Zhi-yong; Feng, Lu-yang; Pei, Zhong; Yao, Xiao-li] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China; [Zhen, Jun] Sun Yat Sen Univ, Affiliated Hosp 5, Dept Rehabil Med, Zhuhai, Guangdong, Peoples R China; [Li, Zhi-Ping] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Resp Med, Guangzhou 510275, Guangdong, Peoples R China; [Ye, Cheng-hui] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Geriatr, Guangzhou 510275, Guangdong, Peoples R China; [Lu, Xi-lin; Shi, Lei; Feng, Lu-yang; Pei, Zhong] Guangdong Key Lab Diag & Treatment Major Neurol D, Guangzhou, Guangdong, Peoples R China; [Yao, Xiao-li] Natl Key Clin Dept, Guangzhou, Guangdong, Peoples R China; [Yao, Xiao-li] Natl Key Discipline, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Pei, Z (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China.	peizhong@yahoo.com; liliyao71@163.com	Liu, Zhiyong/AAJ-2551-2020	Liu, Zhiyong/0000-0002-2959-5189	National Key Clinical Department; National Key Discipline; Guangdong Key Laboratory For Diagnosis And Treatment of Major Neurological Diseases; National Natural Science Foundation of China [81100936]; National Key New Drug Creation Program [2009ZX09103-039]; Key Scientific and Technological Projects of Guangdong Province [2010B050700024, 2012B031800107]; Natural Science Foundation of Guangdong Province [S2011010004860]	National Key Clinical Department; National Key Discipline; Guangdong Key Laboratory For Diagnosis And Treatment of Major Neurological Diseases; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key New Drug Creation Program; Key Scientific and Technological Projects of Guangdong Province; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This study was supported by grants from the National Key Clinical Department, National Key Discipline and Guangdong Key Laboratory For Diagnosis And Treatment of Major Neurological Diseases. This study was supported by the grants from the National Natural Science Foundation of China (number 81100936), the National Key New Drug Creation Program (2009ZX09103-039), the Key Scientific and Technological Projects of Guangdong Province (2010B050700024, 2012B031800107), and the Natural Science Foundation of Guangdong Province(S2011010004860). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Guerreiro RJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002450; Huang R, 2012, NEUROBIOL AGING, V33, P1011; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Iida A, 2012, NEUROBIOL AGING, V33, P786, DOI 10.1016/j.neurobiolaging.2010.06.017; Lagier-Tourenne C, 2009, CELL, V136, P1001, DOI 10.1016/j.cell.2009.03.006; Lattante S, 2013, HUM MUTAT; Paul M, 2012, BIOMED CHROMATOGR, V26, P350, DOI 10.1002/bmc.1664; Tsai CP, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.04.009; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Xiong HL, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-8; Zou ZY, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.03.014	13	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68106	10.1371/journal.pone.0068106	http://dx.doi.org/10.1371/journal.pone.0068106			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874513	Green Published, gold, Green Submitted			2022-12-27	WOS:000321736900057
J	Zhang, S; Yong, LK; Li, DL; Cubas, R; Chen, CY; Yao, QZ				Zhang, Sheng; Yong, Lin-Kin; Li, Dali; Cubas, Rafael; Chen, Changyi; Yao, Qizhi			Mesothelin Virus-Like Particle Immunization Controls Pancreatic Cancer Growth through CD8(+) T Cell Induction and Reduction in the Frequency of CD4(+)foxp3(+)ICOS(-) Regulatory T Cells	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; IMMUNE-RESPONSES; TUMOR-IMMUNITY; VACCINES; IMMUNOTHERAPY; SUPPRESSION; EXPRESSION; ADENOCARCINOMAS; VACCINATION; TOLERANCE	Our previous study has shown that mesothelin (MSLN) is a potential immunotherapeutic target for pancreatic cancer. Here, we further studied the immunogenicity of chimeric murine MSLN-virus-like particles (mMSLN-VLPs), their ability to break tolerance to mMSLN, a self-antigen, and deciphered the mechanism of immune responses elicited by mMSLN-VLP immunization using a pancreatic cancer (PC) mouse model. In addition to what we have found with xenogeneic human MSLN-VLP (hMSLN-VLP), mMSLN-VLP immunization was able to break the tolerance to intrinsic MSLN and mount mMSLN-specific, cytotoxic CD8(+) T cells which led to a significant reduction in tumor volume and prolonged survival in an orthotopic PC mouse model. Furthermore, CD4(+)foxp3(+) regulatory T cells (Tregs) were progressively decreased in both spleen and tumor tissues following mMSLN-VLP immunization and this was at least partly due to elevated levels of IL-6 production from activated plasmocytoid dendritic cell (pDC)-like cells following mMSLN-VLP immunization. Moreover, mMSLN-VLP treatment mainly reduced the frequency of the CD4(+)foxp3(+)ICOS(-) Treg subset. However, mMSLN-VLP induced IL-6 production also increased ICOSL expression on pDC-like cells which supported the proliferation of immunosuppressive CD4(+)foxp3(+)ICOS(+) Treg cells. This study reveals that mMSLN-VLP immunization is capable of controlling PC progression by effectively mounting an immune response against mMSLN, a tumor self-antigen, and altering the immunosuppressive tumor microenvironment via activation of pDCs-like cells and reduction in the frequency of CD4(+)foxp3(+)ICOS(-) Treg cells. However, combination therapies will likely need to be used in order to target residual CD4(+)foxp3(+)ICOS(+) Treg cells.	[Zhang, Sheng; Yong, Lin-Kin; Li, Dali; Cubas, Rafael; Chen, Changyi; Yao, Qizhi] Baylor Coll Med, Michael E DeBakey Dept Surg, Mol Surg Res Ctr, Houston, TX 77030 USA; [Yao, Qizhi] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Yao, Qizhi] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Yao, QZ (corresponding author), Baylor Coll Med, Michael E DeBakey Dept Surg, Mol Surg Res Ctr, Houston, TX 77030 USA.	qizhiyao@bcm.edu	Li, Dali/G-4192-2016; Li, Dali/N-6000-2014	Cubas, Rafael/0000-0002-3450-9054	Dan L Duncan Cancer Center pilot grant from BCM; National Institutes of Health [CA140828, AI053831]; NATIONAL CANCER INSTITUTE [R21CA140828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI053831] Funding Source: NIH RePORTER	Dan L Duncan Cancer Center pilot grant from BCM; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by Dan L Duncan Cancer Center pilot grant from BCM and the National Institutes of Health grant CA140828 for Q. Yao and AI053831 for S. Zhang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Akbari O, 2002, NAT MED, V8, P1024, DOI 10.1038/nm745; Argani P, 2001, CLIN CANCER RES, V7, P3862; Ashley DM, 1997, J EXP MED, V186, P1177, DOI 10.1084/jem.186.7.1177; Bach JF, 2003, NAT REV IMMUNOL, V3, P189, DOI 10.1038/nri1026; Banchereau J, 2005, NAT REV IMMUNOL, V5, P296, DOI 10.1038/nri1592; Barry M, 2002, NAT REV IMMUNOL, V2, P401, DOI 10.1038/nri819; Campbell DJ, 2007, NAT REV IMMUNOL, V7, P305, DOI 10.1038/nri2061; Chen Y, 2012, J IMMUNOL, V188, P1698, DOI 10.4049/jimmunol.1102448; Collison LW, 2011, METHODS MOL BIOL, V707, P21, DOI 10.1007/978-1-61737-979-6_2; Colombo MP, 2007, NAT REV CANCER, V7, P880, DOI 10.1038/nrc2250; Da Silva DM, 2007, J IMMUNOL, V178, P7587, DOI 10.4049/jimmunol.178.12.7587; Finn OJ, 2003, NAT REV IMMUNOL, V3, P630, DOI 10.1038/nri1150; Fogle JE, 2010, AIDS RES HUM RETROV, V26, P201, DOI 10.1089/aid.2009.0162; Gilboa E, 2004, NAT REV CANCER, V4, P401, DOI 10.1038/nrc1359; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Goldberg SM, 2005, CLIN CANCER RES, V11, P8114, DOI 10.1158/1078-0432.CCR-05-1410; Gondek DC, 2005, J IMMUNOL, V174, P1783, DOI 10.4049/jimmunol.174.4.1783; Gotsman I, 2006, CIRCULATION, V114, P2047, DOI 10.1161/CIRCULATIONAHA.106.633263; Guo LZ, 2003, VIROLOGY, V313, P502, DOI 10.1016/S0042-6822(03)00372-6; Hassan R, 2005, AM J CLIN PATHOL, V124, P838, DOI 10.1309/F1B64CL7H8VJKEAF; Hassan R, 2008, EUR J CANCER, V44, P46, DOI 10.1016/j.ejca.2007.08.028; Hoeffel G, 2007, IMMUNITY, V27, P481, DOI 10.1016/j.immuni.2007.07.021; Hung CF, 2007, GENE THER, V14, P921, DOI 10.1038/sj.gt.3302913; Ito T, 2008, IMMUNITY, V28, P870, DOI 10.1016/j.immuni.2008.03.018; Kornete M, 2012, J IMMUNOL, V188, P1064, DOI 10.4049/jimmunol.1101303; Kurooka M, 2007, CANCER RES, V67, P227, DOI 10.1158/0008-5472.CAN-06-1615; Laheru D, 2005, NAT REV CANCER, V5, P459, DOI 10.1038/nrc1630; Li M, 2008, MOL CANCER THER, V7, P286, DOI 10.1158/1535-7163.MCT-07-0483; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Ljunggren HG, 2007, NAT REV IMMUNOL, V7, P329, DOI 10.1038/nri2073; Lollini PL, 2006, NAT REV CANCER, V6, P204, DOI 10.1038/nrc1815; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Miyamoto K, 2005, J IMMUNOL, V175, P7341, DOI 10.4049/jimmunol.175.11.7341; Nair S, 2007, CANCER RES, V67, P371, DOI 10.1158/0008-5472.CAN-06-2903; Onizuka S, 1999, CANCER RES, V59, P3128; Rice J, 2008, NAT REV CANCER, V8, P108, DOI 10.1038/nrc2326; Robertson SJ, 2006, J IMMUNOL, V176, P3342, DOI 10.4049/jimmunol.176.6.3342; Schiller JT, 2001, EXPERT OPIN BIOL TH, V1, P571; Smyth MJ, 2006, J IMMUNOL, V176, P1582, DOI 10.4049/jimmunol.176.3.1582; Tegerstedt K, 2005, CANCER RES, V65, P5953, DOI 10.1158/0008-5472.CAN-05-0335; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; Wang RF, 2006, SPRINGER SEMIN IMMUN, V28, P17, DOI 10.1007/s00281-006-0022-7; Yao QZ, 2000, AIDS RES HUM RETROV, V16, P227, DOI 10.1089/088922200309322; Yao QZ, 2004, J IMMUNOL, V173, P1951, DOI 10.4049/jimmunol.173.3.1951; Zhang RX, 2004, VACCINE, V23, P139, DOI 10.1016/j.vaccine.2004.05.036; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	46	20	20	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68303	10.1371/journal.pone.0068303	http://dx.doi.org/10.1371/journal.pone.0068303			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874581	gold, Green Published, Green Submitted			2022-12-27	WOS:000321736900080
J	Jia, Y; Fong, KW; Choi, YK; See, SS; Qi, RZ				Jia, Yue; Fong, Ka-Wing; Choi, Yuk-Kwan; See, Siu-San; Qi, Robert Z.			Dynamic Recruitment of CDK5RAP2 to Centrosomes Requires Its Association with Dynein	PLOS ONE			English	Article							TUBULIN RING COMPLEX; GAMMA-TUBULIN; LIGHT-CHAIN; PERICENTRIOLAR MATERIAL; MICROTUBULE NUCLEATION; IN-VITRO; INTRAFLAGELLAR TRANSPORT; DYNACTIN; ORGANIZATION; PROTEIN	CDK5RAP2 is a centrosomal protein known to be involved in the regulation of the gamma-tubulin ring complex and thus the organization of microtubule arrays. However, the mechanism by which CDK5RAP2 is itself recruited to centrosomes is poorly understood. We report here that CDK5RAP2 displays highly dynamic attachment to centrosomes in a microtubule-dependent manner. CDK5RAP2 associates with the retrograde transporter dynein-dynactin and contains a sequence motif that binds to dynein light chain 8. Significantly, disruption of cellular dynein-dynactin function reduces the centrosomal level of CDK5RAP2. These results reveal a key role of the dynein-dynactin complex in the dynamic recruitment of CDK5RAP2 to centrosomes.	[Qi, Robert Z.] Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China; Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Qi, RZ (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China.	qirz@ust.hk		Fong, Ka-wing/0000-0001-6995-0264; Qi, Robert Zhong/0000-0001-5596-8172	Research Grants Council [662511, 662612, T13-607/12-R]; University Grants Committee [AoE/M-06/08, SEG_HKUST05]; TUYF Charitable Trust; Hong Kong University of Science and Technology	Research Grants Council(Hong Kong Research Grants Council); University Grants Committee; TUYF Charitable Trust; Hong Kong University of Science and Technology	This work was supported by grants from the Research Grants Council (General Research Fund 662511 and 662612 and Theme-based Research Scheme T13-607/12-R), the University Grants Committee (Area of Excellence Scheme AoE/M-06/08 and Special Equipment Grant SEG_HKUST05), the TUYF Charitable Trust, and by funds from the Hong Kong University of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balczon R, 1999, CELL MOTIL CYTOSKEL, V42, P60, DOI 10.1002/(SICI)1097-0169(1999)42:1<60::AID-CM6>3.0.CO;2-7; Barbar E, 2008, BIOCHEMISTRY-US, V47, P503, DOI 10.1021/bi701995m; Beckwith SM, 1998, J CELL BIOL, V143, P1239, DOI 10.1083/jcb.143.5.1239; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Buchman JJ, 2010, NEURON, V66, P386, DOI 10.1016/j.neuron.2010.03.036; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Choi YK, 2010, J CELL BIOL, V191, P1089, DOI 10.1083/jcb.201007030; Conduit PT, 2010, CURR BIOL, V20, P2178, DOI 10.1016/j.cub.2010.11.011; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; Dell KR, 2003, J CELL BIOL, V160, P291, DOI 10.1083/jcb.200301040; FELIX MA, 1994, J CELL BIOL, V124, P19, DOI 10.1083/jcb.124.1.19; Fong KW, 2008, MOL BIOL CELL, V19, P115, DOI 10.1091/mbc.E07-04-0371; Gao YQ, 2006, BIOPHYS J, V90, P811, DOI 10.1529/biophysj.105.073189; Ge XC, 2010, NEURON, V65, P191, DOI 10.1016/j.neuron.2010.01.011; Hall J, 2008, BIOCHEMISTRY-US, V47, P11940, DOI 10.1021/bi801093k; Hou ZB, 2007, J BIOL CHEM, V282, P18666, DOI 10.1074/jbc.C700052200; Jakobsen L, 2011, EMBO J, V30, P1520, DOI 10.1038/emboj.2011.63; Khodjakov A, 1999, J CELL BIOL, V146, P585, DOI 10.1083/jcb.146.3.585; Kollman JM, 2011, NAT REV MOL CELL BIO, V12, P709, DOI 10.1038/nrm3209; Kubo A, 1999, J CELL BIOL, V147, P969, DOI 10.1083/jcb.147.5.969; Lawo S, 2012, NAT CELL BIOL, V14, P1148, DOI 10.1038/ncb2591; Lee S, 2010, CELL CYCLE, V9, P775, DOI 10.4161/cc.9.4.10667; Levy JR, 2006, INT J DEV NEUROSCI, V24, P103, DOI 10.1016/j.ijdevneu.2005.11.013; Liang J, 1999, NAT STRUCT BIOL, V6, P735; Lizarraga SB, 2010, DEVELOPMENT, V137, P1907, DOI 10.1242/dev.040410; Lo KWH, 2001, J BIOL CHEM, V276, P14059, DOI 10.1074/jbc.M010320200; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; Melkonian KA, 2007, J BIOL CHEM, V282, P19355, DOI 10.1074/jbc.M700003200; Mennella V, 2012, NAT CELL BIOL, V14, P1159, DOI 10.1038/ncb2597; Mohan PMK, 2007, BIOCHEM BIOPH RES CO, V355, P950, DOI 10.1016/j.bbrc.2007.02.072; Moritz M, 1998, J CELL BIOL, V142, P775, DOI 10.1083/jcb.142.3.775; Pazour GJ, 1998, J CELL BIOL, V141, P979, DOI 10.1083/jcb.141.4.979; Purohit A, 1999, J CELL BIOL, V147, P481, DOI 10.1083/jcb.147.3.481; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; Rapali P, 2011, FEBS J, V278, P2980, DOI 10.1111/j.1742-4658.2011.08254.x; Schafer JC, 2003, MOL BIOL CELL, V14, P2057, DOI 10.1091/mbc.E02-10-0677; Schnackenberg BJ, 1998, P NATL ACAD SCI USA, V95, P9295, DOI 10.1073/pnas.95.16.9295; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; STEARNS T, 1994, CELL, V76, P623, DOI 10.1016/0092-8674(94)90503-7; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; Vallee RB, 1996, SCIENCE, V271, P1539, DOI 10.1126/science.271.5255.1539; Wiese C, 2006, J CELL SCI, V119, P4143, DOI 10.1242/jcs.03226; Wittmann T, 1999, METHOD CELL BIOL, V61, P137; Young A, 2000, MOL BIOL CELL, V11, P2047, DOI 10.1091/mbc.11.6.2047; Zhang J, 2007, MOL BIOL CELL, V18, P4037, DOI 10.1091/mbc.E07-05-0474	46	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e68523	10.1371/journal.pone.0068523	http://dx.doi.org/10.1371/journal.pone.0068523			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23874654	gold, Green Published, Green Submitted			2022-12-27	WOS:000322000600010
J	an der Heiden, M; Kopke, K; Buda, S; Buchholz, U; Haas, W				an der Heiden, Matthias; Koepke, Karla; Buda, Silke; Buchholz, Udo; Haas, Walter			Estimates of Excess Medically Attended Acute Respiratory Infections in Periods of Seasonal and Pandemic Influenza in Germany from 2001/02 to 2010/11	PLOS ONE			English	Article							BURDEN; MORTALITY; VACCINATION; DISEASE; EUROPE	Background: The number of patients seeking health care is a central indicator that may serve several different purposes: (1) as a proxy for the impact on the burden of the primary care system; (2) as a starting point to estimate the number of persons ill with influenza; (3) as the denominator data for the calculation of case fatality rate and the proportion hospitalized (severity indicators); (4) for economic calculations. In addition, reliable estimates of burden of disease and on the health care system are essential to communicate the impact of influenza to health care professionals, public health professionals and to the public. Methodology/Principal Findings: Using German syndromic surveillance data, we have developed a novel approach to describe the seasonal variation of medically attended acute respiratory infections (MAARI) and estimate the excess MAARI attributable to influenza. The weekly excess inside a period of influenza circulation is estimated as the difference between the actual MAARI and a MAARI-baseline, which is established using a cyclic regression model for counts. As a result, we estimated the highest ARI burden within the last 10 years for the influenza season 2004/05 with an excess of 7.5 million outpatient visits (CI95% 6.8-8.0). In contrast, the pandemic wave 2009 accounted for one third of this burden with an excess of 2.4 million (CI95% 1.9-2.8). Estimates can be produced for different age groups, different geographic regions in Germany and also in real time during the influenza waves.	[an der Heiden, Matthias; Koepke, Karla; Buda, Silke; Buchholz, Udo; Haas, Walter] Robert Koch Inst, Dept Infect Dis Epidemiol, Berlin, Germany	Robert Koch Institute	an der Heiden, M (corresponding author), Robert Koch Inst, Dept Infect Dis Epidemiol, Berlin, Germany.	anderHeidenM@rki.de		an der Heiden, Matthias/0000-0001-5863-4549	Federal Ministry of Health	Federal Ministry of Health	The Robert Koch Institute is working under the auspices of the Federal Ministry of Health. There was no extra funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso TV, 2004, INT CONGR SER, V1263, P281, DOI 10.1016/j.ics.2004.02.121; Arbeitsgemeinschaft fur Influenza, 2012, BER EP INFL DEUTSCHL; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Goldstein E, 2012, EPIDEMIOLOGY, V23, P829, DOI 10.1097/EDE.0b013e31826c2dda; Gray L, 2012, EUR J PUBLIC HEALTH, V22, P40, DOI 10.1093/eurpub/ckq170; Jansen AGSC, 2008, J CLIN EPIDEMIOL, V61, P803, DOI 10.1016/j.jclinepi.2007.08.017; Kamtsiuris P, 2007, BUNDESGESUNDHEITSBLA, V50, P686, DOI 10.1007/s00103-007-0230-x; Paget WJ, 2010, EUR J PEDIATR, V169, P997, DOI 10.1007/s00431-010-1164-0; Pitman RJ, 2007, J INFECTION, V54, P530, DOI 10.1016/j.jinf.2006.09.017; Reed C, 2009, EMERG INFECT DIS, V15, P2004, DOI 10.3201/eid1512.091413; Sering RE, 1963, PUBLIC HLTH REP, V78, P494; Simonsen L, 2005, ARCH INTERN MED, V165, P265, DOI 10.1001/archinte.165.3.265; Suess T, 2010, AM J EPIDEMIOL, V171, P1157, DOI 10.1093/aje/kwq071; Thompson WW, 2006, J INFECT DIS, V194, pS82, DOI 10.1086/507558; Voigtlander S, 2010, GESUNDHEITSWESEN, V72, P301, DOI 10.1055/s-0029-1233487; Wiese-Posselt M, 2006, VACCINE, V24, P2560, DOI 10.1016/j.vaccine.2005.12.020; Yang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017882; Yang L, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-133	18	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e64593	10.1371/journal.pone.0064593	http://dx.doi.org/10.1371/journal.pone.0064593			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874380	gold, Green Published			2022-12-27	WOS:000322064300001
J	Carvalhais, LC; Dennis, PG; Fan, B; Fedoseyenko, D; Kierul, K; Becker, A; von Wiren, N; Borriss, R				Carvalhais, Lilia C.; Dennis, Paul G.; Fan, Ben; Fedoseyenko, Dmitri; Kierul, Kinga; Becker, Anke; von Wiren, Nicolaus; Borriss, Rainer			Linking Plant Nutritional Status to Plant-Microbe Interactions	PLOS ONE			English	Article							BACILLUS-SUBTILIS; ROOT COLONIZATION; CELL-DENSITY; RHIZOSPHERE; GROWTH; RESPONSES; STRESS; GENES; IDENTIFICATION; ACID	Plants have developed a wide-range of adaptations to overcome nutrient limitation, including changes to the quantity and composition of carbon-containing compounds released by roots. Root-associated bacteria are largely influenced by these compounds which can be perceived as signals or substrates. Here, we evaluate the effect of root exudates collected from maize plants grown under nitrogen (N), phosphate (P), iron (Fe) and potassium (K) deficiencies on the transcriptome of the plant growth promoting rhizobacterium (PGPR) Bacillus amyloliquefaciens FZB42. The largest shifts in gene expression patterns were observed in cells exposed to exudates from N-, followed by P-deficient plants. Exudates from N- deprived maize triggered a general stress response in FZB42 in the exponential growth phase, which was evidenced by the suppression of numerous genes involved in protein synthesis. Exudates from P-deficient plants induced bacterial genes involved in chemotaxis and motility whilst exudates released by Fe and K deficient plants did not cause dramatic changes in the bacterial transcriptome during exponential growth phase. Global transcriptional changes in bacteria elicited by nutrient deficient maize exudates were significantly correlated with concentrations of the amino acids aspartate, valine and glutamate in root exudates suggesting that transcriptional profiling of FZB42 associated with metabolomics of N, P, Fe and K-deficient maize root exudates is a powerful approach to better understand plant-microbe interactions under conditions of nutritional stress.	[Carvalhais, Lilia C.; Fedoseyenko, Dmitri; von Wiren, Nicolaus] Univ Hohenheim, Stuttgart, Germany; [Carvalhais, Lilia C.; Kierul, Kinga; Borriss, Rainer] Univ Berlin, Inst Biol, Berlin, Germany; [Dennis, Paul G.] Univ Queensland, Australian Ctr Ecogenom, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Dennis, Paul G.] Univ Queensland, Adv Water Management Ctr, Brisbane, Qld, Australia; [Fan, Ben] Nanjing Forestry Univ, Inst Forest Protect, Nanjing, Jiangsu, Peoples R China; [Fedoseyenko, Dmitri; von Wiren, Nicolaus] Leibniz Inst Plant Genet & Crop Plant Res, Gatersleben, Germany; [Becker, Anke] Univ Freiburg, Inst Biol 3, Freiburg, Germany; [Borriss, Rainer] ABiTEP GmbH, Berlin, Germany	University Hohenheim; University of Queensland; University of Queensland; Nanjing Forestry University; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; University of Freiburg	Borriss, R (corresponding author), Univ Berlin, Inst Biol, Berlin, Germany.	rainer.borriss@rz.hu-berlin.de	Borriss, Rainer/C-5026-2012; Dennis, Paul G/H-2141-2017	Borriss, Rainer/0000-0003-3726-1004; Dennis, Paul G/0000-0002-4895-3105; von Wiren, Nicolaus/0000-0002-4966-425X; Carvalhais, Lilia C./0000-0001-9882-526X; Becker, Anke/0000-0003-4561-9184	German Ministry for Education and Research (GenoMik-Transfer) [PATHCONTROL 0315654A]; European Union's Seventh Framework Programme (FP) [312117]; EU-FP6	German Ministry for Education and Research (GenoMik-Transfer); European Union's Seventh Framework Programme (FP); EU-FP6(European Commission)	This study was financially supported by funds of the German Ministry for Education and Research (GenoMik-Transfer, PATHCONTROL 0315654A) http://www.genomik-transfer.de/index.php?section = projects, the European Union's Seventh Framework Programme (FP/2007-2013) http://ec.europa.eu/research/fp7/index_en.cfm under Grant agreement no312117, and by the EU-FP6-funded project RHIBAC http://ec.europa.eu/research/fp6/index_en.cfm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesemoye AO, 2009, APPL MICROBIOL BIOT, V85, P1, DOI 10.1007/s00253-009-2196-0; Andrews M, 2003, SYMBIOSIS, V35, P209; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Bardgett RD, 2003, ECOLOGY, V84, P1277, DOI 10.1890/0012-9658(2003)084[1277:SMCEWP]2.0.CO;2; BARNESS E, 1992, PLANT PHYSIOL, V100, P451, DOI 10.1104/pp.100.1.451; Barret M, 2011, BIOL FERT SOILS, V47, P729, DOI 10.1007/s00374-011-0605-x; Baty F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-422; Baty F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-289; Bednarek P, 2005, PLANT PHYSIOL, V138, P1058, DOI 10.1104/pp.104.057794; Berg G, 2009, APPL MICROBIOL BIOT, V84, P11, DOI 10.1007/s00253-009-2092-7; Biller L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-63; Bouche N, 2004, TRENDS PLANT SCI, V9, P110, DOI 10.1016/j.tplants.2004.01.006; Buchan A, 2010, ENVIRON MICROBIOL, V12, P3171, DOI 10.1111/j.1462-2920.2010.02290.x; BUDRENE EO, 1991, NATURE, V349, P630, DOI 10.1038/349630a0; Carvalhais LC, 2012, J MICROBIOL METH, V91, P246, DOI 10.1016/j.mimet.2012.08.011; Carvalhais LC, 2011, J PLANT NUTR SOIL SC, V174, P3, DOI 10.1002/jpln.201000085; Chauhan PS, 2010, LETT APPL MICROBIOL, V50, P205, DOI 10.1111/j.1472-765X.2009.02779.x; Chen WM, 2012, MICROBIOLOGY, P158; Chen XH, 2007, NAT BIOTECHNOL, V25, P1007, DOI 10.1038/nbt1325; CROWLEY DE, 1992, PLANT SOIL, V142, P1; CSONKA LN, 1989, MICROBIOL REV, V53, P121, DOI 10.1128/MMBR.53.1.121-147.1989; Culhane AC, 2002, BIOINFORMATICS, V18, P1600, DOI 10.1093/bioinformatics/18.12.1600; Dauphin LA, 2009, J MICROBIOL METH, V76, P30, DOI 10.1016/j.mimet.2008.09.004; de Mendoza D., 2001, BACILLUS SUBTILIS IT, P43; de Weert S, 2002, MOL PLANT MICROBE IN, V15, P1173, DOI 10.1094/MPMI.2002.15.11.1173; Dennis PG, 2008, J MICROBIOL METH, V75, P12, DOI 10.1016/j.mimet.2008.04.013; Dennis PG, 2010, FEMS MICROBIOL ECOL, V72, P313, DOI 10.1111/j.1574-6941.2010.00860.x; Dennis PG, 2009, J MICROBIOL METH, V76, P101, DOI 10.1016/j.mimet.2008.09.013; Dondrup M, 2003, J BIOTECHNOL, V106, P135, DOI 10.1016/j.jbiotec.2003.08.010; Dudoit S, 2002, STAT SINICA, V12, P111; Dworkin J, 2001, GENE DEV, V15, P1051, DOI 10.1101/gad.892801; Epstein W, 2003, PROG NUCLEIC ACID RE, V75, P293, DOI 10.1016/S0079-6603(03)75008-9; Esquivel-Cote R, 2010, PLANT SOIL, V337, P65, DOI 10.1007/s11104-010-0499-7; EVANS HJ, 1963, PLANT PHYSIOL, V38, P397, DOI 10.1104/pp.38.4.397; Eymann C, 2001, FEMS MICROBIOL LETT, V199, P221, DOI 10.1111/j.1574-6968.2001.tb10678.x; Fan B, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-116; Glawischnig E, 2007, PHYTOCHEMISTRY, V68, P401, DOI 10.1016/j.phytochem.2006.12.005; Hamidi SA, 2008, EUR RESPIR J, V31, P135, DOI 10.1183/09031936.00105807; Hand SC, 1996, ANNU REV PHYSIOL, V58, P539, DOI 10.1146/annurev.ph.58.030196.002543; Hinsinger P, 2005, NEW PHYTOL, V168, P293, DOI 10.1111/j.1469-8137.2005.01512.x; Hoffmann T, 2008, APPL ENVIRON MICROB, V74, P2454, DOI 10.1128/AEM.01573-07; Hordt W, 2000, BIOMETALS, V13, P37, DOI 10.1023/A:1009234612486; Idriss EE, 2002, MICROBIOL-SGM, V148, P2097, DOI 10.1099/00221287-148-7-2097; Irnov I, 2010, NUCLEIC ACIDS RES, V38, P6637, DOI 10.1093/nar/gkq454; Jenson SD, 2003, J CLIN PATHOL-MOL PA, V56, P307, DOI 10.1136/mp.56.6.307; Kaplan HB, 1996, FEMS MICROBIOL LETT, V139, P89, DOI 10.1111/j.1574-6968.1996.tb08185.x; KIM SK, 1992, ANNU REV MICROBIOL, V46, P117, DOI 10.1146/annurev.mi.46.100192.001001; Kinnersley AM, 2000, CRIT REV PLANT SCI, V19, P479, DOI 10.1016/S0735-2689(01)80006-X; Kloepper JW, 1978, P 4 INT C PLANT PATH, VII, P879; Krasny L, 2004, EMBO J, V23, P4473, DOI 10.1038/sj.emboj.7600423; Krishnan P, 2005, J EXP BOT, V56, P255, DOI 10.1093/jxb/eri010; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Liu JJ, 2011, ANN MICROBIOL, V61, P525, DOI 10.1007/s13213-010-0168-3; Lucy M, 2004, ANTON LEEUW INT J G, V86, P1, DOI 10.1023/B:ANTO.0000024903.10757.6e; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Makarewicz I, 2006, J BACTERIOL, V188, P6953, DOI 10.1128/JB.00681-06; Mark GL, 2005, P NATL ACAD SCI USA, V102, P17454, DOI 10.1073/pnas.0506407102; Matilla MA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r179; Millet YA, 2010, PLANT CELL, V22, P973, DOI 10.1105/tpc.109.069658; Nanamiya H, 2008, MOL MICROBIOL, V67, P291, DOI 10.1111/j.1365-2958.2007.06018.x; Neal AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035498; ORDAL GW, 1979, J GEN MICROBIOL, V115, P167, DOI 10.1099/00221287-115-1-167; Pang SS, 2003, J BIOL CHEM, V278, P7639, DOI 10.1074/jbc.M211648200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pichon C, 2008, BIOINFORMATICS, V24, P2807, DOI 10.1093/bioinformatics/btn560; Richardson A. E., 2005, Organic phosphorus in the environment, P165, DOI 10.1079/9780851998220.0165; Richardson AE, 2009, CROP PASTURE SCI, V60, P124, DOI 10.1071/CP07125; Ruiz N, 2005, CURR OPIN MICROBIOL, V8, P122, DOI 10.1016/j.mib.2005.02.013; Rumberger A, 2004, FUNCT PLANT BIOL, V31, P623, DOI 10.1071/FP03249; Schenk PM, 2012, TRENDS BIOTECHNOL, V30, P177, DOI 10.1016/j.tibtech.2011.11.002; Shapiro JA, 1998, ANNU REV MICROBIOL, V52, P81, DOI 10.1146/annurev.micro.52.1.81; Sharma A, 2003, MICROBIOL RES, V158, P77, DOI 10.1078/0944-5013-00182; Sheng XF, 2005, SOIL BIOL BIOCHEM, V37, P1918, DOI 10.1016/j.soilbio.2005.02.026; Steinkellner S, 2007, MOLECULES, V12, P1290, DOI 10.3390/12071290; Storz G, 2002, SCIENCE, V296, P1260, DOI 10.1126/science.1072249; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Takagi H, 2008, APPL MICROBIOL BIOT, V81, P211, DOI 10.1007/s00253-008-1698-5; THOELKE MS, 1990, J BACTERIOL, V172, P1148, DOI 10.1128/jb.172.2.1148-1150.1990; Tunio SA, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-280; Vande Broek A, 1998, MICROBIOL-SGM, V144, P2599, DOI 10.1099/00221287-144-9-2599; VANETTEN HD, 1994, PLANT CELL, V6, P1191; VONWIREN N, 1995, NEW PHYTOL, V130, P511, DOI 10.1111/j.1469-8137.1995.tb04328.x; Walker TS, 2003, PLANT PHYSIOL, V132, P44, DOI 10.1104/pp.102.019661; Wolz C, 2010, INT J MED MICROBIOL, V300, P142, DOI 10.1016/j.ijmm.2009.08.017; Yang CH, 2000, APPL ENVIRON MICROB, V66, P345, DOI 10.1128/AEM.66.1.345-351.2000; Ye BC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007073; Yoneyama K, 2008, NEW PHYTOL, V179, P484, DOI 10.1111/j.1469-8137.2008.02462.x; Yus E, 2009, SCIENCE, V326, P1263, DOI 10.1126/science.1177263; Zhang SY, 2003, J BACTERIOL, V185, P5714, DOI 10.1128/JB.185.19.5714-5721.2003; Zysko A, 2011, PLANT SOIL	90	87	89	5	177	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68555	10.1371/journal.pone.0068555	http://dx.doi.org/10.1371/journal.pone.0068555			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874669	Green Published, Green Submitted, gold			2022-12-27	WOS:000322064300050
J	Frank, ASK; Dickman, CR; Wardle, GM; Greenville, AC				Frank, Anke S. K.; Dickman, Chris R.; Wardle, Glenda M.; Greenville, Aaron C.			Interactions of Grazing History, Cattle Removal and Time since Rain Drive Divergent Short-Term Responses by Desert Biota	PLOS ONE			English	Article							SMINTHOPSIS-YOUNGSONI MARSUPIALIA; ARID AUSTRALIA; DASYURID MARSUPIALS; POPULATION-DYNAMICS; MICROHABITAT USE; CAPTURE RATES; SMALL MAMMALS; VEGETATION; HABITAT; LIZARDS	Arid grasslands are used worldwide for grazing by domestic livestock, generating debate about how this pastoral enterprise may influence native desert biota. One approach to resolving this question is to experimentally reduce livestock numbers and measure the effects. However, a key challenge in doing this is that historical grazing impacts are likely to be cumulative and may therefore confound comparisons of the short-term responses of desert biota to changes in stocking levels. Arid areas are also subject to infrequent flooding rainfalls that drive productivity and dramatically alter abundances of flora and fauna. We took advantage of an opportunity to study the recent effects of a property-scale cattle removal on two properties with similarly varied grazing histories in central Australia. Following the removal of cattle in 2006 and before and after a significant rainfall event at the beginning of 2007, we sampled vegetation and small vertebrates on eight occasions until October 2008. Our results revealed significant interactions of time of survey with both grazing history and grazing removal for vascular plants, small mammals and reptiles. The mammals exhibited a three-way interaction of time, grazing history and grazing removal, thus highlighting the importance of careful sampling designs and timing for future monitoring. The strongest response to the cessation of grazing after two years was depressed reproductive output of plants in areas where cattle continued to graze. Our results confirm that neither vegetation nor small vertebrates necessarily respond immediately to the removal of livestock, but that rainfall events and cumulative grazing history are key determinants of floral and faunal performance in grassland landscapes with low and variable rainfall. We suggest that improved assessments could be made of the health of arid grazing environments if long-term monitoring were implemented to track the complex interactions that influence how native biota respond to grazing.	[Frank, Anke S. K.; Dickman, Chris R.; Wardle, Glenda M.; Greenville, Aaron C.] Univ Sydney, Sch Biol Sci, Desert Ecol Res Grp, Sydney, NSW 2006, Australia	University of Sydney	Frank, ASK (corresponding author), Univ Sydney, Sch Biol Sci, Desert Ecol Res Grp, Sydney, NSW 2006, Australia.	anke.frank@utas.edu.au	Wardle, Glenda/D-6533-2016; Dickman, Christopher/Q-4662-2019; Wardle, Glenda/ABD-9228-2021; Frank, Anke S. K./J-7789-2014; Greenville, Aaron/G-9718-2013	Wardle, Glenda/0000-0003-0189-1899; Dickman, Christopher/0000-0002-1067-3730; Wardle, Glenda/0000-0003-0189-1899; Frank, Anke S. K./0000-0002-0177-4898; Greenville, Aaron/0000-0002-0113-4778; Frank, Anke/0000-0003-4577-2920	Australian Research Council	Australian Research Council(Australian Research Council)	Research was funded by the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R, 2005, FIELD GUIDE PLANTS C; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Arnold G.W., 1978, ETHOLOGY FREE RANGIN; Asner GP, 2004, ANNU REV ENV RESOUR, V29, P261, DOI 10.1146/annurev.energy.29.062403.102142; Avenant NL, 2007, INTEGR ZOOL, V2, P212, DOI 10.1111/j.1749-4877.2007.00064.x; Bostock P.D., 2010, CENSUS QUEENSLAND FL; Cingolani AM, 2005, ECOL APPL, V15, P757, DOI 10.1890/03-5272; Daly BG, 2008, ECOLOGY, V89, P65, DOI 10.1890/06-1991.1; Dickman CR, 2011, J MAMMAL, V92, P1193, DOI 10.1644/10-MAMM-S-329.1; Dickman CR, 2010, J MAMMAL, V91, P798, DOI 10.1644/09-MAMM-S-205.1; Dickman CR, 1999, WILDLIFE RES, V26, P389, DOI 10.1071/WR97057; Dickman CR, 1995, J ARID ENVIRON, V31, P441, DOI 10.1016/S0140-1963(05)80127-2; Dickman CR, 1999, OECOLOGIA, V119, P357, DOI 10.1007/s004420050796; Dickman CR, 2001, WILDLIFE RES, V28, P493, DOI 10.1071/WR00023; Driscoll DA, 2004, ECOL APPL, V14, P220, DOI 10.1890/02-5248; Fensham RJ, 2008, BIOL CONSERV, V141, P1447, DOI 10.1016/j.biocon.2008.03.016; Fensham RJ, 2010, ECOLOGY, V91, P681, DOI 10.1890/08-2356.1; FIELD A, 2000, DISCOVERING STAT SPS; FISHER DO, 1993, J ARID ENVIRON, V25, P397, DOI 10.1006/jare.1993.1072; FLEISCHNER TL, 1994, CONSERV BIOL, V8, P629, DOI 10.1046/j.1523-1739.1994.08030629.x; FOLK RL, 1971, SEDIMENTOLOGY, V16, P5, DOI 10.1111/j.1365-3091.1971.tb00217.x; Frank ASK, 2012, RANGELAND J, V34, P319, DOI 10.1071/RJ12032; Frank ASK, 2010, ECOLOGICAL IMPACTS C; Friedel MH, 2003, J ARID ENVIRON, V55, P327, DOI 10.1016/S0140-1963(03)00026-0; Friedel MH, 1997, J ARID ENVIRON, V37, P145, DOI 10.1006/jare.1997.0260; FRIEND GR, 1989, AUST WILDLIFE RES, V16, P1; Gordon CE, 2010, AUSTRAL ECOL, V35, P41, DOI 10.1111/j.1442-9993.2009.02010.x; Greenville AC, 2009, INT J WILDLAND FIRE, V18, P631, DOI 10.1071/WF08093; Greenville AC, 2009, BIOL J LINN SOC, V97, P531, DOI 10.1111/j.1095-8312.2009.01241.x; Greer A.E., 1989, BIOL EVOLUTION AUSTR; Grigg Gordon, 2002, P53; Gurevitch J., 2002, ECOLOGY PLANTS; Gynther I, 2009, VERTEBRATE FAUNA SUR, P199; Haythornthwaite AS, 2006, J ZOOL, V270, P543, DOI 10.1111/j.1469-7998.2006.00186.x; Haythornthwaite AS, 2006, ECOGRAPHY, V29, P285, DOI 10.1111/j.2006.0906-7590.04307.x; Haythornthwaite AS, 2005, WILDLIFE RES, V32, P609, DOI 10.1071/WR04126; James C, 2003, AUSTRAL ECOL, V28, P137, DOI 10.1046/j.1442-9993.2003.01259.x; Keesing F, 2001, J TROP ECOL, V17, P465, DOI 10.1017/S0266467401001328; Kutt AS, 2012, ANIM CONSERV, V15, P416, DOI 10.1111/j.1469-1795.2012.00530.x; Kutt AS, 2007, J TROP ECOL, V23, P95, DOI 10.1017/S0266467406003579; Lawley V, 2013, J ARID ENVIRON, V88, P156, DOI 10.1016/j.jaridenv.2012.08.014; Lazenby BT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059846; Legge S, 2011, AUSTRAL ECOL, V36, P791, DOI 10.1111/j.1442-9993.2010.02218.x; Letnic M, 2004, RANGELAND J, V26, P34, DOI 10.1071/RJ04003; Letnic M, 2010, BIOL REV, V85, P501, DOI 10.1111/j.1469-185X.2009.00113.x; Letnic M, 2006, BIODIVERS CONSERV, V15, P3847, DOI 10.1007/s10531-005-0601-2; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Mackenzie DI, 2009, ECOLOGY, V90, P823, DOI 10.1890/08-0141.1; MacKenzie DI, 2005, ECOLOGY, V86, P1101, DOI 10.1890/04-1060; MacKenzie DI, 2004, J ANIM ECOL, V73, P546, DOI 10.1111/j.0021-8790.2004.00828.x; Masters P, 2003, AUSTRAL ECOL, V28, P658, DOI 10.1046/j.1442-9993.2003.01327.x; McKeon GM, 2004, PASTURE DEGRADATION; MILCHUNAS DG, 1993, ECOL MONOGR, V63, P327, DOI 10.2307/2937150; Moseby KE, 2001, WILDLIFE RES, V28, P61, DOI 10.1071/WR99058; MURRAY BR, 1994, OECOLOGIA, V99, P216, DOI 10.1007/BF00627733; Nolan C., 2003, SAND HILLS CHANNEL C; NOOS RF, 1994, CONSERV BIOL, V8, P613; Pianka E., 1986, ECOLOGY NATURAL HIST; Pianka ER, 2012, AUSTRAL ECOL, V37, P1, DOI 10.1111/j.1442-9993.2010.02234.x; Potapov P, 2008, ECOL SOC, V13, DOI 10.5751/es-02670-130251; Potts JM, 2012, METHODS ECOL EVOL, V3, P695, DOI 10.1111/j.2041-210X.2012.00205.x; Purdie R., 1990, W ARID REGION LAND 6, P49; Purdie R., 1984, LAND SYSTEMS SIMPSON; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Core Team, 2020, R LANG ENV STAT COMP; Read J, 1999, ENVIRON MONIT ASSESS, V54, P69, DOI 10.1023/A:1005901014386; Read JL, 2002, AUSTRAL ECOL, V27, P55, DOI 10.1046/j.1442-9993.2002.01159.x; Read JL, 1992, RANGELAND J, V14, P143; Read JL, 2010, AUSTRAL ECOL, V35, P314, DOI 10.1111/j.1442-9993.2009.02040.x; Sayre NF, 2009, CONSERV BIOL, V23, P1050, DOI 10.1111/j.1523-1739.2009.01269.x; Schlesinger CA, 2007, WILDLIFE RES, V34, P359, DOI 10.1071/WR06141; Schutz AJ, 2008, AUSTRAL ECOL, V33, P641, DOI 10.1111/j.1442-9993.2007.01830.x; Seymour CL, 2010, J APPL ECOL, V47, P859, DOI 10.1111/j.1365-2664.2010.01833.x; Shephard M., 1992, SIMPSON DESERT NATUR; Smith DMS, 2007, P NATL ACAD SCI USA, V104, P20690, DOI 10.1073/pnas.0704837104; Strong B.W., 1986, Northern Territory Naturalist, P3; Sullivan BK, 2009, CONSERV BIOL, V23, P1047, DOI 10.1111/j.1523-1739.2009.01268.x; Tabeni S, 2007, ACTA OECOL, V31, P259, DOI 10.1016/j.actao.2006.11.002; Teague WR, 2004, J ARID ENVIRON, V58, P97, DOI 10.1016/S0140-1963(03)00122-8; Ward D, 2004, J RANGE MANAGE, V57, P130, DOI 10.2307/4003910; Ward D, 2005, BIODIVERSITY DRYLAND, P233; Wilson P. R., 1990, W ARID REGION LAND U	82	21	22	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68466	10.1371/journal.pone.0068466	http://dx.doi.org/10.1371/journal.pone.0068466			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874635	Green Published, gold, Green Submitted			2022-12-27	WOS:000322064300036
J	Maioli, S; Bavner, A; Ali, Z; Heverin, M; Ismail, MA; Puerta, E; Olin, M; Saeed, A; Shafaati, M; Parini, P; Cedazo-Minguez, A; Bjorkhem, I				Maioli, Silvia; Bavner, Ann; Ali, Zeina; Heverin, Maura; Ismail, Muhammad-Al-Mustafa; Puerta, Elena; Olin, Maria; Saeed, Ahmed; Shafaati, Marjan; Parini, Paolo; Cedazo-Minguez, Angel; Bjorkhem, Ingemar			Is It Possible to Improve Memory Function by Upregulation of the Cholesterol 24S-Hydroxylase (CYP46A1) in the Brain?	PLOS ONE			English	Article							MICE; OXYSTEROLS; 24-HYDROXYLASE; TURNOVER; HIPPOCAMPUS; PLASTICITY; KNOCKOUT; YOUNG	We previously described a heterozygous mouse model overexpressing human HA-tagged 24S- hydroxylase (CYP46A1) utilizing a ubiquitous expression vector. In this study, we generated homozygotes of these mice with circulating levels of 24OH 30-60% higher than the heterozygotes. Female homozygous CYP46A1 transgenic mice, aged 15 months, showed an improvement in spatial memory in the Morris water maze test as compared to the wild type mice. The levels of N-Methyl-D-Aspartate receptor 1, phosphorylated-N-Methyl-D-Aspartate receptor 2A, postsynaptic density 95, synapsin-1 and synapthophysin were significantly increased in the hippocampus of the CYP46A1 transgenic mice as compared to the controls. The levels of lanosterol in the brain of the CYP46A1 transgenic mice were significantly increased, consistent with a higher synthesis of cholesterol. Our results are discussed in relation to the hypothesis that the flux in the mevalonate pathway in the brain is of importance in cognitive functions.	[Maioli, Silvia; Ismail, Muhammad-Al-Mustafa; Puerta, Elena; Cedazo-Minguez, Angel] Karolinska Inst, Alzheimers Dis Res Ctr, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Bavner, Ann; Ali, Zeina; Heverin, Maura; Olin, Maria; Saeed, Ahmed; Shafaati, Marjan; Parini, Paolo; Bjorkhem, Ingemar] Karolinska Inst, Dept Lab Med, Div Clin Chem, Karolinska Univ Hosp, Huddinge, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Maioli, S (corresponding author), Karolinska Inst, Alzheimers Dis Res Ctr, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden.	silvia.maioli@ki.se	Maioli, Silvia/AAM-7312-2020; Puerta, Elena/B-1114-2017; Ismail, Muhammad Al Mustafa/AAD-8555-2020; Cedazo-Minguez, Angel/C-6707-2012	Puerta, Elena/0000-0001-5695-5787; Cedazo-Minguez, Angel/0000-0003-4626-4864; Maioli, Silvia/0000-0002-9577-0803; Bjorkhem, Ingemar/0000-0002-0575-9425; Bjorkhem, Ingemar/0000-0001-6087-9190	Swedish Brain Power; Strategic Neuroscience Programme; Swedish Science Council; Swedish Alzheimer's Foundation; Old Servant's Foundation; Gun och Bertil Stonhes Foundation; Swedish Brain Foundation; Italian Blanceflor Boncompagni-Ludovisi Foundation; Ramon Areces Foundation (Spain)	Swedish Brain Power; Strategic Neuroscience Programme; Swedish Science Council; Swedish Alzheimer's Foundation; Old Servant's Foundation; Gun och Bertil Stonhes Foundation; Swedish Brain Foundation; Italian Blanceflor Boncompagni-Ludovisi Foundation; Ramon Areces Foundation (Spain)	This work was supported by grants from Swedish Brain Power, Strategic Neuroscience Programme, Swedish Science Council, Swedish Alzheimer's Foundation, Old Servant's Foundation, Gun och Bertil Stonhes Foundation, and the Swedish Brain Foundation. S.M. was partially supported by the Italian Blanceflor Boncompagni-Ludovisi Foundation. E.P. was supported by Ramon Areces Foundation (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acimovic J, 2009, J CHROMATOGR B, V877, P2081, DOI 10.1016/j.jchromb.2009.05.050; Adams MM, 2001, J COMP NEUROL, V432, P230, DOI 10.1002/cne.1099; Ali Z, 2013, J LIPID RES, V54, P1033, DOI 10.1194/jlr.M034124; Bergami M, 2008, P NATL ACAD SCI USA, V105, P15570, DOI 10.1073/pnas.0803702105; Bjorkhem I, 2006, J INTERN MED, V260, P493, DOI 10.1111/j.1365-2796.2006.01725.x; Bjorkhem I, 2010, J LIPID RES, V51, P2489, DOI 10.1194/jlr.R006338; Bjorkhem I, 2009, MOL ASPECTS MED, V30, P171, DOI 10.1016/j.mam.2009.02.001; Canas PM, 2009, NEUROBIOL AGING, V30, P1877, DOI 10.1016/j.neurobiolaging.2008.01.003; Clayton DA, 2002, J BIOL CHEM, V277, P14367, DOI 10.1074/jbc.C200074200; Famer D, 2007, BIOCHEM BIOPH RES CO, V359, P46, DOI 10.1016/j.bbrc.2007.05.033; Frick KM, 2003, NEUROBIOL AGING, V24, P615, DOI 10.1016/S0197-4580(02)00138-0; Hudry E, 2010, MOL THER, V18, P44, DOI 10.1038/mt.2009.175; Kotti TJ, 2006, P NATL ACAD SCI USA, V103, P3869, DOI 10.1073/pnas.0600316103; Lund EG, 2003, J BIOL CHEM, V278, P22980, DOI 10.1074/jbc.M303415200; Maioli S, 2012, J ALZHEIMERS DIS, V32, P341, DOI 10.3233/JAD-2012-120697; McHugh TJ, 1996, CELL, V87, P1339, DOI 10.1016/S0092-8674(00)81828-0; McIlwain KL, 2001, PHYSIOL BEHAV, V73, P705, DOI 10.1016/S0031-9384(01)00528-5; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Ohyama Y, 2006, J BIOL CHEM, V281, P3810, DOI 10.1074/jbc.M505179200; Riedel G, 2003, BEHAV BRAIN RES, V140, P1, DOI 10.1016/S0166-4328(02)00272-3; Rosenzweig ES, 2003, PROG NEUROBIOL, V69, P143, DOI 10.1016/S0301-0082(02)00126-0; Russell DW, 2009, ANNU REV BIOCHEM, V78, P1017, DOI 10.1146/annurev.biochem.78.072407.103859; Rutten BPF, 2005, AM J PATHOL, V167, P161, DOI 10.1016/S0002-9440(10)62963-X; Shafaati M, 2011, J INTERN MED, V270, P377, DOI 10.1111/j.1365-2796.2011.02389.x; VanGuilder HD, 2011, NEUROBIOL DIS, V43, P201, DOI 10.1016/j.nbd.2011.03.012; Wagstaff LR, 2003, PHARMACOTHERAPY, V23, P871, DOI 10.1592/phco.23.7.871.32720	26	45	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68534	10.1371/journal.pone.0068534	http://dx.doi.org/10.1371/journal.pone.0068534			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874659	Green Published, Green Submitted, gold			2022-12-27	WOS:000322064300044
J	Zhang, JX; Zhang, HY; Li, JQ; Chen, J; Han, QQ; Lin, JZ; Yang, TH; Fan, M				Zhang, Jiaxing; Zhang, Haiyan; Li, Jinqiang; Chen, Ji; Han, Qiaoqing; Lin, Jianzhong; Yang, Tianhe; Fan, Ming			Adaptive Modulation of Adult Brain Gray and White Matter to High Altitude: Structural MRI Studies	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; VOXEL-BASED MORPHOMETRY; MENTAL ROTATION; EXTREME ALTITUDE; WORKING-MEMORY; HYPOXIA; NEUROGENESIS; RESPONSES; FMRI; ILLNESS	The aim of this study was to investigate brain structural alterations in adult immigrants who adapted to high altitude (HA). Voxel-based morphometry analysis of gray matter (GM) volumes, surface-based analysis of cortical thickness, and Tract-Based Spatial Statistics analysis of white matter fractional anisotropy (FA) based on MRI images were conducted on 16 adults (20-22 years) who immigrated to the Qinghai-Tibet Plateau (2300-4400 m) for 2 years. They had no chronic mountain sickness. Control group consisted of 16 matched sea level subjects. A battery of neuropsychological tests was also conducted. HA immigrants showed significantly decreased GM volumes in the right postcentral gyrus and right superior frontal gyrus, and increased GM volumes in the right middle frontal gyrus, right parahippocampal gyrus, right inferior and middle temporal gyri, bilateral inferior ventral pons, and right cerebellum crus1. While there was some divergence in the left hemisphere, surface-based patterns of GM changes in the right hemisphere resembled those seen for VBM analysis. FA changes were observed in multiple WM tracts. HA immigrants showed significant impairment in pulmonary function, increase in reaction time, and deficit in mental rotation. Parahippocampal and middle frontal GM volumes correlated with vital capacity. Superior frontal GM volume correlated with mental rotation and postcentral GM correlated with reaction time. Paracentral lobule and frontal FA correlated with mental rotation reaction time. There might be structural modifications occurred in the adult immigrants during adaptation to HA. The changes in GM may be related to impaired respiratory function and psychological deficits.	[Zhang, Jiaxing; Zhang, Haiyan; Chen, Ji] Xiamen Univ, Coll Med, Dept Physiol & Neurobiol, Xiamen, Fujian, Peoples R China; [Li, Jinqiang; Han, Qiaoqing] PLA, Gulangyu Sanat, Dept Clin Psychol, Xiamen, Fujian, Peoples R China; [Lin, Jianzhong; Yang, Tianhe] Xiamen Univ, Coll Med, Zhongshan Hosp, Magnet Resonance Ctr, Xiamen, Fujian, Peoples R China; [Fan, Ming] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Cognit Sci, Beijing 100730, Peoples R China	Xiamen University; Xiamen University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Zhang, JX (corresponding author), Xiamen Univ, Coll Med, Dept Physiol & Neurobiol, Xiamen, Fujian, Peoples R China.	zhangjiaxing@xmu.edu.cn		Chen, Ji/0000-0002-9476-1737	National Science Foundation of China [31071041, 81171324]; National Key project [2012CB518200]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key project	This work was supported by National Science Foundation of China (Project No. 31071041; 81171324) and National Key project (2012CB518200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PJ, 2011, CLIN MED INSIGHTS-CI, V5, P27, DOI 10.4137/CCRPM.S6882; Ashburner J, 2001, NEUROIMAGE, V14, P1238, DOI 10.1006/nimg.2001.0961; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Basnyat B, 2003, LANCET, V361, P1967, DOI 10.1016/S0140-6736(03)13591-X; Bookstein FL, 2001, NEUROIMAGE, V14, P1454, DOI 10.1006/nimg.2001.0770; Breakefield XO, 2008, NAT REV NEUROSCI, V9, P222, DOI 10.1038/nrn2337; Bridge H, 2012, CORTEX; Brugniaux JV, 2007, RESP PHYSIOL NEUROBI, V158, P212, DOI 10.1016/j.resp.2007.04.008; Cogo A, 2007, NATO SCI PEACE SEC A, P119, DOI 10.1007/978-1-4020-6300-8_8; Cohen MS, 1996, BRAIN, V119, P89, DOI 10.1093/brain/119.1.89; CORBETTA M, 1995, SCIENCE, V270, P802, DOI 10.1126/science.270.5237.802; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Davenport PW, 2009, RESP PHYSIOL NEUROBI, V167, P72, DOI 10.1016/j.resp.2008.10.001; Evans KC, 2010, BIOL PSYCHOL, V84, P13, DOI 10.1016/j.biopsycho.2010.02.005; Fayed N, 2006, AM J MED, V119, P1; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; GARRIDO E, 1993, INT J SPORTS MED, V14, P232, DOI 10.1055/s-2007-1021169; Gong PY, 2009, J MOL NEUROSCI, V38, P250, DOI 10.1007/s12031-009-9205-8; Gong Y., 1989, MANUAL WECHSLER MEMO; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; GOZAL D, 1995, P NATL ACAD SCI USA, V92, P6607, DOI 10.1073/pnas.92.14.6607; Hackett PH, 1998, JAMA-J AM MED ASSOC, V280, P1920, DOI 10.1001/jama.280.22.1920; HARIK SI, 1995, J PHYSIOL-LONDON, V485, P525, DOI 10.1113/jphysiol.1995.sp020748; Harper RM, 2003, J APPL PHYSIOL, V94, P1583, DOI 10.1152/japplphysiol.00881.2002; Harper RM, 1998, CLIN EXP PHARMACOL P, V25, P483, DOI 10.1111/j.1440-1681.1998.tb02240.x; Hattemer K, 2011, J NEUROIMAGING, V21, P16, DOI 10.1111/j.1552-6569.2009.00402.x; HOCHACHKA PW, 1994, J CEREBR BLOOD F MET, V14, P671, DOI 10.1038/jcbfm.1994.84; HORNBEIN TF, 1989, NEW ENGL J MED, V321, P1714, DOI 10.1056/NEJM198912213212505; HOUSTON CS, 1975, LANCET, V2, P758; Hu WD, 1999, J 4 MIL MED U, V3, P225; Jeong JH, 2002, J KOREAN MED SCI, V17, P861, DOI 10.3346/jkms.2002.17.6.861; Joo EY, 2010, SLEEP, V33, P235, DOI 10.1093/sleep/33.2.235; Kompus K, 2009, NEUROPSYCHOLOGIA, V47, P2252, DOI 10.1016/j.neuropsychologia.2008.11.031; Labate A, 2012, EPILEPSIA, V53, P377, DOI 10.1111/j.1528-1167.2011.03347.x; Macey KE, 2004, J APPL PHYSIOL, V97, P1897, DOI 10.1152/japplphysiol.00359.2004; Macey PM, 2008, SLEEP, V31, P967; Macey PM, 2002, AM J RESP CRIT CARE, V166, P1382, DOI 10.1164/rccm.200201-050OC; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; May A, 2006, CURR OPIN NEUROL, V19, P407, DOI 10.1097/01.wco.0000236622.91495.21; Munoz-Ruiz MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052531; NELSON TO, 1990, J EXP PSYCHOL GEN, V119, P367, DOI 10.1037/0096-3445.119.4.367; NEUBAUER JA, 1990, J APPL PHYSIOL, V68, P441, DOI 10.1152/jappl.1990.68.2.441; O'Donoghue FJ, 2005, AM J RESP CRIT CARE, V171, P1185, DOI 10.1164/rccm.200406-738OC; Paola MD, 2008, EUR J NEUROL, V15, P1050, DOI [10.1111/j.1468-1331.2008.02243.x, 10.1111/j.1468-1331.2008.02137.x]; Penaloza D, 2007, CIRCULATION, V115, P1132, DOI 10.1161/CIRCULATIONAHA.106.624544; Pforte C, 2005, NEUROSCIENCE, V136, P1133, DOI 10.1016/j.neuroscience.2005.08.043; REGARD M, 1989, NEUROLOGY, V39, P210, DOI 10.1212/WNL.39.2.210; Rostrup E, 2005, NEUROIMAGE, V28, P947, DOI 10.1016/j.neuroimage.2005.06.032; Simonyan K, 2007, NEUROIMAGE, V37, P401, DOI 10.1016/j.neuroimage.2007.05.021; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Teppema LJ, 2010, PHYSIOL REV, V90, P675, DOI 10.1152/physrev.00012.2009; Usui C, 2004, HIGH ALT MED BIOL, V5, P77, DOI 10.1089/152702904322963717; Virues-Ortega Javier, 2004, Neuropsychology Review, V14, P197; von Leupoldt A, 2005, CHEST, V128, P345, DOI 10.1378/chest.128.1.345; WAHI PL, 1965, LANCET, V1, P1395; West JB, 2004, OBSERVATORY, V124, P1; WEST JB, 1986, LANCET, V2, P387; Wilson MH, 2009, LANCET NEUROL, V8, P175, DOI 10.1016/S1474-4422(09)70014-6; Wolff C B, 2000, High Alt Med Biol, V1, P33, DOI 10.1089/152702900320667; Wu TY, 2007, HIGH ALT MED BIOL, V8, P88, DOI 10.1089/ham.2007.1015; [肖玮 Xiao Wei], 2007, [心理科学, Psychological Science], V30, P139; Yan XD, 2011, BRAIN COGNITION, V77, P53, DOI 10.1016/j.bandc.2011.06.002; Yan XA, 2011, EXP BRAIN RES, V208, P437, DOI 10.1007/s00221-010-2494-x; Zacks JM, 2008, J COGNITIVE NEUROSCI, V20, P1, DOI 10.1162/jocn.2008.20013; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045; Zhang HY, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000844; Zhang HY, 2012, HIGH ALT MED BIOL, V13, P118, DOI 10.1089/ham.2011.1073; Zhang JX, 2011, HIGH ALT MED BIOL, V12, P37, DOI 10.1089/ham.2009.1085; Zhang JX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011449; Zhu CL, 2009, J CEREBR BLOOD F MET, V29, P342, DOI 10.1038/jcbfm.2008.124; Zhu LL, 2005, BRAIN RES, V1055, P1, DOI 10.1016/j.brainres.2005.04.075	71	31	35	6	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68621	10.1371/journal.pone.0068621	http://dx.doi.org/10.1371/journal.pone.0068621			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874692	Green Published, Green Submitted, gold			2022-12-27	WOS:000322064300055
J	Perez-Quintero, AL; Rodriguez, LM; Dereeper, A; Lopez, C; Koebnik, R; Szurek, B; Cunnac, S				Perez-Quintero, Alvaro L.; Rodriguez, Luis M.; Dereeper, Alexis; Lopez, Camilo; Koebnik, Ralf; Szurek, Boris; Cunnac, Sebastien			An Improved Method for TAL Effectors DNA-Binding Sites Prediction Reveals Functional Convergence in TAL Repertoires of Xanthomonas oryzae Strains	PLOS ONE			English	Article							DISEASE-SUSCEPTIBILITY GENE; BACTERIAL-BLIGHT; RESISTANCE GENE; TRANSCRIPTION FACTOR; PLANT-RESISTANCE; RICE; PATHOGEN; HOST; RECOGNITION; IDENTIFICATION	Transcription Activators-Like Effectors (TALEs) belong to a family of virulence proteins from the Xanthomonas genus of bacterial plant pathogens that are translocated into the plant cell. In the nucleus, TALEs act as transcription factors inducing the expression of susceptibility genes. A code for TALE-DNA binding specificity and high-resolution three-dimensional structures of TALE-DNA complexes were recently reported. Accurate prediction of TAL Effector Binding Elements (EBEs) is essential to elucidate the biological functions of the many sequenced TALEs as well as for robust design of artificial TALE DNA-binding domains in biotechnological applications. In this work a program with improved EBE prediction performances was developed using an updated specificity matrix and a position weight correction function to account for the matching pattern observed in a validation set of TALE-DNA interactions. To gain a systems perspective on the large TALE repertoires from X. oryzae strains, this program was used to predict rice gene targets for 99 sequenced family members. Integrating predictions and available expression data in a TALE-gene network revealed multiple candidate transcriptional targets for many TALEs as well as several possible instances of functional convergence among TALEs.	[Perez-Quintero, Alvaro L.; Rodriguez, Luis M.; Dereeper, Alexis; Koebnik, Ralf; Szurek, Boris; Cunnac, Sebastien] Inst Rech Dev, UMR Resistance Plantes Bioagresseurs 186, Montpellier, France; [Perez-Quintero, Alvaro L.; Lopez, Camilo] Univ Nacl Colombia, Dept Biol, Bogota, DC, Colombia	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universidad Nacional de Colombia	Cunnac, S (corresponding author), Inst Rech Dev, UMR Resistance Plantes Bioagresseurs 186, Montpellier, France.	sebastien.cunnac@ird.fr	Rodriguez-R, Luis M./S-6996-2018; Koebnik, Ralf/J-5627-2014; Perez-Quintero, Alvaro/AAZ-9380-2020	Rodriguez-R, Luis M./0000-0001-7603-3093; Koebnik, Ralf/0000-0002-4419-0542; Perez-Quintero, Alvaro/0000-0003-3530-8251; Cunnac, Sebastien/0000-0002-3695-491X; Szurek, Boris/0000-0002-1808-7082	French Agence Nationale de la Recherche [ANR-2010-GENM-013]; Programme ECOS Nord	French Agence Nationale de la Recherche(French National Research Agency (ANR)); Programme ECOS Nord	This work was supported by the French Agence Nationale de la Recherche [ANR-2010-GENM-013] and Programme ECOS Nord. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony G, 2010, PLANT CELL, V22, P3864, DOI 10.1105/tpc.110.078964; Bai JF, 2000, MOL PLANT MICROBE IN, V13, P1322, DOI 10.1094/MPMI.2000.13.12.1322; Bing Y, 2004, MOL PLANT MICROBE IN, V17, P1192, DOI 10.1094/MPMI.2004.17.11.1192; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Bogdanove AJ, 2010, CURR OPIN PLANT BIOL, V13, P394, DOI 10.1016/j.pbi.2010.04.010; Bradley P, 2012, PROTEIN SCI, V21, P471, DOI 10.1002/pro.2034; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Deng D, 2012, SCIENCE, V335, P720, DOI 10.1126/science.1215670; Doyle EL, 2012, NUCL ACIDS RES; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Grewal RK, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-49; Hummel AW, 2012, NEW PHYTOL, V195, P883, DOI 10.1111/j.1469-8137.2012.04216.x; Johnson LS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-431; Kay S, 2007, SCIENCE, V318, P648, DOI 10.1126/science.1144956; Kay S, 2009, PLANT J, V59, P859, DOI 10.1111/j.1365-313X.2009.03922.x; Kim MC, 2009, MOL PLANT, V2, P13, DOI 10.1093/mp/ssn091; Lee I, 2011, P NATL ACAD SCI USA, V108, P18548, DOI 10.1073/pnas.1110384108; Lee SC, 2005, MOL CELLS, V19, P212; Li T, 2013, ORYZAE RICE MOL PLAN; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Lindeberg M, 2012, TRENDS MICROBIOL, V20, P199, DOI 10.1016/j.tim.2012.01.003; Liu QS, 2011, PLANT CELL ENVIRON, V34, P1958, DOI 10.1111/j.1365-3040.2011.02391.x; Mahfouz MM, 2012, PLANT MOL BIOL, V78, P311, DOI 10.1007/s11103-011-9866-x; Mahfouz Magdy M, 2011, GM Crops, V2, P99, DOI 10.4161/gmcr.2.2.17254; Mak ANS, 2012, SCIENCE, V335, P716, DOI 10.1126/science.1216211; Mansfield J, 2012, MOL PLANT PATHOL, V13, P614, DOI 10.1111/j.1364-3703.2012.00804.x; Meckler JF, 2013, NUCLEIC ACIDS RES, V41, P4118, DOI 10.1093/nar/gkt085; Megraw M, 2010, METHODS MOL BIOL, V592, P149, DOI 10.1007/978-1-60327-005-2_11; Mitra RM, 2004, P NATL ACAD SCI USA, V101, P4701, DOI 10.1073/pnas.0400595101; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Mukhtar MS, 2011, SCIENCE, V333, P596, DOI 10.1126/science.1203659; Murakami MT, 2010, PROTEINS, V78, P3386, DOI 10.1002/prot.22846; Rashid M, 2012, EVOL BIOINFORM, V8, P321, DOI 10.4137/EBO.S9369; Romer P, 2010, NEW PHYTOL, V187, P1048, DOI 10.1111/j.1469-8137.2010.03217.x; Romer P, 2009, P NATL ACAD SCI USA, V106, P20526, DOI 10.1073/pnas.0908812106; Ryan RP, 2011, NAT REV MICROBIOL, V9, P344, DOI 10.1038/nrmicro2558; Scholze H, 2011, CURR OPIN MICROBIOL, V14, P47, DOI 10.1016/j.mib.2010.12.001; Scholze H, 2010, VIRULENCE, V1, P428, DOI 10.4161/viru.1.5.12863; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Strauss T, 2012, P NATL ACAD SCI USA, V109, P19480, DOI 10.1073/pnas.1212415109; Streubel J, 2012, NAT BIOTECHNOL, V30, P593, DOI 10.1038/nbt.2304; Sugio A, 2007, P NATL ACAD SCI USA, V104, P10720, DOI 10.1073/pnas.0701742104; Sun N, 2012, MOL BIOSYST, V8, P1255, DOI 10.1039/c2mb05461b; Tian DS, 2009, MOL PLANT PATHOL, V10, P29, DOI 10.1111/j.1364-3703.2008.00509.x; Treutter D, 2005, PLANT BIOLOGY, V7, P581, DOI 10.1055/s-2005-873009; Verdier V, 2012, NEW PHYTOL, V196, P1197, DOI 10.1111/j.1469-8137.2012.04367.x; White FF, 2009, PLANT PHYSIOL, V150, P1677, DOI 10.1104/pp.109.139360; Yang B, 2006, P NATL ACAD SCI USA, V103, P10503, DOI 10.1073/pnas.0604088103; YANG YO, 1995, J BACTERIOL, V177, P4963, DOI 10.1128/jb.177.17.4963-4968.1995; Yang ZY, 2006, NUCLEIC ACIDS RES, V34, P667, DOI 10.1093/nar/gkj474; Yu YH, 2011, MOL PLANT MICROBE IN, V24, P1102, DOI 10.1094/MPMI-11-10-0254; Yuan T, 2011, MOL PLANT, V4, P300, DOI 10.1093/mp/ssq076; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775; Zou HS, 2010, SCI CHINA LIFE SCI, V53, P1440, DOI 10.1007/s11427-010-4109-y	62	63	68	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2013	8	7							e68464	10.1371/journal.pone.0068464	http://dx.doi.org/10.1371/journal.pone.0068464			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZN	23869221	Green Published, gold, Green Submitted			2022-12-27	WOS:000323110600020
J	Torres-Quesada, O; Millan, V; Nisa-Martinez, R; Bardou, F; Crespi, M; Toro, N; Jimenez-Zurdo, JI				Torres-Quesada, Omar; Millan, Vicenta; Nisa-Martinez, Rafael; Bardou, Florian; Crespi, Martin; Toro, Nicolas; Jimenez-Zurdo, Jose I.			Independent Activity of the Homologous Small Regulatory RNAs AbcR1 and AbcR2 in the Legume Symbiont Sinorhizobium meliloti	PLOS ONE			English	Article							SOLUBLE-RNAS; TARGET RECOGNITION; EXPRESSION VECTORS; TRANSPORT-SYSTEMS; GENE-REGULATION; CHAPERONE HFQ; PUTA GENE; IDENTIFICATION; PROTEIN; RESISTANCE	The legume symbiont Sinorhizobium meliloti expresses a plethora of small noncoding RNAs (sRNAs) whose function is mostly unknown. Here, we have functionally characterized two tandemly encoded S. meliloti Rm1021 sRNAs that are similar in sequence and structure. Homologous sRNAs (designated AbcR1 and AbcR2) have been shown to regulate several ABC transporters in the related alpha-proteobacteria Agrobacterium tumefaciens and Brucella abortus. In Rm1021, AbcR1 and AbcR2 exhibit divergent unlinked regulation and are stabilized by the RNA chaperone Hfq. AbcR1 is transcribed in actively dividing bacteria, either in culture, rhizosphere or within the invasion zone of mature alfalfa nodules. Conversely, AbcR2 expression is induced upon entry into stationary phase and under abiotic stress. Only deletion of AbcR1 resulted into a discrete growth delay in rich medium, but both are dispensable for symbiosis. Periplasmic proteome profiling revealed down-regulation of the branched-chain amino acid binding protein LivK by AbcR1, but not by AbcR2. A double-plasmid reporter assay confirmed the predicted specific targeting of the 59-untranslated region of the livK mRNA by AbcR1 in vivo. Our findings provide evidences of independent regulatory functions of these sRNAs, probably to fine-tune nutrient uptake in free-living and undifferentiated symbiotic rhizobia.	[Torres-Quesada, Omar; Millan, Vicenta; Nisa-Martinez, Rafael; Toro, Nicolas; Jimenez-Zurdo, Jose I.] CSIC, Grp Ecol Genet Rizosfera, Estac Expt Zaidin, Granada, Spain; [Bardou, Florian; Crespi, Martin] CNRS, ISV, Gif Sur Yvette, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Jimenez-Zurdo, JI (corresponding author), CSIC, Grp Ecol Genet Rizosfera, Estac Expt Zaidin, Granada, Spain.	jijz@eez.csic.es	Toro, Nicolas/K-4909-2014; Crespi, Martin/AAB-1424-2020; Jiménez-Zurdo, José I./P-6474-2014	Toro, Nicolas/0000-0002-3614-807X; Crespi, Martin/0000-0002-5698-9482; Jiménez-Zurdo, José I./0000-0002-6378-2199; Torres Quesada, Omar/0000-0003-3394-3075; Millan, Vicenta/0000-0003-2705-4896	ERDF from the former Spanish Ministerio de Ciencia e Innovacion [AGL2009-07925, CSD2009-00006]; Ministerio de Economia y Competitividad; FPI fellowship	ERDF from the former Spanish Ministerio de Ciencia e Innovacion; Ministerio de Economia y Competitividad(Spanish Government); FPI fellowship(Spanish Government)	This work has been funded by ERDF-cofinanced grants AGL2009-07925 and CSD2009-00006 (Consolider-Ingenio Program) from the former Spanish Ministerio de Ciencia e Innovacion, currently Ministerio de Economia y Competitividad, to JIJ-Z and NT, respectively. OT-Q was recipient of a FPI fellowship from the same Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett MJ, 2004, P NATL ACAD SCI USA, V101, P16636, DOI 10.1073/pnas.0407269101; Barra-Bily L, 2010, J BACTERIOL, V192, P1719, DOI 10.1128/JB.01429-09; Batut J, 2004, NAT REV MICROBIOL, V2, P933, DOI 10.1038/nrmicro1044; Berghoff BA, 2011, MOL MICROBIOL, V80, P1479, DOI 10.1111/j.1365-2958.2011.07658.x; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Blatny JM, 1997, APPL ENVIRON MICROB, V63, P370, DOI 10.1128/AEM.63.2.370-379.1997; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Busch A, 2008, BIOINFORMATICS, V24, P2849, DOI 10.1093/bioinformatics/btn544; Cabanes D, 2000, J BACTERIOL, V182, P3632, DOI 10.1128/JB.182.13.3632-3637.2000; Caswell CC, 2012, MOL MICROBIOL, V85, P345, DOI 10.1111/j.1365-2958.2012.08117.x; Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250; del Val C, 2007, MOL MICROBIOL, V66, P1080, DOI 10.1111/j.1365-2958.2007.05978.x; del Val C, 2012, RNA BIOL, V9, P119, DOI 10.4161/rna.18643; Eggenhofer E, 2004, MOL MICROBIOL, V52, P701, DOI 10.1111/j.1365-2958.2004.04022.x; Fry J, 2001, MOL PLANT MICROBE IN, V14, P1016, DOI 10.1094/MPMI.2001.14.8.1016; Galibert F, 2001, SCIENCE, V293, P668, DOI 10.1126/science.1060966; Gao MS, 2010, MOL PLANT MICROBE IN, V23, P355, DOI 10.1094/MPMI-23-4-0355; Garcia-Rodriguez FM, 2011, APPL ENVIRON MICROB, V77, P854, DOI 10.1128/AEM.02319-10; Garcia-Rodriguez FM, 2000, MOL PLANT MICROBE IN, V13, P583, DOI 10.1094/MPMI.2000.13.6.583; GIACOMINI A, 1994, GENE, V144, P17, DOI 10.1016/0378-1119(94)90197-X; GORG A, 1988, ELECTROPHORESIS, V9, P681, DOI 10.1002/elps.1150091103; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Guillier M, 2008, NUCLEIC ACIDS RES, V36, P6781, DOI 10.1093/nar/gkn742; Ishikawa H, 2012, RNA, V18, P1062, DOI 10.1261/rna.031575.111; Jensen JB, 2005, MOL PLANT MICROBE IN, V18, P694, DOI 10.1094/MPMI-18-0694; JimenezZurdo JI, 1997, MOL MICROBIOL, V23, P85, DOI 10.1046/j.1365-2958.1997.1861555.x; Jones KM, 2007, NAT REV MICROBIOL, V5, P619, DOI 10.1038/nrmicro1705; Karimi M, 2005, TRENDS PLANT SCI, V10, P103, DOI 10.1016/j.tplants.2005.01.008; Khan SR, 2008, APPL ENVIRON MICROB, V74, P5053, DOI 10.1128/AEM.01098-08; Laporte P, 2010, PLANT J, V62, P24, DOI 10.1111/j.1365-313X.2009.04121.x; Mauchline TH, 2006, P NATL ACAD SCI USA, V103, P17933, DOI 10.1073/pnas.0606673103; Oldroyd GED, 2008, ANNU REV PLANT BIOL, V59, P519, DOI 10.1146/annurev.arplant.59.032607.092839; OLIVARES J, 1980, APPL ENVIRON MICROB, V39, P967, DOI 10.1128/AEM.39.5.967-970.1980; Otaka H, 2011, P NATL ACAD SCI USA, V108, P13059, DOI 10.1073/pnas.1107050108; Papenfort K, 2006, MOL MICROBIOL, V62, P1674, DOI 10.1111/j.1365-2958.2006.05524.x; Papenfort K, 2010, P NATL ACAD SCI USA, V107, P20435, DOI 10.1073/pnas.1009784107; Papenfort K, 2010, CELL HOST MICROBE, V8, P116, DOI 10.1016/j.chom.2010.06.008; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Prell J, 2006, TRENDS MICROBIOL, V14, P161, DOI 10.1016/j.tim.2006.02.005; Prell J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013933; Reinkensmeier J, 2011, GENES-BASEL, V2, P925, DOI 10.3390/genes2040925; Richter AS, 2010, BIOINFORMATICS, V26, P1, DOI 10.1093/bioinformatics/btp609; RIGAUD J, 1975, J GEN MICROBIOL, V88, P223, DOI 10.1099/00221287-88-2-223; Sauer E, 2011, P NATL ACAD SCI USA, V108, P13065, DOI 10.1073/pnas.1103420108; Schluter JP, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-156; Schluter JP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-245; Schumacher MA, 2002, EMBO J, V21, P3546, DOI 10.1093/emboj/cdf322; Sharma CM, 2007, GENE DEV, V21, P2804, DOI 10.1101/gad.447207; Sharma CM, 2011, MOL MICROBIOL, V81, P1144, DOI 10.1111/j.1365-2958.2011.07751.x; Sharma CM, 2009, CURR OPIN MICROBIOL, V12, P536, DOI 10.1016/j.mib.2009.07.006; Sittka A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000163; Sittka A, 2007, MOL MICROBIOL, V63, P193, DOI 10.1111/j.1365-2958.2006.05489.x; Smith C, 2010, NUCLEIC ACIDS RES, V38, pW373, DOI 10.1093/nar/gkq316; Sobrero P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048494; Soto MJ, 2000, J BACTERIOL, V182, P1935, DOI 10.1128/JB.182.7.1935-1941.2000; Sun XG, 2002, NUCLEIC ACIDS RES, V30, P3662, DOI 10.1093/nar/gkf508; Svenningsen SL, 2009, EMBO J, V28, P429, DOI 10.1038/emboj.2008.300; Tenson T, 1997, J BIOL CHEM, V272, P17425, DOI 10.1074/jbc.272.28.17425; Tenson T, 2001, PEPTIDES, V22, P1661, DOI 10.1016/S0196-9781(01)00501-0; Torres-Cortes G, 2011, ENVIRON MICROBIOL, V13, P1101, DOI 10.1111/j.1462-2920.2010.02422.x; Torres-Quesada O, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-71; Tu KC, 2007, GENE DEV, V21, P221, DOI 10.1101/gad.1502407; Ulve VM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-467; Urban JH, 2008, PLOS BIOL, V6, P631, DOI 10.1371/journal.pbio.0060064; Urban JH, 2007, NUCLEIC ACIDS RES, V35, P1018, DOI 10.1093/nar/gkl1040; Urbanowski ML, 2000, MOL MICROBIOL, V37, P856, DOI 10.1046/j.1365-2958.2000.02051.x; Valoczi A, 2006, PLANT J, V47, P140, DOI 10.1111/j.1365-313X.2006.02766.x; Valverde C, 2008, ADV EXP MED BIOL, V631, P54, DOI 10.1007/978-0-387-78885-2_5; Valverde C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-416; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; Voss B, 2009, BIOCHEM BIOPH RES CO, V390, P331, DOI 10.1016/j.bbrc.2009.09.125; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Wilms I, 2012, J BACTERIOL, V194, P5209, DOI 10.1128/JB.00510-12; Wilms I, 2011, MOL MICROBIOL, V80, P492, DOI 10.1111/j.1365-2958.2011.07589.x	74	45	46	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2013	8	7							e68147	10.1371/journal.pone.0068147	http://dx.doi.org/10.1371/journal.pone.0068147			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZN	23869210	Green Published, Green Submitted, gold			2022-12-27	WOS:000323110600009
J	Bardet, N; Jalil, NE; de Broin, FD; Germain, D; Lambert, O; Amaghzaz, M				Bardet, Nathalie; Jalil, Nour-Eddine; de Broin, France de Lapparent; Germain, Damien; Lambert, Olivier; Amaghzaz, Mbarek			A Giant Chelonioid Turtle from the Late Cretaceous of Morocco with a Suction Feeding Apparatus Unique among Tetrapods	PLOS ONE			English	Article							CHELUS-FIMBRIATUS PLEURODIRA; PREY CAPTURE; MARINE REPTILES; NECKED TURTLES; KINEMATICS; EVOLUTION; MORPHOLOGY; MIOCENE; BASIN	Background: Secondary adaptation to aquatic life occurred independently in several amniote lineages, including reptiles during the Mesozoic and mammals during the Cenozoic. These evolutionary shifts to aquatic environments imply major morphological modifications, especially of the feeding apparatus. Mesozoic (250-65 Myr) marine reptiles, such as ichthyosaurs, plesiosaurs, mosasaurid squamates, crocodiles, and turtles, exhibit a wide range of adaptations to aquatic feeding and a broad overlap of their tooth morphospaces with those of Cenozoic marine mammals. However, despite these multiple feeding behavior convergences, suction feeding, though being a common feeding strategy in aquatic vertebrates and in marine mammals in particular, has been extremely rarely reported for Mesozoic marine reptiles. Principal Findings: A relative of fossil protostegid and dermochelyoid sea turtles, Ocepechelon bouyai gen. et sp. nov. is a new giant chelonioid from the Late Maastrichtian (67 Myr) of Morocco exhibiting remarkable adaptations to marine life (among others, very dorsally and posteriorly located nostrils). The 70-cm-long skull of Ocepechelon not only makes it one of the largest marine turtles ever described, but also deviates significantly from typical turtle cranial morphology. It shares unique convergences with both syngnathid fishes (unique long tubular bony snout ending in a rounded and anteriorly directed mouth) and beaked whales (large size and elongated edentulous jaws). This striking anatomy suggests extreme adaptation for suction feeding unmatched among known turtles. Conclusion/Significance: The feeding apparatus of Ocepechelon, a bony pipette-like snout, is unique among tetrapods. This new taxon exemplifies the successful systematic and ecological diversification of chelonioid turtles during the Late Cretaceous. This new evidence for a unique trophic specialization in turtles, along with the abundant marine vertebrate faunas associated to Ocepechelon in the Late Maastrichtian phosphatic beds of Morocco, further supports the hypothesis that marine life was, at least locally, very diversified just prior to the Cretaceous/Palaeogene (K/Pg) biotic crisis.	[Bardet, Nathalie; de Broin, France de Lapparent; Germain, Damien] Museum Natl Hist Nat, CNRS UMR 7207, Dept Hist Terre, F-75231 Paris, France; [Jalil, Nour-Eddine] Cadi Ayyad Univ, Fac Sci Semlalia, Dept Earth Sci Vertebrate Evolut & Palaeoenvironm, Marrakech, Morocco; [Lambert, Olivier] Inst Royal Sci Nat Belg, Dept Paleontol Bruxelles, Brussels, Belgium; [Amaghzaz, Mbarek] Ctr Minier Khouribga, Off Cherifien Phosphates, Khouribga, Morocco	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Cadi Ayyad University of Marrakech	Bardet, N (corresponding author), Museum Natl Hist Nat, CNRS UMR 7207, Dept Hist Terre, F-75231 Paris, France.	bardet@mnhn.fr	Lambert, Olivier/AEN-2469-2022; BARDET, Nathalie/N-8670-2019; Bardet, Nathalie/I-3805-2015	Lambert, Olivier/0000-0003-0740-5791; Germain, Damien/0000-0002-7608-2212; Bardet, Nathalie/0000-0001-7881-7107; JALIL, Nour-Eddine/0000-0002-7617-7625	CNRS; CNRST [4892]; CNRS, Departement Histoire de la Terre (MNHN, Paris, France) [UMR 7207]; French-Moroccan International Program of Scientific Cooperation	CNRS(Centre National de la Recherche Scientifique (CNRS)); CNRST; CNRS, Departement Histoire de la Terre (MNHN, Paris, France); French-Moroccan International Program of Scientific Cooperation	Funding for this project was obtained from the French-Moroccan International Program of Scientific Cooperation between the CNRS and the CNRST (PICS no 4892 for NB and NEJ) and from the CNRS UMR 7207, Departement Histoire de la Terre (MNHN, Paris, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, TETHYS; [Anonymous], 1979, B AM MUS NAT HIST, V164, P67; Arambourg C., 1952, NOTES ME MOIRES SERV, V92, P1; Bardet N, 2010, HIST BIOL, V22, P186, DOI 10.1080/08912961003754945; Benton MJ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000321; Bergert BA, 1997, MAR BIOL, V127, P563, DOI 10.1007/s002270050046; BOUR R, 1986, Bulletin Mensuel de la Societe Linneenne de Lyon, V55, P87; CARROLL RL, 1991, PHILOS T ROY SOC B, V331, P131, DOI 10.1098/rstb.1991.0004; Ciampaglio CN, 2005, SEDIMENTARY REC, V3, P4, DOI [DOI 10.1371/JOURNAL.P0NE.0063586, 10.2110/sedred.2005.4.4]; Collin Rachel, 1997, P451, DOI 10.1016/B978-012155210-7/50024-7; de Broin France de Lapparent, 2000, Palaeontologia Africana, V36, P43; de la Fuente MS, 2011, LETHAIA, V44, P15, DOI 10.1111/j.1502-3931.2010.00217.x; de Lussanet MHE, 2007, J R SOC INTERFACE, V4, P561, DOI 10.1098/rsif.2006.0201; Ernst CH., 1989, TURTLES WORLD; Gaffney ES, 2006, B AM MUS NAT HIST, P1; Gervais P, 1872, NOUVELLES ARCH MUSEU, V8, P199; Gmira S, 1995, ETUDE CHELONIENS FOS; Heyning John E., 1996, Contributions in Science (Los Angeles), V464, P1; Hirayama R, 1998, NATURE, V392, P705, DOI 10.1038/33669; Hirayama Ren, 1997, P225, DOI 10.1016/B978-012155210-7/50013-2; Jalil NE, 2009, CR PALEVOL, V8, P447, DOI 10.1016/j.crpv.2009.03.002; Jouve S, 2008, J VERTEBR PALEONTOL, V28, P409, DOI 10.1671/0272-4634(2008)28[409:TOACPP]2.0.CO;2; Kear BP, 2006, BIOL LETT-UK, V2, P116, DOI 10.1098/rsbl.2005.0406; Lambert O, 2010, NATURE, V466, P105, DOI 10.1038/nature09067; Lapparent de Broin F de, 2001, DUMERILIA, V4, P155; Lauder G.V., 1985, P210; LAUDER GV, 1992, J EXP BIOL, V164, P55; Lemell P, 2002, J EXP BIOL, V205, P1495; Lemell P, 2010, AMPHIBIA-REPTILIA, V31, P97, DOI 10.1163/156853810790457803; Massare J.A., 1987, Journal of Vertebrate Paleontology, V7, P121; MASSARE JA, 1988, PALEOBIOLOGY, V14, P187, DOI 10.1017/S009483730001191X; Mateus O, 2009, ACTA PALAEONTOL POL, V54, P581, DOI 10.4202/app.2008.0063; Nicholls EL, 2004, J VERTEBR PALEONTOL, V24, P838, DOI 10.1671/0272-4634(2004)024[0838:GIOTTN]2.0.CO;2; Parham JF, 2010, J PALEONTOL, V84, P231, DOI 10.1666/09-077R.1; REIDENBERG JS, 1994, ANAT RECORD, V240, P598, DOI 10.1002/ar.1092400417; Sander PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019480; Sanderson SL, 1993, SKULL, V3; Schumacher GH, 1973, BIOL REPTILIA, V4; Summers AP, 1998, J EXP ZOOL, V281, P280, DOI 10.1002/(SICI)1097-010X(19980701)281:4<280::AID-JEZ4>3.0.CO;2-K; Tong Haiyan, 2004, Revue de Paleobiologie Volume Special, V9, P55; Tong HY, 2008, B SOC GEOL FR, V179, P623, DOI 10.2113/gssgfbull.179.6.623; Van Wassenbergh S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1168; VanDamme J, 1997, J MORPHOL, V233, P113, DOI 10.1002/(SICI)1097-4687(199708)233:2<113::AID-JMOR3>3.0.CO;2-7; Vincent P, 2011, GONDWANA RES, V19, P1062, DOI 10.1016/j.gr.2010.10.005; Werth AJ, 2006, J MAMMAL, V87, P579, DOI 10.1644/05-MAMM-A-279R1.1; Werth Alexander, 2000, P487, DOI 10.1016/B978-012632590-4/50017-4; Werth AJ, 2006, J MORPHOL, V267, P1415, DOI 10.1002/jmor.10486; WINOKUR RM, 1988, J MORPHOL, V196, P33, DOI 10.1002/jmor.1051960105	48	39	42	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e63586	10.1371/journal.pone.0063586	http://dx.doi.org/10.1371/journal.pone.0063586			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874378	Green Published, gold, Green Submitted			2022-12-27	WOS:000322218800001
J	Hew, CS; Khoo, BY; Gam, LH				Hew, Chaw-Sen; Khoo, Boon-Yin; Gam, Lay-Harn			The Anti-Cancer Property of Proteins Extracted from Gynura procumbens (Lour.) Merr.	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE; CELL-PROLIFERATION; PLANT; IL-6; INTERLEUKIN-6; DOMAIN	Gynura procumbens (Lour.) Merr. belongs to the Asteraceae Family. The plant is a well-known traditional herb in South East Asia and it is widely used to treat inflammation, kidney discomfort, high cholesterol level, diabetic, cancer and high blood pressure. Our earlier study showed the presence of valuable plant defense proteins, such as peroxidase, thaumatin-like proteins and miraculin in the leaf of G. procumbens. However, the effects of these defense proteins on cancers have never been determined previously. In the present study, we investigated the bioactivity of gel filtration fractionated proteins of G. procumbens leaf extract. The active protein fraction, SN-F11/12, was found to inhibit the growth of a breast cancer cell line, MDA-MB-231, at an EC50 value of 3.8 mu g/mL. The mRNA expressions of proliferation markers, Ki67 and PCNA, were reduced significantly in the MDA-MB-23 cells treated with SN-F11/12. The expression of invasion marker, CCL2, was also found reduced in the treated MDA-MB-231 cells. All these findings highlight the anti-cancer property of SN-F11/12, therefore, the proteins in this fraction can be a potential chemotherapeutic agent for breast cancer treatment.	[Hew, Chaw-Sen; Gam, Lay-Harn] Univ Sains Malaysia, Sch Pharmaceut Sci, George Town, Malaysia; [Khoo, Boon-Yin] Univ Sains Malaysia, Inst Res Mol Med INFORMM, George Town, Malaysia	Universiti Sains Malaysia; Universiti Sains Malaysia	Gam, LH (corresponding author), Univ Sains Malaysia, Sch Pharmaceut Sci, George Town, Malaysia.	layharn@usm.my	Khoo, Boon Yin/AAF-2783-2019; Khoo, Boon Yin/A-9256-2011	Khoo, Boon Yin/0000-0003-1915-6606	Universiti Sains Malaysia [1001/PFARMASI/815034]; Institute for Graduate Studies of Universiti Sains Malaysia	Universiti Sains Malaysia(Universiti Sains Malaysia); Institute for Graduate Studies of Universiti Sains Malaysia	This work was supported by RU grant from Universiti Sains Malaysia (Project number: 1001/PFARMASI/815034). The authors also thank The Institute for Graduate Studies of Universiti Sains Malaysia for providing scholarship to Hew Chaw-Sen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ara T, 2010, EUR J CANCER, V46, P1223, DOI 10.1016/j.ejca.2010.02.026; Arakaki AK, 1997, FASEB J, V11, P133, DOI 10.1096/fasebj.11.2.9039955; Bernoux M, 2011, CELL HOST MICROBE, V9, P200, DOI 10.1016/j.chom.2011.02.009; Blanchard F, 2009, CYTOKINE GROWTH F R, V20, P19, DOI 10.1016/j.cytogfr.2008.11.004; Bokesch HR, 2001, J NAT PROD, V64, P249, DOI 10.1021/np000372l; Coll NS, 2011, CELL DEATH DIFFER, V18, P1247, DOI 10.1038/cdd.2011.37; David F, 2007, VET SURG, V36, P221, DOI 10.1111/j.1532-950X.2007.00253.x; Fridovich I, 1998, PROTEIN SCI, V7, P2688, DOI 10.1002/pro.5560071225; Gam LH, 2002, J BIOSAINS, V13, P27; Gasparri F, 2004, J BIOMOL SCREEN, V9, P232, DOI 10.1177/1087057103262836; Gong HJ, 2003, PLANT GROWTH REGUL, V40, P139, DOI 10.1023/A:1024243414584; Gorjanovic S, 2007, J I BREWING, V113, P206, DOI 10.1002/j.2050-0416.2007.tb00277.x; Hadji I, 2007, APPL BIOCHEM BIOTECH, V143, P129, DOI 10.1007/s12010-007-0042-3; Harvey AL, 2008, DRUG DISCOV TODAY, V13, P894, DOI 10.1016/j.drudis.2008.07.004; Hew CS, 2010, BIOTECHNOL BIOTEC EQ, V24, P2132, DOI 10.2478/v10133-010-0075-6; Hew CS, 2011, APPL BIOCHEM BIOTECH, V165, P1577, DOI 10.1007/s12010-011-9377-x; Hodge DR, 2005, EUR J CANCER, V41, P2502, DOI 10.1016/j.ejca.2005.08.016; Iskander MN, 2002, PLANT FOOD HUM NUTR, V57, P233, DOI 10.1023/A:1021851230890; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jenie RI, 2007, INDONESIAN J PHARM, V18, P81; Kiba A, 2003, PLANT CELL PHYSIOL, V44, P296, DOI 10.1093/pcp/pcg035; Kim Jeewon, 2008, Nutr Res Pract, V2, P80, DOI 10.4162/nrp.2008.2.2.80; Kim JY, 2009, INT J MOL SCI, V10, P2860, DOI 10.3390/ijms10062860; Knupfer H, 2007, BREAST CANCER RES TR, V102, P129, DOI 10.1007/s10549-006-9328-3; Lee Hee Jae, 2007, Korean Journal of Physiology & Pharmacology, V11, P145; Liu XD, 2007, AM J RESP CELL MOL, V37, P121, DOI 10.1165/rcmb.2005-0253OC; Losa M, 1998, CLIN SCI, V95, P129, DOI 10.1042/CS19970206; Lu X, 2009, J BIOL CHEM, V284, P29087, DOI 10.1074/jbc.M109.035899; Mandyam CD, 2007, NEUROSCIENCE, V146, P108, DOI 10.1016/j.neuroscience.2006.12.064; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Mediavilla MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013501; Mishra P, 2011, J LEUKOCYTE BIOL, V89, P31, DOI 10.1189/jlb.0310182; Nawrot R, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-78; Perry Lily M., 1980, MED PLANTS E SE ASIA; Puangpronpitag D., 2010, Asian Journal of Plant Sciences, V9, P146; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Sfaxi IH, 2012, MOL BIOTECHNOL, V52, P49, DOI 10.1007/s12033-011-9473-8; Shirano Y, 2002, PLANT CELL, V14, P3149, DOI 10.1105/tpc.005348; Sica A, 2009, ENCY CANC, P3064; Tepkeeva II, 2008, B EXP BIOL MED+, V145, P464, DOI 10.1007/s10517-008-0119-1; Tomaz T, 2010, PLANT PHYSIOL, V154, P1143, DOI 10.1104/pp.110.161612; Tsugane K, 1999, PLANT CELL, V11, P1195, DOI 10.1105/tpc.11.7.1195; Ward WW, 2009, CURR ANAL CHEM, V5, P85, DOI 10.2174/157341109787846171; Wiart Christophe, 2006, P1; Yerushalmi Rinat, 2010, Lancet Oncol, V11, P174, DOI 10.1016/S1470-2045(09)70262-1; Zhang X. F., 2000, SMJ, V41, P9; Zhang Y, 2002, CANCER RES, V62, P1205; Zinzalla G, 2010, BIOORG MED CHEM LETT, V20, P7029, DOI 10.1016/j.bmcl.2010.09.117	48	32	33	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e68524	10.1371/journal.pone.0068524	http://dx.doi.org/10.1371/journal.pone.0068524			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874655	Green Published, Green Submitted, gold			2022-12-27	WOS:000322218800035
J	Adolf-Bryfogle, J; Dunbrack, RL				Adolf-Bryfogle, Jared; Dunbrack, Roland L., Jr.			The PyRosetta Toolkit: A Graphical User Interface for the Rosetta Software Suite	PLOS ONE			English	Article							CRYSTALLOGRAPHIC PHASE PROBLEM; PROTEIN-PROTEIN DOCKING; STRUCTURE PREDICTION; ROTAMER PREFERENCES; DESIGN; SEQUENCES; ACCURACY; FOLDIT; SERVER; LOOP	The Rosetta Molecular Modeling suite is a command-line-only collection of applications that enable high-resolution modeling and design of proteins and other molecules. Although extremely useful, Rosetta can be difficult to learn for scientists with little computational or programming experience. To that end, we have created a Graphical User Interface (GUI) for Rosetta, called the PyRosetta Toolkit, for creating and running protocols in Rosetta for common molecular modeling and protein design tasks and for analyzing the results of Rosetta calculations. The program is highly extensible so that developers can add new protocols and analysis tools to the PyRosetta Toolkit GUI.	[Adolf-Bryfogle, Jared; Dunbrack, Roland L., Jr.] Fox Chase Canc Ctr, Inst Canc Res, Philadelphia, PA 19111 USA; [Adolf-Bryfogle, Jared] Drexel Univ, Coll Med, Program Mol & Cell Biol & Genet, Philadelphia, PA 19104 USA	Fox Chase Cancer Center; Drexel University	Dunbrack, RL (corresponding author), Fox Chase Canc Ctr, Inst Canc Res, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	Roland.Dunbrack@fccc.edu	Dunbrack, Roland/ABG-7141-2020	Dunbrack, Roland/0000-0001-7674-6667	National Institutes of Health [R01 GM84453]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084453] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding from National Institutes of Health R01 GM84453. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baugh EH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021931; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; Carrozzini B, 2004, ACTA CRYSTALLOGR A, V60, P331, DOI 10.1107/S0108767304012395; Chaudhury S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022477; Chaudhury S, 2010, BIOINFORMATICS, V26, P689, DOI 10.1093/bioinformatics/btq007; Choi EJ, 2013, PROTEIN ENG DES SEL, V26, P283, DOI 10.1093/protein/gzs108; Dantas G, 2003, J MOL BIOL, V332, P449, DOI 10.1016/S0022-2836(03)00888-X; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DUNBRACK RL, 1994, NAT STRUCT BIOL, V1, P334, DOI 10.1038/nsb0594-334; Dunbrack RL, 1997, PROTEIN SCI, V6, P1661, DOI 10.1002/pro.5560060807; Eiben CB, 2012, NAT BIOTECHNOL, V30, P190, DOI 10.1038/nbt.2109; Elser V, 2003, ACTA CRYSTALLOGR A, V59, P201, DOI 10.1107/S0108767303002812; Hu XZ, 2007, P NATL ACAD SCI USA, V104, P17668, DOI 10.1073/pnas.0707977104; Huang PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024109; Kaufmann KW, 2010, BIOCHEMISTRY-US, V49, P2987, DOI 10.1021/bi902153g; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kleiger G, 2009, CELL, V139, P957, DOI 10.1016/j.cell.2009.10.030; Kortemme T., 2004, SCI STKE, V2004, pl2; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Lauck F, 2010, NUCLEIC ACIDS RES, V38, pW569, DOI 10.1093/nar/gkq369; Leaver-Fay A, 2005, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2005, P16; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lewis SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020872; Lyskov S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063906; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; Parslow GR, 2013, BIOCHEM MOL BIOL EDU, V41, P116, DOI 10.1002/bmb.20686; Payne Philip R O, 2008, AMIA Annu Symp Proc, P566; Qian B, 2007, NATURE, V450, P259, DOI 10.1038/nature06249; R Development Team, 2011, R LANG ENV STAT COMP; Shapovalov MV, 2011, STRUCTURE, V19, P844, DOI 10.1016/j.str.2011.03.019; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Tyka MD, 2011, J MOL BIOL, V405, P607, DOI 10.1016/j.jmb.2010.11.008; Wang C, 2005, PROTEIN SCI, V14, P1328, DOI 10.1110/ps.041222905; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Winum JY, 2006, J ENZYM INHIB MED CH, V21, P477, DOI 10.1080/14756360600642370	38	18	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e66856	10.1371/journal.pone.0066856	http://dx.doi.org/10.1371/journal.pone.0066856			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874400	Green Published, Green Submitted, gold			2022-12-27	WOS:000321736900006
J	Chen, YH; Yu, MM; Zhu, ZB; Zhang, LX; Guo, QS				Chen, Yuhang; Yu, Manman; Zhu, Zaibiao; Zhang, Lixia; Guo, Qiaosheng			Optimisation of Potassium Chloride Nutrition for Proper Growth, Physiological Development and Bioactive Component Production in Prunella vulgaris L.	PLOS ONE			English	Article							ROSMARINIC ACID; DROUGHT STRESS; PHENOLIC-COMPOUNDS; OLEANOLIC ACID; CORN RESPONSE; URSOLIC ACID; PHOTOSYNTHESIS; PLANTS; ACCUMULATION; COTTON	Prunella vulgaris L. is an important medicinal plant with a variety of pharmacological activities, but limited information is available about its response to potassium chloride (KCl) supplementation. P. vulgaris seedlings were cultured in media with four different KCl levels (0, 1.00, 6.00 and 40.00 mM). Characteristics relating to the growth, foliar potassium, water and chlorophyll content, photosynthesis, transpiration, nitrogen metabolism, bioactive constituent concentrations and yield were determined after three months. The appropriate KCl concentration was 6.00 mM to result in the highest values for dry weight, shoot height, spica and root weight, spica length and number in P. vulgaris. The optimum KCl concentration resulted in a maximum net photosynthetic rate (Pn) that could be associated with the highest chlorophyll content and fully open stomata conductance. A supply of surplus KCl resulted in a higher concentration of foliar potassium and negatively correlated with the biomass. Plants that were treated with the appropriate KCl level showed a greater capacity for nitrate assimilation. The Pn was significantly and positively correlated with nitrate reductase (NR) and glutamine synthetase (GS) activities and was positively correlated with leaf-soluble protein and free amino acid (FAA) contents. Both KCl starvation (0 mM) and high KCl (40.00 mM) led to water loss through a high transpiration rate and low water absorption, respectively, and resulted in increased concentrations of ursolic acid (UA), oleanolic acid (OA) and flavonoids, with the exception of rosmarinic acid (RA). Moreover, the optimum concentration of KCl significantly increased the yields of RA, UA, OA and flavonoids. Our findings suggested that significantly higher plant biomass; chlorophyll content; Pn; stronger nitrogen anabolism; lower RA, UA, OA and flavonoid accumulation; and greater RA, UA, OA and flavonoid yields in P. vulgaris could be expected in the presence of the appropriate KCl concentration (6.00 mM).	[Chen, Yuhang; Yu, Manman; Zhu, Zaibiao; Zhang, Lixia; Guo, Qiaosheng] Nanjing Agr Univ, Inst Chinese Med Mat, Nanjing, Jiangsu, Peoples R China; [Chen, Yuhang] Chengdu Med Coll, Coll Pharmaceut Sci, Chengdu, Peoples R China; [Chen, Yuhang] Struct Specif Small Mol Drug Res Univ Key Lab Sic, Chengdu, Peoples R China	Nanjing Agricultural University; Chengdu Medical College	Guo, QS (corresponding author), Nanjing Agr Univ, Inst Chinese Med Mat, Nanjing, Jiangsu, Peoples R China.	gqs@njau.edu.cn		Guo, Qiaosheng/0000-0001-8006-882X; Zhu, Zaibiao/0000-0002-3925-4767	National Nature Science Foundation of China [30772730, 81072986]; Key Discipline Construction Project of Pharmacy in Chengdu Medical College; Scientific Research Foundation of Chengdu Medical College [CYZ12-006, CYXK2012006, CYZ12-037]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Discipline Construction Project of Pharmacy in Chengdu Medical College; Scientific Research Foundation of Chengdu Medical College	This study was funded by the programs of the National Nature Science Foundation of China (No. 30772730 and 81072986), the Key Discipline Construction Project of Pharmacy in Chengdu Medical College and Scientific Research Foundation of Chengdu Medical College (CYZ12-006; CYXK2012006; CYZ12-037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-El Baki GK, 2000, PLANT CELL ENVIRON, V23, P515, DOI 10.1046/j.1365-3040.2000.00568.x; Agati G, 2012, PLANT SCI, V196, P67, DOI 10.1016/j.plantsci.2012.07.014; Alvim FC, 2001, PLANT PHYSIOL, V126, P1042, DOI 10.1104/pp.126.3.1042; Bednarz CW, 1998, ENVIRON EXP BOT, V39, P131, DOI 10.1016/S0098-8472(97)00039-7; Bomme U, 2007, J ALTERN COMPLEM MED, V13, P597, DOI 10.1089/acm.2006.6276; Buah S, 2000, COMMUN SOIL SCI PLAN, V31, P3121, DOI 10.1080/00103620009370655; CAKMAK I, 1994, J EXP BOT, V45, P1259, DOI 10.1093/jxb/45.9.1259; Cakmak I, 2005, J PLANT NUTR SOIL SC, V168, P521, DOI 10.1002/jpln.200420485; Chartzoulakis K, 2006, J PLANT NUTR, V29, P2063, DOI 10.1080/01904160600932682; Chen YH, 2012, J ESSENT OIL BEAR PL, V15, P662, DOI 10.1080/0972060X.2012.10644102; Chen YH, 2012, PHARM BIOL, V50, P1118, DOI 10.3109/13880209.2012.658477; Chen YH, 2012, BIOL RES, V45, P171, DOI 10.4067/S0716-97602012000200009; Chen YH, 2011, J MED PLANTS RES, V5, P1749; Cheung HY, 2008, J CHROMATOGR A, V1213, P231, DOI 10.1016/j.chroma.2008.10.033; Cook NC, 1996, J NUTR BIOCHEM, V7, P66, DOI 10.1016/0955-2863(95)00168-9; CRUZ LJ, 1970, PLANT PHYSIOL, V46, P743, DOI 10.1104/pp.46.5.743; Editorial Board for Flora of China, 1977, FLORA CHINA; FARQUHAR GD, 1982, ANNU REV PLANT PHYS, V33, P317, DOI 10.1146/annurev.pp.33.060182.001533; FISCHER RA, 1968, SCIENCE, V160, P784, DOI 10.1126/science.160.3829.784; FISCHER RA, 1968, PLANT PHYSIOL, V43, P1953, DOI 10.1104/pp.43.12.1953; Gerardeaux E, 2010, ENVIRON EXP BOT, V67, P451, DOI 10.1016/j.envexpbot.2009.09.008; GIFFORD RM, 1981, ANNU REV PLANT PHYS, V32, P485, DOI 10.1146/annurev.pp.32.060181.002413; Grassmann J, 2002, PLANT PHYSIOL BIOCH, V40, P471, DOI 10.1016/S0981-9428(02)01395-5; Gulen H, 2004, PLANT SCI, V166, P739, DOI 10.1016/j.plantsci.2003.11.014; Guo Qiaosheng, 2011, Zhongguo Zhong Yao Za Zhi, V36, P2932; Hale BK, 2005, J CHEM ECOL, V31, P2601, DOI 10.1007/s10886-005-7616-8; Han EH, 2009, FOOD CHEM TOXICOL, V47, P62, DOI 10.1016/j.fct.2008.10.010; HECKMAN JR, 1995, COMMUN SOIL SCI PLAN, V26, P123, DOI 10.1080/00103629509369285; Hermans C, 2006, TRENDS PLANT SCI, V11, P610, DOI 10.1016/j.tplants.2006.10.007; HISCOX JD, 1979, CAN J BOT, V57, P1332, DOI 10.1139/b79-163; Holzmannova V, 1996, CHEM LISTY, V90, P486; KOCH DW, 1975, CROP SCI, V15, P697, DOI 10.2135/cropsci1975.0011183X001500050025x; KOJIMA H, 1990, PHYTOCHEMISTRY, V29, P2351, DOI 10.1016/0031-9422(90)83073-A; KRAMER PJ, 1981, BIOSCIENCE, V31, P29, DOI 10.2307/1308175; Lam HM, 1996, ANNU REV PLANT PHYS, V47, P569, DOI 10.1146/annurev.arplant.47.1.569; LARANJINHA JAN, 1994, BIOCHEM PHARMACOL, V48, P487, DOI 10.1016/0006-2952(94)90278-X; LEIGH RA, 1984, NEW PHYTOL, V97, P1, DOI 10.1111/j.1469-8137.1984.tb04103.x; Liao L, 2012, BIOCHEM SYST ECOL, V45, P209, DOI 10.1016/j.bse.2012.07.030; Liao Li, 2010, Chinese Herbal Medicines, V2, P305; Liu HX, 2003, J PHARMACEUT BIOMED, V32, P479, DOI 10.1016/S0731-7085(03)00235-8; Liu J, 1995, J ETHNOPHARMACOL, V49, P57, DOI 10.1016/0378-8741(95)90032-2; Luczaj L, 2010, J ETHNOPHARMACOL, V128, P395, DOI 10.1016/j.jep.2010.01.038; Martin-Aragon S, 2001, EXP TOXICOL PATHOL, V53, P199, DOI 10.1078/0940-2993-00185; MULLINS GL, 1994, AGRON J, V86, P136, DOI 10.2134/agronj1994.00021962008600010025x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nukaya A., 1991, ACTA HORTIC, V294, P297; Osakabe N, 2004, BIOFACTORS, V21, P127, DOI 10.1002/biof.552210125; Osakabe N, 2002, FREE RADICAL BIO MED, V33, P798, DOI 10.1016/S0891-5849(02)00970-X; Pettigrew WT, 2008, PHYSIOL PLANTARUM, V133, P670, DOI 10.1111/j.1399-3054.2008.01073.x; Pettigrew WT, 1997, J PLANT NUTR, V20, P531, DOI 10.1080/01904169709365272; Psotova J, 2003, PHYTOTHER RES, V17, P1082, DOI 10.1002/ptr.1324; Psotova J, 2006, J PHOTOCH PHOTOBIO B, V84, P167, DOI 10.1016/j.jphotobiol.2006.02.012; Sahin S, 2011, J PHARMACEUT BIOMED, V55, P1227, DOI 10.1016/j.jpba.2011.03.016; Shin R, 2004, P NATL ACAD SCI USA, V101, P8827, DOI 10.1073/pnas.0401707101; Shyu MH, 2008, FOOD CHEM TOXICOL, V46, P3707, DOI 10.1016/j.fct.2008.09.051; Sibout R, 1998, ENVIRON EXP BOT, V40, P173, DOI 10.1016/S0098-8472(98)00032-X; Skottova N, 2004, PHARMACOL RES, V50, P123, DOI 10.1016/j.phrs.2003.12.013; SUKALOVIC VHT, 1986, PHYSIOL PLANTARUM, V67, P247; Turtola S, 2003, J CHEM ECOL, V29, P1981, DOI 10.1023/A:1025674116183; Very AA, 2003, ANNU REV PLANT BIOL, V54, P575, DOI 10.1146/annurev.arplant.54.031902.134831; Vyn TJ, 2001, AGRON J, V93, P487, DOI 10.2134/agronj2001.933487x; Wang N, 2012, J PHOTOCH PHOTOBIO B, V110, P1, DOI 10.1016/j.jphotobiol.2012.02.002; Weng XY, 2007, PHYSIOL PLANTARUM, V131, P614, DOI 10.1111/j.1399-3054.2007.00978.x; Xu YW, 2011, ENVIRON EXP BOT, V71, P292, DOI 10.1016/j.envexpbot.2010.12.015; Yurtseven E, 2005, AGR WATER MANAGE, V78, P128, DOI 10.1016/j.agwat.2005.04.018; Zdarilova A, 2009, TOXICOL IN VITRO, V23, P386, DOI 10.1016/j.tiv.2008.12.021; ZELITCH I, 1982, BIOSCIENCE, V32, P796, DOI 10.2307/1308973; Zhang GW, 2011, INNOV FOOD SCI EMERG, V12, P18, DOI 10.1016/j.ifset.2010.12.003; Zhao DL, 2001, PHOTOSYNTHETICA, V39, P103, DOI 10.1023/A:1012404204910; Zhu ZB, 2009, ENVIRON EXP BOT, V66, P326, DOI 10.1016/j.envexpbot.2009.03.017	70	17	17	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e66259	10.1371/journal.pone.0066259	http://dx.doi.org/10.1371/journal.pone.0066259			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874390	Green Published, Green Submitted, gold			2022-12-27	WOS:000321736900004
J	Dariolli, R; Bassaneze, V; Nakamuta, JS; Omae, SV; Cristina, L; Campos, G; Krieger, JE				Dariolli, Rafael; Bassaneze, Vinicius; Nakamuta, Juliana Sanajotti; Omae, Samantha Vieira; Cristina, Luciene; Campos, Gastalho; Krieger, Jose E.			Porcine Adipose Tissue-Derived Mesenchymal Stem Cells Retain Their Proliferative Characteristics, Senescence, Karyotype and Plasticity after Long-Term Cryopreservation	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; DIMETHYL-SULFOXIDE; IN-VIVO; DIFFERENTIATION; TRANSPLANTATION; DMSO	We and others have provided evidence that adipose tissue-derived mesenchymal stem cells (ASCs) can mitigate rat cardiac functional deterioration after myocardial ischemia, even though the mechanism of action or the relevance of these findings to human conditions remains elusive. In this regard, the porcine model is a key translational step, because it displays heart anatomic-physiological features that are similar to those found in the human heart. Towards this end, we wanted to establish the cultural characteristics of porcine ASCs (pASCs) with or without long-term cryostorage, considering that allogeneic transplantation may also be a future option. Compared to fresh pASCs, thawed cells displayed 90-95% viability and no changes in morphological characteristics or in the expression of surface markers (being pASCs characterized by positive markers CD29(+); CD90(+); CD44(+); CD140b(+); CD105(+); and negative markers CD31(-); CD34(-); CD45(-) and SLA-DR-; n = 3). Mean population doubling time was also comparable (64.26 +/- 15.11 hours to thawed cells vs. 62.74 +/- 18.07 hours to fresh cells) and cumulative population doubling increased constantly until Passage 10 (P10) in the entire cell population, with a small and gradual increase in senescence (P5, 3.25% +/- 0.26 vs. 3.47%+/- 0.32 and P10, 9.6%+/- 0.29 vs. 10.67%+/- 1.25, thawed vs. fresh; SA-beta-Gal staining). Chromosomal aberrations were not observed. In addition, under both conditions pASCs responded to adipogenic and osteogenic chemical cues in vitro. In conclusion, we have demonstrated the growth characteristics, senescence, and the capacity of pASCs to respond to chemical cues in vitro and have provided evidence that these properties are not influenced by cryostorage in 10% DMSO solution.	[Dariolli, Rafael; Bassaneze, Vinicius; Nakamuta, Juliana Sanajotti; Omae, Samantha Vieira; Cristina, Luciene; Campos, Gastalho; Krieger, Jose E.] Univ Sao Paulo, Sch Med, Heart Inst InCor, Sao Paulo, Brazil	Universidade de Sao Paulo	Krieger, JE (corresponding author), Univ Sao Paulo, Sch Med, Heart Inst InCor, Sao Paulo, Brazil.	krieger@incor.usp.br	Campos, Luciene/Y-3562-2019; Bassaneze, Vinícius/E-5577-2012; Dariolli, Rafael/I-3672-2015; Campos, Luciene C/L-7603-2015	Campos, Luciene/0000-0002-5962-661X; Bassaneze, Vinícius/0000-0002-3481-2408; Campos, Luciene C/0000-0002-5962-661X; Dariolli, Rafael/0000-0003-0957-1259; Krieger, Jose E/0000-0001-5464-1792	FAPESP [07/58942-0, 08/52436-9, 08/52335-8]; CNPq [573887/2008-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq [135470/2008-0]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [2008/52334-1, 2008/55918-4, 2009/50624-5, 2010/52516-2]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was funded by grants from FAPESP (07/58942-0, 08/52436-9, 08/52335-8) and CNPq (573887/2008-0). RD was a recipient of a training fellowship from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq - (135470/2008-0). VB, RD, LCGC, and JSN were recipients of training fellowships from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP - (2008/52334-1, 2008/55918-4, 2009/50624-5, 2010/52516-2). RD is enrolled in the Medical Sciences Master's program at the FMUSP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrigoni E, 2009, CELL TISSUE RES, V338, P401, DOI 10.1007/s00441-009-0883-x; Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X; Blande IS, 2009, TRANSFUSION, V49, P2680, DOI 10.1111/j.1537-2995.2009.02346.x; Danoviz ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012077; Danoviz ME, 2011, STEM CELLS DEV, V20, P661, DOI 10.1089/scd.2010.0231; DEPRAETERE S, 1995, J LEUKOCYTE BIOL, V57, P141, DOI 10.1002/jlb.57.1.141; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dixon JA, 2009, CIRC-HEART FAIL, V2, P262, DOI 10.1161/CIRCHEARTFAILURE.108.814459; dos Santos L, 2010, INT J CARDIOL, V145, P34, DOI 10.1016/j.ijcard.2009.06.008; Freshney R.I, 2010, CULTURE ANIMAL CELLS, Vsixth, P732; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; Guilak F, 2006, J CELL PHYSIOL, V206, P229, DOI 10.1002/jcp.20463; Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645; Katkov II, 2006, CRYOBIOLOGY, V53, P194, DOI 10.1016/j.cryobiol.2006.05.005; Kilroy GE, 2007, J CELL PHYSIOL, V212, P702, DOI 10.1002/jcp.21068; Lee JE, 2010, DERMATOL SURG, V36, P1078, DOI 10.1111/j.1524-4725.2010.01586.x; Martinello T, 2011, RES VET SCI, V91, P18, DOI 10.1016/j.rvsc.2010.07.024; Mazo M, 2008, EUR J HEART FAIL, V10, P454, DOI 10.1016/j.ejheart.2008.03.017; McIntosh KR, 2009, TISSUE ENG PT A, V15, P2677, DOI 10.1089/ten.TEA.2008.0566; MORLEY P, 1993, J CELL PHYSIOL, V156, P219, DOI 10.1002/jcp.1041560202; Mummery CL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000558; Nakamuta JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006005; Ock SA, 2011, CELL TRANSPLANT, V20, P1231, DOI 10.3727/096368910X552835; Ogawa R, 2004, BIOCHEM BIOPH RES CO, V313, P871, DOI 10.1016/j.bbrc.2003.12.017; Poh KK, 2007, INT J CARDIOL, V117, P360, DOI 10.1016/j.ijcard.2006.04.092; Puissant N, 2005, BRIT J HAEMATOL, V129, P118, DOI 10.1111/j.1365-2141.2005.05409.x; Qu CQ, 2007, IN VITRO CELL DEV-AN, V43, P95, DOI 10.1007/s11626-006-9008-y; Thirumala S, 2010, STEM CELLS DEV, V19, P513, DOI 10.1089/scd.2009.0173; Williams KJ, 2008, CELLS TISSUES ORGANS, V188, P251, DOI 10.1159/000121431; Yoshimura H, 2007, CELL TISSUE RES, V327, P449, DOI 10.1007/s00441-006-0308-z; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	31	26	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e67939	10.1371/journal.pone.0067939	http://dx.doi.org/10.1371/journal.pone.0067939			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874472	Green Submitted, Green Published, gold			2022-12-27	WOS:000321736900038
J	Le, S; He, XS; Tan, YL; Huang, GT; Zhang, L; Lux, R; Shi, WY; Hu, FQ				Le, Shuai; He, Xuesong; Tan, Yinling; Huang, Guangtao; Zhang, Lin; Lux, Renate; Shi, Wenyuan; Hu, Fuquan			Mapping the Tail Fiber as the Receptor Binding Protein Responsible for Differential Host Specificity of Pseudomonas aeruginosa Bacteriophages PaP1 and JG004	PLOS ONE			English	Article							ANTAGONISTIC COEVOLUTION; PHAGE TP901-1; IDENTIFICATION; MECHANISM; EVOLUTION; INFECTION; BASEPLATE; RANGE; GENE; CONSTRUCTION	The first step in bacteriophage infection is recognition and binding to the host receptor, which is mediated by the phage receptor binding protein (RBP). Different RBPs can lead to differential host specificity. In many bacteriophages, such as Escherichia coli and Lactococcal phages, RBPs have been identified as the tail fiber or protruding baseplate proteins. However, the tail fiber-dependent host specificity in Pseudomonas aeruginosa phages has not been well studied. This study aimed to identify and investigate the binding specificity of the RBP of P. aeruginosa phages PaP1 and JG004. These two phages share high DNA sequence homology but exhibit different host specificities. A spontaneous mutant phage was isolated and exhibited broader host range compared with the parental phage JG004. Sequencing of its putative tail fiber and baseplate region indicated a single point mutation in ORF84 (a putative tail fiber gene), which resulted in the replacement of a positively charged lysine (K) by an uncharged asparagine (N). We further demonstrated that the replacement of the tail fiber gene (ORF69) of PaP1 with the corresponding gene from phage JG004 resulted in a recombinant phage that displayed altered host specificity. Our study revealed the tail fiber-dependent host specificity in P. aeruginosa phages and provided an effective tool for its alteration. These contributions may have potential value in phage therapy.	[Le, Shuai; Tan, Yinling; Huang, Guangtao; Zhang, Lin; Hu, Fuquan] Third Mil Med Univ, Dept Microbiol, Chongqing, Peoples R China; [He, Xuesong; Lux, Renate; Hu, Fuquan] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90095 USA	Army Medical University; University of California System; University of California Los Angeles	Shi, WY (corresponding author), Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90095 USA.	wenyuan@ucla.edu; hufuquan2009@yahoo.cn	SHI, wen/GPW-9531-2022; He, Xuesong/GXN-2297-2022	Le, Shuai/0000-0003-3748-5454	National Natural Science Foundation of China (NSFC) [31171205]; State Scholarship Fund from China Scholarship Council	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); State Scholarship Fund from China Scholarship Council(China Scholarship Council)	This work was supported by the National Natural Science Foundation of China (NSFC, 31171205) and State Scholarship Fund from China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann HW, 2003, RES MICROBIOL, V154, P245, DOI 10.1016/S0923-2508(03)00067-6; Bartual SG, 2010, P NATL ACAD SCI USA, V107, P20287, DOI 10.1073/pnas.1011218107; Bjarnsholt T, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001420; Breidenstein EBM, 2011, TRENDS MICROBIOL, V19, P419, DOI 10.1016/j.tim.2011.04.005; Buckling A, 2002, P ROY SOC B-BIOL SCI, V269, P931, DOI 10.1098/rspb.2001.1945; Chatterjee S, 2012, VIRUSES-BASEL, V4, P3162, DOI 10.3390/v4113162; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Christophersen LJ, 2012, CLIN EXP IMMUNOL, V170, P222, DOI 10.1111/j.1365-2249.2012.04652.x; Cramer N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050731; Duplessis M, 2001, MOL MICROBIOL, V41, P325, DOI 10.1046/j.1365-2958.2001.02521.x; Dupont K, 2004, APPL ENVIRON MICROB, V70, P5818, DOI 10.1128/AEM.70.10.5818-5824.2004; Fothergill JL, 2012, EXPERT REV ANTI-INFE, V10, P219, DOI [10.1586/eri.11.168, 10.1586/ERI.11.168]; Garbe J, 2011, BMC MICROBIOL, V11, P12, DOI [10.1186/1471-2180-11-12, DOI 10.1186/1471-2180-11-12.PUBMED:21241507]; Garcia-Doval C, 2012, P NATL ACAD SCI USA, V109, P9390, DOI 10.1073/pnas.1119719109; Harper DR, 2011, J APPL MICROBIOL, V111, P1, DOI 10.1111/j.1365-2672.2011.05003.x; HASHEMOLHOSSEINI S, 1994, J MOL BIOL, V240, P105, DOI 10.1006/jmbi.1994.1424; Heineman RH, 2008, AM NAT, V171, pE149, DOI 10.1086/528962; HELLER KJ, 1984, VIROLOGY, V139, P11, DOI 10.1016/0042-6822(84)90325-8; Jonah G, 2003, J VIROL, V77, P6709, DOI 10.1128/JVI.77.12.6709-6719.2003; Krahn T, 2012, ANTIMICROB AGENTS CH, V56, P5591, DOI 10.1128/AAC.01446-12; Loessner MJ, 1996, APPL ENVIRON MICROB, V62, P1133, DOI 10.1128/AEM.62.4.1133-1140.1996; Lu SG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062933; Mahichi F, 2009, FEMS MICROBIOL LETT, V295, P211, DOI 10.1111/j.1574-6968.2009.01588.x; Mcvay CS, 2007, ANTIMICROB AGENTS CH, V51, P1934, DOI 10.1128/AAC.01028-06; Morello E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016963; Pal C, 2007, NATURE, V450, P1079, DOI 10.1038/nature06350; Paterson S, 2010, NATURE, V464, P275, DOI 10.1038/nature08798; Plisson C, 2007, EMBO J, V26, P3720, DOI 10.1038/sj.emboj.7601786; Qin X, 2012, ANTIMICROB AGENTS CH, V56, P5971, DOI 10.1128/AAC.01371-12; Rakhuba DV, 2010, POL J MICROBIOL, V59, P145, DOI 10.33073/pjm-2010-023; Rothenberg E, 2011, BIOPHYS J, V100, P2875, DOI 10.1016/j.bpj.2011.05.014; Schwarzer D, 2012, J VIROL, V86, P10384, DOI 10.1128/JVI.00801-12; Sciara G, 2010, P NATL ACAD SCI USA, V107, P6852, DOI 10.1073/pnas.1000232107; Scott AE, 2007, PLOS PATHOG, V3, P1142, DOI 10.1371/journal.ppat.0030119; Skiada A, 2011, INT J ANTIMICROB AG, V37, P187, DOI 10.1016/j.ijantimicag.2010.11.019; Slekovec C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049300; Spinelli S, 2006, J BIOL CHEM, V281, P14256, DOI 10.1074/jbc.M600666200; Sun WZ, 2010, AFR J MICROBIOL RES, V4, P933; Tan YL, 2007, CELL MICROBIOL, V9, P479, DOI 10.1111/j.1462-5822.2006.00804.x; Uchiyama J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026648; Veesler D, 2012, P NATL ACAD SCI USA, V109, P8954, DOI 10.1073/pnas.1200966109; Vegge CS, 2006, J BACTERIOL, V188, P55, DOI 10.1128/JB.188.1.55-63.2006; Wang J, 2000, J BACTERIOL, V182, P508, DOI 10.1128/JB.182.2.508-512.2000; WEST SEH, 1994, GENE, V148, P81, DOI 10.1016/0378-1119(94)90237-2; Yamamoto S, 2012, J IMMUNOL, V189, P4221, DOI 10.4049/jimmunol.1201683	45	78	95	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68562	10.1371/journal.pone.0068562	http://dx.doi.org/10.1371/journal.pone.0068562			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874674	Green Submitted, Green Published, gold			2022-12-27	WOS:000321736900095
J	Yu, SR; Xiao, X; Lu, JW; Qian, XP; Liu, BR; Feng, JF				Yu, Shaorong; Xiao, Xia; Lu, Jianwei; Qian, Xiaoping; Liu, Baorui; Feng, Jifeng			Colorectal Cancer Patients with Low Abundance of KRAS Mutation May Benefit from EGFR Antibody Therapy	PLOS ONE			English	Article							K-RAS MUTATIONS; CETUXIMAB; CHEMOTHERAPY; ASSOCIATION; RESISTANCE; EFFICACY; PCR	Epidermal growth factor receptor monoclonal antibody was approved for treatment of metastatic colorectal cancer patients carrying KRAS wild type DNA. However, recent studies showed that patients with KRAS G13D mutation may benefit from EGFR antibody therapy. In this study we tried to explore whether the abundance of KRAS mutation could affect the efficacy of EGFR antibody therapy. We firstly established a PNA-PCR method which could calculate the percentage of KRAS mutation in total DNA and proved its ability on 47 colorectal cancer samples bearing KRAS mutations. Then we analyzed the correlation between the abundance of KRAS mutations and efficacy of EGFR antibody therapy in another 35 metastatic colorectal cancer patients. We proved that PNA-PCR assay could calculate the abundance of KRAS mutation and the percentage of mutant DNA in tumor cells varied a lot (10.8%similar to 98.3%) on the 47 colorectal cancer patients. The efficacy of EGFR antibody correlated with the abundance of KRAS mutations: in the KRAS mutation less than 30% group, the disease control rate was 44.4% (4/9); the disease control rate of 30 similar to 80% group was 5.6% (1/18) and the >80% group was 12.5% (1/8) (P = 0.038). In summary, our study showed that PNA-PCR method could easily detect the percentage of KRAS mutation in tumor cells and colorectal cancer patients with low abundance of KRAS mutation might benefit from EGFR antibody therapy.	[Yu, Shaorong; Xiao, Xia; Lu, Jianwei; Feng, Jifeng] Nanjing Med Univ, Jiangsu Canc Hosp, Res Ctr Clin Oncol, Affiliated Canc Hosp, Nanjing, Jiangsu, Peoples R China; [Yu, Shaorong; Xiao, Xia; Lu, Jianwei; Feng, Jifeng] Jiangsu Inst Canc Res, Nanjing, Jiangsu, Peoples R China; [Yu, Shaorong; Qian, Xiaoping; Liu, Baorui] Nanjing Univ, Affiliated Drum Tower Hosp, Jiangsu Key Lab Mol Med, Comprehens Canc Ctr,Med Sch, Nanjing 210008, Jiangsu, Peoples R China; [Yu, Shaorong; Qian, Xiaoping; Liu, Baorui] Nanjing Univ, Clin Canc Inst, Nanjing 210008, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing University; Nanjing University	Feng, JF (corresponding author), Nanjing Med Univ, Jiangsu Canc Hosp, Res Ctr Clin Oncol, Affiliated Canc Hosp, Nanjing, Jiangsu, Peoples R China.	fjif@vip.sina.com			Wu Jieping Medical Foundation [320.6700.09050]	Wu Jieping Medical Foundation	The work was supported by Wu Jieping Medical Foundation (320.6700.09050), http://www.wjpmf.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Chen J, 2013, CANCER CHEMOTH PHARM, V71, P265, DOI 10.1007/s00280-012-2005-9; De Roock W, 2010, JAMA-J AM MED ASSOC, V304, P1812, DOI 10.1001/jama.2010.1535; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kobunai T, 2010, BIOCHEM BIOPH RES CO, V395, P158, DOI 10.1016/j.bbrc.2010.03.167; Kristensen LS, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-548; Mao C, 2012, CANCER; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Modest DP, 2012, ONCOLOGY-BASEL, V83, P241, DOI 10.1159/000339534; Molinari F, 2011, CLIN CANCER RES, V17, P4901, DOI 10.1158/1078-0432.CCR-10-3137; Neumann J, 2009, PATHOL RES PRACT, V205, P858, DOI 10.1016/j.prp.2009.07.010; Nordgard O, 2012, DIAGN MOL PATHOL, V21, P9, DOI 10.1097/PDM.0b013e31821e59dc; Ochiai T, 2012, ONCOL LETT, V3, P269, DOI 10.3892/ol.2011.503; Pritchard CC, 2010, BMC CLIN PATHOL, V10, DOI 10.1186/1472-6890-10-6; Roth AD, 2010, J CLIN ONCOL, V28, P466, DOI 10.1200/JCO.2009.23.3452; Tejpar S, 2012, J CLIN ONCOL, V30, P3570, DOI 10.1200/JCO.2012.42.2592; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Yu SR, 2012, CANCER BIOL THER, V13, P314, DOI 10.4161/cbt.19075; Yu SR, 2011, HUM PATHOL, V42, P1312, DOI 10.1016/j.humpath.2010.06.018; Zhou Q, 2011, J CLIN ONCOL, V29, P3316, DOI 10.1200/JCO.2010.33.3757	21	9	10	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68022	10.1371/journal.pone.0068022	http://dx.doi.org/10.1371/journal.pone.0068022			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874486	Green Published, Green Submitted, gold			2022-12-27	WOS:000321736900045
J	Rohr, C; Kerick, M; Fischer, A; Kuhn, A; Kashofer, K; Timmermann, B; Daskalaki, A; Meinel, T; Drichel, D; Borno, ST; Nowka, A; Krobitsch, S; McHardy, AC; Kratsch, C; Becker, T; Wunderlich, A; Barmeyer, C; Viertler, C; Zatloukal, K; Wierling, C; Lehrach, H; Schweiger, MR				Roehr, Christina; Kerick, Martin; Fischer, Axel; Kuehn, Alexander; Kashofer, Karl; Timmermann, Bernd; Daskalaki, Andriani; Meinel, Thomas; Drichel, Dmitriy; Boerno, Stefan T.; Nowka, Anja; Krobitsch, Sylvia; McHardy, Alice C.; Kratsch, Christina; Becker, Tim; Wunderlich, Andrea; Barmeyer, Christian; Viertler, Christian; Zatloukal, Kurt; Wierling, Christoph; Lehrach, Hans; Schweiger, Michal R.			High-Throughput miRNA and mRNA Sequencing of Paired Colorectal Normal, Tumor and Metastasis Tissues and Bioinformatic Modeling of miRNA-1 Therapeutic Applications	PLOS ONE			English	Article							REAL-TIME PCR; MICRORNA EXPRESSION; DOWN-REGULATION; CANCER; GENE; SUPPRESSOR; IDENTIFICATION; PROLIFERATION; HALLMARKS; ALIGNMENT	MiRNAs are discussed as diagnostic and therapeutic molecules. However, effective miRNA drug treatments with miRNAs are, so far, hampered by the complexity of the miRNA networks. To identify potential miRNA drugs in colorectal cancer, we profiled miRNA and mRNA expression in matching normal, tumor and metastasis tissues of eight patients by Illumina sequencing. We validated six miRNAs in a large tissue screen containing 16 additional tumor entities and identified miRNA-1, miRNA-129, miRNA-497 and miRNA-215 as constantly de-regulated within the majority of cancers. Of these, we investigated miRNA-1 as representative in a systems-biology simulation of cellular cancer models implemented in PyBioS and assessed the effects of depletion as well as overexpression in terms of miRNA-1 as a potential treatment option. In this system, miRNA-1 treatment reverted the disease phenotype with different effectiveness among the patients. Scoring the gene expression changes obtained through mRNA-Seq from the same patients we show that the combination of deep sequencing and systems biological modeling can help to identify patient-specific responses to miRNA treatments. We present this data as guideline for future pre-clinical assessments of new and personalized therapeutic options.	[Roehr, Christina; Kerick, Martin; Fischer, Axel; Kuehn, Alexander; Daskalaki, Andriani; Meinel, Thomas; Boerno, Stefan T.; Wunderlich, Andrea; Wierling, Christoph; Lehrach, Hans; Schweiger, Michal R.] Max Planck Inst Mol Genet, Dept Vertebrate Gen, D-14195 Berlin, Germany; [Roehr, Christina; Boerno, Stefan T.; Nowka, Anja; Wunderlich, Andrea] Free Univ Berlin, Dept Biol Chem & Pharm, Berlin, Germany; [Fischer, Axel] Max Planck Inst Mol Plant Physiol, Potsdam, Germany; [Kuehn, Alexander] Alacris Theranost GmbH, Berlin, Germany; [Kashofer, Karl; Viertler, Christian; Zatloukal, Kurt] Med Univ Graz, Inst Pathol, Graz, Austria; [Timmermann, Bernd] Max Planck Inst Mol Genet, Next Generat Sequencing Grp, D-14195 Berlin, Germany; [Meinel, Thomas] Charite, Struct Bioinformat Grp, Inst Physiol, D-13353 Berlin, Germany; [Drichel, Dmitriy; Becker, Tim] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Nowka, Anja; Krobitsch, Sylvia] Max Planck Inst Mol Genet, Otto Warburg Labs, D-14195 Berlin, Germany; [McHardy, Alice C.; Kratsch, Christina] Univ Dusseldorf, Dept Algorithm Bioinformat, D-40225 Dusseldorf, Germany; [Becker, Tim] Univ Bonn, Inst Med Biometry Informat & Epidemiol, Bonn, Germany; [Barmeyer, Christian] Charite, Dept Gastroenterol, D-13353 Berlin, Germany	Max Planck Society; Free University of Berlin; Max Planck Society; Medical University of Graz; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Max Planck Society; Heinrich Heine University Dusseldorf; University of Bonn; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schweiger, MR (corresponding author), Max Planck Inst Mol Genet, Dept Vertebrate Gen, Ihnestr 73, D-14195 Berlin, Germany.	mschweig@molgen.mpg.de	McHardy, Alice/ABF-2322-2020; McHardy, Alice C/K-9377-2018; Schweiger, Michal R/H-5270-2015; Kerick, Martin/AAD-8303-2022	McHardy, Alice/0000-0003-2370-3430; McHardy, Alice C/0000-0003-2370-3430; Schweiger, Michal R/0000-0002-4672-0623; Kerick, Martin/0000-0002-6298-4514; Kratsch, Christina/0000-0003-0565-1112; Wierling, Christoph/0000-0002-8856-8412; Drichel, Dmitriy/0000-0001-5978-3458; Fischer, Axel/0000-0001-6130-6984	Federal Ministry of Education and Research [01GS0891, 01GS08105, 01GS08111, 0315428A, 0316190A-E, 0315852B, 0316065E]; Max Planck Society; Austrian Genome Programme GEN-AU	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Max Planck Society(Max Planck SocietyFoundation CELLEX); Austrian Genome Programme GEN-AU	This work has been funded by grants from the Federal Ministry of Education and Research 'Proceed' (01GS0891), 'Mutanom' (01GS08105), 'Intestinal Modifiers' (01GS08111), 'Predict' (0315428A), 'Epitreat' (0316190A-E), 'treat20' (0315852B) and HNPCCSys (0316065E) and from the Max Planck Society as well as by the Austrian Genome Programme GEN-AU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao Y, 2006, BIOL PHARM BULL, V29, P903, DOI 10.1248/bpb.29.903; Akao Y, 2011, CANCER LETT, V300, P197, DOI 10.1016/j.canlet.2010.10.006; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Borralho PM, 2009, FEBS J, V276, P6689, DOI 10.1111/j.1742-4658.2009.07383.x; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Chen H, 2009, BIOCHEM BIOPH RES CO, V385, P596, DOI 10.1016/j.bbrc.2009.05.113; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Datta J, 2008, CANCER RES, V68, P5049, DOI 10.1158/0008-5472.CAN-07-6655; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Formentini A, MOL CANC, V9, P96; Hamfjord J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034150; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hatley ME, 2010, CANCER CELL, V18, P282, DOI 10.1016/j.ccr.2010.08.013; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kamburov A, 2011, NUCLEIC ACIDS RES, V39, pD712, DOI 10.1093/nar/gkq1156; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Klipp Edda, 2009, SYSTEMS BIOL TXB; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030140; Li J, 2011, MOL CELL BIOCHEM, V357, P31, DOI 10.1007/s11010-011-0872-8; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Menssen A, 2007, CELL CYCLE, V6, P339, DOI 10.4161/cc.6.3.3808; Migliore C, 2012, CLIN CANCER RES, V18, P737, DOI 10.1158/1078-0432.CCR-11-1699; Nagel R, 2008, CANCER RES, V68, P5795, DOI 10.1158/0008-5472.CAN-08-0951; Nasser MW, 2008, J BIOL CHEM, V283, P33394, DOI 10.1074/jbc.M804788200; Okayama H, 2012, DIGEST DIS, V30, P9, DOI 10.1159/000341882; Pekow JR, 2012, INFLAMM BOWEL DIS, V18, P187, DOI 10.1002/ibd.21691; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Ruepp A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r6; Sarver AL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-401; Sassen S, 2008, VIRCHOWS ARCH, V452, P1, DOI 10.1007/s00428-007-0532-2; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Slaby O, 2007, ONCOLOGY-BASEL, V72, P397, DOI 10.1159/000113489; Song B, 2009, ONCOGENE, V28, P4065, DOI 10.1038/onc.2009.274; Song B, 2008, CLIN CANCER RES, V14, P8080, DOI 10.1158/1078-0432.CCR-08-1422; Suzuki H, 2011, CANCER RES, V71, P5646, DOI 10.1158/0008-5472.CAN-11-1076; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsang WP, 2009, CARCINOGENESIS, V30, P953, DOI 10.1093/carcin/bgp094; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Wierling Christoph, 2007, Briefings in Functional Genomics & Proteomics, V6, P240, DOI 10.1093/bfgp/elm027; Wierling C, 2012, MUTAT RES-GEN TOX EN, V746, P163, DOI 10.1016/j.mrgentox.2012.01.005; Yan D, 2009, J BIOL CHEM, V284, P29596, DOI 10.1074/jbc.M109.020511; Zhang Y, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-23	53	59	63	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67461	10.1371/journal.pone.0067461	http://dx.doi.org/10.1371/journal.pone.0067461			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23874421	Green Published, gold			2022-12-27	WOS:000321341000046
J	Kuipers, MT; Vogl, T; Aslami, H; Jongsma, G; van den Berg, E; Vlaar, APJ; Roelofs, JJTH; Juffermans, NP; Schultz, MJ; van der Poll, T; Roth, J; Wieland, CW				Kuipers, Maria T.; Vogl, Thomas; Aslami, Hamid; Jongsma, Geartsje; van den Berg, Elske; Vlaar, Alexander P. J.; Roelofs, Joris J. T. H.; Juffermans, Nicole P.; Schultz, Marcus J.; van der Poll, Tom; Roth, Johannes; Wieland, Catharina W.			High Levels of S100A8/A9 Proteins Aggravate Ventilator-Induced Lung Injury via TLR4 Signaling	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; LOWER TIDAL VOLUMES; MECHANICAL VENTILATION; HEALTHY MICE; RECEPTOR; MRP14; LIPOPOLYSACCHARIDE; EXPRESSION; ENDOTOXIN; MODEL	Background: Bacterial products add to mechanical ventilation in enhancing lung injury. The role of endogenous triggers of innate immunity herein is less well understood. S100A8/A9 proteins are released by phagocytes during inflammation. The present study investigates the role of S100A8/A9 proteins in ventilator-induced lung injury. Methods: Pulmonary S100A8/A9 levels were measured in samples obtained from patients with and without lung injury. Furthermore, wild-type and S100A9 knock-out mice, naive and with lipopolysaccharide-induced injured lungs, were randomized to 5 hours of spontaneously breathing or mechanical ventilation with low or high tidal volume (V-T). In addition, healthy spontaneously breathing and high V-T ventilated mice received S100A8/A9, S100A8 or vehicle intratracheal. Furthermore, the role of Toll-like receptor 4 herein was investigated. Results: S100A8/A9 protein levels were elevated in patients and mice with lung injury. S100A8/A9 levels synergistically increased upon the lipopolysaccharide/high V-T MV double hit. Markers of alveolar barrier dysfunction, cytokine and chemokine levels, and histology scores were attenuated in S100A9 knockout mice undergoing the double-hit. Exogenous S100A8/A9 and S100A8 induced neutrophil influx in spontaneously breathing mice. In ventilated mice, these proteins clearly amplified inflammation: neutrophil influx, cytokine, and chemokine levels were increased compared to ventilated vehicle-treated mice. In contrast, administration of S100A8/A9 to ventilated Toll-like receptor 4 mutant mice did not augment inflammation. Conclusion: S100A8/A9 proteins increase during lung injury and contribute to inflammation induced by HVT MV combined with lipopolysaccharide. In the absence of lipopolysaccharide, high levels of extracellular S100A8/A9 still amplify ventilator-induced lung injury via Toll-like receptor 4.	[Kuipers, Maria T.; Aslami, Hamid; Jongsma, Geartsje; Vlaar, Alexander P. J.; Juffermans, Nicole P.; Schultz, Marcus J.; Wieland, Catharina W.] Univ Amsterdam, Acad Med Ctr, Lab Expt Intens Care & Anesthesiol, NL-1105 AZ Amsterdam, Netherlands; [Kuipers, Maria T.; van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands; [Vogl, Thomas; Roth, Johannes] Univ Munster, Inst Immunol, D-48149 Munster, Germany; [Vogl, Thomas; Roth, Johannes] Univ Munster, Interdisciplinary Ctr Clin Res, D-48149 Munster, Germany; [van den Berg, Elske] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Pediat Intens Care Unit, NL-1105 AZ Amsterdam, Netherlands; [Roelofs, Joris J. T. H.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Juffermans, Nicole P.; Schultz, Marcus J.] Univ Amsterdam, Acad Med Ctr, Dept Intens Care, NL-1105 AZ Amsterdam, Netherlands; [van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Munster; University of Munster; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Kuipers, MT (corresponding author), Univ Amsterdam, Acad Med Ctr, Lab Expt Intens Care & Anesthesiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	Ilse.Kuipers@amc.nl	Schultz, Marcus/AAB-6379-2021	Schultz, Marcus/0000-0003-3969-7792; Roelofs, Joris/0000-0001-9595-6571; Vlaar, Alexander/0000-0002-3453-7186	Netherlands Organization for Scientific Research, The Hague, The Netherlands [91676096]; Interdisciplinary Center of Clinical Research [Vo2/014/09, Ro2/004/10]; German Research Foundation (DFG) CRC Transregio [128-A2, CRC 1009 B8]; Federal Ministry of Education and Research, Germany, project AID-Net	Netherlands Organization for Scientific Research, The Hague, The Netherlands(Netherlands Organization for Scientific Research (NWO)Netherlands Government); Interdisciplinary Center of Clinical Research; German Research Foundation (DFG) CRC Transregio; Federal Ministry of Education and Research, Germany, project AID-Net	This work was supported by a grant to CW from The Netherlands Organization for Scientific Research, The Hague, The Netherlands, grant number 91676096, by the Interdisciplinary Center of Clinical Research grant Vo2/014/09 to TV as well as grant Ro2/004/10 to JR, by the German Research Foundation (DFG) CRC Transregio 128-A2, CRC 1009 B8 to TV and by the Federal Ministry of Education and Research, Germany, project AID-Net to JR and TV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achouiti A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002987; Altemeier WA, 2005, J IMMUNOL, V175, P3369, DOI 10.4049/jimmunol.175.5.3369; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Boelke E, 2000, ANGIOLOGY, V51, P743; Bozinovski S, 2005, J PROTEOME RES, V4, P136, DOI 10.1021/pr049829t; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Chan JK, 2012, J CLIN INVEST, V122, P2711, DOI 10.1172/JCI62423; Chang DW, 2008, AM J RESP CRIT CARE, V178, P701, DOI 10.1164/rccm.200712-1895OC; Copland IB, 2003, AM J RESP CRIT CARE, V168, P1051, DOI 10.1164/rccm.200208-964OC; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; de Torre C, 2006, PROTEOMICS, V6, P3949, DOI 10.1002/pmic.200500693; Determann RM, 2010, CRIT CARE, V14, DOI 10.1186/cc8230; Dolinay T, 2012, AM J RESP CRIT CARE, V185, P1225, DOI 10.1164/rccm.201201-0003OC; dos Santos CC, 2006, ANNU REV PHYSIOL, V68, P585, DOI 10.1146/annurev.physiol.68.072304.113443; Frosch M, 2000, ARTHRITIS RHEUM-US, V43, P628, DOI 10.1002/1529-0131(200003)43:3<628::AID-ANR20>3.0.CO;2-X; Gattinoni L, 1986, J Thorac Imaging, V1, P25, DOI 10.1097/00005382-198607000-00005; Guo WA, 2012, INTENS CARE MED, V38, P1588, DOI 10.1007/s00134-012-2624-y; Henke MO, 2006, EXP LUNG RES, V32, P331, DOI 10.1080/01902140600959580; Heydemann A, 2013, CLIN EXPT ALLERGY, V41, P878; Hu GC, 2010, CRIT CARE MED, V38, P194, DOI 10.1097/CCM.0b013e3181bc7c17; Ikemoto M, 2007, CLIN CHIM ACTA, V376, P197, DOI 10.1016/j.cca.2006.08.018; Kuipers MT, 2012, ANESTHESIOLOGY, V116, P1104, DOI 10.1097/ALN.0b013e3182518bc0; Kuipers MT, 2011, CRIT CARE, V15, DOI 10.1186/cc10437; Li HH, 2010, ANESTHESIOLOGY, V113, P619, DOI 10.1097/ALN.0b013e3181e89ab2; Lorenz E, 2008, RESP MED, V102, P567, DOI 10.1016/j.rmed.2007.11.011; Manitz MP, 2003, MOL CELL BIOL, V23, P1034, DOI 10.1128/MCB.23.3.1034-1043.2003; Martin Thomas R, 2008, Proc Am Thorac Soc, V5, P291, DOI 10.1513/pats.200801-005DR; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; Metnitz PGH, 2009, INTENS CARE MED, V35, P816, DOI 10.1007/s00134-009-1449-9; Moriyama K, 2004, AM J PHYSIOL-LUNG C, V286, pL1114, DOI 10.1152/ajplung.00296.2003; Passey RJ, 1999, J IMMUNOL, V163, P2209; Raquil MA, 2008, J IMMUNOL, V180, P3366, DOI 10.4049/jimmunol.180.5.3366; Reijmers RM, 2011, BLOOD, V117, P6162, DOI 10.1182/blood-2010-12-325522; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Ryckman C, 2003, ARTHRITIS RHEUM-US, V48, P2310, DOI 10.1002/art.11079; Sun Y, 2013, MOL IMMUNOL, V53, P443, DOI 10.1016/j.molimm.2012.10.002; Terragni PP, 2007, AM J RESP CRIT CARE, V175, P160, DOI 10.1164/rccm.200607-915OC; Tremblay L, 1997, J CLIN INVEST, V99, P944, DOI 10.1172/JCI119259; Vaneker M, 2008, ANESTHESIOLOGY, V109, P465, DOI 10.1097/ALN.0b013e318182aef1; Viemann D, 2007, BLOOD, V109, P2453, DOI 10.1182/blood-2006-08-040444; Villar J, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-27; Vlaar APJ, 2011, BLOOD, V117, P4218, DOI 10.1182/blood-2010-10-313973; Vogl T, 2004, BLOOD, V104, P4260, DOI 10.1182/blood-2004-02-0446; Vogl T, 1999, J AM SOC MASS SPECTR, V10, P1124; Vogl T, 2006, BBA-MOL CELL RES, V1763, P1298, DOI 10.1016/j.bbamcr.2006.08.028; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Volz HC, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0250-z; Wolthuis EK, 2009, CRIT CARE, V13, DOI 10.1186/cc7688	48	33	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e68694	10.1371/journal.pone.0068694	http://dx.doi.org/10.1371/journal.pone.0068694			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874727	Green Published, gold, Green Submitted			2022-12-27	WOS:000324146200027
J	Li, XH; Cui, ZX; Liu, Y; Song, CW; Shi, GH				Li, Xihong; Cui, Zhaoxia; Liu, Yuan; Song, Chengwen; Shi, Guohui			Transcriptome Analysis and Discovery of Genes Involved in Immune Pathways from Hepatopancreas of Microbial Challenged Mitten Crab Eriocheir sinensis	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE GENES; LITOPENAEUS-VANNAMEI; RNA-SEQ; ANTILIPOPOLYSACCHARIDE FACTOR; SIGNALING PATHWAYS; WSSV INFECTION; TREMOR DISEASE; WHITE SHRIMP; IDENTIFICATION; EXPRESSION	Background: The Chinese mitten crab Eriocheir sinensis is an important economic crustacean and has been seriously attacked by various diseases, which requires more and more information for immune relevant genes on genome background. Recently, high-throughput RNA sequencing (RNA-seq) technology provides a powerful and efficient method for transcript analysis and immune gene discovery. Methods/Principal Findings: A cDNA library from hepatopancreas of E. sinensis challenged by a mixture of three pathogen strains (Gram-positive bacteria Micrococcus luteus, Gram-negative bacteria Vibrio alginolyticus and fungi Pichia pastoris; 10 8 cfu.mL(-1)) was constructed and randomly sequenced using Illumina technique. Totally 39.76 million clean reads were assembled to 70,300 unigenes. After ruling out short-length and low-quality sequences, 52,074 non-redundant unigenes were compared to public databases for homology searching and 17,617 of them showed high similarity to sequences in NCBI non-redundant protein (Nr) database. For function classification and pathway assignment, 18,734 (36.00%) unigenes were categorized to three Gene Ontology (GO) categories, 12,243 (23.51%) were classified to 25 Clusters of Orthologous Groups (COG), and 8,983 (17.25%) were assigned to six Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways. Potentially, 24, 14, 47 and 132 unigenes were characterized to be involved in Toll, IMD, JAK-STAT and MAPK pathways, respectively. Conclusions/Significance: This is the first systematical transcriptome analysis of components relating to innate immune pathways in E. sinensis. Functional genes and putative pathways identified here will contribute to better understand immune system and prevent various diseases in crab.	[Li, Xihong; Cui, Zhaoxia; Liu, Yuan; Song, Chengwen; Shi, Guohui] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Li, Xihong; Song, Chengwen; Shi, Guohui] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Cui, Zhaoxia] Chinese Acad Sci, Inst Oceanol, Natl & Local Joint Engn Lab Ecol Mariculture, Qingdao, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Oceanology, CAS	Cui, ZX (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.	zhxcui@yahoo.com.cn			National Natural Science Foundation of China [41276165]; Chinese National '863' Project [2012AA10A409]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese National '863' Project(National High Technology Research and Development Program of China)	This research was supported by the National Natural Science Foundation of China (41276165) and the Chinese National '863' Project (No. 2012AA10A409). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bonami JR, 2011, J INVERTEBR PATHOL, V106, P6, DOI 10.1016/j.jip.2010.09.009; Chen WY, 2008, DEV COMP IMMUNOL, V32, P1142, DOI 10.1016/j.dci.2008.03.003; Cheng CH, 2010, FISH SHELLFISH IMMUN, V28, P774, DOI 10.1016/j.fsi.2010.01.022; Djami-Tchatchou AT, 2012, J PHYTOPATHOL, V160, P449, DOI 10.1111/j.1439-0434.2012.01925.x; Feld M, 2005, BEHAV BRAIN RES, V158, P251, DOI 10.1016/j.bbr.2004.09.005; Gai YC, 2008, FISH SHELLFISH IMMUN, V24, P156, DOI 10.1016/j.fsi.2007.08.006; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Gavery MR, 2012, COMP BIOCHEM PHYS D, V7, P94, DOI 10.1016/j.cbd.2011.12.003; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gross PS, 2001, DEV COMP IMMUNOL, V25, P565, DOI 10.1016/S0145-305X(01)00018-0; Harrison DA, 2012, COLD SPRING HARB PER, P4; He L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033735, 10.1371/journal.pone.0045607]; Hsu JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040950; Jiang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011175; Jiang H, 2009, COMP BIOCHEM PHYS D, V4, P227, DOI 10.1016/j.cbd.2009.05.001; Jiang H, 2009, MAR BIOTECHNOL, V11, P317, DOI 10.1007/s10126-008-9146-1; Jin XK, 2012, FISH SHELLFISH IMMUN, V33, P1149, DOI 10.1016/j.fsi.2012.08.027; Jin XK, 2011, FISH SHELLFISH IMMUN, V30, P263, DOI 10.1016/j.fsi.2010.10.016; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Li F, 2010, INT J IMMUNOGENET, V37, P499, DOI 10.1111/j.1744-313X.2010.00954.x; Li FH, 2009, DEV COMP IMMUNOL, V33, P1093, DOI 10.1016/j.dci.2009.06.001; Li WW, 2010, FISH SHELLFISH IMMUN, V29, P1010, DOI 10.1016/j.fsi.2010.08.007; Lin MC, 2012, PEPTIDES, V38, P197, DOI 10.1016/j.peptides.2012.10.003; Lin ZY, 2012, DEV COMP IMMUNOL, V37, P164, DOI 10.1016/j.dci.2011.09.003; [马阿妮 Ma Ani], 2010, [生命科学, Chinese Bulletin of Life Sciences], V22, P978; Morisato D, 1995, ANNU REV GENET, V29, P371, DOI 10.1146/annurev.genet.29.1.371; Mu CK, 2011, FISH SHELLFISH IMMUN, V31, P142, DOI 10.1016/j.fsi.2011.04.013; Mu YN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-506; Ou JT, 2012, FISH SHELLFISH IMMUN, V32, P345, DOI 10.1016/j.fsi.2011.11.027; Ried C, 1996, J BIOL CHEM, V271, P28120, DOI 10.1074/jbc.271.45.28120; Roux MM, 2002, J VIROL, V76, P7140, DOI 10.1128/JVI.76.14.7140-7149.2002; Sun C, 2011, MOL BIOL REP, V38, P5313, DOI 10.1007/s11033-011-0681-x; Takehana A, 2004, EMBO J, V23, P4690, DOI 10.1038/sj.emboj.7600466; Valanne S, 2011, J IMMUNOL, V186, P649, DOI 10.4049/jimmunol.1002302; Wang L., 2011, AFRICAN J BIOTECHNOL, P10; Wang PH, 2012, DEV COMP IMMUNOL, V36, P359, DOI 10.1016/j.dci.2011.07.007; Wang PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024773; Wang PH, 2011, DEV COMP IMMUNOL, V35, P105, DOI 10.1016/j.dci.2010.08.013; Wang PH, 2009, MOL IMMUNOL, V46, P1897, DOI 10.1016/j.molimm.2009.01.005; Wang W, 2002, J INVERTEBR PATHOL, V81, P202, DOI 10.1016/S0022-2011(02)00187-8; Wang W, 2002, DIS AQUAT ORGAN, V48, P149, DOI 10.3354/dao048149; Zhang FJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-303; Zhang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047038; Zhang Y, 2010, DEV COMP IMMUNOL, V34, P42, DOI 10.1016/j.dci.2009.08.001; Zhao XX, 2012, MAR BIOTECHNOL, V14, P730, DOI 10.1007/s10126-012-9438-3	47	63	66	0	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e68233	10.1371/journal.pone.0068233	http://dx.doi.org/10.1371/journal.pone.0068233			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23874555	Green Published, Green Submitted, gold			2022-12-27	WOS:000322000600006
J	Wang, YT; Liu, DZ				Wang, Yuting; Liu, Dingzhen			Low Incidence of Miscarriage Induced by the Scent of Male Littermates of Original Mates: Male Kinship Reduces the Bruce Effect in Female Mice, Mus musculus	PLOS ONE			English	Article							HAMSTERS MESOCRICETUS-AURATUS; INDIVIDUAL RECOGNITION; PREGNANCY-BLOCK; MICROTUS-PENNSYLVANICUS; HOUSE MOUSE; VOLATILE LIGANDS; MEADOW VOLE; ODOR; BEHAVIOR; SIGNALS	The scent of a novel male can elicit pregnancy block in recently mated female mice (Mus musculus), a phenomenon known as the Bruce effect. Despite abundant literature on the Bruce effect in rodents, it remains unclear whether males related to a female's original mate can induce the Bruce effect in out-bred, communally living mice. We investigated this question using Kunming (KM) male mice of varying genetic relatedness. Recently mated females were subjected to three treatments: exposure to the urine of the mate, urine of the mate's male littermate, and urine of a male unrelated to the mate. It was found that the urine of male littermates of the females' mates did not elicit more pregnancy block than that of the females' mates. However, the urine of novel males caused a higher rate of female miscarriage than that of the females' mates. By using a habituation-dishabituation paradigm, we found that unmated females could discriminate the urine scents of two male littermates from those of a novel male unrelated to the littermates. To understand how females use urinary cues to discriminate between males with different genetic relationships, we used gas chromatography coupled with mass spectrometry (GC-MS) to examine the volatile composition of urine from males with varying relatedness. It was found that KM male littermates shared similar volatile compositions in their urine. Our results suggest that male kinship reduces the Bruce effect in female KM mice, and provide additional evidence for mate choice being partly mediated by the Bruce effect in KM mice.	[Wang, Yuting; Liu, Dingzhen] Beijing Normal Univ, Minist Educ, Key Lab Biodivers Sci & Ecol Engn, Coll Life Sci, Beijing 100875, Peoples R China	Beijing Normal University	Liu, DZ (corresponding author), Beijing Normal Univ, Minist Educ, Key Lab Biodivers Sci & Ecol Engn, Coll Life Sci, Beijing 100875, Peoples R China.	dzliu@bnu.edu.cn	Liu, Dingzhen/D-3400-2012	Liu, Dingzhen/0000-0002-1870-6197	National Natural Science Foundation of China (NSFC) [30770290, 31172097]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was financially supported by National Natural Science Foundation of China (NSFC grant # 30770290; 31172097) (http://www.nsfc.gov.cn/Portal0/default166.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagley KR, 2006, ANIM BEHAV, V71, P1439, DOI 10.1016/j.anbehav.2006.01.003; Bartos L, 2011, BEHAV ECOL SOCIOBIOL, V65, P1567, DOI 10.1007/s00265-011-1166-6; Beaton EA, 2005, PSYCHONEUROENDOCRINO, V30, P688, DOI 10.1016/j.psyneuen.2005.03.001; Becker SD, 2009, P ROY SOC B-BIOL SCI, V276, P1723, DOI 10.1098/rspb.2008.1780; BLOCH S, 1972, EXPERIENTIA, V28, P703, DOI 10.1007/BF01944989; BLOCH S, 1974, J REPROD FERTIL, V38, P469, DOI 10.1530/jrf.0.0380469; Brennan PA, 1999, NEUROSCIENCE, V90, P1463, DOI 10.1016/S0306-4522(98)00556-9; Brennan PA, 2006, PHILOS T R SOC B, V361, P2061, DOI 10.1098/rstb.2006.1931; Brennan PA, 2009, BEHAV BRAIN RES, V200, P287, DOI 10.1016/j.bbr.2008.10.045; BRUCE HM, 1959, NATURE, V184, P105, DOI 10.1038/184105a0; Bruce HM, 1968, REPRODUCTION, V17, P407; Chia R, 2005, NAT GENET, V37, P1181, DOI 10.1038/ng1665; CLULOW FV, 1971, J REPROD FERTIL, V24, P275, DOI 10.1530/jrf.0.0240275; COLMENARES F, 1988, FOLIA PRIMATOL, V50, P157, DOI 10.1159/000156343; DelBarco-Trillo J, 2009, BEHAV PROCESS, V82, P18, DOI 10.1016/j.beproc.2009.03.003; Ensminger AL, 2005, ANIM BEHAV, V69, P1147, DOI 10.1016/j.anbehav.2004.07.018; Ensminger AL, 2007, ANIM BEHAV, V74, P23, DOI 10.1016/j.anbehav.2006.11.009; Gerlach G, 1996, BEHAV ECOL SOCIOBIOL, V39, P159, DOI 10.1007/s002650050277; Heth G, 2003, BIOL J LINN SOC, V78, P595, DOI 10.1046/j.0024-4066.2002.00194.x; Huck UW, 1982, REPRODUCTION, V66, P181; JOHNSTON RE, 1993, J COMP PSYCHOL, V107, P201; Johnston RE, 2001, ANIM BEHAV, V61, P545, DOI 10.1006/anbe.2000.1637; KENNEY AM, 1977, J REPROD FERTIL, V49, P365, DOI 10.1530/jrf.0.0490365; Kwak J, 2012, PHYSIOL BEHAV, V107, P112, DOI 10.1016/j.physbeh.2012.06.008; Kwak J, 2010, P ROY SOC B-BIOL SCI, V277, P2417, DOI 10.1098/rspb.2010.0162; Leinders-Zufall T, 2004, SCIENCE, V306, P1033, DOI 10.1126/science.1102818; Liu DZ, 2008, CHINESE SCI BULL, V53, P2793, DOI 10.1007/s11434-008-0373-7; Liu DZ, 2011, CHEM SENSES, V36, P799, DOI 10.1093/chemse/bjr055; MALLORY FF, 1977, CAN J ZOOL, V55, P1, DOI 10.1139/z77-001; Mayeaux DJ, 2002, ANIM BEHAV, V64, P269, DOI 10.1006/anbe.2002.3053; McLean S, 2012, J CHEM ECOL, V38, P1318, DOI 10.1007/s10886-012-0188-5; Mucignat-Caretta C, 2010, CHEM SENSES, V35, P647, DOI 10.1093/chemse/bjq049; Novotny MV, 1999, P ROY SOC B-BIOL SCI, V266, P2017, DOI 10.1098/rspb.1999.0880; PARKES AS, 1961, SCIENCE, V134, P1049, DOI 10.1126/science.134.3485.1049; Raynaud J, 2012, BIOL J LINN SOC, V106, P682, DOI 10.1111/j.1095-8312.2012.01888.x; Roberts EK, 2012, SCIENCE, V335, P1222, DOI 10.1126/science.1213600; Schaefer ML, 2010, CHEM SENSES, V35, P459, DOI 10.1093/chemse/bjq032; Schaefer ML, 2001, J NEUROSCI, V21, P2481, DOI 10.1523/JNEUROSCI.21-07-02481.2001; Schradin C, 2004, BEHAV ECOL SOCIOBIOL, V55, P439, DOI 10.1007/s00265-003-0733-x; SCHWAGMEYER PL, 1979, AM NAT, V114, P932, DOI 10.1086/283541; Shelley DN, 2005, HORM BEHAV, V47, P212, DOI 10.1016/j.yhbeh.2004.09.009; Thom MD, 2004, ANN ZOOL FENN, V41, P765; Tzur S, 2009, BIOL J LINN SOC, V96, P483, DOI 10.1111/j.1095-8312.2008.01155.x; World Health Organization, 2004, LAB BIOS MAN, V3rd; YAMAZAKI K, 1986, P NATL ACAD SCI USA, V83, P740, DOI 10.1073/pnas.83.3.740; Zhang G.M., 1997, CHINA J LAB ZOOLOGY, V4, P246; Zhang JX, 2007, CHEM SENSES, V32, P293, DOI 10.1093/chemse/bjl058	47	2	2	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e68673	10.1371/journal.pone.0068673	http://dx.doi.org/10.1371/journal.pone.0068673			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23874716	gold, Green Published, Green Submitted			2022-12-27	WOS:000322000600015
J	Zhu, HJ; Bogdanov, MB; Boyle, SH; Matson, W; Sharma, S; Matson, S; Churchill, E; Fiehn, O; Rush, JA; Krishnan, RR; Pickering, E; Delnomdedieu, M; Kaddurah-Daouk, R				Zhu, Hongjie; Bogdanov, Mikhail B.; Boyle, Stephen H.; Matson, Wayne; Sharma, Swati; Matson, Samantha; Churchill, Erik; Fiehn, Oliver; Rush, John A.; Krishnan, Ranga R.; Pickering, Eve; Delnomdedieu, Marielle; Kaddurah-Daouk, Rima		Pharmacometabolomics Res Network	Pharmacometabolomics of Response to Sertraline and to Placebo in Major Depressive Disorder - Possible Role for Methoxyindole Pathway	PLOS ONE			English	Article							SEROTONIN REUPTAKE INHIBITORS; VENTRAL TEGMENTAL AREA; PREFRONTAL CORTEX; EXTRACELLULAR LEVELS; METABOLOMIC ANALYSIS; GABA CONCENTRATIONS; PARKINSONS-DISEASE; CIRCADIAN-RHYTHMS; GOLDEN-HAMSTER; PINEAL-GLAND	Therapeutic response to selective serotonin (5-HT) reuptake inhibitors in Major Depressive Disorder (MDD) varies considerably among patients, and the onset of antidepressant therapeutic action is delayed until after 2 to 4 weeks of treatment. The objective of this study was to analyze changes within methoxyindole and kynurenine (KYN) branches of tryptophan pathway to determine whether differential regulation within these branches may contribute to mechanism of variation in response to treatment. Metabolomics approach was used to characterize early biochemical changes in tryptophan pathway and correlated biochemical changes with treatment outcome. Outpatients with MDD were randomly assigned to sertraline (n = 35) or placebo (n = 40) in a double-blind 4-week trial; response to treatment was measured using the 17-item Hamilton Rating Scale for Depression (HAMD(17)). Targeted electrochemistry based metabolomic platform (LCECA) was used to profile serum samples from MDD patients. The response rate was slightly higher for sertraline than for placebo (21/35 [60%] vs. 20/40 [50%], respectively, chi(2) (1) = 0.75, p = 0.39). Patients showing a good response to sertraline had higher pretreatment levels of 5-methoxytryptamine (5-MTPM), greater reduction in 5-MTPM levels after treatment, an increase in 5-Methoxytryptophol (5-MTPOL) and Melatonin (MEL) levels, and decreases in the (KYN)/MEL and 3-Hydroxykynurenine (3-OHKY)/MEL ratios post-treatment compared to pretreatment. These changes were not seen in the patients showing poor response to sertraline. In the placebo group, more favorable treatment outcome was associated with increases in 5-MTPOL and MEL levels and significant decreases in the KYN/MEL and 3-OHKY/MEL; changes in 5-MTPM levels were not associated with the 4-week response. These results suggest that recovery from a depressed state due to treatment with drug or with placebo could be associated with preferential utilization of serotonin for production of melatonin and 5-MTPOL.	[Zhu, Hongjie; Boyle, Stephen H.; Churchill, Erik; Krishnan, Ranga R.; Kaddurah-Daouk, Rima] Duke Univ, Dept Psychiat & Behav Sci, Durham, NC 27706 USA; [Bogdanov, Mikhail B.] Weill Cornell Med Coll, Dept Neurol & Neurosci, New York, NY USA; [Matson, Wayne; Sharma, Swati; Matson, Samantha] Bedford VA Med Ctr, Dept Syst Biochem, Bedford, MA USA; [Matson, Samantha] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Fiehn, Oliver] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Rush, John A.; Krishnan, Ranga R.] Duke NUS Grad Med Sch, Singapore, Singapore; [Pickering, Eve] Pfizer Global R&D, Clin Res Stat, Groton, CT USA; [Delnomdedieu, Marielle] Pfizer Global R&D, Neurosci Clin Res, Groton, CT USA	Duke University; Cornell University; Harvard University; Massachusetts General Hospital; University of California System; University of California Davis; National University of Singapore; Pfizer; Pfizer	Kaddurah-Daouk, R (corresponding author), Duke Univ, Dept Psychiat & Behav Sci, Durham, NC 27706 USA.			Kaddurah-Daouk, Rima/0000-0003-1858-5732; Rush, Augustus/0000-0003-2004-2382	Pfizer Corporation; National Institute of General Medical Sciences [GM078233]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM078233] Funding Source: NIH RePORTER	Pfizer Corporation(Pfizer); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was done with funding from Pfizer Corporation and from National Institute of General Medical Sciences grant GM078233, "The Metabolomics Research Network for Drug Response Phenotype." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JC, 1999, PSYCHOPHARMACOLOGY, V143, P97, DOI 10.1007/s002130050924; BECKFRIIS J, 1985, ACTA PSYCHIAT SCAND, V71, P319, DOI 10.1111/j.1600-0447.1985.tb02531.x; Bhagwagar Z, 2004, AM J PSYCHIAT, V161, P368, DOI 10.1176/appi.ajp.161.2.368; Bismuth-Evenzal Y, 2012, J AFFECT DISORDERS, V136, P99, DOI 10.1016/j.jad.2011.08.013; Bogdanov M, 2008, BRAIN, V131, P389, DOI 10.1093/brain/awm304; Brunoni Andre R, 2009, Ther Clin Risk Manag, V5, P897; Bymaster FP, 2002, PSYCHOPHARMACOLOGY, V160, P353, DOI 10.1007/s00213-001-0986-x; Catena-Dell'Osso M, 2011, CURR MED CHEM, V18, P245, DOI 10.2174/092986711794088353; Charney DS, 1998, J CLIN PSYCHIAT, V59, P11; di Giannantonio M, 2011, J BIOL REG HOMEOS AG, V25, P109; Di Mascio M, 1998, BRAIN RES BULL, V46, P547, DOI 10.1016/S0361-9230(98)00054-9; Dremencov E, 2009, J PSYCHIATR NEUROSCI, V34, P223; Duncan WC, 1996, PHARMACOL THERAPEUT, V71, P253, DOI 10.1016/S0163-7258(96)00092-7; FRAZER A, 1986, J NEURAL TRANSM, P269; GALZIN AM, 1988, J ENDOCRINOL, V118, P389, DOI 10.1677/joe.0.1180389; Gannon RL, 2007, PSYCHOPHARMACOLOGY, V195, P325, DOI 10.1007/s00213-007-0903-z; Golembiowska K, 2000, POL J PHARMACOL, V52, P441; Gorka Z, 1996, PHARMACOL BIOCHEM BE, V54, P229, DOI 10.1016/0091-3057(95)02173-6; Hale A, 2010, INT CLIN PSYCHOPHARM, V25, P305, DOI 10.1097/YIC.0b013e32833a86aa; HEALY D, 1995, PHARMACOL THERAPEUT, V65, P241, DOI 10.1016/0163-7258(94)00077-G; HOFMAN MA, 1995, BRAIN RES, V671, P254, DOI 10.1016/0006-8993(94)01339-J; Insel TR, 2009, PSYCHIAT SERV, V60, P1466, DOI 10.1176/appi.ps.60.11.1466; Jang SW, 2010, P NATL ACAD SCI USA, V107, P3876, DOI 10.1073/pnas.0912531107; Ji Y, 2011, CLIN PHARMACOL THER, V89, P97, DOI 10.1038/clpt.2010.250; Johansen KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007551; Kaddurah-Daouk R, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.22; Kaddurah-Daouk R, 2009, NEUROPSYCHOPHARMACOL, V34, P173, DOI 10.1038/npp.2008.174; Kasper S, 2010, J CLIN PSYCHIAT, V71, P109, DOI 10.4088/JCP.09m05347blu; Katz MM, 2010, J AFFECT DISORDERS, V120, P16, DOI 10.1016/j.jad.2009.08.011; Kirsch Irving, 2008, Mcgill J Med, V11, P219; Kitaichi Y, 2010, EUR J PHARMACOL, V647, P90, DOI 10.1016/j.ejphar.2010.08.026; Kostoglou-Athanassiou I, 1998, BRAIN RES BULL, V46, P417, DOI 10.1016/S0361-9230(98)00027-6; Kristal Bruce S., 2007, V358, P159, DOI 10.1007/978-1-59745-244-1_10; Leonard BE, 2007, DRUG TODAY, V43, P705, DOI 10.1358/dot.2007.43.10.1122223; Mackay GM, 2009, CLIN EXP PHARMACOL P, V36, P425, DOI 10.1111/j.1440-1681.2008.05077.x; Malhi GS, 2005, ACTA PSYCHIAT SCAND, V111, P94, DOI 10.1111/j.1600-0447.2004.00475.x; Marsteller DA, 2007, SYNAPSE, V61, P877, DOI 10.1002/syn.20428; Millan MJ, 2006, PHARMACOL THERAPEUT, V110, P135, DOI 10.1016/j.pharmthera.2005.11.006; Nutt DJ, 2007, J CLIN PSYCHIAT, V68, P42; Nutt DJ, 2006, J CLIN PSYCHIAT, V67, P3; Paige LA, 2007, INT J GERIATR PSYCH, V22, P418, DOI 10.1002/gps.1690; PEVET P, 1980, J NEURAL TRANSM, V49, P229, DOI 10.1007/BF01252128; Raison CL, 2010, MOL PSYCHIATR, V15, P393, DOI 10.1038/mp.2009.116; Ressler KJ, 2000, DEPRESS ANXIETY, V12, P2, DOI 10.1002/1520-6394(2000)12:1+<2::AID-DA2>3.3.CO;2-W; ROMBOGUSLAVSKAYA ES, 1985, FARMAKOL TOKSIKOL, V48, P84; Rozen S, 2005, METABOLOMICS, V1, P101, DOI 10.1007/s11306-005-4810-1; Sanacora G, 2002, AM J PSYCHIAT, V159, P663, DOI 10.1176/appi.ajp.159.4.663; Schipke CG, 2011, J PSYCHIATR RES, V45, P242, DOI 10.1016/j.jpsychires.2010.06.005; Steffens DC, 2010, J GERIATR PSYCH NEUR, V23, P138, DOI 10.1177/0891988709358592; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sullivan GM, 2005, BIOL PSYCHIAT, V58, P947, DOI 10.1016/j.biopsych.2005.05.006; Thomas DN, 1998, J PSYCHOPHARMACOL, V12, P366, DOI 10.1177/026988119801200406; Trivedi MH, 2006, J CLIN PSYCHIAT, V67, P27; Uz T, 1999, BIOL PSYCHIAT, V45, P175, DOI 10.1016/S0006-3223(98)00032-8; vanBemmel AL, 1997, J PSYCHOSOM RES, V42, P555, DOI 10.1016/S0022-3999(97)00003-2; Walsh BT, 2002, JAMA-J AM MED ASSOC, V287, P1840, DOI 10.1001/jama.287.14.1840; Wang SJ, 2003, SYNAPSE, V48, P170, DOI 10.1002/syn.10200; Zhang FX, 2010, MOL BIOSYST, V6, P852, DOI 10.1039/b914751a	58	68	69	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e68283	10.1371/journal.pone.0068283	http://dx.doi.org/10.1371/journal.pone.0068283			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23874572	Green Published, Green Submitted, gold			2022-12-27	WOS:000322000600007
J	Joshi, PK; Prendergast, J; Fraser, RM; Huffman, JE; Vitart, V; Hayward, C; McQuillan, R; Glodzik, D; Polasek, O; Hastie, ND; Rudan, I; Campbell, H; Wright, AF; Haley, CS; Wilson, JF; Navarro, P				Joshi, Peter K.; Prendergast, James; Fraser, Ross M.; Huffman, Jennifer E.; Vitart, Veronique; Hayward, Caroline; McQuillan, Ruth; Glodzik, Dominik; Polasek, Ozren; Hastie, Nicholas D.; Rudan, Igor; Campbell, Harry; Wright, Alan F.; Haley, Chris S.; Wilson, James F.; Navarro, Pau			Local Exome Sequences Facilitate Imputation of Less Common Variants and Increase Power of Genome Wide Association Studies	PLOS ONE			English	Article							GENOTYPE IMPUTATION; FOUNDER POPULATION; AFRICAN-AMERICANS; TRAITS; PANEL; SNPS; RARE; MAP	The analysis of less common variants in genome-wide association studies promises to elucidate complex trait genetics but is hampered by low power to reliably detect association. We show that addition of population-specific exome sequence data to global reference data allows more accurate imputation, particularly of less common SNPs (minor allele frequency 1-10%) in two very different European populations. The imputation improvement corresponds to an increase in effective sample size of 28-38%, for SNPs with a minor allele frequency in the range 1-3%.	[Joshi, Peter K.; Fraser, Ross M.; McQuillan, Ruth; Glodzik, Dominik; Rudan, Igor; Campbell, Harry; Wilson, James F.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Prendergast, James; Huffman, Jennifer E.; Vitart, Veronique; Hayward, Caroline; Glodzik, Dominik; Hastie, Nicholas D.; Wright, Alan F.; Haley, Chris S.; Wilson, James F.; Navarro, Pau] Univ Edinburgh, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland; [Polasek, Ozren] Univ Split, Dept Publ Hlth, Split, Croatia; [Polasek, Ozren] Univ Split, Ctr Global Hlth, Split, Croatia; [Haley, Chris S.] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Split; University of Split; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Wilson, JF (corresponding author), Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland.	jim.wilson@ed.ac.uk; pau.navarro@ed.ac.uk	Haley, Chris S/F-3110-2013; Polasek, Ozren/B-6002-2011; Hayward, Caroline/M-8818-2016; Campbell, Harry/E-2959-2010; Fraser, Ross M/J-9519-2012; Navarro, Pau/AAJ-8091-2021; Wilson, James F/A-5704-2009; Rudan, Igor/I-1467-2012	Polasek, Ozren/0000-0002-5765-1862; Hayward, Caroline/0000-0002-9405-9550; Campbell, Harry/0000-0002-6169-6262; Fraser, Ross M/0000-0003-0488-2592; Navarro, Pau/0000-0001-5576-8584; Wilson, James F/0000-0001-5751-9178; Rudan, Igor/0000-0001-6993-6884; Glodzik, Dominik/0000-0001-8112-9073; Haley, Chris/0000-0002-9811-0210; Prendergast, James/0000-0001-8916-018X; Joshi, Peter/0000-0002-6361-5059	Chief Scientist Office of the Scottish Government; Medical Research Council; European Union; MS Society UK; Volant Trust; Royal Society; Croatian Ministry of Science Education and Sport; MRC [MC_PC_U127561128, MC_PC_U127592696, MC_U127592696] Funding Source: UKRI; Medical Research Council [MC_PC_U127592696, 1201677, MC_PC_U127561128, MC_U127592696] Funding Source: researchfish; Chief Scientist Office [CZB/4/710] Funding Source: researchfish	Chief Scientist Office of the Scottish Government; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); MS Society UK; Volant Trust; Royal Society(Royal Society of London); Croatian Ministry of Science Education and Sport(Ministry of Science, Education and Sports, Republic of Croatia); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	This research was supported by the Chief Scientist Office of the Scottish Government, the Medical Research Council, the European Union Framework Programme 6, the MS Society UK, the Volant Trust, the Royal Society, and the Croatian Ministry of Science Education and Sport. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Auer PL, 2012, AM J HUM GENET, V91, P794, DOI 10.1016/j.ajhg.2012.08.031; Cabrera CP, 2012, G3-GENES GENOM GENET, V2, P1067, DOI 10.1534/g3.112.002618; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Glodzik D, 2013, EUR J HUM GENET; Holm H, 2011, NAT GENET, V43, P316, DOI 10.1038/ng.781; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huang HL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002177; Jewett EM, 2012, GENETICS, V191, P1239, DOI 10.1534/genetics.111.137984; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu EY, 2012, GENET EPIDEMIOL, V36, P107, DOI 10.1002/gepi.21603; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; McQuillan R, 2008, AM J HUM GENET, V83, P359, DOI 10.1016/j.ajhg.2008.08.007; Nagamine Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046501; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Polasek O, 2009, CROAT MED J, V50, P7, DOI 10.3325/cmj.2009.50.7; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Surakka I, 2010, GENOME RES, V20, P1344, DOI 10.1101/gr.106534.110; Uricchio LH, 2012, GENET EPIDEMIOL, V36, P312, DOI 10.1002/gepi.21623; Weale ME, 2010, METHODS MOL BIOL, V628, P341, DOI 10.1007/978-1-60327-367-1_19; Zeggini E, 2011, NAT GENET, V43, P287, DOI 10.1038/ng0411-287	27	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68604	10.1371/journal.pone.0068604	http://dx.doi.org/10.1371/journal.pone.0068604			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874685	Green Published, gold, Green Submitted			2022-12-27	WOS:000322064300053
J	Yates, KL; Schoeman, DS				Yates, Katherine L.; Schoeman, David S.			Spatial Access Priority Mapping (SAPM) with Fishers: A Quantitative GIS Method for Participatory Planning	PLOS ONE			English	Article							MARINE PROTECTED AREAS; ECOSYSTEM MANAGEMENT; LOCAL KNOWLEDGE; STAKEHOLDER PARTICIPATION; ECOLOGICAL KNOWLEDGE; INFORMATION-SYSTEMS; CONSERVATION; RESERVES; DESIGN; BIODIVERSITY	Spatial management tools, such as marine spatial planning and marine protected areas, are playing an increasingly important role in attempts to improve marine management and accommodate conflicting needs. Robust data are needed to inform decisions among different planning options, and early inclusion of stakeholder involvement is widely regarded as vital for success. One of the biggest stakeholder groups, and the most likely to be adversely impacted by spatial restrictions, is the fishing community. In order to take their priorities into account, planners need to understand spatial variation in their perceived value of the sea. Here a readily accessible, novel method for quantitatively mapping fishers' spatial access priorities is presented. Spatial access priority mapping, or SAPM, uses only basic functions of standard spreadsheet and GIS software. Unlike the use of remote-sensing data, SAPM actively engages fishers in participatory mapping, documenting rather than inferring their priorities. By so doing, SAPM also facilitates the gathering of other useful data, such as local ecological knowledge. The method was tested and validated in Northern Ireland, where over 100 fishers participated in a semi-structured questionnaire and mapping exercise. The response rate was excellent, 97%, demonstrating fishers' willingness to be involved. The resultant maps are easily accessible and instantly informative, providing a very clear visual indication of which areas are most important for the fishers. The maps also provide quantitative data, which can be used to analyse the relative impact of different management options on the fishing industry and can be incorporated into planning software, such as MARXAN, to ensure that conservation goals can be met at minimum negative impact to the industry. This research shows how spatial access priority mapping can facilitate the early engagement of fishers and the ready incorporation of their priorities into the decision-making process in a transparent, quantitative way.	[Yates, Katherine L.] Univ Ulster, Environm Sci Res Inst, Coleraine BT52 1SA, Londonderry, North Ireland; [Schoeman, David S.] Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Maroochydore, Qld, Australia	Ulster University; University of the Sunshine Coast	Yates, KL (corresponding author), Univ Ulster, Environm Sci Res Inst, Coleraine BT52 1SA, Londonderry, North Ireland.	yates-k1@email.ulster.ac.uk	Yates, Katherine Lucy/I-7725-2019; Yates, Katherine/H-4888-2012	Yates, Katherine Lucy/0000-0001-8429-2941; Yates, Katherine/0000-0001-8429-2941; Schoeman, David/0000-0003-1258-0885	Department of Education and Learning, Northern Ireland	Department of Education and Learning, Northern Ireland	Research was carried out as part of a PhD, funded by the Department of Education and Learning, Northern Ireland. Additional field work resources and equipment were provided by the Agri-Foods and Biosciences Institute, Northern Ireland, as part of a service agreement with the University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFBI, INSH FISH SCALL; Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; Aswani S, 2006, HUM ORGAN, V65, P81, DOI 10.17730/humo.65.1.4y2q0vhe4l30n0uj; Aswani S, 2004, ENVIRON CONSERV, V31, P69, DOI 10.1017/S037689290400116X; Beierle TC, 2002, RISK ANAL, V22, P739, DOI 10.1111/0272-4332.00065; Beukers-Stewart BD, 2005, MAR ECOL PROG SER, V298, P189, DOI 10.3354/meps298189; Brody SD, 2003, J PLAN EDUC RES, V22, P407, DOI 10.1177/0739456X03022004007; Burton P., 2004, WHAT WORKS COMMUNITY; Cappell R, 2012, VALUE IRISH SEA CONS, DOI Seafish Northern Ireland Advisory Committee (SNIAC); Casey JM, 1998, SCIENCE, V281, P690, DOI 10.1126/science.281.5377.690; Close CH, 2006, J ENVIRON MANAGE, V78, P341, DOI 10.1016/j.jenvman.2005.04.027; Cudney-Bueno R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006253; des Clers S., 2008, FISHERMAP MAPPING GR; DETI, 2009, SHOR WIND MAR REN EN; DETI, 2011, REG LOC GUID RLG OFF; Dietz T., 2008, PUBLIC PARTICIPATION; Duane TP, 1997, ECOL LAW QUART, V24, P771; Fischer A, 2007, BIOL CONSERV, V136, P271, DOI 10.1016/j.biocon.2006.11.024; Gerhardinger LC, 2009, NEOTROP ICHTHYOL, V7, P93, DOI 10.1590/S1679-62252009000100012; Gerritsen H, 2011, ICES J MAR SCI, V68, P245, DOI 10.1093/icesjms/fsq137; Hall GB, 2007, FISH RES, V83, P11, DOI 10.1016/j.fishres.2006.08.015; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2002, ECOL LETT, V5, P361, DOI 10.1046/j.1461-0248.2002.00326.x; Hargreaves-Allen V, 2011, ENVIRON MANAGE, V47, P684, DOI 10.1007/s00267-011-9616-5; Helvey M, 2004, COAST MANAGE, V32, P173, DOI 10.1080/08920750490276236; Heupel MR, 2005, MAR TECHNOL SOC J, V39, P10, DOI 10.4031/002533205787521749; Hinz H, 2013, FISH FISH, V14, P110, DOI 10.1111/j.1467-2979.2012.00475.x; Hyrenbach KD, 2000, AQUAT CONSERV, V10, P437, DOI 10.1002/1099-0755(200011/12)10:6<437::AID-AQC425>3.3.CO;2-H; ICES, 2021, ICES SCI REPORTS, V3, P201, DOI [10.17895/ices.pub.8219, DOI 10.17895/ICES.PUB.8219]; ICES, 2009, BENCHM WORKSH NEPHR; Innes JE, 1996, J AM PLANN ASSOC, V62, P460, DOI 10.1080/01944369608975712; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jameson SC, 2002, MAR POLLUT BULL, V44, P1177, DOI 10.1016/S0025-326X(02)00258-8; Johannes RE, 2000, FISH FISH, V1, P257, DOI 10.1046/j.1467-2979.2000.00019.x; Kelleher G., 1999, GUIDELINES MARINE PR; Kelley K, 2003, INT J QUAL HEALTH C, V15, P261, DOI 10.1093/intqhc/mzg031; Klein CJ, 2008, CONSERV BIOL, V22, P691, DOI 10.1111/j.1523-1739.2008.00896.x; Klein CJ, 2010, FRONT ECOL ENVIRON, V8, P349, DOI 10.1890/090047; Koontz TM, 2006, PUBLIC ADMIN REV, V66, P111, DOI 10.1111/j.1540-6210.2006.00671.x; Lee J, 2010, ICES J MAR SCI, V67, P1260, DOI 10.1093/icesjms/fsq010; Silvano RAM, 2010, HYDROBIOLOGIA, V637, P3, DOI 10.1007/s10750-009-9979-2; Maurstad A, 2002, MAR POLICY, V26, P159, DOI 10.1016/S0308-597X(01)00045-8; Moore J, 2004, BIOL CONSERV, V117, P343, DOI 10.1016/j.biocon.2003.12.013; Moreno-Baez M, 2010, B MAR SCI, V86, P339; Newig J, 2007, RES PRACTICE SUSTAIN, V1, P51; Pacific States Marine Fisheries Commission, 2002, W COAST CATCH BOAT S; Pauly D, 2005, PHILOS T R SOC B, V360, P5, DOI 10.1098/rstb.2004.1574; Reed MS, 2008, BIOL CONSERV, V141, P2417, DOI 10.1016/j.biocon.2008.07.014; Reed MS, 2008, ECOL APPL, V18, P1253, DOI 10.1890/07-0519.1; Richardson EA, 2006, CONSERV BIOL, V20, P1191, DOI 10.1111/j.1523-1739.2006.00426.x; Roberts C., 2000, WWF ENDANGERED SEAS; Roberts CM, 2001, SCIENCE, V294, P1920, DOI 10.1126/science.294.5548.1920; Roberts CM, 2003, ECOL APPL, V13, pS199; Rudd MA, 2002, COAST MANAGE, V30, P133, DOI 10.1080/089207502753504670; Scholz A, 2004, MAR POLICY, V28, P335, DOI 10.1016/j.marpol.2003.09.003; SCHOLZ A, 2006, COMMERCIAL FISHING G; Scholz AJ, 2011, CONSERV BIOL, V25, P485, DOI 10.1111/j.1523-1739.2010.01626.x; Silvano Renato A. M., 2008, Environment Development and Sustainability, V10, P657, DOI 10.1007/s10668-008-9149-0; SMITH AH, 1991, ENVIRON CONSERV, V18, P131, DOI 10.1017/S0376892900021706; Stringer LC, 2007, NAT RESOUR FORUM, V31, P198, DOI 10.1111/j.1477-8947.2007.00154.x; The Crown Estate, 2012, SUCC BIDD NO IR OFFS; Thornton TF, 2012, COLLABORATIVE ENGAGE, V17; Turner M, 2005, REV ECON STUD, V72, P247, DOI 10.1111/0034-6527.00331; Weible CM, 2008, COAST MANAGE, V36, P350, DOI 10.1080/08920750802266387; Wheeler M, 2008, AFR J MAR SCI, V30, P475, DOI 10.2989/AJMS.2008.30.3.3.637; Worm B, 2005, SCIENCE, V309, P1365, DOI 10.1126/science.1113399; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; Yaffee SL, 1996, ECOL APPL, V6, P724, DOI 10.2307/2269472; Yates K., 2012, MAPPING SPATIAL ACCE; Yates KL, 2013, MAR POLICY, V38, P140, DOI 10.1016/j.marpol.2012.05.030	70	33	35	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68424	10.1371/journal.pone.0068424	http://dx.doi.org/10.1371/journal.pone.0068424			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874623				2022-12-27	WOS:000322064300033
J	Mar-Aguilar, F; Trevino, V; Salinas-Hernandez, JE; Tamez-Guerrero, MM; Barron-Gonzalez, MP; Morales-Rubio, E; Trevino-Neavez, J; Verduzco-Martinez, JA; Morales-Vallarta, MR; Resendez-Perez, D				Mar-Aguilar, Fermin; Trevino, Victor; Salinas-Hernandez, Jannet E.; Tamez-Guerrero, Marcela M.; Barron-Gonzalez, Maria P.; Morales-Rubio, Eufemia; Trevino-Neavez, Jaime; Verduzco-Martinez, Jorge A.; Morales-Vallarta, Mario R.; Resendez-Perez, Diana			Identification and Characterization of microRNAS from Entamoeba histolytica HM1-IMSS	PLOS ONE			English	Article							INFECTION; RNAS; SUSCEPTIBILITY; EXPRESSION; EVOLUTION; SYSTEM; GENOME	Background: Entamoeba histolytica is the causative agent of amebiasis, a disease that is a major source of morbidity and mortality in the developing world. MicroRNAs (miRNAs) are a large group of non-coding RNAs that play important roles in regulating gene expression and protein translation in animals. Genome-wide identification of miRNAs is a critical step to facilitating our understanding of genome organization, genome biology, evolution, and post-transcriptional regulation. Methodology/Principal Findings: We sequenced a small RNA library prepared from a culture of trophozoites of Entamoeba histolytica Strain HM1-IMSS using a deep DNA sequencing approach. Deep sequencing yielded 16 million high-quality short sequence reads containing a total of 5 million non-redundant sequence reads. Based on a bioinformatics pipeline, we found that only 0.5% of these non-redundant small RNA reads were a perfect match with the drafted E. histolytica genome. We did not find miRNA homologs in plant or animal miRNAs. We discovered 199 new potential Entamoeba histolytica miRNAs. The expression and sequence of these Ehi-miRNAs were further validated through microarray by mu Paraflo Microfluidic Biochip Technology. Ten potential miRNAs were additionally confirmed by real time RT-PCR analysis. Prediction of target genes matched 32 known genes and 34 hypothetical genes. Conclusions/Significance: These results show that there is a number of regulatory miRNAs in Entamoeba histolytica. The collection of miRNAs in this parasite could be used as a new platform to study genomic structure, gene regulation and networks, development, and host-parasite interactions.	[Mar-Aguilar, Fermin; Salinas-Hernandez, Jannet E.; Tamez-Guerrero, Marcela M.; Barron-Gonzalez, Maria P.; Morales-Rubio, Eufemia; Trevino-Neavez, Jaime; Verduzco-Martinez, Jorge A.; Morales-Vallarta, Mario R.; Resendez-Perez, Diana] Univ Autonoma Nuevo Leon, Fac Ciencias Biol, Dept Biol Celular & Genet, San Nicolas De Los Garza, Nuevo Leon, Mexico; [Trevino, Victor] Inst Tecnol & Estudios Super Monterrey, Dept Ingn Biomed, Monterrey, Nuevo Leon, Mexico	Universidad Autonoma de Nuevo Leon; Tecnologico de Monterrey	Resendez-Perez, D (corresponding author), Univ Autonoma Nuevo Leon, Fac Ciencias Biol, Dept Biol Celular & Genet, San Nicolas De Los Garza, Nuevo Leon, Mexico.	diana.resendezpr@uanl.edu.mx	Resendez-Perez, Diana/AAE-3352-2019; Trevino, Victor/C-9219-2009	Resendez-Perez, Diana/0000-0002-4709-7677; Trevino, Victor/0000-0002-7472-9844; Mar-Aguilar, Fermin/0000-0001-8768-6778; Barron Gonzalez, Maria Porfiria/0000-0002-8386-444X	Programa de Apoyo a la Investigacion Cientifica y Tecnologica grant [GCN040-10]	Programa de Apoyo a la Investigacion Cientifica y Tecnologica grant	Funded by Programa de Apoyo a la Investigacion Cientifica y Tecnologica grant GCN040-10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali IKM, 2007, J CLIN MICROBIOL, V45, P285, DOI 10.1128/JCM.01335-06; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Aurrecoechea C, 2007, NUCLEIC ACIDS RES, V35, pD427, DOI 10.1093/nar/gkl880; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Bosch DE, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.30; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; CUPERS P, 1994, J CELL BIOL, V127, P725, DOI 10.1083/jcb.127.3.725; De S, 2006, EXP PARASITOL, V113, P239, DOI 10.1016/j.exppara.2006.01.009; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; Duggal P, 2004, J INFECT DIS, V189, P520, DOI 10.1086/381272; Enright AJ, 2004, GENOME BIOL, V5; Finnegan EF, 2012, CRIT REV BIOCH MOL B; Gallo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030679; Gao XL, 2004, BIOPOLYMERS, V73, P579, DOI 10.1002/bip.20005; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Haque R, 2003, NEW ENGL J MED, V348, P1565, DOI 10.1056/NEJMra022710; Houpt ER, 2002, J IMMUNOL, V169, P4496, DOI 10.4049/jimmunol.169.8.4496; Huang J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008206; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Labruyere E, 2006, ARCH MED RES, V37, P253, DOI 10.1016/j.arcmed.2005.10.005; Lazzaroni JC, 2002, BIOCHIMIE, V84, P391, DOI 10.1016/S0300-9084(02)01419-0; Li MZ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0015168, 10.1371/journal.pone.0011541]; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; Lopez-Soto F, 2009, INT J PARASITOL, V39, P417, DOI 10.1016/j.ijpara.2008.08.010; Lu David P, 2005, J RNAi Gene Silencing, V1, P44; Manzano-Roman R, 2012, MOL BIOCHEM PARASIT, V186, P81, DOI 10.1016/j.molbiopara.2012.10.001; Meyer C, 2011, J VIROL, V85, P378, DOI 10.1128/JVI.01900-10; Mondal D, 2006, T ROY SOC TROP MED H, V100, P1032, DOI 10.1016/j.trstmh.2005.12.012; Puri V, 2001, J CELL BIOL, V154, P535, DOI 10.1083/jcb.200102084; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Rusconi P, 2012, CURR MED CHEM, V19, P1164; Vaz C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-288; Wang Y, 2011, NAT NANOTECHNOL, V6, P668, DOI [10.1038/NNANO.2011.147, 10.1038/nnano.2011.147]; Wei YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r6; Wei ZL, 2011, INT J BIOL SCI, V7, P180, DOI 10.7150/ijbs.7.180; Zhang HB, 2011, FUTURE MICROBIOL, V6, P103, DOI [10.2217/fmb.10.154, 10.2217/FMB.10.154]; Zhang HB, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000219; Zhao T, 2007, GENE DEV, V21, P1190, DOI 10.1101/gad.1543507; Zhao Zhuo-Shen, 2010, F1000 Biol Rep, V2, P70, DOI 10.3410/B2-70; Zhu Qi, 2007, V382, P287, DOI 10.1007/978-1-59745-304-2_19	43	11	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e68202	10.1371/journal.pone.0068202	http://dx.doi.org/10.1371/journal.pone.0068202			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	23874540	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000321718700012
J	Prata, N; Weidert, K; Fraser, A; Gessessew, A				Prata, Ndola; Weidert, Karen; Fraser, Ashley; Gessessew, Amanuel			Meeting Rural Demand: A Case for Combining Community-Based Distribution and Social Marketing of Injectable Contraceptives in Tigray, Ethiopia	PLOS ONE			English	Article							HEALTH WORKERS; REPRODUCTIVE HEALTH; UNMET NEED; STRATEGIES; PROVISION; ACCESS; PROGRAMS	Background: In Sub-Saharan Africa, policy changes have begun to pave the way for community distribution of injectable contraceptives but sustaining such efforts remains challenging. Combining social marketing with community-based distribution provides an opportunity to recover some program costs and compensate workers with proceeds from contraceptive sales. This paper proposes a model for increasing access to injectable contraceptives in rural settings by using community-based distributers as social marketing agents and incorporating financing systems to improve sustainability. Methods: This intervention was implemented in three districts of the Central Zone of Tigray, Ethiopia and program data has been collected from November 2011 through October 2012. A total of 137 Community Based Reproductive Health Agents (CBRHAs) were trained to provide injectable contraceptives and were provided with a loan of 25 injectable contraceptives from a drug revolving fund, created with project funds. The price of a single dose credited to a CBRHA was 3 birr ($0.17) and they provide injections to women for 5 birr ($0.29), determined with willingness-to-pay data. Social marketing was used to create awareness and generate demand. Both quantitative and qualitative methods were used to examine important feasibility aspects of the intervention. Results: Forty-four percent of CBRHAs were providing family planning methods at the time of the training and 96% believed providing injectable contraceptives would improve their services. By October 2012, 137 CBRHAs had successfully completed training and provided 2541 injections. Of total injections, 47% were provided to new users of injectable contraceptives. Approximately 31% of injections were given for free to the poorest women, including adolescents. Conclusions: Insights gained from the first year of implementation of the model provide a framework for further expansion in Tigray, Ethiopia. Our experience highlights how program planners can tailor interventions to match family planning preferences and create more sustainable contraceptive service provision with greater impact.	[Prata, Ndola; Weidert, Karen; Fraser, Ashley] Univ Calif Berkeley, Sch Publ Hlth, Bixby Ctr Populat Hlth & Sustainabil, Berkeley, CA 94720 USA; [Gessessew, Amanuel] Mekelle Univ, Coll Hlth Sci, Dept Obstet & Gynaecol, Mekelle, Ethiopia	University of California System; University of California Berkeley; Mekelle University	Prata, N (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Bixby Ctr Populat Hlth & Sustainabil, Berkeley, CA 94720 USA.	ndola@berkeley.edu			Joffe Charitable Trust, United Kingdom	Joffe Charitable Trust, United Kingdom	Funding for this work was supported by a grant from the Joffe Charitable Trust, United Kingdom. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMAND F, 2003, SOCIAL MARKETING MOD; Biddlecom AE, 1998, STUD FAMILY PLANN, V29, P360, DOI 10.2307/172249; Bixby Center Mekelle University, 2011, COMM BAS DISTR DMPA; Campbell M, 2006, STUD FAMILY PLANN, V37, P87, DOI 10.1111/j.1728-4465.2006.00088.x; Central Statistical Agency, 2007, 2007 ETH NAT CENS AD; Central Statistical Agency [Ethiopia] ICF International, 2012, ETH DEM HLTH SURV DH; Cleland J, 2006, LANCET, V368, P1810, DOI 10.1016/S0140-6736(06)69480-4; Cleland J, 2012, LANCET, V380, P149, DOI 10.1016/S0140-6736(12)60609-6; Cottingham J, 2012, LANCET, V380, P172, DOI 10.1016/S0140-6736(12)60732-6; Desai J, 2011, DEMOGRAPHY, V48, P749, DOI 10.1007/s13524-011-0029-0; DKT International, 2011, 2010 CONTR SOC MARK; Foreit J., 2011, INCREASING ACCESS FA; Garza-Flores J, 1998, CONTRACEPTION, V58, P7, DOI 10.1016/S0010-7824(98)00062-6; Genna Shimeles, 2006, Ethiop Med J, V44, P1; Getnet Mitike, 2000, Ethiopian Journal of Health Development, V14, P31; Harvey P, 1997, SOCIAL MARKETING THE; Harvey PD, 2008, STUD FAMILY PLANN, V39, P69, DOI 10.1111/j.1728-4465.2008.00152.x; Hoke T, 2012, INT PERSPECT SEX R H, V38, P214, DOI 10.1363/3821412; Hoke TH, 2012, HEALTH POLICY PLANN, V27, P52, DOI 10.1093/heapol/czr003; Katz KR, 1998, INT FAM PLAN PERSPEC, V24, P104, DOI 10.2307/3038206; Kirigia J. M., 2006, E AFRICAN MED J, V83; Malarcher S, 2011, CONTRACEPTION, V83, P495, DOI 10.1016/j.contraception.2010.08.013; Malkin M, 2010, IMPLEMENTING HMC RES; Meekers D, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-10; Osotimehin B, 2012, LANCET, V380, P82, DOI 10.1016/S0140-6736(12)60906-4; Peters DH, 2004, HEALTH POLICY PLANN, V19, pI5, DOI 10.1093/heapol/czh041; Prata N, 2005, CONTRACEPTION, V72, P402, DOI 10.1016/j.contraception.2005.06.059; Prata N, 2011, B WORLD HEALTH ORGAN, V89, P556, DOI 10.2471/BLT.11.086710; Richardson F, 2009, COMMUNITY BASED DIST; Sedgh G., 2007, WOMEN UNMET NEED CON; Shelton JD, 1999, INT FAM PLAN PERSPEC, V25, P191, DOI 10.2307/2991884; Simba Daudi, 2011, Tanzan J Health Res, V13, P1; Singh S, 2012, ADDING IT COSTS BENE; Speidel JJ, 2009, MAKING CASE US INT F; Stanback J, 2007, B WORLD HEALTH ORGAN, V85, P768, DOI 10.2471/BLT.07.040162; Stanback J, 2010, CONTRACEPTION, V81, P181, DOI 10.1016/j.contraception.2009.10.006; Stephenson R, 2004, HEALTH POLICY PLANN, V19, P88, DOI 10.1093/heapol/czh011; Stoebenau K, 2003, INT FAM PLAN PERSPEC, V29, P167, DOI 10.2307/3181045; Tawye Yenehun, 2005, Afr J Reprod Health, V9, P15; Townsend JW, 2011, CONTRACEPTION, V83, P405, DOI 10.1016/j.contraception.2010.08.015; United Nations, 2011, WORLD CONTR US WALL; VERNON R, 1988, STUD FAMILY PLANN, V19, P354, DOI 10.2307/1966629; Walker DG, 2005, J COMMUN HEALTH, V30, P221, DOI 10.1007/s10900-004-1960-4; Weldegerima B, 2008, RES SOC ADMIN PHARM, V4, P302, DOI 10.1016/j.sapharm.2007.10.001; Welsh MJ, 2006, BEST PRACT RES CL OB, V20, P323, DOI 10.1016/j.bpobgyn.2005.12.001; White JS, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-143; World Health Organization, 2008, TASK SHIFT RAT RED T; World Health Organization (WHO), 2007, COMMUNITY HLTH WORKE	48	9	10	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e68794	10.1371/journal.pone.0068794	http://dx.doi.org/10.1371/journal.pone.0068794			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	182CS	23874767	Green Published, Green Submitted, gold			2022-12-27	WOS:000321718700040
J	Vaz, JD; Kac, G; Emmett, P; Davis, JM; Golding, J; Hibbeln, JR				Vaz, Juliana dos Santos; Kac, Gilberto; Emmett, Pauline; Davis, John M.; Golding, Jean; Hibbeln, Joseph R.			Dietary Patterns, n-3 Fatty Acids Intake from Seafood and High Levels of Anxiety Symptoms during Pregnancy: Findings from the Avon Longitudinal Study of Parents and Children	PLOS ONE			English	Article							PSYCHOSOCIAL STRESS; PERINATAL OUTCOMES; LIFE-STYLE; VEGETARIAN; ASSOCIATION; QUESTIONNAIRE; POPULATION; DEPRESSION; OMEGA-3-FATTY-ACIDS; INFLAMMATION	Background: Little is known about relationships between dietary patterns, n-3 polyunsaturated fatty acids (PUFA) intake and excessive anxiety during pregnancy. Objective: To examine whether dietary patterns and n-3 PUFA intake from seafood are associated with high levels of anxiety during pregnancy. Design: Pregnant women enrolled from 1991-1992 in ALSPAC (n 9,530). Dietary patterns were established from a food frequency questionnaire using principal component analysis. Total intake of n-3 PUFA (grams/week) from seafood was also examined. Symptoms of anxiety were measured at 32 weeks of gestation with the Crown-Crisp Experiential Index; scores >= 9 corresponding to the 85th percentile was defined as high anxiety symptoms. Multivariate logistic regression models were used to estimate the OR and 95% CI, adjusted by socioeconomic and lifestyle variables. Results: Multivariate results showed that women in the highest tertile of the health-conscious (OR 0.77; 0.65-0.93) and the traditional (OR 0.84; 0.73-0.97) pattern scores were less likely to report high levels of anxiety symptoms. Women in the highest tertile of the vegetarian pattern score (OR 1.25; 1.08-1.44) were more likely to have high levels of anxiety, as well as those with no n-3 PUFA intake from seafood (OR 1.53; 1.25-1.87) when compared with those with intake of >1.5 grams/week. Conclusions: The present study provides evidence of a relationship between dietary patterns, fish intake or n-3 PUFA intake from seafood and symptoms of anxiety in pregnancy, and suggests that dietary interventions could be used to reduce high anxiety symptoms during pregnancy.	[Vaz, Juliana dos Santos] Univ Fed Pelotas, Fac Nutr, Pelotas, RS, Brazil; [Vaz, Juliana dos Santos; Kac, Gilberto] Univ Fed Rio de Janeiro, Nutr Epidemiol Observ, Rio De Janeiro, Brazil; [Emmett, Pauline; Golding, Jean] Univ Bristol, Sch Social & Community Med, Ctr Child & Adolescent Hlth, Bristol, Avon, England; [Davis, John M.] Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA; [Hibbeln, Joseph R.] NIAAA, NIH, Bethesda, MD 90034 USA	Universidade Federal de Pelotas; Universidade Federal do Rio de Janeiro; University of Bristol; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Vaz, JD (corresponding author), Univ Fed Pelotas, Fac Nutr, Pelotas, RS, Brazil.	juliana.vaz@gmail.com	Emmett, Pauline/AAL-6815-2021; Kac, Gilberto/H-6862-2012; Vaz, Juliana/A-5645-2012	Kac, Gilberto/0000-0001-8603-9077; Emmett, Pauline/0000-0003-1076-4779; Golding, Jean/0000-0003-2826-3307; Vaz, Juliana/0000-0002-2880-767X	Division of Intramural Basic and Clinical Research, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland, United States of America; Coordination for the Training and Improvement of Higher Education Personnel; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000115] Funding Source: NIH RePORTER	Division of Intramural Basic and Clinical Research, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland, United States of America; Coordination for the Training and Improvement of Higher Education Personnel; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The United Kingdom Medical Research Council, the Wellcome Trust, and the University of Bristol currently provide core support for ALSPAC; at the time of data collection in pregnancy support was obtained from a variety of sources including the UK Department of the Environment and the Ministry of Agriculture, Fisheries, and Food; and supported in part by the Division of Intramural Basic and Clinical Research, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland, United States of America, and by a personal gift of John M. Davis. Vaz is a recipient of a scholarship from the Coordination for the Training and Improvement of Higher Education Personnel. Kac is a research fellow from the National Counsel of Technological and Scientific Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chatzi L, 2011, PUBLIC HEALTH NUTR, V14, P1663, DOI 10.1017/S1368980010003629; Craig WJ, 2010, NUTR CLIN PRACT, V25, P613, DOI 10.1177/0884533610385707; CRISP AH, 1978, BRIT J MED PSYCHOL, V51, P269, DOI 10.1111/j.2044-8341.1978.tb02472.x; Crozier SR, 2009, J NUTR, V139, P1956, DOI 10.3945/jn.109.109579; Daniels JL, 2004, EPIDEMIOLOGY, V15, P394, DOI 10.1097/01.ede.0000129514.46451.ce; Davis EP, 2010, CHILD DEV, V81, P131, DOI 10.1111/j.1467-8624.2009.01385.x; Davis EP, 2011, J CHILD PSYCHOL PSYC, V52, P119, DOI 10.1111/j.1469-7610.2010.02314.x; DiPietro JA, 2006, CHILD DEV, V77, P573, DOI 10.1111/j.1467-8624.2006.00891.x; EMMETT P, 1992, J HUM NUTR DIET, V5, P245, DOI 10.1111/j.1365-277X.1992.tb00159.x; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Golding J, 2009, EPIDEMIOLOGY, V20, P598, DOI 10.1097/EDE.0b013e31819d6a57; GRABER SE, 1971, J CLIN INVEST, V50, P1000, DOI 10.1172/JCI106569; Green P, 2006, EUR NEUROPSYCHOPHARM, V16, P107, DOI 10.1016/j.euroneuro.2005.07.005; HELLEGERS A, 1957, AM J CLIN NUTR, V5, P327, DOI 10.1093/ajcn/5.3.327; Hellwig JP, 2006, DIETARY REFERENCE IN; Herrmann W, 2002, CLIN CHIM ACTA, V326, P47, DOI 10.1016/S0009-8981(02)00307-8; Hibbeln JR, 2007, LANCET, V369, P578, DOI 10.1016/S0140-6736(07)60277-3; Hibbeln JR, 2009, PROSTAG LEUKOTR ESS, V81, P179, DOI 10.1016/j.plefa.2009.06.005; Hibbeln JR, 2004, BIOL PSYCHIAT, V56, P895, DOI 10.1016/j.biopsych.2004.08.021; Hornstra G, 2000, AM J CLIN NUTR, V71, p1262S, DOI 10.1093/ajcn/71.5.1262s; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; Jacka FN, 2011, PSYCHOSOM MED, V73, P483, DOI 10.1097/PSY.0b013e318222831a; Jacka FN, 2011, J AFFECT DISORDERS, V129, P332, DOI 10.1016/j.jad.2010.09.004; Jacka FN, 2010, AM J PSYCHIAT, V167, P305, DOI 10.1176/appi.ajp.2009.09060881; Kaiser L, 2008, J AM DIET ASSOC, V108, P553, DOI 10.1016/j.jada.2008.01.030; Key TJ, 2006, P NUTR SOC, V65, P35, DOI 10.1079/PNS2005481; Kiecolt-Glaser JK, 2011, BRAIN BEHAV IMMUN, V25, P1725, DOI 10.1016/j.bbi.2011.07.229; Koletzko B, 2008, J PERINAT MED, V36, P5, DOI 10.1515/JPM.2008.001; Kwok T, 2002, AM J HEMATOL, V70, P186, DOI 10.1002/ajh.10134; Larsen R, 2011, BIOTECHNOL ADV, V29, P508, DOI 10.1016/j.biotechadv.2011.05.017; Littleton HL, 2007, AM J OBSTET GYNECOL, V196, P424, DOI 10.1016/j.ajog.2007.03.042; Littleton HL, 2010, J PSYCHOSOM OBST GYN, V31, P219, DOI 10.3109/0167482X.2010.518776; Loomans EM, 2013, EUR J PUBLIC HEALTH, V23, P485, DOI 10.1093/eurpub/cks097; Maes M, 2000, BIOL PSYCHIAT, V47, P910, DOI 10.1016/S0006-3223(99)00268-1; McNamara RK, 2006, PROSTAG LEUKOTR ESS, V75, P329, DOI 10.1016/j.plefa.2006.07.010; Ministry of Agriculture Fisheries and Food and Royal Society of Chemistry, 1998, FATT AC S MCCANC WID; Newson RB, 2004, J ALLERGY CLIN IMMUN, V114, P531, DOI 10.1016/j.jaci.2004.05.010; Northstone K, 2008, BRIT J NUTR, V99, P406, DOI 10.1017/S0007114507803977; Okubo H, 2011, BRIT J NUTR, V105, P1251, DOI 10.1017/S0007114510004782; Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006; Rogers I, 1998, EUR J CLIN NUTR, V52, P246, DOI 10.1038/sj.ejcn.1600543; Rosell MS, 2005, AM J CLIN NUTR, V82, P327, DOI 10.1093/ajcn/82.2.327; Ross BM, 2009, PROSTAG LEUKOTR ESS, V81, P309, DOI 10.1016/j.plefa.2009.10.004; Sanders TAB, 2009, PROSTAG LEUKOTR ESS, V81, P137, DOI 10.1016/j.plefa.2009.05.013; Schetter CD, 2012, CURR OPIN PSYCHIATR, V25, P141, DOI 10.1097/YCO.0b013e3283503680; Shaheen SO, 2009, THORAX, V64, P411, DOI 10.1136/thx.2008.104703; Sinclair AJ, 2007, ASIA PAC J CLIN NUTR, V16, P391; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Tegethoff M, 2010, PSYCHOSOM MED, V72, P419, DOI 10.1097/PSY.0b013e3181d2f0b0; Williams C, 2001, AM J CLIN NUTR, V73, P316; YARNELL JWG, 1983, HUM NUTR-APPL NUTR, V37, P103	51	26	26	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e67671	10.1371/journal.pone.0067671	http://dx.doi.org/10.1371/journal.pone.0067671			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	182CS	23874437	Green Published, gold, Green Submitted			2022-12-27	WOS:000321718700003
J	Amancio, RT; Japiassu, AM; Gomes, RN; Mesquita, EC; Assis, EF; Medeiros, DM; Grinsztejn, B; Bozza, PT; Neto, HCCF; Bozza, FA				Amancio, Rodrigo T.; Japiassu, Andre M.; Gomes, Rachel N.; Mesquita, Emersom C.; Assis, Edson F.; Medeiros, Denise M.; Grinsztejn, Beatriz; Bozza, Patricia T.; Castro-Faria Neto, Hugo C.; Bozza, Fernando A.			The Innate Immune Response in HIV/AIDS Septic Shock Patients: A Comparative Study	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HIV-INFECTED PATIENTS; C-REACTIVE PROTEIN; CRITICALLY-ILL PATIENTS; SEVERE SEPSIS; ORGAN DYSFUNCTION; INTENSIVE-CARE; UNITED-STATES; EPIDEMIOLOGY; OUTCOMES	Introduction: In recent years, the incidence of sepsis has increased in critically ill HIV/AIDS patients, and the presence of severe sepsis emerged as a major determinant of outcomes in this population. The inflammatory response and deregulated cytokine production play key roles in the pathophysiology of sepsis; however, these mechanisms have not been fully characterized in HIV/AIDS septic patients. Methods: We conducted a prospective cohort study that included HIV/AIDS and non-HIV patients with septic shock. We measured clinical parameters and biomarkers (C-reactive protein and cytokine levels) on the first day of septic shock and compared these parameters between HIV/AIDS and non-HIV patients. Results: We included 30 HIV/AIDS septic shock patients and 30 non-HIV septic shock patients. The HIV/AIDS patients presented low CD4 cell counts (72 [7-268] cells/mm(3)), and 17 (57%) patients were on HAART before hospital admission. Both groups were similar according to the acute severity scores and hospital mortality. The IL-6, IL-10 and G-CSF levels were associated with hospital mortality in the HIV/AIDS septic group; however, the CRP levels and the surrogates of innate immune activation (cytokines) were similar among HIV/AIDS and non-HIV septic patients. Age (odds ratio 1.05, CI 95% 1.02-1.09, p=0.002) and the IL-6 levels (odds ratio 1.00, CI 95% 1.00-1.01, p=0.05) were independent risk factors for hospital mortality. Conclusions: IL-6, IL-10 and G-CSF are biomarkers that can be used to predict prognosis and outcomes in HIV/AIDS septic patients. Although HIV/AIDS patients are immunocompromised, an innate immune response can be activated in these patients, which is similar to that in the non-HIV septic population. In addition, age and the IL-6 levels are independent risk factors for hospital mortality irrespective of HIV/AIDS disease.	[Amancio, Rodrigo T.; Japiassu, Andre M.; Gomes, Rachel N.; Mesquita, Emersom C.; Medeiros, Denise M.; Bozza, Fernando A.] Inst Pesquisa Clin Evandro Chagas IPEC, Lab Med Intens, Rio De Janeiro, RJ, Brazil; [Grinsztejn, Beatriz] Inst Pesquisa Clin Evandro Chagas IPEC, Lab HIV, Rio De Janeiro, RJ, Brazil; [Assis, Edson F.; Bozza, Patricia T.; Castro-Faria Neto, Hugo C.] Fundacao Oswaldo Cruz FIOCRUZ, IOC, Lab Imunofarmacol, Rio De Janeiro, RJ, Brazil; [Japiassu, Andre M.; Bozza, Fernando A.] Inst Or Pesquisa Ensino IDOR, Rio De Janeiro, RJ, Brazil	Fundacao Oswaldo Cruz	Bozza, FA (corresponding author), Inst Pesquisa Clin Evandro Chagas IPEC, Lab Med Intens, Rio De Janeiro, RJ, Brazil.	fernando.bozza@ipec.fiocruz.br	Bozza, Fernando A/A-2618-2013; Bozza, Patricia T./AAM-4537-2021; Bozza, Patricia T./AAE-2933-2021; Gomes, Rachel N/I-7643-2013	Bozza, Fernando A/0000-0003-4878-0256; Bozza, Patricia T./0000-0001-8349-9529; Mesquita, Emersom/0000-0002-5132-3315	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); PAPES/FIOCRUZ	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); PAPES/FIOCRUZ	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) and PAPES/FIOCRUZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andaluz-Ojeda D, 2012, CYTOKINE, V57, P332, DOI 10.1016/j.cyto.2011.12.002; Ballester JCA, 2008, INFECT CONT HOSP EP, V29, P630, DOI 10.1086/589583; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Annane D, 2003, AM J RESP CRIT CARE, V168, P165, DOI 10.1164/rccm.2201087; BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6; Beale R, 2009, INFECTION, V37, P222, DOI 10.1007/s15010-008-8203-z; Benito N, 2004, CLIN DIAGN LAB IMMUN, V11, P608, DOI 10.1128/CDLI.11.3.608-614.2004; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Blanco J, 2008, CRIT CARE, V12, DOI 10.1186/cc7157; Boumendil A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034387; Bozza FA, 2007, CRIT CARE, V11, DOI 10.1186/cc5783; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; CIPOLLE MD, 1993, CRIT CARE CLIN, V9, P261, DOI 10.1016/S0749-0704(18)30196-9; Coquet I, 2010, CRIT CARE, V14, DOI 10.1186/cc9056; Deeks SG, 2012, CURR OPIN IMMUNOL, V24, P501, DOI 10.1016/j.coi.2012.05.004; Dore GJ, 2002, J ACQ IMMUN DEF SYND, V29, P388, DOI 10.1097/00126334-200204010-00010; Faix JD, 2013, CRIT REV CL LAB SCI, V50, P23, DOI 10.3109/10408363.2013.764490; Gilstrap LG, 2012, CLIN CHEM, V58, P72, DOI 10.1373/clinchem.2011.165712; GOTTLIEB MS, 1981, NEW ENGL J MED, V305, P1425, DOI 10.1056/NEJM198112103052401; Greenberg JA, 2012, J CRIT CARE, V27, P51, DOI 10.1016/j.jcrc.2011.08.015; Haddy RI, 2012, J AM BOARD FAM MED, V25, P318, DOI 10.3122/jabfm.2012.03.110106; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Huang L, 2006, NEW ENGL J MED, V355, P173, DOI 10.1056/NEJMra050836; Jacob ST, 2009, PLOS ONE, V4, pA115, DOI 10.1371/journal.pone.0007782; Japiassu AM, 2010, CRIT CARE, V14, DOI 10.1186/cc9221; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Rezende ELLF, 2010, BRAZ J INFECT DIS, V14, P558, DOI [10.1016/S1413-8670(10)70112-4, 10.1590/S1413-86702010000600003]; Ledwaba L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0024243; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Lucas S, 2012, CURR OPIN INFECT DIS, V25, P36, DOI 10.1097/QCO.0b013e32834ef5c4; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mera S, 2011, APMIS, V119, P155, DOI 10.1111/j.1600-0463.2010.02705.x; Mrus JM, 2005, CRIT CARE, V9, pR623, DOI 10.1186/cc3811; Pacheco AG, 2009, JAIDS-J ACQ IMM DEF, V51, P624, DOI 10.1097/QAI.0b013e3181a4ecf5; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Povoa P, 2012, ANN INTENSIVE CARE, V2, DOI 10.1186/2110-5820-2-32; Povoa P, 2011, CRIT CARE, V15, DOI 10.1186/cc10242; Riedemann NC, 2003, J CLIN INVEST, V112, P460, DOI 10.1172/JCI200319523; Rosenberg AL, 2001, CRIT CARE MED, V29, P548, DOI 10.1097/00003246-200103000-00013; Ross AC, 2009, CLIN INFECT DIS, V49, P1119, DOI 10.1086/605578; Salluh JIF, 2011, CRIT CARE, V15, DOI 10.1186/cc10301; Schleicher GK, 2005, EUR RESPIR J, V25, P688, DOI 10.1183/09031936.05.00067604; Suratt BT, 2009, CRIT CARE MED, V37, P1322, DOI 10.1097/CCM.0b013e31819c14fa; Thyrault M, 1997, INTENS CARE MED, V23, P1018, DOI 10.1007/s001340050451; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751	45	16	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e68730	10.1371/journal.pone.0068730	http://dx.doi.org/10.1371/journal.pone.0068730			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874739	Green Submitted, Green Published, gold			2022-12-27	WOS:000322218800042
J	Das, A; Bhattacharya, A; Chakrabarty, S; Ganguli, A; Chakrabarti, G				Das, Amlan; Bhattacharya, Abhijit; Chakrabarty, Subhendu; Ganguli, Arnab; Chakrabarti, Gopal			Smokeless Tobacco Extract (STE)-Induced Toxicity in Mammalian Cells is Mediated by the Disruption of Cellular Microtubule Network: A Key Mechanism of Cytotoxicity	PLOS ONE			English	Article							OXIDATIVE STRESS; TUBULIN; APOPTOSIS; BINDING; PROTEIN; LUNG; POLYMERIZATION; ARREST; HEALTH; CANCER	Smokeless tobacco usage is a growing public health problem worldwide. The molecular mechanism(s) underlying smokeless tobacco associated tissue damage remain largely unidentified. In the present study we have tried to explore the effects of aqueous extract of smokeless tobacco (STE) on tubulin-microtubule, the major cytoskeleton protein that maintains cells morphology and participates in cell division. Exposure to STE resulted in dose-dependent cytotoxicity in a variety of mammalian transformed cell lines such as human lung epithelial cells A549, human liver epithelial cells HepG2, and mouse squamous epithelial cells HCC7, as well as non-tumorogenic human peripheral blood mononuclear cells PBMC. Cellular morphology of STE-treated cells was altered and the associated disruption of microtubule network indicates that STE targets tubulin-microtubule system in both cell lines. Furthermore it was also observed that STE-treatment resulted in the selective degradation of cellular tubulin, whereas actin remains unaltered. In vitro, polymerization of purified tubulin was inhibited by STE with the IC50 value similar to 150 mu g/ml and this is associated with the loss of reactive cysteine residues of tubulin. Application of thiol-based antioxidant N-acetyl cysteine (NAC) significantly abrogates STE-mediated microtubule damage and associated cytotoxicity in both A549 and HepG2 cells. These results suggest that microtubule damage is one of the key mechanisms of STE-induced cytotoxity in mammalian cells.	[Chakrabarti, Gopal] Univ Calcutta, Dept Biotechnol, Kolkata 700073, WB, India; Univ Calcutta, Dr BC Guha Ctr Genet Engn & Biotechnol, Kolkata 700073, WB, India	University of Calcutta; University of Calcutta	Chakrabarti, G (corresponding author), Univ Calcutta, Dept Biotechnol, Kolkata 700073, WB, India.	gcbcg@caluniv.ac.in	Das, Amlan/HHC-0898-2022; Ganguli, Arnab/AAO-8635-2020	Das, Amlan/0000-0002-9295-3743; Ganguli, Arnab/0000-0001-9939-027X	Council of Scientific Industrial Research, Government of India [37(1216)/05/EMR-II]; Board of Research Nuclear Sciences/Department of Atomic Energy Government of India [2006/37/21/BRNS]	Council of Scientific Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Board of Research Nuclear Sciences/Department of Atomic Energy Government of India	The study was supported by Grants from Council of Scientific Industrial Research, Government of India [Grant No. 37(1216)/05/EMR-II] and Board of Research Nuclear Sciences/Department of Atomic Energy Government of India [Grant No. 2006/37/21/BRNS] to GC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avti PK, 2006, TOXICOL SCI, V89, P547, DOI 10.1093/toxsci/kfj041; Avti PK, 2010, CHEM RES TOXICOL, V23, P1163, DOI 10.1021/tx900458x; Bagchi M, 1999, FREE RADICAL BIO MED, V26, P992, DOI 10.1016/S0891-5849(98)00286-X; Bates C, 2003, TOB CONTROL, V12, P360, DOI 10.1136/tc.12.4.360; Bernhard D, 2005, FASEB J, V19, P1096, DOI 10.1096/fj.04-3192com; Blanchard-Fillion B, 2006, J NEUROSCI, V26, P6124, DOI 10.1523/JNEUROSCI.1038-06.2006; Boutte AM, 2006, FASEB J, V20, P1473, DOI 10.1096/fj.06-5920com; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Britto PJ, 2005, BIOCHEM J, V389, P549, DOI 10.1042/BJ20042118; Chakrabarty S, 2011, J AGR FOOD CHEM, V59, P2040, DOI 10.1021/jf104231b; Changrani Jyotsna, 2005, J Immigr Health, V7, P103, DOI 10.1007/s10903-005-2643-7; Choudhury D, 2010, FOOD CHEM TOXICOL, V48, P2872, DOI 10.1016/j.fct.2010.07.020; Costea DE, 2010, J ORAL PATHOL MED, V39, P128, DOI 10.1111/j.1600-0714.2009.00825.x; Critchley JA, 2003, THORAX, V58, P435, DOI 10.1136/thorax.58.5.435; Das A, 2008, BMB REP, V41, P62, DOI 10.5483/BMBRep.2008.41.1.062; Das A, 2012, TOXICOL RES-UK, V1, P171, DOI 10.1039/c2tx00013j; Das A, 2012, BIOCHEM PHARMACOL, V84, P486, DOI 10.1016/j.bcp.2012.04.021; Das A, 2010, CHEM RES TOXICOL, V23, P1054, DOI 10.1021/tx1000442; Das A, 2009, CHEM RES TOXICOL, V22, P446, DOI 10.1021/tx8002142; Hecht SS, 1997, ANN NY ACAD SCI, V833, P91, DOI 10.1111/j.1749-6632.1997.tb48596.x; Hoffmann D, 1997, Adv Dent Res, V11, P322; Kapoor TM, 2002, J CELL BIOL, V157, P551, DOI 10.1083/jcb.200202073; Landino LM, 2007, CHEM RES TOXICOL, V20, P1693, DOI 10.1021/tx7001492; Lombard C, 2010, INT IMMUNOPHARMACOL, V10, P1029, DOI 10.1016/j.intimp.2010.06.002; Mi LX, 2008, J BIOL CHEM, V283, P22136, DOI 10.1074/jbc.M802330200; Mitchell C, 2010, TOXICOL LETT, V195, P23, DOI 10.1016/j.toxlet.2010.02.020; Mitchison TJ, 1989, CURR OPIN CELL BIOL, V1, P67, DOI 10.1016/S0955-0674(89)80039-0; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Poggi P, 2002, J PERIODONTAL RES, V37, P230, DOI 10.1034/j.1600-0765.2002.00317.x; Richter P, 2003, NICOTINE TOB RES, V5, P885, DOI 10.1080/14622200310001614647; Robertson P B, 1997, Adv Dent Res, V11, P307; Robinson AS, 1997, NAT STRUCT BIOL, V4, P450, DOI 10.1038/nsb0697-450; Srivastava P, 2007, FEBS J, V274, P4788, DOI 10.1111/j.1742-4658.2007.06004.x; Stepanov I, 2006, NICOTINE TOB RES, V8, P309, DOI 10.1080/14622200500490151; Stepanov I, 2010, CHEM RES TOXICOL, V23, P66, DOI 10.1021/tx900281u; Stepanov I, 2008, NICOTINE TOB RES, V10, P1773, DOI 10.1080/14622200802443544; Teo KK, 2006, LANCET, V368, P647, DOI 10.1016/S0140-6736(06)69249-0; Zhou J, 2002, J CELL SCI, V115, P3547, DOI 10.1242/jcs.00029	38	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e68224	10.1371/journal.pone.0068224	http://dx.doi.org/10.1371/journal.pone.0068224			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874548	Green Published, gold, Green Submitted			2022-12-27	WOS:000322218800018
J	Nouvellet, P; Newman, C; Buesching, CD; Macdonald, DW				Nouvellet, Pierre; Newman, Chris; Buesching, Christina D.; Macdonald, David W.			A Multi-Metric Approach to Investigate the Effects of Weather Conditions on the Demographic of a Terrestrial Mammal, the European Badger (Meles meles)	PLOS ONE			English	Article							CLIMATE-CHANGE; POPULATION-DYNAMICS; LIFE-HISTORIES; EVOLUTIONARY RESPONSES; SURVIVAL; VARIABILITY; NICHE; CONSEQUENCES; VARIANCE; EXTREMES	Models capturing the full effects of weather conditions on animal populations are scarce. Here we decompose yearly temperature and rainfall into mean trends, yearly amplitude of change and residual variation, using daily records. We establish from multi-model inference procedures, based on 1125 life histories (from 1987 to 2008), that European badger (Meles meles) annual mortality and recruitment rates respond to changes in mean trends and to variability in proximate weather components. Variation in mean rainfall was by far the most influential predictor in our analysis. Juvenile survival and recruitment rates were highest at intermediate levels of mean rainfall, whereas low adult survival rates were associated with only the driest, and not the wettest, years. Both juvenile and adult survival rates also exhibited a range of tolerance for residual standard deviation around daily predicted temperature values, beyond which survival rates declined. Life-history parameters, annual routines and adaptive behavioural responses, which define the badgers' climatic niche, thus appear to be predicated upon a bounded range of climatic conditions, which support optimal survival and recruitment dynamics. That variability in weather conditions is influential, in combination with mean climatic trends, on the vital rates of a generalist, wide ranging and K-selected medium-sized carnivore, has major implications for evolutionary ecology and conservation.	[Nouvellet, Pierre; Newman, Chris; Buesching, Christina D.; Macdonald, David W.] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Recanati Kaplan Ctr, Abingdon, Oxon, England; [Nouvellet, Pierre] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, MRC, Ctr Outbreak Anal & Modelling, London, England	University of Oxford; Imperial College London	Macdonald, DW (corresponding author), Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Recanati Kaplan Ctr, Tubney House, Abingdon, Oxon, England.	david.macdonald@zoo.ox.ac.uk		nouvellet, pierre/0000-0002-6094-5722	European Union Seventh Framework Programme (FP7) [278433-PREDEMICS]; Medical Research Council Centre for Outbreak Analysis and Modelling; Medical Research Council [MR/K010174/1B] Funding Source: researchfish	European Union Seventh Framework Programme (FP7); Medical Research Council Centre for Outbreak Analysis and Modelling(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The People's Trust for Endangered Species generously supported much of this core study. For part of this work, PN received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under Grant Agreement n 278433-PREDEMICS, and thanks the Medical Research Council Centre for Outbreak Analysis and Modelling for support. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyce MS, 2006, TRENDS ECOL EVOL, V21, P141, DOI 10.1016/j.tree.2005.11.018; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Campbell RD, 2012, GLOBAL CHANGE BIOL, V18, P2730, DOI 10.1111/j.1365-2486.2012.02739.x; CASWELL H, 1982, ECOLOGY, V63, P1218, DOI 10.2307/1938846; Davis MB, 2005, ECOLOGY, V86, P1704, DOI 10.1890/03-0788; Dormann CF, 2010, BIOL LETTERS, V6, P229, DOI 10.1098/rsbl.2009.0688; Drake JM, 2005, P ROY SOC B-BIOL SCI, V272, P1823, DOI 10.1098/rspb.2005.3148; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Fero O, 2008, ECOL APPL, V18, P1563, DOI 10.1890/07-1012.1; Fisher N, 2010, WYTHAM WOODS: OXFORD'S ECOLOGICAL LABORATORY, P197; Fisher-Reid MC, 2012, EVOLUTION, V66, P3836, DOI 10.1111/j.1558-5646.2012.01729.x; Folke C, 2006, GLOBAL ENVIRON CHANG, V16, P253, DOI 10.1016/j.gloenvcha.2006.04.002; FRANKLIN A., 2001, WILDLIFE LAND PEOPLE, P350; Gaillard JM, 2003, ECOLOGY, V84, P3294, DOI 10.1890/02-0409; Gallagher J, 2000, RES VET SCI, V69, P203, DOI 10.1053/rvsc.2000.0422; Grosbois V, 2008, BIOL REV, V83, P357, DOI 10.1111/j.1469-185X.2008.00047.x; Johnson DDP, 2002, J BIOGEOGR, V29, P411, DOI 10.1046/j.1365-2699.2002.00680.x; JOLLY GM, 1965, BIOMETRIKA, V52, P225, DOI 10.2307/2333826; Kerr Benjamin, 2007, Biological Theory, V2, P250, DOI 10.1162/biot.2007.2.3.250; King D, 2005, J APPL ECOL, V42, P779, DOI 10.1111/j.1365-2664.2005.01089.x; Kjellstrom E, 2007, CLIMATIC CHANGE, V81, P249, DOI 10.1007/s10584-006-9220-5; Krebs CJ, 2006, CLIM RES, V32, P143, DOI 10.3354/cr032143; Kruuk H., 1985, P521; KRUUK H, 1978, BEHAV ECOL SOCIOBIOL, V4, P75, DOI 10.1007/BF00302562; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; LEHOUEROU HN, 1988, J ARID ENVIRON, V15, P1, DOI 10.1016/S0140-1963(18)31001-2; Lindsay DS, 1997, CLIN MICROBIOL REV, V10, P19, DOI 10.1128/CMR.10.1.19; Macdonald D.W., 1983, P393; Macdonald DW, 2010, GLOBAL CHANGE BIOL, V16, P2913, DOI 10.1111/j.1365-2486.2010.02208.x; Macdonald DW, 2009, J MAMMAL, V90, P1392, DOI 10.1644/08-MAMM-A-356R1.1; Macdonald DW, 2002, J ZOOL, V256, P121, DOI 10.1017/S0952836902000158; Maurel D., 1983, P219; McDermott R, 2008, J POLIT, V70, P335, DOI 10.1017/S0022381608080341; MCNAMARA JM, 1995, P ROY SOC B-BIOL SCI, V261, P279, DOI 10.1098/rspb.1995.0148; Millar CI, 2007, ECOL APPL, V17, P2145, DOI 10.1890/06-1715.1; Mysterud A, 2001, NATURE, V410, P1096, DOI 10.1038/35074099; Newman C, 2001, PARASITOLOGY, V123, P133, DOI 10.1017/S0031182001008265; Nippert JB, 2006, PLANT ECOL, V184, P65, DOI 10.1007/s11258-005-9052-9; Nogues-Bravo D, 2009, GLOBAL ECOL BIOGEOGR, V18, P521, DOI 10.1111/j.1466-8238.2009.00476.x; Nouvellet P, 2011, J ZOOL, V283, P52, DOI 10.1111/j.1469-7998.2010.00743.x; PARKER GA, 1990, NATURE, V348, P27, DOI 10.1038/348027a0; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; PIMM SL, 1988, AM NAT, V132, P757, DOI 10.1086/284889; Portner HO, 2004, PHYSIOL BIOCHEM ZOOL, V77, P959, DOI 10.1086/423742; Ruzzante DE, 2008, MOL ECOL, V17, P2234, DOI 10.1111/j.1365-294X.2008.03738.x; SIMMONS LF, 1990, INT J FORECASTING, V6, P485, DOI 10.1016/0169-2070(90)90025-7; Sutherland WJ, 2006, J APPL ECOL, V43, P599, DOI 10.1111/j.1365-2664.2006.01182.x; Thuiller W, 2005, GLOBAL ECOL BIOGEOGR, V14, P347, DOI 10.1111/j.1466-822x.2005.00162.x; Tingley MW, 2009, P NATL ACAD SCI USA, V106, P19637, DOI 10.1073/pnas.0901562106; Tuljapurkar S, 2010, J ANIM ECOL, V79, P1, DOI 10.1111/j.1365-2656.2009.01619.x; Tuljapurkar S, 2009, PHILOS T R SOC B, V364, P1499, DOI 10.1098/rstb.2009.0021; vanTienderen PH, 1997, EVOLUTION, V51, P1372, DOI [10.1111/j.1558-5646.1997.tb01460.x, 10.2307/2411189]; Vucetich JA, 2004, P ROY SOC B-BIOL SCI, V271, P183, DOI 10.1098/rspb.2003.2589; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; WEBB DR, 1984, J THERM BIOL, V9, P189, DOI 10.1016/0306-4565(84)90020-2; Weltzin JF, 2003, BIOSCIENCE, V53, P941, DOI 10.1641/0006-3568(2003)053[0941:ATROTE]2.0.CO;2; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wolf M, 2007, NATURE, V447, P581, DOI 10.1038/nature05835; WOODROFFE R, 1995, J ANIM ECOL, V64, P12, DOI 10.2307/5823; Zhou YB, 2013, GLOB CHANG BIOL	62	28	28	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e68116	10.1371/journal.pone.0068116	http://dx.doi.org/10.1371/journal.pone.0068116			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874517	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000322218800013
J	Rtveladze, K; Marsh, T; Webber, L; Kilpi, F; Levy, D; Conde, W; McPherson, K; Brown, M				Rtveladze, Ketevan; Marsh, Tim; Webber, Laura; Kilpi, Fanny; Levy, David; Conde, Wolney; McPherson, Klim; Brown, Martin			Health and Economic Burden of Obesity in Brazil	PLOS ONE			English	Article							NUTRITION TRANSITION; TRENDS; PREVALENCE; DISEASES; FUTURE	Introduction: Higher and lower-middle income countries are increasingly affected by obesity. Obesity-related diseases are placing a substantial health and economic burden on Brazil. Our aim is to measure the future consequences of these trends on the associated disease burden and health care costs. Method: A previously developed micro-simulation model is used to project the extent of obesity, obesity-related diseases and associated healthcare costs to 2050. In total, thirteen diseases were considered: coronary heart disease, stroke, hypertension, diabetes, osteoarthritis, and eight cancers. We simulated three hypothetical intervention scenarios: no intervention, 1% and 5% reduction in body mass index (BMI). Results: In 2010, nearly 57% of the Brazilian male population was overweight or obese (BMI >= 25 kg/m(2)), but the model projects rates as high as 95% by 2050. A slightly less pessimistic picture is predicted for females, increasing from 43% in 2010 to 52% in 2050. Coronary heart disease, stroke, hypertension, cancers, osteoarthritis and diabetes prevalence cases are projected to at least double by 2050, reaching nearly 34,000 cases of hypertension by 2050 (per 100,000). 1% and 5% reduction in mean BMI will save over 800 prevalence cases and nearly 3,000 cases of hypertension by 2050 respectively (per 100,000). The health care costs will double from 2010 ($5.8 billion) in 2050 alone ($10.1 billion). Over 40 years costs will reach $330 billion. However, with effective interventions the costs can be reduced to $302 billion by 1% and to $273 billion by 5% reduction in mean BMI across the population. Conclusion: Obesity rates are rapidly increasing creating a high burden of disease and associated costs. However, an effective intervention to decrease obesity by just 1% will substantially reduce obesity burden and will have a significant effect on health care expenditure.	[Rtveladze, Ketevan; Marsh, Tim; Webber, Laura; Kilpi, Fanny; Brown, Martin] Micro Hlth Simulat, London, England; [Levy, David] Georgetown Univ, Washington, DC USA; [Conde, Wolney] Univ Sao Paulo, Sao Paulo, Brazil; [McPherson, Klim] New Coll, Oxford, England	Georgetown University; Universidade de Sao Paulo; University of Oxford	Rtveladze, K (corresponding author), Micro Hlth Simulat, London, England.	ketevan.rtveladze@heartforum.org.uk	Levy, David/GPS-4945-2022	Kilpi, Fanny/0000-0002-3551-2829	GlaxoSmithKline [27875780]	GlaxoSmithKline(GlaxoSmithKline)	GlaxoSmithKline provided a non-discretionary educational grant to fund this project (Grant number 27875780). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcelo A, 2003, B WORLD HEALTH ORGAN, V81, P19; Barreto SM, 2009, REV SAUDE PUBL, V32, P1, DOI DOI 10.1590/S0034-89102009000900006; Beaulieu N., 2009, EC INTELL UNIT, P1; Butland B, 2007, FORESIGHT TACKLING O, P1; Dib MW, 2010, REV PANAM SALUD PUBL, V27, P125, DOI 10.1590/S1020-49892010000200006; Drewnowski A, 1997, NUTR REV, V55, P31, DOI 10.1111/j.1753-4887.1997.tb01593.x; Ferlay J, 2010, IARC CANCERBASE; Fishman G. S., 1995, MONTE CARLO CONCEPTS; Ford ES, 2008, J CLIN ENDOCR METAB, V93, pS1, DOI 10.1210/jc.2008-1356; Gortmaker SL, 2011, LANCET, V378, P838, DOI 10.1016/S0140-6736(11)60815-5; Hawkes C, 2007, MARKETING FOOD CHILD, P1; Kopelman P, 2007, OBES REV, V8, pVI; Levy RB, 2012, REV SAUDE PUBL, V46, P6, DOI 10.1590/S0034-89102011005000088; Lobstein T, 2009, DATA DOCUMENTATION D, VI, P1; Lotufo P A, 2000, Sao Paulo Med J, V118, P161; Macdiarmid J, 1998, NUTR RES REV, V11, P231, DOI 10.1079/NRR19980017; Matsudo Sandra Mahecha, 2003, Rev Panam Salud Publica, V14, P265, DOI 10.1590/S1020-49892003000900007; McPherson K, 2007, TACKLING OBESITIES F, P1; Ministerio da Saude Brasil. VIGITEL Brasil 2006, 2007, VIG FAT RISC PROT DO, P1; Monteiro CA, 2000, EUR J CLIN NUTR, V54, P342, DOI 10.1038/sj.ejcn.1600960; MONTEIRO CA, 1995, EUR J CLIN NUTR, V49, P105; Monteiro CA, 2010, J WORLD PUBLIC HLTH, V6; Monteiro CA, 2007, AM J PUBLIC HEALTH, V97, P1808, DOI 10.2105/AJPH.2006.099630; Monteiro CA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001252; Monteiro CA, 2011, PUBLIC HEALTH NUTR, V14, P5, DOI 10.1017/S1368980010003241; Moura EC, 2009, REV PANAM SALUD PUBL, V26, P17, DOI 10.1590/S1020-49892009000700003; Nooyens ACJ, 2009, PUBLIC HEALTH NUTR, V12, P862, DOI 10.1017/S1368980008003091; POPKIN BM, 1994, NUTR REV, V52, P285, DOI 10.1111/j.1753-4887.1994.tb01460.x; Population Division of the Department of Economic and Social Affairs of the United Nations Secretariat, WORLD POOP PROSP 201; Rich-Edwards JW, 2002, EPIDEMIOLOGY, V13, P184, DOI 10.1097/00001648-200203000-00013; Rtveladze K., 2012, Health, V4, P1471; Rtveladze K, 2013, PUBLIC HEALTH NUTR, V1, P1; Schmidt MI, 2011, LANCET, V377, P1949, DOI 10.1016/S0140-6736(11)60135-9; Sichieri R, 2007, CAD SAUDE PUBLICA, V23, P1721, DOI 10.1590/S0102-311X2007000700025; Stuckler D, 2012, PLOS MED, V9, DOI [10.1371/journal.pmed.1001235, 10.1371/journal.pmed.1001242]; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; The OECD, OB EC PREV FIT NOT F; The United Nations Department of Economic and Social Affairs; Population Devision, 2002, WORLD POP AG 1950 20, P1; The World Health Organization, 1995, PREV CHRON DIS VIT I, pvi; *US BUR LAB STAT, INFL CALC; Visscher TLS, 2006, OBESITY, V14, P2054, DOI 10.1038/oby.2006.240; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Webb P, 2010, P NATL ACAD SCI 1220, P1; Webber L, 2012, OBES REV, V13, P744, DOI 10.1111/j.1467-789X.2012.00999.x; Webber L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039589; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, HLTH STAT HLTH INF S; World Health Organization, BOD MASS IND BMI; World Health Organization, GLOB HLTH OBS DAT RE	49	60	63	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e68785	10.1371/journal.pone.0068785	http://dx.doi.org/10.1371/journal.pone.0068785			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	188UA	23874763	Green Published, Green Submitted, gold			2022-12-27	WOS:000322218800043
J	Sillanpaa, J; Chang, CY; Singh, KV; Montealegre, MC; Nallapareddy, SR; Harvey, BR; Hung, TT; Murray, BE				Sillanpaeae, Jouko; Chang, Chungyu; Singh, Kavindra V.; Montealegre, Maria Camila; Nallapareddy, Sreedhar R.; Harvey, Barrett R.; Hung Ton-That; Murray, Barbara E.			Contribution of Individual Ebp Pilus Subunits of Enterococcus faecalis OG1RF to Pilus Biogenesis, Biofilm Formation and Urinary Tract Infection	PLOS ONE			English	Article							RELATIVE CONTRIBUTIONS; COLLAGEN ADHESIN; BINDING PROTEIN; GENE-EXPRESSION; SURFACE DISPLAY; MURINE MODEL; ENDOCARDITIS; SORTASE; ADHERENCE; LOCUS	The endocarditis and biofilm-associated pilus (Ebp) operon is a component of the core genome of Enterococcus faecalis that has been shown to be important for biofilm formation, adherence to host fibrinogen, collagen and platelets, and in experimental endocarditis and urinary tract infection models. Here, we created single and double deletion mutants of the pilus subunits and sortases; next, by combining western blotting, immunoelectron microscopy, and using ebpR in trans to increase pilus production, we identified EbpA as the tip pilin and EbpB as anchor at the pilus base, the latter attached to cell wall by the housekeeping sortase, SrtA. We also confirmed EbpC and Bps as the major pilin and pilin-specific sortase, respectively, both required for pilus polymerization. Interestingly, pilus length was increased and the number of pili decreased by deleting ebpA, while control overexpression of ebpA in trans restored wild-type levels, suggesting a dual role for EbpA in both initiation and termination of pilus polymerization. We next investigated the contribution of each pilin subunit to biofilm formation and UTI. Significant reduction in biofilm formation was observed with deletion of ebpA or ebpC (P<0.001) while ebpB was found to be dispensable; a similar result was seen in kidney CFUs in experimental UTI (Delta ebpA, Delta ebpC, P <= 0.0093; Delta ebpB, non-significant, each vs. OG1RF). Hence, our data provide important structural and functional information about these ubiquitous E. faecalis pili and, based on their demonstrated importance in biofilm and infection, suggest EbpA and EbpC as potential targets for antibody-based therapeutic approaches.	[Sillanpaeae, Jouko; Singh, Kavindra V.; Montealegre, Maria Camila; Nallapareddy, Sreedhar R.; Harvey, Barrett R.; Murray, Barbara E.] Univ Texas Houston, Sch Med, Dept Internal Med, Div Infect Dis, Houston, TX 77030 USA; [Sillanpaeae, Jouko; Singh, Kavindra V.; Montealegre, Maria Camila; Nallapareddy, Sreedhar R.; Harvey, Barrett R.; Murray, Barbara E.] Univ Texas Houston, Sch Med, Ctr Study Emerging & Reemerging Pathogens, Houston, TX USA; [Chang, Chungyu; Montealegre, Maria Camila; Harvey, Barrett R.; Hung Ton-That; Murray, Barbara E.] Univ Texas Houston, Sch Med, Dept Microbiol & Mol Genet, Houston, TX USA; [Harvey, Barrett R.] Univ Texas Houston, Sch Med, Brown Fdn Inst Mol Med Prevent Human Dis, Ctr Immunol & Autoimmune Dis, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Murray, BE (corresponding author), Univ Texas Houston, Sch Med, Dept Internal Med, Div Infect Dis, Houston, TX 77030 USA.	bem.asst@uth.tmc.edu	Ton-That, Hung/AAB-6155-2020	Montealegre, Maria Camila/0000-0001-9639-9690; Ton-That, Hung/0000-0003-1611-0469	National Institutes of Health from the National Institute of Allergy and Infectious Diseases, NIAID [R01 AI047923, R56 AI061381]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047923, R56AI061381] Funding Source: NIH RePORTER	National Institutes of Health from the National Institute of Allergy and Infectious Diseases, NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants R01 AI047923 to BEM and R56 AI061381 to HTT from the National Institute of Allergy and Infectious Diseases, NIAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; Bourgogne A, 2006, J BACTERIOL, V188, P2875, DOI 10.1128/JB.188.8.2875-2884.2006; Bourgogne A, 2007, J BACTERIOL, V189, P6490, DOI 10.1128/JB.00594-07; Bourgogne A, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-17; Bryan EM, 2000, PLASMID, V44, P183, DOI 10.1006/plas.2000.1484; Budzik JM, 2007, MOL MICROBIOL, V66, P495, DOI 10.1111/j.1365-2958.2007.05939.x; Carniol K, 2004, J BACTERIOL, V186, P8161, DOI 10.1128/JB.186.24.8161-8163.2004; Chang CY, 2011, MOL MICROBIOL, V79, P1236, DOI 10.1111/j.1365-2958.2010.07515.x; Comfort D, 2004, INFECT IMMUN, V72, P2710, DOI 10.1128/IAI.72.5.2710-2722.2004; Dramsi S, 2005, RES MICROBIOL, V156, P289, DOI 10.1016/j.resmic.2004.10.011; Gao P, 2010, J BACTERIOL, V192, P5489, DOI 10.1128/JB.00725-10; Hussain M, 1999, INFECT IMMUN, V67, P6688; Huycke MM, 1998, EMERG INFECT DIS, V4, P239, DOI 10.3201/eid0402.980211; Izore T, 2010, STRUCTURE, V18, P106, DOI 10.1016/j.str.2009.10.019; Kemp KD, 2007, INFECT IMMUN, V75, P5399, DOI 10.1128/IAI.00663-07; Kline KA, 2009, J BACTERIOL, V191, P3237, DOI 10.1128/JB.01837-08; Konto-Ghiorghi Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000422; Kristich CJ, 2007, PLASMID, V57, P131, DOI 10.1016/j.plasmid.2006.08.003; Lalioui L, 2005, INFECT IMMUN, V73, P3342, DOI 10.1128/IAI.73.6.3342-3350.2005; LeMieux J, 2008, J BACTERIOL, V190, P6002, DOI 10.1128/JB.00379-08; Linke C, 2010, J BIOL CHEM, V285, P20381, DOI 10.1074/jbc.M109.089680; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mandlik A, 2008, P NATL ACAD SCI USA, V105, P14147, DOI 10.1073/pnas.0806350105; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Mandlik A, 2007, MOL MICROBIOL, V64, P111, DOI 10.1111/j.1365-2958.2007.05630.x; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; MCGAVIN MH, 1993, INFECT IMMUN, V61, P2479, DOI 10.1128/IAI.61.6.2479-2485.1993; Mishra A, 2010, MOL MICROBIOL, V77, P841, DOI 10.1111/j.1365-2958.2010.07252.x; Mohamed JA, 2004, INFECT IMMUN, V72, P3658, DOI 10.1128/IAI.72.6.3658-3663.2004; MURRAY BE, 1990, CLIN MICROBIOL REV, V3, P46, DOI 10.1128/CMR.3.1.46-65.1990; Nallapareddy SR, 2006, J CLIN INVEST, V116, P2799, DOI 10.1172/JCI29021; Nallapareddy SR, 2006, INFECT IMMUN, V74, P4982, DOI 10.1128/IAI.00476-06; Nallapareddy SR, 2011, INFECT IMMUN, V79, P2901, DOI 10.1128/IAI.00038-11; Nallapareddy SR, 2011, INFECT IMMUN, V79, P2911, DOI 10.1128/IAI.00039-11; Nielsen HV, 2012, MBIO, V3, DOI 10.1128/mBio.00177-12; Nobbs AH, 2008, INFECT IMMUN, V76, P3550, DOI 10.1128/IAI.01613-07; Okura M, 2011, J BACTERIOL, V193, P822, DOI 10.1128/JB.01555-09; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Pinkston KL, 2011, J BACTERIOL, V193, P4317, DOI 10.1128/JB.05026-11; Qin X, 2000, INFECT IMMUN, V68, P2579, DOI 10.1128/IAI.68.5.2579-2586.2000; Rinaudo CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009216; Rosch JW, 2005, MOL MICROBIOL, V58, P959, DOI 10.1111/j.1365-2958.2005.04887.x; Sillanpaa J, 2004, MICROBIOL-SGM, V150, P2069, DOI 10.1099/mic.0.27074-0; Sillanpaa J, 2010, VIRULENCE, V1, P236, DOI 10.4161/viru.1.4.11966; Sillapaa J, 2008, MICROBIOL-SGM, V154, P3199, DOI 10.1099/mic.0.2008/017319-0; Singh KV, 2007, J INFECT DIS, V195, P1671, DOI 10.1086/517524; Smith WD, 2010, J BACTERIOL, V192, P4651, DOI 10.1128/JB.00071-10; Stoll H, 2005, INFECT IMMUN, V73, P2411, DOI 10.1128/IAI.73.4.2411-2423.2005; Swaminathan A, 2007, MOL MICROBIOL, V66, P961, DOI 10.1111/j.1365-2958.2007.05968.x; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Tendolkar PM, 2006, J BACTERIOL, V188, P2063, DOI 10.1128/JB.188.6.2063-2072.2006; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; Ton-That H, 2004, TRENDS MICROBIOL, V12, P228, DOI 10.1016/j.tim.2004.03.004; Vengadesan K, 2011, J MOL BIOL, V407, P731, DOI 10.1016/j.jmb.2011.02.024; Wu C, 2011, J BACTERIOL, V193, P3197, DOI 10.1128/JB.00173-11; YACOUB A, 1994, EUR J BIOCHEM, V222, P919, DOI 10.1111/j.1432-1033.1994.tb18940.x	56	49	53	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e68813	10.1371/journal.pone.0068813	http://dx.doi.org/10.1371/journal.pone.0068813			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874774	Green Submitted, Green Published, gold			2022-12-27	WOS:000322218800046
J	Chen, RD; Wang, Z				Chen, Rongda; Wang, Ze			Curve Fitting of the Corporate Recovery Rates: The Comparison of Beta Distribution Estimation and Kernel Density Estimation	PLOS ONE			English	Article								Recovery rate is essential to the estimation of the portfolio's loss and economic capital. Neglecting the randomness of the distribution of recovery rate may underestimate the risk. The study introduces two kinds of models of distribution, Beta distribution estimation and kernel density distribution estimation, to simulate the distribution of recovery rates of corporate loans and bonds. As is known, models based on Beta distribution are common in daily usage, such as CreditMetrics by J.P. Morgan, Portfolio Manager by KMV and Losscalc by Moody's. However, it has a fatal defect that it can't fit the bimodal or multimodal distributions such as recovery rates of corporate loans and bonds as Moody's new data show. In order to overcome this flaw, the kernel density estimation is introduced and we compare the simulation results by histogram, Beta distribution estimation and kernel density estimation to reach the conclusion that the Gaussian kernel density distribution really better imitates the distribution of the bimodal or multimodal data samples of corporate loans and bonds. Finally, a Chi-square test of the Gaussian kernel density estimation proves that it can fit the curve of recovery rates of loans and bonds. So using the kernel density distribution to precisely delineate the bimodal recovery rates of bonds is optimal in credit risk management.	[Chen, Rongda; Wang, Ze] Zhejiang Univ Finance & Econ, Sch Finance, Hangzhou, Zhejiang, Peoples R China; [Chen, Rongda] Zhejiang Univ Finance & Econ, Coordinated Innovat Ctr Wealth Management & Quant, Hangzhou, Zhejiang, Peoples R China; [Chen, Rongda] Ctr Res Regulat & Policy Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China	Zhejiang University of Finance & Economics; Zhejiang University of Finance & Economics	Chen, RD (corresponding author), Zhejiang Univ Finance & Econ, Sch Finance, Hangzhou, Zhejiang, Peoples R China.	rongdachen@163.com			National Natural Science Foundation of China [71171176]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (Gant No. 71171176). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen Leif., 2004, J CREDIT RISK, V1, P29, DOI [DOI 10.21314/JCR.2005.003, 10.21314/JCR.2005.003]; Arnaud DS, 2004, MEASURING MANAGING C; Chen MZ, 2011, J APPL STAT MANAGEME, V30, P810; Dullmann K, 2004, SYSTEMATIC RISK RECO; Frye J., 2000, RISK, V13, P108; Hazelton ML, 1999, J STAT PLAN INFER, V77, P37, DOI 10.1016/S0378-3758(98)00170-0; Hu Y. -T, 2002, WORKING PAPER; Liu HZ, 2010, WORLD EC PAPER, V2, P46; Martinez-Camblor P, 2008, J STAT PLAN INFER, V138, P4006, DOI 10.1016/j.jspi.2008.02.008; Mugdadi AR, 2004, COMPUT STAT DATA AN, V47, P49, DOI 10.1016/j.csda.2003.10.013; Pykthin Michael., 2003, RISK, V16, P74; Qu WJ, 2011, J SHENGYANG AGR U, V9, P468; Rosch D., 2005, J FIXED INCOME, V15, P63, DOI DOI 10.3905/IFI.2005.591810; Sharon O, 2011, CORPORATE DEFAULT RE, P18; Sharon O, 2012, CORPORATE DEFAULT RE, P23; Shi Z.L., 2009, EC SURVEY, V4, P60; Su JM, 2004, APPL MATLAB TOOL KIT; Wang GD, 2011, CHINESE J MANAGEMENT, V6, P10; Zhen ZY, 2011, STAT DECISION, V9, P22	19	6	6	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68238	10.1371/journal.pone.0068238	http://dx.doi.org/10.1371/journal.pone.0068238			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874558	gold, Green Submitted, Green Published			2022-12-27	WOS:000321765300035
J	Kimura, A; Wada, Y; Masuda, T; Goto, S; Tsuzuki, D; Hibino, H; Cai, DS; Dan, I				Kimura, Atsushi; Wada, Yuji; Masuda, Tomohiro; Goto, Sho-ichi; Tsuzuki, Daisuke; Hibino, Haruo; Cai, Dongsheng; Dan, Ippeita			Memory Color Effect Induced by Familiarity of Brand Logos	PLOS ONE			English	Article							ACTIVATION	Background: When people are asked to adjust the color of familiar objects such as fruits until they appear achromatic, the subjective gray points of the objects are shifted away from the physical gray points in a direction opposite to the memory color (memory color effect). It is still unclear whether the discrepancy between memorized and actual colors of objects is dependent on the familiarity of the objects. Here, we conducted two experiments in order to examine the relationship between the degree of a subject's familiarity with objects and the degree of the memory color effect by using logographs of food and beverage companies. Methods and Findings: In Experiment 1, we measured the memory color effects of logos which varied in terms of their familiarity (high, middle, or low). Results demonstrate that the memory color effect occurs only in the high-familiarity condition, but not in the middle-and low-familiarity conditions. Furthermore, there is a positive correlation between the memory color effect and the actual number of domestic stores of the brand. In Experiment 2, we assessed the semantic association between logos and food/beverage names by using a semantic priming task to elucidate whether the memory color effect of logos relates to consumer brand cognition, and found that the semantic associations between logos and food/beverage names in the high-familiarity brands were stronger than those in the low-familiarity brands only when the logos were colored correctly, but not when they were appropriately or inappropriately colored, or achromatic. Conclusion: The current results provide behavioral evidence of the relationship between the familiarity of objects and the memory color effect and suggest that the memory color effect increases with the familiarity of objects, albeit not constantly.	[Kimura, Atsushi] Tokyo Denki Univ, Dept Informat Environm, Chiba, Japan; [Wada, Yuji; Masuda, Tomohiro; Goto, Sho-ichi] Natl Food Res Inst, Sensory & Cognit Food Sci Lab, Tsukuba, Ibaraki 305, Japan; [Tsuzuki, Daisuke; Dan, Ippeita] Chuo Univ, Fac Sci & Engn, Bunkyo Ku, Tokyo 112, Japan; [Hibino, Haruo] Chiba Univ, Grad Sch Engn, Chiba, Japan; [Cai, Dongsheng] Univ Tsukuba, Grad Sch Syst & Informat Engn, Tsukuba, Ibaraki, Japan	Tokyo Denki University; National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan; Chuo University; Chiba University; University of Tsukuba	Wada, Y (corresponding author), Natl Food Res Inst, Sensory & Cognit Food Sci Lab, 2-1-2 Kannondai, Tsukuba, Ibaraki 305, Japan.	yujiwd@affrc.go.jp			Japan Society for Promotion of Science [22300072, 22700775, 23730718]; Grants-in-Aid for Scientific Research [23650040] Funding Source: KAKEN	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work is supported in part by Grant-in-Aid for Scientific Research (B) from the Japan Society for Promotion of Science 22300072 awarded to H. H. and Y.W., and by Grant-in-Aid for Young Scientists (B) from the Japan Society for Promotion of Science 22700775 awarded to A. K., and 23730718 awarded to Y.W (http://www.jsps.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GK, 1923, AM J PSYCHOL, V34, P359, DOI 10.2307/1413955; Amodio DM, 2011, CURR DIR PSYCHOL SCI, V20, P143, DOI 10.1177/0963721411408562; BARTLESON CJ, 1960, J OPT SOC AM, V50, P73, DOI 10.1364/JOSA.50.000073; BEAUVOIS MF, 1982, PHILOS T R SOC B, V298, P35, DOI 10.1098/rstb.1982.0070; COLLINS AM, 1975, PSYCHOL REV, V82, P407, DOI 10.1037/0033-295X.82.6.407; DAVIDOFF J, 1993, COGNITION, V48, P121, DOI 10.1016/0010-0277(93)90027-S; FAZIO RH, 1986, J PERS SOC PSYCHOL, V50, P229, DOI 10.1037/0022-3514.50.2.229; Gleason TR, 2004, COGNITIVE DEV, V19, P1, DOI 10.1016/S0885-2014(03)00044-3; Hansen T, 2006, NAT NEUROSCI, V9, P1367, DOI 10.1038/nn1794; Hering E, 1964, OUTLINES THEORY LIGH, V1878; Ishihara S, 1951, TESTS COLOR BLINDNES; Kimura A, 2012, APPETITE, V58, P940, DOI 10.1016/j.appet.2012.02.013; Kimura A, 2009, APPETITE, V52, P521, DOI 10.1016/j.appet.2008.11.002; Kitaoka A., 2010, COLOUR DESIGN CREATI, V5, P1; Kohli CS, 2005, J BUS RES, V58, P1506, DOI 10.1016/j.jbusres.2004.07.007; Mitchell P, 1996, BRIT J DEV PSYCHOL, V14, P339, DOI 10.1111/j.2044-835X.1996.tb00710.x; NEWHALL SM, 1957, J OPT SOC AM, V47, P43, DOI 10.1364/JOSA.47.000043; Olkkonen M, 2008, J VISION, V8, DOI [10.1167/8.5.13, 10.1167/8.8.8]; Perez-Carpinell J, 1998, COLOR RES APPL, V23, P416, DOI 10.1002/(SICI)1520-6378(199812)23:6<416::AID-COL10>3.0.CO;2-N	19	10	10	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68474	10.1371/journal.pone.0068474	http://dx.doi.org/10.1371/journal.pone.0068474			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	182SU	23874638	gold, Green Submitted, Green Published			2022-12-27	WOS:000321765300050
J	Gottfried, E; Lang, SA; Renner, K; Bosserhoff, A; Gronwald, W; Rehli, M; Einhell, S; Gedig, I; Singer, K; Seilbeck, A; Mackensen, A; Grauer, O; Hau, P; Dettmer, K; Andreesen, R; Oefner, PJ; Kreutz, M				Gottfried, Eva; Lang, Sven A.; Renner, Kathrin; Bosserhoff, Anja; Gronwald, Wolfram; Rehli, Michael; Einhell, Sabine; Gedig, Isabel; Singer, Katrin; Seilbeck, Anton; Mackensen, Andreas; Grauer, Oliver; Hau, Peter; Dettmer, Katja; Andreesen, Reinhard; Oefner, Peter J.; Kreutz, Marina			New Aspects of an Old Drug - Diclofenac Targets MYC and Glucose Metabolism in Tumor Cells	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; COLON-CANCER CELLS; C-MYC; IN-VIVO; MONOCARBOXYLATE TRANSPORTERS; MALIGNANT-MELANOMA; INDUCED APOPTOSIS; INDUCE APOPTOSIS; SALICYLIC-ACID; GROWTH	Non-steroidal anti-inflammatory drugs such as diclofenac exhibit potent anticancer effects. Up to now these effects were mainly attributed to its classical role as COX-inhibitor. Here we show novel COX-independent effects of diclofenac. Diclofenac significantly diminished MYC expression and modulated glucose metabolism resulting in impaired melanoma, leukemia, and carcinoma cell line proliferation in vitro and reduced melanoma growth in vivo. In contrast, the non-selective COX inhibitor aspirin and the COX-2 specific inhibitor NS-398 had no effect on MYC expression and glucose metabolism. Diclofenac significantly decreased glucose transporter 1 (GLUT1), lactate dehydrogenase A (LDHA), and monocarboxylate transporter 1 (MCT1) gene expression in line with a decrease in glucose uptake and lactate secretion. A significant intracellular accumulation of lactate by diclofenac preceded the observed effect on gene expression, suggesting a direct inhibitory effect of diclofenac on lactate efflux. While intracellular lactate accumulation impairs cellular proliferation and gene expression, it does not inhibit MYC expression as evidenced by the lack of MYC regulation by the MCT inhibitor alpha-cyano-4-hydroxycinnamic acid. Finally, in a cell line with a tetracycline-regulated c-MYC gene, diclofenac decreased proliferation both in the presence and absence of c-MYC. Thus, diclofenac targets tumor cell proliferation via two mechanisms, that is inhibition of MYC and lactate transport. Based on these results, diclofenac holds potential as a clinically applicable MYC and glycolysis inhibitor supporting established tumor therapies.	[Gottfried, Eva; Renner, Kathrin; Rehli, Michael; Einhell, Sabine; Gedig, Isabel; Singer, Katrin; Seilbeck, Anton; Andreesen, Reinhard; Kreutz, Marina] Univ Regensburg, Dept Hematol & Oncol, D-93053 Regensburg, Germany; [Gottfried, Eva; Renner, Kathrin; Rehli, Michael; Andreesen, Reinhard; Kreutz, Marina] Univ Regensburg, Regensburg Ctr Intervent Immunol RCI, D-93053 Regensburg, Germany; [Lang, Sven A.] Univ Regensburg, Dept Surg, D-93053 Regensburg, Germany; [Bosserhoff, Anja] Univ Regensburg, Inst Pathol, D-93053 Regensburg, Germany; [Gronwald, Wolfram; Dettmer, Katja; Oefner, Peter J.] Univ Regensburg, Inst Funct Genom, D-93053 Regensburg, Germany; [Mackensen, Andreas] Univ Erlangen Nurnberg, Dept Internal Med 5, D-91054 Erlangen, Germany; [Grauer, Oliver] Univ Munster, Dept Neurol, D-48149 Munster, Germany; [Grauer, Oliver; Hau, Peter] Univ Regensburg, Dept Neurol, D-93053 Regensburg, Germany; [Hau, Peter] Univ Regensburg, Wilhelm Sander NeuroOncol Unit, D-93053 Regensburg, Germany	University of Regensburg; University of Regensburg; University of Regensburg; University of Regensburg; University of Regensburg; University of Erlangen Nuremberg; University of Munster; University of Regensburg; University of Regensburg	Kreutz, M (corresponding author), Univ Regensburg, Dept Hematol & Oncol, D-93053 Regensburg, Germany.	marina.kreutz@ukr.de	Bosserhoff, Anja/GNH-4801-2022; Renner, Kathrin/H-3211-2013; Dettmer, Katja/D-6218-2018; Dettmer, Katja/N-4562-2016; Rehli, Michael/E-9093-2011	Dettmer, Katja/0000-0001-7337-2380; Dettmer, Katja/0000-0001-7337-2380; Rehli, Michael/0000-0003-3992-932X; Hau, Peter/0000-0003-3894-5053; Bosserhoff, Anja/0000-0001-8147-394X; Renner, Kathrin/0000-0002-7116-1368	Deutsche Forschungsgemeinschaft [Krm-1418/7-1]; BayGene; ReForm-C program	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BayGene; ReForm-C program	This project was supported in part by the Deutsche Forschungsgemeinschaft (Krm-1418/7-1), BayGene, and by intra-mural funding (ReForm-C program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates SE, 2012, CLIN CANCER RES, V18, P5536, DOI 10.1158/1078-0432.CCR-12-2884; Blank C, 2004, CANCER RES, V64, P1140, DOI 10.1158/0008-5472.CAN-03-3259; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Braun FK, 2012, J INVEST DERMATOL, V132, P429, DOI 10.1038/jid.2011.316; Burns P. A., 2003, Angiogenesis, V6, P73, DOI 10.1023/A:1025862731653; CAY O, 1992, CANCER RES, V52, P5794; Cha YI, 2007, ANNU REV MED, V58, P239, DOI 10.1146/annurev.med.57.121304.131253; Chen X, 2006, CANCER RES, V66, P11323, DOI 10.1158/0008-5472.CAN-06-1536; Chirasani SR, 2013, INT J CANCER, V132, P843, DOI 10.1002/ijc.27712; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dang CV, 2008, NAT REV CANCER, V8, P51, DOI 10.1038/nrc2274; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Deora AA, 2005, P NATL ACAD SCI USA, V102, P16245, DOI 10.1073/pnas.0504419102; Dettmer K, 2011, ANAL BIOANAL CHEM, V399, P1127, DOI 10.1007/s00216-010-4425-x; Dettmer K, 2010, ELECTROPHORESIS, V31, P2365, DOI 10.1002/elps.200900778; Elwood PC, 2009, LANCET, V373, P1301, DOI 10.1016/S0140-6736(09)60243-9; Emoto A, 2002, AM J PHYSIOL-CELL PH, V282, pC1064, DOI 10.1152/ajpcell.00179.2001; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Felsher Dean W, 2010, Genes Cancer, V1, P597, DOI 10.1177/1947601910377798; Geschwind JFH, 2002, CANCER RES, V62, P3909; Gronwald W, 2008, ANAL CHEM, V80, P9288, DOI 10.1021/ac801627c; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; HALESTRAP AP, 1975, BIOCHEM J, V148, P85, DOI 10.1042/bj1480085; Hanif R, 1996, BIOCHEM PHARMACOL, V52, P237, DOI 10.1016/0006-2952(96)00181-5; Hirschhaeuser F, 2011, CANCER RES, V71, P6921, DOI 10.1158/0008-5472.CAN-11-1457; HIXSON LJ, 1994, CANCER EPIDEM BIOMAR, V3, P433; Hoferova Z, 2002, CANCER INVEST, V20, P490, DOI 10.1081/CNV-120002149; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; Johnsen JI, 2004, CANCER RES, V64, P7210, DOI 10.1158/0008-5472.CAN-04-1795; Kaelin WG, 2010, NATURE, V465, P562, DOI 10.1038/465562a; Kaur J, 2010, J ENVIRON PATHOL TOX, V29, P41, DOI 10.1615/JEnvironPatholToxicolOncol.v29.i1.70; Lafrance JP, 2009, PHARMACOEPIDEM DR S, V18, P923, DOI 10.1002/pds.1798; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Le Floch R, 2011, P NATL ACAD SCI USA, V108, P16663, DOI 10.1073/pnas.1106123108; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Maschek G, 2004, CANCER RES, V64, P31, DOI 10.1158/0008-5472.CAN-03-3294; Mathupala SP, 2004, NEUROSURGERY, V55, P1410, DOI 10.1227/01.NEU.0000143034.62913.59; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Mayorek N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012715; Miller DM, 2012, CLIN CANCER RES, V18, P5546, DOI 10.1158/1078-0432.CCR-12-0977; Moody TW, 2010, LUNG CANCER, V68, P154, DOI 10.1016/j.lungcan.2009.06.012; Moreno-Sanchez R, 1999, BIOCHEM PHARMACOL, V57, P743, DOI 10.1016/S0006-2952(98)00330-X; Neuhoff S, 2005, EUR J PHARM SCI, V25, P211, DOI 10.1016/j.ejps.2005.02.009; OUELLETTE GS, 1991, J CLIN GASTROENTEROL, V13, P205, DOI 10.1097/00004836-199104000-00018; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Perez-Gutthann S, 1999, PHARMACOTHERAPY, V19, P854, DOI 10.1592/phco.19.10.854.31550; Rattigan YL, 2012, EXP CELL RES, V318, P326, DOI 10.1016/j.yexcr.2011.11.014; Rothhammer T, 2005, CANCER RES, V65, P448; Savino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022284; Semenza GL, 2008, J CLIN INVEST, V118, P3835, DOI 10.1172/JCI37373; Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658; Soucek L, 2002, CANCER RES, V62, P3507; Spitz GA, 2009, BIOCHEM PHARMACOL, V77, P46, DOI 10.1016/j.bcp.2008.09.020; Staege MS, 2002, P NATL ACAD SCI USA, V99, P4550, DOI 10.1073/pnas.072495599; TAMAI I, 1995, BIOCHEM BIOPH RES CO, V214, P482, DOI 10.1006/bbrc.1995.2312; Vellonen KS, 2010, EUR J PHARM SCI, V39, P241, DOI 10.1016/j.ejps.2009.12.006; Walenta S, 2000, CANCER RES, V60, P916; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229; Yustein JT, 2010, P NATL ACAD SCI USA, V107, P3534, DOI 10.1073/pnas.0901230107; Zhang C, 2011, P NATL ACAD SCI USA, V108, P16259, DOI 10.1073/pnas.1113884108; Zhou H, 2010, CANCER CELL, V17, P560, DOI 10.1016/j.ccr.2010.04.023; Zhu GH, 1999, BRIT J CANCER, V79, P393, DOI 10.1038/sj.bjc.6690062; Zhuang LQ, 2007, MODERN PATHOL, V20, P416, DOI 10.1038/modpathol.3800750	65	63	67	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e66987	10.1371/journal.pone.0066987	http://dx.doi.org/10.1371/journal.pone.0066987			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874405	Green Published, Green Submitted, gold			2022-12-27	WOS:000321736900007
J	Lin, YT; Jan, FJ; Lin, CW; Chung, CH; Chen, JC; Yeh, SD; Ku, HM				Lin, Yu-Tsung; Jan, Fuh-Jyh; Lin, Chia-Wei; Chung, Chien-Hung; Chen, Jo-Chu; Yeh, Shy-Dong; Ku, Hsin-Mei			Differential Gene Expression in Response to Papaya ringspot virus Infection in Cucumis metuliferus Using cDNA- Amplified Fragment Length Polymorphism Analysis	PLOS ONE			English	Article							CYSTEINE PROTEINASE-INHIBITORS; DISEASE-RESISTANCE; PLANT DEFENSE; COAT PROTEIN; RAN GTPASE; CELL-DEATH; HSP90; MECHANISMS; STRAINS; ACID	A better understanding of virus resistance mechanisms can offer more effective strategies to control virus diseases. Papaya ringspot virus (PRSV), Potyviridae, causes severe economical losses in papaya and cucurbit production worldwide. However, no resistance gene against PRSV has been identified to date. This study aimed to identify candidate PRSV resistance genes using cDNA-AFLP analysis and offered an open architecture and transcriptomic method to study those transcripts differentially expressed after virus inoculation. The whole genome expression profile of Cucumis metuliferus inoculated with PRSV was generated using cDNA-amplified fragment length polymorphism (cDNA-AFLP) method. Transcript derived fragments (TDFs) identified from the resistant line PI 292190 may represent genes involved in the mechanism of PRSV resistance. C. metuliferus susceptible Acc. 2459 and resistant PI 292190 lines were inoculated with PRSV and subsequently total RNA was isolated for cDNA-AFLP analysis. More than 400 TDFs were expressed specifically in resistant line PI 292190. A total of 116 TDFs were cloned and their expression patterns and putative functions in the PRSV-resistance mechanism were further characterized. Subsequently, 28 out of 116 candidates which showed two-fold higher expression levels in resistant PI 292190 than those in susceptible Acc. 2459 after virus inoculation were selected from the reverse northern blot and bioinformatic analysis. Furthermore, the time point expression profiles of these candidates by northern blot analysis suggested that they might play roles in resistance against PRSV and could potentially provide valuable information for controlling PRSV disease in the future.	[Lin, Yu-Tsung; Lin, Chia-Wei; Chung, Chien-Hung; Chen, Jo-Chu; Ku, Hsin-Mei] Natl Chung Hsing Univ, Dept Agron, Taichung 40227, Taiwan; [Jan, Fuh-Jyh; Yeh, Shy-Dong] Natl Chung Hsing Univ, Dept Plant Pathol, Taichung 40227, Taiwan	National Chung Hsing University; National Chung Hsing University	Ku, HM (corresponding author), Natl Chung Hsing Univ, Dept Agron, Taichung 40227, Taiwan.	hmku@email.nchu.edu.tw	Jan, Fuh-Jyh/Y-1781-2019	Ku, Hsin-Mei/0000-0002-8952-1923	National Science Council in Taiwan [NSC 99-2313-B-005-016-MY3]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the grant (NSC 99-2313-B-005-016-MY3) from National Science Council in Taiwan (web site for NSC in Taiwan http://web1.nsc.gov.tw/mp.aspx?mp = 7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachem CWB, 1998, PLANT MOL BIOL REP, V16, P157, DOI 10.1023/A:1007468801806; Baebler S, 2009, MOL PLANT PATHOL, V10, P263, DOI 10.1111/j.1364-3703.2008.00530.x; Bau HJ, 2003, PHYTOPATHOLOGY, V93, P112, DOI 10.1094/PHYTO.2003.93.1.112; Bendahmane A, 1995, PLANT J, V8, P933, DOI 10.1046/j.1365-313X.1995.8060933.x; Bolton MD, 2009, MOL PLANT MICROBE IN, V22, P487, DOI 10.1094/MPMI-22-5-0487; Boter M, 2007, PLANT CELL, V19, P3791, DOI 10.1105/tpc.107.050427; Chen ZX, 2009, PLANT SIGNAL BEHAV, V4, P493, DOI 10.4161/psb.4.6.8392; Chiang CH, 2001, J GEN VIROL, V82, P2827, DOI 10.1099/0022-1317-82-11-2827; Clarke PR, 2001, TRENDS CELL BIOL, V11, P366, DOI 10.1016/S0962-8924(01)02071-2; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; CONOVER RA, 1986, HORTSCIENCE, V21, P1072; D'Ovidio R, 2004, BBA-PROTEINS PROTEOM, V1696, P237, DOI 10.1016/j.bbapap.2003.08.012; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; De Leo F, 2002, NUCLEIC ACIDS RES, V30, P347, DOI 10.1093/nar/30.1.347; Dillon S, 2006, THEOR APPL GENET, V113, P1159, DOI 10.1007/s00122-006-0375-2; Erickson FL, 1999, PLANT J, V18, P67, DOI 10.1046/j.1365-313X.1999.00426.x; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; Fermin G. A., 2010, TRANSGENIC PLANT J, V4, P1; FLOR HH, 1956, ADV GENET, V8, P29, DOI 10.1016/S0065-2660(08)60498-8; Fukumura R, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng094; GARCIA JA, 1993, PLANT MOL BIOL, V22, P697, DOI 10.1007/BF00047410; Gholizadeh A, 2005, BIOTECHNOL APPL BIOC, V42, P197, DOI 10.1042/BA20050029; Gutierrez-Campos R, 1999, NAT BIOTECHNOL, V17, P1223, DOI 10.1038/70781; Gyetvai G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031526; Hamberg M, 2003, J BIOL CHEM, V278, P51796, DOI 10.1074/jbc.M310514200; HammondKosack KE, 1996, PLANT CELL, V8, P1773, DOI 10.1105/tpc.8.10.1773; Helliwell C, 2003, METHODS, V30, P289, DOI 10.1016/S1046-2023(03)00036-7; Hoelz A, 2004, NATURE, V432, P815, DOI 10.1038/432815a; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Hubert DA, 2003, EMBO J, V22, P5679, DOI 10.1093/emboj/cdg547; Huma Habib, 2007, Biotechnology and Molecular Biology Reviews, V2, P068; Iakimova Elena T., 2005, Journal of Fruit and Ornamental Plant Research, V13, P135; Jansen C, 2005, PLANT SCI, V168, P373, DOI 10.1016/j.plantsci.2004.08.011; Koiwa H, 1997, TRENDS PLANT SCI, V2, P379, DOI 10.1016/S1360-1385(97)90052-2; Li DY, 2008, J EXP BOT, V59, P2133, DOI 10.1093/jxb/ern072; Lin YT, 2011, HORTSCIENCE, V46, P616, DOI 10.21273/HORTSCI.46.4.616; Liu YL, 2004, J BIOL CHEM, V279, P2101, DOI 10.1074/jbc.M310029200; Lu R, 2003, EMBO J, V22, P5690, DOI 10.1093/emboj/cdg546; Meier I, 2011, CURR OPIN PLANT BIOL, V14, P538, DOI 10.1016/j.pbi.2011.06.005; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Moffett P, 2009, ADV VIRUS RES, V75, P1, DOI 10.1016/S0065-3527(09)07501-0; Mohnen D, 2008, CURR OPIN PLANT BIOL, V11, P266, DOI 10.1016/j.pbi.2008.03.006; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; NEILAN BA, 1994, BIOTECHNIQUES, V17, P708; Nersissian AM, 1998, PROTEIN SCI, V7, P1915, DOI 10.1002/pro.5560070907; Oh SK, 2006, PLANTA, V223, P1101, DOI 10.1007/s00425-006-0232-1; Owttrim GW, 2006, NUCLEIC ACIDS RES, V34, P3220, DOI 10.1093/nar/gkl408; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Parker A, 2001, J BIOL CHEM, V276, P5547, DOI 10.1074/jbc.M008463200; Picault N, 2002, J BIOL CHEM, V277, P24204, DOI 10.1074/jbc.M202702200; Pieterse CMJ, 2007, TRENDS PLANT SCI, V12, P564, DOI 10.1016/j.tplants.2007.09.004; PROVVIDENTI R, 1982, J HERED, V73, P239, DOI 10.1093/oxfordjournals.jhered.a109628; PROVVIDENTI R, 1977, J HERED, V68, P56, DOI 10.1093/oxfordjournals.jhered.a108774; Reijans M, 2003, GENOMICS, V82, P606, DOI 10.1016/S0888-7543(03)00179-4; Ren T, 2000, PLANT CELL, V12, P1917, DOI 10.1105/tpc.12.10.1917; Sambrook J, 2006, ISOLATION DNA FRAGME; Takahashi A, 2003, P NATL ACAD SCI USA, V100, P11777, DOI 10.1073/pnas.2033934100; Tameling WIL, 2007, PLANT CELL, V19, P1682, DOI 10.1105/tpc.107.050880; Tameling WIL, 2010, PLANT CELL, V22, P4176, DOI 10.1105/tpc.110.077461; Tao Y, 2003, PLANT CELL, V15, P317, DOI 10.1105/tpc.007591; Truniger V, 2009, ADV VIRUS RES, V75, P119, DOI 10.1016/S0065-3527(09)07504-6; van der Biezen EA, 1998, TRENDS BIOCHEM SCI, V23, P454, DOI 10.1016/S0968-0004(98)01311-5; Van der Vyver C, 2003, PLANT BIOTECHNOL J, V1, P101, DOI 10.1046/j.1467-7652.2003.00010.x; Vashisht AA, 2006, J PHOTOCH PHOTOBIO B, V84, P150, DOI 10.1016/j.jphotobiol.2006.02.010; Wang CH, 1997, ARCH VIROL, V142, P271, DOI 10.1007/s007050050076; Wen R, 2004, VIRUS RES, V105, P175, DOI 10.1016/j.virusres.2004.05.008; YEH SD, 1989, PHYTOPATHOLOGY, V79, P1257, DOI 10.1094/Phyto-79-1257; YEH SD, 1988, PLANT DIS, V72, P375, DOI 10.1094/PD-72-0375; YEH SD, 1992, J GEN VIROL, V73, P2531, DOI 10.1099/0022-1317-73-10-2531; Zhang XX, 2008, PLANT MOL BIOL, V68, P131, DOI 10.1007/s11103-008-9357-x	70	8	8	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68749	10.1371/journal.pone.0068749	http://dx.doi.org/10.1371/journal.pone.0068749			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874746	gold, Green Submitted, Green Published			2022-12-27	WOS:000321736900109
J	Vessieres, E; Guihot, AL; Toutain, B; Maquigneau, M; Fassot, C; Loufrani, L; Henrion, D				Vessieres, Emilie; Guihot, Anne-Laure; Toutain, Bertrand; Maquigneau, Maud; Fassot, Celine; Loufrani, Laurent; Henrion, Daniel			COX-2-Derived Prostanoids and Oxidative Stress Additionally Reduce Endothelium-Mediated Relaxation in Old Type 2 Diabetic Rats	PLOS ONE			English	Article							MESENTERIC RESISTANCE ARTERIES; NITRIC-OXIDE SYNTHASE; BLOOD-FLOW; ANGIOTENSIN-II; KEY ROLE; INDUCED CONTRACTION; METABOLIC SYNDROME; DYSFUNCTION; ACTIVATION; OBESITY	Endothelial dysfunction in resistance arteries alters end organ perfusion in type 2 diabetes. Superoxides and cyclooxygenase-2 (COX-2) derivatives have been shown separately to alter endothelium-mediated relaxation in aging and diabetes but their role in the alteration of vascular tone in old diabetic subjects is not clear, especially in resistance arteries. Consequently, we investigated the role of superoxide and COX-2-derivatives on endothelium-dependent relaxation in 3 and 12 month-old Zucker diabetic fatty (ZDF) and lean (LZ) rats. Mesenteric resistance arteries were isolated and vascular tone was investigated using wire-myography. Endothelium (acetylcholine)-dependent relaxation was lower in ZDF than in LZ rats (60 versus 84% maximal relaxation in young rats and 41 versus 69% in old rats). Blocking NO production with L-NAME was less efficient in old than in young rats. L-NAME had no effect in old ZDF rats although eNOS expression level in old ZDF rats was similar to that in old LZ rats. Superoxide level and NADPH-oxidase subunits (p67phox and gp91phox) expression level were greater in ZDF than in LZ rats and were further increased by aging in ZDF rats. In young ZDF rats reducing superoxide level with tempol restored acetylcholine-dependent relaxation to the level of LZ rats. In old ZDF rats tempol improved acetylcholine-dependent relaxation without increasing it to the level of LZ rats. COX-2 (immunolabelling and Western-blot) was present in arteries of ZDF rats and absent in LZ rats. In old ZDF rats arterial COX-2 level was higher than in young ZDF rats. COX-2 blockade with NS398 restored in part acetylcholine-dependent relaxation in arteries of old ZDF rats and the combination of tempol and NS398 fully restored relaxation in control (LZ rats) level. Accordingly, superoxide production and COX-2 derivatives together reduced endothelium-dependent relaxation in old ZDF rats whereas superoxides alone attenuated relaxation in young ZDF or old LZ rats.	[Vessieres, Emilie; Guihot, Anne-Laure; Toutain, Bertrand; Maquigneau, Maud; Fassot, Celine; Loufrani, Laurent; Henrion, Daniel] Univ Angers, Dept Integrated Neurovasc & Mitochondrial Biol, Angers, France; [Guihot, Anne-Laure; Loufrani, Laurent] CNRS, UMR 6214, Angers, France; [Fassot, Celine; Henrion, Daniel] INSERM, U1083, Angers, France; [Vessieres, Emilie; Henrion, Daniel] CHU Angers, Angers, France	Universite d'Angers; Centre National de la Recherche Scientifique (CNRS); Universite d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Henrion, D (corresponding author), Univ Angers, Dept Integrated Neurovasc & Mitochondrial Biol, Angers, France.	daniel.henrion@univ-angers.fr	Fassot, Celine/K-1494-2015; Henrion, Daniel/AAK-1995-2021; vessieres, emilie/K-1894-2015; Henrion, Daniel/N-7023-2015; Toutain, Bertrand/M-1982-2015; Henrion, Daniel/J-8141-2015; loufrani, laurent/K-1713-2015; Stefanadis, Christodoulos/ABH-2232-2020	Henrion, Daniel/0000-0003-1094-0285; Henrion, Daniel/0000-0003-1094-0285; Henrion, Daniel/0000-0003-1094-0285; Stefanadis, Christodoulos/0000-0001-5974-6454; Toutain, Bertrand/0000-0002-7571-4062	Foundation for Medical Research (FRM: Fondation pour la Recherche Medicale), Paris, France; Region Pays-de-la-Loire; Conseil General du Maine et Loire; Angers-Loire-Metropole	Foundation for Medical Research (FRM: Fondation pour la Recherche Medicale), Paris, France(Fondation pour la Recherche Medicale); Region Pays-de-la-Loire(Region Pays de la Loire); Conseil General du Maine et Loire(Region Pays de la Loire); Angers-Loire-Metropole(Region Pays de la Loire)	This work was supported in part by the Foundation for Medical Research (FRM: Fondation pour la Recherche Medicale), Paris, France; by the Region Pays-de-la-Loire; and by the Conseil General du Maine et Loire and by Angers-Loire-Metropole. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Baron-Menguy C, 2007, FASEB J, V21, P3511, DOI 10.1096/fj.06-7782com; Barton M, 2010, PFLUG ARCH EUR J PHY, V460, P825, DOI 10.1007/s00424-010-0860-y; Ben Driss A, 2000, CIRCULATION, V101, P2764, DOI 10.1161/01.CIR.101.23.2764; Bolla M, 2002, J VASC RES, V39, P353, DOI 10.1159/000065547; Bouvet C, 2007, HYPERTENSION, V50, P248, DOI 10.1161/HYPERTENSIONAHA.107.088716; Cosentino F, 1997, CIRCULATION, V96, P25; Cousin M, 2010, HYPERTENSION, V55, P109, DOI 10.1161/HYPERTENSIONAHA.108.127456; de Chantemele EJB, 2010, CARDIOVASC RES, V86, P516, DOI 10.1093/cvr/cvp411; De Chantemele EJ, 2009, MICROCIRCULATION, V16, P391, DOI 10.1080/10739680902816301; de Chantemele EJB, 2009, CARDIOVASC RES, V81, P788, DOI 10.1093/cvr/cvn334; Ding H, 2007, J CELL PHYSIOL, V212, P682, DOI 10.1002/jcp.21063; Doisaki M, 2010, BIOCHEM BIOPH RES CO, V393, P303, DOI 10.1016/j.bbrc.2010.02.004; Dowell FJ, 1996, J HYPERTENS, V14, P177, DOI 10.1097/00004872-199602000-00005; Dowell FJ, 1996, BRIT J PHARMACOL, V117, P341, DOI 10.1111/j.1476-5381.1996.tb15196.x; Dumont O, 2008, CARDIOVASC RES, V77, P600, DOI 10.1093/cvr/cvm055; Dumont O, 2007, ARTERIOSCL THROM VAS, V27, P317, DOI 10.1161/01.ATV.0000254684.80662.44; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; El-Remessy AB, 2010, EXP DIABETES RES, DOI 10.1155/2010/247861; Ford ES, 2005, DIABETES CARE, V28, P1769, DOI 10.2337/diacare.28.7.1769; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; Freidja ML, 2012, DIABETES, V61, P1562, DOI 10.2337/db11-0750; Freidja ML, 2011, HYPERTENSION, V58, P225, DOI 10.1161/HYPERTENSIONAHA.111.170266; Rodriguez LAG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016780; Gendron ME, 2007, AM J PHYSIOL-HEART C, V292, pH451, DOI 10.1152/ajpheart.00551.2006; Georgescu A, 2011, CLIN SCI, V120, P463, DOI 10.1042/CS20100355; Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092; HENRION D, 1992, EUR J PHARMACOL, V224, P13, DOI 10.1016/0014-2999(92)94812-A; Henrion D, 1997, BRIT J PHARMACOL, V121, P83, DOI 10.1038/sj.bjp.0701109; HENRION D, 1992, CIRC RES, V71, P339, DOI 10.1161/01.RES.71.2.339; Hile Chantel, 2003, Curr Diab Rep, V3, P446, DOI 10.1007/s11892-003-0006-0; Howarth FC, 2011, J PANCREAS, V12, P567; Huang A, 2012, AM J PHYSIOL-REG I, V302, pR674, DOI 10.1152/ajpregu.00699.2011; Kampoli AM, 2011, CURR PHARM DESIGN, V17, P4147, DOI 10.2174/138161211798764825; Laight DW, 2000, CARDIOVASC RES, V47, P457, DOI 10.1016/S0008-6363(00)00054-7; Leo CH, 2011, BRIT J PHARMACOL, V162, P365, DOI 10.1111/j.1476-5381.2010.01023.x; Leo CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020813; Loufrani L, 2002, CIRC RES, V91, P1183, DOI 10.1161/01.RES.0000047505.11002.81; Loufrani L, 2008, AM J PHYSIOL-HEART C, V294, pH1906, DOI 10.1152/ajpheart.00966.2006; Matrougui K, 2000, BRIT J PHARMACOL, V130, P521, DOI 10.1038/sj.bjp.0703371; Matsumoto T, 2010, PHARMACOL RES, V62, P271, DOI 10.1016/j.phrs.2010.03.003; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; Munzel T, 2010, EUR HEART J, V31, P2741, DOI 10.1093/eurheartj/ehq396; MULVANY MJ, 1977, CIRC RES, V41, P19, DOI 10.1161/01.RES.41.1.19; Najjar SS, 2005, HYPERTENSION, V46, P454, DOI 10.1161/01.HYP.0000177474.06749.98; Naka KK, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-127; Oltman CL, 2006, AM J PHYSL HEART CIR; Oniki H, 2012, CLIN EXP HYPERTENS; Pieper GM, 1997, J CARDIOVASC PHARM, V30, P734, DOI 10.1097/00005344-199712000-00006; Pinaud F, 2007, HYPERTENSION, V50, P96, DOI 10.1161/HYPERTENSIONAHA.106.085035; Portik-Dobos V, 2002, DIABETES, V51, P3063, DOI 10.2337/diabetes.51.10.3063; Prevost G, 2011, DIABETES METAB, V37, P106, DOI 10.1016/j.diabet.2010.08.005; Retailleau K, 2010, HYPERTENSION, V55, P339, DOI 10.1161/HYPERTENSIONAHA.109.140236; Sena CM, 2011, BRIT J PHARMACOL, V163, P424, DOI 10.1111/j.1476-5381.2011.01230.x; Sharma A, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/750126; Tarhouni K, 2013, ARTERIOSCL THROM VAS, V33, P605, DOI 10.1161/ATVBAHA.112.300334; Tian XY, 2012, CIRC RES, V110, P1211, DOI [10.1161/CIRCRESAHA.111.262170, 10.1161/circresaha.111.262170]; Tian XY, 2012, ANTIOXID REDOX SIGN, V16, P363, DOI 10.1089/ars.2010.3874; Toda N, 2012, PHARMACOL THERAPEUT, V133, P159, DOI 10.1016/j.pharmthera.2011.10.004; Tousoulis D, 2012, CURR VASC PHARMACOL, V10, P19, DOI 10.2174/157016112798829797; Vessieres E, 2013, VASC PHARMACOL, V58, P356, DOI 10.1016/j.vph.2013.03.001; Vessieres E, 2012, VASC PHARMACOL, V57, P173, DOI 10.1016/j.vph.2012.03.006; Vessieres E, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00145; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Winer N, 2007, ADV CARDIOL, V44, P245, DOI 10.1159/000096745; Wong SL, 2009, CIRC RES, V104, P228, DOI 10.1161/CIRCRESAHA.108.179770	66	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68217	10.1371/journal.pone.0068217	http://dx.doi.org/10.1371/journal.pone.0068217			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874545	gold, Green Submitted, Green Published			2022-12-27	WOS:000321736900069
J	Xu, Y; Wang, YN; Sun, JT; Zhang, JW; Tsujii, J; Chang, E				Xu, Yan; Wang, Yining; Sun, Jian-Tao; Zhang, Jianwen; Tsujii, Junichi; Chang, Eric			Building Large Collections of Chinese and English Medical Terms from Semi-Structured and Encyclopedia Websites	PLOS ONE			English	Article								To build large collections of medical terms from semi-structured information sources (e.g. tables, lists, etc.) and encyclopedia sites on the web. The terms are classified into the three semantic categories, Medical Problems, Medications, and Medical Tests, which were used in i2b2 challenge tasks. We developed two systems, one for Chinese and another for English terms. The two systems share the same methodology and use the same software with minimum language dependent parts. We produced large collections of terms by exploiting billions of semi-structured information sources and encyclopedia sites on the Web. The standard performance metric of recall (R) is extended to three different types of Recall to take the surface variability of terms into consideration. They are Surface Recall (R-S), Object Recall (R-O), and Surface Head recall (R-H). We use two test sets for Chinese. For English, we use a collection of terms in the 2010 i2b2 text. Two collections of terms, one for English and the other for Chinese, have been created. The terms in these collections are classified as either of Medical Problems, Medications, or Medical Tests in the i2b2 challenge tasks. The English collection contains 49,249 (Problems), 89,591 (Medications) and 25,107 (Tests) terms, while the Chinese one contains 66,780 (Problems), 101,025 (Medications), and 15,032 (Tests) terms. The proposed method of constructing a large collection of medical terms is both efficient and effective, and, most of all, independent of language. The collections will be made publicly available.	[Xu, Yan] Beihang Univ, Minist Educ, Key Lab Biomech & Mechanobiol, State Key Lab Software Dev Environm, Beijing, Peoples R China; [Xu, Yan; Wang, Yining; Sun, Jian-Tao; Zhang, Jianwen; Tsujii, Junichi; Chang, Eric] Microsoft Res Asia, Beijing, Peoples R China; [Wang, Yining] Tsinghua Univ, Inst Interdisciplinary Informat Sci, Beijing, Peoples R China	Beihang University; Microsoft; Microsoft Research Asia; Tsinghua University	Chang, E (corresponding author), Microsoft Res Asia, Beijing, Peoples R China.	eric.chang@microsoft.com			Microsoft Research Asia (MSR Asia); MSRA eHealth grant from National Science Foundation of China [61073077]; State Key Laboratory of Software Development Environment in Beihang University in China [SKLSDE-2011ZX-13]	Microsoft Research Asia (MSR Asia); MSRA eHealth grant from National Science Foundation of China; State Key Laboratory of Software Development Environment in Beihang University in China	This work was supported by Microsoft Research Asia (MSR Asia). The work was also supported by MSRA eHealth grant, grant 61073077 from National Science Foundation of China and grant SKLSDE-2011ZX-13 from State Key Laboratory of Software Development Environment in Beihang University in China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manusript.	Banko M., 2009, THESIS U WASHINGTON; Cafarella MJ, 2008, PROC VLDB ENDOW, V1, P538, DOI 10.14778/1453856.1453916; Cohen William W, 2004, P 10 ACM SIGKDD INT, P89, DOI DOI 10.1145/1014052.1014065; Curran J.R., 2002, P ACL 02 WORKSHOP UN, V9, P59, DOI DOI 10.3115/1118627.1118635; Curran JR, 2002, PROCEEDINGS OF THE 2002 CONFERENCE ON EMPIRICAL METHODS IN NATURAL LANGUAGE PROCESSING, P222; Frantzi K., 2000, INT J DIGITAL LIB, V3, P115, DOI [DOI 10.1007/S007999900023, 10.1007/s007999900023]; Gu Y, 2011, CIKM, P1883; Houston AL, 2002, DECISION SUPPORT S2, V30, P171; Kwong OY, 2007, P 2007 JOINT C EMP M, P325; Li D, 2011, J INTELLIGENCE, V30, P147; Li DY, 2001, CHIN J MED LIB, V10, P1; Lu Wen-Hsiang, 2005, AMIA Annu Symp Proc, P475; Tseng H., 2003, P ACL 2003 STUD RES, P72; Uzuner O, 2011, J AM MED INFORM ASSN, V18, P552, DOI 10.1136/amiajnl-2011-000203; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Yakout M., 2012, ACM SIGMOD, P97, DOI DOI 10.1145/2213836.2213848; Yoshida M, 2001, P PAC ASS COMP LING, P332; Zhang AL, 2005, THESIS PEKING UNION	19	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e67526	10.1371/journal.pone.0067526	http://dx.doi.org/10.1371/journal.pone.0067526			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874426	Green Submitted, Green Published, gold			2022-12-27	WOS:000321736900012
J	Chen, Q; Ma, YF; Yang, YM; Chen, ZL; Liao, RR; Xie, XX; Wang, Z; He, PF; Tu, YY; Zhang, XZ; Yang, CS; Yang, HJ; Yu, FQ; Zheng, YM; Zhang, ZW; Wang, QS; Pan, YC				Chen, Qiang; Ma, Yufang; Yang, Yumei; Chen, Zhenliang; Liao, Rongrong; Xie, Xiaoxian; Wang, Zhen; He, Pengfei; Tu, Yingying; Zhang, Xiangzhe; Yang, Changsuo; Yang, Hongjie; Yu, Fuqing; Zheng, Youmin; Zhang, Zhiwu; Wang, Qishan; Pan, Yuchun			Genotyping by Genome Reducing and Sequencing for Outbred Animals	PLOS ONE			English	Article							SNP DISCOVERY; PIG	Next-generation sequencing (NGS) approaches are widely used in genome-wide genetic marker discovery and genotyping. However, current NGS approaches are not easy to apply to general outbred populations (human and some major farm animals) for SNP identification because of the high level of heterogeneity and phase ambiguity in the haplotype. Here, we reported a new method for SNP genotyping, called genotyping by genome reducing and sequencing (GGRS) to genotype outbred species. Through an improved procedure for library preparation and a marker discovery and genotyping pipeline, the GGRS approach can genotype outbred species cost-effectively and high-reproducibly. We also evaluated the efficiency and accuracy of our approach for high-density SNP discovery and genotyping in a large genome pig species (2.8 Gb), for which more than 70,000 single nucleotide polymorphisms (SNPs) can be identified for an expenditure of only $80 (USD)/sample.	[Chen, Qiang; Ma, Yufang; Yang, Yumei; Chen, Zhenliang; Liao, Rongrong; Xie, Xiaoxian; Wang, Zhen; He, Pengfei; Zhang, Xiangzhe; Wang, Qishan; Pan, Yuchun] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai 200030, Peoples R China; [Yang, Yumei] Jiangsu Normal Univ, Xuzhou, Peoples R China; [Tu, Yingying] Shanhai Genome Biotechnol Co, Shanghai, Peoples R China; [Yang, Changsuo] Shanghai Acad Agr Sci, Natl Res Ctr Poultry Engn Technol, Shanghai, Peoples R China; [Yang, Hongjie; Yu, Fuqing; Zheng, Youmin] Natl Anim Husb Serv, Beijing, Peoples R China; [Zhang, Zhiwu] Cornell Univ, Inst Genom Div, Ithaca, NY USA; [Pan, Yuchun] Shanghai Key Lab Vet Biotechol, Shanghai, Peoples R China	Shanghai Jiao Tong University; Jiangsu Normal University; Shanghai Academy of Agricultural Sciences; Cornell University	Wang, QS (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai 200030, Peoples R China.	wangqishan@sjtu.edu.cn; panyuchun1963@yahoo.com.cn	Zhang, zs/GXN-3521-2022; Zhang, Zhiwu/P-6156-2016	Zhang, Zhiwu/0000-0002-5784-9684	Ministry of Agricultrue of China; National Natural Science Foundation of China [31072003, 3100992, 31101706, 31272414]; National 948 Project of China [2012-Z26, 2011-G2A]	Ministry of Agricultrue of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 948 Project of China	This study was supported by the 2011-2012 animal germplasm resources conservation project from Ministry of Agricultrue of China, the National Natural Science Foundation of China (grant no. 31072003, 3100992, 31101706, and 31272414), and the National 948 Project of China (2012-Z26, 2011-G2A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral AJ, 2008, GENETICS, V179, P569, DOI 10.1534/genetics.107.084277; Amaral AJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-374; Andolfatto P, 2011, GENOME RES, V21, P610, DOI 10.1101/gr.115402.110; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lu F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003215; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Wang S, 2012, NAT METHODS, V9, P808, DOI [10.1038/nmeth.2023, 10.1038/NMETH.2023]	11	54	60	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e67500	10.1371/journal.pone.0067500	http://dx.doi.org/10.1371/journal.pone.0067500			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874423	Green Submitted, Green Published, gold			2022-12-27	WOS:000324146200007
J	Kim, TH; Ko, Y; Christophe, T; Cechetto, J; Kim, J; Kim, KA; Boese, AS; Garcia, JM; Fenistein, D; Ju, MK; Kim, J; Han, SJ; Kwon, HJ; Brondani, V; Sommer, P				Kim, Tae-Hee; Ko, Yoonae; Christophe, Thierry; Cechetto, Jonathan; Kim, Junwon; Kim, Kyoung-Ae; Boese, Annette S.; Garcia, Jean-Michel; Fenistein, Denis; Ju, Moon Kyeong; Kim, Junghwan; Han, Sung-Jun; Kwon, Ho Jeong; Brondani, Vincent; Sommer, Peter			Identification of a Novel Sulfonamide Non-Nucleoside Reverse Transcriptase Inhibitor by a Phenotypic HIV-1 Full Replication Assay	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ANTIRETROVIRAL THERAPY; MUTANT VIRUSES; RESISTANCE; DISCOVERY; POTENCY; SUSCEPTIBILITY; FLEXIBILITY; DERIVATIVES; DESIGN	Classical target-based, high-throughput screening has been useful for the identification of inhibitors for known molecular mechanisms involved in the HIV life cycle. In this study, the development of a cell-based assay that uses a phenotypic drug discovery approach based on automated high-content screening is described. Using this screening approach, the antiviral activity of 26,500 small molecules from a relevant chemical scaffold library was evaluated. Among the selected hits, one sulfonamide compound showed strong anti-HIV activity against wild-type and clinically relevant multidrug resistant HIV strains. The biochemical inhibition, point resistance mutations and the activity of structural analogs allowed us to understand the mode of action and propose a binding model for this compound with HIV-1 reverse transcriptase.	[Kim, Tae-Hee; Ko, Yoonae; Christophe, Thierry; Cechetto, Jonathan; Kim, Junwon; Kim, Kyoung-Ae; Boese, Annette S.; Garcia, Jean-Michel; Fenistein, Denis; Ju, Moon Kyeong; Kim, Junghwan; Han, Sung-Jun; Brondani, Vincent; Sommer, Peter] Inst Pasteur Korea, Songnam, Gyeonggi Do, South Korea; [Kim, Tae-Hee; Kwon, Ho Jeong] Yonsei Univ, Coll Life Sci & Biotechnol, Translat Res Ctr Prot Funct Control, Dept Biotechnol, Seoul 120749, South Korea	Institut Pasteur Korea; Yonsei University	Kwon, HJ (corresponding author), Yonsei Univ, Coll Life Sci & Biotechnol, Translat Res Ctr Prot Funct Control, Dept Biotechnol, Seoul 120749, South Korea.	kwonhj@yonsei.ac.kr; peter@ip-korea.org	권, 호정/AAS-3642-2021; Garcia, Jean-Michel/J-7166-2013; Brondani, Vincent/AAB-8394-2021	Garcia, Jean-Michel/0000-0002-6005-9982; Boese, Annette Sophia/0000-0002-5166-7425; Sommer, Peter/0000-0001-9241-5710	National Research Foundation of Korea (NRF) [2010-01103]; Korea government (MEST); National Research Foundation of Korea [2010-0017984]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea (NRF) grant (No. 2010-01103) funded by the Korea government (MEST). HJK was supported by the National Research Foundation of Korea (2010-0017984). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, PROT PREP WIZ SCHROD; [Anonymous], 2012, GLID VERS 5 8; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boese A, 2004, FEBS LETT, V578, P291, DOI 10.1016/j.febslet.2004.11.016; Carr A, 2009, AIDS, V23, P343, DOI 10.1097/QAD.0b013e32831db232; Chiao SK, 2009, CURR OPIN DRUG DISC, V12, P53; Daar ES, 2005, AIDS RES HUM RETROV, V21, P343, DOI 10.1089/aid.2005.21.343; Das K, 2008, P NATL ACAD SCI USA, V105, P1466, DOI 10.1073/pnas.0711209105; Flexner C, 2007, NAT REV DRUG DISCOV, V6, P959, DOI 10.1038/nrd2336; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2011, UNAIDSJC2216E; Kertesz DJ, 2010, BIOORG MED CHEM LETT, V20, P4215, DOI 10.1016/j.bmcl.2010.05.040; Lansdon EB, 2010, J MED CHEM, V53, P4295, DOI 10.1021/jm1002233; Little SJ, 2002, NEW ENGL J MED, V347, P385, DOI 10.1056/NEJMoa013552; MacroModel V, 2012, MACROMODEL; Masuda N, 2005, BIOORGAN MED CHEM, V13, P949, DOI 10.1016/j.bmc.2004.11.045; Masuda N, 2004, BIOORGAN MED CHEM, V12, P6171, DOI 10.1016/j.bmc.2004.08.050; MASUR H, 1981, NEW ENGL J MED, V305, P1431, DOI 10.1056/NEJM198112103052402; MCMAHON JB, 1993, ANTIMICROB AGENTS CH, V37, P754, DOI 10.1128/AAC.37.4.754; Merrill DP, 1997, J INFECT DIS, V176, P265, DOI 10.1086/517263; Petropoulos CJ, 2000, ANTIMICROB AGENTS CH, V44, P920, DOI 10.1128/AAC.44.4.920-928.2000; REED L. J., 1938, AMER JOUR HYG, V27, P493; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Rosenblum LL, 2001, ANTIVIR CHEM CHEMOTH, V12, P91, DOI 10.1177/095632020101200202; Simon V, 2006, LANCET, V368, P489, DOI 10.1016/S0140-6736(06)69157-5; Sommer P, 2004, J MOL BIOL, V344, P11, DOI 10.1016/j.jmb.2004.09.042; Tucker TJ, 2008, J MED CHEM, V51, P6503, DOI 10.1021/jm800856c; Wensing Annemarie M. J., 2003, AIDS Reviews, V5, P140; Westby M, 2005, ANTIVIR RES, V67, P121, DOI 10.1016/j.antiviral.2005.06.006; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	29	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e68767	10.1371/journal.pone.0068767	http://dx.doi.org/10.1371/journal.pone.0068767			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874756	Green Submitted, Green Published, gold			2022-12-27	WOS:000324146200030
J	Watanabe, S; Inoue, J				Watanabe, Sachiko; Inoue, Joe			Intracellular Delivery of Lipopolysaccharide Induces Effective Th1-Immune Responses Independent of IL-12	PLOS ONE			English	Article							MYD88-DEFICIENT DENDRITIC CELLS; MONOPHOSPHORYL-LIPID-A; TOLL-LIKE RECEPTORS; TAPE-STRIPPED SKIN; IMMUNE-RESPONSES; CPG-OLIGODEOXYNUCLEOTIDES; SIGNALING PATHWAY; NC/NGA MICE; T-CELLS; ANTIGEN	Lipopolysaccharide (LPS) is responsible for many of the inflammatory responses and pathogenic effects of Gram-negative bacteria, however, it also induces protective immune responses. LPS induces the production of inflammatory cytokines such as TNF-alpha, IL-6, and IL-12 from dendritic cells (DCs) and macrophages. It is thought that IL-12 is required for one of the protective immune responses induced by LPS, the T helper 1 (Th1)-immune response, which include the production of IFN-gamma from Th1cells and IgG2c class switching. Here, we clearly demonstrate that intracellular delivery of LPS by LPS-formulated liposomes (LPS-liposomes) does not induce the production of inflammatory cytokines from DCs, but enhances Th1-immune responses via type-I IFNs, independent of IL-12. Collectively, our results strongly suggest that LPS-liposomes can effectively induce Th1-immune responses without inducing unnecessary inflammation, and may be useful as an immune adjuvant to induce protective immunity.	[Watanabe, Sachiko; Inoue, Joe] Kitasato Univ, Sch Sci, Dept Biosci, Tokyo, Japan; [Watanabe, Sachiko; Inoue, Joe] Kitasato Univ, Grad Sch Sci, Tokyo, Japan; [Inoue, Joe] Kyoto Univ, Dept Immunol & Cell Biol, Grad Sch Med, Kyoto 6068501, Japan	Kitasato University; Kitasato University; Kyoto University	Inoue, J (corresponding author), Kitasato Univ, Sch Sci, Dept Biosci, Tokyo, Japan.	inoue@imm.med.kyoto-u.ac.jp	sachiko, watanabe/AAM-8862-2021; Watanabe, Sachiko/GRE-6723-2022	sachiko, watanabe/0000-0002-6110-9603; Watanabe, Sachiko/0000-0002-6110-9603	MEXT KAKENHI [19790326]; Kitasato University Research Grant for Young Researchers	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Kitasato University Research Grant for Young Researchers	This project was supported by MEXT KAKENHI Grant Number 19790326 (to JI) and a grant-in aid from Kitasato University Research Grant for Young Researchers (to JI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beutler B, 2002, CURR TOP MICROBIOL, V270, P109; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; Inoue J, 2005, J CONTROL RELEASE, V108, P294, DOI 10.1016/j.jconrel.2005.08.014; Inoue J, 2005, PHARM RES-DORDR, V22, P1627, DOI 10.1007/s11095-005-6834-7; Inoue J, 2007, J INVEST DERMATOL, V127, P614, DOI 10.1038/sj.jid.5700656; Inoue J, 2007, VACCINE, V25, P1007, DOI 10.1016/j.vaccine.2006.09.075; Inoue J, 2007, J IMMUNOL, V178, P584, DOI 10.4049/jimmunol.178.1.584; Inoue J, 2009, J CONTROL RELEASE, V133, P18, DOI 10.1016/j.jconrel.2008.09.078; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kaisho T, 2002, INT IMMUNOL, V14, P695, DOI 10.1093/intimm/dxf039; Kaisho T, 2001, J IMMUNOL, V166, P5688, DOI 10.4049/jimmunol.166.9.5688; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Magram J, 1996, IMMUNITY, V4, P471, DOI 10.1016/S1074-7613(00)80413-6; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Miyake K, 2004, TRENDS MICROBIOL, V12, P186, DOI 10.1016/j.tim.2004.02.009; Munoz-Fontela C, 2008, J EXP MED, V205, P1929, DOI 10.1084/jem.20080383; Petrovsky N, 2004, IMMUNOL CELL BIOL, V82, P488, DOI 10.1111/j.0818-9641.2004.01272.x; Puneet P, 2011, NAT IMMUNOL, V12, P344, DOI 10.1038/ni.2004; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Su SB, 2005, J IMMUNOL, V175, P6303, DOI 10.4049/jimmunol.175.10.6303; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; ten Brinke A, 2010, CANCER IMMUNOL IMMUN, V59, P1185, DOI 10.1007/s00262-010-0843-z; Watanabe S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060078; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Yamamoto M, 2009, ADV EXP MED BIOL, V667, P59, DOI 10.1007/978-1-4419-1603-7_6	30	10	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e68671	10.1371/journal.pone.0068671	http://dx.doi.org/10.1371/journal.pone.0068671			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23874715	gold, Green Published, Green Submitted			2022-12-27	WOS:000322000600014
J	Ritchie, SA; Pyke, AT; Hall-Mendelin, S; Day, A; Mores, CN; Christofferson, RC; Gubler, DJ; Bennett, SN; van den Hurk, AF				Ritchie, Scott A.; Pyke, Alyssa T.; Hall-Mendelin, Sonja; Day, Andrew; Mores, Christopher N.; Christofferson, Rebecca C.; Gubler, Duane J.; Bennett, Shannon N.; van den Hurk, Andrew F.			An Explosive Epidemic of DENV-3 in Cairns, Australia	PLOS ONE			English	Article							AEDES-AEGYPTI DIPTERA; DENGUE VIRUS TYPE-2; NORTH QUEENSLAND; PUERTO-RICO; LETHAL OVITRAP; VECTOR CONTROL; OUTBREAKS; MOSQUITO; FEVER; EFFICACY	From November 2008-May 2009 Cairns Queensland Australia was struck by an explosive epidemic of DENV-3 that exceeded the capacity of highly skilled dengue control team to control it. We describe the environmental, virological and entomological factors associated with this outbreak to better understand the circumstances leading to its occurrence. Patient interviews, serological results and viral sequencing strongly suggest that the imported index case was infected in Kalimantan, Indonesia. A delay in notification of 27 days from importation of the index case until Queensland Health was notified of dengue transmission allowed the virus to amplify and spread unchecked through November 2008. Unseasonably warm weather, with daily mean temperatures exceeding 30 degrees C, occurred in late November and would have shortened the extrinsic incubation period of the virus and enhanced transmission. Analysis of case movements early in the outbreak indicated that the total incubation period was as low as 9-11 days. This was supported by laboratory vector competence studies that found transmission by Aedes aegypti occurred within 5 days post exposure at 28 degrees C. Effective vector competence rates calculated from these transmission studies indicate that early transmission contributed to the explosive dengue transmission observed in this outbreak. Collections from BG sentinel traps and double sticky ovitraps showed that large populations of the vector Ae. aegypti occurred in the transmission areas from November - December 2008. Finally, the seasonal movement of people around the Christmas holiday season enhanced the spread of DENV-3. These results suggest that a strain of DENV-3 with an unusually rapid transmission cycle was able to outpace vector control efforts, especially those reliant upon delayed action control such as lethal ovitraps.	[Ritchie, Scott A.] James Cook Univ, Sch Publ Hlth Trop Med & Rehabil Sci, Cairns, Qld, Australia; [Ritchie, Scott A.] Queensland Hlth, Trop Reg Serv, Cairns Populat Hlth Unit, Cairns, Qld, Australia; [Pyke, Alyssa T.; Hall-Mendelin, Sonja; Day, Andrew; van den Hurk, Andrew F.] Queensland Hlth Forens & Sci Serv, Publ Hlth Virol, Coopers Plains, Qld, Australia; [Mores, Christopher N.; Christofferson, Rebecca C.] Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA; [Gubler, Duane J.] Duke Natl Univ Singapore, Grad Sch Med, Program Emerging Infect Dis, Singapore, Singapore; [Bennett, Shannon N.] Univ Hawaii Manoa, Dept Trop Med Med Microbiol & Pharmacol, John A Burns Sch Med, Honolulu, HI 96822 USA; [Bennett, Shannon N.] Calif Acad Sci, Dept Microbiol, San Francisco, CA 94118 USA	James Cook University; Queensland Health; Queensland Health; Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University; National University of Singapore; University of Hawaii System; University of Hawaii Manoa; California Academy of Sciences	Ritchie, SA (corresponding author), James Cook Univ, Sch Publ Hlth Trop Med & Rehabil Sci, Cairns, Qld, Australia.	scott.ritchie@jcu.edu.au	van den Hurk, Andrew F/G-7992-2012; van den Hurk, Andrew/X-9831-2019	van den Hurk, Andrew/0000-0001-6262-831X; Pyke, Alyssa/0000-0003-3512-4321; Mores, Christopher/0000-0001-6678-9049	Queensland Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM097661] Funding Source: NIH RePORTER	Queensland Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research at QHFSS was funded by an internal funds provided by Queensland Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; AITKEN THG, 1977, MOSQ NEWS, V37, P130; Amarakoon D, 2008, MITIG ADAPT STRAT GL, V13, P341, DOI 10.1007/s11027-007-9114-5; Anderson KB, 2007, LANCET, V369, P1452, DOI 10.1016/S0140-6736(07)60671-0; Armstrong PM, 2001, VECTOR-BORNE ZOONOT, V1, P159, DOI 10.1089/153036601316977769; Armstrong PM, 2003, AM J TROP MED HYG, V68, P539, DOI 10.4269/ajtmh.2003.68.539; Azil AH, 2010, TROP MED INT HEALTH, V15, P1190, DOI 10.1111/j.1365-3156.2010.02592.x; Bangs Michael J., 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P1103; Bennett SN, 2003, MOL BIOL EVOL, V20, P1650, DOI 10.1093/molbev/msg182; Bhatt S, NATURE, DOI [10.1038/nature12060, DOI 10.1038/NATURE12060.[]; Broom AK, 1998, PATHOLOGY, V30, P286, DOI 10.1080/00313029800169456; Chadee DD, 2010, J VECTOR ECOL, V35, P395, DOI 10.1111/j.1948-7134.2010.00098.x; Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972; Christofferson RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016298; Corwin AL, 2001, T ROY SOC TROP MED H, V95, P257, DOI 10.1016/S0035-9203(01)90229-9; de Lamballerie X, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-33; Depradine CA, 2004, INT J ENVIRON HEAL R, V14, P429, DOI 10.1080/09603120400012868; Faddy HM, 2013, EMERG INFECT DIS, V19, P787, DOI 10.3201/eid1905.121664; FOCKS DA, 1993, J MED ENTOMOL, V30, P1003, DOI 10.1093/jmedent/30.6.1003; FOCKS DA, 1995, AM J TROP MED HYG, V53, P489, DOI 10.4269/ajtmh.1995.53.489; George R, 1998, DENGUE DENGUE HEMORR; Gubler DJ, 1999, ADV VIRUS RES, V53, P35, DOI 10.1016/S0065-3527(08)60342-5; GUBLER DJ, 1978, AM J TROP MED HYG, V27, P581, DOI 10.4269/ajtmh.1978.27.581; GUBLER DJ, 1989, AM J TROP MED HYG, V40, P571, DOI 10.4269/ajtmh.1989.40.571; Hales S, 1999, ENVIRON HEALTH PERSP, V107, P99, DOI 10.2307/3434364; Hall-Mendelin S, 2010, P NATL ACAD SCI USA, V107, P11255, DOI 10.1073/pnas.1002040107; Halstead SB, 2008, ANNU REV ENTOMOL, V53, P273, DOI 10.1146/annurev.ento.53.103106.093326; Hanley Kathryn A., 2008, BMC Ecology, V8, P1, DOI 10.1186/1472-6785-8-1; Hanna JN, 2006, AUST NZ J PUBL HEAL, V30, P220, DOI 10.1111/j.1467-842X.2006.tb00861.x; Hanna JN, 1998, MED J AUSTRALIA, V168, P221, DOI 10.5694/j.1326-5377.1998.tb140134.x; Hanna JN, 2001, MED J AUSTRALIA, V174, P178, DOI 10.5694/j.1326-5377.2001.tb143213.x; Krockel U, 2006, J AM MOSQUITO CONTR, V22, P229, DOI 10.2987/8756-971X(2006)22[229:NTFSOA]2.0.CO;2; Kuno G, 1998, DENGUE DENGUE HEMORR; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; Malcolm RL, 1999, AUST NZ J PUBL HEAL, V23, P414, DOI 10.1111/j.1467-842X.1999.tb01285.x; Meltzer MI, 1998, AM J TROP MED HYG, V59, P265, DOI 10.4269/ajtmh.1998.59.265; Messer WB, 2003, EMERG INFECT DIS, V9, P800; MOORE CG, 1978, AM J TROP MED HYG, V27, P1225, DOI 10.4269/ajtmh.1978.27.1225; Moudy RM, 2007, AM J TROP MED HYG, V77, P365, DOI 10.4269/ajtmh.2007.77.365; Ooi EE, 2006, EMERG INFECT DIS, V12, P887, DOI 10.3201/eid1206.051210; Perich MJ, 2003, J AM MOSQUITO CONTR, V19, P58; Pontes RJS, 2000, AM J TROP MED HYG, V62, P378, DOI 10.4269/ajtmh.2000.62.378; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ritchie S. A., 2002, Dengue Bulletin, V26, P7; Ritchie SA, 2008, J AM MOSQUITO CONTR, V24, P47, DOI 10.2987/5658.1; RUTLEDGE L. C., 1964, MOSQUITO NEWS, V24, P407; Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9; Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Steel A, 2010, VIROLOGY, V405, P505, DOI 10.1016/j.virol.2010.05.033; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Vazquez-Prokopec GM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000920; Vazquez-Prokopec GM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000858; Warrilow D, 2002, J MED VIROL, V66, P524, DOI 10.1002/jmv.2176; WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143; Williams CR, 2007, J MED ENTOMOL, V44, P256, DOI 10.1603/0022-2585(2007)44[256:IOABLO]2.0.CO;2; Williams CR, 2006, J AM MOSQUITO CONTR, V22, P296, DOI 10.2987/8756-971X(2006)22[296:FEOTBC]2.0.CO;2	57	79	79	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68137	10.1371/journal.pone.0068137	http://dx.doi.org/10.1371/journal.pone.0068137			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874522	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000322064300017
J	Badouin, H; Belkhir, K; Gregson, E; Galindo, J; Sundstrom, L; Martin, SJ; Butlin, RK; Smadja, CM				Badouin, Helene; Belkhir, Khalid; Gregson, Emma; Galindo, Juan; Sundstrom, Liselotte; Martin, Stephen J.; Butlin, Roger K.; Smadja, Carole M.			Transcriptome Characterisation of the Ant Formica exsecta with New Insights into the Evolution of Desaturase Genes in Social Hymenoptera	PLOS ONE			English	Article							AMINO-ACID SITES; PHYLOGENETIC ANALYSIS; NESTMATE RECOGNITION; MULTIPLE ALIGNMENT; ADAPTIVE EVOLUTION; FIRE ANT; SELECTION; ORGANIZATION; SEQUENCES; ACCURACY	Background: Despite the recent sequencing of seven ant genomes, no genomic data are available for the genus Formica, an important group for the study of eusocial traits. We sequenced the transcriptome of the ant Formica exsecta with the 454 FLX Titanium technology from a pooled sample of workers from 70 Finnish colonies. Results: About 1,000,000 reads were obtained from a normalised cDNA library. We compared the assemblers MIRA3.0 and Newbler2.6 and showed that the latter performed better on this dataset due to a new option which is dedicated to improve contig formation in low depth portions of the assemblies. The 29,579 contigs represent 27 Mb. 50% showed similarity with known proteins and 25% could be assigned a category of gene ontology. We found more than 13,000 high-quality single nucleotide polymorphisms. The Delta 9 desaturase gene family is an important multigene family involved in chemical communication in insects. We found six Delta 9 desaturases in this Formica exsecta transcriptome dataset that were used to reconstruct a maximum-likelihood phylogeny of insect desaturases and to test for signatures of positive selection in this multigene family in ant lineages. We found differences with previous phylogenies of this gene family in ants, and found two clades potentially under positive selection. Conclusion: This first transcriptome reference sequence of Formica exsecta provided sequence and polymorphism data that will allow researchers working on Formica ants to develop studies to tackle the genetic basis of eusocial phenotypes. In addition, this study provided some general guidelines for de novo transcriptome assembly that should be useful for future transcriptome sequencing projects. Finally, we found potential signatures of positive selection in some clades of the Delta 9 desaturase gene family in ants, which suggest the potential role of sequence divergence and adaptive evolution in shaping the large diversity of chemical cues in social insects.	[Badouin, Helene; Belkhir, Khalid; Smadja, Carole M.] Univ Montpellier 2, CNRS, Inst Sci Evolut UMR 5554, Montpellier, France; [Gregson, Emma; Galindo, Juan; Martin, Stephen J.; Butlin, Roger K.; Smadja, Carole M.] Univ Sheffield, Sheffield, S Yorkshire, England; [Galindo, Juan] Univ Vigo, Dept Bioquim Xenet & Inmunoloxia, Facultade Bioloxia, Vigo 36310, Spain; [Sundstrom, Liselotte] Univ Helsinki, Dept Biosci, Ctr Excellence Biol Interact, Helsinki, Finland	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Sheffield; Universidade de Vigo; University of Helsinki	Badouin, H (corresponding author), Univ Paris 11, CNRS, Lab Ecol Syst & Evolut, UMR 8079, F-91405 Orsay, France.	helene.badouin@u-psud.fr	Sundstrom, Liselotte/G-5080-2010; Smadja, Carole/A-1562-2013; Galindo, Juan/M-1367-2014; Butlin, Roger K/F-7709-2013	Sundstrom, Liselotte/0000-0002-6176-8940; Galindo, Juan/0000-0002-8631-8006; Butlin, Roger K/0000-0003-4736-0954; Badouin, Helene/0000-0002-2456-5968; Gregson, Emma/0000-0002-8982-4289	Natural Environment Research Council [NE/F018355/1]; NBAF-Liverpool [NBAF454]; NERC [NE/F018355/1, NBAF010002] Funding Source: UKRI; Natural Environment Research Council [NBAF010002] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NBAF-Liverpool; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding for this work was provided by Natural Environment Research Council ref NE/F018355/1 (http://www.nerc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank NBAF-Liverpool, and in particular Dr. L. Olohan (project NBAF454) for running the sequencing experiment.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Andrade MA, 1997, YEAST, V13, P1363, DOI 10.1002/(SICI)1097-0061(199711)13:14<1363::AID-YEA182>3.0.CO;2-8; Anisimova M, 2002, MOL BIOL EVOL, V19, P950, DOI 10.1093/oxfordjournals.molbev.a004152; Anisimova M, 2001, MOL BIOL EVOL, V18, P1585, DOI 10.1093/oxfordjournals.molbev.a003945; Bajgain P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-370; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Beye M, 1998, BEHAV ECOL SOCIOBIOL, V43, P67, DOI 10.1007/s002650050467; Blankenberg D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/bioinformatics/btq281; Bonasio R, 2010, SCIENCE, V329, P1068, DOI 10.1126/science.1192428; Boomsma JJ, 2003, P NATL ACAD SCI USA, V100, P8799, DOI 10.1073/pnas.1430283100; Bourke A. F., 1995, SOCIAL EVOLUTION ANT; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chernenko A, 2013, BEHAV ECOL SOCIOBIOL, V67, P727, DOI 10.1007/s00265-013-1496-7; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Domisch T, 2006, SOIL BIOL BIOCHEM, V38, P2425, DOI 10.1016/j.soilbio.2006.03.004; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fan YL, 2004, J INSECT PHYSIOL, V50, P609, DOI 10.1016/j.jinsphys.2004.04.007; Fraser BA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-202; Gibb H, 2011, ECOLOGY, V92, P1871, DOI 10.1890/10-2363.1; Gotzek D, 2007, Q REV BIOL, V82, P201, DOI 10.1086/519965; Gyllenstrand N, 2002, MOL ECOL NOTES, V2, P67, DOI 10.1046/j.1471-8286.2002.00152.x; Haapaniemi K, 2012, MOL ECOL, V21, P421, DOI 10.1111/j.1365-294X.2011.05386.x; Hannonen M, 2003, NATURE, V421, P910, DOI 10.1038/421910a; Helantera H, 2007, AM NAT, V170, pE14, DOI 10.1086/518185; Helantera H, 2011, BEHAV ECOL, V22, P710, DOI 10.1093/beheco/arr037; Hochberg Y, 1995, J ROYAL STAT SOC B; Holzer B, 2008, INSECT SOC, V55, P392, DOI 10.1007/s00040-008-1017-2; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jurgensen MF, 2008, J APPL ENTOMOL, V132, P266, DOI 10.1111/j.1439-0418.2008.01280.x; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Keays MC, 2011, MOL ECOL, V20, P3617, DOI 10.1111/j.1365-294X.2011.05208.x; Knipple DC, 2002, GENETICS, V162, P1737; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Kumar S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-571; Leal WS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003762; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Martin S, 2012, ECOL EVOL, V2, P2333, DOI 10.1002/ece3.319; Martin SJ, 2008, J CHEM ECOL, V34, P1072, DOI 10.1007/s10886-008-9482-7; Martin SJ, 2008, P ROY SOC B-BIOL SCI, V275, P1271, DOI 10.1098/rspb.2007.1708; McQuilton P, 2012, NUCLEIC ACIDS RES, V40, pD706, DOI 10.1093/nar/gkr1030; Moreau CS, 2006, SCIENCE, V312, P101, DOI 10.1126/science.1124891; Mundry M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031410; Munoz-Torres MC, 2011, NUCLEIC ACIDS RES, V39, pD658, DOI 10.1093/nar/gkq1145; Nakamura MT, 2004, ANNU REV NUTR, V24, P345, DOI 10.1146/annurev.nutr.24.121803.063211; Niehuis O, 2012, CURR BIOL, V22, P1309, DOI 10.1016/j.cub.2012.05.018; Nygaard S, 2011, GENOME RES, V21, P1339, DOI 10.1101/gr.121392.111; Park Y, 2008, INSECT BIOCHEM MOLEC, V38, P380, DOI 10.1016/j.ibmb.2007.09.008; Penn O, 2010, NUCLEIC ACIDS RES, V38, pW23, DOI 10.1093/nar/gkq443; Pirk CWW, 2001, BEHAV ECOL SOCIOBIOL, V49, P366, DOI 10.1007/s002650000315; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Punttila P, 2009, ANN ZOOL FENN, V46, P1, DOI 10.5735/086.046.0101; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Roelofs WL, 2003, P NATL ACAD SCI USA, V100, P14599, DOI 10.1073/pnas.1233767100; Rosengren R, EXPERIENTIA S, P117; Santure AW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-283; Schwartz TS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-694; Seppa P, 1995, BIOL J LINN SOC, V56, P533, DOI 10.1111/j.1095-8312.1995.tb01109.x; Singer TL, 1998, AM ZOOL, V38, P394; Smadja C, 2009, HEREDITY, V102, P77, DOI 10.1038/hdy.2008.55; Smith CR, 2011, P NATL ACAD SCI USA, V108, P5667, DOI 10.1073/pnas.1007901108; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Suen G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002007; Sundstrom L, 2005, ANN ZOOL FENN, V42, P163; Sundstrom L, 1996, SCIENCE, V274, P993, DOI 10.1126/science.274.5289.993; Sundstrom L, 2003, EVOLUTION, V57, P1552, DOI 10.1111/j.0014-3820.2003.tb00363.x; Swanson WJ, 2003, MOL BIOL EVOL, V20, P18, DOI 10.1093/oxfordjournals.molbev.a004233; van Zweden JS, 2010, J EVOLUTION BIOL, V23, P1498, DOI 10.1111/j.1420-9101.2010.02020.x; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r9; Wang J, 2013, NATURE, V493, P664, DOI 10.1038/nature11832; Wasmuth JD, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-187; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wheat CW, 2010, GENETICA, V138, P433, DOI 10.1007/s10709-008-9326-y; Wong WSW, 2004, GENETICS, V168, P1041, DOI 10.1534/genetics.104.031153; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069; Wurm Y, 2011, P NATL ACAD SCI USA, V108, P5679, DOI 10.1073/pnas.1009690108; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1998, J MOL EVOL, V46, P409, DOI 10.1007/PL00006320; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	88	13	16	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e68200	10.1371/journal.pone.0068200	http://dx.doi.org/10.1371/journal.pone.0068200			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	23874539	Green Accepted, Green Published, gold			2022-12-27	WOS:000321718700011
J	Chikazawa, M; Otaki, N; Shibata, T; Yasueda, T; Matsuda, T; Uchida, K				Chikazawa, Miho; Otaki, Natsuki; Shibata, Takahiro; Yasueda, Takehiko; Matsuda, Tsukasa; Uchida, Koji			An Apoptosis-Associated Mammary Protein Deficiency Leads to Enhanced Production of IgM Antibodies against Multiple Damage-Associated Molecules	PLOS ONE			English	Article							OXIDATION-SPECIFIC EPITOPES; SYSTEMIC-LUPUS-ERYTHEMATOSUS; LIPID-PEROXIDATION PRODUCT; ANTI-DNA ANTIBODIES; DENDRITIC CELLS; AUTOIMMUNE-DISEASE; CRYSTAL-STRUCTURE; IMPAIRED UPTAKE; HEAVY-CHAIN; IDENTIFICATION	Milk fat globule epidermal growth factor 8 (MFG-E8) is a protein that binds to apoptotic cells by recognizing phosphatidylserine and enhances the engulfment of apoptotic cells by macrophages. Many apoptotic cells are left unengulfed in the germinal centers of the spleen in the MFG-E8-deficient (MFG-E8(-/-)) mice, and these mice develop an autoimmune disease resembling human systemic lupus erythematosus. We found that the MFG-E8 deficiency was accompanied by the increased production of immunoglobulins. Further Western blot and ELISA analyses validated the increase in the IgM levels in the MFG-E8(-/-) mice. It was also revealed that the sera from the MFG-E8(-/-) mice cross-reacted with oxidation-specific epitopes generated upon incubation of serum albumin with the peroxidized lipids. Among the modified proteins with several unsaturated aldehydes of chain lengths varying from three to nine carbons, the MFG-E8(-/-) mice sera exclusively cross-reacted with the protein-bound 4-oxo-2-nonenal (ONE), a highly reactive aldehyde originating from the peroxidation of omega 6 polyunsaturated fatty acids. In addition, the IgM monoclonal antibodies (mAbs) that selectively cross-reacted with the ONE-modified proteins were generated from the MFG-E8(-/-) mice. A subset of the ONE-specific IgM mAbs significantly recognized the late apoptotic and necrotic cells and enhanced the phagocytosis by macrophages. These data demonstrate that the impairment of the phagocytic clearance of apoptotic cells through MFG-E8 can lead to the generation of natural antibodies, which may play a critical role in removing multiple damage-associated molecules, including oxidation-specific epitopes and late apoptotic/necrotic cells.	[Chikazawa, Miho; Otaki, Natsuki; Shibata, Takahiro; Uchida, Koji] Nagoya Univ, Grad Sch Bioagr Sci, Lab Food & Biodynam, Nagoya, Aichi 4648601, Japan; [Yasueda, Takehiko; Matsuda, Tsukasa] Nagoya Univ, Grad Sch Bioagr Sci, Lab Mol Bioregulat, Nagoya, Aichi 4648601, Japan	Nagoya University; Nagoya University	Uchida, K (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Lab Food & Biodynam, Nagoya, Aichi 4648601, Japan.	uchidak@agr.nagoya-u.ac.jp	; Shibata, Takahiro/I-6872-2014	Uchida, Koji/0000-0003-3894-5299; Shibata, Takahiro/0000-0003-3194-607X	Ministry of Education, Sciences, Sports, Technology, Japan	Ministry of Education, Sciences, Sports, Technology, Japan	This work was supported in part by grants-in-aid for scientific research and grants-in-aid for scientific research on Innovative Areas (research in a proposed area) from the Ministry of Education, Sciences, Sports, Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], INT IMMUNOL; Antone SM, 1997, J IMMUNOL, V159, P5422; Baumann I, 2002, ARTHRITIS RHEUM-US, V46, P191, DOI 10.1002/1529-0131(200201)46:1<191::AID-ART10027>3.0.CO;2-K; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Boes M, 2000, P NATL ACAD SCI USA, V97, P1184, DOI 10.1073/pnas.97.3.1184; Brash AR, 1996, METHOD ENZYMOL, V272, P250, DOI 10.1016/S0076-6879(96)72030-X; Brissette MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036368; Carrillo J, 2008, MOL IMMUNOL, V45, P3152, DOI 10.1016/j.molimm.2008.03.003; Chang MK, 2004, J EXP MED, V200, P1359, DOI 10.1084/jem.20031763; Chang MK, 1999, P NATL ACAD SCI USA, V96, P6353, DOI 10.1073/pnas.96.11.6353; Chavali GB, 2003, STRUCTURE, V11, P875, DOI 10.1016/S0969-2126(03)00131-X; Chen YF, 2009, J IMMUNOL, V183, P1346, DOI 10.4049/jimmunol.0900948; Chen YF, 2009, J IMMUNOL, V182, P6031, DOI 10.4049/jimmunol.0804191; Chou MY, 2009, J CLIN INVEST, V119, P1335, DOI 10.1172/JCI36800; Deshmukh US, 2006, AUTOIMMUN REV, V5, P414, DOI 10.1016/j.autrev.2005.10.010; Doorn JA, 2002, CHEM RES TOXICOL, V15, P1445, DOI 10.1021/tx025590o; Frostegard J, 2005, ARTHRITIS RHEUM-US, V52, P192, DOI 10.1002/art.20780; Furukawa K, 2006, MOL IMMUNOL, V43, P1751, DOI 10.1016/j.molimm.2005.11.009; GIBSON AL, 1985, MOL IMMUNOL, V22, P499, DOI 10.1016/0161-5890(85)90135-X; Gronwall C, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00066; Grune T, 1997, FREE RADICAL BIO MED, V23, P357, DOI 10.1016/S0891-5849(96)00586-2; Hahn BH, 1998, NEW ENGL J MED, V338, P1359, DOI 10.1056/NEJM199805073381906; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Hartvigsen K, 2009, J LIPID RES, V50, pS388, DOI 10.1194/jlr.R800100-JLR200; Herlands RA, 2008, IMMUNITY, V29, P249, DOI 10.1016/j.immuni.2008.06.009; Iuliano L, 1997, BLOOD, V90, P3931, DOI 10.1182/blood.V90.10.3931; Jian WY, 2005, FREE RADICAL BIO MED, V39, P1162, DOI 10.1016/j.freeradbiomed.2005.06.008; KATZ MS, 1993, J CLIN INVEST, V91, P402, DOI 10.1172/JCI116214; Kranich J, 2008, J EXP MED, V205, P1293, DOI 10.1084/jem.20071019; Krauss N, 2008, PROTEINS, V73, P552, DOI 10.1002/prot.22080; Lee HP, 2009, J NEUROCHEM, V108, P1434, DOI 10.1111/j.1471-4159.2009.05883.x; Lee SH, 2000, CHEM RES TOXICOL, V13, P698, DOI 10.1021/tx000101a; Lescar J, 1997, J MOL BIOL, V267, P1207, DOI 10.1006/jmbi.1997.0950; Lipsanen V, 1997, INT IMMUNOL, V9, P655, DOI 10.1093/intimm/9.5.655; MARNETT LJ, 1980, CANCER RES, V40, P276; Miller YI, 2011, CIRC RES, V108, P235, DOI 10.1161/CIRCRESAHA.110.223875; Miyasaka K, 2004, EUR J IMMUNOL, V34, P1414, DOI 10.1002/eji.200424930; Oe T, 2003, CHEM RES TOXICOL, V16, P1598, DOI 10.1021/tx034178l; Otaki N, 2010, J BIOL CHEM, V285, P33834, DOI 10.1074/jbc.M110.165175; Peng YF, 2011, J CLIN INVEST, V121, P2221, DOI 10.1172/JCI43254; Rindgen D, 1999, CHEM RES TOXICOL, V12, P1195, DOI 10.1021/tx990034o; Sevcik J, 2007, FEBS LETT, V581, P5872, DOI 10.1016/j.febslet.2007.11.067; Shibata T, 2006, J BIOL CHEM, V281, P1196, DOI 10.1074/jbc.M509065200; Shimozu Y, 2009, CHEM RES TOXICOL, V22, P957, DOI 10.1021/tx900059k; Shoenfeld Y, 2005, ARTHRITIS RHEUM, V52, P2599, DOI 10.1002/art.21252; Silverman GJ, 2008, CLIN EXP IMMUNOL, V153, P102, DOI 10.1111/j.1365-2249.2008.03680.x; Tanner JJ, 2001, J MOL BIOL, V314, P807, DOI 10.1006/jmbi.2001.5178; Toyoda K, 2007, J BIOL CHEM, V282, P25769, DOI 10.1074/jbc.M703039200; Weismann D, 2012, BBA-BIOMEMBRANES, V1818, P2465, DOI 10.1016/j.bbamem.2012.01.018; West JD, 2004, CHEM RES TOXICOL, V17, P453, DOI 10.1021/tx034248o; Witte T, 1998, RHEUMATOL INT, V18, P85, DOI 10.1007/s002960050063; Yamaguchi H, 2008, J LEUKOCYTE BIOL, V83, P1300, DOI 10.1189/jlb.1107730; Yocum AK, 2005, J MASS SPECTROM, V40, P754, DOI 10.1002/jms.847; Zhang WH, 2003, CHEM RES TOXICOL, V16, P512, DOI 10.1021/tx020105a; Zhu XC, 2007, CHEM RES TOXICOL, V20, P165, DOI 10.1021/tx600295j	57	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e68468	10.1371/journal.pone.0068468	http://dx.doi.org/10.1371/journal.pone.0068468			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	23874637	Green Published, gold, Green Submitted			2022-12-27	WOS:000321718700031
J	D'Amico, S; Marano, A; Geraci, MA; Legge, E				D'Amico, Simonetta; Marano, Assunta; Geraci, Maria Angela; Legge, Emanuele			Perceived Self-Efficacy and Coping Styles Related to Stressful Critical Life Events	PLOS ONE			English	Article							RESILIENCE; CHILDREN	Objective: The study examined the personal resources, Self-efficacy and Coping Strategies, in a sample of pre-adolescents who experienced an emotionally and socially critical event, such as the earthquake of the 6th of April 2009, related to age and gender. Methods: 198 pre-adolescents, 84 girls and 114 boys (Age Mean 12 years), attending Secondary School in L'Aquila meso-seismic area. The emotional, behavioural and social capacities have been assessed with specific questionnaires administered collectively ten months after the earthquake. Results: Multidimensional analyses produced differentiated profiles according to gender and age: self-efficacy-perception and coping strategy profiles, based on quartiles calculations, revealed the difficulties of the subjects in estimating their ability to cope with the world of relations and emotions after the critical event. Conclusions: The intervention could be specific to the cognitive, emotional and relational state of children and adolescents and differentiated before (prevention), during (intervention) and after the event (intervention and prevention).	[D'Amico, Simonetta; Marano, Assunta] Univ Aquila, Dept Life Hlth & Environm Sci, Coppito, AQ, Italy; [Legge, Emanuele] Local Hlth Agcy Natl Hlth Syst, Dept Mental Hlth, Laquila, Italy	University of L'Aquila	D'Amico, S (corresponding author), Univ Aquila, Dept Life Hlth & Environm Sci, Coppito, AQ, Italy.	simonetta.damico@cc.univaq.it		D'AMICO, SIMONETTA/0000-0002-4418-4978	Italian Association of Psychology (AIP)	Italian Association of Psychology (AIP)	This research was partially supported by a grant from Italian Association of Psychology (AIP) generously provided to Faculty of Psychology, University of L'Aquila, after earthquake of the 6th of April 2009. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANDURA A, 1989, AM PSYCHOL, V44, P1175, DOI 10.1037/0003-066X.44.9.1175; Bandura A, 2005, GREAT MINDS MANAGEME; Bandura A., 2009, HDB PRINCIPLES ORG B, V2, P179; Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; Bandura A, 2008, ADV SELF RES, P15; Benight CC, 2004, BEHAV RES THER, V42, P1129, DOI 10.1016/j.brat.2003.08.008; Caprara G.V., 2001, VALUTAZIONE DELLAUTO, P35; Doctor RM, 2009, ENCY TRAUMA TRAUMATI; Drake RE, 2001, PSYCHIAT SERV, V52, P469, DOI 10.1176/appi.ps.52.4.469; Garmezy, 1983, STRESS COPING DEV CH; GILLIS AJ, 1993, J ADV NURS, V18, P345, DOI 10.1046/j.1365-2648.1993.18030345.x; Gurwitch Robin H, 2004, Prehosp Disaster Med, V19, P21; HOLDEN G, 1990, PSYCHOL REP, V66, P1044, DOI 10.2466/PR0.66.3.1044-1046; HOLDEN G, 1991, SOC WORK HEALTH CARE, V16, P53; Johnston C, 2006, PEDIATRICS, V117, pS458, DOI 10.1542/peds.2006-0099W; Karanci A.N., 2000, INT J MASS EMERG DIS, V18, P403; Kvarme LG, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-85; Pastorelli C, 2001, VALUTAZIONE AUTOEFFI, P87; RUBONIS AV, 1991, PSYCHOL BULL, V109, P384, DOI 10.1037/0033-2909.109.3.384; Rutter M, 2006, ANN NY ACAD SCI, V1094, P1, DOI 10.1196/annals.1376.002; Sica C., 2008, PSICOTERAPIA COGNITI, V14, P27; Sica C, 2008, BPA, V223, P25; Williams R, 2008, CURR OPIN PSYCHIATR, V21, P338, DOI 10.1097/YCO.0b013e328305b6e4; Zeidner M., 1996, HDB COPING THEORY RE, P505	24	20	20	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e67571	10.1371/journal.pone.0067571	http://dx.doi.org/10.1371/journal.pone.0067571			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	182CS	23874429	Green Published, gold, Green Submitted			2022-12-27	WOS:000321718700002
J	Linkenauger, SA; Leyrer, M; Bulthoff, HH; Mohler, BJ				Linkenauger, Sally A.; Leyrer, Markus; Buelthoff, Heinrich H.; Mohler, Betty J.			Welcome to Wonderland: The Influence of the Size and Shape of a Virtual Hand On the Perceived Size and Shape of Virtual Objects	PLOS ONE			English	Article							DISTANCE PERCEPTION; EGOCENTRIC DISTANCE; EYE-HEIGHT; SIMULATION; INDUCTION; COGNITION	The notion of body-based scaling suggests that our body and its action capabilities are used to scale the spatial layout of the environment. Here we present four studies supporting this perspective by showing that the hand acts as a metric which individuals use to scale the apparent sizes of objects in the environment. However to test this, one must be able to manipulate the size and/or dimensions of the perceiver's hand which is difficult in the real world due to impliability of hand dimensions. To overcome this limitation, we used virtual reality to manipulate dimensions of participants' fully-tracked, virtual hands to investigate its influence on the perceived size and shape of virtual objects. In a series of experiments, using several measures, we show that individuals' estimations of the sizes of virtual objects differ depending on the size of their virtual hand in the direction consistent with the body-based scaling hypothesis. Additionally, we found that these effects were specific to participants' virtual hands rather than another avatar's hands or a salient familiar-sized object. While these studies provide support for a body-based approach to the scaling of the spatial layout, they also demonstrate the influence of virtual bodies on perception of virtual environments.	[Linkenauger, Sally A.; Leyrer, Markus; Mohler, Betty J.] Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany; [Buelthoff, Heinrich H.] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea	Max Planck Society; Korea University	Linkenauger, SA (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.	sally.linkenauger@gmail.com	Bülthoff, Heinrich/AAC-8818-2019; Bülthoff, Heinrich H/J-6579-2012	Bülthoff, Heinrich H/0000-0003-2568-0607; Linkenauger, Sally/0000-0002-6056-0187	Alexander von Humboldt fellowship	Alexander von Humboldt fellowship(Alexander von Humboldt Foundation)	This work was supported by an Alexander von Humboldt fellowship granted to the first author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carroll L., 2011, ALICES ADVENTURES WO; Di Luca M, 2010, PRESENCE-TELEOP VIRT, V19, P569, DOI 10.1162/pres_a_00023; Durgin FH, 2009, PSYCHON B REV, V16, P964, DOI 10.3758/PBR.16.5.964; Epstein W., 1965, AM J PSYSCHOLOGY, V74, P333; Gibson J, 1979, J ECOLOGICAL APPROAC; Hutchison JJ, 2006, SPAN J PSYCHOL, V9, P332, DOI 10.1017/S1138741600006235; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Kilteni K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040867; Lessard DA, 2009, PERCEPTION, V38, P1863, DOI 10.1068/p6509; Leyrer Markus, 2011, P ACM SIGGRAPH S APP, P67, DOI [DOI 10.1145/2077451.2077464, DOI 10.1145/2077451]; Linkenauger SA, 2011, J EXP PSYCHOL HUMAN, V37, P1432, DOI 10.1037/a0024248; Linkenauger SA, 2010, PSYCHOL SCI, V21, P1318, DOI 10.1177/0956797610380700; Linkenauger SA, 2009, J EXP PSYCHOL HUMAN, V35, P1649, DOI 10.1037/a0016875; Linkenauger SA, 2009, PSYCHOL SCI, V20, P1373, DOI 10.1111/j.1467-9280.2009.02447.x; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Loomis J, 2008, EGOCENTRIC DISTANCE; Mark JT, 2010, J THEOR BIOL, V266, P504, DOI 10.1016/j.jtbi.2010.07.020; Marr D., 1982, VISION COMPUTATIONAL; Normand JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016128; OBONAI T, 1954, J EXP PSYCHOL, V47, P57, DOI 10.1037/h0057223; Philbeck JW, 1997, J EXP PSYCHOL HUMAN, V23, P72, DOI 10.1037/0096-1523.23.1.72; Proffitt D.R., ACTION SCI FDN EMERG, P171; Pylyshyn Z, 1999, BEHAV BRAIN SCI, V22, P341, DOI 10.1017/S0140525X99002022; Sanchez-Vives MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010381; Schmalzl L, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00034; Schnall S, 2010, PERCEPTION, V39, P464, DOI 10.1068/p6445; Slater M, 2009, FRONT NEUROSCI-SWITZ, V3, P214, DOI 10.3389/neuro.01.029.2009; Slater M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010564; Stefanucci JK, 2009, PERCEPTION, V38, P1782, DOI 10.1068/p6437; Teneva PT, 2010, EGOCENTRIC DISTANCE, P57; van der Hoort B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020195; Witt JK, 2011, J EXP PSYCHOL HUMAN, V37, P1148, DOI 10.1037/a0021933; Witt JK, 2008, J EXP PSYCHOL HUMAN, V34, P1479, DOI 10.1037/a0010781; Witt JK, 2005, J EXP PSYCHOL HUMAN, V31, P880, DOI 10.1037/0096-1523.31.5.880; Wraga M, 1999, J EXP PSYCHOL HUMAN, V25, P518, DOI 10.1037/0096-1523.25.2.518; Wraga M, 2000, PERCEPTION, V29, P1361, DOI 10.1068/p2837; Yang TL, 1999, PERCEPTION, V28, P445, DOI 10.1068/p2854	37	77	77	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e68594	10.1371/journal.pone.0068594	http://dx.doi.org/10.1371/journal.pone.0068594			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	188UA	23874681	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000322218800038
J	Ning, PB; Guo, MC; Guo, KK; Xu, L; Ren, M; Cheng, YY; Zhang, YM				Ning, Pengbo; Guo, Mancai; Guo, Kangkang; Xu, Lei; Ren, Min; Cheng, Yuanyuan; Zhang, Yanming			Identification and Effect Decomposition of Risk Factors for Brucella Contamination of Raw Whole Milk in China	PLOS ONE			English	Article							CATTLE; ERADICATION; INFECTION; PCR; EPIDEMIOLOGY; LIVESTOCK; VACCINES; QUALITY; DISEASE; HERDS	Background: Lack of clear risk factor identification is the main reason for the persistence of brucellosis infection in the Chinese population, and there has been little assessment of the factors contributing to Brucella contamination of raw whole milk. The purpose of this study was to identify risk factors affecting Brucella contamination of raw milk, and to evaluate effective measures for disease reduction in order to determine preventive strategies. Methods and Findings: A nationwide survey was conducted and samples were obtained from 5211 cows corresponding to 25 sampling locations throughout 15 provinces in China. The prevalence of Brucella in the raw milk samples averaged 1.07% over the 15 Chinese provinces, while the prevalence of positive areas within these regions ranged from 0.23-3.84% among the nine provinces with positive samples. The survey examined factors that supposedly influence Brucella contamination of raw whole milk, such as management style, herd size, abortion rate, hygiene and disease control practices. A binary logistic regression analysis was carried out to determine the association between risk factors for Brucella and contamination of milk samples. Furthermore, a relative effect decomposition study was conducted to determine effective strategies for reducing the risk of Brucella contamination of raw whole milk. Our data indicate that disease prevention and control measures, abortion rate, and animal polyculture are the most important risk factors. Meanwhile, culling after quarantine was identified as an effective protective measure in the current Chinese dairy situation. Conclusions: These results indicate that, although there is a low risk of contamination of milk with Brucella nationwide in China, there are individual regions where contamination is a significant problem. Controlling three factors-culling after quarantine, maintaining a low abortion rate, and avoiding mixing reduce the risk of Brucella contamination of raw whole milk.	[Ning, Pengbo; Guo, Kangkang; Xu, Lei; Ren, Min; Cheng, Yuanyuan; Zhang, Yanming] Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China; [Guo, Mancai] Northwest A&F Univ, Coll Sci, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Zhang, YM (corresponding author), Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China.	tommy0627@163.com; zhangym@nwsuaf.edu.cn	Zhang, Yong/K-7945-2016	Zhang, Yong/0000-0001-8642-4071	Special Fund for Agro-scientific Research in the Public Interest [200903055]	Special Fund for Agro-scientific Research in the Public Interest	This project was supported by Special Fund for Agro-scientific Research in the Public Interest (200903055). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas B., 2009, BULG J VET MED, V12, P136; Bertu WJ, 2010, AFR J FOOD SCI, V4; Brooks JC, 2012, FOOD MICROBIOL, V31, P154, DOI 10.1016/j.fm.2012.03.013; Corbel M.J., 2006, BRUCELLOSIS HUMANS A; Corbel MJ, 1997, EMERG INFECT DIS, V3, P213, DOI 10.3201/eid0302.970219; CORDES DO, 1979, NEW ZEAL VET J, V27, P255, DOI 10.1080/00480169.1979.34666; Dayton, 1992, STAT, P1; Dossey BM, 2010, J HOLIST NURS, V28, P38, DOI 10.1177/0898010109356472; Earhart K, 2009, INT J INFECT DIS, V13, P749, DOI 10.1016/j.ijid.2009.02.014; El-Kholy AM, 2008, ASSIUT VET MED J, V54, P117; Gwida M, 2010, CROAT MED J, V51, P289, DOI 10.3325/cmj.2010.51.289; Hamdy MER, 2002, VET J, V163, P299, DOI 10.1053/tvjl.2001.0681; Kaufman JS, 2012, EPIDEMIOLOGY, V23, P785, DOI 10.1097/EDE.0b013e31826c30e6; Khan MY, 2001, CLIN INFECT DIS, V32, P1172, DOI 10.1086/319758; LeJeune JT, 2009, CLIN INFECT DIS, V48, P93, DOI 10.1086/595007; Mantur B G, 2007, Indian J Med Microbiol, V25, P188; Muma JB, 2007, PREV VET MED, V80, P306, DOI 10.1016/j.prevetmed.2007.03.003; Namanda AT, 2009, J INFECT DEV COUNTR, V3, P260; Navarro-Martinez A, 2001, CLIN INFECT DIS, V33, P2017, DOI 10.1086/324489; Ning P, 2012, J DAIRY SCI, V95, P4863, DOI 10.3168/jds.2012-5600; O' Leary S, 2006, RES VET SCI, V81, P170, DOI 10.1016/j.rvsc.2005.12.001; Oliveira SC, 2011, EXPERT REV VACCINES, V10, P1291, DOI [10.1586/erv.11.110, 10.1586/ERV.11.110]; Olsen SC, 2005, EXPERT REV VACCINES, V4, P915, DOI 10.1586/14760584.4.6.915; Omer MK, 2000, PREV VET MED, V46, P257, DOI 10.1016/S0167-5877(00)00152-5; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Qiu JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034246; Rafati N, 2010, PREV VET MED, V96, P170, DOI 10.1016/j.prevetmed.2010.05.008; Ragan VE, 2002, VET MICROBIOL, V90, P11, DOI 10.1016/S0378-1135(02)00240-7; SALMAN MD, 1984, AM J VET RES, V45, P1557; Seleem MN, 2010, VET MICROBIOL, V140, P392, DOI 10.1016/j.vetmic.2009.06.021; Shang DQ, 2002, VET MICROBIOL, V90, P165, DOI 10.1016/S0378-1135(02)00252-3; Steyerberg EW, 1999, J CLIN EPIDEMIOL, V52, P935, DOI 10.1016/S0895-4356(99)00103-1; Stringer LA, 2008, PREV VET MED, V84, P72, DOI 10.1016/j.prevetmed.2007.11.005; Swai E. S., 2011, Asian Pacific Journal of Tropical Biomedicine, V1, P217, DOI 10.1016/S2221-1691(11)60030-0; Vargas FJ, 2002, VET MICROBIOL, V90, P39, DOI 10.1016/S0378-1135(02)00243-2; Xavier MN, 2009, J COMP PATHOL, V140, P149, DOI 10.1016/j.jcpa.2008.10.004; Zowghi E, 1990, Rev Sci Tech, V9, P1175	37	16	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68230	10.1371/journal.pone.0068230	http://dx.doi.org/10.1371/journal.pone.0068230			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874552	Green Published, Green Submitted, gold			2022-12-27	WOS:000321765300034
J	Fu, LT; Bo, TL; Gu, HH; Zheng, XJ				Fu, Lin-Tao; Bo, Tian-Li; Gu, Hai-Hua; Zheng, Xiao-Jing			Incident Angle of Saltating Particles in Wind-Blown Sand	PLOS ONE			English	Article							AEOLIAN SALTATION; COLLISIONS; BED; TRANSPORT; GRAINS; MODEL	Incident angle of saltating particles plays a very important role in aeolian events. In this paper, the incident angles of sand particles near the sand bed were measured in wind tunnel. It reveals that the incident angles range widely from 0 degrees to 180 degrees and thereby the means of angles are larger than published data. Surprisingly, it is found the proportion that angles of 5 degrees-15 degrees occupy is far below previous reports. The measuring height is probably the most important reason for the measurement differences between this study and previous investigations.	[Fu, Lin-Tao; Bo, Tian-Li; Gu, Hai-Hua; Zheng, Xiao-Jing] Lanzhou Univ, Key Lab Mech Environm & Disaster Western China, Minist Educ, Lanzhou 730000, Peoples R China; [Fu, Lin-Tao; Bo, Tian-Li; Gu, Hai-Hua; Zheng, Xiao-Jing] Lanzhou Univ, Sch Civil Engn & Mech, Dept Mech, Lanzhou 730000, Peoples R China	Lanzhou University; Lanzhou University	Bo, TL (corresponding author), Lanzhou Univ, Key Lab Mech Environm & Disaster Western China, Minist Educ, Lanzhou 730000, Peoples R China.	btl@lzu.edu.cn		Fu, Lin-Tao/0000-0001-5167-5559	National Natural Science Foundation of China [11072097, 11232006, 11121202, 10972164, 11202088]; Science Foundation of Ministry of Education of China [308022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Ministry of Education of China(Ministry of Education, China)	This research was supported by grants from the National Natural Science Foundation of China (Nos. 11072097, 11232006, 11121202, 10972164 and 11202088), and the Science Foundation of Ministry of Education of China (No. 308022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammi M, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.021305; ANDERSON RS, 1988, SCIENCE, V241, P820, DOI 10.1126/science.241.4867.820; Bagnold R., 1941, PHYS BLOWN SAND DESE; Beladjine D, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.061305; Carneiro MV, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.098001; Creyssels M, 2009, J FLUID MECH, V625, P47, DOI 10.1017/S0022112008005491; Dong ZB, 2002, EARTH SURF PROC LAND, V27, P641, DOI 10.1002/esp.341; Duran O, 2012, PHYS FLUIDS, V24, DOI 10.1063/1.4757662; Gordon M, 2009, GEOMORPHOLOGY, V129, P79, DOI [10.1016/j. geomorph.2011.01.015, DOI 10.1016/J.GE0M0RPH.2011.01.015]; Huang N, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007480; JENSEN JI, 1986, SEDIMENTOLOGY, V33, P547, DOI 10.1111/j.1365-3091.1986.tb00760.x; Kang LQ, 2008, SCI CHINA SER G, V51, P986, DOI 10.1007/s11433-008-0120-8; Kok JF, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043646; Kok JF, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD011702; Li BL, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052234; Lu H, 1999, J GEOPHYS RES-ATMOS, V104, P16827, DOI 10.1029/1999JD900169; McEwan I, 1991, ACTA MECH S, P53, DOI DOI 10.1007/978-3-7091-6706-9.3; Nalpanis J, 1993, J FLUID MECH, V251, P661, DOI [10.1017/S0022112093003568, DOI 10.1017/S0022112093003568]; Oger L, 2008, COMPUT MATH APPL, V55, P132, DOI 10.1016/j.camwa.2007.04.001; Pahtz T, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/4/043035; Rasmussen KR, 2009, PLANET SPACE SCI, V57, P804, DOI 10.1016/j.pss.2009.03.001; Rasmussen KR, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2007JF000774; Rice MA, 1996, SEDIMENTOLOGY, V43, P21, DOI 10.1111/j.1365-3091.1996.tb01456.x; RICE MA, 1995, SEDIMENTOLOGY, V42, P695, DOI 10.1111/j.1365-3091.1995.tb00401.x; Shao YP, 2008, PHYS MODELLING WIND; Tong D, 2012, J GEOPHYS RES-ATMOS, V117, DOI [10.1029/2011JD017424, 10.1029/2012JE004062]; Wang ZT, 2006, CATENA, V67, P139, DOI 10.1016/j.catena.2006.03.009; WERNER BT, 1990, J GEOL, V98, P1, DOI 10.1086/629371; WHITE BR, 1977, J FLUID MECH, V81, P497, DOI 10.1017/S0022112077002183; WILLETTS BB, 1986, ACTA MECH, V63, P255, DOI 10.1007/BF01182552; WILLETTS BB, 1989, EARTH SURF PROCESSES, V14, P719, DOI 10.1002/esp.3290140806; Zheng XJ, 2009, ENVIRON SCI-GER, P1, DOI 10.1007/978-3-540-88254-1_1; Zheng XJ, 2005, PHYS LETT A, V341, P107, DOI 10.1016/j.physleta.2005.04.084	33	18	20	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e67935	10.1371/journal.pone.0067935	http://dx.doi.org/10.1371/journal.pone.0067935			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874470	Green Published, gold, Green Submitted			2022-12-27	WOS:000321736900037
J	Li, WF; Huang, ZY; Liu, F; Li, ZG; Yan, LM; Zhang, SW; Chen, SL; Zhong, BX; Su, SK				Li, Wenfeng; Huang, Zachary Y.; Liu, Fang; Li, Zhiguo; Yan, Limin; Zhang, Shaowu; Chen, Shenglu; Zhong, Boxiong; Su, Songkun			Molecular Cloning and Characterization of Juvenile Hormone Acid Methyltransferase in the Honey Bee, Apis mellifera, and Its Differential Expression during Caste Differentiation	PLOS ONE			English	Article							KEY REGULATORY ENZYME; O-METHYLTRANSFERASE; MEVALONATE PATHWAY; HEMOLYMPH TITERS; GENE; METAMORPHOSIS; INDUCTION; PROTEIN; PCR	Juvenile hormone acid methyltransferase (JHAMT) is an enzyme involved in one of the final steps of juvenile hormone biosynthesis in insects. It transfers a methyl group from S-adenosyl-L-methionine (SAM) to the carboxyl group of either farnesoic acid (FA) or JH acid (JHA). Several genes coding for JHAMT have been cloned and characterized from insects from different orders, and they have been shown to play critical roles in metamorphosis and reproduction. However, the significance of JHAMT in Hymenopteran insects is unknown. We used RACE amplification method to clone JHAMT cDNA from the honey bee, Apis mellifera (AmJHAMT). The full length cDNA of AmJHAMT that we cloned is 1253bp long and encodes a 278-aa protein that shares 32-36% identity with known JHAMTs. A SAM-binding motif, conserved in the SAM-dependent methyltransferase (SAM-MT) superfamily, is present in AmJHAMT. Its secondary structure also contains a typical SAM-MT fold. Most of the active sites bound with SAM and substrates (JHA or FA) are conserved in AmJHAMT as in other JHAMT orthologs. Phylogenetic analysis clustered AmJHAMT with the other orthologs from Hymenoptera to form a major clade in the phylogenetic tree. Purified recombinant AmJHAMT protein expressed in E. coli was used to produce polyclonal antibodies and to verify the identity of AmJHAMT by immunoblotting and mass spectrometry. Quantitative RT-PCR and immunoblotting analyses revealed that queen larvae contained significantly higher levels of AmJHAMT mRNA and protein than worker larvae during the periods of caste development. The temporal profiles of both AmJHAMT mRNA and protein in queens and workers showed a similar pattern as the JH biosynthesis. These results suggest that the gene that we cloned codes for a functional JHAMT that catalyzes the final reactions of JH biosynthesis in honey bees. In addition, AmJHAMT may play an important role in honey bee caste differentiation.	[Li, Wenfeng; Liu, Fang; Li, Zhiguo; Yan, Limin; Zhang, Shaowu; Chen, Shenglu; Zhong, Boxiong; Su, Songkun] Zhejiang Univ, Coll Anim Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Huang, Zachary Y.] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA; [Zhang, Shaowu] Australian Natl Univ, Coll Med Biol & Environm, Res Sch Biol, ARC Ctr Excellence Vis Sci, Canberra, ACT, Australia; [Su, Songkun] Fujian Agr & Forestry Univ, Coll Bee Sci, Fuzhou, Peoples R China	Zhejiang University; Michigan State University; Australian National University; Fujian Agriculture & Forestry University	Su, SK (corresponding author), Zhejiang Univ, Coll Anim Sci, Hangzhou 310003, Zhejiang, Peoples R China.	susongkun@zju.edu.cn	Huang, Zachary/D-5485-2011	Huang, Zachary/0000-0001-5354-5547; LI, WENFENG/0000-0001-8819-6009	earmarked funds for Modern Agro-industry Technology Research System [CARS-45-KXJ3]; National Natural Science Foundation of China [30571409]	earmarked funds for Modern Agro-industry Technology Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The research was supported by the earmarked funds for Modern Agro-industry Technology Research System (No.CARS-45-KXJ3) and National Natural Science Foundation of China (No.30571409) to SKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Belles X, 2005, ANNU REV ENTOMOL, V50, P181, DOI 10.1146/annurev.ento.50.071803.130356; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen SL, 2002, BEE WORLD, V83, P69, DOI 10.1080/0005772X.2002.11099543; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Defelipe LA, 2011, INSECT BIOCHEM MOLEC, V41, P228, DOI 10.1016/j.ibmb.2010.12.008; DIETZ A, 1979, J INSECT PHYSIOL, V25, P503, DOI 10.1016/S0022-1910(79)80009-8; FLURI P, 1982, J INSECT PHYSIOL, V28, P61, DOI 10.1016/0022-1910(82)90023-3; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gilbert LI, 2000, INSECT BIOCHEM MOLEC, V30, P617, DOI 10.1016/S0965-1748(00)00034-5; GOODMAN WG, 2005, COMPREHENSIVE MOL IN, V3, P319; Hartfelder K, 1997, INVERTEBR REPROD DEV, V31, P237, DOI 10.1080/07924259.1997.9672582; Hartfelder K, 1998, CURR TOP DEV BIOL, V40, P45, DOI 10.1016/S0070-2153(08)60364-6; He P, 2005, PROTEOMICS, V5, P3442, DOI 10.1002/pmic.200401301; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KAGAN RM, 1994, ARCH BIOCHEM BIOPHYS, V310, P417, DOI 10.1006/abbi.1994.1187; Kinjoh T, 2007, INSECT BIOCHEM MOLEC, V37, P808, DOI 10.1016/j.ibmb.2007.03.008; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mackert A, 2008, COMP BIOCHEM PHYS B, V150, P33, DOI 10.1016/j.cbpb.2008.01.004; Marchal E, 2011, INSECT BIOCHEM MOLEC, V41, P219, DOI 10.1016/j.ibmb.2010.12.007; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; Martin JL, 2002, CURR OPIN STRUC BIOL, V12, P783, DOI 10.1016/S0959-440X(02)00391-3; Mayoral JG, 2009, INSECT BIOCHEM MOLEC, V39, P31, DOI 10.1016/j.ibmb.2008.09.010; MICHELETTE ERD, 1993, APIDOLOGIE, V24, P431, DOI 10.1051/apido:19930410; Minakuchi C, 2008, FEBS J, V275, P2919, DOI 10.1111/j.1742-4658.2008.06428.x; Mutti NS, 2011, J EXP BIOL, V214, P3977, DOI 10.1242/jeb.061499; Niwa R, 2008, INSECT BIOCHEM MOLEC, V38, P714, DOI 10.1016/j.ibmb.2008.04.003; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; RACHINSKY A, 1990, GEN COMP ENDOCR, V79, P31, DOI 10.1016/0016-6480(90)90085-Z; REMBOLD H, 1992, SCI UPDATE, P37; REMBOLD H, 1974, J INSECT PHYSIOL, V20, P1193, DOI 10.1016/0022-1910(74)90225-X; RIDDIFORD LM, 1994, ADV INSECT PHYSIOL, V24, P213, DOI 10.1016/S0065-2806(08)60084-3; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; ROBINSON GE, 1989, SCIENCE, V246, P109, DOI 10.1126/science.246.4926.109; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Sheng ZT, 2008, ARCH INSECT BIOCHEM, V69, P143, DOI 10.1002/arch.20268; Shinoda T, 2003, P NATL ACAD SCI USA, V100, P11986, DOI 10.1073/pnas.2134232100; SHUEL R. W., 1960, INSECTES SOCIAUX, V7, P265, DOI 10.1007/BF02224497; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; WIRTZ P, 1972, ENTOMOL EXP APPL, V15, P517, DOI 10.1007/BF00293616; Wyatt GR, 1996, ADV INSECT PHYSIOL, V26, P1, DOI 10.1016/S0065-2806(08)60030-2	43	31	37	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68544	10.1371/journal.pone.0068544	http://dx.doi.org/10.1371/journal.pone.0068544			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874662	Green Published, Green Submitted, gold			2022-12-27	WOS:000321736900093
J	Lin, YJ; Lan, YC; Hung, CH; Lin, TH; Huang, SM; Liao, CC; Lin, CW; Lai, CH; Tien, N; Liu, X; Ho, MW; Chien, WK; Chen, JH; Wang, JH; Tsai, FJ				Lin, Ying-Ju; Lan, Yu-Ching; Hung, Chien-Hui; Lin, Ting-Hsu; Huang, Shao-Mei; Liao, Chiu-Chu; Lin, Cheng-Wen; Lai, Chih-Ho; Tien, Ni; Liu, Xiang; Ho, Mao-Wang; Chien, Wen-Kuei; Chen, Jin-Hua; Wang, Jen-Hsien; Tsai, Fuu-Jen			Variants in ZNRD1 Gene Predict HIV-1/AIDS Disease Progression in a Han Chinese Population in Taiwan	PLOS ONE			English	Article							MAJOR DETERMINANTS; HIV-INFECTION; HOST CONTROL; HLA-C; ASSOCIATION; REPLICATION; EXPRESSION; GENOME; RNA; DATABASE	Patients demonstrate notable variations in disease progression following human immunodeficiency virus (HIV) infection. We aimed to identify ZNRD1 and RNF39 genetic variants linked to AIDS progression. We conducted a genetic association study in HIV-1-infected Han Chinese patients residing in Taiwan. The clinical characteristics of 143 HIV-1-infected patients were measured, and patients were split into 2 groups: AIDS progression and AIDS non-progression. Genotyping of ZNRD1 and RNF39 was performed in all participants. We found that patients in the AIDS progression group had higher HIV-1 viral loads and lower CD4 cell counts than did patients in the AIDS non-progression group. The frequency of the AA genotype of ZNRD1 (rs16896970) was lower in the AIDS progression group than in the AIDS non-progression group. Patients with AA genotypes had lower levels of HIV-1 viral loads and higher levels of CD4 cell counts than did patients with AG+GG genotypes. AIDS progression in patients with the AA group is significantly different from that in patients with the AG and GG groups by using Kaplan-Meier survival analysis. The hazard ratio for progression was lower in the AA group than in the AG and GG groups. We identified a SNP that contributes to AIDS progression in HIV-1-infected patients in this population. This SNP had a significant protective influence on AIDS progression, and polymorphisms of the ZNRD1 gene may play a role in the pathogenesis of HIV-1 infection.	[Lin, Ying-Ju; Lin, Ting-Hsu; Huang, Shao-Mei; Liao, Chiu-Chu; Tsai, Fuu-Jen] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Lin, Ying-Ju; Tsai, Fuu-Jen] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Lan, Yu-Ching] China Med Univ, Dept Hlth Risk Management, Taichung, Taiwan; [Hung, Chien-Hui] Chang Gung Univ, Grad Inst Clin Med Sci, Chiayi, Taiwan; [Lin, Cheng-Wen; Tien, Ni] China Med Univ, Dept Med Lab Sci & Biotechnol, Taichung, Taiwan; [Lai, Chih-Ho] China Med Univ, Sch Med, Dept Microbiol, Taichung, Taiwan; [Liu, Xiang] NIAID, Mol Virol Sect, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA; [Ho, Mao-Wang; Wang, Jen-Hsien] China Med Univ Hosp, Dept Internal Med, Infect Dis Sect, Taichung, Taiwan; [Chien, Wen-Kuei; Chen, Jin-Hua] China Med Univ, Biostat Ctr, Taichung, Taiwan; [Tsai, Fuu-Jen] Asia Univ, Dept Biotechnol, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; Chang Gung University; China Medical University Taiwan; China Medical University Taiwan; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Asia University Taiwan	Wang, JH (corresponding author), China Med Univ Hosp, Dept Internal Med, Infect Dis Sect, Taichung, Taiwan.	jenhsien@mail.cmuh.org.tw; d0704@mail.cmuh.org.tw	Lan, Yu-Ching/F-2449-2017; Tsai, Fuu-Jen/J-4140-2015; Liu, Xiang/F-5731-2014; Lai, Chih-Ho/M-2433-2013	Lan, Yu-Ching/0000-0003-4781-6405; Lai, Chih-Ho/0000-0001-9229-818X	China Medical University [CMU100-S-01]; China Medical University Hospital [DMR-100-060]; Republic of China National Science Council [NSC 99-2628-B-039-001-MY3, NSC100-2320-B-039-012-MY3]	China Medical University(China Medical University); China Medical University Hospital; Republic of China National Science Council(Ministry of Science and Technology, Taiwan)	Support for this research was provided by China Medical University (CMU100-S-01), China Medical University Hospital (DMR-100-060), and the Republic of China National Science Council (NSC 99-2628-B-039-001-MY3; NSC100-2320-B-039-012-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballana E, 2010, CLIN INFECT DIS, V50, P1022, DOI 10.1086/651114; Bao L, 2012, SEX TRANSM INFECT S1, V88, pi3; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; BUCHBINDER SP, 1994, AIDS, V8, P1123, DOI 10.1097/00002030-199408000-00014; Campino S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004105; Catano G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003636; Dalmasso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003907; DUNDR M, 1995, J CELL SCI, V108, P2811; Fan WF, 2000, GENOMICS, V63, P139, DOI 10.1006/geno.1999.6040; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Goff SP, 2007, NAT REV MICROBIOL, V5, P253, DOI 10.1038/nrmicro1541; Hong L, 2007, CARCINOGENESIS, V28, P1622, DOI 10.1093/carcin/bgm064; Hong L, 2011, CELL BIOL INT, V35, P321, DOI 10.1042/CBI20100506; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Lama J, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-52; Le Clerc S, 2009, J INFECT DIS, V200, P1194, DOI 10.1086/605892; Limou S, 2009, J INFECT DIS, V199, P419, DOI 10.1086/596067; Liszewski MK, 2009, METHODS, V47, P254, DOI 10.1016/j.ymeth.2009.01.002; Matsuo R, 2001, BIOCHEM BIOPH RES CO, V289, P479, DOI 10.1006/bbrc.2001.5975; Michienzi A, 2000, P NATL ACAD SCI USA, V97, P8955, DOI 10.1073/pnas.97.16.8955; Pelak K, 2010, J INFECT DIS, V201, P1141, DOI 10.1086/651382; Perez Omar, 2006, Curr HIV/AIDS Rep, V3, P20, DOI 10.1007/s11904-006-0004-3; Saksena NK, 2007, AIDS REV, V9, P195; Sherry ST, 2000, HUM MUTAT, V15, P68, DOI 10.1002/(SICI)1098-1004(200001)15:1<68::AID-HUMU14>3.0.CO;2-6; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Strebel K, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-48; Taylor N, 2009, ANTIVIR THER, V14, P1189, DOI 10.3851/IMP1427; Tindall Elizabeth A, 2010, BMC Res Notes, V3, P39, DOI 10.1186/1756-0500-3-39; Trachtenberg E, 2009, GENES IMMUN, V10, P673, DOI 10.1038/gene.2009.58; van Manen D, 2009, AIDS, V23, P19, DOI 10.1097/QAD.0b013e32831db247; Yedavalli VSRK, 2011, RNA BIOL, V8, P195, DOI 10.4161/rna.8.2.14803; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	37	7	7	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e67572	10.1371/journal.pone.0067572	http://dx.doi.org/10.1371/journal.pone.0067572			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874430	Green Published, gold, Green Submitted			2022-12-27	WOS:000321736900013
J	Moon, HG; Zheng, YJ; An, CH; Kim, YK; Jin, Y				Moon, Hyung-Geun; Zheng, Yijie; An, Chang Hyeok; Kim, Yoon-Keun; Jin, Yang			CCN1 Secretion Induced by Cigarette Smoking Extracts Augments IL-8 Release from Bronchial Epithelial Cells	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; AIRWAY INFLAMMATION; INTERLEUKIN-8; LUNG; AUTOPHAGY; CYR61; EMPHYSEMA; SMOKERS; PATHOGENESIS; PROTEIN-1	Inflammation involves in many cigarette smoke (CS) related diseases including the chronic obstructive pulmonary disease (COPD). Lung epithelial cell released IL-8 plays a crucial role in CS induced lung inflammation. CS and cigarette smoke extracts (CSE) both induce IL-8 secretion and subsequently, IL-8 recruits inflammatory cells into the lung parenchyma. However, the molecular and cellular mechanisms by which CSE triggers IL-8 release remain not completely understood. In this study, we identified a novel extracellular matrix (ECM) molecule, CCN1, which mediated CSE induced IL-8 secretion by lung epithelial cells. We first found that CS and CSE up-regulated CCN1 expression and secretion in lung epithelial cells in vivo and in vitro. CSE up-regulated CCN1 via induction of reactive oxygen spices (ROS) and endoplasmic reticulum (ER) stress. p38 MAPK and JNK activation were also found to mediate the signal pathways in CSE induced CCN1. CCN1 was secreted into ECM via Golgi and membrane channel receptor aquaporin4. After CSE exposure, elevated ECM CCN1 functioned via an autocrine or paracrine manner. Importantly, CCN1 activated Wnt pathway receptor LRP6, subsequently stimulated Wnt pathway component Dvl2 and triggered beta-catenin translocation from cell membrane to cytosol and nucleus. Treatment of Wnt pathway inhibitor suppressed CCN1 induced IL-8 secretion from lung epithelial cells. Taken together, CSE increased CCN1 expression and secretion in lung epithelial cells via induction of ROS and ER stress. Increased ECM CCN1 resulted in augmented IL-8 release through the activation of Wnt pathway.	[Moon, Hyung-Geun; Zheng, Yijie; An, Chang Hyeok; Jin, Yang] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Pulm & Crit Care, Boston, MA 02115 USA; [Moon, Hyung-Geun; Kim, Yoon-Keun] Pohang Univ Sci & Technol POSTECH, Dept Life Sci, Pohang, South Korea; [Moon, Hyung-Geun; Kim, Yoon-Keun] Pohang Univ Sci & Technol POSTECH, Div Mol & Life Sci, Pohang, South Korea	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Jin, Y (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Pulm & Crit Care, Boston, MA 02115 USA.	yjin@rics.bwh.harvard.edu		An, Chang Hyeok/0000-0001-9145-1322	National Institutes of Health [R01 HL102076]; FAMRI CIA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102076] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FAMRI CIA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by National Institutes of Health R01 HL102076 (Y.J.) and FAMRI CIA (Y.J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron SD, 2001, AM J RESP CRIT CARE, V163, P349, DOI 10.1164/ajrccm.163.2.2003122; An CH, 2012, AM J PHYSIOL-LUNG C, V303, pL748, DOI 10.1152/ajplung.00102.2012; Baggiolini M, 2000, IMMUNOL TODAY, V21, P418, DOI 10.1016/S0167-5699(00)01672-8; Barnes PJ, 2001, PHARMACOL REV, V56, P515; Brigstock DR, 2003, J ENDOCRINOL, V178, P169, DOI 10.1677/joe.0.1780169; Chen ZH, 2010, P NATL ACAD SCI USA, V107, P18880, DOI 10.1073/pnas.1005574107; Chen ZH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003316; Chung Kian F., 2005, Current Drug Targets - Inflammation and Allergy, V4, P619, DOI 10.2174/156801005774912806; Crooks SW, 2000, EUR RESPIR J, V15, P274, DOI 10.1034/j.1399-3003.2000.15b09.x; de Boer WI, 2000, J PATHOL, V190, P619, DOI 10.1002/(SICI)1096-9896(200004)190:5<619::AID-PATH555>3.0.CO;2-6; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; HUNNINGHAKE GW, 1983, AM REV RESPIR DIS, V128, P833; Jin Y, 2005, AM J RESP CELL MOL, V33, P297, DOI 10.1165/rcmb.2005-0144OC; Jin Y, 2009, FASEB J, V23, P341, DOI 10.1096/fj.08-108423; Jorgensen E, 2008, BMC CANCER, V11, p[1471, 1478, 1229]; Jun JI, 2011, NAT REV DRUG DISCOV, V10, P945, DOI 10.1038/nrd3599; Keatings VM, 1996, AM J RESP CRIT CARE, V153, P530, DOI 10.1164/ajrccm.153.2.8564092; Kelsen SG, 2012, PULM PHARMACOL THER, V25, P447, DOI 10.1016/j.pupt.2012.07.005; Kim HP, 2009, METHOD ENZYMOL, V453, P197, DOI 10.1016/S0076-6879(08)04010-X; Koval M, 2002, AM J PHYSIOL-LUNG C, V283, pL875, DOI 10.1152/ajplung.00078.2002; Leu SJ, 2002, J BIOL CHEM, V277, P46248, DOI 10.1074/jbc.M209288200; MCCREA KA, 1994, AM J RESP CRIT CARE, V150, P696, DOI 10.1164/ajrccm.150.3.8087340; Menendez JA, 2003, ENDOCR-RELAT CANCER, V10, P141, DOI 10.1677/erc.0.0100141; Mio T, 1997, AM J RESP CRIT CARE, V155, P1770, DOI 10.1164/ajrccm.155.5.9154890; Ning W, 2004, P NATL ACAD SCI USA, V101, P14895, DOI 10.1073/pnas.0401168101; Nocker RET, 1996, INT ARCH ALLERGY IMM, V109, P183, DOI 10.1159/000237218; Roth M, 2008, INT J TUBERC LUNG D, V12, P375; Schutze N, 2001, J CLIN PATHOL-MOL PA, V54, P170, DOI 10.1136/mp.54.3.170; SHERRILL DL, 1991, AM REV RESPIR DIS, V144, P17, DOI 10.1164/ajrccm/144.1.17; Tanino M, 2002, THORAX, V57, P405, DOI 10.1136/thorax.57.5.405; THOMPSON AB, 1989, AM REV RESPIR DIS, V140, P1527, DOI 10.1164/ajrccm/140.6.1527; van der Toorn M, 2007, AM J PHYSIOL-LUNG C, V292, pL1211, DOI 10.1152/ajplung.00291.2006; Wang BN, 2003, INFECT IMMUN, V71, P5523, DOI 10.1128/IAI.71.10.5523-5530.2003; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x	35	21	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68199	10.1371/journal.pone.0068199	http://dx.doi.org/10.1371/journal.pone.0068199			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874538	Green Published, gold, Green Submitted			2022-12-27	WOS:000321736900066
J	Nemeth, T; Toth, A; Szenzenstein, J; Horvath, P; Nosanchuk, JD; Grozer, Z; Toth, R; Papp, C; Hamari, Z; Vagvolgyi, C; Gacser, A				Nemeth, Tibor; Toth, Adel; Szenzenstein, Judit; Horvath, Peter; Nosanchuk, Joshua D.; Grozer, Zsuzsanna; Toth, Renata; Papp, Csaba; Hamari, Zsuzsanna; Vagvoelgyi, Csaba; Gacser, Attila			Characterization of Virulence Properties in the C. parapsilosis Sensu Lato Species	PLOS ONE			English	Article							CANDIDA-PARAPSILOSIS; GALLERIA-MELLONELLA; METAPSILOSIS; ORTHOPSILOSIS; SUSCEPTIBILITY; PATHOGENESIS; PROTEINASES; INFECTIONS; STRAINS; LIPASE	The C. parapsilosis sensu lato group involves three closely related species, C. parapsilosis sensu stricto, C. orthopsilosis and C. metapsilosis. Although their overall clinical importance is dramatically increasing, there are few studies regarding the virulence properties of the species of the psilosis complex. In this study, we tested 63 C. parapsilosis sensu stricto, 12 C. metapsilosis and 18 C. orthopsilosis isolates for the ability to produce extracellular proteases, secrete lipases and form pseudohyphae. Significant differences were noted between species, with the C. metapsilosis strains failing to secrete lipase or to produce pseudohyphae. Nine different clinical isolates each of C. parapsilosis sensu stricto, C. orthopsilosis and C. metapsilosis were co-cultured with immortalized murine or primary human macrophages. C. parapsilosis sensu stricto isolates showed a significantly higher resistance to killing by primary human macrophages compared to C. orthopsilosis and C. metapsilosis isolates. In contrast, the killing of isolates by J774.2 mouse macrophages did not differ significantly between species. However, C. parapsilosis sensu stricto isolates induced the most damage to murine and human macrophages, and C. metapsilosis strains were the least toxic. Furthermore, strains that produced lipase or pseudohyphae were most resistant to macrophage-mediated killing and produced the most cellular damage. Finally, we used 9 isolates of each of the C. parapsilosis sensus lato species to examine their impact on the survival of Galleria mellonella larvae. The mortality rate of G. mellonella larvae infected with C. metapsilosis isolates was significantly lower than those infected with C. parapsilosis sensu stricto or C. orthopsilosis strains. Taken together, our findings demonstrate that C. metapsilosis is indeed the least virulent member of the psilosis group, and also highlight the importance of pseudohyphae and secreted lipases during fungal-host interactions.	[Nemeth, Tibor; Toth, Adel; Szenzenstein, Judit; Horvath, Peter; Grozer, Zsuzsanna; Toth, Renata; Papp, Csaba; Hamari, Zsuzsanna; Vagvoelgyi, Csaba; Gacser, Attila] Univ Szeged, Dept Microbiol, Szeged, Hungary; [Nosanchuk, Joshua D.; Papp, Csaba] Albert Einstein Coll Med, Dept Microbiol & Immunol, New York, NY USA	Szeged University; Yeshiva University	Gacser, A (corresponding author), Univ Szeged, Dept Microbiol, Szeged, Hungary.	gacsera@gmail.com	Gacser, Attila/M-2801-2018; Vagvolgyi, Csaba/L-8497-2018; Hamari, Zsuzsanna/M-2844-2018; Nosanchuk, Joshua/AAS-7801-2021	Gacser, Attila/0000-0003-2939-9580; Vagvolgyi, Csaba/0000-0003-0009-7773; Hamari, Zsuzsanna/0000-0001-6374-5083; Papp, Csaba Gergo/0000-0003-4450-0667	European Union; European Social Fund [TAMOP-4.2.2/B-10/1-2010-0012]; OTKA [NF 84006, NN100374]; EMBO Installation Grant; Irma T. Hirschl/Monique Weill-Caulier Trust Research Award	European Union(European Commission); European Social Fund(European Social Fund (ESF)); OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); EMBO Installation Grant; Irma T. Hirschl/Monique Weill-Caulier Trust Research Award	NT was supported by the European Union and co-funded by the European Social Fund. Project number: TAMOP-4.2.2/B-10/1-2010-0012. AG was supported in part by OTKA NF 84006 (http://www.otka.hu/en), NN100374 (ERA-Net PathoGenomics Program) (http://www.pathogenomics-era.net/) and an EMBO Installation Grant (http://www.embo.org/), JN was supported in part by an Irma T. Hirschl/Monique Weill-Caulier Trust Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertini A, 2013, INT J MED MICROBIOL, V303, P98, DOI 10.1016/j.ijmm.2012.12.006; Bonfietti LX, 2012, J MED MICROBIOL, V61, P1003, DOI 10.1099/jmm.0.037812-0; DIMENT S, 1987, J LEUKOCYTE BIOL, V42, P485, DOI 10.1002/jlb.42.5.485; Fallon John, 2012, Methods Mol Biol, V845, P469, DOI 10.1007/978-1-61779-539-8_33; Gacser A, 2007, FUNGAL GENET BIOL, V44, P1336, DOI 10.1016/j.fgb.2007.02.002; Gacser A, 2007, INFECT IMMUN, V75, P4710, DOI 10.1128/IAI.00372-07; Gacser A, 2007, J CLIN INVEST, V117, P3049, DOI 10.1172/JCI32294; Garcia-Effron G, 2012, J ANTIMICROB CHEMOTH, V67, P2739, DOI 10.1093/jac/dks271; Garcia-Rodas R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024485; Horvath P, 2012, J INFECT DIS, V205, P923, DOI 10.1093/infdis/jir873; Kocsube S, 2007, J MED MICROBIOL, V56, P190, DOI 10.1099/jmm.0.46838-0; KOUKER G, 1987, APPL ENVIRON MICROB, V53, P211, DOI 10.1128/AEM.53.1.211-213.1987; Mesa-Arango AC, 2012, MED MYCOL; Monod M, 2002, BIOL CHEM, V383, P1087, DOI 10.1515/BC.2002.117; Mylonakis E, 2008, MYCOPATHOLOGIA, V165, P1, DOI 10.1007/s11046-007-9082-z; Naglik JR, 2003, MICROBIOL MOL BIOL R, V67, P400, DOI 10.1128/MMBR.67.3.400-428.2003; Netea MG, 2010, MED MYCOL, V48, P897, DOI 10.3109/13693781003621575; Orsi CF, 2010, MED MYCOL, V48, P1024, DOI 10.3109/13693786.2010.489233; PRUZANSKI W, 1988, INFLAMMATION, V12, P87, DOI 10.1007/BF00915894; RUCHEL R, 1982, SABOURAUDIA, V20, P233; Sabino R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-180; Schlenke P, 1998, CLIN DIAGN LAB IMMUN, V5, P808, DOI 10.1128/CDLI.5.6.808-813.1998; Stehr F, 2004, FEMS YEAST RES, V4, P401, DOI 10.1016/S1567-1356(03)00205-8; Tavanti A, 2005, J CLIN MICROBIOL, V43, P284, DOI 10.1128/JCM.43.1.284-292.2005; Tavanti A, 2006, MICROBES INFECT, V8, P791, DOI 10.1016/j.micinf.2005.09.016; Thomaz L, 2013, VIRULENCE, V4, P139, DOI 10.4161/viru.23047; Trofa D, 2008, CLIN MICROBIOL REV, V21, P606, DOI 10.1128/CMR.00013-08	27	55	55	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68704	10.1371/journal.pone.0068704	http://dx.doi.org/10.1371/journal.pone.0068704			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874732	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000321736900105
J	Shang, DS; Ruan, LX; Zhou, SH; Bao, YY; Cheng, KJ; Wang, QY				Shang, De-Sheng; Ruan, Ling-Xiang; Zhou, Shui-Hong; Bao, Yang-Yang; Cheng, Ke-Jia; Wang, Qin-Ying			Differentiating Laryngeal Carcinomas from Precursor Lesions by Diffusion-Weighted Magnetic Resonance Imaging at 3.0 T: A Preliminary Study	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; TURBO SPIN-ECHO; INITIAL-EXPERIENCE; NECK LESIONS; HEAD; COEFFICIENT; CANCER; TUMORS; ENDOSCOPY; DIAGNOSIS	Background: Diffusion-weighted magnetic resonance imaging (DWI) has been introduced in head and neck cancers. Due to limitations in the performance of laryngeal DWI, including the complex anatomical structure of the larynx leading to susceptibility effects, the value of DWI in differentiating benign from malignant laryngeal lesions has largely been ignored. We assessed whether a threshold for the apparent diffusion coefficient (ADC) was useful in differentiating preoperative laryngeal carcinomas from precursor lesions by turbo spin-echo (TSE) DWI and 3.0-T magnetic resonance. Methods: We evaluated DWI and the ADC value in 33 pathologically proven laryngeal carcinomas and 17 precancerous lesions. Results: The sensitivity, specificity, and accuracy were 81.8%, 64.7%, 76.0% by laryngostroboscopy, respectively. The sensitivity, specificity, and accuracy of conventional magnetic resonance imaging were 90.9%, 76.5%, 86.0%, respectively. Qualitative DWI analysis produced sensitivity, specificity, and accuracy values of 100.0, 88.2, and 96.0%, respectively. The ADC values were lower for patients with laryngeal carcinoma (mean 1.195 +/- 0.32x10(-3) mm(2)/s) versus those with laryngeal precancerous lesions (mean 1.780 +/- 0.32x10(-3) mm(2)/s; P<0.001). ROC analysis showed that the area under the curve was 0.956 and the optimum threshold for the ADC was 1.455x10(-3) mm(2)/s, resulting in a sensitivity of 94.1%, a specificity of 90.9%, and an accuracy of 92.9%. Conclusions: Despite some limitations, including the small number of laryngeal carcinomas included, DWI may detect changes in tumor size and shape before they are visible by laryngostroboscopy. The ADC values were lower for patients with laryngeal carcinoma than for those with laryngeal precancerous lesions. The proposed cutoff for the ADC may help distinguish laryngeal carcinomas from laryngeal precancerous lesions.	[Shang, De-Sheng; Ruan, Ling-Xiang] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Radiol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhou, Shui-Hong; Bao, Yang-Yang; Cheng, Ke-Jia; Wang, Qin-Ying] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Otolaryngol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Zhou, SH (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Otolaryngol, Hangzhou 310003, Zhejiang, Peoples R China.	zhouyunzhoush@163.com						Becker M, 2008, RADIOLOGY, V249, P551, DOI 10.1148/radiol.2492072183; Becker M, 2008, EUR J RADIOL, V66, P460, DOI 10.1016/j.ejrad.2008.03.027; de Bree R, 2009, ORAL ONCOL, V45, P386, DOI 10.1016/j.oraloncology.2008.10.015; de Graaf P, 2012, AM J NEURORADIOL, V33, P110, DOI 10.3174/ajnr.A2729; Eida S, 2007, AM J NEURORADIOL, V28, P116; Galban S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035857; GALLO O, 1994, ACTA OTO-LARYNGOL, V114, P213, DOI 10.3109/00016489409126045; Hatakenaka M, 2011, INT J RADIAT ONCOL, V81, P339, DOI 10.1016/j.ijrobp.2010.05.051; Holzapfel K, 2009, EUR J RADIOL, V72, P381, DOI 10.1016/j.ejrad.2008.09.034; Hu Q, 2011, J ULTRAS MED, V30, P1467, DOI 10.7863/jum.2011.30.11.1467; Kim JW, 2008, J LARYNGOL OTOL, V122, P1224, DOI 10.1017/S0022215108001746; Kraft M, 2011, HEAD NECK-J SCI SPEC, V33, P941, DOI 10.1002/hed.21565; Malzahn K, 2002, LARYNGOSCOPE, V112, P488, DOI 10.1097/00005537-200203000-00015; Perrone A, 2011, EUR J RADIOL, V77, P281, DOI 10.1016/j.ejrad.2009.07.039; Razek AAKA, 2008, ACTA RADIOL, V49, P364, DOI 10.1080/02841850701777390; Razek AAKA, 2007, AM J NEURORADIOL, V28, P1146, DOI 10.3174/ajnr.A0491; Razek AAKA, 2010, J COMPUT ASSIST TOMO, V34, P808, DOI 10.1097/RCT.0b013e3181f01796; Razek AAK, 2009, EUR RADIOL, V19, P201, DOI 10.1007/s00330-008-1123-6; Rylander S, 2011, ACTA ONCOL, V50, P866, DOI 10.3109/0284186X.2011.590523; Sakamoto J, 2012, OR SURG OR MED OR PA, V114, P266, DOI 10.1016/j.oooo.2012.03.015; Sasaki M, 2011, AM J NEURORADIOL, V32, P1100, DOI 10.3174/ajnr.A2434; Srinivasan A, 2008, AM J NEURORADIOL, V29, P40, DOI 10.3174/ajnr.A0743; Thoeny HC, 2012, RADIOLOGY, V263, P19, DOI 10.1148/radiol.11101821; Thoeny HC, 2011, CANCER IMAGING, V10, P209, DOI 10.1102/1470-7330.2010.0030; Vandecaveye V, 2006, BRIT J RADIOL, V79, P681, DOI 10.1259/bjr/89661809; Vandecaveye V, 2012, INT J RADIAT ONCOL, V82, P1098, DOI 10.1016/j.ijrobp.2011.02.044; Vandecaveye V, 2010, NEURORADIOLOGY, V52, P773, DOI 10.1007/s00234-010-0743-0; Verhappen MH, 2012, AM J NEURORADIOL, V33, P1239, DOI 10.3174/ajnr.A2949; Vogel DWT, 2013, EUR RADIOL, V23, P562, DOI 10.1007/s00330-012-2596-x; Wang JC, 2001, RADIOLOGY, V220, P621, DOI 10.1148/radiol.2202010063; Warnecke A, 2010, LARYNGOSCOPE, V120, P253, DOI 10.1002/lary.20732	31	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68622	10.1371/journal.pone.0068622	http://dx.doi.org/10.1371/journal.pone.0068622			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874693	Green Published, Green Submitted, gold			2022-12-27	WOS:000321736900098
J	van Klinken, RD; Panetta, FD; Coutts, SR				van Klinken, Rieks D.; Panetta, F. Dane; Coutts, Shaun R.			Are High-Impact Species Predictable? An Analysis of Naturalised Grasses in Northern Australia	PLOS ONE			English	Article							PLANT INTRODUCTIONS; FIRE CYCLE; INVASIONS; CONSEQUENCES; FRAMEWORK	Predicting which species are likely to cause serious impacts in the future is crucial for targeting management efforts, but the characteristics of such species remain largely unconfirmed. We use data and expert opinion on tropical and subtropical grasses naturalised in Australia since European settlement to identify naturalised and high-impact species and subsequently to test whether high-impact species are predictable. High-impact species for the three main affected sectors (environment, pastoral and agriculture) were determined by assessing evidence against pre-defined criteria. Twenty-one of the 155 naturalised species (14%) were classified as high-impact, including four that affected more than one sector. High-impact species were more likely to have faster spread rates (regions invaded per decade) and to be semi-aquatic. Spread rate was best explained by whether species had been actively spread (as pasture), and time since naturalisation, but may not be explanatory as it was tightly correlated with range size and incidence rate. Giving more weight to minimising the chance of overlooking high-impact species, a priority for biosecurity, meant a wider range of predictors was required to identify high-impact species, and the predictive power of the models was reduced. By-sector analysis of predictors of high impact species was limited by their relative rarity, but showed sector differences, including to the universal predictors (spread rate and habitat) and life history. Furthermore, species causing high impact to agriculture have changed in the past 10 years with changes in farming practice, highlighting the importance of context in determining impact. A rationale for invasion ecology is to improve the prediction and response to future threats. Although our study identifies some universal predictors, it suggests improved prediction will require a far greater emphasis on impact rather than invasiveness, and will need to account for the individual circumstances of affected sectors and the relative rarity of high-impact species.	[van Klinken, Rieks D.] CSIRO, CSIRO Ecosyst Sci, Brisbane, Qld, Australia; [Panetta, F. Dane] Univ Melbourne, Melbourne Sch Land & Environm, Melbourne, Vic, Australia; [Coutts, Shaun R.] Univ Queensland, Ctr Biodivers & Conservat Sci, NERP Environm Decis Hub, Brisbane, Qld, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Melbourne; University of Queensland	van Klinken, RD (corresponding author), CSIRO, CSIRO Ecosyst Sci, Brisbane, Qld, Australia.	rieks.vanklinken@csiro.au	Coutts, Shaun R/J-4265-2014; van Klinken, Rieks D/B-1772-2009	Coutts, Shaun R/0000-0003-0282-4559; van Klinken, Rieks D/0000-0002-7578-8977				Aikio S, 2010, OIKOS, V119, P370, DOI 10.1111/j.1600-0706.2009.17963.x; [Anonymous], 2002, FLORA AUSTR; [Anonymous], 2007, AUSTR PLANT HERBAGE; Bates D, 2012, LME4 LINEAR MIXED EF; Bradley BA, 2010, TRENDS ECOL EVOL, V25, P310, DOI 10.1016/j.tree.2009.12.003; Bramer M., 2007, PRINCIPLES DATA MINI, V180; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Butler Don W., 2003, Ecological Management & Restoration, V4, P120, DOI 10.1046/j.1442-8903.2003.00146.x; Caley P, 2006, BIOL INVASIONS, V8, P277, DOI 10.1007/s10530-004-6703-z; Catford JA, 2009, DIVERS DISTRIB, V15, P22, DOI 10.1111/j.1472-4642.2008.00521.x; Cook GD, 2006, AUST J BOT, V54, P601, DOI 10.1071/BT05157; Daehler Curtis C., 2010, Plant Protection Quarterly, V25, P52; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; Drenovsky RE, 2012, ANN BOT-LONDON, V110, P141, DOI 10.1093/aob/mcs100; Ferdinands K, 2005, WILDLIFE RES, V32, P447, DOI 10.1071/WR04036; Forno I, 2000, SUCCESS BIOL CONTROL, P159; Friedel M, 2011, ENV SCI POLICY; Groves R.H., 2003, WEED CATEGORIES NATU; Gurevitch J, 2011, ECOL LETT, V14, P407, DOI 10.1111/j.1461-0248.2011.01594.x; Huang QQ, 2010, BIODIVERS CONSERV, V19, P1251, DOI 10.1007/s10531-009-9751-y; Huang QQ, 2009, BIODIVERS CONSERV, V18, P305, DOI 10.1007/s10531-008-9485-2; Hulme PE, 2012, TRENDS ECOLOGY EVOLU; Kellogg EA, 2009, FLORA AUSTR, V44, P1; KELLOGG EA, 2002, FLORA AUSTR, V43, P245; Klinken R. van, 2004, Weed management: balancing people, planet, profit. 14th Australian Weeds Conference, Wagga Wagga, New South Wales, Australia, 6-9 September 2004: papers and proceedings, P480; Leung B, 2012, ECOL LETT, V15, P1475, DOI 10.1111/ele.12003; LONSDALE WM, 1994, AUST J ECOL, V19, P345, DOI 10.1111/j.1442-9993.1994.tb00498.x; Lowe S., 2000, ENCY BIOL INVASIONS; Mack R. N., 1989, BIOL INVASIONS GLOBA, P155; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Martin TG, 2006, RANGELAND J, V28, P63, DOI 10.1071/RJ06015; McIntyre S, 2005, AUST J BOT, V53, P757, DOI 10.1071/BT05088; Parker I.M., 1999, Biological Invasions, V1, P3, DOI 10.1023/A:1010034312781; Parsons W.T., 2001, NOXIOUS WEEDS AUSTR, Vsecond; Pengelly S.D., 2005, TROPICAL FORAGES; Pimentel D., 2002, BIOL INVASIONS EC EN; Powles SB, 2010, ANNU REV PLANT BIOL, V61, P317, DOI 10.1146/annurev-arplant-042809-112119; Pysek P, 2012, GLOBAL CHANGE BIOL; R Core Team, 2012, R LANG ENV STAT COMP; Randall RP, 2002, GLOBAL COMPENDIUM WE; Ricciardi A, 2007, BIOL INVASIONS, V9, P309, DOI 10.1007/s10530-006-9034-4; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Richardson DM, 2004, INVASIVE ALIEN PLANT; Robinson TP, 2010, ECOL MODEL, V221, P2261, DOI 10.1016/j.ecolmodel.2010.04.018; Rossiter NA, 2003, DIVERS DISTRIB, V9, P169, DOI 10.1046/j.1472-4642.2003.00020.x; SCOTT JK, 1993, J BIOGEOGR, V20, P87, DOI 10.2307/2845742; Setterfield SA, 2010, DIVERS DISTRIB, V16, P854, DOI 10.1111/j.1472-4642.2010.00688.x; Simon BK, 2012, CLASSIFICATION GRASS; Skerman PJ., 1990, TROPICAL GRASSES; Thomsen MS, 2011, ENVIRON RES, V111, P899, DOI 10.1016/j.envres.2011.05.024; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Warnes MGR, 2012, PACKAGE GMODELS; Wearne Lynise J., 2010, Plant Protection Quarterly, V25, P146; Wildin J., 1991, ALEMAN GRASS HYMENAC; Yokomizo H, 2012, BIOL INVASIONS, V14, P839, DOI 10.1007/s10530-011-0120-x	55	14	16	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68678	10.1371/journal.pone.0068678	http://dx.doi.org/10.1371/journal.pone.0068678			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874718	gold, Green Published, Green Accepted			2022-12-27	WOS:000321736900102
J	Zhou, S; Yang, Y; Yang, YQ; Tao, HH; Li, D; Zhang, JL; Jiang, GN; Fang, JM				Zhou, Shuang; Yang, Yang; Yang, Yaoqin; Tao, Huihong; Li, Dong; Zhang, Junli; Jiang, Gening; Fang, Jianmin			Combination Therapy of VEGF-Trap and Gemcitabine Results in Improved Anti-Tumor Efficacy in a Mouse Lung Cancer Model	PLOS ONE			English	Article							ANTI-ANGIOGENIC THERAPY; PHASE-III TRIAL; TUMOR VASCULATURE; 1ST-LINE THERAPY; MURINE MODEL; GROWTH; CHEMOTHERAPY; BEVACIZUMAB; CISPLATIN; REGRESSION	Background: Angiogenesis is essential for the growth and metastasis of cancer. Although anti-angiogenic agents, particularly vascular endothelial growth factor (VEGF) inhibitors, have exhibited single-agent activity, there is considerable interest in combining these novel drugs with conventional chemotherapy reagents to achieve an optimal clinical efficacy. The objective of this study was to evaluate the benefits of the combination therapy of vascular endothelial growth factor trap (VEGF-Trap) with gemcitabine in a lung tumor model. Methods: A luciferase-expressing Lewis lung carcinoma (LLC) model was established in C57BL/6J mice and tumor-bearing mice were randomized into control, VEGF-Trap, gemcitabine and VEGF-Trap/gemcitabine combination groups. Tumor growth and animal survival were monitored. Tumor microvessel density and cell proliferation were evaluated by CD31 and Ki-67 immunohistochemical analysis. TUNEL assay was performed to detect apoptotic cells. The protein levels of Cyclin D1, Pro-Caspase-3, Bcl-2, MMP2 and MMP9 in tumor extracts were examined by western blot. Results: VEGF-Trap in combination with gemcitabine showed significantly enhanced inhibition of tumor growth and prolonged mouse survival compared to the VEGF-Trap or gemcitabine monotherapy. The VEGF-Trap/gemcitabine combination therapy not only potently inhibited tumor angiogenesis and cell proliferation, but also increased cellular apoptosis within tumor tissues. In addition, the combination treatment markedly down-regulated the expression of proliferation, anti-apoptosis and invasion related proteins. Conclusion: Combination therapy using VEGF-Trap and gemcitabine resulted in improved anti-tumor efficacy in a lung cancer model and VEGF-Trap/gemcitabine combination might represent a promising strategy in the treatment of human lung cancer.	[Zhou, Shuang; Yang, Yaoqin; Tao, Huihong] Tongji Univ, Dept Histol & Embryol, Sch Med, Shanghai 200092, Peoples R China; [Li, Dong; Fang, Jianmin] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Yang, Yang; Jiang, Gening] Tongji Univ, Dept Thorac Surg, Shanghai Pulm Hosp, Sch Med, Shanghai 200092, Peoples R China; [Zhang, Junli] Yantai Rongchang Biotechnol Ltd, Yantai, Shandong, Peoples R China	Tongji University; Tongji University; Tongji University	Jiang, GN (corresponding author), Tongji Univ, Dept Thorac Surg, Shanghai Pulm Hosp, Sch Med, Shanghai 200092, Peoples R China.	jgnwp@yahoo.com.cn; jianminfang@gmail.com			Shanghai "Science and Technology Innovation Action Plan" experimental animal research project [10140900400]; National Natural Science Foundation of China [31000527]; Shanghai Health Bureau Research Fund for young investigator; Hong Kong Scholar program [XJ2011025]	Shanghai "Science and Technology Innovation Action Plan" experimental animal research project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Health Bureau Research Fund for young investigator; Hong Kong Scholar program	This study was supported by Shanghai "Science and Technology Innovation Action Plan" experimental animal research project (No. 10140900400), National Natural Science Foundation of China (No. 31000527), Shanghai Health Bureau Research Fund for young investigator (to Dr. Shuang Zhou) and Hong Kong Scholar program (No. XJ2011025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai RZ, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-31; Bello L, 2001, CANCER RES, V61, P7501; Bhattacharya A, 2008, CLIN CANCER RES, V14, P3926, DOI 10.1158/1078-0432.CCR-08-0212; Browder T, 2000, CANCER RES, V60, P1878; Byrne AT, 2003, CLIN CANCER RES, V9, P5721; Chen F, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031645, 10.1371/journal.pone.0039197]; de Gramont A, 2012, LANCET ONCOL, V13, P1225, DOI 10.1016/S1470-2045(12)70509-0; Dickson PV, 2007, CLIN CANCER RES, V13, P3942, DOI 10.1158/1078-0432.CCR-07-0278; Dings RPM, 2007, CLIN CANCER RES, V13, P3395, DOI 10.1158/1078-0432.CCR-06-2441; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; FOLKMAN J, 2005, CANC PRINCIPLES PRAC; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Heinemann V, 2006, J CLIN ONCOL, V24, P3946, DOI 10.1200/JCO.2005.05.1490; Herbst R S, 2001, Curr Oncol Rep, V3, P131, DOI 10.1007/s11912-001-0013-8; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Holash J, 2002, P NATL ACAD SCI USA, V99, P11393, DOI 10.1073/pnas.172398299; Hou JM, 2005, ONCOLOGY-BASEL, V69, P81, DOI 10.1159/000087303; Inai T, 2004, AM J PATHOL, V165, P35, DOI 10.1016/S0002-9440(10)63273-7; Jain RK, 2001, NAT MED, V7, P987, DOI 10.1038/nm0901-987; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kerbel RS, 2006, SCIENCE, V312, P1171, DOI 10.1126/science.1125950; Kim ES, 2002, P NATL ACAD SCI USA, V99, P11399, DOI 10.1073/pnas.172398399; Liu TG, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-250; Longo R., 2002, Angiogenesis, V5, P237, DOI 10.1023/A:1024532022166; Ma J, 2008, MOL CANCER THER, V7, P3670, DOI 10.1158/1535-7163.MCT-08-0715; Martel CL., 2006, COMM ONCOL, V3, P90; Nathan P, 2012, CLIN CANCER RES, V18, P3428, DOI 10.1158/1078-0432.CCR-11-3376; Paz-Ares L, 2006, J CLIN ONCOL, V24, P1428, DOI 10.1200/JCO.2005.04.3299; Reck M, 2010, ANN ONCOL, V21, P1804, DOI 10.1093/annonc/mdq020; Rosen L, 2000, Oncologist, V5 Suppl 1, P20; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Sharma T, 2013, MINI-REV MED CHEM, V13, P530, DOI 10.2174/1389557511313040006; Shi W, 2009, J MOL MED, V87, P493, DOI 10.1007/s00109-009-0444-5; Stone RL, 2010, LANCET ONCOL, V11, P465, DOI 10.1016/S1470-2045(09)70362-6; Tandle Anita, 2004, J Transl Med, V2, P22, DOI 10.1186/1479-5876-2-22; Teoh D, 2012, INT J GYNECOL CANCER, V22, P348, DOI 10.1097/IGC.0b013e31823c6efd; Van Cutsem E, 2012, J CLIN ONCOL, V30, P2119, DOI 10.1200/JCO.2011.39.9824; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Wulff C, 2002, ENDOCRINOLOGY, V143, P2797, DOI 10.1210/en.143.7.2797	39	8	9	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68589	10.1371/journal.pone.0068589	http://dx.doi.org/10.1371/journal.pone.0068589			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874680	Green Published, gold, Green Submitted			2022-12-27	WOS:000321736900096
J	Jia, JJ; Shafiee-Kermani, F; Miller, WL				Jia, Jingjing; Shafiee-Kermani, Farideh; Miller, William L.			Gonadotrope-Specific Expression and Regulation of Ovine Follicle Stimulating Hormone Beta: Transgenic and Adenoviral Approaches Using Primary Murine Gonadotropes	PLOS ONE			English	Article							TRANSCRIPTIONAL ACTIVATION; SUBUNIT GENE; PROMOTER; ACTIVIN; INVOLVEMENT; PROTEIN-1; SEQUENCE; SITES; MODEL; MICE	The beta subunit of follicle stimulating hormone (FSHB) is expressed specifically in pituitary gonadotropes in vertebrates. Transgenic mouse studies have shown that enhancers in the proximal promoter between -172/-1 bp of the ovine FSHB gene are required for gonadotrope expression of ovine FSHB. These enhancers are associated with regulation by activins and gonadotropin releasing hormone (GnRH). Additional distal promoter sequence between -4741/-750 bp is also required for expression. New transgenic studies presented here focus on this distal region and narrow it to 1116 bp between -1866/-750 bp. In addition, adenoviral constructs were produced to identify these critical distal sequences using purified primary mouse gonadotropes as an in vitro model system. The adenoviral constructs contained -2871 bp, -750 bp or -232 bp of the ovine FSHB promoter. They all showed gonadotrope-specific regulation since they were induced only in purified primary gonadotropes by activin A (50 ng/ml) and inhibited by GnRH (100 nM) in the presence of activin (except -232FSHBLuc). However, basal expression of all three viral constructs (in the presence of follistatin to block cellular induction by activin) was relatively high in pituitary non-gonadotropes as well as gonadotropes. Thus, gonadotrope-specific regulation associated with the proximal promoter was observed as expected, but the model was blind to distal promoter elements between -2871/-750 necessary for gonadotrope-specific expression of ovine FSHB in vivo. The new adenoviral-based in vitro technique did detect, however, a novel GnRH response element between -750 bp and -232 bp of the ovine FSHB promoter. We conclude that adenoviral-based studies in primary gonadotropes can adequately recognize regulatory elements on the ovine FSHB promoter associated with gonadotrope-specific regulation/expression, but that more physiologically based techniques, such as transgenic studies, will be needed to identify sequences between -1866/-750 bp of the ovine FSHB promoter that are also required for tissue/cell specific expression in vivo.	[Jia, Jingjing] Mt Sinai Med Ctr, Dept Neurol, New York, NY 10029 USA; [Shafiee-Kermani, Farideh; Miller, William L.] N Carolina State Univ, Dept Mol & Struct Biochem, Raleigh, NC 27695 USA	Icahn School of Medicine at Mount Sinai; University of North Carolina; North Carolina State University	Miller, WL (corresponding author), N Carolina State Univ, Dept Mol & Struct Biochem, Raleigh, NC 27695 USA.	wlmiller@ncsu.edu			North Carolina State University Agricultural Research Service; National Institutes of Health [R01HD-042459]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042459] Funding Source: NIH RePORTER	North Carolina State University Agricultural Research Service; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This manuscript was funded by the North Carolina State University Agricultural Research Service and the National Institutes of Health R01HD-042459. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa S, 2004, BIOCHEM BIOPH RES CO, V324, P946, DOI 10.1016/j.bbrc.2004.09.124; Cai LY, 2007, J REPROD DEVELOP, V53, P201, DOI 10.1262/jrd.18111; Han SO, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-66; Huang HJ, 2001, ENDOCRINOLOGY, V142, P2260, DOI 10.1210/en.142.6.2260; Huang HJ, 2001, ENDOCRINOLOGY, V142, P2267, DOI 10.1210/en.142.6.2267; Jablonka-Shariff A, 2008, J BIOL CHEM, V283, P11485, DOI 10.1074/jbc.M800654200; Kumar TR, 2006, MOL CELL ENDOCRINOL, V247, P103, DOI 10.1016/j.mce.2005.12.006; Lee KB, 2007, J MOL ENDOCRINOL, V38, P315, DOI 10.1677/jme.1.02196; Pernasetti F, 2001, ENDOCRINOLOGY, V142, P2284, DOI 10.1210/en.142.6.2284; Shafiee-Kermani F, 2007, ENDOCRINOLOGY, V148, P3346, DOI 10.1210/en.2006-1740; Strahl BD, 1998, ENDOCRINOLOGY, V139, P4455, DOI 10.1210/en.139.11.4455; Su P, 2007, ENDOCRINOLOGY, V148, P4500, DOI 10.1210/en.2006-1635; Thomas P, 1996, ENDOCRINOLOGY, V137, P2979, DOI 10.1210/en.137.7.2979; Vasilyev VV, 2002, ENDOCRINOLOGY, V143, P1651, DOI 10.1210/en.143.5.1651; Wang Y, 2008, ENDOCRINOLOGY, V149, P5577, DOI 10.1210/en.2008-0220; Wu JC, 2004, ENDOCRINOLOGY, V145, P5832, DOI 10.1210/en.2004-0257; Zakaria MM, 2002, MOL ENDOCRINOL, V16, P1840, DOI 10.1210/me.2002-0088	17	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e66852	10.1371/journal.pone.0066852	http://dx.doi.org/10.1371/journal.pone.0066852			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874399	gold, Green Published, Green Submitted			2022-12-27	WOS:000324146200003
J	Schmidt, P; Schmid, VJ; Gaser, C; Buck, D; Buhrlen, S; Forschler, A; Muhlau, M				Schmidt, Paul; Schmid, Volker J.; Gaser, Christian; Buck, Dorothea; Buehrlen, Susanne; Foerschler, Annette; Muehlau, Mark			Fully Bayesian Inference for Structural MRI: Application to Segmentation and Statistical Analysis of T2-Hypointensities	PLOS ONE			English	Article							WHITE-MATTER LESIONS; GRAY-MATTER; IRON; AGE; MODEL	Aiming at iron-related T2-hypointensity, which is related to normal aging and neurodegenerative processes, we here present two practicable approaches, based on Bayesian inference, for preprocessing and statistical analysis of a complex set of structural MRI data. In particular, Markov Chain Monte Carlo methods were used to simulate posterior distributions. First, we rendered a segmentation algorithm that uses outlier detection based on model checking techniques within a Bayesian mixture model. Second, we rendered an analytical tool comprising a Bayesian regression model with smoothness priors (in the form of Gaussian Markov random fields) mitigating the necessity to smooth data prior to statistical analysis. For validation, we used simulated data and MRI data of 27 healthy controls (age: 30+/-9; range, 20-58). We first observed robust segmentation of both simulated T2-hypointensities and gray-matter regions known to be T2-hypointense. Second, simulated data and images of segmented T2-hypointensity were analyzed. We found not only robust identification of simulated effects but also a biologically plausible age-related increase of T2-hypointensity primarily within the dentate nucleus but also within the globus pallidus, substantia nigra, and red nucleus. Our results indicate that fully Bayesian inference can successfully be applied for preprocessing and statistical analysis of structural MRI data.	[Schmidt, Paul; Buck, Dorothea; Buehrlen, Susanne; Muehlau, Mark] Tech Univ Munich, Dept Neurol, D-80290 Munich, Germany; [Schmidt, Paul; Buck, Dorothea; Buehrlen, Susanne; Foerschler, Annette; Muehlau, Mark] Tech Univ Munich, TUM Neuroimaging Ctr, D-80290 Munich, Germany; [Schmidt, Paul; Schmid, Volker J.] Univ Munich, Dept Stat, Munich, Germany; [Gaser, Christian] Jena Univ Hosp, Dept Psychiat, Jena, Germany; [Gaser, Christian] Jena Univ Hosp, Dept Neurol, Jena, Germany; [Foerschler, Annette] Tech Univ Munich, Dept Neuroradiol, D-80290 Munich, Germany	Technical University of Munich; Technical University of Munich; University of Munich; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Technical University of Munich	Muhlau, M (corresponding author), Tech Univ Munich, Dept Neurol, D-80290 Munich, Germany.	muehlau@lrz.tum.de	Schmid, Volker/F-3251-2010; Gaser, Christian/F-5103-2010; TUM, Forschung Neurorad/C-1202-2014; Forschler, Annette/O-9390-2015	Schmid, Volker/0000-0003-2195-8130; Gaser, Christian/0000-0002-9940-099X; Schmidt, Paul/0000-0002-1676-1774; Forschler, Annette/0000-0001-9665-5228	Novartis Pharma GmbH; German Ministry for Education and Research (BMBF) [01EV0709]; German Ministry for Education and Research (BMBF) (German Competence Network Multiple Sclerosis, KKNMS) [01GI1307B]; German Ministry for Education and Research (BMBF) (KKNMS) [01GI0917]; Kommission fur Klinische Forschung, Technische Universitat Munchen [B16-11]	Novartis Pharma GmbH; German Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Ministry for Education and Research (BMBF) (German Competence Network Multiple Sclerosis, KKNMS)(Federal Ministry of Education & Research (BMBF)); German Ministry for Education and Research (BMBF) (KKNMS)(Federal Ministry of Education & Research (BMBF)); Kommission fur Klinische Forschung, Technische Universitat Munchen	This work was supported by Novartis Pharma GmbH (Project: Whole-brain MRI analysis of T2-hypointensity in Multiple Sclerosis) to M. M.; by the German Ministry for Education and Research (BMBF) to C. G. (BMBF grant 01EV0709), M. M. (German Competence Network Multiple Sclerosis, KKNMS, grant 01GI1307B), and D. B. (KKNMS, grant 01GI0917); as well as by Kommission fur Klinische Forschung, Technische Universitat Munchen to D. B. (KKF fond B16-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anbeek P, 2004, NEUROIMAGE, V21, P1037, DOI 10.1016/j.neuroimage.2003.10.012; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Baker SG., 1992, J COMPUTATIONAL GRAP, V1, P63, DOI DOI 10.2307/1390600; Barkovich AJ, 2000, AM J NEURORADIOL, V21, P1099; BARTKO JJ, 1991, SCHIZOPHRENIA BULL, V17, P483, DOI 10.1093/schbul/17.3.483; Bermel RA, 2005, ARCH NEUROL-CHICAGO, V62, P1371, DOI 10.1001/archneur.62.9.1371; Bilgic B, 2012, NEUROIMAGE, V59, P2625, DOI 10.1016/j.neuroimage.2011.08.077; Brezger A, 2007, J R STAT SOC C-APPL, V56, P327, DOI 10.1111/j.1467-9876.2007.00580.x; Collins DL, 1998, IEEE T MED IMAGING, V17, P463, DOI 10.1109/42.712135; Dhenain M, 1998, NEUROBIOL AGING, V19, P65, DOI 10.1016/S0197-4580(98)00005-0; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; DIEBOLT J, 1994, J ROY STAT SOC B MET, V56, P363; Friston K.J., 1995, HUMAN BRAIN MAPPING; Friston KJ, 2003, NEUROIMAGE, V19, P1240, DOI 10.1016/S1053-8119(03)00144-7; Gelman A, 1996, STAT SINICA, V6, P733; Gelman A., 2003, BAYESIAN DATA ANAL; Gelman A., 2007, DATA ANAL USING REGR; Gelman A, 2003, BAYESIAN DATA ANAL, P464; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gossl C, 2001, BIOMETRICS, V57, P554, DOI 10.1111/j.0006-341X.2001.00554.x; Groves AR, 2009, NEUROIMAGE, V45, P795, DOI 10.1016/j.neuroimage.2008.12.027; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P561, DOI 10.1002/jmri.22293; HALLGREN B, 1958, J NEUROCHEM, V3, P41, DOI 10.1111/j.1471-4159.1958.tb12607.x; Harrison LM, 2007, NEUROIMAGE, V38, P677, DOI 10.1016/j.neuroimage.2007.07.032; Kwan RKS, 1996, LECT NOTES COMPUT SC, V1131, P135, DOI 10.1007/BFb0046947; Lang S, 2004, J COMPUT GRAPH STAT, V13, P183, DOI 10.1198/1061860043010; Maschke M, 2004, J NEUROL, V251, P740, DOI 10.1007/s00415-004-0420-5; Paciorek CJ, 2012, J R STAT SOC C-APPL, V61, P429, DOI 10.1111/j.1467-9876.2011.01035.x; Penny WD, 2005, NEUROIMAGE, V24, P350, DOI 10.1016/j.neuroimage.2004.08.034; Pfefferbaum A, 2009, NEUROIMAGE, V47, P493, DOI 10.1016/j.neuroimage.2009.05.006; Quiros A, 2010, NEUROIMAGE, V52, P995, DOI 10.1016/j.neuroimage.2009.12.085; Rajapakse JC, 1997, IEEE T MED IMAGING, V16, P176, DOI 10.1109/42.563663; RUBIN DB, 1984, ANN STAT, V12, P1151, DOI 10.1214/aos/1176346785; Rue H, 2005, MG STAT PRO, V104; Schmidt P, 2012, NEUROIMAGE, V59, P3774, DOI 10.1016/j.neuroimage.2011.11.032; Stephens M, 2000, J ROY STAT SOC B, V62, P795, DOI 10.1111/1467-9868.00265; VYMAZAL J, 1995, JMRI-J MAGN RESON IM, V5, P554; Woolrich MW, 2012, NEUROIMAGE, V62, P801, DOI 10.1016/j.neuroimage.2011.10.047; Woolrich MW, 2004, IEEE T MED IMAGING, V23, P213, DOI 10.1109/TMI.2003.823065; Woolrich MW, 2004, NEUROIMAGE, V21, P1748, DOI 10.1016/j.neuroimage.2003.12.024; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537; ZIJDENBOS AP, 1994, IEEE T MED IMAGING, V13, P716, DOI 10.1109/42.363096	42	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e68196	10.1371/journal.pone.0068196	http://dx.doi.org/10.1371/journal.pone.0068196			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23874537	gold, Green Published, Green Submitted			2022-12-27	WOS:000322000600005
J	Elliott, EC; Cornell, SJ				Elliott, Elizabeth C.; Cornell, Stephen J.			Are Anomalous Invasion Speeds Robust to Demographic Stochasticity?	PLOS ONE			English	Article							WING DIMORPHISM; CLIMATE-CHANGE; TRADE-OFFS; DISPERSAL; RANGE; REPRODUCTION; EVOLUTION; SPREAD; POLYMORPHISM; POPULATIONS	Two important issues for conservation are the range expansion of species as a result of climate change and the invasion of exotic species. Being able to predict the rate at which species spread is key for successful management. In deterministic models, the invasion speed of a polymorphic population can be faster than that of any of the component phenotypes, and these "anomalous'' invasion speeds persist even when the mutation rate between phenotypes is vanishingly small. Here we investigate whether the same phenomenon is observed in a model with demographic stochasticity. The model that we use is discrete in time and space and we carry out numerical simulations to determine the invasion speed of a population that has two morphs which differ in their dispersal abilities. We find that anomalous speeds are observed in the stochastic model, but only when the carrying capacity of the population is large or the mutation rate between morphs is high enough. These results suggest that only species with large population sizes, such as many insect species, may be able to invade faster if they are polymorphic than if there is only a single morph present in the population.	[Elliott, Elizabeth C.; Cornell, Stephen J.] Univ Leeds, Sch Biol, Leeds, W Yorkshire, England	University of Leeds	Elliott, EC (corresponding author), Univ Leeds, Sch Biol, Leeds, W Yorkshire, England.	jhs5ece@leeds.ac.uk	Cornell, Stephen J/D-3955-2009		Natural Environment Research Council	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Elizabeth Elliott is funded by the Natural Environment Research Council, url: http://www.nerc.ac.uk/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braendle C, 2006, HEREDITY, V97, P192, DOI 10.1038/sj.hdy.6800863; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Clark JS, 2001, AM NAT, V157, P537, DOI 10.1086/319934; Duckworth RA, 2008, AM NAT, V172, pS4, DOI 10.1086/588289; Elliott EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040496; Fisher RA, 1937, ANN EUGENIC, V7, P355, DOI 10.1111/j.1469-1809.1937.tb02153.x; Fjerdingstad EJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-133; Guerra PA, 2011, BIOL REV, V86, P813, DOI 10.1111/j.1469-185X.2010.00172.x; Gurevitch J, 2004, TRENDS ECOL EVOL, V19, P470, DOI 10.1016/j.tree.2004.07.005; Hanski I, 2006, J ANIM ECOL, V75, P91, DOI 10.1111/j.1365-2656.2005.01024.x; Hastings A, 2005, ECOL LETT, V8, P91, DOI 10.1111/j.1461-0248.2004.00687.x; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Hughes CL, 2003, P ROY SOC B-BIOL SCI, V270, pS147, DOI 10.1098/rsbl.2003.0049; Jongejans E, 2008, PERSPECT PLANT ECOL, V9, P153, DOI 10.1016/j.ppees.2007.09.005; Kot M, 2004, THEOR POPUL BIOL, V66, P175, DOI 10.1016/j.tpb.2004.05.005; Lande R., 2003, OXFORD SERIES ECOLOG; Langellotto GA, 2000, ECOLOGY, V81, P865, DOI 10.1890/0012-9658(2000)081[0865:ATOBFC]2.0.CO;2; Lewis MA, 2000, J MATH BIOL, V41, P430, DOI 10.1007/s002850000022; Lewis MA, 2000, J MATH BIOL, V41, P387, DOI 10.1007/s002850000050; MOLLISON D, 1991, MATH BIOSCI, V107, P255, DOI 10.1016/0025-5564(91)90009-8; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Phillips BL, 2009, BIOL LETTERS, V5, P802, DOI 10.1098/rsbl.2009.0367; Phillips BL, 2010, ECOLOGY, V91, P1617, DOI 10.1890/09-0910.1; R Core Team, 2016, R FDN STAT COMP; Roff DA, 1999, J EVOLUTION BIOL, V12, P535, DOI 10.1046/j.1420-9101.1999.00051.x; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Saastamoinen M, 2007, OECOLOGIA, V153, P569, DOI 10.1007/s00442-007-0772-5; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; SKELLAM JG, 1951, BIOMETRIKA, V38, P196, DOI 10.2307/2332328; Snyder RE, 2003, ECOLOGY, V84, P1333, DOI 10.1890/0012-9658(2003)084[1333:HDSCSB]2.0.CO;2; SORENSEN AE, 1978, NATURE, V276, P174, DOI 10.1038/276174a0; Travis JMJ, 2011, METHODS ECOL EVOL, V2, P477, DOI 10.1111/j.2041-210X.2011.00104.x; van Saarloos W, 2003, PHYS REP, V386, P29, DOI 10.1016/j.physrep.2003.08.001; Weinberger HF, 2007, J MATH BIOL, V55, P207, DOI 10.1007/s00285-007-0078-6; Zera AJ, 1997, ANNU REV ENTOMOL, V42, P207, DOI 10.1146/annurev.ento.42.1.207; Ziska LH, 2011, CLIMATIC CHANGE, V105, P13, DOI 10.1007/s10584-010-9879-5	36	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e67871	10.1371/journal.pone.0067871	http://dx.doi.org/10.1371/journal.pone.0067871			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874460	Green Published, Green Submitted, gold			2022-12-27	WOS:000322064300011
J	Ficklin, SP; Feltus, FA				Ficklin, Stephen P.; Feltus, Frank Alex			A Systems-Genetics Approach and Data Mining Tool to Assist in the Discovery of Genes Underlying Complex Traits in Oryza sativa	PLOS ONE			English	Article							COEXPRESSION NETWORKS; DISEASE RESISTANCE; GENOME ANNOTATION; AMYLOSE CONTENT; SCALE-FREE; MAJOR QTL; ARABIDOPSIS; RICE; EXPRESSION; INFORMATION	Many traits of biological and agronomic significance in plants are controlled in a complex manner where multiple genes and environmental signals affect the expression of the phenotype. In Oryza sativa (rice), thousands of quantitative genetic signals have been mapped to the rice genome. In parallel, thousands of gene expression profiles have been generated across many experimental conditions. Through the discovery of networks with real gene co-expression relationships, it is possible to identify co-localized genetic and gene expression signals that implicate complex genotype-phenotype relationships. In this work, we used a knowledge-independent, systems genetics approach, to discover a high-quality set of co-expression networks, termed Gene Interaction Layers (GILs). Twenty-two GILs were constructed from 1,306 Affymetrix microarray rice expression profiles that were pre-clustered to allow for improved capture of gene co-expression relationships. Functional genomic and genetic data, including over 8,000 QTLs and 766 phenotype-tagged SNPs (p-value < = 0.001) from genome-wide association studies, both covering over 230 different rice traits were integrated with the GILs. An online systems genetics data-mining resource, the GeneNet Engine, was constructed to enable dynamic discovery of gene sets (i.e. network modules) that overlap with genetic traits. GeneNet Engine does not provide the exact set of genes underlying a given complex trait, but through the evidence of gene-marker correspondence, co-expression, and functional enrichment, site visitors can identify genes with potential shared causality for a trait which could then be used for experimental validation. A set of 2 million SNPs was incorporated into the database and serve as a potential set of testable biomarkers for genes in modules that overlap with genetic traits. Herein, we describe two modules found using GeneNet Engine, one with significant overlap with the trait amylose content and another with significant overlap with blast disease resistance.	[Ficklin, Stephen P.; Feltus, Frank Alex] Clemson Univ, Clemson, SC 29634 USA; [Feltus, Frank Alex] Clemson Univ, Dept Biochem & Genet, Clemson, SC USA	Clemson University; Clemson University	Feltus, FA (corresponding author), Clemson Univ, Clemson, SC 29634 USA.	ffeltus@clemson.edu	Ficklin, Stephen/L-4324-2019	Ficklin, Stephen/0000-0001-9138-6292; Feltus, Frank/0000-0002-2123-6114				Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; Aoki K, 2007, PLANT CELL PHYSIOL, V48, P381, DOI 10.1093/pcp/pcm013; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Atias O, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-86; Ayliffe MA, 2004, ANN BOT-LONDON, V94, P765, DOI 10.1093/aob/mch207; Barabasi AL, 2003, AIP CONF PROC, V661, P1, DOI 10.1063/1.1571285; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Bassel GW, 2011, PLANT CELL, V23, P3101, DOI 10.1105/tpc.111.088153; Bolstad BM, 2012, RMAEXPRESS; Chen MH, 2008, J CEREAL SCI, V47, P536, DOI 10.1016/j.jcs.2007.06.013; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Edwards KD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-142; Faccioli P, 2005, PLANT MOL BIOL, V58, P739, DOI 10.1007/s11103-005-8159-7; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Ficklin SP, 2010, PLANT PHYSL; Ficklin SP, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar044; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gibson SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055871; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Hwang W, 2006, ALGORITHM MOL BIOL, V1, DOI 10.1186/1748-7188-1-24; Iancu OD, 2012, BIOINFORMATICS, V28, P1592, DOI 10.1093/bioinformatics/bts245; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jaiswal P, 2002, COMPAR FUNCT GENOM, V3, P132, DOI 10.1002/cfg.156; Jaiswal P, 2011, METHODS MOL BIOL, V678, P247, DOI 10.1007/978-1-60761-682-5_18; Jordan IK, 2004, MOL BIOL EVOL, V21, P2058, DOI 10.1093/molbev/msh222; Jupiter D, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-332; Kalinka Alex T, 2011, Bioinformatics, V27, P2011, DOI 10.1093/bioinformatics/btr311; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Lee I, 2010, NAT BIOTECHNOL, V28, P149, DOI 10.1038/nbt.1603; Lee TH, 2009, PLANT PHYSIOL, V151, P16, DOI 10.1104/pp.109.139030; Li DY, 2013, J PHYTOPATHOL, V161, P27, DOI 10.1111/jph.12023; Li H, 2012, BIOLOGIA, V67, P435, DOI 10.2478/s11756-012-0026-9; Lopes CT, 2010, BIOINFORMATICS, V26, P2347, DOI 10.1093/bioinformatics/btq430; Luo F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-299; Manfield IW, 2006, NUCLEIC ACIDS RES, V34, pW504, DOI 10.1093/nar/gkl204; Mao LY, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-346; Massa AN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026801; Mentzen WI, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-76; Miyao A, 2003, PLANT CELL, V15, P1771, DOI 10.1105/tpc.012559; Miyao A, 2007, PLANT MOL BIOL, V63, P625, DOI 10.1007/s11103-006-9118-7; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Mungall CJ, 2007, BIOINFORMATICS, V23, pI337, DOI 10.1093/bioinformatics/btm189; Mutwil M, 2010, PLANT PHYSIOL, V152, P29, DOI 10.1104/pp.109.145318; Nadeau JH, 2011, SCIENCE, V331, P1015, DOI 10.1126/science.1203869; Ni JJ, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap005; Obayashi T, 2009, NUCLEIC ACIDS RES, V37, pD987, DOI 10.1093/nar/gkn807; Ogata Y, 2010, BIOINFORMATICS, V26, P1267, DOI 10.1093/bioinformatics/btq121; Ogata Y, 2009, J WOOD SCI, V55, P395, DOI 10.1007/s10086-009-1058-9; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Parkinson H, 2011, NUCLEIC ACIDS RES, V39, pD1002, DOI 10.1093/nar/gkq1040; Persson S, 2005, P NATL ACAD SCI USA, V102, P8633, DOI 10.1073/pnas.0503392102; Presson AP, 2009, BMC SYSTEMS BIOL, P2; Puelma T, 2012, BIOINFORMATICS, V28, P2256, DOI 10.1093/bioinformatics/bts455; Reverter A, 2008, BIOINFORMATICS, V24, P2491, DOI 10.1093/bioinformatics/btn482; Reverter A, 2006, BIOINFORMATICS, V22, P2396, DOI 10.1093/bioinformatics/btl392; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Spangler JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045041; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Tsaparas P, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-70; Vandepoele K, 2009, PLANT PHYSIOL, V150, P535, DOI 10.1104/pp.109.136028; Wang Y, 2009, INT J MOL SCI, V10, P116, DOI 10.3390/ijms10010116; WANG ZY, 1995, PLANT J, V7, P613, DOI 10.1046/j.1365-313X.1995.7040613.x; Wei HR, 2006, PLANT PHYSIOL, V142, P762, DOI 10.1104/pp.106.080358; Wissuwa M, 2002, THEOR APPL GENET, V105, P890, DOI 10.1007/s00122-002-1051-9; Wolfe CJ, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-227; Yamamoto T, 2009, DNA RES, V16, P141, DOI 10.1093/dnares/dsp006; Zhang XC, 2010, MOL BIOL REP, V37, P653, DOI 10.1007/s11033-009-9507-5; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467	73	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68551	10.1371/journal.pone.0068551	http://dx.doi.org/10.1371/journal.pone.0068551			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874666	Green Published, gold, Green Submitted			2022-12-27	WOS:000322064300047
J	Gogineni, A; Caunt, M; Crow, A; Lee, CV; Fuh, G; van Bruggen, N; Ye, WL; Weimer, RM				Gogineni, Alvin; Caunt, Maresa; Crow, Ailey; Lee, Chingwei V.; Fuh, Germaine; van Bruggen, Nicholas; Ye, Weilan; Weimer, Robby M.			Inhibition of VEGF-C Modulates Distal Lymphatic Remodeling and Secondary Metastasis	PLOS ONE			English	Article							GROWTH-FACTOR-C; PROMOTES TUMOR-METASTASIS; SENTINEL-NODE BIOPSY; BREAST-CANCER; VASCULAR-PERMEABILITY; LYMPHANGIOGENESIS; CELLS; GEMCITABINE; SUPPRESSION; ACTIVATION	Tumor-associated lymphatics are postulated to provide a transit route for disseminating metastatic cells. This notion is supported by preclinical findings that inhibition of pro-lymphangiogenic signaling during tumor development reduces cell spread to sentinel lymph nodes (SLNs). However, it is unclear how lymphatics downstream of SLNs contribute to metastatic spread into distal organs, or if modulating distal lymph transport impacts disease progression. Utilizing murine models of metastasis, longitudinal in vivo imaging of lymph transport, and function blocking antibodies against two VEGF family members, we provide evidence that distal lymphatics undergo disease course-dependent up-regulation of lymph transport coincidental with structural remodeling. Inhibition of VEGF-C activity with antibodies against VEGF-C or NRP2 prevented these disease-associated changes. Furthermore, utilizing a novel model of adjuvant treatment, we demonstrate that antagonism of VEGF-C or NRP2 decreases post SLN metastasis. These data support a potential therapeutic strategy for inhibiting distant metastatic dissemination via targeting tumor-associated lymphatic remodeling.	[Gogineni, Alvin; van Bruggen, Nicholas; Weimer, Robby M.] Genentech Inc, Dept Biomed Imaging, San Francisco, CA 94080 USA; [Caunt, Maresa; Crow, Ailey; Ye, Weilan] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Lee, Chingwei V.; Fuh, Germaine] Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Weimer, RM (corresponding author), Genentech Inc, Dept Biomed Imaging, San Francisco, CA 94080 USA.	weimer.robby@gene.com		Ye, Weilan/0000-0002-6219-3982	Genentech	Genentech(Roche HoldingGenentech)	All research funded by Genentech. Funders had no role in study design, data collection, analysis or preparation of manuscript. There are no current external funding sources for this study.	Alitalo K, 2011, NAT MED, V17, P1371, DOI 10.1038/nm.2545; Allegra CJ, 2011, J CLIN ONCOL, V29, P11, DOI 10.1200/JCO.2010.30.0855; ALLEN JM, 1986, MICROVASC RES, V31, P77, DOI 10.1016/0026-2862(86)90008-7; Campbell NP, 2010, WORLD J GASTROENTERO, V16, P3793, DOI 10.3748/wjg.v16.i30.3793; Caunt M, 2008, CANCER CELL, V13, P331, DOI 10.1016/j.ccr.2008.01.029; Chen ZT, 2005, CANCER RES, V65, P9004, DOI 10.1158/0008-5472.CAN-05-0885; Cohen B, 2009, NEOPLASIA, V11, P921, DOI 10.1593/neo.09636; Duong T, 2012, J ONCOL, V2012, DOI 10.1155/2012/204946; Gallagher DJ, 2009, CURR TREAT OPTION ON, V10, P205, DOI 10.1007/s11864-009-0112-6; Hagendoorn J, 2006, CANCER RES, V66, P3360, DOI 10.1158/0008-5472.CAN-05-2655; Haiko P, 2007, ANGIOGENESIS BASIC S, P53; Harrell MI, 2008, J IMMUNOL METHODS, V332, P170, DOI 10.1016/j.jim.2007.11.012; Harrell MI, 2007, AM J PATHOL, V170, P774, DOI 10.2353/ajpath.2007.060761; He YL, 2005, CANCER RES, V65, P4739, DOI 10.1158/0008-5472.CAN-04-4576; He YL, 2002, J NATL CANCER I, V94, P819, DOI 10.1093/jnci/94.11.819; Hirakawa S, 2007, BLOOD, V109, P1010, DOI 10.1182/blood-2006-05-021758; Hoshida T, 2006, CANCER RES, V66, P8065, DOI 10.1158/0008-5472.CAN-06-1392; Karkkainen MJ, 2001, P NATL ACAD SCI USA, V98, P12677, DOI 10.1073/pnas.221449198; Karnezis T, 2012, CANCER CELL, V21, P181, DOI 10.1016/j.ccr.2011.12.026; Krag D, 1998, NEW ENGL J MED, V339, P941, DOI 10.1056/NEJM199810013391401; Kwon S, 2010, J IMMUNOL METHODS, V360, P167, DOI 10.1016/j.jim.2010.06.016; Kyzas PA, 2005, J PATHOL, V206, P170, DOI 10.1002/path.1776; Liang WC, 2006, J BIOL CHEM, V281, P951, DOI 10.1074/jbc.M508199200; Lin JM, 2005, CANCER RES, V65, P6901, DOI 10.1158/0008-5472.CAN-05-0408; Lin KM, 2002, ONCOLOGY-NY, V16, P567; LIOTTA LA, 1992, SCI AM, V266, P54, DOI 10.1038/scientificamerican0292-54; Mandriota SJ, 2001, EMBO J, V20, P672, DOI 10.1093/emboj/20.4.672; Morton DL, 2006, NEW ENGL J MED, V355, P1307, DOI 10.1056/NEJMoa060992; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Notohamiprodjo M, 2009, EUR RADIOL, V19, P2771, DOI 10.1007/s00330-009-1461-z; Papoutsi M, 2001, MICROSC RES TECHNIQ, V55, P100, DOI 10.1002/jemt.1161; Peintinger F, 2006, CANCER-AM CANCER SOC, V107, P1248, DOI 10.1002/cncr.22111; Pepper MS, 2003, CELL TISSUE RES, V314, P167, DOI 10.1007/s00441-003-0748-7; Pham CD, 1998, CANCER INVEST, V16, P225, DOI 10.3109/07357909809039771; Pipas JM, 2005, ANN SURG ONCOL, V12, P995, DOI 10.1245/ASO.2005.04.503; Planas-Paz L, 2012, EMBO J, V31, P788, DOI 10.1038/emboj.2011.456; Proulx ST, 2010, CANCER RES, V70, P7053, DOI 10.1158/0008-5472.CAN-10-0271; Ramnath N, 2005, CHEST, V128, P3467, DOI 10.1378/chest.128.5.3467; Rasmussen JC, 2009, CURR OPIN BIOTECH, V20, P74, DOI 10.1016/j.copbio.2009.01.009; Ruddell A, 2008, NEOPLASIA, V10, P706, DOI 10.1593/neo.08342; Saad RS, 2006, MODERN PATHOL, V19, P1317, DOI 10.1038/modpathol.3800651; SENGER DR, 1990, CANCER RES, V50, P1774; Sevick-Muraca EM, 2008, RADIOLOGY, V246, P734, DOI 10.1148/radiol.2463070962; Sharma R, 2007, AM J PHYSIOL-HEART C, V292, pH3109, DOI 10.1152/ajpheart.01223.2006; Shibuya M., 2007, ANGIOGENESIS BASIC S, P34; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Stacker SA, 2001, NAT MED, V7, P186, DOI 10.1038/84635; Stacker SA, 2002, NAT REV CANCER, V2, P573, DOI 10.1038/nrc863; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Taylor MD, 2012, ANN THORAC SURG, V93, P1813, DOI 10.1016/j.athoracsur.2012.03.031; Unno N, 2008, EUR J VASC ENDOVASC, V36, P230, DOI 10.1016/j.ejvs.2008.04.013; VANHELDEN DF, 1993, J PHYSIOL-LONDON, V471, P465, DOI 10.1113/jphysiol.1993.sp019910; Veronesi U, 2003, NEW ENGL J MED, V349, P546, DOI 10.1056/NEJMoa012782; Wilson NS, 2012, CANCER CELL, V22, P80, DOI 10.1016/j.ccr.2012.05.014; Zbytek Blazej, 2008, Expert Rev Dermatol, V3, P569, DOI 10.1586/17469872.3.5.569; Zivanovic O, 2009, ONCOLOGIST, V14, P695, DOI 10.1634/theoncologist.2009-0075	56	56	57	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68755	10.1371/journal.pone.0068755	http://dx.doi.org/10.1371/journal.pone.0068755			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874750	gold, Green Published, Green Submitted			2022-12-27	WOS:000322064300068
J	Li, C; Ito, H; Fujita, K; Shiwaku, H; Qi, YL; Tagawa, K; Tamura, T; Okazawa, H				Li, Chan; Ito, Hikaru; Fujita, Kyota; Shiwaku, Hiroki; Qi, Yunlong; Tagawa, Kazuhiko; Tamura, Takuya; Okazawa, Hitoshi			Sox2 Transcriptionally Regulates Pqbp1, an Intellectual Disability-Microcephaly Causative Gene, in Neural Stem Progenitor Cells	PLOS ONE			English	Article							LINKED MENTAL-RETARDATION; RNA SPLICING FACTOR; POU-DOMAIN; POLYGLUTAMINE TRACT; RENPENNING SYNDROME; BINDING PROTEIN; WW DOMAIN; MOUSE; ENHANCER; EXPRESSION	PQBP1 is a nuclear-cytoplasmic shuttling protein that is engaged in RNA metabolism and transcription. In mouse embryonic brain, our previous in situ hybridization study revealed that PQBP1 mRNA was dominantly expressed in the periventricular zone region where neural stem progenitor cells (NSPCs) are located. Because the expression patterns in NSPCs are related to the symptoms of intellectual disability and microcephaly in PQBP1 gene-mutated patients, we investigated the transcriptional regulation of PQBP1 by NSPC-specific transcription factors. We selected 132 genome sequences that matched the consensus sequence for the binding of Sox2 and POU transcription factors upstream and downstream of the mouse PQBP1 gene. We then screened the binding affinity of these sequences to Sox2-Pax6 or Sox2-Brn2 with gel mobility shift assays and found 18 genome sequences that interacted with the NSPC-specific transcription factors. Some of these sequences had cis-regulatory activities in Luciferase assays and in utero electroporation into NSPCs. Furthermore we found decreased levels of expression of PQBP1 protein in NSPCs of heterozygous Sox2-knockout mice in vivo by immunohistochemistry and western blot analysis. Collectively, these results indicated that Sox2 regulated the transcription of PQBP1 in NSPCs.	[Li, Chan; Ito, Hikaru; Fujita, Kyota; Shiwaku, Hiroki; Qi, Yunlong; Tagawa, Kazuhiko; Tamura, Takuya; Okazawa, Hitoshi] Tokyo Med & Dent Univ, Dept Neuropathol, Med Res Inst, Bunkyo Ku, Tokyo, Japan; [Okazawa, Hitoshi] Tokyo Med & Dent Univ, Ctr Brain Integrat Res, Bunkyo Ku, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Okazawa, H (corresponding author), Tokyo Med & Dent Univ, Dept Neuropathol, Med Res Inst, Bunkyo Ku, Tokyo, Japan.	okazawa-tky@umin.ac.jp	Ito, Hikaru/GRR-6595-2022	Ito, Hikaru/0000-0002-4693-2482; Shiwaku, Hiroki/0000-0001-7503-8044	Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [24700374] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Scientific Research on Innovative Areas (Foundation of Synapse and Neurocircuit Pathology) and Strategic Research Program for Brain Sciences (SRPBS) from Ministry of Education, Culture, Sports, Science and Technology of Japan, to HO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Busch A, 2003, J BIOL CHEM, V278, P41452, DOI 10.1074/jbc.M303354200; Chin JH, 2009, BIOCHEM BIOPH RES CO, V388, P247, DOI 10.1016/j.bbrc.2009.07.165; DAILEY L, 1994, MOL CELL BIOL, V14, P7758, DOI 10.1128/MCB.14.12.7758; de Brouwer APM, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9482; Engelen E, 2011, NAT GENET, V43, P607, DOI 10.1038/ng.825; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Huang XJ, 2009, J BIOL CHEM, V284, P25375, DOI 10.1074/jbc.M109.024828; Imafuku I, 1998, BIOCHEM BIOPH RES CO, V253, P16, DOI 10.1006/bbrc.1998.9725; Inoue M, 2007, GENES CELLS, V12, P1049, DOI 10.1111/j.1365-2443.2007.01114.x; Ito H, 2009, HUM MOL GENET, V18, P4239, DOI 10.1093/hmg/ddp378; Kalscheuer VM, 2003, NAT GENET, V35, P313, DOI 10.1038/ng1264; Kamachi Y, 2000, TRENDS GENET, V16, P182, DOI 10.1016/S0168-9525(99)01955-1; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Kleefstra T, 2004, CLIN GENET, V66, P318, DOI 10.1111/j.1399-0004.2004.00308.x; Komuro A, 1999, J BIOL CHEM, V274, P36513, DOI 10.1074/jbc.274.51.36513; Kunde SA, 2011, HUM MOL GENET, V20, P4916, DOI 10.1093/hmg/ddr430; Lengner CJ, 2007, CELL STEM CELL, V1, P403, DOI 10.1016/j.stem.2007.07.020; Lenski C, 2004, AM J HUM GENET, V74, P777, DOI 10.1086/383205; Lindvall O, 2006, NATURE, V441, P1094, DOI 10.1038/nature04960; Llorian M, 2004, BIOCHEM J, V378, P229, DOI 10.1042/BJ20030950; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; MONUKI ES, 1990, SCIENCE, V249, P1300, DOI 10.1126/science.1975954; MONUKI ES, 1989, NEURON, V3, P783, DOI 10.1016/0896-6273(89)90247-X; Nishimoto M, 1999, MOL CELL BIOL, V19, P5453; OKAMOTO K, 1990, CELL, V60, P461, DOI 10.1016/0092-8674(90)90597-8; OKAZAWA H, 1991, EMBO J, V10, P2997, DOI 10.1002/j.1460-2075.1991.tb07850.x; Okazawa H, 2002, NEURON, V34, P701, DOI 10.1016/S0896-6273(02)00697-9; Okuda T, 2004, MOL BRAIN RES, V132, P18, DOI 10.1016/j.molbrainres.2004.08.021; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; Qi YL, 2005, EUR J NEUROSCI, V22, P1277, DOI 10.1111/j.1460-9568.2005.04339.x; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; Stevenson RE, 2005, AM J MED GENET A, V134A, P415, DOI 10.1002/ajmg.a.30664; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tamura T, 2010, J NEUROSCI, V30, P14091, DOI 10.1523/JNEUROSCI.1319-10.2010; Tanaka S, 2004, MOL CELL BIOL, V24, P8834, DOI 10.1128/MCB.24.20.8834-8846.2004; Tapia VE, 2010, J BIOL CHEM, V285, P19391, DOI 10.1074/jbc.M109.084525; Waragai M, 1999, HUM MOL GENET, V8, P977, DOI 10.1093/hmg/8.6.977; Waragai M, 2000, BIOCHEM BIOPH RES CO, V273, P592, DOI 10.1006/bbrc.2000.2992; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635; Zhang YZ, 2000, GENE, V257, P33, DOI 10.1016/S0378-1119(00)00372-3	43	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68627	10.1371/journal.pone.0068627	http://dx.doi.org/10.1371/journal.pone.0068627			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874697	Green Published, Green Submitted, gold			2022-12-27	WOS:000322064300057
J	Quental, NBM; Brucki, SMD; Bueno, OFA				Mota Quental, Natalia Bezerra; Dozzi Brucki, Sonia Maria; Amodeo Bueno, Orlando Francisco			Visuospatial Function in Early Alzheimer's Disease-The Use of the Visual Object and Space Perception (VOSP) Battery	PLOS ONE			English	Article							MINI-MENTAL-STATE; NEUROPSYCHOLOGICAL ASSESSMENT; LEWY BODIES; DEMENTIA; DIAGNOSIS; COGNITION; SEVERITY; PEOPLE; MEMORY; BRAZIL	Alzheimer's disease (AD) is the most frequent cause of dementia. The clinical symptoms of AD begin with impairment of memory and executive function followed by the gradual involvement of other functions, such as language, semantic knowledge, abstract thinking, attention, and visuospatial abilities. Visuospatial function involves the identification of a stimulus and its location and can be impaired at the beginning of AD. The Visual Object and Space Perception (VOSP) battery evaluates visuospatial function, while minimizing the interference of other cognitive functions. Objectives: To evaluate visuospatial function in early AD patients using the VOSP and determine cutoff scores to differentiate between cognitively healthy individuals and AD patients. Methods: Thirty-one patients with mild AD and forty-four healthy elderly were evaluated using a neuropsychological battery and the VOSP. Results: In the VOSP, the AD patients performed more poorly in all subtests examining object perception and in two subtests examining space perception (Number Location and Cube Analysis). The VOSP showed good accuracy and good correlation with tests measuring visuospatial function. Conclusion: Visuospatial function is impaired in the early stages of AD. The VOSP battery is a sensitive battery test for visuospatial deficits with minimal interference by other cognitive functions.	[Mota Quental, Natalia Bezerra; Dozzi Brucki, Sonia Maria; Amodeo Bueno, Orlando Francisco] Univ Fed Sao Paulo, Dept Psychobiol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP)	Quental, NBM (corresponding author), Univ Fed Sao Paulo, Dept Psychobiol, Sao Paulo, Brazil.	natalia_mota@hotmail.com	Brucki, Sonia/L-4201-2019; Brucki, Sonia MD/B-5736-2014	Brucki, Sonia/0000-0002-8303-6732; Brucki, Sonia MD/0000-0002-8303-6732	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP-Sao Paulo Research Foundation); Associacao Fundo de Incentivo a Pesquisa (AFIP-Research Incentive Fund Association)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP-Sao Paulo Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Associacao Fundo de Incentivo a Pesquisa (AFIP-Research Incentive Fund Association)	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP-Sao Paulo Research Foundation) and Associacao Fundo de Incentivo a Pesquisa (AFIP-Research Incentive Fund Association). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida OP, 1999, ARQ NEURO-PSIQUIAT, V57, P421, DOI 10.1590/S0004-282X1999000300013; ARDILA A, 1989, BRAIN COGNITION, V11, P147, DOI 10.1016/0278-2626(89)90015-8; Bak TH, 2006, J NEUROL NEUROSUR PS, V77, P454, DOI 10.1136/jnnp.2005.068239; Bertolucci PHF, 2001, ARQ NEURO-PSIQUIAT, V59, P532, DOI 10.1590/S0004-282X2001000400009; Binetti G, 1998, NEUROPSYCHOLOGY, V12, P29, DOI 10.1037/0894-4105.12.1.29; Bottino CMC, 2006, DEMENCIA E TRANSTORN; Brucki SMD, 1997, ARQ NEURO-PSIQUIAT, V55, P56, DOI 10.1590/S0004-282X1997000100009; Brucki SMD, 2003, ARQ NEURO-PSIQUIAT, V61, P777, DOI 10.1590/S0004-282X2003000500014; Brucki Sonia Maria Dozzi, 2010, Dement. neuropsychol., V4, P153, DOI 10.1590/S1980-57642010DN40300002; Calderon J, 2001, J NEUROL NEUROSUR PS, V70, P157, DOI 10.1136/jnnp.70.2.157; Claeys KG, 2004, CEREB CORTEX, V14, P803, DOI 10.1093/cercor/bhh040; Cronin-Golomb A, 2004, VISION IN ALZHEIMERS, V34; CRONINGOLOMB A, 1991, ANN NEUROL, V29, P41, DOI 10.1002/ana.410290110; Brucki SMD, 2008, ARCH CLIN NEUROPSYCH, V23, P139, DOI 10.1016/j.acn.2007.11.003; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Herrera-Guzman I, 2004, CLIN NEUROPSYCHOL, V18, P385, DOI 10.1080/1385404049052421; KATZ B, 1989, SURV OPHTHALMOL, V34, P31, DOI 10.1016/0039-6257(89)90127-6; Lawrence AD, 2000, BRAIN, V123, P1349, DOI 10.1093/brain/123.7.1349; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Lincoln NB, 2006, INT J GERIATR PSYCH, V21, P1044, DOI 10.1002/gps.1604; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MENDEZ MF, 1990, NEUROLOGY, V40, P439, DOI 10.1212/WNL.40.3_Part_1.439; MERIGAN WH, 1993, ANNU REV NEUROSCI, V16, P369, DOI 10.1146/annurev.ne.16.030193.002101; Mesulam M-M, 1985, PRINCIPLES BEHAV NEU; MILNER B, 1971, BRIT MED BULL, V27, P272, DOI 10.1093/oxfordjournals.bmb.a070866; Nestor PJ, 2003, J NEUROL NEUROSUR PS, V74, P1521, DOI 10.1136/jnnp.74.11.1521; Nitrini R, 2005, ARQ NEURO-PSIQUIAT, V63, P720, DOI 10.1590/S0004-282X2005000400034; Paxton JL, 2007, CORTEX, V43, P967, DOI 10.1016/S0010-9452(08)70694-4; PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323; Piccini C, 1998, J NEUROL SCI, V156, P59, DOI 10.1016/S0022-510X(98)00033-1; Pietrini P, 1996, AM J PSYCHIAT, V153, P1261; Raven JC, 1947, COLORED PROGRESSIVES; Rey A., 1964, LEXAMEN CLINIQUE EN; Rey A, 1983, REATIVO DELLE FIGURE; Salmon DP, 2009, ANNU REV PSYCHOL, V60, P257, DOI 10.1146/annurev.psych.57.102904.190024; SALMON DP, 1999, ALZHEIMER DIS, P39; Schmidt TSL, 1999, BATERIA DE PERCEPCAO; Schmidtke K, 2007, INT PSYCHOGERIATR, V19, P307, DOI 10.1017/S104161020600456X; Shimomura T, 1998, ARCH NEUROL-CHICAGO, V55, P1547, DOI 10.1001/archneur.55.12.1547; Strauss E, 2006, COMPENDIUM NEUROPSYC; SUNDERLAND T, 1989, J AM GERIATR SOC, V37, P725, DOI 10.1111/j.1532-5415.1989.tb02233.x; Thiyagesh SN, 2009, PSYCHIAT RES-NEUROIM, V172, P109, DOI 10.1016/j.pscychresns.2008.11.002; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; Warrington EK., 1991, VISUAL OBJECT SPACE; Williams VG, 2007, ARCH CLIN NEUROPSYCH, V22, P925, DOI 10.1016/j.acn.2007.06.008	45	61	63	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68398	10.1371/journal.pone.0068398	http://dx.doi.org/10.1371/journal.pone.0068398			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	186SF	23874610	Green Published, gold, Green Submitted			2022-12-27	WOS:000322064300028
J	Yeung, SLA; Jiang, CQ; Cheng, KK; Cowling, BJ; Liu, B; Zhang, WS; Lam, TH; Leung, GM; Schooling, CM				Yeung, Shiu Lun Au; Jiang, Chaoqiang; Cheng, Kar Keung; Cowling, Benjamin J.; Liu, Bin; Zhang, Weisen; Lam, Tai Hing; Leung, Gabriel M.; Schooling, C. Mary			Moderate Alcohol Use and Cardiovascular Disease from Mendelian Randomization	PLOS ONE			English	Article							POSTMENOPAUSAL WOMEN; CHINESE POPULATION; CONSUMPTION; ASSOCIATION; RISK; METAANALYSIS; DEFICIENCY; MORTALITY; INSULIN; GLUCOSE	Background: Observational studies show moderate alcohol use negatively associated with ischemic heart disease (IHD) and cardiovascular disease (CVD). However, healthier attributes among moderate users compared to never users may confound the apparent association. A potentially less biased way to examine the association is Mendelian randomization, using alcohol metabolizing genes which influence alcohol use. Methods: We used instrumental variable analysis with aldehyde dehydrogenase 2 (ALDH2) genotypes (AA/GA/GG) as instrumental variables for alcohol use to examine the association of alcohol use (10 g ethanol/day) with CVD risk factors (blood pressure, lipids and glucose) and morbidity (self-reported IHD and CVD) among men in the Guangzhou Biobank Cohort Study. Results: ALDH2 genotypes were a credible instrument for alcohol use (F-statistic 74.6). Alcohol was positively associated with HDL-cholesterol (0.05 mmol/L per alcohol unit, 95% confidence interval (CI) 0.02 to 0.08) and diastolic blood pressure (1.15 mmHg, 95% CI 0.23 to 2.07) but not with systolic blood pressure (1.00 mmHg, 95% CI -0.74 to 2.74), LDL-cholesterol (0.03 mmol/L, 95% CI -0.03 to 0.08), log transformed triglycerides (0.03 mmol/L, 95% CI -0.01 to 0.08) or log transformed fasting glucose (0.01 mmol/L, 95% CI -0.006 to 0.03), self-reported CVD (odds ratio (OR) 0.98, 95% CI 0.76 to 1.27) or self-reported IHD (OR 1.10, 95% CI 0.83 to 1.45). Conclusion: Low to moderate alcohol use among men had the expected effects on most CVD risk factors but not fasting glucose. Larger studies are needed to confirm the null associations with IHD, CVD and fasting glucose.	[Yeung, Shiu Lun Au; Cowling, Benjamin J.; Lam, Tai Hing; Leung, Gabriel M.; Schooling, C. Mary] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Lifestyle & Lifecourse Epidemiol Grp, Hong Kong, Hong Kong, Peoples R China; [Jiang, Chaoqiang; Liu, Bin; Zhang, Weisen] Guangzhou 12 Hosp, Guangzhou, Guangdong, Peoples R China; [Cheng, Kar Keung] Univ Birmingham, Dept Publ Hlth & Epidemiol, Birmingham, W Midlands, England; [Schooling, C. Mary] CUNY, Sch Publ Hlth, New York, NY 10021 USA	University of Hong Kong; University of Birmingham; City University of New York (CUNY) System	Lam, TH (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Lifestyle & Lifecourse Epidemiol Grp, Hong Kong, Hong Kong, Peoples R China.	commed@hkucc.hku.hk	Cowling, Benjamin John/C-4263-2009; Liu, Bin/AAP-2376-2020; SL, Au Yeung/ABD-3938-2021; Cheng, Kar/AAL-8899-2021; Lam, Tai Hing/C-4317-2009	Cowling, Benjamin John/0000-0002-6297-7154; Liu, Bin/0000-0001-5785-2579; SL, Au Yeung/0000-0001-6136-1836; Cheng, Kar/0000-0002-1516-1857; Lam, Tai Hing/0000-0002-2033-9971; Schooling, Mary/0000-0001-9933-5887; Leung, Gabriel/0000-0002-2503-6283	Hong Kong Health and Health Services Research Fund [06070981]; Health, Welfare and Food Bureau, Government of the Hong Kong SAR, People's Republic of China; The University of Hong Kong Foundation for Development and Research; University of Hong Kong University Research Committee Strategic Research Theme Public Health, Hong Kong; Guangzhou Public Health Bureau; Guangzhou Science and Technology Bureau, Guangzhou, China; The University of Birmingham, United Kingdom; Natural Science Foundation of Guangdong, Guangdong, China [9451062001003477]	Hong Kong Health and Health Services Research Fund; Health, Welfare and Food Bureau, Government of the Hong Kong SAR, People's Republic of China; The University of Hong Kong Foundation for Development and Research; University of Hong Kong University Research Committee Strategic Research Theme Public Health, Hong Kong; Guangzhou Public Health Bureau; Guangzhou Science and Technology Bureau, Guangzhou, China; The University of Birmingham, United Kingdom; Natural Science Foundation of Guangdong, Guangdong, China	This study was supported by the Hong Kong Health and Health Services Research Fund (grant no. 06070981), Health, Welfare and Food Bureau, Government of the Hong Kong SAR, People's Republic of China. The Guangzhou Biobank Cohort Study was funded by The University of Hong Kong Foundation for Development and Research, and the University of Hong Kong University Research Committee Strategic Research Theme Public Health, Hong Kong; Guangzhou Public Health Bureau, and Guangzhou Science and Technology Bureau, Guangzhou, China; The University of Birmingham, United Kingdom; and the Natural Science Foundation of Guangdong (grant no. 9451062001003477), Guangdong, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal DP, 2002, ALCOHOL ALCOHOLISM, V37, P409, DOI 10.1093/alcalc/37.5.409; Briel M., 2009, BMJ, V338; Brien SE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d636; Carlsson S, 2005, DIABETOLOGIA, V48, P1051, DOI 10.1007/s00125-005-1768-5; Center for Nutrition Policy and Promotion USDoA, 2011, DIET GUID AM 2010; Chen L, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050052; Davies MJ, 2002, JAMA-J AM MED ASSOC, V287, P2559, DOI 10.1001/jama.287.19.2559; Dickinson HO, 2006, J HYPERTENS, V24, P215, DOI 10.1097/01.hjh.0000199800.72563.26; Didelez V, 2007, STAT METHODS MED RES, V16, P309, DOI 10.1177/0962280206077743; Flanagan DEH, 2002, EUR J CLIN INVEST, V32, P187, DOI 10.1046/j.1365-2362.2002.00970.x; Glymour MM, 2012, AM J EPIDEMIOL, V175, P332, DOI 10.1093/aje/kwr323; Haase CL, 2012, J CLIN ENDOCR METAB, V97, pE248, DOI 10.1210/jc.2011-1846; Hao PP, 2010, ATHEROSCLEROSIS, V212, P213, DOI 10.1016/j.atherosclerosis.2010.05.024; HARADA S, 1982, LANCET, V2, P827, DOI 10.1016/s0140-6736(82)92722-2; HARADA S, 1981, LANCET, V2, P982; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Jiang CQ, 2006, INT J EPIDEMIOL, V35, P844, DOI 10.1093/ije/dyl131; Johansen D, 2006, BMJ-BRIT MED J, V332, P519, DOI 10.1136/bmj.38694.568981.80; Kupelian V, 2010, CLIN ENDOCRINOL, V72, P527, DOI 10.1111/j.1365-2265.2009.03713.x; Lao XQ, 2006, J ENDOCRINOL INVEST, V29, P989, DOI 10.1007/BF03349212; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; McFadden CB, 2005, AM J HYPERTENS, V18, P276, DOI 10.1016/j.amjhyper.2004.07.020; MURAMATSU T, 1995, HUM GENET, V96, P151, DOI 10.1007/BF00207371; Naimi TS, 2005, AM J PREV MED, V28, P369, DOI 10.1016/j.amepre.2005.01.011; Pierce BL, 2012, INT J EPIDEMIOL, V41, P1383, DOI 10.1093/ije/dys141; Pierce BL, 2011, INT J EPIDEMIOL, V40, P740, DOI 10.1093/ije/dyq151; Rassen JA, 2009, AM J EPIDEMIOL, V169, P273, DOI 10.1093/aje/kwn299; Reynolds K, 2003, JAMA-J AM MED ASSOC, V289, P579, DOI 10.1001/jama.289.5.579; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; Ronksley Paul E, 2011, BMJ, V342, pd671, DOI 10.1136/bmj.d671; Roy A, 2010, ATHEROSCLEROSIS, V210, P531, DOI 10.1016/j.atherosclerosis.2010.02.033; Schooling CM, 2009, J EPIDEMIOL COMMUN H, V63, P121, DOI 10.1136/jech.2008.077602; Schooling CM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002370; Shai I, 2007, DIABETES CARE, V30, P3011, DOI 10.2337/dc07-1103; Sierksma A, 2004, ALCOHOL CLIN EXP RES, V28, P780, DOI 10.1097/01.ALC.0000125356.70824.81; Sin DD, 2005, CHEST, V127, P1952, DOI 10.1378/chest.127.6.1952; Sisson JH, 2005, ALCOHOL, V36, P19, DOI 10.1016/j.alcohol.2005.05.002; Smith GD, 2004, INT J EPIDEMIOL, V33, P30, DOI 10.1093/ije/dyh132; Sun WJ, 2009, ANN EPIDEMIOL, V19, P396, DOI 10.1016/j.annepidem.2009.01.011; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Yeung SLA, 2012, AM J EPIDEMIOL, V175, P1021, DOI 10.1093/aje/kwr462; Yeung SLA, 2013, INT J EPIDEMIOL, V42, P318, DOI 10.1093/ije/dys221; Zhang YM, 2011, PHARMACOL THERAPEUT, V132, P86, DOI 10.1016/j.pharmthera.2011.05.008	43	36	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68054	10.1371/journal.pone.0068054	http://dx.doi.org/10.1371/journal.pone.0068054			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874492	Green Published, gold			2022-12-27	WOS:000322064300014
J	Trentini, F; Ji, Y; Iwamoto, T; Qi, Y; Pusztai, L; Muller, P				Trentini, Filippo; Ji, Yuan; Iwamoto, Takayuki; Qi, Yuan; Pusztai, Lajos; Mueller, Peter			Bayesian Mixture Models for Assessment of Gene Differential Behaviour and Prediction of pCR through the Integration of Copy Number and Gene Expression Data	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; FALSE DISCOVERY RATE; TRASTUZUMAB	We consider modeling jointly microarray RNA expression and DNA copy number data. We propose Bayesian mixture models that define latent Gaussian probit scores for the DNA and RNA, and integrate between the two platforms via a regression of the RNA probit scores on the DNA probit scores. Such a regression conveniently allows us to include additional sample specific covariates such as biological conditions and clinical outcomes. The two developed methods are aimed respectively to make inference on differential behaviour of genes in patients showing different subtypes of breast cancer and to predict the pathological complete response (pCR) of patients borrowing strength across the genomic platforms. Posterior inference is carried out via MCMC simulations. We demonstrate the proposed methodology using a published data set consisting of 121 breast cancer patients.	[Trentini, Filippo] Univ Vita Salute San Raffaele, Univ Ctr Stat Biomed Sci, Milan, Italy; [Ji, Yuan] NorthShore Univ HealthSyst, Ctr Clin & Res Informat, Evanston, IL USA; [Iwamoto, Takayuki] Okayama Univ Hosp, Dept Breast & Endocrine Surg, Okayama, Japan; [Qi, Yuan] Univ Texas MD Anderson Canc Ctr, Div Quantitat Sci, Houston, TX 77030 USA; [Pusztai, Lajos] Yale Univ, Sch Med, New Haven, CT USA; [Mueller, Peter] Univ Texas Austin, Dept Math, Austin, TX 78712 USA	Vita-Salute San Raffaele University; NorthShore University Health System; Okayama University; University of Texas System; UTMD Anderson Cancer Center; Yale University; University of Texas System; University of Texas Austin	Ji, Y (corresponding author), NorthShore Univ HealthSyst, Ctr Clin & Res Informat, Evanston, IL USA.	jiyuan@uchicago.edu	Pusztai, Lajos/AAB-2901-2019	trentini, filippo/0000-0001-6915-7282	NIH [R01 CA132897]; NATIONAL CANCER INSTITUTE [R01CA132897] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The research was funded by the parent grant NIH R01 CA132897 and no additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre F, 2009, CLIN CANCER RES, V15; Baladandayuthapani V, 2010, J AM STAT ASSOC, V105, P1358, DOI 10.1198/jasa.2010.ap09250; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonnefoi Herve, 2007, Lancet Oncol, V8, P1071, DOI 10.1016/S1470-2045(07)70345-5; Carvalho CM, 2010, BIOMETRIKA, V1, P1; Choi HW, 2010, J COMPUT BIOL, V17, P121, DOI 10.1089/cmb.2009.0019; Do KA, 2005, J R STAT SOC C-APPL, V54, P627, DOI 10.1111/j.1467-9876.2005.05593.x; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; Fridlyand J, 2004, J MULTIVARIATE ANAL, V90, P132, DOI 10.1016/j.jmva.2004.02.008; Hastie T., 2009, UNSUPERVISED LEARNIN; Horiuchi D, 2012, J EXP MED, V209, P679, DOI 10.1084/jem.20111512; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; Lloyd CJ, 1999, STAT PROBABIL LETT, V44, P221, DOI 10.1016/S0167-7152(99)00012-7; Muller P., 2007, BAYESIAN STAT; Parmigiani G, 2002, J ROY STAT SOC B, V64, P717, DOI 10.1111/1467-9868.00358; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Pinkel D., 2005, NAT GENET, V23, P41; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Snijders A, 1998, NAT GENET, V29, P263; SolinasToldo S, 1997, GENE CHROMOSOME CANC, V20, P399, DOI 10.1002/(SICI)1098-2264(199712)20:4<399::AID-GCC12>3.0.CO;2-I; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tsang RY, 2012, BRIT J CANCER, V106, P6, DOI 10.1038/bjc.2011.516; van Wieringen WN, 2009, BIOMETRICS, V65, P19, DOI 10.1111/j.1541-0420.2008.01052.x; Verma S, 2012, NEW ENGL J MED, V367, P1783, DOI 10.1056/NEJMoa1209124; Xu Jinhua, 2010, Genes Cancer, V1, P629, DOI 10.1177/1947601910378691	27	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e68071	10.1371/journal.pone.0068071	http://dx.doi.org/10.1371/journal.pone.0068071			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	23874497	Green Published, Green Submitted, gold			2022-12-27	WOS:000321718700007
J	Crunk, AE; Monks, J; Murakami, A; Jackman, M; MacLean, PS; Ladinsky, M; Bales, ES; Cain, S; Orlicky, DJ; McManaman, JL				Crunk, Amanda E.; Monks, Jenifer; Murakami, Aya; Jackman, Matthew; MacLean, Paul S.; Ladinsky, Mark; Bales, Elise S.; Cain, Shannon; Orlicky, David J.; McManaman, James L.			Dynamic Regulation of Hepatic Lipid Droplet Properties by Diet	PLOS ONE			English	Article							DIFFERENTIATION-RELATED PROTEIN; FATTY LIVER-DISEASE; MICE; METABOLISM; IDENTIFICATION; REVEALS; OBESITY; CELLS; ADIPOPHILIN; ASSOCIATION	Cytoplasmic lipid droplets (CLD) are organelle-like structures that function in neutral lipid storage, transport and metabolism through the actions of specific surface-associated proteins. Although diet and metabolism influence hepatic CLD levels, how they affect CLD protein composition is largely unknown. We used non-biased, shotgun, proteomics in combination with metabolic analysis, quantitative immunoblotting, electron microscopy and confocal imaging to define the effects of low- and high-fat diets on CLD properties in fasted-refed mice. We found that the hepatic CLD proteome is distinct from that of CLD from other mammalian tissues, containing enzymes from multiple metabolic pathways. The hepatic CLD proteome is also differentially affected by dietary fat content and hepatic metabolic status. High fat feeding markedly increased the CLD surface density of perilipin-2, a critical regulator of hepatic neutral lipid storage, whereas it reduced CLD levels of betaine-homocysteine S-methyltransferase, an enzyme regulator of homocysteine levels linked to fatty liver disease and hepatocellular carcinoma. Collectively our data demonstrate that the hepatic CLD proteome is enriched in metabolic enzymes, and that it is qualitatively and quantitatively regulated by diet and metabolism. These findings implicate CLD in the regulation of hepatic metabolic processes, and suggest that their properties undergo reorganization in response to hepatic metabolic demands.	[Crunk, Amanda E.; Murakami, Aya; McManaman, James L.] Univ Colorado, Sch Med, Grad Program Mol Biol, Aurora, CO 80045 USA; [Crunk, Amanda E.; Monks, Jenifer; Bales, Elise S.; McManaman, James L.] Univ Colorado, Sch Med, Div Basic Reprod Sci, Aurora, CO USA; [Jackman, Matthew; MacLean, Paul S.] Univ Colorado, Sch Med, Div Endocrinol & Metab, Aurora, CO USA; [Jackman, Matthew; MacLean, Paul S.; McManaman, James L.] Univ Colorado, Sch Med, Ctr Human Nutr, Aurora, CO USA; [Jackman, Matthew; MacLean, Paul S.; Cain, Shannon; McManaman, James L.] Univ Colorado, Sch Med, Colorado Obes Res Initiat, Aurora, CO USA; [Ladinsky, Mark] Univ Colorado, Boulder Lab Elect Microscopy 3D, Aurora, CO USA; [Orlicky, David J.] Univ Colorado, Sch Med, Dept Pathol, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	McManaman, JL (corresponding author), Univ Colorado, Sch Med, Grad Program Mol Biol, Aurora, CO 80045 USA.	Jim.mcmanaman@ucdenver.edu	MacLean, Paul/A-7887-2008; Crunk, Amanda/AGF-2426-2022; Monks, Jenifer/GLS-6662-2022	MacLean, Paul/0000-0002-1123-6612; Crunk, Amanda/0000-0001-8168-0172; Monks, Jenifer/0000-0002-7990-3389	National Institutes of Health [2RO1-HD045962, R01DK038088]; Colorado Nutrition and Obesity Research Center (NORC) [DK48520]; Colorado Obesity Research Initiative; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD045965, P01HD038129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520, R01DK038088] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Colorado Nutrition and Obesity Research Center (NORC); Colorado Obesity Research Initiative; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by National Institutes of Health grants 2RO1-HD045962 (JLM), R01DK038088 (PSM), the Colorado Nutrition and Obesity Research Center (NORC, DK48520) and the Colorado Obesity Research Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athenstaedt K, 1999, J BACTERIOL, V181, P6441, DOI 10.1128/JB.181.20.6441-6448.1999; Bartzt R, 2007, J PROTEOME RES, V6, P3256, DOI 10.1021/pr070158j; Begriche K, 2011, J HEPATOL, V54, P773, DOI 10.1016/j.jhep.2010.11.006; Beller M, 2006, MOL CELL PROTEOMICS, V5, P1082, DOI 10.1074/mcp.M600011-MCP200; Bergen WG, 2005, J NUTR, V135, P2499, DOI 10.1093/jn/135.11.2499; Bhala N, 2011, HEPATOLOGY, V54, P1208, DOI 10.1002/hep.24491; Binns D, 2006, J CELL BIOL, V173, P719, DOI 10.1083/jcb.200511125; Bouchoux J, 2011, BIOL CELL, V103, P499, DOI 10.1042/BC20110024; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Catenacci VA, 2009, CLIN CHEST MED, V30, P415, DOI 10.1016/j.ccm.2009.05.001; Cermelli S, 2006, CURR BIOL, V16, P1783, DOI 10.1016/j.cub.2006.07.062; Chang BHJ, 2006, MOL CELL BIOL, V26, P1063, DOI 10.1128/MCB.26.3.1063-1076.2006; Cho SY, 2007, J BIOL CHEM, V282, P2456, DOI 10.1074/jbc.M608042200; Chong BM, 2011, J BIOL CHEM, V286, P23254, DOI 10.1074/jbc.M110.217091; Dalen KT, 2006, J LIPID RES, V47, P931, DOI 10.1194/jlr.M500459-JLR200; den Boer M, 2004, ARTERIOSCL THROM VAS, V24, P644, DOI 10.1161/01.ATV.0000116217.57583.6e; Ding YB, 2012, ACTA BIOCH BIOPH SIN, V44, P394, DOI 10.1093/abbs/gms008; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Fabbrini E, 2009, P NATL ACAD SCI USA, V106, P15430, DOI 10.1073/pnas.0904944106; Finkelstein JD, 2003, AM J CLIN NUTR, V77, P1094, DOI 10.1093/ajcn/77.5.1094; Fu SN, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002902; Fujimoto Y, 2004, BBA-MOL CELL RES, V1644, P47, DOI 10.1016/j.bbamcr.2003.10.018; Greenberg AS, 2011, J CLIN INVEST, V121, P2102, DOI 10.1172/JCI46069; Grimsrud PA, 2012, CELL METAB, V16, P672, DOI 10.1016/j.cmet.2012.10.004; Hodges BDM, 2010, J LIPID RES, V51, P262, DOI 10.1194/jlr.R003582; Imai Y, 2007, GASTROENTEROLOGY, V132, P1947, DOI 10.1053/j.gastro.2007.02.046; Kirpich IA, 2011, J NUTR BIOCHEM, V22, P38, DOI 10.1016/j.jnutbio.2009.11.009; Krahmer N, 2013, MOL CELL PROTEOMICS, V12, P1115, DOI 10.1074/mcp.M112.020230; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lei TC, 2011, MOL VIS, V17, P2628; Li ZH, 2012, CURR BIOL, V22, P2104, DOI 10.1016/j.cub.2012.09.018; LISSNER L, 1987, AM J CLIN NUTR, V46, P886, DOI 10.1093/ajcn/46.6.886; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; McManaman JL, 2013, J LIPID RES, V54, P1346, DOI 10.1194/jlr.M035063; Nagle CA, 2009, J LIPID RES, V50, pS74, DOI 10.1194/jlr.R800053-JLR200; Nan XL, 2006, BIOPHYS J, V91, P728, DOI 10.1529/biophysj.105.074534; Oh TS, 2011, J MICROBIOL BIOTECHN, V21, P1211, DOI 10.4014/jmb.1107.07056; Ohsaki Y, 2009, BBA-MOL CELL BIOL L, V1791, P399, DOI 10.1016/j.bbalip.2008.10.002; Orlicky DJ, 2008, J CELL SCI, V121, P2921, DOI 10.1242/jcs.026153; Orlicky DJ, 2011, ALCOHOL CLIN EXP RES, V35, P1020, DOI 10.1111/j.1530-0277.2011.01434.x; Parks EJ, 2006, J LIPID RES, V47, P1651, DOI 10.1194/jlr.R600018-JLR200; Prattes S, 2000, J CELL SCI, V113, P2977; Rubio-Aliaga I, 2011, PHYSIOL GENOMICS, V43, P408, DOI 10.1152/physiolgenomics.00179.2010; Russell TD, 2008, J LIPID RES, V49, P206, DOI 10.1194/jlr.M700396-JLR200; Russell TD, 2007, J LIPID RES, V48, P1463, DOI 10.1194/jlr.M600474-JLR200; Sato S, 2006, J BIOCHEM, V139, P921, DOI 10.1093/jb/mvj104; Sokolovic M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-528; Stefan N, 2008, ENDOCR REV, V29, P939, DOI 10.1210/er.2008-0009; Straub BK, 2008, HEPATOLOGY, V47, P1936, DOI 10.1002/hep.22268; Tauchi-Sato K, 2002, J BIOL CHEM, V277, P44507, DOI 10.1074/jbc.M207712200; Teng YW, 2011, J BIOL CHEM, V286, P36258, DOI 10.1074/jbc.M111.265348; TOKUYASU KT, 1986, J MICROSC-OXFORD, V143, P139, DOI 10.1111/j.1365-2818.1986.tb02772.x; Turro S, 2006, TRAFFIC, V7, P1254, DOI 10.1111/j.1600-0854.2006.00465.x; Umlauf E, 2004, J BIOL CHEM, V279, P23699, DOI 10.1074/jbc.M310546200; Unger RH, 2010, BBA-MOL CELL BIOL L, V1801, P209, DOI 10.1016/j.bbalip.2009.10.006; Wahlig JL, 2012, OBESITY, V20, P65, DOI 10.1038/oby.2011.196; Wan HC, 2007, FASEB J, V21, P167, DOI 10.1096/fj.06-6711com; Wu CC, 2004, ANAL CHEM, V76, P4951, DOI 10.1021/ac049208j; Yamaguchi K, 2007, HEPATOLOGY, V45, P1366, DOI 10.1002/hep.21655; Yoshiuchi K, 2009, ENDOCR J, V56, P1103, DOI 10.1507/endocrj.K09E-140; Zhang F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027553; Zhang HN, 2011, J PROTEOME RES, V10, P4757, DOI 10.1021/pr200553c	64	53	53	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e67631	10.1371/journal.pone.0067631	http://dx.doi.org/10.1371/journal.pone.0067631			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874434	Green Published, Green Submitted, gold			2022-12-27	WOS:000322218800008
J	Suarez, IR; Leidy, C; Tellez, G; Gay, G; Gonzalez-Mancera, A				Suarez, Ivan Rey; Leidy, Chad; Tellez, Gabriel; Gay, Guillaume; Gonzalez-Mancera, Andres			Slow Sedimentation and Deformability of Charged Lipid Vesicles	PLOS ONE			English	Article							SPHERICAL COLLOIDAL PARTICLES; DOUBLE-LAYER INTERACTION; BUOYANCY-DRIVEN MOTION; MECHANICAL-PROPERTIES; FLUID MEMBRANES; VISCOUS DROPS; DYNAMICS; TENSION; SHAPE; ELASTICITY	The study of vesicles in suspension is important to understand the complicated dynamics exhibited by cells in in vivo and in vitro. We developed a computer simulation based on the boundary-integral method to model the three dimensional gravity-driven sedimentation of charged vesicles towards a flat surface. The membrane mechanical behavior was modeled using the Helfrich Hamiltonian and near incompressibility of the membrane was enforced via a model which accounts for the thermal fluctuations of the membrane. The simulations were verified and compared to experimental data obtained using suspended vesicles labelled with a fluorescent probe, which allows visualization using fluorescence microscopy and confers the membrane with a negative surface charge. The electrostatic interaction between the vesicle and the surface was modeled using the linear Derjaguin approximation for a low ionic concentration solution. The sedimentation rate as a function of the distance of the vesicle to the surface was determined both experimentally and from the computer simulations. The gap between the vesicle and the surface, as well as the shape of the vesicle at equilibrium were also studied. It was determined that inclusion of the electrostatic interaction is fundamental to accurately predict the sedimentation rate as the vesicle approaches the surface and the size of the gap at equilibrium, we also observed that the presence of charge in the membrane increases its rigidity.	[Suarez, Ivan Rey; Gonzalez-Mancera, Andres] Univ Los Andes, Dept Mech Engn, Bogota, Colombia; [Leidy, Chad; Tellez, Gabriel] Univ Los Andes, Dept Phys, Bogota, Colombia; [Gay, Guillaume] Univ Toulouse 3, Toulouse, France	Universidad de los Andes (Colombia); Universidad de los Andes (Colombia); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Gonzalez-Mancera, A (corresponding author), Univ Los Andes, Dept Mech Engn, Bogota, Colombia.	angonzal@uniandes.edu.co		Tellez, Gabriel/0000-0002-6357-260X; Gay, Guillaume/0000-0002-5444-5246; Gonzalez-Mancera, Andres/0000-0002-0663-2653; Rey Suarez, Ivan/0000-0003-4477-1002	Colciencias [263-2008]; CIFI-Facultad de Ingenieria; Universidad de los Andes; ECOS NORD/COLCIENCIAS-MEN-ICETEX	Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); CIFI-Facultad de Ingenieria; Universidad de los Andes; ECOS NORD/COLCIENCIAS-MEN-ICETEX	The authors wish to acknowledge Colciencias for the funding for this research project (grant 263-2008). AGM acknowledges partial financial support from CIFI-Facultad de Ingenieria, Universidad de los Andes. GT acknowledges partial financial support from ECOS NORD/COLCIENCIAS-MEN-ICETEX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abkarian M, 2005, BIOPHYS J, V89, P1055, DOI 10.1529/biophysj.104.056036; Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; ASCOLI EP, 1990, J FLUID MECH, V213, P287, DOI 10.1017/S0022112090002336; Behrens SH, 2001, J CHEM PHYS, V115, P6716, DOI 10.1063/1.1404988; Biben T, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.031921; BLAKE JR, 1971, PROC CAMB PHILOS S-M, V70, P303, DOI 10.1017/S0305004100049902; Boedec G, 2012, J FLUID MECH, V690, P227, DOI 10.1017/jfm.2011.427; Boedec G, 2011, J COMPUT PHYS, V230, P1020, DOI 10.1016/j.jcp.2010.10.021; CARNIE SL, 1994, LANGMUIR, V10, P2993, DOI 10.1021/la00021a024; Cohen JA, 2003, METHOD ENZYMOL, V367, P148; Danker G, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.148102; De Rosa MC, 2007, GENE, V398, P162, DOI 10.1016/j.gene.2007.02.048; Derjaguin B, 1940, T FARADAY SOC, V35, P0203, DOI 10.1039/tf9403500203; Deschamps J, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.118105; EVANS E, 1990, PHYS REV LETT, V64, P2094, DOI 10.1103/PhysRevLett.64.2094; Greger K, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2428277; Groves JT, 1998, P NATL ACAD SCI USA, V95, P935, DOI 10.1073/pnas.95.3.935; HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693, DOI 10.1515/znc-1973-11-1209; Huang ZH, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/3/035026; Iler, 1979, CHEM SILICA SOLUBILI; Kantsler V, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.258101; Kantsler V, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.036001; Kaoui B, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.021903; Kaoui B, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.066319; Kaoui B, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.061905; Kaoui B, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.188101; Kushner J, 2001, J FLUID MECH, V446, P253, DOI 10.1017/S0022112001005699; Ly HV, 2004, BIOPHYS J, V87, P1013, DOI 10.1529/biophysj.103.034280; Menger FM, 1998, ACCOUNTS CHEM RES, V31, P789, DOI 10.1021/ar970103v; Meyer M, 2002, VISUALIZATION MATH, V3, P34; Misbah C, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.028104; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Olsen BN, 2009, J AM CHEM SOC, V131, P4854, DOI 10.1021/ja8095224; Pan JJ, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.198103; Polin M, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.041406; Pozrikidis C, 2001, J COMPUT PHYS, V169, P250, DOI 10.1006/jcph.2000.6582; POZRIKIDIS C, 1992, J FLUID MECH, V237, P627, DOI 10.1017/S0022112092003550; Rother MA, 2004, J COLLOID INTERF SCI, V270, P205, DOI 10.1016/j.jcis.2003.08.011; Rother MA, 2006, COLLOID SURFACE A, V282, P50, DOI 10.1016/j.colsurfa.2005.11.086; Rother MA, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.044501; Rowat AC, 2004, EUROPHYS LETT, V67, P144, DOI 10.1209/epl/i2003-10276-x; SEIFERT U, 1995, Z PHYS B CON MAT, V97, P299, DOI 10.1007/BF01307480; Seifert U, 1999, EUR PHYS J B, V8, P405, DOI 10.1007/s100510050706; Seifert U, 1997, ADV PHYS, V46, P13, DOI 10.1080/00018739700101488; Stankovich J, 1996, LANGMUIR, V12, P1453, DOI 10.1021/la950384k; Sukumaran S, 2001, PHYS REV E, P6401; Tellez G, 2011, PHILOS T R SOC A, V369, P322, DOI 10.1098/rsta.2010.0256; Tomaiuolo G, 2011, MICROVASC RES, V82, P35, DOI 10.1016/j.mvr.2011.03.004; Veerapaneni SK, 2011, J COMPUT PHYS, V230, P5610, DOI 10.1016/j.jcp.2011.03.045; Vlahovska PM, 2009, CR PHYS, V10, P775, DOI 10.1016/j.crhy.2009.10.001; WINTERHALTER M, 1988, J PHYS CHEM-US, V92, P6865, DOI 10.1021/j100335a004; Yoon YZ, 2009, BIOPHYS J, V97, P1606, DOI 10.1016/j.bpj.2009.06.028; Zhao H, 2011, PHYS FLUIDS, V23; Zhao H, 2011, J FLUID MECH, V674, P578, DOI 10.1017/S0022112011000115; ZHONGCAN OY, 1989, PHYS REV A, V39, P5280, DOI 10.1103/PhysRevA.39.5280; Zinchenko AZ, 1997, PHYS FLUIDS, V9, P1493, DOI 10.1063/1.869275	56	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e68309	10.1371/journal.pone.0068309	http://dx.doi.org/10.1371/journal.pone.0068309			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874582	gold, Green Published, Green Submitted			2022-12-27	WOS:000322218800024
J	Ohmayer, U; Gamalinda, M; Sauert, M; Ossowski, J; Poll, G; Linnemann, J; Hierlmeier, T; Perez-Fernandez, J; Kumcuoglu, B; Leger-Silvestre, I; Faubladier, M; Griesenbeck, J; Woolford, J; Tschochner, H; Milkereit, P				Ohmayer, Uli; Gamalinda, Michael; Sauert, Martina; Ossowski, Julius; Poell, Gisela; Linnemann, Jan; Hierlmeier, Thomas; Perez-Fernandez, Jorge; Kumcuoglu, Beril; Leger-Silvestre, Isabelle; Faubladier, Marlene; Griesenbeck, Joachim; Woolford, John; Tschochner, Herbert; Milkereit, Philipp			Studies on the Assembly Characteristics of Large Subunit Ribosomal Proteins in S. cerevisae	PLOS ONE			English	Article							ESCHERICHIA-COLI RIBOSOMES; NUCLEAR EXPORT RECEPTOR; SACCHAROMYCES-CEREVISIAE; TRANSLATION INITIATION; BIOGENESIS FACTORS; RNA; MATURATION; BINDING; NMD3P; RECONSTITUTION	During the assembly process of ribosomal subunits, their structural components, the ribosomal RNAs (rRNAs) and the ribosomal proteins (r-proteins) have to join together in a highly dynamic and defined manner to enable the efficient formation of functional ribosomes. In this work, the assembly of large ribosomal subunit (LSU) r-proteins from the eukaryote S. cerevisiae was systematically investigated. Groups of LSU r-proteins with specific assembly characteristics were detected by comparing the protein composition of affinity purified early, middle, late or mature LSU (precursor) particles by semi-quantitative mass spectrometry. The impact of yeast LSU r-proteins rpL25, rpL2, rpL43, and rpL21 on the composition of intermediate to late nuclear LSU precursors was analyzed in more detail. Effects of these proteins on the assembly states of other r-proteins and on the transient LSU precursor association of several ribosome biogenesis factors, including Nog2, Rsa4 and Nop53, are discussed.	[Ohmayer, Uli; Sauert, Martina; Ossowski, Julius; Poell, Gisela; Linnemann, Jan; Hierlmeier, Thomas; Perez-Fernandez, Jorge; Griesenbeck, Joachim; Tschochner, Herbert; Milkereit, Philipp] Univ Regensburg, Lehrstuhl Biochem 3, D-93053 Regensburg, Germany; [Gamalinda, Michael; Kumcuoglu, Beril; Woolford, John] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Leger-Silvestre, Isabelle; Faubladier, Marlene] Univ Toulouse 3, Lab Biol Mol Eucaryote, UMR 5099, F-31062 Toulouse, France	University of Regensburg; Carnegie Mellon University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Woolford, J (corresponding author), Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA.	jw17@andrew.cmu.edu; herbert.tschochner@vkl.uni-regensburg.de; philipp.milkereit@vkl.uni-regensburg.de	Perez-Fernandez, Jorge/F-6937-2010	Perez-Fernandez, Jorge/0000-0002-0018-5493; Sauert, Martina/0000-0002-2179-9515; Woolford, John/0000-0002-7553-7043; Griesenbeck, Joachim/0000-0002-7817-6095	Deutsche Forschungsgemeinschaft [SFB 960]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028301] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant which was given in the collaborative research center SFB 960 from the "Deutsche Forschungsgemeinschaft" to JG, HT and PM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adilakshmi T, 2008, NATURE, V455, P1268, DOI 10.1038/nature07298; Akanuma G, 2012, J BACTERIOL, V194, P6282, DOI 10.1128/JB.01544-12; Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Altvater M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.63; AUGERBUENDIA MA, 1979, BIOCHIM BIOPHYS ACTA, V563, P113, DOI 10.1016/0005-2787(79)90012-1; BABIANO R, 2010, NUCLEIC ACIDS RES, P92820; BABIANO R, 2012, MOL CELL BIOL; Ballesta JPG, 1996, PROG NUCLEIC ACID RE, V55, P157, DOI 10.1016/S0079-6603(08)60193-2; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; BARONASLOWELL DM, 1990, MOL CELL BIOL, V10, P5235, DOI 10.1128/MCB.10.10.5235; Bassler J, 2001, MOL CELL, V8, P517, DOI 10.1016/S1097-2765(01)00342-2; Bassler J, 2010, MOL CELL, V38, P712, DOI 10.1016/j.molcel.2010.05.024; Ben-Shem A., 2011, SCIENCE; Bradatsch B, 2007, MOL CELL, V27, P767, DOI 10.1016/j.molcel.2007.06.034; Bradatsch B, 2012, NAT STRUCT MOL BIOL, V19, P1234, DOI 10.1038/nsmb.2438; Brodersen DE, 2002, J MOL BIOL, V316, P725, DOI 10.1006/jmbi.2001.5359; Bussiere C, 2012, J CELL BIOL, V197, P747, DOI 10.1083/jcb.201112131; Chen SS, 2013, J MOL BIOL, V425, P767, DOI 10.1016/j.jmb.2012.11.040; CHOOI WY, 1981, P NATL ACAD SCI-BIOL, V78, P4823, DOI 10.1073/pnas.78.8.4823; DABBS ER, 1991, BIOCHIMIE, V73, P639, DOI 10.1016/0300-9084(91)90043-Z; de la Cruz J, 2005, NUCLEIC ACIDS RES, V33, P5728, DOI 10.1093/nar/gki887; DeLabre ML, 2002, BBA-GENE STRUCT EXPR, V1574, P255, DOI 10.1016/S0167-4781(01)00372-4; DESHMUKH M, 1993, MOL CELL BIOL, V13, P2835, DOI 10.1128/MCB.13.5.2835; Dick FA, 1997, FEBS LETT, V419, P1, DOI 10.1016/S0014-5793(97)01402-6; DOHME F, 1976, J MOL BIOL, V107, P585, DOI 10.1016/S0022-2836(76)80085-X; EGEBJERG J, 1991, J MOL BIOL, V222, P251, DOI 10.1016/0022-2836(91)90210-W; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fernandez-Pevida A, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.400564; Ferreira-Cerca S, 2005, MOL CELL, V20, P263, DOI 10.1016/j.molcel.2005.09.005; Ferreira-Cerca S, 2007, MOL CELL, V28, P446, DOI 10.1016/j.molcel.2007.09.029; FRANCESCHI FJ, 1988, BIOCHEMISTRY-US, V27, P7056, DOI 10.1021/bi00418a058; Gadal O, 2001, MOL CELL BIOL, V21, P3405, DOI 10.1128/MCB.21.10.3405-3415.2001; Gamalinda M, 2013, NUCLEIC ACIDS RES, V41, P1965, DOI 10.1093/nar/gks1272; Granato DC, 2005, FEBS J, V272, P4450, DOI 10.1111/j.1742-4658.2005.04861.x; Greber BJ, 2012, NAT STRUCT MOL BIOL, V19, P1228, DOI 10.1038/nsmb.2425; Gutgsell NS, 2012, J BACTERIOL, V194, P6875, DOI 10.1128/JB.01467-12; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; Hedges J, 2005, EMBO J, V24, P567, DOI 10.1038/sj.emboj.7600547; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; HEROLD M, 1986, MOL GEN GENET, V203, P281, DOI 10.1007/BF00333967; Hierlmeier T, 2013, NUCLEIC ACIDS RES, V41, P1191, DOI 10.1093/nar/gks1056; Ho JHN, 2000, J CELL BIOL, V151, P1057, DOI 10.1083/jcb.151.5.1057; Hofer A, 2007, J BIOL CHEM, V282, P32630, DOI 10.1074/jbc.M705057200; Hung NJ, 2008, MOL BIOL CELL, V19, P735, DOI 10.1091/mbc.E07-09-0968; Jakob S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032552; Jakovljevic J, 2012, RNA, V18, P1805, DOI 10.1261/rna.032540.112; Kemmler S, 2009, J CELL BIOL, V186, P863, DOI 10.1083/jcb.200904111; Klein DJ, 2004, J MOL BIOL, V340, P141, DOI 10.1016/j.jmb.2004.03.076; Klinge S., 2011, SCIENCE, V334, P941; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; KOREPANOV AP, 2012, NUCL ACIDS RES; KRESSLER D, 2009, BIOCHIM BIOPHYS ACTA, P79902; Kressler D, 2008, J CELL BIOL, V181, P935, DOI 10.1083/jcb.200801181; Kruger T, 2007, J CELL BIOL, V177, P573, DOI 10.1083/jcb.200612048; KRUISWIJK T, 1978, BIOCHIM BIOPHYS ACTA, V517, P378, DOI 10.1016/0005-2787(78)90204-6; LASTICK SM, 1976, J BIOL CHEM, V251, P2867; LASTICK SM, 1980, EUR J BIOCHEM, V113, P175; Lebreton A, 2006, J CELL BIOL, V173, P349, DOI 10.1083/jcb.200510080; Lebreton A, 2008, NUCLEIC ACIDS RES, V36, P4988, DOI 10.1093/nar/gkn469; Lecompte O, 2002, NUCLEIC ACIDS RES, V30, P5382, DOI 10.1093/nar/gkf693; Leger-Silvestre I, 2004, EMBO J, V23, P2336, DOI 10.1038/sj.emboj.7600252; Lo KY, 2010, MOL CELL, V39, P196, DOI 10.1016/j.molcel.2010.06.018; Lo KY, 2009, J CELL BIOL, V186, P849, DOI 10.1083/jcb.200904110; Mager WH, 1997, NUCLEIC ACIDS RES, V25, P4872, DOI 10.1093/nar/25.24.4872; MARQUARDT O, 1979, NUCLEIC ACIDS RES, V6, P3641, DOI 10.1093/nar/6.11.3641; Mayerle M, 2011, J MOL BIOL, V412, P453, DOI 10.1016/j.jmb.2011.07.048; MCCONKEY EH, 1979, MOL GEN GENET, V169, P1, DOI 10.1007/BF00267538; MERL J, 2010, NUCLEIC ACIDS RES, P801; MITSUI K, 1988, J BIOCHEM-TOKYO, V104, P908, DOI 10.1093/oxfordjournals.jbchem.a122581; MORITZ M, 1990, J CELL BIOL, V111, P2261, DOI 10.1083/jcb.111.6.2261; NIERHAUS KH, 1991, BIOCHIMIE, V73, P739, DOI 10.1016/0300-9084(91)90054-5; NIERHAUS KH, 1973, J MOL BIOL, V74, P587; Nissan TA, 2002, EMBO J, V21, P5539, DOI 10.1093/emboj/cdf547; Nomura M, 1999, J BACTERIOL, V181, P6857, DOI 10.1128/JB.181.22.6857-6864.1999; Oeffinger M, 2007, NAT METHODS, V4, P951, DOI 10.1038/NMETH1101; Ohmayer U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042449; PANSE VG, 2010, TRENDS BIOCH SCI; Phipps KR, 2011, WIRES RNA, V2, P1, DOI 10.1002/wrna.57; Planta RJ, 1998, YEAST, V14, P471, DOI 10.1002/(SICI)1097-0061(19980330)14:5<471::AID-YEA241>3.0.CO;2-U; Poll G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008249; REMACHA M, 1995, MOL CELL BIOL, V15, P4754; RICH BE, 1987, MOL CELL BIOL, V7, P4065, DOI 10.1128/MCB.7.11.4065; RIDGEWAY WK, 2012, P NATL ACAD SCI USA, P69699; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; RODRIGUEZMATEOS M, 2009, NUCLEIC ACIDS RES, P89271; ROHL R, 1982, H-S Z PHYSIOL CHEM, V363, P143, DOI 10.1515/bchm2.1982.363.1.143; Rosado IV, 2007, NUCLEIC ACIDS RES, V35, P4203, DOI 10.1093/nar/gkm388; ROTH HE, 1980, EUR J BIOCHEM, V103, P95, DOI 10.1111/j.1432-1033.1980.tb04292.x; SACHS AB, 1990, SCIENCE, V247, P1077, DOI 10.1126/science.2408148; SAENZROBLES MT, 1990, BIOCHIM BIOPHYS ACTA, V1050, P51, DOI 10.1016/0167-4781(90)90140-W; SAHASRANAMAN A, 2011, EMBO J, P26967; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Saveanu C, 2003, MOL CELL BIOL, V23, P4449, DOI 10.1128/MCB.23.13.4449-4460.2003; Saveanu C, 2001, EMBO J, V20, P6475, DOI 10.1093/emboj/20.22.6475; Schafer T, 2006, NATURE, V441, P651, DOI 10.1038/nature04840; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; SHOJI S, 2011, J MOL BIOL, P45294; STEFFEN KK, 2012, GENETICS, P77630; Strunk BS, 2011, SCIENCE, V333, P1449, DOI 10.1126/science.1208245; STRUNK BS, 2009, POWERING RIBOSOME AS, P50913; Sydorskyy Y, 2005, BIOCHEM J, V388, P819, DOI 10.1042/BJ20041297; Sykes MT, 2009, ANNU REV BIOPHYS, V38, P197, DOI 10.1146/annurev.biophys.050708.133615; Talkington MWT, 2005, NATURE, V438, P628, DOI 10.1038/nature04261; Thomson E, 2005, RNA, V11, P1215, DOI 10.1261/rna.2720205; THOMSON E, 2009, MOL CELL BIOL, P8552; TSURUGI K, 1985, J BIOCHEM-TOKYO, V98, P1427, DOI 10.1093/oxfordjournals.jbchem.a135410; Ulbrich C, 2009, CELL, V138, P911, DOI 10.1016/j.cell.2009.06.045; van Beekvelt CA, 2000, J MOL BIOL, V296, P7, DOI 10.1006/jmbi.1999.3432; van Beekvelt CA, 2001, NUCLEIC ACIDS RES, V29, P5001, DOI 10.1093/nar/29.24.5001; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; WATKINS NJ, 2011, WILEY INTERDISCIP RE; West M, 2005, MOL CELL BIOL, V25, P3802, DOI 10.1128/MCB.25.9.3802-3813.2005; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Zhang JY, 2007, GENE DEV, V21, P2580, DOI 10.1101/gad.1569307; ZINKER S, 1980, BIOCHIM BIOPHYS ACTA, V606, P76, DOI 10.1016/0005-2787(80)90099-4; ZINKER S, 1976, J BIOL CHEM, V251, P1799	118	40	41	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68412	10.1371/journal.pone.0068412	http://dx.doi.org/10.1371/journal.pone.0068412			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874617	Green Published, Green Submitted, gold			2022-12-27	WOS:000321765300049
J	Pedica, F; Ruzzenente, A; Bagante, F; Capelli, P; Cataldo, I; Pedron, S; Iacono, C; Chilosi, M; Scarpa, A; Brunelli, M; Tomezzoli, A; Martignoni, G; Guglielmi, A				Pedica, Federica; Ruzzenente, Andrea; Bagante, Fabio; Capelli, Paola; Cataldo, Ivana; Pedron, Serena; Iacono, Calogero; Chilosi, Marco; Scarpa, Aldo; Brunelli, Matteo; Tomezzoli, Anna; Martignoni, Guido; Guglielmi, Alfredo			A Re-Emerging Marker for Prognosis in Hepatocellular Carcinoma: The Add-Value of FISHing c-myc Gene for Early Relapse	PLOS ONE			English	Article							INTRAHEPATIC RECURRENCE; LIVER-TRANSPLANTATION; RISK-FACTORS; GENOMIC HETEROGENEITY; RESECTION; HEPATECTOMY; EXPRESSION; SURVIVAL; CLASSIFICATION; AMPLIFICATION	Hepatocellular carcinoma is one leading cause of cancer-related death and surgical resection is still one of the major curative therapies. Recently, there has been a major effort to find mechanisms involved in carcinogenesis and early relapse. c-myc gene abnormality is found in hepatocarcinogenesis. Our aim was to analyze the role of c-myc as prognostic factor in terms of overall survival and disease-free survival and to investigate if c-myc may be an important target for therapy. We studied sixty-five hepatocellular carcinomas submitted to surgical resection with curative intent. Size, macro-microvascular invasion, necrosis, number of nodules, grading and serum alfa-fetoprotein level were registered for all cases. We evaluated the c-myc aberrations by using break-apart FISH probes. Probes specific for the centromeric part of chromosome 8 and for the locus specific c-myc gene (8q24) were used to assess disomy, gains of chromosomes (polysomy due to polyploidy) and amplification. c-myc gene amplification was scored as 8q24/CEP8 > 2. Statistical analysis for disease-free survival and overall survival were performed. At molecular level, c-myc was amplified in 19% of hepatocellular carcinoma, whereas showed gains in 55% and set wild in 26% of cases. The 1- and 3-year disease-free survival and overall survival for disomic, polysomic and amplified groups were significantly different (p=0.020 and p=.018 respectively). Multivariate analysis verified that the AFP and c-myc status (amplified vs. not amplified) were significant prognostic factors for overall patients survival. c-myc gene amplification is significantly correlated with disease-free survival and overall survival in patients with hepatocellular carcinoma after surgical resection and this model identifies patients with risk of early relapse (<= 12 months). We suggest that c-myc assessment may be introduced in the clinical practice for improving prognostication (high and low risk of relapse) routinely and may have be proposed as biomarker of efficacy to anti-c-myc targeted drugs in clinical trials.	[Pedica, Federica; Capelli, Paola; Cataldo, Ivana; Pedron, Serena; Chilosi, Marco; Scarpa, Aldo; Brunelli, Matteo; Martignoni, Guido] Univ Verona, FISH Mol Lab, Dept Pathol & Diagnost, Azienda Osped Univ Integrata Verona, I-37100 Verona, Italy; [Ruzzenente, Andrea; Bagante, Fabio; Iacono, Calogero; Guglielmi, Alfredo] Univ Verona, Sch Med, GB Rossi Hosp, Dept Surg,Div Gen Surg A, I-37100 Verona, Italy; [Tomezzoli, Anna] Azienda Osped Univ Integrata Verona, dO DAI Pathol & Diagnost, Verona, Italy	University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona	Guglielmi, A (corresponding author), Univ Verona, Sch Med, GB Rossi Hosp, Dept Surg,Div Gen Surg A, I-37100 Verona, Italy.	alfredo.guglielmi@univr.it	Ruzzenente, Andrea/R-5850-2019; CHILOSI, MARCO/ABB-8028-2021; scarpa, aldo/K-6832-2016; Pedica, Federica/AAB-1557-2019; Brunelli, Matteo/AAA-7679-2019	Ruzzenente, Andrea/0000-0001-6911-563X; scarpa, aldo/0000-0003-1678-739X; Pedica, Federica/0000-0003-0168-4718; IACONO, Calogero/0000-0002-0489-0747; GUGLIELMI, Alfredo/0000-0003-1713-4307; CATALDO, Ivana/0000-0003-2032-2085; BRUNELLI, Matteo/0000-0002-3832-2676; Bagante, Fabio/0000-0002-5386-0958	Ministero dell'Istruzione, dell'Universita e della Ricerca	Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR))	This work was supported by Ministero dell'Istruzione, dell'Universita e della Ricerca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi E, 2002, SURGERY, V131, pS148, DOI 10.1067/msy.2002.119496; Albarello L, 2011, ADV ANAT PATHOL, V18, P53, DOI 10.1097/PAP.0b013e3182026d72; Ataide EC, 2011, TRANSPL P, V43, P1362, DOI 10.1016/j.transproceed.2011.02.032; Boyault S, 2007, HEPATOLOGY, V45, P42, DOI 10.1002/hep.21467; Brunelli M, 2008, AM J CLIN PATHOL, V129, P907, DOI 10.1309/MD79CDXN1D01E862; Camidge DR, 2012, CANCER-AM CANCER SOC, V118, P4486, DOI 10.1002/cncr.27411; Chan ACY, 2012, WORLD J SURG, V36, P151, DOI 10.1007/s00268-011-1323-0; Chan KL, 2004, HUM PATHOL, V35, P1324, DOI 10.1016/j.humpath.2004.06.012; Chiang DY, 2008, CANCER RES, V68, P6779, DOI 10.1158/0008-5472.CAN-08-0742; Cuadros M, 2009, APPL IMMUNOHISTO M M, V17, P1, DOI 10.1097/PAI.0b013e318169fc1c; Dang CV, 2009, CLIN CANCER RES, V15, P6479, DOI 10.1158/1078-0432.CCR-09-0889; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Hoshida Y, 2009, CANCER RES, V69, P7385, DOI 10.1158/0008-5472.CAN-09-1089; Hui AM, 1997, BRIT J CANCER, V76, P335, DOI 10.1038/bjc.1997.387; Imamura H, 2003, J HEPATOL, V38, P200, DOI 10.1016/S0168-8278(02)00360-4; Kawate S, 1999, ONCOLOGY-BASEL, V57, P157, DOI 10.1159/000012024; Kluin P, 2011, HISTOPATHOLOGY, V58, P128, DOI 10.1111/j.1365-2559.2010.03700.x; KUO SH, 1987, LIVER, V7, P359; Lauwers GY, 2002, AM J SURG PATHOL, V26, P25, DOI 10.1097/00000478-200201000-00003; Li WH, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-45; Liu JX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023098; Llovet JM, 2005, SEMIN LIVER DIS, V25, P181, DOI 10.1055/s-2005-871198; Marelli L, 2008, ANN SURG ONCOL, V15, P3503, DOI 10.1245/s10434-008-0128-3; Marrero JA, 2005, HEPATOLOGY, V41, P707, DOI 10.1002/hep.20636; Nakata T, 2008, HEPATO-GASTROENTEROL, V55, P865; Poon RTP, 2000, ANN SURG, V231, P544, DOI 10.1097/00000658-200004000-00014; Poon RTP, 1999, ANN SURG, V229, P216, DOI 10.1097/00000658-199902000-00009; Saeki R, 2000, J HEPATOL, V33, P99, DOI 10.1016/S0168-8278(00)80165-8; Shah SA, 2007, SURGERY, V141, P330, DOI 10.1016/j.surg.2006.06.028; Shimada K, 2007, ANN SURG ONCOL, V14, P2337, DOI 10.1245/s10434-007-9415-7; Sirivatanauksorn Y, 1999, GUT, V45, P761, DOI 10.1136/gut.45.5.761; Takeuchi H, 2009, J NEURO-ONCOL, V91, P33, DOI 10.1007/s11060-008-9690-6; Tang SW, 2009, CANCER LETT, V273, P35, DOI 10.1016/j.canlet.2008.07.038; Venook AP, 2010, ONCOLOGIST, V15, P5, DOI 10.1634/theoncologist.2010-S4-05; Villanueva Augusto, 2011, Gastroenterology, V141, P1943, DOI 10.1053/j.gastro.2011.09.027; Villanueva A, 2011, GASTROENTEROLOGY, V140, P1501, DOI 10.1053/j.gastro.2011.02.006; Villanueva A, 2010, ANNU REV MED, V61, P317, DOI 10.1146/annurev.med.080608.100623; Wang Y, 2002, CANCER-AM CANCER SOC, V95, P2346, DOI 10.1002/cncr.10963; Yamashita T, 2008, CANCER RES, V68, P1451, DOI 10.1158/0008-5472.CAN-07-6013; Zhang QL, 2011, J CELL BIOCHEM, V112, P2910, DOI 10.1002/jcb.23207; Zhang YL, 2012, HEPATOLOGY, V56, P1631, DOI 10.1002/hep.25849; Zhao WC, 2012, WORLD J GASTROENTERO, V18, P3272, DOI 10.3748/wjg.v18.i25.3272	44	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68203	10.1371/journal.pone.0068203	http://dx.doi.org/10.1371/journal.pone.0068203			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874541	Green Submitted, Green Published, gold			2022-12-27	WOS:000321765300033
J	Poutahidis, T; Kleinewietfeld, M; Smillie, C; Levkovich, T; Perrotta, A; Bhela, S; Varian, BJ; Ibrahim, YM; Lakritz, JR; Kearney, SM; Chatzigiagkos, A; Hafler, DA; Alm, EJ; Erdman, SE				Poutahidis, Theofilos; Kleinewietfeld, Markus; Smillie, Christopher; Levkovich, Tatiana; Perrotta, Alison; Bhela, Siddheshvar; Varian, Bernard J.; Ibrahim, Yassin M.; Lakritz, Jessica R.; Kearney, Sean M.; Chatzigiagkos, Antonis; Hafler, David A.; Alm, Eric J.; Erdman, Susan E.			Microbial Reprogramming Inhibits Western Diet-Associated Obesity	PLOS ONE			English	Article							REGULATORY T-CELLS; GUT MICROBIOTA; INSULIN-RESISTANCE; IMMUNE-SYSTEM; INTESTINAL MICROBIOTA; VITAMIN-D; LACTOBACILLUS-REUTERI; APC(MIN/+) MICE; ADIPOSE-TISSUE; INFLAMMATION	A recent epidemiological study showed that eating 'fast food' items such as potato chips increased likelihood of obesity, whereas eating yogurt prevented age-associated weight gain in humans. It was demonstrated previously in animal models of obesity that the immune system plays a critical role in this process. Here we examined human subjects and mouse models consuming Westernized 'fast food' diet, and found CD4(+) T helper (Th) 17-biased immunity and changes in microbial communities and abdominal fat with obesity after eating the Western chow. In striking contrast, eating probiotic yogurt together with Western chow inhibited age-associated weight gain. We went on to test whether a bacteria found in yogurt may serve to lessen fat pathology by using purified Lactobacillus reuteri ATCC 6475 in drinking water. Surprisingly, we discovered that oral L. reuteri therapy alone was sufficient to change the pro-inflammatory immune cell profile and prevent abdominal fat pathology and age-associated weight gain in mice regardless of their baseline diet. These beneficial microbe effects were transferable into naive recipient animals by purified CD4(+) T cells alone. Specifically, bacterial effects depended upon active immune tolerance by induction of Foxp3(+) regulatory T cells (Treg) and interleukin (II)-10, without significantly changing the gut microbial ecology or reducing ad libitum caloric intake. Our finding that microbial targeting restored CD4(+) T cell balance and yielded significantly leaner animals regardless of their dietary 'fast food' indiscretions suggests population-based approaches for weight management and enhancing public health in industrialized societies.	[Poutahidis, Theofilos; Levkovich, Tatiana; Varian, Bernard J.; Ibrahim, Yassin M.; Lakritz, Jessica R.; Kearney, Sean M.; Erdman, Susan E.] MIT, Div Comparat Med, Cambridge, MA 02139 USA; [Poutahidis, Theofilos; Chatzigiagkos, Antonis] Aristotle Univ Thessaloniki, Fac Vet Med, Pathol Lab, GR-54006 Thessaloniki, Greece; [Kleinewietfeld, Markus; Bhela, Siddheshvar; Hafler, David A.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Kleinewietfeld, Markus; Bhela, Siddheshvar; Hafler, David A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA; [Kleinewietfeld, Markus; Hafler, David A.; Alm, Eric J.] Broad Inst Massachusetts Inst Technol & Harvard U, Cambridge, MA USA; [Smillie, Christopher; Perrotta, Alison; Kearney, Sean M.; Alm, Eric J.] MIT, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Aristotle University of Thessaloniki; Yale University; Yale University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Hafler, DA (corresponding author), Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA.	david.hafler@yale.edu; ejalm@mit.edu; serdman@mit.edu	Kleinewietfeld, Markus/AAI-4497-2021	Smillie, Chris/0000-0002-7606-3433; Kleinewietfeld, Markus/0000-0002-2832-3149; Lakritz, Jessica/0000-0003-2510-3869	National Institutes of Health [P30-ES002109, RO1CA108854, P01 AI045757, U19 AI046130, U19 AI070352, P01 AI039671]; National Institute of Neurological Disorders and Stroke [NS2427]; Penates Foundation; Nancy Taylor Foundation for Chronic Diseases, Inc.; NATIONAL CANCER INSTITUTE [R01CA108854, U01CA164337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070352, P01AI039671, P01AI045757, U19AI046130, R01AI091568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Penates Foundation; Nancy Taylor Foundation for Chronic Diseases, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health grants P30-ES002109 (pilot project award to SEE and EJA), RO1CA108854 (to SEE), and P01 AI045757, U19 AI046130, U19 AI070352, and P01 AI039671 (to DAH). DAH is also supported by a Jacob Javits Merit award (NS2427) from the National Institute of Neurological Disorders and Stroke and the Penates Foundation and Nancy Taylor Foundation for Chronic Diseases, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2010, CYTOKINE GROWTH F R, V21, P449, DOI 10.1016/j.cytogfr.2010.10.005; Axling U, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-105; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Baltgalvis KA, 2008, AM J PHYSIOL-REG I, V294, pR393, DOI 10.1152/ajpregu.00716.2007; Berer K, NATURE, V479, P538; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Camerino C, 2009, OBESITY, V17, P980, DOI 10.1038/oby.2009.12; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Chang SH, 2010, J BIOL CHEM, V285, P38751, DOI 10.1074/jbc.C110.185777; Chaudhry A, 2011, IMMUNITY, V34, P566, DOI 10.1016/j.immuni.2011.03.018; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Deiuliis J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016376; Di Giacinto C, 2005, J IMMUNOL, V174, P3237, DOI 10.4049/jimmunol.174.6.3237; Erdman SE, 2005, CANCER RES, V65, P3998, DOI 10.1158/0008-5472.CAN-04-3104; Erdman SE, 2003, AM J PATHOL, V162, P691, DOI 10.1016/S0002-9440(10)63863-1; Erdman SE, 2010, INT J CANCER, V126, P1651, DOI 10.1002/ijc.24923; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Faith JJ, 2011, SCIENCE, V333, P101, DOI 10.1126/science.1206025; Fak F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046837; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Flint HJ, 2012, NAT REV GASTRO HEPAT, V9, P577, DOI 10.1038/nrgastro.2012.156; Frese SA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001314; Gounaris E, 2009, CANCER RES, V69, P5490, DOI 10.1158/0008-5472.CAN-09-0304; Harris DM, 2004, J NUTR, V134, p3463S, DOI 10.1093/jn/134.12.3463S; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Ilan Y, 2010, P NATL ACAD SCI USA, V107, P9765, DOI 10.1073/pnas.0908771107; Kallus SJ, 2012, J CLIN GASTROENTEROL, V46, P16, DOI 10.1097/MCG.0b013e31823711fd; Kang JH, 2010, J MICROBIOL, V48, P712, DOI 10.1007/s12275-010-0363-8; Kim SW, 2013, BIOCHEM BIOPH RES CO, V431, P258, DOI 10.1016/j.bbrc.2012.12.121; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; Lee MN, 2012, NAT IMMUNOL; Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568; Levkovich T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053867; Litonjua AA, 2007, J ALLERGY CLIN IMMUN, V120, P1031, DOI 10.1016/j.jaci.2007.08.028; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Maslowski KM, 2011, NAT IMMUNOL, V12, P5, DOI 10.1038/ni0111-5; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; McNulty NP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002701; Million M, 2013, INT J OBES LOND; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Naito E, 2011, J APPL MICROBIOL, V110, P650, DOI 10.1111/j.1365-2672.2010.04922.x; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Oksaharju A., 2012, BR J NUTR, P1; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Powrie F, 2003, SCIENCE, V299, P1030, DOI 10.1126/science.1082031; Rook GAW, 2009, IMMUNOLOGY, V126, P3, DOI 10.1111/j.1365-2567.2008.03007.x; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Salama P, 2009, J CLIN ONCOL, V27, P186, DOI 10.1200/JCO.2008.18.7229; Santacruz A, 2009, OBESITY, V17, P1906, DOI 10.1038/oby.2009.112; Saulnier DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018783; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Tauber M, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-47; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Walter J, 2011, P NATL ACAD SCI USA, V108, P4645, DOI 10.1073/pnas.1000099107; Wang YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013951; West M, 2009, CURR OPIN ENDOCRINOL, V16, P178, DOI 10.1097/MED.0b013e3283292327; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Winer S, 2009, EUR J IMMUNOL, V39, P2629, DOI 10.1002/eji.200838893; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957; Zuniga LA, 2010, J IMMUNOL, V185, P6947, DOI 10.4049/jimmunol.1001269	67	114	119	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68596	10.1371/journal.pone.0068596	http://dx.doi.org/10.1371/journal.pone.0068596			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874682	Green Submitted, Green Published, gold			2022-12-27	WOS:000321765300055
J	Deliens, G; Schmitz, R; Caudron, I; Mary, A; Leproult, R; Peigneux, P				Deliens, Gaetane; Schmitz, Remy; Caudron, Isaline; Mary, Alison; Leproult, Rachel; Peigneux, Philippe			Does Recall after Sleep-Dependent Memory Consolidation Reinstate Sensitivity to Retroactive Interference?	PLOS ONE			English	Article							RECONSOLIDATION; RETRIEVAL	Previous studies have shown that newly encoded memories are more resistant to retroactive interference when participants are allowed to sleep after learning the original material, suggesting a sleep-related strengthening of memories. In the present study, we investigated delayed, long-term effects of sleep vs. sleep deprivation (SD) on the first post-training night on memory consolidation and resistance to interference. On day 1, participants learned a list of unrelated word pairs (AB), either in the morning or in the evening, then spent the post-training night in a sleep or sleep deprivation condition, in a within-subject paradigm. On day 4, at the same time of day, they learned a novel list of word pairs (AC) in which 50% of the word pairs stemmed with the same word than in the AB list, resulting in retroactive interference. Participants had then to recall items from the AB list upon presentation of the "A" stem. Recall was marginally improved in the evening, as compared to the morning learning group. Most importantly, retroactive interference effects were found in the sleep evening group only, contrary to the hypothesis that sleep exerts a protective role against intrusion by novel but similar learning. We tentatively suggest that these results can be explained in the framework of the memory reconsolidation theory, stating that exposure to similar information sets back consolidated items in a labile form again sensitive to retroactive interference. In this context, sleep might not protect against interference but would promote an update of existing episodic memories while preventing saturation of the memory network due to the accumulation of dual traces.	[Deliens, Gaetane] Univ Libre Bruxelles, CRCN Ctr Res Cognit & Neurosci, Neuropsychol & Funct Neuroimaging Res Grp UR2NF, Brussels, Belgium; UNI ULB Neurosci Inst, Brussels, Belgium	Universite Libre de Bruxelles	Deliens, G (corresponding author), Univ Libre Bruxelles, CRCN Ctr Res Cognit & Neurosci, Neuropsychol & Funct Neuroimaging Res Grp UR2NF, Brussels, Belgium.	Gaetane.Deliens@ulb.ac.be; Philippe.Peigneux@ulb.ac.be	Schmitz, Remy/A-6592-2012	Schmitz, Remy/0000-0002-6303-1846; Mary, Alison/0000-0002-4298-1922; Peigneux, Philippe/0000-0003-4745-1434	"Brains Back to Brussels" project; FRSM-FNRS Research grants [1.5.184.10.F, 3.4.594.08.F]	"Brains Back to Brussels" project; FRSM-FNRS Research grants(Fonds de la Recherche Scientifique - FNRS)	GD and AM are Research Fellows at the Belgian Fonds National de la Recherche Scientifique (FNRS). RS is a PNRS Postdoctoral Researcher. RL is supported by a "Brains Back to Brussels" project. This study has been conducted with support of FRSM-FNRS Research grants 1.5.184.10.F and 3.4.594.08.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; CONTENT A, 1990, ANN PSYCHOL, V90, P551; Debiec J, 2002, NEURON, V36, P527, DOI 10.1016/S0896-6273(02)01001-2; Deliens G, 2013, CORTEX, V49, P2221, DOI 10.1016/j.cortex.2012.11.014; Desrochers A, 2000, CAN J EXP PSYCHOL, V54, P274, DOI 10.1037/h0087347; Dewar MT, 2007, CORTEX, V43, P616, DOI 10.1016/S0010-9452(08)70492-1; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Dudai Y, 2012, ANN REV NEUROSCI, V35; Ebbinghaus, 1885, GEDACHTNIS; EICH JE, 1975, J VERB LEARN VERB BE, V14, P408, DOI 10.1016/S0022-5371(75)80020-X; Ekstrand BR., 1972, HUMAN MEMORY FESTSCH, P59; Ellenbogen JM, 2006, CURR BIOL, V16, P1290, DOI 10.1016/j.cub.2006.05.024; Ellenbogen JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004117; ELLIS BW, 1981, SLEEP, V4, P93, DOI 10.1093/sleep/4.1.93; Gais S, 2006, LEARN MEMORY, V13, P259, DOI 10.1101/lm.132106; GODDEN DR, 1975, BRIT J PSYCHOL, V66, P325, DOI 10.1111/j.2044-8295.1975.tb01468.x; Gomez R., 2012, NEUROSCIENCE BIOBEHA; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Hupbach A, 2007, LEARN MEMORY, V14, P47, DOI 10.1101/lm.365707; IDZIKOWSKI C, 1984, BRIT J PSYCHOL, V75, P439, DOI 10.1111/j.2044-8295.1984.tb01914.x; Jenkins JG, 1924, AM J PSYCHOL, V35, P605, DOI 10.2307/1414040; Kenealy PM, 1997, Q J EXP PSYCHOL-A, V50, P290, DOI 10.1080/027249897392107; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Mednick SC, 2011, TRENDS NEUROSCI, V34, P504, DOI 10.1016/j.tins.2011.06.003; Muller G. E., 1900, Z PSYCHOLOGIE, V1, P1; Nader K, 2010, MEMORY RECONSOLIDATI, P1191; Newman-Smith K, 2011, ASS PROF SLEEP SOC M; Peigneux P., 2015, PRINCIPLES PRACTICE, P335, DOI [10.1016/B978-1-4160-6645-3.00029-3, DOI 10.1016/B978-1-4160-6645-3.00029-3]; Plihal W, 1997, J COGNITIVE NEUROSCI, V9, P534, DOI 10.1162/jocn.1997.9.4.534; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930	33	15	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68727	10.1371/journal.pone.0068727	http://dx.doi.org/10.1371/journal.pone.0068727			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	182JD	23874738	Green Published, Green Submitted, gold			2022-12-27	WOS:000321736900107
J	Fang, SB; Su, H; Liu, W; Tan, KY; Ren, SX				Fang, Shibo; Su, Hua; Liu, Wei; Tan, Kaiyan; Ren, Sanxue			Infrared Warming Reduced Winter Wheat Yields and Some Physiological Parameters, Which Were Mitigated by Irrigation and Worsened by Delayed Sowing	PLOS ONE			English	Article							TEMPERATURE RESPONSE FUNCTIONS; HIGHER NIGHT TEMPERATURE; CLIMATE-CHANGE; ELEVATED CO2; WATER AVAILABILITY; ROCKY-MOUNTAINS; CARBON-DIOXIDE; GAS-EXCHANGE; SPRING WHEAT; GROWTH	Winter wheat has a central role in ensuring the food security and welfare of 1.3 billion people in China. Extensive previous studies have concluded that winter wheat yields would decrease with higher temperatures, owing to warming-induced soil drying or shortening of phenophase. Temperature in China is predicted to increase by 1-5 degrees C by 2100, which may greatly impact plant production and cause other negative effects. We performed a manipulative field experiment, creating diverse growth regimes for wheat by infrared radiation (IR) warming day and night, including IR warming only (DW), IR warming + delayed sowing dates (DS), IR warming + increased irrigation (IW), and a control (CK). The results show that IR warming increased daily average wheat canopy and soil temperatures by 2.0 degrees C and 2.3 degrees C, respectively. DW was associated with an advanced maturity of 10 days and yield reduction of 8.2%. IR-warming effects on the photosynthetic apparatus of wheat varied with season as well as significant differences were found in the booting stage. DS represented a worsened situation, lowering yield per plant by 16.4%, with a significant decline in aboveground biomass and functional leaf area. Wheat under DS showed double-peak patterns of diurnal gas exchange during booting stages and, consequently, lower photosynthetic capacity with high transpiration for cooling. Significantly lower actual water use efficiency and intrinsic water use efficiency from jointing to anthesis stages were also found under DS. However, IW had no significant difference from CK, irrespective of yield and photosynthesis. Therefore, we concluded that delayed sowing date may not be a good choice for winter wheat, whereas a thoroughly-watered wheat agroecosystem should be promoted in the context of global warming.	[Fang, Shibo; Tan, Kaiyan; Ren, Sanxue] Chinese Acad Meteorol Sci, Inst Ecoenvironm Land Agrometeorol, Beijing, Peoples R China; [Su, Hua; Liu, Wei] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China	Chinese Academy of Meteorological Sciences (CAMS); Chinese Academy of Sciences; Institute of Botany, CAS	Fang, SB (corresponding author), Chinese Acad Meteorol Sci, Inst Ecoenvironm Land Agrometeorol, Beijing, Peoples R China.	fangshibo@cams.cma.gov.cn	Su, Hua/H-4780-2012	Su, Hua/0000-0002-8088-3397; fang, shibo/0000-0003-1516-1360	National Research Institutes of Basic Research and Operating Expenses of China [2008Y005]; National Basic Research Program of China [2010CB951300]	National Research Institutes of Basic Research and Operating Expenses of China; National Basic Research Program of China(National Basic Research Program of China)	This research was jointly supported by National Research Institutes of Basic Research and Operating Expenses of China (Grant No. 2008Y005) and National Basic Research Program of China (Grant No. 2010CB951300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apple ME, 2000, INT J PLANT SCI, V161, P127, DOI 10.1086/314237; Asseng S, 2011, GLOBAL CHANGE BIOL, V17, P997, DOI 10.1111/j.1365-2486.2010.02262.x; Bernacchi CJ, 2003, PLANT CELL ENVIRON, V26, P1419, DOI 10.1046/j.0016-8025.2003.01050.x; Bernacchi CJ, 2001, PLANT CELL ENVIRON, V24, P253, DOI 10.1111/j.1365-3040.2001.00668.x; BUTTERFIELD RE, 1992, AGR FOREST METEOROL, V62, P241, DOI 10.1016/0168-1923(92)90017-X; COVENTRY DR, 1993, AUST J EXP AGR, V33, P751, DOI 10.1071/EA9930751; de Boeck HJ, 2012, GLOBAL CHANGE BIOL, V18, P2860, DOI 10.1111/j.1365-2486.2012.02734.x; Easterling WE, 2007, P NATL ACAD SCI USA, V104, P19679, DOI 10.1073/pnas.0710388104; Fang ShiBo, 2010, Scientia Agricultura Sinica, V43, P3251; Gooding MJ, 2003, J CEREAL SCI, V37, P295, DOI 10.1006/jcrs.2002.0501; He WM, 2003, PHOTOSYNTHETICA, V41, P297, DOI 10.1023/B:PHOT.0000011966.30235.91; Huxman TE, 1998, PLANT CELL ENVIRON, V21, P1275, DOI 10.1046/j.1365-3040.1998.00396.x; Kimball BA, 2005, GLOBAL CHANGE BIOL, V11, P2041, DOI 10.1111/j.1365-2486.2005.01028.x; Kimball BA, 2008, GLOBAL CHANGE BIOL, V14, P309, DOI 10.1111/j.1365-2486.2007.01486.x; Kimball BA, 2011, AGR FOREST METEOROL, V151, P420, DOI 10.1016/j.agrformet.2010.11.013; Lavalle C, 2009, AGRON SUSTAIN DEV, V29, P433, DOI 10.1051/agro/2008068; Liu CM, 2002, AGR FOREST METEOROL, V111, P109, DOI 10.1016/S0168-1923(02)00015-1; Llorens L, 2004, ECOSYSTEMS, V7, P613, DOI 10.1007/s10021-004-0180-1; Llorens L, 2003, PHYSIOL PLANTARUM, V119, P231, DOI 10.1034/j.1399-3054.2003.00174.x; Lobell DB, 2007, AGR FOREST METEOROL, V145, P229, DOI 10.1016/j.agrformet.2007.05.002; Lobell DB, 2005, FIELD CROP RES, V94, P250, DOI 10.1016/j.fcr.2005.01.007; Loik ME, 2004, NEW PHYTOL, V162, P331, DOI 10.1111/j.1469-8137.2004.01002.x; Loik ME, 2000, FUNCT ECOL, V14, P166, DOI 10.1046/j.1365-2435.2000.00411.x; Mantel S, 2000, SOIL USE MANAGE, V16, P270, DOI 10.1111/j.1475-2743.2000.tb00208.x; MITCHELL RAC, 1995, PLANT CELL ENVIRON, V18, P736, DOI 10.1111/j.1365-3040.1995.tb00576.x; Morgan JA, 2011, NATURE, V476, P202, DOI 10.1038/nature10274; Niu SL, 2011, GLOBAL CHANGE BIOL, V17, P1073, DOI 10.1111/j.1365-2486.2010.02280.x; Ottman MJ, 2012, AGRON J, V104, P7, DOI 10.2134/agronj2011.0212; Patil RH, 2010, J AGR SCI-CAMBRIDGE, V148, P553, DOI 10.1017/S0021859610000419; Peng SB, 2004, P NATL ACAD SCI USA, V101, P9971, DOI 10.1073/pnas.0403720101; Piao SL, 2010, NATURE, V467, P43, DOI 10.1038/nature09364; Porter JR, 1999, EUR J AGRON, V10, P23, DOI 10.1016/S1161-0301(98)00047-1; REYNOLDS MP, 1994, AUST J PLANT PHYSIOL, V21, P717, DOI 10.1071/PP9940717; Royo C, 2000, AUST J PLANT PHYSIOL, V27, P1051; Shah NH, 2003, PLANT SOIL, V257, P219, DOI 10.1023/A:1026237816578; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Spink JH, 2000, ANN APPL BIOL, V137, P179, DOI 10.1111/j.1744-7348.2000.tb00049.x; Starr G, 2000, GLOBAL CHANGE BIOL, V6, P357, DOI 10.1046/j.1365-2486.2000.00316.x; Tao FL, 2006, AGR FOREST METEOROL, V138, P82, DOI 10.1016/j.agrformet.2006.03.014; van Herwaarden AF, 1998, AUST J AGR RES, V49, P1095, DOI 10.1071/A97041; Volder A, 2007, GLOBAL CHANGE BIOL, V13, P1040, DOI 10.1111/j.1365-2486.2007.01321.x; Wall GW, 2011, GLOBAL CHANGE BIOL, V17, P2113, DOI 10.1111/j.1365-2486.2011.02399.x; Wall GW, 2006, AGRON J, V98, P354, DOI 10.2134/agronj2004.0089; Wan CG, 2002, J ARID ENVIRON, V51, P255, DOI 10.1006/jare.2001.0942; Wan SQ, 2009, ECOLOGY, V90, P2700, DOI 10.1890/08-2026.1; Wang HL, 2008, AGR FOREST METEOROL, V148, P1242, DOI 10.1016/j.agrformet.2008.03.003; White JW, 2011, FIELD CROP RES, V124, P213, DOI 10.1016/j.fcr.2011.06.020; Xia JY, 2010, SCI TOTAL ENVIRON, V408, P2807, DOI 10.1016/j.scitotenv.2010.03.016; Zhang TY, 2012, J SCI FOOD AGR, V92, P1643, DOI 10.1002/jsfa.5523; Zhou XH, 2007, J INTEGR PLANT BIOL, V49, P270, DOI 10.1111/j.1744-7909.2007.00374.x	50	19	27	8	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e67518	10.1371/journal.pone.0067518	http://dx.doi.org/10.1371/journal.pone.0067518			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874424	Green Published, gold, Green Submitted			2022-12-27	WOS:000321736900011
J	Jin, SH; Jeong, W; Seol, J; Kwon, J; Chung, CK				Jin, Seung-Hyun; Jeong, Woorim; Seol, Jaeho; Kwon, Jiyeon; Chung, Chun Kee			Functional Cortical Hubs in the Eyes-Closed Resting Human Brain from an Electrophysiological Perspective Using Magnetoencephalography	PLOS ONE			English	Article							DEFAULT MODE NETWORK; SMALL-WORLD; CONNECTIVITY; MEG; REORGANIZATION; FLUCTUATIONS; ARCHITECTURE; INTEGRATION; COMPLEXITY; FLOW	It is not clear whether specific brain areas act as hubs in the eyes-closed (EC) resting state, which is an unconstrained state free from any passive or active tasks. Here, we used electrophysiological magnetoencephalography (MEG) signals to study functional cortical hubs in 88 participants. We identified several multispectral cortical hubs. Although cortical hubs vary slightly with different applied measures and frequency bands, the most consistent hubs were observed in the medial and posterior cingulate cortex, the left dorsolateral superior frontal cortex, and the left pole of the middle temporal cortex. Hubs were characterized as connector nodes integrating EC resting state functional networks. Hubs in the gamma band were more likely to include midline structures. Our results confirm the existence of multispectral cortical cores in EC resting state functional networks based on MEG and imply the existence of optimized functional networks in the resting brain.	[Jin, Seung-Hyun; Jeong, Woorim; Seol, Jaeho; Kwon, Jiyeon; Chung, Chun Kee] Seoul Natl Univ Hosp, Dept Neurosurg, MEG Ctr, Seoul 110744, South Korea; [Jin, Seung-Hyun; Chung, Chun Kee] Seoul Natl Univ Hosp, Dept Neurosurg, Seoul 110744, South Korea; [Jin, Seung-Hyun; Chung, Chun Kee] Seoul Natl Univ, Med Res Ctr, Neurosci Res Inst, Seoul, South Korea; [Chung, Chun Kee] Seoul Natl Univ, Coll Med, Dept Neurosurg, Seoul, South Korea; [Kwon, Jiyeon] Seoul Natl Univ, Coll Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Chung, CK (corresponding author), Seoul Natl Univ Hosp, Dept Neurosurg, MEG Ctr, Seoul 110744, South Korea.	chungc@snu.ac.kr	Seol, Jaeho/L-2811-2013; Seol, Jaeho/O-4110-2019; Chung, Chun Kee/J-5650-2012	Seol, Jaeho/0000-0002-7953-6179; Seol, Jaeho/0000-0002-7953-6179; Chung, Chun Kee/0000-0003-3485-2327; Jeong, Woorim/0000-0002-6477-2777	Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology (MEST) [2012R1A13007555]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (MEST) (No. 2012R1A13007555). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Babiloni C, 2010, CLIN NEUROPHYSIOL, V121, P1816, DOI 10.1016/j.clinph.2010.04.027; Bassett DS, 2011, TRENDS COGN SCI, V15, P200, DOI 10.1016/j.tics.2011.03.006; Bassett DS, 2009, P NATL ACAD SCI USA, V106, P11747, DOI 10.1073/pnas.0903641106; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; Biswal BB, 1997, NMR BIOMED, V10, P165, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<165::AID-NBM454>3.0.CO;2-7; Brookes MJ, 2011, P NATL ACAD SCI USA, V108, P16783, DOI 10.1073/pnas.1112685108; Brookes MJ, 2011, NEUROIMAGE, V56, P1082, DOI 10.1016/j.neuroimage.2011.02.054; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Buzsaki G, 2004, TRENDS NEUROSCI, V27, P186, DOI 10.1016/j.tins.2004.02.007; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Chavez M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.118701; David O, 2004, NEUROIMAGE, V21, P659, DOI 10.1016/j.neuroimage.2003.10.006; de Pasquale F, 2013, NEUROIMAGE, V69, P51, DOI 10.1016/j.neuroimage.2012.11.051; de Pasquale F, 2012, NEURON, V74, P753, DOI 10.1016/j.neuron.2012.03.031; de Pasquale F, 2010, P NATL ACAD SCI USA, V107, P6040, DOI 10.1073/pnas.0913863107; Ding JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026596; Dominguez LG, 2005, J NEUROSCI, V25, P8077, DOI 10.1523/JNEUROSCI.1046-05.2005; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gross J, 2013, NEUROIMAGE, V65, P349, DOI 10.1016/j.neuroimage.2012.10.001; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hauk O, 2011, NEUROIMAGE, V54, P1966, DOI 10.1016/j.neuroimage.2010.09.053; He BYJ, 2008, P NATL ACAD SCI USA, V105, P16039, DOI 10.1073/pnas.0807010105; He BYJ, 2010, NEURON, V66, P353, DOI 10.1016/j.neuron.2010.04.020; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Hillebrand A, 2012, CLIN NEUROPHYSIOL; Hipp JF, 2012, NAT NEUROSCI, V15, P884, DOI 10.1038/nn.3101; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Jin SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028682; Jin SH, 2011, J NEUROPHYSIOL, V106, P2888, DOI 10.1152/jn.00335.2011; Jin SH, 2011, MOVEMENT DISORD, V26, P1274, DOI 10.1002/mds.23675; Kim H, 2012, NEUROIMAGE, V61, P966, DOI 10.1016/j.neuroimage.2012.03.025; Kitzbichler MG, 2011, J NEUROSCI, V31, P8259, DOI 10.1523/JNEUROSCI.0440-11.2011; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Li W, 2013, NEUROIMAGE, V78, P46, DOI 10.1016/j.neuroimage.2013.04.011; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008525; Nir Y, 2008, NAT NEUROSCI, V11, P1100, DOI 10.1038/nn.2177; Northoff G, 2004, TRENDS COGN SCI, V8, P102, DOI 10.1016/j.tics.2004.01.004; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Olson IR, 2007, BRAIN, V130, P1718, DOI 10.1093/brain/awm052; Pereda E, 2005, PROG NEUROBIOL, V77, P1, DOI 10.1016/j.pneurobio.2005.10.003; Pfefferbaum A, 2011, CEREB CORTEX, V21, P233, DOI 10.1093/cercor/bhq090; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Reichle ME, 2010, TRENDS COGN SCI, V14, P180, DOI 10.1016/j.tics.2010.01.008; Roulston MS, 1999, PHYSICA D, V125, P285, DOI 10.1016/S0167-2789(98)00269-3; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Saenger VM, 2012, NEUROPSYCHOLOGIA, V50, P1308, DOI 10.1016/j.neuropsychologia.2012.02.014; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Sohn Y, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001139; Sporns O, 2011, BRAINS SMALL WORLD M, P101; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Taulu S, 2009, HUM BRAIN MAPP, V30, P1524, DOI 10.1002/hbm.20627; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2009, HUM BRAIN MAPP, V30, P3127, DOI 10.1002/hbm.20737; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Wang L, 2010, BRAIN, V133, P1224, DOI 10.1093/brain/awq043; Wang L, 2009, HUM BRAIN MAPP, V30, P638, DOI 10.1002/hbm.20530; Yan CG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005743	70	18	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68192	10.1371/journal.pone.0068192	http://dx.doi.org/10.1371/journal.pone.0068192			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874535	Green Submitted, gold, Green Published			2022-12-27	WOS:000321736900064
J	Mao, ZH; Sun, J; Feng, B; Ma, JJ; Zang, L; Dong, F; Zhang, DH; Zheng, MH				Mao, Zhihai; Sun, Jing; Feng, Bo; Ma, Junjun; Zang, Lu; Dong, Feng; Zhang, Daohai; Zheng, Minhua			The Metastasis Suppressor, N-myc Downregulated Gene 1 (NDRG1), Is a Prognostic Biomarker for Human Colorectal Cancer	PLOS ONE			English	Article							IRON CHELATORS; TUMOR-METASTASIS; POOR-PROGNOSIS; TGF-BETA; EXPRESSION; GROWTH; CELLS; DRG-1; CAP43/NDRG1/DRG-1; PROLIFERATION	Metastasis remains to be one of the most prevalent causes leading to poor long-term survival of colorectal cancer (CRC) patients. The clinical significances of tumor metastatic suppressor, N-myc downregulated gene 1 (NDRG1), have been inconsistently reported in a variety of cancerous diseases. In this study with 240 CRC clinical specimens, we showed that NDRG1 expression was significantly decreased in most of CRC tissues compared to the paired non-tumor counterparts. Statistical analysis revealed a significant inverse correlation of NDRG1 expression with tumor stage, differentiation status and metastasis. Compared with NDRG1-negative group, NDRG1-positve group had better disease-free/overall survival (p = 0.000) over 5 years' follow-up. Furthermore, NDRG1 was considered to be an independent prognostic factor for overall survival (p = 0.001) and recurrence (p = 0.003). Our study concludes that NDRG1 is a novel favorable predictor for the prognosis in CRC patients.	[Mao, Zhihai; Sun, Jing; Feng, Bo; Ma, Junjun; Zang, Lu; Dong, Feng; Zheng, Minhua] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Gen Surg, Shanghai 200030, Peoples R China; [Sun, Jing; Zhang, Daohai] Univ Sydney, Dept Pathol, Sydney, NSW 2006, Australia; [Mao, Zhihai; Sun, Jing; Feng, Bo; Ma, Junjun; Zang, Lu; Dong, Feng; Zheng, Minhua] Shanghai Minimally Invas Surg Ctr, Shanghai, Peoples R China	Shanghai Jiao Tong University; University of Sydney	Zhang, DH (corresponding author), Univ Sydney, Dept Pathol, Sydney, NSW 2006, Australia.	dave6503@gmail.com; zmhtiger@yeah.net			National Natural Science Foundation of China (NSFC) [30873000]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was financially supported by National Natural Science Foundation of China (NSFC, 30873000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiba J, 2008, ONCOL REP, V20, P1329, DOI 10.3892/or_00000148; Ando T, 2006, DIS ESOPHAGUS, V19, P454, DOI 10.1111/j.1442-2050.2006.00618.x; Azuma K, 2012, J THORAC ONCOL, V7, P779, DOI 10.1097/JTO.0b013e31824c92b4; Bandyopadhyay S, 2004, ONCOGENE, V23, P5675, DOI 10.1038/sj.onc.1207734; Bandyopadhyay S, 2003, CANCER RES, V63, P1731; Bao B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050165; Bolocan A, 2012, CHIRURGIA-BUCHAREST, V107, P555; Chen ZQ, 2012, J BIOL CHEM, V287, P17016, DOI 10.1074/jbc.M112.350470; Cheng J, 2011, CANCER LETT, V310, P35, DOI 10.1016/j.canlet.2011.06.001; Danielsen SA, 2008, HUM MUTAT, V29, pE252, DOI 10.1002/humu.20860; Dixon KM, 2013, BRIT J CANCER, V108, P409, DOI 10.1038/bjc.2012.582; Fujii T, 2008, BREAST CANCER-TOKYO, V15, P73, DOI 10.1007/s12282-007-0015-y; Guang RJ, 2000, CANCER RES, V60, P749; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kok LF, 2010, ARCH GYNECOL OBSTET, V281, P293, DOI 10.1007/s00404-009-1094-0; Koo CL, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-25; Lachat P, 2002, HISTOCHEM CELL BIOL, V118, P399, DOI 10.1007/s00418-002-0460-9; Le NTV, 2004, BLOOD, V104, P2967, DOI 10.1182/blood-2004-05-1866; Lerner A, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/256178; Li Q, 2011, CLIN EXP METASTAS, V28, P127, DOI 10.1007/s10585-010-9366-4; Liang JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052269; Liu W, 2012, EMBO MOL MED, V4, P93, DOI 10.1002/emmm.201100190; Maruyama Y, 2006, CANCER RES, V66, P6233, DOI 10.1158/0008-5472.CAN-06-0183; Nagai MA, 2011, BREAST CANCER RES TR, V126, P1, DOI 10.1007/s10549-010-0867-2; Nishio S, 2008, CANCER LETT, V264, P36, DOI 10.1016/j.canlet.2008.01.020; Popa F, 2011, CHIRURGIA-BUCHAREST, V106, P11; Sidhu R, 2013, CLIN CANCER RES, V19, P969, DOI 10.1158/1078-0432.CCR-12-2502; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Smallbone K, 2005, J THEOR BIOL, V235, P476, DOI 10.1016/j.jtbi.2005.02.001; Song Y, 2010, HUM PATHOL, V41, P214, DOI 10.1016/j.humpath.2009.07.011; Strzelczyk B, 2009, ANN SURG ONCOL, V16, P1287, DOI 10.1245/s10434-009-0381-0; Sun J, 2013, MOL PHARMACOL, V83, P454, DOI 10.1124/mol.112.083097; Sun J, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-85; Tabusa H, 2013, MOL CANCER RES, V11, P109, DOI 10.1158/1541-7786.MCR-12-0466; Tajima Yusuke, 2012, Gan To Kagaku Ryoho, V39, P2240; Tang CM, 2013, J GASTROEN HEPATOL, V28, P401, DOI 10.1111/jgh.12038; Wu Y, 2013, CANCER INVEST, V31, P7, DOI 10.3109/07357907.2012.743556; Yan XR, 2008, CANCER LETT, V262, P133, DOI 10.1016/j.canlet.2007.12.010; Zhang DH, 2005, MOL CELL PROTEOMICS, V4, P1686, DOI 10.1074/mcp.M400221-MCP200	39	45	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68206	10.1371/journal.pone.0068206	http://dx.doi.org/10.1371/journal.pone.0068206			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874544	Green Published, gold, Green Submitted			2022-12-27	WOS:000321736900068
J	Matallana-Surget, S; Cavicchioli, R; Fauconnier, C; Wattiez, R; Leroy, B; Joux, F; Raftery, MJ; Lebaron, P				Matallana-Surget, Sabine; Cavicchioli, Ricardo; Fauconnier, Charles; Wattiez, Ruddy; Leroy, Baptiste; Joux, Fabien; Raftery, Mark J.; Lebaron, Philippe			Shotgun Redox Proteomics: Identification and Quantitation of Carbonylated Proteins in the UVB-Resistant Marine Bacterium, Photobacterium angustum S14	PLOS ONE			English	Article							ESCHERICHIA-COLI; GLUTAMINE-SYNTHETASE; OXIDATIVE STRESS; FRATAXIN MUTANT; ULTRAMICROBACTERIUM; CHROMATOGRAPHY; INACTIVATION; STARVATION; RADIATION; ACONITASE	UVB oxidizes proteins through the generation of reactive oxygen species. One consequence of UVB irradiation is carbonylation, the irreversible formation of a carbonyl group on proline, lysine, arginine or threonine residues. In this study, redox proteomics was performed to identify carbonylated proteins in the UVB resistant marine bacterium Photobacterium angustum. Mass-spectrometry was performed with either biotin-labeled or dinitrophenylhydrazide (DNPH) derivatized proteins. The DNPH redox proteomics method enabled the identification of 62 carbonylated proteins (5% of 1221 identified proteins) in cells exposed to UVB or darkness. Eleven carbonylated proteins were quantified and the UVB/dark abundance ratio was determined at both the protein and peptide levels. As a result we determined which functional classes of proteins were carbonylated, which residues were preferentially modified, and what the implications of the carbonylation were for protein function. As the first large scale, shotgun redox proteomics analysis examining carbonylation to be performed on bacteria, our study provides a new level of understanding about the effects of UVB on cellular proteins, and provides a methodology for advancing studies in other biological systems.	[Matallana-Surget, Sabine; Fauconnier, Charles; Joux, Fabien; Lebaron, Philippe] Univ Paris 06, Lab Oceanog Microbienne, Observ Oceanol, UMR7621, Banyuls Sur Mer, France; [Matallana-Surget, Sabine; Fauconnier, Charles; Joux, Fabien; Lebaron, Philippe] CNRS, Lab Oceanog Microbienne, Observ Oceanol, UMR7621, Banyuls Sur Mer, France; [Cavicchioli, Ricardo] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Wattiez, Ruddy; Leroy, Baptiste] Univ Mons, Res Inst Biosci, Dept Prote & Microbiol, Interdisciplinary Mass Spectrometry Ctr CISMa, B-7000 Mons, Belgium; [Raftery, Mark J.] Univ New S Wales, Bioanalyt Mass Spectrometry Facil, Sydney, NSW, Australia	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; University of New South Wales Sydney; University of Mons; University of New South Wales Sydney	Matallana-Surget, S (corresponding author), Univ Paris 06, Lab Oceanog Microbienne, Observ Oceanol, UMR7621, Banyuls Sur Mer, France.	sabine.matallana@obs-banyus.fr	Cavicchioli, Ricardo/D-4341-2013; Joux, Fabien/F-8107-2010; Surget, Sabine Matallana/AAM-1004-2020	Cavicchioli, Ricardo/0000-0001-8989-6402; Surget, Sabine Matallana/0000-0002-6023-3215; Joux, Fabien/0000-0001-8089-2771; Leroy, Baptiste/0000-0001-7166-4478; wattiez, ruddy/0000-0003-2071-4310	European community project MAMBA [FP7-KBBE-2008-226977]; Australian Research Council	European community project MAMBA; Australian Research Council(Australian Research Council)	This work was supported by the European community project MAMBA (FP7-KBBE-2008-226977). Research in RC and MJRs laboratories was supported by the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboudi M, 2008, CURR MICROBIOL, V57, P412, DOI 10.1007/s00284-008-9214-9; Allen CFH, 1930, J AM CHEM SOC, V52, P2955, DOI 10.1021/ja01370a058; Beal MF, 2002, FREE RADICAL BIO MED, V32, P797, DOI 10.1016/S0891-5849(02)00780-3; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; Bollineni RC, 2011, J PROTEOMICS, V74, P2338, DOI 10.1016/j.jprot.2011.07.002; Cabiscol Elisa, 2000, International Microbiology, V3, P3; Chavez J, 2006, ANAL CHEM, V78, P6847, DOI 10.1021/ac0607257; Chi BK, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009506; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; Dukan S, 2000, P NATL ACAD SCI USA, V97, P5746, DOI 10.1073/pnas.100422497; Dukan S, 1999, J BIOL CHEM, V274, P26027, DOI 10.1074/jbc.274.37.26027; Eguchi M, 1996, APPL ENVIRON MICROB, V62, P1287, DOI 10.1128/AEM.62.4.1287-1294.1996; FARMAN JC, 1985, NATURE, V315, P207, DOI 10.1038/315207a0; GARDNER PR, 1995, J BIOL CHEM, V270, P13399, DOI 10.1074/jbc.270.22.13399; GARDNER PR, 1994, P NATL ACAD SCI USA, V91, P12248, DOI 10.1073/pnas.91.25.12248; Guchhait RB, 1974, J BIOL CHEM, V249, P6653; Kim JH, 2010, OMICS, V14, P689, DOI 10.1089/omi.2010.0051; Kim JH, 2010, J PROTEOME RES, V9, P730, DOI 10.1021/pr900538e; Krisko A, 2010, P NATL ACAD SCI USA, V107, P14373, DOI 10.1073/pnas.1009312107; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lauro FM, 2009, P NATL ACAD SCI USA, V106, P15527, DOI 10.1073/pnas.0903507106; Levine RL, 2002, FREE RADICAL BIO MED, V32, P790, DOI 10.1016/S0891-5849(02)00765-7; LEVINE RL, 1981, P NATL ACAD SCI-BIOL, V78, P2120, DOI 10.1073/pnas.78.4.2120; LEVINE RL, 1983, J BIOL CHEM, V258, P1823; Madian AG, 2011, J PROTEOME RES, V10, P3959, DOI 10.1021/pr200140x; Madian AG, 2010, J PROTEOME RES, V9, P3766, DOI 10.1021/pr1002609; Maisonneuve E, 2008, J BACTERIOL, V190, P6609, DOI 10.1128/JB.00588-08; Maisonneuve E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007269; Matallana-Surget S, 2009, PHOTOCH PHOTOBIO SCI, V8, P1313, DOI 10.1039/b902715g; Matallana-Surget S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042299; Meany DL, 2007, PROTEOMICS, V7, P1150, DOI 10.1002/pmic.200600450; Mirzaei H, 2005, ANAL CHEM, V77, P2386, DOI 10.1021/ac0484373; Moller IM, 2011, J PROTEOMICS, V74, P2228, DOI 10.1016/j.jprot.2011.05.004; Nystrom T, 2005, EMBO J, V24, P1311, DOI 10.1038/sj.emboj.7600599; Nystrom T, 2004, ANNU REV MICROBIOL, V58, P161, DOI 10.1146/annurev.micro.58.030603.123818; Ostling J, 1996, J BACTERIOL, V178, P4901, DOI 10.1128/jb.178.16.4901-4908.1996; Ostrowski M, 2004, PROTEOMICS, V4, P1779, DOI 10.1002/pmic.200300695; Rao RSP, 2011, PROTEOMICS, V11, P4166, DOI 10.1002/pmic.201100223; Ravanat JL, 2001, J PHOTOCH PHOTOBIO B, V63, P88, DOI 10.1016/S1011-1344(01)00206-8; Requena JR, 2003, AMINO ACIDS, V25, P221, DOI 10.1007/s00726-003-0012-1; Rinalducci S, 2008, J EXP BOT, V59, P3781, DOI 10.1093/jxb/ern252; Scaloni A, 2011, J PROTEOMICS, V74, P2223, DOI 10.1016/j.jprot.2011.07.023; Srinivasan S, 1998, J BIOSCIENCE, V23, P501, DOI 10.1007/BF02936144; Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142; Tamarit J, 1998, J BIOL CHEM, V273, P3027, DOI 10.1074/jbc.273.5.3027; Wehr NB, 2012, ANAL BIOCHEM, V423, P241, DOI 10.1016/j.ab.2012.01.031; Yoo YS, 2004, ELECTROPHORESIS, V25, P1334, DOI 10.1002/elps.200405890	47	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68112	10.1371/journal.pone.0068112	http://dx.doi.org/10.1371/journal.pone.0068112			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874515	Green Published, Green Submitted, gold			2022-12-27	WOS:000321736900059
J	Sarchielli, P; Nardi, K; Chiasserini, D; Eusebi, P; Tantucci, M; Di Piero, V; Altieri, M; Marini, C; Russo, T; Silvestrini, M; Paolino, I; Calabresi, P; Parnetti, L				Sarchielli, Paola; Nardi, Katiuscia; Chiasserini, Davide; Eusebi, Paolo; Tantucci, Michela; Di Piero, Vittorio; Altieri, Marta; Marini, Carmine; Russo, Tommasina; Silvestrini, Mauro; Paolino, Isabella; Calabresi, Paolo; Parnetti, Lucilla			Immunological Profile of Silent Brain Infarction and Lacunar Stroke	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; ADHESION MOLECULE-1 EXPRESSION; HEPATOCYTE GROWTH-FACTOR; CORONARY-HEART-DISEASE; WHITE-MATTER LESIONS; ISCHEMIC BRAIN; INTERFERON-GAMMA; FOCAL ISCHEMIA; RISK-FACTOR; INTERLEUKIN-18	Neuroinflammation is believed to be involved in the pathophysiological mechanisms of silent brain infarcts (SBI). However, the immunological profile of SBI has been scarcely investigated. In the context of a national research project named SILENCE, aimed at investigating clinical, biochemical and pathogenic features of SBI, we have measured the plasma profile of some inflammatory-related molecules in SBI patients (n = 21), patients with recent lacunar infarcts (LI, n = 28) and healthy controls (n = 31), consecutively enrolled in four Italian centres. A panel of chemokines (MIG, CTACK, IL16, SDF1a, MCP1), growth factors (SCF, SCGFb, HGF, IL3), immunoglobulin-type adhesion molecules (ICAM1, VCAM1), proinflammatory cytokines (IL18, INFa2, MIF, IL12p40), cell surface receptors on T-cells (IL2Ra), and inductors of apoptosis (TRAIL) was assessed in plasma samples by Luminex xMAP (TM) technology. Immunological parameters were compared using non-parametric statistics and performance to distinguish SBI and LI was evaluated by receiver operating characteristic (ROC) analysis. Plasma levels of ICAM1 were significantly higher in both SBI and LI patients as compared to controls (SBI >= LI > Ctrl). A different trend was observed for IL16 (SBI < LI > Ctrl), SCF (LI < SBI > Ctrl) and SCGFb (SBI > LI < Ctrl). SBI subjects had significantly increased levels of MIG when compared to controls (LI <= SBI > Ctrl) and IL18 when compared to LI patients (Ctrl <= SBI > LI). All the other immunological markers did not significantly differ among groups. According to ROC analysis, the best predictor for SBI condition was the chemokine MIG (AUC = 0.84, sensitivity 86%, specificity 77%), while SCF had the best performance in distinguishing LI patients (AUC = 0.84, sensitivity 86%, specificity 68%). These results confirm the involvement of inflammatory processes in cerebrovascular disorders, particularly in SBI, a very common age-related condition. The differences in plasma profile of inflammatory molecules may underlie different pathological mechanisms in SBI and LI patients.	[Sarchielli, Paola; Nardi, Katiuscia; Chiasserini, Davide; Tantucci, Michela; Calabresi, Paolo; Parnetti, Lucilla] Univ Perugia, Osped Santa Maria della Misericordia, Dept Med & Surg Specialties & Publ Hlth, Neurol Clin, I-06100 Perugia, Italy; [Eusebi, Paolo] Reg Hlth Author Umbria, Dept Epidemiol, Perugia, Italy; [Di Piero, Vittorio; Altieri, Marta] Univ Roma La Sapienza, Dept Neurol Sci, I-00185 Rome, Italy; [Marini, Carmine; Russo, Tommasina] Univ Aquila, Dept Internal Med & Publ Hlth, I-67100 Laquila, Italy; [Silvestrini, Mauro; Paolino, Isabella] Marche Polytech Univ, Osped Riuniti Ancona, Dept Neurosci, Neurol Clin, Ancona, Italy; [Calabresi, Paolo] IRCCS, Fdn S Lucia, Rome, Italy	Hospital Santa Maria della Misericordia; University of Perugia; Sapienza University Rome; University of L'Aquila; Marche Polytechnic University; IRCCS Santa Lucia	Sarchielli, P (corresponding author), Univ Perugia, Osped Santa Maria della Misericordia, Dept Med & Surg Specialties & Publ Hlth, Neurol Clin, I-06100 Perugia, Italy.	paola.sarchielli@gmail.com	Di Piero, Vittorio/U-7714-2019; altieri, marta/AAV-6678-2021; di piero, vittorio/F-6335-2010; Silvestrini, Mauro/AAB-3838-2019; Parnetti, Lucilla/K-8258-2016; Sarchielli, Paola/K-2127-2014; Calabresi, Paolo/G-8496-2011; Chiasserini, Davide/K-7074-2016; Eusebi, Paolo/O-2721-2013	di piero, vittorio/0000-0002-2631-7562; Parnetti, Lucilla/0000-0001-5722-3967; Sarchielli, Paola/0000-0002-7595-9246; Calabresi, Paolo/0000-0003-0326-5509; Chiasserini, Davide/0000-0002-1169-3258; Eusebi, Paolo/0000-0002-0715-6396	Italian Ministry of Education, University and Research (MIUR) [MIUR 2005064857]	Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was supported by the Italian Ministry of Education, University and Research (MIUR): grant number MIUR 2005064857. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramo C, 2006, MICROBES INFECT, V8, P45, DOI 10.1016/j.micinf.2005.05.019; Anan F, 2010, EUR J CLIN INVEST, V40, P585, DOI 10.1111/j.1365-2362.2010.02301.x; Andres RH, 2011, STROKE, V42, P2923, DOI 10.1161/STROKEAHA.110.606368; Antonino MJ, 2009, AM J CARDIOL, V103, P1546, DOI 10.1016/j.amjcard.2009.01.367; Bamford JM, 2000, CEREBROVASC DIS, V10, P2, DOI 10.1159/000047582; Blankenberg S, 2003, CIRCULATION, V108, P2453, DOI 10.1161/01.CIR.0000099509.76044.A2; Blankenberg S, 2002, CIRCULATION, V106, P24, DOI 10.1161/01.CIR.0000020546.30940.92; Bogoslovsky T, 2011, STROKE, V42, P618, DOI 10.1161/STROKEAHA.110.596007; Canoui-Poitrine F, 2011, NEUROLOGY, V77, P1165, DOI 10.1212/WNL.0b013e31822dc7c8; Che XM, 2001, BRAIN RES, V902, P171, DOI 10.1016/S0006-8993(01)02328-9; Chen Y, 2003, J CEREBR BLOOD F MET, V23, P748, DOI 10.1097/01.WCB.0000071885.63724.20; Correia LCL, 2010, CLIN CHIM ACTA, V411, P540, DOI 10.1016/j.cca.2010.01.011; Cui M, 2010, NEUROBIOL DIS, V39, P138, DOI 10.1016/j.nbd.2010.03.018; Cui X, 2007, STEM CELLS, V25, P2777, DOI 10.1634/stemcells.2007-0169; de Lemos JA, 2003, CIRCULATION, V107, P690, DOI 10.1161/01.CIR.0000049742.68848.99; Debette S, 2010, STROKE, V41, P600, DOI 10.1161/STROKEAHA.109.570044; Dentelli P, 1999, J IMMUNOL, V163, P2151; Doeppner TR, 2011, J CEREBR BLOOD F MET, V31, P1251, DOI 10.1038/jcbfm.2010.211; Drake C, 2011, BRAIN BEHAV IMMUN, V25, P1113, DOI 10.1016/j.bbi.2011.02.008; Fisher CM, 1998, NEUROLOGY, V50, P841; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; FUJIKAWA T, 1993, STROKE, V24, P1631, DOI 10.1161/01.STR.24.11.1631; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; Haines BA, 2010, J CEREBR BLOOD F MET, V30, P1825, DOI 10.1038/jcbfm.2010.52; Hiraoka A, 1997, P NATL ACAD SCI USA, V94, P7577, DOI 10.1073/pnas.94.14.7577; Hoshi T, 2005, STROKE, V36, P768, DOI 10.1161/01.STR.0000158915.28329.51; HOSMER DW, 1989, APPL LOGISTIC REGRES; Hoyte LC, 2010, J CEREBR BLOOD F MET, V30, P1178, DOI 10.1038/jcbfm.2009.287; Husted S, 2010, CLIN CARDIOL, V33, P206, DOI 10.1002/clc.20732; Inacio AR, 2011, J CEREBR BLOOD F MET, V31, P1093, DOI 10.1038/jcbfm.2010.194; Ishikawa J, 2007, STROKE, V38, P911, DOI 10.1161/01.STR.0000258115.46765.f1; Keeley EC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021174; Konoeda F, 2010, BIOCHEM BIOPH RES CO, V402, P500, DOI 10.1016/j.bbrc.2010.10.058; KRUPINSKI J, 1994, STROKE, V25, P1794, DOI 10.1161/01.STR.25.9.1794; Lambertsen KL, 2004, J NEUROPATH EXP NEUR, V63, P942, DOI 10.1093/jnen/63.9.942; Lin SG, 2000, CIRC RES, V87, P1202, DOI 10.1161/01.RES.87.12.1202; Lindsberg PJ, 1996, CIRCULATION, V94, P939, DOI 10.1161/01.CIR.94.5.939; Mach F, 1999, J CLIN INVEST, V104, P1041, DOI 10.1172/JCI6993; Mallat Z, 2001, CIRC RES, V89, pE41, DOI 10.1161/hh1901.098735; Mangino M, 2008, J MOL MED, V86, P99, DOI 10.1007/s00109-007-0264-4; Momiyama Y, 2005, CIRC J, V69, P793, DOI 10.1253/circj.69.793; OKADA Y, 1994, STROKE, V25, P202, DOI 10.1161/01.STR.25.1.202; Putaala J, 2011, NEUROLOGY, V76, P1742, DOI 10.1212/WNL.0b013e31821a44ad; Rajpathak SN, 2010, STROKE, V41, P857, DOI 10.1161/STROKEAHA.109.567719; Saino O, 2010, J NEUROSCI RES, V88, P2385, DOI 10.1002/jnr.22410; Schirmer SH, 2009, J AM COLL CARDIOL, V53, P2141, DOI 10.1016/j.jacc.2009.02.049; Schwab JM, 2001, J NEUROIMMUNOL, V114, P232, DOI 10.1016/S0165-5728(00)00433-1; Steinhubl SR, 2007, VASC MED, V12, P113, DOI 10.1177/1358863X07077462; Strecker JK, 2011, PLOS ONE, V6; STRIETER RM, 1995, J BIOL CHEM, V270, P27348, DOI 10.1074/jbc.270.45.27348; Vermeer SE, 2007, LANCET NEUROL, V6, P611, DOI 10.1016/S1474-4422(07)70170-9; Vermeer SE, 2003, STROKE, V34, P1126, DOI 10.1161/01.STR.0000068408.82115.D2; Vermeer SE, 2003, NEW ENGL J MED, V348, P1215, DOI 10.1056/NEJMoa022066; Vogelgesang A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008718; Wang LJ, 2009, STROKE, V40, P973, DOI 10.1161/STROKEAHA.108.530535; Weber R, 2012, STROKE, V43, P350, DOI 10.1161/STROKEAHA.111.631739; Welsh P, 2008, STROKE, V39, P2226, DOI 10.1161/STROKEAHA.107.504498; Wykrzykowska JJ, 2011, INT J CARDIOL, V149, P10, DOI 10.1016/j.ijcard.2009.11.033; Yang LL, 2010, NEUROL RES, V32, P340, DOI 10.1179/016164110X12656393665080; Yuen CM, 2007, CIRC J, V71, P1691, DOI 10.1253/circj.71.1691; Zhao L, 2006, PLATELETS, V17, P100, DOI 10.1080/09537100500235966; Zhu YC, 2011, STROKE, V42, P1140, DOI 10.1161/STROKEAHA.110.600114	62	17	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68428	10.1371/journal.pone.0068428	http://dx.doi.org/10.1371/journal.pone.0068428			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874624	Green Submitted, Green Published, gold			2022-12-27	WOS:000321736900086
J	Jin, X; Yi, L; Chen, ML; Chen, CY; Chang, H; Zhang, T; Wang, L; Zhu, JD; Zhang, QY; Mi, MT				Jin, Xin; Yi, Long; Chen, Ming-liang; Chen, Chun-ye; Chang, Hui; Zhang, Ting; Wang, Li; Zhu, Jun-dong; Zhang, Qian-yong; Mi, Man-tian			Delphinidin-3-Glucoside Protects against Oxidized Low-Density Lipoprotein-Induced Mitochondrial Dysfunction in Vascular Endothelial Cells via the Sodium-Dependent Glucose Transporter SGLT1	PLOS ONE			English	Article							MOLECULAR-MECHANISMS; LIPID-PEROXIDATION; OXIDATIVE STRESS; ANTHOCYANINS; RESVERATROL; APOPTOSIS; ANTIOXIDANTS; CONSUMPTION; METABOLISM; INHIBITION	Delphinidin-3-glucoside (Dp) is a member of a family of bioactive compounds known as anthocyanins that occur naturally in pigmented plants and are known to ameliorate oxidative stress. Previous studies have showed that Dp decreased oxidative stress in vascular endothelial cells, however, the underlying mechanisms remain largely unknown. In the present study, we showed that pretreatment with Dp significantly suppressed oxidized low-density lipoprotein (oxLDL)-induced cell proliferation inhibition and apoptosis in primary human umbilical vein endothelial cells (HUVECs). Also, Dp pretreatment attenuated oxLDL-induced mitochondrial dysfunction via decreased reactive oxygen species (ROS) and superoxide anion generation, thereby repressing mitochondrial membrane potential and closing mitochondrial permeability transition pore. Furthermore, in vitro and in vivo data showed that Dp was transported into endothelial cells in a temperature, concentration, and time-dependent manner via the sodium-dependent glucose transporter (SGLT1). Suppression of SGLT1 by its substrate glucose, its inhibitor phlorizin or SGLT1 siRNA blocked Dp transportation. Repression of SGLT1 significantly inhibited Dp function of ameliorating mitochondrial dysfunction induced by pro-apoptotic factors (Apoptosis-inducing factor, Cytochrome c, Caspase-3 and Bax/Bcl-2 ratio). Taken together, our data indicate that Dp protects VECs via the SGLT1-ROS-mitochodria pathway. This new insight may help to elucidate the molecular mechanisms underlying the vascular protection afforded by Dp, and anthocyanins in general, in the context of prevention of endothelial dysfunction and atherosclerosis.	[Jin, Xin; Yi, Long; Chen, Ming-liang; Chen, Chun-ye; Chang, Hui; Zhang, Ting; Wang, Li; Zhu, Jun-dong; Zhang, Qian-yong; Mi, Man-tian] Third Mil Med Univ, Chongqing Med Nutr Res Ctr, Inst Mil Prevent Med, Res Ctr Nutr & Food Safety,Chongqing Key Lab Nutr, Chongqing, Peoples R China	Army Medical University	Mi, MT (corresponding author), Third Mil Med Univ, Chongqing Med Nutr Res Ctr, Inst Mil Prevent Med, Res Ctr Nutr & Food Safety,Chongqing Key Lab Nutr, Chongqing, Peoples R China.	mi_mt2009@hotmail.com	Chen, Mingliang/AGH-3195-2022	Chang, Hui/0000-0001-6693-2570	National Natural Science Foundation of China [81000133, 81202202]; Youth Innovation Foundation of the Third Military Medical University [2012XJQ06]; Key Scientific and Technological Project of Chongqing [CSTC, 2011AB5040]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Innovation Foundation of the Third Military Medical University; Key Scientific and Technological Project of Chongqing	This work was supported by the General Program of National Natural Science Foundation of China [grant numbers: 81000133 and 81202202], the Youth Innovation Foundation of the Third Military Medical University (2012XJQ06) and the Key Scientific and Technological Project of Chongqing [grant number CSTC, 2011AB5040]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albano E, 2008, MOL ASPECTS MED, V29, P9, DOI 10.1016/j.mam.2007.09.004; Antonsson B, 2000, EXP CELL RES, V256, P50, DOI 10.1006/excr.2000.4839; Ballinger SW, 2005, FREE RADICAL BIO MED, V38, P1278, DOI 10.1016/j.freeradbiomed.2005.02.014; Bertelli A, 1998, DRUG EXP CLIN RES, V24, P133; Biasutto L, 2010, MOLECULES, V15, P6570, DOI 10.3390/molecules15096570; Cao GH, 2001, AM J CLIN NUTR, V73, P920; Chang HC, 2011, J CEREBR BLOOD F MET, V31, P842, DOI 10.1038/jcbfm.2010.180; Chen CY, 2011, CELL BIOCHEM BIOPHYS, V61, P337, DOI 10.1007/s12013-011-9216-2; Chen CY, 2010, CHEM-BIOL INTERACT, V183, P105, DOI 10.1016/j.cbi.2009.09.024; Chen PN, 2006, CANCER LETT, V235, P248, DOI 10.1016/j.canlet.2005.04.033; Cooke D, 2005, EUR J CANCER, V41, P1931, DOI 10.1016/j.ejca.2005.06.009; Danz EDB, 2009, FREE RADICAL BIO MED, V46, P1589, DOI 10.1016/j.freeradbiomed.2009.03.011; Dauchet L, 2009, NAT REV CARDIOL, V6, P599, DOI 10.1038/nrcardio.2009.131; Deng TL, 2008, CELL BIOL INT, V32, P1425, DOI 10.1016/j.cellbi.2008.08.013; Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820; German JB, 2000, ANNU REV NUTR, V20, P561, DOI 10.1146/annurev.nutr.20.1.561; Gronbaek M, 1996, BRIT MED J, V313, P365, DOI 10.1136/bmj.313.7053.365; Henry-Vitrac C, 2006, EUR J NUTR, V45, P376, DOI 10.1007/s00394-006-0609-8; Hoye AT, 2008, ACCOUNTS CHEM RES, V41, P87, DOI 10.1021/ar700135m; Juan ME, 1999, ANAL CHEM, V71, P747, DOI 10.1021/ac9808831; Kahkonen MP, 2003, J AGR FOOD CHEM, V51, P628, DOI 10.1021/jf025551i; Kim J, 2009, TOXICOL LETT, V188, P45, DOI 10.1016/j.toxlet.2009.03.006; Kuhnau J, 1976, World Rev Nutr Diet, V24, P117; Latchoumycandane C, 2002, TOXICOLOGY, V171, P127, DOI 10.1016/S0300-483X(01)00563-7; Lazze MC, 2004, CARCINOGENESIS, V25, P1427, DOI 10.1093/carcin/bgh138; Liu S, 2010, AM J PHYSIOL-ENDOC M, V299, pE351, DOI 10.1152/ajpendo.00005.2010; Mauray A, 2010, GENES NUTR, V5, P343, DOI 10.1007/s12263-010-0171-0; Mazza Giuseppe Joe, 2007, Ann Ist Super Sanita, V43, P369; McGhie TK, 2003, J AGR FOOD CHEM, V51, P4539, DOI 10.1021/jf026206w; Murphy MP, 2008, BBA-BIOENERGETICS, V1777, P1028, DOI 10.1016/j.bbabio.2008.03.029; Murphy MP, 2007, ANNU REV PHARMACOL, V47, P629, DOI 10.1146/annurev.pharmtox.47.120505.105110; Murphy MP, 2003, J BIOL CHEM, V278, P48534, DOI 10.1074/jbc.M308529200; Pendurthi UR, 1999, ARTERIOSCL THROM VAS, V19, P419, DOI 10.1161/01.ATV.19.2.419; Prior RL, 2006, FREE RADICAL RES, V40, P1014, DOI 10.1080/10715760600758522; Qu MY, 2011, NEUROCHEM INT, V59, P1095, DOI 10.1016/j.neuint.2011.10.005; Robertson JD, 2000, CRIT REV TOXICOL, V30, P609, DOI 10.1080/10408440008951122; Salvayre R, 2002, BBA-MOL CELL BIOL L, V1585, P213, DOI 10.1016/S1388-1981(02)00343-8; Schramm DD, 1999, J NUTR BIOCHEM, V10, P193, DOI 10.1016/S0955-2863(98)00104-1; Seeram NP, 2002, J AGR FOOD CHEM, V50, P5308, DOI 10.1021/jf025671q; Smith RAJ, 2004, METHOD ENZYMOL, V382, P45; Smith RAJ, 2003, P NATL ACAD SCI USA, V100, P5407, DOI 10.1073/pnas.0931245100; Teng ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029647; Thomas SR, 2008, ANTIOXID REDOX SIGN, V10, P1713, DOI 10.1089/ars.2008.2027; Tsuda T, 2003, J NUTR, V133, P2125, DOI 10.1093/jn/133.7.2125; Tsuda T, 2000, FEBS LETT, V484, P207, DOI 10.1016/S0014-5793(00)02150-5; Wang Y, 2012, J NUTR, V142, P1033, DOI 10.3945/jn.112.157701; Williamson G, 2005, AM J CLIN NUTR, V81, p243S, DOI [10.1093/ajcn/81.1.243S, 10.1093/ajcn/81.1.230S]; Wu DF, 2003, ALCOHOL RES HEALTH, V27, P277; Wu XL, 2006, J AGR FOOD CHEM, V54, P4069, DOI 10.1021/jf060300l; Xie XP, 2012, J AGR FOOD CHEM, V60, P1850, DOI 10.1021/jf204461z; Xu JW, 2004, FEBS LETT, V574, P176, DOI 10.1016/j.febslet.2004.08.027; Yao Y, 2007, NEUROTOXICOLOGY, V28, P93, DOI 10.1016/j.neuro.2006.07.015; Yi L, 2010, FEBS LETT, V584, P583, DOI 10.1016/j.febslet.2009.12.006; Youdim KA, 2000, FREE RADICAL BIO MED, V29, P51, DOI 10.1016/S0891-5849(00)00329-4; Youdim KA, 2003, J NEUROCHEM, V85, P180, DOI 10.1046/j.1471-4159.2003.01652.x; Yung Lai Ming, 2006, Cardiovascular & Hematological Disorders - Drug Targets, V6, P1; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	59	58	61	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e68617	10.1371/journal.pone.0068617	http://dx.doi.org/10.1371/journal.pone.0068617			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	24205095	Green Submitted, Green Published, gold			2022-12-27	WOS:000324146200023
J	Veldhuizen, EJA; Brouwer, EC; Schneider, VAF; Fluit, AC				Veldhuizen, Edwin J. A.; Brouwer, Ellen C.; Schneider, Viktoria A. F.; Fluit, Ad C.			Chicken Cathelicidins Display Antimicrobial Activity against Multiresistant Bacteria without Inducing Strong Resistance	PLOS ONE			English	Article							ANTIBACTERIAL PEPTIDES; ESCHERICHIA-COLI; IDENTIFICATION; PR-39	The increased prevalence of multidrug-resistant (MDR) bacteria in combination with the relatively limited development of new antibiotics presents a serious threat to public health. In chicken, especially Extended-Spectrum beta-Lactamase (ESBL) carrying Enterobacteriaceae are often asymptomatically present but can infect humans. Due to their broad range antimicrobial activity cathelicidins and other host defence peptides, are considered to be an attractive alternative to conventional antibiotics. In this study, the antimicrobial activity of three chicken cathelicidins against a broad array of multidrug resistant bacteria was determined. All three peptides showed high antibacterial activity independent of the presence of MDR characteristics. Induction experiments using S. aureus and K. pneumoniae showed that although an increase in resistance was initially observed, susceptibility towards chicken cathelicidins remained high and no major resistance was developed. The combined results underline the potential of chicken cathelicidins as a new alternative to antibiotics.	[Veldhuizen, Edwin J. A.; Schneider, Viktoria A. F.] Univ Utrecht, Fac Vet Med, Div Mol Host Def, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Brouwer, Ellen C.; Fluit, Ad C.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University Medical Center	Veldhuizen, EJA (corresponding author), Univ Utrecht, Fac Vet Med, Div Mol Host Def, Dept Infect Dis & Immunol, Utrecht, Netherlands.	E.J.A.Veldhuizen@uu.nl		Stronks, Karien/0000-0002-0921-2232; Kunst, Anton/0000-0002-3313-5273	SEED grant from the Infection & Immunity Center Utrecht of the University Medical Center Utrecht; University of Utrecht	SEED grant from the Infection & Immunity Center Utrecht of the University Medical Center Utrecht; University of Utrecht	The study was partly funded by a SEED grant from the Infection & Immunity Center Utrecht of the University Medical Center Utrecht and University of Utrecht. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Achanta M, 2012, J ANIM SCI BIOTECHNO, V3, DOI 10.1186/2049-1891-3-15; BELDEN WJ, 1994, INFECT IMMUN, V62, P5095, DOI 10.1128/IAI.62.11.5095-5101.1994; BOMAN HG, 1993, INFECT IMMUN, V61, P2978, DOI 10.1128/IAI.61.7.2978-2984.1993; Bommineni YR, 2007, FEBS J, V274, P418, DOI 10.1111/j.1742-4658.2006.05589.x; Clinical and Laboratory Standards Institute (CLSI), 2012, M100S22 CLSI; Fluit AC, 2012, CLIN MICROBIOL INFEC, V18, P735, DOI 10.1111/j.1469-0691.2012.03846.x; Goitsuka R, 2007, P NATL ACAD SCI USA, V104, P15063, DOI 10.1073/pnas.0707037104; Gould IM, 2012, INT J ANTIMICROB AG, V39, P96, DOI 10.1016/j.ijantimicag.2011.09.028; Guina T, 2000, J BACTERIOL, V182, P4077, DOI 10.1128/JB.182.14.4077-4086.2000; Guo L, 1998, CELL, V95, P189, DOI 10.1016/S0092-8674(00)81750-X; Kai-Larsen Y, 2008, FRONT BIOSCI, V13, P3760, DOI 10.2741/2964; Kondo N, 2001, ANTIMICROB AGENTS CH, V45, P815, DOI 10.1128/AAC.45.3.815-824.2001; Koprivnjak T, 2011, CELL MOL LIFE SCI, V68, P2243, DOI 10.1007/s00018-011-0716-4; Peschel A, 2002, TRENDS MICROBIOL, V10, P179, DOI 10.1016/S0966-842X(02)02333-8; Shafer WM, 1998, P NATL ACAD SCI USA, V95, P1829, DOI 10.1073/pnas.95.4.1829; Shi JH, 1996, ANTIMICROB AGENTS CH, V40, P115, DOI 10.1128/AAC.40.1.115; Thomassin JL, 2012, INFECT IMMUN, V80, P483, DOI 10.1128/IAI.05674-11; van Dijk A, 2005, VET IMMUNOL IMMUNOP, V106, P321, DOI 10.1016/j.vetimm.2005.03.003; van Dijk A, 2011, VET MICROBIOL, V153, P27, DOI 10.1016/j.vetmic.2011.03.028; van Dijk A, 2009, MOL IMMUNOL, V46, P2465, DOI 10.1016/j.molimm.2009.05.019; Veldhuizen EJA, 2008, MOL IMMUNOL, V45, P386, DOI 10.1016/j.molimm.2007.06.001; Wayne P.A., 2009, M07A8 CLIN LAB STAND; Woodford N, 2011, FEMS MICROBIOL REV, V35, P736, DOI 10.1111/j.1574-6976.2011.00268.x; Xiao YJ, 2009, J INNATE IMMUN, V1, P268, DOI 10.1159/000174822; Xiao YJ, 2006, J BIOL CHEM, V281, P2858, DOI 10.1074/jbc.M507180200	25	35	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61964	10.1371/journal.pone.0061964	http://dx.doi.org/10.1371/journal.pone.0061964			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23874765	Green Published, gold, Green Submitted			2022-12-27	WOS:000317911500074
J	Liu, Y; He, XF; Lu, YT; Long, H; Song, Y; Qi, ST				Liu Yi; He Xiao-feng; Lu Yun-tao; Long Hao; Song Ye; Qi Song-tao			Association between the XRCC1 Arg399Gln Polymorphism and Risk of Cancer: Evidence from 297 Case-Control Studies	PLOS ONE			English	Article							BASE EXCISION-REPAIR; DNA-POLYMERASE BETA; BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; GENE POLYMORPHISM; LIGASE III; METAANALYSIS; SUSCEPTIBILITY; ARG194TRP	Background: The Arg399Gln polymorphism in the X-ray cross-complementing group 1 (XRCC1) had been implicated in cancer susceptibility. The previous published data on the association between XRCC1 Arg399Gln polymorphism and cancer risk remained controversial. Methodology/Principal Findings: To derive a more precise estimation of the association between the XRCC1 Arg399Gln polymorphism and overall cancer risk, we performed a meta-analysis of 297 case-control studies, in which a total of 93,941 cases and 121,480 controls were included. Overall, significantly increased cancer risk was observed in any genetic model (dominant model: odds ration [OR] = 1.04, 95% confidence interval [CI] = 1.01-1.07; recessive model: OR = 1.08, 95% CI = 1.03-1.13; additive model: OR = 1.09, 95% CI = 1.04-1.14) when all eligible studies were pooled into the meta-analysis. In further stratified and sensitivity analyses, significantly elevated hepatocellular and breast cancers risk were observed in Asians (dominant model: OR = 1.39, 95% CI = 1.06-1.84) and in Indians (dominant model: OR = 1.64, 95% CI = 1.31-2.04; recessive model: OR = 1.94, 95% CI = 1.09-3.47; additive model: OR = 2.06, 95% CI = 1.50-2.84), respectively. Conclusions/Significance: This meta-analysis suggests the participation of XRCC1 Arg399Gln is a genetic susceptibility for hepatocellular cancer in Asians and breast cancer in Indians. Moreover, our work also points out the importance of new studies for Arg399Gln association in some cancer types, such as glioma, gastric cancer, and oral cancer, where at least some of the covariates responsible for heterogeneity could be controlled, to obtain a more conclusive understanding about the function of the XRCC1 Arg399Gln polymorphism in cancer development.	[Liu Yi; Lu Yun-tao; Long Hao; Song Ye; Qi Song-tao] Southern Med Univ, Nanfang Hosp, Neurosurg Dept, Guangzhou, Guangdong, Peoples R China; [He Xiao-feng] Peace Hosp, Changzhi Med Coll, Dept Res, Changzhi, Peoples R China	Southern Medical University - China; Changzhi Medical College	Qi, ST (corresponding author), Southern Med Univ, Nanfang Hosp, Neurosurg Dept, Guangzhou, Guangdong, Peoples R China.	liuyi86818@126.com	Chen, Mingliang/AGH-3195-2022	Chang, Hui/0000-0001-6693-2570				BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Caldecott KW, 1996, NUCLEIC ACIDS RES, V24, P4387, DOI 10.1093/nar/24.22.4387; Cappelli E, 1997, J BIOL CHEM, V272, P23970, DOI 10.1074/jbc.272.38.23970; Chen D, 2008, J BIOL CHEM, V283, P15381, DOI 10.1074/jbc.M710296200; Dai LP, 2012, MOL BIOL REP, V39, P9535, DOI 10.1007/s11033-012-1818-2; Davey SG, 1997, LANCET, V350, P1182, DOI DOI 10.1016/S0140-6736(05)63833-0; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Duan WH, 2012, ASIAN PAC J CANCER P, V13, P3601, DOI 10.7314/APJCP.2012.13.8.3601; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huang YS, 2009, MUTAGENESIS, V24, P331, DOI 10.1093/mutage/gep013; Kiyohara C, 2006, LUNG CANCER, V54, P267, DOI 10.1016/j.lungcan.2006.08.009; Klug SJ, 2009, LANCET ONCOL, V10, P772, DOI 10.1016/S1470-2045(09)70187-1; Kubota Y, 1996, EMBO J, V15, P6662, DOI 10.1002/j.1460-2075.1996.tb01056.x; Li HH, 2009, BREAST, V18, P183, DOI 10.1016/j.breast.2009.03.008; Li J, 2013, TUMOR BIOL, V34, P261, DOI 10.1007/s13277-012-0546-5; Li Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030186, 10.1371/journal.pone.0029003, 10.1371/journal.pone.0042558, 10.1371/journal.pone.0030835, 10.1371/journal.pone.0044441, 10.1371/journal.pone.0035543, 10.1371/journal.pone.0035122]; Liu BM, 2012, GENET MOL RES, V11, P3852, DOI 10.4238/2012.November.12.2; Liu F, 2011, LIVER INT, V31, P804, DOI 10.1111/j.1478-3231.2011.02508.x; Liu L, 2013, MOL BIOL REP, V40, P3943, DOI 10.1007/s11033-012-2471-5; Lu AL, 2001, CELL BIOCHEM BIOPHYS, V35, P141, DOI 10.1385/CBB:35:2:141; MANTEL N, 1959, J NATL CANCER I, V22, P719; Moore DJ, 2000, P NATL ACAD SCI USA, V97, P13649, DOI 10.1073/pnas.250477597; Saadat M, 2009, BREAST CANCER RES TR, V115, P137, DOI 10.1007/s10549-008-0051-0; Shen MR, 1998, CANCER RES, V58, P604; Tebbs RS, 1999, DEV BIOL, V208, P513, DOI 10.1006/dbio.1999.9232; Thacker J, 2003, DNA REPAIR, V2, P655, DOI 10.1016/S1568-7864(03)00062-4; Vidal AE, 2001, EMBO J, V20, P6530, DOI 10.1093/emboj/20.22.6530; Wang YD, 2009, CANCER LETT, V285, P134, DOI 10.1016/j.canlet.2009.05.005; Wei B, 2011, PROSTATE CANCER P D, V14, P225, DOI 10.1038/pcan.2011.26; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Wu KS, 2011, ASIAN PAC J CANCER P, V12, P2237; Xie T, 2012, WORLD J GASTROENTERO, V18, P4207, DOI 10.3748/wjg.v18.i31.4207; Yu Z, 1999, ENVIRON MOL MUTAGEN, V33, P3, DOI 10.1002/(SICI)1098-2280(1999)33:1<3::AID-EM2>3.0.CO;2-L; Zhang Huina, 2010, Wei Sheng Yan Jiu, V39, P664	35	58	61	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78071	10.1371/journal.pone.0078071	http://dx.doi.org/10.1371/journal.pone.0078071			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205095	Green Published, Green Submitted, gold			2022-12-27	WOS:000326270700071
J	Brewer, MS; Swafford, L; Spruill, CL; Bond, JE				Brewer, Michael S.; Swafford, Lynn; Spruill, Chad L.; Bond, Jason E.			Arthropod Phylogenetics in Light of Three Novel Millipede (Myriapoda: Diplopoda) Mitochondrial Genomes with Comments on the Appropriateness of Mitochondrial Genome Sequence Data for Inferring Deep Level Relationships	PLOS ONE			English	Article							NUCLEOTIDE COMPOSITION; GENE ORDER; MODEL; EVOLUTION; XYSTODESMIDAE; MITOGENOMICS; POLYDESMIDA; SYMPHYLA; SYNOPSIS; RESOLVE	Background: Arthropods are the most diverse group of eukaryotic organisms, but their phylogenetic relationships are poorly understood. Herein, we describe three mitochondrial genomes representing orders of millipedes for which complete genomes had not been characterized. Newly sequenced genomes are combined with existing data to characterize the protein coding regions of myriapods and to attempt to reconstruct the evolutionary relationships within the Myriapoda and Arthropoda. Results: The newly sequenced genomes are similar to previously characterized millipede sequences in terms of synteny and length. Unique translocations occurred within the newly sequenced taxa, including one half of the Appalachioria falcifera genome, which is inverted with respect to other millipede genomes. Across myriapods, amino acid conservation levels are highly dependent on the gene region. Additionally, individual loci varied in the level of amino acid conservation. Overall, most gene regions showed low levels of conservation at many sites. Attempts to reconstruct the evolutionary relationships suffered from questionable relationships and low support values. Analyses of phylogenetic informativeness show the lack of signal deep in the trees (i.e., genes evolve too quickly). As a result, the myriapod tree resembles previously published results but lacks convincing support, and, within the arthropod tree, well established groups were recovered as polyphyletic. Conclusions: The novel genome sequences described herein provide useful genomic information concerning millipede groups that had not been investigated. Taken together with existing sequences, the variety of compositions and evolution of myriapod mitochondrial genomes are shown to be more complex than previously thought. Unfortunately, the use of mitochondrial protein-coding regions in deep arthropod phylogenetics appears problematic, a result consistent with previously published studies. Lack of phylogenetic signal renders the resulting tree topologies as suspect. As such, these data are likely inappropriate for investigating such ancient relationships.	[Brewer, Michael S.; Swafford, Lynn; Spruill, Chad L.] E Carolina Univ, Dept Biol, Greenville, NC 27858 USA; [Brewer, Michael S.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Brewer, Michael S.] Univ Calif Berkeley, Essig Museum Entomol, Berkeley, CA 94720 USA; [Bond, Jason E.] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA; [Bond, Jason E.] Auburn Univ, Museum Nat Hist, Auburn, AL 36849 USA	University of North Carolina; East Carolina University; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Auburn University System; Auburn University; Auburn University System; Auburn University	Brewer, MS (corresponding author), E Carolina Univ, Dept Biol, Greenville, NC 27858 USA.	michaelsbrewer@gmail.com	Bond, Jason E./P-1501-2017	Bond, Jason E./0000-0001-6373-3875	National Science Foundation [DEB 05-29715]	National Science Foundation(National Science Foundation (NSF))	This study was supported by the National Science Foundation, DEB 05-29715 (nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Blanquart S, 2008, MOL BIOL EVOL, V25, P842, DOI 10.1093/molbev/msn018; Bond JE, 2002, EVOLUTION, V56, P1123; Boore JL, 1998, CURR OPIN GENET DEV, V8, P668, DOI 10.1016/S0959-437X(98)80035-X; Braband A, 2010, MOL PHYLOGENET EVOL, V57, P285, DOI 10.1016/j.ympev.2010.05.011; Brewer MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037240; Brinkmann H, 2005, SYST BIOL, V54, P743, DOI 10.1080/10635150500234609; Cameron SL, 2004, CLADISTICS, V20, P534, DOI 10.1111/j.1096-0031.2004.00040.x; Chen WJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-246; Curole JP, 1999, TRENDS ECOL EVOL, V14, P394, DOI 10.1016/S0169-5347(99)01660-2; Delsuc F, 2003, SCIENCE, V301, P1482; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; Foster PG, 1997, J MOL EVOL, V44, P282, DOI 10.1007/PL00006145; Gai YH, 2008, MOL PHYLOGENET EVOL, V49, P574, DOI 10.1016/j.ympev.2008.08.010; Gibson A, 2005, MOL BIOL EVOL, V22, P251, DOI 10.1093/molbev/msi012; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Hamilton AJ, 2010, AM NAT, V176, P90, DOI 10.1086/652998; Helfenbein KG, 2001, MOL BIOL EVOL, V18, P1734, DOI 10.1093/oxfordjournals.molbev.a003961; Hoffman R.L., 2002, P505; Hwang UW, 2001, NATURE, V413, P154, DOI 10.1038/35093090; Hwang UW, 2001, MOL PHYLOGENET EVOL, V19, P345, DOI 10.1006/mpev.2001.0940; Jones M, 2007, MOL PHYLOGENET EVOL, V43, P583, DOI 10.1016/j.ympev.2006.11.017; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Klimov PB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-598; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Lavrov DV, 2000, P NATL ACAD SCI USA, V97, P13738, DOI 10.1073/pnas.250402997; Lavrov DV, 2002, MOL BIOL EVOL, V19, P163, DOI 10.1093/oxfordjournals.molbev.a004068; Lopez-Giraldez F, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-152; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Marek P, 2011, CURR BIOL, V21, pR680, DOI 10.1016/j.cub.2011.08.012; Marek PE, 2007, ZOOTAXA, P27; Marek PE, 2006, MOL PHYLOGENET EVOL, V41, P704, DOI 10.1016/j.ympev.2006.05.043; Marek PE, 2009, P NATL ACAD SCI USA, V106, P9755, DOI 10.1073/pnas.0810408106; Masta SE, 2009, MOL PHYLOGENET EVOL, V50, P117, DOI 10.1016/j.ympev.2008.10.010; Meusemann K, 2010, MOL BIOL EVOL, V27, P2451, DOI 10.1093/molbev/msq130; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Negrisolo E, 2004, MOL BIOL EVOL, V21, P770, DOI 10.1093/molbev/msh078; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Perseke M, 2010, MOL PHYLOGENET EVOL, V56, P201, DOI 10.1016/j.ympev.2010.01.035; Pitz KM, 2010, CLADISTICS, V26, P497, DOI 10.1111/j.1096-0031.2009.00303.x; Podsiadlowski L, 2007, MOL PHYLOGENET EVOL, V45, P251, DOI 10.1016/j.ympev.2007.07.017; Regier JC, 2005, MOL PHYLOGENET EVOL, V34, P147, DOI 10.1016/j.ympev.2004.09.005; Regier JC, 2001, ZOOL J LINN SOC-LOND, V132, P469, DOI 10.1006/zjls.2000.0277; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; Regier JC, 2008, SYST BIOL, V57, P920, DOI 10.1080/10635150802570791; Rehm P, 2011, MOL PHYLOGENET EVOL, V61, P880, DOI 10.1016/j.ympev.2011.09.003; Rota-Stabelli O, 2008, MOL PHYLOGENET EVOL, V48, P103, DOI 10.1016/j.ympev.2008.03.033; Rota-Stabelli O, 2011, P ROY SOC B-BIOL SCI, V278, P298, DOI 10.1098/rspb.2010.0590; Rota-Stabelli O, 2010, GENOME BIOL EVOL, V2, P425, DOI 10.1093/gbe/evq030; Saccone C, 2002, GENE, V286, P3, DOI 10.1016/S0378-1119(01)00807-1; Shear William, 2011, Zootaxa, V3148, P159; SHELLEY RM, 1984, CAN J ZOOL, V62, P980, DOI 10.1139/z84-137; Shelley Rowland M., 2005, Fragmenta Faunistica (Warsaw), V48, P137; Sierwald P, 2003, J ZOOL SYST EVOL RES, V41, P87, DOI 10.1046/j.1439-0469.2003.00202.x; Sierwald P, 2007, ANNU REV ENTOMOL, V52, P401, DOI 10.1146/annurev.ento.52.111805.090210; Silvestre D, 2008, GENET MOL BIOL, V31, P451, DOI 10.1590/S1415-47572008000300010; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Spelda J, 2011, ZOOKEYS, P123, DOI 10.3897/zookeys.156.2176; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swafford L, 2009, INVERTEBR SYST, V23, P445, DOI 10.1071/IS09036; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Team RCD, 2009, R LANG ENV STAT COMP; Walker MJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-25; Wesener T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028035; White TR, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-295; Woo HJ, 2007, MOL CELLS, V23, P182; Zhang P, 2008, MOL PHYLOGENET EVOL, V49, P586, DOI 10.1016/j.ympev.2008.08.020; Zhang P, 2009, MOL PHYLOGENET EVOL, V53, P492, DOI 10.1016/j.ympev.2009.07.010	71	33	34	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2013	8	7							e68005	10.1371/journal.pone.0068005	http://dx.doi.org/10.1371/journal.pone.0068005			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZN	23869209	gold, Green Published, Green Submitted			2022-12-27	WOS:000323110600008
J	Santoro, AL; Bastviken, D; Gudasz, C; Tranvik, L; Enrich-Prast, A				Santoro, Ana Lucia; Bastviken, David; Gudasz, Cristian; Tranvik, Lars; Enrich-Prast, Alex			Dark Carbon Fixation: An Important Process in Lake Sediments	PLOS ONE			English	Article							ORGANIC-CARBON; BACTERIAL PRODUCTION; DIOXIDE FIXATION; ACTIVE BACTERIA; WATER INTERFACE; METHANE; CYCLE; TEMPERATE; OXIDATION; CO2	Close to redox boundaries, dark carbon fixation by chemoautotrophic bacteria may be a large contributor to overall carbon fixation. Still, little is known about the relative importance of this process in lake systems, in spite the potentially high chemoautotrophic potential of lake sediments. We compared rates of dark carbon fixation, bacterial production and oxygen consumption in sediments from four Swedish boreal and seven tropical Brazilian lakes. Rates were highly variable and dark carbon fixation amounted up to 80% of the total heterotrophic bacterial production. The results indicate that non-photosynthetic carbon fixation can represent a substantial contribution to bacterial biomass production, especially in sediments with low organic matter content.	[Santoro, Ana Lucia; Enrich-Prast, Alex] Univ Fed Rio de Janeiro, Dept Ecol, Inst Biol, Rio De Janeiro, Brazil; [Bastviken, David] Linkoping Univ, Dept Themat Studies Water & Environm Studies, Linkoping, Sweden; [Gudasz, Cristian; Tranvik, Lars] Uppsala Univ, Dept Ecol & Evolut Limnol, Uppsala, Sweden	Universidade Federal do Rio de Janeiro; Linkoping University; Uppsala University	Enrich-Prast, A (corresponding author), Univ Fed Rio de Janeiro, Dept Ecol, Inst Biol, Rio De Janeiro, Brazil.	aenrichprast@gmail.com	Prast, Alex Enrich/AAL-4722-2021; Enrich-Prast, Alex/H-5391-2012; Nilsson, Markus/C-6920-2012	Prast, Alex Enrich/0000-0003-3561-0936; wahlund, lars-olof/0000-0002-9905-8426; Martensson, Johanna/0000-0002-5936-1439; Nilsson, Markus/0000-0002-3140-8223; van Westen, Danielle/0000-0001-8649-9874; Tranvik, Lars J./0000-0003-3509-8266; Bastviken, David/0000-0003-0038-2152	STINT (Sweden); CNPq (Brazil); Brazilian Research Council (CNPq)	STINT (Sweden); CNPq (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Ana Lucia Santoro received a STINT (Sweden) and CNPq (Brazil) scholarships to develop this research. Alex Enrich-Prast receives a research fellowship from the Brazilian Research Council (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Saez L, 2010, ISME J, V4, P1581, DOI 10.1038/ismej.2010.69; Bastviken D, 2003, ECOLOGY, V84, P969, DOI 10.1890/0012-9658(2003)084[0969:MAASOC]2.0.CO;2; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Buesing N, 2005, LIMNOL OCEANOGR-METH, V3, P101, DOI 10.4319/lom.2005.3.101; Camacho A, 2001, AQUAT SCI, V63, P91, DOI 10.1007/PL00001346; Christian BW, 2007, FUND APPL LIMNOL, V168, P189, DOI 10.1127/1863-9135/2007/0168-0189; Dalsgaard R, 2000, PROTOCOL HDB NICE NI; Dean WE, 1999, J PALEOLIMNOL, V21, P375, DOI 10.1023/A:1008066118210; DETMER AE, 1993, MAR ECOL PROG SER, V99, P197, DOI 10.3354/meps099197; DIJKHUIZEN L, 1984, A VAN LEEUW J MICROB, V50, P473, DOI 10.1007/BF02386221; Enrich-prast A, 2018, ENCY INLAND WATERS, P211, DOI [10.1016/B978-012370626-3.00126-5, DOI 10.1016/B978-012370626-3.00126-5]; Erb TJ, 2009, P NATL ACAD SCI USA, V106, P8871, DOI 10.1073/pnas.0903939106; Evrard V, 2008, AQUAT MICROB ECOL, V53, P257, DOI 10.3354/ame01248; Feisthauer S, 2008, ENVIRON MICROBIOL, V10, P1641, DOI 10.1111/j.1462-2920.2008.01573.x; Fenchel T., 1979, BACTERIA MINERAL CYC; Fenchel T, 2008, J EXP MAR BIOL ECOL, V366, P99, DOI 10.1016/j.jembe.2008.07.013; GALCHENKO VF, 1994, MICROBIOLOGY+, V63, P388; Garcia-Cantizano J, 2005, MICROB ECOL, V50, P230, DOI 10.1007/s00248-004-0144-9; Grey J, 2004, FRESHWATER BIOL, V49, P681, DOI 10.1111/j.1365-2427.2004.01217.x; Gudasz C, 2012, LIMNOL OCEANOGR, V57, P163, DOI 10.4319/lo.2012.57.1.0163; Gudasz C, 2010, NATURE, V466, P478, DOI 10.1038/nature09186; Hadas O, 2001, LIMNOL OCEANOGR, V46, P1968, DOI 10.4319/lo.2001.46.8.1968; Haglund AL, 2003, FEMS MICROBIOL ECOL, V46, P31, DOI 10.1016/S0168-6496(03)00190-9; Haglund AL, 2002, MICROBIAL ECOL, V43, P232, DOI 10.1007/s00248-002-2005-0; Heinen EA, 2004, J GREAT LAKES RES, V30, P113, DOI 10.1016/S0380-1330(04)70381-0; Heip CHR, 1995, OCEANOGR MAR BIOL, V33, P1; JORGENSEN BB, 1991, DEEP-SEA RES, V38, pS1083; Kankaala P, 2006, LIMNOL OCEANOGR, V51, P2821, DOI 10.4319/lo.2006.51.6.2821; Kranzberg G, 1985, ENVIRON POLLUT A, V39, P23; KUUPPOLEINIKKI P, 1992, HYDROBIOLOGIA, V229, P159, DOI 10.1007/BF00006998; Levin LA, 2009, DEEP-SEA RES PT II, V56, P1632, DOI 10.1016/j.dsr2.2009.05.010; Luyssaert S, 2007, GLOBAL CHANGE BIOL, V13, P2509, DOI 10.1111/j.1365-2486.2007.01439.x; Marotta H, 2009, LIMNOLOGY, V10, P195, DOI 10.1007/s10201-009-0272-x; Merlin C, 2003, J BACTERIOL, V185, P6415, DOI 10.1128/JB.185.21.6415-6424.2003; Mitsch W.J., 2007, WETLANDS, V4th ed., DOI DOI 10.1017/CBO9781107415324.004; Molari M, 2013, GLOBAL BIOGEOCHEM CY, V27, P212, DOI 10.1002/gbc.20030; PEDROSALIO C, 1991, PROC INT ASSOC THE 2, V24, P1212; Pimenov NV, 2010, MICROBIOLOGY+, V79, P247, DOI 10.1134/S0026261710020177; Ravinet M, 2010, OIKOS, V119, P409, DOI 10.1111/j.1600-0706.2009.17859.x; Rawcliffe R, 2010, FRESHWATER BIOL, V55, P600, DOI 10.1111/j.1365-2427.2009.02280.x; Richey JE, 2002, NATURE, V416, P617, DOI 10.1038/416617a; SANDER BC, 1993, MICROB ECOL, V26, P79, DOI 10.1007/BF00177045; Sanseverino AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042723; SCHALLENBERG M, 1993, ECOLOGY, V74, P919, DOI 10.2307/1940816; Scheffer M., 1998, ECOLOGY SHALLOW LAKE; Schink B, 2009, MOL MICROBIOL, V73, P975, DOI 10.1111/j.1365-2958.2009.06835.x; Shively JM, 1998, ANNU REV MICROBIOL, V52, P191, DOI 10.1146/annurev.micro.52.1.191; SOUTHWARD AJ, 1981, NATURE, V293, P616, DOI 10.1038/293616a0; Svensson JM, 2001, AQUAT MICROB ECOL, V23, P177, DOI 10.3354/ame023177; SWEERTS JPRA, 1991, LIMNOL OCEANOGR, V36, P1124, DOI 10.4319/lo.1991.36.6.1124; Taylor GT, 2001, LIMNOL OCEANOGR, V46, P148, DOI 10.4319/lo.2001.46.1.0148; THAUER RK, 1988, EUR J BIOCHEM, V176, P497, DOI 10.1111/j.1432-1033.1988.tb14307.x; Thomsen U, 1997, AQUAT MICROB ECOL, V12, P165, DOI 10.3354/ame012165; Tomaszek JA, 2003, HYDROBIOLOGIA, V504, P59, DOI 10.1023/B:HYDR.0000008508.81690.10; Trimmer M, 2012, SCI TOTAL ENVIRON, V434, P143, DOI 10.1016/j.scitotenv.2011.10.074	55	40	41	2	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65813	10.1371/journal.pone.0065813	http://dx.doi.org/10.1371/journal.pone.0065813			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776549	Green Published, Green Submitted, gold			2022-12-27	WOS:000320755400067
J	Torres, I; Hernandez, O; Tamayo, D; Munoz, JF; Leitao, NP; Garcia, AM; Restrepo, A; Puccia, R; McEwen, JG				Torres, Isaura; Hernandez, Orville; Tamayo, Diana; Munoz, Jose F.; Leitao, Natanael P., Jr.; Garcia, Ana M.; Restrepo, Angela; Puccia, Rosana; McEwen, Juan G.			Inhibition of PbGP43 Expression May Suggest that gp43 is a Virulence Factor in Paracoccidioides brasiliensis	PLOS ONE			English	Article							MAJOR DIAGNOSTIC ANTIGEN; 43 KDA GLYCOPROTEIN; 43-KILODALTON GLYCOPROTEIN; EXOCELLULAR COMPONENTS; PROTEOLYTIC ACTIVITY; YEAST PHASE; GENE; PROTEINS; IDENTIFICATION; CHEMOTHERAPY	Glycoprotein gp43 is an immunodominant diagnostic antigen for paracoccidioidomycosis caused by Paracoccidioides brasiliensis. It is abundantly secreted in isolates such as Pb339. It is structurally related to beta-1,3-exoglucanases, however inactive. Its function in fungal biology is unknown, but it elicits humoral, innate and protective cellular immune responses; it binds to extracellular matrix-associated proteins. In this study we applied an antisense RNA (aRNA) technology and Agrobacterium tumefaciens-mediated transformation to generate mitotically stable PbGP43 mutants (PbGP43 aRNA) derived from wild type Pb339 to study its role in P. brasiliensis biology and during infection. Control PbEV was transformed with empty vector. Growth curve, cell vitality and morphology of PbGP43 aRNA mutants were indistinguishable from those of controls. PbGP43 expression was reduced 80-85% in mutants 1 and 2, as determined by real time PCR, correlating with a massive decrease in gp43 expression. This was shown by immunoblotting of culture supernatants revealed with anti-gp43 mouse monoclonal and rabbit polyclonal antibodies, and also by affinity-ligand assays of extracellular molecules with laminin and fibronectin. In vitro, there was significantly increased TNF-alpha production and reduced yeast recovery when PbGP43 aRNA1 was exposed to IFN-gamma-stimulated macrophages, suggesting reduced binding/uptake and/or increased killing. In vivo, fungal burden in lungs of BALB/c mice infected with silenced mutant was negligible and associated with decreased lung I Lambda-10 and IL-6. Therefore, our results correlated low gp43 expression with lower pathogenicity in mice, but that will be definitely proven when PbGP43 knockouts become available. This is the first study of gp43 using genetically modified P. brasiliensis.	[Torres, Isaura; Hernandez, Orville; Tamayo, Diana; Munoz, Jose F.] CIB, Unidad Biol Celular & Mol, Medellin, Colombia; [Torres, Isaura; McEwen, Juan G.] Univ Antioquia, Fac Med, Medellin, Colombia; [Torres, Isaura; Tamayo, Diana; Munoz, Jose F.] Univ Antioquia, Inst Biol, Medellin, Colombia; [Hernandez, Orville] Inst Univ Colegio Mayor Antioquia, Fac Ciencias Salud, Medellin, Colombia; [Leitao, Natanael P., Jr.; Puccia, Rosana] Univ Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil	Universidad de Antioquia; Universidad de Antioquia; Institucion Universitaria Colegio Mayor de Antioquia; Universidade Federal de Sao Paulo (UNIFESP)	Torres, I (corresponding author), CIB, Unidad Biol Celular & Mol, Medellin, Colombia.	isaurap10@gmail.com	Puccia, Rosana/D-7303-2012; McEwen, Juan/AAG-6621-2021; Ciudad, Carlos/D-7917-2014; Noe, Veronica/K-3615-2014	Puccia, Rosana/0000-0002-3332-0487; Ciudad, Carlos/0000-0002-7855-392X; hernandez, jose luis/0000-0002-9172-6004; Munoz, Jose/0000-0003-4987-7957; Garcia Cepero, Ana Maria/0000-0001-9189-764X; Tamayo, Diana/0000-0002-2826-8573; McEwen, Juan Guillermo/0000-0001-8594-9087; Noe, Veronica/0000-0001-7937-8038; Torres, Isaura/0000-0002-4022-8072; Mitjans, Francesc/0000-0001-8331-9954; Messeguer, Ramon/0000-0003-1913-7624	Colciencias project [221340820447]; Corporacion para Investigaciones Biologicas; Universidad de Antioquia Estrategia de Sostenibilidad; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)	Colciencias project(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Corporacion para Investigaciones Biologicas; Universidad de Antioquia Estrategia de Sostenibilidad; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Financial support was provided by Colciencias project No 221340820447, Corporacion para Investigaciones Biologicas and the Universidad de Antioquia Estrategia de Sostenibilidad 2010-2011. This work was also financed by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida AJ, 2007, FUNGAL GENET BIOL, V44, P1387, DOI 10.1016/j.fgb.2007.04.004; Almeida AJ, 2009, FUNGAL GENET BIOL, V46, P919, DOI 10.1016/j.fgb.2009.08.004; Almeida IC, 1996, GLYCOBIOLOGY, V6, P507, DOI 10.1093/glycob/6.5.507; Almeida SR, 1998, MED MYCOL, V36, P405, DOI 10.1080/02681219880000641; BAVA AJ, 1991, MICROBIOL IMMUNOL, V35, P167, DOI 10.1111/j.1348-0421.1991.tb01545.x; BEIJERSBERGEN A, 1992, SCIENCE, V256, P1324, DOI 10.1126/science.256.5061.1324; Blotta MHSL, 1999, AM J TROP MED HYG, V61, P390, DOI 10.4269/ajtmh.1999.61.390; BRUMMER E, 1993, CLIN MICROBIOL REV, V6, P89, DOI 10.1128/CMR.6.2.89-117.1993; Buissa-Filho R, 2008, INFECT IMMUN, V76, P3321, DOI 10.1128/IAI.00349-08; Camargo ZP, 2003, MED MYCOL, V41, P539, DOI 10.1080/13693780310001615358; CAMARGO ZP, 1991, J MED VET MYCOL, V29, P31; CAMPOS MCRM, 1995, J MED VET MYCOL, V33, P223; CARMONA AK, 1995, BIOCHEM J, V309, P209, DOI 10.1042/bj3090209; Carvalho KC, 2005, MICROBES INFECT, V7, P55, DOI 10.1016/j.micinf.2004.09.008; Cisalpino PS, 1996, J BIOL CHEM, V271, P4553, DOI 10.1074/jbc.271.8.4553; de Camargo Z P, 2000, Rev Iberoam Micol, V17, P41; DECAMARGO ZP, 1988, J CLIN MICROBIOL, V26, P2147, DOI 10.1128/JCM.26.10.2147-2151.1988; Donofrio FC, 2009, J MED MICROBIOL, V58, P706, DOI 10.1099/jmm.0.003830-0; Fernandes VC, 2012, MYCOPATHOLOGIA, V174, P93, DOI 10.1007/s11046-012-9530-2; Fernandes VC, 2011, MICROBES INFECT, V13, P1062, DOI 10.1016/j.micinf.2011.06.004; Ferreira KS, 2003, SCAND J IMMUNOL, V58, P290, DOI 10.1046/j.1365-3083.2003.01291.x; Goldman GH, 2003, EUKARYOT CELL, V2, P34, DOI 10.1128/EC.2.1.34-48.2003; Hanna SA, 2000, MICROBES INFECT, V2, P877, DOI 10.1016/S1286-4579(00)00390-7; Hernandez O, 2010, INFECT IMMUN, V78, P5280, DOI 10.1128/IAI.00692-10; Kara B. V., 1987, Proceedings, European Brewery Convention, P409; Konno AYC, 2009, MICROBES INFECT, V11, P92, DOI 10.1016/j.micinf.2008.10.011; Konno FTC, 2012, MICROBES INFECT, V14, P517, DOI 10.1016/j.micinf.2011.12.012; KURITA N, 1993, J MED VET MYCOL, V31, P201; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magalhaes A, 2012, CLIN VACCINE IMMUNOL, V19, P23, DOI 10.1128/CVI.05414-11; Marques AF, 2008, MICROBES INFECT, V10, P1251, DOI 10.1016/j.micinf.2008.07.027; Matute DR, 2006, MOL BIOL EVOL, V23, P65, DOI 10.1093/molbev/msj008; MCEWEN JG, 1987, J MED VET MYCOL, V25, P165; MENDESGIANNINI MJS, 1990, REV INST MED TROP SP, V32, P384, DOI 10.1590/S0036-46651990000500014; Morais FV, 2000, J CLIN MICROBIOL, V38, P3960, DOI 10.1128/JCM.38.11.3960-3966.2000; Pinto AR, 2000, VACCINE, V18, P3050, DOI 10.1016/S0264-410X(00)00074-8; PUCCIA R, 1986, INFECT IMMUN, V53, P199, DOI 10.1128/IAI.53.1.199-206.1986; PUCCIA R, 1991, J MED VET MYCOL, V29, P57; Puccia R, 1998, MED MYCOL, V36, P345, DOI 10.1080/02681219880000541; PUCCIA R, 1991, ARCH BIOCHEM BIOPHYS, V289, P298, DOI 10.1016/0003-9861(91)90475-X; Puccia R, 2008, MYCOPATHOLOGIA, V165, P275, DOI 10.1007/s11046-007-9055-2; Rappleye CA, 2004, MOL MICROBIOL, V53, P153, DOI 10.1111/j.1365-2958.2004.04131.x; Rappleye CA, 2006, ANNU REV MICROBIOL, V60, P281, DOI 10.1146/annurev.micro.59.030804.121055; Reis BS, 2008, VACCINE, V26, P5461, DOI 10.1016/j.vaccine.2008.07.097; Rittner GMG, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001519; Rocha AA, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-277; Rocha AA, 2009, FUNGAL GENET BIOL, V46, P85, DOI 10.1016/j.fgb.2008.10.009; Sambrook J, 1998, MOL CLONING LAB MANU, V2nd; SINGERVERMES LM, 1992, J MED VET MYCOL, V30, P261; Mendes-Giannini MJS, 2006, MICROBES INFECT, V8, P1550, DOI 10.1016/j.micinf.2006.01.012; Straus AH, 1996, J MED VET MYCOL, V34, P181; Taborda CP, 1998, INFECT IMMUN, V66, P786, DOI 10.1128/IAI.66.2.786-793.1998; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Travassos Luiz R., 2007, P241, DOI 10.1007/978-1-4020-6397-8_11; VICENTINI AP, 1994, INFECT IMMUN, V62, P1465, DOI 10.1128/IAI.62.4.1465-1469.1994	56	85	85	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e68434	10.1371/journal.pone.0068434	http://dx.doi.org/10.1371/journal.pone.0068434			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874627	Green Published, Green Submitted, gold			2022-12-27	WOS:000322218800032
J	Wang, C; Deng, PY; Chen, LL; Wang, XT; Ma, H; Hu, W; Yao, NC; Feng, Y; Chai, RH; Yang, GX; He, GY				Wang, Chen; Deng, Pengyi; Chen, Liulin; Wang, Xiatian; Ma, Hui; Hu, Wei; Yao, Ningcong; Feng, Ying; Chai, Ruihong; Yang, Guangxiao; He, Guangyuan			A Wheat WRKY Transcription Factor TaWRKY10 Confers Tolerance to Multiple Abiotic Stresses in Transgenic Tobacco	PLOS ONE			English	Article							OXYGEN GENE NETWORK; PLANT-RESPONSES; SALT-STRESS; SEED-GERMINATION; ABSCISIC-ACID; EXPRESSION; ARABIDOPSIS; PROTEIN; OVEREXPRESSION; DROUGHT	WRKY transcription factors are reported to be involved in defense regulation, stress response and plant growth and development. However, the precise role of WRKY transcription factors in abiotic stress tolerance is not completely understood, especially in crops. In this study, we identified and cloned 10 WRKY genes from genome of wheat (Triticum aestivum L.). TaWRKY10, a gene induced by multiple stresses, was selected for further investigation. TaWRKY10 was upregulated by treatment with polyethylene glycol, NaCl, cold and H2O2. Result of Southern blot indicates that the wheat genome contains three copies of TaWRKY10. The TaWRKY10 protein is localized in the nucleus and functions as a transcriptional activator. Overexpression of TaWRKY10 in tobacco (Nicotiana tabacum L.) resulted in enhanced drought and salt stress tolerance, mainly demonstrated by the transgenic plants exhibiting of increased germination rate, root length, survival rate, and relative water content under these stress conditions. Further investigation showed that transgenic plants also retained higher proline and soluble sugar contents, and lower reactive oxygen species and malonaldehyde contents. Moreover, overexpression of the TaWRKY10 regulated the expression of a series of stress related genes. Taken together, our results indicate that TaWRKY10 functions as a positive factor under drought and salt stresses by regulating the osmotic balance, ROS scavenging and transcription of stress related genes.	[Wang, Chen; Deng, Pengyi; Chen, Liulin; Wang, Xiatian; Ma, Hui; Hu, Wei; Yao, Ningcong; Feng, Ying; Chai, Ruihong; Yang, Guangxiao; He, Guangyuan] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Chinese Natl Ctr Plant Gene Res Wuhan HUST Part, Chinese Minist Educ,Key Lab Mol Biophys,Chinese M, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Yang, GX (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Chinese Natl Ctr Plant Gene Res Wuhan HUST Part, Chinese Minist Educ,Key Lab Mol Biophys,Chinese M, Wuhan 430074, Peoples R China.	ygx@hust.edu.cn; hegy@hust.edu.cn			Ministry of Science and Technology of China [2009DFB30340]; National Genetically Modified New Varieties of Major Projects of China [2011ZX08002-004, 2011ZX08010-004]; Key Projects of Science and Technology Research of the Ministry of Education of China [109105]; Wuhan Municipal Science and Technology research project [201120922286]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Genetically Modified New Varieties of Major Projects of China; Key Projects of Science and Technology Research of the Ministry of Education of China(Ministry of Education, China); Wuhan Municipal Science and Technology research project	This work was supported by the International Science and Technology Cooperation Key Projects of the Ministry of Science and Technology of China (Grant No. 2009DFB30340), the National Genetically Modified New Varieties of Major Projects of China (2011ZX08002-004, 2011ZX08010-004), the Key Projects of Science and Technology Research of the Ministry of Education of China (Grant No. 109105) and the Wuhan Municipal Science and Technology research project (Grant No. 201120922286). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoni R, 2011, CURR OPIN PLANT BIOL, V14, P547, DOI 10.1016/j.pbi.2011.06.004; Baxter CJ, 2001, ANN APPL BIOL, V138, P47, DOI 10.1111/j.1744-7348.2001.tb00084.x; BOHNERT HJ, 1995, PLANT CELL, V7, P1099, DOI 10.1105/tpc.7.7.1099; Bray EA, 1997, TRENDS PLANT SCI, V2, P48, DOI 10.1016/S1360-1385(97)82562-9; Chen H, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-281; Chen LG, 2012, BBA-GENE REGUL MECH, V1819, P120, DOI 10.1016/j.bbagrm.2011.09.002; Chen L, 2010, MOL BIOL REP, V37, P737, DOI 10.1007/s11033-009-9582-7; Chen P, 2008, J CEREAL SCI, V48, P734, DOI 10.1016/j.jcs.2008.04.002; Chen S, 2005, PLANT PHYSIOL, V139, P1163, DOI 10.1104/pp.105.069468; Davletova S, 2005, PLANT CELL, V17, P268, DOI 10.1105/tpc.104.026971; DRAPER HH, 1993, FREE RADICAL BIO MED, V15, P353, DOI 10.1016/0891-5849(93)90035-S; Eshdat Y, 1997, PHYSIOL PLANTARUM, V100, P234, DOI 10.1034/j.1399-3054.1997.1000204.x; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Gadjev I, 2006, PLANT PHYSIOL, V141, P436, DOI 10.1104/pp.106.078717; Garay-Arroyo A, 1999, YEAST, V15, P879, DOI 10.1002/(SICI)1097-0061(199907)15:10A<879::AID-YEA428>3.3.CO;2-H; Guillaumie S, 2010, PLANT MOL BIOL, V72, P215, DOI 10.1007/s11103-009-9563-1; Han QQ, 2012, MOL BIOL REP, V39, P1713, DOI 10.1007/s11033-011-0911-2; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Hong JP, 2005, PLANTA, V220, P875, DOI 10.1007/s00425-004-1412-5; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Hu W, 2012, PLANT CELL PHYSIOL, V53, P2127, DOI 10.1093/pcp/pcs154; ISHIGURO S, 1994, MOL GEN GENET, V244, P563, DOI 10.1007/BF00282746; Ishihama N, 2011, PLANT CELL, V23, P1153, DOI 10.1105/tpc.110.081794; Jiang WB, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-96; Johnson CS, 2002, PLANT CELL, V14, P1359, DOI 10.1105/tpc.001404; Kong XP, 2011, PLANT CELL ENVIRON, V34, P1291, DOI 10.1111/j.1365-3040.2011.02329.x; Lagace M, 2004, PLANTA, V219, P185, DOI 10.1007/s00425-004-1253-2; LATCHMAN DS, 1993, INT J EXP PATHOL, V74, P417; Lee BH, 2002, PLANT CELL, V14, P1235, DOI 10.1105/tpc.010433; Liu JP, 1997, PLANT PHYSIOL, V114, P591, DOI 10.1104/pp.114.2.591; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Makandar R, 2010, MOL PLANT MICROBE IN, V23, P861, DOI 10.1094/MPMI-23-7-0861; Mao GH, 2011, PLANT CELL, V23, P1639, DOI 10.1105/tpc.111.084996; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nevo E., 2002, EVOLUTION WILD EMMER; Niu CF, 2012, PLANT CELL ENVIRON, V35, P1156, DOI 10.1111/j.1365-3040.2012.02480.x; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Podell S, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-37; Proietti S, 2011, J EXP BOT, V62, P1975, DOI 10.1093/jxb/erq396; Reddy ASN, 2011, PLANT CELL, V23, P2010, DOI 10.1105/tpc.111.084988; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Sathiyaraj G, 2011, MOL BIOL REP, V38, P2761, DOI 10.1007/s11033-010-0421-7; Shao HB, 2006, COLLOID SURFACE B, V53, P113, DOI 10.1016/j.colsurfb.2006.08.008; Shewry PR, 2009, J EXP BOT, V60, P1537, DOI 10.1093/jxb/erp058; SHIEH MW, 1993, PLANT PHYSIOL, V101, P353, DOI 10.1104/pp.101.2.353; SKRIVER K, 1990, PLANT CELL, V2, P503, DOI 10.1105/tpc.2.6.503; Song Y, 2009, CHINESE SCI BULL, V54, P4671, DOI 10.1007/s11434-009-0710-5; Takemoto D, 2003, PHYSIOL PLANTARUM, V118, P545, DOI 10.1034/j.1399-3054.2003.00145.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tseng MJ, 2007, PLANT PHYSIOL BIOCH, V45, P822, DOI 10.1016/j.plaphy.2007.07.011; Ueda M, 2011, DEV CELL, V20, P264, DOI 10.1016/j.devcel.2011.01.009; Vinocur B, 2005, CURR OPIN BIOTECH, V16, P123, DOI 10.1016/j.copbio.2005.02.001; Wan JR, 2004, MOL PLANT PATHOL, V5, P125, DOI [10.1111/j.1364-3703.2004.00215.x, 10.1111/J.1364-3703.2004.00215.X]; Wang F, 2012, MOL BIOL REP, V39, P4553, DOI 10.1007/s11033-011-1245-9; Wang HH, 2007, PLANT MOL BIOL, V65, P799, DOI 10.1007/s11103-007-9244-x; Wilkinson MD, 2013, J CEREAL SCI, V57, P1, DOI 10.1016/j.jcs.2012.09.005; Wu LJ, 2008, PLANT PHYSIOL, V148, P1953, DOI 10.1104/pp.108.126813; Xie Z, 2007, PLANT MOL BIOL, V64, P293, DOI 10.1007/s11103-007-9152-0; Xiong L, 2002, PLANT CELL ENVIRON, V25, P131, DOI 10.1046/j.1365-3040.2002.00782.x; Xiong X, 2010, MOL BREEDING, V25, P419, DOI 10.1007/s11032-009-9341-4; Xiong YQ, 2005, PLANT MOL BIOL, V59, P191, DOI 10.1007/s11103-005-6503-6; Yang YO, 1997, GENE DEV, V11, P1621, DOI 10.1101/gad.11.13.1621; Zhang GY, 2009, J EXP BOT, V60, P3781, DOI 10.1093/jxb/erp214; Zhang YJ, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-1; Zhou QY, 2008, PLANT BIOTECHNOL J, V6, P486, DOI 10.1111/j.1467-7652.2008.00336.x; Zhou SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052439; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zou CS, 2010, J EXP BOT, V61, P3901, DOI 10.1093/jxb/erq204	71	334	360	17	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65120	10.1371/journal.pone.0065120	http://dx.doi.org/10.1371/journal.pone.0065120			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762295	Green Published, gold, Green Submitted			2022-12-27	WOS:000320440500026
J	Huang, JH; Zhang, AB; Mao, SL; Huang, Y				Huang, Jianhua; Zhang, Aibing; Mao, Shaoli; Huang, Yuan			DNA Barcoding and Species Boundary Delimitation of Selected Species of Chinese Acridoidea (Orthoptera: Caelifera)	PLOS ONE			English	Article							MOLECULAR PHYLOGENETIC ANALYSIS; MITOCHONDRIAL CYTOCHROME-B; NEIGHBOR-JOINING METHOD; OXIDASE SUBUNIT-I; GRASSHOPPERS ORTHOPTERA; COLOR PATTERN; TAXONOMY; IDENTIFICATION; SEQUENCES; EVOLUTION	We tested the performance of DNA barcoding in Acridoidea and attempted to solve species boundary delimitation problems in selected groups using COI barcodes. Three analysis methods were applied to reconstruct the phylogeny. K2P distances were used to assess the overlap range between intraspecific variation and interspecific divergence. "Best match (BM)", "best close match (BCM)", all species barcodes (ASB)" and "back-propagation neural networks (BP-based method)" were utilized to test he success rate of species identification. Phylogenetic species concept and network analysis were employed to delimitate the species boundary in eight selected species groups. The results demonstrated that the COI barcode region performed better in phylogenetic reconstruction at genus and species levels than at hi her-levels, but showed a little improvement in resolving the higher-level relationships when the third base data or both first and third base data were excluded. Most overlaps and incorrect identifications may be due to imperfect taxonomy, indicating the critical role of taxonomic revision in DNA barcoding study. Species boundary delimitation confirmed the presence of oversplitting in six species groups and suggested that each group should be treated as a single species	[Huang, Jianhua; Mao, Shaoli; Huang, Yuan] Shaanxi Normal Univ, Coll Life Sci, Xian, Peoples R China; [Huang, Jianhua] Guangxi Normal Univ, Coll Life Sci, Guilin, Peoples R China; [Zhang, Aibing] Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China	Shaanxi Normal University; Guangxi Normal University; Capital Normal University	Huang, Y (corresponding author), Shaanxi Normal Univ, Coll Life Sci, Xian, Peoples R China.	yuanh@snnu.edu.cn		zhang, ai bing/0000-0002-6580-5462; ZHANG, Ai-bing/0000-0003-3450-5421	National Natural Science Foundation of China [30970346, 31172076, 31260523]; Fundamental Research Funds for the Central Universities [GK201001004]; China Postdoctoral Science Foundation [20070421105]; Guangxi Natural Science Foundation [2010GXNSFA013070]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province)	This study is supported by National Natural Science Foundation of China (No. 30970346, 31172076, 31260523), the Fundamental Research Funds for the Central Universities (GK201001004), China Postdoctoral Science Foundation (20070421105) and Guangxi Natural Science Foundation (2010GXNSFA013070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amedegnato C, 2003, MOL PHYLOGENET EVOL, V29, P115, DOI 10.1016/S1055-7903(03)00074-5; Austerlitz F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S10; Baker AJ, 2005, P NATL ACAD SCI USA, V102, P8257, DOI 10.1073/pnas.0409435102; Bugrov A, 2006, SYST ENTOMOL, V31, P362, DOI 10.1111/j.1365-3113.2005.00317.x; Burns John M., 2007, Journal of the Lepidopterists' Society, V61, P138; Campbell DC, 2008, MOL ECOL RESOUR, V8, P711, DOI 10.1111/j.1755-0998.2008.02108.x; Chapco W, 1997, ANN ENTOMOL SOC AM, V90, P555, DOI 10.1093/aesa/90.5.555; Chapco W, 2001, MOL PHYLOGENET EVOL, V18, P460, DOI 10.1006/mpev.2000.0902; Chapco William, 2011, Journal of Orthoptera Research, V20, P173, DOI 10.1665/034.020.0205; Chintauan-Marquier IC, 2011, MOL PHYLOGENET EVOL, V58, P22, DOI 10.1016/j.ympev.2010.07.003; Chu KH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S8; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Contreras Daniel, 2006, Journal of Orthoptera Research, V15, P91, DOI 10.1665/1082-6467(2006)15[91:MPEFMD]2.0.CO;2; Cui Ai-Ming, 2012, Yichuan, V34, P597, DOI 10.3724/SP.J.1005.2012.00597; Dai QY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032544; Dasmahapatra KK, 2010, MOL ECOL RESOUR, V10, P264, DOI 10.1111/j.1755-0998.2009.02763.x; DEARN JM, 1981, HEREDITY, V47, P111, DOI 10.1038/hdy.1981.64; DEARN JM, 1978, J AUST ENTOMOL SOC, V17, P135; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; deWaard JR, 2009, BIODIVERS CONSERV, V18, P3825, DOI 10.1007/s10531-009-9682-7; Ding Fang-Mei, 2008, Acta Entomologica Sinica, V51, P55; Eades DC, 2013, ORTHOPTERA SPECIES F; Elias M, 2007, P ROY SOC B-BIOL SCI, V274, P2881, DOI 10.1098/rspb.2007.1035; Feng J, 2010, J THEOR BIOL, V266, P703, DOI 10.1016/j.jtbi.2010.07.040; Flook PK, 1999, SYST BIOL, V48, P233, DOI 10.1080/106351599260274; Flook PK, 1998, INSECT MOL BIOL, V7, P163, DOI 10.1046/j.1365-2583.1998.72060.x; Flook PK, 1997, MOL PHYLOGENET EVOL, V8, P89, DOI 10.1006/mpev.1997.0412; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Foottit RG, 2009, MOL ECOL RESOUR, V9, P188, DOI 10.1111/j.1755-0998.2009.02644.x; Fries Megan, 2007, Journal of Orthoptera Research, V16, P115, DOI 10.1665/1082-6467(2007)16[115:AMPAOT]2.0.CO;2; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Gaines SB, 1991, T NEBRASKA ACAD SCI, V18, P67; Grunshaw J. P., 1988, Journal of the East Africa Natural History Society and National Museum, V78, P1; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI 10.1098/rspb.2002.2218; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hendrich L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014448; Hickerson MJ, 2006, SYST BIOL, V55, P729, DOI 10.1080/10635150600969898; Huang Jianhua, 2007, Zootaxa, V1436, P55; Huang JH, 2009, ZOOTAXA, P39, DOI 10.11646/zootaxa.1976.1.3; Huo Guangming, 2007, Journal of Genetics and Genomics, V34, P294, DOI 10.1016/S1673-8527(07)60031-9; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kuksa P, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S9; Kumar S, 2000, J MOL EVOL, V51, P544, DOI 10.1007/s002390010118; La Rosa M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S7-S4; Lambert DM, 2005, J HERED, V96, P279, DOI 10.1093/jhered/esi035; Lan Ma, 2006, Acta Entomologica Sinica, V49, P982; Lawrence HA, 2009, MOL ECOL RESOUR, V9, P458, DOI 10.1111/j.1755-0998.2008.02370.x; Li HC, 2006, FAUNA SINICA INSECTA, V43; Lis JA, 2011, ZOOTAXA, P47, DOI 10.11646/zootaxa.2932.1.5; Litzenberger G, 2003, ANN ENTOMOL SOC AM, V96, P491, DOI 10.1603/0013-8746(2003)096[0491:TNAMOA]2.0.CO;2; Litzenberger G, 2001, ANN ENTOMOL SOC AM, V94, P505, DOI 10.1603/0013-8746(2001)094[0505:MPOSEP]2.0.CO;2; Liu Dian-Feng, 2005, Acta Entomologica Sinica, V48, P759; Liu Dian-Feng, 2005, Acta Entomologica Sinica, V48, P232; Lopez H, 2007, CONSERV GENET, V8, P587, DOI 10.1007/s10592-006-9199-5; Lu HM, 2001, J NW U NAT SCI ED, V31, P7; Lu Hong-Juan, 2012, Zoological Research, V33, P319, DOI 10.3724/SP.J.1141.2012.03319; LU Hui-Meng, 2006, Insect Science, V13, P103, DOI 10.1111/j.1744-7917.2006.00072.x; Lu Rong-Sheng, 2010, Acta Zootaxonomica Sinica, V35, P782; Luo AR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-84; Luo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-242; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Monaghan MT, 2006, P ROY SOC B-BIOL SCI, V273, P887, DOI 10.1098/rspb.2005.3391; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Moulton MJ, 2010, MOL ECOL RESOUR, V10, P615, DOI 10.1111/j.1755-0998.2009.02823.x; Nei M, 2000, MOL EVOLUTION PHYLOG; Pan Cheng-ying, 2006, Entomotaxonomia, V28, P103; Pan Zhao, 2011, Acta Zootaxonomica Sinica, V36, P179; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Rivera J, 2009, MOL ECOL RESOUR, V9, P224, DOI 10.1111/j.1755-0998.2009.02648.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rowell C. H. F., 2004, Journal of Orthoptera Research, V13, P35, DOI 10.1665/1082-6467(2004)013[0035:ADMPOT]2.0.CO;2; Rowell C.H.F., 1998, Journal of Orthoptera Research, V7, P147; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Savolainen V, 2005, PHILOS T R SOC B, V360, P1805, DOI 10.1098/rstb.2005.1730; Sheffield CS, 2009, MOL ECOL RESOUR, V9, P196, DOI 10.1111/j.1755-0998.2009.02645.x; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Staden R, 2000, Methods Mol Biol, V132, P115; Storozhenko Sergey, 1994, Articulata, V8, P1; Storozhenko SY, 1983, SYSTEMATICS ECOLOGIC, P48; Sun Zheng-Li, 2006, Acta Zoologica Sinica, V52, P302; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TEMPLETON AR, 1992, GENETICS, V132, P619; Templeton AR, 2001, MOL ECOL, V10, P779, DOI 10.1046/j.1365-294x.2001.01199.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tian Ying-fang, 1999, Journal of Shaanxi Normal University Natural Science Edition, V27, P82; Tinkham E. R., 1936, Lingnan Science Journal, V15, P47; Trewick SA, 2008, CLADISTICS, V24, P240, DOI 10.1111/j.1096-0031.2007.00174.x; UVAROV B. P., 1931, LINGNAN SCI JOUR, V10, P217; Virgilio M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031581; Virgilio M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-206; Wang Nai-Xin, 2008, Acta Entomologica Sinica, V51, P1187; Waugh J, 2007, BIOESSAYS, V29, P188, DOI 10.1002/bies.20529; Wei Tao, 2012, Far Eastern Entomologist, V255, P11; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Will KW, 2004, CLADISTICS, V20, P47, DOI 10.1111/j.1096-0031.2003.00008.x; Yassin A, 2009, MOL PHYLOGENET EVOL, V53, P404, DOI 10.1016/j.ympev.2009.06.012; Yin Hong, 2004, Acta Entomologica Sinica, V47, P809; Yin Hong, 2003, Acta Genetica Sinica, V30, P766; Yin XC, 2003, FAUNA SINICA INSECTA, V32; Zhang AB, 2008, SYST BIOL, V57, P202, DOI 10.1080/10635150802032982; Zhang AB, 2012, MOL ECOL, V21, P1848, DOI 10.1111/j.1365-294X.2011.05235.x; Zhang AB, 2010, MOL PHYLOGENET EVOL, V54, P1035, DOI 10.1016/j.ympev.2009.09.014; Zhang AB, 2009, MOL ECOL RESOUR, V9, P104, DOI 10.1111/j.1755-0998.2008.02372.x; Zhang AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030986; Zhang DC, 2011, INSECT SCI, V18, P234, DOI 10.1111/j.1744-7917.2010.01359.x; Zhang Dao-Chuan, 2005, Zootaxa, V1103, P41; Zheng ZM, 1998, FAUNA SINICA INSECTA, V10; Zhou ZJ, 2010, J GENET GENOMICS, V37, P315, DOI 10.1016/S1673-8527(09)60049-7	116	49	51	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82400	10.1371/journal.pone.0082400	http://dx.doi.org/10.1371/journal.pone.0082400			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	23874723	Green Submitted, gold, Green Published			2022-12-27	WOS:000328745100030
J	Huang, JH; Zhong, Y; Fang, XW; Xie, QD; Kang, XJ; Wu, RR; Li, FZ; Xu, XQ; Lu, H; Xu, L; Huang, TH				Huang, JiHua; Zhong, Ying; Fang, XiaoWu; Xie, QingDong; Kang, XiangJin; Wu, RiRan; Li, FangZheng; Xu, XiaoQin; Lu, Hui; Xu, Lan; Huang, TianHua			Hepatitis B Virus S Protein Enhances Sperm Apoptosis and Reduces Sperm Fertilizing Capacity In Vitro	PLOS ONE			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; INDUCED ACROSOME REACTION; HYPERACTIVATED MOTILITY; HUMAN SPERMATOZOA; CELL-DEATH; PORE; TRANSMISSION; ACTIVATION; CASPASES; TARGET	Objective: Studying the impact of Hepatitis B virus S protein (HBs) on early apoptotic events in human spermatozoa and sperm fertilizing capacity. Methodology/Principal Findings: Spermatozoa were exposed to HBs (0, 25, 50, 100 mu g/ml) for 3 h, and then fluo-4 AM calcium assay, Calcein/Co2+ assay, protein extraction and ELISA, ADP/ATP ratio assay, sperm motility and hyperactivation and sperm-zona pellucida (ZP) binding and ZP-induced acrosome reaction (ZPIAR) tests were performed. The results showed that in the spermatozoa, with increasing concentration of HBs, (1) average cytosolic free Ca2+ concentration ([Ca2+](i)) rose; (2) fluorescence intensity of Cal-AM declined; (3) average levels of cytochrome c decreased in mitochondrial fraction and increased in cytosolic fraction; (4) ADP/ATP ratios rose; (5) average rates of total motility and mean hyperactivation declined; (6) average rate of ZPIAR declined. In the above groups the effects of HBs exhibited dose dependency. However, there was no significant difference in the number of sperms bound to ZP between the control and all test groups. Conclusion: HBs could induce early events in the apoptotic cascade in human spermatozoa, such as elevation of [Ca2+](i), opening of mitochondrial permeability transition pore (MPTP), release of cytochrome c (cyt c) and increase of ADP/ATP ratio, but exerted a negative impact on sperm fertilizing capacity.	[Huang, JiHua; Xie, QingDong; Kang, XiangJin; Li, FangZheng; Xu, XiaoQin; Lu, Hui; Xu, Lan; Huang, TianHua] Shantou Univ, Coll Med, Guangdong Prov Key Lab Infect Dis & Mol Immunopat, Res Ctr Reprod Med, Shantou, Guangdong, Peoples R China; [Zhong, Ying] Chengdu Jingjiang Hosp Maternal & Child Hlth Care, Ctr Reprod Med, Chengdu, Sichuan, Peoples R China; [Fang, XiaoWu; Wu, RiRan] Boai Hosp Zhongshan, Ctr Reprod Med, Zhongshan, Guangdong, Peoples R China	Shantou University	Huang, TH (corresponding author), Shantou Univ, Coll Med, Guangdong Prov Key Lab Infect Dis & Mol Immunopat, Res Ctr Reprod Med, Shantou, Guangdong, Peoples R China.	thhuang@stu.edu.cn		zhang, ai bing/0000-0002-6580-5462; ZHANG, Ai-bing/0000-0003-3450-5421	National Natural Science Foundation of China [30972526]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Natural Science Foundation of China (No. 30972526) and the Li Ka Shing Shantou University Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bejarano I, 2012, MALE INFERTILITY, V20, P51; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; CROSS NL, 1991, HUM REPROD, V6, P1279, DOI 10.1093/oxfordjournals.humrep.a137526; Demaurex N, 2003, SCIENCE, V300, P65, DOI 10.1126/science.1083628; Ganem D., 1996, FIELDS VIROLOGY, P2703; HADCHOUEL M, 1985, J MED VIROL, V16, P61, DOI 10.1002/jmv.1890160109; Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5; Ho HC, 2001, BIOL REPROD, V65, P1606, DOI 10.1095/biolreprod65.5.1606; Huang JM, 2002, ASIAN J ANDROL, V4, P209; Javadov S, 2009, J PHARMACOL EXP THER, V330, P670, DOI 10.1124/jpet.109.153213; Kang XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033471; Lang Z W, 1993, Zhonghua Yi Xue Za Zhi, V73, P329; Liu DY, 2007, HUM REPROD, V22, P2632, DOI 10.1093/humrep/dem245; Liu DY, 2004, HUM REPROD, V19, P228, DOI 10.1093/humrep/deh067; Liu DY, 1996, HUM REPROD, V11, P551, DOI 10.1093/HUMREP/11.3.551; Misro M.M., 2012, MALE INFERTILITY CON, P209; Moretti E, 2008, ANDROLOGIA, V40, P286, DOI 10.1111/j.1439-0272.2008.00855.x; Oger P, 2011, REPROD BIOMED ONLINE, V23, P207, DOI 10.1016/j.rbmo.2011.04.008; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Paasch U, 2004, ANN NY ACAD SCI, V1030, P403, DOI 10.1196/annals.1329.050; Patrat C, 2000, BIOL CELL, V92, P255, DOI 10.1016/S0248-4900(00)01072-8; Richburg JH, 2000, TOXICOL LETT, V112, P79, DOI 10.1016/S0378-4274(99)00253-2; Said TM, 2004, HUM REPROD UPDATE, V10, P39, DOI 10.1093/humupd/dmh003; Salisbury J.J., 2004, AM SOC CELL BIOL 44; Schinder AF, 1996, J NEUROSCI, V16, P6125; SCOTT RM, 1980, J INFECT DIS, V142, P67, DOI 10.1093/infdis/142.1.67; Shen HM, 2002, HUM REPROD, V17, P1266, DOI 10.1093/humrep/17.5.1266; Suarez SS, 2006, HUM REPROD UPDATE, V12, P23, DOI 10.1093/humupd/dmi047; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; VANDEVOORT CA, 1995, J ANDROL, V16, P327; Vasudevan SR, 2010, J BIOL CHEM, V285, P18262, DOI 10.1074/jbc.M109.087858; White RJ, 1996, J NEUROSCI, V16, P5688; World Health Organization, 2008, HEP B; Xia JS, 2007, BIOL REPROD, V77, P551, DOI 10.1095/biolreprod.107.061358; Yanagimachi R., 1994, P189; Zhou XL, 2009, HUM REPROD, V24, P1575, DOI 10.1093/humrep/dep050; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	38	49	51	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68688	10.1371/journal.pone.0068688	http://dx.doi.org/10.1371/journal.pone.0068688			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874723	Green Published, gold, Green Submitted			2022-12-27	WOS:000322064300064
J	Abada, YSK; Nguyen, HP; Schreiber, R; Ellenbroek, B				Abada, Yah-se K.; Nguyen, Huu Phuc; Schreiber, Rudy; Ellenbroek, Bart			Assessment of Motor Function, Sensory Motor Gating and Recognition Memory in a Novel BACHD Transgenic Rat Model for Huntington Disease	PLOS ONE			English	Article							YAC128 MOUSE MODEL; COGNITIVE DEFICITS; NEUROPATHOLOGICAL FEATURES; PREPULSE INHIBITION; MUTANT HUNTINGTIN; GENE; SYMPTOMS; MICE; HD; ABNORMALITIES	Rationale: Huntington disease (HD) is frequently first diagnosed by the appearance of motor symptoms; the diagnosis is subsequently confirmed by the presence of expanded CAG repeats (> 35) in the HUNTINGTIN (HTT) gene. A BACHD rat model for HD carrying the human full length mutated HTT with 97 CAG-CAA repeats has been established recently. Behavioral phenotyping of BACHD rats will help to determine the validity of this model and its potential use in preclinical drug discovery studies. Objectives: The present study seeks to characterize the progressive emergence of motor, sensorimotor and cognitive deficits in BACHD rats. Materials and Methods: Wild type and transgenic rats were tested from 1 till 12 months of age. Motor tests were selected to measure spontaneous locomotor activity (open field) and gait coordination. Sensorimotor gating was assessed in acoustic startle response paradigms and recognition memory was evaluated in an object recognition test. Results: Transgenic rats showed hyperactivity at 1 month and hypoactivity starting at 4 months of age. Motor coordination imbalance in a Rotarod test was present at 2 months and gait abnormalities were seen in a Catwalk test at 12 months. Subtle sensorimotor changes were observed, whereas object recognition was unimpaired in BACHD rats up to 12 months of age. Conclusion: The current BACHD rat model recapitulates certain symptoms from HD patients, especially the marked motor deficits. A subtle neuropsychological phenotype was found and further studies are needed to fully address the sensorimotor phenotype and the potential use of BACHD rats for drug discovery purposes.	[Abada, Yah-se K.] EVOTEC AG, Neuropharmacol, Hamburg, Germany; [Abada, Yah-se K.] Univ Bremen, Brain Res Inst, Dept Neuropharmacol, D-28359 Bremen, Germany; [Nguyen, Huu Phuc] Univ Tubingen, Inst Med Genet & Appl Gen, Tubingen, Germany; [Schreiber, Rudy] Univ Groningen, Groningen, Netherlands; [Ellenbroek, Bart] Victoria Univ Wellington, Sch Psychol, Wellington, New Zealand	Evotec; University of Bremen; Eberhard Karls University of Tubingen; University of Groningen; Victoria University Wellington	Abada, YSK (corresponding author), EVOTEC AG, Neuropharmacol, Hamburg, Germany.	yah-se.abada@evotec.com	Nguyen, Huu Phuc/F-5390-2015; Nguyen, Huu Phuc/HDO-3462-2022	Nguyen, Huu Phuc/0000-0001-6139-788X; Nguyen, Huu Phuc/0000-0001-6139-788X; Ellenbroek, Bart/0000-0003-1996-4873; abada, komla yah-se/0000-0003-0085-8747	Neuromodel, an Initial Training Network through the people programme FP7 of the European Union [215618-2]	Neuromodel, an Initial Training Network through the people programme FP7 of the European Union	This work was supported by grant no. 215618-2 from Neuromodel, an Initial Training Network funded through the people programme FP7 of the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abada YSK, 2013, BEHAV BRAIN RES, V238, P243, DOI 10.1016/j.bbr.2012.10.039; Bezprozvanny I, 2004, BIOCHEM BIOPH RES CO, V322, P1310, DOI 10.1016/j.bbrc.2004.08.035; Bowles KR, 2012, BRAIN RES BULL, V88, P276, DOI 10.1016/j.brainresbull.2011.07.021; Brooks S, 2009, BRAIN RES BULL, V79, P310, DOI 10.1016/j.brainresbull.2009.03.003; Carter RJ, 1999, J NEUROSCI, V19, P3248; Castellanos FX, 1996, BIOL PSYCHIAT, V39, P33, DOI 10.1016/0006-3223(95)00101-8; Caviston JP, 2009, TRENDS CELL BIOL, V19, P147, DOI 10.1016/j.tcb.2009.01.005; CHABOT CC, 1992, BEHAV NEUROSCI, V106, P846, DOI 10.1037/0735-7044.106.5.846; Cisbani G, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.121; Crook ZR, 2011, NEURON, V69, P423, DOI 10.1016/j.neuron.2010.12.035; DIMAIO L, 1993, J MED GENET, V30, P289, DOI 10.1136/jmg.30.4.289; Douaud G, 2006, NEUROIMAGE, V32, P1562, DOI 10.1016/j.neuroimage.2006.05.057; Ellenbroek BA, 2004, BIOL PSYCHIAT, V55, P701, DOI 10.1016/j.biopsych.2003.10.024; ESTEBAN A, 1981, J NEUROL NEUROSUR PS, V44, P43, DOI 10.1136/jnnp.44.1.43; Fink KD, 2012, BEHAV NEUROSCI, V126, P479, DOI 10.1037/a0028028; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; GRILLON C, 1992, BIOL PSYCHIAT, V32, P939, DOI 10.1016/0006-3223(92)90183-Z; Hahn-Barma V, 1998, J NEUROL NEUROSUR PS, V64, P172, DOI 10.1136/jnnp.64.2.172; Hamers FPT, 2001, J NEUROTRAUM, V18, P187, DOI 10.1089/08977150150502613; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Huntington G., 1872, MED SURG REP, V26, P320; Jones L, 2011, INT REV NEUROBIOL, V98, P373, DOI 10.1016/B978-0-12-381328-2.00015-8; Kirch RD, 2013, BEHAV BRAIN RES, V239, P15, DOI 10.1016/j.bbr.2012.10.048; Kodsi MH, 1997, BRAIN RES, V773, P45, DOI 10.1016/S0006-8993(97)00869-X; KOLLER WC, 1985, NEUROLOGY, V35, P1450, DOI 10.1212/WNL.35.10.1450; Koopmans GC, 2007, PHYSIOL BEHAV, V92, P993, DOI 10.1016/j.physbeh.2007.07.018; Kordasiewicz HB, 2012, NEURON, V74, P1031, DOI 10.1016/j.neuron.2012.05.009; Lawrence AD, 1996, BRAIN, V119, P1633, DOI 10.1093/brain/119.5.1633; Lawrence AD, 1998, BRAIN, V121, P1329, DOI 10.1093/brain/121.7.1329; Lawrence AD, 2000, BRAIN, V123, P1349, DOI 10.1093/brain/123.7.1349; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Menalled L, 2009, NEUROBIOL DIS, V35, P319, DOI 10.1016/j.nbd.2009.05.007; Montoya A, 2006, NEUROPSYCHOLOGIA, V44, P1984, DOI 10.1016/j.neuropsychologia.2006.01.015; MYERS RH, 1985, J NEUROL NEUROSUR PS, V48, P530, DOI 10.1136/jnnp.48.6.530; Nguyen HP, 2006, HUM MOL GENET, V15, P3177, DOI 10.1093/hmg/ddl394; Pallier PN, 2009, BRAIN RES BULL, V78, P347, DOI 10.1016/j.brainresbull.2008.10.007; Paulsen JS, 2001, J NEUROL NEUROSUR PS, V71, P310, DOI 10.1136/jnnp.71.3.310; Pouladi MA, 2012, HUM MOL GENET, V21, P2219, DOI 10.1093/hmg/dds037; ROSENBERG NK, 1995, J MED GENET, V32, P600, DOI 10.1136/jmg.32.8.600; Seaman RL, 2000, NEUROSCI LETT, V280, P183, DOI 10.1016/S0304-3940(00)00790-4; Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169; Southwell AL, 2009, J NEUROSCI, V29, P13589, DOI 10.1523/JNEUROSCI.4286-09.2009; SWERDLOW NR, 1995, J NEUROL NEUROSUR PS, V58, P192, DOI 10.1136/jnnp.58.2.192; SWERDLOW NR, 1992, PSYCHOPHARMACOLOGY, V108, P189, DOI 10.1007/BF02245306; Tecott LH, 2004, NAT NEUROSCI, V7, P462, DOI 10.1038/nn1225; Trushina E, 2004, MOL CELL BIOL, V24, P8195, DOI 10.1128/MCB.24.18.8195-8209.2004; van Duijn E, 2007, J NEUROPSYCH CLIN N, V19, P441, DOI 10.1176/appi.neuropsych.19.4.441; Van Raamsdonk JM, 2005, J NEUROSCI, V25, P4169, DOI 10.1523/JNEUROSCI.0590-05.2005; Vandeputte C, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-92; von Horsten S, 2003, HUM MOL GENET, V12, P617, DOI 10.1093/hmg/ddg075; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Woodman B, 2007, BRAIN RES BULL, V72, P83, DOI 10.1016/j.brainresbull.2006.11.004; Yang SH, 2008, NATURE, V453, P921, DOI 10.1038/nature06975; Yu-Taeger L, 2012, J NEUROSCI, V32, P15426, DOI 10.1523/JNEUROSCI.1148-12.2012; Zeef DH, 2012, BEHAV BRAIN RES, V227, P194, DOI 10.1016/j.bbr.2011.11.009; Zeef DH, 2012, BEHAV BRAIN RES, V226, P435, DOI 10.1016/j.bbr.2011.09.041; Zheng ZQ, 2012, PROG MOL BIOL TRANSL, V107, P189, DOI 10.1016/B978-0-12-385883-2.00010-2	58	48	49	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e68584	10.1371/journal.pone.0068584	http://dx.doi.org/10.1371/journal.pone.0068584			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874679	Green Published, Green Submitted, gold			2022-12-27	WOS:000322218800037
J	Kim, BJ; Zaveri, HP; Shchelochkov, OA; Yu, ZY; Hernandez-Garcia, A; Seymour, ML; Oghalai, JS; Pereira, FA; Stockton, DW; Justice, MJ; Lee, B; Scott, DA				Kim, Bum Jun; Zaveri, Hitisha P.; Shchelochkov, Oleg A.; Yu, Zhiyin; Hernandez-Garcia, Andres; Seymour, Michelle L.; Oghalai, John S.; Pereira, Fred A.; Stockton, David W.; Justice, Monica J.; Lee, Brendan; Scott, Daryl A.			An Allelic Series of Mice Reveals a Role for RERE in the Development of Multiple Organs Affected in Chromosome 1p36 Deletions	PLOS ONE			English	Article							RETINOIC ACID SYNTHESIS; HISTONE DEACETYLASE; CALRETININ IMMUNOREACTIVITY; SKI PROTOONCOGENE; DENTATE GYRUS; MONOSOMY 1P36; GENE; ZEBRAFISH; DEFECTS; MODELS	Individuals with terminal and interstitial deletions of chromosome 1p36 have a spectrum of defects that includes eye anomalies, postnatal growth deficiency, structural brain anomalies, seizures, cognitive impairment, delayed motor development, behavior problems, hearing loss, cardiovascular malformations, cardiomyopathy, and renal anomalies. The proximal 1p36 genes that contribute to these defects have not been clearly delineated. The arginine-glutamic acid dipeptide (RE) repeats gene (RERE) is located in this region and encodes a nuclear receptor coregulator that plays a critical role in embryonic development as a positive regulator of retinoic acid signaling. Rere-null mice die of cardiac failure between E9.5 and E11.5. This limits their usefulness in studying the role of RERE in the latter stages of development and into adulthood. To overcome this limitation, we created an allelic series of RERE-deficient mice using an Rere-null allele, om, and a novel hypomorphic Rere allele, eyes3 (c.578T>C, p.Val193Ala), which we identified in an N-ethyl-N-nitrosourea (ENU)-based screen for autosomal recessive phenotypes. Analyses of these mice revealed microphthalmia, postnatal growth deficiency, brain hypoplasia, decreased numbers of neuronal nuclear antigen (NeuN)-positive hippocampal neurons, hearing loss, cardiovascular malformations-aortic arch anomalies, double outlet right ventricle, and transposition of the great arteries, and perimembranous ventricular septal defects-spontaneous development of cardiac fibrosis and renal agenesis. These findings suggest that RERE plays a critical role in the development and function of multiple organs including the eye, brain, inner ear, heart and kidney. It follows that haploinsufficiency of RERE may contribute-alone or in conjunction with other genetic, environmental, or stochastic factors-to the development of many of the phenotypes seen in individuals with terminal and interstitial deletions that include the proximal region of chromosome 1p36.	[Kim, Bum Jun; Zaveri, Hitisha P.; Yu, Zhiyin; Hernandez-Garcia, Andres; Justice, Monica J.; Lee, Brendan; Scott, Daryl A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Shchelochkov, Oleg A.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Seymour, Michelle L.; Pereira, Fred A.] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; [Seymour, Michelle L.; Pereira, Fred A.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Oghalai, John S.] Stanford Sch Med, Dept Otolaryngol Head & Neck Surg, Stanford, CA USA; [Pereira, Fred A.] Baylor Coll Med, Dept Otolaryngol Head & Neck Surg, Houston, TX 77030 USA; [Stockton, David W.] Wayne State Univ, Sch Med, Dept Pediat, Detroit, MI 48201 USA; [Stockton, David W.] Wayne State Univ, Sch Med, Dept Internal Med, Detroit, MI 48201 USA; [Lee, Brendan] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Scott, Daryl A.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA	Baylor College of Medicine; University of Iowa; Baylor College of Medicine; Baylor College of Medicine; Stanford University; Baylor College of Medicine; Wayne State University; Wayne State University; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine	Scott, DA (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	dscott@bcm.edu	wu, mingming/GXN-1864-2022; HERNANDEZ-GARCIA, ANDRES/B-9051-2014; KIM, BEUM JUN/G-6829-2011	HERNANDEZ-GARCIA, ANDRES/0000-0002-5343-5513; KIM, BEUM JUN/0000-0003-1797-5026; Hannanta-anan, Pimkhuan/0000-0002-9450-0799; Pereira, Fred/0000-0003-2100-0280	National Institutes of Health (NIH) [R01HD064667, U01HD39372, R03EY014854]; BCM IDDRC from the Eunice Kennedy Shriver National Institute of Child Health and Human Development [5P30HD024064]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BCM IDDRC from the Eunice Kennedy Shriver National Institute of Child Health and Human Development	This project was supported by National Institutes of Health (NIH; http://www.nih.gov/) grants R01HD064667 to DAS, U01HD39372 to MJJ and R03EY014854 to DWS. The project described was also supported by the BCM IDDRC grant number 5P30HD024064 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (http://www.nichd.nih.gov/). The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health and Human Development or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai Y, 2006, P NATL ACAD SCI USA, V103, P9069, DOI 10.1073/pnas.0603453103; Battaglia A, 2008, PEDIATRICS, V121, P404, DOI 10.1542/peds.2007-0929; Beck TF, 2012, HUM MOL GENET; Berk M, 1997, GENE DEV, V11, P2029, DOI 10.1101/gad.11.16.2029; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Cheong JLY, 2008, PEDIATRICS, V121, pE1534, DOI 10.1542/peds.2007-2671; Chiang AP, 2004, AM J HUM GENET, V75, P475, DOI 10.1086/423903; Choudhary R, 2008, AM J PHYSIOL-HEART C, V294, pH633, DOI 10.1152/ajpheart.01301.2007; Colmenares C, 2002, NAT GENET, V30, P106, DOI 10.1038/ng770; Cvekl A, 2009, EXP EYE RES, V89, P280, DOI 10.1016/j.exer.2009.04.012; Doetschman Thomas, 2009, V530, P423, DOI 10.1007/978-1-59745-471-1_23; Gajecka M, 2005, EUR J HUM GENET, V13, P139, DOI 10.1038/sj.ejhg.5201302; Giraudeau F, 2001, J MED GENET, V38, P121, DOI 10.1136/jmg.38.2.121; Golzio C, 2007, AM J HUM GENET, V80, P1179, DOI 10.1086/518177; Heilstedt HA, 2003, AM J HUM GENET, V72, P1200, DOI 10.1086/375179; Heilstedt HA, 2001, EPILEPSIA, V42, P1103, DOI 10.1046/j.1528-1157.2001.08801.x; Hentges KE, 2006, GENE EXPR PATTERNS, V6, P653, DOI 10.1016/j.modgep.2005.11.015; Kang SHL, 2007, CLIN GENET, V72, P329, DOI 10.1111/j.1399-0004.2007.00876.x; KASTNER P, 1994, CELL, V78, P987, DOI 10.1016/0092-8674(94)90274-7; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Linder CC, 2006, ILAR J, V47, P132, DOI 10.1093/ilar.47.2.132; Liu Y, 1996, EXP BRAIN RES, V108, P389; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McIlwain KL, 2001, PHYSIOL BEHAV, V73, P705, DOI 10.1016/S0031-9384(01)00528-5; MENDELSOHN C, 1994, DEVELOPMENT, V120, P2749; Mihalek RM, 1999, P NATL ACAD SCI USA, V96, P12905, DOI 10.1073/pnas.96.22.12905; Mochida GH, 2001, CURR OPIN NEUROL, V14, P151, DOI 10.1097/00019052-200104000-00003; Monaghan AP, 1997, NATURE, V390, P515, DOI 10.1038/37364; Montagutelli X, 2000, J AM SOC NEPHROL, V11, pS101; Murakawa R, 1999, J COMP NEUROL, V411, P413; Nicoulaz A, 2011, AM J MED GENET A, V155A, P1964, DOI 10.1002/ajmg.a.33210; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Niederreither K, 2001, DEVELOPMENT, V128, P1019; Okae H, 2010, DEV DYNAM, V239, P1089, DOI 10.1002/dvdy.22256; Pan J, 2007, VITAM HORM, V75, P257, DOI 10.1016/S0083-6729(06)75010-5; Plaster N, 2007, DEV DYNAM, V236, P1891, DOI 10.1002/dvdy.21196; Probst FJ, 2010, METHOD ENZYMOL, V477, P297, DOI 10.1016/S0076-6879(10)77015-4; Restivo A, 2006, ANAT REC PART A, V288A, P936, DOI 10.1002/ar.a.20367; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; Rosenfeld JA, 2010, AM J MED GENET A, V152A, P1951, DOI 10.1002/ajmg.a.33516; Rudnik-Schoneborn S, 2008, AM J MED GENET A, V146A, P2018, DOI 10.1002/ajmg.a.32405; Sanford LP, 2000, METH MOL B, V158, P217; Sarnat HB, 1998, BRAIN DEV-JPN, V20, P88, DOI 10.1016/S0387-7604(97)00111-3; Savolainen SM, 2009, TOXICOL PATHOL, V37, P395, DOI 10.1177/0192623309335060; Schilling TF, 1996, DEVELOPMENT, V123, P329; Sharkey LM, 2009, J NEUROSCI, V29, P2733, DOI 10.1523/JNEUROSCI.6026-08.2009; Slavotinek A, 1999, J MED GENET, V36, P657; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Stojanovska J, 2012, J THORAC IMAG, V27, P73, DOI 10.1097/RTI.0b013e318218923c; Szabadics J, 2010, J NEUROSCI, V30, P8296, DOI 10.1523/JNEUROSCI.5602-09.2010; Thyagarajan T, 2003, CRIT REV ORAL BIOL M, V14, P154, DOI 10.1177/154411130301400302; Vilhais-Neto GC, 2010, NATURE, V463, P953, DOI 10.1038/nature08763; Wang L, 2006, GENE DEV, V20, P525, DOI 10.1101/gad.1393506; Windpassinger C, 2002, GENE, V292, P25, DOI 10.1016/S0378-1119(02)00649-2; Wu YQ, 1999, HUM MOL GENET, V8, P313, DOI 10.1093/hmg/8.2.313; Xia AP, 2010, DIS MODEL MECH, V3, P209, DOI 10.1242/dmm.004135; Yanagisawa H, 2000, HUM MOL GENET, V9, P1433, DOI 10.1093/hmg/9.9.1433; ZHOU MD, 1995, P NATL ACAD SCI USA, V92, P7391, DOI 10.1073/pnas.92.16.7391; Zoltewicz JS, 2004, DEVELOPMENT, V131, P3, DOI 10.1242/dev.00908	60	106	111	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57460	10.1371/journal.pone.0057460	http://dx.doi.org/10.1371/journal.pone.0057460			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451234	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849500107
J	Kim, BJ; Hannanta-Anan, P; Chau, M; Kim, YS; Swartz, MA; Wu, MM				Kim, Beum Jun; Hannanta-Anan, Pimkhuan; Chau, Michelle; Kim, Yoon Soo; Swartz, Melody A.; Wu, Mingming			Cooperative Roles of SDF-1 alpha and EGF Gradients on Tumor Cell Migration Revealed by a Robust 3D Microfluidic Model	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; CANCER; CHEMOTAXIS; MACROPHAGES; EXPRESSION; MECHANISM; INVASION; DEVICE	Chemokine-mediated directed tumor cell migration within a three dimensional (3D) matrix, or chemoinvasion, is an important early step in cancer metastasis. Despite its clinical importance, it is largely unknown how cytokine and growth factor gradients within the tumor microenvironment regulate chemoinvasion. We studied tumor cell chemoinvasion in well-defined and stable chemical gradients using a robust 3D microfluidic model. We used CXCL12 (also known as SDF-1 alpha) and epidermal growth factor (EGF), two well-known extracellular signaling molecules that co-exist in the tumor microenvironment (e. g. lymph nodes or intravasation sites), and a malignant breast tumor cell line, MDA-MB-231, embedded in type I collagen. When subjected to SDF-1 alpha gradients alone, MDA-MB-231 cells migrated up the gradient, and the measured chemosensitivity (defined as the average cell velocity along the direction of the gradient) followed the ligand - receptor (SDF-1 alpha - CXCR4) binding kinetics. On the other hand, when subjected to EGF gradients alone, tumor cells increased their overall motility, but without statistically significant chemotactic (directed) migration, in contrast to previous reports using 2D chemotaxis assays. Interestingly, we found that the chemoinvasive behavior to SDF-1 alpha gradients was abrogated or even reversed in the presence of uniform concentrations of EGF; however, the presence of SDF-1 alpha and EGF together modulated tumor cell motility cooperatively. These findings demonstrate the capabilities of our microfluidic model in re-creating complex microenvironments for cells, and the importance of cooperative roles of multiple cytokine and growth factor gradients in regulating cell migration in 3D environments.	[Kim, Beum Jun; Hannanta-Anan, Pimkhuan; Chau, Michelle; Kim, Yoon Soo; Wu, Mingming] Cornell Univ, Dept Biol & Environm Engn, Ithaca, NY USA; [Swartz, Melody A.] Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, CH-1015 Lausanne, Switzerland; [Swartz, Melody A.] Ecole Polytech Fed Lausanne, Sch Life Sci, Swiss Inst Expt Canc Res, CH-1015 Lausanne, Switzerland	Cornell University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research	Wu, MM (corresponding author), Cornell Univ, Dept Biol & Environm Engn, Ithaca, NY USA.	mw272@cornell.edu	wu, mingming/GXN-1864-2022; HERNANDEZ-GARCIA, ANDRES/B-9051-2014; KIM, BEUM JUN/G-6829-2011	HERNANDEZ-GARCIA, ANDRES/0000-0002-5343-5513; KIM, BEUM JUN/0000-0003-1797-5026; Hannanta-anan, Pimkhuan/0000-0002-9450-0799; Pereira, Fred/0000-0003-2100-0280	National Cancer Institute [R21CA138366]; Swiss National Science Foundation [IZK0Z3-129723-1]; Cornell Center on the Microenvironment & Metastasis from the National Cancer Institute [U54CA143876]; Cornell NanoScale Science and Technology; Cornell Nanobiotechnology Center	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Cornell Center on the Microenvironment & Metastasis from the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cornell NanoScale Science and Technology; Cornell Nanobiotechnology Center	This work was supported by the National Cancer Institute (Award No R21CA138366), the Swiss National Science Foundation (Award No IZK0Z3-129723-1, International Cooperation), the Cornell Center on the Microenvironment & Metastasis (Award No U54CA143876 from the National Cancer Institute), and the Cornell NanoScale Science and Technology and the Cornell Nanobiotechnology Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhyankar VV, 2008, LAB CHIP, V8, P1507, DOI 10.1039/b803533d; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Cheng SY, 2007, LAB CHIP, V7, P763, DOI 10.1039/b618463d; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Cross VL, 2010, BIOMATERIALS, V31, P8596, DOI 10.1016/j.biomaterials.2010.07.072; Fraley SI, 2010, NAT CELL BIOL, V12, P598, DOI 10.1038/ncb2062; Goswami S, 2005, CANCER RES, V65, P5278, DOI 10.1158/0008-5472.CAN-04-1853; Hachet-Haas M, 2008, J BIOL CHEM, V283, P23189, DOI 10.1074/jbc.M803947200; Haessler U, 2012, INTEGR BIOL-UK, V4, P401, DOI 10.1039/c1ib00128k; Haessler U, 2011, P NATL ACAD SCI USA, V108, P5614, DOI 10.1073/pnas.1014920108; Haessler U, 2009, BIOMED MICRODEVICES, V11, P827, DOI 10.1007/s10544-009-9299-3; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Herzmark P, 2007, P NATL ACAD SCI USA, V104, P13349, DOI 10.1073/pnas.0705889104; Hughes-Alford SK, 2012, CURR OPIN CELL BIOL, V24, P284, DOI 10.1016/j.ceb.2012.01.001; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kim BJ, 2012, ANN BIOMED ENG, V40, P1316, DOI 10.1007/s10439-011-0489-9; Kim S, 2010, INTEGR BIOL-UK, V2, P584, DOI 10.1039/c0ib00055h; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; LEBRUN L, 1993, ENZYME MICROB TECH, V15, P1057, DOI 10.1016/0141-0229(93)90054-6; Maheshwari G, 2001, J CELL BIOL, V155, P1123, DOI 10.1083/jcb.200109060; Mosadegh B, 2008, BIOTECHNOL BIOENG, V100, P1205, DOI 10.1002/bit.21851; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Porcile C, 2005, EXP CELL RES, V308, P241, DOI 10.1016/j.yexcr.2005.04.024; Price JT, 1999, CANCER RES, V59, P5475; Raja WK, 2010, INTEGR BIOL-UK, V2, P696, DOI 10.1039/c0ib00044b; Roussos ET, 2011, NAT REV CANCER, V11, P573, DOI 10.1038/nrc3078; Sawyer C, 2003, CANCER RES, V63, P1667; SCHLESSINGER J, 1986, J CELL BIOL, V103, P2067, DOI 10.1083/jcb.103.6.2067; SCHLESSINGER J, 1988, BIOCHEMISTRY-US, V27, P3119, DOI 10.1021/bi00409a002; Shamloo A, 2008, LAB CHIP, V8, P1292, DOI 10.1039/b719788h; Shields JD, 2007, CANCER CELL, V11, P526, DOI 10.1016/j.ccr.2007.04.020; Soon L, 2005, CELL MOTIL CYTOSKEL, V62, P27, DOI 10.1002/cm.20082; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Sun RH, 2005, CANCER RES, V65, P1433, DOI 10.1158/0008-5472.CAN-04-1163; Sun XQ, 2010, CANCER METAST REV, V29, P709, DOI 10.1007/s10555-010-9256-x; Taylor Anne M., 2006, V321, P167; Valenzuela-Fernandez A, 2001, J BIOL CHEM, V276, P26550, DOI 10.1074/jbc.M100411200; Wang Q, 2005, EMBO REP, V6, P942, DOI 10.1038/sj.embor.7400491; Wang SJ, 2004, EXP CELL RES, V300, P180, DOI 10.1016/j.yexcr.2004.06.030; Wang WG, 2002, CANCER RES, V62, P6278; White JB, 2011, INTEGR BIOL-UK, V3, P1003, DOI 10.1039/c1ib00040c; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wu J, 2010, INVEST NEW DRUG, V28, P268, DOI 10.1007/s10637-009-9242-8; Xue CS, 2006, CANCER RES, V66, P192, DOI 10.1158/0008-5472.CAN-05-1242; ZIGMOND SH, 1977, J CELL BIOL, V75, P606, DOI 10.1083/jcb.75.2.606	49	106	111	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2013	8	7							e68422	10.1371/journal.pone.0068422	http://dx.doi.org/10.1371/journal.pone.0068422			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZN	23451234	Green Submitted, Green Published, gold			2022-12-27	WOS:000323110600016
J	Meng, Q; Kang, J				Meng, Qi; Kang, Jian			Influence of Social and Behavioural Characteristics of Users on Their Evaluation of Subjective Loudness and Acoustic Comfort in Shopping Malls	PLOS ONE			English	Article							RECTANGULAR LONG ENCLOSURES; SPEECH-INTELLIGIBILITY; MULTIPLE LOUDSPEAKERS; REVERBERATION; SOUNDSCAPES; ENVIRONMENT	A large-scale subjective survey was conducted in six shopping malls in Harbin City, China, to determine the influence of social and behavioural characteristics of users on their evaluation of subjective loudness and acoustic comfort. The analysis of social characteristics shows that evaluation of subjective loudness is influenced by income and occupation, with correlation coefficients or contingency coefficients of 0.10 to 0.40 (p<0.05 or p<0.01). Meanwhile, evaluation of acoustic comfort evaluation is influenced by income, education level, and occupation, with correlation coefficients or contingency coefficients of 0.10 to 0.60 (p<0.05 or p<0.01). The effect of gender and age on evaluation of subjective loudness and acoustic comfort is statistically insignificant. The effects of occupation are mainly caused by the differences in income and education level, in which the effects of income are greater than that of education level. In terms of behavioural characteristics, evaluation of subjective loudness is influenced by the reason for visit, frequency of visit, and length of stay, with correlation coefficients or contingency coefficients of 0.10 to 0.40 (p<0.05 or p<0.01). Evaluation of acoustic comfort is influenced by the reason for visit to the site, the frequency of visit, length of stay, and also season of visit, with correlation coefficients of 0.10 to 0.30 (p<0.05 or p<0.01). In particular, users who are waiting for someone show lower evaluation of acoustic comfort, whereas users who go to shopping malls more than once a month show higher evaluation of acoustic comfort. On the contrary, the influence of the period of visit and the accompanying persons are found insignificant.	[Meng, Qi; Kang, Jian] Harbin Inst Technol, Sch Architecture, Harbin 150006, Peoples R China; [Kang, Jian] Univ Sheffield, Sch Architecture, Sheffield, S Yorkshire, England	Harbin Institute of Technology; University of Sheffield	Meng, Q (corresponding author), Harbin Inst Technol, Sch Architecture, Harbin 150006, Peoples R China.	mengq@hit.edu.cn; j.kang@sheffield.ac.uk	Yue, Shanchao/D-1846-2009	Yue, Shanchao/0000-0001-8724-2974; Meng, Qingfeng/0000-0003-0047-3089; Kang, Jian/0000-0001-8995-5636	China Natural Science Foundation [50928801]; PR China Ministry of Education Foundation for PhD Bases [20112302110045]; Harbin Technological Innovation Fund [2012RFXXS046]	China Natural Science Foundation(National Natural Science Foundation of China (NSFC)); PR China Ministry of Education Foundation for PhD Bases; Harbin Technological Innovation Fund	The work was supported by the China Natural Science Foundation (No. 50928801), the PR China Ministry of Education Foundation for PhD Bases (20112302110045) and the Harbin Technological Innovation Fund (2012RFXXS046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertoni D, 1993, P 6 C NOIS PUBL HLTH; Brown AL, 2010, NOISE CONTROL ENG J, V58, P493, DOI 10.3397/1.3484178; Bull Michael, 2000, SOUNDING OUT CITY PE; Chen B., 2004, ARCHIT SCI REV, V47, P107, DOI [10.1080/00038628.2004.9697033, DOI 10.1080/00038628.2004.9697033]; COSMAS SC, 1982, J CONSUM RES, V8, P453, DOI 10.1086/208886; Croome D. J., 1977, NOISE BUILDING PEOPL; Della Crociata S, 2013, BUILD ENVIRON, V59, P369, DOI 10.1016/j.buildenv.2012.09.002; Della Crociata S, 2012, BUILD ENVIRON, V47, P288, DOI 10.1016/j.buildenv.2011.07.011; Deng SC, 1994, CHINESE PUBLIC HLTH, V2, P93; Ellermeier W, 2001, J ACOUST SOC AM, V109, P1464, DOI 10.1121/1.1350402; FIELDS JM, 1993, J ACOUST SOC AM, V93, P2753, DOI 10.1121/1.405851; General Administration of Quality Supervision Inspection and Quarantine of the People's Republic of China, 2008, GB30962008 GEN ADM Q; Harbin Statistical Bureau, 2011, STAT YB HARB 2011; Harbin Statistical Bureau, 2012, STAT YB HARB 2012; Huang L, 2012, BUILD ENVIRON, V49, P304, DOI 10.1016/j.buildenv.2011.07.022; Jin H, 2009, P INT OTT CAN; Job RFS, 1999, P INT FORT LAUD US; Kang J, 1997, APPL ACOUST, V51, P169, DOI 10.1016/S0003-682X(96)00062-X; Kang J, 1996, ACUSTICA, V82, P509; Kang J, 1998, ACUSTICA, V84, P689; Kang J, 2002, ACTA ACUST UNITED AC, V88, P77; Kang J, 1998, J ACOUST SOC AM, V103, P1213, DOI 10.1121/1.421253; Kang J, 1996, APPL ACOUST, V47, P129, DOI 10.1016/0003-682X(95)00037-A; Kang J, 2010, BUILD ENVIRON, V45, P150, DOI 10.1016/j.buildenv.2009.05.014; Kang J, 1996, J ACOUST SOC AM, V99, P985, DOI 10.1121/1.414627; Kang J, 1996, BUILD ENVIRON, V31, P245, DOI 10.1016/0360-1323(95)00046-1; Kang J., 2006, URBAN SOUND ENV; Kang J, 2012, SCI TOTAL ENVIRON, V435, P80, DOI 10.1016/j.scitotenv.2012.06.105; Karlsson Henrik, 2000, J ACOUSTIC ECOLOGY, V1, P10; Li LS, 2006, DESIGN INVESTIGATION; Lin N., 2002, SOCIAL CAPITAL THEOR, V19; Liu SZ, 2011, INT J VENT, V10, P251; Mao Dong-xing, 2009, Technical Acoustics, V28, P693, DOI 10.3969/j.issn1000-3630.2009.06.002; Mehrabian A., 1976, PUBLIC PLACES PRIVAT; Meng Q., 2010, THESIS HARBIN I TECH; Meng Q., 2011, J HARBIN I TECHNO S2, V18, P231; Meng Q., 2010, HUAZHONG ARCHITECTUR, V28, P90; Miedema HME, 1998, J ACOUST SOC AM, V104, P3432, DOI 10.1121/1.423927; Ministry of Environmental Protection of the People's Republic of China, 2008, GB223372008 MIN ENV; Nilsson ME, 2006, ACTA ACUST UNITED AC, V92, P857; Pallant J., 2005, SPSS SURVIVAL GUIDE; Reingold DA, 1999, ECON DEV Q, V13, P23; Schulte-Fortkamp B, 1999, P INT FORT LAUD FL U; Song F, 2011, THESIS HARBIN I TECH; SOUTHWORTH M, 1969, ENVIRON BEHAV, V1, P49; Szeremeta B, 2009, SCI TOTAL ENVIRON, V407, P6143, DOI 10.1016/j.scitotenv.2009.08.039; Tang ZZ, 2009, P EUR 2009 ED SCOTL; Tang ZZ, 2011, J HARBIN I TECHNO S2, V18, P354; Wayne WD, 1979, BUSINESS STAT BASIC; Woolley Helen., 2003, URBAN OPEN SPACES; Yang W, 2005, APPL ACOUST, V66, P211, DOI 10.1016/j.apacoust.2004.07.011; Yang W, 2000, THESIS U SHEFFIELD S; Yang W, 2005, J URBAN DES, V10, P61, DOI 10.1080/13574800500062395; Yu L, 2008, J ACOUST SOC AM, V123, P772, DOI 10.1121/1.2821955; Yu L, 2010, APPL ACOUST, V71, P622, DOI 10.1016/j.apacoust.2010.02.005; Yu L, 2009, J ACOUST SOC AM, V126, P1163, DOI 10.1121/1.3183377; Zhang M, 2007, ENVIRON PLANN B, V34, P68, DOI 10.1068/b31162; Zhang M, 2009, INT J ENVIRON POLLUT, V39, P187, DOI 10.1504/IJEP.2009.027151; Zhao MD, 2009, E MOSCOW HARBIN CITY; Zimmer K, 1999, J ENVIRON PSYCHOL, V19, P295, DOI 10.1006/jevp.1999.0133	60	56	58	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54497	10.1371/journal.pone.0054497	http://dx.doi.org/10.1371/journal.pone.0054497			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	086SQ	23336003	Green Accepted, Green Published, gold			2022-12-27	WOS:000314707700061
J	Li, SH; Arguelles, L; Jiang, F; Chen, WJ; Jin, XM; Yan, CH; Tian, Y; Hong, XM; Qian, C; Zhang, J; Wang, XB; Shen, XM				Li, Shenghui; Arguelles, Lester; Jiang, Fan; Chen, Wenjuan; Jin, Xingming; Yan, Chonghuai; Tian, Ying; Hong, Xiumei; Qian, Ceng; Zhang, Jun; Wang, Xiaobin; Shen, Xiaoming			Sleep, School Performance, and a School-Based Intervention among School-Aged Children: A Sleep Series Study in China	PLOS ONE			English	Article							DAYTIME SLEEPINESS; ACADEMIC-PERFORMANCE; RISK-FACTORS; DURATION; DISTURBANCES; ADOLESCENTS; PREVALENCE; DISRUPTION; DISORDERS; CHILDHOOD	Background: Sufficient sleep during childhood is essential to ensure a transition into a healthy adulthood. However, chronic sleep loss continues to increase worldwide. In this context, it is imperative to make sleep a high-priority and take action to promote sleep health among children. The present series of studies aimed to shed light on sleep patterns, on the longitudinal association of sleep with school performance, and on practical intervention strategy for Chinese school-aged children. Methods and Findings: A serial sleep researches, including a national cross-sectional survey, a prospective cohort study, and a school-based sleep intervention, were conducted in China from November 2005 through December 2009. The national cross-sectional survey was conducted in 8 cities and a random sample of 20,778 children aged 9.0 +/- 1.61 years participated in the survey. The five-year prospective cohort study included 612 children aged 6.8 +/- 0.31 years. The comparative cross-sectional study (baseline: n = 525, aged 10.80 +/- 0.41; post-intervention follow-up: n = 553, aged 10.81 +/- 0.33) was undertaken in 6 primary schools in Shanghai. A battery of parent and teacher reported questionnaires were used to collect information on children's sleep behaviors, school performance, and sociodemographic characteristics. The mean sleep duration was 9.35 +/- 0.77 hours. The prevalence of daytime sleepiness was 64.4% (sometimes: 37.50%; frequently: 26.94%). Daytime sleepiness was significantly associated with impaired attention, learning motivation, and particularly, academic achievement. By contrast, short sleep duration only related to impaired academic achievement. After delaying school start time 30 minutes and 60 minutes, respectively, sleep duration correspondingly increased by 15.6 minutes and 22.8 minutes, respectively. Moreover, intervention significantly improved the sleep duration and daytime sleepiness. Conclusions: Insufficient sleep and daytime sleepiness commonly existed and positively associated with the impairment of school performance, especially academic achievement, among Chinese school-aged children. The effectiveness of delaying school staring time emphasized the benefits of optimal school schedule regulation to children's sleep health.	[Li, Shenghui; Yan, Chonghuai; Zhang, Jun] Shanghai Jiao Tong Univ, MOE Shanghai Key Lab Childrens Environm Hlth, Sch Med, Xinhua Hosp, Shanghai 200030, Peoples R China; [Li, Shenghui; Tian, Ying; Qian, Ceng] Shanghai Jiao Tong Univ, Sch Publ Hlth, Shanghai 200030, Peoples R China; [Arguelles, Lester; Hong, Xiumei; Wang, Xiaobin] Northwestern Univ, Feinberg Sch Med, Mary Ann & J Milburn Smith Child Hlth Res Program, Chicago, IL 60611 USA; [Arguelles, Lester; Hong, Xiumei; Wang, Xiaobin] Childrens Mem Hosp, Chicago, IL 60614 USA; [Arguelles, Lester; Hong, Xiumei; Wang, Xiaobin] Childrens Mem Res Ctr, Chicago, IL USA; [Jiang, Fan; Chen, Wenjuan; Jin, Xingming] Shanghai Jiao Tong Univ, Shanghai Childrens Med Ctr, Sch Med, Shanghai 200030, Peoples R China; [Wang, Xiaobin; Shen, Xiaoming] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Ctr Childhood Origins Dis, Baltimore, MD USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Shanghai Jiao Tong University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Li, SH (corresponding author), Shanghai Jiao Tong Univ, MOE Shanghai Key Lab Childrens Environm Hlth, Sch Med, Xinhua Hosp, Shanghai 200030, Peoples R China.	Lsh9907@163.com; Shenxm9907@126.com	Jiang, Fan/AHA-6297-2022; Jiang, Fan/AGX-9052-2022; CHEN, Haiyong/G-6787-2014; Devreese, Bart/B-2011-2009	Jiang, Fan/0000-0003-0634-101X; Anthony, Arguelles Arias/0000-0003-4359-733X; Fickers, Patrick/0000-0002-2600-5833; CHEN, Haiyong/0000-0002-4889-2752; Devreese, Bart/0000-0002-9764-2581	MOE - Shanghai Key Laboratory of Children's Environmental Health [06DZ22024]; Key Discipline in Public Health of Shanghai Municipal Education Commission; National Natural Science Foundation of China [81072314, 30700670, 81172685]; Innovation Program of Shanghai Municipal Education Commission [13YZ034]; New Bairenjihua in Shanghai Jiaotong University School of Medicine; Shanghai public health academic leader project [GWDTR201222]	MOE - Shanghai Key Laboratory of Children's Environmental Health; Key Discipline in Public Health of Shanghai Municipal Education Commission; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); New Bairenjihua in Shanghai Jiaotong University School of Medicine; Shanghai public health academic leader project	This study was funded by Grants from MOE - Shanghai Key Laboratory of Children's Environmental Health (06DZ22024), the Key Discipline in Public Health of Shanghai Municipal Education Commission, National Natural Science Foundation of China (81072314, 30700670, 81172685), Innovation Program of Shanghai Municipal Education Commission (13YZ034), 2009 New Bairenjihua in Shanghai Jiaotong University School of Medicine, and 2012 Shanghai public health academic leader project (GWDTR201222). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beebe DW, 2010, J ADOLESCENT HEALTH, V47, P523, DOI 10.1016/j.jadohealth.2010.03.005; Bruni O, 2006, SLEEP MED, V7, P43, DOI 10.1016/j.sleep.2005.09.003; Calhoun SL, 2011, SLEEP, V34, P503, DOI 10.1093/sleep/34.4.503; Clinkinbeard SS, 2011, J YOUTH ADOLESCENCE, V40, P916, DOI 10.1007/s10964-010-9594-6; Colten HR, 2006, SLEEP DISORDERS SLEE; Curcio G, 2006, SLEEP MED REV, V10, P323, DOI 10.1016/j.smrv.2005.11.001; Dewald JF, 2010, SLEEP MED REV, V14, P179, DOI 10.1016/j.smrv.2009.10.004; Dexter Donn, 2003, WMJ, V102, P44; Gaina A, 2007, J PEDIATR-US, V151, P518, DOI 10.1016/j.jpeds.2007.04.036; Grandner MA, 2012, SLEEP MED REV, V16, P199, DOI 10.1016/j.smrv.2012.02.001; Gruber R, 2010, SLEEP MED, V11, P289, DOI 10.1016/j.sleep.2009.09.007; Heussler HS, 2005, MED J AUSTRALIA, V182, P484, DOI 10.5694/j.1326-5377.2005.tb06793.x; Holley S, 2010, BEHAV SLEEP MED, V8, P16, DOI 10.1080/15402000903425462; Iglowstein I, 2003, PEDIATRICS, V111, P302, DOI 10.1542/peds.111.2.302; Institute of M. Sleep disorders sleep deprivation, 2006, UNM PUBL HLTH PROBL; Jiang Fan, 2002, Zhonghua Yi Xue Za Zhi, V82, P736; Kerkhof GA, 2010, PROG BRAIN RES, V185, P1, DOI 10.1016/B978-0-444-53702-7.00001-4; Leproult R, 2010, ENDOCR DEV, V17, P11, DOI 10.1159/000262524; Li Sheng-hui, 2007, Zhonghua Er Ke Za Zhi, V45, P176; Li SH, 2007, SLEEP, V30, P361, DOI 10.1093/sleep/30.3.361; Li SH, 2010, SLEEP MED, V11, P907, DOI 10.1016/j.sleep.2010.03.018; Li YC, 2008, SLEEP MED, V9, P142, DOI 10.1016/j.sleep.2007.01.018; Liu XC, 2005, PEDIATRICS, V115, P241, DOI 10.1542/peds.2004-0815F; Matricciani L, 2012, SLEEP MED REV, V16, P203, DOI 10.1016/j.smrv.2011.03.005; Matricciani L, 2011, SLEEP, V34, P651, DOI 10.1093/sleep/34.5.651; Matricciani LA, 2012, PEDIATRICS, V129, P548, DOI 10.1542/peds.2011-2039; Mindell JA, 2003, CLIN GUIDE PEDIAT SL; Mindell JA, 2011, SLEEP MED, V12, P203, DOI 10.1016/j.sleep.2011.01.003; Nieuwenhuis ILC, 2011, BEHAV BRAIN RES, V218, P325, DOI 10.1016/j.bbr.2010.12.009; Nixon GM, 2008, SLEEP, V31, P71, DOI 10.1093/sleep/31.1.71; O'Brien LM, 2009, CHILD ADOL PSYCH CL, V18, P813, DOI 10.1016/j.chc.2009.04.008; Owens JA, 2000, SLEEP, V23, P1043; Owens JA, 2010, ARCH PEDIAT ADOL MED, V164, P608, DOI 10.1001/archpediatrics.2010.96; Perez-Chada D, 2007, SLEEP, V30, P1698, DOI 10.1093/sleep/30.12.1698; Ravid S, 2009, DEV NEUROPSYCHOL, V34, P574, DOI 10.1080/87565640903133533; Ravikiran SR, 2011, INDIAN PEDIATR, V48, P221, DOI 10.1007/s13312-011-0049-2; Seegers V, 2011, AM J EPIDEMIOL, V173, P621, DOI 10.1093/aje/kwq389; Spruyt K, 2005, J SLEEP RES, V14, P163, DOI 10.1111/j.1365-2869.2005.00458.x; Spruyt K, 2011, PEDIATRICS, V127, pE345, DOI 10.1542/peds.2010-0497; Teufel J. A., 2007, American Journal of Health Studies, V22, P10; Wolfson Amy R, 2007, Behav Sleep Med, V5, P194; Yang J., 2007, CHINA J SCH DOCTOR, V21, P379	42	150	156	5	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e67928	10.1371/journal.pone.0067928	http://dx.doi.org/10.1371/journal.pone.0067928			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	182SU	24349428	Green Published, gold, Green Submitted			2022-12-27	WOS:000321765300017
J	Yang, YL; Ji, C; Bi, ZG; Lu, CC; Wang, R; Gu, B; Cheng, L				Yang, Yan-li; Ji, Chao; Bi, Zhi-gang; Lu, Chun-cheng; Wang, Rong; Gu, Bing; Cheng, Lei			Deguelin Induces Both Apoptosis and Autophagy in Cultured Head and Neck Squamous Cell Carcinoma Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CANCER CHEMOPREVENTIVE ACTIVITY; AMPK ACTIVATION; DOWN-REGULATION; AKT INHIBITOR; IN-VITRO; CERAMIDE; GROWTH; HSP90; CONTRIBUTES	Head and neck squamous cell carcinoma (HNSCC) represents more than 5% of all cancers diagnosed annually in United States and around the world. Despite advances in the management of patients with this disease, the survival has not been significantly improved, and the search for potential alternative therapies is encouraging. Here we demonstrate that deguelin administration causes a significant HNSCC cell death. Deguelin induces both cell apoptosis and autophagy by modulating multiple signaling pathways in cultured HNSCC cells. Deguelin inhibits Akt signaling, and down-regulates survivin and cyclin-dependent kinase 4 (Cdk4) expressions, by disrupting their association with heat shock protein-90 (Hsp-90). Deguelin induces ceramide production through de novo synthase pathway to promote HNSCC cell death. Importantly, increased ceramide level activates AMP-activated protein kinase (AMPK), which then directly phosphorylates Ulk1 and eventually leads to cell autophagy. We found that a low dose of deguelin sensitized HNSCC cells to 5-FU. Finally, using a nude mice Hep-2 xenograft model, we also showed a significant anti-tumor ability of deguelin in vivo. Together, we suggest that deguelin may represent a novel and effective chemo-agent against HNSCC.	[Yang, Yan-li; Cheng, Lei] Nanjing Med Univ, Affiliated Hosp 1, Dept Otorhinolaryngol, Nanjing, Jiangsu, Peoples R China; [Ji, Chao] Nanjing Med Univ, Affiliated Hosp 1, Dept Dermatol, Nanjing, Jiangsu, Peoples R China; [Bi, Zhi-gang] Nanjing Med Univ, BenQ Med Ctr, Dept Dermatol, Nanjing, Jiangsu, Peoples R China; [Lu, Chun-cheng] Nanjing Med Univ, Inst Toxicol, Sch Publ Hlth, Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Wang, Rong] Nanjing Med Univ, Res Ctr Bone & Stem Cells, Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Gu, Bing] Nanjing Med Univ, Affiliated Hosp 1, Dept Lab Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Bi, ZG (corresponding author), Nanjing Med Univ, BenQ Med Ctr, Dept Dermatol, Nanjing, Jiangsu, Peoples R China.	eltonbibenqhospital@yahoo.com.cn; jspent@126.com	Cheng, Lei/AAT-2690-2021; yang, yang/HGT-7999-2022; Lang, Ming/HIK-0758-2022; Yang, Ya-Li/GYU-4320-2022	Cheng, Lei/0000-0001-6541-7702; Liu, Rong/0000-0001-7477-6520	National Natural Science Foundation [810701297, 81101188, 30671894, 30972822, 30801016]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Health Promotion Project of Jiangsu Province [XK200719, XK200731, RC2007065, RC2011071]; Science & Technology Development Foundation of Nanjing Medical University, the People's Republic of China [2010NJMUZ19]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Health Promotion Project of Jiangsu Province; Science & Technology Development Foundation of Nanjing Medical University, the People's Republic of China	This research was supported by grants from the National Natural Science Foundation (810701297, 81101188, 30671894, 30972822 and 30801016), the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD 2010-2013), the Health Promotion Project of Jiangsu Province (XK200719, XK200731, RC2007065 and RC2011071), and the Science & Technology Development Foundation of Nanjing Medical University (2010NJMUZ19), the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2004, INT J CANCER, V111, P679, DOI 10.1002/ijc.20333; Bortul R, 2005, BRIT J HAEMATOL, V129, P677, DOI 10.1111/j.1365-2141.2005.05504.x; BOSE R, 1995, CELL, V82, P405, DOI 10.1016/0092-8674(95)90429-8; Bozec A, 2009, EXPERT OPIN EMERG DR, V14, P299, DOI 10.1517/14728210902997947; Brockstein B, 2004, ANN ONCOL, V15, P1179, DOI 10.1093/annonc/mdh308; Bruzzese F, 2006, CLIN CANCER RES, V12, P617, DOI 10.1158/1078-0432.CCR-05-1671; Charles AG, 2001, CANCER CHEMOTH PHARM, V47, P444, DOI 10.1007/s002800000265; Chen MB, 2011, J CELL PHYSIOL, V226, P1915, DOI 10.1002/jcp.22522; Chen MB, 2011, CELL BIOCHEM BIOPHYS, V60, P311, DOI 10.1007/s12013-011-9153-0; Din FVN, 2012, GASTROENTEROLOGY, V142, P1504, DOI 10.1053/j.gastro.2012.02.050; Egan DF, 2011, AUTOPHAGY, V7, P645, DOI 10.4161/auto.7.6.15123; Fortugno P, 2003, P NATL ACAD SCI USA, V100, P13791, DOI 10.1073/pnas.2434345100; Freudlsperger C, 2011, EXPERT OPIN THER TAR, V15, P63, DOI 10.1517/14728222.2011.541440; GERHAUSER C, 1995, NAT MED, V1, P260, DOI 10.1038/nm0395-260; Gills JJ, 2009, CURR ONCOL REP, V11, P102, DOI 10.1007/s11912-009-0016-4; Goerner M, 2010, HEAD NECK ONCOL, V2, DOI 10.1186/1758-3284-2-8; Hwang JT, 2007, CANCER LETT, V247, P115, DOI 10.1016/j.canlet.2006.03.030; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Jang K.Y., 2012, CANC LETT; Jemal A, 2003, CA-CANCER J CLIN, V53, P5, DOI 10.3322/canjclin.53.1.5; Ji C, 2010, ONCOGENE, V29, P6557, DOI 10.1038/onc.2010.379; Ji C, 2012, BIOCH BIOPHYS RES CO; Ji C, 2012, CELL SIGNAL, V24, P1781, DOI 10.1016/j.cellsig.2012.05.003; Ji C, 2012, BIOCHEM BIOPH RES CO, V421, P462, DOI 10.1016/j.bbrc.2012.04.012; Ji C, 2010, INT J MOL MED, V26, P257, DOI 10.3892/ijmm_00000460; Kabakov AE, 2010, J MOL MED, V88, P241, DOI 10.1007/s00109-009-0562-0; Kang MR, 2012, ONCOL REP, V27, P1407, DOI 10.3892/or.2012.1644; Katschinski DM, 2002, J BIOL CHEM, V277, P9262, DOI 10.1074/jbc.M110377200; Kolesnick RN, 1998, ANNU REV PHYSIOL, V60, P643, DOI 10.1146/annurev.physiol.60.1.643; Lee HY, 2005, J NATL CANCER I, V97, P1695, DOI 10.1093/jnci/dji377; Lee JH, 2011, NAT NANOTECHNOL, V6, P418, DOI [10.1038/nnano.2011.95, 10.1038/NNANO.2011.95]; LEE JHW, 2011, J HYDRO-ENVIRON RES, V5, P1, DOI DOI 10.1016/J.JHER.2011.02.001; Lee YK, 2010, CANCER LETT, V292, P228, DOI 10.1016/j.canlet.2009.12.005; Lippert BM, 2007, INT J CANCER, V121, P1169, DOI 10.1002/ijc.22941; Liu YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047049; LoTempio MM, 2005, CLIN CANCER RES, V11, P6994, DOI 10.1158/1078-0432.CCR-05-0301; MERRILL AH, 1993, J BIOL CHEM, V268, P27299; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Moral M, 2008, HISTOL HISTOPATHOL, V23, P1269, DOI 10.14670/HH-23.1269; Murillo G, 2003, INT J CANCER, V104, P7, DOI 10.1002/ijc.10901; Nagalingam A, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3128; Nair AS, 2006, J IMMUNOL, V177, P5612, DOI 10.4049/jimmunol.177.8.5612; Oh SH, 2007, J NATL CANCER I, V99, P949, DOI 10.1093/jnci/djm007; Peng XH, 2007, MOL PHARMACOL, V71, P101, DOI 10.1124/mol.106.027367; Peng YH, 2001, J BIOL CHEM, V276, P40583, DOI 10.1074/jbc.M102817200; Reynolds CP, 2004, CANCER LETT, V206, P169, DOI 10.1016/j.canlet.2003.08.034; Roach PJ, 2011, MOL CELL BIOL, V31, P3082, DOI 10.1128/MCB.05565-11; Rocha GZ, 2011, CLIN CANCER RES, V17, P3993, DOI 10.1158/1078-0432.CCR-10-2243; Rosenfeldt MT, 2011, CARCINOGENESIS, V32, P955, DOI 10.1093/carcin/bgr031; Sano D, 2011, HEAD NECK-J SCI SPEC, V33, P349, DOI 10.1002/hed.21455; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Simmonds MA, 2003, CA-CANCER J CLIN, V53, P4, DOI 10.3322/canjclin.53.1.4; Sommer K, 2001, INT J ONCOL, V18, P1145; STELL PM, 1989, EUR J SURG ONCOL, V15, P407; STELL PM, 1991, HEAD NECK-J SCI SPEC, V13, P277, DOI 10.1002/hed.2880130403; Stepanova L, 1996, GENE DEV, V10, P1491, DOI 10.1101/gad.10.12.1491; Sun H, 2011, CANCER LETT, V310, P118, DOI 10.1016/j.canlet.2011.06.010; Tripathi A, 2003, J CANCER RES CLIN, V129, P642, DOI 10.1007/s00432-003-0485-z; Udeani GO, 1997, CANCER RES, V57, P3424; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Veldman RJ, 1998, BIOCHEM J, V331, P563, DOI 10.1042/bj3310563; Wang CG, 2003, J BIOL CHEM, V278, P2066, DOI 10.1074/jbc.M206697200; Yao C, 2012, CELL BIOCH BIOPHYS; Zhang WB, 2010, J BIOL CHEM, V285, P40461, DOI 10.1074/jbc.M110.164046; Zheng QY, 2012, BIOCHEM BIOPH RES CO, V419, P741, DOI 10.1016/j.bbrc.2012.02.093; Zhu QY, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2010.96	66	286	295	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54736	10.1371/journal.pone.0054736	http://dx.doi.org/10.1371/journal.pone.0054736			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23383172	Green Published, Green Submitted, gold			2022-12-27	WOS:000314021500119
J	Williams, O; Gbadero, D; Edowhorhu, G; Brearley, A; Slusher, T; Lund, TC				Williams, Olatundun; Gbadero, Daniel; Edowhorhu, Grace; Brearley, Ann; Slusher, Tina; Lund, Troy C.			Glucose-6-Phosphate Dehydrogenase Deficiency in Nigerian Children	PLOS ONE			English	Article							ANEMIA	Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common human enzymopathy and in Sub-Saharan Africa, is a significant cause of infection-and drug-induced hemolysis and neonatal jaundice. Our goals were to determine the prevalence of G6PD deficiency among Nigerian children of different ethnic backgrounds and to identify predictors of G6PD deficiency by analyzing vital signs and hematocrit and by asking screening questions about symptoms of hemolysis. We studied 1,122 children (561 males and 561 females) aged 1 month to 15 years. The mean age was 7.4 +/- 3.2 years. Children of Yoruba ethnicity made up the largest group (77.5%) followed by those Igbo descent (10.6%) and those of Igede (10.2%) and Tiv (1.8%) ethnicity. G6PD status was determined using the fluorescent spot method. We found that the overall prevalence of G6PD deficiency was 15.3% (24.1% in males, 6.6% in females). Yoruba children had a higher prevalence (16.9%) than Igede (10.5%), Igbo (10.1%) and Tiv (5.0%) children. The odds of G6PD deficiency were 0.38 times as high in Igbo children compared to Yoruba children (p = 0.0500). The odds for Igede and Tiv children were not significantly different from Yoruba children (p = 0.7528 and 0.9789 respectively). Mean oxygen saturation, heart rate and hematocrit were not significantly different in G6PD deficient and G6PD sufficient children. The odds of being G6PD deficient were 2.1 times higher in children with scleral icterus than those without (p = 0.0351). In conclusion, we determined the prevalence of G6PD deficiency in Nigerian sub-populations. The odds of G6PD deficiency were decreased in Igbo children compared to Yoruba children. There was no association between vital parameters or hematocrit and G6PD deficiency. We found that a history of scleral icterus may increase the odds of G6PD deficiency, but we did not exclude other common causes of icterus such as sickle cell disease or malarial infection.	[Williams, Olatundun; Slusher, Tina; Lund, Troy C.] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Williams, Olatundun; Slusher, Tina; Lund, Troy C.] Univ Minnesota, Div Global Hlth, Minneapolis, MN USA; [Gbadero, Daniel] Bowen Univ, Teaching Hosp, Dept Pediat, Ogbomosho, Nigeria; [Edowhorhu, Grace] Bowen Univ, Teaching Hosp, Dept Lab Med, Ogbomosho, Nigeria; [Brearley, Ann] Univ Minnesota, Biostat Design & Anal Ctr, Clin & Translat Sci Inst, Minneapolis, MN USA; [Lund, Troy C.] Univ Minnesota, Div Blood & Marrow Transplant, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Lund, TC (corresponding author), Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA.	lundx072@umn.edu			National Center for Research Resources [UL1TR000114]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000114] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Biostatistics was made available through grant UL1TR000114 from the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1989, B WORLD HEALTH ORGAN, V67, P601; BEUTLER E, 1968, BLOOD, V32, P816, DOI 10.1182/blood.V32.5.816.816; BIENZLE U, 1975, BLOOD, V46, P591, DOI 10.1182/blood.V46.4.591.591; Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2; Clark TG, 2009, EUR J HUM GENET, V17, P1080, DOI 10.1038/ejhg.2009.8; Kaplan M, 2011, SEMIN PERINATOL, V35, P155, DOI 10.1053/j.semperi.2011.02.010; May J, 2000, TROP MED INT HEALTH, V5, P119, DOI 10.1046/j.1365-3156.2000.00529.x; Orimadegun AE, 2011, J INFECT DEV COUNTR, V5, P792, DOI 10.3855/jidc.1837; Peters AL, 2009, J HISTOCHEM CYTOCHEM, V57, P1003, DOI 10.1369/jhc.2009.953828; STEINBERG MH, 1988, BLOOD, V71, P748	10	39	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e68800	10.1371/journal.pone.0068800	http://dx.doi.org/10.1371/journal.pone.0068800			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	24349006	Green Submitted, Green Published, gold			2022-12-27	WOS:000321718700041
J	Li, K; Chi, Y; Gao, K; Yan, QJ; Matsue, H; Takeda, M; Kitamura, M; Yao, J				Li, Kai; Chi, Yuan; Gao, Kun; Yan, Qiaojing; Matsue, Hiroyuki; Takeda, Masayuki; Kitamura, Masanori; Yao, Jian			Connexin43 Hemichannel-Mediated Regulation of Connexin43	PLOS ONE			English	Article							JUNCTIONAL INTERCELLULAR COMMUNICATION; GAP-JUNCTIONS; SIGNAL-TRANSDUCTION; OXIDATIVE STRESS; GENE-EXPRESSION; LLC-PK1 CELLS; CADMIUM CD2+; C-JUN; PLASMA-MEMBRANE; UP-REGULATION	Background: Many signaling molecules and pathways that regulate gap junctions (GJs) protein expression and function are, in fact, also controlled by GJs. We, therefore, speculated an existence of the GJ channel-mediated self-regulation of GJs. Using a cell culture model in which nonjunctional connexin43 (Cx43) hemichannels were activated by cadmium (Cd2+), we tested this hypothesis. Principal Findings: Incubation of Cx43-transfected LLC-PK1 cells with Cd2+ led to an increased expression of Cx43. This effect of Cd2+ was tightly associated with JNK activation. Inhibition of JNK abolished the elevation of Cx43. Further analysis revealed that the changes of JNK and Cx43 were controlled by GSH. Supplement of a membrane-permeable GSH analogue GSH ethyl ester or GSH precursor N-acetyl-cystein abrogated the effects of Cd2+ on JNK activation and Cx43 expression. Indeed, Cd2+ induced extracellular release of GSH. Blockade of Cx43 hemichannels with heptanol or Cx43 mimetic peptide Gap26 to prevent the efflux of GSH significantly attenuated the Cx43-elevating effects of Cd2+. Conclusions: Collectively, our results thus indicate that Cd2+-induced upregulation of Cx43 is through activation of nonjunctional Cx43 hemichannels. Our findings thus support the existence of a hemichannel-mediated self-regulation of Cx43 and provide novel insights into the molecular mechanisms of Cx43 expression and function.	[Li, Kai; Chi, Yuan; Gao, Kun; Yan, Qiaojing; Kitamura, Masanori; Yao, Jian] Univ Yamanashi, Dept Mol Signaling, Interdisciplinary Grad Sch Med & Engn, Chuo Ku, Yamanashi, Japan; [Li, Kai; Takeda, Masayuki] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Urol, Chuo Ku, Yamanashi, Japan; [Li, Kai] China Med Univ, Hosp 1, Dept Surg Oncol & Gen Surg, Shenyang, Peoples R China; [Matsue, Hiroyuki] Chiba Univ, Sch Med, Dept Dermatol, Chiba 280, Japan	University of Yamanashi; University of Yamanashi; China Medical University; Chiba University	Li, K (corresponding author), Univ Yamanashi, Dept Mol Signaling, Interdisciplinary Grad Sch Med & Engn, Chuo Ku, Yamanashi, Japan.	cmu_likai@hotmail.com; yao@yamanashi.ac.jp	; Li, Ke/I-3804-2013	Yao, Jian/0000-0003-2622-0215; Li, Ke/0000-0003-4869-5393	Ministry of Education, Culture, Sports, Science and Technology, Japan [17659255, 20590953, B21390324]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (17659255 and 20590953 to JY; B21390324 to HM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthoud VM, 2009, ANTIOXID REDOX SIGN, V11, P339, DOI 10.1089/ars.2008.2119; Carmeli C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029341; Chaytor AT, 1998, J PHYSIOL-LONDON, V508, P561, DOI 10.1111/j.1469-7793.1998.561bq.x; Cherian PP, 2005, MOL BIOL CELL, V16, P3100, DOI 10.1091/mbc.E04-10-0912; D'hondt C, 2007, INVEST OPHTH VIS SCI, V48, P120, DOI 10.1167/iovs.06-0770; Evans WH, 2006, BIOCHEM J, V397, P1, DOI 10.1042/BJ20060175; Evans WH, 2012, J MEMBRANE BIOL, V245, P437, DOI 10.1007/s00232-012-9488-5; Fang X, 2011, ANTIOXID REDOX SIGN, V14, P2427, DOI 10.1089/ars.2010.3150; Gao FH, 2007, BIOCHEM BIOPH RES CO, V356, P505, DOI 10.1016/j.bbrc.2007.03.009; Gennari A, 2003, TOXICOLOGY, V183, P211, DOI 10.1016/S0300-483X(02)00546-2; Giepmans BNG, 2004, CARDIOVASC RES, V62, P233, DOI 10.1016/j.cardiores.2003.12.009; HEW KW, 1993, BIOL REPROD, V49, P840, DOI 10.1095/biolreprod49.4.840; Huang T, 2010, CANCER SCI, V101, P713, DOI 10.1111/j.1349-7006.2009.01421.x; Lawal AO, 2010, J TOXICOL SCI, V35, P465, DOI 10.2131/jts.35.465; Li K, 2011, J BIOL CHEM, V286, P41552, DOI 10.1074/jbc.M111.274449; Liu J, 2009, TOXICOL APPL PHARM, V238, P209, DOI 10.1016/j.taap.2009.01.029; Loch-Caruso R, 2005, TOXICOL SCI, V85, P694, DOI 10.1093/toxsci/kfi123; Majoul IV, 2009, HISTOCHEM CELL BIOL, V132, P263, DOI 10.1007/s00418-009-0617-x; Martin PEM, 2001, J CELL SCI, V114, P3845; Mendoza-Naranjo A, 2007, J IMMUNOL, V178, P6949, DOI 10.4049/jimmunol.178.11.6949; Mitchell JA, 2001, CELL COMMUN ADHES, V8, P299, DOI 10.3109/15419060109080741; Oviedo-Orta E, 2001, FASEB J, V15, P768, DOI 10.1096/fj.00-0288com; Ponsaerts R, 2010, FASEB J, V24, P4378, DOI 10.1096/fj.09-153007; PROZIALECK WC, 1991, TOXICOL APPL PHARM, V107, P81, DOI 10.1016/0041-008X(91)90333-A; PROZIALECK WC, 1995, TOXICOL APPL PHARM, V134, P285, DOI 10.1006/taap.1995.1194; Prozialeck WC, 1997, IN VITRO CELL DEV-AN, V33, P516; Prozialeck WC, 1998, TOXICOL IN VITRO, V12, P633, DOI 10.1016/S0887-2333(98)00054-X; Ramachandran S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000712; Retamal MA, 2007, P NATL ACAD SCI USA, V104, P8322, DOI 10.1073/pnas.0702456104; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Salameh A, 2008, J PHARMACOL EXP THER, V326, P315, DOI 10.1124/jpet.108.136663; Shyu KG, 2004, CARDIOVASC RES, V63, P98, DOI 10.1016/j.cardiores.2004.02.018; Son MH, 2001, BIOCHEM PHARMACOL, V62, P1379, DOI 10.1016/S0006-2952(01)00780-8; Stridh MH, 2008, J BIOL CHEM, V283, P10347, DOI 10.1074/jbc.M704153200; Stridh MH, 2010, NEUROCHEM RES, V35, P1231, DOI 10.1007/s11064-010-0179-2; Tacheau C, 2008, J CELL PHYSIOL, V217, P759, DOI 10.1002/jcp.21551; Thevenod F, 2000, J BIOL CHEM, V275, P1887, DOI 10.1074/jbc.275.3.1887; Thomas T, 2005, J CELL SCI, V118, P4451, DOI 10.1242/jcs.02569; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Upham BL, 1997, CARCINOGENESIS, V18, P37, DOI 10.1093/carcin/18.1.37; Upham BL, 2009, ANTIOXID REDOX SIGN, V11, P297, DOI 10.1089/ars.2008.2146; Wilhelm D, 1997, MOL CELL BIOL, V17, P4792, DOI 10.1128/MCB.17.8.4792; Yao J, 2003, CIRC RES, V93, P338, DOI 10.1161/01.RES.0000086802.21850.5D; Yao J, 2010, BRIT J PHARM, P9999; Yao J, 2007, J MEMBRANE BIOL, V217, P123, DOI 10.1007/s00232-007-9023-2; Yao J, 2009, AM J PHYSIOL-RENAL, V296, pF939, DOI 10.1152/ajprenal.90612.2008; Yokouchi M, 2008, J BIOL CHEM, V283, P4252, DOI 10.1074/jbc.M705951200	47	256	266	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e58057	10.1371/journal.pone.0058057	http://dx.doi.org/10.1371/journal.pone.0058057			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23874530	Green Submitted, Green Published, gold			2022-12-27	WOS:000315519000181
J	Li, KR; Zhang, ZQ; Yao, J; Zhao, YX; Duan, J; Cao, C; Jiang, Q				Li, Ke-ran; Zhang, Zhi-qing; Yao, Jin; Zhao, Yu-xia; Duan, Jing; Cao, Cong; Jiang, Qin			Ginsenoside Rg-1 Protects Retinal Pigment Epithelium (RPE) Cells from Cobalt Chloride (CoCl2) and Hypoxia Assaults	PLOS ONE			English	Article							N-TERMINAL KINASE; SIGNALING PATHWAY; INDUCED APOPTOSIS; OXIDATIVE STRESS; IN-VITRO; RG1 PROTECTS; CANCER CELLS; PC12 CELLS; P38 MAPK; ACTIVATION	Severe retinal ischemia causes persistent visual impairments in eye diseases. Retinal pigment epithelium (RPE) cells are located near the choroidal capillaries, and are easily affected by ischemic or hypoxia. Ginsenoside Rg-1 has shown significant neuroprotective effects. This study was performed to test the cytoprotective effect of ginsenoside Rg-1 in RPE cells against hypoxia and cobalt chloride (CoCl2) assaults, and to understand the underlying mechanisms. We found that Rg-1 pre-administration significantly inhibited CoCl2- and hypoxia-induced RPE cell death and apoptosis. Reactive oxygen specisis (ROS)-dependent p38 and c-Jun NH(2)-terminal kinases (JNK) MAPK activation was required for CoCl2-induced RPE cell death, and Rg-1 pre-treatment significantly inhibited ROS production and following p38/JNK activation. Further, CoCl2 suppressed pro-survival mTOR complex 1 (mTORC1) activation in RPE cells through activating of AMP-activated protein kinase (AMPK), while Rg-1 restored mTORC1 activity through inhibiting AMPK activation. CoCl2-induced AMPK activation was also dependent on ROS production, and anti-oxidant N-acetylcysteine (NAC) prevented AMPK activation and RPE cell death by CoCl2. Our results indicated that Rg-1 could be further investigated as a novel cell-protective agent for retinal ischemia.	[Li, Ke-ran; Yao, Jin; Zhao, Yu-xia; Jiang, Qin] Nanjing Med Univ, Affiliated Eye Hosp, Dept Eye, Nanjing, Jiangsu, Peoples R China; [Zhang, Zhi-qing; Cao, Cong] Soochow Univ, Inst Neurosci, Suzhou, Jiangsu, Peoples R China; [Duan, Jing] China Pharmaceut Univ, Acad Inst Pharmaceut Sci, Ctr Safety Evaluat Drugs, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Soochow University - China; China Pharmaceutical University	Cao, C (corresponding author), Soochow Univ, Inst Neurosci, Suzhou, Jiangsu, Peoples R China.	caocong@suda.edu.cn; dryaojin@yahoo.com	; Li, Ke/I-3804-2013	Yao, Jian/0000-0003-2622-0215; Li, Ke/0000-0003-4869-5393	National Natural Science Foundation of China [81070744, 81271028]; Jiangsu Province [1002009B]; Medical Science and Technology Development Project Fund of Nanjing [ZKX12047, YKK12208, YKK12207]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province; Medical Science and Technology Development Project Fund of Nanjing	This work was generously supported by grants from the National Natural Science Foundation of China (Nos. 81070744, 81271028), post-doc fund of Jiangsu Province (No. 1002009B) and Medical Science and Technology Development Project Fund of Nanjing (ZKX12047, YKK12208, YKK12207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borutaite Vilmante, 2008, Biochem J, V412, pe15, DOI 10.1042/BJ20080712; Boulton M, 2001, EYE, V15, P384, DOI 10.1038/eye.2001.141; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Buettner C, 2006, ANN PHARMACOTHER, V40, P83, DOI 10.1345/aph.1G216; Cao C, 2008, J BIOL CHEM, V283, P28897, DOI 10.1074/jbc.M804144200; Chen L, 2010, LAB INVEST, V90, P762, DOI 10.1038/labinvest.2010.36; Chen MB, 2012, INT J CANC; Chen MB, 2011, J CELL PHYSIOL, V226, P1915, DOI 10.1002/jcp.22522; Chen MB, 2011, CELL BIOCHEM BIOPHYS, V60, P311, DOI 10.1007/s12013-011-9153-0; Chen WF, 2013, NEUROCHEM INT, V62, P1065, DOI 10.1016/j.neuint.2013.03.018; Chen XC, 2002, ACTA PHARMACOL SIN, V23, P829; Chen ZY, 2013, MOL CELL BIOCHEM, V377, P35, DOI 10.1007/s11010-013-1568-z; Du JH, 2005, BIOCHEM BIOPH RES CO, V337, P1139, DOI 10.1016/j.bbrc.2005.09.174; Du ZJ, 2011, INVEST OPHTH VIS SCI, V52, P987, DOI 10.1167/iovs.10-5557; Fang F, 2012, BBA-MOL BASIS DIS, V1822, P286, DOI 10.1016/j.bbadis.2011.10.004; Fernandes AF, 2008, J BIOL CHEM, V283, P20745, DOI 10.1074/jbc.M800268200; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardy P, 2005, PROSTAG LEUKOTR ESS, V72, P301, DOI 10.1016/j.plefa.2005.02.004; Hayashi T, 2000, DIABETES, V49, P527, DOI 10.2337/diabetes.49.4.527; Huong NTT, 1998, BIOL PHARM BULL, V21, P978, DOI 10.1248/bpb.21.978; Imamura K, 2001, BIOCHEM BIOPH RES CO, V287, P562, DOI 10.1006/bbrc.2001.5627; Inoki K, 2012, ANNU REV PHARMACOL, V52, P381, DOI 10.1146/annurev-pharmtox-010611-134537; Joo SS, 2005, PLANTA MED, V71, P476, DOI 10.1055/s-2005-864145; Kang MR, 2012, ONCOL REP, V27, P1407, DOI 10.3892/or.2012.1644; Kefas BA, 2003, J MOL ENDOCRINOL, V30, P151, DOI 10.1677/jme.0.0300151; Kim HJ, 2013, J GINSENG RES, V37, P8, DOI 10.5142/jgr.2013.37.8; Kim MH, 2008, APOPTOSIS, V13, P295, DOI 10.1007/s10495-007-0160-y; Kunz M, 2001, CELL GROWTH DIFFER, V12, P137; Lee MS, 2010, PHYTOTHER RES, V24, P1857, DOI 10.1002/ptr.3210; Leung KW, 2007, NEUROPHARMACOLOGY, V52, P827, DOI 10.1016/j.neuropharm.2006.10.001; Li CY, 2002, AM J PHYSIOL-CELL PH, V282, pC227, DOI 10.1152/ajpcell.00112.2001; Li J, 2005, CIRC RES, V97, P872, DOI 10.1161/01.RES.0000187458.77026.10; Li J. Q., 1997, Yaoxue Xuebao, V32, P406; Li W, 2012, BRAIN RES BULL, V88, P501, DOI 10.1016/j.brainresbull.2012.05.002; Liao BS, 2002, EXP NEUROL, V173, P224, DOI 10.1006/exnr.2001.7841; Liu QA, 2011, NEUROCHEM INT, V58, P119, DOI 10.1016/j.neuint.2010.11.004; Liu ZJ, 2010, BRAIN RES, V1333, P1, DOI 10.1016/j.brainres.2010.03.096; Meisse D, 2002, FEBS LETT, V526, P38, DOI 10.1016/S0014-5793(02)03110-1; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Mizushina Y, 2000, BIOCHEM J, V350, P757, DOI 10.1042/0264-6021:3500757; Mu Yan-Yue, 2012, Zhongguo Zhong Xi Yi Jie He Za Zhi, V32, P1539; Nag SA, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00025; Okoshi R, 2008, J BIOL CHEM, V283, P3979, DOI 10.1074/jbc.M705232200; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; Shen L, 2007, ACTA PHARMACOL SIN, V28, P392, DOI 10.1111/j.1745-7254.2007.00511.x; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Terai K, 2005, MOL CELL BIOL, V25, P9554, DOI 10.1128/MCB.25.21.9554-9575.2005; Vogler BK, 1999, EUR J CLIN PHARMACOL, V55, P567, DOI 10.1007/s002280050674; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990; Wang Qiao-Yun, 2013, Zhongguo Zhong Xi Yi Jie He Za Zhi, V33, P229; Wang Wei-xia, 2005, Zhongguo Zhong Xi Yi Jie He Za Zhi, V25, P89; Wu CF, 2007, INT IMMUNOPHARMACOL, V7, P313, DOI 10.1016/j.intimp.2006.04.021; Wu JY, 2012, NEUROPHARMACOLOGY, V63, P349, DOI 10.1016/j.neuropharm.2012.04.005; Xu HM, 2010, NEUROPHARMACOLOGY, V58, P488, DOI 10.1016/j.neuropharm.2009.09.002; Yang XH, 2010, WORLD J GASTROENTERO, V16, P3385, DOI 10.3748/wjg.v16.i27.3385; Yao J, 2013, INT J MOL SCI, V14, P10355, DOI 10.3390/ijms140510355; Yap TA, 2011, J CLIN ONCOL, V29, P4688, DOI 10.1200/JCO.2011.35.5263; Zhang XY, 2008, INVEST OPHTH VIS SCI, V49, P3622, DOI 10.1167/iovs.07-1559; Zheng QY, 2012, BIOCH BIOPHYS RES CO; Zhu D, 2009, J CELL BIOCHEM, V108, P117, DOI 10.1002/jcb.22233; Zong Y, 2012, CURR MED CHEM, V19, P770, DOI 10.2174/092986712798992066	62	256	266	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84171	10.1371/journal.pone.0084171	http://dx.doi.org/10.1371/journal.pone.0084171			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	23874530	Green Published, Green Submitted, gold			2022-12-27	WOS:000329117900080
